id|nct_id|result_group_id|ctgov_group_code|period|reason|count
1562344|NCT04123665|5377772|P2|Overall Study|Lost to Follow-up|0
1562345|NCT04123665|5377773|P1|Overall Study|Lost to Follow-up|1
1562346|NCT04123665|5377772|P2|Overall Study|Withdrawal by Subject|0
1562347|NCT04123665|5377773|P1|Overall Study|Withdrawal by Subject|7
1562348|NCT04106817|5377837|P3|Overall Study|Lost to Follow-up|0
1562349|NCT04106817|5377838|P2|Overall Study|Lost to Follow-up|0
1562350|NCT04106817|5377839|P1|Overall Study|Lost to Follow-up|1
1562351|NCT04098809|5377855|P2|Overall Study|Physician Decision|1
1562352|NCT04098809|5377856|P1|Overall Study|Physician Decision|2
1562353|NCT04098809|5377855|P2|Overall Study|Withdrawal by Subject|3
1562354|NCT04098809|5377856|P1|Overall Study|Withdrawal by Subject|1
1562355|NCT04091659|5377884|P2|Overall Study|Lost to Follow-up|1
1562356|NCT04091659|5377885|P1|Overall Study|Lost to Follow-up|0
1562357|NCT04091659|5377884|P2|Overall Study|Protocol Violation|0
1562358|NCT04091659|5377885|P1|Overall Study|Protocol Violation|3
1562359|NCT04048681|5378014|P5|Overall Study|family emergency|0
1562360|NCT04048681|5378015|P4|Overall Study|family emergency|1
1562361|NCT04048681|5378016|P3|Overall Study|family emergency|0
1562362|NCT04048681|5378017|P2|Overall Study|family emergency|0
1562363|NCT04048681|5378018|P1|Overall Study|family emergency|0
1562364|NCT04032652|5378099|P2|Overall Study|The study was terminated and the PI has|1
1562365|NCT04032652|5378100|P1|Overall Study|The study was terminated and the PI has|1
1562366|NCT04015232|5378170|P2|Overall Study|Medical Grounds|3
1562367|NCT04015232|5378171|P1|Overall Study|Medical Grounds|3
1562368|NCT04015232|5378170|P2|Overall Study|Protocol Violation|0
1562369|NCT04015232|5378171|P1|Overall Study|Protocol Violation|1
1562370|NCT04015232|5378170|P2|Overall Study|Withdrawal by Subject|4
1562371|NCT04015232|5378171|P1|Overall Study|Withdrawal by Subject|7
1562372|NCT04014062|5378243|P2|Period I: Dosing|Withdrawal by Subject|1
1562373|NCT04014062|5378244|P1|Period I: Dosing|Withdrawal by Subject|3
1562374|NCT04014062|5378243|P2|Period I: Dosing|Medical Grounds|5
1562375|NCT04014062|5378244|P1|Period I: Dosing|Medical Grounds|4
1562378|NCT03982433|5378317|P1|Overall Study|Lost to Follow-up|1
1562379|NCT03966365|5378621|P2|Overall Study|Protocol Violation|0
1562380|NCT03966365|5378622|P1|Overall Study|Protocol Violation|1
1562382|NCT03965052|5378653|P2|Overall Study|Protocol Violation|0
1562383|NCT03965052|5378654|P1|Overall Study|Protocol Violation|1
1562384|NCT03961308|5378674|P2|Overall Study|Adverse Event|1
1562385|NCT03961308|5378675|P1|Overall Study|Adverse Event|0
1562386|NCT03961308|5378674|P2|Overall Study|Lost to Follow-up|1
1562387|NCT03961308|5378675|P1|Overall Study|Lost to Follow-up|0
1562388|NCT03961308|5378674|P2|Overall Study|Other|0
1562389|NCT03961308|5378675|P1|Overall Study|Other|1
1562390|NCT03961308|5378674|P2|Overall Study|Withdrawal by Subject|0
1562391|NCT03961308|5378675|P1|Overall Study|Withdrawal by Subject|1
1562392|NCT03948581|5378713|P2|Overall Study|Lost to Follow-up|1
1562393|NCT03948581|5378714|P1|Overall Study|Lost to Follow-up|0
1562394|NCT03946124|5378724|P1|Overall Study|Withdrawal by Subject|19
1562395|NCT03927950|5378987|P1|Overall Study|Adverse Event|9
1562396|NCT03905642|5379014|P1|Overall Study|Completed study but not 24 of 28 days|2
1562397|NCT03905642|5379014|P1|Overall Study|Lack of Efficacy|1
1562398|NCT03905642|5379014|P1|Overall Study|Adverse Event|1
1562399|NCT03905642|5379014|P1|Overall Study|Pregnancy|1
1562400|NCT03905642|5379014|P1|Overall Study|Withdrawal by Subject|3
1562401|NCT03902392|5379025|P2|Overall Study|Lost to Follow-up|7
1562402|NCT03902392|5379026|P1|Overall Study|Lost to Follow-up|7
1562403|NCT03892564|5379174|P1|Overall Study|Withdrawal by Subject|2
1562404|NCT03888391|5379201|P1|Overall Study|Lost to Follow-up|15
1562405|NCT03882047|5379214|P3|Overall Study|Did Not Meet Eligibility|1
1562406|NCT03882047|5379215|P2|Overall Study|Did Not Meet Eligibility|0
1562407|NCT03882047|5379216|P1|Overall Study|Did Not Meet Eligibility|0
1562408|NCT03882047|5379214|P3|Overall Study|Noncompliance With Protocol|0
1562409|NCT03882047|5379215|P2|Overall Study|Noncompliance With Protocol|0
1562410|NCT03882047|5379216|P1|Overall Study|Noncompliance With Protocol|2
1562411|NCT03882047|5379214|P3|Overall Study|Did Not Wish to Continue|1
1562412|NCT03882047|5379215|P2|Overall Study|Did Not Wish to Continue|4
1562413|NCT03882047|5379216|P1|Overall Study|Did Not Wish to Continue|1
1562414|NCT03882047|5379214|P3|Overall Study|Lost to Follow-up|0
1562415|NCT03882047|5379215|P2|Overall Study|Lost to Follow-up|1
1562416|NCT03882047|5379216|P1|Overall Study|Lost to Follow-up|0
1562417|NCT03882047|5379214|P3|Overall Study|Treatment Failure|12
1562418|NCT03882047|5379215|P2|Overall Study|Treatment Failure|3
1562419|NCT03882047|5379216|P1|Overall Study|Treatment Failure|3
1562420|NCT03882047|5379214|P3|Overall Study|Adverse Event|2
1562421|NCT03882047|5379215|P2|Overall Study|Adverse Event|2
1562422|NCT03882047|5379216|P1|Overall Study|Adverse Event|0
1562423|NCT03879772|5379272|P5|Overall Study|Did Not Meet Entry Requirements|0
1562424|NCT03879772|5379273|P4|Overall Study|Did Not Meet Entry Requirements|0
1562425|NCT03879772|5379274|P3|Overall Study|Did Not Meet Entry Requirements|1
1562426|NCT03879772|5379275|P2|Overall Study|Did Not Meet Entry Requirements|0
1562427|NCT03879772|5379276|P1|Overall Study|Did Not Meet Entry Requirements|1
1562428|NCT03879772|5379272|P5|Overall Study|Protocol Violation|2
1562429|NCT03879772|5379273|P4|Overall Study|Protocol Violation|1
1562430|NCT03879772|5379274|P3|Overall Study|Protocol Violation|3
1562431|NCT03879772|5379275|P2|Overall Study|Protocol Violation|0
1562432|NCT03879772|5379276|P1|Overall Study|Protocol Violation|0
1562433|NCT03879772|5379272|P5|Overall Study|Withdrawal by Subject|1
1562434|NCT03879772|5379273|P4|Overall Study|Withdrawal by Subject|1
1562435|NCT03879772|5379274|P3|Overall Study|Withdrawal by Subject|3
1562436|NCT03879772|5379275|P2|Overall Study|Withdrawal by Subject|1
1562437|NCT03879772|5379276|P1|Overall Study|Withdrawal by Subject|0
1562438|NCT03879772|5379272|P5|Overall Study|Lost to Follow-up|1
1562439|NCT03879772|5379273|P4|Overall Study|Lost to Follow-up|0
1562440|NCT03879772|5379274|P3|Overall Study|Lost to Follow-up|0
1562441|NCT03879772|5379275|P2|Overall Study|Lost to Follow-up|0
1562442|NCT03879772|5379276|P1|Overall Study|Lost to Follow-up|0
1562443|NCT03879772|5379272|P5|Overall Study|Treatment Failure|1
1562444|NCT03879772|5379273|P4|Overall Study|Treatment Failure|2
1562445|NCT03879772|5379274|P3|Overall Study|Treatment Failure|0
1562446|NCT03879772|5379275|P2|Overall Study|Treatment Failure|0
1562447|NCT03879772|5379276|P1|Overall Study|Treatment Failure|1
1562448|NCT03879772|5379272|P5|Overall Study|Adverse Event|3
1562449|NCT03879772|5379273|P4|Overall Study|Adverse Event|4
1562450|NCT03879772|5379274|P3|Overall Study|Adverse Event|3
1562451|NCT03879772|5379275|P2|Overall Study|Adverse Event|2
1562452|NCT03879772|5379276|P1|Overall Study|Adverse Event|2
1562453|NCT03861559|5379325|P2|Overall Study|Did not meet eligibility requirements|0
1562454|NCT03861559|5379326|P1|Overall Study|Did not meet eligibility requirements|1
1562455|NCT03861559|5379325|P2|Overall Study|Noncompliance|1
1562456|NCT03861559|5379326|P1|Overall Study|Noncompliance|1
1562457|NCT03861559|5379325|P2|Overall Study|Treatment failure|2
1562458|NCT03861559|5379326|P1|Overall Study|Treatment failure|0
1562459|NCT03861559|5379325|P2|Overall Study|Adverse Event|2
1562460|NCT03861559|5379326|P1|Overall Study|Adverse Event|0
1562461|NCT03855228|5379414|P4|Overall Study|Did Not Meet Entry Requirements|1
1562462|NCT03855228|5379415|P3|Overall Study|Did Not Meet Entry Requirements|1
1562463|NCT03855228|5379416|P2|Overall Study|Did Not Meet Entry Requirements|2
1562464|NCT03855228|5379417|P1|Overall Study|Did Not Meet Entry Requirements|0
1562465|NCT03855228|5379414|P4|Overall Study|Protocol Violation|1
1562466|NCT03855228|5379415|P3|Overall Study|Protocol Violation|2
1562467|NCT03855228|5379416|P2|Overall Study|Protocol Violation|1
1562468|NCT03855228|5379417|P1|Overall Study|Protocol Violation|0
1562469|NCT03855228|5379414|P4|Overall Study|Lost to Follow-up|1
1562470|NCT03855228|5379415|P3|Overall Study|Lost to Follow-up|0
1562471|NCT03855228|5379416|P2|Overall Study|Lost to Follow-up|0
1562472|NCT03855228|5379417|P1|Overall Study|Lost to Follow-up|0
1562473|NCT03855228|5379414|P4|Overall Study|Treatment Failure|8
1562474|NCT03855228|5379415|P3|Overall Study|Treatment Failure|1
1562475|NCT03855228|5379416|P2|Overall Study|Treatment Failure|2
1562476|NCT03855228|5379417|P1|Overall Study|Treatment Failure|1
1562477|NCT03855228|5379414|P4|Overall Study|Adverse Event|8
1562478|NCT03855228|5379415|P3|Overall Study|Adverse Event|4
1562479|NCT03855228|5379416|P2|Overall Study|Adverse Event|4
1562480|NCT03855228|5379417|P1|Overall Study|Adverse Event|2
1562481|NCT03855189|5379466|P3|Overall Study|Did Not Return|0
1562482|NCT03855189|5379467|P2|Overall Study|Did Not Return|3
1562483|NCT03855189|5379468|P1|Overall Study|Did Not Return|4
1562484|NCT03855189|5379466|P3|Overall Study|Noncompliance with Protocol|0
1562485|NCT03855189|5379467|P2|Overall Study|Noncompliance with Protocol|1
1562486|NCT03855189|5379468|P1|Overall Study|Noncompliance with Protocol|0
1562487|NCT03855189|5379466|P3|Overall Study|Treatment Failure|2
1562488|NCT03855189|5379467|P2|Overall Study|Treatment Failure|1
1562489|NCT03855189|5379468|P1|Overall Study|Treatment Failure|1
1562490|NCT03855189|5379466|P3|Overall Study|Adverse Event|4
1562491|NCT03855189|5379467|P2|Overall Study|Adverse Event|2
1562492|NCT03855189|5379468|P1|Overall Study|Adverse Event|5
1562493|NCT03850496|5379587|P3|Overall Study|Lost to Follow-up|4
1562494|NCT03850496|5379588|P2|Overall Study|Lost to Follow-up|1
1562495|NCT03850496|5379589|P1|Overall Study|Lost to Follow-up|0
1562496|NCT03850496|5379587|P3|Overall Study|Withdrawal by Subject|0
1562497|NCT03850496|5379588|P2|Overall Study|Withdrawal by Subject|0
1562498|NCT03850496|5379589|P1|Overall Study|Withdrawal by Subject|1
1562499|NCT03850444|5379599|P2|Overall Study|Ongoing in Study|59
1562500|NCT03850444|5379600|P1|Overall Study|Ongoing in Study|78
1562501|NCT03850444|5379599|P2|Overall Study|Withdrawal by Subject|1
1562502|NCT03850444|5379600|P1|Overall Study|Withdrawal by Subject|0
1562503|NCT03850444|5379599|P2|Overall Study|Lost to Follow-up|1
1562504|NCT03850444|5379600|P1|Overall Study|Lost to Follow-up|0
1562505|NCT03850444|5379599|P2|Overall Study|Death|64
1562506|NCT03850444|5379600|P1|Overall Study|Death|38
1562507|NCT03850444|5379599|P2|Overall Study|Adverse Event|9
1562508|NCT03850444|5379600|P1|Overall Study|Adverse Event|12
1562509|NCT03850093|5379629|P3|Overall Study|Withdrawal by Subject|2
1562510|NCT03850093|5379630|P2|Overall Study|Withdrawal by Subject|0
1562511|NCT03850093|5379631|P1|Overall Study|Withdrawal by Subject|1
1562512|NCT03836664|5379737|P2|Overall Study|Didn't complete forms and lost drug|3
1562513|NCT03836664|5379738|P1|Overall Study|Didn't complete forms and lost drug|3
1562514|NCT03832387|5379750|P2|Overall Study|EXCLUSION CRITERIA|1
1562515|NCT03832387|5379751|P1|Overall Study|EXCLUSION CRITERIA|3
1562516|NCT03832387|5379750|P2|Overall Study|Protocol Violation|6
1562517|NCT03832387|5379751|P1|Overall Study|Protocol Violation|2
1562518|NCT03832322|5379781|P2|Overall Study|Failed cecal intubation in 2nd exam|1
1562606|NCT03733899|5380614|P4|Period 3|Withdrawal by Subject|0
1562519|NCT03832322|5379782|P1|Overall Study|Failed cecal intubation in 2nd exam|3
1562521|NCT03824912|5379815|P3|Overall Study|Participation in another study|0
1562522|NCT03824912|5379816|P2|Overall Study|Participation in another study|1
1562523|NCT03824912|5379817|P1|Overall Study|Participation in another study|0
1562524|NCT03824912|5379815|P3|Overall Study|Withdrawal by Subject|1
1562525|NCT03824912|5379816|P2|Overall Study|Withdrawal by Subject|2
1562526|NCT03824912|5379817|P1|Overall Study|Withdrawal by Subject|3
1562527|NCT03824912|5379815|P3|Overall Study|Protocol Violation|1
1562528|NCT03824912|5379816|P2|Overall Study|Protocol Violation|4
1562529|NCT03824912|5379817|P1|Overall Study|Protocol Violation|1
1562530|NCT03824912|5379815|P3|Overall Study|Non-Compliance with Study Drug|1
1562531|NCT03824912|5379816|P2|Overall Study|Non-Compliance with Study Drug|0
1562532|NCT03824912|5379817|P1|Overall Study|Non-Compliance with Study Drug|0
1562533|NCT03824912|5379815|P3|Overall Study|Negative Baseline Culture Result|57
1562534|NCT03824912|5379816|P2|Overall Study|Negative Baseline Culture Result|112
1562535|NCT03824912|5379817|P1|Overall Study|Negative Baseline Culture Result|118
1562536|NCT03824912|5379815|P3|Overall Study|Lost to Follow-up|8
1562537|NCT03824912|5379816|P2|Overall Study|Lost to Follow-up|15
1562538|NCT03824912|5379817|P1|Overall Study|Lost to Follow-up|18
1562539|NCT03822884|5379843|P6|Overall Study|Withdrawal by Subject|0
1562540|NCT03822884|5379844|P5|Overall Study|Withdrawal by Subject|1
1562541|NCT03822884|5379845|P4|Overall Study|Withdrawal by Subject|0
1562542|NCT03822884|5379846|P3|Overall Study|Withdrawal by Subject|0
1562543|NCT03822884|5379847|P2|Overall Study|Withdrawal by Subject|0
1562544|NCT03822884|5379848|P1|Overall Study|Withdrawal by Subject|0
1562545|NCT03817879|5379973|P2|Overall Study|Withdrawal by Subject|1
1562546|NCT03817879|5379974|P1|Overall Study|Withdrawal by Subject|0
1562547|NCT03817879|5379973|P2|Overall Study|Drop out|12
1562548|NCT03817879|5379974|P1|Overall Study|Drop out|5
1562549|NCT03811093|5380009|P2|Overall Study|Unable to measure body fat percentage|0
1562550|NCT03811093|5380010|P1|Overall Study|Unable to measure body fat percentage|2
1562551|NCT03811093|5380009|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
1562552|NCT03811093|5380010|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
1562553|NCT03809104|5380020|P1|Overall Study|Withdrawal by Subject|3
1562554|NCT03787212|5380119|P2|Period 1|Study Termination|2
1562555|NCT03787212|5380120|P1|Period 1|Study Termination|2
1562556|NCT03783780|5380126|P1|Overall Study|Withdrawn prior to completion|1
1562557|NCT03781375|5380160|P2|Open-label Phase|Other|2
1562558|NCT03781375|5380161|P1|Open-label Phase|Other|2
1562559|NCT03781375|5380160|P2|Open-label Phase|Suboptimal Clinical Response|0
1562560|NCT03781375|5380161|P1|Open-label Phase|Suboptimal Clinical Response|1
1562561|NCT03781375|5380160|P2|Open-label Phase|Protocol Issues|1
1562562|NCT03781375|5380161|P1|Open-label Phase|Protocol Issues|0
1562563|NCT03781375|5380160|P2|Double-blind Phase|Other|3
1562564|NCT03781375|5380161|P1|Double-blind Phase|Other|1
1562565|NCT03781375|5380160|P2|Double-blind Phase|Lack of Response|2
1562566|NCT03781375|5380161|P1|Double-blind Phase|Lack of Response|6
1562567|NCT03781375|5380160|P2|Double-blind Phase|Adverse Event|1
1562568|NCT03781375|5380161|P1|Double-blind Phase|Adverse Event|0
1562569|NCT03780959|5380175|P3|Part 2|Response Status|6
1562570|NCT03780959|5380176|P2|Part 2|Response Status|18
1562571|NCT03780959|5380177|P1|Part 2|Response Status|0
1562572|NCT03780959|5380175|P3|Part 2|Withdrawal by Parent/Guardian|0
1562573|NCT03780959|5380176|P2|Part 2|Withdrawal by Parent/Guardian|1
1562574|NCT03780959|5380177|P1|Part 2|Withdrawal by Parent/Guardian|0
1562575|NCT03780959|5380175|P3|Part 1|Response Status|0
1562576|NCT03780959|5380176|P2|Part 1|Response Status|0
1562577|NCT03780959|5380177|P1|Part 1|Response Status|2
1562578|NCT03780959|5380175|P3|Part 1|Withdrawal by Parent/Guardian|0
1562579|NCT03780959|5380176|P2|Part 1|Withdrawal by Parent/Guardian|0
1562580|NCT03780959|5380177|P1|Part 1|Withdrawal by Parent/Guardian|1
1562581|NCT03780959|5380175|P3|Part 1|Withdrawal by Subject|0
1562582|NCT03780959|5380176|P2|Part 1|Withdrawal by Subject|0
1562583|NCT03780959|5380177|P1|Part 1|Withdrawal by Subject|1
1562584|NCT03780959|5380175|P3|Part 1|Adverse Event|0
1562585|NCT03780959|5380176|P2|Part 1|Adverse Event|0
1562586|NCT03780959|5380177|P1|Part 1|Adverse Event|1
1562587|NCT03772327|5380263|P2|Overall Study|Withdrawal by Subject|3
1562588|NCT03772327|5380264|P1|Overall Study|Withdrawal by Subject|2
1562589|NCT03772327|5380263|P2|Overall Study|Lost to Follow-up|4
1562590|NCT03772327|5380264|P1|Overall Study|Lost to Follow-up|3
1562591|NCT03765138|5380308|P1|Overall Study|Lost to Follow-up|1
1562592|NCT03762668|5380417|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
1562593|NCT03762668|5380418|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
1562594|NCT03760510|5380426|P2|Overall Study|Not ventilated for 24 hours|97
1562595|NCT03760510|5380427|P1|Overall Study|Not ventilated for 24 hours|105
1562596|NCT03755882|5380450|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
1562597|NCT03755882|5380451|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
1562598|NCT03755882|5380450|P2|Period 1|Protocol Violation|0
1562599|NCT03755882|5380451|P1|Period 1|Protocol Violation|1
1562600|NCT03739242|5380556|P2|Overall Study|Protocol Violation|1
1562601|NCT03739242|5380557|P1|Overall Study|Protocol Violation|0
1562602|NCT03739242|5380556|P2|Overall Study|Withdrawal by Subject|1
1562603|NCT03739242|5380557|P1|Overall Study|Withdrawal by Subject|1
1562604|NCT03733899|5380612|P6|Period 3|Withdrawal by Subject|0
1562605|NCT03733899|5380613|P5|Period 3|Withdrawal by Subject|0
1562607|NCT03733899|5380615|P3|Period 3|Withdrawal by Subject|0
1562608|NCT03733899|5380616|P2|Period 3|Withdrawal by Subject|0
1562609|NCT03733899|5380617|P1|Period 3|Withdrawal by Subject|1
1562610|NCT03733899|5380612|P6|Period 2|Unscuccessful Treatment|0
1562611|NCT03733899|5380613|P5|Period 2|Unscuccessful Treatment|0
1562612|NCT03733899|5380614|P4|Period 2|Unscuccessful Treatment|0
1562613|NCT03733899|5380615|P3|Period 2|Unscuccessful Treatment|0
1562614|NCT03733899|5380616|P2|Period 2|Unscuccessful Treatment|1
1562615|NCT03733899|5380617|P1|Period 2|Unscuccessful Treatment|0
1562616|NCT03733899|5380612|P6|Period 1|Protocol Violation|1
1562617|NCT03733899|5380613|P5|Period 1|Protocol Violation|0
1562618|NCT03733899|5380614|P4|Period 1|Protocol Violation|0
1562619|NCT03733899|5380615|P3|Period 1|Protocol Violation|0
1562620|NCT03733899|5380616|P2|Period 1|Protocol Violation|0
1562621|NCT03733899|5380617|P1|Period 1|Protocol Violation|0
1562622|NCT03733470|5380645|P2|Overall Study|PI Decision|1
1562623|NCT03733470|5380646|P1|Overall Study|PI Decision|1
1562624|NCT03728140|5380654|P2|Overall Study|Abnormal embryo transfer operation|7
1562625|NCT03728140|5380655|P1|Overall Study|Abnormal embryo transfer operation|10
1562626|NCT03725085|5380674|P1|Overall Study|Lost to Follow-up|2
1562628|NCT03720847|5380737|P2|Washout|Physician Decision|2
1562629|NCT03720847|5380738|P1|Washout|Physician Decision|1
1562630|NCT03718000|5380764|P2|Overall Study|Pregnancy|1
1562631|NCT03718000|5380765|P1|Overall Study|Pregnancy|0
1562632|NCT03718000|5380764|P2|Overall Study|Relocation|4
1562633|NCT03718000|5380765|P1|Overall Study|Relocation|2
1562634|NCT03717064|5380787|P1|Period 2|Adverse Event|1
1562635|NCT03716050|5380819|P8|Overall Study|Protocol Violation|2
1562636|NCT03716050|5380820|P7|Overall Study|Protocol Violation|0
1562637|NCT03716050|5380821|P6|Overall Study|Protocol Violation|0
1562638|NCT03716050|5380822|P5|Overall Study|Protocol Violation|0
1562639|NCT03716050|5380823|P4|Overall Study|Protocol Violation|1
1562640|NCT03716050|5380824|P3|Overall Study|Protocol Violation|0
1562641|NCT03716050|5380825|P2|Overall Study|Protocol Violation|0
1562642|NCT03716050|5380826|P1|Overall Study|Protocol Violation|0
1562643|NCT03716050|5380819|P8|Overall Study|Physician Decision|0
1562644|NCT03716050|5380820|P7|Overall Study|Physician Decision|0
1562645|NCT03716050|5380821|P6|Overall Study|Physician Decision|0
1562646|NCT03716050|5380822|P5|Overall Study|Physician Decision|0
1562647|NCT03716050|5380823|P4|Overall Study|Physician Decision|1
1562648|NCT03716050|5380824|P3|Overall Study|Physician Decision|0
1562649|NCT03716050|5380825|P2|Overall Study|Physician Decision|0
1562650|NCT03716050|5380826|P1|Overall Study|Physician Decision|0
1562651|NCT03716050|5380819|P8|Overall Study|Lost to Follow-up|0
1562652|NCT03716050|5380820|P7|Overall Study|Lost to Follow-up|0
1562653|NCT03716050|5380821|P6|Overall Study|Lost to Follow-up|0
1562654|NCT03716050|5380822|P5|Overall Study|Lost to Follow-up|0
1562655|NCT03716050|5380823|P4|Overall Study|Lost to Follow-up|0
1562656|NCT03716050|5380824|P3|Overall Study|Lost to Follow-up|1
1562657|NCT03716050|5380825|P2|Overall Study|Lost to Follow-up|0
1562658|NCT03716050|5380826|P1|Overall Study|Lost to Follow-up|0
1562659|NCT03715530|5380881|P3|Overall Study|Lost to Follow-up|2
1562660|NCT03715530|5380882|P2|Overall Study|Lost to Follow-up|1
1562661|NCT03715530|5380883|P1|Overall Study|Lost to Follow-up|3
1562662|NCT03714672|5380938|P4|Overall Study|Lost to Follow-up|0
1562663|NCT03714672|5380939|P3|Overall Study|Lost to Follow-up|0
1562664|NCT03714672|5380940|P2|Overall Study|Lost to Follow-up|1
1562665|NCT03714672|5380941|P1|Overall Study|Lost to Follow-up|1
1562666|NCT03714672|5380938|P4|Overall Study|Other Reason|1
1562667|NCT03714672|5380939|P3|Overall Study|Other Reason|1
1562668|NCT03714672|5380940|P2|Overall Study|Other Reason|2
1562669|NCT03714672|5380941|P1|Overall Study|Other Reason|1
1562670|NCT03714672|5380938|P4|Overall Study|Physician Decision|0
1562671|NCT03714672|5380939|P3|Overall Study|Physician Decision|0
1562672|NCT03714672|5380940|P2|Overall Study|Physician Decision|1
1562673|NCT03714672|5380941|P1|Overall Study|Physician Decision|0
1562674|NCT03714672|5380938|P4|Overall Study|Adverse Event|0
1562675|NCT03714672|5380939|P3|Overall Study|Adverse Event|3
1562676|NCT03714672|5380940|P2|Overall Study|Adverse Event|0
1562677|NCT03714672|5380941|P1|Overall Study|Adverse Event|0
1562678|NCT03712917|5380995|P3|Overall Study|Lost to Follow-up|5
1562679|NCT03712917|5380996|P2|Overall Study|Lost to Follow-up|4
1562680|NCT03712917|5380997|P1|Overall Study|Lost to Follow-up|9
1562681|NCT03712917|5380995|P3|Overall Study|Adverse Event|3
1562682|NCT03712917|5380996|P2|Overall Study|Adverse Event|4
1562683|NCT03712917|5380997|P1|Overall Study|Adverse Event|0
1562684|NCT03712917|5380995|P3|Overall Study|Pregnancy|1
1562685|NCT03712917|5380996|P2|Overall Study|Pregnancy|0
1562686|NCT03712917|5380997|P1|Overall Study|Pregnancy|0
1562687|NCT03708744|5381019|P4|Overall Study|Withdrawal by Subject|0
1562688|NCT03708744|5381020|P3|Overall Study|Withdrawal by Subject|1
1562689|NCT03708744|5381021|P2|Overall Study|Withdrawal by Subject|0
1562690|NCT03708744|5381022|P1|Overall Study|Withdrawal by Subject|0
1562691|NCT03707821|5381056|P2|Overall Study|Unsatisfactory Lens Fitting|0
1562692|NCT03707821|5381057|P1|Overall Study|Unsatisfactory Lens Fitting|1
1562693|NCT03707821|5381056|P2|Overall Study|Unsatisfactory Visual Response|0
1562694|NCT03707821|5381057|P1|Overall Study|Unsatisfactory Visual Response|1
1562695|NCT03707821|5381056|P2|Overall Study|Protocol Violation|1
1562696|NCT03707821|5381057|P1|Overall Study|Protocol Violation|0
1562697|NCT03707522|5381079|P4|Overall Study|Lost to Follow-up|36
1562698|NCT03707522|5381080|P3|Overall Study|Lost to Follow-up|41
1562699|NCT03707522|5381081|P2|Overall Study|Lost to Follow-up|27
1562700|NCT03707522|5381082|P1|Overall Study|Lost to Follow-up|24
1562703|NCT03698591|5381211|P2|Overall Study|Could not establish TMS dosage|1
1562704|NCT03698591|5381212|P1|Overall Study|Could not establish TMS dosage|0
1562705|NCT03698591|5381211|P2|Overall Study|Equipment Error|0
1562706|NCT03698591|5381212|P1|Overall Study|Equipment Error|1
1562707|NCT03698591|5381211|P2|Overall Study|Ineligible for financial compensation|0
1562708|NCT03698591|5381212|P1|Overall Study|Ineligible for financial compensation|1
1562709|NCT03698591|5381211|P2|Overall Study|Failed health screen|1
1562710|NCT03698591|5381212|P1|Overall Study|Failed health screen|0
1562711|NCT03698591|5381211|P2|Overall Study|Failed drug screen|1
1562712|NCT03698591|5381212|P1|Overall Study|Failed drug screen|1
1562713|NCT03698591|5381211|P2|Overall Study|Withdrawal by Subject|2
1562714|NCT03698591|5381212|P1|Overall Study|Withdrawal by Subject|2
1562718|NCT03693989|5381273|P2|Overall Study|Protocol Violation|4
1562719|NCT03693989|5381274|P1|Overall Study|Protocol Violation|3
1562720|NCT03693950|5381298|P2|Overall Study|Withdrawal by Subject|0
1562721|NCT03693950|5381299|P1|Overall Study|Withdrawal by Subject|1
1562722|NCT03683758|5381379|P2|Overall Study|Adverse Event|0
1562723|NCT03683758|5381380|P1|Overall Study|Adverse Event|1
1562724|NCT03683758|5381379|P2|Overall Study|Illness preventing participation|0
1562725|NCT03683758|5381380|P1|Overall Study|Illness preventing participation|1
1562726|NCT03683758|5381379|P2|Overall Study|Non-study commitment conflict|3
1562727|NCT03683758|5381380|P1|Overall Study|Non-study commitment conflict|1
1562728|NCT03679741|5381392|P2|Period 2|Withdrawal by Subject|1
1562729|NCT03679741|5381393|P1|Period 2|Withdrawal by Subject|1
1562730|NCT03679741|5381392|P2|Period 2|Adverse Event|1
1562731|NCT03679741|5381393|P1|Period 2|Adverse Event|2
1562732|NCT03679741|5381392|P2|Period 1|Withdrawal by Subject|1
1562733|NCT03679741|5381393|P1|Period 1|Withdrawal by Subject|0
1562734|NCT03679741|5381392|P2|Period 1|Adverse Event|1
1562735|NCT03679741|5381393|P1|Period 1|Adverse Event|1
1562736|NCT03679741|5381392|P2|Period 1|Lost to Follow-up|1
1562737|NCT03679741|5381393|P1|Period 1|Lost to Follow-up|0
1562738|NCT03679741|5381392|P2|Period 1|No longer meet eligibility criteria|0
1562739|NCT03679741|5381393|P1|Period 1|No longer meet eligibility criteria|1
1562744|NCT03677375|5381449|P1|Overall Study|Physician Decision|1
1562745|NCT03677375|5381449|P1|Overall Study|Adverse Event|3
1562746|NCT03677375|5381449|P1|Overall Study|Incomplete procedure|8
1562747|NCT03673670|5381470|P6|Treatment Period 3 (3 Days)|Adverse Event|0
1562748|NCT03673670|5381471|P5|Treatment Period 3 (3 Days)|Adverse Event|1
1562749|NCT03673670|5381472|P4|Treatment Period 3 (3 Days)|Adverse Event|0
1562750|NCT03673670|5381473|P3|Treatment Period 3 (3 Days)|Adverse Event|0
1562751|NCT03673670|5381474|P2|Treatment Period 3 (3 Days)|Adverse Event|0
1562752|NCT03673670|5381475|P1|Treatment Period 3 (3 Days)|Adverse Event|0
1562753|NCT03673670|5381470|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1562754|NCT03673670|5381471|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
1562755|NCT03673670|5381472|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1562756|NCT03673670|5381473|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1562757|NCT03673670|5381474|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1562758|NCT03673670|5381475|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
1562759|NCT03673670|5381470|P6|Treatment Period 2 (3 Days)|Adverse Event|0
1562760|NCT03673670|5381471|P5|Treatment Period 2 (3 Days)|Adverse Event|1
1562761|NCT03673670|5381472|P4|Treatment Period 2 (3 Days)|Adverse Event|0
1562762|NCT03673670|5381473|P3|Treatment Period 2 (3 Days)|Adverse Event|1
1562763|NCT03673670|5381474|P2|Treatment Period 2 (3 Days)|Adverse Event|0
1562764|NCT03673670|5381475|P1|Treatment Period 2 (3 Days)|Adverse Event|0
1562765|NCT03673670|5381470|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
1562766|NCT03673670|5381471|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1562767|NCT03673670|5381472|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1562768|NCT03673670|5381473|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1562769|NCT03673670|5381474|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1562770|NCT03673670|5381475|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
1562771|NCT03673670|5381470|P6|Treatment Period 1 (3 Days)|Adverse Event|1
1562772|NCT03673670|5381471|P5|Treatment Period 1 (3 Days)|Adverse Event|0
1562773|NCT03673670|5381472|P4|Treatment Period 1 (3 Days)|Adverse Event|0
1562774|NCT03673670|5381473|P3|Treatment Period 1 (3 Days)|Adverse Event|0
1562775|NCT03673670|5381474|P2|Treatment Period 1 (3 Days)|Adverse Event|0
1562776|NCT03673670|5381475|P1|Treatment Period 1 (3 Days)|Adverse Event|0
1562777|NCT03673670|5381470|P6|Treatment Period 1 (3 Days)|Physician Decision|0
1562778|NCT03673670|5381471|P5|Treatment Period 1 (3 Days)|Physician Decision|0
1562779|NCT03673670|5381472|P4|Treatment Period 1 (3 Days)|Physician Decision|0
1562780|NCT03673670|5381473|P3|Treatment Period 1 (3 Days)|Physician Decision|1
1562781|NCT03673670|5381474|P2|Treatment Period 1 (3 Days)|Physician Decision|0
1562782|NCT03673670|5381475|P1|Treatment Period 1 (3 Days)|Physician Decision|0
1562783|NCT03673670|5381470|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1562784|NCT03673670|5381471|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1562785|NCT03673670|5381472|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1562786|NCT03673670|5381473|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1562787|NCT03673670|5381474|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
1562788|NCT03673670|5381475|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
1562789|NCT03670537|5381522|P1|Overall Study|Protocol Violation|1
1562790|NCT03669081|5381528|P2|Overall Study|Data could not be validated|1
1562791|NCT03669081|5381529|P1|Overall Study|Data could not be validated|1
1562792|NCT03663179|5381561|P2|Overall Study|Revealed exclusionary condition|0
1562793|NCT03663179|5381562|P1|Overall Study|Revealed exclusionary condition|1
1562794|NCT03663179|5381561|P2|Overall Study|Lost to Follow-up|1
1562795|NCT03663179|5381562|P1|Overall Study|Lost to Follow-up|1
1562796|NCT03663179|5381561|P2|Overall Study|Withdrawal by Subject|0
1562797|NCT03663179|5381562|P1|Overall Study|Withdrawal by Subject|2
1562798|NCT03662334|5381572|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
1562799|NCT03662334|5381573|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
1562800|NCT03658876|5381667|P2|Overall Study|Transplantation/other operation|5
1562801|NCT03658876|5381668|P1|Overall Study|Transplantation/other operation|1
1562802|NCT03658876|5381667|P2|Overall Study|Intercurrent illness|4
1562803|NCT03658876|5381668|P1|Overall Study|Intercurrent illness|6
1562804|NCT03658876|5381667|P2|Overall Study|Death|1
1562805|NCT03658876|5381668|P1|Overall Study|Death|0
1562806|NCT03658876|5381667|P2|Overall Study|Withdrawal by Subject|0
1562807|NCT03658876|5381668|P1|Overall Study|Withdrawal by Subject|2
1562808|NCT03658876|5381667|P2|Overall Study|Protocol Violation|2
1562809|NCT03658876|5381668|P1|Overall Study|Protocol Violation|3
1562810|NCT03658811|5381674|P1|Overall Study|Lost to Follow-up|3
1562811|NCT03648983|5381805|P1|Overall Study|Study was terminated due to PI departure|95
1562812|NCT03645421|5381826|P4|Overall Study|Study specific withdrawal criteria|0
1562813|NCT03645421|5381827|P3|Overall Study|Study specific withdrawal criteria|1
1562814|NCT03645421|5381828|P2|Overall Study|Study specific withdrawal criteria|0
1562815|NCT03645421|5381829|P1|Overall Study|Study specific withdrawal criteria|0
1562816|NCT03645421|5381826|P4|Overall Study|Withdrawal by patient|3
1562817|NCT03645421|5381827|P3|Overall Study|Withdrawal by patient|0
1562818|NCT03645421|5381828|P2|Overall Study|Withdrawal by patient|0
1562819|NCT03645421|5381829|P1|Overall Study|Withdrawal by patient|0
1562820|NCT03645421|5381826|P4|Overall Study|Adverse Event|1
1562821|NCT03645421|5381827|P3|Overall Study|Adverse Event|4
1562822|NCT03645421|5381828|P2|Overall Study|Adverse Event|0
1562823|NCT03645421|5381829|P1|Overall Study|Adverse Event|0
1562824|NCT03643575|5381934|P6|Washout: 7 Days|Non compliance check in|0
1562825|NCT03643575|5381935|P5|Washout: 7 Days|Non compliance check in|0
1562826|NCT03643575|5381936|P4|Washout: 7 Days|Non compliance check in|0
1562827|NCT03643575|5381937|P3|Washout: 7 Days|Non compliance check in|0
1562828|NCT03643575|5381938|P2|Washout: 7 Days|Non compliance check in|1
1562829|NCT03643575|5381939|P1|Washout: 7 Days|Non compliance check in|0
1562830|NCT03643575|5381934|P6|Washout: 7 Days|Adverse Event|0
1562831|NCT03643575|5381935|P5|Washout: 7 Days|Adverse Event|0
1562832|NCT03643575|5381936|P4|Washout: 7 Days|Adverse Event|0
1562833|NCT03643575|5381937|P3|Washout: 7 Days|Adverse Event|0
1562834|NCT03643575|5381938|P2|Washout: 7 Days|Adverse Event|0
1562835|NCT03643575|5381939|P1|Washout: 7 Days|Adverse Event|1
1562836|NCT03643575|5381934|P6|Washout: 7 Days|Withdrew consent due to illness|0
1562837|NCT03643575|5381935|P5|Washout: 7 Days|Withdrew consent due to illness|0
1562838|NCT03643575|5381936|P4|Washout: 7 Days|Withdrew consent due to illness|1
1562839|NCT03643575|5381937|P3|Washout: 7 Days|Withdrew consent due to illness|0
1562840|NCT03643575|5381938|P2|Washout: 7 Days|Withdrew consent due to illness|0
1562841|NCT03643575|5381939|P1|Washout: 7 Days|Withdrew consent due to illness|0
1562842|NCT03643159|5381997|P1|Overall Study|Withdrawal by Subject|1
1562843|NCT03643159|5381997|P1|Overall Study|Adverse Event|1
1562844|NCT03642873|5382004|P6|Third Intervention (1 Day)|Screen failure|0
1562845|NCT03642873|5382005|P5|Third Intervention (1 Day)|Screen failure|1
1562846|NCT03642873|5382006|P4|Third Intervention (1 Day)|Screen failure|0
1562847|NCT03642873|5382007|P3|Third Intervention (1 Day)|Screen failure|0
1562848|NCT03642873|5382008|P2|Third Intervention (1 Day)|Screen failure|0
1562849|NCT03642873|5382009|P1|Third Intervention (1 Day)|Screen failure|0
1562850|NCT03642262|5382041|P2|Period 1|Adverse Event|1
1562851|NCT03642262|5382042|P1|Period 1|Adverse Event|0
1562852|NCT03642262|5382041|P2|Period 1|Withdrawal by Subject|1
1562853|NCT03642262|5382042|P1|Period 1|Withdrawal by Subject|1
1562854|NCT03641508|5382063|P2|First Injection|Lost to Follow-up|0
1562855|NCT03641508|5382064|P1|First Injection|Lost to Follow-up|2
1562856|NCT03640559|5382091|P2|Overall Study|Withdrawal by Subject|0
1562857|NCT03640559|5382092|P1|Overall Study|Withdrawal by Subject|1
1562858|NCT03640559|5382091|P2|Overall Study|Physician Decision|1
1562859|NCT03640559|5382092|P1|Overall Study|Physician Decision|1
1562866|NCT03638635|5382141|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
1562867|NCT03638635|5382142|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
1562868|NCT03638635|5382141|P2|Initial Hospitalization|Withdrawal by study personnel|1
1562869|NCT03638635|5382142|P1|Initial Hospitalization|Withdrawal by study personnel|0
1562870|NCT03638635|5382141|P2|Initial Hospitalization|Study terminated prematurely|1
1562871|NCT03638635|5382142|P1|Initial Hospitalization|Study terminated prematurely|0
1562872|NCT03633825|5382211|P2|Follow up|Lost to Follow-up|450
1562873|NCT03633825|5382212|P1|Follow up|Lost to Follow-up|478
1562874|NCT03633825|5382211|P2|Enrollment|Post not classified as crisis|13757
1562875|NCT03633825|5382212|P1|Enrollment|Post not classified as crisis|13967
1562876|NCT03633825|5382211|P2|Enrollment|Did not post on network|5080
1562877|NCT03633825|5382212|P1|Enrollment|Did not post on network|5066
1562878|NCT03630016|5382345|P1|Overall Study|Poor Sensor Placement|1
1562881|NCT03629041|5382376|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
1562882|NCT03629041|5382377|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
1562883|NCT03629041|5382378|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
1562884|NCT03629041|5382379|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
1562885|NCT03628599|5382420|P2|Overall Study|Adverse Event|1
1562886|NCT03628599|5382421|P1|Overall Study|Adverse Event|0
1562887|NCT03628417|5382451|P2|Overall Study|Death|1
1562888|NCT03628417|5382452|P1|Overall Study|Death|1
1562889|NCT03620708|5382505|P3|Overall Study|Withdrawal by Subject|1
1562890|NCT03620708|5382506|P2|Overall Study|Withdrawal by Subject|0
1562891|NCT03620708|5382507|P1|Overall Study|Withdrawal by Subject|0
1562892|NCT03620708|5382505|P3|Overall Study|Lost to Follow-up|2
1562893|NCT03620708|5382506|P2|Overall Study|Lost to Follow-up|1
1562894|NCT03620708|5382507|P1|Overall Study|Lost to Follow-up|1
1562895|NCT03618628|5382588|P1|Overall Study|Lost to Follow-up|1
1562896|NCT03618628|5382588|P1|Overall Study|Death|1
1562897|NCT03614975|5382713|P2|Overall Study|Specimens not in lab batch shipment|1
1562898|NCT03614975|5382714|P1|Overall Study|Specimens not in lab batch shipment|1
1562899|NCT03614975|5382713|P2|Overall Study|Withdrawal by Subject|2
1562900|NCT03614975|5382714|P1|Overall Study|Withdrawal by Subject|2
1562901|NCT03614975|5382713|P2|Overall Study|Physician Decision|5
1562902|NCT03614975|5382714|P1|Overall Study|Physician Decision|7
1562903|NCT03610269|5382788|P1|Overall Study|Screen fail|4
1562904|NCT03610269|5382788|P1|Overall Study|Unable to draw blood|1
1562905|NCT03610269|5382788|P1|Overall Study|Protocol Violation|1
1562906|NCT03610269|5382788|P1|Overall Study|Physician Decision|10
1562907|NCT03609619|5382794|P2|Overall Study|Lost to Follow-up|1
1562908|NCT03609619|5382795|P1|Overall Study|Lost to Follow-up|1
1562909|NCT03609619|5382794|P2|Overall Study|Withdrawal by Subject|3
1562910|NCT03609619|5382795|P1|Overall Study|Withdrawal by Subject|2
1562911|NCT03609619|5382794|P2|Overall Study|Protocol Violation|0
1562912|NCT03609619|5382795|P1|Overall Study|Protocol Violation|5
1562913|NCT03609619|5382794|P2|Overall Study|Lack of Efficacy|2
1562914|NCT03609619|5382795|P1|Overall Study|Lack of Efficacy|1
1562915|NCT03609619|5382794|P2|Overall Study|Adverse Event|0
1562916|NCT03609619|5382795|P1|Overall Study|Adverse Event|1
1562917|NCT03605303|5382831|P2|Period 1|Study Terminated|1
1562918|NCT03605303|5382832|P1|Period 1|Study Terminated|2
1562919|NCT03603028|5382914|P1|Overall Study|Withdrawal by Subject|1
1562920|NCT03601715|5382922|P3|Second Intervention|Lost to Follow-up|0
1562921|NCT03601715|5382923|P2|Second Intervention|Lost to Follow-up|1
1562922|NCT03601715|5382924|P1|Second Intervention|Lost to Follow-up|1
1562923|NCT03599349|5382938|P1|Overall Study|Lost to Follow-up|1
1562924|NCT03590613|5382989|P4|Period 2, 4 Days|Physician Decision|1
1562925|NCT03590613|5382990|P3|Period 2, 4 Days|Physician Decision|0
1562926|NCT03590613|5382991|P2|Period 2, 4 Days|Physician Decision|0
1562927|NCT03590613|5382992|P1|Period 2, 4 Days|Physician Decision|0
1562928|NCT03588572|5383112|P2|Visitation 3|Withdrawal by Subject|0
1562929|NCT03588572|5383113|P1|Visitation 3|Withdrawal by Subject|1
1562930|NCT03588572|5383112|P2|Visitation 3|Physician Decision|1
1562931|NCT03588572|5383113|P1|Visitation 3|Physician Decision|1
1562932|NCT03588572|5383112|P2|Visitation 3|Lost to Follow-up|1
1562933|NCT03588572|5383113|P1|Visitation 3|Lost to Follow-up|1
1562934|NCT03588572|5383112|P2|Visitation 2|Withdrawal by Subject|0
1562935|NCT03588572|5383113|P1|Visitation 2|Withdrawal by Subject|1
1562936|NCT03588572|5383112|P2|Visitation 2|Lack of Efficacy|1
1562937|NCT03588572|5383113|P1|Visitation 2|Lack of Efficacy|0
1562938|NCT03588572|5383112|P2|Visitation 2|Lost to Follow-up|1
1562939|NCT03588572|5383113|P1|Visitation 2|Lost to Follow-up|1
1562940|NCT03588572|5383112|P2|Visitation 1|Lack of Efficacy|1
1562941|NCT03588572|5383113|P1|Visitation 1|Lack of Efficacy|1
1562942|NCT03586830|5383235|P4|Overall Study|Withdrawal by Subject|1
1562943|NCT03586830|5383236|P3|Overall Study|Withdrawal by Subject|3
1562944|NCT03586830|5383237|P2|Overall Study|Withdrawal by Subject|0
1562945|NCT03586830|5383238|P1|Overall Study|Withdrawal by Subject|1
1562946|NCT03586830|5383235|P4|Overall Study|Lost to Follow-up|1
1562947|NCT03586830|5383236|P3|Overall Study|Lost to Follow-up|2
1562948|NCT03586830|5383237|P2|Overall Study|Lost to Follow-up|2
1562949|NCT03586830|5383238|P1|Overall Study|Lost to Follow-up|0
1562950|NCT03586830|5383235|P4|Overall Study|Site terminated by Sponsor|3
1562951|NCT03586830|5383236|P3|Overall Study|Site terminated by Sponsor|3
1562952|NCT03586830|5383237|P2|Overall Study|Site terminated by Sponsor|4
1562953|NCT03586830|5383238|P1|Overall Study|Site terminated by Sponsor|1
1562954|NCT03586726|5383260|P1|Overall Study|Withdrawal by Subject|1
1562955|NCT03585504|5383289|P2|Overall Study|Lost to Follow-up|29
1562956|NCT03585504|5383290|P1|Overall Study|Lost to Follow-up|26
1562960|NCT03583385|5383304|P2|Treatment Period 2|Adverse Event|0
1562961|NCT03583385|5383305|P1|Treatment Period 2|Adverse Event|1
1562962|NCT03583385|5383304|P2|Treatment Period 1|Withdrawal by Subject|1
1562963|NCT03583385|5383305|P1|Treatment Period 1|Withdrawal by Subject|1
1562964|NCT03582943|5383323|P2|Analyzed|Protocol Violation|1
1562965|NCT03582943|5383324|P1|Analyzed|Protocol Violation|4
1562966|NCT03582943|5383323|P2|Intervention and Follow up|Withdrawal by Subject|2
1562967|NCT03582943|5383324|P1|Intervention and Follow up|Withdrawal by Subject|4
1562968|NCT03582943|5383323|P2|Allocated to Groups|Withdrawal by Subject|1
1562969|NCT03582943|5383324|P1|Allocated to Groups|Withdrawal by Subject|1
1562970|NCT03579940|5383409|P11|Period 2|Withdrawal by Subject|0
1562971|NCT03579940|5383410|P10|Period 2|Withdrawal by Subject|0
1562972|NCT03579940|5383411|P9|Period 2|Withdrawal by Subject|0
1562973|NCT03579940|5383412|P8|Period 2|Withdrawal by Subject|0
1562974|NCT03579940|5383413|P7|Period 2|Withdrawal by Subject|0
1562975|NCT03579940|5383414|P6|Period 2|Withdrawal by Subject|0
1562976|NCT03579940|5383415|P5|Period 2|Withdrawal by Subject|0
1562977|NCT03579940|5383416|P4|Period 2|Withdrawal by Subject|0
1562978|NCT03579940|5383417|P3|Period 2|Withdrawal by Subject|1
1562979|NCT03579940|5383418|P2|Period 2|Withdrawal by Subject|0
1562980|NCT03579940|5383419|P1|Period 2|Withdrawal by Subject|0
1562981|NCT03579719|5383459|P1|Overall Study|Protocol deviation, pre-existent disease|1
1562982|NCT03578146|5383503|P6|Overall Study|Lost to Follow-up|1
1562983|NCT03578146|5383504|P5|Overall Study|Lost to Follow-up|0
1562984|NCT03578146|5383505|P4|Overall Study|Lost to Follow-up|0
1562985|NCT03578146|5383506|P3|Overall Study|Lost to Follow-up|1
1562986|NCT03578146|5383507|P2|Overall Study|Lost to Follow-up|1
1562987|NCT03578146|5383508|P1|Overall Study|Lost to Follow-up|0
1562988|NCT03578146|5383503|P6|Overall Study|Did Not Receive Treatment|2
1562989|NCT03578146|5383504|P5|Overall Study|Did Not Receive Treatment|0
1562990|NCT03578146|5383505|P4|Overall Study|Did Not Receive Treatment|0
1562991|NCT03578146|5383506|P3|Overall Study|Did Not Receive Treatment|0
1562992|NCT03578146|5383507|P2|Overall Study|Did Not Receive Treatment|0
1562993|NCT03578146|5383508|P1|Overall Study|Did Not Receive Treatment|1
1562994|NCT03575702|5383639|P2|Overall Study|Patient non compliance|0
1562995|NCT03575702|5383640|P1|Overall Study|Patient non compliance|4
1562996|NCT03575702|5383639|P2|Overall Study|Protocol Violation|1
1562997|NCT03575702|5383640|P1|Overall Study|Protocol Violation|0
1562998|NCT03575702|5383639|P2|Overall Study|Lost to Follow-up|2
1562999|NCT03575702|5383640|P1|Overall Study|Lost to Follow-up|1
1563000|NCT03575702|5383639|P2|Overall Study|Withdrawal by Subject|1
1563001|NCT03575702|5383640|P1|Overall Study|Withdrawal by Subject|1
1563002|NCT03573817|5383696|P2|Overall Study|Withdrawal by Subject|1
1563003|NCT03573817|5383697|P1|Overall Study|Withdrawal by Subject|1
1563004|NCT03573817|5383696|P2|Overall Study|Protocol Violation|1
1563005|NCT03573817|5383697|P1|Overall Study|Protocol Violation|0
1563006|NCT03573817|5383696|P2|Overall Study|Adverse Event|2
1563007|NCT03573817|5383697|P1|Overall Study|Adverse Event|0
1563008|NCT03569202|5383934|P2|Part 3|Other|1
1563009|NCT03569202|5383935|P1|Part 3|Other|1
1563010|NCT03569202|5383934|P2|Part 3|Physician Decision|0
1563011|NCT03569202|5383935|P1|Part 3|Physician Decision|1
1563012|NCT03568942|5383984|P1|Overall Study|Lost to Follow-up|1
1563013|NCT03568942|5383984|P1|Overall Study|Family emergency|1
1563014|NCT03566810|5384032|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
1563015|NCT03566810|5384033|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
1563016|NCT03566810|5384034|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
1563017|NCT03566810|5384035|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
1563018|NCT03562117|5384188|P3|Part 1, Up to 3 Days|Adverse Event|0
1563019|NCT03562117|5384189|P2|Part 1, Up to 3 Days|Adverse Event|0
1563020|NCT03562117|5384190|P1|Part 1, Up to 3 Days|Adverse Event|1
1563021|NCT03559062|5384315|P3|Overall Study|Other|0
1563022|NCT03559062|5384316|P2|Overall Study|Other|1
1563023|NCT03559062|5384317|P1|Overall Study|Other|0
1563024|NCT03558555|5384330|P2|Overall Study|Lost to Follow-up|1
1563025|NCT03558555|5384331|P1|Overall Study|Lost to Follow-up|2
1563026|NCT03557801|5384359|P3|Overall Study|Lost to Follow-up|0
1563027|NCT03557801|5384360|P2|Overall Study|Lost to Follow-up|1
1563028|NCT03557801|5384361|P1|Overall Study|Lost to Follow-up|0
1563029|NCT03557801|5384359|P3|Overall Study|Withdrawal by Subject|3
1563030|NCT03557801|5384360|P2|Overall Study|Withdrawal by Subject|0
1563031|NCT03557801|5384361|P1|Overall Study|Withdrawal by Subject|1
1563032|NCT03557801|5384359|P3|Overall Study|Protocol Violation|0
1563033|NCT03557801|5384360|P2|Overall Study|Protocol Violation|0
1563034|NCT03557801|5384361|P1|Overall Study|Protocol Violation|1
1563035|NCT03555890|5384427|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
1563036|NCT03555890|5384428|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1563037|NCT03555890|5384429|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1563038|NCT03555890|5384430|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1563039|NCT03554005|5384589|P6|Overall Study|Other|1
1563040|NCT03554005|5384590|P5|Overall Study|Other|0
1563041|NCT03554005|5384591|P4|Overall Study|Other|0
1563042|NCT03554005|5384592|P3|Overall Study|Other|0
1563043|NCT03554005|5384593|P2|Overall Study|Other|0
1563044|NCT03554005|5384594|P1|Overall Study|Other|0
1563045|NCT03554005|5384589|P6|Overall Study|Physician Decision|0
1563046|NCT03554005|5384590|P5|Overall Study|Physician Decision|1
1563047|NCT03554005|5384591|P4|Overall Study|Physician Decision|0
1563048|NCT03554005|5384592|P3|Overall Study|Physician Decision|0
1563049|NCT03554005|5384593|P2|Overall Study|Physician Decision|0
1563050|NCT03554005|5384594|P1|Overall Study|Physician Decision|0
1563051|NCT03554005|5384589|P6|Overall Study|Adverse Event|3
1563052|NCT03554005|5384590|P5|Overall Study|Adverse Event|0
1563053|NCT03554005|5384591|P4|Overall Study|Adverse Event|0
1563054|NCT03554005|5384592|P3|Overall Study|Adverse Event|0
1563055|NCT03554005|5384593|P2|Overall Study|Adverse Event|0
1563056|NCT03554005|5384594|P1|Overall Study|Adverse Event|0
1563057|NCT03554005|5384589|P6|Overall Study|Disease Progression|6
1563058|NCT03554005|5384590|P5|Overall Study|Disease Progression|5
1563059|NCT03554005|5384591|P4|Overall Study|Disease Progression|1
1563060|NCT03554005|5384592|P3|Overall Study|Disease Progression|1
1563061|NCT03554005|5384593|P2|Overall Study|Disease Progression|1
1563062|NCT03554005|5384594|P1|Overall Study|Disease Progression|1
1563063|NCT03554005|5384589|P6|Overall Study|Not in participant's best interest|1
1563064|NCT03554005|5384590|P5|Overall Study|Not in participant's best interest|0
1563065|NCT03554005|5384591|P4|Overall Study|Not in participant's best interest|0
1563066|NCT03554005|5384592|P3|Overall Study|Not in participant's best interest|0
1563067|NCT03554005|5384593|P2|Overall Study|Not in participant's best interest|0
1563068|NCT03554005|5384594|P1|Overall Study|Not in participant's best interest|0
1563069|NCT03552549|5384622|P2|Overall Study|Administrative|14
1563070|NCT03552549|5384623|P1|Overall Study|Administrative|0
1563071|NCT03552549|5384622|P2|Overall Study|Did not meet eligibility criteria|0
1563072|NCT03552549|5384623|P1|Overall Study|Did not meet eligibility criteria|1
1563073|NCT03552549|5384622|P2|Overall Study|Did not complete study treatment|3
1563074|NCT03552549|5384623|P1|Overall Study|Did not complete study treatment|2
1563075|NCT03552549|5384622|P2|Overall Study|Not in participant's best interest|1
1563076|NCT03552549|5384623|P1|Overall Study|Not in participant's best interest|2
1563077|NCT03552549|5384622|P2|Overall Study|Unknown (no reason provided)|2
1563078|NCT03552549|5384623|P1|Overall Study|Unknown (no reason provided)|4
1563079|NCT03552549|5384622|P2|Overall Study|Withdrawal by Subject|7
1563080|NCT03552549|5384623|P1|Overall Study|Withdrawal by Subject|7
1563081|NCT03552549|5384622|P2|Overall Study|Adverse event in first 12 months|8
1563082|NCT03552549|5384623|P1|Overall Study|Adverse event in first 12 months|12
1563083|NCT03552549|5384622|P2|Overall Study|Disease progression|17
1563084|NCT03552549|5384623|P1|Overall Study|Disease progression|25
1563085|NCT03552523|5384631|P2|Overall Study|Withdrawal by Subject|1
1563086|NCT03552523|5384632|P1|Overall Study|Withdrawal by Subject|1
1563087|NCT03551743|5384649|P4|Overall Study|Withdrawal by Subject|0
1563088|NCT03551743|5384650|P3|Overall Study|Withdrawal by Subject|0
1563089|NCT03551743|5384651|P2|Overall Study|Withdrawal by Subject|0
1563090|NCT03551743|5384652|P1|Overall Study|Withdrawal by Subject|1
1563091|NCT03551743|5384649|P4|Overall Study|Adverse Event|0
1563092|NCT03551743|5384650|P3|Overall Study|Adverse Event|0
1563093|NCT03551743|5384651|P2|Overall Study|Adverse Event|0
1563094|NCT03551743|5384652|P1|Overall Study|Adverse Event|1
1563095|NCT03551730|5384698|P4|Overall Study|Adverse Event|0
1563096|NCT03551730|5384699|P3|Overall Study|Adverse Event|0
1563097|NCT03551730|5384700|P2|Overall Study|Adverse Event|0
1563098|NCT03551730|5384701|P1|Overall Study|Adverse Event|1
1563099|NCT03549429|5384836|P2|Overall Study|Protocol Violation|3
1563100|NCT03549429|5384837|P1|Overall Study|Protocol Violation|5
1563101|NCT03549338|5384850|P3|Overall Study|Clinical Progression|0
1563102|NCT03549338|5384851|P2|Overall Study|Clinical Progression|1
1563103|NCT03549338|5384852|P1|Overall Study|Clinical Progression|0
1563104|NCT03549338|5384850|P3|Overall Study|Progressive Disease|0
1563105|NCT03549338|5384851|P2|Overall Study|Progressive Disease|0
1563106|NCT03549338|5384852|P1|Overall Study|Progressive Disease|1
1563107|NCT03549130|5384860|P2|Overall Study|Lost to Follow-up|1
1563108|NCT03549130|5384861|P1|Overall Study|Lost to Follow-up|0
1563109|NCT03549130|5384860|P2|Overall Study|Adverse Event|1
1563110|NCT03549130|5384861|P1|Overall Study|Adverse Event|0
1563111|NCT03549117|5384879|P2|Overall Study|Withdrawal by Subject|0
1563112|NCT03549117|5384880|P1|Overall Study|Withdrawal by Subject|1
1563113|NCT03547531|5384908|P2|Overall Study|having family occasion|2
1563114|NCT03547531|5384909|P1|Overall Study|having family occasion|0
1563115|NCT03547531|5384908|P2|Overall Study|not coming in data collection : sick|2
1563116|NCT03547531|5384909|P1|Overall Study|not coming in data collection : sick|2
1563117|NCT03547154|5384923|P2|Overall Study|Continued treatment beyond 12 mo.|50
1563118|NCT03547154|5384924|P1|Overall Study|Continued treatment beyond 12 mo.|58
1563119|NCT03547154|5384923|P2|Overall Study|Not Selected|1
1563120|NCT03547154|5384924|P1|Overall Study|Not Selected|0
1563121|NCT03547154|5384923|P2|Overall Study|Withdrawal by Subject|6
1563122|NCT03547154|5384924|P1|Overall Study|Withdrawal by Subject|10
1563123|NCT03547154|5384923|P2|Overall Study|Insufficient Therapeutic Response|10
1563124|NCT03547154|5384924|P1|Overall Study|Insufficient Therapeutic Response|13
1563125|NCT03547154|5384923|P2|Overall Study|Physician Decision|3
1563126|NCT03547154|5384924|P1|Overall Study|Physician Decision|4
1563127|NCT03547154|5384923|P2|Overall Study|Protocol Violation|1
1563128|NCT03547154|5384924|P1|Overall Study|Protocol Violation|6
1563129|NCT03547154|5384923|P2|Overall Study|Adverse Event|31
1563130|NCT03547154|5384924|P1|Overall Study|Adverse Event|26
1563131|NCT03547154|5384923|P2|Overall Study|Disease Progression/Recurrence|14
1563132|NCT03547154|5384924|P1|Overall Study|Disease Progression/Recurrence|6
1563135|NCT03546621|5384949|P4|Overall Study|Progressive disease|1
1563136|NCT03546621|5384950|P3|Overall Study|Progressive disease|0
1563137|NCT03546621|5384951|P2|Overall Study|Progressive disease|0
1563138|NCT03546621|5384952|P1|Overall Study|Progressive disease|0
1563139|NCT03546621|5384949|P4|Overall Study|Adverse Event|1
1563140|NCT03546621|5384950|P3|Overall Study|Adverse Event|0
1563141|NCT03546621|5384951|P2|Overall Study|Adverse Event|1
1563142|NCT03546621|5384952|P1|Overall Study|Adverse Event|0
1563143|NCT03546621|5384949|P4|Overall Study|Lost to Follow-up|0
1563144|NCT03546621|5384950|P3|Overall Study|Lost to Follow-up|0
1563145|NCT03546621|5384951|P2|Overall Study|Lost to Follow-up|1
1563146|NCT03546621|5384952|P1|Overall Study|Lost to Follow-up|0
1563147|NCT03546621|5384949|P4|Overall Study|Withdrawal by Subject|1
1563148|NCT03546621|5384950|P3|Overall Study|Withdrawal by Subject|2
1563149|NCT03546621|5384951|P2|Overall Study|Withdrawal by Subject|1
1563150|NCT03546621|5384952|P1|Overall Study|Withdrawal by Subject|0
1563151|NCT03545984|5385042|P2|Overall Study|CSF cases not present during rotation|9
1563152|NCT03545984|5385043|P1|Overall Study|CSF cases not present during rotation|11
1563153|NCT03543137|5385119|P2|Study Period 2: Up to Day 8|Adverse Event|1
1563154|NCT03543137|5385120|P1|Study Period 2: Up to Day 8|Adverse Event|0
1563155|NCT03543137|5385119|P2|Study Period 2: Up to Day 8|Protocol Violation|0
1563156|NCT03543137|5385120|P1|Study Period 2: Up to Day 8|Protocol Violation|1
1563157|NCT03543137|5385119|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
1563158|NCT03543137|5385120|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
1563159|NCT03528369|5385451|P3|Overall Study|Adverse Event|0
1563160|NCT03528369|5385452|P2|Overall Study|Adverse Event|1
1563161|NCT03528369|5385453|P1|Overall Study|Adverse Event|0
1563162|NCT03528369|5385451|P3|Overall Study|Lost to Follow-up|0
1563163|NCT03528369|5385452|P2|Overall Study|Lost to Follow-up|0
1563164|NCT03528369|5385453|P1|Overall Study|Lost to Follow-up|1
1563165|NCT03528369|5385451|P3|Overall Study|Withdrawal by Subject|0
1563166|NCT03528369|5385452|P2|Overall Study|Withdrawal by Subject|0
1563167|NCT03528369|5385453|P1|Overall Study|Withdrawal by Subject|2
1563168|NCT03528174|5385482|P1|Overall Study|sensors dislodged|1
1563169|NCT03528174|5385482|P1|Overall Study|Adverse Event|1
1563170|NCT03527966|5385502|P2|Overall Study|Lost to Follow-up|0
1563171|NCT03527966|5385503|P1|Overall Study|Lost to Follow-up|3
1563172|NCT03524157|5385550|P3|Overall Study|cytology not readable|1
1563173|NCT03524157|5385551|P2|Overall Study|cytology not readable|0
1563174|NCT03524157|5385552|P1|Overall Study|cytology not readable|0
1563175|NCT03522675|5385606|P1|Overall Study|Non-reactive to histamine|1
1563176|NCT03522675|5385606|P1|Overall Study|Screen fail|1
1563177|NCT03522506|5385624|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
1563178|NCT03522506|5385625|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
1563179|NCT03522506|5385626|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
1563180|NCT03522506|5385627|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
1563181|NCT03522506|5385624|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1563182|NCT03522506|5385625|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1563183|NCT03522506|5385626|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1563184|NCT03522506|5385627|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1563185|NCT03521791|5385689|P2|Overall Study|Protocol Violation|17
1563186|NCT03521791|5385690|P1|Overall Study|Protocol Violation|7
1563187|NCT03519932|5385741|P2|First Intervention|Adverse Event|3
1563188|NCT03519932|5385742|P1|First Intervention|Adverse Event|1
1563189|NCT03519919|5385768|P1|Overall Study|Screen Failure|1
1563190|NCT03519919|5385768|P1|Overall Study|Lack of Efficacy|1
1563191|NCT03519919|5385768|P1|Overall Study|Withdrawal by Subject|1
1563192|NCT03519867|5385820|P10|Overall Study|Reason not provided|0
1563193|NCT03519867|5385821|P9|Overall Study|Reason not provided|1
1563194|NCT03519867|5385822|P8|Overall Study|Reason not provided|1
1563195|NCT03519867|5385823|P7|Overall Study|Reason not provided|0
1563196|NCT03519867|5385824|P6|Overall Study|Reason not provided|1
1563197|NCT03519867|5385825|P5|Overall Study|Reason not provided|0
1563198|NCT03519867|5385826|P4|Overall Study|Reason not provided|1
1563199|NCT03519867|5385827|P3|Overall Study|Reason not provided|1
1563200|NCT03519867|5385828|P2|Overall Study|Reason not provided|1
1563201|NCT03519867|5385829|P1|Overall Study|Reason not provided|1
1563202|NCT03519867|5385820|P10|Overall Study|Admin. of other reversal agent|0
1563203|NCT03519867|5385821|P9|Overall Study|Admin. of other reversal agent|0
1563204|NCT03519867|5385822|P8|Overall Study|Admin. of other reversal agent|0
1563205|NCT03519867|5385823|P7|Overall Study|Admin. of other reversal agent|0
1563206|NCT03519867|5385824|P6|Overall Study|Admin. of other reversal agent|1
1563207|NCT03519867|5385825|P5|Overall Study|Admin. of other reversal agent|0
1563208|NCT03519867|5385826|P4|Overall Study|Admin. of other reversal agent|0
1563209|NCT03519867|5385827|P3|Overall Study|Admin. of other reversal agent|0
1563210|NCT03519867|5385828|P2|Overall Study|Admin. of other reversal agent|1
1563211|NCT03519867|5385829|P1|Overall Study|Admin. of other reversal agent|1
1563212|NCT03519867|5385820|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
1563213|NCT03519867|5385821|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
1563214|NCT03519867|5385822|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
1563215|NCT03519867|5385823|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
1563216|NCT03519867|5385824|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
1563217|NCT03519867|5385825|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
1563218|NCT03519867|5385826|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
1563219|NCT03519867|5385827|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
1563220|NCT03519867|5385828|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
1563221|NCT03519867|5385829|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
1563222|NCT03519867|5385820|P10|Overall Study|Protocol Violation|0
1563223|NCT03519867|5385821|P9|Overall Study|Protocol Violation|0
1563224|NCT03519867|5385822|P8|Overall Study|Protocol Violation|0
1563225|NCT03519867|5385823|P7|Overall Study|Protocol Violation|0
1563226|NCT03519867|5385824|P6|Overall Study|Protocol Violation|1
1563227|NCT03519867|5385825|P5|Overall Study|Protocol Violation|0
1563228|NCT03519867|5385826|P4|Overall Study|Protocol Violation|0
1563229|NCT03519867|5385827|P3|Overall Study|Protocol Violation|0
1563230|NCT03519867|5385828|P2|Overall Study|Protocol Violation|0
1563231|NCT03519867|5385829|P1|Overall Study|Protocol Violation|0
1563232|NCT03519867|5385820|P10|Overall Study|Adverse Event|0
1563233|NCT03519867|5385821|P9|Overall Study|Adverse Event|0
1563234|NCT03519867|5385822|P8|Overall Study|Adverse Event|0
1563235|NCT03519867|5385823|P7|Overall Study|Adverse Event|0
1563236|NCT03519867|5385824|P6|Overall Study|Adverse Event|0
1563237|NCT03519867|5385825|P5|Overall Study|Adverse Event|0
1563238|NCT03519867|5385826|P4|Overall Study|Adverse Event|0
1563239|NCT03519867|5385827|P3|Overall Study|Adverse Event|0
1563240|NCT03519867|5385828|P2|Overall Study|Adverse Event|1
1563241|NCT03519867|5385829|P1|Overall Study|Adverse Event|1
1563242|NCT03519854|5385879|P18|Overall Study|Technical Error|0
1563243|NCT03519854|5385880|P17|Overall Study|Technical Error|0
1563244|NCT03519854|5385881|P16|Overall Study|Technical Error|0
1563245|NCT03519854|5385882|P15|Overall Study|Technical Error|0
1563246|NCT03519854|5385883|P14|Overall Study|Technical Error|0
1563247|NCT03519854|5385884|P13|Overall Study|Technical Error|0
1563248|NCT03519854|5385885|P12|Overall Study|Technical Error|0
1563249|NCT03519854|5385886|P11|Overall Study|Technical Error|0
1563250|NCT03519854|5385887|P10|Overall Study|Technical Error|0
1563251|NCT03519854|5385888|P9|Overall Study|Technical Error|0
1563252|NCT03519854|5385889|P8|Overall Study|Technical Error|0
1563253|NCT03519854|5385890|P7|Overall Study|Technical Error|0
1563254|NCT03519854|5385891|P6|Overall Study|Technical Error|0
1563255|NCT03519854|5385892|P5|Overall Study|Technical Error|0
1563256|NCT03519854|5385893|P4|Overall Study|Technical Error|0
1563257|NCT03519854|5385894|P3|Overall Study|Technical Error|1
1563258|NCT03519854|5385895|P2|Overall Study|Technical Error|0
1563259|NCT03519854|5385896|P1|Overall Study|Technical Error|0
1563260|NCT03519516|5386062|P2|Overall Study|Adverse Event|1
1563261|NCT03519516|5386063|P1|Overall Study|Adverse Event|0
1563262|NCT03519204|5386124|P2|Overall Study|Other Miscellaneous Reasons|0
1563263|NCT03519204|5386125|P1|Overall Study|Other Miscellaneous Reasons|1
1563264|NCT03519204|5386124|P2|Overall Study|Withdrawal by Subject|7
1563265|NCT03519204|5386125|P1|Overall Study|Withdrawal by Subject|9
1563266|NCT03519204|5386124|P2|Overall Study|Lost to Follow-up|8
1563267|NCT03519204|5386125|P1|Overall Study|Lost to Follow-up|3
1563268|NCT03518008|5386142|P2|Period 2, Second Week of Wear|Family emergency|1
1563269|NCT03518008|5386143|P1|Period 2, Second Week of Wear|Family emergency|0
1563270|NCT03512028|5386266|P2|Overall Study|Protocol Violation|0
1563271|NCT03512028|5386267|P1|Overall Study|Protocol Violation|2
1563272|NCT03512028|5386266|P2|Overall Study|Withdrawal by Subject|0
1563273|NCT03512028|5386267|P1|Overall Study|Withdrawal by Subject|2
1563274|NCT03511105|5386275|P2|Overall Study|Withdrew consent|0
1563275|NCT03511105|5386276|P1|Overall Study|Withdrew consent|1
1563276|NCT03511105|5386275|P2|Overall Study|Adverse Event|0
1563277|NCT03511105|5386276|P1|Overall Study|Adverse Event|1
1563278|NCT03509948|5386330|P2|Overall Study|Protocol Violation|1
1563279|NCT03509948|5386331|P1|Overall Study|Protocol Violation|0
1563280|NCT03508843|5386397|P1|Overall Study|technical difficulties|2
1563281|NCT03508843|5386397|P1|Overall Study|Withdrawal by Subject|1
1563282|NCT03506425|5386445|P3|Overall Study|Withdrawal by Subject|1
1563283|NCT03506425|5386446|P2|Overall Study|Withdrawal by Subject|0
1563284|NCT03506425|5386447|P1|Overall Study|Withdrawal by Subject|0
1563285|NCT03506425|5386445|P3|Overall Study|Death|0
1563286|NCT03506425|5386446|P2|Overall Study|Death|0
1563287|NCT03506425|5386447|P1|Overall Study|Death|1
1563288|NCT03506425|5386445|P3|Overall Study|Adverse Event|0
1563289|NCT03506425|5386446|P2|Overall Study|Adverse Event|3
1563290|NCT03506425|5386447|P1|Overall Study|Adverse Event|1
1563294|NCT03503188|5386502|P2|Overall Study|Non eligible in the sub study|1
1563295|NCT03503188|5386503|P1|Overall Study|Non eligible in the sub study|0
1563296|NCT03501277|5386540|P4|Intervention Period 3 (4 Days)|Adverse Event|1
1563297|NCT03501277|5386541|P3|Intervention Period 3 (4 Days)|Adverse Event|0
1563298|NCT03501277|5386542|P2|Intervention Period 3 (4 Days)|Adverse Event|0
1563299|NCT03501277|5386543|P1|Intervention Period 3 (4 Days)|Adverse Event|0
1563300|NCT03501277|5386540|P4|Intervention Period 2 (4 Days)|Adverse Event|1
1563301|NCT03501277|5386541|P3|Intervention Period 2 (4 Days)|Adverse Event|0
1563302|NCT03501277|5386542|P2|Intervention Period 2 (4 Days)|Adverse Event|0
1563303|NCT03501277|5386543|P1|Intervention Period 2 (4 Days)|Adverse Event|0
1563304|NCT03501277|5386540|P4|Intervention Period 1 (4 Days)|Adverse Event|1
1563305|NCT03501277|5386541|P3|Intervention Period 1 (4 Days)|Adverse Event|0
1563306|NCT03501277|5386542|P2|Intervention Period 1 (4 Days)|Adverse Event|0
1563307|NCT03501277|5386543|P1|Intervention Period 1 (4 Days)|Adverse Event|0
1563308|NCT03501277|5386540|P4|Intervention Period 1 (4 Days)|Other|0
1563309|NCT03501277|5386541|P3|Intervention Period 1 (4 Days)|Other|1
1563310|NCT03501277|5386542|P2|Intervention Period 1 (4 Days)|Other|0
1563311|NCT03501277|5386543|P1|Intervention Period 1 (4 Days)|Other|0
1563312|NCT03500679|5386568|P2|Overall Study|Withdrawal by Subject|0
1563313|NCT03500679|5386569|P1|Overall Study|Withdrawal by Subject|3
1563314|NCT03500679|5386568|P2|Overall Study|Lost to Follow-up|3
1563315|NCT03500679|5386569|P1|Overall Study|Lost to Follow-up|6
1563316|NCT03500224|5386636|P1|Overall Study|Withdrawal by Subject|2
1563317|NCT03500159|5386675|P2|Overall Study|Study Terminated|1
1563318|NCT03500159|5386676|P1|Overall Study|Study Terminated|2
1563323|NCT03494985|5386823|P4|Overall Study|Other (Not specified)|0
1563324|NCT03494985|5386824|P3|Overall Study|Other (Not specified)|1
1563325|NCT03494985|5386825|P2|Overall Study|Other (Not specified)|1
1563326|NCT03494985|5386826|P1|Overall Study|Other (Not specified)|0
1563327|NCT03494985|5386823|P4|Overall Study|Other (Withdrawal of consent)|5
1563328|NCT03494985|5386824|P3|Overall Study|Other (Withdrawal of consent)|2
1563329|NCT03494985|5386825|P2|Overall Study|Other (Withdrawal of consent)|3
1563330|NCT03494985|5386826|P1|Overall Study|Other (Withdrawal of consent)|2
1563331|NCT03494985|5386823|P4|Overall Study|Adverse Event|0
1563332|NCT03494985|5386824|P3|Overall Study|Adverse Event|3
1563333|NCT03494985|5386825|P2|Overall Study|Adverse Event|2
1563334|NCT03494985|5386826|P1|Overall Study|Adverse Event|3
1563335|NCT03493386|5386875|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1563336|NCT03493386|5386876|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1563337|NCT03493386|5386877|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
1563338|NCT03493386|5386878|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1563339|NCT03492554|5386998|P2|Overall Study|Protocol Violation|14
1563340|NCT03492554|5386999|P1|Overall Study|Protocol Violation|0
1563341|NCT03489551|5387037|P1|Overall Study|Withdrawal by Subject|2
1563342|NCT03489304|5387041|P1|Overall Study|Lost to Follow-up|4
1563343|NCT03486392|5387058|P5|Overall Study|Death|1
1563344|NCT03486392|5387059|P4|Overall Study|Death|0
1563345|NCT03486392|5387060|P3|Overall Study|Death|0
1563346|NCT03486392|5387061|P2|Overall Study|Death|0
1563347|NCT03486392|5387062|P1|Overall Study|Death|0
1563348|NCT03486392|5387058|P5|Overall Study|Withdrawal by Subject|1
1563349|NCT03486392|5387059|P4|Overall Study|Withdrawal by Subject|4
1563350|NCT03486392|5387060|P3|Overall Study|Withdrawal by Subject|6
1563351|NCT03486392|5387061|P2|Overall Study|Withdrawal by Subject|0
1563352|NCT03486392|5387062|P1|Overall Study|Withdrawal by Subject|3
1563353|NCT03486392|5387058|P5|Overall Study|Lost to Follow-up|2
1563354|NCT03486392|5387059|P4|Overall Study|Lost to Follow-up|5
1563355|NCT03486392|5387060|P3|Overall Study|Lost to Follow-up|8
1563356|NCT03486392|5387061|P2|Overall Study|Lost to Follow-up|0
1563357|NCT03486392|5387062|P1|Overall Study|Lost to Follow-up|0
1563358|NCT03482453|5387132|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563359|NCT03482453|5387133|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
1563360|NCT03482453|5387134|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563361|NCT03482453|5387135|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563362|NCT03482453|5387136|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563363|NCT03482453|5387137|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563364|NCT03482453|5387138|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563365|NCT03482453|5387139|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563366|NCT03482453|5387140|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563367|NCT03482453|5387141|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563368|NCT03482453|5387142|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563369|NCT03482453|5387143|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
1563370|NCT03481309|5387266|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
1563371|NCT03481309|5387267|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
1563372|NCT03481309|5387268|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
1563373|NCT03481309|5387269|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
1563374|NCT03481309|5387270|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
1563375|NCT03481309|5387271|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
1563376|NCT03480841|5387313|P1|Overall Study|Lost to Follow-up|2
1563377|NCT03479216|5387346|P2|Overall Study|Physician Decision|3
1563378|NCT03479216|5387347|P1|Overall Study|Physician Decision|2
1563379|NCT03479216|5387346|P2|Overall Study|Withdrawal by Subject|2
1563380|NCT03479216|5387347|P1|Overall Study|Withdrawal by Subject|3
1563381|NCT03478891|5387368|P3|Overall Study|Lost to Follow-up|1
1563382|NCT03478891|5387369|P2|Overall Study|Lost to Follow-up|0
1563383|NCT03478891|5387370|P1|Overall Study|Lost to Follow-up|1
1563384|NCT03478891|5387368|P3|Overall Study|Moved from area|1
1563385|NCT03478891|5387369|P2|Overall Study|Moved from area|0
1563386|NCT03478891|5387370|P1|Overall Study|Moved from area|0
1563387|NCT03478891|5387368|P3|Overall Study|Enrolled, but product never administered|1
1563388|NCT03478891|5387369|P2|Overall Study|Enrolled, but product never administered|0
1563389|NCT03478891|5387370|P1|Overall Study|Enrolled, but product never administered|0
1563390|NCT03478696|5387421|P2|Overall Study|Withdrawal by Subject|4
1563391|NCT03478696|5387422|P1|Overall Study|Withdrawal by Subject|9
1563392|NCT03478696|5387421|P2|Overall Study|Physician Decision|3
1563393|NCT03478696|5387422|P1|Overall Study|Physician Decision|6
1563394|NCT03478696|5387421|P2|Overall Study|Lost to Follow-up|0
1563395|NCT03478696|5387422|P1|Overall Study|Lost to Follow-up|1
1563396|NCT03478696|5387421|P2|Overall Study|Adverse Event|5
1563397|NCT03478696|5387422|P1|Overall Study|Adverse Event|1
1563398|NCT03478683|5387436|P2|Overall Study|Withdrawal by Subject|7
1563399|NCT03478683|5387437|P1|Overall Study|Withdrawal by Subject|7
1563400|NCT03478683|5387436|P2|Overall Study|Physician Decision|3
1563401|NCT03478683|5387437|P1|Overall Study|Physician Decision|1
1563402|NCT03478683|5387436|P2|Overall Study|Lost to Follow-up|5
1563403|NCT03478683|5387437|P1|Overall Study|Lost to Follow-up|0
1563404|NCT03478683|5387436|P2|Overall Study|Adverse Event|3
1563405|NCT03478683|5387437|P1|Overall Study|Adverse Event|5
1563406|NCT03478657|5387451|P2|Overall Study|Withdrawal by Subject|1
1563407|NCT03478657|5387452|P1|Overall Study|Withdrawal by Subject|0
1563408|NCT03478644|5387467|P2|Phase 2|Lost to Follow-up|0
1563409|NCT03478644|5387468|P1|Phase 2|Lost to Follow-up|1
1563410|NCT03478644|5387467|P2|Phase 2|Withdrawal by Subject|1
1563411|NCT03478644|5387468|P1|Phase 2|Withdrawal by Subject|2
1563412|NCT03478371|5387480|P1|Overall Study|Lost to Follow-up|4
1563413|NCT03478371|5387480|P1|Overall Study|non-compliance|1
1563414|NCT03477903|5387502|P1|Overall Study|Study Terminated by Sponsor|1
1563415|NCT03475875|5387559|P2|Period 2|Protocol Violation|1
1563416|NCT03475875|5387560|P1|Period 2|Protocol Violation|0
1563417|NCT03475875|5387559|P2|Period 2|Adverse Event|0
1563418|NCT03475875|5387560|P1|Period 2|Adverse Event|3
1563419|NCT03475875|5387559|P2|Period 1|Adverse Event|1
1563420|NCT03475875|5387560|P1|Period 1|Adverse Event|2
1563421|NCT03475875|5387559|P2|Period 1|Lost to Follow-up|0
1563422|NCT03475875|5387560|P1|Period 1|Lost to Follow-up|1
1563423|NCT03473808|5387577|P1|Overall Study|Withdrawal by Subject|1
1563434|NCT03473197|5387723|P1|Overall Study|Withdrawal by Subject|5
1563435|NCT03473197|5387723|P1|Overall Study|Lost to Follow-up|1
1563436|NCT03473197|5387723|P1|Overall Study|Adverse Event|4
1563437|NCT03472547|5387731|P1|Overall Study|Withdrawal by Subject|30
1563438|NCT03472534|5387735|P1|Overall Study|Adverse Event|2
1563439|NCT03472534|5387735|P1|Overall Study|Withdrawal by Subject|9
1563465|NCT03468543|5387893|P1|Overall Study|Protocol stopping rules met|3
1563466|NCT03467971|5387905|P2|Treatment Period 2|Withdrawal by Subject|1
1563467|NCT03467971|5387906|P1|Treatment Period 2|Withdrawal by Subject|0
1563468|NCT03467945|5387930|P4|Treatment Period 3|Withdrawal by Subject|1
1563469|NCT03467945|5387931|P3|Treatment Period 3|Withdrawal by Subject|2
1563470|NCT03467945|5387932|P2|Treatment Period 3|Withdrawal by Subject|0
1563471|NCT03467945|5387933|P1|Treatment Period 3|Withdrawal by Subject|1
1563472|NCT03467945|5387930|P4|Treatment Period 2|Withdrawal by Subject|0
1563473|NCT03467945|5387931|P3|Treatment Period 2|Withdrawal by Subject|0
1563474|NCT03467945|5387932|P2|Treatment Period 2|Withdrawal by Subject|1
1563475|NCT03467945|5387933|P1|Treatment Period 2|Withdrawal by Subject|0
1563476|NCT03466658|5387985|P1|Overall Study|Withdrawal by Subject|3
1563477|NCT03466086|5387991|P2|Period 1|Withdrawal by Subject|0
1563478|NCT03466086|5387992|P1|Period 1|Withdrawal by Subject|1
1563479|NCT03466086|5387991|P2|Period 1|Sponsor decision due to study timeline|0
1563480|NCT03466086|5387992|P1|Period 1|Sponsor decision due to study timeline|1
1563481|NCT03466073|5388006|P6|Overall Study|Death|1
1563482|NCT03466073|5388007|P5|Overall Study|Death|0
1563483|NCT03466073|5388008|P4|Overall Study|Death|0
1563484|NCT03466073|5388009|P3|Overall Study|Death|0
1563485|NCT03466073|5388010|P2|Overall Study|Death|0
1563486|NCT03466073|5388011|P1|Overall Study|Death|1
1563487|NCT03466060|5388044|P6|Period 2|Lens Handling Difficulties|0
1563488|NCT03466060|5388045|P5|Period 2|Lens Handling Difficulties|0
1563489|NCT03466060|5388046|P4|Period 2|Lens Handling Difficulties|0
1563490|NCT03466060|5388047|P3|Period 2|Lens Handling Difficulties|1
1563491|NCT03466060|5388048|P2|Period 2|Lens Handling Difficulties|0
1563492|NCT03466060|5388049|P1|Period 2|Lens Handling Difficulties|0
1563493|NCT03466060|5388044|P6|Period 1|Grade 2 Conjunctivitis|0
1563494|NCT03466060|5388045|P5|Period 1|Grade 2 Conjunctivitis|0
1563495|NCT03466060|5388046|P4|Period 1|Grade 2 Conjunctivitis|0
1563496|NCT03466060|5388047|P3|Period 1|Grade 2 Conjunctivitis|1
1563497|NCT03466060|5388048|P2|Period 1|Grade 2 Conjunctivitis|0
1563498|NCT03466060|5388049|P1|Period 1|Grade 2 Conjunctivitis|0
1563499|NCT03466060|5388044|P6|Period 1|Lost to Follow-up|0
1563500|NCT03466060|5388045|P5|Period 1|Lost to Follow-up|0
1563501|NCT03466060|5388046|P4|Period 1|Lost to Follow-up|1
1563502|NCT03466060|5388047|P3|Period 1|Lost to Follow-up|0
1563503|NCT03466060|5388048|P2|Period 1|Lost to Follow-up|0
1563504|NCT03466060|5388049|P1|Period 1|Lost to Follow-up|0
1563505|NCT03466060|5388044|P6|Period 1|Withdrawal by Subject|0
1563506|NCT03466060|5388045|P5|Period 1|Withdrawal by Subject|0
1563507|NCT03466060|5388046|P4|Period 1|Withdrawal by Subject|0
1563508|NCT03466060|5388047|P3|Period 1|Withdrawal by Subject|2
1563509|NCT03466060|5388048|P2|Period 1|Withdrawal by Subject|0
1563510|NCT03466060|5388049|P1|Period 1|Withdrawal by Subject|0
1563511|NCT03466060|5388044|P6|Period 1|Test Lens Damage|0
1563512|NCT03466060|5388045|P5|Period 1|Test Lens Damage|0
1563513|NCT03466060|5388046|P4|Period 1|Test Lens Damage|0
1563514|NCT03466060|5388047|P3|Period 1|Test Lens Damage|0
1563515|NCT03466060|5388048|P2|Period 1|Test Lens Damage|2
1563516|NCT03466060|5388049|P1|Period 1|Test Lens Damage|0
1563517|NCT03465904|5388065|P2|Overall Study|Ineligible for mITT analysis|47
1563518|NCT03465904|5388066|P1|Overall Study|Ineligible for mITT analysis|62
1563519|NCT03465904|5388065|P2|Overall Study|Protocol Violation|5
1563520|NCT03465904|5388066|P1|Overall Study|Protocol Violation|8
1563521|NCT03465904|5388065|P2|Overall Study|Lost to Follow-up|9
1563522|NCT03465904|5388066|P1|Overall Study|Lost to Follow-up|10
1563523|NCT03465904|5388065|P2|Overall Study|Withdrawal by Subject|5
1563524|NCT03465904|5388066|P1|Overall Study|Withdrawal by Subject|9
1563525|NCT03465436|5388088|P4|Period 4|Protocol Violation|0
1563526|NCT03465436|5388089|P3|Period 4|Protocol Violation|1
1563527|NCT03465436|5388090|P2|Period 4|Protocol Violation|0
1563528|NCT03465436|5388091|P1|Period 4|Protocol Violation|0
1563529|NCT03465436|5388088|P4|Period 3|Protocol Violation|0
1563530|NCT03465436|5388089|P3|Period 3|Protocol Violation|0
1563531|NCT03465436|5388090|P2|Period 3|Protocol Violation|1
1563532|NCT03465436|5388091|P1|Period 3|Protocol Violation|1
1563533|NCT03465436|5388088|P4|Period 2|Protocol Violation|0
1563534|NCT03465436|5388089|P3|Period 2|Protocol Violation|0
1563535|NCT03465436|5388090|P2|Period 2|Protocol Violation|1
1563536|NCT03465436|5388091|P1|Period 2|Protocol Violation|0
1563537|NCT03465436|5388088|P4|Period 1|Protocol Violation|0
1563538|NCT03465436|5388089|P3|Period 1|Protocol Violation|1
1563539|NCT03465436|5388090|P2|Period 1|Protocol Violation|0
1563540|NCT03465436|5388091|P1|Period 1|Protocol Violation|0
1563541|NCT03463031|5388147|P2|Overall Study|Use of prohibited medication by subject|0
1563542|NCT03463031|5388148|P1|Overall Study|Use of prohibited medication by subject|1
1563543|NCT03463031|5388147|P2|Overall Study|Adverse Event|1
1563544|NCT03463031|5388148|P1|Overall Study|Adverse Event|4
1563545|NCT03463031|5388147|P2|Overall Study|Lost to Follow-up|1
1563546|NCT03463031|5388148|P1|Overall Study|Lost to Follow-up|1
1563547|NCT03463031|5388147|P2|Overall Study|Investigator/Sponsor Decision|1
1563548|NCT03463031|5388148|P1|Overall Study|Investigator/Sponsor Decision|0
1563549|NCT03463031|5388147|P2|Overall Study|Withdrawal by Subject|2
1563550|NCT03463031|5388148|P1|Overall Study|Withdrawal by Subject|4
1563551|NCT03459196|5388315|P1|Overall Study|Subject didn't receive study catheter|2
1563552|NCT03458702|5388329|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
1563553|NCT03458702|5388330|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
1563554|NCT03458702|5388329|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
1563555|NCT03458702|5388330|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
1563556|NCT03457727|5388359|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
1563557|NCT03457727|5388360|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
1563558|NCT03457727|5388361|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
1563559|NCT03457727|5388362|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
1563560|NCT03457636|5388559|P1|Overall Study|Lost to Follow-up|2
1563561|NCT03456960|5388572|P6|Period 2 (1 Day)|Adverse Event|0
1563562|NCT03456960|5388573|P5|Period 2 (1 Day)|Adverse Event|0
1563563|NCT03456960|5388574|P4|Period 2 (1 Day)|Adverse Event|1
1563564|NCT03456960|5388575|P3|Period 2 (1 Day)|Adverse Event|0
1563565|NCT03456960|5388576|P2|Period 2 (1 Day)|Adverse Event|0
1563566|NCT03456960|5388577|P1|Period 2 (1 Day)|Adverse Event|1
1563567|NCT03456960|5388572|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1563568|NCT03456960|5388573|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1563569|NCT03456960|5388574|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
1563570|NCT03456960|5388575|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
1563571|NCT03456960|5388576|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1563572|NCT03456960|5388577|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1563573|NCT03450070|5388964|P1|Overall Study|Withdrawal by Subject|8
1563574|NCT03448536|5388970|P2|Overall Study|Physician Decision|0
1563575|NCT03448536|5388971|P1|Overall Study|Physician Decision|1
1563576|NCT03448536|5388970|P2|Overall Study|Other|0
1563577|NCT03448536|5388971|P1|Overall Study|Other|3
1563578|NCT03448536|5388970|P2|Overall Study|Inadequate pain reporter|0
1563579|NCT03448536|5388971|P1|Overall Study|Inadequate pain reporter|1
1563580|NCT03448536|5388970|P2|Overall Study|Lost to Follow-up|2
1563581|NCT03448536|5388971|P1|Overall Study|Lost to Follow-up|3
1563582|NCT03448536|5388970|P2|Overall Study|Withdrawal by Subject|2
1563583|NCT03448536|5388971|P1|Overall Study|Withdrawal by Subject|1
1563584|NCT03448536|5388970|P2|Overall Study|Pregnancy|0
1563585|NCT03448536|5388971|P1|Overall Study|Pregnancy|1
1563586|NCT03448536|5388970|P2|Overall Study|Protocol Violation|0
1563587|NCT03448536|5388971|P1|Overall Study|Protocol Violation|2
1563594|NCT03447353|5389036|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
1563595|NCT03447353|5389036|P1|Overall Study|Scheduling Conflicts|3
1563596|NCT03447353|5389036|P1|Overall Study|Lost to Follow-up|4
1563597|NCT03447353|5389036|P1|Overall Study|Failure at Screening Visit|2
1563598|NCT03444584|5389128|P2|Overall Study|Other|1
1563599|NCT03444584|5389129|P1|Overall Study|Other|0
1563600|NCT03444584|5389128|P2|Overall Study|Withdrawal by Subject|1
1563601|NCT03444584|5389129|P1|Overall Study|Withdrawal by Subject|0
1563602|NCT03443414|5389201|P5|Overall Study|Reason not specified|1
1563603|NCT03443414|5389202|P4|Overall Study|Reason not specified|0
1563604|NCT03443414|5389203|P3|Overall Study|Reason not specified|0
1563605|NCT03443414|5389204|P2|Overall Study|Reason not specified|0
1563606|NCT03443414|5389205|P1|Overall Study|Reason not specified|2
1563607|NCT03443414|5389201|P5|Overall Study|Death|0
1563608|NCT03443414|5389202|P4|Overall Study|Death|1
1563609|NCT03443414|5389203|P3|Overall Study|Death|0
1563610|NCT03443414|5389204|P2|Overall Study|Death|1
1563611|NCT03443414|5389205|P1|Overall Study|Death|0
1563612|NCT03443414|5389201|P5|Overall Study|Withdrawal by Subject|1
1563613|NCT03443414|5389202|P4|Overall Study|Withdrawal by Subject|2
1563614|NCT03443414|5389203|P3|Overall Study|Withdrawal by Subject|2
1563615|NCT03443414|5389204|P2|Overall Study|Withdrawal by Subject|2
1563616|NCT03443414|5389205|P1|Overall Study|Withdrawal by Subject|3
1563617|NCT03443414|5389201|P5|Overall Study|Adverse Event|3
1563618|NCT03443414|5389202|P4|Overall Study|Adverse Event|2
1563619|NCT03443414|5389203|P3|Overall Study|Adverse Event|4
1563620|NCT03443414|5389204|P2|Overall Study|Adverse Event|0
1563621|NCT03443414|5389205|P1|Overall Study|Adverse Event|6
1563622|NCT03441984|5389352|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563623|NCT03441984|5389353|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563624|NCT03441984|5389354|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563625|NCT03441984|5389355|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563626|NCT03441984|5389356|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563627|NCT03441984|5389357|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563628|NCT03441984|5389358|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563629|NCT03441984|5389359|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563630|NCT03441984|5389360|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563631|NCT03441984|5389361|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
1563632|NCT03441984|5389362|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563633|NCT03441984|5389363|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
1563634|NCT03441789|5389724|P2|Overall Study|Lost to Follow-up|1
1563635|NCT03441789|5389725|P1|Overall Study|Lost to Follow-up|0
1563636|NCT03441789|5389724|P2|Overall Study|Protocol Violation|1
1563637|NCT03441789|5389725|P1|Overall Study|Protocol Violation|0
1563638|NCT03441789|5389724|P2|Overall Study|Adverse Event|1
1563639|NCT03441789|5389725|P1|Overall Study|Adverse Event|0
1563640|NCT03441789|5389724|P2|Overall Study|Withdrawal by Subject|1
1563641|NCT03441789|5389725|P1|Overall Study|Withdrawal by Subject|1
1563646|NCT03438539|5390012|P6|Overall Study|Lost to Follow-up|8
1563647|NCT03438539|5390013|P5|Overall Study|Lost to Follow-up|3
1563648|NCT03438539|5390014|P4|Overall Study|Lost to Follow-up|9
1563649|NCT03438539|5390015|P3|Overall Study|Lost to Follow-up|10
1563650|NCT03438539|5390016|P2|Overall Study|Lost to Follow-up|4
1563651|NCT03438539|5390017|P1|Overall Study|Lost to Follow-up|8
1563652|NCT03437733|5390054|P2|Overall Study|Eligibility criteria not met|3
1563653|NCT03437733|5390055|P1|Overall Study|Eligibility criteria not met|0
1563654|NCT03437447|5390095|P3|Treatment Period 1|Withdrawal by Subject|1
1563655|NCT03437447|5390096|P2|Treatment Period 1|Withdrawal by Subject|0
1563656|NCT03437447|5390097|P1|Treatment Period 1|Withdrawal by Subject|0
1563657|NCT03436732|5390152|P2|Overall Study|Death|1
1563658|NCT03436732|5390153|P1|Overall Study|Death|0
1563659|NCT03436732|5390152|P2|Overall Study|Adverse Event|0
1563660|NCT03436732|5390153|P1|Overall Study|Adverse Event|2
1563661|NCT03436732|5390152|P2|Overall Study|Off study after cycle 1|0
1563662|NCT03436732|5390153|P1|Overall Study|Off study after cycle 1|1
1563663|NCT03436732|5390152|P2|Overall Study|Not treated-enrolled in different study|0
1563664|NCT03436732|5390153|P1|Overall Study|Not treated-enrolled in different study|1
1563665|NCT03434977|5390196|P2|Washout Period (at Least 6 Days)|Adverse Event|1
1563666|NCT03434977|5390197|P1|Washout Period (at Least 6 Days)|Adverse Event|0
1563667|NCT03434249|5390233|P2|Overall Study|Difficulties in completing daily diary|1
1563668|NCT03434249|5390234|P1|Overall Study|Difficulties in completing daily diary|2
1563669|NCT03434249|5390233|P2|Overall Study|Non-compliance of family|1
1563670|NCT03434249|5390234|P1|Overall Study|Non-compliance of family|2
1563671|NCT03434249|5390233|P2|Overall Study|Lost to Follow-up|1
1563672|NCT03434249|5390234|P1|Overall Study|Lost to Follow-up|0
1563673|NCT03434249|5390233|P2|Overall Study|Adverse Event|0
1563674|NCT03434249|5390234|P1|Overall Study|Adverse Event|1
1563675|NCT03434119|5390268|P2|Overall Study|Other than specified|5
1563676|NCT03434119|5390269|P1|Overall Study|Other than specified|7
1563677|NCT03434119|5390268|P2|Overall Study|Withdrawal by Subject|5
1563678|NCT03434119|5390269|P1|Overall Study|Withdrawal by Subject|7
1563679|NCT03434119|5390268|P2|Overall Study|Study Terminated by Sponsor|102
1563680|NCT03434119|5390269|P1|Overall Study|Study Terminated by Sponsor|91
1563681|NCT03434119|5390268|P2|Overall Study|Poor Compliance to Protocol|1
1563682|NCT03434119|5390269|P1|Overall Study|Poor Compliance to Protocol|0
1563683|NCT03434119|5390268|P2|Overall Study|Adverse Event|0
1563684|NCT03434119|5390269|P1|Overall Study|Adverse Event|1
1563685|NCT03434119|5390268|P2|Overall Study|Randomized but not treated|0
1563686|NCT03434119|5390269|P1|Overall Study|Randomized but not treated|1
1563687|NCT03433703|5390287|P1|Overall Study|Study terminated by Sponsor|2
1563688|NCT03433677|5390296|P2|Period 2|Withdrawal by Subject|1
1563689|NCT03433677|5390297|P1|Period 2|Withdrawal by Subject|1
1563690|NCT03433677|5390296|P2|Period 1|Protocol Violation|0
1563691|NCT03433677|5390297|P1|Period 1|Protocol Violation|1
1563692|NCT03432390|5390317|P2|Apnea Period|Protocol Violation|2
1563693|NCT03432390|5390318|P1|Apnea Period|Protocol Violation|2
1563694|NCT03431441|5390328|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
1563695|NCT03431441|5390328|P1|Overall Study|Adverse Event|2
1563696|NCT03431441|5390328|P1|Overall Study|Withdrawal by Subject|2
1563697|NCT03430245|5390361|P1|Overall Study|Lost to Follow-up|1
1563698|NCT03430245|5390361|P1|Overall Study|Withdrawal by Subject|6
1563699|NCT03429556|5390387|P4|Overall Study|Lost to Follow-up|0
1563700|NCT03429556|5390388|P3|Overall Study|Lost to Follow-up|0
1563701|NCT03429556|5390389|P2|Overall Study|Lost to Follow-up|1
1563702|NCT03429556|5390390|P1|Overall Study|Lost to Follow-up|0
1563703|NCT03428997|5390436|P1|Overall Study|Lost to Follow-up|4
1563704|NCT03428997|5390436|P1|Overall Study|Withdrawal by Subject|3
1563705|NCT03428997|5390436|P1|Overall Study|Sponsor decision.|1
1563706|NCT03428152|5390444|P2|Overall Study|Lack of Efficacy|4
1563707|NCT03428152|5390445|P1|Overall Study|Lack of Efficacy|0
1563708|NCT03428152|5390444|P2|Overall Study|Protocol Violation|5
1563709|NCT03428152|5390445|P1|Overall Study|Protocol Violation|3
1563710|NCT03428152|5390444|P2|Overall Study|Physician Decision|2
1563711|NCT03428152|5390445|P1|Overall Study|Physician Decision|4
1563712|NCT03427892|5390461|P1|Overall Study|Lost to Follow-up|2
1563713|NCT03427073|5390485|P8|Overall Study|Physician Decision|1
1563714|NCT03427073|5390486|P7|Overall Study|Physician Decision|1
1563715|NCT03427073|5390487|P6|Overall Study|Physician Decision|0
1563716|NCT03427073|5390488|P5|Overall Study|Physician Decision|0
1563717|NCT03427073|5390489|P4|Overall Study|Physician Decision|0
1563718|NCT03427073|5390490|P3|Overall Study|Physician Decision|0
1563719|NCT03427073|5390491|P2|Overall Study|Physician Decision|0
1563720|NCT03427073|5390492|P1|Overall Study|Physician Decision|0
1563721|NCT03427073|5390485|P8|Overall Study|Disease Progression|3
1563722|NCT03427073|5390486|P7|Overall Study|Disease Progression|2
1563723|NCT03427073|5390487|P6|Overall Study|Disease Progression|4
1563724|NCT03427073|5390488|P5|Overall Study|Disease Progression|3
1563725|NCT03427073|5390489|P4|Overall Study|Disease Progression|3
1563726|NCT03427073|5390490|P3|Overall Study|Disease Progression|1
1563727|NCT03427073|5390491|P2|Overall Study|Disease Progression|1
1563728|NCT03427073|5390492|P1|Overall Study|Disease Progression|1
1563729|NCT03426787|5390542|P1|Overall Study|Unrelated to intervention death|1
1563730|NCT03426787|5390542|P1|Overall Study|Lost to Follow-up|7
1563731|NCT03426787|5390542|P1|Overall Study|Withdrawal by Subject|6
1563734|NCT03426436|5390565|P1|Overall Study|ECGs not saved|4
1563735|NCT03426436|5390565|P1|Overall Study|Consent issue|1
1563736|NCT03426436|5390565|P1|Overall Study|Withdrawal by Subject|2
1563737|NCT03426436|5390565|P1|Overall Study|Incorrect lead placement|12
1563738|NCT03421730|5390604|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563739|NCT03421730|5390605|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563740|NCT03421730|5390606|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563741|NCT03421730|5390607|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563742|NCT03421730|5390608|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563743|NCT03421730|5390609|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563744|NCT03421730|5390610|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563745|NCT03421730|5390611|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
1563746|NCT03421730|5390612|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563747|NCT03421730|5390613|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563748|NCT03421730|5390614|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563749|NCT03421730|5390615|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
1563750|NCT03421730|5390604|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563751|NCT03421730|5390605|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563752|NCT03421730|5390606|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563753|NCT03421730|5390607|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563754|NCT03421730|5390608|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563755|NCT03421730|5390609|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563756|NCT03421730|5390610|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563757|NCT03421730|5390611|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563758|NCT03421730|5390612|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563759|NCT03421730|5390613|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563760|NCT03421730|5390614|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
1563761|NCT03421730|5390615|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
1563762|NCT03421379|5390688|P2|Period 1|Did not receive treatment|2
1563763|NCT03421379|5390689|P1|Period 1|Did not receive treatment|1
1563764|NCT03421379|5390688|P2|Period 1|Physician Decision|1
1563765|NCT03421379|5390689|P1|Period 1|Physician Decision|1
1563766|NCT03421379|5390688|P2|Period 1|Withdrawal by Subject|1
1563767|NCT03421379|5390689|P1|Period 1|Withdrawal by Subject|0
1563768|NCT03418571|5390784|P2|Overall Study|Consent withdrawn by legal guardian|0
1563769|NCT03418571|5390785|P1|Overall Study|Consent withdrawn by legal guardian|1
1563770|NCT03417830|5390825|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
1563771|NCT03417830|5390826|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
1563772|NCT03417505|5390925|P2|First Lens Type (30 Days)|Lost to Follow-up|1
1563773|NCT03417505|5390926|P1|First Lens Type (30 Days)|Lost to Follow-up|1
1563774|NCT03417219|5390957|P2|Overall Study|Lost to Follow-up|3
1563775|NCT03417219|5390958|P1|Overall Study|Lost to Follow-up|0
1563776|NCT03417024|5390968|P1|Overall Study|Physician Decision|2
1563777|NCT03417024|5390968|P1|Overall Study|Study Termination prior to follow-up|11
1563778|NCT03415178|5391057|P2|Single Arm Period (up to Week 16)|Adverse Event|1
1563779|NCT03415178|5391058|P1|Single Arm Period (up to Week 16)|Adverse Event|0
1563780|NCT03415178|5391057|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
1563781|NCT03415178|5391058|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
1563782|NCT03408639|5391161|P2|Overall Study|Physician Decision|6
1563783|NCT03408639|5391162|P1|Overall Study|Physician Decision|3
1563784|NCT03408639|5391161|P2|Overall Study|Withdrawal by Subject|7
1563785|NCT03408639|5391162|P1|Overall Study|Withdrawal by Subject|2
1563786|NCT03408639|5391161|P2|Overall Study|Lost to Follow-up|4
1563787|NCT03408639|5391162|P1|Overall Study|Lost to Follow-up|1
1563788|NCT03408639|5391161|P2|Overall Study|Death|5
1563789|NCT03408639|5391162|P1|Overall Study|Death|5
1563790|NCT03407430|5391258|P2|Washout|Protocol Violation|0
1563791|NCT03407430|5391259|P1|Washout|Protocol Violation|1
1563792|NCT03406260|5391297|P6|Period 1|Adverse Event|0
1563793|NCT03406260|5391298|P5|Period 1|Adverse Event|1
1563794|NCT03406260|5391299|P4|Period 1|Adverse Event|0
1563795|NCT03406260|5391300|P3|Period 1|Adverse Event|0
1563796|NCT03406260|5391301|P2|Period 1|Adverse Event|0
1563797|NCT03406260|5391302|P1|Period 1|Adverse Event|0
1563798|NCT03405935|5391314|P1|Overall Study|Still on Study|83
1563799|NCT03405935|5391314|P1|Overall Study|Adverse Event|3
1563800|NCT03405818|5391325|P1|Overall Study|Lost to Follow-up|4
1563801|NCT03405818|5391325|P1|Overall Study|Withdrawal by Subject|4
1563802|NCT03404206|5391380|P3|Overall Study|Lost to Follow-up|0
1563803|NCT03404206|5391381|P2|Overall Study|Lost to Follow-up|1
1563804|NCT03404206|5391382|P1|Overall Study|Lost to Follow-up|3
1563805|NCT03404206|5391380|P3|Overall Study|Withdrawal by Subject|0
1563806|NCT03404206|5391381|P2|Overall Study|Withdrawal by Subject|1
1563807|NCT03404206|5391382|P1|Overall Study|Withdrawal by Subject|1
1563808|NCT03403036|5391454|P1|Overall Study|Lack of Efficacy|5
1563809|NCT03402893|5391481|P1|Overall Study|Withdrawal by Subject|1
1563810|NCT03402750|5391492|P2|Overall Study|Lost to Follow-up|1
1563811|NCT03402750|5391493|P1|Overall Study|Lost to Follow-up|2
1563812|NCT03400787|5391552|P2|Overall Study|Unblinded before 3-month follow-upa-|6
1563813|NCT03400787|5391553|P1|Overall Study|Unblinded before 3-month follow-upa-|0
1563814|NCT03400787|5391552|P2|Overall Study|Protocol Violation|2
1563815|NCT03400787|5391553|P1|Overall Study|Protocol Violation|0
1563816|NCT03400787|5391552|P2|Overall Study|Death|0
1563817|NCT03400787|5391553|P1|Overall Study|Death|1
1563818|NCT03400787|5391552|P2|Overall Study|Lost to Follow-up|0
1563819|NCT03400787|5391553|P1|Overall Study|Lost to Follow-up|1
1563820|NCT03396835|5391758|P1|Overall Study|Did not meet criteria for data analysis|1
1563821|NCT03396835|5391758|P1|Overall Study|Withdrawn prior to completion|1
1563822|NCT03394391|5391775|P2|Overall Study|Lost to Follow-up|2
1563823|NCT03394391|5391776|P1|Overall Study|Lost to Follow-up|1
1563824|NCT03392194|5391862|P2|Overall Study|Conflicts with personal schedule|0
1563825|NCT03392194|5391863|P1|Overall Study|Conflicts with personal schedule|1
1563826|NCT03392194|5391862|P2|Overall Study|Withdrawal by Subject|2
1563827|NCT03392194|5391863|P1|Overall Study|Withdrawal by Subject|1
1563828|NCT03390426|5391898|P2|Overall Study|Protocol Violation|1
1563829|NCT03390426|5391899|P1|Overall Study|Protocol Violation|0
1563831|NCT03387059|5391920|P2|Overall Study|Study termination|4
1563832|NCT03387059|5391921|P1|Overall Study|Study termination|5
1563833|NCT03387046|5391935|P2|Overall Study|Adverse Event|1
1563834|NCT03387046|5391936|P1|Overall Study|Adverse Event|1
1563835|NCT03386448|5391962|P2|Overall Study|Adverse Event|2
1563836|NCT03386448|5391963|P1|Overall Study|Adverse Event|0
1563837|NCT03386435|5391971|P2|Overall Study|Protocol Violation|7
1563838|NCT03386435|5391972|P1|Overall Study|Protocol Violation|5
1563839|NCT03384316|5391986|P2|Overall Study|Screen failure|1
1563840|NCT03384316|5391987|P1|Overall Study|Screen failure|0
1563843|NCT03383783|5392019|P1|Overall Study|Withdrawal by Subject|2
1563844|NCT03382834|5392098|P2|Overall Study|Withdrawal by Subject|1
1563845|NCT03382834|5392099|P1|Overall Study|Withdrawal by Subject|0
1563846|NCT03382834|5392098|P2|Overall Study|Lost to Follow-up|0
1563847|NCT03382834|5392099|P1|Overall Study|Lost to Follow-up|1
1563848|NCT03382262|5392115|P4|Overall Study|Withdrawal by Subject|1
1563849|NCT03382262|5392116|P3|Overall Study|Withdrawal by Subject|0
1563850|NCT03382262|5392117|P2|Overall Study|Withdrawal by Subject|0
1563851|NCT03382262|5392118|P1|Overall Study|Withdrawal by Subject|0
1563852|NCT03382262|5392115|P4|Overall Study|Physician Decision|0
1563853|NCT03382262|5392116|P3|Overall Study|Physician Decision|1
1563854|NCT03382262|5392117|P2|Overall Study|Physician Decision|0
1563855|NCT03382262|5392118|P1|Overall Study|Physician Decision|0
1563856|NCT03380429|5392262|P5|Overall Study|Adverse Event|0
1563857|NCT03380429|5392263|P4|Overall Study|Adverse Event|2
1563858|NCT03380429|5392264|P3|Overall Study|Adverse Event|1
1563859|NCT03380429|5392265|P2|Overall Study|Adverse Event|1
1563860|NCT03380429|5392266|P1|Overall Study|Adverse Event|1
1563861|NCT03380429|5392262|P5|Overall Study|Lack of Efficacy|1
1563862|NCT03380429|5392263|P4|Overall Study|Lack of Efficacy|2
1563863|NCT03380429|5392264|P3|Overall Study|Lack of Efficacy|0
1563864|NCT03380429|5392265|P2|Overall Study|Lack of Efficacy|0
1563865|NCT03380429|5392266|P1|Overall Study|Lack of Efficacy|0
1563866|NCT03380429|5392262|P5|Overall Study|Protocol Violation|1
1563867|NCT03380429|5392263|P4|Overall Study|Protocol Violation|0
1563868|NCT03380429|5392264|P3|Overall Study|Protocol Violation|1
1563869|NCT03380429|5392265|P2|Overall Study|Protocol Violation|0
1563870|NCT03380429|5392266|P1|Overall Study|Protocol Violation|1
1563871|NCT03380429|5392262|P5|Overall Study|Lost to Follow-up|1
1563872|NCT03380429|5392263|P4|Overall Study|Lost to Follow-up|3
1563873|NCT03380429|5392264|P3|Overall Study|Lost to Follow-up|4
1563874|NCT03380429|5392265|P2|Overall Study|Lost to Follow-up|2
1563875|NCT03380429|5392266|P1|Overall Study|Lost to Follow-up|0
1563876|NCT03380429|5392262|P5|Overall Study|Withdrawal by Subject|1
1563877|NCT03380429|5392263|P4|Overall Study|Withdrawal by Subject|2
1563878|NCT03380429|5392264|P3|Overall Study|Withdrawal by Subject|5
1563879|NCT03380429|5392265|P2|Overall Study|Withdrawal by Subject|3
1563880|NCT03380429|5392266|P1|Overall Study|Withdrawal by Subject|3
1563881|NCT03380429|5392262|P5|Overall Study|Physician Decision|1
1563882|NCT03380429|5392263|P4|Overall Study|Physician Decision|1
1563883|NCT03380429|5392264|P3|Overall Study|Physician Decision|0
1563884|NCT03380429|5392265|P2|Overall Study|Physician Decision|1
1563885|NCT03380429|5392266|P1|Overall Study|Physician Decision|0
1563886|NCT03380390|5392319|P1|Overall Study|Adverse Event|3
1563887|NCT03379376|5392406|P1|Overall Study|Death|1
1563888|NCT03379376|5392406|P1|Overall Study|Overwhelmed, didn't want to continue|1
1563889|NCT03379376|5392406|P1|Overall Study|Did not wish to complete follow up|1
1563890|NCT03379376|5392406|P1|Overall Study|Lost to Follow-up|2
1563891|NCT03379233|5392416|P2|Overall Study|Technical issues with Concept 2 inhalers|6
1563892|NCT03379233|5392417|P1|Overall Study|Technical issues with Concept 2 inhalers|1
1563893|NCT03376516|5392440|P1|Overall Study|Consent withdrawn|1
1563894|NCT03376516|5392440|P1|Overall Study|Not treated|1
1563897|NCT03374488|5392521|P2|Overall Study|On-going at clinical cut off date|28
1563898|NCT03374488|5392522|P1|Overall Study|On-going at clinical cut off date|30
1563899|NCT03374488|5392521|P2|Overall Study|Withdrawal by Subject|1
1563900|NCT03374488|5392522|P1|Overall Study|Withdrawal by Subject|1
1563901|NCT03374488|5392521|P2|Overall Study|Death|8
1563902|NCT03374488|5392522|P1|Overall Study|Death|10
1563903|NCT03374189|5392534|P2|Overall Study|Lost to Follow-up|0
1563904|NCT03374189|5392535|P1|Overall Study|Lost to Follow-up|1
1563905|NCT03372603|5392616|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
1563906|NCT03372603|5392617|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
1563907|NCT03372603|5392616|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
1563908|NCT03372603|5392617|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
1563909|NCT03372551|5392659|P2|First Intervention (1 Week)|Withdrawal by Subject|0
1563910|NCT03372551|5392660|P1|First Intervention (1 Week)|Withdrawal by Subject|1
1563911|NCT03372369|5392690|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
1563912|NCT03372369|5392691|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
1563913|NCT03372369|5392690|P2|Qualification Period|Inconsistent Eligibility Results|9
1563914|NCT03372369|5392691|P1|Qualification Period|Inconsistent Eligibility Results|10
1563915|NCT03372369|5392690|P2|Qualification Period|Withdrawal by Subject|13
1563916|NCT03372369|5392691|P1|Qualification Period|Withdrawal by Subject|16
1563917|NCT03371459|5392703|P2|Washout|Lost to Follow-up|1
1563918|NCT03371459|5392704|P1|Washout|Lost to Follow-up|0
1563919|NCT03371381|5392712|P1|Overall Study|Other|4
1563920|NCT03371381|5392712|P1|Overall Study|Study terminated by sponsor|3
1563921|NCT03371381|5392712|P1|Overall Study|Death|5
1563922|NCT03370419|5392733|P1|Overall Study|Lost to Follow-up|16
1563923|NCT03370289|5392737|P1|Overall Study|Sample Size Sufficient|4
1563924|NCT03370289|5392737|P1|Overall Study|Screen Failure|1
1563925|NCT03369704|5392756|P2|Follow-up Epoch|Lost to Follow-up|0
1563926|NCT03369704|5392757|P1|Follow-up Epoch|Lost to Follow-up|1
1563927|NCT03369704|5392756|P2|Treatment Epoch|Adverse Event|0
1563928|NCT03369704|5392757|P1|Treatment Epoch|Adverse Event|2
1563929|NCT03369704|5392756|P2|Treatment Epoch|Lack of Efficacy|2
1563930|NCT03369704|5392757|P1|Treatment Epoch|Lack of Efficacy|0
1563931|NCT03369704|5392756|P2|Treatment Epoch|Lost to Follow-up|1
1563932|NCT03369704|5392757|P1|Treatment Epoch|Lost to Follow-up|0
1563933|NCT03369704|5392756|P2|Treatment Epoch|Protocol Violation|0
1563934|NCT03369704|5392757|P1|Treatment Epoch|Protocol Violation|1
1563935|NCT03369704|5392756|P2|Treatment Epoch|technical problems|0
1563936|NCT03369704|5392757|P1|Treatment Epoch|technical problems|1
1563937|NCT03368807|5392877|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
1563938|NCT03368807|5392877|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
1563939|NCT03368807|5392877|P1|Period 1 (Blinded CGM)|Protocol Violation|1
1563940|NCT03368807|5392877|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
1563941|NCT03365934|5392911|P1|Overall Study|Withdrawal by Subject|1
1563942|NCT03365934|5392911|P1|Overall Study|Adverse Event|1
1563943|NCT03365011|5393201|P2|Overall Study|Withdrawal by Subject|2
1563944|NCT03365011|5393202|P1|Overall Study|Withdrawal by Subject|1
1563945|NCT03364608|5393212|P1|Overall Study|Lost to Follow-up|2
1563946|NCT03364608|5393212|P1|Overall Study|Protocol Violation|2
1563947|NCT03364608|5393212|P1|Overall Study|Withdrawal by Subject|4
1563948|NCT03364335|5393239|P5|Overall Study|Lost to Follow-up|11
1563949|NCT03364335|5393240|P4|Overall Study|Lost to Follow-up|11
1563950|NCT03364335|5393241|P3|Overall Study|Lost to Follow-up|10
1563951|NCT03364335|5393242|P2|Overall Study|Lost to Follow-up|7
1563952|NCT03364335|5393243|P1|Overall Study|Lost to Follow-up|7
1563953|NCT03364335|5393239|P5|Overall Study|Adverse Event|0
1563954|NCT03364335|5393240|P4|Overall Study|Adverse Event|2
1563955|NCT03364335|5393241|P3|Overall Study|Adverse Event|1
1563956|NCT03364335|5393242|P2|Overall Study|Adverse Event|4
1563957|NCT03364335|5393243|P1|Overall Study|Adverse Event|3
1563958|NCT03363906|5393315|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
1563959|NCT03363906|5393316|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
1563960|NCT03363906|5393315|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
1563961|NCT03363906|5393316|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
1563962|NCT03363906|5393315|P2|Period 2 (Test or Reference)|Adverse Event|0
1563963|NCT03363906|5393316|P1|Period 2 (Test or Reference)|Adverse Event|2
1563964|NCT03363906|5393315|P2|Period 1 (Reference or Test)|Adverse Event|2
1563965|NCT03363906|5393316|P1|Period 1 (Reference or Test)|Adverse Event|1
1563966|NCT03361865|5393386|P2|Overall Study|On-going at clinical cut off date|39
1563967|NCT03361865|5393387|P1|Overall Study|On-going at clinical cut off date|29
1563968|NCT03361865|5393386|P2|Overall Study|Physician Decision|0
1563969|NCT03361865|5393387|P1|Overall Study|Physician Decision|1
1563970|NCT03361865|5393386|P2|Overall Study|Death|10
1563971|NCT03361865|5393387|P1|Overall Study|Death|13
1563972|NCT03361176|5393399|P2|Overall Study|Withdrawal by Subject|1
1563973|NCT03361176|5393400|P1|Overall Study|Withdrawal by Subject|0
1563974|NCT03361176|5393399|P2|Overall Study|Adverse Event|2
1563975|NCT03361176|5393400|P1|Overall Study|Adverse Event|0
1563976|NCT03361176|5393399|P2|Overall Study|Lost to Follow-up|2
1563977|NCT03361176|5393400|P1|Overall Study|Lost to Follow-up|1
1563978|NCT03360071|5393433|P2|Overall Study|Lost to Follow-up|0
1563979|NCT03360071|5393434|P1|Overall Study|Lost to Follow-up|1
1563980|NCT03358472|5393458|P3|Overall Study|On-going at clinical cut off date|5
1563981|NCT03358472|5393459|P2|Overall Study|On-going at clinical cut off date|6
1563982|NCT03358472|5393460|P1|Overall Study|On-going at clinical cut off date|9
1563983|NCT03358472|5393458|P3|Overall Study|Withdrawal by Subject|1
1563984|NCT03358472|5393459|P2|Overall Study|Withdrawal by Subject|0
1563985|NCT03358472|5393460|P1|Overall Study|Withdrawal by Subject|0
1563986|NCT03358472|5393458|P3|Overall Study|Physician Decision|0
1563987|NCT03358472|5393459|P2|Overall Study|Physician Decision|1
1563988|NCT03358472|5393460|P1|Overall Study|Physician Decision|0
1563989|NCT03358472|5393458|P3|Overall Study|Death|10
1563990|NCT03358472|5393459|P2|Overall Study|Death|3
1563991|NCT03358472|5393460|P1|Overall Study|Death|6
1563992|NCT03358329|5393474|P1|Overall Study|Withdrawal by Subject|2
1563993|NCT03358329|5393474|P1|Overall Study|Lost to Follow-up|2
1563994|NCT03357952|5393482|P2|Overall Study|Sponsor Decision|0
1563995|NCT03357952|5393483|P1|Overall Study|Sponsor Decision|9
1563996|NCT03357952|5393482|P2|Overall Study|Withdrawal by Subject|1
1563997|NCT03357952|5393483|P1|Overall Study|Withdrawal by Subject|0
1563998|NCT03357471|5393492|P2|Overall Study|Lost to Follow-up|0
1563999|NCT03357471|5393493|P1|Overall Study|Lost to Follow-up|1
1564000|NCT03357471|5393492|P2|Overall Study|Adverse Event|0
1564001|NCT03357471|5393493|P1|Overall Study|Adverse Event|1
1564002|NCT03356977|5393517|P1|Overall Study|Withdrawal by parent/guardian|2
1564003|NCT03356977|5393517|P1|Overall Study|Lost to Follow-up|3
1564004|NCT03354663|5393565|P1|Completed 30-day Visit|Missed Visit|1
1564005|NCT03354663|5393565|P1|Completed 30-day Visit|Withdrawal by Subject|1
1564006|NCT03354663|5393565|P1|Enrollment to Catheter Insertion|Adverse Event|1
1564007|NCT03354663|5393565|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
1564008|NCT03352713|5393606|P1|Overall Study|Device incompatible/stolen|5
1564009|NCT03352713|5393606|P1|Overall Study|Completed 0 EMAs|8
1564010|NCT03352713|5393606|P1|Overall Study|Withdrawn by investigator|5
1564011|NCT03352713|5393606|P1|Overall Study|Lost to Follow-up|8
1564012|NCT03351738|5393635|P6|Overall Study|Withdrawal by Subject|0
1564013|NCT03351738|5393636|P5|Overall Study|Withdrawal by Subject|0
1564014|NCT03351738|5393637|P4|Overall Study|Withdrawal by Subject|1
1564015|NCT03351738|5393638|P3|Overall Study|Withdrawal by Subject|0
1564016|NCT03351738|5393639|P2|Overall Study|Withdrawal by Subject|1
1564017|NCT03351738|5393640|P1|Overall Study|Withdrawal by Subject|0
1564018|NCT03351335|5393792|P3|Overall Study|Failure to maintain inclusion/exclusion|4
1564019|NCT03351335|5393793|P2|Overall Study|Failure to maintain inclusion/exclusion|0
1564020|NCT03351335|5393794|P1|Overall Study|Failure to maintain inclusion/exclusion|0
1564021|NCT03351231|5393814|P1|Safety Follow-Up Period|Other reason|2
1564022|NCT03351231|5393814|P1|Safety Follow-Up Period|Participant withdrew consent|1
1564023|NCT03351231|5393814|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
1564024|NCT03351231|5393814|P1|Combination Therapy Period|Study drug toxicity|1
1564025|NCT03351231|5393814|P1|Combination Therapy Period|Disease progression|2
1564026|NCT03351231|5393814|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
1564027|NCT03350984|5393838|P2|Overall Study|Physician Decision|0
1564028|NCT03350984|5393839|P1|Overall Study|Physician Decision|1
1564029|NCT03350984|5393838|P2|Overall Study|Protocol Violation|2
1564030|NCT03350984|5393839|P1|Overall Study|Protocol Violation|1
1564031|NCT03350984|5393838|P2|Overall Study|Lost to Follow-up|6
1564032|NCT03350984|5393839|P1|Overall Study|Lost to Follow-up|5
1564033|NCT03350984|5393838|P2|Overall Study|Death|0
1564034|NCT03350984|5393839|P1|Overall Study|Death|1
1564035|NCT03349515|5393960|P2|Overall Study|Physician Decision|1
1564036|NCT03349515|5393961|P1|Overall Study|Physician Decision|3
1564037|NCT03349515|5393960|P2|Overall Study|Lack of Efficacy|0
1564038|NCT03349515|5393961|P1|Overall Study|Lack of Efficacy|2
1564039|NCT03349437|5393967|P3|Screening|Withdrawn|0
1564040|NCT03349437|5393968|P2|Screening|Withdrawn|0
1564041|NCT03349437|5393969|P1|Screening|Withdrawn|1
1564042|NCT03349437|5393967|P3|Screening|Screen Fail|0
1564043|NCT03349437|5393968|P2|Screening|Screen Fail|0
1564044|NCT03349437|5393969|P1|Screening|Screen Fail|4
1564045|NCT03349333|5393976|P1|Overall Study|Patients in treatment less than 24 month|8
1564046|NCT03349333|5393976|P1|Overall Study|3-week lapse between pralatrexate doses|1
1564047|NCT03349333|5393976|P1|Overall Study|Physician Decision|2
1564048|NCT03349333|5393976|P1|Overall Study|Conditions interfere with participation|2
1564049|NCT03349333|5393976|P1|Overall Study|Withdrawal by Subject|5
1564050|NCT03349333|5393976|P1|Overall Study|Other|6
1564051|NCT03349333|5393976|P1|Overall Study|Adverse Event|11
1564052|NCT03349333|5393976|P1|Overall Study|Progression of Disease|36
1564053|NCT03349099|5393999|P2|Overall Study|Stone migrated from the kidney|0
1564054|NCT03349099|5394000|P1|Overall Study|Stone migrated from the kidney|1
1564055|NCT03349099|5393999|P2|Overall Study|Physician Decision|4
1564056|NCT03349099|5394000|P1|Overall Study|Physician Decision|3
1564057|NCT03349060|5394013|P3|Overall Study|Other|0
1564058|NCT03349060|5394014|P2|Overall Study|Other|1
1564059|NCT03349060|5394015|P1|Overall Study|Other|2
1564060|NCT03349060|5394013|P3|Overall Study|Withdrawal By Parent/Guardian|0
1564061|NCT03349060|5394014|P2|Overall Study|Withdrawal By Parent/Guardian|1
1564062|NCT03349060|5394015|P1|Overall Study|Withdrawal By Parent/Guardian|0
1564063|NCT03349060|5394013|P3|Overall Study|Medication error,no linked adverse event|1
1564064|NCT03349060|5394014|P2|Overall Study|Medication error,no linked adverse event|0
1564065|NCT03349060|5394015|P1|Overall Study|Medication error,no linked adverse event|0
1564066|NCT03349060|5394013|P3|Overall Study|Withdrawal by Subject|4
1564067|NCT03349060|5394014|P2|Overall Study|Withdrawal by Subject|3
1564068|NCT03349060|5394015|P1|Overall Study|Withdrawal by Subject|5
1564069|NCT03349060|5394013|P3|Overall Study|Protocol Violation|1
1564070|NCT03349060|5394014|P2|Overall Study|Protocol Violation|2
1564071|NCT03349060|5394015|P1|Overall Study|Protocol Violation|2
1564072|NCT03349060|5394013|P3|Overall Study|Lost to Follow-up|1
1564073|NCT03349060|5394014|P2|Overall Study|Lost to Follow-up|1
1564074|NCT03349060|5394015|P1|Overall Study|Lost to Follow-up|2
1564075|NCT03349060|5394013|P3|Overall Study|Lack of Efficacy|2
1564076|NCT03349060|5394014|P2|Overall Study|Lack of Efficacy|0
1564077|NCT03349060|5394015|P1|Overall Study|Lack of Efficacy|1
1564078|NCT03349060|5394013|P3|Overall Study|Adverse Event|7
1564079|NCT03349060|5394014|P2|Overall Study|Adverse Event|9
1564080|NCT03349060|5394015|P1|Overall Study|Adverse Event|9
1564081|NCT03348904|5394157|P3|Overall Study|Administrative reason by the sponsor|0
1564082|NCT03348904|5394158|P2|Overall Study|Administrative reason by the sponsor|1
1564083|NCT03348904|5394159|P1|Overall Study|Administrative reason by the sponsor|0
1564084|NCT03346759|5394212|P2|Second Menstrual Cycle|Lost to Follow-up|0
1564085|NCT03346759|5394213|P1|Second Menstrual Cycle|Lost to Follow-up|1
1564086|NCT03346759|5394212|P2|First Menstrual Cycle|Withdrawal by Subject|0
1564087|NCT03346759|5394213|P1|First Menstrual Cycle|Withdrawal by Subject|1
1564088|NCT03346759|5394212|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
1564089|NCT03346759|5394213|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
1564090|NCT03346070|5394258|P5|Overall Study|Screen Failure|1
1564091|NCT03346070|5394259|P4|Overall Study|Screen Failure|1
1564092|NCT03346070|5394260|P3|Overall Study|Screen Failure|0
1564093|NCT03346070|5394261|P2|Overall Study|Screen Failure|0
1564094|NCT03346070|5394262|P1|Overall Study|Screen Failure|0
1564095|NCT03346070|5394258|P5|Overall Study|Study medication not received as planned|2
1564096|NCT03346070|5394259|P4|Overall Study|Study medication not received as planned|3
1564097|NCT03346070|5394260|P3|Overall Study|Study medication not received as planned|2
1564098|NCT03346070|5394261|P2|Overall Study|Study medication not received as planned|3
1564099|NCT03346070|5394262|P1|Overall Study|Study medication not received as planned|2
1564100|NCT03346070|5394258|P5|Overall Study|Withdrawal by Subject|0
1564101|NCT03346070|5394259|P4|Overall Study|Withdrawal by Subject|1
1564102|NCT03346070|5394260|P3|Overall Study|Withdrawal by Subject|0
1564103|NCT03346070|5394261|P2|Overall Study|Withdrawal by Subject|0
1564104|NCT03346070|5394262|P1|Overall Study|Withdrawal by Subject|1
1564105|NCT03346070|5394258|P5|Overall Study|Physician Decision|1
1564106|NCT03346070|5394259|P4|Overall Study|Physician Decision|1
1564107|NCT03346070|5394260|P3|Overall Study|Physician Decision|0
1564108|NCT03346070|5394261|P2|Overall Study|Physician Decision|0
1564109|NCT03346070|5394262|P1|Overall Study|Physician Decision|0
1564110|NCT03346070|5394258|P5|Overall Study|Lost to Follow-up|0
1564111|NCT03346070|5394259|P4|Overall Study|Lost to Follow-up|0
1564112|NCT03346070|5394260|P3|Overall Study|Lost to Follow-up|2
1564113|NCT03346070|5394261|P2|Overall Study|Lost to Follow-up|1
1564114|NCT03346070|5394262|P1|Overall Study|Lost to Follow-up|0
1564115|NCT03346070|5394258|P5|Overall Study|Death|1
1564116|NCT03346070|5394259|P4|Overall Study|Death|0
1564117|NCT03346070|5394260|P3|Overall Study|Death|0
1564118|NCT03346070|5394261|P2|Overall Study|Death|0
1564119|NCT03346070|5394262|P1|Overall Study|Death|0
1564120|NCT03345407|5394353|P7|Overall Study|Adverse Event|16
1564121|NCT03345407|5394354|P6|Overall Study|Adverse Event|5
1564122|NCT03345407|5394355|P5|Overall Study|Adverse Event|6
1564123|NCT03345407|5394356|P4|Overall Study|Adverse Event|4
1564124|NCT03345407|5394357|P3|Overall Study|Adverse Event|5
1564125|NCT03345407|5394358|P2|Overall Study|Adverse Event|0
1564126|NCT03345407|5394359|P1|Overall Study|Adverse Event|4
1564127|NCT03345407|5394353|P7|Overall Study|Lack of Efficacy|3
1564128|NCT03345407|5394354|P6|Overall Study|Lack of Efficacy|0
1564129|NCT03345407|5394355|P5|Overall Study|Lack of Efficacy|1
1564130|NCT03345407|5394356|P4|Overall Study|Lack of Efficacy|1
1564131|NCT03345407|5394357|P3|Overall Study|Lack of Efficacy|1
1564132|NCT03345407|5394358|P2|Overall Study|Lack of Efficacy|1
1564133|NCT03345407|5394359|P1|Overall Study|Lack of Efficacy|1
1564134|NCT03345407|5394353|P7|Overall Study|Protocol Violation|3
1564135|NCT03345407|5394354|P6|Overall Study|Protocol Violation|0
1564136|NCT03345407|5394355|P5|Overall Study|Protocol Violation|1
1564137|NCT03345407|5394356|P4|Overall Study|Protocol Violation|0
1564138|NCT03345407|5394357|P3|Overall Study|Protocol Violation|0
1564139|NCT03345407|5394358|P2|Overall Study|Protocol Violation|0
1564140|NCT03345407|5394359|P1|Overall Study|Protocol Violation|2
1564141|NCT03345407|5394353|P7|Overall Study|Protocol-defined stopping criteria|1
1564142|NCT03345407|5394354|P6|Overall Study|Protocol-defined stopping criteria|1
1564143|NCT03345407|5394355|P5|Overall Study|Protocol-defined stopping criteria|2
1564144|NCT03345407|5394356|P4|Overall Study|Protocol-defined stopping criteria|0
1564145|NCT03345407|5394357|P3|Overall Study|Protocol-defined stopping criteria|0
1564146|NCT03345407|5394358|P2|Overall Study|Protocol-defined stopping criteria|0
1564147|NCT03345407|5394359|P1|Overall Study|Protocol-defined stopping criteria|9
1564148|NCT03345407|5394353|P7|Overall Study|Lost to Follow-up|3
1564149|NCT03345407|5394354|P6|Overall Study|Lost to Follow-up|2
1564150|NCT03345407|5394355|P5|Overall Study|Lost to Follow-up|1
1564151|NCT03345407|5394356|P4|Overall Study|Lost to Follow-up|0
1564152|NCT03345407|5394357|P3|Overall Study|Lost to Follow-up|1
1564153|NCT03345407|5394358|P2|Overall Study|Lost to Follow-up|0
1564154|NCT03345407|5394359|P1|Overall Study|Lost to Follow-up|2
1564155|NCT03345407|5394353|P7|Overall Study|Physician Decision|3
1564156|NCT03345407|5394354|P6|Overall Study|Physician Decision|2
1564157|NCT03345407|5394355|P5|Overall Study|Physician Decision|1
1564158|NCT03345407|5394356|P4|Overall Study|Physician Decision|0
1564159|NCT03345407|5394357|P3|Overall Study|Physician Decision|0
1564160|NCT03345407|5394358|P2|Overall Study|Physician Decision|1
1564161|NCT03345407|5394359|P1|Overall Study|Physician Decision|3
1564162|NCT03345407|5394353|P7|Overall Study|Withdrawal by Subject|16
1564163|NCT03345407|5394354|P6|Overall Study|Withdrawal by Subject|6
1564164|NCT03345407|5394355|P5|Overall Study|Withdrawal by Subject|3
1564165|NCT03345407|5394356|P4|Overall Study|Withdrawal by Subject|6
1564166|NCT03345407|5394357|P3|Overall Study|Withdrawal by Subject|5
1564167|NCT03345407|5394358|P2|Overall Study|Withdrawal by Subject|1
1564168|NCT03345407|5394359|P1|Overall Study|Withdrawal by Subject|11
1564169|NCT03343639|5394596|P2|Overall Study|Protocol Violation|1
1564170|NCT03343639|5394597|P1|Overall Study|Protocol Violation|0
1564171|NCT03343639|5394596|P2|Overall Study|Lost to Follow-up|5
1564172|NCT03343639|5394597|P1|Overall Study|Lost to Follow-up|4
1564173|NCT03343639|5394596|P2|Overall Study|Withdrawal by Subject|6
1564174|NCT03343639|5394597|P1|Overall Study|Withdrawal by Subject|10
1564175|NCT03343067|5394625|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
1564176|NCT03343067|5394626|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
1564177|NCT03343067|5394627|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
1564178|NCT03342560|5394752|P1|Overall Study|Lost to Follow-up|2
1564179|NCT03341923|5394760|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
1564180|NCT03341923|5394761|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
1564181|NCT03341637|5394788|P2|Overall Study|Reason not Specified|1
1564182|NCT03341637|5394789|P1|Overall Study|Reason not Specified|1
1564183|NCT03341637|5394788|P2|Overall Study|Withdrawal by Subject|3
1564184|NCT03341637|5394789|P1|Overall Study|Withdrawal by Subject|3
1564185|NCT03341637|5394788|P2|Overall Study|Lost to Follow-up|0
1564186|NCT03341637|5394789|P1|Overall Study|Lost to Follow-up|1
1564187|NCT03339726|5394845|P3|Overall Study|Lost to Follow-up|0
1564188|NCT03339726|5394846|P2|Overall Study|Lost to Follow-up|1
1564189|NCT03339726|5394847|P1|Overall Study|Lost to Follow-up|0
1564190|NCT03339726|5394845|P3|Overall Study|Withdrawal by Subject|0
1564191|NCT03339726|5394846|P2|Overall Study|Withdrawal by Subject|0
1564192|NCT03339726|5394847|P1|Overall Study|Withdrawal by Subject|1
1564193|NCT03339583|5394905|P2|Follow-up (14 Days)|Physician Decision|3
1564194|NCT03339583|5394906|P1|Follow-up (14 Days)|Physician Decision|6
1564195|NCT03339583|5394905|P2|Second Intervention (14 Days)|Adverse Event|1
1564196|NCT03339583|5394906|P1|Second Intervention (14 Days)|Adverse Event|0
1564197|NCT03339583|5394905|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
1564198|NCT03339583|5394906|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
1564199|NCT03339583|5394905|P2|First Intervention (14 Days)|Adverse Event|0
1564200|NCT03339583|5394906|P1|First Intervention (14 Days)|Adverse Event|1
1564201|NCT03339453|5394944|P2|First Visit of Glucagon Treatment|Adverse Event|1
1564202|NCT03339453|5394945|P1|First Visit of Glucagon Treatment|Adverse Event|0
1564203|NCT03338816|5394963|P2|Open-Label Extension Period|Ongoing in Study|47
1564204|NCT03338816|5394964|P1|Open-Label Extension Period|Ongoing in Study|46
1564205|NCT03338816|5394963|P2|6-Month Double-blind Period|Adverse Event|1
1564206|NCT03338816|5394964|P1|6-Month Double-blind Period|Adverse Event|0
1564207|NCT03338400|5395026|P2|Overall Study|Lost to Follow-up|2
1564208|NCT03338400|5395027|P1|Overall Study|Lost to Follow-up|1
1564209|NCT03337477|5395035|P2|Overall Study|Lost to Follow-up|2
1564210|NCT03337477|5395036|P1|Overall Study|Lost to Follow-up|0
1564211|NCT03337477|5395035|P2|Overall Study|Death|1
1564212|NCT03337477|5395036|P1|Overall Study|Death|0
1564213|NCT03337477|5395035|P2|Overall Study|Withdrawal by Subject|1
1564214|NCT03337477|5395036|P1|Overall Study|Withdrawal by Subject|0
1564215|NCT03337477|5395035|P2|Overall Study|not categorized into the listed ones|9
1564216|NCT03337477|5395036|P1|Overall Study|not categorized into the listed ones|11
1564217|NCT03336502|5395067|P2|Overall Study|Adverse Event|5
1564218|NCT03336502|5395068|P1|Overall Study|Adverse Event|2
1564219|NCT03336502|5395067|P2|Overall Study|Death|2
1564220|NCT03336502|5395068|P1|Overall Study|Death|1
1564221|NCT03336502|5395067|P2|Overall Study|Prohibited Drugs|1
1564222|NCT03336502|5395068|P1|Overall Study|Prohibited Drugs|1
1564223|NCT03336502|5395067|P2|Overall Study|Physician Decision|1
1564224|NCT03336502|5395068|P1|Overall Study|Physician Decision|0
1564225|NCT03335566|5395097|P2|Overall Study|Other than specified above|2
1564226|NCT03335566|5395098|P1|Overall Study|Other than specified above|1
1564227|NCT03335566|5395097|P2|Overall Study|Protocol Violation|0
1564228|NCT03335566|5395098|P1|Overall Study|Protocol Violation|1
1564229|NCT03335566|5395097|P2|Overall Study|Technical Problems|0
1564230|NCT03335566|5395098|P1|Overall Study|Technical Problems|1
1564231|NCT03335566|5395097|P2|Overall Study|Lost to Follow-up|0
1564232|NCT03335566|5395098|P1|Overall Study|Lost to Follow-up|1
1564233|NCT03335566|5395097|P2|Overall Study|Adverse Event|1
1564234|NCT03335566|5395098|P1|Overall Study|Adverse Event|0
1564235|NCT03334422|5395195|P4|Overall Study|Pregnancy|0
1564236|NCT03334422|5395196|P3|Overall Study|Pregnancy|0
1564237|NCT03334422|5395197|P2|Overall Study|Pregnancy|1
1564238|NCT03334422|5395198|P1|Overall Study|Pregnancy|0
1564239|NCT03334422|5395195|P4|Overall Study|Inability to obtain laboratory samples|0
1564240|NCT03334422|5395196|P3|Overall Study|Inability to obtain laboratory samples|0
1564241|NCT03334422|5395197|P2|Overall Study|Inability to obtain laboratory samples|1
1564242|NCT03334422|5395198|P1|Overall Study|Inability to obtain laboratory samples|0
1564243|NCT03334422|5395195|P4|Overall Study|Lost to Follow-up|1
1564244|NCT03334422|5395196|P3|Overall Study|Lost to Follow-up|0
1564245|NCT03334422|5395197|P2|Overall Study|Lost to Follow-up|0
1564246|NCT03334422|5395198|P1|Overall Study|Lost to Follow-up|0
1564247|NCT03334422|5395195|P4|Overall Study|Withdrawal by Subject|0
1564248|NCT03334422|5395196|P3|Overall Study|Withdrawal by Subject|1
1564249|NCT03334422|5395197|P2|Overall Study|Withdrawal by Subject|3
1564250|NCT03334422|5395198|P1|Overall Study|Withdrawal by Subject|8
1564251|NCT03334422|5395195|P4|Overall Study|Lack of Efficacy|3
1564252|NCT03334422|5395196|P3|Overall Study|Lack of Efficacy|7
1564253|NCT03334422|5395197|P2|Overall Study|Lack of Efficacy|2
1564254|NCT03334422|5395198|P1|Overall Study|Lack of Efficacy|10
1564255|NCT03334422|5395195|P4|Overall Study|Adverse Event|2
1564256|NCT03334422|5395196|P3|Overall Study|Adverse Event|2
1564257|NCT03334422|5395197|P2|Overall Study|Adverse Event|3
1564258|NCT03334422|5395198|P1|Overall Study|Adverse Event|1
1564259|NCT03334396|5395301|P4|Overall Study|Started New Job|0
1564260|NCT03334396|5395302|P3|Overall Study|Started New Job|0
1564261|NCT03334396|5395303|P2|Overall Study|Started New Job|0
1564262|NCT03334396|5395304|P1|Overall Study|Started New Job|1
1564263|NCT03334396|5395301|P4|Overall Study|Ineligible|0
1564264|NCT03334396|5395302|P3|Overall Study|Ineligible|0
1564265|NCT03334396|5395303|P2|Overall Study|Ineligible|1
1564266|NCT03334396|5395304|P1|Overall Study|Ineligible|0
1564267|NCT03334396|5395301|P4|Overall Study|Pregnancy|0
1564268|NCT03334396|5395302|P3|Overall Study|Pregnancy|0
1564269|NCT03334396|5395303|P2|Overall Study|Pregnancy|1
1564270|NCT03334396|5395304|P1|Overall Study|Pregnancy|0
1564271|NCT03334396|5395301|P4|Overall Study|Withdrawal by Subject|2
1564272|NCT03334396|5395302|P3|Overall Study|Withdrawal by Subject|7
1564273|NCT03334396|5395303|P2|Overall Study|Withdrawal by Subject|5
1564274|NCT03334396|5395304|P1|Overall Study|Withdrawal by Subject|10
1564275|NCT03334396|5395301|P4|Overall Study|Physician Decision|0
1564276|NCT03334396|5395302|P3|Overall Study|Physician Decision|0
1564277|NCT03334396|5395303|P2|Overall Study|Physician Decision|0
1564278|NCT03334396|5395304|P1|Overall Study|Physician Decision|1
1564279|NCT03334396|5395301|P4|Overall Study|Lost to Follow-up|0
1564280|NCT03334396|5395302|P3|Overall Study|Lost to Follow-up|1
1564281|NCT03334396|5395303|P2|Overall Study|Lost to Follow-up|0
1564282|NCT03334396|5395304|P1|Overall Study|Lost to Follow-up|0
1564283|NCT03334396|5395301|P4|Overall Study|Lack of Efficacy|3
1564284|NCT03334396|5395302|P3|Overall Study|Lack of Efficacy|1
1564285|NCT03334396|5395303|P2|Overall Study|Lack of Efficacy|4
1564286|NCT03334396|5395304|P1|Overall Study|Lack of Efficacy|10
1564287|NCT03334396|5395301|P4|Overall Study|Adverse Event|0
1564288|NCT03334396|5395302|P3|Overall Study|Adverse Event|1
1564289|NCT03334396|5395303|P2|Overall Study|Adverse Event|0
1564290|NCT03334396|5395304|P1|Overall Study|Adverse Event|1
1564291|NCT03334214|5395405|P2|Overall Study|Other|0
1564292|NCT03334214|5395406|P1|Overall Study|Other|1
1564293|NCT03334214|5395405|P2|Overall Study|Withdrawal by Subject|1
1564294|NCT03334214|5395406|P1|Overall Study|Withdrawal by Subject|0
1564295|NCT03334214|5395405|P2|Overall Study|Adverse Event or Serious Adverse Event|1
1564296|NCT03334214|5395406|P1|Overall Study|Adverse Event or Serious Adverse Event|0
1564297|NCT03333876|5395432|P1|Mandibular Advancement|Product Damage|2
1564298|NCT03333876|5395432|P1|Mandibular Advancement|Adverse Event|2
1564299|NCT03333876|5395432|P1|Nasal Dilator|Bed Partner Lost to follow up|6
1564300|NCT03333876|5395432|P1|Screening Period|Screen Failure|4
1564301|NCT03331315|5395629|P2|Overall Study|Physician Decision|14
1564302|NCT03331315|5395630|P1|Overall Study|Physician Decision|18
1564303|NCT03331042|5395654|P4|Overall Study|Lost to Follow-up|1
1564304|NCT03331042|5395655|P3|Overall Study|Lost to Follow-up|0
1564305|NCT03331042|5395656|P2|Overall Study|Lost to Follow-up|0
1564306|NCT03331042|5395657|P1|Overall Study|Lost to Follow-up|0
1564307|NCT03331042|5395654|P4|Overall Study|Physician Decision|0
1564308|NCT03331042|5395655|P3|Overall Study|Physician Decision|1
1564309|NCT03331042|5395656|P2|Overall Study|Physician Decision|0
1564310|NCT03331042|5395657|P1|Overall Study|Physician Decision|0
1564311|NCT03331042|5395654|P4|Overall Study|Protocol Violation|0
1564312|NCT03331042|5395655|P3|Overall Study|Protocol Violation|0
1564313|NCT03331042|5395656|P2|Overall Study|Protocol Violation|0
1564314|NCT03331042|5395657|P1|Overall Study|Protocol Violation|1
1564315|NCT03329885|5395754|P9|Overall Study|Sponsor discontinued the study early|0
1564316|NCT03329885|5395755|P8|Overall Study|Sponsor discontinued the study early|1
1564317|NCT03329885|5395756|P7|Overall Study|Sponsor discontinued the study early|1
1564318|NCT03329885|5395757|P6|Overall Study|Sponsor discontinued the study early|0
1564319|NCT03329885|5395758|P5|Overall Study|Sponsor discontinued the study early|0
1564320|NCT03329885|5395759|P4|Overall Study|Sponsor discontinued the study early|0
1564321|NCT03329885|5395760|P3|Overall Study|Sponsor discontinued the study early|0
1564322|NCT03329885|5395761|P2|Overall Study|Sponsor discontinued the study early|0
1564323|NCT03329885|5395762|P1|Overall Study|Sponsor discontinued the study early|0
1564324|NCT03329573|5395930|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1564325|NCT03329573|5395931|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1564326|NCT03329573|5395932|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
1564327|NCT03329573|5395933|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1564328|NCT03329573|5395930|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1564329|NCT03329573|5395931|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1564330|NCT03329573|5395932|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1564331|NCT03329573|5395933|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
1564332|NCT03329573|5395930|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
1564333|NCT03329573|5395931|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
1564334|NCT03329573|5395932|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
1564335|NCT03329573|5395933|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
1564336|NCT03329573|5395930|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1564337|NCT03329573|5395931|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1564338|NCT03329573|5395932|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
1564339|NCT03329573|5395933|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1564340|NCT03328182|5396018|P1|Overall Study|No Product Evaluated|1
1564341|NCT03328182|5396018|P1|Overall Study|Protocol Violation|2
1564342|NCT03328182|5396018|P1|Overall Study|Withdrawal by Subject|1
1564343|NCT03327402|5396023|P1|Overall Study|Other (Visit Out-Of-Window)|1
1564344|NCT03327402|5396023|P1|Overall Study|Withdrawal by Subject|1
1564345|NCT03326323|5396312|P1|Overall Study|Unable to receive ANH protocol|3
1564346|NCT03325894|5396319|P2|Overall Study|Other (Not received Treatment)|0
1564347|NCT03325894|5396320|P1|Overall Study|Other (Not received Treatment)|1
1564348|NCT03325894|5396319|P2|Overall Study|Study Terminated by Sponsor|43
1564349|NCT03325894|5396320|P1|Overall Study|Study Terminated by Sponsor|38
1564350|NCT03325894|5396319|P2|Overall Study|Lack of Efficacy|14
1564351|NCT03325894|5396320|P1|Overall Study|Lack of Efficacy|8
1564352|NCT03325894|5396319|P2|Overall Study|Lost to Follow-up|9
1564353|NCT03325894|5396320|P1|Overall Study|Lost to Follow-up|4
1564354|NCT03325894|5396319|P2|Overall Study|Withdrawal by Subject|6
1564355|NCT03325894|5396320|P1|Overall Study|Withdrawal by Subject|10
1564356|NCT03325894|5396319|P2|Overall Study|Protocol Violation|2
1564357|NCT03325894|5396320|P1|Overall Study|Protocol Violation|1
1564358|NCT03325894|5396319|P2|Overall Study|Adverse Event|3
1564359|NCT03325894|5396320|P1|Overall Study|Adverse Event|2
1564360|NCT03325881|5396388|P2|Overall Study|Not treated|0
1564361|NCT03325881|5396389|P1|Overall Study|Not treated|1
1564362|NCT03325881|5396388|P2|Overall Study|Lack of Efficacy|0
1564363|NCT03325881|5396389|P1|Overall Study|Lack of Efficacy|2
1564364|NCT03325881|5396388|P2|Overall Study|Withdrawal by Subject|2
1564365|NCT03325881|5396389|P1|Overall Study|Withdrawal by Subject|0
1564366|NCT03325881|5396388|P2|Overall Study|Protocol Violation|1
1564367|NCT03325881|5396389|P1|Overall Study|Protocol Violation|0
1564368|NCT03325673|5396417|P2|Overall Study|Adverse Event|0
1564369|NCT03325673|5396418|P1|Overall Study|Adverse Event|4
1564370|NCT03323736|5396433|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
1564371|NCT03323736|5396434|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
1564372|NCT03323736|5396435|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
1564373|NCT03323736|5396433|P3|Overall Study|Withdrawal Before Treatment|1
1564374|NCT03323736|5396434|P2|Overall Study|Withdrawal Before Treatment|1
1564375|NCT03323736|5396435|P1|Overall Study|Withdrawal Before Treatment|3
1564376|NCT03323736|5396433|P3|Overall Study|Screen Failure|1
1564377|NCT03323736|5396434|P2|Overall Study|Screen Failure|9
1564378|NCT03323736|5396435|P1|Overall Study|Screen Failure|14
1564379|NCT03323086|5396462|P2|Overall Study|Lost to Follow-up|2
1564380|NCT03323086|5396463|P1|Overall Study|Lost to Follow-up|3
1564381|NCT03322566|5396491|P3|Overall Study|On-going at clinical cut off date|36
1564382|NCT03322566|5396492|P2|Overall Study|On-going at clinical cut off date|74
1564383|NCT03322566|5396493|P1|Overall Study|On-going at clinical cut off date|68
1564384|NCT03322566|5396491|P3|Overall Study|Withdrawal by Subject|5
1564385|NCT03322566|5396492|P2|Overall Study|Withdrawal by Subject|1
1564386|NCT03322566|5396493|P1|Overall Study|Withdrawal by Subject|3
1564387|NCT03322566|5396491|P3|Overall Study|Physician Decision|1
1564388|NCT03322566|5396492|P2|Overall Study|Physician Decision|0
1564389|NCT03322566|5396493|P1|Overall Study|Physician Decision|0
1564390|NCT03322566|5396491|P3|Overall Study|Death|13
1564391|NCT03322566|5396492|P2|Overall Study|Death|12
1564392|NCT03322566|5396493|P1|Overall Study|Death|20
1564393|NCT03322540|5396512|P2|Overall Study|Participants Ongoing|59
1564394|NCT03322540|5396513|P1|Overall Study|Participants Ongoing|63
1564395|NCT03322540|5396512|P2|Overall Study|Withdrawal by Subject|1
1564396|NCT03322540|5396513|P1|Overall Study|Withdrawal by Subject|2
1564397|NCT03322540|5396512|P2|Overall Study|Physician Decision|1
1564398|NCT03322540|5396513|P1|Overall Study|Physician Decision|0
1564399|NCT03322540|5396512|P2|Overall Study|Lost to Follow-up|1
1564400|NCT03322540|5396513|P1|Overall Study|Lost to Follow-up|0
1564401|NCT03322540|5396512|P2|Overall Study|Death|15
1564402|NCT03322540|5396513|P1|Overall Study|Death|12
1564403|NCT03322514|5396521|P2|Overall Study|Withdrawal by Subject|1
1564404|NCT03322514|5396522|P1|Overall Study|Withdrawal by Subject|1
1564405|NCT03322423|5396532|P2|Period 2|Subject not eligible for Pytergiumectomy|1
1564406|NCT03322423|5396533|P1|Period 2|Subject not eligible for Pytergiumectomy|0
1564407|NCT03322423|5396532|P2|Period 2|Protocol Violation|0
1564408|NCT03322423|5396533|P1|Period 2|Protocol Violation|1
1564409|NCT03322423|5396532|P2|Period 2|Dispensed incorrect lens in left eye|1
1564410|NCT03322423|5396533|P1|Period 2|Dispensed incorrect lens in left eye|0
1564411|NCT03322423|5396532|P2|Period 1|Unsatisfactory Lens Fitting|0
1564412|NCT03322423|5396533|P1|Period 1|Unsatisfactory Lens Fitting|1
1564413|NCT03322423|5396532|P2|Period 1|Incorrect Lens Dispensed|0
1564414|NCT03322423|5396533|P1|Period 1|Incorrect Lens Dispensed|1
1564415|NCT03322423|5396532|P2|Period 1|Withdrawal by Subject|1
1564416|NCT03322423|5396533|P1|Period 1|Withdrawal by Subject|0
1564417|NCT03322423|5396532|P2|Period 1|Subject no longer eligible|1
1564418|NCT03322423|5396533|P1|Period 1|Subject no longer eligible|0
1564419|NCT03322293|5396546|P3|Overall Study|Lost to Follow-up|1
1564420|NCT03322293|5396547|P2|Overall Study|Lost to Follow-up|0
1564421|NCT03322293|5396548|P1|Overall Study|Lost to Follow-up|0
1564422|NCT03321396|5396568|P1|Overall Study|Physician Decision|1
1564423|NCT03320941|5396587|P5|Overall Study|subject/guardian decision|0
1564424|NCT03320941|5396588|P4|Overall Study|subject/guardian decision|1
1564425|NCT03320941|5396589|P3|Overall Study|subject/guardian decision|0
1564426|NCT03320941|5396590|P2|Overall Study|subject/guardian decision|0
1564427|NCT03320941|5396591|P1|Overall Study|subject/guardian decision|0
1564428|NCT03320564|5396692|P1|Overall Study|Protocol Violation|1
1564429|NCT03319719|5396708|P1|Overall Study|Lost to Follow-up|1
1564430|NCT03319212|5396741|P2|Overall Study|Physician Decision|0
1564431|NCT03319212|5396742|P1|Overall Study|Physician Decision|1
1564432|NCT03319212|5396741|P2|Overall Study|Lost to Follow-up|1
1564433|NCT03319212|5396742|P1|Overall Study|Lost to Follow-up|0
1564434|NCT03319212|5396741|P2|Overall Study|Withdrawal by Subject|1
1564435|NCT03319212|5396742|P1|Overall Study|Withdrawal by Subject|0
1564436|NCT03319212|5396741|P2|Overall Study|Adverse Event|2
1564437|NCT03319212|5396742|P1|Overall Study|Adverse Event|2
1564438|NCT03319212|5396741|P2|Overall Study|Discontinued as moving out of local area|1
1564439|NCT03319212|5396742|P1|Overall Study|Discontinued as moving out of local area|0
1564440|NCT03316911|5396842|P2|Overall Study|Lost to Follow-up|29
1564441|NCT03316911|5396843|P1|Overall Study|Lost to Follow-up|33
1564442|NCT03316131|5396888|P2|Treatment Period 2|Protocol deviation|0
1564443|NCT03316131|5396889|P1|Treatment Period 2|Protocol deviation|1
1564444|NCT03315286|5397010|P2|Overall Study|Protocol Violation|1
1564445|NCT03315286|5397011|P1|Overall Study|Protocol Violation|0
1564446|NCT03315286|5397010|P2|Overall Study|Withdrawal by Subject|0
1564447|NCT03315286|5397011|P1|Overall Study|Withdrawal by Subject|1
1564448|NCT03315286|5397010|P2|Overall Study|Lost to Follow-up|3
1564449|NCT03315286|5397011|P1|Overall Study|Lost to Follow-up|0
1564450|NCT03314233|5397052|P1|Overall Study|No longer eligible at time of delivery|1
1564451|NCT03313037|5397065|P2|Overall Study|Randomized but not treated|0
1564452|NCT03313037|5397066|P1|Overall Study|Randomized but not treated|1
1564453|NCT03313037|5397065|P2|Overall Study|Lost to Follow-up|8
1564454|NCT03313037|5397066|P1|Overall Study|Lost to Follow-up|9
1564455|NCT03313037|5397065|P2|Overall Study|No longer meets eligibility criteria|7
1564456|NCT03313037|5397066|P1|Overall Study|No longer meets eligibility criteria|1
1564457|NCT03313037|5397065|P2|Overall Study|Withdrawal by Subject|3
1564458|NCT03313037|5397066|P1|Overall Study|Withdrawal by Subject|4
1564459|NCT03313037|5397065|P2|Overall Study|Other|1
1564460|NCT03313037|5397066|P1|Overall Study|Other|1
1564461|NCT03313037|5397065|P2|Overall Study|Protocol Violation|1
1564462|NCT03313037|5397066|P1|Overall Study|Protocol Violation|4
1564463|NCT03312933|5397088|P1|Overall Study|Withdrawal by Subject|3
1564464|NCT03312933|5397088|P1|Overall Study|Lost to Follow-up|36
1564465|NCT03312933|5397088|P1|Overall Study|Protocol Violation|15
1564466|NCT03312543|5397094|P2|Regression (Week 12 to Week 24)|Death|1
1564467|NCT03312543|5397095|P1|Regression (Week 12 to Week 24)|Death|0
1564468|NCT03312543|5397094|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
1564469|NCT03312543|5397095|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
1564470|NCT03312543|5397094|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
1564471|NCT03312543|5397095|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
1564472|NCT03312543|5397094|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
1564473|NCT03312543|5397095|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
1564474|NCT03312543|5397094|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
1564475|NCT03312543|5397095|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
1564476|NCT03312543|5397094|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
1564477|NCT03312543|5397095|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
1564478|NCT03311841|5397191|P5|14-day Wash-out|Non-Compliance With Study Drug|0
1564479|NCT03311841|5397192|P4|14-day Wash-out|Non-Compliance With Study Drug|1
1564480|NCT03311841|5397193|P3|14-day Wash-out|Non-Compliance With Study Drug|0
1564481|NCT03311841|5397194|P2|14-day Wash-out|Non-Compliance With Study Drug|0
1564482|NCT03311841|5397195|P1|14-day Wash-out|Non-Compliance With Study Drug|0
1564483|NCT03311841|5397191|P5|14-day Wash-out|Adverse Event|0
1564484|NCT03311841|5397192|P4|14-day Wash-out|Adverse Event|0
1564485|NCT03311841|5397193|P3|14-day Wash-out|Adverse Event|0
1564486|NCT03311841|5397194|P2|14-day Wash-out|Adverse Event|1
1564487|NCT03311841|5397195|P1|14-day Wash-out|Adverse Event|0
1564488|NCT03311659|5397296|P1|Overall Study|Protocol Violation|1
1564489|NCT03311646|5397311|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
1564490|NCT03311646|5397311|P1|Overall Study|Lost to Follow-up|5
1564491|NCT03311646|5397311|P1|Overall Study|Withdrawal by Subject|5
1564492|NCT03311646|5397311|P1|Overall Study|Physician Decision|1
1564493|NCT03311230|5397322|P4|Overall Study|Unrelated injury|0
1564494|NCT03311230|5397323|P3|Overall Study|Unrelated injury|0
1564495|NCT03311230|5397324|P2|Overall Study|Unrelated injury|1
1564496|NCT03311230|5397325|P1|Overall Study|Unrelated injury|0
1564497|NCT03311230|5397322|P4|Overall Study|Withdrawal by Subject|7
1564498|NCT03311230|5397323|P3|Overall Study|Withdrawal by Subject|2
1564499|NCT03311230|5397324|P2|Overall Study|Withdrawal by Subject|4
1564500|NCT03311230|5397325|P1|Overall Study|Withdrawal by Subject|1
1564501|NCT03310580|5397350|P3|Overall Study|Adverse Event|0
1564502|NCT03310580|5397351|P2|Overall Study|Adverse Event|1
1564503|NCT03310580|5397352|P1|Overall Study|Adverse Event|0
1564504|NCT03310411|5397385|P4|Period 1|Adverse Event|1
1564505|NCT03310411|5397386|P3|Period 1|Adverse Event|0
1564506|NCT03310411|5397387|P2|Period 1|Adverse Event|0
1564507|NCT03310411|5397388|P1|Period 1|Adverse Event|0
1564508|NCT03310268|5397409|P3|Overall Study|(Not specified)|0
1564509|NCT03310268|5397410|P2|Overall Study|(Not specified)|5
1564510|NCT03310268|5397411|P1|Overall Study|(Not specified)|1
1564511|NCT03309202|5397426|P4|Overall Study|Lost to Follow-up|0
1564512|NCT03309202|5397427|P3|Overall Study|Lost to Follow-up|0
1564513|NCT03309202|5397428|P2|Overall Study|Lost to Follow-up|0
1564514|NCT03309202|5397429|P1|Overall Study|Lost to Follow-up|1
1564515|NCT03308968|5397514|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
1564516|NCT03308968|5397515|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
1564517|NCT03308968|5397516|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
1564518|NCT03308968|5397514|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
1564519|NCT03308968|5397515|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
1564520|NCT03308968|5397516|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
1564521|NCT03308968|5397514|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
1564522|NCT03308968|5397515|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
1564523|NCT03308968|5397516|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
1564524|NCT03308968|5397514|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
1564525|NCT03308968|5397515|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
1564526|NCT03308968|5397516|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
1564527|NCT03308968|5397514|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
1564528|NCT03308968|5397515|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
1564529|NCT03308968|5397516|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
1564530|NCT03308968|5397514|P3|Open-Label Period (12 Weeks)|Adverse Event|1
1564531|NCT03308968|5397515|P2|Open-Label Period (12 Weeks)|Adverse Event|1
1564532|NCT03308968|5397516|P1|Open-Label Period (12 Weeks)|Adverse Event|4
1564533|NCT03308968|5397514|P3|Open-Label Period (12 Weeks)|Other than specified|1
1564534|NCT03308968|5397515|P2|Open-Label Period (12 Weeks)|Other than specified|2
1564535|NCT03308968|5397516|P1|Open-Label Period (12 Weeks)|Other than specified|1
1564536|NCT03308968|5397514|P3|Double-Blind Period (12 Weeks)|Other than specified|2
1564537|NCT03308968|5397515|P2|Double-Blind Period (12 Weeks)|Other than specified|0
1564538|NCT03308968|5397516|P1|Double-Blind Period (12 Weeks)|Other than specified|1
1564539|NCT03308968|5397514|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
1564540|NCT03308968|5397515|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
1564541|NCT03308968|5397516|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
1564542|NCT03308968|5397514|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
1564543|NCT03308968|5397515|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
1564544|NCT03308968|5397516|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
1564545|NCT03308968|5397514|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
1564546|NCT03308968|5397515|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
1564547|NCT03308968|5397516|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
1564548|NCT03308968|5397514|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
1564549|NCT03308968|5397515|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
1564550|NCT03308968|5397516|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
1564551|NCT03308968|5397514|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
1564552|NCT03308968|5397515|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
1564553|NCT03308968|5397516|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
1564554|NCT03308968|5397514|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
1564555|NCT03308968|5397515|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
1564556|NCT03308968|5397516|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
1564557|NCT03308825|5397594|P4|Overall Study|Protocol Violation|0
1564558|NCT03308825|5397595|P3|Overall Study|Protocol Violation|0
1564559|NCT03308825|5397596|P2|Overall Study|Protocol Violation|2
1564560|NCT03308825|5397597|P1|Overall Study|Protocol Violation|0
1564561|NCT03308825|5397594|P4|Overall Study|Lost to Follow-up|0
1564562|NCT03308825|5397595|P3|Overall Study|Lost to Follow-up|1
1564563|NCT03308825|5397596|P2|Overall Study|Lost to Follow-up|2
1564564|NCT03308825|5397597|P1|Overall Study|Lost to Follow-up|2
1564565|NCT03307252|5397685|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
1564566|NCT03307252|5397686|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564567|NCT03307252|5397687|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564568|NCT03307252|5397688|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564569|NCT03307252|5397689|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564570|NCT03307252|5397690|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564571|NCT03307252|5397691|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564572|NCT03307252|5397692|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564573|NCT03307252|5397693|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564574|NCT03307252|5397694|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564575|NCT03307252|5397695|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1564576|NCT03307252|5397685|P11|Part 2, Period 4|Other than listed|0
1564577|NCT03307252|5397686|P10|Part 2, Period 4|Other than listed|0
1564578|NCT03307252|5397687|P9|Part 2, Period 4|Other than listed|0
1564579|NCT03307252|5397688|P8|Part 2, Period 4|Other than listed|0
1564580|NCT03307252|5397689|P7|Part 2, Period 4|Other than listed|1
1564581|NCT03307252|5397690|P6|Part 2, Period 4|Other than listed|0
1564582|NCT03307252|5397691|P5|Part 2, Period 4|Other than listed|0
1564583|NCT03307252|5397692|P4|Part 2, Period 4|Other than listed|0
1564584|NCT03307252|5397693|P3|Part 2, Period 4|Other than listed|0
1564585|NCT03307252|5397694|P2|Part 2, Period 4|Other than listed|0
1564586|NCT03307252|5397695|P1|Part 2, Period 4|Other than listed|0
1564587|NCT03307252|5397685|P11|Part 2, Period 3|Other than listed|0
1564588|NCT03307252|5397686|P10|Part 2, Period 3|Other than listed|0
1564589|NCT03307252|5397687|P9|Part 2, Period 3|Other than listed|0
1564590|NCT03307252|5397688|P8|Part 2, Period 3|Other than listed|0
1564591|NCT03307252|5397689|P7|Part 2, Period 3|Other than listed|0
1564592|NCT03307252|5397690|P6|Part 2, Period 3|Other than listed|0
1564593|NCT03307252|5397691|P5|Part 2, Period 3|Other than listed|1
1564594|NCT03307252|5397692|P4|Part 2, Period 3|Other than listed|0
1564595|NCT03307252|5397693|P3|Part 2, Period 3|Other than listed|0
1564596|NCT03307252|5397694|P2|Part 2, Period 3|Other than listed|0
1564597|NCT03307252|5397695|P1|Part 2, Period 3|Other than listed|0
1564598|NCT03307252|5397685|P11|Part 2, Period 1|Treatment not received|0
1564599|NCT03307252|5397686|P10|Part 2, Period 1|Treatment not received|0
1564600|NCT03307252|5397687|P9|Part 2, Period 1|Treatment not received|0
1564601|NCT03307252|5397688|P8|Part 2, Period 1|Treatment not received|0
1564602|NCT03307252|5397689|P7|Part 2, Period 1|Treatment not received|0
1564603|NCT03307252|5397690|P6|Part 2, Period 1|Treatment not received|1
1564604|NCT03307252|5397691|P5|Part 2, Period 1|Treatment not received|0
1564605|NCT03307252|5397692|P4|Part 2, Period 1|Treatment not received|0
1564606|NCT03307252|5397693|P3|Part 2, Period 1|Treatment not received|0
1564607|NCT03307252|5397694|P2|Part 2, Period 1|Treatment not received|0
1564608|NCT03307252|5397695|P1|Part 2, Period 1|Treatment not received|0
1564609|NCT03305770|5397999|P2|Overall Study|Subject moved|0
1564610|NCT03305770|5398000|P1|Overall Study|Subject moved|1
1564611|NCT03305770|5397999|P2|Overall Study|Physician Decision - prior to dispense|1
1564612|NCT03305770|5398000|P1|Overall Study|Physician Decision - prior to dispense|0
1564614|NCT03305419|5398025|P8|Part B (14 Days)|Physician Decision|0
1564615|NCT03305419|5398026|P7|Part B (14 Days)|Physician Decision|1
1564616|NCT03305419|5398027|P6|Part B (14 Days)|Physician Decision|8
1564617|NCT03305419|5398028|P5|Part B (14 Days)|Physician Decision|2
1564618|NCT03305419|5398029|P4|Part B (14 Days)|Physician Decision|0
1564619|NCT03305419|5398030|P3|Part B (14 Days)|Physician Decision|0
1564620|NCT03305419|5398031|P2|Part B (14 Days)|Physician Decision|0
1564621|NCT03305419|5398032|P1|Part B (14 Days)|Physician Decision|0
1564622|NCT03305419|5398025|P8|Part B (14 Days)|Adverse Event|0
1564623|NCT03305419|5398026|P7|Part B (14 Days)|Adverse Event|4
1564624|NCT03305419|5398027|P6|Part B (14 Days)|Adverse Event|2
1564625|NCT03305419|5398028|P5|Part B (14 Days)|Adverse Event|1
1564626|NCT03305419|5398029|P4|Part B (14 Days)|Adverse Event|0
1564627|NCT03305419|5398030|P3|Part B (14 Days)|Adverse Event|0
1564628|NCT03305419|5398031|P2|Part B (14 Days)|Adverse Event|0
1564629|NCT03305419|5398032|P1|Part B (14 Days)|Adverse Event|0
1564630|NCT03305419|5398025|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1564631|NCT03305419|5398026|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1564632|NCT03305419|5398027|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1564633|NCT03305419|5398028|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1564634|NCT03305419|5398029|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1564635|NCT03305419|5398030|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1564636|NCT03305419|5398031|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1564637|NCT03305419|5398032|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
1564638|NCT03305419|5398025|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1564639|NCT03305419|5398026|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1564640|NCT03305419|5398027|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1564641|NCT03305419|5398028|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1564642|NCT03305419|5398029|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1564643|NCT03305419|5398030|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1564644|NCT03305419|5398031|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1564645|NCT03305419|5398032|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
1564646|NCT03305419|5398025|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1564647|NCT03305419|5398026|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1564648|NCT03305419|5398027|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1564649|NCT03305419|5398028|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1564650|NCT03305419|5398029|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1564651|NCT03305419|5398030|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1564652|NCT03305419|5398031|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
1564653|NCT03305419|5398032|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1564654|NCT03305055|5398173|P2|Overall Study|Adverse Event|1
1564655|NCT03305055|5398174|P1|Overall Study|Adverse Event|1
1564656|NCT03305055|5398173|P2|Overall Study|Withdrawal by Subject|1
1564657|NCT03305055|5398174|P1|Overall Study|Withdrawal by Subject|0
1564672|NCT03303417|5398273|P2|Overall Study|Withdrawal by Subject|1
1564673|NCT03303417|5398274|P1|Overall Study|Withdrawal by Subject|1
1564674|NCT03302975|5398288|P1|Overall Study|Lost to Follow-up|4
1564675|NCT03302936|5398296|P2|Overall Study|Protocol Violation|4
1564676|NCT03302936|5398297|P1|Overall Study|Protocol Violation|3
1564677|NCT03302559|5398318|P1|Overall Study|Withdrew Consent|3
1564678|NCT03302559|5398318|P1|Overall Study|Lost to Follow-up|1
1564679|NCT03302559|5398318|P1|Overall Study|Adverse Event|2
1564680|NCT03301844|5398334|P2|Overall Study|suspected colon cancer|1
1564681|NCT03301844|5398335|P1|Overall Study|suspected colon cancer|1
1564682|NCT03301649|5398352|P3|Overall Study|Other than specified|0
1564683|NCT03301649|5398353|P2|Overall Study|Other than specified|3
1564684|NCT03301649|5398354|P1|Overall Study|Other than specified|5
1564685|NCT03301649|5398352|P3|Overall Study|Withdrawal by Subject|0
1564686|NCT03301649|5398353|P2|Overall Study|Withdrawal by Subject|4
1564687|NCT03301649|5398354|P1|Overall Study|Withdrawal by Subject|10
1564688|NCT03301649|5398352|P3|Overall Study|Protocol Violation|1
1564689|NCT03301649|5398353|P2|Overall Study|Protocol Violation|1
1564690|NCT03301649|5398354|P1|Overall Study|Protocol Violation|0
1564691|NCT03301649|5398352|P3|Overall Study|Lost to Follow-up|3
1564692|NCT03301649|5398353|P2|Overall Study|Lost to Follow-up|11
1564693|NCT03301649|5398354|P1|Overall Study|Lost to Follow-up|11
1564694|NCT03301649|5398352|P3|Overall Study|Need alternate therapy due to live lice|81
1564695|NCT03301649|5398353|P2|Overall Study|Need alternate therapy due to live lice|25
1564696|NCT03301649|5398354|P1|Overall Study|Need alternate therapy due to live lice|17
1564697|NCT03300570|5398439|P2|Overall Study|Inadequate bowel prep|0
1564698|NCT03300570|5398440|P1|Overall Study|Inadequate bowel prep|1
1564699|NCT03300570|5398439|P2|Overall Study|Withdrawal by Subject|0
1564700|NCT03300570|5398440|P1|Overall Study|Withdrawal by Subject|1
1564701|NCT03300570|5398439|P2|Overall Study|Adverse Event|1
1564702|NCT03300570|5398440|P1|Overall Study|Adverse Event|0
1564703|NCT03300024|5398452|P2|Overall Study|Physician Decision|6
1564704|NCT03300024|5398453|P1|Overall Study|Physician Decision|4
1564705|NCT03295201|5398643|P2|Overall Study|Hospital admission|1
1564706|NCT03295201|5398644|P1|Overall Study|Hospital admission|0
1564707|NCT03295201|5398643|P2|Overall Study|Lost to Follow-up|1
1564708|NCT03295201|5398644|P1|Overall Study|Lost to Follow-up|1
1564709|NCT03294538|5398730|P3|Overall Study|Outside of Visit Window|1
1564710|NCT03294538|5398731|P2|Overall Study|Outside of Visit Window|4
1564711|NCT03294538|5398732|P1|Overall Study|Outside of Visit Window|4
1564712|NCT03294538|5398730|P3|Overall Study|Lost to Follow-up|0
1564713|NCT03294538|5398731|P2|Overall Study|Lost to Follow-up|0
1564714|NCT03294538|5398732|P1|Overall Study|Lost to Follow-up|1
1564715|NCT03294538|5398730|P3|Overall Study|Adverse Event|1
1564716|NCT03294538|5398731|P2|Overall Study|Adverse Event|1
1564717|NCT03294538|5398732|P1|Overall Study|Adverse Event|0
1564718|NCT03293485|5398747|P1|Overall Study|Withdrawal by Subject|2
1564719|NCT03293485|5398747|P1|Overall Study|Screen Failure|2
1564720|NCT03293485|5398747|P1|Overall Study|Death|1
1564721|NCT03293394|5398758|P2|Follow-up (6 Months)|Adverse Event|2
1564722|NCT03293394|5398759|P1|Follow-up (6 Months)|Adverse Event|4
1564723|NCT03290300|5398846|P1|Overall Study|Lost to Follow-up|3
1564724|NCT03289676|5398866|P2|Overall Study|Lost to Follow-up|1
1564725|NCT03289676|5398867|P1|Overall Study|Lost to Follow-up|0
1564726|NCT03289676|5398866|P2|Overall Study|Protocol Violation|0
1564727|NCT03289676|5398867|P1|Overall Study|Protocol Violation|2
1564728|NCT03289676|5398866|P2|Overall Study|Withdrawal by Subject|0
1564729|NCT03289676|5398867|P1|Overall Study|Withdrawal by Subject|2
1564730|NCT03288779|5398892|P1|Overall Study|Withdrawal by Subject|3
1564731|NCT03287791|5398915|P3|Overall Study|Did not meet inclusion criteria|0
1564732|NCT03287791|5398916|P2|Overall Study|Did not meet inclusion criteria|0
1564733|NCT03287791|5398917|P1|Overall Study|Did not meet inclusion criteria|1
1564734|NCT03287791|5398915|P3|Overall Study|Non-compliance|0
1564735|NCT03287791|5398916|P2|Overall Study|Non-compliance|1
1564736|NCT03287791|5398917|P1|Overall Study|Non-compliance|0
1564737|NCT03287791|5398915|P3|Overall Study|Too much time between 2 visits|0
1564738|NCT03287791|5398916|P2|Overall Study|Too much time between 2 visits|1
1564739|NCT03287791|5398917|P1|Overall Study|Too much time between 2 visits|0
1564740|NCT03287791|5398915|P3|Overall Study|Participant was enrolled at 2 sites|1
1564741|NCT03287791|5398916|P2|Overall Study|Participant was enrolled at 2 sites|0
1564742|NCT03287791|5398917|P1|Overall Study|Participant was enrolled at 2 sites|1
1564743|NCT03287791|5398915|P3|Overall Study|Protocol Violation|1
1564744|NCT03287791|5398916|P2|Overall Study|Protocol Violation|2
1564745|NCT03287791|5398917|P1|Overall Study|Protocol Violation|7
1564746|NCT03287791|5398915|P3|Overall Study|Lost to Follow-up|11
1564747|NCT03287791|5398916|P2|Overall Study|Lost to Follow-up|14
1564748|NCT03287791|5398917|P1|Overall Study|Lost to Follow-up|8
1564749|NCT03287791|5398915|P3|Overall Study|Missed more than 6 consecutive doses|2
1564750|NCT03287791|5398916|P2|Overall Study|Missed more than 6 consecutive doses|2
1564751|NCT03287791|5398917|P1|Overall Study|Missed more than 6 consecutive doses|3
1564752|NCT03287791|5398915|P3|Overall Study|Withdrawal by Subject|17
1564753|NCT03287791|5398916|P2|Overall Study|Withdrawal by Subject|12
1564754|NCT03287791|5398917|P1|Overall Study|Withdrawal by Subject|12
1564755|NCT03287791|5398915|P3|Overall Study|Adverse Event|3
1564756|NCT03287791|5398916|P2|Overall Study|Adverse Event|4
1564757|NCT03287791|5398917|P1|Overall Study|Adverse Event|0
1564758|NCT03287791|5398915|P3|Overall Study|Insufficient Therapeutic Response|1
1564759|NCT03287791|5398916|P2|Overall Study|Insufficient Therapeutic Response|0
1564760|NCT03287791|5398917|P1|Overall Study|Insufficient Therapeutic Response|0
1564761|NCT03286218|5398944|P12|Treatment Phase Period 4|Withdrawal by Subject|1
1564762|NCT03286218|5398945|P11|Treatment Phase Period 4|Withdrawal by Subject|0
1564763|NCT03286218|5398946|P10|Treatment Phase Period 4|Withdrawal by Subject|0
1564764|NCT03286218|5398947|P9|Treatment Phase Period 4|Withdrawal by Subject|0
1564765|NCT03286218|5398948|P8|Treatment Phase Period 4|Withdrawal by Subject|0
1564766|NCT03286218|5398949|P7|Treatment Phase Period 4|Withdrawal by Subject|0
1564767|NCT03286218|5398950|P6|Treatment Phase Period 4|Withdrawal by Subject|0
1564768|NCT03286218|5398951|P5|Treatment Phase Period 4|Withdrawal by Subject|0
1564769|NCT03286218|5398952|P4|Treatment Phase Period 4|Withdrawal by Subject|0
1564770|NCT03286218|5398953|P3|Treatment Phase Period 4|Withdrawal by Subject|0
1564771|NCT03286218|5398954|P2|Treatment Phase Period 4|Withdrawal by Subject|0
1564772|NCT03286218|5398955|P1|Treatment Phase Period 4|Withdrawal by Subject|0
1564773|NCT03286218|5398944|P12|Treatment Phase Period 1|Withdrawal by Subject|1
1564774|NCT03286218|5398945|P11|Treatment Phase Period 1|Withdrawal by Subject|0
1564775|NCT03286218|5398946|P10|Treatment Phase Period 1|Withdrawal by Subject|0
1564776|NCT03286218|5398947|P9|Treatment Phase Period 1|Withdrawal by Subject|0
1564777|NCT03286218|5398948|P8|Treatment Phase Period 1|Withdrawal by Subject|0
1564778|NCT03286218|5398949|P7|Treatment Phase Period 1|Withdrawal by Subject|0
1564779|NCT03286218|5398950|P6|Treatment Phase Period 1|Withdrawal by Subject|1
1564780|NCT03286218|5398951|P5|Treatment Phase Period 1|Withdrawal by Subject|0
1564781|NCT03286218|5398952|P4|Treatment Phase Period 1|Withdrawal by Subject|1
1564782|NCT03286218|5398953|P3|Treatment Phase Period 1|Withdrawal by Subject|1
1564783|NCT03286218|5398954|P2|Treatment Phase Period 1|Withdrawal by Subject|0
1564784|NCT03286218|5398955|P1|Treatment Phase Period 1|Withdrawal by Subject|0
1564785|NCT03286218|5398944|P12|Qualification Phase Period 2|Withdrawal by Subject|0
1564786|NCT03286218|5398945|P11|Qualification Phase Period 2|Withdrawal by Subject|0
1564787|NCT03286218|5398946|P10|Qualification Phase Period 2|Withdrawal by Subject|0
1564788|NCT03286218|5398947|P9|Qualification Phase Period 2|Withdrawal by Subject|0
1564789|NCT03286218|5398948|P8|Qualification Phase Period 2|Withdrawal by Subject|0
1564790|NCT03286218|5398949|P7|Qualification Phase Period 2|Withdrawal by Subject|0
1564791|NCT03286218|5398950|P6|Qualification Phase Period 2|Withdrawal by Subject|0
1564792|NCT03286218|5398951|P5|Qualification Phase Period 2|Withdrawal by Subject|0
1564793|NCT03286218|5398952|P4|Qualification Phase Period 2|Withdrawal by Subject|0
1564794|NCT03286218|5398953|P3|Qualification Phase Period 2|Withdrawal by Subject|0
1564795|NCT03286218|5398954|P2|Qualification Phase Period 2|Withdrawal by Subject|2
1564796|NCT03286218|5398955|P1|Qualification Phase Period 2|Withdrawal by Subject|1
1564797|NCT03286218|5398944|P12|Qualification Phase Period 2|Protocol Violation|0
1564798|NCT03286218|5398945|P11|Qualification Phase Period 2|Protocol Violation|0
1564799|NCT03286218|5398946|P10|Qualification Phase Period 2|Protocol Violation|0
1564800|NCT03286218|5398947|P9|Qualification Phase Period 2|Protocol Violation|0
1564801|NCT03286218|5398948|P8|Qualification Phase Period 2|Protocol Violation|0
1564802|NCT03286218|5398949|P7|Qualification Phase Period 2|Protocol Violation|0
1564803|NCT03286218|5398950|P6|Qualification Phase Period 2|Protocol Violation|0
1564804|NCT03286218|5398951|P5|Qualification Phase Period 2|Protocol Violation|0
1564805|NCT03286218|5398952|P4|Qualification Phase Period 2|Protocol Violation|0
1564806|NCT03286218|5398953|P3|Qualification Phase Period 2|Protocol Violation|0
1564807|NCT03286218|5398954|P2|Qualification Phase Period 2|Protocol Violation|0
1564808|NCT03286218|5398955|P1|Qualification Phase Period 2|Protocol Violation|2
1564809|NCT03286218|5398944|P12|Qualification Phase Period 2|Lost to Follow-up|0
1564810|NCT03286218|5398945|P11|Qualification Phase Period 2|Lost to Follow-up|0
1564811|NCT03286218|5398946|P10|Qualification Phase Period 2|Lost to Follow-up|0
1564812|NCT03286218|5398947|P9|Qualification Phase Period 2|Lost to Follow-up|0
1564813|NCT03286218|5398948|P8|Qualification Phase Period 2|Lost to Follow-up|0
1564814|NCT03286218|5398949|P7|Qualification Phase Period 2|Lost to Follow-up|0
1564815|NCT03286218|5398950|P6|Qualification Phase Period 2|Lost to Follow-up|0
1564816|NCT03286218|5398951|P5|Qualification Phase Period 2|Lost to Follow-up|0
1564817|NCT03286218|5398952|P4|Qualification Phase Period 2|Lost to Follow-up|0
1564818|NCT03286218|5398953|P3|Qualification Phase Period 2|Lost to Follow-up|0
1564819|NCT03286218|5398954|P2|Qualification Phase Period 2|Lost to Follow-up|1
1564820|NCT03286218|5398955|P1|Qualification Phase Period 2|Lost to Follow-up|0
1564821|NCT03286218|5398944|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564822|NCT03286218|5398945|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564823|NCT03286218|5398946|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564824|NCT03286218|5398947|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564825|NCT03286218|5398948|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564826|NCT03286218|5398949|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564827|NCT03286218|5398950|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564828|NCT03286218|5398951|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564829|NCT03286218|5398952|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564830|NCT03286218|5398953|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
1564831|NCT03286218|5398954|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
1564832|NCT03286218|5398955|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
1564833|NCT03286218|5398944|P12|Qualification Phase Period 2|Adverse Event|0
1564834|NCT03286218|5398945|P11|Qualification Phase Period 2|Adverse Event|0
1564835|NCT03286218|5398946|P10|Qualification Phase Period 2|Adverse Event|0
1564836|NCT03286218|5398947|P9|Qualification Phase Period 2|Adverse Event|0
1564837|NCT03286218|5398948|P8|Qualification Phase Period 2|Adverse Event|0
1564838|NCT03286218|5398949|P7|Qualification Phase Period 2|Adverse Event|0
1564839|NCT03286218|5398950|P6|Qualification Phase Period 2|Adverse Event|0
1564840|NCT03286218|5398951|P5|Qualification Phase Period 2|Adverse Event|0
1564841|NCT03286218|5398952|P4|Qualification Phase Period 2|Adverse Event|0
1564842|NCT03286218|5398953|P3|Qualification Phase Period 2|Adverse Event|0
1564843|NCT03286218|5398954|P2|Qualification Phase Period 2|Adverse Event|1
1564844|NCT03286218|5398955|P1|Qualification Phase Period 2|Adverse Event|0
1564845|NCT03286218|5398944|P12|Qualification Phase Period 1|Withdrawal by Subject|0
1564846|NCT03286218|5398945|P11|Qualification Phase Period 1|Withdrawal by Subject|0
1564847|NCT03286218|5398946|P10|Qualification Phase Period 1|Withdrawal by Subject|0
1564848|NCT03286218|5398947|P9|Qualification Phase Period 1|Withdrawal by Subject|0
1564849|NCT03286218|5398948|P8|Qualification Phase Period 1|Withdrawal by Subject|0
1564850|NCT03286218|5398949|P7|Qualification Phase Period 1|Withdrawal by Subject|0
1564851|NCT03286218|5398950|P6|Qualification Phase Period 1|Withdrawal by Subject|0
1564852|NCT03286218|5398951|P5|Qualification Phase Period 1|Withdrawal by Subject|0
1564853|NCT03286218|5398952|P4|Qualification Phase Period 1|Withdrawal by Subject|0
1564854|NCT03286218|5398953|P3|Qualification Phase Period 1|Withdrawal by Subject|0
1564855|NCT03286218|5398954|P2|Qualification Phase Period 1|Withdrawal by Subject|1
1564856|NCT03286218|5398955|P1|Qualification Phase Period 1|Withdrawal by Subject|0
1564857|NCT03286218|5398944|P12|Qualification Phase Period 1|Adverse Event|0
1564858|NCT03286218|5398945|P11|Qualification Phase Period 1|Adverse Event|0
1564859|NCT03286218|5398946|P10|Qualification Phase Period 1|Adverse Event|0
1564860|NCT03286218|5398947|P9|Qualification Phase Period 1|Adverse Event|0
1564861|NCT03286218|5398948|P8|Qualification Phase Period 1|Adverse Event|0
1564862|NCT03286218|5398949|P7|Qualification Phase Period 1|Adverse Event|0
1564863|NCT03286218|5398950|P6|Qualification Phase Period 1|Adverse Event|0
1564864|NCT03286218|5398951|P5|Qualification Phase Period 1|Adverse Event|0
1564865|NCT03286218|5398952|P4|Qualification Phase Period 1|Adverse Event|0
1564866|NCT03286218|5398953|P3|Qualification Phase Period 1|Adverse Event|0
1564867|NCT03286218|5398954|P2|Qualification Phase Period 1|Adverse Event|0
1564868|NCT03286218|5398955|P1|Qualification Phase Period 1|Adverse Event|1
1564869|NCT03285295|5399069|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1564870|NCT03285295|5399070|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1564871|NCT03285295|5399071|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1564872|NCT03285295|5399072|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1564873|NCT03285295|5399073|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
1564874|NCT03285295|5399069|P5|Alinity s Chagas|No Results Generated|0
1564875|NCT03285295|5399070|P4|Alinity s Chagas|No Results Generated|0
1564876|NCT03285295|5399071|P3|Alinity s Chagas|No Results Generated|0
1564877|NCT03285295|5399072|P2|Alinity s Chagas|No Results Generated|0
1564878|NCT03285295|5399073|P1|Alinity s Chagas|No Results Generated|105
1564879|NCT03285295|5399069|P5|Alinity s Chagas|No Results on Comparator Assay|0
1564880|NCT03285295|5399070|P4|Alinity s Chagas|No Results on Comparator Assay|0
1564881|NCT03285295|5399071|P3|Alinity s Chagas|No Results on Comparator Assay|0
1564882|NCT03285295|5399072|P2|Alinity s Chagas|No Results on Comparator Assay|0
1564883|NCT03285295|5399073|P1|Alinity s Chagas|No Results on Comparator Assay|38
1564884|NCT03285295|5399069|P5|Alinity s Chagas|Protocol Violation|0
1564885|NCT03285295|5399070|P4|Alinity s Chagas|Protocol Violation|0
1564886|NCT03285295|5399071|P3|Alinity s Chagas|Protocol Violation|0
1564887|NCT03285295|5399072|P2|Alinity s Chagas|Protocol Violation|0
1564888|NCT03285295|5399073|P1|Alinity s Chagas|Protocol Violation|76
1564889|NCT03285295|5399069|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1564890|NCT03285295|5399070|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1564891|NCT03285295|5399071|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1564892|NCT03285295|5399072|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1564893|NCT03285295|5399073|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
1564894|NCT03285295|5399069|P5|Alinity s Anti-HBc|No Results Generated|0
1564895|NCT03285295|5399070|P4|Alinity s Anti-HBc|No Results Generated|0
1564896|NCT03285295|5399071|P3|Alinity s Anti-HBc|No Results Generated|0
1564897|NCT03285295|5399072|P2|Alinity s Anti-HBc|No Results Generated|0
1564898|NCT03285295|5399073|P1|Alinity s Anti-HBc|No Results Generated|70
1564899|NCT03285295|5399069|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
1564900|NCT03285295|5399070|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
1564901|NCT03285295|5399071|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
1564902|NCT03285295|5399072|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
1564903|NCT03285295|5399073|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
1564904|NCT03285295|5399069|P5|Alinity s Anti-HBc|Protocol Violation|0
1564905|NCT03285295|5399070|P4|Alinity s Anti-HBc|Protocol Violation|0
1564906|NCT03285295|5399071|P3|Alinity s Anti-HBc|Protocol Violation|0
1564907|NCT03285295|5399072|P2|Alinity s Anti-HBc|Protocol Violation|0
1564908|NCT03285295|5399073|P1|Alinity s Anti-HBc|Protocol Violation|8
1564909|NCT03285295|5399069|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1564910|NCT03285295|5399070|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1564911|NCT03285295|5399071|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1564912|NCT03285295|5399072|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1564913|NCT03285295|5399073|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
1564914|NCT03285295|5399069|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1564915|NCT03285295|5399070|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1564916|NCT03285295|5399071|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1564917|NCT03285295|5399072|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1564918|NCT03285295|5399073|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
1564919|NCT03285295|5399069|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1564920|NCT03285295|5399070|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1564921|NCT03285295|5399071|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1564922|NCT03285295|5399072|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1564923|NCT03285295|5399073|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
1564924|NCT03285295|5399069|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1564925|NCT03285295|5399070|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1564926|NCT03285295|5399071|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1564927|NCT03285295|5399072|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1564928|NCT03285295|5399073|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
1564929|NCT03285295|5399069|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1564930|NCT03285295|5399070|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1564931|NCT03285295|5399071|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1564932|NCT03285295|5399072|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1564933|NCT03285295|5399073|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
1564934|NCT03285295|5399069|P5|Alinity s Anti-HCV|No Results Generated|0
1564935|NCT03285295|5399070|P4|Alinity s Anti-HCV|No Results Generated|0
1564936|NCT03285295|5399071|P3|Alinity s Anti-HCV|No Results Generated|0
1564937|NCT03285295|5399072|P2|Alinity s Anti-HCV|No Results Generated|0
1564938|NCT03285295|5399073|P1|Alinity s Anti-HCV|No Results Generated|71
1564939|NCT03285295|5399069|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
1564940|NCT03285295|5399070|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
1564941|NCT03285295|5399071|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
1564942|NCT03285295|5399072|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
1564943|NCT03285295|5399073|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
1564944|NCT03285295|5399069|P5|Alinity s Anti-HCV|Protocol Violation|0
1564945|NCT03285295|5399070|P4|Alinity s Anti-HCV|Protocol Violation|0
1564946|NCT03285295|5399071|P3|Alinity s Anti-HCV|Protocol Violation|0
1564947|NCT03285295|5399072|P2|Alinity s Anti-HCV|Protocol Violation|0
1564948|NCT03285295|5399073|P1|Alinity s Anti-HCV|Protocol Violation|12
1564949|NCT03285295|5399069|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1564950|NCT03285295|5399070|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1564951|NCT03285295|5399071|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1564952|NCT03285295|5399072|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1564953|NCT03285295|5399073|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
1564954|NCT03285295|5399069|P5|Alinity s HTLV I/II|No Results Generated|0
1564955|NCT03285295|5399070|P4|Alinity s HTLV I/II|No Results Generated|0
1564956|NCT03285295|5399071|P3|Alinity s HTLV I/II|No Results Generated|0
1564957|NCT03285295|5399072|P2|Alinity s HTLV I/II|No Results Generated|0
1564958|NCT03285295|5399073|P1|Alinity s HTLV I/II|No Results Generated|70
1564959|NCT03285295|5399069|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
1564960|NCT03285295|5399070|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
1564961|NCT03285295|5399071|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
1564962|NCT03285295|5399072|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
1564963|NCT03285295|5399073|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
1564964|NCT03285295|5399069|P5|Alinity s HTLV I/II|Protocol Violation|0
1564965|NCT03285295|5399070|P4|Alinity s HTLV I/II|Protocol Violation|0
1564966|NCT03285295|5399071|P3|Alinity s HTLV I/II|Protocol Violation|0
1564967|NCT03285295|5399072|P2|Alinity s HTLV I/II|Protocol Violation|0
1564968|NCT03285295|5399073|P1|Alinity s HTLV I/II|Protocol Violation|6
1564969|NCT03285295|5399069|P5|Alinity s HBsAg|No Results Generated|0
1564970|NCT03285295|5399070|P4|Alinity s HBsAg|No Results Generated|0
1564971|NCT03285295|5399071|P3|Alinity s HBsAg|No Results Generated|0
1564972|NCT03285295|5399072|P2|Alinity s HBsAg|No Results Generated|6
1564973|NCT03285295|5399073|P1|Alinity s HBsAg|No Results Generated|74
1564974|NCT03285295|5399069|P5|Alinity s HBsAg|No Result on Comparator Assay|0
1564975|NCT03285295|5399070|P4|Alinity s HBsAg|No Result on Comparator Assay|0
1564976|NCT03285295|5399071|P3|Alinity s HBsAg|No Result on Comparator Assay|0
1564977|NCT03285295|5399072|P2|Alinity s HBsAg|No Result on Comparator Assay|0
1564978|NCT03285295|5399073|P1|Alinity s HBsAg|No Result on Comparator Assay|17
1564979|NCT03285295|5399069|P5|Alinity s HBsAg|Protocol Violation|0
1564980|NCT03285295|5399070|P4|Alinity s HBsAg|Protocol Violation|0
1564981|NCT03285295|5399071|P3|Alinity s HBsAg|Protocol Violation|0
1564982|NCT03285295|5399072|P2|Alinity s HBsAg|Protocol Violation|0
1564983|NCT03285295|5399073|P1|Alinity s HBsAg|Protocol Violation|11
1564984|NCT03283319|5399108|P6|Overall Study|BARDA regulatory agency or IRB decision|0
1564985|NCT03283319|5399109|P5|Overall Study|BARDA regulatory agency or IRB decision|0
1564986|NCT03283319|5399110|P4|Overall Study|BARDA regulatory agency or IRB decision|1
1564987|NCT03283319|5399111|P3|Overall Study|BARDA regulatory agency or IRB decision|0
1564988|NCT03283319|5399112|P2|Overall Study|BARDA regulatory agency or IRB decision|0
1564989|NCT03283319|5399113|P1|Overall Study|BARDA regulatory agency or IRB decision|0
1564990|NCT03283319|5399108|P6|Overall Study|Withdrawal by Subject|1
1564991|NCT03283319|5399109|P5|Overall Study|Withdrawal by Subject|0
1564992|NCT03283319|5399110|P4|Overall Study|Withdrawal by Subject|1
1564993|NCT03283319|5399111|P3|Overall Study|Withdrawal by Subject|2
1564994|NCT03283319|5399112|P2|Overall Study|Withdrawal by Subject|2
1564995|NCT03283319|5399113|P1|Overall Study|Withdrawal by Subject|2
1564996|NCT03283319|5399108|P6|Overall Study|Lost to Follow-up|3
1564997|NCT03283319|5399109|P5|Overall Study|Lost to Follow-up|4
1564998|NCT03283319|5399110|P4|Overall Study|Lost to Follow-up|5
1564999|NCT03283319|5399111|P3|Overall Study|Lost to Follow-up|5
1565000|NCT03283319|5399112|P2|Overall Study|Lost to Follow-up|4
1565001|NCT03283319|5399113|P1|Overall Study|Lost to Follow-up|5
1565002|NCT03283098|5399255|P2|Overall Study|Withdrawal by Subject|1
1565003|NCT03283098|5399256|P1|Overall Study|Withdrawal by Subject|0
1565004|NCT03282240|5399312|P3|Overall Study|Withdrawal by Subject|1
1565005|NCT03282240|5399313|P2|Overall Study|Withdrawal by Subject|0
1565006|NCT03282240|5399314|P1|Overall Study|Withdrawal by Subject|1
1565007|NCT03282240|5399312|P3|Overall Study|Protocol Deviation|2
1565008|NCT03282240|5399313|P2|Overall Study|Protocol Deviation|1
1565009|NCT03282240|5399314|P1|Overall Study|Protocol Deviation|4
1565010|NCT03282240|5399312|P3|Overall Study|Lost to Follow-up|0
1565011|NCT03282240|5399313|P2|Overall Study|Lost to Follow-up|0
1565012|NCT03282240|5399314|P1|Overall Study|Lost to Follow-up|3
1565013|NCT03282240|5399312|P3|Overall Study|Adverse Event|0
1565014|NCT03282240|5399313|P2|Overall Study|Adverse Event|2
1565015|NCT03282240|5399314|P1|Overall Study|Adverse Event|2
1565016|NCT03281668|5399366|P1|Overall Study|Lost to Follow-up|1
1565017|NCT03281668|5399366|P1|Overall Study|Withdrawal by Subject|4
1565018|NCT03281668|5399366|P1|Overall Study|scheduling conflict, family circumstance|2
1565019|NCT03281668|5399366|P1|Overall Study|Physician Decision|1
1565020|NCT03280615|5399414|P2|Overall Study|Withdrawal by Subject|2
1565021|NCT03280615|5399415|P1|Overall Study|Withdrawal by Subject|2
1565022|NCT03280615|5399414|P2|Overall Study|Adverse Event|1
1565023|NCT03280615|5399415|P1|Overall Study|Adverse Event|1
1565024|NCT03280615|5399414|P2|Overall Study|Lost to Follow-up|2
1565025|NCT03280615|5399415|P1|Overall Study|Lost to Follow-up|1
1565026|NCT03280381|5399427|P2|Overall Study|Physician Decision|2
1565027|NCT03280381|5399428|P1|Overall Study|Physician Decision|0
1565028|NCT03280108|5399438|P2|Overall Study|Lost to Follow-up|0
1565029|NCT03280108|5399439|P1|Overall Study|Lost to Follow-up|2
1565030|NCT03278106|5399476|P1|Overall Study|No protocol treatment|1
1565031|NCT03278028|5399892|P2|Overall Study|Pregnancy|1
1565032|NCT03278028|5399893|P1|Overall Study|Pregnancy|0
1565033|NCT03278028|5399892|P2|Overall Study|Withdrawal by Subject|1
1565034|NCT03278028|5399893|P1|Overall Study|Withdrawal by Subject|3
1565035|NCT03278028|5399892|P2|Overall Study|Lost to Follow-up|0
1565036|NCT03278028|5399893|P1|Overall Study|Lost to Follow-up|1
1565037|NCT03277846|5399901|P2|Overall Study|Inpatient stay too brief|11
1565038|NCT03277846|5399902|P1|Overall Study|Inpatient stay too brief|12
1565039|NCT03276078|5399947|P1|Overall Study|Adverse Event|1
1565040|NCT03276026|5399976|P2|Overall Study|Protocol Violation|0
1565041|NCT03276026|5399977|P1|Overall Study|Protocol Violation|1
1565042|NCT03274453|5400006|P4|Overall Study|Surgery Cancelled|0
1565043|NCT03274453|5400007|P3|Overall Study|Surgery Cancelled|0
1565044|NCT03274453|5400008|P2|Overall Study|Surgery Cancelled|1
1565045|NCT03274453|5400009|P1|Overall Study|Surgery Cancelled|0
1565046|NCT03274453|5400006|P4|Overall Study|Physician Decision|3
1565047|NCT03274453|5400007|P3|Overall Study|Physician Decision|0
1565048|NCT03274453|5400008|P2|Overall Study|Physician Decision|0
1565049|NCT03274453|5400009|P1|Overall Study|Physician Decision|2
1565050|NCT03274453|5400006|P4|Overall Study|Lost to Follow-up|1
1565051|NCT03274453|5400007|P3|Overall Study|Lost to Follow-up|4
1565052|NCT03274453|5400008|P2|Overall Study|Lost to Follow-up|5
1565053|NCT03274453|5400009|P1|Overall Study|Lost to Follow-up|2
1565054|NCT03273946|5400019|P1|Overall Study|Participant relative refused to use drug|1
1565055|NCT03273946|5400019|P1|Overall Study|Participant refused to use the drug|2
1565056|NCT03273946|5400019|P1|Overall Study|Unwillingness of the guardian|1
1565057|NCT03273946|5400019|P1|Overall Study|Withdrawal by Subject|5
1565058|NCT03273387|5400027|P2|Overall Study|Withdrawal by Subject|1
1565059|NCT03273387|5400028|P1|Overall Study|Withdrawal by Subject|1
1565060|NCT03273387|5400027|P2|Overall Study|Death|2
1565061|NCT03273387|5400028|P1|Overall Study|Death|2
1565074|NCT03270644|5400077|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
1565075|NCT03270644|5400077|P1|Day 1 Lasmiditan Reference|Physician Decision|1
1565076|NCT03269552|5400098|P1|Overall Study|Adverse Event|2
1565077|NCT03268941|5400109|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
1565078|NCT03268941|5400110|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
1565079|NCT03268941|5400111|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
1565080|NCT03268941|5400112|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
1565081|NCT03268941|5400113|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
1565082|NCT03268941|5400114|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
1565083|NCT03268941|5400115|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
1565084|NCT03268941|5400109|P7|Part 2: Days 17 to 25|Reason not specified|1
1565085|NCT03268941|5400110|P6|Part 2: Days 17 to 25|Reason not specified|0
1565086|NCT03268941|5400111|P5|Part 2: Days 17 to 25|Reason not specified|0
1565087|NCT03268941|5400112|P4|Part 2: Days 17 to 25|Reason not specified|0
1565088|NCT03268941|5400113|P3|Part 2: Days 17 to 25|Reason not specified|0
1565089|NCT03268941|5400114|P2|Part 2: Days 17 to 25|Reason not specified|0
1565090|NCT03268941|5400115|P1|Part 2: Days 17 to 25|Reason not specified|0
1565091|NCT03268941|5400109|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
1565092|NCT03268941|5400110|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
1565093|NCT03268941|5400111|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
1565094|NCT03268941|5400112|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
1565095|NCT03268941|5400113|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
1565096|NCT03268941|5400114|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
1565097|NCT03268941|5400115|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
1565098|NCT03268941|5400109|P7|Part 1 (Days 1 to 9)|Adverse Event|0
1565099|NCT03268941|5400110|P6|Part 1 (Days 1 to 9)|Adverse Event|0
1565100|NCT03268941|5400111|P5|Part 1 (Days 1 to 9)|Adverse Event|0
1565101|NCT03268941|5400112|P4|Part 1 (Days 1 to 9)|Adverse Event|1
1565102|NCT03268941|5400113|P3|Part 1 (Days 1 to 9)|Adverse Event|0
1565103|NCT03268941|5400114|P2|Part 1 (Days 1 to 9)|Adverse Event|0
1565104|NCT03268941|5400115|P1|Part 1 (Days 1 to 9)|Adverse Event|0
1565105|NCT03268941|5400109|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1565106|NCT03268941|5400110|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1565107|NCT03268941|5400111|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1565108|NCT03268941|5400112|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
1565109|NCT03268941|5400113|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1565110|NCT03268941|5400114|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1565111|NCT03268941|5400115|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1565112|NCT03268746|5400177|P1|Overall Study|Withdrawal by Subject|1
1565113|NCT03268590|5400199|P1|Overall Study|Previously unknown exclusion criteria|1
1565114|NCT03267940|5400238|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
1565115|NCT03267940|5400239|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
1565116|NCT03267940|5400240|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
1565117|NCT03267940|5400241|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
1565118|NCT03267940|5400242|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
1565119|NCT03267940|5400243|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
1565120|NCT03267940|5400238|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
1565121|NCT03267940|5400239|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
1565122|NCT03267940|5400240|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
1565123|NCT03267940|5400241|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
1565124|NCT03267940|5400242|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
1565125|NCT03267940|5400243|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
1565126|NCT03267940|5400238|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
1565127|NCT03267940|5400239|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
1565128|NCT03267940|5400240|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
1565129|NCT03267940|5400241|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
1565130|NCT03267940|5400242|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
1565131|NCT03267940|5400243|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
1565132|NCT03267940|5400238|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
1565133|NCT03267940|5400239|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
1565134|NCT03267940|5400240|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
1565135|NCT03267940|5400241|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
1565136|NCT03267940|5400242|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
1565137|NCT03267940|5400243|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
1565138|NCT03267940|5400238|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1565139|NCT03267940|5400239|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
1565140|NCT03267940|5400240|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
1565141|NCT03267940|5400241|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1565142|NCT03267940|5400242|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1565143|NCT03267940|5400243|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
1565144|NCT03267940|5400238|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1565145|NCT03267940|5400239|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1565146|NCT03267940|5400240|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1565147|NCT03267940|5400241|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
1565148|NCT03267940|5400242|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
1565149|NCT03267940|5400243|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
1565150|NCT03267940|5400238|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1565151|NCT03267940|5400239|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1565152|NCT03267940|5400240|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1565153|NCT03267940|5400241|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1565154|NCT03267940|5400242|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
1565155|NCT03267940|5400243|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
1565156|NCT03267940|5400238|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1565157|NCT03267940|5400239|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1565158|NCT03267940|5400240|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1565159|NCT03267940|5400241|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1565160|NCT03267940|5400242|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
1565161|NCT03267940|5400243|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
1565162|NCT03267940|5400238|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1565163|NCT03267940|5400239|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1565164|NCT03267940|5400240|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1565165|NCT03267940|5400241|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
1565166|NCT03267940|5400242|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
1565167|NCT03267940|5400243|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
1565168|NCT03267576|5400345|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
1565169|NCT03267576|5400346|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
1565170|NCT03267576|5400345|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
1565171|NCT03267576|5400346|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
1565172|NCT03267511|5400384|P4|Overall Study|Lost to Follow-up|1
1565173|NCT03267511|5400385|P3|Overall Study|Lost to Follow-up|0
1565174|NCT03267511|5400386|P2|Overall Study|Lost to Follow-up|0
1565175|NCT03267511|5400387|P1|Overall Study|Lost to Follow-up|0
1565176|NCT03267264|5400403|P4|Overall Study|Withdrawal by Subject|4
1565177|NCT03267264|5400404|P3|Overall Study|Withdrawal by Subject|2
1565178|NCT03267264|5400405|P2|Overall Study|Withdrawal by Subject|0
1565179|NCT03267264|5400406|P1|Overall Study|Withdrawal by Subject|1
1565180|NCT03266172|5400437|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
1565181|NCT03266172|5400438|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1565182|NCT03266172|5400439|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1565183|NCT03266172|5400437|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
1565184|NCT03266172|5400438|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1565185|NCT03266172|5400439|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
1565186|NCT03266172|5400437|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
1565187|NCT03266172|5400438|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
1565188|NCT03266172|5400439|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
1565189|NCT03266172|5400437|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
1565190|NCT03266172|5400438|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
1565191|NCT03266172|5400439|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
1565192|NCT03266172|5400437|P3|Part A: Washout Period (7 Days)|Adverse Event|0
1565193|NCT03266172|5400438|P2|Part A: Washout Period (7 Days)|Adverse Event|0
1565194|NCT03266172|5400439|P1|Part A: Washout Period (7 Days)|Adverse Event|1
1565195|NCT03266172|5400437|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
1565196|NCT03266172|5400438|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
1565197|NCT03266172|5400439|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
1565198|NCT03265600|5400686|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
1565199|NCT03265600|5400687|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
1565200|NCT03265600|5400686|P2|Overall Study|Withdrawal by Subject|2
1565201|NCT03265600|5400687|P1|Overall Study|Withdrawal by Subject|4
1565202|NCT03265600|5400686|P2|Overall Study|Lost to Follow-up|5
1565203|NCT03265600|5400687|P1|Overall Study|Lost to Follow-up|17
1565204|NCT03265119|5400713|P2|Overall Study|Lack of Compliance|0
1565205|NCT03265119|5400714|P1|Overall Study|Lack of Compliance|1
1565206|NCT03265119|5400713|P2|Overall Study|Lost to Follow-up|0
1565207|NCT03265119|5400714|P1|Overall Study|Lost to Follow-up|1
1565208|NCT03265119|5400713|P2|Overall Study|Withdrawal by Subject|4
1565209|NCT03265119|5400714|P1|Overall Study|Withdrawal by Subject|2
1565210|NCT03265119|5400713|P2|Overall Study|Protocol Violation|2
1565211|NCT03265119|5400714|P1|Overall Study|Protocol Violation|1
1565212|NCT03265119|5400713|P2|Overall Study|Lack of Efficacy|0
1565213|NCT03265119|5400714|P1|Overall Study|Lack of Efficacy|3
1565214|NCT03265119|5400713|P2|Overall Study|Adverse Event|1
1565215|NCT03265119|5400714|P1|Overall Study|Adverse Event|2
1565216|NCT03264456|5400722|P1|Overall Study|Lost to Follow-up|1
1565217|NCT03264456|5400722|P1|Overall Study|Withdrawal by Subject|3
1565218|NCT03263806|5400757|P2|Overall Study|Study Termination|6
1565219|NCT03263806|5400758|P1|Overall Study|Study Termination|5
1565220|NCT03263806|5400757|P2|Overall Study|Withdrawal by Subject|1
1565221|NCT03263806|5400758|P1|Overall Study|Withdrawal by Subject|0
1565222|NCT03263806|5400757|P2|Overall Study|Elevated Troponin (failed screen)|0
1565223|NCT03263806|5400758|P1|Overall Study|Elevated Troponin (failed screen)|1
1565224|NCT03262233|5400774|P4|Overall Study|data collection artifact|0
1565225|NCT03262233|5400775|P3|Overall Study|data collection artifact|0
1565226|NCT03262233|5400776|P2|Overall Study|data collection artifact|1
1565227|NCT03262233|5400777|P1|Overall Study|data collection artifact|0
1565228|NCT03262233|5400774|P4|Overall Study|Protocol Violation|13
1565229|NCT03262233|5400775|P3|Overall Study|Protocol Violation|2
1565230|NCT03262233|5400776|P2|Overall Study|Protocol Violation|10
1565231|NCT03262233|5400777|P1|Overall Study|Protocol Violation|5
1565232|NCT03262233|5400774|P4|Overall Study|Declined due to shock|3
1565233|NCT03262233|5400775|P3|Overall Study|Declined due to shock|2
1565234|NCT03262233|5400776|P2|Overall Study|Declined due to shock|2
1565235|NCT03262233|5400777|P1|Overall Study|Declined due to shock|1
1565236|NCT03262233|5400774|P4|Overall Study|Withdrawal by Subject|13
1565237|NCT03262233|5400775|P3|Overall Study|Withdrawal by Subject|21
1565238|NCT03262233|5400776|P2|Overall Study|Withdrawal by Subject|8
1565239|NCT03262233|5400777|P1|Overall Study|Withdrawal by Subject|12
1565240|NCT03261531|5400799|P1|Overall Study|Withdrawal by Subject|4
1565241|NCT03261167|5400817|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
1565242|NCT03261167|5400818|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
1565243|NCT03261167|5400817|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
1565244|NCT03261167|5400818|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
1565245|NCT03261167|5400817|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
1565246|NCT03261167|5400818|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
1565247|NCT03261167|5400817|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
1565248|NCT03261167|5400818|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
1565249|NCT03261167|5400817|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
1565250|NCT03261167|5400818|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
1565251|NCT03260894|5400856|P2|Overall Study|On-going at clinical cut off date|31
1565252|NCT03260894|5400857|P1|Overall Study|On-going at clinical cut off date|36
1565253|NCT03260894|5400856|P2|Overall Study|Withdrawal by Subject|11
1565254|NCT03260894|5400857|P1|Overall Study|Withdrawal by Subject|4
1565255|NCT03260894|5400856|P2|Overall Study|Death|8
1565256|NCT03260894|5400857|P1|Overall Study|Death|6
1565257|NCT03260868|5400869|P2|Overall Study|Other than specified above|0
1565258|NCT03260868|5400870|P1|Overall Study|Other than specified above|1
1565259|NCT03260868|5400869|P2|Overall Study|Study Terminated By Sponsor|1
1565260|NCT03260868|5400870|P1|Overall Study|Study Terminated By Sponsor|2
1565261|NCT03260868|5400869|P2|Overall Study|Poor Compliance to Protocol|2
1565262|NCT03260868|5400870|P1|Overall Study|Poor Compliance to Protocol|0
1565263|NCT03260205|5400992|P5|Overall Study|Participant Who Did Not Received AnyDose|1
1565264|NCT03260205|5400993|P4|Overall Study|Participant Who Did Not Received AnyDose|3
1565265|NCT03260205|5400994|P3|Overall Study|Participant Who Did Not Received AnyDose|2
1565266|NCT03260205|5400995|P2|Overall Study|Participant Who Did Not Received AnyDose|1
1565267|NCT03260205|5400996|P1|Overall Study|Participant Who Did Not Received AnyDose|1
1565268|NCT03260205|5400992|P5|Overall Study|Other: Unspecified|1
1565269|NCT03260205|5400993|P4|Overall Study|Other: Unspecified|1
1565270|NCT03260205|5400994|P3|Overall Study|Other: Unspecified|3
1565271|NCT03260205|5400995|P2|Overall Study|Other: Unspecified|0
1565272|NCT03260205|5400996|P1|Overall Study|Other: Unspecified|0
1565273|NCT03260205|5400992|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
1565274|NCT03260205|5400993|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
1565275|NCT03260205|5400994|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
1565276|NCT03260205|5400995|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
1565277|NCT03260205|5400996|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
1565278|NCT03260205|5400992|P5|Overall Study|Protocol Violation|1
1565279|NCT03260205|5400993|P4|Overall Study|Protocol Violation|0
1565280|NCT03260205|5400994|P3|Overall Study|Protocol Violation|2
1565281|NCT03260205|5400995|P2|Overall Study|Protocol Violation|0
1565282|NCT03260205|5400996|P1|Overall Study|Protocol Violation|0
1565283|NCT03260205|5400992|P5|Overall Study|Lost to Follow-up|5
1565284|NCT03260205|5400993|P4|Overall Study|Lost to Follow-up|1
1565285|NCT03260205|5400994|P3|Overall Study|Lost to Follow-up|1
1565286|NCT03260205|5400995|P2|Overall Study|Lost to Follow-up|2
1565287|NCT03260205|5400996|P1|Overall Study|Lost to Follow-up|2
1565288|NCT03260205|5400992|P5|Overall Study|Adverse Event|4
1565289|NCT03260205|5400993|P4|Overall Study|Adverse Event|2
1565290|NCT03260205|5400994|P3|Overall Study|Adverse Event|2
1565291|NCT03260205|5400995|P2|Overall Study|Adverse Event|0
1565292|NCT03260205|5400996|P1|Overall Study|Adverse Event|2
1565293|NCT03259555|5401059|P2|Overall Study|Other|0
1565294|NCT03259555|5401060|P1|Overall Study|Other|1
1565295|NCT03259555|5401059|P2|Overall Study|Physician Decision|2
1565296|NCT03259555|5401060|P1|Overall Study|Physician Decision|1
1565297|NCT03259555|5401059|P2|Overall Study|Withdrawal by Subject|16
1565298|NCT03259555|5401060|P1|Overall Study|Withdrawal by Subject|19
1565299|NCT03259555|5401059|P2|Overall Study|Progressive Disease|2
1565300|NCT03259555|5401060|P1|Overall Study|Progressive Disease|0
1565301|NCT03259555|5401059|P2|Overall Study|Non-Compliance With Study Drug|0
1565302|NCT03259555|5401060|P1|Overall Study|Non-Compliance With Study Drug|1
1565303|NCT03259555|5401059|P2|Overall Study|Lost to Follow-up|2
1565304|NCT03259555|5401060|P1|Overall Study|Lost to Follow-up|0
1565305|NCT03259555|5401059|P2|Overall Study|Lack of Efficacy|4
1565306|NCT03259555|5401060|P1|Overall Study|Lack of Efficacy|6
1565307|NCT03259555|5401059|P2|Overall Study|Adverse Event|4
1565308|NCT03259555|5401060|P1|Overall Study|Adverse Event|6
1565313|NCT03259087|5401102|P5|Period 2 of Part 2|Adverse Event|1
1565314|NCT03259087|5401103|P4|Period 2 of Part 2|Adverse Event|0
1565315|NCT03259087|5401104|P3|Period 2 of Part 2|Adverse Event|0
1565316|NCT03259087|5401105|P2|Period 2 of Part 2|Adverse Event|0
1565317|NCT03259087|5401106|P1|Period 2 of Part 2|Adverse Event|0
1565318|NCT03259087|5401102|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
1565319|NCT03259087|5401103|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
1565320|NCT03259087|5401104|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
1565321|NCT03259087|5401105|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
1565322|NCT03259087|5401106|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
1565323|NCT03258814|5401234|P3|Overall Study|Early Termination|10
1565324|NCT03258814|5401235|P2|Overall Study|Early Termination|3
1565325|NCT03258814|5401236|P1|Overall Study|Early Termination|4
1565326|NCT03258762|5401291|P2|Overall Study|Lost to Follow-up|1
1565327|NCT03258762|5401292|P1|Overall Study|Lost to Follow-up|0
1565328|NCT03258710|5401352|P1|Overall Study|Protocol-defined stopping criteria|1
1565329|NCT03258710|5401352|P1|Overall Study|Adverse Event|1
1565330|NCT03257995|5401390|P6|Overall Study|Protocol deviation|2
1565331|NCT03257995|5401391|P5|Overall Study|Protocol deviation|0
1565332|NCT03257995|5401392|P4|Overall Study|Protocol deviation|0
1565333|NCT03257995|5401393|P3|Overall Study|Protocol deviation|0
1565334|NCT03257995|5401394|P2|Overall Study|Protocol deviation|0
1565335|NCT03257995|5401395|P1|Overall Study|Protocol deviation|0
1565336|NCT03257995|5401390|P6|Overall Study|Adverse Event|0
1565337|NCT03257995|5401391|P5|Overall Study|Adverse Event|0
1565338|NCT03257995|5401392|P4|Overall Study|Adverse Event|0
1565339|NCT03257995|5401393|P3|Overall Study|Adverse Event|0
1565340|NCT03257995|5401394|P2|Overall Study|Adverse Event|1
1565341|NCT03257995|5401395|P1|Overall Study|Adverse Event|0
1565342|NCT03257865|5401445|P2|Overall Study|Lost to Follow-up|4
1565343|NCT03257865|5401446|P1|Overall Study|Lost to Follow-up|4
1565344|NCT03257865|5401445|P2|Overall Study|Other|1
1565345|NCT03257865|5401446|P1|Overall Study|Other|0
1565346|NCT03257865|5401445|P2|Overall Study|Physician Decision|1
1565347|NCT03257865|5401446|P1|Overall Study|Physician Decision|3
1565348|NCT03257865|5401445|P2|Overall Study|Withdrawal by Subject|17
1565349|NCT03257865|5401446|P1|Overall Study|Withdrawal by Subject|23
1565350|NCT03257865|5401445|P2|Overall Study|Non-compliance with Study Drug|2
1565351|NCT03257865|5401446|P1|Overall Study|Non-compliance with Study Drug|0
1565352|NCT03257865|5401445|P2|Overall Study|Lack of Efficacy|2
1565353|NCT03257865|5401446|P1|Overall Study|Lack of Efficacy|1
1565354|NCT03257865|5401445|P2|Overall Study|Adverse Event|8
1565355|NCT03257865|5401446|P1|Overall Study|Adverse Event|4
1565356|NCT03257813|5401456|P2|Overall Study|Protocol Violation|3
1565357|NCT03257813|5401457|P1|Overall Study|Protocol Violation|6
1565358|NCT03257631|5401481|P4|Overall Study|Still on Study|4
1565359|NCT03257631|5401482|P3|Overall Study|Still on Study|4
1565360|NCT03257631|5401483|P2|Overall Study|Still on Study|2
1565361|NCT03257631|5401484|P1|Overall Study|Still on Study|3
1565362|NCT03257631|5401481|P4|Overall Study|Lost to Follow-up|0
1565363|NCT03257631|5401482|P3|Overall Study|Lost to Follow-up|1
1565364|NCT03257631|5401483|P2|Overall Study|Lost to Follow-up|0
1565365|NCT03257631|5401484|P1|Overall Study|Lost to Follow-up|0
1565366|NCT03257631|5401481|P4|Overall Study|Withdrawal by Parent/Guardian|1
1565367|NCT03257631|5401482|P3|Overall Study|Withdrawal by Parent/Guardian|4
1565368|NCT03257631|5401483|P2|Overall Study|Withdrawal by Parent/Guardian|2
1565369|NCT03257631|5401484|P1|Overall Study|Withdrawal by Parent/Guardian|0
1565370|NCT03257631|5401481|P4|Overall Study|Progressive Disease|0
1565371|NCT03257631|5401482|P3|Overall Study|Progressive Disease|1
1565372|NCT03257631|5401483|P2|Overall Study|Progressive Disease|0
1565373|NCT03257631|5401484|P1|Overall Study|Progressive Disease|0
1565374|NCT03257631|5401481|P4|Overall Study|Death|5
1565375|NCT03257631|5401482|P3|Overall Study|Death|13
1565376|NCT03257631|5401483|P2|Overall Study|Death|5
1565377|NCT03257631|5401484|P1|Overall Study|Death|8
1565378|NCT03256851|5401542|P2|Overall Study|Withdrawal by Subject|0
1565379|NCT03256851|5401543|P1|Overall Study|Withdrawal by Subject|1
1565380|NCT03256695|5401555|P1|Overall Study|Other than specified|3
1565381|NCT03256695|5401555|P1|Overall Study|Protocol Violation|5
1565382|NCT03256695|5401555|P1|Overall Study|Lack of Efficacy|3
1565383|NCT03256695|5401555|P1|Overall Study|Lost to Follow-up|3
1565384|NCT03256695|5401555|P1|Overall Study|Non-compliance with study drug|1
1565385|NCT03256695|5401555|P1|Overall Study|Withdrawal by Subject|14
1565386|NCT03256695|5401555|P1|Overall Study|Death|2
1565387|NCT03256695|5401555|P1|Overall Study|Adverse Event|8
1565388|NCT03256552|5401563|P1|Overall Study|Withdrawal by Subject|2
1565389|NCT03256552|5401563|P1|Overall Study|Adverse Event|1
1565390|NCT03256552|5401563|P1|Overall Study|Physician Decision|1
1565391|NCT03256552|5401563|P1|Overall Study|Protocol Violation|1
1565392|NCT03256526|5401588|P3|Overall Study|Lost to Follow-up|2
1565393|NCT03256526|5401589|P2|Overall Study|Lost to Follow-up|0
1565394|NCT03256526|5401590|P1|Overall Study|Lost to Follow-up|1
1565395|NCT03256526|5401588|P3|Overall Study|Adverse Event|1
1565396|NCT03256526|5401589|P2|Overall Study|Adverse Event|0
1565397|NCT03256526|5401590|P1|Overall Study|Adverse Event|1
1565398|NCT03255733|5401636|P1|Overall Study|Lost to Follow-up|4
1565399|NCT03255655|5401643|P2|Overall Study|Lost to Follow-up|4
1565400|NCT03255655|5401644|P1|Overall Study|Lost to Follow-up|7
1565401|NCT03255382|5401654|P2|Overall Study|Other|0
1565402|NCT03255382|5401655|P1|Overall Study|Other|6
1565403|NCT03255382|5401654|P2|Overall Study|Withdrawal by Subject|0
1565404|NCT03255382|5401655|P1|Overall Study|Withdrawal by Subject|2
1565405|NCT03255382|5401654|P2|Overall Study|Lost to Follow-up|0
1565406|NCT03255382|5401655|P1|Overall Study|Lost to Follow-up|2
1565407|NCT03255382|5401654|P2|Overall Study|Adverse Event|0
1565408|NCT03255382|5401655|P1|Overall Study|Adverse Event|3
1565409|NCT03255291|5401829|P6|Overall Study|Baseline data collection issues|0
1565410|NCT03255291|5401830|P5|Overall Study|Baseline data collection issues|2
1565411|NCT03255291|5401831|P4|Overall Study|Baseline data collection issues|0
1565412|NCT03255291|5401832|P3|Overall Study|Baseline data collection issues|0
1565413|NCT03255291|5401833|P2|Overall Study|Baseline data collection issues|0
1565414|NCT03255291|5401834|P1|Overall Study|Baseline data collection issues|3
1565415|NCT03255291|5401829|P6|Overall Study|Determined to be ineligible|10
1565416|NCT03255291|5401830|P5|Overall Study|Determined to be ineligible|5
1565417|NCT03255291|5401831|P4|Overall Study|Determined to be ineligible|6
1565418|NCT03255291|5401832|P3|Overall Study|Determined to be ineligible|6
1565419|NCT03255291|5401833|P2|Overall Study|Determined to be ineligible|12
1565420|NCT03255291|5401834|P1|Overall Study|Determined to be ineligible|10
1565421|NCT03255187|5401867|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
1565422|NCT03255187|5401868|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
1565423|NCT03255187|5401867|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
1565424|NCT03255187|5401868|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
1565425|NCT03254602|5401908|P1|Overall Study|Lost to Follow-up|4
1565426|NCT03254459|5401916|P2|Overall Study|Miscellaneous|1
1565427|NCT03254459|5401917|P1|Overall Study|Miscellaneous|0
1565428|NCT03254459|5401916|P2|Overall Study|Lost to Follow-up|1
1565429|NCT03254459|5401917|P1|Overall Study|Lost to Follow-up|0
1565430|NCT03254459|5401916|P2|Overall Study|Withdrawal by Subject Consent|1
1565431|NCT03254459|5401917|P1|Overall Study|Withdrawal by Subject Consent|3
1565432|NCT03254459|5401916|P2|Overall Study|Adverse Event|20
1565433|NCT03254459|5401917|P1|Overall Study|Adverse Event|7
1565434|NCT03254134|5401942|P2|Overall Study|Not eligible patients|3630
1565435|NCT03254134|5401943|P1|Overall Study|Not eligible patients|599
1565436|NCT03252015|5401969|P4|Overall Study|Adverse Event|1
1565437|NCT03252015|5401970|P3|Overall Study|Adverse Event|0
1565438|NCT03252015|5401971|P2|Overall Study|Adverse Event|0
1565439|NCT03252015|5401972|P1|Overall Study|Adverse Event|1
1565440|NCT03252015|5401969|P4|Overall Study|Withdrawal by Subject|0
1565441|NCT03252015|5401970|P3|Overall Study|Withdrawal by Subject|1
1565442|NCT03252015|5401971|P2|Overall Study|Withdrawal by Subject|1
1565443|NCT03252015|5401972|P1|Overall Study|Withdrawal by Subject|0
1565444|NCT03251482|5402013|P5|Overall Study|Withdrawal by Subject|0
1565445|NCT03251482|5402014|P4|Overall Study|Withdrawal by Subject|0
1565446|NCT03251482|5402015|P3|Overall Study|Withdrawal by Subject|0
1565447|NCT03251482|5402016|P2|Overall Study|Withdrawal by Subject|1
1565448|NCT03251482|5402017|P1|Overall Study|Withdrawal by Subject|0
1565449|NCT03249935|5402161|P1|Overall Study|Protocol Violation|5
1565450|NCT03249935|5402161|P1|Overall Study|Negative for chlamydia at enrollment|4
1565451|NCT03249935|5402161|P1|Overall Study|Discharged from facility early|36
1565452|NCT03249454|5402172|P11|Overall Study|Withdrawal by Subject|1
1565453|NCT03249454|5402173|P10|Overall Study|Withdrawal by Subject|1
1565454|NCT03249454|5402174|P9|Overall Study|Withdrawal by Subject|0
1565455|NCT03249454|5402175|P8|Overall Study|Withdrawal by Subject|0
1565456|NCT03249454|5402176|P7|Overall Study|Withdrawal by Subject|0
1565457|NCT03249454|5402177|P6|Overall Study|Withdrawal by Subject|0
1565458|NCT03249454|5402178|P5|Overall Study|Withdrawal by Subject|0
1565459|NCT03249454|5402179|P4|Overall Study|Withdrawal by Subject|0
1565460|NCT03249454|5402180|P3|Overall Study|Withdrawal by Subject|0
1565461|NCT03249454|5402181|P2|Overall Study|Withdrawal by Subject|0
1565462|NCT03249454|5402182|P1|Overall Study|Withdrawal by Subject|0
1565498|NCT03247673|5402303|P3|Overall Study|Lost to Follow-up|1
1565499|NCT03247673|5402304|P2|Overall Study|Lost to Follow-up|0
1565500|NCT03247673|5402305|P1|Overall Study|Lost to Follow-up|0
1565501|NCT03247673|5402303|P3|Overall Study|Withdrawal by Subject|3
1565502|NCT03247673|5402304|P2|Overall Study|Withdrawal by Subject|0
1565503|NCT03247673|5402305|P1|Overall Study|Withdrawal by Subject|1
1565504|NCT03246672|5402325|P1|Overall Study|Lost to Follow-up|2
1565505|NCT03246152|5402331|P1|Overall Study|Protocol Violation|1
1565506|NCT03246152|5402331|P1|Overall Study|Lost to Follow-up|2
1565507|NCT03245619|5402363|P17|Part A (Up to Day 22)|Physician Decision|0
1565508|NCT03245619|5402364|P16|Part A (Up to Day 22)|Physician Decision|0
1565509|NCT03245619|5402365|P15|Part A (Up to Day 22)|Physician Decision|0
1565510|NCT03245619|5402366|P14|Part A (Up to Day 22)|Physician Decision|0
1565511|NCT03245619|5402367|P13|Part A (Up to Day 22)|Physician Decision|0
1565512|NCT03245619|5402368|P12|Part A (Up to Day 22)|Physician Decision|0
1565513|NCT03245619|5402369|P11|Part A (Up to Day 22)|Physician Decision|0
1565514|NCT03245619|5402370|P10|Part A (Up to Day 22)|Physician Decision|0
1565515|NCT03245619|5402371|P9|Part A (Up to Day 22)|Physician Decision|0
1565516|NCT03245619|5402372|P8|Part A (Up to Day 22)|Physician Decision|0
1565517|NCT03245619|5402373|P7|Part A (Up to Day 22)|Physician Decision|0
1565518|NCT03245619|5402374|P6|Part A (Up to Day 22)|Physician Decision|0
1565519|NCT03245619|5402375|P5|Part A (Up to Day 22)|Physician Decision|0
1565520|NCT03245619|5402376|P4|Part A (Up to Day 22)|Physician Decision|0
1565521|NCT03245619|5402377|P3|Part A (Up to Day 22)|Physician Decision|6
1565522|NCT03245619|5402378|P2|Part A (Up to Day 22)|Physician Decision|6
1565523|NCT03245619|5402379|P1|Part A (Up to Day 22)|Physician Decision|4
1565524|NCT03245398|5402653|P2|Overall Study|Travelled to another island|0
1565525|NCT03245398|5402654|P1|Overall Study|Travelled to another island|1
1565526|NCT03244800|5402684|P4|Overall Study|Withdrew treatment|1
1565527|NCT03244800|5402685|P3|Overall Study|Withdrew treatment|0
1565528|NCT03244800|5402686|P2|Overall Study|Withdrew treatment|0
1565529|NCT03244800|5402687|P1|Overall Study|Withdrew treatment|0
1565530|NCT03244800|5402684|P4|Overall Study|Adverse Event|1
1565531|NCT03244800|5402685|P3|Overall Study|Adverse Event|0
1565532|NCT03244800|5402686|P2|Overall Study|Adverse Event|1
1565533|NCT03244800|5402687|P1|Overall Study|Adverse Event|0
1565534|NCT03243084|5402766|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
1565535|NCT03243084|5402767|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
1565536|NCT03242434|5402789|P2|Overall Study|Death|2
1565537|NCT03242434|5402790|P1|Overall Study|Death|0
1565538|NCT03239873|5402804|P2|Overall Study|Protocol Violation|0
1565539|NCT03239873|5402805|P1|Overall Study|Protocol Violation|1
1565540|NCT03239873|5402804|P2|Overall Study|Contraindication to study medication|0
1565541|NCT03239873|5402805|P1|Overall Study|Contraindication to study medication|1
1565542|NCT03239873|5402804|P2|Overall Study|Withdrawal by Subject|0
1565543|NCT03239873|5402805|P1|Overall Study|Withdrawal by Subject|2
1565544|NCT03239873|5402804|P2|Overall Study|Withdrawal by Parent/Guardian|11
1565545|NCT03239873|5402805|P1|Overall Study|Withdrawal by Parent/Guardian|12
1565546|NCT03239873|5402804|P2|Overall Study|Physician Decision|0
1565547|NCT03239873|5402805|P1|Overall Study|Physician Decision|1
1565548|NCT03239873|5402804|P2|Overall Study|Lost to Follow-up|16
1565549|NCT03239873|5402805|P1|Overall Study|Lost to Follow-up|15
1565550|NCT03239483|5402941|P2|Overall Study|Withdrawal by Subject|0
1565551|NCT03239483|5402942|P1|Overall Study|Withdrawal by Subject|1
1565552|NCT03239483|5402941|P2|Overall Study|Lost to Follow-up|0
1565553|NCT03239483|5402942|P1|Overall Study|Lost to Follow-up|1
1565554|NCT03238924|5402958|P2|Overall Study|Withdrawal by Subject|2
1565555|NCT03238924|5402959|P1|Overall Study|Withdrawal by Subject|2
1565560|NCT03238781|5403015|P3|Overall Study|Decision by sponsor|0
1565561|NCT03238781|5403016|P2|Overall Study|Decision by sponsor|1
1565562|NCT03238781|5403017|P1|Overall Study|Decision by sponsor|0
1565563|NCT03238781|5403015|P3|Overall Study|Withdrawal by Subject|16
1565564|NCT03238781|5403016|P2|Overall Study|Withdrawal by Subject|14
1565565|NCT03238781|5403017|P1|Overall Study|Withdrawal by Subject|23
1565566|NCT03238781|5403015|P3|Overall Study|Lost to Follow-up|2
1565567|NCT03238781|5403016|P2|Overall Study|Lost to Follow-up|1
1565568|NCT03238781|5403017|P1|Overall Study|Lost to Follow-up|2
1565569|NCT03238781|5403015|P3|Overall Study|Adverse Event|2
1565570|NCT03238781|5403016|P2|Overall Study|Adverse Event|1
1565571|NCT03238781|5403017|P1|Overall Study|Adverse Event|1
1565572|NCT03238352|5403067|P3|Overall Study|Withdrawal by Subject|0
1565573|NCT03238352|5403068|P2|Overall Study|Withdrawal by Subject|1
1565574|NCT03238352|5403069|P1|Overall Study|Withdrawal by Subject|0
1565575|NCT03238352|5403067|P3|Overall Study|Lost to Follow-up|1
1565576|NCT03238352|5403068|P2|Overall Study|Lost to Follow-up|2
1565577|NCT03238352|5403069|P1|Overall Study|Lost to Follow-up|0
1565578|NCT03238001|5403080|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
1565579|NCT03238001|5403080|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
1565580|NCT03238001|5403080|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
1565581|NCT03238001|5403080|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
1565582|NCT03238001|5403080|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
1565583|NCT03238001|5403080|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
1565584|NCT03238001|5403080|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
1565585|NCT03238001|5403080|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
1565596|NCT03237013|5403253|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
1565597|NCT03237013|5403254|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
1565598|NCT03237013|5403255|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
1565599|NCT03236311|5403304|P2|Overall Study|Adverse Event|1
1565600|NCT03236311|5403305|P1|Overall Study|Adverse Event|0
1565601|NCT03236311|5403304|P2|Overall Study|Study terminated by sponsor|2
1565602|NCT03236311|5403305|P1|Overall Study|Study terminated by sponsor|0
1565603|NCT03235726|5403349|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565604|NCT03235726|5403350|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565605|NCT03235726|5403351|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565606|NCT03235726|5403352|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565607|NCT03235726|5403353|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565608|NCT03235726|5403354|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
1565609|NCT03235726|5403355|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565610|NCT03235726|5403356|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565611|NCT03235726|5403357|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565612|NCT03235726|5403358|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1565613|NCT03235726|5403349|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565614|NCT03235726|5403350|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565615|NCT03235726|5403351|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565616|NCT03235726|5403352|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565617|NCT03235726|5403353|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565618|NCT03235726|5403354|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
1565619|NCT03235726|5403355|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565620|NCT03235726|5403356|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565621|NCT03235726|5403357|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565622|NCT03235726|5403358|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1565623|NCT03235349|5403510|P1|Overall Study|Other|1
1565624|NCT03235349|5403510|P1|Overall Study|Adverse Event|1
1565625|NCT03235284|5403520|P3|Overall Study|Adverse Event|1
1565626|NCT03235284|5403521|P2|Overall Study|Adverse Event|2
1565627|NCT03235284|5403522|P1|Overall Study|Adverse Event|1
1565628|NCT03235115|5403539|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
1565629|NCT03235115|5403540|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1565630|NCT03235115|5403541|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1565631|NCT03235115|5403542|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1565632|NCT03235115|5403543|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1565633|NCT03235115|5403544|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
1565634|NCT03234036|5403567|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
1565635|NCT03234036|5403568|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
1565636|NCT03234036|5403569|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
1565637|NCT03234036|5403570|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
1565638|NCT03233529|5403741|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
1565639|NCT03233529|5403741|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
1565640|NCT03233438|5403785|P2|Overall Study|No recording of dalbavancin|1
1565641|NCT03233438|5403786|P1|Overall Study|No recording of dalbavancin|0
1565642|NCT03233438|5403785|P2|Overall Study|Withdrawal by Subject|1
1565643|NCT03233438|5403786|P1|Overall Study|Withdrawal by Subject|2
1565644|NCT03233438|5403785|P2|Overall Study|Lost to Follow-up|9
1565645|NCT03233438|5403786|P1|Overall Study|Lost to Follow-up|4
1565646|NCT03233308|5403852|P1|Overall Study|Protocol Violation|1
1565647|NCT03233308|5403852|P1|Overall Study|Adverse Event|1
1565648|NCT03233009|5403902|P1|Overall Study|Lost to Follow-up|1
1565649|NCT03232567|5403976|P4|Overall Study|Withdrawal by Subject|0
1565650|NCT03232567|5403977|P3|Overall Study|Withdrawal by Subject|0
1565651|NCT03232567|5403978|P2|Overall Study|Withdrawal by Subject|1
1565652|NCT03232567|5403979|P1|Overall Study|Withdrawal by Subject|0
1565653|NCT03232333|5404001|P1|Overall Study|Withdrawal by Subject|2
1565654|NCT03232333|5404001|P1|Overall Study|Lost to Follow-up|4
1565655|NCT03232333|5404001|P1|Overall Study|Infection or Osteomyelitis|9
1565656|NCT03231943|5404018|P13|Part 2|Withdrawal by Subject|0
1565657|NCT03231943|5404019|P12|Part 2|Withdrawal by Subject|1
1565658|NCT03231943|5404020|P11|Part 2|Withdrawal by Subject|0
1565659|NCT03231943|5404021|P10|Part 2|Withdrawal by Subject|0
1565660|NCT03231943|5404022|P9|Part 2|Withdrawal by Subject|0
1565661|NCT03231943|5404023|P8|Part 2|Withdrawal by Subject|0
1565662|NCT03231943|5404024|P7|Part 2|Withdrawal by Subject|0
1565663|NCT03231943|5404025|P6|Part 2|Withdrawal by Subject|0
1565664|NCT03231943|5404026|P5|Part 2|Withdrawal by Subject|0
1565665|NCT03231943|5404027|P4|Part 2|Withdrawal by Subject|0
1565666|NCT03231943|5404028|P3|Part 2|Withdrawal by Subject|0
1565667|NCT03231943|5404029|P2|Part 2|Withdrawal by Subject|0
1565668|NCT03231943|5404030|P1|Part 2|Withdrawal by Subject|0
1565669|NCT03231943|5404018|P13|Part 2|Adverse Event|0
1565670|NCT03231943|5404019|P12|Part 2|Adverse Event|0
1565671|NCT03231943|5404020|P11|Part 2|Adverse Event|1
1565672|NCT03231943|5404021|P10|Part 2|Adverse Event|0
1565673|NCT03231943|5404022|P9|Part 2|Adverse Event|0
1565674|NCT03231943|5404023|P8|Part 2|Adverse Event|0
1565675|NCT03231943|5404024|P7|Part 2|Adverse Event|0
1565676|NCT03231943|5404025|P6|Part 2|Adverse Event|0
1565677|NCT03231943|5404026|P5|Part 2|Adverse Event|0
1565678|NCT03231943|5404027|P4|Part 2|Adverse Event|0
1565679|NCT03231943|5404028|P3|Part 2|Adverse Event|0
1565680|NCT03231943|5404029|P2|Part 2|Adverse Event|0
1565681|NCT03231943|5404030|P1|Part 2|Adverse Event|0
1565682|NCT03231943|5404018|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565683|NCT03231943|5404019|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565684|NCT03231943|5404020|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565685|NCT03231943|5404021|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565686|NCT03231943|5404022|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565687|NCT03231943|5404023|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565688|NCT03231943|5404024|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565689|NCT03231943|5404025|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565690|NCT03231943|5404026|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565691|NCT03231943|5404027|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565692|NCT03231943|5404028|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565693|NCT03231943|5404029|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
1565694|NCT03231943|5404030|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
1565695|NCT03231943|5404018|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565696|NCT03231943|5404019|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565697|NCT03231943|5404020|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565698|NCT03231943|5404021|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565699|NCT03231943|5404022|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565700|NCT03231943|5404023|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565701|NCT03231943|5404024|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565702|NCT03231943|5404025|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565703|NCT03231943|5404026|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565704|NCT03231943|5404027|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565705|NCT03231943|5404028|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565706|NCT03231943|5404029|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
1565707|NCT03231943|5404030|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
1565708|NCT03231943|5404018|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565709|NCT03231943|5404019|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565710|NCT03231943|5404020|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565711|NCT03231943|5404021|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565712|NCT03231943|5404022|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565713|NCT03231943|5404023|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565714|NCT03231943|5404024|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565715|NCT03231943|5404025|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565716|NCT03231943|5404026|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565717|NCT03231943|5404027|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565718|NCT03231943|5404028|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
1565719|NCT03231943|5404029|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
1565720|NCT03231943|5404030|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
1565721|NCT03231709|5404493|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
1565722|NCT03231709|5404494|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
1565723|NCT03231709|5404493|P2|Treatment Period 1|Reason not Specified|1
1565724|NCT03231709|5404494|P1|Treatment Period 1|Reason not Specified|0
1565725|NCT03231371|5404512|P1|Overall Study|chose or were ineligible to have MRI|12
1565726|NCT03231371|5404512|P1|Overall Study|Withdrawal by Subject|1
1565727|NCT03230864|5404526|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
1565728|NCT03230864|5404527|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
1565729|NCT03230864|5404528|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
1565730|NCT03230864|5404529|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
1565731|NCT03230864|5404526|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
1565732|NCT03230864|5404527|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
1565733|NCT03230864|5404528|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
1565734|NCT03230864|5404529|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
1565735|NCT03230864|5404526|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
1565736|NCT03230864|5404527|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
1565737|NCT03230864|5404528|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
1565738|NCT03230864|5404529|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
1565739|NCT03230864|5404526|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
1565740|NCT03230864|5404527|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
1565741|NCT03230864|5404528|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
1565742|NCT03230864|5404529|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
1565743|NCT03230864|5404526|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
1565744|NCT03230864|5404527|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
1565745|NCT03230864|5404528|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
1565746|NCT03230864|5404529|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
1565747|NCT03230864|5404526|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
1565748|NCT03230864|5404527|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
1565749|NCT03230864|5404528|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
1565750|NCT03230864|5404529|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
1565751|NCT03230864|5404526|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1565752|NCT03230864|5404527|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1565753|NCT03230864|5404528|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
1565754|NCT03230864|5404529|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
1565755|NCT03230864|5404526|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
1565756|NCT03230864|5404527|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
1565757|NCT03230864|5404528|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
1565758|NCT03230864|5404529|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
1565759|NCT03230864|5404526|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1565760|NCT03230864|5404527|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1565761|NCT03230864|5404528|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
1565762|NCT03230864|5404529|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1565763|NCT03230864|5404526|P4|Prospective Confirmation (PC) Period|Adverse Event|0
1565764|NCT03230864|5404527|P3|Prospective Confirmation (PC) Period|Adverse Event|0
1565765|NCT03230864|5404528|P2|Prospective Confirmation (PC) Period|Adverse Event|0
1565766|NCT03230864|5404529|P1|Prospective Confirmation (PC) Period|Adverse Event|3
1565767|NCT03229109|5404568|P4|Overall Study|Withdrawal by Subject|1
1565768|NCT03229109|5404569|P3|Overall Study|Withdrawal by Subject|0
1565769|NCT03229109|5404570|P2|Overall Study|Withdrawal by Subject|0
1565770|NCT03229109|5404571|P1|Overall Study|Withdrawal by Subject|0
1565771|NCT03228433|5404587|P6|Overall Study|Positive alcohol test|0
1565772|NCT03228433|5404588|P5|Overall Study|Positive alcohol test|0
1565773|NCT03228433|5404589|P4|Overall Study|Positive alcohol test|1
1565774|NCT03228433|5404590|P3|Overall Study|Positive alcohol test|0
1565775|NCT03228433|5404591|P2|Overall Study|Positive alcohol test|0
1565776|NCT03228433|5404592|P1|Overall Study|Positive alcohol test|0
1565777|NCT03228433|5404587|P6|Overall Study|Lost to Follow-up|0
1565778|NCT03228433|5404588|P5|Overall Study|Lost to Follow-up|0
1565779|NCT03228433|5404589|P4|Overall Study|Lost to Follow-up|0
1565780|NCT03228433|5404590|P3|Overall Study|Lost to Follow-up|0
1565781|NCT03228433|5404591|P2|Overall Study|Lost to Follow-up|0
1565782|NCT03228433|5404592|P1|Overall Study|Lost to Follow-up|1
1565783|NCT03228212|5404667|P2|Period 2|Lost to Follow-up|0
1565784|NCT03228212|5404668|P1|Period 2|Lost to Follow-up|1
1565785|NCT03228212|5404667|P2|Period 1|no longer meets eligibility criteria|1
1565786|NCT03228212|5404668|P1|Period 1|no longer meets eligibility criteria|0
1565787|NCT03228212|5404667|P2|Period 1|Adverse Event|0
1565788|NCT03228212|5404668|P1|Period 1|Adverse Event|1
1565789|NCT03227861|5404684|P1|Overall Study|Other|5
1565790|NCT03227861|5404684|P1|Overall Study|Protocol Violation|1
1565791|NCT03227861|5404684|P1|Overall Study|Adverse Event|1
1565792|NCT03227861|5404684|P1|Overall Study|Withdrawal by Subject|1
1565793|NCT03227861|5404684|P1|Overall Study|Lost to Follow-up|4
1565794|NCT03227445|5404709|P4|Period 2 (28 Days)|Withdrawal by Subject|1
1565795|NCT03227445|5404710|P3|Period 2 (28 Days)|Withdrawal by Subject|0
1565796|NCT03227445|5404711|P2|Period 2 (28 Days)|Withdrawal by Subject|1
1565797|NCT03227445|5404712|P1|Period 2 (28 Days)|Withdrawal by Subject|0
1565798|NCT03227445|5404709|P4|Period 2 (28 Days)|Protocol Violation|1
1565799|NCT03227445|5404710|P3|Period 2 (28 Days)|Protocol Violation|0
1565800|NCT03227445|5404711|P2|Period 2 (28 Days)|Protocol Violation|0
1565801|NCT03227445|5404712|P1|Period 2 (28 Days)|Protocol Violation|0
1565802|NCT03227445|5404709|P4|Period 2 (28 Days)|Adverse Event|1
1565803|NCT03227445|5404710|P3|Period 2 (28 Days)|Adverse Event|2
1565804|NCT03227445|5404711|P2|Period 2 (28 Days)|Adverse Event|0
1565805|NCT03227445|5404712|P1|Period 2 (28 Days)|Adverse Event|1
1565806|NCT03227445|5404709|P4|Period 1 (28 Days)|Withdrawal by Subject|1
1565807|NCT03227445|5404710|P3|Period 1 (28 Days)|Withdrawal by Subject|1
1565808|NCT03227445|5404711|P2|Period 1 (28 Days)|Withdrawal by Subject|0
1565809|NCT03227445|5404712|P1|Period 1 (28 Days)|Withdrawal by Subject|0
1565810|NCT03227445|5404709|P4|Period 1 (28 Days)|Protocol Violation|0
1565811|NCT03227445|5404710|P3|Period 1 (28 Days)|Protocol Violation|0
1565812|NCT03227445|5404711|P2|Period 1 (28 Days)|Protocol Violation|0
1565813|NCT03227445|5404712|P1|Period 1 (28 Days)|Protocol Violation|1
1565814|NCT03227445|5404709|P4|Period 1 (28 Days)|Adverse Event|1
1565815|NCT03227445|5404710|P3|Period 1 (28 Days)|Adverse Event|0
1565816|NCT03227445|5404711|P2|Period 1 (28 Days)|Adverse Event|2
1565817|NCT03227445|5404712|P1|Period 1 (28 Days)|Adverse Event|1
1565818|NCT03226353|5404736|P1|Overall Study|Screen Failure|5
1565819|NCT03226353|5404736|P1|Overall Study|Withdrawal by Subject|1
1565820|NCT03226275|5404760|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
1565821|NCT03226275|5404761|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
1565822|NCT03226275|5404762|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
1565823|NCT03226275|5404763|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
1565824|NCT03226275|5404760|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
1565825|NCT03226275|5404761|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
1565826|NCT03226275|5404762|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
1565827|NCT03226275|5404763|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
1565828|NCT03224325|5404877|P7|Overall Study|Withdrawal by Subject|0
1565829|NCT03224325|5404878|P6|Overall Study|Withdrawal by Subject|0
1565830|NCT03224325|5404879|P5|Overall Study|Withdrawal by Subject|0
1565831|NCT03224325|5404880|P4|Overall Study|Withdrawal by Subject|1
1565832|NCT03224325|5404881|P3|Overall Study|Withdrawal by Subject|0
1565833|NCT03224325|5404882|P2|Overall Study|Withdrawal by Subject|0
1565834|NCT03224325|5404883|P1|Overall Study|Withdrawal by Subject|0
1565835|NCT03224325|5404877|P7|Overall Study|Adverse Event|1
1565836|NCT03224325|5404878|P6|Overall Study|Adverse Event|0
1565837|NCT03224325|5404879|P5|Overall Study|Adverse Event|0
1565838|NCT03224325|5404880|P4|Overall Study|Adverse Event|0
1565839|NCT03224325|5404881|P3|Overall Study|Adverse Event|0
1565840|NCT03224325|5404882|P2|Overall Study|Adverse Event|0
1565841|NCT03224325|5404883|P1|Overall Study|Adverse Event|1
1565842|NCT03224130|5404946|P2|Overall Study|consent issue|1
1565843|NCT03224130|5404947|P1|Overall Study|consent issue|0
1565844|NCT03223909|5404968|P3|Overall Study|Protocol Violation|16
1565845|NCT03223909|5404969|P2|Overall Study|Protocol Violation|45
1565846|NCT03223909|5404970|P1|Overall Study|Protocol Violation|48
1565847|NCT03223662|5404999|P1|Overall Study|Study closure|1
1565848|NCT03223662|5404999|P1|Overall Study|Physician Decision|1
1565849|NCT03222583|5405084|P2|Overall Study|Other|3
1565850|NCT03222583|5405085|P1|Overall Study|Other|1
1565851|NCT03222583|5405084|P2|Overall Study|Lost to Follow-up|0
1565852|NCT03222583|5405085|P1|Overall Study|Lost to Follow-up|1
1565853|NCT03222583|5405084|P2|Overall Study|Withdrawal by Subject|3
1565854|NCT03222583|5405085|P1|Overall Study|Withdrawal by Subject|3
1565855|NCT03222141|5405135|P1|Overall Study|Lost to Follow-up|3
1565856|NCT03222141|5405135|P1|Overall Study|Death|15
1565857|NCT03219723|5405249|P1|Overall Study|Protocol Deviation|4
1565858|NCT03219723|5405249|P1|Overall Study|Case Report Forms Uncollected|6
1565859|NCT03218397|5405292|P2|Overall Study|Randomized during laboratory off hours|1
1565860|NCT03218397|5405293|P1|Overall Study|Randomized during laboratory off hours|2
1565861|NCT03218397|5405292|P2|Overall Study|No gram-negative bacilli (GNB)|2
1565862|NCT03218397|5405293|P1|Overall Study|No gram-negative bacilli (GNB)|0
1565863|NCT03218397|5405292|P2|Overall Study|Inaccessible hospital records|5
1565864|NCT03218397|5405293|P1|Overall Study|Inaccessible hospital records|2
1565865|NCT03218397|5405292|P2|Overall Study|Mixed culture|2
1565866|NCT03218397|5405293|P1|Overall Study|Mixed culture|2
1565867|NCT03218397|5405292|P2|Overall Study|Comfort care and mixed culture|1
1565868|NCT03218397|5405293|P1|Overall Study|Comfort care and mixed culture|0
1565869|NCT03218397|5405292|P2|Overall Study|Comfort care and positive blood culture|0
1565870|NCT03218397|5405293|P1|Overall Study|Comfort care and positive blood culture|1
1565871|NCT03218397|5405292|P2|Overall Study|Comfort care|5
1565872|NCT03218397|5405293|P1|Overall Study|Comfort care|8
1565873|NCT03218397|5405292|P2|Overall Study|Prior positive blood culture|13
1565874|NCT03218397|5405293|P1|Overall Study|Prior positive blood culture|8
1565875|NCT03217968|5405325|P1|Overall Study|Protocol Violation|6
1565876|NCT03217968|5405325|P1|Overall Study|Lost to Follow-up|1
1565877|NCT03217968|5405325|P1|Overall Study|Withdrawal by Subject|4
1565878|NCT03217175|5405334|P2|Overall Study|Physician Decision|1
1565879|NCT03217175|5405335|P1|Overall Study|Physician Decision|4
1565880|NCT03216850|5405349|P1|Overall Study|Pre-analytical error|6
1565881|NCT03216265|5405377|P3|Overall Study|Withdrawal by Subject|1
1565882|NCT03216265|5405378|P2|Overall Study|Withdrawal by Subject|0
1565883|NCT03216265|5405379|P1|Overall Study|Withdrawal by Subject|0
1565884|NCT03216265|5405377|P3|Overall Study|Lost to Follow-up|0
1565885|NCT03216265|5405378|P2|Overall Study|Lost to Follow-up|1
1565886|NCT03216265|5405379|P1|Overall Study|Lost to Follow-up|0
1565887|NCT03216265|5405377|P3|Overall Study|Adverse Event|2
1565888|NCT03216265|5405378|P2|Overall Study|Adverse Event|0
1565889|NCT03216265|5405379|P1|Overall Study|Adverse Event|2
1565890|NCT03215758|5405436|P2|Overall Study|Subject/Guardian Decision|3
1565891|NCT03215758|5405437|P1|Overall Study|Subject/Guardian Decision|3
1565892|NCT03215758|5405436|P2|Overall Study|Adverse Event|2
1565893|NCT03215758|5405437|P1|Overall Study|Adverse Event|1
1565894|NCT03215758|5405436|P2|Overall Study|Death|1
1565895|NCT03215758|5405437|P1|Overall Study|Death|0
1565896|NCT03215758|5405436|P2|Overall Study|Physician Decision|1
1565897|NCT03215758|5405437|P1|Overall Study|Physician Decision|0
1565898|NCT03215758|5405436|P2|Overall Study|Protocol deviation|1
1565899|NCT03215758|5405437|P1|Overall Study|Protocol deviation|0
1565900|NCT03215758|5405436|P2|Overall Study|Technical Problems|0
1565901|NCT03215758|5405437|P1|Overall Study|Technical Problems|1
1565902|NCT03214952|5405449|P1|Overall Study|Case Report Forms Uncollected|13
1565903|NCT03214952|5405449|P1|Overall Study|Protocol Deviation|45
1565904|NCT03214588|5405464|P3|Overall Study|Reason Not Specified|0
1565905|NCT03214588|5405465|P2|Overall Study|Reason Not Specified|1
1565906|NCT03214588|5405466|P1|Overall Study|Reason Not Specified|0
1565907|NCT03214588|5405464|P3|Overall Study|Adverse Event|2
1565908|NCT03214588|5405465|P2|Overall Study|Adverse Event|0
1565909|NCT03214588|5405466|P1|Overall Study|Adverse Event|1
1565910|NCT03214406|5405533|P2|Overall Study|Lost to Follow-up|2
1565911|NCT03214406|5405534|P1|Overall Study|Lost to Follow-up|0
1565912|NCT03214406|5405533|P2|Overall Study|Withdrawal by Subject|0
1565913|NCT03214406|5405534|P1|Overall Study|Withdrawal by Subject|1
1565914|NCT03214406|5405533|P2|Overall Study|did not meet enrollment criteria|13
1565915|NCT03214406|5405534|P1|Overall Study|did not meet enrollment criteria|9
1565916|NCT03214224|5405547|P3|Validation Study|Practice controls or therapists|6
1565917|NCT03214224|5405548|P2|Validation Study|Practice controls or therapists|0
1565918|NCT03214224|5405549|P1|Validation Study|Practice controls or therapists|0
1565919|NCT03214224|5405547|P3|Validation Study|Withdrawal by Subject|2
1565920|NCT03214224|5405548|P2|Validation Study|Withdrawal by Subject|0
1565921|NCT03214224|5405549|P1|Validation Study|Withdrawal by Subject|0
1565922|NCT03214224|5405547|P3|Validation Study|Protocol Violation|1
1565923|NCT03214224|5405548|P2|Validation Study|Protocol Violation|0
1565924|NCT03214224|5405549|P1|Validation Study|Protocol Violation|0
1565925|NCT03214081|5405558|P1|Overall Study|Protocol Deviation|54
1565926|NCT03214081|5405558|P1|Overall Study|Case Report Forms Uncollected|9
1565927|NCT03213509|5405575|P2|Overall Study|Did not consent for verbal autopsy|5
1565928|NCT03213509|5405576|P1|Overall Study|Did not consent for verbal autopsy|4
1565929|NCT03213366|5405589|P2|Overall Study|Lost to Follow-up|4
1565930|NCT03213366|5405590|P1|Overall Study|Lost to Follow-up|9
1565931|NCT03212521|5405644|P1|Overall Study|Other|1
1565932|NCT03212521|5405644|P1|Overall Study|Withdrawal by Subject|1
1565933|NCT03212521|5405644|P1|Overall Study|Lost to Follow-up|4
1565934|NCT03212521|5405644|P1|Overall Study|Adverse Event|1
1565935|NCT03212326|5405651|P1|Overall Study|Physician Decision|4
1565936|NCT03212261|5405656|P1|Overall Study|Too busy/ No time|5
1565937|NCT03212261|5405656|P1|Overall Study|Family Emergency|1
1565938|NCT03212261|5405656|P1|Overall Study|Lost to Follow-up|7
1565939|NCT03212261|5405656|P1|Overall Study|Tech Trouble- No first study visit|1
1565940|NCT03212261|5405656|P1|Overall Study|Became ineligible d/t tech|2
1565941|NCT03211858|5405664|P2|Overall Study|Other than specified above|21
1565942|NCT03211858|5405665|P1|Overall Study|Other than specified above|22
1565943|NCT03211858|5405664|P2|Overall Study|Non-serious Hypoglycemia|0
1565944|NCT03211858|5405665|P1|Overall Study|Non-serious Hypoglycemia|1
1565945|NCT03211858|5405664|P2|Overall Study|Poor compliance to protocol|2
1565946|NCT03211858|5405665|P1|Overall Study|Poor compliance to protocol|6
1565947|NCT03211858|5405664|P2|Overall Study|Lack of Efficacy|4
1565948|NCT03211858|5405665|P1|Overall Study|Lack of Efficacy|0
1565949|NCT03211858|5405664|P2|Overall Study|Adverse Event|6
1565950|NCT03211858|5405665|P1|Overall Study|Adverse Event|8
1565951|NCT03210220|5405733|P2|Overall Study|Physician Decision|0
1565952|NCT03210220|5405734|P1|Overall Study|Physician Decision|1
1565953|NCT03209570|5405742|P2|Overall Study|Withdrawal by Subject|3
1565954|NCT03209570|5405743|P1|Overall Study|Withdrawal by Subject|0
1565955|NCT03209570|5405742|P2|Overall Study|Protocol Violation|0
1565956|NCT03209570|5405743|P1|Overall Study|Protocol Violation|1
1565957|NCT03209570|5405742|P2|Overall Study|Incomplete Data|10
1565958|NCT03209570|5405743|P1|Overall Study|Incomplete Data|8
1565959|NCT03209570|5405742|P2|Overall Study|Death|0
1565960|NCT03209570|5405743|P1|Overall Study|Death|1
1565961|NCT03209518|5405753|P1|Overall Study|Protocol Deviation|1
1565962|NCT03209518|5405753|P1|Overall Study|Case Report Forms Uncollected|1
1565963|NCT03209492|5405758|P1|Overall Study|Case Report Forms Uncollected|5
1565964|NCT03207750|5405797|P2|Overall Study|OTHER, NOT SPECIFIED|4
1565965|NCT03207750|5405798|P1|Overall Study|OTHER, NOT SPECIFIED|5
1565966|NCT03207750|5405797|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
1565967|NCT03207750|5405798|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
1565968|NCT03207750|5405797|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
1565969|NCT03207750|5405798|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
1565970|NCT03207750|5405797|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
1565971|NCT03207750|5405798|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
1565972|NCT03207750|5405797|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
1565973|NCT03207750|5405798|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
1565974|NCT03207750|5405797|P2|Overall Study|Protocol Violation|1
1565975|NCT03207750|5405798|P1|Overall Study|Protocol Violation|0
1565976|NCT03207750|5405797|P2|Overall Study|Lost to Follow-up|29
1565977|NCT03207750|5405798|P1|Overall Study|Lost to Follow-up|21
1565978|NCT03207750|5405797|P2|Overall Study|Adverse Event|2
1565979|NCT03207750|5405798|P1|Overall Study|Adverse Event|3
1565980|NCT03206216|5405878|P2|Overall Study|Withdrawal by Subject|1
1565981|NCT03206216|5405879|P1|Overall Study|Withdrawal by Subject|0
1565982|NCT03205163|5405889|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
1565983|NCT03205163|5405890|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
1565984|NCT03203291|5405953|P1|Overall Study|Withdrawal by Subject|1
1565998|NCT03200912|5405985|P3|Overall Study|Non-compliance with study drug|0
1565999|NCT03200912|5405986|P2|Overall Study|Non-compliance with study drug|1
1566000|NCT03200912|5405987|P1|Overall Study|Non-compliance with study drug|0
1566001|NCT03200912|5405985|P3|Overall Study|Withdrawal by Subject|4
1566002|NCT03200912|5405986|P2|Overall Study|Withdrawal by Subject|2
1566003|NCT03200912|5405987|P1|Overall Study|Withdrawal by Subject|1
1566004|NCT03200912|5405985|P3|Overall Study|Adverse Event|0
1566005|NCT03200912|5405986|P2|Overall Study|Adverse Event|0
1566006|NCT03200912|5405987|P1|Overall Study|Adverse Event|3
1566009|NCT03198767|5406046|P7|Overall Study|Protocol Violation|0
1566010|NCT03198767|5406047|P6|Overall Study|Protocol Violation|0
1566011|NCT03198767|5406048|P5|Overall Study|Protocol Violation|0
1566012|NCT03198767|5406049|P4|Overall Study|Protocol Violation|6
1566013|NCT03198767|5406050|P3|Overall Study|Protocol Violation|0
1566014|NCT03198767|5406051|P2|Overall Study|Protocol Violation|0
1566015|NCT03198767|5406052|P1|Overall Study|Protocol Violation|0
1566016|NCT03197883|5406205|P2|Overall Study|Other (Not Specified)|5
1566017|NCT03197883|5406206|P1|Overall Study|Other (Not Specified)|0
1566018|NCT03197883|5406205|P2|Overall Study|Protocol Violation|0
1566019|NCT03197883|5406206|P1|Overall Study|Protocol Violation|1
1566020|NCT03197883|5406205|P2|Overall Study|Lost to Follow-up|0
1566021|NCT03197883|5406206|P1|Overall Study|Lost to Follow-up|1
1566022|NCT03197883|5406205|P2|Overall Study|Adverse Event|1
1566023|NCT03197883|5406206|P1|Overall Study|Adverse Event|1
1566024|NCT03197558|5406236|P1|Overall Study|Tubes not placed|1
1566025|NCT03197376|5406244|P4|Overall Study|Not vaccine related|6
1566026|NCT03197376|5406245|P3|Overall Study|Not vaccine related|0
1566027|NCT03197376|5406246|P2|Overall Study|Not vaccine related|2
1566028|NCT03197376|5406247|P1|Overall Study|Not vaccine related|1
1566029|NCT03197376|5406244|P4|Overall Study|Ineligibility criteria|2
1566030|NCT03197376|5406245|P3|Overall Study|Ineligibility criteria|4
1566031|NCT03197376|5406246|P2|Overall Study|Ineligibility criteria|1
1566032|NCT03197376|5406247|P1|Overall Study|Ineligibility criteria|1
1566033|NCT03197376|5406244|P4|Overall Study|Withdrawal by subject's parents|11
1566034|NCT03197376|5406245|P3|Overall Study|Withdrawal by subject's parents|14
1566035|NCT03197376|5406246|P2|Overall Study|Withdrawal by subject's parents|10
1566036|NCT03197376|5406247|P1|Overall Study|Withdrawal by subject's parents|11
1566037|NCT03197376|5406244|P4|Overall Study|Physician Decision|3
1566038|NCT03197376|5406245|P3|Overall Study|Physician Decision|1
1566039|NCT03197376|5406246|P2|Overall Study|Physician Decision|0
1566040|NCT03197376|5406247|P1|Overall Study|Physician Decision|1
1566041|NCT03197376|5406244|P4|Overall Study|Lost to Follow-up|0
1566042|NCT03197376|5406245|P3|Overall Study|Lost to Follow-up|1
1566043|NCT03197376|5406246|P2|Overall Study|Lost to Follow-up|0
1566044|NCT03197376|5406247|P1|Overall Study|Lost to Follow-up|0
1566045|NCT03197376|5406244|P4|Overall Study|Death|2
1566046|NCT03197376|5406245|P3|Overall Study|Death|0
1566047|NCT03197376|5406246|P2|Overall Study|Death|0
1566048|NCT03197376|5406247|P1|Overall Study|Death|1
1566049|NCT03197376|5406244|P4|Overall Study|Adverse Event|1
1566050|NCT03197376|5406245|P3|Overall Study|Adverse Event|0
1566051|NCT03197376|5406246|P2|Overall Study|Adverse Event|0
1566052|NCT03197376|5406247|P1|Overall Study|Adverse Event|0
1566053|NCT03196635|5406305|P1|Overall Study|Withdrawal by Subject|1
1566054|NCT03196349|5406326|P3|Overall Study|Study Terminated early|11
1566055|NCT03196349|5406327|P2|Overall Study|Study Terminated early|9
1566056|NCT03196349|5406328|P1|Overall Study|Study Terminated early|15
1566057|NCT03196349|5406326|P3|Overall Study|No data entered|0
1566058|NCT03196349|5406327|P2|Overall Study|No data entered|4
1566059|NCT03196349|5406328|P1|Overall Study|No data entered|2
1566060|NCT03196349|5406326|P3|Overall Study|Did not receive study drug|2
1566061|NCT03196349|5406327|P2|Overall Study|Did not receive study drug|1
1566062|NCT03196349|5406328|P1|Overall Study|Did not receive study drug|0
1566063|NCT03194490|5406429|P2|Overall Study|participant developed specific neck pain|0
1566064|NCT03194490|5406430|P1|Overall Study|participant developed specific neck pain|1
1566065|NCT03194490|5406429|P2|Overall Study|Lost to Follow-up|3
1566066|NCT03194490|5406430|P1|Overall Study|Lost to Follow-up|1
1566067|NCT03193021|5406583|P2|Overall Study|Lost to Follow-up|1
1566068|NCT03193021|5406584|P1|Overall Study|Lost to Follow-up|1
1566069|NCT03192475|5406631|P2|Overall Study|Lost to Follow-up|8
1566070|NCT03192475|5406632|P1|Overall Study|Lost to Follow-up|13
1566071|NCT03192475|5406631|P2|Overall Study|Death|1
1566072|NCT03192475|5406632|P1|Overall Study|Death|0
1566073|NCT03192306|5406668|P2|Overall Study|Protocol Violation|1
1566074|NCT03192306|5406669|P1|Overall Study|Protocol Violation|1
1566075|NCT03192306|5406668|P2|Overall Study|Lost to Follow-up|0
1566076|NCT03192306|5406669|P1|Overall Study|Lost to Follow-up|1
1566077|NCT03192306|5406668|P2|Overall Study|Withdrawal by Subject|1
1566078|NCT03192306|5406669|P1|Overall Study|Withdrawal by Subject|1
1566079|NCT03192306|5406668|P2|Overall Study|Did not treat cold sore during study|143
1566080|NCT03192306|5406669|P1|Overall Study|Did not treat cold sore during study|149
1566081|NCT03191552|5406690|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
1566082|NCT03191552|5406691|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
1566083|NCT03191552|5406692|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
1566084|NCT03191552|5406690|P3|Overall Study|Lost to Follow-up|0
1566085|NCT03191552|5406691|P2|Overall Study|Lost to Follow-up|0
1566086|NCT03191552|5406692|P1|Overall Study|Lost to Follow-up|1
1566087|NCT03191396|5406745|P2|Overall Study|Withdrawal by Subject|2
1566088|NCT03191396|5406746|P1|Overall Study|Withdrawal by Subject|3
1566089|NCT03191396|5406745|P2|Overall Study|Lost to Follow-up|3
1566090|NCT03191396|5406746|P1|Overall Study|Lost to Follow-up|0
1566091|NCT03190369|5406834|P2|Overall Study|Randomized but not treated|2
1566092|NCT03190369|5406835|P1|Overall Study|Randomized but not treated|0
1566093|NCT03190369|5406834|P2|Overall Study|Withdraw before treatment|5
1566094|NCT03190369|5406835|P1|Overall Study|Withdraw before treatment|1
1566095|NCT03190369|5406834|P2|Overall Study|Poor compliance to protocol|1
1566096|NCT03190369|5406835|P1|Overall Study|Poor compliance to protocol|0
1566097|NCT03188120|5406972|P1|Overall Study|No visit after the first visit|13
1566098|NCT03188120|5406972|P1|Overall Study|Other than specified|3
1566099|NCT03188120|5406972|P1|Overall Study|Lost to Follow-up|7
1566100|NCT03188120|5406972|P1|Overall Study|Improved|12
1566101|NCT03188120|5406972|P1|Overall Study|Insufficient Effectiveness|8
1566102|NCT03188120|5406972|P1|Overall Study|Adverse Event|4
1566133|NCT03185481|5407001|P1|Overall Study|Study Terminated by Sponsor|4
1566134|NCT03185481|5407001|P1|Overall Study|Adverse Event|1
1566135|NCT03184441|5407040|P1|Overall Study|Withdrawal by Subject|1
1566136|NCT03184077|5407050|P2|Overall Study|Lost to Follow-up|21
1566137|NCT03184077|5407051|P1|Overall Study|Lost to Follow-up|21
1566138|NCT03183518|5407070|P1|Overall Study|Other (Withdrawal of consent)|1
1566139|NCT03183518|5407070|P1|Overall Study|Other (Not specified)|2
1566140|NCT03182738|5407133|P2|Overall Study|Withdrawal by Subject|1
1566141|NCT03182738|5407134|P1|Overall Study|Withdrawal by Subject|0
1566142|NCT03182738|5407133|P2|Overall Study|Pregnancy|1
1566143|NCT03182738|5407134|P1|Overall Study|Pregnancy|0
1566144|NCT03182738|5407133|P2|Overall Study|Lost to Follow-up|3
1566145|NCT03182738|5407134|P1|Overall Study|Lost to Follow-up|9
1566146|NCT03181594|5407183|P1|Overall Study|Physician Decision|1
1566147|NCT03181594|5407183|P1|Overall Study|Lost to Follow-up|1
1566156|NCT03180801|5407240|P3|Overall Study|Lost to Follow-up|3
1566157|NCT03180801|5407241|P2|Overall Study|Lost to Follow-up|2
1566158|NCT03180801|5407242|P1|Overall Study|Lost to Follow-up|0
1566159|NCT03180801|5407240|P3|Overall Study|Withdrawal by Subject|1
1566160|NCT03180801|5407241|P2|Overall Study|Withdrawal by Subject|2
1566161|NCT03180801|5407242|P1|Overall Study|Withdrawal by Subject|2
1566162|NCT03180801|5407240|P3|Overall Study|Adverse Event|2
1566163|NCT03180801|5407241|P2|Overall Study|Adverse Event|0
1566164|NCT03180801|5407242|P1|Overall Study|Adverse Event|1
1566165|NCT03180801|5407240|P3|Overall Study|Inoculation Target Reached|3
1566166|NCT03180801|5407241|P2|Overall Study|Inoculation Target Reached|1
1566167|NCT03180801|5407242|P1|Overall Study|Inoculation Target Reached|1
1566168|NCT03180801|5407240|P3|Overall Study|Non-compliance|0
1566169|NCT03180801|5407241|P2|Overall Study|Non-compliance|4
1566170|NCT03180801|5407242|P1|Overall Study|Non-compliance|1
1566171|NCT03180801|5407240|P3|Overall Study|Physician Decision|1
1566172|NCT03180801|5407241|P2|Overall Study|Physician Decision|3
1566173|NCT03180801|5407242|P1|Overall Study|Physician Decision|3
1566174|NCT03180645|5407283|P3|Overall Study|Adverse Event|2
1566175|NCT03180645|5407284|P2|Overall Study|Adverse Event|1
1566176|NCT03180645|5407285|P1|Overall Study|Adverse Event|0
1566177|NCT03180138|5407430|P3|Overall Study|Found to be >24 mon after randomization|3
1566178|NCT03180138|5407431|P2|Overall Study|Found to be >24 mon after randomization|0
1566179|NCT03180138|5407432|P1|Overall Study|Found to be >24 mon after randomization|3
1566180|NCT03180138|5407430|P3|Overall Study|No prior immunization records|6
1566181|NCT03180138|5407431|P2|Overall Study|No prior immunization records|0
1566182|NCT03180138|5407432|P1|Overall Study|No prior immunization records|17
1566183|NCT03180138|5407430|P3|Overall Study|Mobile-phone could not be verified|15
1566184|NCT03180138|5407431|P2|Overall Study|Mobile-phone could not be verified|13
1566185|NCT03180138|5407432|P1|Overall Study|Mobile-phone could not be verified|2
1566186|NCT03178942|5407445|P2|Overall Study|Lost to Follow-up|2
1566187|NCT03178942|5407446|P1|Overall Study|Lost to Follow-up|1
1566188|NCT03178942|5407445|P2|Overall Study|Withdrawal by Subject|0
1566189|NCT03178942|5407446|P1|Overall Study|Withdrawal by Subject|2
1566190|NCT03178266|5407475|P2|Overall Study|Withdrawal by Subject|2
1566191|NCT03178266|5407476|P1|Overall Study|Withdrawal by Subject|0
1566192|NCT03178266|5407475|P2|Overall Study|Disont. Early|1
1566193|NCT03178266|5407476|P1|Overall Study|Disont. Early|0
1566194|NCT03178266|5407475|P2|Overall Study|Death|1
1566195|NCT03178266|5407476|P1|Overall Study|Death|0
1566196|NCT03176407|5407627|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
1566197|NCT03176407|5407627|P1|Overall Study|human failure|1
1566198|NCT03176407|5407627|P1|Overall Study|Protocol Violation|1
1566199|NCT03175562|5407635|P1|Overall Study|Other (Not Specified)|5
1566200|NCT03175562|5407635|P1|Overall Study|Withdrawal by Subject|7
1566201|NCT03175562|5407635|P1|Overall Study|Lost to Follow-up|3
1566202|NCT03175562|5407635|P1|Overall Study|Adverse Event|1
1566203|NCT03175172|5407660|P1|Overall Study|Study Terminated by Sponsor|3
1566204|NCT03175172|5407660|P1|Overall Study|Lost to Follow-up|1
1566205|NCT03175172|5407660|P1|Overall Study|Withdrawal by Subject|3
1566206|NCT03175172|5407660|P1|Overall Study|Death|3
1566207|NCT03172481|5407736|P2|Double-blind|Withdrawal by Subject|0
1566208|NCT03172481|5407737|P1|Double-blind|Withdrawal by Subject|1
1566209|NCT03172364|5407745|P2|Overall Study|Protocol Violation|0
1566210|NCT03172364|5407746|P1|Overall Study|Protocol Violation|1
1566211|NCT03172364|5407745|P2|Overall Study|Adverse Event|1
1566212|NCT03172364|5407746|P1|Overall Study|Adverse Event|1
1566213|NCT03171415|5407767|P5|Overall Study|Lost to Follow-up|2
1566214|NCT03171415|5407768|P4|Overall Study|Lost to Follow-up|0
1566215|NCT03171415|5407769|P3|Overall Study|Lost to Follow-up|0
1566216|NCT03171415|5407770|P2|Overall Study|Lost to Follow-up|0
1566217|NCT03171415|5407771|P1|Overall Study|Lost to Follow-up|0
1566218|NCT03170609|5407839|P7|Overall Study|Other|0
1566219|NCT03170609|5407840|P6|Overall Study|Other|1
1566220|NCT03170609|5407841|P5|Overall Study|Other|0
1566221|NCT03170609|5407842|P4|Overall Study|Other|0
1566222|NCT03170609|5407843|P3|Overall Study|Other|0
1566223|NCT03170609|5407844|P2|Overall Study|Other|0
1566224|NCT03170609|5407845|P1|Overall Study|Other|1
1566225|NCT03170609|5407839|P7|Overall Study|Lost to Follow-up|0
1566226|NCT03170609|5407840|P6|Overall Study|Lost to Follow-up|1
1566227|NCT03170609|5407841|P5|Overall Study|Lost to Follow-up|1
1566228|NCT03170609|5407842|P4|Overall Study|Lost to Follow-up|2
1566229|NCT03170609|5407843|P3|Overall Study|Lost to Follow-up|5
1566230|NCT03170609|5407844|P2|Overall Study|Lost to Follow-up|0
1566231|NCT03170609|5407845|P1|Overall Study|Lost to Follow-up|1
1566232|NCT03170609|5407839|P7|Overall Study|Withdrawal by Subject|1
1566233|NCT03170609|5407840|P6|Overall Study|Withdrawal by Subject|0
1566234|NCT03170609|5407841|P5|Overall Study|Withdrawal by Subject|0
1566235|NCT03170609|5407842|P4|Overall Study|Withdrawal by Subject|0
1566236|NCT03170609|5407843|P3|Overall Study|Withdrawal by Subject|0
1566237|NCT03170609|5407844|P2|Overall Study|Withdrawal by Subject|2
1566238|NCT03170609|5407845|P1|Overall Study|Withdrawal by Subject|1
1566239|NCT03170609|5407839|P7|Overall Study|Death|0
1566240|NCT03170609|5407840|P6|Overall Study|Death|0
1566241|NCT03170609|5407841|P5|Overall Study|Death|0
1566242|NCT03170609|5407842|P4|Overall Study|Death|0
1566243|NCT03170609|5407843|P3|Overall Study|Death|1
1566244|NCT03170609|5407844|P2|Overall Study|Death|0
1566245|NCT03170609|5407845|P1|Overall Study|Death|0
1566246|NCT03170544|5407915|P12|Part 1|Not treated|0
1566247|NCT03170544|5407916|P11|Part 1|Not treated|0
1566248|NCT03170544|5407917|P10|Part 1|Not treated|0
1566249|NCT03170544|5407918|P9|Part 1|Not treated|0
1566250|NCT03170544|5407919|P8|Part 1|Not treated|0
1566251|NCT03170544|5407920|P7|Part 1|Not treated|0
1566252|NCT03170544|5407921|P6|Part 1|Not treated|0
1566253|NCT03170544|5407922|P5|Part 1|Not treated|0
1566254|NCT03170544|5407923|P4|Part 1|Not treated|1
1566255|NCT03170544|5407924|P3|Part 1|Not treated|0
1566256|NCT03170544|5407925|P2|Part 1|Not treated|0
1566257|NCT03170544|5407926|P1|Part 1|Not treated|0
1566258|NCT03170544|5407915|P12|Part 1|Lost to Follow-up|0
1566259|NCT03170544|5407916|P11|Part 1|Lost to Follow-up|0
1566260|NCT03170544|5407917|P10|Part 1|Lost to Follow-up|0
1566261|NCT03170544|5407918|P9|Part 1|Lost to Follow-up|0
1566262|NCT03170544|5407919|P8|Part 1|Lost to Follow-up|0
1566263|NCT03170544|5407920|P7|Part 1|Lost to Follow-up|0
1566264|NCT03170544|5407921|P6|Part 1|Lost to Follow-up|0
1566265|NCT03170544|5407922|P5|Part 1|Lost to Follow-up|0
1566266|NCT03170544|5407923|P4|Part 1|Lost to Follow-up|0
1566267|NCT03170544|5407924|P3|Part 1|Lost to Follow-up|0
1566268|NCT03170544|5407925|P2|Part 1|Lost to Follow-up|0
1566269|NCT03170544|5407926|P1|Part 1|Lost to Follow-up|1
1566270|NCT03170232|5408090|P2|Overall Study|Withdrawal by Subject|1
1566271|NCT03170232|5408091|P1|Overall Study|Withdrawal by Subject|0
1566272|NCT03170232|5408090|P2|Overall Study|Lost to Follow-up|0
1566273|NCT03170232|5408091|P1|Overall Study|Lost to Follow-up|1
1566274|NCT03170232|5408090|P2|Overall Study|Study closed/terminated|23
1566275|NCT03170232|5408091|P1|Overall Study|Study closed/terminated|26
1566276|NCT03170232|5408090|P2|Overall Study|Lack of Efficacy|1
1566277|NCT03170232|5408091|P1|Overall Study|Lack of Efficacy|0
1566278|NCT03170232|5408090|P2|Overall Study|Protocol Violation|1
1566279|NCT03170232|5408091|P1|Overall Study|Protocol Violation|0
1566280|NCT03170232|5408090|P2|Overall Study|Adverse Event|1
1566281|NCT03170232|5408091|P1|Overall Study|Adverse Event|0
1566282|NCT03170193|5408169|P7|Overall Study|Lost to Follow-up|0
1566283|NCT03170193|5408170|P6|Overall Study|Lost to Follow-up|0
1566284|NCT03170193|5408171|P5|Overall Study|Lost to Follow-up|0
1566285|NCT03170193|5408172|P4|Overall Study|Lost to Follow-up|0
1566286|NCT03170193|5408173|P3|Overall Study|Lost to Follow-up|0
1566287|NCT03170193|5408174|P2|Overall Study|Lost to Follow-up|1
1566288|NCT03170193|5408175|P1|Overall Study|Lost to Follow-up|1
1566289|NCT03170193|5408169|P7|Overall Study|Withdrawal by Subject|0
1566290|NCT03170193|5408170|P6|Overall Study|Withdrawal by Subject|0
1566291|NCT03170193|5408171|P5|Overall Study|Withdrawal by Subject|0
1566292|NCT03170193|5408172|P4|Overall Study|Withdrawal by Subject|1
1566293|NCT03170193|5408173|P3|Overall Study|Withdrawal by Subject|0
1566294|NCT03170193|5408174|P2|Overall Study|Withdrawal by Subject|0
1566295|NCT03170193|5408175|P1|Overall Study|Withdrawal by Subject|0
1566296|NCT03169530|5408246|P2|Overall Study|Study ended by NIH|17
1566297|NCT03169530|5408247|P1|Overall Study|Study ended by NIH|15
1566298|NCT03169153|5408265|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
1566299|NCT03169153|5408266|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
1566300|NCT03169153|5408265|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
1566301|NCT03169153|5408266|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
1566302|NCT03169153|5408265|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
1566303|NCT03169153|5408266|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
1566304|NCT03169153|5408265|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1566305|NCT03169153|5408266|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1566306|NCT03168919|5408277|P1|Overall Study|Withdrawal by Subject|2
1566307|NCT03168906|5408287|P2|Overall Study|Lack of Efficacy|6
1566308|NCT03168906|5408288|P1|Overall Study|Lack of Efficacy|6
1566309|NCT03168425|5408320|P2|Overall Study|unable to confirm post op opioids|3
1566310|NCT03168425|5408321|P1|Overall Study|unable to confirm post op opioids|2
1566311|NCT03168425|5408320|P2|Overall Study|Lost to Follow-up|8
1566312|NCT03168425|5408321|P1|Overall Study|Lost to Follow-up|5
1566313|NCT03166618|5408397|P2|Overall Study|Study was Terminated|1
1566314|NCT03166618|5408398|P1|Overall Study|Study was Terminated|0
1566315|NCT03166215|5408410|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
1566316|NCT03166215|5408411|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
1566317|NCT03166215|5408412|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
1566318|NCT03166215|5408410|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
1566319|NCT03166215|5408411|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
1566320|NCT03166215|5408412|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
1566321|NCT03165110|5408498|P1|Overall Study|Anroid phone software incompatibility|1
1566322|NCT03162614|5408559|P6|Overall Study|Missed vaccination, exclusion criteria|0
1566323|NCT03162614|5408560|P5|Overall Study|Missed vaccination, exclusion criteria|3
1566324|NCT03162614|5408561|P4|Overall Study|Missed vaccination, exclusion criteria|4
1566325|NCT03162614|5408562|P3|Overall Study|Missed vaccination, exclusion criteria|2
1566326|NCT03162614|5408563|P2|Overall Study|Missed vaccination, exclusion criteria|2
1566327|NCT03162614|5408564|P1|Overall Study|Missed vaccination, exclusion criteria|2
1566328|NCT03162614|5408559|P6|Overall Study|Withdrawal by Subject|0
1566329|NCT03162614|5408560|P5|Overall Study|Withdrawal by Subject|0
1566330|NCT03162614|5408561|P4|Overall Study|Withdrawal by Subject|1
1566331|NCT03162614|5408562|P3|Overall Study|Withdrawal by Subject|1
1566332|NCT03162614|5408563|P2|Overall Study|Withdrawal by Subject|1
1566333|NCT03162614|5408564|P1|Overall Study|Withdrawal by Subject|2
1566334|NCT03162614|5408559|P6|Overall Study|Protocol Violation|0
1566335|NCT03162614|5408560|P5|Overall Study|Protocol Violation|0
1566336|NCT03162614|5408561|P4|Overall Study|Protocol Violation|1
1566337|NCT03162614|5408562|P3|Overall Study|Protocol Violation|0
1566338|NCT03162614|5408563|P2|Overall Study|Protocol Violation|1
1566339|NCT03162614|5408564|P1|Overall Study|Protocol Violation|0
1566340|NCT03162614|5408559|P6|Overall Study|Lost to Follow-up|0
1566341|NCT03162614|5408560|P5|Overall Study|Lost to Follow-up|2
1566342|NCT03162614|5408561|P4|Overall Study|Lost to Follow-up|1
1566343|NCT03162614|5408562|P3|Overall Study|Lost to Follow-up|1
1566344|NCT03162614|5408563|P2|Overall Study|Lost to Follow-up|1
1566345|NCT03162614|5408564|P1|Overall Study|Lost to Follow-up|2
1566346|NCT03162328|5408683|P3|Study Period|Withdrawal by Subject|1
1566347|NCT03162328|5408684|P2|Study Period|Withdrawal by Subject|0
1566348|NCT03162328|5408685|P1|Study Period|Withdrawal by Subject|0
1566349|NCT03162328|5408683|P3|Screening Period|Withdrawal by Subject|0
1566350|NCT03162328|5408684|P2|Screening Period|Withdrawal by Subject|0
1566351|NCT03162328|5408685|P1|Screening Period|Withdrawal by Subject|1
1566352|NCT03162328|5408683|P3|Screening Period|Did not meet inclusion/exclusion|0
1566353|NCT03162328|5408684|P2|Screening Period|Did not meet inclusion/exclusion|0
1566354|NCT03162328|5408685|P1|Screening Period|Did not meet inclusion/exclusion|21
1566355|NCT03162055|5408714|P2|Overall Study|Other|15
1566356|NCT03162055|5408715|P1|Overall Study|Other|8
1566357|NCT03162055|5408714|P2|Overall Study|Incorrect randomization|3
1566358|NCT03162055|5408715|P1|Overall Study|Incorrect randomization|4
1566359|NCT03162055|5408714|P2|Overall Study|Did not receive treatment|0
1566360|NCT03162055|5408715|P1|Overall Study|Did not receive treatment|2
1566361|NCT03162055|5408714|P2|Overall Study|Withdrawal by Subject|2
1566362|NCT03162055|5408715|P1|Overall Study|Withdrawal by Subject|17
1566363|NCT03162055|5408714|P2|Overall Study|Study-specific withdrawal criteria|14
1566364|NCT03162055|5408715|P1|Overall Study|Study-specific withdrawal criteria|22
1566365|NCT03162055|5408714|P2|Overall Study|Lost to Follow-up|1
1566366|NCT03162055|5408715|P1|Overall Study|Lost to Follow-up|0
1566367|NCT03162055|5408714|P2|Overall Study|Death|3
1566368|NCT03162055|5408715|P1|Overall Study|Death|3
1566369|NCT03162055|5408714|P2|Overall Study|Adverse Event|5
1566370|NCT03162055|5408715|P1|Overall Study|Adverse Event|6
1566371|NCT03161405|5408739|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
1566372|NCT03160716|5408755|P1|Overall Study|Lost to Follow-up|1
1566373|NCT03160703|5408766|P4|Overall Study|Withdrawal by Subject|1
1566374|NCT03160703|5408767|P3|Overall Study|Withdrawal by Subject|0
1566375|NCT03160703|5408768|P2|Overall Study|Withdrawal by Subject|0
1566376|NCT03160703|5408769|P1|Overall Study|Withdrawal by Subject|0
1566377|NCT03159611|5408847|P2|Overall Study|Inability to perform procedures|0
1566378|NCT03159611|5408848|P1|Overall Study|Inability to perform procedures|1
1566379|NCT03159611|5408847|P2|Overall Study|Non-compliance with protocol requirement|2
1566380|NCT03159611|5408848|P1|Overall Study|Non-compliance with protocol requirement|3
1566381|NCT03159611|5408847|P2|Overall Study|Withdrawal by Subject|1
1566382|NCT03159611|5408848|P1|Overall Study|Withdrawal by Subject|1
1566383|NCT03159611|5408847|P2|Overall Study|Adverse Event|0
1566384|NCT03159611|5408848|P1|Overall Study|Adverse Event|1
1566385|NCT03159611|5408847|P2|Overall Study|Protocol Violation|4
1566386|NCT03159611|5408848|P1|Overall Study|Protocol Violation|7
1566387|NCT03159611|5408847|P2|Overall Study|Did Not Meet Exclusion Criteria|3
1566388|NCT03159611|5408848|P1|Overall Study|Did Not Meet Exclusion Criteria|1
1566389|NCT03159611|5408847|P2|Overall Study|Did Not Meet Inclusion Criteria|5
1566390|NCT03159611|5408848|P1|Overall Study|Did Not Meet Inclusion Criteria|9
1566391|NCT03159468|5408868|P6|Overall Study|Withdrawal by Subject|0
1566392|NCT03159468|5408869|P5|Overall Study|Withdrawal by Subject|0
1566393|NCT03159468|5408870|P4|Overall Study|Withdrawal by Subject|0
1566394|NCT03159468|5408871|P3|Overall Study|Withdrawal by Subject|3
1566395|NCT03159468|5408872|P2|Overall Study|Withdrawal by Subject|0
1566396|NCT03159468|5408873|P1|Overall Study|Withdrawal by Subject|0
1566397|NCT03158220|5408913|P2|Overall Study|Physician Decision|0
1566398|NCT03158220|5408914|P1|Overall Study|Physician Decision|1
1566399|NCT03158220|5408913|P2|Overall Study|Lost to Follow-up|5
1566400|NCT03158220|5408914|P1|Overall Study|Lost to Follow-up|8
1566401|NCT03158220|5408913|P2|Overall Study|Status unknown|1
1566402|NCT03158220|5408914|P1|Overall Study|Status unknown|0
1566403|NCT03158220|5408913|P2|Overall Study|Withdrawal by Subject|9
1566404|NCT03158220|5408914|P1|Overall Study|Withdrawal by Subject|8
1566405|NCT03158220|5408913|P2|Overall Study|Screen Failure|1
1566406|NCT03158220|5408914|P1|Overall Study|Screen Failure|0
1566407|NCT03158012|5408951|P2|Overall Study|Withdrawal by Subject|1
1566408|NCT03158012|5408952|P1|Overall Study|Withdrawal by Subject|0
1566409|NCT03157583|5408958|P1|Overall Study|Other (did not meet study criteria)|1
1566410|NCT03157531|5408976|P1|Overall Study|Lost to Follow-up|4
1566411|NCT03157531|5408976|P1|Overall Study|Death|2
1566412|NCT03155269|5408997|P2|Overall Study|Lost to Follow-up|2
1566413|NCT03155269|5408998|P1|Overall Study|Lost to Follow-up|1
1566414|NCT03155269|5408997|P2|Overall Study|Withdrawal by Subject|5
1566415|NCT03155269|5408998|P1|Overall Study|Withdrawal by Subject|4
1566416|NCT03154086|5409066|P15|Part B (Up to 25 Days)|Adverse Event|0
1566417|NCT03154086|5409067|P14|Part B (Up to 25 Days)|Adverse Event|0
1566418|NCT03154086|5409068|P13|Part B (Up to 25 Days)|Adverse Event|0
1566419|NCT03154086|5409069|P12|Part B (Up to 25 Days)|Adverse Event|0
1566420|NCT03154086|5409070|P11|Part B (Up to 25 Days)|Adverse Event|1
1566421|NCT03154086|5409071|P10|Part B (Up to 25 Days)|Adverse Event|0
1566422|NCT03154086|5409072|P9|Part B (Up to 25 Days)|Adverse Event|0
1566423|NCT03154086|5409073|P8|Part B (Up to 25 Days)|Adverse Event|0
1566424|NCT03154086|5409074|P7|Part B (Up to 25 Days)|Adverse Event|0
1566425|NCT03154086|5409075|P6|Part B (Up to 25 Days)|Adverse Event|0
1566426|NCT03154086|5409076|P5|Part B (Up to 25 Days)|Adverse Event|0
1566427|NCT03154086|5409077|P4|Part B (Up to 25 Days)|Adverse Event|0
1566428|NCT03154086|5409078|P3|Part B (Up to 25 Days)|Adverse Event|0
1566429|NCT03154086|5409079|P2|Part B (Up to 25 Days)|Adverse Event|0
1566430|NCT03154086|5409080|P1|Part B (Up to 25 Days)|Adverse Event|0
1566431|NCT03154086|5409066|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566432|NCT03154086|5409067|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566433|NCT03154086|5409068|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566434|NCT03154086|5409069|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566435|NCT03154086|5409070|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566436|NCT03154086|5409071|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566437|NCT03154086|5409072|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566438|NCT03154086|5409073|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
1566439|NCT03154086|5409074|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566440|NCT03154086|5409075|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566441|NCT03154086|5409076|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566442|NCT03154086|5409077|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566443|NCT03154086|5409078|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566444|NCT03154086|5409079|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566445|NCT03154086|5409080|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
1566446|NCT03154086|5409066|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566447|NCT03154086|5409067|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566448|NCT03154086|5409068|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566449|NCT03154086|5409069|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566450|NCT03154086|5409070|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566451|NCT03154086|5409071|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566452|NCT03154086|5409072|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
1566453|NCT03154086|5409073|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566454|NCT03154086|5409074|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566455|NCT03154086|5409075|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566456|NCT03154086|5409076|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566457|NCT03154086|5409077|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566458|NCT03154086|5409078|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566459|NCT03154086|5409079|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566460|NCT03154086|5409080|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
1566461|NCT03154086|5409066|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566462|NCT03154086|5409067|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566463|NCT03154086|5409068|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566464|NCT03154086|5409069|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566465|NCT03154086|5409070|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566466|NCT03154086|5409071|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566467|NCT03154086|5409072|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566468|NCT03154086|5409073|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566469|NCT03154086|5409074|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566470|NCT03154086|5409075|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566471|NCT03154086|5409076|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566472|NCT03154086|5409077|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566473|NCT03154086|5409078|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566474|NCT03154086|5409079|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
1566475|NCT03154086|5409080|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
1566476|NCT03154086|5409066|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566477|NCT03154086|5409067|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566478|NCT03154086|5409068|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566479|NCT03154086|5409069|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566480|NCT03154086|5409070|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566481|NCT03154086|5409071|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566482|NCT03154086|5409072|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566483|NCT03154086|5409073|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566484|NCT03154086|5409074|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566485|NCT03154086|5409075|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566486|NCT03154086|5409076|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566487|NCT03154086|5409077|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566488|NCT03154086|5409078|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
1566489|NCT03154086|5409079|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566490|NCT03154086|5409080|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
1566491|NCT03154086|5409066|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566492|NCT03154086|5409067|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566493|NCT03154086|5409068|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566494|NCT03154086|5409069|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566495|NCT03154086|5409070|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566496|NCT03154086|5409071|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566497|NCT03154086|5409072|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566498|NCT03154086|5409073|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566499|NCT03154086|5409074|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566500|NCT03154086|5409075|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566501|NCT03154086|5409076|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566502|NCT03154086|5409077|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566503|NCT03154086|5409078|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566504|NCT03154086|5409079|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
1566505|NCT03154086|5409080|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
1566506|NCT03154086|5409066|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566507|NCT03154086|5409067|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566508|NCT03154086|5409068|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566509|NCT03154086|5409069|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566510|NCT03154086|5409070|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566511|NCT03154086|5409071|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566512|NCT03154086|5409072|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566513|NCT03154086|5409073|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566514|NCT03154086|5409074|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566515|NCT03154086|5409075|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566516|NCT03154086|5409076|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566517|NCT03154086|5409077|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
1566518|NCT03154086|5409078|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566519|NCT03154086|5409079|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566520|NCT03154086|5409080|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
1566521|NCT03154047|5409480|P1|Overall Study|Withdrawal by Subject|3
1566522|NCT03154047|5409480|P1|Overall Study|Study terminated by sponsor|76
1566523|NCT03154047|5409480|P1|Overall Study|Death|1
1566524|NCT03152552|5409514|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
1566525|NCT03152552|5409515|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
1566526|NCT03152552|5409516|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
1566527|NCT03152552|5409517|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
1566528|NCT03152552|5409518|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
1566529|NCT03152552|5409514|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
1566530|NCT03152552|5409515|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
1566531|NCT03152552|5409516|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
1566532|NCT03152552|5409517|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
1566533|NCT03152552|5409518|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
1566534|NCT03152552|5409514|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
1566535|NCT03152552|5409515|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
1566536|NCT03152552|5409516|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
1566537|NCT03152552|5409517|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
1566538|NCT03152552|5409518|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
1566539|NCT03152552|5409514|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1566540|NCT03152552|5409515|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1566541|NCT03152552|5409516|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1566542|NCT03152552|5409517|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1566543|NCT03152552|5409518|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1566544|NCT03152552|5409514|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
1566545|NCT03152552|5409515|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
1566546|NCT03152552|5409516|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
1566547|NCT03152552|5409517|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
1566548|NCT03152552|5409518|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
1566549|NCT03152552|5409514|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
1566550|NCT03152552|5409515|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
1566551|NCT03152552|5409516|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
1566552|NCT03152552|5409517|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
1566553|NCT03152552|5409518|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
1566554|NCT03152552|5409514|P5|Treatment Period 1 (12 Weeks)|Death|1
1566555|NCT03152552|5409515|P4|Treatment Period 1 (12 Weeks)|Death|0
1566556|NCT03152552|5409516|P3|Treatment Period 1 (12 Weeks)|Death|0
1566557|NCT03152552|5409517|P2|Treatment Period 1 (12 Weeks)|Death|1
1566558|NCT03152552|5409518|P1|Treatment Period 1 (12 Weeks)|Death|0
1566561|NCT03151551|5409674|P2|Overall Study|Ongoing|266
1566562|NCT03151551|5409675|P1|Overall Study|Ongoing|262
1566563|NCT03151551|5409674|P2|Overall Study|Physician Decision|0
1566564|NCT03151551|5409675|P1|Overall Study|Physician Decision|2
1566565|NCT03151551|5409674|P2|Overall Study|Lack of Efficacy|1
1566566|NCT03151551|5409675|P1|Overall Study|Lack of Efficacy|2
1566567|NCT03151551|5409674|P2|Overall Study|Protocol Violation|2
1566568|NCT03151551|5409675|P1|Overall Study|Protocol Violation|1
1566569|NCT03151551|5409674|P2|Overall Study|Withdrawal by Subject|6
1566570|NCT03151551|5409675|P1|Overall Study|Withdrawal by Subject|7
1566571|NCT03151551|5409674|P2|Overall Study|Adverse Event|1
1566572|NCT03151551|5409675|P1|Overall Study|Adverse Event|1
1566573|NCT03151226|5409710|P1|Overall Study|not wear device correctly|1
1566574|NCT03151226|5409710|P1|Overall Study|Withdrawal by Subject|2
1566575|NCT03150719|5409720|P2|Overall Study|Other|0
1566576|NCT03150719|5409721|P1|Overall Study|Other|1
1566577|NCT03150719|5409720|P2|Overall Study|Death|1
1566578|NCT03150719|5409721|P1|Overall Study|Death|0
1566579|NCT03150719|5409720|P2|Overall Study|Adverse Event|1
1566580|NCT03150719|5409721|P1|Overall Study|Adverse Event|0
1566581|NCT03150485|5409737|P6|Overall Study|Unsatisfactory Lens Fitting|0
1566582|NCT03150485|5409738|P5|Overall Study|Unsatisfactory Lens Fitting|0
1566583|NCT03150485|5409739|P4|Overall Study|Unsatisfactory Lens Fitting|0
1566584|NCT03150485|5409740|P3|Overall Study|Unsatisfactory Lens Fitting|0
1566585|NCT03150485|5409741|P2|Overall Study|Unsatisfactory Lens Fitting|1
1566586|NCT03150485|5409742|P1|Overall Study|Unsatisfactory Lens Fitting|0
1566587|NCT03150082|5409867|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
1566588|NCT03150082|5409868|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
1566589|NCT03149848|5409945|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
1566590|NCT03149848|5409945|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
1566591|NCT03148756|5409984|P2|Overall Study|Study Terminated|1
1566592|NCT03148756|5409985|P1|Overall Study|Study Terminated|0
1566593|NCT03148691|5410018|P3|Overall Study|Withdrawal by Subject|0
1566594|NCT03148691|5410019|P2|Overall Study|Withdrawal by Subject|0
1566595|NCT03148691|5410020|P1|Overall Study|Withdrawal by Subject|1
1566596|NCT03148691|5410018|P3|Overall Study|Other|0
1566597|NCT03148691|5410019|P2|Overall Study|Other|0
1566598|NCT03148691|5410020|P1|Overall Study|Other|1
1566599|NCT03148691|5410018|P3|Overall Study|Lost to Follow-up|1
1566600|NCT03148691|5410019|P2|Overall Study|Lost to Follow-up|0
1566601|NCT03148691|5410020|P1|Overall Study|Lost to Follow-up|0
1566602|NCT03148691|5410018|P3|Overall Study|Protocol Violation|7
1566603|NCT03148691|5410019|P2|Overall Study|Protocol Violation|2
1566604|NCT03148691|5410020|P1|Overall Study|Protocol Violation|1
1566605|NCT03148067|5410066|P1|Overall Study|Death|1
1566606|NCT03148067|5410066|P1|Overall Study|Lost to Follow-up|3
1566607|NCT03146403|5410073|P2|Overall Study|Lost to Follow-up|0
1566608|NCT03146403|5410074|P1|Overall Study|Lost to Follow-up|2
1566609|NCT03146403|5410073|P2|Overall Study|Withdrawal by Subject|3
1566610|NCT03146403|5410074|P1|Overall Study|Withdrawal by Subject|0
1566611|NCT03144180|5410118|P2|Overall Study|Scrub tech removed tube cap|1
1566612|NCT03144180|5410119|P1|Overall Study|Scrub tech removed tube cap|0
1566613|NCT03144180|5410118|P2|Overall Study|Provider forgot to use the Q-cup|1
1566614|NCT03144180|5410119|P1|Overall Study|Provider forgot to use the Q-cup|0
1566615|NCT03144180|5410118|P2|Overall Study|Provider forgot to fill out forms|3
1566616|NCT03144180|5410119|P1|Overall Study|Provider forgot to fill out forms|1
1566617|NCT03144180|5410118|P2|Overall Study|STAT Delivery|1
1566618|NCT03144180|5410119|P1|Overall Study|STAT Delivery|1
1566619|NCT03143166|5410154|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
1566620|NCT03143101|5410173|P3|Overall Study|Lost to Follow-up|0
1566621|NCT03143101|5410174|P2|Overall Study|Lost to Follow-up|2
1566622|NCT03143101|5410175|P1|Overall Study|Lost to Follow-up|2
1566623|NCT03143101|5410173|P3|Overall Study|Withdrawal by Subject|0
1566624|NCT03143101|5410174|P2|Overall Study|Withdrawal by Subject|1
1566625|NCT03143101|5410175|P1|Overall Study|Withdrawal by Subject|0
1566626|NCT03142932|5410230|P2|Overall Study|Lost to Follow-up|11
1566627|NCT03142932|5410231|P1|Overall Study|Lost to Follow-up|2
1566628|NCT03142750|5410247|P2|Overall Study|Lost to Follow-up|1
1566629|NCT03142750|5410248|P1|Overall Study|Lost to Follow-up|4
1566630|NCT03141307|5410325|P2|Follow-Up|Lost to Follow-up|54
1566631|NCT03141307|5410326|P1|Follow-Up|Lost to Follow-up|97
1566632|NCT03141307|5410325|P2|In-Hospital|Protocol Violation|0
1566633|NCT03141307|5410326|P1|In-Hospital|Protocol Violation|4
1566634|NCT03141307|5410325|P2|In-Hospital|Withdrawal by Subject|2
1566635|NCT03141307|5410326|P1|In-Hospital|Withdrawal by Subject|0
1566636|NCT03141086|5410344|P2|Overall Study|Adverse Event|2
1566637|NCT03141086|5410345|P1|Overall Study|Adverse Event|0
1566638|NCT03141086|5410344|P2|Overall Study|Protocol Violation|1
1566639|NCT03141086|5410345|P1|Overall Study|Protocol Violation|0
1566640|NCT03141086|5410344|P2|Overall Study|Withdrawal by Subject|1
1566641|NCT03141086|5410345|P1|Overall Study|Withdrawal by Subject|0
1566642|NCT03141086|5410344|P2|Overall Study|Study Terminated By Sponsor|1
1566643|NCT03141086|5410345|P1|Overall Study|Study Terminated By Sponsor|1
1566644|NCT03139552|5410420|P1|Overall Study|unable to attend tasting due to schedule|3
1566645|NCT03139448|5410463|P2|Overall Study|Physician Decision|2
1566646|NCT03139448|5410464|P1|Overall Study|Physician Decision|0
1566647|NCT03139448|5410463|P2|Overall Study|Screen fail|3
1566648|NCT03139448|5410464|P1|Overall Study|Screen fail|1
1566649|NCT03139448|5410463|P2|Overall Study|Withdrawal by Subject|6
1566650|NCT03139448|5410464|P1|Overall Study|Withdrawal by Subject|3
1566651|NCT03139448|5410463|P2|Overall Study|Location of procedure changed|8
1566652|NCT03139448|5410464|P1|Overall Study|Location of procedure changed|2
1566653|NCT03139448|5410463|P2|Overall Study|Lack of Efficacy|7
1566654|NCT03139448|5410464|P1|Overall Study|Lack of Efficacy|6
1566655|NCT03139279|5410488|P2|Overall Study|Withdrawal by Subject|2
1566656|NCT03139279|5410489|P1|Overall Study|Withdrawal by Subject|0
1566657|NCT03139279|5410488|P2|Overall Study|Protocol Violation|4
1566658|NCT03139279|5410489|P1|Overall Study|Protocol Violation|5
1566659|NCT03139279|5410488|P2|Overall Study|Physician Decision|0
1566660|NCT03139279|5410489|P1|Overall Study|Physician Decision|2
1566661|NCT03139240|5410507|P4|Overall Study|Lost to Follow-up|0
1566662|NCT03139240|5410508|P3|Overall Study|Lost to Follow-up|1
1566663|NCT03139240|5410509|P2|Overall Study|Lost to Follow-up|1
1566664|NCT03139240|5410510|P1|Overall Study|Lost to Follow-up|0
1566665|NCT03138967|5410522|P2|Overall Study|Physician Decision|3
1566666|NCT03138967|5410523|P1|Overall Study|Physician Decision|1
1566667|NCT03138967|5410522|P2|Overall Study|Death|1
1566668|NCT03138967|5410523|P1|Overall Study|Death|0
1566669|NCT03137784|5410577|P6|Overall Study|Non-compliance with study treatment|0
1566670|NCT03137784|5410578|P5|Overall Study|Non-compliance with study treatment|1
1566671|NCT03137784|5410579|P4|Overall Study|Non-compliance with study treatment|0
1566672|NCT03137784|5410580|P3|Overall Study|Non-compliance with study treatment|0
1566673|NCT03137784|5410581|P2|Overall Study|Non-compliance with study treatment|0
1566674|NCT03137784|5410582|P1|Overall Study|Non-compliance with study treatment|0
1566675|NCT03137784|5410577|P6|Overall Study|Subject/guardian decision|0
1566676|NCT03137784|5410578|P5|Overall Study|Subject/guardian decision|0
1566677|NCT03137784|5410579|P4|Overall Study|Subject/guardian decision|0
1566678|NCT03137784|5410580|P3|Overall Study|Subject/guardian decision|0
1566679|NCT03137784|5410581|P2|Overall Study|Subject/guardian decision|0
1566680|NCT03137784|5410582|P1|Overall Study|Subject/guardian decision|1
1566681|NCT03137784|5410577|P6|Overall Study|Adverse Event|0
1566682|NCT03137784|5410578|P5|Overall Study|Adverse Event|0
1566683|NCT03137784|5410579|P4|Overall Study|Adverse Event|0
1566684|NCT03137784|5410580|P3|Overall Study|Adverse Event|0
1566685|NCT03137784|5410581|P2|Overall Study|Adverse Event|1
1566686|NCT03137784|5410582|P1|Overall Study|Adverse Event|1
1566743|NCT03136484|5410660|P2|Overall Study|Death|0
1566744|NCT03136484|5410661|P1|Overall Study|Death|1
1566745|NCT03136484|5410660|P2|Overall Study|Lost to Follow-up|8
1566746|NCT03136484|5410661|P1|Overall Study|Lost to Follow-up|7
1566747|NCT03136484|5410660|P2|Overall Study|Withdrawal by Subject|14
1566748|NCT03136484|5410661|P1|Overall Study|Withdrawal by Subject|19
1566749|NCT03136380|5410789|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1566750|NCT03136380|5410790|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1566751|NCT03136380|5410791|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1566752|NCT03136380|5410792|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
1566753|NCT03136380|5410793|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
1566754|NCT03136107|5410972|P1|Overall Study|Other (Not specified)|1
1566755|NCT03136068|5410982|P2|Overall Study|Protocol Violation|0
1566756|NCT03136068|5410983|P1|Overall Study|Protocol Violation|1
1566757|NCT03136068|5410982|P2|Overall Study|Lost to Follow-up|1
1566758|NCT03136068|5410983|P1|Overall Study|Lost to Follow-up|1
1566759|NCT03135899|5411005|P8|Overall Study|Withdrawal by Subject|0
1566760|NCT03135899|5411006|P7|Overall Study|Withdrawal by Subject|0
1566761|NCT03135899|5411007|P6|Overall Study|Withdrawal by Subject|2
1566762|NCT03135899|5411008|P5|Overall Study|Withdrawal by Subject|0
1566763|NCT03135899|5411009|P4|Overall Study|Withdrawal by Subject|0
1566764|NCT03135899|5411010|P3|Overall Study|Withdrawal by Subject|0
1566765|NCT03135899|5411011|P2|Overall Study|Withdrawal by Subject|0
1566766|NCT03135899|5411012|P1|Overall Study|Withdrawal by Subject|0
1566767|NCT03135899|5411005|P8|Overall Study|Failed spirometry,unable to repeat visit|0
1566768|NCT03135899|5411006|P7|Overall Study|Failed spirometry,unable to repeat visit|1
1566769|NCT03135899|5411007|P6|Overall Study|Failed spirometry,unable to repeat visit|0
1566770|NCT03135899|5411008|P5|Overall Study|Failed spirometry,unable to repeat visit|0
1566771|NCT03135899|5411009|P4|Overall Study|Failed spirometry,unable to repeat visit|0
1566772|NCT03135899|5411010|P3|Overall Study|Failed spirometry,unable to repeat visit|0
1566773|NCT03135899|5411011|P2|Overall Study|Failed spirometry,unable to repeat visit|0
1566774|NCT03135899|5411012|P1|Overall Study|Failed spirometry,unable to repeat visit|0
1566775|NCT03135548|5411045|P3|Overall Study|Other than listed|2
1566776|NCT03135548|5411046|P2|Overall Study|Other than listed|2
1566777|NCT03135548|5411047|P1|Overall Study|Other than listed|0
1566778|NCT03135548|5411045|P3|Overall Study|Withdrawal by Subject|1
1566779|NCT03135548|5411046|P2|Overall Study|Withdrawal by Subject|2
1566780|NCT03135548|5411047|P1|Overall Study|Withdrawal by Subject|2
1566781|NCT03135548|5411045|P3|Overall Study|Lost to Follow-up|0
1566782|NCT03135548|5411046|P2|Overall Study|Lost to Follow-up|0
1566783|NCT03135548|5411047|P1|Overall Study|Lost to Follow-up|3
1566784|NCT03135431|5411069|P2|Overall Study|Study Surgeon not available|0
1566785|NCT03135431|5411070|P1|Overall Study|Study Surgeon not available|2
1566786|NCT03134911|5411093|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
1566787|NCT03134911|5411093|P1|Overall Study|Screen failure|31
1566788|NCT03134599|5411120|P6|Week 3|Lost to Follow-up|1
1566789|NCT03134599|5411121|P5|Week 3|Lost to Follow-up|0
1566790|NCT03134599|5411122|P4|Week 3|Lost to Follow-up|1
1566791|NCT03134599|5411123|P3|Week 3|Lost to Follow-up|0
1566792|NCT03134599|5411124|P2|Week 3|Lost to Follow-up|0
1566793|NCT03134599|5411125|P1|Week 3|Lost to Follow-up|0
1566794|NCT03134599|5411120|P6|Week 2|Lost to Follow-up|0
1566795|NCT03134599|5411121|P5|Week 2|Lost to Follow-up|1
1566796|NCT03134599|5411122|P4|Week 2|Lost to Follow-up|1
1566797|NCT03134599|5411123|P3|Week 2|Lost to Follow-up|0
1566798|NCT03134599|5411124|P2|Week 2|Lost to Follow-up|0
1566799|NCT03134599|5411125|P1|Week 2|Lost to Follow-up|1
1566800|NCT03134599|5411120|P6|Week 1|Lost to Follow-up|0
1566801|NCT03134599|5411121|P5|Week 1|Lost to Follow-up|1
1566802|NCT03134599|5411122|P4|Week 1|Lost to Follow-up|0
1566803|NCT03134599|5411123|P3|Week 1|Lost to Follow-up|0
1566804|NCT03134599|5411124|P2|Week 1|Lost to Follow-up|0
1566805|NCT03134599|5411125|P1|Week 1|Lost to Follow-up|0
1566806|NCT03134183|5411164|P2|Overall Study|Withdrawal by Subject|1
1566807|NCT03134183|5411165|P1|Overall Study|Withdrawal by Subject|1
1566808|NCT03133767|5411175|P2|Overall Study|Protocol Violation|1
1566809|NCT03133767|5411176|P1|Overall Study|Protocol Violation|0
1566810|NCT03133767|5411175|P2|Overall Study|Lost to Follow-up|24
1566811|NCT03133767|5411176|P1|Overall Study|Lost to Follow-up|38
1566812|NCT03133481|5411192|P2|Overall Study|FC Catheter fell out post operative day1|4
1566813|NCT03133481|5411193|P1|Overall Study|FC Catheter fell out post operative day1|0
1566814|NCT03132220|5411269|P2|Overall Study|Withdrawal by Subject|4
1566815|NCT03132220|5411270|P1|Overall Study|Withdrawal by Subject|1
1566816|NCT03132220|5411269|P2|Overall Study|Lost to Follow-up|8
1566817|NCT03132220|5411270|P1|Overall Study|Lost to Follow-up|17
1566818|NCT03131895|5411300|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
1566819|NCT03131895|5411301|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
1566820|NCT03131895|5411302|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
1566821|NCT03131895|5411303|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
1566822|NCT03131895|5411300|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
1566823|NCT03131895|5411301|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
1566824|NCT03131895|5411302|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
1566825|NCT03131895|5411303|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
1566826|NCT03131895|5411300|P4|Washout Period (at Least 5 Days)|Other|0
1566827|NCT03131895|5411301|P3|Washout Period (at Least 5 Days)|Other|2
1566828|NCT03131895|5411302|P2|Washout Period (at Least 5 Days)|Other|0
1566829|NCT03131895|5411303|P1|Washout Period (at Least 5 Days)|Other|0
1566830|NCT03131895|5411300|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
1566831|NCT03131895|5411301|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1566832|NCT03131895|5411302|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
1566833|NCT03131895|5411303|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
1566834|NCT03131895|5411300|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
1566835|NCT03131895|5411301|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
1566836|NCT03131895|5411302|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
1566837|NCT03131895|5411303|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
1566838|NCT03131895|5411300|P4|Washout Period (at Least 5 Days)|Adverse Event|1
1566839|NCT03131895|5411301|P3|Washout Period (at Least 5 Days)|Adverse Event|0
1566840|NCT03131895|5411302|P2|Washout Period (at Least 5 Days)|Adverse Event|0
1566841|NCT03131895|5411303|P1|Washout Period (at Least 5 Days)|Adverse Event|1
1566842|NCT03131713|5411323|P2|Overall Study|Lost to Follow-up|0
1566843|NCT03131713|5411324|P1|Overall Study|Lost to Follow-up|5
1566844|NCT03131687|5411348|P6|Overall Study|Inadvertent Enrollment|0
1566845|NCT03131687|5411349|P5|Overall Study|Inadvertent Enrollment|0
1566846|NCT03131687|5411350|P4|Overall Study|Inadvertent Enrollment|1
1566847|NCT03131687|5411351|P3|Overall Study|Inadvertent Enrollment|0
1566848|NCT03131687|5411352|P2|Overall Study|Inadvertent Enrollment|0
1566849|NCT03131687|5411353|P1|Overall Study|Inadvertent Enrollment|0
1566850|NCT03131687|5411348|P6|Overall Study|Principle Investigator Decision|0
1566851|NCT03131687|5411349|P5|Overall Study|Principle Investigator Decision|0
1566852|NCT03131687|5411350|P4|Overall Study|Principle Investigator Decision|0
1566853|NCT03131687|5411351|P3|Overall Study|Principle Investigator Decision|0
1566854|NCT03131687|5411352|P2|Overall Study|Principle Investigator Decision|1
1566855|NCT03131687|5411353|P1|Overall Study|Principle Investigator Decision|0
1566856|NCT03131687|5411348|P6|Overall Study|Participant Started New Diabetic Drug|0
1566857|NCT03131687|5411349|P5|Overall Study|Participant Started New Diabetic Drug|0
1566858|NCT03131687|5411350|P4|Overall Study|Participant Started New Diabetic Drug|0
1566859|NCT03131687|5411351|P3|Overall Study|Participant Started New Diabetic Drug|0
1566860|NCT03131687|5411352|P2|Overall Study|Participant Started New Diabetic Drug|0
1566861|NCT03131687|5411353|P1|Overall Study|Participant Started New Diabetic Drug|1
1566862|NCT03131687|5411348|P6|Overall Study|Lost to Follow-up|2
1566863|NCT03131687|5411349|P5|Overall Study|Lost to Follow-up|4
1566864|NCT03131687|5411350|P4|Overall Study|Lost to Follow-up|1
1566865|NCT03131687|5411351|P3|Overall Study|Lost to Follow-up|0
1566866|NCT03131687|5411352|P2|Overall Study|Lost to Follow-up|4
1566867|NCT03131687|5411353|P1|Overall Study|Lost to Follow-up|1
1566868|NCT03131687|5411348|P6|Overall Study|Withdrawal by Subject|1
1566869|NCT03131687|5411349|P5|Overall Study|Withdrawal by Subject|2
1566870|NCT03131687|5411350|P4|Overall Study|Withdrawal by Subject|1
1566871|NCT03131687|5411351|P3|Overall Study|Withdrawal by Subject|3
1566872|NCT03131687|5411352|P2|Overall Study|Withdrawal by Subject|3
1566873|NCT03131687|5411353|P1|Overall Study|Withdrawal by Subject|3
1566874|NCT03131687|5411348|P6|Overall Study|Death|0
1566875|NCT03131687|5411349|P5|Overall Study|Death|0
1566876|NCT03131687|5411350|P4|Overall Study|Death|0
1566877|NCT03131687|5411351|P3|Overall Study|Death|0
1566878|NCT03131687|5411352|P2|Overall Study|Death|0
1566879|NCT03131687|5411353|P1|Overall Study|Death|1
1566880|NCT03131687|5411348|P6|Overall Study|Adverse Event|2
1566881|NCT03131687|5411349|P5|Overall Study|Adverse Event|2
1566882|NCT03131687|5411350|P4|Overall Study|Adverse Event|1
1566883|NCT03131687|5411351|P3|Overall Study|Adverse Event|0
1566884|NCT03131687|5411352|P2|Overall Study|Adverse Event|1
1566885|NCT03131687|5411353|P1|Overall Study|Adverse Event|0
1566886|NCT03131596|5411463|P2|Overall Study|Lost to Follow-up|0
1566887|NCT03131596|5411464|P1|Overall Study|Lost to Follow-up|3
1566888|NCT03131596|5411463|P2|Overall Study|Protocol Violation|3
1566889|NCT03131596|5411464|P1|Overall Study|Protocol Violation|3
1566890|NCT03131479|5411481|P5|Overall Study|Subject/Guardian Decision|0
1566891|NCT03131479|5411482|P4|Overall Study|Subject/Guardian Decision|1
1566892|NCT03131479|5411483|P3|Overall Study|Subject/Guardian Decision|0
1566893|NCT03131479|5411484|P2|Overall Study|Subject/Guardian Decision|0
1566894|NCT03131479|5411485|P1|Overall Study|Subject/Guardian Decision|0
1566895|NCT03131479|5411481|P5|Overall Study|Adverse Event|0
1566896|NCT03131479|5411482|P4|Overall Study|Adverse Event|1
1566897|NCT03131479|5411483|P3|Overall Study|Adverse Event|1
1566898|NCT03131479|5411484|P2|Overall Study|Adverse Event|0
1566899|NCT03131479|5411485|P1|Overall Study|Adverse Event|0
1566900|NCT03131167|5411580|P13|Overall Study|Other (Unspecified)|0
1566901|NCT03131167|5411581|P12|Overall Study|Other (Unspecified)|0
1566902|NCT03131167|5411582|P11|Overall Study|Other (Unspecified)|0
1566903|NCT03131167|5411583|P10|Overall Study|Other (Unspecified)|0
1566904|NCT03131167|5411584|P9|Overall Study|Other (Unspecified)|0
1566905|NCT03131167|5411585|P8|Overall Study|Other (Unspecified)|0
1566906|NCT03131167|5411586|P7|Overall Study|Other (Unspecified)|0
1566907|NCT03131167|5411587|P6|Overall Study|Other (Unspecified)|1
1566908|NCT03131167|5411588|P5|Overall Study|Other (Unspecified)|0
1566909|NCT03131167|5411589|P4|Overall Study|Other (Unspecified)|0
1566910|NCT03131167|5411590|P3|Overall Study|Other (Unspecified)|0
1566911|NCT03131167|5411591|P2|Overall Study|Other (Unspecified)|0
1566912|NCT03131167|5411592|P1|Overall Study|Other (Unspecified)|0
1566913|NCT03128723|5411679|P1|Overall Study|Withdrawal by Subject|2
1566914|NCT03128307|5411698|P1|Overall Study|Withdrawal by Subject|5
1566915|NCT03128307|5411698|P1|Overall Study|Lost to Follow-up|29
1566916|NCT03127644|5411724|P3|Overall Study|Study-specific withdrawal criteria|2
1566917|NCT03127644|5411725|P2|Overall Study|Study-specific withdrawal criteria|0
1566918|NCT03127644|5411726|P1|Overall Study|Study-specific withdrawal criteria|0
1566919|NCT03127384|5411758|P1|Overall Study|Subject request|2
1566920|NCT03127384|5411758|P1|Overall Study|Lost to Follow-up|4
1566926|NCT03125941|5411813|P2|Overall Study|did not receive intervention|2
1566927|NCT03125941|5411814|P1|Overall Study|did not receive intervention|1
1566928|NCT03125200|5411853|P7|Overall Study|Consent Withdrawn by Subject|1
1566929|NCT03125200|5411854|P6|Overall Study|Consent Withdrawn by Subject|0
1566930|NCT03125200|5411855|P5|Overall Study|Consent Withdrawn by Subject|1
1566931|NCT03125200|5411856|P4|Overall Study|Consent Withdrawn by Subject|0
1566932|NCT03125200|5411857|P3|Overall Study|Consent Withdrawn by Subject|0
1566933|NCT03125200|5411858|P2|Overall Study|Consent Withdrawn by Subject|1
1566934|NCT03125200|5411859|P1|Overall Study|Consent Withdrawn by Subject|0
1566935|NCT03125200|5411853|P7|Overall Study|Toxicity|0
1566936|NCT03125200|5411854|P6|Overall Study|Toxicity|0
1566937|NCT03125200|5411855|P5|Overall Study|Toxicity|0
1566938|NCT03125200|5411856|P4|Overall Study|Toxicity|1
1566939|NCT03125200|5411857|P3|Overall Study|Toxicity|0
1566940|NCT03125200|5411858|P2|Overall Study|Toxicity|0
1566941|NCT03125200|5411859|P1|Overall Study|Toxicity|0
1566942|NCT03125200|5411853|P7|Overall Study|Lack of Efficacy|0
1566943|NCT03125200|5411854|P6|Overall Study|Lack of Efficacy|0
1566944|NCT03125200|5411855|P5|Overall Study|Lack of Efficacy|0
1566945|NCT03125200|5411856|P4|Overall Study|Lack of Efficacy|1
1566946|NCT03125200|5411857|P3|Overall Study|Lack of Efficacy|0
1566947|NCT03125200|5411858|P2|Overall Study|Lack of Efficacy|0
1566948|NCT03125200|5411859|P1|Overall Study|Lack of Efficacy|0
1566949|NCT03125200|5411853|P7|Overall Study|Progressive Disease|1
1566950|NCT03125200|5411854|P6|Overall Study|Progressive Disease|0
1566951|NCT03125200|5411855|P5|Overall Study|Progressive Disease|2
1566952|NCT03125200|5411856|P4|Overall Study|Progressive Disease|1
1566953|NCT03125200|5411857|P3|Overall Study|Progressive Disease|2
1566954|NCT03125200|5411858|P2|Overall Study|Progressive Disease|1
1566955|NCT03125200|5411859|P1|Overall Study|Progressive Disease|2
1566956|NCT03125200|5411853|P7|Overall Study|Clinical Progression|0
1566957|NCT03125200|5411854|P6|Overall Study|Clinical Progression|1
1566958|NCT03125200|5411855|P5|Overall Study|Clinical Progression|0
1566959|NCT03125200|5411856|P4|Overall Study|Clinical Progression|1
1566960|NCT03125200|5411857|P3|Overall Study|Clinical Progression|0
1566961|NCT03125200|5411858|P2|Overall Study|Clinical Progression|0
1566962|NCT03125200|5411859|P1|Overall Study|Clinical Progression|0
1566963|NCT03125200|5411853|P7|Overall Study|Study Termination|1
1566964|NCT03125200|5411854|P6|Overall Study|Study Termination|2
1566965|NCT03125200|5411855|P5|Overall Study|Study Termination|1
1566966|NCT03125200|5411856|P4|Overall Study|Study Termination|1
1566967|NCT03125200|5411857|P3|Overall Study|Study Termination|0
1566968|NCT03125200|5411858|P2|Overall Study|Study Termination|0
1566969|NCT03125200|5411859|P1|Overall Study|Study Termination|0
1566970|NCT03124784|5412099|P1|Overall Study|Computer/Equip Malfunction|1
1566971|NCT03124784|5412099|P1|Overall Study|Adverse Event|1
1566972|NCT03124563|5412121|P2|Overall Study|Withdrawal by Subject|1
1566973|NCT03124563|5412122|P1|Overall Study|Withdrawal by Subject|1
1566974|NCT03124563|5412121|P2|Overall Study|Lost to Follow-up|1
1566975|NCT03124563|5412122|P1|Overall Study|Lost to Follow-up|1
1566976|NCT03124381|5412140|P2|Overall Study|Non-Compliance with Study Treatment|0
1566977|NCT03124381|5412141|P1|Overall Study|Non-Compliance with Study Treatment|1
1566978|NCT03124381|5412140|P2|Overall Study|Adverse Event|1
1566979|NCT03124381|5412141|P1|Overall Study|Adverse Event|1
1566980|NCT03124381|5412140|P2|Overall Study|Protocol Violation|1
1566981|NCT03124381|5412141|P1|Overall Study|Protocol Violation|0
1566982|NCT03124381|5412140|P2|Overall Study|Withdrawal by Subject|3
1566983|NCT03124381|5412141|P1|Overall Study|Withdrawal by Subject|6
1566984|NCT03124381|5412140|P2|Overall Study|Lost to Follow-up|1
1566985|NCT03124381|5412141|P1|Overall Study|Lost to Follow-up|1
1566986|NCT03124199|5412248|P1|Overall Study|Lost to Follow-up|4
1566987|NCT03124108|5412257|P3|Overall Study|Adverse Event|0
1566988|NCT03124108|5412258|P2|Overall Study|Adverse Event|1
1566989|NCT03124108|5412259|P1|Overall Study|Adverse Event|0
1566990|NCT03123471|5412427|P2|Apremilast Extension Phase|Withdrawal by Subject|7
1566991|NCT03123471|5412428|P1|Apremilast Extension Phase|Withdrawal by Subject|3
1566992|NCT03123471|5412427|P2|Apremilast Extension Phase|Lack of Efficacy|8
1566993|NCT03123471|5412428|P1|Apremilast Extension Phase|Lack of Efficacy|2
1566994|NCT03123471|5412427|P2|Apremilast Extension Phase|Adverse Event|5
1566995|NCT03123471|5412428|P1|Apremilast Extension Phase|Adverse Event|1
1566996|NCT03123471|5412427|P2|Apremilast Extension Phase|Lost to Follow-up|5
1566997|NCT03123471|5412428|P1|Apremilast Extension Phase|Lost to Follow-up|2
1566998|NCT03123471|5412427|P2|Placebo-controlled Phase|Miscellaneous|1
1566999|NCT03123471|5412428|P1|Placebo-controlled Phase|Miscellaneous|0
1567000|NCT03123471|5412427|P2|Placebo-controlled Phase|Protocol Deviation|1
1567001|NCT03123471|5412428|P1|Placebo-controlled Phase|Protocol Deviation|2
1567002|NCT03123471|5412427|P2|Placebo-controlled Phase|Lost to Follow-up|3
1567003|NCT03123471|5412428|P1|Placebo-controlled Phase|Lost to Follow-up|1
1567004|NCT03123471|5412427|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
1567005|NCT03123471|5412428|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
1567006|NCT03123471|5412427|P2|Placebo-controlled Phase|Withdrawal by Subject|16
1567007|NCT03123471|5412428|P1|Placebo-controlled Phase|Withdrawal by Subject|6
1567008|NCT03123471|5412427|P2|Placebo-controlled Phase|Lack of Efficacy|4
1567009|NCT03123471|5412428|P1|Placebo-controlled Phase|Lack of Efficacy|3
1567010|NCT03123471|5412427|P2|Placebo-controlled Phase|Adverse Event|8
1567011|NCT03123471|5412428|P1|Placebo-controlled Phase|Adverse Event|3
1567012|NCT03123354|5412453|P1|Overall Study|Physician Decision|6
1567013|NCT03122548|5412464|P1|Overall Study|Study Terminated by Sponsor|2
1567014|NCT03122548|5412464|P1|Overall Study|Progression - subject went into hospice|1
1567015|NCT03122548|5412464|P1|Overall Study|Death|2
1567016|NCT03122184|5412474|P2|Overall Study|Terminated due to cognitive problem|0
1567017|NCT03122184|5412475|P1|Overall Study|Terminated due to cognitive problem|1
1567018|NCT03122184|5412474|P2|Overall Study|Withdrawal by Subject|0
1567019|NCT03122184|5412475|P1|Overall Study|Withdrawal by Subject|3
1567020|NCT03122184|5412474|P2|Overall Study|Lost to Follow-up|6
1567021|NCT03122184|5412475|P1|Overall Study|Lost to Follow-up|4
1567022|NCT03121950|5412514|P2|Overall Study|Withdrawal by Subject|2
1567023|NCT03121950|5412515|P1|Overall Study|Withdrawal by Subject|10
1567024|NCT03120676|5412592|P1|Overall Study|Not treated|1
1567025|NCT03120520|5412600|P4|Overall Study|Other|0
1567026|NCT03120520|5412601|P3|Overall Study|Other|0
1567027|NCT03120520|5412602|P2|Overall Study|Other|1
1567028|NCT03120520|5412603|P1|Overall Study|Other|0
1567029|NCT03120520|5412600|P4|Overall Study|Withdrawal by Subject|2
1567030|NCT03120520|5412601|P3|Overall Study|Withdrawal by Subject|3
1567031|NCT03120520|5412602|P2|Overall Study|Withdrawal by Subject|2
1567032|NCT03120520|5412603|P1|Overall Study|Withdrawal by Subject|3
1567033|NCT03120520|5412600|P4|Overall Study|Lost to Follow-up|1
1567034|NCT03120520|5412601|P3|Overall Study|Lost to Follow-up|1
1567035|NCT03120520|5412602|P2|Overall Study|Lost to Follow-up|1
1567036|NCT03120520|5412603|P1|Overall Study|Lost to Follow-up|1
1567037|NCT03120013|5412625|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
1567038|NCT03120013|5412626|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
1567039|NCT03119688|5412668|P1|Overall Study|Adverse Event|4
1567040|NCT03119662|5412701|P2|Overall Study|Withdrawal by Subject|1
1567041|NCT03119662|5412702|P1|Overall Study|Withdrawal by Subject|0
1567042|NCT03118934|5412804|P6|Overall Study|Discontinued prior to exposure|0
1567043|NCT03118934|5412805|P5|Overall Study|Discontinued prior to exposure|2
1567044|NCT03118934|5412806|P4|Overall Study|Discontinued prior to exposure|1
1567045|NCT03118934|5412807|P3|Overall Study|Discontinued prior to exposure|1
1567046|NCT03118934|5412808|P2|Overall Study|Discontinued prior to exposure|1
1567047|NCT03118934|5412809|P1|Overall Study|Discontinued prior to exposure|0
1567048|NCT03118934|5412804|P6|Overall Study|Physician Decision|1
1567049|NCT03118934|5412805|P5|Overall Study|Physician Decision|0
1567050|NCT03118934|5412806|P4|Overall Study|Physician Decision|0
1567051|NCT03118934|5412807|P3|Overall Study|Physician Decision|0
1567052|NCT03118934|5412808|P2|Overall Study|Physician Decision|0
1567053|NCT03118934|5412809|P1|Overall Study|Physician Decision|0
1567054|NCT03118934|5412804|P6|Overall Study|Adverse Event|1
1567055|NCT03118934|5412805|P5|Overall Study|Adverse Event|0
1567056|NCT03118934|5412806|P4|Overall Study|Adverse Event|0
1567057|NCT03118934|5412807|P3|Overall Study|Adverse Event|0
1567058|NCT03118934|5412808|P2|Overall Study|Adverse Event|0
1567059|NCT03118934|5412809|P1|Overall Study|Adverse Event|0
1567060|NCT03118765|5412833|P5|Overall Study|Sponsor Decision|1
1567061|NCT03118765|5412834|P4|Overall Study|Sponsor Decision|0
1567062|NCT03118765|5412835|P3|Overall Study|Sponsor Decision|1
1567063|NCT03118765|5412836|P2|Overall Study|Sponsor Decision|0
1567064|NCT03118765|5412837|P1|Overall Study|Sponsor Decision|1
1567065|NCT03118765|5412833|P5|Overall Study|Lost to Follow-up|0
1567066|NCT03118765|5412834|P4|Overall Study|Lost to Follow-up|0
1567067|NCT03118765|5412835|P3|Overall Study|Lost to Follow-up|1
1567068|NCT03118765|5412836|P2|Overall Study|Lost to Follow-up|0
1567069|NCT03118765|5412837|P1|Overall Study|Lost to Follow-up|1
1567070|NCT03118765|5412833|P5|Overall Study|COPD Exacerbation|0
1567071|NCT03118765|5412834|P4|Overall Study|COPD Exacerbation|1
1567072|NCT03118765|5412835|P3|Overall Study|COPD Exacerbation|0
1567073|NCT03118765|5412836|P2|Overall Study|COPD Exacerbation|0
1567074|NCT03118765|5412837|P1|Overall Study|COPD Exacerbation|1
1567075|NCT03118765|5412833|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
1567076|NCT03118765|5412834|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
1567077|NCT03118765|5412835|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
1567078|NCT03118765|5412836|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
1567079|NCT03118765|5412837|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
1567080|NCT03118765|5412833|P5|Overall Study|Non compliance with Study Procedures|0
1567081|NCT03118765|5412834|P4|Overall Study|Non compliance with Study Procedures|1
1567082|NCT03118765|5412835|P3|Overall Study|Non compliance with Study Procedures|0
1567083|NCT03118765|5412836|P2|Overall Study|Non compliance with Study Procedures|0
1567084|NCT03118765|5412837|P1|Overall Study|Non compliance with Study Procedures|0
1567085|NCT03118765|5412833|P5|Overall Study|Adverse Event|1
1567086|NCT03118765|5412834|P4|Overall Study|Adverse Event|1
1567087|NCT03118765|5412835|P3|Overall Study|Adverse Event|1
1567088|NCT03118765|5412836|P2|Overall Study|Adverse Event|1
1567089|NCT03118765|5412837|P1|Overall Study|Adverse Event|1
1567090|NCT03118765|5412833|P5|Overall Study|Withdrawal by Subject|0
1567091|NCT03118765|5412834|P4|Overall Study|Withdrawal by Subject|0
1567092|NCT03118765|5412835|P3|Overall Study|Withdrawal by Subject|1
1567093|NCT03118765|5412836|P2|Overall Study|Withdrawal by Subject|0
1567094|NCT03118765|5412837|P1|Overall Study|Withdrawal by Subject|0
1567095|NCT03118739|5412933|P2|Overall Study|Lost to Follow-up|0
1567096|NCT03118739|5412934|P1|Overall Study|Lost to Follow-up|2
1567097|NCT03118739|5412933|P2|Overall Study|Withdrawal by Subject|3
1567098|NCT03118739|5412934|P1|Overall Study|Withdrawal by Subject|5
1567099|NCT03118739|5412933|P2|Overall Study|Physician Decision|1
1567100|NCT03118739|5412934|P1|Overall Study|Physician Decision|0
1567101|NCT03118297|5413047|P2|Overall Study|Lost to Follow-up|2
1567102|NCT03118297|5413048|P1|Overall Study|Lost to Follow-up|0
1567103|NCT03116698|5413181|P4|Overall Study|Death|0
1567104|NCT03116698|5413182|P3|Overall Study|Death|2
1567105|NCT03116698|5413183|P2|Overall Study|Death|0
1567106|NCT03116698|5413184|P1|Overall Study|Death|0
1567107|NCT03116698|5413181|P4|Overall Study|Protocol Violation|0
1567108|NCT03116698|5413182|P3|Overall Study|Protocol Violation|0
1567109|NCT03116698|5413183|P2|Overall Study|Protocol Violation|0
1567110|NCT03116698|5413184|P1|Overall Study|Protocol Violation|1
1567111|NCT03116698|5413181|P4|Overall Study|Physician Decision|0
1567112|NCT03116698|5413182|P3|Overall Study|Physician Decision|0
1567113|NCT03116698|5413183|P2|Overall Study|Physician Decision|1
1567114|NCT03116698|5413184|P1|Overall Study|Physician Decision|1
1567115|NCT03116698|5413181|P4|Overall Study|Lost to Follow-up|0
1567116|NCT03116698|5413182|P3|Overall Study|Lost to Follow-up|0
1567117|NCT03116698|5413183|P2|Overall Study|Lost to Follow-up|0
1567118|NCT03116698|5413184|P1|Overall Study|Lost to Follow-up|2
1567119|NCT03116698|5413181|P4|Overall Study|Withdrawal by Subject|2
1567120|NCT03116698|5413182|P3|Overall Study|Withdrawal by Subject|5
1567121|NCT03116698|5413183|P2|Overall Study|Withdrawal by Subject|4
1567122|NCT03116698|5413184|P1|Overall Study|Withdrawal by Subject|1
1567123|NCT03116698|5413181|P4|Overall Study|Adverse Event|0
1567124|NCT03116698|5413182|P3|Overall Study|Adverse Event|1
1567125|NCT03116698|5413183|P2|Overall Study|Adverse Event|1
1567126|NCT03116698|5413184|P1|Overall Study|Adverse Event|1
1567127|NCT03115476|5413227|P3|LP0084-1369|Trial terminated by Sponsor|160
1567128|NCT03115476|5413228|P2|LP0084-1369|Trial terminated by Sponsor|210
1567129|NCT03115476|5413229|P1|LP0084-1369|Trial terminated by Sponsor|190
1567130|NCT03115476|5413227|P3|LP0084-1369|Death|2
1567131|NCT03115476|5413228|P2|LP0084-1369|Death|0
1567132|NCT03115476|5413229|P1|LP0084-1369|Death|1
1567133|NCT03114969|5413278|P9|Overall Study|Adverse Event|2
1567134|NCT03114969|5413279|P8|Overall Study|Adverse Event|0
1567135|NCT03114969|5413280|P7|Overall Study|Adverse Event|1
1567136|NCT03114969|5413281|P6|Overall Study|Adverse Event|1
1567137|NCT03114969|5413282|P5|Overall Study|Adverse Event|0
1567138|NCT03114969|5413283|P4|Overall Study|Adverse Event|0
1567139|NCT03114969|5413284|P3|Overall Study|Adverse Event|1
1567140|NCT03114969|5413285|P2|Overall Study|Adverse Event|0
1567141|NCT03114969|5413286|P1|Overall Study|Adverse Event|0
1567142|NCT03114969|5413278|P9|Overall Study|Lost to Follow-up|0
1567143|NCT03114969|5413279|P8|Overall Study|Lost to Follow-up|0
1567144|NCT03114969|5413280|P7|Overall Study|Lost to Follow-up|0
1567145|NCT03114969|5413281|P6|Overall Study|Lost to Follow-up|0
1567146|NCT03114969|5413282|P5|Overall Study|Lost to Follow-up|0
1567147|NCT03114969|5413283|P4|Overall Study|Lost to Follow-up|2
1567148|NCT03114969|5413284|P3|Overall Study|Lost to Follow-up|3
1567149|NCT03114969|5413285|P2|Overall Study|Lost to Follow-up|0
1567150|NCT03114969|5413286|P1|Overall Study|Lost to Follow-up|0
1567151|NCT03114488|5413381|P2|Time Period 2|Withdrawal by Subject|3
1567152|NCT03114488|5413382|P1|Time Period 2|Withdrawal by Subject|1
1567153|NCT03111108|5413441|P2|Overall Study|Withdrawal by Subject|0
1567154|NCT03111108|5413442|P1|Overall Study|Withdrawal by Subject|1
1567155|NCT03111108|5413441|P2|Overall Study|Death|1
1567156|NCT03111108|5413442|P1|Overall Study|Death|0
1567157|NCT03110900|5413460|P2|Overall Study|Sponsor withdrew|1
1567158|NCT03110900|5413461|P1|Overall Study|Sponsor withdrew|1
1567159|NCT03110380|5413485|P2|Overall Study|Lost to Follow-up|1
1567160|NCT03110380|5413486|P1|Overall Study|Lost to Follow-up|4
1567161|NCT03110380|5413485|P2|Overall Study|Withdrew Consent|16
1567162|NCT03110380|5413486|P1|Overall Study|Withdrew Consent|9
1567163|NCT03110380|5413485|P2|Overall Study|Protocol Violation|1
1567164|NCT03110380|5413486|P1|Overall Study|Protocol Violation|0
1567165|NCT03110380|5413485|P2|Overall Study|Non-Compliance with Study Drug|1
1567166|NCT03110380|5413486|P1|Overall Study|Non-Compliance with Study Drug|1
1567167|NCT03110380|5413485|P2|Overall Study|Investigator's Discretion|2
1567168|NCT03110380|5413486|P1|Overall Study|Investigator's Discretion|1
1567169|NCT03110380|5413485|P2|Overall Study|Death|1
1567170|NCT03110380|5413486|P1|Overall Study|Death|2
1567171|NCT03110380|5413485|P2|Overall Study|Adverse Event|3
1567172|NCT03110380|5413486|P1|Overall Study|Adverse Event|3
1567173|NCT03110380|5413485|P2|Overall Study|Still in Study|256
1567174|NCT03110380|5413486|P1|Overall Study|Still in Study|264
1567175|NCT03110380|5413485|P2|Overall Study|Randomized and Never Treated|2
1567176|NCT03110380|5413486|P1|Overall Study|Randomized and Never Treated|0
1567177|NCT03110159|5413496|P1|Overall Study|Study termination|1
1567178|NCT03110029|5413507|P2|Overall Study|Withdrawal by Subject|1
1567179|NCT03110029|5413508|P1|Overall Study|Withdrawal by Subject|1
1567180|NCT03109184|5413576|P2|Overall Study|Withdrawal by Subject|1
1567181|NCT03109184|5413577|P1|Overall Study|Withdrawal by Subject|1
1567182|NCT03109184|5413576|P2|Overall Study|Lost to Follow-up|6
1567183|NCT03109184|5413577|P1|Overall Study|Lost to Follow-up|6
1567184|NCT03108157|5413738|P2|Overall Study|Protocol Violation|4
1567185|NCT03108157|5413739|P1|Overall Study|Protocol Violation|15
1567186|NCT03108027|5413745|P6|Period 3|Adverse Event|0
1567187|NCT03108027|5413746|P5|Period 3|Adverse Event|0
1567188|NCT03108027|5413747|P4|Period 3|Adverse Event|0
1567189|NCT03108027|5413748|P3|Period 3|Adverse Event|0
1567190|NCT03108027|5413749|P2|Period 3|Adverse Event|1
1567191|NCT03108027|5413750|P1|Period 3|Adverse Event|0
1567192|NCT03108027|5413745|P6|Period 1|Subject/Guardian Decision|0
1567193|NCT03108027|5413746|P5|Period 1|Subject/Guardian Decision|0
1567194|NCT03108027|5413747|P4|Period 1|Subject/Guardian Decision|2
1567195|NCT03108027|5413748|P3|Period 1|Subject/Guardian Decision|0
1567196|NCT03108027|5413749|P2|Period 1|Subject/Guardian Decision|0
1567197|NCT03108027|5413750|P1|Period 1|Subject/Guardian Decision|0
1567200|NCT03105297|5413823|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
1567201|NCT03105297|5413823|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
1567202|NCT03105297|5413823|P1|Baseline Phase (Day 1)|Other|21
1567203|NCT03104816|5413867|P3|Overall Study|Protocol Violation|2
1567204|NCT03104816|5413868|P2|Overall Study|Protocol Violation|0
1567205|NCT03104816|5413869|P1|Overall Study|Protocol Violation|2
1567206|NCT03104816|5413867|P3|Overall Study|Lack of Efficacy|0
1567207|NCT03104816|5413868|P2|Overall Study|Lack of Efficacy|2
1567208|NCT03104816|5413869|P1|Overall Study|Lack of Efficacy|0
1567209|NCT03103919|5413921|P2|Overall Study|Adverse Event|2
1567210|NCT03103919|5413922|P1|Overall Study|Adverse Event|2
1567211|NCT03103906|5413958|P2|Overall Study|Other|0
1567212|NCT03103906|5413959|P1|Overall Study|Other|2
1567213|NCT03103906|5413958|P2|Overall Study|Adverse Event|3
1567214|NCT03103906|5413959|P1|Overall Study|Adverse Event|2
1567215|NCT03102918|5413986|P2|Overall Study|Protocol Violation|0
1567216|NCT03102918|5413987|P1|Overall Study|Protocol Violation|1
1567217|NCT03102762|5414013|P2|Overall Study|Lost to Follow-up|0
1567218|NCT03102762|5414014|P1|Overall Study|Lost to Follow-up|1
1567219|NCT03102034|5414051|P2|Overall Study|Withdrawal by Subject|0
1567220|NCT03102034|5414052|P1|Overall Study|Withdrawal by Subject|1
1567221|NCT03101462|5414080|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
1567222|NCT03101462|5414081|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
1567229|NCT03101293|5414118|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
1567230|NCT03101293|5414119|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
1567231|NCT03101150|5414133|P2|Overall Study|Miscarriage|6
1567232|NCT03101150|5414134|P1|Overall Study|Miscarriage|3
1567233|NCT03101150|5414133|P2|Overall Study|Lost to Follow-up|4
1567234|NCT03101150|5414134|P1|Overall Study|Lost to Follow-up|2
1567235|NCT03101020|5414169|P2|Overall Study|Withdrawal by Subject|2
1567236|NCT03101020|5414170|P1|Overall Study|Withdrawal by Subject|0
1567237|NCT03101020|5414169|P2|Overall Study|Ran over by a car|1
1567238|NCT03101020|5414170|P1|Overall Study|Ran over by a car|0
1567239|NCT03101020|5414169|P2|Overall Study|Lack of time to participate|0
1567240|NCT03101020|5414170|P1|Overall Study|Lack of time to participate|1
1567241|NCT03100942|5414205|P4|Overall Study|Randomized but didn't receive study drug|1
1567242|NCT03100942|5414206|P3|Overall Study|Randomized but didn't receive study drug|0
1567243|NCT03100942|5414207|P2|Overall Study|Randomized but didn't receive study drug|1
1567244|NCT03100942|5414208|P1|Overall Study|Randomized but didn't receive study drug|0
1567245|NCT03100942|5414205|P4|Overall Study|Still on the Study|17
1567246|NCT03100942|5414206|P3|Overall Study|Still on the Study|23
1567247|NCT03100942|5414207|P2|Overall Study|Still on the Study|15
1567248|NCT03100942|5414208|P1|Overall Study|Still on the Study|22
1567249|NCT03100942|5414205|P4|Overall Study|Protocol Violation|1
1567250|NCT03100942|5414206|P3|Overall Study|Protocol Violation|0
1567251|NCT03100942|5414207|P2|Overall Study|Protocol Violation|0
1567252|NCT03100942|5414208|P1|Overall Study|Protocol Violation|1
1567253|NCT03100942|5414205|P4|Overall Study|Investigator's Discretion|0
1567254|NCT03100942|5414206|P3|Overall Study|Investigator's Discretion|0
1567255|NCT03100942|5414207|P2|Overall Study|Investigator's Discretion|1
1567256|NCT03100942|5414208|P1|Overall Study|Investigator's Discretion|1
1567257|NCT03100942|5414205|P4|Overall Study|Adverse Event|0
1567258|NCT03100942|5414206|P3|Overall Study|Adverse Event|1
1567259|NCT03100942|5414207|P2|Overall Study|Adverse Event|6
1567260|NCT03100942|5414208|P1|Overall Study|Adverse Event|1
1567261|NCT03100942|5414205|P4|Overall Study|Withdrew Consent|4
1567262|NCT03100942|5414206|P3|Overall Study|Withdrew Consent|2
1567263|NCT03100942|5414207|P2|Overall Study|Withdrew Consent|4
1567264|NCT03100942|5414208|P1|Overall Study|Withdrew Consent|4
1567265|NCT03100838|5414234|P4|Overall Study|Lost to Follow-up|0
1567266|NCT03100838|5414235|P3|Overall Study|Lost to Follow-up|1
1567267|NCT03100838|5414236|P2|Overall Study|Lost to Follow-up|0
1567268|NCT03100838|5414237|P1|Overall Study|Lost to Follow-up|0
1567269|NCT03100838|5414234|P4|Overall Study|Pregnancy|0
1567270|NCT03100838|5414235|P3|Overall Study|Pregnancy|0
1567271|NCT03100838|5414236|P2|Overall Study|Pregnancy|1
1567272|NCT03100838|5414237|P1|Overall Study|Pregnancy|0
1567273|NCT03100838|5414234|P4|Overall Study|Physician Decision|1
1567274|NCT03100838|5414235|P3|Overall Study|Physician Decision|1
1567275|NCT03100838|5414236|P2|Overall Study|Physician Decision|1
1567276|NCT03100838|5414237|P1|Overall Study|Physician Decision|1
1567277|NCT03100838|5414234|P4|Overall Study|Adverse Event|0
1567278|NCT03100838|5414235|P3|Overall Study|Adverse Event|0
1567279|NCT03100838|5414236|P2|Overall Study|Adverse Event|0
1567280|NCT03100838|5414237|P1|Overall Study|Adverse Event|1
1567281|NCT03100344|5414276|P4|Overall Study|Lost to Follow-up|1
1567282|NCT03100344|5414277|P3|Overall Study|Lost to Follow-up|1
1567283|NCT03100344|5414278|P2|Overall Study|Lost to Follow-up|1
1567284|NCT03100344|5414279|P1|Overall Study|Lost to Follow-up|1
1567285|NCT03100344|5414276|P4|Overall Study|Withdrawal by Subject|8
1567286|NCT03100344|5414277|P3|Overall Study|Withdrawal by Subject|4
1567287|NCT03100344|5414278|P2|Overall Study|Withdrawal by Subject|7
1567288|NCT03100344|5414279|P1|Overall Study|Withdrawal by Subject|10
1567289|NCT03100344|5414276|P4|Overall Study|Protocol Violation|0
1567290|NCT03100344|5414277|P3|Overall Study|Protocol Violation|0
1567291|NCT03100344|5414278|P2|Overall Study|Protocol Violation|0
1567292|NCT03100344|5414279|P1|Overall Study|Protocol Violation|1
1567293|NCT03100344|5414276|P4|Overall Study|Lack of Efficacy|0
1567294|NCT03100344|5414277|P3|Overall Study|Lack of Efficacy|0
1567295|NCT03100344|5414278|P2|Overall Study|Lack of Efficacy|0
1567296|NCT03100344|5414279|P1|Overall Study|Lack of Efficacy|2
1567297|NCT03100344|5414276|P4|Overall Study|Adverse Event|3
1567298|NCT03100344|5414277|P3|Overall Study|Adverse Event|2
1567299|NCT03100344|5414278|P2|Overall Study|Adverse Event|3
1567300|NCT03100344|5414279|P1|Overall Study|Adverse Event|0
1567301|NCT03100058|5414366|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567302|NCT03100058|5414367|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567303|NCT03100058|5414368|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567304|NCT03100058|5414369|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
1567305|NCT03100058|5414370|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567306|NCT03100058|5414371|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567307|NCT03100058|5414372|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567308|NCT03100058|5414373|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567309|NCT03100058|5414374|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567310|NCT03100058|5414375|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567311|NCT03100058|5414376|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567312|NCT03100058|5414377|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567313|NCT03100058|5414378|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
1567314|NCT03100058|5414366|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
1567315|NCT03100058|5414367|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567316|NCT03100058|5414368|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567317|NCT03100058|5414369|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567318|NCT03100058|5414370|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567319|NCT03100058|5414371|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567320|NCT03100058|5414372|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567321|NCT03100058|5414373|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567322|NCT03100058|5414374|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567323|NCT03100058|5414375|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567324|NCT03100058|5414376|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567325|NCT03100058|5414377|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567326|NCT03100058|5414378|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
1567327|NCT03100058|5414366|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567328|NCT03100058|5414367|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567329|NCT03100058|5414368|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
1567330|NCT03100058|5414369|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567331|NCT03100058|5414370|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567332|NCT03100058|5414371|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567333|NCT03100058|5414372|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567334|NCT03100058|5414373|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567335|NCT03100058|5414374|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567336|NCT03100058|5414375|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567337|NCT03100058|5414376|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567338|NCT03100058|5414377|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567339|NCT03100058|5414378|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
1567340|NCT03100058|5414366|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
1567341|NCT03100058|5414367|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567342|NCT03100058|5414368|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
1567343|NCT03100058|5414369|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
1567344|NCT03100058|5414370|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567345|NCT03100058|5414371|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567346|NCT03100058|5414372|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567347|NCT03100058|5414373|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567348|NCT03100058|5414374|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567349|NCT03100058|5414375|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567350|NCT03100058|5414376|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567351|NCT03100058|5414377|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567352|NCT03100058|5414378|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
1567353|NCT03100058|5414366|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567354|NCT03100058|5414367|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
1567355|NCT03100058|5414368|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
1567356|NCT03100058|5414369|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567357|NCT03100058|5414370|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567358|NCT03100058|5414371|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567359|NCT03100058|5414372|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567360|NCT03100058|5414373|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567361|NCT03100058|5414374|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567362|NCT03100058|5414375|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567363|NCT03100058|5414376|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567364|NCT03100058|5414377|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567365|NCT03100058|5414378|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
1567366|NCT03100058|5414366|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
1567367|NCT03100058|5414367|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
1567368|NCT03100058|5414368|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
1567369|NCT03100058|5414369|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567370|NCT03100058|5414370|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567371|NCT03100058|5414371|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567372|NCT03100058|5414372|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567373|NCT03100058|5414373|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567374|NCT03100058|5414374|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567375|NCT03100058|5414375|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567376|NCT03100058|5414376|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567377|NCT03100058|5414377|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567378|NCT03100058|5414378|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
1567379|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567380|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567381|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567382|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567383|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567384|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567385|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
1567386|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567387|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567388|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567389|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567390|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567391|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
1567392|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567393|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567394|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567395|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567396|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567397|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567398|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567399|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567400|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567401|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567402|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567403|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
1567404|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
1567405|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
1567406|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
1567407|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
1567408|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
1567409|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
1567410|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
1567411|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
1567412|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
1567413|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
1567414|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
1567415|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
1567416|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
1567417|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
1567418|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567419|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567420|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567421|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567422|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567423|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567424|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
1567425|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567426|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567427|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
1567428|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567429|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567430|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
1567431|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567432|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567433|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567434|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567435|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567436|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
1567437|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567438|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567439|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567440|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
1567441|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567442|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567443|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
1567444|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567445|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567446|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567447|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567448|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1567449|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567450|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1567451|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567452|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567453|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567454|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1567455|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
1567456|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
1567457|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567458|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567459|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567460|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567461|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567462|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567463|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1567464|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1567465|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567466|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567467|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1567468|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
1567469|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
1567470|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1567471|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1567472|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1567473|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
1567474|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
1567475|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
1567476|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
1567477|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
1567478|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
1567479|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
1567480|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
1567481|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
1567482|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
1567483|NCT03100058|5414366|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1567484|NCT03100058|5414367|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1567485|NCT03100058|5414368|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1567486|NCT03100058|5414369|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1567487|NCT03100058|5414370|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
1567488|NCT03100058|5414371|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
1567489|NCT03100058|5414372|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
1567490|NCT03100058|5414373|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1567491|NCT03100058|5414374|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
1567492|NCT03100058|5414375|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
1567493|NCT03100058|5414376|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
1567494|NCT03100058|5414377|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1567495|NCT03100058|5414378|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
1567496|NCT03099694|5414585|P2|Overall Study|Lost to Follow-up|5
1567497|NCT03099694|5414586|P1|Overall Study|Lost to Follow-up|9
1567498|NCT03099694|5414585|P2|Overall Study|Withdrawal by Subject|13
1567499|NCT03099694|5414586|P1|Overall Study|Withdrawal by Subject|11
1567522|NCT03099161|5414690|P3|Overall Study|Progressive Disease|1
1567523|NCT03099161|5414691|P2|Overall Study|Progressive Disease|4
1567524|NCT03099161|5414692|P1|Overall Study|Progressive Disease|1
1567525|NCT03099161|5414690|P3|Overall Study|Physician Decision|0
1567526|NCT03099161|5414691|P2|Overall Study|Physician Decision|0
1567527|NCT03099161|5414692|P1|Overall Study|Physician Decision|2
1567528|NCT03099161|5414690|P3|Overall Study|Adverse Event|2
1567529|NCT03099161|5414691|P2|Overall Study|Adverse Event|0
1567530|NCT03099161|5414692|P1|Overall Study|Adverse Event|0
1567531|NCT03099096|5414709|P1|Overall Study|Physician Decision|1
1567532|NCT03099096|5414709|P1|Overall Study|Adverse Event|1
1567533|NCT03098979|5414722|P6|Overall Study|Protocol Violation|1
1567534|NCT03098979|5414723|P5|Overall Study|Protocol Violation|0
1567535|NCT03098979|5414724|P4|Overall Study|Protocol Violation|0
1567536|NCT03098979|5414725|P3|Overall Study|Protocol Violation|0
1567537|NCT03098979|5414726|P2|Overall Study|Protocol Violation|0
1567538|NCT03098979|5414727|P1|Overall Study|Protocol Violation|0
1567539|NCT03098979|5414722|P6|Overall Study|Non-compliance|1
1567540|NCT03098979|5414723|P5|Overall Study|Non-compliance|0
1567541|NCT03098979|5414724|P4|Overall Study|Non-compliance|0
1567542|NCT03098979|5414725|P3|Overall Study|Non-compliance|0
1567543|NCT03098979|5414726|P2|Overall Study|Non-compliance|0
1567544|NCT03098979|5414727|P1|Overall Study|Non-compliance|0
1567545|NCT03098979|5414722|P6|Overall Study|Physician Decision|0
1567546|NCT03098979|5414723|P5|Overall Study|Physician Decision|0
1567547|NCT03098979|5414724|P4|Overall Study|Physician Decision|0
1567548|NCT03098979|5414725|P3|Overall Study|Physician Decision|0
1567549|NCT03098979|5414726|P2|Overall Study|Physician Decision|1
1567550|NCT03098979|5414727|P1|Overall Study|Physician Decision|2
1567551|NCT03098979|5414722|P6|Overall Study|Death|0
1567552|NCT03098979|5414723|P5|Overall Study|Death|1
1567553|NCT03098979|5414724|P4|Overall Study|Death|0
1567554|NCT03098979|5414725|P3|Overall Study|Death|2
1567555|NCT03098979|5414726|P2|Overall Study|Death|0
1567556|NCT03098979|5414727|P1|Overall Study|Death|1
1567557|NCT03098979|5414722|P6|Overall Study|Withdrawal by Subject|1
1567558|NCT03098979|5414723|P5|Overall Study|Withdrawal by Subject|2
1567559|NCT03098979|5414724|P4|Overall Study|Withdrawal by Subject|1
1567560|NCT03098979|5414725|P3|Overall Study|Withdrawal by Subject|1
1567561|NCT03098979|5414726|P2|Overall Study|Withdrawal by Subject|1
1567562|NCT03098979|5414727|P1|Overall Study|Withdrawal by Subject|2
1567563|NCT03098979|5414722|P6|Overall Study|Adverse Event|1
1567564|NCT03098979|5414723|P5|Overall Study|Adverse Event|6
1567565|NCT03098979|5414724|P4|Overall Study|Adverse Event|4
1567566|NCT03098979|5414725|P3|Overall Study|Adverse Event|1
1567567|NCT03098979|5414726|P2|Overall Study|Adverse Event|0
1567568|NCT03098979|5414727|P1|Overall Study|Adverse Event|1
1567569|NCT03097861|5414869|P3|Overall Study|Reason not provided|1
1567570|NCT03097861|5414870|P2|Overall Study|Reason not provided|1
1567571|NCT03097861|5414871|P1|Overall Study|Reason not provided|3
1567572|NCT03097861|5414869|P3|Overall Study|Withdrawal by Subject|3
1567573|NCT03097861|5414870|P2|Overall Study|Withdrawal by Subject|5
1567574|NCT03097861|5414871|P1|Overall Study|Withdrawal by Subject|1
1567575|NCT03097861|5414869|P3|Overall Study|Lost to Follow-up|1
1567576|NCT03097861|5414870|P2|Overall Study|Lost to Follow-up|7
1567577|NCT03097861|5414871|P1|Overall Study|Lost to Follow-up|0
1567578|NCT03097861|5414869|P3|Overall Study|Investigator Decision|0
1567579|NCT03097861|5414870|P2|Overall Study|Investigator Decision|1
1567580|NCT03097861|5414871|P1|Overall Study|Investigator Decision|0
1567581|NCT03097861|5414869|P3|Overall Study|Adverse Event|4
1567582|NCT03097861|5414870|P2|Overall Study|Adverse Event|8
1567583|NCT03097861|5414871|P1|Overall Study|Adverse Event|3
1567584|NCT03097614|5414888|P1|Overall Study|Adverse Event|3
1567585|NCT03097289|5414990|P1|Overall Study|Collected platelet product unusable|3
1567586|NCT03097289|5414990|P1|Overall Study|Equipment failure|2
1567587|NCT03097289|5414990|P1|Overall Study|Adverse Event|1
1567588|NCT03096483|5415034|P1|Overall Study|Withdrawal by site|1
1567589|NCT03096314|5415063|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
1567590|NCT03096314|5415064|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
1567591|NCT03095651|5415120|P8|Overall Study|Withdrawal by Subject|0
1567592|NCT03095651|5415121|P7|Overall Study|Withdrawal by Subject|0
1567593|NCT03095651|5415122|P6|Overall Study|Withdrawal by Subject|1
1567594|NCT03095651|5415123|P5|Overall Study|Withdrawal by Subject|0
1567595|NCT03095651|5415124|P4|Overall Study|Withdrawal by Subject|0
1567596|NCT03095651|5415125|P3|Overall Study|Withdrawal by Subject|0
1567597|NCT03095651|5415126|P2|Overall Study|Withdrawal by Subject|0
1567598|NCT03095651|5415127|P1|Overall Study|Withdrawal by Subject|0
1567599|NCT03095651|5415120|P8|Overall Study|Lost to Follow-up|0
1567600|NCT03095651|5415121|P7|Overall Study|Lost to Follow-up|0
1567601|NCT03095651|5415122|P6|Overall Study|Lost to Follow-up|0
1567602|NCT03095651|5415123|P5|Overall Study|Lost to Follow-up|0
1567603|NCT03095651|5415124|P4|Overall Study|Lost to Follow-up|1
1567604|NCT03095651|5415125|P3|Overall Study|Lost to Follow-up|0
1567605|NCT03095651|5415126|P2|Overall Study|Lost to Follow-up|1
1567606|NCT03095651|5415127|P1|Overall Study|Lost to Follow-up|1
1567607|NCT03095599|5415406|P2|Overall Study|Withdrawal prior to vaccination|0
1567608|NCT03095599|5415407|P1|Overall Study|Withdrawal prior to vaccination|1
1567609|NCT03095599|5415406|P2|Overall Study|Lost to Follow-up|0
1567610|NCT03095599|5415407|P1|Overall Study|Lost to Follow-up|1
1567611|NCT03095599|5415406|P2|Overall Study|Withdrawal by Subject|0
1567612|NCT03095599|5415407|P1|Overall Study|Withdrawal by Subject|1
1567613|NCT03095521|5415443|P2|Overall Study|Lost to Follow-up|1
1567614|NCT03095521|5415444|P1|Overall Study|Lost to Follow-up|0
1567615|NCT03095521|5415443|P2|Overall Study|Withdrawal by Subject|1
1567616|NCT03095521|5415444|P1|Overall Study|Withdrawal by Subject|0
1567617|NCT03095508|5415462|P2|Overall Study|Adverse Event|1
1567618|NCT03095508|5415463|P1|Overall Study|Adverse Event|0
1567619|NCT03095027|5415511|P2|Period 2, Second Week of Wear|Adverse Event|0
1567620|NCT03095027|5415512|P1|Period 2, Second Week of Wear|Adverse Event|1
1567633|NCT03092791|5415606|P8|Overall Study|Reason Not Specified|0
1567634|NCT03092791|5415607|P7|Overall Study|Reason Not Specified|0
1567635|NCT03092791|5415608|P6|Overall Study|Reason Not Specified|1
1567636|NCT03092791|5415609|P5|Overall Study|Reason Not Specified|1
1567637|NCT03092791|5415610|P4|Overall Study|Reason Not Specified|0
1567638|NCT03092791|5415611|P3|Overall Study|Reason Not Specified|0
1567639|NCT03092791|5415612|P2|Overall Study|Reason Not Specified|0
1567640|NCT03092791|5415613|P1|Overall Study|Reason Not Specified|0
1567641|NCT03092791|5415606|P8|Overall Study|Death|1
1567642|NCT03092791|5415607|P7|Overall Study|Death|0
1567643|NCT03092791|5415608|P6|Overall Study|Death|1
1567644|NCT03092791|5415609|P5|Overall Study|Death|0
1567645|NCT03092791|5415610|P4|Overall Study|Death|0
1567646|NCT03092791|5415611|P3|Overall Study|Death|0
1567647|NCT03092791|5415612|P2|Overall Study|Death|0
1567648|NCT03092791|5415613|P1|Overall Study|Death|0
1567649|NCT03092791|5415606|P8|Overall Study|Study Termination|55
1567650|NCT03092791|5415607|P7|Overall Study|Study Termination|53
1567651|NCT03092791|5415608|P6|Overall Study|Study Termination|46
1567652|NCT03092791|5415609|P5|Overall Study|Study Termination|55
1567653|NCT03092791|5415610|P4|Overall Study|Study Termination|0
1567654|NCT03092791|5415611|P3|Overall Study|Study Termination|0
1567655|NCT03092791|5415612|P2|Overall Study|Study Termination|0
1567656|NCT03092791|5415613|P1|Overall Study|Study Termination|0
1567657|NCT03092791|5415606|P8|Overall Study|Withdrawal of Consent|4
1567658|NCT03092791|5415607|P7|Overall Study|Withdrawal of Consent|6
1567659|NCT03092791|5415608|P6|Overall Study|Withdrawal of Consent|12
1567660|NCT03092791|5415609|P5|Overall Study|Withdrawal of Consent|4
1567661|NCT03092791|5415610|P4|Overall Study|Withdrawal of Consent|0
1567662|NCT03092791|5415611|P3|Overall Study|Withdrawal of Consent|0
1567663|NCT03092791|5415612|P2|Overall Study|Withdrawal of Consent|0
1567664|NCT03092791|5415613|P1|Overall Study|Withdrawal of Consent|0
1567665|NCT03092791|5415606|P8|Overall Study|Lost to Follow-up|0
1567666|NCT03092791|5415607|P7|Overall Study|Lost to Follow-up|1
1567667|NCT03092791|5415608|P6|Overall Study|Lost to Follow-up|0
1567668|NCT03092791|5415609|P5|Overall Study|Lost to Follow-up|0
1567669|NCT03092791|5415610|P4|Overall Study|Lost to Follow-up|0
1567670|NCT03092791|5415611|P3|Overall Study|Lost to Follow-up|0
1567671|NCT03092791|5415612|P2|Overall Study|Lost to Follow-up|0
1567672|NCT03092791|5415613|P1|Overall Study|Lost to Follow-up|0
1567673|NCT03092752|5415728|P1|Overall Study|<6 month history|245900
1567674|NCT03092752|5415728|P1|Overall Study|Average hospital visit interval >92 days|10779
1567675|NCT03092752|5415728|P1|Overall Study|Having no claim of study drugs|29282
1567676|NCT03092752|5415728|P1|Overall Study|At least one claim with T2DM|61299
1567677|NCT03092752|5415728|P1|Overall Study|Aged <40 years|14209
1567678|NCT03092726|5415793|P2|Overall Study|Withdrawal by Subject|3
1567679|NCT03092726|5415794|P1|Overall Study|Withdrawal by Subject|5
1567680|NCT03092726|5415793|P2|Overall Study|Lost to Follow-up|0
1567681|NCT03092726|5415794|P1|Overall Study|Lost to Follow-up|1
1567682|NCT03092726|5415793|P2|Overall Study|Lack of Efficacy|1
1567683|NCT03092726|5415794|P1|Overall Study|Lack of Efficacy|0
1567684|NCT03092726|5415793|P2|Overall Study|Adverse Event|10
1567685|NCT03092726|5415794|P1|Overall Study|Adverse Event|3
1567690|NCT03091777|5415858|P3|Overall Study|Abnormal Laboratory Value|12
1567691|NCT03091777|5415859|P2|Overall Study|Abnormal Laboratory Value|11
1567692|NCT03091777|5415860|P1|Overall Study|Abnormal Laboratory Value|7
1567693|NCT03091777|5415858|P3|Overall Study|Physician Decision|1
1567694|NCT03091777|5415859|P2|Overall Study|Physician Decision|0
1567695|NCT03091777|5415860|P1|Overall Study|Physician Decision|1
1567696|NCT03091777|5415858|P3|Overall Study|Noncompliance with study drug|1
1567697|NCT03091777|5415859|P2|Overall Study|Noncompliance with study drug|3
1567698|NCT03091777|5415860|P1|Overall Study|Noncompliance with study drug|2
1567699|NCT03091777|5415858|P3|Overall Study|Lack of Efficacy|5
1567700|NCT03091777|5415859|P2|Overall Study|Lack of Efficacy|0
1567701|NCT03091777|5415860|P1|Overall Study|Lack of Efficacy|0
1567702|NCT03091777|5415858|P3|Overall Study|Lost to Follow-up|7
1567703|NCT03091777|5415859|P2|Overall Study|Lost to Follow-up|14
1567704|NCT03091777|5415860|P1|Overall Study|Lost to Follow-up|12
1567705|NCT03091777|5415858|P3|Overall Study|Protocol Violation|1
1567706|NCT03091777|5415859|P2|Overall Study|Protocol Violation|1
1567707|NCT03091777|5415860|P1|Overall Study|Protocol Violation|2
1567708|NCT03091777|5415858|P3|Overall Study|Withdrawal by Subject|6
1567709|NCT03091777|5415859|P2|Overall Study|Withdrawal by Subject|2
1567710|NCT03091777|5415860|P1|Overall Study|Withdrawal by Subject|4
1567711|NCT03091777|5415858|P3|Overall Study|Adverse Event|4
1567712|NCT03091777|5415859|P2|Overall Study|Adverse Event|1
1567713|NCT03091777|5415860|P1|Overall Study|Adverse Event|2
1567714|NCT03091777|5415858|P3|Overall Study|Pregnancy|0
1567715|NCT03091777|5415859|P2|Overall Study|Pregnancy|1
1567716|NCT03091777|5415860|P1|Overall Study|Pregnancy|2
1567717|NCT03091439|5415902|P2|Overall Study|Study Terminated by the Sponsor|0
1567718|NCT03091439|5415903|P1|Overall Study|Study Terminated by the Sponsor|1
1567719|NCT03091348|5415931|P2|Overall Study|Lost to Follow-up|1
1567720|NCT03091348|5415932|P1|Overall Study|Lost to Follow-up|2
1567721|NCT03090100|5416008|P2|Overall Study|Other|2
1567722|NCT03090100|5416009|P1|Overall Study|Other|2
1567723|NCT03090100|5416008|P2|Overall Study|Non-compliance|0
1567724|NCT03090100|5416009|P1|Overall Study|Non-compliance|2
1567725|NCT03090100|5416008|P2|Overall Study|Protocol Violation|6
1567726|NCT03090100|5416009|P1|Overall Study|Protocol Violation|2
1567727|NCT03090100|5416008|P2|Overall Study|Withdrawal by Subject|19
1567728|NCT03090100|5416009|P1|Overall Study|Withdrawal by Subject|7
1567729|NCT03090100|5416008|P2|Overall Study|Lost to Follow-up|2
1567730|NCT03090100|5416009|P1|Overall Study|Lost to Follow-up|2
1567731|NCT03090100|5416008|P2|Overall Study|Lack of Efficacy|7
1567732|NCT03090100|5416009|P1|Overall Study|Lack of Efficacy|2
1567733|NCT03090100|5416008|P2|Overall Study|Pregnancy|1
1567734|NCT03090100|5416009|P1|Overall Study|Pregnancy|1
1567735|NCT03090100|5416008|P2|Overall Study|Adverse Event|11
1567736|NCT03090100|5416009|P1|Overall Study|Adverse Event|9
1567737|NCT03089580|5416083|P1|Overall Study|Lost to Follow-up|2
1567738|NCT03089216|5416094|P4|Overall Study|Adverse Event|1
1567739|NCT03089216|5416095|P3|Overall Study|Adverse Event|0
1567740|NCT03089216|5416096|P2|Overall Study|Adverse Event|0
1567741|NCT03089216|5416097|P1|Overall Study|Adverse Event|0
1567742|NCT03088917|5416111|P1|Overall Study|Moved outside study region|50
1567743|NCT03088917|5416111|P1|Overall Study|Severe comorbidity/short life expectancy|5
1567744|NCT03088917|5416111|P1|Overall Study|Contact not established|13
1567745|NCT03088917|5416111|P1|Overall Study|Refuse re-evaluation|13
1567746|NCT03088917|5416111|P1|Overall Study|In care/cured elsewhere|15
1567747|NCT03087643|5416162|P2|Overall Study|Death|2
1567748|NCT03087643|5416163|P1|Overall Study|Death|2
1567749|NCT03087643|5416162|P2|Overall Study|Withdrawal by Subject|4
1567750|NCT03087643|5416163|P1|Overall Study|Withdrawal by Subject|2
1567751|NCT03086447|5416192|P2|Overall Study|Lens Discomfort|1
1567752|NCT03086447|5416193|P1|Overall Study|Lens Discomfort|2
1567753|NCT03086447|5416192|P2|Overall Study|Adverse Event|0
1567754|NCT03086447|5416193|P1|Overall Study|Adverse Event|3
1567755|NCT03086447|5416192|P2|Overall Study|Lost to Follow-up|1
1567756|NCT03086447|5416193|P1|Overall Study|Lost to Follow-up|0
1567757|NCT03086447|5416192|P2|Overall Study|Protocol Violation|4
1567758|NCT03086447|5416193|P1|Overall Study|Protocol Violation|2
1567759|NCT03086447|5416192|P2|Overall Study|Test Article No Longer Available|0
1567760|NCT03086447|5416193|P1|Overall Study|Test Article No Longer Available|1
1567761|NCT03086447|5416192|P2|Overall Study|Unsatisfactory Lens Fitting|1
1567762|NCT03086447|5416193|P1|Overall Study|Unsatisfactory Lens Fitting|0
1567763|NCT03086447|5416192|P2|Overall Study|Lens Damage|6
1567764|NCT03086447|5416193|P1|Overall Study|Lens Damage|1
1567765|NCT03086447|5416192|P2|Overall Study|Product quality complaint|1
1567766|NCT03086447|5416193|P1|Overall Study|Product quality complaint|0
1567767|NCT03086447|5416192|P2|Overall Study|Lost Lens|5
1567768|NCT03086447|5416193|P1|Overall Study|Lost Lens|2
1567769|NCT03086447|5416192|P2|Overall Study|No Longer Meets Eligibility Criteria|1
1567770|NCT03086447|5416193|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1567771|NCT03086330|5416224|P2|Overall Study|Lost to Follow-up|2
1567772|NCT03086330|5416225|P1|Overall Study|Lost to Follow-up|1
1567773|NCT03086330|5416224|P2|Overall Study|Withdrawal by Subject|2
1567774|NCT03086330|5416225|P1|Overall Study|Withdrawal by Subject|3
1567775|NCT03086135|5416345|P1|Overall Study|Lost to Follow-up|2
1567776|NCT03086135|5416345|P1|Overall Study|Adverse Event|1
1567777|NCT03086018|5416372|P1|Final Testing for End of Trial|Withdrawal by Subject|1
1567778|NCT03086018|5416372|P1|Final Testing for End of Trial|Adverse Event|1
1567779|NCT03085238|5416432|P1|Overall Study|Death|2
1567780|NCT03085238|5416432|P1|Overall Study|Adverse Event|2
1567781|NCT03083639|5416472|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
1567782|NCT03083639|5416473|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
1567783|NCT03083639|5416472|P2|Washout Period (at Least 6 Days)|Pregnancy|1
1567784|NCT03083639|5416473|P1|Washout Period (at Least 6 Days)|Pregnancy|0
1567785|NCT03083483|5416486|P3|Overall Study|technological issues|1
1567786|NCT03083483|5416487|P2|Overall Study|technological issues|0
1567787|NCT03083483|5416488|P1|Overall Study|technological issues|1
1567788|NCT03083483|5416486|P3|Overall Study|Lost to Follow-up|1
1567789|NCT03083483|5416487|P2|Overall Study|Lost to Follow-up|1
1567790|NCT03083483|5416488|P1|Overall Study|Lost to Follow-up|2
1567791|NCT03083483|5416486|P3|Overall Study|Adverse Event|1
1567792|NCT03083483|5416487|P2|Overall Study|Adverse Event|1
1567793|NCT03083483|5416488|P1|Overall Study|Adverse Event|1
1567794|NCT03083470|5416507|P5|Overall Study|Withdrawal by Subject|1
1567795|NCT03083470|5416508|P4|Overall Study|Withdrawal by Subject|0
1567796|NCT03083470|5416509|P3|Overall Study|Withdrawal by Subject|0
1567797|NCT03083470|5416510|P2|Overall Study|Withdrawal by Subject|0
1567798|NCT03083470|5416511|P1|Overall Study|Withdrawal by Subject|0
1567799|NCT03083470|5416507|P5|Overall Study|Lost to Follow-up|1
1567800|NCT03083470|5416508|P4|Overall Study|Lost to Follow-up|0
1567801|NCT03083470|5416509|P3|Overall Study|Lost to Follow-up|0
1567802|NCT03083470|5416510|P2|Overall Study|Lost to Follow-up|0
1567803|NCT03083470|5416511|P1|Overall Study|Lost to Follow-up|0
1567804|NCT03082599|5416559|P2|Overall Study|Lost to Follow-up|0
1567805|NCT03082599|5416560|P1|Overall Study|Lost to Follow-up|1
1567806|NCT03080961|5416586|P1|Overall Study|Withdrawal by Subject|3
1567807|NCT03080454|5416595|P1|Anodal FU (7 Days)|Lost to Follow-up|4
1567808|NCT03080454|5416595|P1|Anodal Doublestim (5 Days)|Adverse Event|1
1567809|NCT03080454|5416595|P1|Baseline|Adverse Event|2
1567810|NCT03078556|5416675|P4|Washout Period 1 (7 Days)|Physician Decision|0
1567811|NCT03078556|5416676|P3|Washout Period 1 (7 Days)|Physician Decision|0
1567812|NCT03078556|5416677|P2|Washout Period 1 (7 Days)|Physician Decision|1
1567813|NCT03078556|5416678|P1|Washout Period 1 (7 Days)|Physician Decision|0
1567814|NCT03078556|5416675|P4|Washout Period 1 (7 Days)|Adverse Event|1
1567815|NCT03078556|5416676|P3|Washout Period 1 (7 Days)|Adverse Event|0
1567816|NCT03078556|5416677|P2|Washout Period 1 (7 Days)|Adverse Event|1
1567817|NCT03078556|5416678|P1|Washout Period 1 (7 Days)|Adverse Event|0
1567818|NCT03078556|5416675|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
1567819|NCT03078556|5416676|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
1567820|NCT03078556|5416677|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
1567821|NCT03078556|5416678|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
1567822|NCT03078556|5416675|P4|Treatment Period 1 (4 Days)|Adverse Event|0
1567823|NCT03078556|5416676|P3|Treatment Period 1 (4 Days)|Adverse Event|0
1567824|NCT03078556|5416677|P2|Treatment Period 1 (4 Days)|Adverse Event|1
1567825|NCT03078556|5416678|P1|Treatment Period 1 (4 Days)|Adverse Event|0
1567826|NCT03077724|5416896|P2|Overall Study|Withdrawal by Subject|1
1567827|NCT03077724|5416897|P1|Overall Study|Withdrawal by Subject|3
1567828|NCT03077724|5416896|P2|Overall Study|Lost to Follow-up|1
1567829|NCT03077724|5416897|P1|Overall Study|Lost to Follow-up|5
1567830|NCT03077711|5416909|P2|Overall Study|noncompliant taking medication|0
1567831|NCT03077711|5416910|P1|Overall Study|noncompliant taking medication|2
1567832|NCT03077711|5416909|P2|Overall Study|Lost to Follow-up|2
1567833|NCT03077711|5416910|P1|Overall Study|Lost to Follow-up|2
1567834|NCT03077659|5416929|P3|Overall Study|Withdrawal by Subject|1
1567835|NCT03077659|5416930|P2|Overall Study|Withdrawal by Subject|0
1567836|NCT03077659|5416931|P1|Overall Study|Withdrawal by Subject|0
1567837|NCT03077607|5416962|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
1567838|NCT03077607|5416963|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
1567839|NCT03077607|5416962|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
1567840|NCT03077607|5416963|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
1567841|NCT03077607|5416962|P2|Period 1 (15 Days)|Death|0
1567842|NCT03077607|5416963|P1|Period 1 (15 Days)|Death|1
1567843|NCT03077607|5416962|P2|Period 1 (15 Days)|Adverse Event|0
1567844|NCT03077607|5416963|P1|Period 1 (15 Days)|Adverse Event|1
1567845|NCT03076996|5417029|P1|Overall Study|Literacy precluded participation|1
1567846|NCT03076996|5417029|P1|Overall Study|Lost to Follow-up|3
1567847|NCT03076996|5417029|P1|Overall Study|Withdrawal by Subject|2
1567848|NCT03076970|5417055|P6|Period 3|Failure to meet I/E criteria|0
1567849|NCT03076970|5417056|P5|Period 3|Failure to meet I/E criteria|1
1567850|NCT03076970|5417057|P4|Period 3|Failure to meet I/E criteria|0
1567851|NCT03076970|5417058|P3|Period 3|Failure to meet I/E criteria|0
1567852|NCT03076970|5417059|P2|Period 3|Failure to meet I/E criteria|0
1567853|NCT03076970|5417060|P1|Period 3|Failure to meet I/E criteria|0
1567854|NCT03076970|5417055|P6|Period 3|Withdrawal by Subject|1
1567855|NCT03076970|5417056|P5|Period 3|Withdrawal by Subject|0
1567856|NCT03076970|5417057|P4|Period 3|Withdrawal by Subject|0
1567857|NCT03076970|5417058|P3|Period 3|Withdrawal by Subject|0
1567858|NCT03076970|5417059|P2|Period 3|Withdrawal by Subject|0
1567859|NCT03076970|5417060|P1|Period 3|Withdrawal by Subject|0
1567860|NCT03076970|5417055|P6|Washout Period 2|Adverse Event|0
1567861|NCT03076970|5417056|P5|Washout Period 2|Adverse Event|1
1567862|NCT03076970|5417057|P4|Washout Period 2|Adverse Event|0
1567863|NCT03076970|5417058|P3|Washout Period 2|Adverse Event|0
1567864|NCT03076970|5417059|P2|Washout Period 2|Adverse Event|0
1567865|NCT03076970|5417060|P1|Washout Period 2|Adverse Event|0
1567866|NCT03075904|5417110|P1|Overall Study|Need for Medication not Permitted|1
1567867|NCT03075904|5417110|P1|Overall Study|Physician Decision|3
1567868|NCT03075891|5417120|P2|Overall Study|Drug abuse relapse issue|1
1567869|NCT03075891|5417121|P1|Overall Study|Drug abuse relapse issue|0
1567870|NCT03075891|5417120|P2|Overall Study|Patient requiring study withdrawal|1
1567871|NCT03075891|5417121|P1|Overall Study|Patient requiring study withdrawal|0
1567872|NCT03075891|5417120|P2|Overall Study|Other visits not performed (no time)|0
1567873|NCT03075891|5417121|P1|Overall Study|Other visits not performed (no time)|1
1567874|NCT03075891|5417120|P2|Overall Study|Pregnancy|1
1567875|NCT03075891|5417121|P1|Overall Study|Pregnancy|3
1567876|NCT03075891|5417120|P2|Overall Study|Lost to Follow-up|0
1567877|NCT03075891|5417121|P1|Overall Study|Lost to Follow-up|1
1567878|NCT03075891|5417120|P2|Overall Study|Withdrawal by Subject|6
1567879|NCT03075891|5417121|P1|Overall Study|Withdrawal by Subject|3
1567880|NCT03075891|5417120|P2|Overall Study|Adverse Event|4
1567881|NCT03075891|5417121|P1|Overall Study|Adverse Event|1
1567882|NCT03075527|5417127|P1|Overall Study|Ongoing treatment|2
1567883|NCT03075410|5417140|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567884|NCT03075410|5417141|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567885|NCT03075410|5417142|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567886|NCT03075410|5417143|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567887|NCT03075410|5417144|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567888|NCT03075410|5417145|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567889|NCT03075410|5417146|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567890|NCT03075410|5417147|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
1567891|NCT03075410|5417148|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
1567892|NCT03075410|5417140|P9|Part A-Period 2 (14 Days)|Personal reasons|0
1567893|NCT03075410|5417141|P8|Part A-Period 2 (14 Days)|Personal reasons|0
1567894|NCT03075410|5417142|P7|Part A-Period 2 (14 Days)|Personal reasons|0
1567895|NCT03075410|5417143|P6|Part A-Period 2 (14 Days)|Personal reasons|0
1567896|NCT03075410|5417144|P5|Part A-Period 2 (14 Days)|Personal reasons|0
1567897|NCT03075410|5417145|P4|Part A-Period 2 (14 Days)|Personal reasons|0
1567898|NCT03075410|5417146|P3|Part A-Period 2 (14 Days)|Personal reasons|1
1567899|NCT03075410|5417147|P2|Part A-Period 2 (14 Days)|Personal reasons|0
1567900|NCT03075410|5417148|P1|Part A-Period 2 (14 Days)|Personal reasons|1
1567901|NCT03075163|5417314|P2|Overall Study|not eligible for treatment limb|138
1567902|NCT03075163|5417315|P1|Overall Study|not eligible for treatment limb|138
1567903|NCT03074500|5417346|P3|Overall Study|Adverse Event|1
1567904|NCT03074500|5417347|P2|Overall Study|Adverse Event|0
1567905|NCT03074500|5417348|P1|Overall Study|Adverse Event|0
1567906|NCT03074500|5417346|P3|Overall Study|Lack of Efficacy|0
1567907|NCT03074500|5417347|P2|Overall Study|Lack of Efficacy|1
1567908|NCT03074500|5417348|P1|Overall Study|Lack of Efficacy|0
1567909|NCT03074500|5417346|P3|Overall Study|Lost to Follow-up|0
1567910|NCT03074500|5417347|P2|Overall Study|Lost to Follow-up|0
1567911|NCT03074500|5417348|P1|Overall Study|Lost to Follow-up|1
1567912|NCT03074331|5417385|P1|Overall Study|Withdrew Consent|1
1567913|NCT03074331|5417385|P1|Overall Study|Lost to Follow-up|5
1567914|NCT03074331|5417385|P1|Overall Study|Enrolled but Not Treated|1
1567915|NCT03074162|5417397|P6|Period 3|Withdrawal by Subject|0
1567916|NCT03074162|5417398|P5|Period 3|Withdrawal by Subject|1
1567917|NCT03074162|5417399|P4|Period 3|Withdrawal by Subject|0
1567918|NCT03074162|5417400|P3|Period 3|Withdrawal by Subject|0
1567919|NCT03074162|5417401|P2|Period 3|Withdrawal by Subject|0
1567920|NCT03074162|5417402|P1|Period 3|Withdrawal by Subject|1
1567921|NCT03074162|5417397|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
1567922|NCT03074162|5417398|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
1567923|NCT03074162|5417399|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
1567924|NCT03074162|5417400|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
1567925|NCT03074162|5417401|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
1567926|NCT03074162|5417402|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
1567927|NCT03074162|5417397|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
1567928|NCT03074162|5417398|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
1567929|NCT03074162|5417399|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
1567930|NCT03074162|5417400|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
1567931|NCT03074162|5417401|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
1567932|NCT03074162|5417402|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
1567933|NCT03073798|5417464|P1|Overall Study|Withdrawal by Subject|1
1567934|NCT03073798|5417464|P1|Overall Study|Adverse Event|1
1567935|NCT03072875|5417488|P1|Overall Study|Lost to Follow-up|1
1567936|NCT03072719|5417495|P2|Overall Study|Adverse Event|1
1567937|NCT03072719|5417496|P1|Overall Study|Adverse Event|1
1567938|NCT03071263|5417523|P2|Overall Study|Participant moved to another city|1
1567939|NCT03071263|5417524|P1|Overall Study|Participant moved to another city|0
1567940|NCT03071263|5417523|P2|Overall Study|Physician Decision|0
1567941|NCT03071263|5417524|P1|Overall Study|Physician Decision|1
1567942|NCT03071263|5417523|P2|Overall Study|Withdrawal by Subject|3
1567943|NCT03071263|5417524|P1|Overall Study|Withdrawal by Subject|1
1567944|NCT03071263|5417523|P2|Overall Study|Adverse Event|3
1567945|NCT03071263|5417524|P1|Overall Study|Adverse Event|1
1567946|NCT03070171|5417760|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
1567947|NCT03070171|5417761|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
1567948|NCT03070171|5417760|P2|Treatment Period 2 + Washout|Other Adverse Event|1
1567949|NCT03070171|5417761|P1|Treatment Period 2 + Washout|Other Adverse Event|0
1567950|NCT03070002|5417777|P1|Follow up for 2 Years|Death|1
1567951|NCT03069989|5417785|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
1567952|NCT03069989|5417786|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
1567953|NCT03069365|5417891|P1|Overall Study|Adverse Event|1
1567954|NCT03069313|5417897|P1|Overall Study|Adverse Event|5
1567955|NCT03068767|5417906|P2|Overall Study|Protocol Violation|0
1567956|NCT03068767|5417907|P1|Overall Study|Protocol Violation|3
1567957|NCT03068767|5417906|P2|Overall Study|Lost to Follow-up|3
1567958|NCT03068767|5417907|P1|Overall Study|Lost to Follow-up|7
1567959|NCT03066999|5417953|P2|Overall Study|abnormal urethraBladder neck contracture|2
1567960|NCT03066999|5417954|P1|Overall Study|abnormal urethraBladder neck contracture|0
1567961|NCT03066622|5417974|P2|Overall Study|Withdrawal by Subject|1
1567962|NCT03066622|5417975|P1|Overall Study|Withdrawal by Subject|2
1567963|NCT03066622|5417974|P2|Overall Study|Lost to Follow-up|25
1567964|NCT03066622|5417975|P1|Overall Study|Lost to Follow-up|24
1567965|NCT03066609|5417988|P4|OVERALL STUDY|discontinued follow up|0
1567966|NCT03066609|5417989|P3|OVERALL STUDY|discontinued follow up|0
1567967|NCT03066609|5417990|P2|OVERALL STUDY|discontinued follow up|2
1567968|NCT03066609|5417991|P1|OVERALL STUDY|discontinued follow up|0
1567969|NCT03066609|5417988|P4|OVERALL STUDY|Lack of Efficacy|1
1567970|NCT03066609|5417989|P3|OVERALL STUDY|Lack of Efficacy|1
1567971|NCT03066609|5417990|P2|OVERALL STUDY|Lack of Efficacy|1
1567972|NCT03066609|5417991|P1|OVERALL STUDY|Lack of Efficacy|2
1567973|NCT03066609|5417988|P4|OVERALL STUDY|Pregnancy|0
1567974|NCT03066609|5417989|P3|OVERALL STUDY|Pregnancy|1
1567975|NCT03066609|5417990|P2|OVERALL STUDY|Pregnancy|0
1567976|NCT03066609|5417991|P1|OVERALL STUDY|Pregnancy|1
1567977|NCT03066609|5417988|P4|OVERALL STUDY|Lost to Follow-up|1
1567978|NCT03066609|5417989|P3|OVERALL STUDY|Lost to Follow-up|1
1567979|NCT03066609|5417990|P2|OVERALL STUDY|Lost to Follow-up|1
1567980|NCT03066609|5417991|P1|OVERALL STUDY|Lost to Follow-up|1
1567981|NCT03066609|5417988|P4|OVERALL STUDY|Withdrawal by Subject|2
1567982|NCT03066609|5417989|P3|OVERALL STUDY|Withdrawal by Subject|1
1567983|NCT03066609|5417990|P2|OVERALL STUDY|Withdrawal by Subject|2
1567984|NCT03066609|5417991|P1|OVERALL STUDY|Withdrawal by Subject|4
1567985|NCT03066609|5417988|P4|OVERALL STUDY|Adverse Event|1
1567986|NCT03066609|5417989|P3|OVERALL STUDY|Adverse Event|0
1567987|NCT03066609|5417990|P2|OVERALL STUDY|Adverse Event|2
1567988|NCT03066609|5417991|P1|OVERALL STUDY|Adverse Event|2
1567989|NCT03066609|5417988|P4|MAINTENANCE|Lack of Efficacy|1
1567990|NCT03066609|5417989|P3|MAINTENANCE|Lack of Efficacy|0
1567991|NCT03066609|5417990|P2|MAINTENANCE|Lack of Efficacy|1
1567992|NCT03066609|5417991|P1|MAINTENANCE|Lack of Efficacy|2
1567993|NCT03066609|5417988|P4|MAINTENANCE|Pregnancy|0
1567994|NCT03066609|5417989|P3|MAINTENANCE|Pregnancy|0
1567995|NCT03066609|5417990|P2|MAINTENANCE|Pregnancy|0
1567996|NCT03066609|5417991|P1|MAINTENANCE|Pregnancy|1
1567997|NCT03066609|5417988|P4|MAINTENANCE|Lost to Follow-up|0
1567998|NCT03066609|5417989|P3|MAINTENANCE|Lost to Follow-up|1
1567999|NCT03066609|5417990|P2|MAINTENANCE|Lost to Follow-up|1
1568000|NCT03066609|5417991|P1|MAINTENANCE|Lost to Follow-up|0
1568001|NCT03066609|5417988|P4|MAINTENANCE|Withdrawal by Subject|1
1568002|NCT03066609|5417989|P3|MAINTENANCE|Withdrawal by Subject|1
1568003|NCT03066609|5417990|P2|MAINTENANCE|Withdrawal by Subject|2
1568004|NCT03066609|5417991|P1|MAINTENANCE|Withdrawal by Subject|4
1568005|NCT03066609|5417988|P4|MAINTENANCE|Adverse Event|1
1568006|NCT03066609|5417989|P3|MAINTENANCE|Adverse Event|0
1568007|NCT03066609|5417990|P2|MAINTENANCE|Adverse Event|0
1568008|NCT03066609|5417991|P1|MAINTENANCE|Adverse Event|0
1568009|NCT03066609|5417988|P4|INDUCTION|Adverse Event|0
1568010|NCT03066609|5417989|P3|INDUCTION|Adverse Event|0
1568011|NCT03066609|5417990|P2|INDUCTION|Adverse Event|2
1568012|NCT03066609|5417991|P1|INDUCTION|Adverse Event|2
1568013|NCT03066609|5417988|P4|INDUCTION|Lack of Efficacy|0
1568014|NCT03066609|5417989|P3|INDUCTION|Lack of Efficacy|1
1568015|NCT03066609|5417990|P2|INDUCTION|Lack of Efficacy|0
1568016|NCT03066609|5417991|P1|INDUCTION|Lack of Efficacy|0
1568017|NCT03066609|5417988|P4|INDUCTION|Pregnancy|0
1568018|NCT03066609|5417989|P3|INDUCTION|Pregnancy|1
1568019|NCT03066609|5417990|P2|INDUCTION|Pregnancy|0
1568020|NCT03066609|5417991|P1|INDUCTION|Pregnancy|0
1568022|NCT03065933|5418034|P1|Overall Study|study terminated|5
1568023|NCT03065530|5418042|P4|Overall Study|Protocol Violation|1
1568024|NCT03065530|5418043|P3|Overall Study|Protocol Violation|1
1568025|NCT03065530|5418044|P2|Overall Study|Protocol Violation|0
1568026|NCT03065530|5418045|P1|Overall Study|Protocol Violation|1
1568027|NCT03065530|5418042|P4|Overall Study|Lack of Efficacy|1
1568028|NCT03065530|5418043|P3|Overall Study|Lack of Efficacy|0
1568029|NCT03065530|5418044|P2|Overall Study|Lack of Efficacy|1
1568030|NCT03065530|5418045|P1|Overall Study|Lack of Efficacy|1
1568031|NCT03065023|5418144|P5|Overall Study|Withdrawal by Subject|0
1568032|NCT03065023|5418145|P4|Overall Study|Withdrawal by Subject|1
1568033|NCT03065023|5418146|P3|Overall Study|Withdrawal by Subject|0
1568034|NCT03065023|5418147|P2|Overall Study|Withdrawal by Subject|0
1568035|NCT03065023|5418148|P1|Overall Study|Withdrawal by Subject|0
1568036|NCT03065023|5418144|P5|Overall Study|Participant Decision|0
1568037|NCT03065023|5418145|P4|Overall Study|Participant Decision|1
1568038|NCT03065023|5418146|P3|Overall Study|Participant Decision|0
1568039|NCT03065023|5418147|P2|Overall Study|Participant Decision|0
1568040|NCT03065023|5418148|P1|Overall Study|Participant Decision|0
1568041|NCT03065023|5418144|P5|Overall Study|Lost to Follow-up|0
1568042|NCT03065023|5418145|P4|Overall Study|Lost to Follow-up|0
1568043|NCT03065023|5418146|P3|Overall Study|Lost to Follow-up|0
1568044|NCT03065023|5418147|P2|Overall Study|Lost to Follow-up|1
1568045|NCT03065023|5418148|P1|Overall Study|Lost to Follow-up|0
1568046|NCT03065023|5418144|P5|Overall Study|Death|0
1568047|NCT03065023|5418145|P4|Overall Study|Death|1
1568048|NCT03065023|5418146|P3|Overall Study|Death|1
1568049|NCT03065023|5418147|P2|Overall Study|Death|0
1568050|NCT03065023|5418148|P1|Overall Study|Death|2
1568051|NCT03065023|5418144|P5|Overall Study|Progressive Disease|0
1568052|NCT03065023|5418145|P4|Overall Study|Progressive Disease|0
1568053|NCT03065023|5418146|P3|Overall Study|Progressive Disease|0
1568054|NCT03065023|5418147|P2|Overall Study|Progressive Disease|1
1568055|NCT03065023|5418148|P1|Overall Study|Progressive Disease|0
1568056|NCT03064841|5418214|P1|Overall Study|Screen failure|2
1568057|NCT03064841|5418214|P1|Overall Study|No glycated haemoglobinA1c measurement|11
1568058|NCT03064841|5418214|P1|Overall Study|Inclusion/exclusion criteria violation|4
1568059|NCT03063086|5418299|P6|Overall Study|Physician Decision|0
1568060|NCT03063086|5418300|P5|Overall Study|Physician Decision|0
1568061|NCT03063086|5418301|P4|Overall Study|Physician Decision|1
1568062|NCT03063086|5418302|P3|Overall Study|Physician Decision|0
1568063|NCT03063086|5418303|P2|Overall Study|Physician Decision|0
1568064|NCT03063086|5418304|P1|Overall Study|Physician Decision|0
1568065|NCT03063086|5418299|P6|Overall Study|Non-compliance with study treatment|1
1568066|NCT03063086|5418300|P5|Overall Study|Non-compliance with study treatment|0
1568067|NCT03063086|5418301|P4|Overall Study|Non-compliance with study treatment|1
1568068|NCT03063086|5418302|P3|Overall Study|Non-compliance with study treatment|0
1568069|NCT03063086|5418303|P2|Overall Study|Non-compliance with study treatment|0
1568070|NCT03063086|5418304|P1|Overall Study|Non-compliance with study treatment|0
1568071|NCT03063086|5418299|P6|Overall Study|subject/guardian decision|0
1568072|NCT03063086|5418300|P5|Overall Study|subject/guardian decision|0
1568073|NCT03063086|5418301|P4|Overall Study|subject/guardian decision|0
1568074|NCT03063086|5418302|P3|Overall Study|subject/guardian decision|0
1568075|NCT03063086|5418303|P2|Overall Study|subject/guardian decision|0
1568076|NCT03063086|5418304|P1|Overall Study|subject/guardian decision|1
1568077|NCT03063086|5418299|P6|Overall Study|Adverse Event|0
1568078|NCT03063086|5418300|P5|Overall Study|Adverse Event|0
1568079|NCT03063086|5418301|P4|Overall Study|Adverse Event|1
1568080|NCT03063086|5418302|P3|Overall Study|Adverse Event|1
1568081|NCT03063086|5418303|P2|Overall Study|Adverse Event|1
1568082|NCT03063086|5418304|P1|Overall Study|Adverse Event|1
1568083|NCT03063086|5418299|P6|Overall Study|technical problems|0
1568084|NCT03063086|5418300|P5|Overall Study|technical problems|0
1568085|NCT03063086|5418301|P4|Overall Study|technical problems|0
1568086|NCT03063086|5418302|P3|Overall Study|technical problems|0
1568087|NCT03063086|5418303|P2|Overall Study|technical problems|0
1568088|NCT03063086|5418304|P1|Overall Study|technical problems|1
1568089|NCT03061331|5418389|P2|Washout Period (8 Weeks)|Adverse Event|1
1568090|NCT03061331|5418390|P1|Washout Period (8 Weeks)|Adverse Event|2
1568091|NCT03060512|5418398|P2|Overall Study|Non-compliance with study medication|2
1568092|NCT03060512|5418399|P1|Overall Study|Non-compliance with study medication|1
1568093|NCT03060512|5418398|P2|Overall Study|Withdrawal by Subject|0
1568094|NCT03060512|5418399|P1|Overall Study|Withdrawal by Subject|1
1568095|NCT03060512|5418398|P2|Overall Study|Lost to Follow-up|1
1568096|NCT03060512|5418399|P1|Overall Study|Lost to Follow-up|1
1568097|NCT03060512|5418398|P2|Overall Study|Adverse Event|6
1568098|NCT03060512|5418399|P1|Overall Study|Adverse Event|4
1568105|NCT03058705|5418464|P1|Overall Study|Physician Decision|2
1568106|NCT03058705|5418464|P1|Overall Study|Withdrawal by Subject|2
1568107|NCT03058692|5418470|P2|Overall Study|Withdrawal by Subject|1
1568108|NCT03058692|5418471|P1|Overall Study|Withdrawal by Subject|1
1568109|NCT03058692|5418470|P2|Overall Study|Lost to Follow-up|1
1568110|NCT03058692|5418471|P1|Overall Study|Lost to Follow-up|2
1568111|NCT03056352|5418630|P1|Overall Study|Lost to Follow-up|1
1568112|NCT03056300|5418636|P1|Overall Study|Surgical reason per study protocol|3
1568113|NCT03056040|5418653|P2|Primary Evaluation Period|Pregnancy|1
1568114|NCT03056040|5418654|P1|Primary Evaluation Period|Pregnancy|0
1568115|NCT03056040|5418653|P2|Primary Evaluation Period|Lack of Efficacy|1
1568116|NCT03056040|5418654|P1|Primary Evaluation Period|Lack of Efficacy|0
1568117|NCT03056040|5418653|P2|Primary Evaluation Period|Withdrawal by Subject|1
1568118|NCT03056040|5418654|P1|Primary Evaluation Period|Withdrawal by Subject|1
1568119|NCT03055988|5418668|P2|Period 2|Other than listed|1
1568120|NCT03055988|5418669|P1|Period 2|Other than listed|1
1568121|NCT03055988|5418668|P2|Period 2|Adverse Event|1
1568122|NCT03055988|5418669|P1|Period 2|Adverse Event|0
1568123|NCT03055988|5418668|P2|Period 1|Withdrawal by Subject|4
1568124|NCT03055988|5418669|P1|Period 1|Withdrawal by Subject|0
1568125|NCT03055988|5418668|P2|Period 1|Lost to Follow-up|0
1568126|NCT03055988|5418669|P1|Period 1|Lost to Follow-up|1
1568127|NCT03055988|5418668|P2|Period 1|Adverse Event|1
1568128|NCT03055988|5418669|P1|Period 1|Adverse Event|0
1568129|NCT03055832|5418693|P2|Week 2|Withdrawal by Subject|0
1568130|NCT03055832|5418694|P1|Week 2|Withdrawal by Subject|1
1568131|NCT03055806|5418754|P4|Overall Study|Partner not willing to try intercourse|0
1568132|NCT03055806|5418755|P3|Overall Study|Partner not willing to try intercourse|0
1568133|NCT03055806|5418756|P2|Overall Study|Partner not willing to try intercourse|0
1568134|NCT03055806|5418757|P1|Overall Study|Partner not willing to try intercourse|1
1568135|NCT03055806|5418754|P4|Overall Study|Withdrawal of consent to continue study|6
1568136|NCT03055806|5418755|P3|Overall Study|Withdrawal of consent to continue study|4
1568137|NCT03055806|5418756|P2|Overall Study|Withdrawal of consent to continue study|3
1568138|NCT03055806|5418757|P1|Overall Study|Withdrawal of consent to continue study|2
1568139|NCT03055806|5418754|P4|Overall Study|Withdrawal of consent to continue drug|0
1568140|NCT03055806|5418755|P3|Overall Study|Withdrawal of consent to continue drug|2
1568141|NCT03055806|5418756|P2|Overall Study|Withdrawal of consent to continue drug|1
1568142|NCT03055806|5418757|P1|Overall Study|Withdrawal of consent to continue drug|1
1568143|NCT03055806|5418754|P4|Overall Study|Protocol Violation|0
1568144|NCT03055806|5418755|P3|Overall Study|Protocol Violation|0
1568145|NCT03055806|5418756|P2|Overall Study|Protocol Violation|0
1568146|NCT03055806|5418757|P1|Overall Study|Protocol Violation|1
1568147|NCT03055806|5418754|P4|Overall Study|Physician Decision|1
1568148|NCT03055806|5418755|P3|Overall Study|Physician Decision|0
1568149|NCT03055806|5418756|P2|Overall Study|Physician Decision|0
1568150|NCT03055806|5418757|P1|Overall Study|Physician Decision|1
1568151|NCT03055806|5418754|P4|Overall Study|Lost to Follow-up|7
1568152|NCT03055806|5418755|P3|Overall Study|Lost to Follow-up|6
1568153|NCT03055806|5418756|P2|Overall Study|Lost to Follow-up|3
1568154|NCT03055806|5418757|P1|Overall Study|Lost to Follow-up|0
1568155|NCT03055806|5418754|P4|Overall Study|Adverse Event|1
1568156|NCT03055806|5418755|P3|Overall Study|Adverse Event|1
1568157|NCT03055806|5418756|P2|Overall Study|Adverse Event|0
1568158|NCT03055806|5418757|P1|Overall Study|Adverse Event|0
1568159|NCT03055338|5418802|P3|Overall Study|Withdrawal by Subject|7
1568160|NCT03055338|5418803|P2|Overall Study|Withdrawal by Subject|8
1568161|NCT03055338|5418804|P1|Overall Study|Withdrawal by Subject|9
1568162|NCT03055338|5418802|P3|Overall Study|Physician Decision|2
1568163|NCT03055338|5418803|P2|Overall Study|Physician Decision|0
1568164|NCT03055338|5418804|P1|Overall Study|Physician Decision|0
1568165|NCT03055338|5418802|P3|Overall Study|No Post-treatment Protocol Contact|0
1568166|NCT03055338|5418803|P2|Overall Study|No Post-treatment Protocol Contact|1
1568167|NCT03055338|5418804|P1|Overall Study|No Post-treatment Protocol Contact|0
1568168|NCT03055338|5418802|P3|Overall Study|Lost to Follow-up|3
1568169|NCT03055338|5418803|P2|Overall Study|Lost to Follow-up|2
1568170|NCT03055338|5418804|P1|Overall Study|Lost to Follow-up|9
1568171|NCT03055221|5418821|P1|Overall Study|Study terminated by Sponsor|3
1568172|NCT03055221|5418821|P1|Overall Study|Physician Decision|1
1568173|NCT03055221|5418821|P1|Overall Study|Death|6
1568174|NCT03055221|5418821|P1|Overall Study|Withdrawal by Subject|4
1568175|NCT03055221|5418821|P1|Overall Study|Adverse Event|2
1568186|NCT03054428|5418996|P3|Overall Study|Lost to Follow-up|1
1568187|NCT03054428|5418997|P2|Overall Study|Lost to Follow-up|0
1568188|NCT03054428|5418998|P1|Overall Study|Lost to Follow-up|0
1568189|NCT03054428|5418996|P3|Overall Study|Withdrawal by Subject|3
1568190|NCT03054428|5418997|P2|Overall Study|Withdrawal by Subject|2
1568191|NCT03054428|5418998|P1|Overall Study|Withdrawal by Subject|3
1568192|NCT03054428|5418996|P3|Overall Study|Transitioned to OLE study|73
1568193|NCT03054428|5418997|P2|Overall Study|Transitioned to OLE study|76
1568194|NCT03054428|5418998|P1|Overall Study|Transitioned to OLE study|76
1568195|NCT03054428|5418996|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
1568196|NCT03054428|5418997|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
1568197|NCT03054428|5418998|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
1568198|NCT03054428|5418996|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
1568199|NCT03054428|5418997|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
1568200|NCT03054428|5418998|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
1568201|NCT03054428|5418996|P3|Overall Study|Lack of Efficacy|0
1568202|NCT03054428|5418997|P2|Overall Study|Lack of Efficacy|1
1568203|NCT03054428|5418998|P1|Overall Study|Lack of Efficacy|3
1568204|NCT03054428|5418996|P3|Overall Study|Physician Decision|1
1568205|NCT03054428|5418997|P2|Overall Study|Physician Decision|1
1568206|NCT03054428|5418998|P1|Overall Study|Physician Decision|0
1568207|NCT03053427|5419133|P2|Overall Study|Miscellaneous|1
1568208|NCT03053427|5419134|P1|Overall Study|Miscellaneous|0
1568209|NCT03053427|5419133|P2|Overall Study|Withdrawal by Subject|2
1568210|NCT03053427|5419134|P1|Overall Study|Withdrawal by Subject|3
1568211|NCT03053427|5419133|P2|Overall Study|Protocol Deviation|3
1568212|NCT03053427|5419134|P1|Overall Study|Protocol Deviation|3
1568213|NCT03053427|5419133|P2|Overall Study|Worsening of the target disease|1
1568214|NCT03053427|5419134|P1|Overall Study|Worsening of the target disease|0
1568215|NCT03053427|5419133|P2|Overall Study|Lost to Follow-up|2
1568216|NCT03053427|5419134|P1|Overall Study|Lost to Follow-up|2
1568217|NCT03053427|5419133|P2|Overall Study|Lack of Efficacy|3
1568218|NCT03053427|5419134|P1|Overall Study|Lack of Efficacy|1
1568219|NCT03053427|5419133|P2|Overall Study|Adverse Event|4
1568220|NCT03053427|5419134|P1|Overall Study|Adverse Event|4
1568221|NCT03053180|5419156|P1|Overall Study|Failure to Return|1
1568222|NCT03052764|5419167|P2|Double-Blind Treatment Period|Reason not Specified|1
1568223|NCT03052764|5419168|P1|Double-Blind Treatment Period|Reason not Specified|2
1568224|NCT03052764|5419167|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1568225|NCT03052764|5419168|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
1568226|NCT03052764|5419167|P2|Double-Blind Treatment Period|Protocol Violation|1
1568227|NCT03052764|5419168|P1|Double-Blind Treatment Period|Protocol Violation|2
1568228|NCT03052764|5419167|P2|Double-Blind Treatment Period|Lack of Efficacy|0
1568229|NCT03052764|5419168|P1|Double-Blind Treatment Period|Lack of Efficacy|1
1568230|NCT03052764|5419167|P2|Double-Blind Treatment Period|Adverse Event|0
1568231|NCT03052764|5419168|P1|Double-Blind Treatment Period|Adverse Event|2
1568232|NCT03052725|5419188|P2|Overall Study|Study terminated by sponsor|144
1568233|NCT03052725|5419189|P1|Overall Study|Study terminated by sponsor|143
1568234|NCT03052725|5419188|P2|Overall Study|Site closure|1
1568235|NCT03052725|5419189|P1|Overall Study|Site closure|0
1568236|NCT03052725|5419188|P2|Overall Study|Pregnancy|1
1568237|NCT03052725|5419189|P1|Overall Study|Pregnancy|0
1568238|NCT03052725|5419188|P2|Overall Study|Withdrawal by Subject|4
1568239|NCT03052725|5419189|P1|Overall Study|Withdrawal by Subject|3
1568240|NCT03052725|5419188|P2|Overall Study|Adverse Event|0
1568241|NCT03052725|5419189|P1|Overall Study|Adverse Event|2
1568242|NCT03052426|5419236|P3|Overall Study|Lost to Follow-up|1
1568243|NCT03052426|5419237|P2|Overall Study|Lost to Follow-up|0
1568244|NCT03052426|5419238|P1|Overall Study|Lost to Follow-up|2
1568245|NCT03052426|5419236|P3|Overall Study|Withdrawal by Subject|0
1568246|NCT03052426|5419237|P2|Overall Study|Withdrawal by Subject|1
1568247|NCT03052426|5419238|P1|Overall Study|Withdrawal by Subject|0
1568248|NCT03052322|5419253|P2|Overall Study|Adverse Event|13
1568249|NCT03052322|5419254|P1|Overall Study|Adverse Event|6
1568250|NCT03052322|5419253|P2|Overall Study|Lost to Follow-up|4
1568251|NCT03052322|5419254|P1|Overall Study|Lost to Follow-up|2
1568252|NCT03052322|5419253|P2|Overall Study|Protocol Violation|0
1568253|NCT03052322|5419254|P1|Overall Study|Protocol Violation|1
1568254|NCT03052322|5419253|P2|Overall Study|Lack of Efficacy|2
1568255|NCT03052322|5419254|P1|Overall Study|Lack of Efficacy|1
1568256|NCT03052322|5419253|P2|Overall Study|Death|2
1568257|NCT03052322|5419254|P1|Overall Study|Death|0
1568258|NCT03052322|5419253|P2|Overall Study|Withdrawal by Subject|9
1568259|NCT03052322|5419254|P1|Overall Study|Withdrawal by Subject|10
1568260|NCT03052322|5419253|P2|Overall Study|Other un-specified|2
1568261|NCT03052322|5419254|P1|Overall Study|Other un-specified|1
1568262|NCT03051607|5419315|P1|Overall Study|Adverse Event|66
1568263|NCT03051217|5419325|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1568264|NCT03051217|5419326|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
1568265|NCT03051217|5419327|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1568266|NCT03051217|5419328|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1568267|NCT03051217|5419329|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1568268|NCT03051217|5419330|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1568269|NCT03051217|5419331|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
1568270|NCT03051217|5419325|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1568271|NCT03051217|5419326|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1568272|NCT03051217|5419327|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
1568273|NCT03051217|5419328|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1568274|NCT03051217|5419329|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1568275|NCT03051217|5419330|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1568276|NCT03051217|5419331|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
1568277|NCT03051217|5419325|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1568278|NCT03051217|5419326|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1568279|NCT03051217|5419327|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1568280|NCT03051217|5419328|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
1568281|NCT03051217|5419329|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1568282|NCT03051217|5419330|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1568283|NCT03051217|5419331|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
1568284|NCT03051217|5419325|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1568285|NCT03051217|5419326|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1568286|NCT03051217|5419327|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1568287|NCT03051217|5419328|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
1568288|NCT03051217|5419329|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1568289|NCT03051217|5419330|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1568290|NCT03051217|5419331|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
1568291|NCT03051217|5419325|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1568292|NCT03051217|5419326|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1568293|NCT03051217|5419327|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
1568294|NCT03051217|5419328|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
1568295|NCT03051217|5419329|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1568296|NCT03051217|5419330|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1568297|NCT03051217|5419331|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
1568298|NCT03051217|5419325|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1568376|NCT03045887|5419866|P3|Part A, Period 2 (1 Day)|Adverse Event|0
1568299|NCT03051217|5419326|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1568300|NCT03051217|5419327|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1568301|NCT03051217|5419328|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1568302|NCT03051217|5419329|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1568303|NCT03051217|5419330|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1568304|NCT03051217|5419331|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1568305|NCT03051217|5419325|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1568306|NCT03051217|5419326|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1568307|NCT03051217|5419327|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1568308|NCT03051217|5419328|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1568309|NCT03051217|5419329|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1568310|NCT03051217|5419330|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
1568311|NCT03051217|5419331|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
1568312|NCT03051217|5419325|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
1568313|NCT03051217|5419326|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
1568314|NCT03051217|5419327|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
1568315|NCT03051217|5419328|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
1568316|NCT03051217|5419329|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
1568317|NCT03051217|5419330|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
1568318|NCT03051217|5419331|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
1568319|NCT03051165|5419360|P1|Overall Study|Early termination of study|12
1568320|NCT03051165|5419360|P1|Overall Study|Withdrawal by Subject|1
1568321|NCT03050372|5419577|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
1568322|NCT03050372|5419578|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
1568323|NCT03050372|5419577|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
1568324|NCT03050372|5419578|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
1568328|NCT03048058|5419722|P2|Overall Study|Withdrawal by Subject|4
1568329|NCT03048058|5419723|P1|Overall Study|Withdrawal by Subject|0
1568330|NCT03048058|5419722|P2|Overall Study|Lost to Follow-up|0
1568331|NCT03048058|5419723|P1|Overall Study|Lost to Follow-up|4
1568332|NCT03047551|5419749|P2|Overall Study|Ineligible|1
1568333|NCT03047551|5419750|P1|Overall Study|Ineligible|0
1568334|NCT03047551|5419749|P2|Overall Study|Probe malfunction|1
1568335|NCT03047551|5419750|P1|Overall Study|Probe malfunction|0
1568336|NCT03047551|5419749|P2|Overall Study|Withdrawal by Subject|1
1568337|NCT03047551|5419750|P1|Overall Study|Withdrawal by Subject|0
1568338|NCT03047551|5419749|P2|Overall Study|Physician Decision|0
1568339|NCT03047551|5419750|P1|Overall Study|Physician Decision|1
1568340|NCT03047551|5419749|P2|Overall Study|Did not receive TAS|0
1568341|NCT03047551|5419750|P1|Overall Study|Did not receive TAS|1
1568342|NCT03046446|5419796|P1|Overall Study|Non OA related knee surgery|1
1568343|NCT03046446|5419796|P1|Overall Study|Disease Progression (see caveats)|25
1568344|NCT03046446|5419796|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
1568345|NCT03046446|5419796|P1|Overall Study|Withdrawal by Subject|14
1568346|NCT03046446|5419796|P1|Overall Study|Lost to Follow-up|3
1568347|NCT03046446|5419796|P1|Overall Study|Adverse Event|6
1568348|NCT03046446|5419796|P1|Overall Study|Lack of Efficacy|7
1568349|NCT03045887|5419859|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568350|NCT03045887|5419860|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568351|NCT03045887|5419861|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568352|NCT03045887|5419862|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568353|NCT03045887|5419863|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568354|NCT03045887|5419864|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568355|NCT03045887|5419865|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
1568356|NCT03045887|5419866|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568357|NCT03045887|5419867|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568358|NCT03045887|5419868|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
1568359|NCT03045887|5419859|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568360|NCT03045887|5419860|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568361|NCT03045887|5419861|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568362|NCT03045887|5419862|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568363|NCT03045887|5419863|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568364|NCT03045887|5419864|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568365|NCT03045887|5419865|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
1568366|NCT03045887|5419866|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
1568367|NCT03045887|5419867|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568368|NCT03045887|5419868|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
1568369|NCT03045887|5419859|P10|Part A, Period 2 (1 Day)|Adverse Event|0
1568370|NCT03045887|5419860|P9|Part A, Period 2 (1 Day)|Adverse Event|0
1568371|NCT03045887|5419861|P8|Part A, Period 2 (1 Day)|Adverse Event|0
1568372|NCT03045887|5419862|P7|Part A, Period 2 (1 Day)|Adverse Event|0
1568373|NCT03045887|5419863|P6|Part A, Period 2 (1 Day)|Adverse Event|0
1568374|NCT03045887|5419864|P5|Part A, Period 2 (1 Day)|Adverse Event|0
1568375|NCT03045887|5419865|P4|Part A, Period 2 (1 Day)|Adverse Event|0
1568377|NCT03045887|5419867|P2|Part A, Period 2 (1 Day)|Adverse Event|0
1568378|NCT03045887|5419868|P1|Part A, Period 2 (1 Day)|Adverse Event|1
1568379|NCT03045887|5419859|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568380|NCT03045887|5419860|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568381|NCT03045887|5419861|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568382|NCT03045887|5419862|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568383|NCT03045887|5419863|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568384|NCT03045887|5419864|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568385|NCT03045887|5419865|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
1568386|NCT03045887|5419866|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568387|NCT03045887|5419867|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568388|NCT03045887|5419868|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
1568389|NCT03045887|5419859|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568390|NCT03045887|5419860|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568391|NCT03045887|5419861|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568392|NCT03045887|5419862|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568393|NCT03045887|5419863|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568394|NCT03045887|5419864|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568395|NCT03045887|5419865|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568396|NCT03045887|5419866|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568397|NCT03045887|5419867|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
1568398|NCT03045887|5419868|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
1568399|NCT03045302|5420150|P1|Overall Study|Pre-treatment adverse event|1
1568400|NCT03045081|5420156|P2|Overall Study|Withdrawal by Subject|11
1568401|NCT03045081|5420157|P1|Overall Study|Withdrawal by Subject|6
1568402|NCT03044886|5420176|P3|Overall Study|Lost to Follow-up|12
1568403|NCT03044886|5420177|P2|Overall Study|Lost to Follow-up|10
1568404|NCT03044886|5420178|P1|Overall Study|Lost to Follow-up|15
1568405|NCT03044574|5420230|P2|Overall Study|Lost to Follow-up|45
1568406|NCT03044574|5420231|P1|Overall Study|Lost to Follow-up|37
1568407|NCT03044431|5420257|P1|Overall Study|Lost to Follow-up|59
1568408|NCT03044353|5420270|P3|Overall Study|Adverse Event|0
1568409|NCT03044353|5420271|P2|Overall Study|Adverse Event|1
1568410|NCT03044353|5420272|P1|Overall Study|Adverse Event|0
1568411|NCT03044197|5420355|P2|Overall Study|Withdrawal by Subject|1
1568412|NCT03044197|5420356|P1|Overall Study|Withdrawal by Subject|3
1568413|NCT03044106|5420366|P2|Washout (1 Week)|Withdrawal by Subject|2
1568414|NCT03044106|5420367|P1|Washout (1 Week)|Withdrawal by Subject|0
1568415|NCT03042910|5420425|P1|Overall Study|Enrolled but not treated|1
1568416|NCT03042910|5420425|P1|Overall Study|Withdrawal by Subject|3
1568417|NCT03042910|5420425|P1|Overall Study|Disease Progression|2
1568418|NCT03042910|5420425|P1|Overall Study|Adverse Event|1
1568419|NCT03042559|5420469|P2|Overall Study|drop out|1
1568420|NCT03042559|5420470|P1|Overall Study|drop out|1
1568421|NCT03041792|5420583|P2|Overall Study|Randomized but not treated|1
1568422|NCT03041792|5420584|P1|Overall Study|Randomized but not treated|0
1568423|NCT03041792|5420583|P2|Overall Study|Death in the family|2
1568424|NCT03041792|5420584|P1|Overall Study|Death in the family|0
1568425|NCT03041792|5420583|P2|Overall Study|Adverse Event|0
1568426|NCT03041792|5420584|P1|Overall Study|Adverse Event|4
1568427|NCT03041181|5420616|P2|Overall Study|Disease Progression|2
1568428|NCT03041181|5420617|P1|Overall Study|Disease Progression|1
1568429|NCT03041090|5420633|P2|Overall Study|technical error|3
1568430|NCT03041090|5420634|P1|Overall Study|technical error|0
1568431|NCT03040687|5420647|P3|Overall Study|Withdrawal by Subject|0
1568432|NCT03040687|5420648|P2|Overall Study|Withdrawal by Subject|0
1568433|NCT03040687|5420649|P1|Overall Study|Withdrawal by Subject|1
1568434|NCT03039738|5420716|P2|Overall Study|Incomplete data sets|0
1568435|NCT03039738|5420717|P1|Overall Study|Incomplete data sets|54
1568436|NCT03039569|5420739|P2|Overall Study|Lost to Follow-up|4
1568437|NCT03039569|5420740|P1|Overall Study|Lost to Follow-up|5
1568438|NCT03039283|5420785|P1|Overall Study|Protocol Violation|2
1568439|NCT03037619|5420844|P2|Overall Study|Lost to Follow-up|1
1568440|NCT03037619|5420845|P1|Overall Study|Lost to Follow-up|0
1568441|NCT03037489|5420870|P2|Overall Study|Withdrawal by Subject|0
1568442|NCT03037489|5420871|P1|Overall Study|Withdrawal by Subject|3
1568443|NCT03037489|5420870|P2|Overall Study|Adverse Event|0
1568444|NCT03037489|5420871|P1|Overall Study|Adverse Event|4
1568445|NCT03037307|5420877|P6|Period 1|Did Not Meet Study Criteria|0
1568446|NCT03037307|5420878|P5|Period 1|Did Not Meet Study Criteria|0
1568447|NCT03037307|5420879|P4|Period 1|Did Not Meet Study Criteria|1
1568448|NCT03037307|5420880|P3|Period 1|Did Not Meet Study Criteria|0
1568449|NCT03037307|5420881|P2|Period 1|Did Not Meet Study Criteria|0
1568450|NCT03037307|5420882|P1|Period 1|Did Not Meet Study Criteria|0
1568451|NCT03036852|5420921|P1|Overall Study|Lost to Follow-up|1
1568452|NCT03036852|5420921|P1|Overall Study|Adverse Event|1
1568453|NCT03036852|5420921|P1|Overall Study|Lack of Efficacy|2
1568454|NCT03036852|5420921|P1|Overall Study|Death|2
1568455|NCT03036839|5420978|P3|Overall Study|Withdrew Consent|1
1568456|NCT03036839|5420979|P2|Overall Study|Withdrew Consent|0
1568457|NCT03036839|5420980|P1|Overall Study|Withdrew Consent|0
1568458|NCT03036839|5420978|P3|Overall Study|Death|3
1568459|NCT03036839|5420979|P2|Overall Study|Death|0
1568460|NCT03036839|5420980|P1|Overall Study|Death|3
1568461|NCT03036839|5420978|P3|Overall Study|Adverse Event|1
1568462|NCT03036839|5420979|P2|Overall Study|Adverse Event|0
1568463|NCT03036839|5420980|P1|Overall Study|Adverse Event|0
1568464|NCT03035916|5421068|P3|Overall Study|Puncture failed|0
1568465|NCT03035916|5421069|P2|Overall Study|Puncture failed|2
1568466|NCT03035916|5421070|P1|Overall Study|Puncture failed|0
1568467|NCT03035864|5421119|P2|Follow-up Period|Other|2
1568468|NCT03035864|5421120|P1|Follow-up Period|Other|3
1568469|NCT03035864|5421119|P2|Follow-up Period|Physician Decision|0
1568470|NCT03035864|5421120|P1|Follow-up Period|Physician Decision|1
1568471|NCT03035864|5421119|P2|Follow-up Period|Lost to Follow-up|2
1568472|NCT03035864|5421120|P1|Follow-up Period|Lost to Follow-up|6
1568473|NCT03035864|5421119|P2|Follow-up Period|Adverse Event|0
1568474|NCT03035864|5421120|P1|Follow-up Period|Adverse Event|1
1568475|NCT03035864|5421119|P2|Treatment Period|Other|1
1568476|NCT03035864|5421120|P1|Treatment Period|Other|3
1568477|NCT03035864|5421119|P2|Treatment Period|Adverse Event|0
1568478|NCT03035864|5421120|P1|Treatment Period|Adverse Event|1
1568479|NCT03034967|5421200|P6|Overall Study|Adverse Event, Serious Fatal|1
1568480|NCT03034967|5421201|P5|Overall Study|Adverse Event, Serious Fatal|1
1568481|NCT03034967|5421202|P4|Overall Study|Adverse Event, Serious Fatal|2
1568482|NCT03034967|5421203|P3|Overall Study|Adverse Event, Serious Fatal|1
1568483|NCT03034967|5421204|P2|Overall Study|Adverse Event, Serious Fatal|1
1568484|NCT03034967|5421205|P1|Overall Study|Adverse Event, Serious Fatal|0
1568485|NCT03034967|5421200|P6|Overall Study|Adverse Event, non-fatal|8
1568486|NCT03034967|5421201|P5|Overall Study|Adverse Event, non-fatal|2
1568487|NCT03034967|5421202|P4|Overall Study|Adverse Event, non-fatal|0
1568488|NCT03034967|5421203|P3|Overall Study|Adverse Event, non-fatal|2
1568489|NCT03034967|5421204|P2|Overall Study|Adverse Event, non-fatal|1
1568490|NCT03034967|5421205|P1|Overall Study|Adverse Event, non-fatal|3
1568491|NCT03034967|5421200|P6|Overall Study|Lack of Efficacy|0
1568492|NCT03034967|5421201|P5|Overall Study|Lack of Efficacy|1
1568493|NCT03034967|5421202|P4|Overall Study|Lack of Efficacy|1
1568494|NCT03034967|5421203|P3|Overall Study|Lack of Efficacy|2
1568495|NCT03034967|5421204|P2|Overall Study|Lack of Efficacy|1
1568496|NCT03034967|5421205|P1|Overall Study|Lack of Efficacy|0
1568497|NCT03034967|5421200|P6|Overall Study|Protocol Violation|2
1568498|NCT03034967|5421201|P5|Overall Study|Protocol Violation|0
1568499|NCT03034967|5421202|P4|Overall Study|Protocol Violation|0
1568500|NCT03034967|5421203|P3|Overall Study|Protocol Violation|0
1568501|NCT03034967|5421204|P2|Overall Study|Protocol Violation|0
1568502|NCT03034967|5421205|P1|Overall Study|Protocol Violation|1
1568503|NCT03034967|5421200|P6|Overall Study|Liver function test abnormality|0
1568504|NCT03034967|5421201|P5|Overall Study|Liver function test abnormality|0
1568505|NCT03034967|5421202|P4|Overall Study|Liver function test abnormality|0
1568506|NCT03034967|5421203|P3|Overall Study|Liver function test abnormality|1
1568507|NCT03034967|5421204|P2|Overall Study|Liver function test abnormality|0
1568508|NCT03034967|5421205|P1|Overall Study|Liver function test abnormality|0
1568509|NCT03034967|5421200|P6|Overall Study|Lost to Follow-up|2
1568510|NCT03034967|5421201|P5|Overall Study|Lost to Follow-up|0
1568511|NCT03034967|5421202|P4|Overall Study|Lost to Follow-up|1
1568512|NCT03034967|5421203|P3|Overall Study|Lost to Follow-up|0
1568513|NCT03034967|5421204|P2|Overall Study|Lost to Follow-up|0
1568514|NCT03034967|5421205|P1|Overall Study|Lost to Follow-up|0
1568515|NCT03034967|5421200|P6|Overall Study|Physician Decision|0
1568516|NCT03034967|5421201|P5|Overall Study|Physician Decision|1
1568517|NCT03034967|5421202|P4|Overall Study|Physician Decision|1
1568518|NCT03034967|5421203|P3|Overall Study|Physician Decision|1
1568519|NCT03034967|5421204|P2|Overall Study|Physician Decision|0
1568520|NCT03034967|5421205|P1|Overall Study|Physician Decision|1
1568521|NCT03034967|5421200|P6|Overall Study|Withdrawal by Subject|2
1568522|NCT03034967|5421201|P5|Overall Study|Withdrawal by Subject|9
1568523|NCT03034967|5421202|P4|Overall Study|Withdrawal by Subject|6
1568524|NCT03034967|5421203|P3|Overall Study|Withdrawal by Subject|6
1568525|NCT03034967|5421204|P2|Overall Study|Withdrawal by Subject|2
1568526|NCT03034967|5421205|P1|Overall Study|Withdrawal by Subject|9
1568527|NCT03034954|5421403|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
1568528|NCT03034954|5421404|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
1568529|NCT03034915|5421471|P3|Overall Study|Physician Decision|2
1568530|NCT03034915|5421472|P2|Overall Study|Physician Decision|5
1568531|NCT03034915|5421473|P1|Overall Study|Physician Decision|1
1568532|NCT03034915|5421471|P3|Overall Study|Protocol-defined withdrawal criteria met|29
1568533|NCT03034915|5421472|P2|Overall Study|Protocol-defined withdrawal criteria met|26
1568534|NCT03034915|5421473|P1|Overall Study|Protocol-defined withdrawal criteria met|19
1568535|NCT03034915|5421471|P3|Overall Study|Site closed|4
1568536|NCT03034915|5421472|P2|Overall Study|Site closed|2
1568537|NCT03034915|5421473|P1|Overall Study|Site closed|2
1568538|NCT03034915|5421471|P3|Overall Study|Lack of Efficacy|18
1568539|NCT03034915|5421472|P2|Overall Study|Lack of Efficacy|16
1568540|NCT03034915|5421473|P1|Overall Study|Lack of Efficacy|8
1568541|NCT03034915|5421471|P3|Overall Study|Protocol Deviation|7
1568542|NCT03034915|5421472|P2|Overall Study|Protocol Deviation|14
1568543|NCT03034915|5421473|P1|Overall Study|Protocol Deviation|2
1568544|NCT03034915|5421471|P3|Overall Study|Withdrawal by Subject|41
1568545|NCT03034915|5421472|P2|Overall Study|Withdrawal by Subject|46
1568546|NCT03034915|5421473|P1|Overall Study|Withdrawal by Subject|29
1568547|NCT03034915|5421471|P3|Overall Study|Lost to Follow-up|3
1568548|NCT03034915|5421472|P2|Overall Study|Lost to Follow-up|13
1568549|NCT03034915|5421473|P1|Overall Study|Lost to Follow-up|5
1568550|NCT03034915|5421471|P3|Overall Study|Adverse Event|22
1568551|NCT03034915|5421472|P2|Overall Study|Adverse Event|32
1568552|NCT03034915|5421473|P1|Overall Study|Adverse Event|29
1568553|NCT03034577|5421513|P2|Overall Study|Lost to Follow-up|26
1568554|NCT03034577|5421514|P1|Overall Study|Lost to Follow-up|25
1568555|NCT03034577|5421513|P2|Overall Study|Withdrawal by Subject|9
1568556|NCT03034577|5421514|P1|Overall Study|Withdrawal by Subject|6
1568557|NCT03034057|5421530|P1|Overall Study|Medication error without associated AE|1
1568558|NCT03034057|5421530|P1|Overall Study|Adverse Event|22
1568559|NCT03034057|5421530|P1|Overall Study|Lost to Follow-up|19
1568560|NCT03034057|5421530|P1|Overall Study|Not defined|2
1568561|NCT03034057|5421530|P1|Overall Study|Protocol Violation|1
1568562|NCT03034057|5421530|P1|Overall Study|Withdrawal by Subject|10
1568563|NCT03034044|5421536|P1|Overall Study|Enrolled, but not received Xyntha|1
1568564|NCT03033745|5421559|P3|Overall Study|Withdrawal by Subject|0
1568565|NCT03033745|5421560|P2|Overall Study|Withdrawal by Subject|1
1568566|NCT03033745|5421561|P1|Overall Study|Withdrawal by Subject|0
1568567|NCT03033745|5421559|P3|Overall Study|Adverse Event|1
1568568|NCT03033745|5421560|P2|Overall Study|Adverse Event|0
1568569|NCT03033745|5421561|P1|Overall Study|Adverse Event|1
1568570|NCT03033745|5421559|P3|Overall Study|Protocol Violation|1
1568571|NCT03033745|5421560|P2|Overall Study|Protocol Violation|0
1568572|NCT03033745|5421561|P1|Overall Study|Protocol Violation|0
1568573|NCT03032523|5421644|P2|Overall Study|Physician Decision|0
1568574|NCT03032523|5421645|P1|Overall Study|Physician Decision|1
1568575|NCT03032523|5421644|P2|Overall Study|Withdrawal by Subject|2
1568576|NCT03032523|5421645|P1|Overall Study|Withdrawal by Subject|2
1568577|NCT03032510|5421657|P2|Overall Study|Physician Decision|0
1568578|NCT03032510|5421658|P1|Overall Study|Physician Decision|2
1568579|NCT03032510|5421657|P2|Overall Study|Subject noncompliance|2
1568580|NCT03032510|5421658|P1|Overall Study|Subject noncompliance|4
1568581|NCT03032510|5421657|P2|Overall Study|Withdrawal by Subject|7
1568582|NCT03032510|5421658|P1|Overall Study|Withdrawal by Subject|8
1568583|NCT03032510|5421657|P2|Overall Study|Lost to Follow-up|7
1568584|NCT03032510|5421658|P1|Overall Study|Lost to Follow-up|8
1568585|NCT03032510|5421657|P2|Overall Study|Adverse Event|2
1568586|NCT03032510|5421658|P1|Overall Study|Adverse Event|5
1568587|NCT03031899|5421685|P1|Overall Study|lesion disappeared after stopping habit|1
1568588|NCT03031899|5421685|P1|Overall Study|Protocol Violation|1
1568589|NCT03031496|5421702|P2|Period 1|Withdrawal by Subject|2
1568590|NCT03031496|5421703|P1|Period 1|Withdrawal by Subject|0
1568591|NCT03031496|5421702|P2|Period 1|Adverse Event|0
1568592|NCT03031496|5421703|P1|Period 1|Adverse Event|2
1568593|NCT03031431|5421739|P1|Overall Study|Infant removed by maternal request|1
1568594|NCT03029832|5421817|P2|Overall Study|Study Terminated By Sponsor|1
1568595|NCT03029832|5421818|P1|Overall Study|Study Terminated By Sponsor|1
1568596|NCT03029832|5421817|P2|Overall Study|Death due to Disease Progression|0
1568597|NCT03029832|5421818|P1|Overall Study|Death due to Disease Progression|1
1568598|NCT03029832|5421817|P2|Overall Study|Safety Follow-Up Completed|0
1568599|NCT03029832|5421818|P1|Overall Study|Safety Follow-Up Completed|2
1568600|NCT03029819|5421848|P2|Overall Study|Removed due to disruptive behavior|1
1568601|NCT03029819|5421849|P1|Overall Study|Removed due to disruptive behavior|0
1568602|NCT03029819|5421848|P2|Overall Study|Lost to Follow-up|5
1568603|NCT03029819|5421849|P1|Overall Study|Lost to Follow-up|3
1568604|NCT03029780|5421863|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1568605|NCT03029780|5421864|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
1568606|NCT03029780|5421863|P2|Overall Study|Study Drug Toxicity|5
1568607|NCT03029780|5421864|P1|Overall Study|Study Drug Toxicity|5
1568608|NCT03029780|5421863|P2|Overall Study|Disease Progression|3
1568609|NCT03029780|5421864|P1|Overall Study|Disease Progression|1
1568610|NCT03029650|5421876|P2|Washout (1 Week)|Physician Decision|1
1568611|NCT03029650|5421877|P1|Washout (1 Week)|Physician Decision|0
1568612|NCT03029650|5421876|P2|Washout (1 Week)|Withdrawal by Subject|1
1568613|NCT03029650|5421877|P1|Washout (1 Week)|Withdrawal by Subject|1
1568614|NCT03029234|5421892|P1|Overall Study|Death|61
1568615|NCT03029234|5421892|P1|Overall Study|Withdrawal by Subject|5
1568616|NCT03029234|5421892|P1|Overall Study|Sponsor Decision|1
1568617|NCT03028870|5421986|P4|Overall Study|Administrative|4
1568618|NCT03028870|5421987|P3|Overall Study|Administrative|12
1568619|NCT03028870|5421988|P2|Overall Study|Administrative|5
1568620|NCT03028870|5421989|P1|Overall Study|Administrative|5
1568621|NCT03028870|5421986|P4|Overall Study|Lack of Efficacy|0
1568622|NCT03028870|5421987|P3|Overall Study|Lack of Efficacy|0
1568623|NCT03028870|5421988|P2|Overall Study|Lack of Efficacy|0
1568624|NCT03028870|5421989|P1|Overall Study|Lack of Efficacy|3
1568625|NCT03028870|5421986|P4|Overall Study|Lost to Follow-up|0
1568626|NCT03028870|5421987|P3|Overall Study|Lost to Follow-up|0
1568627|NCT03028870|5421988|P2|Overall Study|Lost to Follow-up|0
1568628|NCT03028870|5421989|P1|Overall Study|Lost to Follow-up|1
1568629|NCT03028870|5421986|P4|Overall Study|Withdrawal by Subject|2
1568630|NCT03028870|5421987|P3|Overall Study|Withdrawal by Subject|1
1568631|NCT03028870|5421988|P2|Overall Study|Withdrawal by Subject|1
1568632|NCT03028870|5421989|P1|Overall Study|Withdrawal by Subject|1
1568633|NCT03028870|5421986|P4|Overall Study|Adverse Event|3
1568634|NCT03028870|5421987|P3|Overall Study|Adverse Event|3
1568635|NCT03028870|5421988|P2|Overall Study|Adverse Event|4
1568636|NCT03028870|5421989|P1|Overall Study|Adverse Event|7
1568637|NCT03028142|5422189|P6|Overall Study|Withdrawal by Subject|0
1568638|NCT03028142|5422190|P5|Overall Study|Withdrawal by Subject|1
1568639|NCT03028142|5422191|P4|Overall Study|Withdrawal by Subject|0
1568640|NCT03028142|5422192|P3|Overall Study|Withdrawal by Subject|0
1568641|NCT03028142|5422193|P2|Overall Study|Withdrawal by Subject|0
1568642|NCT03028142|5422194|P1|Overall Study|Withdrawal by Subject|0
1568643|NCT03028142|5422189|P6|Overall Study|Adverse Event|1
1568644|NCT03028142|5422190|P5|Overall Study|Adverse Event|0
1568645|NCT03028142|5422191|P4|Overall Study|Adverse Event|0
1568646|NCT03028142|5422192|P3|Overall Study|Adverse Event|0
1568647|NCT03028142|5422193|P2|Overall Study|Adverse Event|1
1568648|NCT03028142|5422194|P1|Overall Study|Adverse Event|1
1568649|NCT03028129|5422213|P2|Overall Study|Withdrawal by Subject|45
1568650|NCT03028129|5422214|P1|Overall Study|Withdrawal by Subject|62
1568651|NCT03028129|5422213|P2|Overall Study|Protocol Violation|1
1568652|NCT03028129|5422214|P1|Overall Study|Protocol Violation|1
1568653|NCT03028129|5422213|P2|Overall Study|Physician Decision|1
1568654|NCT03028129|5422214|P1|Overall Study|Physician Decision|0
1568655|NCT03028129|5422213|P2|Overall Study|Lost to Follow-up|38
1568656|NCT03028129|5422214|P1|Overall Study|Lost to Follow-up|50
1568657|NCT03028129|5422213|P2|Overall Study|Adverse Event|2
1568658|NCT03028129|5422214|P1|Overall Study|Adverse Event|13
1568659|NCT03026530|5422310|P2|Overall Study|Protocol Violation|5
1568660|NCT03026530|5422311|P1|Overall Study|Protocol Violation|2
1568661|NCT03026530|5422310|P2|Overall Study|Lost to Follow-up|24
1568662|NCT03026530|5422311|P1|Overall Study|Lost to Follow-up|19
1568663|NCT03026257|5422325|P6|Overall Study|Withdrawal by Subject|0
1568664|NCT03026257|5422326|P5|Overall Study|Withdrawal by Subject|0
1568665|NCT03026257|5422327|P4|Overall Study|Withdrawal by Subject|0
1568666|NCT03026257|5422328|P3|Overall Study|Withdrawal by Subject|0
1568667|NCT03026257|5422329|P2|Overall Study|Withdrawal by Subject|1
1568668|NCT03026257|5422330|P1|Overall Study|Withdrawal by Subject|1
1568669|NCT03026257|5422325|P6|Overall Study|Protocol Violation|0
1568670|NCT03026257|5422326|P5|Overall Study|Protocol Violation|1
1568671|NCT03026257|5422327|P4|Overall Study|Protocol Violation|1
1568672|NCT03026257|5422328|P3|Overall Study|Protocol Violation|0
1568673|NCT03026257|5422329|P2|Overall Study|Protocol Violation|0
1568674|NCT03026257|5422330|P1|Overall Study|Protocol Violation|1
1568675|NCT03026257|5422325|P6|Overall Study|Lost to Follow-up|0
1568676|NCT03026257|5422326|P5|Overall Study|Lost to Follow-up|0
1568677|NCT03026257|5422327|P4|Overall Study|Lost to Follow-up|0
1568678|NCT03026257|5422328|P3|Overall Study|Lost to Follow-up|0
1568679|NCT03026257|5422329|P2|Overall Study|Lost to Follow-up|0
1568680|NCT03026257|5422330|P1|Overall Study|Lost to Follow-up|1
1568681|NCT03026257|5422325|P6|Overall Study|Adverse Event|0
1568682|NCT03026257|5422326|P5|Overall Study|Adverse Event|0
1568683|NCT03026257|5422327|P4|Overall Study|Adverse Event|0
1568684|NCT03026257|5422328|P3|Overall Study|Adverse Event|0
1568685|NCT03026257|5422329|P2|Overall Study|Adverse Event|0
1568686|NCT03026257|5422330|P1|Overall Study|Adverse Event|3
1568687|NCT03026088|5422344|P1|Overall Study|Study termination|20
1568688|NCT03026075|5422368|P1|Overall Study|Physician Decision|1
1568689|NCT03025217|5422381|P1|Overall Study|Not eligible, poor English|2
1568690|NCT03025217|5422381|P1|Overall Study|Lost to Follow-up|1
1568691|NCT03025217|5422381|P1|Overall Study|Pregnancy|1
1568692|NCT03024606|5422388|P2|Overall Study|Withdrawal by Subject|10
1568693|NCT03024606|5422389|P1|Overall Study|Withdrawal by Subject|9
1568694|NCT03023423|5422466|P3|Overall Study|Ongoing|24
1568695|NCT03023423|5422467|P2|Overall Study|Ongoing|32
1568696|NCT03023423|5422468|P1|Overall Study|Ongoing|2
1568697|NCT03023423|5422466|P3|Overall Study|Other|2
1568698|NCT03023423|5422467|P2|Overall Study|Other|2
1568699|NCT03023423|5422468|P1|Overall Study|Other|0
1568700|NCT03023423|5422466|P3|Overall Study|Death|20
1568701|NCT03023423|5422467|P2|Overall Study|Death|12
1568702|NCT03023423|5422468|P1|Overall Study|Death|5
1568703|NCT03023137|5422505|P2|Overall Study|Lost the baby in a car accident|0
1568704|NCT03023137|5422506|P1|Overall Study|Lost the baby in a car accident|1
1568705|NCT03023137|5422505|P2|Overall Study|Protocol Violation|4
1568706|NCT03023137|5422506|P1|Overall Study|Protocol Violation|0
1568707|NCT03023137|5422505|P2|Overall Study|Lost to Follow-up|1
1568708|NCT03023137|5422506|P1|Overall Study|Lost to Follow-up|1
1568709|NCT03023137|5422505|P2|Overall Study|Multiple pregnancy|4
1568710|NCT03023137|5422506|P1|Overall Study|Multiple pregnancy|2
1568711|NCT03022630|5422544|P2|Overall Study|Withdrawal by Subject|5
1568712|NCT03022630|5422545|P1|Overall Study|Withdrawal by Subject|0
1568713|NCT03022630|5422544|P2|Overall Study|Death|7
1568714|NCT03022630|5422545|P1|Overall Study|Death|9
1568715|NCT03022422|5422625|P6|Overall Study|3 subjects consented but not vaccinated|0
1568716|NCT03022422|5422626|P5|Overall Study|3 subjects consented but not vaccinated|0
1568717|NCT03022422|5422627|P4|Overall Study|3 subjects consented but not vaccinated|0
1568718|NCT03022422|5422628|P3|Overall Study|3 subjects consented but not vaccinated|3
1568719|NCT03022422|5422629|P2|Overall Study|3 subjects consented but not vaccinated|0
1568720|NCT03022422|5422630|P1|Overall Study|3 subjects consented but not vaccinated|0
1568721|NCT03022045|5422683|P2|Overall Study|Withdrawal by Subject|1
1568722|NCT03022045|5422684|P1|Overall Study|Withdrawal by Subject|1
1568723|NCT03022045|5422683|P2|Overall Study|Adverse Event|1
1568724|NCT03022045|5422684|P1|Overall Study|Adverse Event|0
1568725|NCT03021668|5422713|P2|Overall Study|Physician Decision|1
1568726|NCT03021668|5422714|P1|Overall Study|Physician Decision|0
1568727|NCT03021642|5422726|P2|Washout Period (21 Days)|Adverse Event|1
1568728|NCT03021642|5422727|P1|Washout Period (21 Days)|Adverse Event|1
1568729|NCT03021304|5422776|P1|Overall Study|Lack of Efficacy|1
1568730|NCT03021187|5422785|P4|Overall Study|Lost to Follow-up|4
1568731|NCT03021187|5422786|P3|Overall Study|Lost to Follow-up|1
1568732|NCT03021187|5422787|P2|Overall Study|Lost to Follow-up|3
1568733|NCT03021187|5422788|P1|Overall Study|Lost to Follow-up|10
1568734|NCT03021187|5422785|P4|Overall Study|Withdrawal by Subject|5
1568735|NCT03021187|5422786|P3|Overall Study|Withdrawal by Subject|2
1568736|NCT03021187|5422787|P2|Overall Study|Withdrawal by Subject|6
1568737|NCT03021187|5422788|P1|Overall Study|Withdrawal by Subject|0
1568738|NCT03021187|5422785|P4|Overall Study|Death|0
1568739|NCT03021187|5422786|P3|Overall Study|Death|3
1568740|NCT03021187|5422787|P2|Overall Study|Death|0
1568741|NCT03021187|5422788|P1|Overall Study|Death|0
1568742|NCT03021018|5422944|P3|Overall Study|Fall with subsequent nasal fracture|0
1568743|NCT03021018|5422945|P2|Overall Study|Fall with subsequent nasal fracture|0
1568744|NCT03021018|5422946|P1|Overall Study|Fall with subsequent nasal fracture|1
1568745|NCT03021018|5422944|P3|Overall Study|Adverse Event|0
1568746|NCT03021018|5422945|P2|Overall Study|Adverse Event|0
1568747|NCT03021018|5422946|P1|Overall Study|Adverse Event|1
1568748|NCT03020745|5422983|P10|Part 2 (Up to 169 Days)|Ongoing in study|0
1568749|NCT03020745|5422984|P9|Part 2 (Up to 169 Days)|Ongoing in study|0
1568750|NCT03020745|5422985|P8|Part 2 (Up to 169 Days)|Ongoing in study|1
1568751|NCT03020745|5422986|P7|Part 2 (Up to 169 Days)|Ongoing in study|0
1568752|NCT03020745|5422987|P6|Part 2 (Up to 169 Days)|Ongoing in study|0
1568753|NCT03020745|5422988|P5|Part 2 (Up to 169 Days)|Ongoing in study|0
1568754|NCT03020745|5422989|P4|Part 2 (Up to 169 Days)|Ongoing in study|0
1568755|NCT03020745|5422990|P3|Part 2 (Up to 169 Days)|Ongoing in study|0
1568756|NCT03020745|5422991|P2|Part 2 (Up to 169 Days)|Ongoing in study|0
1568757|NCT03020745|5422992|P1|Part 2 (Up to 169 Days)|Ongoing in study|0
1568758|NCT03020745|5422983|P10|Part 2 (Up to 169 Days)|Adverse Event|0
1568759|NCT03020745|5422984|P9|Part 2 (Up to 169 Days)|Adverse Event|1
1568760|NCT03020745|5422985|P8|Part 2 (Up to 169 Days)|Adverse Event|0
1568761|NCT03020745|5422986|P7|Part 2 (Up to 169 Days)|Adverse Event|0
1568762|NCT03020745|5422987|P6|Part 2 (Up to 169 Days)|Adverse Event|0
1568763|NCT03020745|5422988|P5|Part 2 (Up to 169 Days)|Adverse Event|0
1568764|NCT03020745|5422989|P4|Part 2 (Up to 169 Days)|Adverse Event|0
1568765|NCT03020745|5422990|P3|Part 2 (Up to 169 Days)|Adverse Event|0
1568766|NCT03020745|5422991|P2|Part 2 (Up to 169 Days)|Adverse Event|0
1568767|NCT03020745|5422992|P1|Part 2 (Up to 169 Days)|Adverse Event|0
1568768|NCT03020576|5423253|P2|Overall Study|Withdrawal by Subject|2
1568769|NCT03020576|5423254|P1|Overall Study|Withdrawal by Subject|1
1568770|NCT03020160|5423309|P2|Overall Study|Continuing to receive emicizumab|41
1568771|NCT03020160|5423310|P1|Overall Study|Continuing to receive emicizumab|7
1568772|NCT03019627|5423397|P2|Overall Study|Other|2
1568773|NCT03019627|5423398|P1|Overall Study|Other|2
1568774|NCT03019627|5423397|P2|Overall Study|not compliance|2
1568775|NCT03019627|5423398|P1|Overall Study|not compliance|2
1568776|NCT03019627|5423397|P2|Overall Study|Lost to Follow-up|1
1568777|NCT03019627|5423398|P1|Overall Study|Lost to Follow-up|2
1568778|NCT03019627|5423397|P2|Overall Study|Unrelated to adverse event|3
1568779|NCT03019627|5423398|P1|Overall Study|Unrelated to adverse event|1
1568780|NCT03019627|5423397|P2|Overall Study|Adverse Event|0
1568781|NCT03019627|5423398|P1|Overall Study|Adverse Event|8
1568782|NCT03019549|5423414|P1|Period 2|Withdrawal by Subject|1
1568783|NCT03019549|5423414|P1|Period 2|Physician Decision|2
1568784|NCT03019549|5423414|P1|Period 2|Adverse Event|2
1568785|NCT03019549|5423414|P1|Washout|DId not meet genotype criteria|11
1568786|NCT03018340|5423427|P2|Overall Study|Not further specified|1
1568787|NCT03018340|5423428|P1|Overall Study|Not further specified|0
1568788|NCT03018340|5423427|P2|Overall Study|Protocol Violation|7
1568789|NCT03018340|5423428|P1|Overall Study|Protocol Violation|3
1568790|NCT03018340|5423427|P2|Overall Study|Lost to Follow-up|7
1568791|NCT03018340|5423428|P1|Overall Study|Lost to Follow-up|1
1568792|NCT03018340|5423427|P2|Overall Study|Non-compliance with study drug/procedure|4
1568793|NCT03018340|5423428|P1|Overall Study|Non-compliance with study drug/procedure|3
1568794|NCT03018340|5423427|P2|Overall Study|Lack of Efficacy|1
1568795|NCT03018340|5423428|P1|Overall Study|Lack of Efficacy|0
1568796|NCT03018340|5423427|P2|Overall Study|Withdrawal by Subject|8
1568797|NCT03018340|5423428|P1|Overall Study|Withdrawal by Subject|0
1568798|NCT03018340|5423427|P2|Overall Study|Adverse Event|2
1568799|NCT03018340|5423428|P1|Overall Study|Adverse Event|1
1568800|NCT03018106|5423487|P2|Overall Study|Lost to Follow-up|1
1568801|NCT03018106|5423488|P1|Overall Study|Lost to Follow-up|0
1568802|NCT03018028|5423501|P5|Overall Study|Withdrawal by Subject|0
1568803|NCT03018028|5423502|P4|Overall Study|Withdrawal by Subject|2
1568804|NCT03018028|5423503|P3|Overall Study|Withdrawal by Subject|1
1568805|NCT03018028|5423504|P2|Overall Study|Withdrawal by Subject|0
1568806|NCT03018028|5423505|P1|Overall Study|Withdrawal by Subject|3
1568807|NCT03017846|5423750|P1|Overall Study|Adverse Event|2
1568808|NCT03017846|5423750|P1|Overall Study|Lost to Follow-up|3
1568809|NCT03017612|5423758|P1|Overall Study|Adverse Event|2
1568810|NCT03017235|5423768|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
1568811|NCT03017235|5423769|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
1568812|NCT03017235|5423768|P2|Overall Study|Protocol Violation|1
1568813|NCT03017235|5423769|P1|Overall Study|Protocol Violation|2
1568814|NCT03017235|5423768|P2|Overall Study|Adverse Event|1
1568815|NCT03017235|5423769|P1|Overall Study|Adverse Event|0
1568816|NCT03017235|5423768|P2|Overall Study|Lost to Follow-up|7
1568817|NCT03017235|5423769|P1|Overall Study|Lost to Follow-up|2
1568818|NCT03017235|5423768|P2|Overall Study|Withdrawal by Subject|3
1568819|NCT03017235|5423769|P1|Overall Study|Withdrawal by Subject|4
1568820|NCT03016078|5423830|P1|Overall Study|Protocol Violation|1
1568821|NCT03016078|5423830|P1|Overall Study|Protocol Violation|1
1568822|NCT03015220|5423845|P4|Overall Study|Lost to Follow-up|0
1568823|NCT03015220|5423846|P3|Overall Study|Lost to Follow-up|1
1568824|NCT03015220|5423847|P2|Overall Study|Lost to Follow-up|0
1568825|NCT03015220|5423848|P1|Overall Study|Lost to Follow-up|0
1568826|NCT03015220|5423845|P4|Overall Study|Withdrawal by Subject|2
1568827|NCT03015220|5423846|P3|Overall Study|Withdrawal by Subject|2
1568828|NCT03015220|5423847|P2|Overall Study|Withdrawal by Subject|2
1568829|NCT03015220|5423848|P1|Overall Study|Withdrawal by Subject|3
1568851|NCT03014674|5424145|P3|Overall Study|Withdrawal by Subject|0
1568852|NCT03014674|5424146|P2|Overall Study|Withdrawal by Subject|0
1568853|NCT03014674|5424147|P1|Overall Study|Withdrawal by Subject|1
1568854|NCT03014479|5424211|P2|Overall Study|Unacceptable Inability of Site Visit|1
1568855|NCT03014479|5424212|P1|Overall Study|Unacceptable Inability of Site Visit|0
1568856|NCT03014479|5424211|P2|Overall Study|Voluntary Withdrawal|2
1568857|NCT03014479|5424212|P1|Overall Study|Voluntary Withdrawal|0
1568858|NCT03014479|5424211|P2|Overall Study|Adverse Event|1
1568859|NCT03014479|5424212|P1|Overall Study|Adverse Event|0
1568860|NCT03014206|5424258|P1|Overall Study|Registration Violation|12
1568861|NCT03014180|5424262|P1|Overall Study|Protocol Violation|2
1568862|NCT03014011|5424271|P2|Washout|Withdrawal by Subject|0
1568863|NCT03014011|5424272|P1|Washout|Withdrawal by Subject|1
1568864|NCT03014011|5424271|P2|First Intervention|Withdrawal by Subject|0
1568865|NCT03014011|5424272|P1|First Intervention|Withdrawal by Subject|1
1568866|NCT03012828|5424284|P6|Overall Study|Delay to last visit would delay DBL|1
1568867|NCT03012828|5424285|P5|Overall Study|Delay to last visit would delay DBL|0
1568868|NCT03012828|5424286|P4|Overall Study|Delay to last visit would delay DBL|0
1568869|NCT03012828|5424287|P3|Overall Study|Delay to last visit would delay DBL|0
1568870|NCT03012828|5424288|P2|Overall Study|Delay to last visit would delay DBL|0
1568871|NCT03012828|5424289|P1|Overall Study|Delay to last visit would delay DBL|0
1568872|NCT03012828|5424284|P6|Overall Study|Non-compliance with protocol|0
1568873|NCT03012828|5424285|P5|Overall Study|Non-compliance with protocol|1
1568874|NCT03012828|5424286|P4|Overall Study|Non-compliance with protocol|0
1568875|NCT03012828|5424287|P3|Overall Study|Non-compliance with protocol|0
1568876|NCT03012828|5424288|P2|Overall Study|Non-compliance with protocol|0
1568877|NCT03012828|5424289|P1|Overall Study|Non-compliance with protocol|0
1568878|NCT03012828|5424284|P6|Overall Study|Withdrawal by Subject|1
1568879|NCT03012828|5424285|P5|Overall Study|Withdrawal by Subject|0
1568880|NCT03012828|5424286|P4|Overall Study|Withdrawal by Subject|0
1568881|NCT03012828|5424287|P3|Overall Study|Withdrawal by Subject|1
1568882|NCT03012828|5424288|P2|Overall Study|Withdrawal by Subject|0
1568883|NCT03012828|5424289|P1|Overall Study|Withdrawal by Subject|0
1568884|NCT03012828|5424284|P6|Overall Study|Lost to Follow-up|0
1568885|NCT03012828|5424285|P5|Overall Study|Lost to Follow-up|1
1568886|NCT03012828|5424286|P4|Overall Study|Lost to Follow-up|0
1568887|NCT03012828|5424287|P3|Overall Study|Lost to Follow-up|1
1568888|NCT03012828|5424288|P2|Overall Study|Lost to Follow-up|0
1568889|NCT03012828|5424289|P1|Overall Study|Lost to Follow-up|1
1568890|NCT03012334|5424332|P10|Period 4|Adverse Event|0
1568891|NCT03012334|5424333|P9|Period 4|Adverse Event|1
1568892|NCT03012334|5424334|P8|Period 4|Adverse Event|0
1568893|NCT03012334|5424335|P7|Period 4|Adverse Event|0
1568894|NCT03012334|5424336|P6|Period 4|Adverse Event|0
1568895|NCT03012334|5424337|P5|Period 4|Adverse Event|0
1568896|NCT03012334|5424338|P4|Period 4|Adverse Event|0
1568897|NCT03012334|5424339|P3|Period 4|Adverse Event|0
1568898|NCT03012334|5424340|P2|Period 4|Adverse Event|0
1568899|NCT03012334|5424341|P1|Period 4|Adverse Event|0
1568900|NCT03012334|5424332|P10|Period 4|Non-Compliance|0
1568901|NCT03012334|5424333|P9|Period 4|Non-Compliance|0
1568902|NCT03012334|5424334|P8|Period 4|Non-Compliance|0
1568903|NCT03012334|5424335|P7|Period 4|Non-Compliance|1
1568904|NCT03012334|5424336|P6|Period 4|Non-Compliance|0
1568905|NCT03012334|5424337|P5|Period 4|Non-Compliance|0
1568906|NCT03012334|5424338|P4|Period 4|Non-Compliance|0
1568907|NCT03012334|5424339|P3|Period 4|Non-Compliance|0
1568908|NCT03012334|5424340|P2|Period 4|Non-Compliance|0
1568909|NCT03012334|5424341|P1|Period 4|Non-Compliance|0
1568910|NCT03012334|5424332|P10|Period 2|Protocol Violation|0
1568911|NCT03012334|5424333|P9|Period 2|Protocol Violation|0
1568912|NCT03012334|5424334|P8|Period 2|Protocol Violation|1
1568913|NCT03012334|5424335|P7|Period 2|Protocol Violation|0
1568914|NCT03012334|5424336|P6|Period 2|Protocol Violation|0
1568915|NCT03012334|5424337|P5|Period 2|Protocol Violation|0
1568916|NCT03012334|5424338|P4|Period 2|Protocol Violation|0
1568917|NCT03012334|5424339|P3|Period 2|Protocol Violation|1
1568918|NCT03012334|5424340|P2|Period 2|Protocol Violation|0
1568919|NCT03012334|5424341|P1|Period 2|Protocol Violation|0
1568920|NCT03012334|5424332|P10|Period 2|Withdrawal by Subject|0
1568921|NCT03012334|5424333|P9|Period 2|Withdrawal by Subject|0
1568922|NCT03012334|5424334|P8|Period 2|Withdrawal by Subject|0
1568923|NCT03012334|5424335|P7|Period 2|Withdrawal by Subject|0
1568924|NCT03012334|5424336|P6|Period 2|Withdrawal by Subject|0
1568925|NCT03012334|5424337|P5|Period 2|Withdrawal by Subject|0
1568926|NCT03012334|5424338|P4|Period 2|Withdrawal by Subject|0
1568927|NCT03012334|5424339|P3|Period 2|Withdrawal by Subject|0
1568928|NCT03012334|5424340|P2|Period 2|Withdrawal by Subject|1
1568929|NCT03012334|5424341|P1|Period 2|Withdrawal by Subject|0
1568930|NCT03012334|5424332|P10|Period 1|Withdrawal by Subject|1
1568931|NCT03012334|5424333|P9|Period 1|Withdrawal by Subject|0
1568932|NCT03012334|5424334|P8|Period 1|Withdrawal by Subject|0
1568933|NCT03012334|5424335|P7|Period 1|Withdrawal by Subject|0
1568934|NCT03012334|5424336|P6|Period 1|Withdrawal by Subject|0
1568935|NCT03012334|5424337|P5|Period 1|Withdrawal by Subject|0
1568936|NCT03012334|5424338|P4|Period 1|Withdrawal by Subject|0
1568937|NCT03012334|5424339|P3|Period 1|Withdrawal by Subject|0
1568938|NCT03012334|5424340|P2|Period 1|Withdrawal by Subject|0
1568939|NCT03012334|5424341|P1|Period 1|Withdrawal by Subject|0
1568940|NCT03012061|5424411|P3|Overall Study|Adverse Event|0
1568941|NCT03012061|5424412|P2|Overall Study|Adverse Event|0
1568942|NCT03012061|5424413|P1|Overall Study|Adverse Event|2
1568943|NCT03012061|5424411|P3|Overall Study|Lack of Efficacy|0
1568944|NCT03012061|5424412|P2|Overall Study|Lack of Efficacy|1
1568945|NCT03012061|5424413|P1|Overall Study|Lack of Efficacy|0
1568946|NCT03012061|5424411|P3|Overall Study|Protocol Violation|2
1568947|NCT03012061|5424412|P2|Overall Study|Protocol Violation|0
1568948|NCT03012061|5424413|P1|Overall Study|Protocol Violation|0
1568949|NCT03012061|5424411|P3|Overall Study|Met Protocol Withdrawal Criterion|1
1568950|NCT03012061|5424412|P2|Overall Study|Met Protocol Withdrawal Criterion|0
1568951|NCT03012061|5424413|P1|Overall Study|Met Protocol Withdrawal Criterion|0
1568952|NCT03012061|5424411|P3|Overall Study|Study closed/ Terminated|1
1568953|NCT03012061|5424412|P2|Overall Study|Study closed/ Terminated|0
1568954|NCT03012061|5424413|P1|Overall Study|Study closed/ Terminated|0
1568955|NCT03012061|5424411|P3|Overall Study|Lost to Follow-up|0
1568956|NCT03012061|5424412|P2|Overall Study|Lost to Follow-up|1
1568957|NCT03012061|5424413|P1|Overall Study|Lost to Follow-up|2
1568958|NCT03012061|5424411|P3|Overall Study|Investigator Site Closed|0
1568959|NCT03012061|5424412|P2|Overall Study|Investigator Site Closed|2
1568960|NCT03012061|5424413|P1|Overall Study|Investigator Site Closed|1
1568961|NCT03012061|5424411|P3|Overall Study|Withdrawal by Subject|4
1568962|NCT03012061|5424412|P2|Overall Study|Withdrawal by Subject|5
1568963|NCT03012061|5424413|P1|Overall Study|Withdrawal by Subject|1
1568964|NCT03011840|5424438|P2|Overall Study|Not received PIL in post PIL phase|21
1568965|NCT03011840|5424439|P1|Overall Study|Not received PIL in post PIL phase|0
1568966|NCT03011099|5424449|P2|Overall Study|Withdrawal by Subject|2
1568967|NCT03011099|5424450|P1|Overall Study|Withdrawal by Subject|0
1568968|NCT03010501|5424483|P6|Study Week 3|Withdrawal by Subject|0
1568969|NCT03010501|5424484|P5|Study Week 3|Withdrawal by Subject|0
1568970|NCT03010501|5424485|P4|Study Week 3|Withdrawal by Subject|1
1568971|NCT03010501|5424486|P3|Study Week 3|Withdrawal by Subject|0
1568972|NCT03010501|5424487|P2|Study Week 3|Withdrawal by Subject|0
1568973|NCT03010501|5424488|P1|Study Week 3|Withdrawal by Subject|0
1568974|NCT03010501|5424483|P6|Study Week 1|Withdrawal by Subject|0
1568975|NCT03010501|5424484|P5|Study Week 1|Withdrawal by Subject|0
1568976|NCT03010501|5424485|P4|Study Week 1|Withdrawal by Subject|2
1568977|NCT03010501|5424486|P3|Study Week 1|Withdrawal by Subject|0
1568978|NCT03010501|5424487|P2|Study Week 1|Withdrawal by Subject|1
1568979|NCT03010501|5424488|P1|Study Week 1|Withdrawal by Subject|2
1568980|NCT03007966|5424583|P2|Overall Study|Did not meeting inclusion/exclusion|0
1568981|NCT03007966|5424584|P1|Overall Study|Did not meeting inclusion/exclusion|1
1568982|NCT03006341|5424629|P4|Overall Study|Not linked in the EMR|10685
1568983|NCT03006341|5424630|P3|Overall Study|Not linked in the EMR|30993
1568984|NCT03006341|5424631|P2|Overall Study|Not linked in the EMR|67505
1568985|NCT03006341|5424632|P1|Overall Study|Not linked in the EMR|25069
1568986|NCT03005067|5424676|P2|Overall Study|Protocol Violation|1
1568987|NCT03005067|5424677|P1|Overall Study|Protocol Violation|0
1568988|NCT03005067|5424676|P2|Overall Study|Other (reason not specified)|1
1568989|NCT03005067|5424677|P1|Overall Study|Other (reason not specified)|3
1568990|NCT03005067|5424676|P2|Overall Study|Adverse Event|3
1568991|NCT03005067|5424677|P1|Overall Study|Adverse Event|4
1568992|NCT03005067|5424676|P2|Overall Study|Withdrawal by Subject|2
1568993|NCT03005067|5424677|P1|Overall Study|Withdrawal by Subject|3
1568994|NCT03004924|5424705|P3|Overall Study|HSV1 Positive|0
1568995|NCT03004924|5424706|P2|Overall Study|HSV1 Positive|0
1568996|NCT03004924|5424707|P1|Overall Study|HSV1 Positive|1
1568997|NCT03004924|5424705|P3|Overall Study|Missed Study Visit|2
1568998|NCT03004924|5424706|P2|Overall Study|Missed Study Visit|0
1568999|NCT03004924|5424707|P1|Overall Study|Missed Study Visit|0
1569000|NCT03004924|5424705|P3|Overall Study|Terminated by Sponsor|1
1569001|NCT03004924|5424706|P2|Overall Study|Terminated by Sponsor|0
1569002|NCT03004924|5424707|P1|Overall Study|Terminated by Sponsor|0
1569003|NCT03004924|5424705|P3|Overall Study|Pregnancy|0
1569004|NCT03004924|5424706|P2|Overall Study|Pregnancy|1
1569005|NCT03004924|5424707|P1|Overall Study|Pregnancy|0
1569006|NCT03004924|5424705|P3|Overall Study|Screen Failure|0
1569007|NCT03004924|5424706|P2|Overall Study|Screen Failure|0
1569008|NCT03004924|5424707|P1|Overall Study|Screen Failure|1
1569009|NCT03004924|5424705|P3|Overall Study|Withdrawal by parent/guardian|2
1569010|NCT03004924|5424706|P2|Overall Study|Withdrawal by parent/guardian|0
1569011|NCT03004924|5424707|P1|Overall Study|Withdrawal by parent/guardian|1
1569012|NCT03004924|5424705|P3|Overall Study|Physician Decision|1
1569013|NCT03004924|5424706|P2|Overall Study|Physician Decision|0
1569014|NCT03004924|5424707|P1|Overall Study|Physician Decision|1
1569015|NCT03004924|5424705|P3|Overall Study|Lack of Efficacy|2
1569016|NCT03004924|5424706|P2|Overall Study|Lack of Efficacy|4
1569017|NCT03004924|5424707|P1|Overall Study|Lack of Efficacy|2
1569018|NCT03004924|5424705|P3|Overall Study|Lost to Follow-up|4
1569019|NCT03004924|5424706|P2|Overall Study|Lost to Follow-up|1
1569020|NCT03004924|5424707|P1|Overall Study|Lost to Follow-up|6
1569021|NCT03004924|5424705|P3|Overall Study|Withdrawal by Subject|5
1569022|NCT03004924|5424706|P2|Overall Study|Withdrawal by Subject|3
1569023|NCT03004924|5424707|P1|Overall Study|Withdrawal by Subject|5
1569024|NCT03004924|5424705|P3|Overall Study|Protocol Violation|1
1569025|NCT03004924|5424706|P2|Overall Study|Protocol Violation|0
1569026|NCT03004924|5424707|P1|Overall Study|Protocol Violation|4
1569027|NCT03004924|5424705|P3|Overall Study|Adverse Event|10
1569028|NCT03004924|5424706|P2|Overall Study|Adverse Event|5
1569029|NCT03004924|5424707|P1|Overall Study|Adverse Event|6
1569030|NCT03004469|5424946|P3|Overall Study|Other unspecified reason|1
1569031|NCT03004469|5424947|P2|Overall Study|Other unspecified reason|4
1569032|NCT03004469|5424948|P1|Overall Study|Other unspecified reason|0
1569033|NCT03004469|5424946|P3|Overall Study|Withdrawal by Subject|10
1569034|NCT03004469|5424947|P2|Overall Study|Withdrawal by Subject|27
1569035|NCT03004469|5424948|P1|Overall Study|Withdrawal by Subject|29
1569036|NCT03004469|5424946|P3|Overall Study|Protocol Violation|1
1569037|NCT03004469|5424947|P2|Overall Study|Protocol Violation|0
1569038|NCT03004469|5424948|P1|Overall Study|Protocol Violation|0
1569039|NCT03004469|5424946|P3|Overall Study|Non-Compliance with Study Drug|0
1569040|NCT03004469|5424947|P2|Overall Study|Non-Compliance with Study Drug|0
1569041|NCT03004469|5424948|P1|Overall Study|Non-Compliance with Study Drug|2
1569042|NCT03004469|5424946|P3|Overall Study|Lost to Follow-up|6
1569043|NCT03004469|5424947|P2|Overall Study|Lost to Follow-up|14
1569044|NCT03004469|5424948|P1|Overall Study|Lost to Follow-up|23
1569045|NCT03004469|5424946|P3|Overall Study|Lack of Efficacy|1
1569046|NCT03004469|5424947|P2|Overall Study|Lack of Efficacy|0
1569047|NCT03004469|5424948|P1|Overall Study|Lack of Efficacy|1
1569048|NCT03004469|5424946|P3|Overall Study|Adverse Event|6
1569049|NCT03004469|5424947|P2|Overall Study|Adverse Event|4
1569050|NCT03004469|5424948|P1|Overall Study|Adverse Event|6
1569051|NCT03003520|5424991|P2|Follow-up|Withdrawal by Subject|0
1569052|NCT03003520|5424992|P1|Follow-up|Withdrawal by Subject|1
1569053|NCT03003520|5424991|P2|Follow-up|Ongoing|2
1569054|NCT03003520|5424992|P1|Follow-up|Ongoing|12
1569055|NCT03003520|5424991|P2|Follow-up|Death|1
1569056|NCT03003520|5424992|P1|Follow-up|Death|1
1569057|NCT03003520|5424991|P2|Consolidation|Withdrawal by Subject|0
1569058|NCT03003520|5424992|P1|Consolidation|Withdrawal by Subject|1
1569059|NCT03003520|5424991|P2|Consolidation|Progressive disease|1
1569060|NCT03003520|5424992|P1|Consolidation|Progressive disease|3
1569061|NCT03003520|5424991|P2|Consolidation|Adverse Event|0
1569062|NCT03003520|5424992|P1|Consolidation|Adverse Event|2
1569063|NCT03003520|5424991|P2|Consolidation|Ongoing|0
1569064|NCT03003520|5424992|P1|Consolidation|Ongoing|18
1569065|NCT03003520|5424991|P2|Induction|Progressive disease|0
1569066|NCT03003520|5424992|P1|Induction|Progressive disease|1
1569067|NCT03003520|5424991|P2|Induction|Withdrawal by Subject|0
1569068|NCT03003520|5424992|P1|Induction|Withdrawal by Subject|3
1569069|NCT03003520|5424991|P2|Induction|Physician Decision|0
1569070|NCT03003520|5424992|P1|Induction|Physician Decision|2
1569071|NCT03003520|5424991|P2|Induction|Palliative care|0
1569072|NCT03003520|5424992|P1|Induction|Palliative care|1
1569073|NCT03003520|5424991|P2|Induction|Death|0
1569074|NCT03003520|5424992|P1|Induction|Death|1
1569075|NCT03003520|5424991|P2|Induction|Adverse Event|0
1569076|NCT03003520|5424992|P1|Induction|Adverse Event|4
1569077|NCT03003520|5424991|P2|Induction|Ongoing|0
1569078|NCT03003520|5424992|P1|Induction|Ongoing|1
1569079|NCT03003494|5425010|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
1569080|NCT03003000|5425022|P3|Overall Study|Other than listed|1
1569081|NCT03003000|5425023|P2|Overall Study|Other than listed|1
1569082|NCT03003000|5425024|P1|Overall Study|Other than listed|1
1569083|NCT03003000|5425022|P3|Overall Study|Refused to continue medication|0
1569084|NCT03003000|5425023|P2|Overall Study|Refused to continue medication|0
1569085|NCT03003000|5425024|P1|Overall Study|Refused to continue medication|2
1569086|NCT03003000|5425022|P3|Overall Study|Non-compliant with protocol|1
1569087|NCT03003000|5425023|P2|Overall Study|Non-compliant with protocol|1
1569088|NCT03003000|5425024|P1|Overall Study|Non-compliant with protocol|0
1569089|NCT03003000|5425022|P3|Overall Study|Lack of Efficacy|0
1569090|NCT03003000|5425023|P2|Overall Study|Lack of Efficacy|0
1569091|NCT03003000|5425024|P1|Overall Study|Lack of Efficacy|1
1569092|NCT03003000|5425022|P3|Overall Study|Adverse Event|3
1569093|NCT03003000|5425023|P2|Overall Study|Adverse Event|2
1569094|NCT03003000|5425024|P1|Overall Study|Adverse Event|1
1569095|NCT03002818|5425050|P1|Overall Study|Decision of the investigator|1
1569096|NCT03002623|5425076|P2|Overall Study|Physician Decision|1
1569097|NCT03002623|5425077|P1|Overall Study|Physician Decision|1
1569098|NCT03002623|5425076|P2|Overall Study|Lost to Follow-up|0
1569099|NCT03002623|5425077|P1|Overall Study|Lost to Follow-up|1
1569100|NCT03002610|5425094|P3|Overall Study|Withdrawal by Subject|13
1569101|NCT03002610|5425095|P2|Overall Study|Withdrawal by Subject|25
1569102|NCT03002610|5425096|P1|Overall Study|Withdrawal by Subject|6
1569108|NCT03001219|5425467|P2|Extension Period Analysis|Withdrawal by Subject|5
1569109|NCT03001219|5425468|P1|Extension Period Analysis|Withdrawal by Subject|4
1569110|NCT03001219|5425467|P2|Extension Period Analysis|Protocol Deviation|1
1569111|NCT03001219|5425468|P1|Extension Period Analysis|Protocol Deviation|0
1569112|NCT03001219|5425467|P2|Extension Period Analysis|Adverse Event|1
1569113|NCT03001219|5425468|P1|Extension Period Analysis|Adverse Event|1
1569114|NCT03001219|5425467|P2|Extension Period Analysis|Physician Decision|1
1569115|NCT03001219|5425468|P1|Extension Period Analysis|Physician Decision|0
1569116|NCT03001219|5425467|P2|Extension Period Analysis|Participant Non-Compliance|1
1569117|NCT03001219|5425468|P1|Extension Period Analysis|Participant Non-Compliance|0
1569118|NCT03001219|5425467|P2|Extension Period Analysis|Study Termination by Sponsor|36
1569119|NCT03001219|5425468|P1|Extension Period Analysis|Study Termination by Sponsor|0
1569120|NCT03001219|5425467|P2|Proof of Concept|Physician Decision|0
1569121|NCT03001219|5425468|P1|Proof of Concept|Physician Decision|1
1569122|NCT03001219|5425467|P2|Proof of Concept|Adverse Event|1
1569123|NCT03001219|5425468|P1|Proof of Concept|Adverse Event|1
1569124|NCT03001219|5425467|P2|Proof of Concept|Protocol Deviation|1
1569125|NCT03001219|5425468|P1|Proof of Concept|Protocol Deviation|0
1569126|NCT03001219|5425467|P2|Proof of Concept|Withdrawal by Subject|4
1569127|NCT03001219|5425468|P1|Proof of Concept|Withdrawal by Subject|0
1569128|NCT03001219|5425467|P2|Proof of Concept|Study Termination by Sponsor|1
1569129|NCT03001219|5425468|P1|Proof of Concept|Study Termination by Sponsor|0
1569130|NCT03000686|5425529|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
1569131|NCT03000686|5425530|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
1569132|NCT03000686|5425531|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
1569133|NCT03000686|5425532|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
1569134|NCT03000452|5425609|P1|Follow-Up Period|Withdrawal by Subject|3
1569135|NCT03000452|5425609|P1|Follow-Up Period|Death|3
1569136|NCT03000452|5425609|P1|Follow-Up Period|Study Terminated by Sponsor|1
1569137|NCT03000452|5425609|P1|Treatment Period|Miscellaneous|2
1569138|NCT03000452|5425609|P1|Treatment Period|Physician Decision|1
1569139|NCT03000452|5425609|P1|Treatment Period|Progressive Disease (PD)|14
1569140|NCT03000452|5425609|P1|Treatment Period|Death|1
1569141|NCT03000075|5425657|P7|Part B|Adverse Event|0
1569142|NCT03000075|5425658|P6|Part B|Adverse Event|0
1569143|NCT03000075|5425659|P5|Part B|Adverse Event|1
1569144|NCT03000075|5425660|P4|Part B|Adverse Event|0
1569145|NCT03000075|5425661|P3|Part B|Adverse Event|0
1569146|NCT03000075|5425662|P2|Part B|Adverse Event|0
1569147|NCT03000075|5425663|P1|Part B|Adverse Event|0
1569148|NCT03000075|5425657|P7|Part B|Not dosed due to AE|1
1569149|NCT03000075|5425658|P6|Part B|Not dosed due to AE|2
1569150|NCT03000075|5425659|P5|Part B|Not dosed due to AE|0
1569151|NCT03000075|5425660|P4|Part B|Not dosed due to AE|0
1569152|NCT03000075|5425661|P3|Part B|Not dosed due to AE|0
1569153|NCT03000075|5425662|P2|Part B|Not dosed due to AE|0
1569154|NCT03000075|5425663|P1|Part B|Not dosed due to AE|0
1569155|NCT03000075|5425657|P7|Part A|Adverse Event|0
1569156|NCT03000075|5425658|P6|Part A|Adverse Event|0
1569157|NCT03000075|5425659|P5|Part A|Adverse Event|0
1569158|NCT03000075|5425660|P4|Part A|Adverse Event|0
1569159|NCT03000075|5425661|P3|Part A|Adverse Event|0
1569160|NCT03000075|5425662|P2|Part A|Adverse Event|0
1569161|NCT03000075|5425663|P1|Part A|Adverse Event|4
1569162|NCT02999672|5425716|P2|Overall Study|Adverse Event|0
1569163|NCT02999672|5425717|P1|Overall Study|Adverse Event|4
1569164|NCT02999672|5425716|P2|Overall Study|Progressive Disease|5
1569165|NCT02999672|5425717|P1|Overall Study|Progressive Disease|9
1569166|NCT02999672|5425716|P2|Overall Study|Study Terminated by Sponsor|1
1569167|NCT02999672|5425717|P1|Overall Study|Study Terminated by Sponsor|0
1569168|NCT02999672|5425716|P2|Overall Study|Death|1
1569169|NCT02999672|5425717|P1|Overall Study|Death|0
1569170|NCT02999633|5425733|P1|Overall Study|Progressive disease|12
1569171|NCT02999633|5425733|P1|Overall Study|Adverse Event|2
1569172|NCT02998996|5425747|P6|Overall Study|Family reasons|0
1569173|NCT02998996|5425748|P5|Overall Study|Family reasons|1
1569174|NCT02998996|5425749|P4|Overall Study|Family reasons|0
1569175|NCT02998996|5425750|P3|Overall Study|Family reasons|0
1569176|NCT02998996|5425751|P2|Overall Study|Family reasons|0
1569177|NCT02998996|5425752|P1|Overall Study|Family reasons|0
1569178|NCT02998996|5425747|P6|Overall Study|Pregnancy|0
1569179|NCT02998996|5425748|P5|Overall Study|Pregnancy|0
1569180|NCT02998996|5425749|P4|Overall Study|Pregnancy|0
1569181|NCT02998996|5425750|P3|Overall Study|Pregnancy|0
1569182|NCT02998996|5425751|P2|Overall Study|Pregnancy|1
1569183|NCT02998996|5425752|P1|Overall Study|Pregnancy|0
1569184|NCT02998996|5425747|P6|Overall Study|Lost to Follow-up|0
1569185|NCT02998996|5425748|P5|Overall Study|Lost to Follow-up|0
1569186|NCT02998996|5425749|P4|Overall Study|Lost to Follow-up|0
1569187|NCT02998996|5425750|P3|Overall Study|Lost to Follow-up|1
1569188|NCT02998996|5425751|P2|Overall Study|Lost to Follow-up|0
1569189|NCT02998996|5425752|P1|Overall Study|Lost to Follow-up|0
1569190|NCT02998671|5425786|P5|Period 2|Lost to Follow-up|0
1569191|NCT02998671|5425787|P4|Period 2|Lost to Follow-up|1
1569192|NCT02998671|5425788|P3|Period 2|Lost to Follow-up|0
1569193|NCT02998671|5425789|P2|Period 2|Lost to Follow-up|0
1569194|NCT02998671|5425790|P1|Period 2|Lost to Follow-up|0
1569195|NCT02998671|5425786|P5|Period 2|Withdrawal by Subject|0
1569196|NCT02998671|5425787|P4|Period 2|Withdrawal by Subject|0
1569197|NCT02998671|5425788|P3|Period 2|Withdrawal by Subject|0
1569198|NCT02998671|5425789|P2|Period 2|Withdrawal by Subject|1
1569199|NCT02998671|5425790|P1|Period 2|Withdrawal by Subject|0
1569200|NCT02998671|5425786|P5|Period 2|Study Terminated By Sponsor|0
1569201|NCT02998671|5425787|P4|Period 2|Study Terminated By Sponsor|3
1569202|NCT02998671|5425788|P3|Period 2|Study Terminated By Sponsor|1
1569203|NCT02998671|5425789|P2|Period 2|Study Terminated By Sponsor|5
1569204|NCT02998671|5425790|P1|Period 2|Study Terminated By Sponsor|3
1569205|NCT02998671|5425786|P5|Period 2|Adverse Event|0
1569206|NCT02998671|5425787|P4|Period 2|Adverse Event|0
1569207|NCT02998671|5425788|P3|Period 2|Adverse Event|0
1569208|NCT02998671|5425789|P2|Period 2|Adverse Event|1
1569209|NCT02998671|5425790|P1|Period 2|Adverse Event|0
1569210|NCT02998671|5425786|P5|Period 1|Adverse Event|1
1569211|NCT02998671|5425787|P4|Period 1|Adverse Event|0
1569212|NCT02998671|5425788|P3|Period 1|Adverse Event|0
1569213|NCT02998671|5425789|P2|Period 1|Adverse Event|0
1569214|NCT02998671|5425790|P1|Period 1|Adverse Event|0
1569215|NCT02998671|5425786|P5|Period 1|Pregnancy|0
1569216|NCT02998671|5425787|P4|Period 1|Pregnancy|0
1569217|NCT02998671|5425788|P3|Period 1|Pregnancy|0
1569218|NCT02998671|5425789|P2|Period 1|Pregnancy|0
1569219|NCT02998671|5425790|P1|Period 1|Pregnancy|1
1569220|NCT02998671|5425786|P5|Period 1|Withdrawal by Subject|2
1569221|NCT02998671|5425787|P4|Period 1|Withdrawal by Subject|0
1569222|NCT02998671|5425788|P3|Period 1|Withdrawal by Subject|0
1569223|NCT02998671|5425789|P2|Period 1|Withdrawal by Subject|2
1569224|NCT02998671|5425790|P1|Period 1|Withdrawal by Subject|1
1569225|NCT02998671|5425786|P5|Period 1|Study Terminated By Sponsor|1
1569226|NCT02998671|5425787|P4|Period 1|Study Terminated By Sponsor|0
1569227|NCT02998671|5425788|P3|Period 1|Study Terminated By Sponsor|0
1569228|NCT02998671|5425789|P2|Period 1|Study Terminated By Sponsor|1
1569229|NCT02998671|5425790|P1|Period 1|Study Terminated By Sponsor|2
1569230|NCT02998021|5425835|P2|Overall Study|unsafe home|1
1569231|NCT02998021|5425836|P1|Overall Study|unsafe home|0
1569232|NCT02998021|5425835|P2|Overall Study|Withdrawal by Subject|1
1569233|NCT02998021|5425836|P1|Overall Study|Withdrawal by Subject|3
1569238|NCT02996968|5426037|P2|Overall Study|Withdrawal by Subject|0
1569239|NCT02996968|5426038|P1|Overall Study|Withdrawal by Subject|1
1569240|NCT02996682|5426046|P2|Overall Study|Death|3
1569241|NCT02996682|5426047|P1|Overall Study|Death|0
1569242|NCT02996097|5426120|P2|Overall Study|Lost to Follow-up|11
1569243|NCT02996097|5426121|P1|Overall Study|Lost to Follow-up|11
1569244|NCT02995980|5426128|P1|Overall Study|Lost to Follow-up|14
1569245|NCT02994056|5426203|P1|Overall Study|Withdrew Consent|1
1569246|NCT02994056|5426203|P1|Overall Study|Death|8
1569247|NCT02993926|5426237|P3|Enantone Treatment Phase|Reason Not Specified|0
1569248|NCT02993926|5426238|P2|Enantone Treatment Phase|Reason Not Specified|0
1569249|NCT02993926|5426239|P1|Enantone Treatment Phase|Reason Not Specified|4
1569250|NCT02993926|5426237|P3|Enantone Treatment Phase|Investigator Judgment|0
1569251|NCT02993926|5426238|P2|Enantone Treatment Phase|Investigator Judgment|0
1569252|NCT02993926|5426239|P1|Enantone Treatment Phase|Investigator Judgment|1
1569253|NCT02993926|5426237|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
1569254|NCT02993926|5426238|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
1569255|NCT02993926|5426239|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
1569256|NCT02993926|5426237|P3|Enantone Treatment Phase|Adverse Event|0
1569257|NCT02993926|5426238|P2|Enantone Treatment Phase|Adverse Event|0
1569258|NCT02993926|5426239|P1|Enantone Treatment Phase|Adverse Event|1
1569259|NCT02993783|5426271|P2|Overall Study|Reason not Specified|9
1569260|NCT02993783|5426272|P1|Overall Study|Reason not Specified|6
1569261|NCT02993471|5426302|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
1569262|NCT02993471|5426302|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
1569263|NCT02993250|5426353|P2|Overall Study|Lost to Follow-up|1
1569264|NCT02993250|5426354|P1|Overall Study|Lost to Follow-up|0
1569265|NCT02992691|5426374|P1|Overall Study|Withdrawal by Subject|1
1569266|NCT02992691|5426374|P1|Overall Study|Adverse Event|2
1569267|NCT02992288|5426397|P6|Overall Study|Withdrawal by Subject|4
1569268|NCT02992288|5426398|P5|Overall Study|Withdrawal by Subject|3
1569269|NCT02992288|5426399|P4|Overall Study|Withdrawal by Subject|5
1569270|NCT02992288|5426400|P3|Overall Study|Withdrawal by Subject|1
1569271|NCT02992288|5426401|P2|Overall Study|Withdrawal by Subject|2
1569272|NCT02992288|5426402|P1|Overall Study|Withdrawal by Subject|4
1569273|NCT02992288|5426397|P6|Overall Study|Protocol Violation|1
1569274|NCT02992288|5426398|P5|Overall Study|Protocol Violation|0
1569275|NCT02992288|5426399|P4|Overall Study|Protocol Violation|0
1569276|NCT02992288|5426400|P3|Overall Study|Protocol Violation|0
1569277|NCT02992288|5426401|P2|Overall Study|Protocol Violation|0
1569278|NCT02992288|5426402|P1|Overall Study|Protocol Violation|0
1569279|NCT02992288|5426397|P6|Overall Study|Lost to Follow-up|0
1569280|NCT02992288|5426398|P5|Overall Study|Lost to Follow-up|0
1569281|NCT02992288|5426399|P4|Overall Study|Lost to Follow-up|1
1569282|NCT02992288|5426400|P3|Overall Study|Lost to Follow-up|0
1569283|NCT02992288|5426401|P2|Overall Study|Lost to Follow-up|0
1569284|NCT02992288|5426402|P1|Overall Study|Lost to Follow-up|0
1569285|NCT02992288|5426397|P6|Overall Study|Death|0
1569286|NCT02992288|5426398|P5|Overall Study|Death|2
1569287|NCT02992288|5426399|P4|Overall Study|Death|1
1569288|NCT02992288|5426400|P3|Overall Study|Death|2
1569289|NCT02992288|5426401|P2|Overall Study|Death|0
1569290|NCT02992288|5426402|P1|Overall Study|Death|2
1569291|NCT02992288|5426397|P6|Overall Study|Physician Decision|1
1569292|NCT02992288|5426398|P5|Overall Study|Physician Decision|0
1569293|NCT02992288|5426399|P4|Overall Study|Physician Decision|0
1569294|NCT02992288|5426400|P3|Overall Study|Physician Decision|1
1569295|NCT02992288|5426401|P2|Overall Study|Physician Decision|0
1569296|NCT02992288|5426402|P1|Overall Study|Physician Decision|3
1569297|NCT02992288|5426397|P6|Overall Study|Non-compliance with study drug|0
1569298|NCT02992288|5426398|P5|Overall Study|Non-compliance with study drug|1
1569299|NCT02992288|5426399|P4|Overall Study|Non-compliance with study drug|0
1569300|NCT02992288|5426400|P3|Overall Study|Non-compliance with study drug|1
1569301|NCT02992288|5426401|P2|Overall Study|Non-compliance with study drug|1
1569302|NCT02992288|5426402|P1|Overall Study|Non-compliance with study drug|0
1569303|NCT02992288|5426397|P6|Overall Study|Adverse Event|7
1569304|NCT02992288|5426398|P5|Overall Study|Adverse Event|2
1569305|NCT02992288|5426399|P4|Overall Study|Adverse Event|2
1569306|NCT02992288|5426400|P3|Overall Study|Adverse Event|2
1569307|NCT02992288|5426401|P2|Overall Study|Adverse Event|2
1569308|NCT02992288|5426402|P1|Overall Study|Adverse Event|8
1569309|NCT02992132|5426474|P3|Overall Study|Physician Decision|1
1569310|NCT02992132|5426475|P2|Overall Study|Physician Decision|0
1569311|NCT02992132|5426476|P1|Overall Study|Physician Decision|0
1569312|NCT02992132|5426474|P3|Overall Study|Withdrawal by Subject|1
1569313|NCT02992132|5426475|P2|Overall Study|Withdrawal by Subject|2
1569314|NCT02992132|5426476|P1|Overall Study|Withdrawal by Subject|0
1569315|NCT02992132|5426474|P3|Overall Study|Caregiver withdrew consent|2
1569316|NCT02992132|5426475|P2|Overall Study|Caregiver withdrew consent|3
1569317|NCT02992132|5426476|P1|Overall Study|Caregiver withdrew consent|2
1569318|NCT02992132|5426474|P3|Overall Study|Protocol Violation|0
1569319|NCT02992132|5426475|P2|Overall Study|Protocol Violation|2
1569320|NCT02992132|5426476|P1|Overall Study|Protocol Violation|2
1569321|NCT02992132|5426474|P3|Overall Study|Progressive disease|0
1569322|NCT02992132|5426475|P2|Overall Study|Progressive disease|0
1569323|NCT02992132|5426476|P1|Overall Study|Progressive disease|1
1569324|NCT02992132|5426474|P3|Overall Study|Non-compliance with study drug|0
1569325|NCT02992132|5426475|P2|Overall Study|Non-compliance with study drug|0
1569326|NCT02992132|5426476|P1|Overall Study|Non-compliance with study drug|2
1569327|NCT02992132|5426474|P3|Overall Study|Lack of Efficacy|0
1569328|NCT02992132|5426475|P2|Overall Study|Lack of Efficacy|0
1569329|NCT02992132|5426476|P1|Overall Study|Lack of Efficacy|2
1569330|NCT02992132|5426474|P3|Overall Study|Adverse Event|3
1569331|NCT02992132|5426475|P2|Overall Study|Adverse Event|1
1569332|NCT02992132|5426476|P1|Overall Study|Adverse Event|4
1569333|NCT02991430|5426607|P3|Post-treatment Observation Period|Study Termination|5
1569334|NCT02991430|5426608|P2|Post-treatment Observation Period|Study Termination|6
1569335|NCT02991430|5426609|P1|Post-treatment Observation Period|Study Termination|3
1569336|NCT02991430|5426607|P3|Treatment Period 2|Lost to Follow-up|1
1569337|NCT02991430|5426608|P2|Treatment Period 2|Lost to Follow-up|0
1569338|NCT02991430|5426609|P1|Treatment Period 2|Lost to Follow-up|0
1569339|NCT02991430|5426607|P3|Treatment Period 2|Study Termination|3
1569340|NCT02991430|5426608|P2|Treatment Period 2|Study Termination|3
1569341|NCT02991430|5426609|P1|Treatment Period 2|Study Termination|6
1569342|NCT02991430|5426607|P3|Treatment Period 1|Withdrawal by Subject|0
1569343|NCT02991430|5426608|P2|Treatment Period 1|Withdrawal by Subject|4
1569344|NCT02991430|5426609|P1|Treatment Period 1|Withdrawal by Subject|0
1569345|NCT02991430|5426607|P3|Treatment Period 1|Adverse Event|2
1569346|NCT02991430|5426608|P2|Treatment Period 1|Adverse Event|0
1569347|NCT02991430|5426609|P1|Treatment Period 1|Adverse Event|1
1569348|NCT02991040|5426644|P1|Overall Study|Lost to Follow-up|2
1569349|NCT02991040|5426644|P1|Overall Study|Withdrawal by Subject|2
1569350|NCT02990910|5426659|P2|Overall Study|Lack of Efficacy|10
1569351|NCT02990910|5426660|P1|Overall Study|Lack of Efficacy|6
1569352|NCT02990338|5426670|P2|Overall Study|Randomized but not treated|2
1569353|NCT02990338|5426671|P1|Overall Study|Randomized but not treated|4
1569354|NCT02990338|5426670|P2|Overall Study|Other|4
1569355|NCT02990338|5426671|P1|Overall Study|Other|1
1569356|NCT02990338|5426670|P2|Overall Study|Withdrawal by Subject|5
1569357|NCT02990338|5426671|P1|Overall Study|Withdrawal by Subject|6
1569358|NCT02990338|5426670|P2|Overall Study|Poor compliance to protocol|1
1569359|NCT02990338|5426671|P1|Overall Study|Poor compliance to protocol|0
1569360|NCT02990338|5426670|P2|Overall Study|Progressive disease|66
1569361|NCT02990338|5426671|P1|Overall Study|Progressive disease|88
1569362|NCT02990338|5426670|P2|Overall Study|Adverse Event|11
1569363|NCT02990338|5426671|P1|Overall Study|Adverse Event|19
1569364|NCT02989649|5426800|P1|Overall Study|Reason Not Specified|13
1569365|NCT02989649|5426800|P1|Overall Study|Lost For Observation During Study|3
1569366|NCT02989649|5426800|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
1569367|NCT02989649|5426800|P1|Overall Study|Patient/Investigator’s Decision to Stop|403
1569368|NCT02988622|5426825|P1|Overall Study|Lost to Follow-up|17
1569369|NCT02988219|5426860|P2|Overall Study|Withdrawal by Subject|2
1569370|NCT02988219|5426861|P1|Overall Study|Withdrawal by Subject|0
1569371|NCT02988219|5426860|P2|Overall Study|Lack of Efficacy|1
1569372|NCT02988219|5426861|P1|Overall Study|Lack of Efficacy|1
1569373|NCT02987972|5426881|P3|Overall Study|Withdrawal by Subject|21
1569374|NCT02987972|5426882|P2|Overall Study|Withdrawal by Subject|17
1569375|NCT02987972|5426883|P1|Overall Study|Withdrawal by Subject|22
1569376|NCT02987972|5426881|P3|Overall Study|Protocol Violation|5
1569377|NCT02987972|5426882|P2|Overall Study|Protocol Violation|1
1569378|NCT02987972|5426883|P1|Overall Study|Protocol Violation|2
1569379|NCT02987972|5426881|P3|Overall Study|Physician Decision|0
1569380|NCT02987972|5426882|P2|Overall Study|Physician Decision|6
1569381|NCT02987972|5426883|P1|Overall Study|Physician Decision|1
1569382|NCT02987972|5426881|P3|Overall Study|Lost to Follow-up|4
1569383|NCT02987972|5426882|P2|Overall Study|Lost to Follow-up|8
1569384|NCT02987972|5426883|P1|Overall Study|Lost to Follow-up|7
1569385|NCT02987972|5426881|P3|Overall Study|Lack of Efficacy|12
1569386|NCT02987972|5426882|P2|Overall Study|Lack of Efficacy|12
1569387|NCT02987972|5426883|P1|Overall Study|Lack of Efficacy|9
1569388|NCT02987972|5426881|P3|Overall Study|Death|0
1569389|NCT02987972|5426882|P2|Overall Study|Death|0
1569390|NCT02987972|5426883|P1|Overall Study|Death|1
1569391|NCT02987972|5426881|P3|Overall Study|Adverse Event|0
1569392|NCT02987972|5426882|P2|Overall Study|Adverse Event|1
1569393|NCT02987972|5426883|P1|Overall Study|Adverse Event|1
1569394|NCT02987660|5426921|P2|Overall Study|Study terminated by sponsor|10
1569395|NCT02987660|5426922|P1|Overall Study|Study terminated by sponsor|10
1569396|NCT02987205|5426956|P1|Overall Study|Withdrawal by Subject|3
1569397|NCT02987205|5426956|P1|Overall Study|Adverse Event|1
1569398|NCT02986854|5426990|P3|Overall Study|Lost to Follow-up|2
1569399|NCT02986854|5426991|P2|Overall Study|Lost to Follow-up|11
1569400|NCT02986854|5426992|P1|Overall Study|Lost to Follow-up|3
1569401|NCT02986854|5426990|P3|Overall Study|Withdrawal by Subject|1
1569402|NCT02986854|5426991|P2|Overall Study|Withdrawal by Subject|1
1569403|NCT02986854|5426992|P1|Overall Study|Withdrawal by Subject|0
1569404|NCT02986373|5427076|P1|Overall Study|Other|24
1569405|NCT02986373|5427076|P1|Overall Study|Withdrawal by Subject|10
1569406|NCT02986373|5427076|P1|Overall Study|Lost to Follow-up|1
1569407|NCT02986373|5427076|P1|Overall Study|Adverse Event|4
1569408|NCT02986139|5427118|P2|Overall Study|Lost to Follow-up|1
1569409|NCT02986139|5427119|P1|Overall Study|Lost to Follow-up|0
1569410|NCT02986139|5427118|P2|Overall Study|Withdrawal by Subject|1
1569411|NCT02986139|5427119|P1|Overall Study|Withdrawal by Subject|0
1569412|NCT02986139|5427118|P2|Overall Study|Sponsor Decision|2
1569413|NCT02986139|5427119|P1|Overall Study|Sponsor Decision|1
1569414|NCT02985996|5427136|P5|Overall Study|Protocol Violation|0
1569415|NCT02985996|5427137|P4|Overall Study|Protocol Violation|0
1569416|NCT02985996|5427138|P3|Overall Study|Protocol Violation|0
1569417|NCT02985996|5427139|P2|Overall Study|Protocol Violation|1
1569418|NCT02985996|5427140|P1|Overall Study|Protocol Violation|0
1569419|NCT02985996|5427136|P5|Overall Study|Withdrawal by Subject|0
1569420|NCT02985996|5427137|P4|Overall Study|Withdrawal by Subject|0
1569421|NCT02985996|5427138|P3|Overall Study|Withdrawal by Subject|1
1569422|NCT02985996|5427139|P2|Overall Study|Withdrawal by Subject|0
1569423|NCT02985996|5427140|P1|Overall Study|Withdrawal by Subject|0
1569424|NCT02985684|5427274|P1|6-Month Closure Success Evaluation|Device Removal|3
1569425|NCT02985684|5427274|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
1569426|NCT02985684|5427274|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
1569433|NCT02984982|5427335|P2|Overall Study|Randomized but not treated|1
1569434|NCT02984982|5427336|P1|Overall Study|Randomized but not treated|0
1569435|NCT02984982|5427335|P2|Overall Study|Withdrawal by Subject|0
1569436|NCT02984982|5427336|P1|Overall Study|Withdrawal by Subject|2
1569437|NCT02984982|5427335|P2|Overall Study|Poor Compliance to Protocol|4
1569438|NCT02984982|5427336|P1|Overall Study|Poor Compliance to Protocol|4
1569439|NCT02984982|5427335|P2|Overall Study|Adverse Event|5
1569440|NCT02984982|5427336|P1|Overall Study|Adverse Event|2
1569441|NCT02984267|5427459|P2|Overall Study|Withdrawal by Subject|1
1569442|NCT02984267|5427460|P1|Overall Study|Withdrawal by Subject|0
1569443|NCT02984267|5427459|P2|Overall Study|Protocol Violation|0
1569444|NCT02984267|5427460|P1|Overall Study|Protocol Violation|1
1569445|NCT02983604|5427502|P4|Overall Study|Enrolled but not Treated|0
1569446|NCT02983604|5427503|P3|Overall Study|Enrolled but not Treated|1
1569447|NCT02983604|5427504|P2|Overall Study|Enrolled but not Treated|0
1569448|NCT02983604|5427505|P1|Overall Study|Enrolled but not Treated|0
1569449|NCT02983305|5427554|P2|Overall Study|incomplete data|0
1569450|NCT02983305|5427555|P1|Overall Study|incomplete data|2
1569451|NCT02982863|5427572|P5|Overall Study|Not eligible patients|492
1569452|NCT02982863|5427573|P4|Overall Study|Not eligible patients|1400
1569453|NCT02982863|5427574|P3|Overall Study|Not eligible patients|1852
1569454|NCT02982863|5427575|P2|Overall Study|Not eligible patients|4261
1569455|NCT02982863|5427576|P1|Overall Study|Not eligible patients|809
1569456|NCT02982720|5427633|P1|Overall Study|Death|1
1569457|NCT02982720|5427633|P1|Overall Study|Adverse Event|3
1569458|NCT02982239|5427643|P2|Overall Study|Lost to Follow-up|2
1569459|NCT02982239|5427644|P1|Overall Study|Lost to Follow-up|3
1569460|NCT02982187|5427660|P8|Overall Study|Withdrawal by Subject|0
1569461|NCT02982187|5427661|P7|Overall Study|Withdrawal by Subject|1
1569462|NCT02982187|5427662|P6|Overall Study|Withdrawal by Subject|0
1569463|NCT02982187|5427663|P5|Overall Study|Withdrawal by Subject|0
1569464|NCT02982187|5427664|P4|Overall Study|Withdrawal by Subject|0
1569465|NCT02982187|5427665|P3|Overall Study|Withdrawal by Subject|0
1569466|NCT02982187|5427666|P2|Overall Study|Withdrawal by Subject|0
1569467|NCT02982187|5427667|P1|Overall Study|Withdrawal by Subject|0
1569468|NCT02982018|5427717|P2|Overall Study|Withdrawal by Subject|1
1569469|NCT02982018|5427718|P1|Overall Study|Withdrawal by Subject|0
1569470|NCT02982018|5427717|P2|Overall Study|Lens Discomfort|0
1569471|NCT02982018|5427718|P1|Overall Study|Lens Discomfort|2
1569472|NCT02982018|5427717|P2|Overall Study|Adverse Event|1
1569473|NCT02982018|5427718|P1|Overall Study|Adverse Event|1
1569474|NCT02982018|5427717|P2|Overall Study|Protocol Violation|1
1569475|NCT02982018|5427718|P1|Overall Study|Protocol Violation|1
1569476|NCT02982018|5427717|P2|Overall Study|Incorrect Lens Dispensed|0
1569477|NCT02982018|5427718|P1|Overall Study|Incorrect Lens Dispensed|1
1569478|NCT02981524|5427732|P1|Overall Study|Withdrawal by Subject|1
1569479|NCT02981524|5427732|P1|Overall Study|Treatment Related Toxicity|1
1569480|NCT02981524|5427732|P1|Overall Study|Death (unrelated)|1
1569481|NCT02981524|5427732|P1|Overall Study|Progressive Disease|14
1569482|NCT02981342|5427744|P4|Overall Study|Lost to Follow-up|0
1569483|NCT02981342|5427745|P3|Overall Study|Lost to Follow-up|0
1569484|NCT02981342|5427746|P2|Overall Study|Lost to Follow-up|1
1569485|NCT02981342|5427747|P1|Overall Study|Lost to Follow-up|0
1569486|NCT02981342|5427744|P4|Overall Study|Randomized, Never Treated|7
1569487|NCT02981342|5427745|P3|Overall Study|Randomized, Never Treated|0
1569488|NCT02981342|5427746|P2|Overall Study|Randomized, Never Treated|1
1569489|NCT02981342|5427747|P1|Overall Study|Randomized, Never Treated|0
1569490|NCT02981342|5427744|P4|Overall Study|Study closed by sponsor|1
1569491|NCT02981342|5427745|P3|Overall Study|Study closed by sponsor|1
1569492|NCT02981342|5427746|P2|Overall Study|Study closed by sponsor|0
1569493|NCT02981342|5427747|P1|Overall Study|Study closed by sponsor|0
1569494|NCT02981342|5427744|P4|Overall Study|Withdrawal by Subject|1
1569495|NCT02981342|5427745|P3|Overall Study|Withdrawal by Subject|3
1569496|NCT02981342|5427746|P2|Overall Study|Withdrawal by Subject|0
1569497|NCT02981342|5427747|P1|Overall Study|Withdrawal by Subject|0
1569498|NCT02981342|5427744|P4|Overall Study|Death|4
1569499|NCT02981342|5427745|P3|Overall Study|Death|9
1569500|NCT02981342|5427746|P2|Overall Study|Death|9
1569501|NCT02981342|5427747|P1|Overall Study|Death|0
1569502|NCT02981342|5427744|P4|Overall Study|Adverse Event|1
1569503|NCT02981342|5427745|P3|Overall Study|Adverse Event|0
1569504|NCT02981342|5427746|P2|Overall Study|Adverse Event|0
1569505|NCT02981342|5427747|P1|Overall Study|Adverse Event|0
1569506|NCT02980783|5427805|P1|Overall Study|Lost to Follow-up|1
1569507|NCT02980601|5427818|P2|Overall Study|Failed to sign consent|0
1569508|NCT02980601|5427819|P1|Overall Study|Failed to sign consent|2
1569509|NCT02980601|5427818|P2|Overall Study|Graft loss|0
1569510|NCT02980601|5427819|P1|Overall Study|Graft loss|1
1569511|NCT02980601|5427818|P2|Overall Study|Death|1
1569512|NCT02980601|5427819|P1|Overall Study|Death|0
1569513|NCT02980601|5427818|P2|Overall Study|Lost to Follow-up|2
1569514|NCT02980601|5427819|P1|Overall Study|Lost to Follow-up|2
1569515|NCT02980523|5427912|P5|Overall Study|Did not receive intervention|0
1569516|NCT02980523|5427913|P4|Overall Study|Did not receive intervention|1
1569517|NCT02980523|5427914|P3|Overall Study|Did not receive intervention|0
1569518|NCT02980523|5427915|P2|Overall Study|Did not receive intervention|0
1569519|NCT02980523|5427916|P1|Overall Study|Did not receive intervention|0
1569520|NCT02980523|5427912|P5|Overall Study|Lack of Efficacy|8
1569521|NCT02980523|5427913|P4|Overall Study|Lack of Efficacy|5
1569522|NCT02980523|5427914|P3|Overall Study|Lack of Efficacy|4
1569523|NCT02980523|5427915|P2|Overall Study|Lack of Efficacy|4
1569524|NCT02980523|5427916|P1|Overall Study|Lack of Efficacy|1
1569525|NCT02980523|5427912|P5|Overall Study|Excluded from analysis|1
1569526|NCT02980523|5427913|P4|Overall Study|Excluded from analysis|1
1569527|NCT02980523|5427914|P3|Overall Study|Excluded from analysis|1
1569528|NCT02980523|5427915|P2|Overall Study|Excluded from analysis|3
1569529|NCT02980523|5427916|P1|Overall Study|Excluded from analysis|1
1569530|NCT02980523|5427912|P5|Overall Study|Lost to Follow-up|1
1569531|NCT02980523|5427913|P4|Overall Study|Lost to Follow-up|2
1569532|NCT02980523|5427914|P3|Overall Study|Lost to Follow-up|1
1569533|NCT02980523|5427915|P2|Overall Study|Lost to Follow-up|4
1569534|NCT02980523|5427916|P1|Overall Study|Lost to Follow-up|1
1569535|NCT02980224|5427960|P2|Overall Study|Withdrawal by Subject|2
1569536|NCT02980224|5427961|P1|Overall Study|Withdrawal by Subject|0
1569537|NCT02980224|5427960|P2|Overall Study|Adverse Event|1
1569538|NCT02980224|5427961|P1|Overall Study|Adverse Event|4
1569539|NCT02980107|5427977|P2|Overall Study|Withdrawal by Subject|62
1569540|NCT02980107|5427978|P1|Overall Study|Withdrawal by Subject|51
1569541|NCT02980042|5427992|P2|Overall Study|Insurance issues/treatment plan changes|0
1569542|NCT02980042|5427993|P1|Overall Study|Insurance issues/treatment plan changes|2
1569543|NCT02980042|5427992|P2|Overall Study|Lost to Follow-up|0
1569544|NCT02980042|5427993|P1|Overall Study|Lost to Follow-up|5
1569545|NCT02979639|5428010|P1|Overall Study|Adverse Event|2
1569546|NCT02979639|5428010|P1|Overall Study|Withdrawal by Subject|3
1569547|NCT02979639|5428010|P1|Overall Study|Lost to Follow-up|8
1569548|NCT02979639|5428010|P1|Overall Study|Withdrawal based on medical judgement|1
1569549|NCT02979613|5428042|P2|Open-Label Extension (OLE) Phase|Death|1
1569550|NCT02979613|5428043|P1|Open-Label Extension (OLE) Phase|Death|0
1569551|NCT02979613|5428042|P2|Open-Label Extension (OLE) Phase|Still in the OLE Phase|226
1569552|NCT02979613|5428043|P1|Open-Label Extension (OLE) Phase|Still in the OLE Phase|223
1569553|NCT02979613|5428042|P2|Double-Blind Phase|Randomized but Never Treated|0
1569554|NCT02979613|5428043|P1|Double-Blind Phase|Randomized but Never Treated|2
1569555|NCT02979613|5428042|P2|Double-Blind Phase|Protocol Violation|1
1569556|NCT02979613|5428043|P1|Double-Blind Phase|Protocol Violation|1
1569557|NCT02979613|5428042|P2|Double-Blind Phase|Lost to Follow-up|1
1569558|NCT02979613|5428043|P1|Double-Blind Phase|Lost to Follow-up|1
1569559|NCT02979613|5428042|P2|Double-Blind Phase|Adverse Event|0
1569560|NCT02979613|5428043|P1|Double-Blind Phase|Adverse Event|2
1569561|NCT02979613|5428042|P2|Double-Blind Phase|Pregnancy|2
1569562|NCT02979613|5428043|P1|Double-Blind Phase|Pregnancy|2
1569563|NCT02979613|5428042|P2|Double-Blind Phase|Withdrew Consent|4
1569564|NCT02979613|5428043|P1|Double-Blind Phase|Withdrew Consent|2
1569565|NCT02979431|5428079|P4|Overall Study|Subject left country after Day14|0
1569566|NCT02979431|5428080|P3|Overall Study|Subject left country after Day14|0
1569567|NCT02979431|5428081|P2|Overall Study|Subject left country after Day14|0
1569568|NCT02979431|5428082|P1|Overall Study|Subject left country after Day14|1
1569569|NCT02979431|5428079|P4|Overall Study|Adverse Event|0
1569570|NCT02979431|5428080|P3|Overall Study|Adverse Event|1
1569571|NCT02979431|5428081|P2|Overall Study|Adverse Event|0
1569572|NCT02979431|5428082|P1|Overall Study|Adverse Event|0
1569573|NCT02979431|5428079|P4|Overall Study|Randomized but received no study drug|0
1569574|NCT02979431|5428080|P3|Overall Study|Randomized but received no study drug|0
1569575|NCT02979431|5428081|P2|Overall Study|Randomized but received no study drug|1
1569576|NCT02979431|5428082|P1|Overall Study|Randomized but received no study drug|1
1569577|NCT02979431|5428079|P4|Overall Study|Parent/guardian withdrew consent|1
1569578|NCT02979431|5428080|P3|Overall Study|Parent/guardian withdrew consent|1
1569579|NCT02979431|5428081|P2|Overall Study|Parent/guardian withdrew consent|1
1569580|NCT02979431|5428082|P1|Overall Study|Parent/guardian withdrew consent|2
1569581|NCT02979197|5428163|P3|Overall Study|Subject unable to commit to study dates|0
1569582|NCT02979197|5428164|P2|Overall Study|Subject unable to commit to study dates|1
1569583|NCT02979197|5428165|P1|Overall Study|Subject unable to commit to study dates|0
1569584|NCT02979197|5428163|P3|Overall Study|Protocol Violation|0
1569585|NCT02979197|5428164|P2|Overall Study|Protocol Violation|1
1569586|NCT02979197|5428165|P1|Overall Study|Protocol Violation|0
1569587|NCT02979197|5428163|P3|Overall Study|Adverse Event|0
1569588|NCT02979197|5428164|P2|Overall Study|Adverse Event|2
1569589|NCT02979197|5428165|P1|Overall Study|Adverse Event|4
1569590|NCT02978833|5428208|P2|Overall Study|Study terminated|1
1569591|NCT02978833|5428209|P1|Overall Study|Study terminated|1
1569592|NCT02977572|5428246|P2|Overall Study|Exclusion criterion|2
1569593|NCT02977572|5428247|P1|Overall Study|Exclusion criterion|2
1569594|NCT02977507|5428269|P2|Overall Study|Lost to Follow-up|0
1569595|NCT02977507|5428270|P1|Overall Study|Lost to Follow-up|1
1569596|NCT02977507|5428269|P2|Overall Study|Protocol Deviation|0
1569597|NCT02977507|5428270|P1|Overall Study|Protocol Deviation|1
1569598|NCT02976519|5428300|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
1569599|NCT02976519|5428301|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1569600|NCT02976519|5428302|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1569601|NCT02976519|5428303|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1569602|NCT02976519|5428304|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1569603|NCT02976519|5428305|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1569604|NCT02976519|5428306|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
1569605|NCT02976519|5428300|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
1569606|NCT02976519|5428301|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1569607|NCT02976519|5428302|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1569608|NCT02976519|5428303|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1569609|NCT02976519|5428304|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1569610|NCT02976519|5428305|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1569611|NCT02976519|5428306|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
1569612|NCT02976519|5428300|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
1569613|NCT02976519|5428301|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
1569614|NCT02976519|5428302|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
1569615|NCT02976519|5428303|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
1569616|NCT02976519|5428304|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
1569617|NCT02976519|5428305|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
1569618|NCT02976519|5428306|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
1569619|NCT02976519|5428300|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1569620|NCT02976519|5428301|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1569621|NCT02976519|5428302|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1569622|NCT02976519|5428303|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
1569623|NCT02976519|5428304|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1569624|NCT02976519|5428305|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1569625|NCT02976519|5428306|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
1569626|NCT02976519|5428300|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1569627|NCT02976519|5428301|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1569628|NCT02976519|5428302|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1569629|NCT02976519|5428303|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1569630|NCT02976519|5428304|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1569631|NCT02976519|5428305|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
1569632|NCT02976519|5428306|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
1569639|NCT02974855|5428412|P4|Overall Study|Adverse Event|1
1569640|NCT02974855|5428413|P3|Overall Study|Adverse Event|0
1569641|NCT02974855|5428414|P2|Overall Study|Adverse Event|1
1569642|NCT02974855|5428415|P1|Overall Study|Adverse Event|0
1569643|NCT02974543|5428603|P2|Overall Study|Withdrawal by Subject|0
1569644|NCT02974543|5428604|P1|Overall Study|Withdrawal by Subject|1
1569645|NCT02974140|5428624|P1|Overall Study|Study Terminated by Sponsor|36
1569646|NCT02974140|5428624|P1|Overall Study|Lost to Follow-up|1
1569647|NCT02974140|5428624|P1|Overall Study|Adverse Event|2
1569648|NCT02974114|5428640|P3|Overall Study|Other (Not specified)|2
1569649|NCT02974114|5428641|P2|Overall Study|Other (Not specified)|1
1569650|NCT02974114|5428642|P1|Overall Study|Other (Not specified)|0
1569651|NCT02974088|5428685|P2|Overall Study|Adverse Event|1
1569652|NCT02974088|5428686|P1|Overall Study|Adverse Event|0
1569653|NCT02974088|5428685|P2|Overall Study|Lost to Follow-up|2
1569654|NCT02974088|5428686|P1|Overall Study|Lost to Follow-up|0
1569655|NCT02973802|5428692|P1|Overall Study|Withdrawal by Subject|1
1569656|NCT02973802|5428692|P1|Overall Study|Lost to Follow-up|1
1569657|NCT02973100|5428710|P4|Overall Study|Failed to attend Safety followup period|0
1569658|NCT02973100|5428711|P3|Overall Study|Failed to attend Safety followup period|1
1569659|NCT02973100|5428712|P2|Overall Study|Failed to attend Safety followup period|0
1569660|NCT02973100|5428713|P1|Overall Study|Failed to attend Safety followup period|0
1569661|NCT02973100|5428710|P4|Overall Study|Notification of change in address|1
1569662|NCT02973100|5428711|P3|Overall Study|Notification of change in address|0
1569663|NCT02973100|5428712|P2|Overall Study|Notification of change in address|0
1569664|NCT02973100|5428713|P1|Overall Study|Notification of change in address|0
1569665|NCT02973100|5428710|P4|Overall Study|Withdrawal by Subject|4
1569666|NCT02973100|5428711|P3|Overall Study|Withdrawal by Subject|1
1569667|NCT02973100|5428712|P2|Overall Study|Withdrawal by Subject|5
1569668|NCT02973100|5428713|P1|Overall Study|Withdrawal by Subject|3
1569669|NCT02973100|5428710|P4|Overall Study|Lost to Follow-up|0
1569670|NCT02973100|5428711|P3|Overall Study|Lost to Follow-up|1
1569671|NCT02973100|5428712|P2|Overall Study|Lost to Follow-up|1
1569672|NCT02973100|5428713|P1|Overall Study|Lost to Follow-up|3
1569673|NCT02973100|5428710|P4|Overall Study|Adverse Event|2
1569674|NCT02973100|5428711|P3|Overall Study|Adverse Event|1
1569675|NCT02973100|5428712|P2|Overall Study|Adverse Event|2
1569676|NCT02973100|5428713|P1|Overall Study|Adverse Event|1
1569677|NCT02972658|5428753|P4|Overall Study|Sponsor Decision|119
1569678|NCT02972658|5428754|P3|Overall Study|Sponsor Decision|72
1569679|NCT02972658|5428755|P2|Overall Study|Sponsor Decision|127
1569680|NCT02972658|5428756|P1|Overall Study|Sponsor Decision|70
1569681|NCT02972658|5428753|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
1569682|NCT02972658|5428754|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
1569683|NCT02972658|5428755|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
1569684|NCT02972658|5428756|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
1569685|NCT02972658|5428753|P4|Overall Study|Withdrawal by Subject|6
1569686|NCT02972658|5428754|P3|Overall Study|Withdrawal by Subject|1
1569687|NCT02972658|5428755|P2|Overall Study|Withdrawal by Subject|4
1569688|NCT02972658|5428756|P1|Overall Study|Withdrawal by Subject|4
1569689|NCT02972658|5428753|P4|Overall Study|Progressive Disease|1
1569690|NCT02972658|5428754|P3|Overall Study|Progressive Disease|0
1569691|NCT02972658|5428755|P2|Overall Study|Progressive Disease|1
1569692|NCT02972658|5428756|P1|Overall Study|Progressive Disease|0
1569693|NCT02972658|5428753|P4|Overall Study|Lost to Follow-up|2
1569694|NCT02972658|5428754|P3|Overall Study|Lost to Follow-up|1
1569695|NCT02972658|5428755|P2|Overall Study|Lost to Follow-up|1
1569696|NCT02972658|5428756|P1|Overall Study|Lost to Follow-up|0
1569697|NCT02972658|5428753|P4|Overall Study|Death|1
1569698|NCT02972658|5428754|P3|Overall Study|Death|0
1569699|NCT02972658|5428755|P2|Overall Study|Death|0
1569700|NCT02972658|5428756|P1|Overall Study|Death|0
1569701|NCT02972658|5428753|P4|Overall Study|Other-determined by Investigator|0
1569702|NCT02972658|5428754|P3|Overall Study|Other-determined by Investigator|0
1569703|NCT02972658|5428755|P2|Overall Study|Other-determined by Investigator|1
1569704|NCT02972658|5428756|P1|Overall Study|Other-determined by Investigator|1
1569705|NCT02972658|5428753|P4|Overall Study|Adverse Event|2
1569706|NCT02972658|5428754|P3|Overall Study|Adverse Event|0
1569707|NCT02972658|5428755|P2|Overall Study|Adverse Event|3
1569708|NCT02972658|5428756|P1|Overall Study|Adverse Event|0
1569709|NCT02972632|5428786|P1|Overall Study|Voluntary Withdrawal|10
1569710|NCT02972632|5428786|P1|Overall Study|Lost to Follow-up|4
1569711|NCT02972632|5428786|P1|Overall Study|Pretreatment Event/Adverse Event|3
1569712|NCT02972515|5428816|P1|Overall Study|Lost to Follow-up|78
1569713|NCT02972502|5428825|P2|Overall Study|Withdrawal by Subject|1
1569714|NCT02972502|5428826|P1|Overall Study|Withdrawal by Subject|1
1569715|NCT02972502|5428825|P2|Overall Study|Lost to Follow-up|1
1569716|NCT02972502|5428826|P1|Overall Study|Lost to Follow-up|3
1569717|NCT02972359|5428836|P1|Overall Study|Missing|1
1569718|NCT02972359|5428836|P1|Overall Study|Other reasons|5
1569719|NCT02972359|5428836|P1|Overall Study|Lost to Follow-up|26
1569720|NCT02972359|5428836|P1|Overall Study|Protocol Violation|1
1569721|NCT02972359|5428836|P1|Overall Study|Withdrawal by Subject|30
1569722|NCT02972359|5428836|P1|Overall Study|Death|1
1569723|NCT02972359|5428836|P1|Overall Study|Adverse Event|4
1569724|NCT02972359|5428836|P1|Overall Study|Lack of Efficacy|1
1569725|NCT02972359|5428836|P1|Overall Study|Incl. criteria not met/Exclusion met|2
1569726|NCT02971670|5428851|P4|Overall Study|Withdrawal by Subject|2
1569727|NCT02971670|5428852|P3|Overall Study|Withdrawal by Subject|1
1569728|NCT02971670|5428853|P2|Overall Study|Withdrawal by Subject|1
1569729|NCT02971670|5428854|P1|Overall Study|Withdrawal by Subject|4
1569730|NCT02971605|5428893|P1|Overall Study|Withdrawal by Subject|1
1569731|NCT02971202|5429007|P3|Overall Study|screen fail after consent|1
1569732|NCT02971202|5429008|P2|Overall Study|screen fail after consent|0
1569733|NCT02971202|5429009|P1|Overall Study|screen fail after consent|1
1569734|NCT02971202|5429007|P3|Overall Study|Pregnancy|0
1569735|NCT02971202|5429008|P2|Overall Study|Pregnancy|0
1569736|NCT02971202|5429009|P1|Overall Study|Pregnancy|1
1569737|NCT02971007|5429026|P3|Overall Study|Patient discontinued study drug|0
1569738|NCT02971007|5429027|P2|Overall Study|Patient discontinued study drug|1
1569739|NCT02971007|5429028|P1|Overall Study|Patient discontinued study drug|0
1569740|NCT02971007|5429026|P3|Overall Study|Patient had yeast at Day 5 visit|0
1569741|NCT02971007|5429027|P2|Overall Study|Patient had yeast at Day 5 visit|0
1569742|NCT02971007|5429028|P1|Overall Study|Patient had yeast at Day 5 visit|1
1569743|NCT02971007|5429026|P3|Overall Study|Withdrawal by Subject|0
1569744|NCT02971007|5429027|P2|Overall Study|Withdrawal by Subject|1
1569745|NCT02971007|5429028|P1|Overall Study|Withdrawal by Subject|0
1569746|NCT02971007|5429026|P3|Overall Study|Lost to Follow-up|1
1569747|NCT02971007|5429027|P2|Overall Study|Lost to Follow-up|1
1569748|NCT02971007|5429028|P1|Overall Study|Lost to Follow-up|0
1569749|NCT02971007|5429026|P3|Overall Study|Adverse Event|0
1569750|NCT02971007|5429027|P2|Overall Study|Adverse Event|0
1569751|NCT02971007|5429028|P1|Overall Study|Adverse Event|1
1569752|NCT02970669|5429056|P2|Open-label Period|Physician Decision|0
1569753|NCT02970669|5429057|P1|Open-label Period|Physician Decision|1
1569754|NCT02970669|5429056|P2|Open-label Period|Adverse Event|0
1569755|NCT02970669|5429057|P1|Open-label Period|Adverse Event|1
1569756|NCT02970669|5429056|P2|Open-label Period|Withdrawal by Subject|2
1569757|NCT02970669|5429057|P1|Open-label Period|Withdrawal by Subject|2
1569758|NCT02970669|5429056|P2|Double-blind Period|Withdrawal by Subject|2
1569759|NCT02970669|5429057|P1|Double-blind Period|Withdrawal by Subject|2
1569760|NCT02970669|5429056|P2|Double-blind Period|Physician Decision|2
1569761|NCT02970669|5429057|P1|Double-blind Period|Physician Decision|0
1569762|NCT02970669|5429056|P2|Double-blind Period|Study terminated by sponsor|2
1569763|NCT02970669|5429057|P1|Double-blind Period|Study terminated by sponsor|1
1569764|NCT02970669|5429056|P2|Double-blind Period|Death|0
1569765|NCT02970669|5429057|P1|Double-blind Period|Death|1
1569766|NCT02970669|5429056|P2|Double-blind Period|Adverse Event|0
1569767|NCT02970669|5429057|P1|Double-blind Period|Adverse Event|4
1569768|NCT02969863|5429133|P6|Overall Study|Physician Decision|0
1569769|NCT02969863|5429134|P5|Overall Study|Physician Decision|0
1569770|NCT02969863|5429135|P4|Overall Study|Physician Decision|0
1569771|NCT02969863|5429136|P3|Overall Study|Physician Decision|0
1569772|NCT02969863|5429137|P2|Overall Study|Physician Decision|0
1569773|NCT02969863|5429138|P1|Overall Study|Physician Decision|1
1569774|NCT02969655|5429154|P2|Overall Study|Adverse Event|8
1569775|NCT02969655|5429155|P1|Overall Study|Adverse Event|10
1569776|NCT02969655|5429154|P2|Overall Study|Protocol-specified withdrawal criteria|2
1569777|NCT02969655|5429155|P1|Overall Study|Protocol-specified withdrawal criteria|4
1569778|NCT02969655|5429154|P2|Overall Study|Physician Decision|3
1569779|NCT02969655|5429155|P1|Overall Study|Physician Decision|4
1569780|NCT02969655|5429154|P2|Overall Study|Withdrawal by Subject|2
1569781|NCT02969655|5429155|P1|Overall Study|Withdrawal by Subject|3
1569782|NCT02969590|5429190|P3|Screening Period|Hormones not suppressed post Lupron|0
1569783|NCT02969590|5429191|P2|Screening Period|Hormones not suppressed post Lupron|0
1569784|NCT02969590|5429192|P1|Screening Period|Hormones not suppressed post Lupron|1
1569785|NCT02969408|5429223|P1|Overall Study|Other than specified|1
1569786|NCT02969408|5429223|P1|Overall Study|Protocol Violation|1
1569787|NCT02969408|5429223|P1|Overall Study|Lost to Follow-up|4
1569788|NCT02969408|5429223|P1|Overall Study|Withdrawal by Subject|8
1569789|NCT02969408|5429223|P1|Overall Study|Adverse Event|2
1569790|NCT02969356|5429231|P1|Overall Study|Personal reasons|5
1569791|NCT02969356|5429231|P1|Overall Study|Did not need to be reinjected|6
1569792|NCT02969356|5429231|P1|Overall Study|Lost to Follow-up|3
1569793|NCT02969356|5429231|P1|Overall Study|Consent withdrawn|2
1569794|NCT02969356|5429231|P1|Overall Study|Adverse Event|7
1569795|NCT02969044|5429274|P2|Overall Study|Adverse Event|0
1569796|NCT02969044|5429275|P1|Overall Study|Adverse Event|3
1569797|NCT02969044|5429274|P2|Overall Study|Withdrawal by Subject|6
1569798|NCT02969044|5429275|P1|Overall Study|Withdrawal by Subject|2
1569799|NCT02969018|5429334|P8|Overall Study|Withdrawal by Subject|3
1569800|NCT02969018|5429335|P7|Overall Study|Withdrawal by Subject|4
1569801|NCT02969018|5429336|P6|Overall Study|Withdrawal by Subject|4
1569802|NCT02969018|5429337|P5|Overall Study|Withdrawal by Subject|0
1569803|NCT02969018|5429338|P4|Overall Study|Withdrawal by Subject|1
1569804|NCT02969018|5429339|P3|Overall Study|Withdrawal by Subject|2
1569805|NCT02969018|5429340|P2|Overall Study|Withdrawal by Subject|1
1569806|NCT02969018|5429341|P1|Overall Study|Withdrawal by Subject|0
1569807|NCT02969018|5429334|P8|Overall Study|Protocol Violation|0
1569808|NCT02969018|5429335|P7|Overall Study|Protocol Violation|0
1569809|NCT02969018|5429336|P6|Overall Study|Protocol Violation|0
1569810|NCT02969018|5429337|P5|Overall Study|Protocol Violation|0
1569811|NCT02969018|5429338|P4|Overall Study|Protocol Violation|1
1569812|NCT02969018|5429339|P3|Overall Study|Protocol Violation|1
1569813|NCT02969018|5429340|P2|Overall Study|Protocol Violation|0
1569814|NCT02969018|5429341|P1|Overall Study|Protocol Violation|0
1569815|NCT02969018|5429334|P8|Overall Study|Pregnancy|0
1569816|NCT02969018|5429335|P7|Overall Study|Pregnancy|0
1569817|NCT02969018|5429336|P6|Overall Study|Pregnancy|1
1569818|NCT02969018|5429337|P5|Overall Study|Pregnancy|0
1569819|NCT02969018|5429338|P4|Overall Study|Pregnancy|0
1569820|NCT02969018|5429339|P3|Overall Study|Pregnancy|0
1569821|NCT02969018|5429340|P2|Overall Study|Pregnancy|0
1569822|NCT02969018|5429341|P1|Overall Study|Pregnancy|0
1569823|NCT02969018|5429334|P8|Overall Study|Other|2
1569824|NCT02969018|5429335|P7|Overall Study|Other|0
1569825|NCT02969018|5429336|P6|Overall Study|Other|0
1569826|NCT02969018|5429337|P5|Overall Study|Other|0
1569827|NCT02969018|5429338|P4|Overall Study|Other|1
1569828|NCT02969018|5429339|P3|Overall Study|Other|0
1569829|NCT02969018|5429340|P2|Overall Study|Other|0
1569830|NCT02969018|5429341|P1|Overall Study|Other|0
1569831|NCT02969018|5429334|P8|Overall Study|Non-Compliance With Study Drug|0
1569832|NCT02969018|5429335|P7|Overall Study|Non-Compliance With Study Drug|0
1569833|NCT02969018|5429336|P6|Overall Study|Non-Compliance With Study Drug|0
1569834|NCT02969018|5429337|P5|Overall Study|Non-Compliance With Study Drug|0
1569835|NCT02969018|5429338|P4|Overall Study|Non-Compliance With Study Drug|0
1569836|NCT02969018|5429339|P3|Overall Study|Non-Compliance With Study Drug|0
1569837|NCT02969018|5429340|P2|Overall Study|Non-Compliance With Study Drug|0
1569838|NCT02969018|5429341|P1|Overall Study|Non-Compliance With Study Drug|1
1569839|NCT02969018|5429334|P8|Overall Study|No Longer Meets Eligibility Criteria|0
1569840|NCT02969018|5429335|P7|Overall Study|No Longer Meets Eligibility Criteria|1
1569841|NCT02969018|5429336|P6|Overall Study|No Longer Meets Eligibility Criteria|0
1569842|NCT02969018|5429337|P5|Overall Study|No Longer Meets Eligibility Criteria|0
1569843|NCT02969018|5429338|P4|Overall Study|No Longer Meets Eligibility Criteria|0
1569844|NCT02969018|5429339|P3|Overall Study|No Longer Meets Eligibility Criteria|0
1569845|NCT02969018|5429340|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1569846|NCT02969018|5429341|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1569847|NCT02969018|5429334|P8|Overall Study|Lost to Follow-up|1
1569848|NCT02969018|5429335|P7|Overall Study|Lost to Follow-up|0
1569849|NCT02969018|5429336|P6|Overall Study|Lost to Follow-up|1
1569850|NCT02969018|5429337|P5|Overall Study|Lost to Follow-up|1
1569851|NCT02969018|5429338|P4|Overall Study|Lost to Follow-up|0
1569852|NCT02969018|5429339|P3|Overall Study|Lost to Follow-up|2
1569853|NCT02969018|5429340|P2|Overall Study|Lost to Follow-up|2
1569854|NCT02969018|5429341|P1|Overall Study|Lost to Follow-up|1
1569855|NCT02969018|5429334|P8|Overall Study|Lack of Efficacy|1
1569856|NCT02969018|5429335|P7|Overall Study|Lack of Efficacy|1
1569857|NCT02969018|5429336|P6|Overall Study|Lack of Efficacy|1
1569858|NCT02969018|5429337|P5|Overall Study|Lack of Efficacy|1
1569859|NCT02969018|5429338|P4|Overall Study|Lack of Efficacy|0
1569860|NCT02969018|5429339|P3|Overall Study|Lack of Efficacy|0
1569861|NCT02969018|5429340|P2|Overall Study|Lack of Efficacy|1
1569862|NCT02969018|5429341|P1|Overall Study|Lack of Efficacy|0
1569863|NCT02969018|5429334|P8|Overall Study|Adverse Event|0
1569864|NCT02969018|5429335|P7|Overall Study|Adverse Event|2
1569865|NCT02969018|5429336|P6|Overall Study|Adverse Event|1
1569866|NCT02969018|5429337|P5|Overall Study|Adverse Event|0
1569867|NCT02969018|5429338|P4|Overall Study|Adverse Event|2
1569868|NCT02969018|5429339|P3|Overall Study|Adverse Event|1
1569869|NCT02969018|5429340|P2|Overall Study|Adverse Event|4
1569870|NCT02969018|5429341|P1|Overall Study|Adverse Event|2
1569871|NCT02968979|5429458|P1|Overall Study|Withdrawal by Subject|1
1569872|NCT02968979|5429458|P1|Overall Study|Protocol Violation|7
1569873|NCT02968576|5429583|P2|Overall Study|Pregnancy|1
1569874|NCT02968576|5429584|P1|Overall Study|Pregnancy|0
1569875|NCT02968173|5429620|P1|Overall Study|Withdrawal by Subject|1
1569876|NCT02966795|5429867|P2|Overall Study|Patient Left the Country|1
1569877|NCT02966795|5429868|P1|Overall Study|Patient Left the Country|0
1569878|NCT02966509|5429879|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
1569879|NCT02966509|5429880|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
1569880|NCT02966509|5429879|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
1569881|NCT02966509|5429880|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
1569882|NCT02966509|5429879|P2|6 Month Satisfaction Survey|Refused to Answer|11
1569883|NCT02966509|5429880|P1|6 Month Satisfaction Survey|Refused to Answer|8
1569884|NCT02966509|5429879|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
1569885|NCT02966509|5429880|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
1569886|NCT02966509|5429879|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
1569887|NCT02966509|5429880|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
1569888|NCT02966509|5429879|P2|6 Month Satisfaction Survey|Death|33
1569889|NCT02966509|5429880|P1|6 Month Satisfaction Survey|Death|36
1569890|NCT02966509|5429879|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
1569891|NCT02966509|5429880|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
1569892|NCT02966509|5429879|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
1569893|NCT02966509|5429880|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
1569894|NCT02966509|5429879|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
1569895|NCT02966509|5429880|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
1569896|NCT02966509|5429879|P2|6 Month Satisfaction Decision Survey|Death|25
1569897|NCT02966509|5429880|P1|6 Month Satisfaction Decision Survey|Death|22
1569898|NCT02966509|5429879|P2|Baseline Satisfaction Survey|Refused to Answer|2
1569899|NCT02966509|5429880|P1|Baseline Satisfaction Survey|Refused to Answer|1
1569900|NCT02966509|5429879|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
1569901|NCT02966509|5429880|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
1569902|NCT02966509|5429879|P2|Baseline Satisfaction Survey|Death|1
1569903|NCT02966509|5429880|P1|Baseline Satisfaction Survey|Death|0
1569904|NCT02966509|5429879|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
1569905|NCT02966509|5429880|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
1569906|NCT02966340|5429904|P2|Overall Study|startle non-responder|1
1569907|NCT02966340|5429905|P1|Overall Study|startle non-responder|1
1569908|NCT02966340|5429904|P2|Overall Study|data acquisition error|0
1569909|NCT02966340|5429905|P1|Overall Study|data acquisition error|1
1569910|NCT02966340|5429904|P2|Overall Study|Withdrawal by Subject|0
1569911|NCT02966340|5429905|P1|Overall Study|Withdrawal by Subject|1
1569912|NCT02966340|5429904|P2|Overall Study|Lost to Follow-up|1
1569913|NCT02966340|5429905|P1|Overall Study|Lost to Follow-up|0
1569914|NCT02966340|5429904|P2|Overall Study|Adverse Event|1
1569915|NCT02966340|5429905|P1|Overall Study|Adverse Event|0
1569916|NCT02966015|5429950|P2|Inclusion Visit|did not answer questionnaire|3
1569917|NCT02966015|5429951|P1|Inclusion Visit|did not answer questionnaire|8
1569918|NCT02966002|5429957|P1|Overall Study|Lost to Follow-up|1
1569919|NCT02966002|5429957|P1|Overall Study|Adverse Event|1
1569920|NCT02966002|5429957|P1|Overall Study|Withdrawal by Subject|2
1569921|NCT02965846|5429972|P3|Overall Study|Participants not randomized|33
1569922|NCT02965846|5429973|P2|Overall Study|Participants not randomized|0
1569923|NCT02965846|5429974|P1|Overall Study|Participants not randomized|0
1569924|NCT02965846|5429972|P3|Overall Study|Study Terminated By Sponsor|0
1569925|NCT02965846|5429973|P2|Overall Study|Study Terminated By Sponsor|4
1569926|NCT02965846|5429974|P1|Overall Study|Study Terminated By Sponsor|4
1569927|NCT02965846|5429972|P3|Overall Study|Withdrawal by Subject|0
1569928|NCT02965846|5429973|P2|Overall Study|Withdrawal by Subject|1
1569929|NCT02965846|5429974|P1|Overall Study|Withdrawal by Subject|0
1569930|NCT02965846|5429972|P3|Overall Study|Lost to Follow-up|0
1569931|NCT02965846|5429973|P2|Overall Study|Lost to Follow-up|0
1569932|NCT02965846|5429974|P1|Overall Study|Lost to Follow-up|1
1569933|NCT02965833|5429982|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
1569934|NCT02965833|5429983|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
1569935|NCT02965833|5429982|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1569936|NCT02965833|5429983|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1569937|NCT02965833|5429982|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
1569938|NCT02965833|5429983|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
1569939|NCT02965833|5429982|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1569940|NCT02965833|5429983|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
1569941|NCT02965833|5429982|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1569942|NCT02965833|5429983|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1569943|NCT02965820|5429989|P2|Period 2, Second 30 Days|Adverse Event|1
1569944|NCT02965820|5429990|P1|Period 2, Second 30 Days|Adverse Event|1
1569945|NCT02965599|5430029|P2|Overall Study|Protocol-defined stop criteria reached|0
1569946|NCT02965599|5430030|P1|Overall Study|Protocol-defined stop criteria reached|1
1569947|NCT02965456|5430109|P2|Overall Study|Participant ran out of study drug|1
1569948|NCT02965456|5430110|P1|Overall Study|Participant ran out of study drug|0
1569949|NCT02965456|5430109|P2|Overall Study|Protocol Violation|1
1569950|NCT02965456|5430110|P1|Overall Study|Protocol Violation|0
1569951|NCT02965456|5430109|P2|Overall Study|Pregnancy|0
1569952|NCT02965456|5430110|P1|Overall Study|Pregnancy|1
1569953|NCT02965456|5430109|P2|Overall Study|Physician Decision|1
1569954|NCT02965456|5430110|P1|Overall Study|Physician Decision|0
1569955|NCT02965456|5430109|P2|Overall Study|Lack of Efficacy|0
1569956|NCT02965456|5430110|P1|Overall Study|Lack of Efficacy|1
1569957|NCT02965456|5430109|P2|Overall Study|Worsening Condition|2
1569958|NCT02965456|5430110|P1|Overall Study|Worsening Condition|0
1569959|NCT02965456|5430109|P2|Overall Study|Noncompliance with Study Drug|1
1569960|NCT02965456|5430110|P1|Overall Study|Noncompliance with Study Drug|1
1569961|NCT02965456|5430109|P2|Overall Study|Adverse Event|0
1569962|NCT02965456|5430110|P1|Overall Study|Adverse Event|3
1569963|NCT02965456|5430109|P2|Overall Study|Withdrawal by Parent or Guardian|6
1569964|NCT02965456|5430110|P1|Overall Study|Withdrawal by Parent or Guardian|3
1569965|NCT02965456|5430109|P2|Overall Study|Subject Request|13
1569966|NCT02965456|5430110|P1|Overall Study|Subject Request|22
1569967|NCT02965456|5430109|P2|Overall Study|Lost to Follow-up|18
1569968|NCT02965456|5430110|P1|Overall Study|Lost to Follow-up|40
1569969|NCT02964338|5430164|P3|Overall Study|Did not meet criteria|0
1569970|NCT02964338|5430165|P2|Overall Study|Did not meet criteria|0
1569971|NCT02964338|5430166|P1|Overall Study|Did not meet criteria|1
1569972|NCT02964338|5430164|P3|Overall Study|Non-compliant with e-diary|0
1569973|NCT02964338|5430165|P2|Overall Study|Non-compliant with e-diary|1
1569974|NCT02964338|5430166|P1|Overall Study|Non-compliant with e-diary|0
1569975|NCT02964338|5430164|P3|Overall Study|Adverse Event|1
1569976|NCT02964338|5430165|P2|Overall Study|Adverse Event|1
1569977|NCT02964338|5430166|P1|Overall Study|Adverse Event|2
1569978|NCT02964338|5430164|P3|Overall Study|Withdrawal by Subject|1
1569979|NCT02964338|5430165|P2|Overall Study|Withdrawal by Subject|3
1569980|NCT02964338|5430166|P1|Overall Study|Withdrawal by Subject|1
1569981|NCT02964338|5430164|P3|Overall Study|Protocol Violation|0
1569982|NCT02964338|5430165|P2|Overall Study|Protocol Violation|1
1569983|NCT02964338|5430166|P1|Overall Study|Protocol Violation|0
1569984|NCT02964338|5430164|P3|Overall Study|Lost to Follow-up|3
1569985|NCT02964338|5430165|P2|Overall Study|Lost to Follow-up|0
1569986|NCT02964338|5430166|P1|Overall Study|Lost to Follow-up|1
1569987|NCT02964338|5430164|P3|Overall Study|Lack of Efficacy|0
1569988|NCT02964338|5430165|P2|Overall Study|Lack of Efficacy|3
1569989|NCT02964338|5430166|P1|Overall Study|Lack of Efficacy|0
1569990|NCT02964338|5430164|P3|Overall Study|Sponsor terminated study for futility|14
1569991|NCT02964338|5430165|P2|Overall Study|Sponsor terminated study for futility|15
1569992|NCT02964338|5430166|P1|Overall Study|Sponsor terminated study for futility|12
1569993|NCT02964312|5430210|P1|Overall Study|Lack of Efficacy|7
1569994|NCT02964312|5430210|P1|Overall Study|Withdrawal by Subject|8
1569995|NCT02964312|5430210|P1|Overall Study|Lost to Follow-up|12
1569996|NCT02964247|5430218|P2|Overall Study|Withdrawal by Subject|2
1569997|NCT02964247|5430219|P1|Overall Study|Withdrawal by Subject|1
1569998|NCT02964247|5430218|P2|Overall Study|Lost to Follow-up|0
1569999|NCT02964247|5430219|P1|Overall Study|Lost to Follow-up|2
1570000|NCT02963935|5430288|P2|Overall Study|Unclassified|22
1570001|NCT02963935|5430289|P1|Overall Study|Unclassified|13
1570002|NCT02963935|5430288|P2|Overall Study|Lost to Follow-up|6
1570003|NCT02963935|5430289|P1|Overall Study|Lost to Follow-up|1
1570004|NCT02963935|5430288|P2|Overall Study|Lack of Efficacy|2
1570005|NCT02963935|5430289|P1|Overall Study|Lack of Efficacy|0
1570006|NCT02963935|5430288|P2|Overall Study|Protocol Violation|1
1570007|NCT02963935|5430289|P1|Overall Study|Protocol Violation|2
1570008|NCT02963935|5430288|P2|Overall Study|Adverse Event|6
1570009|NCT02963935|5430289|P1|Overall Study|Adverse Event|12
1570010|NCT02963922|5430397|P2|Overall Study|Other|14
1570011|NCT02963922|5430398|P1|Overall Study|Other|8
1570012|NCT02963922|5430397|P2|Overall Study|Lost to Follow-up|3
1570013|NCT02963922|5430398|P1|Overall Study|Lost to Follow-up|2
1570014|NCT02963922|5430397|P2|Overall Study|Lack of Efficacy|1
1570015|NCT02963922|5430398|P1|Overall Study|Lack of Efficacy|1
1570016|NCT02963922|5430397|P2|Overall Study|Protocol deviation|6
1570017|NCT02963922|5430398|P1|Overall Study|Protocol deviation|6
1570018|NCT02963922|5430397|P2|Overall Study|Adverse Event|6
1570019|NCT02963922|5430398|P1|Overall Study|Adverse Event|15
1570020|NCT02963701|5430496|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
1570021|NCT02963701|5430497|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
1570022|NCT02962960|5430530|P3|Overall Study|Protocol Violation|0
1570023|NCT02962960|5430531|P2|Overall Study|Protocol Violation|0
1570024|NCT02962960|5430532|P1|Overall Study|Protocol Violation|1
1570025|NCT02962960|5430530|P3|Overall Study|Adverse Event|0
1570026|NCT02962960|5430531|P2|Overall Study|Adverse Event|1
1570027|NCT02962960|5430532|P1|Overall Study|Adverse Event|1
1570028|NCT02962960|5430530|P3|Overall Study|Withdrawal by Subject|0
1570029|NCT02962960|5430531|P2|Overall Study|Withdrawal by Subject|1
1570030|NCT02962960|5430532|P1|Overall Study|Withdrawal by Subject|1
1570031|NCT02962908|5430616|P4|Overall Study|Physician Decision|0
1570032|NCT02962908|5430617|P3|Overall Study|Physician Decision|0
1570033|NCT02962908|5430618|P2|Overall Study|Physician Decision|1
1570034|NCT02962908|5430619|P1|Overall Study|Physician Decision|0
1570035|NCT02962908|5430616|P4|Overall Study|Protocol Violation|0
1570036|NCT02962908|5430617|P3|Overall Study|Protocol Violation|0
1570037|NCT02962908|5430618|P2|Overall Study|Protocol Violation|1
1570038|NCT02962908|5430619|P1|Overall Study|Protocol Violation|0
1570039|NCT02962908|5430616|P4|Overall Study|Withdrawal by Subject|2
1570040|NCT02962908|5430617|P3|Overall Study|Withdrawal by Subject|0
1570041|NCT02962908|5430618|P2|Overall Study|Withdrawal by Subject|3
1570042|NCT02962908|5430619|P1|Overall Study|Withdrawal by Subject|0
1570043|NCT02962908|5430616|P4|Overall Study|Lost to Follow-up|1
1570044|NCT02962908|5430617|P3|Overall Study|Lost to Follow-up|0
1570045|NCT02962908|5430618|P2|Overall Study|Lost to Follow-up|3
1570046|NCT02962908|5430619|P1|Overall Study|Lost to Follow-up|0
1570047|NCT02962882|5430661|P1|Overall Study|Transfer from ICU|32
1570048|NCT02962882|5430661|P1|Overall Study|Withdrawal by Subject|2
1570049|NCT02962882|5430661|P1|Overall Study|Adverse Event|2
1570050|NCT02962284|5430723|P2|Overall Study|Withdrawal by Subject|0
1570051|NCT02962284|5430724|P1|Overall Study|Withdrawal by Subject|1
1570052|NCT02962284|5430723|P2|Overall Study|Progressive disease|3
1570053|NCT02962284|5430724|P1|Overall Study|Progressive disease|2
1570054|NCT02962284|5430723|P2|Overall Study|Death|0
1570055|NCT02962284|5430724|P1|Overall Study|Death|2
1570056|NCT02961920|5430755|P2|Overall Study|did not achive stydy protocol schedule|1
1570057|NCT02961920|5430756|P1|Overall Study|did not achive stydy protocol schedule|1
1570058|NCT02961790|5430766|P4|Overall Study|without post baseline data|1
1570059|NCT02961790|5430767|P3|Overall Study|without post baseline data|4
1570060|NCT02961790|5430768|P2|Overall Study|without post baseline data|6
1570061|NCT02961790|5430769|P1|Overall Study|without post baseline data|7
1570062|NCT02961790|5430766|P4|Overall Study|without baseline data|0
1570063|NCT02961790|5430767|P3|Overall Study|without baseline data|1
1570064|NCT02961790|5430768|P2|Overall Study|without baseline data|0
1570065|NCT02961790|5430769|P1|Overall Study|without baseline data|4
1570066|NCT02961790|5430766|P4|Overall Study|Canceled|4
1570067|NCT02961790|5430767|P3|Overall Study|Canceled|1
1570068|NCT02961790|5430768|P2|Overall Study|Canceled|5
1570069|NCT02961790|5430769|P1|Overall Study|Canceled|4
1570070|NCT02961751|5430790|P1|Overall Study|Protocol Violation|1
1570071|NCT02961751|5430790|P1|Overall Study|Not Eligible at Enrollment|1
1570072|NCT02961751|5430790|P1|Overall Study|Physician Decision|2
1570073|NCT02961751|5430790|P1|Overall Study|Lost to Follow-up|11
1570074|NCT02961244|5430803|P2|Overall Study|İnadequate data|2
1570075|NCT02961244|5430804|P1|Overall Study|İnadequate data|0
1570076|NCT02961244|5430803|P2|Overall Study|Lost to Follow-up|2
1570077|NCT02961244|5430804|P1|Overall Study|Lost to Follow-up|0
1570078|NCT02961244|5430803|P2|Overall Study|Surgery plan change after study approval|2
1570079|NCT02961244|5430804|P1|Overall Study|Surgery plan change after study approval|0
1570080|NCT02961244|5430803|P2|Overall Study|Withdrawal by Subject|2
1570081|NCT02961244|5430804|P1|Overall Study|Withdrawal by Subject|1
1570082|NCT02961244|5430803|P2|Overall Study|Protocol Violation|1
1570083|NCT02961244|5430804|P1|Overall Study|Protocol Violation|0
1570084|NCT02960854|5430857|P2|Overall Study|Death|6
1570085|NCT02960854|5430858|P1|Overall Study|Death|4
1570086|NCT02960854|5430857|P2|Overall Study|Subject Withdrew Consent|1
1570087|NCT02960854|5430858|P1|Overall Study|Subject Withdrew Consent|0
1570088|NCT02960854|5430857|P2|Overall Study|Subject No Longer Meets Study Criteria|0
1570089|NCT02960854|5430858|P1|Overall Study|Subject No Longer Meets Study Criteria|1
1570090|NCT02960854|5430857|P2|Overall Study|Not Disclosed|2
1570091|NCT02960854|5430858|P1|Overall Study|Not Disclosed|2
1570092|NCT02959983|5430922|P2|Overall Study|Withdrawal by Subject|12
1570093|NCT02959983|5430923|P1|Overall Study|Withdrawal by Subject|7
1570094|NCT02959983|5430922|P2|Overall Study|Adverse Event|1
1570095|NCT02959983|5430923|P1|Overall Study|Adverse Event|5
1570096|NCT02959983|5430922|P2|Overall Study|Physician Decision|0
1570097|NCT02959983|5430923|P1|Overall Study|Physician Decision|1
1570098|NCT02959983|5430922|P2|Overall Study|Other|1
1570099|NCT02959983|5430923|P1|Overall Study|Other|1
1570100|NCT02959983|5430922|P2|Overall Study|Lost to Follow-up|9
1570101|NCT02959983|5430923|P1|Overall Study|Lost to Follow-up|12
1570102|NCT02959983|5430922|P2|Overall Study|Lack of Efficacy|1
1570103|NCT02959983|5430923|P1|Overall Study|Lack of Efficacy|0
1570104|NCT02959983|5430922|P2|Overall Study|Protocol Violation|1
1570105|NCT02959983|5430923|P1|Overall Study|Protocol Violation|0
1570106|NCT02959970|5430937|P2|Overall Study|Lost to Follow-up|5
1570107|NCT02959970|5430938|P1|Overall Study|Lost to Follow-up|1
1570108|NCT02959970|5430937|P2|Overall Study|Withdrawal by Subject|2
1570109|NCT02959970|5430938|P1|Overall Study|Withdrawal by Subject|0
1570110|NCT02959970|5430937|P2|Overall Study|Adverse Event|0
1570111|NCT02959970|5430938|P1|Overall Study|Adverse Event|1
1570112|NCT02959892|5430972|P2|Overall Study|Study termination|1
1570113|NCT02959892|5430973|P1|Overall Study|Study termination|0
1570114|NCT02959892|5430972|P2|Overall Study|PET tracer synthesis failure|0
1570115|NCT02959892|5430973|P1|Overall Study|PET tracer synthesis failure|1
1570116|NCT02959866|5430981|P1|Overall Study|Withdrawal by Subject|1
1570117|NCT02959814|5431070|P1|Overall Study|Excluded by FFR core-lab|24
1570118|NCT02959814|5431070|P1|Overall Study|In-procedure QFR not computed|6
1570119|NCT02959814|5431070|P1|Overall Study|FFR not measured|2
1570120|NCT02959814|5431070|P1|Overall Study|Protocol Violation|7
1570121|NCT02959814|5431070|P1|Overall Study|Excluded based on anatomical criteria|2
1570122|NCT02959814|5431070|P1|Overall Study|Excluded based on diagnostic angiography|16
1570144|NCT02959138|5431149|P3|Overall Study|Enrolled but Never Treated|0
1570145|NCT02959138|5431150|P2|Overall Study|Enrolled but Never Treated|1
1570146|NCT02959138|5431151|P1|Overall Study|Enrolled but Never Treated|0
1570147|NCT02958267|5431305|P2|Follow-up Visits|Additional treatment pursued|1
1570148|NCT02958267|5431306|P1|Follow-up Visits|Additional treatment pursued|2
1570149|NCT02958267|5431305|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
1570150|NCT02958267|5431306|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
1570151|NCT02958267|5431305|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
1570152|NCT02958267|5431306|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
1570153|NCT02957747|5431318|P2|Overall Study|Lost to Follow-up|5
1570154|NCT02957747|5431319|P1|Overall Study|Lost to Follow-up|10
1570155|NCT02957747|5431318|P2|Overall Study|Withdrawal by Subject|3
1570156|NCT02957747|5431319|P1|Overall Study|Withdrawal by Subject|0
1570157|NCT02956967|5431345|P1|Overall Study|Termination of Nivestim administration|29
1570158|NCT02956967|5431345|P1|Overall Study|Missing|1
1570159|NCT02956967|5431345|P1|Overall Study|Lost to Follow-up|5
1570160|NCT02956967|5431345|P1|Overall Study|Reason non-related to neutropenia|10
1570161|NCT02956967|5431345|P1|Overall Study|Adverse Event|3
1570162|NCT02956837|5431372|P4|Overall Study|Lost to Follow-up|0
1570163|NCT02956837|5431373|P3|Overall Study|Lost to Follow-up|2
1570164|NCT02956837|5431374|P2|Overall Study|Lost to Follow-up|1
1570165|NCT02956837|5431375|P1|Overall Study|Lost to Follow-up|0
1570166|NCT02956837|5431372|P4|Overall Study|Withdrawal by Subject|3
1570167|NCT02956837|5431373|P3|Overall Study|Withdrawal by Subject|0
1570168|NCT02956837|5431374|P2|Overall Study|Withdrawal by Subject|1
1570169|NCT02956837|5431375|P1|Overall Study|Withdrawal by Subject|0
1570170|NCT02956837|5431372|P4|Overall Study|Serious Adverse Events|0
1570171|NCT02956837|5431373|P3|Overall Study|Serious Adverse Events|0
1570172|NCT02956837|5431374|P2|Overall Study|Serious Adverse Events|1
1570173|NCT02956837|5431375|P1|Overall Study|Serious Adverse Events|0
1570174|NCT02956629|5431510|P6|Overall Study|Withdrawal by Subject|0
1570175|NCT02956629|5431511|P5|Overall Study|Withdrawal by Subject|0
1570176|NCT02956629|5431512|P4|Overall Study|Withdrawal by Subject|0
1570177|NCT02956629|5431513|P3|Overall Study|Withdrawal by Subject|0
1570178|NCT02956629|5431514|P2|Overall Study|Withdrawal by Subject|1
1570179|NCT02956629|5431515|P1|Overall Study|Withdrawal by Subject|3
1570180|NCT02956629|5431510|P6|Overall Study|Lost to Follow-up|1
1570181|NCT02956629|5431511|P5|Overall Study|Lost to Follow-up|0
1570182|NCT02956629|5431512|P4|Overall Study|Lost to Follow-up|1
1570183|NCT02956629|5431513|P3|Overall Study|Lost to Follow-up|3
1570184|NCT02956629|5431514|P2|Overall Study|Lost to Follow-up|5
1570185|NCT02956629|5431515|P1|Overall Study|Lost to Follow-up|2
1570186|NCT02956629|5431510|P6|Overall Study|Adverse Event|0
1570187|NCT02956629|5431511|P5|Overall Study|Adverse Event|0
1570188|NCT02956629|5431512|P4|Overall Study|Adverse Event|0
1570189|NCT02956629|5431513|P3|Overall Study|Adverse Event|1
1570190|NCT02956629|5431514|P2|Overall Study|Adverse Event|0
1570191|NCT02956629|5431515|P1|Overall Study|Adverse Event|0
1570192|NCT02956460|5431594|P2|Lens 1|Lost to Follow-up|0
1570193|NCT02956460|5431595|P1|Lens 1|Lost to Follow-up|1
1570194|NCT02954952|5431675|P3|Overall Study|No data collected|0
1570195|NCT02954952|5431676|P2|Overall Study|No data collected|1
1570196|NCT02954952|5431677|P1|Overall Study|No data collected|0
1570197|NCT02954952|5431675|P3|Overall Study|Withdrawal by Subject|0
1570198|NCT02954952|5431676|P2|Overall Study|Withdrawal by Subject|0
1570199|NCT02954952|5431677|P1|Overall Study|Withdrawal by Subject|1
1570200|NCT02954848|5431687|P2|Overall Study|Withdrawal by Participant|1
1570201|NCT02954848|5431688|P1|Overall Study|Withdrawal by Participant|0
1570202|NCT02954848|5431687|P2|Overall Study|Adverse Event|3
1570203|NCT02954848|5431688|P1|Overall Study|Adverse Event|2
1570204|NCT02954848|5431687|P2|Overall Study|Randomized but Not Treated|1
1570205|NCT02954848|5431688|P1|Overall Study|Randomized but Not Treated|0
1570206|NCT02954653|5431748|P9|Overall Study|Treatment failure and consent withdrawal|0
1570207|NCT02954653|5431749|P8|Overall Study|Treatment failure and consent withdrawal|0
1570208|NCT02954653|5431750|P7|Overall Study|Treatment failure and consent withdrawal|0
1570209|NCT02954653|5431751|P6|Overall Study|Treatment failure and consent withdrawal|0
1570210|NCT02954653|5431752|P5|Overall Study|Treatment failure and consent withdrawal|0
1570211|NCT02954653|5431753|P4|Overall Study|Treatment failure and consent withdrawal|0
1570212|NCT02954653|5431754|P3|Overall Study|Treatment failure and consent withdrawal|0
1570213|NCT02954653|5431755|P2|Overall Study|Treatment failure and consent withdrawal|1
1570214|NCT02954653|5431756|P1|Overall Study|Treatment failure and consent withdrawal|0
1570215|NCT02954653|5431748|P9|Overall Study|Started another anti-cancer therapy|0
1570216|NCT02954653|5431749|P8|Overall Study|Started another anti-cancer therapy|0
1570217|NCT02954653|5431750|P7|Overall Study|Started another anti-cancer therapy|0
1570218|NCT02954653|5431751|P6|Overall Study|Started another anti-cancer therapy|0
1570219|NCT02954653|5431752|P5|Overall Study|Started another anti-cancer therapy|0
1570220|NCT02954653|5431753|P4|Overall Study|Started another anti-cancer therapy|0
1570221|NCT02954653|5431754|P3|Overall Study|Started another anti-cancer therapy|0
1570222|NCT02954653|5431755|P2|Overall Study|Started another anti-cancer therapy|1
1570223|NCT02954653|5431756|P1|Overall Study|Started another anti-cancer therapy|0
1570224|NCT02954653|5431748|P9|Overall Study|Randomized but did not receive treatment|0
1570225|NCT02954653|5431749|P8|Overall Study|Randomized but did not receive treatment|0
1570226|NCT02954653|5431750|P7|Overall Study|Randomized but did not receive treatment|0
1570227|NCT02954653|5431751|P6|Overall Study|Randomized but did not receive treatment|0
1570228|NCT02954653|5431752|P5|Overall Study|Randomized but did not receive treatment|0
1570229|NCT02954653|5431753|P4|Overall Study|Randomized but did not receive treatment|0
1570230|NCT02954653|5431754|P3|Overall Study|Randomized but did not receive treatment|0
1570231|NCT02954653|5431755|P2|Overall Study|Randomized but did not receive treatment|0
1570232|NCT02954653|5431756|P1|Overall Study|Randomized but did not receive treatment|1
1570233|NCT02954653|5431748|P9|Overall Study|Death|0
1570234|NCT02954653|5431749|P8|Overall Study|Death|0
1570235|NCT02954653|5431750|P7|Overall Study|Death|0
1570236|NCT02954653|5431751|P6|Overall Study|Death|0
1570237|NCT02954653|5431752|P5|Overall Study|Death|0
1570238|NCT02954653|5431753|P4|Overall Study|Death|0
1570239|NCT02954653|5431754|P3|Overall Study|Death|0
1570240|NCT02954653|5431755|P2|Overall Study|Death|1
1570241|NCT02954653|5431756|P1|Overall Study|Death|3
1570242|NCT02954601|5431875|P4|First Intervention (Five Days)|Withdrawal by Subject|0
1570243|NCT02954601|5431876|P3|First Intervention (Five Days)|Withdrawal by Subject|1
1570244|NCT02954601|5431877|P2|First Intervention (Five Days)|Withdrawal by Subject|0
1570245|NCT02954601|5431878|P1|First Intervention (Five Days)|Withdrawal by Subject|0
1570246|NCT02954575|5431900|P1|Overall Study|Adverse Event|1
1570247|NCT02954575|5431900|P1|Overall Study|Withdrawal by Subject|2
1570248|NCT02954354|5431920|P3|Overall Study|Miscellaneous|1
1570249|NCT02954354|5431921|P2|Overall Study|Miscellaneous|2
1570250|NCT02954354|5431922|P1|Overall Study|Miscellaneous|2
1570251|NCT02954354|5431920|P3|Overall Study|Lost to Follow-up|0
1570252|NCT02954354|5431921|P2|Overall Study|Lost to Follow-up|5
1570253|NCT02954354|5431922|P1|Overall Study|Lost to Follow-up|12
1570254|NCT02954354|5431920|P3|Overall Study|Withdrawal by Subject|11
1570255|NCT02954354|5431921|P2|Overall Study|Withdrawal by Subject|9
1570256|NCT02954354|5431922|P1|Overall Study|Withdrawal by Subject|17
1570257|NCT02954354|5431920|P3|Overall Study|Lack of Efficacy|0
1570258|NCT02954354|5431921|P2|Overall Study|Lack of Efficacy|2
1570259|NCT02954354|5431922|P1|Overall Study|Lack of Efficacy|0
1570260|NCT02954354|5431920|P3|Overall Study|Failure to Meet Eligibility Criteria|0
1570261|NCT02954354|5431921|P2|Overall Study|Failure to Meet Eligibility Criteria|0
1570262|NCT02954354|5431922|P1|Overall Study|Failure to Meet Eligibility Criteria|1
1570263|NCT02954354|5431920|P3|Overall Study|Adverse Event|4
1570264|NCT02954354|5431921|P2|Overall Study|Adverse Event|2
1570265|NCT02954354|5431922|P1|Overall Study|Adverse Event|2
1570270|NCT02953678|5432053|P1|Overall Study|Reason unspecified|2
1570271|NCT02953678|5432053|P1|Overall Study|Withdrawal by Subject|3
1570272|NCT02953678|5432053|P1|Overall Study|Relapse of Underlying Malignancy|2
1570273|NCT02953678|5432053|P1|Overall Study|Progressive Disease of GVHD|6
1570274|NCT02953678|5432053|P1|Overall Study|Physician Decision|20
1570275|NCT02953678|5432053|P1|Overall Study|Death|7
1570276|NCT02953678|5432053|P1|Overall Study|Adverse Event|20
1570277|NCT02953314|5432064|P2|Overall Study|Withdrawal of consent (not due to AE)|2
1570278|NCT02953314|5432065|P1|Overall Study|Withdrawal of consent (not due to AE)|0
1570279|NCT02953314|5432064|P2|Overall Study|Adverse Event|1
1570280|NCT02953314|5432065|P1|Overall Study|Adverse Event|0
1570281|NCT02952898|5432091|P3|Overall Study|Non-compliance with study drug|2
1570282|NCT02952898|5432092|P2|Overall Study|Non-compliance with study drug|1
1570283|NCT02952898|5432093|P1|Overall Study|Non-compliance with study drug|1
1570284|NCT02952898|5432091|P3|Overall Study|Lost to Follow-up|2
1570285|NCT02952898|5432092|P2|Overall Study|Lost to Follow-up|2
1570286|NCT02952898|5432093|P1|Overall Study|Lost to Follow-up|3
1570287|NCT02952898|5432091|P3|Overall Study|Adverse Event|3
1570288|NCT02952898|5432092|P2|Overall Study|Adverse Event|8
1570289|NCT02952898|5432093|P1|Overall Study|Adverse Event|8
1570290|NCT02952898|5432091|P3|Overall Study|Withdrawal by Subject|8
1570291|NCT02952898|5432092|P2|Overall Study|Withdrawal by Subject|8
1570292|NCT02952898|5432093|P1|Overall Study|Withdrawal by Subject|10
1570293|NCT02952820|5432217|P3|Active Treatment Period (6 Months)|Not treated|1
1570294|NCT02952820|5432218|P2|Active Treatment Period (6 Months)|Not treated|0
1570295|NCT02952820|5432219|P1|Active Treatment Period (6 Months)|Not treated|0
1570296|NCT02952820|5432217|P3|Active Treatment Period (6 Months)|Other than specified|2
1570297|NCT02952820|5432218|P2|Active Treatment Period (6 Months)|Other than specified|6
1570298|NCT02952820|5432219|P1|Active Treatment Period (6 Months)|Other than specified|0
1570299|NCT02952820|5432217|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
1570300|NCT02952820|5432218|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
1570301|NCT02952820|5432219|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
1570302|NCT02952820|5432217|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
1570303|NCT02952820|5432218|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
1570304|NCT02952820|5432219|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
1570305|NCT02952820|5432217|P3|Active Treatment Period (6 Months)|Subject choice|7
1570306|NCT02952820|5432218|P2|Active Treatment Period (6 Months)|Subject choice|10
1570307|NCT02952820|5432219|P1|Active Treatment Period (6 Months)|Subject choice|0
1570308|NCT02952820|5432217|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
1570309|NCT02952820|5432218|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
1570310|NCT02952820|5432219|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
1570311|NCT02952820|5432217|P3|Active Treatment Period (6 Months)|Adverse Event|5
1570312|NCT02952820|5432218|P2|Active Treatment Period (6 Months)|Adverse Event|6
1570313|NCT02952820|5432219|P1|Active Treatment Period (6 Months)|Adverse Event|0
1570314|NCT02952820|5432217|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
1570315|NCT02952820|5432218|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
1570316|NCT02952820|5432219|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
1570317|NCT02952820|5432217|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
1570318|NCT02952820|5432218|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
1570319|NCT02952820|5432219|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
1570320|NCT02952820|5432217|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
1570321|NCT02952820|5432218|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
1570322|NCT02952820|5432219|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
1570323|NCT02952820|5432217|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
1570324|NCT02952820|5432218|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
1570325|NCT02952820|5432219|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
1570326|NCT02952820|5432217|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
1570327|NCT02952820|5432218|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
1570328|NCT02952820|5432219|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
1570329|NCT02952820|5432217|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
1570330|NCT02952820|5432218|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
1570331|NCT02952820|5432219|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
1570332|NCT02952820|5432217|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
1570333|NCT02952820|5432218|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
1570334|NCT02952820|5432219|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
1570335|NCT02952313|5432279|P1|Overall Study|Missed visit|1
1570336|NCT02952313|5432279|P1|Overall Study|Lack of Efficacy|1
1570337|NCT02952313|5432279|P1|Overall Study|Withdrawal by Subject|1
1570338|NCT02952313|5432279|P1|Overall Study|Lost to Follow-up|4
1570339|NCT02952261|5432287|P2|Overall Study|Protocol Violation|0
1570340|NCT02952261|5432288|P1|Overall Study|Protocol Violation|1
1570341|NCT02952261|5432287|P2|Overall Study|Withdrawal by Subject|5
1570342|NCT02952261|5432288|P1|Overall Study|Withdrawal by Subject|4
1570353|NCT02951780|5432350|P9|Period 2|Scheduling Conflicts|0
1570354|NCT02951780|5432351|P8|Period 2|Scheduling Conflicts|1
1570355|NCT02951780|5432352|P7|Period 2|Scheduling Conflicts|0
1570356|NCT02951780|5432353|P6|Period 2|Scheduling Conflicts|0
1570357|NCT02951780|5432354|P5|Period 2|Scheduling Conflicts|0
1570358|NCT02951780|5432355|P4|Period 2|Scheduling Conflicts|0
1570359|NCT02951780|5432356|P3|Period 2|Scheduling Conflicts|0
1570360|NCT02951780|5432357|P2|Period 2|Scheduling Conflicts|0
1570361|NCT02951780|5432358|P1|Period 2|Scheduling Conflicts|0
1570362|NCT02951780|5432350|P9|Period 1|Scheduling Conflicts|0
1570363|NCT02951780|5432351|P8|Period 1|Scheduling Conflicts|1
1570364|NCT02951780|5432352|P7|Period 1|Scheduling Conflicts|0
1570365|NCT02951780|5432353|P6|Period 1|Scheduling Conflicts|0
1570366|NCT02951780|5432354|P5|Period 1|Scheduling Conflicts|0
1570367|NCT02951780|5432355|P4|Period 1|Scheduling Conflicts|0
1570368|NCT02951780|5432356|P3|Period 1|Scheduling Conflicts|0
1570369|NCT02951780|5432357|P2|Period 1|Scheduling Conflicts|0
1570370|NCT02951780|5432358|P1|Period 1|Scheduling Conflicts|0
1570371|NCT02951780|5432350|P9|Period 1|Adverse Event|0
1570372|NCT02951780|5432351|P8|Period 1|Adverse Event|0
1570373|NCT02951780|5432352|P7|Period 1|Adverse Event|0
1570374|NCT02951780|5432353|P6|Period 1|Adverse Event|0
1570375|NCT02951780|5432354|P5|Period 1|Adverse Event|0
1570376|NCT02951780|5432355|P4|Period 1|Adverse Event|1
1570377|NCT02951780|5432356|P3|Period 1|Adverse Event|0
1570378|NCT02951780|5432357|P2|Period 1|Adverse Event|0
1570379|NCT02951780|5432358|P1|Period 1|Adverse Event|0
1570380|NCT02951767|5432423|P1|Overall Study|Lost to Follow-up|1
1570381|NCT02951767|5432423|P1|Overall Study|Death|59
1570382|NCT02951767|5432423|P1|Overall Study|Withdrawal by Subject|5
1570383|NCT02951767|5432423|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
1570392|NCT02951052|5432651|P2|Overall Study|Ongoing|0
1570393|NCT02951052|5432652|P1|Overall Study|Ongoing|1
1570394|NCT02951052|5432651|P2|Overall Study|Lack of Efficacy|4
1570395|NCT02951052|5432652|P1|Overall Study|Lack of Efficacy|3
1570396|NCT02951052|5432651|P2|Overall Study|Protocol Violation|3
1570397|NCT02951052|5432652|P1|Overall Study|Protocol Violation|5
1570398|NCT02951052|5432651|P2|Overall Study|Protocol-specified withdrawal criterion|0
1570399|NCT02951052|5432652|P1|Overall Study|Protocol-specified withdrawal criterion|1
1570400|NCT02951052|5432651|P2|Overall Study|Lost to Follow-up|1
1570401|NCT02951052|5432652|P1|Overall Study|Lost to Follow-up|1
1570402|NCT02951052|5432651|P2|Overall Study|Physician Decision|0
1570403|NCT02951052|5432652|P1|Overall Study|Physician Decision|2
1570404|NCT02951052|5432651|P2|Overall Study|Withdrawal by Subject|5
1570405|NCT02951052|5432652|P1|Overall Study|Withdrawal by Subject|1
1570406|NCT02951052|5432651|P2|Overall Study|Adverse Event|5
1570407|NCT02951052|5432652|P1|Overall Study|Adverse Event|13
1570408|NCT02950831|5432820|P1|Overall Study|stimulation trail failure|5
1570409|NCT02950831|5432820|P1|Overall Study|Withdrawal by Subject|3
1570410|NCT02950831|5432820|P1|Overall Study|Lost to Follow-up|1
1570411|NCT02950480|5432858|P2|Overall Study|Withdrawal by Subject|0
1570412|NCT02950480|5432859|P1|Overall Study|Withdrawal by Subject|1
1570413|NCT02949908|5432917|P1|Overall Study|Study termination|2
1570414|NCT02949271|5432952|P2|Overall Study|Outside the window for cervical dilation|3
1570415|NCT02949271|5432953|P1|Overall Study|Outside the window for cervical dilation|2
1570416|NCT02949271|5432952|P2|Overall Study|Delivered prior to intervention|9
1570417|NCT02949271|5432953|P1|Overall Study|Delivered prior to intervention|7
1570418|NCT02949271|5432952|P2|Overall Study|Withdrawal by Subject|0
1570419|NCT02949271|5432953|P1|Overall Study|Withdrawal by Subject|1
1570420|NCT02949271|5432952|P2|Overall Study|Protocol Violation|3
1570421|NCT02949271|5432953|P1|Overall Study|Protocol Violation|6
1570422|NCT02949271|5432952|P2|Overall Study|Physician Decision|5
1570423|NCT02949271|5432953|P1|Overall Study|Physician Decision|5
1570424|NCT02949271|5432952|P2|Overall Study|Lost to Follow-up|6
1570425|NCT02949271|5432953|P1|Overall Study|Lost to Follow-up|3
1570426|NCT02949271|5432952|P2|Overall Study|Lack of Efficacy|4
1570427|NCT02949271|5432953|P1|Overall Study|Lack of Efficacy|5
1570428|NCT02949219|5432979|P1|Overall Study|Withdrawal by Subject|1
1570429|NCT02949128|5432993|P1|Extension Period|Withdrawal by Subject|1
1570430|NCT02949128|5432993|P1|Extension Period|Physician Decision|1
1570431|NCT02949128|5432993|P1|Initial Evaluation Period|Protocol Violation|1
1570432|NCT02949128|5432993|P1|Initial Evaluation Period|Physician Decision|1
1570433|NCT02949128|5432993|P1|Initial Evaluation Period|Death|2
1570434|NCT02949128|5432993|P1|Initial Evaluation Period|Adverse Event|3
1570435|NCT02949128|5432993|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
1570436|NCT02949011|5433010|P3|Overall Study|Miscellaneous|6
1570437|NCT02949011|5433011|P2|Overall Study|Miscellaneous|4
1570438|NCT02949011|5433012|P1|Overall Study|Miscellaneous|2
1570439|NCT02949011|5433010|P3|Overall Study|Death|1
1570440|NCT02949011|5433011|P2|Overall Study|Death|0
1570441|NCT02949011|5433012|P1|Overall Study|Death|0
1570442|NCT02949011|5433010|P3|Overall Study|Lost to Follow-up|5
1570443|NCT02949011|5433011|P2|Overall Study|Lost to Follow-up|5
1570444|NCT02949011|5433012|P1|Overall Study|Lost to Follow-up|7
1570445|NCT02949011|5433010|P3|Overall Study|Withdrawal by Subject|21
1570446|NCT02949011|5433011|P2|Overall Study|Withdrawal by Subject|13
1570447|NCT02949011|5433012|P1|Overall Study|Withdrawal by Subject|13
1570448|NCT02949011|5433010|P3|Overall Study|Lack of Efficacy|0
1570449|NCT02949011|5433011|P2|Overall Study|Lack of Efficacy|2
1570450|NCT02949011|5433012|P1|Overall Study|Lack of Efficacy|0
1570451|NCT02949011|5433010|P3|Overall Study|Protocol Deviation|3
1570452|NCT02949011|5433011|P2|Overall Study|Protocol Deviation|3
1570453|NCT02949011|5433012|P1|Overall Study|Protocol Deviation|5
1570454|NCT02949011|5433010|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
1570455|NCT02949011|5433011|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
1570456|NCT02949011|5433012|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
1570457|NCT02949011|5433010|P3|Overall Study|Adverse Event|3
1570458|NCT02949011|5433011|P2|Overall Study|Adverse Event|7
1570459|NCT02949011|5433012|P1|Overall Study|Adverse Event|6
1570460|NCT02948582|5433080|P6|Washout Period 4|Adverse Event|0
1570461|NCT02948582|5433081|P5|Washout Period 4|Adverse Event|0
1570462|NCT02948582|5433082|P4|Washout Period 4|Adverse Event|0
1570463|NCT02948582|5433083|P3|Washout Period 4|Adverse Event|1
1570464|NCT02948582|5433084|P2|Washout Period 4|Adverse Event|0
1570465|NCT02948582|5433085|P1|Washout Period 4|Adverse Event|1
1570466|NCT02948582|5433080|P6|Washout Period 2|personal reasons|0
1570467|NCT02948582|5433081|P5|Washout Period 2|personal reasons|0
1570468|NCT02948582|5433082|P4|Washout Period 2|personal reasons|1
1570469|NCT02948582|5433083|P3|Washout Period 2|personal reasons|0
1570470|NCT02948582|5433084|P2|Washout Period 2|personal reasons|0
1570471|NCT02948582|5433085|P1|Washout Period 2|personal reasons|0
1570472|NCT02948582|5433080|P6|Washout Period 2|Adverse Event|0
1570473|NCT02948582|5433081|P5|Washout Period 2|Adverse Event|0
1570474|NCT02948582|5433082|P4|Washout Period 2|Adverse Event|0
1570475|NCT02948582|5433083|P3|Washout Period 2|Adverse Event|0
1570476|NCT02948582|5433084|P2|Washout Period 2|Adverse Event|1
1570477|NCT02948582|5433085|P1|Washout Period 2|Adverse Event|0
1570478|NCT02948582|5433080|P6|Washout Period 1|Protocol Violation|1
1570479|NCT02948582|5433081|P5|Washout Period 1|Protocol Violation|0
1570480|NCT02948582|5433082|P4|Washout Period 1|Protocol Violation|0
1570481|NCT02948582|5433083|P3|Washout Period 1|Protocol Violation|0
1570482|NCT02948582|5433084|P2|Washout Period 1|Protocol Violation|0
1570483|NCT02948582|5433085|P1|Washout Period 1|Protocol Violation|0
1570484|NCT02948582|5433080|P6|Washout Period 1|Adverse Event|0
1570485|NCT02948582|5433081|P5|Washout Period 1|Adverse Event|0
1570486|NCT02948582|5433082|P4|Washout Period 1|Adverse Event|0
1570487|NCT02948582|5433083|P3|Washout Period 1|Adverse Event|0
1570488|NCT02948582|5433084|P2|Washout Period 1|Adverse Event|2
1570489|NCT02948582|5433085|P1|Washout Period 1|Adverse Event|0
1570490|NCT02947022|5433207|P1|Overall Study|Study Stopped|1
1570491|NCT02946580|5433228|P2|Overall Study|Did not undergo posterior spinal fusion|1
1570492|NCT02946580|5433229|P1|Overall Study|Did not undergo posterior spinal fusion|0
1570493|NCT02946580|5433228|P2|Overall Study|Adverse Event|2
1570494|NCT02946580|5433229|P1|Overall Study|Adverse Event|0
1570495|NCT02946580|5433228|P2|Overall Study|Withdrawal by Subject|2
1570496|NCT02946580|5433229|P1|Overall Study|Withdrawal by Subject|1
1570497|NCT02946515|5433247|P2|Overall Study|Lost to Follow-up|1
1570498|NCT02946515|5433248|P1|Overall Study|Lost to Follow-up|2
1570499|NCT02946463|5433261|P2|Primary Evaluation Period|Withdrawal by Subject|1
1570500|NCT02946463|5433262|P1|Primary Evaluation Period|Withdrawal by Subject|0
1570501|NCT02946463|5433261|P2|Primary Evaluation Period|Physician Decision|1
1570502|NCT02946463|5433262|P1|Primary Evaluation Period|Physician Decision|0
1570503|NCT02946385|5433284|P6|Overall Study|Lost to Follow-up|1
1570504|NCT02946385|5433285|P5|Overall Study|Lost to Follow-up|2
1570505|NCT02946385|5433286|P4|Overall Study|Lost to Follow-up|0
1570506|NCT02946385|5433287|P3|Overall Study|Lost to Follow-up|3
1570507|NCT02946385|5433288|P2|Overall Study|Lost to Follow-up|0
1570508|NCT02946385|5433289|P1|Overall Study|Lost to Follow-up|0
1570509|NCT02945657|5433392|P1|Overall Study|Withdrawal by Parent/Guardian|3
1570510|NCT02945657|5433392|P1|Overall Study|Adverse Event|1
1570511|NCT02945410|5433415|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
1570512|NCT02945410|5433416|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
1570513|NCT02945410|5433417|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
1570514|NCT02945410|5433418|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
1570515|NCT02945410|5433419|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
1570516|NCT02945410|5433420|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
1570517|NCT02945410|5433415|P6|Intervention 1 (5 Days)|Adverse Event|1
1570518|NCT02945410|5433416|P5|Intervention 1 (5 Days)|Adverse Event|0
1570519|NCT02945410|5433417|P4|Intervention 1 (5 Days)|Adverse Event|0
1570520|NCT02945410|5433418|P3|Intervention 1 (5 Days)|Adverse Event|0
1570521|NCT02945410|5433419|P2|Intervention 1 (5 Days)|Adverse Event|0
1570522|NCT02945410|5433420|P1|Intervention 1 (5 Days)|Adverse Event|1
1570523|NCT02945410|5433415|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
1570524|NCT02945410|5433416|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
1570525|NCT02945410|5433417|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
1570526|NCT02945410|5433418|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
1570527|NCT02945410|5433419|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
1570528|NCT02945410|5433420|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
1570529|NCT02945254|5433451|P2|Overall Study|Withdrawal by Subject|0
1570530|NCT02945254|5433452|P1|Overall Study|Withdrawal by Subject|1
1570531|NCT02945254|5433451|P2|Overall Study|Lost to Follow-up|0
1570532|NCT02945254|5433452|P1|Overall Study|Lost to Follow-up|1
1570533|NCT02944968|5433460|P1|Overall Study|Subject didn't meet eligibility criteria|2
1570534|NCT02944968|5433460|P1|Overall Study|Subject excluded before study procedure|1
1570535|NCT02944656|5433467|P2|Overall Study|Lost to Follow-up|10
1570536|NCT02944656|5433468|P1|Overall Study|Lost to Follow-up|7
1570537|NCT02944656|5433467|P2|Overall Study|No longer eligible|0
1570538|NCT02944656|5433468|P1|Overall Study|No longer eligible|3
1570539|NCT02944513|5433504|P2|Overall Study|Withdrawal by Subject|1
1570540|NCT02944513|5433505|P1|Overall Study|Withdrawal by Subject|4
1570541|NCT02943577|5433536|P2|Overall Study|Pregnancy|0
1570542|NCT02943577|5433537|P1|Overall Study|Pregnancy|1
1570543|NCT02943577|5433536|P2|Overall Study|Withdrawal by Subject|1
1570544|NCT02943577|5433537|P1|Overall Study|Withdrawal by Subject|1
1570545|NCT02943577|5433536|P2|Overall Study|Lost to Follow-up|1
1570546|NCT02943577|5433537|P1|Overall Study|Lost to Follow-up|0
1570547|NCT02943577|5433536|P2|Overall Study|Adverse Event|2
1570548|NCT02943577|5433537|P1|Overall Study|Adverse Event|3
1570549|NCT02943577|5433536|P2|Overall Study|Protocol Violation|1
1570550|NCT02943577|5433537|P1|Overall Study|Protocol Violation|0
1570551|NCT02943564|5433552|P3|Overall Study|Lack of Efficacy|0
1570552|NCT02943564|5433553|P2|Overall Study|Lack of Efficacy|1
1570553|NCT02943564|5433554|P1|Overall Study|Lack of Efficacy|0
1570554|NCT02943564|5433552|P3|Overall Study|Adverse Event|1
1570555|NCT02943564|5433553|P2|Overall Study|Adverse Event|2
1570556|NCT02943564|5433554|P1|Overall Study|Adverse Event|1
1570557|NCT02943564|5433552|P3|Overall Study|Withdrawal by Subject|2
1570558|NCT02943564|5433553|P2|Overall Study|Withdrawal by Subject|5
1570559|NCT02943564|5433554|P1|Overall Study|Withdrawal by Subject|6
1570560|NCT02943564|5433552|P3|Overall Study|Lost to Follow-up|0
1570561|NCT02943564|5433553|P2|Overall Study|Lost to Follow-up|0
1570562|NCT02943564|5433554|P1|Overall Study|Lost to Follow-up|1
1570563|NCT02943564|5433552|P3|Overall Study|Protocol Violation|2
1570564|NCT02943564|5433553|P2|Overall Study|Protocol Violation|2
1570565|NCT02943564|5433554|P1|Overall Study|Protocol Violation|2
1570566|NCT02943564|5433552|P3|Overall Study|Pregnancy|1
1570567|NCT02943564|5433553|P2|Overall Study|Pregnancy|1
1570568|NCT02943564|5433554|P1|Overall Study|Pregnancy|0
1570569|NCT02943564|5433552|P3|Overall Study|Non-compliance with study drug|0
1570570|NCT02943564|5433553|P2|Overall Study|Non-compliance with study drug|1
1570571|NCT02943564|5433554|P1|Overall Study|Non-compliance with study drug|0
1570572|NCT02943564|5433552|P3|Overall Study|Site terminated by sponsor|0
1570573|NCT02943564|5433553|P2|Overall Study|Site terminated by sponsor|1
1570574|NCT02943564|5433554|P1|Overall Study|Site terminated by sponsor|0
1570575|NCT02943564|5433552|P3|Overall Study|Miscellaneous Reasons|3
1570576|NCT02943564|5433553|P2|Overall Study|Miscellaneous Reasons|0
1570577|NCT02943564|5433554|P1|Overall Study|Miscellaneous Reasons|0
1570578|NCT02943460|5433577|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
1570579|NCT02943460|5433578|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
1570580|NCT02943460|5433579|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
1570581|NCT02943460|5433577|P3|Open Label Extension (OLE)|Investigator's Discretion|0
1570582|NCT02943460|5433578|P2|Open Label Extension (OLE)|Investigator's Discretion|1
1570583|NCT02943460|5433579|P1|Open Label Extension (OLE)|Investigator's Discretion|0
1570584|NCT02943460|5433577|P3|Open Label Extension (OLE)|Withdrew Consent|0
1570585|NCT02943460|5433578|P2|Open Label Extension (OLE)|Withdrew Consent|1
1570586|NCT02943460|5433579|P1|Open Label Extension (OLE)|Withdrew Consent|1
1570587|NCT02943460|5433577|P3|Open Label Extension (OLE)|Adverse Event|1
1570588|NCT02943460|5433578|P2|Open Label Extension (OLE)|Adverse Event|2
1570589|NCT02943460|5433579|P1|Open Label Extension (OLE)|Adverse Event|0
1570590|NCT02943460|5433577|P3|Blinded Study|Withdrew Consent|0
1570591|NCT02943460|5433578|P2|Blinded Study|Withdrew Consent|1
1570592|NCT02943460|5433579|P1|Blinded Study|Withdrew Consent|0
1570593|NCT02943460|5433577|P3|Blinded Study|Adverse Event|0
1570594|NCT02943460|5433578|P2|Blinded Study|Adverse Event|0
1570595|NCT02943460|5433579|P1|Blinded Study|Adverse Event|3
1570596|NCT02943447|5433597|P3|Overall Study|Still on Study|11
1570597|NCT02943447|5433598|P2|Overall Study|Still on Study|22
1570598|NCT02943447|5433599|P1|Overall Study|Still on Study|21
1570599|NCT02943447|5433597|P3|Overall Study|Withdrew Consent|1
1570600|NCT02943447|5433598|P2|Overall Study|Withdrew Consent|2
1570601|NCT02943447|5433599|P1|Overall Study|Withdrew Consent|1
1570602|NCT02943447|5433597|P3|Overall Study|Lack of Efficacy|0
1570603|NCT02943447|5433598|P2|Overall Study|Lack of Efficacy|2
1570604|NCT02943447|5433599|P1|Overall Study|Lack of Efficacy|2
1570605|NCT02943447|5433597|P3|Overall Study|Adverse Event|1
1570606|NCT02943447|5433598|P2|Overall Study|Adverse Event|4
1570607|NCT02943447|5433599|P1|Overall Study|Adverse Event|4
1570608|NCT02943096|5433668|P2|Overall Study|Lack of Efficacy|1
1570609|NCT02943096|5433669|P1|Overall Study|Lack of Efficacy|0
1570610|NCT02942576|5433685|P2|Overall Study|Other|8
1570611|NCT02942576|5433686|P1|Overall Study|Other|10
1570612|NCT02942576|5433685|P2|Overall Study|Physician Decision|4
1570613|NCT02942576|5433686|P1|Overall Study|Physician Decision|1
1570614|NCT02942576|5433685|P2|Overall Study|Withdrawal by Subject|5
1570615|NCT02942576|5433686|P1|Overall Study|Withdrawal by Subject|7
1570616|NCT02942576|5433685|P2|Overall Study|Adverse Event|6
1570617|NCT02942576|5433686|P1|Overall Study|Adverse Event|28
1570618|NCT02942017|5433700|P2|Overall Study|Randomized but not dosed|3
1570619|NCT02942017|5433701|P1|Overall Study|Randomized but not dosed|1
1570620|NCT02942017|5433700|P2|Overall Study|Lost to Follow-up|1
1570621|NCT02942017|5433701|P1|Overall Study|Lost to Follow-up|1
1570622|NCT02942017|5433700|P2|Overall Study|Withdrawal by Subject|1
1570623|NCT02942017|5433701|P1|Overall Study|Withdrawal by Subject|0
1570624|NCT02942017|5433700|P2|Overall Study|Adverse Event|1
1570625|NCT02942017|5433701|P1|Overall Study|Adverse Event|0
1570626|NCT02942004|5433732|P3|Overall Study|Randomized but not dosed|4
1570627|NCT02942004|5433733|P2|Overall Study|Randomized but not dosed|9
1570628|NCT02942004|5433734|P1|Overall Study|Randomized but not dosed|3
1570629|NCT02942004|5433732|P3|Overall Study|Lost to Follow-up|2
1570630|NCT02942004|5433733|P2|Overall Study|Lost to Follow-up|1
1570631|NCT02942004|5433734|P1|Overall Study|Lost to Follow-up|1
1570632|NCT02942004|5433732|P3|Overall Study|Withdrawal by Subject|3
1570633|NCT02942004|5433733|P2|Overall Study|Withdrawal by Subject|2
1570634|NCT02942004|5433734|P1|Overall Study|Withdrawal by Subject|0
1570635|NCT02940691|5433823|P1|Overall Study|Incarceration|1
1570636|NCT02940691|5433823|P1|Overall Study|Lost to Follow-up|5
1570637|NCT02940626|5433832|P2|Overall Study|Prohibited Concomitant Medication|1
1570638|NCT02940626|5433833|P1|Overall Study|Prohibited Concomitant Medication|0
1570639|NCT02940626|5433832|P2|Overall Study|Transfer to Hospice Care|0
1570640|NCT02940626|5433833|P1|Overall Study|Transfer to Hospice Care|1
1570641|NCT02940626|5433832|P2|Overall Study|Withdrawal by Subject|0
1570642|NCT02940626|5433833|P1|Overall Study|Withdrawal by Subject|1
1570643|NCT02940626|5433832|P2|Overall Study|Lost to Follow-up|2
1570644|NCT02940626|5433833|P1|Overall Study|Lost to Follow-up|5
1570645|NCT02940626|5433832|P2|Overall Study|Death|32
1570646|NCT02940626|5433833|P1|Overall Study|Death|40
1570647|NCT02940574|5433855|P2|1-year Follow-up|Lost to Follow-up|4
1570648|NCT02940574|5433856|P1|1-year Follow-up|Lost to Follow-up|3
1570649|NCT02940574|5433855|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
1570650|NCT02940574|5433856|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
1570651|NCT02940522|5433894|P2|Overall Study|Withdrawal by Subject|0
1570652|NCT02940522|5433895|P1|Overall Study|Withdrawal by Subject|1
1570653|NCT02940522|5433894|P2|Overall Study|Lost to Follow-up|2
1570654|NCT02940522|5433895|P1|Overall Study|Lost to Follow-up|1
1570655|NCT02939950|5433913|P2|Overall Study|Ineligible at Baseline|8
1570656|NCT02939950|5433914|P1|Overall Study|Ineligible at Baseline|2
1570657|NCT02939950|5433913|P2|Overall Study|Randomized, not dispensed|0
1570658|NCT02939950|5433914|P1|Overall Study|Randomized, not dispensed|1
1570659|NCT02939950|5433913|P2|Overall Study|Adverse Event|3
1570660|NCT02939950|5433914|P1|Overall Study|Adverse Event|7
1570661|NCT02939950|5433913|P2|Overall Study|Withdrawal by Subject|28
1570662|NCT02939950|5433914|P1|Overall Study|Withdrawal by Subject|12
1570663|NCT02939950|5433913|P2|Overall Study|Pregnancy|7
1570664|NCT02939950|5433914|P1|Overall Study|Pregnancy|6
1570665|NCT02939950|5433913|P2|Overall Study|Physician Decision|0
1570666|NCT02939950|5433914|P1|Overall Study|Physician Decision|2
1570667|NCT02939950|5433913|P2|Overall Study|Protocol Violation|3
1570668|NCT02939950|5433914|P1|Overall Study|Protocol Violation|6
1570669|NCT02939950|5433913|P2|Overall Study|Unacceptable lens movement|0
1570670|NCT02939950|5433914|P1|Overall Study|Unacceptable lens movement|2
1570671|NCT02939950|5433913|P2|Overall Study|Study related symptoms|8
1570672|NCT02939950|5433914|P1|Overall Study|Study related symptoms|8
1570673|NCT02939950|5433913|P2|Overall Study|Participant Relocated|3
1570674|NCT02939950|5433914|P1|Overall Study|Participant Relocated|5
1570675|NCT02939950|5433913|P2|Overall Study|Military orders|0
1570676|NCT02939950|5433914|P1|Overall Study|Military orders|1
1570677|NCT02939950|5433913|P2|Overall Study|Unacceptable distance lens visual acuity|1
1570678|NCT02939950|5433914|P1|Overall Study|Unacceptable distance lens visual acuity|1
1570679|NCT02939950|5433913|P2|Overall Study|Lack of motivation|2
1570680|NCT02939950|5433914|P1|Overall Study|Lack of motivation|0
1570681|NCT02939950|5433913|P2|Overall Study|Chalazion upper lid|1
1570682|NCT02939950|5433914|P1|Overall Study|Chalazion upper lid|0
1570683|NCT02939950|5433913|P2|Overall Study|Positive slit lamp findings|1
1570684|NCT02939950|5433914|P1|Overall Study|Positive slit lamp findings|0
1570685|NCT02939950|5433913|P2|Overall Study|Lost to Follow-up|16
1570686|NCT02939950|5433914|P1|Overall Study|Lost to Follow-up|13
1570687|NCT02939937|5433924|P2|Overall Study|Lost to Follow-up|3
1570688|NCT02939937|5433925|P1|Overall Study|Lost to Follow-up|1
1570689|NCT02939937|5433924|P2|Overall Study|Adverse Event|0
1570690|NCT02939937|5433925|P1|Overall Study|Adverse Event|5
1570691|NCT02939560|5433939|P1|Overall Study|Protocol Violation|1
1570692|NCT02939560|5433939|P1|Overall Study|Withdrawal by Subject|2
1570693|NCT02939079|5433997|P2|Overall Study|relapse during the study|1
1570694|NCT02939079|5433998|P1|Overall Study|relapse during the study|1
1570695|NCT02939079|5433997|P2|Overall Study|Withdrawal by Subject|1
1570696|NCT02939079|5433998|P1|Overall Study|Withdrawal by Subject|0
1570697|NCT02939079|5433997|P2|Overall Study|Protocol Violation|0
1570698|NCT02939079|5433998|P1|Overall Study|Protocol Violation|1
1570699|NCT02939079|5433997|P2|Overall Study|Lost to Follow-up|2
1570700|NCT02939079|5433998|P1|Overall Study|Lost to Follow-up|0
1570701|NCT02939079|5433997|P2|Overall Study|Adverse Event|1
1570702|NCT02939079|5433998|P1|Overall Study|Adverse Event|2
1570709|NCT02938585|5434073|P4|Overall Study|Withdrawal by Subject|5
1570710|NCT02938585|5434074|P3|Overall Study|Withdrawal by Subject|0
1570711|NCT02938585|5434075|P2|Overall Study|Withdrawal by Subject|0
1570712|NCT02938585|5434076|P1|Overall Study|Withdrawal by Subject|0
1570713|NCT02938585|5434073|P4|Overall Study|Withdrawal by parent or guardian|0
1570714|NCT02938585|5434074|P3|Overall Study|Withdrawal by parent or guardian|0
1570715|NCT02938585|5434075|P2|Overall Study|Withdrawal by parent or guardian|1
1570716|NCT02938585|5434076|P1|Overall Study|Withdrawal by parent or guardian|0
1570717|NCT02938520|5434240|P2|Overall Study|Adverse Event|4
1570718|NCT02938520|5434241|P1|Overall Study|Adverse Event|9
1570719|NCT02938520|5434240|P2|Overall Study|Lack of Efficacy|3
1570720|NCT02938520|5434241|P1|Overall Study|Lack of Efficacy|5
1570721|NCT02938520|5434240|P2|Overall Study|Protocol Violation|1
1570722|NCT02938520|5434241|P1|Overall Study|Protocol Violation|0
1570723|NCT02938520|5434240|P2|Overall Study|Withdrawal by Subject|7
1570724|NCT02938520|5434241|P1|Overall Study|Withdrawal by Subject|7
1570725|NCT02938520|5434240|P2|Overall Study|Lost to Follow-up|2
1570726|NCT02938520|5434241|P1|Overall Study|Lost to Follow-up|2
1570727|NCT02938520|5434240|P2|Overall Study|Physician Decision|5
1570728|NCT02938520|5434241|P1|Overall Study|Physician Decision|2
1570729|NCT02938520|5434240|P2|Overall Study|On-going at the time of analysis|261
1570730|NCT02938520|5434241|P1|Overall Study|On-going at the time of analysis|258
1570731|NCT02937870|5434385|P1|Overall Study|Protocol Deviation|2
1570732|NCT02937870|5434385|P1|Overall Study|Adverse Event|1
1570733|NCT02937740|5434416|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
1570734|NCT02937740|5434417|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
1570735|NCT02937740|5434416|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
1570736|NCT02937740|5434417|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
1570737|NCT02937740|5434416|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
1570738|NCT02937740|5434417|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
1570739|NCT02937740|5434416|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
1570740|NCT02937740|5434417|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
1570741|NCT02937740|5434416|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
1570742|NCT02937740|5434417|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
1570743|NCT02937740|5434416|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
1570744|NCT02937740|5434417|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
1570745|NCT02937701|5434433|P5|Week 22 to Week 50|Other|1
1570746|NCT02937701|5434434|P4|Week 22 to Week 50|Other|0
1570747|NCT02937701|5434435|P3|Week 22 to Week 50|Other|0
1570748|NCT02937701|5434436|P2|Week 22 to Week 50|Other|0
1570749|NCT02937701|5434437|P1|Week 22 to Week 50|Other|0
1570750|NCT02937701|5434433|P5|Week 22 to Week 50|Physician Decision|1
1570751|NCT02937701|5434434|P4|Week 22 to Week 50|Physician Decision|0
1570752|NCT02937701|5434435|P3|Week 22 to Week 50|Physician Decision|2
1570753|NCT02937701|5434436|P2|Week 22 to Week 50|Physician Decision|0
1570754|NCT02937701|5434437|P1|Week 22 to Week 50|Physician Decision|0
1570755|NCT02937701|5434433|P5|Week 22 to Week 50|Lost to Follow-up|1
1570756|NCT02937701|5434434|P4|Week 22 to Week 50|Lost to Follow-up|0
1570757|NCT02937701|5434435|P3|Week 22 to Week 50|Lost to Follow-up|2
1570758|NCT02937701|5434436|P2|Week 22 to Week 50|Lost to Follow-up|0
1570759|NCT02937701|5434437|P1|Week 22 to Week 50|Lost to Follow-up|0
1570760|NCT02937701|5434433|P5|Week 22 to Week 50|Withdrawal by Subject|1
1570761|NCT02937701|5434434|P4|Week 22 to Week 50|Withdrawal by Subject|2
1570762|NCT02937701|5434435|P3|Week 22 to Week 50|Withdrawal by Subject|8
1570763|NCT02937701|5434436|P2|Week 22 to Week 50|Withdrawal by Subject|0
1570764|NCT02937701|5434437|P1|Week 22 to Week 50|Withdrawal by Subject|0
1570765|NCT02937701|5434433|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
1570766|NCT02937701|5434434|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
1570767|NCT02937701|5434435|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
1570768|NCT02937701|5434436|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
1570769|NCT02937701|5434437|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
1570770|NCT02937701|5434433|P5|Week 22 to Week 50|Adverse Event|3
1570771|NCT02937701|5434434|P4|Week 22 to Week 50|Adverse Event|3
1570772|NCT02937701|5434435|P3|Week 22 to Week 50|Adverse Event|10
1570773|NCT02937701|5434436|P2|Week 22 to Week 50|Adverse Event|0
1570774|NCT02937701|5434437|P1|Week 22 to Week 50|Adverse Event|0
1570775|NCT02937701|5434433|P5|Day 1 to Week 22|Other|0
1570776|NCT02937701|5434434|P4|Day 1 to Week 22|Other|0
1570777|NCT02937701|5434435|P3|Day 1 to Week 22|Other|0
1570778|NCT02937701|5434436|P2|Day 1 to Week 22|Other|0
1570779|NCT02937701|5434437|P1|Day 1 to Week 22|Other|1
1570780|NCT02937701|5434433|P5|Day 1 to Week 22|Physician Decision|0
1570781|NCT02937701|5434434|P4|Day 1 to Week 22|Physician Decision|0
1570782|NCT02937701|5434435|P3|Day 1 to Week 22|Physician Decision|0
1570783|NCT02937701|5434436|P2|Day 1 to Week 22|Physician Decision|0
1570784|NCT02937701|5434437|P1|Day 1 to Week 22|Physician Decision|2
1570785|NCT02937701|5434433|P5|Day 1 to Week 22|Lost to Follow-up|0
1570786|NCT02937701|5434434|P4|Day 1 to Week 22|Lost to Follow-up|0
1570787|NCT02937701|5434435|P3|Day 1 to Week 22|Lost to Follow-up|0
1570788|NCT02937701|5434436|P2|Day 1 to Week 22|Lost to Follow-up|1
1570789|NCT02937701|5434437|P1|Day 1 to Week 22|Lost to Follow-up|1
1570790|NCT02937701|5434433|P5|Day 1 to Week 22|Protocol Violation|0
1570791|NCT02937701|5434434|P4|Day 1 to Week 22|Protocol Violation|0
1570792|NCT02937701|5434435|P3|Day 1 to Week 22|Protocol Violation|0
1570793|NCT02937701|5434436|P2|Day 1 to Week 22|Protocol Violation|1
1570794|NCT02937701|5434437|P1|Day 1 to Week 22|Protocol Violation|1
1570795|NCT02937701|5434433|P5|Day 1 to Week 22|Death|0
1570796|NCT02937701|5434434|P4|Day 1 to Week 22|Death|0
1570797|NCT02937701|5434435|P3|Day 1 to Week 22|Death|0
1570798|NCT02937701|5434436|P2|Day 1 to Week 22|Death|1
1570799|NCT02937701|5434437|P1|Day 1 to Week 22|Death|1
1570800|NCT02937701|5434433|P5|Day 1 to Week 22|Withdrawal by Subject|0
1570801|NCT02937701|5434434|P4|Day 1 to Week 22|Withdrawal by Subject|0
1570802|NCT02937701|5434435|P3|Day 1 to Week 22|Withdrawal by Subject|0
1570803|NCT02937701|5434436|P2|Day 1 to Week 22|Withdrawal by Subject|6
1570804|NCT02937701|5434437|P1|Day 1 to Week 22|Withdrawal by Subject|6
1570805|NCT02937701|5434433|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
1570806|NCT02937701|5434434|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
1570807|NCT02937701|5434435|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
1570808|NCT02937701|5434436|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
1570809|NCT02937701|5434437|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
1570810|NCT02937701|5434433|P5|Day 1 to Week 22|Protocol Specified Criteria|0
1570811|NCT02937701|5434434|P4|Day 1 to Week 22|Protocol Specified Criteria|0
1570812|NCT02937701|5434435|P3|Day 1 to Week 22|Protocol Specified Criteria|0
1570813|NCT02937701|5434436|P2|Day 1 to Week 22|Protocol Specified Criteria|7
1570814|NCT02937701|5434437|P1|Day 1 to Week 22|Protocol Specified Criteria|7
1570815|NCT02937701|5434433|P5|Day 1 to Week 22|Adverse Event|0
1570816|NCT02937701|5434434|P4|Day 1 to Week 22|Adverse Event|0
1570817|NCT02937701|5434435|P3|Day 1 to Week 22|Adverse Event|0
1570818|NCT02937701|5434436|P2|Day 1 to Week 22|Adverse Event|14
1570819|NCT02937701|5434437|P1|Day 1 to Week 22|Adverse Event|11
1570820|NCT02937636|5434468|P2|Overall Study|Other (Not specified)|2
1570821|NCT02937636|5434469|P1|Overall Study|Other (Not specified)|3
1570822|NCT02937584|5434496|P2|Washout|Adverse Event|1
1570823|NCT02937584|5434497|P1|Washout|Adverse Event|0
1570824|NCT02937584|5434496|P2|Period 1|Adverse Event|2
1570825|NCT02937584|5434497|P1|Period 1|Adverse Event|1
1570826|NCT02936869|5434560|P2|Overall Study|Protocol Violation|0
1570827|NCT02936869|5434561|P1|Overall Study|Protocol Violation|1
1570828|NCT02936869|5434560|P2|Overall Study|Legal Case|1
1570829|NCT02936869|5434561|P1|Overall Study|Legal Case|0
1570830|NCT02936869|5434560|P2|Overall Study|Death|1
1570831|NCT02936869|5434561|P1|Overall Study|Death|0
1570832|NCT02936869|5434560|P2|Overall Study|Lost to Follow-up|3
1570833|NCT02936869|5434561|P1|Overall Study|Lost to Follow-up|1
1570834|NCT02935894|5434592|P1|Overall Study|Subject dismissed|1
1570835|NCT02935673|5434621|P3|Overall Study|Withdrawal by Subject|0
1570836|NCT02935673|5434622|P2|Overall Study|Withdrawal by Subject|2
1570837|NCT02935673|5434623|P1|Overall Study|Withdrawal by Subject|1
1570838|NCT02935673|5434621|P3|Overall Study|Adverse Event|0
1570839|NCT02935673|5434622|P2|Overall Study|Adverse Event|1
1570840|NCT02935673|5434623|P1|Overall Study|Adverse Event|0
1570841|NCT02935192|5434757|P2|Overall Study|Withdrawal by Subject|4
1570842|NCT02935192|5434758|P1|Overall Study|Withdrawal by Subject|8
1570843|NCT02933528|5434921|P1|Overall Study|Lost to Follow-up|2
1570844|NCT02933060|5434949|P2|Overall Study|Withdrawal by Subject|1
1570845|NCT02933060|5434950|P1|Overall Study|Withdrawal by Subject|0
1570846|NCT02932943|5434991|P2|Overall Study|Withdrawal by Subject|3
1570847|NCT02932943|5434992|P1|Overall Study|Withdrawal by Subject|3
1570848|NCT02932943|5434991|P2|Overall Study|Adverse Event|2
1570849|NCT02932943|5434992|P1|Overall Study|Adverse Event|2
1570850|NCT02932943|5434991|P2|Overall Study|Lost to Follow-up|2
1570851|NCT02932943|5434992|P1|Overall Study|Lost to Follow-up|0
1570852|NCT02932904|5435008|P4|Overall Study|Randomized But Not Treated|2
1570853|NCT02932904|5435009|P3|Overall Study|Randomized But Not Treated|0
1570854|NCT02932904|5435010|P2|Overall Study|Randomized But Not Treated|1
1570855|NCT02932904|5435011|P1|Overall Study|Randomized But Not Treated|1
1570856|NCT02932904|5435008|P4|Overall Study|Pretreatment Event/Adverse Event|3
1570857|NCT02932904|5435009|P3|Overall Study|Pretreatment Event/Adverse Event|1
1570858|NCT02932904|5435010|P2|Overall Study|Pretreatment Event/Adverse Event|5
1570859|NCT02932904|5435011|P1|Overall Study|Pretreatment Event/Adverse Event|3
1570860|NCT02932904|5435008|P4|Overall Study|Significant Protocol Deviation|1
1570861|NCT02932904|5435009|P3|Overall Study|Significant Protocol Deviation|6
1570862|NCT02932904|5435010|P2|Overall Study|Significant Protocol Deviation|3
1570863|NCT02932904|5435011|P1|Overall Study|Significant Protocol Deviation|2
1570864|NCT02932904|5435008|P4|Overall Study|Lost to Follow-up|0
1570865|NCT02932904|5435009|P3|Overall Study|Lost to Follow-up|6
1570866|NCT02932904|5435010|P2|Overall Study|Lost to Follow-up|3
1570867|NCT02932904|5435011|P1|Overall Study|Lost to Follow-up|5
1570868|NCT02932904|5435008|P4|Overall Study|Voluntary Withdrawal|2
1570869|NCT02932904|5435009|P3|Overall Study|Voluntary Withdrawal|4
1570870|NCT02932904|5435010|P2|Overall Study|Voluntary Withdrawal|1
1570871|NCT02932904|5435011|P1|Overall Study|Voluntary Withdrawal|2
1570872|NCT02932904|5435008|P4|Overall Study|Study Termination|0
1570873|NCT02932904|5435009|P3|Overall Study|Study Termination|0
1570874|NCT02932904|5435010|P2|Overall Study|Study Termination|1
1570875|NCT02932904|5435011|P1|Overall Study|Study Termination|0
1570876|NCT02932904|5435008|P4|Overall Study|Pregnancy|0
1570877|NCT02932904|5435009|P3|Overall Study|Pregnancy|1
1570878|NCT02932904|5435010|P2|Overall Study|Pregnancy|1
1570879|NCT02932904|5435011|P1|Overall Study|Pregnancy|0
1570880|NCT02932904|5435008|P4|Overall Study|Noncompliance with Study Drug|4
1570881|NCT02932904|5435009|P3|Overall Study|Noncompliance with Study Drug|3
1570882|NCT02932904|5435010|P2|Overall Study|Noncompliance with Study Drug|3
1570883|NCT02932904|5435011|P1|Overall Study|Noncompliance with Study Drug|2
1570884|NCT02932904|5435008|P4|Overall Study|Reason not Specified|2
1570885|NCT02932904|5435009|P3|Overall Study|Reason not Specified|2
1570886|NCT02932904|5435010|P2|Overall Study|Reason not Specified|0
1570887|NCT02932904|5435011|P1|Overall Study|Reason not Specified|1
1570888|NCT02932891|5435046|P1|Overall Study|HPA Suppress|2
1570889|NCT02932891|5435046|P1|Overall Study|Lost to Follow-up|2
1570890|NCT02932878|5435052|P2|Overall Study|Due to Lab Results|1
1570891|NCT02932878|5435053|P1|Overall Study|Due to Lab Results|2
1570892|NCT02932462|5435061|P2|Overall Study|Progressive Disease|0
1570893|NCT02932462|5435062|P1|Overall Study|Progressive Disease|1
1570894|NCT02932462|5435061|P2|Overall Study|Non-Compliance With Study Drug|1
1570895|NCT02932462|5435062|P1|Overall Study|Non-Compliance With Study Drug|0
1570896|NCT02932462|5435061|P2|Overall Study|Withdrawal by Subject|4
1570897|NCT02932462|5435062|P1|Overall Study|Withdrawal by Subject|1
1570898|NCT02932462|5435061|P2|Overall Study|Protocol Violation|5
1570899|NCT02932462|5435062|P1|Overall Study|Protocol Violation|0
1570900|NCT02932462|5435061|P2|Overall Study|Lost to Follow-up|1
1570901|NCT02932462|5435062|P1|Overall Study|Lost to Follow-up|4
1570902|NCT02932462|5435061|P2|Overall Study|Adverse Event|2
1570903|NCT02932462|5435062|P1|Overall Study|Adverse Event|1
1570904|NCT02932306|5435074|P2|Overall Study|Withdrew due to burning,itching,stinging|0
1570905|NCT02932306|5435075|P1|Overall Study|Withdrew due to burning,itching,stinging|1
1570906|NCT02932306|5435074|P2|Overall Study|Worsening condition|0
1570907|NCT02932306|5435075|P1|Overall Study|Worsening condition|2
1570908|NCT02932306|5435074|P2|Overall Study|Lack of Efficacy|2
1570909|NCT02932306|5435075|P1|Overall Study|Lack of Efficacy|0
1570910|NCT02932306|5435074|P2|Overall Study|Withdrawal by Parent or Guardian|8
1570911|NCT02932306|5435075|P1|Overall Study|Withdrawal by Parent or Guardian|6
1570912|NCT02932306|5435074|P2|Overall Study|Lost to Follow-up|40
1570913|NCT02932306|5435075|P1|Overall Study|Lost to Follow-up|36
1570914|NCT02932306|5435074|P2|Overall Study|Noncompliance with Study Drug|1
1570915|NCT02932306|5435075|P1|Overall Study|Noncompliance with Study Drug|1
1570916|NCT02932306|5435074|P2|Overall Study|Protocol Violation|1
1570917|NCT02932306|5435075|P1|Overall Study|Protocol Violation|1
1570918|NCT02932306|5435074|P2|Overall Study|Pregnancy|0
1570919|NCT02932306|5435075|P1|Overall Study|Pregnancy|2
1570920|NCT02932306|5435074|P2|Overall Study|Adverse Event|0
1570921|NCT02932306|5435075|P1|Overall Study|Adverse Event|3
1570922|NCT02932306|5435074|P2|Overall Study|Withdrawal by Subject|25
1570923|NCT02932306|5435075|P1|Overall Study|Withdrawal by Subject|16
1570924|NCT02932267|5435089|P1|Overall Study|Pregnancy|1
1570925|NCT02932267|5435089|P1|Overall Study|Lost to Follow-up|4
1570926|NCT02932267|5435089|P1|Overall Study|Withdrawal by Subject|3
1570927|NCT02932228|5435095|P2|Overall Study|not eligible upon chart review|5
1570928|NCT02932228|5435096|P1|Overall Study|not eligible upon chart review|2
1570929|NCT02932228|5435095|P2|Overall Study|Death|23
1570930|NCT02932228|5435096|P1|Overall Study|Death|8
1570931|NCT02931396|5435117|P2|Overall Study|Withdrawal by Subject|0
1570932|NCT02931396|5435118|P1|Overall Study|Withdrawal by Subject|2
1570933|NCT02931396|5435117|P2|Overall Study|Lost to Follow-up|0
1570934|NCT02931396|5435118|P1|Overall Study|Lost to Follow-up|3
1570935|NCT02930837|5435132|P1|Overall Study|Withdrawal by Subject|1
1570936|NCT02930837|5435132|P1|Overall Study|Lost to Follow-up|5
1570937|NCT02930837|5435132|P1|Overall Study|Adverse Event|6
1570938|NCT02930005|5435442|P2|Overall Study|Lost to Follow-up|5
1570939|NCT02930005|5435443|P1|Overall Study|Lost to Follow-up|1
1570940|NCT02929498|5435467|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
1570941|NCT02929498|5435468|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
1570942|NCT02929498|5435469|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
1570943|NCT02929498|5435467|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
1570944|NCT02929498|5435468|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
1570945|NCT02929498|5435469|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
1570946|NCT02929407|5435563|P1|Overall Study|Adverse Event|1
1570947|NCT02928770|5435578|P1|Overall Study|Withdrawal by Subject|2
1570948|NCT02927795|5435614|P1|Overall Study|Not Treated|4
1570949|NCT02927795|5435614|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
1570950|NCT02927431|5435661|P3|Overall Study|Withdrawal by Subject|1
1570951|NCT02927431|5435662|P2|Overall Study|Withdrawal by Subject|0
1570952|NCT02927431|5435663|P1|Overall Study|Withdrawal by Subject|0
1570957|NCT02926573|5435797|P2|Overall Study|Delirium|1
1570958|NCT02926573|5435798|P1|Overall Study|Delirium|0
1570959|NCT02926573|5435797|P2|Overall Study|Return to operating room|2
1570960|NCT02926573|5435798|P1|Overall Study|Return to operating room|0
1570961|NCT02926573|5435797|P2|Overall Study|Withdrawal by Subject|2
1570962|NCT02926573|5435798|P1|Overall Study|Withdrawal by Subject|0
1570963|NCT02926573|5435797|P2|Overall Study|Change to outpatient status|1
1570964|NCT02926573|5435798|P1|Overall Study|Change to outpatient status|5
1570965|NCT02926573|5435797|P2|Overall Study|Change in surgery plan|1
1570966|NCT02926573|5435798|P1|Overall Study|Change in surgery plan|3
1570967|NCT02926573|5435797|P2|Overall Study|Remain intubated|2
1570968|NCT02926573|5435798|P1|Overall Study|Remain intubated|2
1570969|NCT02926573|5435797|P2|Overall Study|Nausea|0
1570970|NCT02926573|5435798|P1|Overall Study|Nausea|1
1570971|NCT02926209|5435816|P2|Study Cohort|Poor Bowel Preparation|0
1570972|NCT02926209|5435817|P1|Study Cohort|Poor Bowel Preparation|1
1570973|NCT02925403|5435889|P2|Overall Study|Lost to Follow-up|1
1570974|NCT02925403|5435890|P1|Overall Study|Lost to Follow-up|0
1570975|NCT02924883|5435904|P2|Overall Study|Ongoing in Study|115
1570976|NCT02924883|5435905|P1|Overall Study|Ongoing in Study|56
1570977|NCT02924883|5435904|P2|Overall Study|Death|13
1570978|NCT02924883|5435905|P1|Overall Study|Death|8
1570979|NCT02924883|5435904|P2|Overall Study|Protocol Violation|1
1570980|NCT02924883|5435905|P1|Overall Study|Protocol Violation|0
1570981|NCT02924883|5435904|P2|Overall Study|Withdrawal by Subject|4
1570982|NCT02924883|5435905|P1|Overall Study|Withdrawal by Subject|5
1571025|NCT02924051|5436018|P2|Overall Study|Withdrawal by Subject|9
1571026|NCT02924051|5436019|P1|Overall Study|Withdrawal by Subject|1
1571027|NCT02923830|5436046|P2|Overall Study|Physician Decision|15
1571028|NCT02923830|5436047|P1|Overall Study|Physician Decision|13
1571029|NCT02923245|5436078|P2|Overall Study|ultrasound order was cancelled|1
1571030|NCT02923245|5436079|P1|Overall Study|ultrasound order was cancelled|2
1571031|NCT02921425|5436201|P1|Overall Study|Protocol Violation|9
1571032|NCT02921087|5436273|P2|Overall Study|Withdrawal by Subject|1
1571033|NCT02921087|5436274|P1|Overall Study|Withdrawal by Subject|0
1571034|NCT02920983|5436294|P6|Dispense 3|Unacceptable Lens Fit|0
1571035|NCT02920983|5436295|P5|Dispense 3|Unacceptable Lens Fit|1
1571036|NCT02920983|5436296|P4|Dispense 3|Unacceptable Lens Fit|0
1571037|NCT02920983|5436297|P3|Dispense 3|Unacceptable Lens Fit|0
1571038|NCT02920983|5436298|P2|Dispense 3|Unacceptable Lens Fit|1
1571039|NCT02920983|5436299|P1|Dispense 3|Unacceptable Lens Fit|1
1571040|NCT02920983|5436294|P6|Dispense 2|Unscceptable lens fit|0
1571041|NCT02920983|5436295|P5|Dispense 2|Unscceptable lens fit|1
1571042|NCT02920983|5436296|P4|Dispense 2|Unscceptable lens fit|0
1571043|NCT02920983|5436297|P3|Dispense 2|Unscceptable lens fit|0
1571044|NCT02920983|5436298|P2|Dispense 2|Unscceptable lens fit|0
1571045|NCT02920983|5436299|P1|Dispense 2|Unscceptable lens fit|1
1571046|NCT02920983|5436294|P6|Dispense 1|Unacceptable Lens Fit|0
1571047|NCT02920983|5436295|P5|Dispense 1|Unacceptable Lens Fit|1
1571048|NCT02920983|5436296|P4|Dispense 1|Unacceptable Lens Fit|0
1571049|NCT02920983|5436297|P3|Dispense 1|Unacceptable Lens Fit|0
1571050|NCT02920983|5436298|P2|Dispense 1|Unacceptable Lens Fit|0
1571051|NCT02920983|5436299|P1|Dispense 1|Unacceptable Lens Fit|0
1571052|NCT02920970|5436328|P2|Second Intervention|Poor Lens Fit|0
1571053|NCT02920970|5436329|P1|Second Intervention|Poor Lens Fit|1
1571054|NCT02920970|5436328|P2|First Intervention|Adverse Event|1
1571055|NCT02920970|5436329|P1|First Intervention|Adverse Event|0
1571056|NCT02920970|5436328|P2|First Intervention|Protocol Violation|1
1571057|NCT02920970|5436329|P1|First Intervention|Protocol Violation|0
1571058|NCT02920957|5436355|P2|Second Intervention: 1 Month|Lost to Follow-up|1
1571059|NCT02920957|5436356|P1|Second Intervention: 1 Month|Lost to Follow-up|0
1571060|NCT02920957|5436355|P2|First Intervention : 1 Month|Adverse Event|0
1571061|NCT02920957|5436356|P1|First Intervention : 1 Month|Adverse Event|1
1571062|NCT02920957|5436355|P2|First Intervention : 1 Month|Lost to Follow-up|0
1571063|NCT02920957|5436356|P1|First Intervention : 1 Month|Lost to Follow-up|1
1571064|NCT02920957|5436355|P2|First Intervention : 1 Month|Withdrawal by Subject|0
1571065|NCT02920957|5436356|P1|First Intervention : 1 Month|Withdrawal by Subject|2
1571066|NCT02920450|5436445|P4|Overall Study|Withdrawal by Subject|0
1571067|NCT02920450|5436446|P3|Overall Study|Withdrawal by Subject|0
1571068|NCT02920450|5436447|P2|Overall Study|Withdrawal by Subject|0
1571069|NCT02920450|5436448|P1|Overall Study|Withdrawal by Subject|1
1571070|NCT02920450|5436445|P4|Overall Study|Death|0
1571071|NCT02920450|5436446|P3|Overall Study|Death|0
1571072|NCT02920450|5436447|P2|Overall Study|Death|0
1571073|NCT02920450|5436448|P1|Overall Study|Death|1
1571074|NCT02920242|5436459|P3|Overall Study|Did not meet inc./exc. criteria|0
1571075|NCT02920242|5436460|P2|Overall Study|Did not meet inc./exc. criteria|0
1571076|NCT02920242|5436461|P1|Overall Study|Did not meet inc./exc. criteria|1
1571077|NCT02920242|5436459|P3|Overall Study|Withdrawal by Subject|1
1571078|NCT02920242|5436460|P2|Overall Study|Withdrawal by Subject|0
1571079|NCT02920242|5436461|P1|Overall Study|Withdrawal by Subject|1
1571080|NCT02919995|5436493|P6|Overall Study|Adverse Event|1
1571081|NCT02919995|5436494|P5|Overall Study|Adverse Event|0
1571082|NCT02919995|5436495|P4|Overall Study|Adverse Event|0
1571083|NCT02919995|5436496|P3|Overall Study|Adverse Event|0
1571084|NCT02919995|5436497|P2|Overall Study|Adverse Event|0
1571085|NCT02919995|5436498|P1|Overall Study|Adverse Event|0
1571086|NCT02919618|5436551|P1|Overall Study|Death|1
1571087|NCT02919267|5436581|P4|Overall Study|Protocol Violation|4
1571088|NCT02919267|5436582|P3|Overall Study|Protocol Violation|3
1571089|NCT02919267|5436583|P2|Overall Study|Protocol Violation|3
1571090|NCT02919267|5436584|P1|Overall Study|Protocol Violation|0
1571091|NCT02918552|5436724|P2|Overall Study|Lost to Follow-up|1
1571092|NCT02918552|5436725|P1|Overall Study|Lost to Follow-up|0
1571093|NCT02918552|5436724|P2|Overall Study|Withdrawal by Subject|1
1571094|NCT02918552|5436725|P1|Overall Study|Withdrawal by Subject|0
1571095|NCT02918552|5436724|P2|Overall Study|Failed Pharmacokinetics|0
1571096|NCT02918552|5436725|P1|Overall Study|Failed Pharmacokinetics|1
1571097|NCT02918266|5436808|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571098|NCT02918266|5436809|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571099|NCT02918266|5436810|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
1571100|NCT02918266|5436811|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571101|NCT02918266|5436812|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
1571102|NCT02918266|5436813|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571103|NCT02918266|5436814|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571104|NCT02918266|5436815|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571105|NCT02918266|5436816|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571106|NCT02918266|5436817|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
1571107|NCT02918266|5436818|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
1571108|NCT02918071|5436917|P1|Overall Study|Lost to Follow-up|1
1571109|NCT02918071|5436917|P1|Overall Study|Withdrawal by Subject|2
1571110|NCT02917265|5436955|P2|Overall Study|Withdrawal by Subject|0
1571111|NCT02917265|5436956|P1|Overall Study|Withdrawal by Subject|1
1571112|NCT02917265|5436955|P2|Overall Study|Physician Decision|0
1571113|NCT02917265|5436956|P1|Overall Study|Physician Decision|1
1571114|NCT02915978|5437023|P3|Overall Study|Adverse Event|0
1571115|NCT02915978|5437024|P2|Overall Study|Adverse Event|1
1571116|NCT02915978|5437025|P1|Overall Study|Adverse Event|2
1571117|NCT02915874|5437077|P2|Overall Study|Started New Anxiety Medication|1
1571118|NCT02915874|5437078|P1|Overall Study|Started New Anxiety Medication|0
1571119|NCT02915874|5437077|P2|Overall Study|Withdrawal by Subject|1
1571120|NCT02915874|5437078|P1|Overall Study|Withdrawal by Subject|1
1571121|NCT02915874|5437077|P2|Overall Study|Lost to Follow-up|4
1571122|NCT02915874|5437078|P1|Overall Study|Lost to Follow-up|5
1571123|NCT02915835|5437098|P2|Overall Study|Withdrawal by Subject|1
1571124|NCT02915835|5437099|P1|Overall Study|Withdrawal by Subject|0
1571125|NCT02915835|5437098|P2|Overall Study|Physician Decision|0
1571126|NCT02915835|5437099|P1|Overall Study|Physician Decision|1
1571127|NCT02915302|5437299|P2|Overall Study|Other|0
1571128|NCT02915302|5437300|P1|Overall Study|Other|1
1571129|NCT02915302|5437299|P2|Overall Study|Withdrawal by Subject|29
1571130|NCT02915302|5437300|P1|Overall Study|Withdrawal by Subject|22
1571131|NCT02915302|5437299|P2|Overall Study|Lost to Follow-up|22
1571132|NCT02915302|5437300|P1|Overall Study|Lost to Follow-up|19
1571133|NCT02915302|5437299|P2|Overall Study|Protocol Violation|27
1571134|NCT02915302|5437300|P1|Overall Study|Protocol Violation|20
1571135|NCT02915302|5437299|P2|Overall Study|Adverse Event|0
1571136|NCT02915302|5437300|P1|Overall Study|Adverse Event|3
1571137|NCT02915159|5437312|P2|Overall Study|Lack of Efficacy|3
1571138|NCT02915159|5437313|P1|Overall Study|Lack of Efficacy|0
1571139|NCT02915159|5437312|P2|Overall Study|Adverse Event|2
1571140|NCT02915159|5437313|P1|Overall Study|Adverse Event|2
1571141|NCT02915159|5437312|P2|Overall Study|Request to discontinue treatment|2
1571142|NCT02915159|5437313|P1|Overall Study|Request to discontinue treatment|1
1571143|NCT02915159|5437312|P2|Overall Study|Participant withdrew consent|1
1571144|NCT02915159|5437313|P1|Overall Study|Participant withdrew consent|5
1571145|NCT02915159|5437312|P2|Overall Study|poor/non-compliance|0
1571146|NCT02915159|5437313|P1|Overall Study|poor/non-compliance|1
1571147|NCT02915159|5437312|P2|Overall Study|Participant no longer meets criteria|0
1571148|NCT02915159|5437313|P1|Overall Study|Participant no longer meets criteria|2
1571149|NCT02914275|5437442|P2|Overall Study|Excluded due to invalid informed consent|0
1571150|NCT02914275|5437443|P1|Overall Study|Excluded due to invalid informed consent|3
1571151|NCT02914275|5437442|P2|Overall Study|Other|1
1571152|NCT02914275|5437443|P1|Overall Study|Other|4
1571153|NCT02914275|5437442|P2|Overall Study|Physician Decision|1
1571154|NCT02914275|5437443|P1|Overall Study|Physician Decision|3
1571155|NCT02914275|5437442|P2|Overall Study|Protocol Violation|1
1571156|NCT02914275|5437443|P1|Overall Study|Protocol Violation|1
1571157|NCT02914275|5437442|P2|Overall Study|Withdrawal by Subject|10
1571158|NCT02914275|5437443|P1|Overall Study|Withdrawal by Subject|26
1571159|NCT02914275|5437442|P2|Overall Study|Lost to Follow-up|29
1571160|NCT02914275|5437443|P1|Overall Study|Lost to Follow-up|84
1571161|NCT02914236|5437475|P1|Overall Study|Lost to Follow-up|1
1571162|NCT02914184|5437521|P4|Overall Study|Migrated/moved from the study area|1
1571163|NCT02914184|5437522|P3|Overall Study|Migrated/moved from the study area|2
1571164|NCT02914184|5437523|P2|Overall Study|Migrated/moved from the study area|1
1571165|NCT02914184|5437524|P1|Overall Study|Migrated/moved from the study area|2
1571166|NCT02914184|5437521|P4|Overall Study|Other|0
1571167|NCT02914184|5437522|P3|Overall Study|Other|0
1571168|NCT02914184|5437523|P2|Overall Study|Other|0
1571169|NCT02914184|5437524|P1|Overall Study|Other|1
1571170|NCT02914184|5437521|P4|Overall Study|Withdrawal by Subject|3
1571171|NCT02914184|5437522|P3|Overall Study|Withdrawal by Subject|7
1571172|NCT02914184|5437523|P2|Overall Study|Withdrawal by Subject|2
1571173|NCT02914184|5437524|P1|Overall Study|Withdrawal by Subject|4
1571174|NCT02914184|5437521|P4|Overall Study|Lost to Follow-up|7
1571175|NCT02914184|5437522|P3|Overall Study|Lost to Follow-up|8
1571176|NCT02914184|5437523|P2|Overall Study|Lost to Follow-up|10
1571177|NCT02914184|5437524|P1|Overall Study|Lost to Follow-up|7
1571178|NCT02913326|5437581|P2|Overall Study|Adverse Event|0
1571179|NCT02913326|5437582|P1|Overall Study|Adverse Event|1
1571180|NCT02913326|5437581|P2|Overall Study|Lost to Follow-up|1
1571181|NCT02913326|5437582|P1|Overall Study|Lost to Follow-up|0
1571182|NCT02913326|5437581|P2|Overall Study|Reason not listed|1
1571183|NCT02913326|5437582|P1|Overall Study|Reason not listed|0
1571184|NCT02913105|5437605|P3|Overall Study|Withdrawal by Subject|1
1571185|NCT02913105|5437606|P2|Overall Study|Withdrawal by Subject|3
1571186|NCT02913105|5437607|P1|Overall Study|Withdrawal by Subject|0
1571187|NCT02913105|5437605|P3|Overall Study|Physician Decision|0
1571188|NCT02913105|5437606|P2|Overall Study|Physician Decision|1
1571189|NCT02913105|5437607|P1|Overall Study|Physician Decision|1
1571190|NCT02913105|5437605|P3|Overall Study|Reason Not Specified|1
1571191|NCT02913105|5437606|P2|Overall Study|Reason Not Specified|1
1571192|NCT02913105|5437607|P1|Overall Study|Reason Not Specified|3
1571193|NCT02913105|5437605|P3|Overall Study|Non-Compliance With Study Drug|1
1571194|NCT02913105|5437606|P2|Overall Study|Non-Compliance With Study Drug|0
1571195|NCT02913105|5437607|P1|Overall Study|Non-Compliance With Study Drug|0
1571196|NCT02913105|5437605|P3|Overall Study|Adverse Event|4
1571197|NCT02913105|5437606|P2|Overall Study|Adverse Event|0
1571198|NCT02913105|5437607|P1|Overall Study|Adverse Event|11
1571199|NCT02912650|5437660|P4|Overall Study|Adverse Event|0
1571200|NCT02912650|5437661|P3|Overall Study|Adverse Event|1
1571201|NCT02912650|5437662|P2|Overall Study|Adverse Event|0
1571202|NCT02912650|5437663|P1|Overall Study|Adverse Event|0
1571203|NCT02912650|5437660|P4|Overall Study|Withdrawal by Subject|5
1571204|NCT02912650|5437661|P3|Overall Study|Withdrawal by Subject|1
1571205|NCT02912650|5437662|P2|Overall Study|Withdrawal by Subject|0
1571206|NCT02912650|5437663|P1|Overall Study|Withdrawal by Subject|1
1571207|NCT02912468|5437747|P2|Overall Study|Randomized and not treated|1
1571208|NCT02912468|5437748|P1|Overall Study|Randomized and not treated|0
1571209|NCT02912468|5437747|P2|Overall Study|Withdrawal by Subject|2
1571210|NCT02912468|5437748|P1|Overall Study|Withdrawal by Subject|6
1571211|NCT02912468|5437747|P2|Overall Study|Adverse Event|2
1571212|NCT02912468|5437748|P1|Overall Study|Adverse Event|3
1571221|NCT02911688|5438079|P2|Washout|Withdrawal by Subject|1
1571222|NCT02911688|5438080|P1|Washout|Withdrawal by Subject|0
1571223|NCT02911688|5438079|P2|Washout|Lost to Follow-up|1
1571224|NCT02911688|5438080|P1|Washout|Lost to Follow-up|1
1571225|NCT02910739|5438104|P4|Overall Study|Adverse Event|0
1571226|NCT02910739|5438105|P3|Overall Study|Adverse Event|0
1571227|NCT02910739|5438106|P2|Overall Study|Adverse Event|0
1571228|NCT02910739|5438107|P1|Overall Study|Adverse Event|1
1571229|NCT02910713|5438133|P1|Overall Study|Investigator Discretion|1
1571230|NCT02910713|5438133|P1|Overall Study|Enrollment cap|7
1571231|NCT02910713|5438133|P1|Overall Study|Received Neither Application|18
1571232|NCT02910713|5438133|P1|Overall Study|Received One Application|10
1571233|NCT02910713|5438133|P1|Overall Study|Subject Choice|4
1571234|NCT02910713|5438133|P1|Overall Study|Protocol Violation|2
1571235|NCT02910167|5438149|P1|Overall Study|Lost to Follow-up|18
1571236|NCT02910167|5438149|P1|Overall Study|Adverse Event|1
1571237|NCT02910089|5438159|P2|Overall Study|Lost insurance eligibility|16
1571238|NCT02910089|5438160|P1|Overall Study|Lost insurance eligibility|22
1571239|NCT02909907|5438174|P2|Overall Study|Withdrawal by Subject|1
1571240|NCT02909907|5438175|P1|Overall Study|Withdrawal by Subject|0
1571241|NCT02909153|5438221|P5|Overall Study|Withdrawal by Subject|0
1571242|NCT02909153|5438222|P4|Overall Study|Withdrawal by Subject|0
1571243|NCT02909153|5438223|P3|Overall Study|Withdrawal by Subject|0
1571244|NCT02909153|5438224|P2|Overall Study|Withdrawal by Subject|1
1571245|NCT02909153|5438225|P1|Overall Study|Withdrawal by Subject|0
1571246|NCT02909101|5438315|P2|Overall Study|Lost to Follow-up|1
1571247|NCT02909101|5438316|P1|Overall Study|Lost to Follow-up|1
1571248|NCT02908880|5438334|P1|Overall Study|Death|5
1571249|NCT02908880|5438334|P1|Overall Study|Withdrawal by Subject|17
1571250|NCT02908880|5438334|P1|Overall Study|Explantation of the device|1
1571251|NCT02908880|5438334|P1|Overall Study|Lost to Follow-up|4
1571252|NCT02908529|5438383|P2|Overall Study|Lost to Follow-up|2
1571253|NCT02908529|5438384|P1|Overall Study|Lost to Follow-up|0
1571254|NCT02908516|5438394|P2|Overall Study|Study Terminated|3
1571255|NCT02908516|5438395|P1|Overall Study|Study Terminated|3
1571256|NCT02908347|5438411|P2|Overall Study|Lost to Follow-up|0
1571257|NCT02908347|5438412|P1|Overall Study|Lost to Follow-up|1
1571258|NCT02908347|5438411|P2|Overall Study|Adverse Event|1
1571259|NCT02908347|5438412|P1|Overall Study|Adverse Event|0
1571260|NCT02907892|5438507|P2|Overall Study|Lost to Follow-up|40
1571261|NCT02907892|5438508|P1|Overall Study|Lost to Follow-up|27
1571262|NCT02907619|5438528|P3|Overall Study|Other|0
1571263|NCT02907619|5438529|P2|Overall Study|Other|1
1571264|NCT02907619|5438530|P1|Overall Study|Other|0
1571265|NCT02907619|5438528|P3|Overall Study|Withdrawal by Subject|0
1571266|NCT02907619|5438529|P2|Overall Study|Withdrawal by Subject|1
1571267|NCT02907619|5438530|P1|Overall Study|Withdrawal by Subject|1
1571268|NCT02907619|5438528|P3|Overall Study|Death|1
1571269|NCT02907619|5438529|P2|Overall Study|Death|0
1571270|NCT02907619|5438530|P1|Overall Study|Death|0
1571271|NCT02907619|5438528|P3|Overall Study|Study terminated by sponsor|19
1571272|NCT02907619|5438529|P2|Overall Study|Study terminated by sponsor|18
1571273|NCT02907619|5438530|P1|Overall Study|Study terminated by sponsor|18
1571274|NCT02907463|5438746|P1|Overall Study|Missing Exit Form|1
1571275|NCT02907463|5438746|P1|Overall Study|Device Explanted|1
1571276|NCT02907463|5438746|P1|Overall Study|Not Implanted with Study Device|2
1571277|NCT02907463|5438746|P1|Overall Study|MIS Approach was not used|2
1571278|NCT02907463|5438746|P1|Overall Study|Withdrawal by Subject|4
1571279|NCT02907463|5438746|P1|Overall Study|Death|10
1571280|NCT02907463|5438746|P1|Overall Study|Lost to Follow-up|17
1571281|NCT02907216|5438828|P2|Overall Study|Withdrawal by Subject|0
1571282|NCT02907216|5438829|P1|Overall Study|Withdrawal by Subject|1
1571283|NCT02907216|5438828|P2|Overall Study|No benefit to be obtained by continuing|1
1571284|NCT02907216|5438829|P1|Overall Study|No benefit to be obtained by continuing|0
1571301|NCT02906917|5439077|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
1571302|NCT02906917|5439078|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
1571303|NCT02906917|5439077|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
1571304|NCT02906917|5439078|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
1571305|NCT02906917|5439077|P2|Intensification Period (Week 26-38)|Adverse Event|2
1571306|NCT02906917|5439078|P1|Intensification Period (Week 26-38)|Adverse Event|0
1571307|NCT02906917|5439077|P2|Intensification Period (Week 26-38)|Unclassified|2
1571308|NCT02906917|5439078|P1|Intensification Period (Week 26-38)|Unclassified|3
1571309|NCT02906917|5439077|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
1571310|NCT02906917|5439078|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
1571311|NCT02906917|5439077|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
1571312|NCT02906917|5439078|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
1571313|NCT02906917|5439077|P2|Initiation Period (Week 0-26)|Adverse Event|0
1571314|NCT02906917|5439078|P1|Initiation Period (Week 0-26)|Adverse Event|1
1571315|NCT02906917|5439077|P2|Initiation Period (Week 0-26)|Unclassified|3
1571316|NCT02906917|5439078|P1|Initiation Period (Week 0-26)|Unclassified|1
1571317|NCT02906709|5439139|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
1571318|NCT02906709|5439140|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
1571319|NCT02906709|5439139|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
1571320|NCT02906709|5439140|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
1571321|NCT02906709|5439139|P2|Phase A (Week 0 to Week 16)|Death|1
1571322|NCT02906709|5439140|P1|Phase A (Week 0 to Week 16)|Death|0
1571323|NCT02906709|5439139|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
1571324|NCT02906709|5439140|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
1571325|NCT02906644|5439174|P2|Weeks 3 to 14|Lost to Follow-up|4
1571326|NCT02906644|5439175|P1|Weeks 3 to 14|Lost to Follow-up|3
1571327|NCT02906644|5439174|P2|Weeks 3 to 14|Withdrawal by Subject|7
1571328|NCT02906644|5439175|P1|Weeks 3 to 14|Withdrawal by Subject|13
1571329|NCT02906644|5439174|P2|First 2 Weeks|Physician Decision|1
1571330|NCT02906644|5439175|P1|First 2 Weeks|Physician Decision|1
1571331|NCT02906644|5439174|P2|First 2 Weeks|Withdrawal by Subject|2
1571332|NCT02906644|5439175|P1|First 2 Weeks|Withdrawal by Subject|0
1571333|NCT02906358|5439210|P2|Overall Study|Lost to Follow-up|15
1571334|NCT02906358|5439211|P1|Overall Study|Lost to Follow-up|12
1571335|NCT02906358|5439210|P2|Overall Study|Withdrawal by Subject|7
1571336|NCT02906358|5439211|P1|Overall Study|Withdrawal by Subject|10
1571337|NCT02905825|5439239|P1|Overall Study|Device Malfunction|1
1571338|NCT02905825|5439239|P1|Overall Study|Protocol Violation|11
1571339|NCT02905331|5439247|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
1571340|NCT02905331|5439248|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
1571341|NCT02905331|5439249|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
1571342|NCT02905331|5439247|P3|Active Treatment and Follow up (wk16-40)|Other|0
1571343|NCT02905331|5439248|P2|Active Treatment and Follow up (wk16-40)|Other|6
1571344|NCT02905331|5439249|P1|Active Treatment and Follow up (wk16-40)|Other|0
1571345|NCT02905331|5439247|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
1571346|NCT02905331|5439248|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
1571347|NCT02905331|5439249|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
1571348|NCT02905331|5439247|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
1571349|NCT02905331|5439248|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
1571350|NCT02905331|5439249|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
1571351|NCT02905331|5439247|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
1571352|NCT02905331|5439248|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
1571353|NCT02905331|5439249|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
1571354|NCT02905266|5439277|P2|Maintenance Phase Part 2|Not Reported|17
1571355|NCT02905266|5439278|P1|Maintenance Phase Part 2|Not Reported|10
1571356|NCT02905266|5439277|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|1
1571357|NCT02905266|5439278|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
1571358|NCT02905266|5439277|P2|Maintenance Phase Part 2|Study Drug Toxicity|2
1571359|NCT02905266|5439278|P1|Maintenance Phase Part 2|Study Drug Toxicity|1
1571360|NCT02905266|5439277|P2|Maintenance Phase Part 2|Disease Progression|2
1571361|NCT02905266|5439278|P1|Maintenance Phase Part 2|Disease Progression|8
1571362|NCT02905266|5439277|P2|Treatment Period Part 1|Maximum Clinical Benefit|1
1571363|NCT02905266|5439278|P1|Treatment Period Part 1|Maximum Clinical Benefit|0
1571364|NCT02905266|5439277|P2|Treatment Period Part 1|Study Drug Toxicity|15
1571365|NCT02905266|5439278|P1|Treatment Period Part 1|Study Drug Toxicity|22
1571366|NCT02905266|5439277|P2|Treatment Period Part 1|Disease Progression|7
1571367|NCT02905266|5439278|P1|Treatment Period Part 1|Disease Progression|6
1571368|NCT02905266|5439277|P2|Treatment Period Part 1|Subject Withdrew Consent|0
1571369|NCT02905266|5439278|P1|Treatment Period Part 1|Subject Withdrew Consent|1
1571370|NCT02904902|5439311|P1|Overall Study|Withdrawal by Subject|1
1571371|NCT02904096|5439324|P2|Overall Study|Sponsor instructed|0
1571372|NCT02904096|5439325|P1|Overall Study|Sponsor instructed|1
1571373|NCT02904096|5439324|P2|Overall Study|Non-compliant|1
1571374|NCT02904096|5439325|P1|Overall Study|Non-compliant|3
1571375|NCT02904096|5439324|P2|Overall Study|Lost to Follow-up|17
1571376|NCT02904096|5439325|P1|Overall Study|Lost to Follow-up|10
1571377|NCT02904096|5439324|P2|Overall Study|Withdrawal by Subject|3
1571378|NCT02904096|5439325|P1|Overall Study|Withdrawal by Subject|4
1571379|NCT02904096|5439324|P2|Overall Study|Adverse Event|0
1571380|NCT02904096|5439325|P1|Overall Study|Adverse Event|1
1571381|NCT02903238|5439378|P1|Overall Study|Lost to Follow-up|4
1571382|NCT02903030|5439389|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
1571383|NCT02903030|5439390|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
1571384|NCT02902965|5439408|P1|Overall Study|Withdrawal by Subject|10
1571385|NCT02902809|5439425|P1|Overall Study|Discontinuation of asthma program|28
1571386|NCT02901054|5439480|P1|Overall Study|Withdrawal by Subject|3
1571387|NCT02901054|5439480|P1|Overall Study|Physician Decision|1
1571388|NCT02900378|5439495|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
1571389|NCT02900378|5439496|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
1571390|NCT02900378|5439495|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
1571391|NCT02900378|5439496|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
1571392|NCT02900378|5439495|P2|Randomization (Visit 2)|Protocol Deviation|7
1571393|NCT02900378|5439496|P1|Randomization (Visit 2)|Protocol Deviation|1
1571394|NCT02900378|5439495|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
1571395|NCT02900378|5439496|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
1571396|NCT02900378|5439495|P2|Randomization (Visit 2)|Lost to Follow-up|0
1571397|NCT02900378|5439496|P1|Randomization (Visit 2)|Lost to Follow-up|1
1571398|NCT02900378|5439495|P2|Randomization (Visit 2)|Death|4
1571399|NCT02900378|5439496|P1|Randomization (Visit 2)|Death|1
1571400|NCT02900378|5439495|P2|Randomization (Visit 2)|Adverse Event|11
1571401|NCT02900378|5439496|P1|Randomization (Visit 2)|Adverse Event|14
1571402|NCT02900092|5439540|P1|Overall Study|Adverse Event|1
1571403|NCT02899377|5439558|P2|Overall Study|Adverse Event|0
1571404|NCT02899377|5439559|P1|Overall Study|Adverse Event|1
1571405|NCT02899338|5439592|P2|Overall Study|Withdrawal by Subject|0
1571406|NCT02899338|5439593|P1|Overall Study|Withdrawal by Subject|2
1571407|NCT02899338|5439592|P2|Overall Study|Adverse Event|2
1571408|NCT02899338|5439593|P1|Overall Study|Adverse Event|1
1571409|NCT02898662|5439629|P2|Overall Study|Other|1
1571410|NCT02898662|5439630|P1|Overall Study|Other|0
1571411|NCT02898662|5439629|P2|Overall Study|Subject decision|0
1571412|NCT02898662|5439630|P1|Overall Study|Subject decision|1
1571413|NCT02898662|5439629|P2|Overall Study|Randomized in error|1
1571414|NCT02898662|5439630|P1|Overall Study|Randomized in error|0
1571415|NCT02898662|5439629|P2|Overall Study|Technical issue|1
1571416|NCT02898662|5439630|P1|Overall Study|Technical issue|0
1571417|NCT02898662|5439629|P2|Overall Study|Withdrawal by Subject|1
1571418|NCT02898662|5439630|P1|Overall Study|Withdrawal by Subject|4
1571419|NCT02898662|5439629|P2|Overall Study|Loss of asthma control|24
1571420|NCT02898662|5439630|P1|Overall Study|Loss of asthma control|23
1571421|NCT02898662|5439629|P2|Overall Study|Adverse Event|0
1571422|NCT02898662|5439630|P1|Overall Study|Adverse Event|1
1571423|NCT02898597|5439654|P2|Overall Study|Death|1
1571424|NCT02898597|5439655|P1|Overall Study|Death|0
1571425|NCT02898597|5439654|P2|Overall Study|Lost to Follow-up|9
1571426|NCT02898597|5439655|P1|Overall Study|Lost to Follow-up|0
1571427|NCT02898597|5439654|P2|Overall Study|Protocol Violation|2
1571428|NCT02898597|5439655|P1|Overall Study|Protocol Violation|4
1571429|NCT02898454|5439664|P3|Overall Study|Did Not Met Eligibility Criteria|0
1571430|NCT02898454|5439665|P2|Overall Study|Did Not Met Eligibility Criteria|0
1571431|NCT02898454|5439666|P1|Overall Study|Did Not Met Eligibility Criteria|1
1571432|NCT02898454|5439664|P3|Overall Study|Lost to Follow-up|0
1571433|NCT02898454|5439665|P2|Overall Study|Lost to Follow-up|0
1571434|NCT02898454|5439666|P1|Overall Study|Lost to Follow-up|1
1571435|NCT02898454|5439664|P3|Overall Study|Withdrawal by Subject|3
1571436|NCT02898454|5439665|P2|Overall Study|Withdrawal by Subject|3
1571437|NCT02898454|5439666|P1|Overall Study|Withdrawal by Subject|6
1571438|NCT02898454|5439664|P3|Overall Study|Lack of Efficacy|0
1571439|NCT02898454|5439665|P2|Overall Study|Lack of Efficacy|1
1571440|NCT02898454|5439666|P1|Overall Study|Lack of Efficacy|4
1571441|NCT02898454|5439664|P3|Overall Study|Protocol Violation|1
1571442|NCT02898454|5439665|P2|Overall Study|Protocol Violation|0
1571443|NCT02898454|5439666|P1|Overall Study|Protocol Violation|1
1571444|NCT02898454|5439664|P3|Overall Study|Adverse Event|2
1571445|NCT02898454|5439665|P2|Overall Study|Adverse Event|1
1571446|NCT02898454|5439666|P1|Overall Study|Adverse Event|4
1571447|NCT02898116|5439779|P1|Overall Study|Progressive disease|1
1571448|NCT02898116|5439779|P1|Overall Study|Adverse Event|1
1571449|NCT02897349|5439787|P2|Overall Study|Other than listed above|1
1571450|NCT02897349|5439788|P1|Overall Study|Other than listed above|0
1571451|NCT02897349|5439787|P2|Overall Study|Adverse Event|3
1571452|NCT02897349|5439788|P1|Overall Study|Adverse Event|3
1571453|NCT02897349|5439787|P2|Overall Study|Lost to Follow-up|2
1571454|NCT02897349|5439788|P1|Overall Study|Lost to Follow-up|2
1571455|NCT02897115|5439830|P2|Overall Study|Early termination of study by sponsor|8
1571456|NCT02897115|5439831|P1|Overall Study|Early termination of study by sponsor|11
1571457|NCT02896855|5439908|P2|Overall Study|Withdrawal by Subject|1
1571458|NCT02896855|5439909|P1|Overall Study|Withdrawal by Subject|1
1571459|NCT02896855|5439908|P2|Overall Study|Lost to Follow-up|0
1571460|NCT02896855|5439909|P1|Overall Study|Lost to Follow-up|5
1571461|NCT02896855|5439908|P2|Overall Study|Death|12
1571462|NCT02896855|5439909|P1|Overall Study|Death|13
1571463|NCT02896855|5439908|P2|Overall Study|In Follow-Up|49
1571464|NCT02896855|5439909|P1|Overall Study|In Follow-Up|61
1571465|NCT02896855|5439908|P2|Overall Study|On Study Treatment|60
1571466|NCT02896855|5439909|P1|Overall Study|On Study Treatment|41
1571467|NCT02896361|5439990|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
1571468|NCT02896361|5439991|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
1571469|NCT02896361|5439992|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
1571470|NCT02896361|5439990|P3|Third Intervention (2 Weeks)|Protocol Violation|0
1571471|NCT02896361|5439991|P2|Third Intervention (2 Weeks)|Protocol Violation|0
1571472|NCT02896361|5439992|P1|Third Intervention (2 Weeks)|Protocol Violation|1
1571473|NCT02896296|5440010|P1|Overall Study|Relocation|1
1571474|NCT02896296|5440010|P1|Overall Study|Incarceration|1
1571475|NCT02896296|5440010|P1|Overall Study|Site closing|7
1571476|NCT02896296|5440010|P1|Overall Study|Withdrawal by Subject|10
1571477|NCT02896296|5440010|P1|Overall Study|Physician Decision|2
1571478|NCT02896296|5440010|P1|Overall Study|Pregnancy|1
1571479|NCT02896296|5440010|P1|Overall Study|Lost to Follow-up|19
1571480|NCT02896296|5440010|P1|Overall Study|Adverse Event|1
1571481|NCT02895347|5440018|P2|Overall Study|Withdrawal by Subject|1
1571482|NCT02895347|5440019|P1|Overall Study|Withdrawal by Subject|3
1571483|NCT02895295|5440031|P3|Overall Study|Survey Non-response|92
1571484|NCT02895295|5440032|P2|Overall Study|Survey Non-response|94
1571485|NCT02895295|5440033|P1|Overall Study|Survey Non-response|71
1571486|NCT02894840|5440067|P4|Overall Study|Lost to Follow-up|0
1571487|NCT02894840|5440068|P3|Overall Study|Lost to Follow-up|3
1571488|NCT02894840|5440069|P2|Overall Study|Lost to Follow-up|0
1571489|NCT02894840|5440070|P1|Overall Study|Lost to Follow-up|1
1571490|NCT02892734|5440342|P1|Follow up for 2 Years|Study closed early|1
1571491|NCT02892734|5440342|P1|Follow up for 2 Years|Death|2
1571492|NCT02892734|5440342|P1|Treatment on Study|Progressive Disease|2
1571493|NCT02892513|5440348|P2|Overall Study|Withdrawal by Subject|1
1571494|NCT02892513|5440349|P1|Overall Study|Withdrawal by Subject|0
1571495|NCT02892409|5440357|P2|Overall Study|Withdrawal by Subject|1
1571496|NCT02892409|5440358|P1|Overall Study|Withdrawal by Subject|2
1571497|NCT02892409|5440357|P2|Overall Study|Adverse Event|0
1571498|NCT02892409|5440358|P1|Overall Study|Adverse Event|1
1571499|NCT02892344|5440380|P2|Overall Study|Technical problems|1
1571500|NCT02892344|5440381|P1|Overall Study|Technical problems|0
1571501|NCT02892344|5440380|P2|Overall Study|Subject/guardian decision|4
1571502|NCT02892344|5440381|P1|Overall Study|Subject/guardian decision|0
1571503|NCT02892344|5440380|P2|Overall Study|Physician Decision|2
1571504|NCT02892344|5440381|P1|Overall Study|Physician Decision|0
1571505|NCT02892344|5440380|P2|Overall Study|Non-compliance with study treatment|1
1571506|NCT02892344|5440381|P1|Overall Study|Non-compliance with study treatment|0
1571507|NCT02892344|5440380|P2|Overall Study|Lost to Follow-up|1
1571508|NCT02892344|5440381|P1|Overall Study|Lost to Follow-up|0
1571509|NCT02892344|5440380|P2|Overall Study|Adverse Event|8
1571510|NCT02892344|5440381|P1|Overall Study|Adverse Event|1
1571511|NCT02892344|5440380|P2|Overall Study|Protocol deviation|4
1571512|NCT02892344|5440381|P1|Overall Study|Protocol deviation|3
1571513|NCT02892019|5440430|P2|Overall Study|Adverse Event|1
1571514|NCT02892019|5440431|P1|Overall Study|Adverse Event|1
1571515|NCT02892019|5440430|P2|Overall Study|Withdrawal by Subject|1
1571516|NCT02892019|5440431|P1|Overall Study|Withdrawal by Subject|0
1571517|NCT02892019|5440430|P2|Overall Study|randomized but not treated|1
1571518|NCT02892019|5440431|P1|Overall Study|randomized but not treated|0
1571519|NCT02891174|5440471|P2|Second Intervention (24 Hours)|Protocol Violation|1
1571520|NCT02891174|5440472|P1|Second Intervention (24 Hours)|Protocol Violation|0
1571521|NCT02891174|5440471|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
1571522|NCT02891174|5440472|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
1571523|NCT02891174|5440471|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
1571524|NCT02891174|5440472|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
1571525|NCT02891174|5440471|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
1571526|NCT02891174|5440472|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
1571527|NCT02891174|5440471|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
1571528|NCT02891174|5440472|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
1571529|NCT02891174|5440471|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
1571530|NCT02891174|5440472|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
1571531|NCT02891174|5440471|P2|First Intervention (24 Hours)|Declined any study medication|5
1571532|NCT02891174|5440472|P1|First Intervention (24 Hours)|Declined any study medication|1
1571533|NCT02891070|5440486|P2|Overall Study|Death|0
1571534|NCT02891070|5440487|P1|Overall Study|Death|3
1571535|NCT02891070|5440486|P2|Overall Study|Withdrawal by Subject|2
1571536|NCT02891070|5440487|P1|Overall Study|Withdrawal by Subject|1
1571537|NCT02891070|5440486|P2|Overall Study|Protocol Violation|1
1571538|NCT02891070|5440487|P1|Overall Study|Protocol Violation|0
1571539|NCT02891070|5440486|P2|Overall Study|Other|0
1571540|NCT02891070|5440487|P1|Overall Study|Other|1
1571541|NCT02891070|5440486|P2|Overall Study|Lost to Follow-up|4
1571542|NCT02891070|5440487|P1|Overall Study|Lost to Follow-up|4
1571543|NCT02891070|5440486|P2|Overall Study|Physician Decision|1
1571544|NCT02891070|5440487|P1|Overall Study|Physician Decision|0
1571545|NCT02891070|5440486|P2|Overall Study|Adverse Event|0
1571546|NCT02891070|5440487|P1|Overall Study|Adverse Event|1
1571547|NCT02890992|5440513|P8|130 Weeks Open-Label Extension Period|Other than specified|0
1571548|NCT02890992|5440514|P7|130 Weeks Open-Label Extension Period|Other than specified|0
1571549|NCT02890992|5440515|P6|130 Weeks Open-Label Extension Period|Other than specified|0
1571550|NCT02890992|5440516|P5|130 Weeks Open-Label Extension Period|Other than specified|0
1571551|NCT02890992|5440517|P4|130 Weeks Open-Label Extension Period|Other than specified|0
1571552|NCT02890992|5440518|P3|130 Weeks Open-Label Extension Period|Other than specified|0
1571553|NCT02890992|5440519|P2|130 Weeks Open-Label Extension Period|Other than specified|2
1571554|NCT02890992|5440520|P1|130 Weeks Open-Label Extension Period|Other than specified|0
1571555|NCT02890992|5440513|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
1571556|NCT02890992|5440514|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
1571557|NCT02890992|5440515|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
1571558|NCT02890992|5440516|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
1571559|NCT02890992|5440517|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
1571560|NCT02890992|5440518|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
1571561|NCT02890992|5440519|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
1571562|NCT02890992|5440520|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
1571563|NCT02890992|5440513|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
1571564|NCT02890992|5440514|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
1571565|NCT02890992|5440515|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
1571566|NCT02890992|5440516|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
1571567|NCT02890992|5440517|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
1571568|NCT02890992|5440518|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
1571569|NCT02890992|5440519|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
1571570|NCT02890992|5440520|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
1571571|NCT02888756|5440731|P3|Analytical Treatment Interruption|Physician Decision|5
1571572|NCT02888756|5440732|P2|Analytical Treatment Interruption|Physician Decision|6
1571573|NCT02888756|5440733|P1|Analytical Treatment Interruption|Physician Decision|10
1571574|NCT02887989|5440789|P2|Overall Study|Death|0
1571575|NCT02887989|5440790|P1|Overall Study|Death|1
1571576|NCT02887989|5440789|P2|Overall Study|Withdrawal by Subject|11
1571577|NCT02887989|5440790|P1|Overall Study|Withdrawal by Subject|8
1571578|NCT02887183|5440800|P1|Overall Study|Withdrawal by Subject|35
1571579|NCT02887183|5440800|P1|Overall Study|Physician Decision|10
1571580|NCT02887183|5440800|P1|Overall Study|Lost to Follow-up|13
1571581|NCT02887183|5440800|P1|Overall Study|Technical Problems|2
1571582|NCT02887183|5440800|P1|Overall Study|Protocol Violation|6
1571583|NCT02887183|5440800|P1|Overall Study|Pregnancy|1
1571584|NCT02887183|5440800|P1|Overall Study|Death|30
1571585|NCT02887183|5440800|P1|Overall Study|Adverse Event|44
1571586|NCT02886715|5440827|P3|Overall Study|missing|2
1571587|NCT02886715|5440828|P2|Overall Study|missing|2
1571588|NCT02886715|5440829|P1|Overall Study|missing|7
1571589|NCT02886715|5440827|P3|Overall Study|Withdrawal by Subject|5
1571590|NCT02886715|5440828|P2|Overall Study|Withdrawal by Subject|18
1571591|NCT02886715|5440829|P1|Overall Study|Withdrawal by Subject|20
1571592|NCT02886715|5440827|P3|Overall Study|Protocol Violation|1
1571593|NCT02886715|5440828|P2|Overall Study|Protocol Violation|2
1571594|NCT02886715|5440829|P1|Overall Study|Protocol Violation|3
1571595|NCT02886715|5440827|P3|Overall Study|Pregnancy|1
1571596|NCT02886715|5440828|P2|Overall Study|Pregnancy|1
1571597|NCT02886715|5440829|P1|Overall Study|Pregnancy|1
1571598|NCT02886715|5440827|P3|Overall Study|Lost to Follow-up|10
1571599|NCT02886715|5440828|P2|Overall Study|Lost to Follow-up|26
1571600|NCT02886715|5440829|P1|Overall Study|Lost to Follow-up|29
1571601|NCT02886715|5440827|P3|Overall Study|Lack of Efficacy|1
1571602|NCT02886715|5440828|P2|Overall Study|Lack of Efficacy|2
1571603|NCT02886715|5440829|P1|Overall Study|Lack of Efficacy|0
1571604|NCT02886715|5440827|P3|Overall Study|Adverse Event|0
1571605|NCT02886715|5440828|P2|Overall Study|Adverse Event|2
1571606|NCT02886715|5440829|P1|Overall Study|Adverse Event|4
1571607|NCT02886715|5440827|P3|Overall Study|Non-Compliance With Study Drug|0
1571608|NCT02886715|5440828|P2|Overall Study|Non-Compliance With Study Drug|2
1571609|NCT02886715|5440829|P1|Overall Study|Non-Compliance With Study Drug|0
1571610|NCT02886702|5440846|P3|Overall Study|Administrative Reasons|1
1571611|NCT02886702|5440847|P2|Overall Study|Administrative Reasons|0
1571612|NCT02886702|5440848|P1|Overall Study|Administrative Reasons|0
1571613|NCT02886702|5440846|P3|Overall Study|Adverse Event|3
1571614|NCT02886702|5440847|P2|Overall Study|Adverse Event|9
1571615|NCT02886702|5440848|P1|Overall Study|Adverse Event|4
1571616|NCT02886702|5440846|P3|Overall Study|Lack of Efficacy|5
1571617|NCT02886702|5440847|P2|Overall Study|Lack of Efficacy|4
1571618|NCT02886702|5440848|P1|Overall Study|Lack of Efficacy|3
1571619|NCT02886702|5440846|P3|Overall Study|Lost to Follow-up|8
1571620|NCT02886702|5440847|P2|Overall Study|Lost to Follow-up|13
1571621|NCT02886702|5440848|P1|Overall Study|Lost to Follow-up|11
1571622|NCT02886702|5440846|P3|Overall Study|Non-Compliance With Study Drug|4
1571623|NCT02886702|5440847|P2|Overall Study|Non-Compliance With Study Drug|1
1571624|NCT02886702|5440848|P1|Overall Study|Non-Compliance With Study Drug|0
1571625|NCT02886702|5440846|P3|Overall Study|Protocol Violation|1
1571626|NCT02886702|5440847|P2|Overall Study|Protocol Violation|2
1571627|NCT02886702|5440848|P1|Overall Study|Protocol Violation|2
1571628|NCT02886702|5440846|P3|Overall Study|Significant Worsening of Condition|0
1571629|NCT02886702|5440847|P2|Overall Study|Significant Worsening of Condition|1
1571630|NCT02886702|5440848|P1|Overall Study|Significant Worsening of Condition|0
1571631|NCT02886702|5440846|P3|Overall Study|Withdrawal by Subject|22
1571632|NCT02886702|5440847|P2|Overall Study|Withdrawal by Subject|18
1571633|NCT02886702|5440848|P1|Overall Study|Withdrawal by Subject|24
1571634|NCT02886702|5440846|P3|Overall Study|Other|9
1571635|NCT02886702|5440847|P2|Overall Study|Other|3
1571636|NCT02886702|5440848|P1|Overall Study|Other|4
1571637|NCT02886624|5440862|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
1571638|NCT02886624|5440862|P1|12-week Post Treatment Follow-up|Death|1
1571639|NCT02886338|5440871|P1|Overall Study|Withdrawal by Subject|1
1571640|NCT02885181|5441048|P4|Overall Study|Withdrawal by Subject|1
1571641|NCT02885181|5441049|P3|Overall Study|Withdrawal by Subject|0
1571642|NCT02885181|5441050|P2|Overall Study|Withdrawal by Subject|0
1571643|NCT02885181|5441051|P1|Overall Study|Withdrawal by Subject|0
1571644|NCT02885181|5441048|P4|Overall Study|Adverse Event|1
1571645|NCT02885181|5441049|P3|Overall Study|Adverse Event|0
1571646|NCT02885181|5441050|P2|Overall Study|Adverse Event|0
1571647|NCT02885181|5441051|P1|Overall Study|Adverse Event|0
1571648|NCT02885181|5441048|P4|Overall Study|Investigator's Discretion|1
1571649|NCT02885181|5441049|P3|Overall Study|Investigator's Discretion|0
1571650|NCT02885181|5441050|P2|Overall Study|Investigator's Discretion|1
1571651|NCT02885181|5441051|P1|Overall Study|Investigator's Discretion|0
1571652|NCT02884089|5441118|P4|Follow-up Visit|Withdrawal by Subject|1
1571653|NCT02884089|5441119|P3|Follow-up Visit|Withdrawal by Subject|0
1571654|NCT02884089|5441120|P2|Follow-up Visit|Withdrawal by Subject|0
1571655|NCT02884089|5441121|P1|Follow-up Visit|Withdrawal by Subject|1
1571656|NCT02884089|5441118|P4|Period 4|Lost to Follow-up|0
1571657|NCT02884089|5441119|P3|Period 4|Lost to Follow-up|0
1571658|NCT02884089|5441120|P2|Period 4|Lost to Follow-up|0
1571659|NCT02884089|5441121|P1|Period 4|Lost to Follow-up|1
1571660|NCT02884089|5441118|P4|Period 4|Withdrawal by Subject|0
1571661|NCT02884089|5441119|P3|Period 4|Withdrawal by Subject|0
1571662|NCT02884089|5441120|P2|Period 4|Withdrawal by Subject|1
1571663|NCT02884089|5441121|P1|Period 4|Withdrawal by Subject|0
1571664|NCT02884089|5441118|P4|Washout Period 3|Lost to Follow-up|1
1571665|NCT02884089|5441119|P3|Washout Period 3|Lost to Follow-up|0
1571666|NCT02884089|5441120|P2|Washout Period 3|Lost to Follow-up|0
1571667|NCT02884089|5441121|P1|Washout Period 3|Lost to Follow-up|0
1571668|NCT02884089|5441118|P4|Washout Period 3|Withdrawal by Subject|0
1571669|NCT02884089|5441119|P3|Washout Period 3|Withdrawal by Subject|1
1571670|NCT02884089|5441120|P2|Washout Period 3|Withdrawal by Subject|0
1571671|NCT02884089|5441121|P1|Washout Period 3|Withdrawal by Subject|0
1571672|NCT02884089|5441118|P4|Period 3|Withdrawal by Subject|0
1571673|NCT02884089|5441119|P3|Period 3|Withdrawal by Subject|1
1571674|NCT02884089|5441120|P2|Period 3|Withdrawal by Subject|0
1571675|NCT02884089|5441121|P1|Period 3|Withdrawal by Subject|0
1571676|NCT02884089|5441118|P4|Period 2|Adverse Event|0
1571677|NCT02884089|5441119|P3|Period 2|Adverse Event|0
1571678|NCT02884089|5441120|P2|Period 2|Adverse Event|0
1571679|NCT02884089|5441121|P1|Period 2|Adverse Event|1
1571680|NCT02884089|5441118|P4|Washout Period 1|Withdrawal by Subject|0
1571681|NCT02884089|5441119|P3|Washout Period 1|Withdrawal by Subject|0
1571682|NCT02884089|5441120|P2|Washout Period 1|Withdrawal by Subject|1
1571683|NCT02884089|5441121|P1|Washout Period 1|Withdrawal by Subject|0
1571684|NCT02884089|5441118|P4|Washout Period 1|Lost to Follow-up|1
1571685|NCT02884089|5441119|P3|Washout Period 1|Lost to Follow-up|0
1571686|NCT02884089|5441120|P2|Washout Period 1|Lost to Follow-up|1
1571687|NCT02884089|5441121|P1|Washout Period 1|Lost to Follow-up|0
1571688|NCT02884089|5441118|P4|Period 1|Dosing error|0
1571689|NCT02884089|5441119|P3|Period 1|Dosing error|0
1571690|NCT02884089|5441120|P2|Period 1|Dosing error|2
1571691|NCT02884089|5441121|P1|Period 1|Dosing error|2
1571692|NCT02883244|5441137|P2|Overall Study|Lost to Follow-up|1
1571693|NCT02883244|5441138|P1|Overall Study|Lost to Follow-up|0
1571694|NCT02882854|5441156|P2|Overall Study|Physician Decision|1
1571695|NCT02882854|5441157|P1|Overall Study|Physician Decision|0
1571696|NCT02882854|5441156|P2|Overall Study|Lost to Follow-up|2
1571697|NCT02882854|5441157|P1|Overall Study|Lost to Follow-up|1
1571698|NCT02882152|5441194|P2|Overall Study|Lost to Follow-up|0
1571699|NCT02882152|5441195|P1|Overall Study|Lost to Follow-up|1
1571700|NCT02881567|5441265|P1|Overall Study|Reason not Specified|3
1571701|NCT02881567|5441265|P1|Overall Study|Study terminated by sponsor|9
1571702|NCT02881567|5441265|P1|Overall Study|Investigator decision|1
1571703|NCT02881567|5441265|P1|Overall Study|Consent withdrawn|1
1571704|NCT02881567|5441265|P1|Overall Study|Lost to Follow-up|3
1571705|NCT02881567|5441265|P1|Overall Study|Adverse Event|1
1571706|NCT02880761|5441353|P2|Overall Study|Lost to Follow-up|4
1571707|NCT02880761|5441354|P1|Overall Study|Lost to Follow-up|3
1571708|NCT02880761|5441353|P2|Overall Study|Protocol Violation|3
1571709|NCT02880761|5441354|P1|Overall Study|Protocol Violation|4
1571710|NCT02880761|5441353|P2|Overall Study|Withdrawal by Subject|6
1571711|NCT02880761|5441354|P1|Overall Study|Withdrawal by Subject|3
1571712|NCT02880761|5441353|P2|Overall Study|Death|8
1571713|NCT02880761|5441354|P1|Overall Study|Death|6
1571714|NCT02878590|5441563|P1|Overall Study|Withdrawal by Subject|2
1571715|NCT02878330|5441588|P2|Overall Study|Other|7
1571716|NCT02878330|5441589|P1|Overall Study|Other|4
1571717|NCT02878330|5441588|P2|Overall Study|Withdrawal by Subject|21
1571718|NCT02878330|5441589|P1|Overall Study|Withdrawal by Subject|11
1571719|NCT02878330|5441588|P2|Overall Study|Lost to Follow-up|26
1571720|NCT02878330|5441589|P1|Overall Study|Lost to Follow-up|11
1571721|NCT02878330|5441588|P2|Overall Study|Death|2
1571722|NCT02878330|5441589|P1|Overall Study|Death|3
1571723|NCT02878213|5441605|P1|Overall Study|Adverse Event|1
1571724|NCT02878213|5441605|P1|Overall Study|Withdrawal by Subject|2
1571725|NCT02877927|5441612|P2|Overall Study|Missed EOT/PTE Visit|6
1571726|NCT02877927|5441613|P1|Overall Study|Missed EOT/PTE Visit|5
1571727|NCT02877927|5441612|P2|Overall Study|Physician Decision|1
1571728|NCT02877927|5441613|P1|Overall Study|Physician Decision|0
1571729|NCT02877927|5441612|P2|Overall Study|Withdrawal by Subject|12
1571730|NCT02877927|5441613|P1|Overall Study|Withdrawal by Subject|11
1571731|NCT02877927|5441612|P2|Overall Study|Lost to Follow-up|38
1571732|NCT02877927|5441613|P1|Overall Study|Lost to Follow-up|37
1571733|NCT02877927|5441612|P2|Overall Study|Adverse Event|0
1571734|NCT02877927|5441613|P1|Overall Study|Adverse Event|1
1571735|NCT02877082|5441651|P1|Overall Study|Trial was closed early|5
1571736|NCT02877004|5441662|P3|Overall Study|Pregnancy|1
1571737|NCT02877004|5441663|P2|Overall Study|Pregnancy|0
1571738|NCT02877004|5441664|P1|Overall Study|Pregnancy|0
1571823|NCT02873221|5442138|P2|Safety Follow-up Period|Lost to Follow-up|5
1571739|NCT02876601|5441711|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
1571740|NCT02876601|5441712|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
1571741|NCT02876601|5441713|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
1571742|NCT02876601|5441714|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
1571743|NCT02875977|5441812|P2|Overall Study|Lost to Follow-up|29
1571744|NCT02875977|5441813|P1|Overall Study|Lost to Follow-up|42
1571745|NCT02875613|5441827|P1|Overall Study|Withdrawal by Subject|1
1571746|NCT02875366|5441833|P2|Overall Study|Noncompliance|1
1571747|NCT02875366|5441834|P1|Overall Study|Noncompliance|0
1571748|NCT02875366|5441833|P2|Overall Study|Adverse Event|2
1571749|NCT02875366|5441834|P1|Overall Study|Adverse Event|0
1571750|NCT02875340|5441886|P1|Overall Study|Adverse Event|1
1571751|NCT02875340|5441886|P1|Overall Study|Physician Decision|3
1571752|NCT02875340|5441886|P1|Overall Study|Withdrawal by Subject|2
1571753|NCT02875340|5441886|P1|Overall Study|Death|2
1571754|NCT02875028|5441910|P2|Washout Period|Withdrawal by Subject|1
1571755|NCT02875028|5441911|P1|Washout Period|Withdrawal by Subject|0
1571756|NCT02874924|5441942|P3|Overall Study|Withdrawal by Subject|0
1571757|NCT02874924|5441943|P2|Overall Study|Withdrawal by Subject|0
1571758|NCT02874924|5441944|P1|Overall Study|Withdrawal by Subject|1
1571759|NCT02874924|5441942|P3|Overall Study|Adverse Event|0
1571760|NCT02874924|5441943|P2|Overall Study|Adverse Event|0
1571761|NCT02874924|5441944|P1|Overall Study|Adverse Event|2
1571762|NCT02874742|5441978|P3|Overall Study|Ongoing|15
1571763|NCT02874742|5441979|P2|Overall Study|Ongoing|98
1571764|NCT02874742|5441980|P1|Overall Study|Ongoing|87
1571765|NCT02874742|5441978|P3|Overall Study|Other|0
1571766|NCT02874742|5441979|P2|Overall Study|Other|1
1571767|NCT02874742|5441980|P1|Overall Study|Other|3
1571768|NCT02874742|5441978|P3|Overall Study|Withdrawal by Subject|0
1571769|NCT02874742|5441979|P2|Overall Study|Withdrawal by Subject|4
1571770|NCT02874742|5441980|P1|Overall Study|Withdrawal by Subject|8
1571771|NCT02874742|5441978|P3|Overall Study|Lost to Follow-up|0
1571772|NCT02874742|5441979|P2|Overall Study|Lost to Follow-up|0
1571773|NCT02874742|5441980|P1|Overall Study|Lost to Follow-up|2
1571774|NCT02874742|5441978|P3|Overall Study|Death|1
1571775|NCT02874742|5441979|P2|Overall Study|Death|1
1571776|NCT02874742|5441980|P1|Overall Study|Death|3
1571777|NCT02873754|5442040|P1|Overall Study|Couldn't complete study procedures|1
1571778|NCT02873754|5442040|P1|Overall Study|Lost to Follow-up|5
1571779|NCT02873702|5442057|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
1571780|NCT02873702|5442058|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
1571781|NCT02873702|5442059|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
1571782|NCT02873702|5442060|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
1571783|NCT02873702|5442057|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
1571784|NCT02873702|5442058|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
1571785|NCT02873702|5442059|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
1571786|NCT02873702|5442060|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
1571787|NCT02873702|5442057|P4|Maintenance Period (up to Month 6)|Adverse Event|0
1571788|NCT02873702|5442058|P3|Maintenance Period (up to Month 6)|Adverse Event|1
1571789|NCT02873702|5442059|P2|Maintenance Period (up to Month 6)|Adverse Event|0
1571790|NCT02873702|5442060|P1|Maintenance Period (up to Month 6)|Adverse Event|0
1571791|NCT02873702|5442057|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
1571792|NCT02873702|5442058|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
1571793|NCT02873702|5442059|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
1571794|NCT02873702|5442060|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
1571795|NCT02873702|5442057|P4|Healing Period (up to Week 8)|Adverse Event|0
1571796|NCT02873702|5442058|P3|Healing Period (up to Week 8)|Adverse Event|0
1571797|NCT02873702|5442059|P2|Healing Period (up to Week 8)|Adverse Event|0
1571798|NCT02873702|5442060|P1|Healing Period (up to Week 8)|Adverse Event|1
1571799|NCT02873689|5442072|P2|Overall Study|Randomized but not Treated|1
1571800|NCT02873689|5442073|P1|Overall Study|Randomized but not Treated|1
1571801|NCT02873689|5442072|P2|Overall Study|Adverse Event|2
1571802|NCT02873689|5442073|P1|Overall Study|Adverse Event|2
1571803|NCT02873689|5442072|P2|Overall Study|Protocol Violation|0
1571804|NCT02873689|5442073|P1|Overall Study|Protocol Violation|1
1571805|NCT02873689|5442072|P2|Overall Study|Withdrawal by Subject|2
1571806|NCT02873689|5442073|P1|Overall Study|Withdrawal by Subject|2
1571807|NCT02873689|5442072|P2|Overall Study|Lack of Efficacy|0
1571808|NCT02873689|5442073|P1|Overall Study|Lack of Efficacy|1
1571809|NCT02873429|5442101|P2|16 Weeks|Lost to Follow-up|0
1571810|NCT02873429|5442102|P1|16 Weeks|Lost to Follow-up|3
1571811|NCT02873429|5442101|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
1571812|NCT02873429|5442102|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
1571813|NCT02873429|5442101|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
1571814|NCT02873429|5442102|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
1571815|NCT02873377|5442114|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
1571816|NCT02873377|5442115|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
1571817|NCT02873377|5442114|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
1571818|NCT02873377|5442115|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
1571819|NCT02873221|5442137|P3|Safety Follow-up Period|Withdrawal of Consent|8
1571820|NCT02873221|5442138|P2|Safety Follow-up Period|Withdrawal of Consent|10
1571821|NCT02873221|5442139|P1|Safety Follow-up Period|Withdrawal of Consent|4
1571822|NCT02873221|5442137|P3|Safety Follow-up Period|Lost to Follow-up|5
1571824|NCT02873221|5442139|P1|Safety Follow-up Period|Lost to Follow-up|3
1571825|NCT02873221|5442137|P3|Safety Follow-up Period|Protocol Violation|1
1571826|NCT02873221|5442138|P2|Safety Follow-up Period|Protocol Violation|0
1571827|NCT02873221|5442139|P1|Safety Follow-up Period|Protocol Violation|0
1571828|NCT02873221|5442137|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
1571829|NCT02873221|5442138|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
1571830|NCT02873221|5442139|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
1571831|NCT02873221|5442137|P3|Treatment Period|Lost to Follow-up|26
1571832|NCT02873221|5442138|P2|Treatment Period|Lost to Follow-up|30
1571833|NCT02873221|5442139|P1|Treatment Period|Lost to Follow-up|26
1571834|NCT02873221|5442137|P3|Treatment Period|Adverse Event|11
1571835|NCT02873221|5442138|P2|Treatment Period|Adverse Event|9
1571836|NCT02873221|5442139|P1|Treatment Period|Adverse Event|4
1571837|NCT02873221|5442137|P3|Treatment Period|Lack of Efficacy|12
1571838|NCT02873221|5442138|P2|Treatment Period|Lack of Efficacy|17
1571839|NCT02873221|5442139|P1|Treatment Period|Lack of Efficacy|0
1571840|NCT02873221|5442137|P3|Treatment Period|Withdrawal of Consent|41
1571841|NCT02873221|5442138|P2|Treatment Period|Withdrawal of Consent|51
1571842|NCT02873221|5442139|P1|Treatment Period|Withdrawal of Consent|52
1571843|NCT02873221|5442137|P3|Treatment Period|Lack of Qualifying Event|1
1571844|NCT02873221|5442138|P2|Treatment Period|Lack of Qualifying Event|3
1571845|NCT02873221|5442139|P1|Treatment Period|Lack of Qualifying Event|0
1571846|NCT02873221|5442137|P3|Treatment Period|Pregnancy|3
1571847|NCT02873221|5442138|P2|Treatment Period|Pregnancy|6
1571848|NCT02873221|5442139|P1|Treatment Period|Pregnancy|4
1571849|NCT02873221|5442137|P3|Treatment Period|Protocol Violation|8
1571850|NCT02873221|5442138|P2|Treatment Period|Protocol Violation|5
1571851|NCT02873221|5442139|P1|Treatment Period|Protocol Violation|2
1571852|NCT02873221|5442137|P3|Treatment Period|Non-Compliance with Study Drug|2
1571853|NCT02873221|5442138|P2|Treatment Period|Non-Compliance with Study Drug|3
1571854|NCT02873221|5442139|P1|Treatment Period|Non-Compliance with Study Drug|0
1571855|NCT02873221|5442137|P3|Treatment Period|Other Miscellaneous Reasons|1
1571856|NCT02873221|5442138|P2|Treatment Period|Other Miscellaneous Reasons|2
1571857|NCT02873221|5442139|P1|Treatment Period|Other Miscellaneous Reasons|0
1571858|NCT02873195|5442161|P2|Overall Study|Ineligible|0
1571859|NCT02873195|5442162|P1|Overall Study|Ineligible|5
1571860|NCT02872311|5442209|P5|Overall Study|Protocol Violation|0
1571861|NCT02872311|5442210|P4|Overall Study|Protocol Violation|0
1571862|NCT02872311|5442211|P3|Overall Study|Protocol Violation|1
1571863|NCT02872311|5442212|P2|Overall Study|Protocol Violation|2
1571864|NCT02872311|5442213|P1|Overall Study|Protocol Violation|0
1571865|NCT02872311|5442209|P5|Overall Study|Lost to Follow-up|0
1571866|NCT02872311|5442210|P4|Overall Study|Lost to Follow-up|0
1571867|NCT02872311|5442211|P3|Overall Study|Lost to Follow-up|0
1571868|NCT02872311|5442212|P2|Overall Study|Lost to Follow-up|0
1571869|NCT02872311|5442213|P1|Overall Study|Lost to Follow-up|2
1571870|NCT02872311|5442209|P5|Overall Study|Death|0
1571871|NCT02872311|5442210|P4|Overall Study|Death|0
1571872|NCT02872311|5442211|P3|Overall Study|Death|0
1571873|NCT02872311|5442212|P2|Overall Study|Death|0
1571874|NCT02872311|5442213|P1|Overall Study|Death|2
1571875|NCT02872285|5442274|P2|Overall Study|Discontinued due to back surgery|0
1571876|NCT02872285|5442275|P1|Overall Study|Discontinued due to back surgery|1
1571877|NCT02872285|5442274|P2|Overall Study|Lost to Follow-up|2
1571878|NCT02872285|5442275|P1|Overall Study|Lost to Follow-up|2
1571879|NCT02872285|5442274|P2|Overall Study|Withdrawal by Subject|0
1571880|NCT02872285|5442275|P1|Overall Study|Withdrawal by Subject|2
1571881|NCT02872012|5442321|P5|Overall Study|Withdrawal by Subject|0
1571882|NCT02872012|5442322|P4|Overall Study|Withdrawal by Subject|0
1571883|NCT02872012|5442323|P3|Overall Study|Withdrawal by Subject|0
1571884|NCT02872012|5442324|P2|Overall Study|Withdrawal by Subject|0
1571885|NCT02872012|5442325|P1|Overall Study|Withdrawal by Subject|1
1571886|NCT02871739|5442343|P4|Overall Study|Lost to Follow-up|2
1571887|NCT02871739|5442344|P3|Overall Study|Lost to Follow-up|0
1571888|NCT02871739|5442345|P2|Overall Study|Lost to Follow-up|2
1571889|NCT02871739|5442346|P1|Overall Study|Lost to Follow-up|3
1571890|NCT02871375|5442403|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
1571891|NCT02871375|5442404|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
1571892|NCT02869438|5442488|P2|Overall Study|Withdrawal by Subject|2
1571893|NCT02869438|5442489|P1|Overall Study|Withdrawal by Subject|1
1571894|NCT02869438|5442488|P2|Overall Study|Adverse Event|0
1571895|NCT02869438|5442489|P1|Overall Study|Adverse Event|1
1571896|NCT02869438|5442488|P2|Overall Study|Lost to Follow-up|0
1571897|NCT02869438|5442489|P1|Overall Study|Lost to Follow-up|1
1571898|NCT02868892|5442537|P1|Overall Study|Investigator left site and no follow-up|6
1571899|NCT02868554|5442546|P3|Overall Study|Lost to Follow-up|1
1571900|NCT02868554|5442547|P2|Overall Study|Lost to Follow-up|0
1571901|NCT02868554|5442548|P1|Overall Study|Lost to Follow-up|3
1571902|NCT02868216|5442583|P2|Overall Study|Withdrawal by Subject|5
1571903|NCT02868216|5442584|P1|Overall Study|Withdrawal by Subject|7
1571904|NCT02868216|5442583|P2|Overall Study|coronary artery bypass|0
1571905|NCT02868216|5442584|P1|Overall Study|coronary artery bypass|1
1571906|NCT02868216|5442583|P2|Overall Study|Death|1
1571907|NCT02868216|5442584|P1|Overall Study|Death|0
1571908|NCT02867995|5442592|P2|Overall Study|Lost to Follow-up|2
1571909|NCT02867995|5442593|P1|Overall Study|Lost to Follow-up|0
1571910|NCT02867995|5442592|P2|Overall Study|Withdrawal by Subject|1
1571911|NCT02867995|5442593|P1|Overall Study|Withdrawal by Subject|0
1571912|NCT02867709|5442612|P3|Safety Follow-up Period|Protocol Violation|1
1571913|NCT02867709|5442613|P2|Safety Follow-up Period|Protocol Violation|1
1571914|NCT02867709|5442614|P1|Safety Follow-up Period|Protocol Violation|0
1571915|NCT02867709|5442612|P3|Safety Follow-up Period|Pregnancy|0
1571916|NCT02867709|5442613|P2|Safety Follow-up Period|Pregnancy|1
1571917|NCT02867709|5442614|P1|Safety Follow-up Period|Pregnancy|0
1571918|NCT02867709|5442612|P3|Safety Follow-up Period|Lost to Follow-up|7
1571919|NCT02867709|5442613|P2|Safety Follow-up Period|Lost to Follow-up|5
1571920|NCT02867709|5442614|P1|Safety Follow-up Period|Lost to Follow-up|10
1571921|NCT02867709|5442612|P3|Safety Follow-up Period|Withdrawal of Consent|6
1571922|NCT02867709|5442613|P2|Safety Follow-up Period|Withdrawal of Consent|8
1571923|NCT02867709|5442614|P1|Safety Follow-up Period|Withdrawal of Consent|1
1571924|NCT02867709|5442612|P3|Treatment Period|Protocol Violation|3
1571925|NCT02867709|5442613|P2|Treatment Period|Protocol Violation|2
1571926|NCT02867709|5442614|P1|Treatment Period|Protocol Violation|3
1571927|NCT02867709|5442612|P3|Treatment Period|Lack of Qualifying Event|42
1571928|NCT02867709|5442613|P2|Treatment Period|Lack of Qualifying Event|55
1571929|NCT02867709|5442614|P1|Treatment Period|Lack of Qualifying Event|42
1571930|NCT02867709|5442612|P3|Treatment Period|Lost to Follow-up|20
1571931|NCT02867709|5442613|P2|Treatment Period|Lost to Follow-up|20
1571932|NCT02867709|5442614|P1|Treatment Period|Lost to Follow-up|17
1571933|NCT02867709|5442612|P3|Treatment Period|Withdrawal of Consent|8
1571934|NCT02867709|5442613|P2|Treatment Period|Withdrawal of Consent|9
1571935|NCT02867709|5442614|P1|Treatment Period|Withdrawal of Consent|7
1571936|NCT02867709|5442612|P3|Treatment Period|Adverse Event|2
1571937|NCT02867709|5442613|P2|Treatment Period|Adverse Event|1
1571938|NCT02867709|5442614|P1|Treatment Period|Adverse Event|1
1571939|NCT02866942|5442660|P1|Overall Study|Invalid consent|1
1571940|NCT02866695|5442665|P1|Overall Study|Lost to Follow-up|1
1571941|NCT02866695|5442665|P1|Overall Study|Adverse Event|1
1571942|NCT02865499|5442697|P1|Baseline|Withdrawal by Subject|1
1571943|NCT02865499|5442697|P1|Baseline|Adverse Event|1
1571944|NCT02865395|5442704|P3|Overall Study|Physician Decision|7
1571945|NCT02865395|5442705|P2|Overall Study|Physician Decision|10
1571946|NCT02865395|5442706|P1|Overall Study|Physician Decision|6
1571947|NCT02865083|5442719|P2|Overall Study|Early Termination|1
1571948|NCT02865083|5442720|P1|Overall Study|Early Termination|3
1571949|NCT02864342|5442781|P2|Overall Study|Adverse Event|0
1571950|NCT02864342|5442782|P1|Overall Study|Adverse Event|1
1571951|NCT02864342|5442781|P2|Overall Study|Lost Device|0
1571952|NCT02864342|5442782|P1|Overall Study|Lost Device|1
1571953|NCT02864342|5442781|P2|Overall Study|Lost to Follow-up|5
1571954|NCT02864342|5442782|P1|Overall Study|Lost to Follow-up|1
1571955|NCT02864342|5442781|P2|Overall Study|Did Not Start Treatment with Symbicort|1
1571956|NCT02864342|5442782|P1|Overall Study|Did Not Start Treatment with Symbicort|0
1571957|NCT02864342|5442781|P2|Overall Study|Death|1
1571958|NCT02864342|5442782|P1|Overall Study|Death|0
1571959|NCT02864342|5442781|P2|Overall Study|Device Technology Issue|7
1571960|NCT02864342|5442782|P1|Overall Study|Device Technology Issue|6
1571961|NCT02864342|5442781|P2|Overall Study|Withdrawal by Subject|2
1571962|NCT02864342|5442782|P1|Overall Study|Withdrawal by Subject|4
1571963|NCT02864342|5442781|P2|Overall Study|Eligibility Criteria Deviation|3
1571964|NCT02864342|5442782|P1|Overall Study|Eligibility Criteria Deviation|2
1571965|NCT02864316|5442799|P2|Overall Study|Adverse Event|1
1571966|NCT02864316|5442800|P1|Overall Study|Adverse Event|0
1571967|NCT02864316|5442799|P2|Overall Study|Progressive Disease|1
1571968|NCT02864316|5442800|P1|Overall Study|Progressive Disease|2
1571969|NCT02863575|5442838|P3|Overall Study|Adverse Event|0
1571970|NCT02863575|5442839|P2|Overall Study|Adverse Event|1
1571971|NCT02863575|5442840|P1|Overall Study|Adverse Event|0
1571972|NCT02863575|5442838|P3|Overall Study|Withdrawal by Subject|1
1571973|NCT02863575|5442839|P2|Overall Study|Withdrawal by Subject|1
1571974|NCT02863575|5442840|P1|Overall Study|Withdrawal by Subject|0
1571975|NCT02863575|5442838|P3|Overall Study|Participants Unable To Swallow Capsule|0
1571976|NCT02863575|5442839|P2|Overall Study|Participants Unable To Swallow Capsule|0
1571977|NCT02863575|5442840|P1|Overall Study|Participants Unable To Swallow Capsule|1
1571978|NCT02863419|5442892|P3|Overall Study|Died|1
1571979|NCT02863419|5442893|P2|Overall Study|Died|4
1571980|NCT02863419|5442894|P1|Overall Study|Died|3
1571981|NCT02863419|5442892|P3|Overall Study|Withdrawal by Subject|3
1571982|NCT02863419|5442893|P2|Overall Study|Withdrawal by Subject|5
1571983|NCT02863419|5442894|P1|Overall Study|Withdrawal by Subject|5
1571984|NCT02863419|5442892|P3|Overall Study|Lost to Follow-up|4
1571985|NCT02863419|5442893|P2|Overall Study|Lost to Follow-up|1
1571986|NCT02863419|5442894|P1|Overall Study|Lost to Follow-up|0
1571987|NCT02863328|5443011|P2|Overall Study|Died|1
1571988|NCT02863328|5443012|P1|Overall Study|Died|0
1571989|NCT02863328|5443011|P2|Overall Study|Withdrawal by Subject|12
1571990|NCT02863328|5443012|P1|Overall Study|Withdrawal by Subject|7
1571991|NCT02863328|5443011|P2|Overall Study|Lost to Follow-up|10
1571992|NCT02863328|5443012|P1|Overall Study|Lost to Follow-up|4
1571993|NCT02862730|5443156|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1571994|NCT02862730|5443157|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1571995|NCT02862730|5443158|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1571996|NCT02862730|5443159|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
1572078|NCT02858492|5443461|P3|Overall Study|Withdrawal by Subject|0
1571997|NCT02862730|5443160|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1571998|NCT02862730|5443161|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1571999|NCT02862730|5443162|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
1572000|NCT02862730|5443156|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1572001|NCT02862730|5443157|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1572002|NCT02862730|5443158|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1572003|NCT02862730|5443159|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1572004|NCT02862730|5443160|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
1572005|NCT02862730|5443161|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1572006|NCT02862730|5443162|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
1572007|NCT02862730|5443156|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
1572008|NCT02862730|5443157|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
1572009|NCT02862730|5443158|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
1572010|NCT02862730|5443159|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
1572011|NCT02862730|5443160|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
1572012|NCT02862730|5443161|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
1572013|NCT02862730|5443162|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
1572014|NCT02862730|5443156|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1572015|NCT02862730|5443157|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1572016|NCT02862730|5443158|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1572017|NCT02862730|5443159|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1572018|NCT02862730|5443160|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
1572019|NCT02862730|5443161|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1572020|NCT02862730|5443162|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
1572021|NCT02862600|5443217|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
1572022|NCT02862600|5443217|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
1572023|NCT02862600|5443217|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
1572024|NCT02862600|5443217|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
1572025|NCT02862574|5443227|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
1572026|NCT02862574|5443228|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
1572027|NCT02862574|5443229|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
1572028|NCT02862574|5443227|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
1572029|NCT02862574|5443228|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
1572030|NCT02862574|5443229|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
1572031|NCT02862574|5443227|P3|Double-Blind Treatment Period|Adverse Event|0
1572032|NCT02862574|5443228|P2|Double-Blind Treatment Period|Adverse Event|1
1572033|NCT02862574|5443229|P1|Double-Blind Treatment Period|Adverse Event|0
1572034|NCT02862548|5443249|P2|Open-Label Extension Phase|Still on Study|24
1572035|NCT02862548|5443250|P1|Open-Label Extension Phase|Still on Study|26
1572036|NCT02862548|5443249|P2|Open-Label Phase|Death|1
1572037|NCT02862548|5443250|P1|Open-Label Phase|Death|0
1572038|NCT02862106|5443280|P2|Overall Study|Subjects moved to other city|0
1572039|NCT02862106|5443281|P1|Overall Study|Subjects moved to other city|1
1572040|NCT02862106|5443280|P2|Overall Study|Withdrawal by Subject|0
1572041|NCT02862106|5443281|P1|Overall Study|Withdrawal by Subject|2
1572042|NCT02862106|5443280|P2|Overall Study|Lost to Follow-up|5
1572043|NCT02862106|5443281|P1|Overall Study|Lost to Follow-up|15
1572044|NCT02862106|5443280|P2|Overall Study|Protocol Violation|1
1572045|NCT02862106|5443281|P1|Overall Study|Protocol Violation|16
1572046|NCT02862106|5443280|P2|Overall Study|Adverse Event|0
1572047|NCT02862106|5443281|P1|Overall Study|Adverse Event|4
1572048|NCT02861807|5443341|P2|Overall Study|Withdrawal by Subject|8
1572049|NCT02861807|5443342|P1|Overall Study|Withdrawal by Subject|5
1572050|NCT02861807|5443341|P2|Overall Study|Lost to Follow-up|6
1572051|NCT02861807|5443342|P1|Overall Study|Lost to Follow-up|7
1572052|NCT02861664|5443358|P2|Overall Study|Withdrawal of Consent|1
1572053|NCT02861664|5443359|P1|Overall Study|Withdrawal of Consent|0
1572054|NCT02860169|5443414|P1|Part C|Other (Screening failure)|1
1572055|NCT02860169|5443414|P1|Part B|Withdrawal by Subject|1
1572056|NCT02860169|5443414|P1|Part B|Other (Screening failure)|10
1572057|NCT02860169|5443414|P1|Part A|Other (did not completed consent)|1
1572058|NCT02860169|5443414|P1|Part A|Other (Survey not completed)|3
1572059|NCT02860169|5443414|P1|Part A|Other (Screening failure)|6
1572060|NCT02860169|5443414|P1|Part A|Withdrawal by Subject|1
1572065|NCT02858492|5443460|P4|Overall Study|Protocol defined stopping criteria|1
1572066|NCT02858492|5443461|P3|Overall Study|Protocol defined stopping criteria|0
1572067|NCT02858492|5443462|P2|Overall Study|Protocol defined stopping criteria|0
1572068|NCT02858492|5443463|P1|Overall Study|Protocol defined stopping criteria|0
1572069|NCT02858492|5443460|P4|Overall Study|Lack of Efficacy|1
1572070|NCT02858492|5443461|P3|Overall Study|Lack of Efficacy|0
1572071|NCT02858492|5443462|P2|Overall Study|Lack of Efficacy|0
1572072|NCT02858492|5443463|P1|Overall Study|Lack of Efficacy|0
1572073|NCT02858492|5443460|P4|Overall Study|Adverse Event|3
1572074|NCT02858492|5443461|P3|Overall Study|Adverse Event|0
1572075|NCT02858492|5443462|P2|Overall Study|Adverse Event|0
1572076|NCT02858492|5443463|P1|Overall Study|Adverse Event|0
1572077|NCT02858492|5443460|P4|Overall Study|Withdrawal by Subject|1
1572079|NCT02858492|5443462|P2|Overall Study|Withdrawal by Subject|1
1572080|NCT02858492|5443463|P1|Overall Study|Withdrawal by Subject|0
1572081|NCT02858440|5443639|P1|Overall Study|Migrated/moved from study area|4
1572082|NCT02858440|5443639|P1|Overall Study|Consent withdrawal|3
1572083|NCT02858440|5443639|P1|Overall Study|Protocol Violation|2
1572084|NCT02858440|5443639|P1|Overall Study|Lost to Follow-up|3
1572099|NCT02858362|5444089|P3|Overall Study|Lost to Follow-up|0
1572100|NCT02858362|5444090|P2|Overall Study|Lost to Follow-up|0
1572101|NCT02858362|5444091|P1|Overall Study|Lost to Follow-up|1
1572102|NCT02858362|5444089|P3|Overall Study|Early Study Termination|3
1572103|NCT02858362|5444090|P2|Overall Study|Early Study Termination|0
1572104|NCT02858362|5444091|P1|Overall Study|Early Study Termination|0
1572105|NCT02858362|5444089|P3|Overall Study|Withdrawal by Subject|0
1572106|NCT02858362|5444090|P2|Overall Study|Withdrawal by Subject|0
1572107|NCT02858362|5444091|P1|Overall Study|Withdrawal by Subject|1
1572108|NCT02858362|5444089|P3|Overall Study|Protocol Violation|0
1572109|NCT02858362|5444090|P2|Overall Study|Protocol Violation|1
1572110|NCT02858362|5444091|P1|Overall Study|Protocol Violation|0
1572111|NCT02857816|5444139|P1|Overall Study|Lost to Follow-up|1
1572112|NCT02857816|5444139|P1|Overall Study|Withdrawal by Subject|4
1572113|NCT02857816|5444139|P1|Overall Study|Screen Failure|33
1572114|NCT02856880|5444145|P1|Overall Study|Withdrawal of consent|1
1572115|NCT02856282|5444186|P1|Overall Study|Withdrawal by Subject|1
1572116|NCT02855541|5444213|P1|Overall Study|Withdrawal by Subject|2
1572117|NCT02855541|5444213|P1|Overall Study|Change in health status|2
1572118|NCT02855411|5444233|P1|Overall Study|Does not meet entrance criteria|14
1572119|NCT02855411|5444233|P1|Overall Study|Study terminated by sponsor|21
1572120|NCT02855359|5444255|P4|Overall Study|Study Termination by Sponsor|0
1572121|NCT02855359|5444256|P3|Overall Study|Study Termination by Sponsor|0
1572122|NCT02855359|5444257|P2|Overall Study|Study Termination by Sponsor|11
1572123|NCT02855359|5444258|P1|Overall Study|Study Termination by Sponsor|9
1572124|NCT02855359|5444255|P4|Overall Study|Death|0
1572125|NCT02855359|5444256|P3|Overall Study|Death|0
1572126|NCT02855359|5444257|P2|Overall Study|Death|2
1572127|NCT02855359|5444258|P1|Overall Study|Death|2
1572128|NCT02854631|5444303|P2|Overall Study|Lost to Follow-up|2
1572129|NCT02854631|5444304|P1|Overall Study|Lost to Follow-up|4
1572130|NCT02854631|5444303|P2|Overall Study|Subjects Randomized but Never Treated|0
1572131|NCT02854631|5444304|P1|Overall Study|Subjects Randomized but Never Treated|2
1572132|NCT02854631|5444303|P2|Overall Study|Protocol Violation|1
1572133|NCT02854631|5444304|P1|Overall Study|Protocol Violation|0
1572134|NCT02854631|5444303|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
1572135|NCT02854631|5444304|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
1572136|NCT02854631|5444303|P2|Overall Study|Death|8
1572137|NCT02854631|5444304|P1|Overall Study|Death|12
1572138|NCT02854631|5444303|P2|Overall Study|Investigator's Discretion|0
1572139|NCT02854631|5444304|P1|Overall Study|Investigator's Discretion|2
1572140|NCT02854631|5444303|P2|Overall Study|Withdrew Consent|2
1572141|NCT02854631|5444304|P1|Overall Study|Withdrew Consent|3
1572142|NCT02854631|5444303|P2|Overall Study|Adverse Event|2
1572143|NCT02854631|5444304|P1|Overall Study|Adverse Event|1
1572144|NCT02854605|5444365|P3|Overall Study|Protocol Violation|1
1572145|NCT02854605|5444366|P2|Overall Study|Protocol Violation|0
1572146|NCT02854605|5444367|P1|Overall Study|Protocol Violation|0
1572147|NCT02854605|5444365|P3|Overall Study|Investigator's Discretion|0
1572148|NCT02854605|5444366|P2|Overall Study|Investigator's Discretion|0
1572149|NCT02854605|5444367|P1|Overall Study|Investigator's Discretion|1
1572150|NCT02854605|5444365|P3|Overall Study|Withdrew Consent|1
1572151|NCT02854605|5444366|P2|Overall Study|Withdrew Consent|0
1572152|NCT02854605|5444367|P1|Overall Study|Withdrew Consent|1
1572153|NCT02854605|5444365|P3|Overall Study|Lost to Follow-up|0
1572154|NCT02854605|5444366|P2|Overall Study|Lost to Follow-up|2
1572155|NCT02854605|5444367|P1|Overall Study|Lost to Follow-up|0
1572156|NCT02854605|5444365|P3|Overall Study|Adverse Event|2
1572157|NCT02854605|5444366|P2|Overall Study|Adverse Event|5
1572158|NCT02854605|5444367|P1|Overall Study|Adverse Event|1
1572159|NCT02854527|5444397|P10|Overall Study|Lost to Follow-up|0
1572160|NCT02854527|5444398|P9|Overall Study|Lost to Follow-up|0
1572161|NCT02854527|5444399|P8|Overall Study|Lost to Follow-up|0
1572162|NCT02854527|5444400|P7|Overall Study|Lost to Follow-up|0
1572163|NCT02854527|5444401|P6|Overall Study|Lost to Follow-up|0
1572164|NCT02854527|5444402|P5|Overall Study|Lost to Follow-up|0
1572165|NCT02854527|5444403|P4|Overall Study|Lost to Follow-up|1
1572166|NCT02854527|5444404|P3|Overall Study|Lost to Follow-up|0
1572167|NCT02854527|5444405|P2|Overall Study|Lost to Follow-up|0
1572168|NCT02854527|5444406|P1|Overall Study|Lost to Follow-up|0
1572169|NCT02854527|5444397|P10|Overall Study|Adverse Event|0
1572170|NCT02854527|5444398|P9|Overall Study|Adverse Event|0
1572171|NCT02854527|5444399|P8|Overall Study|Adverse Event|0
1572172|NCT02854527|5444400|P7|Overall Study|Adverse Event|0
1572173|NCT02854527|5444401|P6|Overall Study|Adverse Event|0
1572174|NCT02854527|5444402|P5|Overall Study|Adverse Event|1
1572175|NCT02854527|5444403|P4|Overall Study|Adverse Event|0
1572176|NCT02854527|5444404|P3|Overall Study|Adverse Event|0
1572177|NCT02854527|5444405|P2|Overall Study|Adverse Event|0
1572178|NCT02854527|5444406|P1|Overall Study|Adverse Event|0
1572179|NCT02853929|5444464|P2|Overall Study|Subjects enrolled but not vaccinated|4
1572180|NCT02853929|5444465|P1|Overall Study|Subjects enrolled but not vaccinated|7
1572181|NCT02853929|5444464|P2|Overall Study|Withdrawal by Subject|0
1572182|NCT02853929|5444465|P1|Overall Study|Withdrawal by Subject|1
1572183|NCT02853929|5444464|P2|Overall Study|Lost to Follow-up|0
1572184|NCT02853929|5444465|P1|Overall Study|Lost to Follow-up|3
1572185|NCT02853435|5444506|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1572186|NCT02853435|5444507|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
1572187|NCT02853435|5444508|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1572188|NCT02853435|5444509|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1572189|NCT02853435|5444510|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1572190|NCT02853435|5444511|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
1572191|NCT02853331|5444821|P2|Overall Study|Ongoing in study|325
1572192|NCT02853331|5444822|P1|Overall Study|Ongoing in study|368
1572193|NCT02853331|5444821|P2|Overall Study|Withdrawal by Subject|9
1572194|NCT02853331|5444822|P1|Overall Study|Withdrawal by Subject|5
1572195|NCT02853331|5444821|P2|Overall Study|Death|95
1572196|NCT02853331|5444822|P1|Overall Study|Death|59
1572197|NCT02853123|5444854|P2|Washout Period|Adverse Event|0
1572198|NCT02853123|5444855|P1|Washout Period|Adverse Event|1
1572199|NCT02853123|5444854|P2|Washout Period|Worsening of COPD|3
1572200|NCT02853123|5444855|P1|Washout Period|Worsening of COPD|0
1572201|NCT02853123|5444854|P2|Treatment Period 1|Adverse Event|3
1572202|NCT02853123|5444855|P1|Treatment Period 1|Adverse Event|0
1572203|NCT02852434|5444878|P2|Overall Study|Unsuccessful Dilator Procedure|0
1572204|NCT02852434|5444879|P1|Overall Study|Unsuccessful Dilator Procedure|2
1572205|NCT02852434|5444878|P2|Overall Study|Withdrawal by Subject|1
1572206|NCT02852434|5444879|P1|Overall Study|Withdrawal by Subject|0
1572207|NCT02852265|5444895|P2|3-month Follow-up|Lost to Follow-up|1
1572208|NCT02852265|5444896|P1|3-month Follow-up|Lost to Follow-up|1
1572209|NCT02851069|5444920|P1|Overall Study|Other|3
1572210|NCT02851069|5444920|P1|Overall Study|Failure to Return|3
1572211|NCT02850978|5444942|P1|Overall Study|Reason not listed|88
1572212|NCT02850978|5444942|P1|Overall Study|Lost to Follow-up|121
1572213|NCT02850978|5444942|P1|Overall Study|Improvement in condition|34
1572214|NCT02850978|5444942|P1|Overall Study|Lack of Efficacy|40
1572215|NCT02850978|5444942|P1|Overall Study|Adverse Event|81
1572216|NCT02850978|5444942|P1|Overall Study|No visit since the first visit|35
1572217|NCT02850978|5444942|P1|Overall Study|Uncollectable CRF|27
1572218|NCT02850965|5444949|P2|Overall Study|Randomized but not treated|1
1572219|NCT02850965|5444950|P1|Overall Study|Randomized but not treated|0
1572220|NCT02850965|5444949|P2|Overall Study|Physician Decision|1
1572221|NCT02850965|5444950|P1|Overall Study|Physician Decision|0
1572222|NCT02850965|5444949|P2|Overall Study|Withdrawal by Subject|4
1572223|NCT02850965|5444950|P1|Overall Study|Withdrawal by Subject|3
1572224|NCT02850965|5444949|P2|Overall Study|Adverse Event|2
1572225|NCT02850965|5444950|P1|Overall Study|Adverse Event|3
1572226|NCT02850965|5444949|P2|Overall Study|Lack of Efficacy|8
1572227|NCT02850965|5444950|P1|Overall Study|Lack of Efficacy|4
1572228|NCT02850965|5444949|P2|Overall Study|Lost to Follow-up|3
1572229|NCT02850965|5444950|P1|Overall Study|Lost to Follow-up|5
1572230|NCT02850965|5444949|P2|Overall Study|Protocol Violation|2
1572231|NCT02850965|5444950|P1|Overall Study|Protocol Violation|0
1572232|NCT02850965|5444949|P2|Overall Study|Other than listed|4
1572233|NCT02850965|5444950|P1|Overall Study|Other than listed|3
1572234|NCT02850276|5444966|P1|Overall Study|Lost to Follow-up|2
1572235|NCT02850276|5444966|P1|Overall Study|Physician Decision|2
1572236|NCT02850276|5444966|P1|Overall Study|Withdrawal by Subject|14
1572237|NCT02850276|5444966|P1|Overall Study|screen failure|43
1572238|NCT02849990|5444993|P1|Overall Study|Withdrawal by Subject|1
1572239|NCT02849990|5444993|P1|Overall Study|Adverse Event|1
1572240|NCT02849704|5445018|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
1572241|NCT02849704|5445019|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
1572242|NCT02849704|5445018|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
1572243|NCT02849704|5445019|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
1572244|NCT02849704|5445018|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
1572245|NCT02849704|5445019|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
1572246|NCT02849678|5445034|P2|Overall Study|Protocol Violation|6
1572247|NCT02849678|5445035|P1|Overall Study|Protocol Violation|3
1572248|NCT02849509|5445056|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
1572249|NCT02849509|5445057|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
1572250|NCT02849509|5445058|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
1572251|NCT02849509|5445056|P3|Overall Study|Other, reason not specified|25
1572252|NCT02849509|5445057|P2|Overall Study|Other, reason not specified|29
1572253|NCT02849509|5445058|P1|Overall Study|Other, reason not specified|14
1572254|NCT02849509|5445056|P3|Overall Study|Lost to Follow-up|36
1572255|NCT02849509|5445057|P2|Overall Study|Lost to Follow-up|67
1572256|NCT02849509|5445058|P1|Overall Study|Lost to Follow-up|27
1572257|NCT02849509|5445056|P3|Overall Study|Withdrawal by Subject|12
1572258|NCT02849509|5445057|P2|Overall Study|Withdrawal by Subject|17
1572259|NCT02849509|5445058|P1|Overall Study|Withdrawal by Subject|6
1572260|NCT02849509|5445056|P3|Overall Study|Other adverse event|8
1572261|NCT02849509|5445057|P2|Overall Study|Other adverse event|41
1572262|NCT02849509|5445058|P1|Overall Study|Other adverse event|36
1572263|NCT02849509|5445056|P3|Overall Study|Worsening of other pre-existing disease|2
1572264|NCT02849509|5445057|P2|Overall Study|Worsening of other pre-existing disease|1
1572265|NCT02849509|5445058|P1|Overall Study|Worsening of other pre-existing disease|0
1572266|NCT02849509|5445056|P3|Overall Study|Worsening of disease under study|1
1572267|NCT02849509|5445057|P2|Overall Study|Worsening of disease under study|1
1572268|NCT02849509|5445058|P1|Overall Study|Worsening of disease under study|1
1572275|NCT02848729|5445326|P2|Overall Study|Emesis|11
1572276|NCT02848729|5445327|P1|Overall Study|Emesis|15
1572277|NCT02848729|5445326|P2|Overall Study|Withdrawal by Subject|0
1572278|NCT02848729|5445327|P1|Overall Study|Withdrawal by Subject|1
1572279|NCT02848664|5445344|P1|Overall Study|no assistance for device training|1
1572280|NCT02848664|5445344|P1|Overall Study|Adverse Event|1
1572281|NCT02848664|5445344|P1|Overall Study|Withdrawal by Subject|2
1572282|NCT02848326|5445358|P6|Safety Follow-up Period|Lost to Follow-up|3
1572283|NCT02848326|5445359|P5|Safety Follow-up Period|Lost to Follow-up|1
1572284|NCT02848326|5445360|P4|Safety Follow-up Period|Lost to Follow-up|0
1572285|NCT02848326|5445361|P3|Safety Follow-up Period|Lost to Follow-up|2
1572286|NCT02848326|5445362|P2|Safety Follow-up Period|Lost to Follow-up|0
1572287|NCT02848326|5445363|P1|Safety Follow-up Period|Lost to Follow-up|4
1572288|NCT02848326|5445358|P6|Safety Follow-up Period|Withdrawal of Consent|2
1572289|NCT02848326|5445359|P5|Safety Follow-up Period|Withdrawal of Consent|0
1572290|NCT02848326|5445360|P4|Safety Follow-up Period|Withdrawal of Consent|0
1572291|NCT02848326|5445361|P3|Safety Follow-up Period|Withdrawal of Consent|1
1572292|NCT02848326|5445362|P2|Safety Follow-up Period|Withdrawal of Consent|1
1572293|NCT02848326|5445363|P1|Safety Follow-up Period|Withdrawal of Consent|0
1572294|NCT02848326|5445358|P6|Treatment Period|Non-compliance with Study Drug|0
1572295|NCT02848326|5445359|P5|Treatment Period|Non-compliance with Study Drug|0
1572296|NCT02848326|5445360|P4|Treatment Period|Non-compliance with Study Drug|1
1572297|NCT02848326|5445361|P3|Treatment Period|Non-compliance with Study Drug|0
1572298|NCT02848326|5445362|P2|Treatment Period|Non-compliance with Study Drug|0
1572299|NCT02848326|5445363|P1|Treatment Period|Non-compliance with Study Drug|4
1572300|NCT02848326|5445358|P6|Treatment Period|Protocol Violation|3
1572301|NCT02848326|5445359|P5|Treatment Period|Protocol Violation|3
1572302|NCT02848326|5445360|P4|Treatment Period|Protocol Violation|2
1572303|NCT02848326|5445361|P3|Treatment Period|Protocol Violation|4
1572304|NCT02848326|5445362|P2|Treatment Period|Protocol Violation|3
1572305|NCT02848326|5445363|P1|Treatment Period|Protocol Violation|4
1572306|NCT02848326|5445358|P6|Treatment Period|Pregnancy|1
1572307|NCT02848326|5445359|P5|Treatment Period|Pregnancy|0
1572308|NCT02848326|5445360|P4|Treatment Period|Pregnancy|1
1572309|NCT02848326|5445361|P3|Treatment Period|Pregnancy|1
1572310|NCT02848326|5445362|P2|Treatment Period|Pregnancy|0
1572311|NCT02848326|5445363|P1|Treatment Period|Pregnancy|0
1572312|NCT02848326|5445358|P6|Treatment Period|Lost to Follow-up|3
1572313|NCT02848326|5445359|P5|Treatment Period|Lost to Follow-up|2
1572314|NCT02848326|5445360|P4|Treatment Period|Lost to Follow-up|7
1572315|NCT02848326|5445361|P3|Treatment Period|Lost to Follow-up|11
1572316|NCT02848326|5445362|P2|Treatment Period|Lost to Follow-up|1
1572317|NCT02848326|5445363|P1|Treatment Period|Lost to Follow-up|5
1572318|NCT02848326|5445358|P6|Treatment Period|Withdrawal of Consent|6
1572319|NCT02848326|5445359|P5|Treatment Period|Withdrawal of Consent|9
1572320|NCT02848326|5445360|P4|Treatment Period|Withdrawal of Consent|6
1572321|NCT02848326|5445361|P3|Treatment Period|Withdrawal of Consent|9
1572322|NCT02848326|5445362|P2|Treatment Period|Withdrawal of Consent|6
1572323|NCT02848326|5445363|P1|Treatment Period|Withdrawal of Consent|20
1572324|NCT02848326|5445358|P6|Treatment Period|Adverse Event|7
1572325|NCT02848326|5445359|P5|Treatment Period|Adverse Event|5
1572326|NCT02848326|5445360|P4|Treatment Period|Adverse Event|6
1572327|NCT02848326|5445361|P3|Treatment Period|Adverse Event|11
1572328|NCT02848326|5445362|P2|Treatment Period|Adverse Event|4
1572329|NCT02848326|5445363|P1|Treatment Period|Adverse Event|5
1572330|NCT02847858|5445410|P2|Overall Study|Lost to Follow-up|269
1572331|NCT02847858|5445411|P1|Overall Study|Lost to Follow-up|401
1572332|NCT02847650|5445437|P2|Overall Study|Withdrawal by Subject|1
1572333|NCT02847650|5445438|P1|Overall Study|Withdrawal by Subject|1
1572334|NCT02847650|5445437|P2|Overall Study|Protocol Violation|1
1572335|NCT02847650|5445438|P1|Overall Study|Protocol Violation|0
1572336|NCT02847650|5445437|P2|Overall Study|Lost to Follow-up|0
1572337|NCT02847650|5445438|P1|Overall Study|Lost to Follow-up|1
1572338|NCT02847650|5445437|P2|Overall Study|Adverse Event|4
1572339|NCT02847650|5445438|P1|Overall Study|Adverse Event|2
1572340|NCT02847637|5445462|P4|Overall Study|First emicizumab dose delayed|0
1572341|NCT02847637|5445463|P3|Overall Study|First emicizumab dose delayed|0
1572342|NCT02847637|5445464|P2|Overall Study|First emicizumab dose delayed|0
1572343|NCT02847637|5445465|P1|Overall Study|First emicizumab dose delayed|1
1572344|NCT02847637|5445462|P4|Overall Study|Ongoing treatment with emicizumab|63
1572345|NCT02847637|5445463|P3|Overall Study|Ongoing treatment with emicizumab|34
1572346|NCT02847637|5445464|P2|Overall Study|Ongoing treatment with emicizumab|35
1572347|NCT02847637|5445465|P1|Overall Study|Ongoing treatment with emicizumab|16
1572348|NCT02847637|5445462|P4|Overall Study|Withdrew from treatment due to AE|0
1572349|NCT02847637|5445463|P3|Overall Study|Withdrew from treatment due to AE|1
1572350|NCT02847637|5445464|P2|Overall Study|Withdrew from treatment due to AE|0
1572351|NCT02847637|5445465|P1|Overall Study|Withdrew from treatment due to AE|0
1572352|NCT02847494|5445579|P2|Overall Study|Lost to Follow-up|5
1572353|NCT02847494|5445580|P1|Overall Study|Lost to Follow-up|8
1572354|NCT02847260|5445590|P1|Overall Study|Physician Decision|1
1572355|NCT02847260|5445590|P1|Overall Study|Clinical Deterioration|1
1572356|NCT02847260|5445590|P1|Overall Study|Withdrawal by Subject|2
1572357|NCT02847260|5445590|P1|Overall Study|Adverse Event|3
1572358|NCT02847182|5445604|P2|Overall Study|Withdrawal by Subject|1
1572359|NCT02847182|5445605|P1|Overall Study|Withdrawal by Subject|0
1572360|NCT02846779|5445705|P3|Overall Study|Less than 31 days of follow-up|52
1572361|NCT02846779|5445706|P2|Overall Study|Less than 31 days of follow-up|45
1572362|NCT02846779|5445707|P1|Overall Study|Less than 31 days of follow-up|56
1572363|NCT02846779|5445705|P3|Overall Study|Lost Enrollment|86
1572364|NCT02846779|5445706|P2|Overall Study|Lost Enrollment|82
1572365|NCT02846779|5445707|P1|Overall Study|Lost Enrollment|83
1572366|NCT02846558|5445763|P4|Overall Study|Lost to Follow-up|0
1572367|NCT02846558|5445764|P3|Overall Study|Lost to Follow-up|0
1572368|NCT02846558|5445765|P2|Overall Study|Lost to Follow-up|0
1572369|NCT02846558|5445766|P1|Overall Study|Lost to Follow-up|2
1572370|NCT02846558|5445763|P4|Overall Study|Withdrawal by Subject|2
1572371|NCT02846558|5445764|P3|Overall Study|Withdrawal by Subject|2
1572372|NCT02846558|5445765|P2|Overall Study|Withdrawal by Subject|4
1572373|NCT02846558|5445766|P1|Overall Study|Withdrawal by Subject|5
1572374|NCT02846558|5445763|P4|Overall Study|Adverse Event|0
1572375|NCT02846558|5445764|P3|Overall Study|Adverse Event|0
1572376|NCT02846558|5445765|P2|Overall Study|Adverse Event|0
1572377|NCT02846558|5445766|P1|Overall Study|Adverse Event|1
1572383|NCT02844920|5445881|P1|Overall Study|Lost to Follow-up|2
1572384|NCT02844543|5445899|P1|Overall Study|Did not meet eligibility criteria|1
1572385|NCT02844543|5445899|P1|Overall Study|Withdrawal by Subject|4
1572386|NCT02843659|5445909|P3|Overall Study|Adverse Event|0
1572387|NCT02843659|5445910|P2|Overall Study|Adverse Event|1
1572388|NCT02843659|5445911|P1|Overall Study|Adverse Event|0
1572389|NCT02843659|5445909|P3|Overall Study|Administrative Reason by Sponsor|4
1572390|NCT02843659|5445910|P2|Overall Study|Administrative Reason by Sponsor|5
1572391|NCT02843659|5445911|P1|Overall Study|Administrative Reason by Sponsor|4
1572392|NCT02843659|5445909|P3|Overall Study|Subject Withdrew Consent|1
1572393|NCT02843659|5445910|P2|Overall Study|Subject Withdrew Consent|0
1572394|NCT02843659|5445911|P1|Overall Study|Subject Withdrew Consent|0
1572395|NCT02843178|5445980|P4|Overall Study|Withdrawal by Subject|1
1572396|NCT02843178|5445981|P3|Overall Study|Withdrawal by Subject|1
1572397|NCT02843178|5445982|P2|Overall Study|Withdrawal by Subject|0
1572398|NCT02843178|5445983|P1|Overall Study|Withdrawal by Subject|0
1572399|NCT02843178|5445980|P4|Overall Study|Lost to Follow-up|3
1572400|NCT02843178|5445981|P3|Overall Study|Lost to Follow-up|6
1572401|NCT02843178|5445982|P2|Overall Study|Lost to Follow-up|8
1572402|NCT02843178|5445983|P1|Overall Study|Lost to Follow-up|8
1572411|NCT02842736|5446032|P1|Overall Study|Diary or safety evaluation not available|1
1572412|NCT02842736|5446032|P1|Overall Study|Intervention for menstrual bleeding|4
1572413|NCT02842736|5446032|P1|Overall Study|Lost to Follow-up|7
1572414|NCT02842151|5446062|P1|Overall Study|Subject moved too far away|1
1572415|NCT02842151|5446062|P1|Overall Study|Adverse Event|1
1572416|NCT02842073|5446068|P1|Overall Study|Withdrawal by Subject|1
1572417|NCT02841787|5446094|P3|Overall Study|Withdrawal by Subject|0
1572418|NCT02841787|5446095|P2|Overall Study|Withdrawal by Subject|4
1572419|NCT02841787|5446096|P1|Overall Study|Withdrawal by Subject|1
1572420|NCT02841787|5446094|P3|Overall Study|Symptoms dropped below threshold|0
1572421|NCT02841787|5446095|P2|Overall Study|Symptoms dropped below threshold|0
1572422|NCT02841787|5446096|P1|Overall Study|Symptoms dropped below threshold|1
1572423|NCT02841787|5446094|P3|Overall Study|Lost to Follow-up|0
1572424|NCT02841787|5446095|P2|Overall Study|Lost to Follow-up|0
1572425|NCT02841787|5446096|P1|Overall Study|Lost to Follow-up|1
1572426|NCT02840721|5446134|P1|Follow-Up|Withdrawal of Consent|2
1572427|NCT02840721|5446134|P1|Follow-Up|Withdrawal by Subject|4
1572428|NCT02840721|5446134|P1|Follow-Up|Lack of Efficacy|1
1572429|NCT02840721|5446134|P1|Treatment Period|Adverse Event|1
1572430|NCT02840253|5446153|P1|Overall Study|Unsuccessful block|4
1572431|NCT02839876|5446238|P2|Overall Study|Protocol Violation|11
1572432|NCT02839876|5446239|P1|Overall Study|Protocol Violation|10
1572433|NCT02839746|5446341|P1|Overall Study|Not met selection criteria|12
1572434|NCT02839681|5446355|P1|Overall Study|Death|2
1572435|NCT02839330|5446368|P4|Overall Study|Other reason, not specified|6
1572436|NCT02839330|5446369|P3|Overall Study|Other reason, not specified|3
1572437|NCT02839330|5446370|P2|Overall Study|Other reason, not specified|3
1572438|NCT02839330|5446371|P1|Overall Study|Other reason, not specified|4
1572439|NCT02839330|5446368|P4|Overall Study|Protocol Violation|3
1572440|NCT02839330|5446369|P3|Overall Study|Protocol Violation|2
1572441|NCT02839330|5446370|P2|Overall Study|Protocol Violation|2
1572442|NCT02839330|5446371|P1|Overall Study|Protocol Violation|1
1572443|NCT02839330|5446368|P4|Overall Study|Administrative Reason|1
1572444|NCT02839330|5446369|P3|Overall Study|Administrative Reason|0
1572445|NCT02839330|5446370|P2|Overall Study|Administrative Reason|0
1572446|NCT02839330|5446371|P1|Overall Study|Administrative Reason|0
1572447|NCT02839330|5446368|P4|Overall Study|Lost to Follow-up|25
1572448|NCT02839330|5446369|P3|Overall Study|Lost to Follow-up|29
1572449|NCT02839330|5446370|P2|Overall Study|Lost to Follow-up|27
1572450|NCT02839330|5446371|P1|Overall Study|Lost to Follow-up|22
1572451|NCT02839330|5446368|P4|Overall Study|Withdrawal by Subject|13
1572452|NCT02839330|5446369|P3|Overall Study|Withdrawal by Subject|11
1572453|NCT02839330|5446370|P2|Overall Study|Withdrawal by Subject|19
1572454|NCT02839330|5446371|P1|Overall Study|Withdrawal by Subject|27
1572455|NCT02839330|5446368|P4|Overall Study|Death|1
1572456|NCT02839330|5446369|P3|Overall Study|Death|1
1572457|NCT02839330|5446370|P2|Overall Study|Death|6
1572458|NCT02839330|5446371|P1|Overall Study|Death|4
1572459|NCT02839330|5446368|P4|Overall Study|Adverse Event|2
1572460|NCT02839330|5446369|P3|Overall Study|Adverse Event|2
1572461|NCT02839330|5446370|P2|Overall Study|Adverse Event|1
1572462|NCT02839330|5446371|P1|Overall Study|Adverse Event|0
1572463|NCT02838901|5446402|P2|Overall Study|Lost to Follow-up|1
1572464|NCT02838901|5446403|P1|Overall Study|Lost to Follow-up|1
1572465|NCT02838901|5446402|P2|Overall Study|Withdrawal by Subject|1
1572466|NCT02838901|5446403|P1|Overall Study|Withdrawal by Subject|1
1572467|NCT02838420|5446433|P2|Overall Study|Death|13
1572468|NCT02838420|5446434|P1|Overall Study|Death|8
1572469|NCT02838420|5446433|P2|Overall Study|Withdrawal by Subject|4
1572470|NCT02838420|5446434|P1|Overall Study|Withdrawal by Subject|3
1572471|NCT02838420|5446433|P2|Overall Study|Lost to Follow-up|0
1572472|NCT02838420|5446434|P1|Overall Study|Lost to Follow-up|1
1572473|NCT02838420|5446433|P2|Overall Study|Ongoing in Study|45
1572474|NCT02838420|5446434|P1|Overall Study|Ongoing in Study|113
1572475|NCT02838134|5446497|P2|Overall Study|logistic problems|1
1572476|NCT02838134|5446498|P1|Overall Study|logistic problems|1
1572477|NCT02838134|5446497|P2|Overall Study|Lost to Follow-up|2
1572478|NCT02838134|5446498|P1|Overall Study|Lost to Follow-up|1
1572479|NCT02838017|5446530|P2|Overall Study|Lost to Follow-up|11
1572480|NCT02838017|5446531|P1|Overall Study|Lost to Follow-up|14
1572481|NCT02837952|5446549|P2|Overall Study|Medication Error|0
1572482|NCT02837952|5446550|P1|Overall Study|Medication Error|1
1572483|NCT02837952|5446549|P2|Overall Study|Withdrawal by Subject|5
1572484|NCT02837952|5446550|P1|Overall Study|Withdrawal by Subject|4
1572485|NCT02837952|5446549|P2|Overall Study|Adverse Event|1
1572486|NCT02837952|5446550|P1|Overall Study|Adverse Event|0
1572487|NCT02836613|5446602|P2|Overall Study|Withdrawal by Subject|2
1572488|NCT02836613|5446603|P1|Overall Study|Withdrawal by Subject|0
1572489|NCT02836613|5446602|P2|Overall Study|Lost to Follow-up|1
1572490|NCT02836613|5446603|P1|Overall Study|Lost to Follow-up|0
1572491|NCT02836613|5446602|P2|Overall Study|Accidental drowning|0
1572492|NCT02836613|5446603|P1|Overall Study|Accidental drowning|1
1572507|NCT02836236|5446653|P2|Overall Study|Still on Study|49
1572508|NCT02836236|5446654|P1|Overall Study|Still on Study|101
1572509|NCT02836236|5446653|P2|Overall Study|Investigator's Discretion|0
1572510|NCT02836236|5446654|P1|Overall Study|Investigator's Discretion|1
1572511|NCT02836236|5446653|P2|Overall Study|Adverse Event|1
1572512|NCT02836236|5446654|P1|Overall Study|Adverse Event|0
1572513|NCT02836236|5446653|P2|Overall Study|Withdrew Consent|0
1572514|NCT02836236|5446654|P1|Overall Study|Withdrew Consent|2
1572515|NCT02836236|5446653|P2|Overall Study|Randomized but Never Treated|0
1572516|NCT02836236|5446654|P1|Overall Study|Randomized but Never Treated|1
1572517|NCT02835820|5446670|P2|Overall Study|Baseline Screen Failure|3
1572518|NCT02835820|5446671|P1|Overall Study|Baseline Screen Failure|0
1572519|NCT02835690|5446718|P3|Overall Study|Not Treated|0
1572520|NCT02835690|5446719|P2|Overall Study|Not Treated|2
1572521|NCT02835690|5446720|P1|Overall Study|Not Treated|0
1572522|NCT02835690|5446718|P3|Overall Study|Ongoing in Study (Follow-up)|9
1572523|NCT02835690|5446719|P2|Overall Study|Ongoing in Study (Follow-up)|7
1572524|NCT02835690|5446720|P1|Overall Study|Ongoing in Study (Follow-up)|10
1572525|NCT02835690|5446718|P3|Overall Study|Death|6
1572526|NCT02835690|5446719|P2|Overall Study|Death|6
1572527|NCT02835690|5446720|P1|Overall Study|Death|4
1572528|NCT02835092|5446793|P3|Overall Study|Lost to Follow-up|0
1572529|NCT02835092|5446794|P2|Overall Study|Lost to Follow-up|2
1572530|NCT02835092|5446795|P1|Overall Study|Lost to Follow-up|0
1572531|NCT02835092|5446793|P3|Overall Study|Withdrawal by Subject|3
1572532|NCT02835092|5446794|P2|Overall Study|Withdrawal by Subject|6
1572533|NCT02835092|5446795|P1|Overall Study|Withdrawal by Subject|3
1572534|NCT02834819|5446805|P2|Overall Study|Did not complete 7 day follow up call.|0
1572535|NCT02834819|5446806|P1|Overall Study|Did not complete 7 day follow up call.|5
1572536|NCT02833974|5446841|P2|Overall Study|Adverse Event|3
1572537|NCT02833974|5446842|P1|Overall Study|Adverse Event|0
1572538|NCT02833974|5446841|P2|Overall Study|Lost to Follow-up|0
1572539|NCT02833974|5446842|P1|Overall Study|Lost to Follow-up|1
1572540|NCT02833948|5446868|P2|Overall Study|scans could not be evaluated|2
1572541|NCT02833948|5446869|P1|Overall Study|scans could not be evaluated|5
1572542|NCT02833948|5446868|P2|Overall Study|were not scanned|13
1572543|NCT02833948|5446869|P1|Overall Study|were not scanned|8
1572544|NCT02833948|5446868|P2|Overall Study|Death|3
1572545|NCT02833948|5446869|P1|Overall Study|Death|2
1572546|NCT02833350|5446942|P7|Overall Study|Withdrawal by Subject|2
1572547|NCT02833350|5446943|P6|Overall Study|Withdrawal by Subject|0
1572548|NCT02833350|5446944|P5|Overall Study|Withdrawal by Subject|2
1572549|NCT02833350|5446945|P4|Overall Study|Withdrawal by Subject|0
1572550|NCT02833350|5446946|P3|Overall Study|Withdrawal by Subject|2
1572551|NCT02833350|5446947|P2|Overall Study|Withdrawal by Subject|3
1572552|NCT02833350|5446948|P1|Overall Study|Withdrawal by Subject|3
1572553|NCT02833350|5446942|P7|Overall Study|Lost to Follow-up|1
1572554|NCT02833350|5446943|P6|Overall Study|Lost to Follow-up|0
1572555|NCT02833350|5446944|P5|Overall Study|Lost to Follow-up|0
1572556|NCT02833350|5446945|P4|Overall Study|Lost to Follow-up|0
1572557|NCT02833350|5446946|P3|Overall Study|Lost to Follow-up|0
1572558|NCT02833350|5446947|P2|Overall Study|Lost to Follow-up|1
1572559|NCT02833350|5446948|P1|Overall Study|Lost to Follow-up|0
1572560|NCT02833350|5446942|P7|Overall Study|Lack of Efficacy|1
1572561|NCT02833350|5446943|P6|Overall Study|Lack of Efficacy|1
1572562|NCT02833350|5446944|P5|Overall Study|Lack of Efficacy|0
1572563|NCT02833350|5446945|P4|Overall Study|Lack of Efficacy|4
1572564|NCT02833350|5446946|P3|Overall Study|Lack of Efficacy|1
1572565|NCT02833350|5446947|P2|Overall Study|Lack of Efficacy|2
1572566|NCT02833350|5446948|P1|Overall Study|Lack of Efficacy|0
1572567|NCT02833350|5446942|P7|Overall Study|Death|0
1572568|NCT02833350|5446943|P6|Overall Study|Death|0
1572569|NCT02833350|5446944|P5|Overall Study|Death|0
1572570|NCT02833350|5446945|P4|Overall Study|Death|0
1572571|NCT02833350|5446946|P3|Overall Study|Death|1
1572572|NCT02833350|5446947|P2|Overall Study|Death|0
1572573|NCT02833350|5446948|P1|Overall Study|Death|0
1572574|NCT02833350|5446942|P7|Overall Study|Adverse Event|1
1572575|NCT02833350|5446943|P6|Overall Study|Adverse Event|0
1572576|NCT02833350|5446944|P5|Overall Study|Adverse Event|1
1572577|NCT02833350|5446945|P4|Overall Study|Adverse Event|4
1572578|NCT02833350|5446946|P3|Overall Study|Adverse Event|4
1572579|NCT02833350|5446947|P2|Overall Study|Adverse Event|3
1572580|NCT02833350|5446948|P1|Overall Study|Adverse Event|0
1572581|NCT02832375|5447160|P2|Overall Study|Withdrawal of Consent|0
1572582|NCT02832375|5447161|P1|Overall Study|Withdrawal of Consent|1
1572583|NCT02832375|5447160|P2|Overall Study|Lost to Follow-up|0
1572584|NCT02832375|5447161|P1|Overall Study|Lost to Follow-up|1
1572585|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
1572586|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
1572587|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
1572588|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
1572589|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
1572590|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
1572591|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
1572592|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
1572593|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
1572594|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Other|5
1572595|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Other|2
1572596|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Other|0
1572597|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
1572598|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
1572599|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
1572600|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
1572601|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
1572602|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
1572603|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
1572604|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
1572605|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
1572606|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Death|2
1572607|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Death|0
1572608|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Death|0
1572609|NCT02831855|5447179|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
1572610|NCT02831855|5447180|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
1572611|NCT02831855|5447181|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
1572612|NCT02831855|5447179|P3|Open Label Phase (24 Weeks)|Other|0
1572613|NCT02831855|5447180|P2|Open Label Phase (24 Weeks)|Other|0
1572614|NCT02831855|5447181|P1|Open Label Phase (24 Weeks)|Other|4
1572615|NCT02831855|5447179|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
1572616|NCT02831855|5447180|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
1572617|NCT02831855|5447181|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
1572618|NCT02831855|5447179|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
1572619|NCT02831855|5447180|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
1572620|NCT02831855|5447181|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
1572621|NCT02831855|5447179|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
1572622|NCT02831855|5447180|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
1572623|NCT02831855|5447181|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
1572624|NCT02831855|5447179|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
1572625|NCT02831855|5447180|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
1572626|NCT02831855|5447181|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
1572627|NCT02831855|5447179|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
1572628|NCT02831855|5447180|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
1572629|NCT02831855|5447181|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
1572630|NCT02831855|5447179|P3|Open Label Phase (24 Weeks)|Adverse Event|0
1572631|NCT02831855|5447180|P2|Open Label Phase (24 Weeks)|Adverse Event|0
1572632|NCT02831855|5447181|P1|Open Label Phase (24 Weeks)|Adverse Event|39
1572633|NCT02831764|5447242|P2|Overall Study|Ongoing at the time of the analysis|335
1572634|NCT02831764|5447243|P1|Overall Study|Ongoing at the time of the analysis|330
1572635|NCT02831764|5447242|P2|Overall Study|Protocol Violation|2
1572636|NCT02831764|5447243|P1|Overall Study|Protocol Violation|5
1572637|NCT02831764|5447242|P2|Overall Study|Lack of Efficacy|2
1572638|NCT02831764|5447243|P1|Overall Study|Lack of Efficacy|2
1572639|NCT02831764|5447242|P2|Overall Study|Adverse Event|5
1572640|NCT02831764|5447243|P1|Overall Study|Adverse Event|8
1572641|NCT02831764|5447242|P2|Overall Study|Lost to Follow-up|5
1572642|NCT02831764|5447243|P1|Overall Study|Lost to Follow-up|6
1572643|NCT02831764|5447242|P2|Overall Study|Physician Decision|2
1572644|NCT02831764|5447243|P1|Overall Study|Physician Decision|2
1572645|NCT02831764|5447242|P2|Overall Study|Withdrawal by Subject|6
1572646|NCT02831764|5447243|P1|Overall Study|Withdrawal by Subject|7
1572647|NCT02831764|5447242|P2|Overall Study|Protocol specific withdrawal criteria|2
1572648|NCT02831764|5447243|P1|Overall Study|Protocol specific withdrawal criteria|0
1572649|NCT02831673|5447307|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
1572650|NCT02831673|5447308|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
1572651|NCT02831673|5447307|P2|Overall Study|Withdrawal by Subject|4
1572652|NCT02831673|5447308|P1|Overall Study|Withdrawal by Subject|6
1572653|NCT02831673|5447307|P2|Overall Study|Physician Decision|3
1572654|NCT02831673|5447308|P1|Overall Study|Physician Decision|6
1572655|NCT02831673|5447307|P2|Overall Study|Lost to Follow-up|6
1572656|NCT02831673|5447308|P1|Overall Study|Lost to Follow-up|9
1572657|NCT02831673|5447307|P2|Overall Study|Protocol Withdrawal Criterion Met|6
1572658|NCT02831673|5447308|P1|Overall Study|Protocol Withdrawal Criterion Met|1
1572659|NCT02831673|5447307|P2|Overall Study|Protocol Violation|4
1572660|NCT02831673|5447308|P1|Overall Study|Protocol Violation|5
1572661|NCT02831673|5447307|P2|Overall Study|Lack of Efficacy|1
1572662|NCT02831673|5447308|P1|Overall Study|Lack of Efficacy|3
1572663|NCT02831673|5447307|P2|Overall Study|Adverse Event|4
1572664|NCT02831673|5447308|P1|Overall Study|Adverse Event|6
1572665|NCT02831387|5447381|P2|Overall Study|Discontinued due to stock recovery|1
1572666|NCT02831387|5447382|P1|Overall Study|Discontinued due to stock recovery|0
1572667|NCT02831387|5447381|P2|Overall Study|Withdrawal by Subject|1
1572668|NCT02831387|5447382|P1|Overall Study|Withdrawal by Subject|1
1572669|NCT02830880|5447400|P1|Overall Study|Physician Decision|1
1572670|NCT02830880|5447400|P1|Overall Study|Death|1
1572671|NCT02830880|5447400|P1|Overall Study|Adverse reaction to chemotherapy|1
1572672|NCT02830087|5447415|P6|Overall Study|No study staff to follow-up patients|3
1572673|NCT02830087|5447416|P5|Overall Study|No study staff to follow-up patients|3
1572674|NCT02830087|5447417|P4|Overall Study|No study staff to follow-up patients|3
1572675|NCT02830087|5447418|P3|Overall Study|No study staff to follow-up patients|4
1572676|NCT02830087|5447419|P2|Overall Study|No study staff to follow-up patients|4
1572677|NCT02830087|5447420|P1|Overall Study|No study staff to follow-up patients|4
1572678|NCT02829996|5447487|P5|Overall Study|Withdrawal by Subject|0
1572679|NCT02829996|5447488|P4|Overall Study|Withdrawal by Subject|0
1572680|NCT02829996|5447489|P3|Overall Study|Withdrawal by Subject|0
1572681|NCT02829996|5447490|P2|Overall Study|Withdrawal by Subject|0
1572682|NCT02829996|5447491|P1|Overall Study|Withdrawal by Subject|1
1572683|NCT02829775|5447514|P1|Overall Study|Disease remission|1
1572684|NCT02829775|5447514|P1|Overall Study|Withdrawal by Subject|3
1572685|NCT02829775|5447514|P1|Overall Study|Death|1
1572686|NCT02829138|5447596|P2|Overall Study|Withdrawal by Subject|0
1572687|NCT02829138|5447597|P1|Overall Study|Withdrawal by Subject|1
1572688|NCT02828644|5447622|P2|Overall Study|Lost to Follow-up|22
1572689|NCT02828644|5447623|P1|Overall Study|Lost to Follow-up|23
1572690|NCT02828241|5447632|P2|Overall Study|Protocol Violation|0
1572691|NCT02828241|5447633|P1|Overall Study|Protocol Violation|1
1572692|NCT02828241|5447632|P2|Overall Study|Adverse Event|2
1572693|NCT02828241|5447633|P1|Overall Study|Adverse Event|7
1572694|NCT02828124|5447660|P4|Overall Study|Subject Withdrew Consent|1
1572695|NCT02828124|5447661|P3|Overall Study|Subject Withdrew Consent|0
1572696|NCT02828124|5447662|P2|Overall Study|Subject Withdrew Consent|0
1572697|NCT02828124|5447663|P1|Overall Study|Subject Withdrew Consent|0
1572698|NCT02828124|5447660|P4|Overall Study|AE Unrelated to Study Drug|1
1572699|NCT02828124|5447661|P3|Overall Study|AE Unrelated to Study Drug|0
1572700|NCT02828124|5447662|P2|Overall Study|AE Unrelated to Study Drug|0
1572701|NCT02828124|5447663|P1|Overall Study|AE Unrelated to Study Drug|0
1572702|NCT02828124|5447660|P4|Overall Study|Disease Progression|4
1572703|NCT02828124|5447661|P3|Overall Study|Disease Progression|1
1572704|NCT02828124|5447662|P2|Overall Study|Disease Progression|2
1572705|NCT02828124|5447663|P1|Overall Study|Disease Progression|1
1572706|NCT02828111|5447778|P5|Overall Study|Lost to Follow-up|1
1572707|NCT02828111|5447779|P4|Overall Study|Lost to Follow-up|1
1572708|NCT02828111|5447780|P3|Overall Study|Lost to Follow-up|0
1572709|NCT02828111|5447781|P2|Overall Study|Lost to Follow-up|0
1572710|NCT02828111|5447782|P1|Overall Study|Lost to Follow-up|0
1572711|NCT02828111|5447778|P5|Overall Study|Withdrawal by Subject|0
1572712|NCT02828111|5447779|P4|Overall Study|Withdrawal by Subject|0
1572713|NCT02828111|5447780|P3|Overall Study|Withdrawal by Subject|2
1572714|NCT02828111|5447781|P2|Overall Study|Withdrawal by Subject|0
1572715|NCT02828111|5447782|P1|Overall Study|Withdrawal by Subject|0
1572716|NCT02828020|5447843|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
1572717|NCT02828020|5447844|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
1572718|NCT02828020|5447845|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
1572719|NCT02828020|5447843|P3|Safety Follow-up Period|Protocol Violation|1
1572720|NCT02828020|5447844|P2|Safety Follow-up Period|Protocol Violation|2
1572721|NCT02828020|5447845|P1|Safety Follow-up Period|Protocol Violation|0
1572722|NCT02828020|5447843|P3|Safety Follow-up Period|Lost to Follow-up|11
1572723|NCT02828020|5447844|P2|Safety Follow-up Period|Lost to Follow-up|8
1572724|NCT02828020|5447845|P1|Safety Follow-up Period|Lost to Follow-up|9
1572725|NCT02828020|5447843|P3|Safety Follow-up Period|Withdrawal of Consent|7
1572726|NCT02828020|5447844|P2|Safety Follow-up Period|Withdrawal of Consent|8
1572727|NCT02828020|5447845|P1|Safety Follow-up Period|Withdrawal of Consent|10
1572728|NCT02828020|5447843|P3|Treatment Period|Other Miscellaneous Reasons|0
1572729|NCT02828020|5447844|P2|Treatment Period|Other Miscellaneous Reasons|1
1572730|NCT02828020|5447845|P1|Treatment Period|Other Miscellaneous Reasons|0
1572731|NCT02828020|5447843|P3|Treatment Period|Protocol Violation|7
1572732|NCT02828020|5447844|P2|Treatment Period|Protocol Violation|4
1572733|NCT02828020|5447845|P1|Treatment Period|Protocol Violation|2
1572734|NCT02828020|5447843|P3|Treatment Period|Pregnancy|0
1572735|NCT02828020|5447844|P2|Treatment Period|Pregnancy|2
1572736|NCT02828020|5447845|P1|Treatment Period|Pregnancy|0
1572737|NCT02828020|5447843|P3|Treatment Period|Lack of Qualifying Event|43
1572738|NCT02828020|5447844|P2|Treatment Period|Lack of Qualifying Event|53
1572739|NCT02828020|5447845|P1|Treatment Period|Lack of Qualifying Event|44
1572740|NCT02828020|5447843|P3|Treatment Period|Lost to Follow-up|18
1572741|NCT02828020|5447844|P2|Treatment Period|Lost to Follow-up|24
1572742|NCT02828020|5447845|P1|Treatment Period|Lost to Follow-up|21
1572743|NCT02828020|5447843|P3|Treatment Period|Withdrawal of Consent|9
1572744|NCT02828020|5447844|P2|Treatment Period|Withdrawal of Consent|14
1572745|NCT02828020|5447845|P1|Treatment Period|Withdrawal of Consent|10
1572746|NCT02828020|5447843|P3|Treatment Period|Adverse Event|1
1572747|NCT02828020|5447844|P2|Treatment Period|Adverse Event|1
1572748|NCT02828020|5447845|P1|Treatment Period|Adverse Event|3
1572755|NCT02827500|5447956|P2|Overall Study|Other|1
1572756|NCT02827500|5447957|P1|Overall Study|Other|5
1572757|NCT02827500|5447956|P2|Overall Study|Missing primary endpoint data|1
1572758|NCT02827500|5447957|P1|Overall Study|Missing primary endpoint data|3
1572759|NCT02827500|5447956|P2|Overall Study|Withdrawal by Subject|1
1572760|NCT02827500|5447957|P1|Overall Study|Withdrawal by Subject|3
1572761|NCT02827500|5447956|P2|Overall Study|Lost to Follow-up|1
1572762|NCT02827500|5447957|P1|Overall Study|Lost to Follow-up|1
1572763|NCT02827500|5447956|P2|Overall Study|Death|3
1572764|NCT02827500|5447957|P1|Overall Study|Death|7
1572765|NCT02826603|5447975|P2|Overall Study|New therapy for study indication|1
1572766|NCT02826603|5447976|P1|Overall Study|New therapy for study indication|0
1572767|NCT02826603|5447975|P2|Overall Study|Death|0
1572768|NCT02826603|5447976|P1|Overall Study|Death|2
1572769|NCT02826603|5447975|P2|Overall Study|Withdrawal by Subject|19
1572770|NCT02826603|5447976|P1|Overall Study|Withdrawal by Subject|20
1572771|NCT02826603|5447975|P2|Overall Study|Protocol Violation|3
1572772|NCT02826603|5447976|P1|Overall Study|Protocol Violation|3
1572773|NCT02826603|5447975|P2|Overall Study|Pregnancy|2
1572774|NCT02826603|5447976|P1|Overall Study|Pregnancy|1
1572775|NCT02826603|5447975|P2|Overall Study|Physician Decision|7
1572776|NCT02826603|5447976|P1|Overall Study|Physician Decision|1
1572777|NCT02826603|5447975|P2|Overall Study|Noncompliance with treatment|2
1572778|NCT02826603|5447976|P1|Overall Study|Noncompliance with treatment|0
1572779|NCT02826603|5447975|P2|Overall Study|Lost to Follow-up|12
1572780|NCT02826603|5447976|P1|Overall Study|Lost to Follow-up|13
1572781|NCT02826603|5447975|P2|Overall Study|Lack of Efficacy|9
1572782|NCT02826603|5447976|P1|Overall Study|Lack of Efficacy|4
1572783|NCT02826603|5447975|P2|Overall Study|Adverse Event|9
1572784|NCT02826603|5447976|P1|Overall Study|Adverse Event|17
1572785|NCT02826421|5448016|P4|Overall Study|Reason not given|0
1572786|NCT02826421|5448017|P3|Overall Study|Reason not given|1
1572787|NCT02826421|5448018|P2|Overall Study|Reason not given|0
1572788|NCT02826421|5448019|P1|Overall Study|Reason not given|1
1572789|NCT02826421|5448016|P4|Overall Study|Withdrawal by Subject|1
1572790|NCT02826421|5448017|P3|Overall Study|Withdrawal by Subject|1
1572791|NCT02826421|5448018|P2|Overall Study|Withdrawal by Subject|3
1572792|NCT02826421|5448019|P1|Overall Study|Withdrawal by Subject|1
1572793|NCT02826421|5448016|P4|Overall Study|Adverse Event|1
1572794|NCT02826421|5448017|P3|Overall Study|Adverse Event|0
1572795|NCT02826421|5448018|P2|Overall Study|Adverse Event|0
1572796|NCT02826421|5448019|P1|Overall Study|Adverse Event|1
1572797|NCT02825550|5448031|P1|Overall Study|Physician Decision|1
1572798|NCT02825251|5448039|P2|Overall Study|Unclassified|0
1572799|NCT02825251|5448040|P1|Overall Study|Unclassified|2
1572800|NCT02825251|5448039|P2|Overall Study|Withdrawal by Subject|4
1572801|NCT02825251|5448040|P1|Overall Study|Withdrawal by Subject|1
1572802|NCT02825251|5448039|P2|Overall Study|Lost to Follow-up|1
1572803|NCT02825251|5448040|P1|Overall Study|Lost to Follow-up|0
1572804|NCT02825251|5448039|P2|Overall Study|Adverse Event|1
1572805|NCT02825251|5448040|P1|Overall Study|Adverse Event|0
1572806|NCT02824562|5448243|P2|Overall Study|Death|1
1572807|NCT02824562|5448244|P1|Overall Study|Death|0
1572808|NCT02824562|5448243|P2|Overall Study|Lost to Follow-up|4
1572809|NCT02824562|5448244|P1|Overall Study|Lost to Follow-up|3
1572810|NCT02824432|5448253|P2|Overall Study|Major Protocol Deviation|0
1572811|NCT02824432|5448254|P1|Overall Study|Major Protocol Deviation|1
1572812|NCT02824224|5448330|P2|Overall Study|Did not show up for allocation visit|0
1572813|NCT02824224|5448331|P1|Overall Study|Did not show up for allocation visit|2
1572814|NCT02824224|5448330|P2|Overall Study|Discontinued, IUS expulsion|1
1572815|NCT02824224|5448331|P1|Overall Study|Discontinued, IUS expulsion|0
1572816|NCT02824198|5448351|P2|Overall Study|Withdrawal by Subject|0
1572817|NCT02824198|5448352|P1|Overall Study|Withdrawal by Subject|5
1572818|NCT02824198|5448351|P2|Overall Study|Lost to Follow-up|2
1572819|NCT02824198|5448352|P1|Overall Study|Lost to Follow-up|5
1572820|NCT02824198|5448351|P2|Overall Study|Non-compliance with the protocol|1
1572821|NCT02824198|5448352|P1|Overall Study|Non-compliance with the protocol|5
1572822|NCT02823964|5448382|P1|Overall Study|Withdrawal by Subject|1
1572823|NCT02823964|5448382|P1|Overall Study|Lack of Efficacy|1
1572824|NCT02823964|5448382|P1|Overall Study|Physician Decision|1
1572825|NCT02823964|5448382|P1|Overall Study|Adverse Event|2
1572826|NCT02823470|5448396|P2|Overall Study|Study terminated by sponsor|15
1572827|NCT02823470|5448397|P1|Overall Study|Study terminated by sponsor|8
1572828|NCT02823470|5448396|P2|Overall Study|Adverse Event|0
1572829|NCT02823470|5448397|P1|Overall Study|Adverse Event|1
1572830|NCT02822794|5448465|P2|Overall Study|Withdrew Consent|0
1572831|NCT02822794|5448466|P1|Overall Study|Withdrew Consent|1
1572844|NCT02821962|5448592|P2|Overall Study|Lost to Follow-up|0
1572845|NCT02821962|5448593|P1|Overall Study|Lost to Follow-up|2
1572858|NCT02821819|5448704|P1|Overall Study|Protocol Violation|1
1572859|NCT02821000|5448735|P1|Overall Study|Ongoing in Study|58
1572860|NCT02821000|5448735|P1|Overall Study|Withdrawal by Subject|1
1572861|NCT02821000|5448735|P1|Overall Study|Death|44
1572862|NCT02820844|5448773|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
1572863|NCT02820844|5448774|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572864|NCT02820844|5448775|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572865|NCT02820844|5448776|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572866|NCT02820844|5448777|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572867|NCT02820844|5448778|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572868|NCT02820844|5448773|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1572869|NCT02820844|5448774|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
1572870|NCT02820844|5448775|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1572871|NCT02820844|5448776|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1572872|NCT02820844|5448777|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1572873|NCT02820844|5448778|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
1572874|NCT02820844|5448773|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572875|NCT02820844|5448774|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572876|NCT02820844|5448775|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
1572877|NCT02820844|5448776|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
1572878|NCT02820844|5448777|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572879|NCT02820844|5448778|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
1572880|NCT02820844|5448773|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1572881|NCT02820844|5448774|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1572882|NCT02820844|5448775|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1572883|NCT02820844|5448776|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
1572884|NCT02820844|5448777|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1572885|NCT02820844|5448778|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
1572886|NCT02820844|5448773|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1572887|NCT02820844|5448774|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1572888|NCT02820844|5448775|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
1572889|NCT02820844|5448776|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
1572890|NCT02820844|5448777|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1572891|NCT02820844|5448778|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
1572892|NCT02820844|5448773|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1572893|NCT02820844|5448774|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1572894|NCT02820844|5448775|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1572895|NCT02820844|5448776|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1572896|NCT02820844|5448777|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
1572897|NCT02820844|5448778|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
1572898|NCT02820844|5448773|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1572899|NCT02820844|5448774|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1572900|NCT02820844|5448775|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1572901|NCT02820844|5448776|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
1572902|NCT02820844|5448777|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
1572903|NCT02820844|5448778|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
1572904|NCT02820844|5448773|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1572905|NCT02820844|5448774|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1572906|NCT02820844|5448775|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1572907|NCT02820844|5448776|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1572908|NCT02820844|5448777|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
1572909|NCT02820844|5448778|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
1572910|NCT02820844|5448773|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1572911|NCT02820844|5448774|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1572912|NCT02820844|5448775|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1572913|NCT02820844|5448776|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
1572914|NCT02820844|5448777|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
1572915|NCT02820844|5448778|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
1572916|NCT02820844|5448773|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1572917|NCT02820844|5448774|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1572918|NCT02820844|5448775|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1572919|NCT02820844|5448776|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
1572920|NCT02820844|5448777|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
1572921|NCT02820844|5448778|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
1572922|NCT02820597|5448992|P1|Overall Study|Lost to Follow-up|12
1572923|NCT02820038|5449004|P4|Overall Study|Withdrawal by Subject|13
1572924|NCT02820038|5449005|P3|Overall Study|Withdrawal by Subject|3
1572925|NCT02820038|5449006|P2|Overall Study|Withdrawal by Subject|14
1572926|NCT02820038|5449007|P1|Overall Study|Withdrawal by Subject|3
1572927|NCT02820038|5449004|P4|Overall Study|Lost to Follow-up|9
1572928|NCT02820038|5449005|P3|Overall Study|Lost to Follow-up|2
1572929|NCT02820038|5449006|P2|Overall Study|Lost to Follow-up|11
1572930|NCT02820038|5449007|P1|Overall Study|Lost to Follow-up|7
1572931|NCT02819804|5449109|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
1572956|NCT02818998|5449232|P3|Overall Study|Withdrawal by Subject|5
1572957|NCT02818998|5449233|P2|Overall Study|Withdrawal by Subject|4
1572958|NCT02818998|5449234|P1|Overall Study|Withdrawal by Subject|4
1572959|NCT02818998|5449232|P3|Overall Study|Death|4
1572960|NCT02818998|5449233|P2|Overall Study|Death|3
1572961|NCT02818998|5449234|P1|Overall Study|Death|2
1572962|NCT02818998|5449232|P3|Overall Study|Other|1
1572963|NCT02818998|5449233|P2|Overall Study|Other|1
1572964|NCT02818998|5449234|P1|Overall Study|Other|0
1572965|NCT02818998|5449232|P3|Overall Study|Missing information|2
1572966|NCT02818998|5449233|P2|Overall Study|Missing information|0
1572967|NCT02818998|5449234|P1|Overall Study|Missing information|0
1572968|NCT02818998|5449232|P3|Overall Study|Lost to Follow-up|2
1572969|NCT02818998|5449233|P2|Overall Study|Lost to Follow-up|0
1572970|NCT02818998|5449234|P1|Overall Study|Lost to Follow-up|2
1572971|NCT02818998|5449232|P3|Overall Study|Adverse Event|0
1572972|NCT02818998|5449233|P2|Overall Study|Adverse Event|0
1572973|NCT02818998|5449234|P1|Overall Study|Adverse Event|3
1572980|NCT02818777|5449259|P1|Overall Study|Adverse Event|3
1572981|NCT02818036|5449326|P2|Overall Study|Withdrawal by Subject|0
1572982|NCT02818036|5449327|P1|Overall Study|Withdrawal by Subject|1
1572983|NCT02818036|5449326|P2|Overall Study|head did not fit in fMRI scanner headres|0
1572984|NCT02818036|5449327|P1|Overall Study|head did not fit in fMRI scanner headres|1
1572985|NCT02817841|5449335|P1|Overall Study|Protocol Violation|94
1572986|NCT02817841|5449335|P1|Overall Study|Other reasons|53
1572987|NCT02817841|5449335|P1|Overall Study|Pregnancy wish|17
1572988|NCT02817841|5449335|P1|Overall Study|Pregnancy|32
1572989|NCT02817841|5449335|P1|Overall Study|Adverse event related to bleeding|51
1572990|NCT02817841|5449335|P1|Overall Study|Adverse event not related to bleeding|131
1572991|NCT02817841|5449335|P1|Overall Study|Withdrawal by Subject|183
1572992|NCT02817841|5449335|P1|Overall Study|Lost to Follow-up|287
1572993|NCT02817828|5449362|P1|Overall Study|Other|26
1572994|NCT02817828|5449362|P1|Overall Study|Withdrawal by Subject|78
1572995|NCT02817828|5449362|P1|Overall Study|Pregnancy wish|15
1572996|NCT02817828|5449362|P1|Overall Study|Pregnancy|7
1572997|NCT02817828|5449362|P1|Overall Study|Protocol Violation|11
1572998|NCT02817828|5449362|P1|Overall Study|Adverse event related to bleeding|53
1572999|NCT02817828|5449362|P1|Overall Study|Adverse event not related to bleeding|104
1573000|NCT02817828|5449362|P1|Overall Study|Lost to Follow-up|41
1573001|NCT02817594|5449397|P1|Overall Study|Did Not Receive Treatment|1
1573002|NCT02817594|5449397|P1|Overall Study|Other|1
1573003|NCT02817594|5449397|P1|Overall Study|Withdrawal by Subject|1
1573004|NCT02817555|5449418|P2|Overall Study|changed to Peritoneal Dialysis|1
1573005|NCT02817555|5449419|P1|Overall Study|changed to Peritoneal Dialysis|0
1573006|NCT02817555|5449418|P2|Overall Study|transplant|1
1573007|NCT02817555|5449419|P1|Overall Study|transplant|1
1573008|NCT02817555|5449418|P2|Overall Study|moved away|0
1573009|NCT02817555|5449419|P1|Overall Study|moved away|1
1573010|NCT02817555|5449418|P2|Overall Study|Death|3
1573011|NCT02817555|5449419|P1|Overall Study|Death|1
1573012|NCT02817516|5449439|P4|Overall Study|Other|0
1573013|NCT02817516|5449440|P3|Overall Study|Other|1
1573014|NCT02817516|5449441|P2|Overall Study|Other|0
1573015|NCT02817516|5449442|P1|Overall Study|Other|0
1573016|NCT02816138|5449568|P1|Overall Study|Adverse Event|1
1573017|NCT02815735|5449614|P2|Second Intervention (4 Weeks)|Protocol Violation|0
1573018|NCT02815735|5449615|P1|Second Intervention (4 Weeks)|Protocol Violation|1
1573019|NCT02815735|5449614|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
1573020|NCT02815735|5449615|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
1573021|NCT02815735|5449614|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
1573022|NCT02815735|5449615|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
1573023|NCT02815735|5449614|P2|First Intervention (4 Weeks)|Discomfort|0
1573024|NCT02815735|5449615|P1|First Intervention (4 Weeks)|Discomfort|1
1573025|NCT02815397|5449651|P1|Overall Study|Physician Decision|2
1573026|NCT02815293|5449661|P3|Overall Study|Adverse Event|0
1573027|NCT02815293|5449662|P2|Overall Study|Adverse Event|1
1573028|NCT02815293|5449663|P1|Overall Study|Adverse Event|0
1573029|NCT02815293|5449661|P3|Overall Study|Participants not randomized|18
1573030|NCT02815293|5449662|P2|Overall Study|Participants not randomized|0
1573031|NCT02815293|5449663|P1|Overall Study|Participants not randomized|0
1573032|NCT02815293|5449661|P3|Overall Study|Study termination by sponsor|0
1573033|NCT02815293|5449662|P2|Overall Study|Study termination by sponsor|7
1573034|NCT02815293|5449663|P1|Overall Study|Study termination by sponsor|10
1573035|NCT02814643|5449778|P2|Overall Study|Withdrawal by Subject|2
1573036|NCT02814643|5449779|P1|Overall Study|Withdrawal by Subject|1
1573037|NCT02814643|5449778|P2|Overall Study|Lost to Follow-up|1
1573038|NCT02814643|5449779|P1|Overall Study|Lost to Follow-up|0
1573039|NCT02814565|5449803|P2|Overall Study|Subject decision, caused by AE Influenza|1
1573040|NCT02814565|5449804|P1|Overall Study|Subject decision, caused by AE Influenza|1
1573041|NCT02814565|5449803|P2|Overall Study|Lack of Efficacy|1
1573042|NCT02814565|5449804|P1|Overall Study|Lack of Efficacy|0
1573043|NCT02813694|5449874|P2|Overall Study|Patient hospitalized|0
1573044|NCT02813694|5449875|P1|Overall Study|Patient hospitalized|1
1573045|NCT02813694|5449874|P2|Overall Study|Randomized- did not receive study drug|0
1573046|NCT02813694|5449875|P1|Overall Study|Randomized- did not receive study drug|2
1573047|NCT02813694|5449874|P2|Overall Study|Death|3
1573048|NCT02813694|5449875|P1|Overall Study|Death|3
1573049|NCT02813694|5449874|P2|Overall Study|Lost to Follow-up|1
1573050|NCT02813694|5449875|P1|Overall Study|Lost to Follow-up|1
1573051|NCT02813694|5449874|P2|Overall Study|Withdrawal by Subject|9
1573052|NCT02813694|5449875|P1|Overall Study|Withdrawal by Subject|10
1573053|NCT02813694|5449874|P2|Overall Study|Physician Decision|1
1573054|NCT02813694|5449875|P1|Overall Study|Physician Decision|0
1573055|NCT02813681|5449888|P3|Overall Study|Lost to Follow-up|0
1573056|NCT02813681|5449889|P2|Overall Study|Lost to Follow-up|1
1573057|NCT02813681|5449890|P1|Overall Study|Lost to Follow-up|0
1573058|NCT02813681|5449888|P3|Overall Study|Physician Decision|0
1573059|NCT02813681|5449889|P2|Overall Study|Physician Decision|5
1573060|NCT02813681|5449890|P1|Overall Study|Physician Decision|5
1573061|NCT02811159|5450009|P1|Treatment Course 1|Lost to Follow-up|1
1573062|NCT02809833|5450083|P1|Overall Study|Missing Information|52
1573063|NCT02809833|5450083|P1|Overall Study|Other|5
1573064|NCT02809833|5450083|P1|Overall Study|Adverse Event (AE)|24
1573065|NCT02809833|5450083|P1|Overall Study|Lost to Follow-up|35
1573066|NCT02809833|5450083|P1|Overall Study|Withdrawal by Subject|34
1573067|NCT02809833|5450083|P1|Overall Study|Noncompliance|1
1573068|NCT02809833|5450083|P1|Overall Study|Remission/Treatment No Longer Needed|3
1573069|NCT02809833|5450083|P1|Overall Study|Lack of Efficacy|89
1573070|NCT02809833|5450083|P1|Overall Study|Intolerance|54
1573071|NCT02809833|5450083|P1|Overall Study|Death|3
1573072|NCT02808338|5450214|P1|Overnight In-lab Polysomonography|Reason not given|1
1573073|NCT02808338|5450214|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
1573074|NCT02808338|5450214|P1|Screening|Screen Failure|10
1573075|NCT02807948|5450275|P2|Overall Study|Physician Decision|0
1573076|NCT02807948|5450276|P1|Overall Study|Physician Decision|1
1573077|NCT02807402|5450281|P1|Overall Study|Other|2
1573078|NCT02807402|5450281|P1|Overall Study|Death|3
1573079|NCT02807402|5450281|P1|Overall Study|Failure to Return|1
1573080|NCT02807376|5450319|P2|Overall Study|Lost to Follow-up|1
1573081|NCT02807376|5450320|P1|Overall Study|Lost to Follow-up|0
1573082|NCT02807376|5450319|P2|Overall Study|Intra-operative exclusion criteria|0
1573083|NCT02807376|5450320|P1|Overall Study|Intra-operative exclusion criteria|3
1573084|NCT02806973|5450328|P4|Period 3|Adverse Event|0
1573085|NCT02806973|5450329|P3|Period 3|Adverse Event|1
1573086|NCT02806973|5450330|P2|Period 3|Adverse Event|0
1573087|NCT02806973|5450331|P1|Period 3|Adverse Event|0
1573088|NCT02806973|5450328|P4|Period 3|Withdrawal by Subject|3
1573089|NCT02806973|5450329|P3|Period 3|Withdrawal by Subject|0
1573090|NCT02806973|5450330|P2|Period 3|Withdrawal by Subject|0
1573091|NCT02806973|5450331|P1|Period 3|Withdrawal by Subject|0
1573092|NCT02806973|5450328|P4|Period 1|Adverse Event|1
1573093|NCT02806973|5450329|P3|Period 1|Adverse Event|0
1573094|NCT02806973|5450330|P2|Period 1|Adverse Event|0
1573095|NCT02806973|5450331|P1|Period 1|Adverse Event|0
1573096|NCT02806973|5450328|P4|Period 1|Withdrawal by Subject|1
1573097|NCT02806973|5450329|P3|Period 1|Withdrawal by Subject|1
1573098|NCT02806973|5450330|P2|Period 1|Withdrawal by Subject|2
1573099|NCT02806973|5450331|P1|Period 1|Withdrawal by Subject|0
1573100|NCT02806960|5450365|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
1573101|NCT02806960|5450366|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
1573102|NCT02806960|5450367|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
1573103|NCT02806960|5450368|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
1573104|NCT02806947|5450404|P2|Overall Study|Withdrawal by Subject|1
1573105|NCT02806947|5450405|P1|Overall Study|Withdrawal by Subject|5
1573106|NCT02806726|5450446|P1|Overall Study|Lost to Follow-up|1
1573107|NCT02806713|5450455|P2|Overall Study|cancelled surgery|2
1573108|NCT02806713|5450456|P1|Overall Study|cancelled surgery|1
1573109|NCT02806713|5450455|P2|Overall Study|Urethral injury during procedure|0
1573110|NCT02806713|5450456|P1|Overall Study|Urethral injury during procedure|1
1573111|NCT02806505|5450475|P2|Overall Study|Insufficient therapeutic response|4
1573112|NCT02806505|5450476|P1|Overall Study|Insufficient therapeutic response|2
1573113|NCT02806505|5450475|P2|Overall Study|Failure to return|1
1573114|NCT02806505|5450476|P1|Overall Study|Failure to return|0
1573115|NCT02806505|5450475|P2|Overall Study|Did not cooperate/refused treatment|3
1573116|NCT02806505|5450476|P1|Overall Study|Did not cooperate/refused treatment|3
1573117|NCT02806505|5450475|P2|Overall Study|Death|0
1573118|NCT02806505|5450476|P1|Overall Study|Death|4
1573119|NCT02806505|5450475|P2|Overall Study|Adverse event/intercurrent illness|3
1573120|NCT02806505|5450476|P1|Overall Study|Adverse event/intercurrent illness|1
1573121|NCT02806232|5450495|P9|Overall Study|Withdrawal by Subject|0
1573122|NCT02806232|5450496|P8|Overall Study|Withdrawal by Subject|0
1573123|NCT02806232|5450497|P7|Overall Study|Withdrawal by Subject|0
1573124|NCT02806232|5450498|P6|Overall Study|Withdrawal by Subject|1
1573125|NCT02806232|5450499|P5|Overall Study|Withdrawal by Subject|2
1573126|NCT02806232|5450500|P4|Overall Study|Withdrawal by Subject|0
1573127|NCT02806232|5450501|P3|Overall Study|Withdrawal by Subject|0
1573128|NCT02806232|5450502|P2|Overall Study|Withdrawal by Subject|2
1573129|NCT02806232|5450503|P1|Overall Study|Withdrawal by Subject|0
1573130|NCT02806232|5450495|P9|Overall Study|Lost to Follow-up|0
1573131|NCT02806232|5450496|P8|Overall Study|Lost to Follow-up|0
1573132|NCT02806232|5450497|P7|Overall Study|Lost to Follow-up|0
1573133|NCT02806232|5450498|P6|Overall Study|Lost to Follow-up|1
1573134|NCT02806232|5450499|P5|Overall Study|Lost to Follow-up|0
1573135|NCT02806232|5450500|P4|Overall Study|Lost to Follow-up|0
1573136|NCT02806232|5450501|P3|Overall Study|Lost to Follow-up|1
1573137|NCT02806232|5450502|P2|Overall Study|Lost to Follow-up|2
1573138|NCT02806232|5450503|P1|Overall Study|Lost to Follow-up|1
1573139|NCT02806024|5450543|P2|Overall Study|DVT during antepartum admission|1
1573140|NCT02806024|5450544|P1|Overall Study|DVT during antepartum admission|0
1573141|NCT02806024|5450543|P2|Overall Study|Night Delivery|1
1573142|NCT02806024|5450544|P1|Overall Study|Night Delivery|1
1573143|NCT02805907|5450554|P2|Overall Study|Lost to Follow-up|3
1573144|NCT02805907|5450555|P1|Overall Study|Lost to Follow-up|3
1573145|NCT02804750|5450578|P2|Period 4|Adverse Event|5
1573146|NCT02804750|5450579|P1|Period 4|Adverse Event|0
1573147|NCT02804750|5450578|P2|Period 3|Adverse Event|2
1573148|NCT02804750|5450579|P1|Period 3|Adverse Event|0
1573149|NCT02804750|5450578|P2|Period 2|Adverse Event|0
1573150|NCT02804750|5450579|P1|Period 2|Adverse Event|1
1573151|NCT02804750|5450578|P2|Period 1|Withdrawal by Subject|1
1573152|NCT02804750|5450579|P1|Period 1|Withdrawal by Subject|0
1573153|NCT02804750|5450578|P2|Period 1|Adverse Event|2
1573154|NCT02804750|5450579|P1|Period 1|Adverse Event|0
1573155|NCT02804399|5450606|P2|Period 2|Adverse Event|1
1573156|NCT02804399|5450607|P1|Period 2|Adverse Event|0
1573157|NCT02803580|5450679|P1|Overall Study|Inclusion in clinical trial|1
1573158|NCT02803580|5450679|P1|Overall Study|Withdrawal by Subject|3
1573159|NCT02803580|5450679|P1|Overall Study|Lost to Follow-up|19
1573160|NCT02803580|5450679|P1|Overall Study|Death|13
1573161|NCT02803138|5450718|P1|Overall Study|Other, not specified|28
1573162|NCT02803138|5450718|P1|Overall Study|Death|1
1573163|NCT02803138|5450718|P1|Overall Study|Withdrawn consent|1
1573164|NCT02803138|5450718|P1|Overall Study|Insufficient virological response|2
1573165|NCT02803138|5450718|P1|Overall Study|Failure to return|38
1573166|NCT02802878|5450734|P2|Overall Study|Protocol Violation|0
1573167|NCT02802878|5450735|P1|Overall Study|Protocol Violation|1
1573168|NCT02802878|5450734|P2|Overall Study|Withdrawal by Subject|3
1573169|NCT02802878|5450735|P1|Overall Study|Withdrawal by Subject|3
1573170|NCT02802865|5450751|P2|Overall Study|Ineliegible due to tuberculosis|1
1573171|NCT02802865|5450752|P1|Overall Study|Ineliegible due to tuberculosis|0
1573172|NCT02802865|5450751|P2|Overall Study|Pregnancy|1
1573173|NCT02802865|5450752|P1|Overall Study|Pregnancy|1
1573174|NCT02802592|5450774|P1|Overall Study|Study terminated due to loss of funding|4
1573175|NCT02802345|5450806|P2|Overall Study|Other than listed|5
1573176|NCT02802345|5450807|P1|Overall Study|Other than listed|1
1573177|NCT02802345|5450806|P2|Overall Study|Protocol Violation|1
1573178|NCT02802345|5450807|P1|Overall Study|Protocol Violation|0
1573179|NCT02802345|5450806|P2|Overall Study|Withdrawal by Subject|3
1573180|NCT02802345|5450807|P1|Overall Study|Withdrawal by Subject|3
1573181|NCT02802345|5450806|P2|Overall Study|Adverse Event|20
1573182|NCT02802345|5450807|P1|Overall Study|Adverse Event|28
1573183|NCT02802345|5450806|P2|Overall Study|Not Treated|1
1573184|NCT02802345|5450807|P1|Overall Study|Not Treated|0
1573185|NCT02802319|5450823|P2|Overall Study|Lost to Follow-up|4
1573186|NCT02802319|5450824|P1|Overall Study|Lost to Follow-up|0
1573187|NCT02802319|5450823|P2|Overall Study|Physician Decision|1
1573188|NCT02802319|5450824|P1|Overall Study|Physician Decision|2
1573189|NCT02801877|5450959|P4|Overall Study|Never Started Treatment|0
1573190|NCT02801877|5450960|P3|Overall Study|Never Started Treatment|4
1573191|NCT02801877|5450961|P2|Overall Study|Never Started Treatment|0
1573192|NCT02801877|5450962|P1|Overall Study|Never Started Treatment|2
1573193|NCT02801877|5450959|P4|Overall Study|Lost to Follow-up|0
1573194|NCT02801877|5450960|P3|Overall Study|Lost to Follow-up|2
1573195|NCT02801877|5450961|P2|Overall Study|Lost to Follow-up|1
1573196|NCT02801877|5450962|P1|Overall Study|Lost to Follow-up|1
1573197|NCT02801617|5450982|P2|Overall Study|Protocol Violation|6
1573198|NCT02801617|5450983|P1|Overall Study|Protocol Violation|2
1573199|NCT02801396|5451001|P6|Period 1|Withdrawal by Subject|0
1573200|NCT02801396|5451002|P5|Period 1|Withdrawal by Subject|1
1573201|NCT02801396|5451003|P4|Period 1|Withdrawal by Subject|0
1573202|NCT02801396|5451004|P3|Period 1|Withdrawal by Subject|0
1573203|NCT02801396|5451005|P2|Period 1|Withdrawal by Subject|0
1573204|NCT02801396|5451006|P1|Period 1|Withdrawal by Subject|0
1573205|NCT02800928|5451040|P2|Overall Study|Protocol Violation|1
1573206|NCT02800928|5451041|P1|Overall Study|Protocol Violation|1
1573207|NCT02800928|5451040|P2|Overall Study|Withdrawal by Subject|1
1573208|NCT02800928|5451041|P1|Overall Study|Withdrawal by Subject|1
1573209|NCT02799784|5451067|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
1573210|NCT02799784|5451068|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
1573211|NCT02799784|5451067|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
1573212|NCT02799784|5451068|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
1573213|NCT02799784|5451067|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
1573214|NCT02799784|5451068|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
1573215|NCT02799784|5451067|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
1573216|NCT02799784|5451068|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
1573217|NCT02799784|5451067|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
1573218|NCT02799784|5451068|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
1573219|NCT02799784|5451067|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1573220|NCT02799784|5451068|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
1573221|NCT02799472|5451076|P2|Overall Study|Lost to Follow-up|1
1573222|NCT02799472|5451077|P1|Overall Study|Lost to Follow-up|0
1573223|NCT02799472|5451076|P2|Overall Study|Lack of Efficacy|0
1573224|NCT02799472|5451077|P1|Overall Study|Lack of Efficacy|2
1573225|NCT02799472|5451076|P2|Overall Study|Withdrawal by Subject|4
1573226|NCT02799472|5451077|P1|Overall Study|Withdrawal by Subject|2
1573227|NCT02799082|5451137|P2|Overall Study|Protocol Violation|1
1573228|NCT02799082|5451138|P1|Overall Study|Protocol Violation|0
1573229|NCT02799082|5451137|P2|Overall Study|Refused second PDT or withdraw consent|3
1573230|NCT02799082|5451138|P1|Overall Study|Refused second PDT or withdraw consent|4
1573231|NCT02799069|5451175|P3|Overall Study|Protocol Violation|2
1573232|NCT02799069|5451176|P2|Overall Study|Protocol Violation|0
1573233|NCT02799069|5451177|P1|Overall Study|Protocol Violation|1
1573234|NCT02799069|5451175|P3|Overall Study|Withdrawal by Subject|3
1573235|NCT02799069|5451176|P2|Overall Study|Withdrawal by Subject|4
1573236|NCT02799069|5451177|P1|Overall Study|Withdrawal by Subject|4
1573237|NCT02799069|5451175|P3|Overall Study|Lost to Follow-up|0
1573238|NCT02799069|5451176|P2|Overall Study|Lost to Follow-up|1
1573239|NCT02799069|5451177|P1|Overall Study|Lost to Follow-up|1
1573240|NCT02799069|5451175|P3|Overall Study|Lack of Efficacy|0
1573241|NCT02799069|5451176|P2|Overall Study|Lack of Efficacy|0
1573242|NCT02799069|5451177|P1|Overall Study|Lack of Efficacy|2
1573243|NCT02799069|5451175|P3|Overall Study|Adverse Event|2
1573244|NCT02799069|5451176|P2|Overall Study|Adverse Event|2
1573245|NCT02799069|5451177|P1|Overall Study|Adverse Event|0
1573246|NCT02798315|5451546|P1|Overall Study|Failure to return|1
1573247|NCT02797678|5451580|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
1573248|NCT02797678|5451581|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
1573249|NCT02797678|5451582|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
1573250|NCT02797678|5451583|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
1573251|NCT02797678|5451580|P4|First Intervention (5 Nights)|study/device use non-compliance|0
1573252|NCT02797678|5451581|P3|First Intervention (5 Nights)|study/device use non-compliance|0
1573253|NCT02797678|5451582|P2|First Intervention (5 Nights)|study/device use non-compliance|1
1573254|NCT02797678|5451583|P1|First Intervention (5 Nights)|study/device use non-compliance|0
1573255|NCT02797678|5451580|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
1573256|NCT02797678|5451581|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
1573257|NCT02797678|5451582|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
1573258|NCT02797678|5451583|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
1573259|NCT02797522|5451609|P11|Overall Study|Study Terminated by Sponsor|1
1573260|NCT02797522|5451610|P10|Overall Study|Study Terminated by Sponsor|4
1573261|NCT02797522|5451611|P9|Overall Study|Study Terminated by Sponsor|2
1573262|NCT02797522|5451612|P8|Overall Study|Study Terminated by Sponsor|4
1573263|NCT02797522|5451613|P7|Overall Study|Study Terminated by Sponsor|0
1573264|NCT02797522|5451614|P6|Overall Study|Study Terminated by Sponsor|0
1573265|NCT02797522|5451615|P5|Overall Study|Study Terminated by Sponsor|0
1573266|NCT02797522|5451616|P4|Overall Study|Study Terminated by Sponsor|0
1573267|NCT02797522|5451617|P3|Overall Study|Study Terminated by Sponsor|0
1573268|NCT02797522|5451618|P2|Overall Study|Study Terminated by Sponsor|0
1573269|NCT02797522|5451619|P1|Overall Study|Study Terminated by Sponsor|0
1573270|NCT02797132|5451725|P1|Part B (24 Weeks)|Adverse Event|3
1573271|NCT02797132|5451725|P1|Part A (15 Days)|Adverse Event|1
1573272|NCT02797080|5451777|P1|Overall Study|Withdrawal by Subject|1
1573273|NCT02797080|5451777|P1|Overall Study|Lost to Follow-up|1
1573274|NCT02796963|5451819|P4|Overall Study|Lost to Follow-up|72
1573275|NCT02796963|5451820|P3|Overall Study|Lost to Follow-up|69
1573276|NCT02796963|5451821|P2|Overall Study|Lost to Follow-up|76
1573277|NCT02796963|5451822|P1|Overall Study|Lost to Follow-up|89
1573278|NCT02796677|5451888|P4|Overall Study|Reason not mentioned|5
1573279|NCT02796677|5451889|P3|Overall Study|Reason not mentioned|0
1573280|NCT02796677|5451890|P2|Overall Study|Reason not mentioned|3
1573281|NCT02796677|5451891|P1|Overall Study|Reason not mentioned|2
1573282|NCT02796677|5451888|P4|Overall Study|Progressive disease|18
1573283|NCT02796677|5451889|P3|Overall Study|Progressive disease|13
1573284|NCT02796677|5451890|P2|Overall Study|Progressive disease|15
1573285|NCT02796677|5451891|P1|Overall Study|Progressive disease|6
1573286|NCT02796677|5451888|P4|Overall Study|Withdrawal by Subject|7
1573287|NCT02796677|5451889|P3|Overall Study|Withdrawal by Subject|6
1573288|NCT02796677|5451890|P2|Overall Study|Withdrawal by Subject|14
1573289|NCT02796677|5451891|P1|Overall Study|Withdrawal by Subject|4
1573290|NCT02796677|5451888|P4|Overall Study|Lack of Efficacy|20
1573291|NCT02796677|5451889|P3|Overall Study|Lack of Efficacy|14
1573292|NCT02796677|5451890|P2|Overall Study|Lack of Efficacy|9
1573293|NCT02796677|5451891|P1|Overall Study|Lack of Efficacy|7
1573294|NCT02796677|5451888|P4|Overall Study|Lost to Follow-up|2
1573295|NCT02796677|5451889|P3|Overall Study|Lost to Follow-up|2
1573296|NCT02796677|5451890|P2|Overall Study|Lost to Follow-up|5
1573297|NCT02796677|5451891|P1|Overall Study|Lost to Follow-up|1
1573298|NCT02796677|5451888|P4|Overall Study|Protocol Violation|8
1573299|NCT02796677|5451889|P3|Overall Study|Protocol Violation|4
1573300|NCT02796677|5451890|P2|Overall Study|Protocol Violation|5
1573301|NCT02796677|5451891|P1|Overall Study|Protocol Violation|7
1573302|NCT02796677|5451888|P4|Overall Study|Adverse Event|14
1573303|NCT02796677|5451889|P3|Overall Study|Adverse Event|14
1573304|NCT02796677|5451890|P2|Overall Study|Adverse Event|22
1573305|NCT02796677|5451891|P1|Overall Study|Adverse Event|11
1573306|NCT02796651|5451915|P1|Overall Study|Other|10
1573307|NCT02796651|5451915|P1|Overall Study|Lack of Efficacy|1
1573308|NCT02796651|5451915|P1|Overall Study|Protocol Violation|4
1573309|NCT02796651|5451915|P1|Overall Study|Withdrawal by Subject|4
1573310|NCT02796651|5451915|P1|Overall Study|Lost to Follow-up|1
1573311|NCT02796651|5451915|P1|Overall Study|Adverse Event|6
1573312|NCT02795832|5451996|P6|Overall Study|Adverse Event|3
1573313|NCT02795832|5451997|P5|Overall Study|Adverse Event|0
1573314|NCT02795832|5451998|P4|Overall Study|Adverse Event|0
1573315|NCT02795832|5451999|P3|Overall Study|Adverse Event|0
1573316|NCT02795832|5452000|P2|Overall Study|Adverse Event|0
1573317|NCT02795832|5452001|P1|Overall Study|Adverse Event|0
1573318|NCT02795767|5452068|P3|Overall Study|Lack of Efficacy|1
1573319|NCT02795767|5452069|P2|Overall Study|Lack of Efficacy|0
1573320|NCT02795767|5452070|P1|Overall Study|Lack of Efficacy|0
1573321|NCT02795767|5452068|P3|Overall Study|Ongoing Study Treatment|9
1573322|NCT02795767|5452069|P2|Overall Study|Ongoing Study Treatment|10
1573323|NCT02795767|5452070|P1|Overall Study|Ongoing Study Treatment|66
1573324|NCT02795767|5452068|P3|Overall Study|Received Commercial Emicizumab|0
1573325|NCT02795767|5452069|P2|Overall Study|Received Commercial Emicizumab|0
1573326|NCT02795767|5452070|P1|Overall Study|Received Commercial Emicizumab|2
1573327|NCT02794974|5452191|P2|Overall Study|Physician Decision|1
1573328|NCT02794974|5452192|P1|Overall Study|Physician Decision|0
1573329|NCT02794870|5452208|P2|Overall Study|Withdrawal by Subject|0
1573330|NCT02794870|5452209|P1|Overall Study|Withdrawal by Subject|2
1573331|NCT02794480|5452245|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1573332|NCT02794480|5452246|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1573333|NCT02794480|5452247|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1573334|NCT02794480|5452248|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1573335|NCT02794480|5452245|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1573336|NCT02794480|5452246|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1573337|NCT02794480|5452247|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
1573338|NCT02794480|5452248|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1573339|NCT02794480|5452245|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
1573340|NCT02794480|5452246|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1573341|NCT02794480|5452247|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1573342|NCT02794480|5452248|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
1573343|NCT02794480|5452245|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1573344|NCT02794480|5452246|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
1573345|NCT02794480|5452247|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1573346|NCT02794480|5452248|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
1573347|NCT02794480|5452245|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1573348|NCT02794480|5452246|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
1573349|NCT02794480|5452247|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1573350|NCT02794480|5452248|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
1573351|NCT02794103|5452299|P1|Overall Study|Loss to follow up due to high sedation|3
1573352|NCT02793947|5452310|P2|Overall Study|Physician Decision|5
1573353|NCT02793947|5452311|P1|Overall Study|Physician Decision|1
1573354|NCT02793947|5452310|P2|Overall Study|Death|0
1573355|NCT02793947|5452311|P1|Overall Study|Death|1
1573356|NCT02793232|5452366|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1573357|NCT02793232|5452367|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1573358|NCT02793232|5452368|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
1573359|NCT02793232|5452369|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1573360|NCT02793232|5452370|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
1573361|NCT02793232|5452371|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1573362|NCT02793232|5452372|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1573363|NCT02793232|5452373|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1573364|NCT02793232|5452374|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
1573365|NCT02792829|5452635|P8|Treatment Period 2|Use of proscribed medications|1
1573366|NCT02792829|5452636|P7|Treatment Period 2|Use of proscribed medications|0
1573367|NCT02792829|5452637|P6|Treatment Period 2|Use of proscribed medications|0
1573368|NCT02792829|5452638|P5|Treatment Period 2|Use of proscribed medications|0
1573369|NCT02792829|5452639|P4|Treatment Period 2|Use of proscribed medications|0
1573370|NCT02792829|5452640|P3|Treatment Period 2|Use of proscribed medications|0
1573371|NCT02792829|5452641|P2|Treatment Period 2|Use of proscribed medications|0
1573372|NCT02792829|5452642|P1|Treatment Period 2|Use of proscribed medications|0
1573373|NCT02792829|5452635|P8|Treatment Period 2|Adverse Event|1
1573374|NCT02792829|5452636|P7|Treatment Period 2|Adverse Event|1
1573375|NCT02792829|5452637|P6|Treatment Period 2|Adverse Event|0
1573376|NCT02792829|5452638|P5|Treatment Period 2|Adverse Event|1
1573377|NCT02792829|5452639|P4|Treatment Period 2|Adverse Event|0
1573378|NCT02792829|5452640|P3|Treatment Period 2|Adverse Event|0
1573379|NCT02792829|5452641|P2|Treatment Period 2|Adverse Event|0
1573380|NCT02792829|5452642|P1|Treatment Period 2|Adverse Event|0
1573381|NCT02792829|5452635|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
1573382|NCT02792829|5452636|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
1573383|NCT02792829|5452637|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
1573384|NCT02792829|5452638|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
1573385|NCT02792829|5452639|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
1573386|NCT02792829|5452640|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
1573387|NCT02792829|5452641|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
1573388|NCT02792829|5452642|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
1573389|NCT02792777|5452750|P2|Overall Study|Participant interviewed twice|0
1573390|NCT02792777|5452751|P1|Overall Study|Participant interviewed twice|1
1573391|NCT02792777|5452750|P2|Overall Study|Later determined to be ineligible|0
1573392|NCT02792777|5452751|P1|Overall Study|Later determined to be ineligible|2
1573393|NCT02792777|5452750|P2|Overall Study|Recording malfunction|0
1573394|NCT02792777|5452751|P1|Overall Study|Recording malfunction|2
1573395|NCT02792777|5452750|P2|Overall Study|Withdrawal by Subject|0
1573396|NCT02792777|5452751|P1|Overall Study|Withdrawal by Subject|2
1573397|NCT02792699|5452767|P3|Overall Study|Other|0
1573398|NCT02792699|5452768|P2|Overall Study|Other|0
1573399|NCT02792699|5452769|P1|Overall Study|Other|1
1573400|NCT02792699|5452767|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
1573401|NCT02792699|5452768|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
1573402|NCT02792699|5452769|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
1573403|NCT02792699|5452767|P3|Overall Study|Physician Decision|0
1573404|NCT02792699|5452768|P2|Overall Study|Physician Decision|0
1573405|NCT02792699|5452769|P1|Overall Study|Physician Decision|2
1573406|NCT02792699|5452767|P3|Overall Study|Lost to Follow-up|2
1573407|NCT02792699|5452768|P2|Overall Study|Lost to Follow-up|1
1573408|NCT02792699|5452769|P1|Overall Study|Lost to Follow-up|0
1573409|NCT02792699|5452767|P3|Overall Study|Withdrawal by Subject|3
1573410|NCT02792699|5452768|P2|Overall Study|Withdrawal by Subject|4
1573411|NCT02792699|5452769|P1|Overall Study|Withdrawal by Subject|4
1573412|NCT02792699|5452767|P3|Overall Study|Adverse Event|4
1573413|NCT02792699|5452768|P2|Overall Study|Adverse Event|2
1573414|NCT02792699|5452769|P1|Overall Study|Adverse Event|1
1573415|NCT02792517|5452850|P1|Overall Study|Lost to Follow-up|3
1573416|NCT02792517|5452850|P1|Overall Study|Decision by Sponsor|7
1573417|NCT02792517|5452850|P1|Overall Study|Withdrawal by Subject|10
1573418|NCT02792062|5452870|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1573419|NCT02792062|5452871|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1573420|NCT02792062|5452872|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1573421|NCT02792062|5452873|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1573422|NCT02792062|5452874|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
1573423|NCT02792062|5452875|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
1573424|NCT02791763|5452927|P3|Overall Study|Adverse Event|7
1573425|NCT02791763|5452928|P2|Overall Study|Adverse Event|13
1573426|NCT02791763|5452929|P1|Overall Study|Adverse Event|12
1573427|NCT02791763|5452927|P3|Overall Study|Met hemoglobin stopping criteria|0
1573428|NCT02791763|5452928|P2|Overall Study|Met hemoglobin stopping criteria|0
1573429|NCT02791763|5452929|P1|Overall Study|Met hemoglobin stopping criteria|1
1573430|NCT02791763|5452927|P3|Overall Study|Participant had renal transplant|0
1573431|NCT02791763|5452928|P2|Overall Study|Participant had renal transplant|0
1573432|NCT02791763|5452929|P1|Overall Study|Participant had renal transplant|3
1573433|NCT02791763|5452927|P3|Overall Study|Cancer event|0
1573434|NCT02791763|5452928|P2|Overall Study|Cancer event|3
1573435|NCT02791763|5452929|P1|Overall Study|Cancer event|1
1573436|NCT02791763|5452927|P3|Overall Study|Needs maintenance/changes in dialysis|5
1573437|NCT02791763|5452928|P2|Overall Study|Needs maintenance/changes in dialysis|19
1573438|NCT02791763|5452929|P1|Overall Study|Needs maintenance/changes in dialysis|16
1573439|NCT02791763|5452927|P3|Overall Study|Physician Decision|0
1573440|NCT02791763|5452928|P2|Overall Study|Physician Decision|1
1573441|NCT02791763|5452929|P1|Overall Study|Physician Decision|0
1573442|NCT02791763|5452927|P3|Overall Study|Withdrawal by Subject|0
1573443|NCT02791763|5452928|P2|Overall Study|Withdrawal by Subject|1
1573444|NCT02791763|5452929|P1|Overall Study|Withdrawal by Subject|5
1573445|NCT02791763|5452927|P3|Overall Study|Protocol Violation|1
1573446|NCT02791763|5452928|P2|Overall Study|Protocol Violation|0
1573447|NCT02791763|5452929|P1|Overall Study|Protocol Violation|0
1573448|NCT02791659|5453048|P2|Overall Study|Protocol Violation|1
1573449|NCT02791659|5453049|P1|Overall Study|Protocol Violation|0
1573450|NCT02791516|5453057|P2|Overall Study|Withdrawal by Subject|1
1573451|NCT02791516|5453058|P1|Overall Study|Withdrawal by Subject|1
1573452|NCT02791490|5453070|P2|Overall Study|Withdrawal by Subject|6
1573453|NCT02791490|5453071|P1|Overall Study|Withdrawal by Subject|2
1573454|NCT02791490|5453070|P2|Overall Study|Lost to Follow-up|2
1573455|NCT02791490|5453071|P1|Overall Study|Lost to Follow-up|1
1573456|NCT02791438|5453091|P2|Treatment Period|Withdrawal by Parent/Guardian|0
1573457|NCT02791438|5453092|P1|Treatment Period|Withdrawal by Parent/Guardian|2
1573458|NCT02791438|5453091|P2|Treatment Period|Withdrawal by Subject|1
1573459|NCT02791438|5453092|P1|Treatment Period|Withdrawal by Subject|0
1573460|NCT02791438|5453091|P2|Treatment Period|Adverse Event|0
1573461|NCT02791438|5453092|P1|Treatment Period|Adverse Event|1
1573462|NCT02791269|5453120|P2|Overall Study|Lost to Follow-up|1
1573463|NCT02791269|5453121|P1|Overall Study|Lost to Follow-up|0
1573464|NCT02790606|5453199|P1|Overall Study|Physician Decision|1
1573465|NCT02790606|5453199|P1|Overall Study|Lost to Follow-up|1
1573466|NCT02790606|5453199|P1|Overall Study|Death|6
1573467|NCT02790073|5453231|P1|Overall Study|Withdrawal by Subject|1
1573468|NCT02790073|5453231|P1|Overall Study|Withdrawal from HD|1
1573469|NCT02790073|5453231|P1|Overall Study|Death|1
1573472|NCT02788474|5453275|P2|Open Label Treatment Period|Non-compliance|0
1573473|NCT02788474|5453276|P1|Open Label Treatment Period|Non-compliance|1
1573474|NCT02788474|5453275|P2|Open Label Treatment Period|Patient's refusal|3
1573475|NCT02788474|5453276|P1|Open Label Treatment Period|Patient's refusal|1
1573476|NCT02788474|5453275|P2|Open Label Treatment Period|Other than reason specified|0
1573477|NCT02788474|5453276|P1|Open Label Treatment Period|Other than reason specified|1
1573478|NCT02788474|5453275|P2|Open Label Treatment Period|Adverse Event|9
1573479|NCT02788474|5453276|P1|Open Label Treatment Period|Adverse Event|29
1573480|NCT02788474|5453275|P2|Double Blind Treatment Period|Adverse Event|4
1573481|NCT02788474|5453276|P1|Double Blind Treatment Period|Adverse Event|6
1573482|NCT02788474|5453275|P2|Double Blind Treatment Period|Patient's refusal|0
1573483|NCT02788474|5453276|P1|Double Blind Treatment Period|Patient's refusal|3
1573484|NCT02788474|5453275|P2|Double Blind Treatment Period|Not treated|0
1573485|NCT02788474|5453276|P1|Double Blind Treatment Period|Not treated|1
1573486|NCT02788357|5453291|P2|Overall Study|Lost to Follow-up|0
1573487|NCT02788357|5453292|P1|Overall Study|Lost to Follow-up|3
1573488|NCT02788279|5453307|P3|Overall Study|Sponsor decision|11
1573489|NCT02788279|5453308|P2|Overall Study|Sponsor decision|29
1573490|NCT02788279|5453309|P1|Overall Study|Sponsor decision|18
1573491|NCT02788279|5453307|P3|Overall Study|Lost to Follow-up|2
1573492|NCT02788279|5453308|P2|Overall Study|Lost to Follow-up|3
1573493|NCT02788279|5453309|P1|Overall Study|Lost to Follow-up|0
1573494|NCT02788279|5453307|P3|Overall Study|Withdrawal by Subject|5
1573495|NCT02788279|5453308|P2|Overall Study|Withdrawal by Subject|15
1573496|NCT02788279|5453309|P1|Overall Study|Withdrawal by Subject|10
1573497|NCT02788279|5453307|P3|Overall Study|Death|72
1573498|NCT02788279|5453308|P2|Overall Study|Death|136
1573499|NCT02788279|5453309|P1|Overall Study|Death|62
1573519|NCT02787551|5453483|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
1573520|NCT02787551|5453484|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
1573521|NCT02787551|5453483|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
1573522|NCT02787551|5453484|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
1573523|NCT02787551|5453483|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
1573524|NCT02787551|5453484|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
1573525|NCT02787551|5453483|P2|Core Period: 26 Weeks|Other than specified|1
1573526|NCT02787551|5453484|P1|Core Period: 26 Weeks|Other than specified|3
1573527|NCT02787551|5453483|P2|Core Period: 26 Weeks|Randomized but not treated|1
1573528|NCT02787551|5453484|P1|Core Period: 26 Weeks|Randomized but not treated|2
1573529|NCT02787551|5453483|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
1573530|NCT02787551|5453484|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
1573531|NCT02787551|5453483|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
1573532|NCT02787551|5453484|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
1573533|NCT02787551|5453483|P2|Core Period: 26 Weeks|Lack of Efficacy|0
1573534|NCT02787551|5453484|P1|Core Period: 26 Weeks|Lack of Efficacy|1
1573535|NCT02787551|5453483|P2|Core Period: 26 Weeks|Adverse Event|0
1573536|NCT02787551|5453484|P1|Core Period: 26 Weeks|Adverse Event|10
1573537|NCT02787304|5453520|P4|Overall Study|Study terminated by sponsor|32
1573538|NCT02787304|5453521|P3|Overall Study|Study terminated by sponsor|31
1573539|NCT02787304|5453522|P2|Overall Study|Study terminated by sponsor|31
1573540|NCT02787304|5453523|P1|Overall Study|Study terminated by sponsor|25
1573541|NCT02787304|5453520|P4|Overall Study|Physician Decision|0
1573542|NCT02787304|5453521|P3|Overall Study|Physician Decision|1
1573543|NCT02787304|5453522|P2|Overall Study|Physician Decision|0
1573544|NCT02787304|5453523|P1|Overall Study|Physician Decision|0
1573545|NCT02787304|5453520|P4|Overall Study|Noncompliance with study drug|0
1573546|NCT02787304|5453521|P3|Overall Study|Noncompliance with study drug|1
1573547|NCT02787304|5453522|P2|Overall Study|Noncompliance with study drug|0
1573548|NCT02787304|5453523|P1|Overall Study|Noncompliance with study drug|0
1573549|NCT02787304|5453520|P4|Overall Study|Lost to Follow-up|1
1573550|NCT02787304|5453521|P3|Overall Study|Lost to Follow-up|0
1573551|NCT02787304|5453522|P2|Overall Study|Lost to Follow-up|0
1573552|NCT02787304|5453523|P1|Overall Study|Lost to Follow-up|1
1573553|NCT02787304|5453520|P4|Overall Study|Withdrawal by Subject|0
1573554|NCT02787304|5453521|P3|Overall Study|Withdrawal by Subject|0
1573555|NCT02787304|5453522|P2|Overall Study|Withdrawal by Subject|4
1573556|NCT02787304|5453523|P1|Overall Study|Withdrawal by Subject|1
1573557|NCT02787304|5453520|P4|Overall Study|Adverse Event|1
1573558|NCT02787304|5453521|P3|Overall Study|Adverse Event|8
1573559|NCT02787304|5453522|P2|Overall Study|Adverse Event|3
1573560|NCT02787304|5453523|P1|Overall Study|Adverse Event|9
1573561|NCT02787083|5453571|P2|Overall Study|Withdrawal by Subject|2
1573562|NCT02787083|5453572|P1|Overall Study|Withdrawal by Subject|2
1573563|NCT02787083|5453571|P2|Overall Study|Adverse Event|0
1573564|NCT02787083|5453572|P1|Overall Study|Adverse Event|1
1573565|NCT02786953|5453582|P2|Overall Study|Physician Decision|1
1573566|NCT02786953|5453583|P1|Overall Study|Physician Decision|0
1573567|NCT02786953|5453582|P2|Overall Study|Withdrawal by Subject|0
1573568|NCT02786953|5453583|P1|Overall Study|Withdrawal by Subject|3
1573569|NCT02786927|5453605|P1|Overall Study|Protocol Violation|4
1573570|NCT02786927|5453605|P1|Overall Study|Adverse Event|1
1573571|NCT02786004|5453635|P2|Overall Study|Withdrawal by Subject|1
1573572|NCT02786004|5453636|P1|Overall Study|Withdrawal by Subject|0
1573579|NCT02785900|5453653|P2|Overall Study|Physician Decision|2
1573580|NCT02785900|5453654|P1|Overall Study|Physician Decision|3
1573581|NCT02785900|5453653|P2|Overall Study|Withdrawal by Subject|8
1573582|NCT02785900|5453654|P1|Overall Study|Withdrawal by Subject|4
1573583|NCT02785900|5453653|P2|Overall Study|Death|32
1573584|NCT02785900|5453654|P1|Overall Study|Death|46
1573585|NCT02785900|5453653|P2|Overall Study|Study Termination by Sponsor|81
1573586|NCT02785900|5453654|P1|Overall Study|Study Termination by Sponsor|64
1573587|NCT02785770|5453678|P4|Intervention Period 3 (1 Day)|Adverse Event|1
1573588|NCT02785770|5453679|P3|Intervention Period 3 (1 Day)|Adverse Event|0
1573589|NCT02785770|5453680|P2|Intervention Period 3 (1 Day)|Adverse Event|0
1573590|NCT02785770|5453681|P1|Intervention Period 3 (1 Day)|Adverse Event|0
1573591|NCT02785770|5453678|P4|Intervention Period 2 (1 Day)|Family related obligations|0
1573592|NCT02785770|5453679|P3|Intervention Period 2 (1 Day)|Family related obligations|1
1573593|NCT02785770|5453680|P2|Intervention Period 2 (1 Day)|Family related obligations|0
1573594|NCT02785770|5453681|P1|Intervention Period 2 (1 Day)|Family related obligations|0
1573595|NCT02785770|5453678|P4|Intervention Period 2 (1 Day)|Adverse Event|0
1573596|NCT02785770|5453679|P3|Intervention Period 2 (1 Day)|Adverse Event|0
1573597|NCT02785770|5453680|P2|Intervention Period 2 (1 Day)|Adverse Event|1
1573598|NCT02785770|5453681|P1|Intervention Period 2 (1 Day)|Adverse Event|0
1573599|NCT02785588|5453748|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
1573848|NCT02776033|5455362|P1|Overall Study|Adverse Event|1
1573600|NCT02785588|5453748|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
1573601|NCT02784834|5453875|P1|Overall Study|Lack of Efficacy|1
1573602|NCT02784704|5453881|P2|Overall Study|Subject Non Compliance|0
1573603|NCT02784704|5453882|P1|Overall Study|Subject Non Compliance|2
1573604|NCT02784704|5453881|P2|Overall Study|Withdrawal by Subject|3
1573605|NCT02784704|5453882|P1|Overall Study|Withdrawal by Subject|1
1573606|NCT02784704|5453881|P2|Overall Study|Lost to Follow-up|4
1573607|NCT02784704|5453882|P1|Overall Study|Lost to Follow-up|6
1573608|NCT02784704|5453881|P2|Overall Study|Adverse Event|2
1573609|NCT02784704|5453882|P1|Overall Study|Adverse Event|4
1573610|NCT02784106|5453958|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1573611|NCT02784106|5453959|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
1573612|NCT02784106|5453960|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1573613|NCT02784106|5453961|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
1573614|NCT02784106|5453958|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
1573615|NCT02784106|5453959|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
1573616|NCT02784106|5453960|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1573617|NCT02784106|5453961|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
1573618|NCT02784106|5453958|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1573619|NCT02784106|5453959|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1573620|NCT02784106|5453960|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1573621|NCT02784106|5453961|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
1573622|NCT02784106|5453958|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
1573623|NCT02784106|5453959|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
1573624|NCT02784106|5453960|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
1573625|NCT02784106|5453961|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
1573626|NCT02784106|5453958|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1573627|NCT02784106|5453959|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1573628|NCT02784106|5453960|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
1573629|NCT02784106|5453961|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
1573630|NCT02784106|5453958|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1573631|NCT02784106|5453959|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
1573632|NCT02784106|5453960|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
1573633|NCT02784106|5453961|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
1573634|NCT02783729|5454049|P4|Overall Study|Lost to Follow-up|0
1573635|NCT02783729|5454050|P3|Overall Study|Lost to Follow-up|1
1573636|NCT02783729|5454051|P2|Overall Study|Lost to Follow-up|1
1573637|NCT02783729|5454052|P1|Overall Study|Lost to Follow-up|2
1573638|NCT02783729|5454049|P4|Overall Study|Participant's choice|1
1573639|NCT02783729|5454050|P3|Overall Study|Participant's choice|2
1573640|NCT02783729|5454051|P2|Overall Study|Participant's choice|1
1573641|NCT02783729|5454052|P1|Overall Study|Participant's choice|2
1573642|NCT02783729|5454049|P4|Overall Study|Withdrawal by Subject|2
1573643|NCT02783729|5454050|P3|Overall Study|Withdrawal by Subject|1
1573644|NCT02783729|5454051|P2|Overall Study|Withdrawal by Subject|3
1573645|NCT02783729|5454052|P1|Overall Study|Withdrawal by Subject|2
1573646|NCT02783729|5454049|P4|Overall Study|Other|3
1573647|NCT02783729|5454050|P3|Overall Study|Other|2
1573648|NCT02783729|5454051|P2|Overall Study|Other|6
1573649|NCT02783729|5454052|P1|Overall Study|Other|1
1573650|NCT02783729|5454049|P4|Overall Study|Adverse Event|3
1573651|NCT02783729|5454050|P3|Overall Study|Adverse Event|2
1573652|NCT02783729|5454051|P2|Overall Study|Adverse Event|6
1573653|NCT02783729|5454052|P1|Overall Study|Adverse Event|2
1573654|NCT02783729|5454049|P4|Overall Study|Lack of Efficacy|0
1573655|NCT02783729|5454050|P3|Overall Study|Lack of Efficacy|0
1573656|NCT02783729|5454051|P2|Overall Study|Lack of Efficacy|0
1573657|NCT02783729|5454052|P1|Overall Study|Lack of Efficacy|1
1573658|NCT02783599|5454118|P1|Overall Study|Death|1
1573659|NCT02783599|5454118|P1|Overall Study|Physician Decision|2
1573660|NCT02783599|5454118|P1|Overall Study|Adverse Event|4
1573661|NCT02783599|5454118|P1|Overall Study|Surgical Resection|10
1573662|NCT02783599|5454118|P1|Overall Study|Progressive disease|23
1573663|NCT02783573|5454134|P3|Delayed-Start Period|Sponsor Decision|12
1573664|NCT02783573|5454135|P2|Delayed-Start Period|Sponsor Decision|17
1573665|NCT02783573|5454136|P1|Delayed-Start Period|Sponsor Decision|0
1573666|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
1573667|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
1573668|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
1573669|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
1573670|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
1573671|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
1573672|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
1573673|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
1573674|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
1573675|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
1573676|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
1573677|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
1573678|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Physician Decision|3
1573679|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Physician Decision|1
1573680|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Physician Decision|3
1573681|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
1573682|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
1573683|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
1573684|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
1573685|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
1573686|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
1573687|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
1573688|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
1573689|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
1573690|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
1573691|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
1573692|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
1573693|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Death|3
1573694|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Death|2
1573695|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Death|4
1573696|NCT02783573|5454134|P3|Placebo-Controlled Treatment Period|Adverse Event|13
1573697|NCT02783573|5454135|P2|Placebo-Controlled Treatment Period|Adverse Event|17
1573698|NCT02783573|5454136|P1|Placebo-Controlled Treatment Period|Adverse Event|13
1573699|NCT02783170|5454201|P2|Overall Study|Randomized but not Vaccinated|0
1573700|NCT02783170|5454202|P1|Overall Study|Randomized but not Vaccinated|1
1573701|NCT02782676|5454260|P2|Overall Study|Lost to Follow-up|1
1573702|NCT02782676|5454261|P1|Overall Study|Lost to Follow-up|0
1573703|NCT02782325|5454291|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
1573704|NCT02782325|5454292|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
1573705|NCT02782325|5454293|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
1573706|NCT02782325|5454291|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
1573707|NCT02782325|5454292|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
1573708|NCT02782325|5454293|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
1573709|NCT02782169|5454321|P2|Overall Study|Lost to Follow-up|2
1573710|NCT02782169|5454322|P1|Overall Study|Lost to Follow-up|1
1573711|NCT02781818|5454339|P3|Overall Study|Lost to Follow-up|1
1573712|NCT02781818|5454340|P2|Overall Study|Lost to Follow-up|2
1573713|NCT02781818|5454341|P1|Overall Study|Lost to Follow-up|4
1573714|NCT02781558|5454407|P2|Overall Study|Adverse Event|0
1573715|NCT02781558|5454408|P1|Overall Study|Adverse Event|1
1573716|NCT02781558|5454407|P2|Overall Study|Lost to Follow-up|2
1573717|NCT02781558|5454408|P1|Overall Study|Lost to Follow-up|2
1573718|NCT02781324|5454495|P2|Overall Study|Physician Decision|2
1573719|NCT02781324|5454496|P1|Overall Study|Physician Decision|1
1573720|NCT02781324|5454495|P2|Overall Study|Withdrawal by Subject|0
1573721|NCT02781324|5454496|P1|Overall Study|Withdrawal by Subject|1
1573722|NCT02781311|5454525|P3|Overall Study|Non-Compliance with Study Drug|0
1573723|NCT02781311|5454526|P2|Overall Study|Non-Compliance with Study Drug|0
1573724|NCT02781311|5454527|P1|Overall Study|Non-Compliance with Study Drug|2
1573725|NCT02781311|5454525|P3|Overall Study|Lost to Follow-up|1
1573726|NCT02781311|5454526|P2|Overall Study|Lost to Follow-up|8
1573727|NCT02781311|5454527|P1|Overall Study|Lost to Follow-up|11
1573728|NCT02781311|5454525|P3|Overall Study|Withdrawal of Consent|2
1573729|NCT02781311|5454526|P2|Overall Study|Withdrawal of Consent|12
1573730|NCT02781311|5454527|P1|Overall Study|Withdrawal of Consent|11
1573731|NCT02781311|5454525|P3|Overall Study|Adverse Event|1
1573732|NCT02781311|5454526|P2|Overall Study|Adverse Event|6
1573733|NCT02781311|5454527|P1|Overall Study|Adverse Event|2
1573734|NCT02780856|5454554|P1|Overall Study|Lost to Follow-up|1
1573735|NCT02780700|5454573|P1|Overall Study|Progressive disease|1
1573736|NCT02780388|5454642|P5|Overall Study|Withdrawal by Subject|0
1573737|NCT02780388|5454643|P4|Overall Study|Withdrawal by Subject|0
1573738|NCT02780388|5454644|P3|Overall Study|Withdrawal by Subject|0
1573739|NCT02780388|5454645|P2|Overall Study|Withdrawal by Subject|1
1573740|NCT02780388|5454646|P1|Overall Study|Withdrawal by Subject|1
1573741|NCT02780388|5454642|P5|Overall Study|Lost to Follow-up|0
1573742|NCT02780388|5454643|P4|Overall Study|Lost to Follow-up|0
1573743|NCT02780388|5454644|P3|Overall Study|Lost to Follow-up|0
1573744|NCT02780388|5454645|P2|Overall Study|Lost to Follow-up|1
1573745|NCT02780388|5454646|P1|Overall Study|Lost to Follow-up|0
1573746|NCT02780167|5454712|P5|Overall Study|Other|2
1573747|NCT02780167|5454713|P4|Overall Study|Other|1
1573748|NCT02780167|5454714|P3|Overall Study|Other|3
1573749|NCT02780167|5454715|P2|Overall Study|Other|0
1573750|NCT02780167|5454716|P1|Overall Study|Other|0
1573751|NCT02780167|5454712|P5|Overall Study|Withdrawal by Subject|4
1573752|NCT02780167|5454713|P4|Overall Study|Withdrawal by Subject|3
1573753|NCT02780167|5454714|P3|Overall Study|Withdrawal by Subject|4
1573754|NCT02780167|5454715|P2|Overall Study|Withdrawal by Subject|4
1573755|NCT02780167|5454716|P1|Overall Study|Withdrawal by Subject|6
1573756|NCT02780167|5454712|P5|Overall Study|Protocol Violation|2
1573757|NCT02780167|5454713|P4|Overall Study|Protocol Violation|1
1573758|NCT02780167|5454714|P3|Overall Study|Protocol Violation|1
1573759|NCT02780167|5454715|P2|Overall Study|Protocol Violation|5
1573760|NCT02780167|5454716|P1|Overall Study|Protocol Violation|5
1573761|NCT02780167|5454712|P5|Overall Study|No longer meets eligibility criteria|1
1573762|NCT02780167|5454713|P4|Overall Study|No longer meets eligibility criteria|1
1573763|NCT02780167|5454714|P3|Overall Study|No longer meets eligibility criteria|0
1573764|NCT02780167|5454715|P2|Overall Study|No longer meets eligibility criteria|0
1573765|NCT02780167|5454716|P1|Overall Study|No longer meets eligibility criteria|0
1573766|NCT02780167|5454712|P5|Overall Study|Does not meet entrance criteria|0
1573767|NCT02780167|5454713|P4|Overall Study|Does not meet entrance criteria|0
1573768|NCT02780167|5454714|P3|Overall Study|Does not meet entrance criteria|1
1573769|NCT02780167|5454715|P2|Overall Study|Does not meet entrance criteria|0
1573770|NCT02780167|5454716|P1|Overall Study|Does not meet entrance criteria|0
1573771|NCT02780167|5454712|P5|Overall Study|Lost to Follow-up|0
1573772|NCT02780167|5454713|P4|Overall Study|Lost to Follow-up|0
1573773|NCT02780167|5454714|P3|Overall Study|Lost to Follow-up|1
1573774|NCT02780167|5454715|P2|Overall Study|Lost to Follow-up|0
1573775|NCT02780167|5454716|P1|Overall Study|Lost to Follow-up|2
1573776|NCT02780167|5454712|P5|Overall Study|Lack of Efficacy|0
1573777|NCT02780167|5454713|P4|Overall Study|Lack of Efficacy|1
1573778|NCT02780167|5454714|P3|Overall Study|Lack of Efficacy|6
1573779|NCT02780167|5454715|P2|Overall Study|Lack of Efficacy|5
1573780|NCT02780167|5454716|P1|Overall Study|Lack of Efficacy|6
1573781|NCT02780167|5454712|P5|Overall Study|Adverse Event|8
1573782|NCT02780167|5454713|P4|Overall Study|Adverse Event|12
1573783|NCT02780167|5454714|P3|Overall Study|Adverse Event|8
1573784|NCT02780167|5454715|P2|Overall Study|Adverse Event|8
1573785|NCT02780167|5454716|P1|Overall Study|Adverse Event|9
1573786|NCT02778555|5454904|P3|Overall Study|Withdrawal by Subject|107
1573787|NCT02778555|5454905|P2|Overall Study|Withdrawal by Subject|32
1573788|NCT02778555|5454906|P1|Overall Study|Withdrawal by Subject|55
1573789|NCT02778100|5454962|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
1573790|NCT02778100|5454963|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
1573791|NCT02778074|5454994|P2|Overall Study|Lost to Follow-up|10
1573792|NCT02778074|5454995|P1|Overall Study|Lost to Follow-up|7
1573793|NCT02777918|5455027|P2|Overall Study|Withdrawal by Subject|1
1573794|NCT02777918|5455028|P1|Overall Study|Withdrawal by Subject|1
1573795|NCT02777918|5455027|P2|Overall Study|Too busy / stressed|1
1573796|NCT02777918|5455028|P1|Overall Study|Too busy / stressed|1
1573797|NCT02777918|5455027|P2|Overall Study|Medical reasons|2
1573798|NCT02777918|5455028|P1|Overall Study|Medical reasons|1
1573799|NCT02777827|5455046|P6|Washout Between Periods 3 and 4|Protocol Violation|0
1573800|NCT02777827|5455047|P5|Washout Between Periods 3 and 4|Protocol Violation|0
1573801|NCT02777827|5455048|P4|Washout Between Periods 3 and 4|Protocol Violation|0
1573802|NCT02777827|5455049|P3|Washout Between Periods 3 and 4|Protocol Violation|1
1573803|NCT02777827|5455050|P2|Washout Between Periods 3 and 4|Protocol Violation|0
1573804|NCT02777827|5455051|P1|Washout Between Periods 3 and 4|Protocol Violation|0
1573805|NCT02777242|5455254|P1|Overall Study|Withdrawal by Subject|1
1573806|NCT02777242|5455254|P1|Overall Study|Sponsor's request|1
1573807|NCT02777242|5455254|P1|Overall Study|Multiple|1
1573808|NCT02777242|5455254|P1|Overall Study|Lost to Follow-up|1
1573809|NCT02777242|5455254|P1|Overall Study|Other|2
1573810|NCT02777125|5455260|P2|Overall Study|Protocol Violation|12
1573811|NCT02777125|5455261|P1|Overall Study|Protocol Violation|8
1573812|NCT02777125|5455260|P2|Overall Study|Assent form violation|23
1573813|NCT02777125|5455261|P1|Overall Study|Assent form violation|21
1573814|NCT02777125|5455260|P2|Overall Study|Consent form violation|12
1573815|NCT02777125|5455261|P1|Overall Study|Consent form violation|14
1573816|NCT02776683|5455289|P2|Post-switch Period|Other than listed|15
1573817|NCT02776683|5455290|P1|Post-switch Period|Other than listed|0
1573818|NCT02776683|5455289|P2|Post-switch Period|Progressive disease|20
1573819|NCT02776683|5455290|P1|Post-switch Period|Progressive disease|0
1573820|NCT02776683|5455289|P2|Post-switch Period|Physician Decision|3
1573821|NCT02776683|5455290|P1|Post-switch Period|Physician Decision|0
1573822|NCT02776683|5455289|P2|Post-switch Period|Withdrawal by Subject|2
1573823|NCT02776683|5455290|P1|Post-switch Period|Withdrawal by Subject|0
1573824|NCT02776683|5455289|P2|Post-switch Period|Adverse Event|3
1573825|NCT02776683|5455290|P1|Post-switch Period|Adverse Event|0
1573826|NCT02776683|5455289|P2|Pre-switch Period|Other than listed|0
1573827|NCT02776683|5455290|P1|Pre-switch Period|Other than listed|3
1573828|NCT02776683|5455289|P2|Pre-switch Period|Progressive disease|0
1573829|NCT02776683|5455290|P1|Pre-switch Period|Progressive disease|39
1573830|NCT02776683|5455289|P2|Pre-switch Period|Physician Decision|0
1573831|NCT02776683|5455290|P1|Pre-switch Period|Physician Decision|7
1573832|NCT02776683|5455289|P2|Pre-switch Period|Withdrawal by Subject|0
1573833|NCT02776683|5455290|P1|Pre-switch Period|Withdrawal by Subject|9
1573834|NCT02776683|5455289|P2|Pre-switch Period|Adverse Event|0
1573835|NCT02776683|5455290|P1|Pre-switch Period|Adverse Event|21
1573836|NCT02776683|5455289|P2|Pre-switch Period|Protocol Violation|0
1573837|NCT02776683|5455290|P1|Pre-switch Period|Protocol Violation|1
1573838|NCT02776670|5455301|P2|Overall Study|Other - Reason not given|1
1573839|NCT02776670|5455302|P1|Overall Study|Other - Reason not given|0
1573840|NCT02776670|5455301|P2|Overall Study|Withdrawal by Subject|1
1573841|NCT02776670|5455302|P1|Overall Study|Withdrawal by Subject|0
1573842|NCT02776670|5455301|P2|Overall Study|Protocol Violation|2
1573843|NCT02776670|5455302|P1|Overall Study|Protocol Violation|0
1573844|NCT02776670|5455301|P2|Overall Study|Adverse Event|2
1573845|NCT02776670|5455302|P1|Overall Study|Adverse Event|0
1573846|NCT02776033|5455360|P3|Overall Study|Adverse Event|0
1573847|NCT02776033|5455361|P2|Overall Study|Adverse Event|2
1573849|NCT02776033|5455360|P3|Overall Study|Lost to Follow-up|0
1573850|NCT02776033|5455361|P2|Overall Study|Lost to Follow-up|0
1573851|NCT02776033|5455362|P1|Overall Study|Lost to Follow-up|1
1573852|NCT02776033|5455360|P3|Overall Study|Physician Decision|0
1573853|NCT02776033|5455361|P2|Overall Study|Physician Decision|0
1573854|NCT02776033|5455362|P1|Overall Study|Physician Decision|2
1573855|NCT02776033|5455360|P3|Overall Study|Withdrawal by Subject|2
1573856|NCT02776033|5455361|P2|Overall Study|Withdrawal by Subject|0
1573857|NCT02776033|5455362|P1|Overall Study|Withdrawal by Subject|0
1573858|NCT02775916|5455427|P2|Overall Study|Subject/Guardian Decision|0
1573859|NCT02775916|5455428|P1|Overall Study|Subject/Guardian Decision|2
1573860|NCT02775916|5455427|P2|Overall Study|Adverse Event|0
1573861|NCT02775916|5455428|P1|Overall Study|Adverse Event|1
1573862|NCT02775864|5455450|P4|Overall Study|Medicaid eligibility discontinued|890
1573863|NCT02775864|5455451|P3|Overall Study|Medicaid eligibility discontinued|720
1573864|NCT02775864|5455452|P2|Overall Study|Medicaid eligibility discontinued|2019
1573865|NCT02775864|5455453|P1|Overall Study|Medicaid eligibility discontinued|1478
1573866|NCT02775864|5455450|P4|Overall Study|Data ended end of 2010|1194
1573867|NCT02775864|5455451|P3|Overall Study|Data ended end of 2010|1140
1573868|NCT02775864|5455452|P2|Overall Study|Data ended end of 2010|2880
1573869|NCT02775864|5455453|P1|Overall Study|Data ended end of 2010|1764
1573886|NCT02775344|5455505|P2|Overall Study|No ovarian cyst identified|2
1573887|NCT02775344|5455506|P1|Overall Study|No ovarian cyst identified|3
1573891|NCT02774278|5455667|P1|Overall Study|Protocol Violation|2
1573892|NCT02774278|5455667|P1|Overall Study|Withdrawal by Subject|3
1573893|NCT02774278|5455667|P1|Overall Study|Administrative reasons|6
1573894|NCT02774278|5455667|P1|Overall Study|Refused treatment/did not cooperate|9
1573895|NCT02774278|5455667|P1|Overall Study|Adverse event/intercurrent illness|16
1573896|NCT02774278|5455667|P1|Overall Study|Death|29
1573897|NCT02774278|5455667|P1|Overall Study|Lack of Efficacy|199
1573898|NCT02773537|5455842|P3|Overall Study|Lost to Follow-up|4
1573899|NCT02773537|5455843|P2|Overall Study|Lost to Follow-up|1
1573900|NCT02773537|5455844|P1|Overall Study|Lost to Follow-up|0
1573901|NCT02773446|5455879|P6|First Admission|Lost to Follow-up|0
1573902|NCT02773446|5455880|P5|First Admission|Lost to Follow-up|0
1573903|NCT02773446|5455881|P4|First Admission|Lost to Follow-up|0
1573904|NCT02773446|5455882|P3|First Admission|Lost to Follow-up|0
1573905|NCT02773446|5455883|P2|First Admission|Lost to Follow-up|0
1573906|NCT02773446|5455884|P1|First Admission|Lost to Follow-up|1
1573907|NCT02773446|5455879|P6|First Admission|Withdrawal by Subject|0
1573908|NCT02773446|5455880|P5|First Admission|Withdrawal by Subject|0
1573909|NCT02773446|5455881|P4|First Admission|Withdrawal by Subject|1
1573910|NCT02773446|5455882|P3|First Admission|Withdrawal by Subject|0
1573911|NCT02773446|5455883|P2|First Admission|Withdrawal by Subject|0
1573912|NCT02773446|5455884|P1|First Admission|Withdrawal by Subject|0
1573913|NCT02773368|5455925|P2|Overall Study|Missing|1
1573914|NCT02773368|5455926|P1|Overall Study|Missing|0
1573915|NCT02773368|5455925|P2|Overall Study|Unclassified|1
1573916|NCT02773368|5455926|P1|Overall Study|Unclassified|1
1573917|NCT02773368|5455925|P2|Overall Study|Withdrawal by Subject|1
1573918|NCT02773368|5455926|P1|Overall Study|Withdrawal by Subject|5
1573919|NCT02773368|5455925|P2|Overall Study|Lost to Follow-up|1
1573920|NCT02773368|5455926|P1|Overall Study|Lost to Follow-up|4
1573921|NCT02772757|5455999|P3|Overall Study|Physician Decision|3
1573922|NCT02772757|5456000|P2|Overall Study|Physician Decision|3
1573923|NCT02772757|5456001|P1|Overall Study|Physician Decision|0
1573924|NCT02772757|5455999|P3|Overall Study|Protocol Violation|1
1573925|NCT02772757|5456000|P2|Overall Study|Protocol Violation|0
1573926|NCT02772757|5456001|P1|Overall Study|Protocol Violation|0
1573927|NCT02772757|5455999|P3|Overall Study|Withdrawal by Subject|1
1573928|NCT02772757|5456000|P2|Overall Study|Withdrawal by Subject|0
1573929|NCT02772757|5456001|P1|Overall Study|Withdrawal by Subject|1
1573930|NCT02771522|5456036|P1|Overall Study|No white spot lesions|3
1573931|NCT02771522|5456036|P1|Overall Study|Withdrawal by Subject|2
1573932|NCT02771522|5456036|P1|Overall Study|Lost to Follow-up|3
1573933|NCT02771366|5456047|P2|Period 2 (Crossover)|Withdrawal by Subject|0
1573934|NCT02771366|5456048|P1|Period 2 (Crossover)|Withdrawal by Subject|2
1573935|NCT02771366|5456047|P2|Period 1|Withdrawal by Subject|2
1573936|NCT02771366|5456048|P1|Period 1|Withdrawal by Subject|0
1573937|NCT02771275|5456055|P1|Overall Study|On Study|11
1573938|NCT02771275|5456055|P1|Overall Study|Reoperation|2
1573939|NCT02771145|5456063|P1|Overall Study|Lost to Follow-up|1
1573940|NCT02771145|5456063|P1|Overall Study|Adverse Event|3
1573941|NCT02770612|5456170|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
1573942|NCT02770547|5456176|P2|Overall Study|Adverse Event|1
1573943|NCT02770547|5456177|P1|Overall Study|Adverse Event|0
1573944|NCT02770547|5456176|P2|Overall Study|Patient non-compliant|0
1573945|NCT02770547|5456177|P1|Overall Study|Patient non-compliant|1
1573946|NCT02770248|5456203|P2|Overall Study|Randomized in error, prior to treatment|1
1573947|NCT02770248|5456204|P1|Overall Study|Randomized in error, prior to treatment|0
1573948|NCT02770248|5456203|P2|Overall Study|Adverse Event|1
1573949|NCT02770248|5456204|P1|Overall Study|Adverse Event|0
1573950|NCT02769858|5456222|P1|Overall Study|Withdrawal by Subject|2
1573951|NCT02769312|5456246|P2|Follow-up|Lost to Follow-up|1
1573952|NCT02769312|5456247|P1|Follow-up|Lost to Follow-up|1
1573953|NCT02769312|5456246|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
1573954|NCT02769312|5456247|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
1573955|NCT02769312|5456246|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
1573956|NCT02769312|5456247|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
1573957|NCT02769312|5456246|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
1573958|NCT02769312|5456247|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
1573959|NCT02769312|5456246|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
1573960|NCT02769312|5456247|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
1573961|NCT02769247|5456264|P4|Overall Study|Physician Decision|0
1573962|NCT02769247|5456265|P3|Overall Study|Physician Decision|0
1573963|NCT02769247|5456266|P2|Overall Study|Physician Decision|0
1573964|NCT02769247|5456267|P1|Overall Study|Physician Decision|1
1573965|NCT02769247|5456264|P4|Overall Study|Protocol Violation|0
1573966|NCT02769247|5456265|P3|Overall Study|Protocol Violation|1
1573967|NCT02769247|5456266|P2|Overall Study|Protocol Violation|0
1573968|NCT02769247|5456267|P1|Overall Study|Protocol Violation|0
1573969|NCT02769247|5456264|P4|Overall Study|Withdrawal by Subject|1
1573970|NCT02769247|5456265|P3|Overall Study|Withdrawal by Subject|0
1573971|NCT02769247|5456266|P2|Overall Study|Withdrawal by Subject|0
1573972|NCT02769247|5456267|P1|Overall Study|Withdrawal by Subject|1
1573973|NCT02769065|5456335|P30|Overall Study|Pre-treatment Event/Adverse Event|0
1573974|NCT02769065|5456336|P29|Overall Study|Pre-treatment Event/Adverse Event|0
1573975|NCT02769065|5456337|P28|Overall Study|Pre-treatment Event/Adverse Event|0
1573976|NCT02769065|5456338|P27|Overall Study|Pre-treatment Event/Adverse Event|0
1573977|NCT02769065|5456339|P26|Overall Study|Pre-treatment Event/Adverse Event|0
1573978|NCT02769065|5456340|P25|Overall Study|Pre-treatment Event/Adverse Event|0
1573979|NCT02769065|5456341|P24|Overall Study|Pre-treatment Event/Adverse Event|0
1573980|NCT02769065|5456342|P23|Overall Study|Pre-treatment Event/Adverse Event|0
1573981|NCT02769065|5456343|P22|Overall Study|Pre-treatment Event/Adverse Event|0
1573982|NCT02769065|5456344|P21|Overall Study|Pre-treatment Event/Adverse Event|0
1573983|NCT02769065|5456345|P20|Overall Study|Pre-treatment Event/Adverse Event|0
1573984|NCT02769065|5456346|P19|Overall Study|Pre-treatment Event/Adverse Event|0
1573985|NCT02769065|5456347|P18|Overall Study|Pre-treatment Event/Adverse Event|0
1573986|NCT02769065|5456348|P17|Overall Study|Pre-treatment Event/Adverse Event|0
1573987|NCT02769065|5456349|P16|Overall Study|Pre-treatment Event/Adverse Event|0
1573988|NCT02769065|5456350|P15|Overall Study|Pre-treatment Event/Adverse Event|0
1573989|NCT02769065|5456351|P14|Overall Study|Pre-treatment Event/Adverse Event|0
1573990|NCT02769065|5456352|P13|Overall Study|Pre-treatment Event/Adverse Event|0
1573991|NCT02769065|5456353|P12|Overall Study|Pre-treatment Event/Adverse Event|0
1573992|NCT02769065|5456354|P11|Overall Study|Pre-treatment Event/Adverse Event|1
1573993|NCT02769065|5456355|P10|Overall Study|Pre-treatment Event/Adverse Event|0
1573994|NCT02769065|5456356|P9|Overall Study|Pre-treatment Event/Adverse Event|0
1573995|NCT02769065|5456357|P8|Overall Study|Pre-treatment Event/Adverse Event|0
1573996|NCT02769065|5456358|P7|Overall Study|Pre-treatment Event/Adverse Event|0
1573997|NCT02769065|5456359|P6|Overall Study|Pre-treatment Event/Adverse Event|0
1573998|NCT02769065|5456360|P5|Overall Study|Pre-treatment Event/Adverse Event|0
1573999|NCT02769065|5456361|P4|Overall Study|Pre-treatment Event/Adverse Event|0
1574000|NCT02769065|5456362|P3|Overall Study|Pre-treatment Event/Adverse Event|0
1574001|NCT02769065|5456363|P2|Overall Study|Pre-treatment Event/Adverse Event|0
1574002|NCT02769065|5456364|P1|Overall Study|Pre-treatment Event/Adverse Event|0
1574003|NCT02769065|5456335|P30|Overall Study|Reason Not Specified|0
1574004|NCT02769065|5456336|P29|Overall Study|Reason Not Specified|0
1574005|NCT02769065|5456337|P28|Overall Study|Reason Not Specified|0
1574006|NCT02769065|5456338|P27|Overall Study|Reason Not Specified|0
1574007|NCT02769065|5456339|P26|Overall Study|Reason Not Specified|0
1574008|NCT02769065|5456340|P25|Overall Study|Reason Not Specified|0
1574009|NCT02769065|5456341|P24|Overall Study|Reason Not Specified|0
1574010|NCT02769065|5456342|P23|Overall Study|Reason Not Specified|0
1574011|NCT02769065|5456343|P22|Overall Study|Reason Not Specified|0
1574012|NCT02769065|5456344|P21|Overall Study|Reason Not Specified|0
1574013|NCT02769065|5456345|P20|Overall Study|Reason Not Specified|0
1574014|NCT02769065|5456346|P19|Overall Study|Reason Not Specified|0
1574015|NCT02769065|5456347|P18|Overall Study|Reason Not Specified|0
1574016|NCT02769065|5456348|P17|Overall Study|Reason Not Specified|0
1574017|NCT02769065|5456349|P16|Overall Study|Reason Not Specified|0
1574018|NCT02769065|5456350|P15|Overall Study|Reason Not Specified|0
1574019|NCT02769065|5456351|P14|Overall Study|Reason Not Specified|0
1574020|NCT02769065|5456352|P13|Overall Study|Reason Not Specified|0
1574021|NCT02769065|5456353|P12|Overall Study|Reason Not Specified|0
1574022|NCT02769065|5456354|P11|Overall Study|Reason Not Specified|0
1574023|NCT02769065|5456355|P10|Overall Study|Reason Not Specified|0
1574024|NCT02769065|5456356|P9|Overall Study|Reason Not Specified|0
1574025|NCT02769065|5456357|P8|Overall Study|Reason Not Specified|0
1574026|NCT02769065|5456358|P7|Overall Study|Reason Not Specified|1
1574027|NCT02769065|5456359|P6|Overall Study|Reason Not Specified|0
1574028|NCT02769065|5456360|P5|Overall Study|Reason Not Specified|0
1574029|NCT02769065|5456361|P4|Overall Study|Reason Not Specified|0
1574030|NCT02769065|5456362|P3|Overall Study|Reason Not Specified|0
1574031|NCT02769065|5456363|P2|Overall Study|Reason Not Specified|0
1574032|NCT02769065|5456364|P1|Overall Study|Reason Not Specified|0
1574033|NCT02769065|5456335|P30|Overall Study|Voluntary Withdrawal|0
1574034|NCT02769065|5456336|P29|Overall Study|Voluntary Withdrawal|0
1574035|NCT02769065|5456337|P28|Overall Study|Voluntary Withdrawal|0
1574036|NCT02769065|5456338|P27|Overall Study|Voluntary Withdrawal|0
1574037|NCT02769065|5456339|P26|Overall Study|Voluntary Withdrawal|0
1574038|NCT02769065|5456340|P25|Overall Study|Voluntary Withdrawal|0
1574039|NCT02769065|5456341|P24|Overall Study|Voluntary Withdrawal|0
1574040|NCT02769065|5456342|P23|Overall Study|Voluntary Withdrawal|0
1574041|NCT02769065|5456343|P22|Overall Study|Voluntary Withdrawal|0
1574042|NCT02769065|5456344|P21|Overall Study|Voluntary Withdrawal|0
1574043|NCT02769065|5456345|P20|Overall Study|Voluntary Withdrawal|0
1574044|NCT02769065|5456346|P19|Overall Study|Voluntary Withdrawal|0
1574045|NCT02769065|5456347|P18|Overall Study|Voluntary Withdrawal|0
1574046|NCT02769065|5456348|P17|Overall Study|Voluntary Withdrawal|0
1574047|NCT02769065|5456349|P16|Overall Study|Voluntary Withdrawal|0
1574048|NCT02769065|5456350|P15|Overall Study|Voluntary Withdrawal|0
1574049|NCT02769065|5456351|P14|Overall Study|Voluntary Withdrawal|0
1574050|NCT02769065|5456352|P13|Overall Study|Voluntary Withdrawal|0
1574051|NCT02769065|5456353|P12|Overall Study|Voluntary Withdrawal|0
1574052|NCT02769065|5456354|P11|Overall Study|Voluntary Withdrawal|0
1574053|NCT02769065|5456355|P10|Overall Study|Voluntary Withdrawal|0
1574054|NCT02769065|5456356|P9|Overall Study|Voluntary Withdrawal|0
1574055|NCT02769065|5456357|P8|Overall Study|Voluntary Withdrawal|0
1574056|NCT02769065|5456358|P7|Overall Study|Voluntary Withdrawal|0
1574057|NCT02769065|5456359|P6|Overall Study|Voluntary Withdrawal|0
1574058|NCT02769065|5456360|P5|Overall Study|Voluntary Withdrawal|0
1574059|NCT02769065|5456361|P4|Overall Study|Voluntary Withdrawal|0
1574060|NCT02769065|5456362|P3|Overall Study|Voluntary Withdrawal|0
1574061|NCT02769065|5456363|P2|Overall Study|Voluntary Withdrawal|0
1574062|NCT02769065|5456364|P1|Overall Study|Voluntary Withdrawal|1
1574063|NCT02768870|5456774|P1|Overall Study|On Study|19
1574064|NCT02768870|5456774|P1|Overall Study|Reoperation|4
1574065|NCT02768870|5456774|P1|Overall Study|Death|1
1574066|NCT02768870|5456774|P1|Overall Study|Not Implanted with Device|2
1574067|NCT02768194|5456816|P6|Period 3|Other (Reason not specified)|0
1574068|NCT02768194|5456817|P5|Period 3|Other (Reason not specified)|0
1574069|NCT02768194|5456818|P4|Period 3|Other (Reason not specified)|0
1574070|NCT02768194|5456819|P3|Period 3|Other (Reason not specified)|0
1574071|NCT02768194|5456820|P2|Period 3|Other (Reason not specified)|1
1574072|NCT02768194|5456821|P1|Period 3|Other (Reason not specified)|0
1574073|NCT02768194|5456816|P6|Period 2|Other (Reason not specified)|0
1574074|NCT02768194|5456817|P5|Period 2|Other (Reason not specified)|0
1574075|NCT02768194|5456818|P4|Period 2|Other (Reason not specified)|0
1574076|NCT02768194|5456819|P3|Period 2|Other (Reason not specified)|0
1574077|NCT02768194|5456820|P2|Period 2|Other (Reason not specified)|0
1574078|NCT02768194|5456821|P1|Period 2|Other (Reason not specified)|1
1574079|NCT02768194|5456816|P6|Period 1|Adverse Event|0
1574080|NCT02768194|5456817|P5|Period 1|Adverse Event|0
1574081|NCT02768194|5456818|P4|Period 1|Adverse Event|1
1574082|NCT02768194|5456819|P3|Period 1|Adverse Event|0
1574083|NCT02768194|5456820|P2|Period 1|Adverse Event|0
1574084|NCT02768194|5456821|P1|Period 1|Adverse Event|0
1574085|NCT02767765|5456860|P1|Overall Study|Withdrawal by Subject|1
1574086|NCT02767765|5456860|P1|Overall Study|Non-Compliance|1
1574087|NCT02767765|5456860|P1|Overall Study|Investigator decision|1
1574088|NCT02767765|5456860|P1|Overall Study|Lost to Follow-up|2
1574089|NCT02767765|5456860|P1|Overall Study|Insufficient response|1
1574090|NCT02767765|5456860|P1|Overall Study|Death|1
1574091|NCT02767765|5456860|P1|Overall Study|Adverse Event|4
1574092|NCT02766608|5457007|P5|Overall Study|Administrative Reasons|0
1574093|NCT02766608|5457008|P4|Overall Study|Administrative Reasons|0
1574094|NCT02766608|5457009|P3|Overall Study|Administrative Reasons|1
1574095|NCT02766608|5457010|P2|Overall Study|Administrative Reasons|1
1574096|NCT02766608|5457011|P1|Overall Study|Administrative Reasons|3
1574097|NCT02766608|5457007|P5|Overall Study|Protocol Violation|1
1574098|NCT02766608|5457008|P4|Overall Study|Protocol Violation|0
1574099|NCT02766608|5457009|P3|Overall Study|Protocol Violation|4
1574100|NCT02766608|5457010|P2|Overall Study|Protocol Violation|4
1574101|NCT02766608|5457011|P1|Overall Study|Protocol Violation|0
1574102|NCT02766608|5457007|P5|Overall Study|Protocol disc criteria|0
1574103|NCT02766608|5457008|P4|Overall Study|Protocol disc criteria|0
1574104|NCT02766608|5457009|P3|Overall Study|Protocol disc criteria|4
1574105|NCT02766608|5457010|P2|Overall Study|Protocol disc criteria|3
1574106|NCT02766608|5457011|P1|Overall Study|Protocol disc criteria|3
1574107|NCT02766608|5457007|P5|Overall Study|Physician Decision|2
1574108|NCT02766608|5457008|P4|Overall Study|Physician Decision|1
1574109|NCT02766608|5457009|P3|Overall Study|Physician Decision|3
1574110|NCT02766608|5457010|P2|Overall Study|Physician Decision|2
1574111|NCT02766608|5457011|P1|Overall Study|Physician Decision|3
1574112|NCT02766608|5457007|P5|Overall Study|Lost to Follow-up|2
1574113|NCT02766608|5457008|P4|Overall Study|Lost to Follow-up|2
1574114|NCT02766608|5457009|P3|Overall Study|Lost to Follow-up|5
1574115|NCT02766608|5457010|P2|Overall Study|Lost to Follow-up|3
1574116|NCT02766608|5457011|P1|Overall Study|Lost to Follow-up|6
1574117|NCT02766608|5457007|P5|Overall Study|Lack of Efficacy|2
1574118|NCT02766608|5457008|P4|Overall Study|Lack of Efficacy|8
1574119|NCT02766608|5457009|P3|Overall Study|Lack of Efficacy|32
1574120|NCT02766608|5457010|P2|Overall Study|Lack of Efficacy|15
1574121|NCT02766608|5457011|P1|Overall Study|Lack of Efficacy|16
1574122|NCT02766608|5457007|P5|Overall Study|Withdrawal by Subject|10
1574123|NCT02766608|5457008|P4|Overall Study|Withdrawal by Subject|13
1574124|NCT02766608|5457009|P3|Overall Study|Withdrawal by Subject|24
1574125|NCT02766608|5457010|P2|Overall Study|Withdrawal by Subject|20
1574126|NCT02766608|5457011|P1|Overall Study|Withdrawal by Subject|21
1574127|NCT02766608|5457007|P5|Overall Study|Adverse Event|12
1574128|NCT02766608|5457008|P4|Overall Study|Adverse Event|13
1574129|NCT02766608|5457009|P3|Overall Study|Adverse Event|17
1574130|NCT02766608|5457010|P2|Overall Study|Adverse Event|22
1574131|NCT02766608|5457011|P1|Overall Study|Adverse Event|27
1574132|NCT02766400|5457103|P2|Overall Study|Withdrawal by Subject|0
1574133|NCT02766400|5457104|P1|Overall Study|Withdrawal by Subject|1
1574134|NCT02766400|5457103|P2|Overall Study|Death|2
1574135|NCT02766400|5457104|P1|Overall Study|Death|1
1574136|NCT02766283|5457119|P1|Overall Study|Lost to Follow-up|27
1574137|NCT02766023|5457154|P2|Overall Study|Not Eligible at Enrollment|1
1574138|NCT02766023|5457155|P1|Overall Study|Not Eligible at Enrollment|0
1574139|NCT02766023|5457154|P2|Overall Study|Physician Decision|0
1574140|NCT02766023|5457155|P1|Overall Study|Physician Decision|1
1574141|NCT02766023|5457154|P2|Overall Study|Withdrawal by Subject|5
1574142|NCT02766023|5457155|P1|Overall Study|Withdrawal by Subject|4
1574143|NCT02766023|5457154|P2|Overall Study|Adverse Event|0
1574144|NCT02766023|5457155|P1|Overall Study|Adverse Event|1
1574145|NCT02766023|5457154|P2|Overall Study|Pregnancy|0
1574146|NCT02766023|5457155|P1|Overall Study|Pregnancy|1
1574147|NCT02766023|5457154|P2|Overall Study|Lost to Follow-up|11
1574148|NCT02766023|5457155|P1|Overall Study|Lost to Follow-up|23
1574149|NCT02765490|5457205|P2|Overall Study|Death|1
1574150|NCT02765490|5457206|P1|Overall Study|Death|0
1574151|NCT02765490|5457205|P2|Overall Study|Other|1
1574152|NCT02765490|5457206|P1|Overall Study|Other|0
1574153|NCT02765490|5457205|P2|Overall Study|Lost to Follow-up|1
1574154|NCT02765490|5457206|P1|Overall Study|Lost to Follow-up|1
1574155|NCT02764775|5457252|P1|Overall Study|Withdrawal by Subject|3
1574156|NCT02764775|5457252|P1|Overall Study|Lost to Follow-up|2
1574157|NCT02764775|5457252|P1|Overall Study|Death|1
1574158|NCT02764697|5457256|P1|Overall Study|Lack of Efficacy|3
1574159|NCT02764229|5457261|P1|Overall Study|Study Stopped by Sponsor|69
1574160|NCT02764229|5457261|P1|Overall Study|Lack of Efficacy|1
1574161|NCT02764229|5457261|P1|Overall Study|Lost to Follow-up|3
1574162|NCT02764229|5457261|P1|Overall Study|Physician Decision|5
1574163|NCT02764229|5457261|P1|Overall Study|Adverse Event|9
1574164|NCT02764229|5457261|P1|Overall Study|Withdrawal by Subject|15
1574165|NCT02764190|5457267|P2|Overall Study|Lost to Follow-up|13
1574166|NCT02764190|5457268|P1|Overall Study|Lost to Follow-up|17
1574167|NCT02764151|5457316|P4|Overall Study|Other|2
1574168|NCT02764151|5457317|P3|Overall Study|Other|0
1574169|NCT02764151|5457318|P2|Overall Study|Other|0
1574170|NCT02764151|5457319|P1|Overall Study|Other|0
1574171|NCT02764151|5457316|P4|Overall Study|Subject refused further follow-up|1
1574172|NCT02764151|5457317|P3|Overall Study|Subject refused further follow-up|0
1574173|NCT02764151|5457318|P2|Overall Study|Subject refused further follow-up|0
1574174|NCT02764151|5457319|P1|Overall Study|Subject refused further follow-up|0
1574175|NCT02763644|5457458|P2|Overall Study|Adverse Event|1
1574176|NCT02763644|5457459|P1|Overall Study|Adverse Event|1
1574177|NCT02763644|5457458|P2|Overall Study|Death|1
1574178|NCT02763644|5457459|P1|Overall Study|Death|1
1574179|NCT02763644|5457458|P2|Overall Study|Patient/guardian decision|0
1574180|NCT02763644|5457459|P1|Overall Study|Patient/guardian decision|1
1574181|NCT02763579|5457479|P2|Overall Study|On-going in study|60
1574182|NCT02763579|5457480|P1|Overall Study|On-going in study|77
1574183|NCT02763579|5457479|P2|Overall Study|Physician Decision|0
1574184|NCT02763579|5457480|P1|Overall Study|Physician Decision|2
1574185|NCT02763579|5457479|P2|Overall Study|Withdrawal by Subject|9
1574186|NCT02763579|5457480|P1|Overall Study|Withdrawal by Subject|18
1574187|NCT02763579|5457479|P2|Overall Study|Lost to Follow-up|1
1574188|NCT02763579|5457480|P1|Overall Study|Lost to Follow-up|3
1574189|NCT02763579|5457479|P2|Overall Study|Death|132
1574190|NCT02763579|5457480|P1|Overall Study|Death|101
1574191|NCT02763254|5457488|P1|Overall Study|Adverse Event|1
1574192|NCT02763189|5457495|P2|Overall Study|Device failure|2
1574193|NCT02763189|5457496|P1|Overall Study|Device failure|0
1574194|NCT02762578|5457600|P2|Overall Study|Unclassified|0
1574195|NCT02762578|5457601|P1|Overall Study|Unclassified|6
1574196|NCT02762578|5457600|P2|Overall Study|Withdrawal by Subject|2
1574197|NCT02762578|5457601|P1|Overall Study|Withdrawal by Subject|4
1574198|NCT02762578|5457600|P2|Overall Study|Protocol Violation|2
1574199|NCT02762578|5457601|P1|Overall Study|Protocol Violation|4
1574200|NCT02762578|5457600|P2|Overall Study|Adverse Event|6
1574201|NCT02762578|5457601|P1|Overall Study|Adverse Event|1
1574202|NCT02762500|5457703|P2|Overall Study|Adverse Event|2
1574203|NCT02762500|5457704|P1|Overall Study|Adverse Event|0
1574204|NCT02762500|5457703|P2|Overall Study|Withdrawal by Subject|1
1574205|NCT02762500|5457704|P1|Overall Study|Withdrawal by Subject|1
1574206|NCT02762500|5457703|P2|Overall Study|Lack of Efficacy|0
1574207|NCT02762500|5457704|P1|Overall Study|Lack of Efficacy|1
1574208|NCT02762370|5457724|P2|Overall Study|Protocol Violation|0
1574209|NCT02762370|5457725|P1|Overall Study|Protocol Violation|1
1574210|NCT02762084|5457765|P3|Overall Study|Adverse Event|1
1574211|NCT02762084|5457766|P2|Overall Study|Adverse Event|0
1574212|NCT02762084|5457767|P1|Overall Study|Adverse Event|0
1574213|NCT02762084|5457765|P3|Overall Study|Withdrawal by Subject|0
1574214|NCT02762084|5457766|P2|Overall Study|Withdrawal by Subject|0
1574215|NCT02762084|5457767|P1|Overall Study|Withdrawal by Subject|1
1574216|NCT02761980|5457809|P4|Overall Study|Other|0
1574217|NCT02761980|5457810|P3|Overall Study|Other|1
1574218|NCT02761980|5457811|P2|Overall Study|Other|0
1574219|NCT02761980|5457812|P1|Overall Study|Other|0
1574220|NCT02761980|5457809|P4|Overall Study|Withdrawal by Subject|0
1574221|NCT02761980|5457810|P3|Overall Study|Withdrawal by Subject|0
1574222|NCT02761980|5457811|P2|Overall Study|Withdrawal by Subject|1
1574223|NCT02761980|5457812|P1|Overall Study|Withdrawal by Subject|0
1574224|NCT02761980|5457809|P4|Overall Study|Adverse Event|6
1574225|NCT02761980|5457810|P3|Overall Study|Adverse Event|5
1574226|NCT02761980|5457811|P2|Overall Study|Adverse Event|6
1574227|NCT02761980|5457812|P1|Overall Study|Adverse Event|4
1574228|NCT02761733|5457859|P4|Overall Study|Cognitive Impairment|0
1574229|NCT02761733|5457860|P3|Overall Study|Cognitive Impairment|1
1574230|NCT02761733|5457861|P2|Overall Study|Cognitive Impairment|0
1574231|NCT02761733|5457862|P1|Overall Study|Cognitive Impairment|5
1574232|NCT02761733|5457859|P4|Overall Study|Discharged from Study Site|11
1574233|NCT02761733|5457860|P3|Overall Study|Discharged from Study Site|25
1574234|NCT02761733|5457861|P2|Overall Study|Discharged from Study Site|9
1574235|NCT02761733|5457862|P1|Overall Study|Discharged from Study Site|10
1574236|NCT02761733|5457859|P4|Overall Study|Withdrawal by Subject|0
1574237|NCT02761733|5457860|P3|Overall Study|Withdrawal by Subject|0
1574238|NCT02761733|5457861|P2|Overall Study|Withdrawal by Subject|0
1574239|NCT02761733|5457862|P1|Overall Study|Withdrawal by Subject|2
1574240|NCT02761733|5457859|P4|Overall Study|Physician Decision|0
1574241|NCT02761733|5457860|P3|Overall Study|Physician Decision|0
1574242|NCT02761733|5457861|P2|Overall Study|Physician Decision|0
1574243|NCT02761733|5457862|P1|Overall Study|Physician Decision|4
1574244|NCT02761733|5457859|P4|Overall Study|Lost to Follow-up|3
1574245|NCT02761733|5457860|P3|Overall Study|Lost to Follow-up|0
1574246|NCT02761733|5457861|P2|Overall Study|Lost to Follow-up|7
1574247|NCT02761733|5457862|P1|Overall Study|Lost to Follow-up|6
1574248|NCT02761733|5457859|P4|Overall Study|Death|1
1574249|NCT02761733|5457860|P3|Overall Study|Death|1
1574250|NCT02761733|5457861|P2|Overall Study|Death|5
1574251|NCT02761733|5457862|P1|Overall Study|Death|3
1574252|NCT02761642|5457892|P1|Overall Study|Reason Unspecified|21
1574253|NCT02761642|5457892|P1|Overall Study|Physician Decision|1
1574254|NCT02761642|5457892|P1|Overall Study|Lack of Efficacy|20
1574255|NCT02761642|5457892|P1|Overall Study|Death|3
1574256|NCT02761642|5457892|P1|Overall Study|Non-compliant|7
1574257|NCT02761642|5457892|P1|Overall Study|Withdrawal by Subject|2
1574258|NCT02761642|5457892|P1|Overall Study|Adverse Event|13
1574259|NCT02761642|5457892|P1|Overall Study|Did not Receive Study Treatment|3
1574260|NCT02761629|5457905|P2|Overall Study|Randomized But Not Treated|4
1574261|NCT02761629|5457906|P1|Overall Study|Randomized But Not Treated|8
1574262|NCT02761629|5457905|P2|Overall Study|Lost to Follow-up|1
1574263|NCT02761629|5457906|P1|Overall Study|Lost to Follow-up|4
1574264|NCT02761629|5457905|P2|Overall Study|Other|2
1574265|NCT02761629|5457906|P1|Overall Study|Other|0
1574266|NCT02761629|5457905|P2|Overall Study|Withdrawal by Subject|3
1574267|NCT02761629|5457906|P1|Overall Study|Withdrawal by Subject|0
1574268|NCT02761629|5457905|P2|Overall Study|Protocol Violation|2
1574269|NCT02761629|5457906|P1|Overall Study|Protocol Violation|2
1574270|NCT02761629|5457905|P2|Overall Study|Did not Cooperate/Refused Treatment|4
1574271|NCT02761629|5457906|P1|Overall Study|Did not Cooperate/Refused Treatment|2
1574272|NCT02761629|5457905|P2|Overall Study|Failure to Return|4
1574273|NCT02761629|5457906|P1|Overall Study|Failure to Return|2
1574274|NCT02761629|5457905|P2|Overall Study|Insufficient Therapeutic Response|7
1574275|NCT02761629|5457906|P1|Overall Study|Insufficient Therapeutic Response|2
1574276|NCT02761629|5457905|P2|Overall Study|Adverse Event/Intercurrent Illness|5
1574277|NCT02761629|5457906|P1|Overall Study|Adverse Event/Intercurrent Illness|7
1574278|NCT02760927|5457953|P1|Overall Study|Tube Slippage from Device|1
1574279|NCT02760810|5457961|P1|Overall Study|Protocol Violation|1
1574280|NCT02760654|5457969|P2|Overall Study|Withdrawal by Subject|3
1574281|NCT02760654|5457970|P1|Overall Study|Withdrawal by Subject|4
1574282|NCT02760654|5457969|P2|Overall Study|Lost to Follow-up|3
1574283|NCT02760654|5457970|P1|Overall Study|Lost to Follow-up|3
1574284|NCT02760602|5457996|P2|Overall Study|Terminated by sponsor|13
1574285|NCT02760602|5457997|P1|Overall Study|Terminated by sponsor|12
1574286|NCT02760602|5457996|P2|Overall Study|Withdrawal by Subject|0
1574287|NCT02760602|5457997|P1|Overall Study|Withdrawal by Subject|1
1574288|NCT02759939|5458209|P4|Overall Study|Lost to Follow-up|650
1574289|NCT02759939|5458210|P3|Overall Study|Lost to Follow-up|783
1574290|NCT02759939|5458211|P2|Overall Study|Lost to Follow-up|791
1574291|NCT02759939|5458212|P1|Overall Study|Lost to Follow-up|735
1574292|NCT02759939|5458209|P4|Overall Study|Ineligible for T2 and T3|391
1574293|NCT02759939|5458210|P3|Overall Study|Ineligible for T2 and T3|366
1574294|NCT02759939|5458211|P2|Overall Study|Ineligible for T2 and T3|179
1574295|NCT02759939|5458212|P1|Overall Study|Ineligible for T2 and T3|310
1574296|NCT02759939|5458209|P4|Overall Study|Missing data on first outcome assessed|2
1574297|NCT02759939|5458210|P3|Overall Study|Missing data on first outcome assessed|5
1574298|NCT02759939|5458211|P2|Overall Study|Missing data on first outcome assessed|2
1574299|NCT02759939|5458212|P1|Overall Study|Missing data on first outcome assessed|11
1574300|NCT02759692|5458222|P2|Period 2|Test article no longer available|1
1574301|NCT02759692|5458223|P1|Period 2|Test article no longer available|0
1574302|NCT02759692|5458222|P2|Period 2|Lost to Follow-up|0
1574303|NCT02759692|5458223|P1|Period 2|Lost to Follow-up|1
1574304|NCT02759692|5458222|P2|Period 1|Miss-Randomized|1
1574305|NCT02759692|5458223|P1|Period 1|Miss-Randomized|1
1574306|NCT02759692|5458222|P2|Period 1|No longer meets eligibility criteria.|0
1574307|NCT02759692|5458223|P1|Period 1|No longer meets eligibility criteria.|1
1574308|NCT02759692|5458222|P2|Period 1|Test article no longer available|1
1574309|NCT02759692|5458223|P1|Period 1|Test article no longer available|1
1574310|NCT02759562|5458241|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
1574311|NCT02759562|5458242|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
1574312|NCT02759562|5458241|P2|Open-Label Treatment Period|Withdrew Consent|0
1574313|NCT02759562|5458242|P1|Open-Label Treatment Period|Withdrew Consent|1
1574314|NCT02759471|5458255|P1|Overall Study|discomfort|2
1574315|NCT02759315|5458311|P5|Overall Study|Study terminated prior to completion|1
1574316|NCT02759315|5458312|P4|Overall Study|Study terminated prior to completion|0
1574317|NCT02759315|5458313|P3|Overall Study|Study terminated prior to completion|5
1574318|NCT02759315|5458314|P2|Overall Study|Study terminated prior to completion|0
1574319|NCT02759315|5458315|P1|Overall Study|Study terminated prior to completion|2
1574320|NCT02759315|5458311|P5|Overall Study|Protocol Violation|0
1574321|NCT02759315|5458312|P4|Overall Study|Protocol Violation|0
1574322|NCT02759315|5458313|P3|Overall Study|Protocol Violation|0
1574323|NCT02759315|5458314|P2|Overall Study|Protocol Violation|1
1574324|NCT02759315|5458315|P1|Overall Study|Protocol Violation|0
1574325|NCT02759315|5458311|P5|Overall Study|Lost to Follow-up|0
1574326|NCT02759315|5458312|P4|Overall Study|Lost to Follow-up|0
1574327|NCT02759315|5458313|P3|Overall Study|Lost to Follow-up|4
1574328|NCT02759315|5458314|P2|Overall Study|Lost to Follow-up|0
1574329|NCT02759315|5458315|P1|Overall Study|Lost to Follow-up|2
1574330|NCT02759315|5458311|P5|Overall Study|Death|0
1574331|NCT02759315|5458312|P4|Overall Study|Death|0
1574332|NCT02759315|5458313|P3|Overall Study|Death|1
1574333|NCT02759315|5458314|P2|Overall Study|Death|0
1574334|NCT02759315|5458315|P1|Overall Study|Death|0
1574335|NCT02759315|5458311|P5|Overall Study|Adverse Event|0
1574336|NCT02759315|5458312|P4|Overall Study|Adverse Event|1
1574337|NCT02759315|5458313|P3|Overall Study|Adverse Event|0
1574338|NCT02759315|5458314|P2|Overall Study|Adverse Event|0
1574339|NCT02759315|5458315|P1|Overall Study|Adverse Event|0
1574340|NCT02758613|5458363|P4|Treatment|Withdrawal by Subject|0
1574341|NCT02758613|5458364|P3|Treatment|Withdrawal by Subject|1
1574342|NCT02758613|5458365|P2|Treatment|Withdrawal by Subject|0
1574343|NCT02758613|5458366|P1|Treatment|Withdrawal by Subject|1
1574344|NCT02758613|5458363|P4|Treatment|Physician and Sponsor Decision|0
1574345|NCT02758613|5458364|P3|Treatment|Physician and Sponsor Decision|0
1574346|NCT02758613|5458365|P2|Treatment|Physician and Sponsor Decision|0
1574347|NCT02758613|5458366|P1|Treatment|Physician and Sponsor Decision|1
1574348|NCT02758301|5458384|P2|Overall Study|Protocol Violation|1
1574349|NCT02758301|5458385|P1|Overall Study|Protocol Violation|0
1574350|NCT02758301|5458384|P2|Overall Study|Lost to Follow-up|0
1574351|NCT02758301|5458385|P1|Overall Study|Lost to Follow-up|7
1574352|NCT02758301|5458384|P2|Overall Study|Withdrawal by Subject|6
1574353|NCT02758301|5458385|P1|Overall Study|Withdrawal by Subject|5
1574354|NCT02758301|5458384|P2|Overall Study|Physician Decision|1
1574355|NCT02758301|5458385|P1|Overall Study|Physician Decision|10
1574356|NCT02758301|5458384|P2|Overall Study|Death|0
1574357|NCT02758301|5458385|P1|Overall Study|Death|12
1574358|NCT02758171|5458404|P2|Wash-out|Other reason|0
1574359|NCT02758171|5458405|P1|Wash-out|Other reason|1
1574360|NCT02758171|5458404|P2|Wash-out|Withdrawal by Subject|0
1574361|NCT02758171|5458405|P1|Wash-out|Withdrawal by Subject|1
1574362|NCT02757963|5458459|P1|Overall Study|Withdrawal by Subject|34
1574363|NCT02757963|5458459|P1|Overall Study|Physician Decision|1
1574364|NCT02757963|5458459|P1|Overall Study|Lost to Follow-up|5
1574365|NCT02757963|5458459|P1|Overall Study|Reached Stopping Criteria|1054
1574366|NCT02757963|5458459|P1|Overall Study|Adverse Event|3
1574367|NCT02757768|5458499|P2|Overall Study|Miscellaneous|2
1574368|NCT02757768|5458500|P1|Overall Study|Miscellaneous|4
1574369|NCT02757768|5458499|P2|Overall Study|Withdrawal by Subject|9
1574370|NCT02757768|5458500|P1|Overall Study|Withdrawal by Subject|16
1574371|NCT02757768|5458499|P2|Overall Study|Protocol Deviation|9
1574372|NCT02757768|5458500|P1|Overall Study|Protocol Deviation|2
1574373|NCT02757768|5458499|P2|Overall Study|Lost to Follow-up|0
1574374|NCT02757768|5458500|P1|Overall Study|Lost to Follow-up|1
1574375|NCT02757768|5458499|P2|Overall Study|Lack of Efficacy|1
1574376|NCT02757768|5458500|P1|Overall Study|Lack of Efficacy|2
1574377|NCT02757768|5458499|P2|Overall Study|Adverse Event|3
1574378|NCT02757768|5458500|P1|Overall Study|Adverse Event|5
1574379|NCT02757768|5458499|P2|Overall Study|Randomized Never Received Study Drug|4
1574380|NCT02757768|5458500|P1|Overall Study|Randomized Never Received Study Drug|3
1574381|NCT02757625|5458548|P4|Overall Study|Adverse Event|0
1574382|NCT02757625|5458549|P3|Overall Study|Adverse Event|1
1574383|NCT02757625|5458550|P2|Overall Study|Adverse Event|0
1574384|NCT02757625|5458551|P1|Overall Study|Adverse Event|0
1574385|NCT02757625|5458548|P4|Overall Study|Investigator’s discretion|0
1574386|NCT02757625|5458549|P3|Overall Study|Investigator’s discretion|1
1574387|NCT02757625|5458550|P2|Overall Study|Investigator’s discretion|0
1574388|NCT02757625|5458551|P1|Overall Study|Investigator’s discretion|0
1574389|NCT02757521|5458710|P2|Overall Study|Adverse Event|0
1574390|NCT02757521|5458711|P1|Overall Study|Adverse Event|1
1574391|NCT02757430|5458717|P1|Overall Study|No procedure performed|2
1574392|NCT02757430|5458717|P1|Overall Study|No informed consent|1
1574393|NCT02757430|5458717|P1|Overall Study|Inclusion/Exclusion criteria not met|3
1574394|NCT02757430|5458717|P1|Overall Study|Physician Decision|6
1574395|NCT02756832|5458782|P1|Overall Study|Protocol Deviation|10
1574396|NCT02756832|5458782|P1|Overall Study|Reason not Specified|9
1574397|NCT02756832|5458782|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
1574398|NCT02756832|5458782|P1|Overall Study|Insufficient Efficacy|2
1574399|NCT02756832|5458782|P1|Overall Study|Patient’s Unwillingness|12
1574400|NCT02756832|5458782|P1|Overall Study|Lost for Observation|13
1574401|NCT02756832|5458782|P1|Overall Study|Lost for Observation after Baseline|6
1574402|NCT02756819|5458796|P1|Overall Study|Reason not Specified|9
1574403|NCT02756819|5458796|P1|Overall Study|Adverse Event|2
1574404|NCT02756819|5458796|P1|Overall Study|Insufficient efficacy|2
1574405|NCT02756819|5458796|P1|Overall Study|Patient’s unwillingness|16
1574406|NCT02756819|5458796|P1|Overall Study|Lost for observation|23
1574407|NCT02756637|5458897|P2|Overall Study|Did not complete curative therapy|0
1574408|NCT02756637|5458898|P1|Overall Study|Did not complete curative therapy|33
1574409|NCT02756637|5458897|P2|Overall Study|No available NLR value|44
1574410|NCT02756637|5458898|P1|Overall Study|No available NLR value|44
1574411|NCT02756637|5458897|P2|Overall Study|Not eligible for initial SWOG study|10
1574412|NCT02756637|5458898|P1|Overall Study|Not eligible for initial SWOG study|10
1574413|NCT02756338|5458930|P1|Overall Study|Device Replaced with Pacemaker|4
1574414|NCT02756338|5458930|P1|Overall Study|Withdrawn by Investigator|1
1574415|NCT02756182|5458939|P1|Overall Study|StudyTechnical Difficulties|4
1574416|NCT02756078|5458954|P2|Period 2|Withdrawal by Subject|1
1574417|NCT02756078|5458955|P1|Period 2|Withdrawal by Subject|3
1574418|NCT02756078|5458954|P2|Period 2|Unsatisfactory Lens Fitting|1
1574419|NCT02756078|5458955|P1|Period 2|Unsatisfactory Lens Fitting|0
1574420|NCT02756078|5458954|P2|Period 2|Adverse Event|5
1574421|NCT02756078|5458955|P1|Period 2|Adverse Event|3
1574422|NCT02756078|5458954|P2|Period 1|Lens Discomfort|2
1574423|NCT02756078|5458955|P1|Period 1|Lens Discomfort|2
1574424|NCT02756078|5458954|P2|Period 1|Withdrawal by Subject|6
1574425|NCT02756078|5458955|P1|Period 1|Withdrawal by Subject|6
1574426|NCT02756078|5458954|P2|Period 1|Adverse Event|10
1574427|NCT02756078|5458955|P1|Period 1|Adverse Event|1
1574428|NCT02756078|5458954|P2|Period 1|Protocol Violation|1
1574429|NCT02756078|5458955|P1|Period 1|Protocol Violation|0
1574430|NCT02756078|5458954|P2|Period 1|Lost to Follow-up|2
1574431|NCT02756078|5458955|P1|Period 1|Lost to Follow-up|0
1574432|NCT02756078|5458954|P2|Period 1|Unsatisfactory Lens Fitting|1
1574433|NCT02756078|5458955|P1|Period 1|Unsatisfactory Lens Fitting|0
1574434|NCT02755831|5458980|P2|Overall Study|Lost to Follow-up|3
1574435|NCT02755831|5458981|P1|Overall Study|Lost to Follow-up|3
1574444|NCT02755805|5459036|P2|Overall Study|Withdrawal by Subject|2
1574445|NCT02755805|5459037|P1|Overall Study|Withdrawal by Subject|0
1574446|NCT02755805|5459036|P2|Overall Study|Refused assessments|0
1574447|NCT02755805|5459037|P1|Overall Study|Refused assessments|1
1574448|NCT02755805|5459036|P2|Overall Study|Lost to Follow-up|2
1574449|NCT02755805|5459037|P1|Overall Study|Lost to Follow-up|1
1574450|NCT02755090|5459051|P2|Overall Study|equipment malfunction|0
1574451|NCT02755090|5459052|P1|Overall Study|equipment malfunction|1
1574452|NCT02754492|5459104|P4|Overall Study|Venous access issues not resulting in AE|4
1574453|NCT02754492|5459105|P3|Overall Study|Venous access issues not resulting in AE|0
1574454|NCT02754492|5459106|P2|Overall Study|Venous access issues not resulting in AE|0
1574455|NCT02754492|5459107|P1|Overall Study|Venous access issues not resulting in AE|0
1574456|NCT02754492|5459104|P4|Overall Study|Adverse Event|13
1574457|NCT02754492|5459105|P3|Overall Study|Adverse Event|0
1574458|NCT02754492|5459106|P2|Overall Study|Adverse Event|0
1574459|NCT02754492|5459107|P1|Overall Study|Adverse Event|0
1574460|NCT02754492|5459104|P4|Overall Study|Equipment malfuntion|5
1574461|NCT02754492|5459105|P3|Overall Study|Equipment malfuntion|2
1574462|NCT02754492|5459106|P2|Overall Study|Equipment malfuntion|0
1574463|NCT02754492|5459107|P1|Overall Study|Equipment malfuntion|0
1574464|NCT02754492|5459104|P4|Overall Study|Withdrawal by Subject|0
1574465|NCT02754492|5459105|P3|Overall Study|Withdrawal by Subject|0
1574466|NCT02754492|5459106|P2|Overall Study|Withdrawal by Subject|0
1574467|NCT02754492|5459107|P1|Overall Study|Withdrawal by Subject|2
1574468|NCT02754492|5459104|P4|Overall Study|Protocol Violation|1
1574469|NCT02754492|5459105|P3|Overall Study|Protocol Violation|0
1574470|NCT02754492|5459106|P2|Overall Study|Protocol Violation|2
1574471|NCT02754492|5459107|P1|Overall Study|Protocol Violation|2
1574472|NCT02754440|5459123|P4|Overall Study|Subject issues not resulting in AE|12
1574473|NCT02754440|5459124|P3|Overall Study|Subject issues not resulting in AE|0
1574474|NCT02754440|5459125|P2|Overall Study|Subject issues not resulting in AE|0
1574475|NCT02754440|5459126|P1|Overall Study|Subject issues not resulting in AE|0
1574476|NCT02754440|5459123|P4|Overall Study|Equipment failure|7
1574477|NCT02754440|5459124|P3|Overall Study|Equipment failure|5
1574478|NCT02754440|5459125|P2|Overall Study|Equipment failure|5
1574479|NCT02754440|5459126|P1|Overall Study|Equipment failure|0
1574480|NCT02754440|5459123|P4|Overall Study|Withdrawal by Subject|1
1574481|NCT02754440|5459124|P3|Overall Study|Withdrawal by Subject|0
1574482|NCT02754440|5459125|P2|Overall Study|Withdrawal by Subject|0
1574483|NCT02754440|5459126|P1|Overall Study|Withdrawal by Subject|0
1574484|NCT02754440|5459123|P4|Overall Study|Adverse Event|9
1574485|NCT02754440|5459124|P3|Overall Study|Adverse Event|0
1574486|NCT02754440|5459125|P2|Overall Study|Adverse Event|1
1574487|NCT02754440|5459126|P1|Overall Study|Adverse Event|3
1574488|NCT02754440|5459123|P4|Overall Study|Protocol Violation|6
1574489|NCT02754440|5459124|P3|Overall Study|Protocol Violation|2
1574490|NCT02754440|5459125|P2|Overall Study|Protocol Violation|2
1574491|NCT02754440|5459126|P1|Overall Study|Protocol Violation|3
1574492|NCT02753946|5459178|P2|Overall Study|Physician Decision|2
1574493|NCT02753946|5459179|P1|Overall Study|Physician Decision|0
1574494|NCT02753946|5459178|P2|Overall Study|Lack of Efficacy|0
1574495|NCT02753946|5459179|P1|Overall Study|Lack of Efficacy|1
1574496|NCT02753946|5459178|P2|Overall Study|Withdrawal by Subject|1
1574497|NCT02753946|5459179|P1|Overall Study|Withdrawal by Subject|6
1574498|NCT02753946|5459178|P2|Overall Study|Adverse Event|6
1574499|NCT02753946|5459179|P1|Overall Study|Adverse Event|7
1574500|NCT02753075|5459259|P3|Overall Study|Physician Decision|0
1574501|NCT02753075|5459260|P2|Overall Study|Physician Decision|1
1574502|NCT02753075|5459261|P1|Overall Study|Physician Decision|3
1574503|NCT02753075|5459259|P3|Overall Study|Withdrawal of Consent|3
1574504|NCT02753075|5459260|P2|Overall Study|Withdrawal of Consent|1
1574505|NCT02753075|5459261|P1|Overall Study|Withdrawal of Consent|1
1574506|NCT02753075|5459259|P3|Overall Study|Lost to Follow-up|0
1574507|NCT02753075|5459260|P2|Overall Study|Lost to Follow-up|0
1574508|NCT02753075|5459261|P1|Overall Study|Lost to Follow-up|2
1574509|NCT02753075|5459259|P3|Overall Study|Adverse Event|0
1574510|NCT02753075|5459260|P2|Overall Study|Adverse Event|1
1574511|NCT02753075|5459261|P1|Overall Study|Adverse Event|2
1574512|NCT02752958|5459286|P1|Overall Study|Other (Reason not specified)|2
1574513|NCT02752958|5459286|P1|Overall Study|Withdrawal by Subject|2
1574514|NCT02752958|5459286|P1|Overall Study|Protocol Violation|1
1574515|NCT02752958|5459286|P1|Overall Study|Lost to Follow-up|1
1574516|NCT02752958|5459286|P1|Overall Study|Adverse Event|3
1574517|NCT02752802|5459368|P2|Overall Study|Contrast Volume Not Collected|0
1574518|NCT02752802|5459369|P1|Overall Study|Contrast Volume Not Collected|1
1574519|NCT02752776|5459381|P3|Overall Study|Withdrawal by Subject|2
1574520|NCT02752776|5459382|P2|Overall Study|Withdrawal by Subject|4
1574521|NCT02752776|5459383|P1|Overall Study|Withdrawal by Subject|3
1574522|NCT02752776|5459381|P3|Overall Study|Death|1
1574523|NCT02752776|5459382|P2|Overall Study|Death|0
1574524|NCT02752776|5459383|P1|Overall Study|Death|0
1574525|NCT02752776|5459381|P3|Overall Study|Subject/guardian decision|4
1574526|NCT02752776|5459382|P2|Overall Study|Subject/guardian decision|6
1574527|NCT02752776|5459383|P1|Overall Study|Subject/guardian decision|8
1574528|NCT02752776|5459381|P3|Overall Study|Protocol Violation|6
1574529|NCT02752776|5459382|P2|Overall Study|Protocol Violation|13
1574530|NCT02752776|5459383|P1|Overall Study|Protocol Violation|10
1574531|NCT02752776|5459381|P3|Overall Study|Pregnancy|3
1574532|NCT02752776|5459382|P2|Overall Study|Pregnancy|6
1574533|NCT02752776|5459383|P1|Overall Study|Pregnancy|1
1574534|NCT02752776|5459381|P3|Overall Study|Physician Decision|2
1574535|NCT02752776|5459382|P2|Overall Study|Physician Decision|6
1574536|NCT02752776|5459383|P1|Overall Study|Physician Decision|2
1574537|NCT02752776|5459381|P3|Overall Study|Non-compliance with study treatment|1
1574538|NCT02752776|5459382|P2|Overall Study|Non-compliance with study treatment|0
1574539|NCT02752776|5459383|P1|Overall Study|Non-compliance with study treatment|0
1574540|NCT02752776|5459381|P3|Overall Study|Lost to Follow-up|4
1574541|NCT02752776|5459382|P2|Overall Study|Lost to Follow-up|12
1574542|NCT02752776|5459383|P1|Overall Study|Lost to Follow-up|11
1574543|NCT02752776|5459381|P3|Overall Study|Lack of Efficacy|14
1574544|NCT02752776|5459382|P2|Overall Study|Lack of Efficacy|6
1574545|NCT02752776|5459383|P1|Overall Study|Lack of Efficacy|2
1574546|NCT02752776|5459381|P3|Overall Study|Adverse Event|11
1574547|NCT02752776|5459382|P2|Overall Study|Adverse Event|23
1574548|NCT02752776|5459383|P1|Overall Study|Adverse Event|15
1574549|NCT02752633|5459429|P1|Overall Study|Withdrawal by Subject|1
1574550|NCT02752074|5459469|P2|Overall Study|Status not Recorded|251
1574551|NCT02752074|5459470|P1|Overall Study|Status not Recorded|244
1574552|NCT02752074|5459469|P2|Overall Study|Withdrawal by Subject|8
1574553|NCT02752074|5459470|P1|Overall Study|Withdrawal by Subject|6
1574554|NCT02752074|5459469|P2|Overall Study|Death|91
1574555|NCT02752074|5459470|P1|Overall Study|Death|104
1574556|NCT02752074|5459469|P2|Overall Study|Lost to Follow-up|2
1574557|NCT02752074|5459470|P1|Overall Study|Lost to Follow-up|0
1574558|NCT02751983|5459494|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
1574559|NCT02751983|5459495|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
1574560|NCT02751983|5459494|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
1574561|NCT02751983|5459495|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
1574562|NCT02751983|5459494|P2|Post-Treatment Assessment|Lost to Follow-up|0
1574563|NCT02751983|5459495|P1|Post-Treatment Assessment|Lost to Follow-up|5
1574564|NCT02751983|5459494|P2|Treatment|Discharged prior to beginning ACT|0
1574565|NCT02751983|5459495|P1|Treatment|Discharged prior to beginning ACT|2
1574566|NCT02751983|5459494|P2|Treatment|Stopped ACT, but Remained in study|0
1574567|NCT02751983|5459495|P1|Treatment|Stopped ACT, but Remained in study|2
1574568|NCT02751450|5459532|P2|Overall Study|Adverse Event|0
1574569|NCT02751450|5459533|P1|Overall Study|Adverse Event|1
1574570|NCT02751424|5459554|P9|Part 2|Adverse Event|0
1574571|NCT02751424|5459555|P8|Part 2|Adverse Event|5
1574572|NCT02751424|5459556|P7|Part 2|Adverse Event|0
1574573|NCT02751424|5459557|P6|Part 2|Adverse Event|0
1574574|NCT02751424|5459558|P5|Part 2|Adverse Event|0
1574575|NCT02751424|5459559|P4|Part 2|Adverse Event|0
1574576|NCT02751424|5459560|P3|Part 2|Adverse Event|0
1574577|NCT02751424|5459561|P2|Part 2|Adverse Event|0
1574578|NCT02751424|5459562|P1|Part 2|Adverse Event|0
1574579|NCT02751320|5459718|P1|Overall Study|Withdrawal by Subject|1
1574580|NCT02751320|5459718|P1|Overall Study|Adverse Event|2
1574581|NCT02750943|5459756|P2|Overall Study|Withdrawal by Subject|7
1574582|NCT02750943|5459757|P1|Overall Study|Withdrawal by Subject|5
1574583|NCT02750943|5459756|P2|Overall Study|Lost to Follow-up|2
1574584|NCT02750943|5459757|P1|Overall Study|Lost to Follow-up|1
1574585|NCT02750930|5459771|P1|Overall Study|Study closed/terminated|8
1574586|NCT02750813|5459783|P2|Period 1, First 14 Days of Wear|Reason not given|1
1574587|NCT02750813|5459784|P1|Period 1, First 14 Days of Wear|Reason not given|0
1574588|NCT02750813|5459783|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
1574589|NCT02750813|5459784|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
1574590|NCT02750800|5459799|P1|Overall Study|Other, not specified|3
1574591|NCT02750800|5459799|P1|Overall Study|Patient request|12
1574592|NCT02750800|5459799|P1|Overall Study|Investigator decision|53
1574593|NCT02750800|5459799|P1|Overall Study|Lost to Follow-up|12
1574594|NCT02750800|5459799|P1|Overall Study|Adverse Event|18
1574595|NCT02750761|5459904|P6|Overall Study|Lost to Follow-up|0
1574596|NCT02750761|5459905|P5|Overall Study|Lost to Follow-up|0
1574597|NCT02750761|5459906|P4|Overall Study|Lost to Follow-up|0
1574598|NCT02750761|5459907|P3|Overall Study|Lost to Follow-up|1
1574599|NCT02750761|5459908|P2|Overall Study|Lost to Follow-up|0
1574600|NCT02750761|5459909|P1|Overall Study|Lost to Follow-up|0
1574601|NCT02750709|5460005|P6|Treatment Period 1|Adverse Event|1
1574602|NCT02750709|5460006|P5|Treatment Period 1|Adverse Event|0
1574603|NCT02750709|5460007|P4|Treatment Period 1|Adverse Event|0
1574604|NCT02750709|5460008|P3|Treatment Period 1|Adverse Event|0
1574605|NCT02750709|5460009|P2|Treatment Period 1|Adverse Event|0
1574606|NCT02750709|5460010|P1|Treatment Period 1|Adverse Event|0
1574607|NCT02750592|5460052|P1|Overall Study|Lack of Efficacy|2
1574608|NCT02750592|5460052|P1|Overall Study|Adverse Event|3
1574609|NCT02750501|5460071|P1|Overall Study|Non-compliant use of PERT|1
1574610|NCT02750501|5460071|P1|Overall Study|G-tube came out|1
1574611|NCT02750501|5460071|P1|Overall Study|Protocol Violation|1
1574612|NCT02750501|5460071|P1|Overall Study|Physician Decision|1
1574613|NCT02750501|5460071|P1|Overall Study|Adverse Event|4
1574614|NCT02750410|5460085|P2|Open-Label Extension Period|Withdrawal by Subject|2
1574615|NCT02750410|5460086|P1|Open-Label Extension Period|Withdrawal by Subject|1
1574616|NCT02750410|5460085|P2|Open-Label Extension Period|Protocol Violation|1
1574617|NCT02750410|5460086|P1|Open-Label Extension Period|Protocol Violation|0
1574618|NCT02750410|5460085|P2|Open-Label Extension Period|Adverse Event|3
1574619|NCT02750410|5460086|P1|Open-Label Extension Period|Adverse Event|5
1574620|NCT02750410|5460085|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1574621|NCT02750410|5460086|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1574622|NCT02750410|5460085|P2|Double-Blind Treatment Period|Adverse Event|2
1574623|NCT02750410|5460086|P1|Double-Blind Treatment Period|Adverse Event|2
1574624|NCT02750345|5460104|P6|Intervention 1|Adverse Event|0
1574625|NCT02750345|5460105|P5|Intervention 1|Adverse Event|1
1574626|NCT02750345|5460106|P4|Intervention 1|Adverse Event|0
1574627|NCT02750345|5460107|P3|Intervention 1|Adverse Event|0
1574628|NCT02750345|5460108|P2|Intervention 1|Adverse Event|0
1574629|NCT02750345|5460109|P1|Intervention 1|Adverse Event|0
1574630|NCT02750332|5460135|P2|Treatment Period 1|Withdrawal by Subject|1
1574631|NCT02750332|5460136|P1|Treatment Period 1|Withdrawal by Subject|0
1574632|NCT02750306|5460156|P2|Overall Study|Protocol Violation|0
1574633|NCT02750306|5460157|P1|Overall Study|Protocol Violation|1
1574634|NCT02750306|5460156|P2|Overall Study|Withdrawal by Subject|2
1574635|NCT02750306|5460157|P1|Overall Study|Withdrawal by Subject|5
1574636|NCT02749370|5460216|P1|Overall Study|Lost to Follow-up|3
1574637|NCT02749370|5460216|P1|Overall Study|Withdrawal by Subject|11
1574638|NCT02748863|5460262|P5|Treatment Period 2|Pregnancy|1
1574639|NCT02748863|5460263|P4|Treatment Period 2|Pregnancy|0
1574640|NCT02748863|5460264|P3|Treatment Period 2|Pregnancy|0
1574641|NCT02748863|5460265|P2|Treatment Period 2|Pregnancy|0
1574642|NCT02748863|5460266|P1|Treatment Period 2|Pregnancy|0
1574643|NCT02748863|5460262|P5|Treatment Period 2|Lack of Efficacy|0
1574644|NCT02748863|5460263|P4|Treatment Period 2|Lack of Efficacy|0
1574645|NCT02748863|5460264|P3|Treatment Period 2|Lack of Efficacy|0
1574646|NCT02748863|5460265|P2|Treatment Period 2|Lack of Efficacy|1
1574647|NCT02748863|5460266|P1|Treatment Period 2|Lack of Efficacy|0
1574648|NCT02748863|5460262|P5|Treatment Period 2|Adverse Event|0
1574649|NCT02748863|5460263|P4|Treatment Period 2|Adverse Event|2
1574650|NCT02748863|5460264|P3|Treatment Period 2|Adverse Event|0
1574651|NCT02748863|5460265|P2|Treatment Period 2|Adverse Event|2
1574652|NCT02748863|5460266|P1|Treatment Period 2|Adverse Event|3
1574653|NCT02748863|5460262|P5|Treatment Period 2|Lost to Follow-up|0
1574654|NCT02748863|5460263|P4|Treatment Period 2|Lost to Follow-up|0
1574655|NCT02748863|5460264|P3|Treatment Period 2|Lost to Follow-up|0
1574656|NCT02748863|5460265|P2|Treatment Period 2|Lost to Follow-up|0
1574657|NCT02748863|5460266|P1|Treatment Period 2|Lost to Follow-up|2
1574658|NCT02748863|5460262|P5|Treatment Period 1|Withdrawal by Subject|0
1574659|NCT02748863|5460263|P4|Treatment Period 1|Withdrawal by Subject|0
1574660|NCT02748863|5460264|P3|Treatment Period 1|Withdrawal by Subject|1
1574661|NCT02748863|5460265|P2|Treatment Period 1|Withdrawal by Subject|1
1574662|NCT02748863|5460266|P1|Treatment Period 1|Withdrawal by Subject|0
1574663|NCT02748863|5460262|P5|Treatment Period 1|Lack of Efficacy|0
1574664|NCT02748863|5460263|P4|Treatment Period 1|Lack of Efficacy|0
1574665|NCT02748863|5460264|P3|Treatment Period 1|Lack of Efficacy|1
1574666|NCT02748863|5460265|P2|Treatment Period 1|Lack of Efficacy|0
1574667|NCT02748863|5460266|P1|Treatment Period 1|Lack of Efficacy|0
1574668|NCT02748863|5460262|P5|Treatment Period 1|Adverse Event|0
1574669|NCT02748863|5460263|P4|Treatment Period 1|Adverse Event|0
1574670|NCT02748863|5460264|P3|Treatment Period 1|Adverse Event|0
1574671|NCT02748863|5460265|P2|Treatment Period 1|Adverse Event|1
1574672|NCT02748863|5460266|P1|Treatment Period 1|Adverse Event|0
1574673|NCT02748213|5460350|P2|Overall Study|Other|29
1574674|NCT02748213|5460351|P1|Overall Study|Other|30
1574675|NCT02748213|5460350|P2|Overall Study|Failure to Return|0
1574676|NCT02748213|5460351|P1|Overall Study|Failure to Return|1
1574677|NCT02748213|5460350|P2|Overall Study|Refused Treatment*|6
1574678|NCT02748213|5460351|P1|Overall Study|Refused Treatment*|6
1574679|NCT02748213|5460350|P2|Overall Study|Protocol Violation|4
1574680|NCT02748213|5460351|P1|Overall Study|Protocol Violation|6
1574681|NCT02748213|5460350|P2|Overall Study|Violation of Selection Criteria|0
1574682|NCT02748213|5460351|P1|Overall Study|Violation of Selection Criteria|2
1574683|NCT02748213|5460350|P2|Overall Study|Insufficient Therapeutic Response|57
1574684|NCT02748213|5460351|P1|Overall Study|Insufficient Therapeutic Response|56
1574685|NCT02748213|5460350|P2|Overall Study|Death|3
1574686|NCT02748213|5460351|P1|Overall Study|Death|5
1574687|NCT02748213|5460350|P2|Overall Study|Adverse Event or Intercurrent Illness|11
1574688|NCT02748213|5460351|P1|Overall Study|Adverse Event or Intercurrent Illness|5
1574689|NCT02748213|5460350|P2|Overall Study|Abnormal Laboratory Test|0
1574690|NCT02748213|5460351|P1|Overall Study|Abnormal Laboratory Test|1
1574691|NCT02748213|5460350|P2|Overall Study|Withdrawal Prior to Treatment|2
1574692|NCT02748213|5460351|P1|Overall Study|Withdrawal Prior to Treatment|1
1574693|NCT02748057|5460369|P2|Overall Study|Withdrawal by Subject|0
1574694|NCT02748057|5460370|P1|Overall Study|Withdrawal by Subject|1
1574695|NCT02748057|5460369|P2|Overall Study|Participant Moved|0
1574696|NCT02748057|5460370|P1|Overall Study|Participant Moved|1
1574697|NCT02748057|5460369|P2|Overall Study|Protocol Violation|1
1574698|NCT02748057|5460370|P1|Overall Study|Protocol Violation|2
1574699|NCT02748057|5460369|P2|Overall Study|Physician Decision|1
1574700|NCT02748057|5460370|P1|Overall Study|Physician Decision|0
1574701|NCT02748057|5460369|P2|Overall Study|Adverse Event|0
1574702|NCT02748057|5460370|P1|Overall Study|Adverse Event|1
1574703|NCT02747004|5460392|P3|Overall Study|on study treatment/follow-up|41
1574704|NCT02747004|5460393|P2|Overall Study|on study treatment/follow-up|42
1574705|NCT02747004|5460394|P1|Overall Study|on study treatment/follow-up|48
1574706|NCT02747004|5460392|P3|Overall Study|Lost to Follow-up|2
1574707|NCT02747004|5460393|P2|Overall Study|Lost to Follow-up|2
1574708|NCT02747004|5460394|P1|Overall Study|Lost to Follow-up|1
1574709|NCT02747004|5460392|P3|Overall Study|Withdrawal by Subject|4
1574710|NCT02747004|5460393|P2|Overall Study|Withdrawal by Subject|5
1574711|NCT02747004|5460394|P1|Overall Study|Withdrawal by Subject|8
1574712|NCT02746679|5460442|P2|Overall Study|Lost to Follow-up|6
1574713|NCT02746679|5460443|P1|Overall Study|Lost to Follow-up|4
1574714|NCT02746627|5460476|P3|Overall Study|Withdrawal by Subject|1
1574715|NCT02746627|5460477|P2|Overall Study|Withdrawal by Subject|1
1574716|NCT02746627|5460478|P1|Overall Study|Withdrawal by Subject|1
1574717|NCT02746575|5460501|P1|Overall Study|Unknown history of CVA|1
1574718|NCT02746575|5460501|P1|Overall Study|PI unavailable|1
1574719|NCT02746575|5460501|P1|Overall Study|typ of surgery|1
1574720|NCT02746575|5460501|P1|Overall Study|type of surgery|1
1574721|NCT02746575|5460501|P1|Overall Study|put on beta-blocker|3
1574722|NCT02746575|5460501|P1|Overall Study|Study paused|8
1574723|NCT02746575|5460501|P1|Overall Study|Bradycardia/hypotension|9
1574724|NCT02746575|5460501|P1|Overall Study|Withdrawal by Subject|3
1574725|NCT02746575|5460501|P1|Overall Study|Received epidural|10
1574726|NCT02746575|5460501|P1|Overall Study|Surgery cancelled or time chaned|13
1574727|NCT02745535|5460564|P1|Overall Study|Lost to Follow-up|2
1574728|NCT02745535|5460564|P1|Overall Study|Adverse Event|3
1574729|NCT02745535|5460564|P1|Overall Study|Death|1
1574730|NCT02745392|5460576|P4|Overall Study|Lost to Follow-up|0
1574731|NCT02745392|5460577|P3|Overall Study|Lost to Follow-up|0
1574732|NCT02745392|5460578|P2|Overall Study|Lost to Follow-up|1
1574733|NCT02745392|5460579|P1|Overall Study|Lost to Follow-up|0
1574734|NCT02745145|5460605|P3|Overall Study|Study Termination|7
1574735|NCT02745145|5460606|P2|Overall Study|Study Termination|3
1574736|NCT02745145|5460607|P1|Overall Study|Study Termination|8
1574737|NCT02745145|5460605|P3|Overall Study|Withdrew consent|1
1574738|NCT02745145|5460606|P2|Overall Study|Withdrew consent|1
1574739|NCT02745145|5460607|P1|Overall Study|Withdrew consent|1
1574740|NCT02745145|5460605|P3|Overall Study|Progressive disease|1
1574741|NCT02745145|5460606|P2|Overall Study|Progressive disease|0
1574742|NCT02745145|5460607|P1|Overall Study|Progressive disease|0
1574743|NCT02745145|5460605|P3|Overall Study|Death|0
1574744|NCT02745145|5460606|P2|Overall Study|Death|1
1574745|NCT02745145|5460607|P1|Overall Study|Death|0
1574746|NCT02745145|5460605|P3|Overall Study|Adverse Event|0
1574747|NCT02745145|5460606|P2|Overall Study|Adverse Event|0
1574748|NCT02745145|5460607|P1|Overall Study|Adverse Event|1
1574749|NCT02745119|5460646|P4|Overall Study|Reason Not Specified|1
1574750|NCT02745119|5460647|P3|Overall Study|Reason Not Specified|0
1574751|NCT02745119|5460648|P2|Overall Study|Reason Not Specified|2
1574752|NCT02745119|5460649|P1|Overall Study|Reason Not Specified|0
1574753|NCT02745119|5460646|P4|Overall Study|Physician Decision|2
1574754|NCT02745119|5460647|P3|Overall Study|Physician Decision|2
1574755|NCT02745119|5460648|P2|Overall Study|Physician Decision|2
1574756|NCT02745119|5460649|P1|Overall Study|Physician Decision|0
1574757|NCT02745119|5460646|P4|Overall Study|Study Terminated by Sponsor|251
1574758|NCT02745119|5460647|P3|Overall Study|Study Terminated by Sponsor|135
1574759|NCT02745119|5460648|P2|Overall Study|Study Terminated by Sponsor|252
1574760|NCT02745119|5460649|P1|Overall Study|Study Terminated by Sponsor|134
1574761|NCT02745119|5460646|P4|Overall Study|Withdrawal by Subject|14
1574762|NCT02745119|5460647|P3|Overall Study|Withdrawal by Subject|8
1574763|NCT02745119|5460648|P2|Overall Study|Withdrawal by Subject|15
1574764|NCT02745119|5460649|P1|Overall Study|Withdrawal by Subject|7
1574765|NCT02745119|5460646|P4|Overall Study|Protocol Deviation|1
1574766|NCT02745119|5460647|P3|Overall Study|Protocol Deviation|0
1574767|NCT02745119|5460648|P2|Overall Study|Protocol Deviation|0
1574768|NCT02745119|5460649|P1|Overall Study|Protocol Deviation|0
1574769|NCT02745119|5460646|P4|Overall Study|Lost to Follow-up|1
1574770|NCT02745119|5460647|P3|Overall Study|Lost to Follow-up|0
1574771|NCT02745119|5460648|P2|Overall Study|Lost to Follow-up|0
1574772|NCT02745119|5460649|P1|Overall Study|Lost to Follow-up|0
1574773|NCT02745119|5460646|P4|Overall Study|Death|4
1574774|NCT02745119|5460647|P3|Overall Study|Death|0
1574775|NCT02745119|5460648|P2|Overall Study|Death|3
1574776|NCT02745119|5460649|P1|Overall Study|Death|3
1574777|NCT02745119|5460646|P4|Overall Study|Adverse Event|3
1574778|NCT02745119|5460647|P3|Overall Study|Adverse Event|1
1574779|NCT02745119|5460648|P2|Overall Study|Adverse Event|0
1574780|NCT02745119|5460649|P1|Overall Study|Adverse Event|1
1574781|NCT02744755|5460681|P2|Study Period 2|Lack of Efficacy|2
1574782|NCT02744755|5460682|P1|Study Period 2|Lack of Efficacy|3
1574783|NCT02744755|5460681|P2|Study Period 2|Withdrawal by Subject|2
1574784|NCT02744755|5460682|P1|Study Period 2|Withdrawal by Subject|2
1574785|NCT02744755|5460681|P2|Study Period 2|Lost to Follow-up|2
1574786|NCT02744755|5460682|P1|Study Period 2|Lost to Follow-up|0
1574787|NCT02744755|5460681|P2|Study Period 2|not defined|2
1574788|NCT02744755|5460682|P1|Study Period 2|not defined|3
1574789|NCT02744755|5460681|P2|Study Period 2|Protocol Violation|0
1574790|NCT02744755|5460682|P1|Study Period 2|Protocol Violation|1
1574791|NCT02744755|5460681|P2|Study Period 2|Adverse Event|0
1574792|NCT02744755|5460682|P1|Study Period 2|Adverse Event|5
1574793|NCT02744755|5460681|P2|Study Period 1|Withdrawal by Subject|4
1574794|NCT02744755|5460682|P1|Study Period 1|Withdrawal by Subject|8
1574795|NCT02744755|5460681|P2|Study Period 1|Lack of Efficacy|0
1574796|NCT02744755|5460682|P1|Study Period 1|Lack of Efficacy|1
1574797|NCT02744755|5460681|P2|Study Period 1|Lost to Follow-up|1
1574798|NCT02744755|5460682|P1|Study Period 1|Lost to Follow-up|1
1574799|NCT02744755|5460681|P2|Study Period 1|Adverse Event|1
1574800|NCT02744755|5460682|P1|Study Period 1|Adverse Event|1
1574801|NCT02744755|5460681|P2|Study Period 1|Pregnancy|0
1574802|NCT02744755|5460682|P1|Study Period 1|Pregnancy|1
1574803|NCT02744755|5460681|P2|Study Period 1|not defined|1
1574804|NCT02744755|5460682|P1|Study Period 1|not defined|0
1574805|NCT02744755|5460681|P2|Study Period 1|Protocol Violation|1
1574806|NCT02744755|5460682|P1|Study Period 1|Protocol Violation|2
1574807|NCT02744391|5460742|P1|Overall Study|Withdrawal by Subject|3
1574808|NCT02744391|5460742|P1|Overall Study|Physician Decision|2
1574809|NCT02744391|5460742|P1|Overall Study|Lost to Follow-up|9
1574810|NCT02744066|5460766|P2|Overall Study|Discharged from NICU prior to completion|4
1574811|NCT02744066|5460767|P1|Overall Study|Discharged from NICU prior to completion|0
1574812|NCT02744066|5460766|P2|Overall Study|Withdrawal by parent|1
1574813|NCT02744066|5460767|P1|Overall Study|Withdrawal by parent|0
1574814|NCT02743962|5460777|P2|Overall Study|Atrophic vaginitis diagnosed|0
1574815|NCT02743962|5460778|P1|Overall Study|Atrophic vaginitis diagnosed|1
1574825|NCT02743780|5460829|P5|Part 3 (7 Days)|Adverse Event|0
1574826|NCT02743780|5460830|P4|Part 3 (7 Days)|Adverse Event|0
1574827|NCT02743780|5460831|P3|Part 3 (7 Days)|Adverse Event|1
1574828|NCT02743780|5460832|P2|Part 3 (7 Days)|Adverse Event|0
1574829|NCT02743780|5460833|P1|Part 3 (7 Days)|Adverse Event|0
1574830|NCT02743221|5460923|P2|Overall Study|Patient not eligible, not treated|1
1574831|NCT02743221|5460924|P1|Overall Study|Patient not eligible, not treated|0
1574832|NCT02743221|5460923|P2|Overall Study|Physician Decision|5
1574833|NCT02743221|5460924|P1|Overall Study|Physician Decision|2
1574834|NCT02743221|5460923|P2|Overall Study|non medical reason|2
1574835|NCT02743221|5460924|P1|Overall Study|non medical reason|8
1574836|NCT02743221|5460923|P2|Overall Study|Adverse Event|14
1574837|NCT02743221|5460924|P1|Overall Study|Adverse Event|17
1574838|NCT02743221|5460923|P2|Overall Study|Progressive disease|38
1574839|NCT02743221|5460924|P1|Overall Study|Progressive disease|29
1574840|NCT02743117|5460940|P2|Overall Study|Other|0
1574841|NCT02743117|5460941|P1|Overall Study|Other|1
1574842|NCT02743117|5460940|P2|Overall Study|Lost to Follow-up|1
1574843|NCT02743117|5460941|P1|Overall Study|Lost to Follow-up|0
1574844|NCT02742818|5460966|P2|Overall Study|Protocol Violation|1
1574845|NCT02742818|5460967|P1|Overall Study|Protocol Violation|0
1574846|NCT02742818|5460966|P2|Overall Study|Adverse Event|1
1574847|NCT02742818|5460967|P1|Overall Study|Adverse Event|0
1574848|NCT02742766|5461000|P19|Part 2 (Up to 22 Days)|Physician Decision|0
1574849|NCT02742766|5461001|P18|Part 2 (Up to 22 Days)|Physician Decision|0
1574850|NCT02742766|5461002|P17|Part 2 (Up to 22 Days)|Physician Decision|0
1574851|NCT02742766|5461003|P16|Part 2 (Up to 22 Days)|Physician Decision|1
1574852|NCT02742766|5461004|P15|Part 2 (Up to 22 Days)|Physician Decision|0
1574853|NCT02742766|5461005|P14|Part 2 (Up to 22 Days)|Physician Decision|5
1574854|NCT02742766|5461006|P13|Part 2 (Up to 22 Days)|Physician Decision|2
1574855|NCT02742766|5461007|P12|Part 2 (Up to 22 Days)|Physician Decision|0
1574856|NCT02742766|5461008|P11|Part 2 (Up to 22 Days)|Physician Decision|0
1574857|NCT02742766|5461009|P10|Part 2 (Up to 22 Days)|Physician Decision|0
1574858|NCT02742766|5461010|P9|Part 2 (Up to 22 Days)|Physician Decision|0
1574859|NCT02742766|5461011|P8|Part 2 (Up to 22 Days)|Physician Decision|0
1574860|NCT02742766|5461012|P7|Part 2 (Up to 22 Days)|Physician Decision|0
1574861|NCT02742766|5461013|P6|Part 2 (Up to 22 Days)|Physician Decision|0
1574862|NCT02742766|5461014|P5|Part 2 (Up to 22 Days)|Physician Decision|0
1574863|NCT02742766|5461015|P4|Part 2 (Up to 22 Days)|Physician Decision|0
1574864|NCT02742766|5461016|P3|Part 2 (Up to 22 Days)|Physician Decision|0
1574865|NCT02742766|5461017|P2|Part 2 (Up to 22 Days)|Physician Decision|0
1574866|NCT02742766|5461018|P1|Part 2 (Up to 22 Days)|Physician Decision|0
1574867|NCT02742766|5461000|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574868|NCT02742766|5461001|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574869|NCT02742766|5461002|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574870|NCT02742766|5461003|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574871|NCT02742766|5461004|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574872|NCT02742766|5461005|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
1574873|NCT02742766|5461006|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574874|NCT02742766|5461007|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574875|NCT02742766|5461008|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574876|NCT02742766|5461009|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574877|NCT02742766|5461010|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574878|NCT02742766|5461011|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574879|NCT02742766|5461012|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574880|NCT02742766|5461013|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574881|NCT02742766|5461014|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574882|NCT02742766|5461015|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574883|NCT02742766|5461016|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574884|NCT02742766|5461017|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574885|NCT02742766|5461018|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
1574886|NCT02742649|5461278|P5|Open-Label Period|Lost to Follow-up|1
1574887|NCT02742649|5461279|P4|Open-Label Period|Lost to Follow-up|0
1574888|NCT02742649|5461280|P3|Open-Label Period|Lost to Follow-up|0
1574889|NCT02742649|5461281|P2|Open-Label Period|Lost to Follow-up|0
1574890|NCT02742649|5461282|P1|Open-Label Period|Lost to Follow-up|0
1574891|NCT02742649|5461278|P5|Double-Blind Treatment Period|Adverse Event|0
1574892|NCT02742649|5461279|P4|Double-Blind Treatment Period|Adverse Event|0
1574893|NCT02742649|5461280|P3|Double-Blind Treatment Period|Adverse Event|0
1574894|NCT02742649|5461281|P2|Double-Blind Treatment Period|Adverse Event|1
1574895|NCT02742649|5461282|P1|Double-Blind Treatment Period|Adverse Event|0
1574896|NCT02742649|5461278|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1574897|NCT02742649|5461279|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1574898|NCT02742649|5461280|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1574899|NCT02742649|5461281|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
1574900|NCT02742649|5461282|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
1574901|NCT02742519|5461310|P3|Part 2 Open Label Period (32 Weeks)|Other|1
1574902|NCT02742519|5461311|P2|Part 2 Open Label Period (32 Weeks)|Other|0
1574903|NCT02742519|5461312|P1|Part 2 Open Label Period (32 Weeks)|Other|0
1574904|NCT02742519|5461310|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
1574905|NCT02742519|5461311|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
1574906|NCT02742519|5461312|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
1574907|NCT02742519|5461310|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
1574908|NCT02742519|5461311|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
1574909|NCT02742519|5461312|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
1574910|NCT02742441|5461332|P2|Overall Study|Adverse Event|2
1574911|NCT02742441|5461333|P1|Overall Study|Adverse Event|0
1574912|NCT02742441|5461332|P2|Overall Study|Withdrawal by Subject|2
1574913|NCT02742441|5461333|P1|Overall Study|Withdrawal by Subject|2
1574914|NCT02742441|5461332|P2|Overall Study|Lost to Follow-up|4
1574915|NCT02742441|5461333|P1|Overall Study|Lost to Follow-up|4
1574916|NCT02741713|5461380|P2|Overall Study|Surgery type changed intra-operatively|1
1574917|NCT02741713|5461381|P1|Overall Study|Surgery type changed intra-operatively|2
1574918|NCT02741518|5461423|P2|Overall Study|Withdrawal by Subject|1
1574919|NCT02741518|5461424|P1|Overall Study|Withdrawal by Subject|1
1574920|NCT02741310|5461434|P2|Overall Study|Sponsor Decision|2
1574921|NCT02741310|5461435|P1|Overall Study|Sponsor Decision|2
1574922|NCT02741271|5461480|P2|Overall Study|Withdrawal by Parent/Guardian|2
1574923|NCT02741271|5461481|P1|Overall Study|Withdrawal by Parent/Guardian|0
1574924|NCT02741271|5461480|P2|Overall Study|Lost to Follow-up|0
1574925|NCT02741271|5461481|P1|Overall Study|Lost to Follow-up|2
1574926|NCT02741245|5461514|P5|Overall Study|Withdrawal by Subject|0
1574927|NCT02741245|5461515|P4|Overall Study|Withdrawal by Subject|1
1574928|NCT02741245|5461516|P3|Overall Study|Withdrawal by Subject|0
1574929|NCT02741245|5461517|P2|Overall Study|Withdrawal by Subject|0
1574930|NCT02741245|5461518|P1|Overall Study|Withdrawal by Subject|0
1574931|NCT02741245|5461514|P5|Overall Study|Protocol Violation|0
1574932|NCT02741245|5461515|P4|Overall Study|Protocol Violation|1
1574933|NCT02741245|5461516|P3|Overall Study|Protocol Violation|0
1574934|NCT02741245|5461517|P2|Overall Study|Protocol Violation|1
1574935|NCT02741245|5461518|P1|Overall Study|Protocol Violation|0
1574936|NCT02741245|5461514|P5|Overall Study|Adverse Event|2
1574937|NCT02741245|5461515|P4|Overall Study|Adverse Event|2
1574938|NCT02741245|5461516|P3|Overall Study|Adverse Event|0
1574939|NCT02741245|5461517|P2|Overall Study|Adverse Event|0
1574940|NCT02741245|5461518|P1|Overall Study|Adverse Event|0
1574941|NCT02741076|5461624|P4|Overall Study|No additional information available|1
1574942|NCT02741076|5461625|P3|Overall Study|No additional information available|1
1574943|NCT02741076|5461626|P2|Overall Study|No additional information available|0
1574944|NCT02741076|5461627|P1|Overall Study|No additional information available|0
1574945|NCT02741076|5461624|P4|Overall Study|Sponsor Request|1
1574946|NCT02741076|5461625|P3|Overall Study|Sponsor Request|0
1574947|NCT02741076|5461626|P2|Overall Study|Sponsor Request|3
1574948|NCT02741076|5461627|P1|Overall Study|Sponsor Request|2
1574949|NCT02741076|5461624|P4|Overall Study|Withdrawal by Subject|0
1574950|NCT02741076|5461625|P3|Overall Study|Withdrawal by Subject|0
1574951|NCT02741076|5461626|P2|Overall Study|Withdrawal by Subject|1
1574952|NCT02741076|5461627|P1|Overall Study|Withdrawal by Subject|0
1574953|NCT02741076|5461624|P4|Overall Study|Lack of Efficacy|0
1574954|NCT02741076|5461625|P3|Overall Study|Lack of Efficacy|0
1574955|NCT02741076|5461626|P2|Overall Study|Lack of Efficacy|0
1574956|NCT02741076|5461627|P1|Overall Study|Lack of Efficacy|1
1574957|NCT02741076|5461624|P4|Overall Study|Adverse Event|0
1574958|NCT02741076|5461625|P3|Overall Study|Adverse Event|1
1574959|NCT02741076|5461626|P2|Overall Study|Adverse Event|1
1574960|NCT02741076|5461627|P1|Overall Study|Adverse Event|0
1574961|NCT02740049|5461743|P1|Overall Study|Isolated cells did not grow sufficiently|1
1574962|NCT02739997|5461749|P1|Overall Study|Withdrawal by Subject|1
1574963|NCT02739997|5461749|P1|Overall Study|Death|1
1574964|NCT02739984|5461763|P2|Overall Study|Lost to Follow-up|0
1574965|NCT02739984|5461764|P1|Overall Study|Lost to Follow-up|3
1574966|NCT02739984|5461763|P2|Overall Study|Death|1
1574967|NCT02739984|5461764|P1|Overall Study|Death|0
1574968|NCT02739984|5461763|P2|Overall Study|Withdrawal by Subject|1
1574969|NCT02739984|5461764|P1|Overall Study|Withdrawal by Subject|1
1574970|NCT02739984|5461763|P2|Overall Study|Sponsor Decision|0
1574971|NCT02739984|5461764|P1|Overall Study|Sponsor Decision|1
1574972|NCT02739828|5461812|P1|Overall Study|Lost to Follow-up|4
1574973|NCT02739828|5461812|P1|Overall Study|Adverse Event|1
1574974|NCT02739594|5461857|P2|Overall Study|Other|2
1574975|NCT02739594|5461858|P1|Overall Study|Other|6
1574976|NCT02739594|5461857|P2|Overall Study|Elevated Serum Creatinine|1
1574977|NCT02739594|5461858|P1|Overall Study|Elevated Serum Creatinine|0
1574978|NCT02739594|5461857|P2|Overall Study|Lost to Follow-up|1
1574979|NCT02739594|5461858|P1|Overall Study|Lost to Follow-up|0
1574980|NCT02739594|5461857|P2|Overall Study|Withdrawal by Subject|1
1574981|NCT02739594|5461858|P1|Overall Study|Withdrawal by Subject|1
1574982|NCT02739594|5461857|P2|Overall Study|Administrative Reasons|3
1574983|NCT02739594|5461858|P1|Overall Study|Administrative Reasons|1
1574984|NCT02739594|5461857|P2|Overall Study|Renal Insufficiency|6
1574985|NCT02739594|5461858|P1|Overall Study|Renal Insufficiency|4
1574986|NCT02739594|5461857|P2|Overall Study|Death|2
1574987|NCT02739594|5461858|P1|Overall Study|Death|4
1574988|NCT02739594|5461857|P2|Overall Study|Protocol Violation|6
1574989|NCT02739594|5461858|P1|Overall Study|Protocol Violation|5
1574990|NCT02739594|5461857|P2|Overall Study|Violation of Eligibility Criteria|2
1574991|NCT02739594|5461858|P1|Overall Study|Violation of Eligibility Criteria|1
1574992|NCT02739594|5461857|P2|Overall Study|Undesired Event|4
1574993|NCT02739594|5461858|P1|Overall Study|Undesired Event|3
1574994|NCT02739360|5461888|P1|Overall Study|Study terminated by Sponsor|2
1574995|NCT02739360|5461888|P1|Overall Study|Adverse Event|1
1574996|NCT02739321|5461894|P2|Overall Study|Withdrawal by Subject|2
1574997|NCT02739321|5461895|P1|Overall Study|Withdrawal by Subject|1
1574998|NCT02739321|5461894|P2|Overall Study|Lost to Follow-up|1
1574999|NCT02739321|5461895|P1|Overall Study|Lost to Follow-up|1
1575000|NCT02739321|5461894|P2|Overall Study|Lack of Efficacy|1
1575001|NCT02739321|5461895|P1|Overall Study|Lack of Efficacy|1
1575002|NCT02739269|5461941|P2|Overall Study|Withdrawal by Subject|2
1575003|NCT02739269|5461942|P1|Overall Study|Withdrawal by Subject|0
1575004|NCT02739269|5461941|P2|Overall Study|Cycle cancellation|2
1575005|NCT02739269|5461942|P1|Overall Study|Cycle cancellation|2
1575006|NCT02739269|5461941|P2|Overall Study|Protocol Violation|0
1575007|NCT02739269|5461942|P1|Overall Study|Protocol Violation|5
1575008|NCT02738879|5461969|P2|Overall Study|Withdrawal by Subject|7
1575009|NCT02738879|5461970|P1|Overall Study|Withdrawal by Subject|5
1575010|NCT02738879|5461969|P2|Overall Study|Site Discontinued Study Participation|0
1575011|NCT02738879|5461970|P1|Overall Study|Site Discontinued Study Participation|1
1575012|NCT02738879|5461969|P2|Overall Study|Screen Failure|2
1575013|NCT02738879|5461970|P1|Overall Study|Screen Failure|1
1575014|NCT02738879|5461969|P2|Overall Study|Pregnancy|1
1575015|NCT02738879|5461970|P1|Overall Study|Pregnancy|0
1575016|NCT02738879|5461969|P2|Overall Study|Physician Decision|4
1575017|NCT02738879|5461970|P1|Overall Study|Physician Decision|3
1575018|NCT02738879|5461969|P2|Overall Study|Protocol Violation|3
1575019|NCT02738879|5461970|P1|Overall Study|Protocol Violation|1
1575020|NCT02738879|5461969|P2|Overall Study|Lost to Follow-up|5
1575021|NCT02738879|5461970|P1|Overall Study|Lost to Follow-up|1
1575022|NCT02738879|5461969|P2|Overall Study|Death|2
1575023|NCT02738879|5461970|P1|Overall Study|Death|0
1575024|NCT02738879|5461969|P2|Overall Study|Adverse Event|1
1575025|NCT02738879|5461970|P1|Overall Study|Adverse Event|1
1575026|NCT02738333|5462023|P3|Overall Study|Lost to Follow-up|0
1575027|NCT02738333|5462024|P2|Overall Study|Lost to Follow-up|0
1575028|NCT02738333|5462025|P1|Overall Study|Lost to Follow-up|1
1575029|NCT02738333|5462023|P3|Overall Study|Death|0
1575030|NCT02738333|5462024|P2|Overall Study|Death|0
1575031|NCT02738333|5462025|P1|Overall Study|Death|1
1575032|NCT02738203|5462114|P2|Overall Study|Protocol Violation|1
1575033|NCT02738203|5462115|P1|Overall Study|Protocol Violation|0
1575034|NCT02738203|5462114|P2|Overall Study|Failed IUD Insertion|2
1575035|NCT02738203|5462115|P1|Overall Study|Failed IUD Insertion|2
1575036|NCT02738151|5462131|P2|Overall Study|Other than specified above|21
1575037|NCT02738151|5462132|P1|Overall Study|Other than specified above|11
1575038|NCT02738151|5462131|P2|Overall Study|Poor Compliance to Protocol|3
1575039|NCT02738151|5462132|P1|Overall Study|Poor Compliance to Protocol|4
1575040|NCT02738151|5462131|P2|Overall Study|Hypoglycemia|1
1575041|NCT02738151|5462132|P1|Overall Study|Hypoglycemia|0
1575042|NCT02738151|5462131|P2|Overall Study|Adverse Event|5
1575043|NCT02738151|5462132|P1|Overall Study|Adverse Event|4
1575044|NCT02738151|5462131|P2|Overall Study|Randomized but not treated|1
1575045|NCT02738151|5462132|P1|Overall Study|Randomized but not treated|4
1575046|NCT02738138|5462176|P2|Overall Study|Other - not further specified|0
1575047|NCT02738138|5462177|P1|Overall Study|Other - not further specified|1
1575048|NCT02738138|5462176|P2|Overall Study|Lost to Follow-up|0
1575049|NCT02738138|5462177|P1|Overall Study|Lost to Follow-up|2
1575050|NCT02738138|5462176|P2|Overall Study|Adverse Event|1
1575051|NCT02738138|5462177|P1|Overall Study|Adverse Event|0
1575052|NCT02738008|5462214|P3|Overall Study|Adverse Event|2
1575053|NCT02738008|5462215|P2|Overall Study|Adverse Event|1
1575054|NCT02738008|5462216|P1|Overall Study|Adverse Event|0
1575055|NCT02738008|5462214|P3|Overall Study|Study Terminated by Sponsor|3
1575056|NCT02738008|5462215|P2|Overall Study|Study Terminated by Sponsor|5
1575057|NCT02738008|5462216|P1|Overall Study|Study Terminated by Sponsor|1
1575058|NCT02737852|5462241|P1|Overall Study|Withdrawal by Subject|2
1575059|NCT02737722|5462250|P4|Overall Study|Physician Decision|0
1575060|NCT02737722|5462251|P3|Overall Study|Physician Decision|1
1575061|NCT02737722|5462252|P2|Overall Study|Physician Decision|0
1575062|NCT02737722|5462253|P1|Overall Study|Physician Decision|0
1575063|NCT02737618|5462304|P1|Overall Study|Withdrawal by Subject|9
1575064|NCT02737592|5462309|P1|Overall Study|Withdrawal by Subject|1
1575065|NCT02736890|5462382|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
1575066|NCT02736890|5462383|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
1575067|NCT02736890|5462382|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
1575068|NCT02736890|5462383|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
1575073|NCT02736721|5462446|P1|Overall Study|Other|5
1575074|NCT02736721|5462446|P1|Overall Study|Lost to Follow-up|3
1575075|NCT02736721|5462446|P1|Overall Study|Adverse Event|8
1575076|NCT02736578|5462457|P2|Overall Study|Adverse Event|0
1575077|NCT02736578|5462458|P1|Overall Study|Adverse Event|1
1575078|NCT02736188|5462476|P1|Overall Study|Other|6
1575079|NCT02736188|5462476|P1|Overall Study|Withdrawal by Subject|1
1575080|NCT02736188|5462476|P1|Overall Study|Adverse Event|1
1575081|NCT02736188|5462476|P1|Overall Study|Discontinuation of Study by Sponsor|134
1575082|NCT02735915|5462511|P1|Overall Study|Withdrawal by Subject|1
1575083|NCT02735915|5462511|P1|Overall Study|Withdrawal following SAE|2
1575084|NCT02735915|5462511|P1|Overall Study|Not vaccinated but subject ID assigned|8
1575085|NCT02735421|5462543|P1|Overall Study|Pregnancy|1
1575086|NCT02735421|5462543|P1|Overall Study|Inadequate compliance to treatment|1
1575087|NCT02735421|5462543|P1|Overall Study|Lost to Follow-up|3
1575088|NCT02735421|5462543|P1|Overall Study|Withdrawal by Subject|6
1575089|NCT02735421|5462543|P1|Overall Study|Adverse Event|2
1575090|NCT02735200|5462573|P2|Overall Study|Withdrawal by Subject|0
1575091|NCT02735200|5462574|P1|Overall Study|Withdrawal by Subject|8
1575092|NCT02735200|5462573|P2|Overall Study|Lost to Follow-up|5
1575093|NCT02735200|5462574|P1|Overall Study|Lost to Follow-up|0
1575094|NCT02735096|5462613|P1|Overall Study|No symptoms in clinic/personal leave|1
1575095|NCT02735044|5462622|P2|Overall Study|Other, not specified above|11
1575096|NCT02735044|5462623|P1|Overall Study|Other, not specified above|5
1575097|NCT02735044|5462622|P2|Overall Study|Randomized and not treated|2
1575098|NCT02735044|5462623|P1|Overall Study|Randomized and not treated|0
1575099|NCT02735044|5462622|P2|Overall Study|Poor compliance to protocol|7
1575100|NCT02735044|5462623|P1|Overall Study|Poor compliance to protocol|7
1575101|NCT02735044|5462622|P2|Overall Study|Lack of Efficacy|0
1575102|NCT02735044|5462623|P1|Overall Study|Lack of Efficacy|1
1575103|NCT02735044|5462622|P2|Overall Study|Adverse Event|3
1575104|NCT02735044|5462623|P1|Overall Study|Adverse Event|3
1575105|NCT02734810|5462691|P2|Overall Study|Lack of Efficacy|0
1575106|NCT02734810|5462692|P1|Overall Study|Lack of Efficacy|1
1575107|NCT02734810|5462691|P2|Overall Study|Adverse Event|0
1575108|NCT02734810|5462692|P1|Overall Study|Adverse Event|1
1575109|NCT02734212|5462764|P2|Overall Study|Lost to Follow-up|10
1575110|NCT02734212|5462765|P1|Overall Study|Lost to Follow-up|5
1575111|NCT02733991|5462786|P2|Overall Study|Withdrawal by Subject|5
1575112|NCT02733991|5462787|P1|Overall Study|Withdrawal by Subject|0
1575113|NCT02733991|5462786|P2|Overall Study|Adverse Event|0
1575114|NCT02733991|5462787|P1|Overall Study|Adverse Event|1
1575115|NCT02733367|5462810|P1|Overall Study|Withdrawal by Subject|6
1575116|NCT02732951|5462819|P2|Overall Study|Protocol Violation|1
1575117|NCT02732951|5462820|P1|Overall Study|Protocol Violation|0
1575118|NCT02732951|5462819|P2|Overall Study|Adverse Event|4
1575119|NCT02732951|5462820|P1|Overall Study|Adverse Event|4
1575120|NCT02732951|5462819|P2|Overall Study|Lost to Follow-up|1
1575121|NCT02732951|5462820|P1|Overall Study|Lost to Follow-up|0
1575122|NCT02732951|5462819|P2|Overall Study|Other than listed|0
1575123|NCT02732951|5462820|P1|Overall Study|Other than listed|1
1575124|NCT02732938|5462830|P3|Overall Study|Study terminated by sponsor|0
1575125|NCT02732938|5462831|P2|Overall Study|Study terminated by sponsor|6
1575126|NCT02732938|5462832|P1|Overall Study|Study terminated by sponsor|3
1575127|NCT02732938|5462830|P3|Overall Study|Refused further follow-up|0
1575128|NCT02732938|5462831|P2|Overall Study|Refused further follow-up|0
1575129|NCT02732938|5462832|P1|Overall Study|Refused further follow-up|1
1575130|NCT02732938|5462830|P3|Overall Study|Randomized but did not receive treatment|0
1575131|NCT02732938|5462831|P2|Overall Study|Randomized but did not receive treatment|1
1575132|NCT02732938|5462832|P1|Overall Study|Randomized but did not receive treatment|0
1575133|NCT02732938|5462830|P3|Overall Study|Death|0
1575134|NCT02732938|5462831|P2|Overall Study|Death|11
1575135|NCT02732938|5462832|P1|Overall Study|Death|0
1575136|NCT02732912|5462878|P2|Overall Study|No outcome; discharged or refused|9
1575137|NCT02732912|5462879|P1|Overall Study|No outcome; discharged or refused|6
1575138|NCT02732912|5462878|P2|Overall Study|Incomplete completion of questionnaire|3
1575139|NCT02732912|5462879|P1|Overall Study|Incomplete completion of questionnaire|2
1575140|NCT02732912|5462878|P2|Overall Study|Discharged before night|6
1575141|NCT02732912|5462879|P1|Overall Study|Discharged before night|2
1575142|NCT02732639|5462904|P1|Overall Study|Lost to Follow-up|1
1575143|NCT02732561|5462921|P2|Overall Study|Withdrawal by Subject|0
1575144|NCT02732561|5462922|P1|Overall Study|Withdrawal by Subject|1
1575145|NCT02732561|5462921|P2|Overall Study|Lost to Follow-up|1
1575146|NCT02732561|5462922|P1|Overall Study|Lost to Follow-up|1
1575147|NCT02732327|5462932|P2|Overall Study|Protocol Violation|1
1575148|NCT02732327|5462933|P1|Overall Study|Protocol Violation|0
1575149|NCT02732210|5462941|P2|Overall Study|Missing|8
1575150|NCT02732210|5462942|P1|Overall Study|Missing|0
1575151|NCT02732210|5462941|P2|Overall Study|Other|103
1575152|NCT02732210|5462942|P1|Overall Study|Other|35
1575153|NCT02732210|5462941|P2|Overall Study|Death|15
1575154|NCT02732210|5462942|P1|Overall Study|Death|4
1575155|NCT02732210|5462941|P2|Overall Study|Lost to Follow-up|57
1575156|NCT02732210|5462942|P1|Overall Study|Lost to Follow-up|5
1575157|NCT02732210|5462941|P2|Overall Study|Withdrawal by Subject|87
1575158|NCT02732210|5462942|P1|Overall Study|Withdrawal by Subject|28
1575159|NCT02732210|5462941|P2|Overall Study|Study Ended|13
1575160|NCT02732210|5462942|P1|Overall Study|Study Ended|13
1575161|NCT02732210|5462941|P2|Overall Study|Site Closed|11
1575162|NCT02732210|5462942|P1|Overall Study|Site Closed|0
1575163|NCT02731755|5463121|P2|First Intervention|Withdrawal by Subject|2
1575164|NCT02731755|5463122|P1|First Intervention|Withdrawal by Subject|0
1575165|NCT02731742|5463146|P4|Overall Study|Study Terminated by Sponsor|1
1575166|NCT02731742|5463147|P3|Overall Study|Study Terminated by Sponsor|1
1575167|NCT02731742|5463148|P2|Overall Study|Study Terminated by Sponsor|1
1575168|NCT02731742|5463149|P1|Overall Study|Study Terminated by Sponsor|2
1575169|NCT02731742|5463146|P4|Overall Study|Physician Decision|1
1575170|NCT02731742|5463147|P3|Overall Study|Physician Decision|0
1575171|NCT02731742|5463148|P2|Overall Study|Physician Decision|0
1575172|NCT02731742|5463149|P1|Overall Study|Physician Decision|0
1575173|NCT02731742|5463146|P4|Overall Study|Death|0
1575174|NCT02731742|5463147|P3|Overall Study|Death|5
1575175|NCT02731742|5463148|P2|Overall Study|Death|2
1575176|NCT02731742|5463149|P1|Overall Study|Death|1
1575177|NCT02731690|5463167|P1|Overall Study|Discontinuation of Study by Sponsor|26
1575178|NCT02731690|5463167|P1|Overall Study|Withdrawal by Subject|3
1575179|NCT02731690|5463167|P1|Overall Study|Adverse Event|1
1575180|NCT02731638|5463187|P2|Overall Study|Lost to Follow-up|9
1575181|NCT02731638|5463188|P1|Overall Study|Lost to Follow-up|6
1575182|NCT02731157|5463431|P1|First Rejuvenated RCE|Withdrawal by Subject|1
1575183|NCT02731131|5463449|P2|Overall Study|Refused Therapy|1
1575184|NCT02731131|5463450|P1|Overall Study|Refused Therapy|0
1575185|NCT02731131|5463449|P2|Overall Study|Psychiatric Disorder|1
1575186|NCT02731131|5463450|P1|Overall Study|Psychiatric Disorder|0
1575187|NCT02730871|5463479|P2|Overall Study|Adverse Event|0
1575188|NCT02730871|5463480|P1|Overall Study|Adverse Event|6
1575189|NCT02730819|5463494|P1|Overall Study|Lost to Follow-up|9
1575190|NCT02730728|5463503|P3|Overall Study|Lack of Efficacy|1
1575191|NCT02730728|5463504|P2|Overall Study|Lack of Efficacy|1
1575192|NCT02730728|5463505|P1|Overall Study|Lack of Efficacy|0
1575193|NCT02730728|5463503|P3|Overall Study|Withdrawal by Subject|0
1575194|NCT02730728|5463504|P2|Overall Study|Withdrawal by Subject|1
1575195|NCT02730728|5463505|P1|Overall Study|Withdrawal by Subject|0
1575196|NCT02730598|5463534|P2|Overall Study|Unrelated Injury affecting outcomes.|0
1575197|NCT02730598|5463535|P1|Overall Study|Unrelated Injury affecting outcomes.|1
1575198|NCT02730598|5463534|P2|Overall Study|Protocol Violation|1
1575199|NCT02730598|5463535|P1|Overall Study|Protocol Violation|0
1575200|NCT02730598|5463534|P2|Overall Study|Withdrawal by Subject|3
1575201|NCT02730598|5463535|P1|Overall Study|Withdrawal by Subject|3
1575202|NCT02730455|5463558|P3|Overall Study|Other|0
1575203|NCT02730455|5463559|P2|Overall Study|Other|2
1575204|NCT02730455|5463560|P1|Overall Study|Other|2
1575205|NCT02730455|5463558|P3|Overall Study|Other|2
1575206|NCT02730455|5463559|P2|Overall Study|Other|1
1575207|NCT02730455|5463560|P1|Overall Study|Other|1
1575208|NCT02730455|5463558|P3|Overall Study|Lost to Follow-up|4
1575209|NCT02730455|5463559|P2|Overall Study|Lost to Follow-up|1
1575210|NCT02730455|5463560|P1|Overall Study|Lost to Follow-up|3
1575211|NCT02730455|5463558|P3|Overall Study|Consent withdrawn|1
1575212|NCT02730455|5463559|P2|Overall Study|Consent withdrawn|4
1575213|NCT02730455|5463560|P1|Overall Study|Consent withdrawn|2
1575214|NCT02730455|5463558|P3|Overall Study|Death|4
1575215|NCT02730455|5463559|P2|Overall Study|Death|6
1575216|NCT02730455|5463560|P1|Overall Study|Death|5
1575217|NCT02730351|5463592|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
1575218|NCT02730351|5463593|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
1575219|NCT02730351|5463592|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
1575220|NCT02730351|5463593|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
1575221|NCT02730351|5463592|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
1575222|NCT02730351|5463593|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
1575223|NCT02730351|5463592|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
1575224|NCT02730351|5463593|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
1575225|NCT02730351|5463592|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
1575226|NCT02730351|5463593|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
1575227|NCT02730208|5463616|P2|Overall Study|Withdrawal of consent (not due to AE)|1
1575228|NCT02730208|5463617|P1|Overall Study|Withdrawal of consent (not due to AE)|0
1575229|NCT02730195|5463625|P1|Overall Study|Withdrawal by Subject|1
1575230|NCT02729909|5463639|P2|Overall Study|Voluntary Withdrawal|0
1575231|NCT02729909|5463640|P1|Overall Study|Voluntary Withdrawal|1
1575232|NCT02729909|5463639|P2|Overall Study|Significant Protocol Deviation|2
1575233|NCT02729909|5463640|P1|Overall Study|Significant Protocol Deviation|0
1575234|NCT02729909|5463639|P2|Overall Study|Lack of Efficacy|2
1575235|NCT02729909|5463640|P1|Overall Study|Lack of Efficacy|0
1575236|NCT02729909|5463639|P2|Overall Study|Lost to Follow-up|1
1575237|NCT02729909|5463640|P1|Overall Study|Lost to Follow-up|0
1575238|NCT02729896|5463659|P3|Overall Study|Progressive Disease|1
1575239|NCT02729896|5463660|P2|Overall Study|Progressive Disease|0
1575240|NCT02729896|5463661|P1|Overall Study|Progressive Disease|0
1575241|NCT02729896|5463659|P3|Overall Study|Physician Decision|5
1575242|NCT02729896|5463660|P2|Overall Study|Physician Decision|0
1575243|NCT02729896|5463661|P1|Overall Study|Physician Decision|0
1575244|NCT02729896|5463659|P3|Overall Study|Death|10
1575245|NCT02729896|5463660|P2|Overall Study|Death|2
1575246|NCT02729896|5463661|P1|Overall Study|Death|0
1575247|NCT02729831|5463682|P4|6 Month Follow-up|Death|1
1575248|NCT02729831|5463683|P3|6 Month Follow-up|Death|0
1575249|NCT02729831|5463684|P2|6 Month Follow-up|Death|3
1575250|NCT02729831|5463685|P1|6 Month Follow-up|Death|1
1575251|NCT02729831|5463682|P4|6 Month Follow-up|Lost to Follow-up|42
1575252|NCT02729831|5463683|P3|6 Month Follow-up|Lost to Follow-up|48
1575253|NCT02729831|5463684|P2|6 Month Follow-up|Lost to Follow-up|51
1575254|NCT02729831|5463685|P1|6 Month Follow-up|Lost to Follow-up|54
1575255|NCT02729831|5463682|P4|1 Week Post-visit|Lost to Follow-up|36
1575256|NCT02729831|5463683|P3|1 Week Post-visit|Lost to Follow-up|38
1575257|NCT02729831|5463684|P2|1 Week Post-visit|Lost to Follow-up|40
1575258|NCT02729831|5463685|P1|1 Week Post-visit|Lost to Follow-up|43
1575259|NCT02729831|5463682|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
1575260|NCT02729831|5463683|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
1575261|NCT02729831|5463684|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
1575262|NCT02729831|5463685|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
1575263|NCT02729753|5463713|P2|Overall Study|Device Malfunction. No units in stock.|1
1575264|NCT02729753|5463714|P1|Overall Study|Device Malfunction. No units in stock.|0
1575265|NCT02729545|5463728|P2|Overall Study|Withdrawal by Subject|3
1575266|NCT02729545|5463729|P1|Overall Study|Withdrawal by Subject|2
1575267|NCT02729545|5463728|P2|Overall Study|Lost to Follow-up|1
1575268|NCT02729545|5463729|P1|Overall Study|Lost to Follow-up|0
1575269|NCT02729545|5463728|P2|Overall Study|Pregnancy|1
1575270|NCT02729545|5463729|P1|Overall Study|Pregnancy|1
1575271|NCT02729194|5463751|P1|Overall Study|Withdrawal by Subject|3
1575272|NCT02729051|5463763|P2|Overall Study|Withdrawal by Subject|17
1575273|NCT02729051|5463764|P1|Overall Study|Withdrawal by Subject|6
1575274|NCT02729051|5463763|P2|Overall Study|Physician Decision|1
1575275|NCT02729051|5463764|P1|Overall Study|Physician Decision|1
1575276|NCT02729051|5463763|P2|Overall Study|Lost to Follow-up|2
1575277|NCT02729051|5463764|P1|Overall Study|Lost to Follow-up|1
1575278|NCT02729051|5463763|P2|Overall Study|Lack of Efficacy|1
1575279|NCT02729051|5463764|P1|Overall Study|Lack of Efficacy|1
1575280|NCT02729051|5463763|P2|Overall Study|Adverse Event|11
1575281|NCT02729051|5463764|P1|Overall Study|Adverse Event|21
1575282|NCT02729025|5463908|P2|Overall Study|Sponsor Decision|1
1575283|NCT02729025|5463909|P1|Overall Study|Sponsor Decision|0
1575284|NCT02728895|5463923|P2|Overall Study|Withdrawal by Subject|3
1575285|NCT02728895|5463924|P1|Overall Study|Withdrawal by Subject|0
1575286|NCT02728895|5463923|P2|Overall Study|Other|2
1575287|NCT02728895|5463924|P1|Overall Study|Other|1
1575288|NCT02728206|5463944|P1|Overall Study|Death|1
1575289|NCT02728089|5463952|P1|Overall Study|Withdrawal by Subject|1
1575290|NCT02728089|5463952|P1|Overall Study|Physician Decision|2
1575291|NCT02727660|5464040|P3|Overall Study|Administrative Reasons|4
1575292|NCT02727660|5464041|P2|Overall Study|Administrative Reasons|3
1575293|NCT02727660|5464042|P1|Overall Study|Administrative Reasons|2
1575294|NCT02727660|5464040|P3|Overall Study|Protocol Specified Disc. Criteria|2
1575295|NCT02727660|5464041|P2|Overall Study|Protocol Specified Disc. Criteria|5
1575296|NCT02727660|5464042|P1|Overall Study|Protocol Specified Disc. Criteria|5
1575297|NCT02727660|5464040|P3|Overall Study|Protocol Violation|5
1575298|NCT02727660|5464041|P2|Overall Study|Protocol Violation|5
1575299|NCT02727660|5464042|P1|Overall Study|Protocol Violation|7
1575300|NCT02727660|5464040|P3|Overall Study|Lost to Follow-up|8
1575301|NCT02727660|5464041|P2|Overall Study|Lost to Follow-up|9
1575302|NCT02727660|5464042|P1|Overall Study|Lost to Follow-up|5
1575303|NCT02727660|5464040|P3|Overall Study|Physician Decision|14
1575304|NCT02727660|5464041|P2|Overall Study|Physician Decision|8
1575305|NCT02727660|5464042|P1|Overall Study|Physician Decision|3
1575306|NCT02727660|5464040|P3|Overall Study|Withdrawal by Subject|30
1575307|NCT02727660|5464041|P2|Overall Study|Withdrawal by Subject|25
1575308|NCT02727660|5464042|P1|Overall Study|Withdrawal by Subject|26
1575309|NCT02727660|5464040|P3|Overall Study|Adverse Event|32
1575310|NCT02727660|5464041|P2|Overall Study|Adverse Event|21
1575311|NCT02727660|5464042|P1|Overall Study|Adverse Event|28
1575312|NCT02727660|5464040|P3|Overall Study|Lack of Efficacy|70
1575313|NCT02727660|5464041|P2|Overall Study|Lack of Efficacy|40
1575314|NCT02727660|5464042|P1|Overall Study|Lack of Efficacy|40
1575315|NCT02727322|5464061|P2|Overall Study|Protocol Violation|0
1575316|NCT02727322|5464062|P1|Overall Study|Protocol Violation|1
1575317|NCT02727322|5464061|P2|Overall Study|Withdrawal by Subject|1
1575318|NCT02727322|5464062|P1|Overall Study|Withdrawal by Subject|1
1575319|NCT02726945|5464088|P3|Overall Study|Elected to have total knee replacement|0
1575320|NCT02726945|5464089|P2|Overall Study|Elected to have total knee replacement|1
1575321|NCT02726945|5464090|P1|Overall Study|Elected to have total knee replacement|0
1575322|NCT02726945|5464088|P3|Overall Study|Withdrawal by Subject|1
1575323|NCT02726945|5464089|P2|Overall Study|Withdrawal by Subject|0
1575324|NCT02726945|5464090|P1|Overall Study|Withdrawal by Subject|0
1575325|NCT02726399|5464207|P1|Overall Study|Progression of disease|4
1575326|NCT02726399|5464207|P1|Overall Study|Adverse Event|2
1575327|NCT02726399|5464207|P1|Overall Study|Participant Non-Compliance|1
1575328|NCT02726113|5464224|P2|Genomic Analysis|Insurance non-coverage for surgery|1
1575329|NCT02726113|5464225|P1|Genomic Analysis|Insurance non-coverage for surgery|1
1575330|NCT02726113|5464224|P2|Genomic Analysis|Withdrawal by Subject|1
1575331|NCT02726113|5464225|P1|Genomic Analysis|Withdrawal by Subject|2
1575332|NCT02726113|5464224|P2|Genomic Analysis|Protocol Violation|0
1575333|NCT02726113|5464225|P1|Genomic Analysis|Protocol Violation|1
1575334|NCT02726113|5464224|P2|Total Enrollment|Insurance non-coverage for surgery|1
1575335|NCT02726113|5464225|P1|Total Enrollment|Insurance non-coverage for surgery|1
1575336|NCT02726113|5464224|P2|Total Enrollment|Withdrawal by Subject|1
1575337|NCT02726113|5464225|P1|Total Enrollment|Withdrawal by Subject|2
1575338|NCT02726113|5464224|P2|Total Enrollment|Protocol Violation|0
1575339|NCT02726113|5464225|P1|Total Enrollment|Protocol Violation|1
1575340|NCT02726113|5464224|P2|Total Enrollment|Physician Decision|1
1575341|NCT02726113|5464225|P1|Total Enrollment|Physician Decision|0
1575342|NCT02726074|5464232|P1|Overall Study|Others|3
1575343|NCT02726074|5464232|P1|Overall Study|Lost to Follow-up|2
1575344|NCT02726074|5464232|P1|Overall Study|Protocol Violation|3
1575345|NCT02726074|5464232|P1|Overall Study|Adverse Event|14
1575346|NCT02726074|5464232|P1|Overall Study|Withdrawal by Subject|4
1575347|NCT02726022|5464244|P1|Overall Study|Treatment Failure and Poor Compliance|1
1575348|NCT02726022|5464244|P1|Overall Study|Poor Compliance|13
1575349|NCT02726022|5464244|P1|Overall Study|Treatment Failure|8
1575350|NCT02726022|5464244|P1|Overall Study|Adverse Event|14
1575351|NCT02725866|5464253|P1|Overall Study|Other, not specified|4
1575352|NCT02725866|5464253|P1|Overall Study|Insufficient virological response|1
1575353|NCT02725866|5464253|P1|Overall Study|Withdrew consent|3
1575354|NCT02725866|5464253|P1|Overall Study|Failure to return|6
1575355|NCT02725788|5464266|P2|Overall Study|Protocol Violation|1
1575356|NCT02725788|5464267|P1|Overall Study|Protocol Violation|0
1575357|NCT02725788|5464266|P2|Overall Study|Lost to Follow-up|1
1575358|NCT02725788|5464267|P1|Overall Study|Lost to Follow-up|1
1575359|NCT02725710|5464275|P2|Overall Study|Lost to Follow-up|0
1575360|NCT02725710|5464276|P1|Overall Study|Lost to Follow-up|1
1575362|NCT02725515|5464314|P2|Overall Study|Lack of Response|1
1575363|NCT02725515|5464315|P1|Overall Study|Lack of Response|0
1575364|NCT02725515|5464314|P2|Overall Study|Completed Study Under Original Protocol|1
1575365|NCT02725515|5464315|P1|Overall Study|Completed Study Under Original Protocol|0
1575366|NCT02725515|5464314|P2|Overall Study|No Documented Disease Improvement|1
1575367|NCT02725515|5464315|P1|Overall Study|No Documented Disease Improvement|0
1575368|NCT02725515|5464314|P2|Overall Study|Adverse Event|2
1575369|NCT02725515|5464315|P1|Overall Study|Adverse Event|7
1575370|NCT02725515|5464314|P2|Overall Study|Lost to Follow-up|1
1575371|NCT02725515|5464315|P1|Overall Study|Lost to Follow-up|1
1575372|NCT02725515|5464314|P2|Overall Study|Non-Compliance With Study Drug|3
1575373|NCT02725515|5464315|P1|Overall Study|Non-Compliance With Study Drug|0
1575374|NCT02725515|5464314|P2|Overall Study|Withdrawal by Subject|1
1575375|NCT02725515|5464315|P1|Overall Study|Withdrawal by Subject|2
1575376|NCT02725515|5464314|P2|Overall Study|Loss of Improvement per Protocol|25
1575377|NCT02725515|5464315|P1|Overall Study|Loss of Improvement per Protocol|14
1575378|NCT02725515|5464314|P2|Overall Study|Refused infusion (no study treatment)|0
1575379|NCT02725515|5464315|P1|Overall Study|Refused infusion (no study treatment)|1
1575380|NCT02725476|5464327|P2|Overall Study|Adverse Event|1
1575381|NCT02725476|5464328|P1|Overall Study|Adverse Event|1
1575382|NCT02725476|5464327|P2|Overall Study|Physician Decision|0
1575383|NCT02725476|5464328|P1|Overall Study|Physician Decision|2
1575384|NCT02725008|5464338|P2|Overall Study|Admitted to hospital|1
1575385|NCT02725008|5464339|P1|Overall Study|Admitted to hospital|0
1575386|NCT02725008|5464338|P2|Overall Study|Withdrawal by Subject|2
1575387|NCT02725008|5464339|P1|Overall Study|Withdrawal by Subject|2
1575388|NCT02725008|5464338|P2|Overall Study|Lost to Follow-up|9
1575389|NCT02725008|5464339|P1|Overall Study|Lost to Follow-up|7
1575390|NCT02724644|5464357|P2|Overall Study|Administrative|0
1575391|NCT02724644|5464358|P1|Overall Study|Administrative|1
1575392|NCT02724644|5464357|P2|Overall Study|Withdrawal by Subject|1
1575393|NCT02724644|5464358|P1|Overall Study|Withdrawal by Subject|7
1575394|NCT02724644|5464357|P2|Overall Study|Lost to Follow-up|2
1575395|NCT02724644|5464358|P1|Overall Study|Lost to Follow-up|6
1575396|NCT02724644|5464357|P2|Overall Study|Adverse Event|1
1575397|NCT02724644|5464358|P1|Overall Study|Adverse Event|7
1575398|NCT02724111|5464392|P2|Overall Study|Protocol Violation|5
1575399|NCT02724111|5464393|P1|Overall Study|Protocol Violation|2
1575400|NCT02723786|5464413|P1|Overall Study|Lost to Follow-up|1
1575401|NCT02723630|5464441|P6|Intervention Period 3|consumption of restricted item|0
1575402|NCT02723630|5464442|P5|Intervention Period 3|consumption of restricted item|0
1575403|NCT02723630|5464443|P4|Intervention Period 3|consumption of restricted item|0
1575404|NCT02723630|5464444|P3|Intervention Period 3|consumption of restricted item|0
1575405|NCT02723630|5464445|P2|Intervention Period 3|consumption of restricted item|1
1575406|NCT02723630|5464446|P1|Intervention Period 3|consumption of restricted item|0
1575407|NCT02723630|5464441|P6|Intervention Period 1|Adverse Event|0
1575408|NCT02723630|5464442|P5|Intervention Period 1|Adverse Event|0
1575409|NCT02723630|5464443|P4|Intervention Period 1|Adverse Event|0
1575410|NCT02723630|5464444|P3|Intervention Period 1|Adverse Event|0
1575411|NCT02723630|5464445|P2|Intervention Period 1|Adverse Event|0
1575412|NCT02723630|5464446|P1|Intervention Period 1|Adverse Event|1
1575413|NCT02723201|5464478|P3|Second Intervention Period|Adverse Event|0
1575414|NCT02723201|5464479|P2|Second Intervention Period|Adverse Event|0
1575415|NCT02723201|5464480|P1|Second Intervention Period|Adverse Event|1
1575416|NCT02723201|5464478|P3|Second Intervention Period|Protocol Violation|0
1575417|NCT02723201|5464479|P2|Second Intervention Period|Protocol Violation|0
1575418|NCT02723201|5464480|P1|Second Intervention Period|Protocol Violation|1
1575419|NCT02723188|5464539|P3|Overall Study|Withdrawal by Subject|0
1575420|NCT02723188|5464540|P2|Overall Study|Withdrawal by Subject|0
1575421|NCT02723188|5464541|P1|Overall Study|Withdrawal by Subject|1
1575422|NCT02723175|5464554|P2|Overall Study|Lost to 3 Month Follow Up|1
1575423|NCT02723175|5464555|P1|Overall Study|Lost to 3 Month Follow Up|1
1575424|NCT02723175|5464554|P2|Overall Study|Lost to 1 Month Follow Up|2
1575425|NCT02723175|5464555|P1|Overall Study|Lost to 1 Month Follow Up|3
1575426|NCT02723084|5464597|P2|Overall Study|Lost to Follow-up|0
1575427|NCT02723084|5464598|P1|Overall Study|Lost to Follow-up|3
1575428|NCT02723084|5464597|P2|Overall Study|Withdrawal by Subject|1
1575429|NCT02723084|5464598|P1|Overall Study|Withdrawal by Subject|1
1575430|NCT02722967|5464612|P3|Overall Study|Non-adherence of the patch to the skin|2
1575431|NCT02722967|5464613|P2|Overall Study|Non-adherence of the patch to the skin|0
1575432|NCT02722967|5464614|P1|Overall Study|Non-adherence of the patch to the skin|0
1575433|NCT02722967|5464612|P3|Overall Study|Physician Decision|0
1575434|NCT02722967|5464613|P2|Overall Study|Physician Decision|0
1575435|NCT02722967|5464614|P1|Overall Study|Physician Decision|1
1575436|NCT02722967|5464612|P3|Overall Study|Withdrawal by Subject|1
1575437|NCT02722967|5464613|P2|Overall Study|Withdrawal by Subject|0
1575438|NCT02722967|5464614|P1|Overall Study|Withdrawal by Subject|1
1575439|NCT02722967|5464612|P3|Overall Study|Non-compliance with patch wearing|1
1575440|NCT02722967|5464613|P2|Overall Study|Non-compliance with patch wearing|1
1575441|NCT02722967|5464614|P1|Overall Study|Non-compliance with patch wearing|2
1575442|NCT02722967|5464612|P3|Overall Study|Lost to Follow-up|0
1575443|NCT02722967|5464613|P2|Overall Study|Lost to Follow-up|1
1575444|NCT02722967|5464614|P1|Overall Study|Lost to Follow-up|0
1575445|NCT02722967|5464612|P3|Overall Study|Adverse Event|0
1575446|NCT02722967|5464613|P2|Overall Study|Adverse Event|0
1575447|NCT02722967|5464614|P1|Overall Study|Adverse Event|1
1575448|NCT02722928|5464624|P2|Overall Study|Required Intraoperative MRI|7
1575449|NCT02722928|5464625|P1|Overall Study|Required Intraoperative MRI|5
1575450|NCT02722928|5464624|P2|Overall Study|Standard CT was not as required per prot|13
1575451|NCT02722928|5464625|P1|Overall Study|Standard CT was not as required per prot|5
1575452|NCT02722304|5464696|P5|Overall Study|Other|1
1575453|NCT02722304|5464697|P4|Overall Study|Other|1
1575454|NCT02722304|5464698|P3|Overall Study|Other|0
1575455|NCT02722304|5464699|P2|Overall Study|Other|0
1575456|NCT02722304|5464700|P1|Overall Study|Other|0
1575457|NCT02722304|5464696|P5|Overall Study|Study Terminated by Sponsor|1
1575458|NCT02722304|5464697|P4|Overall Study|Study Terminated by Sponsor|1
1575459|NCT02722304|5464698|P3|Overall Study|Study Terminated by Sponsor|2
1575460|NCT02722304|5464699|P2|Overall Study|Study Terminated by Sponsor|0
1575461|NCT02722304|5464700|P1|Overall Study|Study Terminated by Sponsor|1
1575462|NCT02722278|5464752|P2|Overall Study|Site closure not study related|1
1575463|NCT02722278|5464753|P1|Overall Study|Site closure not study related|0
1575464|NCT02722278|5464752|P2|Overall Study|Subject declined after tx assignment|1
1575465|NCT02722278|5464753|P1|Overall Study|Subject declined after tx assignment|0
1575466|NCT02722278|5464752|P2|Overall Study|High PSA pre-study/ not eligible|1
1575467|NCT02722278|5464753|P1|Overall Study|High PSA pre-study/ not eligible|0
1575468|NCT02722278|5464752|P2|Overall Study|Protocol Violation|0
1575469|NCT02722278|5464753|P1|Overall Study|Protocol Violation|1
1575470|NCT02722278|5464752|P2|Overall Study|Lost to Follow-up|0
1575471|NCT02722278|5464753|P1|Overall Study|Lost to Follow-up|2
1575472|NCT02722278|5464752|P2|Overall Study|Adverse Event|1
1575473|NCT02722278|5464753|P1|Overall Study|Adverse Event|4
1575474|NCT02722278|5464752|P2|Overall Study|Withdrawal by Subject|3
1575475|NCT02722278|5464753|P1|Overall Study|Withdrawal by Subject|5
1575476|NCT02722148|5464777|P1|Overall Study|Non compliant with treatment regimen|3
1575477|NCT02722148|5464777|P1|Overall Study|Lost to Follow-up|2
1575478|NCT02722044|5464784|P1|Overall Study|Did Not Meet Criteria at Week 14|1
1575479|NCT02722044|5464784|P1|Overall Study|Withdrawal by Subject|1
1575480|NCT02722044|5464784|P1|Overall Study|Physician Decision|1
1575481|NCT02722044|5464784|P1|Overall Study|Adverse Event|2
1575482|NCT02721875|5464813|P2|Overall Study|Progressive disease/relapse|0
1575483|NCT02721875|5464814|P1|Overall Study|Progressive disease/relapse|1
1575484|NCT02721147|5464865|P3|Overall Study|Lost to Follow-up|0
1575485|NCT02721147|5464866|P2|Overall Study|Lost to Follow-up|0
1575486|NCT02721147|5464867|P1|Overall Study|Lost to Follow-up|2
1575487|NCT02720757|5464911|P1|Overall Study|General exclusion|3
1575488|NCT02720757|5464911|P1|Overall Study|Missing|3
1575489|NCT02720757|5464911|P1|Overall Study|Patients wish to withdraw|2
1575490|NCT02720757|5464911|P1|Overall Study|Informed consent withdrawal|1
1575491|NCT02720757|5464911|P1|Overall Study|Loss of contact|4
1575492|NCT02720757|5464911|P1|Overall Study|Other reason|5
1575493|NCT02720523|5464924|P7|Period 2: Long-term Extension Period|Other|3
1575494|NCT02720523|5464925|P6|Period 2: Long-term Extension Period|Other|0
1575495|NCT02720523|5464926|P5|Period 2: Long-term Extension Period|Other|2
1575496|NCT02720523|5464927|P4|Period 2: Long-term Extension Period|Other|0
1575497|NCT02720523|5464928|P3|Period 2: Long-term Extension Period|Other|0
1575498|NCT02720523|5464929|P2|Period 2: Long-term Extension Period|Other|0
1575499|NCT02720523|5464930|P1|Period 2: Long-term Extension Period|Other|0
1575500|NCT02720523|5464924|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
1575501|NCT02720523|5464925|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
1575502|NCT02720523|5464926|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
1575503|NCT02720523|5464927|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1575504|NCT02720523|5464928|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1575505|NCT02720523|5464929|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1575506|NCT02720523|5464930|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
1575507|NCT02720523|5464924|P7|Period 2: Long-term Extension Period|Adverse Event|11
1575508|NCT02720523|5464925|P6|Period 2: Long-term Extension Period|Adverse Event|7
1575509|NCT02720523|5464926|P5|Period 2: Long-term Extension Period|Adverse Event|4
1575510|NCT02720523|5464927|P4|Period 2: Long-term Extension Period|Adverse Event|0
1575511|NCT02720523|5464928|P3|Period 2: Long-term Extension Period|Adverse Event|0
1575512|NCT02720523|5464929|P2|Period 2: Long-term Extension Period|Adverse Event|0
1575513|NCT02720523|5464930|P1|Period 2: Long-term Extension Period|Adverse Event|0
1575514|NCT02720523|5464924|P7|Period 2: Long-term Extension Period|Ongoing|45
1575515|NCT02720523|5464925|P6|Period 2: Long-term Extension Period|Ongoing|54
1575516|NCT02720523|5464926|P5|Period 2: Long-term Extension Period|Ongoing|57
1575517|NCT02720523|5464927|P4|Period 2: Long-term Extension Period|Ongoing|0
1575518|NCT02720523|5464928|P3|Period 2: Long-term Extension Period|Ongoing|0
1575519|NCT02720523|5464929|P2|Period 2: Long-term Extension Period|Ongoing|0
1575520|NCT02720523|5464930|P1|Period 2: Long-term Extension Period|Ongoing|0
1575521|NCT02720523|5464924|P7|Period 1: Placebo-controlled Period|Other|0
1575522|NCT02720523|5464925|P6|Period 1: Placebo-controlled Period|Other|0
1575523|NCT02720523|5464926|P5|Period 1: Placebo-controlled Period|Other|0
1575524|NCT02720523|5464927|P4|Period 1: Placebo-controlled Period|Other|1
1575525|NCT02720523|5464928|P3|Period 1: Placebo-controlled Period|Other|1
1575526|NCT02720523|5464929|P2|Period 1: Placebo-controlled Period|Other|0
1575527|NCT02720523|5464930|P1|Period 1: Placebo-controlled Period|Other|0
1575528|NCT02720523|5464924|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1575529|NCT02720523|5464925|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1575530|NCT02720523|5464926|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1575531|NCT02720523|5464927|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1575532|NCT02720523|5464928|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1575533|NCT02720523|5464929|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
1575534|NCT02720523|5464930|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
1575535|NCT02720523|5464924|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1575536|NCT02720523|5464925|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1575537|NCT02720523|5464926|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1575538|NCT02720523|5464927|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1575539|NCT02720523|5464928|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1575540|NCT02720523|5464929|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
1575541|NCT02720523|5464930|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
1575542|NCT02720523|5464924|P7|Period 1: Placebo-controlled Period|Adverse Event|0
1575543|NCT02720523|5464925|P6|Period 1: Placebo-controlled Period|Adverse Event|0
1575544|NCT02720523|5464926|P5|Period 1: Placebo-controlled Period|Adverse Event|0
1575545|NCT02720523|5464927|P4|Period 1: Placebo-controlled Period|Adverse Event|5
1575546|NCT02720523|5464928|P3|Period 1: Placebo-controlled Period|Adverse Event|1
1575547|NCT02720523|5464929|P2|Period 1: Placebo-controlled Period|Adverse Event|0
1575548|NCT02720523|5464930|P1|Period 1: Placebo-controlled Period|Adverse Event|0
1575549|NCT02720510|5464989|P2|Overall Study|Physician Decision|2
1575550|NCT02720510|5464990|P1|Overall Study|Physician Decision|1
1575551|NCT02720510|5464989|P2|Overall Study|Adverse Event|1
1575552|NCT02720510|5464990|P1|Overall Study|Adverse Event|0
1575553|NCT02720510|5464989|P2|Overall Study|Study Terminated by the sponsor|0
1575554|NCT02720510|5464990|P1|Overall Study|Study Terminated by the sponsor|2
1575555|NCT02720484|5465008|P1|Follow Up for 2 Years|Lost to Follow-up|2
1575556|NCT02720484|5465008|P1|Follow Up for 2 Years|Death|3
1575557|NCT02720484|5465008|P1|Follow Up for 2 Years|Withdrawal by Subject|1
1575558|NCT02720484|5465008|P1|Treatment on Study|Progressive Disease|4
1575559|NCT02720484|5465008|P1|Treatment on Study|Withdrawal by Subject|1
1575560|NCT02720484|5465008|P1|Treatment on Study|Adverse Event|1
1575561|NCT02720198|5465040|P2|Overall Study|Withdrawal by Subject|1
1575562|NCT02720198|5465041|P1|Overall Study|Withdrawal by Subject|0
1575563|NCT02720081|5465076|P2|Overall Study|Protocol Violation|1
1575564|NCT02720081|5465077|P1|Overall Study|Protocol Violation|4
1575565|NCT02720081|5465076|P2|Overall Study|Adverse Event|3
1575566|NCT02720081|5465077|P1|Overall Study|Adverse Event|0
1575567|NCT02719743|5465159|P5|Overall Study|Lost to Follow-up|0
1575568|NCT02719743|5465160|P4|Overall Study|Lost to Follow-up|0
1575569|NCT02719743|5465161|P3|Overall Study|Lost to Follow-up|0
1575570|NCT02719743|5465162|P2|Overall Study|Lost to Follow-up|1
1575571|NCT02719743|5465163|P1|Overall Study|Lost to Follow-up|1
1575572|NCT02719743|5465159|P5|Overall Study|Migrated/moved from study area|2
1575573|NCT02719743|5465160|P4|Overall Study|Migrated/moved from study area|0
1575574|NCT02719743|5465161|P3|Overall Study|Migrated/moved from study area|0
1575575|NCT02719743|5465162|P2|Overall Study|Migrated/moved from study area|0
1575576|NCT02719743|5465163|P1|Overall Study|Migrated/moved from study area|0
1575577|NCT02719743|5465159|P5|Overall Study|Consent withdrawal|0
1575578|NCT02719743|5465160|P4|Overall Study|Consent withdrawal|1
1575579|NCT02719743|5465161|P3|Overall Study|Consent withdrawal|0
1575580|NCT02719743|5465162|P2|Overall Study|Consent withdrawal|2
1575581|NCT02719743|5465163|P1|Overall Study|Consent withdrawal|0
1575582|NCT02719171|5465304|P5|Overall Study|Other|0
1575583|NCT02719171|5465305|P4|Overall Study|Other|1
1575584|NCT02719171|5465306|P3|Overall Study|Other|0
1575585|NCT02719171|5465307|P2|Overall Study|Other|0
1575586|NCT02719171|5465308|P1|Overall Study|Other|0
1575587|NCT02719171|5465304|P5|Overall Study|Subject Withdrawal|0
1575588|NCT02719171|5465305|P4|Overall Study|Subject Withdrawal|1
1575589|NCT02719171|5465306|P3|Overall Study|Subject Withdrawal|2
1575590|NCT02719171|5465307|P2|Overall Study|Subject Withdrawal|2
1575591|NCT02719171|5465308|P1|Overall Study|Subject Withdrawal|0
1575592|NCT02719171|5465304|P5|Overall Study|Lost to Follow-up|0
1575593|NCT02719171|5465305|P4|Overall Study|Lost to Follow-up|0
1575594|NCT02719171|5465306|P3|Overall Study|Lost to Follow-up|1
1575595|NCT02719171|5465307|P2|Overall Study|Lost to Follow-up|0
1575596|NCT02719171|5465308|P1|Overall Study|Lost to Follow-up|0
1575597|NCT02719171|5465304|P5|Overall Study|Adverse Event|2
1575598|NCT02719171|5465305|P4|Overall Study|Adverse Event|0
1575599|NCT02719171|5465306|P3|Overall Study|Adverse Event|0
1575600|NCT02719171|5465307|P2|Overall Study|Adverse Event|2
1575601|NCT02719171|5465308|P1|Overall Study|Adverse Event|1
1575602|NCT02719028|5465403|P4|Overall Study|Protocol Violation|1
1575603|NCT02719028|5465404|P3|Overall Study|Protocol Violation|0
1575604|NCT02719028|5465405|P2|Overall Study|Protocol Violation|0
1575605|NCT02719028|5465406|P1|Overall Study|Protocol Violation|0
1575606|NCT02719028|5465403|P4|Overall Study|Use of prohibited medication|0
1575607|NCT02719028|5465404|P3|Overall Study|Use of prohibited medication|1
1575608|NCT02719028|5465405|P2|Overall Study|Use of prohibited medication|0
1575609|NCT02719028|5465406|P1|Overall Study|Use of prohibited medication|0
1575610|NCT02719028|5465403|P4|Overall Study|Physician Decision|1
1575611|NCT02719028|5465404|P3|Overall Study|Physician Decision|1
1575612|NCT02719028|5465405|P2|Overall Study|Physician Decision|1
1575613|NCT02719028|5465406|P1|Overall Study|Physician Decision|0
1575614|NCT02719028|5465403|P4|Overall Study|Adverse Event|8
1575615|NCT02719028|5465404|P3|Overall Study|Adverse Event|4
1575616|NCT02719028|5465405|P2|Overall Study|Adverse Event|1
1575617|NCT02719028|5465406|P1|Overall Study|Adverse Event|2
1575618|NCT02718898|5465430|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
1575619|NCT02718898|5465431|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
1575620|NCT02718898|5465432|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
1575621|NCT02718898|5465433|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
1575622|NCT02718898|5465434|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
1575623|NCT02718898|5465435|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
1575624|NCT02718898|5465436|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
1575625|NCT02718898|5465430|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
1575626|NCT02718898|5465431|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
1575627|NCT02718898|5465432|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
1575628|NCT02718898|5465433|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
1575629|NCT02718898|5465434|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
1575630|NCT02718898|5465435|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
1575631|NCT02718898|5465436|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
1575632|NCT02718898|5465430|P7|Post Treatment Follow-up Period|Adverse Event|1
1575633|NCT02718898|5465431|P6|Post Treatment Follow-up Period|Adverse Event|1
1575634|NCT02718898|5465432|P5|Post Treatment Follow-up Period|Adverse Event|0
1575635|NCT02718898|5465433|P4|Post Treatment Follow-up Period|Adverse Event|0
1575636|NCT02718898|5465434|P3|Post Treatment Follow-up Period|Adverse Event|0
1575637|NCT02718898|5465435|P2|Post Treatment Follow-up Period|Adverse Event|0
1575638|NCT02718898|5465436|P1|Post Treatment Follow-up Period|Adverse Event|0
1575639|NCT02718898|5465430|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
1575640|NCT02718898|5465431|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
1575641|NCT02718898|5465432|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
1575642|NCT02718898|5465433|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
1575643|NCT02718898|5465434|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
1575644|NCT02718898|5465435|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
1575645|NCT02718898|5465436|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
1575646|NCT02718898|5465430|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
1575647|NCT02718898|5465431|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
1575648|NCT02718898|5465432|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
1575649|NCT02718898|5465433|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
1575650|NCT02718898|5465434|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
1575651|NCT02718898|5465435|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
1575652|NCT02718898|5465436|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
1575653|NCT02718898|5465430|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
1575654|NCT02718898|5465431|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
1575655|NCT02718898|5465432|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
1575656|NCT02718898|5465433|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
1575657|NCT02718898|5465434|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
1575658|NCT02718898|5465435|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
1575659|NCT02718898|5465436|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
1575660|NCT02718898|5465430|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
1575661|NCT02718898|5465431|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
1575662|NCT02718898|5465432|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
1575663|NCT02718898|5465433|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
1575664|NCT02718898|5465434|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
1575665|NCT02718898|5465435|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
1575666|NCT02718898|5465436|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
1575667|NCT02718898|5465430|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
1575668|NCT02718898|5465431|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
1575669|NCT02718898|5465432|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
1575670|NCT02718898|5465433|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
1575671|NCT02718898|5465434|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
1575672|NCT02718898|5465435|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
1575673|NCT02718898|5465436|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
1575674|NCT02718898|5465430|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
1575675|NCT02718898|5465431|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
1575676|NCT02718898|5465432|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
1575677|NCT02718898|5465433|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
1575678|NCT02718898|5465434|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
1575679|NCT02718898|5465435|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
1575680|NCT02718898|5465436|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
1575681|NCT02718898|5465430|P7|Blinded Treatment Period|Lost to Follow-up|0
1575682|NCT02718898|5465431|P6|Blinded Treatment Period|Lost to Follow-up|0
1575683|NCT02718898|5465432|P5|Blinded Treatment Period|Lost to Follow-up|0
1575684|NCT02718898|5465433|P4|Blinded Treatment Period|Lost to Follow-up|0
1575685|NCT02718898|5465434|P3|Blinded Treatment Period|Lost to Follow-up|0
1575686|NCT02718898|5465435|P2|Blinded Treatment Period|Lost to Follow-up|0
1575687|NCT02718898|5465436|P1|Blinded Treatment Period|Lost to Follow-up|2
1575688|NCT02718898|5465430|P7|Blinded Treatment Period|Lack of Efficacy|0
1575689|NCT02718898|5465431|P6|Blinded Treatment Period|Lack of Efficacy|0
1575690|NCT02718898|5465432|P5|Blinded Treatment Period|Lack of Efficacy|0
1575691|NCT02718898|5465433|P4|Blinded Treatment Period|Lack of Efficacy|0
1575692|NCT02718898|5465434|P3|Blinded Treatment Period|Lack of Efficacy|0
1575693|NCT02718898|5465435|P2|Blinded Treatment Period|Lack of Efficacy|0
1575694|NCT02718898|5465436|P1|Blinded Treatment Period|Lack of Efficacy|1
1575695|NCT02718898|5465430|P7|Blinded Treatment Period|Physician Decision|0
1575696|NCT02718898|5465431|P6|Blinded Treatment Period|Physician Decision|0
1575697|NCT02718898|5465432|P5|Blinded Treatment Period|Physician Decision|0
1575698|NCT02718898|5465433|P4|Blinded Treatment Period|Physician Decision|0
1575699|NCT02718898|5465434|P3|Blinded Treatment Period|Physician Decision|0
1575700|NCT02718898|5465435|P2|Blinded Treatment Period|Physician Decision|0
1575701|NCT02718898|5465436|P1|Blinded Treatment Period|Physician Decision|1
1575702|NCT02718898|5465430|P7|Blinded Treatment Period|Adverse Event|0
1575703|NCT02718898|5465431|P6|Blinded Treatment Period|Adverse Event|0
1575704|NCT02718898|5465432|P5|Blinded Treatment Period|Adverse Event|0
1575705|NCT02718898|5465433|P4|Blinded Treatment Period|Adverse Event|0
1575706|NCT02718898|5465434|P3|Blinded Treatment Period|Adverse Event|0
1575707|NCT02718898|5465435|P2|Blinded Treatment Period|Adverse Event|1
1575708|NCT02718898|5465436|P1|Blinded Treatment Period|Adverse Event|5
1575709|NCT02718417|5465472|P3|Maintenance Phase|Ongoing|172
1575710|NCT02718417|5465473|P2|Maintenance Phase|Ongoing|180
1575711|NCT02718417|5465474|P1|Maintenance Phase|Ongoing|155
1575712|NCT02718417|5465472|P3|Maintenance Phase|Lost to Follow-up|2
1575713|NCT02718417|5465473|P2|Maintenance Phase|Lost to Follow-up|0
1575714|NCT02718417|5465474|P1|Maintenance Phase|Lost to Follow-up|0
1575715|NCT02718417|5465472|P3|Maintenance Phase|Study terminated by sponsor|1
1575716|NCT02718417|5465473|P2|Maintenance Phase|Study terminated by sponsor|0
1575717|NCT02718417|5465474|P1|Maintenance Phase|Study terminated by sponsor|0
1575718|NCT02718417|5465472|P3|Maintenance Phase|Withdrawal by Subject|27
1575719|NCT02718417|5465473|P2|Maintenance Phase|Withdrawal by Subject|10
1575720|NCT02718417|5465474|P1|Maintenance Phase|Withdrawal by Subject|13
1575721|NCT02718417|5465472|P3|Maintenance Phase|Other|5
1575722|NCT02718417|5465473|P2|Maintenance Phase|Other|1
1575723|NCT02718417|5465474|P1|Maintenance Phase|Other|2
1575724|NCT02718417|5465472|P3|Maintenance Phase|Progressive disease|66
1575725|NCT02718417|5465473|P2|Maintenance Phase|Progressive disease|64
1575726|NCT02718417|5465474|P1|Maintenance Phase|Progressive disease|72
1575727|NCT02718417|5465472|P3|Maintenance Phase|Physician's decision|9
1575728|NCT02718417|5465473|P2|Maintenance Phase|Physician's decision|5
1575729|NCT02718417|5465474|P1|Maintenance Phase|Physician's decision|4
1575730|NCT02718417|5465472|P3|Maintenance Phase|No longer met eligibility criteria|0
1575731|NCT02718417|5465473|P2|Maintenance Phase|No longer met eligibility criteria|1
1575732|NCT02718417|5465474|P1|Maintenance Phase|No longer met eligibility criteria|0
1575733|NCT02718417|5465472|P3|Maintenance Phase|Global deterioration of health status|1
1575734|NCT02718417|5465473|P2|Maintenance Phase|Global deterioration of health status|2
1575735|NCT02718417|5465474|P1|Maintenance Phase|Global deterioration of health status|5
1575736|NCT02718417|5465472|P3|Maintenance Phase|Death leading to discontinuation|2
1575737|NCT02718417|5465473|P2|Maintenance Phase|Death leading to discontinuation|1
1575738|NCT02718417|5465474|P1|Maintenance Phase|Death leading to discontinuation|0
1575739|NCT02718417|5465472|P3|Maintenance Phase|Adverse Event|1
1575740|NCT02718417|5465473|P2|Maintenance Phase|Adverse Event|23
1575741|NCT02718417|5465474|P1|Maintenance Phase|Adverse Event|16
1575742|NCT02718417|5465472|P3|Chemotherapy Phase|Other|0
1575743|NCT02718417|5465473|P2|Chemotherapy Phase|Other|0
1575744|NCT02718417|5465474|P1|Chemotherapy Phase|Other|2
1575745|NCT02718417|5465472|P3|Chemotherapy Phase|Withdrawal by Subject|15
1575746|NCT02718417|5465473|P2|Chemotherapy Phase|Withdrawal by Subject|8
1575747|NCT02718417|5465474|P1|Chemotherapy Phase|Withdrawal by Subject|13
1575748|NCT02718417|5465472|P3|Chemotherapy Phase|Progressive disease|10
1575749|NCT02718417|5465473|P2|Chemotherapy Phase|Progressive disease|7
1575750|NCT02718417|5465474|P1|Chemotherapy Phase|Progressive disease|11
1575751|NCT02718417|5465472|P3|Chemotherapy Phase|Physician's decision|4
1575752|NCT02718417|5465473|P2|Chemotherapy Phase|Physician's decision|0
1575753|NCT02718417|5465474|P1|Chemotherapy Phase|Physician's decision|5
1575754|NCT02718417|5465472|P3|Chemotherapy Phase|No longer met eligibility criteria|1
1575755|NCT02718417|5465473|P2|Chemotherapy Phase|No longer met eligibility criteria|2
1575756|NCT02718417|5465474|P1|Chemotherapy Phase|No longer met eligibility criteria|4
1575757|NCT02718417|5465472|P3|Chemotherapy Phase|Global deterioration of health status|1
1575758|NCT02718417|5465473|P2|Chemotherapy Phase|Global deterioration of health status|2
1575759|NCT02718417|5465474|P1|Chemotherapy Phase|Global deterioration of health status|3
1575760|NCT02718417|5465472|P3|Chemotherapy Phase|Death leading to discontinuation|1
1575761|NCT02718417|5465473|P2|Chemotherapy Phase|Death leading to discontinuation|4
1575762|NCT02718417|5465474|P1|Chemotherapy Phase|Death leading to discontinuation|5
1575763|NCT02718417|5465472|P3|Chemotherapy Phase|Adverse Event|13
1575764|NCT02718417|5465473|P2|Chemotherapy Phase|Adverse Event|14
1575765|NCT02718417|5465474|P1|Chemotherapy Phase|Adverse Event|9
1575766|NCT02718326|5465536|P3|Overall Study|Un-specified|0
1575767|NCT02718326|5465537|P2|Overall Study|Un-specified|0
1575768|NCT02718326|5465538|P1|Overall Study|Un-specified|1
1575769|NCT02718326|5465536|P3|Overall Study|Protocol Deviation|0
1575770|NCT02718326|5465537|P2|Overall Study|Protocol Deviation|0
1575771|NCT02718326|5465538|P1|Overall Study|Protocol Deviation|1
1575772|NCT02718326|5465536|P3|Overall Study|Lost to Follow-up|5
1575773|NCT02718326|5465537|P2|Overall Study|Lost to Follow-up|4
1575774|NCT02718326|5465538|P1|Overall Study|Lost to Follow-up|12
1575775|NCT02718326|5465536|P3|Overall Study|Withdrawal by Subject|4
1575776|NCT02718326|5465537|P2|Overall Study|Withdrawal by Subject|5
1575777|NCT02718326|5465538|P1|Overall Study|Withdrawal by Subject|2
1575778|NCT02718326|5465536|P3|Overall Study|Death|1
1575779|NCT02718326|5465537|P2|Overall Study|Death|0
1575780|NCT02718326|5465538|P1|Overall Study|Death|6
1575781|NCT02718326|5465536|P3|Overall Study|Adverse Event|0
1575782|NCT02718326|5465537|P2|Overall Study|Adverse Event|4
1575783|NCT02718326|5465538|P1|Overall Study|Adverse Event|2
1575784|NCT02717754|5465659|P6|Overall Study|Incorrect Infusion Duration|20
1575785|NCT02717754|5465660|P5|Overall Study|Incorrect Infusion Duration|20
1575786|NCT02717754|5465661|P4|Overall Study|Incorrect Infusion Duration|10
1575787|NCT02717754|5465662|P3|Overall Study|Incorrect Infusion Duration|0
1575788|NCT02717754|5465663|P2|Overall Study|Incorrect Infusion Duration|0
1575789|NCT02717754|5465664|P1|Overall Study|Incorrect Infusion Duration|0
1575790|NCT02717494|5465695|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
1575791|NCT02717494|5465696|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
1575792|NCT02717494|5465697|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
1575793|NCT02717494|5465695|P3|First Intervention (Step 1)|Death|1
1575794|NCT02717494|5465696|P2|First Intervention (Step 1)|Death|0
1575795|NCT02717494|5465697|P1|First Intervention (Step 1)|Death|0
1575796|NCT02717494|5465695|P3|First Intervention (Step 1)|Withdrawal by Subject|1
1575797|NCT02717494|5465696|P2|First Intervention (Step 1)|Withdrawal by Subject|0
1575798|NCT02717494|5465697|P1|First Intervention (Step 1)|Withdrawal by Subject|2
1575799|NCT02717494|5465695|P3|First Intervention (Step 1)|Lost to Follow-up|3
1575800|NCT02717494|5465696|P2|First Intervention (Step 1)|Lost to Follow-up|7
1575801|NCT02717494|5465697|P1|First Intervention (Step 1)|Lost to Follow-up|4
1575802|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
1575803|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
1575804|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
1575805|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
1575806|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
1575807|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1575808|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1575809|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
1575810|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1575811|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
1575812|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
1575813|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1575814|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1575815|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1575816|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
1575817|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Change of residence|1
1575818|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Change of residence|1
1575819|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Change of residence|0
1575820|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Change of residence|0
1575821|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Change of residence|0
1575822|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
1575823|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
1575824|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
1575825|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
1575826|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
1575827|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
1575828|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
1575829|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
1575830|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
1575831|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
1575832|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Patient decision|2
1575833|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Patient decision|2
1575834|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Patient decision|0
1575835|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Patient decision|0
1575836|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Patient decision|0
1575837|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1575838|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1575839|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
1575840|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1575841|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
1575842|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
1575843|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
1575844|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
1575845|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
1575846|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
1575847|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
1575848|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
1575849|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
1575850|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
1575851|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
1575852|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
1575853|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
1575854|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
1575855|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
1575856|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
1575857|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
1575858|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
1575859|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
1575860|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
1575861|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
1575862|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
1575863|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
1575864|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
1575865|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
1575866|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
1575867|NCT02717195|5465759|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
1575868|NCT02717195|5465760|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
1575869|NCT02717195|5465761|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
1575870|NCT02717195|5465762|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
1575871|NCT02717195|5465763|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
1575872|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1575873|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1575874|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1575875|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
1575876|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
1575877|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1575878|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1575879|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1575880|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
1575881|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
1575882|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
1575883|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
1575884|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
1575885|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
1575886|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
1575887|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
1575888|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
1575889|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
1575890|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
1575891|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
1575892|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1575893|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1575894|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1575895|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
1575896|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
1575897|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1575898|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1575899|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1575900|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
1575901|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
1575902|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1575903|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1575904|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1575905|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
1575906|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
1575907|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Investigator decision|0
1575908|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Investigator decision|0
1575909|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Investigator decision|0
1575910|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Investigator decision|1
1575911|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Investigator decision|2
1575912|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1575913|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1575914|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1575915|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
1575916|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
1575917|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
1575918|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
1575919|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
1575920|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
1575921|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
1575922|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1575923|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1575924|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1575925|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
1575926|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
1575927|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Patient decision|0
1575928|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Patient decision|0
1575929|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Patient decision|0
1575930|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Patient decision|2
1575931|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Patient decision|5
1575932|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Technical error|0
1575933|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Technical error|0
1575934|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Technical error|0
1575935|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Technical error|0
1575936|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Technical error|1
1575937|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1575938|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1575939|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1575940|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
1575941|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
1575942|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
1575943|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
1575944|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
1575945|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
1575946|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
1575947|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
1575948|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
1575949|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
1575950|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
1575951|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
1575952|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
1575953|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
1575954|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
1575955|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
1575956|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
1575957|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1575958|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1575959|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
1575960|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
1575961|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
1575962|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
1575963|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
1575964|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
1575965|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
1575966|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
1575967|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
1575968|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
1575969|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
1575970|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
1575971|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
1575972|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1575973|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1575974|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
1575975|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
1575976|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
1575977|NCT02717195|5465759|P5|Prospective Confirmation (PC) Period|Adverse Event|0
1575978|NCT02717195|5465760|P4|Prospective Confirmation (PC) Period|Adverse Event|0
1575979|NCT02717195|5465761|P3|Prospective Confirmation (PC) Period|Adverse Event|0
1575980|NCT02717195|5465762|P2|Prospective Confirmation (PC) Period|Adverse Event|7
1575981|NCT02717195|5465763|P1|Prospective Confirmation (PC) Period|Adverse Event|19
1575982|NCT02716896|5465796|P2|Overall Study|Physician Decision|1
1575983|NCT02716896|5465797|P1|Overall Study|Physician Decision|0
1575984|NCT02716805|5465848|P4|Overall Study|Progressive disease|0
1575985|NCT02716805|5465849|P3|Overall Study|Progressive disease|0
1575986|NCT02716805|5465850|P2|Overall Study|Progressive disease|0
1575987|NCT02716805|5465851|P1|Overall Study|Progressive disease|2
1575988|NCT02716779|5465859|P3|Combination Therapy|Adverse Event|1
1575989|NCT02716779|5465860|P2|Combination Therapy|Adverse Event|2
1575990|NCT02716779|5465861|P1|Combination Therapy|Adverse Event|0
1575991|NCT02716779|5465859|P3|Monotherapy|Adverse Event|1
1575992|NCT02716779|5465860|P2|Monotherapy|Adverse Event|1
1575993|NCT02716779|5465861|P1|Monotherapy|Adverse Event|0
1575994|NCT02716584|5465936|P2|Overall Study|Lost to Follow-up|5
1575995|NCT02716584|5465937|P1|Overall Study|Lost to Follow-up|8
1575996|NCT02716298|5465993|P2|First Intervention (1 Month)|Lens discomfort|1
1575997|NCT02716298|5465994|P1|First Intervention (1 Month)|Lens discomfort|1
1575998|NCT02716194|5466012|P3|Period 1 - ADVATE|Withdrawal by Subject|0
1575999|NCT02716194|5466013|P2|Period 1 - ADVATE|Withdrawal by Subject|1
1576000|NCT02716194|5466014|P1|Period 1 - ADVATE|Withdrawal by Subject|1
1576001|NCT02715726|5466094|P2|Overall Study|Randomized but not treated|2
1576002|NCT02715726|5466095|P1|Overall Study|Randomized but not treated|1
1576003|NCT02715726|5466094|P2|Overall Study|Other than specified above|15
1576004|NCT02715726|5466095|P1|Overall Study|Other than specified above|11
1576005|NCT02715726|5466094|P2|Overall Study|Participant moved|3
1576006|NCT02715726|5466095|P1|Overall Study|Participant moved|1
1576007|NCT02715726|5466094|P2|Overall Study|Death|1
1576008|NCT02715726|5466095|P1|Overall Study|Death|2
1576009|NCT02715726|5466094|P2|Overall Study|Protocol Violation|0
1576010|NCT02715726|5466095|P1|Overall Study|Protocol Violation|1
1576011|NCT02715726|5466094|P2|Overall Study|Adverse Event|6
1576012|NCT02715726|5466095|P1|Overall Study|Adverse Event|2
1576013|NCT02714868|5466175|P2|Overall Study|PI withdraw did not meet inclusion|0
1576014|NCT02714868|5466176|P1|Overall Study|PI withdraw did not meet inclusion|1
1576015|NCT02714868|5466175|P2|Overall Study|PI withdrawal safety risk self/others|0
1576016|NCT02714868|5466176|P1|Overall Study|PI withdrawal safety risk self/others|1
1576017|NCT02714868|5466175|P2|Overall Study|Withdrawal by Subject|0
1576018|NCT02714868|5466176|P1|Overall Study|Withdrawal by Subject|3
1576019|NCT02714426|5466203|P2|Overall Study|Withdrawal by Subject|2
1576020|NCT02714426|5466204|P1|Overall Study|Withdrawal by Subject|2
1576021|NCT02714218|5466250|P3|Overall Study|Stop treatment, but will do follow up|0
1576022|NCT02714218|5466251|P2|Overall Study|Stop treatment, but will do follow up|1
1576023|NCT02714218|5466252|P1|Overall Study|Stop treatment, but will do follow up|0
1576024|NCT02714218|5466250|P3|Overall Study|Complete Response|0
1576025|NCT02714218|5466251|P2|Overall Study|Complete Response|0
1576026|NCT02714218|5466252|P1|Overall Study|Complete Response|1
1576027|NCT02714218|5466250|P3|Overall Study|Dose Delayed > 6 weeks|0
1576028|NCT02714218|5466251|P2|Overall Study|Dose Delayed > 6 weeks|0
1576029|NCT02714218|5466252|P1|Overall Study|Dose Delayed > 6 weeks|1
1576030|NCT02714218|5466250|P3|Overall Study|Completed|0
1576031|NCT02714218|5466251|P2|Overall Study|Completed|0
1576032|NCT02714218|5466252|P1|Overall Study|Completed|2
1576033|NCT02714218|5466250|P3|Overall Study|Not Reported|0
1576034|NCT02714218|5466251|P2|Overall Study|Not Reported|5
1576035|NCT02714218|5466252|P1|Overall Study|Not Reported|9
1576036|NCT02714218|5466250|P3|Overall Study|Medical Decision|0
1576037|NCT02714218|5466251|P2|Overall Study|Medical Decision|1
1576038|NCT02714218|5466252|P1|Overall Study|Medical Decision|0
1576039|NCT02714218|5466250|P3|Overall Study|Maximum Clinical Benefit|0
1576040|NCT02714218|5466251|P2|Overall Study|Maximum Clinical Benefit|2
1576041|NCT02714218|5466252|P1|Overall Study|Maximum Clinical Benefit|2
1576042|NCT02714218|5466250|P3|Overall Study|Participant Withdrew Consent|0
1576043|NCT02714218|5466251|P2|Overall Study|Participant Withdrew Consent|3
1576044|NCT02714218|5466252|P1|Overall Study|Participant Withdrew Consent|2
1576045|NCT02714218|5466250|P3|Overall Study|Request to Discontinue Treatment|1
1576046|NCT02714218|5466251|P2|Overall Study|Request to Discontinue Treatment|5
1576047|NCT02714218|5466252|P1|Overall Study|Request to Discontinue Treatment|1
1576048|NCT02714218|5466250|P3|Overall Study|Study Drug Toxicity|4
1576049|NCT02714218|5466251|P2|Overall Study|Study Drug Toxicity|69
1576050|NCT02714218|5466252|P1|Overall Study|Study Drug Toxicity|46
1576051|NCT02714218|5466250|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
1576052|NCT02714218|5466251|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
1576053|NCT02714218|5466252|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
1576054|NCT02714218|5466250|P3|Overall Study|Disease Progression|14
1576055|NCT02714218|5466251|P2|Overall Study|Disease Progression|51
1576056|NCT02714218|5466252|P1|Overall Study|Disease Progression|56
1576057|NCT02714062|5466302|P3|Overall Study|Protocol Violation|0
1576058|NCT02714062|5466303|P2|Overall Study|Protocol Violation|1
1576059|NCT02714062|5466304|P1|Overall Study|Protocol Violation|0
1576060|NCT02714062|5466302|P3|Overall Study|Withdrawal by Subject|1
1576061|NCT02714062|5466303|P2|Overall Study|Withdrawal by Subject|0
1576062|NCT02714062|5466304|P1|Overall Study|Withdrawal by Subject|1
1576063|NCT02714062|5466302|P3|Overall Study|Adverse Event|2
1576064|NCT02714062|5466303|P2|Overall Study|Adverse Event|0
1576065|NCT02714062|5466304|P1|Overall Study|Adverse Event|0
1576066|NCT02713828|5466350|P2|Overall Study|study terminated but patient allowed to|0
1576067|NCT02713828|5466351|P1|Overall Study|study terminated but patient allowed to|2
1576068|NCT02713828|5466350|P2|Overall Study|Withdrawal by Subject|0
1576069|NCT02713828|5466351|P1|Overall Study|Withdrawal by Subject|1
1576070|NCT02713828|5466350|P2|Overall Study|Death|0
1576071|NCT02713828|5466351|P1|Overall Study|Death|2
1576072|NCT02713789|5466363|P3|Overall Study|Lost to Follow-up|1
1576073|NCT02713789|5466364|P2|Overall Study|Lost to Follow-up|1
1576074|NCT02713789|5466365|P1|Overall Study|Lost to Follow-up|0
1576075|NCT02713594|5466428|P2|Overall Study|Lost to Follow-up|374
1576076|NCT02713594|5466429|P1|Overall Study|Lost to Follow-up|358
1576077|NCT02713594|5466428|P2|Overall Study|Withdrawal by Subject|22
1576078|NCT02713594|5466429|P1|Overall Study|Withdrawal by Subject|32
1576079|NCT02713542|5466441|P2|Overall Study|Withdrawal by Subject|1
1576080|NCT02713542|5466442|P1|Overall Study|Withdrawal by Subject|4
1576081|NCT02713542|5466441|P2|Overall Study|Use of prohibited medication|5
1576082|NCT02713542|5466442|P1|Overall Study|Use of prohibited medication|14
1576083|NCT02713243|5466461|P2|Overall Study|Protocol deviation|1
1576084|NCT02713243|5466462|P1|Overall Study|Protocol deviation|0
1576085|NCT02713243|5466461|P2|Overall Study|Administrative problems|1
1576086|NCT02713243|5466462|P1|Overall Study|Administrative problems|0
1576087|NCT02713243|5466461|P2|Overall Study|Abnormal laboratory value(s)#|0
1576088|NCT02713243|5466462|P1|Overall Study|Abnormal laboratory value(s)#|1
1576089|NCT02713204|5466480|P8|From Week 12 up to Week 36|Participant Re-located|0
1576090|NCT02713204|5466481|P7|From Week 12 up to Week 36|Participant Re-located|0
1576091|NCT02713204|5466482|P6|From Week 12 up to Week 36|Participant Re-located|0
1576092|NCT02713204|5466483|P5|From Week 12 up to Week 36|Participant Re-located|1
1576093|NCT02713204|5466484|P4|From Week 12 up to Week 36|Participant Re-located|0
1576094|NCT02713204|5466485|P3|From Week 12 up to Week 36|Participant Re-located|0
1576095|NCT02713204|5466486|P2|From Week 12 up to Week 36|Participant Re-located|0
1576096|NCT02713204|5466487|P1|From Week 12 up to Week 36|Participant Re-located|0
1576097|NCT02713204|5466480|P8|From Week 12 up to Week 36|Lost to Follow-up|0
1576098|NCT02713204|5466481|P7|From Week 12 up to Week 36|Lost to Follow-up|0
1576099|NCT02713204|5466482|P6|From Week 12 up to Week 36|Lost to Follow-up|0
1576100|NCT02713204|5466483|P5|From Week 12 up to Week 36|Lost to Follow-up|0
1576101|NCT02713204|5466484|P4|From Week 12 up to Week 36|Lost to Follow-up|2
1576102|NCT02713204|5466485|P3|From Week 12 up to Week 36|Lost to Follow-up|0
1576103|NCT02713204|5466486|P2|From Week 12 up to Week 36|Lost to Follow-up|0
1576104|NCT02713204|5466487|P1|From Week 12 up to Week 36|Lost to Follow-up|0
1576105|NCT02713204|5466480|P8|From Week 12 up to Week 36|Death|3
1576106|NCT02713204|5466481|P7|From Week 12 up to Week 36|Death|0
1576107|NCT02713204|5466482|P6|From Week 12 up to Week 36|Death|1
1576108|NCT02713204|5466483|P5|From Week 12 up to Week 36|Death|0
1576109|NCT02713204|5466484|P4|From Week 12 up to Week 36|Death|1
1576110|NCT02713204|5466485|P3|From Week 12 up to Week 36|Death|0
1576111|NCT02713204|5466486|P2|From Week 12 up to Week 36|Death|0
1576112|NCT02713204|5466487|P1|From Week 12 up to Week 36|Death|0
1576113|NCT02713204|5466480|P8|From Week 12 up to Week 36|Adverse Event|1
1576114|NCT02713204|5466481|P7|From Week 12 up to Week 36|Adverse Event|2
1576115|NCT02713204|5466482|P6|From Week 12 up to Week 36|Adverse Event|0
1576116|NCT02713204|5466483|P5|From Week 12 up to Week 36|Adverse Event|1
1576117|NCT02713204|5466484|P4|From Week 12 up to Week 36|Adverse Event|1
1576118|NCT02713204|5466485|P3|From Week 12 up to Week 36|Adverse Event|0
1576119|NCT02713204|5466486|P2|From Week 12 up to Week 36|Adverse Event|0
1576120|NCT02713204|5466487|P1|From Week 12 up to Week 36|Adverse Event|1
1576121|NCT02713204|5466480|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576122|NCT02713204|5466481|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576123|NCT02713204|5466482|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576124|NCT02713204|5466483|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576125|NCT02713204|5466484|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576126|NCT02713204|5466485|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576127|NCT02713204|5466486|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
1576128|NCT02713204|5466487|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576129|NCT02713204|5466480|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576130|NCT02713204|5466481|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576131|NCT02713204|5466482|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576132|NCT02713204|5466483|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576133|NCT02713204|5466484|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576134|NCT02713204|5466485|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
1576135|NCT02713204|5466486|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576136|NCT02713204|5466487|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576137|NCT02713204|5466480|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
1576138|NCT02713204|5466481|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
1576139|NCT02713204|5466482|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
1576140|NCT02713204|5466483|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
1576141|NCT02713204|5466484|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
1576142|NCT02713204|5466485|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
1576143|NCT02713204|5466486|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
1576144|NCT02713204|5466487|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
1576145|NCT02712788|5466546|P2|Overall Study|Protocol Violation|0
1576146|NCT02712788|5466547|P1|Overall Study|Protocol Violation|1
1576147|NCT02712788|5466546|P2|Overall Study|Physician Decision|0
1576148|NCT02712788|5466547|P1|Overall Study|Physician Decision|1
1576149|NCT02712554|5466557|P2|Part B: Treatment Phase|Other|1
1576150|NCT02712554|5466558|P1|Part B: Treatment Phase|Other|0
1576151|NCT02712554|5466557|P2|Part B: Treatment Phase|Withdrawal by Subject|1
1576152|NCT02712554|5466558|P1|Part B: Treatment Phase|Withdrawal by Subject|0
1576153|NCT02712554|5466557|P2|Part B: Treatment Phase|Adverse Event|1
1576154|NCT02712554|5466558|P1|Part B: Treatment Phase|Adverse Event|0
1576155|NCT02712554|5466557|P2|Part B: Qualification Phase|Adverse Event|1
1576156|NCT02712554|5466558|P1|Part B: Qualification Phase|Adverse Event|0
1576157|NCT02712554|5466557|P2|Part B: Qualification Phase|Withdrawal by Subject|3
1576158|NCT02712554|5466558|P1|Part B: Qualification Phase|Withdrawal by Subject|0
1576159|NCT02712554|5466557|P2|Part B: Qualification Phase|Sponsor Decision|4
1576160|NCT02712554|5466558|P1|Part B: Qualification Phase|Sponsor Decision|0
1576161|NCT02712554|5466557|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
1576162|NCT02712554|5466558|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
1576163|NCT02712333|5466703|P2|First Period|Withdrawal by Subject|2
1576164|NCT02712333|5466704|P1|First Period|Withdrawal by Subject|3
1576165|NCT02712320|5466722|P1|Overall Study|Treating with the prohibited medications|2
1576166|NCT02712320|5466722|P1|Overall Study|Transferred to another facility|1
1576167|NCT02712320|5466722|P1|Overall Study|Withdrawal by Subject|1
1576168|NCT02712320|5466722|P1|Overall Study|Lost to Follow-up|1
1576169|NCT02712008|5466765|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
1576170|NCT02712008|5466766|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
1576171|NCT02712008|5466767|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
1576172|NCT02712008|5466768|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
1576173|NCT02712008|5466769|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
1576174|NCT02712008|5466770|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
1576175|NCT02712008|5466771|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
1576176|NCT02712008|5466772|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
1576177|NCT02712008|5466765|P8|From Week 12 up to Week 36|Physician Decision|0
1576178|NCT02712008|5466766|P7|From Week 12 up to Week 36|Physician Decision|0
1576179|NCT02712008|5466767|P6|From Week 12 up to Week 36|Physician Decision|0
1576180|NCT02712008|5466768|P5|From Week 12 up to Week 36|Physician Decision|1
1576181|NCT02712008|5466769|P4|From Week 12 up to Week 36|Physician Decision|1
1576182|NCT02712008|5466770|P3|From Week 12 up to Week 36|Physician Decision|0
1576183|NCT02712008|5466771|P2|From Week 12 up to Week 36|Physician Decision|0
1576184|NCT02712008|5466772|P1|From Week 12 up to Week 36|Physician Decision|0
1576185|NCT02712008|5466765|P8|From Week 12 up to Week 36|Lost to Follow-up|0
1576186|NCT02712008|5466766|P7|From Week 12 up to Week 36|Lost to Follow-up|1
1576187|NCT02712008|5466767|P6|From Week 12 up to Week 36|Lost to Follow-up|0
1576188|NCT02712008|5466768|P5|From Week 12 up to Week 36|Lost to Follow-up|0
1576189|NCT02712008|5466769|P4|From Week 12 up to Week 36|Lost to Follow-up|1
1576190|NCT02712008|5466770|P3|From Week 12 up to Week 36|Lost to Follow-up|0
1576191|NCT02712008|5466771|P2|From Week 12 up to Week 36|Lost to Follow-up|0
1576192|NCT02712008|5466772|P1|From Week 12 up to Week 36|Lost to Follow-up|0
1576193|NCT02712008|5466765|P8|From Week 12 up to Week 36|Death|0
1576194|NCT02712008|5466766|P7|From Week 12 up to Week 36|Death|1
1576195|NCT02712008|5466767|P6|From Week 12 up to Week 36|Death|0
1576196|NCT02712008|5466768|P5|From Week 12 up to Week 36|Death|0
1576197|NCT02712008|5466769|P4|From Week 12 up to Week 36|Death|0
1576198|NCT02712008|5466770|P3|From Week 12 up to Week 36|Death|0
1576199|NCT02712008|5466771|P2|From Week 12 up to Week 36|Death|0
1576200|NCT02712008|5466772|P1|From Week 12 up to Week 36|Death|1
1576201|NCT02712008|5466765|P8|From Week 12 up to Week 36|Adverse Event|2
1576202|NCT02712008|5466766|P7|From Week 12 up to Week 36|Adverse Event|0
1576203|NCT02712008|5466767|P6|From Week 12 up to Week 36|Adverse Event|0
1576204|NCT02712008|5466768|P5|From Week 12 up to Week 36|Adverse Event|1
1576205|NCT02712008|5466769|P4|From Week 12 up to Week 36|Adverse Event|0
1576206|NCT02712008|5466770|P3|From Week 12 up to Week 36|Adverse Event|0
1576207|NCT02712008|5466771|P2|From Week 12 up to Week 36|Adverse Event|0
1576208|NCT02712008|5466772|P1|From Week 12 up to Week 36|Adverse Event|0
1576209|NCT02712008|5466765|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
1576210|NCT02712008|5466766|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
1576211|NCT02712008|5466767|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
1576212|NCT02712008|5466768|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
1576213|NCT02712008|5466769|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
1576214|NCT02712008|5466770|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
1576215|NCT02712008|5466771|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
1576216|NCT02712008|5466772|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
1576217|NCT02712008|5466765|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
1576218|NCT02712008|5466766|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
1576219|NCT02712008|5466767|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
1576220|NCT02712008|5466768|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
1576221|NCT02712008|5466769|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
1576222|NCT02712008|5466770|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
1576223|NCT02712008|5466771|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
1576224|NCT02712008|5466772|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
1576225|NCT02712008|5466765|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576226|NCT02712008|5466766|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576227|NCT02712008|5466767|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576228|NCT02712008|5466768|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576229|NCT02712008|5466769|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576230|NCT02712008|5466770|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
1576231|NCT02712008|5466771|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
1576232|NCT02712008|5466772|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
1576233|NCT02712008|5466765|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576234|NCT02712008|5466766|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576235|NCT02712008|5466767|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576236|NCT02712008|5466768|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576237|NCT02712008|5466769|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576238|NCT02712008|5466770|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
1576239|NCT02712008|5466771|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
1576240|NCT02712008|5466772|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
1576241|NCT02712008|5466765|P8|Baseline (Day 1) up to Week 12|Death|0
1576242|NCT02712008|5466766|P7|Baseline (Day 1) up to Week 12|Death|0
1576243|NCT02712008|5466767|P6|Baseline (Day 1) up to Week 12|Death|0
1576244|NCT02712008|5466768|P5|Baseline (Day 1) up to Week 12|Death|0
1576245|NCT02712008|5466769|P4|Baseline (Day 1) up to Week 12|Death|0
1576246|NCT02712008|5466770|P3|Baseline (Day 1) up to Week 12|Death|0
1576247|NCT02712008|5466771|P2|Baseline (Day 1) up to Week 12|Death|0
1576248|NCT02712008|5466772|P1|Baseline (Day 1) up to Week 12|Death|3
1576249|NCT02711995|5466804|P1|Washout (90 Days)|Conflicting medication|1
1576250|NCT02711800|5466843|P1|Overall Study|Withdrawal by Subject|1
1576251|NCT02711800|5466843|P1|Overall Study|Lost to Follow-up|1
1576252|NCT02711345|5466862|P10|Overall Study|Death|0
1576253|NCT02711345|5466863|P9|Overall Study|Death|0
1576254|NCT02711345|5466864|P8|Overall Study|Death|1
1576255|NCT02711345|5466865|P7|Overall Study|Death|0
1576256|NCT02711345|5466866|P6|Overall Study|Death|0
1576257|NCT02711345|5466867|P5|Overall Study|Death|0
1576258|NCT02711345|5466868|P4|Overall Study|Death|0
1576259|NCT02711345|5466869|P3|Overall Study|Death|0
1576260|NCT02711345|5466870|P2|Overall Study|Death|0
1576261|NCT02711345|5466871|P1|Overall Study|Death|1
1576262|NCT02711345|5466862|P10|Overall Study|Subject/guardian decision|4
1576263|NCT02711345|5466863|P9|Overall Study|Subject/guardian decision|0
1576264|NCT02711345|5466864|P8|Overall Study|Subject/guardian decision|1
1576265|NCT02711345|5466865|P7|Overall Study|Subject/guardian decision|3
1576266|NCT02711345|5466866|P6|Overall Study|Subject/guardian decision|2
1576267|NCT02711345|5466867|P5|Overall Study|Subject/guardian decision|0
1576268|NCT02711345|5466868|P4|Overall Study|Subject/guardian decision|0
1576269|NCT02711345|5466869|P3|Overall Study|Subject/guardian decision|0
1576270|NCT02711345|5466870|P2|Overall Study|Subject/guardian decision|0
1576271|NCT02711345|5466871|P1|Overall Study|Subject/guardian decision|0
1576272|NCT02711345|5466862|P10|Overall Study|Progressive disease|6
1576273|NCT02711345|5466863|P9|Overall Study|Progressive disease|5
1576274|NCT02711345|5466864|P8|Overall Study|Progressive disease|4
1576275|NCT02711345|5466865|P7|Overall Study|Progressive disease|8
1576276|NCT02711345|5466866|P6|Overall Study|Progressive disease|2
1576277|NCT02711345|5466867|P5|Overall Study|Progressive disease|7
1576278|NCT02711345|5466868|P4|Overall Study|Progressive disease|3
1576279|NCT02711345|5466869|P3|Overall Study|Progressive disease|5
1576280|NCT02711345|5466870|P2|Overall Study|Progressive disease|3
1576281|NCT02711345|5466871|P1|Overall Study|Progressive disease|1
1576282|NCT02711345|5466862|P10|Overall Study|Physician Decision|0
1576283|NCT02711345|5466863|P9|Overall Study|Physician Decision|1
1576284|NCT02711345|5466864|P8|Overall Study|Physician Decision|0
1576285|NCT02711345|5466865|P7|Overall Study|Physician Decision|0
1576286|NCT02711345|5466866|P6|Overall Study|Physician Decision|0
1576287|NCT02711345|5466867|P5|Overall Study|Physician Decision|0
1576288|NCT02711345|5466868|P4|Overall Study|Physician Decision|0
1576289|NCT02711345|5466869|P3|Overall Study|Physician Decision|1
1576290|NCT02711345|5466870|P2|Overall Study|Physician Decision|0
1576291|NCT02711345|5466871|P1|Overall Study|Physician Decision|0
1576292|NCT02711345|5466862|P10|Overall Study|Adverse Event|2
1576293|NCT02711345|5466863|P9|Overall Study|Adverse Event|0
1576294|NCT02711345|5466864|P8|Overall Study|Adverse Event|0
1576295|NCT02711345|5466865|P7|Overall Study|Adverse Event|1
1576296|NCT02711345|5466866|P6|Overall Study|Adverse Event|2
1576297|NCT02711345|5466867|P5|Overall Study|Adverse Event|1
1576298|NCT02711345|5466868|P4|Overall Study|Adverse Event|1
1576299|NCT02711345|5466869|P3|Overall Study|Adverse Event|0
1576300|NCT02711345|5466870|P2|Overall Study|Adverse Event|0
1576301|NCT02711345|5466871|P1|Overall Study|Adverse Event|0
1576302|NCT02711306|5467057|P2|Overall Study|Withdrawal by Subject|2
1576303|NCT02711306|5467058|P1|Overall Study|Withdrawal by Subject|2
1576304|NCT02710422|5467146|P2|Overall Study|Termination of study|9
1576305|NCT02710422|5467147|P1|Overall Study|Termination of study|9
1576306|NCT02710292|5467163|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
1576307|NCT02710292|5467164|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
1576308|NCT02710292|5467163|P2|Period 1, First 10 Days of Wear|Adverse Event|1
1576309|NCT02710292|5467164|P1|Period 1, First 10 Days of Wear|Adverse Event|0
1576310|NCT02710136|5467173|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
1576311|NCT02710136|5467174|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
1576312|NCT02710045|5467200|P3|Overall Study|Poor Attendance|0
1576313|NCT02710045|5467201|P2|Overall Study|Poor Attendance|1
1576314|NCT02710045|5467202|P1|Overall Study|Poor Attendance|0
1576315|NCT02710045|5467200|P3|Overall Study|Physician Decision|1
1576316|NCT02710045|5467201|P2|Overall Study|Physician Decision|0
1576317|NCT02710045|5467202|P1|Overall Study|Physician Decision|0
1576318|NCT02710045|5467200|P3|Overall Study|Lost to Follow-up|7
1576319|NCT02710045|5467201|P2|Overall Study|Lost to Follow-up|6
1576320|NCT02710045|5467202|P1|Overall Study|Lost to Follow-up|3
1576321|NCT02710045|5467200|P3|Overall Study|Protocol Violation|3
1576322|NCT02710045|5467201|P2|Overall Study|Protocol Violation|2
1576323|NCT02710045|5467202|P1|Overall Study|Protocol Violation|1
1576324|NCT02710045|5467200|P3|Overall Study|Withdrawal by Subject|2
1576325|NCT02710045|5467201|P2|Overall Study|Withdrawal by Subject|6
1576326|NCT02710045|5467202|P1|Overall Study|Withdrawal by Subject|6
1576327|NCT02710045|5467200|P3|Overall Study|Death|0
1576328|NCT02710045|5467201|P2|Overall Study|Death|2
1576329|NCT02710045|5467202|P1|Overall Study|Death|1
1576330|NCT02709785|5467231|P3|Overall Study|Withdrawal by Subject|1
1576331|NCT02709785|5467232|P2|Overall Study|Withdrawal by Subject|2
1576332|NCT02709785|5467233|P1|Overall Study|Withdrawal by Subject|1
1576333|NCT02709577|5467255|P4|Overall Study|Withdrawal by Subject|0
1576334|NCT02709577|5467256|P3|Overall Study|Withdrawal by Subject|2
1576335|NCT02709577|5467257|P2|Overall Study|Withdrawal by Subject|3
1576336|NCT02709577|5467258|P1|Overall Study|Withdrawal by Subject|2
1576337|NCT02709577|5467255|P4|Overall Study|procedural complication|0
1576338|NCT02709577|5467256|P3|Overall Study|procedural complication|0
1576339|NCT02709577|5467257|P2|Overall Study|procedural complication|1
1576340|NCT02709577|5467258|P1|Overall Study|procedural complication|0
1576341|NCT02709577|5467255|P4|Overall Study|non-accommodating anatomy|0
1576342|NCT02709577|5467256|P3|Overall Study|non-accommodating anatomy|0
1576343|NCT02709577|5467257|P2|Overall Study|non-accommodating anatomy|1
1576344|NCT02709577|5467258|P1|Overall Study|non-accommodating anatomy|0
1576375|NCT02709486|5467286|P3|Overall Study|Withdrawal by Subject|32
1576376|NCT02709486|5467287|P2|Overall Study|Withdrawal by Subject|22
1576377|NCT02709486|5467288|P1|Overall Study|Withdrawal by Subject|32
1576378|NCT02709486|5467286|P3|Overall Study|Other|3
1576379|NCT02709486|5467287|P2|Overall Study|Other|2
1576380|NCT02709486|5467288|P1|Overall Study|Other|0
1576381|NCT02709486|5467286|P3|Overall Study|Lost to Follow-up|2
1576382|NCT02709486|5467287|P2|Overall Study|Lost to Follow-up|2
1576383|NCT02709486|5467288|P1|Overall Study|Lost to Follow-up|3
1576384|NCT02709486|5467286|P3|Overall Study|Insufficient clinical response|3
1576385|NCT02709486|5467287|P2|Overall Study|Insufficient clinical response|3
1576386|NCT02709486|5467288|P1|Overall Study|Insufficient clinical response|7
1576387|NCT02709486|5467286|P3|Overall Study|Death|2
1576388|NCT02709486|5467287|P2|Overall Study|Death|0
1576389|NCT02709486|5467288|P1|Overall Study|Death|0
1576390|NCT02709486|5467286|P3|Overall Study|Adverse Event|3
1576391|NCT02709486|5467287|P2|Overall Study|Adverse Event|5
1576392|NCT02709486|5467288|P1|Overall Study|Adverse Event|2
1576393|NCT02709369|5467479|P1|Overall Study|Did not received intervention|2
1576394|NCT02709369|5467479|P1|Overall Study|Withdrawal by Subject|10
1576395|NCT02709369|5467479|P1|Overall Study|Lost to Follow-up|15
1576396|NCT02709330|5467513|P2|Overall Study|Withdrawal by Subject|0
1576397|NCT02709330|5467514|P1|Overall Study|Withdrawal by Subject|4
1576398|NCT02709330|5467513|P2|Overall Study|Physician Decision|0
1576399|NCT02709330|5467514|P1|Overall Study|Physician Decision|2
1576400|NCT02709330|5467513|P2|Overall Study|Lost to Follow-up|0
1576401|NCT02709330|5467514|P1|Overall Study|Lost to Follow-up|2
1576402|NCT02709330|5467513|P2|Overall Study|Death|0
1576403|NCT02709330|5467514|P1|Overall Study|Death|5
1576404|NCT02709096|5467528|P2|Overall Study|non-compliance|1
1576405|NCT02709096|5467529|P1|Overall Study|non-compliance|1
1576406|NCT02709083|5467535|P1|Overall Study|Original PI left institution|7
1576407|NCT02709005|5467548|P2|Overall Study|Withdrawal by Subject|0
1576408|NCT02709005|5467549|P1|Overall Study|Withdrawal by Subject|3
1576409|NCT02709005|5467548|P2|Overall Study|Lost to Follow-up|1
1576410|NCT02709005|5467549|P1|Overall Study|Lost to Follow-up|1
1576411|NCT02708524|5467607|P4|Overall Study|Subject lost study lens|0
1576412|NCT02708524|5467608|P3|Overall Study|Subject lost study lens|0
1576413|NCT02708524|5467609|P2|Overall Study|Subject lost study lens|0
1576414|NCT02708524|5467610|P1|Overall Study|Subject lost study lens|1
1576415|NCT02708524|5467607|P4|Overall Study|Did not wear lens at final visit|0
1576416|NCT02708524|5467608|P3|Overall Study|Did not wear lens at final visit|0
1576417|NCT02708524|5467609|P2|Overall Study|Did not wear lens at final visit|1
1576418|NCT02708524|5467610|P1|Overall Study|Did not wear lens at final visit|0
1576419|NCT02708524|5467607|P4|Overall Study|Dispensed incorrect study lens|0
1576420|NCT02708524|5467608|P3|Overall Study|Dispensed incorrect study lens|1
1576421|NCT02708524|5467609|P2|Overall Study|Dispensed incorrect study lens|1
1576422|NCT02708524|5467610|P1|Overall Study|Dispensed incorrect study lens|0
1576423|NCT02708524|5467607|P4|Overall Study|Withdrawal by Subject|0
1576424|NCT02708524|5467608|P3|Overall Study|Withdrawal by Subject|0
1576425|NCT02708524|5467609|P2|Overall Study|Withdrawal by Subject|1
1576426|NCT02708524|5467610|P1|Overall Study|Withdrawal by Subject|1
1576427|NCT02708524|5467607|P4|Overall Study|Protocol Violation|0
1576428|NCT02708524|5467608|P3|Overall Study|Protocol Violation|0
1576429|NCT02708524|5467609|P2|Overall Study|Protocol Violation|1
1576430|NCT02708524|5467610|P1|Overall Study|Protocol Violation|0
1576431|NCT02708524|5467607|P4|Overall Study|Lost to Follow-up|0
1576432|NCT02708524|5467608|P3|Overall Study|Lost to Follow-up|1
1576433|NCT02708524|5467609|P2|Overall Study|Lost to Follow-up|1
1576434|NCT02708524|5467610|P1|Overall Study|Lost to Follow-up|1
1576435|NCT02708524|5467607|P4|Overall Study|Lens Discomfort|0
1576436|NCT02708524|5467608|P3|Overall Study|Lens Discomfort|1
1576437|NCT02708524|5467609|P2|Overall Study|Lens Discomfort|0
1576438|NCT02708524|5467610|P1|Overall Study|Lens Discomfort|1
1576439|NCT02708524|5467607|P4|Overall Study|Adverse Event|0
1576440|NCT02708524|5467608|P3|Overall Study|Adverse Event|0
1576441|NCT02708524|5467609|P2|Overall Study|Adverse Event|1
1576442|NCT02708524|5467610|P1|Overall Study|Adverse Event|0
1576443|NCT02708485|5467658|P2|Overall Study|Withdrawal by Subject|2
1576444|NCT02708485|5467659|P1|Overall Study|Withdrawal by Subject|3
1576445|NCT02708355|5467679|P3|Overall Study|Adverse Event|0
1576446|NCT02708355|5467680|P2|Overall Study|Adverse Event|0
1576447|NCT02708355|5467681|P1|Overall Study|Adverse Event|1
1576448|NCT02708277|5467705|P2|Overall Study|Lost to Follow-up|4
1576449|NCT02708277|5467706|P1|Overall Study|Lost to Follow-up|7
1576450|NCT02708121|5467749|P2|Overall Study|Withdrawal by Subject|4
1576451|NCT02708121|5467750|P1|Overall Study|Withdrawal by Subject|0
1576452|NCT02708121|5467749|P2|Overall Study|Withdrawn by Study Team|1
1576453|NCT02708121|5467750|P1|Overall Study|Withdrawn by Study Team|1
1576454|NCT02708095|5467762|P3|Overall Study|Withdrawal by Subject|4
1576455|NCT02708095|5467763|P2|Overall Study|Withdrawal by Subject|3
1576456|NCT02708095|5467764|P1|Overall Study|Withdrawal by Subject|5
1576457|NCT02708095|5467762|P3|Overall Study|Protocol Violation|1
1576458|NCT02708095|5467763|P2|Overall Study|Protocol Violation|0
1576459|NCT02708095|5467764|P1|Overall Study|Protocol Violation|0
1576460|NCT02708095|5467762|P3|Overall Study|Physician Decision|2
1576461|NCT02708095|5467763|P2|Overall Study|Physician Decision|3
1576462|NCT02708095|5467764|P1|Overall Study|Physician Decision|2
1576463|NCT02708095|5467762|P3|Overall Study|Lost to Follow-up|0
1576464|NCT02708095|5467763|P2|Overall Study|Lost to Follow-up|0
1576465|NCT02708095|5467764|P1|Overall Study|Lost to Follow-up|2
1576466|NCT02708095|5467762|P3|Overall Study|Lack of Efficacy|0
1576467|NCT02708095|5467763|P2|Overall Study|Lack of Efficacy|3
1576468|NCT02708095|5467764|P1|Overall Study|Lack of Efficacy|9
1576469|NCT02708095|5467762|P3|Overall Study|Adverse Event|11
1576470|NCT02708095|5467763|P2|Overall Study|Adverse Event|10
1576471|NCT02708095|5467764|P1|Overall Study|Adverse Event|4
1576472|NCT02707991|5467787|P2|Overall Study|Became ineligible|1
1576473|NCT02707991|5467788|P1|Overall Study|Became ineligible|0
1576474|NCT02707991|5467787|P2|Overall Study|Protocol Violation|0
1576475|NCT02707991|5467788|P1|Overall Study|Protocol Violation|1
1576476|NCT02707952|5467800|P4|Overall Study|Withdrawal by Subject|0
1576477|NCT02707952|5467801|P3|Overall Study|Withdrawal by Subject|2
1576478|NCT02707952|5467802|P2|Overall Study|Withdrawal by Subject|1
1576479|NCT02707952|5467803|P1|Overall Study|Withdrawal by Subject|0
1576480|NCT02707952|5467800|P4|Overall Study|Lost to Follow-up|0
1576481|NCT02707952|5467801|P3|Overall Study|Lost to Follow-up|0
1576482|NCT02707952|5467802|P2|Overall Study|Lost to Follow-up|0
1576483|NCT02707952|5467803|P1|Overall Study|Lost to Follow-up|1
1576484|NCT02707952|5467800|P4|Overall Study|Adverse Event|0
1576485|NCT02707952|5467801|P3|Overall Study|Adverse Event|0
1576486|NCT02707952|5467802|P2|Overall Study|Adverse Event|0
1576487|NCT02707952|5467803|P1|Overall Study|Adverse Event|1
1576488|NCT02707640|5467824|P2|Overall Study|Sponsor Discretion|0
1576489|NCT02707640|5467825|P1|Overall Study|Sponsor Discretion|1
1576490|NCT02707640|5467824|P2|Overall Study|Participant's Personal Decision|2
1576491|NCT02707640|5467825|P1|Overall Study|Participant's Personal Decision|1
1576492|NCT02707640|5467824|P2|Overall Study|Withdrawal by Subject|1
1576493|NCT02707640|5467825|P1|Overall Study|Withdrawal by Subject|0
1576494|NCT02707640|5467824|P2|Overall Study|Physician Decision|0
1576495|NCT02707640|5467825|P1|Overall Study|Physician Decision|2
1576496|NCT02707640|5467824|P2|Overall Study|Death|2
1576497|NCT02707640|5467825|P1|Overall Study|Death|1
1576498|NCT02707640|5467824|P2|Overall Study|Adverse Event|2
1576499|NCT02707640|5467825|P1|Overall Study|Adverse Event|4
1576500|NCT02707601|5467845|P2|Overall Study|Participants Randomized but Not Treated|0
1576501|NCT02707601|5467846|P1|Overall Study|Participants Randomized but Not Treated|2
1576502|NCT02707601|5467845|P2|Overall Study|Lost to Follow-up|1
1576503|NCT02707601|5467846|P1|Overall Study|Lost to Follow-up|1
1576504|NCT02707601|5467845|P2|Overall Study|Withdrew Consent|1
1576505|NCT02707601|5467846|P1|Overall Study|Withdrew Consent|0
1576506|NCT02707601|5467845|P2|Overall Study|Investigator's Discretion|0
1576507|NCT02707601|5467846|P1|Overall Study|Investigator's Discretion|1
1576508|NCT02707601|5467845|P2|Overall Study|Lack of Efficacy|1
1576509|NCT02707601|5467846|P1|Overall Study|Lack of Efficacy|0
1576510|NCT02707601|5467845|P2|Overall Study|Death|1
1576511|NCT02707601|5467846|P1|Overall Study|Death|0
1576524|NCT02706938|5467915|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
1576525|NCT02706938|5467916|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
1576526|NCT02706938|5467915|P2|Second Period, 6 Weeks|Adverse Event|7
1576527|NCT02706938|5467916|P1|Second Period, 6 Weeks|Adverse Event|0
1576528|NCT02706938|5467915|P2|First Period, 6 Weeks|Withdrawal by Subject|0
1576529|NCT02706938|5467916|P1|First Period, 6 Weeks|Withdrawal by Subject|1
1576530|NCT02706938|5467915|P2|First Period, 6 Weeks|Lost to Follow-up|2
1576531|NCT02706938|5467916|P1|First Period, 6 Weeks|Lost to Follow-up|2
1576532|NCT02706938|5467915|P2|First Period, 6 Weeks|Adverse Event|0
1576533|NCT02706938|5467916|P1|First Period, 6 Weeks|Adverse Event|8
1576534|NCT02706899|5467980|P2|Overall Study|Study Termination by Sponsor|6
1576535|NCT02706899|5467981|P1|Overall Study|Study Termination by Sponsor|4
1576536|NCT02706899|5467980|P2|Overall Study|Death|0
1576537|NCT02706899|5467981|P1|Overall Study|Death|8
1576538|NCT02706899|5467980|P2|Overall Study|Withdrawal by Subject|0
1576539|NCT02706899|5467981|P1|Overall Study|Withdrawal by Subject|1
1576540|NCT02706886|5468012|P9|Part A: SAD Period|Withdrawal by Subject|0
1576541|NCT02706886|5468013|P8|Part A: SAD Period|Withdrawal by Subject|0
1576542|NCT02706886|5468014|P7|Part A: SAD Period|Withdrawal by Subject|0
1576543|NCT02706886|5468015|P6|Part A: SAD Period|Withdrawal by Subject|0
1576544|NCT02706886|5468016|P5|Part A: SAD Period|Withdrawal by Subject|0
1576545|NCT02706886|5468017|P4|Part A: SAD Period|Withdrawal by Subject|2
1576546|NCT02706886|5468018|P3|Part A: SAD Period|Withdrawal by Subject|0
1576547|NCT02706886|5468019|P2|Part A: SAD Period|Withdrawal by Subject|0
1576548|NCT02706886|5468020|P1|Part A: SAD Period|Withdrawal by Subject|0
1576613|NCT02706834|5468285|P11|Overall Study|Other Reason Not Specified|0
1576614|NCT02706834|5468286|P10|Overall Study|Other Reason Not Specified|0
1576615|NCT02706834|5468287|P9|Overall Study|Other Reason Not Specified|0
1576616|NCT02706834|5468288|P8|Overall Study|Other Reason Not Specified|0
1576617|NCT02706834|5468289|P7|Overall Study|Other Reason Not Specified|0
1576618|NCT02706834|5468290|P6|Overall Study|Other Reason Not Specified|0
1576619|NCT02706834|5468291|P5|Overall Study|Other Reason Not Specified|1
1576620|NCT02706834|5468292|P4|Overall Study|Other Reason Not Specified|0
1576621|NCT02706834|5468293|P3|Overall Study|Other Reason Not Specified|0
1576622|NCT02706834|5468294|P2|Overall Study|Other Reason Not Specified|0
1576623|NCT02706834|5468295|P1|Overall Study|Other Reason Not Specified|1
1576624|NCT02706834|5468285|P11|Overall Study|Voluntary Withdrawal|0
1576625|NCT02706834|5468286|P10|Overall Study|Voluntary Withdrawal|1
1576626|NCT02706834|5468287|P9|Overall Study|Voluntary Withdrawal|0
1576627|NCT02706834|5468288|P8|Overall Study|Voluntary Withdrawal|0
1576628|NCT02706834|5468289|P7|Overall Study|Voluntary Withdrawal|0
1576629|NCT02706834|5468290|P6|Overall Study|Voluntary Withdrawal|0
1576630|NCT02706834|5468291|P5|Overall Study|Voluntary Withdrawal|0
1576631|NCT02706834|5468292|P4|Overall Study|Voluntary Withdrawal|0
1576632|NCT02706834|5468293|P3|Overall Study|Voluntary Withdrawal|0
1576633|NCT02706834|5468294|P2|Overall Study|Voluntary Withdrawal|0
1576634|NCT02706834|5468295|P1|Overall Study|Voluntary Withdrawal|1
1576635|NCT02706834|5468285|P11|Overall Study|Lost to Follow-up|0
1576636|NCT02706834|5468286|P10|Overall Study|Lost to Follow-up|0
1576637|NCT02706834|5468287|P9|Overall Study|Lost to Follow-up|0
1576638|NCT02706834|5468288|P8|Overall Study|Lost to Follow-up|0
1576639|NCT02706834|5468289|P7|Overall Study|Lost to Follow-up|0
1576640|NCT02706834|5468290|P6|Overall Study|Lost to Follow-up|0
1576641|NCT02706834|5468291|P5|Overall Study|Lost to Follow-up|0
1576642|NCT02706834|5468292|P4|Overall Study|Lost to Follow-up|0
1576643|NCT02706834|5468293|P3|Overall Study|Lost to Follow-up|1
1576644|NCT02706834|5468294|P2|Overall Study|Lost to Follow-up|0
1576645|NCT02706834|5468295|P1|Overall Study|Lost to Follow-up|0
1576646|NCT02706834|5468285|P11|Overall Study|Pretreatment Event/Adverse Event|1
1576647|NCT02706834|5468286|P10|Overall Study|Pretreatment Event/Adverse Event|0
1576648|NCT02706834|5468287|P9|Overall Study|Pretreatment Event/Adverse Event|0
1576649|NCT02706834|5468288|P8|Overall Study|Pretreatment Event/Adverse Event|0
1576650|NCT02706834|5468289|P7|Overall Study|Pretreatment Event/Adverse Event|0
1576651|NCT02706834|5468290|P6|Overall Study|Pretreatment Event/Adverse Event|0
1576652|NCT02706834|5468291|P5|Overall Study|Pretreatment Event/Adverse Event|0
1576653|NCT02706834|5468292|P4|Overall Study|Pretreatment Event/Adverse Event|0
1576654|NCT02706834|5468293|P3|Overall Study|Pretreatment Event/Adverse Event|0
1576655|NCT02706834|5468294|P2|Overall Study|Pretreatment Event/Adverse Event|1
1576656|NCT02706834|5468295|P1|Overall Study|Pretreatment Event/Adverse Event|0
1576657|NCT02706717|5468439|P2|Overall Study|Death|1
1576658|NCT02706717|5468440|P1|Overall Study|Death|0
1576659|NCT02706717|5468439|P2|Overall Study|Physician Decision|1
1576660|NCT02706717|5468440|P1|Overall Study|Physician Decision|0
1576661|NCT02706717|5468439|P2|Overall Study|Lost to Follow-up|1
1576662|NCT02706717|5468440|P1|Overall Study|Lost to Follow-up|0
1576663|NCT02706717|5468439|P2|Overall Study|Withdrawal by Subject|8
1576664|NCT02706717|5468440|P1|Overall Study|Withdrawal by Subject|1
1576665|NCT02706691|5468504|P1|Overall Study|Adverse Event|1
1576666|NCT02706327|5468514|P3|Overall Study|Lost to Follow-up|2
1576667|NCT02706327|5468515|P2|Overall Study|Lost to Follow-up|1
1576668|NCT02706327|5468516|P1|Overall Study|Lost to Follow-up|1
1576669|NCT02705716|5468568|P2|Overall Study|Withdrawal of Consent|1
1576670|NCT02705716|5468569|P1|Overall Study|Withdrawal of Consent|1
1576671|NCT02705716|5468568|P2|Overall Study|Protocol Violation|0
1576672|NCT02705716|5468569|P1|Overall Study|Protocol Violation|3
1576673|NCT02705716|5468568|P2|Overall Study|Adverse Event|1
1576674|NCT02705716|5468569|P1|Overall Study|Adverse Event|0
1576675|NCT02705625|5468582|P3|Overall Study|Overdosing|1
1576676|NCT02705625|5468583|P2|Overall Study|Overdosing|0
1576677|NCT02705625|5468584|P1|Overall Study|Overdosing|0
1576678|NCT02705625|5468582|P3|Overall Study|Non-compliance|1
1576679|NCT02705625|5468583|P2|Overall Study|Non-compliance|1
1576680|NCT02705625|5468584|P1|Overall Study|Non-compliance|0
1576681|NCT02705625|5468582|P3|Overall Study|Lost to Follow-up|1
1576682|NCT02705625|5468583|P2|Overall Study|Lost to Follow-up|0
1576683|NCT02705625|5468584|P1|Overall Study|Lost to Follow-up|0
1576684|NCT02705625|5468582|P3|Overall Study|Withdrawal by Subject|5
1576685|NCT02705625|5468583|P2|Overall Study|Withdrawal by Subject|4
1576686|NCT02705625|5468584|P1|Overall Study|Withdrawal by Subject|1
1576687|NCT02705625|5468582|P3|Overall Study|Death|1
1576688|NCT02705625|5468583|P2|Overall Study|Death|0
1576689|NCT02705625|5468584|P1|Overall Study|Death|0
1576690|NCT02705625|5468582|P3|Overall Study|Adverse Event|2
1576691|NCT02705625|5468583|P2|Overall Study|Adverse Event|5
1576692|NCT02705625|5468584|P1|Overall Study|Adverse Event|6
1576693|NCT02705625|5468582|P3|Overall Study|Protocol Violation|0
1576694|NCT02705625|5468583|P2|Overall Study|Protocol Violation|0
1576695|NCT02705625|5468584|P1|Overall Study|Protocol Violation|1
1576696|NCT02705586|5468613|P1|Overall Study|Vacation/Planned Absence|1
1576697|NCT02705586|5468613|P1|Overall Study|Transportation Difficulties|5
1576698|NCT02705586|5468613|P1|Overall Study|Health Issues|2
1576699|NCT02704689|5468686|P1|Overall Study|Study device not implanted|2
1576700|NCT02704689|5468686|P1|Overall Study|Physician Decision|1
1576701|NCT02703636|5468744|P1|Overall Study|Withdrawal by Subject|1
1576702|NCT02703636|5468744|P1|Overall Study|Study stopped by sponsor|1
1576703|NCT02703636|5468744|P1|Overall Study|Adverse Event|14
1576704|NCT02703532|5468759|P4|Overall Study|Lost to Follow-up|0
1576705|NCT02703532|5468760|P3|Overall Study|Lost to Follow-up|2
1576706|NCT02703532|5468761|P2|Overall Study|Lost to Follow-up|0
1576707|NCT02703532|5468762|P1|Overall Study|Lost to Follow-up|2
1576708|NCT02703532|5468759|P4|Overall Study|Withdrawal by Subject|1
1576709|NCT02703532|5468760|P3|Overall Study|Withdrawal by Subject|0
1576710|NCT02703532|5468761|P2|Overall Study|Withdrawal by Subject|1
1576711|NCT02703532|5468762|P1|Overall Study|Withdrawal by Subject|0
1576712|NCT02703454|5468824|P2|Overall Study|Study discontinuation|8
1576713|NCT02703454|5468825|P1|Overall Study|Study discontinuation|5
1576714|NCT02703454|5468824|P2|Overall Study|Lost to Follow-up|2
1576715|NCT02703454|5468825|P1|Overall Study|Lost to Follow-up|1
1576716|NCT02703454|5468824|P2|Overall Study|Withdrawal by Subject|3
1576717|NCT02703454|5468825|P1|Overall Study|Withdrawal by Subject|4
1576718|NCT02703454|5468824|P2|Overall Study|Not treated|3
1576719|NCT02703454|5468825|P1|Overall Study|Not treated|1
1576720|NCT02703259|5468835|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
1576721|NCT02703259|5468836|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
1576722|NCT02703259|5468835|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
1576723|NCT02703259|5468836|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
1576724|NCT02703259|5468835|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
1576725|NCT02703259|5468836|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
1576732|NCT02702193|5468907|P2|12 Month Follow up|Lost to Follow-up|18
1576733|NCT02702193|5468908|P1|12 Month Follow up|Lost to Follow-up|16
1576734|NCT02702193|5468907|P2|12 Month Follow up|Withdrawal by Subject|0
1576735|NCT02702193|5468908|P1|12 Month Follow up|Withdrawal by Subject|1
1576736|NCT02702193|5468907|P2|8 Month Follow up|Lost to Follow-up|18
1576737|NCT02702193|5468908|P1|8 Month Follow up|Lost to Follow-up|14
1576738|NCT02702193|5468907|P2|8 Month Follow up|Withdrawal by Subject|0
1576739|NCT02702193|5468908|P1|8 Month Follow up|Withdrawal by Subject|1
1576740|NCT02702193|5468907|P2|4 Month Follow up|Lost to Follow-up|18
1576741|NCT02702193|5468908|P1|4 Month Follow up|Lost to Follow-up|17
1576742|NCT02702193|5468907|P2|4 Month Follow up|Withdrawal by Subject|0
1576743|NCT02702193|5468908|P1|4 Month Follow up|Withdrawal by Subject|1
1576744|NCT02702193|5468907|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
1576745|NCT02702193|5468908|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
1576746|NCT02702011|5468936|P4|Overall Study|Withdrawal by Subject|0
1576747|NCT02702011|5468937|P3|Overall Study|Withdrawal by Subject|0
1576748|NCT02702011|5468938|P2|Overall Study|Withdrawal by Subject|1
1576749|NCT02702011|5468939|P1|Overall Study|Withdrawal by Subject|0
1576750|NCT02701985|5468951|P2|Overall Study|Adverse Event|5
1576751|NCT02701985|5468952|P1|Overall Study|Adverse Event|0
1576752|NCT02701985|5468951|P2|Overall Study|Death|0
1576753|NCT02701985|5468952|P1|Overall Study|Death|1
1576754|NCT02701985|5468951|P2|Overall Study|Lost to Follow-up|0
1576755|NCT02701985|5468952|P1|Overall Study|Lost to Follow-up|1
1576756|NCT02701985|5468951|P2|Overall Study|Withdrawal by Subject|1
1576757|NCT02701985|5468952|P1|Overall Study|Withdrawal by Subject|1
1576758|NCT02701764|5468995|P2|Overall Study|Lost to Follow-up|1
1576759|NCT02701764|5468996|P1|Overall Study|Lost to Follow-up|0
1576760|NCT02701634|5469055|P2|Overall Study|Randomized but not treated|0
1576761|NCT02701634|5469056|P1|Overall Study|Randomized but not treated|1
1576762|NCT02701634|5469055|P2|Overall Study|Withdrew Consent|7
1576763|NCT02701634|5469056|P1|Overall Study|Withdrew Consent|6
1576764|NCT02701634|5469055|P2|Overall Study|Study terminated by Sponsor|17
1576765|NCT02701634|5469056|P1|Overall Study|Study terminated by Sponsor|15
1576766|NCT02701634|5469055|P2|Overall Study|Investigator's Discretion|4
1576767|NCT02701634|5469056|P1|Overall Study|Investigator's Discretion|7
1576768|NCT02701634|5469055|P2|Overall Study|Death|0
1576769|NCT02701634|5469056|P1|Overall Study|Death|1
1576770|NCT02701634|5469055|P2|Overall Study|Adverse Event|3
1576771|NCT02701634|5469056|P1|Overall Study|Adverse Event|2
1576772|NCT02701361|5469126|P3|Overall Study|incarceration|1
1576773|NCT02701361|5469127|P2|Overall Study|incarceration|0
1576774|NCT02701361|5469128|P1|Overall Study|incarceration|0
1576775|NCT02701361|5469126|P3|Overall Study|timed out in rehab center|0
1576776|NCT02701361|5469127|P2|Overall Study|timed out in rehab center|1
1576777|NCT02701361|5469128|P1|Overall Study|timed out in rehab center|0
1576778|NCT02701361|5469126|P3|Overall Study|Withdrawal by Subject|0
1576779|NCT02701361|5469127|P2|Overall Study|Withdrawal by Subject|0
1576780|NCT02701361|5469128|P1|Overall Study|Withdrawal by Subject|4
1576781|NCT02701361|5469126|P3|Overall Study|Lost to Follow-up|1
1576782|NCT02701361|5469127|P2|Overall Study|Lost to Follow-up|2
1576783|NCT02701361|5469128|P1|Overall Study|Lost to Follow-up|5
1576784|NCT02701296|5469169|P2|Overall Study|Incomplete Data|2
1576785|NCT02701296|5469170|P1|Overall Study|Incomplete Data|0
1576786|NCT02700997|5469416|P1|Overall Study|No CT measurement - pelvic calcification|1
1576787|NCT02700997|5469416|P1|Overall Study|Did not undergo CT imaging|1
1576788|NCT02700984|5469422|P2|Overall Study|Reason not specified|2
1576789|NCT02700984|5469423|P1|Overall Study|Reason not specified|3
1576790|NCT02700984|5469422|P2|Overall Study|Withdrawal by Subject|9
1576791|NCT02700984|5469423|P1|Overall Study|Withdrawal by Subject|8
1576792|NCT02700984|5469422|P2|Overall Study|Physician Decision|1
1576793|NCT02700984|5469423|P1|Overall Study|Physician Decision|0
1576794|NCT02700984|5469422|P2|Overall Study|Lost to Follow-up|1
1576795|NCT02700984|5469423|P1|Overall Study|Lost to Follow-up|2
1576796|NCT02700984|5469422|P2|Overall Study|Death|1
1576797|NCT02700984|5469423|P1|Overall Study|Death|2
1576798|NCT02700815|5469476|P4|Overall Study|Withdrawal by Subject|0
1576799|NCT02700815|5469477|P3|Overall Study|Withdrawal by Subject|1
1576800|NCT02700815|5469478|P2|Overall Study|Withdrawal by Subject|0
1576801|NCT02700815|5469479|P1|Overall Study|Withdrawal by Subject|0
1576802|NCT02700815|5469476|P4|Overall Study|Refusal to continue medication|1
1576803|NCT02700815|5469477|P3|Overall Study|Refusal to continue medication|0
1576804|NCT02700815|5469478|P2|Overall Study|Refusal to continue medication|1
1576805|NCT02700815|5469479|P1|Overall Study|Refusal to continue medication|0
1576806|NCT02700815|5469476|P4|Overall Study|Lost to Follow-up|1
1576807|NCT02700815|5469477|P3|Overall Study|Lost to Follow-up|0
1576808|NCT02700815|5469478|P2|Overall Study|Lost to Follow-up|0
1576809|NCT02700815|5469479|P1|Overall Study|Lost to Follow-up|1
1576810|NCT02700815|5469476|P4|Overall Study|Lack of Efficacy|2
1576811|NCT02700815|5469477|P3|Overall Study|Lack of Efficacy|1
1576812|NCT02700815|5469478|P2|Overall Study|Lack of Efficacy|0
1576813|NCT02700815|5469479|P1|Overall Study|Lack of Efficacy|0
1576814|NCT02700815|5469476|P4|Overall Study|Adverse Event|3
1576815|NCT02700815|5469477|P3|Overall Study|Adverse Event|2
1576816|NCT02700815|5469478|P2|Overall Study|Adverse Event|6
1576817|NCT02700815|5469479|P1|Overall Study|Adverse Event|0
1576818|NCT02699983|5469519|P2|Overall Study|Withdrawal by Subject|0
1576819|NCT02699983|5469520|P1|Overall Study|Withdrawal by Subject|1
1576820|NCT02699892|5469585|P1|Overall Study|Other|36
1576821|NCT02699684|5469590|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
1576822|NCT02699684|5469591|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
1576823|NCT02699593|5469608|P2|Period 2|Torn Contact Lens|0
1576824|NCT02699593|5469609|P1|Period 2|Torn Contact Lens|1
1576825|NCT02699593|5469608|P2|Period 2|Lost Contact Lens|1
1576826|NCT02699593|5469609|P1|Period 2|Lost Contact Lens|0
1576827|NCT02699593|5469608|P2|Period 2|Adverse Event|1
1576828|NCT02699593|5469609|P1|Period 2|Adverse Event|1
1576829|NCT02699593|5469608|P2|Period 1|Adverse Event|1
1576830|NCT02699593|5469609|P1|Period 1|Adverse Event|1
1576831|NCT02699593|5469608|P2|Period 1|Withdrawal by Subject|1
1576832|NCT02699593|5469609|P1|Period 1|Withdrawal by Subject|0
1576833|NCT02699593|5469608|P2|Period 1|Protocol Violation|1
1576834|NCT02699593|5469609|P1|Period 1|Protocol Violation|0
1576835|NCT02699593|5469608|P2|Period 1|Torn Contact Len|3
1576836|NCT02699593|5469609|P1|Period 1|Torn Contact Len|4
1576837|NCT02699593|5469608|P2|Period 1|Unsatisfactory Visual Response|1
1576838|NCT02699593|5469609|P1|Period 1|Unsatisfactory Visual Response|0
1576839|NCT02699099|5469620|P3|Overall Study|Withdrawal by Subject|2
1576840|NCT02699099|5469621|P2|Overall Study|Withdrawal by Subject|1
1576841|NCT02699099|5469622|P1|Overall Study|Withdrawal by Subject|6
1576842|NCT02699099|5469620|P3|Overall Study|Lost to Follow-up|0
1576843|NCT02699099|5469621|P2|Overall Study|Lost to Follow-up|1
1576844|NCT02699099|5469622|P1|Overall Study|Lost to Follow-up|0
1576845|NCT02699099|5469620|P3|Overall Study|Adverse Event|1
1576846|NCT02699099|5469621|P2|Overall Study|Adverse Event|0
1576847|NCT02699099|5469622|P1|Overall Study|Adverse Event|1
1576848|NCT02698436|5469728|P2|Overall Study|Non-compliance with study regimen|0
1576849|NCT02698436|5469729|P1|Overall Study|Non-compliance with study regimen|1
1576850|NCT02698436|5469728|P2|Overall Study|Lost to Follow-up|4
1576851|NCT02698436|5469729|P1|Overall Study|Lost to Follow-up|2
1576852|NCT02698436|5469728|P2|Overall Study|Withdrawal by Subject|3
1576853|NCT02698436|5469729|P1|Overall Study|Withdrawal by Subject|3
1576854|NCT02698436|5469728|P2|Overall Study|Adverse Event|0
1576855|NCT02698436|5469729|P1|Overall Study|Adverse Event|1
1576856|NCT02698423|5469769|P2|Overall Study|Lost to Follow-up|24
1576857|NCT02698423|5469770|P1|Overall Study|Lost to Follow-up|19
1576858|NCT02698371|5469778|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
1576859|NCT02698371|5469778|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
1576860|NCT02698371|5469778|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
1576861|NCT02698371|5469778|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
1576862|NCT02698371|5469778|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
1576863|NCT02698371|5469778|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
1576864|NCT02698371|5469778|P1|All Participants Flow|Lost to Follow-up|3
1576865|NCT02698241|5469900|P1|Overall Study|Death|2
1576866|NCT02698241|5469900|P1|Overall Study|geographic and licensing issue|1
1576867|NCT02698241|5469900|P1|Overall Study|Subject on inodrip not safe to continue|6
1576868|NCT02698241|5469900|P1|Overall Study|Lost to Follow-up|3
1576869|NCT02698241|5469900|P1|Overall Study|Subject underwent system modification|2
1576870|NCT02698241|5469900|P1|Overall Study|Physician Decision|2
1576871|NCT02698241|5469900|P1|Overall Study|Withdrawal by Subject|7
1576872|NCT02698241|5469900|P1|Overall Study|Screening not met|7
1576873|NCT02698241|5469900|P1|Overall Study|Inclusion/exclusion criteria not met|4
1576874|NCT02698189|5469907|P2|Overall Study|Still ongoing in the study|1
1576875|NCT02698189|5469908|P1|Overall Study|Still ongoing in the study|0
1576876|NCT02698189|5469907|P2|Overall Study|Progressive disease|5
1576877|NCT02698189|5469908|P1|Overall Study|Progressive disease|3
1576878|NCT02698176|5469938|P4|Overall Study|Clinical progression|0
1576879|NCT02698176|5469939|P3|Overall Study|Clinical progression|0
1576880|NCT02698176|5469940|P2|Overall Study|Clinical progression|0
1576881|NCT02698176|5469941|P1|Overall Study|Clinical progression|3
1576882|NCT02698176|5469938|P4|Overall Study|Adverse Event|0
1576883|NCT02698176|5469939|P3|Overall Study|Adverse Event|0
1576884|NCT02698176|5469940|P2|Overall Study|Adverse Event|0
1576885|NCT02698176|5469941|P1|Overall Study|Adverse Event|2
1576886|NCT02698176|5469938|P4|Overall Study|Progressive disease|0
1576887|NCT02698176|5469939|P3|Overall Study|Progressive disease|1
1576888|NCT02698176|5469940|P2|Overall Study|Progressive disease|3
1576889|NCT02698176|5469941|P1|Overall Study|Progressive disease|4
1576890|NCT02697773|5469998|P3|Overall Study|Randomized but not treated|0
1576891|NCT02697773|5469999|P2|Overall Study|Randomized but not treated|1
1576892|NCT02697773|5470000|P1|Overall Study|Randomized but not treated|1
1576893|NCT02697773|5469998|P3|Overall Study|Withdrawal by Subject|13
1576894|NCT02697773|5469999|P2|Overall Study|Withdrawal by Subject|13
1576895|NCT02697773|5470000|P1|Overall Study|Withdrawal by Subject|10
1576896|NCT02697773|5469998|P3|Overall Study|Protocol Violation|0
1576897|NCT02697773|5469999|P2|Overall Study|Protocol Violation|1
1576898|NCT02697773|5470000|P1|Overall Study|Protocol Violation|1
1576899|NCT02697773|5469998|P3|Overall Study|Other|10
1576900|NCT02697773|5469999|P2|Overall Study|Other|11
1576901|NCT02697773|5470000|P1|Overall Study|Other|15
1576902|NCT02697773|5469998|P3|Overall Study|Lost to Follow-up|7
1576903|NCT02697773|5469999|P2|Overall Study|Lost to Follow-up|5
1576904|NCT02697773|5470000|P1|Overall Study|Lost to Follow-up|5
1576905|NCT02697773|5469998|P3|Overall Study|Lack of Efficacy|6
1576906|NCT02697773|5469999|P2|Overall Study|Lack of Efficacy|6
1576907|NCT02697773|5470000|P1|Overall Study|Lack of Efficacy|4
1576908|NCT02697773|5469998|P3|Overall Study|Death|2
1576909|NCT02697773|5469999|P2|Overall Study|Death|0
1576910|NCT02697773|5470000|P1|Overall Study|Death|0
1576911|NCT02697773|5469998|P3|Overall Study|Adverse Event|2
1576912|NCT02697773|5469999|P2|Overall Study|Adverse Event|1
1576913|NCT02697773|5470000|P1|Overall Study|Adverse Event|2
1576914|NCT02697435|5470181|P2|Overall Study|Physician Decision|4
1576915|NCT02697435|5470182|P1|Overall Study|Physician Decision|0
1576916|NCT02697435|5470181|P2|Overall Study|Withdrawal by Subject|0
1576917|NCT02697435|5470182|P1|Overall Study|Withdrawal by Subject|1
1576918|NCT02696850|5470236|P2|Overall Study|Lost to Follow-up|5
1576919|NCT02696850|5470237|P1|Overall Study|Lost to Follow-up|8
1576920|NCT02696850|5470236|P2|Overall Study|Withdrawal by Subject|3
1576921|NCT02696850|5470237|P1|Overall Study|Withdrawal by Subject|3
1576922|NCT02696798|5470250|P3|Post-treatment Follow-up Period|No progressive improvement|0
1576923|NCT02696798|5470251|P2|Post-treatment Follow-up Period|No progressive improvement|1
1576924|NCT02696798|5470252|P1|Post-treatment Follow-up Period|No progressive improvement|0
1576925|NCT02696798|5470250|P3|Post-treatment Follow-up Period|Physician Decision|0
1576926|NCT02696798|5470251|P2|Post-treatment Follow-up Period|Physician Decision|2
1576927|NCT02696798|5470252|P1|Post-treatment Follow-up Period|Physician Decision|0
1576928|NCT02696798|5470250|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
1576929|NCT02696798|5470251|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
1576930|NCT02696798|5470252|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
1576931|NCT02696798|5470250|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
1576932|NCT02696798|5470251|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
1576933|NCT02696798|5470252|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
1576934|NCT02696798|5470250|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
1576935|NCT02696798|5470251|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
1576936|NCT02696798|5470252|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
1576937|NCT02696798|5470250|P3|Post-treatment Follow-up Period|Adverse Event|6
1576938|NCT02696798|5470251|P2|Post-treatment Follow-up Period|Adverse Event|12
1576939|NCT02696798|5470252|P1|Post-treatment Follow-up Period|Adverse Event|2
1576940|NCT02696798|5470250|P3|Extended Treatment Period|Withdrawal by Subject|3
1576941|NCT02696798|5470251|P2|Extended Treatment Period|Withdrawal by Subject|2
1576942|NCT02696798|5470252|P1|Extended Treatment Period|Withdrawal by Subject|3
1576943|NCT02696798|5470250|P3|Extended Treatment Period|Physician Decision|0
1576944|NCT02696798|5470251|P2|Extended Treatment Period|Physician Decision|1
1576945|NCT02696798|5470252|P1|Extended Treatment Period|Physician Decision|0
1576946|NCT02696798|5470250|P3|Extended Treatment Period|Lost to Follow-up|0
1576947|NCT02696798|5470251|P2|Extended Treatment Period|Lost to Follow-up|0
1576948|NCT02696798|5470252|P1|Extended Treatment Period|Lost to Follow-up|1
1576949|NCT02696798|5470250|P3|Extended Treatment Period|Lack of Efficacy|2
1576950|NCT02696798|5470251|P2|Extended Treatment Period|Lack of Efficacy|2
1576951|NCT02696798|5470252|P1|Extended Treatment Period|Lack of Efficacy|7
1576952|NCT02696798|5470250|P3|Extended Treatment Period|Adverse Event|5
1576953|NCT02696798|5470251|P2|Extended Treatment Period|Adverse Event|4
1576954|NCT02696798|5470252|P1|Extended Treatment Period|Adverse Event|1
1576955|NCT02696798|5470250|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
1576956|NCT02696798|5470251|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
1576957|NCT02696798|5470252|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
1576958|NCT02696798|5470250|P3|Blinded Treatment Dosing Period|Physician Decision|0
1576959|NCT02696798|5470251|P2|Blinded Treatment Dosing Period|Physician Decision|1
1576960|NCT02696798|5470252|P1|Blinded Treatment Dosing Period|Physician Decision|0
1576961|NCT02696798|5470250|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
1576962|NCT02696798|5470251|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
1576963|NCT02696798|5470252|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
1576964|NCT02696798|5470250|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
1576965|NCT02696798|5470251|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
1576966|NCT02696798|5470252|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
1576967|NCT02696798|5470250|P3|Blinded Treatment Dosing Period|Death|1
1576968|NCT02696798|5470251|P2|Blinded Treatment Dosing Period|Death|0
1576969|NCT02696798|5470252|P1|Blinded Treatment Dosing Period|Death|0
1576970|NCT02696798|5470250|P3|Blinded Treatment Dosing Period|Adverse Event|2
1576971|NCT02696798|5470251|P2|Blinded Treatment Dosing Period|Adverse Event|9
1576972|NCT02696798|5470252|P1|Blinded Treatment Dosing Period|Adverse Event|2
1576973|NCT02696785|5470349|P4|Follow-up Period|Withdrawal by Subject|4
1576974|NCT02696785|5470350|P3|Follow-up Period|Withdrawal by Subject|5
1576975|NCT02696785|5470351|P2|Follow-up Period|Withdrawal by Subject|0
1576976|NCT02696785|5470352|P1|Follow-up Period|Withdrawal by Subject|1
1576977|NCT02696785|5470349|P4|Follow-up Period|Lack of Efficacy|1
1576978|NCT02696785|5470350|P3|Follow-up Period|Lack of Efficacy|0
1576979|NCT02696785|5470351|P2|Follow-up Period|Lack of Efficacy|0
1576980|NCT02696785|5470352|P1|Follow-up Period|Lack of Efficacy|0
1576981|NCT02696785|5470349|P4|Follow-up Period|Lost to Follow-up|1
1576982|NCT02696785|5470350|P3|Follow-up Period|Lost to Follow-up|0
1576983|NCT02696785|5470351|P2|Follow-up Period|Lost to Follow-up|0
1576984|NCT02696785|5470352|P1|Follow-up Period|Lost to Follow-up|0
1576985|NCT02696785|5470349|P4|Follow-up Period|Adverse Event|2
1576986|NCT02696785|5470350|P3|Follow-up Period|Adverse Event|8
1576987|NCT02696785|5470351|P2|Follow-up Period|Adverse Event|0
1576988|NCT02696785|5470352|P1|Follow-up Period|Adverse Event|0
1576989|NCT02696785|5470349|P4|Extended Treatment Period|Withdrawal by Subject|5
1576990|NCT02696785|5470350|P3|Extended Treatment Period|Withdrawal by Subject|3
1576991|NCT02696785|5470351|P2|Extended Treatment Period|Withdrawal by Subject|2
1576992|NCT02696785|5470352|P1|Extended Treatment Period|Withdrawal by Subject|1
1576993|NCT02696785|5470349|P4|Extended Treatment Period|Lack of Efficacy|0
1576994|NCT02696785|5470350|P3|Extended Treatment Period|Lack of Efficacy|0
1576995|NCT02696785|5470351|P2|Extended Treatment Period|Lack of Efficacy|1
1576996|NCT02696785|5470352|P1|Extended Treatment Period|Lack of Efficacy|0
1576997|NCT02696785|5470349|P4|Extended Treatment Period|Adverse Event|1
1576998|NCT02696785|5470350|P3|Extended Treatment Period|Adverse Event|2
1576999|NCT02696785|5470351|P2|Extended Treatment Period|Adverse Event|3
1577000|NCT02696785|5470352|P1|Extended Treatment Period|Adverse Event|2
1577001|NCT02696785|5470349|P4|Washout Period|Lack of Efficacy|0
1577002|NCT02696785|5470350|P3|Washout Period|Lack of Efficacy|0
1577003|NCT02696785|5470351|P2|Washout Period|Lack of Efficacy|1
1577004|NCT02696785|5470352|P1|Washout Period|Lack of Efficacy|0
1577005|NCT02696785|5470349|P4|Washout Period|Withdrawal by Subject|0
1577006|NCT02696785|5470350|P3|Washout Period|Withdrawal by Subject|0
1577007|NCT02696785|5470351|P2|Washout Period|Withdrawal by Subject|1
1577008|NCT02696785|5470352|P1|Washout Period|Withdrawal by Subject|0
1577009|NCT02696785|5470349|P4|Blinded Treatment Period|Screen Failure|0
1577010|NCT02696785|5470350|P3|Blinded Treatment Period|Screen Failure|0
1577011|NCT02696785|5470351|P2|Blinded Treatment Period|Screen Failure|0
1577012|NCT02696785|5470352|P1|Blinded Treatment Period|Screen Failure|1
1577013|NCT02696785|5470349|P4|Blinded Treatment Period|Lack of Efficacy|1
1577014|NCT02696785|5470350|P3|Blinded Treatment Period|Lack of Efficacy|0
1577015|NCT02696785|5470351|P2|Blinded Treatment Period|Lack of Efficacy|0
1577016|NCT02696785|5470352|P1|Blinded Treatment Period|Lack of Efficacy|0
1577017|NCT02696785|5470349|P4|Blinded Treatment Period|Withdrawal by Subject|2
1577018|NCT02696785|5470350|P3|Blinded Treatment Period|Withdrawal by Subject|1
1577019|NCT02696785|5470351|P2|Blinded Treatment Period|Withdrawal by Subject|1
1577020|NCT02696785|5470352|P1|Blinded Treatment Period|Withdrawal by Subject|0
1577021|NCT02696785|5470349|P4|Blinded Treatment Period|Adverse Event|0
1577022|NCT02696785|5470350|P3|Blinded Treatment Period|Adverse Event|3
1577023|NCT02696785|5470351|P2|Blinded Treatment Period|Adverse Event|1
1577024|NCT02696785|5470352|P1|Blinded Treatment Period|Adverse Event|0
1577025|NCT02696434|5470472|P2|Overall Study|Physician Decision|1
1577026|NCT02696434|5470473|P1|Overall Study|Physician Decision|0
1577027|NCT02696434|5470472|P2|Overall Study|Withdrawal by Subject|12
1577028|NCT02696434|5470473|P1|Overall Study|Withdrawal by Subject|14
1577029|NCT02696434|5470472|P2|Overall Study|Lost to Follow-up|4
1577030|NCT02696434|5470473|P1|Overall Study|Lost to Follow-up|5
1577031|NCT02696434|5470472|P2|Overall Study|Adverse Event|1
1577032|NCT02696434|5470473|P1|Overall Study|Adverse Event|3
1577033|NCT02696317|5470491|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
1577034|NCT02696317|5470492|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
1577035|NCT02696317|5470491|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
1577036|NCT02696317|5470492|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
1577037|NCT02696226|5470536|P4|Overall Study|Study terminated - lack of enrollment|0
1577038|NCT02696226|5470537|P3|Overall Study|Study terminated - lack of enrollment|2
1577039|NCT02696226|5470538|P2|Overall Study|Study terminated - lack of enrollment|0
1577040|NCT02696226|5470539|P1|Overall Study|Study terminated - lack of enrollment|1
1577041|NCT02695719|5470569|P2|Overall Study|Voluntary Withdrawal|0
1577042|NCT02695719|5470570|P1|Overall Study|Voluntary Withdrawal|1
1577043|NCT02695719|5470569|P2|Overall Study|Significant Protocol Deviation|1
1577044|NCT02695719|5470570|P1|Overall Study|Significant Protocol Deviation|0
1577045|NCT02695719|5470569|P2|Overall Study|Pretreatment Event/Adverse Event|9
1577046|NCT02695719|5470570|P1|Overall Study|Pretreatment Event/Adverse Event|2
1577047|NCT02695628|5470588|P1|Overall Study|Withdrawal by Subject|1
1577048|NCT02695524|5470596|P2|Overall Study|Death|1
1577049|NCT02695524|5470597|P1|Overall Study|Death|0
1577050|NCT02695524|5470596|P2|Overall Study|Lost to Follow-up|2
1577051|NCT02695524|5470597|P1|Overall Study|Lost to Follow-up|3
1577052|NCT02695420|5470626|P4|Overall Study|Death|0
1577053|NCT02695420|5470627|P3|Overall Study|Death|0
1577054|NCT02695420|5470628|P2|Overall Study|Death|1
1577055|NCT02695420|5470629|P1|Overall Study|Death|0
1577056|NCT02695329|5470651|P2|Overall Study|Poor X-ray quality for measurement|5
1577057|NCT02695329|5470652|P1|Overall Study|Poor X-ray quality for measurement|4
1577058|NCT02695329|5470651|P2|Overall Study|Adverse Event|0
1577059|NCT02695329|5470652|P1|Overall Study|Adverse Event|1
1577060|NCT02694978|5470672|P2|Overall Study|Other-Withdrew prior to dosing|8
1577061|NCT02694978|5470673|P1|Overall Study|Other-Withdrew prior to dosing|9
1577062|NCT02694978|5470672|P2|Overall Study|Other-Personal reasons|3
1577063|NCT02694978|5470673|P1|Overall Study|Other-Personal reasons|3
1577064|NCT02694978|5470672|P2|Overall Study|Other-Protocol noncompliant|1
1577065|NCT02694978|5470673|P1|Overall Study|Other-Protocol noncompliant|2
1577066|NCT02694978|5470672|P2|Overall Study|Other-Unable to be reached|1
1577067|NCT02694978|5470673|P1|Overall Study|Other-Unable to be reached|0
1577068|NCT02694978|5470672|P2|Overall Study|Other-Investigator’s decision|0
1577069|NCT02694978|5470673|P1|Overall Study|Other-Investigator’s decision|1
1577070|NCT02694978|5470672|P2|Overall Study|Other-Decision of Participant|1
1577071|NCT02694978|5470673|P1|Overall Study|Other-Decision of Participant|6
1577072|NCT02694978|5470672|P2|Overall Study|Death|1
1577073|NCT02694978|5470673|P1|Overall Study|Death|4
1577074|NCT02694978|5470672|P2|Overall Study|Lost to Follow-up|17
1577075|NCT02694978|5470673|P1|Overall Study|Lost to Follow-up|14
1577076|NCT02694978|5470672|P2|Overall Study|Withdrawal by Subject|19
1577077|NCT02694978|5470673|P1|Overall Study|Withdrawal by Subject|22
1577078|NCT02694978|5470672|P2|Overall Study|Adverse Event|9
1577079|NCT02694978|5470673|P1|Overall Study|Adverse Event|10
1577080|NCT02694744|5470696|P2|Overall Study|Taking potassium supplement: exclusion 6|1
1577081|NCT02694744|5470697|P1|Overall Study|Taking potassium supplement: exclusion 6|0
1577082|NCT02694744|5470696|P2|Overall Study|Lost to Follow-up|0
1577083|NCT02694744|5470697|P1|Overall Study|Lost to Follow-up|1
1577084|NCT02694744|5470696|P2|Overall Study|Physician Decision|2
1577085|NCT02694744|5470697|P1|Overall Study|Physician Decision|1
1577086|NCT02694744|5470696|P2|Overall Study|Withdrawal by Subject|1
1577087|NCT02694744|5470697|P1|Overall Study|Withdrawal by Subject|2
1577088|NCT02694744|5470696|P2|Overall Study|Adverse Event|1
1577089|NCT02694744|5470697|P1|Overall Study|Adverse Event|2
1577090|NCT02694718|5470705|P1|Overall Study|Withdrawal by Subject|1
1577091|NCT02694718|5470705|P1|Overall Study|Death|1
1577092|NCT02694562|5470723|P1|Overall Study|Physician Decision|1
1577093|NCT02694562|5470723|P1|Overall Study|Screen Failure|2
1577094|NCT02694562|5470723|P1|Overall Study|Lost to Follow-up|3
1577095|NCT02694562|5470723|P1|Overall Study|Protocol Violation|4
1577096|NCT02694562|5470723|P1|Overall Study|Death|8
1577097|NCT02694549|5470732|P1|Overall Study|screen failures|2
1577098|NCT02694536|5470738|P1|Overall Study|Other|22
1577099|NCT02694536|5470738|P1|Overall Study|Death|8
1577100|NCT02694536|5470738|P1|Overall Study|Withdrawal by Subject|8
1577101|NCT02694536|5470738|P1|Overall Study|Study Drug-Related Adverse Event|1
1577102|NCT02694536|5470738|P1|Overall Study|Lost to Follow-up|1
1577103|NCT02694536|5470738|P1|Overall Study|Progressive Disease|40
1577104|NCT02694523|5470749|P7|Part B|Other|1
1577105|NCT02694523|5470750|P6|Part B|Other|0
1577106|NCT02694523|5470751|P5|Part B|Other|0
1577107|NCT02694523|5470752|P4|Part B|Other|0
1577108|NCT02694523|5470753|P3|Part B|Other|1
1577109|NCT02694523|5470754|P2|Part B|Other|0
1577110|NCT02694523|5470755|P1|Part B|Other|0
1577111|NCT02694523|5470749|P7|Part B|Withdrawal by Subject|0
1577112|NCT02694523|5470750|P6|Part B|Withdrawal by Subject|3
1577113|NCT02694523|5470751|P5|Part B|Withdrawal by Subject|1
1577114|NCT02694523|5470752|P4|Part B|Withdrawal by Subject|0
1577115|NCT02694523|5470753|P3|Part B|Withdrawal by Subject|9
1577116|NCT02694523|5470754|P2|Part B|Withdrawal by Subject|0
1577117|NCT02694523|5470755|P1|Part B|Withdrawal by Subject|0
1577118|NCT02694523|5470749|P7|Part B|Lost to Follow-up|1
1577119|NCT02694523|5470750|P6|Part B|Lost to Follow-up|0
1577120|NCT02694523|5470751|P5|Part B|Lost to Follow-up|2
1577121|NCT02694523|5470752|P4|Part B|Lost to Follow-up|3
1577122|NCT02694523|5470753|P3|Part B|Lost to Follow-up|2
1577123|NCT02694523|5470754|P2|Part B|Lost to Follow-up|0
1577124|NCT02694523|5470755|P1|Part B|Lost to Follow-up|0
1577125|NCT02694523|5470749|P7|Part B|Protocol Violation|0
1577126|NCT02694523|5470750|P6|Part B|Protocol Violation|0
1577127|NCT02694523|5470751|P5|Part B|Protocol Violation|0
1577128|NCT02694523|5470752|P4|Part B|Protocol Violation|0
1577129|NCT02694523|5470753|P3|Part B|Protocol Violation|1
1577130|NCT02694523|5470754|P2|Part B|Protocol Violation|0
1577131|NCT02694523|5470755|P1|Part B|Protocol Violation|0
1577132|NCT02694523|5470749|P7|Part B|Adverse Event|0
1577133|NCT02694523|5470750|P6|Part B|Adverse Event|2
1577134|NCT02694523|5470751|P5|Part B|Adverse Event|1
1577135|NCT02694523|5470752|P4|Part B|Adverse Event|1
1577136|NCT02694523|5470753|P3|Part B|Adverse Event|7
1577137|NCT02694523|5470754|P2|Part B|Adverse Event|0
1577138|NCT02694523|5470755|P1|Part B|Adverse Event|0
1577139|NCT02694523|5470749|P7|Part A|Other|0
1577140|NCT02694523|5470750|P6|Part A|Other|0
1577141|NCT02694523|5470751|P5|Part A|Other|0
1577142|NCT02694523|5470752|P4|Part A|Other|0
1577143|NCT02694523|5470753|P3|Part A|Other|0
1577144|NCT02694523|5470754|P2|Part A|Other|1
1577145|NCT02694523|5470755|P1|Part A|Other|1
1577146|NCT02694523|5470749|P7|Part A|Withdrawal by Subject|0
1577147|NCT02694523|5470750|P6|Part A|Withdrawal by Subject|0
1577148|NCT02694523|5470751|P5|Part A|Withdrawal by Subject|0
1577149|NCT02694523|5470752|P4|Part A|Withdrawal by Subject|0
1577150|NCT02694523|5470753|P3|Part A|Withdrawal by Subject|0
1577151|NCT02694523|5470754|P2|Part A|Withdrawal by Subject|1
1577152|NCT02694523|5470755|P1|Part A|Withdrawal by Subject|3
1577153|NCT02694523|5470749|P7|Part A|Lost to Follow-up|0
1577154|NCT02694523|5470750|P6|Part A|Lost to Follow-up|0
1577155|NCT02694523|5470751|P5|Part A|Lost to Follow-up|0
1577156|NCT02694523|5470752|P4|Part A|Lost to Follow-up|0
1577157|NCT02694523|5470753|P3|Part A|Lost to Follow-up|0
1577158|NCT02694523|5470754|P2|Part A|Lost to Follow-up|2
1577159|NCT02694523|5470755|P1|Part A|Lost to Follow-up|1
1577160|NCT02694523|5470749|P7|Part A|Protocol Violation|0
1577161|NCT02694523|5470750|P6|Part A|Protocol Violation|0
1577162|NCT02694523|5470751|P5|Part A|Protocol Violation|0
1577163|NCT02694523|5470752|P4|Part A|Protocol Violation|0
1577164|NCT02694523|5470753|P3|Part A|Protocol Violation|0
1577165|NCT02694523|5470754|P2|Part A|Protocol Violation|0
1577166|NCT02694523|5470755|P1|Part A|Protocol Violation|1
1577167|NCT02694523|5470749|P7|Part A|Adverse Event|0
1577168|NCT02694523|5470750|P6|Part A|Adverse Event|0
1577169|NCT02694523|5470751|P5|Part A|Adverse Event|0
1577170|NCT02694523|5470752|P4|Part A|Adverse Event|0
1577171|NCT02694523|5470753|P3|Part A|Adverse Event|0
1577172|NCT02694523|5470754|P2|Part A|Adverse Event|3
1577173|NCT02694523|5470755|P1|Part A|Adverse Event|7
1577174|NCT02694328|5470781|P2|Overall Study|Abnormal Laboratory Value|3
1577175|NCT02694328|5470782|P1|Overall Study|Abnormal Laboratory Value|0
1577176|NCT02694328|5470781|P2|Overall Study|Protocol Violation|5
1577177|NCT02694328|5470782|P1|Overall Study|Protocol Violation|6
1577178|NCT02694328|5470781|P2|Overall Study|Pregnancy|1
1577179|NCT02694328|5470782|P1|Overall Study|Pregnancy|1
1577180|NCT02694328|5470781|P2|Overall Study|Lack of Efficacy|2
1577181|NCT02694328|5470782|P1|Overall Study|Lack of Efficacy|1
1577182|NCT02694328|5470781|P2|Overall Study|Incarceration|1
1577183|NCT02694328|5470782|P1|Overall Study|Incarceration|1
1577184|NCT02694328|5470781|P2|Overall Study|Noncompliant with study drug|8
1577185|NCT02694328|5470782|P1|Overall Study|Noncompliant with study drug|11
1577186|NCT02694328|5470781|P2|Overall Study|Lost to Follow-up|22
1577187|NCT02694328|5470782|P1|Overall Study|Lost to Follow-up|26
1577188|NCT02694328|5470781|P2|Overall Study|Withdrawal by Subject|23
1577189|NCT02694328|5470782|P1|Overall Study|Withdrawal by Subject|27
1577190|NCT02694328|5470781|P2|Overall Study|Adverse Event|33
1577191|NCT02694328|5470782|P1|Overall Study|Adverse Event|27
1577192|NCT02693171|5470829|P1|Overall Study|Discontinuation of Study by Sponsor|8
1577193|NCT02693171|5470829|P1|Overall Study|Adverse Event|1
1577194|NCT02693002|5470863|P2|Overall Study|Withdrawal by Subject|0
1577195|NCT02693002|5470864|P1|Overall Study|Withdrawal by Subject|1
1577196|NCT02692703|5470885|P1|Overall Study|Other|1
1577197|NCT02692703|5470885|P1|Overall Study|Lost to Follow-up|1
1577198|NCT02692560|5470893|P2|Overall Study|Withdrawal by Subject|6
1577199|NCT02692560|5470894|P1|Overall Study|Withdrawal by Subject|0
1577200|NCT02692482|5470934|P2|Overall Study|Withdrawal by Subject|2
1577201|NCT02692482|5470935|P1|Overall Study|Withdrawal by Subject|1
1577202|NCT02692482|5470934|P2|Overall Study|Death|2
1577203|NCT02692482|5470935|P1|Overall Study|Death|2
1577204|NCT02692417|5470949|P2|Overall Study|Adverse Event|0
1577205|NCT02692417|5470950|P1|Overall Study|Adverse Event|1
1577206|NCT02692417|5470949|P2|Overall Study|Withdrawal by Subject|1
1577207|NCT02692417|5470950|P1|Overall Study|Withdrawal by Subject|5
1577208|NCT02692235|5470962|P2|Overall Study|Adverse Event|2
1577209|NCT02692235|5470963|P1|Overall Study|Adverse Event|1
1577210|NCT02692235|5470962|P2|Overall Study|Withdrawal by Subject|1
1577211|NCT02692235|5470963|P1|Overall Study|Withdrawal by Subject|2
1577212|NCT02691936|5470973|P2|Overall Study|Withdrawal by Subject|5
1577213|NCT02691936|5470974|P1|Overall Study|Withdrawal by Subject|2
1577214|NCT02691741|5470996|P2|Overall Study|Withdrawal by Subject|4
1577215|NCT02691741|5470997|P1|Overall Study|Withdrawal by Subject|0
1577216|NCT02691741|5470996|P2|Overall Study|Physician Decision|1
1577217|NCT02691741|5470997|P1|Overall Study|Physician Decision|0
1577218|NCT02691741|5470996|P2|Overall Study|Lost to Follow-up|0
1577219|NCT02691741|5470997|P1|Overall Study|Lost to Follow-up|1
1577220|NCT02691741|5470996|P2|Overall Study|Adverse Event|2
1577221|NCT02691741|5470997|P1|Overall Study|Adverse Event|0
1577222|NCT02691702|5471037|P11|Overall Study|Protocol Violation|0
1577223|NCT02691702|5471038|P10|Overall Study|Protocol Violation|2
1577224|NCT02691702|5471039|P9|Overall Study|Protocol Violation|0
1577225|NCT02691702|5471040|P8|Overall Study|Protocol Violation|0
1577226|NCT02691702|5471041|P7|Overall Study|Protocol Violation|0
1577227|NCT02691702|5471042|P6|Overall Study|Protocol Violation|0
1577228|NCT02691702|5471043|P5|Overall Study|Protocol Violation|0
1577229|NCT02691702|5471044|P4|Overall Study|Protocol Violation|0
1577230|NCT02691702|5471045|P3|Overall Study|Protocol Violation|0
1577231|NCT02691702|5471046|P2|Overall Study|Protocol Violation|0
1577232|NCT02691702|5471047|P1|Overall Study|Protocol Violation|0
1577233|NCT02691702|5471037|P11|Overall Study|Other|0
1577234|NCT02691702|5471038|P10|Overall Study|Other|0
1577235|NCT02691702|5471039|P9|Overall Study|Other|1
1577236|NCT02691702|5471040|P8|Overall Study|Other|0
1577237|NCT02691702|5471041|P7|Overall Study|Other|1
1577238|NCT02691702|5471042|P6|Overall Study|Other|0
1577239|NCT02691702|5471043|P5|Overall Study|Other|0
1577240|NCT02691702|5471044|P4|Overall Study|Other|0
1577241|NCT02691702|5471045|P3|Overall Study|Other|0
1577242|NCT02691702|5471046|P2|Overall Study|Other|0
1577243|NCT02691702|5471047|P1|Overall Study|Other|0
1577244|NCT02691702|5471037|P11|Overall Study|Withdrawal by Subject|0
1577245|NCT02691702|5471038|P10|Overall Study|Withdrawal by Subject|0
1577246|NCT02691702|5471039|P9|Overall Study|Withdrawal by Subject|0
1577247|NCT02691702|5471040|P8|Overall Study|Withdrawal by Subject|0
1577248|NCT02691702|5471041|P7|Overall Study|Withdrawal by Subject|2
1577249|NCT02691702|5471042|P6|Overall Study|Withdrawal by Subject|1
1577250|NCT02691702|5471043|P5|Overall Study|Withdrawal by Subject|0
1577251|NCT02691702|5471044|P4|Overall Study|Withdrawal by Subject|0
1577252|NCT02691702|5471045|P3|Overall Study|Withdrawal by Subject|0
1577253|NCT02691702|5471046|P2|Overall Study|Withdrawal by Subject|1
1577254|NCT02691702|5471047|P1|Overall Study|Withdrawal by Subject|1
1577255|NCT02691702|5471037|P11|Overall Study|Lost to Follow-up|1
1577256|NCT02691702|5471038|P10|Overall Study|Lost to Follow-up|0
1577257|NCT02691702|5471039|P9|Overall Study|Lost to Follow-up|0
1577258|NCT02691702|5471040|P8|Overall Study|Lost to Follow-up|0
1577259|NCT02691702|5471041|P7|Overall Study|Lost to Follow-up|0
1577260|NCT02691702|5471042|P6|Overall Study|Lost to Follow-up|2
1577261|NCT02691702|5471043|P5|Overall Study|Lost to Follow-up|0
1577262|NCT02691702|5471044|P4|Overall Study|Lost to Follow-up|0
1577263|NCT02691702|5471045|P3|Overall Study|Lost to Follow-up|1
1577264|NCT02691702|5471046|P2|Overall Study|Lost to Follow-up|0
1577265|NCT02691702|5471047|P1|Overall Study|Lost to Follow-up|0
1577266|NCT02691702|5471037|P11|Overall Study|Adverse Event|1
1577267|NCT02691702|5471038|P10|Overall Study|Adverse Event|0
1577268|NCT02691702|5471039|P9|Overall Study|Adverse Event|1
1577269|NCT02691702|5471040|P8|Overall Study|Adverse Event|0
1577270|NCT02691702|5471041|P7|Overall Study|Adverse Event|0
1577271|NCT02691702|5471042|P6|Overall Study|Adverse Event|0
1577272|NCT02691702|5471043|P5|Overall Study|Adverse Event|0
1577273|NCT02691702|5471044|P4|Overall Study|Adverse Event|0
1577274|NCT02691702|5471045|P3|Overall Study|Adverse Event|0
1577275|NCT02691702|5471046|P2|Overall Study|Adverse Event|0
1577276|NCT02691702|5471047|P1|Overall Study|Adverse Event|1
1577277|NCT02691572|5471333|P2|Overall Study|Protocol Violation|1
1577278|NCT02691572|5471334|P1|Overall Study|Protocol Violation|0
1577279|NCT02691572|5471333|P2|Overall Study|Withdrawal by Subject|0
1577280|NCT02691572|5471334|P1|Overall Study|Withdrawal by Subject|1
1577281|NCT02691507|5471342|P2|Overall Study|Missed Visit 3|1
1577282|NCT02691507|5471343|P1|Overall Study|Missed Visit 3|0
1577283|NCT02691468|5471475|P2|Overall Study|Failure to advance FOB|0
1577284|NCT02691468|5471476|P1|Overall Study|Failure to advance FOB|2
1577285|NCT02691468|5471475|P2|Overall Study|Lost to Follow-up|1
1577286|NCT02691468|5471476|P1|Overall Study|Lost to Follow-up|2
1577287|NCT02691468|5471475|P2|Overall Study|Bronchial blocker use|1
1577288|NCT02691468|5471476|P1|Overall Study|Bronchial blocker use|2
1577289|NCT02691013|5471537|P2|Overall Study|Withdrawal by Subject|0
1577290|NCT02691013|5471538|P1|Overall Study|Withdrawal by Subject|3
1577291|NCT02690974|5471552|P1|Overall Study|Protocol Deviation|1
1577292|NCT02690974|5471552|P1|Overall Study|Protocol-defined stopping criteria|1
1577293|NCT02690974|5471552|P1|Overall Study|Non-compliance with study treatment|1
1577294|NCT02690974|5471552|P1|Overall Study|Physician Decision|2
1577295|NCT02690974|5471552|P1|Overall Study|Withdrawal of Informed Consent|3
1577296|NCT02690974|5471552|P1|Overall Study|Lost to Follow-up|3
1577297|NCT02690974|5471552|P1|Overall Study|Subject/guardian decision|4
1577298|NCT02690974|5471552|P1|Overall Study|Death|9
1577299|NCT02690974|5471552|P1|Overall Study|Adverse Event|16
1577300|NCT02690727|5471593|P2|Overall Study|Adverse Event|2
1577301|NCT02690727|5471594|P1|Overall Study|Adverse Event|2
1577302|NCT02690701|5471606|P2|Treatment Period 2|Protocol Violation|1
1577303|NCT02690701|5471607|P1|Treatment Period 2|Protocol Violation|0
1577304|NCT02690701|5471606|P2|Treatment Period 2|Withdrawal by Subject|2
1577305|NCT02690701|5471607|P1|Treatment Period 2|Withdrawal by Subject|0
1577306|NCT02690701|5471606|P2|Treatment Period 2|Lost to Follow-up|2
1577307|NCT02690701|5471607|P1|Treatment Period 2|Lost to Follow-up|0
1577308|NCT02690701|5471606|P2|Treatment Period 2|Lack of Efficacy|0
1577309|NCT02690701|5471607|P1|Treatment Period 2|Lack of Efficacy|1
1577310|NCT02690701|5471606|P2|Treatment Period 2|Adverse Event|0
1577311|NCT02690701|5471607|P1|Treatment Period 2|Adverse Event|2
1577312|NCT02690701|5471606|P2|Treatment Period 1|Withdrawal by Subject|1
1577313|NCT02690701|5471607|P1|Treatment Period 1|Withdrawal by Subject|0
1577314|NCT02690701|5471606|P2|Treatment Period 1|Adverse Event|2
1577315|NCT02690701|5471607|P1|Treatment Period 1|Adverse Event|2
1577316|NCT02690194|5471675|P3|Overall Study|Withdrawal by Subject|0
1577317|NCT02690194|5471676|P2|Overall Study|Withdrawal by Subject|4
1577318|NCT02690194|5471677|P1|Overall Study|Withdrawal by Subject|1
1577319|NCT02689804|5471884|P2|Overall Study|Withdrawal by Subject|0
1577320|NCT02689804|5471885|P1|Overall Study|Withdrawal by Subject|2
1577321|NCT02689492|5471911|P1|Overall Study|Other than listed|1
1577322|NCT02689492|5471911|P1|Overall Study|Withdrawal/ Physician’s Decision|1
1577323|NCT02689492|5471911|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
1577324|NCT02689492|5471911|P1|Overall Study|Physician Decision|2
1577325|NCT02689492|5471911|P1|Overall Study|Death|9
1577326|NCT02689492|5471911|P1|Overall Study|Withdrawal by Subject|11
1577327|NCT02689492|5471911|P1|Overall Study|Lost to Follow-up|61
1577328|NCT02689219|5471927|P2|Overall Study|Disease Progression|6
1577329|NCT02689219|5471928|P1|Overall Study|Disease Progression|10
1577330|NCT02689219|5471927|P2|Overall Study|Death|1
1577331|NCT02689219|5471928|P1|Overall Study|Death|1
1577357|NCT02688933|5472162|P2|Overall Study|Lost to Follow-up|5
1577358|NCT02688933|5472163|P1|Overall Study|Lost to Follow-up|1
1577359|NCT02688933|5472162|P2|Overall Study|Other than Specified|25
1577360|NCT02688933|5472163|P1|Overall Study|Other than Specified|14
1577361|NCT02688933|5472162|P2|Overall Study|Hypoglycemia|0
1577362|NCT02688933|5472163|P1|Overall Study|Hypoglycemia|2
1577363|NCT02688933|5472162|P2|Overall Study|Poor compliance to protocol|4
1577364|NCT02688933|5472163|P1|Overall Study|Poor compliance to protocol|7
1577365|NCT02688933|5472162|P2|Overall Study|Lack of Efficacy|2
1577366|NCT02688933|5472163|P1|Overall Study|Lack of Efficacy|2
1577367|NCT02688933|5472162|P2|Overall Study|Adverse Event|1
1577368|NCT02688933|5472163|P1|Overall Study|Adverse Event|3
1577369|NCT02688764|5472224|P2|Overall Study|Withdrawal by parent|0
1577370|NCT02688764|5472225|P1|Overall Study|Withdrawal by parent|3
1577371|NCT02688764|5472224|P2|Overall Study|Subject taken off dialysis|0
1577372|NCT02688764|5472225|P1|Overall Study|Subject taken off dialysis|1
1577373|NCT02688764|5472224|P2|Overall Study|Subject moving out|0
1577374|NCT02688764|5472225|P1|Overall Study|Subject moving out|2
1577375|NCT02688764|5472224|P2|Overall Study|Study drug taste/Withd. parent|0
1577376|NCT02688764|5472225|P1|Overall Study|Study drug taste/Withd. parent|1
1577377|NCT02688764|5472224|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
1577378|NCT02688764|5472225|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
1577379|NCT02688764|5472224|P2|Overall Study|Phosphorus level outside safe range|1
1577380|NCT02688764|5472225|P1|Overall Study|Phosphorus level outside safe range|0
1577381|NCT02688764|5472224|P2|Overall Study|Non-compl./Withd. subject|2
1577382|NCT02688764|5472225|P1|Overall Study|Non-compl./Withd. subject|0
1577383|NCT02688764|5472224|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
1577384|NCT02688764|5472225|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
1577385|NCT02688764|5472224|P2|Overall Study|Non-compl./Physician decision|0
1577386|NCT02688764|5472225|P1|Overall Study|Non-compl./Physician decision|2
1577387|NCT02688764|5472224|P2|Overall Study|Non-compliance with study drug|0
1577388|NCT02688764|5472225|P1|Overall Study|Non-compliance with study drug|4
1577389|NCT02688764|5472224|P2|Overall Study|Lack of efficacy/Physician decision|1
1577390|NCT02688764|5472225|P1|Overall Study|Lack of efficacy/Physician decision|0
1577391|NCT02688764|5472224|P2|Overall Study|Lack of Efficacy|2
1577392|NCT02688764|5472225|P1|Overall Study|Lack of Efficacy|3
1577393|NCT02688764|5472224|P2|Overall Study|Kidney transplant|4
1577394|NCT02688764|5472225|P1|Overall Study|Kidney transplant|10
1577395|NCT02688764|5472224|P2|Overall Study|AE/Withd. subject|0
1577396|NCT02688764|5472225|P1|Overall Study|AE/Withd. subject|1
1577397|NCT02688764|5472224|P2|Overall Study|AE/Withd. parent/Withd. subject|1
1577398|NCT02688764|5472225|P1|Overall Study|AE/Withd. parent/Withd. subject|1
1577399|NCT02688764|5472224|P2|Overall Study|AE/Withd. parent|0
1577400|NCT02688764|5472225|P1|Overall Study|AE/Withd. parent|3
1577401|NCT02688764|5472224|P2|Overall Study|AE/Physician decision|0
1577402|NCT02688764|5472225|P1|Overall Study|AE/Physician decision|1
1577403|NCT02688764|5472224|P2|Overall Study|AE/Other|1
1577404|NCT02688764|5472225|P1|Overall Study|AE/Other|0
1577405|NCT02688764|5472224|P2|Overall Study|AE/Non-compl./Withd. parent|1
1577406|NCT02688764|5472225|P1|Overall Study|AE/Non-compl./Withd. parent|0
1577407|NCT02688764|5472224|P2|Overall Study|AE/Non-compl.|0
1577408|NCT02688764|5472225|P1|Overall Study|AE/Non-compl.|1
1577409|NCT02688764|5472224|P2|Overall Study|AE/Lack of efficacy|0
1577410|NCT02688764|5472225|P1|Overall Study|AE/Lack of efficacy|1
1577411|NCT02688764|5472224|P2|Overall Study|AE/Kidney transplant|0
1577412|NCT02688764|5472225|P1|Overall Study|AE/Kidney transplant|1
1577413|NCT02688764|5472224|P2|Overall Study|Adverse Event|3
1577414|NCT02688764|5472225|P1|Overall Study|Adverse Event|3
1577415|NCT02688387|5472292|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577416|NCT02688387|5472293|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577417|NCT02688387|5472294|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
1577418|NCT02688387|5472295|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577419|NCT02688387|5472296|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577420|NCT02688387|5472297|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577421|NCT02688387|5472298|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577422|NCT02688387|5472299|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577423|NCT02688387|5472300|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577424|NCT02688387|5472301|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577425|NCT02688387|5472302|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577426|NCT02688387|5472303|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577427|NCT02688387|5472304|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577428|NCT02688387|5472305|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577429|NCT02688387|5472306|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577430|NCT02688387|5472307|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577431|NCT02688387|5472308|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577432|NCT02688387|5472309|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577433|NCT02688387|5472310|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577434|NCT02688387|5472311|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577435|NCT02688387|5472312|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577436|NCT02688387|5472313|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
1577437|NCT02688387|5472292|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577438|NCT02688387|5472293|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
1577439|NCT02688387|5472294|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577440|NCT02688387|5472295|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
1577441|NCT02688387|5472296|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577442|NCT02688387|5472297|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577443|NCT02688387|5472298|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577444|NCT02688387|5472299|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577445|NCT02688387|5472300|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577446|NCT02688387|5472301|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577447|NCT02688387|5472302|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577448|NCT02688387|5472303|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577449|NCT02688387|5472304|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577450|NCT02688387|5472305|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577451|NCT02688387|5472306|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577452|NCT02688387|5472307|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577453|NCT02688387|5472308|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577454|NCT02688387|5472309|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577455|NCT02688387|5472310|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577456|NCT02688387|5472311|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577457|NCT02688387|5472312|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577458|NCT02688387|5472313|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
1577459|NCT02688387|5472292|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577460|NCT02688387|5472293|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
1577461|NCT02688387|5472294|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577462|NCT02688387|5472295|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577463|NCT02688387|5472296|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577464|NCT02688387|5472297|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577465|NCT02688387|5472298|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577466|NCT02688387|5472299|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577467|NCT02688387|5472300|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577468|NCT02688387|5472301|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577469|NCT02688387|5472302|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577470|NCT02688387|5472303|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577471|NCT02688387|5472304|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577472|NCT02688387|5472305|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577473|NCT02688387|5472306|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577474|NCT02688387|5472307|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577475|NCT02688387|5472308|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577476|NCT02688387|5472309|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577477|NCT02688387|5472310|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577478|NCT02688387|5472311|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577479|NCT02688387|5472312|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577480|NCT02688387|5472313|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
1577481|NCT02688387|5472292|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577482|NCT02688387|5472293|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577483|NCT02688387|5472294|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577484|NCT02688387|5472295|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577485|NCT02688387|5472296|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577486|NCT02688387|5472297|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577487|NCT02688387|5472298|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577488|NCT02688387|5472299|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
1577489|NCT02688387|5472300|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577490|NCT02688387|5472301|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577491|NCT02688387|5472302|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577492|NCT02688387|5472303|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577493|NCT02688387|5472304|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577494|NCT02688387|5472305|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577495|NCT02688387|5472306|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577496|NCT02688387|5472307|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577497|NCT02688387|5472308|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577498|NCT02688387|5472309|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577499|NCT02688387|5472310|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577500|NCT02688387|5472311|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577501|NCT02688387|5472312|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577502|NCT02688387|5472313|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577503|NCT02688387|5472292|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577504|NCT02688387|5472293|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577505|NCT02688387|5472294|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577506|NCT02688387|5472295|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577507|NCT02688387|5472296|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577508|NCT02688387|5472297|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577509|NCT02688387|5472298|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577510|NCT02688387|5472299|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577511|NCT02688387|5472300|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577512|NCT02688387|5472301|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577513|NCT02688387|5472302|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577514|NCT02688387|5472303|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
1577515|NCT02688387|5472304|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577516|NCT02688387|5472305|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577517|NCT02688387|5472306|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577518|NCT02688387|5472307|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577519|NCT02688387|5472308|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577520|NCT02688387|5472309|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577521|NCT02688387|5472310|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577522|NCT02688387|5472311|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577523|NCT02688387|5472312|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577524|NCT02688387|5472313|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
1577525|NCT02688387|5472292|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577526|NCT02688387|5472293|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577527|NCT02688387|5472294|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577528|NCT02688387|5472295|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577529|NCT02688387|5472296|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577530|NCT02688387|5472297|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577531|NCT02688387|5472298|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577532|NCT02688387|5472299|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577533|NCT02688387|5472300|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577534|NCT02688387|5472301|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577535|NCT02688387|5472302|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577536|NCT02688387|5472303|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577537|NCT02688387|5472304|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577538|NCT02688387|5472305|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577539|NCT02688387|5472306|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577540|NCT02688387|5472307|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577541|NCT02688387|5472308|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577542|NCT02688387|5472309|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577543|NCT02688387|5472310|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577544|NCT02688387|5472311|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577545|NCT02688387|5472312|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
1577546|NCT02688387|5472313|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
1577547|NCT02688387|5472292|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577548|NCT02688387|5472293|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577549|NCT02688387|5472294|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577550|NCT02688387|5472295|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577551|NCT02688387|5472296|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577552|NCT02688387|5472297|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577553|NCT02688387|5472298|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577554|NCT02688387|5472299|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577555|NCT02688387|5472300|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577556|NCT02688387|5472301|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577557|NCT02688387|5472302|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577558|NCT02688387|5472303|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577559|NCT02688387|5472304|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577560|NCT02688387|5472305|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577561|NCT02688387|5472306|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577562|NCT02688387|5472307|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577563|NCT02688387|5472308|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577564|NCT02688387|5472309|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
1577565|NCT02688387|5472310|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577566|NCT02688387|5472311|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
1577567|NCT02688387|5472312|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577568|NCT02688387|5472313|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
1577569|NCT02688387|5472292|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577570|NCT02688387|5472293|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577571|NCT02688387|5472294|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577572|NCT02688387|5472295|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577573|NCT02688387|5472296|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577574|NCT02688387|5472297|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577575|NCT02688387|5472298|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577576|NCT02688387|5472299|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577577|NCT02688387|5472300|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577578|NCT02688387|5472301|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577579|NCT02688387|5472302|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577580|NCT02688387|5472303|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577581|NCT02688387|5472304|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577582|NCT02688387|5472305|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577583|NCT02688387|5472306|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577584|NCT02688387|5472307|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577585|NCT02688387|5472308|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577586|NCT02688387|5472309|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577587|NCT02688387|5472310|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577588|NCT02688387|5472311|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577589|NCT02688387|5472312|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
1577590|NCT02688387|5472313|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
1577591|NCT02688387|5472292|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577592|NCT02688387|5472293|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577593|NCT02688387|5472294|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577594|NCT02688387|5472295|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577595|NCT02688387|5472296|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577596|NCT02688387|5472297|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577597|NCT02688387|5472298|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577598|NCT02688387|5472299|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577599|NCT02688387|5472300|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577600|NCT02688387|5472301|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577601|NCT02688387|5472302|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577602|NCT02688387|5472303|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577603|NCT02688387|5472304|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577604|NCT02688387|5472305|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577605|NCT02688387|5472306|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577606|NCT02688387|5472307|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577607|NCT02688387|5472308|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577608|NCT02688387|5472309|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577609|NCT02688387|5472310|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
1577610|NCT02688387|5472311|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577611|NCT02688387|5472312|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577612|NCT02688387|5472313|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
1577613|NCT02688387|5472292|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577614|NCT02688387|5472293|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577615|NCT02688387|5472294|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577616|NCT02688387|5472295|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577617|NCT02688387|5472296|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577618|NCT02688387|5472297|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577619|NCT02688387|5472298|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577620|NCT02688387|5472299|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577621|NCT02688387|5472300|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577622|NCT02688387|5472301|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577623|NCT02688387|5472302|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577624|NCT02688387|5472303|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577625|NCT02688387|5472304|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577626|NCT02688387|5472305|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577627|NCT02688387|5472306|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577628|NCT02688387|5472307|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577629|NCT02688387|5472308|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577630|NCT02688387|5472309|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577631|NCT02688387|5472310|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577632|NCT02688387|5472311|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
1577633|NCT02688387|5472312|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577634|NCT02688387|5472313|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
1577635|NCT02688153|5472581|P2|Overall Study|Conversion to Commercial Valve|0
1577636|NCT02688153|5472582|P1|Overall Study|Conversion to Commercial Valve|3
1577637|NCT02688153|5472581|P2|Overall Study|Valve Explant|0
1577638|NCT02688153|5472582|P1|Overall Study|Valve Explant|1
1577639|NCT02688153|5472581|P2|Overall Study|Withdrawal by Subject|2
1577640|NCT02688153|5472582|P1|Overall Study|Withdrawal by Subject|4
1577641|NCT02688153|5472581|P2|Overall Study|Death|5
1577642|NCT02688153|5472582|P1|Overall Study|Death|7
1577643|NCT02687919|5472642|P2|Overall Study|Protocol Violation|0
1577644|NCT02687919|5472643|P1|Overall Study|Protocol Violation|2
1577645|NCT02687919|5472642|P2|Overall Study|Withdrawal by Subject|6
1577646|NCT02687919|5472643|P1|Overall Study|Withdrawal by Subject|6
1577647|NCT02687542|5472676|P5|Overall Study|Withdrawal by Subject|4
1577648|NCT02687542|5472677|P4|Overall Study|Withdrawal by Subject|2
1577649|NCT02687542|5472678|P3|Overall Study|Withdrawal by Subject|1
1577650|NCT02687542|5472679|P2|Overall Study|Withdrawal by Subject|1
1577651|NCT02687542|5472680|P1|Overall Study|Withdrawal by Subject|0
1577652|NCT02687542|5472676|P5|Overall Study|Adverse Event|9
1577653|NCT02687542|5472677|P4|Overall Study|Adverse Event|2
1577654|NCT02687542|5472678|P3|Overall Study|Adverse Event|3
1577655|NCT02687542|5472679|P2|Overall Study|Adverse Event|1
1577656|NCT02687542|5472680|P1|Overall Study|Adverse Event|3
1577657|NCT02687542|5472676|P5|Overall Study|Other|5
1577658|NCT02687542|5472677|P4|Overall Study|Other|6
1577659|NCT02687542|5472678|P3|Overall Study|Other|10
1577660|NCT02687542|5472679|P2|Overall Study|Other|9
1577661|NCT02687542|5472680|P1|Overall Study|Other|5
1577662|NCT02687542|5472676|P5|Overall Study|Protocol Violation|0
1577663|NCT02687542|5472677|P4|Overall Study|Protocol Violation|0
1577664|NCT02687542|5472678|P3|Overall Study|Protocol Violation|0
1577665|NCT02687542|5472679|P2|Overall Study|Protocol Violation|1
1577666|NCT02687542|5472680|P1|Overall Study|Protocol Violation|0
1577667|NCT02687542|5472676|P5|Overall Study|Lost to Follow-up|1
1577668|NCT02687542|5472677|P4|Overall Study|Lost to Follow-up|0
1577669|NCT02687542|5472678|P3|Overall Study|Lost to Follow-up|0
1577670|NCT02687542|5472679|P2|Overall Study|Lost to Follow-up|0
1577671|NCT02687542|5472680|P1|Overall Study|Lost to Follow-up|0
1577672|NCT02687542|5472676|P5|Overall Study|Medication error without associated AEs|1
1577673|NCT02687542|5472677|P4|Overall Study|Medication error without associated AEs|0
1577674|NCT02687542|5472678|P3|Overall Study|Medication error without associated AEs|0
1577675|NCT02687542|5472679|P2|Overall Study|Medication error without associated AEs|0
1577676|NCT02687542|5472680|P1|Overall Study|Medication error without associated AEs|0
1577677|NCT02687191|5472809|P6|Overall Study|Withdrawal by Subject|0
1577678|NCT02687191|5472810|P5|Overall Study|Withdrawal by Subject|0
1577679|NCT02687191|5472811|P4|Overall Study|Withdrawal by Subject|1
1577680|NCT02687191|5472812|P3|Overall Study|Withdrawal by Subject|0
1577681|NCT02687191|5472813|P2|Overall Study|Withdrawal by Subject|0
1577682|NCT02687191|5472814|P1|Overall Study|Withdrawal by Subject|0
1577683|NCT02687191|5472809|P6|Overall Study|Death|1
1577684|NCT02687191|5472810|P5|Overall Study|Death|1
1577685|NCT02687191|5472811|P4|Overall Study|Death|0
1577686|NCT02687191|5472812|P3|Overall Study|Death|1
1577687|NCT02687191|5472813|P2|Overall Study|Death|1
1577688|NCT02687191|5472814|P1|Overall Study|Death|0
1577689|NCT02686164|5472966|P1|Overall Study|Clinical progression|1
1577690|NCT02686164|5472966|P1|Overall Study|Withdrawal of consent|1
1577691|NCT02686164|5472966|P1|Overall Study|Adverse Event|1
1577692|NCT02686034|5472978|P2|Open Label Period 3|Lost to Follow-up|1
1577693|NCT02686034|5472979|P1|Open Label Period 3|Lost to Follow-up|0
1577694|NCT02686034|5472978|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
1577695|NCT02686034|5472979|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
1577696|NCT02686034|5472978|P2|Randomized Controlled Period 2|Adverse Event|2
1577697|NCT02686034|5472979|P1|Randomized Controlled Period 2|Adverse Event|0
1577698|NCT02686034|5472978|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
1577699|NCT02686034|5472979|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
1577700|NCT02686034|5472978|P2|Randomized Controlled Period 2|Lost to Follow-up|2
1577701|NCT02686034|5472979|P1|Randomized Controlled Period 2|Lost to Follow-up|1
1577702|NCT02686034|5472978|P2|Run-In Period 1|Lost to Follow-up|4
1577703|NCT02686034|5472979|P1|Run-In Period 1|Lost to Follow-up|4
1577704|NCT02686034|5472978|P2|Run-In Period 1|Withdrawal by Subject|3
1577705|NCT02686034|5472979|P1|Run-In Period 1|Withdrawal by Subject|4
1577706|NCT02686034|5472978|P2|Run-In Period 1|Eligibility|10
1577707|NCT02686034|5472979|P1|Run-In Period 1|Eligibility|12
1577708|NCT02685826|5473018|P3|Overall Study|Full Clinical Hold by FDA|20
1577709|NCT02685826|5473019|P2|Overall Study|Full Clinical Hold by FDA|9
1577710|NCT02685826|5473020|P1|Overall Study|Full Clinical Hold by FDA|19
1577711|NCT02685826|5473018|P3|Overall Study|Withdrawal by Subject|0
1577712|NCT02685826|5473019|P2|Overall Study|Withdrawal by Subject|0
1577713|NCT02685826|5473020|P1|Overall Study|Withdrawal by Subject|2
1577714|NCT02685826|5473018|P3|Overall Study|Progressive Disease|0
1577715|NCT02685826|5473019|P2|Overall Study|Progressive Disease|1
1577716|NCT02685826|5473020|P1|Overall Study|Progressive Disease|2
1577717|NCT02685826|5473018|P3|Overall Study|Adverse Event|1
1577718|NCT02685826|5473019|P2|Overall Study|Adverse Event|0
1577719|NCT02685826|5473020|P1|Overall Study|Adverse Event|2
1577720|NCT02685488|5473105|P2|Overall Study|Withdrawal by Subject|1
1577721|NCT02685488|5473106|P1|Overall Study|Withdrawal by Subject|0
1577722|NCT02685202|5473159|P1|Overall Study|Lost to Follow-up|9
1577723|NCT02685072|5473167|P2|1-Month Follow-Up|Withdrawal by Subject|0
1577724|NCT02685072|5473168|P1|1-Month Follow-Up|Withdrawal by Subject|1
1577725|NCT02685072|5473167|P2|Treatment Period|Withdrawal by Subject|3
1577726|NCT02685072|5473168|P1|Treatment Period|Withdrawal by Subject|1
1577727|NCT02685072|5473167|P2|Treatment Period|Lost to Follow-up|6
1577728|NCT02685072|5473168|P1|Treatment Period|Lost to Follow-up|12
1577729|NCT02685033|5473212|P2|Overall Study|Adverse Event|0
1577730|NCT02685033|5473213|P1|Overall Study|Adverse Event|1
1577731|NCT02685033|5473212|P2|Overall Study|Lost to Follow-up|1
1577732|NCT02685033|5473213|P1|Overall Study|Lost to Follow-up|2
1577733|NCT02685033|5473212|P2|Overall Study|Withdrawal of Consent|1
1577734|NCT02685033|5473213|P1|Overall Study|Withdrawal of Consent|0
1577735|NCT02684981|5473242|P3|Overall Study|Other|17
1577736|NCT02684981|5473243|P2|Overall Study|Other|49
1577737|NCT02684981|5473244|P1|Overall Study|Other|83
1577738|NCT02684981|5473242|P3|Overall Study|Permanently discontinued the treatment|110
1577739|NCT02684981|5473243|P2|Overall Study|Permanently discontinued the treatment|161
1577740|NCT02684981|5473244|P1|Overall Study|Permanently discontinued the treatment|157
1577741|NCT02684370|5473404|P6|Part B|Subject Withdrawal|2
1577742|NCT02684370|5473405|P5|Part B|Subject Withdrawal|1
1577743|NCT02684370|5473406|P4|Part B|Subject Withdrawal|1
1577744|NCT02684370|5473407|P3|Part B|Subject Withdrawal|0
1577745|NCT02684370|5473408|P2|Part B|Subject Withdrawal|0
1577746|NCT02684370|5473409|P1|Part B|Subject Withdrawal|0
1577747|NCT02684370|5473404|P6|Part B|Lost to Follow-up|5
1577748|NCT02684370|5473405|P5|Part B|Lost to Follow-up|2
1577749|NCT02684370|5473406|P4|Part B|Lost to Follow-up|1
1577750|NCT02684370|5473407|P3|Part B|Lost to Follow-up|0
1577751|NCT02684370|5473408|P2|Part B|Lost to Follow-up|0
1577752|NCT02684370|5473409|P1|Part B|Lost to Follow-up|0
1577753|NCT02684370|5473404|P6|Part B|Adverse Event|1
1577754|NCT02684370|5473405|P5|Part B|Adverse Event|2
1577755|NCT02684370|5473406|P4|Part B|Adverse Event|0
1577756|NCT02684370|5473407|P3|Part B|Adverse Event|0
1577757|NCT02684370|5473408|P2|Part B|Adverse Event|0
1577758|NCT02684370|5473409|P1|Part B|Adverse Event|0
1577759|NCT02684370|5473404|P6|Part A|Other|0
1577760|NCT02684370|5473405|P5|Part A|Other|0
1577761|NCT02684370|5473406|P4|Part A|Other|0
1577762|NCT02684370|5473407|P3|Part A|Other|1
1577763|NCT02684370|5473408|P2|Part A|Other|0
1577764|NCT02684370|5473409|P1|Part A|Other|0
1577765|NCT02684370|5473404|P6|Part A|Subject Withdrawal|0
1577766|NCT02684370|5473405|P5|Part A|Subject Withdrawal|0
1577767|NCT02684370|5473406|P4|Part A|Subject Withdrawal|0
1577768|NCT02684370|5473407|P3|Part A|Subject Withdrawal|3
1577769|NCT02684370|5473408|P2|Part A|Subject Withdrawal|0
1577770|NCT02684370|5473409|P1|Part A|Subject Withdrawal|1
1577771|NCT02684370|5473404|P6|Part A|Lost to Follow-up|0
1577772|NCT02684370|5473405|P5|Part A|Lost to Follow-up|0
1577773|NCT02684370|5473406|P4|Part A|Lost to Follow-up|0
1577774|NCT02684370|5473407|P3|Part A|Lost to Follow-up|0
1577775|NCT02684370|5473408|P2|Part A|Lost to Follow-up|1
1577776|NCT02684370|5473409|P1|Part A|Lost to Follow-up|1
1577777|NCT02684370|5473404|P6|Part A|Adverse Event|0
1577778|NCT02684370|5473405|P5|Part A|Adverse Event|0
1577779|NCT02684370|5473406|P4|Part A|Adverse Event|0
1577780|NCT02684370|5473407|P3|Part A|Adverse Event|1
1577781|NCT02684370|5473408|P2|Part A|Adverse Event|0
1577782|NCT02684370|5473409|P1|Part A|Adverse Event|2
1577783|NCT02684357|5473454|P6|Part B|Other|1
1577784|NCT02684357|5473455|P5|Part B|Other|0
1577785|NCT02684357|5473456|P4|Part B|Other|1
1577786|NCT02684357|5473457|P3|Part B|Other|0
1577787|NCT02684357|5473458|P2|Part B|Other|0
1577788|NCT02684357|5473459|P1|Part B|Other|0
1577789|NCT02684357|5473454|P6|Part B|Withdrawal by Subject|4
1577790|NCT02684357|5473455|P5|Part B|Withdrawal by Subject|2
1577791|NCT02684357|5473456|P4|Part B|Withdrawal by Subject|0
1577792|NCT02684357|5473457|P3|Part B|Withdrawal by Subject|0
1577793|NCT02684357|5473458|P2|Part B|Withdrawal by Subject|0
1577794|NCT02684357|5473459|P1|Part B|Withdrawal by Subject|0
1577795|NCT02684357|5473454|P6|Part B|Lost to Follow-up|7
1577796|NCT02684357|5473455|P5|Part B|Lost to Follow-up|1
1577797|NCT02684357|5473456|P4|Part B|Lost to Follow-up|1
1577798|NCT02684357|5473457|P3|Part B|Lost to Follow-up|0
1577799|NCT02684357|5473458|P2|Part B|Lost to Follow-up|0
1577800|NCT02684357|5473459|P1|Part B|Lost to Follow-up|0
1577801|NCT02684357|5473454|P6|Part B|Adverse Event (Other)|1
1577802|NCT02684357|5473455|P5|Part B|Adverse Event (Other)|1
1577803|NCT02684357|5473456|P4|Part B|Adverse Event (Other)|1
1577804|NCT02684357|5473457|P3|Part B|Adverse Event (Other)|0
1577805|NCT02684357|5473458|P2|Part B|Adverse Event (Other)|0
1577806|NCT02684357|5473459|P1|Part B|Adverse Event (Other)|0
1577807|NCT02684357|5473454|P6|Part A|Other|0
1577808|NCT02684357|5473455|P5|Part A|Other|0
1577809|NCT02684357|5473456|P4|Part A|Other|0
1577810|NCT02684357|5473457|P3|Part A|Other|0
1577811|NCT02684357|5473458|P2|Part A|Other|1
1577812|NCT02684357|5473459|P1|Part A|Other|0
1577813|NCT02684357|5473454|P6|Part A|Withdrawal by Subject|0
1577814|NCT02684357|5473455|P5|Part A|Withdrawal by Subject|0
1577815|NCT02684357|5473456|P4|Part A|Withdrawal by Subject|0
1577816|NCT02684357|5473457|P3|Part A|Withdrawal by Subject|0
1577817|NCT02684357|5473458|P2|Part A|Withdrawal by Subject|0
1577818|NCT02684357|5473459|P1|Part A|Withdrawal by Subject|3
1577819|NCT02684357|5473454|P6|Part A|Lost to Follow-up|0
1577820|NCT02684357|5473455|P5|Part A|Lost to Follow-up|0
1577821|NCT02684357|5473456|P4|Part A|Lost to Follow-up|0
1577822|NCT02684357|5473457|P3|Part A|Lost to Follow-up|2
1577823|NCT02684357|5473458|P2|Part A|Lost to Follow-up|2
1577824|NCT02684357|5473459|P1|Part A|Lost to Follow-up|0
1577825|NCT02684357|5473454|P6|Part A|Adverse Event (Worsening of Disease)|0
1577826|NCT02684357|5473455|P5|Part A|Adverse Event (Worsening of Disease)|0
1577827|NCT02684357|5473456|P4|Part A|Adverse Event (Worsening of Disease)|0
1577828|NCT02684357|5473457|P3|Part A|Adverse Event (Worsening of Disease)|0
1577829|NCT02684357|5473458|P2|Part A|Adverse Event (Worsening of Disease)|0
1577830|NCT02684357|5473459|P1|Part A|Adverse Event (Worsening of Disease)|1
1577831|NCT02684344|5473509|P2|Overall Study|Withdrawal by Subject|1
1577832|NCT02684344|5473510|P1|Overall Study|Withdrawal by Subject|0
1577833|NCT02684097|5473545|P2|Overall Study|Lack of Efficacy|6
1577834|NCT02684097|5473546|P1|Overall Study|Lack of Efficacy|13
1577835|NCT02683785|5473573|P2|Overall Study|Adverse Event|2
1577836|NCT02683785|5473574|P1|Overall Study|Adverse Event|0
1577837|NCT02683785|5473573|P2|Overall Study|Lost to Follow-up|1
1577838|NCT02683785|5473574|P1|Overall Study|Lost to Follow-up|0
1577839|NCT02683785|5473573|P2|Overall Study|Withdrawal by Subject|1
1577840|NCT02683785|5473574|P1|Overall Study|Withdrawal by Subject|1
1577841|NCT02683746|5473631|P2|Overall Study|Physician Decision|1
1577842|NCT02683746|5473632|P1|Overall Study|Physician Decision|2
1577843|NCT02683746|5473631|P2|Overall Study|Withdrawal by Subject|5
1577844|NCT02683746|5473632|P1|Overall Study|Withdrawal by Subject|6
1577845|NCT02683746|5473631|P2|Overall Study|Lost to Follow-up|6
1577846|NCT02683746|5473632|P1|Overall Study|Lost to Follow-up|5
1577847|NCT02683746|5473631|P2|Overall Study|Adverse Event|2
1577848|NCT02683746|5473632|P1|Overall Study|Adverse Event|3
1577849|NCT02683668|5473675|P3|Period 2|Withdrawal by Subject|0
1577850|NCT02683668|5473676|P2|Period 2|Withdrawal by Subject|1
1577851|NCT02683668|5473677|P1|Period 2|Withdrawal by Subject|0
1577852|NCT02683109|5473784|P2|Overall Study|Adverse Event|0
1577853|NCT02683109|5473785|P1|Overall Study|Adverse Event|1
1577854|NCT02682823|5473806|P5|Overall Study|Adverse Event|0
1577855|NCT02682823|5473807|P4|Overall Study|Adverse Event|1
1577856|NCT02682823|5473808|P3|Overall Study|Adverse Event|0
1577857|NCT02682823|5473809|P2|Overall Study|Adverse Event|0
1577858|NCT02682823|5473810|P1|Overall Study|Adverse Event|0
1577859|NCT02682823|5473806|P5|Overall Study|Protocol Deviation|0
1577860|NCT02682823|5473807|P4|Overall Study|Protocol Deviation|0
1577861|NCT02682823|5473808|P3|Overall Study|Protocol Deviation|0
1577862|NCT02682823|5473809|P2|Overall Study|Protocol Deviation|1
1577863|NCT02682823|5473810|P1|Overall Study|Protocol Deviation|0
1577864|NCT02682823|5473806|P5|Overall Study|Withdrawal by Subject|1
1577865|NCT02682823|5473807|P4|Overall Study|Withdrawal by Subject|0
1577866|NCT02682823|5473808|P3|Overall Study|Withdrawal by Subject|1
1577867|NCT02682823|5473809|P2|Overall Study|Withdrawal by Subject|0
1577868|NCT02682823|5473810|P1|Overall Study|Withdrawal by Subject|0
1577869|NCT02682602|5473846|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
1577870|NCT02682602|5473847|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
1577871|NCT02682602|5473846|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
1577872|NCT02682602|5473847|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
1577873|NCT02681510|5473982|P1|Overall Study|Lost to Follow-up|9
1577874|NCT02681510|5473982|P1|Overall Study|Withdrawal by Subject|1
1577875|NCT02681094|5474012|P3|2 - Enrolled Participants Set|No treatment given|1
1577876|NCT02681094|5474013|P2|2 - Enrolled Participants Set|No treatment given|1
1577877|NCT02681094|5474014|P1|2 - Enrolled Participants Set|No treatment given|0
1577878|NCT02681094|5474012|P3|2 - Enrolled Participants Set|Other|7
1577879|NCT02681094|5474013|P2|2 - Enrolled Participants Set|Other|6
1577880|NCT02681094|5474014|P1|2 - Enrolled Participants Set|Other|6
1577881|NCT02681094|5474012|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
1577882|NCT02681094|5474013|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
1577883|NCT02681094|5474014|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
1577884|NCT02681094|5474012|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
1577885|NCT02681094|5474013|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
1577886|NCT02681094|5474014|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
1577887|NCT02681094|5474012|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
1577888|NCT02681094|5474013|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
1577889|NCT02681094|5474014|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
1577890|NCT02681094|5474012|P3|2 - Enrolled Participants Set|Adverse Event|1
1577891|NCT02681094|5474013|P2|2 - Enrolled Participants Set|Adverse Event|4
1577892|NCT02681094|5474014|P1|2 - Enrolled Participants Set|Adverse Event|10
1577893|NCT02681094|5474012|P3|2 - Enrolled Participants Set|Participant decision|9
1577894|NCT02681094|5474013|P2|2 - Enrolled Participants Set|Participant decision|10
1577895|NCT02681094|5474014|P1|2 - Enrolled Participants Set|Participant decision|7
1577896|NCT02681094|5474012|P3|1 -Modified Enrolled Participants Set|No treatment given|1
1577897|NCT02681094|5474013|P2|1 -Modified Enrolled Participants Set|No treatment given|1
1577898|NCT02681094|5474014|P1|1 -Modified Enrolled Participants Set|No treatment given|0
1577899|NCT02681094|5474012|P3|1 -Modified Enrolled Participants Set|Other|7
1577900|NCT02681094|5474013|P2|1 -Modified Enrolled Participants Set|Other|6
1577901|NCT02681094|5474014|P1|1 -Modified Enrolled Participants Set|Other|6
1577902|NCT02681094|5474012|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
1577903|NCT02681094|5474013|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
1577904|NCT02681094|5474014|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
1577905|NCT02681094|5474012|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
1577906|NCT02681094|5474013|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
1577907|NCT02681094|5474014|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
1577908|NCT02681094|5474012|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
1577909|NCT02681094|5474013|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
1577910|NCT02681094|5474014|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
1577911|NCT02681094|5474012|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
1577912|NCT02681094|5474013|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
1577913|NCT02681094|5474014|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
1577914|NCT02681094|5474012|P3|1 -Modified Enrolled Participants Set|Participant decision|9
1577915|NCT02681094|5474013|P2|1 -Modified Enrolled Participants Set|Participant decision|10
1577916|NCT02681094|5474014|P1|1 -Modified Enrolled Participants Set|Participant decision|7
1577917|NCT02680847|5474033|P3|Overall Study|Adverse Event|1
1577918|NCT02680847|5474034|P2|Overall Study|Adverse Event|0
1577919|NCT02680847|5474035|P1|Overall Study|Adverse Event|0
1577920|NCT02680847|5474033|P3|Overall Study|Lack of Efficacy|2
1577921|NCT02680847|5474034|P2|Overall Study|Lack of Efficacy|0
1577922|NCT02680847|5474035|P1|Overall Study|Lack of Efficacy|0
1577923|NCT02680847|5474033|P3|Overall Study|Unwilling to participate in study|0
1577924|NCT02680847|5474034|P2|Overall Study|Unwilling to participate in study|1
1577925|NCT02680847|5474035|P1|Overall Study|Unwilling to participate in study|1
1577926|NCT02680847|5474033|P3|Overall Study|No longer met eligibility criteria|0
1577927|NCT02680847|5474034|P2|Overall Study|No longer met eligibility criteria|2
1577928|NCT02680847|5474035|P1|Overall Study|No longer met eligibility criteria|2
1577929|NCT02680847|5474033|P3|Overall Study|Other|0
1577930|NCT02680847|5474034|P2|Overall Study|Other|0
1577931|NCT02680847|5474035|P1|Overall Study|Other|2
1577958|NCT02680665|5474118|P1|Overall Study|No visit after the first prescription|5
1577959|NCT02680639|5474124|P3|Screening Period|Screen Failure|0
1577960|NCT02680639|5474125|P2|Screening Period|Screen Failure|0
1577961|NCT02680639|5474126|P1|Screening Period|Screen Failure|7
1577962|NCT02680041|5474192|P1|Overall Study|Lost to Follow-up|2
1577963|NCT02680041|5474192|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
1577964|NCT02679729|5474226|P9|Overall Study|Participant decision|0
1577965|NCT02679729|5474227|P8|Overall Study|Participant decision|0
1577966|NCT02679729|5474228|P7|Overall Study|Participant decision|1
1577967|NCT02679729|5474229|P6|Overall Study|Participant decision|0
1577968|NCT02679729|5474230|P5|Overall Study|Participant decision|0
1577969|NCT02679729|5474231|P4|Overall Study|Participant decision|0
1577970|NCT02679729|5474232|P3|Overall Study|Participant decision|0
1577971|NCT02679729|5474233|P2|Overall Study|Participant decision|1
1577972|NCT02679729|5474234|P1|Overall Study|Participant decision|0
1577973|NCT02679729|5474226|P9|Overall Study|Lost to Follow-up|0
1577974|NCT02679729|5474227|P8|Overall Study|Lost to Follow-up|0
1577975|NCT02679729|5474228|P7|Overall Study|Lost to Follow-up|0
1577976|NCT02679729|5474229|P6|Overall Study|Lost to Follow-up|0
1577977|NCT02679729|5474230|P5|Overall Study|Lost to Follow-up|1
1577978|NCT02679729|5474231|P4|Overall Study|Lost to Follow-up|0
1577979|NCT02679729|5474232|P3|Overall Study|Lost to Follow-up|0
1577980|NCT02679729|5474233|P2|Overall Study|Lost to Follow-up|1
1577981|NCT02679729|5474234|P1|Overall Study|Lost to Follow-up|0
1577982|NCT02679274|5474352|P2|Overall Study|Withdrawal by Subject|0
1577983|NCT02679274|5474353|P1|Overall Study|Withdrawal by Subject|1
1577984|NCT02678923|5474385|P2|Overall Study|Did Not Return for Study Visits|0
1577985|NCT02678923|5474386|P1|Overall Study|Did Not Return for Study Visits|1
1577986|NCT02678923|5474385|P2|Overall Study|Lost to Follow-up|0
1577987|NCT02678923|5474386|P1|Overall Study|Lost to Follow-up|1
1577988|NCT02678923|5474385|P2|Overall Study|Withdrawal by Subject|2
1577989|NCT02678923|5474386|P1|Overall Study|Withdrawal by Subject|3
1577990|NCT02678923|5474385|P2|Overall Study|Protocol Deviation (Not Dosed)|3
1577991|NCT02678923|5474386|P1|Overall Study|Protocol Deviation (Not Dosed)|1
1577992|NCT02678676|5474402|P2|Overall Study|Unconfirmed for lost to follow-up|67
1577993|NCT02678676|5474403|P1|Overall Study|Unconfirmed for lost to follow-up|85
1577994|NCT02678676|5474402|P2|Overall Study|Lost to Follow-up|151
1577995|NCT02678676|5474403|P1|Overall Study|Lost to Follow-up|171
1577996|NCT02678676|5474402|P2|Overall Study|Withdrawal by Subject|5
1577997|NCT02678676|5474403|P1|Overall Study|Withdrawal by Subject|13
1577998|NCT02678676|5474402|P2|Overall Study|Death|649
1577999|NCT02678676|5474403|P1|Overall Study|Death|619
1578000|NCT02678416|5474434|P1|Part 2|Withdrawal by Subject|1
1578001|NCT02678416|5474434|P1|Part 2|Adverse Event|2
1578002|NCT02678416|5474434|P1|Part 1|Withdrawal by Subject|1
1578003|NCT02678286|5474454|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1578004|NCT02678286|5474455|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
1578005|NCT02678286|5474454|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
1578006|NCT02678286|5474455|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
1578007|NCT02678286|5474454|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
1578008|NCT02678286|5474455|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
1578009|NCT02678286|5474454|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
1578010|NCT02678286|5474455|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
1578011|NCT02678286|5474454|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
1578012|NCT02678286|5474455|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
1578013|NCT02678000|5474507|P5|PART 2|Withdrawal by Subject|0
1578014|NCT02678000|5474508|P4|PART 2|Withdrawal by Subject|0
1578015|NCT02678000|5474509|P3|PART 2|Withdrawal by Subject|1
1578016|NCT02678000|5474510|P2|PART 2|Withdrawal by Subject|0
1578017|NCT02678000|5474511|P1|PART 2|Withdrawal by Subject|0
1578018|NCT02678000|5474507|P5|PART 2|Adverse Event|0
1578019|NCT02678000|5474508|P4|PART 2|Adverse Event|1
1578020|NCT02678000|5474509|P3|PART 2|Adverse Event|2
1578021|NCT02678000|5474510|P2|PART 2|Adverse Event|0
1578022|NCT02678000|5474511|P1|PART 2|Adverse Event|0
1578039|NCT02677844|5474578|P7|Period 3|Withdrawal by Subject|0
1578040|NCT02677844|5474579|P6|Period 3|Withdrawal by Subject|0
1578041|NCT02677844|5474580|P5|Period 3|Withdrawal by Subject|0
1578042|NCT02677844|5474581|P4|Period 3|Withdrawal by Subject|1
1578043|NCT02677844|5474582|P3|Period 3|Withdrawal by Subject|0
1578044|NCT02677844|5474583|P2|Period 3|Withdrawal by Subject|0
1578045|NCT02677844|5474584|P1|Period 3|Withdrawal by Subject|0
1578046|NCT02677220|5474686|P1|Overall Study|Adverse Event|1
1578047|NCT02676895|5474695|P3|Overall Study|Withdrawal by Subject|1
1578048|NCT02676895|5474696|P2|Overall Study|Withdrawal by Subject|0
1578049|NCT02676895|5474697|P1|Overall Study|Withdrawal by Subject|0
1578050|NCT02676895|5474695|P3|Overall Study|Lost to Follow-up|1
1578051|NCT02676895|5474696|P2|Overall Study|Lost to Follow-up|0
1578052|NCT02676895|5474697|P1|Overall Study|Lost to Follow-up|0
1578053|NCT02676895|5474695|P3|Overall Study|Adverse Event|1
1578054|NCT02676895|5474696|P2|Overall Study|Adverse Event|3
1578055|NCT02676895|5474697|P1|Overall Study|Adverse Event|0
1578056|NCT02676895|5474695|P3|Overall Study|Protocol Violation|0
1578057|NCT02676895|5474696|P2|Overall Study|Protocol Violation|0
1578058|NCT02676895|5474697|P1|Overall Study|Protocol Violation|1
1578059|NCT02676895|5474695|P3|Overall Study|Administrative reason|0
1578060|NCT02676895|5474696|P2|Overall Study|Administrative reason|0
1578061|NCT02676895|5474697|P1|Overall Study|Administrative reason|1
1578062|NCT02676882|5474740|P2|Overall Study|Withdrawal by Subject|2
1578063|NCT02676882|5474741|P1|Overall Study|Withdrawal by Subject|1
1578064|NCT02676882|5474740|P2|Overall Study|Lost to Follow-up|0
1578065|NCT02676882|5474741|P1|Overall Study|Lost to Follow-up|1
1578066|NCT02676882|5474740|P2|Overall Study|Adverse Event|0
1578067|NCT02676882|5474741|P1|Overall Study|Adverse Event|1
1578068|NCT02676466|5474760|P8|Overall Study|Withdrawal by Subject|1
1578069|NCT02676466|5474761|P7|Overall Study|Withdrawal by Subject|1
1578070|NCT02676466|5474762|P6|Overall Study|Withdrawal by Subject|1
1578071|NCT02676466|5474763|P5|Overall Study|Withdrawal by Subject|3
1578072|NCT02676466|5474764|P4|Overall Study|Withdrawal by Subject|0
1578073|NCT02676466|5474765|P3|Overall Study|Withdrawal by Subject|1
1578074|NCT02676466|5474766|P2|Overall Study|Withdrawal by Subject|3
1578075|NCT02676466|5474767|P1|Overall Study|Withdrawal by Subject|4
1578076|NCT02676466|5474760|P8|Overall Study|Death|0
1578077|NCT02676466|5474761|P7|Overall Study|Death|0
1578078|NCT02676466|5474762|P6|Overall Study|Death|0
1578079|NCT02676466|5474763|P5|Overall Study|Death|0
1578080|NCT02676466|5474764|P4|Overall Study|Death|0
1578081|NCT02676466|5474765|P3|Overall Study|Death|1
1578082|NCT02676466|5474766|P2|Overall Study|Death|2
1578083|NCT02676466|5474767|P1|Overall Study|Death|0
1578084|NCT02675907|5474848|P2|Study Overall|Lost to Follow-up|2
1578085|NCT02675907|5474849|P1|Study Overall|Lost to Follow-up|0
1578086|NCT02675907|5474848|P2|Study Overall|Withdrawal by Subject|2
1578087|NCT02675907|5474849|P1|Study Overall|Withdrawal by Subject|2
1578088|NCT02675907|5474848|P2|Study Overall|Lack of Efficacy|0
1578089|NCT02675907|5474849|P1|Study Overall|Lack of Efficacy|1
1578090|NCT02675907|5474848|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1578091|NCT02675907|5474849|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
1578092|NCT02675907|5474848|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1578093|NCT02675907|5474849|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
1578094|NCT02675751|5474894|P1|Overall Study|Lost to Follow-up|16
1578095|NCT02675634|5474898|P6|Test Period 2|Adverse Event|1
1578096|NCT02675634|5474899|P5|Test Period 2|Adverse Event|0
1578097|NCT02675634|5474900|P4|Test Period 2|Adverse Event|0
1578098|NCT02675634|5474901|P3|Test Period 2|Adverse Event|0
1578099|NCT02675634|5474902|P2|Test Period 2|Adverse Event|0
1578100|NCT02675634|5474903|P1|Test Period 2|Adverse Event|0
1578101|NCT02675634|5474898|P6|Test Period 2|Lack of Efficacy|0
1578102|NCT02675634|5474899|P5|Test Period 2|Lack of Efficacy|0
1578103|NCT02675634|5474900|P4|Test Period 2|Lack of Efficacy|0
1578104|NCT02675634|5474901|P3|Test Period 2|Lack of Efficacy|0
1578105|NCT02675634|5474902|P2|Test Period 2|Lack of Efficacy|0
1578106|NCT02675634|5474903|P1|Test Period 2|Lack of Efficacy|1
1578107|NCT02675634|5474898|P6|Test Period 1|Device deficiency that did not lead to A|0
1578108|NCT02675634|5474899|P5|Test Period 1|Device deficiency that did not lead to A|0
1578109|NCT02675634|5474900|P4|Test Period 1|Device deficiency that did not lead to A|0
1578110|NCT02675634|5474901|P3|Test Period 1|Device deficiency that did not lead to A|1
1578111|NCT02675634|5474902|P2|Test Period 1|Device deficiency that did not lead to A|0
1578112|NCT02675634|5474903|P1|Test Period 1|Device deficiency that did not lead to A|0
1578113|NCT02675634|5474898|P6|Test Period 1|Adverse Event|0
1578114|NCT02675634|5474899|P5|Test Period 1|Adverse Event|0
1578115|NCT02675634|5474900|P4|Test Period 1|Adverse Event|1
1578116|NCT02675634|5474901|P3|Test Period 1|Adverse Event|0
1578117|NCT02675634|5474902|P2|Test Period 1|Adverse Event|1
1578118|NCT02675634|5474903|P1|Test Period 1|Adverse Event|0
1578119|NCT02675517|5474920|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
1578120|NCT02675517|5474920|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
1578133|NCT02674854|5474978|P3|Overall Study|Subject missed V6.2|0
1578134|NCT02674854|5474979|P2|Overall Study|Subject missed V6.2|0
1578135|NCT02674854|5474980|P1|Overall Study|Subject missed V6.2|1
1578136|NCT02674854|5474978|P3|Overall Study|Death|0
1578137|NCT02674854|5474979|P2|Overall Study|Death|1
1578138|NCT02674854|5474980|P1|Overall Study|Death|0
1578139|NCT02674854|5474978|P3|Overall Study|Protocol Violation|2
1578140|NCT02674854|5474979|P2|Overall Study|Protocol Violation|1
1578141|NCT02674854|5474980|P1|Overall Study|Protocol Violation|1
1578142|NCT02674854|5474978|P3|Overall Study|Disallowed Concurrent Medication|0
1578143|NCT02674854|5474979|P2|Overall Study|Disallowed Concurrent Medication|2
1578144|NCT02674854|5474980|P1|Overall Study|Disallowed Concurrent Medication|2
1578145|NCT02674854|5474978|P3|Overall Study|Lack of Efficacy|0
1578146|NCT02674854|5474979|P2|Overall Study|Lack of Efficacy|3
1578147|NCT02674854|5474980|P1|Overall Study|Lack of Efficacy|0
1578148|NCT02674854|5474978|P3|Overall Study|Lost to Follow-up|2
1578149|NCT02674854|5474979|P2|Overall Study|Lost to Follow-up|0
1578150|NCT02674854|5474980|P1|Overall Study|Lost to Follow-up|1
1578151|NCT02674854|5474978|P3|Overall Study|No-compliant subject|1
1578152|NCT02674854|5474979|P2|Overall Study|No-compliant subject|0
1578153|NCT02674854|5474980|P1|Overall Study|No-compliant subject|1
1578154|NCT02674854|5474978|P3|Overall Study|Withdrawal by Subject|4
1578155|NCT02674854|5474979|P2|Overall Study|Withdrawal by Subject|5
1578156|NCT02674854|5474980|P1|Overall Study|Withdrawal by Subject|1
1578157|NCT02674854|5474978|P3|Overall Study|Adverse Event|5
1578158|NCT02674854|5474979|P2|Overall Study|Adverse Event|15
1578159|NCT02674854|5474980|P1|Overall Study|Adverse Event|17
1578160|NCT02674568|5475013|P1|Overall Study|Other, Not Specified|20
1578161|NCT02674568|5475013|P1|Overall Study|Lost to Follow-up|9
1578162|NCT02674568|5475013|P1|Overall Study|Physician Decision|2
1578163|NCT02674568|5475013|P1|Overall Study|Death|303
1578164|NCT02674568|5475013|P1|Overall Study|Withdrawal by Subject|5
1578165|NCT02674477|5475038|P2|Overall Study|Protocol Violation|2
1578166|NCT02674477|5475039|P1|Overall Study|Protocol Violation|8
1578167|NCT02674334|5475062|P2|Overall Study|NIRS not recording|0
1578168|NCT02674334|5475063|P1|Overall Study|NIRS not recording|1
1578169|NCT02674334|5475062|P2|Overall Study|participant difficulty breathing|0
1578170|NCT02674334|5475063|P1|Overall Study|participant difficulty breathing|1
1578171|NCT02674334|5475062|P2|Overall Study|Lost to Follow-up|3
1578172|NCT02674334|5475063|P1|Overall Study|Lost to Follow-up|5
1578173|NCT02674204|5475073|P2|Overall Study|Adverse Event|0
1578174|NCT02674204|5475074|P1|Overall Study|Adverse Event|1
1578175|NCT02673619|5475146|P4|Overall Study|Lack of Efficacy|0
1578176|NCT02673619|5475147|P3|Overall Study|Lack of Efficacy|1
1578177|NCT02673619|5475148|P2|Overall Study|Lack of Efficacy|0
1578178|NCT02673619|5475149|P1|Overall Study|Lack of Efficacy|0
1578179|NCT02673619|5475146|P4|Overall Study|Adverse Event|0
1578180|NCT02673619|5475147|P3|Overall Study|Adverse Event|1
1578181|NCT02673619|5475148|P2|Overall Study|Adverse Event|0
1578182|NCT02673619|5475149|P1|Overall Study|Adverse Event|0
1578183|NCT02673619|5475146|P4|Overall Study|Withdrawal by Subject|0
1578184|NCT02673619|5475147|P3|Overall Study|Withdrawal by Subject|1
1578185|NCT02673619|5475148|P2|Overall Study|Withdrawal by Subject|1
1578186|NCT02673619|5475149|P1|Overall Study|Withdrawal by Subject|1
1578187|NCT02673619|5475146|P4|Overall Study|Lost to Follow-up|0
1578188|NCT02673619|5475147|P3|Overall Study|Lost to Follow-up|0
1578189|NCT02673619|5475148|P2|Overall Study|Lost to Follow-up|0
1578190|NCT02673619|5475149|P1|Overall Study|Lost to Follow-up|1
1578191|NCT02673489|5475260|P2|Follow Up Period|Unable to return for follow-up|1
1578192|NCT02673489|5475261|P1|Follow Up Period|Unable to return for follow-up|0
1578193|NCT02673489|5475260|P2|Follow Up Period|Unable to return for week 24 follow-up|1
1578194|NCT02673489|5475261|P1|Follow Up Period|Unable to return for week 24 follow-up|0
1578195|NCT02673489|5475260|P2|Treatment Period|Adverse Event|1
1578196|NCT02673489|5475261|P1|Treatment Period|Adverse Event|0
1578197|NCT02673489|5475260|P2|Treatment Period|Participant was incarcerated|1
1578198|NCT02673489|5475261|P1|Treatment Period|Participant was incarcerated|0
1578199|NCT02673489|5475260|P2|Treatment Period|Participant moved to another province|0
1578200|NCT02673489|5475261|P1|Treatment Period|Participant moved to another province|1
1578201|NCT02673489|5475260|P2|Treatment Period|Participant request to discontinue|1
1578202|NCT02673489|5475261|P1|Treatment Period|Participant request to discontinue|1
1578203|NCT02673489|5475260|P2|Treatment Period|Lost to Follow-up|0
1578204|NCT02673489|5475261|P1|Treatment Period|Lost to Follow-up|3
1578205|NCT02672852|5475326|P7|Part B|Other|2
1578206|NCT02672852|5475327|P6|Part B|Other|1
1578207|NCT02672852|5475328|P5|Part B|Other|4
1578208|NCT02672852|5475329|P4|Part B|Other|0
1578209|NCT02672852|5475330|P3|Part B|Other|0
1578210|NCT02672852|5475331|P2|Part B|Other|0
1578211|NCT02672852|5475332|P1|Part B|Other|0
1578212|NCT02672852|5475326|P7|Part B|Withdrawal by Subject|7
1578213|NCT02672852|5475327|P6|Part B|Withdrawal by Subject|0
1578214|NCT02672852|5475328|P5|Part B|Withdrawal by Subject|5
1578215|NCT02672852|5475329|P4|Part B|Withdrawal by Subject|0
1578216|NCT02672852|5475330|P3|Part B|Withdrawal by Subject|0
1578217|NCT02672852|5475331|P2|Part B|Withdrawal by Subject|0
1578218|NCT02672852|5475332|P1|Part B|Withdrawal by Subject|0
1578219|NCT02672852|5475326|P7|Part B|Lost to Follow-up|1
1578220|NCT02672852|5475327|P6|Part B|Lost to Follow-up|4
1578221|NCT02672852|5475328|P5|Part B|Lost to Follow-up|3
1578222|NCT02672852|5475329|P4|Part B|Lost to Follow-up|0
1578223|NCT02672852|5475330|P3|Part B|Lost to Follow-up|0
1578224|NCT02672852|5475331|P2|Part B|Lost to Follow-up|0
1578225|NCT02672852|5475332|P1|Part B|Lost to Follow-up|0
1578226|NCT02672852|5475326|P7|Part B|Other adverse event|1
1578227|NCT02672852|5475327|P6|Part B|Other adverse event|5
1578228|NCT02672852|5475328|P5|Part B|Other adverse event|3
1578229|NCT02672852|5475329|P4|Part B|Other adverse event|0
1578230|NCT02672852|5475330|P3|Part B|Other adverse event|0
1578231|NCT02672852|5475331|P2|Part B|Other adverse event|0
1578232|NCT02672852|5475332|P1|Part B|Other adverse event|0
1578233|NCT02672852|5475326|P7|Part B|Worsening pre-existing condition|0
1578234|NCT02672852|5475327|P6|Part B|Worsening pre-existing condition|1
1578235|NCT02672852|5475328|P5|Part B|Worsening pre-existing condition|0
1578236|NCT02672852|5475329|P4|Part B|Worsening pre-existing condition|0
1578237|NCT02672852|5475330|P3|Part B|Worsening pre-existing condition|0
1578238|NCT02672852|5475331|P2|Part B|Worsening pre-existing condition|0
1578239|NCT02672852|5475332|P1|Part B|Worsening pre-existing condition|0
1578240|NCT02672852|5475326|P7|Part B|Disease worsening|1
1578241|NCT02672852|5475327|P6|Part B|Disease worsening|0
1578242|NCT02672852|5475328|P5|Part B|Disease worsening|1
1578243|NCT02672852|5475329|P4|Part B|Disease worsening|0
1578244|NCT02672852|5475330|P3|Part B|Disease worsening|0
1578245|NCT02672852|5475331|P2|Part B|Disease worsening|0
1578246|NCT02672852|5475332|P1|Part B|Disease worsening|0
1578247|NCT02672852|5475326|P7|Part A2|Not entered in Part B|0
1578248|NCT02672852|5475327|P6|Part A2|Not entered in Part B|0
1578249|NCT02672852|5475328|P5|Part A2|Not entered in Part B|0
1578250|NCT02672852|5475329|P4|Part A2|Not entered in Part B|4
1578251|NCT02672852|5475330|P3|Part A2|Not entered in Part B|0
1578252|NCT02672852|5475331|P2|Part A2|Not entered in Part B|0
1578253|NCT02672852|5475332|P1|Part A2|Not entered in Part B|0
1578254|NCT02672852|5475326|P7|Part A2|Other|0
1578255|NCT02672852|5475327|P6|Part A2|Other|0
1578256|NCT02672852|5475328|P5|Part A2|Other|0
1578257|NCT02672852|5475329|P4|Part A2|Other|0
1578258|NCT02672852|5475330|P3|Part A2|Other|3
1578259|NCT02672852|5475331|P2|Part A2|Other|0
1578260|NCT02672852|5475332|P1|Part A2|Other|0
1578261|NCT02672852|5475326|P7|Part A2|Withdrawal by Subject|0
1578262|NCT02672852|5475327|P6|Part A2|Withdrawal by Subject|0
1578263|NCT02672852|5475328|P5|Part A2|Withdrawal by Subject|0
1578264|NCT02672852|5475329|P4|Part A2|Withdrawal by Subject|0
1578265|NCT02672852|5475330|P3|Part A2|Withdrawal by Subject|1
1578266|NCT02672852|5475331|P2|Part A2|Withdrawal by Subject|0
1578267|NCT02672852|5475332|P1|Part A2|Withdrawal by Subject|0
1578268|NCT02672852|5475326|P7|Part A2|Lost to Follow-up|0
1578269|NCT02672852|5475327|P6|Part A2|Lost to Follow-up|0
1578270|NCT02672852|5475328|P5|Part A2|Lost to Follow-up|0
1578271|NCT02672852|5475329|P4|Part A2|Lost to Follow-up|0
1578272|NCT02672852|5475330|P3|Part A2|Lost to Follow-up|2
1578273|NCT02672852|5475331|P2|Part A2|Lost to Follow-up|0
1578274|NCT02672852|5475332|P1|Part A2|Lost to Follow-up|0
1578275|NCT02672852|5475326|P7|Part A2|Adverse Event|0
1578276|NCT02672852|5475327|P6|Part A2|Adverse Event|0
1578277|NCT02672852|5475328|P5|Part A2|Adverse Event|0
1578278|NCT02672852|5475329|P4|Part A2|Adverse Event|0
1578279|NCT02672852|5475330|P3|Part A2|Adverse Event|3
1578280|NCT02672852|5475331|P2|Part A2|Adverse Event|0
1578281|NCT02672852|5475332|P1|Part A2|Adverse Event|0
1578282|NCT02672852|5475326|P7|Part A2|Disease worsening|0
1578283|NCT02672852|5475327|P6|Part A2|Disease worsening|0
1578284|NCT02672852|5475328|P5|Part A2|Disease worsening|0
1578285|NCT02672852|5475329|P4|Part A2|Disease worsening|0
1578286|NCT02672852|5475330|P3|Part A2|Disease worsening|1
1578287|NCT02672852|5475331|P2|Part A2|Disease worsening|0
1578288|NCT02672852|5475332|P1|Part A2|Disease worsening|0
1578289|NCT02672852|5475326|P7|Part A1|Withdrawal by Subject|0
1578290|NCT02672852|5475327|P6|Part A1|Withdrawal by Subject|0
1578291|NCT02672852|5475328|P5|Part A1|Withdrawal by Subject|0
1578292|NCT02672852|5475329|P4|Part A1|Withdrawal by Subject|0
1578293|NCT02672852|5475330|P3|Part A1|Withdrawal by Subject|0
1578294|NCT02672852|5475331|P2|Part A1|Withdrawal by Subject|1
1578295|NCT02672852|5475332|P1|Part A1|Withdrawal by Subject|1
1578296|NCT02672852|5475326|P7|Part A1|Lost to Follow-up|0
1578297|NCT02672852|5475327|P6|Part A1|Lost to Follow-up|0
1578298|NCT02672852|5475328|P5|Part A1|Lost to Follow-up|0
1578299|NCT02672852|5475329|P4|Part A1|Lost to Follow-up|0
1578300|NCT02672852|5475330|P3|Part A1|Lost to Follow-up|0
1578301|NCT02672852|5475331|P2|Part A1|Lost to Follow-up|2
1578302|NCT02672852|5475332|P1|Part A1|Lost to Follow-up|1
1578303|NCT02672852|5475326|P7|Part A1|Adverse Event|0
1578304|NCT02672852|5475327|P6|Part A1|Adverse Event|0
1578305|NCT02672852|5475328|P5|Part A1|Adverse Event|0
1578306|NCT02672852|5475329|P4|Part A1|Adverse Event|0
1578307|NCT02672852|5475330|P3|Part A1|Adverse Event|0
1578308|NCT02672852|5475331|P2|Part A1|Adverse Event|1
1578309|NCT02672852|5475332|P1|Part A1|Adverse Event|0
1578310|NCT02672852|5475326|P7|Part A1|Disease Worsening|0
1578311|NCT02672852|5475327|P6|Part A1|Disease Worsening|0
1578312|NCT02672852|5475328|P5|Part A1|Disease Worsening|0
1578313|NCT02672852|5475329|P4|Part A1|Disease Worsening|0
1578314|NCT02672852|5475330|P3|Part A1|Disease Worsening|0
1578315|NCT02672852|5475331|P2|Part A1|Disease Worsening|0
1578316|NCT02672852|5475332|P1|Part A1|Disease Worsening|1
1578317|NCT02672553|5475363|P2|Overall Study|Intraoperative screen failure|0
1578318|NCT02672553|5475364|P1|Overall Study|Intraoperative screen failure|2
1578319|NCT02672553|5475363|P2|Overall Study|Withdrawal by Subject|3
1578320|NCT02672553|5475364|P1|Overall Study|Withdrawal by Subject|3
1578321|NCT02672553|5475363|P2|Overall Study|Conversion to Commercial Valve|0
1578322|NCT02672553|5475364|P1|Overall Study|Conversion to Commercial Valve|3
1578323|NCT02672553|5475363|P2|Overall Study|Valve Explant|0
1578324|NCT02672553|5475364|P1|Overall Study|Valve Explant|1
1578325|NCT02672553|5475363|P2|Overall Study|Death|5
1578326|NCT02672553|5475364|P1|Overall Study|Death|3
1578327|NCT02672423|5475436|P10|Period 3|Physician Decision|0
1578328|NCT02672423|5475437|P9|Period 3|Physician Decision|0
1578329|NCT02672423|5475438|P8|Period 3|Physician Decision|0
1578330|NCT02672423|5475439|P7|Period 3|Physician Decision|0
1578331|NCT02672423|5475440|P6|Period 3|Physician Decision|1
1578332|NCT02672423|5475441|P5|Period 3|Physician Decision|0
1578333|NCT02672423|5475442|P4|Period 3|Physician Decision|0
1578334|NCT02672423|5475443|P3|Period 3|Physician Decision|0
1578335|NCT02672423|5475444|P2|Period 3|Physician Decision|0
1578336|NCT02672423|5475445|P1|Period 3|Physician Decision|0
1578337|NCT02672423|5475436|P10|Period 3|Withdrawal by Subject|0
1578338|NCT02672423|5475437|P9|Period 3|Withdrawal by Subject|0
1578339|NCT02672423|5475438|P8|Period 3|Withdrawal by Subject|1
1578340|NCT02672423|5475439|P7|Period 3|Withdrawal by Subject|0
1578341|NCT02672423|5475440|P6|Period 3|Withdrawal by Subject|0
1578342|NCT02672423|5475441|P5|Period 3|Withdrawal by Subject|0
1578343|NCT02672423|5475442|P4|Period 3|Withdrawal by Subject|0
1578344|NCT02672423|5475443|P3|Period 3|Withdrawal by Subject|0
1578345|NCT02672423|5475444|P2|Period 3|Withdrawal by Subject|0
1578346|NCT02672423|5475445|P1|Period 3|Withdrawal by Subject|0
1578347|NCT02672423|5475436|P10|Period 2|Withdrawal by Subject|0
1578348|NCT02672423|5475437|P9|Period 2|Withdrawal by Subject|0
1578349|NCT02672423|5475438|P8|Period 2|Withdrawal by Subject|0
1578350|NCT02672423|5475439|P7|Period 2|Withdrawal by Subject|0
1578351|NCT02672423|5475440|P6|Period 2|Withdrawal by Subject|0
1578352|NCT02672423|5475441|P5|Period 2|Withdrawal by Subject|0
1578353|NCT02672423|5475442|P4|Period 2|Withdrawal by Subject|0
1578354|NCT02672423|5475443|P3|Period 2|Withdrawal by Subject|1
1578355|NCT02672423|5475444|P2|Period 2|Withdrawal by Subject|0
1578356|NCT02672423|5475445|P1|Period 2|Withdrawal by Subject|0
1578357|NCT02672423|5475436|P10|Period 1|Adverse Event|0
1578358|NCT02672423|5475437|P9|Period 1|Adverse Event|0
1578359|NCT02672423|5475438|P8|Period 1|Adverse Event|0
1578360|NCT02672423|5475439|P7|Period 1|Adverse Event|0
1578361|NCT02672423|5475440|P6|Period 1|Adverse Event|0
1578362|NCT02672423|5475441|P5|Period 1|Adverse Event|1
1578363|NCT02672423|5475442|P4|Period 1|Adverse Event|0
1578364|NCT02672423|5475443|P3|Period 1|Adverse Event|0
1578365|NCT02672423|5475444|P2|Period 1|Adverse Event|0
1578366|NCT02672423|5475445|P1|Period 1|Adverse Event|0
1578367|NCT02671760|5475540|P3|Overall Study|Lost to Follow-up|0
1578368|NCT02671760|5475541|P2|Overall Study|Lost to Follow-up|1
1578369|NCT02671760|5475542|P1|Overall Study|Lost to Follow-up|0
1578370|NCT02671500|5475568|P1|Overall Study|Lost to Follow-up|2
1578371|NCT02671500|5475568|P1|Overall Study|Lack of Efficacy|12
1578372|NCT02671461|5475583|P3|Follow-up|Administrative Reason by Sponsor|0
1578373|NCT02671461|5475584|P2|Follow-up|Administrative Reason by Sponsor|1
1578374|NCT02671461|5475585|P1|Follow-up|Administrative Reason by Sponsor|0
1578375|NCT02671461|5475583|P3|Follow-up|Lost to Follow-up|1
1578376|NCT02671461|5475584|P2|Follow-up|Lost to Follow-up|0
1578377|NCT02671461|5475585|P1|Follow-up|Lost to Follow-up|0
1578378|NCT02671461|5475583|P3|Follow-up|Withdrawal by Subject|0
1578379|NCT02671461|5475584|P2|Follow-up|Withdrawal by Subject|0
1578380|NCT02671461|5475585|P1|Follow-up|Withdrawal by Subject|1
1578381|NCT02671461|5475583|P3|Treatment|Randomized, not treated|0
1578382|NCT02671461|5475584|P2|Treatment|Randomized, not treated|0
1578383|NCT02671461|5475585|P1|Treatment|Randomized, not treated|1
1578384|NCT02671461|5475583|P3|Treatment|Administrative Reason by Sponsor|4
1578385|NCT02671461|5475584|P2|Treatment|Administrative Reason by Sponsor|3
1578386|NCT02671461|5475585|P1|Treatment|Administrative Reason by Sponsor|1
1578387|NCT02671461|5475583|P3|Treatment|Adverse Event|1
1578388|NCT02671461|5475584|P2|Treatment|Adverse Event|0
1578389|NCT02671461|5475585|P1|Treatment|Adverse Event|0
1578390|NCT02671266|5475610|P2|Overall Study|Withdrawal by Subject|1
1578391|NCT02671266|5475611|P1|Overall Study|Withdrawal by Subject|1
1578392|NCT02670928|5475634|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
1578393|NCT02670928|5475635|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
1578394|NCT02670928|5475634|P2|Overall Study|Lost to Follow-up|0
1578395|NCT02670928|5475635|P1|Overall Study|Lost to Follow-up|1
1578396|NCT02670928|5475634|P2|Overall Study|Withdrawal by Subject|0
1578397|NCT02670928|5475635|P1|Overall Study|Withdrawal by Subject|4
1578398|NCT02670928|5475634|P2|Overall Study|Adverse Event|1
1578399|NCT02670928|5475635|P1|Overall Study|Adverse Event|3
1578400|NCT02670915|5475662|P3|Overall Study|Unclassified|0
1578401|NCT02670915|5475663|P2|Overall Study|Unclassified|3
1578402|NCT02670915|5475664|P1|Overall Study|Unclassified|0
1578403|NCT02670915|5475662|P3|Overall Study|Withdrawal by parent/guardian|1
1578404|NCT02670915|5475663|P2|Overall Study|Withdrawal by parent/guardian|4
1578405|NCT02670915|5475664|P1|Overall Study|Withdrawal by parent/guardian|4
1578406|NCT02670915|5475662|P3|Overall Study|Withdrawal by Subject|4
1578407|NCT02670915|5475663|P2|Overall Study|Withdrawal by Subject|1
1578408|NCT02670915|5475664|P1|Overall Study|Withdrawal by Subject|0
1578409|NCT02670551|5475948|P3|Overall Study|Did Not Receive Treatment|0
1578410|NCT02670551|5475949|P2|Overall Study|Did Not Receive Treatment|3
1578411|NCT02670551|5475950|P1|Overall Study|Did Not Receive Treatment|5
1578412|NCT02670551|5475948|P3|Overall Study|Other Miscellaneous Reasons|3
1578413|NCT02670551|5475949|P2|Overall Study|Other Miscellaneous Reasons|3
1578414|NCT02670551|5475950|P1|Overall Study|Other Miscellaneous Reasons|2
1578415|NCT02670551|5475948|P3|Overall Study|Noncompliance with study drug|2
1578416|NCT02670551|5475949|P2|Overall Study|Noncompliance with study drug|3
1578417|NCT02670551|5475950|P1|Overall Study|Noncompliance with study drug|3
1578418|NCT02670551|5475948|P3|Overall Study|Protocol Violation|0
1578419|NCT02670551|5475949|P2|Overall Study|Protocol Violation|0
1578420|NCT02670551|5475950|P1|Overall Study|Protocol Violation|1
1578421|NCT02670551|5475948|P3|Overall Study|Lost to Follow-up|6
1578422|NCT02670551|5475949|P2|Overall Study|Lost to Follow-up|7
1578423|NCT02670551|5475950|P1|Overall Study|Lost to Follow-up|5
1578424|NCT02670551|5475948|P3|Overall Study|Withdrawal of Consent|8
1578425|NCT02670551|5475949|P2|Overall Study|Withdrawal of Consent|3
1578426|NCT02670551|5475950|P1|Overall Study|Withdrawal of Consent|6
1578427|NCT02670551|5475948|P3|Overall Study|Lack of Efficacy|3
1578428|NCT02670551|5475949|P2|Overall Study|Lack of Efficacy|0
1578429|NCT02670551|5475950|P1|Overall Study|Lack of Efficacy|2
1578430|NCT02670551|5475948|P3|Overall Study|Adverse Event|9
1578431|NCT02670551|5475949|P2|Overall Study|Adverse Event|7
1578432|NCT02670551|5475950|P1|Overall Study|Adverse Event|4
1578433|NCT02670538|5475964|P3|Overall Study|Other Miscellaneous Reasons|2
1578434|NCT02670538|5475965|P2|Overall Study|Other Miscellaneous Reasons|1
1578435|NCT02670538|5475966|P1|Overall Study|Other Miscellaneous Reasons|0
1578436|NCT02670538|5475964|P3|Overall Study|Noncompliance with Study Drug|2
1578437|NCT02670538|5475965|P2|Overall Study|Noncompliance with Study Drug|3
1578438|NCT02670538|5475966|P1|Overall Study|Noncompliance with Study Drug|1
1578439|NCT02670538|5475964|P3|Overall Study|Protocol Violation|1
1578440|NCT02670538|5475965|P2|Overall Study|Protocol Violation|4
1578441|NCT02670538|5475966|P1|Overall Study|Protocol Violation|3
1578442|NCT02670538|5475964|P3|Overall Study|Lack of Efficacy|2
1578443|NCT02670538|5475965|P2|Overall Study|Lack of Efficacy|1
1578444|NCT02670538|5475966|P1|Overall Study|Lack of Efficacy|7
1578445|NCT02670538|5475964|P3|Overall Study|Adverse Event|11
1578446|NCT02670538|5475965|P2|Overall Study|Adverse Event|5
1578447|NCT02670538|5475966|P1|Overall Study|Adverse Event|5
1578448|NCT02670538|5475964|P3|Overall Study|Lost to Follow-up|7
1578449|NCT02670538|5475965|P2|Overall Study|Lost to Follow-up|12
1578450|NCT02670538|5475966|P1|Overall Study|Lost to Follow-up|8
1578451|NCT02670538|5475964|P3|Overall Study|Withdrawal of Consent|5
1578452|NCT02670538|5475965|P2|Overall Study|Withdrawal of Consent|6
1578453|NCT02670538|5475966|P1|Overall Study|Withdrawal of Consent|8
1578454|NCT02670473|5475977|P1|Overall Study|Withdrawal by Subject|1
1578455|NCT02670330|5476036|P2|Overall Study|Lost to Follow-up|2
1578456|NCT02670330|5476037|P1|Overall Study|Lost to Follow-up|3
1578457|NCT02670330|5476036|P2|Overall Study|Withdrawal by Subject|29
1578458|NCT02670330|5476037|P1|Overall Study|Withdrawal by Subject|34
1578459|NCT02670330|5476036|P2|Overall Study|Adverse Event|3
1578460|NCT02670330|5476037|P1|Overall Study|Adverse Event|1
1578461|NCT02670330|5476036|P2|Overall Study|Study Terminated By Sponsor|43
1578462|NCT02670330|5476037|P1|Overall Study|Study Terminated By Sponsor|36
1578463|NCT02670330|5476036|P2|Overall Study|Protocol Deviation|0
1578464|NCT02670330|5476037|P1|Overall Study|Protocol Deviation|1
1578465|NCT02669940|5476049|P2|Overall Study|Insufficient follow-up data|0
1578466|NCT02669940|5476050|P1|Overall Study|Insufficient follow-up data|1
1578467|NCT02669940|5476049|P2|Overall Study|Failure to return|3
1578468|NCT02669940|5476050|P1|Overall Study|Failure to return|0
1578469|NCT02669862|5476152|P3|Overall Study|Protocol Violation|1
1578470|NCT02669862|5476153|P2|Overall Study|Protocol Violation|0
1578471|NCT02669862|5476154|P1|Overall Study|Protocol Violation|0
1578472|NCT02669862|5476152|P3|Overall Study|moved|0
1578473|NCT02669862|5476153|P2|Overall Study|moved|1
1578474|NCT02669862|5476154|P1|Overall Study|moved|0
1578475|NCT02669862|5476152|P3|Overall Study|Withdrawal by Subject|3
1578476|NCT02669862|5476153|P2|Overall Study|Withdrawal by Subject|2
1578477|NCT02669862|5476154|P1|Overall Study|Withdrawal by Subject|2
1578478|NCT02669862|5476152|P3|Overall Study|Lost to Follow-up|1
1578479|NCT02669862|5476153|P2|Overall Study|Lost to Follow-up|2
1578480|NCT02669862|5476154|P1|Overall Study|Lost to Follow-up|0
1578481|NCT02669849|5476170|P3|Overall Study|Other|2
1578482|NCT02669849|5476171|P2|Overall Study|Other|0
1578483|NCT02669849|5476172|P1|Overall Study|Other|0
1578484|NCT02669849|5476170|P3|Overall Study|Study terminated by sponsor|14
1578485|NCT02669849|5476171|P2|Overall Study|Study terminated by sponsor|1
1578486|NCT02669849|5476172|P1|Overall Study|Study terminated by sponsor|16
1578487|NCT02669849|5476170|P3|Overall Study|Death|2
1578488|NCT02669849|5476171|P2|Overall Study|Death|1
1578489|NCT02669849|5476172|P1|Overall Study|Death|1
1578490|NCT02669849|5476170|P3|Overall Study|Lost to Follow-up|3
1578491|NCT02669849|5476171|P2|Overall Study|Lost to Follow-up|0
1578492|NCT02669849|5476172|P1|Overall Study|Lost to Follow-up|1
1578493|NCT02669849|5476170|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
1578494|NCT02669849|5476171|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
1578495|NCT02669849|5476172|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
1578496|NCT02669758|5476215|P1|Overall Study|Protocol Violation|1
1578497|NCT02669758|5476215|P1|Overall Study|Study noncompliance|1
1578498|NCT02669758|5476215|P1|Overall Study|Pregnancy|1
1578499|NCT02669758|5476215|P1|Overall Study|Lack of Efficacy|5
1578500|NCT02669758|5476215|P1|Overall Study|Non-Compliance with Study Drug|8
1578501|NCT02669758|5476215|P1|Overall Study|Adverse Event|16
1578502|NCT02669758|5476215|P1|Overall Study|Lost to Follow-up|19
1578503|NCT02669758|5476215|P1|Overall Study|Withdrawal by Subject|43
1578504|NCT02669667|5476226|P7|Overall Study|Lost to Follow-up|0
1578505|NCT02669667|5476227|P6|Overall Study|Lost to Follow-up|1
1578506|NCT02669667|5476228|P5|Overall Study|Lost to Follow-up|0
1578507|NCT02669667|5476229|P4|Overall Study|Lost to Follow-up|0
1578508|NCT02669667|5476230|P3|Overall Study|Lost to Follow-up|0
1578509|NCT02669667|5476231|P2|Overall Study|Lost to Follow-up|0
1578510|NCT02669667|5476232|P1|Overall Study|Lost to Follow-up|0
1578511|NCT02669433|5476335|P3|Overall Study|Death|1
1578512|NCT02669433|5476336|P2|Overall Study|Death|1
1578513|NCT02669433|5476337|P1|Overall Study|Death|0
1578514|NCT02669433|5476335|P3|Overall Study|Withdrawal by Caregiver|2
1578515|NCT02669433|5476336|P2|Overall Study|Withdrawal by Caregiver|0
1578516|NCT02669433|5476337|P1|Overall Study|Withdrawal by Caregiver|1
1578517|NCT02669433|5476335|P3|Overall Study|Withdrawal by Subject|0
1578518|NCT02669433|5476336|P2|Overall Study|Withdrawal by Subject|1
1578519|NCT02669433|5476337|P1|Overall Study|Withdrawal by Subject|5
1578520|NCT02669433|5476335|P3|Overall Study|Sponsor Termination|1
1578521|NCT02669433|5476336|P2|Overall Study|Sponsor Termination|0
1578522|NCT02669433|5476337|P1|Overall Study|Sponsor Termination|1
1578523|NCT02669433|5476335|P3|Overall Study|Adverse Event|10
1578524|NCT02669433|5476336|P2|Overall Study|Adverse Event|7
1578525|NCT02669433|5476337|P1|Overall Study|Adverse Event|6
1578526|NCT02669433|5476335|P3|Overall Study|Physician Decision|0
1578527|NCT02669433|5476336|P2|Overall Study|Physician Decision|1
1578528|NCT02669433|5476337|P1|Overall Study|Physician Decision|1
1578529|NCT02669433|5476335|P3|Overall Study|Disease Progression|0
1578530|NCT02669433|5476336|P2|Overall Study|Disease Progression|0
1578531|NCT02669433|5476337|P1|Overall Study|Disease Progression|1
1578532|NCT02669433|5476335|P3|Overall Study|Protocol Violation|1
1578533|NCT02669433|5476336|P2|Overall Study|Protocol Violation|4
1578534|NCT02669433|5476337|P1|Overall Study|Protocol Violation|0
1578535|NCT02669407|5476351|P1|Overall Study|Physician Decision|3
1578536|NCT02669264|5476375|P7|Overall Study|Miscellaneous|2
1578537|NCT02669264|5476376|P6|Overall Study|Miscellaneous|0
1578538|NCT02669264|5476377|P5|Overall Study|Miscellaneous|0
1578539|NCT02669264|5476378|P4|Overall Study|Miscellaneous|0
1578540|NCT02669264|5476379|P3|Overall Study|Miscellaneous|0
1578541|NCT02669264|5476380|P2|Overall Study|Miscellaneous|0
1578542|NCT02669264|5476381|P1|Overall Study|Miscellaneous|0
1578543|NCT02669264|5476375|P7|Overall Study|Lost to Follow-up|0
1578544|NCT02669264|5476376|P6|Overall Study|Lost to Follow-up|0
1578545|NCT02669264|5476377|P5|Overall Study|Lost to Follow-up|1
1578546|NCT02669264|5476378|P4|Overall Study|Lost to Follow-up|0
1578547|NCT02669264|5476379|P3|Overall Study|Lost to Follow-up|0
1578548|NCT02669264|5476380|P2|Overall Study|Lost to Follow-up|0
1578549|NCT02669264|5476381|P1|Overall Study|Lost to Follow-up|0
1578550|NCT02669264|5476375|P7|Overall Study|Withdrawal by Subject|0
1578551|NCT02669264|5476376|P6|Overall Study|Withdrawal by Subject|0
1578552|NCT02669264|5476377|P5|Overall Study|Withdrawal by Subject|1
1578553|NCT02669264|5476378|P4|Overall Study|Withdrawal by Subject|0
1578554|NCT02669264|5476379|P3|Overall Study|Withdrawal by Subject|0
1578555|NCT02669264|5476380|P2|Overall Study|Withdrawal by Subject|1
1578556|NCT02669264|5476381|P1|Overall Study|Withdrawal by Subject|0
1578557|NCT02669264|5476375|P7|Overall Study|Death|3
1578558|NCT02669264|5476376|P6|Overall Study|Death|6
1578559|NCT02669264|5476377|P5|Overall Study|Death|3
1578560|NCT02669264|5476378|P4|Overall Study|Death|3
1578561|NCT02669264|5476379|P3|Overall Study|Death|3
1578562|NCT02669264|5476380|P2|Overall Study|Death|5
1578563|NCT02669264|5476381|P1|Overall Study|Death|5
1578564|NCT02669095|5476527|P2|Overall Study|Visit 5 assessments not completed|1
1578565|NCT02669095|5476528|P1|Overall Study|Visit 5 assessments not completed|0
1578566|NCT02669095|5476527|P2|Overall Study|Torn Lens|1
1578567|NCT02669095|5476528|P1|Overall Study|Torn Lens|0
1578568|NCT02669095|5476527|P2|Overall Study|Unsatisfactory Lens Fitting|1
1578569|NCT02669095|5476528|P1|Overall Study|Unsatisfactory Lens Fitting|0
1578570|NCT02669095|5476527|P2|Overall Study|Adverse Event|0
1578571|NCT02669095|5476528|P1|Overall Study|Adverse Event|1
1578572|NCT02669082|5476536|P1|Overall Study|Adverse Event|1
1578573|NCT02669043|5476548|P1|Overall Study|Didn't meet I/E criteria|4
1578574|NCT02668822|5476575|P2|Overall Study|Study Terminated by Sponsor|9
1578575|NCT02668822|5476576|P1|Overall Study|Study Terminated by Sponsor|7
1578576|NCT02668822|5476575|P2|Overall Study|Protocol Violation|0
1578577|NCT02668822|5476576|P1|Overall Study|Protocol Violation|2
1578578|NCT02668783|5476598|P2|Overall Study|Withdrawal by Subject|0
1578579|NCT02668783|5476599|P1|Overall Study|Withdrawal by Subject|1
1578580|NCT02668783|5476598|P2|Overall Study|Subject moved|0
1578581|NCT02668783|5476599|P1|Overall Study|Subject moved|1
1578582|NCT02668783|5476598|P2|Overall Study|Study terminated by sponsor|10
1578583|NCT02668783|5476599|P1|Overall Study|Study terminated by sponsor|9
1578584|NCT02668783|5476598|P2|Overall Study|Protocol Violation|1
1578585|NCT02668783|5476599|P1|Overall Study|Protocol Violation|2
1578586|NCT02668783|5476598|P2|Overall Study|Pregnancy|1
1578587|NCT02668783|5476599|P1|Overall Study|Pregnancy|0
1578588|NCT02668640|5476619|P1|Overall Study|Other, not specified|1
1578589|NCT02668640|5476619|P1|Overall Study|Lost to Follow-up|13
1578590|NCT02668302|5476671|P2|Overall Study|Withdrawal by Subject|0
1578591|NCT02668302|5476672|P1|Overall Study|Withdrawal by Subject|1
1578592|NCT02667912|5476692|P2|Overall Study|Withdrawal by Subject|0
1578593|NCT02667912|5476693|P1|Overall Study|Withdrawal by Subject|1
1578594|NCT02667912|5476692|P2|Overall Study|Withdrawal by Subject|2
1578595|NCT02667912|5476693|P1|Overall Study|Withdrawal by Subject|1
1578596|NCT02667912|5476692|P2|Overall Study|Death|1
1578597|NCT02667912|5476693|P1|Overall Study|Death|3
1578598|NCT02667288|5476791|P1|Overall Study|Withdrawal by Subject|5
1578599|NCT02667288|5476791|P1|Overall Study|Lost to Follow-up|3
1578600|NCT02667288|5476791|P1|Overall Study|Protocol Violation|5
1578601|NCT02667275|5476798|P2|Overall Study|Discontinued early without completing|1
1578602|NCT02667275|5476799|P1|Overall Study|Discontinued early without completing|0
1578603|NCT02667275|5476798|P2|Overall Study|Withdrawal by Subject|5
1578604|NCT02667275|5476799|P1|Overall Study|Withdrawal by Subject|0
1578605|NCT02667275|5476798|P2|Overall Study|Lost to Follow-up|2
1578606|NCT02667275|5476799|P1|Overall Study|Lost to Follow-up|0
1578607|NCT02667275|5476798|P2|Overall Study|Protocol Violation|7
1578608|NCT02667275|5476799|P1|Overall Study|Protocol Violation|11
1578609|NCT02667236|5476809|P2|Overall Study|Withdrawal by Subject|0
1578610|NCT02667236|5476810|P1|Overall Study|Withdrawal by Subject|2
1578611|NCT02667236|5476809|P2|Overall Study|Adverse Event|1
1578612|NCT02667236|5476810|P1|Overall Study|Adverse Event|1
1578613|NCT02666222|5476954|P1|Overall Study|Death|2
1578614|NCT02665689|5476964|P2|Overall Study|Lost to Follow-up|1
1578615|NCT02665689|5476965|P1|Overall Study|Lost to Follow-up|0
1578616|NCT02665689|5476964|P2|Overall Study|Trial termination|1
1578617|NCT02665689|5476965|P1|Overall Study|Trial termination|1
1578618|NCT02665689|5476964|P2|Overall Study|Adverse Event|0
1578619|NCT02665689|5476965|P1|Overall Study|Adverse Event|1
1578620|NCT02665455|5477000|P1|Overall Study|Protocol Violation|1
1578621|NCT02665455|5477000|P1|Overall Study|Adverse Event|1
1578622|NCT02665455|5477000|P1|Overall Study|Lost to Follow-up|1
1578623|NCT02665455|5477000|P1|Overall Study|Withdrawal by Subject|6
1578624|NCT02665286|5477007|P3|Overall Study|Lost to Follow-up|1
1578625|NCT02665286|5477008|P2|Overall Study|Lost to Follow-up|2
1578626|NCT02665286|5477009|P1|Overall Study|Lost to Follow-up|3
1578627|NCT02664415|5477108|P2|Overall Study|Adverse Event|0
1578628|NCT02664415|5477109|P1|Overall Study|Adverse Event|1
1578629|NCT02664272|5477150|P1|Overall Study|Fluoroscopic images not made available|2
1578630|NCT02663817|5477171|P1|Overall Study|Screen failure|2
1578631|NCT02663687|5477191|P5|Overall Study|Other|0
1578632|NCT02663687|5477192|P4|Overall Study|Other|0
1578633|NCT02663687|5477193|P3|Overall Study|Other|1
1578634|NCT02663687|5477194|P2|Overall Study|Other|0
1578635|NCT02663687|5477195|P1|Overall Study|Other|1
1578636|NCT02663687|5477191|P5|Overall Study|Adverse Event|0
1578637|NCT02663687|5477192|P4|Overall Study|Adverse Event|0
1578638|NCT02663687|5477193|P3|Overall Study|Adverse Event|0
1578639|NCT02663687|5477194|P2|Overall Study|Adverse Event|0
1578640|NCT02663687|5477195|P1|Overall Study|Adverse Event|1
1578641|NCT02663674|5477249|P2|Overall Study|Other Event (Health Related)|1
1578642|NCT02663674|5477250|P1|Overall Study|Other Event (Health Related)|0
1578643|NCT02663674|5477249|P2|Overall Study|Physician Decision|1
1578644|NCT02663674|5477250|P1|Overall Study|Physician Decision|1
1578645|NCT02663674|5477249|P2|Overall Study|Withdrawal by Subject|4
1578646|NCT02663674|5477250|P1|Overall Study|Withdrawal by Subject|1
1578647|NCT02663674|5477249|P2|Overall Study|Lost to Follow-up|4
1578648|NCT02663674|5477250|P1|Overall Study|Lost to Follow-up|5
1578649|NCT02663453|5477514|P2|Overall Study|Withdrawal by Subject|0
1578650|NCT02663453|5477515|P1|Overall Study|Withdrawal by Subject|1
1578651|NCT02663453|5477514|P2|Overall Study|Death|4
1578652|NCT02663453|5477515|P1|Overall Study|Death|4
1578653|NCT02663128|5477560|P6|Period 2|Physician Decision|0
1578654|NCT02663128|5477561|P5|Period 2|Physician Decision|1
1578655|NCT02663128|5477562|P4|Period 2|Physician Decision|0
1578656|NCT02663128|5477563|P3|Period 2|Physician Decision|0
1578657|NCT02663128|5477564|P2|Period 2|Physician Decision|0
1578658|NCT02663128|5477565|P1|Period 2|Physician Decision|0
1578659|NCT02662764|5477579|P1|Overall Study|Patient discharged prior to 24 hrs|5
1578660|NCT02662764|5477579|P1|Overall Study|Patient changed treatment|1
1578661|NCT02662764|5477579|P1|Overall Study|Device failure|4
1578662|NCT02662764|5477579|P1|Overall Study|Withdrawal by Subject|5
1578663|NCT02662764|5477579|P1|Overall Study|Protocol Violation|1
1578664|NCT02662764|5477579|P1|Overall Study|Lack of Efficacy|8
1578665|NCT02662764|5477579|P1|Overall Study|Adverse Event|6
1578666|NCT02662569|5477647|P4|Overall Study|Lost to Follow-up|0
1578667|NCT02662569|5477648|P3|Overall Study|Lost to Follow-up|0
1578668|NCT02662569|5477649|P2|Overall Study|Lost to Follow-up|0
1578669|NCT02662569|5477650|P1|Overall Study|Lost to Follow-up|1
1578670|NCT02662569|5477647|P4|Overall Study|Withdrawal by Subject|4
1578671|NCT02662569|5477648|P3|Overall Study|Withdrawal by Subject|6
1578672|NCT02662569|5477649|P2|Overall Study|Withdrawal by Subject|1
1578673|NCT02662569|5477650|P1|Overall Study|Withdrawal by Subject|6
1578674|NCT02662556|5477748|P1|Overall Study|Lack of Efficacy|4
1578675|NCT02662556|5477748|P1|Overall Study|Adverse Event|4
1578676|NCT02661815|5477817|P4|Overall Study|Withdrawal by Subject|0
1578677|NCT02661815|5477818|P3|Overall Study|Withdrawal by Subject|0
1578678|NCT02661815|5477819|P2|Overall Study|Withdrawal by Subject|0
1578679|NCT02661815|5477820|P1|Overall Study|Withdrawal by Subject|1
1578680|NCT02661594|5477842|P4|Overall Study|Protocol Violation|0
1578681|NCT02661594|5477843|P3|Overall Study|Protocol Violation|1
1578682|NCT02661594|5477844|P2|Overall Study|Protocol Violation|0
1578683|NCT02661594|5477845|P1|Overall Study|Protocol Violation|1
1578684|NCT02661061|5477964|P2|Overall Study|Withdrawal by Subject|1
1578685|NCT02661061|5477965|P1|Overall Study|Withdrawal by Subject|1
1578686|NCT02661061|5477964|P2|Overall Study|Lack of Efficacy|1
1578687|NCT02661061|5477965|P1|Overall Study|Lack of Efficacy|1
1578688|NCT02660983|5477975|P2|Open Label Extension Phase (24 Weeks)|Other|1
1578689|NCT02660983|5477976|P1|Open Label Extension Phase (24 Weeks)|Other|0
1578690|NCT02660983|5477975|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
1578691|NCT02660983|5477976|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
1578692|NCT02660983|5477975|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
1578693|NCT02660983|5477976|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
1578694|NCT02660983|5477975|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
1578695|NCT02660983|5477976|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
1578696|NCT02660983|5477975|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
1578697|NCT02660983|5477976|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
1578698|NCT02660983|5477975|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
1578699|NCT02660983|5477976|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
1578700|NCT02660983|5477975|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
1578701|NCT02660983|5477976|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
1578702|NCT02660580|5478052|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
1578703|NCT02660580|5478053|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
1578704|NCT02660580|5478054|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
1578705|NCT02660580|5478055|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
1578706|NCT02660580|5478056|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
1578707|NCT02660580|5478052|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
1578708|NCT02660580|5478053|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
1578709|NCT02660580|5478054|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
1578710|NCT02660580|5478055|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
1578711|NCT02660580|5478056|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
1578712|NCT02660580|5478052|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
1578713|NCT02660580|5478053|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
1578714|NCT02660580|5478054|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
1578715|NCT02660580|5478055|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
1578716|NCT02660580|5478056|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
1578717|NCT02660580|5478052|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
1578718|NCT02660580|5478053|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
1578719|NCT02660580|5478054|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
1578720|NCT02660580|5478055|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
1578721|NCT02660580|5478056|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
1578722|NCT02660580|5478052|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
1578723|NCT02660580|5478053|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
1578724|NCT02660580|5478054|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
1578725|NCT02660580|5478055|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
1578726|NCT02660580|5478056|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
1578727|NCT02660580|5478052|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
1578728|NCT02660580|5478053|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
1578729|NCT02660580|5478054|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
1578730|NCT02660580|5478055|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
1578731|NCT02660580|5478056|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
1578732|NCT02660580|5478052|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
1578733|NCT02660580|5478053|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
1578734|NCT02660580|5478054|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
1578735|NCT02660580|5478055|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
1578736|NCT02660580|5478056|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
1578737|NCT02660580|5478052|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
1578738|NCT02660580|5478053|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
1578739|NCT02660580|5478054|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
1578740|NCT02660580|5478055|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
1578741|NCT02660580|5478056|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
1578742|NCT02660580|5478052|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
1578743|NCT02660580|5478053|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
1578744|NCT02660580|5478054|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
1578745|NCT02660580|5478055|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
1578746|NCT02660580|5478056|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
1578747|NCT02660580|5478052|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1578748|NCT02660580|5478053|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1578749|NCT02660580|5478054|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1578750|NCT02660580|5478055|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
1578751|NCT02660580|5478056|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
1578752|NCT02660580|5478052|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1578753|NCT02660580|5478053|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1578754|NCT02660580|5478054|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1578755|NCT02660580|5478055|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
1578756|NCT02660580|5478056|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
1578757|NCT02660580|5478052|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
1578758|NCT02660580|5478053|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
1578759|NCT02660580|5478054|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
1578760|NCT02660580|5478055|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
1578761|NCT02660580|5478056|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
1578762|NCT02660580|5478052|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
1578763|NCT02660580|5478053|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
1578764|NCT02660580|5478054|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
1578765|NCT02660580|5478055|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
1578766|NCT02660580|5478056|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
1578767|NCT02660242|5478165|P1|Glucagon Injection|Lost to Follow-up|1
1578768|NCT02660242|5478165|P1|Glucose Tabs|Lost to Follow-up|1
1578769|NCT02660229|5478221|P2|Overall Study|Withdrawal by Subject|1
1578770|NCT02660229|5478222|P1|Overall Study|Withdrawal by Subject|0
1578771|NCT02660229|5478221|P2|Overall Study|Adverse Event|0
1578772|NCT02660229|5478222|P1|Overall Study|Adverse Event|2
1578773|NCT02659540|5478255|P2|Overall Study|Progressive disease|6
1578774|NCT02659540|5478256|P1|Overall Study|Progressive disease|2
1578775|NCT02659540|5478255|P2|Overall Study|Death|0
1578776|NCT02659540|5478256|P1|Overall Study|Death|1
1578777|NCT02659540|5478255|P2|Overall Study|Adverse Event|2
1578778|NCT02659540|5478256|P1|Overall Study|Adverse Event|3
1578779|NCT02658149|5478377|P2|Overall Study|Physician Decision|0
1578780|NCT02658149|5478378|P1|Overall Study|Physician Decision|1
1578781|NCT02658084|5478394|P2|Overall Study|Study Termination|0
1578782|NCT02658084|5478395|P1|Overall Study|Study Termination|1
1578783|NCT02658084|5478394|P2|Overall Study|Withdrawal by Subject|0
1578784|NCT02658084|5478395|P1|Overall Study|Withdrawal by Subject|1
1578785|NCT02657889|5478448|P4|Overall Study|Ongoing in Study|19
1578786|NCT02657889|5478449|P3|Overall Study|Ongoing in Study|24
1578787|NCT02657889|5478450|P2|Overall Study|Ongoing in Study|5
1578788|NCT02657889|5478451|P1|Overall Study|Ongoing in Study|0
1578789|NCT02657889|5478448|P4|Overall Study|Withdrawal by Subject|0
1578790|NCT02657889|5478449|P3|Overall Study|Withdrawal by Subject|8
1578791|NCT02657889|5478450|P2|Overall Study|Withdrawal by Subject|0
1578792|NCT02657889|5478451|P1|Overall Study|Withdrawal by Subject|0
1578793|NCT02657889|5478448|P4|Overall Study|Lost to Follow-up|2
1578794|NCT02657889|5478449|P3|Overall Study|Lost to Follow-up|1
1578795|NCT02657889|5478450|P2|Overall Study|Lost to Follow-up|0
1578796|NCT02657889|5478451|P1|Overall Study|Lost to Follow-up|2
1578797|NCT02657889|5478448|P4|Overall Study|Death|34
1578798|NCT02657889|5478449|P3|Overall Study|Death|20
1578799|NCT02657889|5478450|P2|Overall Study|Death|2
1578800|NCT02657889|5478451|P1|Overall Study|Death|5
1578801|NCT02657408|5478492|P2|Overall Study|Adverse Event|7
1578802|NCT02657408|5478493|P1|Overall Study|Adverse Event|3
1578803|NCT02657369|5478517|P1|Overall Study|Study terminated by sponsor|7
1578804|NCT02657369|5478517|P1|Overall Study|Death|27
1578805|NCT02657031|5478548|P2|Overall Study|Adverse Event|2
1578806|NCT02657031|5478549|P1|Overall Study|Adverse Event|1
1578807|NCT02656693|5478577|P3|Overall Study|Bariatric surgery|2
1578808|NCT02656693|5478578|P2|Overall Study|Bariatric surgery|1
1578809|NCT02656693|5478579|P1|Overall Study|Bariatric surgery|0
1578810|NCT02656693|5478577|P3|Overall Study|Pregnancy|1
1578811|NCT02656693|5478578|P2|Overall Study|Pregnancy|1
1578812|NCT02656693|5478579|P1|Overall Study|Pregnancy|1
1578813|NCT02656329|5478662|P2|Overall Study|Other than specified above|6
1578814|NCT02656329|5478663|P1|Overall Study|Other than specified above|5
1578815|NCT02656329|5478662|P2|Overall Study|Study termination by Sponsor|142
1578816|NCT02656329|5478663|P1|Overall Study|Study termination by Sponsor|150
1578817|NCT02656329|5478662|P2|Overall Study|Withdrawal by Subject|6
1578818|NCT02656329|5478663|P1|Overall Study|Withdrawal by Subject|7
1578819|NCT02656329|5478662|P2|Overall Study|Lost to Follow-up|3
1578820|NCT02656329|5478663|P1|Overall Study|Lost to Follow-up|2
1578821|NCT02656173|5478688|P2|Overall Study|Miscellaneous|0
1578822|NCT02656173|5478689|P1|Overall Study|Miscellaneous|2
1578823|NCT02656173|5478688|P2|Overall Study|Protocol Violation|1
1578824|NCT02656173|5478689|P1|Overall Study|Protocol Violation|0
1578825|NCT02656173|5478688|P2|Overall Study|Withdrawal by Subject|3
1578826|NCT02656173|5478689|P1|Overall Study|Withdrawal by Subject|1
1578827|NCT02656173|5478688|P2|Overall Study|Adverse Event|5
1578828|NCT02656173|5478689|P1|Overall Study|Adverse Event|7
1578829|NCT02656173|5478688|P2|Overall Study|Deviation from the Eligible Criteria|2
1578830|NCT02656173|5478689|P1|Overall Study|Deviation from the Eligible Criteria|3
1578831|NCT02655887|5478761|P1|Overall Study|Missed 12-month follow-up visit|4
1578832|NCT02655887|5478761|P1|Overall Study|Withdrawal by Subject|3
1578833|NCT02655887|5478761|P1|Overall Study|Death|4
1578834|NCT02655887|5478761|P1|Overall Study|Lost to Follow-up|3
1578835|NCT02655679|5478780|P5|Overall Study|Other Miscellaneous Reasons|0
1578836|NCT02655679|5478781|P4|Overall Study|Other Miscellaneous Reasons|0
1578837|NCT02655679|5478782|P3|Overall Study|Other Miscellaneous Reasons|0
1578838|NCT02655679|5478783|P2|Overall Study|Other Miscellaneous Reasons|0
1578839|NCT02655679|5478784|P1|Overall Study|Other Miscellaneous Reasons|1
1578840|NCT02655679|5478780|P5|Overall Study|Lost to Follow-up|0
1578841|NCT02655679|5478781|P4|Overall Study|Lost to Follow-up|1
1578842|NCT02655679|5478782|P3|Overall Study|Lost to Follow-up|1
1578843|NCT02655679|5478783|P2|Overall Study|Lost to Follow-up|1
1578844|NCT02655679|5478784|P1|Overall Study|Lost to Follow-up|0
1578845|NCT02655679|5478780|P5|Overall Study|Inability to Comply with the Protocol|0
1578846|NCT02655679|5478781|P4|Overall Study|Inability to Comply with the Protocol|0
1578847|NCT02655679|5478782|P3|Overall Study|Inability to Comply with the Protocol|0
1578848|NCT02655679|5478783|P2|Overall Study|Inability to Comply with the Protocol|0
1578849|NCT02655679|5478784|P1|Overall Study|Inability to Comply with the Protocol|1
1578850|NCT02655679|5478780|P5|Overall Study|Withdrawal by Subject|1
1578851|NCT02655679|5478781|P4|Overall Study|Withdrawal by Subject|3
1578852|NCT02655679|5478782|P3|Overall Study|Withdrawal by Subject|0
1578853|NCT02655679|5478783|P2|Overall Study|Withdrawal by Subject|1
1578854|NCT02655679|5478784|P1|Overall Study|Withdrawal by Subject|1
1578855|NCT02655679|5478780|P5|Overall Study|Adverse Event|0
1578856|NCT02655679|5478781|P4|Overall Study|Adverse Event|0
1578857|NCT02655679|5478782|P3|Overall Study|Adverse Event|0
1578858|NCT02655679|5478783|P2|Overall Study|Adverse Event|1
1578859|NCT02655679|5478784|P1|Overall Study|Adverse Event|0
1578860|NCT02655666|5478856|P1|Overall Study|Sponsor stopped this clinical research.|12
1578861|NCT02655419|5478885|P2|Overall Study|Other|1
1578862|NCT02655419|5478886|P1|Overall Study|Other|0
1578863|NCT02655419|5478885|P2|Overall Study|Withdrawal by Subject|1
1578864|NCT02655419|5478886|P1|Overall Study|Withdrawal by Subject|4
1578865|NCT02655419|5478885|P2|Overall Study|Enrolled but not treated|5
1578866|NCT02655419|5478886|P1|Overall Study|Enrolled but not treated|1
1578867|NCT02655237|5479006|P2|Overall Study|Randomized but Not Treated|0
1578868|NCT02655237|5479007|P1|Overall Study|Randomized but Not Treated|1
1578869|NCT02655237|5479006|P2|Overall Study|Reduction of Hemoglobin Concentration|0
1578870|NCT02655237|5479007|P1|Overall Study|Reduction of Hemoglobin Concentration|1
1578871|NCT02655237|5479006|P2|Overall Study|Recovery Leading to Surgery|1
1578872|NCT02655237|5479007|P1|Overall Study|Recovery Leading to Surgery|2
1578873|NCT02655237|5479006|P2|Overall Study|Lack of Efficacy|1
1578874|NCT02655237|5479007|P1|Overall Study|Lack of Efficacy|0
1578875|NCT02655237|5479006|P2|Overall Study|Withdrawal by Participant|2
1578876|NCT02655237|5479007|P1|Overall Study|Withdrawal by Participant|1
1578877|NCT02655237|5479006|P2|Overall Study|Protocol Deviation|0
1578878|NCT02655237|5479007|P1|Overall Study|Protocol Deviation|2
1578879|NCT02655237|5479006|P2|Overall Study|Adverse Event|7
1578880|NCT02655237|5479007|P1|Overall Study|Adverse Event|10
1578881|NCT02655224|5479047|P2|Overall Study|Adverse Event|1
1578882|NCT02655224|5479048|P1|Overall Study|Adverse Event|1
1578883|NCT02654717|5479091|P2|Overall Study|Non-permitted medication|0
1578884|NCT02654717|5479092|P1|Overall Study|Non-permitted medication|3
1578885|NCT02654717|5479091|P2|Overall Study|Withdrawal by Subject|1
1578886|NCT02654717|5479092|P1|Overall Study|Withdrawal by Subject|0
1578887|NCT02654717|5479091|P2|Overall Study|Protocol Violation|2
1578888|NCT02654717|5479092|P1|Overall Study|Protocol Violation|1
1578889|NCT02654717|5479091|P2|Overall Study|Adverse Event|2
1578890|NCT02654717|5479092|P1|Overall Study|Adverse Event|2
1578891|NCT02654145|5479143|P1|Overall Study|Withdrawal by Subject|5
1578892|NCT02654145|5479143|P1|Overall Study|Protocol Violation|1
1578893|NCT02654145|5479143|P1|Overall Study|Lack of Efficacy|1
1578894|NCT02654132|5479152|P2|Overall Study|Never treated|2
1578895|NCT02654132|5479153|P1|Overall Study|Never treated|0
1578896|NCT02654132|5479152|P2|Overall Study|Clinical Progression (not protocol)|1
1578897|NCT02654132|5479153|P1|Overall Study|Clinical Progression (not protocol)|0
1578898|NCT02654132|5479152|P2|Overall Study|Inadequate response to therapy|0
1578899|NCT02654132|5479153|P1|Overall Study|Inadequate response to therapy|1
1578900|NCT02654132|5479152|P2|Overall Study|Subject Withdrew Consent|1
1578901|NCT02654132|5479153|P1|Overall Study|Subject Withdrew Consent|2
1578902|NCT02654132|5479152|P2|Overall Study|Not Reported|1
1578903|NCT02654132|5479153|P1|Overall Study|Not Reported|0
1578904|NCT02654132|5479152|P2|Overall Study|Subj Request to Discontinue Treatment|0
1578905|NCT02654132|5479153|P1|Overall Study|Subj Request to Discontinue Treatment|1
1578906|NCT02654132|5479152|P2|Overall Study|Maximum Clinical Benefit|2
1578907|NCT02654132|5479153|P1|Overall Study|Maximum Clinical Benefit|0
1578908|NCT02654132|5479152|P2|Overall Study|Study Drug Toxicity|2
1578909|NCT02654132|5479153|P1|Overall Study|Study Drug Toxicity|1
1578910|NCT02654132|5479152|P2|Overall Study|Switched to another tx|1
1578911|NCT02654132|5479153|P1|Overall Study|Switched to another tx|0
1578912|NCT02654132|5479152|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
1578913|NCT02654132|5479153|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
1578914|NCT02654132|5479152|P2|Overall Study|Disease Progression|31
1578915|NCT02654132|5479153|P1|Overall Study|Disease Progression|26
1578916|NCT02653625|5479196|P1|Overall Study|Suspected Drug Induced Liver Injury|1
1578917|NCT02653625|5479196|P1|Overall Study|Protocol Violation|1
1578918|NCT02653625|5479196|P1|Overall Study|Non-compliance with Study Drug|1
1578919|NCT02653625|5479196|P1|Overall Study|Adverse Event|1
1578920|NCT02653495|5479220|P2|Overall Study|Screening Failure|0
1578921|NCT02653495|5479221|P1|Overall Study|Screening Failure|10
1578922|NCT02653495|5479220|P2|Overall Study|Lost to Follow-up|0
1578923|NCT02653495|5479221|P1|Overall Study|Lost to Follow-up|2
1578924|NCT02653326|5479273|P2|Overall Study|Lost to Follow-up|7
1578925|NCT02653326|5479274|P1|Overall Study|Lost to Follow-up|10
1578926|NCT02653170|5479312|P3|Overall Study|Lost to Follow-up|10
1578927|NCT02653170|5479313|P2|Overall Study|Lost to Follow-up|4
1578928|NCT02653170|5479314|P1|Overall Study|Lost to Follow-up|12
1578929|NCT02653170|5479312|P3|Overall Study|withdrawn by study team|5
1578930|NCT02653170|5479313|P2|Overall Study|withdrawn by study team|4
1578931|NCT02653170|5479314|P1|Overall Study|withdrawn by study team|2
1578932|NCT02653170|5479312|P3|Overall Study|Withdrawal by Subject|3
1578933|NCT02653170|5479313|P2|Overall Study|Withdrawal by Subject|8
1578934|NCT02653170|5479314|P1|Overall Study|Withdrawal by Subject|3
1578935|NCT02652949|5479334|P1|Overall Study|Death|1
1578936|NCT02652767|5479365|P1|Overall Study|Withdrawal by Subject|1
1578937|NCT02652767|5479365|P1|Overall Study|Lost to Follow-up|1
1578938|NCT02652767|5479365|P1|Overall Study|Death|2
1578939|NCT02652624|5479393|P2|Extension Phase|Withdrew Consent|1
1578940|NCT02652624|5479394|P1|Extension Phase|Withdrew Consent|0
1578941|NCT02652624|5479393|P2|Extension Phase|Adverse Event|1
1578942|NCT02652624|5479394|P1|Extension Phase|Adverse Event|0
1578943|NCT02652624|5479393|P2|Extension Phase|Pregnancy|1
1578944|NCT02652624|5479394|P1|Extension Phase|Pregnancy|1
1578945|NCT02652624|5479393|P2|Extension Phase|Lost to Follow-up|1
1578946|NCT02652624|5479394|P1|Extension Phase|Lost to Follow-up|3
1578947|NCT02652624|5479393|P2|Randomized Phase|Lost to Follow-up|1
1578948|NCT02652624|5479394|P1|Randomized Phase|Lost to Follow-up|0
1578949|NCT02652624|5479393|P2|Randomized Phase|Death|1
1578950|NCT02652624|5479394|P1|Randomized Phase|Death|0
1578951|NCT02652624|5479393|P2|Randomized Phase|Investigator's Discretion|2
1578952|NCT02652624|5479394|P1|Randomized Phase|Investigator's Discretion|0
1578953|NCT02652624|5479393|P2|Randomized Phase|Pregnancy|1
1578954|NCT02652624|5479394|P1|Randomized Phase|Pregnancy|3
1578955|NCT02652260|5479482|P2|Overall Study|Withdrawal by Subject|1
1578956|NCT02652260|5479483|P1|Overall Study|Withdrawal by Subject|0
1578957|NCT02652260|5479482|P2|Overall Study|Pregnancy|1
1578958|NCT02652260|5479483|P1|Overall Study|Pregnancy|0
1578959|NCT02652156|5479542|P3|Overall Study|Physician Decision|0
1578960|NCT02652156|5479543|P2|Overall Study|Physician Decision|0
1578961|NCT02652156|5479544|P1|Overall Study|Physician Decision|1
1578962|NCT02651922|5479570|P1|Overall Study|due to exclusion criteria|2
1578963|NCT02651688|5479590|P3|Overall Study|Withdrawal by Subject|2
1578964|NCT02651688|5479591|P2|Overall Study|Withdrawal by Subject|0
1578965|NCT02651688|5479592|P1|Overall Study|Withdrawal by Subject|1
1578966|NCT02651688|5479590|P3|Overall Study|Lost to Follow-up|0
1578967|NCT02651688|5479591|P2|Overall Study|Lost to Follow-up|3
1578968|NCT02651688|5479592|P1|Overall Study|Lost to Follow-up|1
1578969|NCT02651688|5479590|P3|Overall Study|Principal Investigator (PI) decision|0
1578970|NCT02651688|5479591|P2|Overall Study|Principal Investigator (PI) decision|2
1578971|NCT02651688|5479592|P1|Overall Study|Principal Investigator (PI) decision|0
1578972|NCT02651688|5479590|P3|Overall Study|Non-compliance|1
1578973|NCT02651688|5479591|P2|Overall Study|Non-compliance|0
1578974|NCT02651688|5479592|P1|Overall Study|Non-compliance|0
1578975|NCT02651467|5479675|P3|Overall Study|Other (Not specified)|2
1578976|NCT02651467|5479676|P2|Overall Study|Other (Not specified)|0
1578977|NCT02651467|5479677|P1|Overall Study|Other (Not specified)|1
1578978|NCT02651467|5479675|P3|Overall Study|Withdrawal by Subject|2
1578979|NCT02651467|5479676|P2|Overall Study|Withdrawal by Subject|0
1578980|NCT02651467|5479677|P1|Overall Study|Withdrawal by Subject|0
1578981|NCT02651194|5479705|P1|Overall Study|Other|2
1578982|NCT02651194|5479705|P1|Overall Study|Lost to Follow-up|3
1578983|NCT02651155|5479713|P2|Overall Study|Voluntary Withdrawal|0
1578984|NCT02651155|5479714|P1|Overall Study|Voluntary Withdrawal|5
1578985|NCT02651155|5479713|P2|Overall Study|Pretreatment Event/Adverse Event|2
1578986|NCT02651155|5479714|P1|Overall Study|Pretreatment Event/Adverse Event|1
1578987|NCT02650921|5479734|P1|Overall Study|Due to Medical Condition|1
1578988|NCT02650921|5479734|P1|Overall Study|Adverse Event|1
1578989|NCT02650921|5479734|P1|Overall Study|Lost to Follow-up|2
1578990|NCT02650921|5479734|P1|Overall Study|Withdrawal by Subject|4
1578991|NCT02650895|5479788|P6|Overall Study|Withdrawal by Subject|0
1578992|NCT02650895|5479789|P5|Overall Study|Withdrawal by Subject|0
1578993|NCT02650895|5479790|P4|Overall Study|Withdrawal by Subject|0
1578994|NCT02650895|5479791|P3|Overall Study|Withdrawal by Subject|0
1578995|NCT02650895|5479792|P2|Overall Study|Withdrawal by Subject|1
1578996|NCT02650895|5479793|P1|Overall Study|Withdrawal by Subject|0
1578997|NCT02650466|5479827|P1|Overall Study|Lost to Follow-up|1
1578998|NCT02650466|5479827|P1|Overall Study|Withdrawal by Subject|5
1578999|NCT02650466|5479827|P1|Overall Study|Physician Decision|1
1579000|NCT02650128|5479957|P1|Overall Study|Death|2
1579001|NCT02649946|5479966|P2|Overall Study|Missed 6-month follow-up visit|4
1579002|NCT02649946|5479967|P1|Overall Study|Missed 6-month follow-up visit|0
1579003|NCT02649946|5479966|P2|Overall Study|Erroneously enrolled|0
1579004|NCT02649946|5479967|P1|Overall Study|Erroneously enrolled|1
1579005|NCT02649946|5479966|P2|Overall Study|Lost to Follow-up|1
1579006|NCT02649946|5479967|P1|Overall Study|Lost to Follow-up|2
1579007|NCT02649946|5479966|P2|Overall Study|Physician Decision|0
1579008|NCT02649946|5479967|P1|Overall Study|Physician Decision|1
1579009|NCT02649946|5479966|P2|Overall Study|Death|9
1579010|NCT02649946|5479967|P1|Overall Study|Death|7
1579011|NCT02649946|5479966|P2|Overall Study|Withdrawal by Subject|1
1579012|NCT02649946|5479967|P1|Overall Study|Withdrawal by Subject|1
1579013|NCT02649634|5480002|P2|Overall Study|Lost to Follow-up|1
1579014|NCT02649634|5480003|P1|Overall Study|Lost to Follow-up|0
1579015|NCT02649634|5480002|P2|Overall Study|Withdrawal by Subject|5
1579016|NCT02649634|5480003|P1|Overall Study|Withdrawal by Subject|3
1579017|NCT02648438|5480225|P3|Overall Study|Withdrawal by Subject|0
1579018|NCT02648438|5480226|P2|Overall Study|Withdrawal by Subject|1
1579019|NCT02648438|5480227|P1|Overall Study|Withdrawal by Subject|1
1579020|NCT02648438|5480225|P3|Overall Study|Protocol Violation|0
1579021|NCT02648438|5480226|P2|Overall Study|Protocol Violation|0
1579022|NCT02648438|5480227|P1|Overall Study|Protocol Violation|2
1579023|NCT02648438|5480225|P3|Overall Study|Eligibility criteria not fulfilled|0
1579024|NCT02648438|5480226|P2|Overall Study|Eligibility criteria not fulfilled|2
1579025|NCT02648438|5480227|P1|Overall Study|Eligibility criteria not fulfilled|0
1579026|NCT02648217|5480273|P2|Overall Study|Unclassified|0
1579027|NCT02648217|5480274|P1|Overall Study|Unclassified|5
1579028|NCT02648217|5480273|P2|Overall Study|Withdrawal by Subject|3
1579029|NCT02648217|5480274|P1|Overall Study|Withdrawal by Subject|4
1579030|NCT02648217|5480273|P2|Overall Study|Lost to Follow-up|1
1579031|NCT02648217|5480274|P1|Overall Study|Lost to Follow-up|1
1579032|NCT02648217|5480273|P2|Overall Study|Adverse Event|1
1579033|NCT02648217|5480274|P1|Overall Study|Adverse Event|0
1579034|NCT02648204|5480296|P4|Overall Study|Adverse Event|0
1579035|NCT02648204|5480297|P3|Overall Study|Adverse Event|1
1579036|NCT02648204|5480298|P2|Overall Study|Adverse Event|0
1579037|NCT02648204|5480299|P1|Overall Study|Adverse Event|0
1579038|NCT02648204|5480296|P4|Overall Study|Death|2
1579039|NCT02648204|5480297|P3|Overall Study|Death|2
1579040|NCT02648204|5480298|P2|Overall Study|Death|1
1579041|NCT02648204|5480299|P1|Overall Study|Death|1
1579042|NCT02648204|5480296|P4|Overall Study|Missing follow-up information|2
1579043|NCT02648204|5480297|P3|Overall Study|Missing follow-up information|4
1579044|NCT02648204|5480298|P2|Overall Study|Missing follow-up information|4
1579045|NCT02648204|5480299|P1|Overall Study|Missing follow-up information|4
1579046|NCT02648204|5480296|P4|Overall Study|Lost to Follow-up|6
1579047|NCT02648204|5480297|P3|Overall Study|Lost to Follow-up|4
1579048|NCT02648204|5480298|P2|Overall Study|Lost to Follow-up|8
1579049|NCT02648204|5480299|P1|Overall Study|Lost to Follow-up|5
1579050|NCT02648204|5480296|P4|Overall Study|Withdrawal by Subject|6
1579051|NCT02648204|5480297|P3|Overall Study|Withdrawal by Subject|2
1579052|NCT02648204|5480298|P2|Overall Study|Withdrawal by Subject|8
1579053|NCT02648204|5480299|P1|Overall Study|Withdrawal by Subject|12
1579054|NCT02647944|5480437|P2|Overall Study|Adverse Event|0
1579055|NCT02647944|5480438|P1|Overall Study|Adverse Event|2
1579056|NCT02647944|5480437|P2|Overall Study|Withdrawal by Subject|3
1579057|NCT02647944|5480438|P1|Overall Study|Withdrawal by Subject|0
1579058|NCT02647905|5480462|P1|Overall Study|Withdrawal by Subject|2
1579059|NCT02647905|5480462|P1|Overall Study|Lost to Follow-up|1
1579060|NCT02647788|5480469|P2|Overall Study|Felt nauseous with assigned medication|1
1579061|NCT02647788|5480470|P1|Overall Study|Felt nauseous with assigned medication|1
1579062|NCT02647788|5480469|P2|Overall Study|Felt itchy with assigned medication|0
1579063|NCT02647788|5480470|P1|Overall Study|Felt itchy with assigned medication|1
1579064|NCT02647788|5480469|P2|Overall Study|Withdrawal by Subject|0
1579065|NCT02647788|5480470|P1|Overall Study|Withdrawal by Subject|1
1579066|NCT02647788|5480469|P2|Overall Study|Did not want opiate|1
1579067|NCT02647788|5480470|P1|Overall Study|Did not want opiate|0
1579068|NCT02647788|5480469|P2|Overall Study|Lost to Follow-up|11
1579069|NCT02647788|5480470|P1|Overall Study|Lost to Follow-up|13
1579070|NCT02647658|5480482|P2|Overall Study|Consent refusal|24
1579071|NCT02647658|5480483|P1|Overall Study|Consent refusal|15
1579072|NCT02647645|5480511|P2|Overall Study|Lost to Follow-up|1
1579073|NCT02647645|5480512|P1|Overall Study|Lost to Follow-up|2
1579074|NCT02647320|5480534|P5|Overall Study|Disposition Missing Due to Fire at Site|4
1579075|NCT02647320|5480535|P4|Overall Study|Disposition Missing Due to Fire at Site|3
1579076|NCT02647320|5480536|P3|Overall Study|Disposition Missing Due to Fire at Site|4
1579077|NCT02647320|5480537|P2|Overall Study|Disposition Missing Due to Fire at Site|3
1579078|NCT02647320|5480538|P1|Overall Study|Disposition Missing Due to Fire at Site|2
1579079|NCT02647320|5480534|P5|Overall Study|Lack of Efficacy|0
1579080|NCT02647320|5480535|P4|Overall Study|Lack of Efficacy|1
1579081|NCT02647320|5480536|P3|Overall Study|Lack of Efficacy|0
1579082|NCT02647320|5480537|P2|Overall Study|Lack of Efficacy|0
1579083|NCT02647320|5480538|P1|Overall Study|Lack of Efficacy|0
1579084|NCT02647320|5480534|P5|Overall Study|Develop anemia|0
1579085|NCT02647320|5480535|P4|Overall Study|Develop anemia|0
1579086|NCT02647320|5480536|P3|Overall Study|Develop anemia|0
1579087|NCT02647320|5480537|P2|Overall Study|Develop anemia|0
1579088|NCT02647320|5480538|P1|Overall Study|Develop anemia|1
1579089|NCT02647320|5480534|P5|Overall Study|Lost to Follow-up|0
1579090|NCT02647320|5480535|P4|Overall Study|Lost to Follow-up|0
1579091|NCT02647320|5480536|P3|Overall Study|Lost to Follow-up|0
1579092|NCT02647320|5480537|P2|Overall Study|Lost to Follow-up|1
1579093|NCT02647320|5480538|P1|Overall Study|Lost to Follow-up|1
1579094|NCT02647320|5480534|P5|Overall Study|Reason not provided|2
1579095|NCT02647320|5480535|P4|Overall Study|Reason not provided|0
1579096|NCT02647320|5480536|P3|Overall Study|Reason not provided|1
1579097|NCT02647320|5480537|P2|Overall Study|Reason not provided|0
1579098|NCT02647320|5480538|P1|Overall Study|Reason not provided|0
1579099|NCT02647320|5480534|P5|Overall Study|Study terminated by sponsor|2
1579100|NCT02647320|5480535|P4|Overall Study|Study terminated by sponsor|1
1579101|NCT02647320|5480536|P3|Overall Study|Study terminated by sponsor|1
1579102|NCT02647320|5480537|P2|Overall Study|Study terminated by sponsor|1
1579103|NCT02647320|5480538|P1|Overall Study|Study terminated by sponsor|1
1579104|NCT02647320|5480534|P5|Overall Study|Persistent hyperglycemia|1
1579105|NCT02647320|5480535|P4|Overall Study|Persistent hyperglycemia|1
1579106|NCT02647320|5480536|P3|Overall Study|Persistent hyperglycemia|1
1579107|NCT02647320|5480537|P2|Overall Study|Persistent hyperglycemia|1
1579108|NCT02647320|5480538|P1|Overall Study|Persistent hyperglycemia|0
1579109|NCT02647320|5480534|P5|Overall Study|Withdrawal by Subject|7
1579110|NCT02647320|5480535|P4|Overall Study|Withdrawal by Subject|2
1579111|NCT02647320|5480536|P3|Overall Study|Withdrawal by Subject|2
1579112|NCT02647320|5480537|P2|Overall Study|Withdrawal by Subject|4
1579113|NCT02647320|5480538|P1|Overall Study|Withdrawal by Subject|7
1579114|NCT02647320|5480534|P5|Overall Study|Protocol Violation|0
1579115|NCT02647320|5480535|P4|Overall Study|Protocol Violation|0
1579116|NCT02647320|5480536|P3|Overall Study|Protocol Violation|3
1579117|NCT02647320|5480537|P2|Overall Study|Protocol Violation|0
1579118|NCT02647320|5480538|P1|Overall Study|Protocol Violation|0
1579119|NCT02647320|5480534|P5|Overall Study|Adverse Event|1
1579120|NCT02647320|5480535|P4|Overall Study|Adverse Event|2
1579121|NCT02647320|5480536|P3|Overall Study|Adverse Event|3
1579122|NCT02647320|5480537|P2|Overall Study|Adverse Event|1
1579123|NCT02647320|5480538|P1|Overall Study|Adverse Event|0
1579124|NCT02647281|5480629|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
1579125|NCT02647281|5480630|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579212|NCT02642614|5481565|P4|Overall Study|Lost to Follow-up|0
1579126|NCT02647281|5480631|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579127|NCT02647281|5480632|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579128|NCT02647281|5480633|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579129|NCT02647281|5480634|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579130|NCT02647281|5480635|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579131|NCT02647281|5480636|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579132|NCT02647281|5480637|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
1579133|NCT02646566|5480865|P3|Overall Study|Treatment failure|0
1579134|NCT02646566|5480866|P2|Overall Study|Treatment failure|0
1579135|NCT02646566|5480867|P1|Overall Study|Treatment failure|1
1579136|NCT02646566|5480865|P3|Overall Study|Lost to Follow-up|5
1579137|NCT02646566|5480866|P2|Overall Study|Lost to Follow-up|4
1579138|NCT02646566|5480867|P1|Overall Study|Lost to Follow-up|5
1579139|NCT02646124|5480918|P2|Overall Study|Lost to Follow-up|2
1579140|NCT02646124|5480919|P1|Overall Study|Lost to Follow-up|0
1579145|NCT02644356|5481140|P1|Overall Study|Withdrawal by Subject|2
1579146|NCT02644122|5481223|P1|Overall Study|Withdrawal by Subject|1
1579147|NCT02644109|5481233|P2|Overall Study|Adverse Event|4
1579148|NCT02644109|5481234|P1|Overall Study|Adverse Event|0
1579149|NCT02644096|5481242|P2|Overall Study|Withdrawal by Subject|25
1579150|NCT02644096|5481243|P1|Overall Study|Withdrawal by Subject|28
1579151|NCT02643693|5481281|P6|Overall Study|Protocol Adherence Issues|1
1579152|NCT02643693|5481282|P5|Overall Study|Protocol Adherence Issues|0
1579153|NCT02643693|5481283|P4|Overall Study|Protocol Adherence Issues|0
1579154|NCT02643693|5481284|P3|Overall Study|Protocol Adherence Issues|1
1579155|NCT02643693|5481285|P2|Overall Study|Protocol Adherence Issues|0
1579156|NCT02643693|5481286|P1|Overall Study|Protocol Adherence Issues|2
1579157|NCT02643693|5481281|P6|Overall Study|Withdrawal by Subject|0
1579158|NCT02643693|5481282|P5|Overall Study|Withdrawal by Subject|0
1579159|NCT02643693|5481283|P4|Overall Study|Withdrawal by Subject|0
1579160|NCT02643693|5481284|P3|Overall Study|Withdrawal by Subject|0
1579161|NCT02643693|5481285|P2|Overall Study|Withdrawal by Subject|1
1579162|NCT02643693|5481286|P1|Overall Study|Withdrawal by Subject|0
1579163|NCT02643693|5481281|P6|Overall Study|Physician Decision|0
1579164|NCT02643693|5481282|P5|Overall Study|Physician Decision|0
1579165|NCT02643693|5481283|P4|Overall Study|Physician Decision|0
1579166|NCT02643693|5481284|P3|Overall Study|Physician Decision|0
1579167|NCT02643693|5481285|P2|Overall Study|Physician Decision|1
1579168|NCT02643693|5481286|P1|Overall Study|Physician Decision|0
1579169|NCT02643628|5481299|P2|Overall Study|Relocated out of state|1
1579170|NCT02643628|5481300|P1|Overall Study|Relocated out of state|0
1579171|NCT02643628|5481299|P2|Overall Study|Withdrawal by Subject|1
1579172|NCT02643628|5481300|P1|Overall Study|Withdrawal by Subject|0
1579173|NCT02643628|5481299|P2|Overall Study|Lost to Follow-up|4
1579174|NCT02643628|5481300|P1|Overall Study|Lost to Follow-up|1
1579175|NCT02643472|5481331|P2|Overall Study|Lost to Follow-up|26
1579176|NCT02643472|5481332|P1|Overall Study|Lost to Follow-up|22
1579177|NCT02643472|5481331|P2|Overall Study|Protocol Violation|1
1579178|NCT02643472|5481332|P1|Overall Study|Protocol Violation|0
1579179|NCT02643472|5481331|P2|Overall Study|Withdrawal by Subject|2
1579180|NCT02643472|5481332|P1|Overall Study|Withdrawal by Subject|3
1579181|NCT02643472|5481331|P2|Overall Study|Death|5
1579182|NCT02643472|5481332|P1|Overall Study|Death|2
1579183|NCT02643394|5481358|P2|Overall Study|Protocol Violation|5
1579184|NCT02643394|5481359|P1|Overall Study|Protocol Violation|4
1579185|NCT02643355|5481369|P2|Overall Study|Protocol Violation|2
1579186|NCT02643355|5481370|P1|Overall Study|Protocol Violation|0
1579187|NCT02643355|5481369|P2|Overall Study|Withdrawal by Subject|3
1579188|NCT02643355|5481370|P1|Overall Study|Withdrawal by Subject|1
1579189|NCT02643251|5481384|P2|Overall Study|PI Decision to terminate patient|0
1579190|NCT02643251|5481385|P1|Overall Study|PI Decision to terminate patient|1
1579191|NCT02643251|5481384|P2|Overall Study|Protocol Violation|0
1579192|NCT02643251|5481385|P1|Overall Study|Protocol Violation|1
1579193|NCT02643251|5481384|P2|Overall Study|Lost to Follow-up|1
1579194|NCT02643251|5481385|P1|Overall Study|Lost to Follow-up|4
1579195|NCT02643251|5481384|P2|Overall Study|Withdrawal by Subject|0
1579196|NCT02643251|5481385|P1|Overall Study|Withdrawal by Subject|2
1579197|NCT02643251|5481384|P2|Overall Study|Adverse Event|1
1579198|NCT02643251|5481385|P1|Overall Study|Adverse Event|3
1579199|NCT02643082|5481417|P2|Period 1|Adverse Event|0
1579200|NCT02643082|5481418|P1|Period 1|Adverse Event|1
1579201|NCT02642965|5481476|P1|Overall Study|Physician Decision|9
1579202|NCT02642965|5481476|P1|Overall Study|Lack of Efficacy|4
1579203|NCT02642679|5481520|P1|Overall Study|Physician Decision|1
1579204|NCT02642679|5481520|P1|Overall Study|Physician Decision|1
1579205|NCT02642679|5481520|P1|Overall Study|Withdrawal by Subject|1
1579206|NCT02642653|5481528|P2|Overall Study|Adverse Event|0
1579207|NCT02642653|5481529|P1|Overall Study|Adverse Event|2
1579208|NCT02642614|5481565|P4|Overall Study|Withdrawal by Subject|0
1579209|NCT02642614|5481566|P3|Overall Study|Withdrawal by Subject|0
1579210|NCT02642614|5481567|P2|Overall Study|Withdrawal by Subject|1
1579211|NCT02642614|5481568|P1|Overall Study|Withdrawal by Subject|1
1579213|NCT02642614|5481566|P3|Overall Study|Lost to Follow-up|0
1579214|NCT02642614|5481567|P2|Overall Study|Lost to Follow-up|0
1579215|NCT02642614|5481568|P1|Overall Study|Lost to Follow-up|1
1579216|NCT02642614|5481565|P4|Overall Study|Adverse Event|2
1579217|NCT02642614|5481566|P3|Overall Study|Adverse Event|2
1579218|NCT02642614|5481567|P2|Overall Study|Adverse Event|1
1579219|NCT02642614|5481568|P1|Overall Study|Adverse Event|1
1579220|NCT02642432|5481635|P1|Overall Study|Other|3
1579221|NCT02642432|5481635|P1|Overall Study|Lost to Follow-up|2
1579222|NCT02642432|5481635|P1|Overall Study|Withdrew Consent|1
1579223|NCT02642432|5481635|P1|Overall Study|Adverse Event|2
1579224|NCT02642159|5481652|P2|Overall Study|Other than specified above|3
1579225|NCT02642159|5481653|P1|Overall Study|Other than specified above|10
1579226|NCT02642159|5481652|P2|Overall Study|Poor compliance to study protocol|0
1579227|NCT02642159|5481653|P1|Overall Study|Poor compliance to study protocol|1
1579228|NCT02642159|5481652|P2|Overall Study|Withdrawal by Subject|1
1579229|NCT02642159|5481653|P1|Overall Study|Withdrawal by Subject|9
1579230|NCT02642159|5481652|P2|Overall Study|Adverse Event|4
1579231|NCT02642159|5481653|P1|Overall Study|Adverse Event|10
1579232|NCT02642159|5481652|P2|Overall Study|Randomized but not treated|0
1579233|NCT02642159|5481653|P1|Overall Study|Randomized but not treated|1
1579234|NCT02641730|5481777|P5|Observational Period (Week 60 - Week 84)|Other|1
1579235|NCT02641730|5481778|P4|Observational Period (Week 60 - Week 84)|Other|0
1579236|NCT02641730|5481779|P3|Observational Period (Week 60 - Week 84)|Other|0
1579237|NCT02641730|5481780|P2|Observational Period (Week 60 - Week 84)|Other|0
1579238|NCT02641730|5481781|P1|Observational Period (Week 60 - Week 84)|Other|0
1579239|NCT02641730|5481777|P5|After Controlled Period (Week 16 – 52)|Other|1
1579240|NCT02641730|5481778|P4|After Controlled Period (Week 16 – 52)|Other|0
1579241|NCT02641730|5481779|P3|After Controlled Period (Week 16 – 52)|Other|1
1579242|NCT02641730|5481780|P2|After Controlled Period (Week 16 – 52)|Other|1
1579243|NCT02641730|5481781|P1|After Controlled Period (Week 16 – 52)|Other|0
1579244|NCT02641730|5481777|P5|After Controlled Period (Week 16 – 52)|Pregnancy|1
1579245|NCT02641730|5481778|P4|After Controlled Period (Week 16 – 52)|Pregnancy|1
1579246|NCT02641730|5481779|P3|After Controlled Period (Week 16 – 52)|Pregnancy|0
1579247|NCT02641730|5481780|P2|After Controlled Period (Week 16 – 52)|Pregnancy|0
1579248|NCT02641730|5481781|P1|After Controlled Period (Week 16 – 52)|Pregnancy|0
1579249|NCT02641730|5481777|P5|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
1579250|NCT02641730|5481778|P4|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
1579251|NCT02641730|5481779|P3|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
1579252|NCT02641730|5481780|P2|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
1579253|NCT02641730|5481781|P1|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
1579254|NCT02641730|5481777|P5|After Controlled Period (Week 16 – 52)|Adverse Event|4
1579255|NCT02641730|5481778|P4|After Controlled Period (Week 16 – 52)|Adverse Event|5
1579256|NCT02641730|5481779|P3|After Controlled Period (Week 16 – 52)|Adverse Event|1
1579257|NCT02641730|5481780|P2|After Controlled Period (Week 16 – 52)|Adverse Event|1
1579258|NCT02641730|5481781|P1|After Controlled Period (Week 16 – 52)|Adverse Event|0
1579259|NCT02641730|5481777|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
1579260|NCT02641730|5481778|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
1579261|NCT02641730|5481779|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1579262|NCT02641730|5481780|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
1579263|NCT02641730|5481781|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
1579264|NCT02641587|5481885|P2|Ambulatory Period|Withdrawal by Subject|0
1579265|NCT02641587|5481886|P1|Ambulatory Period|Withdrawal by Subject|1
1579266|NCT02641587|5481885|P2|Confinement Period|Withdrawal by Subject|1
1579267|NCT02641587|5481886|P1|Confinement Period|Withdrawal by Subject|2
1579268|NCT02641587|5481885|P2|Confinement Period|Adverse Event|0
1579269|NCT02641587|5481886|P1|Confinement Period|Adverse Event|1
1579270|NCT02641392|5482007|P3|Overall Study|Death|1
1579271|NCT02641392|5482008|P2|Overall Study|Death|0
1579272|NCT02641392|5482009|P1|Overall Study|Death|0
1579273|NCT02641392|5482007|P3|Overall Study|Miscellaneous|3
1579274|NCT02641392|5482008|P2|Overall Study|Miscellaneous|0
1579275|NCT02641392|5482009|P1|Overall Study|Miscellaneous|0
1579276|NCT02641392|5482007|P3|Overall Study|Lack of Efficacy|101
1579277|NCT02641392|5482008|P2|Overall Study|Lack of Efficacy|0
1579278|NCT02641392|5482009|P1|Overall Study|Lack of Efficacy|0
1579279|NCT02641392|5482007|P3|Overall Study|Study Terminated by Sponsor|144
1579280|NCT02641392|5482008|P2|Overall Study|Study Terminated by Sponsor|12
1579281|NCT02641392|5482009|P1|Overall Study|Study Terminated by Sponsor|4
1579282|NCT02641392|5482007|P3|Overall Study|Adverse Event|25
1579283|NCT02641392|5482008|P2|Overall Study|Adverse Event|1
1579284|NCT02641392|5482009|P1|Overall Study|Adverse Event|0
1579285|NCT02641392|5482007|P3|Overall Study|Withdrawal by Subject|17
1579286|NCT02641392|5482008|P2|Overall Study|Withdrawal by Subject|0
1579287|NCT02641392|5482009|P1|Overall Study|Withdrawal by Subject|0
1579288|NCT02641392|5482007|P3|Overall Study|Lost to Follow-up|2
1579289|NCT02641392|5482008|P2|Overall Study|Lost to Follow-up|0
1579290|NCT02641392|5482009|P1|Overall Study|Lost to Follow-up|0
1579291|NCT02641379|5482028|P11|Overall Study|PCR positive|0
1579292|NCT02641379|5482029|P10|Overall Study|PCR positive|0
1579293|NCT02641379|5482030|P9|Overall Study|PCR positive|0
1579294|NCT02641379|5482031|P8|Overall Study|PCR positive|0
1579295|NCT02641379|5482032|P7|Overall Study|PCR positive|1
1579296|NCT02641379|5482033|P6|Overall Study|PCR positive|0
1579297|NCT02641379|5482034|P5|Overall Study|PCR positive|0
1579298|NCT02641379|5482035|P4|Overall Study|PCR positive|0
1579299|NCT02641379|5482036|P3|Overall Study|PCR positive|0
1579300|NCT02641379|5482037|P2|Overall Study|PCR positive|0
1579301|NCT02641379|5482038|P1|Overall Study|PCR positive|0
1579302|NCT02641379|5482028|P11|Overall Study|Missing PCR result at Week 8|0
1579303|NCT02641379|5482029|P10|Overall Study|Missing PCR result at Week 8|1
1579304|NCT02641379|5482030|P9|Overall Study|Missing PCR result at Week 8|0
1579305|NCT02641379|5482031|P8|Overall Study|Missing PCR result at Week 8|0
1579306|NCT02641379|5482032|P7|Overall Study|Missing PCR result at Week 8|0
1579307|NCT02641379|5482033|P6|Overall Study|Missing PCR result at Week 8|0
1579308|NCT02641379|5482034|P5|Overall Study|Missing PCR result at Week 8|0
1579309|NCT02641379|5482035|P4|Overall Study|Missing PCR result at Week 8|0
1579310|NCT02641379|5482036|P3|Overall Study|Missing PCR result at Week 8|0
1579311|NCT02641379|5482037|P2|Overall Study|Missing PCR result at Week 8|0
1579312|NCT02641379|5482038|P1|Overall Study|Missing PCR result at Week 8|0
1579313|NCT02641379|5482028|P11|Overall Study|Participant treated after Week 24|0
1579314|NCT02641379|5482029|P10|Overall Study|Participant treated after Week 24|0
1579315|NCT02641379|5482030|P9|Overall Study|Participant treated after Week 24|1
1579316|NCT02641379|5482031|P8|Overall Study|Participant treated after Week 24|0
1579317|NCT02641379|5482032|P7|Overall Study|Participant treated after Week 24|0
1579318|NCT02641379|5482033|P6|Overall Study|Participant treated after Week 24|0
1579319|NCT02641379|5482034|P5|Overall Study|Participant treated after Week 24|0
1579320|NCT02641379|5482035|P4|Overall Study|Participant treated after Week 24|0
1579321|NCT02641379|5482036|P3|Overall Study|Participant treated after Week 24|0
1579322|NCT02641379|5482037|P2|Overall Study|Participant treated after Week 24|0
1579323|NCT02641379|5482038|P1|Overall Study|Participant treated after Week 24|0
1579324|NCT02641379|5482028|P11|Overall Study|Participant’s PCR high|0
1579325|NCT02641379|5482029|P10|Overall Study|Participant’s PCR high|0
1579326|NCT02641379|5482030|P9|Overall Study|Participant’s PCR high|0
1579327|NCT02641379|5482031|P8|Overall Study|Participant’s PCR high|1
1579328|NCT02641379|5482032|P7|Overall Study|Participant’s PCR high|0
1579329|NCT02641379|5482033|P6|Overall Study|Participant’s PCR high|0
1579330|NCT02641379|5482034|P5|Overall Study|Participant’s PCR high|0
1579331|NCT02641379|5482035|P4|Overall Study|Participant’s PCR high|0
1579332|NCT02641379|5482036|P3|Overall Study|Participant’s PCR high|0
1579333|NCT02641379|5482037|P2|Overall Study|Participant’s PCR high|0
1579334|NCT02641379|5482038|P1|Overall Study|Participant’s PCR high|0
1579335|NCT02641379|5482028|P11|Overall Study|Negative PCR result|0
1579336|NCT02641379|5482029|P10|Overall Study|Negative PCR result|1
1579337|NCT02641379|5482030|P9|Overall Study|Negative PCR result|0
1579338|NCT02641379|5482031|P8|Overall Study|Negative PCR result|0
1579339|NCT02641379|5482032|P7|Overall Study|Negative PCR result|0
1579340|NCT02641379|5482033|P6|Overall Study|Negative PCR result|0
1579341|NCT02641379|5482034|P5|Overall Study|Negative PCR result|0
1579342|NCT02641379|5482035|P4|Overall Study|Negative PCR result|0
1579343|NCT02641379|5482036|P3|Overall Study|Negative PCR result|0
1579344|NCT02641379|5482037|P2|Overall Study|Negative PCR result|0
1579345|NCT02641379|5482038|P1|Overall Study|Negative PCR result|0
1579346|NCT02641379|5482028|P11|Overall Study|No 2 Log drop at Week 12|1
1579347|NCT02641379|5482029|P10|Overall Study|No 2 Log drop at Week 12|0
1579348|NCT02641379|5482030|P9|Overall Study|No 2 Log drop at Week 12|0
1579349|NCT02641379|5482031|P8|Overall Study|No 2 Log drop at Week 12|0
1579350|NCT02641379|5482032|P7|Overall Study|No 2 Log drop at Week 12|0
1579351|NCT02641379|5482033|P6|Overall Study|No 2 Log drop at Week 12|0
1579352|NCT02641379|5482034|P5|Overall Study|No 2 Log drop at Week 12|0
1579353|NCT02641379|5482035|P4|Overall Study|No 2 Log drop at Week 12|0
1579354|NCT02641379|5482036|P3|Overall Study|No 2 Log drop at Week 12|0
1579355|NCT02641379|5482037|P2|Overall Study|No 2 Log drop at Week 12|0
1579356|NCT02641379|5482038|P1|Overall Study|No 2 Log drop at Week 12|0
1579357|NCT02641379|5482028|P11|Overall Study|Non-response Week 12|0
1579358|NCT02641379|5482029|P10|Overall Study|Non-response Week 12|0
1579359|NCT02641379|5482030|P9|Overall Study|Non-response Week 12|0
1579360|NCT02641379|5482031|P8|Overall Study|Non-response Week 12|1
1579361|NCT02641379|5482032|P7|Overall Study|Non-response Week 12|0
1579362|NCT02641379|5482033|P6|Overall Study|Non-response Week 12|0
1579363|NCT02641379|5482034|P5|Overall Study|Non-response Week 12|0
1579364|NCT02641379|5482035|P4|Overall Study|Non-response Week 12|0
1579365|NCT02641379|5482036|P3|Overall Study|Non-response Week 12|0
1579366|NCT02641379|5482037|P2|Overall Study|Non-response Week 12|0
1579367|NCT02641379|5482038|P1|Overall Study|Non-response Week 12|0
1579368|NCT02641379|5482028|P11|Overall Study|Participant showed weight reduction|0
1579369|NCT02641379|5482029|P10|Overall Study|Participant showed weight reduction|0
1579370|NCT02641379|5482030|P9|Overall Study|Participant showed weight reduction|0
1579371|NCT02641379|5482031|P8|Overall Study|Participant showed weight reduction|1
1579372|NCT02641379|5482032|P7|Overall Study|Participant showed weight reduction|0
1579373|NCT02641379|5482033|P6|Overall Study|Participant showed weight reduction|0
1579374|NCT02641379|5482034|P5|Overall Study|Participant showed weight reduction|0
1579375|NCT02641379|5482035|P4|Overall Study|Participant showed weight reduction|0
1579376|NCT02641379|5482036|P3|Overall Study|Participant showed weight reduction|0
1579377|NCT02641379|5482037|P2|Overall Study|Participant showed weight reduction|0
1579378|NCT02641379|5482038|P1|Overall Study|Participant showed weight reduction|0
1579379|NCT02641379|5482028|P11|Overall Study|Source data not found|0
1579380|NCT02641379|5482029|P10|Overall Study|Source data not found|0
1579381|NCT02641379|5482030|P9|Overall Study|Source data not found|0
1579382|NCT02641379|5482031|P8|Overall Study|Source data not found|0
1579383|NCT02641379|5482032|P7|Overall Study|Source data not found|0
1579384|NCT02641379|5482033|P6|Overall Study|Source data not found|1
1579385|NCT02641379|5482034|P5|Overall Study|Source data not found|0
1579386|NCT02641379|5482035|P4|Overall Study|Source data not found|0
1579387|NCT02641379|5482036|P3|Overall Study|Source data not found|0
1579388|NCT02641379|5482037|P2|Overall Study|Source data not found|0
1579389|NCT02641379|5482038|P1|Overall Study|Source data not found|0
1579390|NCT02641379|5482028|P11|Overall Study|Lost to Follow-up|0
1579391|NCT02641379|5482029|P10|Overall Study|Lost to Follow-up|0
1579392|NCT02641379|5482030|P9|Overall Study|Lost to Follow-up|1
1579393|NCT02641379|5482031|P8|Overall Study|Lost to Follow-up|0
1579394|NCT02641379|5482032|P7|Overall Study|Lost to Follow-up|0
1579395|NCT02641379|5482033|P6|Overall Study|Lost to Follow-up|0
1579396|NCT02641379|5482034|P5|Overall Study|Lost to Follow-up|0
1579397|NCT02641379|5482035|P4|Overall Study|Lost to Follow-up|0
1579398|NCT02641379|5482036|P3|Overall Study|Lost to Follow-up|0
1579399|NCT02641379|5482037|P2|Overall Study|Lost to Follow-up|0
1579400|NCT02641379|5482038|P1|Overall Study|Lost to Follow-up|0
1579401|NCT02641379|5482028|P11|Overall Study|Participation in sili rescue study|0
1579402|NCT02641379|5482029|P10|Overall Study|Participation in sili rescue study|0
1579403|NCT02641379|5482030|P9|Overall Study|Participation in sili rescue study|0
1579404|NCT02641379|5482031|P8|Overall Study|Participation in sili rescue study|0
1579405|NCT02641379|5482032|P7|Overall Study|Participation in sili rescue study|0
1579406|NCT02641379|5482033|P6|Overall Study|Participation in sili rescue study|1
1579407|NCT02641379|5482034|P5|Overall Study|Participation in sili rescue study|0
1579408|NCT02641379|5482035|P4|Overall Study|Participation in sili rescue study|0
1579409|NCT02641379|5482036|P3|Overall Study|Participation in sili rescue study|0
1579410|NCT02641379|5482037|P2|Overall Study|Participation in sili rescue study|0
1579411|NCT02641379|5482038|P1|Overall Study|Participation in sili rescue study|0
1579412|NCT02641379|5482028|P11|Overall Study|Protocol Violation|0
1579413|NCT02641379|5482029|P10|Overall Study|Protocol Violation|0
1579414|NCT02641379|5482030|P9|Overall Study|Protocol Violation|1
1579415|NCT02641379|5482031|P8|Overall Study|Protocol Violation|0
1579416|NCT02641379|5482032|P7|Overall Study|Protocol Violation|0
1579417|NCT02641379|5482033|P6|Overall Study|Protocol Violation|0
1579418|NCT02641379|5482034|P5|Overall Study|Protocol Violation|2
1579419|NCT02641379|5482035|P4|Overall Study|Protocol Violation|0
1579420|NCT02641379|5482036|P3|Overall Study|Protocol Violation|0
1579421|NCT02641379|5482037|P2|Overall Study|Protocol Violation|0
1579422|NCT02641379|5482038|P1|Overall Study|Protocol Violation|0
1579423|NCT02641379|5482028|P11|Overall Study|Blood could not be drawn|0
1579424|NCT02641379|5482029|P10|Overall Study|Blood could not be drawn|0
1579425|NCT02641379|5482030|P9|Overall Study|Blood could not be drawn|0
1579426|NCT02641379|5482031|P8|Overall Study|Blood could not be drawn|0
1579427|NCT02641379|5482032|P7|Overall Study|Blood could not be drawn|0
1579428|NCT02641379|5482033|P6|Overall Study|Blood could not be drawn|0
1579429|NCT02641379|5482034|P5|Overall Study|Blood could not be drawn|1
1579430|NCT02641379|5482035|P4|Overall Study|Blood could not be drawn|0
1579431|NCT02641379|5482036|P3|Overall Study|Blood could not be drawn|0
1579432|NCT02641379|5482037|P2|Overall Study|Blood could not be drawn|0
1579433|NCT02641379|5482038|P1|Overall Study|Blood could not be drawn|0
1579434|NCT02641379|5482028|P11|Overall Study|Baseline viral load unavailable|0
1579435|NCT02641379|5482029|P10|Overall Study|Baseline viral load unavailable|0
1579436|NCT02641379|5482030|P9|Overall Study|Baseline viral load unavailable|0
1579437|NCT02641379|5482031|P8|Overall Study|Baseline viral load unavailable|0
1579438|NCT02641379|5482032|P7|Overall Study|Baseline viral load unavailable|0
1579439|NCT02641379|5482033|P6|Overall Study|Baseline viral load unavailable|0
1579440|NCT02641379|5482034|P5|Overall Study|Baseline viral load unavailable|0
1579441|NCT02641379|5482035|P4|Overall Study|Baseline viral load unavailable|1
1579442|NCT02641379|5482036|P3|Overall Study|Baseline viral load unavailable|0
1579443|NCT02641379|5482037|P2|Overall Study|Baseline viral load unavailable|0
1579444|NCT02641379|5482038|P1|Overall Study|Baseline viral load unavailable|0
1579445|NCT02641379|5482028|P11|Overall Study|Inclusion criteria not fulfilled|0
1579446|NCT02641379|5482029|P10|Overall Study|Inclusion criteria not fulfilled|0
1579447|NCT02641379|5482030|P9|Overall Study|Inclusion criteria not fulfilled|0
1579448|NCT02641379|5482031|P8|Overall Study|Inclusion criteria not fulfilled|0
1579449|NCT02641379|5482032|P7|Overall Study|Inclusion criteria not fulfilled|0
1579450|NCT02641379|5482033|P6|Overall Study|Inclusion criteria not fulfilled|0
1579451|NCT02641379|5482034|P5|Overall Study|Inclusion criteria not fulfilled|0
1579452|NCT02641379|5482035|P4|Overall Study|Inclusion criteria not fulfilled|1
1579453|NCT02641379|5482036|P3|Overall Study|Inclusion criteria not fulfilled|0
1579454|NCT02641379|5482037|P2|Overall Study|Inclusion criteria not fulfilled|0
1579455|NCT02641379|5482038|P1|Overall Study|Inclusion criteria not fulfilled|0
1579456|NCT02641379|5482028|P11|Overall Study|PCR sample for Week 4 not drawn|0
1579457|NCT02641379|5482029|P10|Overall Study|PCR sample for Week 4 not drawn|0
1579458|NCT02641379|5482030|P9|Overall Study|PCR sample for Week 4 not drawn|0
1579459|NCT02641379|5482031|P8|Overall Study|PCR sample for Week 4 not drawn|0
1579460|NCT02641379|5482032|P7|Overall Study|PCR sample for Week 4 not drawn|0
1579461|NCT02641379|5482033|P6|Overall Study|PCR sample for Week 4 not drawn|0
1579462|NCT02641379|5482034|P5|Overall Study|PCR sample for Week 4 not drawn|0
1579463|NCT02641379|5482035|P4|Overall Study|PCR sample for Week 4 not drawn|1
1579464|NCT02641379|5482036|P3|Overall Study|PCR sample for Week 4 not drawn|0
1579465|NCT02641379|5482037|P2|Overall Study|PCR sample for Week 4 not drawn|0
1579466|NCT02641379|5482038|P1|Overall Study|PCR sample for Week 4 not drawn|0
1579467|NCT02641379|5482028|P11|Overall Study|PCR positive at Week 28|0
1579468|NCT02641379|5482029|P10|Overall Study|PCR positive at Week 28|0
1579469|NCT02641379|5482030|P9|Overall Study|PCR positive at Week 28|0
1579470|NCT02641379|5482031|P8|Overall Study|PCR positive at Week 28|0
1579471|NCT02641379|5482032|P7|Overall Study|PCR positive at Week 28|0
1579472|NCT02641379|5482033|P6|Overall Study|PCR positive at Week 28|0
1579473|NCT02641379|5482034|P5|Overall Study|PCR positive at Week 28|0
1579474|NCT02641379|5482035|P4|Overall Study|PCR positive at Week 28|0
1579475|NCT02641379|5482036|P3|Overall Study|PCR positive at Week 28|1
1579476|NCT02641379|5482037|P2|Overall Study|PCR positive at Week 28|0
1579477|NCT02641379|5482038|P1|Overall Study|PCR positive at Week 28|0
1579478|NCT02641379|5482028|P11|Overall Study|No PCR at baseline|0
1579479|NCT02641379|5482029|P10|Overall Study|No PCR at baseline|0
1579480|NCT02641379|5482030|P9|Overall Study|No PCR at baseline|0
1579481|NCT02641379|5482031|P8|Overall Study|No PCR at baseline|0
1579482|NCT02641379|5482032|P7|Overall Study|No PCR at baseline|0
1579483|NCT02641379|5482033|P6|Overall Study|No PCR at baseline|0
1579484|NCT02641379|5482034|P5|Overall Study|No PCR at baseline|0
1579485|NCT02641379|5482035|P4|Overall Study|No PCR at baseline|0
1579486|NCT02641379|5482036|P3|Overall Study|No PCR at baseline|1
1579487|NCT02641379|5482037|P2|Overall Study|No PCR at baseline|0
1579488|NCT02641379|5482038|P1|Overall Study|No PCR at baseline|0
1579489|NCT02641379|5482028|P11|Overall Study|PCR not performed at Week 12|0
1579490|NCT02641379|5482029|P10|Overall Study|PCR not performed at Week 12|0
1579491|NCT02641379|5482030|P9|Overall Study|PCR not performed at Week 12|0
1579492|NCT02641379|5482031|P8|Overall Study|PCR not performed at Week 12|0
1579493|NCT02641379|5482032|P7|Overall Study|PCR not performed at Week 12|0
1579494|NCT02641379|5482033|P6|Overall Study|PCR not performed at Week 12|0
1579495|NCT02641379|5482034|P5|Overall Study|PCR not performed at Week 12|0
1579496|NCT02641379|5482035|P4|Overall Study|PCR not performed at Week 12|0
1579497|NCT02641379|5482036|P3|Overall Study|PCR not performed at Week 12|1
1579498|NCT02641379|5482037|P2|Overall Study|PCR not performed at Week 12|0
1579499|NCT02641379|5482038|P1|Overall Study|PCR not performed at Week 12|0
1579500|NCT02641379|5482028|P11|Overall Study|PCR positive at Week 48|0
1579501|NCT02641379|5482029|P10|Overall Study|PCR positive at Week 48|0
1579502|NCT02641379|5482030|P9|Overall Study|PCR positive at Week 48|0
1579503|NCT02641379|5482031|P8|Overall Study|PCR positive at Week 48|0
1579504|NCT02641379|5482032|P7|Overall Study|PCR positive at Week 48|0
1579505|NCT02641379|5482033|P6|Overall Study|PCR positive at Week 48|0
1579506|NCT02641379|5482034|P5|Overall Study|PCR positive at Week 48|0
1579507|NCT02641379|5482035|P4|Overall Study|PCR positive at Week 48|0
1579508|NCT02641379|5482036|P3|Overall Study|PCR positive at Week 48|0
1579509|NCT02641379|5482037|P2|Overall Study|PCR positive at Week 48|1
1579510|NCT02641379|5482038|P1|Overall Study|PCR positive at Week 48|0
1579511|NCT02641379|5482028|P11|Overall Study|PCR positive at Week 68|0
1579512|NCT02641379|5482029|P10|Overall Study|PCR positive at Week 68|0
1579513|NCT02641379|5482030|P9|Overall Study|PCR positive at Week 68|0
1579514|NCT02641379|5482031|P8|Overall Study|PCR positive at Week 68|0
1579515|NCT02641379|5482032|P7|Overall Study|PCR positive at Week 68|0
1579516|NCT02641379|5482033|P6|Overall Study|PCR positive at Week 68|0
1579517|NCT02641379|5482034|P5|Overall Study|PCR positive at Week 68|0
1579518|NCT02641379|5482035|P4|Overall Study|PCR positive at Week 68|0
1579519|NCT02641379|5482036|P3|Overall Study|PCR positive at Week 68|0
1579520|NCT02641379|5482037|P2|Overall Study|PCR positive at Week 68|1
1579521|NCT02641379|5482038|P1|Overall Study|PCR positive at Week 68|0
1579522|NCT02641379|5482028|P11|Overall Study|Financial problems|0
1579523|NCT02641379|5482029|P10|Overall Study|Financial problems|0
1579524|NCT02641379|5482030|P9|Overall Study|Financial problems|0
1579525|NCT02641379|5482031|P8|Overall Study|Financial problems|0
1579526|NCT02641379|5482032|P7|Overall Study|Financial problems|0
1579527|NCT02641379|5482033|P6|Overall Study|Financial problems|0
1579528|NCT02641379|5482034|P5|Overall Study|Financial problems|0
1579529|NCT02641379|5482035|P4|Overall Study|Financial problems|0
1579530|NCT02641379|5482036|P3|Overall Study|Financial problems|0
1579531|NCT02641379|5482037|P2|Overall Study|Financial problems|1
1579532|NCT02641379|5482038|P1|Overall Study|Financial problems|0
1579533|NCT02641379|5482028|P11|Overall Study|Therapy stopped due to misunderstanding|0
1579534|NCT02641379|5482029|P10|Overall Study|Therapy stopped due to misunderstanding|0
1579535|NCT02641379|5482030|P9|Overall Study|Therapy stopped due to misunderstanding|0
1579536|NCT02641379|5482031|P8|Overall Study|Therapy stopped due to misunderstanding|0
1579537|NCT02641379|5482032|P7|Overall Study|Therapy stopped due to misunderstanding|0
1579538|NCT02641379|5482033|P6|Overall Study|Therapy stopped due to misunderstanding|0
1579539|NCT02641379|5482034|P5|Overall Study|Therapy stopped due to misunderstanding|0
1579540|NCT02641379|5482035|P4|Overall Study|Therapy stopped due to misunderstanding|0
1579541|NCT02641379|5482036|P3|Overall Study|Therapy stopped due to misunderstanding|0
1579542|NCT02641379|5482037|P2|Overall Study|Therapy stopped due to misunderstanding|0
1579543|NCT02641379|5482038|P1|Overall Study|Therapy stopped due to misunderstanding|1
1579544|NCT02641379|5482028|P11|Overall Study|Participant stopped study/treatment|0
1579545|NCT02641379|5482029|P10|Overall Study|Participant stopped study/treatment|0
1579546|NCT02641379|5482030|P9|Overall Study|Participant stopped study/treatment|1
1579547|NCT02641379|5482031|P8|Overall Study|Participant stopped study/treatment|0
1579548|NCT02641379|5482032|P7|Overall Study|Participant stopped study/treatment|2
1579549|NCT02641379|5482033|P6|Overall Study|Participant stopped study/treatment|1
1579550|NCT02641379|5482034|P5|Overall Study|Participant stopped study/treatment|0
1579551|NCT02641379|5482035|P4|Overall Study|Participant stopped study/treatment|0
1579552|NCT02641379|5482036|P3|Overall Study|Participant stopped study/treatment|1
1579553|NCT02641379|5482037|P2|Overall Study|Participant stopped study/treatment|3
1579554|NCT02641379|5482038|P1|Overall Study|Participant stopped study/treatment|1
1579555|NCT02641379|5482028|P11|Overall Study|Participant showed relapse|0
1579556|NCT02641379|5482029|P10|Overall Study|Participant showed relapse|0
1579557|NCT02641379|5482030|P9|Overall Study|Participant showed relapse|0
1579558|NCT02641379|5482031|P8|Overall Study|Participant showed relapse|0
1579559|NCT02641379|5482032|P7|Overall Study|Participant showed relapse|1
1579560|NCT02641379|5482033|P6|Overall Study|Participant showed relapse|0
1579561|NCT02641379|5482034|P5|Overall Study|Participant showed relapse|0
1579562|NCT02641379|5482035|P4|Overall Study|Participant showed relapse|0
1579563|NCT02641379|5482036|P3|Overall Study|Participant showed relapse|0
1579564|NCT02641379|5482037|P2|Overall Study|Participant showed relapse|0
1579565|NCT02641379|5482038|P1|Overall Study|Participant showed relapse|1
1579566|NCT02641379|5482028|P11|Overall Study|PCR positive at follow up 2|0
1579567|NCT02641379|5482029|P10|Overall Study|PCR positive at follow up 2|0
1579568|NCT02641379|5482030|P9|Overall Study|PCR positive at follow up 2|0
1579569|NCT02641379|5482031|P8|Overall Study|PCR positive at follow up 2|0
1579570|NCT02641379|5482032|P7|Overall Study|PCR positive at follow up 2|0
1579571|NCT02641379|5482033|P6|Overall Study|PCR positive at follow up 2|0
1579572|NCT02641379|5482034|P5|Overall Study|PCR positive at follow up 2|0
1579573|NCT02641379|5482035|P4|Overall Study|PCR positive at follow up 2|0
1579574|NCT02641379|5482036|P3|Overall Study|PCR positive at follow up 2|0
1579575|NCT02641379|5482037|P2|Overall Study|PCR positive at follow up 2|0
1579576|NCT02641379|5482038|P1|Overall Study|PCR positive at follow up 2|1
1579577|NCT02641379|5482028|P11|Overall Study|PCR positive at Week 24|0
1579578|NCT02641379|5482029|P10|Overall Study|PCR positive at Week 24|1
1579579|NCT02641379|5482030|P9|Overall Study|PCR positive at Week 24|0
1579580|NCT02641379|5482031|P8|Overall Study|PCR positive at Week 24|8
1579581|NCT02641379|5482032|P7|Overall Study|PCR positive at Week 24|3
1579582|NCT02641379|5482033|P6|Overall Study|PCR positive at Week 24|6
1579583|NCT02641379|5482034|P5|Overall Study|PCR positive at Week 24|0
1579584|NCT02641379|5482035|P4|Overall Study|PCR positive at Week 24|0
1579585|NCT02641379|5482036|P3|Overall Study|PCR positive at Week 24|62
1579586|NCT02641379|5482037|P2|Overall Study|PCR positive at Week 24|21
1579587|NCT02641379|5482038|P1|Overall Study|PCR positive at Week 24|15
1579588|NCT02641379|5482028|P11|Overall Study|Participant cannot be reached|1
1579589|NCT02641379|5482029|P10|Overall Study|Participant cannot be reached|2
1579590|NCT02641379|5482030|P9|Overall Study|Participant cannot be reached|0
1579591|NCT02641379|5482031|P8|Overall Study|Participant cannot be reached|1
1579592|NCT02641379|5482032|P7|Overall Study|Participant cannot be reached|0
1579593|NCT02641379|5482033|P6|Overall Study|Participant cannot be reached|1
1579594|NCT02641379|5482034|P5|Overall Study|Participant cannot be reached|2
1579595|NCT02641379|5482035|P4|Overall Study|Participant cannot be reached|8
1579596|NCT02641379|5482036|P3|Overall Study|Participant cannot be reached|0
1579597|NCT02641379|5482037|P2|Overall Study|Participant cannot be reached|4
1579598|NCT02641379|5482038|P1|Overall Study|Participant cannot be reached|4
1579599|NCT02641379|5482028|P11|Overall Study|Participant’s compliance|1
1579600|NCT02641379|5482029|P10|Overall Study|Participant’s compliance|1
1579601|NCT02641379|5482030|P9|Overall Study|Participant’s compliance|1
1579602|NCT02641379|5482031|P8|Overall Study|Participant’s compliance|0
1579603|NCT02641379|5482032|P7|Overall Study|Participant’s compliance|0
1579604|NCT02641379|5482033|P6|Overall Study|Participant’s compliance|2
1579605|NCT02641379|5482034|P5|Overall Study|Participant’s compliance|0
1579606|NCT02641379|5482035|P4|Overall Study|Participant’s compliance|1
1579607|NCT02641379|5482036|P3|Overall Study|Participant’s compliance|0
1579608|NCT02641379|5482037|P2|Overall Study|Participant’s compliance|1
1579609|NCT02641379|5482038|P1|Overall Study|Participant’s compliance|0
1579610|NCT02641379|5482028|P11|Overall Study|Participant unable to attend study visit|0
1579611|NCT02641379|5482029|P10|Overall Study|Participant unable to attend study visit|2
1579612|NCT02641379|5482030|P9|Overall Study|Participant unable to attend study visit|0
1579613|NCT02641379|5482031|P8|Overall Study|Participant unable to attend study visit|1
1579614|NCT02641379|5482032|P7|Overall Study|Participant unable to attend study visit|1
1579615|NCT02641379|5482033|P6|Overall Study|Participant unable to attend study visit|1
1579616|NCT02641379|5482034|P5|Overall Study|Participant unable to attend study visit|5
1579617|NCT02641379|5482035|P4|Overall Study|Participant unable to attend study visit|2
1579618|NCT02641379|5482036|P3|Overall Study|Participant unable to attend study visit|1
1579619|NCT02641379|5482037|P2|Overall Study|Participant unable to attend study visit|10
1579620|NCT02641379|5482038|P1|Overall Study|Participant unable to attend study visit|4
1579621|NCT02641379|5482028|P11|Overall Study|Lack of Efficacy|0
1579622|NCT02641379|5482029|P10|Overall Study|Lack of Efficacy|0
1579623|NCT02641379|5482030|P9|Overall Study|Lack of Efficacy|0
1579624|NCT02641379|5482031|P8|Overall Study|Lack of Efficacy|5
1579625|NCT02641379|5482032|P7|Overall Study|Lack of Efficacy|0
1579626|NCT02641379|5482033|P6|Overall Study|Lack of Efficacy|2
1579627|NCT02641379|5482034|P5|Overall Study|Lack of Efficacy|0
1579628|NCT02641379|5482035|P4|Overall Study|Lack of Efficacy|0
1579629|NCT02641379|5482036|P3|Overall Study|Lack of Efficacy|2
1579630|NCT02641379|5482037|P2|Overall Study|Lack of Efficacy|0
1579631|NCT02641379|5482038|P1|Overall Study|Lack of Efficacy|0
1579632|NCT02641379|5482028|P11|Overall Study|Adverse Event|5
1579633|NCT02641379|5482029|P10|Overall Study|Adverse Event|1
1579634|NCT02641379|5482030|P9|Overall Study|Adverse Event|1
1579635|NCT02641379|5482031|P8|Overall Study|Adverse Event|0
1579636|NCT02641379|5482032|P7|Overall Study|Adverse Event|5
1579637|NCT02641379|5482033|P6|Overall Study|Adverse Event|1
1579638|NCT02641379|5482034|P5|Overall Study|Adverse Event|5
1579639|NCT02641379|5482035|P4|Overall Study|Adverse Event|2
1579640|NCT02641379|5482036|P3|Overall Study|Adverse Event|2
1579641|NCT02641379|5482037|P2|Overall Study|Adverse Event|8
1579642|NCT02641379|5482038|P1|Overall Study|Adverse Event|7
1579643|NCT02641379|5482028|P11|Overall Study|Withdrawal of informed consent|0
1579644|NCT02641379|5482029|P10|Overall Study|Withdrawal of informed consent|0
1579645|NCT02641379|5482030|P9|Overall Study|Withdrawal of informed consent|0
1579646|NCT02641379|5482031|P8|Overall Study|Withdrawal of informed consent|1
1579647|NCT02641379|5482032|P7|Overall Study|Withdrawal of informed consent|0
1579648|NCT02641379|5482033|P6|Overall Study|Withdrawal of informed consent|0
1579649|NCT02641379|5482034|P5|Overall Study|Withdrawal of informed consent|0
1579650|NCT02641379|5482035|P4|Overall Study|Withdrawal of informed consent|0
1579651|NCT02641379|5482036|P3|Overall Study|Withdrawal of informed consent|0
1579652|NCT02641379|5482037|P2|Overall Study|Withdrawal of informed consent|1
1579653|NCT02641379|5482038|P1|Overall Study|Withdrawal of informed consent|0
1579654|NCT02641379|5482028|P11|Overall Study|Exclusion criterion during screening|0
1579655|NCT02641379|5482029|P10|Overall Study|Exclusion criterion during screening|0
1579656|NCT02641379|5482030|P9|Overall Study|Exclusion criterion during screening|0
1579657|NCT02641379|5482031|P8|Overall Study|Exclusion criterion during screening|0
1579658|NCT02641379|5482032|P7|Overall Study|Exclusion criterion during screening|0
1579659|NCT02641379|5482033|P6|Overall Study|Exclusion criterion during screening|0
1579660|NCT02641379|5482034|P5|Overall Study|Exclusion criterion during screening|2
1579661|NCT02641379|5482035|P4|Overall Study|Exclusion criterion during screening|1
1579662|NCT02641379|5482036|P3|Overall Study|Exclusion criterion during screening|0
1579663|NCT02641379|5482037|P2|Overall Study|Exclusion criterion during screening|0
1579664|NCT02641379|5482038|P1|Overall Study|Exclusion criterion during screening|1
1579665|NCT02640755|5482137|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
1579666|NCT02640755|5482138|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
1579667|NCT02640755|5482137|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
1579668|NCT02640755|5482138|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
1579669|NCT02640755|5482137|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
1579670|NCT02640755|5482138|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
1579671|NCT02640612|5482176|P3|Overall Study|Lack of Efficacy|0
1579672|NCT02640612|5482177|P2|Overall Study|Lack of Efficacy|1
1579673|NCT02640612|5482178|P1|Overall Study|Lack of Efficacy|1
1579674|NCT02640612|5482176|P3|Overall Study|Protocol Violation|0
1579675|NCT02640612|5482177|P2|Overall Study|Protocol Violation|2
1579676|NCT02640612|5482178|P1|Overall Study|Protocol Violation|0
1579677|NCT02640612|5482176|P3|Overall Study|Lost to Follow-up|1
1579678|NCT02640612|5482177|P2|Overall Study|Lost to Follow-up|1
1579679|NCT02640612|5482178|P1|Overall Study|Lost to Follow-up|4
1579680|NCT02640612|5482176|P3|Overall Study|Withdrawal by Subject|3
1579681|NCT02640612|5482177|P2|Overall Study|Withdrawal by Subject|3
1579682|NCT02640612|5482178|P1|Overall Study|Withdrawal by Subject|10
1579683|NCT02640612|5482176|P3|Overall Study|Death|0
1579684|NCT02640612|5482177|P2|Overall Study|Death|0
1579685|NCT02640612|5482178|P1|Overall Study|Death|1
1579686|NCT02640612|5482176|P3|Overall Study|Adverse Event|2
1579687|NCT02640612|5482177|P2|Overall Study|Adverse Event|7
1579688|NCT02640612|5482178|P1|Overall Study|Adverse Event|6
1579689|NCT02640547|5482202|P1|Overall Study|Miscellaneous|3
1579690|NCT02640547|5482202|P1|Overall Study|Death|6
1579691|NCT02640547|5482202|P1|Overall Study|Withdrawal by Subject|1
1579692|NCT02640547|5482202|P1|Overall Study|Failure to Return|1
1579693|NCT02640482|5482279|P2|Overall Study|Lost to Follow-up|0
1579694|NCT02640482|5482280|P1|Overall Study|Lost to Follow-up|3
1579695|NCT02640404|5482292|P2|Overall Study|Withdrawal by Subject|0
1579696|NCT02640404|5482293|P1|Overall Study|Withdrawal by Subject|1
1579697|NCT02640404|5482292|P2|Overall Study|Protocol Violation|0
1579698|NCT02640404|5482293|P1|Overall Study|Protocol Violation|1
1579699|NCT02640157|5482304|P3|Overall Study|Randomized in error; did not receive Tx|0
1579700|NCT02640157|5482305|P2|Overall Study|Randomized in error; did not receive Tx|1
1579701|NCT02640157|5482306|P1|Overall Study|Randomized in error; did not receive Tx|0
1579702|NCT02640157|5482304|P3|Overall Study|Lost to Follow-up|7
1579703|NCT02640157|5482305|P2|Overall Study|Lost to Follow-up|2
1579704|NCT02640157|5482306|P1|Overall Study|Lost to Follow-up|9
1579705|NCT02640157|5482304|P3|Overall Study|Withdrew consent|2
1579706|NCT02640157|5482305|P2|Overall Study|Withdrew consent|0
1579707|NCT02640157|5482306|P1|Overall Study|Withdrew consent|2
1579708|NCT02640157|5482304|P3|Overall Study|Adverse Event|1
1579709|NCT02640157|5482305|P2|Overall Study|Adverse Event|2
1579710|NCT02640157|5482306|P1|Overall Study|Adverse Event|2
1579711|NCT02640053|5482325|P2|Overall Study|Chemo regimen changed after 1st Rx|1
1579712|NCT02640053|5482326|P1|Overall Study|Chemo regimen changed after 1st Rx|0
1579713|NCT02640053|5482325|P2|Overall Study|Alternative Therapy|1
1579714|NCT02640053|5482326|P1|Overall Study|Alternative Therapy|1
1579715|NCT02640053|5482325|P2|Overall Study|Adverse Event|1
1579716|NCT02640053|5482326|P1|Overall Study|Adverse Event|1
1579717|NCT02640053|5482325|P2|Overall Study|Withdrawal by Subject|1
1579718|NCT02640053|5482326|P1|Overall Study|Withdrawal by Subject|2
1579719|NCT02639559|5482433|P2|Overall Study|Issues with vascular acess|0
1579720|NCT02639559|5482434|P1|Overall Study|Issues with vascular acess|1
1579721|NCT02639559|5482433|P2|Overall Study|Mobilization failure|3
1579722|NCT02639559|5482434|P1|Overall Study|Mobilization failure|0
1579723|NCT02639338|5482860|P2|Overall Study|Randomized but Not Treated|1
1579724|NCT02639338|5482861|P1|Overall Study|Randomized but Not Treated|0
1579725|NCT02639338|5482860|P2|Overall Study|Death|0
1579726|NCT02639338|5482861|P1|Overall Study|Death|1
1579727|NCT02639338|5482860|P2|Overall Study|Withdrew Consent|2
1579728|NCT02639338|5482861|P1|Overall Study|Withdrew Consent|1
1579729|NCT02639338|5482860|P2|Overall Study|Lost to Follow-up|2
1579730|NCT02639338|5482861|P1|Overall Study|Lost to Follow-up|2
1579731|NCT02639247|5482879|P2|Overall Study|Protocol Violation|0
1579732|NCT02639247|5482880|P1|Overall Study|Protocol Violation|1
1579733|NCT02639247|5482879|P2|Overall Study|Withdrew Consent|1
1579734|NCT02639247|5482880|P1|Overall Study|Withdrew Consent|0
1579735|NCT02639247|5482879|P2|Overall Study|Death|0
1579736|NCT02639247|5482880|P1|Overall Study|Death|2
1579737|NCT02639247|5482879|P2|Overall Study|Lost to Follow-up|1
1579738|NCT02639247|5482880|P1|Overall Study|Lost to Follow-up|2
1579739|NCT02639052|5482896|P1|Overall Study|Lost to Follow-up|1
1579740|NCT02638948|5482933|P4|Overall Study|Other than specified above|1
1579741|NCT02638948|5482934|P3|Overall Study|Other than specified above|1
1579742|NCT02638948|5482935|P2|Overall Study|Other than specified above|1
1579743|NCT02638948|5482936|P1|Overall Study|Other than specified above|4
1579744|NCT02638948|5482933|P4|Overall Study|Participant no longer met study criteria|0
1579745|NCT02638948|5482934|P3|Overall Study|Participant no longer met study criteria|0
1579746|NCT02638948|5482935|P2|Overall Study|Participant no longer met study criteria|1
1579747|NCT02638948|5482936|P1|Overall Study|Participant no longer met study criteria|0
1579748|NCT02638948|5482933|P4|Overall Study|Poor/Non-Compliance|0
1579749|NCT02638948|5482934|P3|Overall Study|Poor/Non-Compliance|1
1579750|NCT02638948|5482935|P2|Overall Study|Poor/Non-Compliance|2
1579751|NCT02638948|5482936|P1|Overall Study|Poor/Non-Compliance|0
1579752|NCT02638948|5482933|P4|Overall Study|Lost to Follow-up|1
1579753|NCT02638948|5482934|P3|Overall Study|Lost to Follow-up|1
1579754|NCT02638948|5482935|P2|Overall Study|Lost to Follow-up|0
1579755|NCT02638948|5482936|P1|Overall Study|Lost to Follow-up|0
1579756|NCT02638948|5482933|P4|Overall Study|Lack of Efficacy|0
1579757|NCT02638948|5482934|P3|Overall Study|Lack of Efficacy|0
1579758|NCT02638948|5482935|P2|Overall Study|Lack of Efficacy|1
1579759|NCT02638948|5482936|P1|Overall Study|Lack of Efficacy|1
1579760|NCT02638948|5482933|P4|Overall Study|Adverse Event|1
1579761|NCT02638948|5482934|P3|Overall Study|Adverse Event|1
1579762|NCT02638948|5482935|P2|Overall Study|Adverse Event|0
1579763|NCT02638948|5482936|P1|Overall Study|Adverse Event|0
1579764|NCT02638948|5482933|P4|Overall Study|Administrative Reason by Sponsor|4
1579765|NCT02638948|5482934|P3|Overall Study|Administrative Reason by Sponsor|0
1579766|NCT02638948|5482935|P2|Overall Study|Administrative Reason by Sponsor|1
1579767|NCT02638948|5482936|P1|Overall Study|Administrative Reason by Sponsor|0
1579768|NCT02638948|5482933|P4|Overall Study|Withdrawal by Subject|1
1579769|NCT02638948|5482934|P3|Overall Study|Withdrawal by Subject|3
1579770|NCT02638948|5482935|P2|Overall Study|Withdrawal by Subject|5
1579771|NCT02638948|5482936|P1|Overall Study|Withdrawal by Subject|4
1579772|NCT02638493|5483035|P3|Overall Study|Inability to provide semen samples|0
1579773|NCT02638493|5483036|P2|Overall Study|Inability to provide semen samples|0
1579774|NCT02638493|5483037|P1|Overall Study|Inability to provide semen samples|2
1579775|NCT02638337|5483068|P2|Overall Study|Other - Miscellaneous|3
1579776|NCT02638337|5483069|P1|Overall Study|Other - Miscellaneous|4
1579777|NCT02638337|5483068|P2|Overall Study|Lost to Follow-up|7
1579778|NCT02638337|5483069|P1|Overall Study|Lost to Follow-up|7
1579779|NCT02638337|5483068|P2|Overall Study|Withdrawal by Subject|16
1579780|NCT02638337|5483069|P1|Overall Study|Withdrawal by Subject|13
1579781|NCT02638337|5483068|P2|Overall Study|Protocol Violation|0
1579782|NCT02638337|5483069|P1|Overall Study|Protocol Violation|3
1579783|NCT02638337|5483068|P2|Overall Study|Adverse Event|10
1579784|NCT02638337|5483069|P1|Overall Study|Adverse Event|6
1579785|NCT02638259|5483153|P2|Treatment Period 2|Withdrawal by Subject|7
1579786|NCT02638259|5483154|P1|Treatment Period 2|Withdrawal by Subject|1
1579787|NCT02638259|5483153|P2|Treatment Period 2|Adverse Event|4
1579788|NCT02638259|5483154|P1|Treatment Period 2|Adverse Event|5
1579789|NCT02638259|5483153|P2|Treatment Period 1|Withdrawn per sponsor decision|2
1579790|NCT02638259|5483154|P1|Treatment Period 1|Withdrawn per sponsor decision|0
1579791|NCT02638259|5483153|P2|Treatment Period 1|Withdrawal by Subject|6
1579792|NCT02638259|5483154|P1|Treatment Period 1|Withdrawal by Subject|4
1579793|NCT02638259|5483153|P2|Treatment Period 1|Protocol Violation|3
1579794|NCT02638259|5483154|P1|Treatment Period 1|Protocol Violation|0
1579795|NCT02638259|5483153|P2|Treatment Period 1|Lack of Efficacy|1
1579796|NCT02638259|5483154|P1|Treatment Period 1|Lack of Efficacy|0
1579797|NCT02638259|5483153|P2|Treatment Period 1|Death|1
1579798|NCT02638259|5483154|P1|Treatment Period 1|Death|0
1579799|NCT02638259|5483153|P2|Treatment Period 1|Adverse Event|5
1579800|NCT02638259|5483154|P1|Treatment Period 1|Adverse Event|1
1579801|NCT02638129|5483246|P2|Overall Study|Study terminated|30
1579802|NCT02638129|5483247|P1|Overall Study|Study terminated|28
1579835|NCT02637557|5483503|P4|Overall Study|Withdrawal by Subject|2
1579836|NCT02637557|5483504|P3|Overall Study|Withdrawal by Subject|4
1579837|NCT02637557|5483505|P2|Overall Study|Withdrawal by Subject|3
1579838|NCT02637557|5483506|P1|Overall Study|Withdrawal by Subject|1
1579839|NCT02637557|5483503|P4|Overall Study|Protocol Violation|1
1579840|NCT02637557|5483504|P3|Overall Study|Protocol Violation|2
1579841|NCT02637557|5483505|P2|Overall Study|Protocol Violation|0
1579842|NCT02637557|5483506|P1|Overall Study|Protocol Violation|2
1579843|NCT02637557|5483503|P4|Overall Study|Physician Decision|0
1579844|NCT02637557|5483504|P3|Overall Study|Physician Decision|0
1579845|NCT02637557|5483505|P2|Overall Study|Physician Decision|0
1579846|NCT02637557|5483506|P1|Overall Study|Physician Decision|1
1579847|NCT02637557|5483503|P4|Overall Study|Lost to Follow-up|1
1579848|NCT02637557|5483504|P3|Overall Study|Lost to Follow-up|0
1579849|NCT02637557|5483505|P2|Overall Study|Lost to Follow-up|1
1579850|NCT02637557|5483506|P1|Overall Study|Lost to Follow-up|1
1579851|NCT02637557|5483503|P4|Overall Study|Adverse Event|3
1579852|NCT02637557|5483504|P3|Overall Study|Adverse Event|3
1579853|NCT02637557|5483505|P2|Overall Study|Adverse Event|1
1579854|NCT02637557|5483506|P1|Overall Study|Adverse Event|3
1579855|NCT02637323|5483598|P2|Overall Study|Protocol Violation|1
1579856|NCT02637323|5483599|P1|Overall Study|Protocol Violation|0
1579857|NCT02637323|5483598|P2|Overall Study|Lost to Follow-up|0
1579858|NCT02637323|5483599|P1|Overall Study|Lost to Follow-up|2
1579859|NCT02637141|5483610|P3|Overall Study|Withdrawal by Subject|1
1579860|NCT02637141|5483611|P2|Overall Study|Withdrawal by Subject|1
1579861|NCT02637141|5483612|P1|Overall Study|Withdrawal by Subject|1
1579862|NCT02637141|5483610|P3|Overall Study|Adverse Event|0
1579863|NCT02637141|5483611|P2|Overall Study|Adverse Event|1
1579864|NCT02637141|5483612|P1|Overall Study|Adverse Event|1
1579865|NCT02637063|5483647|P3|Overall Study|Withdrawal by Subject|3
1579866|NCT02637063|5483648|P2|Overall Study|Withdrawal by Subject|2
1579867|NCT02637063|5483649|P1|Overall Study|Withdrawal by Subject|2
1579868|NCT02637063|5483647|P3|Overall Study|Lost to Follow-up|3
1579869|NCT02637063|5483648|P2|Overall Study|Lost to Follow-up|2
1579870|NCT02637063|5483649|P1|Overall Study|Lost to Follow-up|3
1579871|NCT02637037|5483677|P2|Overall Study|Adverse Event|0
1579872|NCT02637037|5483678|P1|Overall Study|Adverse Event|1
1579873|NCT02637037|5483677|P2|Overall Study|Withdrawal by Subject|1
1579874|NCT02637037|5483678|P1|Overall Study|Withdrawal by Subject|2
1579875|NCT02637037|5483677|P2|Overall Study|Positive drug screen at admission|0
1579876|NCT02637037|5483678|P1|Overall Study|Positive drug screen at admission|1
1579877|NCT02636907|5483744|P1|Extension Phase|Lack of Efficacy|1
1579878|NCT02636907|5483744|P1|Extension Phase|Lost to Follow-up|2
1579879|NCT02636907|5483744|P1|Extension Phase|Physician Decision|1
1579880|NCT02636907|5483744|P1|Extension Phase|Withdrawal by Subject|4
1579881|NCT02636907|5483744|P1|Extension Phase|Adverse Event|2
1579882|NCT02636907|5483744|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
1579883|NCT02636907|5483744|P1|Autoinjector Assessment Period|Adverse Event|2
1579884|NCT02636608|5483761|P1|Overall Study|Did Not Receive Treatment|1
1579885|NCT02636608|5483761|P1|Overall Study|Other|2
1579886|NCT02636608|5483761|P1|Overall Study|Death|3
1579887|NCT02636608|5483761|P1|Overall Study|Insufficient Virological Response|1
1579888|NCT02636608|5483761|P1|Overall Study|Failure to Return|4
1579889|NCT02636595|5483789|P1|Overall Study|Other|1
1579890|NCT02636595|5483789|P1|Overall Study|Lost to Follow-up|1
1579891|NCT02636283|5483797|P2|Overall Study|Trial Terminated Prematurely|3
1579892|NCT02636283|5483798|P1|Overall Study|Trial Terminated Prematurely|0
1579893|NCT02636283|5483797|P2|Overall Study|Adverse Event|0
1579894|NCT02636283|5483798|P1|Overall Study|Adverse Event|2
1579895|NCT02635984|5483826|P2|Overall Study|Study Arm Closed|0
1579896|NCT02635984|5483827|P1|Overall Study|Study Arm Closed|1
1579897|NCT02635984|5483826|P2|Overall Study|Lost to Follow-up|4
1579898|NCT02635984|5483827|P1|Overall Study|Lost to Follow-up|2
1579899|NCT02635646|5483859|P2|Overall Study|Pregnancy|1
1579900|NCT02635646|5483860|P1|Overall Study|Pregnancy|1
1579901|NCT02635646|5483859|P2|Overall Study|Lost to Follow-up|25
1579902|NCT02635646|5483860|P1|Overall Study|Lost to Follow-up|24
1579903|NCT02635347|5483896|P2|Overall Study|Failed screening|7
1579904|NCT02635347|5483897|P1|Overall Study|Failed screening|20
1579905|NCT02635204|5483928|P2|Overall Study|Lost to Follow-up|1
1579906|NCT02635204|5483929|P1|Overall Study|Lost to Follow-up|1
1579907|NCT02635204|5483928|P2|Overall Study|Adverse Event|0
1579908|NCT02635204|5483929|P1|Overall Study|Adverse Event|1
1579909|NCT02634983|5483939|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
1579910|NCT02634983|5483940|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
1579911|NCT02634801|5483999|P3|Follow-up Period|Adverse Event|0
1579912|NCT02634801|5484000|P2|Follow-up Period|Adverse Event|5
1579913|NCT02634801|5484001|P1|Follow-up Period|Adverse Event|1
1579914|NCT02634801|5483999|P3|Follow-up Period|Withdrawal by Subject|5
1579915|NCT02634801|5484000|P2|Follow-up Period|Withdrawal by Subject|2
1579916|NCT02634801|5484001|P1|Follow-up Period|Withdrawal by Subject|1
1579917|NCT02634801|5483999|P3|Follow-up Period|Physician Decision|1
1579918|NCT02634801|5484000|P2|Follow-up Period|Physician Decision|0
1579919|NCT02634801|5484001|P1|Follow-up Period|Physician Decision|0
1579920|NCT02634801|5483999|P3|Follow-up Period|Lost to Follow-up|2
1579921|NCT02634801|5484000|P2|Follow-up Period|Lost to Follow-up|1
1579922|NCT02634801|5484001|P1|Follow-up Period|Lost to Follow-up|3
1579923|NCT02634801|5483999|P3|Extension Period (Weeks 24 to 36)|Missing|0
1579924|NCT02634801|5484000|P2|Extension Period (Weeks 24 to 36)|Missing|0
1579925|NCT02634801|5484001|P1|Extension Period (Weeks 24 to 36)|Missing|1
1579926|NCT02634801|5483999|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1579927|NCT02634801|5484000|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1579928|NCT02634801|5484001|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
1579929|NCT02634801|5483999|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
1579930|NCT02634801|5484000|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
1579931|NCT02634801|5484001|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
1579932|NCT02634801|5483999|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
1579933|NCT02634801|5484000|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
1579934|NCT02634801|5484001|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
1579935|NCT02634801|5483999|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
1579936|NCT02634801|5484000|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
1579937|NCT02634801|5484001|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
1579938|NCT02634801|5483999|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
1579939|NCT02634801|5484000|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
1579940|NCT02634801|5484001|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
1579941|NCT02634801|5483999|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
1579942|NCT02634801|5484000|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
1579943|NCT02634801|5484001|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
1579944|NCT02634801|5483999|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
1579945|NCT02634801|5484000|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
1579946|NCT02634801|5484001|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
1579947|NCT02634801|5483999|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
1579948|NCT02634801|5484000|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
1579949|NCT02634801|5484001|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
1579950|NCT02634788|5484101|P4|Overall Study|Withdrawal by Subject|0
1579951|NCT02634788|5484102|P3|Overall Study|Withdrawal by Subject|1
1579952|NCT02634788|5484103|P2|Overall Study|Withdrawal by Subject|1
1579953|NCT02634788|5484104|P1|Overall Study|Withdrawal by Subject|0
1579954|NCT02634788|5484101|P4|Overall Study|Lost to Follow-up|0
1579955|NCT02634788|5484102|P3|Overall Study|Lost to Follow-up|0
1579956|NCT02634788|5484103|P2|Overall Study|Lost to Follow-up|1
1579957|NCT02634788|5484104|P1|Overall Study|Lost to Follow-up|0
1579958|NCT02634788|5484101|P4|Overall Study|Lack of Efficacy|4
1579959|NCT02634788|5484102|P3|Overall Study|Lack of Efficacy|1
1579960|NCT02634788|5484103|P2|Overall Study|Lack of Efficacy|0
1579961|NCT02634788|5484104|P1|Overall Study|Lack of Efficacy|4
1579962|NCT02634788|5484101|P4|Overall Study|Adverse Event|1
1579963|NCT02634788|5484102|P3|Overall Study|Adverse Event|3
1579964|NCT02634788|5484103|P2|Overall Study|Adverse Event|8
1579965|NCT02634788|5484104|P1|Overall Study|Adverse Event|0
1579966|NCT02634606|5484170|P1|Overall Study|unable to obtain the drug at start|13
1579967|NCT02634580|5484182|P4|Overall Study|Subject Request|1
1579968|NCT02634580|5484183|P3|Overall Study|Subject Request|1
1579969|NCT02634580|5484184|P2|Overall Study|Subject Request|0
1579970|NCT02634580|5484185|P1|Overall Study|Subject Request|1
1579971|NCT02634346|5484242|P3|Overall Study|Protocol Violation|0
1579972|NCT02634346|5484243|P2|Overall Study|Protocol Violation|1
1579973|NCT02634346|5484244|P1|Overall Study|Protocol Violation|0
1579974|NCT02634346|5484242|P3|Overall Study|Lost to Follow-up|0
1579975|NCT02634346|5484243|P2|Overall Study|Lost to Follow-up|0
1579976|NCT02634346|5484244|P1|Overall Study|Lost to Follow-up|1
1579977|NCT02634346|5484242|P3|Overall Study|Lack of Efficacy|8
1579978|NCT02634346|5484243|P2|Overall Study|Lack of Efficacy|2
1579979|NCT02634346|5484244|P1|Overall Study|Lack of Efficacy|1
1579980|NCT02634346|5484242|P3|Overall Study|Adverse Event|7
1579981|NCT02634346|5484243|P2|Overall Study|Adverse Event|2
1579982|NCT02634346|5484244|P1|Overall Study|Adverse Event|2
1579983|NCT02634346|5484242|P3|Overall Study|Withdrawal by Subject|8
1579984|NCT02634346|5484243|P2|Overall Study|Withdrawal by Subject|9
1579985|NCT02634346|5484244|P1|Overall Study|Withdrawal by Subject|8
1579986|NCT02634320|5484258|P1|Overall Study|Lack of Efficacy|2
1579987|NCT02634320|5484258|P1|Overall Study|Withdrawal by Subject|5
1579988|NCT02634320|5484258|P1|Overall Study|Protocol Violation|1
1579989|NCT02634320|5484258|P1|Overall Study|Out of window for study visits|1
1579990|NCT02634320|5484258|P1|Overall Study|Moved out of area|2
1579991|NCT02634320|5484258|P1|Overall Study|Lost to Follow-up|3
1579992|NCT02634320|5484258|P1|Overall Study|Adverse Event|2
1579993|NCT02633800|5484383|P2|Overall Study|Patient Request|1
1579994|NCT02633800|5484384|P1|Overall Study|Patient Request|1
1579995|NCT02633800|5484383|P2|Overall Study|Withdrawal by Subject|3
1579996|NCT02633800|5484384|P1|Overall Study|Withdrawal by Subject|0
1579997|NCT02633800|5484383|P2|Overall Study|Adverse event, non-fatal|2
1579998|NCT02633800|5484384|P1|Overall Study|Adverse event, non-fatal|7
1579999|NCT02633800|5484383|P2|Overall Study|Study terminated by sponsor|5
1580000|NCT02633800|5484384|P1|Overall Study|Study terminated by sponsor|6
1580001|NCT02633800|5484383|P2|Overall Study|Clinical progression|6
1580002|NCT02633800|5484384|P1|Overall Study|Clinical progression|3
1580003|NCT02633800|5484383|P2|Overall Study|Radiologic(al) progression|23
1580004|NCT02633800|5484384|P1|Overall Study|Radiologic(al) progression|23
1580005|NCT02633800|5484383|P2|Overall Study|Reason not provided|0
1580006|NCT02633800|5484384|P1|Overall Study|Reason not provided|1
1580007|NCT02633800|5484383|P2|Overall Study|Death|3
1580008|NCT02633800|5484384|P1|Overall Study|Death|3
1580009|NCT02633787|5484394|P1|Overall Study|Withdrawal by Subject|1
1580010|NCT02633501|5484406|P6|Overall Study|Lost to Follow-up|0
1580011|NCT02633501|5484407|P5|Overall Study|Lost to Follow-up|2
1580012|NCT02633501|5484408|P4|Overall Study|Lost to Follow-up|1
1580013|NCT02633501|5484409|P3|Overall Study|Lost to Follow-up|0
1580014|NCT02633501|5484410|P2|Overall Study|Lost to Follow-up|0
1580015|NCT02633501|5484411|P1|Overall Study|Lost to Follow-up|0
1580016|NCT02633501|5484406|P6|Overall Study|Various other reasons|11
1580017|NCT02633501|5484407|P5|Overall Study|Various other reasons|7
1580018|NCT02633501|5484408|P4|Overall Study|Various other reasons|1
1580019|NCT02633501|5484409|P3|Overall Study|Various other reasons|4
1580020|NCT02633501|5484410|P2|Overall Study|Various other reasons|2
1580021|NCT02633501|5484411|P1|Overall Study|Various other reasons|0
1580022|NCT02633501|5484406|P6|Overall Study|Withdrawal by Subject|3
1580023|NCT02633501|5484407|P5|Overall Study|Withdrawal by Subject|1
1580024|NCT02633501|5484408|P4|Overall Study|Withdrawal by Subject|2
1580025|NCT02633501|5484409|P3|Overall Study|Withdrawal by Subject|2
1580026|NCT02633501|5484410|P2|Overall Study|Withdrawal by Subject|1
1580027|NCT02633501|5484411|P1|Overall Study|Withdrawal by Subject|2
1580028|NCT02633501|5484406|P6|Overall Study|Adverse Event|1
1580029|NCT02633501|5484407|P5|Overall Study|Adverse Event|1
1580030|NCT02633501|5484408|P4|Overall Study|Adverse Event|0
1580031|NCT02633501|5484409|P3|Overall Study|Adverse Event|1
1580032|NCT02633501|5484410|P2|Overall Study|Adverse Event|0
1580033|NCT02633501|5484411|P1|Overall Study|Adverse Event|0
1580034|NCT02633215|5484464|P2|Overall Study|Lost to Follow-up|3
1580035|NCT02633215|5484465|P1|Overall Study|Lost to Follow-up|2
1580036|NCT02633020|5484477|P2|Overall Study|Adverse Event|0
1580037|NCT02633020|5484478|P1|Overall Study|Adverse Event|1
1580038|NCT02632838|5484502|P2|Overall Study|Lost to Follow-up|2
1580039|NCT02632838|5484503|P1|Overall Study|Lost to Follow-up|0
1580040|NCT02632838|5484502|P2|Overall Study|Withdrawal by Subject|0
1580041|NCT02632838|5484503|P1|Overall Study|Withdrawal by Subject|3
1580042|NCT02632786|5484540|P2|Overall Study|Withdrawal by Subject|0
1580043|NCT02632786|5484541|P1|Overall Study|Withdrawal by Subject|1
1580044|NCT02632786|5484540|P2|Overall Study|Physician Decision|4
1580045|NCT02632786|5484541|P1|Overall Study|Physician Decision|5
1580046|NCT02632786|5484540|P2|Overall Study|Death|2
1580047|NCT02632786|5484541|P1|Overall Study|Death|3
1580048|NCT02632786|5484540|P2|Overall Study|Adverse Event|1
1580049|NCT02632786|5484541|P1|Overall Study|Adverse Event|2
1580050|NCT02632110|5484751|P10|Overall Study|Withdrawal by Subject|1
1580051|NCT02632110|5484752|P9|Overall Study|Withdrawal by Subject|1
1580052|NCT02632110|5484753|P8|Overall Study|Withdrawal by Subject|3
1580053|NCT02632110|5484754|P7|Overall Study|Withdrawal by Subject|3
1580054|NCT02632110|5484755|P6|Overall Study|Withdrawal by Subject|1
1580055|NCT02632110|5484756|P5|Overall Study|Withdrawal by Subject|1
1580056|NCT02632110|5484757|P4|Overall Study|Withdrawal by Subject|0
1580057|NCT02632110|5484758|P3|Overall Study|Withdrawal by Subject|0
1580058|NCT02632110|5484759|P2|Overall Study|Withdrawal by Subject|1
1580059|NCT02632110|5484760|P1|Overall Study|Withdrawal by Subject|1
1580060|NCT02631746|5485240|P1|Overall Study|Lack of Efficacy|3
1580061|NCT02631577|5485253|P2|Overall Study|Withdrawal by Subject|1
1580062|NCT02631577|5485254|P1|Overall Study|Withdrawal by Subject|0
1580063|NCT02631577|5485253|P2|Overall Study|Death|3
1580064|NCT02631577|5485254|P1|Overall Study|Death|1
1580065|NCT02631551|5485272|P4|Overall Study|Other, specific reasons not collected|2
1580066|NCT02631551|5485273|P3|Overall Study|Other, specific reasons not collected|2
1580067|NCT02631551|5485274|P2|Overall Study|Other, specific reasons not collected|7
1580068|NCT02631551|5485275|P1|Overall Study|Other, specific reasons not collected|5
1580069|NCT02631551|5485272|P4|Overall Study|Non-compliance with study drug|0
1580070|NCT02631551|5485273|P3|Overall Study|Non-compliance with study drug|0
1580071|NCT02631551|5485274|P2|Overall Study|Non-compliance with study drug|0
1580072|NCT02631551|5485275|P1|Overall Study|Non-compliance with study drug|1
1580073|NCT02631551|5485272|P4|Overall Study|Non-compliance with study procedures|1
1580074|NCT02631551|5485273|P3|Overall Study|Non-compliance with study procedures|1
1580075|NCT02631551|5485274|P2|Overall Study|Non-compliance with study procedures|0
1580076|NCT02631551|5485275|P1|Overall Study|Non-compliance with study procedures|0
1580077|NCT02631551|5485272|P4|Overall Study|Protocol deviation|0
1580078|NCT02631551|5485273|P3|Overall Study|Protocol deviation|3
1580079|NCT02631551|5485274|P2|Overall Study|Protocol deviation|6
1580080|NCT02631551|5485275|P1|Overall Study|Protocol deviation|3
1580081|NCT02631551|5485272|P4|Overall Study|Withdrawal by Subject|5
1580082|NCT02631551|5485273|P3|Overall Study|Withdrawal by Subject|0
1580083|NCT02631551|5485274|P2|Overall Study|Withdrawal by Subject|2
1580084|NCT02631551|5485275|P1|Overall Study|Withdrawal by Subject|2
1580085|NCT02631551|5485272|P4|Overall Study|Lost to Follow-up|3
1580086|NCT02631551|5485273|P3|Overall Study|Lost to Follow-up|0
1580087|NCT02631551|5485274|P2|Overall Study|Lost to Follow-up|2
1580088|NCT02631551|5485275|P1|Overall Study|Lost to Follow-up|1
1580089|NCT02631551|5485272|P4|Overall Study|Lack of Efficacy|0
1580090|NCT02631551|5485273|P3|Overall Study|Lack of Efficacy|1
1580091|NCT02631551|5485274|P2|Overall Study|Lack of Efficacy|0
1580092|NCT02631551|5485275|P1|Overall Study|Lack of Efficacy|0
1580093|NCT02631551|5485272|P4|Overall Study|Adverse Event|0
1580094|NCT02631551|5485273|P3|Overall Study|Adverse Event|4
1580095|NCT02631551|5485274|P2|Overall Study|Adverse Event|2
1580096|NCT02631551|5485275|P1|Overall Study|Adverse Event|1
1580097|NCT02630966|5485313|P2|Overall Study|Lack of Efficacy|2
1580098|NCT02630966|5485314|P1|Overall Study|Lack of Efficacy|0
1580099|NCT02630966|5485313|P2|Overall Study|Voluntary Withdrawal|1
1580100|NCT02630966|5485314|P1|Overall Study|Voluntary Withdrawal|1
1580101|NCT02630966|5485313|P2|Overall Study|Significant Protocol Deviation|2
1580102|NCT02630966|5485314|P1|Overall Study|Significant Protocol Deviation|0
1580103|NCT02630966|5485313|P2|Overall Study|Adverse Event|3
1580104|NCT02630966|5485314|P1|Overall Study|Adverse Event|1
1580105|NCT02630706|5485342|P3|Overall Study|Withdrawal by Subject|7
1580106|NCT02630706|5485343|P2|Overall Study|Withdrawal by Subject|5
1580107|NCT02630706|5485344|P1|Overall Study|Withdrawal by Subject|4
1580108|NCT02630706|5485342|P3|Overall Study|Pregnancy|0
1580109|NCT02630706|5485343|P2|Overall Study|Pregnancy|1
1580110|NCT02630706|5485344|P1|Overall Study|Pregnancy|0
1580111|NCT02630706|5485342|P3|Overall Study|Physician Decision|0
1580112|NCT02630706|5485343|P2|Overall Study|Physician Decision|1
1580113|NCT02630706|5485344|P1|Overall Study|Physician Decision|1
1580114|NCT02630706|5485342|P3|Overall Study|Lost to Follow-up|2
1580115|NCT02630706|5485343|P2|Overall Study|Lost to Follow-up|1
1580116|NCT02630706|5485344|P1|Overall Study|Lost to Follow-up|0
1580117|NCT02630706|5485342|P3|Overall Study|Adverse Event|1
1580118|NCT02630706|5485343|P2|Overall Study|Adverse Event|1
1580119|NCT02630706|5485344|P1|Overall Study|Adverse Event|2
1580120|NCT02630693|5485453|P2|Overall Study|No receive treatment|1
1580121|NCT02630693|5485454|P1|Overall Study|No receive treatment|0
1580122|NCT02630563|5485466|P1|Overall Study|Administrative|1
1580123|NCT02630472|5485477|P2|Overall Study|Physician Decision|0
1580124|NCT02630472|5485478|P1|Overall Study|Physician Decision|10
1580125|NCT02630459|5485496|P4|Overall Study|Subject missed week 24 assessment|0
1580126|NCT02630459|5485497|P3|Overall Study|Subject missed week 24 assessment|0
1580127|NCT02630459|5485498|P2|Overall Study|Subject missed week 24 assessment|0
1580128|NCT02630459|5485499|P1|Overall Study|Subject missed week 24 assessment|1
1580129|NCT02630459|5485496|P4|Overall Study|Withdrawal by Subject|1
1580130|NCT02630459|5485497|P3|Overall Study|Withdrawal by Subject|4
1580131|NCT02630459|5485498|P2|Overall Study|Withdrawal by Subject|1
1580132|NCT02630459|5485499|P1|Overall Study|Withdrawal by Subject|2
1580133|NCT02630459|5485496|P4|Overall Study|Sponsor decision|0
1580134|NCT02630459|5485497|P3|Overall Study|Sponsor decision|1
1580135|NCT02630459|5485498|P2|Overall Study|Sponsor decision|0
1580136|NCT02630459|5485499|P1|Overall Study|Sponsor decision|0
1580137|NCT02630459|5485496|P4|Overall Study|Protocol-specified criteria|2
1580138|NCT02630459|5485497|P3|Overall Study|Protocol-specified criteria|0
1580139|NCT02630459|5485498|P2|Overall Study|Protocol-specified criteria|1
1580140|NCT02630459|5485499|P1|Overall Study|Protocol-specified criteria|0
1580141|NCT02630251|5485521|P4|Overall Study|Physician Decision|0
1580142|NCT02630251|5485522|P3|Overall Study|Physician Decision|1
1580143|NCT02630251|5485523|P2|Overall Study|Physician Decision|0
1580144|NCT02630251|5485524|P1|Overall Study|Physician Decision|0
1580145|NCT02630186|5485638|P1|Overall Study|Withdrawal by Subject|1
1580146|NCT02629965|5485654|P2|Period 2|Adverse Event|0
1580147|NCT02629965|5485655|P1|Period 2|Adverse Event|1
1580148|NCT02629965|5485654|P2|Period 1|Other than listed above|2
1580149|NCT02629965|5485655|P1|Period 1|Other than listed above|1
1580150|NCT02629965|5485654|P2|Period 1|Unexpected worsening of disease|0
1580151|NCT02629965|5485655|P1|Period 1|Unexpected worsening of disease|2
1580152|NCT02629965|5485654|P2|Period 1|Adverse Event|0
1580153|NCT02629965|5485655|P1|Period 1|Adverse Event|1
1580154|NCT02629861|5485694|P3|Overall Study|Pregnancy|0
1580155|NCT02629861|5485695|P2|Overall Study|Pregnancy|1
1580156|NCT02629861|5485696|P1|Overall Study|Pregnancy|2
1580157|NCT02629861|5485694|P3|Overall Study|Other|0
1580158|NCT02629861|5485695|P2|Overall Study|Other|1
1580159|NCT02629861|5485696|P1|Overall Study|Other|1
1580160|NCT02629861|5485694|P3|Overall Study|Lost to Follow-up|4
1580161|NCT02629861|5485695|P2|Overall Study|Lost to Follow-up|9
1580162|NCT02629861|5485696|P1|Overall Study|Lost to Follow-up|12
1580163|NCT02629861|5485694|P3|Overall Study|Protocol Violation|7
1580164|NCT02629861|5485695|P2|Overall Study|Protocol Violation|3
1580165|NCT02629861|5485696|P1|Overall Study|Protocol Violation|2
1580166|NCT02629861|5485694|P3|Overall Study|Withdrawal by Subject|13
1580167|NCT02629861|5485695|P2|Overall Study|Withdrawal by Subject|8
1580168|NCT02629861|5485696|P1|Overall Study|Withdrawal by Subject|5
1580169|NCT02629861|5485694|P3|Overall Study|Adverse Event|4
1580170|NCT02629861|5485695|P2|Overall Study|Adverse Event|5
1580171|NCT02629861|5485696|P1|Overall Study|Adverse Event|7
1580172|NCT02629822|5485743|P1|Extension Study|Extension Period is Ongoing|6
1580173|NCT02629822|5485743|P1|Base Study|Non-Compliance With Study Drug|1
1580174|NCT02629822|5485743|P1|Base Study|Lost to Follow-up|2
1580175|NCT02629159|5485785|P3|Overall Study|Other|8
1580176|NCT02629159|5485786|P2|Overall Study|Other|4
1580177|NCT02629159|5485787|P1|Overall Study|Other|6
1580178|NCT02629159|5485785|P3|Overall Study|Lack of Efficacy|1
1580179|NCT02629159|5485786|P2|Overall Study|Lack of Efficacy|0
1580180|NCT02629159|5485787|P1|Overall Study|Lack of Efficacy|4
1580181|NCT02629159|5485785|P3|Overall Study|Lost to Follow-up|5
1580182|NCT02629159|5485786|P2|Overall Study|Lost to Follow-up|4
1580183|NCT02629159|5485787|P1|Overall Study|Lost to Follow-up|7
1580184|NCT02629159|5485785|P3|Overall Study|Withdrawal by Subject|15
1580185|NCT02629159|5485786|P2|Overall Study|Withdrawal by Subject|11
1580186|NCT02629159|5485787|P1|Overall Study|Withdrawal by Subject|22
1580187|NCT02629159|5485785|P3|Overall Study|Adverse Event|22
1580188|NCT02629159|5485786|P2|Overall Study|Adverse Event|20
1580189|NCT02629159|5485787|P1|Overall Study|Adverse Event|17
1580190|NCT02628938|5485866|P3|Overall Study|Failure to comply with the instructions|3
1580191|NCT02628938|5485867|P2|Overall Study|Failure to comply with the instructions|0
1580192|NCT02628938|5485868|P1|Overall Study|Failure to comply with the instructions|3
1580193|NCT02628938|5485866|P3|Overall Study|Did not attend the follow up recall|1
1580194|NCT02628938|5485867|P2|Overall Study|Did not attend the follow up recall|2
1580195|NCT02628938|5485868|P1|Overall Study|Did not attend the follow up recall|2
1580196|NCT02628769|5485882|P2|Second Intervention|Physician Decision|1
1580197|NCT02628769|5485883|P1|Second Intervention|Physician Decision|0
1580198|NCT02628769|5485882|P2|Second Intervention|Adverse Event|0
1580199|NCT02628769|5485883|P1|Second Intervention|Adverse Event|2
1580200|NCT02628769|5485882|P2|First Intervention|Withdrawal by Subject|1
1580201|NCT02628769|5485883|P1|First Intervention|Withdrawal by Subject|0
1580202|NCT02628769|5485882|P2|First Intervention|Adverse Event|0
1580203|NCT02628769|5485883|P1|First Intervention|Adverse Event|1
1580204|NCT02628743|5485921|P1|Overall Study|Physician Decision|2
1580205|NCT02628743|5485921|P1|Overall Study|Study Terminated by Sponsor|76
1580206|NCT02628743|5485921|P1|Overall Study|Withdrawal by Subject|50
1580207|NCT02628743|5485921|P1|Overall Study|Other|3
1580208|NCT02628600|5485947|P2|Overall Study|Other not specified|0
1580209|NCT02628600|5485948|P1|Overall Study|Other not specified|1
1580210|NCT02628600|5485947|P2|Overall Study|Physician Decision|2
1580211|NCT02628600|5485948|P1|Overall Study|Physician Decision|2
1580212|NCT02628600|5485947|P2|Overall Study|Lost to Follow-up|0
1580213|NCT02628600|5485948|P1|Overall Study|Lost to Follow-up|1
1580214|NCT02628600|5485947|P2|Overall Study|Withdrawal by Subject|8
1580215|NCT02628600|5485948|P1|Overall Study|Withdrawal by Subject|13
1580216|NCT02628600|5485947|P2|Overall Study|Lack of Efficacy|0
1580217|NCT02628600|5485948|P1|Overall Study|Lack of Efficacy|2
1580218|NCT02628600|5485947|P2|Overall Study|Protocol Violation|1
1580219|NCT02628600|5485948|P1|Overall Study|Protocol Violation|0
1580220|NCT02628600|5485947|P2|Overall Study|Adverse Event|20
1580221|NCT02628600|5485948|P1|Overall Study|Adverse Event|3
1580222|NCT02628600|5485947|P2|Overall Study|Death|1
1580223|NCT02628600|5485948|P1|Overall Study|Death|2
1580224|NCT02628418|5485962|P2|Overall Study|Lost to Follow-up|2
1580225|NCT02628418|5485963|P1|Overall Study|Lost to Follow-up|1
1580226|NCT02628028|5486054|P8|Long-term Extension (LTE) Period|Other|3
1580227|NCT02628028|5486055|P7|Long-term Extension (LTE) Period|Other|4
1580228|NCT02628028|5486056|P6|Long-term Extension (LTE) Period|Other|3
1580229|NCT02628028|5486057|P5|Long-term Extension (LTE) Period|Other|0
1580230|NCT02628028|5486058|P4|Long-term Extension (LTE) Period|Other|0
1580231|NCT02628028|5486059|P3|Long-term Extension (LTE) Period|Other|0
1580232|NCT02628028|5486060|P2|Long-term Extension (LTE) Period|Other|0
1580233|NCT02628028|5486061|P1|Long-term Extension (LTE) Period|Other|0
1580234|NCT02628028|5486054|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
1580235|NCT02628028|5486055|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
1580236|NCT02628028|5486056|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
1580237|NCT02628028|5486057|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1580238|NCT02628028|5486058|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1580239|NCT02628028|5486059|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1580240|NCT02628028|5486060|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1580241|NCT02628028|5486061|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
1580242|NCT02628028|5486054|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
1580243|NCT02628028|5486055|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
1580244|NCT02628028|5486056|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
1580245|NCT02628028|5486057|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1580246|NCT02628028|5486058|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1580247|NCT02628028|5486059|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1580248|NCT02628028|5486060|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1580249|NCT02628028|5486061|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
1580250|NCT02628028|5486054|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
1580251|NCT02628028|5486055|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
1580252|NCT02628028|5486056|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
1580253|NCT02628028|5486057|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
1580254|NCT02628028|5486058|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
1580255|NCT02628028|5486059|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
1580256|NCT02628028|5486060|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
1580257|NCT02628028|5486061|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
1580258|NCT02628028|5486054|P8|Long-term Extension (LTE) Period|Adverse Event|3
1580259|NCT02628028|5486055|P7|Long-term Extension (LTE) Period|Adverse Event|0
1580260|NCT02628028|5486056|P6|Long-term Extension (LTE) Period|Adverse Event|1
1580261|NCT02628028|5486057|P5|Long-term Extension (LTE) Period|Adverse Event|0
1580262|NCT02628028|5486058|P4|Long-term Extension (LTE) Period|Adverse Event|0
1580263|NCT02628028|5486059|P3|Long-term Extension (LTE) Period|Adverse Event|0
1580264|NCT02628028|5486060|P2|Long-term Extension (LTE) Period|Adverse Event|0
1580265|NCT02628028|5486061|P1|Long-term Extension (LTE) Period|Adverse Event|0
1580266|NCT02628028|5486054|P8|Dosing Period|Other|4
1580267|NCT02628028|5486055|P7|Dosing Period|Other|2
1580268|NCT02628028|5486056|P6|Dosing Period|Other|1
1580269|NCT02628028|5486057|P5|Dosing Period|Other|2
1580270|NCT02628028|5486058|P4|Dosing Period|Other|0
1580271|NCT02628028|5486059|P3|Dosing Period|Other|0
1580272|NCT02628028|5486060|P2|Dosing Period|Other|0
1580273|NCT02628028|5486061|P1|Dosing Period|Other|0
1580274|NCT02628028|5486054|P8|Dosing Period|Lost to Follow-up|0
1580275|NCT02628028|5486055|P7|Dosing Period|Lost to Follow-up|1
1580276|NCT02628028|5486056|P6|Dosing Period|Lost to Follow-up|0
1580277|NCT02628028|5486057|P5|Dosing Period|Lost to Follow-up|0
1580278|NCT02628028|5486058|P4|Dosing Period|Lost to Follow-up|0
1580279|NCT02628028|5486059|P3|Dosing Period|Lost to Follow-up|0
1580280|NCT02628028|5486060|P2|Dosing Period|Lost to Follow-up|0
1580281|NCT02628028|5486061|P1|Dosing Period|Lost to Follow-up|0
1580282|NCT02628028|5486054|P8|Dosing Period|Site Terminated by Sponsor|0
1580283|NCT02628028|5486055|P7|Dosing Period|Site Terminated by Sponsor|1
1580284|NCT02628028|5486056|P6|Dosing Period|Site Terminated by Sponsor|1
1580285|NCT02628028|5486057|P5|Dosing Period|Site Terminated by Sponsor|0
1580286|NCT02628028|5486058|P4|Dosing Period|Site Terminated by Sponsor|0
1580287|NCT02628028|5486059|P3|Dosing Period|Site Terminated by Sponsor|0
1580288|NCT02628028|5486060|P2|Dosing Period|Site Terminated by Sponsor|0
1580289|NCT02628028|5486061|P1|Dosing Period|Site Terminated by Sponsor|0
1580290|NCT02628028|5486054|P8|Dosing Period|Physician Decision|0
1580291|NCT02628028|5486055|P7|Dosing Period|Physician Decision|0
1580292|NCT02628028|5486056|P6|Dosing Period|Physician Decision|1
1580293|NCT02628028|5486057|P5|Dosing Period|Physician Decision|0
1580294|NCT02628028|5486058|P4|Dosing Period|Physician Decision|0
1580295|NCT02628028|5486059|P3|Dosing Period|Physician Decision|0
1580296|NCT02628028|5486060|P2|Dosing Period|Physician Decision|0
1580297|NCT02628028|5486061|P1|Dosing Period|Physician Decision|0
1580298|NCT02628028|5486054|P8|Dosing Period|Study Terminated by Sponsor|7
1580299|NCT02628028|5486055|P7|Dosing Period|Study Terminated by Sponsor|7
1580300|NCT02628028|5486056|P6|Dosing Period|Study Terminated by Sponsor|6
1580301|NCT02628028|5486057|P5|Dosing Period|Study Terminated by Sponsor|7
1580302|NCT02628028|5486058|P4|Dosing Period|Study Terminated by Sponsor|0
1580303|NCT02628028|5486059|P3|Dosing Period|Study Terminated by Sponsor|0
1580304|NCT02628028|5486060|P2|Dosing Period|Study Terminated by Sponsor|0
1580305|NCT02628028|5486061|P1|Dosing Period|Study Terminated by Sponsor|0
1580306|NCT02628028|5486054|P8|Dosing Period|Lack of Efficacy|0
1580307|NCT02628028|5486055|P7|Dosing Period|Lack of Efficacy|1
1580308|NCT02628028|5486056|P6|Dosing Period|Lack of Efficacy|0
1580309|NCT02628028|5486057|P5|Dosing Period|Lack of Efficacy|3
1580310|NCT02628028|5486058|P4|Dosing Period|Lack of Efficacy|0
1580311|NCT02628028|5486059|P3|Dosing Period|Lack of Efficacy|0
1580312|NCT02628028|5486060|P2|Dosing Period|Lack of Efficacy|0
1580313|NCT02628028|5486061|P1|Dosing Period|Lack of Efficacy|0
1580314|NCT02628028|5486054|P8|Dosing Period|Death|1
1580315|NCT02628028|5486055|P7|Dosing Period|Death|0
1580316|NCT02628028|5486056|P6|Dosing Period|Death|0
1580317|NCT02628028|5486057|P5|Dosing Period|Death|0
1580318|NCT02628028|5486058|P4|Dosing Period|Death|0
1580319|NCT02628028|5486059|P3|Dosing Period|Death|0
1580320|NCT02628028|5486060|P2|Dosing Period|Death|0
1580321|NCT02628028|5486061|P1|Dosing Period|Death|0
1580322|NCT02628028|5486054|P8|Dosing Period|Adverse Event|2
1580323|NCT02628028|5486055|P7|Dosing Period|Adverse Event|3
1580324|NCT02628028|5486056|P6|Dosing Period|Adverse Event|1
1580325|NCT02628028|5486057|P5|Dosing Period|Adverse Event|2
1580326|NCT02628028|5486058|P4|Dosing Period|Adverse Event|0
1580327|NCT02628028|5486059|P3|Dosing Period|Adverse Event|0
1580328|NCT02628028|5486060|P2|Dosing Period|Adverse Event|0
1580329|NCT02628028|5486061|P1|Dosing Period|Adverse Event|0
1580330|NCT02628028|5486054|P8|Dosing Period|Withdrawal by Subject|1
1580331|NCT02628028|5486055|P7|Dosing Period|Withdrawal by Subject|1
1580332|NCT02628028|5486056|P6|Dosing Period|Withdrawal by Subject|4
1580333|NCT02628028|5486057|P5|Dosing Period|Withdrawal by Subject|2
1580334|NCT02628028|5486058|P4|Dosing Period|Withdrawal by Subject|0
1580335|NCT02628028|5486059|P3|Dosing Period|Withdrawal by Subject|1
1580336|NCT02628028|5486060|P2|Dosing Period|Withdrawal by Subject|0
1580337|NCT02628028|5486061|P1|Dosing Period|Withdrawal by Subject|0
1580338|NCT02627144|5486146|P1|Overall Study|Other|17
1580339|NCT02627144|5486146|P1|Overall Study|Enrolled, not treated|6
1580340|NCT02627144|5486146|P1|Overall Study|Lost to Follow-up|8
1580341|NCT02627144|5486146|P1|Overall Study|Administrative reasons|65
1580342|NCT02627144|5486146|P1|Overall Study|Refusal of treatment / poor cooperation|38
1580343|NCT02627144|5486146|P1|Overall Study|Death from other cause|8
1580344|NCT02627144|5486146|P1|Overall Study|Death from cancer|20
1580345|NCT02627144|5486146|P1|Overall Study|Cancer progression|171
1580346|NCT02627144|5486146|P1|Overall Study|Serious adverse event|32
1580347|NCT02626819|5486187|P2|Overall Study|Diagnosed w/ catastrophic illness|1
1580348|NCT02626819|5486188|P1|Overall Study|Diagnosed w/ catastrophic illness|0
1580349|NCT02626819|5486187|P2|Overall Study|Withdrawal by Subject|0
1580350|NCT02626819|5486188|P1|Overall Study|Withdrawal by Subject|1
1580351|NCT02626819|5486187|P2|Overall Study|Lost to Follow-up|2
1580352|NCT02626819|5486188|P1|Overall Study|Lost to Follow-up|3
1580353|NCT02626780|5486208|P1|Overall Study|Withdrawal by Subject|3
1580354|NCT02626520|5486241|P2|Overall Study|Study terminated|1
1580355|NCT02626520|5486242|P1|Overall Study|Study terminated|0
1580356|NCT02626520|5486241|P2|Overall Study|Did not start protocol therapy|2
1580357|NCT02626520|5486242|P1|Overall Study|Did not start protocol therapy|0
1580358|NCT02626520|5486241|P2|Overall Study|Lack of Efficacy|2
1580359|NCT02626520|5486242|P1|Overall Study|Lack of Efficacy|0
1580360|NCT02626520|5486241|P2|Overall Study|Adverse Event|4
1580361|NCT02626520|5486242|P1|Overall Study|Adverse Event|0
1580362|NCT02626520|5486241|P2|Overall Study|Physician Decision|1
1580363|NCT02626520|5486242|P1|Overall Study|Physician Decision|1
1580364|NCT02626182|5486254|P2|Overall Study|Adverse Event|0
1580365|NCT02626182|5486255|P1|Overall Study|Adverse Event|2
1580366|NCT02626000|5486265|P1|Overall Study|Death|23
1580367|NCT02626000|5486265|P1|Overall Study|Continuing Study|13
1580368|NCT02625974|5486279|P2|Overall Study|Protocol Violation|1
1580369|NCT02625974|5486280|P1|Overall Study|Protocol Violation|0
1580370|NCT02625974|5486279|P2|Overall Study|non-compliance with study drug|2
1580371|NCT02625974|5486280|P1|Overall Study|non-compliance with study drug|0
1580372|NCT02625974|5486279|P2|Overall Study|positive parasitemia|0
1580373|NCT02625974|5486280|P1|Overall Study|positive parasitemia|1
1580374|NCT02625974|5486279|P2|Overall Study|Withdrawal by Subject|1
1580375|NCT02625974|5486280|P1|Overall Study|Withdrawal by Subject|3
1580376|NCT02625974|5486279|P2|Overall Study|Adverse Event|2
1580377|NCT02625974|5486280|P1|Overall Study|Adverse Event|12
1580378|NCT02625922|5486388|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
1580379|NCT02625922|5486389|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
1580380|NCT02625922|5486388|P2|Overall Study|Non-availability of IMP|1
1580381|NCT02625922|5486389|P1|Overall Study|Non-availability of IMP|1
1580382|NCT02625623|5486408|P2|Overall Study|Off-Treatment, but follow up ongoing|24
1580383|NCT02625623|5486409|P1|Overall Study|Off-Treatment, but follow up ongoing|30
1580384|NCT02625623|5486408|P2|Overall Study|Still on Treatment|10
1580385|NCT02625623|5486409|P1|Overall Study|Still on Treatment|10
1580386|NCT02625623|5486408|P2|Overall Study|Participants randomized but not treated|1
1580387|NCT02625623|5486409|P1|Overall Study|Participants randomized but not treated|9
1580388|NCT02625324|5486461|P1|Overall Study|Death|1
1580389|NCT02625259|5486482|P5|First Intervention (Day 1)|Withdrawal by Subject|0
1580390|NCT02625259|5486483|P4|First Intervention (Day 1)|Withdrawal by Subject|1
1580391|NCT02625259|5486484|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1580392|NCT02625259|5486485|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1580393|NCT02625259|5486486|P1|First Intervention (Day 1)|Withdrawal by Subject|0
1580394|NCT02625259|5486482|P5|First Intervention (Day 1)|Adverse Event|0
1580395|NCT02625259|5486483|P4|First Intervention (Day 1)|Adverse Event|0
1580396|NCT02625259|5486484|P3|First Intervention (Day 1)|Adverse Event|0
1580397|NCT02625259|5486485|P2|First Intervention (Day 1)|Adverse Event|1
1580398|NCT02625259|5486486|P1|First Intervention (Day 1)|Adverse Event|2
1580399|NCT02625259|5486482|P5|First Intervention (Day 1)|Other|0
1580400|NCT02625259|5486483|P4|First Intervention (Day 1)|Other|0
1580401|NCT02625259|5486484|P3|First Intervention (Day 1)|Other|1
1580402|NCT02625259|5486485|P2|First Intervention (Day 1)|Other|0
1580403|NCT02625259|5486486|P1|First Intervention (Day 1)|Other|0
1580404|NCT02625233|5486523|P2|Overall Study|Adverse Event|0
1580405|NCT02625233|5486524|P1|Overall Study|Adverse Event|2
1580406|NCT02625220|5486532|P1|Overall Study|Study discontinued at site|2
1580407|NCT02625220|5486532|P1|Overall Study|Protocol Violation|1
1580408|NCT02625220|5486532|P1|Overall Study|Lost to Follow-up|2
1580409|NCT02625220|5486532|P1|Overall Study|Adverse Event|2
1580410|NCT02624791|5486652|P6|Overall Study|Withdrawal by Subject|0
1580411|NCT02624791|5486653|P5|Overall Study|Withdrawal by Subject|0
1580412|NCT02624791|5486654|P4|Overall Study|Withdrawal by Subject|0
1580413|NCT02624791|5486655|P3|Overall Study|Withdrawal by Subject|0
1580414|NCT02624791|5486656|P2|Overall Study|Withdrawal by Subject|0
1580415|NCT02624791|5486657|P1|Overall Study|Withdrawal by Subject|2
1580416|NCT02624713|5486664|P2|Overall Study|Lost to Follow-up|0
1580417|NCT02624713|5486665|P1|Overall Study|Lost to Follow-up|14
1580418|NCT02624687|5486674|P2|Overall Study|medical leave from work|1
1580419|NCT02624687|5486675|P1|Overall Study|medical leave from work|0
1580420|NCT02624687|5486674|P2|Overall Study|Withdrawal by Subject|1
1580421|NCT02624687|5486675|P1|Overall Study|Withdrawal by Subject|1
1580422|NCT02624492|5486706|P3|Overall Study|Progressive disease|3
1580423|NCT02624492|5486707|P2|Overall Study|Progressive disease|2
1580424|NCT02624492|5486708|P1|Overall Study|Progressive disease|0
1580425|NCT02624492|5486706|P3|Overall Study|Adverse Event|2
1580426|NCT02624492|5486707|P2|Overall Study|Adverse Event|2
1580427|NCT02624492|5486708|P1|Overall Study|Adverse Event|2
1580428|NCT02624284|5486743|P3|Overall Study|Adverse Event|1
1580429|NCT02624284|5486744|P2|Overall Study|Adverse Event|0
1580430|NCT02624284|5486745|P1|Overall Study|Adverse Event|0
1580431|NCT02624284|5486743|P3|Overall Study|Revealed exclusionary condition|0
1580432|NCT02624284|5486744|P2|Overall Study|Revealed exclusionary condition|2
1580433|NCT02624284|5486745|P1|Overall Study|Revealed exclusionary condition|2
1580434|NCT02624284|5486743|P3|Overall Study|Protocol Violation|7
1580435|NCT02624284|5486744|P2|Overall Study|Protocol Violation|10
1580436|NCT02624284|5486745|P1|Overall Study|Protocol Violation|9
1580437|NCT02624284|5486743|P3|Overall Study|Withdrawal by Subject|3
1580438|NCT02624284|5486744|P2|Overall Study|Withdrawal by Subject|6
1580439|NCT02624284|5486745|P1|Overall Study|Withdrawal by Subject|3
1580440|NCT02624050|5486764|P2|Overall Study|Protocol Violation|0
1580441|NCT02624050|5486765|P1|Overall Study|Protocol Violation|2
1580442|NCT02624050|5486764|P2|Overall Study|Physician Decision|0
1580443|NCT02624050|5486765|P1|Overall Study|Physician Decision|4
1580444|NCT02623959|5486793|P2|Overall Study|Progression|1
1580445|NCT02623959|5486794|P1|Overall Study|Progression|0
1580446|NCT02623725|5486874|P2|Overall Study|Withdrawal by Subject|1
1580447|NCT02623725|5486875|P1|Overall Study|Withdrawal by Subject|7
1580448|NCT02623725|5486874|P2|Overall Study|Serious adverse event|2
1580449|NCT02623725|5486875|P1|Overall Study|Serious adverse event|0
1580450|NCT02623725|5486874|P2|Overall Study|Non compliance with protocol|3
1580451|NCT02623725|5486875|P1|Overall Study|Non compliance with protocol|9
1580452|NCT02623361|5486909|P2|Overall Study|Withdrawal by Subject|1
1580453|NCT02623361|5486910|P1|Overall Study|Withdrawal by Subject|0
1580454|NCT02623361|5486909|P2|Overall Study|Protocol Violation|1
1580455|NCT02623361|5486910|P1|Overall Study|Protocol Violation|0
1580456|NCT02623335|5486949|P2|Overall Study|Protocol Violation|1
1580457|NCT02623335|5486950|P1|Overall Study|Protocol Violation|2
1580458|NCT02623335|5486949|P2|Overall Study|Withdrawal by Subject|5
1580459|NCT02623335|5486950|P1|Overall Study|Withdrawal by Subject|2
1580460|NCT02623335|5486949|P2|Overall Study|Lost to Follow-up|23
1580461|NCT02623335|5486950|P1|Overall Study|Lost to Follow-up|15
1580462|NCT02623335|5486949|P2|Overall Study|Death|7
1580463|NCT02623335|5486950|P1|Overall Study|Death|8
1580464|NCT02623322|5486977|P3|Overall Study|Lost to Follow-up|0
1580465|NCT02623322|5486978|P2|Overall Study|Lost to Follow-up|1
1580466|NCT02623322|5486979|P1|Overall Study|Lost to Follow-up|2
1580467|NCT02623218|5487017|P5|Overall Study|Lost to Follow-up|0
1580468|NCT02623218|5487018|P4|Overall Study|Lost to Follow-up|0
1580469|NCT02623218|5487019|P3|Overall Study|Lost to Follow-up|0
1580470|NCT02623218|5487020|P2|Overall Study|Lost to Follow-up|1
1580471|NCT02623218|5487021|P1|Overall Study|Lost to Follow-up|0
1580472|NCT02622828|5487043|P1|Overall Study|participant withdrew|3
1580473|NCT02622568|5487050|P2|Overall Study|Lost to Follow-up|5
1580474|NCT02622568|5487051|P1|Overall Study|Lost to Follow-up|5
1580475|NCT02622321|5487061|P4|Overall Study|Withdrawal by Subject|0
1580476|NCT02622321|5487062|P3|Overall Study|Withdrawal by Subject|0
1580477|NCT02622321|5487063|P2|Overall Study|Withdrawal by Subject|0
1580478|NCT02622321|5487064|P1|Overall Study|Withdrawal by Subject|1
1580479|NCT02622321|5487061|P4|Overall Study|Ongoing treatment with emicizumab|7
1580480|NCT02622321|5487062|P3|Overall Study|Ongoing treatment with emicizumab|49
1580481|NCT02622321|5487063|P2|Overall Study|Ongoing treatment with emicizumab|13
1580482|NCT02622321|5487064|P1|Overall Study|Ongoing treatment with emicizumab|31
1580483|NCT02622321|5487061|P4|Overall Study|Ongoing in safety follow-up|0
1580484|NCT02622321|5487062|P3|Overall Study|Ongoing in safety follow-up|0
1580485|NCT02622321|5487063|P2|Overall Study|Ongoing in safety follow-up|0
1580486|NCT02622321|5487064|P1|Overall Study|Ongoing in safety follow-up|3
1580487|NCT02622321|5487061|P4|Overall Study|Ongoing treatment with no emicizumab|0
1580488|NCT02622321|5487062|P3|Overall Study|Ongoing treatment with no emicizumab|0
1580489|NCT02622321|5487063|P2|Overall Study|Ongoing treatment with no emicizumab|5
1580490|NCT02622321|5487064|P1|Overall Study|Ongoing treatment with no emicizumab|0
1580491|NCT02622113|5487135|P2|Overall Study|Stopping Criteria|3
1580492|NCT02622113|5487136|P1|Overall Study|Stopping Criteria|1
1580493|NCT02622113|5487135|P2|Overall Study|Withdrawal by Subject|2
1580494|NCT02622113|5487136|P1|Overall Study|Withdrawal by Subject|0
1580495|NCT02622113|5487135|P2|Overall Study|Physician Decision|1
1580496|NCT02622113|5487136|P1|Overall Study|Physician Decision|0
1580497|NCT02622113|5487135|P2|Overall Study|Adverse Event|4
1580498|NCT02622113|5487136|P1|Overall Study|Adverse Event|4
1580499|NCT02622074|5487154|P6|Overall Study|Ongoing in Study|10
1580500|NCT02622074|5487155|P5|Overall Study|Ongoing in Study|10
1580501|NCT02622074|5487156|P4|Overall Study|Ongoing in Study|9
1580502|NCT02622074|5487157|P3|Overall Study|Ongoing in Study|10
1580503|NCT02622074|5487158|P2|Overall Study|Ongoing in Study|9
1580504|NCT02622074|5487159|P1|Overall Study|Ongoing in Study|6
1580505|NCT02622074|5487154|P6|Overall Study|Withdrawal by Subject|0
1580506|NCT02622074|5487155|P5|Overall Study|Withdrawal by Subject|0
1580507|NCT02622074|5487156|P4|Overall Study|Withdrawal by Subject|0
1580508|NCT02622074|5487157|P3|Overall Study|Withdrawal by Subject|0
1580509|NCT02622074|5487158|P2|Overall Study|Withdrawal by Subject|1
1580510|NCT02622074|5487159|P1|Overall Study|Withdrawal by Subject|0
1580511|NCT02622074|5487154|P6|Overall Study|Death|0
1580512|NCT02622074|5487155|P5|Overall Study|Death|0
1580513|NCT02622074|5487156|P4|Overall Study|Death|1
1580514|NCT02622074|5487157|P3|Overall Study|Death|0
1580515|NCT02622074|5487158|P2|Overall Study|Death|0
1580516|NCT02622074|5487159|P1|Overall Study|Death|4
1580517|NCT02621931|5487251|P3|Overall Study|Other|3
1580518|NCT02621931|5487252|P2|Overall Study|Other|1
1580519|NCT02621931|5487253|P1|Overall Study|Other|1
1580520|NCT02621931|5487251|P3|Overall Study|Lack of Efficacy|1
1580521|NCT02621931|5487252|P2|Overall Study|Lack of Efficacy|0
1580522|NCT02621931|5487253|P1|Overall Study|Lack of Efficacy|0
1580523|NCT02621931|5487251|P3|Overall Study|Lost to Follow-up|10
1580524|NCT02621931|5487252|P2|Overall Study|Lost to Follow-up|7
1580525|NCT02621931|5487253|P1|Overall Study|Lost to Follow-up|8
1580526|NCT02621931|5487251|P3|Overall Study|Noncompliance to study procedures|2
1580527|NCT02621931|5487252|P2|Overall Study|Noncompliance to study procedures|1
1580528|NCT02621931|5487253|P1|Overall Study|Noncompliance to study procedures|0
1580529|NCT02621931|5487251|P3|Overall Study|Pregnancy|0
1580530|NCT02621931|5487252|P2|Overall Study|Pregnancy|0
1580531|NCT02621931|5487253|P1|Overall Study|Pregnancy|2
1580532|NCT02621931|5487251|P3|Overall Study|Protocol Violation|2
1580533|NCT02621931|5487252|P2|Overall Study|Protocol Violation|2
1580534|NCT02621931|5487253|P1|Overall Study|Protocol Violation|2
1580535|NCT02621931|5487251|P3|Overall Study|Withdrawal by Subject|11
1580536|NCT02621931|5487252|P2|Overall Study|Withdrawal by Subject|10
1580537|NCT02621931|5487253|P1|Overall Study|Withdrawal by Subject|12
1580538|NCT02621931|5487251|P3|Overall Study|Adverse Event|7
1580539|NCT02621931|5487252|P2|Overall Study|Adverse Event|5
1580540|NCT02621931|5487253|P1|Overall Study|Adverse Event|8
1580541|NCT02621931|5487251|P3|Overall Study|Death|0
1580542|NCT02621931|5487252|P2|Overall Study|Death|1
1580543|NCT02621931|5487253|P1|Overall Study|Death|0
1580544|NCT02621606|5487316|P3|Overall Study|Withdrawal by Subject|0
1580545|NCT02621606|5487317|P2|Overall Study|Withdrawal by Subject|1
1580546|NCT02621606|5487318|P1|Overall Study|Withdrawal by Subject|0
1580547|NCT02621073|5487346|P2|Overall Study|Physician Decision|2
1580548|NCT02621073|5487347|P1|Overall Study|Physician Decision|3
1580549|NCT02621073|5487346|P2|Overall Study|Lost to Follow-up|1
1580550|NCT02621073|5487347|P1|Overall Study|Lost to Follow-up|0
1580551|NCT02621047|5487409|P3|Overall Study|Adverse Event|1
1580552|NCT02621047|5487410|P2|Overall Study|Adverse Event|0
1580553|NCT02621047|5487411|P1|Overall Study|Adverse Event|0
1580554|NCT02621034|5487527|P3|Overall Study|Lost to Follow-up|5
1580555|NCT02621034|5487528|P2|Overall Study|Lost to Follow-up|2
1580556|NCT02621034|5487529|P1|Overall Study|Lost to Follow-up|3
1580557|NCT02620787|5487554|P2|Overall Study|Eligibility Criteria Not Met|0
1580558|NCT02620787|5487555|P1|Overall Study|Eligibility Criteria Not Met|1
1580559|NCT02620787|5487554|P2|Overall Study|Adverse Event|0
1580560|NCT02620787|5487555|P1|Overall Study|Adverse Event|1
1580561|NCT02620384|5487597|P2|Overall Study|Drug shortage prevented 2nd dose|1
1580562|NCT02620384|5487598|P1|Overall Study|Drug shortage prevented 2nd dose|0
1580563|NCT02620384|5487597|P2|Overall Study|Discharged prior to 2nd dose|5
1580564|NCT02620384|5487598|P1|Overall Study|Discharged prior to 2nd dose|2
1580565|NCT02620384|5487597|P2|Overall Study|Adverse Event|1
1580566|NCT02620384|5487598|P1|Overall Study|Adverse Event|2
1580567|NCT02620020|5487630|P4|Overall Study|Death|0
1580568|NCT02620020|5487631|P3|Overall Study|Death|0
1580569|NCT02620020|5487632|P2|Overall Study|Death|1
1580570|NCT02620020|5487633|P1|Overall Study|Death|0
1580571|NCT02620020|5487630|P4|Overall Study|Withdrawal by Subject|12
1580572|NCT02620020|5487631|P3|Overall Study|Withdrawal by Subject|17
1580573|NCT02620020|5487632|P2|Overall Study|Withdrawal by Subject|16
1580574|NCT02620020|5487633|P1|Overall Study|Withdrawal by Subject|20
1580575|NCT02620020|5487630|P4|Overall Study|Protocol Violation|1
1580576|NCT02620020|5487631|P3|Overall Study|Protocol Violation|1
1580577|NCT02620020|5487632|P2|Overall Study|Protocol Violation|2
1580578|NCT02620020|5487633|P1|Overall Study|Protocol Violation|5
1580579|NCT02620020|5487630|P4|Overall Study|Physician Decision|4
1580580|NCT02620020|5487631|P3|Overall Study|Physician Decision|3
1580581|NCT02620020|5487632|P2|Overall Study|Physician Decision|4
1580582|NCT02620020|5487633|P1|Overall Study|Physician Decision|7
1580583|NCT02620020|5487630|P4|Overall Study|Lost to Follow-up|4
1580584|NCT02620020|5487631|P3|Overall Study|Lost to Follow-up|1
1580585|NCT02620020|5487632|P2|Overall Study|Lost to Follow-up|8
1580586|NCT02620020|5487633|P1|Overall Study|Lost to Follow-up|4
1580587|NCT02620020|5487630|P4|Overall Study|Adverse Event|5
1580588|NCT02620020|5487631|P3|Overall Study|Adverse Event|3
1580589|NCT02620020|5487632|P2|Overall Study|Adverse Event|4
1580590|NCT02620020|5487633|P1|Overall Study|Adverse Event|8
1580591|NCT02619812|5487659|P4|Overall Study|Withdrawal by Subject|2
1580592|NCT02619812|5487660|P3|Overall Study|Withdrawal by Subject|1
1580593|NCT02619812|5487661|P2|Overall Study|Withdrawal by Subject|0
1580594|NCT02619812|5487662|P1|Overall Study|Withdrawal by Subject|0
1580595|NCT02619617|5487695|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
1580596|NCT02619617|5487696|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
1580597|NCT02619617|5487695|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
1580598|NCT02619617|5487696|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
1580599|NCT02619175|5487743|P2|Overall Study|foot pain|0
1580600|NCT02619175|5487744|P1|Overall Study|foot pain|1
1580601|NCT02619175|5487743|P2|Overall Study|Withdrawal by Subject|0
1580602|NCT02619175|5487744|P1|Overall Study|Withdrawal by Subject|1
1580603|NCT02618928|5487758|P1|Overall Study|Treatment Never Started|7
1580604|NCT02618928|5487758|P1|Overall Study|Missing|6
1580605|NCT02618928|5487758|P1|Overall Study|Other|11
1580606|NCT02618928|5487758|P1|Overall Study|Death|3
1580607|NCT02618928|5487758|P1|Overall Study|Withdrawal by Subject|2
1580608|NCT02618928|5487758|P1|Overall Study|Insufficient Virological Response|1
1580609|NCT02618928|5487758|P1|Overall Study|Failure to Return|28
1580610|NCT02618759|5487853|P2|Overall Study|Other Reasons|4
1580611|NCT02618759|5487854|P1|Overall Study|Other Reasons|1
1580612|NCT02618759|5487853|P2|Overall Study|Withdrawal by Subject|0
1580613|NCT02618759|5487854|P1|Overall Study|Withdrawal by Subject|1
1580614|NCT02618759|5487853|P2|Overall Study|Lost to Follow-up|1
1580615|NCT02618759|5487854|P1|Overall Study|Lost to Follow-up|0
1580616|NCT02616900|5488040|P1|Overall Study|Incomplete data|6
1580617|NCT02616900|5488040|P1|Overall Study|Withdrawal by Subject|3
1580618|NCT02616900|5488040|P1|Overall Study|Protocol Violation|5
1580619|NCT02616900|5488040|P1|Overall Study|Lost to Follow-up|2
1580620|NCT02616900|5488040|P1|Overall Study|Lack of Efficacy|7
1580621|NCT02616783|5488048|P2|Overall Study|Withdrew Consent|1
1580622|NCT02616783|5488049|P1|Overall Study|Withdrew Consent|1
1580623|NCT02616783|5488048|P2|Overall Study|Protocol Violation|1
1580624|NCT02616783|5488049|P1|Overall Study|Protocol Violation|1
1580625|NCT02616783|5488048|P2|Overall Study|Non-Compliance with Study Drug|0
1580626|NCT02616783|5488049|P1|Overall Study|Non-Compliance with Study Drug|1
1580627|NCT02616783|5488048|P2|Overall Study|Death|0
1580628|NCT02616783|5488049|P1|Overall Study|Death|1
1580629|NCT02616783|5488048|P2|Overall Study|Adverse Event|0
1580630|NCT02616783|5488049|P1|Overall Study|Adverse Event|1
1580631|NCT02616783|5488048|P2|Overall Study|Randomized but Not Treated|0
1580632|NCT02616783|5488049|P1|Overall Study|Randomized but Not Treated|1
1580633|NCT02616601|5488072|P3|Overall Study|Non-Compliance with Test Article|1
1580634|NCT02616601|5488073|P2|Overall Study|Non-Compliance with Test Article|0
1580635|NCT02616601|5488074|P1|Overall Study|Non-Compliance with Test Article|1
1580636|NCT02616601|5488072|P3|Overall Study|Lost to Follow-up|1
1580637|NCT02616601|5488073|P2|Overall Study|Lost to Follow-up|0
1580638|NCT02616601|5488074|P1|Overall Study|Lost to Follow-up|1
1580639|NCT02616601|5488072|P3|Overall Study|Death|0
1580640|NCT02616601|5488073|P2|Overall Study|Death|0
1580641|NCT02616601|5488074|P1|Overall Study|Death|1
1580642|NCT02616601|5488072|P3|Overall Study|Adverse Event|2
1580643|NCT02616601|5488073|P2|Overall Study|Adverse Event|0
1580644|NCT02616601|5488074|P1|Overall Study|Adverse Event|2
1580645|NCT02616601|5488072|P3|Overall Study|Withdrawal by Subject|3
1580646|NCT02616601|5488073|P2|Overall Study|Withdrawal by Subject|4
1580647|NCT02616601|5488074|P1|Overall Study|Withdrawal by Subject|4
1580648|NCT02616380|5488101|P1|Overall Study|Other|2
1580649|NCT02616380|5488101|P1|Overall Study|Lost to Follow-up|1
1580650|NCT02616146|5488125|P2|Overall Study|Physician Decision|1
1580651|NCT02616146|5488126|P1|Overall Study|Physician Decision|2
1580652|NCT02616146|5488125|P2|Overall Study|Withdrawal by Subject|24
1580653|NCT02616146|5488126|P1|Overall Study|Withdrawal by Subject|30
1580654|NCT02616146|5488125|P2|Overall Study|Participant moved|3
1580655|NCT02616146|5488126|P1|Overall Study|Participant moved|4
1580656|NCT02616146|5488125|P2|Overall Study|Study terminated by sponsor|432
1580657|NCT02616146|5488126|P1|Overall Study|Study terminated by sponsor|1372
1580658|NCT02616146|5488125|P2|Overall Study|Protocol Violation|3
1580659|NCT02616146|5488126|P1|Overall Study|Protocol Violation|6
1580660|NCT02616146|5488125|P2|Overall Study|Pregnancy wish|0
1580661|NCT02616146|5488126|P1|Overall Study|Pregnancy wish|3
1580662|NCT02616146|5488125|P2|Overall Study|Pregnancy|2
1580663|NCT02616146|5488126|P1|Overall Study|Pregnancy|2
1580664|NCT02616146|5488125|P2|Overall Study|Non-compliance with study drug|2
1580665|NCT02616146|5488126|P1|Overall Study|Non-compliance with study drug|4
1580666|NCT02616146|5488125|P2|Overall Study|Non-compliance with study protocol|0
1580667|NCT02616146|5488126|P1|Overall Study|Non-compliance with study protocol|2
1580668|NCT02616146|5488125|P2|Overall Study|Lost to Follow-up|13
1580669|NCT02616146|5488126|P1|Overall Study|Lost to Follow-up|23
1580670|NCT02616146|5488125|P2|Overall Study|Adverse Event|24
1580671|NCT02616146|5488126|P1|Overall Study|Adverse Event|64
1580672|NCT02616029|5488142|P2|Overall Study|Still on Study|8
1580673|NCT02616029|5488143|P1|Overall Study|Still on Study|0
1580674|NCT02616029|5488142|P2|Overall Study|Withdrew Consent|0
1580675|NCT02616029|5488143|P1|Overall Study|Withdrew Consent|1
1580676|NCT02616029|5488142|P2|Overall Study|Protocol Violation|0
1580677|NCT02616029|5488143|P1|Overall Study|Protocol Violation|1
1580678|NCT02616029|5488142|P2|Overall Study|Adverse Event|0
1580679|NCT02616029|5488143|P1|Overall Study|Adverse Event|1
1580680|NCT02616029|5488142|P2|Overall Study|Enrolled and Never Treated|1
1580681|NCT02616029|5488143|P1|Overall Study|Enrolled and Never Treated|1
1580682|NCT02615990|5488166|P2|Overall Study|study terminated|1
1580683|NCT02615990|5488167|P1|Overall Study|study terminated|1
1580684|NCT02615470|5488266|P2|Overall Study|Lost to Follow-up|32
1580685|NCT02615470|5488267|P1|Overall Study|Lost to Follow-up|21
1580686|NCT02615145|5488280|P4|Overall Study|Other, Not Specified|0
1580687|NCT02615145|5488281|P3|Overall Study|Other, Not Specified|0
1580688|NCT02615145|5488282|P2|Overall Study|Other, Not Specified|2
1580689|NCT02615145|5488283|P1|Overall Study|Other, Not Specified|5
1580690|NCT02615145|5488280|P4|Overall Study|Death|0
1580691|NCT02615145|5488281|P3|Overall Study|Death|0
1580692|NCT02615145|5488282|P2|Overall Study|Death|3
1580693|NCT02615145|5488283|P1|Overall Study|Death|2
1580694|NCT02615145|5488280|P4|Overall Study|Failure to Return|0
1580695|NCT02615145|5488281|P3|Overall Study|Failure to Return|7
1580696|NCT02615145|5488282|P2|Overall Study|Failure to Return|10
1580697|NCT02615145|5488283|P1|Overall Study|Failure to Return|20
1580698|NCT02615145|5488280|P4|Overall Study|Did Not Start Treatment|1
1580699|NCT02615145|5488281|P3|Overall Study|Did Not Start Treatment|1
1580700|NCT02615145|5488282|P2|Overall Study|Did Not Start Treatment|0
1580701|NCT02615145|5488283|P1|Overall Study|Did Not Start Treatment|0
1580702|NCT02614898|5488370|P2|Overall Study|Missing|1
1580703|NCT02614898|5488371|P1|Overall Study|Missing|0
1580704|NCT02614898|5488370|P2|Overall Study|Other-Additional Information Unavailable|11
1580705|NCT02614898|5488371|P1|Overall Study|Other-Additional Information Unavailable|0
1580706|NCT02614898|5488370|P2|Overall Study|Withdrawal by Parent/Guardian|1
1580707|NCT02614898|5488371|P1|Overall Study|Withdrawal by Parent/Guardian|1
1580708|NCT02614898|5488370|P2|Overall Study|Withdrawal by Subject|2
1580709|NCT02614898|5488371|P1|Overall Study|Withdrawal by Subject|0
1580710|NCT02614898|5488370|P2|Overall Study|Study Terminated by Sponsor|0
1580711|NCT02614898|5488371|P1|Overall Study|Study Terminated by Sponsor|3
1580712|NCT02614898|5488370|P2|Overall Study|Physician Decision|8
1580713|NCT02614898|5488371|P1|Overall Study|Physician Decision|1
1580714|NCT02614898|5488370|P2|Overall Study|Lost to Follow-up|2
1580715|NCT02614898|5488371|P1|Overall Study|Lost to Follow-up|0
1580716|NCT02614898|5488370|P2|Overall Study|Participated until study termination|26
1580717|NCT02614898|5488371|P1|Overall Study|Participated until study termination|10
1580718|NCT02614729|5488383|P2|Overall Study|Withdrawal by Subject|0
1580719|NCT02614729|5488384|P1|Overall Study|Withdrawal by Subject|1
1580720|NCT02614703|5488404|P2|Overall Study|Withdrawal by Subject|1
1580721|NCT02614703|5488405|P1|Overall Study|Withdrawal by Subject|7
1580722|NCT02614560|5488449|P2|Overall Study|Death|2
1580723|NCT02614560|5488450|P1|Overall Study|Death|6
1580724|NCT02614287|5488498|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
1580725|NCT02614287|5488499|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
1580726|NCT02614287|5488498|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
1580727|NCT02614287|5488499|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
1580728|NCT02614287|5488498|P2|Post Treatment Follow-up Phase|Adverse Event|0
1580729|NCT02614287|5488499|P1|Post Treatment Follow-up Phase|Adverse Event|1
1580730|NCT02614287|5488498|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
1580731|NCT02614287|5488499|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
1580732|NCT02614287|5488498|P2|Open Label (OL) Treatment Phase|Physician Decision|0
1580733|NCT02614287|5488499|P1|Open Label (OL) Treatment Phase|Physician Decision|1
1580734|NCT02614287|5488498|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
1580735|NCT02614287|5488499|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
1580736|NCT02614287|5488498|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
1580737|NCT02614287|5488499|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
1580738|NCT02614287|5488498|P2|Open Label (OL) Treatment Phase|Adverse Event|6
1580739|NCT02614287|5488499|P1|Open Label (OL) Treatment Phase|Adverse Event|7
1580740|NCT02614261|5488545|P3|Overall Study|Withdrawal by Subject|7
1580741|NCT02614261|5488546|P2|Overall Study|Withdrawal by Subject|4
1580742|NCT02614261|5488547|P1|Overall Study|Withdrawal by Subject|19
1580743|NCT02614261|5488545|P3|Overall Study|Protocol Violation|0
1580744|NCT02614261|5488546|P2|Overall Study|Protocol Violation|1
1580745|NCT02614261|5488547|P1|Overall Study|Protocol Violation|6
1580746|NCT02614261|5488545|P3|Overall Study|Pregnancy|0
1580747|NCT02614261|5488546|P2|Overall Study|Pregnancy|2
1580748|NCT02614261|5488547|P1|Overall Study|Pregnancy|2
1580749|NCT02614261|5488545|P3|Overall Study|Physician Decision|1
1580750|NCT02614261|5488546|P2|Overall Study|Physician Decision|1
1580751|NCT02614261|5488547|P1|Overall Study|Physician Decision|2
1580752|NCT02614261|5488545|P3|Overall Study|Lost to Follow-up|1
1580753|NCT02614261|5488546|P2|Overall Study|Lost to Follow-up|4
1580754|NCT02614261|5488547|P1|Overall Study|Lost to Follow-up|10
1580755|NCT02614261|5488545|P3|Overall Study|Lack of Efficacy|0
1580756|NCT02614261|5488546|P2|Overall Study|Lack of Efficacy|0
1580757|NCT02614261|5488547|P1|Overall Study|Lack of Efficacy|4
1580758|NCT02614261|5488545|P3|Overall Study|Adverse Event|2
1580759|NCT02614261|5488546|P2|Overall Study|Adverse Event|3
1580760|NCT02614261|5488547|P1|Overall Study|Adverse Event|6
1580761|NCT02614196|5488613|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
1580762|NCT02614196|5488614|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
1580763|NCT02614196|5488615|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
1580764|NCT02614196|5488616|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
1580765|NCT02614196|5488617|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
1580766|NCT02614196|5488618|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
1580767|NCT02614196|5488613|P6|Post Treatment Follow-up Phase|Protocol Violation|0
1580768|NCT02614196|5488614|P5|Post Treatment Follow-up Phase|Protocol Violation|1
1580769|NCT02614196|5488615|P4|Post Treatment Follow-up Phase|Protocol Violation|0
1580770|NCT02614196|5488616|P3|Post Treatment Follow-up Phase|Protocol Violation|0
1580771|NCT02614196|5488617|P2|Post Treatment Follow-up Phase|Protocol Violation|1
1580772|NCT02614196|5488618|P1|Post Treatment Follow-up Phase|Protocol Violation|0
1580773|NCT02614196|5488613|P6|Post Treatment Follow-up Phase|Pregnancy|0
1580774|NCT02614196|5488614|P5|Post Treatment Follow-up Phase|Pregnancy|0
1580775|NCT02614196|5488615|P4|Post Treatment Follow-up Phase|Pregnancy|0
1580776|NCT02614196|5488616|P3|Post Treatment Follow-up Phase|Pregnancy|0
1580777|NCT02614196|5488617|P2|Post Treatment Follow-up Phase|Pregnancy|0
1580778|NCT02614196|5488618|P1|Post Treatment Follow-up Phase|Pregnancy|2
1580779|NCT02614196|5488613|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
1580780|NCT02614196|5488614|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
1580781|NCT02614196|5488615|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
1580782|NCT02614196|5488616|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
1580783|NCT02614196|5488617|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
1580784|NCT02614196|5488618|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
1580785|NCT02614196|5488613|P6|Double Blind Treatment Phase|Did not receive study drug|0
1580786|NCT02614196|5488614|P5|Double Blind Treatment Phase|Did not receive study drug|0
1580787|NCT02614196|5488615|P4|Double Blind Treatment Phase|Did not receive study drug|0
1580788|NCT02614196|5488616|P3|Double Blind Treatment Phase|Did not receive study drug|3
1580789|NCT02614196|5488617|P2|Double Blind Treatment Phase|Did not receive study drug|2
1580790|NCT02614196|5488618|P1|Double Blind Treatment Phase|Did not receive study drug|2
1580791|NCT02614196|5488613|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
1580792|NCT02614196|5488614|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
1580793|NCT02614196|5488615|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
1580794|NCT02614196|5488616|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
1580795|NCT02614196|5488617|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
1580796|NCT02614196|5488618|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
1580797|NCT02614196|5488613|P6|Double Blind Treatment Phase|Terminated by sponsor|0
1580798|NCT02614196|5488614|P5|Double Blind Treatment Phase|Terminated by sponsor|0
1580799|NCT02614196|5488615|P4|Double Blind Treatment Phase|Terminated by sponsor|0
1580800|NCT02614196|5488616|P3|Double Blind Treatment Phase|Terminated by sponsor|0
1580801|NCT02614196|5488617|P2|Double Blind Treatment Phase|Terminated by sponsor|0
1580802|NCT02614196|5488618|P1|Double Blind Treatment Phase|Terminated by sponsor|1
1580803|NCT02614196|5488613|P6|Double Blind Treatment Phase|Protocol Violation|0
1580804|NCT02614196|5488614|P5|Double Blind Treatment Phase|Protocol Violation|1
1580805|NCT02614196|5488615|P4|Double Blind Treatment Phase|Protocol Violation|0
1580806|NCT02614196|5488616|P3|Double Blind Treatment Phase|Protocol Violation|1
1580807|NCT02614196|5488617|P2|Double Blind Treatment Phase|Protocol Violation|2
1580808|NCT02614196|5488618|P1|Double Blind Treatment Phase|Protocol Violation|5
1580809|NCT02614196|5488613|P6|Double Blind Treatment Phase|Pregnancy|0
1580810|NCT02614196|5488614|P5|Double Blind Treatment Phase|Pregnancy|0
1580811|NCT02614196|5488615|P4|Double Blind Treatment Phase|Pregnancy|0
1580812|NCT02614196|5488616|P3|Double Blind Treatment Phase|Pregnancy|0
1580813|NCT02614196|5488617|P2|Double Blind Treatment Phase|Pregnancy|2
1580814|NCT02614196|5488618|P1|Double Blind Treatment Phase|Pregnancy|1
1580815|NCT02614196|5488613|P6|Double Blind Treatment Phase|Physician Decision|0
1580816|NCT02614196|5488614|P5|Double Blind Treatment Phase|Physician Decision|0
1580817|NCT02614196|5488615|P4|Double Blind Treatment Phase|Physician Decision|0
1580818|NCT02614196|5488616|P3|Double Blind Treatment Phase|Physician Decision|2
1580819|NCT02614196|5488617|P2|Double Blind Treatment Phase|Physician Decision|0
1580820|NCT02614196|5488618|P1|Double Blind Treatment Phase|Physician Decision|4
1580821|NCT02614196|5488613|P6|Double Blind Treatment Phase|Lost to Follow-up|0
1580822|NCT02614196|5488614|P5|Double Blind Treatment Phase|Lost to Follow-up|0
1580823|NCT02614196|5488615|P4|Double Blind Treatment Phase|Lost to Follow-up|0
1580824|NCT02614196|5488616|P3|Double Blind Treatment Phase|Lost to Follow-up|1
1580825|NCT02614196|5488617|P2|Double Blind Treatment Phase|Lost to Follow-up|7
1580826|NCT02614196|5488618|P1|Double Blind Treatment Phase|Lost to Follow-up|10
1580827|NCT02614196|5488613|P6|Double Blind Treatment Phase|Lack of Efficacy|0
1580828|NCT02614196|5488614|P5|Double Blind Treatment Phase|Lack of Efficacy|0
1580829|NCT02614196|5488615|P4|Double Blind Treatment Phase|Lack of Efficacy|0
1580830|NCT02614196|5488616|P3|Double Blind Treatment Phase|Lack of Efficacy|1
1580831|NCT02614196|5488617|P2|Double Blind Treatment Phase|Lack of Efficacy|1
1580832|NCT02614196|5488618|P1|Double Blind Treatment Phase|Lack of Efficacy|6
1580833|NCT02614196|5488613|P6|Double Blind Treatment Phase|Adverse Event|0
1580834|NCT02614196|5488614|P5|Double Blind Treatment Phase|Adverse Event|0
1580835|NCT02614196|5488615|P4|Double Blind Treatment Phase|Adverse Event|0
1580836|NCT02614196|5488616|P3|Double Blind Treatment Phase|Adverse Event|9
1580837|NCT02614196|5488617|P2|Double Blind Treatment Phase|Adverse Event|5
1580838|NCT02614196|5488618|P1|Double Blind Treatment Phase|Adverse Event|8
1580839|NCT02614183|5488664|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
1580840|NCT02614183|5488665|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
1580841|NCT02614183|5488666|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
1580842|NCT02614183|5488664|P3|Post Treatment Follow-up Phase|Protocol Violation|0
1580843|NCT02614183|5488665|P2|Post Treatment Follow-up Phase|Protocol Violation|0
1580844|NCT02614183|5488666|P1|Post Treatment Follow-up Phase|Protocol Violation|1
1580845|NCT02614183|5488664|P3|Post Treatment Follow-up Phase|Physician Decision|2
1580846|NCT02614183|5488665|P2|Post Treatment Follow-up Phase|Physician Decision|1
1580847|NCT02614183|5488666|P1|Post Treatment Follow-up Phase|Physician Decision|5
1580848|NCT02614183|5488664|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
1580849|NCT02614183|5488665|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
1580850|NCT02614183|5488666|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
1580851|NCT02614183|5488664|P3|Double Blind Treatment Phase|Did not receive study drug|2
1580852|NCT02614183|5488665|P2|Double Blind Treatment Phase|Did not receive study drug|1
1580853|NCT02614183|5488666|P1|Double Blind Treatment Phase|Did not receive study drug|1
1580854|NCT02614183|5488664|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
1580855|NCT02614183|5488665|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
1580856|NCT02614183|5488666|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
1580857|NCT02614183|5488664|P3|Double Blind Treatment Phase|Protocol Violation|2
1580858|NCT02614183|5488665|P2|Double Blind Treatment Phase|Protocol Violation|2
1580859|NCT02614183|5488666|P1|Double Blind Treatment Phase|Protocol Violation|2
1580860|NCT02614183|5488664|P3|Double Blind Treatment Phase|Pregnancy|3
1580861|NCT02614183|5488665|P2|Double Blind Treatment Phase|Pregnancy|1
1580862|NCT02614183|5488666|P1|Double Blind Treatment Phase|Pregnancy|2
1580863|NCT02614183|5488664|P3|Double Blind Treatment Phase|Physician Decision|2
1580864|NCT02614183|5488665|P2|Double Blind Treatment Phase|Physician Decision|3
1580865|NCT02614183|5488666|P1|Double Blind Treatment Phase|Physician Decision|7
1580866|NCT02614183|5488664|P3|Double Blind Treatment Phase|Lost to Follow-up|5
1580867|NCT02614183|5488665|P2|Double Blind Treatment Phase|Lost to Follow-up|9
1580868|NCT02614183|5488666|P1|Double Blind Treatment Phase|Lost to Follow-up|18
1580869|NCT02614183|5488664|P3|Double Blind Treatment Phase|Lack of Efficacy|2
1580870|NCT02614183|5488665|P2|Double Blind Treatment Phase|Lack of Efficacy|1
1580871|NCT02614183|5488666|P1|Double Blind Treatment Phase|Lack of Efficacy|10
1580872|NCT02614183|5488664|P3|Double Blind Treatment Phase|Adverse Event|7
1580873|NCT02614183|5488665|P2|Double Blind Treatment Phase|Adverse Event|9
1580874|NCT02614183|5488666|P1|Double Blind Treatment Phase|Adverse Event|10
1580875|NCT02614131|5488710|P7|Overall Study|Adverse Event|1
1580876|NCT02614131|5488711|P6|Overall Study|Adverse Event|0
1580877|NCT02614131|5488712|P5|Overall Study|Adverse Event|0
1580878|NCT02614131|5488713|P4|Overall Study|Adverse Event|0
1580879|NCT02614131|5488714|P3|Overall Study|Adverse Event|0
1580880|NCT02614131|5488715|P2|Overall Study|Adverse Event|0
1580881|NCT02614131|5488716|P1|Overall Study|Adverse Event|0
1580882|NCT02614131|5488710|P7|Overall Study|Withdrawal by Subject|0
1580883|NCT02614131|5488711|P6|Overall Study|Withdrawal by Subject|0
1580884|NCT02614131|5488712|P5|Overall Study|Withdrawal by Subject|0
1580885|NCT02614131|5488713|P4|Overall Study|Withdrawal by Subject|0
1580886|NCT02614131|5488714|P3|Overall Study|Withdrawal by Subject|0
1580887|NCT02614131|5488715|P2|Overall Study|Withdrawal by Subject|0
1580888|NCT02614131|5488716|P1|Overall Study|Withdrawal by Subject|1
1580889|NCT02614079|5488747|P1|Overall Study|Withdrawal by Subject|1
1580890|NCT02613910|5488751|P1|Overall Study|Termination of study|1
1580891|NCT02613871|5488837|P1|Overall Study|Withdrew Consent|1
1580892|NCT02613871|5488837|P1|Overall Study|Death|2
1580893|NCT02613507|5488858|P2|Overall Study|Randomized but not Treated|10
1580894|NCT02613507|5488859|P1|Overall Study|Randomized but not Treated|1
1580895|NCT02613507|5488858|P2|Overall Study|Subject no Longer Meets Study Criteria|0
1580896|NCT02613507|5488859|P1|Overall Study|Subject no Longer Meets Study Criteria|1
1580897|NCT02613507|5488858|P2|Overall Study|Brain Radiotherapy Activity Limited|0
1580898|NCT02613507|5488859|P1|Overall Study|Brain Radiotherapy Activity Limited|1
1580899|NCT02613507|5488858|P2|Overall Study|Maximum Clinical Benefit|10
1580900|NCT02613507|5488859|P1|Overall Study|Maximum Clinical Benefit|4
1580901|NCT02613507|5488858|P2|Overall Study|Lost to Follow-up|0
1580902|NCT02613507|5488859|P1|Overall Study|Lost to Follow-up|1
1580903|NCT02613507|5488858|P2|Overall Study|Participant Withdrew Consent|2
1580904|NCT02613507|5488859|P1|Overall Study|Participant Withdrew Consent|0
1580905|NCT02613507|5488858|P2|Overall Study|Request to Discontinue Study Treatment|17
1580906|NCT02613507|5488859|P1|Overall Study|Request to Discontinue Study Treatment|8
1580907|NCT02613507|5488858|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
1580908|NCT02613507|5488859|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
1580909|NCT02613507|5488858|P2|Overall Study|Death|0
1580910|NCT02613507|5488859|P1|Overall Study|Death|3
1580911|NCT02613507|5488858|P2|Overall Study|Study Drug Toxicity|14
1580912|NCT02613507|5488859|P1|Overall Study|Study Drug Toxicity|15
1580913|NCT02613507|5488858|P2|Overall Study|Disease Progression|109
1580914|NCT02613507|5488859|P1|Overall Study|Disease Progression|237
1580915|NCT02613481|5488875|P1|Overall Study|Withdrawal by Subject|2
1580916|NCT02613481|5488875|P1|Overall Study|Lost to Follow-up|7
1580917|NCT02613403|5488886|P5|Overall Study|Withdrawal by Subject|0
1580918|NCT02613403|5488887|P4|Overall Study|Withdrawal by Subject|0
1580919|NCT02613403|5488888|P3|Overall Study|Withdrawal by Subject|0
1580920|NCT02613403|5488889|P2|Overall Study|Withdrawal by Subject|0
1580921|NCT02613403|5488890|P1|Overall Study|Withdrawal by Subject|2
1580922|NCT02613403|5488886|P5|Overall Study|Lost to Follow-up|0
1580923|NCT02613403|5488887|P4|Overall Study|Lost to Follow-up|0
1580924|NCT02613403|5488888|P3|Overall Study|Lost to Follow-up|0
1580925|NCT02613403|5488889|P2|Overall Study|Lost to Follow-up|1
1580926|NCT02613403|5488890|P1|Overall Study|Lost to Follow-up|0
1580927|NCT02613221|5488942|P1|Overall Study|Enrolled but Not Treated|1
1580928|NCT02613221|5488942|P1|Overall Study|Delayed Treatment|1
1580929|NCT02613221|5488942|P1|Overall Study|Voluntary Discontinuation|1
1580930|NCT02613221|5488942|P1|Overall Study|Adverse Event|2
1580931|NCT02613221|5488942|P1|Overall Study|Lack of efficacy (exacerbation)|50
1580937|NCT02613182|5488968|P1|Overall Study|Withdrawal by Subject|6
1580938|NCT02613182|5488968|P1|Overall Study|Study Terminated by Sponsor|21
1580939|NCT02613182|5488968|P1|Overall Study|Physician Decision|1
1580940|NCT02613182|5488968|P1|Overall Study|Death|6
1580941|NCT02612909|5488977|P5|Phase 3|Withdrawal by Subject|0
1580942|NCT02612909|5488978|P4|Phase 3|Withdrawal by Subject|1
1580943|NCT02612909|5488979|P3|Phase 3|Withdrawal by Subject|0
1580944|NCT02612909|5488980|P2|Phase 3|Withdrawal by Subject|0
1580945|NCT02612909|5488981|P1|Phase 3|Withdrawal by Subject|0
1580946|NCT02612909|5488977|P5|Phase 2|Pregnancy|0
1580947|NCT02612909|5488978|P4|Phase 2|Pregnancy|0
1580948|NCT02612909|5488979|P3|Phase 2|Pregnancy|1
1580949|NCT02612909|5488980|P2|Phase 2|Pregnancy|0
1580950|NCT02612909|5488981|P1|Phase 2|Pregnancy|0
1580951|NCT02612909|5488977|P5|Phase 2|Withdrawal by Subject|0
1580952|NCT02612909|5488978|P4|Phase 2|Withdrawal by Subject|0
1580953|NCT02612909|5488979|P3|Phase 2|Withdrawal by Subject|0
1580954|NCT02612909|5488980|P2|Phase 2|Withdrawal by Subject|5
1580955|NCT02612909|5488981|P1|Phase 2|Withdrawal by Subject|2
1580956|NCT02612727|5489064|P2|Overall Study|Direct hyperbilirubinemia|2
1580957|NCT02612727|5489065|P1|Overall Study|Direct hyperbilirubinemia|0
1580958|NCT02612727|5489064|P2|Overall Study|Needed treatment incompatible with PT|1
1580959|NCT02612727|5489065|P1|Overall Study|Needed treatment incompatible with PT|1
1580960|NCT02612727|5489064|P2|Overall Study|Parent request|1
1580961|NCT02612727|5489065|P1|Overall Study|Parent request|4
1580962|NCT02612623|5489077|P4|Overall Study|Adverse Event|0
1580963|NCT02612623|5489078|P3|Overall Study|Adverse Event|1
1580964|NCT02612623|5489079|P2|Overall Study|Adverse Event|0
1580965|NCT02612623|5489080|P1|Overall Study|Adverse Event|1
1580966|NCT02612623|5489077|P4|Overall Study|Withdrawal by Subject|0
1580967|NCT02612623|5489078|P3|Overall Study|Withdrawal by Subject|0
1580968|NCT02612623|5489079|P2|Overall Study|Withdrawal by Subject|1
1580969|NCT02612623|5489080|P1|Overall Study|Withdrawal by Subject|0
1580970|NCT02612610|5489094|P4|Overall Study|Cough Improvement|0
1580971|NCT02612610|5489095|P3|Overall Study|Cough Improvement|1
1580972|NCT02612610|5489096|P2|Overall Study|Cough Improvement|0
1580973|NCT02612610|5489097|P1|Overall Study|Cough Improvement|0
1580974|NCT02612610|5489094|P4|Overall Study|Noncompliance|0
1580975|NCT02612610|5489095|P3|Overall Study|Noncompliance|0
1580976|NCT02612610|5489096|P2|Overall Study|Noncompliance|0
1580977|NCT02612610|5489097|P1|Overall Study|Noncompliance|1
1580978|NCT02612610|5489094|P4|Overall Study|Physician Decision|0
1580979|NCT02612610|5489095|P3|Overall Study|Physician Decision|0
1580980|NCT02612610|5489096|P2|Overall Study|Physician Decision|1
1580981|NCT02612610|5489097|P1|Overall Study|Physician Decision|0
1580982|NCT02612610|5489094|P4|Overall Study|Lack of Efficacy|1
1580983|NCT02612610|5489095|P3|Overall Study|Lack of Efficacy|0
1580984|NCT02612610|5489096|P2|Overall Study|Lack of Efficacy|2
1580985|NCT02612610|5489097|P1|Overall Study|Lack of Efficacy|1
1580986|NCT02612610|5489094|P4|Overall Study|Protocol Violation|0
1580987|NCT02612610|5489095|P3|Overall Study|Protocol Violation|1
1580988|NCT02612610|5489096|P2|Overall Study|Protocol Violation|1
1580989|NCT02612610|5489097|P1|Overall Study|Protocol Violation|0
1580990|NCT02612610|5489094|P4|Overall Study|Lost to Follow-up|0
1580991|NCT02612610|5489095|P3|Overall Study|Lost to Follow-up|0
1580992|NCT02612610|5489096|P2|Overall Study|Lost to Follow-up|1
1580993|NCT02612610|5489097|P1|Overall Study|Lost to Follow-up|0
1580994|NCT02612610|5489094|P4|Overall Study|Adverse Event|10
1580995|NCT02612610|5489095|P3|Overall Study|Adverse Event|3
1580996|NCT02612610|5489096|P2|Overall Study|Adverse Event|2
1580997|NCT02612610|5489097|P1|Overall Study|Adverse Event|2
1580998|NCT02612610|5489094|P4|Overall Study|Withdrawal by Subject|2
1580999|NCT02612610|5489095|P3|Overall Study|Withdrawal by Subject|0
1581000|NCT02612610|5489096|P2|Overall Study|Withdrawal by Subject|1
1581001|NCT02612610|5489097|P1|Overall Study|Withdrawal by Subject|1
1581002|NCT02612428|5489341|P2|VTL-308E|Lost to Follow-up|0
1581003|NCT02612428|5489342|P1|VTL-308E|Lost to Follow-up|2
1581004|NCT02612428|5489341|P2|VTL-308E|Death|7
1581005|NCT02612428|5489342|P1|VTL-308E|Death|9
1581006|NCT02612428|5489341|P2|VTL-308|Withdrawal by Subject|1
1581007|NCT02612428|5489342|P1|VTL-308|Withdrawal by Subject|0
1581008|NCT02612428|5489341|P2|VTL-308|Death|16
1581009|NCT02612428|5489342|P1|VTL-308|Death|14
1581010|NCT02612285|5489352|P1|Overall Study|Withdrawal by Subject|1
1581011|NCT02612077|5489356|P1|Overall Study|Unknown reason|2
1581012|NCT02612077|5489356|P1|Overall Study|Disease Progression|3
1581013|NCT02612077|5489356|P1|Overall Study|Enrollment in a Clinical Trial|1
1581014|NCT02612077|5489356|P1|Overall Study|Moved or Changed Medical Team|23
1581015|NCT02612077|5489356|P1|Overall Study|Death|377
1581016|NCT02612077|5489356|P1|Overall Study|Lost to Follow-up|20
1581017|NCT02612077|5489356|P1|Overall Study|Protocol Violation|28
1581018|NCT02612077|5489356|P1|Overall Study|Withdrawal by Subject|9
1581019|NCT02612077|5489356|P1|Overall Study|Adverse Event|3
1581020|NCT02612064|5489368|P2|Overall Study|Other|2
1581021|NCT02612064|5489369|P1|Overall Study|Other|0
1581022|NCT02612064|5489368|P2|Overall Study|Withdrawal by Subject|1
1581023|NCT02612064|5489369|P1|Overall Study|Withdrawal by Subject|1
1581024|NCT02611830|5489383|P4|Maintenance Phase|Reason not specified|0
1581025|NCT02611830|5489384|P3|Maintenance Phase|Reason not specified|4
1581026|NCT02611830|5489385|P2|Maintenance Phase|Reason not specified|1
1581027|NCT02611830|5489386|P1|Maintenance Phase|Reason not specified|0
1581028|NCT02611830|5489383|P4|Maintenance Phase|Pregnancy|0
1581029|NCT02611830|5489384|P3|Maintenance Phase|Pregnancy|1
1581030|NCT02611830|5489385|P2|Maintenance Phase|Pregnancy|0
1581031|NCT02611830|5489386|P1|Maintenance Phase|Pregnancy|0
1581032|NCT02611830|5489383|P4|Maintenance Phase|Voluntary Withdrawal|5
1581033|NCT02611830|5489384|P3|Maintenance Phase|Voluntary Withdrawal|2
1581034|NCT02611830|5489385|P2|Maintenance Phase|Voluntary Withdrawal|1
1581035|NCT02611830|5489386|P1|Maintenance Phase|Voluntary Withdrawal|0
1581036|NCT02611830|5489383|P4|Maintenance Phase|Lost to Follow-up|1
1581037|NCT02611830|5489384|P3|Maintenance Phase|Lost to Follow-up|0
1581038|NCT02611830|5489385|P2|Maintenance Phase|Lost to Follow-up|0
1581039|NCT02611830|5489386|P1|Maintenance Phase|Lost to Follow-up|0
1581040|NCT02611830|5489383|P4|Maintenance Phase|Significant Protocol Deviation|1
1581041|NCT02611830|5489384|P3|Maintenance Phase|Significant Protocol Deviation|1
1581042|NCT02611830|5489385|P2|Maintenance Phase|Significant Protocol Deviation|0
1581043|NCT02611830|5489386|P1|Maintenance Phase|Significant Protocol Deviation|0
1581044|NCT02611830|5489383|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
1581045|NCT02611830|5489384|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
1581046|NCT02611830|5489385|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
1581047|NCT02611830|5489386|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
1581048|NCT02611830|5489383|P4|Maintenance Phase|Lack of Efficacy|6
1581049|NCT02611830|5489384|P3|Maintenance Phase|Lack of Efficacy|18
1581050|NCT02611830|5489385|P2|Maintenance Phase|Lack of Efficacy|29
1581051|NCT02611830|5489386|P1|Maintenance Phase|Lack of Efficacy|0
1581052|NCT02611830|5489383|P4|OL Induction Phase|Reason not specified|0
1581053|NCT02611830|5489384|P3|OL Induction Phase|Reason not specified|0
1581054|NCT02611830|5489385|P2|OL Induction Phase|Reason not specified|0
1581055|NCT02611830|5489386|P1|OL Induction Phase|Reason not specified|3
1581056|NCT02611830|5489383|P4|OL Induction Phase|Lack of Efficacy|0
1581057|NCT02611830|5489384|P3|OL Induction Phase|Lack of Efficacy|0
1581058|NCT02611830|5489385|P2|OL Induction Phase|Lack of Efficacy|0
1581059|NCT02611830|5489386|P1|OL Induction Phase|Lack of Efficacy|9
1581060|NCT02611830|5489383|P4|OL Induction Phase|Voluntary Withdrawal|0
1581061|NCT02611830|5489384|P3|OL Induction Phase|Voluntary Withdrawal|0
1581062|NCT02611830|5489385|P2|OL Induction Phase|Voluntary Withdrawal|0
1581063|NCT02611830|5489386|P1|OL Induction Phase|Voluntary Withdrawal|5
1581064|NCT02611830|5489383|P4|OL Induction Phase|Significant Protocol Deviation|0
1581065|NCT02611830|5489384|P3|OL Induction Phase|Significant Protocol Deviation|0
1581066|NCT02611830|5489385|P2|OL Induction Phase|Significant Protocol Deviation|0
1581067|NCT02611830|5489386|P1|OL Induction Phase|Significant Protocol Deviation|4
1581068|NCT02611830|5489383|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
1581069|NCT02611830|5489384|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
1581070|NCT02611830|5489385|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
1581071|NCT02611830|5489386|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
1581072|NCT02611752|5489418|P2|Overall Study|Adverse Event|1
1581073|NCT02611752|5489419|P1|Overall Study|Adverse Event|0
1581074|NCT02611479|5489451|P1|Data Cleaning|No baseline function or pain metrics|2
1581075|NCT02611479|5489451|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
1581076|NCT02611479|5489451|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
1581077|NCT02611479|5489451|P1|Baseline Enrollment|Exited study|13
1581078|NCT02610842|5489583|P1|Overall Study|Lost to Follow-up|5
1581079|NCT02610816|5489592|P4|Phase 2|Pregnancy|1
1581080|NCT02610816|5489593|P3|Phase 2|Pregnancy|0
1581081|NCT02610816|5489594|P2|Phase 2|Pregnancy|0
1581082|NCT02610816|5489595|P1|Phase 2|Pregnancy|0
1581083|NCT02610816|5489592|P4|Phase 2|Physician Decision|2
1581084|NCT02610816|5489593|P3|Phase 2|Physician Decision|0
1581085|NCT02610816|5489594|P2|Phase 2|Physician Decision|0
1581086|NCT02610816|5489595|P1|Phase 2|Physician Decision|0
1581087|NCT02610816|5489592|P4|Phase 2|Lost to Follow-up|0
1581088|NCT02610816|5489593|P3|Phase 2|Lost to Follow-up|2
1581089|NCT02610816|5489594|P2|Phase 2|Lost to Follow-up|0
1581090|NCT02610816|5489595|P1|Phase 2|Lost to Follow-up|0
1581091|NCT02610816|5489592|P4|Phase 2|Withdrawal by Subject|3
1581092|NCT02610816|5489593|P3|Phase 2|Withdrawal by Subject|9
1581093|NCT02610816|5489594|P2|Phase 2|Withdrawal by Subject|0
1581094|NCT02610816|5489595|P1|Phase 2|Withdrawal by Subject|0
1581095|NCT02610816|5489592|P4|Phase 1|Physician Decision|0
1581096|NCT02610816|5489593|P3|Phase 1|Physician Decision|0
1581097|NCT02610816|5489594|P2|Phase 1|Physician Decision|1
1581098|NCT02610816|5489595|P1|Phase 1|Physician Decision|0
1581099|NCT02610816|5489592|P4|Phase 1|Lost to Follow-up|0
1581100|NCT02610816|5489593|P3|Phase 1|Lost to Follow-up|0
1581101|NCT02610816|5489594|P2|Phase 1|Lost to Follow-up|1
1581102|NCT02610816|5489595|P1|Phase 1|Lost to Follow-up|2
1581103|NCT02610816|5489592|P4|Phase 1|Withdrawal by Subject|0
1581104|NCT02610816|5489593|P3|Phase 1|Withdrawal by Subject|0
1581105|NCT02610816|5489594|P2|Phase 1|Withdrawal by Subject|6
1581106|NCT02610816|5489595|P1|Phase 1|Withdrawal by Subject|2
1581107|NCT02610725|5489616|P1|Overall Study|self-reported contraindication|9
1581108|NCT02610725|5489616|P1|Overall Study|Lost to Follow-up|197
1581109|NCT02610231|5489631|P1|Overall Study|Other|3
1581110|NCT02610231|5489631|P1|Overall Study|Non Compliance|2
1581111|NCT02610231|5489631|P1|Overall Study|Physician Decision|1
1581112|NCT02610231|5489631|P1|Overall Study|Surgery|2
1581113|NCT02610231|5489631|P1|Overall Study|Death|5
1581114|NCT02610231|5489631|P1|Overall Study|Adverse Event|20
1581115|NCT02610231|5489631|P1|Overall Study|Withdrawal by Subject|27
1581116|NCT02610192|5489638|P1|Overall Study|Physician Decision|1
1581117|NCT02610192|5489638|P1|Overall Study|Received other treatment|8
1581118|NCT02609672|5489661|P2|Overall Study|Lost to Follow-up|1
1581119|NCT02609672|5489662|P1|Overall Study|Lost to Follow-up|3
1581120|NCT02609659|5489696|P1|Overall Study|Other|1
1581121|NCT02609659|5489696|P1|Overall Study|Lost to Follow-up|6
1581122|NCT02609659|5489696|P1|Overall Study|Adverse Event|1
1581123|NCT02609633|5489706|P2|Overall Study|Reason not Specified|1
1581124|NCT02609633|5489707|P1|Overall Study|Reason not Specified|2
1581125|NCT02609633|5489706|P2|Overall Study|Non-Compliant with Study Procedures|0
1581126|NCT02609633|5489707|P1|Overall Study|Non-Compliant with Study Procedures|2
1581127|NCT02609633|5489706|P2|Overall Study|Protocol Deviation|0
1581128|NCT02609633|5489707|P1|Overall Study|Protocol Deviation|1
1581129|NCT02609633|5489706|P2|Overall Study|Consent Withdrawn|1
1581130|NCT02609633|5489707|P1|Overall Study|Consent Withdrawn|0
1581131|NCT02609607|5489734|P2|Overall Study|Lost to Follow-up|1
1581132|NCT02609607|5489735|P1|Overall Study|Lost to Follow-up|0
1581133|NCT02609399|5489759|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
1581134|NCT02609399|5489760|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
1581135|NCT02609399|5489759|P2|Influenza Season 2016-2017|Lost to Follow-up|5
1581136|NCT02609399|5489760|P1|Influenza Season 2016-2017|Lost to Follow-up|8
1581137|NCT02609399|5489759|P2|Influenza Season 2015-2016|Lost to Follow-up|2
1581138|NCT02609399|5489760|P1|Influenza Season 2015-2016|Lost to Follow-up|3
1581139|NCT02609178|5489790|P6|First Crown|Withdrawal by Subject|0
1581140|NCT02609178|5489791|P5|First Crown|Withdrawal by Subject|0
1581141|NCT02609178|5489792|P4|First Crown|Withdrawal by Subject|1
1581142|NCT02609178|5489793|P3|First Crown|Withdrawal by Subject|1
1581143|NCT02609178|5489794|P2|First Crown|Withdrawal by Subject|0
1581144|NCT02609178|5489795|P1|First Crown|Withdrawal by Subject|0
1581145|NCT02608892|5489846|P2|Overall Study|Lost to Follow-up|0
1581146|NCT02608892|5489847|P1|Overall Study|Lost to Follow-up|1
1581147|NCT02607956|5489904|P2|Overall Study|Lost to Follow-up|7
1581148|NCT02607956|5489905|P1|Overall Study|Lost to Follow-up|14
1581149|NCT02607956|5489904|P2|Overall Study|Withdrew Consent|14
1581150|NCT02607956|5489905|P1|Overall Study|Withdrew Consent|12
1581151|NCT02607956|5489904|P2|Overall Study|Protocol Violation|1
1581152|NCT02607956|5489905|P1|Overall Study|Protocol Violation|2
1581153|NCT02607956|5489904|P2|Overall Study|Non-Compliance with Study Drug|2
1581154|NCT02607956|5489905|P1|Overall Study|Non-Compliance with Study Drug|0
1581155|NCT02607956|5489904|P2|Overall Study|Investigator's Discretion|2
1581156|NCT02607956|5489905|P1|Overall Study|Investigator's Discretion|7
1581157|NCT02607956|5489904|P2|Overall Study|Death|3
1581158|NCT02607956|5489905|P1|Overall Study|Death|3
1581159|NCT02607956|5489904|P2|Overall Study|Adverse Event|3
1581160|NCT02607956|5489905|P1|Overall Study|Adverse Event|4
1581161|NCT02607956|5489904|P2|Overall Study|Still on Study|293
1581162|NCT02607956|5489905|P1|Overall Study|Still on Study|278
1581163|NCT02607956|5489904|P2|Overall Study|Randomized and Never Treated|5
1581164|NCT02607956|5489905|P1|Overall Study|Randomized and Never Treated|7
1581165|NCT02607930|5489927|P2|Overall Study|Lost to Follow-up|12
1581166|NCT02607930|5489928|P1|Overall Study|Lost to Follow-up|17
1581167|NCT02607930|5489927|P2|Overall Study|Withdrew Consent|9
1581168|NCT02607930|5489928|P1|Overall Study|Withdrew Consent|8
1581169|NCT02607930|5489927|P2|Overall Study|Protocol Violation|2
1581170|NCT02607930|5489928|P1|Overall Study|Protocol Violation|1
1581171|NCT02607930|5489927|P2|Overall Study|Non-Compliance with Study Drug|2
1581172|NCT02607930|5489928|P1|Overall Study|Non-Compliance with Study Drug|2
1581173|NCT02607930|5489927|P2|Overall Study|Investigator's Discretion|0
1581174|NCT02607930|5489928|P1|Overall Study|Investigator's Discretion|4
1581175|NCT02607930|5489927|P2|Overall Study|Death|0
1581176|NCT02607930|5489928|P1|Overall Study|Death|2
1581177|NCT02607930|5489927|P2|Overall Study|Adverse Event|4
1581178|NCT02607930|5489928|P1|Overall Study|Adverse Event|0
1581179|NCT02607930|5489927|P2|Overall Study|Still in Study|286
1581180|NCT02607930|5489928|P1|Overall Study|Still in Study|280
1581181|NCT02607930|5489927|P2|Overall Study|Randomized and Never Treated|0
1581182|NCT02607930|5489928|P1|Overall Study|Randomized and Never Treated|2
1581183|NCT02607800|5489962|P2|Overall Study|Randomized/Enrolled but Not Treated|1
1581184|NCT02607800|5489963|P1|Overall Study|Randomized/Enrolled but Not Treated|1
1581185|NCT02607800|5489962|P2|Overall Study|Withdrew Consent|0
1581186|NCT02607800|5489963|P1|Overall Study|Withdrew Consent|2
1581187|NCT02607800|5489962|P2|Overall Study|Lost to Follow-up|10
1581188|NCT02607800|5489963|P1|Overall Study|Lost to Follow-up|7
1581189|NCT02607735|5489981|P3|Deferred Treatment Substudy|Withdrew Consent|1
1581190|NCT02607735|5489982|P2|Deferred Treatment Substudy|Withdrew Consent|0
1581191|NCT02607735|5489983|P1|Deferred Treatment Substudy|Withdrew Consent|0
1581192|NCT02607735|5489981|P3|Deferred Treatment Substudy|Lost to Follow-up|4
1581193|NCT02607735|5489982|P2|Deferred Treatment Substudy|Lost to Follow-up|0
1581194|NCT02607735|5489983|P1|Deferred Treatment Substudy|Lost to Follow-up|0
1581195|NCT02607735|5489981|P3|Primary Study|Withdrew Consent|0
1581196|NCT02607735|5489982|P2|Primary Study|Withdrew Consent|0
1581197|NCT02607735|5489983|P1|Primary Study|Withdrew Consent|2
1581198|NCT02607735|5489981|P3|Primary Study|Lost to Follow-up|0
1581199|NCT02607735|5489982|P2|Primary Study|Lost to Follow-up|0
1581200|NCT02607735|5489983|P1|Primary Study|Lost to Follow-up|4
1581201|NCT02607735|5489981|P3|Primary Study|Randomized but Never Treated|0
1581202|NCT02607735|5489982|P2|Primary Study|Randomized but Never Treated|0
1581203|NCT02607735|5489983|P1|Primary Study|Randomized but Never Treated|1
1581219|NCT02606877|5490178|P2|Overall Study|Other than listed above|0
1581220|NCT02606877|5490179|P1|Overall Study|Other than listed above|1
1581221|NCT02606877|5490178|P2|Overall Study|Non-compliance with protocol|1
1581222|NCT02606877|5490179|P1|Overall Study|Non-compliance with protocol|0
1581223|NCT02606877|5490178|P2|Overall Study|Adverse Event|0
1581224|NCT02606877|5490179|P1|Overall Study|Adverse Event|3
1581225|NCT02606643|5490207|P2|Overall Study|did not meet inclusion criteria|3
1581226|NCT02606643|5490208|P1|Overall Study|did not meet inclusion criteria|1
1581227|NCT02606279|5490266|P2|Overall Study|Lost to Follow-up|1
1581228|NCT02606279|5490267|P1|Overall Study|Lost to Follow-up|0
1581229|NCT02606253|5490282|P3|Overall Study|Physician Decision|0
1581230|NCT02606253|5490283|P2|Overall Study|Physician Decision|1
1581231|NCT02606253|5490284|P1|Overall Study|Physician Decision|1
1581232|NCT02606253|5490282|P3|Overall Study|Protocol Violation|0
1581233|NCT02606253|5490283|P2|Overall Study|Protocol Violation|1
1581234|NCT02606253|5490284|P1|Overall Study|Protocol Violation|2
1581235|NCT02606253|5490282|P3|Overall Study|Adverse Event|0
1581236|NCT02606253|5490283|P2|Overall Study|Adverse Event|0
1581237|NCT02606253|5490284|P1|Overall Study|Adverse Event|2
1581238|NCT02605954|5490386|P2|Overall Study|Randomized but not treated|1
1581239|NCT02605954|5490387|P1|Overall Study|Randomized but not treated|0
1581240|NCT02605954|5490386|P2|Overall Study|Lost to Follow-up|0
1581241|NCT02605954|5490387|P1|Overall Study|Lost to Follow-up|3
1581242|NCT02605954|5490386|P2|Overall Study|Withdrew Consent|2
1581243|NCT02605954|5490387|P1|Overall Study|Withdrew Consent|2
1581244|NCT02605954|5490386|P2|Overall Study|Non-Compliance with Study Drug|0
1581245|NCT02605954|5490387|P1|Overall Study|Non-Compliance with Study Drug|1
1581246|NCT02605954|5490386|P2|Overall Study|Investigator's Discretion|0
1581247|NCT02605954|5490387|P1|Overall Study|Investigator's Discretion|1
1581248|NCT02605954|5490386|P2|Overall Study|Adverse Event|1
1581249|NCT02605954|5490387|P1|Overall Study|Adverse Event|5
1581250|NCT02605928|5490404|P1|Overall Study|Lack of Efficacy|5
1581251|NCT02605928|5490404|P1|Overall Study|Model tuning phase|28
1581252|NCT02605824|5490447|P2|Overall Study|Physician Decision|0
1581253|NCT02605824|5490448|P1|Overall Study|Physician Decision|1
1581254|NCT02605642|5490458|P2|Overall Study|Lack of response|11
1581255|NCT02605642|5490459|P1|Overall Study|Lack of response|24
1581256|NCT02605642|5490458|P2|Overall Study|Withdrawal by Subject|2
1581257|NCT02605642|5490459|P1|Overall Study|Withdrawal by Subject|23
1581258|NCT02605642|5490458|P2|Overall Study|Adverse Event|2
1581259|NCT02605642|5490459|P1|Overall Study|Adverse Event|14
1581260|NCT02605642|5490458|P2|Overall Study|Lost to Follow-up|1
1581261|NCT02605642|5490459|P1|Overall Study|Lost to Follow-up|12
1581262|NCT02605642|5490458|P2|Overall Study|Physician Decision|0
1581263|NCT02605642|5490459|P1|Overall Study|Physician Decision|10
1581264|NCT02605642|5490458|P2|Overall Study|Participant non-compliance|4
1581265|NCT02605642|5490459|P1|Overall Study|Participant non-compliance|2
1581266|NCT02605642|5490458|P2|Overall Study|Other|1
1581267|NCT02605642|5490459|P1|Overall Study|Other|11
1581268|NCT02605174|5490606|P7|Overall Study|Randomization Failure|30
1581269|NCT02605174|5490607|P6|Overall Study|Randomization Failure|11
1581270|NCT02605174|5490608|P5|Overall Study|Randomization Failure|16
1581271|NCT02605174|5490609|P4|Overall Study|Randomization Failure|7
1581272|NCT02605174|5490610|P3|Overall Study|Randomization Failure|20
1581273|NCT02605174|5490611|P2|Overall Study|Randomization Failure|6
1581274|NCT02605174|5490612|P1|Overall Study|Randomization Failure|22
1581275|NCT02605174|5490606|P7|Overall Study|Physician Decision|3
1581276|NCT02605174|5490607|P6|Overall Study|Physician Decision|0
1581277|NCT02605174|5490608|P5|Overall Study|Physician Decision|0
1581278|NCT02605174|5490609|P4|Overall Study|Physician Decision|0
1581279|NCT02605174|5490610|P3|Overall Study|Physician Decision|0
1581280|NCT02605174|5490611|P2|Overall Study|Physician Decision|0
1581281|NCT02605174|5490612|P1|Overall Study|Physician Decision|2
1581282|NCT02605174|5490606|P7|Overall Study|Withdrawal by Subject|15
1581283|NCT02605174|5490607|P6|Overall Study|Withdrawal by Subject|4
1581284|NCT02605174|5490608|P5|Overall Study|Withdrawal by Subject|6
1581285|NCT02605174|5490609|P4|Overall Study|Withdrawal by Subject|11
1581286|NCT02605174|5490610|P3|Overall Study|Withdrawal by Subject|14
1581287|NCT02605174|5490611|P2|Overall Study|Withdrawal by Subject|6
1581288|NCT02605174|5490612|P1|Overall Study|Withdrawal by Subject|9
1581289|NCT02605174|5490606|P7|Overall Study|Pregnancy|0
1581290|NCT02605174|5490607|P6|Overall Study|Pregnancy|0
1581291|NCT02605174|5490608|P5|Overall Study|Pregnancy|0
1581292|NCT02605174|5490609|P4|Overall Study|Pregnancy|2
1581293|NCT02605174|5490610|P3|Overall Study|Pregnancy|0
1581294|NCT02605174|5490611|P2|Overall Study|Pregnancy|0
1581295|NCT02605174|5490612|P1|Overall Study|Pregnancy|1
1581296|NCT02605174|5490606|P7|Overall Study|Protocol Violation|12
1581297|NCT02605174|5490607|P6|Overall Study|Protocol Violation|7
1581298|NCT02605174|5490608|P5|Overall Study|Protocol Violation|7
1581299|NCT02605174|5490609|P4|Overall Study|Protocol Violation|6
1581300|NCT02605174|5490610|P3|Overall Study|Protocol Violation|14
1581301|NCT02605174|5490611|P2|Overall Study|Protocol Violation|4
1581302|NCT02605174|5490612|P1|Overall Study|Protocol Violation|10
1581303|NCT02605174|5490606|P7|Overall Study|Lost to Follow-up|29
1581304|NCT02605174|5490607|P6|Overall Study|Lost to Follow-up|10
1581305|NCT02605174|5490608|P5|Overall Study|Lost to Follow-up|20
1581306|NCT02605174|5490609|P4|Overall Study|Lost to Follow-up|10
1581307|NCT02605174|5490610|P3|Overall Study|Lost to Follow-up|27
1581308|NCT02605174|5490611|P2|Overall Study|Lost to Follow-up|7
1581309|NCT02605174|5490612|P1|Overall Study|Lost to Follow-up|20
1581310|NCT02605174|5490606|P7|Overall Study|Adverse Event|0
1581311|NCT02605174|5490607|P6|Overall Study|Adverse Event|0
1581312|NCT02605174|5490608|P5|Overall Study|Adverse Event|4
1581313|NCT02605174|5490609|P4|Overall Study|Adverse Event|0
1581314|NCT02605174|5490610|P3|Overall Study|Adverse Event|1
1581315|NCT02605174|5490611|P2|Overall Study|Adverse Event|0
1581316|NCT02605174|5490612|P1|Overall Study|Adverse Event|0
1581317|NCT02605122|5490674|P2|Overall Study|Lost to Follow-up|1
1581318|NCT02605122|5490675|P1|Overall Study|Lost to Follow-up|1
1581319|NCT02605122|5490674|P2|Overall Study|Withdrawal by Subject|1
1581320|NCT02605122|5490675|P1|Overall Study|Withdrawal by Subject|4
1581321|NCT02604589|5490698|P3|Overall Study|catheter dislodgement|1
1581322|NCT02604589|5490699|P2|Overall Study|catheter dislodgement|0
1581323|NCT02604589|5490700|P1|Overall Study|catheter dislodgement|0
1581324|NCT02604550|5490728|P2|Overall Study|Incomplete data using paper journal|19
1581325|NCT02604550|5490729|P1|Overall Study|Incomplete data using paper journal|18
1581326|NCT02604550|5490728|P2|Overall Study|Withdrawal by Subject|1
1581327|NCT02604550|5490729|P1|Overall Study|Withdrawal by Subject|0
1581328|NCT02604550|5490728|P2|Overall Study|Lost to Follow-up|6
1581329|NCT02604550|5490729|P1|Overall Study|Lost to Follow-up|7
1581330|NCT02604433|5490755|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
1581331|NCT02604433|5490756|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
1581332|NCT02604433|5490755|P2|Double-blind Treatment Period|Study is ongoing|74
1581333|NCT02604433|5490756|P1|Double-blind Treatment Period|Study is ongoing|156
1581334|NCT02604433|5490755|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
1581335|NCT02604433|5490756|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
1581336|NCT02604433|5490755|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
1581337|NCT02604433|5490756|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
1581338|NCT02604433|5490755|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
1581339|NCT02604433|5490756|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
1581340|NCT02604433|5490755|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
1581341|NCT02604433|5490756|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
1581429|NCT02603393|5491150|P1|Overall Study|Lost to Follow-up|1
1581342|NCT02604433|5490755|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
1581343|NCT02604433|5490756|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
1581344|NCT02604433|5490755|P2|Double-blind Treatment Period|Death|1
1581345|NCT02604433|5490756|P1|Double-blind Treatment Period|Death|1
1581346|NCT02604433|5490755|P2|Double-blind Treatment Period|Personal reasons or moved|1
1581347|NCT02604433|5490756|P1|Double-blind Treatment Period|Personal reasons or moved|2
1581348|NCT02604433|5490755|P2|Double-blind Treatment Period|Adverse Event|0
1581349|NCT02604433|5490756|P1|Double-blind Treatment Period|Adverse Event|4
1581350|NCT02604433|5490755|P2|Double-blind Treatment Period|Withdrawal by Subject|6
1581351|NCT02604433|5490756|P1|Double-blind Treatment Period|Withdrawal by Subject|13
1581352|NCT02604407|5490825|P3|Overall Study|Other|4
1581353|NCT02604407|5490826|P2|Overall Study|Other|1
1581354|NCT02604407|5490827|P1|Overall Study|Other|3
1581355|NCT02604407|5490825|P3|Overall Study|Lack of Efficacy|0
1581356|NCT02604407|5490826|P2|Overall Study|Lack of Efficacy|0
1581357|NCT02604407|5490827|P1|Overall Study|Lack of Efficacy|1
1581358|NCT02604407|5490825|P3|Overall Study|Lost to Follow-up|2
1581359|NCT02604407|5490826|P2|Overall Study|Lost to Follow-up|1
1581360|NCT02604407|5490827|P1|Overall Study|Lost to Follow-up|2
1581361|NCT02604407|5490825|P3|Overall Study|Withdrawal by Subject|5
1581362|NCT02604407|5490826|P2|Overall Study|Withdrawal by Subject|3
1581363|NCT02604407|5490827|P1|Overall Study|Withdrawal by Subject|3
1581364|NCT02604407|5490825|P3|Overall Study|Protocol Violation|0
1581365|NCT02604407|5490826|P2|Overall Study|Protocol Violation|0
1581366|NCT02604407|5490827|P1|Overall Study|Protocol Violation|2
1581367|NCT02604407|5490825|P3|Overall Study|Adverse Event|5
1581368|NCT02604407|5490826|P2|Overall Study|Adverse Event|7
1581369|NCT02604407|5490827|P1|Overall Study|Adverse Event|0
1581370|NCT02604342|5490840|P2|Overall Study|Physician Decision|0
1581371|NCT02604342|5490841|P1|Overall Study|Physician Decision|2
1581372|NCT02604342|5490840|P2|Overall Study|Lost to Follow-up|1
1581373|NCT02604342|5490841|P1|Overall Study|Lost to Follow-up|1
1581374|NCT02604342|5490840|P2|Overall Study|Study Termination by Sponsor|0
1581375|NCT02604342|5490841|P1|Overall Study|Study Termination by Sponsor|1
1581376|NCT02604342|5490840|P2|Overall Study|Other|0
1581377|NCT02604342|5490841|P1|Overall Study|Other|1
1581378|NCT02604342|5490840|P2|Overall Study|Withdrawal by Subject|6
1581379|NCT02604342|5490841|P1|Overall Study|Withdrawal by Subject|5
1581380|NCT02604342|5490840|P2|Overall Study|Progression of disease|0
1581381|NCT02604342|5490841|P1|Overall Study|Progression of disease|1
1581382|NCT02604342|5490840|P2|Overall Study|Death|16
1581383|NCT02604342|5490841|P1|Overall Study|Death|32
1581384|NCT02604264|5490893|P2|Intervention|Didn't use CVC for at least 21 days|242
1581385|NCT02604264|5490894|P1|Intervention|Didn't use CVC for at least 21 days|200
1581386|NCT02604212|5490904|P4|Overall Study|Withdrawal by Subject|0
1581387|NCT02604212|5490905|P3|Overall Study|Withdrawal by Subject|1
1581388|NCT02604212|5490906|P2|Overall Study|Withdrawal by Subject|0
1581389|NCT02604212|5490907|P1|Overall Study|Withdrawal by Subject|0
1581390|NCT02604212|5490904|P4|Overall Study|Study Terminated by Sponsor|3
1581391|NCT02604212|5490905|P3|Overall Study|Study Terminated by Sponsor|3
1581392|NCT02604212|5490906|P2|Overall Study|Study Terminated by Sponsor|1
1581393|NCT02604212|5490907|P1|Overall Study|Study Terminated by Sponsor|2
1581394|NCT02604199|5490975|P4|Overall Study|Withdrawal by Subject|0
1581395|NCT02604199|5490976|P3|Overall Study|Withdrawal by Subject|0
1581396|NCT02604199|5490977|P2|Overall Study|Withdrawal by Subject|1
1581397|NCT02604199|5490978|P1|Overall Study|Withdrawal by Subject|0
1581398|NCT02604199|5490975|P4|Overall Study|Study terminated by sponsor|2
1581399|NCT02604199|5490976|P3|Overall Study|Study terminated by sponsor|0
1581400|NCT02604199|5490977|P2|Overall Study|Study terminated by sponsor|2
1581401|NCT02604199|5490978|P1|Overall Study|Study terminated by sponsor|0
1581402|NCT02604199|5490975|P4|Overall Study|Pregnancy|1
1581403|NCT02604199|5490976|P3|Overall Study|Pregnancy|0
1581404|NCT02604199|5490977|P2|Overall Study|Pregnancy|0
1581405|NCT02604199|5490978|P1|Overall Study|Pregnancy|0
1581406|NCT02604160|5491047|P2|Overall Study|Physician Decision|1
1581407|NCT02604160|5491048|P1|Overall Study|Physician Decision|0
1581408|NCT02604160|5491047|P2|Overall Study|Protocol Violation|1
1581409|NCT02604160|5491048|P1|Overall Study|Protocol Violation|0
1581410|NCT02604017|5491062|P2|Overall Study|Other|0
1581411|NCT02604017|5491063|P1|Overall Study|Other|1
1581412|NCT02604017|5491062|P2|Overall Study|Lost to Follow-up|6
1581413|NCT02604017|5491063|P1|Overall Study|Lost to Follow-up|5
1581414|NCT02604017|5491062|P2|Overall Study|Withdrew Consent|2
1581415|NCT02604017|5491063|P1|Overall Study|Withdrew Consent|0
1581416|NCT02603952|5491092|P4|Overall Study|Received oseltamivir by error|1
1581417|NCT02603952|5491093|P3|Overall Study|Received oseltamivir by error|0
1581418|NCT02603952|5491094|P2|Overall Study|Received oseltamivir by error|0
1581419|NCT02603952|5491095|P1|Overall Study|Received oseltamivir by error|0
1581420|NCT02603952|5491092|P4|Overall Study|Withdrawal by Subject|0
1581421|NCT02603952|5491093|P3|Overall Study|Withdrawal by Subject|0
1581422|NCT02603952|5491094|P2|Overall Study|Withdrawal by Subject|0
1581423|NCT02603952|5491095|P1|Overall Study|Withdrawal by Subject|1
1581424|NCT02603393|5491149|P2|Overall Study|Sponsor decision|0
1581425|NCT02603393|5491150|P1|Overall Study|Sponsor decision|1
1581426|NCT02603393|5491149|P2|Overall Study|Non-compliance with study treatment|0
1581427|NCT02603393|5491150|P1|Overall Study|Non-compliance with study treatment|1
1581428|NCT02603393|5491149|P2|Overall Study|Lost to Follow-up|2
1581430|NCT02603393|5491149|P2|Overall Study|Protocol deviation|3
1581431|NCT02603393|5491150|P1|Overall Study|Protocol deviation|2
1581432|NCT02603393|5491149|P2|Overall Study|Physician Decision|3
1581433|NCT02603393|5491150|P1|Overall Study|Physician Decision|3
1581434|NCT02603393|5491149|P2|Overall Study|Death|4
1581435|NCT02603393|5491150|P1|Overall Study|Death|3
1581436|NCT02603393|5491149|P2|Overall Study|Lack of Efficacy|2
1581437|NCT02603393|5491150|P1|Overall Study|Lack of Efficacy|7
1581438|NCT02603393|5491149|P2|Overall Study|Technical problems|7
1581439|NCT02603393|5491150|P1|Overall Study|Technical problems|4
1581440|NCT02603393|5491149|P2|Overall Study|Adverse Event|15
1581441|NCT02603393|5491150|P1|Overall Study|Adverse Event|17
1581442|NCT02603393|5491149|P2|Overall Study|Patient/guardian decision|18
1581443|NCT02603393|5491150|P1|Overall Study|Patient/guardian decision|32
1581444|NCT02603172|5491189|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
1581445|NCT02603172|5491190|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
1581446|NCT02603172|5491191|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
1581447|NCT02603172|5491192|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
1581448|NCT02603172|5491193|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
1581449|NCT02603172|5491194|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
1581450|NCT02603172|5491195|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
1581451|NCT02603172|5491196|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
1581452|NCT02603120|5491324|P2|Overall Study|Lost to Follow-up|2
1581453|NCT02603120|5491325|P1|Overall Study|Lost to Follow-up|2
1581454|NCT02603120|5491324|P2|Overall Study|Withdrew Consent|7
1581455|NCT02603120|5491325|P1|Overall Study|Withdrew Consent|3
1581456|NCT02603120|5491324|P2|Overall Study|Pregnancy|1
1581457|NCT02603120|5491325|P1|Overall Study|Pregnancy|0
1581458|NCT02603120|5491324|P2|Overall Study|Death|0
1581459|NCT02603120|5491325|P1|Overall Study|Death|2
1581460|NCT02603120|5491324|P2|Overall Study|Adverse Event|2
1581461|NCT02603120|5491325|P1|Overall Study|Adverse Event|3
1581462|NCT02603120|5491324|P2|Overall Study|Still in Study|269
1581463|NCT02603120|5491325|P1|Overall Study|Still in Study|272
1581464|NCT02603120|5491324|P2|Overall Study|Randomized but Never Treated|2
1581465|NCT02603120|5491325|P1|Overall Study|Randomized but Never Treated|2
1581466|NCT02603107|5491345|P2|Optional Extension Phase|Still in Study|213
1581467|NCT02603107|5491346|P1|Optional Extension Phase|Still in Study|241
1581468|NCT02603107|5491345|P2|Randomized Phase|Lost to Follow-up|3
1581469|NCT02603107|5491346|P1|Randomized Phase|Lost to Follow-up|0
1581470|NCT02603107|5491345|P2|Randomized Phase|Withdrew Consent|14
1581471|NCT02603107|5491346|P1|Randomized Phase|Withdrew Consent|8
1581472|NCT02603107|5491345|P2|Randomized Phase|Protocol Violation|0
1581473|NCT02603107|5491346|P1|Randomized Phase|Protocol Violation|1
1581474|NCT02603107|5491345|P2|Randomized Phase|Non-Compliance with Study Drug|1
1581475|NCT02603107|5491346|P1|Randomized Phase|Non-Compliance with Study Drug|1
1581476|NCT02603107|5491345|P2|Randomized Phase|Investigator's Discretion|1
1581477|NCT02603107|5491346|P1|Randomized Phase|Investigator's Discretion|0
1581478|NCT02603107|5491345|P2|Randomized Phase|Death|1
1581479|NCT02603107|5491346|P1|Randomized Phase|Death|1
1581480|NCT02603107|5491345|P2|Randomized Phase|Adverse Event|0
1581481|NCT02603107|5491346|P1|Randomized Phase|Adverse Event|2
1581482|NCT02603107|5491345|P2|Randomized Phase|Still in Study|27
1581483|NCT02603107|5491346|P1|Randomized Phase|Still in Study|32
1581484|NCT02603107|5491345|P2|Randomized Phase|Randomized and Never Treated|1
1581485|NCT02603107|5491346|P1|Randomized Phase|Randomized and Never Treated|0
1581486|NCT02602080|5491409|P3|Overall Study|Protocol Violation|3
1581487|NCT02602080|5491410|P2|Overall Study|Protocol Violation|1
1581488|NCT02602080|5491411|P1|Overall Study|Protocol Violation|6
1581489|NCT02601820|5491454|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
1581490|NCT02601820|5491454|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
1581491|NCT02601820|5491454|P1|Late On-Treatment (T3)|missing T3 Record|49
1581492|NCT02601820|5491454|P1|Early On-Treatment (T2)|Missing T2 Record|51
1581493|NCT02601625|5491483|P4|Overall Study|Lost to Follow-up|1
1581494|NCT02601625|5491484|P3|Overall Study|Lost to Follow-up|1
1581495|NCT02601625|5491485|P2|Overall Study|Lost to Follow-up|0
1581496|NCT02601625|5491486|P1|Overall Study|Lost to Follow-up|0
1581497|NCT02601573|5491539|P5|Overall Study|Withdrawal by Subject|0
1581498|NCT02601573|5491540|P4|Overall Study|Withdrawal by Subject|1
1581499|NCT02601573|5491541|P3|Overall Study|Withdrawal by Subject|0
1581500|NCT02601573|5491542|P2|Overall Study|Withdrawal by Subject|1
1581501|NCT02601573|5491543|P1|Overall Study|Withdrawal by Subject|0
1581502|NCT02601573|5491539|P5|Overall Study|Lost to Follow-up|2
1581503|NCT02601573|5491540|P4|Overall Study|Lost to Follow-up|0
1581504|NCT02601573|5491541|P3|Overall Study|Lost to Follow-up|1
1581505|NCT02601573|5491542|P2|Overall Study|Lost to Follow-up|3
1581506|NCT02601573|5491543|P1|Overall Study|Lost to Follow-up|0
1581507|NCT02601560|5491578|P8|Overall Study|Other|0
1581508|NCT02601560|5491579|P7|Overall Study|Other|1
1581509|NCT02601560|5491580|P6|Overall Study|Other|0
1581510|NCT02601560|5491581|P5|Overall Study|Other|0
1581511|NCT02601560|5491582|P4|Overall Study|Other|0
1581512|NCT02601560|5491583|P3|Overall Study|Other|0
1581513|NCT02601560|5491584|P2|Overall Study|Other|0
1581514|NCT02601560|5491585|P1|Overall Study|Other|0
1581515|NCT02601469|5491769|P2|Overall Study|Enrolled in Error|0
1581516|NCT02601469|5491770|P1|Overall Study|Enrolled in Error|1
1581517|NCT02601300|5491776|P1|Extension Phase|Lack of Efficacy|10
1581518|NCT02601300|5491776|P1|Extension Phase|Adverse Event|4
1581519|NCT02601300|5491776|P1|Extension Phase|Withdrawal by Subject|3
1581520|NCT02601300|5491776|P1|Induction Phase|Protocol Violation|1
1581521|NCT02601300|5491776|P1|Induction Phase|Lack of Efficacy|2
1581522|NCT02600871|5491791|P2|Overall Study|Lost to Follow-up|10
1581523|NCT02600871|5491792|P1|Overall Study|Lost to Follow-up|13
1581524|NCT02600845|5491802|P1|Overall Study|Consent Withdrawal|5
1581525|NCT02600845|5491802|P1|Overall Study|Non-compliance with Study Procedures|10
1581526|NCT02600845|5491802|P1|Overall Study|Reason Not Specified|3
1581527|NCT02600819|5491817|P2|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|7
1581528|NCT02600819|5491818|P1|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|0
1581529|NCT02600819|5491817|P2|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|0
1581530|NCT02600819|5491818|P1|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|3
1581531|NCT02600819|5491817|P2|Main Study (E/C/F/TAF)|Lost to Follow-up|0
1581532|NCT02600819|5491818|P1|Main Study (E/C/F/TAF)|Lost to Follow-up|2
1581533|NCT02600819|5491817|P2|Main Study (E/C/F/TAF)|Withdrew Consent|0
1581534|NCT02600819|5491818|P1|Main Study (E/C/F/TAF)|Withdrew Consent|5
1581535|NCT02600819|5491817|P2|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|0
1581536|NCT02600819|5491818|P1|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|1
1581537|NCT02600819|5491817|P2|Main Study (E/C/F/TAF)|Investigator's Discretion|0
1581538|NCT02600819|5491818|P1|Main Study (E/C/F/TAF)|Investigator's Discretion|4
1581539|NCT02600819|5491817|P2|Main Study (E/C/F/TAF)|Death|0
1581540|NCT02600819|5491818|P1|Main Study (E/C/F/TAF)|Death|2
1581541|NCT02600819|5491817|P2|Main Study (E/C/F/TAF)|Adverse Event|0
1581542|NCT02600819|5491818|P1|Main Study (E/C/F/TAF)|Adverse Event|2
1581543|NCT02600351|5491922|P4|Overall Study|Randomized but Not Treated|3
1581544|NCT02600351|5491923|P3|Overall Study|Randomized but Not Treated|1
1581545|NCT02600351|5491924|P2|Overall Study|Randomized but Not Treated|0
1581546|NCT02600351|5491925|P1|Overall Study|Randomized but Not Treated|1
1581547|NCT02600351|5491922|P4|Overall Study|Lost to Follow-up|0
1581548|NCT02600351|5491923|P3|Overall Study|Lost to Follow-up|0
1581549|NCT02600351|5491924|P2|Overall Study|Lost to Follow-up|0
1581550|NCT02600351|5491925|P1|Overall Study|Lost to Follow-up|1
1581551|NCT02600351|5491922|P4|Overall Study|Lack of Efficacy|2
1581552|NCT02600351|5491923|P3|Overall Study|Lack of Efficacy|5
1581553|NCT02600351|5491924|P2|Overall Study|Lack of Efficacy|0
1581554|NCT02600351|5491925|P1|Overall Study|Lack of Efficacy|3
1581555|NCT02599129|5492024|P2|Overall Study|Withdrawal by Subject|1
1581556|NCT02599129|5492025|P1|Overall Study|Withdrawal by Subject|2
1581557|NCT02599129|5492024|P2|Overall Study|Lost to Follow-up|0
1581558|NCT02599129|5492025|P1|Overall Study|Lost to Follow-up|1
1581559|NCT02599129|5492024|P2|Overall Study|Lack of Efficacy|2
1581560|NCT02599129|5492025|P1|Overall Study|Lack of Efficacy|2
1581561|NCT02598934|5492041|P2|Overall Study|Protocol Violation|2
1581562|NCT02598934|5492042|P1|Overall Study|Protocol Violation|1
1581563|NCT02598934|5492041|P2|Overall Study|Administrative|1
1581564|NCT02598934|5492042|P1|Overall Study|Administrative|2
1581565|NCT02598934|5492041|P2|Overall Study|Withdrawal by Subject|3
1581566|NCT02598934|5492042|P1|Overall Study|Withdrawal by Subject|2
1581567|NCT02598934|5492041|P2|Overall Study|Failure to Return|3
1581568|NCT02598934|5492042|P1|Overall Study|Failure to Return|3
1581569|NCT02598934|5492041|P2|Overall Study|Adverse Event|13
1581570|NCT02598934|5492042|P1|Overall Study|Adverse Event|11
1581571|NCT02598622|5492054|P2|Overall Study|Physician Decision|0
1581572|NCT02598622|5492055|P1|Overall Study|Physician Decision|3
1581573|NCT02598622|5492054|P2|Overall Study|Withdrawal by Subject|0
1581574|NCT02598622|5492055|P1|Overall Study|Withdrawal by Subject|3
1581575|NCT02598297|5492084|P2|Overall Study|Followed for survival|0
1581576|NCT02598297|5492085|P1|Overall Study|Followed for survival|1
1581577|NCT02598297|5492084|P2|Overall Study|Subject/guardian decision|0
1581578|NCT02598297|5492085|P1|Overall Study|Subject/guardian decision|1
1581579|NCT02598297|5492084|P2|Overall Study|Physician Decision|0
1581580|NCT02598297|5492085|P1|Overall Study|Physician Decision|1
1581581|NCT02598297|5492084|P2|Overall Study|Adverse Event|1
1581582|NCT02598297|5492085|P1|Overall Study|Adverse Event|1
1581583|NCT02598297|5492084|P2|Overall Study|Study terminated by Sponsor|23
1581584|NCT02598297|5492085|P1|Overall Study|Study terminated by Sponsor|21
1581585|NCT02598193|5492111|P1|Overall Study|Does not want to take Nintedanib|1
1581586|NCT02598193|5492111|P1|Overall Study|Listed in active lung transplant list|1
1581587|NCT02598193|5492111|P1|Overall Study|Withdrawal by Subject|1
1581588|NCT02598193|5492111|P1|Overall Study|Adverse Event|13
1581589|NCT02598128|5492119|P4|Period A: Days -7 to -1|Adverse Event|0
1581590|NCT02598128|5492120|P3|Period A: Days -7 to -1|Adverse Event|0
1581591|NCT02598128|5492121|P2|Period A: Days -7 to -1|Adverse Event|0
1581592|NCT02598128|5492122|P1|Period A: Days -7 to -1|Adverse Event|1
1581593|NCT02598076|5492165|P2|Overall Study|Lost to Follow-up|3
1581594|NCT02598076|5492166|P1|Overall Study|Lost to Follow-up|2
1581595|NCT02597946|5492180|P1|Overall Study|Other than above|1
1581596|NCT02597946|5492180|P1|Overall Study|Progressive disease|16
1581597|NCT02597946|5492180|P1|Overall Study|Withdrawal by Subject|1
1581598|NCT02597933|5492191|P2|Overall Study|Other than stated above|14
1581599|NCT02597933|5492192|P1|Overall Study|Other than stated above|7
1581600|NCT02597933|5492191|P2|Overall Study|Not treated|2
1581601|NCT02597933|5492192|P1|Overall Study|Not treated|2
1581602|NCT02597933|5492191|P2|Overall Study|Adverse Event|28
1581603|NCT02597933|5492192|P1|Overall Study|Adverse Event|20
1581604|NCT02597933|5492191|P2|Overall Study|Protocol Violation|2
1581605|NCT02597933|5492192|P1|Overall Study|Protocol Violation|2
1581606|NCT02597933|5492191|P2|Overall Study|Withdrawal by Subject|5
1581607|NCT02597933|5492192|P1|Overall Study|Withdrawal by Subject|7
1581608|NCT02597920|5492223|P3|Overall Study|Other|0
1581609|NCT02597920|5492224|P2|Overall Study|Other|0
1581610|NCT02597920|5492225|P1|Overall Study|Other|1
1581611|NCT02597920|5492223|P3|Overall Study|Other than specified|5
1581612|NCT02597920|5492224|P2|Overall Study|Other than specified|31
1581613|NCT02597920|5492225|P1|Overall Study|Other than specified|10
1581614|NCT02597920|5492223|P3|Overall Study|Refuse to continue in the study|1
1581615|NCT02597920|5492224|P2|Overall Study|Refuse to continue in the study|13
1581616|NCT02597920|5492225|P1|Overall Study|Refuse to continue in the study|3
1581617|NCT02597920|5492223|P3|Overall Study|Lost to Follow-up|0
1581618|NCT02597920|5492224|P2|Overall Study|Lost to Follow-up|9
1581619|NCT02597920|5492225|P1|Overall Study|Lost to Follow-up|7
1581620|NCT02597920|5492223|P3|Overall Study|Other adverse event|0
1581621|NCT02597920|5492224|P2|Overall Study|Other adverse event|30
1581622|NCT02597920|5492225|P1|Overall Study|Other adverse event|20
1581623|NCT02597920|5492223|P3|Overall Study|Worsening of other pre-existing disease|0
1581624|NCT02597920|5492224|P2|Overall Study|Worsening of other pre-existing disease|1
1581625|NCT02597920|5492225|P1|Overall Study|Worsening of other pre-existing disease|0
1581626|NCT02597855|5492259|P2|Overall Study|Lost to Follow-up|1
1581627|NCT02597855|5492260|P1|Overall Study|Lost to Follow-up|2
1581628|NCT02597049|5492411|P3|Overall Study|Noncompliant with Study Visits|0
1581629|NCT02597049|5492412|P2|Overall Study|Noncompliant with Study Visits|0
1581630|NCT02597049|5492413|P1|Overall Study|Noncompliant with Study Visits|1
1581631|NCT02597049|5492411|P3|Overall Study|Death|0
1581632|NCT02597049|5492412|P2|Overall Study|Death|0
1581633|NCT02597049|5492413|P1|Overall Study|Death|2
1581634|NCT02597049|5492411|P3|Overall Study|Adverse Event|0
1581635|NCT02597049|5492412|P2|Overall Study|Adverse Event|0
1581636|NCT02597049|5492413|P1|Overall Study|Adverse Event|2
1581637|NCT02597049|5492411|P3|Overall Study|Withdrawal by Subject|1
1581638|NCT02597049|5492412|P2|Overall Study|Withdrawal by Subject|2
1581639|NCT02597049|5492413|P1|Overall Study|Withdrawal by Subject|2
1581640|NCT02597049|5492411|P3|Overall Study|Lost to Follow-up|2
1581641|NCT02597049|5492412|P2|Overall Study|Lost to Follow-up|3
1581642|NCT02597049|5492413|P1|Overall Study|Lost to Follow-up|0
1581643|NCT02596971|5492454|P3|Overall Study|Death|0
1581644|NCT02596971|5492455|P2|Overall Study|Death|0
1581645|NCT02596971|5492456|P1|Overall Study|Death|2
1581646|NCT02596971|5492454|P3|Overall Study|In Follow-up|15
1581647|NCT02596971|5492455|P2|Overall Study|In Follow-up|0
1581648|NCT02596971|5492456|P1|Overall Study|In Follow-up|4
1581649|NCT02596971|5492454|P3|Overall Study|Ongoing|24
1581650|NCT02596971|5492455|P2|Overall Study|Ongoing|6
1581651|NCT02596971|5492456|P1|Overall Study|Ongoing|36
1581652|NCT02596971|5492454|P3|Overall Study|Withdrawal by Subject|2
1581653|NCT02596971|5492455|P2|Overall Study|Withdrawal by Subject|0
1581654|NCT02596971|5492456|P1|Overall Study|Withdrawal by Subject|0
1581655|NCT02596971|5492454|P3|Overall Study|Physician Decision|1
1581656|NCT02596971|5492455|P2|Overall Study|Physician Decision|0
1581657|NCT02596971|5492456|P1|Overall Study|Physician Decision|0
1581658|NCT02596971|5492454|P3|Overall Study|Disease Progression|0
1581659|NCT02596971|5492455|P2|Overall Study|Disease Progression|1
1581660|NCT02596971|5492456|P1|Overall Study|Disease Progression|0
1581661|NCT02596958|5492485|P1|Overall Study|Excluded Due to Second Line Treatment|9
1581662|NCT02596958|5492485|P1|Overall Study|Missing|32
1581663|NCT02596958|5492485|P1|Overall Study|Lost to Follow-up|33
1581664|NCT02596958|5492485|P1|Overall Study|Administrative Reasons/Other|231
1581665|NCT02596958|5492485|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
1581666|NCT02596958|5492485|P1|Overall Study|Death From Other Cause|33
1581667|NCT02596958|5492485|P1|Overall Study|Death From Cancer|112
1581668|NCT02596958|5492485|P1|Overall Study|Cancer Progression|441
1581669|NCT02596958|5492485|P1|Overall Study|Serious Adverse Drug Reactions|44
1581670|NCT02596945|5492497|P1|Overall Study|Missing|1
1581671|NCT02596945|5492497|P1|Overall Study|Withdrawal by Subject|1
1581672|NCT02596945|5492497|P1|Overall Study|Other Erythropoietin stimulating agent|4
1581673|NCT02596945|5492497|P1|Overall Study|Change to hemodialysis|15
1581674|NCT02596945|5492497|P1|Overall Study|Other|32
1581675|NCT02596945|5492497|P1|Overall Study|No documentation of study drug dosing|3
1581676|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
1581677|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
1581678|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
1581679|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
1581680|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
1581681|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
1581682|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
1581683|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
1581684|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Death|0
1581685|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Death|1
1581686|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Death|0
1581687|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Death|0
1581688|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
1581689|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
1581690|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
1581691|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
1581692|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
1581693|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
1581694|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
1581695|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
1581696|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
1581697|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
1581698|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
1581699|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
1581700|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
1581701|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
1581702|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
1581703|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
1581704|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
1581705|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
1581706|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
1581707|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
1581708|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
1581709|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
1581710|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
1581711|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
1581712|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
1581713|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
1581714|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
1581715|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
1581716|NCT02596893|5492507|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
1581717|NCT02596893|5492508|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
1581718|NCT02596893|5492509|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
1581719|NCT02596893|5492510|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
1581720|NCT02596854|5492569|P1|Overall Study|Withdrawn|8
1581721|NCT02596620|5492590|P2|Overall Study|Lost to Follow-up|1
1581722|NCT02596620|5492591|P1|Overall Study|Lost to Follow-up|1
1581723|NCT02596035|5492627|P3|Overall Study|Other Reasons|0
1581724|NCT02596035|5492628|P2|Overall Study|Other Reasons|4
1581725|NCT02596035|5492629|P1|Overall Study|Other Reasons|3
1581726|NCT02596035|5492627|P3|Overall Study|Poor/Non-Compliance|0
1581727|NCT02596035|5492628|P2|Overall Study|Poor/Non-Compliance|1
1581728|NCT02596035|5492629|P1|Overall Study|Poor/Non-Compliance|0
1581729|NCT02596035|5492627|P3|Overall Study|Withdrawal by Subject|0
1581730|NCT02596035|5492628|P2|Overall Study|Withdrawal by Subject|2
1581731|NCT02596035|5492629|P1|Overall Study|Withdrawal by Subject|4
1581732|NCT02596035|5492627|P3|Overall Study|Adverse Event|0
1581733|NCT02596035|5492628|P2|Overall Study|Adverse Event|2
1581734|NCT02596035|5492629|P1|Overall Study|Adverse Event|6
1581735|NCT02596035|5492627|P3|Overall Study|Study Drug Toxicity|0
1581736|NCT02596035|5492628|P2|Overall Study|Study Drug Toxicity|3
1581737|NCT02596035|5492629|P1|Overall Study|Study Drug Toxicity|11
1581738|NCT02596035|5492627|P3|Overall Study|Disease Progression|1
1581739|NCT02596035|5492628|P2|Overall Study|Disease Progression|32
1581740|NCT02596035|5492629|P1|Overall Study|Disease Progression|62
1581741|NCT02596009|5492665|P6|Overall Study|Administrative problems|0
1581742|NCT02596009|5492666|P5|Overall Study|Administrative problems|0
1581743|NCT02596009|5492667|P4|Overall Study|Administrative problems|0
1581744|NCT02596009|5492668|P3|Overall Study|Administrative problems|0
1581745|NCT02596009|5492669|P2|Overall Study|Administrative problems|1
1581746|NCT02596009|5492670|P1|Overall Study|Administrative problems|0
1581747|NCT02595970|5492687|P1|Overall Study|Lack of Efficacy|7
1581748|NCT02595970|5492687|P1|Overall Study|Adverse Event|5
1581749|NCT02595970|5492687|P1|Overall Study|Protocol Violation|4
1581750|NCT02595970|5492687|P1|Overall Study|Physician Decision|2
1581751|NCT02595970|5492687|P1|Overall Study|Withdrawal by Subject|2
1581752|NCT02595723|5492704|P3|First Washout (21 Days)|Lost to Follow-up|0
1581753|NCT02595723|5492705|P2|First Washout (21 Days)|Lost to Follow-up|0
1581754|NCT02595723|5492706|P1|First Washout (21 Days)|Lost to Follow-up|1
1581755|NCT02595723|5492704|P3|First Washout (21 Days)|Withdrawal by Subject|0
1581756|NCT02595723|5492705|P2|First Washout (21 Days)|Withdrawal by Subject|0
1581757|NCT02595723|5492706|P1|First Washout (21 Days)|Withdrawal by Subject|1
1581758|NCT02595502|5492718|P2|Period 3|Received Incorrect Treatment at period 3|1
1581759|NCT02595502|5492719|P1|Period 3|Received Incorrect Treatment at period 3|0
1581760|NCT02595502|5492718|P2|Period 3|Lost to Follow-up|0
1581761|NCT02595502|5492719|P1|Period 3|Lost to Follow-up|1
1581762|NCT02595502|5492718|P2|Period 3|Protocol Violation|1
1581763|NCT02595502|5492719|P1|Period 3|Protocol Violation|0
1581764|NCT02595502|5492718|P2|Period 2|Received incorrect lens at Period 1|1
1581765|NCT02595502|5492719|P1|Period 2|Received incorrect lens at Period 1|0
1581766|NCT02595502|5492718|P2|Period 2|Adverse Event|1
1581767|NCT02595502|5492719|P1|Period 2|Adverse Event|1
1581768|NCT02595502|5492718|P2|Period 1|Lost to Follow-up|1
1581769|NCT02595502|5492719|P1|Period 1|Lost to Follow-up|0
1581770|NCT02595502|5492718|P2|Period 1|Withdrawal by Subject|0
1581771|NCT02595502|5492719|P1|Period 1|Withdrawal by Subject|1
1581772|NCT02595502|5492718|P2|Period 1|Adverse Event|1
1581773|NCT02595502|5492719|P1|Period 1|Adverse Event|0
1581774|NCT02595450|5492725|P1|Overall Study|Enrolled, but not treated|8
1581775|NCT02595450|5492725|P1|Overall Study|Unspecified (only completed 1 cycle)|73
1581776|NCT02595437|5492731|P1|Triferic Via IV|Withdrawal by Subject|1
1581777|NCT02595073|5492751|P2|Overall Study|Protocol Violation|0
1581778|NCT02595073|5492752|P1|Overall Study|Protocol Violation|2
1581779|NCT02595073|5492751|P2|Overall Study|Progressive Disease|1
1581780|NCT02595073|5492752|P1|Overall Study|Progressive Disease|0
1581781|NCT02595008|5492762|P2|Overall Study|Enrolled In Error|0
1581782|NCT02595008|5492763|P1|Overall Study|Enrolled In Error|1
1581783|NCT02594163|5492801|P2|Follow-up Period|Physician Decision|1
1581784|NCT02594163|5492802|P1|Follow-up Period|Physician Decision|0
1581785|NCT02594163|5492801|P2|Follow-up Period|Progressive Disease|0
1581786|NCT02594163|5492802|P1|Follow-up Period|Progressive Disease|2
1581787|NCT02594163|5492801|P2|Follow-up Period|Adverse Event|1
1581788|NCT02594163|5492802|P1|Follow-up Period|Adverse Event|0
1581789|NCT02594163|5492801|P2|Follow-up Period|Death|5
1581790|NCT02594163|5492802|P1|Follow-up Period|Death|2
1581791|NCT02594163|5492801|P2|Follow-up Period|Lost to Follow-up|0
1581792|NCT02594163|5492802|P1|Follow-up Period|Lost to Follow-up|1
1581793|NCT02594163|5492801|P2|Follow-up Period|Study Termination by Sponsor|4
1581794|NCT02594163|5492802|P1|Follow-up Period|Study Termination by Sponsor|6
1581795|NCT02594163|5492801|P2|Follow-up Period|Withdrawal by Subject|1
1581796|NCT02594163|5492802|P1|Follow-up Period|Withdrawal by Subject|0
1581797|NCT02594163|5492801|P2|Treatment Period|Other, Non-AE|0
1581798|NCT02594163|5492802|P1|Treatment Period|Other, Non-AE|1
1581799|NCT02594163|5492801|P2|Treatment Period|Study termination by sponsor|1
1581800|NCT02594163|5492802|P1|Treatment Period|Study termination by sponsor|2
1581801|NCT02594163|5492801|P2|Treatment Period|Physician Decision|3
1581802|NCT02594163|5492802|P1|Treatment Period|Physician Decision|1
1581803|NCT02594163|5492801|P2|Treatment Period|Adverse Event|5
1581804|NCT02594163|5492802|P1|Treatment Period|Adverse Event|1
1581805|NCT02594163|5492801|P2|Treatment Period|Progressive disease|3
1581806|NCT02594163|5492802|P1|Treatment Period|Progressive disease|2
1581807|NCT02594098|5492820|P2|Overall Study|Other|1
1581808|NCT02594098|5492821|P1|Overall Study|Other|0
1581809|NCT02594098|5492820|P2|Overall Study|Seek alternative treatment|1
1581810|NCT02594098|5492821|P1|Overall Study|Seek alternative treatment|2
1581811|NCT02594098|5492820|P2|Overall Study|Terminated participation|2
1581812|NCT02594098|5492821|P1|Overall Study|Terminated participation|6
1581813|NCT02594098|5492820|P2|Overall Study|Withdrawal by Subject|3
1581814|NCT02594098|5492821|P1|Overall Study|Withdrawal by Subject|1
1581815|NCT02594098|5492820|P2|Overall Study|Lack of Efficacy|6
1581816|NCT02594098|5492821|P1|Overall Study|Lack of Efficacy|17
1581817|NCT02593864|5492890|P1|Overall Study|Lost to Follow-up|3
1581818|NCT02593864|5492890|P1|Overall Study|Withdrawal by Subject|3
1581819|NCT02593773|5492895|P1|Overall Study|Death|1
1581820|NCT02593773|5492895|P1|Overall Study|Study Terminated by Sponsor|31
1581821|NCT02593773|5492895|P1|Overall Study|Voluntary Withdrawal|3
1581822|NCT02593305|5492927|P3|Post 1|Comparison only group. No intervention.|10
1581823|NCT02593305|5492928|P2|Post 1|Comparison only group. No intervention.|0
1581824|NCT02593305|5492929|P1|Post 1|Comparison only group. No intervention.|0
1581825|NCT02593149|5492944|P2|Intervention|Didn't use CVC for at least 21 day|115
1581826|NCT02593149|5492945|P1|Intervention|Didn't use CVC for at least 21 day|116
1581827|NCT02593149|5492944|P2|Run-In|Didn't use CVC for at least 21 days|38
1581828|NCT02593149|5492945|P1|Run-In|Didn't use CVC for at least 21 days|36
1581829|NCT02592876|5492953|P2|Overall Study|Death|9
1581830|NCT02592876|5492954|P1|Overall Study|Death|6
1581831|NCT02592876|5492953|P2|Overall Study|Lost to Follow-up|1
1581832|NCT02592876|5492954|P1|Overall Study|Lost to Follow-up|0
1581833|NCT02592876|5492953|P2|Overall Study|Study Termination by Sponsor|27
1581834|NCT02592876|5492954|P1|Overall Study|Study Termination by Sponsor|32
1581835|NCT02592876|5492953|P2|Overall Study|Withdrawal by Subject|3
1581836|NCT02592876|5492954|P1|Overall Study|Withdrawal by Subject|3
1581837|NCT02592447|5493025|P2|Overall Study|Withdrawal by Subject|1
1581838|NCT02592447|5493026|P1|Overall Study|Withdrawal by Subject|0
1581839|NCT02592447|5493025|P2|Overall Study|Ineligible after randomization|0
1581840|NCT02592447|5493026|P1|Overall Study|Ineligible after randomization|1
1581841|NCT02592447|5493025|P2|Overall Study|Lost to Follow-up|0
1581842|NCT02592447|5493026|P1|Overall Study|Lost to Follow-up|1
1581873|NCT02591290|5493199|P1|Overall Study|Withdrawal by Subject|2
1581874|NCT02591238|5493209|P4|Overall Study|personal circumstances|0
1581875|NCT02591238|5493210|P3|Overall Study|personal circumstances|0
1581876|NCT02591238|5493211|P2|Overall Study|personal circumstances|1
1581877|NCT02591238|5493212|P1|Overall Study|personal circumstances|0
1581878|NCT02591238|5493209|P4|Overall Study|personal circumstances|1
1581879|NCT02591238|5493210|P3|Overall Study|personal circumstances|0
1581880|NCT02591238|5493211|P2|Overall Study|personal circumstances|0
1581881|NCT02591238|5493212|P1|Overall Study|personal circumstances|0
1581882|NCT02591238|5493209|P4|Overall Study|influenza|1
1581883|NCT02591238|5493210|P3|Overall Study|influenza|0
1581884|NCT02591238|5493211|P2|Overall Study|influenza|0
1581885|NCT02591238|5493212|P1|Overall Study|influenza|0
1581886|NCT02591238|5493209|P4|Overall Study|Withdrawal by Subject|1
1581887|NCT02591238|5493210|P3|Overall Study|Withdrawal by Subject|0
1581888|NCT02591238|5493211|P2|Overall Study|Withdrawal by Subject|0
1581889|NCT02591238|5493212|P1|Overall Study|Withdrawal by Subject|0
1581890|NCT02591238|5493209|P4|Overall Study|Pregnancy|0
1581891|NCT02591238|5493210|P3|Overall Study|Pregnancy|0
1581892|NCT02591238|5493211|P2|Overall Study|Pregnancy|0
1581893|NCT02591238|5493212|P1|Overall Study|Pregnancy|1
1581894|NCT02590939|5493248|P2|Overall Study|Failed the nociceptive test|1
1581895|NCT02590939|5493249|P1|Overall Study|Failed the nociceptive test|2
1581896|NCT02590939|5493248|P2|Overall Study|Withdrawal by Subject|1
1581897|NCT02590939|5493249|P1|Overall Study|Withdrawal by Subject|3
1581898|NCT02590588|5493269|P1|Overall Study|Adverse Event|1
1581899|NCT02590562|5493277|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
1581900|NCT02590432|5493336|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581901|NCT02590432|5493337|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
1581902|NCT02590432|5493338|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581903|NCT02590432|5493339|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581904|NCT02590432|5493340|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581905|NCT02590432|5493341|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581906|NCT02590432|5493342|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581907|NCT02590432|5493343|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581908|NCT02590432|5493344|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
1581909|NCT02590432|5493336|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581910|NCT02590432|5493337|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
1581911|NCT02590432|5493338|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581912|NCT02590432|5493339|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581913|NCT02590432|5493340|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581914|NCT02590432|5493341|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581915|NCT02590432|5493342|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581916|NCT02590432|5493343|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581917|NCT02590432|5493344|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
1581918|NCT02590432|5493336|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
1581919|NCT02590432|5493337|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581920|NCT02590432|5493338|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581921|NCT02590432|5493339|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581922|NCT02590432|5493340|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581923|NCT02590432|5493341|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581924|NCT02590432|5493342|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581925|NCT02590432|5493343|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581926|NCT02590432|5493344|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
1581927|NCT02590432|5493336|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
1581928|NCT02590432|5493337|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581929|NCT02590432|5493338|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581930|NCT02590432|5493339|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581931|NCT02590432|5493340|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581932|NCT02590432|5493341|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581933|NCT02590432|5493342|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581934|NCT02590432|5493343|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581935|NCT02590432|5493344|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
1581936|NCT02590432|5493336|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
1581937|NCT02590432|5493337|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
1581938|NCT02590432|5493338|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1581939|NCT02590432|5493339|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1581940|NCT02590432|5493340|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1581941|NCT02590432|5493341|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1581942|NCT02590432|5493342|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1581943|NCT02590432|5493343|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1581944|NCT02590432|5493344|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
1581945|NCT02590432|5493336|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581946|NCT02590432|5493337|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
1581947|NCT02590432|5493338|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581948|NCT02590432|5493339|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581949|NCT02590432|5493340|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581950|NCT02590432|5493341|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581951|NCT02590432|5493342|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581952|NCT02590432|5493343|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581953|NCT02590432|5493344|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
1581954|NCT02590432|5493336|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
1581955|NCT02590432|5493337|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
1581956|NCT02590432|5493338|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
1581957|NCT02590432|5493339|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
1581958|NCT02590432|5493340|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
1581959|NCT02590432|5493341|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
1581960|NCT02590432|5493342|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
1581961|NCT02590432|5493343|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
1581962|NCT02590432|5493344|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
1581963|NCT02590432|5493336|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581964|NCT02590432|5493337|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581965|NCT02590432|5493338|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581966|NCT02590432|5493339|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
1581967|NCT02590432|5493340|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581968|NCT02590432|5493341|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581969|NCT02590432|5493342|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581970|NCT02590432|5493343|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581971|NCT02590432|5493344|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
1581972|NCT02590432|5493336|P9|Double-blind Treatment Period|Lost to Follow-up|0
1581973|NCT02590432|5493337|P8|Double-blind Treatment Period|Lost to Follow-up|0
1581974|NCT02590432|5493338|P7|Double-blind Treatment Period|Lost to Follow-up|0
1581975|NCT02590432|5493339|P6|Double-blind Treatment Period|Lost to Follow-up|2
1581976|NCT02590432|5493340|P5|Double-blind Treatment Period|Lost to Follow-up|0
1581977|NCT02590432|5493341|P4|Double-blind Treatment Period|Lost to Follow-up|0
1581978|NCT02590432|5493342|P3|Double-blind Treatment Period|Lost to Follow-up|1
1581979|NCT02590432|5493343|P2|Double-blind Treatment Period|Lost to Follow-up|0
1581980|NCT02590432|5493344|P1|Double-blind Treatment Period|Lost to Follow-up|0
1581981|NCT02590432|5493336|P9|Double-blind Treatment Period|Withdrawal of Consent|0
1581982|NCT02590432|5493337|P8|Double-blind Treatment Period|Withdrawal of Consent|0
1581983|NCT02590432|5493338|P7|Double-blind Treatment Period|Withdrawal of Consent|1
1581984|NCT02590432|5493339|P6|Double-blind Treatment Period|Withdrawal of Consent|1
1581985|NCT02590432|5493340|P5|Double-blind Treatment Period|Withdrawal of Consent|3
1581986|NCT02590432|5493341|P4|Double-blind Treatment Period|Withdrawal of Consent|3
1581987|NCT02590432|5493342|P3|Double-blind Treatment Period|Withdrawal of Consent|1
1581988|NCT02590432|5493343|P2|Double-blind Treatment Period|Withdrawal of Consent|0
1581989|NCT02590432|5493344|P1|Double-blind Treatment Period|Withdrawal of Consent|0
1581990|NCT02590432|5493336|P9|Double-blind Treatment Period|Lack of Efficacy|0
1581991|NCT02590432|5493337|P8|Double-blind Treatment Period|Lack of Efficacy|0
1581992|NCT02590432|5493338|P7|Double-blind Treatment Period|Lack of Efficacy|0
1581993|NCT02590432|5493339|P6|Double-blind Treatment Period|Lack of Efficacy|0
1581994|NCT02590432|5493340|P5|Double-blind Treatment Period|Lack of Efficacy|0
1581995|NCT02590432|5493341|P4|Double-blind Treatment Period|Lack of Efficacy|0
1581996|NCT02590432|5493342|P3|Double-blind Treatment Period|Lack of Efficacy|1
1581997|NCT02590432|5493343|P2|Double-blind Treatment Period|Lack of Efficacy|0
1581998|NCT02590432|5493344|P1|Double-blind Treatment Period|Lack of Efficacy|0
1581999|NCT02590432|5493336|P9|Double-blind Treatment Period|Adverse Event|0
1582000|NCT02590432|5493337|P8|Double-blind Treatment Period|Adverse Event|0
1582001|NCT02590432|5493338|P7|Double-blind Treatment Period|Adverse Event|20
1582002|NCT02590432|5493339|P6|Double-blind Treatment Period|Adverse Event|22
1582003|NCT02590432|5493340|P5|Double-blind Treatment Period|Adverse Event|6
1582004|NCT02590432|5493341|P4|Double-blind Treatment Period|Adverse Event|12
1582005|NCT02590432|5493342|P3|Double-blind Treatment Period|Adverse Event|14
1582006|NCT02590432|5493343|P2|Double-blind Treatment Period|Adverse Event|0
1582007|NCT02590432|5493344|P1|Double-blind Treatment Period|Adverse Event|0
1582008|NCT02590432|5493336|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
1582009|NCT02590432|5493337|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
1582010|NCT02590432|5493338|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
1582011|NCT02590432|5493339|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
1582012|NCT02590432|5493340|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
1582013|NCT02590432|5493341|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
1582014|NCT02590432|5493342|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
1582015|NCT02590432|5493343|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
1582016|NCT02590432|5493344|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
1582017|NCT02590432|5493336|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
1582018|NCT02590432|5493337|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
1582019|NCT02590432|5493338|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
1582020|NCT02590432|5493339|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
1582021|NCT02590432|5493340|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
1582022|NCT02590432|5493341|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
1582023|NCT02590432|5493342|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
1582024|NCT02590432|5493343|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
1582025|NCT02590432|5493344|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
1582026|NCT02590432|5493336|P9|Open-label Treatment Period|Protocol Violation|0
1582027|NCT02590432|5493337|P8|Open-label Treatment Period|Protocol Violation|0
1582028|NCT02590432|5493338|P7|Open-label Treatment Period|Protocol Violation|0
1582029|NCT02590432|5493339|P6|Open-label Treatment Period|Protocol Violation|0
1582030|NCT02590432|5493340|P5|Open-label Treatment Period|Protocol Violation|0
1582031|NCT02590432|5493341|P4|Open-label Treatment Period|Protocol Violation|0
1582032|NCT02590432|5493342|P3|Open-label Treatment Period|Protocol Violation|0
1582033|NCT02590432|5493343|P2|Open-label Treatment Period|Protocol Violation|4
1582034|NCT02590432|5493344|P1|Open-label Treatment Period|Protocol Violation|10
1582035|NCT02590432|5493336|P9|Open-label Treatment Period|Lost to Follow-up|0
1582036|NCT02590432|5493337|P8|Open-label Treatment Period|Lost to Follow-up|0
1582037|NCT02590432|5493338|P7|Open-label Treatment Period|Lost to Follow-up|0
1582038|NCT02590432|5493339|P6|Open-label Treatment Period|Lost to Follow-up|0
1582039|NCT02590432|5493340|P5|Open-label Treatment Period|Lost to Follow-up|0
1582040|NCT02590432|5493341|P4|Open-label Treatment Period|Lost to Follow-up|0
1582041|NCT02590432|5493342|P3|Open-label Treatment Period|Lost to Follow-up|0
1582042|NCT02590432|5493343|P2|Open-label Treatment Period|Lost to Follow-up|29
1582043|NCT02590432|5493344|P1|Open-label Treatment Period|Lost to Follow-up|51
1582044|NCT02590432|5493336|P9|Open-label Treatment Period|Withdrawal of Consent|0
1582045|NCT02590432|5493337|P8|Open-label Treatment Period|Withdrawal of Consent|0
1582046|NCT02590432|5493338|P7|Open-label Treatment Period|Withdrawal of Consent|0
1582047|NCT02590432|5493339|P6|Open-label Treatment Period|Withdrawal of Consent|0
1582048|NCT02590432|5493340|P5|Open-label Treatment Period|Withdrawal of Consent|0
1582049|NCT02590432|5493341|P4|Open-label Treatment Period|Withdrawal of Consent|0
1582050|NCT02590432|5493342|P3|Open-label Treatment Period|Withdrawal of Consent|0
1582051|NCT02590432|5493343|P2|Open-label Treatment Period|Withdrawal of Consent|28
1582052|NCT02590432|5493344|P1|Open-label Treatment Period|Withdrawal of Consent|43
1582053|NCT02590432|5493336|P9|Open-label Treatment Period|Lack of Efficacy|0
1582054|NCT02590432|5493337|P8|Open-label Treatment Period|Lack of Efficacy|0
1582055|NCT02590432|5493338|P7|Open-label Treatment Period|Lack of Efficacy|0
1582056|NCT02590432|5493339|P6|Open-label Treatment Period|Lack of Efficacy|0
1582057|NCT02590432|5493340|P5|Open-label Treatment Period|Lack of Efficacy|0
1582058|NCT02590432|5493341|P4|Open-label Treatment Period|Lack of Efficacy|0
1582059|NCT02590432|5493342|P3|Open-label Treatment Period|Lack of Efficacy|0
1582060|NCT02590432|5493343|P2|Open-label Treatment Period|Lack of Efficacy|5
1582061|NCT02590432|5493344|P1|Open-label Treatment Period|Lack of Efficacy|14
1582062|NCT02590432|5493336|P9|Open-label Treatment Period|Adverse Event|0
1582063|NCT02590432|5493337|P8|Open-label Treatment Period|Adverse Event|0
1582064|NCT02590432|5493338|P7|Open-label Treatment Period|Adverse Event|0
1582065|NCT02590432|5493339|P6|Open-label Treatment Period|Adverse Event|0
1582066|NCT02590432|5493340|P5|Open-label Treatment Period|Adverse Event|0
1582067|NCT02590432|5493341|P4|Open-label Treatment Period|Adverse Event|0
1582068|NCT02590432|5493342|P3|Open-label Treatment Period|Adverse Event|0
1582069|NCT02590432|5493343|P2|Open-label Treatment Period|Adverse Event|79
1582070|NCT02590432|5493344|P1|Open-label Treatment Period|Adverse Event|97
1582071|NCT02590354|5493378|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
1582072|NCT02590354|5493378|P1|Phase 1|Lost to Follow-up|1
1582073|NCT02590354|5493378|P1|Phase 1|Subject does not want to participate|20
1582074|NCT02590354|5493378|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
1582075|NCT02590354|5493378|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
1582076|NCT02590354|5493378|P1|Phase 1|Active hepatitis B or C infection|1
1582077|NCT02590003|5493405|P2|Overall Study|Death|2
1582078|NCT02590003|5493406|P1|Overall Study|Death|1
1582079|NCT02589639|5493433|P3|Overall Study|Not Treated|0
1582080|NCT02589639|5493434|P2|Overall Study|Not Treated|3
1582081|NCT02589639|5493435|P1|Overall Study|Not Treated|0
1582082|NCT02589639|5493433|P3|Overall Study|Other reason than specified above|1
1582083|NCT02589639|5493434|P2|Overall Study|Other reason than specified above|2
1582084|NCT02589639|5493435|P1|Overall Study|Other reason than specified above|1
1582085|NCT02589639|5493433|P3|Overall Study|Adverse Event|3
1582086|NCT02589639|5493434|P2|Overall Study|Adverse Event|5
1582087|NCT02589639|5493435|P1|Overall Study|Adverse Event|4
1582088|NCT02589639|5493433|P3|Overall Study|Patient withdrawal, not due to AE|0
1582089|NCT02589639|5493434|P2|Overall Study|Patient withdrawal, not due to AE|0
1582090|NCT02589639|5493435|P1|Overall Study|Patient withdrawal, not due to AE|3
1582091|NCT02589639|5493433|P3|Overall Study|Protocol Violation|0
1582092|NCT02589639|5493434|P2|Overall Study|Protocol Violation|0
1582093|NCT02589639|5493435|P1|Overall Study|Protocol Violation|1
1582094|NCT02589639|5493433|P3|Overall Study|Lost to Follow-up|0
1582095|NCT02589639|5493434|P2|Overall Study|Lost to Follow-up|0
1582096|NCT02589639|5493435|P1|Overall Study|Lost to Follow-up|1
1582097|NCT02589626|5493448|P2|Overall Study|Adverse Event|1
1582098|NCT02589626|5493449|P1|Overall Study|Adverse Event|1
1582099|NCT02589626|5493448|P2|Overall Study|Withdrawal by Subject|1
1582100|NCT02589626|5493449|P1|Overall Study|Withdrawal by Subject|1
1582101|NCT02589626|5493448|P2|Overall Study|Other than the reason specified|0
1582102|NCT02589626|5493449|P1|Overall Study|Other than the reason specified|1
1582103|NCT02589405|5493457|P1|Overall Study|Withdrawal by Subject|1
1582104|NCT02589405|5493457|P1|Overall Study|Adverse Event|3
1582105|NCT02588339|5493595|P1|Overall Study|GVHD Progression prior to treatment|2
1582106|NCT02588339|5493595|P1|Overall Study|Withdrawal by Subject|1
1582107|NCT02588261|5493607|P2|Overall Study|Lost to Follow-up|0
1582108|NCT02588261|5493608|P1|Overall Study|Lost to Follow-up|1
1582109|NCT02588261|5493607|P2|Overall Study|Adverse Event|24
1582110|NCT02588261|5493608|P1|Overall Study|Adverse Event|29
1582111|NCT02588261|5493607|P2|Overall Study|Progressive Disease|82
1582112|NCT02588261|5493608|P1|Overall Study|Progressive Disease|61
1582113|NCT02588261|5493607|P2|Overall Study|Miscellaneous|4
1582114|NCT02588261|5493608|P1|Overall Study|Miscellaneous|5
1582115|NCT02588261|5493607|P2|Overall Study|Noncompliance with Study Drug|1
1582116|NCT02588261|5493608|P1|Overall Study|Noncompliance with Study Drug|0
1582117|NCT02588261|5493607|P2|Overall Study|Withdrawal by Subject|8
1582118|NCT02588261|5493608|P1|Overall Study|Withdrawal by Subject|12
1582119|NCT02588261|5493607|P2|Overall Study|Death|2
1582120|NCT02588261|5493608|P1|Overall Study|Death|1
1582121|NCT02588261|5493607|P2|Overall Study|Protocol Deviation|0
1582122|NCT02588261|5493608|P1|Overall Study|Protocol Deviation|1
1582123|NCT02588261|5493607|P2|Overall Study|Study Terminated by Sponsor|142
1582124|NCT02588261|5493608|P1|Overall Study|Study Terminated by Sponsor|157
1582125|NCT02587819|5493634|P1|Overall Study|Lost to Follow-up|1
1582126|NCT02587819|5493634|P1|Overall Study|Adverse Event|1
1582127|NCT02587234|5493654|P2|Overall Study|Lost to Follow-up|2
1582128|NCT02587234|5493655|P1|Overall Study|Lost to Follow-up|0
1582129|NCT02587234|5493654|P2|Overall Study|Withdrawal by Subject|1
1582130|NCT02587234|5493655|P1|Overall Study|Withdrawal by Subject|1
1582131|NCT02587143|5493667|P2|Overall Study|Adverse Event|0
1582132|NCT02587143|5493668|P1|Overall Study|Adverse Event|1
1582133|NCT02587065|5493685|P1|Overall Study|Reason not Specified|3
1582134|NCT02587065|5493685|P1|Overall Study|Discontinuation of Study Medication|2
1582135|NCT02587065|5493685|P1|Overall Study|Non-adherence to the Protocol|3
1582136|NCT02587065|5493685|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
1582137|NCT02587065|5493685|P1|Overall Study|Adverse Event|14
1582138|NCT02586805|5493718|P4|Overall Study|Physician Decision|0
1582139|NCT02586805|5493719|P3|Overall Study|Physician Decision|0
1582140|NCT02586805|5493720|P2|Overall Study|Physician Decision|0
1582141|NCT02586805|5493721|P1|Overall Study|Physician Decision|1
1582142|NCT02586805|5493718|P4|Overall Study|Lost to Follow-up|0
1582143|NCT02586805|5493719|P3|Overall Study|Lost to Follow-up|1
1582144|NCT02586805|5493720|P2|Overall Study|Lost to Follow-up|0
1582145|NCT02586805|5493721|P1|Overall Study|Lost to Follow-up|0
1582146|NCT02586805|5493718|P4|Overall Study|Adverse Event|0
1582147|NCT02586805|5493719|P3|Overall Study|Adverse Event|1
1582148|NCT02586805|5493720|P2|Overall Study|Adverse Event|0
1582149|NCT02586805|5493721|P1|Overall Study|Adverse Event|2
1582150|NCT02586805|5493718|P4|Overall Study|Withdrawal by Subject|2
1582151|NCT02586805|5493719|P3|Overall Study|Withdrawal by Subject|1
1582152|NCT02586805|5493720|P2|Overall Study|Withdrawal by Subject|1
1582153|NCT02586805|5493721|P1|Overall Study|Withdrawal by Subject|3
1582154|NCT02586506|5493749|P1|Overall Study|Other Reason|2
1582155|NCT02586506|5493749|P1|Overall Study|Lost to Follow-up|1
1582156|NCT02586506|5493749|P1|Overall Study|Protocol Violation|6
1582157|NCT02586493|5493755|P1|Overall Study|Withdrawal by Subject|1
1582158|NCT02586493|5493755|P1|Overall Study|Lost to Follow-up|1
1582159|NCT02586493|5493755|P1|Overall Study|Protocol Violation|6
1582160|NCT02586493|5493755|P1|Overall Study|Adverse Event|4
1582161|NCT02586415|5493763|P2|Overall Study|Lost to Follow-up|2
1582162|NCT02586415|5493764|P1|Overall Study|Lost to Follow-up|1
1582163|NCT02586415|5493763|P2|Overall Study|Death|23
1582164|NCT02586415|5493764|P1|Overall Study|Death|13
1582165|NCT02586025|5493776|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
1582166|NCT02586025|5493777|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
1582167|NCT02586025|5493776|P2|Adjuvant Treatment|Recurrent Disease|4
1582168|NCT02586025|5493777|P1|Adjuvant Treatment|Recurrent Disease|1
1582169|NCT02586025|5493776|P2|Adjuvant Treatment|Physician Decision|1
1582170|NCT02586025|5493777|P1|Adjuvant Treatment|Physician Decision|0
1582171|NCT02586025|5493776|P2|Adjuvant Treatment|Withdrawal by Subject|3
1582172|NCT02586025|5493777|P1|Adjuvant Treatment|Withdrawal by Subject|5
1582173|NCT02586025|5493776|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
1582174|NCT02586025|5493777|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
1582175|NCT02586025|5493776|P2|Neoadjuvant Treatment|Progressive Disease|3
1582176|NCT02586025|5493777|P1|Neoadjuvant Treatment|Progressive Disease|2
1582177|NCT02586025|5493776|P2|Neoadjuvant Treatment|Physician Decision|1
1582178|NCT02586025|5493777|P1|Neoadjuvant Treatment|Physician Decision|2
1582179|NCT02586025|5493776|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
1582180|NCT02586025|5493777|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
1582181|NCT02586025|5493776|P2|Neoadjuvant Treatment|Adverse Event|0
1582182|NCT02586025|5493777|P1|Neoadjuvant Treatment|Adverse Event|1
1582183|NCT02586025|5493776|P2|Neoadjuvant Treatment|Death|0
1582184|NCT02586025|5493777|P1|Neoadjuvant Treatment|Death|1
1582185|NCT02586025|5493776|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
1582186|NCT02586025|5493777|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
1582187|NCT02585999|5493813|P1|Overall Study|Protocol Violation|1
1582188|NCT02585999|5493813|P1|Overall Study|Lost to Follow-up|1
1582189|NCT02585960|5493821|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
1582190|NCT02585960|5493822|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
1582191|NCT02585960|5493823|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
1582192|NCT02585960|5493821|P3|Prophylactic Treatment Period|Major protocol deviation|0
1582193|NCT02585960|5493822|P2|Prophylactic Treatment Period|Major protocol deviation|4
1582194|NCT02585960|5493823|P1|Prophylactic Treatment Period|Major protocol deviation|0
1582195|NCT02585960|5493821|P3|PK/Safety Assessment Period|Screen Failure|1
1582196|NCT02585960|5493822|P2|PK/Safety Assessment Period|Screen Failure|0
1582197|NCT02585960|5493823|P1|PK/Safety Assessment Period|Screen Failure|0
1582198|NCT02585960|5493821|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
1582199|NCT02585960|5493822|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
1582200|NCT02585960|5493823|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
1582201|NCT02585960|5493821|P3|PK/Safety Assessment Period|Other|0
1582202|NCT02585960|5493822|P2|PK/Safety Assessment Period|Other|4
1582203|NCT02585960|5493823|P1|PK/Safety Assessment Period|Other|4
1582204|NCT02585960|5493821|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
1582205|NCT02585960|5493822|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
1582206|NCT02585960|5493823|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
1582207|NCT02585960|5493821|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
1582208|NCT02585960|5493822|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
1582209|NCT02585960|5493823|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
1582210|NCT02585960|5493821|P3|PK/Safety Assessment Period|Physician Decision|0
1582211|NCT02585960|5493822|P2|PK/Safety Assessment Period|Physician Decision|1
1582212|NCT02585960|5493823|P1|PK/Safety Assessment Period|Physician Decision|0
1582213|NCT02585934|5493893|P2|Overall Study|Another Reason|5
1582214|NCT02585934|5493894|P1|Overall Study|Another Reason|10
1582215|NCT02585934|5493893|P2|Overall Study|Sponsor Termination|2
1582216|NCT02585934|5493894|P1|Overall Study|Sponsor Termination|1
1582217|NCT02585934|5493893|P2|Overall Study|Caregiver Withdrew Consent|7
1582218|NCT02585934|5493894|P1|Overall Study|Caregiver Withdrew Consent|7
1582219|NCT02585934|5493893|P2|Overall Study|Death|0
1582220|NCT02585934|5493894|P1|Overall Study|Death|2
1582221|NCT02585934|5493893|P2|Overall Study|Lack of Efficacy|1
1582222|NCT02585934|5493894|P1|Overall Study|Lack of Efficacy|2
1582223|NCT02585934|5493893|P2|Overall Study|Withdrawal by Subject|21
1582224|NCT02585934|5493894|P1|Overall Study|Withdrawal by Subject|7
1582225|NCT02585934|5493893|P2|Overall Study|Physician Decision|2
1582226|NCT02585934|5493894|P1|Overall Study|Physician Decision|3
1582227|NCT02585934|5493893|P2|Overall Study|Adverse Event|22
1582228|NCT02585934|5493894|P1|Overall Study|Adverse Event|21
1582229|NCT02585934|5493893|P2|Overall Study|Protocol Violation|11
1582230|NCT02585934|5493894|P1|Overall Study|Protocol Violation|14
1582231|NCT02585934|5493893|P2|Overall Study|Lost to Follow-up|2
1582232|NCT02585934|5493894|P1|Overall Study|Lost to Follow-up|2
1582234|NCT02585778|5493959|P2|Overall Study|Other than specified above|2
1582235|NCT02585778|5493960|P1|Overall Study|Other than specified above|6
1582236|NCT02585778|5493959|P2|Overall Study|Randomized but not treated|2
1582237|NCT02585778|5493960|P1|Overall Study|Randomized but not treated|1
1582238|NCT02585778|5493959|P2|Overall Study|Death|1
1582239|NCT02585778|5493960|P1|Overall Study|Death|0
1582240|NCT02585778|5493959|P2|Overall Study|Poor compliance to study protocol|2
1582241|NCT02585778|5493960|P1|Overall Study|Poor compliance to study protocol|0
1582242|NCT02585778|5493959|P2|Overall Study|Participant did not wish to continue|4
1582243|NCT02585778|5493960|P1|Overall Study|Participant did not wish to continue|9
1582244|NCT02585778|5493959|P2|Overall Study|Adverse Event|4
1582245|NCT02585778|5493960|P1|Overall Study|Adverse Event|17
1582246|NCT02585713|5494076|P2|Overall Study|Other|1
1582247|NCT02585713|5494077|P1|Overall Study|Other|3
1582248|NCT02585713|5494076|P2|Overall Study|Withdrew prior to treatment|7
1582249|NCT02585713|5494077|P1|Overall Study|Withdrew prior to treatment|2
1582250|NCT02584959|5494140|P3|Period 2|Withdrawn from study|2
1582251|NCT02584959|5494141|P2|Period 2|Withdrawn from study|1
1582252|NCT02584959|5494142|P1|Period 2|Withdrawn from study|6
1582253|NCT02584959|5494140|P3|Period 1|Withdrawn from study|0
1582254|NCT02584959|5494141|P2|Period 1|Withdrawn from study|4
1582255|NCT02584959|5494142|P1|Period 1|Withdrawn from study|3
1582256|NCT02584855|5494197|P6|Post Treatment Follow-up Period|Protocol Violation|0
1582257|NCT02584855|5494198|P5|Post Treatment Follow-up Period|Protocol Violation|1
1582258|NCT02584855|5494199|P4|Post Treatment Follow-up Period|Protocol Violation|0
1582259|NCT02584855|5494200|P3|Post Treatment Follow-up Period|Protocol Violation|0
1582260|NCT02584855|5494201|P2|Post Treatment Follow-up Period|Protocol Violation|0
1582261|NCT02584855|5494202|P1|Post Treatment Follow-up Period|Protocol Violation|0
1582262|NCT02584855|5494197|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
1582263|NCT02584855|5494198|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
1582264|NCT02584855|5494199|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
1582265|NCT02584855|5494200|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
1582266|NCT02584855|5494201|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
1582267|NCT02584855|5494202|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
1582268|NCT02584855|5494197|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1582269|NCT02584855|5494198|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1582270|NCT02584855|5494199|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1582271|NCT02584855|5494200|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1582272|NCT02584855|5494201|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
1582273|NCT02584855|5494202|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
1582274|NCT02584855|5494197|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
1582275|NCT02584855|5494198|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
1582276|NCT02584855|5494199|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
1582277|NCT02584855|5494200|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
1582278|NCT02584855|5494201|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
1582279|NCT02584855|5494202|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
1582280|NCT02584855|5494197|P6|Double-Blind Withdrawal Period|Adverse Event|0
1582281|NCT02584855|5494198|P5|Double-Blind Withdrawal Period|Adverse Event|0
1582282|NCT02584855|5494199|P4|Double-Blind Withdrawal Period|Adverse Event|1
1582283|NCT02584855|5494200|P3|Double-Blind Withdrawal Period|Adverse Event|0
1582284|NCT02584855|5494201|P2|Double-Blind Withdrawal Period|Adverse Event|4
1582285|NCT02584855|5494202|P1|Double-Blind Withdrawal Period|Adverse Event|0
1582286|NCT02584855|5494197|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1582287|NCT02584855|5494198|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1582288|NCT02584855|5494199|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1582289|NCT02584855|5494200|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
1582290|NCT02584855|5494201|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1582291|NCT02584855|5494202|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
1582292|NCT02584855|5494197|P6|Open-Label Treatment Period|Sponsor Decision|0
1582293|NCT02584855|5494198|P5|Open-Label Treatment Period|Sponsor Decision|0
1582294|NCT02584855|5494199|P4|Open-Label Treatment Period|Sponsor Decision|0
1582295|NCT02584855|5494200|P3|Open-Label Treatment Period|Sponsor Decision|0
1582296|NCT02584855|5494201|P2|Open-Label Treatment Period|Sponsor Decision|0
1582297|NCT02584855|5494202|P1|Open-Label Treatment Period|Sponsor Decision|1
1582298|NCT02584855|5494197|P6|Open-Label Treatment Period|No PI Available|0
1582299|NCT02584855|5494198|P5|Open-Label Treatment Period|No PI Available|0
1582300|NCT02584855|5494199|P4|Open-Label Treatment Period|No PI Available|0
1582301|NCT02584855|5494200|P3|Open-Label Treatment Period|No PI Available|0
1582302|NCT02584855|5494201|P2|Open-Label Treatment Period|No PI Available|0
1582303|NCT02584855|5494202|P1|Open-Label Treatment Period|No PI Available|2
1582304|NCT02584855|5494197|P6|Open-Label Treatment Period|Protocol Violation|0
1582305|NCT02584855|5494198|P5|Open-Label Treatment Period|Protocol Violation|0
1582306|NCT02584855|5494199|P4|Open-Label Treatment Period|Protocol Violation|0
1582307|NCT02584855|5494200|P3|Open-Label Treatment Period|Protocol Violation|0
1582308|NCT02584855|5494201|P2|Open-Label Treatment Period|Protocol Violation|0
1582309|NCT02584855|5494202|P1|Open-Label Treatment Period|Protocol Violation|1
1582310|NCT02584855|5494197|P6|Open-Label Treatment Period|Lost to Follow-up|0
1582311|NCT02584855|5494198|P5|Open-Label Treatment Period|Lost to Follow-up|0
1582312|NCT02584855|5494199|P4|Open-Label Treatment Period|Lost to Follow-up|0
1582313|NCT02584855|5494200|P3|Open-Label Treatment Period|Lost to Follow-up|0
1582314|NCT02584855|5494201|P2|Open-Label Treatment Period|Lost to Follow-up|0
1582315|NCT02584855|5494202|P1|Open-Label Treatment Period|Lost to Follow-up|1
1582316|NCT02584855|5494197|P6|Open-Label Treatment Period|Death|0
1582317|NCT02584855|5494198|P5|Open-Label Treatment Period|Death|0
1582318|NCT02584855|5494199|P4|Open-Label Treatment Period|Death|0
1582319|NCT02584855|5494200|P3|Open-Label Treatment Period|Death|0
1582320|NCT02584855|5494201|P2|Open-Label Treatment Period|Death|0
1582321|NCT02584855|5494202|P1|Open-Label Treatment Period|Death|2
1582322|NCT02584855|5494197|P6|Open-Label Treatment Period|Adverse Event|0
1582323|NCT02584855|5494198|P5|Open-Label Treatment Period|Adverse Event|0
1582324|NCT02584855|5494199|P4|Open-Label Treatment Period|Adverse Event|0
1582325|NCT02584855|5494200|P3|Open-Label Treatment Period|Adverse Event|0
1582326|NCT02584855|5494201|P2|Open-Label Treatment Period|Adverse Event|0
1582327|NCT02584855|5494202|P1|Open-Label Treatment Period|Adverse Event|14
1582328|NCT02584855|5494197|P6|Open-Label Treatment Period|Withdrawal by Subject|0
1582329|NCT02584855|5494198|P5|Open-Label Treatment Period|Withdrawal by Subject|0
1582330|NCT02584855|5494199|P4|Open-Label Treatment Period|Withdrawal by Subject|0
1582331|NCT02584855|5494200|P3|Open-Label Treatment Period|Withdrawal by Subject|0
1582332|NCT02584855|5494201|P2|Open-Label Treatment Period|Withdrawal by Subject|0
1582333|NCT02584855|5494202|P1|Open-Label Treatment Period|Withdrawal by Subject|21
1582334|NCT02584855|5494197|P6|Open-Label Treatment Period|Lack of Efficacy|0
1582335|NCT02584855|5494198|P5|Open-Label Treatment Period|Lack of Efficacy|0
1582336|NCT02584855|5494199|P4|Open-Label Treatment Period|Lack of Efficacy|0
1582337|NCT02584855|5494200|P3|Open-Label Treatment Period|Lack of Efficacy|0
1582338|NCT02584855|5494201|P2|Open-Label Treatment Period|Lack of Efficacy|0
1582339|NCT02584855|5494202|P1|Open-Label Treatment Period|Lack of Efficacy|61
1582340|NCT02584660|5494288|P2|Overall Study|Other|1
1582341|NCT02584660|5494289|P1|Overall Study|Other|0
1582342|NCT02584660|5494288|P2|Overall Study|Withdrawal by Subject|2
1582343|NCT02584660|5494289|P1|Overall Study|Withdrawal by Subject|0
1582344|NCT02584660|5494288|P2|Overall Study|Protocol Violation|1
1582345|NCT02584660|5494289|P1|Overall Study|Protocol Violation|0
1582346|NCT02584660|5494288|P2|Overall Study|Lost to Follow-up|4
1582347|NCT02584660|5494289|P1|Overall Study|Lost to Follow-up|3
1582348|NCT02584660|5494288|P2|Overall Study|Adverse Event|0
1582349|NCT02584660|5494289|P1|Overall Study|Adverse Event|4
1582350|NCT02584504|5494308|P3|Open-label Treatment|Entered but not treated|1
1582351|NCT02584504|5494309|P2|Open-label Treatment|Entered but not treated|1
1582352|NCT02584504|5494310|P1|Open-label Treatment|Entered but not treated|0
1582353|NCT02584504|5494308|P3|Open-label Treatment|Physician Decision|0
1582354|NCT02584504|5494309|P2|Open-label Treatment|Physician Decision|1
1582355|NCT02584504|5494310|P1|Open-label Treatment|Physician Decision|0
1582356|NCT02584504|5494308|P3|Open-label Treatment|Adverse Event|3
1582357|NCT02584504|5494309|P2|Open-label Treatment|Adverse Event|2
1582358|NCT02584504|5494310|P1|Open-label Treatment|Adverse Event|2
1582359|NCT02584504|5494308|P3|Open-label Treatment|Participant withdrew consent|4
1582360|NCT02584504|5494309|P2|Open-label Treatment|Participant withdrew consent|0
1582361|NCT02584504|5494310|P1|Open-label Treatment|Participant withdrew consent|0
1582362|NCT02584504|5494308|P3|Double-blind Treatment|Family Matter|0
1582363|NCT02584504|5494309|P2|Double-blind Treatment|Family Matter|1
1582364|NCT02584504|5494310|P1|Double-blind Treatment|Family Matter|0
1582365|NCT02584504|5494308|P3|Double-blind Treatment|Adverse Event|0
1582366|NCT02584504|5494309|P2|Double-blind Treatment|Adverse Event|1
1582367|NCT02584504|5494310|P1|Double-blind Treatment|Adverse Event|0
1582368|NCT02584504|5494308|P3|Double-blind Treatment|Participant withdrew consent|1
1582369|NCT02584504|5494309|P2|Double-blind Treatment|Participant withdrew consent|0
1582370|NCT02584504|5494310|P1|Double-blind Treatment|Participant withdrew consent|0
1582371|NCT02584452|5494366|P2|Overall Study|Lost to Follow-up|1
1582372|NCT02584452|5494367|P1|Overall Study|Lost to Follow-up|1
1582373|NCT02584452|5494366|P2|Overall Study|Physician Decision|1
1582374|NCT02584452|5494367|P1|Overall Study|Physician Decision|1
1582375|NCT02583477|5494397|P2|Overall Study|Study terminated|2
1582376|NCT02583477|5494398|P1|Overall Study|Study terminated|2
1582377|NCT02583477|5494397|P2|Overall Study|Death|16
1582378|NCT02583477|5494398|P1|Overall Study|Death|1
1582379|NCT02583477|5494397|P2|Overall Study|Adverse Event|2
1582380|NCT02583477|5494398|P1|Overall Study|Adverse Event|0
1582381|NCT02583425|5494418|P1|Treatment Period|Adverse Event|1
1582382|NCT02583425|5494418|P1|Baseline|Did not meet continued criteria|5
1582383|NCT02583425|5494418|P1|Screening|Did not meet entry criteria|12
1582384|NCT02583269|5494428|P5|Overall Study|Patient hospitalized prior to start|0
1582385|NCT02583269|5494429|P4|Overall Study|Patient hospitalized prior to start|0
1582386|NCT02583269|5494430|P3|Overall Study|Patient hospitalized prior to start|0
1582387|NCT02583269|5494431|P2|Overall Study|Patient hospitalized prior to start|0
1582388|NCT02583269|5494432|P1|Overall Study|Patient hospitalized prior to start|1
1582389|NCT02583256|5494461|P4|Overall Study|Administrative/Other|2
1582390|NCT02583256|5494462|P3|Overall Study|Administrative/Other|1
1582391|NCT02583256|5494463|P2|Overall Study|Administrative/Other|0
1582392|NCT02583256|5494464|P1|Overall Study|Administrative/Other|2
1582393|NCT02583256|5494461|P4|Overall Study|Lost to Follow-up|1
1582394|NCT02583256|5494462|P3|Overall Study|Lost to Follow-up|0
1582395|NCT02583256|5494463|P2|Overall Study|Lost to Follow-up|1
1582396|NCT02583256|5494464|P1|Overall Study|Lost to Follow-up|1
1582397|NCT02583256|5494461|P4|Overall Study|Withdrawal by Subject|0
1582398|NCT02583256|5494462|P3|Overall Study|Withdrawal by Subject|1
1582399|NCT02583256|5494463|P2|Overall Study|Withdrawal by Subject|1
1582400|NCT02583256|5494464|P1|Overall Study|Withdrawal by Subject|0
1582401|NCT02583048|5494561|P3|Overall Study|Failed to meet eligibility criterion|1
1582402|NCT02583048|5494562|P2|Overall Study|Failed to meet eligibility criterion|0
1582403|NCT02583048|5494563|P1|Overall Study|Failed to meet eligibility criterion|0
1582404|NCT02583048|5494561|P3|Overall Study|Withdrawal by Subject|0
1582405|NCT02583048|5494562|P2|Overall Study|Withdrawal by Subject|1
1582406|NCT02583048|5494563|P1|Overall Study|Withdrawal by Subject|0
1582407|NCT02582983|5494598|P1|Overall Study|Adverse Event|1
1582408|NCT02582983|5494598|P1|Overall Study|Withdrawal by Subject|2
1582409|NCT02582983|5494598|P1|Overall Study|Death|3
1582410|NCT02582814|5494661|P2|Overall Study|Adverse Event|4
1582411|NCT02582814|5494662|P1|Overall Study|Adverse Event|4
1582412|NCT02582814|5494661|P2|Overall Study|Withdrawal by Subject|3
1582413|NCT02582814|5494662|P1|Overall Study|Withdrawal by Subject|4
1582414|NCT02582814|5494661|P2|Overall Study|Study-specific withdrawal criteria|0
1582415|NCT02582814|5494662|P1|Overall Study|Study-specific withdrawal criteria|1
1582416|NCT02582749|5494702|P2|Overall Study|Withdrawal by Subject|1
1582417|NCT02582749|5494703|P1|Overall Study|Withdrawal by Subject|0
1582418|NCT02582749|5494702|P2|Overall Study|Study terminated by funder|10
1582419|NCT02582749|5494703|P1|Overall Study|Study terminated by funder|5
1582420|NCT02582684|5494733|P1|Overall Study|Found to be ineligible after enrollment|2
1582421|NCT02582684|5494733|P1|Overall Study|Subject withdrew consent|1
1582422|NCT02582684|5494733|P1|Overall Study|Subject not able to get to clinic|10
1582423|NCT02582684|5494733|P1|Overall Study|Unable to contact subject/parent|4
1582424|NCT02582671|5494752|P1|Overall Study|Other, not specified|1
1582425|NCT02582671|5494752|P1|Overall Study|Failure to return|1
1582426|NCT02582658|5494764|P1|Overall Study|Not further specified|11
1582427|NCT02582658|5494764|P1|Overall Study|Death|1
1582428|NCT02582658|5494764|P1|Overall Study|Withdrawn Consent|1
1582429|NCT02582658|5494764|P1|Overall Study|Insufficient Virological Response|2
1582430|NCT02582658|5494764|P1|Overall Study|Failure to Return|10
1582431|NCT02582632|5494782|P1|Overall Study|Other|1
1582432|NCT02582515|5494797|P2|Overall Study|Withdrawal by Subject|1
1582433|NCT02582515|5494798|P1|Overall Study|Withdrawal by Subject|0
1582434|NCT02582255|5494806|P2|Overall Study|Protocol Violation|3
1582435|NCT02582255|5494807|P1|Overall Study|Protocol Violation|0
1582436|NCT02582242|5494820|P2|Overall Study|Unclassified|1
1582437|NCT02582242|5494821|P1|Overall Study|Unclassified|2
1582438|NCT02582242|5494820|P2|Overall Study|Withdrawal by Subject|11
1582439|NCT02582242|5494821|P1|Overall Study|Withdrawal by Subject|11
1582440|NCT02582242|5494820|P2|Overall Study|Lost to Follow-up|1
1582441|NCT02582242|5494821|P1|Overall Study|Lost to Follow-up|0
1582442|NCT02582242|5494820|P2|Overall Study|Protocol Violation|1
1582443|NCT02582242|5494821|P1|Overall Study|Protocol Violation|3
1582444|NCT02582242|5494820|P2|Overall Study|Adverse Event|3
1582445|NCT02582242|5494821|P1|Overall Study|Adverse Event|4
1582446|NCT02581995|5494880|P1|Overall Study|Death|4
1582447|NCT02581995|5494880|P1|Overall Study|Physician Decision|1
1582448|NCT02581995|5494880|P1|Overall Study|Withdrawal by participant|12
1582449|NCT02581995|5494880|P1|Overall Study|Lost to Follow-up|5
1582450|NCT02581995|5494880|P1|Overall Study|Adverse Event|6
1582451|NCT02581995|5494880|P1|Overall Study|Unspecified other|3
1582452|NCT02581930|5494894|P1|Overall Study|patient declined further treatment|1
1582453|NCT02581930|5494894|P1|Overall Study|Withdrawal by Subject|1
1582454|NCT02581488|5494902|P2|Overall Study|Protocol Violation|4
1582455|NCT02581488|5494903|P1|Overall Study|Protocol Violation|0
1582456|NCT02581488|5494902|P2|Overall Study|Non-Compliance|0
1582457|NCT02581488|5494903|P1|Overall Study|Non-Compliance|1
1582458|NCT02581488|5494902|P2|Overall Study|Withdrawal by Subject|0
1582459|NCT02581488|5494903|P1|Overall Study|Withdrawal by Subject|1
1582460|NCT02581488|5494902|P2|Overall Study|Lost to Follow-up|0
1582461|NCT02581488|5494903|P1|Overall Study|Lost to Follow-up|1
1582462|NCT02581488|5494902|P2|Overall Study|Adverse Event|7
1582463|NCT02581488|5494903|P1|Overall Study|Adverse Event|6
1582464|NCT02581410|5494934|P2|End of Study Phase|Other-transfer of subject not completed|1
1582465|NCT02581410|5494935|P1|End of Study Phase|Other-transfer of subject not completed|0
1582466|NCT02581410|5494934|P2|End of Study Phase|Lost to Follow-up|2
1582467|NCT02581410|5494935|P1|End of Study Phase|Lost to Follow-up|0
1582468|NCT02581410|5494934|P2|End of Study Phase|Migrated/moved from study area|3
1582469|NCT02581410|5494935|P1|End of Study Phase|Migrated/moved from study area|0
1582470|NCT02581410|5494934|P2|End of Study Phase|Withdrawal by Subject|2
1582471|NCT02581410|5494935|P1|End of Study Phase|Withdrawal by Subject|1
1582472|NCT02581410|5494934|P2|End of Study Phase|Adverse Event|3
1582473|NCT02581410|5494935|P1|End of Study Phase|Adverse Event|4
1582474|NCT02581410|5494934|P2|Vaccination Phase|Migrated/moved from study area|1
1582475|NCT02581410|5494935|P1|Vaccination Phase|Migrated/moved from study area|0
1582476|NCT02581410|5494934|P2|Vaccination Phase|Withdrawal by Subject|1
1582477|NCT02581410|5494935|P1|Vaccination Phase|Withdrawal by Subject|0
1582478|NCT02581410|5494934|P2|Vaccination Phase|Adverse Event|1
1582479|NCT02581410|5494935|P1|Vaccination Phase|Adverse Event|2
1582480|NCT02581345|5494965|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
1582481|NCT02581345|5494966|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
1582482|NCT02581345|5494967|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
1582483|NCT02581345|5494968|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
1582484|NCT02581345|5494965|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
1582485|NCT02581345|5494966|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
1582486|NCT02581345|5494967|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
1582487|NCT02581345|5494968|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
1582488|NCT02581345|5494965|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
1582489|NCT02581345|5494966|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
1582490|NCT02581345|5494967|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
1582491|NCT02581345|5494968|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
1582492|NCT02581345|5494965|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
1582493|NCT02581345|5494966|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
1582494|NCT02581345|5494967|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
1582495|NCT02581345|5494968|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
1582496|NCT02581345|5494965|P4|Part 2: Week 17 to Week 47|Physician Decision|1
1582497|NCT02581345|5494966|P3|Part 2: Week 17 to Week 47|Physician Decision|2
1582498|NCT02581345|5494967|P2|Part 2: Week 17 to Week 47|Physician Decision|0
1582499|NCT02581345|5494968|P1|Part 2: Week 17 to Week 47|Physician Decision|3
1582500|NCT02581345|5494965|P4|Part 2: Week 17 to Week 47|Adverse Event|2
1582501|NCT02581345|5494966|P3|Part 2: Week 17 to Week 47|Adverse Event|2
1582502|NCT02581345|5494967|P2|Part 2: Week 17 to Week 47|Adverse Event|0
1582503|NCT02581345|5494968|P1|Part 2: Week 17 to Week 47|Adverse Event|5
1582504|NCT02581345|5494965|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
1582505|NCT02581345|5494966|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
1582506|NCT02581345|5494967|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
1582507|NCT02581345|5494968|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
1582508|NCT02581345|5494965|P4|Part 1: up to Week 16|Unspecified Reason|0
1582509|NCT02581345|5494966|P3|Part 1: up to Week 16|Unspecified Reason|0
1582510|NCT02581345|5494967|P2|Part 1: up to Week 16|Unspecified Reason|3
1582511|NCT02581345|5494968|P1|Part 1: up to Week 16|Unspecified Reason|3
1582512|NCT02581345|5494965|P4|Part 1: up to Week 16|Lost to Follow-up|0
1582513|NCT02581345|5494966|P3|Part 1: up to Week 16|Lost to Follow-up|0
1582514|NCT02581345|5494967|P2|Part 1: up to Week 16|Lost to Follow-up|0
1582515|NCT02581345|5494968|P1|Part 1: up to Week 16|Lost to Follow-up|2
1582516|NCT02581345|5494965|P4|Part 1: up to Week 16|Withdrawal by Subject|0
1582517|NCT02581345|5494966|P3|Part 1: up to Week 16|Withdrawal by Subject|0
1582518|NCT02581345|5494967|P2|Part 1: up to Week 16|Withdrawal by Subject|7
1582519|NCT02581345|5494968|P1|Part 1: up to Week 16|Withdrawal by Subject|4
1582520|NCT02581345|5494965|P4|Part 1: up to Week 16|Physician Decision|0
1582521|NCT02581345|5494966|P3|Part 1: up to Week 16|Physician Decision|0
1582522|NCT02581345|5494967|P2|Part 1: up to Week 16|Physician Decision|4
1582523|NCT02581345|5494968|P1|Part 1: up to Week 16|Physician Decision|2
1582524|NCT02581345|5494965|P4|Part 1: up to Week 16|Adverse Event|0
1582525|NCT02581345|5494966|P3|Part 1: up to Week 16|Adverse Event|0
1582526|NCT02581345|5494967|P2|Part 1: up to Week 16|Adverse Event|8
1582527|NCT02581345|5494968|P1|Part 1: up to Week 16|Adverse Event|3
1582528|NCT02581202|5495070|P1|Overall Study|Pregnancy|3
1582529|NCT02581202|5495070|P1|Overall Study|Lost to Follow-up|5
1582530|NCT02581202|5495070|P1|Overall Study|Withdrawal by Subject|4
1582531|NCT02581202|5495070|P1|Overall Study|Lack of Efficacy|2
1582532|NCT02581189|5495109|P1|Overall Study|Other, not specified|7
1582533|NCT02581189|5495109|P1|Overall Study|Insufficient virological response|2
1582534|NCT02581189|5495109|P1|Overall Study|Death|3
1582535|NCT02581189|5495109|P1|Overall Study|Withdrew consent|5
1582536|NCT02581189|5495109|P1|Overall Study|Failure to return|36
1582537|NCT02581163|5495123|P1|Overall Study|Other, not specified|9
1582538|NCT02581163|5495123|P1|Overall Study|Death|1
1582539|NCT02581163|5495123|P1|Overall Study|Withdrew consent|1
1582540|NCT02581163|5495123|P1|Overall Study|Insufficient virological response|3
1582541|NCT02581163|5495123|P1|Overall Study|Failure to return|15
1582542|NCT02580591|5495181|P4|Overall Study|Other than specified|2
1582543|NCT02580591|5495182|P3|Overall Study|Other than specified|5
1582544|NCT02580591|5495183|P2|Overall Study|Other than specified|2
1582545|NCT02580591|5495184|P1|Overall Study|Other than specified|3
1582546|NCT02580591|5495181|P4|Overall Study|Not treated|0
1582547|NCT02580591|5495182|P3|Overall Study|Not treated|0
1582548|NCT02580591|5495183|P2|Overall Study|Not treated|1
1582549|NCT02580591|5495184|P1|Overall Study|Not treated|1
1582550|NCT02580591|5495181|P4|Overall Study|Withdrawal by Subject|3
1582551|NCT02580591|5495182|P3|Overall Study|Withdrawal by Subject|2
1582552|NCT02580591|5495183|P2|Overall Study|Withdrawal by Subject|1
1582553|NCT02580591|5495184|P1|Overall Study|Withdrawal by Subject|6
1582554|NCT02580591|5495181|P4|Overall Study|Lost to Follow-up|1
1582555|NCT02580591|5495182|P3|Overall Study|Lost to Follow-up|3
1582556|NCT02580591|5495183|P2|Overall Study|Lost to Follow-up|3
1582557|NCT02580591|5495184|P1|Overall Study|Lost to Follow-up|5
1582558|NCT02580591|5495181|P4|Overall Study|Protocol Violation|1
1582559|NCT02580591|5495182|P3|Overall Study|Protocol Violation|1
1582560|NCT02580591|5495183|P2|Overall Study|Protocol Violation|2
1582561|NCT02580591|5495184|P1|Overall Study|Protocol Violation|3
1582562|NCT02580591|5495181|P4|Overall Study|Adverse Event|5
1582563|NCT02580591|5495182|P3|Overall Study|Adverse Event|2
1582564|NCT02580591|5495183|P2|Overall Study|Adverse Event|1
1582565|NCT02580591|5495184|P1|Overall Study|Adverse Event|0
1582566|NCT02580357|5495217|P3|Overall Study|Protocol Violation|0
1582567|NCT02580357|5495218|P2|Overall Study|Protocol Violation|0
1582568|NCT02580357|5495219|P1|Overall Study|Protocol Violation|1
1582569|NCT02580357|5495217|P3|Overall Study|Lost to Follow-up|0
1582570|NCT02580357|5495218|P2|Overall Study|Lost to Follow-up|0
1582571|NCT02580357|5495219|P1|Overall Study|Lost to Follow-up|2
1582572|NCT02580240|5495236|P2|Overall Study|Physician Decision|0
1582573|NCT02580240|5495237|P1|Overall Study|Physician Decision|2
1582574|NCT02580058|5495261|P3|Overall Study|Withdrawal by Subject|36
1582575|NCT02580058|5495262|P2|Overall Study|Withdrawal by Subject|26
1582576|NCT02580058|5495263|P1|Overall Study|Withdrawal by Subject|24
1582577|NCT02580058|5495261|P3|Overall Study|Ongoing|46
1582578|NCT02580058|5495262|P2|Overall Study|Ongoing|55
1582579|NCT02580058|5495263|P1|Overall Study|Ongoing|51
1582580|NCT02580058|5495261|P3|Overall Study|Lost to Follow-up|4
1582581|NCT02580058|5495262|P2|Overall Study|Lost to Follow-up|5
1582582|NCT02580058|5495263|P1|Overall Study|Lost to Follow-up|4
1582583|NCT02579863|5495362|P2|Overall Study|Withdrawal by Subject|19
1582584|NCT02579863|5495363|P1|Overall Study|Withdrawal by Subject|17
1582585|NCT02579863|5495362|P2|Overall Study|Study Terminated at Selected Sites|3
1582586|NCT02579863|5495363|P1|Overall Study|Study Terminated at Selected Sites|3
1582587|NCT02579863|5495362|P2|Overall Study|Screen Failure|2
1582588|NCT02579863|5495363|P1|Overall Study|Screen Failure|1
1582589|NCT02579863|5495362|P2|Overall Study|Physician Decision|2
1582590|NCT02579863|5495363|P1|Overall Study|Physician Decision|0
1582591|NCT02579863|5495362|P2|Overall Study|Lost to Follow-up|1
1582592|NCT02579863|5495363|P1|Overall Study|Lost to Follow-up|2
1582593|NCT02579863|5495362|P2|Overall Study|Death|3
1582594|NCT02579863|5495363|P1|Overall Study|Death|11
1582595|NCT02579863|5495362|P2|Overall Study|Adverse Event|12
1582596|NCT02579863|5495363|P1|Overall Study|Adverse Event|17
1582597|NCT02579863|5495362|P2|Overall Study|Ongoing in Trial|112
1582598|NCT02579863|5495363|P1|Overall Study|Ongoing in Trial|105
1582599|NCT02579772|5495383|P2|Overall Study|flu-like illness, orthopedic trauma|1
1582600|NCT02579772|5495384|P1|Overall Study|flu-like illness, orthopedic trauma|1
1582601|NCT02579772|5495383|P2|Overall Study|Usage of additional antioxidants|0
1582602|NCT02579772|5495384|P1|Overall Study|Usage of additional antioxidants|1
1582603|NCT02579772|5495383|P2|Overall Study|Withdrawal by Subject|1
1582604|NCT02579772|5495384|P1|Overall Study|Withdrawal by Subject|0
1582605|NCT02579603|5495404|P2|Overall Study|Other than stated|0
1582606|NCT02579603|5495405|P1|Overall Study|Other than stated|1
1582607|NCT02579603|5495404|P2|Overall Study|Adverse Event|2
1582608|NCT02579603|5495405|P1|Overall Study|Adverse Event|2
1582609|NCT02579603|5495404|P2|Overall Study|Not treated|0
1582610|NCT02579603|5495405|P1|Overall Study|Not treated|1
1582611|NCT02578992|5495460|P2|Overall Study|equipment not available or malfunction|3
1582612|NCT02578992|5495461|P1|Overall Study|equipment not available or malfunction|3
1582613|NCT02578940|5495473|P1|Overall Study|Lost to Follow-up|1
1582614|NCT02578940|5495473|P1|Overall Study|Screening failure|5
1582615|NCT02578862|5495482|P2|Overall Study|Unplanned unilateral procedure|1
1582616|NCT02578862|5495483|P1|Overall Study|Unplanned unilateral procedure|0
1582617|NCT02578862|5495482|P2|Overall Study|Withdrawal by Subject|1
1582618|NCT02578862|5495483|P1|Overall Study|Withdrawal by Subject|0
1582619|NCT02578706|5495521|P3|Overall Study|Physician Decision|0
1582620|NCT02578706|5495522|P2|Overall Study|Physician Decision|1
1582621|NCT02578706|5495523|P1|Overall Study|Physician Decision|0
1582622|NCT02578706|5495521|P3|Overall Study|Lost to Follow-up|0
1582623|NCT02578706|5495522|P2|Overall Study|Lost to Follow-up|4
1582624|NCT02578706|5495523|P1|Overall Study|Lost to Follow-up|0
1582625|NCT02578706|5495521|P3|Overall Study|Withdrawal by Subject|0
1582626|NCT02578706|5495522|P2|Overall Study|Withdrawal by Subject|0
1582627|NCT02578706|5495523|P1|Overall Study|Withdrawal by Subject|1
1582628|NCT02578680|5495602|P2|Overall Study|Ongoing in Study|96
1582629|NCT02578680|5495603|P1|Overall Study|Ongoing in Study|276
1582630|NCT02578680|5495602|P2|Overall Study|Withdrawal by Subject|5
1582631|NCT02578680|5495603|P1|Overall Study|Withdrawal by Subject|8
1582632|NCT02578680|5495602|P2|Overall Study|Withdrawal by Parent/Guardian|0
1582633|NCT02578680|5495603|P1|Overall Study|Withdrawal by Parent/Guardian|1
1582634|NCT02578680|5495602|P2|Overall Study|Protocol Violation|1
1582635|NCT02578680|5495603|P1|Overall Study|Protocol Violation|1
1582636|NCT02578680|5495602|P2|Overall Study|Death|104
1582637|NCT02578680|5495603|P1|Overall Study|Death|124
1582638|NCT02578316|5495619|P1|Extension Phase|Progression of disease|6
1582639|NCT02578186|5495652|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
1582640|NCT02578186|5495653|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
1582641|NCT02578186|5495652|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1582642|NCT02578186|5495653|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1582643|NCT02577887|5495742|P1|Overall Study|Withdrawal by Subject|80
1582644|NCT02577887|5495742|P1|Overall Study|Protocol Violation|125
1582645|NCT02577887|5495742|P1|Overall Study|Death|93
1582646|NCT02577718|5495768|P1|Overall Study|Withdrawal by Subject|2
1582647|NCT02577718|5495768|P1|Overall Study|Death|6
1582648|NCT02577315|5495810|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1582649|NCT02577315|5495811|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1582650|NCT02577146|5495827|P1|Overall Study|Screen Failure|17
1582651|NCT02577146|5495827|P1|Overall Study|Physician Decision|3
1582652|NCT02577146|5495827|P1|Overall Study|Lost to Follow-up|8
1582653|NCT02577107|5495834|P2|Overall Study|Protocol deviation|1
1582654|NCT02577107|5495835|P1|Overall Study|Protocol deviation|0
1582655|NCT02577029|5495855|P8|Overall Study|Sponsor Termination of the Study|12
1582656|NCT02577029|5495856|P7|Overall Study|Sponsor Termination of the Study|12
1582657|NCT02577029|5495857|P6|Overall Study|Sponsor Termination of the Study|12
1582658|NCT02577029|5495858|P5|Overall Study|Sponsor Termination of the Study|10
1582659|NCT02577029|5495859|P4|Overall Study|Sponsor Termination of the Study|12
1582660|NCT02577029|5495860|P3|Overall Study|Sponsor Termination of the Study|5
1582661|NCT02577029|5495861|P2|Overall Study|Sponsor Termination of the Study|2
1582662|NCT02577029|5495862|P1|Overall Study|Sponsor Termination of the Study|9
1582663|NCT02577029|5495855|P8|Overall Study|Withdrawal by Subject|0
1582664|NCT02577029|5495856|P7|Overall Study|Withdrawal by Subject|0
1582665|NCT02577029|5495857|P6|Overall Study|Withdrawal by Subject|1
1582666|NCT02577029|5495858|P5|Overall Study|Withdrawal by Subject|0
1582667|NCT02577029|5495859|P4|Overall Study|Withdrawal by Subject|0
1582668|NCT02577029|5495860|P3|Overall Study|Withdrawal by Subject|0
1582669|NCT02577029|5495861|P2|Overall Study|Withdrawal by Subject|0
1582670|NCT02577029|5495862|P1|Overall Study|Withdrawal by Subject|0
1582671|NCT02577029|5495855|P8|Overall Study|Adverse Event|0
1582672|NCT02577029|5495856|P7|Overall Study|Adverse Event|0
1582673|NCT02577029|5495857|P6|Overall Study|Adverse Event|0
1582674|NCT02577029|5495858|P5|Overall Study|Adverse Event|1
1582675|NCT02577029|5495859|P4|Overall Study|Adverse Event|0
1582676|NCT02577029|5495860|P3|Overall Study|Adverse Event|2
1582677|NCT02577029|5495861|P2|Overall Study|Adverse Event|0
1582678|NCT02577029|5495862|P1|Overall Study|Adverse Event|1
1582679|NCT02577016|5495970|P2|Overall Study|Physician Decision|1
1582680|NCT02577016|5495971|P1|Overall Study|Physician Decision|0
1582681|NCT02577016|5495970|P2|Overall Study|Adverse Event|1
1582682|NCT02577016|5495971|P1|Overall Study|Adverse Event|2
1582683|NCT02577003|5495989|P2|Overall Study|Withdrawal by Subject|1
1582684|NCT02577003|5495990|P1|Overall Study|Withdrawal by Subject|0
1582685|NCT02577003|5495989|P2|Overall Study|Adverse Event|4
1582686|NCT02577003|5495990|P1|Overall Study|Adverse Event|2
1582687|NCT02576977|5496010|P2|Overall Study|Ongoing in trial|77
1582688|NCT02576977|5496011|P1|Overall Study|Ongoing in trial|53
1582689|NCT02576977|5496010|P2|Overall Study|Withdrawal by Subject|9
1582690|NCT02576977|5496011|P1|Overall Study|Withdrawal by Subject|9
1582691|NCT02576977|5496010|P2|Overall Study|Study Terminated at Selected Sites|2
1582692|NCT02576977|5496011|P1|Overall Study|Study Terminated at Selected Sites|3
1582693|NCT02576977|5496010|P2|Overall Study|Screen failure|0
1582694|NCT02576977|5496011|P1|Overall Study|Screen failure|1
1582695|NCT02576977|5496010|P2|Overall Study|Death|35
1582696|NCT02576977|5496011|P1|Overall Study|Death|47
1582697|NCT02576977|5496010|P2|Overall Study|Adverse Event|2
1582698|NCT02576977|5496011|P1|Overall Study|Adverse Event|13
1582699|NCT02576951|5496033|P4|Overall Study|Protocol Violation|1
1582700|NCT02576951|5496034|P3|Overall Study|Protocol Violation|0
1582701|NCT02576951|5496035|P2|Overall Study|Protocol Violation|0
1582702|NCT02576951|5496036|P1|Overall Study|Protocol Violation|0
1582703|NCT02576951|5496033|P4|Overall Study|Withdrawal by Subject|2
1582704|NCT02576951|5496034|P3|Overall Study|Withdrawal by Subject|0
1582705|NCT02576951|5496035|P2|Overall Study|Withdrawal by Subject|0
1582706|NCT02576951|5496036|P1|Overall Study|Withdrawal by Subject|1
1582707|NCT02576951|5496033|P4|Overall Study|Lost to Follow-up|2
1582708|NCT02576951|5496034|P3|Overall Study|Lost to Follow-up|2
1582709|NCT02576951|5496035|P2|Overall Study|Lost to Follow-up|0
1582710|NCT02576951|5496036|P1|Overall Study|Lost to Follow-up|0
1582711|NCT02576938|5496060|P3|Overall Study|Met Exclusion Criteria|0
1582712|NCT02576938|5496061|P2|Overall Study|Met Exclusion Criteria|1
1582713|NCT02576938|5496062|P1|Overall Study|Met Exclusion Criteria|0
1582714|NCT02576938|5496060|P3|Overall Study|Physician Decision|0
1582715|NCT02576938|5496061|P2|Overall Study|Physician Decision|1
1582716|NCT02576938|5496062|P1|Overall Study|Physician Decision|0
1582717|NCT02576938|5496060|P3|Overall Study|Lost to Follow-up|1
1582718|NCT02576938|5496061|P2|Overall Study|Lost to Follow-up|0
1582719|NCT02576938|5496062|P1|Overall Study|Lost to Follow-up|2
1582720|NCT02576938|5496060|P3|Overall Study|Lack of Efficacy|0
1582721|NCT02576938|5496061|P2|Overall Study|Lack of Efficacy|4
1582722|NCT02576938|5496062|P1|Overall Study|Lack of Efficacy|9
1582723|NCT02576938|5496060|P3|Overall Study|Withdrawal by Subject|4
1582724|NCT02576938|5496061|P2|Overall Study|Withdrawal by Subject|2
1582725|NCT02576938|5496062|P1|Overall Study|Withdrawal by Subject|3
1582726|NCT02576938|5496060|P3|Overall Study|Protocol Violation|1
1582727|NCT02576938|5496061|P2|Overall Study|Protocol Violation|1
1582728|NCT02576938|5496062|P1|Overall Study|Protocol Violation|1
1582729|NCT02576938|5496060|P3|Overall Study|Adverse Event|6
1582730|NCT02576938|5496061|P2|Overall Study|Adverse Event|3
1582731|NCT02576938|5496062|P1|Overall Study|Adverse Event|5
1582747|NCT02576652|5496127|P1|Overall Study|Withdrawal by Subject|2
1582748|NCT02576639|5496139|P5|Overall Study|Physician Decision|1
1582749|NCT02576639|5496140|P4|Overall Study|Physician Decision|0
1582750|NCT02576639|5496141|P3|Overall Study|Physician Decision|0
1582751|NCT02576639|5496142|P2|Overall Study|Physician Decision|0
1582752|NCT02576639|5496143|P1|Overall Study|Physician Decision|0
1582753|NCT02576639|5496139|P5|Overall Study|Adverse Event|2
1582754|NCT02576639|5496140|P4|Overall Study|Adverse Event|1
1582755|NCT02576639|5496141|P3|Overall Study|Adverse Event|1
1582756|NCT02576639|5496142|P2|Overall Study|Adverse Event|0
1582757|NCT02576639|5496143|P1|Overall Study|Adverse Event|1
1582758|NCT02576639|5496139|P5|Overall Study|Withdrawal by Subject|1
1582759|NCT02576639|5496140|P4|Overall Study|Withdrawal by Subject|0
1582760|NCT02576639|5496141|P3|Overall Study|Withdrawal by Subject|1
1582761|NCT02576639|5496142|P2|Overall Study|Withdrawal by Subject|2
1582762|NCT02576639|5496143|P1|Overall Study|Withdrawal by Subject|1
1582763|NCT02576587|5496202|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
1582764|NCT02576587|5496203|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
1582765|NCT02576587|5496202|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
1582766|NCT02576587|5496203|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
1582767|NCT02576587|5496202|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
1582768|NCT02576587|5496203|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
1582769|NCT02576587|5496202|P2|Baseline|Equipment failure|1
1582770|NCT02576587|5496203|P1|Baseline|Equipment failure|0
1582771|NCT02576535|5496221|P1|Overall Study|Withdrawal by Subject|2
1582772|NCT02576145|5496245|P2|Overall Study|Tetanus Titers Decreased|1
1582773|NCT02576145|5496246|P1|Overall Study|Tetanus Titers Decreased|0
1582774|NCT02576145|5496245|P2|Overall Study|Acute rejection|0
1582775|NCT02576145|5496246|P1|Overall Study|Acute rejection|1
1582776|NCT02576145|5496245|P2|Overall Study|Withdrawal by Subject|0
1582777|NCT02576145|5496246|P1|Overall Study|Withdrawal by Subject|1
1582778|NCT02576145|5496245|P2|Overall Study|Adverse Event|0
1582779|NCT02576145|5496246|P1|Overall Study|Adverse Event|1
1582780|NCT02576054|5496282|P1|Overall Study|Withdrawal by Subject|1
1582781|NCT02575950|5496303|P4|Overall Study|Lost to Follow-up|3
1582782|NCT02575950|5496304|P3|Overall Study|Lost to Follow-up|0
1582783|NCT02575950|5496305|P2|Overall Study|Lost to Follow-up|1
1582784|NCT02575950|5496306|P1|Overall Study|Lost to Follow-up|0
1582785|NCT02575950|5496303|P4|Overall Study|Withdrawal by Subject|2
1582786|NCT02575950|5496304|P3|Overall Study|Withdrawal by Subject|0
1582787|NCT02575950|5496305|P2|Overall Study|Withdrawal by Subject|0
1582788|NCT02575950|5496306|P1|Overall Study|Withdrawal by Subject|0
1582789|NCT02575911|5496335|P1|Overall Study|Lost to Follow-up|1
1582790|NCT02575833|5496355|P2|Overall Study|Lost to Follow-up|0
1582791|NCT02575833|5496356|P1|Overall Study|Lost to Follow-up|1
1582792|NCT02575833|5496355|P2|Overall Study|Withdrawal by Subject|1
1582793|NCT02575833|5496356|P1|Overall Study|Withdrawal by Subject|0
1582794|NCT02575807|5496371|P5|Overall Study|Withdrawal by Subject|2
1582795|NCT02575807|5496372|P4|Overall Study|Withdrawal by Subject|1
1582796|NCT02575807|5496373|P3|Overall Study|Withdrawal by Subject|1
1582797|NCT02575807|5496374|P2|Overall Study|Withdrawal by Subject|0
1582798|NCT02575807|5496375|P1|Overall Study|Withdrawal by Subject|0
1582799|NCT02575807|5496371|P5|Overall Study|Subject ineligible - medical implant|0
1582800|NCT02575807|5496372|P4|Overall Study|Subject ineligible - medical implant|1
1582801|NCT02575807|5496373|P3|Overall Study|Subject ineligible - medical implant|0
1582802|NCT02575807|5496374|P2|Overall Study|Subject ineligible - medical implant|0
1582803|NCT02575807|5496375|P1|Overall Study|Subject ineligible - medical implant|0
1582804|NCT02575807|5496371|P5|Overall Study|Terminated due to physician decision|0
1582805|NCT02575807|5496372|P4|Overall Study|Terminated due to physician decision|0
1582806|NCT02575807|5496373|P3|Overall Study|Terminated due to physician decision|1
1582807|NCT02575807|5496374|P2|Overall Study|Terminated due to physician decision|0
1582808|NCT02575807|5496375|P1|Overall Study|Terminated due to physician decision|0
1582809|NCT02575807|5496371|P5|Overall Study|Terminated due to FDA clinical hold|0
1582810|NCT02575807|5496372|P4|Overall Study|Terminated due to FDA clinical hold|0
1582811|NCT02575807|5496373|P3|Overall Study|Terminated due to FDA clinical hold|0
1582812|NCT02575807|5496374|P2|Overall Study|Terminated due to FDA clinical hold|0
1582813|NCT02575807|5496375|P1|Overall Study|Terminated due to FDA clinical hold|1
1582814|NCT02575807|5496371|P5|Overall Study|Study terminated by Sponsor|1
1582815|NCT02575807|5496372|P4|Overall Study|Study terminated by Sponsor|0
1582816|NCT02575807|5496373|P3|Overall Study|Study terminated by Sponsor|7
1582817|NCT02575807|5496374|P2|Overall Study|Study terminated by Sponsor|1
1582818|NCT02575807|5496375|P1|Overall Study|Study terminated by Sponsor|0
1582819|NCT02575807|5496371|P5|Overall Study|Death|1
1582820|NCT02575807|5496372|P4|Overall Study|Death|0
1582821|NCT02575807|5496373|P3|Overall Study|Death|7
1582822|NCT02575807|5496374|P2|Overall Study|Death|3
1582823|NCT02575807|5496375|P1|Overall Study|Death|8
1582824|NCT02575365|5496415|P1|Overall Study|Lost to Follow-up|4
1582825|NCT02575079|5496435|P2|Overall Study|Withdrawal by Subject|0
1582826|NCT02575079|5496436|P1|Overall Study|Withdrawal by Subject|3
1582827|NCT02575079|5496435|P2|Overall Study|Death|0
1582828|NCT02575079|5496436|P1|Overall Study|Death|3
1582829|NCT02574845|5496461|P6|Overall Study|Adverse Event|1
1582830|NCT02574845|5496462|P5|Overall Study|Adverse Event|0
1582831|NCT02574845|5496463|P4|Overall Study|Adverse Event|0
1582832|NCT02574845|5496464|P3|Overall Study|Adverse Event|0
1582833|NCT02574845|5496465|P2|Overall Study|Adverse Event|1
1582834|NCT02574845|5496466|P1|Overall Study|Adverse Event|0
1582835|NCT02574845|5496461|P6|Overall Study|Consent withdrawn further participation|0
1582836|NCT02574845|5496462|P5|Overall Study|Consent withdrawn further participation|1
1582837|NCT02574845|5496463|P4|Overall Study|Consent withdrawn further participation|0
1582838|NCT02574845|5496464|P3|Overall Study|Consent withdrawn further participation|0
1582839|NCT02574845|5496465|P2|Overall Study|Consent withdrawn further participation|0
1582840|NCT02574845|5496466|P1|Overall Study|Consent withdrawn further participation|0
1582841|NCT02574481|5496500|P4|Overall Study|Death|0
1582842|NCT02574481|5496501|P3|Overall Study|Death|0
1582843|NCT02574481|5496502|P2|Overall Study|Death|6
1582844|NCT02574481|5496503|P1|Overall Study|Death|6
1582845|NCT02574481|5496500|P4|Overall Study|Other|0
1582846|NCT02574481|5496501|P3|Overall Study|Other|0
1582847|NCT02574481|5496502|P2|Overall Study|Other|0
1582848|NCT02574481|5496503|P1|Overall Study|Other|1
1582849|NCT02574481|5496500|P4|Overall Study|Visit Missed|0
1582850|NCT02574481|5496501|P3|Overall Study|Visit Missed|2
1582851|NCT02574481|5496502|P2|Overall Study|Visit Missed|4
1582852|NCT02574481|5496503|P1|Overall Study|Visit Missed|12
1582853|NCT02574481|5496500|P4|Overall Study|Adverse Event|0
1582854|NCT02574481|5496501|P3|Overall Study|Adverse Event|0
1582855|NCT02574481|5496502|P2|Overall Study|Adverse Event|0
1582856|NCT02574481|5496503|P1|Overall Study|Adverse Event|2
1582857|NCT02574481|5496500|P4|Overall Study|Withdrawal by Subject|0
1582858|NCT02574481|5496501|P3|Overall Study|Withdrawal by Subject|1
1582859|NCT02574481|5496502|P2|Overall Study|Withdrawal by Subject|4
1582860|NCT02574481|5496503|P1|Overall Study|Withdrawal by Subject|6
1582861|NCT02574260|5496541|P1|Overall Study|Disease Progression|1
1582862|NCT02574247|5496550|P3|Overall Study|Did not meet inclusion criteria|5
1582863|NCT02574247|5496551|P2|Overall Study|Did not meet inclusion criteria|3
1582864|NCT02574247|5496552|P1|Overall Study|Did not meet inclusion criteria|4
1582865|NCT02574247|5496550|P3|Overall Study|Withdrawal by Subject|0
1582866|NCT02574247|5496551|P2|Overall Study|Withdrawal by Subject|0
1582867|NCT02574247|5496552|P1|Overall Study|Withdrawal by Subject|1
1582868|NCT02573948|5496564|P1|Longitudinal Cohort|Incarcerated|25
1582869|NCT02573948|5496564|P1|Longitudinal Cohort|Lost to Follow-up|22
1582870|NCT02573948|5496564|P1|Longitudinal Cohort|Death|9
1582871|NCT02573870|5496574|P2|Overall Study|Other: Fail to Meet Visit|2
1582872|NCT02573870|5496575|P1|Overall Study|Other: Fail to Meet Visit|0
1582873|NCT02573870|5496574|P2|Overall Study|Lost to Follow-up|1
1582874|NCT02573870|5496575|P1|Overall Study|Lost to Follow-up|0
1582875|NCT02573870|5496574|P2|Overall Study|Other: Reached defined stopping criteria|1
1582876|NCT02573870|5496575|P1|Overall Study|Other: Reached defined stopping criteria|0
1582877|NCT02573870|5496574|P2|Overall Study|Lack of Efficacy|1
1582878|NCT02573870|5496575|P1|Overall Study|Lack of Efficacy|0
1582879|NCT02573870|5496574|P2|Overall Study|Adverse Event|2
1582880|NCT02573870|5496575|P1|Overall Study|Adverse Event|0
1582881|NCT02573467|5496585|P4|Post-treatment Follow up Epoch|Technical problems|0
1582882|NCT02573467|5496586|P3|Post-treatment Follow up Epoch|Technical problems|1
1582883|NCT02573467|5496587|P2|Post-treatment Follow up Epoch|Technical problems|0
1582884|NCT02573467|5496588|P1|Post-treatment Follow up Epoch|Technical problems|0
1582885|NCT02573467|5496585|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
1582886|NCT02573467|5496586|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
1582887|NCT02573467|5496587|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
1582888|NCT02573467|5496588|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
1582889|NCT02573467|5496585|P4|Post-treatment Follow up Epoch|Death|1
1582890|NCT02573467|5496586|P3|Post-treatment Follow up Epoch|Death|0
1582891|NCT02573467|5496587|P2|Post-treatment Follow up Epoch|Death|1
1582892|NCT02573467|5496588|P1|Post-treatment Follow up Epoch|Death|1
1582893|NCT02573467|5496585|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
1582894|NCT02573467|5496586|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
1582895|NCT02573467|5496587|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
1582896|NCT02573467|5496588|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
1582897|NCT02573467|5496585|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
1582898|NCT02573467|5496586|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
1582899|NCT02573467|5496587|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
1582900|NCT02573467|5496588|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
1582901|NCT02573467|5496585|P4|Double-blind Treatment Epoch|Adverse Event|0
1582902|NCT02573467|5496586|P3|Double-blind Treatment Epoch|Adverse Event|1
1582903|NCT02573467|5496587|P2|Double-blind Treatment Epoch|Adverse Event|0
1582904|NCT02573467|5496588|P1|Double-blind Treatment Epoch|Adverse Event|1
1582905|NCT02573467|5496585|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
1582906|NCT02573467|5496586|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
1582907|NCT02573467|5496587|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
1582908|NCT02573467|5496588|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
1582909|NCT02573155|5496705|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
1582910|NCT02573155|5496706|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
1582911|NCT02573155|5496705|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
1582912|NCT02573155|5496706|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
1582913|NCT02573155|5496705|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
1582914|NCT02573155|5496706|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
1582915|NCT02573155|5496705|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
1582916|NCT02573155|5496706|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
1582917|NCT02573155|5496705|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
1582918|NCT02573155|5496706|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
1582919|NCT02573155|5496705|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
1582920|NCT02573155|5496706|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
1582921|NCT02573155|5496705|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
1582922|NCT02573155|5496706|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
1582923|NCT02573155|5496705|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
1582924|NCT02573155|5496706|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
1582925|NCT02573012|5496854|P2|Overall Study|Physician Decision|2
1582926|NCT02573012|5496855|P1|Overall Study|Physician Decision|1
1582927|NCT02573012|5496854|P2|Overall Study|Study Ended per Protocol|0
1582928|NCT02573012|5496855|P1|Overall Study|Study Ended per Protocol|1
1582929|NCT02573012|5496854|P2|Overall Study|Withdrawal by Subject|2
1582930|NCT02573012|5496855|P1|Overall Study|Withdrawal by Subject|2
1582931|NCT02573012|5496854|P2|Overall Study|Non-compliance|2
1582932|NCT02573012|5496855|P1|Overall Study|Non-compliance|1
1582933|NCT02573012|5496854|P2|Overall Study|Lack of Efficacy|4
1582934|NCT02573012|5496855|P1|Overall Study|Lack of Efficacy|5
1582935|NCT02573012|5496854|P2|Overall Study|Adverse Event|5
1582936|NCT02573012|5496855|P1|Overall Study|Adverse Event|5
1582937|NCT02572817|5496907|P2|Overall Study|Lost to Follow-up|3
1582938|NCT02572817|5496908|P1|Overall Study|Lost to Follow-up|3
1582939|NCT02572817|5496907|P2|Overall Study|Death|3
1582940|NCT02572817|5496908|P1|Overall Study|Death|6
1582941|NCT02572401|5497016|P4|Overall Study|Death|1
1582942|NCT02572401|5497017|P3|Overall Study|Death|0
1582943|NCT02572401|5497018|P2|Overall Study|Death|0
1582944|NCT02572401|5497019|P1|Overall Study|Death|0
1582945|NCT02572401|5497016|P4|Overall Study|Lost to Follow-up|9
1582946|NCT02572401|5497017|P3|Overall Study|Lost to Follow-up|9
1582947|NCT02572401|5497018|P2|Overall Study|Lost to Follow-up|8
1582948|NCT02572401|5497019|P1|Overall Study|Lost to Follow-up|5
1582949|NCT02572388|5497049|P4|Overall Study|Withdrawal by Subject|2
1582950|NCT02572388|5497050|P3|Overall Study|Withdrawal by Subject|2
1582951|NCT02572388|5497051|P2|Overall Study|Withdrawal by Subject|1
1582952|NCT02572388|5497052|P1|Overall Study|Withdrawal by Subject|1
1582953|NCT02572167|5497077|P3|Overall Study|Did not meet inclusion criteria|1
1582954|NCT02572167|5497078|P2|Overall Study|Did not meet inclusion criteria|0
1582955|NCT02572167|5497079|P1|Overall Study|Did not meet inclusion criteria|0
1582956|NCT02572167|5497077|P3|Overall Study|Death|1
1582957|NCT02572167|5497078|P2|Overall Study|Death|3
1582958|NCT02572167|5497079|P1|Overall Study|Death|0
1582959|NCT02572167|5497077|P3|Overall Study|Lost to Follow-up|1
1582960|NCT02572167|5497078|P2|Overall Study|Lost to Follow-up|2
1582961|NCT02572167|5497079|P1|Overall Study|Lost to Follow-up|0
1582962|NCT02572167|5497077|P3|Overall Study|Withdrawal by Subject|1
1582963|NCT02572167|5497078|P2|Overall Study|Withdrawal by Subject|3
1582964|NCT02572167|5497079|P1|Overall Study|Withdrawal by Subject|0
1582965|NCT02572167|5497077|P3|Overall Study|In follow up|27
1582966|NCT02572167|5497078|P2|Overall Study|In follow up|48
1582967|NCT02572167|5497079|P1|Overall Study|In follow up|6
1582968|NCT02572076|5497093|P1|Overall Study|Protocol Violation|1
1582969|NCT02571972|5497097|P1|Overall Study|Withdrawal by Subject|2
1582970|NCT02571972|5497097|P1|Overall Study|Protocol Violation|2
1582971|NCT02571452|5497114|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
1582972|NCT02571452|5497115|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
1582973|NCT02571452|5497114|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
1582974|NCT02571452|5497115|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
1582975|NCT02571452|5497114|P2|Overall Study Treatment|Protocol Violation|1
1582976|NCT02571452|5497115|P1|Overall Study Treatment|Protocol Violation|0
1582977|NCT02571244|5497156|P2|Overall Study|Unable to reach out post discharge|0
1582978|NCT02571244|5497157|P1|Overall Study|Unable to reach out post discharge|3
1582979|NCT02571244|5497156|P2|Overall Study|Lost to Follow-up|1
1582980|NCT02571244|5497157|P1|Overall Study|Lost to Follow-up|0
1582981|NCT02571075|5497215|P2|Overall Study|Lost to Follow-up|24
1582982|NCT02571075|5497216|P1|Overall Study|Lost to Follow-up|20
1582983|NCT02571049|5497230|P2|Randomization|Adverse Event|1
1582984|NCT02571049|5497231|P1|Randomization|Adverse Event|0
1582985|NCT02571049|5497230|P2|Randomization|No migraine attack|1
1582986|NCT02571049|5497231|P1|Randomization|No migraine attack|0
1582987|NCT02571049|5497230|P2|Screening|Did not meet entry criteria|2
1582988|NCT02571049|5497231|P1|Screening|Did not meet entry criteria|2
1582989|NCT02570750|5497239|P2|Overall Study|Adverse Event|1
1582990|NCT02570750|5497240|P1|Overall Study|Adverse Event|2
1582991|NCT02570750|5497239|P2|Overall Study|Lost to Follow-up|2
1582992|NCT02570750|5497240|P1|Overall Study|Lost to Follow-up|2
1582993|NCT02570750|5497239|P2|Overall Study|Withdrawal by Subject|0
1582994|NCT02570750|5497240|P1|Overall Study|Withdrawal by Subject|5
1582995|NCT02570750|5497239|P2|Overall Study|Protocol deviation|2
1582996|NCT02570750|5497240|P1|Overall Study|Protocol deviation|4
1582997|NCT02570750|5497239|P2|Overall Study|Inclusion/exclusion criteria deviation|0
1582998|NCT02570750|5497240|P1|Overall Study|Inclusion/exclusion criteria deviation|1
1582999|NCT02570711|5497258|P2|Overall Study|Early Termination of Study by Sponsor|2
1583000|NCT02570711|5497259|P1|Overall Study|Early Termination of Study by Sponsor|0
1583001|NCT02570711|5497258|P2|Overall Study|Death|0
1583002|NCT02570711|5497259|P1|Overall Study|Death|1
1583003|NCT02570165|5497347|P7|Overall Study|Withdrawal Request by GSK|0
1583004|NCT02570165|5497348|P6|Overall Study|Withdrawal Request by GSK|0
1583005|NCT02570165|5497349|P5|Overall Study|Withdrawal Request by GSK|0
1583006|NCT02570165|5497350|P4|Overall Study|Withdrawal Request by GSK|0
1583007|NCT02570165|5497351|P3|Overall Study|Withdrawal Request by GSK|2
1583008|NCT02570165|5497352|P2|Overall Study|Withdrawal Request by GSK|0
1583009|NCT02570165|5497353|P1|Overall Study|Withdrawal Request by GSK|0
1583010|NCT02570165|5497347|P7|Overall Study|Par. did not Meet Continuation Criteria|0
1583011|NCT02570165|5497348|P6|Overall Study|Par. did not Meet Continuation Criteria|1
1583012|NCT02570165|5497349|P5|Overall Study|Par. did not Meet Continuation Criteria|0
1583013|NCT02570165|5497350|P4|Overall Study|Par. did not Meet Continuation Criteria|0
1583014|NCT02570165|5497351|P3|Overall Study|Par. did not Meet Continuation Criteria|0
1583015|NCT02570165|5497352|P2|Overall Study|Par. did not Meet Continuation Criteria|0
1583016|NCT02570165|5497353|P1|Overall Study|Par. did not Meet Continuation Criteria|0
1583017|NCT02570165|5497347|P7|Overall Study|Withdrawal by Subject|0
1583018|NCT02570165|5497348|P6|Overall Study|Withdrawal by Subject|0
1583019|NCT02570165|5497349|P5|Overall Study|Withdrawal by Subject|1
1583020|NCT02570165|5497350|P4|Overall Study|Withdrawal by Subject|2
1583021|NCT02570165|5497351|P3|Overall Study|Withdrawal by Subject|0
1583022|NCT02570165|5497352|P2|Overall Study|Withdrawal by Subject|0
1583023|NCT02570165|5497353|P1|Overall Study|Withdrawal by Subject|0
1583024|NCT02570165|5497347|P7|Overall Study|Physician Decision|0
1583025|NCT02570165|5497348|P6|Overall Study|Physician Decision|0
1583026|NCT02570165|5497349|P5|Overall Study|Physician Decision|0
1583027|NCT02570165|5497350|P4|Overall Study|Physician Decision|0
1583028|NCT02570165|5497351|P3|Overall Study|Physician Decision|0
1583029|NCT02570165|5497352|P2|Overall Study|Physician Decision|1
1583030|NCT02570165|5497353|P1|Overall Study|Physician Decision|0
1583031|NCT02570165|5497347|P7|Overall Study|Lost to Follow-up|0
1583032|NCT02570165|5497348|P6|Overall Study|Lost to Follow-up|0
1583033|NCT02570165|5497349|P5|Overall Study|Lost to Follow-up|0
1583034|NCT02570165|5497350|P4|Overall Study|Lost to Follow-up|1
1583035|NCT02570165|5497351|P3|Overall Study|Lost to Follow-up|1
1583036|NCT02570165|5497352|P2|Overall Study|Lost to Follow-up|0
1583037|NCT02570165|5497353|P1|Overall Study|Lost to Follow-up|0
1583038|NCT02570165|5497347|P7|Overall Study|Par. Reached Stopping Criteria|0
1583039|NCT02570165|5497348|P6|Overall Study|Par. Reached Stopping Criteria|1
1583040|NCT02570165|5497349|P5|Overall Study|Par. Reached Stopping Criteria|1
1583041|NCT02570165|5497350|P4|Overall Study|Par. Reached Stopping Criteria|2
1583042|NCT02570165|5497351|P3|Overall Study|Par. Reached Stopping Criteria|0
1583043|NCT02570165|5497352|P2|Overall Study|Par. Reached Stopping Criteria|1
1583044|NCT02570165|5497353|P1|Overall Study|Par. Reached Stopping Criteria|1
1583045|NCT02570165|5497347|P7|Overall Study|Lack of Efficacy|0
1583046|NCT02570165|5497348|P6|Overall Study|Lack of Efficacy|0
1583047|NCT02570165|5497349|P5|Overall Study|Lack of Efficacy|4
1583048|NCT02570165|5497350|P4|Overall Study|Lack of Efficacy|0
1583049|NCT02570165|5497351|P3|Overall Study|Lack of Efficacy|0
1583050|NCT02570165|5497352|P2|Overall Study|Lack of Efficacy|1
1583051|NCT02570165|5497353|P1|Overall Study|Lack of Efficacy|0
1583052|NCT02570165|5497347|P7|Overall Study|Adverse Event|0
1583053|NCT02570165|5497348|P6|Overall Study|Adverse Event|0
1583054|NCT02570165|5497349|P5|Overall Study|Adverse Event|0
1583055|NCT02570165|5497350|P4|Overall Study|Adverse Event|0
1583056|NCT02570165|5497351|P3|Overall Study|Adverse Event|2
1583057|NCT02570165|5497352|P2|Overall Study|Adverse Event|0
1583058|NCT02570165|5497353|P1|Overall Study|Adverse Event|1
1583059|NCT02570126|5497393|P2|Overall Study|Withdrawal by Subject|7
1583060|NCT02570126|5497394|P1|Overall Study|Withdrawal by Subject|3
1583061|NCT02570126|5497393|P2|Overall Study|Protocol Violation|1
1583062|NCT02570126|5497394|P1|Overall Study|Protocol Violation|0
1583063|NCT02570126|5497393|P2|Overall Study|Violation Of Procedures GSK|1
1583064|NCT02570126|5497394|P1|Overall Study|Violation Of Procedures GSK|0
1583065|NCT02570126|5497393|P2|Overall Study|Unable To Arrange Visit 3|0
1583066|NCT02570126|5497394|P1|Overall Study|Unable To Arrange Visit 3|1
1583067|NCT02570126|5497393|P2|Overall Study|Lost to Follow-up|0
1583068|NCT02570126|5497394|P1|Overall Study|Lost to Follow-up|2
1583069|NCT02570074|5497420|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
1583070|NCT02570074|5497421|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
1583071|NCT02569996|5497490|P1|Overall Study|Unknown reason|1
1583072|NCT02569996|5497490|P1|Overall Study|Complete remission|7
1583073|NCT02569996|5497490|P1|Overall Study|Lost to Follow-up|5
1583074|NCT02569996|5497490|P1|Overall Study|Withdrawal by Subject|5
1583075|NCT02569996|5497490|P1|Overall Study|Non-compliance|9
1583076|NCT02569996|5497490|P1|Overall Study|New anti-lymphoma treatment|1
1583077|NCT02569996|5497490|P1|Overall Study|Progression of the disease|18
1583078|NCT02569996|5497490|P1|Overall Study|Physician Decision|3
1583079|NCT02569996|5497490|P1|Overall Study|Adverse Event|6
1583080|NCT02569957|5497502|P2|Overall Study|Withdrawal by Subject|1
1583081|NCT02569957|5497503|P1|Overall Study|Withdrawal by Subject|0
1583082|NCT02569853|5497535|P2|Overall Study|Physician Decision|1
1583083|NCT02569853|5497536|P1|Overall Study|Physician Decision|1
1583084|NCT02569853|5497535|P2|Overall Study|Did not experience migraine attack|7
1583085|NCT02569853|5497536|P1|Overall Study|Did not experience migraine attack|10
1583086|NCT02569853|5497535|P2|Overall Study|Protocol Violation|1
1583087|NCT02569853|5497536|P1|Overall Study|Protocol Violation|1
1583088|NCT02569853|5497535|P2|Overall Study|Lost to Follow-up|3
1583089|NCT02569853|5497536|P1|Overall Study|Lost to Follow-up|3
1583090|NCT02569853|5497535|P2|Overall Study|Withdrawal by Subject|2
1583091|NCT02569853|5497536|P1|Overall Study|Withdrawal by Subject|3
1583092|NCT02569853|5497535|P2|Overall Study|Adverse Event|0
1583093|NCT02569853|5497536|P1|Overall Study|Adverse Event|2
1583094|NCT02569710|5497554|P10|Overall Study|Withdrawal by Subject|0
1583095|NCT02569710|5497555|P9|Overall Study|Withdrawal by Subject|0
1583096|NCT02569710|5497556|P8|Overall Study|Withdrawal by Subject|0
1583097|NCT02569710|5497557|P7|Overall Study|Withdrawal by Subject|0
1583098|NCT02569710|5497558|P6|Overall Study|Withdrawal by Subject|1
1583099|NCT02569710|5497559|P5|Overall Study|Withdrawal by Subject|0
1583100|NCT02569710|5497560|P4|Overall Study|Withdrawal by Subject|0
1583101|NCT02569710|5497561|P3|Overall Study|Withdrawal by Subject|0
1583102|NCT02569710|5497562|P2|Overall Study|Withdrawal by Subject|0
1583103|NCT02569710|5497563|P1|Overall Study|Withdrawal by Subject|0
1583104|NCT02569710|5497554|P10|Overall Study|Virologic failure|0
1583105|NCT02569710|5497555|P9|Overall Study|Virologic failure|0
1583106|NCT02569710|5497556|P8|Overall Study|Virologic failure|0
1583107|NCT02569710|5497557|P7|Overall Study|Virologic failure|1
1583108|NCT02569710|5497558|P6|Overall Study|Virologic failure|0
1583109|NCT02569710|5497559|P5|Overall Study|Virologic failure|1
1583110|NCT02569710|5497560|P4|Overall Study|Virologic failure|0
1583111|NCT02569710|5497561|P3|Overall Study|Virologic failure|0
1583112|NCT02569710|5497562|P2|Overall Study|Virologic failure|0
1583113|NCT02569710|5497563|P1|Overall Study|Virologic failure|0
1583114|NCT02569710|5497554|P10|Overall Study|Lost to Follow-up|0
1583115|NCT02569710|5497555|P9|Overall Study|Lost to Follow-up|1
1583116|NCT02569710|5497556|P8|Overall Study|Lost to Follow-up|0
1583117|NCT02569710|5497557|P7|Overall Study|Lost to Follow-up|1
1583118|NCT02569710|5497558|P6|Overall Study|Lost to Follow-up|0
1583119|NCT02569710|5497559|P5|Overall Study|Lost to Follow-up|0
1583120|NCT02569710|5497560|P4|Overall Study|Lost to Follow-up|0
1583121|NCT02569710|5497561|P3|Overall Study|Lost to Follow-up|0
1583122|NCT02569710|5497562|P2|Overall Study|Lost to Follow-up|0
1583123|NCT02569710|5497563|P1|Overall Study|Lost to Follow-up|0
1583124|NCT02569710|5497554|P10|Overall Study|Adverse Event|0
1583125|NCT02569710|5497555|P9|Overall Study|Adverse Event|0
1583126|NCT02569710|5497556|P8|Overall Study|Adverse Event|0
1583127|NCT02569710|5497557|P7|Overall Study|Adverse Event|0
1583128|NCT02569710|5497558|P6|Overall Study|Adverse Event|0
1583129|NCT02569710|5497559|P5|Overall Study|Adverse Event|0
1583130|NCT02569710|5497560|P4|Overall Study|Adverse Event|0
1583131|NCT02569710|5497561|P3|Overall Study|Adverse Event|0
1583132|NCT02569710|5497562|P2|Overall Study|Adverse Event|0
1583133|NCT02569710|5497563|P1|Overall Study|Adverse Event|1
1583134|NCT02569437|5497903|P2|Overall Study|Lost to Follow-up|14
1583135|NCT02569437|5497904|P1|Overall Study|Lost to Follow-up|12
1583136|NCT02569398|5497921|P3|Overall Study|Other|13
1583137|NCT02569398|5497922|P2|Overall Study|Other|14
1583138|NCT02569398|5497923|P1|Overall Study|Other|12
1583139|NCT02569398|5497921|P3|Overall Study|Study terminated by sponsor|134
1583140|NCT02569398|5497922|P2|Overall Study|Study terminated by sponsor|131
1583141|NCT02569398|5497923|P1|Overall Study|Study terminated by sponsor|130
1583142|NCT02569398|5497921|P3|Overall Study|Withdrawal by Subject|30
1583143|NCT02569398|5497922|P2|Overall Study|Withdrawal by Subject|43
1583144|NCT02569398|5497923|P1|Overall Study|Withdrawal by Subject|43
1583145|NCT02569398|5497921|P3|Overall Study|Adverse Event|6
1583146|NCT02569398|5497922|P2|Overall Study|Adverse Event|1
1583147|NCT02569398|5497923|P1|Overall Study|Adverse Event|0
1583148|NCT02568683|5497998|P2|Overall Study|Study Terminated By Sponsor|2
1583149|NCT02568683|5497999|P1|Overall Study|Study Terminated By Sponsor|5
1583150|NCT02568683|5497998|P2|Overall Study|Withdrew Consent|0
1583151|NCT02568683|5497999|P1|Overall Study|Withdrew Consent|1
1583152|NCT02568683|5497998|P2|Overall Study|Death|2
1583153|NCT02568683|5497999|P1|Overall Study|Death|0
1583154|NCT02568397|5498011|P2|Period 2|Physician Decision|1
1583155|NCT02568397|5498012|P1|Period 2|Physician Decision|0
1583156|NCT02568397|5498011|P2|Period 2|Withdrawal by Subject|1
1583157|NCT02568397|5498012|P1|Period 2|Withdrawal by Subject|0
1583158|NCT02568384|5498036|P1|Overall Study|Mobile devices incompatible with App|2
1583159|NCT02568254|5498050|P6|Period 3|Unstatisfactory Lens fitting|0
1583160|NCT02568254|5498051|P5|Period 3|Unstatisfactory Lens fitting|1
1583161|NCT02568254|5498052|P4|Period 3|Unstatisfactory Lens fitting|0
1583162|NCT02568254|5498053|P3|Period 3|Unstatisfactory Lens fitting|0
1583163|NCT02568254|5498054|P2|Period 3|Unstatisfactory Lens fitting|0
1583164|NCT02568254|5498055|P1|Period 3|Unstatisfactory Lens fitting|0
1583165|NCT02568254|5498050|P6|Period 2|Adverse Event|0
1583166|NCT02568254|5498051|P5|Period 2|Adverse Event|0
1583167|NCT02568254|5498052|P4|Period 2|Adverse Event|0
1583168|NCT02568254|5498053|P3|Period 2|Adverse Event|1
1583169|NCT02568254|5498054|P2|Period 2|Adverse Event|0
1583170|NCT02568254|5498055|P1|Period 2|Adverse Event|0
1583171|NCT02568046|5498065|P2|Overall Study|Other Events|1
1583172|NCT02568046|5498066|P1|Overall Study|Other Events|0
1583173|NCT02568046|5498065|P2|Overall Study|Withdrawal by Subject|1
1583174|NCT02568046|5498066|P1|Overall Study|Withdrawal by Subject|2
1583175|NCT02568046|5498065|P2|Overall Study|Progressive Disease|0
1583176|NCT02568046|5498066|P1|Overall Study|Progressive Disease|1
1583177|NCT02568046|5498065|P2|Overall Study|Death|0
1583178|NCT02568046|5498066|P1|Overall Study|Death|2
1583179|NCT02568046|5498065|P2|Overall Study|Adverse Event|1
1583180|NCT02568046|5498066|P1|Overall Study|Adverse Event|0
1583181|NCT02567708|5498129|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
1583182|NCT02567708|5498130|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1583183|NCT02567708|5498129|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
1583184|NCT02567708|5498130|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
1583185|NCT02567708|5498129|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
1583186|NCT02567708|5498130|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
1583187|NCT02567708|5498129|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
1583188|NCT02567708|5498130|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
1583189|NCT02567656|5498175|P6|Overall Study|Premature discontinuation due to PD|0
1583190|NCT02567656|5498176|P5|Overall Study|Premature discontinuation due to PD|0
1583191|NCT02567656|5498177|P4|Overall Study|Premature discontinuation due to PD|0
1583192|NCT02567656|5498178|P3|Overall Study|Premature discontinuation due to PD|2
1583193|NCT02567656|5498179|P2|Overall Study|Premature discontinuation due to PD|1
1583194|NCT02567656|5498180|P1|Overall Study|Premature discontinuation due to PD|1
1583195|NCT02567552|5498212|P2|Overall Study|Adverse Event|1
1583196|NCT02567552|5498213|P1|Overall Study|Adverse Event|0
1583197|NCT02567188|5498243|P1|Overall Study|Protocol Violation|5
1583198|NCT02567188|5498243|P1|Overall Study|Started Hemodialysis|2
1583199|NCT02567188|5498243|P1|Overall Study|Moved and Changed Clinic|1
1583200|NCT02567188|5498243|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
1583201|NCT02567188|5498243|P1|Overall Study|Withdrawal by Subject|1
1583202|NCT02567188|5498243|P1|Overall Study|Adverse Event|1
1583203|NCT02567188|5498243|P1|Overall Study|Lost to Follow-up|5
1583204|NCT02567188|5498243|P1|Overall Study|Terminated Mircera Treatment|9
1583205|NCT02567188|5498243|P1|Overall Study|Death|10
1583206|NCT02566785|5498274|P2|Overall Study|Worsening condition|1
1583207|NCT02566785|5498275|P1|Overall Study|Worsening condition|1
1583208|NCT02566785|5498274|P2|Overall Study|Lost to Follow-up|2
1583209|NCT02566785|5498275|P1|Overall Study|Lost to Follow-up|0
1583210|NCT02566759|5498302|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
1583211|NCT02566759|5498303|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583212|NCT02566759|5498304|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583213|NCT02566759|5498305|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583214|NCT02566759|5498306|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583215|NCT02566759|5498307|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583216|NCT02566759|5498308|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583217|NCT02566759|5498309|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583218|NCT02566759|5498310|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583219|NCT02566759|5498311|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583220|NCT02566759|5498312|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583221|NCT02566759|5498313|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583222|NCT02566759|5498314|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583223|NCT02566759|5498315|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583224|NCT02566759|5498316|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583225|NCT02566759|5498317|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583226|NCT02566759|5498318|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
1583227|NCT02566759|5498302|P17|All Parts|Other|0
1583228|NCT02566759|5498303|P16|All Parts|Other|0
1583229|NCT02566759|5498304|P15|All Parts|Other|0
1583230|NCT02566759|5498305|P14|All Parts|Other|2
1583231|NCT02566759|5498306|P13|All Parts|Other|0
1583232|NCT02566759|5498307|P12|All Parts|Other|0
1583233|NCT02566759|5498308|P11|All Parts|Other|0
1583234|NCT02566759|5498309|P10|All Parts|Other|0
1583235|NCT02566759|5498310|P9|All Parts|Other|0
1583236|NCT02566759|5498311|P8|All Parts|Other|0
1583237|NCT02566759|5498312|P7|All Parts|Other|0
1583238|NCT02566759|5498313|P6|All Parts|Other|0
1583239|NCT02566759|5498314|P5|All Parts|Other|0
1583240|NCT02566759|5498315|P4|All Parts|Other|0
1583241|NCT02566759|5498316|P3|All Parts|Other|0
1583242|NCT02566759|5498317|P2|All Parts|Other|0
1583243|NCT02566759|5498318|P1|All Parts|Other|0
1583244|NCT02566759|5498302|P17|All Parts|Adverse Event|0
1583245|NCT02566759|5498303|P16|All Parts|Adverse Event|0
1583246|NCT02566759|5498304|P15|All Parts|Adverse Event|0
1583247|NCT02566759|5498305|P14|All Parts|Adverse Event|3
1583248|NCT02566759|5498306|P13|All Parts|Adverse Event|1
1583249|NCT02566759|5498307|P12|All Parts|Adverse Event|0
1583250|NCT02566759|5498308|P11|All Parts|Adverse Event|0
1583251|NCT02566759|5498309|P10|All Parts|Adverse Event|0
1583252|NCT02566759|5498310|P9|All Parts|Adverse Event|0
1583253|NCT02566759|5498311|P8|All Parts|Adverse Event|0
1583254|NCT02566759|5498312|P7|All Parts|Adverse Event|0
1583255|NCT02566759|5498313|P6|All Parts|Adverse Event|0
1583256|NCT02566759|5498314|P5|All Parts|Adverse Event|0
1583257|NCT02566759|5498315|P4|All Parts|Adverse Event|0
1583258|NCT02566759|5498316|P3|All Parts|Adverse Event|0
1583259|NCT02566759|5498317|P2|All Parts|Adverse Event|0
1583260|NCT02566759|5498318|P1|All Parts|Adverse Event|0
1583261|NCT02566759|5498302|P17|All Parts|Withdrawal by Subject|0
1583262|NCT02566759|5498303|P16|All Parts|Withdrawal by Subject|0
1583263|NCT02566759|5498304|P15|All Parts|Withdrawal by Subject|0
1583264|NCT02566759|5498305|P14|All Parts|Withdrawal by Subject|0
1583265|NCT02566759|5498306|P13|All Parts|Withdrawal by Subject|0
1583266|NCT02566759|5498307|P12|All Parts|Withdrawal by Subject|0
1583267|NCT02566759|5498308|P11|All Parts|Withdrawal by Subject|0
1583268|NCT02566759|5498309|P10|All Parts|Withdrawal by Subject|0
1583269|NCT02566759|5498310|P9|All Parts|Withdrawal by Subject|0
1583270|NCT02566759|5498311|P8|All Parts|Withdrawal by Subject|0
1583271|NCT02566759|5498312|P7|All Parts|Withdrawal by Subject|0
1583272|NCT02566759|5498313|P6|All Parts|Withdrawal by Subject|0
1583273|NCT02566759|5498314|P5|All Parts|Withdrawal by Subject|0
1583274|NCT02566759|5498315|P4|All Parts|Withdrawal by Subject|0
1583275|NCT02566759|5498316|P3|All Parts|Withdrawal by Subject|0
1583276|NCT02566759|5498317|P2|All Parts|Withdrawal by Subject|1
1583277|NCT02566759|5498318|P1|All Parts|Withdrawal by Subject|0
1583278|NCT02566577|5498480|P2|Overall Study|Physical limitation|0
1583279|NCT02566577|5498481|P1|Overall Study|Physical limitation|1
1583280|NCT02566577|5498480|P2|Overall Study|Equipment failure|1
1583281|NCT02566577|5498481|P1|Overall Study|Equipment failure|1
1583282|NCT02566577|5498480|P2|Overall Study|Withdrawal by Subject|1
1583283|NCT02566577|5498481|P1|Overall Study|Withdrawal by Subject|1
1583284|NCT02566109|5498561|P1|Overall Study|Withdrawal by Subject|1
1583285|NCT02566031|5498625|P2|Overall Study|Lost to Follow-up|1
1583286|NCT02566031|5498626|P1|Overall Study|Lost to Follow-up|1
1583287|NCT02566031|5498625|P2|Overall Study|Adverse Event|1
1583288|NCT02566031|5498626|P1|Overall Study|Adverse Event|3
1583289|NCT02566031|5498625|P2|Overall Study|Protocol deviation|3
1583290|NCT02566031|5498626|P1|Overall Study|Protocol deviation|2
1583291|NCT02566031|5498625|P2|Overall Study|Patient/guardian decision|7
1583292|NCT02566031|5498626|P1|Overall Study|Patient/guardian decision|14
1583293|NCT02566005|5498643|P2|Overall Study|labor after randomization|4
1583294|NCT02566005|5498644|P1|Overall Study|labor after randomization|0
1583295|NCT02566005|5498643|P2|Overall Study|did not receive foley|1
1583296|NCT02566005|5498644|P1|Overall Study|did not receive foley|0
1583297|NCT02566005|5498643|P2|Overall Study|received foley|0
1583298|NCT02566005|5498644|P1|Overall Study|received foley|8
1583299|NCT02566005|5498643|P2|Overall Study|vaginal bleeding|1
1583300|NCT02566005|5498644|P1|Overall Study|vaginal bleeding|0
1583301|NCT02565810|5498672|P1|Overall Study|Withdrawal by Subject|1
1583302|NCT02565784|5498681|P1|Second Treatment|Withdrawal by Subject|2
1583303|NCT02565784|5498681|P1|First Treatment|Withdrawal by Subject|1
1583304|NCT02565784|5498681|P1|First Treatment|Adverse Event|1
1583305|NCT02565706|5498693|P4|Overall Study|Lost to Follow-up|74
1583306|NCT02565706|5498694|P3|Overall Study|Lost to Follow-up|82
1583307|NCT02565706|5498695|P2|Overall Study|Lost to Follow-up|75
1583308|NCT02565706|5498696|P1|Overall Study|Lost to Follow-up|72
1583309|NCT02565706|5498693|P4|Overall Study|Withdrawal by Subject|11
1583310|NCT02565706|5498694|P3|Overall Study|Withdrawal by Subject|7
1583311|NCT02565706|5498695|P2|Overall Study|Withdrawal by Subject|7
1583312|NCT02565706|5498696|P1|Overall Study|Withdrawal by Subject|5
1583313|NCT02565615|5498802|P5|Overall Study|Untreated|567
1583314|NCT02565615|5498803|P4|Overall Study|Untreated|0
1583315|NCT02565615|5498804|P3|Overall Study|Untreated|0
1583316|NCT02565615|5498805|P2|Overall Study|Untreated|0
1583317|NCT02565615|5498806|P1|Overall Study|Untreated|0
1583318|NCT02565615|5498802|P5|Overall Study|Adverse Event|9
1583319|NCT02565615|5498803|P4|Overall Study|Adverse Event|0
1583320|NCT02565615|5498804|P3|Overall Study|Adverse Event|0
1583321|NCT02565615|5498805|P2|Overall Study|Adverse Event|1
1583322|NCT02565615|5498806|P1|Overall Study|Adverse Event|1
1583323|NCT02565615|5498802|P5|Overall Study|Reason not defined|62
1583324|NCT02565615|5498803|P4|Overall Study|Reason not defined|1
1583325|NCT02565615|5498804|P3|Overall Study|Reason not defined|0
1583326|NCT02565615|5498805|P2|Overall Study|Reason not defined|2
1583327|NCT02565615|5498806|P1|Overall Study|Reason not defined|0
1583328|NCT02565615|5498802|P5|Overall Study|Not meeting eligibility criteria|25
1583329|NCT02565615|5498803|P4|Overall Study|Not meeting eligibility criteria|0
1583330|NCT02565615|5498804|P3|Overall Study|Not meeting eligibility criteria|0
1583331|NCT02565615|5498805|P2|Overall Study|Not meeting eligibility criteria|7
1583332|NCT02565615|5498806|P1|Overall Study|Not meeting eligibility criteria|0
1583333|NCT02565615|5498802|P5|Overall Study|Lost to Follow-up|765
1583334|NCT02565615|5498803|P4|Overall Study|Lost to Follow-up|1
1583335|NCT02565615|5498804|P3|Overall Study|Lost to Follow-up|0
1583336|NCT02565615|5498805|P2|Overall Study|Lost to Follow-up|4
1583337|NCT02565615|5498806|P1|Overall Study|Lost to Follow-up|0
1583338|NCT02565615|5498802|P5|Overall Study|Not willing to participate in study|169
1583339|NCT02565615|5498803|P4|Overall Study|Not willing to participate in study|1
1583340|NCT02565615|5498804|P3|Overall Study|Not willing to participate in study|0
1583341|NCT02565615|5498805|P2|Overall Study|Not willing to participate in study|21
1583342|NCT02565615|5498806|P1|Overall Study|Not willing to participate in study|2
1583343|NCT02565615|5498802|P5|Overall Study|Death|4
1583344|NCT02565615|5498803|P4|Overall Study|Death|0
1583345|NCT02565615|5498804|P3|Overall Study|Death|0
1583346|NCT02565615|5498805|P2|Overall Study|Death|1
1583347|NCT02565615|5498806|P1|Overall Study|Death|0
1583348|NCT02565576|5498920|P2|Overall Study|Adverse Event|0
1583349|NCT02565576|5498921|P1|Overall Study|Adverse Event|1
1583350|NCT02565576|5498920|P2|Overall Study|Death|2
1583351|NCT02565576|5498921|P1|Overall Study|Death|0
1583352|NCT02565576|5498920|P2|Overall Study|Lost to Follow-up|0
1583353|NCT02565576|5498921|P1|Overall Study|Lost to Follow-up|1
1583354|NCT02565576|5498920|P2|Overall Study|subject / guardian decision|3
1583355|NCT02565576|5498921|P1|Overall Study|subject / guardian decision|1
1583356|NCT02565576|5498920|P2|Overall Study|abnormal lab value|0
1583357|NCT02565576|5498921|P1|Overall Study|abnormal lab value|2
1583358|NCT02565381|5498964|P3|Overall Study|Lost to Follow-up|1
1583359|NCT02565381|5498965|P2|Overall Study|Lost to Follow-up|0
1583360|NCT02565381|5498966|P1|Overall Study|Lost to Follow-up|1
1583361|NCT02565147|5499006|P2|Overall Study|Death|1
1583362|NCT02565147|5499007|P1|Overall Study|Death|1
1583363|NCT02565147|5499006|P2|Overall Study|Lost to Follow-up|1
1583364|NCT02565147|5499007|P1|Overall Study|Lost to Follow-up|0
1583365|NCT02565147|5499006|P2|Overall Study|Withdrawal by Subject|1
1583366|NCT02565147|5499007|P1|Overall Study|Withdrawal by Subject|5
1583367|NCT02565108|5499031|P2|Overall Study|Withdrew Consent|0
1583368|NCT02565108|5499032|P1|Overall Study|Withdrew Consent|1
1583369|NCT02565108|5499031|P2|Overall Study|Adverse Event|0
1583370|NCT02565108|5499032|P1|Overall Study|Adverse Event|1
1583371|NCT02564952|5499048|P1|Overall Study|Participant Met Withdrawal Criteria|1
1583372|NCT02564952|5499048|P1|Overall Study|Low Efficacy|1
1583373|NCT02564952|5499048|P1|Overall Study|Withdrawal by Subject|1
1583374|NCT02564952|5499048|P1|Overall Study|Participant Withdrawn by Investigator|1
1583375|NCT02564952|5499048|P1|Overall Study|Lost to Follow-up|1
1583376|NCT02564952|5499048|P1|Overall Study|Adverse Event|6
1583377|NCT02564718|5499093|P2|Overall Study|Withdrew from treatment|1
1583378|NCT02564718|5499094|P1|Overall Study|Withdrew from treatment|0
1583379|NCT02564263|5499151|P2|Overall Study|Ongoing in Study|25
1583380|NCT02564263|5499152|P1|Overall Study|Ongoing in Study|42
1583381|NCT02564263|5499151|P2|Overall Study|Withdrawal by Subject|18
1583382|NCT02564263|5499152|P1|Overall Study|Withdrawal by Subject|5
1583383|NCT02564263|5499151|P2|Overall Study|Death|242
1583384|NCT02564263|5499152|P1|Overall Study|Death|236
1583385|NCT02564263|5499151|P2|Overall Study|Adverse Event|29
1583386|NCT02564263|5499152|P1|Overall Study|Adverse Event|31
1583387|NCT02564211|5499174|P1|Overall Study|Adverse Event|4
1583388|NCT02564055|5499186|P6|Overall Study|Withdrawal by Subject|10
1583389|NCT02564055|5499187|P5|Overall Study|Withdrawal by Subject|10
1583390|NCT02564055|5499188|P4|Overall Study|Withdrawal by Subject|3
1583391|NCT02564055|5499189|P3|Overall Study|Withdrawal by Subject|3
1583392|NCT02564055|5499190|P2|Overall Study|Withdrawal by Subject|4
1583393|NCT02564055|5499191|P1|Overall Study|Withdrawal by Subject|4
1583394|NCT02564055|5499186|P6|Overall Study|Physician Decision|0
1583395|NCT02564055|5499187|P5|Overall Study|Physician Decision|0
1583396|NCT02564055|5499188|P4|Overall Study|Physician Decision|0
1583397|NCT02564055|5499189|P3|Overall Study|Physician Decision|1
1583398|NCT02564055|5499190|P2|Overall Study|Physician Decision|0
1583399|NCT02564055|5499191|P1|Overall Study|Physician Decision|0
1583400|NCT02564055|5499186|P6|Overall Study|Lost to Follow-up|0
1583401|NCT02564055|5499187|P5|Overall Study|Lost to Follow-up|1
1583402|NCT02564055|5499188|P4|Overall Study|Lost to Follow-up|2
1583403|NCT02564055|5499189|P3|Overall Study|Lost to Follow-up|4
1583404|NCT02564055|5499190|P2|Overall Study|Lost to Follow-up|1
1583405|NCT02564055|5499191|P1|Overall Study|Lost to Follow-up|0
1583406|NCT02564055|5499186|P6|Overall Study|Reached stopping criteria|1
1583407|NCT02564055|5499187|P5|Overall Study|Reached stopping criteria|0
1583408|NCT02564055|5499188|P4|Overall Study|Reached stopping criteria|0
1583409|NCT02564055|5499189|P3|Overall Study|Reached stopping criteria|0
1583410|NCT02564055|5499190|P2|Overall Study|Reached stopping criteria|0
1583411|NCT02564055|5499191|P1|Overall Study|Reached stopping criteria|0
1583412|NCT02564055|5499186|P6|Overall Study|Protocol Violation|0
1583413|NCT02564055|5499187|P5|Overall Study|Protocol Violation|0
1583414|NCT02564055|5499188|P4|Overall Study|Protocol Violation|0
1583415|NCT02564055|5499189|P3|Overall Study|Protocol Violation|0
1583416|NCT02564055|5499190|P2|Overall Study|Protocol Violation|0
1583417|NCT02564055|5499191|P1|Overall Study|Protocol Violation|1
1583418|NCT02564055|5499186|P6|Overall Study|Adverse Event|1
1583419|NCT02564055|5499187|P5|Overall Study|Adverse Event|4
1583420|NCT02564055|5499188|P4|Overall Study|Adverse Event|1
1583421|NCT02564055|5499189|P3|Overall Study|Adverse Event|4
1583422|NCT02564055|5499190|P2|Overall Study|Adverse Event|0
1583423|NCT02564055|5499191|P1|Overall Study|Adverse Event|1
1583424|NCT02564042|5499445|P6|Overall Study|Withdrawal by Subject|12
1583425|NCT02564042|5499446|P5|Overall Study|Withdrawal by Subject|10
1583426|NCT02564042|5499447|P4|Overall Study|Withdrawal by Subject|2
1583427|NCT02564042|5499448|P3|Overall Study|Withdrawal by Subject|2
1583428|NCT02564042|5499449|P2|Overall Study|Withdrawal by Subject|3
1583429|NCT02564042|5499450|P1|Overall Study|Withdrawal by Subject|5
1583430|NCT02564042|5499445|P6|Overall Study|Physician Decision|0
1583431|NCT02564042|5499446|P5|Overall Study|Physician Decision|0
1583432|NCT02564042|5499447|P4|Overall Study|Physician Decision|1
1583433|NCT02564042|5499448|P3|Overall Study|Physician Decision|0
1583434|NCT02564042|5499449|P2|Overall Study|Physician Decision|0
1583435|NCT02564042|5499450|P1|Overall Study|Physician Decision|1
1583436|NCT02564042|5499445|P6|Overall Study|Lost to Follow-up|1
1583437|NCT02564042|5499446|P5|Overall Study|Lost to Follow-up|1
1583438|NCT02564042|5499447|P4|Overall Study|Lost to Follow-up|0
1583439|NCT02564042|5499448|P3|Overall Study|Lost to Follow-up|1
1583440|NCT02564042|5499449|P2|Overall Study|Lost to Follow-up|1
1583441|NCT02564042|5499450|P1|Overall Study|Lost to Follow-up|1
1583442|NCT02564042|5499445|P6|Overall Study|Adverse Event|1
1583443|NCT02564042|5499446|P5|Overall Study|Adverse Event|0
1583444|NCT02564042|5499447|P4|Overall Study|Adverse Event|0
1583445|NCT02564042|5499448|P3|Overall Study|Adverse Event|3
1583446|NCT02564042|5499449|P2|Overall Study|Adverse Event|4
1583447|NCT02564042|5499450|P1|Overall Study|Adverse Event|4
1583448|NCT02563899|5499745|P4|Overall Study|Withdrawal by Subject|0
1583449|NCT02563899|5499746|P3|Overall Study|Withdrawal by Subject|1
1583450|NCT02563899|5499747|P2|Overall Study|Withdrawal by Subject|0
1583451|NCT02563899|5499748|P1|Overall Study|Withdrawal by Subject|0
1583452|NCT02563899|5499745|P4|Overall Study|Protocol Violation|0
1583453|NCT02563899|5499746|P3|Overall Study|Protocol Violation|0
1583454|NCT02563899|5499747|P2|Overall Study|Protocol Violation|0
1583455|NCT02563899|5499748|P1|Overall Study|Protocol Violation|1
1583456|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1583457|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
1583458|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1583459|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1583460|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1583461|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
1583462|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
1583463|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1583464|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1583465|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1583466|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1583467|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
1583468|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
1583469|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1583470|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1583471|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1583472|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1583473|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
1583474|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
1583475|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1583476|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1583477|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1583478|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1583479|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
1583480|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
1583481|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
1583482|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1583483|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1583484|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1583485|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
1583486|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1583487|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
1583488|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1583489|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1583490|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1583491|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
1583492|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
1583493|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
1583494|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1583495|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1583496|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1583497|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
1583498|NCT02563548|5499824|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
1583499|NCT02563548|5499825|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
1583500|NCT02563548|5499826|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1583501|NCT02563548|5499827|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1583502|NCT02563548|5499828|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1583503|NCT02563548|5499829|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
1583504|NCT02563548|5499824|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1583505|NCT02563548|5499825|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1583506|NCT02563548|5499826|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
1583507|NCT02563548|5499827|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
1583508|NCT02563548|5499828|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1583509|NCT02563548|5499829|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
1583510|NCT02563548|5499824|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1583511|NCT02563548|5499825|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1583512|NCT02563548|5499826|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1583513|NCT02563548|5499827|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
1583514|NCT02563548|5499828|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1583515|NCT02563548|5499829|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
1583516|NCT02563548|5499824|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
1583517|NCT02563548|5499825|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
1583518|NCT02563548|5499826|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
1583519|NCT02563548|5499827|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
1583603|NCT02561195|5500187|P1|Overall Study|Withdrawal by Subject|3
1583520|NCT02563548|5499828|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
1583521|NCT02563548|5499829|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
1583522|NCT02563548|5499824|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1583523|NCT02563548|5499825|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1583524|NCT02563548|5499826|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
1583525|NCT02563548|5499827|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1583526|NCT02563548|5499828|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
1583527|NCT02563548|5499829|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
1583528|NCT02563106|5499893|P2|Overall Study|Other reason - not specified|1
1583529|NCT02563106|5499894|P1|Overall Study|Other reason - not specified|2
1583530|NCT02563106|5499893|P2|Overall Study|Physician Decision|1
1583531|NCT02563106|5499894|P1|Overall Study|Physician Decision|3
1583532|NCT02563106|5499893|P2|Overall Study|Lost to Follow-up|2
1583533|NCT02563106|5499894|P1|Overall Study|Lost to Follow-up|3
1583534|NCT02563106|5499893|P2|Overall Study|Use of non-permitted concurrent therapy|2
1583535|NCT02563106|5499894|P1|Overall Study|Use of non-permitted concurrent therapy|1
1583536|NCT02563106|5499893|P2|Overall Study|Protocol Violation|0
1583537|NCT02563106|5499894|P1|Overall Study|Protocol Violation|1
1583538|NCT02563106|5499893|P2|Overall Study|Adverse Event|15
1583539|NCT02563106|5499894|P1|Overall Study|Adverse Event|17
1583540|NCT02563106|5499893|P2|Overall Study|Withdrawal by Subject|8
1583541|NCT02563106|5499894|P1|Overall Study|Withdrawal by Subject|7
1583542|NCT02563028|5499933|P1|Overall Study|Unable to elicit VEP post induction|1
1583543|NCT02563028|5499933|P1|Overall Study|Lack of equipment|1
1583556|NCT02561832|5500045|P2|Overall Study|Disease progression|3
1583557|NCT02561832|5500046|P1|Overall Study|Disease progression|3
1583558|NCT02561832|5500045|P2|Overall Study|Adverse Event|0
1583559|NCT02561832|5500046|P1|Overall Study|Adverse Event|3
1583560|NCT02561832|5500045|P2|Overall Study|Withdrawal by Subject|1
1583561|NCT02561832|5500046|P1|Overall Study|Withdrawal by Subject|1
1583562|NCT02561806|5500054|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
1583563|NCT02561806|5500055|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
1583564|NCT02561806|5500054|P2|Post-Treatment Follow-up|Lost to Follow-up|1
1583565|NCT02561806|5500055|P1|Post-Treatment Follow-up|Lost to Follow-up|1
1583566|NCT02561806|5500054|P2|Maintenance Period|Site staff became unblinded|1
1583567|NCT02561806|5500055|P1|Maintenance Period|Site staff became unblinded|0
1583568|NCT02561806|5500054|P2|Maintenance Period|Withdrawal by Subject|3
1583569|NCT02561806|5500055|P1|Maintenance Period|Withdrawal by Subject|5
1583570|NCT02561806|5500054|P2|Maintenance Period|Protocol Violation|0
1583571|NCT02561806|5500055|P1|Maintenance Period|Protocol Violation|1
1583572|NCT02561806|5500054|P2|Maintenance Period|Lost to Follow-up|2
1583573|NCT02561806|5500055|P1|Maintenance Period|Lost to Follow-up|2
1583574|NCT02561806|5500054|P2|Maintenance Period|Lack of Efficacy|1
1583575|NCT02561806|5500055|P1|Maintenance Period|Lack of Efficacy|3
1583576|NCT02561806|5500054|P2|Maintenance Period|Adverse Event|1
1583577|NCT02561806|5500055|P1|Maintenance Period|Adverse Event|2
1583578|NCT02561806|5500054|P2|Induction Period|Randomized but not treated|1
1583579|NCT02561806|5500055|P1|Induction Period|Randomized but not treated|0
1583580|NCT02561806|5500054|P2|Induction Period|Site staff became unblinded|0
1583581|NCT02561806|5500055|P1|Induction Period|Site staff became unblinded|1
1583582|NCT02561806|5500054|P2|Induction Period|Withdrawal by Subject|2
1583583|NCT02561806|5500055|P1|Induction Period|Withdrawal by Subject|0
1583584|NCT02561806|5500054|P2|Induction Period|Lack of Efficacy|0
1583585|NCT02561806|5500055|P1|Induction Period|Lack of Efficacy|1
1583586|NCT02561806|5500054|P2|Induction Period|Adverse Event|2
1583587|NCT02561806|5500055|P1|Induction Period|Adverse Event|0
1583588|NCT02561572|5500159|P2|Overall Study|Protocol Violation|1
1583589|NCT02561572|5500160|P1|Overall Study|Protocol Violation|0
1583590|NCT02561572|5500159|P2|Overall Study|Inadequate time before surgery|1
1583591|NCT02561572|5500160|P1|Overall Study|Inadequate time before surgery|2
1583592|NCT02561195|5500182|P6|Overall Study|Randomized but not treated|0
1583593|NCT02561195|5500183|P5|Overall Study|Randomized but not treated|0
1583594|NCT02561195|5500184|P4|Overall Study|Randomized but not treated|0
1583595|NCT02561195|5500185|P3|Overall Study|Randomized but not treated|0
1583596|NCT02561195|5500186|P2|Overall Study|Randomized but not treated|0
1583597|NCT02561195|5500187|P1|Overall Study|Randomized but not treated|1
1583598|NCT02561195|5500182|P6|Overall Study|Withdrawal by Subject|0
1583599|NCT02561195|5500183|P5|Overall Study|Withdrawal by Subject|6
1583600|NCT02561195|5500184|P4|Overall Study|Withdrawal by Subject|2
1583601|NCT02561195|5500185|P3|Overall Study|Withdrawal by Subject|4
1583602|NCT02561195|5500186|P2|Overall Study|Withdrawal by Subject|4
1583604|NCT02561195|5500182|P6|Overall Study|Death|0
1583605|NCT02561195|5500183|P5|Overall Study|Death|0
1583606|NCT02561195|5500184|P4|Overall Study|Death|2
1583607|NCT02561195|5500185|P3|Overall Study|Death|0
1583608|NCT02561195|5500186|P2|Overall Study|Death|1
1583609|NCT02561195|5500187|P1|Overall Study|Death|2
1583610|NCT02561195|5500182|P6|Overall Study|Protocol Violation|2
1583611|NCT02561195|5500183|P5|Overall Study|Protocol Violation|5
1583612|NCT02561195|5500184|P4|Overall Study|Protocol Violation|2
1583613|NCT02561195|5500185|P3|Overall Study|Protocol Violation|1
1583614|NCT02561195|5500186|P2|Overall Study|Protocol Violation|0
1583615|NCT02561195|5500187|P1|Overall Study|Protocol Violation|1
1583616|NCT02561195|5500182|P6|Overall Study|Other|1
1583617|NCT02561195|5500183|P5|Overall Study|Other|5
1583618|NCT02561195|5500184|P4|Overall Study|Other|7
1583619|NCT02561195|5500185|P3|Overall Study|Other|1
1583620|NCT02561195|5500186|P2|Overall Study|Other|3
1583621|NCT02561195|5500187|P1|Overall Study|Other|7
1583622|NCT02561195|5500182|P6|Overall Study|No longer willing to participate|3
1583623|NCT02561195|5500183|P5|Overall Study|No longer willing to participate|1
1583624|NCT02561195|5500184|P4|Overall Study|No longer willing to participate|4
1583625|NCT02561195|5500185|P3|Overall Study|No longer willing to participate|0
1583626|NCT02561195|5500186|P2|Overall Study|No longer willing to participate|4
1583627|NCT02561195|5500187|P1|Overall Study|No longer willing to participate|2
1583628|NCT02561195|5500182|P6|Overall Study|No longer meets eligibility criteria|1
1583629|NCT02561195|5500183|P5|Overall Study|No longer meets eligibility criteria|4
1583630|NCT02561195|5500184|P4|Overall Study|No longer meets eligibility criteria|4
1583631|NCT02561195|5500185|P3|Overall Study|No longer meets eligibility criteria|0
1583632|NCT02561195|5500186|P2|Overall Study|No longer meets eligibility criteria|1
1583633|NCT02561195|5500187|P1|Overall Study|No longer meets eligibility criteria|0
1583634|NCT02561195|5500182|P6|Overall Study|Lost to Follow-up|3
1583635|NCT02561195|5500183|P5|Overall Study|Lost to Follow-up|3
1583636|NCT02561195|5500184|P4|Overall Study|Lost to Follow-up|2
1583637|NCT02561195|5500185|P3|Overall Study|Lost to Follow-up|0
1583638|NCT02561195|5500186|P2|Overall Study|Lost to Follow-up|4
1583639|NCT02561195|5500187|P1|Overall Study|Lost to Follow-up|3
1583640|NCT02561195|5500182|P6|Overall Study|Adverse Event|0
1583641|NCT02561195|5500183|P5|Overall Study|Adverse Event|4
1583642|NCT02561195|5500184|P4|Overall Study|Adverse Event|3
1583643|NCT02561195|5500185|P3|Overall Study|Adverse Event|0
1583644|NCT02561195|5500186|P2|Overall Study|Adverse Event|5
1583645|NCT02561195|5500187|P1|Overall Study|Adverse Event|4
1583646|NCT02561156|5500348|P13|Part 2|Adverse Event|0
1583647|NCT02561156|5500349|P12|Part 2|Adverse Event|1
1583648|NCT02561156|5500350|P11|Part 2|Adverse Event|0
1583649|NCT02561156|5500351|P10|Part 2|Adverse Event|0
1583650|NCT02561156|5500352|P9|Part 2|Adverse Event|0
1583651|NCT02561156|5500353|P8|Part 2|Adverse Event|0
1583652|NCT02561156|5500354|P7|Part 2|Adverse Event|0
1583653|NCT02561156|5500355|P6|Part 2|Adverse Event|0
1583654|NCT02561156|5500356|P5|Part 2|Adverse Event|0
1583655|NCT02561156|5500357|P4|Part 2|Adverse Event|0
1583656|NCT02561156|5500358|P3|Part 2|Adverse Event|0
1583657|NCT02561156|5500359|P2|Part 2|Adverse Event|0
1583658|NCT02561156|5500360|P1|Part 2|Adverse Event|0
1583659|NCT02560389|5500642|P3|Overall Study|Tested positive for illicit substance|0
1583660|NCT02560389|5500643|P2|Overall Study|Tested positive for illicit substance|1
1583661|NCT02560389|5500644|P1|Overall Study|Tested positive for illicit substance|0
1583662|NCT02560389|5500642|P3|Overall Study|Lost to Follow-up|2
1583663|NCT02560389|5500643|P2|Overall Study|Lost to Follow-up|2
1583664|NCT02560389|5500644|P1|Overall Study|Lost to Follow-up|1
1583665|NCT02560025|5500742|P1|Overall Study|Ineligible after consent/ registration|3
1583666|NCT02560012|5500748|P1|Overall Study|Study Terminated|2
1583670|NCT02559622|5500765|P4|Overall Study|Patient/guardian decision|1
1583671|NCT02559622|5500766|P3|Overall Study|Patient/guardian decision|0
1583672|NCT02559622|5500767|P2|Overall Study|Patient/guardian decision|2
1583673|NCT02559622|5500768|P1|Overall Study|Patient/guardian decision|1
1583674|NCT02559622|5500765|P4|Overall Study|Adverse Event|2
1583675|NCT02559622|5500766|P3|Overall Study|Adverse Event|2
1583676|NCT02559622|5500767|P2|Overall Study|Adverse Event|2
1583677|NCT02559622|5500768|P1|Overall Study|Adverse Event|0
1583678|NCT02559622|5500765|P4|Overall Study|Progressive disease|0
1583679|NCT02559622|5500766|P3|Overall Study|Progressive disease|0
1583680|NCT02559622|5500767|P2|Overall Study|Progressive disease|1
1583681|NCT02559622|5500768|P1|Overall Study|Progressive disease|0
1583682|NCT02559570|5500852|P5|Overall Study|Other Miscellaneous Reasons|0
1583683|NCT02559570|5500853|P4|Overall Study|Other Miscellaneous Reasons|0
1583684|NCT02559570|5500854|P3|Overall Study|Other Miscellaneous Reasons|1
1583685|NCT02559570|5500855|P2|Overall Study|Other Miscellaneous Reasons|0
1583686|NCT02559570|5500856|P1|Overall Study|Other Miscellaneous Reasons|0
1583687|NCT02559570|5500852|P5|Overall Study|Protocol Violation|1
1583688|NCT02559570|5500853|P4|Overall Study|Protocol Violation|0
1583689|NCT02559570|5500854|P3|Overall Study|Protocol Violation|0
1583690|NCT02559570|5500855|P2|Overall Study|Protocol Violation|0
1583691|NCT02559570|5500856|P1|Overall Study|Protocol Violation|1
1583692|NCT02559570|5500852|P5|Overall Study|Lost to Follow-up|0
1583693|NCT02559570|5500853|P4|Overall Study|Lost to Follow-up|0
1583694|NCT02559570|5500854|P3|Overall Study|Lost to Follow-up|0
1583695|NCT02559570|5500855|P2|Overall Study|Lost to Follow-up|0
1583696|NCT02559570|5500856|P1|Overall Study|Lost to Follow-up|1
1583697|NCT02559570|5500852|P5|Overall Study|Withdrawal of Consent|1
1583698|NCT02559570|5500853|P4|Overall Study|Withdrawal of Consent|2
1583699|NCT02559570|5500854|P3|Overall Study|Withdrawal of Consent|1
1583700|NCT02559570|5500855|P2|Overall Study|Withdrawal of Consent|0
1583701|NCT02559570|5500856|P1|Overall Study|Withdrawal of Consent|0
1583702|NCT02559570|5500852|P5|Overall Study|Adverse Event|0
1583703|NCT02559570|5500853|P4|Overall Study|Adverse Event|1
1583704|NCT02559570|5500854|P3|Overall Study|Adverse Event|0
1583705|NCT02559570|5500855|P2|Overall Study|Adverse Event|2
1583706|NCT02559570|5500856|P1|Overall Study|Adverse Event|0
1583707|NCT02559414|5500894|P3|Overall Study|Other|1
1583708|NCT02559414|5500895|P2|Overall Study|Other|1
1583709|NCT02559414|5500896|P1|Overall Study|Other|0
1583710|NCT02559414|5500894|P3|Overall Study|Withdrawal by Subject|1
1583711|NCT02559414|5500895|P2|Overall Study|Withdrawal by Subject|0
1583712|NCT02559414|5500896|P1|Overall Study|Withdrawal by Subject|1
1583713|NCT02559414|5500894|P3|Overall Study|Lost to Follow-up|0
1583714|NCT02559414|5500895|P2|Overall Study|Lost to Follow-up|1
1583715|NCT02559414|5500896|P1|Overall Study|Lost to Follow-up|0
1583716|NCT02559310|5500936|P2|Overall Study|Randomized but not treated|2
1583717|NCT02559310|5500937|P1|Overall Study|Randomized but not treated|3
1583718|NCT02559310|5500936|P2|Overall Study|Sponsor Decision|1
1583719|NCT02559310|5500937|P1|Overall Study|Sponsor Decision|0
1583720|NCT02559310|5500936|P2|Overall Study|Withdrawal by Subject|9
1583721|NCT02559310|5500937|P1|Overall Study|Withdrawal by Subject|13
1583722|NCT02559310|5500936|P2|Overall Study|Physician Decision|1
1583723|NCT02559310|5500937|P1|Overall Study|Physician Decision|2
1583724|NCT02559310|5500936|P2|Overall Study|Lost to Follow-up|3
1583725|NCT02559310|5500937|P1|Overall Study|Lost to Follow-up|5
1583726|NCT02559310|5500936|P2|Overall Study|Death|3
1583727|NCT02559310|5500937|P1|Overall Study|Death|4
1583728|NCT02558894|5500949|P2|Overall Study|Closure of Part A|1
1583729|NCT02558894|5500950|P1|Overall Study|Closure of Part A|2
1583730|NCT02558894|5500949|P2|Overall Study|Withdrawal by Subject|1
1583731|NCT02558894|5500950|P1|Overall Study|Withdrawal by Subject|2
1583732|NCT02558894|5500949|P2|Overall Study|Death; any cause, entire study duration|31
1583733|NCT02558894|5500950|P1|Overall Study|Death; any cause, entire study duration|28
1583734|NCT02558790|5501011|P1|Overall Study|Screen Fail|3
1583735|NCT02558790|5501011|P1|Overall Study|Withdrawal by Subject|1
1583736|NCT02558790|5501011|P1|Overall Study|Physician Decision|1
1583737|NCT02558790|5501011|P1|Overall Study|Lost to Follow-up|2
1583738|NCT02558400|5501018|P3|Overall Study|Ineligible for the study|0
1583739|NCT02558400|5501019|P2|Overall Study|Ineligible for the study|2
1583740|NCT02558400|5501020|P1|Overall Study|Ineligible for the study|0
1583741|NCT02558400|5501018|P3|Overall Study|Death|0
1583742|NCT02558400|5501019|P2|Overall Study|Death|1
1583743|NCT02558400|5501020|P1|Overall Study|Death|0
1583744|NCT02558400|5501018|P3|Overall Study|Protocol Violation|8
1583745|NCT02558400|5501019|P2|Overall Study|Protocol Violation|3
1583746|NCT02558400|5501020|P1|Overall Study|Protocol Violation|6
1583747|NCT02558400|5501018|P3|Overall Study|Physician Decision|0
1583748|NCT02558400|5501019|P2|Overall Study|Physician Decision|2
1583749|NCT02558400|5501020|P1|Overall Study|Physician Decision|2
1583750|NCT02558400|5501018|P3|Overall Study|Disallowed Concurrent Medication|5
1583751|NCT02558400|5501019|P2|Overall Study|Disallowed Concurrent Medication|7
1583752|NCT02558400|5501020|P1|Overall Study|Disallowed Concurrent Medication|6
1583753|NCT02558400|5501018|P3|Overall Study|Lack of Efficacy|1
1583754|NCT02558400|5501019|P2|Overall Study|Lack of Efficacy|13
1583755|NCT02558400|5501020|P1|Overall Study|Lack of Efficacy|0
1583756|NCT02558400|5501018|P3|Overall Study|Lost to Follow-up|4
1583757|NCT02558400|5501019|P2|Overall Study|Lost to Follow-up|5
1583758|NCT02558400|5501020|P1|Overall Study|Lost to Follow-up|5
1583759|NCT02558400|5501018|P3|Overall Study|Non-Compliant|3
1583760|NCT02558400|5501019|P2|Overall Study|Non-Compliant|1
1583761|NCT02558400|5501020|P1|Overall Study|Non-Compliant|0
1583762|NCT02558400|5501018|P3|Overall Study|Withdrawal by Subject|8
1583763|NCT02558400|5501019|P2|Overall Study|Withdrawal by Subject|9
1583764|NCT02558400|5501020|P1|Overall Study|Withdrawal by Subject|13
1583765|NCT02558400|5501018|P3|Overall Study|Adverse Event|4
1583766|NCT02558400|5501019|P2|Overall Study|Adverse Event|53
1583767|NCT02558400|5501020|P1|Overall Study|Adverse Event|47
1583768|NCT02557646|5501109|P1|Overall Study|Other|14
1583769|NCT02557646|5501109|P1|Overall Study|Lost to Follow-up|17
1583770|NCT02557646|5501109|P1|Overall Study|Withdrawal by Subject|18
1583771|NCT02557646|5501109|P1|Overall Study|Lack of Efficacy|186
1583772|NCT02557646|5501109|P1|Overall Study|Death|1
1583773|NCT02557646|5501109|P1|Overall Study|Adverse Event|40
1583774|NCT02557516|5501136|P4|Overall Study|Sponsor decision|8
1583775|NCT02557516|5501137|P3|Overall Study|Sponsor decision|2
1583776|NCT02557516|5501138|P2|Overall Study|Sponsor decision|1
1583777|NCT02557516|5501139|P1|Overall Study|Sponsor decision|0
1583778|NCT02557516|5501136|P4|Overall Study|Physician Decision|0
1583779|NCT02557516|5501137|P3|Overall Study|Physician Decision|0
1583780|NCT02557516|5501138|P2|Overall Study|Physician Decision|2
1583781|NCT02557516|5501139|P1|Overall Study|Physician Decision|0
1583782|NCT02557516|5501136|P4|Overall Study|Disease progression|0
1583783|NCT02557516|5501137|P3|Overall Study|Disease progression|0
1583784|NCT02557516|5501138|P2|Overall Study|Disease progression|2
1583785|NCT02557516|5501139|P1|Overall Study|Disease progression|0
1583786|NCT02557516|5501136|P4|Overall Study|Adverse Event|1
1583787|NCT02557516|5501137|P3|Overall Study|Adverse Event|2
1583788|NCT02557516|5501138|P2|Overall Study|Adverse Event|0
1583789|NCT02557516|5501139|P1|Overall Study|Adverse Event|1
1583790|NCT02557399|5501160|P2|Overall Study|Withdrawal by Subject|1
1583791|NCT02557399|5501161|P1|Overall Study|Withdrawal by Subject|1
1583792|NCT02557399|5501160|P2|Overall Study|Protocol-defined stopping criteria|1
1583793|NCT02557399|5501161|P1|Overall Study|Protocol-defined stopping criteria|0
1583794|NCT02557399|5501160|P2|Overall Study|Protocol Violation|1
1583795|NCT02557399|5501161|P1|Overall Study|Protocol Violation|0
1583796|NCT02557399|5501160|P2|Overall Study|Adverse Event|5
1583797|NCT02557399|5501161|P1|Overall Study|Adverse Event|6
1583798|NCT02556918|5501220|P2|Overall Study|Withdrawal by Subject|4
1583799|NCT02556918|5501221|P1|Overall Study|Withdrawal by Subject|4
1583800|NCT02556918|5501220|P2|Overall Study|Protocol Violation|6
1583801|NCT02556918|5501221|P1|Overall Study|Protocol Violation|5
1583802|NCT02556801|5501281|P4|Overall Study|Personal reasons patient|1
1583803|NCT02556801|5501282|P3|Overall Study|Personal reasons patient|0
1583804|NCT02556801|5501283|P2|Overall Study|Personal reasons patient|0
1583805|NCT02556801|5501284|P1|Overall Study|Personal reasons patient|0
1583806|NCT02556801|5501281|P4|Overall Study|Pregnancy|0
1583807|NCT02556801|5501282|P3|Overall Study|Pregnancy|0
1583808|NCT02556801|5501283|P2|Overall Study|Pregnancy|1
1583809|NCT02556801|5501284|P1|Overall Study|Pregnancy|0
1583810|NCT02556801|5501281|P4|Overall Study|Adverse Event|3
1583811|NCT02556801|5501282|P3|Overall Study|Adverse Event|0
1583812|NCT02556801|5501283|P2|Overall Study|Adverse Event|2
1583813|NCT02556801|5501284|P1|Overall Study|Adverse Event|0
1583814|NCT02556801|5501281|P4|Overall Study|Protocol Violation|1
1583815|NCT02556801|5501282|P3|Overall Study|Protocol Violation|1
1583816|NCT02556801|5501283|P2|Overall Study|Protocol Violation|3
1583817|NCT02556801|5501284|P1|Overall Study|Protocol Violation|0
1583818|NCT02556801|5501281|P4|Overall Study|Withdrawal by Subject|0
1583819|NCT02556801|5501282|P3|Overall Study|Withdrawal by Subject|1
1583820|NCT02556801|5501283|P2|Overall Study|Withdrawal by Subject|1
1583821|NCT02556801|5501284|P1|Overall Study|Withdrawal by Subject|1
1583822|NCT02556801|5501281|P4|Overall Study|Lost to Follow-up|0
1583823|NCT02556801|5501282|P3|Overall Study|Lost to Follow-up|2
1583824|NCT02556801|5501283|P2|Overall Study|Lost to Follow-up|0
1583825|NCT02556801|5501284|P1|Overall Study|Lost to Follow-up|1
1583826|NCT02556632|5501346|P3|Overall Study|Treatment or Change Delay|1
1583827|NCT02556632|5501347|P2|Overall Study|Treatment or Change Delay|0
1583828|NCT02556632|5501348|P1|Overall Study|Treatment or Change Delay|0
1583829|NCT02556632|5501346|P3|Overall Study|Disliked Study Procedures|1
1583830|NCT02556632|5501347|P2|Overall Study|Disliked Study Procedures|0
1583831|NCT02556632|5501348|P1|Overall Study|Disliked Study Procedures|0
1583832|NCT02556632|5501346|P3|Overall Study|Ineligible|0
1583833|NCT02556632|5501347|P2|Overall Study|Ineligible|1
1583834|NCT02556632|5501348|P1|Overall Study|Ineligible|0
1583835|NCT02556632|5501346|P3|Overall Study|Did Not Start RT|0
1583836|NCT02556632|5501347|P2|Overall Study|Did Not Start RT|1
1583837|NCT02556632|5501348|P1|Overall Study|Did Not Start RT|0
1583838|NCT02556632|5501346|P3|Overall Study|Possibly Related Adverse Event|1
1583839|NCT02556632|5501347|P2|Overall Study|Possibly Related Adverse Event|0
1583840|NCT02556632|5501348|P1|Overall Study|Possibly Related Adverse Event|0
1583841|NCT02556632|5501346|P3|Overall Study|Related Adverse Event|0
1583842|NCT02556632|5501347|P2|Overall Study|Related Adverse Event|1
1583843|NCT02556632|5501348|P1|Overall Study|Related Adverse Event|0
1583844|NCT02556632|5501346|P3|Overall Study|Unrelated Adverse Event|3
1583845|NCT02556632|5501347|P2|Overall Study|Unrelated Adverse Event|0
1583846|NCT02556632|5501348|P1|Overall Study|Unrelated Adverse Event|1
1583847|NCT02556632|5501346|P3|Overall Study|Withdrew (Unrelated Medical)|0
1583848|NCT02556632|5501347|P2|Overall Study|Withdrew (Unrelated Medical)|0
1583849|NCT02556632|5501348|P1|Overall Study|Withdrew (Unrelated Medical)|1
1583850|NCT02556632|5501346|P3|Overall Study|Changed Mind|0
1583851|NCT02556632|5501347|P2|Overall Study|Changed Mind|1
1583852|NCT02556632|5501348|P1|Overall Study|Changed Mind|0
1583853|NCT02556632|5501346|P3|Overall Study|Personal Issues|1
1583854|NCT02556632|5501347|P2|Overall Study|Personal Issues|1
1583855|NCT02556632|5501348|P1|Overall Study|Personal Issues|0
1583856|NCT02556632|5501346|P3|Overall Study|No Reason|1
1583857|NCT02556632|5501347|P2|Overall Study|No Reason|0
1583858|NCT02556632|5501348|P1|Overall Study|No Reason|1
1583859|NCT02556632|5501346|P3|Overall Study|Disliked Intervention|1
1583860|NCT02556632|5501347|P2|Overall Study|Disliked Intervention|1
1583861|NCT02556632|5501348|P1|Overall Study|Disliked Intervention|1
1583862|NCT02556632|5501346|P3|Overall Study|Lost to Follow-up|0
1583863|NCT02556632|5501347|P2|Overall Study|Lost to Follow-up|0
1583864|NCT02556632|5501348|P1|Overall Study|Lost to Follow-up|1
1583865|NCT02556307|5501366|P1|Overall Study|Enrolled but not treated|2
1583866|NCT02556307|5501366|P1|Overall Study|Change to triple therapy|4
1583867|NCT02556307|5501366|P1|Overall Study|Lost to Follow-up|36
1583868|NCT02556307|5501366|P1|Overall Study|Premature treatment interruption|11
1583869|NCT02556255|5501376|P1|Overall Study|Lost to Follow-up|4
1583870|NCT02556203|5501391|P2|Overall Study|Adverse Event|0
1583871|NCT02556203|5501392|P1|Overall Study|Adverse Event|1
1583872|NCT02556203|5501391|P2|Overall Study|Lost to Follow-up|5
1583873|NCT02556203|5501392|P1|Overall Study|Lost to Follow-up|5
1583874|NCT02556203|5501391|P2|Overall Study|Withdrawal by Subject|21
1583875|NCT02556203|5501392|P1|Overall Study|Withdrawal by Subject|21
1583876|NCT02556177|5501414|P2|Overall Study|Subjects did not complete all 4 visits|61
1583877|NCT02556177|5501415|P1|Overall Study|Subjects did not complete all 4 visits|283
1583878|NCT02556138|5501423|P1|Overall Study|Withdrawal by Subject|1
1583879|NCT02555878|5501431|P2|Overall Study|Other|17
1583880|NCT02555878|5501432|P1|Overall Study|Other|17
1583881|NCT02555878|5501431|P2|Overall Study|Physician Decision|13
1583882|NCT02555878|5501432|P1|Overall Study|Physician Decision|12
1583883|NCT02555878|5501431|P2|Overall Study|Protocol Violation|2
1583884|NCT02555878|5501432|P1|Overall Study|Protocol Violation|1
1583885|NCT02555878|5501431|P2|Overall Study|Death|59
1583886|NCT02555878|5501432|P1|Overall Study|Death|74
1583887|NCT02555878|5501431|P2|Overall Study|Adverse Event|8
1583888|NCT02555878|5501432|P1|Overall Study|Adverse Event|12
1583889|NCT02555878|5501431|P2|Overall Study|Withdrawal by Subject|48
1583890|NCT02555878|5501432|P1|Overall Study|Withdrawal by Subject|48
1583891|NCT02555878|5501431|P2|Overall Study|Lost to Follow-up|3
1583892|NCT02555878|5501432|P1|Overall Study|Lost to Follow-up|2
1583893|NCT02555722|5501464|P2|Month 2|Lost to Follow-up|0
1583894|NCT02555722|5501465|P1|Month 2|Lost to Follow-up|1
1583895|NCT02555722|5501464|P2|Month 2|Withdrawal by Subject|0
1583896|NCT02555722|5501465|P1|Month 2|Withdrawal by Subject|3
1583897|NCT02555722|5501464|P2|Month 1|Lens Discomfort|0
1583898|NCT02555722|5501465|P1|Month 1|Lens Discomfort|1
1583899|NCT02555722|5501464|P2|Week 2|Withdrawal by Subject|0
1583900|NCT02555722|5501465|P1|Week 2|Withdrawal by Subject|1
1583901|NCT02555722|5501464|P2|Week 2|Adverse Event|1
1583902|NCT02555722|5501465|P1|Week 2|Adverse Event|0
1583903|NCT02555618|5501656|P2|Overall Study|Sponsor's Circumstances|0
1583904|NCT02555618|5501657|P1|Overall Study|Sponsor's Circumstances|1
1583905|NCT02555371|5501699|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1583906|NCT02555371|5501700|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
1583907|NCT02555371|5501701|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1583908|NCT02555371|5501702|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1583909|NCT02555371|5501703|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
1583910|NCT02555371|5501699|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
1583911|NCT02555371|5501700|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1583912|NCT02555371|5501701|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1583913|NCT02555371|5501702|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1583914|NCT02555371|5501703|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
1583915|NCT02555371|5501699|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
1583916|NCT02555371|5501700|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1583917|NCT02555371|5501701|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1583918|NCT02555371|5501702|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1583919|NCT02555371|5501703|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
1583920|NCT02555371|5501699|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1583921|NCT02555371|5501700|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
1583922|NCT02555371|5501701|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1583923|NCT02555371|5501702|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1583924|NCT02555371|5501703|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
1583925|NCT02555371|5501699|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1583926|NCT02555371|5501700|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
1583927|NCT02555371|5501701|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1583928|NCT02555371|5501702|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1583929|NCT02555371|5501703|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
1583930|NCT02555371|5501699|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
1583931|NCT02555371|5501700|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
1583932|NCT02555371|5501701|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
1583933|NCT02555371|5501702|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
1583934|NCT02555371|5501703|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
1583935|NCT02555371|5501699|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1583936|NCT02555371|5501700|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1583937|NCT02555371|5501701|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1583938|NCT02555371|5501702|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
1583939|NCT02555371|5501703|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
1583940|NCT02555371|5501699|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
1583941|NCT02555371|5501700|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
1583942|NCT02555371|5501701|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
1583943|NCT02555371|5501702|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
1583944|NCT02555371|5501703|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
1583945|NCT02555371|5501699|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
1583946|NCT02555371|5501700|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
1583947|NCT02555371|5501701|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
1583948|NCT02555371|5501702|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
1583949|NCT02555371|5501703|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
1583950|NCT02555371|5501699|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1583951|NCT02555371|5501700|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1583952|NCT02555371|5501701|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1583953|NCT02555371|5501702|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
1583954|NCT02555371|5501703|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
1583955|NCT02555371|5501699|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1583956|NCT02555371|5501700|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1583957|NCT02555371|5501701|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1583958|NCT02555371|5501702|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
1583959|NCT02555371|5501703|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
1583960|NCT02555371|5501699|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1583961|NCT02555371|5501700|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1583962|NCT02555371|5501701|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1583963|NCT02555371|5501702|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
1583964|NCT02555371|5501703|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
1583965|NCT02555371|5501699|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1583966|NCT02555371|5501700|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1583967|NCT02555371|5501701|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1583968|NCT02555371|5501702|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
1583969|NCT02555371|5501703|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
1583970|NCT02555371|5501699|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1583971|NCT02555371|5501700|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1583972|NCT02555371|5501701|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1583973|NCT02555371|5501702|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
1583974|NCT02555371|5501703|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
1583975|NCT02555215|5501754|P1|Overall Study|Investigator Decision|2
1583976|NCT02555215|5501754|P1|Overall Study|Other|1
1583977|NCT02554981|5501765|P1|Overall Study|Other Miscellaneous Reasons|3
1583978|NCT02554981|5501765|P1|Overall Study|Administrative Reasons|1
1583979|NCT02554981|5501765|P1|Overall Study|Adverse Event|1
1583980|NCT02554929|5501791|P2|Overall Study|Withdrawal by Subject|8
1583981|NCT02554929|5501792|P1|Overall Study|Withdrawal by Subject|2
1583982|NCT02554929|5501791|P2|Overall Study|Lost to Follow-up|4
1583983|NCT02554929|5501792|P1|Overall Study|Lost to Follow-up|4
1583984|NCT02554890|5501810|P2|Open-label|Withdrawal by Subject|1
1583985|NCT02554890|5501811|P1|Open-label|Withdrawal by Subject|0
1583986|NCT02554890|5501810|P2|Open-label|Technical problems|1
1583987|NCT02554890|5501811|P1|Open-label|Technical problems|0
1583988|NCT02554890|5501810|P2|Open-label|Lost to Follow-up|7
1583989|NCT02554890|5501811|P1|Open-label|Lost to Follow-up|0
1583990|NCT02554890|5501810|P2|Open-label|Subject/Guardian decision|11
1583991|NCT02554890|5501811|P1|Open-label|Subject/Guardian decision|0
1583992|NCT02554890|5501810|P2|Open-label|Physician Decision|1
1583993|NCT02554890|5501811|P1|Open-label|Physician Decision|0
1583994|NCT02554890|5501810|P2|Open-label|Death|1
1583995|NCT02554890|5501811|P1|Open-label|Death|0
1583996|NCT02554890|5501810|P2|Open-label|Adverse Event|30
1583997|NCT02554890|5501811|P1|Open-label|Adverse Event|0
1583998|NCT02554890|5501810|P2|Double-blind|Noncompliance with study treatment|5
1583999|NCT02554890|5501811|P1|Double-blind|Noncompliance with study treatment|6
1584000|NCT02554890|5501810|P2|Double-blind|Withdrawal by Subject|6
1584001|NCT02554890|5501811|P1|Double-blind|Withdrawal by Subject|5
1584002|NCT02554890|5501810|P2|Double-blind|Technical problems|0
1584003|NCT02554890|5501811|P1|Double-blind|Technical problems|1
1584004|NCT02554890|5501810|P2|Double-blind|Lost to Follow-up|5
1584005|NCT02554890|5501811|P1|Double-blind|Lost to Follow-up|7
1584006|NCT02554890|5501810|P2|Double-blind|Subject/Guardian decision|16
1584007|NCT02554890|5501811|P1|Double-blind|Subject/Guardian decision|21
1584008|NCT02554890|5501810|P2|Double-blind|Physician Decision|3
1584009|NCT02554890|5501811|P1|Double-blind|Physician Decision|4
1584010|NCT02554890|5501810|P2|Double-blind|Protocol Violation|1
1584011|NCT02554890|5501811|P1|Double-blind|Protocol Violation|1
1584012|NCT02554890|5501810|P2|Double-blind|Death|4
1584013|NCT02554890|5501811|P1|Double-blind|Death|6
1584014|NCT02554890|5501810|P2|Double-blind|Adverse Event|51
1584015|NCT02554890|5501811|P1|Double-blind|Adverse Event|45
1584016|NCT02554877|5501839|P4|Overall Study|No longer willing to participate|0
1584017|NCT02554877|5501840|P3|Overall Study|No longer willing to participate|2
1584018|NCT02554877|5501841|P2|Overall Study|No longer willing to participate|2
1584019|NCT02554877|5501842|P1|Overall Study|No longer willing to participate|0
1584020|NCT02554877|5501839|P4|Overall Study|Insufficient clinical response|0
1584021|NCT02554877|5501840|P3|Overall Study|Insufficient clinical response|0
1584022|NCT02554877|5501841|P2|Overall Study|Insufficient clinical response|0
1584023|NCT02554877|5501842|P1|Overall Study|Insufficient clinical response|4
1584024|NCT02554877|5501839|P4|Overall Study|Other|3
1584025|NCT02554877|5501840|P3|Overall Study|Other|0
1584026|NCT02554877|5501841|P2|Overall Study|Other|3
1584027|NCT02554877|5501842|P1|Overall Study|Other|1
1584028|NCT02554877|5501839|P4|Overall Study|Protocol Violation|0
1584029|NCT02554877|5501840|P3|Overall Study|Protocol Violation|1
1584030|NCT02554877|5501841|P2|Overall Study|Protocol Violation|1
1584031|NCT02554877|5501842|P1|Overall Study|Protocol Violation|3
1584032|NCT02554877|5501839|P4|Overall Study|No longer met eligibility criteria|1
1584033|NCT02554877|5501840|P3|Overall Study|No longer met eligibility criteria|1
1584034|NCT02554877|5501841|P2|Overall Study|No longer met eligibility criteria|0
1584035|NCT02554877|5501842|P1|Overall Study|No longer met eligibility criteria|1
1584036|NCT02554877|5501839|P4|Overall Study|Did not meet entrance criteria|0
1584037|NCT02554877|5501840|P3|Overall Study|Did not meet entrance criteria|1
1584038|NCT02554877|5501841|P2|Overall Study|Did not meet entrance criteria|0
1584039|NCT02554877|5501842|P1|Overall Study|Did not meet entrance criteria|0
1584040|NCT02554877|5501839|P4|Overall Study|Lost to Follow-up|2
1584041|NCT02554877|5501840|P3|Overall Study|Lost to Follow-up|1
1584042|NCT02554877|5501841|P2|Overall Study|Lost to Follow-up|1
1584043|NCT02554877|5501842|P1|Overall Study|Lost to Follow-up|1
1584044|NCT02554877|5501839|P4|Overall Study|Adverse Event|1
1584045|NCT02554877|5501840|P3|Overall Study|Adverse Event|0
1584046|NCT02554877|5501841|P2|Overall Study|Adverse Event|0
1584047|NCT02554877|5501842|P1|Overall Study|Adverse Event|2
1584048|NCT02554682|5501935|P10|Overall Study|Physician Decision|0
1584049|NCT02554682|5501936|P9|Overall Study|Physician Decision|0
1584050|NCT02554682|5501937|P8|Overall Study|Physician Decision|0
1584051|NCT02554682|5501938|P7|Overall Study|Physician Decision|0
1584052|NCT02554682|5501939|P6|Overall Study|Physician Decision|0
1584053|NCT02554682|5501940|P5|Overall Study|Physician Decision|0
1584054|NCT02554682|5501941|P4|Overall Study|Physician Decision|0
1584055|NCT02554682|5501942|P3|Overall Study|Physician Decision|0
1584056|NCT02554682|5501943|P2|Overall Study|Physician Decision|2
1584057|NCT02554682|5501944|P1|Overall Study|Physician Decision|2
1584058|NCT02554682|5501935|P10|Overall Study|Withdrawal by Subject|0
1584059|NCT02554682|5501936|P9|Overall Study|Withdrawal by Subject|0
1584060|NCT02554682|5501937|P8|Overall Study|Withdrawal by Subject|0
1584061|NCT02554682|5501938|P7|Overall Study|Withdrawal by Subject|0
1584062|NCT02554682|5501939|P6|Overall Study|Withdrawal by Subject|0
1584063|NCT02554682|5501940|P5|Overall Study|Withdrawal by Subject|0
1584064|NCT02554682|5501941|P4|Overall Study|Withdrawal by Subject|0
1584065|NCT02554682|5501942|P3|Overall Study|Withdrawal by Subject|0
1584066|NCT02554682|5501943|P2|Overall Study|Withdrawal by Subject|1
1584067|NCT02554682|5501944|P1|Overall Study|Withdrawal by Subject|2
1584068|NCT02554682|5501935|P10|Overall Study|Lost to Follow-up|2
1584069|NCT02554682|5501936|P9|Overall Study|Lost to Follow-up|2
1584070|NCT02554682|5501937|P8|Overall Study|Lost to Follow-up|6
1584071|NCT02554682|5501938|P7|Overall Study|Lost to Follow-up|6
1584072|NCT02554682|5501939|P6|Overall Study|Lost to Follow-up|1
1584073|NCT02554682|5501940|P5|Overall Study|Lost to Follow-up|2
1584074|NCT02554682|5501941|P4|Overall Study|Lost to Follow-up|3
1584075|NCT02554682|5501942|P3|Overall Study|Lost to Follow-up|4
1584076|NCT02554682|5501943|P2|Overall Study|Lost to Follow-up|9
1584077|NCT02554682|5501944|P1|Overall Study|Lost to Follow-up|11
1584078|NCT02554656|5501993|P1|Overall Study|Protocol Violation|3
1584079|NCT02554279|5502038|P2|Overall Study|Other reason|6
1584080|NCT02554279|5502039|P1|Overall Study|Other reason|19
1584081|NCT02554279|5502038|P2|Overall Study|Protocol Violation|1
1584082|NCT02554279|5502039|P1|Overall Study|Protocol Violation|2
1584083|NCT02554279|5502038|P2|Overall Study|Withdrawal by Subject|4
1584084|NCT02554279|5502039|P1|Overall Study|Withdrawal by Subject|6
1584085|NCT02554279|5502038|P2|Overall Study|Lost to Follow-up|2
1584086|NCT02554279|5502039|P1|Overall Study|Lost to Follow-up|3
1584087|NCT02554279|5502038|P2|Overall Study|Adverse Event|5
1584088|NCT02554279|5502039|P1|Overall Study|Adverse Event|2
1584089|NCT02554019|5502074|P3|Overall Study|Adverse Event|0
1584090|NCT02554019|5502075|P2|Overall Study|Adverse Event|0
1584091|NCT02554019|5502076|P1|Overall Study|Adverse Event|1
1584092|NCT02554019|5502074|P3|Overall Study|Withdrawal by Subject|2
1584093|NCT02554019|5502075|P2|Overall Study|Withdrawal by Subject|0
1584094|NCT02554019|5502076|P1|Overall Study|Withdrawal by Subject|1
1584095|NCT02553928|5502098|P2|Overall Study|Administrative reason(s)|1
1584096|NCT02553928|5502099|P1|Overall Study|Administrative reason(s)|0
1584097|NCT02553928|5502098|P2|Overall Study|Lost to Follow-up|1
1584098|NCT02553928|5502099|P1|Overall Study|Lost to Follow-up|0
1584099|NCT02553928|5502098|P2|Overall Study|Adverse Event|1
1584100|NCT02553928|5502099|P1|Overall Study|Adverse Event|2
1584101|NCT02553772|5502153|P2|Overall Study|Other Miscellaneous Reasons|1
1584102|NCT02553772|5502154|P1|Overall Study|Other Miscellaneous Reasons|0
1584103|NCT02553772|5502153|P2|Overall Study|Lack of Efficacy|0
1584104|NCT02553772|5502154|P1|Overall Study|Lack of Efficacy|1
1584105|NCT02553772|5502153|P2|Overall Study|Withdrawal of Consent|1
1584106|NCT02553772|5502154|P1|Overall Study|Withdrawal of Consent|1
1584107|NCT02553772|5502153|P2|Overall Study|Lost to Follow-up|1
1584108|NCT02553772|5502154|P1|Overall Study|Lost to Follow-up|2
1584109|NCT02553772|5502153|P2|Overall Study|Adverse Event|3
1584110|NCT02553772|5502154|P1|Overall Study|Adverse Event|2
1584111|NCT02553629|5502199|P2|Overall Study|Logistic reasons|6
1584112|NCT02553629|5502200|P1|Overall Study|Logistic reasons|3
1584113|NCT02553538|5502216|P2|Overall Study|Died or Left Network|56
1584114|NCT02553538|5502217|P1|Overall Study|Died or Left Network|54
1584115|NCT02553538|5502216|P2|Overall Study|Could Not Reach by Telephone|0
1584116|NCT02553538|5502217|P1|Overall Study|Could Not Reach by Telephone|133
1584117|NCT02553499|5502251|P14|Overall Study|Withdrawal by Subject|0
1584118|NCT02553499|5502252|P13|Overall Study|Withdrawal by Subject|0
1584119|NCT02553499|5502253|P12|Overall Study|Withdrawal by Subject|0
1584120|NCT02553499|5502254|P11|Overall Study|Withdrawal by Subject|1
1584121|NCT02553499|5502255|P10|Overall Study|Withdrawal by Subject|0
1584122|NCT02553499|5502256|P9|Overall Study|Withdrawal by Subject|1
1584123|NCT02553499|5502257|P8|Overall Study|Withdrawal by Subject|1
1584124|NCT02553499|5502258|P7|Overall Study|Withdrawal by Subject|0
1584125|NCT02553499|5502259|P6|Overall Study|Withdrawal by Subject|0
1584126|NCT02553499|5502260|P5|Overall Study|Withdrawal by Subject|0
1584127|NCT02553499|5502261|P4|Overall Study|Withdrawal by Subject|0
1584128|NCT02553499|5502262|P3|Overall Study|Withdrawal by Subject|0
1584129|NCT02553499|5502263|P2|Overall Study|Withdrawal by Subject|0
1584130|NCT02553499|5502264|P1|Overall Study|Withdrawal by Subject|2
1584131|NCT02553499|5502251|P14|Overall Study|Study Terminated by Sponsor|0
1584132|NCT02553499|5502252|P13|Overall Study|Study Terminated by Sponsor|0
1584133|NCT02553499|5502253|P12|Overall Study|Study Terminated by Sponsor|0
1584134|NCT02553499|5502254|P11|Overall Study|Study Terminated by Sponsor|0
1584135|NCT02553499|5502255|P10|Overall Study|Study Terminated by Sponsor|0
1584136|NCT02553499|5502256|P9|Overall Study|Study Terminated by Sponsor|1
1584137|NCT02553499|5502257|P8|Overall Study|Study Terminated by Sponsor|0
1584138|NCT02553499|5502258|P7|Overall Study|Study Terminated by Sponsor|0
1584139|NCT02553499|5502259|P6|Overall Study|Study Terminated by Sponsor|0
1584140|NCT02553499|5502260|P5|Overall Study|Study Terminated by Sponsor|0
1584141|NCT02553499|5502261|P4|Overall Study|Study Terminated by Sponsor|0
1584142|NCT02553499|5502262|P3|Overall Study|Study Terminated by Sponsor|0
1584143|NCT02553499|5502263|P2|Overall Study|Study Terminated by Sponsor|0
1584144|NCT02553499|5502264|P1|Overall Study|Study Terminated by Sponsor|0
1584145|NCT02553499|5502251|P14|Overall Study|Progressive Disease|1
1584146|NCT02553499|5502252|P13|Overall Study|Progressive Disease|2
1584147|NCT02553499|5502253|P12|Overall Study|Progressive Disease|0
1584148|NCT02553499|5502254|P11|Overall Study|Progressive Disease|0
1584149|NCT02553499|5502255|P10|Overall Study|Progressive Disease|1
1584150|NCT02553499|5502256|P9|Overall Study|Progressive Disease|0
1584151|NCT02553499|5502257|P8|Overall Study|Progressive Disease|0
1584152|NCT02553499|5502258|P7|Overall Study|Progressive Disease|1
1584153|NCT02553499|5502259|P6|Overall Study|Progressive Disease|1
1584154|NCT02553499|5502260|P5|Overall Study|Progressive Disease|1
1584155|NCT02553499|5502261|P4|Overall Study|Progressive Disease|2
1584156|NCT02553499|5502262|P3|Overall Study|Progressive Disease|0
1584157|NCT02553499|5502263|P2|Overall Study|Progressive Disease|0
1584158|NCT02553499|5502264|P1|Overall Study|Progressive Disease|0
1584159|NCT02553499|5502251|P14|Overall Study|Physician Decision|0
1584160|NCT02553499|5502252|P13|Overall Study|Physician Decision|1
1584161|NCT02553499|5502253|P12|Overall Study|Physician Decision|3
1584162|NCT02553499|5502254|P11|Overall Study|Physician Decision|1
1584163|NCT02553499|5502255|P10|Overall Study|Physician Decision|2
1584164|NCT02553499|5502256|P9|Overall Study|Physician Decision|1
1584165|NCT02553499|5502257|P8|Overall Study|Physician Decision|1
1584166|NCT02553499|5502258|P7|Overall Study|Physician Decision|0
1584167|NCT02553499|5502259|P6|Overall Study|Physician Decision|0
1584168|NCT02553499|5502260|P5|Overall Study|Physician Decision|1
1584169|NCT02553499|5502261|P4|Overall Study|Physician Decision|0
1584170|NCT02553499|5502262|P3|Overall Study|Physician Decision|1
1584171|NCT02553499|5502263|P2|Overall Study|Physician Decision|1
1584172|NCT02553499|5502264|P1|Overall Study|Physician Decision|0
1584173|NCT02553499|5502251|P14|Overall Study|Lost to Follow-up|0
1584174|NCT02553499|5502252|P13|Overall Study|Lost to Follow-up|0
1584175|NCT02553499|5502253|P12|Overall Study|Lost to Follow-up|0
1584176|NCT02553499|5502254|P11|Overall Study|Lost to Follow-up|0
1584177|NCT02553499|5502255|P10|Overall Study|Lost to Follow-up|0
1584178|NCT02553499|5502256|P9|Overall Study|Lost to Follow-up|0
1584179|NCT02553499|5502257|P8|Overall Study|Lost to Follow-up|0
1584180|NCT02553499|5502258|P7|Overall Study|Lost to Follow-up|1
1584181|NCT02553499|5502259|P6|Overall Study|Lost to Follow-up|0
1584182|NCT02553499|5502260|P5|Overall Study|Lost to Follow-up|0
1584183|NCT02553499|5502261|P4|Overall Study|Lost to Follow-up|0
1584184|NCT02553499|5502262|P3|Overall Study|Lost to Follow-up|0
1584185|NCT02553499|5502263|P2|Overall Study|Lost to Follow-up|0
1584186|NCT02553499|5502264|P1|Overall Study|Lost to Follow-up|0
1584187|NCT02553499|5502251|P14|Overall Study|Death|0
1584188|NCT02553499|5502252|P13|Overall Study|Death|0
1584189|NCT02553499|5502253|P12|Overall Study|Death|0
1584190|NCT02553499|5502254|P11|Overall Study|Death|1
1584191|NCT02553499|5502255|P10|Overall Study|Death|0
1584192|NCT02553499|5502256|P9|Overall Study|Death|0
1584193|NCT02553499|5502257|P8|Overall Study|Death|0
1584194|NCT02553499|5502258|P7|Overall Study|Death|0
1584195|NCT02553499|5502259|P6|Overall Study|Death|2
1584196|NCT02553499|5502260|P5|Overall Study|Death|1
1584197|NCT02553499|5502261|P4|Overall Study|Death|0
1584198|NCT02553499|5502262|P3|Overall Study|Death|1
1584199|NCT02553499|5502263|P2|Overall Study|Death|1
1584200|NCT02553499|5502264|P1|Overall Study|Death|0
1584201|NCT02553499|5502251|P14|Overall Study|Adverse Event|1
1584202|NCT02553499|5502252|P13|Overall Study|Adverse Event|0
1584203|NCT02553499|5502253|P12|Overall Study|Adverse Event|0
1584204|NCT02553499|5502254|P11|Overall Study|Adverse Event|0
1584205|NCT02553499|5502255|P10|Overall Study|Adverse Event|0
1584206|NCT02553499|5502256|P9|Overall Study|Adverse Event|0
1584207|NCT02553499|5502257|P8|Overall Study|Adverse Event|1
1584208|NCT02553499|5502258|P7|Overall Study|Adverse Event|1
1584209|NCT02553499|5502259|P6|Overall Study|Adverse Event|0
1584210|NCT02553499|5502260|P5|Overall Study|Adverse Event|0
1584211|NCT02553499|5502261|P4|Overall Study|Adverse Event|0
1584212|NCT02553499|5502262|P3|Overall Study|Adverse Event|0
1584213|NCT02553499|5502263|P2|Overall Study|Adverse Event|0
1584214|NCT02553499|5502264|P1|Overall Study|Adverse Event|0
1584215|NCT02553421|5502366|P2|Overall Study|Improper Device Placement|0
1584216|NCT02553421|5502367|P1|Overall Study|Improper Device Placement|3
1584217|NCT02553421|5502366|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
1584218|NCT02553421|5502367|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
1584219|NCT02553421|5502366|P2|Overall Study|Lost to Follow-up|1
1584220|NCT02553421|5502367|P1|Overall Study|Lost to Follow-up|21
1584221|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
1584222|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
1584223|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
1584224|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
1584225|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
1584226|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
1584227|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
1584228|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
1584229|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
1584230|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
1584231|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Adverse Event|5
1584232|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Adverse Event|6
1584233|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Death|3
1584234|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Death|1
1584235|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
1584236|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
1584237|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Physician Decision|4
1584238|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Physician Decision|2
1584239|NCT02553317|5502377|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
1584240|NCT02553317|5502378|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
1584241|NCT02552355|5502436|P4|Overall Study|Withdrawal by Subject|1
1584242|NCT02552355|5502437|P3|Overall Study|Withdrawal by Subject|0
1584243|NCT02552355|5502438|P2|Overall Study|Withdrawal by Subject|0
1584244|NCT02552355|5502439|P1|Overall Study|Withdrawal by Subject|0
1584245|NCT02552355|5502436|P4|Overall Study|Adverse Event|0
1584246|NCT02552355|5502437|P3|Overall Study|Adverse Event|2
1584247|NCT02552355|5502438|P2|Overall Study|Adverse Event|2
1584248|NCT02552355|5502439|P1|Overall Study|Adverse Event|0
1584249|NCT02552303|5502485|P4|Follow-Up|ineligible|0
1584250|NCT02552303|5502486|P3|Follow-Up|ineligible|0
1584251|NCT02552303|5502487|P2|Follow-Up|ineligible|2
1584252|NCT02552303|5502488|P1|Follow-Up|ineligible|0
1584253|NCT02552303|5502485|P4|Follow-Up|Lost to Follow-up|0
1584254|NCT02552303|5502486|P3|Follow-Up|Lost to Follow-up|1
1584255|NCT02552303|5502487|P2|Follow-Up|Lost to Follow-up|0
1584256|NCT02552303|5502488|P1|Follow-Up|Lost to Follow-up|0
1584257|NCT02552303|5502485|P4|Allocation|ineligible|0
1584258|NCT02552303|5502486|P3|Allocation|ineligible|0
1584259|NCT02552303|5502487|P2|Allocation|ineligible|1
1584260|NCT02552303|5502488|P1|Allocation|ineligible|1
1584261|NCT02552303|5502485|P4|Allocation|Withdrawal by Subject|1
1584262|NCT02552303|5502486|P3|Allocation|Withdrawal by Subject|1
1584263|NCT02552303|5502487|P2|Allocation|Withdrawal by Subject|1
1584264|NCT02552303|5502488|P1|Allocation|Withdrawal by Subject|2
1584265|NCT02552147|5502502|P2|Second Intervention (7 Days)|Protocol Violation|0
1584266|NCT02552147|5502503|P1|Second Intervention (7 Days)|Protocol Violation|2
1584267|NCT02552147|5502502|P2|First Intervention (7 Days)|Protocol Violation|0
1584268|NCT02552147|5502503|P1|First Intervention (7 Days)|Protocol Violation|1
1584269|NCT02552121|5502537|P8|Part 2: Cohort Expansion|Death|0
1584270|NCT02552121|5502538|P7|Part 2: Cohort Expansion|Death|0
1584271|NCT02552121|5502539|P6|Part 2: Cohort Expansion|Death|0
1584272|NCT02552121|5502540|P5|Part 2: Cohort Expansion|Death|0
1584273|NCT02552121|5502541|P4|Part 2: Cohort Expansion|Death|0
1584274|NCT02552121|5502542|P3|Part 2: Cohort Expansion|Death|1
1584275|NCT02552121|5502543|P2|Part 2: Cohort Expansion|Death|0
1584276|NCT02552121|5502544|P1|Part 2: Cohort Expansion|Death|0
1584277|NCT02552121|5502537|P8|Part 2: Cohort Expansion|Adverse Event|0
1584278|NCT02552121|5502538|P7|Part 2: Cohort Expansion|Adverse Event|0
1584279|NCT02552121|5502539|P6|Part 2: Cohort Expansion|Adverse Event|0
1584280|NCT02552121|5502540|P5|Part 2: Cohort Expansion|Adverse Event|0
1584281|NCT02552121|5502541|P4|Part 2: Cohort Expansion|Adverse Event|1
1584282|NCT02552121|5502542|P3|Part 2: Cohort Expansion|Adverse Event|6
1584283|NCT02552121|5502543|P2|Part 2: Cohort Expansion|Adverse Event|0
1584284|NCT02552121|5502544|P1|Part 2: Cohort Expansion|Adverse Event|0
1584285|NCT02552121|5502537|P8|Part 2: Cohort Expansion|Disease Progression|3
1584286|NCT02552121|5502538|P7|Part 2: Cohort Expansion|Disease Progression|0
1584287|NCT02552121|5502539|P6|Part 2: Cohort Expansion|Disease Progression|4
1584288|NCT02552121|5502540|P5|Part 2: Cohort Expansion|Disease Progression|1
1584289|NCT02552121|5502541|P4|Part 2: Cohort Expansion|Disease Progression|2
1584290|NCT02552121|5502542|P3|Part 2: Cohort Expansion|Disease Progression|3
1584291|NCT02552121|5502543|P2|Part 2: Cohort Expansion|Disease Progression|0
1584292|NCT02552121|5502544|P1|Part 2: Cohort Expansion|Disease Progression|0
1584293|NCT02552121|5502537|P8|Part 2: Cohort Expansion|Patient Choice|0
1584294|NCT02552121|5502538|P7|Part 2: Cohort Expansion|Patient Choice|1
1584295|NCT02552121|5502539|P6|Part 2: Cohort Expansion|Patient Choice|0
1584296|NCT02552121|5502540|P5|Part 2: Cohort Expansion|Patient Choice|0
1584297|NCT02552121|5502541|P4|Part 2: Cohort Expansion|Patient Choice|0
1584298|NCT02552121|5502542|P3|Part 2: Cohort Expansion|Patient Choice|1
1584299|NCT02552121|5502543|P2|Part 2: Cohort Expansion|Patient Choice|0
1584300|NCT02552121|5502544|P1|Part 2: Cohort Expansion|Patient Choice|0
1584301|NCT02552121|5502537|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1584302|NCT02552121|5502538|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1584303|NCT02552121|5502539|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1584304|NCT02552121|5502540|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1584305|NCT02552121|5502541|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1584306|NCT02552121|5502542|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1584307|NCT02552121|5502543|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
1584308|NCT02552121|5502544|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
1584309|NCT02552121|5502537|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1584310|NCT02552121|5502538|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1584311|NCT02552121|5502539|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1584312|NCT02552121|5502540|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1584313|NCT02552121|5502541|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1584314|NCT02552121|5502542|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1584315|NCT02552121|5502543|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
1584316|NCT02552121|5502544|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
1584317|NCT02552121|5502537|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1584318|NCT02552121|5502538|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1584319|NCT02552121|5502539|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1584320|NCT02552121|5502540|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1584321|NCT02552121|5502541|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1584322|NCT02552121|5502542|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1584323|NCT02552121|5502543|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
1584324|NCT02552121|5502544|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
1584325|NCT02552121|5502537|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1584326|NCT02552121|5502538|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1584327|NCT02552121|5502539|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1584328|NCT02552121|5502540|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1584329|NCT02552121|5502541|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1584330|NCT02552121|5502542|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1584331|NCT02552121|5502543|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
1584332|NCT02552121|5502544|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
1584333|NCT02552121|5502537|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1584334|NCT02552121|5502538|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1584335|NCT02552121|5502539|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1584336|NCT02552121|5502540|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1584337|NCT02552121|5502541|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1584338|NCT02552121|5502542|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1584339|NCT02552121|5502543|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
1584340|NCT02552121|5502544|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
1584341|NCT02552121|5502537|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1584342|NCT02552121|5502538|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1584343|NCT02552121|5502539|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1584344|NCT02552121|5502540|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1584345|NCT02552121|5502541|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1584346|NCT02552121|5502542|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1584347|NCT02552121|5502543|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
1584348|NCT02552121|5502544|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
1584349|NCT02551874|5502805|P2|Overall Study|Did not enter long-term study|25
1584350|NCT02551874|5502806|P1|Overall Study|Did not enter long-term study|18
1584351|NCT02551874|5502805|P2|Overall Study|Did not receive randomized treatment|7
1584352|NCT02551874|5502806|P1|Overall Study|Did not receive randomized treatment|0
1584353|NCT02551874|5502805|P2|Overall Study|Reason not reported|4
1584354|NCT02551874|5502806|P1|Overall Study|Reason not reported|10
1584355|NCT02551874|5502805|P2|Overall Study|Pregnancy|1
1584356|NCT02551874|5502806|P1|Overall Study|Pregnancy|0
1584357|NCT02551874|5502805|P2|Overall Study|Lost to Follow-up|2
1584358|NCT02551874|5502806|P1|Overall Study|Lost to Follow-up|0
1584359|NCT02551731|5502875|P1|Overall Study|Withdrawal by Subject|2
1584360|NCT02551692|5502895|P3|Overall Study|Withdrawal by Subject|1
1584361|NCT02551692|5502896|P2|Overall Study|Withdrawal by Subject|0
1584362|NCT02551692|5502897|P1|Overall Study|Withdrawal by Subject|1
1584363|NCT02551692|5502895|P3|Overall Study|Lost to Follow-up|4
1584364|NCT02551692|5502896|P2|Overall Study|Lost to Follow-up|1
1584365|NCT02551692|5502897|P1|Overall Study|Lost to Follow-up|0
1584366|NCT02551055|5502944|P8|Overall Study|Reason not specified|0
1584367|NCT02551055|5502945|P7|Overall Study|Reason not specified|1
1584368|NCT02551055|5502946|P6|Overall Study|Reason not specified|0
1584369|NCT02551055|5502947|P5|Overall Study|Reason not specified|1
1584370|NCT02551055|5502948|P4|Overall Study|Reason not specified|0
1584371|NCT02551055|5502949|P3|Overall Study|Reason not specified|0
1584372|NCT02551055|5502950|P2|Overall Study|Reason not specified|0
1584373|NCT02551055|5502951|P1|Overall Study|Reason not specified|0
1584374|NCT02551055|5502944|P8|Overall Study|Withdrawal by Subject|0
1584375|NCT02551055|5502945|P7|Overall Study|Withdrawal by Subject|0
1584376|NCT02551055|5502946|P6|Overall Study|Withdrawal by Subject|0
1584377|NCT02551055|5502947|P5|Overall Study|Withdrawal by Subject|2
1584378|NCT02551055|5502948|P4|Overall Study|Withdrawal by Subject|1
1584379|NCT02551055|5502949|P3|Overall Study|Withdrawal by Subject|0
1584380|NCT02551055|5502950|P2|Overall Study|Withdrawal by Subject|1
1584381|NCT02551055|5502951|P1|Overall Study|Withdrawal by Subject|1
1584382|NCT02551055|5502944|P8|Overall Study|Study Terminated by Sponsor|0
1584383|NCT02551055|5502945|P7|Overall Study|Study Terminated by Sponsor|0
1584384|NCT02551055|5502946|P6|Overall Study|Study Terminated by Sponsor|0
1584385|NCT02551055|5502947|P5|Overall Study|Study Terminated by Sponsor|2
1584386|NCT02551055|5502948|P4|Overall Study|Study Terminated by Sponsor|2
1584387|NCT02551055|5502949|P3|Overall Study|Study Terminated by Sponsor|0
1584388|NCT02551055|5502950|P2|Overall Study|Study Terminated by Sponsor|1
1584389|NCT02551055|5502951|P1|Overall Study|Study Terminated by Sponsor|1
1584390|NCT02551055|5502944|P8|Overall Study|Death|0
1584391|NCT02551055|5502945|P7|Overall Study|Death|2
1584392|NCT02551055|5502946|P6|Overall Study|Death|1
1584393|NCT02551055|5502947|P5|Overall Study|Death|2
1584394|NCT02551055|5502948|P4|Overall Study|Death|2
1584395|NCT02551055|5502949|P3|Overall Study|Death|2
1584396|NCT02551055|5502950|P2|Overall Study|Death|4
1584397|NCT02551055|5502951|P1|Overall Study|Death|2
1584398|NCT02550873|5503026|P3|Open Label Extension|Study ongoing|111
1584399|NCT02550873|5503027|P2|Open Label Extension|Study ongoing|0
1584400|NCT02550873|5503028|P1|Open Label Extension|Study ongoing|0
1584401|NCT02550873|5503026|P3|Randomized Double Blind|Disease progression|0
1584402|NCT02550873|5503027|P2|Randomized Double Blind|Disease progression|1
1584403|NCT02550873|5503028|P1|Randomized Double Blind|Disease progression|1
1584404|NCT02550873|5503026|P3|Randomized Double Blind|Adverse Event|0
1584405|NCT02550873|5503027|P2|Randomized Double Blind|Adverse Event|1
1584406|NCT02550873|5503028|P1|Randomized Double Blind|Adverse Event|3
1584407|NCT02550288|5503111|P5|Overall Study|Withdrawal by Subject|0
1584408|NCT02550288|5503112|P4|Overall Study|Withdrawal by Subject|1
1584409|NCT02550288|5503113|P3|Overall Study|Withdrawal by Subject|0
1584410|NCT02550288|5503114|P2|Overall Study|Withdrawal by Subject|0
1584411|NCT02550288|5503115|P1|Overall Study|Withdrawal by Subject|0
1584412|NCT02550288|5503111|P5|Overall Study|Participant moved|0
1584413|NCT02550288|5503112|P4|Overall Study|Participant moved|1
1584414|NCT02550288|5503113|P3|Overall Study|Participant moved|0
1584415|NCT02550288|5503114|P2|Overall Study|Participant moved|0
1584416|NCT02550288|5503115|P1|Overall Study|Participant moved|0
1584417|NCT02550288|5503111|P5|Overall Study|Protocol Violation|3
1584418|NCT02550288|5503112|P4|Overall Study|Protocol Violation|0
1584419|NCT02550288|5503113|P3|Overall Study|Protocol Violation|1
1584420|NCT02550288|5503114|P2|Overall Study|Protocol Violation|2
1584421|NCT02550288|5503115|P1|Overall Study|Protocol Violation|2
1584422|NCT02550288|5503111|P5|Overall Study|Physician Decision|0
1584423|NCT02550288|5503112|P4|Overall Study|Physician Decision|1
1584424|NCT02550288|5503113|P3|Overall Study|Physician Decision|0
1584425|NCT02550288|5503114|P2|Overall Study|Physician Decision|0
1584426|NCT02550288|5503115|P1|Overall Study|Physician Decision|0
1584427|NCT02550288|5503111|P5|Overall Study|Adverse Event|0
1584428|NCT02550288|5503112|P4|Overall Study|Adverse Event|0
1584429|NCT02550288|5503113|P3|Overall Study|Adverse Event|0
1584430|NCT02550288|5503114|P2|Overall Study|Adverse Event|1
1584431|NCT02550288|5503115|P1|Overall Study|Adverse Event|0
1584436|NCT02549573|5503316|P2|Overall Study|Protocol Violation|1
1584437|NCT02549573|5503317|P1|Overall Study|Protocol Violation|0
1584438|NCT02549573|5503316|P2|Overall Study|Withdrawal by Subject|2
1584439|NCT02549573|5503317|P1|Overall Study|Withdrawal by Subject|0
1584440|NCT02549352|5503371|P2|12-month Follow-up|Other|3
1584441|NCT02549352|5503372|P1|12-month Follow-up|Other|1
1584442|NCT02549352|5503371|P2|12-month Follow-up|Protocol Violation|1
1584443|NCT02549352|5503372|P1|12-month Follow-up|Protocol Violation|0
1584444|NCT02549352|5503371|P2|12-month Follow-up|Death|1
1584445|NCT02549352|5503372|P1|12-month Follow-up|Death|0
1584446|NCT02549352|5503371|P2|12-month Follow-up|Lost to Follow-up|2
1584447|NCT02549352|5503372|P1|12-month Follow-up|Lost to Follow-up|3
1584448|NCT02549352|5503371|P2|12-month Follow-up|Withdrawal by Subject|5
1584449|NCT02549352|5503372|P1|12-month Follow-up|Withdrawal by Subject|4
1584450|NCT02549352|5503371|P2|3-day Treatment and 8-week Follow-up|Other|2
1584451|NCT02549352|5503372|P1|3-day Treatment and 8-week Follow-up|Other|0
1584452|NCT02549352|5503371|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
1584453|NCT02549352|5503372|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
1584454|NCT02549352|5503371|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
1584455|NCT02549352|5503372|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
1584456|NCT02549339|5503388|P2|12-month Follow-up|Other|3
1584457|NCT02549339|5503389|P1|12-month Follow-up|Other|0
1584458|NCT02549339|5503388|P2|12-month Follow-up|Lost to Follow-up|3
1584459|NCT02549339|5503389|P1|12-month Follow-up|Lost to Follow-up|1
1584460|NCT02549339|5503388|P2|12-month Follow-up|Withdrawal by Subject|3
1584461|NCT02549339|5503389|P1|12-month Follow-up|Withdrawal by Subject|8
1584462|NCT02549339|5503388|P2|12-month Follow-up|Lack of Efficacy|2
1584463|NCT02549339|5503389|P1|12-month Follow-up|Lack of Efficacy|0
1584464|NCT02549339|5503388|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
1584465|NCT02549339|5503389|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
1584466|NCT02549339|5503388|P2|3-day Treatment and 8-week Follow-up|Other|0
1584467|NCT02549339|5503389|P1|3-day Treatment and 8-week Follow-up|Other|1
1584468|NCT02549339|5503388|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
1584469|NCT02549339|5503389|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
1584470|NCT02549339|5503388|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
1584471|NCT02549339|5503389|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
1584472|NCT02549287|5503405|P2|Overall Study|Withdrawal by Subject|6
1584473|NCT02549287|5503406|P1|Overall Study|Withdrawal by Subject|15
1584474|NCT02549287|5503405|P2|Overall Study|Lost to Follow-up|26
1584475|NCT02549287|5503406|P1|Overall Study|Lost to Follow-up|65
1584476|NCT02549196|5503440|P4|Overall Study|Withdrawal by Subject|0
1584477|NCT02549196|5503441|P3|Overall Study|Withdrawal by Subject|1
1584478|NCT02549196|5503442|P2|Overall Study|Withdrawal by Subject|0
1584479|NCT02549196|5503443|P1|Overall Study|Withdrawal by Subject|1
1584480|NCT02549196|5503440|P4|Overall Study|Protocol Violation|1
1584481|NCT02549196|5503441|P3|Overall Study|Protocol Violation|0
1584482|NCT02549196|5503442|P2|Overall Study|Protocol Violation|0
1584483|NCT02549196|5503443|P1|Overall Study|Protocol Violation|0
1584484|NCT02549027|5503499|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1584485|NCT02549027|5503500|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
1584486|NCT02549027|5503501|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1584487|NCT02549027|5503502|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1584488|NCT02549027|5503503|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1584489|NCT02549027|5503504|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1584490|NCT02549027|5503499|P6|Washout After Period 4|Withdrawal by Subject|0
1584491|NCT02549027|5503500|P5|Washout After Period 4|Withdrawal by Subject|0
1584492|NCT02549027|5503501|P4|Washout After Period 4|Withdrawal by Subject|1
1584493|NCT02549027|5503502|P3|Washout After Period 4|Withdrawal by Subject|1
1584494|NCT02549027|5503503|P2|Washout After Period 4|Withdrawal by Subject|1
1584495|NCT02549027|5503504|P1|Washout After Period 4|Withdrawal by Subject|0
1584496|NCT02548962|5503634|P2|Overall Study|Withdrawal by Subject|0
1584497|NCT02548962|5503635|P1|Overall Study|Withdrawal by Subject|1
1584498|NCT02548650|5503674|P2|Double Therapy|Withdrawal by Subject|1
1584499|NCT02548650|5503675|P1|Double Therapy|Withdrawal by Subject|0
1584500|NCT02548650|5503674|P2|Double Therapy|Adverse Event|1
1584501|NCT02548650|5503675|P1|Double Therapy|Adverse Event|1
1584502|NCT02548650|5503674|P2|Triple Therapy|Withdrawal by Subject|4
1584503|NCT02548650|5503675|P1|Triple Therapy|Withdrawal by Subject|0
1584504|NCT02548650|5503674|P2|Triple Therapy|Adverse Event|0
1584505|NCT02548650|5503675|P1|Triple Therapy|Adverse Event|1
1584506|NCT02548585|5503690|P7|Overall Study|Randomized but not treated|0
1584507|NCT02548585|5503691|P6|Overall Study|Randomized but not treated|1
1584508|NCT02548585|5503692|P5|Overall Study|Randomized but not treated|0
1584509|NCT02548585|5503693|P4|Overall Study|Randomized but not treated|0
1584510|NCT02548585|5503694|P3|Overall Study|Randomized but not treated|0
1584511|NCT02548585|5503695|P2|Overall Study|Randomized but not treated|0
1584512|NCT02548585|5503696|P1|Overall Study|Randomized but not treated|0
1584513|NCT02548585|5503690|P7|Overall Study|Other|1
1584514|NCT02548585|5503691|P6|Overall Study|Other|0
1584515|NCT02548585|5503692|P5|Overall Study|Other|3
1584516|NCT02548585|5503693|P4|Overall Study|Other|2
1584517|NCT02548585|5503694|P3|Overall Study|Other|0
1584518|NCT02548585|5503695|P2|Overall Study|Other|0
1584519|NCT02548585|5503696|P1|Overall Study|Other|1
1584520|NCT02548585|5503690|P7|Overall Study|Lost to Follow-up|0
1584521|NCT02548585|5503691|P6|Overall Study|Lost to Follow-up|0
1584522|NCT02548585|5503692|P5|Overall Study|Lost to Follow-up|0
1584523|NCT02548585|5503693|P4|Overall Study|Lost to Follow-up|0
1584524|NCT02548585|5503694|P3|Overall Study|Lost to Follow-up|0
1584525|NCT02548585|5503695|P2|Overall Study|Lost to Follow-up|0
1584526|NCT02548585|5503696|P1|Overall Study|Lost to Follow-up|1
1584527|NCT02548585|5503690|P7|Overall Study|Withdrawal by Subject|0
1584528|NCT02548585|5503691|P6|Overall Study|Withdrawal by Subject|1
1584529|NCT02548585|5503692|P5|Overall Study|Withdrawal by Subject|0
1584530|NCT02548585|5503693|P4|Overall Study|Withdrawal by Subject|0
1584531|NCT02548585|5503694|P3|Overall Study|Withdrawal by Subject|0
1584532|NCT02548585|5503695|P2|Overall Study|Withdrawal by Subject|0
1584533|NCT02548585|5503696|P1|Overall Study|Withdrawal by Subject|0
1584534|NCT02548455|5503914|P1|Overall Study|Visit not completed|173
1584535|NCT02548455|5503914|P1|Overall Study|Lost to Follow-up|14
1584536|NCT02548455|5503914|P1|Overall Study|Death|26
1584537|NCT02548455|5503914|P1|Overall Study|Withdrawal by Subject|27
1584538|NCT02548156|5503975|P6|Washout Period 1|Lost to Follow-up|0
1584539|NCT02548156|5503976|P5|Washout Period 1|Lost to Follow-up|1
1584540|NCT02548156|5503977|P4|Washout Period 1|Lost to Follow-up|0
1584541|NCT02548156|5503978|P3|Washout Period 1|Lost to Follow-up|0
1584542|NCT02548156|5503979|P2|Washout Period 1|Lost to Follow-up|0
1584543|NCT02548156|5503980|P1|Washout Period 1|Lost to Follow-up|0
1584544|NCT02548143|5503999|P2|Overall Study|Withdrawal by Subject|1
1584545|NCT02548143|5504000|P1|Overall Study|Withdrawal by Subject|0
1584546|NCT02548143|5503999|P2|Overall Study|Adverse Event|0
1584547|NCT02548143|5504000|P1|Overall Study|Adverse Event|1
1584548|NCT02548078|5504012|P2|Overall Study|Lost to Follow-up|3
1584549|NCT02548078|5504013|P1|Overall Study|Lost to Follow-up|1
1584550|NCT02548078|5504012|P2|Overall Study|Moved from study area|3
1584551|NCT02548078|5504013|P1|Overall Study|Moved from study area|3
1584552|NCT02548078|5504012|P2|Overall Study|Serious adverse event/Adverse event|0
1584553|NCT02548078|5504013|P1|Overall Study|Serious adverse event/Adverse event|1
1584554|NCT02547987|5504201|P1|Overall Study|Adverse Event|2
1584555|NCT02547987|5504201|P1|Overall Study|Withdrawal by Subject|1
1584556|NCT02547974|5504209|P4|Overall Study|Withdrawal by Subject|0
1584557|NCT02547974|5504210|P3|Overall Study|Withdrawal by Subject|0
1584558|NCT02547974|5504211|P2|Overall Study|Withdrawal by Subject|0
1584559|NCT02547974|5504212|P1|Overall Study|Withdrawal by Subject|1
1584560|NCT02547935|5504299|P3|Overall Study|Death|0
1584561|NCT02547935|5504300|P2|Overall Study|Death|1
1584562|NCT02547935|5504301|P1|Overall Study|Death|1
1584563|NCT02547935|5504299|P3|Overall Study|Lost to Follow-up|1
1584564|NCT02547935|5504300|P2|Overall Study|Lost to Follow-up|2
1584565|NCT02547935|5504301|P1|Overall Study|Lost to Follow-up|0
1584566|NCT02547935|5504299|P3|Overall Study|Physician Decision|0
1584567|NCT02547935|5504300|P2|Overall Study|Physician Decision|1
1584568|NCT02547935|5504301|P1|Overall Study|Physician Decision|0
1584569|NCT02547935|5504299|P3|Overall Study|Screen Failure|0
1584570|NCT02547935|5504300|P2|Overall Study|Screen Failure|0
1584571|NCT02547935|5504301|P1|Overall Study|Screen Failure|2
1584572|NCT02547935|5504299|P3|Overall Study|Withdrawal by Subject|4
1584573|NCT02547935|5504300|P2|Overall Study|Withdrawal by Subject|3
1584574|NCT02547935|5504301|P1|Overall Study|Withdrawal by Subject|2
1584575|NCT02547935|5504299|P3|Overall Study|Other|0
1584576|NCT02547935|5504300|P2|Overall Study|Other|1
1584577|NCT02547935|5504301|P1|Overall Study|Other|0
1584579|NCT02547649|5504359|P3|Overall Study|Withdrawal by Subject|2
1584580|NCT02547649|5504360|P2|Overall Study|Withdrawal by Subject|4
1584581|NCT02547649|5504361|P1|Overall Study|Withdrawal by Subject|0
1584582|NCT02547649|5504359|P3|Overall Study|Not vaccinated|1
1584583|NCT02547649|5504360|P2|Overall Study|Not vaccinated|0
1584584|NCT02547649|5504361|P1|Overall Study|Not vaccinated|0
1584585|NCT02547649|5504359|P3|Overall Study|Lost to Follow-up|1
1584586|NCT02547649|5504360|P2|Overall Study|Lost to Follow-up|1
1584587|NCT02547649|5504361|P1|Overall Study|Lost to Follow-up|3
1584588|NCT02547454|5504426|P1|Overall Study|No data|11
1584589|NCT02547454|5504426|P1|Overall Study|Other|39
1584590|NCT02547454|5504426|P1|Overall Study|Lost to Follow-up|26
1584591|NCT02547454|5504426|P1|Overall Study|Death|38
1584592|NCT02547454|5504426|P1|Overall Study|Due to no further need to treat|4
1584593|NCT02547454|5504426|P1|Overall Study|Due to transplantation|1
1584594|NCT02547454|5504426|P1|Overall Study|Due to hemodialysis|53
1584595|NCT02547363|5504456|P2|12-month Follow-up|Other|0
1584596|NCT02547363|5504457|P1|12-month Follow-up|Other|1
1584597|NCT02547363|5504456|P2|12-month Follow-up|Lack of Efficacy|1
1584598|NCT02547363|5504457|P1|12-month Follow-up|Lack of Efficacy|1
1584599|NCT02547363|5504456|P2|12-month Follow-up|Lost to Follow-up|1
1584600|NCT02547363|5504457|P1|12-month Follow-up|Lost to Follow-up|4
1584601|NCT02547363|5504456|P2|12-month Follow-up|Withdrawal by Subject|3
1584602|NCT02547363|5504457|P1|12-month Follow-up|Withdrawal by Subject|4
1584603|NCT02547363|5504456|P2|3-day Treatment and 8-week Follow-up|Other|1
1584604|NCT02547363|5504457|P1|3-day Treatment and 8-week Follow-up|Other|1
1584605|NCT02547363|5504456|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1584606|NCT02547363|5504457|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1584607|NCT02547363|5504456|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
1584608|NCT02547363|5504457|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
1584609|NCT02547363|5504456|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
1584610|NCT02547363|5504457|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
1584611|NCT02547233|5504473|P2|12-month Follow-up|Other|1
1584612|NCT02547233|5504474|P1|12-month Follow-up|Other|0
1584613|NCT02547233|5504473|P2|12-month Follow-up|Protocol Violation|1
1584614|NCT02547233|5504474|P1|12-month Follow-up|Protocol Violation|0
1584615|NCT02547233|5504473|P2|12-month Follow-up|Lack of Efficacy|2
1584616|NCT02547233|5504474|P1|12-month Follow-up|Lack of Efficacy|1
1584617|NCT02547233|5504473|P2|12-month Follow-up|Lost to Follow-up|3
1584618|NCT02547233|5504474|P1|12-month Follow-up|Lost to Follow-up|3
1584619|NCT02547233|5504473|P2|12-month Follow-up|Withdrawal by Subject|10
1584620|NCT02547233|5504474|P1|12-month Follow-up|Withdrawal by Subject|10
1584621|NCT02547233|5504473|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
1584622|NCT02547233|5504474|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
1584623|NCT02547233|5504473|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
1584624|NCT02547233|5504474|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
1584625|NCT02547233|5504473|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
1584626|NCT02547233|5504474|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
1584627|NCT02547233|5504473|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
1584628|NCT02547233|5504474|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
1584629|NCT02547129|5504490|P2|Overall Study|Difficulty with ongoing infection|0
1584630|NCT02547129|5504491|P1|Overall Study|Difficulty with ongoing infection|1
1584631|NCT02547038|5504534|P2|Overall Study|Lost to Follow-up|2
1584632|NCT02547038|5504535|P1|Overall Study|Lost to Follow-up|3
1584633|NCT02546986|5504552|P2|Survival Follow-Up Phase|Lost to Follow-up|2
1584634|NCT02546986|5504553|P1|Survival Follow-Up Phase|Lost to Follow-up|2
1584635|NCT02546986|5504552|P2|Survival Follow-Up Phase|Alive|16
1584636|NCT02546986|5504553|P1|Survival Follow-Up Phase|Alive|13
1584637|NCT02546986|5504552|P2|Survival Follow-Up Phase|Death|12
1584638|NCT02546986|5504553|P1|Survival Follow-Up Phase|Death|18
1584639|NCT02546986|5504552|P2|Survival Follow-Up Phase|Missing Status|5
1584640|NCT02546986|5504553|P1|Survival Follow-Up Phase|Missing Status|3
1584641|NCT02546986|5504552|P2|Treatment Period|Miscellaneous|9
1584642|NCT02546986|5504553|P1|Treatment Period|Miscellaneous|7
1584643|NCT02546986|5504552|P2|Treatment Period|Study Terminated by Sponsor|1
1584644|NCT02546986|5504553|P1|Treatment Period|Study Terminated by Sponsor|0
1584645|NCT02546986|5504552|P2|Treatment Period|Non-compliance with Study Drug|1
1584646|NCT02546986|5504553|P1|Treatment Period|Non-compliance with Study Drug|0
1584647|NCT02546986|5504552|P2|Treatment Period|Withdrawal by Subject|1
1584648|NCT02546986|5504553|P1|Treatment Period|Withdrawal by Subject|1
1584649|NCT02546986|5504552|P2|Treatment Period|Protocol Violation|0
1584650|NCT02546986|5504553|P1|Treatment Period|Protocol Violation|1
1584651|NCT02546986|5504552|P2|Treatment Period|Physician Decision|2
1584652|NCT02546986|5504553|P1|Treatment Period|Physician Decision|1
1584653|NCT02546986|5504552|P2|Treatment Period|Death|4
1584654|NCT02546986|5504553|P1|Treatment Period|Death|3
1584655|NCT02546986|5504552|P2|Treatment Period|Symptomatic Deterioration|3
1584656|NCT02546986|5504553|P1|Treatment Period|Symptomatic Deterioration|4
1584657|NCT02546986|5504552|P2|Treatment Period|Adverse Event|6
1584658|NCT02546986|5504553|P1|Treatment Period|Adverse Event|14
1584659|NCT02546986|5504552|P2|Treatment Period|Progressive Disease|22
1584660|NCT02546986|5504553|P1|Treatment Period|Progressive Disease|20
1584661|NCT02546765|5504580|P4|Overall Study|Withdrawal by Subject|0
1584662|NCT02546765|5504581|P3|Overall Study|Withdrawal by Subject|0
1584663|NCT02546765|5504582|P2|Overall Study|Withdrawal by Subject|1
1584664|NCT02546765|5504583|P1|Overall Study|Withdrawal by Subject|0
1584665|NCT02546609|5504624|P3|Overall Study|travel or work schedule restriction|2
1584666|NCT02546609|5504625|P2|Overall Study|travel or work schedule restriction|0
1584667|NCT02546609|5504626|P1|Overall Study|travel or work schedule restriction|0
1584668|NCT02546609|5504624|P3|Overall Study|Lost to Follow-up|1
1584669|NCT02546609|5504625|P2|Overall Study|Lost to Follow-up|3
1584670|NCT02546609|5504626|P1|Overall Study|Lost to Follow-up|2
1584671|NCT02546609|5504624|P3|Overall Study|Protocol Violation|1
1584672|NCT02546609|5504625|P2|Overall Study|Protocol Violation|1
1584673|NCT02546609|5504626|P1|Overall Study|Protocol Violation|0
1584674|NCT02546609|5504624|P3|Overall Study|Adverse Event|1
1584675|NCT02546609|5504625|P2|Overall Study|Adverse Event|6
1584676|NCT02546609|5504626|P1|Overall Study|Adverse Event|0
1584677|NCT02546609|5504624|P3|Overall Study|Withdrawal by Subject|2
1584678|NCT02546609|5504625|P2|Overall Study|Withdrawal by Subject|1
1584679|NCT02546609|5504626|P1|Overall Study|Withdrawal by Subject|0
1584680|NCT02546544|5504667|P1|Overall Study|Withdrawal by Subject|1
1584681|NCT02546544|5504667|P1|Overall Study|Adverse Event|1
1584682|NCT02546544|5504667|P1|Overall Study|Disease Progression|14
1584683|NCT02546362|5504698|P1|12-week Treatment Period|Change in medication|1
1584684|NCT02546362|5504698|P1|12-week Treatment Period|Lost to Follow-up|2
1584685|NCT02546362|5504698|P1|12-week Treatment Period|Withdrawal by Subject|6
1584686|NCT02546362|5504698|P1|4-week Treatment Period|Change in medication|2
1584687|NCT02546362|5504698|P1|4-week Treatment Period|Lost to Follow-up|1
1584688|NCT02546323|5504719|P2|Overall Study|Met Withdrawal Criteria|14
1584689|NCT02546323|5504720|P1|Overall Study|Met Withdrawal Criteria|2
1584690|NCT02546323|5504719|P2|Overall Study|Non-compliance with Study Drug|2
1584691|NCT02546323|5504720|P1|Overall Study|Non-compliance with Study Drug|2
1584692|NCT02546323|5504719|P2|Overall Study|Lost to Follow-up|3
1584693|NCT02546323|5504720|P1|Overall Study|Lost to Follow-up|2
1584694|NCT02546323|5504719|P2|Overall Study|Patient Specific Reasons|2
1584695|NCT02546323|5504720|P1|Overall Study|Patient Specific Reasons|1
1584696|NCT02546323|5504719|P2|Overall Study|Adverse Event|11
1584697|NCT02546323|5504720|P1|Overall Study|Adverse Event|17
1584698|NCT02546323|5504719|P2|Overall Study|Eligibility Criteria not Fulfilled|1
1584699|NCT02546323|5504720|P1|Overall Study|Eligibility Criteria not Fulfilled|0
1584700|NCT02546323|5504719|P2|Overall Study|Withdrawal by Subject|33
1584701|NCT02546323|5504720|P1|Overall Study|Withdrawal by Subject|36
1584702|NCT02546193|5504740|P4|Overall Study|Not eligible at time of induction|0
1584703|NCT02546193|5504741|P3|Overall Study|Not eligible at time of induction|1
1584704|NCT02546193|5504742|P2|Overall Study|Not eligible at time of induction|6
1584705|NCT02546193|5504743|P1|Overall Study|Not eligible at time of induction|4
1584706|NCT02546193|5504740|P4|Overall Study|Withdrawal by Subject|0
1584707|NCT02546193|5504741|P3|Overall Study|Withdrawal by Subject|1
1584708|NCT02546193|5504742|P2|Overall Study|Withdrawal by Subject|0
1584709|NCT02546193|5504743|P1|Overall Study|Withdrawal by Subject|2
1584710|NCT02545868|5504780|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
1584711|NCT02545868|5504781|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
1584712|NCT02545868|5504782|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
1584713|NCT02545543|5504865|P2|Overall Study|Enrolment of subject at >1 study site|1
1584714|NCT02545543|5504866|P1|Overall Study|Enrolment of subject at >1 study site|1
1584715|NCT02545543|5504865|P2|Overall Study|Noncomplaince|0
1584716|NCT02545543|5504866|P1|Overall Study|Noncomplaince|1
1584717|NCT02545543|5504865|P2|Overall Study|Withdrawal by Subject|8
1584718|NCT02545543|5504866|P1|Overall Study|Withdrawal by Subject|9
1584719|NCT02545543|5504865|P2|Overall Study|Physician Decision|0
1584720|NCT02545543|5504866|P1|Overall Study|Physician Decision|3
1584721|NCT02545543|5504865|P2|Overall Study|Lost to Follow-up|25
1584722|NCT02545543|5504866|P1|Overall Study|Lost to Follow-up|67
1584723|NCT02545322|5504890|P1|Overall Study|Withdrawal by Subject|3
1584724|NCT02545270|5504898|P3|Overall Study|Videos being too similar to other|2
1584725|NCT02545270|5504899|P2|Overall Study|Videos being too similar to other|0
1584726|NCT02545270|5504900|P1|Overall Study|Videos being too similar to other|0
1584727|NCT02545270|5504898|P3|Overall Study|technical difficulties|0
1584728|NCT02545270|5504899|P2|Overall Study|technical difficulties|1
1584729|NCT02545270|5504900|P1|Overall Study|technical difficulties|0
1584730|NCT02544633|5504944|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
1584731|NCT02544633|5504945|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
1584732|NCT02544633|5504946|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
1584733|NCT02544633|5504947|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
1584734|NCT02544633|5504944|P4|Survival Follow-up Period|Withdrawal by Subject|0
1584735|NCT02544633|5504945|P3|Survival Follow-up Period|Withdrawal by Subject|1
1584736|NCT02544633|5504946|P2|Survival Follow-up Period|Withdrawal by Subject|0
1584737|NCT02544633|5504947|P1|Survival Follow-up Period|Withdrawal by Subject|4
1584738|NCT02544633|5504944|P4|Survival Follow-up Period|Lost to Follow-up|0
1584739|NCT02544633|5504945|P3|Survival Follow-up Period|Lost to Follow-up|1
1584740|NCT02544633|5504946|P2|Survival Follow-up Period|Lost to Follow-up|1
1584741|NCT02544633|5504947|P1|Survival Follow-up Period|Lost to Follow-up|0
1584742|NCT02544633|5504944|P4|Survival Follow-up Period|Death|9
1584743|NCT02544633|5504945|P3|Survival Follow-up Period|Death|3
1584744|NCT02544633|5504946|P2|Survival Follow-up Period|Death|14
1584745|NCT02544633|5504947|P1|Survival Follow-up Period|Death|12
1584746|NCT02544633|5504944|P4|Treatment Period|Clinical Disease Progression|1
1584747|NCT02544633|5504945|P3|Treatment Period|Clinical Disease Progression|0
1584748|NCT02544633|5504946|P2|Treatment Period|Clinical Disease Progression|0
1584749|NCT02544633|5504947|P1|Treatment Period|Clinical Disease Progression|0
1584750|NCT02544633|5504944|P4|Treatment Period|Non-compliance|0
1584751|NCT02544633|5504945|P3|Treatment Period|Non-compliance|1
1584752|NCT02544633|5504946|P2|Treatment Period|Non-compliance|0
1584753|NCT02544633|5504947|P1|Treatment Period|Non-compliance|0
1584754|NCT02544633|5504944|P4|Treatment Period|Death|0
1584755|NCT02544633|5504945|P3|Treatment Period|Death|1
1584756|NCT02544633|5504946|P2|Treatment Period|Death|0
1584757|NCT02544633|5504947|P1|Treatment Period|Death|0
1584758|NCT02544633|5504944|P4|Treatment Period|Lost to Follow-up|0
1584759|NCT02544633|5504945|P3|Treatment Period|Lost to Follow-up|0
1584760|NCT02544633|5504946|P2|Treatment Period|Lost to Follow-up|1
1584761|NCT02544633|5504947|P1|Treatment Period|Lost to Follow-up|0
1584762|NCT02544633|5504944|P4|Treatment Period|Withdrawal by Subject|0
1584763|NCT02544633|5504945|P3|Treatment Period|Withdrawal by Subject|0
1584764|NCT02544633|5504946|P2|Treatment Period|Withdrawal by Subject|0
1584765|NCT02544633|5504947|P1|Treatment Period|Withdrawal by Subject|1
1584766|NCT02544633|5504944|P4|Treatment Period|Global Deterioration of Health|1
1584767|NCT02544633|5504945|P3|Treatment Period|Global Deterioration of Health|0
1584768|NCT02544633|5504946|P2|Treatment Period|Global Deterioration of Health|3
1584769|NCT02544633|5504947|P1|Treatment Period|Global Deterioration of Health|3
1584770|NCT02544633|5504944|P4|Treatment Period|Lack of Efficacy|5
1584771|NCT02544633|5504945|P3|Treatment Period|Lack of Efficacy|5
1584772|NCT02544633|5504946|P2|Treatment Period|Lack of Efficacy|11
1584773|NCT02544633|5504947|P1|Treatment Period|Lack of Efficacy|17
1584774|NCT02544633|5504944|P4|Treatment Period|Adverse Event|5
1584775|NCT02544633|5504945|P3|Treatment Period|Adverse Event|0
1584776|NCT02544633|5504946|P2|Treatment Period|Adverse Event|4
1584777|NCT02544633|5504947|P1|Treatment Period|Adverse Event|7
1584778|NCT02544633|5504944|P4|Treatment Period|Patient Still on Treatment/Study|0
1584779|NCT02544633|5504945|P3|Treatment Period|Patient Still on Treatment/Study|1
1584780|NCT02544633|5504946|P2|Treatment Period|Patient Still on Treatment/Study|1
1584781|NCT02544633|5504947|P1|Treatment Period|Patient Still on Treatment/Study|0
1584782|NCT02544451|5504989|P3|Overall Study|Other|0
1584783|NCT02544451|5504990|P2|Overall Study|Other|4
1584784|NCT02544451|5504991|P1|Overall Study|Other|4
1584785|NCT02544451|5504989|P3|Overall Study|Physician Decision|0
1584786|NCT02544451|5504990|P2|Overall Study|Physician Decision|0
1584787|NCT02544451|5504991|P1|Overall Study|Physician Decision|4
1584788|NCT02544451|5504989|P3|Overall Study|Lost to Follow-up|0
1584789|NCT02544451|5504990|P2|Overall Study|Lost to Follow-up|0
1584790|NCT02544451|5504991|P1|Overall Study|Lost to Follow-up|2
1584791|NCT02544451|5504989|P3|Overall Study|Withdrawal of consent (not due to AE)|1
1584792|NCT02544451|5504990|P2|Overall Study|Withdrawal of consent (not due to AE)|2
1584793|NCT02544451|5504991|P1|Overall Study|Withdrawal of consent (not due to AE)|3
1584794|NCT02544451|5504989|P3|Overall Study|Adverse Event|0
1584795|NCT02544451|5504990|P2|Overall Study|Adverse Event|6
1584796|NCT02544451|5504991|P1|Overall Study|Adverse Event|1
1584797|NCT02544152|5505036|P2|Overall Study|Other|0
1584798|NCT02544152|5505037|P1|Overall Study|Other|1
1584799|NCT02544152|5505036|P2|Overall Study|Withdrawal by Subject|3
1584800|NCT02544152|5505037|P1|Overall Study|Withdrawal by Subject|0
1584801|NCT02544152|5505036|P2|Overall Study|Adverse Event|4
1584802|NCT02544152|5505037|P1|Overall Study|Adverse Event|0
1584803|NCT02544074|5505080|P21|Overall Study|Tablet error|0
1584804|NCT02544074|5505081|P20|Overall Study|Tablet error|0
1584805|NCT02544074|5505082|P19|Overall Study|Tablet error|0
1584806|NCT02544074|5505083|P18|Overall Study|Tablet error|0
1584807|NCT02544074|5505084|P17|Overall Study|Tablet error|0
1584808|NCT02544074|5505085|P16|Overall Study|Tablet error|0
1584809|NCT02544074|5505086|P15|Overall Study|Tablet error|0
1584810|NCT02544074|5505087|P14|Overall Study|Tablet error|0
1584811|NCT02544074|5505088|P13|Overall Study|Tablet error|0
1584812|NCT02544074|5505089|P12|Overall Study|Tablet error|0
1584813|NCT02544074|5505090|P11|Overall Study|Tablet error|0
1584814|NCT02544074|5505091|P10|Overall Study|Tablet error|1
1584815|NCT02544074|5505092|P9|Overall Study|Tablet error|0
1584816|NCT02544074|5505093|P8|Overall Study|Tablet error|0
1584817|NCT02544074|5505094|P7|Overall Study|Tablet error|0
1584818|NCT02544074|5505095|P6|Overall Study|Tablet error|1
1584819|NCT02544074|5505096|P5|Overall Study|Tablet error|0
1584820|NCT02544074|5505097|P4|Overall Study|Tablet error|0
1584821|NCT02544074|5505098|P3|Overall Study|Tablet error|0
1584822|NCT02544074|5505099|P2|Overall Study|Tablet error|0
1584823|NCT02544074|5505100|P1|Overall Study|Tablet error|0
1584824|NCT02544074|5505080|P21|Overall Study|Withdrawal by Subject|0
1584825|NCT02544074|5505081|P20|Overall Study|Withdrawal by Subject|0
1584826|NCT02544074|5505082|P19|Overall Study|Withdrawal by Subject|0
1584827|NCT02544074|5505083|P18|Overall Study|Withdrawal by Subject|0
1584828|NCT02544074|5505084|P17|Overall Study|Withdrawal by Subject|0
1584829|NCT02544074|5505085|P16|Overall Study|Withdrawal by Subject|0
1584830|NCT02544074|5505086|P15|Overall Study|Withdrawal by Subject|0
1584831|NCT02544074|5505087|P14|Overall Study|Withdrawal by Subject|0
1584832|NCT02544074|5505088|P13|Overall Study|Withdrawal by Subject|0
1584833|NCT02544074|5505089|P12|Overall Study|Withdrawal by Subject|0
1584834|NCT02544074|5505090|P11|Overall Study|Withdrawal by Subject|0
1584835|NCT02544074|5505091|P10|Overall Study|Withdrawal by Subject|0
1584836|NCT02544074|5505092|P9|Overall Study|Withdrawal by Subject|0
1584837|NCT02544074|5505093|P8|Overall Study|Withdrawal by Subject|0
1584838|NCT02544074|5505094|P7|Overall Study|Withdrawal by Subject|0
1584839|NCT02544074|5505095|P6|Overall Study|Withdrawal by Subject|0
1584840|NCT02544074|5505096|P5|Overall Study|Withdrawal by Subject|0
1584841|NCT02544074|5505097|P4|Overall Study|Withdrawal by Subject|0
1584842|NCT02544074|5505098|P3|Overall Study|Withdrawal by Subject|0
1584843|NCT02544074|5505099|P2|Overall Study|Withdrawal by Subject|1
1584844|NCT02544074|5505100|P1|Overall Study|Withdrawal by Subject|0
1584845|NCT02543918|5505136|P2|Overall Study|Adverse Event|1
1584846|NCT02543918|5505137|P1|Overall Study|Adverse Event|1
1584847|NCT02543918|5505136|P2|Overall Study|Withdrawal by Subject|1
1584848|NCT02543918|5505137|P1|Overall Study|Withdrawal by Subject|1
1584849|NCT02543918|5505136|P2|Overall Study|Lost to Follow-up|1
1584850|NCT02543918|5505137|P1|Overall Study|Lost to Follow-up|1
1584851|NCT02543918|5505136|P2|Overall Study|Never treated|1
1584852|NCT02543918|5505137|P1|Overall Study|Never treated|0
1584853|NCT02543892|5505151|P8|Had Immunology Data|Withdrawal by Subject|0
1584854|NCT02543892|5505152|P7|Had Immunology Data|Withdrawal by Subject|1
1584855|NCT02543892|5505153|P6|Had Immunology Data|Withdrawal by Subject|0
1584856|NCT02543892|5505154|P5|Had Immunology Data|Withdrawal by Subject|0
1584857|NCT02543892|5505155|P4|Had Immunology Data|Withdrawal by Subject|0
1584858|NCT02543892|5505156|P3|Had Immunology Data|Withdrawal by Subject|0
1584859|NCT02543892|5505157|P2|Had Immunology Data|Withdrawal by Subject|0
1584860|NCT02543892|5505158|P1|Had Immunology Data|Withdrawal by Subject|0
1584861|NCT02543892|5505151|P8|Received Vaccination 2|Adverse Event|0
1584862|NCT02543892|5505152|P7|Received Vaccination 2|Adverse Event|0
1584863|NCT02543892|5505153|P6|Received Vaccination 2|Adverse Event|0
1584864|NCT02543892|5505154|P5|Received Vaccination 2|Adverse Event|0
1584865|NCT02543892|5505155|P4|Received Vaccination 2|Adverse Event|0
1584866|NCT02543892|5505156|P3|Received Vaccination 2|Adverse Event|0
1584867|NCT02543892|5505157|P2|Received Vaccination 2|Adverse Event|1
1584868|NCT02543892|5505158|P1|Received Vaccination 2|Adverse Event|0
1584869|NCT02543892|5505151|P8|Received Vaccination 2|Physician Decision|0
1584870|NCT02543892|5505152|P7|Received Vaccination 2|Physician Decision|0
1584871|NCT02543892|5505153|P6|Received Vaccination 2|Physician Decision|1
1584872|NCT02543892|5505154|P5|Received Vaccination 2|Physician Decision|0
1584873|NCT02543892|5505155|P4|Received Vaccination 2|Physician Decision|0
1584874|NCT02543892|5505156|P3|Received Vaccination 2|Physician Decision|0
1584875|NCT02543892|5505157|P2|Received Vaccination 2|Physician Decision|0
1584876|NCT02543892|5505158|P1|Received Vaccination 2|Physician Decision|0
1584877|NCT02543892|5505151|P8|Received Vaccination 2|Withdrawal by Subject|1
1584878|NCT02543892|5505152|P7|Received Vaccination 2|Withdrawal by Subject|0
1584879|NCT02543892|5505153|P6|Received Vaccination 2|Withdrawal by Subject|0
1584880|NCT02543892|5505154|P5|Received Vaccination 2|Withdrawal by Subject|0
1584881|NCT02543892|5505155|P4|Received Vaccination 2|Withdrawal by Subject|0
1584882|NCT02543892|5505156|P3|Received Vaccination 2|Withdrawal by Subject|0
1584883|NCT02543892|5505157|P2|Received Vaccination 2|Withdrawal by Subject|0
1584884|NCT02543892|5505158|P1|Received Vaccination 2|Withdrawal by Subject|1
1584885|NCT02543801|5505208|P4|Overall Study|Protocol Violation|0
1584886|NCT02543801|5505209|P3|Overall Study|Protocol Violation|0
1584887|NCT02543801|5505210|P2|Overall Study|Protocol Violation|2
1584888|NCT02543801|5505211|P1|Overall Study|Protocol Violation|1
1584889|NCT02543528|5505240|P5|Extended Wear Period|Withdrawal by Subject|0
1584890|NCT02543528|5505241|P4|Extended Wear Period|Withdrawal by Subject|5
1584891|NCT02543528|5505242|P3|Extended Wear Period|Withdrawal by Subject|4
1584892|NCT02543528|5505243|P2|Extended Wear Period|Withdrawal by Subject|9
1584893|NCT02543528|5505244|P1|Extended Wear Period|Withdrawal by Subject|10
1584894|NCT02543528|5505240|P5|Extended Wear Period|Lost to Follow-up|0
1584895|NCT02543528|5505241|P4|Extended Wear Period|Lost to Follow-up|1
1584896|NCT02543528|5505242|P3|Extended Wear Period|Lost to Follow-up|2
1584897|NCT02543528|5505243|P2|Extended Wear Period|Lost to Follow-up|1
1584898|NCT02543528|5505244|P1|Extended Wear Period|Lost to Follow-up|0
1584899|NCT02543528|5505240|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
1584900|NCT02543528|5505241|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
1584901|NCT02543528|5505242|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
1584902|NCT02543528|5505243|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
1584903|NCT02543528|5505244|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
1584904|NCT02543528|5505240|P5|Extended Wear Period|Missed too many scheduled visits|0
1584905|NCT02543528|5505241|P4|Extended Wear Period|Missed too many scheduled visits|3
1584906|NCT02543528|5505242|P3|Extended Wear Period|Missed too many scheduled visits|1
1584907|NCT02543528|5505243|P2|Extended Wear Period|Missed too many scheduled visits|0
1584908|NCT02543528|5505244|P1|Extended Wear Period|Missed too many scheduled visits|0
1584909|NCT02543528|5505240|P5|Extended Wear Period|Adverse Event|0
1584910|NCT02543528|5505241|P4|Extended Wear Period|Adverse Event|3
1584911|NCT02543528|5505242|P3|Extended Wear Period|Adverse Event|16
1584912|NCT02543528|5505243|P2|Extended Wear Period|Adverse Event|11
1584913|NCT02543528|5505244|P1|Extended Wear Period|Adverse Event|17
1584914|NCT02543528|5505240|P5|Adaptation Period|Adverse Event|2
1584915|NCT02543528|5505241|P4|Adaptation Period|Adverse Event|0
1584916|NCT02543528|5505242|P3|Adaptation Period|Adverse Event|0
1584917|NCT02543528|5505243|P2|Adaptation Period|Adverse Event|0
1584918|NCT02543528|5505244|P1|Adaptation Period|Adverse Event|0
1584919|NCT02543528|5505240|P5|Adaptation Period|Lost to Follow-up|14
1584920|NCT02543528|5505241|P4|Adaptation Period|Lost to Follow-up|0
1584921|NCT02543528|5505242|P3|Adaptation Period|Lost to Follow-up|0
1584922|NCT02543528|5505243|P2|Adaptation Period|Lost to Follow-up|0
1584923|NCT02543528|5505244|P1|Adaptation Period|Lost to Follow-up|0
1584924|NCT02543528|5505240|P5|Adaptation Period|Lens Handling Difficultes|8
1584925|NCT02543528|5505241|P4|Adaptation Period|Lens Handling Difficultes|0
1584926|NCT02543528|5505242|P3|Adaptation Period|Lens Handling Difficultes|0
1584927|NCT02543528|5505243|P2|Adaptation Period|Lens Handling Difficultes|0
1584928|NCT02543528|5505244|P1|Adaptation Period|Lens Handling Difficultes|0
1584929|NCT02543528|5505240|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
1584930|NCT02543528|5505241|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
1584931|NCT02543528|5505242|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
1584932|NCT02543528|5505243|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
1584933|NCT02543528|5505244|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
1584934|NCT02543346|5505277|P4|Second Priming Visit|Adverse Event|0
1584935|NCT02543346|5505278|P3|Second Priming Visit|Adverse Event|0
1584936|NCT02543346|5505279|P2|Second Priming Visit|Adverse Event|0
1584937|NCT02543346|5505280|P1|Second Priming Visit|Adverse Event|1
1584938|NCT02543346|5505277|P4|Second Priming Visit|Withdrawal by Subject|2
1584939|NCT02543346|5505278|P3|Second Priming Visit|Withdrawal by Subject|2
1584940|NCT02543346|5505279|P2|Second Priming Visit|Withdrawal by Subject|2
1584941|NCT02543346|5505280|P1|Second Priming Visit|Withdrawal by Subject|0
1584942|NCT02543294|5505306|P1|Overall Study|Withdrawal by Subject|7
1584943|NCT02543294|5505306|P1|Overall Study|Physician Decision|2
1584944|NCT02543294|5505306|P1|Overall Study|Lost to Follow-up|3
1584945|NCT02542943|5505314|P3|Overall Study|Withdrawal by Subject|0
1584946|NCT02542943|5505315|P2|Overall Study|Withdrawal by Subject|1
1584947|NCT02542943|5505316|P1|Overall Study|Withdrawal by Subject|0
1584948|NCT02542943|5505314|P3|Overall Study|Lost to Follow-up|0
1584949|NCT02542943|5505315|P2|Overall Study|Lost to Follow-up|0
1584950|NCT02542943|5505316|P1|Overall Study|Lost to Follow-up|1
1584951|NCT02542865|5505343|P2|Overall Study|Withdrawal by Subject|0
1584952|NCT02542865|5505344|P1|Overall Study|Withdrawal by Subject|16
1584953|NCT02542865|5505343|P2|Overall Study|Identified as screen failure|0
1584954|NCT02542865|5505344|P1|Overall Study|Identified as screen failure|1
1584955|NCT02542631|5505407|P2|Overall Study|Used Prohibited Medication|1
1584956|NCT02542631|5505408|P1|Overall Study|Used Prohibited Medication|2
1584957|NCT02542631|5505407|P2|Overall Study|Other|1
1584958|NCT02542631|5505408|P1|Overall Study|Other|2
1584959|NCT02542631|5505407|P2|Overall Study|Death|2
1584960|NCT02542631|5505408|P1|Overall Study|Death|1
1584961|NCT02542631|5505407|P2|Overall Study|Lost to Follow-up|5
1584962|NCT02542631|5505408|P1|Overall Study|Lost to Follow-up|6
1584963|NCT02542631|5505407|P2|Overall Study|Physician Decision|4
1584964|NCT02542631|5505408|P1|Overall Study|Physician Decision|6
1584965|NCT02542631|5505407|P2|Overall Study|Protocol Violation|1
1584966|NCT02542631|5505408|P1|Overall Study|Protocol Violation|1
1584967|NCT02542631|5505407|P2|Overall Study|Withdrawal by Subject|16
1584968|NCT02542631|5505408|P1|Overall Study|Withdrawal by Subject|11
1584969|NCT02542631|5505407|P2|Overall Study|Sponsor Termination|0
1584970|NCT02542631|5505408|P1|Overall Study|Sponsor Termination|1
1584971|NCT02542631|5505407|P2|Overall Study|Adverse Event|1
1584972|NCT02542631|5505408|P1|Overall Study|Adverse Event|1
1584973|NCT02542605|5505430|P3|Part B: Randomization Phase|Withdrawal by Subject|1
1584974|NCT02542605|5505431|P2|Part B: Randomization Phase|Withdrawal by Subject|0
1584975|NCT02542605|5505432|P1|Part B: Randomization Phase|Withdrawal by Subject|0
1584976|NCT02542605|5505430|P3|Part B: Challenge Phase|Sponsor decision|0
1584977|NCT02542605|5505431|P2|Part B: Challenge Phase|Sponsor decision|0
1584978|NCT02542605|5505432|P1|Part B: Challenge Phase|Sponsor decision|1
1584979|NCT02542072|5505522|P2|Second Intervention (1 Month)|Lens discomfort|0
1584980|NCT02542072|5505523|P1|Second Intervention (1 Month)|Lens discomfort|1
1584981|NCT02542072|5505522|P2|Second Intervention (1 Month)|Lost to Follow-up|0
1584982|NCT02542072|5505523|P1|Second Intervention (1 Month)|Lost to Follow-up|1
1584983|NCT02542072|5505522|P2|First Intervention (1 Month)|Protocol Violation|0
1584984|NCT02542072|5505523|P1|First Intervention (1 Month)|Protocol Violation|1
1584985|NCT02542072|5505522|P2|First Intervention (1 Month)|Lens discomfort|2
1584986|NCT02542072|5505523|P1|First Intervention (1 Month)|Lens discomfort|1
1584987|NCT02542072|5505522|P2|First Intervention (1 Month)|Lost to Follow-up|0
1584988|NCT02542072|5505523|P1|First Intervention (1 Month)|Lost to Follow-up|2
1584989|NCT02542072|5505522|P2|First Intervention (1 Month)|Adverse Event|1
1584990|NCT02542072|5505523|P1|First Intervention (1 Month)|Adverse Event|1
1584991|NCT02541669|5505661|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
1584992|NCT02541669|5505662|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
1584993|NCT02541669|5505663|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
1584994|NCT02541669|5505664|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
1584995|NCT02541669|5505665|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
1585056|NCT02540850|5505838|P3|Overall Study|Lost to Follow-up|34
1585057|NCT02540850|5505839|P2|Overall Study|Lost to Follow-up|66
1585058|NCT02540850|5505840|P1|Overall Study|Lost to Follow-up|69
1585059|NCT02540668|5505881|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
1585060|NCT02540668|5505882|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
1585061|NCT02540538|5505902|P3|Overall Study|Pregnancy|0
1585062|NCT02540538|5505903|P2|Overall Study|Pregnancy|1
1585063|NCT02540538|5505904|P1|Overall Study|Pregnancy|0
1585064|NCT02540356|5505972|P2|Overall Study|Terminated due to disease progression|0
1585065|NCT02540356|5505973|P1|Overall Study|Terminated due to disease progression|1
1585086|NCT02540265|5506046|P3|Overall Study|Lost to Follow-up|1
1585087|NCT02540265|5506047|P2|Overall Study|Lost to Follow-up|0
1585088|NCT02540265|5506048|P1|Overall Study|Lost to Follow-up|0
1585089|NCT02540213|5506068|P1|Overall Study|Enrolled but not treated|2
1585090|NCT02540213|5506068|P1|Overall Study|Consent withdrawn|7
1585091|NCT02540213|5506068|P1|Overall Study|Lack of Efficacy|6
1585092|NCT02540213|5506068|P1|Overall Study|Kidney transplant|3
1585093|NCT02540213|5506068|P1|Overall Study|Administrative reasons|3
1585094|NCT02540213|5506068|P1|Overall Study|Death/adverse event|18
1585095|NCT02540083|5506089|P1|Overall Study|Withdrawal by Subject|16
1585096|NCT02539797|5506130|P3|Overall Study|Lost to Follow-up|0
1585097|NCT02539797|5506131|P2|Overall Study|Lost to Follow-up|1
1585098|NCT02539797|5506132|P1|Overall Study|Lost to Follow-up|0
1585099|NCT02539368|5506184|P5|Overall Study|Missing|0
1585100|NCT02539368|5506185|P4|Overall Study|Missing|0
1585101|NCT02539368|5506186|P3|Overall Study|Missing|0
1585102|NCT02539368|5506187|P2|Overall Study|Missing|3
1585103|NCT02539368|5506188|P1|Overall Study|Missing|10
1585104|NCT02539368|5506184|P5|Overall Study|Other|3
1585105|NCT02539368|5506185|P4|Overall Study|Other|1
1585106|NCT02539368|5506186|P3|Overall Study|Other|24
1585107|NCT02539368|5506187|P2|Overall Study|Other|18
1585108|NCT02539368|5506188|P1|Overall Study|Other|145
1585109|NCT02539368|5506184|P5|Overall Study|Participant Non-compliant|0
1585110|NCT02539368|5506185|P4|Overall Study|Participant Non-compliant|1
1585111|NCT02539368|5506186|P3|Overall Study|Participant Non-compliant|1
1585112|NCT02539368|5506187|P2|Overall Study|Participant Non-compliant|2
1585113|NCT02539368|5506188|P1|Overall Study|Participant Non-compliant|13
1585114|NCT02539368|5506184|P5|Overall Study|Adverse Event|3
1585115|NCT02539368|5506185|P4|Overall Study|Adverse Event|0
1585116|NCT02539368|5506186|P3|Overall Study|Adverse Event|9
1585117|NCT02539368|5506187|P2|Overall Study|Adverse Event|5
1585118|NCT02539368|5506188|P1|Overall Study|Adverse Event|44
1585119|NCT02539368|5506184|P5|Overall Study|Lost to Follow-up|3
1585120|NCT02539368|5506185|P4|Overall Study|Lost to Follow-up|4
1585121|NCT02539368|5506186|P3|Overall Study|Lost to Follow-up|16
1585122|NCT02539368|5506187|P2|Overall Study|Lost to Follow-up|21
1585123|NCT02539368|5506188|P1|Overall Study|Lost to Follow-up|96
1585124|NCT02539368|5506184|P5|Overall Study|Physician Decision|2
1585125|NCT02539368|5506185|P4|Overall Study|Physician Decision|0
1585126|NCT02539368|5506186|P3|Overall Study|Physician Decision|7
1585127|NCT02539368|5506187|P2|Overall Study|Physician Decision|15
1585128|NCT02539368|5506188|P1|Overall Study|Physician Decision|49
1585129|NCT02539368|5506184|P5|Overall Study|Withdrawal by Subject|3
1585130|NCT02539368|5506185|P4|Overall Study|Withdrawal by Subject|1
1585131|NCT02539368|5506186|P3|Overall Study|Withdrawal by Subject|9
1585132|NCT02539368|5506187|P2|Overall Study|Withdrawal by Subject|35
1585133|NCT02539368|5506188|P1|Overall Study|Withdrawal by Subject|44
1585134|NCT02539368|5506184|P5|Overall Study|Death|0
1585135|NCT02539368|5506185|P4|Overall Study|Death|0
1585136|NCT02539368|5506186|P3|Overall Study|Death|1
1585137|NCT02539368|5506187|P2|Overall Study|Death|2
1585138|NCT02539368|5506188|P1|Overall Study|Death|4
1585161|NCT02539134|5506349|P6|Overall Study|Lost to Follow-up|0
1585162|NCT02539134|5506350|P5|Overall Study|Lost to Follow-up|0
1585163|NCT02539134|5506351|P4|Overall Study|Lost to Follow-up|0
1585164|NCT02539134|5506352|P3|Overall Study|Lost to Follow-up|0
1585165|NCT02539134|5506353|P2|Overall Study|Lost to Follow-up|0
1585166|NCT02539134|5506354|P1|Overall Study|Lost to Follow-up|1
1585167|NCT02538965|5506423|P1|Follow-Up Period|Withdrawal by Parent|4
1585168|NCT02538965|5506423|P1|Follow-Up Period|Other = Death due to disease progression|13
1585169|NCT02538965|5506423|P1|Treatment Period|Physician Decision|2
1585170|NCT02538965|5506423|P1|Treatment Period|Disease Progression|1
1585171|NCT02538965|5506423|P1|Treatment Period|Treatment Failure|9
1585172|NCT02538965|5506423|P1|Treatment Period|Withdrawal by Parent/Guardian|2
1585173|NCT02538965|5506423|P1|Treatment Period|Adverse Event|2
1585174|NCT02538965|5506423|P1|Treatment Period|Other = Death due to disease progression|1
1585184|NCT02538471|5506501|P1|Overall Study|Progression of disease|2
1585185|NCT02538107|5506528|P1|Overall Study|Not recorded|7
1585186|NCT02538107|5506528|P1|Overall Study|Other|7
1585187|NCT02538107|5506528|P1|Overall Study|Surgery|1
1585188|NCT02538107|5506528|P1|Overall Study|Adverse Event|4
1585189|NCT02538107|5506528|P1|Overall Study|Administrative reason|5
1585190|NCT02538107|5506528|P1|Overall Study|Death|4
1585191|NCT02538107|5506528|P1|Overall Study|Withdrawal by Subject|17
1585192|NCT02538107|5506528|P1|Overall Study|No further treatment necessary|18
1585193|NCT02538107|5506528|P1|Overall Study|Administration of other ESA|11
1585194|NCT02538107|5506528|P1|Overall Study|Necessity of dialysis|20
1585195|NCT02538107|5506528|P1|Overall Study|Missing|5
1585196|NCT02538107|5506528|P1|Overall Study|Did not receive any Mircera dose|11
1585197|NCT02538029|5506570|P3|Overall Study|unable to complete cognitive assessments|1
1585198|NCT02538029|5506571|P2|Overall Study|unable to complete cognitive assessments|0
1585199|NCT02538029|5506572|P1|Overall Study|unable to complete cognitive assessments|1
1585200|NCT02537574|5506618|P3|Overall Study|Noncompliance with Protocol|1
1585201|NCT02537574|5506619|P2|Overall Study|Noncompliance with Protocol|0
1585202|NCT02537574|5506620|P1|Overall Study|Noncompliance with Protocol|0
1585203|NCT02537574|5506618|P3|Overall Study|Subject did not want last Vivitrol Injec|1
1585204|NCT02537574|5506619|P2|Overall Study|Subject did not want last Vivitrol Injec|0
1585205|NCT02537574|5506620|P1|Overall Study|Subject did not want last Vivitrol Injec|0
1585206|NCT02537574|5506618|P3|Overall Study|Transportation Issues|1
1585207|NCT02537574|5506619|P2|Overall Study|Transportation Issues|0
1585208|NCT02537574|5506620|P1|Overall Study|Transportation Issues|0
1585209|NCT02537574|5506618|P3|Overall Study|Failed Naloxone Challenge|0
1585210|NCT02537574|5506619|P2|Overall Study|Failed Naloxone Challenge|1
1585211|NCT02537574|5506620|P1|Overall Study|Failed Naloxone Challenge|0
1585212|NCT02537574|5506618|P3|Overall Study|Incarceration|0
1585213|NCT02537574|5506619|P2|Overall Study|Incarceration|1
1585214|NCT02537574|5506620|P1|Overall Study|Incarceration|0
1585215|NCT02537574|5506618|P3|Overall Study|Patient not Stable|0
1585216|NCT02537574|5506619|P2|Overall Study|Patient not Stable|1
1585217|NCT02537574|5506620|P1|Overall Study|Patient not Stable|0
1585218|NCT02537574|5506618|P3|Overall Study|Duplicate Patient|0
1585219|NCT02537574|5506619|P2|Overall Study|Duplicate Patient|0
1585220|NCT02537574|5506620|P1|Overall Study|Duplicate Patient|1
1585221|NCT02537574|5506618|P3|Overall Study|Lack of Efficacy|15
1585222|NCT02537574|5506619|P2|Overall Study|Lack of Efficacy|16
1585223|NCT02537574|5506620|P1|Overall Study|Lack of Efficacy|14
1585224|NCT02537574|5506618|P3|Overall Study|Withdrawal by Subject|29
1585225|NCT02537574|5506619|P2|Overall Study|Withdrawal by Subject|27
1585226|NCT02537574|5506620|P1|Overall Study|Withdrawal by Subject|37
1585227|NCT02537574|5506618|P3|Overall Study|Protocol Violation|3
1585228|NCT02537574|5506619|P2|Overall Study|Protocol Violation|2
1585229|NCT02537574|5506620|P1|Overall Study|Protocol Violation|4
1585230|NCT02537574|5506618|P3|Overall Study|Physician Decision|0
1585231|NCT02537574|5506619|P2|Overall Study|Physician Decision|0
1585232|NCT02537574|5506620|P1|Overall Study|Physician Decision|2
1585233|NCT02537574|5506618|P3|Overall Study|Noncompliance with study drug|1
1585234|NCT02537574|5506619|P2|Overall Study|Noncompliance with study drug|1
1585235|NCT02537574|5506620|P1|Overall Study|Noncompliance with study drug|0
1585236|NCT02537574|5506618|P3|Overall Study|Lost to Follow-up|55
1585237|NCT02537574|5506619|P2|Overall Study|Lost to Follow-up|51
1585238|NCT02537574|5506620|P1|Overall Study|Lost to Follow-up|40
1585239|NCT02537574|5506618|P3|Overall Study|Adverse Event|2
1585240|NCT02537574|5506619|P2|Overall Study|Adverse Event|3
1585241|NCT02537574|5506620|P1|Overall Study|Adverse Event|1
1585242|NCT02537522|5506646|P4|Phase II - Period 1 Bilateral|Adverse Event|1
1585243|NCT02537522|5506647|P3|Phase II - Period 1 Bilateral|Adverse Event|0
1585244|NCT02537522|5506648|P2|Phase II - Period 1 Bilateral|Adverse Event|0
1585245|NCT02537522|5506649|P1|Phase II - Period 1 Bilateral|Adverse Event|0
1585246|NCT02537522|5506646|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
1585247|NCT02537522|5506647|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
1585248|NCT02537522|5506648|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
1585249|NCT02537522|5506649|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
1585250|NCT02537522|5506646|P4|Phase I - Contralateral|incorrect randomization|0
1585251|NCT02537522|5506647|P3|Phase I - Contralateral|incorrect randomization|0
1585252|NCT02537522|5506648|P2|Phase I - Contralateral|incorrect randomization|1
1585253|NCT02537522|5506649|P1|Phase I - Contralateral|incorrect randomization|0
1585254|NCT02537522|5506646|P4|Phase I - Contralateral|Withdrawal by Subject|0
1585255|NCT02537522|5506647|P3|Phase I - Contralateral|Withdrawal by Subject|0
1585256|NCT02537522|5506648|P2|Phase I - Contralateral|Withdrawal by Subject|1
1585257|NCT02537522|5506649|P1|Phase I - Contralateral|Withdrawal by Subject|0
1585258|NCT02537522|5506646|P4|Phase I - Contralateral|Subject no longer eligible|0
1585259|NCT02537522|5506647|P3|Phase I - Contralateral|Subject no longer eligible|0
1585260|NCT02537522|5506648|P2|Phase I - Contralateral|Subject no longer eligible|7
1585261|NCT02537522|5506649|P1|Phase I - Contralateral|Subject no longer eligible|15
1585262|NCT02537431|5506666|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
1585263|NCT02537015|5506695|P1|Overall Study|Other Miscellaneous Reasons|1
1585264|NCT02537015|5506695|P1|Overall Study|Withdrawal by Subject|2
1585265|NCT02537015|5506695|P1|Overall Study|Adverse Event|3
1585266|NCT02536976|5506701|P2|Overall Study|Physician Decision|1
1585267|NCT02536976|5506702|P1|Overall Study|Physician Decision|0
1585268|NCT02536781|5506714|P2|Overall Study|Lost to Follow-up|0
1585269|NCT02536781|5506715|P1|Overall Study|Lost to Follow-up|2
1585270|NCT02536664|5506725|P2|Overall Study|Missing|20
1585271|NCT02536664|5506726|P1|Overall Study|Missing|53
1585272|NCT02536664|5506725|P2|Overall Study|Other|24
1585273|NCT02536664|5506726|P1|Overall Study|Other|18
1585274|NCT02536664|5506725|P2|Overall Study|Withdrawal by Subject|5
1585275|NCT02536664|5506726|P1|Overall Study|Withdrawal by Subject|8
1585276|NCT02536664|5506725|P2|Overall Study|Intolerability|6
1585277|NCT02536664|5506726|P1|Overall Study|Intolerability|8
1585278|NCT02536664|5506725|P2|Overall Study|Death due to other reason|2
1585279|NCT02536664|5506726|P1|Overall Study|Death due to other reason|3
1585280|NCT02536664|5506725|P2|Overall Study|Death due to lymphoma|1
1585281|NCT02536664|5506726|P1|Overall Study|Death due to lymphoma|2
1585282|NCT02536664|5506725|P2|Overall Study|Progression|18
1585283|NCT02536664|5506726|P1|Overall Study|Progression|13
1585284|NCT02536664|5506725|P2|Overall Study|Inadequate completion of documentation|4
1585285|NCT02536664|5506726|P1|Overall Study|Inadequate completion of documentation|2
1585286|NCT02536313|5506746|P2|Overall Study|Lack of Efficacy|1
1585287|NCT02536313|5506747|P1|Overall Study|Lack of Efficacy|0
1585288|NCT02535741|5506801|P1|Overall Study|Missing data|6
1585289|NCT02535741|5506801|P1|Overall Study|Exclusion criteria: Bilateral implant|4
1585290|NCT02535741|5506801|P1|Overall Study|Lost to Follow-up|10
1585291|NCT02535741|5506801|P1|Overall Study|Withdrawal by Subject|9
1585292|NCT02535741|5506801|P1|Overall Study|Adverse Event|3
1585293|NCT02535715|5506809|P3|Overall Study|Withdrawal by Subject|1
1585294|NCT02535715|5506810|P2|Overall Study|Withdrawal by Subject|0
1585295|NCT02535715|5506811|P1|Overall Study|Withdrawal by Subject|0
1585296|NCT02535416|5506840|P9|Overall Study|Family bereavement overseas|0
1585297|NCT02535416|5506841|P8|Overall Study|Family bereavement overseas|0
1585298|NCT02535416|5506842|P7|Overall Study|Family bereavement overseas|0
1585299|NCT02535416|5506843|P6|Overall Study|Family bereavement overseas|0
1585300|NCT02535416|5506844|P5|Overall Study|Family bereavement overseas|0
1585301|NCT02535416|5506845|P4|Overall Study|Family bereavement overseas|0
1585302|NCT02535416|5506846|P3|Overall Study|Family bereavement overseas|0
1585303|NCT02535416|5506847|P2|Overall Study|Family bereavement overseas|0
1585304|NCT02535416|5506848|P1|Overall Study|Family bereavement overseas|1
1585305|NCT02535364|5506900|P1|12-Month Follow-up Period|Subject transferred to hospice|1
1585306|NCT02535364|5506900|P1|12-Month Follow-up Period|Subject received alternative therapy|2
1585307|NCT02535364|5506900|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
1585308|NCT02535364|5506900|P1|12-Month Follow-up Period|Death|5
1585309|NCT02535364|5506900|P1|12-Month Follow-up Period|Disease progression|22
1585310|NCT02535364|5506900|P1|Study Treatment|Study placed on clinical hold by FDA|1
1585311|NCT02535364|5506900|P1|Study Treatment|Death|1
1585312|NCT02535364|5506900|P1|Part B Screening|Change in diagnosis, no longer eligible|2
1585313|NCT02535364|5506900|P1|Part B Screening|Adverse Event|1
1585314|NCT02535364|5506900|P1|Part B Screening|Withdrawal by Subject|1
1585315|NCT02535364|5506900|P1|Part B Screening|Physician Decision|1
1585316|NCT02535364|5506900|P1|Part B Screening|Death|2
1585317|NCT02535364|5506900|P1|Part B Screening|Unable to manufacture JCAR015|3
1585318|NCT02535364|5506900|P1|Part B Screening|Study placed on clinical hold by FDA|7
1585319|NCT02535364|5506900|P1|Part A Screening Through Leukapheresis|Disease progression|1
1585320|NCT02535364|5506900|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
1585321|NCT02535364|5506900|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
1585322|NCT02534935|5506985|P3|Overall Study|Lost to Follow-up|1
1585323|NCT02534935|5506986|P2|Overall Study|Lost to Follow-up|1
1585324|NCT02534935|5506987|P1|Overall Study|Lost to Follow-up|0
1585325|NCT02534935|5506985|P3|Overall Study|Adverse Event|0
1585326|NCT02534935|5506986|P2|Overall Study|Adverse Event|2
1585327|NCT02534935|5506987|P1|Overall Study|Adverse Event|0
1585328|NCT02534935|5506985|P3|Overall Study|No longer meets the eligibility criteria|0
1585329|NCT02534935|5506986|P2|Overall Study|No longer meets the eligibility criteria|3
1585330|NCT02534935|5506987|P1|Overall Study|No longer meets the eligibility criteria|0
1585331|NCT02534935|5506985|P3|Overall Study|Withdrawal by Subject|3
1585332|NCT02534935|5506986|P2|Overall Study|Withdrawal by Subject|3
1585333|NCT02534935|5506987|P1|Overall Study|Withdrawal by Subject|0
1585334|NCT02534935|5506985|P3|Overall Study|No longer willing to participate|1
1585335|NCT02534935|5506986|P2|Overall Study|No longer willing to participate|1
1585336|NCT02534935|5506987|P1|Overall Study|No longer willing to participate|0
1585337|NCT02534896|5507148|P3|Overall Study|Insufficient therapeutic response|0
1585338|NCT02534896|5507149|P2|Overall Study|Insufficient therapeutic response|0
1585339|NCT02534896|5507150|P1|Overall Study|Insufficient therapeutic response|2
1585340|NCT02534896|5507148|P3|Overall Study|Adverse Event|1
1585341|NCT02534896|5507149|P2|Overall Study|Adverse Event|1
1585342|NCT02534896|5507150|P1|Overall Study|Adverse Event|2
1585343|NCT02534883|5507169|P2|Overall Study|Early Termination|3
1585344|NCT02534883|5507170|P1|Overall Study|Early Termination|8
1585345|NCT02534493|5507186|P1|Overall Study|Withdrawal by Subject|1
1585346|NCT02534493|5507186|P1|Overall Study|Lost to Follow-up|1
1585347|NCT02534350|5507197|P2|Overall Study|Withdrew Consent|0
1585348|NCT02534350|5507198|P1|Overall Study|Withdrew Consent|2
1585349|NCT02534350|5507197|P2|Overall Study|Protocol Violation|0
1585350|NCT02534350|5507198|P1|Overall Study|Protocol Violation|1
1585351|NCT02534350|5507197|P2|Overall Study|Randomized But Not Treated|0
1585352|NCT02534350|5507198|P1|Overall Study|Randomized But Not Treated|1
1585353|NCT02534324|5507212|P2|Overall Study|Adverse Event|0
1585354|NCT02534324|5507213|P1|Overall Study|Adverse Event|1
1585355|NCT02534324|5507212|P2|Overall Study|Lost to Follow-up|7
1585356|NCT02534324|5507213|P1|Overall Study|Lost to Follow-up|20
1585357|NCT02534324|5507212|P2|Overall Study|Protocol Violation|1
1585358|NCT02534324|5507213|P1|Overall Study|Protocol Violation|4
1585359|NCT02533999|5507232|P2|Overall Study|Randomized but intervention not received|1
1585360|NCT02533999|5507233|P1|Overall Study|Randomized but intervention not received|0
1585361|NCT02533999|5507232|P2|Overall Study|Adverse Event|1
1585362|NCT02533999|5507233|P1|Overall Study|Adverse Event|0
1585363|NCT02533999|5507232|P2|Overall Study|Protocol Violation|0
1585364|NCT02533999|5507233|P1|Overall Study|Protocol Violation|3
1585365|NCT02533999|5507232|P2|Overall Study|Lost to Follow-up|5
1585366|NCT02533999|5507233|P1|Overall Study|Lost to Follow-up|3
1585367|NCT02533570|5507284|P3|Overall Study|Adverse Event|1
1585368|NCT02533570|5507285|P2|Overall Study|Adverse Event|1
1585369|NCT02533570|5507286|P1|Overall Study|Adverse Event|0
1585370|NCT02533531|5507297|P1|Overall Study|Device did not turn on|1
1585371|NCT02533453|5507360|P1|Overall Study|Withdrawal by Subject|2
1585372|NCT02533453|5507360|P1|Overall Study|Protocol Violation|1
1585373|NCT02533453|5507360|P1|Overall Study|Adverse Event|6
1585374|NCT02533401|5507369|P1|Overall Study|Violation of Selection Criteria|1
1585375|NCT02533401|5507369|P1|Overall Study|Lost to Follow-up|1
1585376|NCT02533401|5507369|P1|Overall Study|Insufficient Response/Progressed Disease|1
1585377|NCT02533401|5507369|P1|Overall Study|Death|5
1585378|NCT02533401|5507369|P1|Overall Study|Adverse Event/Intercurrent Disease|3
1585379|NCT02533375|5507377|P1|Overall Study|Adverse Event|2
1585380|NCT02533375|5507377|P1|Overall Study|Lack of Efficacy|3
1585381|NCT02533258|5507409|P1|Overall Study|Lack of Efficacy|2
1585382|NCT02533258|5507409|P1|Overall Study|Progression of pleural effusion|1
1585383|NCT02533258|5507409|P1|Overall Study|Economic factor|1
1585384|NCT02533258|5507409|P1|Overall Study|Other|1
1585385|NCT02533258|5507409|P1|Overall Study|Death|2
1585386|NCT02533258|5507409|P1|Overall Study|Adverse Event|1
1585387|NCT02532855|5507548|P2|Overall Study|Withdrawal by Subject|8
1585388|NCT02532855|5507549|P1|Overall Study|Withdrawal by Subject|4
1585389|NCT02532855|5507548|P2|Overall Study|Lost to Follow-up|3
1585390|NCT02532855|5507549|P1|Overall Study|Lost to Follow-up|4
1585391|NCT02532764|5507583|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
1585392|NCT02532764|5507584|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
1585393|NCT02532764|5507585|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
1585394|NCT02532764|5507586|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1585395|NCT02532764|5507587|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1585396|NCT02532764|5507588|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1585397|NCT02532764|5507589|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1585398|NCT02532764|5507590|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1585399|NCT02532764|5507591|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1585400|NCT02532764|5507592|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
1585401|NCT02532647|5507743|P3|Overall Study|Did not receive trial medication|1
1585402|NCT02532647|5507744|P2|Overall Study|Did not receive trial medication|0
1585403|NCT02532647|5507745|P1|Overall Study|Did not receive trial medication|1
1585404|NCT02532543|5507763|P4|Overall Study|Lost to Follow-up|0
1585405|NCT02532543|5507764|P3|Overall Study|Lost to Follow-up|1
1585406|NCT02532543|5507765|P2|Overall Study|Lost to Follow-up|0
1585407|NCT02532543|5507766|P1|Overall Study|Lost to Follow-up|0
1585408|NCT02532465|5507802|P2|Overall Study|Lack of Efficacy|1
1585409|NCT02532465|5507803|P1|Overall Study|Lack of Efficacy|0
1585410|NCT02532465|5507802|P2|Overall Study|Protocol Violation|0
1585411|NCT02532465|5507803|P1|Overall Study|Protocol Violation|1
1585414|NCT02532179|5507837|P1|Overall Study|Subject received depot steroid injection|1
1585415|NCT02532179|5507837|P1|Overall Study|Pregnancy|1
1585416|NCT02532179|5507837|P1|Overall Study|Lost to Follow-up|1
1585417|NCT02531802|5507892|P21|Received Vaccination 2|Withdrawal by Subject|0
1585418|NCT02531802|5507893|P20|Received Vaccination 2|Withdrawal by Subject|1
1585419|NCT02531802|5507894|P19|Received Vaccination 2|Withdrawal by Subject|1
1585420|NCT02531802|5507895|P18|Received Vaccination 2|Withdrawal by Subject|1
1585421|NCT02531802|5507896|P17|Received Vaccination 2|Withdrawal by Subject|0
1585422|NCT02531802|5507897|P16|Received Vaccination 2|Withdrawal by Subject|0
1585423|NCT02531802|5507898|P15|Received Vaccination 2|Withdrawal by Subject|1
1585424|NCT02531802|5507899|P14|Received Vaccination 2|Withdrawal by Subject|1
1585425|NCT02531802|5507900|P13|Received Vaccination 2|Withdrawal by Subject|1
1585426|NCT02531802|5507901|P12|Received Vaccination 2|Withdrawal by Subject|0
1585427|NCT02531802|5507902|P11|Received Vaccination 2|Withdrawal by Subject|1
1585428|NCT02531802|5507903|P10|Received Vaccination 2|Withdrawal by Subject|0
1585429|NCT02531802|5507904|P9|Received Vaccination 2|Withdrawal by Subject|0
1585430|NCT02531802|5507905|P8|Received Vaccination 2|Withdrawal by Subject|0
1585431|NCT02531802|5507906|P7|Received Vaccination 2|Withdrawal by Subject|0
1585432|NCT02531802|5507907|P6|Received Vaccination 2|Withdrawal by Subject|0
1585433|NCT02531802|5507908|P5|Received Vaccination 2|Withdrawal by Subject|0
1585434|NCT02531802|5507909|P4|Received Vaccination 2|Withdrawal by Subject|0
1585435|NCT02531802|5507910|P3|Received Vaccination 2|Withdrawal by Subject|0
1585436|NCT02531802|5507911|P2|Received Vaccination 2|Withdrawal by Subject|0
1585437|NCT02531802|5507912|P1|Received Vaccination 2|Withdrawal by Subject|0
1585438|NCT02531802|5507892|P21|Received Vaccination 2|Adverse Event|1
1585439|NCT02531802|5507893|P20|Received Vaccination 2|Adverse Event|0
1585440|NCT02531802|5507894|P19|Received Vaccination 2|Adverse Event|1
1585441|NCT02531802|5507895|P18|Received Vaccination 2|Adverse Event|2
1585442|NCT02531802|5507896|P17|Received Vaccination 2|Adverse Event|0
1585443|NCT02531802|5507897|P16|Received Vaccination 2|Adverse Event|0
1585444|NCT02531802|5507898|P15|Received Vaccination 2|Adverse Event|0
1585445|NCT02531802|5507899|P14|Received Vaccination 2|Adverse Event|0
1585446|NCT02531802|5507900|P13|Received Vaccination 2|Adverse Event|0
1585447|NCT02531802|5507901|P12|Received Vaccination 2|Adverse Event|0
1585448|NCT02531802|5507902|P11|Received Vaccination 2|Adverse Event|0
1585449|NCT02531802|5507903|P10|Received Vaccination 2|Adverse Event|0
1585450|NCT02531802|5507904|P9|Received Vaccination 2|Adverse Event|0
1585451|NCT02531802|5507905|P8|Received Vaccination 2|Adverse Event|0
1585452|NCT02531802|5507906|P7|Received Vaccination 2|Adverse Event|0
1585453|NCT02531802|5507907|P6|Received Vaccination 2|Adverse Event|2
1585454|NCT02531802|5507908|P5|Received Vaccination 2|Adverse Event|0
1585455|NCT02531802|5507909|P4|Received Vaccination 2|Adverse Event|0
1585456|NCT02531802|5507910|P3|Received Vaccination 2|Adverse Event|0
1585457|NCT02531802|5507911|P2|Received Vaccination 2|Adverse Event|0
1585458|NCT02531802|5507912|P1|Received Vaccination 2|Adverse Event|0
1585459|NCT02531802|5507892|P21|Received Vaccination 2|Physician Decision|0
1585460|NCT02531802|5507893|P20|Received Vaccination 2|Physician Decision|0
1585461|NCT02531802|5507894|P19|Received Vaccination 2|Physician Decision|0
1585462|NCT02531802|5507895|P18|Received Vaccination 2|Physician Decision|1
1585463|NCT02531802|5507896|P17|Received Vaccination 2|Physician Decision|0
1585464|NCT02531802|5507897|P16|Received Vaccination 2|Physician Decision|0
1585465|NCT02531802|5507898|P15|Received Vaccination 2|Physician Decision|0
1585466|NCT02531802|5507899|P14|Received Vaccination 2|Physician Decision|1
1585467|NCT02531802|5507900|P13|Received Vaccination 2|Physician Decision|0
1585468|NCT02531802|5507901|P12|Received Vaccination 2|Physician Decision|0
1585469|NCT02531802|5507902|P11|Received Vaccination 2|Physician Decision|0
1585470|NCT02531802|5507903|P10|Received Vaccination 2|Physician Decision|2
1585471|NCT02531802|5507904|P9|Received Vaccination 2|Physician Decision|0
1585472|NCT02531802|5507905|P8|Received Vaccination 2|Physician Decision|0
1585473|NCT02531802|5507906|P7|Received Vaccination 2|Physician Decision|0
1585474|NCT02531802|5507907|P6|Received Vaccination 2|Physician Decision|1
1585475|NCT02531802|5507908|P5|Received Vaccination 2|Physician Decision|0
1585476|NCT02531802|5507909|P4|Received Vaccination 2|Physician Decision|0
1585477|NCT02531802|5507910|P3|Received Vaccination 2|Physician Decision|0
1585478|NCT02531802|5507911|P2|Received Vaccination 2|Physician Decision|0
1585479|NCT02531802|5507912|P1|Received Vaccination 2|Physician Decision|0
1585480|NCT02531802|5507892|P21|Received Vaccination 2|Medication interfering with study taken|0
1585481|NCT02531802|5507893|P20|Received Vaccination 2|Medication interfering with study taken|0
1585482|NCT02531802|5507894|P19|Received Vaccination 2|Medication interfering with study taken|1
1585483|NCT02531802|5507895|P18|Received Vaccination 2|Medication interfering with study taken|0
1585484|NCT02531802|5507896|P17|Received Vaccination 2|Medication interfering with study taken|0
1585485|NCT02531802|5507897|P16|Received Vaccination 2|Medication interfering with study taken|0
1585486|NCT02531802|5507898|P15|Received Vaccination 2|Medication interfering with study taken|0
1585487|NCT02531802|5507899|P14|Received Vaccination 2|Medication interfering with study taken|0
1585488|NCT02531802|5507900|P13|Received Vaccination 2|Medication interfering with study taken|1
1585489|NCT02531802|5507901|P12|Received Vaccination 2|Medication interfering with study taken|0
1585490|NCT02531802|5507902|P11|Received Vaccination 2|Medication interfering with study taken|1
1585491|NCT02531802|5507903|P10|Received Vaccination 2|Medication interfering with study taken|1
1585492|NCT02531802|5507904|P9|Received Vaccination 2|Medication interfering with study taken|0
1585493|NCT02531802|5507905|P8|Received Vaccination 2|Medication interfering with study taken|0
1585494|NCT02531802|5507906|P7|Received Vaccination 2|Medication interfering with study taken|0
1585495|NCT02531802|5507907|P6|Received Vaccination 2|Medication interfering with study taken|0
1585496|NCT02531802|5507908|P5|Received Vaccination 2|Medication interfering with study taken|0
1585497|NCT02531802|5507909|P4|Received Vaccination 2|Medication interfering with study taken|0
1585498|NCT02531802|5507910|P3|Received Vaccination 2|Medication interfering with study taken|1
1585499|NCT02531802|5507911|P2|Received Vaccination 2|Medication interfering with study taken|0
1585500|NCT02531802|5507912|P1|Received Vaccination 2|Medication interfering with study taken|0
1585501|NCT02531698|5508344|P2|Overall Study|Lost to Follow-up|0
1585502|NCT02531698|5508345|P1|Overall Study|Lost to Follow-up|1
1585503|NCT02531698|5508344|P2|Overall Study|Protocol Violation|0
1585504|NCT02531698|5508345|P1|Overall Study|Protocol Violation|2
1585505|NCT02531698|5508344|P2|Overall Study|Withdrawal by Subject|1
1585506|NCT02531698|5508345|P1|Overall Study|Withdrawal by Subject|6
1585507|NCT02531698|5508344|P2|Overall Study|Adverse Event|1
1585508|NCT02531698|5508345|P1|Overall Study|Adverse Event|2
1585509|NCT02531646|5508592|P3|Overall Study|equip. image processing issue|0
1585510|NCT02531646|5508593|P2|Overall Study|equip. image processing issue|1
1585511|NCT02531646|5508594|P1|Overall Study|equip. image processing issue|5
1585512|NCT02531633|5508613|P10|Part B (104 Weeks)|Lost to Follow-up|0
1585513|NCT02531633|5508614|P9|Part B (104 Weeks)|Lost to Follow-up|0
1585514|NCT02531633|5508615|P8|Part B (104 Weeks)|Lost to Follow-up|1
1585515|NCT02531633|5508616|P7|Part B (104 Weeks)|Lost to Follow-up|0
1585516|NCT02531633|5508617|P6|Part B (104 Weeks)|Lost to Follow-up|0
1585517|NCT02531633|5508618|P5|Part B (104 Weeks)|Lost to Follow-up|0
1585518|NCT02531633|5508619|P4|Part B (104 Weeks)|Lost to Follow-up|0
1585519|NCT02531633|5508620|P3|Part B (104 Weeks)|Lost to Follow-up|0
1585520|NCT02531633|5508621|P2|Part B (104 Weeks)|Lost to Follow-up|0
1585521|NCT02531633|5508622|P1|Part B (104 Weeks)|Lost to Follow-up|0
1585522|NCT02531633|5508613|P10|Part B (104 Weeks)|Sponsor request|4
1585523|NCT02531633|5508614|P9|Part B (104 Weeks)|Sponsor request|5
1585524|NCT02531633|5508615|P8|Part B (104 Weeks)|Sponsor request|3
1585525|NCT02531633|5508616|P7|Part B (104 Weeks)|Sponsor request|5
1585526|NCT02531633|5508617|P6|Part B (104 Weeks)|Sponsor request|8
1585527|NCT02531633|5508618|P5|Part B (104 Weeks)|Sponsor request|0
1585528|NCT02531633|5508619|P4|Part B (104 Weeks)|Sponsor request|0
1585529|NCT02531633|5508620|P3|Part B (104 Weeks)|Sponsor request|0
1585530|NCT02531633|5508621|P2|Part B (104 Weeks)|Sponsor request|0
1585531|NCT02531633|5508622|P1|Part B (104 Weeks)|Sponsor request|0
1585532|NCT02531633|5508613|P10|Part A (52 Weeks)|Other|0
1585533|NCT02531633|5508614|P9|Part A (52 Weeks)|Other|0
1585534|NCT02531633|5508615|P8|Part A (52 Weeks)|Other|0
1585535|NCT02531633|5508616|P7|Part A (52 Weeks)|Other|0
1585536|NCT02531633|5508617|P6|Part A (52 Weeks)|Other|0
1585537|NCT02531633|5508618|P5|Part A (52 Weeks)|Other|0
1585538|NCT02531633|5508619|P4|Part A (52 Weeks)|Other|0
1585539|NCT02531633|5508620|P3|Part A (52 Weeks)|Other|0
1585540|NCT02531633|5508621|P2|Part A (52 Weeks)|Other|0
1585541|NCT02531633|5508622|P1|Part A (52 Weeks)|Other|2
1585542|NCT02531633|5508613|P10|Part A (52 Weeks)|Withdrawal by Subject|0
1585543|NCT02531633|5508614|P9|Part A (52 Weeks)|Withdrawal by Subject|0
1585544|NCT02531633|5508615|P8|Part A (52 Weeks)|Withdrawal by Subject|0
1585545|NCT02531633|5508616|P7|Part A (52 Weeks)|Withdrawal by Subject|0
1585546|NCT02531633|5508617|P6|Part A (52 Weeks)|Withdrawal by Subject|0
1585547|NCT02531633|5508618|P5|Part A (52 Weeks)|Withdrawal by Subject|3
1585548|NCT02531633|5508619|P4|Part A (52 Weeks)|Withdrawal by Subject|3
1585549|NCT02531633|5508620|P3|Part A (52 Weeks)|Withdrawal by Subject|1
1585550|NCT02531633|5508621|P2|Part A (52 Weeks)|Withdrawal by Subject|6
1585551|NCT02531633|5508622|P1|Part A (52 Weeks)|Withdrawal by Subject|6
1585552|NCT02531633|5508613|P10|Part A (52 Weeks)|Physician Decision|0
1585553|NCT02531633|5508614|P9|Part A (52 Weeks)|Physician Decision|0
1585554|NCT02531633|5508615|P8|Part A (52 Weeks)|Physician Decision|0
1585555|NCT02531633|5508616|P7|Part A (52 Weeks)|Physician Decision|0
1585556|NCT02531633|5508617|P6|Part A (52 Weeks)|Physician Decision|0
1585557|NCT02531633|5508618|P5|Part A (52 Weeks)|Physician Decision|0
1585558|NCT02531633|5508619|P4|Part A (52 Weeks)|Physician Decision|1
1585559|NCT02531633|5508620|P3|Part A (52 Weeks)|Physician Decision|3
1585560|NCT02531633|5508621|P2|Part A (52 Weeks)|Physician Decision|4
1585561|NCT02531633|5508622|P1|Part A (52 Weeks)|Physician Decision|1
1585562|NCT02531633|5508613|P10|Part A (52 Weeks)|Lost to Follow-up|0
1585563|NCT02531633|5508614|P9|Part A (52 Weeks)|Lost to Follow-up|0
1585564|NCT02531633|5508615|P8|Part A (52 Weeks)|Lost to Follow-up|0
1585565|NCT02531633|5508616|P7|Part A (52 Weeks)|Lost to Follow-up|0
1585566|NCT02531633|5508617|P6|Part A (52 Weeks)|Lost to Follow-up|0
1585567|NCT02531633|5508618|P5|Part A (52 Weeks)|Lost to Follow-up|1
1585568|NCT02531633|5508619|P4|Part A (52 Weeks)|Lost to Follow-up|0
1585569|NCT02531633|5508620|P3|Part A (52 Weeks)|Lost to Follow-up|0
1585570|NCT02531633|5508621|P2|Part A (52 Weeks)|Lost to Follow-up|0
1585571|NCT02531633|5508622|P1|Part A (52 Weeks)|Lost to Follow-up|0
1585572|NCT02531633|5508613|P10|Part A (52 Weeks)|Protocol Violation|0
1585573|NCT02531633|5508614|P9|Part A (52 Weeks)|Protocol Violation|0
1585574|NCT02531633|5508615|P8|Part A (52 Weeks)|Protocol Violation|0
1585575|NCT02531633|5508616|P7|Part A (52 Weeks)|Protocol Violation|0
1585576|NCT02531633|5508617|P6|Part A (52 Weeks)|Protocol Violation|0
1585577|NCT02531633|5508618|P5|Part A (52 Weeks)|Protocol Violation|0
1585578|NCT02531633|5508619|P4|Part A (52 Weeks)|Protocol Violation|0
1585579|NCT02531633|5508620|P3|Part A (52 Weeks)|Protocol Violation|0
1585580|NCT02531633|5508621|P2|Part A (52 Weeks)|Protocol Violation|0
1585581|NCT02531633|5508622|P1|Part A (52 Weeks)|Protocol Violation|1
1585582|NCT02531633|5508613|P10|Part A (52 Weeks)|Sponsor request|0
1585583|NCT02531633|5508614|P9|Part A (52 Weeks)|Sponsor request|0
1585584|NCT02531633|5508615|P8|Part A (52 Weeks)|Sponsor request|0
1585585|NCT02531633|5508616|P7|Part A (52 Weeks)|Sponsor request|0
1585586|NCT02531633|5508617|P6|Part A (52 Weeks)|Sponsor request|0
1585587|NCT02531633|5508618|P5|Part A (52 Weeks)|Sponsor request|19
1585588|NCT02531633|5508619|P4|Part A (52 Weeks)|Sponsor request|18
1585589|NCT02531633|5508620|P3|Part A (52 Weeks)|Sponsor request|18
1585590|NCT02531633|5508621|P2|Part A (52 Weeks)|Sponsor request|24
1585591|NCT02531633|5508622|P1|Part A (52 Weeks)|Sponsor request|24
1585592|NCT02531438|5509101|P2|Overall Study|Randomized with Exclusion Criteria|0
1585593|NCT02531438|5509102|P1|Overall Study|Randomized with Exclusion Criteria|1
1585594|NCT02531438|5509101|P2|Overall Study|Missed EOT/PTE Visit|2
1585595|NCT02531438|5509102|P1|Overall Study|Missed EOT/PTE Visit|5
1585596|NCT02531438|5509101|P2|Overall Study|Randomized, but Not Treated|0
1585597|NCT02531438|5509102|P1|Overall Study|Randomized, but Not Treated|4
1585598|NCT02531438|5509101|P2|Overall Study|Death|3
1585599|NCT02531438|5509102|P1|Overall Study|Death|6
1585600|NCT02531438|5509101|P2|Overall Study|Physician Decision|1
1585601|NCT02531438|5509102|P1|Overall Study|Physician Decision|0
1585602|NCT02531438|5509101|P2|Overall Study|Withdrawal by Subject|8
1585603|NCT02531438|5509102|P1|Overall Study|Withdrawal by Subject|7
1585604|NCT02531438|5509101|P2|Overall Study|Lost to Follow-up|3
1585605|NCT02531438|5509102|P1|Overall Study|Lost to Follow-up|0
1585606|NCT02531438|5509101|P2|Overall Study|Adverse Event|9
1585607|NCT02531438|5509102|P1|Overall Study|Adverse Event|7
1585608|NCT02531373|5509121|P9|Overall Study|Withdrawal by Subject|0
1585609|NCT02531373|5509122|P8|Overall Study|Withdrawal by Subject|0
1585610|NCT02531373|5509123|P7|Overall Study|Withdrawal by Subject|0
1585611|NCT02531373|5509124|P6|Overall Study|Withdrawal by Subject|0
1585612|NCT02531373|5509125|P5|Overall Study|Withdrawal by Subject|3
1585613|NCT02531373|5509126|P4|Overall Study|Withdrawal by Subject|0
1585614|NCT02531373|5509127|P3|Overall Study|Withdrawal by Subject|0
1585615|NCT02531373|5509128|P2|Overall Study|Withdrawal by Subject|0
1585616|NCT02531373|5509129|P1|Overall Study|Withdrawal by Subject|0
1585617|NCT02531373|5509121|P9|Overall Study|Withdrawal by Parent/Guardian|3
1585618|NCT02531373|5509122|P8|Overall Study|Withdrawal by Parent/Guardian|1
1585619|NCT02531373|5509123|P7|Overall Study|Withdrawal by Parent/Guardian|4
1585620|NCT02531373|5509124|P6|Overall Study|Withdrawal by Parent/Guardian|3
1585621|NCT02531373|5509125|P5|Overall Study|Withdrawal by Parent/Guardian|0
1585622|NCT02531373|5509126|P4|Overall Study|Withdrawal by Parent/Guardian|0
1585623|NCT02531373|5509127|P3|Overall Study|Withdrawal by Parent/Guardian|0
1585624|NCT02531373|5509128|P2|Overall Study|Withdrawal by Parent/Guardian|0
1585625|NCT02531373|5509129|P1|Overall Study|Withdrawal by Parent/Guardian|0
1585626|NCT02531373|5509121|P9|Overall Study|Protocol Violation|1
1585627|NCT02531373|5509122|P8|Overall Study|Protocol Violation|0
1585628|NCT02531373|5509123|P7|Overall Study|Protocol Violation|1
1585629|NCT02531373|5509124|P6|Overall Study|Protocol Violation|1
1585630|NCT02531373|5509125|P5|Overall Study|Protocol Violation|0
1585631|NCT02531373|5509126|P4|Overall Study|Protocol Violation|0
1585632|NCT02531373|5509127|P3|Overall Study|Protocol Violation|0
1585633|NCT02531373|5509128|P2|Overall Study|Protocol Violation|0
1585634|NCT02531373|5509129|P1|Overall Study|Protocol Violation|0
1585635|NCT02531373|5509121|P9|Overall Study|Physician Decision|0
1585636|NCT02531373|5509122|P8|Overall Study|Physician Decision|0
1585637|NCT02531373|5509123|P7|Overall Study|Physician Decision|0
1585638|NCT02531373|5509124|P6|Overall Study|Physician Decision|1
1585639|NCT02531373|5509125|P5|Overall Study|Physician Decision|2
1585640|NCT02531373|5509126|P4|Overall Study|Physician Decision|0
1585641|NCT02531373|5509127|P3|Overall Study|Physician Decision|0
1585642|NCT02531373|5509128|P2|Overall Study|Physician Decision|0
1585643|NCT02531373|5509129|P1|Overall Study|Physician Decision|0
1585644|NCT02531373|5509121|P9|Overall Study|Lost to Follow-up|0
1585645|NCT02531373|5509122|P8|Overall Study|Lost to Follow-up|0
1585646|NCT02531373|5509123|P7|Overall Study|Lost to Follow-up|2
1585647|NCT02531373|5509124|P6|Overall Study|Lost to Follow-up|2
1585648|NCT02531373|5509125|P5|Overall Study|Lost to Follow-up|0
1585649|NCT02531373|5509126|P4|Overall Study|Lost to Follow-up|0
1585650|NCT02531373|5509127|P3|Overall Study|Lost to Follow-up|0
1585651|NCT02531373|5509128|P2|Overall Study|Lost to Follow-up|0
1585652|NCT02531373|5509129|P1|Overall Study|Lost to Follow-up|0
1585653|NCT02531373|5509121|P9|Overall Study|Lack of Efficacy|5
1585654|NCT02531373|5509122|P8|Overall Study|Lack of Efficacy|8
1585655|NCT02531373|5509123|P7|Overall Study|Lack of Efficacy|4
1585656|NCT02531373|5509124|P6|Overall Study|Lack of Efficacy|2
1585657|NCT02531373|5509125|P5|Overall Study|Lack of Efficacy|3
1585658|NCT02531373|5509126|P4|Overall Study|Lack of Efficacy|0
1585659|NCT02531373|5509127|P3|Overall Study|Lack of Efficacy|0
1585660|NCT02531373|5509128|P2|Overall Study|Lack of Efficacy|0
1585661|NCT02531373|5509129|P1|Overall Study|Lack of Efficacy|0
1585662|NCT02531035|5509203|P2|Overall Study|Randomized, not treated|1
1585663|NCT02531035|5509204|P1|Overall Study|Randomized, not treated|2
1585664|NCT02531035|5509203|P2|Overall Study|Lost to Follow-up|10
1585665|NCT02531035|5509204|P1|Overall Study|Lost to Follow-up|8
1585666|NCT02531035|5509203|P2|Overall Study|Withdrawal by Subject|32
1585667|NCT02531035|5509204|P1|Overall Study|Withdrawal by Subject|42
1585668|NCT02531035|5509203|P2|Overall Study|Other|2
1585669|NCT02531035|5509204|P1|Overall Study|Other|3
1585670|NCT02531035|5509203|P2|Overall Study|Adverse Event|45
1585671|NCT02531035|5509204|P1|Overall Study|Adverse Event|16
1585672|NCT02531035|5509203|P2|Overall Study|Physician Decision|0
1585673|NCT02531035|5509204|P1|Overall Study|Physician Decision|1
1585674|NCT02531035|5509203|P2|Overall Study|Noncompliance with study drug|3
1585675|NCT02531035|5509204|P1|Overall Study|Noncompliance with study drug|8
1585676|NCT02531035|5509203|P2|Overall Study|Protocol Violation|1
1585677|NCT02531035|5509204|P1|Overall Study|Protocol Violation|1
1585678|NCT02531035|5509203|P2|Overall Study|Death|1
1585679|NCT02531035|5509204|P1|Overall Study|Death|0
1585680|NCT02530671|5509231|P2|Overall Study|Withdrawal by Subject|0
1585681|NCT02530671|5509232|P1|Overall Study|Withdrawal by Subject|1
1585682|NCT02530671|5509231|P2|Overall Study|Lost to Follow-up|0
1585683|NCT02530671|5509232|P1|Overall Study|Lost to Follow-up|2
1585684|NCT02530385|5509281|P2|Overall Study|Withdrawal by Subject|1
1585685|NCT02530385|5509282|P1|Overall Study|Withdrawal by Subject|0
1585686|NCT02530125|5509345|P1|Followed for Survival for 2 Years|Early termination of study|3
1585687|NCT02530125|5509345|P1|Completed Treatment|Early termination of study|1
1585688|NCT02529995|5509359|P2|Part B|Discontinued Study|5
1585689|NCT02529995|5509360|P1|Part B|Discontinued Study|6
1585690|NCT02529995|5509359|P2|Part B|Ongoing Study at Data Cut-off|7
1585691|NCT02529995|5509360|P1|Part B|Ongoing Study at Data Cut-off|0
1585692|NCT02529995|5509359|P2|Part A|Discontinued Study|0
1585693|NCT02529995|5509360|P1|Part A|Discontinued Study|1
1585694|NCT02529995|5509359|P2|Part A|Ongoing Study at Data Cut-off|16
1585695|NCT02529995|5509360|P1|Part A|Ongoing Study at Data Cut-off|14
1585696|NCT02529488|5509394|P1|Overall Study|Death|3
1585697|NCT02529488|5509394|P1|Overall Study|Adverse Event|1
1585698|NCT02529137|5509402|P1|Overall Study|Discontinuation for different reasons|8
1585699|NCT02528643|5509426|P2|Overall Study|No End of Study Information Available|0
1585700|NCT02528643|5509427|P1|Overall Study|No End of Study Information Available|1
1585701|NCT02528643|5509426|P2|Overall Study|Miscellaneous|1
1585702|NCT02528643|5509427|P1|Overall Study|Miscellaneous|0
1585703|NCT02528643|5509426|P2|Overall Study|Withdrawal by Subject|7
1585704|NCT02528643|5509427|P1|Overall Study|Withdrawal by Subject|0
1585705|NCT02528643|5509426|P2|Overall Study|Lost to Follow-up|1
1585706|NCT02528643|5509427|P1|Overall Study|Lost to Follow-up|0
1585707|NCT02528643|5509426|P2|Overall Study|Death|76
1585708|NCT02528643|5509427|P1|Overall Study|Death|38
1585709|NCT02528331|5509444|P1|Overall Study|Withdrawal by Subject|2
1585710|NCT02528305|5509512|P1|Overall Study|Physician Decision|1
1585711|NCT02528305|5509512|P1|Overall Study|Adverse Event|1
1585712|NCT02528305|5509512|P1|Overall Study|Withdrawal by Subject|1
1585753|NCT02528214|5509856|P2|Overall Study|Other than specified above|1
1585754|NCT02528214|5509857|P1|Overall Study|Other than specified above|0
1585755|NCT02528214|5509856|P2|Overall Study|Adverse Event|1
1585756|NCT02528214|5509857|P1|Overall Study|Adverse Event|0
1585757|NCT02528214|5509856|P2|Overall Study|Protocol Violation|1
1585758|NCT02528214|5509857|P1|Overall Study|Protocol Violation|0
1585759|NCT02528188|5509892|P3|Overall Study|Randomized but not treated|12
1585760|NCT02528188|5509893|P2|Overall Study|Randomized but not treated|7
1585761|NCT02528188|5509894|P1|Overall Study|Randomized but not treated|6
1585762|NCT02528188|5509892|P3|Overall Study|Other|74
1585763|NCT02528188|5509893|P2|Overall Study|Other|91
1585764|NCT02528188|5509894|P1|Overall Study|Other|89
1585765|NCT02528188|5509892|P3|Overall Study|Death|0
1585766|NCT02528188|5509893|P2|Overall Study|Death|4
1585767|NCT02528188|5509894|P1|Overall Study|Death|4
1585768|NCT02528188|5509892|P3|Overall Study|Lost to Follow-up|31
1585769|NCT02528188|5509893|P2|Overall Study|Lost to Follow-up|21
1585770|NCT02528188|5509894|P1|Overall Study|Lost to Follow-up|25
1585771|NCT02528188|5509892|P3|Overall Study|Withdrawal by Subject|100
1585772|NCT02528188|5509893|P2|Overall Study|Withdrawal by Subject|104
1585773|NCT02528188|5509894|P1|Overall Study|Withdrawal by Subject|97
1585774|NCT02528188|5509892|P3|Overall Study|Lack of Efficacy|22
1585775|NCT02528188|5509893|P2|Overall Study|Lack of Efficacy|21
1585776|NCT02528188|5509894|P1|Overall Study|Lack of Efficacy|19
1585777|NCT02528188|5509892|P3|Overall Study|Protocol Violation|4
1585778|NCT02528188|5509893|P2|Overall Study|Protocol Violation|6
1585779|NCT02528188|5509894|P1|Overall Study|Protocol Violation|4
1585780|NCT02528188|5509892|P3|Overall Study|Adverse Event|8
1585781|NCT02528188|5509893|P2|Overall Study|Adverse Event|22
1585782|NCT02528188|5509894|P1|Overall Study|Adverse Event|23
1585798|NCT02527161|5510229|P1|Overall Study|Consent violation|4
1585799|NCT02527161|5510229|P1|Overall Study|MRI contraindication|2
1585800|NCT02527161|5510229|P1|Overall Study|Delay in or unfit for surgery|5
1585801|NCT02527161|5510229|P1|Overall Study|Exclusion RA diagnosis|1
1585802|NCT02527161|5510229|P1|Overall Study|Exclusion for excessive deformity|1
1585803|NCT02527161|5510229|P1|Overall Study|Exclusion for BMI|2
1585804|NCT02527161|5510229|P1|Overall Study|Shape Match not used in surgery|2
1585805|NCT02527161|5510229|P1|Overall Study|Withdrawal by Subject|6
1585806|NCT02527161|5510229|P1|Overall Study|Failed MRI|39
1585807|NCT02527148|5510248|P2|Overall Study|Did not receive study intervention|0
1585808|NCT02527148|5510249|P1|Overall Study|Did not receive study intervention|1
1585809|NCT02526693|5510269|P2|Overall Study|Physician Decision|1
1585810|NCT02526693|5510270|P1|Overall Study|Physician Decision|3
1585811|NCT02526550|5510299|P1|Overall Study|Lost to Follow-up|1
1585812|NCT02526524|5510311|P6|Overall Study|Sponsor Decision|0
1585813|NCT02526524|5510312|P5|Overall Study|Sponsor Decision|0
1585814|NCT02526524|5510313|P4|Overall Study|Sponsor Decision|0
1585815|NCT02526524|5510314|P3|Overall Study|Sponsor Decision|0
1585816|NCT02526524|5510315|P2|Overall Study|Sponsor Decision|0
1585817|NCT02526524|5510316|P1|Overall Study|Sponsor Decision|1
1585818|NCT02526524|5510311|P6|Overall Study|Physician Decision|0
1585819|NCT02526524|5510312|P5|Overall Study|Physician Decision|1
1585820|NCT02526524|5510313|P4|Overall Study|Physician Decision|0
1585821|NCT02526524|5510314|P3|Overall Study|Physician Decision|0
1585822|NCT02526524|5510315|P2|Overall Study|Physician Decision|0
1585823|NCT02526524|5510316|P1|Overall Study|Physician Decision|0
1585824|NCT02526524|5510311|P6|Overall Study|Loss of Glucose Control|0
1585825|NCT02526524|5510312|P5|Overall Study|Loss of Glucose Control|2
1585826|NCT02526524|5510313|P4|Overall Study|Loss of Glucose Control|0
1585827|NCT02526524|5510314|P3|Overall Study|Loss of Glucose Control|3
1585828|NCT02526524|5510315|P2|Overall Study|Loss of Glucose Control|0
1585829|NCT02526524|5510316|P1|Overall Study|Loss of Glucose Control|0
1585830|NCT02526524|5510311|P6|Overall Study|Protocol Violation|3
1585831|NCT02526524|5510312|P5|Overall Study|Protocol Violation|4
1585832|NCT02526524|5510313|P4|Overall Study|Protocol Violation|3
1585833|NCT02526524|5510314|P3|Overall Study|Protocol Violation|5
1585834|NCT02526524|5510315|P2|Overall Study|Protocol Violation|1
1585835|NCT02526524|5510316|P1|Overall Study|Protocol Violation|3
1585836|NCT02526524|5510311|P6|Overall Study|Lost to Follow-up|5
1585837|NCT02526524|5510312|P5|Overall Study|Lost to Follow-up|2
1585838|NCT02526524|5510313|P4|Overall Study|Lost to Follow-up|1
1585839|NCT02526524|5510314|P3|Overall Study|Lost to Follow-up|8
1585840|NCT02526524|5510315|P2|Overall Study|Lost to Follow-up|3
1585841|NCT02526524|5510316|P1|Overall Study|Lost to Follow-up|2
1585842|NCT02526524|5510311|P6|Overall Study|Adverse Event|8
1585843|NCT02526524|5510312|P5|Overall Study|Adverse Event|6
1585844|NCT02526524|5510313|P4|Overall Study|Adverse Event|2
1585845|NCT02526524|5510314|P3|Overall Study|Adverse Event|4
1585846|NCT02526524|5510315|P2|Overall Study|Adverse Event|2
1585847|NCT02526524|5510316|P1|Overall Study|Adverse Event|3
1585848|NCT02526524|5510311|P6|Overall Study|Withdrawal by Subject|5
1585849|NCT02526524|5510312|P5|Overall Study|Withdrawal by Subject|9
1585850|NCT02526524|5510313|P4|Overall Study|Withdrawal by Subject|1
1585851|NCT02526524|5510314|P3|Overall Study|Withdrawal by Subject|6
1585852|NCT02526524|5510315|P2|Overall Study|Withdrawal by Subject|3
1585853|NCT02526524|5510316|P1|Overall Study|Withdrawal by Subject|3
1585854|NCT02526290|5510330|P1|Overall Study|Physician Decision|1
1585855|NCT02526290|5510330|P1|Overall Study|Withdrawal by Subject|4
1585856|NCT02526290|5510330|P1|Overall Study|Adverse Event|3
1585857|NCT02525874|5510362|P1|Overall Study|New lesions in Brain|1
1585858|NCT02525874|5510362|P1|Overall Study|Alternative Treatment for MS|2
1585859|NCT02525874|5510362|P1|Overall Study|Disease relapse|4
1585860|NCT02525874|5510362|P1|Overall Study|Disease progression, defined by protocol|2
1585861|NCT02525874|5510362|P1|Overall Study|Lost to Follow-up|7
1585862|NCT02525874|5510362|P1|Overall Study|Adverse Event|17
1585863|NCT02525874|5510362|P1|Overall Study|Non-compliance with study drug|3
1585864|NCT02525874|5510362|P1|Overall Study|Consent withdrawn|22
1585865|NCT02525874|5510362|P1|Overall Study|Investigator Decision|1
1585866|NCT02525874|5510362|P1|Overall Study|Other|1
1585867|NCT02525627|5510392|P2|Overall Study|Site terminated|10
1585868|NCT02525627|5510393|P1|Overall Study|Site terminated|11
1585869|NCT02525627|5510392|P2|Overall Study|Death|0
1585870|NCT02525627|5510393|P1|Overall Study|Death|1
1585871|NCT02525627|5510392|P2|Overall Study|Withdrawal by Subject|2
1585872|NCT02525627|5510393|P1|Overall Study|Withdrawal by Subject|1
1585873|NCT02525627|5510392|P2|Overall Study|Revision|1
1585874|NCT02525627|5510393|P1|Overall Study|Revision|1
1585875|NCT02525094|5510499|P2|Overall Study|Not Treated|1
1585876|NCT02525094|5510500|P1|Overall Study|Not Treated|1
1585877|NCT02525094|5510499|P2|Overall Study|Withdrawal by Subject|6
1585878|NCT02525094|5510500|P1|Overall Study|Withdrawal by Subject|5
1585879|NCT02525094|5510499|P2|Overall Study|Lost to Follow-up|1
1585880|NCT02525094|5510500|P1|Overall Study|Lost to Follow-up|2
1585881|NCT02524665|5510563|P1|Overall Study|Lost to Follow-up|1
1585882|NCT02524288|5510614|P1|Overall Study|Physician Decision|2
1585883|NCT02524288|5510614|P1|Overall Study|Pregnancy|22
1585884|NCT02524288|5510614|P1|Overall Study|Withdrawal by Subject|76
1585885|NCT02524288|5510614|P1|Overall Study|Subject Moved|32
1585886|NCT02524288|5510614|P1|Overall Study|Study Terminated By Sponsor|1417
1585887|NCT02524288|5510614|P1|Overall Study|Site Discontinued Study Participation|1
1585888|NCT02524288|5510614|P1|Overall Study|Screen Failure|2
1585889|NCT02524288|5510614|P1|Overall Study|Protocol Violation|6
1585890|NCT02524288|5510614|P1|Overall Study|Pregnancy Wish|6
1585891|NCT02524288|5510614|P1|Overall Study|Non-Compliance With Study Drug|14
1585892|NCT02524288|5510614|P1|Overall Study|Non-Compliance With Protocol|32
1585893|NCT02524288|5510614|P1|Overall Study|Lost to Follow-up|216
1585894|NCT02524288|5510614|P1|Overall Study|Adverse Event|115
1585895|NCT02524158|5510624|P2|6-month Assessment|Lost to Follow-up|20
1585896|NCT02524158|5510625|P1|6-month Assessment|Lost to Follow-up|21
1585897|NCT02524158|5510624|P2|6-month Assessment|Withdrawal by Subject|1
1585898|NCT02524158|5510625|P1|6-month Assessment|Withdrawal by Subject|1
1585899|NCT02524158|5510624|P2|12-weeks Assessment|Lost to Follow-up|12
1585900|NCT02524158|5510625|P1|12-weeks Assessment|Lost to Follow-up|18
1585901|NCT02524158|5510624|P2|12-weeks Assessment|Withdrawal by Subject|1
1585902|NCT02524158|5510625|P1|12-weeks Assessment|Withdrawal by Subject|1
1585903|NCT02524145|5510667|P3|Overall Study|Withdrawal by Subject|3
1585904|NCT02524145|5510668|P2|Overall Study|Withdrawal by Subject|2
1585905|NCT02524145|5510669|P1|Overall Study|Withdrawal by Subject|2
1585906|NCT02522884|5510766|P1|Overall Study|Missed 12-month Follow-up|9
1585907|NCT02522884|5510766|P1|Overall Study|Death|3
1585908|NCT02522884|5510766|P1|Overall Study|Withdrawal by Subject|6
1585909|NCT02522728|5510773|P2|Overall Study|Did not receive randomized study device|1
1585910|NCT02522728|5510774|P1|Overall Study|Did not receive randomized study device|0
1585911|NCT02522728|5510773|P2|Overall Study|Adverse Event|1
1585912|NCT02522728|5510774|P1|Overall Study|Adverse Event|2
1585913|NCT02522728|5510773|P2|Overall Study|Death|3
1585914|NCT02522728|5510774|P1|Overall Study|Death|4
1585915|NCT02522728|5510773|P2|Overall Study|Withdrawal by Subject|6
1585916|NCT02522728|5510774|P1|Overall Study|Withdrawal by Subject|6
1585917|NCT02522624|5510790|P2|Overall Study|Technical failure|0
1585918|NCT02522624|5510791|P1|Overall Study|Technical failure|1
1585919|NCT02522403|5510826|P2|Overall Study|Withdrawal by Subject|4
1585920|NCT02522403|5510827|P1|Overall Study|Withdrawal by Subject|2
1585921|NCT02522403|5510826|P2|Overall Study|Lost to Follow-up|2
1585922|NCT02522403|5510827|P1|Overall Study|Lost to Follow-up|2
1585923|NCT02522377|5510839|P2|Overall Study|Remission Achieved|0
1585924|NCT02522377|5510840|P1|Overall Study|Remission Achieved|3
1585925|NCT02522377|5510839|P2|Overall Study|Withdrawal by Subject|0
1585926|NCT02522377|5510840|P1|Overall Study|Withdrawal by Subject|1
1585927|NCT02522325|5510856|P2|Overall Study|Adverse Event|1
1585928|NCT02522325|5510857|P1|Overall Study|Adverse Event|0
1585929|NCT02522299|5510865|P2|Overall Study|Withdrawal by Subject|0
1585930|NCT02522299|5510866|P1|Overall Study|Withdrawal by Subject|2
1585931|NCT02522299|5510865|P2|Overall Study|Physician Decision|1
1585932|NCT02522299|5510866|P1|Overall Study|Physician Decision|0
1585933|NCT02522299|5510865|P2|Overall Study|Adverse Event|0
1585934|NCT02522299|5510866|P1|Overall Study|Adverse Event|2
1585935|NCT02522286|5510949|P4|Overall Study|Withdrawal by Subject|3
1585936|NCT02522286|5510950|P3|Overall Study|Withdrawal by Subject|0
1585937|NCT02522286|5510951|P2|Overall Study|Withdrawal by Subject|0
1585938|NCT02522286|5510952|P1|Overall Study|Withdrawal by Subject|3
1585939|NCT02521948|5510978|P1|Overall Study|Did not attend one or both follow-ups|6
1585940|NCT02521948|5510978|P1|Overall Study|Lost to Follow-up|1
1585941|NCT02521948|5510978|P1|Overall Study|Death|4
1585942|NCT02521948|5510978|P1|Overall Study|Adverse Event|2
1585943|NCT02521376|5510991|P4|Overall Study|Enrolled, But Not Treated|0
1585944|NCT02521376|5510992|P3|Overall Study|Enrolled, But Not Treated|0
1585945|NCT02521376|5510993|P2|Overall Study|Enrolled, But Not Treated|0
1585946|NCT02521376|5510994|P1|Overall Study|Enrolled, But Not Treated|1
1585947|NCT02520726|5511035|P2|Overall Study|Lost to Follow-up|2
1585948|NCT02520726|5511036|P1|Overall Study|Lost to Follow-up|3
1585949|NCT02520531|5511046|P2|Overall Study|Not study device|0
1585950|NCT02520531|5511047|P1|Overall Study|Not study device|1
1585951|NCT02520531|5511046|P2|Overall Study|Withdrawal by Subject|0
1585952|NCT02520531|5511047|P1|Overall Study|Withdrawal by Subject|1
1585953|NCT02520531|5511046|P2|Overall Study|Meet exclusion criterion|1
1585954|NCT02520531|5511047|P1|Overall Study|Meet exclusion criterion|0
1585955|NCT02520531|5511046|P2|Overall Study|Lost to Follow-up|1
1585956|NCT02520531|5511047|P1|Overall Study|Lost to Follow-up|1
1585957|NCT02520531|5511046|P2|Overall Study|Death|2
1585958|NCT02520531|5511047|P1|Overall Study|Death|1
1585959|NCT02520531|5511046|P2|Overall Study|Revision of study device components|2
1585960|NCT02520531|5511047|P1|Overall Study|Revision of study device components|2
1585961|NCT02520388|5511132|P2|Overall Study|Other (reason not defined)|4
1585962|NCT02520388|5511133|P1|Overall Study|Other (reason not defined)|4
1585963|NCT02520388|5511132|P2|Overall Study|Lost to Follow-up|2
1585964|NCT02520388|5511133|P1|Overall Study|Lost to Follow-up|3
1585965|NCT02520388|5511132|P2|Overall Study|Adverse Event|4
1585966|NCT02520388|5511133|P1|Overall Study|Adverse Event|1
1585967|NCT02520388|5511132|P2|Overall Study|Subject or parent/guardian request|6
1585968|NCT02520388|5511133|P1|Overall Study|Subject or parent/guardian request|0
1585969|NCT02520388|5511132|P2|Overall Study|Physician Decision|0
1585970|NCT02520388|5511133|P1|Overall Study|Physician Decision|1
1585971|NCT02520310|5511141|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
1585972|NCT02520310|5511141|P1|At 6 Months Clinical Follow-up|Death|1
1585973|NCT02520284|5511276|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
1585974|NCT02520284|5511277|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
1585975|NCT02520284|5511278|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
1585976|NCT02520284|5511276|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
1585977|NCT02520284|5511277|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
1585978|NCT02520284|5511278|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
1585979|NCT02520284|5511276|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
1585980|NCT02520284|5511277|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
1585981|NCT02520284|5511278|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
1585982|NCT02520284|5511276|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
1585983|NCT02520284|5511277|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
1585984|NCT02520284|5511278|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
1585985|NCT02520284|5511276|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
1585986|NCT02520284|5511277|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
1585987|NCT02520284|5511278|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
1585988|NCT02520284|5511276|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
1585989|NCT02520284|5511277|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
1585990|NCT02520284|5511278|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
1585991|NCT02520284|5511276|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
1585992|NCT02520284|5511277|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
1585993|NCT02520284|5511278|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
1585994|NCT02520284|5511276|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
1585995|NCT02520284|5511277|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
1585996|NCT02520284|5511278|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
1586075|NCT02518971|5511603|P2|Overall Study|Lost to Follow-up|1
1585997|NCT02520284|5511276|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
1585998|NCT02520284|5511277|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
1585999|NCT02520284|5511278|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
1586000|NCT02520284|5511276|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
1586001|NCT02520284|5511277|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
1586002|NCT02520284|5511278|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
1586003|NCT02520284|5511276|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
1586004|NCT02520284|5511277|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
1586005|NCT02520284|5511278|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
1586006|NCT02520089|5511312|P2|Overall Study|Lost to Follow-up|4
1586007|NCT02520089|5511313|P1|Overall Study|Lost to Follow-up|3
1586008|NCT02519855|5511323|P2|Overall Study|Lost to Follow-up|3
1586009|NCT02519855|5511324|P1|Overall Study|Lost to Follow-up|3
1586010|NCT02519855|5511323|P2|Overall Study|Adverse Event|1
1586011|NCT02519855|5511324|P1|Overall Study|Adverse Event|0
1586012|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
1586013|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1586014|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
1586015|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
1586016|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1586017|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
1586018|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
1586019|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1586020|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
1586021|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
1586022|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1586023|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
1586024|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Death|1
1586025|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Death|0
1586026|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Death|0
1586027|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
1586028|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1586029|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
1586030|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
1586031|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1586032|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
1586033|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Adverse Event|1
1586034|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Adverse Event|0
1586035|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Adverse Event|0
1586036|NCT02519842|5511342|P3|Optional Extension: Cycles 2-6|Physician Decision|5
1586037|NCT02519842|5511343|P2|Optional Extension: Cycles 2-6|Physician Decision|0
1586038|NCT02519842|5511344|P1|Optional Extension: Cycles 2-6|Physician Decision|0
1586039|NCT02519842|5511342|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
1586040|NCT02519842|5511343|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
1586041|NCT02519842|5511344|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
1586042|NCT02519842|5511342|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1586043|NCT02519842|5511343|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
1586044|NCT02519842|5511344|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
1586045|NCT02519842|5511342|P3|Base Study: Cycle 1|Adverse Event|0
1586046|NCT02519842|5511343|P2|Base Study: Cycle 1|Adverse Event|0
1586047|NCT02519842|5511344|P1|Base Study: Cycle 1|Adverse Event|1
1586048|NCT02519842|5511342|P3|Base Study: Cycle 1|Screening Failure|0
1586049|NCT02519842|5511343|P2|Base Study: Cycle 1|Screening Failure|1
1586050|NCT02519842|5511344|P1|Base Study: Cycle 1|Screening Failure|1
1586051|NCT02519712|5511363|P1|Overall Study|Accruals are donors|2
1586052|NCT02519712|5511363|P1|Overall Study|Disease Progression|1
1586053|NCT02519712|5511363|P1|Overall Study|Disease Relapse|1
1586054|NCT02519595|5511370|P3|Overall Study|Protocol Violation|16
1586055|NCT02519595|5511371|P2|Overall Study|Protocol Violation|22
1586056|NCT02519595|5511372|P1|Overall Study|Protocol Violation|8
1586057|NCT02519504|5511397|P2|Overall Study|Did not participate in direct testing|86
1586058|NCT02519504|5511398|P1|Overall Study|Did not participate in direct testing|95
1586059|NCT02519504|5511397|P2|Overall Study|Ineligible for direct testing|12
1586060|NCT02519504|5511398|P1|Overall Study|Ineligible for direct testing|12
1586061|NCT02519504|5511397|P2|Overall Study|Protocol Violation|5
1586062|NCT02519504|5511398|P1|Overall Study|Protocol Violation|6
1586063|NCT02518971|5511603|P2|Overall Study|eligibility criteria no longer met|3
1586064|NCT02518971|5511604|P1|Overall Study|eligibility criteria no longer met|6
1586065|NCT02518971|5511603|P2|Overall Study|medication lost in mail|1
1586066|NCT02518971|5511604|P1|Overall Study|medication lost in mail|0
1586067|NCT02518971|5511603|P2|Overall Study|Side effects|0
1586068|NCT02518971|5511604|P1|Overall Study|Side effects|1
1586069|NCT02518971|5511603|P2|Overall Study|Withdrawal by Subject|5
1586070|NCT02518971|5511604|P1|Overall Study|Withdrawal by Subject|4
1586071|NCT02518971|5511603|P2|Overall Study|Protocol Violation|4
1586072|NCT02518971|5511604|P1|Overall Study|Protocol Violation|6
1586073|NCT02518971|5511603|P2|Overall Study|Physician Decision|6
1586074|NCT02518971|5511604|P1|Overall Study|Physician Decision|6
1586076|NCT02518971|5511604|P1|Overall Study|Lost to Follow-up|0
1586077|NCT02518919|5511624|P3|Overall Study|Protocol Violation|2
1586078|NCT02518919|5511625|P2|Overall Study|Protocol Violation|1
1586079|NCT02518919|5511626|P1|Overall Study|Protocol Violation|1
1586080|NCT02518685|5511656|P2|Overall Study|Lost to Follow-up|4
1586081|NCT02518685|5511657|P1|Overall Study|Lost to Follow-up|1
1586082|NCT02518685|5511656|P2|Overall Study|Physician Decision|0
1586083|NCT02518685|5511657|P1|Overall Study|Physician Decision|1
1586084|NCT02518685|5511656|P2|Overall Study|Pregnancy|0
1586085|NCT02518685|5511657|P1|Overall Study|Pregnancy|1
1586086|NCT02518685|5511656|P2|Overall Study|relocation, study fatigue|2
1586087|NCT02518685|5511657|P1|Overall Study|relocation, study fatigue|7
1586088|NCT02518685|5511656|P2|Overall Study|Withdrawal by Subject|3
1586089|NCT02518685|5511657|P1|Overall Study|Withdrawal by Subject|10
1586090|NCT02518685|5511656|P2|Overall Study|Adverse Event|1
1586091|NCT02518685|5511657|P1|Overall Study|Adverse Event|29
1586092|NCT02518620|5511666|P2|Overall Study|Relocation|1
1586093|NCT02518620|5511667|P1|Overall Study|Relocation|2
1586094|NCT02518620|5511666|P2|Overall Study|Pregnancy|0
1586095|NCT02518620|5511667|P1|Overall Study|Pregnancy|1
1586096|NCT02518620|5511666|P2|Overall Study|Pregnancy Wish|0
1586097|NCT02518620|5511667|P1|Overall Study|Pregnancy Wish|3
1586098|NCT02518620|5511666|P2|Overall Study|Death|0
1586099|NCT02518620|5511667|P1|Overall Study|Death|1
1586100|NCT02518620|5511666|P2|Overall Study|Withdrawal by Subject|9
1586101|NCT02518620|5511667|P1|Overall Study|Withdrawal by Subject|17
1586102|NCT02518620|5511666|P2|Overall Study|Lost to Follow-up|1
1586103|NCT02518620|5511667|P1|Overall Study|Lost to Follow-up|1
1586104|NCT02518620|5511666|P2|Overall Study|Sponsor's Decision|3
1586105|NCT02518620|5511667|P1|Overall Study|Sponsor's Decision|0
1586106|NCT02518620|5511666|P2|Overall Study|Physician Decision|1
1586107|NCT02518620|5511667|P1|Overall Study|Physician Decision|1
1586108|NCT02518620|5511666|P2|Overall Study|Non-Compliance with Study Drug|0
1586109|NCT02518620|5511667|P1|Overall Study|Non-Compliance with Study Drug|1
1586110|NCT02518620|5511666|P2|Overall Study|Lack of Efficacy|0
1586111|NCT02518620|5511667|P1|Overall Study|Lack of Efficacy|2
1586112|NCT02518620|5511666|P2|Overall Study|Adverse Event|11
1586113|NCT02518620|5511667|P1|Overall Study|Adverse Event|23
1586114|NCT02518464|5511690|P1|Overall Study|Adverse Event|2
1586115|NCT02518113|5511711|P4|Overall Study|Progressive Disease|0
1586116|NCT02518113|5511712|P3|Overall Study|Progressive Disease|3
1586117|NCT02518113|5511713|P2|Overall Study|Progressive Disease|2
1586118|NCT02518113|5511714|P1|Overall Study|Progressive Disease|1
1586119|NCT02518113|5511711|P4|Overall Study|Physician Decision|0
1586120|NCT02518113|5511712|P3|Overall Study|Physician Decision|0
1586121|NCT02518113|5511713|P2|Overall Study|Physician Decision|1
1586122|NCT02518113|5511714|P1|Overall Study|Physician Decision|0
1586123|NCT02518113|5511711|P4|Overall Study|Death|0
1586124|NCT02518113|5511712|P3|Overall Study|Death|0
1586125|NCT02518113|5511713|P2|Overall Study|Death|2
1586126|NCT02518113|5511714|P1|Overall Study|Death|1
1586127|NCT02518113|5511711|P4|Overall Study|Adverse Event|0
1586128|NCT02518113|5511712|P3|Overall Study|Adverse Event|1
1586129|NCT02518113|5511713|P2|Overall Study|Adverse Event|0
1586130|NCT02518113|5511714|P1|Overall Study|Adverse Event|1
1586131|NCT02518048|5511755|P1|Overall Study|Withdrawal by Subject|1
1586132|NCT02517866|5511781|P3|Overall Study|Reason not specified|0
1586133|NCT02517866|5511782|P2|Overall Study|Reason not specified|0
1586134|NCT02517866|5511783|P1|Overall Study|Reason not specified|2
1586135|NCT02517866|5511781|P3|Overall Study|Investigator Decision|0
1586136|NCT02517866|5511782|P2|Overall Study|Investigator Decision|1
1586137|NCT02517866|5511783|P1|Overall Study|Investigator Decision|2
1586138|NCT02517866|5511781|P3|Overall Study|Voluntary Withdrawal|0
1586139|NCT02517866|5511782|P2|Overall Study|Voluntary Withdrawal|2
1586140|NCT02517866|5511783|P1|Overall Study|Voluntary Withdrawal|2
1586141|NCT02517866|5511781|P3|Overall Study|Lost to Follow-up|0
1586142|NCT02517866|5511782|P2|Overall Study|Lost to Follow-up|0
1586143|NCT02517866|5511783|P1|Overall Study|Lost to Follow-up|1
1586144|NCT02517866|5511781|P3|Overall Study|Significant Protocol Deviation|0
1586145|NCT02517866|5511782|P2|Overall Study|Significant Protocol Deviation|1
1586146|NCT02517866|5511783|P1|Overall Study|Significant Protocol Deviation|4
1586147|NCT02517866|5511781|P3|Overall Study|Pretreatment Event/Adverse Event|0
1586148|NCT02517866|5511782|P2|Overall Study|Pretreatment Event/Adverse Event|2
1586149|NCT02517866|5511783|P1|Overall Study|Pretreatment Event/Adverse Event|9
1586150|NCT02517541|5511854|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
1586151|NCT02517541|5511854|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
1586152|NCT02517541|5511854|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
1586153|NCT02517541|5511854|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
1586154|NCT02517541|5511854|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
1586155|NCT02517541|5511854|P1|Baseline Period (Own Product)|Protocol Violation|1
1586156|NCT02517528|5511860|P1|Overall Study|Withdrawal by Subject|1
1586157|NCT02517515|5511870|P2|Overall Study|Other|0
1586158|NCT02517515|5511871|P1|Overall Study|Other|1
1586159|NCT02517515|5511870|P2|Overall Study|Lost to Follow-up|0
1586160|NCT02517515|5511871|P1|Overall Study|Lost to Follow-up|1
1586161|NCT02517515|5511870|P2|Overall Study|Withdrew Consent|1
1586162|NCT02517515|5511871|P1|Overall Study|Withdrew Consent|0
1586163|NCT02517515|5511870|P2|Overall Study|Adverse Event|1
1586164|NCT02517515|5511871|P1|Overall Study|Adverse Event|0
1586165|NCT02517463|5511888|P2|Overall Study|Lost to Follow-up|2
1586166|NCT02517463|5511889|P1|Overall Study|Lost to Follow-up|5
1586167|NCT02517268|5511901|P2|Overall Study|Withdrawal by Subject|0
1586168|NCT02517268|5511902|P1|Overall Study|Withdrawal by Subject|1
1586169|NCT02516982|5511954|P4|Overall Study|Did not install the app|47
1586170|NCT02516982|5511955|P3|Overall Study|Did not install the app|46
1586171|NCT02516982|5511956|P2|Overall Study|Did not install the app|0
1586172|NCT02516982|5511957|P1|Overall Study|Did not install the app|0
1586173|NCT02516982|5511954|P4|Overall Study|Protocol Violation|1
1586174|NCT02516982|5511955|P3|Overall Study|Protocol Violation|1
1586175|NCT02516982|5511956|P2|Overall Study|Protocol Violation|0
1586176|NCT02516982|5511957|P1|Overall Study|Protocol Violation|0
1586177|NCT02516982|5511954|P4|Overall Study|Withdrawal by Subject|2
1586178|NCT02516982|5511955|P3|Overall Study|Withdrawal by Subject|1
1586179|NCT02516982|5511956|P2|Overall Study|Withdrawal by Subject|0
1586180|NCT02516982|5511957|P1|Overall Study|Withdrawal by Subject|0
1586181|NCT02516982|5511954|P4|Overall Study|Called in to antenatal appointment|0
1586182|NCT02516982|5511955|P3|Overall Study|Called in to antenatal appointment|0
1586183|NCT02516982|5511956|P2|Overall Study|Called in to antenatal appointment|35
1586184|NCT02516982|5511957|P1|Overall Study|Called in to antenatal appointment|32
1586185|NCT02516605|5511984|P5|Overall Study|Withdrawal by Subject|0
1586186|NCT02516605|5511985|P4|Overall Study|Withdrawal by Subject|1
1586187|NCT02516605|5511986|P3|Overall Study|Withdrawal by Subject|0
1586188|NCT02516605|5511987|P2|Overall Study|Withdrawal by Subject|0
1586189|NCT02516605|5511988|P1|Overall Study|Withdrawal by Subject|0
1586190|NCT02516605|5511984|P5|Overall Study|Protocol Violation|1
1586191|NCT02516605|5511985|P4|Overall Study|Protocol Violation|0
1586192|NCT02516605|5511986|P3|Overall Study|Protocol Violation|0
1586193|NCT02516605|5511987|P2|Overall Study|Protocol Violation|0
1586194|NCT02516605|5511988|P1|Overall Study|Protocol Violation|0
1586195|NCT02516592|5512059|P2|Overall Study|Death|1
1586196|NCT02516592|5512060|P1|Overall Study|Death|1
1586197|NCT02516592|5512059|P2|Overall Study|Abnormal test procedure result|0
1586198|NCT02516592|5512060|P1|Overall Study|Abnormal test procedure result|1
1586199|NCT02516592|5512059|P2|Overall Study|Adverse Event|2
1586200|NCT02516592|5512060|P1|Overall Study|Adverse Event|1
1586201|NCT02516592|5512059|P2|Overall Study|Patient/guardian decision|1
1586202|NCT02516592|5512060|P1|Overall Study|Patient/guardian decision|2
1586203|NCT02516592|5512059|P2|Overall Study|Lost to Follow-up|3
1586204|NCT02516592|5512060|P1|Overall Study|Lost to Follow-up|2
1586205|NCT02516592|5512059|P2|Overall Study|Protocol deviation|4
1586206|NCT02516592|5512060|P1|Overall Study|Protocol deviation|4
1586207|NCT02516592|5512059|P2|Overall Study|Patient withdrew consent|2
1586208|NCT02516592|5512060|P1|Overall Study|Patient withdrew consent|5
1586209|NCT02516410|5512076|P2|Overall Study|Withdrawal by Subject|1
1586210|NCT02516410|5512077|P1|Overall Study|Withdrawal by Subject|0
1586211|NCT02516410|5512076|P2|Overall Study|Adverse Event|1
1586212|NCT02516410|5512077|P1|Overall Study|Adverse Event|0
1586213|NCT02516306|5512106|P2|Period 2: Day 8 - 91|Protocol Violation|2
1586214|NCT02516306|5512107|P1|Period 2: Day 8 - 91|Protocol Violation|1
1586215|NCT02516202|5512116|P3|Overall Study|Stopped Follow-up|1
1586216|NCT02516202|5512117|P2|Overall Study|Stopped Follow-up|0
1586217|NCT02516202|5512118|P1|Overall Study|Stopped Follow-up|0
1586218|NCT02516202|5512116|P3|Overall Study|Lost to Follow-up|1
1586219|NCT02516202|5512117|P2|Overall Study|Lost to Follow-up|1
1586220|NCT02516202|5512118|P1|Overall Study|Lost to Follow-up|1
1586221|NCT02516202|5512116|P3|Overall Study|Withdrawal by Subject|1
1586222|NCT02516202|5512117|P2|Overall Study|Withdrawal by Subject|0
1586223|NCT02516202|5512118|P1|Overall Study|Withdrawal by Subject|1
1586224|NCT02516163|5512144|P1|Overall Study|MRI contraindication exclusion|6
1586225|NCT02516163|5512144|P1|Overall Study|Data not recorded|2
1586226|NCT02516163|5512144|P1|Overall Study|Use of incorrect measurement technique|5
1586227|NCT02516163|5512144|P1|Overall Study|Unfit/delay in surgery|3
1586228|NCT02516163|5512144|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
1586229|NCT02516163|5512144|P1|Overall Study|Withdrawal by Subject|1
1586230|NCT02516098|5512158|P2|Period 2|Withdrawal by Subject|1
1586231|NCT02516098|5512159|P1|Period 2|Withdrawal by Subject|0
1586232|NCT02516098|5512158|P2|Washout After Period 1|Adverse Event|1
1586233|NCT02516098|5512159|P1|Washout After Period 1|Adverse Event|0
1586234|NCT02516098|5512158|P2|Period 1|Protocol Violation|0
1586235|NCT02516098|5512159|P1|Period 1|Protocol Violation|1
1586236|NCT02515994|5512173|P2|Overall Study|Withdrawal by Subject|0
1586237|NCT02515994|5512174|P1|Overall Study|Withdrawal by Subject|2
1586238|NCT02515994|5512173|P2|Overall Study|Adverse Event|1
1586239|NCT02515994|5512174|P1|Overall Study|Adverse Event|3
1586240|NCT02515994|5512173|P2|Overall Study|No Longer Meets Eligibility Criteria|1
1586241|NCT02515994|5512174|P1|Overall Study|No Longer Meets Eligibility Criteria|2
1586242|NCT02515994|5512173|P2|Overall Study|Protocol Violation|5
1586243|NCT02515994|5512174|P1|Overall Study|Protocol Violation|3
1586244|NCT02515942|5512189|P3|Overall Study|Withdrawal by Subject|2
1586245|NCT02515942|5512190|P2|Overall Study|Withdrawal by Subject|3
1586246|NCT02515942|5512191|P1|Overall Study|Withdrawal by Subject|0
1586247|NCT02515942|5512189|P3|Overall Study|Lost to Follow-up|0
1586248|NCT02515942|5512190|P2|Overall Study|Lost to Follow-up|0
1586249|NCT02515942|5512191|P1|Overall Study|Lost to Follow-up|2
1586250|NCT02515942|5512189|P3|Overall Study|Lack of Efficacy|1
1586251|NCT02515942|5512190|P2|Overall Study|Lack of Efficacy|0
1586252|NCT02515942|5512191|P1|Overall Study|Lack of Efficacy|0
1586253|NCT02515942|5512189|P3|Overall Study|Death|1
1586254|NCT02515942|5512190|P2|Overall Study|Death|0
1586255|NCT02515942|5512191|P1|Overall Study|Death|0
1586256|NCT02515942|5512189|P3|Overall Study|Adverse Event|0
1586257|NCT02515942|5512190|P2|Overall Study|Adverse Event|0
1586258|NCT02515942|5512191|P1|Overall Study|Adverse Event|5
1586263|NCT02515331|5512345|P3|Overall Study|Adverse Event|0
1586264|NCT02515331|5512346|P2|Overall Study|Adverse Event|0
1586265|NCT02515331|5512347|P1|Overall Study|Adverse Event|2
1586266|NCT02515331|5512345|P3|Overall Study|Protocol deviation|3
1586267|NCT02515331|5512346|P2|Overall Study|Protocol deviation|0
1586268|NCT02515331|5512347|P1|Overall Study|Protocol deviation|0
1586269|NCT02515331|5512345|P3|Overall Study|Withdrawal by Subject|1
1586270|NCT02515331|5512346|P2|Overall Study|Withdrawal by Subject|0
1586271|NCT02515331|5512347|P1|Overall Study|Withdrawal by Subject|0
1586272|NCT02515279|5512368|P1|Overall Study|Other|22
1586273|NCT02515279|5512368|P1|Overall Study|End-of-treatment visit not attended|17
1586274|NCT02515279|5512368|P1|Overall Study|Withdrawal by Subject|18
1586275|NCT02515279|5512368|P1|Overall Study|Lost to Follow-up|9
1586276|NCT02515279|5512368|P1|Overall Study|Lack of Efficacy|31
1586277|NCT02515279|5512368|P1|Overall Study|Adverse Event|7
1586278|NCT02515097|5512387|P2|Overall Study|Adverse Event|1
1586279|NCT02515097|5512388|P1|Overall Study|Adverse Event|2
1586280|NCT02515097|5512387|P2|Overall Study|Withdrawal by Subject|3
1586281|NCT02515097|5512388|P1|Overall Study|Withdrawal by Subject|1
1586282|NCT02515097|5512387|P2|Overall Study|Lost to Follow-up|2
1586283|NCT02515097|5512388|P1|Overall Study|Lost to Follow-up|4
1586284|NCT02515045|5512409|P3|Overall Study|Lost to Follow-up|1
1586285|NCT02515045|5512410|P2|Overall Study|Lost to Follow-up|1
1586286|NCT02515045|5512411|P1|Overall Study|Lost to Follow-up|0
1586287|NCT02515045|5512409|P3|Overall Study|Adverse Event|3
1586288|NCT02515045|5512410|P2|Overall Study|Adverse Event|3
1586289|NCT02515045|5512411|P1|Overall Study|Adverse Event|0
1586290|NCT02514772|5512448|P2|Overall Study|Withdrawal by Subject|1
1586291|NCT02514772|5512449|P1|Overall Study|Withdrawal by Subject|2
1586292|NCT02514772|5512448|P2|Overall Study|Death|1
1586293|NCT02514772|5512449|P1|Overall Study|Death|0
1586294|NCT02514772|5512448|P2|Overall Study|Adverse Event|0
1586295|NCT02514772|5512449|P1|Overall Study|Adverse Event|1
1586296|NCT02514577|5512463|P2|Overall Study|Adverse Event|1
1586297|NCT02514577|5512464|P1|Overall Study|Adverse Event|1
1586298|NCT02514577|5512463|P2|Overall Study|Withdrawal by Subject|6
1586299|NCT02514577|5512464|P1|Overall Study|Withdrawal by Subject|6
1586300|NCT02514577|5512463|P2|Overall Study|Protocol Violation|0
1586301|NCT02514577|5512464|P1|Overall Study|Protocol Violation|1
1586302|NCT02514577|5512463|P2|Overall Study|Lost to Follow-up|6
1586303|NCT02514577|5512464|P1|Overall Study|Lost to Follow-up|6
1586304|NCT02514551|5512474|P2|Overall Study|Participant Never Treated|2
1586305|NCT02514551|5512475|P1|Overall Study|Participant Never Treated|0
1586306|NCT02514551|5512474|P2|Overall Study|Lost to Follow-up|1
1586307|NCT02514551|5512475|P1|Overall Study|Lost to Follow-up|0
1586308|NCT02514473|5512492|P2|Overall Study|Other|1
1586309|NCT02514473|5512493|P1|Overall Study|Other|1
1586310|NCT02514473|5512492|P2|Overall Study|Lost to Follow-up|1
1586311|NCT02514473|5512493|P1|Overall Study|Lost to Follow-up|0
1586312|NCT02514473|5512492|P2|Overall Study|Withdrawal by Subject|1
1586313|NCT02514473|5512493|P1|Overall Study|Withdrawal by Subject|2
1586314|NCT02514473|5512492|P2|Overall Study|Adverse Event|2
1586315|NCT02514473|5512493|P1|Overall Study|Adverse Event|0
1586316|NCT02514122|5512536|P2|Overall Study|Withdrawal by Subject|0
1586317|NCT02514122|5512537|P1|Overall Study|Withdrawal by Subject|2
1586318|NCT02513823|5512584|P1|Overall Study|Physician Decision|1
1586319|NCT02513823|5512584|P1|Overall Study|Lost to Follow-up|4
1586320|NCT02513771|5512591|P2|Overall Study|Not being able to get to clinic|0
1586321|NCT02513771|5512592|P1|Overall Study|Not being able to get to clinic|1
1586322|NCT02513771|5512591|P2|Overall Study|Lost to Follow-up|1
1586323|NCT02513771|5512592|P1|Overall Study|Lost to Follow-up|1
1586324|NCT02513745|5512630|P2|Overall Study|Criteria at time of surgery not met.|3
1586325|NCT02513745|5512631|P1|Overall Study|Criteria at time of surgery not met.|3
1586326|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Labor Reasons|0
1586327|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Labor Reasons|0
1586328|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Labor Reasons|0
1586329|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Labor Reasons|1
1586330|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Labor Reasons|0
1586331|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Labor Reasons|0
1586332|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1586333|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1586334|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1586335|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
1586336|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1586337|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
1586338|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Subject move out of town|0
1586339|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Subject move out of town|0
1586340|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Subject move out of town|0
1586341|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Subject move out of town|1
1586342|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Subject move out of town|0
1586343|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Subject move out of town|0
1586344|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Death|0
1586345|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Death|0
1586346|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Death|0
1586347|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Death|1
1586348|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Death|0
1586349|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Death|0
1586350|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Physician Decision|0
1586351|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Physician Decision|0
1586352|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Physician Decision|0
1586353|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Physician Decision|0
1586354|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Physician Decision|0
1586355|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Physician Decision|2
1586356|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Adverse Event|0
1586357|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Adverse Event|0
1586358|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Adverse Event|0
1586359|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Adverse Event|4
1586360|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Adverse Event|1
1586361|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Adverse Event|1
1586362|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
1586363|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
1586364|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
1586365|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
1586366|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
1586367|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
1586368|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1586369|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1586370|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
1586371|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
1586372|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
1586373|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
1586374|NCT02513550|5512852|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1586375|NCT02513550|5512853|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1586376|NCT02513550|5512854|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
1586377|NCT02513550|5512855|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
1586378|NCT02513550|5512856|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
1586379|NCT02513550|5512857|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
1586380|NCT02513550|5512852|P6|Double Blind Treatment Period|Death|0
1586381|NCT02513550|5512853|P5|Double Blind Treatment Period|Death|0
1586382|NCT02513550|5512854|P4|Double Blind Treatment Period|Death|0
1586383|NCT02513550|5512855|P3|Double Blind Treatment Period|Death|2
1586384|NCT02513550|5512856|P2|Double Blind Treatment Period|Death|0
1586385|NCT02513550|5512857|P1|Double Blind Treatment Period|Death|1
1586386|NCT02513550|5512852|P6|Double Blind Treatment Period|Due to personal business|0
1586387|NCT02513550|5512853|P5|Double Blind Treatment Period|Due to personal business|0
1586388|NCT02513550|5512854|P4|Double Blind Treatment Period|Due to personal business|0
1586389|NCT02513550|5512855|P3|Double Blind Treatment Period|Due to personal business|1
1586390|NCT02513550|5512856|P2|Double Blind Treatment Period|Due to personal business|0
1586391|NCT02513550|5512857|P1|Double Blind Treatment Period|Due to personal business|2
1586392|NCT02513550|5512852|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1586393|NCT02513550|5512853|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1586394|NCT02513550|5512854|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1586395|NCT02513550|5512855|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
1586396|NCT02513550|5512856|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1586397|NCT02513550|5512857|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
1586398|NCT02513550|5512852|P6|Double Blind Treatment Period|Site terminated by sponsor|0
1586399|NCT02513550|5512853|P5|Double Blind Treatment Period|Site terminated by sponsor|0
1586400|NCT02513550|5512854|P4|Double Blind Treatment Period|Site terminated by sponsor|0
1586401|NCT02513550|5512855|P3|Double Blind Treatment Period|Site terminated by sponsor|3
1586402|NCT02513550|5512856|P2|Double Blind Treatment Period|Site terminated by sponsor|1
1586403|NCT02513550|5512857|P1|Double Blind Treatment Period|Site terminated by sponsor|1
1586404|NCT02513550|5512852|P6|Double Blind Treatment Period|Physician Decision|0
1586405|NCT02513550|5512853|P5|Double Blind Treatment Period|Physician Decision|0
1586406|NCT02513550|5512854|P4|Double Blind Treatment Period|Physician Decision|0
1586407|NCT02513550|5512855|P3|Double Blind Treatment Period|Physician Decision|4
1586408|NCT02513550|5512856|P2|Double Blind Treatment Period|Physician Decision|0
1586409|NCT02513550|5512857|P1|Double Blind Treatment Period|Physician Decision|2
1586410|NCT02513550|5512852|P6|Double Blind Treatment Period|Protocol Violation|0
1586411|NCT02513550|5512853|P5|Double Blind Treatment Period|Protocol Violation|0
1586412|NCT02513550|5512854|P4|Double Blind Treatment Period|Protocol Violation|0
1586413|NCT02513550|5512855|P3|Double Blind Treatment Period|Protocol Violation|4
1586414|NCT02513550|5512856|P2|Double Blind Treatment Period|Protocol Violation|1
1586415|NCT02513550|5512857|P1|Double Blind Treatment Period|Protocol Violation|1
1586416|NCT02513550|5512852|P6|Double Blind Treatment Period|Lack of Efficacy|0
1586417|NCT02513550|5512853|P5|Double Blind Treatment Period|Lack of Efficacy|0
1586418|NCT02513550|5512854|P4|Double Blind Treatment Period|Lack of Efficacy|0
1586419|NCT02513550|5512855|P3|Double Blind Treatment Period|Lack of Efficacy|6
1586420|NCT02513550|5512856|P2|Double Blind Treatment Period|Lack of Efficacy|5
1586421|NCT02513550|5512857|P1|Double Blind Treatment Period|Lack of Efficacy|4
1586422|NCT02513550|5512852|P6|Double Blind Treatment Period|Lost to Follow-up|1
1586423|NCT02513550|5512853|P5|Double Blind Treatment Period|Lost to Follow-up|0
1586424|NCT02513550|5512854|P4|Double Blind Treatment Period|Lost to Follow-up|0
1586425|NCT02513550|5512855|P3|Double Blind Treatment Period|Lost to Follow-up|11
1586426|NCT02513550|5512856|P2|Double Blind Treatment Period|Lost to Follow-up|7
1586427|NCT02513550|5512857|P1|Double Blind Treatment Period|Lost to Follow-up|9
1586428|NCT02513550|5512852|P6|Double Blind Treatment Period|Adverse Event|0
1586429|NCT02513550|5512853|P5|Double Blind Treatment Period|Adverse Event|1
1586430|NCT02513550|5512854|P4|Double Blind Treatment Period|Adverse Event|0
1586431|NCT02513550|5512855|P3|Double Blind Treatment Period|Adverse Event|17
1586432|NCT02513550|5512856|P2|Double Blind Treatment Period|Adverse Event|13
1586433|NCT02513550|5512857|P1|Double Blind Treatment Period|Adverse Event|5
1586434|NCT02513550|5512852|P6|Double Blind Treatment Period|Withdrawal by Subject|0
1586435|NCT02513550|5512853|P5|Double Blind Treatment Period|Withdrawal by Subject|0
1586436|NCT02513550|5512854|P4|Double Blind Treatment Period|Withdrawal by Subject|0
1586437|NCT02513550|5512855|P3|Double Blind Treatment Period|Withdrawal by Subject|25
1586438|NCT02513550|5512856|P2|Double Blind Treatment Period|Withdrawal by Subject|11
1586439|NCT02513550|5512857|P1|Double Blind Treatment Period|Withdrawal by Subject|11
1586440|NCT02513160|5512967|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1586441|NCT02513160|5512968|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1586442|NCT02513160|5512969|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
1586443|NCT02513160|5512970|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
1586444|NCT02513160|5512967|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1586445|NCT02513160|5512968|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1586446|NCT02513160|5512969|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
1586447|NCT02513160|5512970|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
1586448|NCT02513160|5512967|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1586449|NCT02513160|5512968|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1586450|NCT02513160|5512969|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
1586451|NCT02513160|5512970|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
1586452|NCT02513160|5512967|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1586453|NCT02513160|5512968|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1586454|NCT02513160|5512969|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
1586455|NCT02513160|5512970|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
1586456|NCT02513160|5512967|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
1586457|NCT02513160|5512968|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
1586458|NCT02513160|5512969|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1586459|NCT02513160|5512970|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
1586460|NCT02513160|5512967|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1586461|NCT02513160|5512968|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1586462|NCT02513160|5512969|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
1586463|NCT02513160|5512970|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
1586464|NCT02513160|5512967|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1586465|NCT02513160|5512968|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1586466|NCT02513160|5512969|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
1586467|NCT02513160|5512970|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
1586468|NCT02513160|5512967|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1586469|NCT02513160|5512968|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1586470|NCT02513160|5512969|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
1586471|NCT02513160|5512970|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
1586472|NCT02513160|5512967|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1586473|NCT02513160|5512968|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1586474|NCT02513160|5512969|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
1586475|NCT02513160|5512970|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
1586476|NCT02513160|5512967|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1586477|NCT02513160|5512968|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1586478|NCT02513160|5512969|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
1586479|NCT02513160|5512970|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
1586480|NCT02513160|5512967|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1586481|NCT02513160|5512968|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1586482|NCT02513160|5512969|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
1586483|NCT02513160|5512970|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
1586484|NCT02513160|5512967|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1586485|NCT02513160|5512968|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1586486|NCT02513160|5512969|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
1586487|NCT02513160|5512970|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
1586488|NCT02513095|5513028|P2|Overall Study|Stampede resulted in transfers out of ER|16
1586489|NCT02513095|5513029|P1|Overall Study|Stampede resulted in transfers out of ER|14
1586490|NCT02512861|5513075|P2|Overall Study|Withdrawal by Subject|1
1586491|NCT02512861|5513076|P1|Overall Study|Withdrawal by Subject|0
1586492|NCT02512861|5513075|P2|Overall Study|Physician Decision|1
1586493|NCT02512861|5513076|P1|Overall Study|Physician Decision|3
1586494|NCT02512861|5513075|P2|Overall Study|Protocol Violation|7
1586495|NCT02512861|5513076|P1|Overall Study|Protocol Violation|3
1586496|NCT02512302|5513354|P10|Period 4|Adverse Event|0
1586497|NCT02512302|5513355|P9|Period 4|Adverse Event|0
1586498|NCT02512302|5513356|P8|Period 4|Adverse Event|0
1586499|NCT02512302|5513357|P7|Period 4|Adverse Event|1
1586500|NCT02512302|5513358|P6|Period 4|Adverse Event|0
1586501|NCT02512302|5513359|P5|Period 4|Adverse Event|0
1586502|NCT02512302|5513360|P4|Period 4|Adverse Event|0
1586503|NCT02512302|5513361|P3|Period 4|Adverse Event|0
1586504|NCT02512302|5513362|P2|Period 4|Adverse Event|0
1586505|NCT02512302|5513363|P1|Period 4|Adverse Event|0
1586506|NCT02512302|5513354|P10|Period 3|Lost to Follow-up|0
1586507|NCT02512302|5513355|P9|Period 3|Lost to Follow-up|0
1586508|NCT02512302|5513356|P8|Period 3|Lost to Follow-up|0
1586509|NCT02512302|5513357|P7|Period 3|Lost to Follow-up|0
1586510|NCT02512302|5513358|P6|Period 3|Lost to Follow-up|0
1586511|NCT02512302|5513359|P5|Period 3|Lost to Follow-up|0
1586512|NCT02512302|5513360|P4|Period 3|Lost to Follow-up|0
1586513|NCT02512302|5513361|P3|Period 3|Lost to Follow-up|1
1586514|NCT02512302|5513362|P2|Period 3|Lost to Follow-up|0
1586515|NCT02512302|5513363|P1|Period 3|Lost to Follow-up|0
1586516|NCT02512302|5513354|P10|Period 2|Adverse Event|1
1586517|NCT02512302|5513355|P9|Period 2|Adverse Event|0
1586518|NCT02512302|5513356|P8|Period 2|Adverse Event|0
1586519|NCT02512302|5513357|P7|Period 2|Adverse Event|0
1586520|NCT02512302|5513358|P6|Period 2|Adverse Event|0
1586521|NCT02512302|5513359|P5|Period 2|Adverse Event|0
1586522|NCT02512302|5513360|P4|Period 2|Adverse Event|0
1586523|NCT02512302|5513361|P3|Period 2|Adverse Event|0
1586524|NCT02512302|5513362|P2|Period 2|Adverse Event|0
1586525|NCT02512302|5513363|P1|Period 2|Adverse Event|0
1586526|NCT02512302|5513354|P10|Period 1|Adverse Event|0
1586527|NCT02512302|5513355|P9|Period 1|Adverse Event|0
1586528|NCT02512302|5513356|P8|Period 1|Adverse Event|0
1586529|NCT02512302|5513357|P7|Period 1|Adverse Event|0
1586530|NCT02512302|5513358|P6|Period 1|Adverse Event|0
1586531|NCT02512302|5513359|P5|Period 1|Adverse Event|0
1586532|NCT02512302|5513360|P4|Period 1|Adverse Event|0
1586533|NCT02512302|5513361|P3|Period 1|Adverse Event|0
1586534|NCT02512302|5513362|P2|Period 1|Adverse Event|1
1586535|NCT02512302|5513363|P1|Period 1|Adverse Event|0
1586536|NCT02512068|5513479|P2|Overall Study|Reason Not Specified|5
1586537|NCT02512068|5513480|P1|Overall Study|Reason Not Specified|3
1586538|NCT02512068|5513479|P2|Overall Study|Lack of Efficacy|1
1586539|NCT02512068|5513480|P1|Overall Study|Lack of Efficacy|0
1586540|NCT02512068|5513479|P2|Overall Study|Voluntary Withdrawal|1
1586541|NCT02512068|5513480|P1|Overall Study|Voluntary Withdrawal|0
1586542|NCT02512068|5513479|P2|Overall Study|Major Protocol Deviation|0
1586543|NCT02512068|5513480|P1|Overall Study|Major Protocol Deviation|1
1586544|NCT02512068|5513479|P2|Overall Study|Pretreatment Event/Adverse Event|6
1586545|NCT02512068|5513480|P1|Overall Study|Pretreatment Event/Adverse Event|8
1586546|NCT02511782|5513507|P3|Overall Study|Withdrawal by Subject|0
1586547|NCT02511782|5513508|P2|Overall Study|Withdrawal by Subject|0
1586548|NCT02511782|5513509|P1|Overall Study|Withdrawal by Subject|1
1586549|NCT02511678|5513528|P1|Overall Study|Received Radiation Treatment|1
1586550|NCT02511678|5513528|P1|Overall Study|Protocol Violation|1
1586551|NCT02511678|5513528|P1|Overall Study|Biopsy was Negative|1
1586552|NCT02511678|5513528|P1|Overall Study|Required Radiofrequency Ablation|1
1586553|NCT02511678|5513528|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
1586554|NCT02511678|5513528|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
1586555|NCT02511678|5513528|P1|Overall Study|Adverse Event|1
1586556|NCT02511678|5513528|P1|Overall Study|Death|19
1586557|NCT02511678|5513528|P1|Overall Study|Lost to Follow-up|4
1586558|NCT02511678|5513528|P1|Overall Study|Withdrawal by Subject|2
1586559|NCT02511431|5513582|P6|Treatment|Lost to Follow-up|1
1586560|NCT02511431|5513583|P5|Treatment|Lost to Follow-up|0
1586561|NCT02511431|5513584|P4|Treatment|Lost to Follow-up|0
1586562|NCT02511431|5513585|P3|Treatment|Lost to Follow-up|1
1586563|NCT02511431|5513586|P2|Treatment|Lost to Follow-up|0
1586564|NCT02511431|5513587|P1|Treatment|Lost to Follow-up|0
1586565|NCT02511184|5513614|P2|Overall Study|Withdrawal by Subject|1
1586566|NCT02511184|5513615|P1|Overall Study|Withdrawal by Subject|0
1586567|NCT02511184|5513614|P2|Overall Study|Study terminated by sponsor|5
1586568|NCT02511184|5513615|P1|Overall Study|Study terminated by sponsor|1
1586569|NCT02511184|5513614|P2|Overall Study|Lost to Follow-up|1
1586570|NCT02511184|5513615|P1|Overall Study|Lost to Follow-up|0
1586571|NCT02511184|5513614|P2|Overall Study|Death|0
1586572|NCT02511184|5513615|P1|Overall Study|Death|1
1586573|NCT02510820|5513665|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1586574|NCT02510820|5513666|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1586575|NCT02510820|5513665|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
1586576|NCT02510820|5513666|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
1586586|NCT02510014|5513751|P2|Treatment Period|Incarceration, pregnancy, misc|5
1586587|NCT02510014|5513752|P1|Treatment Period|Incarceration, pregnancy, misc|29
1586588|NCT02510014|5513751|P2|Treatment Period|Protocol Violation|4
1586589|NCT02510014|5513752|P1|Treatment Period|Protocol Violation|4
1586590|NCT02510014|5513751|P2|Treatment Period|Withdrawn by the investigator|1
1586591|NCT02510014|5513752|P1|Treatment Period|Withdrawn by the investigator|7
1586592|NCT02510014|5513751|P2|Treatment Period|Withdrawal by Subject|24
1586593|NCT02510014|5513752|P1|Treatment Period|Withdrawal by Subject|67
1586594|NCT02510014|5513751|P2|Treatment Period|Physician Decision|0
1586595|NCT02510014|5513752|P1|Treatment Period|Physician Decision|5
1586596|NCT02510014|5513751|P2|Treatment Period|Lost to Follow-up|19
1586597|NCT02510014|5513752|P1|Treatment Period|Lost to Follow-up|80
1586598|NCT02510014|5513751|P2|Treatment Period|Withdrawal symptoms|0
1586599|NCT02510014|5513752|P1|Treatment Period|Withdrawal symptoms|3
1586600|NCT02510014|5513751|P2|Treatment Period|Adverse Event|4
1586601|NCT02510014|5513752|P1|Treatment Period|Adverse Event|11
1586602|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Other|1
1586603|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Other|19
1586604|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
1586605|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
1586606|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
1586607|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
1586608|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
1586609|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
1586610|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
1586611|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
1586612|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
1586613|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
1586614|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
1586615|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
1586616|NCT02510014|5513751|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1586617|NCT02510014|5513752|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
1586618|NCT02509117|5513855|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
1586619|NCT02509117|5513856|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586620|NCT02509117|5513857|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586621|NCT02509117|5513858|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586622|NCT02509117|5513859|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586623|NCT02509117|5513860|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586624|NCT02509117|5513861|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586625|NCT02509117|5513862|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586626|NCT02509117|5513863|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586627|NCT02509117|5513864|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
1586628|NCT02509117|5513855|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
1586629|NCT02509117|5513856|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586630|NCT02509117|5513857|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586631|NCT02509117|5513858|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586632|NCT02509117|5513859|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586633|NCT02509117|5513860|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586634|NCT02509117|5513861|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586635|NCT02509117|5513862|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586636|NCT02509117|5513863|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586637|NCT02509117|5513864|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
1586638|NCT02509117|5513855|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586639|NCT02509117|5513856|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586640|NCT02509117|5513857|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586641|NCT02509117|5513858|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586642|NCT02509117|5513859|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586643|NCT02509117|5513860|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586644|NCT02509117|5513861|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586645|NCT02509117|5513862|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586646|NCT02509117|5513863|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
1586647|NCT02509117|5513864|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
1586648|NCT02509078|5514075|P2|Overall Study|Protocol Violation|1
1586649|NCT02509078|5514076|P1|Overall Study|Protocol Violation|1
1586650|NCT02508935|5514219|P1|Overall Study|Trial terminated by sponsor|5
1586651|NCT02508935|5514219|P1|Overall Study|Physician Decision|1
1586652|NCT02508935|5514219|P1|Overall Study|Protocol Violation|1
1586653|NCT02508935|5514219|P1|Overall Study|Adverse Event|3
1586654|NCT02508935|5514219|P1|Overall Study|Emesis|3
1586655|NCT02508935|5514219|P1|Overall Study|Pain Score <4|1
1586656|NCT02508935|5514219|P1|Overall Study|Withdrawal by Caregiver|8
1586657|NCT02508935|5514219|P1|Overall Study|Withdrawal by Subject|1
1586658|NCT02508701|5514235|P4|Overall Study|Lost to Follow-up|3
1586659|NCT02508701|5514236|P3|Overall Study|Lost to Follow-up|5
1586660|NCT02508701|5514237|P2|Overall Study|Lost to Follow-up|5
1586661|NCT02508701|5514238|P1|Overall Study|Lost to Follow-up|9
1586662|NCT02508194|5514298|P2|Overall Study|Principal Investigator Decision|2
1586663|NCT02508194|5514299|P1|Overall Study|Principal Investigator Decision|1
1586664|NCT02508194|5514298|P2|Overall Study|Error in Randomization|3
1586665|NCT02508194|5514299|P1|Overall Study|Error in Randomization|1
1586666|NCT02508194|5514298|P2|Overall Study|Withdrawal by Subject|18
1586667|NCT02508194|5514299|P1|Overall Study|Withdrawal by Subject|20
1586668|NCT02508194|5514298|P2|Overall Study|Lost to Follow-up|18
1586669|NCT02508194|5514299|P1|Overall Study|Lost to Follow-up|25
1586670|NCT02508194|5514298|P2|Overall Study|Death|3
1586671|NCT02508194|5514299|P1|Overall Study|Death|5
1586672|NCT02508116|5514339|P2|Overall Study|Physician Decision|0
1586673|NCT02508116|5514340|P1|Overall Study|Physician Decision|2
1586674|NCT02508116|5514339|P2|Overall Study|Protocol Violation|2
1586675|NCT02508116|5514340|P1|Overall Study|Protocol Violation|1
1586676|NCT02508116|5514339|P2|Overall Study|Withdrawal by Subject|2
1586677|NCT02508116|5514340|P1|Overall Study|Withdrawal by Subject|3
1586678|NCT02508116|5514339|P2|Overall Study|Lost to Follow-up|3
1586679|NCT02508116|5514340|P1|Overall Study|Lost to Follow-up|2
1586680|NCT02507973|5514367|P1|Overall Study|Adverse Event|1
1586681|NCT02507752|5514373|P1|Overall Study|Participant didn't perform visit Week 24|1
1586682|NCT02507752|5514373|P1|Overall Study|Participant didn't perform visit Week 12|1
1586683|NCT02507752|5514373|P1|Overall Study|Infusion reaction at first infusion|1
1586684|NCT02507752|5514373|P1|Overall Study|Lost to Follow-up|7
1586685|NCT02507752|5514373|P1|Overall Study|Protocol Violation|6
1586686|NCT02507752|5514373|P1|Overall Study|Adverse Event|1
1586687|NCT02507375|5514417|P2|Overall Study|Adverse Event|1
1586688|NCT02507375|5514418|P1|Overall Study|Adverse Event|0
1586689|NCT02507375|5514417|P2|Overall Study|Refused treatment|1
1586690|NCT02507375|5514418|P1|Overall Study|Refused treatment|0
1586691|NCT02507375|5514417|P2|Overall Study|Death|1
1586692|NCT02507375|5514418|P1|Overall Study|Death|0
1586693|NCT02507375|5514417|P2|Overall Study|Progressive Disease|5
1586694|NCT02507375|5514418|P1|Overall Study|Progressive Disease|4
1586695|NCT02507349|5514437|P2|Overall Study|Lost to Follow-up|144
1586696|NCT02507349|5514438|P1|Overall Study|Lost to Follow-up|174
1586697|NCT02507349|5514437|P2|Overall Study|Withdrawal by Subject|1
1586698|NCT02507349|5514438|P1|Overall Study|Withdrawal by Subject|1
1586699|NCT02507349|5514437|P2|Overall Study|Death|16
1586700|NCT02507349|5514438|P1|Overall Study|Death|12
1586701|NCT02507219|5514462|P6|Overall Study|Withdrawal by Subject|0
1586702|NCT02507219|5514463|P5|Overall Study|Withdrawal by Subject|1
1586703|NCT02507219|5514464|P4|Overall Study|Withdrawal by Subject|0
1586704|NCT02507219|5514465|P3|Overall Study|Withdrawal by Subject|0
1586705|NCT02507219|5514466|P2|Overall Study|Withdrawal by Subject|0
1586706|NCT02507219|5514467|P1|Overall Study|Withdrawal by Subject|0
1586707|NCT02507219|5514462|P6|Overall Study|Physician Decision|0
1586708|NCT02507219|5514463|P5|Overall Study|Physician Decision|0
1586709|NCT02507219|5514464|P4|Overall Study|Physician Decision|0
1586710|NCT02507219|5514465|P3|Overall Study|Physician Decision|0
1586711|NCT02507219|5514466|P2|Overall Study|Physician Decision|0
1586712|NCT02507219|5514467|P1|Overall Study|Physician Decision|1
1586713|NCT02506881|5514496|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
1586714|NCT02506881|5514497|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
1586715|NCT02506881|5514498|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
1586716|NCT02506881|5514499|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
1586717|NCT02506881|5514496|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1586718|NCT02506881|5514497|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1586719|NCT02506881|5514498|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1586720|NCT02506881|5514499|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1586721|NCT02506881|5514496|P4|First Intervention (Day 1)|Protocol Violation|0
1586722|NCT02506881|5514497|P3|First Intervention (Day 1)|Protocol Violation|1
1586723|NCT02506881|5514498|P2|First Intervention (Day 1)|Protocol Violation|0
1586724|NCT02506881|5514499|P1|First Intervention (Day 1)|Protocol Violation|0
1586725|NCT02506816|5514572|P1|Overall Study|Adverse Event|3
1586726|NCT02506257|5514698|P4|Overall Study|Protocol Violation|0
1586727|NCT02506257|5514699|P3|Overall Study|Protocol Violation|1
1586728|NCT02506257|5514700|P2|Overall Study|Protocol Violation|0
1586729|NCT02506257|5514701|P1|Overall Study|Protocol Violation|0
1586730|NCT02506257|5514698|P4|Overall Study|Adverse Event|0
1586731|NCT02506257|5514699|P3|Overall Study|Adverse Event|3
1586732|NCT02506257|5514700|P2|Overall Study|Adverse Event|2
1586733|NCT02506257|5514701|P1|Overall Study|Adverse Event|0
1586734|NCT02506101|5514733|P2|Overall Study|No enrollment and staff unavailability|0
1586735|NCT02506101|5514734|P1|Overall Study|No enrollment and staff unavailability|1
1586736|NCT02506101|5514733|P2|Overall Study|Transportation issues|0
1586737|NCT02506101|5514734|P1|Overall Study|Transportation issues|1
1586738|NCT02506036|5514750|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
1586739|NCT02506036|5514751|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
1586740|NCT02506036|5514750|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
1586741|NCT02506036|5514751|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
1586742|NCT02506036|5514750|P2|First Intervention (4-6 Weeks)|Death|0
1586743|NCT02506036|5514751|P1|First Intervention (4-6 Weeks)|Death|1
1586744|NCT02505945|5514759|P2|Overall Study|Lost to Follow-up|1
1586745|NCT02505945|5514760|P1|Overall Study|Lost to Follow-up|6
1586746|NCT02505945|5514759|P2|Overall Study|Physician Decision|1
1586747|NCT02505945|5514760|P1|Overall Study|Physician Decision|2
1586748|NCT02505945|5514759|P2|Overall Study|Adverse Event|0
1586749|NCT02505945|5514760|P1|Overall Study|Adverse Event|1
1586750|NCT02505945|5514759|P2|Overall Study|Withdrawal by Subject|2
1586751|NCT02505945|5514760|P1|Overall Study|Withdrawal by Subject|13
1586752|NCT02505867|5514770|P2|Overall Study|Lack of Efficacy|6
1586753|NCT02505867|5514771|P1|Overall Study|Lack of Efficacy|6
1586754|NCT02505334|5514779|P2|Extension Treatment Period|Unclassified|0
1586755|NCT02505334|5514780|P1|Extension Treatment Period|Unclassified|3
1586756|NCT02505334|5514779|P2|Extension Treatment Period|Withdrawal by Subject|0
1586757|NCT02505334|5514780|P1|Extension Treatment Period|Withdrawal by Subject|6
1586758|NCT02505334|5514779|P2|Extension Treatment Period|Lack of Efficacy|0
1586759|NCT02505334|5514780|P1|Extension Treatment Period|Lack of Efficacy|4
1586760|NCT02505334|5514779|P2|Extension Treatment Period|Adverse Event|0
1586761|NCT02505334|5514780|P1|Extension Treatment Period|Adverse Event|5
1586762|NCT02505334|5514779|P2|Main Treatment Period|Unclassified|10
1586763|NCT02505334|5514780|P1|Main Treatment Period|Unclassified|4
1586764|NCT02505334|5514779|P2|Main Treatment Period|Withdrawal by Subject|8
1586765|NCT02505334|5514780|P1|Main Treatment Period|Withdrawal by Subject|1
1586766|NCT02505334|5514779|P2|Main Treatment Period|Protocol Violation|1
1586767|NCT02505334|5514780|P1|Main Treatment Period|Protocol Violation|0
1586768|NCT02505334|5514779|P2|Main Treatment Period|Lack of Efficacy|17
1586769|NCT02505334|5514780|P1|Main Treatment Period|Lack of Efficacy|7
1586770|NCT02505334|5514779|P2|Main Treatment Period|Adverse Event|3
1586771|NCT02505334|5514780|P1|Main Treatment Period|Adverse Event|3
1586772|NCT02504892|5514916|P1|Overall Study|Adverse event-pneumonitis|2
1586773|NCT02504827|5514923|P1|Overall Study|Could not produce sputum|1
1586774|NCT02504671|5514962|P6|Overall Study|Protocol defined stopping criteria|3
1586775|NCT02504671|5514963|P5|Overall Study|Protocol defined stopping criteria|3
1586776|NCT02504671|5514964|P4|Overall Study|Protocol defined stopping criteria|5
1586777|NCT02504671|5514965|P3|Overall Study|Protocol defined stopping criteria|3
1586778|NCT02504671|5514966|P2|Overall Study|Protocol defined stopping criteria|4
1586779|NCT02504671|5514967|P1|Overall Study|Protocol defined stopping criteria|7
1586780|NCT02504671|5514962|P6|Overall Study|Lost to Follow-up|1
1586781|NCT02504671|5514963|P5|Overall Study|Lost to Follow-up|0
1586782|NCT02504671|5514964|P4|Overall Study|Lost to Follow-up|0
1586783|NCT02504671|5514965|P3|Overall Study|Lost to Follow-up|2
1586784|NCT02504671|5514966|P2|Overall Study|Lost to Follow-up|0
1586785|NCT02504671|5514967|P1|Overall Study|Lost to Follow-up|0
1586786|NCT02504671|5514962|P6|Overall Study|Protocol Violation|1
1586787|NCT02504671|5514963|P5|Overall Study|Protocol Violation|0
1586788|NCT02504671|5514964|P4|Overall Study|Protocol Violation|0
1586789|NCT02504671|5514965|P3|Overall Study|Protocol Violation|0
1586790|NCT02504671|5514966|P2|Overall Study|Protocol Violation|1
1586791|NCT02504671|5514967|P1|Overall Study|Protocol Violation|2
1586792|NCT02504671|5514962|P6|Overall Study|Adverse Event|2
1586793|NCT02504671|5514963|P5|Overall Study|Adverse Event|0
1586794|NCT02504671|5514964|P4|Overall Study|Adverse Event|1
1586795|NCT02504671|5514965|P3|Overall Study|Adverse Event|0
1586796|NCT02504671|5514966|P2|Overall Study|Adverse Event|1
1586797|NCT02504671|5514967|P1|Overall Study|Adverse Event|1
1586798|NCT02504671|5514962|P6|Overall Study|Lack of Efficacy|4
1586799|NCT02504671|5514963|P5|Overall Study|Lack of Efficacy|4
1586800|NCT02504671|5514964|P4|Overall Study|Lack of Efficacy|0
1586801|NCT02504671|5514965|P3|Overall Study|Lack of Efficacy|1
1586802|NCT02504671|5514966|P2|Overall Study|Lack of Efficacy|3
1586803|NCT02504671|5514967|P1|Overall Study|Lack of Efficacy|1
1586804|NCT02504671|5514962|P6|Overall Study|Withdrawal by Subject|3
1586805|NCT02504671|5514963|P5|Overall Study|Withdrawal by Subject|5
1586806|NCT02504671|5514964|P4|Overall Study|Withdrawal by Subject|4
1586807|NCT02504671|5514965|P3|Overall Study|Withdrawal by Subject|4
1586808|NCT02504671|5514966|P2|Overall Study|Withdrawal by Subject|5
1586809|NCT02504671|5514967|P1|Overall Study|Withdrawal by Subject|1
1586810|NCT02504541|5515139|P1|Overall Study|Multiple|5
1586811|NCT02504541|5515139|P1|Overall Study|Other|2
1586812|NCT02504541|5515139|P1|Overall Study|Termination by Sponsor|1
1586813|NCT02504541|5515139|P1|Overall Study|Protocol Violation|2
1586814|NCT02504541|5515139|P1|Overall Study|Met Stopping Criteria|1
1586815|NCT02504541|5515139|P1|Overall Study|Lost to Follow-up|1
1586816|NCT02504541|5515139|P1|Overall Study|Withdrawal by Subject|4
1586817|NCT02504541|5515139|P1|Overall Study|Adverse Event|4
1586818|NCT02504502|5515145|P2|Crossover to Enhanced Report|Lost to Follow-up|0
1586819|NCT02504502|5515146|P1|Crossover to Enhanced Report|Lost to Follow-up|5
1586820|NCT02504502|5515145|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
1586821|NCT02504502|5515146|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
1586822|NCT02504424|5515152|P1|Overall Study|Withdrawal by Subject|2
1586823|NCT02504320|5515161|P4|Treatment Period 3|Adverse Event|0
1586824|NCT02504320|5515162|P3|Treatment Period 3|Adverse Event|1
1586825|NCT02504320|5515163|P2|Treatment Period 3|Adverse Event|0
1586826|NCT02504320|5515164|P1|Treatment Period 3|Adverse Event|0
1586827|NCT02504320|5515161|P4|Treatment Period 3|Positive Drug Screen|1
1586828|NCT02504320|5515162|P3|Treatment Period 3|Positive Drug Screen|0
1586829|NCT02504320|5515163|P2|Treatment Period 3|Positive Drug Screen|0
1586830|NCT02504320|5515164|P1|Treatment Period 3|Positive Drug Screen|0
1586831|NCT02504320|5515161|P4|Treatment Period 2|Positive Drug Screen|0
1586832|NCT02504320|5515162|P3|Treatment Period 2|Positive Drug Screen|0
1586833|NCT02504320|5515163|P2|Treatment Period 2|Positive Drug Screen|1
1586834|NCT02504320|5515164|P1|Treatment Period 2|Positive Drug Screen|0
1586835|NCT02504320|5515161|P4|Treatment Period 1|Positive Drug Screen|0
1586836|NCT02504320|5515162|P3|Treatment Period 1|Positive Drug Screen|1
1586837|NCT02504320|5515163|P2|Treatment Period 1|Positive Drug Screen|0
1586838|NCT02504320|5515164|P1|Treatment Period 1|Positive Drug Screen|0
1586839|NCT02504294|5515184|P2|Overall Study|Lost to Follow-up|7
1586840|NCT02504294|5515185|P1|Overall Study|Lost to Follow-up|6
1586841|NCT02504294|5515184|P2|Overall Study|Physician Decision|2
1586842|NCT02504294|5515185|P1|Overall Study|Physician Decision|1
1586843|NCT02504294|5515184|P2|Overall Study|Protocol Violation|26
1586844|NCT02504294|5515185|P1|Overall Study|Protocol Violation|27
1586845|NCT02504294|5515184|P2|Overall Study|Withdrawal by Subject|1
1586846|NCT02504294|5515185|P1|Overall Study|Withdrawal by Subject|7
1586847|NCT02504294|5515184|P2|Overall Study|Adverse Event|12
1586848|NCT02504294|5515185|P1|Overall Study|Adverse Event|15
1586849|NCT02504268|5515195|P2|Overall Study|Not Disclosed|0
1586850|NCT02504268|5515196|P1|Overall Study|Not Disclosed|1
1586851|NCT02504268|5515195|P2|Overall Study|Poor/Non-Compliance|2
1586852|NCT02504268|5515196|P1|Overall Study|Poor/Non-Compliance|3
1586853|NCT02504268|5515195|P2|Overall Study|Lack of Efficacy|35
1586854|NCT02504268|5515196|P1|Overall Study|Lack of Efficacy|11
1586855|NCT02504268|5515195|P2|Overall Study|No Longer Meets Study Criteria|3
1586856|NCT02504268|5515196|P1|Overall Study|No Longer Meets Study Criteria|2
1586857|NCT02504268|5515195|P2|Overall Study|Subject Request to Discontinue|3
1586858|NCT02504268|5515196|P1|Overall Study|Subject Request to Discontinue|11
1586859|NCT02504268|5515195|P2|Overall Study|Death|1
1586860|NCT02504268|5515196|P1|Overall Study|Death|1
1586861|NCT02504268|5515195|P2|Overall Study|Lost to Follow-up|6
1586862|NCT02504268|5515196|P1|Overall Study|Lost to Follow-up|3
1586863|NCT02504268|5515195|P2|Overall Study|Pregnancy|0
1586864|NCT02504268|5515196|P1|Overall Study|Pregnancy|2
1586865|NCT02504268|5515195|P2|Overall Study|Withdrawal of Consent|10
1586866|NCT02504268|5515196|P1|Overall Study|Withdrawal of Consent|11
1586867|NCT02504268|5515195|P2|Overall Study|Adverse Event|8
1586868|NCT02504268|5515196|P1|Overall Study|Adverse Event|18
1586869|NCT02503865|5515231|P3|Overall Study|Refused treatment|2
1586870|NCT02503865|5515232|P2|Overall Study|Refused treatment|39
1586871|NCT02503865|5515233|P1|Overall Study|Refused treatment|4
1586872|NCT02503865|5515231|P3|Overall Study|Moved out of area|0
1586873|NCT02503865|5515232|P2|Overall Study|Moved out of area|8
1586874|NCT02503865|5515233|P1|Overall Study|Moved out of area|1
1586875|NCT02503787|5515278|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
1586876|NCT02503787|5515278|P1|Implant to 3 Month Endpoint|Adverse Event|2
1586877|NCT02503787|5515278|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
1586878|NCT02503787|5515278|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
1586879|NCT02503787|5515278|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
1586880|NCT02503787|5515278|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
1586881|NCT02503787|5515278|P1|Enrollment|Unable to be programmed|1
1586882|NCT02503787|5515278|P1|Enrollment|Inability to implant system|1
1586883|NCT02503787|5515278|P1|Enrollment|Protocol Violation|1
1586884|NCT02503787|5515278|P1|Enrollment|Adverse Event|1
1586885|NCT02503787|5515278|P1|Enrollment|Study closure|1
1586886|NCT02503787|5515278|P1|Enrollment|Lost to Follow-up|1
1586887|NCT02503787|5515278|P1|Enrollment|Insurance issue|2
1586888|NCT02503787|5515278|P1|Enrollment|Physician Decision|2
1586889|NCT02503787|5515278|P1|Enrollment|Inclusion/exclusion criteria not met|4
1586890|NCT02503787|5515278|P1|Enrollment|Withdrawal by Subject|6
1586891|NCT02503540|5515295|P1|Overall Study|Withdrawal by Subject|1
1586892|NCT02503540|5515295|P1|Overall Study|Death|2
1586893|NCT02503215|5515353|P1|Overall Study|Unable to use positive airway pressure|2
1586894|NCT02503215|5515353|P1|Overall Study|Unable to wear compression stockings|1
1586895|NCT02503202|5515364|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
1586896|NCT02503202|5515365|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
1586897|NCT02503202|5515366|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
1586898|NCT02503202|5515367|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
1586899|NCT02503202|5515368|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
1586900|NCT02503202|5515364|P5|Extension: Month 6 to 24|Physician Decision|0
1586901|NCT02503202|5515365|P4|Extension: Month 6 to 24|Physician Decision|3
1586902|NCT02503202|5515366|P3|Extension: Month 6 to 24|Physician Decision|1
1586903|NCT02503202|5515367|P2|Extension: Month 6 to 24|Physician Decision|0
1586904|NCT02503202|5515368|P1|Extension: Month 6 to 24|Physician Decision|1
1586905|NCT02503202|5515364|P5|Extension: Month 6 to 24|Lost to Follow-up|1
1586906|NCT02503202|5515365|P4|Extension: Month 6 to 24|Lost to Follow-up|10
1586907|NCT02503202|5515366|P3|Extension: Month 6 to 24|Lost to Follow-up|6
1586908|NCT02503202|5515367|P2|Extension: Month 6 to 24|Lost to Follow-up|8
1586909|NCT02503202|5515368|P1|Extension: Month 6 to 24|Lost to Follow-up|4
1586910|NCT02503202|5515364|P5|Extension: Month 6 to 24|Death|0
1586911|NCT02503202|5515365|P4|Extension: Month 6 to 24|Death|0
1586912|NCT02503202|5515366|P3|Extension: Month 6 to 24|Death|0
1586913|NCT02503202|5515367|P2|Extension: Month 6 to 24|Death|0
1586914|NCT02503202|5515368|P1|Extension: Month 6 to 24|Death|1
1586915|NCT02503202|5515364|P5|Extension: Month 6 to 24|Protocol Violation|0
1586916|NCT02503202|5515365|P4|Extension: Month 6 to 24|Protocol Violation|1
1586917|NCT02503202|5515366|P3|Extension: Month 6 to 24|Protocol Violation|0
1586918|NCT02503202|5515367|P2|Extension: Month 6 to 24|Protocol Violation|0
1586919|NCT02503202|5515368|P1|Extension: Month 6 to 24|Protocol Violation|0
1586920|NCT02503202|5515364|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
1586921|NCT02503202|5515365|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
1586922|NCT02503202|5515366|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
1586923|NCT02503202|5515367|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
1586924|NCT02503202|5515368|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
1586925|NCT02503202|5515364|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
1586926|NCT02503202|5515365|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
1586927|NCT02503202|5515366|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
1586928|NCT02503202|5515367|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
1586929|NCT02503202|5515368|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
1586930|NCT02503202|5515364|P5|Base Study: Up to Month 6|Physician Decision|1
1586931|NCT02503202|5515365|P4|Base Study: Up to Month 6|Physician Decision|0
1586932|NCT02503202|5515366|P3|Base Study: Up to Month 6|Physician Decision|0
1586933|NCT02503202|5515367|P2|Base Study: Up to Month 6|Physician Decision|0
1586934|NCT02503202|5515368|P1|Base Study: Up to Month 6|Physician Decision|0
1586935|NCT02503202|5515364|P5|Base Study: Up to Month 6|Lost to Follow-up|1
1586936|NCT02503202|5515365|P4|Base Study: Up to Month 6|Lost to Follow-up|5
1586937|NCT02503202|5515366|P3|Base Study: Up to Month 6|Lost to Follow-up|10
1586938|NCT02503202|5515367|P2|Base Study: Up to Month 6|Lost to Follow-up|8
1586939|NCT02503202|5515368|P1|Base Study: Up to Month 6|Lost to Follow-up|11
1586940|NCT02503202|5515364|P5|Base Study: Up to Month 6|Death|0
1586941|NCT02503202|5515365|P4|Base Study: Up to Month 6|Death|0
1586942|NCT02503202|5515366|P3|Base Study: Up to Month 6|Death|0
1586943|NCT02503202|5515367|P2|Base Study: Up to Month 6|Death|1
1586944|NCT02503202|5515368|P1|Base Study: Up to Month 6|Death|1
1586945|NCT02503085|5515410|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1586946|NCT02503085|5515411|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1586947|NCT02503085|5515412|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
1586948|NCT02503085|5515413|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
1586949|NCT02502864|5515452|P1|Overall Study|Withdrawal by Subject|1
1586950|NCT02502734|5515461|P2|Washout Period|Adverse Event|0
1586951|NCT02502734|5515462|P1|Washout Period|Adverse Event|1
1586952|NCT02502734|5515461|P2|Double-blind Treatment Period 1|Adverse Event|0
1586953|NCT02502734|5515462|P1|Double-blind Treatment Period 1|Adverse Event|1
1586954|NCT02502526|5515473|P3|Overall Study|Enrollment suspension|1
1586955|NCT02502526|5515474|P2|Overall Study|Enrollment suspension|1
1586956|NCT02502526|5515475|P1|Overall Study|Enrollment suspension|4
1586957|NCT02502526|5515473|P3|Overall Study|Disqualified due to cataract grading|1
1586958|NCT02502526|5515474|P2|Overall Study|Disqualified due to cataract grading|0
1586959|NCT02502526|5515475|P1|Overall Study|Disqualified due to cataract grading|0
1586960|NCT02502526|5515473|P3|Overall Study|Withdrawal by Subject|1
1586961|NCT02502526|5515474|P2|Overall Study|Withdrawal by Subject|1
1586962|NCT02502526|5515475|P1|Overall Study|Withdrawal by Subject|0
1586963|NCT02502526|5515473|P3|Overall Study|Lost to Follow-up|3
1586964|NCT02502526|5515474|P2|Overall Study|Lost to Follow-up|2
1586965|NCT02502526|5515475|P1|Overall Study|Lost to Follow-up|2
1586966|NCT02502149|5515572|P5|Intermediate|Discontinued prematurely|0
1586967|NCT02502149|5515573|P4|Intermediate|Discontinued prematurely|0
1586968|NCT02502149|5515574|P3|Intermediate|Discontinued prematurely|0
1586969|NCT02502149|5515575|P2|Intermediate|Discontinued prematurely|0
1586970|NCT02502149|5515576|P1|Intermediate|Discontinued prematurely|1
1586971|NCT02501629|5515716|P2|Overall Study|Subject did not return to site|1
1586972|NCT02501629|5515717|P1|Overall Study|Subject did not return to site|0
1586973|NCT02501629|5515716|P2|Overall Study|Withdrawal by Subject|5
1586974|NCT02501629|5515717|P1|Overall Study|Withdrawal by Subject|3
1586975|NCT02501629|5515716|P2|Overall Study|Early termination by sponsor|0
1586976|NCT02501629|5515717|P1|Overall Study|Early termination by sponsor|1
1586977|NCT02501629|5515716|P2|Overall Study|Withdrawn from study by sponsor|0
1586978|NCT02501629|5515717|P1|Overall Study|Withdrawn from study by sponsor|1
1586979|NCT02501629|5515716|P2|Overall Study|Death|1
1586980|NCT02501629|5515717|P1|Overall Study|Death|0
1586981|NCT02501161|5515750|P2|Overall Study|Other|0
1586982|NCT02501161|5515751|P1|Overall Study|Other|3
1586983|NCT02501161|5515750|P2|Overall Study|Withdrawal by Subject|15
1586984|NCT02501161|5515751|P1|Overall Study|Withdrawal by Subject|10
1586985|NCT02501161|5515750|P2|Overall Study|Lost to Follow-up|4
1586986|NCT02501161|5515751|P1|Overall Study|Lost to Follow-up|7
1586987|NCT02501161|5515750|P2|Overall Study|Adverse Event|6
1586988|NCT02501161|5515751|P1|Overall Study|Adverse Event|2
1586989|NCT02500979|5515875|P2|Period 2|Change in risk|0
1586990|NCT02500979|5515876|P1|Period 2|Change in risk|1
1586991|NCT02500979|5515875|P2|Period 1|Subject decision|0
1586992|NCT02500979|5515876|P1|Period 1|Subject decision|2
1586993|NCT02500979|5515875|P2|Period 1|Adverse Event|0
1586994|NCT02500979|5515876|P1|Period 1|Adverse Event|1
1586995|NCT02500979|5515875|P2|Period 1|Severe non-compliance to protocol|1
1586996|NCT02500979|5515876|P1|Period 1|Severe non-compliance to protocol|0
1586997|NCT02500979|5515875|P2|Period 1|Hyperglycemia|0
1586998|NCT02500979|5515876|P1|Period 1|Hyperglycemia|1
1586999|NCT02500901|5515910|P1|Overall Study|Disease ProgressionDD|2
1587000|NCT02500758|5515932|P2|Second Intervention (2 Minutes)|Protocol Violation|1
1587001|NCT02500758|5515933|P1|Second Intervention (2 Minutes)|Protocol Violation|1
1587002|NCT02500758|5515932|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
1587003|NCT02500758|5515933|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
1587004|NCT02500758|5515932|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
1587005|NCT02500758|5515933|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
1587006|NCT02500758|5515932|P2|Washout (1 Week)|Lost to Follow-up|2
1587007|NCT02500758|5515933|P1|Washout (1 Week)|Lost to Follow-up|2
1587008|NCT02500758|5515932|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
1587009|NCT02500758|5515933|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
1587010|NCT02500706|5515944|P3|Overall Study|Unclassified|1
1587011|NCT02500706|5515945|P2|Overall Study|Unclassified|0
1587012|NCT02500706|5515946|P1|Overall Study|Unclassified|0
1587013|NCT02500706|5515944|P3|Overall Study|Withdrawal by Subject|4
1587014|NCT02500706|5515945|P2|Overall Study|Withdrawal by Subject|6
1587015|NCT02500706|5515946|P1|Overall Study|Withdrawal by Subject|4
1587016|NCT02500706|5515944|P3|Overall Study|Lost to Follow-up|1
1587017|NCT02500706|5515945|P2|Overall Study|Lost to Follow-up|1
1587018|NCT02500706|5515946|P1|Overall Study|Lost to Follow-up|0
1587019|NCT02500706|5515944|P3|Overall Study|Adverse Event|1
1587020|NCT02500706|5515945|P2|Overall Study|Adverse Event|0
1587021|NCT02500706|5515946|P1|Overall Study|Adverse Event|0
1587022|NCT02500641|5516100|P2|Overall Study|Non compliance to study drug|1
1587023|NCT02500641|5516101|P1|Overall Study|Non compliance to study drug|0
1587024|NCT02500641|5516100|P2|Overall Study|Sponsor decision|0
1587025|NCT02500641|5516101|P1|Overall Study|Sponsor decision|1
1587026|NCT02500641|5516100|P2|Overall Study|Lost to Follow-up|0
1587027|NCT02500641|5516101|P1|Overall Study|Lost to Follow-up|1
1587028|NCT02500641|5516100|P2|Overall Study|Protocol Violation|2
1587029|NCT02500641|5516101|P1|Overall Study|Protocol Violation|1
1587030|NCT02500641|5516100|P2|Overall Study|Unable to follow study procedures|2
1587031|NCT02500641|5516101|P1|Overall Study|Unable to follow study procedures|3
1587032|NCT02500641|5516100|P2|Overall Study|Withdrawal by Subject|5
1587033|NCT02500641|5516101|P1|Overall Study|Withdrawal by Subject|4
1587034|NCT02500641|5516100|P2|Overall Study|Adverse Event|2
1587035|NCT02500641|5516101|P1|Overall Study|Adverse Event|0
1587036|NCT02500537|5516122|P2|Overall Study|Withdrawal by Subject|0
1587037|NCT02500537|5516123|P1|Overall Study|Withdrawal by Subject|1
1587038|NCT02500537|5516122|P2|Overall Study|Lost to Follow-up|1
1587039|NCT02500537|5516123|P1|Overall Study|Lost to Follow-up|0
1587040|NCT02500537|5516122|P2|Overall Study|Death|0
1587041|NCT02500537|5516123|P1|Overall Study|Death|2
1587042|NCT02500056|5516192|P2|Overall Study|Death|1
1587043|NCT02500056|5516193|P1|Overall Study|Death|3
1587044|NCT02500056|5516192|P2|Overall Study|Recurrence|0
1587045|NCT02500056|5516193|P1|Overall Study|Recurrence|1
1587046|NCT02500056|5516192|P2|Overall Study|Lost to Follow-up|7
1587047|NCT02500056|5516193|P1|Overall Study|Lost to Follow-up|3
1587048|NCT02499952|5516203|P1|Overall Study|Death|9
1587049|NCT02499952|5516203|P1|Overall Study|Lost to Follow-up|1
1587050|NCT02499900|5516212|P2|Extension Study Period|Other|2
1587051|NCT02499900|5516213|P1|Extension Study Period|Other|0
1587052|NCT02499900|5516212|P2|Extension Study Period|Lost to Follow-up|5
1587053|NCT02499900|5516213|P1|Extension Study Period|Lost to Follow-up|2
1587054|NCT02499900|5516212|P2|Extension Study Period|Pregnancy|2
1587055|NCT02499900|5516213|P1|Extension Study Period|Pregnancy|1
1587056|NCT02499900|5516212|P2|Extension Study Period|Physician Decision|5
1587057|NCT02499900|5516213|P1|Extension Study Period|Physician Decision|2
1587058|NCT02499900|5516212|P2|Extension Study Period|Withdrawal by Subject|2
1587059|NCT02499900|5516213|P1|Extension Study Period|Withdrawal by Subject|5
1587060|NCT02499900|5516212|P2|Extension Study Period|Adverse Event|4
1587061|NCT02499900|5516213|P1|Extension Study Period|Adverse Event|2
1587062|NCT02499900|5516212|P2|Completed Core, Continued Into Extension|Personal motivation|0
1587063|NCT02499900|5516213|P1|Completed Core, Continued Into Extension|Personal motivation|1
1587064|NCT02499900|5516212|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
1587065|NCT02499900|5516213|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
1587066|NCT02499900|5516212|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
1587067|NCT02499900|5516213|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
1587068|NCT02499900|5516212|P2|Completed Core, Continued Into Extension|Physician Decision|0
1587069|NCT02499900|5516213|P1|Completed Core, Continued Into Extension|Physician Decision|1
1587070|NCT02499900|5516212|P2|Core Study Period|Death|1
1587071|NCT02499900|5516213|P1|Core Study Period|Death|0
1587072|NCT02499900|5516212|P2|Core Study Period|Adverse Event|14
1587073|NCT02499900|5516213|P1|Core Study Period|Adverse Event|18
1587074|NCT02499900|5516212|P2|Core Study Period|Withdrawal by Subject|10
1587075|NCT02499900|5516213|P1|Core Study Period|Withdrawal by Subject|11
1587076|NCT02499900|5516212|P2|Core Study Period|Protocol Violation|0
1587077|NCT02499900|5516213|P1|Core Study Period|Protocol Violation|3
1587078|NCT02499900|5516212|P2|Core Study Period|Pregnancy|0
1587079|NCT02499900|5516213|P1|Core Study Period|Pregnancy|1
1587080|NCT02499900|5516212|P2|Core Study Period|Per sponsor request|1
1587081|NCT02499900|5516213|P1|Core Study Period|Per sponsor request|0
1587082|NCT02499900|5516212|P2|Core Study Period|Lost to Follow-up|2
1587083|NCT02499900|5516213|P1|Core Study Period|Lost to Follow-up|1
1587084|NCT02499900|5516212|P2|Core Study Period|Other|4
1587085|NCT02499900|5516213|P1|Core Study Period|Other|1
1587086|NCT02499783|5516244|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
1587087|NCT02499783|5516245|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
1587088|NCT02499783|5516246|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
1587089|NCT02499783|5516244|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
1587090|NCT02499783|5516245|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
1587091|NCT02499783|5516246|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
1587092|NCT02499783|5516244|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
1587093|NCT02499783|5516245|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
1587094|NCT02499783|5516246|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
1587095|NCT02499783|5516244|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
1587096|NCT02499783|5516245|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
1587097|NCT02499783|5516246|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
1587098|NCT02499783|5516244|P3|DB Period: Weeks 0-8|Other|0
1587099|NCT02499783|5516245|P2|DB Period: Weeks 0-8|Other|1
1587100|NCT02499783|5516246|P1|DB Period: Weeks 0-8|Other|1
1587101|NCT02499783|5516244|P3|DB Period: Weeks 0-8|Withdrew Consent|0
1587102|NCT02499783|5516245|P2|DB Period: Weeks 0-8|Withdrew Consent|0
1587103|NCT02499783|5516246|P1|DB Period: Weeks 0-8|Withdrew Consent|1
1587104|NCT02499783|5516244|P3|DB Period: Weeks 0-8|Adverse Event|0
1587105|NCT02499783|5516245|P2|DB Period: Weeks 0-8|Adverse Event|6
1587106|NCT02499783|5516246|P1|DB Period: Weeks 0-8|Adverse Event|8
1587107|NCT02499783|5516244|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
1587108|NCT02499783|5516245|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
1587109|NCT02499783|5516246|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
1587110|NCT02499783|5516244|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
1587111|NCT02499783|5516245|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
1587112|NCT02499783|5516246|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
1587113|NCT02499783|5516244|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
1587114|NCT02499783|5516245|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
1587115|NCT02499783|5516246|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
1587116|NCT02499575|5516304|P2|Overall Study|Protocol Violation|1
1587117|NCT02499575|5516305|P1|Overall Study|Protocol Violation|0
1587118|NCT02499406|5516315|P1|Overall Study|missed 3 treatment sessions|4
1587119|NCT02499263|5516336|P1|Overall Study|Pregnancy|1
1587120|NCT02499263|5516336|P1|Overall Study|Participant's decision|3
1587121|NCT02499263|5516336|P1|Overall Study|Adverse Events/Serious Adverse Events|11
1587122|NCT02499263|5516336|P1|Overall Study|investigator's judgment|12
1587123|NCT02499263|5516336|P1|Overall Study|Lack of Efficacy|22
1587124|NCT02499263|5516336|P1|Overall Study|Participant's withdrawal of consent|4
1587125|NCT02499263|5516336|P1|Overall Study|Lost to Follow-up|9
1587126|NCT02499172|5516373|P4|Overall Study|Lost to Follow-up|0
1587127|NCT02499172|5516374|P3|Overall Study|Lost to Follow-up|0
1587128|NCT02499172|5516375|P2|Overall Study|Lost to Follow-up|64
1587129|NCT02499172|5516376|P1|Overall Study|Lost to Follow-up|65
1587130|NCT02499172|5516373|P4|Overall Study|Financial reason|436
1587131|NCT02499172|5516374|P3|Overall Study|Financial reason|523
1587132|NCT02499172|5516375|P2|Overall Study|Financial reason|0
1587133|NCT02499172|5516376|P1|Overall Study|Financial reason|0
1587134|NCT02499159|5516388|P2|30-Day Follow-Up Phone Call|Other|0
1587135|NCT02499159|5516389|P1|30-Day Follow-Up Phone Call|Other|1
1587136|NCT02499159|5516388|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
1587137|NCT02499159|5516389|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
1587138|NCT02499159|5516388|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
1587139|NCT02499159|5516389|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
1587140|NCT02499159|5516388|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
1587141|NCT02499159|5516389|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
1587142|NCT02499159|5516388|P2|Randomization|Protocol Violation|1
1587143|NCT02499159|5516389|P1|Randomization|Protocol Violation|1
1587144|NCT02499146|5516413|P1|Overall Study|Began other treatment/therapy|13
1587145|NCT02499146|5516413|P1|Overall Study|Ongoing at date of cut-off|9
1587146|NCT02499146|5516413|P1|Overall Study|Other|2
1587147|NCT02499146|5516413|P1|Overall Study|Withdrawal by Subject|1
1587148|NCT02499146|5516413|P1|Overall Study|Lost to Follow-up|1
1587149|NCT02499120|5516453|P2|Overall Study|Ongoing on study|11
1587150|NCT02499120|5516454|P1|Overall Study|Ongoing on study|15
1587151|NCT02499120|5516453|P2|Overall Study|Other|0
1587152|NCT02499120|5516454|P1|Overall Study|Other|1
1587153|NCT02499120|5516453|P2|Overall Study|Withdrawal by Subject|5
1587154|NCT02499120|5516454|P1|Overall Study|Withdrawal by Subject|2
1587155|NCT02499120|5516453|P2|Overall Study|Participant refused further follow-up|0
1587156|NCT02499120|5516454|P1|Overall Study|Participant refused further follow-up|1
1587157|NCT02499120|5516453|P2|Overall Study|Lost to Follow-up|2
1587158|NCT02499120|5516454|P1|Overall Study|Lost to Follow-up|1
1587159|NCT02499120|5516453|P2|Overall Study|Death|42
1587160|NCT02499120|5516454|P1|Overall Study|Death|45
1587161|NCT02499029|5516485|P2|Overall Study|Death|0
1587162|NCT02499029|5516486|P1|Overall Study|Death|1
1587163|NCT02499029|5516485|P2|Overall Study|Physician Decision|1
1587164|NCT02499029|5516486|P1|Overall Study|Physician Decision|2
1587165|NCT02499029|5516485|P2|Overall Study|Lost to Follow-up|2
1587166|NCT02499029|5516486|P1|Overall Study|Lost to Follow-up|2
1587167|NCT02498821|5516513|P2|Overall Study|Screen failure|5
1587168|NCT02498821|5516514|P1|Overall Study|Screen failure|3
1587169|NCT02498678|5516558|P2|Overall Study|interference from the surgical team|2
1587170|NCT02498678|5516559|P1|Overall Study|interference from the surgical team|0
1587171|NCT02498652|5516575|P2|Overall Study|Protocol Violation|1
1587172|NCT02498652|5516576|P1|Overall Study|Protocol Violation|0
1587173|NCT02498418|5516704|P3|Overall Study|Participant taken prohibited medication|1
1587174|NCT02498418|5516705|P2|Overall Study|Participant taken prohibited medication|1
1587175|NCT02498418|5516706|P1|Overall Study|Participant taken prohibited medication|0
1587176|NCT02498418|5516704|P3|Overall Study|Lost to Follow-up|1
1587177|NCT02498418|5516705|P2|Overall Study|Lost to Follow-up|1
1587178|NCT02498418|5516706|P1|Overall Study|Lost to Follow-up|0
1587179|NCT02498418|5516704|P3|Overall Study|Withdrawal by Subject|3
1587180|NCT02498418|5516705|P2|Overall Study|Withdrawal by Subject|0
1587181|NCT02498418|5516706|P1|Overall Study|Withdrawal by Subject|2
1587182|NCT02498418|5516704|P3|Overall Study|Lack of Efficacy|1
1587183|NCT02498418|5516705|P2|Overall Study|Lack of Efficacy|0
1587184|NCT02498418|5516706|P1|Overall Study|Lack of Efficacy|0
1587185|NCT02498236|5516730|P8|Overall Study|Withdrawal by Subject|0
1587186|NCT02498236|5516731|P7|Overall Study|Withdrawal by Subject|0
1587187|NCT02498236|5516732|P6|Overall Study|Withdrawal by Subject|0
1587188|NCT02498236|5516733|P5|Overall Study|Withdrawal by Subject|1
1587189|NCT02498236|5516734|P4|Overall Study|Withdrawal by Subject|0
1587190|NCT02498236|5516735|P3|Overall Study|Withdrawal by Subject|0
1587191|NCT02498236|5516736|P2|Overall Study|Withdrawal by Subject|0
1587192|NCT02498236|5516737|P1|Overall Study|Withdrawal by Subject|0
1587193|NCT02498236|5516730|P8|Overall Study|Equipment failure|0
1587194|NCT02498236|5516731|P7|Overall Study|Equipment failure|1
1587195|NCT02498236|5516732|P6|Overall Study|Equipment failure|0
1587196|NCT02498236|5516733|P5|Overall Study|Equipment failure|0
1587197|NCT02498236|5516734|P4|Overall Study|Equipment failure|0
1587198|NCT02498236|5516735|P3|Overall Study|Equipment failure|0
1587199|NCT02498236|5516736|P2|Overall Study|Equipment failure|0
1587200|NCT02498236|5516737|P1|Overall Study|Equipment failure|0
1587201|NCT02498236|5516730|P8|Overall Study|Did not show for testing|1
1587202|NCT02498236|5516731|P7|Overall Study|Did not show for testing|0
1587203|NCT02498236|5516732|P6|Overall Study|Did not show for testing|0
1587204|NCT02498236|5516733|P5|Overall Study|Did not show for testing|0
1587205|NCT02498236|5516734|P4|Overall Study|Did not show for testing|0
1587206|NCT02498236|5516735|P3|Overall Study|Did not show for testing|0
1587207|NCT02498236|5516736|P2|Overall Study|Did not show for testing|0
1587208|NCT02498236|5516737|P1|Overall Study|Did not show for testing|1
1587209|NCT02497976|5516768|P2|Overall Study|Moved out of area|1
1587210|NCT02497976|5516769|P1|Overall Study|Moved out of area|0
1587211|NCT02497976|5516768|P2|Overall Study|Withdrawal by Subject|0
1587212|NCT02497976|5516769|P1|Overall Study|Withdrawal by Subject|2
1587213|NCT02497781|5516864|P2|Overall Study|Lost to Follow-up|1
1587214|NCT02497781|5516865|P1|Overall Study|Lost to Follow-up|1
1587215|NCT02497781|5516864|P2|Overall Study|Randomised but not treated|1
1587216|NCT02497781|5516865|P1|Overall Study|Randomised but not treated|1
1587217|NCT02497781|5516864|P2|Overall Study|Lack of Efficacy|1
1587218|NCT02497781|5516865|P1|Overall Study|Lack of Efficacy|0
1587219|NCT02497781|5516864|P2|Overall Study|Withdrawal by Subject|0
1587220|NCT02497781|5516865|P1|Overall Study|Withdrawal by Subject|2
1587221|NCT02497755|5516928|P2|Overall Study|Protocol Violation|0
1587222|NCT02497755|5516929|P1|Overall Study|Protocol Violation|1
1587223|NCT02497469|5516944|P2|Overall Study|Reason not Specified|6
1587224|NCT02497469|5516945|P1|Overall Study|Reason not Specified|6
1587225|NCT02497469|5516944|P2|Overall Study|Lack of Efficacy|40
1587226|NCT02497469|5516945|P1|Overall Study|Lack of Efficacy|86
1587227|NCT02497469|5516944|P2|Overall Study|Pregnancy|1
1587228|NCT02497469|5516945|P1|Overall Study|Pregnancy|1
1587229|NCT02497469|5516944|P2|Overall Study|Voluntary Withdrawal|41
1587230|NCT02497469|5516945|P1|Overall Study|Voluntary Withdrawal|39
1587231|NCT02497469|5516944|P2|Overall Study|Lost to Follow-up|4
1587232|NCT02497469|5516945|P1|Overall Study|Lost to Follow-up|14
1587233|NCT02497469|5516944|P2|Overall Study|Significant Protocol Deviation|5
1587234|NCT02497469|5516945|P1|Overall Study|Significant Protocol Deviation|4
1587235|NCT02497469|5516944|P2|Overall Study|Leukopenia or Lymphopenia|0
1587236|NCT02497469|5516945|P1|Overall Study|Leukopenia or Lymphopenia|1
1587237|NCT02497469|5516944|P2|Overall Study|Pretreatment Event/Adverse Event|16
1587238|NCT02497469|5516945|P1|Overall Study|Pretreatment Event/Adverse Event|18
1587239|NCT02497469|5516944|P2|Overall Study|Randomized but not Treated|2
1587240|NCT02497469|5516945|P1|Overall Study|Randomized but not Treated|0
1587241|NCT02497391|5516955|P6|Period 3 (14 Days)|Withdrawal by Subject|0
1587242|NCT02497391|5516956|P5|Period 3 (14 Days)|Withdrawal by Subject|0
1587243|NCT02497391|5516957|P4|Period 3 (14 Days)|Withdrawal by Subject|0
1587244|NCT02497391|5516958|P3|Period 3 (14 Days)|Withdrawal by Subject|1
1587245|NCT02497391|5516959|P2|Period 3 (14 Days)|Withdrawal by Subject|0
1587246|NCT02497391|5516960|P1|Period 3 (14 Days)|Withdrawal by Subject|0
1587247|NCT02497391|5516955|P6|Period 3 (14 Days)|Sponsor Decision|0
1587248|NCT02497391|5516956|P5|Period 3 (14 Days)|Sponsor Decision|1
1587249|NCT02497391|5516957|P4|Period 3 (14 Days)|Sponsor Decision|0
1587250|NCT02497391|5516958|P3|Period 3 (14 Days)|Sponsor Decision|0
1587251|NCT02497391|5516959|P2|Period 3 (14 Days)|Sponsor Decision|0
1587252|NCT02497391|5516960|P1|Period 3 (14 Days)|Sponsor Decision|0
1587253|NCT02497391|5516955|P6|Period 3 (14 Days)|Adverse Event|0
1587254|NCT02497391|5516956|P5|Period 3 (14 Days)|Adverse Event|0
1587255|NCT02497391|5516957|P4|Period 3 (14 Days)|Adverse Event|0
1587256|NCT02497391|5516958|P3|Period 3 (14 Days)|Adverse Event|0
1587257|NCT02497391|5516959|P2|Period 3 (14 Days)|Adverse Event|1
1587258|NCT02497391|5516960|P1|Period 3 (14 Days)|Adverse Event|0
1587259|NCT02497391|5516955|P6|Period 2 (14 Days)|Sponsor Decision|3
1587260|NCT02497391|5516956|P5|Period 2 (14 Days)|Sponsor Decision|2
1587261|NCT02497391|5516957|P4|Period 2 (14 Days)|Sponsor Decision|3
1587262|NCT02497391|5516958|P3|Period 2 (14 Days)|Sponsor Decision|2
1587263|NCT02497391|5516959|P2|Period 2 (14 Days)|Sponsor Decision|1
1587264|NCT02497391|5516960|P1|Period 2 (14 Days)|Sponsor Decision|3
1587265|NCT02497391|5516955|P6|Period 2 (14 Days)|Withdrawal by Subject|0
1587266|NCT02497391|5516956|P5|Period 2 (14 Days)|Withdrawal by Subject|0
1587267|NCT02497391|5516957|P4|Period 2 (14 Days)|Withdrawal by Subject|0
1587268|NCT02497391|5516958|P3|Period 2 (14 Days)|Withdrawal by Subject|1
1587269|NCT02497391|5516959|P2|Period 2 (14 Days)|Withdrawal by Subject|0
1587270|NCT02497391|5516960|P1|Period 2 (14 Days)|Withdrawal by Subject|1
1587271|NCT02497287|5516971|P1|Follow-up Phase (4 Week)|Other|1
1587272|NCT02497287|5516971|P1|Follow-up Phase (4 Week)|Adverse Event|3
1587273|NCT02497287|5516971|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
1587274|NCT02497287|5516971|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
1587275|NCT02497287|5516971|P1|Follow-up Phase (4 Week)|PI Decision|12
1587276|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
1587277|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Death|2
1587278|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
1587279|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
1587280|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
1587281|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
1587282|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Other|21
1587283|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
1587284|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
1587285|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
1587286|NCT02497287|5516971|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
1587287|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
1587288|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Protocol Violation|1
1587289|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
1587290|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Other|13
1587291|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
1587292|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
1587293|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Adverse Event|52
1587294|NCT02497287|5516971|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
1587295|NCT02496702|5517064|P2|Overall Study|Only partially tested|2
1587296|NCT02496702|5517065|P1|Overall Study|Only partially tested|0
1587297|NCT02496702|5517064|P2|Overall Study|Lost to Follow-up|6
1587298|NCT02496702|5517065|P1|Overall Study|Lost to Follow-up|8
1587299|NCT02496533|5517087|P2|Overall Study|Late for radiologic testing|2
1587300|NCT02496533|5517088|P1|Overall Study|Late for radiologic testing|0
1587301|NCT02496533|5517087|P2|Overall Study|Patient did not complete all measures|4
1587302|NCT02496533|5517088|P1|Overall Study|Patient did not complete all measures|0
1587303|NCT02496533|5517087|P2|Overall Study|Lack of data on outcome|0
1587304|NCT02496533|5517088|P1|Overall Study|Lack of data on outcome|3
1587305|NCT02496221|5517100|P2|Treatment Period 2 - 4 Days|Physician Decision|0
1587306|NCT02496221|5517101|P1|Treatment Period 2 - 4 Days|Physician Decision|1
1587307|NCT02496221|5517100|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
1587308|NCT02496221|5517101|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
1587309|NCT02496221|5517100|P2|Treatment Period 2 - 4 Days|Adverse Event|1
1587310|NCT02496221|5517101|P1|Treatment Period 2 - 4 Days|Adverse Event|0
1587311|NCT02496039|5517135|P1|Overall Study|Protocol Violation|1
1587312|NCT02496039|5517135|P1|Overall Study|Adverse Event|3
1587313|NCT02496000|5517150|P3|Overall Study|undetermined|0
1587314|NCT02496000|5517151|P2|Overall Study|undetermined|1
1587315|NCT02496000|5517152|P1|Overall Study|undetermined|0
1587316|NCT02496000|5517150|P3|Overall Study|Non-compliance or lack of cooperation|0
1587317|NCT02496000|5517151|P2|Overall Study|Non-compliance or lack of cooperation|2
1587318|NCT02496000|5517152|P1|Overall Study|Non-compliance or lack of cooperation|0
1587319|NCT02496000|5517150|P3|Overall Study|Protocol Violation|1
1587320|NCT02496000|5517151|P2|Overall Study|Protocol Violation|0
1587321|NCT02496000|5517152|P1|Overall Study|Protocol Violation|0
1587322|NCT02496000|5517150|P3|Overall Study|Lost to Follow-up|1
1587323|NCT02496000|5517151|P2|Overall Study|Lost to Follow-up|0
1587324|NCT02496000|5517152|P1|Overall Study|Lost to Follow-up|1
1587325|NCT02496000|5517150|P3|Overall Study|Withdrawal by Subject|0
1587326|NCT02496000|5517151|P2|Overall Study|Withdrawal by Subject|2
1587327|NCT02496000|5517152|P1|Overall Study|Withdrawal by Subject|1
1587328|NCT02495948|5517173|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1587329|NCT02495948|5517174|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1587330|NCT02495948|5517173|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1587331|NCT02495948|5517174|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1587332|NCT02495844|5517183|P2|Overall Study|Hepatitis Positivity|1
1587333|NCT02495844|5517184|P1|Overall Study|Hepatitis Positivity|0
1587334|NCT02495844|5517183|P2|Overall Study|AE, non-fatal|1
1587335|NCT02495844|5517184|P1|Overall Study|AE, non-fatal|0
1587336|NCT02495844|5517183|P2|Overall Study|Lack of Efficacy|2
1587337|NCT02495844|5517184|P1|Overall Study|Lack of Efficacy|1
1587338|NCT02495233|5517307|P2|Overall Study|Miscellaneous|1
1587339|NCT02495233|5517308|P1|Overall Study|Miscellaneous|0
1587340|NCT02495168|5517337|P3|Overall Study|Lack of Efficacy|3
1587341|NCT02495168|5517338|P2|Overall Study|Lack of Efficacy|0
1587342|NCT02495168|5517339|P1|Overall Study|Lack of Efficacy|0
1587343|NCT02495168|5517337|P3|Overall Study|Adverse Event|3
1587344|NCT02495168|5517338|P2|Overall Study|Adverse Event|8
1587345|NCT02495168|5517339|P1|Overall Study|Adverse Event|4
1587346|NCT02495168|5517337|P3|Overall Study|Protocol Violation|1
1587347|NCT02495168|5517338|P2|Overall Study|Protocol Violation|10
1587348|NCT02495168|5517339|P1|Overall Study|Protocol Violation|0
1587349|NCT02495168|5517337|P3|Overall Study|Withdrawal by Subject|2
1587350|NCT02495168|5517338|P2|Overall Study|Withdrawal by Subject|4
1587351|NCT02495168|5517339|P1|Overall Study|Withdrawal by Subject|1
1587352|NCT02495168|5517337|P3|Overall Study|Lost to Follow-up|1
1587353|NCT02495168|5517338|P2|Overall Study|Lost to Follow-up|6
1587354|NCT02495168|5517339|P1|Overall Study|Lost to Follow-up|10
1587355|NCT02495168|5517337|P3|Overall Study|Physician Decision|0
1587356|NCT02495168|5517338|P2|Overall Study|Physician Decision|1
1587357|NCT02495168|5517339|P1|Overall Study|Physician Decision|1
1587358|NCT02495168|5517337|P3|Overall Study|Did not Complete Final Visit On Time|2
1587359|NCT02495168|5517338|P2|Overall Study|Did not Complete Final Visit On Time|3
1587360|NCT02495168|5517339|P1|Overall Study|Did not Complete Final Visit On Time|4
1587361|NCT02495168|5517337|P3|Overall Study|Other than Specified|5
1587362|NCT02495168|5517338|P2|Overall Study|Other than Specified|22
1587363|NCT02495168|5517339|P1|Overall Study|Other than Specified|18
1587364|NCT02495025|5517398|P2|Overall Study|Withdrawal by Subject|0
1587365|NCT02495025|5517399|P1|Overall Study|Withdrawal by Subject|5
1587366|NCT02495025|5517398|P2|Overall Study|Lost to Follow-up|14
1587367|NCT02495025|5517399|P1|Overall Study|Lost to Follow-up|21
1587368|NCT02494596|5517451|P3|Overall Study|Refused Treatment|0
1587369|NCT02494596|5517452|P2|Overall Study|Refused Treatment|1
1587370|NCT02494596|5517453|P1|Overall Study|Refused Treatment|0
1587371|NCT02494596|5517451|P3|Overall Study|Adverse Event|0
1587372|NCT02494596|5517452|P2|Overall Study|Adverse Event|1
1587373|NCT02494596|5517453|P1|Overall Study|Adverse Event|0
1587374|NCT02494596|5517451|P3|Overall Study|Insufficient Therapeutic Response|1
1587375|NCT02494596|5517452|P2|Overall Study|Insufficient Therapeutic Response|3
1587376|NCT02494596|5517453|P1|Overall Study|Insufficient Therapeutic Response|3
1587377|NCT02494401|5517523|P2|Overall Study|Withdrawal by Subject|2
1587378|NCT02494401|5517524|P1|Overall Study|Withdrawal by Subject|3
1587379|NCT02494401|5517523|P2|Overall Study|Lost to Follow-up|25
1587380|NCT02494401|5517524|P1|Overall Study|Lost to Follow-up|22
1587381|NCT02494206|5517567|P1|Overall Study|Disease Progression|1
1587382|NCT02494206|5517567|P1|Overall Study|Adverse Event|1
1587383|NCT02493946|5517621|P3|Open Label Period|Site error|1
1587384|NCT02493946|5517622|P2|Open Label Period|Site error|0
1587385|NCT02493946|5517623|P1|Open Label Period|Site error|0
1587386|NCT02493946|5517621|P3|Open Label Period|Pregnancy|3
1587387|NCT02493946|5517622|P2|Open Label Period|Pregnancy|0
1587388|NCT02493946|5517623|P1|Open Label Period|Pregnancy|0
1587389|NCT02493946|5517621|P3|Open Label Period|Investigator decision, non-availability|1
1587390|NCT02493946|5517622|P2|Open Label Period|Investigator decision, non-availability|0
1587391|NCT02493946|5517623|P1|Open Label Period|Investigator decision, non-availability|0
1587392|NCT02493946|5517621|P3|Open Label Period|Investigator decision, non-compliance|2
1587393|NCT02493946|5517622|P2|Open Label Period|Investigator decision, non-compliance|0
1587394|NCT02493946|5517623|P1|Open Label Period|Investigator decision, non-compliance|0
1587395|NCT02493946|5517621|P3|Open Label Period|Lost to Follow-up|1
1587396|NCT02493946|5517622|P2|Open Label Period|Lost to Follow-up|0
1587397|NCT02493946|5517623|P1|Open Label Period|Lost to Follow-up|0
1587398|NCT02493946|5517621|P3|Open Label Period|Adverse Event|4
1587399|NCT02493946|5517622|P2|Open Label Period|Adverse Event|0
1587400|NCT02493946|5517623|P1|Open Label Period|Adverse Event|0
1587401|NCT02493946|5517621|P3|Open Label Period|Withdrawal by Subject|74
1587402|NCT02493946|5517622|P2|Open Label Period|Withdrawal by Subject|0
1587403|NCT02493946|5517623|P1|Open Label Period|Withdrawal by Subject|0
1587404|NCT02493946|5517621|P3|DB Period|Withdrawal by Subject|0
1587405|NCT02493946|5517622|P2|DB Period|Withdrawal by Subject|5
1587406|NCT02493946|5517623|P1|DB Period|Withdrawal by Subject|8
1587407|NCT02493868|5517656|P2|Follow-up Phase|Other|1
1587408|NCT02493868|5517657|P1|Follow-up Phase|Other|2
1587409|NCT02493868|5517656|P2|Follow-up Phase|Investigator Decision|1
1587410|NCT02493868|5517657|P1|Follow-up Phase|Investigator Decision|5
1587411|NCT02493868|5517656|P2|Follow-up Phase|Withdrawal by Subject|0
1587412|NCT02493868|5517657|P1|Follow-up Phase|Withdrawal by Subject|3
1587413|NCT02493868|5517656|P2|Follow-up Phase|Lost to Follow-up|0
1587414|NCT02493868|5517657|P1|Follow-up Phase|Lost to Follow-up|1
1587415|NCT02493868|5517656|P2|Maintenance Phase: DE+TE Participants|Other|9
1587416|NCT02493868|5517657|P1|Maintenance Phase: DE+TE Participants|Other|4
1587417|NCT02493868|5517656|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
1587418|NCT02493868|5517657|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
1587419|NCT02493868|5517656|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
1587420|NCT02493868|5517657|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
1587421|NCT02493868|5517656|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
1587422|NCT02493868|5517657|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
1587423|NCT02493868|5517656|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
1587424|NCT02493868|5517657|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
1587425|NCT02493868|5517656|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
1587426|NCT02493868|5517657|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
1587427|NCT02493868|5517656|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
1587428|NCT02493868|5517657|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
1587429|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|Other|2
1587430|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|Other|10
1587431|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
1587432|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
1587433|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
1587434|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
1587435|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
1587436|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
1587437|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
1587438|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
1587439|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
1587440|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
1587441|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
1587442|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
1587443|NCT02493868|5517656|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
1587444|NCT02493868|5517657|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
1587445|NCT02493868|5517656|P2|Induction Phase: DE Participants|Other|0
1587446|NCT02493868|5517657|P1|Induction Phase: DE Participants|Other|8
1587447|NCT02493868|5517656|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
1587448|NCT02493868|5517657|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
1587449|NCT02493868|5517656|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
1587450|NCT02493868|5517657|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
1587451|NCT02493868|5517656|P2|Induction Phase: DE Participants|Protocol Violation|0
1587452|NCT02493868|5517657|P1|Induction Phase: DE Participants|Protocol Violation|2
1587453|NCT02493868|5517656|P2|Induction Phase: DE Participants|Lack of Efficacy|0
1587454|NCT02493868|5517657|P1|Induction Phase: DE Participants|Lack of Efficacy|2
1587455|NCT02493868|5517656|P2|Induction Phase: DE Participants|Lost to Follow-up|0
1587456|NCT02493868|5517657|P1|Induction Phase: DE Participants|Lost to Follow-up|1
1587457|NCT02493868|5517656|P2|Induction Phase: DE Participants|Adverse Event|0
1587458|NCT02493868|5517657|P1|Induction Phase: DE Participants|Adverse Event|22
1587459|NCT02493855|5517706|P3|Overall Study|Withdrawal by Subject|0
1587460|NCT02493855|5517707|P2|Overall Study|Withdrawal by Subject|0
1587461|NCT02493855|5517708|P1|Overall Study|Withdrawal by Subject|1
1587462|NCT02493855|5517706|P3|Overall Study|Adverse Event|0
1587463|NCT02493855|5517707|P2|Overall Study|Adverse Event|1
1587464|NCT02493855|5517708|P1|Overall Study|Adverse Event|0
1587465|NCT02493855|5517706|P3|Overall Study|Non-compliance|0
1587466|NCT02493855|5517707|P2|Overall Study|Non-compliance|0
1587467|NCT02493855|5517708|P1|Overall Study|Non-compliance|1
1587468|NCT02493777|5517718|P2|Overall Study|Lost to Follow-up|1
1587469|NCT02493777|5517719|P1|Overall Study|Lost to Follow-up|0
1587470|NCT02493751|5517729|P2|Overall Study|Ongoing|23
1587471|NCT02493751|5517730|P1|Overall Study|Ongoing|11
1587472|NCT02493751|5517729|P2|Overall Study|Withdrawal by Subject|5
1587473|NCT02493751|5517730|P1|Overall Study|Withdrawal by Subject|2
1587474|NCT02493751|5517729|P2|Overall Study|Lost to Follow-up|1
1587475|NCT02493751|5517730|P1|Overall Study|Lost to Follow-up|0
1587476|NCT02493517|5517748|P2|Overall Study|Missed study visit|1
1587477|NCT02493517|5517749|P1|Overall Study|Missed study visit|0
1587478|NCT02493517|5517748|P2|Overall Study|Adverse Event|2
1587479|NCT02493517|5517749|P1|Overall Study|Adverse Event|0
1587480|NCT02493517|5517748|P2|Overall Study|Withdrawal by Subject|2
1587481|NCT02493517|5517749|P1|Overall Study|Withdrawal by Subject|1
1587482|NCT02493517|5517748|P2|Overall Study|Protocol Violation|2
1587483|NCT02493517|5517749|P1|Overall Study|Protocol Violation|1
1587484|NCT02493127|5517814|P2|Overall Study|Lost to Follow-up|1
1587485|NCT02493127|5517815|P1|Overall Study|Lost to Follow-up|1
1587486|NCT02493062|5517833|P1|Overall Study|Physician Decision|12
1587487|NCT02492984|5517856|P2|Overall Study|Withdrawal by Subject|0
1587488|NCT02492984|5517857|P1|Overall Study|Withdrawal by Subject|1
1587489|NCT02492984|5517856|P2|Overall Study|Protocol Violation|0
1587490|NCT02492984|5517857|P1|Overall Study|Protocol Violation|1
1587491|NCT02492984|5517856|P2|Overall Study|Adverse Event|0
1587492|NCT02492984|5517857|P1|Overall Study|Adverse Event|1
1587493|NCT02492958|5517881|P4|Overall Study|Adverse Event|0
1587494|NCT02492958|5517882|P3|Overall Study|Adverse Event|1
1587495|NCT02492958|5517883|P2|Overall Study|Adverse Event|0
1587496|NCT02492958|5517884|P1|Overall Study|Adverse Event|1
1587497|NCT02492958|5517881|P4|Overall Study|Withdrawal by Subject|0
1587498|NCT02492958|5517882|P3|Overall Study|Withdrawal by Subject|1
1587499|NCT02492958|5517883|P2|Overall Study|Withdrawal by Subject|0
1587500|NCT02492958|5517884|P1|Overall Study|Withdrawal by Subject|0
1587501|NCT02492880|5517970|P1|Overall Study|Protocol Violation|1
1587502|NCT02492880|5517970|P1|Overall Study|Lost to Follow-up|1
1587503|NCT02492841|5517977|P3|Overall Study|Lost to Follow-up|35
1587504|NCT02492841|5517978|P2|Overall Study|Lost to Follow-up|31
1587505|NCT02492841|5517979|P1|Overall Study|Lost to Follow-up|34
1587506|NCT02492763|5517998|P4|Overall Study|Study Terminated by Sponsor|10
1587507|NCT02492763|5517999|P3|Overall Study|Study Terminated by Sponsor|6
1587508|NCT02492763|5518000|P2|Overall Study|Study Terminated by Sponsor|10
1587509|NCT02492763|5518001|P1|Overall Study|Study Terminated by Sponsor|13
1587510|NCT02492763|5517998|P4|Overall Study|Screen Failure|1
1587511|NCT02492763|5517999|P3|Overall Study|Screen Failure|0
1587512|NCT02492763|5518000|P2|Overall Study|Screen Failure|0
1587513|NCT02492763|5518001|P1|Overall Study|Screen Failure|0
1587514|NCT02492763|5517998|P4|Overall Study|Non-Compliance With Study Drug|0
1587515|NCT02492763|5517999|P3|Overall Study|Non-Compliance With Study Drug|0
1587516|NCT02492763|5518000|P2|Overall Study|Non-Compliance With Study Drug|1
1587517|NCT02492763|5518001|P1|Overall Study|Non-Compliance With Study Drug|0
1587518|NCT02492763|5517998|P4|Overall Study|Lost to Follow-up|0
1587519|NCT02492763|5517999|P3|Overall Study|Lost to Follow-up|1
1587520|NCT02492763|5518000|P2|Overall Study|Lost to Follow-up|0
1587521|NCT02492763|5518001|P1|Overall Study|Lost to Follow-up|0
1587522|NCT02492763|5517998|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
1587523|NCT02492763|5517999|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
1587524|NCT02492763|5518000|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
1587525|NCT02492763|5518001|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
1587526|NCT02492763|5517998|P4|Overall Study|Death|0
1587527|NCT02492763|5517999|P3|Overall Study|Death|1
1587528|NCT02492763|5518000|P2|Overall Study|Death|0
1587529|NCT02492763|5518001|P1|Overall Study|Death|0
1587530|NCT02492763|5517998|P4|Overall Study|Adverse Event|2
1587531|NCT02492763|5517999|P3|Overall Study|Adverse Event|1
1587532|NCT02492763|5518000|P2|Overall Study|Adverse Event|1
1587533|NCT02492763|5518001|P1|Overall Study|Adverse Event|3
1587534|NCT02492763|5517998|P4|Overall Study|Withdrawal by Subject|0
1587535|NCT02492763|5517999|P3|Overall Study|Withdrawal by Subject|1
1587536|NCT02492763|5518000|P2|Overall Study|Withdrawal by Subject|2
1587537|NCT02492763|5518001|P1|Overall Study|Withdrawal by Subject|0
1587538|NCT02492165|5518072|P4|Overall Study|Withdrawal by Subject|0
1587539|NCT02492165|5518073|P3|Overall Study|Withdrawal by Subject|0
1587540|NCT02492165|5518074|P2|Overall Study|Withdrawal by Subject|1
1587541|NCT02492165|5518075|P1|Overall Study|Withdrawal by Subject|0
1587542|NCT02492100|5518097|P1|Overall Study|Death|1
1587543|NCT02491892|5518126|P2|Overall Study|Lost to Follow-up|0
1587544|NCT02491892|5518127|P1|Overall Study|Lost to Follow-up|1
1587545|NCT02491892|5518126|P2|Overall Study|Refused Treatment|0
1587546|NCT02491892|5518127|P1|Overall Study|Refused Treatment|1
1587547|NCT02491892|5518126|P2|Overall Study|Lack of Efficacy|36
1587548|NCT02491892|5518127|P1|Overall Study|Lack of Efficacy|37
1587549|NCT02491892|5518126|P2|Overall Study|Death|1
1587550|NCT02491892|5518127|P1|Overall Study|Death|1
1587551|NCT02491892|5518126|P2|Overall Study|Adverse Event|1
1587552|NCT02491892|5518127|P1|Overall Study|Adverse Event|1
1587553|NCT02491684|5518173|P2|Treatment Phase|Investigator and Sponsor decision|1
1587554|NCT02491684|5518174|P1|Treatment Phase|Investigator and Sponsor decision|0
1587555|NCT02491684|5518173|P2|Treatment Phase|Incorrect randomisation|0
1587556|NCT02491684|5518174|P1|Treatment Phase|Incorrect randomisation|1
1587557|NCT02491684|5518173|P2|Treatment Phase|Adverse Event|2
1587558|NCT02491684|5518174|P1|Treatment Phase|Adverse Event|2
1587559|NCT02491463|5518212|P4|Overall Study|Lost to Follow-up|0
1587560|NCT02491463|5518213|P3|Overall Study|Lost to Follow-up|3
1587561|NCT02491463|5518214|P2|Overall Study|Lost to Follow-up|3
1587562|NCT02491463|5518215|P1|Overall Study|Lost to Follow-up|0
1587563|NCT02491463|5518212|P4|Overall Study|Migrated/moved from study area|1
1587564|NCT02491463|5518213|P3|Overall Study|Migrated/moved from study area|1
1587565|NCT02491463|5518214|P2|Overall Study|Migrated/moved from study area|5
1587566|NCT02491463|5518215|P1|Overall Study|Migrated/moved from study area|1
1587567|NCT02491463|5518212|P4|Overall Study|Withdrawal by Subject|0
1587568|NCT02491463|5518213|P3|Overall Study|Withdrawal by Subject|0
1587569|NCT02491463|5518214|P2|Overall Study|Withdrawal by Subject|2
1587570|NCT02491463|5518215|P1|Overall Study|Withdrawal by Subject|1
1587571|NCT02491411|5518318|P1|Overall Study|Physician Decision|4
1587572|NCT02491073|5518349|P2|Overall Study|screen failure|0
1587573|NCT02491073|5518350|P1|Overall Study|screen failure|1
1587574|NCT02490475|5518402|P4|Period 2: Extension Phase|Adverse Event|0
1587575|NCT02490475|5518403|P3|Period 2: Extension Phase|Adverse Event|1
1587576|NCT02490475|5518404|P2|Period 2: Extension Phase|Adverse Event|0
1587577|NCT02490475|5518405|P1|Period 2: Extension Phase|Adverse Event|0
1587578|NCT02490475|5518402|P4|Period 2: Extension Phase|Refused Treatment|1
1587579|NCT02490475|5518403|P3|Period 2: Extension Phase|Refused Treatment|0
1587580|NCT02490475|5518404|P2|Period 2: Extension Phase|Refused Treatment|0
1587581|NCT02490475|5518405|P1|Period 2: Extension Phase|Refused Treatment|0
1587582|NCT02490475|5518402|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1587583|NCT02490475|5518403|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
1587584|NCT02490475|5518404|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1587585|NCT02490475|5518405|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
1587586|NCT02490475|5518402|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
1587587|NCT02490475|5518403|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
1587588|NCT02490475|5518404|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1587589|NCT02490475|5518405|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1587590|NCT02490475|5518402|P4|Period 1: First 6 Cycles|Refused Treatment|0
1587591|NCT02490475|5518403|P3|Period 1: First 6 Cycles|Refused Treatment|0
1587592|NCT02490475|5518404|P2|Period 1: First 6 Cycles|Refused Treatment|0
1587593|NCT02490475|5518405|P1|Period 1: First 6 Cycles|Refused Treatment|1
1587594|NCT02490475|5518402|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1587595|NCT02490475|5518403|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1587596|NCT02490475|5518404|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
1587597|NCT02490475|5518405|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1587598|NCT02490475|5518402|P4|Period 1: First 6 Cycles|Adverse Event|1
1587599|NCT02490475|5518403|P3|Period 1: First 6 Cycles|Adverse Event|0
1587600|NCT02490475|5518404|P2|Period 1: First 6 Cycles|Adverse Event|1
1587601|NCT02490475|5518405|P1|Period 1: First 6 Cycles|Adverse Event|2
1587602|NCT02490371|5518483|P2|Overall Study|Lost to Follow-up|1
1587603|NCT02490371|5518484|P1|Overall Study|Lost to Follow-up|1
1587604|NCT02489981|5518511|P1|Overall Study|Other than listed|28
1587605|NCT02489981|5518511|P1|Overall Study|Lost to Follow-up|31
1587606|NCT02489981|5518511|P1|Overall Study|Improved|31
1587607|NCT02489981|5518511|P1|Overall Study|Insufficient effectiveness|16
1587608|NCT02489981|5518511|P1|Overall Study|Adverse Event|21
1587609|NCT02489968|5518518|P6|Double-blind Treatment Period|Other than specified above|0
1587610|NCT02489968|5518519|P5|Double-blind Treatment Period|Other than specified above|1
1587611|NCT02489968|5518520|P4|Double-blind Treatment Period|Other than specified above|0
1587612|NCT02489968|5518521|P3|Double-blind Treatment Period|Other than specified above|0
1587613|NCT02489968|5518522|P2|Double-blind Treatment Period|Other than specified above|0
1587614|NCT02489968|5518523|P1|Double-blind Treatment Period|Other than specified above|0
1587615|NCT02489968|5518518|P6|Double-blind Treatment Period|Withdrawal by Subject|2
1587616|NCT02489968|5518519|P5|Double-blind Treatment Period|Withdrawal by Subject|0
1587617|NCT02489968|5518520|P4|Double-blind Treatment Period|Withdrawal by Subject|2
1587618|NCT02489968|5518521|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1587619|NCT02489968|5518522|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1587620|NCT02489968|5518523|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1587621|NCT02489968|5518518|P6|Double-blind Treatment Period|Protocol Violation|1
1587622|NCT02489968|5518519|P5|Double-blind Treatment Period|Protocol Violation|1
1587623|NCT02489968|5518520|P4|Double-blind Treatment Period|Protocol Violation|0
1587624|NCT02489968|5518521|P3|Double-blind Treatment Period|Protocol Violation|0
1587625|NCT02489968|5518522|P2|Double-blind Treatment Period|Protocol Violation|0
1587626|NCT02489968|5518523|P1|Double-blind Treatment Period|Protocol Violation|0
1587627|NCT02489968|5518518|P6|Double-blind Treatment Period|Adverse Event|5
1587628|NCT02489968|5518519|P5|Double-blind Treatment Period|Adverse Event|4
1587629|NCT02489968|5518520|P4|Double-blind Treatment Period|Adverse Event|6
1587630|NCT02489968|5518521|P3|Double-blind Treatment Period|Adverse Event|2
1587631|NCT02489968|5518522|P2|Double-blind Treatment Period|Adverse Event|0
1587632|NCT02489968|5518523|P1|Double-blind Treatment Period|Adverse Event|0
1587633|NCT02489968|5518518|P6|Open-label Treatment Period|Other than specified above|0
1587634|NCT02489968|5518519|P5|Open-label Treatment Period|Other than specified above|0
1587635|NCT02489968|5518520|P4|Open-label Treatment Period|Other than specified above|0
1587636|NCT02489968|5518521|P3|Open-label Treatment Period|Other than specified above|0
1587637|NCT02489968|5518522|P2|Open-label Treatment Period|Other than specified above|189
1587638|NCT02489968|5518523|P1|Open-label Treatment Period|Other than specified above|204
1587639|NCT02489968|5518518|P6|Open-label Treatment Period|Withdrawal by Subject|0
1587640|NCT02489968|5518519|P5|Open-label Treatment Period|Withdrawal by Subject|0
1587641|NCT02489968|5518520|P4|Open-label Treatment Period|Withdrawal by Subject|0
1587642|NCT02489968|5518521|P3|Open-label Treatment Period|Withdrawal by Subject|0
1587643|NCT02489968|5518522|P2|Open-label Treatment Period|Withdrawal by Subject|7
1587644|NCT02489968|5518523|P1|Open-label Treatment Period|Withdrawal by Subject|4
1587645|NCT02489968|5518518|P6|Open-label Treatment Period|Lost to Follow-up|0
1587646|NCT02489968|5518519|P5|Open-label Treatment Period|Lost to Follow-up|0
1587647|NCT02489968|5518520|P4|Open-label Treatment Period|Lost to Follow-up|0
1587648|NCT02489968|5518521|P3|Open-label Treatment Period|Lost to Follow-up|0
1587649|NCT02489968|5518522|P2|Open-label Treatment Period|Lost to Follow-up|3
1587650|NCT02489968|5518523|P1|Open-label Treatment Period|Lost to Follow-up|0
1587651|NCT02489968|5518518|P6|Open-label Treatment Period|Protocol Violation|0
1587652|NCT02489968|5518519|P5|Open-label Treatment Period|Protocol Violation|0
1587653|NCT02489968|5518520|P4|Open-label Treatment Period|Protocol Violation|0
1587654|NCT02489968|5518521|P3|Open-label Treatment Period|Protocol Violation|0
1587655|NCT02489968|5518522|P2|Open-label Treatment Period|Protocol Violation|2
1587656|NCT02489968|5518523|P1|Open-label Treatment Period|Protocol Violation|2
1587657|NCT02489968|5518518|P6|Open-label Treatment Period|Adverse Event|0
1587658|NCT02489968|5518519|P5|Open-label Treatment Period|Adverse Event|0
1587659|NCT02489968|5518520|P4|Open-label Treatment Period|Adverse Event|0
1587660|NCT02489968|5518521|P3|Open-label Treatment Period|Adverse Event|0
1587661|NCT02489968|5518522|P2|Open-label Treatment Period|Adverse Event|7
1587662|NCT02489968|5518523|P1|Open-label Treatment Period|Adverse Event|14
1587663|NCT02489799|5518537|P2|Overall Study|Death|1
1587664|NCT02489799|5518538|P1|Overall Study|Death|0
1587665|NCT02489799|5518537|P2|Overall Study|Withdrawal by Subject|1
1587666|NCT02489799|5518538|P1|Overall Study|Withdrawal by Subject|1
1587667|NCT02489799|5518537|P2|Overall Study|Failure to Maintain Eligibility|6
1587668|NCT02489799|5518538|P1|Overall Study|Failure to Maintain Eligibility|4
1587669|NCT02489799|5518537|P2|Overall Study|Lost to Follow-up|1
1587670|NCT02489799|5518538|P1|Overall Study|Lost to Follow-up|4
1587671|NCT02489773|5518564|P2|Overall Study|Leave the country or the state|1
1587672|NCT02489773|5518565|P1|Overall Study|Leave the country or the state|1
1587673|NCT02489773|5518564|P2|Overall Study|Withdrawal by Subject|0
1587674|NCT02489773|5518565|P1|Overall Study|Withdrawal by Subject|1
1587675|NCT02489773|5518564|P2|Overall Study|Physician Decision|0
1587676|NCT02489773|5518565|P1|Overall Study|Physician Decision|1
1587677|NCT02489773|5518564|P2|Overall Study|Lost to Follow-up|1
1587678|NCT02489773|5518565|P1|Overall Study|Lost to Follow-up|4
1587679|NCT02489500|5518575|P2|Overall Study|Death|1
1587680|NCT02489500|5518576|P1|Overall Study|Death|1
1587681|NCT02489344|5518594|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
1587682|NCT02489344|5518594|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
1587683|NCT02489344|5518594|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
1587684|NCT02489344|5518594|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
1587685|NCT02489279|5518636|P2|Overall Study|Lost to Follow-up|10
1587686|NCT02489279|5518637|P1|Overall Study|Lost to Follow-up|12
1587687|NCT02488980|5518678|P3|Overall Study|Protocol Violation|2
1587688|NCT02488980|5518679|P2|Overall Study|Protocol Violation|2
1587689|NCT02488980|5518680|P1|Overall Study|Protocol Violation|2
1587690|NCT02488915|5518697|P1|Overall Study|Withdrawal by Subject|1
1587691|NCT02488915|5518697|P1|Overall Study|Lost to Follow-up|4
1587692|NCT02488915|5518697|P1|Overall Study|Death|21
1587693|NCT02488824|5518715|P2|Overall Study|Adverse Event|1
1587694|NCT02488824|5518716|P1|Overall Study|Adverse Event|1
1587695|NCT02488681|5518730|P1|Overall Study|Implant unsuccessful|7
1587696|NCT02488330|5518734|P1|Overall Study|Study Termination by Sponsor|4
1587697|NCT02488330|5518734|P1|Overall Study|Disease Progression|3
1587698|NCT02488330|5518734|P1|Overall Study|Death|2
1587699|NCT02488330|5518734|P1|Overall Study|Physician Decision|2
1587700|NCT02488330|5518734|P1|Overall Study|Adverse Event|1
1587701|NCT02488239|5518755|P1|Overall Study|Did not undergo implant procedure|1
1587702|NCT02488239|5518755|P1|Overall Study|Consent ineligible|1
1587703|NCT02488239|5518755|P1|Overall Study|Physician Decision|2
1587704|NCT02488239|5518755|P1|Overall Study|Withdrawal by Subject|3
1587705|NCT02488239|5518755|P1|Overall Study|Death|3
1587706|NCT02488005|5518772|P1|Overall Study|Lost to Follow-up|2
1587707|NCT02487979|5518782|P1|Overall Study|Progressive Disease|17
1587708|NCT02487979|5518782|P1|Overall Study|Withdrawal by Subject|2
1587709|NCT02487979|5518782|P1|Overall Study|Physician Decision|2
1587710|NCT02487810|5518794|P2|Overall Study|Withdrawal by Subject|0
1587711|NCT02487810|5518795|P1|Overall Study|Withdrawal by Subject|1
1587712|NCT02487771|5518827|P2|Overall Study|Withdrawal by Subject|5
1587713|NCT02487771|5518828|P1|Overall Study|Withdrawal by Subject|3
1587714|NCT02487771|5518827|P2|Overall Study|Moved out of area|6
1587715|NCT02487771|5518828|P1|Overall Study|Moved out of area|5
1587716|NCT02487771|5518827|P2|Overall Study|Lost to Follow-up|3
1587717|NCT02487771|5518828|P1|Overall Study|Lost to Follow-up|2
1587718|NCT02487498|5518978|P2|Period: Period 2|Physician Decision|0
1587719|NCT02487498|5518979|P1|Period: Period 2|Physician Decision|1
1587720|NCT02487498|5518978|P2|Period: Period 2|Death|1
1587721|NCT02487498|5518979|P1|Period: Period 2|Death|0
1587722|NCT02487498|5518978|P2|Period: Period 2|Lost to Follow-up|1
1587723|NCT02487498|5518979|P1|Period: Period 2|Lost to Follow-up|1
1587724|NCT02487498|5518978|P2|Period: Period 2|Subject/guardian decision|1
1587725|NCT02487498|5518979|P1|Period: Period 2|Subject/guardian decision|2
1587726|NCT02487498|5518978|P2|Period: Period 2|Adverse Event|2
1587727|NCT02487498|5518979|P1|Period: Period 2|Adverse Event|2
1587728|NCT02487498|5518978|P2|Period: Washout|Non-compliance with study treatment|1
1587729|NCT02487498|5518979|P1|Period: Washout|Non-compliance with study treatment|0
1587730|NCT02487498|5518978|P2|Period: Washout|Physician Decision|0
1587731|NCT02487498|5518979|P1|Period: Washout|Physician Decision|1
1587732|NCT02487498|5518978|P2|Period: Washout|Lack of Efficacy|1
1587733|NCT02487498|5518979|P1|Period: Washout|Lack of Efficacy|1
1587734|NCT02487498|5518978|P2|Period: Washout|Subject/guardian decision|5
1587735|NCT02487498|5518979|P1|Period: Washout|Subject/guardian decision|0
1587736|NCT02487498|5518978|P2|Period: Period 1|Protocol deviation|0
1587737|NCT02487498|5518979|P1|Period: Period 1|Protocol deviation|1
1587738|NCT02487498|5518978|P2|Period: Period 1|Physician Decision|1
1587739|NCT02487498|5518979|P1|Period: Period 1|Physician Decision|0
1587740|NCT02487498|5518978|P2|Period: Period 1|Lack of Efficacy|0
1587741|NCT02487498|5518979|P1|Period: Period 1|Lack of Efficacy|1
1587742|NCT02487498|5518978|P2|Period: Period 1|Lost to Follow-up|2
1587743|NCT02487498|5518979|P1|Period: Period 1|Lost to Follow-up|0
1587744|NCT02487498|5518978|P2|Period: Period 1|Subject/guardian decision|4
1587745|NCT02487498|5518979|P1|Period: Period 1|Subject/guardian decision|2
1587746|NCT02487498|5518978|P2|Period: Period 1|Adverse Event|4
1587747|NCT02487498|5518979|P1|Period: Period 1|Adverse Event|2
1587748|NCT02487472|5519002|P1|Overall Study|Other|2
1587749|NCT02487472|5519002|P1|Overall Study|Did not complete telephonic interviews|9
1587750|NCT02487446|5519018|P2|Period 2|Adverse Event|2
1587751|NCT02487446|5519019|P1|Period 2|Adverse Event|6
1587752|NCT02487446|5519018|P2|Period 2|Withdrawal by Subject|1
1587753|NCT02487446|5519019|P1|Period 2|Withdrawal by Subject|1
1587754|NCT02487446|5519018|P2|Period 2|Lost to Follow-up|1
1587755|NCT02487446|5519019|P1|Period 2|Lost to Follow-up|1
1587756|NCT02487446|5519018|P2|Period 2|Protocol deviation|1
1587757|NCT02487446|5519019|P1|Period 2|Protocol deviation|0
1587758|NCT02487446|5519018|P2|Washout|Adverse Event|2
1587759|NCT02487446|5519019|P1|Washout|Adverse Event|2
1587760|NCT02487446|5519018|P2|Washout|Withdrawal by Subject|4
1587761|NCT02487446|5519019|P1|Washout|Withdrawal by Subject|1
1587762|NCT02487446|5519018|P2|Washout|Lost to Follow-up|2
1587763|NCT02487446|5519019|P1|Washout|Lost to Follow-up|0
1587764|NCT02487446|5519018|P2|Period 1|Adverse Event|5
1587765|NCT02487446|5519019|P1|Period 1|Adverse Event|5
1587766|NCT02487446|5519018|P2|Period 1|Withdrawal by Subject|0
1587767|NCT02487446|5519019|P1|Period 1|Withdrawal by Subject|2
1587768|NCT02487446|5519018|P2|Period 1|Lost to Follow-up|0
1587769|NCT02487446|5519019|P1|Period 1|Lost to Follow-up|2
1587770|NCT02487446|5519018|P2|Period 1|Protocol deviation|2
1587771|NCT02487446|5519019|P1|Period 1|Protocol deviation|3
1587772|NCT02487446|5519018|P2|Period 1|Lack of Efficacy|0
1587773|NCT02487446|5519019|P1|Period 1|Lack of Efficacy|1
1587774|NCT02487446|5519018|P2|Period 1|Physician Decision|1
1587775|NCT02487446|5519019|P1|Period 1|Physician Decision|0
1587776|NCT02487199|5519099|P2|Overall Study|Withdrew Consent|1
1587777|NCT02487199|5519100|P1|Overall Study|Withdrew Consent|0
1587778|NCT02487030|5519119|P7|Overall Study|Death|0
1587779|NCT02487030|5519120|P6|Overall Study|Death|0
1587780|NCT02487030|5519121|P5|Overall Study|Death|1
1587781|NCT02487030|5519122|P4|Overall Study|Death|0
1587782|NCT02487030|5519123|P3|Overall Study|Death|0
1587783|NCT02487030|5519124|P2|Overall Study|Death|0
1587784|NCT02487030|5519125|P1|Overall Study|Death|0
1587785|NCT02487030|5519119|P7|Overall Study|Adverse Event|0
1587786|NCT02487030|5519120|P6|Overall Study|Adverse Event|0
1587787|NCT02487030|5519121|P5|Overall Study|Adverse Event|0
1587788|NCT02487030|5519122|P4|Overall Study|Adverse Event|1
1587789|NCT02487030|5519123|P3|Overall Study|Adverse Event|0
1587790|NCT02487030|5519124|P2|Overall Study|Adverse Event|0
1587791|NCT02487030|5519125|P1|Overall Study|Adverse Event|0
1587792|NCT02487030|5519119|P7|Overall Study|Lost to Follow-up|0
1587793|NCT02487030|5519120|P6|Overall Study|Lost to Follow-up|1
1587794|NCT02487030|5519121|P5|Overall Study|Lost to Follow-up|0
1587795|NCT02487030|5519122|P4|Overall Study|Lost to Follow-up|1
1587796|NCT02487030|5519123|P3|Overall Study|Lost to Follow-up|1
1587797|NCT02487030|5519124|P2|Overall Study|Lost to Follow-up|0
1587798|NCT02487030|5519125|P1|Overall Study|Lost to Follow-up|0
1587799|NCT02487030|5519119|P7|Overall Study|Lack of Efficacy|0
1587800|NCT02487030|5519120|P6|Overall Study|Lack of Efficacy|0
1587801|NCT02487030|5519121|P5|Overall Study|Lack of Efficacy|1
1587802|NCT02487030|5519122|P4|Overall Study|Lack of Efficacy|0
1587803|NCT02487030|5519123|P3|Overall Study|Lack of Efficacy|1
1587804|NCT02487030|5519124|P2|Overall Study|Lack of Efficacy|4
1587805|NCT02487030|5519125|P1|Overall Study|Lack of Efficacy|2
1587806|NCT02486952|5519156|P1|Overall Study|Other|2
1587807|NCT02486952|5519156|P1|Overall Study|Lost to Follow-up|26
1587808|NCT02486952|5519156|P1|Overall Study|Lack of Efficacy|3
1587809|NCT02486952|5519156|P1|Overall Study|Death|15
1587810|NCT02486952|5519156|P1|Overall Study|Adverse Event|1
1587811|NCT02486952|5519156|P1|Overall Study|Not Started Induction Therapy|3
1587812|NCT02486796|5519174|P2|Overall Study|Physician Decision|0
1587813|NCT02486796|5519175|P1|Overall Study|Physician Decision|1
1587814|NCT02486796|5519174|P2|Overall Study|Withdrawal by Subject|1
1587815|NCT02486796|5519175|P1|Overall Study|Withdrawal by Subject|1
1587816|NCT02486757|5519187|P1|Overall Study|Lost to Follow-up|1
1587817|NCT02486692|5519193|P2|Overall Study|did not login for randomization|7
1587818|NCT02486692|5519194|P1|Overall Study|did not login for randomization|4
1587819|NCT02486653|5519206|P2|Overall Study|surgery cancelled|1
1587820|NCT02486653|5519207|P1|Overall Study|surgery cancelled|4
1587821|NCT02486653|5519206|P2|Overall Study|Protocol Violation|0
1587822|NCT02486653|5519207|P1|Overall Study|Protocol Violation|1
1587823|NCT02486653|5519206|P2|Overall Study|Withdrawal by Subject|3
1587824|NCT02486653|5519207|P1|Overall Study|Withdrawal by Subject|1
1587825|NCT02486627|5519231|P2|Overall Study|Lost to Follow-up|3
1587826|NCT02486627|5519232|P1|Overall Study|Lost to Follow-up|1
1587827|NCT02486627|5519231|P2|Overall Study|Significant Participant Noncompliance|1
1587828|NCT02486627|5519232|P1|Overall Study|Significant Participant Noncompliance|1
1587829|NCT02486627|5519231|P2|Overall Study|Consent Withdrawn by Participant|3
1587830|NCT02486627|5519232|P1|Overall Study|Consent Withdrawn by Participant|4
1587831|NCT02486627|5519231|P2|Overall Study|Other Unspecified|2
1587832|NCT02486627|5519232|P1|Overall Study|Other Unspecified|0
1587833|NCT02486627|5519231|P2|Overall Study|Death|0
1587834|NCT02486627|5519232|P1|Overall Study|Death|1
1587835|NCT02486302|5519249|P1|Overall Study|Not treated|3
1587836|NCT02486302|5519249|P1|Overall Study|Excluded due to legal reasons|8
1587837|NCT02486302|5519249|P1|Overall Study|Documentation not completed|255
1587838|NCT02486302|5519249|P1|Overall Study|Discontinued prematurely|410
1587839|NCT02485925|5519329|P1|Overall Study|Lost to Follow-up|11
1587840|NCT02485925|5519329|P1|Overall Study|Death|1
1587841|NCT02485925|5519329|P1|Overall Study|Withdrawal by Subject|3
1587842|NCT02485717|5519361|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
1587843|NCT02485717|5519362|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
1587844|NCT02485717|5519363|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
1587845|NCT02485717|5519361|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
1587846|NCT02485717|5519362|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
1587847|NCT02485717|5519363|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
1587848|NCT02485717|5519361|P3|Overall Study|Withdrawal by Subject|1
1587849|NCT02485717|5519362|P2|Overall Study|Withdrawal by Subject|0
1587850|NCT02485717|5519363|P1|Overall Study|Withdrawal by Subject|0
1587851|NCT02485717|5519361|P3|Overall Study|Lost to Follow-up|0
1587852|NCT02485717|5519362|P2|Overall Study|Lost to Follow-up|0
1587853|NCT02485717|5519363|P1|Overall Study|Lost to Follow-up|6
1587854|NCT02485704|5519378|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
1587855|NCT02485704|5519379|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
1587856|NCT02485704|5519378|P2|Overall Study|Withdrawal by Subject|3
1587857|NCT02485704|5519379|P1|Overall Study|Withdrawal by Subject|0
1587858|NCT02485704|5519378|P2|Overall Study|Lost to Follow-up|5
1587859|NCT02485704|5519379|P1|Overall Study|Lost to Follow-up|4
1587860|NCT02485483|5519427|P2|Overall Study|Discontinued after baseline|0
1587861|NCT02485483|5519428|P1|Overall Study|Discontinued after baseline|39
1587862|NCT02485483|5519427|P2|Overall Study|Depression at baseline|0
1587863|NCT02485483|5519428|P1|Overall Study|Depression at baseline|15
1587864|NCT02485353|5519443|P1|Overall Study|Disease Progression|1
1587865|NCT02485353|5519443|P1|Overall Study|Death|1
1587866|NCT02485301|5519450|P2|Overall Study|Other|4
1587867|NCT02485301|5519451|P1|Overall Study|Other|3
1587868|NCT02485301|5519450|P2|Overall Study|Lost to Follow-up|17
1587869|NCT02485301|5519451|P1|Overall Study|Lost to Follow-up|17
1587870|NCT02485301|5519450|P2|Overall Study|Migrated/moved from study area|19
1587871|NCT02485301|5519451|P1|Overall Study|Migrated/moved from study area|10
1587872|NCT02485301|5519450|P2|Overall Study|Withdrawal by Subject|7
1587873|NCT02485301|5519451|P1|Overall Study|Withdrawal by Subject|6
1587874|NCT02485301|5519450|P2|Overall Study|Protocol Violation|1
1587875|NCT02485301|5519451|P1|Overall Study|Protocol Violation|0
1587876|NCT02485301|5519450|P2|Overall Study|Serious Adverse Events|1
1587877|NCT02485301|5519451|P1|Overall Study|Serious Adverse Events|2
1587878|NCT02485158|5519501|P1|Overall Study|expected drug side effect|1
1587879|NCT02485158|5519501|P1|Overall Study|Withdrawal by Subject|3
1587880|NCT02484911|5519590|P2|Overall Study|Protocol Violation|1
1587881|NCT02484911|5519591|P1|Overall Study|Protocol Violation|2
1587882|NCT02484911|5519590|P2|Overall Study|Withdrawal by Subject|1
1587883|NCT02484911|5519591|P1|Overall Study|Withdrawal by Subject|2
1587884|NCT02484729|5519681|P10|Overall Study|Failure of IntelliCap Error|1
1587885|NCT02484729|5519682|P9|Overall Study|Failure of IntelliCap Error|0
1587886|NCT02484729|5519683|P8|Overall Study|Failure of IntelliCap Error|0
1587887|NCT02484729|5519684|P7|Overall Study|Failure of IntelliCap Error|0
1587888|NCT02484729|5519685|P6|Overall Study|Failure of IntelliCap Error|0
1587889|NCT02484729|5519686|P5|Overall Study|Failure of IntelliCap Error|0
1587890|NCT02484729|5519687|P4|Overall Study|Failure of IntelliCap Error|0
1587891|NCT02484729|5519688|P3|Overall Study|Failure of IntelliCap Error|0
1587892|NCT02484729|5519689|P2|Overall Study|Failure of IntelliCap Error|0
1587893|NCT02484729|5519690|P1|Overall Study|Failure of IntelliCap Error|0
1587894|NCT02484651|5519888|P2|Overall Study|Time of the procedure less than 90 min.|2
1587895|NCT02484651|5519889|P1|Overall Study|Time of the procedure less than 90 min.|1
1587896|NCT02484651|5519888|P2|Overall Study|BIS monitoring failed.|1
1587897|NCT02484651|5519889|P1|Overall Study|BIS monitoring failed.|1
1587898|NCT02484651|5519888|P2|Overall Study|Patients' data files were corrupted.|1
1587899|NCT02484651|5519889|P1|Overall Study|Patients' data files were corrupted.|1
1587900|NCT02483975|5519910|P2|Overall Study|Physician Decision|0
1587901|NCT02483975|5519911|P1|Overall Study|Physician Decision|2
1587902|NCT02483975|5519910|P2|Overall Study|Lost to Follow-up|1
1587903|NCT02483975|5519911|P1|Overall Study|Lost to Follow-up|0
1587904|NCT02483975|5519910|P2|Overall Study|Adverse Event|1
1587905|NCT02483975|5519911|P1|Overall Study|Adverse Event|0
1587906|NCT02483611|5519928|P3|Overall Study|Protocol Violation|1
1587907|NCT02483611|5519929|P2|Overall Study|Protocol Violation|0
1587908|NCT02483611|5519930|P1|Overall Study|Protocol Violation|0
1587909|NCT02483585|5520027|P2|Open-label Treatment Phase|Lost to Follow-up|5
1587910|NCT02483585|5520028|P1|Open-label Treatment Phase|Lost to Follow-up|3
1587911|NCT02483585|5520027|P2|Open-label Treatment Phase|Withdrawal by Subject|14
1587912|NCT02483585|5520028|P1|Open-label Treatment Phase|Withdrawal by Subject|18
1587913|NCT02483585|5520027|P2|Open-label Treatment Phase|Decision by Sponsor|1
1587914|NCT02483585|5520028|P1|Open-label Treatment Phase|Decision by Sponsor|0
1587915|NCT02483585|5520027|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
1587916|NCT02483585|5520028|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
1587917|NCT02483585|5520027|P2|Double-blind Treatment Phase|Lost to Follow-up|2
1587918|NCT02483585|5520028|P1|Double-blind Treatment Phase|Lost to Follow-up|3
1587919|NCT02483585|5520027|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
1587920|NCT02483585|5520028|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
1587921|NCT02483585|5520027|P2|Double-blind Treatment Phase|Decision by Sponsor|1
1587922|NCT02483585|5520028|P1|Double-blind Treatment Phase|Decision by Sponsor|1
1587923|NCT02483572|5520050|P2|Overall Study|Physician Decision|1
1587924|NCT02483572|5520051|P1|Overall Study|Physician Decision|0
1587925|NCT02483572|5520050|P2|Overall Study|Lost to Follow-up|0
1587926|NCT02483572|5520051|P1|Overall Study|Lost to Follow-up|1
1587927|NCT02483572|5520050|P2|Overall Study|Withdrawal by Subject|0
1587928|NCT02483572|5520051|P1|Overall Study|Withdrawal by Subject|1
1587929|NCT02483533|5520065|P2|Overall Study|Lack of Efficacy|50
1587930|NCT02483533|5520066|P1|Overall Study|Lack of Efficacy|50
1587931|NCT02483416|5520076|P2|Overall Study|Treatment stop|0
1587932|NCT02483416|5520077|P1|Overall Study|Treatment stop|3
1587933|NCT02483416|5520076|P2|Overall Study|Other reason|1
1587934|NCT02483416|5520077|P1|Overall Study|Other reason|0
1587935|NCT02482935|5520132|P2|Period 1|Withdrawal by Subject|0
1587936|NCT02482935|5520133|P1|Period 1|Withdrawal by Subject|1
1587937|NCT02482805|5520161|P3|Overall Study|Lost to Follow-up|0
1587938|NCT02482805|5520162|P2|Overall Study|Lost to Follow-up|4
1587939|NCT02482805|5520163|P1|Overall Study|Lost to Follow-up|4
1587940|NCT02482571|5520282|P1|Overall Study|Withdrawal by Subject|4
1587941|NCT02482571|5520282|P1|Overall Study|Scanner or Respiract failure|3
1587942|NCT02482571|5520282|P1|Overall Study|Adverse Event|1
1587943|NCT02482428|5520294|P5|Overall Study|subject/guardian decision|2
1587944|NCT02482428|5520295|P4|Overall Study|subject/guardian decision|0
1587945|NCT02482428|5520296|P3|Overall Study|subject/guardian decision|0
1587946|NCT02482428|5520297|P2|Overall Study|subject/guardian decision|2
1587947|NCT02482428|5520298|P1|Overall Study|subject/guardian decision|4
1587948|NCT02482428|5520294|P5|Overall Study|protocol deviation|0
1587949|NCT02482428|5520295|P4|Overall Study|protocol deviation|0
1587950|NCT02482428|5520296|P3|Overall Study|protocol deviation|0
1587951|NCT02482428|5520297|P2|Overall Study|protocol deviation|1
1587952|NCT02482428|5520298|P1|Overall Study|protocol deviation|1
1587953|NCT02482428|5520294|P5|Overall Study|Physician Decision|1
1587954|NCT02482428|5520295|P4|Overall Study|Physician Decision|0
1587955|NCT02482428|5520296|P3|Overall Study|Physician Decision|0
1587956|NCT02482428|5520297|P2|Overall Study|Physician Decision|0
1587957|NCT02482428|5520298|P1|Overall Study|Physician Decision|0
1587958|NCT02482428|5520294|P5|Overall Study|Lost to Follow-up|4
1587959|NCT02482428|5520295|P4|Overall Study|Lost to Follow-up|2
1587960|NCT02482428|5520296|P3|Overall Study|Lost to Follow-up|1
1587961|NCT02482428|5520297|P2|Overall Study|Lost to Follow-up|9
1587962|NCT02482428|5520298|P1|Overall Study|Lost to Follow-up|4
1587963|NCT02482298|5520321|P3|Overall Study|Lost to Follow-up|0
1587964|NCT02482298|5520322|P2|Overall Study|Lost to Follow-up|1
1587965|NCT02482298|5520323|P1|Overall Study|Lost to Follow-up|0
1587966|NCT02482298|5520321|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
1587967|NCT02482298|5520322|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1587968|NCT02482298|5520323|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
1587969|NCT02482298|5520321|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
1587970|NCT02482298|5520322|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
1587971|NCT02482298|5520323|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
1587972|NCT02482298|5520321|P3|Overall Study|Withdrawal by Subject|2
1587973|NCT02482298|5520322|P2|Overall Study|Withdrawal by Subject|1
1587974|NCT02482298|5520323|P1|Overall Study|Withdrawal by Subject|2
1587975|NCT02482233|5520345|P2|Overall Study|Lost to Follow-up|1
1587976|NCT02482233|5520346|P1|Overall Study|Lost to Follow-up|1
1587977|NCT02482129|5520382|P2|Overall Study|Criteria not met|0
1587978|NCT02482129|5520383|P1|Overall Study|Criteria not met|1
1587979|NCT02482129|5520382|P2|Overall Study|Withdrawal by Subject|0
1587980|NCT02482129|5520383|P1|Overall Study|Withdrawal by Subject|2
1587981|NCT02482129|5520382|P2|Overall Study|Adverse Event|0
1587982|NCT02482129|5520383|P1|Overall Study|Adverse Event|1
1587983|NCT02482129|5520382|P2|Overall Study|Criteria not met-prior to treatment|0
1587984|NCT02482129|5520383|P1|Overall Study|Criteria not met-prior to treatment|1
1587985|NCT02482129|5520382|P2|Overall Study|Unable to draw blood-prior to treatment|0
1587986|NCT02482129|5520383|P1|Overall Study|Unable to draw blood-prior to treatment|1
1587987|NCT02482129|5520382|P2|Overall Study|Withdrawal by subject-prior to treatment|1
1587988|NCT02482129|5520383|P1|Overall Study|Withdrawal by subject-prior to treatment|0
1587989|NCT02482129|5520382|P2|Overall Study|Adverse Event-prior to treatment|1
1587990|NCT02482129|5520383|P1|Overall Study|Adverse Event-prior to treatment|0
1587991|NCT02481934|5520410|P1|Overall Study|Death|2
1587992|NCT02481830|5520417|P2|Overall Study|Participant not eligible for trial|1
1587993|NCT02481830|5520418|P1|Overall Study|Participant not eligible for trial|0
1587994|NCT02481830|5520417|P2|Overall Study|Disease Progression|1
1587995|NCT02481830|5520418|P1|Overall Study|Disease Progression|1
1587996|NCT02481830|5520417|P2|Overall Study|Withdrawal by Subject|14
1587997|NCT02481830|5520418|P1|Overall Study|Withdrawal by Subject|0
1587998|NCT02481830|5520417|P2|Overall Study|No longer meets Study Criteria|4
1587999|NCT02481830|5520418|P1|Overall Study|No longer meets Study Criteria|1
1588000|NCT02481050|5520567|P1|Overall Study|Other|3
1588001|NCT02481050|5520567|P1|Overall Study|Withdrawal by Subject|7
1588002|NCT02481050|5520567|P1|Overall Study|Disease Progression|47
1588003|NCT02481050|5520567|P1|Overall Study|Adverse Event|1
1588004|NCT02480764|5520594|P3|Overall Study|Reason not Specified|0
1588005|NCT02480764|5520595|P2|Overall Study|Reason not Specified|1
1588006|NCT02480764|5520596|P1|Overall Study|Reason not Specified|0
1588007|NCT02480764|5520594|P3|Overall Study|Lack of Efficacy|3
1588008|NCT02480764|5520595|P2|Overall Study|Lack of Efficacy|3
1588009|NCT02480764|5520596|P1|Overall Study|Lack of Efficacy|0
1588010|NCT02480764|5520594|P3|Overall Study|Voluntary Withdrawal|10
1588011|NCT02480764|5520595|P2|Overall Study|Voluntary Withdrawal|5
1588012|NCT02480764|5520596|P1|Overall Study|Voluntary Withdrawal|6
1588013|NCT02480764|5520594|P3|Overall Study|Lost to Follow-up|2
1588014|NCT02480764|5520595|P2|Overall Study|Lost to Follow-up|1
1588015|NCT02480764|5520596|P1|Overall Study|Lost to Follow-up|0
1588016|NCT02480764|5520594|P3|Overall Study|Major Protocol Deviation|3
1588017|NCT02480764|5520595|P2|Overall Study|Major Protocol Deviation|4
1588018|NCT02480764|5520596|P1|Overall Study|Major Protocol Deviation|1
1588019|NCT02480764|5520594|P3|Overall Study|Pretreatment Event/Adverse Event|3
1588020|NCT02480764|5520595|P2|Overall Study|Pretreatment Event/Adverse Event|6
1588021|NCT02480764|5520596|P1|Overall Study|Pretreatment Event/Adverse Event|3
1588022|NCT02480712|5520622|P1|Overall Study|Lack of Efficacy|1
1588023|NCT02480712|5520622|P1|Overall Study|Death|1
1588024|NCT02480712|5520622|P1|Overall Study|Withdrew Consent|3
1588025|NCT02480712|5520622|P1|Overall Study|Lost to Follow-up|5
1588026|NCT02480712|5520622|P1|Overall Study|Enrolled but Never Treated|1
1588027|NCT02480621|5520641|P2|Follow Up|Lost to Follow-up|2
1588028|NCT02480621|5520642|P1|Follow Up|Lost to Follow-up|4
1588029|NCT02480621|5520641|P2|Randomization|Surgeon did not give intervention|1
1588030|NCT02480621|5520642|P1|Randomization|Surgeon did not give intervention|0
1588031|NCT02480621|5520641|P2|Randomization|Withdrawal by Subject|0
1588032|NCT02480621|5520642|P1|Randomization|Withdrawal by Subject|1
1588033|NCT02480153|5520719|P3|Period 3: Week 52 Dosing to Week 78|Death|0
1588034|NCT02480153|5520720|P2|Period 3: Week 52 Dosing to Week 78|Death|1
1588035|NCT02480153|5520721|P1|Period 3: Week 52 Dosing to Week 78|Death|0
1588036|NCT02480153|5520719|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
1588037|NCT02480153|5520720|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
1588038|NCT02480153|5520721|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
1588039|NCT02480153|5520719|P3|Period 3: Week 52 Dosing to Week 78|Other|1
1588040|NCT02480153|5520720|P2|Period 3: Week 52 Dosing to Week 78|Other|0
1588041|NCT02480153|5520721|P1|Period 3: Week 52 Dosing to Week 78|Other|0
1588042|NCT02480153|5520719|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
1588043|NCT02480153|5520720|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
1588044|NCT02480153|5520721|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
1588045|NCT02480153|5520719|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
1588046|NCT02480153|5520720|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
1588047|NCT02480153|5520721|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
1588048|NCT02480153|5520719|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
1588049|NCT02480153|5520720|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
1588050|NCT02480153|5520721|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
1588051|NCT02480153|5520719|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
1588052|NCT02480153|5520720|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
1588053|NCT02480153|5520721|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
1588054|NCT02480153|5520719|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
1588055|NCT02480153|5520720|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
1588056|NCT02480153|5520721|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
1588057|NCT02480153|5520719|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
1588058|NCT02480153|5520720|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
1588059|NCT02480153|5520721|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
1588060|NCT02480153|5520719|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
1588061|NCT02480153|5520720|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
1588062|NCT02480153|5520721|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
1588063|NCT02480153|5520719|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
1588064|NCT02480153|5520720|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
1588065|NCT02480153|5520721|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
1588066|NCT02480153|5520719|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
1588067|NCT02480153|5520720|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
1588068|NCT02480153|5520721|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
1588069|NCT02480153|5520719|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
1588070|NCT02480153|5520720|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
1588071|NCT02480153|5520721|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
1588072|NCT02480153|5520719|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
1588073|NCT02480153|5520720|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
1588074|NCT02480153|5520721|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
1588075|NCT02480153|5520719|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
1588076|NCT02480153|5520720|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
1588077|NCT02480153|5520721|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
1588078|NCT02480153|5520719|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
1588079|NCT02480153|5520720|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
1588080|NCT02480153|5520721|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
1588081|NCT02480153|5520719|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
1588082|NCT02480153|5520720|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
1588083|NCT02480153|5520721|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
1588084|NCT02480153|5520719|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
1588085|NCT02480153|5520720|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
1588086|NCT02480153|5520721|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
1588087|NCT02480010|5520898|P2|Overall Study|Refused Treatment|3
1588088|NCT02480010|5520899|P1|Overall Study|Refused Treatment|0
1588089|NCT02480010|5520898|P2|Overall Study|Insufficient therapeutic response|29
1588090|NCT02480010|5520899|P1|Overall Study|Insufficient therapeutic response|31
1588091|NCT02480010|5520898|P2|Overall Study|Death|0
1588092|NCT02480010|5520899|P1|Overall Study|Death|1
1588093|NCT02480010|5520898|P2|Overall Study|Adverse Event|1
1588094|NCT02480010|5520899|P1|Overall Study|Adverse Event|3
1588095|NCT02479880|5520945|P2|Overall Study|Pregnancy|1
1588096|NCT02479880|5520946|P1|Overall Study|Pregnancy|0
1588097|NCT02479880|5520945|P2|Overall Study|Study Terminated by Sponsor|12
1588098|NCT02479880|5520946|P1|Overall Study|Study Terminated by Sponsor|13
1588099|NCT02479412|5520970|P9|Overall Study|Randomization to wrong PK sampling group|0
1588100|NCT02479412|5520971|P8|Overall Study|Randomization to wrong PK sampling group|0
1588101|NCT02479412|5520972|P7|Overall Study|Randomization to wrong PK sampling group|0
1588102|NCT02479412|5520973|P6|Overall Study|Randomization to wrong PK sampling group|0
1588103|NCT02479412|5520974|P5|Overall Study|Randomization to wrong PK sampling group|1
1588104|NCT02479412|5520975|P4|Overall Study|Randomization to wrong PK sampling group|0
1588105|NCT02479412|5520976|P3|Overall Study|Randomization to wrong PK sampling group|0
1588106|NCT02479412|5520977|P2|Overall Study|Randomization to wrong PK sampling group|0
1588107|NCT02479412|5520978|P1|Overall Study|Randomization to wrong PK sampling group|0
1588108|NCT02479412|5520970|P9|Overall Study|Study-specific withdrawal criteria|1
1588109|NCT02479412|5520971|P8|Overall Study|Study-specific withdrawal criteria|1
1588110|NCT02479412|5520972|P7|Overall Study|Study-specific withdrawal criteria|0
1588111|NCT02479412|5520973|P6|Overall Study|Study-specific withdrawal criteria|0
1588112|NCT02479412|5520974|P5|Overall Study|Study-specific withdrawal criteria|0
1588113|NCT02479412|5520975|P4|Overall Study|Study-specific withdrawal criteria|1
1588114|NCT02479412|5520976|P3|Overall Study|Study-specific withdrawal criteria|1
1588115|NCT02479412|5520977|P2|Overall Study|Study-specific withdrawal criteria|0
1588116|NCT02479412|5520978|P1|Overall Study|Study-specific withdrawal criteria|0
1588117|NCT02479412|5520970|P9|Overall Study|Adverse Event|0
1588118|NCT02479412|5520971|P8|Overall Study|Adverse Event|0
1588119|NCT02479412|5520972|P7|Overall Study|Adverse Event|0
1588120|NCT02479412|5520973|P6|Overall Study|Adverse Event|0
1588121|NCT02479412|5520974|P5|Overall Study|Adverse Event|0
1588122|NCT02479412|5520975|P4|Overall Study|Adverse Event|0
1588123|NCT02479412|5520976|P3|Overall Study|Adverse Event|1
1588124|NCT02479412|5520977|P2|Overall Study|Adverse Event|0
1588125|NCT02479412|5520978|P1|Overall Study|Adverse Event|0
1588126|NCT02479139|5521055|P6|Overall Study|Other Miscellaneous Reasons|0
1588127|NCT02479139|5521056|P5|Overall Study|Other Miscellaneous Reasons|1
1588128|NCT02479139|5521057|P4|Overall Study|Other Miscellaneous Reasons|1
1588129|NCT02479139|5521058|P3|Overall Study|Other Miscellaneous Reasons|1
1588130|NCT02479139|5521059|P2|Overall Study|Other Miscellaneous Reasons|0
1588131|NCT02479139|5521060|P1|Overall Study|Other Miscellaneous Reasons|1
1588132|NCT02479139|5521055|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
1588133|NCT02479139|5521056|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
1588134|NCT02479139|5521057|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
1588135|NCT02479139|5521058|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
1588136|NCT02479139|5521059|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
1588137|NCT02479139|5521060|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
1588138|NCT02479139|5521055|P6|Overall Study|Withdrew Consent|1
1588139|NCT02479139|5521056|P5|Overall Study|Withdrew Consent|1
1588140|NCT02479139|5521057|P4|Overall Study|Withdrew Consent|4
1588141|NCT02479139|5521058|P3|Overall Study|Withdrew Consent|1
1588142|NCT02479139|5521059|P2|Overall Study|Withdrew Consent|6
1588143|NCT02479139|5521060|P1|Overall Study|Withdrew Consent|5
1588144|NCT02479139|5521055|P6|Overall Study|Lost to Follow-up|5
1588145|NCT02479139|5521056|P5|Overall Study|Lost to Follow-up|3
1588146|NCT02479139|5521057|P4|Overall Study|Lost to Follow-up|2
1588147|NCT02479139|5521058|P3|Overall Study|Lost to Follow-up|4
1588148|NCT02479139|5521059|P2|Overall Study|Lost to Follow-up|4
1588149|NCT02479139|5521060|P1|Overall Study|Lost to Follow-up|2
1588150|NCT02478632|5521093|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
1588151|NCT02478632|5521094|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
1588152|NCT02478632|5521093|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
1588153|NCT02478632|5521094|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
1588154|NCT02478632|5521093|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
1588155|NCT02478632|5521094|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
1588156|NCT02478398|5521131|P2|Overall Study|Withdrawal By Participant|4
1588157|NCT02478398|5521132|P1|Overall Study|Withdrawal By Participant|10
1588158|NCT02478398|5521131|P2|Overall Study|Withdrawal By Parent/Guardian|6
1588159|NCT02478398|5521132|P1|Overall Study|Withdrawal By Parent/Guardian|9
1588160|NCT02478398|5521131|P2|Overall Study|Protocol Violation|1
1588161|NCT02478398|5521132|P1|Overall Study|Protocol Violation|3
1588162|NCT02478398|5521131|P2|Overall Study|Non-Compliance With Study Drug|1
1588163|NCT02478398|5521132|P1|Overall Study|Non-Compliance With Study Drug|5
1588164|NCT02478398|5521131|P2|Overall Study|Lost to Follow-up|4
1588165|NCT02478398|5521132|P1|Overall Study|Lost to Follow-up|5
1588166|NCT02478398|5521131|P2|Overall Study|Adverse Event|5
1588167|NCT02478398|5521132|P1|Overall Study|Adverse Event|20
1588168|NCT02478372|5521152|P2|Overall Study|Death|2
1588169|NCT02478372|5521153|P1|Overall Study|Death|0
1588170|NCT02478372|5521152|P2|Overall Study|Lost to Follow-up|4
1588171|NCT02478372|5521153|P1|Overall Study|Lost to Follow-up|1
1588172|NCT02478372|5521152|P2|Overall Study|Protocol Violation|8
1588173|NCT02478372|5521153|P1|Overall Study|Protocol Violation|12
1588176|NCT02478164|5521250|P1|Overall Study|Withdrawal by Subject|1
1588177|NCT02478164|5521250|P1|Overall Study|Adverse Event|1
1588178|NCT02478164|5521250|P1|Overall Study|Lack of Efficacy|13
1588179|NCT02477618|5521263|P2|Overall Study|Left Study Site for Rehabilitation|1
1588180|NCT02477618|5521264|P1|Overall Study|Left Study Site for Rehabilitation|0
1588181|NCT02477618|5521263|P2|Overall Study|Transferred Away from Study Site|0
1588182|NCT02477618|5521264|P1|Overall Study|Transferred Away from Study Site|1
1588183|NCT02477618|5521263|P2|Overall Study|Adverse Event|1
1588184|NCT02477618|5521264|P1|Overall Study|Adverse Event|1
1588185|NCT02477618|5521263|P2|Overall Study|Died in Double-Blind Treatment Period|11
1588186|NCT02477618|5521264|P1|Overall Study|Died in Double-Blind Treatment Period|11
1588187|NCT02477618|5521263|P2|Overall Study|Completed Visits but Discontinued Drug|1
1588188|NCT02477618|5521264|P1|Overall Study|Completed Visits but Discontinued Drug|2
1588189|NCT02477605|5521288|P2|Overall Study|Administered gas during surgery|1
1588190|NCT02477605|5521289|P1|Overall Study|Administered gas during surgery|0
1588191|NCT02477605|5521288|P2|Overall Study|Withdrawal by Subject|1
1588192|NCT02477605|5521289|P1|Overall Study|Withdrawal by Subject|0
1588193|NCT02477605|5521288|P2|Overall Study|Lost to Follow-up|2
1588194|NCT02477605|5521289|P1|Overall Study|Lost to Follow-up|0
1588195|NCT02477605|5521288|P2|Overall Study|Discontinued prior to treatment|0
1588196|NCT02477605|5521289|P1|Overall Study|Discontinued prior to treatment|1
1588197|NCT02477553|5521305|P2|Overall Study|patient deceased|0
1588198|NCT02477553|5521306|P1|Overall Study|patient deceased|1
1588199|NCT02477553|5521305|P2|Overall Study|MD advised against screening|3
1588200|NCT02477553|5521306|P1|Overall Study|MD advised against screening|1
1588201|NCT02477553|5521305|P2|Overall Study|Elevated risk for CRC|2
1588202|NCT02477553|5521306|P1|Overall Study|Elevated risk for CRC|2
1588203|NCT02477553|5521305|P2|Overall Study|Technical issues with intervention|0
1588204|NCT02477553|5521306|P1|Overall Study|Technical issues with intervention|2
1588205|NCT02477553|5521305|P2|Overall Study|Workup consistent w/CRC|1
1588206|NCT02477553|5521306|P1|Overall Study|Workup consistent w/CRC|1
1588207|NCT02477553|5521305|P2|Overall Study|No MD visit|1
1588208|NCT02477553|5521306|P1|Overall Study|No MD visit|1
1588209|NCT02477553|5521305|P2|Overall Study|Screening up-to-date|13
1588210|NCT02477553|5521306|P1|Overall Study|Screening up-to-date|12
1588211|NCT02477527|5521326|P1|Overall Study|Screen Failure|3
1588212|NCT02477527|5521326|P1|Overall Study|Withdrawal by Subject|1
1588213|NCT02477527|5521326|P1|Overall Study|Lost to Follow-up|2
1588214|NCT02477332|5521340|P6|Overall Study|Withdrawal by Subject|0
1588215|NCT02477332|5521341|P5|Overall Study|Withdrawal by Subject|1
1588216|NCT02477332|5521342|P4|Overall Study|Withdrawal by Subject|2
1588217|NCT02477332|5521343|P3|Overall Study|Withdrawal by Subject|1
1588218|NCT02477332|5521344|P2|Overall Study|Withdrawal by Subject|3
1588219|NCT02477332|5521345|P1|Overall Study|Withdrawal by Subject|0
1588220|NCT02477332|5521340|P6|Overall Study|Physician Decision|1
1588221|NCT02477332|5521341|P5|Overall Study|Physician Decision|0
1588222|NCT02477332|5521342|P4|Overall Study|Physician Decision|3
1588223|NCT02477332|5521343|P3|Overall Study|Physician Decision|1
1588224|NCT02477332|5521344|P2|Overall Study|Physician Decision|0
1588225|NCT02477332|5521345|P1|Overall Study|Physician Decision|0
1588226|NCT02477332|5521340|P6|Overall Study|Lost to Follow-up|0
1588227|NCT02477332|5521341|P5|Overall Study|Lost to Follow-up|0
1588228|NCT02477332|5521342|P4|Overall Study|Lost to Follow-up|0
1588229|NCT02477332|5521343|P3|Overall Study|Lost to Follow-up|2
1588230|NCT02477332|5521344|P2|Overall Study|Lost to Follow-up|0
1588231|NCT02477332|5521345|P1|Overall Study|Lost to Follow-up|0
1588232|NCT02477332|5521340|P6|Overall Study|Technical problems|0
1588233|NCT02477332|5521341|P5|Overall Study|Technical problems|0
1588234|NCT02477332|5521342|P4|Overall Study|Technical problems|0
1588235|NCT02477332|5521343|P3|Overall Study|Technical problems|1
1588236|NCT02477332|5521344|P2|Overall Study|Technical problems|0
1588237|NCT02477332|5521345|P1|Overall Study|Technical problems|0
1588238|NCT02477332|5521340|P6|Overall Study|Protocol Violation|1
1588239|NCT02477332|5521341|P5|Overall Study|Protocol Violation|1
1588240|NCT02477332|5521342|P4|Overall Study|Protocol Violation|3
1588241|NCT02477332|5521343|P3|Overall Study|Protocol Violation|3
1588242|NCT02477332|5521344|P2|Overall Study|Protocol Violation|0
1588243|NCT02477332|5521345|P1|Overall Study|Protocol Violation|2
1588244|NCT02477332|5521340|P6|Overall Study|Pregnancy|0
1588245|NCT02477332|5521341|P5|Overall Study|Pregnancy|0
1588246|NCT02477332|5521342|P4|Overall Study|Pregnancy|1
1588247|NCT02477332|5521343|P3|Overall Study|Pregnancy|0
1588248|NCT02477332|5521344|P2|Overall Study|Pregnancy|0
1588249|NCT02477332|5521345|P1|Overall Study|Pregnancy|0
1588250|NCT02477332|5521340|P6|Overall Study|Non-compliance with study treatment|0
1588251|NCT02477332|5521341|P5|Overall Study|Non-compliance with study treatment|0
1588252|NCT02477332|5521342|P4|Overall Study|Non-compliance with study treatment|0
1588253|NCT02477332|5521343|P3|Overall Study|Non-compliance with study treatment|2
1588254|NCT02477332|5521344|P2|Overall Study|Non-compliance with study treatment|1
1588255|NCT02477332|5521345|P1|Overall Study|Non-compliance with study treatment|0
1588256|NCT02477332|5521340|P6|Overall Study|Lack of Efficacy|1
1588257|NCT02477332|5521341|P5|Overall Study|Lack of Efficacy|1
1588258|NCT02477332|5521342|P4|Overall Study|Lack of Efficacy|2
1588259|NCT02477332|5521343|P3|Overall Study|Lack of Efficacy|1
1588260|NCT02477332|5521344|P2|Overall Study|Lack of Efficacy|2
1588261|NCT02477332|5521345|P1|Overall Study|Lack of Efficacy|1
1588262|NCT02477332|5521340|P6|Overall Study|Adverse Event|2
1588263|NCT02477332|5521341|P5|Overall Study|Adverse Event|1
1588264|NCT02477332|5521342|P4|Overall Study|Adverse Event|2
1588265|NCT02477332|5521343|P3|Overall Study|Adverse Event|1
1588266|NCT02477332|5521344|P2|Overall Study|Adverse Event|1
1588267|NCT02477332|5521345|P1|Overall Study|Adverse Event|0
1588268|NCT02477215|5521423|P3|Fixed Dose Phase|Physician Decision|0
1588269|NCT02477215|5521424|P2|Fixed Dose Phase|Physician Decision|7
1588270|NCT02477215|5521425|P1|Fixed Dose Phase|Physician Decision|0
1588271|NCT02477215|5521423|P3|Dose Escalation Phase|Physician Decision|0
1588272|NCT02477215|5521424|P2|Dose Escalation Phase|Physician Decision|2
1588273|NCT02477215|5521425|P1|Dose Escalation Phase|Physician Decision|1
1588274|NCT02477020|5521441|P2|Overall Study|Lack of Efficacy|5
1588275|NCT02477020|5521442|P1|Overall Study|Lack of Efficacy|14
1588276|NCT02477020|5521441|P2|Overall Study|Reason not Specified|1
1588277|NCT02477020|5521442|P1|Overall Study|Reason not Specified|3
1588278|NCT02477020|5521441|P2|Overall Study|Voluntary Withdrawal|16
1588279|NCT02477020|5521442|P1|Overall Study|Voluntary Withdrawal|7
1588280|NCT02477020|5521441|P2|Overall Study|Pretreatment Event/Adverse Event|6
1588281|NCT02477020|5521442|P1|Overall Study|Pretreatment Event/Adverse Event|6
1588282|NCT02476994|5521472|P2|Overall Study|Based on feedback from FDA|0
1588283|NCT02476994|5521473|P1|Overall Study|Based on feedback from FDA|1
1588284|NCT02476617|5521542|P1|Overall Study|Lost to Follow-up|1
1588285|NCT02476617|5521542|P1|Overall Study|Adverse Event|1
1588286|NCT02476578|5521548|P2|Overall Study|Lost to Follow-up|13
1588287|NCT02476578|5521549|P1|Overall Study|Lost to Follow-up|6
1588288|NCT02476578|5521548|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
1588289|NCT02476578|5521549|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
1588290|NCT02476422|5521611|P2|Overall Study|Subject/guardian decision|1
1588291|NCT02476422|5521612|P1|Overall Study|Subject/guardian decision|0
1588292|NCT02476175|5521642|P1|Overall Study|Adverse Event|2
1588293|NCT02475980|5521666|P1|Overall Study|Withdrawal by Subject|1
1588294|NCT02475980|5521666|P1|Overall Study|Lost to Follow-up|4
1588295|NCT02475733|5521692|P2|Overall Study|Physician Decision|0
1588296|NCT02475733|5521693|P1|Overall Study|Physician Decision|1
1588297|NCT02475733|5521692|P2|Overall Study|Withdrawal by Subject|0
1588298|NCT02475733|5521693|P1|Overall Study|Withdrawal by Subject|1
1588299|NCT02475655|5521750|P2|Overall Study|Lost to Follow-up|1
1588300|NCT02475655|5521751|P1|Overall Study|Lost to Follow-up|0
1588301|NCT02475564|5521812|P2|Overall Study|Intense Menstrual bleeding|0
1588302|NCT02475564|5521813|P1|Overall Study|Intense Menstrual bleeding|1
1588303|NCT02475564|5521812|P2|Overall Study|Lost to Follow-up|1
1588304|NCT02475564|5521813|P1|Overall Study|Lost to Follow-up|2
1588305|NCT02475564|5521812|P2|Overall Study|Withdrawal by Subject|0
1588306|NCT02475564|5521813|P1|Overall Study|Withdrawal by Subject|1
1588307|NCT02475395|5521825|P2|Overall Study|Protocol Violation|3
1588308|NCT02475395|5521826|P1|Overall Study|Protocol Violation|30
1588309|NCT02475278|5521836|P1|Overall Study|Reason Not Specified|1
1588310|NCT02475278|5521836|P1|Overall Study|Lost to Follow-up|1
1588311|NCT02475265|5521847|P1|Overall Study|Withdrawal by Subject|2
1588312|NCT02475265|5521847|P1|Overall Study|Physician Decision|1
1588313|NCT02474589|5521898|P2|Overall Study|Inability to complete study procedures|1
1588314|NCT02474589|5521899|P1|Overall Study|Inability to complete study procedures|5
1588315|NCT02474589|5521898|P2|Overall Study|Withdrawal by Subject|0
1588316|NCT02474589|5521899|P1|Overall Study|Withdrawal by Subject|4
1588317|NCT02474589|5521898|P2|Overall Study|Protocol Violation|1
1588318|NCT02474589|5521899|P1|Overall Study|Protocol Violation|4
1588319|NCT02474589|5521898|P2|Overall Study|Lost to Follow-up|1
1588320|NCT02474589|5521899|P1|Overall Study|Lost to Follow-up|6
1588321|NCT02474589|5521898|P2|Overall Study|Adverse Event|2
1588322|NCT02474589|5521899|P1|Overall Study|Adverse Event|6
1588323|NCT02474082|5521958|P2|Overall Study|Protocol deviation|1
1588324|NCT02474082|5521959|P1|Overall Study|Protocol deviation|0
1588325|NCT02474082|5521958|P2|Overall Study|Non-compliance with study treatment|2
1588326|NCT02474082|5521959|P1|Overall Study|Non-compliance with study treatment|0
1588327|NCT02474082|5521958|P2|Overall Study|Participant/guardian decision|2
1588328|NCT02474082|5521959|P1|Overall Study|Participant/guardian decision|1
1588329|NCT02474082|5521958|P2|Overall Study|Dose tapering not achieved|4
1588330|NCT02474082|5521959|P1|Overall Study|Dose tapering not achieved|0
1588331|NCT02474082|5521958|P2|Overall Study|Lost to Follow-up|2
1588332|NCT02474082|5521959|P1|Overall Study|Lost to Follow-up|2
1588333|NCT02474082|5521958|P2|Overall Study|Withdrawal of informed consent|11
1588334|NCT02474082|5521959|P1|Overall Study|Withdrawal of informed consent|1
1588335|NCT02474082|5521958|P2|Overall Study|Adverse Event|32
1588336|NCT02474082|5521959|P1|Overall Study|Adverse Event|2
1588337|NCT02474069|5521993|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
1588338|NCT02474069|5521994|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
1588339|NCT02474069|5521995|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
1588340|NCT02474069|5521993|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
1588341|NCT02474069|5521994|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
1588342|NCT02474069|5521995|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
1588343|NCT02474069|5521993|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
1588344|NCT02474069|5521994|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
1588345|NCT02474069|5521995|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
1588346|NCT02474069|5521993|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
1588347|NCT02474069|5521994|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
1588348|NCT02474069|5521995|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
1588349|NCT02474069|5521993|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
1588350|NCT02474069|5521994|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
1588351|NCT02474069|5521995|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
1588352|NCT02474069|5521993|P3|Selection Phase (SP)|Withdrawal by Subject|0
1588353|NCT02474069|5521994|P2|Selection Phase (SP)|Withdrawal by Subject|0
1588354|NCT02474069|5521995|P1|Selection Phase (SP)|Withdrawal by Subject|3
1588355|NCT02474069|5521993|P3|Selection Phase (SP)|Technical Problem|0
1588356|NCT02474069|5521994|P2|Selection Phase (SP)|Technical Problem|0
1588357|NCT02474069|5521995|P1|Selection Phase (SP)|Technical Problem|1
1588358|NCT02474069|5521993|P3|Selection Phase (SP)|No longer requires treatment|0
1588359|NCT02474069|5521994|P2|Selection Phase (SP)|No longer requires treatment|0
1588360|NCT02474069|5521995|P1|Selection Phase (SP)|No longer requires treatment|1
1588361|NCT02474069|5521993|P3|Selection Phase (SP)|Protocol Violation|0
1588362|NCT02474069|5521994|P2|Selection Phase (SP)|Protocol Violation|0
1588363|NCT02474069|5521995|P1|Selection Phase (SP)|Protocol Violation|1
1588364|NCT02474069|5521993|P3|Selection Phase (SP)|Physician Decision|0
1588365|NCT02474069|5521994|P2|Selection Phase (SP)|Physician Decision|0
1588366|NCT02474069|5521995|P1|Selection Phase (SP)|Physician Decision|1
1588367|NCT02474069|5521993|P3|Selection Phase (SP)|Lost to Follow-up|0
1588368|NCT02474069|5521994|P2|Selection Phase (SP)|Lost to Follow-up|0
1588369|NCT02474069|5521995|P1|Selection Phase (SP)|Lost to Follow-up|4
1588370|NCT02474069|5521993|P3|Selection Phase (SP)|Lack of Efficacy|0
1588371|NCT02474069|5521994|P2|Selection Phase (SP)|Lack of Efficacy|0
1588372|NCT02474069|5521995|P1|Selection Phase (SP)|Lack of Efficacy|1
1588373|NCT02474069|5521993|P3|Selection Phase (SP)|Adverse Event|0
1588374|NCT02474069|5521994|P2|Selection Phase (SP)|Adverse Event|0
1588375|NCT02474069|5521995|P1|Selection Phase (SP)|Adverse Event|8
1588376|NCT02473952|5522028|P2|Overall Study|Withdrawal by Subject|6
1588377|NCT02473952|5522029|P1|Overall Study|Withdrawal by Subject|0
1588378|NCT02473952|5522028|P2|Overall Study|Adverse Event|2
1588379|NCT02473952|5522029|P1|Overall Study|Adverse Event|2
1588380|NCT02473640|5522069|P1|Treatment Period 1|Adverse Event|1
1588381|NCT02473523|5522078|P1|Overall Study|Lost to Follow-up|1
1588382|NCT02473523|5522078|P1|Overall Study|Death|1
1588383|NCT02473510|5522099|P2|Overall Study|Lost to Follow-up|2
1588384|NCT02473510|5522100|P1|Overall Study|Lost to Follow-up|1
1588385|NCT02473471|5522114|P1|Overall Study|Lost to Follow-up|1
1588386|NCT02473471|5522114|P1|Overall Study|poor oral hygiene|2
1588387|NCT02473445|5522145|P1|Overall Study|Sponsor Decision|20
1588388|NCT02473445|5522145|P1|Overall Study|Withdrawal by Subject|2
1588389|NCT02473367|5522151|P1|Period 4|Lost to Follow-up|1
1588390|NCT02473367|5522151|P1|Wait 1|Withdrawal by Subject|1
1588391|NCT02473289|5522171|P2|Overall Study|Other|0
1588392|NCT02473289|5522172|P1|Overall Study|Other|2
1588393|NCT02473289|5522171|P2|Overall Study|Treatment Unblinded + Adverse event|1
1588394|NCT02473289|5522172|P1|Overall Study|Treatment Unblinded + Adverse event|0
1588395|NCT02473289|5522171|P2|Overall Study|Withdrawal of consent|7
1588396|NCT02473289|5522172|P1|Overall Study|Withdrawal of consent|6
1588397|NCT02473289|5522171|P2|Overall Study|Protocol Violation|1
1588398|NCT02473289|5522172|P1|Overall Study|Protocol Violation|0
1588399|NCT02473289|5522171|P2|Overall Study|Lost to Follow-up|1
1588400|NCT02473289|5522172|P1|Overall Study|Lost to Follow-up|1
1588401|NCT02473289|5522171|P2|Overall Study|Adverse Event|3
1588402|NCT02473289|5522172|P1|Overall Study|Adverse Event|2
1588403|NCT02472977|5522197|P3|Overall Study|Subject request to discontinue treatment|0
1588404|NCT02472977|5522198|P2|Overall Study|Subject request to discontinue treatment|1
1588405|NCT02472977|5522199|P1|Overall Study|Subject request to discontinue treatment|0
1588406|NCT02472977|5522197|P3|Overall Study|Study drug toxicity|2
1588407|NCT02472977|5522198|P2|Overall Study|Study drug toxicity|0
1588408|NCT02472977|5522199|P1|Overall Study|Study drug toxicity|2
1588409|NCT02472977|5522197|P3|Overall Study|Withdrawal by Subject|0
1588410|NCT02472977|5522198|P2|Overall Study|Withdrawal by Subject|1
1588411|NCT02472977|5522199|P1|Overall Study|Withdrawal by Subject|0
1588412|NCT02472977|5522197|P3|Overall Study|Disease progression|6
1588413|NCT02472977|5522198|P2|Overall Study|Disease progression|25
1588414|NCT02472977|5522199|P1|Overall Study|Disease progression|4
1588415|NCT02472964|5522224|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
1588416|NCT02472964|5522225|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
1588417|NCT02472964|5522224|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
1588418|NCT02472964|5522225|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
1588419|NCT02472964|5522224|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
1588420|NCT02472964|5522225|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
1588421|NCT02472964|5522224|P2|Part 2 (Week 24-week 48)|Physician Decision|1
1588422|NCT02472964|5522225|P1|Part 2 (Week 24-week 48)|Physician Decision|1
1588423|NCT02472964|5522224|P2|Part 2 (Week 24-week 48)|Death|1
1588424|NCT02472964|5522225|P1|Part 2 (Week 24-week 48)|Death|0
1588425|NCT02472964|5522224|P2|Part 2 (Week 24-week 48)|Disease Progression|56
1588426|NCT02472964|5522225|P1|Part 2 (Week 24-week 48)|Disease Progression|52
1588427|NCT02472964|5522224|P2|Part 2 (Week 24-week 48)|Adverse Event|2
1588428|NCT02472964|5522225|P1|Part 2 (Week 24-week 48)|Adverse Event|4
1588429|NCT02472964|5522224|P2|Part 1 (up to Week 24)|Other|1
1588430|NCT02472964|5522225|P1|Part 1 (up to Week 24)|Other|2
1588431|NCT02472964|5522224|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
1588432|NCT02472964|5522225|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
1588433|NCT02472964|5522224|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
1588434|NCT02472964|5522225|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
1588435|NCT02472964|5522224|P2|Part 1 (up to Week 24)|Physician Decision|1
1588436|NCT02472964|5522225|P1|Part 1 (up to Week 24)|Physician Decision|3
1588437|NCT02472964|5522224|P2|Part 1 (up to Week 24)|Death|6
1588438|NCT02472964|5522225|P1|Part 1 (up to Week 24)|Death|3
1588439|NCT02472964|5522224|P2|Part 1 (up to Week 24)|disease progression|47
1588440|NCT02472964|5522225|P1|Part 1 (up to Week 24)|disease progression|58
1588441|NCT02472964|5522224|P2|Part 1 (up to Week 24)|Adverse Event|4
1588442|NCT02472964|5522225|P1|Part 1 (up to Week 24)|Adverse Event|2
1588443|NCT02472886|5522234|P3|Overall Study|Lack of Efficacy|1
1588444|NCT02472886|5522235|P2|Overall Study|Lack of Efficacy|2
1588445|NCT02472886|5522236|P1|Overall Study|Lack of Efficacy|0
1588446|NCT02472847|5522264|P2|Overall Study|Withdrawal by Subject|5
1588447|NCT02472847|5522265|P1|Overall Study|Withdrawal by Subject|1
1588448|NCT02472756|5522271|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
1588449|NCT02472756|5522271|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
1588450|NCT02472756|5522271|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
1588451|NCT02472756|5522271|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
1588452|NCT02472756|5522271|P1|Induction (Approximately 6 Months)|Adverse Event|1
1588453|NCT02472652|5522292|P1|Overall Study|Lost to Follow-up|1
1588454|NCT02472639|5522299|P2|Overall Study|Physician Decision|3
1588455|NCT02472639|5522300|P1|Overall Study|Physician Decision|4
1588456|NCT02472405|5522347|P1|Overall Study|Adverse Event|1
1588457|NCT02472405|5522347|P1|Overall Study|Lost to Follow-up|9
1588458|NCT02472366|5522355|P2|Overall Study|Lost to Follow-up|0
1588459|NCT02472366|5522356|P1|Overall Study|Lost to Follow-up|1
1588460|NCT02472353|5522372|P2|Overall Study|Study Termination|4
1588461|NCT02472353|5522373|P1|Overall Study|Study Termination|1
1588462|NCT02472353|5522372|P2|Overall Study|Withdrawal by Subject|1
1588463|NCT02472353|5522373|P1|Overall Study|Withdrawal by Subject|2
1588464|NCT02472353|5522372|P2|Overall Study|Lost to Follow-up|1
1588465|NCT02472353|5522373|P1|Overall Study|Lost to Follow-up|1
1588466|NCT02472145|5522410|P3|Overall Study|Other|43
1588467|NCT02472145|5522411|P2|Overall Study|Other|45
1588468|NCT02472145|5522412|P1|Overall Study|Other|0
1588469|NCT02472145|5522410|P3|Overall Study|Sponsor decision|2
1588470|NCT02472145|5522411|P2|Overall Study|Sponsor decision|3
1588471|NCT02472145|5522412|P1|Overall Study|Sponsor decision|0
1588472|NCT02472145|5522410|P3|Overall Study|Withdrawal by Subject|13
1588473|NCT02472145|5522411|P2|Overall Study|Withdrawal by Subject|9
1588474|NCT02472145|5522412|P1|Overall Study|Withdrawal by Subject|0
1588475|NCT02472145|5522410|P3|Overall Study|Lost to Follow-up|0
1588476|NCT02472145|5522411|P2|Overall Study|Lost to Follow-up|1
1588477|NCT02472145|5522412|P1|Overall Study|Lost to Follow-up|0
1588478|NCT02472145|5522410|P3|Overall Study|Death|99
1588479|NCT02472145|5522411|P2|Overall Study|Death|101
1588480|NCT02472145|5522412|P1|Overall Study|Death|10
1588481|NCT02471755|5522433|P2|Overall Study|Lost to Follow-up|1
1588482|NCT02471755|5522434|P1|Overall Study|Lost to Follow-up|0
1588483|NCT02471755|5522433|P2|Overall Study|Withdrawal by Subject|0
1588484|NCT02471755|5522434|P1|Overall Study|Withdrawal by Subject|1
1588485|NCT02471612|5522463|P1|Overall Study|Lost to Follow-up|2
1588486|NCT02471404|5522494|P3|Overall Study|Other reasons not specified|12
1588487|NCT02471404|5522495|P2|Overall Study|Other reasons not specified|7
1588488|NCT02471404|5522496|P1|Overall Study|Other reasons not specified|10
1588489|NCT02471404|5522494|P3|Overall Study|Withdrawal by Subject|5
1588490|NCT02471404|5522495|P2|Overall Study|Withdrawal by Subject|4
1588491|NCT02471404|5522496|P1|Overall Study|Withdrawal by Subject|8
1588492|NCT02471404|5522494|P3|Overall Study|Protocol Violation|0
1588493|NCT02471404|5522495|P2|Overall Study|Protocol Violation|0
1588494|NCT02471404|5522496|P1|Overall Study|Protocol Violation|1
1588495|NCT02471404|5522494|P3|Overall Study|Lost to Follow-up|3
1588496|NCT02471404|5522495|P2|Overall Study|Lost to Follow-up|1
1588497|NCT02471404|5522496|P1|Overall Study|Lost to Follow-up|1
1588498|NCT02471404|5522494|P3|Overall Study|Failure to Meet Randomization Criteria|1
1588499|NCT02471404|5522495|P2|Overall Study|Failure to Meet Randomization Criteria|0
1588500|NCT02471404|5522496|P1|Overall Study|Failure to Meet Randomization Criteria|2
1588501|NCT02471404|5522494|P3|Overall Study|Developed Study Withdrawal Criteria|2
1588502|NCT02471404|5522495|P2|Overall Study|Developed Study Withdrawal Criteria|1
1588503|NCT02471404|5522496|P1|Overall Study|Developed Study Withdrawal Criteria|4
1588504|NCT02471404|5522494|P3|Overall Study|Adverse Event|2
1588505|NCT02471404|5522495|P2|Overall Study|Adverse Event|1
1588506|NCT02471404|5522496|P1|Overall Study|Adverse Event|7
1588507|NCT02471183|5522528|P1|Extended Treatment Period|Lack of Efficacy|1
1588508|NCT02471183|5522528|P1|Main Treatment Period|Withdrawal by Subject|1
1588509|NCT02471183|5522528|P1|Main Treatment Period|Adverse Event|1
1588510|NCT02470429|5522607|P2|Overall Study|Withdrawal by Subject|0
1588511|NCT02470429|5522608|P1|Overall Study|Withdrawal by Subject|1
1588512|NCT02470429|5522607|P2|Overall Study|Adverse Event|0
1588513|NCT02470429|5522608|P1|Overall Study|Adverse Event|1
1588514|NCT02470403|5522626|P5|Overall Study|Subject/guardian decision|0
1588515|NCT02470403|5522627|P4|Overall Study|Subject/guardian decision|4
1588516|NCT02470403|5522628|P3|Overall Study|Subject/guardian decision|0
1588517|NCT02470403|5522629|P2|Overall Study|Subject/guardian decision|0
1588518|NCT02470403|5522630|P1|Overall Study|Subject/guardian decision|1
1588519|NCT02470403|5522626|P5|Overall Study|Lost to Follow-up|0
1588520|NCT02470403|5522627|P4|Overall Study|Lost to Follow-up|0
1588521|NCT02470403|5522628|P3|Overall Study|Lost to Follow-up|0
1588522|NCT02470403|5522629|P2|Overall Study|Lost to Follow-up|1
1588523|NCT02470403|5522630|P1|Overall Study|Lost to Follow-up|0
1588524|NCT02470403|5522626|P5|Overall Study|Adverse Event|0
1588525|NCT02470403|5522627|P4|Overall Study|Adverse Event|0
1588526|NCT02470403|5522628|P3|Overall Study|Adverse Event|0
1588527|NCT02470403|5522629|P2|Overall Study|Adverse Event|0
1588528|NCT02470403|5522630|P1|Overall Study|Adverse Event|1
1588529|NCT02469961|5522710|P2|Overall Study|Physician Decision|1
1588530|NCT02469961|5522711|P1|Overall Study|Physician Decision|4
1588531|NCT02469896|5522725|P2|Overall Study|Withdrawal by Subject|0
1588532|NCT02469896|5522726|P1|Overall Study|Withdrawal by Subject|2
1588533|NCT02469623|5522796|P1|Overall Study|Death|3
1588534|NCT02469623|5522796|P1|Overall Study|Withdrawal by Subject|2
1588535|NCT02469623|5522796|P1|Overall Study|Lost to Follow-up|4
1588536|NCT02469623|5522796|P1|Overall Study|Not consented for long-term follow-up|4
1588537|NCT02469610|5522803|P2|Overall Study|exclusion criteria|1
1588538|NCT02469610|5522804|P1|Overall Study|exclusion criteria|2
1588539|NCT02469610|5522803|P2|Overall Study|Lost to Follow-up|0
1588540|NCT02469610|5522804|P1|Overall Study|Lost to Follow-up|1
1588541|NCT02469610|5522803|P2|Overall Study|Death|0
1588542|NCT02469610|5522804|P1|Overall Study|Death|1
1588543|NCT02469415|5522831|P1|Overall Study|Investigational agent placed on hold|2
1588544|NCT02469415|5522831|P1|Overall Study|Withdrawal by Subject|1
1588545|NCT02469298|5522839|P4|Overall Study|Withdrawal by Subject|1
1588546|NCT02469298|5522840|P3|Overall Study|Withdrawal by Subject|0
1588547|NCT02469298|5522841|P2|Overall Study|Withdrawal by Subject|0
1588548|NCT02469298|5522842|P1|Overall Study|Withdrawal by Subject|0
1588549|NCT02469298|5522839|P4|Overall Study|Physician Decision|1
1588550|NCT02469298|5522840|P3|Overall Study|Physician Decision|0
1588551|NCT02469298|5522841|P2|Overall Study|Physician Decision|0
1588552|NCT02469298|5522842|P1|Overall Study|Physician Decision|0
1588553|NCT02469298|5522839|P4|Overall Study|Lost to Follow-up|0
1588554|NCT02469298|5522840|P3|Overall Study|Lost to Follow-up|1
1588555|NCT02469298|5522841|P2|Overall Study|Lost to Follow-up|0
1588556|NCT02469298|5522842|P1|Overall Study|Lost to Follow-up|1
1588557|NCT02469298|5522839|P4|Overall Study|Protocol Violation|0
1588558|NCT02469298|5522840|P3|Overall Study|Protocol Violation|1
1588559|NCT02469298|5522841|P2|Overall Study|Protocol Violation|1
1588560|NCT02469298|5522842|P1|Overall Study|Protocol Violation|0
1588561|NCT02469246|5522982|P2|Double-Blind Phase|Lost to Follow-up|5
1588562|NCT02469246|5522983|P1|Double-Blind Phase|Lost to Follow-up|9
1588563|NCT02469246|5522982|P2|Double-Blind Phase|Withdrew Consent|25
1588564|NCT02469246|5522983|P1|Double-Blind Phase|Withdrew Consent|25
1588565|NCT02469246|5522982|P2|Double-Blind Phase|Protocol Violation|1
1588566|NCT02469246|5522983|P1|Double-Blind Phase|Protocol Violation|1
1588567|NCT02469246|5522982|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
1588568|NCT02469246|5522983|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
1588569|NCT02469246|5522982|P2|Double-Blind Phase|Investigator's Discretion|8
1588570|NCT02469246|5522983|P1|Double-Blind Phase|Investigator's Discretion|8
1588571|NCT02469246|5522982|P2|Double-Blind Phase|Lack of Efficacy|1
1588572|NCT02469246|5522983|P1|Double-Blind Phase|Lack of Efficacy|2
1588573|NCT02469246|5522982|P2|Double-Blind Phase|Death|0
1588574|NCT02469246|5522983|P1|Double-Blind Phase|Death|2
1588575|NCT02469246|5522982|P2|Double-Blind Phase|Adverse Event|9
1588576|NCT02469246|5522983|P1|Double-Blind Phase|Adverse Event|12
1588577|NCT02469246|5522982|P2|Double-Blind Phase|Randomized and Never Treated|6
1588578|NCT02469246|5522983|P1|Double-Blind Phase|Randomized and Never Treated|5
1588579|NCT02469168|5523015|P2|Overall Study|Trial closed|0
1588580|NCT02469168|5523016|P1|Overall Study|Trial closed|1
1588581|NCT02469064|5523036|P2|Overall Study|Request not to receive intervention.|3
1588582|NCT02469064|5523037|P1|Overall Study|Request not to receive intervention.|1
1588583|NCT02468934|5523045|P1|Overall Study|Screen Failure|3
1588584|NCT02468934|5523045|P1|Overall Study|Withdrawal by Subject|4
1588585|NCT02468674|5523096|P9|Overall Study|Protocol Deviation|1
1588586|NCT02468674|5523097|P8|Overall Study|Protocol Deviation|1
1588587|NCT02468674|5523098|P7|Overall Study|Protocol Deviation|0
1588588|NCT02468674|5523099|P6|Overall Study|Protocol Deviation|0
1588589|NCT02468674|5523100|P5|Overall Study|Protocol Deviation|0
1588590|NCT02468674|5523101|P4|Overall Study|Protocol Deviation|0
1588591|NCT02468674|5523102|P3|Overall Study|Protocol Deviation|0
1588592|NCT02468674|5523103|P2|Overall Study|Protocol Deviation|0
1588593|NCT02468674|5523104|P1|Overall Study|Protocol Deviation|0
1588594|NCT02468674|5523096|P9|Overall Study|Patient/Guardian Decision|1
1588595|NCT02468674|5523097|P8|Overall Study|Patient/Guardian Decision|2
1588596|NCT02468674|5523098|P7|Overall Study|Patient/Guardian Decision|0
1588597|NCT02468674|5523099|P6|Overall Study|Patient/Guardian Decision|0
1588598|NCT02468674|5523100|P5|Overall Study|Patient/Guardian Decision|1
1588599|NCT02468674|5523101|P4|Overall Study|Patient/Guardian Decision|0
1588600|NCT02468674|5523102|P3|Overall Study|Patient/Guardian Decision|0
1588601|NCT02468674|5523103|P2|Overall Study|Patient/Guardian Decision|0
1588602|NCT02468674|5523104|P1|Overall Study|Patient/Guardian Decision|0
1588603|NCT02468674|5523096|P9|Overall Study|Physician Decision|0
1588604|NCT02468674|5523097|P8|Overall Study|Physician Decision|0
1588605|NCT02468674|5523098|P7|Overall Study|Physician Decision|1
1588606|NCT02468674|5523099|P6|Overall Study|Physician Decision|0
1588607|NCT02468674|5523100|P5|Overall Study|Physician Decision|0
1588608|NCT02468674|5523101|P4|Overall Study|Physician Decision|0
1588609|NCT02468674|5523102|P3|Overall Study|Physician Decision|0
1588610|NCT02468674|5523103|P2|Overall Study|Physician Decision|0
1588611|NCT02468674|5523104|P1|Overall Study|Physician Decision|0
1588612|NCT02468674|5523096|P9|Overall Study|Lost to Follow-up|1
1588613|NCT02468674|5523097|P8|Overall Study|Lost to Follow-up|1
1588614|NCT02468674|5523098|P7|Overall Study|Lost to Follow-up|0
1588615|NCT02468674|5523099|P6|Overall Study|Lost to Follow-up|0
1588616|NCT02468674|5523100|P5|Overall Study|Lost to Follow-up|0
1588617|NCT02468674|5523101|P4|Overall Study|Lost to Follow-up|0
1588618|NCT02468674|5523102|P3|Overall Study|Lost to Follow-up|0
1588619|NCT02468674|5523103|P2|Overall Study|Lost to Follow-up|0
1588620|NCT02468674|5523104|P1|Overall Study|Lost to Follow-up|1
1588621|NCT02468674|5523096|P9|Overall Study|Adverse Event|0
1588622|NCT02468674|5523097|P8|Overall Study|Adverse Event|0
1588623|NCT02468674|5523098|P7|Overall Study|Adverse Event|0
1588624|NCT02468674|5523099|P6|Overall Study|Adverse Event|1
1588625|NCT02468674|5523100|P5|Overall Study|Adverse Event|0
1588626|NCT02468674|5523101|P4|Overall Study|Adverse Event|1
1588627|NCT02468674|5523102|P3|Overall Study|Adverse Event|0
1588628|NCT02468674|5523103|P2|Overall Study|Adverse Event|0
1588629|NCT02468674|5523104|P1|Overall Study|Adverse Event|0
1588630|NCT02468414|5523201|P2|Overall Study|Screen Failure|0
1588631|NCT02468414|5523202|P1|Overall Study|Screen Failure|1
1588632|NCT02468414|5523201|P2|Overall Study|Poor in-vitro secreting TARGTs|0
1588633|NCT02468414|5523202|P1|Overall Study|Poor in-vitro secreting TARGTs|1
1588634|NCT02468414|5523201|P2|Overall Study|Early Study Termination by Sponsor|0
1588635|NCT02468414|5523202|P1|Overall Study|Early Study Termination by Sponsor|1
1588636|NCT02466659|5523363|P2|Overall Study|Lost to Follow-up|2
1588637|NCT02466659|5523364|P1|Overall Study|Lost to Follow-up|5
1588638|NCT02466555|5523372|P1|Overall Study|Lost to Follow-up|2
1588639|NCT02466516|5523384|P5|Overall Study|Lost to Follow-up|0
1588640|NCT02466516|5523385|P4|Overall Study|Lost to Follow-up|0
1588641|NCT02466516|5523386|P3|Overall Study|Lost to Follow-up|1
1588642|NCT02466516|5523387|P2|Overall Study|Lost to Follow-up|0
1588643|NCT02466516|5523388|P1|Overall Study|Lost to Follow-up|2
1588644|NCT02466516|5523384|P5|Overall Study|Withdrew Consent|0
1588645|NCT02466516|5523385|P4|Overall Study|Withdrew Consent|0
1588646|NCT02466516|5523386|P3|Overall Study|Withdrew Consent|0
1588647|NCT02466516|5523387|P2|Overall Study|Withdrew Consent|0
1588648|NCT02466516|5523388|P1|Overall Study|Withdrew Consent|1
1588649|NCT02466516|5523384|P5|Overall Study|Adverse Event|0
1588650|NCT02466516|5523385|P4|Overall Study|Adverse Event|0
1588651|NCT02466516|5523386|P3|Overall Study|Adverse Event|0
1588652|NCT02466516|5523387|P2|Overall Study|Adverse Event|1
1588653|NCT02466516|5523388|P1|Overall Study|Adverse Event|1
1588654|NCT02466425|5523407|P2|Overall Study|Withdrawal by Parent/Guardian|0
1588655|NCT02466425|5523408|P1|Overall Study|Withdrawal by Parent/Guardian|2
1588656|NCT02466425|5523407|P2|Overall Study|Other|3
1588657|NCT02466425|5523408|P1|Overall Study|Other|1
1588658|NCT02466425|5523407|P2|Overall Study|Withdrawal by Subject|1
1588659|NCT02466425|5523408|P1|Overall Study|Withdrawal by Subject|0
1588660|NCT02466425|5523407|P2|Overall Study|Protocol Violation|0
1588661|NCT02466425|5523408|P1|Overall Study|Protocol Violation|1
1588662|NCT02466425|5523407|P2|Overall Study|Lost to Follow-up|0
1588663|NCT02466425|5523408|P1|Overall Study|Lost to Follow-up|3
1588664|NCT02466425|5523407|P2|Overall Study|Lack of Efficacy|1
1588665|NCT02466425|5523408|P1|Overall Study|Lack of Efficacy|4
1588666|NCT02466425|5523407|P2|Overall Study|Adverse Event|11
1588667|NCT02466425|5523408|P1|Overall Study|Adverse Event|3
1588668|NCT02465931|5523446|P2|Overall Study|Withdrawal by Subject|0
1588669|NCT02465931|5523447|P1|Overall Study|Withdrawal by Subject|1
1588670|NCT02465931|5523446|P2|Overall Study|Protocol Violation|0
1588671|NCT02465931|5523447|P1|Overall Study|Protocol Violation|1
1588672|NCT02465931|5523446|P2|Overall Study|Lost to Follow-up|11
1588673|NCT02465931|5523447|P1|Overall Study|Lost to Follow-up|9
1588674|NCT02465866|5523453|P4|Period 3|Withdrawal by Subject|0
1588675|NCT02465866|5523454|P3|Period 3|Withdrawal by Subject|0
1588676|NCT02465866|5523455|P2|Period 3|Withdrawal by Subject|1
1588677|NCT02465866|5523456|P1|Period 3|Withdrawal by Subject|0
1588678|NCT02465528|5523546|P4|Overall Study|Physician Decision|0
1588679|NCT02465528|5523547|P3|Overall Study|Physician Decision|1
1588680|NCT02465528|5523548|P2|Overall Study|Physician Decision|0
1588681|NCT02465528|5523549|P1|Overall Study|Physician Decision|0
1588682|NCT02465528|5523546|P4|Overall Study|Adverse Event|1
1588683|NCT02465528|5523547|P3|Overall Study|Adverse Event|0
1588684|NCT02465528|5523548|P2|Overall Study|Adverse Event|0
1588685|NCT02465528|5523549|P1|Overall Study|Adverse Event|0
1588686|NCT02465528|5523546|P4|Overall Study|Withdrawal by Subject|0
1588687|NCT02465528|5523547|P3|Overall Study|Withdrawal by Subject|2
1588688|NCT02465528|5523548|P2|Overall Study|Withdrawal by Subject|0
1588689|NCT02465528|5523549|P1|Overall Study|Withdrawal by Subject|0
1588690|NCT02465528|5523546|P4|Overall Study|Study terminated by sponsor|0
1588691|NCT02465528|5523547|P3|Overall Study|Study terminated by sponsor|0
1588692|NCT02465528|5523548|P2|Overall Study|Study terminated by sponsor|2
1588693|NCT02465528|5523549|P1|Overall Study|Study terminated by sponsor|1
1588694|NCT02465528|5523546|P4|Overall Study|Progressive disease|4
1588695|NCT02465528|5523547|P3|Overall Study|Progressive disease|9
1588696|NCT02465528|5523548|P2|Overall Study|Progressive disease|2
1588697|NCT02465528|5523549|P1|Overall Study|Progressive disease|0
1588698|NCT02465515|5523582|P2|Overall Study|Lost to Follow-up|51
1588699|NCT02465515|5523583|P1|Overall Study|Lost to Follow-up|68
1588700|NCT02465515|5523582|P2|Overall Study|Physician Decision|12
1588701|NCT02465515|5523583|P1|Overall Study|Physician Decision|8
1588702|NCT02465515|5523582|P2|Overall Study|Withdrawal by Subject|43
1588703|NCT02465515|5523583|P1|Overall Study|Withdrawal by Subject|74
1588704|NCT02465515|5523582|P2|Overall Study|Investigator site closed|5
1588705|NCT02465515|5523583|P1|Overall Study|Investigator site closed|4
1588706|NCT02465489|5523629|P1|Overall Study|Adverse Event|5
1588707|NCT02465463|5523658|P2|Overall Study|Protocol Violation|0
1588708|NCT02465463|5523659|P1|Overall Study|Protocol Violation|1
1588709|NCT02465463|5523658|P2|Overall Study|Death|0
1588710|NCT02465463|5523659|P1|Overall Study|Death|1
1588711|NCT02465463|5523658|P2|Overall Study|Lost to Follow-up|1
1588712|NCT02465463|5523659|P1|Overall Study|Lost to Follow-up|2
1588713|NCT02465437|5523707|P4|Overall Study|Adverse Event|0
1588714|NCT02465437|5523708|P3|Overall Study|Adverse Event|0
1588715|NCT02465437|5523709|P2|Overall Study|Adverse Event|1
1588716|NCT02465437|5523710|P1|Overall Study|Adverse Event|0
1588717|NCT02465437|5523707|P4|Overall Study|Withdrawal by Subject|1
1588718|NCT02465437|5523708|P3|Overall Study|Withdrawal by Subject|0
1588719|NCT02465437|5523709|P2|Overall Study|Withdrawal by Subject|0
1588720|NCT02465437|5523710|P1|Overall Study|Withdrawal by Subject|1
1588721|NCT02465437|5523707|P4|Overall Study|Physician Decision|0
1588722|NCT02465437|5523708|P3|Overall Study|Physician Decision|1
1588723|NCT02465437|5523709|P2|Overall Study|Physician Decision|0
1588724|NCT02465437|5523710|P1|Overall Study|Physician Decision|0
1588725|NCT02465203|5523770|P3|Overall Study|Patient/guardian decision|1
1588726|NCT02465203|5523771|P2|Overall Study|Patient/guardian decision|1
1588727|NCT02465203|5523772|P1|Overall Study|Patient/guardian decision|1
1588728|NCT02465203|5523770|P3|Overall Study|New therapy for study indication|0
1588729|NCT02465203|5523771|P2|Overall Study|New therapy for study indication|0
1588730|NCT02465203|5523772|P1|Overall Study|New therapy for study indication|4
1588731|NCT02465203|5523770|P3|Overall Study|Study terminated by sponsor|11
1588732|NCT02465203|5523771|P2|Overall Study|Study terminated by sponsor|34
1588733|NCT02465203|5523772|P1|Overall Study|Study terminated by sponsor|50
1588734|NCT02465203|5523770|P3|Overall Study|Protocol Violation|1
1588735|NCT02465203|5523771|P2|Overall Study|Protocol Violation|1
1588736|NCT02465203|5523772|P1|Overall Study|Protocol Violation|1
1588737|NCT02463409|5523932|P1|Overall Study|Screen failure|1
1588738|NCT02463409|5523932|P1|Overall Study|Withdrawal by Subject|1
1588739|NCT02463331|5523940|P2|Overall Study|Physician Decision|0
1588740|NCT02463331|5523941|P1|Overall Study|Physician Decision|3
1588741|NCT02463331|5523940|P2|Overall Study|Lack of Efficacy|0
1588742|NCT02463331|5523941|P1|Overall Study|Lack of Efficacy|6
1588743|NCT02463331|5523940|P2|Overall Study|Pregnancy|3
1588744|NCT02463331|5523941|P1|Overall Study|Pregnancy|2
1588745|NCT02463331|5523940|P2|Overall Study|Lost to Follow-up|1
1588746|NCT02463331|5523941|P1|Overall Study|Lost to Follow-up|1
1588747|NCT02463331|5523940|P2|Overall Study|Adverse Event|2
1588748|NCT02463331|5523941|P1|Overall Study|Adverse Event|4
1588749|NCT02463097|5523957|P1|Overall Study|Withdrawal by Subject|1
1588750|NCT02463071|5523966|P3|Overall Study|Lost to Follow-up|1
1588751|NCT02463071|5523967|P2|Overall Study|Lost to Follow-up|0
1588752|NCT02463071|5523968|P1|Overall Study|Lost to Follow-up|0
1588753|NCT02463071|5523966|P3|Overall Study|Protocol Violation|0
1588754|NCT02463071|5523967|P2|Overall Study|Protocol Violation|2
1588755|NCT02463071|5523968|P1|Overall Study|Protocol Violation|0
1588756|NCT02463071|5523966|P3|Overall Study|Reason not specified|4
1588757|NCT02463071|5523967|P2|Overall Study|Reason not specified|9
1588758|NCT02463071|5523968|P1|Overall Study|Reason not specified|7
1588759|NCT02463071|5523966|P3|Overall Study|Eligibility criteria not fulfilled|0
1588760|NCT02463071|5523967|P2|Overall Study|Eligibility criteria not fulfilled|0
1588761|NCT02463071|5523968|P1|Overall Study|Eligibility criteria not fulfilled|1
1588762|NCT02463071|5523966|P3|Overall Study|Death|0
1588763|NCT02463071|5523967|P2|Overall Study|Death|0
1588764|NCT02463071|5523968|P1|Overall Study|Death|1
1588765|NCT02463071|5523966|P3|Overall Study|Adverse Event|1
1588766|NCT02463071|5523967|P2|Overall Study|Adverse Event|5
1588767|NCT02463071|5523968|P1|Overall Study|Adverse Event|3
1588768|NCT02462759|5523996|P3|Part 1: Double Blind|Death|0
1588769|NCT02462759|5523997|P2|Part 1: Double Blind|Death|0
1588770|NCT02462759|5523998|P1|Part 1: Double Blind|Death|1
1588771|NCT02462720|5524046|P2|Part 2|Protocol Violation|1
1588772|NCT02462720|5524047|P1|Part 2|Protocol Violation|0
1588773|NCT02462720|5524046|P2|Part 2|Withdrawal by Subject|0
1588774|NCT02462720|5524047|P1|Part 2|Withdrawal by Subject|1
1588775|NCT02462473|5524057|P1|Overall Study|Other|3
1588776|NCT02462473|5524057|P1|Overall Study|Death|1
1588777|NCT02462083|5524137|P1|Overall Study|Other than specified|45
1588778|NCT02462083|5524137|P1|Overall Study|Worsening condition|16
1588779|NCT02462083|5524137|P1|Overall Study|Adverse Event|33
1588780|NCT02462083|5524137|P1|Overall Study|Protocol Violation|6
1588781|NCT02462083|5524137|P1|Overall Study|Pregnancy|1
1588782|NCT02462083|5524137|P1|Overall Study|Lack of Efficacy|151
1588783|NCT02462083|5524137|P1|Overall Study|Lost to Follow-up|41
1588784|NCT02462083|5524137|P1|Overall Study|Withdrawal by Subject|87
1588785|NCT02462083|5524137|P1|Overall Study|Sponsor request|39
1588786|NCT02462057|5524146|P5|Overall Study|Joined HealthyFood Before Intervention|17
1588787|NCT02462057|5524147|P4|Overall Study|Joined HealthyFood Before Intervention|16
1588788|NCT02462057|5524148|P3|Overall Study|Joined HealthyFood Before Intervention|23
1588789|NCT02462057|5524149|P2|Overall Study|Joined HealthyFood Before Intervention|13
1588790|NCT02462057|5524150|P1|Overall Study|Joined HealthyFood Before Intervention|22
1588791|NCT02462057|5524146|P5|Overall Study|Left Vitality|33
1588792|NCT02462057|5524147|P4|Overall Study|Left Vitality|35
1588793|NCT02462057|5524148|P3|Overall Study|Left Vitality|23
1588794|NCT02462057|5524149|P2|Overall Study|Left Vitality|27
1588795|NCT02462057|5524150|P1|Overall Study|Left Vitality|32
1588796|NCT02461758|5524196|P4|Overall Study|Lost to Follow-up|0
1588797|NCT02461758|5524197|P3|Overall Study|Lost to Follow-up|1
1588798|NCT02461758|5524198|P2|Overall Study|Lost to Follow-up|1
1588799|NCT02461758|5524199|P1|Overall Study|Lost to Follow-up|0
1588800|NCT02461628|5524240|P2|Overall Study|Refused to complete survey|7
1588801|NCT02461628|5524241|P1|Overall Study|Refused to complete survey|4
1588802|NCT02461589|5524265|P10|Overall Study|Withdrawal from trial before exposure|1
1588803|NCT02461589|5524266|P9|Overall Study|Withdrawal from trial before exposure|0
1588804|NCT02461589|5524267|P8|Overall Study|Withdrawal from trial before exposure|0
1588805|NCT02461589|5524268|P7|Overall Study|Withdrawal from trial before exposure|0
1588806|NCT02461589|5524269|P6|Overall Study|Withdrawal from trial before exposure|0
1588807|NCT02461589|5524270|P5|Overall Study|Withdrawal from trial before exposure|0
1588808|NCT02461589|5524271|P4|Overall Study|Withdrawal from trial before exposure|0
1588809|NCT02461589|5524272|P3|Overall Study|Withdrawal from trial before exposure|0
1588810|NCT02461589|5524273|P2|Overall Study|Withdrawal from trial before exposure|0
1588811|NCT02461589|5524274|P1|Overall Study|Withdrawal from trial before exposure|0
1588812|NCT02461589|5524265|P10|Overall Study|Missing follow-up information|0
1588813|NCT02461589|5524266|P9|Overall Study|Missing follow-up information|0
1588814|NCT02461589|5524267|P8|Overall Study|Missing follow-up information|0
1588815|NCT02461589|5524268|P7|Overall Study|Missing follow-up information|1
1588816|NCT02461589|5524269|P6|Overall Study|Missing follow-up information|0
1588817|NCT02461589|5524270|P5|Overall Study|Missing follow-up information|0
1588818|NCT02461589|5524271|P4|Overall Study|Missing follow-up information|0
1588819|NCT02461589|5524272|P3|Overall Study|Missing follow-up information|0
1588820|NCT02461589|5524273|P2|Overall Study|Missing follow-up information|1
1588821|NCT02461589|5524274|P1|Overall Study|Missing follow-up information|1
1588822|NCT02461589|5524265|P10|Overall Study|Unclassified|2
1588823|NCT02461589|5524266|P9|Overall Study|Unclassified|0
1588824|NCT02461589|5524267|P8|Overall Study|Unclassified|0
1588825|NCT02461589|5524268|P7|Overall Study|Unclassified|1
1588826|NCT02461589|5524269|P6|Overall Study|Unclassified|0
1588827|NCT02461589|5524270|P5|Overall Study|Unclassified|0
1588828|NCT02461589|5524271|P4|Overall Study|Unclassified|0
1588829|NCT02461589|5524272|P3|Overall Study|Unclassified|0
1588830|NCT02461589|5524273|P2|Overall Study|Unclassified|0
1588831|NCT02461589|5524274|P1|Overall Study|Unclassified|0
1588832|NCT02461589|5524265|P10|Overall Study|Death|0
1588833|NCT02461589|5524266|P9|Overall Study|Death|0
1588834|NCT02461589|5524267|P8|Overall Study|Death|1
1588835|NCT02461589|5524268|P7|Overall Study|Death|0
1588836|NCT02461589|5524269|P6|Overall Study|Death|0
1588837|NCT02461589|5524270|P5|Overall Study|Death|0
1588838|NCT02461589|5524271|P4|Overall Study|Death|0
1588839|NCT02461589|5524272|P3|Overall Study|Death|0
1588840|NCT02461589|5524273|P2|Overall Study|Death|0
1588841|NCT02461589|5524274|P1|Overall Study|Death|0
1588842|NCT02461589|5524265|P10|Overall Study|Lost to Follow-up|1
1588843|NCT02461589|5524266|P9|Overall Study|Lost to Follow-up|3
1588844|NCT02461589|5524267|P8|Overall Study|Lost to Follow-up|1
1588845|NCT02461589|5524268|P7|Overall Study|Lost to Follow-up|3
1588846|NCT02461589|5524269|P6|Overall Study|Lost to Follow-up|1
1588847|NCT02461589|5524270|P5|Overall Study|Lost to Follow-up|1
1588848|NCT02461589|5524271|P4|Overall Study|Lost to Follow-up|3
1588849|NCT02461589|5524272|P3|Overall Study|Lost to Follow-up|2
1588850|NCT02461589|5524273|P2|Overall Study|Lost to Follow-up|0
1588851|NCT02461589|5524274|P1|Overall Study|Lost to Follow-up|0
1588852|NCT02461589|5524265|P10|Overall Study|Withdrawal by Subject|1
1588853|NCT02461589|5524266|P9|Overall Study|Withdrawal by Subject|3
1588854|NCT02461589|5524267|P8|Overall Study|Withdrawal by Subject|3
1588855|NCT02461589|5524268|P7|Overall Study|Withdrawal by Subject|1
1588856|NCT02461589|5524269|P6|Overall Study|Withdrawal by Subject|2
1588857|NCT02461589|5524270|P5|Overall Study|Withdrawal by Subject|1
1588858|NCT02461589|5524271|P4|Overall Study|Withdrawal by Subject|2
1588859|NCT02461589|5524272|P3|Overall Study|Withdrawal by Subject|3
1588860|NCT02461589|5524273|P2|Overall Study|Withdrawal by Subject|1
1588861|NCT02461589|5524274|P1|Overall Study|Withdrawal by Subject|5
1588862|NCT02461290|5524407|P1|Overall Study|Lost to Follow-up|3
1588863|NCT02461290|5524407|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
1588864|NCT02461160|5524427|P13|Overall Study|Lost to Follow-up|0
1588865|NCT02461160|5524428|P12|Overall Study|Lost to Follow-up|0
1588866|NCT02461160|5524429|P11|Overall Study|Lost to Follow-up|0
1588867|NCT02461160|5524430|P10|Overall Study|Lost to Follow-up|0
1588868|NCT02461160|5524431|P9|Overall Study|Lost to Follow-up|0
1588869|NCT02461160|5524432|P8|Overall Study|Lost to Follow-up|1
1588870|NCT02461160|5524433|P7|Overall Study|Lost to Follow-up|0
1588871|NCT02461160|5524434|P6|Overall Study|Lost to Follow-up|0
1588872|NCT02461160|5524435|P5|Overall Study|Lost to Follow-up|0
1588873|NCT02461160|5524436|P4|Overall Study|Lost to Follow-up|0
1588874|NCT02461160|5524437|P3|Overall Study|Lost to Follow-up|0
1588875|NCT02461160|5524438|P2|Overall Study|Lost to Follow-up|0
1588876|NCT02461160|5524439|P1|Overall Study|Lost to Follow-up|0
1588877|NCT02461134|5524650|P1|Overall Study|Adverse Event|1
1588878|NCT02460991|5524658|P2|Overall Study|Withdrawal by Subject|2
1588879|NCT02460991|5524659|P1|Overall Study|Withdrawal by Subject|0
1588880|NCT02460978|5524676|P3|Overall Study|Pregnancy|2
1588881|NCT02460978|5524677|P2|Overall Study|Pregnancy|0
1588882|NCT02460978|5524678|P1|Overall Study|Pregnancy|0
1588883|NCT02460978|5524676|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
1588884|NCT02460978|5524677|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
1588885|NCT02460978|5524678|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
1588886|NCT02460978|5524676|P3|Overall Study|Protocol Violation|1
1588887|NCT02460978|5524677|P2|Overall Study|Protocol Violation|1
1588888|NCT02460978|5524678|P1|Overall Study|Protocol Violation|1
1588889|NCT02460978|5524676|P3|Overall Study|Lost to Follow-up|1
1588890|NCT02460978|5524677|P2|Overall Study|Lost to Follow-up|3
1588891|NCT02460978|5524678|P1|Overall Study|Lost to Follow-up|2
1588892|NCT02460978|5524676|P3|Overall Study|Withdrawal by Subject|14
1588893|NCT02460978|5524677|P2|Overall Study|Withdrawal by Subject|5
1588894|NCT02460978|5524678|P1|Overall Study|Withdrawal by Subject|5
1588895|NCT02460978|5524676|P3|Overall Study|Adverse Event|11
1588896|NCT02460978|5524677|P2|Overall Study|Adverse Event|11
1588897|NCT02460978|5524678|P1|Overall Study|Adverse Event|17
1588898|NCT02460822|5524704|P1|Overall Study|Withdrawal by Subject|1
1588899|NCT02460562|5524715|P2|Overall Study|Lost to Follow-up|16
1588900|NCT02460562|5524716|P1|Overall Study|Lost to Follow-up|15
1588901|NCT02460380|5524732|P2|Overall Study|Withdrawal by Subject|5
1588902|NCT02460380|5524733|P1|Overall Study|Withdrawal by Subject|10
1588903|NCT02460159|5524769|P2|Overall Study|Withdrawal by Subject|0
1588904|NCT02460159|5524770|P1|Overall Study|Withdrawal by Subject|2
1588905|NCT02460159|5524769|P2|Overall Study|Adverse Event|1
1588906|NCT02460159|5524770|P1|Overall Study|Adverse Event|4
1588907|NCT02459951|5524798|P1|Overall Study|Unable to meet holding requirement|1
1588908|NCT02459899|5524809|P4|Overall Study|Withdrawal by Subject|0
1588909|NCT02459899|5524810|P3|Overall Study|Withdrawal by Subject|0
1588910|NCT02459899|5524811|P2|Overall Study|Withdrawal by Subject|3
1588911|NCT02459899|5524812|P1|Overall Study|Withdrawal by Subject|1
1588912|NCT02459899|5524809|P4|Overall Study|Non-compliance with the treatment|1
1588913|NCT02459899|5524810|P3|Overall Study|Non-compliance with the treatment|0
1588914|NCT02459899|5524811|P2|Overall Study|Non-compliance with the treatment|0
1588915|NCT02459899|5524812|P1|Overall Study|Non-compliance with the treatment|0
1588916|NCT02459899|5524809|P4|Overall Study|Lost to Follow-up|1
1588917|NCT02459899|5524810|P3|Overall Study|Lost to Follow-up|0
1588918|NCT02459899|5524811|P2|Overall Study|Lost to Follow-up|2
1588919|NCT02459899|5524812|P1|Overall Study|Lost to Follow-up|1
1588920|NCT02459899|5524809|P4|Overall Study|Adverse Event|0
1588921|NCT02459899|5524810|P3|Overall Study|Adverse Event|0
1588922|NCT02459899|5524811|P2|Overall Study|Adverse Event|1
1588923|NCT02459899|5524812|P1|Overall Study|Adverse Event|1
1588924|NCT02459665|5524846|P4|Overall Study|Withdrawal by Subject|2
1588925|NCT02459665|5524847|P3|Overall Study|Withdrawal by Subject|1
1588926|NCT02459665|5524848|P2|Overall Study|Withdrawal by Subject|1
1588927|NCT02459665|5524849|P1|Overall Study|Withdrawal by Subject|0
1588928|NCT02459418|5524880|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
1588929|NCT02459418|5524881|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
1588930|NCT02459418|5524880|P2|Overall Study|Elevated Creatine Kinase|0
1588931|NCT02459418|5524881|P1|Overall Study|Elevated Creatine Kinase|1
1588932|NCT02459418|5524880|P2|Overall Study|Withdrawal by Subject|1
1588933|NCT02459418|5524881|P1|Overall Study|Withdrawal by Subject|1
1588934|NCT02459418|5524880|P2|Overall Study|Adverse Event|1
1588935|NCT02459418|5524881|P1|Overall Study|Adverse Event|0
1588936|NCT02459418|5524880|P2|Overall Study|Endometrial thickness of >5 mm|0
1588937|NCT02459418|5524881|P1|Overall Study|Endometrial thickness of >5 mm|1
1588938|NCT02459418|5524880|P2|Overall Study|Physician Decision|2
1588939|NCT02459418|5524881|P1|Overall Study|Physician Decision|0
1588940|NCT02459418|5524880|P2|Overall Study|Protocol Violation|2
1588941|NCT02459418|5524881|P1|Overall Study|Protocol Violation|0
1588942|NCT02459418|5524880|P2|Overall Study|Exclusion Criteria|0
1588943|NCT02459418|5524881|P1|Overall Study|Exclusion Criteria|4
1588944|NCT02459093|5524920|P2|Overall Study|Lost to Follow-up|7
1588945|NCT02459093|5524921|P1|Overall Study|Lost to Follow-up|6
1588946|NCT02459093|5524920|P2|Overall Study|Protocol Violation|11
1588947|NCT02459093|5524921|P1|Overall Study|Protocol Violation|6
1588948|NCT02458287|5525001|P4|Overall Study|Relocated Out of State|1
1588949|NCT02458287|5525002|P3|Overall Study|Relocated Out of State|0
1588950|NCT02458287|5525003|P2|Overall Study|Relocated Out of State|0
1588951|NCT02458287|5525004|P1|Overall Study|Relocated Out of State|0
1588952|NCT02458287|5525001|P4|Overall Study|Withdrawal by Subject|1
1588953|NCT02458287|5525002|P3|Overall Study|Withdrawal by Subject|2
1588954|NCT02458287|5525003|P2|Overall Study|Withdrawal by Subject|2
1588955|NCT02458287|5525004|P1|Overall Study|Withdrawal by Subject|0
1588956|NCT02458287|5525001|P4|Overall Study|Protocol Violation|0
1588957|NCT02458287|5525002|P3|Overall Study|Protocol Violation|0
1588958|NCT02458287|5525003|P2|Overall Study|Protocol Violation|1
1588959|NCT02458287|5525004|P1|Overall Study|Protocol Violation|0
1588960|NCT02458287|5525001|P4|Overall Study|Lost to Follow-up|0
1588961|NCT02458287|5525002|P3|Overall Study|Lost to Follow-up|1
1588962|NCT02458287|5525003|P2|Overall Study|Lost to Follow-up|1
1588963|NCT02458287|5525004|P1|Overall Study|Lost to Follow-up|0
1588964|NCT02458287|5525001|P4|Overall Study|Adverse Event|1
1588965|NCT02458287|5525002|P3|Overall Study|Adverse Event|0
1588966|NCT02458287|5525003|P2|Overall Study|Adverse Event|0
1588967|NCT02458287|5525004|P1|Overall Study|Adverse Event|0
1588968|NCT02457819|5525056|P1|Overall Study|Adverse Event|33
1588969|NCT02457819|5525056|P1|Overall Study|Lack of Efficacy|19
1588970|NCT02457819|5525056|P1|Overall Study|Lost to Follow-up|10
1588971|NCT02457819|5525056|P1|Overall Study|non compliance with study drug|4
1588972|NCT02457819|5525056|P1|Overall Study|Protocol Violation|1
1588973|NCT02457819|5525056|P1|Overall Study|Withdrawal by Subject|24
1588974|NCT02457819|5525056|P1|Overall Study|reason not given|8
1588975|NCT02457793|5525068|P6|Overall Study|Physician Decision|3
1588976|NCT02457793|5525069|P5|Overall Study|Physician Decision|1
1588977|NCT02457793|5525070|P4|Overall Study|Physician Decision|1
1588978|NCT02457793|5525071|P3|Overall Study|Physician Decision|1
1588979|NCT02457793|5525072|P2|Overall Study|Physician Decision|0
1588980|NCT02457793|5525073|P1|Overall Study|Physician Decision|1
1588981|NCT02457793|5525068|P6|Overall Study|Adverse Event|0
1588982|NCT02457793|5525069|P5|Overall Study|Adverse Event|0
1588983|NCT02457793|5525070|P4|Overall Study|Adverse Event|1
1588984|NCT02457793|5525071|P3|Overall Study|Adverse Event|0
1588985|NCT02457793|5525072|P2|Overall Study|Adverse Event|0
1588986|NCT02457793|5525073|P1|Overall Study|Adverse Event|0
1588987|NCT02457793|5525068|P6|Overall Study|Withdrawal by Subject|2
1588988|NCT02457793|5525069|P5|Overall Study|Withdrawal by Subject|2
1588989|NCT02457793|5525070|P4|Overall Study|Withdrawal by Subject|2
1588990|NCT02457793|5525071|P3|Overall Study|Withdrawal by Subject|2
1588991|NCT02457793|5525072|P2|Overall Study|Withdrawal by Subject|4
1588992|NCT02457793|5525073|P1|Overall Study|Withdrawal by Subject|0
1588993|NCT02457793|5525068|P6|Overall Study|Reason not specified|1
1588994|NCT02457793|5525069|P5|Overall Study|Reason not specified|1
1588995|NCT02457793|5525070|P4|Overall Study|Reason not specified|1
1588996|NCT02457793|5525071|P3|Overall Study|Reason not specified|0
1588997|NCT02457793|5525072|P2|Overall Study|Reason not specified|0
1588998|NCT02457793|5525073|P1|Overall Study|Reason not specified|0
1588999|NCT02457637|5525217|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
1589000|NCT02457611|5525224|P1|Overall Study|Lost to Follow-up|3
1589001|NCT02457546|5525238|P2|Overall Study|Adverse Event|1
1589002|NCT02457546|5525239|P1|Overall Study|Adverse Event|0
1589003|NCT02457546|5525238|P2|Overall Study|Lost to Follow-up|1
1589004|NCT02457546|5525239|P1|Overall Study|Lost to Follow-up|4
1589005|NCT02457546|5525238|P2|Overall Study|Refused to complete study/procedures|1
1589006|NCT02457546|5525239|P1|Overall Study|Refused to complete study/procedures|1
1589007|NCT02457546|5525238|P2|Overall Study|Other reasons|1
1589008|NCT02457546|5525239|P1|Overall Study|Other reasons|4
1589009|NCT02457247|5525294|P4|Period 2|Voluntary Withdrawal|0
1589010|NCT02457247|5525295|P3|Period 2|Voluntary Withdrawal|0
1589011|NCT02457247|5525296|P2|Period 2|Voluntary Withdrawal|1
1589012|NCT02457247|5525297|P1|Period 2|Voluntary Withdrawal|1
1589013|NCT02457247|5525294|P4|Period 2|Lost to Follow-up|0
1589014|NCT02457247|5525295|P3|Period 2|Lost to Follow-up|0
1589015|NCT02457247|5525296|P2|Period 2|Lost to Follow-up|1
1589016|NCT02457247|5525297|P1|Period 2|Lost to Follow-up|0
1589017|NCT02457247|5525294|P4|Period 2|Significant Protocol Deviation|0
1589018|NCT02457247|5525295|P3|Period 2|Significant Protocol Deviation|0
1589019|NCT02457247|5525296|P2|Period 2|Significant Protocol Deviation|0
1589020|NCT02457247|5525297|P1|Period 2|Significant Protocol Deviation|1
1589021|NCT02457247|5525294|P4|Period 2|Pretreatment Event/Adverse Event|0
1589022|NCT02457247|5525295|P3|Period 2|Pretreatment Event/Adverse Event|0
1589023|NCT02457247|5525296|P2|Period 2|Pretreatment Event/Adverse Event|1
1589024|NCT02457247|5525297|P1|Period 2|Pretreatment Event/Adverse Event|0
1589025|NCT02457247|5525294|P4|Period 1|Voluntary Withdrawal|0
1589026|NCT02457247|5525295|P3|Period 1|Voluntary Withdrawal|0
1589027|NCT02457247|5525296|P2|Period 1|Voluntary Withdrawal|0
1589028|NCT02457247|5525297|P1|Period 1|Voluntary Withdrawal|1
1589029|NCT02457247|5525294|P4|Period 1|Significant Protocol Deviation|0
1589030|NCT02457247|5525295|P3|Period 1|Significant Protocol Deviation|0
1589031|NCT02457247|5525296|P2|Period 1|Significant Protocol Deviation|1
1589032|NCT02457247|5525297|P1|Period 1|Significant Protocol Deviation|1
1589033|NCT02457247|5525294|P4|Period 1|Pretreatment Event/Adverse Event|0
1589034|NCT02457247|5525295|P3|Period 1|Pretreatment Event/Adverse Event|0
1589035|NCT02457247|5525296|P2|Period 1|Pretreatment Event/Adverse Event|1
1589036|NCT02457247|5525297|P1|Period 1|Pretreatment Event/Adverse Event|0
1589037|NCT02457195|5525317|P1|Overall Study|Withdrawal by Subject|4
1589038|NCT02457195|5525317|P1|Overall Study|Protocol Violation|2
1589039|NCT02457195|5525317|P1|Overall Study|Adverse Event|3
1589040|NCT02457182|5525323|P2|Overall Study|Lost to Follow-up|0
1589041|NCT02457182|5525324|P1|Overall Study|Lost to Follow-up|1
1589042|NCT02457065|5525342|P2|Overall Study|Lost to Follow-up|11
1589043|NCT02457065|5525343|P1|Overall Study|Lost to Follow-up|9
1589044|NCT02456740|5525365|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1589045|NCT02456740|5525366|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1589046|NCT02456740|5525367|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1589047|NCT02456740|5525368|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
1589048|NCT02456740|5525369|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
1589049|NCT02456740|5525370|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
1589050|NCT02456740|5525371|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1589051|NCT02456740|5525372|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1589052|NCT02456740|5525373|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1589053|NCT02456740|5525365|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589054|NCT02456740|5525366|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
1589055|NCT02456740|5525367|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589056|NCT02456740|5525368|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589057|NCT02456740|5525369|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589058|NCT02456740|5525370|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589059|NCT02456740|5525371|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589060|NCT02456740|5525372|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589061|NCT02456740|5525373|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
1589062|NCT02456740|5525365|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1589063|NCT02456740|5525366|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1589064|NCT02456740|5525367|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
1589065|NCT02456740|5525368|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
1589066|NCT02456740|5525369|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
1589067|NCT02456740|5525370|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
1589068|NCT02456740|5525371|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1589069|NCT02456740|5525372|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1589070|NCT02456740|5525373|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1589071|NCT02456740|5525365|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
1589072|NCT02456740|5525366|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1589073|NCT02456740|5525367|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1589074|NCT02456740|5525368|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1589075|NCT02456740|5525369|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
1589076|NCT02456740|5525370|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
1589077|NCT02456740|5525371|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1589078|NCT02456740|5525372|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1589079|NCT02456740|5525373|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
1589080|NCT02456740|5525365|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1589081|NCT02456740|5525366|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1589082|NCT02456740|5525367|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1589083|NCT02456740|5525368|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1589084|NCT02456740|5525369|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1589085|NCT02456740|5525370|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
1589086|NCT02456740|5525371|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
1589087|NCT02456740|5525372|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
1589088|NCT02456740|5525373|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
1589089|NCT02456740|5525365|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1589090|NCT02456740|5525366|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1589091|NCT02456740|5525367|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1589092|NCT02456740|5525368|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1589093|NCT02456740|5525369|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1589094|NCT02456740|5525370|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
1589095|NCT02456740|5525371|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
1589096|NCT02456740|5525372|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
1589097|NCT02456740|5525373|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
1589098|NCT02456740|5525365|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1589099|NCT02456740|5525366|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1589100|NCT02456740|5525367|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1589101|NCT02456740|5525368|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1589102|NCT02456740|5525369|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1589103|NCT02456740|5525370|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
1589104|NCT02456740|5525371|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1589105|NCT02456740|5525372|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1589106|NCT02456740|5525373|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
1589107|NCT02455518|5525399|P4|Overall Study|Protocol Violation|3
1589108|NCT02455518|5525400|P3|Overall Study|Protocol Violation|1
1589109|NCT02455518|5525401|P2|Overall Study|Protocol Violation|1
1589110|NCT02455518|5525402|P1|Overall Study|Protocol Violation|0
1589111|NCT02455388|5525424|P3|Overall Study|Withdrawal by Subject|7
1589112|NCT02455388|5525425|P2|Overall Study|Withdrawal by Subject|0
1589113|NCT02455388|5525426|P1|Overall Study|Withdrawal by Subject|0
1589114|NCT02455388|5525424|P3|Overall Study|Protocol Violation|4
1589115|NCT02455388|5525425|P2|Overall Study|Protocol Violation|0
1589116|NCT02455388|5525426|P1|Overall Study|Protocol Violation|1
1589117|NCT02455336|5525437|P2|Overall Study|Non-responder to treatment|0
1589118|NCT02455336|5525438|P1|Overall Study|Non-responder to treatment|2
1589119|NCT02455336|5525437|P2|Overall Study|Adverse Event|0
1589120|NCT02455336|5525438|P1|Overall Study|Adverse Event|3
1589121|NCT02455336|5525437|P2|Overall Study|Withdrawal by Subject|2
1589122|NCT02455336|5525438|P1|Overall Study|Withdrawal by Subject|0
1589123|NCT02455076|5525453|P5|Outpatient|Lost to Follow-up|12
1589124|NCT02455076|5525454|P4|Outpatient|Lost to Follow-up|1
1589125|NCT02455076|5525455|P3|Outpatient|Lost to Follow-up|0
1589126|NCT02455076|5525456|P2|Outpatient|Lost to Follow-up|0
1589127|NCT02455076|5525457|P1|Outpatient|Lost to Follow-up|0
1589128|NCT02455076|5525453|P5|Outpatient|Adverse Event|0
1589129|NCT02455076|5525454|P4|Outpatient|Adverse Event|5
1589130|NCT02455076|5525455|P3|Outpatient|Adverse Event|0
1589131|NCT02455076|5525456|P2|Outpatient|Adverse Event|0
1589132|NCT02455076|5525457|P1|Outpatient|Adverse Event|0
1589133|NCT02455076|5525453|P5|Inpatient|Adverse Event|0
1589134|NCT02455076|5525454|P4|Inpatient|Adverse Event|0
1589135|NCT02455076|5525455|P3|Inpatient|Adverse Event|0
1589136|NCT02455076|5525456|P2|Inpatient|Adverse Event|0
1589137|NCT02455076|5525457|P1|Inpatient|Adverse Event|3
1589138|NCT02455076|5525453|P5|Inpatient|Discharged <24 h after admission|0
1589139|NCT02455076|5525454|P4|Inpatient|Discharged <24 h after admission|0
1589140|NCT02455076|5525455|P3|Inpatient|Discharged <24 h after admission|0
1589141|NCT02455076|5525456|P2|Inpatient|Discharged <24 h after admission|1
1589142|NCT02455076|5525457|P1|Inpatient|Discharged <24 h after admission|0
1589143|NCT02455076|5525453|P5|Inpatient|Withdrawal by Subject|0
1589144|NCT02455076|5525454|P4|Inpatient|Withdrawal by Subject|0
1589145|NCT02455076|5525455|P3|Inpatient|Withdrawal by Subject|0
1589146|NCT02455076|5525456|P2|Inpatient|Withdrawal by Subject|0
1589147|NCT02455076|5525457|P1|Inpatient|Withdrawal by Subject|1
1589148|NCT02455050|5525543|P4|Treatment Period 2|Lost to Follow-up|1
1589149|NCT02455050|5525544|P3|Treatment Period 2|Lost to Follow-up|2
1589150|NCT02455050|5525545|P2|Treatment Period 2|Lost to Follow-up|0
1589151|NCT02455050|5525546|P1|Treatment Period 2|Lost to Follow-up|1
1589152|NCT02455050|5525543|P4|Treatment Period 1|Lost to Follow-up|2
1589153|NCT02455050|5525544|P3|Treatment Period 1|Lost to Follow-up|1
1589154|NCT02455050|5525545|P2|Treatment Period 1|Lost to Follow-up|1
1589155|NCT02455050|5525546|P1|Treatment Period 1|Lost to Follow-up|1
1589156|NCT02454959|5525610|P1|Overall Study|Adverse Event|2
1589157|NCT02454959|5525610|P1|Overall Study|Withdrawal by Subject|3
1589158|NCT02454959|5525610|P1|Overall Study|Physician Decision|1
1589159|NCT02454959|5525610|P1|Overall Study|Protocol-Specified Criteria|3
1589160|NCT02454933|5525630|P2|Overall Study|Withdrawal by Subject|2
1589161|NCT02454933|5525631|P1|Overall Study|Withdrawal by Subject|0
1589162|NCT02454933|5525630|P2|Overall Study|Adverse Event|1
1589163|NCT02454933|5525631|P1|Overall Study|Adverse Event|1
1589164|NCT02454933|5525630|P2|Overall Study|Progressive disease|5
1589165|NCT02454933|5525631|P1|Overall Study|Progressive disease|7
1589166|NCT02454608|5525639|P3|Open Label Period|Withdrawal by Subject|8
1589167|NCT02454608|5525640|P2|Open Label Period|Withdrawal by Subject|0
1589168|NCT02454608|5525641|P1|Open Label Period|Withdrawal by Subject|0
1589169|NCT02454608|5525639|P3|Open Label Period|Lost to Follow-up|11
1589170|NCT02454608|5525640|P2|Open Label Period|Lost to Follow-up|0
1589171|NCT02454608|5525641|P1|Open Label Period|Lost to Follow-up|0
1589172|NCT02454608|5525639|P3|Double-Blind Period|Lack of Efficacy|0
1589173|NCT02454608|5525640|P2|Double-Blind Period|Lack of Efficacy|2
1589174|NCT02454608|5525641|P1|Double-Blind Period|Lack of Efficacy|0
1589175|NCT02454530|5525664|P2|Overall Study|Lost to Follow-up|4
1589176|NCT02454530|5525665|P1|Overall Study|Lost to Follow-up|4
1589177|NCT02454530|5525664|P2|Overall Study|Death|41
1589178|NCT02454530|5525665|P1|Overall Study|Death|2
1589179|NCT02454530|5525664|P2|Overall Study|Missing information|69
1589180|NCT02454530|5525665|P1|Overall Study|Missing information|56
1589181|NCT02454530|5525664|P2|Overall Study|Other|13
1589182|NCT02454530|5525665|P1|Overall Study|Other|8
1589183|NCT02454478|5525702|P1|Overall Study|Incomplete DLT Evaluation|1
1589184|NCT02454101|5525796|P2|Overall Study|Lost to Follow-up|4
1589185|NCT02454101|5525797|P1|Overall Study|Lost to Follow-up|3
1589186|NCT02454101|5525796|P2|Overall Study|Adverse Event|3
1589187|NCT02454101|5525797|P1|Overall Study|Adverse Event|2
1589188|NCT02453841|5525819|P1|Overall Study|Unable to obtain blood samples|2
1589189|NCT02453841|5525819|P1|Overall Study|Protocol Violation|1
1589190|NCT02453685|5525835|P2|Overall Study|Unclassified|2
1589191|NCT02453685|5525836|P1|Overall Study|Unclassified|4
1589192|NCT02453685|5525835|P2|Overall Study|Withdrawal by Subject|4
1589193|NCT02453685|5525836|P1|Overall Study|Withdrawal by Subject|8
1589194|NCT02453685|5525835|P2|Overall Study|Lost to Follow-up|1
1589195|NCT02453685|5525836|P1|Overall Study|Lost to Follow-up|0
1589196|NCT02453685|5525835|P2|Overall Study|Protocol Violation|4
1589197|NCT02453685|5525836|P1|Overall Study|Protocol Violation|7
1589198|NCT02453685|5525835|P2|Overall Study|Adverse Event|1
1589199|NCT02453685|5525836|P1|Overall Study|Adverse Event|0
1589200|NCT02453555|5525894|P6|Extension Period|Withdrawal by Subject|0
1589201|NCT02453555|5525895|P5|Extension Period|Withdrawal by Subject|0
1589202|NCT02453555|5525896|P4|Extension Period|Withdrawal by Subject|0
1589203|NCT02453555|5525897|P3|Extension Period|Withdrawal by Subject|1
1589204|NCT02453555|5525898|P2|Extension Period|Withdrawal by Subject|0
1589205|NCT02453555|5525899|P1|Extension Period|Withdrawal by Subject|0
1589206|NCT02453555|5525894|P6|Extension Period|Protocol Violation|0
1589207|NCT02453555|5525895|P5|Extension Period|Protocol Violation|0
1589208|NCT02453555|5525896|P4|Extension Period|Protocol Violation|0
1589209|NCT02453555|5525897|P3|Extension Period|Protocol Violation|1
1589210|NCT02453555|5525898|P2|Extension Period|Protocol Violation|0
1589211|NCT02453555|5525899|P1|Extension Period|Protocol Violation|0
1589212|NCT02453555|5525894|P6|Extension Period|Adverse Event|1
1589213|NCT02453555|5525895|P5|Extension Period|Adverse Event|1
1589214|NCT02453555|5525896|P4|Extension Period|Adverse Event|2
1589215|NCT02453555|5525897|P3|Extension Period|Adverse Event|1
1589216|NCT02453555|5525898|P2|Extension Period|Adverse Event|0
1589217|NCT02453555|5525899|P1|Extension Period|Adverse Event|0
1589218|NCT02453555|5525894|P6|24-week Double-blind Treatment Period|Other than specified above|0
1589219|NCT02453555|5525895|P5|24-week Double-blind Treatment Period|Other than specified above|0
1589220|NCT02453555|5525896|P4|24-week Double-blind Treatment Period|Other than specified above|0
1589221|NCT02453555|5525897|P3|24-week Double-blind Treatment Period|Other than specified above|0
1589222|NCT02453555|5525898|P2|24-week Double-blind Treatment Period|Other than specified above|3
1589223|NCT02453555|5525899|P1|24-week Double-blind Treatment Period|Other than specified above|0
1589224|NCT02453555|5525894|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
1589225|NCT02453555|5525895|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
1589226|NCT02453555|5525896|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
1589227|NCT02453555|5525897|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
1589228|NCT02453555|5525898|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
1589229|NCT02453555|5525899|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
1589230|NCT02453555|5525894|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
1589231|NCT02453555|5525895|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
1589232|NCT02453555|5525896|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
1589233|NCT02453555|5525897|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
1589234|NCT02453555|5525898|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
1589235|NCT02453555|5525899|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
1589236|NCT02453555|5525894|P6|24-week Double-blind Treatment Period|Adverse Event|0
1589237|NCT02453555|5525895|P5|24-week Double-blind Treatment Period|Adverse Event|0
1589238|NCT02453555|5525896|P4|24-week Double-blind Treatment Period|Adverse Event|0
1589239|NCT02453555|5525897|P3|24-week Double-blind Treatment Period|Adverse Event|0
1589240|NCT02453555|5525898|P2|24-week Double-blind Treatment Period|Adverse Event|0
1589241|NCT02453555|5525899|P1|24-week Double-blind Treatment Period|Adverse Event|2
1589242|NCT02453386|5525915|P3|Overall Study|Other|1
1589243|NCT02453386|5525916|P2|Overall Study|Other|0
1589244|NCT02453386|5525917|P1|Overall Study|Other|1
1589245|NCT02453386|5525915|P3|Overall Study|Lost to Follow-up|1
1589246|NCT02453386|5525916|P2|Overall Study|Lost to Follow-up|0
1589247|NCT02453386|5525917|P1|Overall Study|Lost to Follow-up|0
1589248|NCT02453386|5525915|P3|Overall Study|Sponsor Terminated by Investigator|2
1589249|NCT02453386|5525916|P2|Overall Study|Sponsor Terminated by Investigator|1
1589250|NCT02453386|5525917|P1|Overall Study|Sponsor Terminated by Investigator|0
1589251|NCT02453386|5525915|P3|Overall Study|Subject Terminated by Sponsor|1
1589252|NCT02453386|5525916|P2|Overall Study|Subject Terminated by Sponsor|1
1589253|NCT02453386|5525917|P1|Overall Study|Subject Terminated by Sponsor|1
1589254|NCT02453386|5525915|P3|Overall Study|Sponsor Terminated Study|11
1589255|NCT02453386|5525916|P2|Overall Study|Sponsor Terminated Study|8
1589256|NCT02453386|5525917|P1|Overall Study|Sponsor Terminated Study|14
1589257|NCT02453386|5525915|P3|Overall Study|Withdrawal by Subject|9
1589258|NCT02453386|5525916|P2|Overall Study|Withdrawal by Subject|9
1589259|NCT02453386|5525917|P1|Overall Study|Withdrawal by Subject|10
1589260|NCT02453386|5525915|P3|Overall Study|Protocol Violation|1
1589261|NCT02453386|5525916|P2|Overall Study|Protocol Violation|0
1589262|NCT02453386|5525917|P1|Overall Study|Protocol Violation|1
1589263|NCT02453386|5525915|P3|Overall Study|Adverse Event|15
1589264|NCT02453386|5525916|P2|Overall Study|Adverse Event|30
1589265|NCT02453386|5525917|P1|Overall Study|Adverse Event|22
1589266|NCT02453321|5525981|P3|Overall Study|Deep Venous Thrombosis|0
1589267|NCT02453321|5525982|P2|Overall Study|Deep Venous Thrombosis|1
1589268|NCT02453321|5525983|P1|Overall Study|Deep Venous Thrombosis|0
1589269|NCT02453321|5525981|P3|Overall Study|Weakness|2
1589270|NCT02453321|5525982|P2|Overall Study|Weakness|1
1589271|NCT02453321|5525983|P1|Overall Study|Weakness|1
1589272|NCT02453282|5526003|P3|Overall Study|Other|1
1589273|NCT02453282|5526004|P2|Overall Study|Other|1
1589274|NCT02453282|5526005|P1|Overall Study|Other|1
1589275|NCT02453282|5526003|P3|Overall Study|Participants ongoing at data cut-off|62
1589276|NCT02453282|5526004|P2|Overall Study|Participants ongoing at data cut-off|84
1589277|NCT02453282|5526005|P1|Overall Study|Participants ongoing at data cut-off|85
1589278|NCT02453282|5526003|P3|Overall Study|Withdrawal by Subject|11
1589279|NCT02453282|5526004|P2|Overall Study|Withdrawal by Subject|10
1589280|NCT02453282|5526005|P1|Overall Study|Withdrawal by Subject|12
1589281|NCT02453282|5526003|P3|Overall Study|Lost to Follow-up|2
1589282|NCT02453282|5526004|P2|Overall Study|Lost to Follow-up|0
1589283|NCT02453282|5526005|P1|Overall Study|Lost to Follow-up|1
1589284|NCT02453282|5526003|P3|Overall Study|Death|296
1589285|NCT02453282|5526004|P2|Overall Study|Death|277
1589286|NCT02453282|5526005|P1|Overall Study|Death|275
1589287|NCT02453256|5526086|P2|Open Label Period|Withdrawal by Subject|1
1589288|NCT02453256|5526087|P1|Open Label Period|Withdrawal by Subject|5
1589289|NCT02453256|5526086|P2|Open Label Period|Other|2
1589290|NCT02453256|5526087|P1|Open Label Period|Other|0
1589291|NCT02453256|5526086|P2|Open Label Period|Lost to Follow-up|0
1589292|NCT02453256|5526087|P1|Open Label Period|Lost to Follow-up|1
1589293|NCT02453256|5526086|P2|Open Label Period|Death|1
1589294|NCT02453256|5526087|P1|Open Label Period|Death|0
1589295|NCT02453256|5526086|P2|Open Label Period|Adverse Event|3
1589296|NCT02453256|5526087|P1|Open Label Period|Adverse Event|1
1589297|NCT02453256|5526086|P2|Double Blind Period|Other|1
1589298|NCT02453256|5526087|P1|Double Blind Period|Other|0
1589299|NCT02453256|5526086|P2|Double Blind Period|Withdrawal by Subject|5
1589300|NCT02453256|5526087|P1|Double Blind Period|Withdrawal by Subject|9
1589301|NCT02453256|5526086|P2|Double Blind Period|Adverse Event|2
1589302|NCT02453256|5526087|P1|Double Blind Period|Adverse Event|3
1589303|NCT02453256|5526086|P2|Double Blind Period|Death|1
1589304|NCT02453256|5526087|P1|Double Blind Period|Death|1
1589305|NCT02453048|5526212|P5|Overall Study|Lost to Follow-up|0
1589306|NCT02453048|5526213|P4|Overall Study|Lost to Follow-up|0
1589307|NCT02453048|5526214|P3|Overall Study|Lost to Follow-up|2
1589308|NCT02453048|5526215|P2|Overall Study|Lost to Follow-up|1
1589309|NCT02453048|5526216|P1|Overall Study|Lost to Follow-up|0
1589310|NCT02453048|5526212|P5|Overall Study|Only part of initial 6 mo. study|6
1589311|NCT02453048|5526213|P4|Overall Study|Only part of initial 6 mo. study|0
1589312|NCT02453048|5526214|P3|Overall Study|Only part of initial 6 mo. study|0
1589313|NCT02453048|5526215|P2|Overall Study|Only part of initial 6 mo. study|0
1589314|NCT02453048|5526216|P1|Overall Study|Only part of initial 6 mo. study|0
1589315|NCT02452892|5526253|P4|Follow-up|Subject left town on Day 42|0
1589316|NCT02452892|5526254|P3|Follow-up|Subject left town on Day 42|0
1589317|NCT02452892|5526255|P2|Follow-up|Subject left town on Day 42|0
1589318|NCT02452892|5526256|P1|Follow-up|Subject left town on Day 42|1
1589319|NCT02452892|5526253|P4|Follow-up|Withdrawal by Subject|1
1589320|NCT02452892|5526254|P3|Follow-up|Withdrawal by Subject|0
1589321|NCT02452892|5526255|P2|Follow-up|Withdrawal by Subject|0
1589322|NCT02452892|5526256|P1|Follow-up|Withdrawal by Subject|0
1589323|NCT02452892|5526253|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1589324|NCT02452892|5526254|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1589325|NCT02452892|5526255|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
1589326|NCT02452892|5526256|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
1589327|NCT02452892|5526253|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
1589328|NCT02452892|5526254|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1589329|NCT02452892|5526255|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1589330|NCT02452892|5526256|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
1589331|NCT02452892|5526253|P4|Week 1 Initial Randommization|Lost to Follow-up|0
1589332|NCT02452892|5526254|P3|Week 1 Initial Randommization|Lost to Follow-up|1
1589333|NCT02452892|5526255|P2|Week 1 Initial Randommization|Lost to Follow-up|0
1589334|NCT02452892|5526256|P1|Week 1 Initial Randommization|Lost to Follow-up|0
1589335|NCT02452892|5526253|P4|Week 1 Initial Randommization|Adverse Event|0
1589336|NCT02452892|5526254|P3|Week 1 Initial Randommization|Adverse Event|0
1589337|NCT02452892|5526255|P2|Week 1 Initial Randommization|Adverse Event|0
1589338|NCT02452892|5526256|P1|Week 1 Initial Randommization|Adverse Event|1
1589339|NCT02452554|5526291|P6|Overall Study|Never Received Treatment|0
1589340|NCT02452554|5526292|P5|Overall Study|Never Received Treatment|0
1589341|NCT02452554|5526293|P4|Overall Study|Never Received Treatment|0
1589342|NCT02452554|5526294|P3|Overall Study|Never Received Treatment|0
1589343|NCT02452554|5526295|P2|Overall Study|Never Received Treatment|0
1589344|NCT02452554|5526296|P1|Overall Study|Never Received Treatment|1
1589345|NCT02452554|5526291|P6|Overall Study|Ineligible|0
1589346|NCT02452554|5526292|P5|Overall Study|Ineligible|0
1589347|NCT02452554|5526293|P4|Overall Study|Ineligible|0
1589348|NCT02452554|5526294|P3|Overall Study|Ineligible|0
1589349|NCT02452554|5526295|P2|Overall Study|Ineligible|1
1589350|NCT02452554|5526296|P1|Overall Study|Ineligible|0
1589351|NCT02452554|5526291|P6|Overall Study|Withdrawal by Subject|1
1589352|NCT02452554|5526292|P5|Overall Study|Withdrawal by Subject|0
1589353|NCT02452554|5526293|P4|Overall Study|Withdrawal by Subject|0
1589354|NCT02452554|5526294|P3|Overall Study|Withdrawal by Subject|2
1589355|NCT02452554|5526295|P2|Overall Study|Withdrawal by Subject|0
1589356|NCT02452554|5526296|P1|Overall Study|Withdrawal by Subject|1
1589357|NCT02452554|5526291|P6|Overall Study|Physician Decision|0
1589358|NCT02452554|5526292|P5|Overall Study|Physician Decision|0
1589359|NCT02452554|5526293|P4|Overall Study|Physician Decision|0
1589360|NCT02452554|5526294|P3|Overall Study|Physician Decision|0
1589361|NCT02452554|5526295|P2|Overall Study|Physician Decision|1
1589362|NCT02452554|5526296|P1|Overall Study|Physician Decision|0
1589363|NCT02452554|5526291|P6|Overall Study|Lack of Efficacy|8
1589364|NCT02452554|5526292|P5|Overall Study|Lack of Efficacy|5
1589365|NCT02452554|5526293|P4|Overall Study|Lack of Efficacy|1
1589366|NCT02452554|5526294|P3|Overall Study|Lack of Efficacy|9
1589367|NCT02452554|5526295|P2|Overall Study|Lack of Efficacy|14
1589368|NCT02452554|5526296|P1|Overall Study|Lack of Efficacy|13
1589369|NCT02452554|5526291|P6|Overall Study|Death|0
1589370|NCT02452554|5526292|P5|Overall Study|Death|0
1589371|NCT02452554|5526293|P4|Overall Study|Death|0
1589372|NCT02452554|5526294|P3|Overall Study|Death|0
1589373|NCT02452554|5526295|P2|Overall Study|Death|1
1589374|NCT02452554|5526296|P1|Overall Study|Death|2
1589375|NCT02452424|5526357|P11|Overall Study|Adverse Event|1
1589376|NCT02452424|5526358|P10|Overall Study|Adverse Event|0
1589377|NCT02452424|5526359|P9|Overall Study|Adverse Event|0
1589378|NCT02452424|5526360|P8|Overall Study|Adverse Event|0
1589379|NCT02452424|5526361|P7|Overall Study|Adverse Event|0
1589380|NCT02452424|5526362|P6|Overall Study|Adverse Event|0
1589381|NCT02452424|5526363|P5|Overall Study|Adverse Event|0
1589382|NCT02452424|5526364|P4|Overall Study|Adverse Event|0
1589383|NCT02452424|5526365|P3|Overall Study|Adverse Event|0
1589384|NCT02452424|5526366|P2|Overall Study|Adverse Event|0
1589385|NCT02452424|5526367|P1|Overall Study|Adverse Event|0
1589386|NCT02452424|5526357|P11|Overall Study|Progressive disease (per RECIST)|0
1589387|NCT02452424|5526358|P10|Overall Study|Progressive disease (per RECIST)|0
1589388|NCT02452424|5526359|P9|Overall Study|Progressive disease (per RECIST)|2
1589389|NCT02452424|5526360|P8|Overall Study|Progressive disease (per RECIST)|0
1589390|NCT02452424|5526361|P7|Overall Study|Progressive disease (per RECIST)|0
1589391|NCT02452424|5526362|P6|Overall Study|Progressive disease (per RECIST)|0
1589392|NCT02452424|5526363|P5|Overall Study|Progressive disease (per RECIST)|0
1589393|NCT02452424|5526364|P4|Overall Study|Progressive disease (per RECIST)|0
1589394|NCT02452424|5526365|P3|Overall Study|Progressive disease (per RECIST)|0
1589395|NCT02452424|5526366|P2|Overall Study|Progressive disease (per RECIST)|0
1589396|NCT02452424|5526367|P1|Overall Study|Progressive disease (per RECIST)|0
1589397|NCT02452424|5526357|P11|Overall Study|Other|1
1589398|NCT02452424|5526358|P10|Overall Study|Other|0
1589399|NCT02452424|5526359|P9|Overall Study|Other|0
1589400|NCT02452424|5526360|P8|Overall Study|Other|3
1589401|NCT02452424|5526361|P7|Overall Study|Other|4
1589402|NCT02452424|5526362|P6|Overall Study|Other|1
1589403|NCT02452424|5526363|P5|Overall Study|Other|0
1589404|NCT02452424|5526364|P4|Overall Study|Other|0
1589405|NCT02452424|5526365|P3|Overall Study|Other|1
1589406|NCT02452424|5526366|P2|Overall Study|Other|0
1589407|NCT02452424|5526367|P1|Overall Study|Other|0
1589408|NCT02452424|5526357|P11|Overall Study|Withdrawal by Subject|0
1589409|NCT02452424|5526358|P10|Overall Study|Withdrawal by Subject|1
1589410|NCT02452424|5526359|P9|Overall Study|Withdrawal by Subject|1
1589411|NCT02452424|5526360|P8|Overall Study|Withdrawal by Subject|0
1589412|NCT02452424|5526361|P7|Overall Study|Withdrawal by Subject|1
1589413|NCT02452424|5526362|P6|Overall Study|Withdrawal by Subject|0
1589414|NCT02452424|5526363|P5|Overall Study|Withdrawal by Subject|0
1589415|NCT02452424|5526364|P4|Overall Study|Withdrawal by Subject|2
1589416|NCT02452424|5526365|P3|Overall Study|Withdrawal by Subject|3
1589417|NCT02452424|5526366|P2|Overall Study|Withdrawal by Subject|0
1589418|NCT02452424|5526367|P1|Overall Study|Withdrawal by Subject|0
1589419|NCT02452424|5526357|P11|Overall Study|Lost to Follow-up|0
1589420|NCT02452424|5526358|P10|Overall Study|Lost to Follow-up|0
1589421|NCT02452424|5526359|P9|Overall Study|Lost to Follow-up|0
1589422|NCT02452424|5526360|P8|Overall Study|Lost to Follow-up|0
1589423|NCT02452424|5526361|P7|Overall Study|Lost to Follow-up|0
1589424|NCT02452424|5526362|P6|Overall Study|Lost to Follow-up|0
1589425|NCT02452424|5526363|P5|Overall Study|Lost to Follow-up|0
1589426|NCT02452424|5526364|P4|Overall Study|Lost to Follow-up|0
1589427|NCT02452424|5526365|P3|Overall Study|Lost to Follow-up|1
1589428|NCT02452424|5526366|P2|Overall Study|Lost to Follow-up|1
1589429|NCT02452424|5526367|P1|Overall Study|Lost to Follow-up|0
1589430|NCT02452424|5526357|P11|Overall Study|Death|0
1589431|NCT02452424|5526358|P10|Overall Study|Death|1
1589432|NCT02452424|5526359|P9|Overall Study|Death|3
1589433|NCT02452424|5526360|P8|Overall Study|Death|1
1589434|NCT02452424|5526361|P7|Overall Study|Death|5
1589435|NCT02452424|5526362|P6|Overall Study|Death|0
1589436|NCT02452424|5526363|P5|Overall Study|Death|2
1589437|NCT02452424|5526364|P4|Overall Study|Death|6
1589438|NCT02452424|5526365|P3|Overall Study|Death|2
1589439|NCT02452424|5526366|P2|Overall Study|Death|2
1589440|NCT02452424|5526367|P1|Overall Study|Death|2
1589441|NCT02452320|5526410|P2|Overall Study|Adverse Event|1
1589442|NCT02452320|5526411|P1|Overall Study|Adverse Event|0
1589443|NCT02452190|5526423|P2|Overall Study|Death|1
1589444|NCT02452190|5526424|P1|Overall Study|Death|0
1589445|NCT02452190|5526423|P2|Overall Study|Participant traveled abroad|0
1589446|NCT02452190|5526424|P1|Overall Study|Participant traveled abroad|1
1589447|NCT02452190|5526423|P2|Overall Study|Noncompliance with study drug|0
1589448|NCT02452190|5526424|P1|Overall Study|Noncompliance with study drug|1
1589449|NCT02452190|5526423|P2|Overall Study|Withdrawal by Subject|11
1589450|NCT02452190|5526424|P1|Overall Study|Withdrawal by Subject|20
1589451|NCT02452190|5526423|P2|Overall Study|Adverse Event|5
1589452|NCT02452190|5526424|P1|Overall Study|Adverse Event|2
1589453|NCT02452190|5526423|P2|Overall Study|Lost to Follow-up|3
1589454|NCT02452190|5526424|P1|Overall Study|Lost to Follow-up|4
1589455|NCT02452190|5526423|P2|Overall Study|Lack of Efficacy|1
1589456|NCT02452190|5526424|P1|Overall Study|Lack of Efficacy|3
1589457|NCT02452190|5526423|P2|Overall Study|Investigator's Decision|0
1589458|NCT02452190|5526424|P1|Overall Study|Investigator's Decision|2
1589459|NCT02452190|5526423|P2|Overall Study|Pregnancy|0
1589460|NCT02452190|5526424|P1|Overall Study|Pregnancy|1
1589461|NCT02452190|5526423|P2|Overall Study|Withdrawal by Sponsor|3
1589462|NCT02452190|5526424|P1|Overall Study|Withdrawal by Sponsor|1
1589463|NCT02452047|5526451|P3|Overall Study|Withdrawal by Subject|0
1589464|NCT02452047|5526452|P2|Overall Study|Withdrawal by Subject|0
1589465|NCT02452047|5526453|P1|Overall Study|Withdrawal by Subject|1
1589466|NCT02452047|5526451|P3|Overall Study|Lost to Follow-up|0
1589467|NCT02452047|5526452|P2|Overall Study|Lost to Follow-up|1
1589468|NCT02452047|5526453|P1|Overall Study|Lost to Follow-up|1
1589469|NCT02452047|5526451|P3|Overall Study|Physician Decision|0
1589470|NCT02452047|5526452|P2|Overall Study|Physician Decision|0
1589471|NCT02452047|5526453|P1|Overall Study|Physician Decision|1
1589472|NCT02452047|5526451|P3|Overall Study|Death|1
1589473|NCT02452047|5526452|P2|Overall Study|Death|3
1589474|NCT02452047|5526453|P1|Overall Study|Death|1
1589475|NCT02452047|5526451|P3|Overall Study|Adverse Event|1
1589476|NCT02452047|5526452|P2|Overall Study|Adverse Event|1
1589477|NCT02452047|5526453|P1|Overall Study|Adverse Event|0
1589478|NCT02452034|5526518|P6|Overall Study|Withdrawn by Parent/Guardian|0
1589479|NCT02452034|5526519|P5|Overall Study|Withdrawn by Parent/Guardian|0
1589480|NCT02452034|5526520|P4|Overall Study|Withdrawn by Parent/Guardian|0
1589481|NCT02452034|5526521|P3|Overall Study|Withdrawn by Parent/Guardian|0
1589482|NCT02452034|5526522|P2|Overall Study|Withdrawn by Parent/Guardian|0
1589483|NCT02452034|5526523|P1|Overall Study|Withdrawn by Parent/Guardian|1
1589484|NCT02452034|5526518|P6|Overall Study|Screen Failure|0
1589485|NCT02452034|5526519|P5|Overall Study|Screen Failure|0
1589486|NCT02452034|5526520|P4|Overall Study|Screen Failure|1
1589487|NCT02452034|5526521|P3|Overall Study|Screen Failure|0
1589488|NCT02452034|5526522|P2|Overall Study|Screen Failure|0
1589489|NCT02452034|5526523|P1|Overall Study|Screen Failure|1
1589490|NCT02452034|5526518|P6|Overall Study|Protocol Violation|1
1589491|NCT02452034|5526519|P5|Overall Study|Protocol Violation|0
1589492|NCT02452034|5526520|P4|Overall Study|Protocol Violation|0
1589493|NCT02452034|5526521|P3|Overall Study|Protocol Violation|0
1589494|NCT02452034|5526522|P2|Overall Study|Protocol Violation|0
1589495|NCT02452034|5526523|P1|Overall Study|Protocol Violation|0
1589496|NCT02452034|5526518|P6|Overall Study|Physician Decision|0
1589497|NCT02452034|5526519|P5|Overall Study|Physician Decision|0
1589498|NCT02452034|5526520|P4|Overall Study|Physician Decision|0
1589499|NCT02452034|5526521|P3|Overall Study|Physician Decision|1
1589500|NCT02452034|5526522|P2|Overall Study|Physician Decision|1
1589501|NCT02452034|5526523|P1|Overall Study|Physician Decision|0
1589502|NCT02452034|5526518|P6|Overall Study|Death|1
1589503|NCT02452034|5526519|P5|Overall Study|Death|1
1589504|NCT02452034|5526520|P4|Overall Study|Death|0
1589505|NCT02452034|5526521|P3|Overall Study|Death|0
1589506|NCT02452034|5526522|P2|Overall Study|Death|0
1589507|NCT02452034|5526523|P1|Overall Study|Death|0
1589508|NCT02452034|5526518|P6|Overall Study|Adverse Event|1
1589509|NCT02452034|5526519|P5|Overall Study|Adverse Event|0
1589510|NCT02452034|5526520|P4|Overall Study|Adverse Event|0
1589511|NCT02452034|5526521|P3|Overall Study|Adverse Event|0
1589512|NCT02452034|5526522|P2|Overall Study|Adverse Event|0
1589513|NCT02452034|5526523|P1|Overall Study|Adverse Event|0
1589514|NCT02451943|5526596|P2|Overall Study|Lost to Follow-up|4
1589515|NCT02451943|5526597|P1|Overall Study|Lost to Follow-up|3
1589516|NCT02451943|5526596|P2|Overall Study|Withdrawal by Subject|16
1589517|NCT02451943|5526597|P1|Overall Study|Withdrawal by Subject|13
1589518|NCT02451943|5526596|P2|Overall Study|On Treatment|4
1589519|NCT02451943|5526597|P1|Overall Study|On Treatment|4
1589520|NCT02451917|5526625|P2|First Intervention (24 Weeks)|Adverse Event|2
1589521|NCT02451917|5526626|P1|First Intervention (24 Weeks)|Adverse Event|0
1589522|NCT02451917|5526625|P2|First Intervention (24 Weeks)|Death|1
1589523|NCT02451917|5526626|P1|First Intervention (24 Weeks)|Death|0
1589524|NCT02451917|5526625|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
1589525|NCT02451917|5526626|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
1589526|NCT02451670|5526668|P2|Overall Study|Did not have qualifying follow-up visit.|696
1589527|NCT02451670|5526669|P1|Overall Study|Did not have qualifying follow-up visit.|714
1589528|NCT02451358|5526688|P4|Overall Study|Protocol Violation|0
1589529|NCT02451358|5526689|P3|Overall Study|Protocol Violation|1
1589530|NCT02451358|5526690|P2|Overall Study|Protocol Violation|1
1589531|NCT02451358|5526691|P1|Overall Study|Protocol Violation|0
1589532|NCT02451358|5526688|P4|Overall Study|Withdrawal by Subject|0
1589533|NCT02451358|5526689|P3|Overall Study|Withdrawal by Subject|0
1589534|NCT02451358|5526690|P2|Overall Study|Withdrawal by Subject|1
1589535|NCT02451358|5526691|P1|Overall Study|Withdrawal by Subject|1
1589536|NCT02451137|5526779|P2|Overall Study|Other than specified above|3
1589537|NCT02451137|5526780|P1|Overall Study|Other than specified above|2
1589538|NCT02451137|5526779|P2|Overall Study|Withdrawal by Subject|63
1589539|NCT02451137|5526780|P1|Overall Study|Withdrawal by Subject|40
1589540|NCT02451137|5526779|P2|Overall Study|Sponsor decision|25
1589541|NCT02451137|5526780|P1|Overall Study|Sponsor decision|13
1589542|NCT02451137|5526779|P2|Overall Study|Physician Decision|5
1589543|NCT02451137|5526780|P1|Overall Study|Physician Decision|6
1589544|NCT02451137|5526779|P2|Overall Study|Lost to Follow-up|61
1589545|NCT02451137|5526780|P1|Overall Study|Lost to Follow-up|53
1589546|NCT02451137|5526779|P2|Overall Study|Investigator's decision|19
1589547|NCT02451137|5526780|P1|Overall Study|Investigator's decision|23
1589548|NCT02451137|5526779|P2|Overall Study|Hypoglycemia|1
1589549|NCT02451137|5526780|P1|Overall Study|Hypoglycemia|2
1589550|NCT02451137|5526779|P2|Overall Study|Participant decision:discontinue insulin|43
1589551|NCT02451137|5526780|P1|Overall Study|Participant decision:discontinue insulin|41
1589552|NCT02451137|5526779|P2|Overall Study|Lack of Efficacy|9
1589553|NCT02451137|5526780|P1|Overall Study|Lack of Efficacy|4
1589554|NCT02451137|5526779|P2|Overall Study|Adverse Event|42
1589555|NCT02451137|5526780|P1|Overall Study|Adverse Event|43
1589556|NCT02451137|5526779|P2|Overall Study|Randomized but not treated|27
1589557|NCT02451137|5526780|P1|Overall Study|Randomized but not treated|19
1589558|NCT02451124|5526810|P1|Overall Study|Withdrawal by Subject|1
1589559|NCT02451007|5526821|P1|Overall Study|Disease Progression|2
1589560|NCT02451007|5526821|P1|Overall Study|Adverse Event|1
1589561|NCT02451007|5526821|P1|Overall Study|Withdrawal by Subject|4
1589562|NCT02450552|5526860|P3|Overall Study|Physician Decision|1
1589563|NCT02450552|5526861|P2|Overall Study|Physician Decision|0
1589564|NCT02450552|5526862|P1|Overall Study|Physician Decision|1
1589565|NCT02450552|5526860|P3|Overall Study|Withdrawal by Subject|4
1589566|NCT02450552|5526861|P2|Overall Study|Withdrawal by Subject|0
1589567|NCT02450552|5526862|P1|Overall Study|Withdrawal by Subject|4
1589568|NCT02450539|5526905|P2|Overall Study|On study treatment/follow up|25
1589569|NCT02450539|5526906|P1|Overall Study|On study treatment/follow up|27
1589570|NCT02450539|5526905|P2|Overall Study|Lost to Follow-up|1
1589571|NCT02450539|5526906|P1|Overall Study|Lost to Follow-up|4
1589572|NCT02450539|5526905|P2|Overall Study|Withdrawal by Subject|7
1589573|NCT02450539|5526906|P1|Overall Study|Withdrawal by Subject|19
1589574|NCT02450526|5526930|P5|OL Period (Cycles 2-5)|Protocol Violation|7
1589575|NCT02450526|5526931|P4|OL Period (Cycles 2-5)|Protocol Violation|0
1589576|NCT02450526|5526932|P3|OL Period (Cycles 2-5)|Protocol Violation|0
1589577|NCT02450526|5526933|P2|OL Period (Cycles 2-5)|Protocol Violation|0
1589578|NCT02450526|5526934|P1|OL Period (Cycles 2-5)|Protocol Violation|0
1589579|NCT02450526|5526930|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
1589580|NCT02450526|5526931|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
1589581|NCT02450526|5526932|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
1589582|NCT02450526|5526933|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
1589583|NCT02450526|5526934|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
1589584|NCT02450526|5526930|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
1589585|NCT02450526|5526931|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1589586|NCT02450526|5526932|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1589587|NCT02450526|5526933|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1589588|NCT02450526|5526934|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
1589589|NCT02450526|5526930|P5|OL Period (Cycles 2-5)|Adverse Event|2
1589590|NCT02450526|5526931|P4|OL Period (Cycles 2-5)|Adverse Event|0
1589591|NCT02450526|5526932|P3|OL Period (Cycles 2-5)|Adverse Event|0
1589592|NCT02450526|5526933|P2|OL Period (Cycles 2-5)|Adverse Event|0
1589593|NCT02450526|5526934|P1|OL Period (Cycles 2-5)|Adverse Event|0
1589594|NCT02450526|5526930|P5|DB Period (Cycle 1)|Protocol Violation|0
1589595|NCT02450526|5526931|P4|DB Period (Cycle 1)|Protocol Violation|1
1589596|NCT02450526|5526932|P3|DB Period (Cycle 1)|Protocol Violation|0
1589597|NCT02450526|5526933|P2|DB Period (Cycle 1)|Protocol Violation|0
1589598|NCT02450526|5526934|P1|DB Period (Cycle 1)|Protocol Violation|2
1589599|NCT02450526|5526930|P5|DB Period (Cycle 1)|Lost to Follow-up|0
1589600|NCT02450526|5526931|P4|DB Period (Cycle 1)|Lost to Follow-up|0
1589601|NCT02450526|5526932|P3|DB Period (Cycle 1)|Lost to Follow-up|0
1589602|NCT02450526|5526933|P2|DB Period (Cycle 1)|Lost to Follow-up|0
1589603|NCT02450526|5526934|P1|DB Period (Cycle 1)|Lost to Follow-up|1
1589604|NCT02450526|5526930|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
1589605|NCT02450526|5526931|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
1589606|NCT02450526|5526932|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
1589607|NCT02450526|5526933|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
1589608|NCT02450526|5526934|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
1589609|NCT02450526|5526930|P5|DB Period (Cycle 1)|Adverse Event|0
1589610|NCT02450526|5526931|P4|DB Period (Cycle 1)|Adverse Event|0
1589611|NCT02450526|5526932|P3|DB Period (Cycle 1)|Adverse Event|2
1589612|NCT02450526|5526933|P2|DB Period (Cycle 1)|Adverse Event|0
1589613|NCT02450526|5526934|P1|DB Period (Cycle 1)|Adverse Event|0
1589614|NCT02449915|5527036|P2|Overall Study|Abnormal preop lab|1
1589615|NCT02449915|5527037|P1|Overall Study|Abnormal preop lab|0
1589616|NCT02449915|5527036|P2|Overall Study|Intraoperative surgical findings|1
1589617|NCT02449915|5527037|P1|Overall Study|Intraoperative surgical findings|1
1589618|NCT02449915|5527036|P2|Overall Study|Withdrawal by Subject|2
1589619|NCT02449915|5527037|P1|Overall Study|Withdrawal by Subject|0
1589620|NCT02449915|5527036|P2|Overall Study|Exclusion criteria - drug use|0
1589621|NCT02449915|5527037|P1|Overall Study|Exclusion criteria - drug use|1
1589622|NCT02449902|5527045|P2|Overall Study|Withdrawal by Subject|1
1589623|NCT02449902|5527046|P1|Overall Study|Withdrawal by Subject|0
1589624|NCT02449902|5527045|P2|Overall Study|Adverse Event|1
1589625|NCT02449902|5527046|P1|Overall Study|Adverse Event|0
1589626|NCT02449889|5527073|P3|Overall Study|Protocol Violation|1
1589627|NCT02449889|5527074|P2|Overall Study|Protocol Violation|4
1589628|NCT02449889|5527075|P1|Overall Study|Protocol Violation|0
1589629|NCT02449889|5527073|P3|Overall Study|Adverse Event|0
1589630|NCT02449889|5527074|P2|Overall Study|Adverse Event|2
1589631|NCT02449889|5527075|P1|Overall Study|Adverse Event|1
1589632|NCT02449044|5527200|P1|Overall Study|Sponsor Discontinued Trial|3
1589633|NCT02449044|5527200|P1|Overall Study|Physician Decision|9
1589634|NCT02449044|5527200|P1|Overall Study|Met Withdrawal Criteria|7
1589635|NCT02449044|5527200|P1|Overall Study|Adverse Event|30
1589636|NCT02449044|5527200|P1|Overall Study|Withdrawal by Subject|13
1589637|NCT02449044|5527200|P1|Overall Study|Lost to Follow-up|2
1589638|NCT02449018|5527221|P2|Overall Study|Patient decision|0
1589639|NCT02449018|5527222|P1|Overall Study|Patient decision|2
1589640|NCT02449018|5527221|P2|Overall Study|Protocol deviation|0
1589641|NCT02449018|5527222|P1|Overall Study|Protocol deviation|4
1589642|NCT02449018|5527221|P2|Overall Study|Adverse Event|1
1589643|NCT02449018|5527222|P1|Overall Study|Adverse Event|5
1589644|NCT02449018|5527221|P2|Overall Study|Administrative problems|0
1589645|NCT02449018|5527222|P1|Overall Study|Administrative problems|1
1589646|NCT02449018|5527221|P2|Overall Study|Abnormal laboratory value|1
1589647|NCT02449018|5527222|P1|Overall Study|Abnormal laboratory value|0
1589648|NCT02448875|5527269|P3|Overall Study|Withdrawal by Subject|0
1589649|NCT02448875|5527270|P2|Overall Study|Withdrawal by Subject|0
1589650|NCT02448875|5527271|P1|Overall Study|Withdrawal by Subject|1
1589651|NCT02448875|5527269|P3|Overall Study|Investigator Decision|1
1589652|NCT02448875|5527270|P2|Overall Study|Investigator Decision|0
1589653|NCT02448875|5527271|P1|Overall Study|Investigator Decision|3
1589654|NCT02448875|5527269|P3|Overall Study|Lost to Follow-up|0
1589655|NCT02448875|5527270|P2|Overall Study|Lost to Follow-up|0
1589656|NCT02448875|5527271|P1|Overall Study|Lost to Follow-up|1
1589657|NCT02448875|5527269|P3|Overall Study|Adverse Event|0
1589658|NCT02448875|5527270|P2|Overall Study|Adverse Event|1
1589659|NCT02448875|5527271|P1|Overall Study|Adverse Event|2
1589660|NCT02448810|5527319|P8|Overall Study|Other (unspecified)|0
1589661|NCT02448810|5527320|P7|Overall Study|Other (unspecified)|2
1589662|NCT02448810|5527321|P6|Overall Study|Other (unspecified)|0
1589663|NCT02448810|5527322|P5|Overall Study|Other (unspecified)|0
1589664|NCT02448810|5527323|P4|Overall Study|Other (unspecified)|0
1589665|NCT02448810|5527324|P3|Overall Study|Other (unspecified)|0
1589666|NCT02448810|5527325|P2|Overall Study|Other (unspecified)|0
1589667|NCT02448810|5527326|P1|Overall Study|Other (unspecified)|0
1589668|NCT02448810|5527319|P8|Overall Study|Lost to Follow-up|0
1589669|NCT02448810|5527320|P7|Overall Study|Lost to Follow-up|0
1589670|NCT02448810|5527321|P6|Overall Study|Lost to Follow-up|0
1589671|NCT02448810|5527322|P5|Overall Study|Lost to Follow-up|0
1589672|NCT02448810|5527323|P4|Overall Study|Lost to Follow-up|0
1589673|NCT02448810|5527324|P3|Overall Study|Lost to Follow-up|0
1589674|NCT02448810|5527325|P2|Overall Study|Lost to Follow-up|1
1589675|NCT02448810|5527326|P1|Overall Study|Lost to Follow-up|0
1589676|NCT02448810|5527319|P8|Overall Study|Other (Progressive disease)|5
1589677|NCT02448810|5527320|P7|Overall Study|Other (Progressive disease)|14
1589678|NCT02448810|5527321|P6|Overall Study|Other (Progressive disease)|9
1589679|NCT02448810|5527322|P5|Overall Study|Other (Progressive disease)|23
1589680|NCT02448810|5527323|P4|Overall Study|Other (Progressive disease)|3
1589681|NCT02448810|5527324|P3|Overall Study|Other (Progressive disease)|0
1589682|NCT02448810|5527325|P2|Overall Study|Other (Progressive disease)|2
1589683|NCT02448810|5527326|P1|Overall Study|Other (Progressive disease)|2
1589684|NCT02448810|5527319|P8|Overall Study|Death|0
1589685|NCT02448810|5527320|P7|Overall Study|Death|0
1589686|NCT02448810|5527321|P6|Overall Study|Death|0
1589687|NCT02448810|5527322|P5|Overall Study|Death|1
1589688|NCT02448810|5527323|P4|Overall Study|Death|0
1589689|NCT02448810|5527324|P3|Overall Study|Death|1
1589690|NCT02448810|5527325|P2|Overall Study|Death|0
1589691|NCT02448810|5527326|P1|Overall Study|Death|1
1589692|NCT02448810|5527319|P8|Overall Study|Other (study terminated by sponsor)|1
1589693|NCT02448810|5527320|P7|Overall Study|Other (study terminated by sponsor)|2
1589694|NCT02448810|5527321|P6|Overall Study|Other (study terminated by sponsor)|2
1589695|NCT02448810|5527322|P5|Overall Study|Other (study terminated by sponsor)|4
1589696|NCT02448810|5527323|P4|Overall Study|Other (study terminated by sponsor)|0
1589697|NCT02448810|5527324|P3|Overall Study|Other (study terminated by sponsor)|0
1589698|NCT02448810|5527325|P2|Overall Study|Other (study terminated by sponsor)|0
1589699|NCT02448810|5527326|P1|Overall Study|Other (study terminated by sponsor)|0
1589700|NCT02448810|5527319|P8|Overall Study|Withdrawal by Subject|2
1589701|NCT02448810|5527320|P7|Overall Study|Withdrawal by Subject|0
1589702|NCT02448810|5527321|P6|Overall Study|Withdrawal by Subject|5
1589703|NCT02448810|5527322|P5|Overall Study|Withdrawal by Subject|3
1589704|NCT02448810|5527323|P4|Overall Study|Withdrawal by Subject|0
1589705|NCT02448810|5527324|P3|Overall Study|Withdrawal by Subject|1
1589706|NCT02448810|5527325|P2|Overall Study|Withdrawal by Subject|0
1589707|NCT02448810|5527326|P1|Overall Study|Withdrawal by Subject|0
1589708|NCT02448810|5527319|P8|Overall Study|Adverse Event|0
1589709|NCT02448810|5527320|P7|Overall Study|Adverse Event|0
1589710|NCT02448810|5527321|P6|Overall Study|Adverse Event|0
1589711|NCT02448810|5527322|P5|Overall Study|Adverse Event|0
1589712|NCT02448810|5527323|P4|Overall Study|Adverse Event|0
1589713|NCT02448810|5527324|P3|Overall Study|Adverse Event|1
1589714|NCT02448810|5527325|P2|Overall Study|Adverse Event|0
1589715|NCT02448810|5527326|P1|Overall Study|Adverse Event|0
1589716|NCT02448719|5527403|P11|Overall Study|Withdrawal by Subject|0
1589717|NCT02448719|5527404|P10|Overall Study|Withdrawal by Subject|0
1589718|NCT02448719|5527405|P9|Overall Study|Withdrawal by Subject|0
1589719|NCT02448719|5527406|P8|Overall Study|Withdrawal by Subject|0
1589720|NCT02448719|5527407|P7|Overall Study|Withdrawal by Subject|0
1589721|NCT02448719|5527408|P6|Overall Study|Withdrawal by Subject|0
1589722|NCT02448719|5527409|P5|Overall Study|Withdrawal by Subject|1
1589723|NCT02448719|5527410|P4|Overall Study|Withdrawal by Subject|0
1589724|NCT02448719|5527411|P3|Overall Study|Withdrawal by Subject|0
1589725|NCT02448719|5527412|P2|Overall Study|Withdrawal by Subject|0
1589726|NCT02448719|5527413|P1|Overall Study|Withdrawal by Subject|0
1589727|NCT02448706|5527637|P2|Overall Study|Protocol Violation|1
1589728|NCT02448706|5527638|P1|Overall Study|Protocol Violation|1
1589729|NCT02448706|5527637|P2|Overall Study|Withdrawal by Subject|3
1589730|NCT02448706|5527638|P1|Overall Study|Withdrawal by Subject|4
1589731|NCT02448563|5527654|P2|Overall Study|Withdrawal by Subject|1
1589732|NCT02448563|5527655|P1|Overall Study|Withdrawal by Subject|0
1589733|NCT02448563|5527654|P2|Overall Study|Lost to Follow-up|10
1589734|NCT02448563|5527655|P1|Overall Study|Lost to Follow-up|16
1589735|NCT02448537|5527677|P3|Overall Study|Withdrawal by Subject|1
1589736|NCT02448537|5527678|P2|Overall Study|Withdrawal by Subject|1
1589737|NCT02448537|5527679|P1|Overall Study|Withdrawal by Subject|1
1589738|NCT02448043|5527793|P2|Overall Study|Protocol Violation|2
1589739|NCT02448043|5527794|P1|Overall Study|Protocol Violation|1
1589740|NCT02448043|5527793|P2|Overall Study|Withdrawal by Subject|2
1589741|NCT02448043|5527794|P1|Overall Study|Withdrawal by Subject|2
1589742|NCT02447952|5527812|P1|Overall Study|Withdrawal by Subject|4
1589743|NCT02447952|5527812|P1|Overall Study|Physician Decision|1
1589744|NCT02447952|5527812|P1|Overall Study|Adverse Event|2
1589745|NCT02447887|5527869|P1|Overall Study|Study was terminated|3
1589746|NCT02447848|5527882|P1|Overall Study|Withdrawal by Subject|4
1589747|NCT02447848|5527882|P1|Overall Study|Lack of Efficacy|4
1589748|NCT02447848|5527882|P1|Overall Study|Patient discharged|3
1589749|NCT02447458|5527894|P6|Overall Study|Other|0
1589750|NCT02447458|5527895|P5|Overall Study|Other|0
1589751|NCT02447458|5527896|P4|Overall Study|Other|0
1589752|NCT02447458|5527897|P3|Overall Study|Other|1
1589753|NCT02447458|5527898|P2|Overall Study|Other|0
1589754|NCT02447458|5527899|P1|Overall Study|Other|0
1589755|NCT02447432|5527997|P2|Epoch 001|Lost to Follow-up|3
1589756|NCT02447432|5527998|P1|Epoch 001|Lost to Follow-up|1
1589757|NCT02447432|5527997|P2|Epoch 001|Migrated/moved from study area|5
1589758|NCT02447432|5527998|P1|Epoch 001|Migrated/moved from study area|3
1589759|NCT02447432|5527997|P2|Epoch 001|Withdrawal by Subject|4
1589760|NCT02447432|5527998|P1|Epoch 001|Withdrawal by Subject|0
1589761|NCT02447432|5527997|P2|Epoch 001|Adverse Event|1
1589762|NCT02447432|5527998|P1|Epoch 001|Adverse Event|1
1589763|NCT02447328|5528030|P1|Overall Study|Withdrawal by Subject|1
1589764|NCT02447250|5528034|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
1589765|NCT02447250|5528034|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
1589766|NCT02447250|5528034|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
1589767|NCT02447081|5528051|P1|Overall Study|unsuccessful implant procedure|10
1589768|NCT02447081|5528051|P1|Overall Study|Visit not completed|17
1589769|NCT02447081|5528051|P1|Overall Study|Lost to Follow-up|36
1589770|NCT02447081|5528051|P1|Overall Study|Death|161
1589771|NCT02447029|5528067|P2|Overall Study|Withdrawal by Subject|2
1589772|NCT02447029|5528068|P1|Overall Study|Withdrawal by Subject|3
1589773|NCT02446990|5528088|P2|Overall Study|Withdrawal by Subject|199
1589774|NCT02446990|5528089|P1|Overall Study|Withdrawal by Subject|231
1589775|NCT02446990|5528088|P2|Overall Study|Physician Decision|0
1589776|NCT02446990|5528089|P1|Overall Study|Physician Decision|1
1589777|NCT02446990|5528088|P2|Overall Study|Lost to Follow-up|1
1589778|NCT02446990|5528089|P1|Overall Study|Lost to Follow-up|3
1589779|NCT02446990|5528088|P2|Overall Study|Death|458
1589780|NCT02446990|5528089|P1|Overall Study|Death|485
1589781|NCT02446912|5528124|P3|Overall Study|Miscellaneous|4
1589782|NCT02446912|5528125|P2|Overall Study|Miscellaneous|2
1589783|NCT02446912|5528126|P1|Overall Study|Miscellaneous|2
1589784|NCT02446912|5528124|P3|Overall Study|Withdrawal by Subject|15
1589785|NCT02446912|5528125|P2|Overall Study|Withdrawal by Subject|15
1589786|NCT02446912|5528126|P1|Overall Study|Withdrawal by Subject|10
1589787|NCT02446912|5528124|P3|Overall Study|Severe non-compliance to protocol|1
1589788|NCT02446912|5528125|P2|Overall Study|Severe non-compliance to protocol|0
1589789|NCT02446912|5528126|P1|Overall Study|Severe non-compliance to protocol|1
1589790|NCT02446912|5528124|P3|Overall Study|Lost to Follow-up|2
1589791|NCT02446912|5528125|P2|Overall Study|Lost to Follow-up|0
1589792|NCT02446912|5528126|P1|Overall Study|Lost to Follow-up|0
1589793|NCT02446912|5528124|P3|Overall Study|Lack of Efficacy|7
1589794|NCT02446912|5528125|P2|Overall Study|Lack of Efficacy|4
1589795|NCT02446912|5528126|P1|Overall Study|Lack of Efficacy|1
1589796|NCT02446912|5528124|P3|Overall Study|Study-specific withdrawal criteria|0
1589797|NCT02446912|5528125|P2|Overall Study|Study-specific withdrawal criteria|0
1589798|NCT02446912|5528126|P1|Overall Study|Study-specific withdrawal criteria|1
1589799|NCT02446912|5528124|P3|Overall Study|Condition under investigation worsened|1
1589800|NCT02446912|5528125|P2|Overall Study|Condition under investigation worsened|1
1589801|NCT02446912|5528126|P1|Overall Study|Condition under investigation worsened|0
1589802|NCT02446912|5528124|P3|Overall Study|Adverse Event|5
1589803|NCT02446912|5528125|P2|Overall Study|Adverse Event|13
1589804|NCT02446912|5528126|P1|Overall Study|Adverse Event|3
1589805|NCT02446769|5528197|P3|Study Period|Randomized in Error|0
1589806|NCT02446769|5528198|P2|Study Period|Randomized in Error|2
1589807|NCT02446769|5528199|P1|Study Period|Randomized in Error|0
1589808|NCT02446769|5528197|P3|Screening Period|Screen Failure|0
1589809|NCT02446769|5528198|P2|Screening Period|Screen Failure|0
1589810|NCT02446769|5528199|P1|Screening Period|Screen Failure|11
1589811|NCT02446743|5528220|P2|Overall Study|Other|3
1589812|NCT02446743|5528221|P1|Overall Study|Other|2
1589813|NCT02446743|5528220|P2|Overall Study|Adverse Event|1
1589814|NCT02446743|5528221|P1|Overall Study|Adverse Event|1
1589815|NCT02446743|5528220|P2|Overall Study|Lost to Follow-up|0
1589816|NCT02446743|5528221|P1|Overall Study|Lost to Follow-up|1
1589817|NCT02446743|5528220|P2|Overall Study|Withdrawal by Subject|1
1589818|NCT02446743|5528221|P1|Overall Study|Withdrawal by Subject|1
1589819|NCT02446717|5528376|P5|Overall Study|Withdrew consent|0
1589820|NCT02446717|5528377|P4|Overall Study|Withdrew consent|1
1589821|NCT02446717|5528378|P3|Overall Study|Withdrew consent|0
1589822|NCT02446717|5528379|P2|Overall Study|Withdrew consent|0
1589823|NCT02446717|5528380|P1|Overall Study|Withdrew consent|0
1589824|NCT02446717|5528376|P5|Overall Study|Lost to Follow-up|1
1589825|NCT02446717|5528377|P4|Overall Study|Lost to Follow-up|0
1589826|NCT02446717|5528378|P3|Overall Study|Lost to Follow-up|1
1589827|NCT02446717|5528379|P2|Overall Study|Lost to Follow-up|1
1589828|NCT02446717|5528380|P1|Overall Study|Lost to Follow-up|0
1589829|NCT02446717|5528376|P5|Overall Study|Adverse Event|0
1589830|NCT02446717|5528377|P4|Overall Study|Adverse Event|0
1589831|NCT02446717|5528378|P3|Overall Study|Adverse Event|1
1589832|NCT02446717|5528379|P2|Overall Study|Adverse Event|0
1589833|NCT02446717|5528380|P1|Overall Study|Adverse Event|0
1589834|NCT02446691|5528407|P1|Overall Study|Protocol Violation|1
1589835|NCT02446691|5528407|P1|Overall Study|Lost to Follow-up|8
1589836|NCT02446691|5528407|P1|Overall Study|Withdrawal by Subject|2
1589837|NCT02446418|5528477|P2|Overall Study|Protocol defined stopping criteria reach|0
1589838|NCT02446418|5528478|P1|Overall Study|Protocol defined stopping criteria reach|1
1589839|NCT02446418|5528477|P2|Overall Study|Lack of Efficacy|0
1589840|NCT02446418|5528478|P1|Overall Study|Lack of Efficacy|2
1589841|NCT02446418|5528477|P2|Overall Study|Protocol Violation|2
1589842|NCT02446418|5528478|P1|Overall Study|Protocol Violation|1
1589843|NCT02446418|5528477|P2|Overall Study|Lost to Follow-up|2
1589844|NCT02446418|5528478|P1|Overall Study|Lost to Follow-up|2
1589845|NCT02446418|5528477|P2|Overall Study|Withdrawal by Subject|3
1589846|NCT02446418|5528478|P1|Overall Study|Withdrawal by Subject|3
1589847|NCT02446418|5528477|P2|Overall Study|Physician Decision|1
1589848|NCT02446418|5528478|P1|Overall Study|Physician Decision|5
1589849|NCT02446418|5528477|P2|Overall Study|Adverse Event|8
1589850|NCT02446418|5528478|P1|Overall Study|Adverse Event|4
1589851|NCT02446171|5528549|P4|Overall Study|Withdrawal by Subject|0
1589852|NCT02446171|5528550|P3|Overall Study|Withdrawal by Subject|2
1589853|NCT02446171|5528551|P2|Overall Study|Withdrawal by Subject|0
1589854|NCT02446171|5528552|P1|Overall Study|Withdrawal by Subject|0
1589855|NCT02446015|5528623|P2|Overall Study|Withdrawal by Subject|0
1589856|NCT02446015|5528624|P1|Overall Study|Withdrawal by Subject|1
1589857|NCT02446015|5528623|P2|Overall Study|Adverse Event|1
1589858|NCT02446015|5528624|P1|Overall Study|Adverse Event|0
1589859|NCT02445755|5528734|P1|Overall Study|Screen Failure|5
1589860|NCT02445755|5528734|P1|Overall Study|Protocol Violation|6
1589861|NCT02445755|5528734|P1|Overall Study|Withdrawal by Subject|2
1589862|NCT02445586|5528748|P1|Overall Study|Medical Condition|1
1589863|NCT02445586|5528748|P1|Overall Study|Protocol Violation|1
1589864|NCT02445586|5528748|P1|Overall Study|Disease Progression|10
1589865|NCT02445586|5528748|P1|Overall Study|Withdrawal by Subject|13
1589866|NCT02445586|5528748|P1|Overall Study|Death|14
1589867|NCT02445573|5528788|P2|Overall Study|Lost to Follow-up|1
1589868|NCT02445573|5528789|P1|Overall Study|Lost to Follow-up|0
1589869|NCT02445573|5528788|P2|Overall Study|Withdrawal by Subject|1
1589870|NCT02445573|5528789|P1|Overall Study|Withdrawal by Subject|1
1589871|NCT02444793|5528886|P4|Overall Study|Objective progression or relapse|3
1589872|NCT02444793|5528887|P3|Overall Study|Objective progression or relapse|2
1589873|NCT02444793|5528888|P2|Overall Study|Objective progression or relapse|1
1589874|NCT02444793|5528889|P1|Overall Study|Objective progression or relapse|9
1589875|NCT02444793|5528886|P4|Overall Study|Other|0
1589876|NCT02444793|5528887|P3|Overall Study|Other|2
1589877|NCT02444793|5528888|P2|Overall Study|Other|0
1589878|NCT02444793|5528889|P1|Overall Study|Other|0
1589879|NCT02444793|5528886|P4|Overall Study|Death|0
1589880|NCT02444793|5528887|P3|Overall Study|Death|0
1589881|NCT02444793|5528888|P2|Overall Study|Death|3
1589882|NCT02444793|5528889|P1|Overall Study|Death|0
1589883|NCT02444793|5528886|P4|Overall Study|Lost to Follow-up|0
1589884|NCT02444793|5528887|P3|Overall Study|Lost to Follow-up|0
1589885|NCT02444793|5528888|P2|Overall Study|Lost to Follow-up|2
1589886|NCT02444793|5528889|P1|Overall Study|Lost to Follow-up|2
1589887|NCT02444533|5529048|P2|Overall Study|Only gave post-procedure complications|2
1589888|NCT02444533|5529049|P1|Overall Study|Only gave post-procedure complications|2
1589889|NCT02444533|5529048|P2|Overall Study|Not able to complete forms|2
1589890|NCT02444533|5529049|P1|Overall Study|Not able to complete forms|0
1589891|NCT02444182|5529082|P2|Overall Study|Lost to Follow-up|4
1589892|NCT02444182|5529083|P1|Overall Study|Lost to Follow-up|0
1589893|NCT02444182|5529082|P2|Overall Study|non-compliance|1
1589894|NCT02444182|5529083|P1|Overall Study|non-compliance|2
1589895|NCT02443883|5529106|P4|Overall Study|Randomized, but never treated|1
1589896|NCT02443883|5529107|P3|Overall Study|Randomized, but never treated|1
1589897|NCT02443883|5529108|P2|Overall Study|Randomized, but never treated|0
1589898|NCT02443883|5529109|P1|Overall Study|Randomized, but never treated|2
1589899|NCT02443883|5529106|P4|Overall Study|Withdrawal by Subject|1
1589900|NCT02443883|5529107|P3|Overall Study|Withdrawal by Subject|2
1589901|NCT02443883|5529108|P2|Overall Study|Withdrawal by Subject|0
1589902|NCT02443883|5529109|P1|Overall Study|Withdrawal by Subject|1
1589903|NCT02443883|5529106|P4|Overall Study|Physician Decision|3
1589904|NCT02443883|5529107|P3|Overall Study|Physician Decision|0
1589905|NCT02443883|5529108|P2|Overall Study|Physician Decision|1
1589906|NCT02443883|5529109|P1|Overall Study|Physician Decision|2
1589907|NCT02443883|5529106|P4|Overall Study|Lost to Follow-up|0
1589908|NCT02443883|5529107|P3|Overall Study|Lost to Follow-up|0
1589909|NCT02443883|5529108|P2|Overall Study|Lost to Follow-up|2
1589910|NCT02443883|5529109|P1|Overall Study|Lost to Follow-up|1
1589911|NCT02443883|5529106|P4|Overall Study|Adverse Event|2
1589912|NCT02443883|5529107|P3|Overall Study|Adverse Event|1
1589913|NCT02443883|5529108|P2|Overall Study|Adverse Event|2
1589914|NCT02443883|5529109|P1|Overall Study|Adverse Event|0
1589915|NCT02443805|5529129|P2|Overall Study|Any other reason not above-mentioned|2
1589916|NCT02443805|5529130|P1|Overall Study|Any other reason not above-mentioned|3
1589917|NCT02443805|5529129|P2|Overall Study|Withdrawal by parent/guardian|5
1589918|NCT02443805|5529130|P1|Overall Study|Withdrawal by parent/guardian|3
1589919|NCT02443805|5529129|P2|Overall Study|Non-compliance with study drug|4
1589920|NCT02443805|5529130|P1|Overall Study|Non-compliance with study drug|6
1589921|NCT02443805|5529129|P2|Overall Study|Lack of Efficacy|1
1589922|NCT02443805|5529130|P1|Overall Study|Lack of Efficacy|1
1589923|NCT02443805|5529129|P2|Overall Study|Protocol Violation|4
1589924|NCT02443805|5529130|P1|Overall Study|Protocol Violation|2
1589925|NCT02443805|5529129|P2|Overall Study|Pregnancy|5
1589926|NCT02443805|5529130|P1|Overall Study|Pregnancy|6
1589927|NCT02443805|5529129|P2|Overall Study|Lost to Follow-up|14
1589928|NCT02443805|5529130|P1|Overall Study|Lost to Follow-up|19
1589929|NCT02443805|5529129|P2|Overall Study|Withdrawal by Subject|74
1589930|NCT02443805|5529130|P1|Overall Study|Withdrawal by Subject|73
1589931|NCT02443805|5529129|P2|Overall Study|Adverse Event|18
1589932|NCT02443805|5529130|P1|Overall Study|Adverse Event|100
1589933|NCT02443740|5529161|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589934|NCT02443740|5529162|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589935|NCT02443740|5529163|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589936|NCT02443740|5529164|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589937|NCT02443740|5529165|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589938|NCT02443740|5529166|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
1589939|NCT02443740|5529167|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589940|NCT02443740|5529168|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589941|NCT02443740|5529169|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589942|NCT02443740|5529170|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589943|NCT02443740|5529171|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
1589944|NCT02443740|5529161|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
1589945|NCT02443740|5529162|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
1589946|NCT02443740|5529163|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
1589947|NCT02443740|5529164|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
1589948|NCT02443740|5529165|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
1589949|NCT02443740|5529166|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
1589950|NCT02443740|5529167|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
1589951|NCT02443740|5529168|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
1589952|NCT02443740|5529169|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
1589953|NCT02443740|5529170|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
1589954|NCT02443740|5529171|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
1589955|NCT02443740|5529161|P11|Intervention Period 1 (3 Days)|Adverse Event|0
1589956|NCT02443740|5529162|P10|Intervention Period 1 (3 Days)|Adverse Event|0
1589957|NCT02443740|5529163|P9|Intervention Period 1 (3 Days)|Adverse Event|0
1589958|NCT02443740|5529164|P8|Intervention Period 1 (3 Days)|Adverse Event|0
1589959|NCT02443740|5529165|P7|Intervention Period 1 (3 Days)|Adverse Event|0
1589960|NCT02443740|5529166|P6|Intervention Period 1 (3 Days)|Adverse Event|1
1589961|NCT02443740|5529167|P5|Intervention Period 1 (3 Days)|Adverse Event|0
1589962|NCT02443740|5529168|P4|Intervention Period 1 (3 Days)|Adverse Event|0
1589963|NCT02443740|5529169|P3|Intervention Period 1 (3 Days)|Adverse Event|0
1589964|NCT02443740|5529170|P2|Intervention Period 1 (3 Days)|Adverse Event|0
1589965|NCT02443740|5529171|P1|Intervention Period 1 (3 Days)|Adverse Event|0
1589966|NCT02443688|5529353|P3|Overall Study|Sponsor Request|0
1589967|NCT02443688|5529354|P2|Overall Study|Sponsor Request|1
1589968|NCT02443688|5529355|P1|Overall Study|Sponsor Request|2
1589969|NCT02443688|5529353|P3|Overall Study|Non-compliance with study drug|4
1589970|NCT02443688|5529354|P2|Overall Study|Non-compliance with study drug|2
1589971|NCT02443688|5529355|P1|Overall Study|Non-compliance with study drug|1
1589972|NCT02443688|5529353|P3|Overall Study|Withdrawal by Subject|4
1589973|NCT02443688|5529354|P2|Overall Study|Withdrawal by Subject|3
1589974|NCT02443688|5529355|P1|Overall Study|Withdrawal by Subject|3
1589975|NCT02443688|5529353|P3|Overall Study|Pregnancy|1
1589976|NCT02443688|5529354|P2|Overall Study|Pregnancy|0
1589977|NCT02443688|5529355|P1|Overall Study|Pregnancy|0
1589978|NCT02443688|5529353|P3|Overall Study|Physician Decision|1
1589979|NCT02443688|5529354|P2|Overall Study|Physician Decision|0
1589980|NCT02443688|5529355|P1|Overall Study|Physician Decision|3
1589981|NCT02443688|5529353|P3|Overall Study|Lost to Follow-up|0
1589982|NCT02443688|5529354|P2|Overall Study|Lost to Follow-up|0
1589983|NCT02443688|5529355|P1|Overall Study|Lost to Follow-up|1
1589984|NCT02443688|5529353|P3|Overall Study|Adverse Event|2
1589985|NCT02443688|5529354|P2|Overall Study|Adverse Event|3
1589986|NCT02443688|5529355|P1|Overall Study|Adverse Event|2
1589987|NCT02443402|5529434|P2|Overall Study|Screen Failure|2
1589988|NCT02443402|5529435|P1|Overall Study|Screen Failure|1
1589989|NCT02443402|5529434|P2|Overall Study|Withdrawal by Subject|1
1589990|NCT02443402|5529435|P1|Overall Study|Withdrawal by Subject|3
1589991|NCT02443298|5529497|P2|Overall Study|Withdrawal by Subject|2
1589992|NCT02443298|5529498|P1|Overall Study|Withdrawal by Subject|1
1589993|NCT02443298|5529497|P2|Overall Study|Adverse Event|3
1589994|NCT02443298|5529498|P1|Overall Study|Adverse Event|3
1589995|NCT02443103|5529518|P1|Overall Study|Noncompliance|1
1589996|NCT02443103|5529518|P1|Overall Study|Adverse Event|2
1589997|NCT02442830|5529531|P2|Overall Study|Technical Failure|1
1589998|NCT02442830|5529532|P1|Overall Study|Technical Failure|0
1589999|NCT02442804|5529542|P2|Overall Study|Adverse Event|0
1590000|NCT02442804|5529543|P1|Overall Study|Adverse Event|1
1590001|NCT02442804|5529542|P2|Overall Study|Withdrawal by Subject|1
1590002|NCT02442804|5529543|P1|Overall Study|Withdrawal by Subject|0
1590003|NCT02442349|5529648|P1|Overall Study|On-going Study at Data Cut-off|149
1590004|NCT02442349|5529648|P1|Overall Study|Withdrawal by Subject|8
1590005|NCT02442349|5529648|P1|Overall Study|Death|14
1590006|NCT02442310|5529653|P1|Overall Study|Withdrawal by Subject|1
1590007|NCT02442310|5529653|P1|Overall Study|Adverse Event|2
1590008|NCT02442284|5529675|P1|Overall Study|Other|1
1590009|NCT02442284|5529675|P1|Overall Study|Lost to Follow-up|3
1590010|NCT02442284|5529675|P1|Overall Study|Withdrew Consent|2
1590011|NCT02442284|5529675|P1|Overall Study|Adverse Event|1
1590012|NCT02442271|5529682|P1|Overall Study|Other|1
1590013|NCT02442271|5529682|P1|Overall Study|Lost to Follow-up|1
1590014|NCT02442271|5529682|P1|Overall Study|Withdrew Consent|1
1590015|NCT02442271|5529682|P1|Overall Study|Adverse Event|1
1590016|NCT02442206|5529708|P2|Period 2|Adverse Event|0
1590017|NCT02442206|5529709|P1|Period 2|Adverse Event|1
1590018|NCT02442206|5529708|P2|Period 1|COPD exacerbation|1
1590019|NCT02442206|5529709|P1|Period 1|COPD exacerbation|0
1590020|NCT02442206|5529708|P2|Period 1|withdrew consent|1
1590021|NCT02442206|5529709|P1|Period 1|withdrew consent|0
1590022|NCT02442206|5529708|P2|Period 1|Adverse Event|1
1590023|NCT02442206|5529709|P1|Period 1|Adverse Event|1
1590024|NCT02441946|5529741|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
1590025|NCT02441946|5529742|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
1590026|NCT02441946|5529743|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
1590027|NCT02441946|5529741|P3|Extension Period (8 Weeks)|Adverse Event|0
1590028|NCT02441946|5529742|P2|Extension Period (8 Weeks)|Adverse Event|0
1590029|NCT02441946|5529743|P1|Extension Period (8 Weeks)|Adverse Event|1
1590030|NCT02441946|5529741|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1590031|NCT02441946|5529742|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
1590032|NCT02441946|5529743|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
1590033|NCT02441946|5529741|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1590034|NCT02441946|5529742|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
1590035|NCT02441946|5529743|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
1590036|NCT02441946|5529741|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1590037|NCT02441946|5529742|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
1590038|NCT02441946|5529743|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
1590039|NCT02441946|5529741|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1590040|NCT02441946|5529742|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
1590041|NCT02441946|5529743|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
1590042|NCT02441946|5529741|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1590043|NCT02441946|5529742|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
1590044|NCT02441946|5529743|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
1590045|NCT02441946|5529741|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1590046|NCT02441946|5529742|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
1590047|NCT02441946|5529743|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
1590048|NCT02441946|5529741|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1590049|NCT02441946|5529742|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
1590050|NCT02441946|5529743|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
1590051|NCT02441946|5529741|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1590052|NCT02441946|5529742|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
1590053|NCT02441946|5529743|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
1590054|NCT02441946|5529741|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
1590055|NCT02441946|5529742|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1590056|NCT02441946|5529743|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
1590057|NCT02441517|5529764|P1|Overall Study|Study Terminated by Sponsor|1
1590058|NCT02441517|5529764|P1|Overall Study|Withdrawal by Subject|2
1590059|NCT02441517|5529764|P1|Overall Study|Lost to Follow-up|1
1590060|NCT02441309|5529777|P3|Overall Study|Withdrawal by Subject|1
1590061|NCT02441309|5529778|P2|Overall Study|Withdrawal by Subject|0
1590062|NCT02441309|5529779|P1|Overall Study|Withdrawal by Subject|1
1590063|NCT02441309|5529777|P3|Overall Study|Adverse Event|0
1590064|NCT02441309|5529778|P2|Overall Study|Adverse Event|1
1590065|NCT02441309|5529779|P1|Overall Study|Adverse Event|0
1590066|NCT02441309|5529777|P3|Overall Study|Disease progression|2
1590067|NCT02441309|5529778|P2|Overall Study|Disease progression|1
1590068|NCT02441309|5529779|P1|Overall Study|Disease progression|2
1590069|NCT02441218|5529810|P2|Overall Study|Lost to Follow-up|1
1590070|NCT02441218|5529811|P1|Overall Study|Lost to Follow-up|2
1590071|NCT02441218|5529810|P2|Overall Study|Withdrawal by Subject|58
1590072|NCT02441218|5529811|P1|Overall Study|Withdrawal by Subject|73
1590073|NCT02441218|5529810|P2|Overall Study|Death|553
1590074|NCT02441218|5529811|P1|Overall Study|Death|503
1590075|NCT02441179|5529837|P2|Overall Study|Withdrawal by Subject|1
1590076|NCT02441179|5529838|P1|Overall Study|Withdrawal by Subject|1
1590077|NCT02441114|5529856|P1|Washout2|Withdrawal by Subject|4
1590078|NCT02441036|5529867|P5|Overall Study|No tissue resected|0
1590079|NCT02441036|5529868|P4|Overall Study|No tissue resected|1
1590080|NCT02441036|5529869|P3|Overall Study|No tissue resected|0
1590081|NCT02441036|5529870|P2|Overall Study|No tissue resected|1
1590082|NCT02441036|5529871|P1|Overall Study|No tissue resected|0
1590083|NCT02440789|5529898|P1|Overall Study|Not willing to adhere to reqs|1
1590084|NCT02440789|5529898|P1|Overall Study|Withdrawal by Subject|3
1590085|NCT02440594|5529973|P8|Overall Study|Administratively w/drawn|1
1590086|NCT02440594|5529974|P7|Overall Study|Administratively w/drawn|2
1590087|NCT02440594|5529975|P6|Overall Study|Administratively w/drawn|0
1590088|NCT02440594|5529976|P5|Overall Study|Administratively w/drawn|0
1590089|NCT02440594|5529977|P4|Overall Study|Administratively w/drawn|0
1590090|NCT02440594|5529978|P3|Overall Study|Administratively w/drawn|0
1590091|NCT02440594|5529979|P2|Overall Study|Administratively w/drawn|2
1590092|NCT02440594|5529980|P1|Overall Study|Administratively w/drawn|3
1590093|NCT02440594|5529973|P8|Overall Study|Withdrawal by Subject|7
1590094|NCT02440594|5529974|P7|Overall Study|Withdrawal by Subject|7
1590095|NCT02440594|5529975|P6|Overall Study|Withdrawal by Subject|2
1590096|NCT02440594|5529976|P5|Overall Study|Withdrawal by Subject|2
1590097|NCT02440594|5529977|P4|Overall Study|Withdrawal by Subject|38
1590098|NCT02440594|5529978|P3|Overall Study|Withdrawal by Subject|59
1590099|NCT02440594|5529979|P2|Overall Study|Withdrawal by Subject|67
1590100|NCT02440594|5529980|P1|Overall Study|Withdrawal by Subject|81
1590101|NCT02440594|5529973|P8|Overall Study|Cognitive Impairment/Communication Issue|0
1590102|NCT02440594|5529974|P7|Overall Study|Cognitive Impairment/Communication Issue|0
1590103|NCT02440594|5529975|P6|Overall Study|Cognitive Impairment/Communication Issue|1
1590104|NCT02440594|5529976|P5|Overall Study|Cognitive Impairment/Communication Issue|2
1590105|NCT02440594|5529977|P4|Overall Study|Cognitive Impairment/Communication Issue|4
1590106|NCT02440594|5529978|P3|Overall Study|Cognitive Impairment/Communication Issue|4
1590107|NCT02440594|5529979|P2|Overall Study|Cognitive Impairment/Communication Issue|6
1590108|NCT02440594|5529980|P1|Overall Study|Cognitive Impairment/Communication Issue|14
1590109|NCT02440594|5529973|P8|Overall Study|Lost to Follow-up|48
1590110|NCT02440594|5529974|P7|Overall Study|Lost to Follow-up|28
1590111|NCT02440594|5529975|P6|Overall Study|Lost to Follow-up|4
1590112|NCT02440594|5529976|P5|Overall Study|Lost to Follow-up|5
1590113|NCT02440594|5529977|P4|Overall Study|Lost to Follow-up|47
1590114|NCT02440594|5529978|P3|Overall Study|Lost to Follow-up|54
1590115|NCT02440594|5529979|P2|Overall Study|Lost to Follow-up|33
1590116|NCT02440594|5529980|P1|Overall Study|Lost to Follow-up|34
1590117|NCT02439320|5530070|P3|Overall Study|Randomization Failure|34
1590118|NCT02439320|5530071|P2|Overall Study|Randomization Failure|46
1590119|NCT02439320|5530072|P1|Overall Study|Randomization Failure|35
1590120|NCT02439320|5530070|P3|Overall Study|Sponsor Request|1
1590121|NCT02439320|5530071|P2|Overall Study|Sponsor Request|2
1590122|NCT02439320|5530072|P1|Overall Study|Sponsor Request|0
1590123|NCT02439320|5530070|P3|Overall Study|Physician Decision|0
1590124|NCT02439320|5530071|P2|Overall Study|Physician Decision|1
1590125|NCT02439320|5530072|P1|Overall Study|Physician Decision|2
1590126|NCT02439320|5530070|P3|Overall Study|Withdrawal by Subject|14
1590127|NCT02439320|5530071|P2|Overall Study|Withdrawal by Subject|16
1590128|NCT02439320|5530072|P1|Overall Study|Withdrawal by Subject|12
1590129|NCT02439320|5530070|P3|Overall Study|Pregnancy|1
1590130|NCT02439320|5530071|P2|Overall Study|Pregnancy|1
1590131|NCT02439320|5530072|P1|Overall Study|Pregnancy|0
1590132|NCT02439320|5530070|P3|Overall Study|Noncompliance with Protocol|7
1590133|NCT02439320|5530071|P2|Overall Study|Noncompliance with Protocol|11
1590134|NCT02439320|5530072|P1|Overall Study|Noncompliance with Protocol|10
1590135|NCT02439320|5530070|P3|Overall Study|Death|0
1590136|NCT02439320|5530071|P2|Overall Study|Death|1
1590137|NCT02439320|5530072|P1|Overall Study|Death|0
1590138|NCT02439320|5530070|P3|Overall Study|Lost to Follow-up|42
1590139|NCT02439320|5530071|P2|Overall Study|Lost to Follow-up|34
1590140|NCT02439320|5530072|P1|Overall Study|Lost to Follow-up|37
1590141|NCT02439320|5530070|P3|Overall Study|Adverse Event|0
1590142|NCT02439320|5530071|P2|Overall Study|Adverse Event|2
1590143|NCT02439320|5530072|P1|Overall Study|Adverse Event|0
1590144|NCT02439138|5530152|P1|Overall Study|PI decision to terminate the study|2
1590145|NCT02439138|5530152|P1|Overall Study|Adverse Event|1
1590146|NCT02438826|5530165|P2|Overall Study|Screen Failure|0
1590147|NCT02438826|5530166|P1|Overall Study|Screen Failure|2
1590148|NCT02438826|5530165|P2|Overall Study|Protocol Violation|2
1590149|NCT02438826|5530166|P1|Overall Study|Protocol Violation|1
1590150|NCT02438826|5530165|P2|Overall Study|Withdrawal by Subject|1
1590151|NCT02438826|5530166|P1|Overall Study|Withdrawal by Subject|1
1590152|NCT02438826|5530165|P2|Overall Study|Lack of Efficacy|0
1590153|NCT02438826|5530166|P1|Overall Study|Lack of Efficacy|1
1590154|NCT02438826|5530165|P2|Overall Study|Adverse Event|1
1590155|NCT02438826|5530166|P1|Overall Study|Adverse Event|1
1590156|NCT02438813|5530194|P1|Overall Study|Patients Not Treated/No EOT Visit|249
1590157|NCT02438813|5530194|P1|Overall Study|Study Ended by Sponsor|80
1590158|NCT02438813|5530194|P1|Overall Study|Patient Lost to Follow-Up|137
1590159|NCT02438813|5530194|P1|Overall Study|Patient Decision|59
1590160|NCT02438787|5530246|P3|Overall Study|Site terminated by sponsor|1
1590161|NCT02438787|5530247|P2|Overall Study|Site terminated by sponsor|0
1590162|NCT02438787|5530248|P1|Overall Study|Site terminated by sponsor|0
1590163|NCT02438787|5530246|P3|Overall Study|Other|0
1590164|NCT02438787|5530247|P2|Overall Study|Other|1
1590165|NCT02438787|5530248|P1|Overall Study|Other|0
1590166|NCT02438787|5530246|P3|Overall Study|Study discontinued by sponsor|69
1590167|NCT02438787|5530247|P2|Overall Study|Study discontinued by sponsor|72
1590168|NCT02438787|5530248|P1|Overall Study|Study discontinued by sponsor|64
1590169|NCT02438787|5530246|P3|Overall Study|Withdrawal by Subject|10
1590170|NCT02438787|5530247|P2|Overall Study|Withdrawal by Subject|7
1590171|NCT02438787|5530248|P1|Overall Study|Withdrawal by Subject|15
1590172|NCT02438787|5530246|P3|Overall Study|Protocol Violation|1
1590173|NCT02438787|5530247|P2|Overall Study|Protocol Violation|0
1590174|NCT02438787|5530248|P1|Overall Study|Protocol Violation|0
1590175|NCT02438787|5530246|P3|Overall Study|Lost to Follow-up|0
1590176|NCT02438787|5530247|P2|Overall Study|Lost to Follow-up|1
1590177|NCT02438787|5530248|P1|Overall Study|Lost to Follow-up|0
1590178|NCT02438787|5530246|P3|Overall Study|Lack of Efficacy|0
1590179|NCT02438787|5530247|P2|Overall Study|Lack of Efficacy|2
1590180|NCT02438787|5530248|P1|Overall Study|Lack of Efficacy|1
1590181|NCT02438787|5530246|P3|Overall Study|Adverse Event|2
1590182|NCT02438787|5530247|P2|Overall Study|Adverse Event|0
1590183|NCT02438787|5530248|P1|Overall Study|Adverse Event|1
1590184|NCT02438280|5530367|P2|Overall Study|Physician Decision|0
1590185|NCT02438280|5530368|P1|Overall Study|Physician Decision|1
1590186|NCT02438137|5530378|P2|Overall Study|Physician Decision|1
1590187|NCT02438137|5530379|P1|Overall Study|Physician Decision|0
1590188|NCT02438137|5530378|P2|Overall Study|Withdrawal by Subject|3
1590189|NCT02438137|5530379|P1|Overall Study|Withdrawal by Subject|4
1590190|NCT02438137|5530378|P2|Overall Study|Adverse Event|0
1590191|NCT02438137|5530379|P1|Overall Study|Adverse Event|1
1590192|NCT02438137|5530378|P2|Overall Study|Lost to Follow-up|2
1590193|NCT02438137|5530379|P1|Overall Study|Lost to Follow-up|3
1590194|NCT02437903|5530387|P1|Overall Study|Lost to Follow-up|3
1590195|NCT02437903|5530387|P1|Overall Study|Withdrawal by Subject|1
1590196|NCT02437903|5530387|P1|Overall Study|Adverse Event|1
1590197|NCT02437890|5530400|P5|Overall Study|Death|0
1590198|NCT02437890|5530401|P4|Overall Study|Death|2
1590199|NCT02437890|5530402|P3|Overall Study|Death|0
1590200|NCT02437890|5530403|P2|Overall Study|Death|0
1590201|NCT02437890|5530404|P1|Overall Study|Death|0
1590202|NCT02437890|5530400|P5|Overall Study|Withdrawal by Subject|5
1590203|NCT02437890|5530401|P4|Overall Study|Withdrawal by Subject|5
1590204|NCT02437890|5530402|P3|Overall Study|Withdrawal by Subject|6
1590205|NCT02437890|5530403|P2|Overall Study|Withdrawal by Subject|2
1590206|NCT02437890|5530404|P1|Overall Study|Withdrawal by Subject|1
1590207|NCT02437890|5530400|P5|Overall Study|Adverse Event|7
1590208|NCT02437890|5530401|P4|Overall Study|Adverse Event|11
1590209|NCT02437890|5530402|P3|Overall Study|Adverse Event|5
1590210|NCT02437890|5530403|P2|Overall Study|Adverse Event|9
1590211|NCT02437890|5530404|P1|Overall Study|Adverse Event|4
1590212|NCT02437890|5530400|P5|Overall Study|Lack of Efficacy|1
1590213|NCT02437890|5530401|P4|Overall Study|Lack of Efficacy|3
1590214|NCT02437890|5530402|P3|Overall Study|Lack of Efficacy|0
1590215|NCT02437890|5530403|P2|Overall Study|Lack of Efficacy|3
1590216|NCT02437890|5530404|P1|Overall Study|Lack of Efficacy|1
1590217|NCT02437890|5530400|P5|Overall Study|Unable to attend visit(s)|0
1590218|NCT02437890|5530401|P4|Overall Study|Unable to attend visit(s)|0
1590219|NCT02437890|5530402|P3|Overall Study|Unable to attend visit(s)|0
1590220|NCT02437890|5530403|P2|Overall Study|Unable to attend visit(s)|0
1590221|NCT02437890|5530404|P1|Overall Study|Unable to attend visit(s)|1
1590222|NCT02437890|5530400|P5|Overall Study|Physician Decision|0
1590223|NCT02437890|5530401|P4|Overall Study|Physician Decision|1
1590224|NCT02437890|5530402|P3|Overall Study|Physician Decision|0
1590225|NCT02437890|5530403|P2|Overall Study|Physician Decision|0
1590226|NCT02437890|5530404|P1|Overall Study|Physician Decision|0
1590227|NCT02437890|5530400|P5|Overall Study|Sponsor's decision|2
1590228|NCT02437890|5530401|P4|Overall Study|Sponsor's decision|0
1590229|NCT02437890|5530402|P3|Overall Study|Sponsor's decision|4
1590230|NCT02437890|5530403|P2|Overall Study|Sponsor's decision|1
1590231|NCT02437890|5530404|P1|Overall Study|Sponsor's decision|1
1590232|NCT02437890|5530400|P5|Overall Study|Non-compliance to study drug|1
1590233|NCT02437890|5530401|P4|Overall Study|Non-compliance to study drug|0
1590234|NCT02437890|5530402|P3|Overall Study|Non-compliance to study drug|0
1590235|NCT02437890|5530403|P2|Overall Study|Non-compliance to study drug|1
1590236|NCT02437890|5530404|P1|Overall Study|Non-compliance to study drug|0
1590237|NCT02437864|5530617|P2|Overall Study|Protocol Violation|0
1590238|NCT02437864|5530618|P1|Overall Study|Protocol Violation|4
1590239|NCT02437513|5530639|P1|Overall Study|Withdrawal by Subject|2
1590240|NCT02437409|5530664|P1|Overall Study|Screening failure|12
1590241|NCT02437409|5530664|P1|Overall Study|Withdrawal by Subject|3
1590242|NCT02437318|5530757|P2|Overall Study|Untreated|1
1590243|NCT02437318|5530758|P1|Overall Study|Untreated|0
1590244|NCT02437318|5530757|P2|Overall Study|Protocol Violation|6
1590245|NCT02437318|5530758|P1|Overall Study|Protocol Violation|5
1590246|NCT02437318|5530757|P2|Overall Study|Death|4
1590247|NCT02437318|5530758|P1|Overall Study|Death|4
1590248|NCT02437318|5530757|P2|Overall Study|Adverse Event|3
1590249|NCT02437318|5530758|P1|Overall Study|Adverse Event|14
1590250|NCT02437318|5530757|P2|Overall Study|Physician Decision|10
1590251|NCT02437318|5530758|P1|Overall Study|Physician Decision|11
1590252|NCT02437318|5530757|P2|Overall Study|Subject/guardian decision|10
1590253|NCT02437318|5530758|P1|Overall Study|Subject/guardian decision|22
1590254|NCT02437318|5530757|P2|Overall Study|Progressive disease|208
1590255|NCT02437318|5530758|P1|Overall Study|Progressive disease|173
1590256|NCT02437305|5530766|P2|Overall Study|Lost to Follow-up|12
1590257|NCT02437305|5530767|P1|Overall Study|Lost to Follow-up|18
1590258|NCT02437188|5530794|P2|Overall Study|Adverse Event|1
1590259|NCT02437188|5530795|P1|Overall Study|Adverse Event|0
1590260|NCT02437188|5530794|P2|Overall Study|Randomized but did not receive surgery|8
1590261|NCT02437188|5530795|P1|Overall Study|Randomized but did not receive surgery|4
1590262|NCT02437162|5530812|P3|Overall Study|Other|1
1590263|NCT02437162|5530813|P2|Overall Study|Other|0
1590264|NCT02437162|5530814|P1|Overall Study|Other|0
1590265|NCT02437162|5530812|P3|Overall Study|Death|0
1590266|NCT02437162|5530813|P2|Overall Study|Death|1
1590267|NCT02437162|5530814|P1|Overall Study|Death|0
1590268|NCT02437162|5530812|P3|Overall Study|Lost to Follow-up|1
1590269|NCT02437162|5530813|P2|Overall Study|Lost to Follow-up|0
1590270|NCT02437162|5530814|P1|Overall Study|Lost to Follow-up|1
1590271|NCT02437162|5530812|P3|Overall Study|Adverse Event|0
1590272|NCT02437162|5530813|P2|Overall Study|Adverse Event|1
1590273|NCT02437162|5530814|P1|Overall Study|Adverse Event|0
1590274|NCT02437162|5530812|P3|Overall Study|Withdrawal by Subject|9
1590275|NCT02437162|5530813|P2|Overall Study|Withdrawal by Subject|7
1590276|NCT02437162|5530814|P1|Overall Study|Withdrawal by Subject|13
1590277|NCT02437162|5530812|P3|Overall Study|Study discontinued by Sponsor|97
1590278|NCT02437162|5530813|P2|Overall Study|Study discontinued by Sponsor|98
1590279|NCT02437162|5530814|P1|Overall Study|Study discontinued by Sponsor|93
1590280|NCT02437162|5530812|P3|Overall Study|Randomized but not treated|1
1590281|NCT02437162|5530813|P2|Overall Study|Randomized but not treated|0
1590282|NCT02437162|5530814|P1|Overall Study|Randomized but not treated|0
1590283|NCT02437162|5530812|P3|Overall Study|Protocol Violation|0
1590284|NCT02437162|5530813|P2|Overall Study|Protocol Violation|1
1590285|NCT02437162|5530814|P1|Overall Study|Protocol Violation|0
1590286|NCT02436915|5530934|P2|Overall Study|Withdrawal by Subject|1
1590287|NCT02436915|5530935|P1|Overall Study|Withdrawal by Subject|0
1590288|NCT02436889|5530957|P2|Overall Study|Does not like/could not tolerate medicat|1
1590289|NCT02436889|5530958|P1|Overall Study|Does not like/could not tolerate medicat|0
1590290|NCT02436889|5530957|P2|Overall Study|No improvement in symptoms|0
1590291|NCT02436889|5530958|P1|Overall Study|No improvement in symptoms|1
1590292|NCT02436811|5530977|P3|Overall Study|Lost to Follow-up|7
1590293|NCT02436811|5530978|P2|Overall Study|Lost to Follow-up|9
1590294|NCT02436811|5530979|P1|Overall Study|Lost to Follow-up|2
1590295|NCT02436681|5530987|P1|Overall Study|Death|2
1590296|NCT02436681|5530987|P1|Overall Study|Withdrawal by Subject|2
1590297|NCT02436681|5530987|P1|Overall Study|Lost to Follow-up|10
1590298|NCT02436577|5531004|P6|Overall Study|Protocol Deviation|0
1590299|NCT02436577|5531005|P5|Overall Study|Protocol Deviation|0
1590300|NCT02436577|5531006|P4|Overall Study|Protocol Deviation|0
1590301|NCT02436577|5531007|P3|Overall Study|Protocol Deviation|0
1590302|NCT02436577|5531008|P2|Overall Study|Protocol Deviation|1
1590303|NCT02436577|5531009|P1|Overall Study|Protocol Deviation|0
1590304|NCT02436330|5531064|P2|Cohort 6|Withdrawal by Subject|1
1590305|NCT02436330|5531065|P1|Cohort 6|Withdrawal by Subject|1
1590306|NCT02436330|5531064|P2|Cohort 6|Lost to Follow-up|0
1590307|NCT02436330|5531065|P1|Cohort 6|Lost to Follow-up|2
1590308|NCT02436330|5531064|P2|Cohort 5|Withdrawal by Subject|2
1590309|NCT02436330|5531065|P1|Cohort 5|Withdrawal by Subject|3
1590310|NCT02436330|5531064|P2|Cohort 5|Lost to Follow-up|2
1590311|NCT02436330|5531065|P1|Cohort 5|Lost to Follow-up|3
1590312|NCT02436330|5531064|P2|Cohort 4|Withdrawal by Subject|0
1590313|NCT02436330|5531065|P1|Cohort 4|Withdrawal by Subject|1
1590314|NCT02436330|5531064|P2|Cohort 4|Lost to Follow-up|0
1590315|NCT02436330|5531065|P1|Cohort 4|Lost to Follow-up|1
1590316|NCT02436330|5531064|P2|Cohort 3|Withdrawal by Subject|0
1590317|NCT02436330|5531065|P1|Cohort 3|Withdrawal by Subject|4
1590318|NCT02436330|5531064|P2|Cohort 3|Lost to Follow-up|0
1590319|NCT02436330|5531065|P1|Cohort 3|Lost to Follow-up|1
1590320|NCT02436330|5531064|P2|Cohort 2|Withdrawal by Subject|3
1590321|NCT02436330|5531065|P1|Cohort 2|Withdrawal by Subject|2
1590322|NCT02436330|5531064|P2|Cohort 2|Lost to Follow-up|0
1590323|NCT02436330|5531065|P1|Cohort 2|Lost to Follow-up|2
1590324|NCT02436330|5531064|P2|Cohort 1|Withdrawal by Subject|1
1590325|NCT02436330|5531065|P1|Cohort 1|Withdrawal by Subject|0
1590326|NCT02436330|5531064|P2|Cohort 1|Lost to Follow-up|2
1590327|NCT02436330|5531065|P1|Cohort 1|Lost to Follow-up|5
1590328|NCT02436304|5531110|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
1590329|NCT02436304|5531111|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
1590330|NCT02436304|5531112|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
1590331|NCT02436304|5531110|P3|Overall Study|Withdrawal by Subject|0
1590332|NCT02436304|5531111|P2|Overall Study|Withdrawal by Subject|1
1590333|NCT02436304|5531112|P1|Overall Study|Withdrawal by Subject|0
1590334|NCT02436304|5531110|P3|Overall Study|Lost to Follow-up|0
1590335|NCT02436304|5531111|P2|Overall Study|Lost to Follow-up|1
1590336|NCT02436304|5531112|P1|Overall Study|Lost to Follow-up|0
1590337|NCT02436239|5531131|P4|Down-Taper Period|Withdrawal by Subject|2
1590338|NCT02436239|5531132|P3|Down-Taper Period|Withdrawal by Subject|1
1590339|NCT02436239|5531133|P2|Down-Taper Period|Withdrawal by Subject|4
1590340|NCT02436239|5531134|P1|Down-Taper Period|Withdrawal by Subject|4
1590341|NCT02436239|5531131|P4|Open-Lable Treatment Period|Other Reason|0
1590342|NCT02436239|5531132|P3|Open-Lable Treatment Period|Other Reason|0
1590343|NCT02436239|5531133|P2|Open-Lable Treatment Period|Other Reason|1
1590344|NCT02436239|5531134|P1|Open-Lable Treatment Period|Other Reason|1
1590345|NCT02436239|5531131|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
1590346|NCT02436239|5531132|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
1590347|NCT02436239|5531133|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
1590348|NCT02436239|5531134|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
1590349|NCT02436239|5531131|P4|Open-Lable Treatment Period|Protocol Violation|0
1590350|NCT02436239|5531132|P3|Open-Lable Treatment Period|Protocol Violation|1
1590351|NCT02436239|5531133|P2|Open-Lable Treatment Period|Protocol Violation|1
1590352|NCT02436239|5531134|P1|Open-Lable Treatment Period|Protocol Violation|0
1590353|NCT02436239|5531131|P4|Open-Lable Treatment Period|Lost to Follow-up|1
1590354|NCT02436239|5531132|P3|Open-Lable Treatment Period|Lost to Follow-up|4
1590355|NCT02436239|5531133|P2|Open-Lable Treatment Period|Lost to Follow-up|2
1590356|NCT02436239|5531134|P1|Open-Lable Treatment Period|Lost to Follow-up|4
1590357|NCT02436239|5531131|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
1590358|NCT02436239|5531132|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
1590359|NCT02436239|5531133|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
1590360|NCT02436239|5531134|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
1590361|NCT02436239|5531131|P4|Open-Lable Treatment Period|Lack of Efficacy|1
1590362|NCT02436239|5531132|P3|Open-Lable Treatment Period|Lack of Efficacy|6
1590363|NCT02436239|5531133|P2|Open-Lable Treatment Period|Lack of Efficacy|6
1590364|NCT02436239|5531134|P1|Open-Lable Treatment Period|Lack of Efficacy|1
1590365|NCT02436239|5531131|P4|Open-Lable Treatment Period|Adverse Event|2
1590366|NCT02436239|5531132|P3|Open-Lable Treatment Period|Adverse Event|4
1590367|NCT02436239|5531133|P2|Open-Lable Treatment Period|Adverse Event|3
1590368|NCT02436239|5531134|P1|Open-Lable Treatment Period|Adverse Event|12
1590369|NCT02436200|5531156|P1|Overall Study|Significant outlier|1
1590370|NCT02435966|5531175|P3|Overall Study|Withdrawal by Subject|0
1590371|NCT02435966|5531176|P2|Overall Study|Withdrawal by Subject|1
1590372|NCT02435966|5531177|P1|Overall Study|Withdrawal by Subject|0
1590373|NCT02435914|5531189|P4|Overall Study|Other Miscellaneous Reason|0
1590374|NCT02435914|5531190|P3|Overall Study|Other Miscellaneous Reason|1
1590375|NCT02435914|5531191|P2|Overall Study|Other Miscellaneous Reason|0
1590376|NCT02435914|5531192|P1|Overall Study|Other Miscellaneous Reason|0
1590377|NCT02435914|5531189|P4|Overall Study|Withdrawal by Subject|0
1590378|NCT02435914|5531190|P3|Overall Study|Withdrawal by Subject|0
1590379|NCT02435914|5531191|P2|Overall Study|Withdrawal by Subject|1
1590380|NCT02435914|5531192|P1|Overall Study|Withdrawal by Subject|0
1590381|NCT02435914|5531189|P4|Overall Study|Ocular Adverse Event|0
1590382|NCT02435914|5531190|P3|Overall Study|Ocular Adverse Event|0
1590383|NCT02435914|5531191|P2|Overall Study|Ocular Adverse Event|0
1590384|NCT02435914|5531192|P1|Overall Study|Ocular Adverse Event|1
1590385|NCT02435836|5531214|P1|Overall Study|AE of Worsening Schizophrenia|96
1590386|NCT02435836|5531214|P1|Overall Study|Met Withdrawal Criteria|7
1590387|NCT02435836|5531214|P1|Overall Study|Protocol Violation|6
1590388|NCT02435836|5531214|P1|Overall Study|Noncompliance|27
1590389|NCT02435836|5531214|P1|Overall Study|Sponsor discontinued trial|167
1590390|NCT02435836|5531214|P1|Overall Study|Adverse Event|44
1590391|NCT02435836|5531214|P1|Overall Study|Insufficient Clinical Response|26
1590392|NCT02435836|5531214|P1|Overall Study|Withdrawal by Subject|236
1590393|NCT02435836|5531214|P1|Overall Study|Lack of Efficacy|1
1590394|NCT02435836|5531214|P1|Overall Study|Lost to Follow-up|21
1590395|NCT02435433|5531273|P5|Overall Study|Lost to Follow-up|0
1590396|NCT02435433|5531274|P4|Overall Study|Lost to Follow-up|0
1590397|NCT02435433|5531275|P3|Overall Study|Lost to Follow-up|0
1590398|NCT02435433|5531276|P2|Overall Study|Lost to Follow-up|2
1590399|NCT02435433|5531277|P1|Overall Study|Lost to Follow-up|2
1590400|NCT02435433|5531273|P5|Overall Study|Withdrawal by Subject|0
1590401|NCT02435433|5531274|P4|Overall Study|Withdrawal by Subject|0
1590402|NCT02435433|5531275|P3|Overall Study|Withdrawal by Subject|0
1590403|NCT02435433|5531276|P2|Overall Study|Withdrawal by Subject|3
1590404|NCT02435433|5531277|P1|Overall Study|Withdrawal by Subject|2
1590405|NCT02435433|5531273|P5|Overall Study|On Treatment|0
1590406|NCT02435433|5531274|P4|Overall Study|On Treatment|0
1590407|NCT02435433|5531275|P3|Overall Study|On Treatment|0
1590408|NCT02435433|5531276|P2|Overall Study|On Treatment|0
1590409|NCT02435433|5531277|P1|Overall Study|On Treatment|11
1590410|NCT02435277|5531303|P4|Overall Study|Withdrawal by Subject|0
1590411|NCT02435277|5531304|P3|Overall Study|Withdrawal by Subject|0
1590412|NCT02435277|5531305|P2|Overall Study|Withdrawal by Subject|0
1590413|NCT02435277|5531306|P1|Overall Study|Withdrawal by Subject|1
1590414|NCT02435277|5531303|P4|Overall Study|Adverse Event|0
1590415|NCT02435277|5531304|P3|Overall Study|Adverse Event|0
1590416|NCT02435277|5531305|P2|Overall Study|Adverse Event|1
1590417|NCT02435277|5531306|P1|Overall Study|Adverse Event|1
1590418|NCT02435147|5531320|P1|Overall Study|non-evaluable DXA scan|11
1590419|NCT02435069|5531325|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
1590420|NCT02435069|5531326|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
1590421|NCT02435069|5531327|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
1590422|NCT02435069|5531328|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
1590423|NCT02435069|5531329|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
1590424|NCT02435069|5531325|P5|Dose Response - First Intervention|Adverse Event|0
1590425|NCT02435069|5531326|P4|Dose Response - First Intervention|Adverse Event|0
1590426|NCT02435069|5531327|P3|Dose Response - First Intervention|Adverse Event|1
1590427|NCT02435069|5531328|P2|Dose Response - First Intervention|Adverse Event|1
1590428|NCT02435069|5531329|P1|Dose Response - First Intervention|Adverse Event|0
1590429|NCT02434939|5531351|P2|Overall Study|Adverse Event|1
1590430|NCT02434939|5531352|P1|Overall Study|Adverse Event|0
1590431|NCT02434939|5531351|P2|Overall Study|Withdrawal by Subject|0
1590432|NCT02434939|5531352|P1|Overall Study|Withdrawal by Subject|3
1590433|NCT02434939|5531351|P2|Overall Study|Lack of Efficacy|48
1590434|NCT02434939|5531352|P1|Overall Study|Lack of Efficacy|34
1590435|NCT02434471|5531479|P1|Overall Study|Physician Decision|9
1590436|NCT02434328|5531488|P2|Overall Study|Other|1
1590437|NCT02434328|5531489|P1|Overall Study|Other|4
1590438|NCT02434328|5531488|P2|Overall Study|Lost to Follow-up|6
1590439|NCT02434328|5531489|P1|Overall Study|Lost to Follow-up|1
1590440|NCT02434328|5531488|P2|Overall Study|Death|7
1590441|NCT02434328|5531489|P1|Overall Study|Death|4
1590442|NCT02434328|5531488|P2|Overall Study|Withdrawal by Subject|21
1590443|NCT02434328|5531489|P1|Overall Study|Withdrawal by Subject|12
1590444|NCT02434328|5531488|P2|Overall Study|Physician Decision|1
1590445|NCT02434328|5531489|P1|Overall Study|Physician Decision|0
1590446|NCT02434328|5531488|P2|Overall Study|Lack of Efficacy|2
1590447|NCT02434328|5531489|P1|Overall Study|Lack of Efficacy|0
1590448|NCT02434328|5531488|P2|Overall Study|Adverse Event|4
1590449|NCT02434328|5531489|P1|Overall Study|Adverse Event|9
1590450|NCT02433834|5531564|P1|Overall Study|Physician Decision|1
1590451|NCT02433834|5531564|P1|Overall Study|Adverse Event|6
1590452|NCT02433834|5531564|P1|Overall Study|Withdrawal by Subject|14
1590453|NCT02433834|5531564|P1|Overall Study|Lost to Follow-up|6
1590454|NCT02433834|5531564|P1|Overall Study|Protocol Violation|3
1590455|NCT02433834|5531564|P1|Overall Study|Protocol-specified criteria|7
1590456|NCT02433678|5531624|P2|Overall Study|Lost to Follow-up|2
1590457|NCT02433678|5531625|P1|Overall Study|Lost to Follow-up|1
1590458|NCT02433483|5531692|P1|Overall Study|Other antineoplastic therapy/HSCT|1
1590459|NCT02433483|5531692|P1|Overall Study|Unacceptable toxicity|1
1590460|NCT02433340|5531719|P4|Overall Study|Other|0
1590461|NCT02433340|5531720|P3|Overall Study|Other|0
1590462|NCT02433340|5531721|P2|Overall Study|Other|1
1590463|NCT02433340|5531722|P1|Overall Study|Other|0
1590464|NCT02433340|5531719|P4|Overall Study|Required Alternative/Prohibited Therapy|0
1590465|NCT02433340|5531720|P3|Overall Study|Required Alternative/Prohibited Therapy|0
1590466|NCT02433340|5531721|P2|Overall Study|Required Alternative/Prohibited Therapy|0
1590467|NCT02433340|5531722|P1|Overall Study|Required Alternative/Prohibited Therapy|1
1590468|NCT02433340|5531719|P4|Overall Study|Lost to Follow-up|0
1590469|NCT02433340|5531720|P3|Overall Study|Lost to Follow-up|0
1590470|NCT02433340|5531721|P2|Overall Study|Lost to Follow-up|1
1590471|NCT02433340|5531722|P1|Overall Study|Lost to Follow-up|0
1590472|NCT02433340|5531719|P4|Overall Study|Withdrawal by Subject|2
1590473|NCT02433340|5531720|P3|Overall Study|Withdrawal by Subject|1
1590474|NCT02433340|5531721|P2|Overall Study|Withdrawal by Subject|0
1590475|NCT02433340|5531722|P1|Overall Study|Withdrawal by Subject|1
1590476|NCT02433340|5531719|P4|Overall Study|Adverse Event|0
1590477|NCT02433340|5531720|P3|Overall Study|Adverse Event|1
1590478|NCT02433340|5531721|P2|Overall Study|Adverse Event|0
1590479|NCT02433340|5531722|P1|Overall Study|Adverse Event|0
1590480|NCT02433288|5532616|P2|Overall Study|Death|3
1590481|NCT02433288|5532617|P1|Overall Study|Death|0
1590482|NCT02433288|5532616|P2|Overall Study|Lost to Follow-up|14
1590483|NCT02433288|5532617|P1|Overall Study|Lost to Follow-up|2
1590484|NCT02433288|5532616|P2|Overall Study|Withdrawal by Subject|99
1590485|NCT02433288|5532617|P1|Overall Study|Withdrawal by Subject|101
1590486|NCT02433288|5532616|P2|Overall Study|Eligibility criteria not fullfilled|3
1590487|NCT02433288|5532617|P1|Overall Study|Eligibility criteria not fullfilled|7
1590488|NCT02433288|5532616|P2|Overall Study|Severe non-compliance to protocol|7
1590489|NCT02433288|5532617|P1|Overall Study|Severe non-compliance to protocol|13
1590490|NCT02432196|5532717|P1|Overall Study|On Study|20
1590491|NCT02432196|5532717|P1|Overall Study|Reoperation|3
1590492|NCT02432196|5532717|P1|Overall Study|Death|2
1590493|NCT02432196|5532717|P1|Overall Study|Not Implanted with Device|1
1590494|NCT02432144|5532725|P1|Overall Study|Participant Non-Compliance|1
1590495|NCT02432105|5532733|P3|Overall Study|Randomized in error|2
1590496|NCT02432105|5532734|P2|Overall Study|Randomized in error|0
1590497|NCT02432105|5532735|P1|Overall Study|Randomized in error|0
1590498|NCT02432105|5532733|P3|Overall Study|Culture positive for yeast|0
1590499|NCT02432105|5532734|P2|Overall Study|Culture positive for yeast|1
1590500|NCT02432105|5532735|P1|Overall Study|Culture positive for yeast|0
1590501|NCT02432105|5532733|P3|Overall Study|Withdrawal by Subject|1
1590502|NCT02432105|5532734|P2|Overall Study|Withdrawal by Subject|0
1590503|NCT02432105|5532735|P1|Overall Study|Withdrawal by Subject|1
1590504|NCT02432105|5532733|P3|Overall Study|Lost to Follow-up|0
1590505|NCT02432105|5532734|P2|Overall Study|Lost to Follow-up|1
1590506|NCT02432105|5532735|P1|Overall Study|Lost to Follow-up|1
1590507|NCT02432040|5532752|P2|Overall Study|Physician Decision|1
1590508|NCT02432040|5532753|P1|Overall Study|Physician Decision|1
1590509|NCT02432040|5532752|P2|Overall Study|Lost to Follow-up|5
1590510|NCT02432040|5532753|P1|Overall Study|Lost to Follow-up|4
1590511|NCT02432040|5532752|P2|Overall Study|Lack of Efficacy|0
1590512|NCT02432040|5532753|P1|Overall Study|Lack of Efficacy|3
1590513|NCT02431793|5532776|P3|Overall Study|Lost to Follow-up|104
1590514|NCT02431793|5532777|P2|Overall Study|Lost to Follow-up|122
1590515|NCT02431793|5532778|P1|Overall Study|Lost to Follow-up|101
1590516|NCT02431793|5532776|P3|Overall Study|Withdrawal by Subject|5
1590517|NCT02431793|5532777|P2|Overall Study|Withdrawal by Subject|5
1590518|NCT02431793|5532778|P1|Overall Study|Withdrawal by Subject|7
1590519|NCT02431793|5532776|P3|Overall Study|Ineligible doe to not filling Rx|8
1590520|NCT02431793|5532777|P2|Overall Study|Ineligible doe to not filling Rx|7
1590521|NCT02431793|5532778|P1|Overall Study|Ineligible doe to not filling Rx|11
1590522|NCT02431559|5532856|P4|Overall Study|Physician Decision|1
1590523|NCT02431559|5532857|P3|Overall Study|Physician Decision|0
1590524|NCT02431559|5532858|P2|Overall Study|Physician Decision|0
1590525|NCT02431559|5532859|P1|Overall Study|Physician Decision|0
1590526|NCT02431559|5532856|P4|Overall Study|Withdrawal by Subject|4
1590527|NCT02431559|5532857|P3|Overall Study|Withdrawal by Subject|0
1590528|NCT02431559|5532858|P2|Overall Study|Withdrawal by Subject|1
1590529|NCT02431559|5532859|P1|Overall Study|Withdrawal by Subject|0
1590530|NCT02431559|5532856|P4|Overall Study|Progressive disease|22
1590531|NCT02431559|5532857|P3|Overall Study|Progressive disease|4
1590532|NCT02431559|5532858|P2|Overall Study|Progressive disease|1
1590533|NCT02431559|5532859|P1|Overall Study|Progressive disease|2
1590534|NCT02431559|5532856|P4|Overall Study|Adverse Event|4
1590535|NCT02431559|5532857|P3|Overall Study|Adverse Event|0
1590536|NCT02431559|5532858|P2|Overall Study|Adverse Event|1
1590537|NCT02431559|5532859|P1|Overall Study|Adverse Event|0
1590538|NCT02431533|5532883|P2|Overall Study|Developed Exclusionary criteria|0
1590539|NCT02431533|5532884|P1|Overall Study|Developed Exclusionary criteria|1
1590540|NCT02431533|5532883|P2|Overall Study|Withdrawal by Subject|3
1590541|NCT02431533|5532884|P1|Overall Study|Withdrawal by Subject|1
1590542|NCT02431468|5532950|P3|Overall Study|noncompliance, investigator termination,|2
1590543|NCT02431468|5532951|P2|Overall Study|noncompliance, investigator termination,|2
1590544|NCT02431468|5532952|P1|Overall Study|noncompliance, investigator termination,|2
1590545|NCT02431468|5532950|P3|Overall Study|Withdrawal by Subject|2
1590546|NCT02431468|5532951|P2|Overall Study|Withdrawal by Subject|12
1590547|NCT02431468|5532952|P1|Overall Study|Withdrawal by Subject|4
1590548|NCT02431468|5532950|P3|Overall Study|Adverse Event|5
1590549|NCT02431468|5532951|P2|Overall Study|Adverse Event|4
1590550|NCT02431468|5532952|P1|Overall Study|Adverse Event|2
1590551|NCT02431260|5533043|P14|Overall Study|Other Unspecified|0
1590552|NCT02431260|5533044|P13|Overall Study|Other Unspecified|1
1590553|NCT02431260|5533045|P12|Overall Study|Other Unspecified|1
1590554|NCT02431260|5533046|P11|Overall Study|Other Unspecified|0
1590555|NCT02431260|5533047|P10|Overall Study|Other Unspecified|0
1590556|NCT02431260|5533048|P9|Overall Study|Other Unspecified|0
1590557|NCT02431260|5533049|P8|Overall Study|Other Unspecified|0
1590558|NCT02431260|5533050|P7|Overall Study|Other Unspecified|0
1590559|NCT02431260|5533051|P6|Overall Study|Other Unspecified|0
1590560|NCT02431260|5533052|P5|Overall Study|Other Unspecified|0
1590561|NCT02431260|5533053|P4|Overall Study|Other Unspecified|0
1590562|NCT02431260|5533054|P3|Overall Study|Other Unspecified|0
1590563|NCT02431260|5533055|P2|Overall Study|Other Unspecified|0
1590564|NCT02431260|5533056|P1|Overall Study|Other Unspecified|0
1590565|NCT02431260|5533043|P14|Overall Study|Physician Decision|0
1590566|NCT02431260|5533044|P13|Overall Study|Physician Decision|0
1590567|NCT02431260|5533045|P12|Overall Study|Physician Decision|0
1590568|NCT02431260|5533046|P11|Overall Study|Physician Decision|0
1590569|NCT02431260|5533047|P10|Overall Study|Physician Decision|0
1590570|NCT02431260|5533048|P9|Overall Study|Physician Decision|0
1590571|NCT02431260|5533049|P8|Overall Study|Physician Decision|0
1590572|NCT02431260|5533050|P7|Overall Study|Physician Decision|0
1590573|NCT02431260|5533051|P6|Overall Study|Physician Decision|1
1590574|NCT02431260|5533052|P5|Overall Study|Physician Decision|0
1590575|NCT02431260|5533053|P4|Overall Study|Physician Decision|0
1590576|NCT02431260|5533054|P3|Overall Study|Physician Decision|0
1590577|NCT02431260|5533055|P2|Overall Study|Physician Decision|0
1590578|NCT02431260|5533056|P1|Overall Study|Physician Decision|0
1590579|NCT02431260|5533043|P14|Overall Study|Study Terminated by the Sponsor|0
1590580|NCT02431260|5533044|P13|Overall Study|Study Terminated by the Sponsor|4
1590581|NCT02431260|5533045|P12|Overall Study|Study Terminated by the Sponsor|0
1590582|NCT02431260|5533046|P11|Overall Study|Study Terminated by the Sponsor|1
1590583|NCT02431260|5533047|P10|Overall Study|Study Terminated by the Sponsor|1
1590584|NCT02431260|5533048|P9|Overall Study|Study Terminated by the Sponsor|1
1590585|NCT02431260|5533049|P8|Overall Study|Study Terminated by the Sponsor|2
1590586|NCT02431260|5533050|P7|Overall Study|Study Terminated by the Sponsor|1
1590587|NCT02431260|5533051|P6|Overall Study|Study Terminated by the Sponsor|0
1590588|NCT02431260|5533052|P5|Overall Study|Study Terminated by the Sponsor|1
1590589|NCT02431260|5533053|P4|Overall Study|Study Terminated by the Sponsor|1
1590590|NCT02431260|5533054|P3|Overall Study|Study Terminated by the Sponsor|2
1590591|NCT02431260|5533055|P2|Overall Study|Study Terminated by the Sponsor|0
1590592|NCT02431260|5533056|P1|Overall Study|Study Terminated by the Sponsor|0
1590593|NCT02431260|5533043|P14|Overall Study|Lost to Follow-up|0
1590594|NCT02431260|5533044|P13|Overall Study|Lost to Follow-up|0
1590595|NCT02431260|5533045|P12|Overall Study|Lost to Follow-up|0
1590596|NCT02431260|5533046|P11|Overall Study|Lost to Follow-up|0
1590597|NCT02431260|5533047|P10|Overall Study|Lost to Follow-up|0
1590598|NCT02431260|5533048|P9|Overall Study|Lost to Follow-up|0
1590599|NCT02431260|5533049|P8|Overall Study|Lost to Follow-up|0
1590600|NCT02431260|5533050|P7|Overall Study|Lost to Follow-up|0
1590601|NCT02431260|5533051|P6|Overall Study|Lost to Follow-up|1
1590602|NCT02431260|5533052|P5|Overall Study|Lost to Follow-up|0
1590603|NCT02431260|5533053|P4|Overall Study|Lost to Follow-up|0
1590604|NCT02431260|5533054|P3|Overall Study|Lost to Follow-up|0
1590605|NCT02431260|5533055|P2|Overall Study|Lost to Follow-up|0
1590606|NCT02431260|5533056|P1|Overall Study|Lost to Follow-up|0
1590607|NCT02431260|5533043|P14|Overall Study|Death|1
1590608|NCT02431260|5533044|P13|Overall Study|Death|5
1590609|NCT02431260|5533045|P12|Overall Study|Death|2
1590610|NCT02431260|5533046|P11|Overall Study|Death|3
1590611|NCT02431260|5533047|P10|Overall Study|Death|6
1590612|NCT02431260|5533048|P9|Overall Study|Death|6
1590613|NCT02431260|5533049|P8|Overall Study|Death|1
1590614|NCT02431260|5533050|P7|Overall Study|Death|3
1590615|NCT02431260|5533051|P6|Overall Study|Death|2
1590616|NCT02431260|5533052|P5|Overall Study|Death|2
1590617|NCT02431260|5533053|P4|Overall Study|Death|4
1590618|NCT02431260|5533054|P3|Overall Study|Death|3
1590619|NCT02431260|5533055|P2|Overall Study|Death|4
1590620|NCT02431260|5533056|P1|Overall Study|Death|4
1590621|NCT02431260|5533043|P14|Overall Study|Subject Decision|0
1590622|NCT02431260|5533044|P13|Overall Study|Subject Decision|0
1590623|NCT02431260|5533045|P12|Overall Study|Subject Decision|1
1590624|NCT02431260|5533046|P11|Overall Study|Subject Decision|0
1590625|NCT02431260|5533047|P10|Overall Study|Subject Decision|1
1590626|NCT02431260|5533048|P9|Overall Study|Subject Decision|1
1590627|NCT02431260|5533049|P8|Overall Study|Subject Decision|0
1590628|NCT02431260|5533050|P7|Overall Study|Subject Decision|0
1590629|NCT02431260|5533051|P6|Overall Study|Subject Decision|0
1590630|NCT02431260|5533052|P5|Overall Study|Subject Decision|0
1590631|NCT02431260|5533053|P4|Overall Study|Subject Decision|0
1590632|NCT02431260|5533054|P3|Overall Study|Subject Decision|1
1590633|NCT02431260|5533055|P2|Overall Study|Subject Decision|1
1590634|NCT02431260|5533056|P1|Overall Study|Subject Decision|0
1590635|NCT02431247|5533149|P2|Overall Study|Non-compliance with study drug|0
1590636|NCT02431247|5533150|P1|Overall Study|Non-compliance with study drug|1
1590637|NCT02431247|5533149|P2|Overall Study|Ongoing|336
1590638|NCT02431247|5533150|P1|Overall Study|Ongoing|339
1590639|NCT02431247|5533149|P2|Overall Study|Other|1
1590640|NCT02431247|5533150|P1|Overall Study|Other|2
1590641|NCT02431247|5533149|P2|Overall Study|Withdrawal by Subject|6
1590642|NCT02431247|5533150|P1|Overall Study|Withdrawal by Subject|4
1590643|NCT02431247|5533149|P2|Overall Study|Physician Decision|0
1590644|NCT02431247|5533150|P1|Overall Study|Physician Decision|3
1590645|NCT02431247|5533149|P2|Overall Study|Adverse Event|15
1590646|NCT02431247|5533150|P1|Overall Study|Adverse Event|8
1590647|NCT02431247|5533149|P2|Overall Study|Lost to Follow-up|5
1590648|NCT02431247|5533150|P1|Overall Study|Lost to Follow-up|5
1590649|NCT02430870|5533243|P8|Part 2|Other Reason Not Specified|1
1590650|NCT02430870|5533244|P7|Part 2|Other Reason Not Specified|0
1590651|NCT02430870|5533245|P6|Part 2|Other Reason Not Specified|0
1590652|NCT02430870|5533246|P5|Part 2|Other Reason Not Specified|0
1590653|NCT02430870|5533247|P4|Part 2|Other Reason Not Specified|0
1590654|NCT02430870|5533248|P3|Part 2|Other Reason Not Specified|0
1590655|NCT02430870|5533249|P2|Part 2|Other Reason Not Specified|0
1590656|NCT02430870|5533250|P1|Part 2|Other Reason Not Specified|0
1590657|NCT02430870|5533243|P8|Part 2|Voluntary Withdrawal|0
1590658|NCT02430870|5533244|P7|Part 2|Voluntary Withdrawal|1
1590659|NCT02430870|5533245|P6|Part 2|Voluntary Withdrawal|0
1590660|NCT02430870|5533246|P5|Part 2|Voluntary Withdrawal|0
1590661|NCT02430870|5533247|P4|Part 2|Voluntary Withdrawal|0
1590662|NCT02430870|5533248|P3|Part 2|Voluntary Withdrawal|0
1590663|NCT02430870|5533249|P2|Part 2|Voluntary Withdrawal|0
1590664|NCT02430870|5533250|P1|Part 2|Voluntary Withdrawal|0
1590665|NCT02430532|5533337|P2|Overall Study|Adverse Event|1
1590666|NCT02430532|5533338|P1|Overall Study|Adverse Event|0
1590667|NCT02430532|5533337|P2|Overall Study|Consent Withdrawn|2
1590668|NCT02430532|5533338|P1|Overall Study|Consent Withdrawn|0
1590669|NCT02430532|5533337|P2|Overall Study|Sponsor Decision to Stop Study Early|25
1590670|NCT02430532|5533338|P1|Overall Study|Sponsor Decision to Stop Study Early|30
1590671|NCT02430311|5533379|P2|Part B|Death|0
1590672|NCT02430311|5533380|P1|Part B|Death|1
1590673|NCT02430311|5533379|P2|Part B|Adverse Event|0
1590674|NCT02430311|5533380|P1|Part B|Adverse Event|1
1590675|NCT02430311|5533379|P2|Part B|Withdrawal by Subject|2
1590676|NCT02430311|5533380|P1|Part B|Withdrawal by Subject|2
1590677|NCT02430311|5533379|P2|Part B|Meet study-specific withdrawal criteria|6
1590678|NCT02430311|5533380|P1|Part B|Meet study-specific withdrawal criteria|6
1590679|NCT02430311|5533379|P2|Part A|Withdrawal by Subject|0
1590680|NCT02430311|5533380|P1|Part A|Withdrawal by Subject|1
1590681|NCT02430311|5533379|P2|Part A|Adverse Event|1
1590682|NCT02430311|5533380|P1|Part A|Adverse Event|0
1590683|NCT02429856|5533434|P2|Overall Study|Withdrawal by Subject|1
1590684|NCT02429856|5533435|P1|Overall Study|Withdrawal by Subject|1
1590685|NCT02429856|5533434|P2|Overall Study|Lost to Follow-up|5
1590686|NCT02429856|5533435|P1|Overall Study|Lost to Follow-up|6
1590687|NCT02429856|5533434|P2|Overall Study|Death|13
1590688|NCT02429856|5533435|P1|Overall Study|Death|12
1590689|NCT02429791|5533453|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
1590690|NCT02429791|5533454|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
1590691|NCT02429791|5533453|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1590692|NCT02429791|5533454|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1590693|NCT02429791|5533453|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
1590694|NCT02429791|5533454|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
1590695|NCT02429791|5533453|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
1590696|NCT02429791|5533454|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
1590697|NCT02429791|5533453|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
1590698|NCT02429791|5533454|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
1590699|NCT02429791|5533453|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
1590700|NCT02429791|5533454|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
1590701|NCT02429791|5533453|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
1590702|NCT02429791|5533454|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
1590703|NCT02429791|5533453|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
1590704|NCT02429791|5533454|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
1590705|NCT02429791|5533453|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
1590706|NCT02429791|5533454|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1590707|NCT02429791|5533453|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
1590708|NCT02429791|5533454|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
1590709|NCT02429791|5533453|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
1590710|NCT02429791|5533454|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
1590711|NCT02429791|5533453|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
1590712|NCT02429791|5533454|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
1590713|NCT02429778|5533542|P2|Overall Study|Withdrawal by Subject|0
1590714|NCT02429778|5533543|P1|Overall Study|Withdrawal by Subject|5
1590715|NCT02429778|5533542|P2|Overall Study|Lost to Follow-up|0
1590716|NCT02429778|5533543|P1|Overall Study|Lost to Follow-up|2
1590717|NCT02429310|5533557|P2|Overall Study|Protocol Violation|1
1590718|NCT02429310|5533558|P1|Overall Study|Protocol Violation|1
1590719|NCT02429310|5533557|P2|Overall Study|Lost to Follow-up|2
1590720|NCT02429310|5533558|P1|Overall Study|Lost to Follow-up|1
1590721|NCT02429258|5533568|P2|Overall Study|Protocol Violation|1
1590722|NCT02429258|5533569|P1|Overall Study|Protocol Violation|0
1590723|NCT02429258|5533568|P2|Overall Study|Withdrawal by Subject|0
1590724|NCT02429258|5533569|P1|Overall Study|Withdrawal by Subject|2
1590725|NCT02428699|5533623|P2|Washout Period 1|Screen Failure|2
1590726|NCT02428699|5533624|P1|Washout Period 1|Screen Failure|1
1590727|NCT02428608|5533652|P1|Overall Study|various|16
1590728|NCT02428608|5533652|P1|Overall Study|Death|1
1590729|NCT02428608|5533652|P1|Overall Study|moved away|10
1590730|NCT02428608|5533652|P1|Overall Study|scheduling conflicts|15
1590731|NCT02428608|5533652|P1|Overall Study|Withdrawal by Subject|2
1590732|NCT02428608|5533652|P1|Overall Study|Lost to Follow-up|37
1590733|NCT02428608|5533652|P1|Overall Study|Pregnancy|2
1590734|NCT02428413|5533684|P2|Overall Study|Nurse Refusal|0
1590735|NCT02428413|5533685|P1|Overall Study|Nurse Refusal|1
1590736|NCT02428413|5533684|P2|Overall Study|Missed Cases|2
1590737|NCT02428413|5533685|P1|Overall Study|Missed Cases|1
1590738|NCT02428413|5533684|P2|Overall Study|Case Cancelled|0
1590739|NCT02428413|5533685|P1|Overall Study|Case Cancelled|2
1590740|NCT02428413|5533684|P2|Overall Study|Protocol Violation|2
1590741|NCT02428413|5533685|P1|Overall Study|Protocol Violation|1
1590742|NCT02428413|5533684|P2|Overall Study|Device to measure WAG malfunctioned|5
1590743|NCT02428413|5533685|P1|Overall Study|Device to measure WAG malfunctioned|3
1590744|NCT02428296|5533720|P1|Overall Study|Withdrawal by Subject|2
1590745|NCT02428296|5533720|P1|Overall Study|Adverse Event|7
1590746|NCT02428231|5533732|P2|Overall Study|Adverse Event|0
1590747|NCT02428231|5533733|P1|Overall Study|Adverse Event|3
1590748|NCT02428231|5533732|P2|Overall Study|Required Symptomatic Therapy|1
1590749|NCT02428231|5533733|P1|Overall Study|Required Symptomatic Therapy|0
1590750|NCT02428231|5533732|P2|Overall Study|Other|16
1590751|NCT02428231|5533733|P1|Overall Study|Other|10
1590752|NCT02427984|5533750|P3|Overall Study|Lost to Follow-up|18
1590753|NCT02427984|5533751|P2|Overall Study|Lost to Follow-up|5
1590754|NCT02427984|5533752|P1|Overall Study|Lost to Follow-up|13
1590755|NCT02427958|5533766|P1|Overall Study|Lack of Efficacy|1
1590756|NCT02427958|5533766|P1|Overall Study|Withdrawal by Subject|14
1590757|NCT02427958|5533766|P1|Overall Study|Lost to Follow-up|6
1590758|NCT02427958|5533766|P1|Overall Study|Pretreatment Event (PTE) or AE|3
1590759|NCT02427646|5533859|P2|Overall Study|Bothersome hand weakness|4
1590760|NCT02427646|5533860|P1|Overall Study|Bothersome hand weakness|2
1590761|NCT02427646|5533859|P2|Overall Study|Protocol Violation|3
1590762|NCT02427646|5533860|P1|Overall Study|Protocol Violation|3
1590763|NCT02427646|5533859|P2|Overall Study|Physician Decision|4
1590764|NCT02427646|5533860|P1|Overall Study|Physician Decision|1
1590765|NCT02427646|5533859|P2|Overall Study|Lack of Efficacy|3
1590766|NCT02427646|5533860|P1|Overall Study|Lack of Efficacy|2
1590767|NCT02427607|5533868|P1|Overall Study|Withdrawal by Subject|1
1590768|NCT02427477|5533874|P2|Period 1|Adverse Event|0
1590769|NCT02427477|5533875|P1|Period 1|Adverse Event|1
1590770|NCT02427399|5533888|P5|Overall Study|Protocol Violation|15
1590771|NCT02427399|5533889|P4|Overall Study|Protocol Violation|18
1590772|NCT02427399|5533890|P3|Overall Study|Protocol Violation|12
1590773|NCT02427399|5533891|P2|Overall Study|Protocol Violation|16
1590774|NCT02427399|5533892|P1|Overall Study|Protocol Violation|14
1590775|NCT02427100|5533916|P2|Overall Study|Lost to Follow-up|2
1590776|NCT02427100|5533917|P1|Overall Study|Lost to Follow-up|0
1590777|NCT02426918|5533928|P3|Overall Study|Other|9
1590778|NCT02426918|5533929|P2|Overall Study|Other|11
1590779|NCT02426918|5533930|P1|Overall Study|Other|9
1590780|NCT02426918|5533928|P3|Overall Study|Withdrawal by Subject|4
1590781|NCT02426918|5533929|P2|Overall Study|Withdrawal by Subject|5
1590782|NCT02426918|5533930|P1|Overall Study|Withdrawal by Subject|5
1590783|NCT02426918|5533928|P3|Overall Study|Physician Decision|1
1590784|NCT02426918|5533929|P2|Overall Study|Physician Decision|1
1590785|NCT02426918|5533930|P1|Overall Study|Physician Decision|1
1590786|NCT02426918|5533928|P3|Overall Study|Adverse Event|0
1590787|NCT02426918|5533929|P2|Overall Study|Adverse Event|2
1590788|NCT02426918|5533930|P1|Overall Study|Adverse Event|2
1590789|NCT02426580|5533967|P2|Overall Study|Allergic to egg white|0
1590790|NCT02426580|5533968|P1|Overall Study|Allergic to egg white|1
1590791|NCT02426580|5533967|P2|Overall Study|Kidney transplant|0
1590792|NCT02426580|5533968|P1|Overall Study|Kidney transplant|3
1590793|NCT02426580|5533967|P2|Overall Study|transfer to hemodialysis|5
1590794|NCT02426580|5533968|P1|Overall Study|transfer to hemodialysis|5
1590795|NCT02426580|5533967|P2|Overall Study|Lost to Follow-up|9
1590796|NCT02426580|5533968|P1|Overall Study|Lost to Follow-up|0
1590797|NCT02426580|5533967|P2|Overall Study|Death|2
1590798|NCT02426580|5533968|P1|Overall Study|Death|2
1590799|NCT02426541|5533976|P2|Overall Study|Protocol Violation|0
1590800|NCT02426541|5533977|P1|Overall Study|Protocol Violation|1
1590801|NCT02426138|5533989|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
1590802|NCT02426138|5533990|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
1590803|NCT02426125|5534030|P2|Overall Study|Withdrawal by Subject|16
1590804|NCT02426125|5534031|P1|Overall Study|Withdrawal by Subject|16
1590805|NCT02426125|5534030|P2|Overall Study|Protocol Violation|0
1590806|NCT02426125|5534031|P1|Overall Study|Protocol Violation|1
1590807|NCT02426125|5534030|P2|Overall Study|Lost to Follow-up|10
1590808|NCT02426125|5534031|P1|Overall Study|Lost to Follow-up|12
1590809|NCT02425826|5534062|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
1590810|NCT02425826|5534063|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1590811|NCT02425826|5534064|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
1590812|NCT02425826|5534062|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
1590813|NCT02425826|5534063|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
1590814|NCT02425826|5534064|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
1590815|NCT02425826|5534062|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
1590816|NCT02425826|5534063|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
1590817|NCT02425826|5534064|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
1590818|NCT02425826|5534062|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
1590819|NCT02425826|5534063|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
1590820|NCT02425826|5534064|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
1590821|NCT02425826|5534062|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
1590822|NCT02425826|5534063|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
1590823|NCT02425826|5534064|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
1590824|NCT02425826|5534062|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
1590825|NCT02425826|5534063|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
1590826|NCT02425826|5534064|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
1590827|NCT02425826|5534062|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
1590828|NCT02425826|5534063|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
1590829|NCT02425826|5534064|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
1590830|NCT02425826|5534062|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
1590831|NCT02425826|5534063|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
1590832|NCT02425826|5534064|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
1590833|NCT02425826|5534062|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1590834|NCT02425826|5534063|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
1590835|NCT02425826|5534064|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
1590836|NCT02425826|5534062|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
1590837|NCT02425826|5534063|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
1590838|NCT02425826|5534064|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
1590839|NCT02425111|5534118|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
1590840|NCT02425111|5534118|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
1590841|NCT02425111|5534118|P1|Part A: Treatment Period|Lost to Follow-up|2
1590842|NCT02425111|5534118|P1|Part A: Treatment Period|Voluntary Withdrawal|4
1590843|NCT02425111|5534118|P1|Part A: Treatment Period|Lack of Efficacy|15
1590844|NCT02425111|5534118|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
1590845|NCT02425098|5534139|P2|Overall Study|Reason not Specified|1
1590846|NCT02425098|5534140|P1|Overall Study|Reason not Specified|0
1590847|NCT02425098|5534139|P2|Overall Study|Pregnancy|0
1590848|NCT02425098|5534140|P1|Overall Study|Pregnancy|2
1590849|NCT02425098|5534139|P2|Overall Study|Withdrawal by Subject|8
1590850|NCT02425098|5534140|P1|Overall Study|Withdrawal by Subject|4
1590851|NCT02425098|5534139|P2|Overall Study|Lost to Follow-up|7
1590852|NCT02425098|5534140|P1|Overall Study|Lost to Follow-up|7
1590853|NCT02424734|5534292|P3|Overall Study|Treatment stopped to be discharged home|0
1590854|NCT02424734|5534293|P2|Overall Study|Treatment stopped to be discharged home|2
1590855|NCT02424734|5534294|P1|Overall Study|Treatment stopped to be discharged home|2
1590856|NCT02424591|5534313|P2|Overall Study|Protocol Violation|3
1590857|NCT02424591|5534314|P1|Overall Study|Protocol Violation|2
1590858|NCT02424578|5534326|P2|Overall Study|Withdrawal by Subject|1
1590859|NCT02424578|5534327|P1|Overall Study|Withdrawal by Subject|0
1590860|NCT02424565|5534333|P2|Period 1 (D0)|Protocol Violation|1
1590861|NCT02424565|5534334|P1|Period 1 (D0)|Protocol Violation|0
1590862|NCT02424539|5534343|P3|Overall Study|Other: Reached stopping criteria|6
1590863|NCT02424539|5534344|P2|Overall Study|Other: Reached stopping criteria|7
1590864|NCT02424539|5534345|P1|Overall Study|Other: Reached stopping criteria|11
1590865|NCT02424539|5534343|P3|Overall Study|Withdrawal by Subject|0
1590866|NCT02424539|5534344|P2|Overall Study|Withdrawal by Subject|1
1590867|NCT02424539|5534345|P1|Overall Study|Withdrawal by Subject|3
1590868|NCT02424539|5534343|P3|Overall Study|Physician Decision|1
1590869|NCT02424539|5534344|P2|Overall Study|Physician Decision|0
1590870|NCT02424539|5534345|P1|Overall Study|Physician Decision|0
1590871|NCT02424539|5534343|P3|Overall Study|Adverse Event|1
1590872|NCT02424539|5534344|P2|Overall Study|Adverse Event|0
1590873|NCT02424539|5534345|P1|Overall Study|Adverse Event|0
1590874|NCT02424344|5534420|P2|Overall Study|Adverse Event|8
1590875|NCT02424344|5534421|P1|Overall Study|Adverse Event|4
1590876|NCT02424344|5534420|P2|Overall Study|Lost to Follow-up|0
1590877|NCT02424344|5534421|P1|Overall Study|Lost to Follow-up|1
1590878|NCT02424344|5534420|P2|Overall Study|Withdrawal by Subject|1
1590879|NCT02424344|5534421|P1|Overall Study|Withdrawal by Subject|2
1590880|NCT02424344|5534420|P2|Overall Study|Lack of Efficacy|1
1590881|NCT02424344|5534421|P1|Overall Study|Lack of Efficacy|0
1590882|NCT02424149|5534439|P2|Overall Study|Withdrawal by Subject|1
1590883|NCT02424149|5534440|P1|Overall Study|Withdrawal by Subject|0
1590884|NCT02424149|5534439|P2|Overall Study|surgery cancelled|0
1590885|NCT02424149|5534440|P1|Overall Study|surgery cancelled|2
1590886|NCT02424097|5534456|P2|Overall Study|Lost to Follow-up|2
1590887|NCT02424097|5534457|P1|Overall Study|Lost to Follow-up|1
1590888|NCT02423798|5534512|P1|Overall Study|Withdrawal by Subject|3
1590889|NCT02423291|5534578|P1|Overall Study|Adverse Event|1
1590890|NCT02423291|5534578|P1|Overall Study|Lack of Efficacy|14
1590891|NCT02423109|5534608|P2|Lens 1|Adverse Event|0
1590892|NCT02423109|5534609|P1|Lens 1|Adverse Event|1
1590921|NCT02422615|5534731|P2|Overall Study|Technical problems|1
1590922|NCT02422615|5534732|P1|Overall Study|Technical problems|0
1590923|NCT02422615|5534731|P2|Overall Study|Protocol Violation|1
1590924|NCT02422615|5534732|P1|Overall Study|Protocol Violation|1
1590925|NCT02422615|5534731|P2|Overall Study|Death|0
1590926|NCT02422615|5534732|P1|Overall Study|Death|2
1590927|NCT02422615|5534731|P2|Overall Study|Subject/guardian decision|5
1590928|NCT02422615|5534732|P1|Overall Study|Subject/guardian decision|21
1590929|NCT02422615|5534731|P2|Overall Study|Physician Decision|7
1590930|NCT02422615|5534732|P1|Overall Study|Physician Decision|22
1590931|NCT02422615|5534731|P2|Overall Study|Adverse Event|10
1590932|NCT02422615|5534732|P1|Overall Study|Adverse Event|41
1590933|NCT02422615|5534731|P2|Overall Study|Progressive disease|142
1590934|NCT02422615|5534732|P1|Overall Study|Progressive disease|193
1590935|NCT02422303|5534749|P2|Overall Study|Lost to Follow-up|1
1590936|NCT02422303|5534750|P1|Overall Study|Lost to Follow-up|1
1590937|NCT02422264|5534758|P2|Overall Study|Subject vaccinated outside of the study|1
1590938|NCT02422264|5534759|P1|Overall Study|Subject vaccinated outside of the study|0
1590939|NCT02422264|5534758|P2|Overall Study|Migrated/moved from study area|1
1590940|NCT02422264|5534759|P1|Overall Study|Migrated/moved from study area|3
1590941|NCT02422264|5534758|P2|Overall Study|Withdrawal by Subject|2
1590942|NCT02422264|5534759|P1|Overall Study|Withdrawal by Subject|1
1590943|NCT02422264|5534758|P2|Overall Study|Serious Adverse Event|0
1590944|NCT02422264|5534759|P1|Overall Study|Serious Adverse Event|1
1590945|NCT02422186|5534805|P2|Follow-up Phase (2 Weeks)|Other|0
1590946|NCT02422186|5534806|P1|Follow-up Phase (2 Weeks)|Other|3
1590947|NCT02422186|5534805|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
1590948|NCT02422186|5534806|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
1590949|NCT02422186|5534805|P2|Double-blind Induction Phase (4 Weeks)|Other|0
1590950|NCT02422186|5534806|P1|Double-blind Induction Phase (4 Weeks)|Other|1
1590951|NCT02422186|5534805|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
1590952|NCT02422186|5534806|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
1590953|NCT02422186|5534805|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
1590954|NCT02422186|5534806|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
1590955|NCT02422186|5534805|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
1590956|NCT02422186|5534806|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
1590957|NCT02422186|5534805|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
1590958|NCT02422186|5534806|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
1590959|NCT02422186|5534805|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
1590960|NCT02422186|5534806|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
1590961|NCT02421939|5534830|P2|Overall Study|Protocol deviation|1
1590962|NCT02421939|5534831|P1|Overall Study|Protocol deviation|1
1590963|NCT02421939|5534830|P2|Overall Study|Miscellaneous|5
1590964|NCT02421939|5534831|P1|Overall Study|Miscellaneous|4
1590965|NCT02421939|5534830|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
1590966|NCT02421939|5534831|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
1590967|NCT02421939|5534830|P2|Overall Study|Physician Decision|11
1590968|NCT02421939|5534831|P1|Overall Study|Physician Decision|11
1590969|NCT02421939|5534830|P2|Overall Study|Withdrawal by Subject|24
1590970|NCT02421939|5534831|P1|Overall Study|Withdrawal by Subject|5
1590971|NCT02421939|5534830|P2|Overall Study|Adverse Event|5
1590972|NCT02421939|5534831|P1|Overall Study|Adverse Event|28
1590973|NCT02421939|5534830|P2|Overall Study|Disease relapse|2
1590974|NCT02421939|5534831|P1|Overall Study|Disease relapse|33
1590975|NCT02421939|5534830|P2|Overall Study|Death|10
1590976|NCT02421939|5534831|P1|Overall Study|Death|36
1590977|NCT02421939|5534830|P2|Overall Study|Lack of Efficacy|31
1590978|NCT02421939|5534831|P1|Overall Study|Lack of Efficacy|21
1590979|NCT02421939|5534830|P2|Overall Study|Progressive disease|16
1590980|NCT02421939|5534831|P1|Overall Study|Progressive disease|70
1590981|NCT02421887|5534859|P2|Overall Study|Adverse Event|0
1590982|NCT02421887|5534860|P1|Overall Study|Adverse Event|2
1590983|NCT02421887|5534859|P2|Overall Study|Physician Decision|4
1590984|NCT02421887|5534860|P1|Overall Study|Physician Decision|2
1590985|NCT02421887|5534859|P2|Overall Study|Withdrawal by Subject|5
1590986|NCT02421887|5534860|P1|Overall Study|Withdrawal by Subject|8
1590987|NCT02421887|5534859|P2|Overall Study|Lost to Follow-up|0
1590988|NCT02421887|5534860|P1|Overall Study|Lost to Follow-up|5
1590989|NCT02421510|5534887|P3|Overall Study|Lost to Follow-up|0
1590990|NCT02421510|5534888|P2|Overall Study|Lost to Follow-up|1
1590991|NCT02421510|5534889|P1|Overall Study|Lost to Follow-up|1
1590992|NCT02421510|5534887|P3|Overall Study|Withdrawal by Subject|12
1590993|NCT02421510|5534888|P2|Overall Study|Withdrawal by Subject|18
1590994|NCT02421510|5534889|P1|Overall Study|Withdrawal by Subject|14
1590995|NCT02421510|5534887|P3|Overall Study|Pregnancy|0
1590996|NCT02421510|5534888|P2|Overall Study|Pregnancy|1
1590997|NCT02421510|5534889|P1|Overall Study|Pregnancy|1
1590998|NCT02421510|5534887|P3|Overall Study|Adverse Event|18
1590999|NCT02421510|5534888|P2|Overall Study|Adverse Event|10
1591000|NCT02421510|5534889|P1|Overall Study|Adverse Event|9
1591001|NCT02421510|5534887|P3|Overall Study|Physician Decision|3
1591002|NCT02421510|5534888|P2|Overall Study|Physician Decision|1
1591003|NCT02421510|5534889|P1|Overall Study|Physician Decision|1
1591004|NCT02421510|5534887|P3|Overall Study|Noncompliance with study drug|0
1591005|NCT02421510|5534888|P2|Overall Study|Noncompliance with study drug|0
1591006|NCT02421510|5534889|P1|Overall Study|Noncompliance with study drug|1
1591007|NCT02421510|5534887|P3|Overall Study|Death|0
1591008|NCT02421510|5534888|P2|Overall Study|Death|0
1591009|NCT02421510|5534889|P1|Overall Study|Death|1
1591010|NCT02421510|5534887|P3|Overall Study|Protocol Violation|0
1591011|NCT02421510|5534888|P2|Overall Study|Protocol Violation|2
1591012|NCT02421510|5534889|P1|Overall Study|Protocol Violation|1
1591013|NCT02421510|5534887|P3|Overall Study|Other|3
1591014|NCT02421510|5534888|P2|Overall Study|Other|2
1591015|NCT02421510|5534889|P1|Overall Study|Other|4
1591016|NCT02421419|5534921|P3|Overall Study|Physician Decision|1
1591017|NCT02421419|5534922|P2|Overall Study|Physician Decision|0
1591018|NCT02421419|5534923|P1|Overall Study|Physician Decision|0
1591019|NCT02421172|5534993|P5|Period 2|Patient/guardian decision|1
1591020|NCT02421172|5534994|P4|Period 2|Patient/guardian decision|2
1591021|NCT02421172|5534995|P3|Period 2|Patient/guardian decision|3
1591022|NCT02421172|5534996|P2|Period 2|Patient/guardian decision|0
1591023|NCT02421172|5534997|P1|Period 2|Patient/guardian decision|0
1591024|NCT02421172|5534993|P5|Period 2|Lost to Follow-up|0
1591025|NCT02421172|5534994|P4|Period 2|Lost to Follow-up|1
1591026|NCT02421172|5534995|P3|Period 2|Lost to Follow-up|0
1591027|NCT02421172|5534996|P2|Period 2|Lost to Follow-up|0
1591028|NCT02421172|5534997|P1|Period 2|Lost to Follow-up|0
1591029|NCT02421172|5534993|P5|Period 2|Adverse Event|0
1591030|NCT02421172|5534994|P4|Period 2|Adverse Event|0
1591031|NCT02421172|5534995|P3|Period 2|Adverse Event|4
1591032|NCT02421172|5534996|P2|Period 2|Adverse Event|0
1591033|NCT02421172|5534997|P1|Period 2|Adverse Event|0
1591034|NCT02421172|5534993|P5|Period 1|Patient/guardian decision|0
1591035|NCT02421172|5534994|P4|Period 1|Patient/guardian decision|0
1591036|NCT02421172|5534995|P3|Period 1|Patient/guardian decision|0
1591037|NCT02421172|5534996|P2|Period 1|Patient/guardian decision|1
1591038|NCT02421172|5534997|P1|Period 1|Patient/guardian decision|0
1591039|NCT02421172|5534993|P5|Period 1|Lost to Follow-up|0
1591040|NCT02421172|5534994|P4|Period 1|Lost to Follow-up|0
1591041|NCT02421172|5534995|P3|Period 1|Lost to Follow-up|0
1591042|NCT02421172|5534996|P2|Period 1|Lost to Follow-up|1
1591043|NCT02421172|5534997|P1|Period 1|Lost to Follow-up|3
1591044|NCT02421172|5534993|P5|Period 1|Adverse Event|0
1591045|NCT02421172|5534994|P4|Period 1|Adverse Event|0
1591046|NCT02421172|5534995|P3|Period 1|Adverse Event|0
1591047|NCT02421172|5534996|P2|Period 1|Adverse Event|0
1591048|NCT02421172|5534997|P1|Period 1|Adverse Event|1
1591049|NCT02421120|5535041|P1|Overall Study|Adverse Event|1
1591050|NCT02420821|5535083|P2|Overall Study|Death|116
1591051|NCT02420821|5535084|P1|Overall Study|Death|129
1591052|NCT02420821|5535083|P2|Overall Study|Withdrawal by Subject|17
1591053|NCT02420821|5535084|P1|Overall Study|Withdrawal by Subject|31
1591054|NCT02420821|5535083|P2|Overall Study|Physician Decision|2
1591055|NCT02420821|5535084|P1|Overall Study|Physician Decision|5
1591056|NCT02420821|5535083|P2|Overall Study|Non-compliance|2
1591057|NCT02420821|5535084|P1|Overall Study|Non-compliance|1
1591058|NCT02420821|5535083|P2|Overall Study|Lost to Follow-up|0
1591059|NCT02420821|5535084|P1|Overall Study|Lost to Follow-up|2
1591060|NCT02420353|5535154|P2|Overall Study|Withdrawal by Subject|1
1591061|NCT02420353|5535155|P1|Overall Study|Withdrawal by Subject|0
1591062|NCT02420327|5535247|P1|Overall Study|Protocol Violation|1
1591063|NCT02420327|5535247|P1|Overall Study|Lost to Follow-up|1
1591064|NCT02420327|5535247|P1|Overall Study|Withdrawal by Subject|6
1591065|NCT02420327|5535247|P1|Overall Study|Pregnancy|1
1591066|NCT02420327|5535247|P1|Overall Study|Adverse Event|7
1591067|NCT02420262|5535283|P2|Overall Study|Unclassified|1
1591068|NCT02420262|5535284|P1|Overall Study|Unclassified|0
1591069|NCT02420262|5535283|P2|Overall Study|Withdrawal by Subject|4
1591070|NCT02420262|5535284|P1|Overall Study|Withdrawal by Subject|1
1591071|NCT02420262|5535283|P2|Overall Study|Adverse Event|0
1591072|NCT02420262|5535284|P1|Overall Study|Adverse Event|1
1591073|NCT02420093|5535310|P2|Overall Study|Withdrawal by Subject|1
1591074|NCT02420093|5535311|P1|Overall Study|Withdrawal by Subject|1
1591075|NCT02419937|5535373|P2|Overall Study|Lost to Follow-up|0
1591076|NCT02419937|5535374|P1|Overall Study|Lost to Follow-up|1
1591077|NCT02419755|5535382|P2|Overall Study|Withdrawal by Subject|0
1591078|NCT02419755|5535383|P1|Overall Study|Withdrawal by Subject|1
1591079|NCT02419755|5535382|P2|Overall Study|Ineligible|0
1591080|NCT02419755|5535383|P1|Overall Study|Ineligible|1
1591081|NCT02419755|5535382|P2|Overall Study|Relapse|1
1591082|NCT02419755|5535383|P1|Overall Study|Relapse|0
1591083|NCT02419755|5535382|P2|Overall Study|Death|3
1591084|NCT02419755|5535383|P1|Overall Study|Death|1
1591085|NCT02419612|5535409|P2|Overall Study|Subject moved out of state|1
1591086|NCT02419612|5535410|P1|Overall Study|Subject moved out of state|0
1591087|NCT02419612|5535409|P2|Overall Study|Worsening of liver function|1
1591088|NCT02419612|5535410|P1|Overall Study|Worsening of liver function|0
1591089|NCT02419612|5535409|P2|Overall Study|Noncompliance With Study Drug|2
1591090|NCT02419612|5535410|P1|Overall Study|Noncompliance With Study Drug|0
1591091|NCT02419612|5535409|P2|Overall Study|Subject Request To Discontinue Treatment|1
1591092|NCT02419612|5535410|P1|Overall Study|Subject Request To Discontinue Treatment|1
1591093|NCT02419612|5535409|P2|Overall Study|Withdrawal by Subject|9
1591094|NCT02419612|5535410|P1|Overall Study|Withdrawal by Subject|9
1591095|NCT02419612|5535409|P2|Overall Study|Lost to Follow-up|6
1591096|NCT02419612|5535410|P1|Overall Study|Lost to Follow-up|6
1591097|NCT02419612|5535409|P2|Overall Study|Death|2
1591098|NCT02419612|5535410|P1|Overall Study|Death|0
1591099|NCT02419612|5535409|P2|Overall Study|Adverse Event|1
1591100|NCT02419612|5535410|P1|Overall Study|Adverse Event|1
1591101|NCT02419573|5535426|P2|Overall Study|Withdrawal by Subject|0
1591102|NCT02419573|5535427|P1|Overall Study|Withdrawal by Subject|1
1591103|NCT02419573|5535426|P2|Overall Study|Lost to Follow-up|0
1591104|NCT02419573|5535427|P1|Overall Study|Lost to Follow-up|3
1591105|NCT02419508|5535457|P2|Overall Study|Other - Reason not specified|1
1591106|NCT02419508|5535458|P1|Overall Study|Other - Reason not specified|0
1591107|NCT02419508|5535457|P2|Overall Study|Withdrawal by Subject|0
1591108|NCT02419508|5535458|P1|Overall Study|Withdrawal by Subject|1
1591109|NCT02419508|5535457|P2|Overall Study|Adverse Event|3
1591110|NCT02419508|5535458|P1|Overall Study|Adverse Event|9
1591111|NCT02419469|5535476|P1|Overall Study|Withdrawal by Subject|1
1591112|NCT02419313|5535480|P2|Second Intervention|Lost to Follow-up|0
1591113|NCT02419313|5535481|P1|Second Intervention|Lost to Follow-up|1
1591114|NCT02419313|5535480|P2|First Intervention|Lost to Follow-up|0
1591115|NCT02419313|5535481|P1|First Intervention|Lost to Follow-up|2
1591116|NCT02419001|5535493|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
1591117|NCT02419001|5535494|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
1591118|NCT02418910|5535504|P1|Overall Study|Withdrawal by Subject|4
1591119|NCT02418910|5535504|P1|Overall Study|Lost to Follow-up|3
1591120|NCT02418819|5535512|P4|Overall Study|No longer willing to participate|1
1591121|NCT02418819|5535513|P3|Overall Study|No longer willing to participate|2
1591122|NCT02418819|5535514|P2|Overall Study|No longer willing to participate|0
1591123|NCT02418819|5535515|P1|Overall Study|No longer willing to participate|0
1591124|NCT02418819|5535512|P4|Overall Study|No longer meets eligibility criteria|0
1591125|NCT02418819|5535513|P3|Overall Study|No longer meets eligibility criteria|1
1591126|NCT02418819|5535514|P2|Overall Study|No longer meets eligibility criteria|0
1591127|NCT02418819|5535515|P1|Overall Study|No longer meets eligibility criteria|0
1591128|NCT02418819|5535512|P4|Overall Study|Lost to Follow-up|0
1591129|NCT02418819|5535513|P3|Overall Study|Lost to Follow-up|0
1591130|NCT02418819|5535514|P2|Overall Study|Lost to Follow-up|0
1591131|NCT02418819|5535515|P1|Overall Study|Lost to Follow-up|1
1591132|NCT02418819|5535512|P4|Overall Study|Adverse Event|0
1591133|NCT02418819|5535513|P3|Overall Study|Adverse Event|1
1591134|NCT02418819|5535514|P2|Overall Study|Adverse Event|0
1591135|NCT02418819|5535515|P1|Overall Study|Adverse Event|0
1591136|NCT02418585|5535573|P2|Follow-up Phase (24 Weeks)|Other|2
1591137|NCT02418585|5535574|P1|Follow-up Phase (24 Weeks)|Other|3
1591138|NCT02418585|5535573|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
1591139|NCT02418585|5535574|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
1591140|NCT02418585|5535573|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
1591141|NCT02418585|5535574|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
1591142|NCT02418585|5535573|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
1591143|NCT02418585|5535574|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
1591144|NCT02418585|5535573|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
1591145|NCT02418585|5535574|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
1591146|NCT02418585|5535573|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
1591147|NCT02418585|5535574|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
1591148|NCT02418585|5535573|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
1591149|NCT02418585|5535574|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
1591150|NCT02418585|5535573|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
1591151|NCT02418585|5535574|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
1591152|NCT02418585|5535573|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
1591153|NCT02418585|5535574|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
1591154|NCT02418585|5535573|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
1591155|NCT02418585|5535574|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
1591156|NCT02418468|5535614|P2|Overall Study|Withdrawal of informed consent|1
1591157|NCT02418468|5535615|P1|Overall Study|Withdrawal of informed consent|1
1591158|NCT02418468|5535614|P2|Overall Study|Adverse Event|0
1591159|NCT02418468|5535615|P1|Overall Study|Adverse Event|1
1591160|NCT02418455|5535621|P1|Continuation Period|Sponsor Decision|7
1591161|NCT02418455|5535621|P1|48-Week Treatment Period|Other- Not Specified|1
1591166|NCT02418156|5535677|P1|Overall Study|Subject refused to return|1
1591167|NCT02418156|5535677|P1|Overall Study|Withdrawal by Subject|1
1591168|NCT02418156|5535677|P1|Overall Study|Physician Decision|1
1591169|NCT02418156|5535677|P1|Overall Study|Death|2
1591170|NCT02418156|5535677|P1|Overall Study|Lost to Follow-up|12
1591171|NCT02418000|5535719|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
1591172|NCT02418000|5535720|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591173|NCT02418000|5535721|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591174|NCT02418000|5535722|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591175|NCT02418000|5535723|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591176|NCT02418000|5535719|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
1591177|NCT02418000|5535720|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1591178|NCT02418000|5535721|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1591179|NCT02418000|5535722|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1591180|NCT02418000|5535723|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
1591181|NCT02418000|5535719|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591182|NCT02418000|5535720|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
1591183|NCT02418000|5535721|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591184|NCT02418000|5535722|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591185|NCT02418000|5535723|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591186|NCT02418000|5535719|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591187|NCT02418000|5535720|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591188|NCT02418000|5535721|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
1591189|NCT02418000|5535722|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591190|NCT02418000|5535723|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
1591191|NCT02418000|5535719|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1591192|NCT02418000|5535720|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1591193|NCT02418000|5535721|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1591194|NCT02418000|5535722|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
1591195|NCT02418000|5535723|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
1591196|NCT02418000|5535719|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1591197|NCT02418000|5535720|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1591198|NCT02418000|5535721|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1591199|NCT02418000|5535722|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
1591200|NCT02418000|5535723|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
1591201|NCT02418000|5535719|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1591202|NCT02418000|5535720|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1591203|NCT02418000|5535721|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1591204|NCT02418000|5535722|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
1591205|NCT02418000|5535723|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
1591206|NCT02418000|5535719|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1591207|NCT02418000|5535720|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1591208|NCT02418000|5535721|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1591209|NCT02418000|5535722|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
1591210|NCT02418000|5535723|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
1591211|NCT02418000|5535719|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1591212|NCT02418000|5535720|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1591213|NCT02418000|5535721|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1591214|NCT02418000|5535722|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
1591215|NCT02418000|5535723|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
1591216|NCT02417961|5535841|P1|Overall Study|Withdrawal by Subject|2
1591217|NCT02417961|5535841|P1|Overall Study|Lost to Follow-up|1
1591218|NCT02417961|5535841|P1|Overall Study|Adverse Event|1
1591219|NCT02417935|5535853|P2|Treatment Period|Physician Decision|1
1591220|NCT02417935|5535854|P1|Treatment Period|Physician Decision|3
1591221|NCT02417935|5535853|P2|Treatment Period|Withdrawal by Subject|3
1591222|NCT02417935|5535854|P1|Treatment Period|Withdrawal by Subject|3
1591223|NCT02417935|5535853|P2|Treatment Period|Protocol Violation|1
1591224|NCT02417935|5535854|P1|Treatment Period|Protocol Violation|2
1591225|NCT02417935|5535853|P2|Treatment Period|Entry Criteria not met|1
1591226|NCT02417935|5535854|P1|Treatment Period|Entry Criteria not met|0
1591227|NCT02417935|5535853|P2|Treatment Period|Lost to Follow-up|0
1591228|NCT02417935|5535854|P1|Treatment Period|Lost to Follow-up|1
1591229|NCT02417935|5535853|P2|Treatment Period|Adverse Event|10
1591230|NCT02417935|5535854|P1|Treatment Period|Adverse Event|12
1591231|NCT02417753|5535878|P1|Overall Study|Death|1
1591232|NCT02417441|5535898|P2|Overall Study|Inconclusive due to missing data|19
1591233|NCT02417441|5535899|P1|Overall Study|Inconclusive due to missing data|52
1591234|NCT02417246|5535967|P2|Phase 2 1st Generic Administered|Physician Decision|0
1591235|NCT02417246|5535968|P1|Phase 2 1st Generic Administered|Physician Decision|1
1591236|NCT02417246|5535967|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
1591237|NCT02417246|5535968|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
1591238|NCT02417246|5535967|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
1591239|NCT02417246|5535968|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
1591240|NCT02417246|5535967|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
1591241|NCT02417246|5535968|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
1591242|NCT02417233|5535991|P3|Overall Study|Mentally unstable|0
1591243|NCT02417233|5535992|P2|Overall Study|Mentally unstable|1
1591244|NCT02417233|5535993|P1|Overall Study|Mentally unstable|0
1591245|NCT02417233|5535991|P3|Overall Study|Relocation out of study area|1
1591246|NCT02417233|5535992|P2|Overall Study|Relocation out of study area|0
1591247|NCT02417233|5535993|P1|Overall Study|Relocation out of study area|1
1591248|NCT02417233|5535991|P3|Overall Study|Withdrawal by Subject|8
1591249|NCT02417233|5535992|P2|Overall Study|Withdrawal by Subject|1
1591250|NCT02417233|5535993|P1|Overall Study|Withdrawal by Subject|2
1591251|NCT02417233|5535991|P3|Overall Study|Protocol Violation|2
1591252|NCT02417233|5535992|P2|Overall Study|Protocol Violation|0
1591253|NCT02417233|5535993|P1|Overall Study|Protocol Violation|2
1591254|NCT02417233|5535991|P3|Overall Study|Lost to Follow-up|34
1591255|NCT02417233|5535992|P2|Overall Study|Lost to Follow-up|39
1591256|NCT02417233|5535993|P1|Overall Study|Lost to Follow-up|27
1591257|NCT02417233|5535991|P3|Overall Study|Death|14
1591258|NCT02417233|5535992|P2|Overall Study|Death|10
1591259|NCT02417233|5535993|P1|Overall Study|Death|4
1591260|NCT02417064|5536030|P3|Follow-up Phase (24 Weeks)|Other|3
1591261|NCT02417064|5536031|P2|Follow-up Phase (24 Weeks)|Other|2
1591262|NCT02417064|5536032|P1|Follow-up Phase (24 Weeks)|Other|2
1591263|NCT02417064|5536030|P3|Follow-up Phase (24 Weeks)|PI Decision|44
1591264|NCT02417064|5536031|P2|Follow-up Phase (24 Weeks)|PI Decision|29
1591265|NCT02417064|5536032|P1|Follow-up Phase (24 Weeks)|PI Decision|34
1591266|NCT02417064|5536030|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
1591267|NCT02417064|5536031|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
1591268|NCT02417064|5536032|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
1591269|NCT02417064|5536030|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
1591270|NCT02417064|5536031|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
1591271|NCT02417064|5536032|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
1591272|NCT02417064|5536030|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
1591273|NCT02417064|5536031|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
1591274|NCT02417064|5536032|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
1591275|NCT02417064|5536030|P3|Double-blind Induction Phase (4 Weeks)|Other|2
1591276|NCT02417064|5536031|P2|Double-blind Induction Phase (4 Weeks)|Other|4
1591277|NCT02417064|5536032|P1|Double-blind Induction Phase (4 Weeks)|Other|1
1591278|NCT02417064|5536030|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
1591279|NCT02417064|5536031|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
1591280|NCT02417064|5536032|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
1591281|NCT02417064|5536030|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
1591282|NCT02417064|5536031|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
1591283|NCT02417064|5536032|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
1591284|NCT02417064|5536030|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
1591285|NCT02417064|5536031|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
1591286|NCT02417064|5536032|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
1591287|NCT02417064|5536030|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
1591288|NCT02417064|5536031|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
1591289|NCT02417064|5536032|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
1591290|NCT02417064|5536030|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
1591291|NCT02417064|5536031|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
1591292|NCT02417064|5536032|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
1591293|NCT02416934|5536103|P2|Overall Study|re-operation|0
1591294|NCT02416934|5536104|P1|Overall Study|re-operation|1
1591295|NCT02416934|5536103|P2|Overall Study|surgery started late|1
1591296|NCT02416934|5536104|P1|Overall Study|surgery started late|0
1591297|NCT02416934|5536103|P2|Overall Study|Protocol Violation|1
1591298|NCT02416934|5536104|P1|Overall Study|Protocol Violation|0
1591299|NCT02416934|5536103|P2|Overall Study|recruited during continuing renewal proc|1
1591300|NCT02416934|5536104|P1|Overall Study|recruited during continuing renewal proc|0
1591301|NCT02416934|5536103|P2|Overall Study|Withdrawal by Subject|0
1591302|NCT02416934|5536104|P1|Overall Study|Withdrawal by Subject|1
1591303|NCT02416934|5536103|P2|Overall Study|Lost to Follow-up|2
1591304|NCT02416934|5536104|P1|Overall Study|Lost to Follow-up|0
1591305|NCT02416934|5536103|P2|Overall Study|given steroids|2
1591306|NCT02416934|5536104|P1|Overall Study|given steroids|1
1591307|NCT02416180|5536133|P1|Overall Study|Withdrawal by Subject|1
1591308|NCT02415959|5536145|P5|Overall Study|Protocol Violation|0
1591309|NCT02415959|5536146|P4|Overall Study|Protocol Violation|1
1591310|NCT02415959|5536147|P3|Overall Study|Protocol Violation|0
1591311|NCT02415959|5536148|P2|Overall Study|Protocol Violation|0
1591312|NCT02415959|5536149|P1|Overall Study|Protocol Violation|0
1591313|NCT02415959|5536145|P5|Overall Study|Adverse Event|0
1591314|NCT02415959|5536146|P4|Overall Study|Adverse Event|0
1591315|NCT02415959|5536147|P3|Overall Study|Adverse Event|0
1591316|NCT02415959|5536148|P2|Overall Study|Adverse Event|1
1591317|NCT02415959|5536149|P1|Overall Study|Adverse Event|0
1591318|NCT02415595|5536578|P4|Overall Study|Other|0
1591319|NCT02415595|5536579|P3|Overall Study|Other|1
1591320|NCT02415595|5536580|P2|Overall Study|Other|1
1591321|NCT02415595|5536581|P1|Overall Study|Other|0
1591322|NCT02415595|5536578|P4|Overall Study|Withdrawal by Subject|3
1591323|NCT02415595|5536579|P3|Overall Study|Withdrawal by Subject|1
1591324|NCT02415595|5536580|P2|Overall Study|Withdrawal by Subject|0
1591325|NCT02415595|5536581|P1|Overall Study|Withdrawal by Subject|4
1591326|NCT02415595|5536578|P4|Overall Study|Reached stopping criteria|0
1591327|NCT02415595|5536579|P3|Overall Study|Reached stopping criteria|1
1591328|NCT02415595|5536580|P2|Overall Study|Reached stopping criteria|1
1591329|NCT02415595|5536581|P1|Overall Study|Reached stopping criteria|0
1591330|NCT02415595|5536578|P4|Overall Study|Poor/Non-compliance|0
1591331|NCT02415595|5536579|P3|Overall Study|Poor/Non-compliance|1
1591332|NCT02415595|5536580|P2|Overall Study|Poor/Non-compliance|0
1591333|NCT02415595|5536581|P1|Overall Study|Poor/Non-compliance|1
1591334|NCT02415595|5536578|P4|Overall Study|Lost to Follow-up|1
1591335|NCT02415595|5536579|P3|Overall Study|Lost to Follow-up|1
1591336|NCT02415595|5536580|P2|Overall Study|Lost to Follow-up|3
1591337|NCT02415595|5536581|P1|Overall Study|Lost to Follow-up|1
1591338|NCT02415595|5536578|P4|Overall Study|Lack of Efficacy|0
1591339|NCT02415595|5536579|P3|Overall Study|Lack of Efficacy|0
1591340|NCT02415595|5536580|P2|Overall Study|Lack of Efficacy|4
1591341|NCT02415595|5536581|P1|Overall Study|Lack of Efficacy|4
1591342|NCT02415595|5536578|P4|Overall Study|Adverse Event|10
1591343|NCT02415595|5536579|P3|Overall Study|Adverse Event|5
1591344|NCT02415595|5536580|P2|Overall Study|Adverse Event|3
1591345|NCT02415595|5536581|P1|Overall Study|Adverse Event|1
1591346|NCT02415595|5536578|P4|Overall Study|Administrative reason by sponsor|39
1591347|NCT02415595|5536579|P3|Overall Study|Administrative reason by sponsor|41
1591348|NCT02415595|5536580|P2|Overall Study|Administrative reason by sponsor|40
1591349|NCT02415595|5536581|P1|Overall Study|Administrative reason by sponsor|39
1591350|NCT02415400|5536723|P4|Overall Study|Site closure; participant won't transfer|1
1591351|NCT02415400|5536724|P3|Overall Study|Site closure; participant won't transfer|0
1591352|NCT02415400|5536725|P2|Overall Study|Site closure; participant won't transfer|0
1591353|NCT02415400|5536726|P1|Overall Study|Site closure; participant won't transfer|0
1591354|NCT02415400|5536723|P4|Overall Study|Investigator decision|1
1591355|NCT02415400|5536724|P3|Overall Study|Investigator decision|1
1591356|NCT02415400|5536725|P2|Overall Study|Investigator decision|0
1591357|NCT02415400|5536726|P1|Overall Study|Investigator decision|0
1591358|NCT02415400|5536723|P4|Overall Study|Participant in jail|0
1591359|NCT02415400|5536724|P3|Overall Study|Participant in jail|1
1591360|NCT02415400|5536725|P2|Overall Study|Participant in jail|0
1591361|NCT02415400|5536726|P1|Overall Study|Participant in jail|0
1591362|NCT02415400|5536723|P4|Overall Study|Poor treatment monitoring|0
1591363|NCT02415400|5536724|P3|Overall Study|Poor treatment monitoring|1
1591364|NCT02415400|5536725|P2|Overall Study|Poor treatment monitoring|0
1591365|NCT02415400|5536726|P1|Overall Study|Poor treatment monitoring|0
1591366|NCT02415400|5536723|P4|Overall Study|State regulations prevent participation|0
1591367|NCT02415400|5536724|P3|Overall Study|State regulations prevent participation|1
1591368|NCT02415400|5536725|P2|Overall Study|State regulations prevent participation|0
1591369|NCT02415400|5536726|P1|Overall Study|State regulations prevent participation|0
1591370|NCT02415400|5536723|P4|Overall Study|Coagulation values cannot be set|0
1591371|NCT02415400|5536724|P3|Overall Study|Coagulation values cannot be set|1
1591372|NCT02415400|5536725|P2|Overall Study|Coagulation values cannot be set|0
1591373|NCT02415400|5536726|P1|Overall Study|Coagulation values cannot be set|0
1591374|NCT02415400|5536723|P4|Overall Study|Stroke and stroke rehabilitation|0
1591375|NCT02415400|5536724|P3|Overall Study|Stroke and stroke rehabilitation|1
1591376|NCT02415400|5536725|P2|Overall Study|Stroke and stroke rehabilitation|0
1591377|NCT02415400|5536726|P1|Overall Study|Stroke and stroke rehabilitation|0
1591378|NCT02415400|5536723|P4|Overall Study|No study drug on site|0
1591379|NCT02415400|5536724|P3|Overall Study|No study drug on site|0
1591380|NCT02415400|5536725|P2|Overall Study|No study drug on site|1
1591381|NCT02415400|5536726|P1|Overall Study|No study drug on site|0
1591382|NCT02415400|5536723|P4|Overall Study|Randomized in error|0
1591383|NCT02415400|5536724|P3|Overall Study|Randomized in error|0
1591384|NCT02415400|5536725|P2|Overall Study|Randomized in error|0
1591385|NCT02415400|5536726|P1|Overall Study|Randomized in error|2
1591386|NCT02415400|5536723|P4|Overall Study|Participant wanted home visits|0
1591387|NCT02415400|5536724|P3|Overall Study|Participant wanted home visits|0
1591388|NCT02415400|5536725|P2|Overall Study|Participant wanted home visits|0
1591389|NCT02415400|5536726|P1|Overall Study|Participant wanted home visits|1
1591390|NCT02415400|5536723|P4|Overall Study|Participant doesn't answer phone|0
1591391|NCT02415400|5536724|P3|Overall Study|Participant doesn't answer phone|0
1591392|NCT02415400|5536725|P2|Overall Study|Participant doesn't answer phone|0
1591393|NCT02415400|5536726|P1|Overall Study|Participant doesn't answer phone|1
1591394|NCT02415400|5536723|P4|Overall Study|Participant no longer meets criteria|1
1591395|NCT02415400|5536724|P3|Overall Study|Participant no longer meets criteria|0
1591396|NCT02415400|5536725|P2|Overall Study|Participant no longer meets criteria|0
1591397|NCT02415400|5536726|P1|Overall Study|Participant no longer meets criteria|2
1591398|NCT02415400|5536723|P4|Overall Study|Poor/Non-Compliance|4
1591399|NCT02415400|5536724|P3|Overall Study|Poor/Non-Compliance|3
1591400|NCT02415400|5536725|P2|Overall Study|Poor/Non-Compliance|1
1591401|NCT02415400|5536726|P1|Overall Study|Poor/Non-Compliance|0
1591402|NCT02415400|5536723|P4|Overall Study|Lost to Follow-up|5
1591403|NCT02415400|5536724|P3|Overall Study|Lost to Follow-up|2
1591404|NCT02415400|5536725|P2|Overall Study|Lost to Follow-up|3
1591405|NCT02415400|5536726|P1|Overall Study|Lost to Follow-up|3
1591406|NCT02415400|5536723|P4|Overall Study|Death|42
1591407|NCT02415400|5536724|P3|Overall Study|Death|35
1591408|NCT02415400|5536725|P2|Overall Study|Death|41
1591409|NCT02415400|5536726|P1|Overall Study|Death|39
1591410|NCT02415400|5536723|P4|Overall Study|Participant withdrew consent|21
1591411|NCT02415400|5536724|P3|Overall Study|Participant withdrew consent|30
1591412|NCT02415400|5536725|P2|Overall Study|Participant withdrew consent|12
1591413|NCT02415400|5536726|P1|Overall Study|Participant withdrew consent|14
1591414|NCT02415400|5536723|P4|Overall Study|Participant request to stop therapy|6
1591415|NCT02415400|5536724|P3|Overall Study|Participant request to stop therapy|8
1591416|NCT02415400|5536725|P2|Overall Study|Participant request to stop therapy|3
1591417|NCT02415400|5536726|P1|Overall Study|Participant request to stop therapy|4
1591418|NCT02415400|5536723|P4|Overall Study|Adverse Event|2
1591419|NCT02415400|5536724|P3|Overall Study|Adverse Event|1
1591420|NCT02415400|5536725|P2|Overall Study|Adverse Event|1
1591421|NCT02415400|5536726|P1|Overall Study|Adverse Event|0
1591422|NCT02415127|5536794|P2|Overall Study|Adverse Event|0
1591423|NCT02415127|5536795|P1|Overall Study|Adverse Event|1
1591424|NCT02414958|5536812|P3|Overall Study|Other than specified|5
1591425|NCT02414958|5536813|P2|Overall Study|Other than specified|4
1591426|NCT02414958|5536814|P1|Overall Study|Other than specified|4
1591427|NCT02414958|5536812|P3|Overall Study|Withdrawal by Subject|5
1591428|NCT02414958|5536813|P2|Overall Study|Withdrawal by Subject|3
1591429|NCT02414958|5536814|P1|Overall Study|Withdrawal by Subject|5
1591430|NCT02414958|5536812|P3|Overall Study|Lost to Follow-up|0
1591431|NCT02414958|5536813|P2|Overall Study|Lost to Follow-up|4
1591432|NCT02414958|5536814|P1|Overall Study|Lost to Follow-up|7
1591433|NCT02414958|5536812|P3|Overall Study|Protocol Violation|1
1591434|NCT02414958|5536813|P2|Overall Study|Protocol Violation|3
1591435|NCT02414958|5536814|P1|Overall Study|Protocol Violation|10
1591436|NCT02414958|5536812|P3|Overall Study|Adverse Event|3
1591437|NCT02414958|5536813|P2|Overall Study|Adverse Event|6
1591438|NCT02414958|5536814|P1|Overall Study|Adverse Event|6
1591439|NCT02414854|5536847|P4|Overall Study|Other than specified above|37
1591440|NCT02414854|5536848|P3|Overall Study|Other than specified above|17
1591441|NCT02414854|5536849|P2|Overall Study|Other than specified above|37
1591442|NCT02414854|5536850|P1|Overall Study|Other than specified above|12
1591443|NCT02414854|5536847|P4|Overall Study|Poor compliance to protocol|2
1591444|NCT02414854|5536848|P3|Overall Study|Poor compliance to protocol|2
1591445|NCT02414854|5536849|P2|Overall Study|Poor compliance to protocol|1
1591446|NCT02414854|5536850|P1|Overall Study|Poor compliance to protocol|1
1591447|NCT02414854|5536847|P4|Overall Study|Adverse Event|12
1591448|NCT02414854|5536848|P3|Overall Study|Adverse Event|1
1591449|NCT02414854|5536849|P2|Overall Study|Adverse Event|7
1591450|NCT02414854|5536850|P1|Overall Study|Adverse Event|9
1591451|NCT02414841|5537014|P2|Overall Study|Randomized But Not Treated|4
1591452|NCT02414841|5537015|P1|Overall Study|Randomized But Not Treated|6
1591453|NCT02414841|5537014|P2|Overall Study|Received a Kidney Transplant|4
1591454|NCT02414841|5537015|P1|Overall Study|Received a Kidney Transplant|13
1591455|NCT02414841|5537014|P2|Overall Study|Death|14
1591456|NCT02414841|5537015|P1|Overall Study|Death|17
1591457|NCT02414841|5537014|P2|Overall Study|Lost to Follow-up|6
1591458|NCT02414841|5537015|P1|Overall Study|Lost to Follow-up|13
1591459|NCT02414841|5537014|P2|Overall Study|Withdrawal by Subject|5
1591460|NCT02414841|5537015|P1|Overall Study|Withdrawal by Subject|7
1591461|NCT02414828|5537027|P4|Overall Study|Lost to Follow-up|2
1591462|NCT02414828|5537028|P3|Overall Study|Lost to Follow-up|1
1591463|NCT02414828|5537029|P2|Overall Study|Lost to Follow-up|1
1591464|NCT02414828|5537030|P1|Overall Study|Lost to Follow-up|0
1591465|NCT02414152|5537123|P1|Overall Study|Lack of Efficacy|1
1591466|NCT02414152|5537123|P1|Overall Study|Withdrawal by Subject|1
1591467|NCT02413996|5537129|P2|Overall Study|not comfortable with the intervention|2
1591468|NCT02413996|5537130|P1|Overall Study|not comfortable with the intervention|9
1591469|NCT02413593|5537175|P1|Overall Study|Adverse Event|1
1591470|NCT02413593|5537175|P1|Overall Study|Lost to Follow-up|3
1591471|NCT02413489|5537187|P3|Overall Study|Study Terminated By Sponsor|1
1591472|NCT02413489|5537188|P2|Overall Study|Study Terminated By Sponsor|13
1591473|NCT02413489|5537189|P1|Overall Study|Study Terminated By Sponsor|2
1591474|NCT02413489|5537187|P3|Overall Study|Withdrawal by Subject|0
1591475|NCT02413489|5537188|P2|Overall Study|Withdrawal by Subject|0
1591476|NCT02413489|5537189|P1|Overall Study|Withdrawal by Subject|2
1591477|NCT02413489|5537187|P3|Overall Study|Death|4
1591478|NCT02413489|5537188|P2|Overall Study|Death|3
1591479|NCT02413489|5537189|P1|Overall Study|Death|11
1591480|NCT02413398|5537230|P2|Overall Study|Other Eligibility criteria|2
1591481|NCT02413398|5537231|P1|Overall Study|Other Eligibility criteria|1
1591482|NCT02413398|5537230|P2|Overall Study|Withdrawal by Subject|1
1591483|NCT02413398|5537231|P1|Overall Study|Withdrawal by Subject|1
1591484|NCT02413398|5537230|P2|Overall Study|Lost to Follow-up|4
1591485|NCT02413398|5537231|P1|Overall Study|Lost to Follow-up|2
1591486|NCT02413372|5537246|P3|Follow-up|Subject unable to return for visit|1
1591487|NCT02413372|5537247|P2|Follow-up|Subject unable to return for visit|0
1591488|NCT02413372|5537248|P1|Follow-up|Subject unable to return for visit|0
1591489|NCT02413372|5537246|P3|Follow-up|Subject Withdrew Consent|1
1591490|NCT02413372|5537247|P2|Follow-up|Subject Withdrew Consent|0
1591491|NCT02413372|5537248|P1|Follow-up|Subject Withdrew Consent|1
1591492|NCT02413372|5537246|P3|Follow-up|Lost to Follow-up|0
1591493|NCT02413372|5537247|P2|Follow-up|Lost to Follow-up|1
1591494|NCT02413372|5537248|P1|Follow-up|Lost to Follow-up|1
1591495|NCT02413372|5537246|P3|Treatment|Withdrawal by Subject|0
1591496|NCT02413372|5537247|P2|Treatment|Withdrawal by Subject|0
1591497|NCT02413372|5537248|P1|Treatment|Withdrawal by Subject|1
1591498|NCT02413372|5537246|P3|Treatment|Lost to Follow-up|1
1591499|NCT02413372|5537247|P2|Treatment|Lost to Follow-up|2
1591500|NCT02413372|5537248|P1|Treatment|Lost to Follow-up|0
1591501|NCT02413346|5537297|P2|Overall Study|Other Miscellaneous Reasons|3
1591502|NCT02413346|5537298|P1|Overall Study|Other Miscellaneous Reasons|4
1591503|NCT02413346|5537297|P2|Overall Study|Protocol Violation|0
1591504|NCT02413346|5537298|P1|Overall Study|Protocol Violation|2
1591505|NCT02413346|5537297|P2|Overall Study|Lost to Follow-up|21
1591506|NCT02413346|5537298|P1|Overall Study|Lost to Follow-up|17
1591507|NCT02413346|5537297|P2|Overall Study|Withdrawal by Subject|40
1591508|NCT02413346|5537298|P1|Overall Study|Withdrawal by Subject|30
1591509|NCT02413346|5537297|P2|Overall Study|Adverse Event|6
1591510|NCT02413346|5537298|P1|Overall Study|Adverse Event|6
1591511|NCT02413333|5537308|P2|Period 2|Protocol Deviation|0
1591512|NCT02413333|5537309|P1|Period 2|Protocol Deviation|1
1591513|NCT02413333|5537308|P2|Period 1|Reason Not Specified|1
1591514|NCT02413333|5537309|P1|Period 1|Reason Not Specified|0
1591515|NCT02413333|5537308|P2|Period 1|Adverse Event|0
1591516|NCT02413333|5537309|P1|Period 1|Adverse Event|1
1591517|NCT02413294|5537317|P1|Overall Study|Withdrawal by Subject|1
1591518|NCT02413255|5537352|P17|Overall Study|Voluntary Withdrawal|0
1591519|NCT02413255|5537353|P16|Overall Study|Voluntary Withdrawal|0
1591520|NCT02413255|5537354|P15|Overall Study|Voluntary Withdrawal|1
1591521|NCT02413255|5537355|P14|Overall Study|Voluntary Withdrawal|0
1591522|NCT02413255|5537356|P13|Overall Study|Voluntary Withdrawal|0
1591523|NCT02413255|5537357|P12|Overall Study|Voluntary Withdrawal|0
1591524|NCT02413255|5537358|P11|Overall Study|Voluntary Withdrawal|0
1591525|NCT02413255|5537359|P10|Overall Study|Voluntary Withdrawal|0
1591526|NCT02413255|5537360|P9|Overall Study|Voluntary Withdrawal|0
1591527|NCT02413255|5537361|P8|Overall Study|Voluntary Withdrawal|0
1591528|NCT02413255|5537362|P7|Overall Study|Voluntary Withdrawal|0
1591529|NCT02413255|5537363|P6|Overall Study|Voluntary Withdrawal|0
1591530|NCT02413255|5537364|P5|Overall Study|Voluntary Withdrawal|0
1591531|NCT02413255|5537365|P4|Overall Study|Voluntary Withdrawal|0
1591532|NCT02413255|5537366|P3|Overall Study|Voluntary Withdrawal|0
1591533|NCT02413255|5537367|P2|Overall Study|Voluntary Withdrawal|0
1591534|NCT02413255|5537368|P1|Overall Study|Voluntary Withdrawal|0
1591535|NCT02413229|5537724|P8|Overall Study|Progressive Disease|1
1591536|NCT02413229|5537725|P7|Overall Study|Progressive Disease|0
1591537|NCT02413229|5537726|P6|Overall Study|Progressive Disease|0
1591538|NCT02413229|5537727|P5|Overall Study|Progressive Disease|0
1591539|NCT02413229|5537728|P4|Overall Study|Progressive Disease|0
1591540|NCT02413229|5537729|P3|Overall Study|Progressive Disease|0
1591541|NCT02413229|5537730|P2|Overall Study|Progressive Disease|0
1591542|NCT02413229|5537731|P1|Overall Study|Progressive Disease|0
1591543|NCT02413229|5537724|P8|Overall Study|Withdrawal by Subject|2
1591544|NCT02413229|5537725|P7|Overall Study|Withdrawal by Subject|0
1591545|NCT02413229|5537726|P6|Overall Study|Withdrawal by Subject|0
1591546|NCT02413229|5537727|P5|Overall Study|Withdrawal by Subject|1
1591547|NCT02413229|5537728|P4|Overall Study|Withdrawal by Subject|0
1591548|NCT02413229|5537729|P3|Overall Study|Withdrawal by Subject|0
1591549|NCT02413229|5537730|P2|Overall Study|Withdrawal by Subject|1
1591550|NCT02413229|5537731|P1|Overall Study|Withdrawal by Subject|1
1591551|NCT02413229|5537724|P8|Overall Study|Lost to Follow-up|0
1591552|NCT02413229|5537725|P7|Overall Study|Lost to Follow-up|0
1591553|NCT02413229|5537726|P6|Overall Study|Lost to Follow-up|0
1591554|NCT02413229|5537727|P5|Overall Study|Lost to Follow-up|2
1591555|NCT02413229|5537728|P4|Overall Study|Lost to Follow-up|0
1591556|NCT02413229|5537729|P3|Overall Study|Lost to Follow-up|1
1591557|NCT02413229|5537730|P2|Overall Study|Lost to Follow-up|0
1591558|NCT02413229|5537731|P1|Overall Study|Lost to Follow-up|0
1591559|NCT02413229|5537724|P8|Overall Study|Adverse Event|1
1591560|NCT02413229|5537725|P7|Overall Study|Adverse Event|0
1591561|NCT02413229|5537726|P6|Overall Study|Adverse Event|0
1591562|NCT02413229|5537727|P5|Overall Study|Adverse Event|0
1591563|NCT02413229|5537728|P4|Overall Study|Adverse Event|1
1591564|NCT02413229|5537729|P3|Overall Study|Adverse Event|0
1591565|NCT02413229|5537730|P2|Overall Study|Adverse Event|0
1591566|NCT02413229|5537731|P1|Overall Study|Adverse Event|0
1591567|NCT02412878|5537870|P2|Overall Study|Lost to Follow-up|3
1591568|NCT02412878|5537871|P1|Overall Study|Lost to Follow-up|2
1591569|NCT02412878|5537870|P2|Overall Study|Withdrawal by Subject|10
1591570|NCT02412878|5537871|P1|Overall Study|Withdrawal by Subject|19
1591571|NCT02412761|5537885|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
1591572|NCT02412761|5537886|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
1591573|NCT02412761|5537887|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
1591574|NCT02412761|5537888|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
1591575|NCT02412761|5537889|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
1591576|NCT02412761|5537890|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
1591577|NCT02412657|5537901|P3|Overall Study|Protocol Violation|3
1591578|NCT02412657|5537902|P2|Overall Study|Protocol Violation|2
1591579|NCT02412657|5537903|P1|Overall Study|Protocol Violation|0
1591580|NCT02412657|5537901|P3|Overall Study|Lost to Follow-up|0
1591581|NCT02412657|5537902|P2|Overall Study|Lost to Follow-up|0
1591582|NCT02412657|5537903|P1|Overall Study|Lost to Follow-up|1
1591583|NCT02412488|5537947|P1|Overall Study|Reveal LINQ explant|1
1591584|NCT02412488|5537947|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
1591585|NCT02412488|5537947|P1|Overall Study|Physician Decision|1
1591586|NCT02412488|5537947|P1|Overall Study|Withdrawal by Subject|5
1591587|NCT02412488|5537947|P1|Overall Study|Lost to Follow-up|10
1591588|NCT02412436|5537951|P1|Overall Study|Not Willing to Adhere to Requirements|1
1591589|NCT02412436|5537951|P1|Overall Study|Death|1
1591590|NCT02412436|5537951|P1|Overall Study|Unable to get to clinic|3
1591591|NCT02412436|5537951|P1|Overall Study|Lost to Follow-up|6
1591592|NCT02412436|5537951|P1|Overall Study|Protocol-mandated Discontinuation|7
1591593|NCT02412306|5537970|P5|Overall Study|Death|2
1591594|NCT02412306|5537971|P4|Overall Study|Death|0
1591595|NCT02412306|5537972|P3|Overall Study|Death|15
1591596|NCT02412306|5537973|P2|Overall Study|Death|7
1591597|NCT02412306|5537974|P1|Overall Study|Death|5
1591598|NCT02412306|5537970|P5|Overall Study|Withdrawal by Subject|0
1591599|NCT02412306|5537971|P4|Overall Study|Withdrawal by Subject|0
1591600|NCT02412306|5537972|P3|Overall Study|Withdrawal by Subject|1
1591601|NCT02412306|5537973|P2|Overall Study|Withdrawal by Subject|0
1591602|NCT02412306|5537974|P1|Overall Study|Withdrawal by Subject|0
1591603|NCT02412306|5537970|P5|Overall Study|Lost to Follow-up|0
1591604|NCT02412306|5537971|P4|Overall Study|Lost to Follow-up|0
1591605|NCT02412306|5537972|P3|Overall Study|Lost to Follow-up|0
1591606|NCT02412306|5537973|P2|Overall Study|Lost to Follow-up|1
1591607|NCT02412306|5537974|P1|Overall Study|Lost to Follow-up|0
1591608|NCT02412111|5538036|P3|Active Comparator Period (8 Weeks)|Other|2
1591609|NCT02412111|5538037|P2|Active Comparator Period (8 Weeks)|Other|0
1591610|NCT02412111|5538038|P1|Active Comparator Period (8 Weeks)|Other|0
1591611|NCT02412111|5538036|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
1591612|NCT02412111|5538037|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
1591613|NCT02412111|5538038|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
1591614|NCT02412111|5538036|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
1591615|NCT02412111|5538037|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
1591616|NCT02412111|5538038|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
1591617|NCT02412111|5538036|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
1591618|NCT02412111|5538037|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
1591619|NCT02412111|5538038|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
1591620|NCT02412111|5538036|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
1591621|NCT02412111|5538037|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
1591622|NCT02412111|5538038|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
1591623|NCT02412111|5538036|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
1591624|NCT02412111|5538037|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
1591625|NCT02412111|5538038|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
1591626|NCT02412111|5538036|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
1591627|NCT02412111|5538037|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
1591628|NCT02412111|5538038|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
1591629|NCT02411747|5538121|P2|Overall Study|Protocol Violation|4
1591630|NCT02411747|5538122|P1|Overall Study|Protocol Violation|2
1591631|NCT02411747|5538121|P2|Overall Study|Withdrawal by Subject|0
1591632|NCT02411747|5538122|P1|Overall Study|Withdrawal by Subject|1
1591633|NCT02411578|5538137|P2|Crossover Trial Phase|Pregnancy|1
1591634|NCT02411578|5538138|P1|Crossover Trial Phase|Pregnancy|0
1591635|NCT02411539|5538195|P2|Overall Study|Confounding medical condition|1
1591636|NCT02411539|5538196|P1|Overall Study|Confounding medical condition|0
1591637|NCT02411539|5538195|P2|Overall Study|Lost to Follow-up|0
1591638|NCT02411539|5538196|P1|Overall Study|Lost to Follow-up|2
1591639|NCT02411396|5538284|P1|Overall Study|Death|10
1591640|NCT02411396|5538284|P1|Overall Study|Lost to Follow-up|31
1591641|NCT02411292|5538297|P1|Overall Study|Lost to Follow-up|3
1591642|NCT02411292|5538297|P1|Overall Study|Death|2
1591643|NCT02411292|5538297|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
1591644|NCT02411201|5538303|P1|Overall Study|Age group completed|2
1591645|NCT02411201|5538303|P1|Overall Study|Withdrawal by Subject|2
1591646|NCT02411201|5538303|P1|Overall Study|Adverse Event|2
1591647|NCT02411110|5538316|P2|Treatment Period 2|Personal Reasons|2
1591648|NCT02411110|5538317|P1|Treatment Period 2|Personal Reasons|0
1591649|NCT02411110|5538316|P2|Treatment Period 2|Lost to Follow-up|2
1591650|NCT02411110|5538317|P1|Treatment Period 2|Lost to Follow-up|0
1591651|NCT02411110|5538316|P2|Treatment Period 2|Adverse Event|0
1591652|NCT02411110|5538317|P1|Treatment Period 2|Adverse Event|1
1591653|NCT02411110|5538316|P2|Treatment Period 1|Other Miscellaneous Reasons|0
1591654|NCT02411110|5538317|P1|Treatment Period 1|Other Miscellaneous Reasons|2
1591655|NCT02411110|5538316|P2|Treatment Period 1|Personal Reasons|5
1591656|NCT02411110|5538317|P1|Treatment Period 1|Personal Reasons|2
1591657|NCT02411110|5538316|P2|Treatment Period 1|Lost to Follow-up|0
1591658|NCT02411110|5538317|P1|Treatment Period 1|Lost to Follow-up|1
1591659|NCT02411110|5538316|P2|Treatment Period 1|Adverse Event|2
1591660|NCT02411110|5538317|P1|Treatment Period 1|Adverse Event|4
1591661|NCT02411084|5538327|P2|Overall Study|Other reasons|5
1591662|NCT02411084|5538328|P1|Overall Study|Other reasons|0
1591663|NCT02411084|5538327|P2|Overall Study|Adverse Event|1
1591664|NCT02411084|5538328|P1|Overall Study|Adverse Event|2
1591665|NCT02411084|5538327|P2|Overall Study|Death|4
1591666|NCT02411084|5538328|P1|Overall Study|Death|5
1591667|NCT02411084|5538327|P2|Overall Study|Lack of Efficacy|3
1591668|NCT02411084|5538328|P1|Overall Study|Lack of Efficacy|6
1591669|NCT02410824|5538360|P2|First Intervention (One Week)|Headache|1
1591670|NCT02410824|5538361|P1|First Intervention (One Week)|Headache|0
1591671|NCT02410551|5538397|P1|Overall Study|FDA Clinical hold-patients taken off|2
1591672|NCT02410551|5538397|P1|Overall Study|Withdrawal by Subject|1
1591673|NCT02410551|5538397|P1|Overall Study|Adverse Event|1
1591674|NCT02410343|5538415|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
1591675|NCT02410343|5538416|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
1591676|NCT02410343|5538415|P2|Extension Period (12 Months)|Adverse Event|0
1591677|NCT02410343|5538416|P1|Extension Period (12 Months)|Adverse Event|1
1591678|NCT02410343|5538415|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
1591679|NCT02410343|5538416|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
1591680|NCT02410343|5538415|P2|Core Period (24 Weeks)|Adverse Event|0
1591681|NCT02410343|5538416|P1|Core Period (24 Weeks)|Adverse Event|1
1591682|NCT02410278|5538462|P3|Study Treatment Period|GSRS Threshold Not Met|0
1591683|NCT02410278|5538463|P2|Study Treatment Period|GSRS Threshold Not Met|1
1591684|NCT02410278|5538464|P1|Study Treatment Period|GSRS Threshold Not Met|0
1591685|NCT02410278|5538462|P3|Study Treatment Period|Other|0
1591686|NCT02410278|5538463|P2|Study Treatment Period|Other|3
1591687|NCT02410278|5538464|P1|Study Treatment Period|Other|0
1591688|NCT02410278|5538462|P3|Study Treatment Period|Withdrawal by Subject|0
1591689|NCT02410278|5538463|P2|Study Treatment Period|Withdrawal by Subject|1
1591690|NCT02410278|5538464|P1|Study Treatment Period|Withdrawal by Subject|0
1591691|NCT02410278|5538462|P3|Study Treatment Period|Physician Decision|1
1591692|NCT02410278|5538463|P2|Study Treatment Period|Physician Decision|0
1591693|NCT02410278|5538464|P1|Study Treatment Period|Physician Decision|0
1591694|NCT02410278|5538462|P3|Study Treatment Period|Adverse Event|3
1591695|NCT02410278|5538463|P2|Study Treatment Period|Adverse Event|6
1591696|NCT02410278|5538464|P1|Study Treatment Period|Adverse Event|0
1591697|NCT02410278|5538462|P3|Run-in Period|Pregnancy|0
1591698|NCT02410278|5538463|P2|Run-in Period|Pregnancy|0
1591699|NCT02410278|5538464|P1|Run-in Period|Pregnancy|1
1591700|NCT02410278|5538462|P3|Run-in Period|Withdrawal by Subject|0
1591701|NCT02410278|5538463|P2|Run-in Period|Withdrawal by Subject|0
1591702|NCT02410278|5538464|P1|Run-in Period|Withdrawal by Subject|1
1591703|NCT02410278|5538462|P3|Run-in Period|Lost to Follow-up|0
1591704|NCT02410278|5538463|P2|Run-in Period|Lost to Follow-up|0
1591705|NCT02410278|5538464|P1|Run-in Period|Lost to Follow-up|1
1591706|NCT02410278|5538462|P3|Run-in Period|GSRS Threshold Not Met|0
1591707|NCT02410278|5538463|P2|Run-in Period|GSRS Threshold Not Met|0
1591708|NCT02410278|5538464|P1|Run-in Period|GSRS Threshold Not Met|30
1591709|NCT02410278|5538462|P3|Run-in Period|Adverse Event|0
1591710|NCT02410278|5538463|P2|Run-in Period|Adverse Event|0
1591711|NCT02410278|5538464|P1|Run-in Period|Adverse Event|5
1591712|NCT02410252|5538489|P1|Overall Study|Physician Decision|2
1591713|NCT02410252|5538489|P1|Overall Study|Withdrawal by Subject|4
1591714|NCT02410200|5538502|P1|Overall Study|Adverse Event|2
1591715|NCT02409732|5538572|P1|Overall Study|Lost to Follow-up|2
1591716|NCT02409732|5538572|P1|Overall Study|Withdrawal by Subject|4
1591717|NCT02409719|5538582|P2|Overall Study|Lost to Follow-up|3
1591718|NCT02409719|5538583|P1|Overall Study|Lost to Follow-up|3
1591719|NCT02409667|5538593|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1591720|NCT02409667|5538594|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1591721|NCT02409667|5538595|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
1591722|NCT02409667|5538596|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1591723|NCT02409667|5538597|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
1591724|NCT02409667|5538593|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
1591725|NCT02409667|5538594|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
1591726|NCT02409667|5538595|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
1591727|NCT02409667|5538596|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
1591728|NCT02409667|5538597|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
1591729|NCT02409667|5538593|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
1591730|NCT02409667|5538594|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
1591731|NCT02409667|5538595|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
1591732|NCT02409667|5538596|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
1591733|NCT02409667|5538597|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
1591734|NCT02409667|5538593|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
1591735|NCT02409667|5538594|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
1591736|NCT02409667|5538595|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
1591737|NCT02409667|5538596|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
1591738|NCT02409667|5538597|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
1591739|NCT02409667|5538593|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
1591740|NCT02409667|5538594|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
1591741|NCT02409667|5538595|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
1591742|NCT02409667|5538596|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
1591743|NCT02409667|5538597|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
1591744|NCT02409667|5538593|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1591745|NCT02409667|5538594|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
1591746|NCT02409667|5538595|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1591747|NCT02409667|5538596|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1591748|NCT02409667|5538597|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
1591749|NCT02409667|5538593|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
1591750|NCT02409667|5538594|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
1591751|NCT02409667|5538595|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
1591752|NCT02409667|5538596|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
1591753|NCT02409667|5538597|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
1591754|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1591755|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1591756|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1591757|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
1591758|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
1591759|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1591760|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1591761|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1591762|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
1591763|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
1591764|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1591765|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1591766|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1591767|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
1591768|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
1591769|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1591770|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1591771|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1591772|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
1591773|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
1591774|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1591775|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1591776|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1591777|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
1591778|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
1591779|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1591780|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1591781|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1591782|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
1591783|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
1591784|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1591785|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1591786|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1591787|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
1591788|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
1591789|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1591790|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1591791|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1591792|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
1591793|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
1591794|NCT02409667|5538593|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1591795|NCT02409667|5538594|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1591796|NCT02409667|5538595|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1591797|NCT02409667|5538596|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
1591798|NCT02409667|5538597|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
1591799|NCT02409355|5538659|P2|Overall Study|Study terminated by Sponsor|3
1591800|NCT02409355|5538660|P1|Overall Study|Study terminated by Sponsor|2
1591801|NCT02409355|5538659|P2|Overall Study|Death|1
1591802|NCT02409355|5538660|P1|Overall Study|Death|1
1591803|NCT02409355|5538659|P2|Overall Study|Withdrawal by Subject|0
1591804|NCT02409355|5538660|P1|Overall Study|Withdrawal by Subject|1
1591805|NCT02408068|5538791|P6|Treatment 3 (1.5 Days)|Adverse Event|0
1591806|NCT02408068|5538792|P5|Treatment 3 (1.5 Days)|Adverse Event|0
1591807|NCT02408068|5538793|P4|Treatment 3 (1.5 Days)|Adverse Event|0
1591808|NCT02408068|5538794|P3|Treatment 3 (1.5 Days)|Adverse Event|1
1591809|NCT02408068|5538795|P2|Treatment 3 (1.5 Days)|Adverse Event|0
1591810|NCT02408068|5538796|P1|Treatment 3 (1.5 Days)|Adverse Event|0
1591811|NCT02407704|5538823|P4|Overall Study|Withdrawal by Subject|0
1591812|NCT02407704|5538824|P3|Overall Study|Withdrawal by Subject|1
1591813|NCT02407704|5538825|P2|Overall Study|Withdrawal by Subject|0
1591814|NCT02407704|5538826|P1|Overall Study|Withdrawal by Subject|0
1591815|NCT02407704|5538823|P4|Overall Study|Protocol Violation|1
1591816|NCT02407704|5538824|P3|Overall Study|Protocol Violation|0
1591817|NCT02407704|5538825|P2|Overall Study|Protocol Violation|0
1591818|NCT02407704|5538826|P1|Overall Study|Protocol Violation|0
1591819|NCT02407704|5538823|P4|Overall Study|Lost to Follow-up|2
1591820|NCT02407704|5538824|P3|Overall Study|Lost to Follow-up|0
1591821|NCT02407704|5538825|P2|Overall Study|Lost to Follow-up|0
1591822|NCT02407704|5538826|P1|Overall Study|Lost to Follow-up|0
1591823|NCT02407249|5538860|P1|Overall Study|Not treated|13
1591824|NCT02407249|5538860|P1|Overall Study|Did not complete 12-month follow-up|13
1591913|NCT02407223|5539123|P3|Overall Study|Other|25
1591914|NCT02407223|5539124|P2|Overall Study|Other|27
1591915|NCT02407223|5539125|P1|Overall Study|Other|29
1591916|NCT02407223|5539123|P3|Overall Study|Subject Refused Further Study Treatment|0
1591917|NCT02407223|5539124|P2|Overall Study|Subject Refused Further Study Treatment|1
1591918|NCT02407223|5539125|P1|Overall Study|Subject Refused Further Study Treatment|0
1591919|NCT02407223|5539123|P3|Overall Study|Study Terminated by Sponsor|86
1591920|NCT02407223|5539124|P2|Overall Study|Study Terminated by Sponsor|80
1591921|NCT02407223|5539125|P1|Overall Study|Study Terminated by Sponsor|77
1591922|NCT02407223|5539123|P3|Overall Study|Withdrawal by Subject|4
1591923|NCT02407223|5539124|P2|Overall Study|Withdrawal by Subject|4
1591924|NCT02407223|5539125|P1|Overall Study|Withdrawal by Subject|2
1591925|NCT02407223|5539123|P3|Overall Study|Lost to Follow-up|2
1591926|NCT02407223|5539124|P2|Overall Study|Lost to Follow-up|0
1591927|NCT02407223|5539125|P1|Overall Study|Lost to Follow-up|1
1591928|NCT02407223|5539123|P3|Overall Study|Lack of Efficacy|4
1591929|NCT02407223|5539124|P2|Overall Study|Lack of Efficacy|6
1591930|NCT02407223|5539125|P1|Overall Study|Lack of Efficacy|6
1591931|NCT02407223|5539123|P3|Overall Study|Adverse Event|1
1591932|NCT02407223|5539124|P2|Overall Study|Adverse Event|0
1591933|NCT02407223|5539125|P1|Overall Study|Adverse Event|1
1591934|NCT02406677|5539258|P2|Overall Study|Withdrawal by Subject|0
1591935|NCT02406677|5539259|P1|Overall Study|Withdrawal by Subject|1
1591936|NCT02406677|5539258|P2|Overall Study|Discharged on prasugrel|587
1591937|NCT02406677|5539259|P1|Overall Study|Discharged on prasugrel|283
1591938|NCT02406677|5539258|P2|Overall Study|Discharged without P2Y12|3
1591939|NCT02406677|5539259|P1|Overall Study|Discharged without P2Y12|1
1591940|NCT02406677|5539258|P2|Overall Study|Death|8
1591941|NCT02406677|5539259|P1|Overall Study|Death|16
1591942|NCT02406612|5539273|P2|Overall Study|Guidewire Failure|1
1591943|NCT02406612|5539274|P1|Overall Study|Guidewire Failure|0
1591944|NCT02406612|5539273|P2|Overall Study|Intra-procedural Exclusion|3
1591945|NCT02406612|5539274|P1|Overall Study|Intra-procedural Exclusion|1
1591946|NCT02406612|5539273|P2|Overall Study|Screening Failure|0
1591947|NCT02406612|5539274|P1|Overall Study|Screening Failure|3
1591948|NCT02406586|5539289|P3|Overall Study|Withdrawal by Subject|0
1591949|NCT02406586|5539290|P2|Overall Study|Withdrawal by Subject|0
1591950|NCT02406586|5539291|P1|Overall Study|Withdrawal by Subject|1
1591951|NCT02406586|5539289|P3|Overall Study|Lost to Follow-up|2
1591952|NCT02406586|5539290|P2|Overall Study|Lost to Follow-up|4
1591953|NCT02406586|5539291|P1|Overall Study|Lost to Follow-up|0
1591954|NCT02406261|5539433|P2|Period 2|Withdrawal by Subject|1
1591955|NCT02406261|5539434|P1|Period 2|Withdrawal by Subject|0
1591956|NCT02406261|5539433|P2|Period 2|Protocol Violation|1
1591957|NCT02406261|5539434|P1|Period 2|Protocol Violation|0
1591958|NCT02406261|5539433|P2|Period 2|Physician Decision|1
1591959|NCT02406261|5539434|P1|Period 2|Physician Decision|0
1591960|NCT02406261|5539433|P2|Period 1|Adverse Event|0
1591961|NCT02406261|5539434|P1|Period 1|Adverse Event|1
1591962|NCT02406261|5539433|P2|Period 1|Lost to Follow-up|0
1591963|NCT02406261|5539434|P1|Period 1|Lost to Follow-up|2
1591964|NCT02406248|5539446|P1|Overall Study|Withdrawal by Subject|2
1591965|NCT02406248|5539446|P1|Overall Study|Death|7
1591966|NCT02406027|5539457|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
1591967|NCT02406027|5539458|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
1591968|NCT02406027|5539459|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
1591969|NCT02406027|5539460|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
1591970|NCT02406027|5539461|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
1591971|NCT02406027|5539462|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
1591972|NCT02406027|5539463|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
1591973|NCT02406027|5539457|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
1591974|NCT02406027|5539458|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
1591975|NCT02406027|5539459|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
1591976|NCT02406027|5539460|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
1591977|NCT02406027|5539461|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
1591978|NCT02406027|5539462|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
1591979|NCT02406027|5539463|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
1591980|NCT02406027|5539457|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
1591981|NCT02406027|5539458|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
1591982|NCT02406027|5539459|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
1591983|NCT02406027|5539460|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
1591984|NCT02406027|5539461|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
1591985|NCT02406027|5539462|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
1591986|NCT02406027|5539463|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
1591987|NCT02406027|5539457|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
1591988|NCT02406027|5539458|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
1591989|NCT02406027|5539459|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
1591990|NCT02406027|5539460|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
1591991|NCT02406027|5539461|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
1591992|NCT02406027|5539462|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
1591993|NCT02406027|5539463|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
1591994|NCT02406027|5539457|P7|Open-label Phase (Period 2)|Physician Decision|1
1591995|NCT02406027|5539458|P6|Open-label Phase (Period 2)|Physician Decision|1
1591996|NCT02406027|5539459|P5|Open-label Phase (Period 2)|Physician Decision|0
1591997|NCT02406027|5539460|P4|Open-label Phase (Period 2)|Physician Decision|0
1591998|NCT02406027|5539461|P3|Open-label Phase (Period 2)|Physician Decision|0
1591999|NCT02406027|5539462|P2|Open-label Phase (Period 2)|Physician Decision|0
1592000|NCT02406027|5539463|P1|Open-label Phase (Period 2)|Physician Decision|0
1592001|NCT02406027|5539457|P7|Open-label Phase (Period 2)|Adverse Event|0
1592002|NCT02406027|5539458|P6|Open-label Phase (Period 2)|Adverse Event|0
1592003|NCT02406027|5539459|P5|Open-label Phase (Period 2)|Adverse Event|2
1592004|NCT02406027|5539460|P4|Open-label Phase (Period 2)|Adverse Event|2
1592005|NCT02406027|5539461|P3|Open-label Phase (Period 2)|Adverse Event|0
1592006|NCT02406027|5539462|P2|Open-label Phase (Period 2)|Adverse Event|0
1592007|NCT02406027|5539463|P1|Open-label Phase (Period 2)|Adverse Event|0
1592008|NCT02406027|5539457|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
1592009|NCT02406027|5539458|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
1592010|NCT02406027|5539459|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
1592011|NCT02406027|5539460|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
1592012|NCT02406027|5539461|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
1592013|NCT02406027|5539462|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
1592014|NCT02406027|5539463|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
1592015|NCT02406027|5539457|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
1592016|NCT02406027|5539458|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
1592017|NCT02406027|5539459|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
1592018|NCT02406027|5539460|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
1592019|NCT02406027|5539461|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
1592020|NCT02406027|5539462|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
1592021|NCT02406027|5539463|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
1592022|NCT02406027|5539457|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
1592023|NCT02406027|5539458|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
1592024|NCT02406027|5539459|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
1592025|NCT02406027|5539460|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
1592026|NCT02406027|5539461|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
1592027|NCT02406027|5539462|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
1592028|NCT02406027|5539463|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
1592029|NCT02406027|5539457|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
1592030|NCT02406027|5539458|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
1592031|NCT02406027|5539459|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
1592032|NCT02406027|5539460|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
1592033|NCT02406027|5539461|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
1592034|NCT02406027|5539462|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
1592035|NCT02406027|5539463|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
1592036|NCT02405962|5539493|P2|Overall Study|A participant has moved to another place|1
1592037|NCT02405962|5539494|P1|Overall Study|A participant has moved to another place|0
1592038|NCT02405962|5539493|P2|Overall Study|Lost to Follow-up|4
1592039|NCT02405962|5539494|P1|Overall Study|Lost to Follow-up|1
1592040|NCT02405780|5539532|P4|Period II|Non-compliance with study procedures|4
1592041|NCT02405780|5539533|P3|Period II|Non-compliance with study procedures|7
1592042|NCT02405780|5539534|P2|Period II|Non-compliance with study procedures|2
1592043|NCT02405780|5539535|P1|Period II|Non-compliance with study procedures|5
1592044|NCT02405780|5539532|P4|Period II|Withdrawal by Subject|3
1592045|NCT02405780|5539533|P3|Period II|Withdrawal by Subject|0
1592046|NCT02405780|5539534|P2|Period II|Withdrawal by Subject|4
1592047|NCT02405780|5539535|P1|Period II|Withdrawal by Subject|7
1592048|NCT02405780|5539532|P4|Period II|Pregnancy|0
1592049|NCT02405780|5539533|P3|Period II|Pregnancy|1
1592050|NCT02405780|5539534|P2|Period II|Pregnancy|0
1592051|NCT02405780|5539535|P1|Period II|Pregnancy|0
1592052|NCT02405780|5539532|P4|Period II|Medical reason|0
1592053|NCT02405780|5539533|P3|Period II|Medical reason|0
1592054|NCT02405780|5539534|P2|Period II|Medical reason|1
1592055|NCT02405780|5539535|P1|Period II|Medical reason|0
1592056|NCT02405780|5539532|P4|Period II|Adverse Event|11
1592057|NCT02405780|5539533|P3|Period II|Adverse Event|4
1592058|NCT02405780|5539534|P2|Period II|Adverse Event|5
1592059|NCT02405780|5539535|P1|Period II|Adverse Event|3
1592060|NCT02405780|5539532|P4|Period I|Non-compliance with study procedures|11
1592061|NCT02405780|5539533|P3|Period I|Non-compliance with study procedures|8
1592062|NCT02405780|5539534|P2|Period I|Non-compliance with study procedures|6
1592063|NCT02405780|5539535|P1|Period I|Non-compliance with study procedures|8
1592064|NCT02405780|5539532|P4|Period I|Withdrawal by Subject|4
1592065|NCT02405780|5539533|P3|Period I|Withdrawal by Subject|3
1592066|NCT02405780|5539534|P2|Period I|Withdrawal by Subject|1
1592067|NCT02405780|5539535|P1|Period I|Withdrawal by Subject|9
1592068|NCT02405780|5539532|P4|Period I|Screening Failure|0
1592069|NCT02405780|5539533|P3|Period I|Screening Failure|1
1592070|NCT02405780|5539534|P2|Period I|Screening Failure|0
1592071|NCT02405780|5539535|P1|Period I|Screening Failure|1
1592072|NCT02405780|5539532|P4|Period I|Medical reasons|1
1592073|NCT02405780|5539533|P3|Period I|Medical reasons|0
1592074|NCT02405780|5539534|P2|Period I|Medical reasons|1
1592075|NCT02405780|5539535|P1|Period I|Medical reasons|1
1592076|NCT02405780|5539532|P4|Period I|Adverse Event|7
1592077|NCT02405780|5539533|P3|Period I|Adverse Event|3
1592078|NCT02405780|5539534|P2|Period I|Adverse Event|0
1592079|NCT02405780|5539535|P1|Period I|Adverse Event|8
1592080|NCT02405442|5539598|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
1592081|NCT02405442|5539599|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
1592082|NCT02405442|5539600|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
1592083|NCT02405442|5539601|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
1592084|NCT02405442|5539598|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
1592085|NCT02405442|5539599|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
1592086|NCT02405442|5539600|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
1592087|NCT02405442|5539601|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
1592088|NCT02405442|5539598|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
1592089|NCT02405442|5539599|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
1592090|NCT02405442|5539600|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
1592091|NCT02405442|5539601|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
1592092|NCT02405442|5539598|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
1592093|NCT02405442|5539599|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
1592094|NCT02405442|5539600|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
1592095|NCT02405442|5539601|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
1592096|NCT02405442|5539598|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
1592097|NCT02405442|5539599|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
1592098|NCT02405442|5539600|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
1592099|NCT02405442|5539601|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
1592100|NCT02405442|5539598|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
1592101|NCT02405442|5539599|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
1592102|NCT02405442|5539600|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
1592103|NCT02405442|5539601|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
1592104|NCT02405442|5539598|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
1592105|NCT02405442|5539599|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
1592106|NCT02405442|5539600|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
1592107|NCT02405442|5539601|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
1592108|NCT02405442|5539598|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
1592109|NCT02405442|5539599|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
1592110|NCT02405442|5539600|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
1592111|NCT02405442|5539601|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
1592112|NCT02405442|5539598|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
1592113|NCT02405442|5539599|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
1592114|NCT02405442|5539600|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
1592115|NCT02405442|5539601|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
1592116|NCT02405442|5539598|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
1592117|NCT02405442|5539599|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
1592118|NCT02405442|5539600|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
1592119|NCT02405442|5539601|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
1592120|NCT02405442|5539598|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
1592121|NCT02405442|5539599|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
1592122|NCT02405442|5539600|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
1592123|NCT02405442|5539601|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
1592124|NCT02405442|5539598|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
1592125|NCT02405442|5539599|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
1592126|NCT02405442|5539600|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
1592127|NCT02405442|5539601|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
1592128|NCT02405442|5539598|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
1592129|NCT02405442|5539599|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
1592130|NCT02405442|5539600|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
1592131|NCT02405442|5539601|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
1592132|NCT02405442|5539598|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
1592133|NCT02405442|5539599|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
1592134|NCT02405442|5539600|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
1592135|NCT02405442|5539601|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
1592136|NCT02405091|5539655|P3|Overall Study|Physician Decision|0
1592137|NCT02405091|5539656|P2|Overall Study|Physician Decision|2
1592138|NCT02405091|5539657|P1|Overall Study|Physician Decision|2
1592139|NCT02405091|5539655|P3|Overall Study|Lost to Follow-up|0
1592140|NCT02405091|5539656|P2|Overall Study|Lost to Follow-up|6
1592141|NCT02405091|5539657|P1|Overall Study|Lost to Follow-up|5
1592142|NCT02405091|5539655|P3|Overall Study|Death|0
1592143|NCT02405091|5539656|P2|Overall Study|Death|1
1592144|NCT02405091|5539657|P1|Overall Study|Death|0
1592145|NCT02405091|5539655|P3|Overall Study|Withdrawal by Subject|0
1592146|NCT02405091|5539656|P2|Overall Study|Withdrawal by Subject|8
1592147|NCT02405091|5539657|P1|Overall Study|Withdrawal by Subject|4
1592148|NCT02405091|5539655|P3|Overall Study|Noncompliance|2
1592149|NCT02405091|5539656|P2|Overall Study|Noncompliance|6
1592150|NCT02405091|5539657|P1|Overall Study|Noncompliance|1
1592151|NCT02405091|5539655|P3|Overall Study|Protocol Violation|0
1592152|NCT02405091|5539656|P2|Overall Study|Protocol Violation|0
1592153|NCT02405091|5539657|P1|Overall Study|Protocol Violation|1
1592154|NCT02405091|5539655|P3|Overall Study|Adverse Event|0
1592155|NCT02405091|5539656|P2|Overall Study|Adverse Event|10
1592156|NCT02405091|5539657|P1|Overall Study|Adverse Event|16
1592157|NCT02404649|5539693|P2|Overall Study|Adverse Event|2
1592158|NCT02404649|5539694|P1|Overall Study|Adverse Event|1
1592159|NCT02404545|5539711|P2|Overall Study|Sponsor Termination|6
1592160|NCT02404545|5539712|P1|Overall Study|Sponsor Termination|6
1592161|NCT02404493|5539731|P2|Overall Study|Adverse Event|1
1592162|NCT02404493|5539732|P1|Overall Study|Adverse Event|1
1592163|NCT02404389|5539977|P5|Overall Study|Subject/guardian decision|1
1592164|NCT02404389|5539978|P4|Overall Study|Subject/guardian decision|1
1592165|NCT02404389|5539979|P3|Overall Study|Subject/guardian decision|0
1592166|NCT02404389|5539980|P2|Overall Study|Subject/guardian decision|0
1592167|NCT02404389|5539981|P1|Overall Study|Subject/guardian decision|1
1592168|NCT02404389|5539977|P5|Overall Study|Adverse Event|2
1592169|NCT02404389|5539978|P4|Overall Study|Adverse Event|0
1592170|NCT02404389|5539979|P3|Overall Study|Adverse Event|1
1592171|NCT02404389|5539980|P2|Overall Study|Adverse Event|0
1592172|NCT02404389|5539981|P1|Overall Study|Adverse Event|1
1592173|NCT02404350|5540021|P4|Overall Study|Due to Technical problems|1
1592174|NCT02404350|5540022|P3|Overall Study|Due to Technical problems|0
1592175|NCT02404350|5540023|P2|Overall Study|Due to Technical problems|0
1592176|NCT02404350|5540024|P1|Overall Study|Due to Technical problems|0
1592177|NCT02404350|5540021|P4|Overall Study|Due to Non-compliance with treatment|1
1592178|NCT02404350|5540022|P3|Overall Study|Due to Non-compliance with treatment|0
1592179|NCT02404350|5540023|P2|Overall Study|Due to Non-compliance with treatment|0
1592180|NCT02404350|5540024|P1|Overall Study|Due to Non-compliance with treatment|0
1592181|NCT02404350|5540021|P4|Overall Study|Due to Withdrawal by Subject|19
1592182|NCT02404350|5540022|P3|Overall Study|Due to Withdrawal by Subject|3
1592183|NCT02404350|5540023|P2|Overall Study|Due to Withdrawal by Subject|3
1592184|NCT02404350|5540024|P1|Overall Study|Due to Withdrawal by Subject|7
1592185|NCT02404350|5540021|P4|Overall Study|Due to Pregnancy|1
1592186|NCT02404350|5540022|P3|Overall Study|Due to Pregnancy|0
1592187|NCT02404350|5540023|P2|Overall Study|Due to Pregnancy|0
1592188|NCT02404350|5540024|P1|Overall Study|Due to Pregnancy|0
1592189|NCT02404350|5540021|P4|Overall Study|Due to Physician Decision|2
1592190|NCT02404350|5540022|P3|Overall Study|Due to Physician Decision|0
1592191|NCT02404350|5540023|P2|Overall Study|Due to Physician Decision|0
1592192|NCT02404350|5540024|P1|Overall Study|Due to Physician Decision|1
1592193|NCT02404350|5540021|P4|Overall Study|Due to Lost to Follow-up|1
1592194|NCT02404350|5540022|P3|Overall Study|Due to Lost to Follow-up|0
1592195|NCT02404350|5540023|P2|Overall Study|Due to Lost to Follow-up|0
1592196|NCT02404350|5540024|P1|Overall Study|Due to Lost to Follow-up|2
1592197|NCT02404350|5540021|P4|Overall Study|Due to Lack of efficacy|3
1592198|NCT02404350|5540022|P3|Overall Study|Due to Lack of efficacy|0
1592199|NCT02404350|5540023|P2|Overall Study|Due to Lack of efficacy|1
1592200|NCT02404350|5540024|P1|Overall Study|Due to Lack of efficacy|3
1592201|NCT02404350|5540021|P4|Overall Study|Due to Adverse event|9
1592202|NCT02404350|5540022|P3|Overall Study|Due to Adverse event|3
1592203|NCT02404350|5540023|P2|Overall Study|Due to Adverse event|2
1592204|NCT02404350|5540024|P1|Overall Study|Due to Adverse event|2
1592205|NCT02404220|5540078|P4|Overall Study|Enrolled but Never Treated|0
1592206|NCT02404220|5540079|P3|Overall Study|Enrolled but Never Treated|0
1592207|NCT02404220|5540080|P2|Overall Study|Enrolled but Never Treated|2
1592208|NCT02404220|5540081|P1|Overall Study|Enrolled but Never Treated|0
1592209|NCT02404220|5540078|P4|Overall Study|Withdrawal by Subject|0
1592210|NCT02404220|5540079|P3|Overall Study|Withdrawal by Subject|0
1592211|NCT02404220|5540080|P2|Overall Study|Withdrawal by Subject|1
1592212|NCT02404220|5540081|P1|Overall Study|Withdrawal by Subject|0
1592213|NCT02404220|5540078|P4|Overall Study|Study Terminated by Sponsor|1
1592214|NCT02404220|5540079|P3|Overall Study|Study Terminated by Sponsor|2
1592215|NCT02404220|5540080|P2|Overall Study|Study Terminated by Sponsor|0
1592216|NCT02404220|5540081|P1|Overall Study|Study Terminated by Sponsor|0
1592217|NCT02404220|5540078|P4|Overall Study|Progressive Disease|1
1592218|NCT02404220|5540079|P3|Overall Study|Progressive Disease|1
1592219|NCT02404220|5540080|P2|Overall Study|Progressive Disease|0
1592220|NCT02404220|5540081|P1|Overall Study|Progressive Disease|0
1592221|NCT02404220|5540078|P4|Overall Study|Death|8
1592222|NCT02404220|5540079|P3|Overall Study|Death|3
1592223|NCT02404220|5540080|P2|Overall Study|Death|5
1592224|NCT02404220|5540081|P1|Overall Study|Death|5
1592225|NCT02404220|5540078|P4|Overall Study|Adverse Event|0
1592226|NCT02404220|5540079|P3|Overall Study|Adverse Event|1
1592227|NCT02404220|5540080|P2|Overall Study|Adverse Event|0
1592228|NCT02404220|5540081|P1|Overall Study|Adverse Event|0
1592229|NCT02404103|5540117|P2|Overall Study|Lost to Follow-up|3
1592230|NCT02404103|5540118|P1|Overall Study|Lost to Follow-up|3
1592231|NCT02404103|5540117|P2|Overall Study|Adverse Event|0
1592232|NCT02404103|5540118|P1|Overall Study|Adverse Event|1
1592233|NCT02404025|5540138|P1|Overall Study|Lack of Efficacy|3
1592234|NCT02404025|5540138|P1|Overall Study|Adverse Event|1
1592235|NCT02403817|5540220|P2|Overall Study|Withdrawal by Subject|0
1592236|NCT02403817|5540221|P1|Overall Study|Withdrawal by Subject|5
1592237|NCT02403674|5540252|P2|Overall Study|Protocol Violation|2
1592238|NCT02403674|5540253|P1|Overall Study|Protocol Violation|4
1592239|NCT02403674|5540252|P2|Overall Study|Pregnancy|1
1592240|NCT02403674|5540253|P1|Overall Study|Pregnancy|1
1592241|NCT02403674|5540252|P2|Overall Study|Not treated with study drug|2
1592242|NCT02403674|5540253|P1|Overall Study|Not treated with study drug|4
1592243|NCT02403674|5540252|P2|Overall Study|Physician Decision|2
1592244|NCT02403674|5540253|P1|Overall Study|Physician Decision|2
1592245|NCT02403674|5540252|P2|Overall Study|Withdrawal by Subject|11
1592246|NCT02403674|5540253|P1|Overall Study|Withdrawal by Subject|8
1592247|NCT02403674|5540252|P2|Overall Study|Noncompliance with study drug|2
1592248|NCT02403674|5540253|P1|Overall Study|Noncompliance with study drug|1
1592249|NCT02403674|5540252|P2|Overall Study|Lost to Follow-up|7
1592250|NCT02403674|5540253|P1|Overall Study|Lost to Follow-up|6
1592251|NCT02403674|5540252|P2|Overall Study|Lack of Efficacy|10
1592252|NCT02403674|5540253|P1|Overall Study|Lack of Efficacy|18
1592253|NCT02403674|5540252|P2|Overall Study|Death|3
1592254|NCT02403674|5540253|P1|Overall Study|Death|1
1592255|NCT02403674|5540252|P2|Overall Study|Adverse Event|23
1592256|NCT02403674|5540253|P1|Overall Study|Adverse Event|10
1592257|NCT02403635|5540292|P1|Overall Study|Not eligible|9
1592258|NCT02403271|5540369|P2|Period 2|Other varied reasons|10
1592259|NCT02403271|5540370|P1|Period 2|Other varied reasons|0
1592260|NCT02403271|5540369|P2|Period 2|Study Terminated by Sponsor|14
1592261|NCT02403271|5540370|P1|Period 2|Study Terminated by Sponsor|0
1592262|NCT02403271|5540369|P2|Period 2|Lost to Follow-up|2
1592263|NCT02403271|5540370|P1|Period 2|Lost to Follow-up|0
1592264|NCT02403271|5540369|P2|Period 2|Death|84
1592265|NCT02403271|5540370|P1|Period 2|Death|0
1592266|NCT02403271|5540369|P2|Period 2|Withdrawal by Subject|14
1592267|NCT02403271|5540370|P1|Period 2|Withdrawal by Subject|0
1592268|NCT02403271|5540369|P2|Period 1|Other varied reasons|0
1592269|NCT02403271|5540370|P1|Period 1|Other varied reasons|1
1592270|NCT02403206|5540384|P2|Overall Study|Reason not given|4
1592271|NCT02403206|5540385|P1|Overall Study|Reason not given|2
1592272|NCT02403206|5540384|P2|Overall Study|Withdrawal by Subject|3
1592273|NCT02403206|5540385|P1|Overall Study|Withdrawal by Subject|3
1592274|NCT02403206|5540384|P2|Overall Study|Physician Decision|0
1592275|NCT02403206|5540385|P1|Overall Study|Physician Decision|2
1592276|NCT02403206|5540384|P2|Overall Study|Lost to Follow-up|3
1592277|NCT02403206|5540385|P1|Overall Study|Lost to Follow-up|4
1592278|NCT02403180|5540396|P2|Period 2 (5 Days)|Withdrawal by Subject|1
1592279|NCT02403180|5540397|P1|Period 2 (5 Days)|Withdrawal by Subject|0
1592280|NCT02403180|5540396|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
1592281|NCT02403180|5540397|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
1592282|NCT02402933|5540426|P1|Overall Study|Discontinued; Site Termination|10
1592283|NCT02402933|5540426|P1|Overall Study|Withdrawal by Subject|4
1592284|NCT02402322|5540455|P3|Follow-up|Withdrawal by Subject|24
1592285|NCT02402322|5540456|P2|Follow-up|Withdrawal by Subject|3
1592286|NCT02402322|5540457|P1|Follow-up|Withdrawal by Subject|6
1592287|NCT02402322|5540455|P3|Pretreatment|Withdrawal by Subject|1
1592288|NCT02402322|5540456|P2|Pretreatment|Withdrawal by Subject|1
1592289|NCT02402322|5540457|P1|Pretreatment|Withdrawal by Subject|3
1592290|NCT02402218|5540507|P3|Overall Study|Withdrawal by Subject|1
1592291|NCT02402218|5540508|P2|Overall Study|Withdrawal by Subject|1
1592292|NCT02402218|5540509|P1|Overall Study|Withdrawal by Subject|1
1592293|NCT02402218|5540507|P3|Overall Study|Adverse Event|1
1592294|NCT02402218|5540508|P2|Overall Study|Adverse Event|2
1592295|NCT02402218|5540509|P1|Overall Study|Adverse Event|0
1592296|NCT02402218|5540507|P3|Overall Study|Reinfection|1
1592297|NCT02402218|5540508|P2|Overall Study|Reinfection|0
1592298|NCT02402218|5540509|P1|Overall Study|Reinfection|0
1592299|NCT02402218|5540507|P3|Overall Study|Death|0
1592300|NCT02402218|5540508|P2|Overall Study|Death|0
1592301|NCT02402218|5540509|P1|Overall Study|Death|1
1592302|NCT02402218|5540507|P3|Overall Study|Lack of Efficacy|1
1592303|NCT02402218|5540508|P2|Overall Study|Lack of Efficacy|1
1592304|NCT02402218|5540509|P1|Overall Study|Lack of Efficacy|0
1592305|NCT02402218|5540507|P3|Overall Study|Did not pickup study medication|13
1592306|NCT02402218|5540508|P2|Overall Study|Did not pickup study medication|9
1592307|NCT02402218|5540509|P1|Overall Study|Did not pickup study medication|12
1592308|NCT02402166|5540532|P1|Overall Study|Lost to Follow-up|1
1592309|NCT02402166|5540532|P1|Overall Study|Withdrawal by Subject|2
1592310|NCT02402166|5540532|P1|Overall Study|Adverse Event|2
1592311|NCT02401867|5540589|P1|Analysis|Cervical assay could not be conducted|9
1592312|NCT02401867|5540589|P1|Specimen Collection|Didn't receive 1 or more tests|10
1592313|NCT02401529|5540624|P2|Overall Study|Protocol Violation|0
1592314|NCT02401529|5540625|P1|Overall Study|Protocol Violation|5
1592315|NCT02401529|5540624|P2|Overall Study|Physician Decision|6
1592316|NCT02401529|5540625|P1|Overall Study|Physician Decision|2
1592317|NCT02401529|5540624|P2|Overall Study|Lost to Follow-up|1
1592318|NCT02401529|5540625|P1|Overall Study|Lost to Follow-up|2
1592319|NCT02401412|5540692|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
1592320|NCT02401412|5540693|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
1592321|NCT02401412|5540692|P2|Overall Study|Subject withdrawal prior to intervention|1
1592322|NCT02401412|5540693|P1|Overall Study|Subject withdrawal prior to intervention|0
1592323|NCT02401412|5540692|P2|Overall Study|Withdrawal by Subject|4
1592324|NCT02401412|5540693|P1|Overall Study|Withdrawal by Subject|4
1592325|NCT02401412|5540692|P2|Overall Study|Discontinued Intervention|21
1592326|NCT02401412|5540693|P1|Overall Study|Discontinued Intervention|15
1592327|NCT02401412|5540692|P2|Overall Study|Lost to Follow-up|0
1592328|NCT02401412|5540693|P1|Overall Study|Lost to Follow-up|1
1592329|NCT02401256|5540701|P1|Overall Study|Withdrawal by Subject|12
1592330|NCT02401256|5540701|P1|Overall Study|Adverse Event|5
1592331|NCT02401230|5540710|P3|Overall Study|Lost to Follow-up|3
1592332|NCT02401230|5540711|P2|Overall Study|Lost to Follow-up|3
1592333|NCT02401230|5540712|P1|Overall Study|Lost to Follow-up|1
1592334|NCT02401230|5540710|P3|Overall Study|Withdrawal by Subject|1
1592335|NCT02401230|5540711|P2|Overall Study|Withdrawal by Subject|1
1592336|NCT02401230|5540712|P1|Overall Study|Withdrawal by Subject|2
1592337|NCT02401230|5540710|P3|Overall Study|Adverse Event|0
1592338|NCT02401230|5540711|P2|Overall Study|Adverse Event|2
1592339|NCT02401230|5540712|P1|Overall Study|Adverse Event|3
1592340|NCT02400905|5540791|P1|Overall Study|Subject refused visit|1
1592341|NCT02400905|5540791|P1|Overall Study|Death|3
1592342|NCT02400905|5540791|P1|Overall Study|Withdrawal by Subject|5
1592343|NCT02400905|5540791|P1|Overall Study|Lost to Follow-up|6
1592344|NCT02400905|5540791|P1|Overall Study|Ongoing Follow-up|256
1592345|NCT02400749|5540801|P2|Week 17 - 32|Adverse Event|1
1592346|NCT02400749|5540802|P1|Week 17 - 32|Adverse Event|2
1592347|NCT02400749|5540801|P2|Week 17 - 32|Withdrawal by Subject|2
1592348|NCT02400749|5540802|P1|Week 17 - 32|Withdrawal by Subject|3
1592349|NCT02400749|5540801|P2|Week 0 -16|Protocol Violation|0
1592350|NCT02400749|5540802|P1|Week 0 -16|Protocol Violation|1
1592351|NCT02400749|5540801|P2|Week 0 -16|Lost to Follow-up|0
1592352|NCT02400749|5540802|P1|Week 0 -16|Lost to Follow-up|2
1592353|NCT02400749|5540801|P2|Week 0 -16|Adverse Event|1
1592354|NCT02400749|5540802|P1|Week 0 -16|Adverse Event|3
1592355|NCT02400749|5540801|P2|Week 0 -16|Withdrawal by Subject|5
1592356|NCT02400749|5540802|P1|Week 0 -16|Withdrawal by Subject|5
1592357|NCT02400580|5540829|P2|Overall Study|Adverse Event|0
1592358|NCT02400580|5540830|P1|Overall Study|Adverse Event|1
1592359|NCT02400580|5540829|P2|Overall Study|Withdrawal by Subject|1
1592360|NCT02400580|5540830|P1|Overall Study|Withdrawal by Subject|1
1592361|NCT02400346|5540846|P1|Overall Study|Lost to Follow-up|1
1592362|NCT02400346|5540846|P1|Overall Study|Administrative or other reason(s)|2
1592363|NCT02400346|5540846|P1|Overall Study|Withdrawal by Subject|7
1592364|NCT02400346|5540846|P1|Overall Study|Non-compliance with IMP|1
1592365|NCT02400346|5540846|P1|Overall Study|Lack of Efficacy|9
1592366|NCT02400346|5540846|P1|Overall Study|Adverse Event|24
1592367|NCT02400333|5540854|P4|Overall Study|Protocol Violation|1
1592368|NCT02400333|5540855|P3|Overall Study|Protocol Violation|2
1592369|NCT02400333|5540856|P2|Overall Study|Protocol Violation|0
1592370|NCT02400333|5540857|P1|Overall Study|Protocol Violation|1
1592371|NCT02400333|5540854|P4|Overall Study|Withdrawal by Subject|1
1592372|NCT02400333|5540855|P3|Overall Study|Withdrawal by Subject|0
1592373|NCT02400333|5540856|P2|Overall Study|Withdrawal by Subject|1
1592374|NCT02400333|5540857|P1|Overall Study|Withdrawal by Subject|0
1592375|NCT02400307|5540917|P2|Overall Study|Enrolled and Never Dosed|0
1592376|NCT02400307|5540918|P1|Overall Study|Enrolled and Never Dosed|1
1592377|NCT02399254|5540972|P1|Overall Study|Physician Decision|2
1592378|NCT02399163|5540979|P1|Overall Study|Withdrawal by Participant|5
1592379|NCT02399163|5540979|P1|Overall Study|Protocol Deviation|2
1592380|NCT02399163|5540979|P1|Overall Study|Adverse Event|2
1592381|NCT02398227|5541034|P2|Overall Study|Removed from treatment and dropped out|0
1592382|NCT02398227|5541035|P1|Overall Study|Removed from treatment and dropped out|1
1592383|NCT02398227|5541034|P2|Overall Study|Withdrawal by Subject|6
1592384|NCT02398227|5541035|P1|Overall Study|Withdrawal by Subject|5
1592385|NCT02398227|5541034|P2|Overall Study|Lost to Follow-up|12
1592386|NCT02398227|5541035|P1|Overall Study|Lost to Follow-up|21
1592387|NCT02398188|5541045|P2|Overall Study|Withdrawal by Subject|16
1592388|NCT02398188|5541046|P1|Overall Study|Withdrawal by Subject|7
1592389|NCT02398188|5541045|P2|Overall Study|Pregnancy|0
1592390|NCT02398188|5541046|P1|Overall Study|Pregnancy|1
1592391|NCT02398188|5541045|P2|Overall Study|Sponsor Decision|1
1592392|NCT02398188|5541046|P1|Overall Study|Sponsor Decision|2
1592393|NCT02398188|5541045|P2|Overall Study|Protocol Violation|10
1592394|NCT02398188|5541046|P1|Overall Study|Protocol Violation|6
1592395|NCT02398188|5541045|P2|Overall Study|Non-compliance|4
1592396|NCT02398188|5541046|P1|Overall Study|Non-compliance|4
1592397|NCT02398188|5541045|P2|Overall Study|Lost to Follow-up|0
1592398|NCT02398188|5541046|P1|Overall Study|Lost to Follow-up|5
1592399|NCT02398188|5541045|P2|Overall Study|Adverse Event|3
1592400|NCT02398188|5541046|P1|Overall Study|Adverse Event|2
1592401|NCT02397915|5541064|P4|Period 1|Physician Decision|0
1592402|NCT02397915|5541065|P3|Period 1|Physician Decision|0
1592403|NCT02397915|5541066|P2|Period 1|Physician Decision|0
1592404|NCT02397915|5541067|P1|Period 1|Physician Decision|1
1592405|NCT02397915|5541064|P4|Period 1|Protocol Violation|0
1592406|NCT02397915|5541065|P3|Period 1|Protocol Violation|0
1592407|NCT02397915|5541066|P2|Period 1|Protocol Violation|1
1592408|NCT02397915|5541067|P1|Period 1|Protocol Violation|0
1592409|NCT02397694|5541166|P2|Open Label Extension Phase|Withdrawal by Subject|0
1592410|NCT02397694|5541167|P1|Open Label Extension Phase|Withdrawal by Subject|1
1592411|NCT02397694|5541166|P2|Open Label Extension Phase|Still on Study Drug|30
1592412|NCT02397694|5541167|P1|Open Label Extension Phase|Still on Study Drug|61
1592413|NCT02397694|5541166|P2|Double-Blinded Phase|Lost to Follow-up|1
1592414|NCT02397694|5541167|P1|Double-Blinded Phase|Lost to Follow-up|1
1592415|NCT02397694|5541166|P2|Double-Blinded Phase|Withdrawal by Subject|0
1592416|NCT02397694|5541167|P1|Double-Blinded Phase|Withdrawal by Subject|1
1592417|NCT02397694|5541166|P2|Double-Blinded Phase|Non-compliance with study drug|2
1592418|NCT02397694|5541167|P1|Double-Blinded Phase|Non-compliance with study drug|0
1592419|NCT02397694|5541166|P2|Double-Blinded Phase|Adverse Event|0
1592420|NCT02397694|5541167|P1|Double-Blinded Phase|Adverse Event|1
1592421|NCT02397655|5541205|P1|Overall Study|data not completed|1301
1592422|NCT02397473|5541216|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
1592423|NCT02397473|5541217|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
1592424|NCT02397473|5541216|P2|Post Treatment Follow-up Phase|Protocol Violation|0
1592425|NCT02397473|5541217|P1|Post Treatment Follow-up Phase|Protocol Violation|1
1592426|NCT02397473|5541216|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
1592427|NCT02397473|5541217|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
1592428|NCT02397473|5541216|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
1592429|NCT02397473|5541217|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
1592430|NCT02397473|5541216|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
1592431|NCT02397473|5541217|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
1592432|NCT02397473|5541216|P2|Treatment Phase|Withdrawal by Subject|1
1592433|NCT02397473|5541217|P1|Treatment Phase|Withdrawal by Subject|2
1592434|NCT02397473|5541216|P2|Treatment Phase|Lost to Follow-up|0
1592435|NCT02397473|5541217|P1|Treatment Phase|Lost to Follow-up|1
1592436|NCT02397473|5541216|P2|Treatment Phase|Lack of Efficacy|1
1592437|NCT02397473|5541217|P1|Treatment Phase|Lack of Efficacy|8
1592438|NCT02397473|5541216|P2|Treatment Phase|Adverse Event|2
1592439|NCT02397473|5541217|P1|Treatment Phase|Adverse Event|1
1592440|NCT02397096|5541276|P2|Study Extensions|Ongoing|202
1592441|NCT02397096|5541277|P1|Study Extensions|Ongoing|399
1592442|NCT02397096|5541276|P2|Week 24 to Week 48|Lost to Follow-up|0
1592443|NCT02397096|5541277|P1|Week 24 to Week 48|Lost to Follow-up|2
1592444|NCT02397096|5541276|P2|Week 24 to Week 48|Withdrawal by Subject|2
1592445|NCT02397096|5541277|P1|Week 24 to Week 48|Withdrawal by Subject|5
1592446|NCT02397096|5541276|P2|Week 24 to Week 48|Physician Decision|1
1592447|NCT02397096|5541277|P1|Week 24 to Week 48|Physician Decision|2
1592448|NCT02397096|5541276|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
1592449|NCT02397096|5541277|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
1592450|NCT02397096|5541276|P2|Week 24 to Week 48|Lack of Efficacy|1
1592451|NCT02397096|5541277|P1|Week 24 to Week 48|Lack of Efficacy|5
1592452|NCT02397096|5541276|P2|Week 24 to Week 48|Adverse Event|2
1592453|NCT02397096|5541277|P1|Week 24 to Week 48|Adverse Event|6
1592454|NCT02397096|5541276|P2|Day 1 to Week 24|Withdrawal by Subject|1
1592455|NCT02397096|5541277|P1|Day 1 to Week 24|Withdrawal by Subject|6
1592456|NCT02397096|5541276|P2|Day 1 to Week 24|Protocol Violation|4
1592457|NCT02397096|5541277|P1|Day 1 to Week 24|Protocol Violation|1
1592458|NCT02397096|5541276|P2|Day 1 to Week 24|Physician Decision|3
1592459|NCT02397096|5541277|P1|Day 1 to Week 24|Physician Decision|2
1592460|NCT02397096|5541276|P2|Day 1 to Week 24|Lost to Follow-up|4
1592461|NCT02397096|5541277|P1|Day 1 to Week 24|Lost to Follow-up|3
1592462|NCT02397096|5541276|P2|Day 1 to Week 24|Lack of Efficacy|1
1592463|NCT02397096|5541277|P1|Day 1 to Week 24|Lack of Efficacy|0
1592464|NCT02397096|5541276|P2|Day 1 to Week 24|Death|0
1592465|NCT02397096|5541277|P1|Day 1 to Week 24|Death|1
1592466|NCT02397096|5541276|P2|Day 1 to Week 24|Adverse Event|1
1592467|NCT02397096|5541277|P1|Day 1 to Week 24|Adverse Event|7
1592468|NCT02396953|5541310|P3|Overall Study|Personal Reasons|0
1592469|NCT02396953|5541311|P2|Overall Study|Personal Reasons|1
1592470|NCT02396953|5541312|P1|Overall Study|Personal Reasons|1
1592471|NCT02396953|5541310|P3|Overall Study|Insulin like Growth Factor-1 increased|2
1592472|NCT02396953|5541311|P2|Overall Study|Insulin like Growth Factor-1 increased|2
1592473|NCT02396953|5541312|P1|Overall Study|Insulin like Growth Factor-1 increased|3
1592474|NCT02396953|5541310|P3|Overall Study|Withdrawal by Subject|1
1592475|NCT02396953|5541311|P2|Overall Study|Withdrawal by Subject|0
1592476|NCT02396953|5541312|P1|Overall Study|Withdrawal by Subject|0
1592477|NCT02396537|5541387|P2|Overall Study|Protocol Violation|1
1592478|NCT02396537|5541388|P1|Overall Study|Protocol Violation|0
1592479|NCT02396420|5541400|P1|Overall Study|Death|1
1592480|NCT02396381|5541424|P2|Overall Study|Randomization/Screening Error|1
1592481|NCT02396381|5541425|P1|Overall Study|Randomization/Screening Error|3
1592482|NCT02396381|5541424|P2|Overall Study|Possible conflict of interest|0
1592483|NCT02396381|5541425|P1|Overall Study|Possible conflict of interest|1
1592484|NCT02396381|5541424|P2|Overall Study|Could not complete visit|0
1592485|NCT02396381|5541425|P1|Overall Study|Could not complete visit|1
1592486|NCT02396381|5541424|P2|Overall Study|Moved out of town/state|3
1592487|NCT02396381|5541425|P1|Overall Study|Moved out of town/state|1
1592488|NCT02396381|5541424|P2|Overall Study|Non-compliance with study procedures|0
1592489|NCT02396381|5541425|P1|Overall Study|Non-compliance with study procedures|1
1592490|NCT02396381|5541424|P2|Overall Study|Pregnancy|0
1592491|NCT02396381|5541425|P1|Overall Study|Pregnancy|2
1592492|NCT02396381|5541424|P2|Overall Study|Physician Decision|5
1592493|NCT02396381|5541425|P1|Overall Study|Physician Decision|5
1592494|NCT02396381|5541424|P2|Overall Study|Site terminated by sponsor|8
1592495|NCT02396381|5541425|P1|Overall Study|Site terminated by sponsor|7
1592496|NCT02396381|5541424|P2|Overall Study|Protocol Violation|0
1592497|NCT02396381|5541425|P1|Overall Study|Protocol Violation|1
1592498|NCT02396381|5541424|P2|Overall Study|Lost to Follow-up|31
1592499|NCT02396381|5541425|P1|Overall Study|Lost to Follow-up|49
1592500|NCT02396381|5541424|P2|Overall Study|Withdrawal by Subject|24
1592501|NCT02396381|5541425|P1|Overall Study|Withdrawal by Subject|33
1592502|NCT02396381|5541424|P2|Overall Study|Adverse Event|2
1592503|NCT02396381|5541425|P1|Overall Study|Adverse Event|3
1592504|NCT02396316|5541464|P2|Overall Study|Treatment unblinded|1
1592505|NCT02396316|5541465|P1|Overall Study|Treatment unblinded|0
1592506|NCT02396316|5541464|P2|Overall Study|Protocol Violation|1
1592507|NCT02396316|5541465|P1|Overall Study|Protocol Violation|0
1592508|NCT02396316|5541464|P2|Overall Study|Progressive disease|3
1592509|NCT02396316|5541465|P1|Overall Study|Progressive disease|6
1592510|NCT02396316|5541464|P2|Overall Study|Physician Decision|0
1592511|NCT02396316|5541465|P1|Overall Study|Physician Decision|1
1592512|NCT02396212|5541484|P1|Overall Study|Lack of Efficacy|2
1592513|NCT02396212|5541484|P1|Overall Study|Adverse Event|1
1592514|NCT02395822|5541591|P1|Overall Study|Death|1
1592515|NCT02395822|5541591|P1|Overall Study|Withdrawal by Subject|1
1592516|NCT02395653|5541610|P1|Overall Study|Lost to Follow-up|1
1592517|NCT02395653|5541610|P1|Overall Study|Withdrawal by Subject|1
1592518|NCT02395653|5541610|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
1592519|NCT02395653|5541610|P1|Overall Study|Investigator Decision at Screening|1
1592520|NCT02395653|5541610|P1|Overall Study|SSEC Application But With 0 Dose|1
1592521|NCT02395653|5541610|P1|Overall Study|Consent Withdrawn at Screening|1
1592522|NCT02395653|5541610|P1|Overall Study|Exclusion Criteria Met at Screening|4
1592523|NCT02395536|5541619|P2|Overall Study|Insurance issue|1
1592524|NCT02395536|5541620|P1|Overall Study|Insurance issue|0
1592525|NCT02395536|5541619|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
1592526|NCT02395536|5541620|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
1592527|NCT02395536|5541619|P2|Overall Study|Withdrawal by Subject|17
1592528|NCT02395536|5541620|P1|Overall Study|Withdrawal by Subject|9
1592529|NCT02395536|5541619|P2|Overall Study|Physician Decision|6
1592530|NCT02395536|5541620|P1|Overall Study|Physician Decision|4
1592531|NCT02395536|5541619|P2|Overall Study|Death|0
1592532|NCT02395536|5541620|P1|Overall Study|Death|2
1592533|NCT02395536|5541619|P2|Overall Study|Lost to Follow-up|4
1592534|NCT02395536|5541620|P1|Overall Study|Lost to Follow-up|4
1592535|NCT02395471|5541628|P2|Overall Study|Subject not eligible|0
1592536|NCT02395471|5541629|P1|Overall Study|Subject not eligible|1
1592537|NCT02395471|5541628|P2|Overall Study|Patient did not return for procedure|1
1592538|NCT02395471|5541629|P1|Overall Study|Patient did not return for procedure|0
1592539|NCT02395471|5541628|P2|Overall Study|Failure to swollow sponge twice|0
1592540|NCT02395471|5541629|P1|Overall Study|Failure to swollow sponge twice|1
1592541|NCT02395471|5541628|P2|Overall Study|Protocol Violation|1
1592542|NCT02395471|5541629|P1|Overall Study|Protocol Violation|0
1592543|NCT02395471|5541628|P2|Overall Study|Physician Decision|0
1592544|NCT02395471|5541629|P1|Overall Study|Physician Decision|1
1592545|NCT02395471|5541628|P2|Overall Study|Withdrawal by Subject|1
1592546|NCT02395471|5541629|P1|Overall Study|Withdrawal by Subject|2
1592547|NCT02395471|5541628|P2|Overall Study|Lost to Follow-up|0
1592548|NCT02395471|5541629|P1|Overall Study|Lost to Follow-up|2
1592549|NCT02395302|5541644|P1|Overall Study|Physician Decision|2
1592550|NCT02395302|5541644|P1|Overall Study|Withdrawal by Subject|2
1592551|NCT02395302|5541644|P1|Overall Study|Run In Failure|7
1592552|NCT02395302|5541644|P1|Overall Study|Screen Failure|3
1592553|NCT02395172|5541664|P2|Overall Study|Treatment ongoing|5
1592554|NCT02395172|5541665|P1|Overall Study|Treatment ongoing|49
1592555|NCT02395172|5541664|P2|Overall Study|Participants randomized but not treated|31
1592556|NCT02395172|5541665|P1|Overall Study|Participants randomized but not treated|3
1592557|NCT02395133|5541704|P4|Overall Study|Other than specified above|4
1592558|NCT02395133|5541705|P3|Overall Study|Other than specified above|2
1592559|NCT02395133|5541706|P2|Overall Study|Other than specified above|2
1592560|NCT02395133|5541707|P1|Overall Study|Other than specified above|5
1592561|NCT02395133|5541704|P4|Overall Study|Sponsor decision|1
1592562|NCT02395133|5541705|P3|Overall Study|Sponsor decision|0
1592563|NCT02395133|5541706|P2|Overall Study|Sponsor decision|0
1592564|NCT02395133|5541707|P1|Overall Study|Sponsor decision|2
1592565|NCT02395133|5541704|P4|Overall Study|Consent withdrawn with personal reason|3
1592566|NCT02395133|5541705|P3|Overall Study|Consent withdrawn with personal reason|0
1592567|NCT02395133|5541706|P2|Overall Study|Consent withdrawn with personal reason|1
1592568|NCT02395133|5541707|P1|Overall Study|Consent withdrawn with personal reason|0
1592569|NCT02395133|5541704|P4|Overall Study|Consent withdrawn with no reason given|2
1592570|NCT02395133|5541705|P3|Overall Study|Consent withdrawn with no reason given|0
1592571|NCT02395133|5541706|P2|Overall Study|Consent withdrawn with no reason given|3
1592572|NCT02395133|5541707|P1|Overall Study|Consent withdrawn with no reason given|1
1592573|NCT02395133|5541704|P4|Overall Study|Pregnancy|0
1592574|NCT02395133|5541705|P3|Overall Study|Pregnancy|3
1592575|NCT02395133|5541706|P2|Overall Study|Pregnancy|0
1592576|NCT02395133|5541707|P1|Overall Study|Pregnancy|0
1592577|NCT02395133|5541704|P4|Overall Study|Lost to Follow-up|0
1592578|NCT02395133|5541705|P3|Overall Study|Lost to Follow-up|1
1592579|NCT02395133|5541706|P2|Overall Study|Lost to Follow-up|1
1592580|NCT02395133|5541707|P1|Overall Study|Lost to Follow-up|0
1592581|NCT02395133|5541704|P4|Overall Study|Protocol Violation|3
1592582|NCT02395133|5541705|P3|Overall Study|Protocol Violation|0
1592583|NCT02395133|5541706|P2|Overall Study|Protocol Violation|1
1592584|NCT02395133|5541707|P1|Overall Study|Protocol Violation|1
1592585|NCT02395133|5541704|P4|Overall Study|Lack of Efficacy|1
1592586|NCT02395133|5541705|P3|Overall Study|Lack of Efficacy|1
1592587|NCT02395133|5541706|P2|Overall Study|Lack of Efficacy|0
1592588|NCT02395133|5541707|P1|Overall Study|Lack of Efficacy|1
1592589|NCT02395133|5541704|P4|Overall Study|Adverse Event|0
1592590|NCT02395133|5541705|P3|Overall Study|Adverse Event|3
1592591|NCT02395133|5541706|P2|Overall Study|Adverse Event|1
1592592|NCT02395133|5541707|P1|Overall Study|Adverse Event|4
1592593|NCT02395055|5541795|P2|Overall Study|Withdrawal by Subject|3
1592594|NCT02395055|5541796|P1|Overall Study|Withdrawal by Subject|7
1592595|NCT02395042|5541809|P3|Treatment 2 Period|Lack of Efficacy|0
1592596|NCT02395042|5541810|P2|Treatment 2 Period|Lack of Efficacy|1
1592597|NCT02395042|5541811|P1|Treatment 2 Period|Lack of Efficacy|1
1592598|NCT02395042|5541809|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
1592599|NCT02395042|5541810|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
1592600|NCT02395042|5541811|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
1592601|NCT02395042|5541809|P3|Treatment 1 Period|Lost to Follow-up|0
1592602|NCT02395042|5541810|P2|Treatment 1 Period|Lost to Follow-up|0
1592603|NCT02395042|5541811|P1|Treatment 1 Period|Lost to Follow-up|1
1592604|NCT02395042|5541809|P3|Treatment 1 Period|Lack of Efficacy|0
1592605|NCT02395042|5541810|P2|Treatment 1 Period|Lack of Efficacy|1
1592606|NCT02395042|5541811|P1|Treatment 1 Period|Lack of Efficacy|1
1592607|NCT02395042|5541809|P3|Treatment 1 Period|Adverse Event|1
1592608|NCT02395042|5541810|P2|Treatment 1 Period|Adverse Event|3
1592609|NCT02395042|5541811|P1|Treatment 1 Period|Adverse Event|1
1592610|NCT02394925|5541849|P1|Overall Study|Unsatisfactory Visual Response|5
1592611|NCT02394925|5541849|P1|Overall Study|No longer meet eligibility criteria|1
1592612|NCT02394925|5541849|P1|Overall Study|Protocol Violation|5
1592613|NCT02394925|5541849|P1|Overall Study|Lost to Follow-up|9
1592614|NCT02394925|5541849|P1|Overall Study|Lens handling difficulities|5
1592615|NCT02394925|5541849|P1|Overall Study|Lens Discomfort|3
1592616|NCT02394925|5541849|P1|Overall Study|Adverse Event|1
1592617|NCT02394808|5541859|P2|Period 2|Lost to Follow-up|0
1592618|NCT02394808|5541860|P1|Period 2|Lost to Follow-up|1
1592619|NCT02394808|5541859|P2|Period 1|Unsatisfactory lens fitting|1
1592620|NCT02394808|5541860|P1|Period 1|Unsatisfactory lens fitting|0
1592621|NCT02394756|5541868|P6|Period 2|Unsatisfactory Visual Response|0
1592622|NCT02394756|5541869|P5|Period 2|Unsatisfactory Visual Response|1
1592623|NCT02394756|5541870|P4|Period 2|Unsatisfactory Visual Response|0
1592624|NCT02394756|5541871|P3|Period 2|Unsatisfactory Visual Response|0
1592625|NCT02394756|5541872|P2|Period 2|Unsatisfactory Visual Response|0
1592626|NCT02394756|5541873|P1|Period 2|Unsatisfactory Visual Response|0
1592627|NCT02394756|5541868|P6|Period 1|Withdrawal by Subject|0
1592628|NCT02394756|5541869|P5|Period 1|Withdrawal by Subject|0
1592629|NCT02394756|5541870|P4|Period 1|Withdrawal by Subject|1
1592630|NCT02394756|5541871|P3|Period 1|Withdrawal by Subject|1
1592631|NCT02394756|5541872|P2|Period 1|Withdrawal by Subject|1
1592632|NCT02394756|5541873|P1|Period 1|Withdrawal by Subject|0
1592633|NCT02394756|5541868|P6|Period 1|Lens Discomfort|1
1592634|NCT02394756|5541869|P5|Period 1|Lens Discomfort|0
1592635|NCT02394756|5541870|P4|Period 1|Lens Discomfort|0
1592636|NCT02394756|5541871|P3|Period 1|Lens Discomfort|0
1592637|NCT02394756|5541872|P2|Period 1|Lens Discomfort|0
1592638|NCT02394756|5541873|P1|Period 1|Lens Discomfort|0
1592639|NCT02394730|5541886|P2|Overall Study|Withdrawal by Subject|1
1592640|NCT02394730|5541887|P1|Overall Study|Withdrawal by Subject|0
1592641|NCT02394730|5541886|P2|Overall Study|Lost to Follow-up|0
1592642|NCT02394730|5541887|P1|Overall Study|Lost to Follow-up|1
1592643|NCT02394665|5541924|P3|Overall Study|Physician Decision|0
1592644|NCT02394665|5541925|P2|Overall Study|Physician Decision|0
1592645|NCT02394665|5541926|P1|Overall Study|Physician Decision|1
1592646|NCT02394600|5541948|P2|Overall Study|Protocol Violation|0
1592647|NCT02394600|5541949|P1|Overall Study|Protocol Violation|1
1592648|NCT02394600|5541948|P2|Overall Study|Withdrawal by Subject|1
1592649|NCT02394600|5541949|P1|Overall Study|Withdrawal by Subject|0
1592650|NCT02394600|5541948|P2|Overall Study|Lost to Follow-up|1
1592651|NCT02394600|5541949|P1|Overall Study|Lost to Follow-up|0
1592652|NCT02394600|5541948|P2|Overall Study|Adverse Event|0
1592653|NCT02394600|5541949|P1|Overall Study|Adverse Event|3
1592654|NCT02394561|5541959|P2|Extension Phase|Lack of Efficacy|3
1592655|NCT02394561|5541960|P1|Extension Phase|Lack of Efficacy|3
1592656|NCT02394561|5541959|P2|Extension Phase|Withdrawal by Subject|5
1592657|NCT02394561|5541960|P1|Extension Phase|Withdrawal by Subject|0
1592658|NCT02394561|5541959|P2|Extension Phase|Physician Decision|2
1592659|NCT02394561|5541960|P1|Extension Phase|Physician Decision|0
1592660|NCT02394561|5541959|P2|Extension Phase|Lost to Follow-up|0
1592661|NCT02394561|5541960|P1|Extension Phase|Lost to Follow-up|1
1592662|NCT02394561|5541959|P2|Extension Phase|Protocol Violation|0
1592663|NCT02394561|5541960|P1|Extension Phase|Protocol Violation|1
1592664|NCT02394561|5541959|P2|Extension Phase|Death|1
1592665|NCT02394561|5541960|P1|Extension Phase|Death|0
1592666|NCT02394561|5541959|P2|Extension Phase|Adverse Event|1
1592667|NCT02394561|5541960|P1|Extension Phase|Adverse Event|6
1592668|NCT02394561|5541959|P2|CORE Phase|Lack of Efficacy|6
1592669|NCT02394561|5541960|P1|CORE Phase|Lack of Efficacy|1
1592670|NCT02394561|5541959|P2|CORE Phase|Withdrawal by Subject|2
1592671|NCT02394561|5541960|P1|CORE Phase|Withdrawal by Subject|2
1592672|NCT02394561|5541959|P2|CORE Phase|Physician Decision|1
1592673|NCT02394561|5541960|P1|CORE Phase|Physician Decision|1
1592674|NCT02394561|5541959|P2|CORE Phase|Lost to Follow-up|0
1592675|NCT02394561|5541960|P1|CORE Phase|Lost to Follow-up|1
1592676|NCT02394561|5541959|P2|CORE Phase|Pregnancy|0
1592677|NCT02394561|5541960|P1|CORE Phase|Pregnancy|1
1592678|NCT02394561|5541959|P2|CORE Phase|Death|1
1592679|NCT02394561|5541960|P1|CORE Phase|Death|0
1592680|NCT02394561|5541959|P2|CORE Phase|Adverse Event|9
1592681|NCT02394561|5541960|P1|CORE Phase|Adverse Event|7
1592682|NCT02394340|5542007|P1|Overall Study|Adverse Event|1
1592683|NCT02394340|5542007|P1|Overall Study|Failed drug screen test|1
1592684|NCT02393950|5542014|P2|Overall Study|Withdrawal by Subject|1
1592685|NCT02393950|5542015|P1|Overall Study|Withdrawal by Subject|0
1592686|NCT02393950|5542014|P2|Overall Study|Adverse Event|0
1592687|NCT02393950|5542015|P1|Overall Study|Adverse Event|1
1592688|NCT02393547|5542089|P1|Overall Study|Lost to Follow-up|1
1592689|NCT02393547|5542089|P1|Overall Study|Withdrawal by Subject|3
1592690|NCT02393547|5542089|P1|Overall Study|Adverse Event|2
1592691|NCT02393209|5542180|P4|Overall Study|Lost to Follow-up|0
1592692|NCT02393209|5542181|P3|Overall Study|Lost to Follow-up|0
1592693|NCT02393209|5542182|P2|Overall Study|Lost to Follow-up|1
1592694|NCT02393209|5542183|P1|Overall Study|Lost to Follow-up|0
1592695|NCT02393209|5542180|P4|Overall Study|Patient Seen by Another Oncologist|0
1592696|NCT02393209|5542181|P3|Overall Study|Patient Seen by Another Oncologist|0
1592697|NCT02393209|5542182|P2|Overall Study|Patient Seen by Another Oncologist|1
1592698|NCT02393209|5542183|P1|Overall Study|Patient Seen by Another Oncologist|0
1592699|NCT02393209|5542180|P4|Overall Study|Death from Legionella Infection|0
1592700|NCT02393209|5542181|P3|Overall Study|Death from Legionella Infection|0
1592701|NCT02393209|5542182|P2|Overall Study|Death from Legionella Infection|1
1592702|NCT02393209|5542183|P1|Overall Study|Death from Legionella Infection|0
1592703|NCT02393209|5542180|P4|Overall Study|Death due to Disease Progression|0
1592704|NCT02393209|5542181|P3|Overall Study|Death due to Disease Progression|0
1592705|NCT02393209|5542182|P2|Overall Study|Death due to Disease Progression|2
1592706|NCT02393209|5542183|P1|Overall Study|Death due to Disease Progression|2
1592707|NCT02393209|5542180|P4|Overall Study|Death|0
1592708|NCT02393209|5542181|P3|Overall Study|Death|0
1592709|NCT02393209|5542182|P2|Overall Study|Death|2
1592710|NCT02393209|5542183|P1|Overall Study|Death|2
1592711|NCT02393209|5542180|P4|Overall Study|Withdrawal by Patient|0
1592712|NCT02393209|5542181|P3|Overall Study|Withdrawal by Patient|0
1592713|NCT02393209|5542182|P2|Overall Study|Withdrawal by Patient|0
1592714|NCT02393209|5542183|P1|Overall Study|Withdrawal by Patient|1
1592715|NCT02393209|5542180|P4|Overall Study|Study Terminated by Sponsor|0
1592716|NCT02393209|5542181|P3|Overall Study|Study Terminated by Sponsor|0
1592717|NCT02393209|5542182|P2|Overall Study|Study Terminated by Sponsor|1
1592718|NCT02393209|5542183|P1|Overall Study|Study Terminated by Sponsor|1
1592719|NCT02392624|5542272|P3|Overall Study|Other|1
1592720|NCT02392624|5542273|P2|Overall Study|Other|1
1592721|NCT02392624|5542274|P1|Overall Study|Other|49
1592722|NCT02392624|5542272|P3|Overall Study|Sponsor/Investigator Decision|0
1592723|NCT02392624|5542273|P2|Overall Study|Sponsor/Investigator Decision|1
1592724|NCT02392624|5542274|P1|Overall Study|Sponsor/Investigator Decision|2
1592725|NCT02392624|5542272|P3|Overall Study|Protocol Violation|1
1592726|NCT02392624|5542273|P2|Overall Study|Protocol Violation|0
1592727|NCT02392624|5542274|P1|Overall Study|Protocol Violation|0
1592728|NCT02392624|5542272|P3|Overall Study|Pregnancy|0
1592729|NCT02392624|5542273|P2|Overall Study|Pregnancy|0
1592730|NCT02392624|5542274|P1|Overall Study|Pregnancy|1
1592731|NCT02392624|5542272|P3|Overall Study|Adverse Event|2
1592732|NCT02392624|5542273|P2|Overall Study|Adverse Event|1
1592733|NCT02392624|5542274|P1|Overall Study|Adverse Event|4
1592734|NCT02392624|5542272|P3|Overall Study|Withdrawal by Subject|9
1592735|NCT02392624|5542273|P2|Overall Study|Withdrawal by Subject|12
1592736|NCT02392624|5542274|P1|Overall Study|Withdrawal by Subject|15
1592737|NCT02392507|5542287|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|11
1592738|NCT02392507|5542287|P1|Maintenance Regimen|Death|1
1592739|NCT02392507|5542287|P1|Induction Regimen|Withdrawal by Subject|2
1592740|NCT02392507|5542287|P1|Induction Regimen|Physician Decision|1
1592741|NCT02392507|5542287|P1|Induction Regimen|On Study Treatment at Study Conclusion|11
1592742|NCT02392507|5542287|P1|Induction Regimen|Death|3
1592743|NCT02392481|5542326|P4|Overall Study|Withdrawal by Subject|0
1592744|NCT02392481|5542327|P3|Overall Study|Withdrawal by Subject|1
1592745|NCT02392481|5542328|P2|Overall Study|Withdrawal by Subject|0
1592746|NCT02392481|5542329|P1|Overall Study|Withdrawal by Subject|0
1592747|NCT02392481|5542326|P4|Overall Study|Adverse Event|2
1592748|NCT02392481|5542327|P3|Overall Study|Adverse Event|1
1592749|NCT02392481|5542328|P2|Overall Study|Adverse Event|0
1592750|NCT02392481|5542329|P1|Overall Study|Adverse Event|0
1592751|NCT02392403|5542351|P1|Overall Study|Withdrawal by Subject|1
1592752|NCT02392403|5542351|P1|Overall Study|Death|1
1592753|NCT02392403|5542351|P1|Overall Study|Adverse Event|1
1592754|NCT02392377|5542365|P2|Overall Study|Withdrawal by Subject|1
1592755|NCT02392377|5542366|P1|Overall Study|Withdrawal by Subject|0
1592756|NCT02392247|5542458|P1|Overall Study|Surgery cancelled; no data|1
1592757|NCT02392247|5542458|P1|Overall Study|Withdrawal by Subject|1
1592758|NCT02392234|5542469|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
1592759|NCT02392234|5542470|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
1592760|NCT02392234|5542471|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
1592761|NCT02392234|5542472|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
1592762|NCT02392234|5542473|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
1592763|NCT02392234|5542474|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
1592764|NCT02392234|5542469|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1592765|NCT02392234|5542470|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1592766|NCT02392234|5542471|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1592767|NCT02392234|5542472|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
1592768|NCT02392234|5542473|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1592769|NCT02392234|5542474|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
1592770|NCT02392234|5542469|P6|Treatment Period 1 (8 Weeks)|Other|0
1592771|NCT02392234|5542470|P5|Treatment Period 1 (8 Weeks)|Other|0
1592772|NCT02392234|5542471|P4|Treatment Period 1 (8 Weeks)|Other|0
1592773|NCT02392234|5542472|P3|Treatment Period 1 (8 Weeks)|Other|0
1592774|NCT02392234|5542473|P2|Treatment Period 1 (8 Weeks)|Other|0
1592775|NCT02392234|5542474|P1|Treatment Period 1 (8 Weeks)|Other|1
1592776|NCT02392234|5542469|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
1592777|NCT02392234|5542470|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
1592778|NCT02392234|5542471|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
1592779|NCT02392234|5542472|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
1592780|NCT02392234|5542473|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
1592781|NCT02392234|5542474|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
1592782|NCT02392234|5542469|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
1592783|NCT02392234|5542470|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
1592784|NCT02392234|5542471|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
1592785|NCT02392234|5542472|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
1592786|NCT02392234|5542473|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
1592787|NCT02392234|5542474|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
1592788|NCT02392234|5542469|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1592789|NCT02392234|5542470|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1592790|NCT02392234|5542471|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1592791|NCT02392234|5542472|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1592792|NCT02392234|5542473|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1592793|NCT02392234|5542474|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1592794|NCT02392234|5542469|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1592795|NCT02392234|5542470|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
1592796|NCT02392234|5542471|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1592797|NCT02392234|5542472|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1592798|NCT02392234|5542473|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1592799|NCT02392234|5542474|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
1592800|NCT02392234|5542469|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
1592801|NCT02392234|5542470|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
1592802|NCT02392234|5542471|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
1592803|NCT02392234|5542472|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
1592804|NCT02392234|5542473|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
1592805|NCT02392234|5542474|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
1592806|NCT02392104|5542506|P1|Overall Study|INRs drawn by visiting nurse services|1
1592807|NCT02392104|5542506|P1|Overall Study|admitted to skilled nursing facility|3
1592808|NCT02392104|5542506|P1|Overall Study|INR goal range changed|1
1592809|NCT02392104|5542506|P1|Overall Study|transferred care to another doctor|2
1592810|NCT02392104|5542506|P1|Overall Study|bleeding event|1
1592811|NCT02392104|5542506|P1|Overall Study|discontinuation of warfarin|3
1592812|NCT02392000|5542517|P1|Overall Study|Lost to Follow-up|8
1592813|NCT02392000|5542517|P1|Overall Study|Withdrawal by Subject|1
1592814|NCT02392000|5542517|P1|Overall Study|Greater than mild sleep apnea exclusion|18
1592815|NCT02391948|5542543|P5|24-month Assessment|Not able to schedule visit in timeframe|8
1592816|NCT02391948|5542544|P4|24-month Assessment|Not able to schedule visit in timeframe|9
1592817|NCT02391948|5542545|P3|24-month Assessment|Not able to schedule visit in timeframe|2
1592818|NCT02391948|5542546|P2|24-month Assessment|Not able to schedule visit in timeframe|5
1592819|NCT02391948|5542547|P1|24-month Assessment|Not able to schedule visit in timeframe|8
1592820|NCT02391948|5542543|P5|24-month Assessment|Medical issue/illness|0
1592821|NCT02391948|5542544|P4|24-month Assessment|Medical issue/illness|0
1592822|NCT02391948|5542545|P3|24-month Assessment|Medical issue/illness|1
1592823|NCT02391948|5542546|P2|24-month Assessment|Medical issue/illness|0
1592824|NCT02391948|5542547|P1|24-month Assessment|Medical issue/illness|0
1592825|NCT02391948|5542543|P5|24-month Assessment|Lost to Follow-up|0
1592826|NCT02391948|5542544|P4|24-month Assessment|Lost to Follow-up|0
1592827|NCT02391948|5542545|P3|24-month Assessment|Lost to Follow-up|0
1592828|NCT02391948|5542546|P2|24-month Assessment|Lost to Follow-up|4
1592829|NCT02391948|5542547|P1|24-month Assessment|Lost to Follow-up|5
1592830|NCT02391948|5542543|P5|24-month Assessment|Withdrawal by Subject|1
1592831|NCT02391948|5542544|P4|24-month Assessment|Withdrawal by Subject|0
1592832|NCT02391948|5542545|P3|24-month Assessment|Withdrawal by Subject|0
1592833|NCT02391948|5542546|P2|24-month Assessment|Withdrawal by Subject|1
1592834|NCT02391948|5542547|P1|24-month Assessment|Withdrawal by Subject|1
1592835|NCT02391948|5542543|P5|24-month Assessment|Death|1
1592836|NCT02391948|5542544|P4|24-month Assessment|Death|0
1592837|NCT02391948|5542545|P3|24-month Assessment|Death|0
1592838|NCT02391948|5542546|P2|24-month Assessment|Death|0
1592839|NCT02391948|5542547|P1|24-month Assessment|Death|0
1592840|NCT02391948|5542543|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
1592841|NCT02391948|5542544|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
1592842|NCT02391948|5542545|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
1592843|NCT02391948|5542546|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
1592844|NCT02391948|5542547|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
1592845|NCT02391948|5542543|P5|18-month Assessment|Not able to schedule visit in timeframe|4
1592846|NCT02391948|5542544|P4|18-month Assessment|Not able to schedule visit in timeframe|1
1592847|NCT02391948|5542545|P3|18-month Assessment|Not able to schedule visit in timeframe|2
1592848|NCT02391948|5542546|P2|18-month Assessment|Not able to schedule visit in timeframe|3
1592849|NCT02391948|5542547|P1|18-month Assessment|Not able to schedule visit in timeframe|3
1592850|NCT02391948|5542543|P5|18-month Assessment|Lost to Follow-up|3
1592851|NCT02391948|5542544|P4|18-month Assessment|Lost to Follow-up|2
1592852|NCT02391948|5542545|P3|18-month Assessment|Lost to Follow-up|2
1592853|NCT02391948|5542546|P2|18-month Assessment|Lost to Follow-up|6
1592854|NCT02391948|5542547|P1|18-month Assessment|Lost to Follow-up|2
1592855|NCT02391948|5542543|P5|18-month Assessment|Withdrawal by Subject|0
1592856|NCT02391948|5542544|P4|18-month Assessment|Withdrawal by Subject|1
1592857|NCT02391948|5542545|P3|18-month Assessment|Withdrawal by Subject|0
1592858|NCT02391948|5542546|P2|18-month Assessment|Withdrawal by Subject|0
1592859|NCT02391948|5542547|P1|18-month Assessment|Withdrawal by Subject|1
1592860|NCT02391948|5542543|P5|18-month Assessment|Death|1
1592861|NCT02391948|5542544|P4|18-month Assessment|Death|1
1592862|NCT02391948|5542545|P3|18-month Assessment|Death|0
1592863|NCT02391948|5542546|P2|18-month Assessment|Death|0
1592864|NCT02391948|5542547|P1|18-month Assessment|Death|0
1592865|NCT02391948|5542543|P5|12-month Assessment|Not able to schedule visit in timeframe|1
1592866|NCT02391948|5542544|P4|12-month Assessment|Not able to schedule visit in timeframe|2
1592867|NCT02391948|5542545|P3|12-month Assessment|Not able to schedule visit in timeframe|0
1592868|NCT02391948|5542546|P2|12-month Assessment|Not able to schedule visit in timeframe|4
1592869|NCT02391948|5542547|P1|12-month Assessment|Not able to schedule visit in timeframe|2
1592870|NCT02391948|5542543|P5|12-month Assessment|Medical issue/illness|0
1592871|NCT02391948|5542544|P4|12-month Assessment|Medical issue/illness|1
1592872|NCT02391948|5542545|P3|12-month Assessment|Medical issue/illness|0
1592873|NCT02391948|5542546|P2|12-month Assessment|Medical issue/illness|1
1592874|NCT02391948|5542547|P1|12-month Assessment|Medical issue/illness|0
1592875|NCT02391948|5542543|P5|12-month Assessment|Lost to Follow-up|5
1592876|NCT02391948|5542544|P4|12-month Assessment|Lost to Follow-up|4
1592877|NCT02391948|5542545|P3|12-month Assessment|Lost to Follow-up|4
1592878|NCT02391948|5542546|P2|12-month Assessment|Lost to Follow-up|4
1592879|NCT02391948|5542547|P1|12-month Assessment|Lost to Follow-up|5
1592880|NCT02391948|5542543|P5|12-month Assessment|Withdrawal by Subject|0
1592881|NCT02391948|5542544|P4|12-month Assessment|Withdrawal by Subject|1
1592882|NCT02391948|5542545|P3|12-month Assessment|Withdrawal by Subject|0
1592883|NCT02391948|5542546|P2|12-month Assessment|Withdrawal by Subject|0
1592884|NCT02391948|5542547|P1|12-month Assessment|Withdrawal by Subject|1
1592885|NCT02391948|5542543|P5|12-month Assessment|Death|0
1592886|NCT02391948|5542544|P4|12-month Assessment|Death|1
1592887|NCT02391948|5542545|P3|12-month Assessment|Death|0
1592888|NCT02391948|5542546|P2|12-month Assessment|Death|0
1592889|NCT02391948|5542547|P1|12-month Assessment|Death|0
1592890|NCT02391948|5542543|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
1592891|NCT02391948|5542544|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
1592892|NCT02391948|5542545|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
1592893|NCT02391948|5542546|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
1592894|NCT02391948|5542547|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
1592895|NCT02391948|5542543|P5|6-month Assessment|Not able to schedule visit in timeframe|0
1592896|NCT02391948|5542544|P4|6-month Assessment|Not able to schedule visit in timeframe|5
1592897|NCT02391948|5542545|P3|6-month Assessment|Not able to schedule visit in timeframe|4
1592898|NCT02391948|5542546|P2|6-month Assessment|Not able to schedule visit in timeframe|8
1592899|NCT02391948|5542547|P1|6-month Assessment|Not able to schedule visit in timeframe|6
1592900|NCT02391948|5542543|P5|6-month Assessment|Medical issue/illness|0
1592901|NCT02391948|5542544|P4|6-month Assessment|Medical issue/illness|0
1592902|NCT02391948|5542545|P3|6-month Assessment|Medical issue/illness|0
1592903|NCT02391948|5542546|P2|6-month Assessment|Medical issue/illness|1
1592904|NCT02391948|5542547|P1|6-month Assessment|Medical issue/illness|1
1592905|NCT02391948|5542543|P5|6-month Assessment|Lost to Follow-up|1
1592906|NCT02391948|5542544|P4|6-month Assessment|Lost to Follow-up|3
1592907|NCT02391948|5542545|P3|6-month Assessment|Lost to Follow-up|2
1592908|NCT02391948|5542546|P2|6-month Assessment|Lost to Follow-up|5
1592909|NCT02391948|5542547|P1|6-month Assessment|Lost to Follow-up|4
1592910|NCT02391948|5542543|P5|6-month Assessment|Withdrawal by Subject|0
1592911|NCT02391948|5542544|P4|6-month Assessment|Withdrawal by Subject|2
1592912|NCT02391948|5542545|P3|6-month Assessment|Withdrawal by Subject|1
1592913|NCT02391948|5542546|P2|6-month Assessment|Withdrawal by Subject|0
1592914|NCT02391948|5542547|P1|6-month Assessment|Withdrawal by Subject|0
1592915|NCT02391948|5542543|P5|6-month Assessment|Death|1
1592916|NCT02391948|5542544|P4|6-month Assessment|Death|0
1592917|NCT02391948|5542545|P3|6-month Assessment|Death|0
1592918|NCT02391948|5542546|P2|6-month Assessment|Death|0
1592919|NCT02391948|5542547|P1|6-month Assessment|Death|0
1592920|NCT02391584|5542654|P2|12 Month (End of Study)|Lost to Follow-up|0
1592921|NCT02391584|5542655|P1|12 Month (End of Study)|Lost to Follow-up|2
1592922|NCT02391584|5542654|P2|6 Month|Withdrawal by Subject|0
1592923|NCT02391584|5542655|P1|6 Month|Withdrawal by Subject|1
1592924|NCT02391584|5542654|P2|3 Month|Lost to Follow-up|0
1592925|NCT02391584|5542655|P1|3 Month|Lost to Follow-up|1
1592926|NCT02391584|5542654|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
1592927|NCT02391584|5542655|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
1592928|NCT02391584|5542654|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
1592929|NCT02391584|5542655|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
1592930|NCT02391545|5542672|P2|Overall Study|Other Reasons|4
1592931|NCT02391545|5542673|P1|Overall Study|Other Reasons|6
1592932|NCT02391545|5542672|P2|Overall Study|Withdrawal by Subject|1
1592933|NCT02391545|5542673|P1|Overall Study|Withdrawal by Subject|0
1592934|NCT02391545|5542672|P2|Overall Study|Termination of study by sponsor|20
1592935|NCT02391545|5542673|P1|Overall Study|Termination of study by sponsor|20
1592936|NCT02391545|5542672|P2|Overall Study|Lost to Follow-up|1
1592937|NCT02391545|5542673|P1|Overall Study|Lost to Follow-up|0
1592938|NCT02391545|5542672|P2|Overall Study|Death|2
1592939|NCT02391545|5542673|P1|Overall Study|Death|0
1592940|NCT02391363|5542693|P2|Overall Study|Withdrawal by Subject|3
1592941|NCT02391363|5542694|P1|Overall Study|Withdrawal by Subject|6
1592942|NCT02391363|5542693|P2|Overall Study|Lost to Follow-up|5
1592943|NCT02391363|5542694|P1|Overall Study|Lost to Follow-up|5
1592944|NCT02391311|5542760|P2|Overall Study|deemed ineligible after baseline|1
1592945|NCT02391311|5542761|P1|Overall Study|deemed ineligible after baseline|1
1592946|NCT02391311|5542760|P2|Overall Study|Lost to Follow-up|1
1592947|NCT02391311|5542761|P1|Overall Study|Lost to Follow-up|2
1592948|NCT02391116|5542769|P1|Survival Follow-up|Switching to Other Therapy|1
1592949|NCT02391116|5542769|P1|Survival Follow-up|Withdrawal by Subject|3
1592950|NCT02391116|5542769|P1|Active Follow-up|Switching to Other Therapy|2
1592951|NCT02391116|5542769|P1|Active Follow-up|Withdrawal by Subject|1
1592952|NCT02391116|5542769|P1|Safety Follow-up|Deterioration of General Conditions|3
1592953|NCT02391116|5542769|P1|Safety Follow-up|No Follow Up|1
1592954|NCT02391116|5542769|P1|Safety Follow-up|Switching to Other Therapy|4
1592955|NCT02391116|5542769|P1|Safety Follow-up|Withdrawal by Subject|4
1592956|NCT02391116|5542769|P1|Safety Follow-up|Adverse Event|1
1592957|NCT02391116|5542769|P1|Treatment|AE with Clinical PD|3
1592958|NCT02391116|5542769|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
1592959|NCT02391116|5542769|P1|Treatment|Protocol Violation|1
1592960|NCT02391116|5542769|P1|Treatment|Withdrawal by Subject|1
1592961|NCT02391038|5542823|P3|Overall Study|Progressive disease|6
1592962|NCT02391038|5542824|P2|Overall Study|Progressive disease|3
1592963|NCT02391038|5542825|P1|Overall Study|Progressive disease|3
1592964|NCT02390557|5542969|P3|Wave 2|Survey non-respondent|23
1592965|NCT02390557|5542970|P2|Wave 2|Survey non-respondent|41
1592966|NCT02390557|5542971|P1|Wave 2|Survey non-respondent|72
1592967|NCT02390362|5542981|P2|Overall Study|Withdrawal by Subject|1
1592968|NCT02390362|5542982|P1|Overall Study|Withdrawal by Subject|0
1592969|NCT02390219|5542990|P1|Overall Study|Other|2
1592970|NCT02390219|5542990|P1|Overall Study|Lost to Follow-up|2
1592971|NCT02390219|5542990|P1|Overall Study|Withdrawal by Subject|1
1592972|NCT02390219|5542990|P1|Overall Study|Adverse Event|6
1592973|NCT02390219|5542990|P1|Overall Study|Physician Decision|1
1592974|NCT02390219|5542990|P1|Overall Study|Death|1
1592975|NCT02390167|5543000|P1|Overall Study|Lost to Follow-up|1
1592976|NCT02390076|5543022|P3|Overall Study|Lost to Follow-up|4
1592977|NCT02390076|5543023|P2|Overall Study|Lost to Follow-up|1
1592978|NCT02390076|5543024|P1|Overall Study|Lost to Follow-up|2
1592979|NCT02389894|5543053|P3|Overall Study|Lost to Follow-up|1
1592980|NCT02389894|5543054|P2|Overall Study|Lost to Follow-up|1
1592981|NCT02389894|5543055|P1|Overall Study|Lost to Follow-up|2
1592982|NCT02389894|5543053|P3|Overall Study|Withdrawal by Subject|5
1592983|NCT02389894|5543054|P2|Overall Study|Withdrawal by Subject|4
1592984|NCT02389894|5543055|P1|Overall Study|Withdrawal by Subject|2
1592985|NCT02389894|5543053|P3|Overall Study|Death|3
1592986|NCT02389894|5543054|P2|Overall Study|Death|5
1592987|NCT02389894|5543055|P1|Overall Study|Death|4
1592988|NCT02389829|5543187|P2|Overall Study|Lost to Follow-up|1
1592989|NCT02389829|5543188|P1|Overall Study|Lost to Follow-up|0
1592990|NCT02389816|5543203|P3|Overall Study|Reason not Specified|0
1592991|NCT02389816|5543204|P2|Overall Study|Reason not Specified|2
1592992|NCT02389816|5543205|P1|Overall Study|Reason not Specified|0
1592993|NCT02389816|5543203|P3|Overall Study|Non Compliance with Study Drug|1
1592994|NCT02389816|5543204|P2|Overall Study|Non Compliance with Study Drug|1
1592995|NCT02389816|5543205|P1|Overall Study|Non Compliance with Study Drug|1
1592996|NCT02389816|5543203|P3|Overall Study|Lack of Efficacy|0
1592997|NCT02389816|5543204|P2|Overall Study|Lack of Efficacy|0
1592998|NCT02389816|5543205|P1|Overall Study|Lack of Efficacy|1
1592999|NCT02389816|5543203|P3|Overall Study|Withdrawal of Consent|4
1593000|NCT02389816|5543204|P2|Overall Study|Withdrawal of Consent|4
1593001|NCT02389816|5543205|P1|Overall Study|Withdrawal of Consent|6
1593002|NCT02389816|5543203|P3|Overall Study|Lost to Follow-up|0
1593003|NCT02389816|5543204|P2|Overall Study|Lost to Follow-up|0
1593004|NCT02389816|5543205|P1|Overall Study|Lost to Follow-up|1
1593005|NCT02389816|5543203|P3|Overall Study|Major Protocol Deviation|0
1593006|NCT02389816|5543204|P2|Overall Study|Major Protocol Deviation|0
1593007|NCT02389816|5543205|P1|Overall Study|Major Protocol Deviation|1
1593008|NCT02389816|5543203|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
1593009|NCT02389816|5543204|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
1593010|NCT02389816|5543205|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
1593011|NCT02389816|5543203|P3|Overall Study|Randomized but Not Treated|0
1593012|NCT02389816|5543204|P2|Overall Study|Randomized but Not Treated|0
1593013|NCT02389816|5543205|P1|Overall Study|Randomized but Not Treated|1
1593014|NCT02389764|5543237|P1|Overall Study|Lack of Efficacy|9
1593015|NCT02389621|5543272|P2|Posttreatment Period|Other - Miscellaneous|0
1593016|NCT02389621|5543273|P1|Posttreatment Period|Other - Miscellaneous|2
1593017|NCT02389621|5543272|P2|Posttreatment Period|Lost to Follow-up|1
1593018|NCT02389621|5543273|P1|Posttreatment Period|Lost to Follow-up|1
1593019|NCT02389621|5543272|P2|Posttreatment Period|Withdrawal by Subject|2
1593020|NCT02389621|5543273|P1|Posttreatment Period|Withdrawal by Subject|3
1593021|NCT02389621|5543272|P2|Posttreatment Period|Adverse Event|1
1593022|NCT02389621|5543273|P1|Posttreatment Period|Adverse Event|3
1593023|NCT02389621|5543272|P2|Treatment Period|Withdrawal by Subject|1
1593024|NCT02389621|5543273|P1|Treatment Period|Withdrawal by Subject|1
1593025|NCT02389452|5543303|P1|Overall Study|Enrolled but Not Eligible for Study|6
1593026|NCT02389452|5543303|P1|Overall Study|Withdrawal by Subject|5
1593027|NCT02389452|5543303|P1|Overall Study|Adverse Event|1
1593028|NCT02389452|5543303|P1|Overall Study|Lost to Follow-up|13
1593029|NCT02388997|5543415|P2|Overall Study|Tested positive for virus during run-in|1
1593030|NCT02388997|5543416|P1|Overall Study|Tested positive for virus during run-in|0
1593031|NCT02388997|5543415|P2|Overall Study|Lung function exclusion criteria|2
1593032|NCT02388997|5543416|P1|Overall Study|Lung function exclusion criteria|0
1593033|NCT02388997|5543415|P2|Overall Study|Withdrawal by Subject|1
1593034|NCT02388997|5543416|P1|Overall Study|Withdrawal by Subject|2
1593035|NCT02388997|5543415|P2|Overall Study|Adverse Event|2
1593036|NCT02388997|5543416|P1|Overall Study|Adverse Event|1
1593037|NCT02388932|5543434|P1|Overall Study|Death|1
1593038|NCT02388776|5543455|P1|Overall Study|Lost to Follow-up|1
1593039|NCT02388776|5543455|P1|Overall Study|Death|1
1593040|NCT02388763|5543460|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1593041|NCT02388763|5543461|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1593042|NCT02388763|5543460|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1593043|NCT02388763|5543461|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1593062|NCT02388724|5543511|P2|Overall Study|Randomized but not Treated|2
1593063|NCT02388724|5543512|P1|Overall Study|Randomized but not Treated|0
1593064|NCT02388724|5543511|P2|Overall Study|Voluntary Withdrawal|5
1593065|NCT02388724|5543512|P1|Overall Study|Voluntary Withdrawal|6
1593066|NCT02388724|5543511|P2|Overall Study|Pretreatment Event/Adverse Event|2
1593067|NCT02388724|5543512|P1|Overall Study|Pretreatment Event/Adverse Event|3
1593068|NCT02388724|5543511|P2|Overall Study|Major Protocol Deviation|3
1593069|NCT02388724|5543512|P1|Overall Study|Major Protocol Deviation|3
1593070|NCT02388724|5543511|P2|Overall Study|Reason not Specified|1
1593071|NCT02388724|5543512|P1|Overall Study|Reason not Specified|0
1593072|NCT02388347|5543558|P5|Overall Study|Withdrawal by Subject|0
1593073|NCT02388347|5543559|P4|Overall Study|Withdrawal by Subject|0
1593074|NCT02388347|5543560|P3|Overall Study|Withdrawal by Subject|1
1593075|NCT02388347|5543561|P2|Overall Study|Withdrawal by Subject|0
1593076|NCT02388347|5543562|P1|Overall Study|Withdrawal by Subject|0
1593077|NCT02388295|5543641|P3|Treatment Weeks 3 to 12|Adverse Event|0
1593078|NCT02388295|5543642|P2|Treatment Weeks 3 to 12|Adverse Event|1
1593079|NCT02388295|5543643|P1|Treatment Weeks 3 to 12|Adverse Event|1
1593080|NCT02388295|5543641|P3|Dose Escalation Week 2|Determined not eligible|1
1593081|NCT02388295|5543642|P2|Dose Escalation Week 2|Determined not eligible|1
1593082|NCT02388295|5543643|P1|Dose Escalation Week 2|Determined not eligible|1
1593083|NCT02388295|5543641|P3|Dose Escalation Week 2|Protocol Violation|0
1593084|NCT02388295|5543642|P2|Dose Escalation Week 2|Protocol Violation|1
1593085|NCT02388295|5543643|P1|Dose Escalation Week 2|Protocol Violation|0
1593086|NCT02388295|5543641|P3|Dose Escalation Week 1|Determined not eligible|1
1593087|NCT02388295|5543642|P2|Dose Escalation Week 1|Determined not eligible|1
1593088|NCT02388295|5543643|P1|Dose Escalation Week 1|Determined not eligible|1
1593089|NCT02388295|5543641|P3|Dose Escalation Week 1|Adverse Event|1
1593090|NCT02388295|5543642|P2|Dose Escalation Week 1|Adverse Event|2
1593091|NCT02388295|5543643|P1|Dose Escalation Week 1|Adverse Event|1
1593092|NCT02388269|5543661|P3|Overall Study|Screen Failure|10
1593093|NCT02388269|5543662|P2|Overall Study|Screen Failure|0
1593094|NCT02388269|5543663|P1|Overall Study|Screen Failure|0
1593095|NCT02388269|5543661|P3|Overall Study|Protocol Violation|0
1593096|NCT02388269|5543662|P2|Overall Study|Protocol Violation|0
1593097|NCT02388269|5543663|P1|Overall Study|Protocol Violation|2
1593098|NCT02388269|5543661|P3|Overall Study|no diary data|0
1593099|NCT02388269|5543662|P2|Overall Study|no diary data|0
1593100|NCT02388269|5543663|P1|Overall Study|no diary data|3
1593101|NCT02388269|5543661|P3|Overall Study|less than 50% stimulations|0
1593102|NCT02388269|5543662|P2|Overall Study|less than 50% stimulations|0
1593103|NCT02388269|5543663|P1|Overall Study|less than 50% stimulations|1
1593104|NCT02388269|5543661|P3|Overall Study|Withdrawal by Subject|0
1593105|NCT02388269|5543662|P2|Overall Study|Withdrawal by Subject|2
1593106|NCT02388269|5543663|P1|Overall Study|Withdrawal by Subject|1
1593107|NCT02388269|5543661|P3|Overall Study|Adverse Event|0
1593108|NCT02388269|5543662|P2|Overall Study|Adverse Event|0
1593109|NCT02388269|5543663|P1|Overall Study|Adverse Event|2
1593110|NCT02388191|5543695|P2|Overall Study|Patient did not receive IUD|0
1593111|NCT02388191|5543696|P1|Overall Study|Patient did not receive IUD|1
1593112|NCT02388074|5543710|P1|Overall Study|Sample Not Returned|1
1593113|NCT02388074|5543710|P1|Overall Study|Lost in Transit|2
1593114|NCT02387996|5543714|P1|Overall Study|Poor/Non-Compliance|1
1593115|NCT02387996|5543714|P1|Overall Study|Lost to Follow-up|1
1593116|NCT02387996|5543714|P1|Overall Study|Subject Withdrew Consent|1
1593117|NCT02387996|5543714|P1|Overall Study|Subject Request to Discontinue Treatment|9
1593118|NCT02387996|5543714|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
1593119|NCT02387996|5543714|P1|Overall Study|Study Drug Toxicity|14
1593120|NCT02387996|5543714|P1|Overall Study|Disease Progression|144
1593121|NCT02387983|5543725|P1|Overall Study|Withdrawal by Subject|2
1593122|NCT02387983|5543725|P1|Overall Study|Protocol Violation|1
1593123|NCT02387983|5543725|P1|Overall Study|Adverse Event|4
1593126|NCT02387957|5543761|P3|Overall Study|The study was discontinued|20
1593127|NCT02387957|5543762|P2|Overall Study|The study was discontinued|21
1593128|NCT02387957|5543763|P1|Overall Study|The study was discontinued|21
1593129|NCT02387762|5543834|P2|Overall Study|Withdrawal by Subject|0
1593130|NCT02387762|5543835|P1|Overall Study|Withdrawal by Subject|1
1593131|NCT02387580|5543867|P6|Overall Study|Withdrawal by Subject|0
1593132|NCT02387580|5543868|P5|Overall Study|Withdrawal by Subject|0
1593133|NCT02387580|5543869|P4|Overall Study|Withdrawal by Subject|1
1593134|NCT02387580|5543870|P3|Overall Study|Withdrawal by Subject|0
1593135|NCT02387580|5543871|P2|Overall Study|Withdrawal by Subject|0
1593136|NCT02387580|5543872|P1|Overall Study|Withdrawal by Subject|0
1593137|NCT02387372|5543965|P2|Overall Study|Not Treated|0
1593138|NCT02387372|5543966|P1|Overall Study|Not Treated|1
1593139|NCT02386345|5544076|P1|Overall Study|Did not complete 12-month follow-up|72
1593140|NCT02386345|5544076|P1|Overall Study|Repeat Procedure|10
1593141|NCT02386345|5544076|P1|Overall Study|Adverse Event|5
1593142|NCT02386345|5544076|P1|Overall Study|Lost to Follow-up|1
1593143|NCT02386345|5544076|P1|Overall Study|Not treated|14
1593144|NCT02386189|5544086|P2|Overall Study|Death|0
1593145|NCT02386189|5544087|P1|Overall Study|Death|1
1593146|NCT02386189|5544086|P2|Overall Study|Withdrawal by Subject|0
1593147|NCT02386189|5544087|P1|Overall Study|Withdrawal by Subject|1
1593148|NCT02386189|5544086|P2|Overall Study|Lost to Follow-up|3
1593149|NCT02386189|5544087|P1|Overall Study|Lost to Follow-up|2
1593150|NCT02386098|5544110|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1593151|NCT02386098|5544111|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1593152|NCT02386098|5544112|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
1593153|NCT02386098|5544113|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
1593154|NCT02386098|5544114|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
1593155|NCT02386098|5544110|P5|Stage 1 (96 Weeks)|Other|0
1593156|NCT02386098|5544111|P4|Stage 1 (96 Weeks)|Other|0
1593157|NCT02386098|5544112|P3|Stage 1 (96 Weeks)|Other|0
1593158|NCT02386098|5544113|P2|Stage 1 (96 Weeks)|Other|0
1593159|NCT02386098|5544114|P1|Stage 1 (96 Weeks)|Other|1
1593160|NCT02386098|5544110|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1593161|NCT02386098|5544111|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1593162|NCT02386098|5544112|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
1593163|NCT02386098|5544113|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
1593164|NCT02386098|5544114|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
1593165|NCT02386098|5544110|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1593166|NCT02386098|5544111|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1593167|NCT02386098|5544112|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1593168|NCT02386098|5544113|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
1593169|NCT02386098|5544114|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
1593170|NCT02386098|5544110|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
1593171|NCT02386098|5544111|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
1593172|NCT02386098|5544112|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
1593173|NCT02386098|5544113|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
1593174|NCT02386098|5544114|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
1593175|NCT02386098|5544110|P5|Stage 1 (96 Weeks)|Adverse Event|0
1593176|NCT02386098|5544111|P4|Stage 1 (96 Weeks)|Adverse Event|0
1593177|NCT02386098|5544112|P3|Stage 1 (96 Weeks)|Adverse Event|0
1593178|NCT02386098|5544113|P2|Stage 1 (96 Weeks)|Adverse Event|1
1593179|NCT02386098|5544114|P1|Stage 1 (96 Weeks)|Adverse Event|2
1593180|NCT02386098|5544110|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1593181|NCT02386098|5544111|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1593182|NCT02386098|5544112|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
1593183|NCT02386098|5544113|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
1593184|NCT02386098|5544114|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
1593185|NCT02385799|5544193|P2|Overall Study|Withdrawal by Subject|4
1593186|NCT02385799|5544194|P1|Overall Study|Withdrawal by Subject|0
1593187|NCT02385799|5544193|P2|Overall Study|Adverse Event|2
1593188|NCT02385799|5544194|P1|Overall Study|Adverse Event|4
1593189|NCT02385799|5544193|P2|Overall Study|Lost to Follow-up|2
1593190|NCT02385799|5544194|P1|Overall Study|Lost to Follow-up|1
1593191|NCT02385708|5544235|P2|Overall Study|Protocol Violation|1
1593192|NCT02385708|5544236|P1|Overall Study|Protocol Violation|1
1593193|NCT02385708|5544235|P2|Overall Study|Investigator decision|7
1593194|NCT02385708|5544236|P1|Overall Study|Investigator decision|5
1593195|NCT02385708|5544235|P2|Overall Study|Withdrawn - surgery canceled|5
1593196|NCT02385708|5544236|P1|Overall Study|Withdrawn - surgery canceled|2
1593197|NCT02385708|5544235|P2|Overall Study|Withdrawal by Subject|2
1593198|NCT02385708|5544236|P1|Overall Study|Withdrawal by Subject|0
1593199|NCT02385669|5544242|P1|Overall Study|Adverse Event|2
1593200|NCT02385526|5544250|P3|Overall Study|Protocol Violation|0
1593201|NCT02385526|5544251|P2|Overall Study|Protocol Violation|0
1593202|NCT02385526|5544252|P1|Overall Study|Protocol Violation|1
1593203|NCT02385526|5544250|P3|Overall Study|Physician Decision|0
1593204|NCT02385526|5544251|P2|Overall Study|Physician Decision|0
1593205|NCT02385526|5544252|P1|Overall Study|Physician Decision|1
1593206|NCT02385526|5544250|P3|Overall Study|Lost to Follow-up|0
1593207|NCT02385526|5544251|P2|Overall Study|Lost to Follow-up|1
1593208|NCT02385526|5544252|P1|Overall Study|Lost to Follow-up|0
1593209|NCT02385526|5544250|P3|Overall Study|Withdrawal by Subject|0
1593210|NCT02385526|5544251|P2|Overall Study|Withdrawal by Subject|2
1593211|NCT02385526|5544252|P1|Overall Study|Withdrawal by Subject|0
1593212|NCT02385084|5544260|P6|Period 2|Protocol Violation|0
1593213|NCT02385084|5544261|P5|Period 2|Protocol Violation|0
1593214|NCT02385084|5544262|P4|Period 2|Protocol Violation|0
1593215|NCT02385084|5544263|P3|Period 2|Protocol Violation|1
1593216|NCT02385084|5544264|P2|Period 2|Protocol Violation|0
1593217|NCT02385084|5544265|P1|Period 2|Protocol Violation|0
1593218|NCT02384941|5544279|P3|Overall Study|Other than specified above|1
1593219|NCT02384941|5544280|P2|Overall Study|Other than specified above|0
1593220|NCT02384941|5544281|P1|Overall Study|Other than specified above|4
1593221|NCT02384941|5544279|P3|Overall Study|Pregnancy|1
1593222|NCT02384941|5544280|P2|Overall Study|Pregnancy|0
1593223|NCT02384941|5544281|P1|Overall Study|Pregnancy|0
1593224|NCT02384941|5544279|P3|Overall Study|Withdrawal by Subject|20
1593225|NCT02384941|5544280|P2|Overall Study|Withdrawal by Subject|19
1593226|NCT02384941|5544281|P1|Overall Study|Withdrawal by Subject|26
1593227|NCT02384941|5544279|P3|Overall Study|Protocol Violation|0
1593228|NCT02384941|5544280|P2|Overall Study|Protocol Violation|0
1593229|NCT02384941|5544281|P1|Overall Study|Protocol Violation|3
1593230|NCT02384941|5544279|P3|Overall Study|Physician Decision|0
1593231|NCT02384941|5544280|P2|Overall Study|Physician Decision|1
1593232|NCT02384941|5544281|P1|Overall Study|Physician Decision|1
1593233|NCT02384941|5544279|P3|Overall Study|Non-Compliance With Study Drug|1
1593234|NCT02384941|5544280|P2|Overall Study|Non-Compliance With Study Drug|0
1593235|NCT02384941|5544281|P1|Overall Study|Non-Compliance With Study Drug|2
1593236|NCT02384941|5544279|P3|Overall Study|Lost to Follow-up|1
1593237|NCT02384941|5544280|P2|Overall Study|Lost to Follow-up|2
1593238|NCT02384941|5544281|P1|Overall Study|Lost to Follow-up|3
1593239|NCT02384941|5544279|P3|Overall Study|Adverse Event|17
1593240|NCT02384941|5544280|P2|Overall Study|Adverse Event|13
1593241|NCT02384941|5544281|P1|Overall Study|Adverse Event|11
1593242|NCT02384538|5544312|P2|Overall Study|Other|3
1593243|NCT02384538|5544313|P1|Overall Study|Other|1
1593244|NCT02384538|5544312|P2|Overall Study|Withdrew Consent|4
1593245|NCT02384538|5544313|P1|Overall Study|Withdrew Consent|0
1593246|NCT02384538|5544312|P2|Overall Study|Lack of Efficacy|4
1593247|NCT02384538|5544313|P1|Overall Study|Lack of Efficacy|4
1593248|NCT02384538|5544312|P2|Overall Study|Adverse Event|4
1593249|NCT02384538|5544313|P1|Overall Study|Adverse Event|1
1593250|NCT02384460|5544333|P2|Overall Study|Non-compliance|0
1593251|NCT02384460|5544334|P1|Overall Study|Non-compliance|1
1593252|NCT02384460|5544333|P2|Overall Study|Elective medical treatment|0
1593253|NCT02384460|5544334|P1|Overall Study|Elective medical treatment|1
1593254|NCT02384460|5544333|P2|Overall Study|Withdrawal by Subject|3
1593255|NCT02384460|5544334|P1|Overall Study|Withdrawal by Subject|0
1593256|NCT02384460|5544333|P2|Overall Study|Adverse Event|2
1593257|NCT02384460|5544334|P1|Overall Study|Adverse Event|5
1593258|NCT02384460|5544333|P2|Overall Study|Returned to previous therapeutic regimen|1
1593259|NCT02384460|5544334|P1|Overall Study|Returned to previous therapeutic regimen|0
1593260|NCT02384460|5544333|P2|Overall Study|Protocol Violation|1
1593261|NCT02384460|5544334|P1|Overall Study|Protocol Violation|0
1593262|NCT02383966|5544419|P2|Overall Study|Randomized, but not treated|3
1593263|NCT02383966|5544420|P1|Overall Study|Randomized, but not treated|1
1593264|NCT02383966|5544419|P2|Overall Study|Ongoing at clinical cut-off date|4
1593265|NCT02383966|5544420|P1|Overall Study|Ongoing at clinical cut-off date|25
1593266|NCT02383940|5544440|P2|Overall Study|Other than specified above|0
1593267|NCT02383940|5544441|P1|Overall Study|Other than specified above|1
1593268|NCT02383940|5544440|P2|Overall Study|Randomized but not treated|0
1593269|NCT02383940|5544441|P1|Overall Study|Randomized but not treated|2
1593270|NCT02383940|5544440|P2|Overall Study|Withdrawal by Subject|1
1593271|NCT02383940|5544441|P1|Overall Study|Withdrawal by Subject|1
1593272|NCT02383940|5544440|P2|Overall Study|Physician Decision|0
1593273|NCT02383940|5544441|P1|Overall Study|Physician Decision|2
1593274|NCT02383940|5544440|P2|Overall Study|Lost to Follow-up|2
1593275|NCT02383940|5544441|P1|Overall Study|Lost to Follow-up|2
1593276|NCT02383940|5544440|P2|Overall Study|Adverse Event|0
1593277|NCT02383940|5544441|P1|Overall Study|Adverse Event|1
1593278|NCT02383862|5544457|P2|3 Month Follow up|Lost to Follow-up|21
1593279|NCT02383862|5544458|P1|3 Month Follow up|Lost to Follow-up|23
1593280|NCT02383758|5544491|P2|Overall Study|Withdrawal by Subject|2
1593281|NCT02383758|5544492|P1|Overall Study|Withdrawal by Subject|0
1593282|NCT02383589|5544520|P2|Overall Study|Non-compliance with study drug|1
1593283|NCT02383589|5544521|P1|Overall Study|Non-compliance with study drug|0
1593284|NCT02383589|5544520|P2|Overall Study|Withdrawal by Subject|5
1593285|NCT02383589|5544521|P1|Overall Study|Withdrawal by Subject|0
1593286|NCT02383589|5544520|P2|Overall Study|Lost to Follow-up|1
1593287|NCT02383589|5544521|P1|Overall Study|Lost to Follow-up|0
1593288|NCT02383589|5544520|P2|Overall Study|Adverse Event|3
1593289|NCT02383589|5544521|P1|Overall Study|Adverse Event|1
1593290|NCT02383576|5544544|P2|Overall Study|Administrative/Other|4
1593291|NCT02383576|5544545|P1|Overall Study|Administrative/Other|2
1593292|NCT02383576|5544544|P2|Overall Study|Investigator's Decision|1
1593293|NCT02383576|5544545|P1|Overall Study|Investigator's Decision|0
1593294|NCT02383576|5544544|P2|Overall Study|Withdrew Consent|6
1593295|NCT02383576|5544545|P1|Overall Study|Withdrew Consent|1
1593296|NCT02383576|5544544|P2|Overall Study|Lost to Follow-up|1
1593297|NCT02383576|5544545|P1|Overall Study|Lost to Follow-up|7
1593298|NCT02383576|5544544|P2|Overall Study|Death|33
1593299|NCT02383576|5544545|P1|Overall Study|Death|53
1593300|NCT02383472|5544561|P2|Overall Study|Withdrawal by Subject|1
1593301|NCT02383472|5544562|P1|Overall Study|Withdrawal by Subject|1
1593302|NCT02383433|5544576|P1|Overall Study|Disease progression|2
1593303|NCT02383355|5544595|P2|Overall Study|Adverse Event|0
1593304|NCT02383355|5544596|P1|Overall Study|Adverse Event|2
1593305|NCT02383056|5544612|P2|Overall Study|Lost to Follow-up|2
1593306|NCT02383056|5544613|P1|Overall Study|Lost to Follow-up|0
1593307|NCT02383056|5544612|P2|Overall Study|Adverse Event|0
1593308|NCT02383056|5544613|P1|Overall Study|Adverse Event|1
1593309|NCT02382991|5544639|P2|Overall Study|Withdrawal by Subject|1
1593310|NCT02382991|5544640|P1|Overall Study|Withdrawal by Subject|0
1593311|NCT02382991|5544639|P2|Overall Study|Lost to Follow-up|0
1593312|NCT02382991|5544640|P1|Overall Study|Lost to Follow-up|1
1593313|NCT02382991|5544639|P2|Overall Study|Adverse Event|2
1593314|NCT02382991|5544640|P1|Overall Study|Adverse Event|1
1593315|NCT02382640|5544767|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1593316|NCT02382640|5544768|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1593317|NCT02382640|5544769|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1593318|NCT02382640|5544770|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
1593319|NCT02382133|5544808|P1|Overall Study|pressure injury both sites|1
1593320|NCT02382133|5544808|P1|Overall Study|arterial catheter loss|4
1593321|NCT02382133|5544808|P1|Overall Study|Physician Decision|2
1593322|NCT02382133|5544808|P1|Overall Study|transfer out of ICU|4
1593323|NCT02382133|5544808|P1|Overall Study|Death|22
1593324|NCT02382016|5544815|P2|OL Extension Period|Withdrawal by Subject|0
1593325|NCT02382016|5544816|P1|OL Extension Period|Withdrawal by Subject|1
1593326|NCT02382016|5544815|P2|OL Extension Period|Death|0
1593327|NCT02382016|5544816|P1|OL Extension Period|Death|2
1593328|NCT02382016|5544815|P2|OL Extension Period|Physician Decision|0
1593329|NCT02382016|5544816|P1|OL Extension Period|Physician Decision|3
1593330|NCT02382016|5544815|P2|Open-label (OL) Treatment Period|Death|0
1593331|NCT02382016|5544816|P1|Open-label (OL) Treatment Period|Death|4
1593332|NCT02382016|5544815|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
1593333|NCT02382016|5544816|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
1593334|NCT02382016|5544815|P2|Open-label (OL) Treatment Period|Physician Decision|0
1593335|NCT02382016|5544816|P1|Open-label (OL) Treatment Period|Physician Decision|3
1593336|NCT02382016|5544815|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
1593337|NCT02382016|5544816|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
1593338|NCT02382016|5544815|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
1593339|NCT02382016|5544816|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
1593340|NCT02382016|5544815|P2|Double-blind (DB) Treatment Period|Physician Decision|0
1593341|NCT02382016|5544816|P1|Double-blind (DB) Treatment Period|Physician Decision|3
1593342|NCT02381795|5544840|P1|Overall Study|Study Terminated|2
1593343|NCT02381795|5544840|P1|Overall Study|Withdrawal by Subject|1
1593344|NCT02380859|5544948|P2|Overall Study|Withdrawal by Subject|0
1593345|NCT02380859|5544949|P1|Overall Study|Withdrawal by Subject|2
1593346|NCT02380742|5544985|P2|Overall Study|Withdrawal by Subject|0
1593347|NCT02380742|5544986|P1|Overall Study|Withdrawal by Subject|1
1593348|NCT02380287|5545006|P8|Overall Study|Adverse Event|0
1593349|NCT02380287|5545007|P7|Overall Study|Adverse Event|0
1593350|NCT02380287|5545008|P6|Overall Study|Adverse Event|0
1593351|NCT02380287|5545009|P5|Overall Study|Adverse Event|0
1593352|NCT02380287|5545010|P4|Overall Study|Adverse Event|0
1593353|NCT02380287|5545011|P3|Overall Study|Adverse Event|1
1593354|NCT02380287|5545012|P2|Overall Study|Adverse Event|0
1593355|NCT02380287|5545013|P1|Overall Study|Adverse Event|0
1593356|NCT02380248|5545029|P1|Overall Study|Withdrawal by Subject|3
1593357|NCT02380248|5545029|P1|Overall Study|Lost to Follow-up|11
1593358|NCT02379923|5545045|P1|Overall Study|Death|5
1593359|NCT02379637|5545074|P2|Overall Study|Withdrawal by Subject|0
1593360|NCT02379637|5545075|P1|Overall Study|Withdrawal by Subject|1
1593361|NCT02379637|5545074|P2|Overall Study|Adverse Event|0
1593362|NCT02379637|5545075|P1|Overall Study|Adverse Event|1
1593363|NCT02379637|5545074|P2|Overall Study|Protocol Violation|1
1593364|NCT02379637|5545075|P1|Overall Study|Protocol Violation|0
1593365|NCT02379390|5545114|P2|Overall Study|Study Termination|1
1593366|NCT02379390|5545115|P1|Overall Study|Study Termination|0
1593367|NCT02379390|5545114|P2|Overall Study|Investigator’s decision|0
1593368|NCT02379390|5545115|P1|Overall Study|Investigator’s decision|1
1593369|NCT02379390|5545114|P2|Overall Study|Adverse Event|1
1593370|NCT02379390|5545115|P1|Overall Study|Adverse Event|1
1593371|NCT02379221|5545143|P1|Overall Study|Lost to Follow-up|1
1593372|NCT02379091|5545179|P4|Overall Study|Lack of Efficacy|0
1593373|NCT02379091|5545180|P3|Overall Study|Lack of Efficacy|0
1593374|NCT02379091|5545181|P2|Overall Study|Lack of Efficacy|0
1593375|NCT02379091|5545182|P1|Overall Study|Lack of Efficacy|3
1593376|NCT02379091|5545179|P4|Overall Study|Study Termination|8
1593377|NCT02379091|5545180|P3|Overall Study|Study Termination|5
1593378|NCT02379091|5545181|P2|Overall Study|Study Termination|2
1593379|NCT02379091|5545182|P1|Overall Study|Study Termination|7
1593380|NCT02379091|5545179|P4|Overall Study|Voluntary Withdrawal|4
1593381|NCT02379091|5545180|P3|Overall Study|Voluntary Withdrawal|2
1593382|NCT02379091|5545181|P2|Overall Study|Voluntary Withdrawal|5
1593383|NCT02379091|5545182|P1|Overall Study|Voluntary Withdrawal|2
1593384|NCT02379091|5545179|P4|Overall Study|Lost to Follow-up|1
1593385|NCT02379091|5545180|P3|Overall Study|Lost to Follow-up|0
1593386|NCT02379091|5545181|P2|Overall Study|Lost to Follow-up|0
1593387|NCT02379091|5545182|P1|Overall Study|Lost to Follow-up|0
1593388|NCT02379091|5545179|P4|Overall Study|Principal Investigator Discretion|0
1593389|NCT02379091|5545180|P3|Overall Study|Principal Investigator Discretion|0
1593390|NCT02379091|5545181|P2|Overall Study|Principal Investigator Discretion|1
1593391|NCT02379091|5545182|P1|Overall Study|Principal Investigator Discretion|0
1593392|NCT02379091|5545179|P4|Overall Study|Pretreatment Event/Adverse Event|1
1593393|NCT02379091|5545180|P3|Overall Study|Pretreatment Event/Adverse Event|0
1593394|NCT02379091|5545181|P2|Overall Study|Pretreatment Event/Adverse Event|2
1593395|NCT02379091|5545182|P1|Overall Study|Pretreatment Event/Adverse Event|0
1593396|NCT02378961|5545222|P4|Overall Study|Death|0
1593397|NCT02378961|5545223|P3|Overall Study|Death|1
1593398|NCT02378961|5545224|P2|Overall Study|Death|0
1593399|NCT02378961|5545225|P1|Overall Study|Death|0
1593400|NCT02378961|5545222|P4|Overall Study|Lack of Efficacy|1
1593401|NCT02378961|5545223|P3|Overall Study|Lack of Efficacy|0
1593402|NCT02378961|5545224|P2|Overall Study|Lack of Efficacy|2
1593403|NCT02378961|5545225|P1|Overall Study|Lack of Efficacy|4
1593404|NCT02378935|5545262|P7|Overall Study|Death|0
1593405|NCT02378935|5545263|P6|Overall Study|Death|0
1593406|NCT02378935|5545264|P5|Overall Study|Death|0
1593407|NCT02378935|5545265|P4|Overall Study|Death|0
1593408|NCT02378935|5545266|P3|Overall Study|Death|1
1593409|NCT02378935|5545267|P2|Overall Study|Death|0
1593410|NCT02378935|5545268|P1|Overall Study|Death|0
1593411|NCT02378935|5545262|P7|Overall Study|Lack of Efficacy|0
1593412|NCT02378935|5545263|P6|Overall Study|Lack of Efficacy|0
1593413|NCT02378935|5545264|P5|Overall Study|Lack of Efficacy|0
1593414|NCT02378935|5545265|P4|Overall Study|Lack of Efficacy|6
1593415|NCT02378935|5545266|P3|Overall Study|Lack of Efficacy|2
1593416|NCT02378935|5545267|P2|Overall Study|Lack of Efficacy|0
1593417|NCT02378935|5545268|P1|Overall Study|Lack of Efficacy|10
1593418|NCT02378883|5545319|P1|12 Months Follow-Up|Death|2
1593419|NCT02378883|5545319|P1|12 Months Follow-Up|Lost to Follow-up|3
1593420|NCT02378883|5545319|P1|30 Day Follow-Up|Death|1
1593421|NCT02378883|5545319|P1|30 Day Follow-Up|Missed Visit|2
1593422|NCT02378883|5545319|P1|30 Day Follow-Up|Physician Decision|2
1593423|NCT02378883|5545319|P1|30 Day Follow-Up|Withdrawal by Subject|1
1593424|NCT02378883|5545319|P1|Enrollment|Attempt to use Apollo was not performed|3
1593425|NCT02378883|5545319|P1|Enrollment|Subject did not meet Inclusion criteria|6
1593426|NCT02378662|5545385|P2|Overall Study|Early Discontinuation|0
1593427|NCT02378662|5545386|P1|Overall Study|Early Discontinuation|2
1593428|NCT02378506|5545392|P1|Overall Study|Randomized But Not Treated|1
1593429|NCT02378506|5545392|P1|Overall Study|Adverse Event|14
1593430|NCT02378506|5545392|P1|Overall Study|Death|1
1593431|NCT02378506|5545392|P1|Overall Study|Protocol Violation|2
1593432|NCT02378506|5545392|P1|Overall Study|Withdrawal by Subject|4
1593433|NCT02378506|5545392|P1|Overall Study|Lack of Efficacy|3
1593434|NCT02378480|5545411|P2|Overall Study|Lost to Follow-up|18
1593435|NCT02378480|5545412|P1|Overall Study|Lost to Follow-up|10
1593436|NCT02378480|5545411|P2|Overall Study|Withdrawal by Subject|4
1593437|NCT02378480|5545412|P1|Overall Study|Withdrawal by Subject|9
1593438|NCT02378480|5545411|P2|Overall Study|Missed EOT/PTE Visit|2
1593439|NCT02378480|5545412|P1|Overall Study|Missed EOT/PTE Visit|1
1593440|NCT02378480|5545411|P2|Overall Study|Adverse Event|1
1593441|NCT02378480|5545412|P1|Overall Study|Adverse Event|0
1593442|NCT02378480|5545411|P2|Overall Study|Randomized, but Not Treated|4
1593443|NCT02378480|5545412|P1|Overall Study|Randomized, but Not Treated|6
1593444|NCT02378480|5545411|P2|Overall Study|Death|2
1593445|NCT02378480|5545412|P1|Overall Study|Death|1
1593446|NCT02378480|5545411|P2|Overall Study|Physician Decision|1
1593447|NCT02378480|5545412|P1|Overall Study|Physician Decision|1
1593448|NCT02378220|5545439|P2|Overall Study|Death|1
1593449|NCT02378220|5545440|P1|Overall Study|Death|6
1593450|NCT02377921|5545509|P2|Overall Study|Subject non-compliance|1
1593451|NCT02377921|5545510|P1|Overall Study|Subject non-compliance|1
1593452|NCT02377466|5545534|P2|Overall Study|Other: Randomized and not treated|2
1593453|NCT02377466|5545535|P1|Overall Study|Other: Randomized and not treated|0
1593454|NCT02377427|5545653|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1593455|NCT02377427|5545654|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1593456|NCT02377427|5545655|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
1593457|NCT02377427|5545656|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1593458|NCT02377427|5545657|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
1593459|NCT02377427|5545653|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
1593460|NCT02377427|5545654|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
1593461|NCT02377427|5545655|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
1593462|NCT02377427|5545656|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
1593463|NCT02377427|5545657|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
1593464|NCT02377427|5545653|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1593465|NCT02377427|5545654|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1593466|NCT02377427|5545655|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1593467|NCT02377427|5545656|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
1593468|NCT02377427|5545657|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
1593469|NCT02377427|5545653|P5|Part A (Up to Week 20)|Physician Decision|0
1593470|NCT02377427|5545654|P4|Part A (Up to Week 20)|Physician Decision|0
1593471|NCT02377427|5545655|P3|Part A (Up to Week 20)|Physician Decision|0
1593472|NCT02377427|5545656|P2|Part A (Up to Week 20)|Physician Decision|0
1593473|NCT02377427|5545657|P1|Part A (Up to Week 20)|Physician Decision|1
1593474|NCT02377362|5545730|P13|Part B Overall|Withdrawal by Subject|0
1593475|NCT02377362|5545731|P12|Part B Overall|Withdrawal by Subject|1
1593476|NCT02377362|5545732|P11|Part B Overall|Withdrawal by Subject|0
1593477|NCT02377362|5545733|P10|Part B Overall|Withdrawal by Subject|0
1593478|NCT02377362|5545734|P9|Part B Overall|Withdrawal by Subject|0
1593479|NCT02377362|5545735|P8|Part B Overall|Withdrawal by Subject|0
1593480|NCT02377362|5545736|P7|Part B Overall|Withdrawal by Subject|1
1593481|NCT02377362|5545737|P6|Part B Overall|Withdrawal by Subject|0
1593482|NCT02377362|5545738|P5|Part B Overall|Withdrawal by Subject|0
1593483|NCT02377362|5545739|P4|Part B Overall|Withdrawal by Subject|0
1593484|NCT02377362|5545740|P3|Part B Overall|Withdrawal by Subject|0
1593485|NCT02377362|5545741|P2|Part B Overall|Withdrawal by Subject|0
1593486|NCT02377362|5545742|P1|Part B Overall|Withdrawal by Subject|0
1593487|NCT02377362|5545730|P13|Part B Overall|Adverse Event|0
1593488|NCT02377362|5545731|P12|Part B Overall|Adverse Event|0
1593489|NCT02377362|5545732|P11|Part B Overall|Adverse Event|0
1593490|NCT02377362|5545733|P10|Part B Overall|Adverse Event|0
1593491|NCT02377362|5545734|P9|Part B Overall|Adverse Event|0
1593492|NCT02377362|5545735|P8|Part B Overall|Adverse Event|1
1593493|NCT02377362|5545736|P7|Part B Overall|Adverse Event|1
1593494|NCT02377362|5545737|P6|Part B Overall|Adverse Event|0
1593495|NCT02377362|5545738|P5|Part B Overall|Adverse Event|0
1593496|NCT02377362|5545739|P4|Part B Overall|Adverse Event|0
1593497|NCT02377362|5545740|P3|Part B Overall|Adverse Event|0
1593498|NCT02377362|5545741|P2|Part B Overall|Adverse Event|0
1593499|NCT02377362|5545742|P1|Part B Overall|Adverse Event|0
1593500|NCT02377362|5545730|P13|Part B Overall|Protocol Violation|0
1593501|NCT02377362|5545731|P12|Part B Overall|Protocol Violation|0
1593502|NCT02377362|5545732|P11|Part B Overall|Protocol Violation|0
1593503|NCT02377362|5545733|P10|Part B Overall|Protocol Violation|1
1593504|NCT02377362|5545734|P9|Part B Overall|Protocol Violation|0
1593505|NCT02377362|5545735|P8|Part B Overall|Protocol Violation|0
1593506|NCT02377362|5545736|P7|Part B Overall|Protocol Violation|0
1593507|NCT02377362|5545737|P6|Part B Overall|Protocol Violation|0
1593508|NCT02377362|5545738|P5|Part B Overall|Protocol Violation|0
1593509|NCT02377362|5545739|P4|Part B Overall|Protocol Violation|0
1593510|NCT02377362|5545740|P3|Part B Overall|Protocol Violation|0
1593511|NCT02377362|5545741|P2|Part B Overall|Protocol Violation|0
1593512|NCT02377362|5545742|P1|Part B Overall|Protocol Violation|0
1593513|NCT02377362|5545730|P13|Part A Third Treatment|Highest dose level 1200 not used|0
1593514|NCT02377362|5545731|P12|Part A Third Treatment|Highest dose level 1200 not used|0
1593515|NCT02377362|5545732|P11|Part A Third Treatment|Highest dose level 1200 not used|0
1593516|NCT02377362|5545733|P10|Part A Third Treatment|Highest dose level 1200 not used|0
1593517|NCT02377362|5545734|P9|Part A Third Treatment|Highest dose level 1200 not used|0
1593518|NCT02377362|5545735|P8|Part A Third Treatment|Highest dose level 1200 not used|0
1593519|NCT02377362|5545736|P7|Part A Third Treatment|Highest dose level 1200 not used|0
1593520|NCT02377362|5545737|P6|Part A Third Treatment|Highest dose level 1200 not used|4
1593521|NCT02377362|5545738|P5|Part A Third Treatment|Highest dose level 1200 not used|3
1593522|NCT02377362|5545739|P4|Part A Third Treatment|Highest dose level 1200 not used|4
1593523|NCT02377362|5545740|P3|Part A Third Treatment|Highest dose level 1200 not used|0
1593524|NCT02377362|5545741|P2|Part A Third Treatment|Highest dose level 1200 not used|0
1593525|NCT02377362|5545742|P1|Part A Third Treatment|Highest dose level 1200 not used|0
1593526|NCT02377362|5545730|P13|Part A Second Treatment|Protocol Violation|0
1593527|NCT02377362|5545731|P12|Part A Second Treatment|Protocol Violation|0
1593528|NCT02377362|5545732|P11|Part A Second Treatment|Protocol Violation|0
1593529|NCT02377362|5545733|P10|Part A Second Treatment|Protocol Violation|0
1593530|NCT02377362|5545734|P9|Part A Second Treatment|Protocol Violation|0
1593531|NCT02377362|5545735|P8|Part A Second Treatment|Protocol Violation|0
1593532|NCT02377362|5545736|P7|Part A Second Treatment|Protocol Violation|0
1593533|NCT02377362|5545737|P6|Part A Second Treatment|Protocol Violation|0
1593534|NCT02377362|5545738|P5|Part A Second Treatment|Protocol Violation|1
1593535|NCT02377362|5545739|P4|Part A Second Treatment|Protocol Violation|0
1593536|NCT02377362|5545740|P3|Part A Second Treatment|Protocol Violation|0
1593537|NCT02377362|5545741|P2|Part A Second Treatment|Protocol Violation|0
1593538|NCT02377362|5545742|P1|Part A Second Treatment|Protocol Violation|0
1593539|NCT02377349|5545951|P2|Overall Study|Other|1
1593540|NCT02377349|5545952|P1|Overall Study|Other|0
1593541|NCT02377349|5545951|P2|Overall Study|Lost to follow-up (complete vaccination)|5
1593542|NCT02377349|5545952|P1|Overall Study|Lost to follow-up (complete vaccination)|6
1593543|NCT02377349|5545951|P2|Overall Study|Lost to follow-up (partial vaccination)|0
1593544|NCT02377349|5545952|P1|Overall Study|Lost to follow-up (partial vaccination)|1
1593545|NCT02377349|5545951|P2|Overall Study|Withdrawal by Subject|3
1593546|NCT02377349|5545952|P1|Overall Study|Withdrawal by Subject|5
1593547|NCT02377349|5545951|P2|Overall Study|Protocol Violation|2
1593548|NCT02377349|5545952|P1|Overall Study|Protocol Violation|3
1593549|NCT02377349|5545951|P2|Overall Study|Serious Adverse Event|0
1593550|NCT02377349|5545952|P1|Overall Study|Serious Adverse Event|1
1593551|NCT02377063|5545990|P1|Overall Study|Non-compliance|5
1593552|NCT02376790|5546008|P3|Overall Study|Lost to Follow-up|12
1593553|NCT02376790|5546009|P2|Overall Study|Lost to Follow-up|10
1593554|NCT02376790|5546010|P1|Overall Study|Lost to Follow-up|15
1593555|NCT02376790|5546008|P3|Overall Study|Decision by Sponsor|4
1593556|NCT02376790|5546009|P2|Overall Study|Decision by Sponsor|1
1593557|NCT02376790|5546010|P1|Overall Study|Decision by Sponsor|2
1593558|NCT02376790|5546008|P3|Overall Study|Withdrawal by Subject|37
1593559|NCT02376790|5546009|P2|Overall Study|Withdrawal by Subject|36
1593560|NCT02376790|5546010|P1|Overall Study|Withdrawal by Subject|43
1593561|NCT02376166|5546201|P1|Overall Study|Discontinued metformin early|2
1593562|NCT02376166|5546201|P1|Overall Study|Adverse Event|1
1593563|NCT02375971|5546229|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
1593564|NCT02375971|5546230|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1593565|NCT02375971|5546231|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
1593566|NCT02375971|5546229|P3|Follow-Up Phase (up to Day 169)|Death|4
1593567|NCT02375971|5546230|P2|Follow-Up Phase (up to Day 169)|Death|4
1593568|NCT02375971|5546231|P1|Follow-Up Phase (up to Day 169)|Death|4
1593569|NCT02375971|5546229|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1593570|NCT02375971|5546230|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
1593571|NCT02375971|5546231|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
1593572|NCT02375971|5546229|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
1593573|NCT02375971|5546230|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
1593574|NCT02375971|5546231|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
1593575|NCT02375971|5546229|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
1593576|NCT02375971|5546230|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
1593577|NCT02375971|5546231|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
1593578|NCT02375971|5546229|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
1593579|NCT02375971|5546230|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1593580|NCT02375971|5546231|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
1593581|NCT02375971|5546229|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
1593582|NCT02375971|5546230|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
1593583|NCT02375971|5546231|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
1593584|NCT02375971|5546229|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
1593585|NCT02375971|5546230|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1593586|NCT02375971|5546231|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
1593587|NCT02375724|5546273|P2|Overall Study|Adverse Event|4
1593588|NCT02375724|5546274|P1|Overall Study|Adverse Event|2
1593589|NCT02375724|5546273|P2|Overall Study|Protocol Violation|0
1593590|NCT02375724|5546274|P1|Overall Study|Protocol Violation|1
1593591|NCT02375724|5546273|P2|Overall Study|Lost to Follow-up|0
1593592|NCT02375724|5546274|P1|Overall Study|Lost to Follow-up|1
1593593|NCT02375724|5546273|P2|Overall Study|Withdrawal by Subject|1
1593594|NCT02375724|5546274|P1|Overall Study|Withdrawal by Subject|1
1593595|NCT02375724|5546273|P2|Overall Study|Lack of Efficacy|1
1593596|NCT02375724|5546274|P1|Overall Study|Lack of Efficacy|1
1593597|NCT02375698|5546286|P2|Overall Study|Physician Decision|0
1593598|NCT02375698|5546287|P1|Overall Study|Physician Decision|2
1593599|NCT02375698|5546286|P2|Overall Study|Withdrawal by Subject|2
1593600|NCT02375698|5546287|P1|Overall Study|Withdrawal by Subject|0
1593601|NCT02375373|5546295|P1|Overall Study|Withdrawal by Subject|11
1593602|NCT02375347|5546299|P1|Overall Study|Protocol Violation|1
1593603|NCT02374957|5546305|P2|Overall Study|Patient did not complete forms correctly|0
1593604|NCT02374957|5546306|P1|Overall Study|Patient did not complete forms correctly|1
1593605|NCT02374671|5546335|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
1593606|NCT02374671|5546336|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
1593607|NCT02374671|5546337|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
1593608|NCT02374671|5546335|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
1593609|NCT02374671|5546336|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
1593610|NCT02374671|5546337|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
1593611|NCT02374671|5546335|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
1593612|NCT02374671|5546336|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
1593613|NCT02374671|5546337|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
1593614|NCT02374671|5546335|P3|Observation (Deferred Implantation)|Adverse Event|1
1593615|NCT02374671|5546336|P2|Observation (Deferred Implantation)|Adverse Event|0
1593616|NCT02374671|5546337|P1|Observation (Deferred Implantation)|Adverse Event|0
1593617|NCT02374671|5546335|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
1593618|NCT02374671|5546336|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
1593619|NCT02374671|5546337|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
1593620|NCT02374593|5546345|P2|Overall Study|non-compliant|0
1593621|NCT02374593|5546346|P1|Overall Study|non-compliant|2
1593622|NCT02374346|5546389|P1|Overall Study|operated or discharged during weekend|48
1593623|NCT02374307|5546397|P2|6-months Follow-up|Withdrawal by Subject|3
1593624|NCT02374307|5546398|P1|6-months Follow-up|Withdrawal by Subject|0
1593625|NCT02374307|5546397|P2|6-months Follow-up|Death|1
1593626|NCT02374307|5546398|P1|6-months Follow-up|Death|2
1593627|NCT02374307|5546397|P2|6-months Follow-up|Lost to Follow-up|2
1593628|NCT02374307|5546398|P1|6-months Follow-up|Lost to Follow-up|1
1593629|NCT02374307|5546397|P2|3-months Follow-up|Missed first follow-up|1
1593630|NCT02374307|5546398|P1|3-months Follow-up|Missed first follow-up|5
1593631|NCT02374307|5546397|P2|3-months Follow-up|Death|2
1593632|NCT02374307|5546398|P1|3-months Follow-up|Death|1
1593633|NCT02374307|5546397|P2|3-months Follow-up|Withdrawal by Subject|4
1593634|NCT02374307|5546398|P1|3-months Follow-up|Withdrawal by Subject|1
1593635|NCT02374307|5546397|P2|3-months Follow-up|Lost to Follow-up|2
1593636|NCT02374307|5546398|P1|3-months Follow-up|Lost to Follow-up|1
1593637|NCT02374255|5546429|P4|Overall Study|Withdrawal by Subject|0
1593638|NCT02374255|5546430|P3|Overall Study|Withdrawal by Subject|0
1593639|NCT02374255|5546431|P2|Overall Study|Withdrawal by Subject|0
1593640|NCT02374255|5546432|P1|Overall Study|Withdrawal by Subject|2
1593641|NCT02374099|5546533|P2|Overall Study|Study Terminated by Sponsor|4
1593642|NCT02374099|5546534|P1|Overall Study|Study Terminated by Sponsor|3
1593643|NCT02374099|5546533|P2|Overall Study|Randomized, but not treated|1
1593644|NCT02374099|5546534|P1|Overall Study|Randomized, but not treated|2
1593645|NCT02374099|5546533|P2|Overall Study|Miscellaneous|3
1593646|NCT02374099|5546534|P1|Overall Study|Miscellaneous|2
1593647|NCT02374099|5546533|P2|Overall Study|Withdrawal by Subject|1
1593648|NCT02374099|5546534|P1|Overall Study|Withdrawal by Subject|5
1593649|NCT02374099|5546533|P2|Overall Study|Progressive Disease|40
1593650|NCT02374099|5546534|P1|Overall Study|Progressive Disease|35
1593651|NCT02374099|5546533|P2|Overall Study|Adverse Event|0
1593652|NCT02374099|5546534|P1|Overall Study|Adverse Event|1
1593653|NCT02373202|5546642|P4|Overall Study|Other|0
1593654|NCT02373202|5546643|P3|Overall Study|Other|0
1593655|NCT02373202|5546644|P2|Overall Study|Other|1
1593656|NCT02373202|5546645|P1|Overall Study|Other|0
1593657|NCT02373202|5546642|P4|Overall Study|Lack of Efficacy|0
1593658|NCT02373202|5546643|P3|Overall Study|Lack of Efficacy|1
1593659|NCT02373202|5546644|P2|Overall Study|Lack of Efficacy|0
1593660|NCT02373202|5546645|P1|Overall Study|Lack of Efficacy|0
1593661|NCT02373202|5546642|P4|Overall Study|Adverse Event|1
1593662|NCT02373202|5546643|P3|Overall Study|Adverse Event|2
1593663|NCT02373202|5546644|P2|Overall Study|Adverse Event|5
1593664|NCT02373202|5546645|P1|Overall Study|Adverse Event|2
1593665|NCT02373098|5546720|P2|Overall Study|Adverse Event|0
1593666|NCT02373098|5546721|P1|Overall Study|Adverse Event|3
1593667|NCT02373098|5546720|P2|Overall Study|Withdrawal by Subject|0
1593668|NCT02373098|5546721|P1|Overall Study|Withdrawal by Subject|5
1593669|NCT02373098|5546720|P2|Overall Study|Protocol Violation|0
1593670|NCT02373098|5546721|P1|Overall Study|Protocol Violation|3
1593671|NCT02373098|5546720|P2|Overall Study|Lost to Follow-up|0
1593672|NCT02373098|5546721|P1|Overall Study|Lost to Follow-up|1
1593673|NCT02372799|5546749|P3|Down-taper Period|Lost to Follow-up|2
1593674|NCT02372799|5546750|P2|Down-taper Period|Lost to Follow-up|2
1593675|NCT02372799|5546751|P1|Down-taper Period|Lost to Follow-up|1
1593676|NCT02372799|5546749|P3|Treatment Period|Miscellaneous Reasons|0
1593677|NCT02372799|5546750|P2|Treatment Period|Miscellaneous Reasons|1
1593678|NCT02372799|5546751|P1|Treatment Period|Miscellaneous Reasons|1
1593679|NCT02372799|5546749|P3|Treatment Period|Non-compliance with study drug|4
1593680|NCT02372799|5546750|P2|Treatment Period|Non-compliance with study drug|4
1593681|NCT02372799|5546751|P1|Treatment Period|Non-compliance with study drug|4
1593682|NCT02372799|5546749|P3|Treatment Period|Protocol Violation|0
1593683|NCT02372799|5546750|P2|Treatment Period|Protocol Violation|0
1593684|NCT02372799|5546751|P1|Treatment Period|Protocol Violation|3
1593685|NCT02372799|5546749|P3|Treatment Period|Lost to Follow-up|3
1593686|NCT02372799|5546750|P2|Treatment Period|Lost to Follow-up|5
1593687|NCT02372799|5546751|P1|Treatment Period|Lost to Follow-up|11
1593688|NCT02372799|5546749|P3|Treatment Period|Withdrawal by Subject|2
1593689|NCT02372799|5546750|P2|Treatment Period|Withdrawal by Subject|10
1593690|NCT02372799|5546751|P1|Treatment Period|Withdrawal by Subject|10
1593691|NCT02372799|5546749|P3|Treatment Period|Insufficient therapeutic response|0
1593692|NCT02372799|5546750|P2|Treatment Period|Insufficient therapeutic response|2
1593693|NCT02372799|5546751|P1|Treatment Period|Insufficient therapeutic response|2
1593694|NCT02372799|5546749|P3|Treatment Period|Adverse Event|6
1593695|NCT02372799|5546750|P2|Treatment Period|Adverse Event|10
1593696|NCT02372799|5546751|P1|Treatment Period|Adverse Event|3
1593697|NCT02372396|5546780|P2|Overall Study|Lost to Follow-up|9
1593698|NCT02372396|5546781|P1|Overall Study|Lost to Follow-up|7
1593699|NCT02372253|5546805|P2|Overall Study|Non Compliance|0
1593700|NCT02372253|5546806|P1|Overall Study|Non Compliance|2
1593701|NCT02372071|5546851|P1|Overall Study|Protocol Violation|18
1593702|NCT02372058|5546856|P1|Overall Study|Withdrawal by Subject|3
1593703|NCT02371759|5546895|P8|Overall Study|Withdrawal by Subject|1
1593704|NCT02371759|5546896|P7|Overall Study|Withdrawal by Subject|0
1593705|NCT02371759|5546897|P6|Overall Study|Withdrawal by Subject|0
1593706|NCT02371759|5546898|P5|Overall Study|Withdrawal by Subject|0
1593707|NCT02371759|5546899|P4|Overall Study|Withdrawal by Subject|0
1593708|NCT02371759|5546900|P3|Overall Study|Withdrawal by Subject|0
1593709|NCT02371759|5546901|P2|Overall Study|Withdrawal by Subject|0
1593710|NCT02371759|5546902|P1|Overall Study|Withdrawal by Subject|0
1593711|NCT02371759|5546895|P8|Overall Study|Protocol Violation|3
1593712|NCT02371759|5546896|P7|Overall Study|Protocol Violation|0
1593713|NCT02371759|5546897|P6|Overall Study|Protocol Violation|1
1593714|NCT02371759|5546898|P5|Overall Study|Protocol Violation|3
1593715|NCT02371759|5546899|P4|Overall Study|Protocol Violation|0
1593716|NCT02371759|5546900|P3|Overall Study|Protocol Violation|1
1593717|NCT02371759|5546901|P2|Overall Study|Protocol Violation|1
1593718|NCT02371759|5546902|P1|Overall Study|Protocol Violation|3
1593719|NCT02371746|5547119|P7|Overall Study|Consent withdrawn|1
1593720|NCT02371746|5547120|P6|Overall Study|Consent withdrawn|0
1593721|NCT02371746|5547121|P5|Overall Study|Consent withdrawn|0
1593722|NCT02371746|5547122|P4|Overall Study|Consent withdrawn|0
1593723|NCT02371746|5547123|P3|Overall Study|Consent withdrawn|0
1593724|NCT02371746|5547124|P2|Overall Study|Consent withdrawn|0
1593725|NCT02371746|5547125|P1|Overall Study|Consent withdrawn|0
1593726|NCT02371629|5547168|P2|Overall Study|Protocol deviation|1
1593727|NCT02371629|5547169|P1|Overall Study|Protocol deviation|0
1593728|NCT02371629|5547168|P2|Overall Study|Lack of Efficacy|2
1593729|NCT02371629|5547169|P1|Overall Study|Lack of Efficacy|0
1593730|NCT02371629|5547168|P2|Overall Study|Noncompliance with study treatment|0
1593731|NCT02371629|5547169|P1|Overall Study|Noncompliance with study treatment|1
1593732|NCT02371629|5547168|P2|Overall Study|Death|1
1593733|NCT02371629|5547169|P1|Overall Study|Death|1
1593734|NCT02371629|5547168|P2|Overall Study|Physician Decision|3
1593735|NCT02371629|5547169|P1|Overall Study|Physician Decision|2
1593736|NCT02371629|5547168|P2|Overall Study|Adverse Event|8
1593737|NCT02371629|5547169|P1|Overall Study|Adverse Event|8
1593738|NCT02371629|5547168|P2|Overall Study|Patient decision|10
1593739|NCT02371629|5547169|P1|Overall Study|Patient decision|14
1593740|NCT02371616|5547205|P2|Overall Study|Other (Not specified)|5
1593741|NCT02371616|5547206|P1|Overall Study|Other (Not specified)|1
1593742|NCT02371616|5547205|P2|Overall Study|Withdrawal of Consent|0
1593743|NCT02371616|5547206|P1|Overall Study|Withdrawal of Consent|1
1593744|NCT02371616|5547205|P2|Overall Study|Adverse Event|1
1593745|NCT02371616|5547206|P1|Overall Study|Adverse Event|0
1593746|NCT02371616|5547205|P2|Overall Study|Protocol Violation|1
1593747|NCT02371616|5547206|P1|Overall Study|Protocol Violation|2
1593748|NCT02371369|5547224|P2|Part 2|Death|1
1593749|NCT02371369|5547225|P1|Part 2|Death|0
1593750|NCT02371369|5547224|P2|Part 2|Physician Decision|0
1593751|NCT02371369|5547225|P1|Part 2|Physician Decision|1
1593752|NCT02371369|5547224|P2|Part 2|Withdrawal by Subject|1
1593753|NCT02371369|5547225|P1|Part 2|Withdrawal by Subject|5
1593754|NCT02371369|5547224|P2|Part 2|Adverse Event|2
1593755|NCT02371369|5547225|P1|Part 2|Adverse Event|3
1593756|NCT02371369|5547224|P2|Part 1|Protocol Violation|1
1593757|NCT02371369|5547225|P1|Part 1|Protocol Violation|0
1593758|NCT02371369|5547224|P2|Part 1|Disease progression|1
1593759|NCT02371369|5547225|P1|Part 1|Disease progression|0
1593760|NCT02371369|5547224|P2|Part 1|Withdrawal by Subject|6
1593761|NCT02371369|5547225|P1|Part 1|Withdrawal by Subject|1
1593762|NCT02371369|5547224|P2|Part 1|Adverse Event|0
1593763|NCT02371369|5547225|P1|Part 1|Adverse Event|8
1593764|NCT02371369|5547224|P2|Part 1|Physician Decision|3
1593765|NCT02371369|5547225|P1|Part 1|Physician Decision|0
1593766|NCT02370914|5547290|P1|Overall Study|Protocol Violation|2
1593767|NCT02370888|5547298|P1|Overall Study|did not meet chimerism criteria|6
1593768|NCT02370888|5547298|P1|Overall Study|disease progression|2
1593769|NCT02370667|5547309|P3|Overall Study|Lost to Follow-up|0
1593770|NCT02370667|5547310|P2|Overall Study|Lost to Follow-up|1
1593771|NCT02370667|5547311|P1|Overall Study|Lost to Follow-up|0
1593772|NCT02370641|5547375|P2|Overall Study|dropped study|2
1593773|NCT02370641|5547376|P1|Overall Study|dropped study|4
1593774|NCT02370615|5547384|P2|Overall Study|Adverse Event|0
1593775|NCT02370615|5547385|P1|Overall Study|Adverse Event|1
1593776|NCT02370602|5547428|P6|Overall Study|Pretreatment Event/Adverse Event|0
1593777|NCT02370602|5547429|P5|Overall Study|Pretreatment Event/Adverse Event|0
1593778|NCT02370602|5547430|P4|Overall Study|Pretreatment Event/Adverse Event|0
1593779|NCT02370602|5547431|P3|Overall Study|Pretreatment Event/Adverse Event|0
1593780|NCT02370602|5547432|P2|Overall Study|Pretreatment Event/Adverse Event|0
1593781|NCT02370602|5547433|P1|Overall Study|Pretreatment Event/Adverse Event|1
1593782|NCT02370537|5547527|P3|Part B|Withdrawal by Subject|0
1593783|NCT02370537|5547528|P2|Part B|Withdrawal by Subject|1
1593784|NCT02370537|5547529|P1|Part B|Withdrawal by Subject|0
1593785|NCT02370537|5547527|P3|Part B|Not randomised to receive treatment|259
1593786|NCT02370537|5547528|P2|Part B|Not randomised to receive treatment|2
1593787|NCT02370537|5547529|P1|Part B|Not randomised to receive treatment|1
1593788|NCT02370537|5547527|P3|Part A (Open-label Recruitment)|Adverse Event|1
1593789|NCT02370537|5547528|P2|Part A (Open-label Recruitment)|Adverse Event|0
1593790|NCT02370537|5547529|P1|Part A (Open-label Recruitment)|Adverse Event|0
1593791|NCT02370537|5547527|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1593792|NCT02370537|5547528|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
1593793|NCT02370537|5547529|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1593794|NCT02370498|5547578|P2|Overall Study|Ongoing In Trial|33
1593795|NCT02370498|5547579|P1|Overall Study|Ongoing In Trial|56
1593796|NCT02370498|5547578|P2|Overall Study|Withdrawal by Subject|11
1593797|NCT02370498|5547579|P1|Overall Study|Withdrawal by Subject|6
1593798|NCT02370498|5547578|P2|Overall Study|Protocol Violation|2
1593799|NCT02370498|5547579|P1|Overall Study|Protocol Violation|1
1593800|NCT02370498|5547578|P2|Overall Study|Lost to Follow-up|0
1593801|NCT02370498|5547579|P1|Overall Study|Lost to Follow-up|1
1593802|NCT02370498|5547578|P2|Overall Study|Death|242
1593803|NCT02370498|5547579|P1|Overall Study|Death|222
1593804|NCT02370498|5547578|P2|Overall Study|Adverse Event|8
1593805|NCT02370498|5547579|P1|Overall Study|Adverse Event|10
1593806|NCT02370420|5547633|P2|Overall Study|Lost to Follow-up|9
1593807|NCT02370420|5547634|P1|Overall Study|Lost to Follow-up|11
1593808|NCT02370420|5547633|P2|Overall Study|Physician Decision|3
1593809|NCT02370420|5547634|P1|Overall Study|Physician Decision|3
1593810|NCT02370394|5547671|P2|Overall Study|Withdrawal by Subject|1
1593811|NCT02370394|5547672|P1|Overall Study|Withdrawal by Subject|0
1593812|NCT02370394|5547671|P2|Overall Study|Lost to Follow-up|1
1593813|NCT02370394|5547672|P1|Overall Study|Lost to Follow-up|2
1593814|NCT02370251|5547686|P1|Overall Study|Death|4
1593815|NCT02370251|5547686|P1|Overall Study|Received less than 8 days of Omegaven|7
1593816|NCT02370160|5547692|P3|Overall Study|Death|1
1593817|NCT02370160|5547693|P2|Overall Study|Death|4
1593818|NCT02370160|5547694|P1|Overall Study|Death|3
1593819|NCT02370121|5547718|P2|Overall Study|Lost to Follow-up|1
1593820|NCT02370121|5547719|P1|Overall Study|Lost to Follow-up|1
1593821|NCT02370095|5547759|P2|Overall Study|Withdrawal by Subject|1
1593822|NCT02370095|5547760|P1|Overall Study|Withdrawal by Subject|0
1593823|NCT02370043|5547790|P6|Overall Study|Withdrawal by Subject|1
1593824|NCT02370043|5547791|P5|Overall Study|Withdrawal by Subject|1
1593825|NCT02370043|5547792|P4|Overall Study|Withdrawal by Subject|0
1593826|NCT02370043|5547793|P3|Overall Study|Withdrawal by Subject|0
1593827|NCT02370043|5547794|P2|Overall Study|Withdrawal by Subject|0
1593828|NCT02370043|5547795|P1|Overall Study|Withdrawal by Subject|0
1593829|NCT02369874|5547927|P3|Overall Study|Participant Ongoing|32
1593830|NCT02369874|5547928|P2|Overall Study|Participant Ongoing|45
1593831|NCT02369874|5547929|P1|Overall Study|Participant Ongoing|34
1593832|NCT02369874|5547927|P3|Overall Study|Miscellaneous|0
1593833|NCT02369874|5547928|P2|Overall Study|Miscellaneous|1
1593834|NCT02369874|5547929|P1|Overall Study|Miscellaneous|1
1593835|NCT02369874|5547927|P3|Overall Study|Withdrawal by Subject|27
1593836|NCT02369874|5547928|P2|Overall Study|Withdrawal by Subject|9
1593837|NCT02369874|5547929|P1|Overall Study|Withdrawal by Subject|7
1593838|NCT02369874|5547927|P3|Overall Study|Lost to Follow-up|2
1593839|NCT02369874|5547928|P2|Overall Study|Lost to Follow-up|2
1593840|NCT02369874|5547929|P1|Overall Study|Lost to Follow-up|2
1593841|NCT02369848|5547976|P1|Overall Study|Lost to Follow-up|1
1593842|NCT02369848|5547976|P1|Overall Study|Withdrawal by Subject|2
1593843|NCT02369848|5547976|P1|Overall Study|Death|1
1593844|NCT02369510|5548054|P3|Overall Study|Epidural Activation|5
1593845|NCT02369510|5548055|P2|Overall Study|Epidural Activation|1
1593846|NCT02369510|5548056|P1|Overall Study|Epidural Activation|1
1593847|NCT02369510|5548054|P3|Overall Study|Spilled Medication|1
1593848|NCT02369510|5548055|P2|Overall Study|Spilled Medication|2
1593849|NCT02369510|5548056|P1|Overall Study|Spilled Medication|1
1593850|NCT02369341|5548095|P2|Overall Study|Migrated/moved from study area|0
1593851|NCT02369341|5548096|P1|Overall Study|Migrated/moved from study area|1
1593852|NCT02368886|5548272|P4|Overall Study|Ineligible|1
1593853|NCT02368886|5548273|P3|Overall Study|Ineligible|0
1593854|NCT02368886|5548274|P2|Overall Study|Ineligible|0
1593855|NCT02368886|5548275|P1|Overall Study|Ineligible|0
1593856|NCT02368886|5548272|P4|Overall Study|Cancel|3
1593857|NCT02368886|5548273|P3|Overall Study|Cancel|1
1593858|NCT02368886|5548274|P2|Overall Study|Cancel|1
1593859|NCT02368886|5548275|P1|Overall Study|Cancel|1
1593860|NCT02368314|5548306|P2|Overall Study|Adverse Event|2
1593861|NCT02368314|5548307|P1|Overall Study|Adverse Event|1
1593862|NCT02368314|5548306|P2|Overall Study|Withdrawal by Subject|1
1593863|NCT02368314|5548307|P1|Overall Study|Withdrawal by Subject|2
1593864|NCT02368210|5548319|P2|Overall Study|Adverse Event|1
1593865|NCT02368210|5548320|P1|Overall Study|Adverse Event|0
1593866|NCT02368210|5548319|P2|Overall Study|Withdrawal by Subject|0
1593867|NCT02368210|5548320|P1|Overall Study|Withdrawal by Subject|1
1593868|NCT02367911|5548347|P2|Overall Study|Lost to Follow-up|2
1593869|NCT02367911|5548348|P1|Overall Study|Lost to Follow-up|2
1593870|NCT02367911|5548347|P2|Overall Study|Withdrawal by Subject|2
1593871|NCT02367911|5548348|P1|Overall Study|Withdrawal by Subject|3
1593872|NCT02367885|5548359|P3|Overall Study|Withdrawal by Subject|0
1593873|NCT02367885|5548360|P2|Overall Study|Withdrawal by Subject|0
1593874|NCT02367885|5548361|P1|Overall Study|Withdrawal by Subject|1
1593875|NCT02367885|5548359|P3|Overall Study|Lost to Follow-up|0
1593876|NCT02367885|5548360|P2|Overall Study|Lost to Follow-up|0
1593877|NCT02367885|5548361|P1|Overall Study|Lost to Follow-up|1
1593878|NCT02367833|5548604|P3|Overall Study|Withdrawal by Subject|0
1593879|NCT02367833|5548605|P2|Overall Study|Withdrawal by Subject|1
1593880|NCT02367833|5548606|P1|Overall Study|Withdrawal by Subject|1
1593881|NCT02367794|5548620|P3|Overall Study|Hypercalcemia prior to C1D1|1
1593882|NCT02367794|5548621|P2|Overall Study|Hypercalcemia prior to C1D1|0
1593883|NCT02367794|5548622|P1|Overall Study|Hypercalcemia prior to C1D1|0
1593884|NCT02367794|5548620|P3|Overall Study|Patient unable to receive carboplatin|1
1593885|NCT02367794|5548621|P2|Overall Study|Patient unable to receive carboplatin|0
1593886|NCT02367794|5548622|P1|Overall Study|Patient unable to receive carboplatin|0
1593887|NCT02367794|5548620|P3|Overall Study|Randomized in error|1
1593888|NCT02367794|5548621|P2|Overall Study|Randomized in error|0
1593889|NCT02367794|5548622|P1|Overall Study|Randomized in error|0
1593890|NCT02367794|5548620|P3|Overall Study|Brain metastasis|0
1593891|NCT02367794|5548621|P2|Overall Study|Brain metastasis|0
1593892|NCT02367794|5548622|P1|Overall Study|Brain metastasis|1
1593893|NCT02367794|5548620|P3|Overall Study|Withdrawal by Subject|14
1593894|NCT02367794|5548621|P2|Overall Study|Withdrawal by Subject|12
1593895|NCT02367794|5548622|P1|Overall Study|Withdrawal by Subject|25
1593896|NCT02367794|5548620|P3|Overall Study|Protocol Violation|1
1593897|NCT02367794|5548621|P2|Overall Study|Protocol Violation|0
1593898|NCT02367794|5548622|P1|Overall Study|Protocol Violation|1
1593899|NCT02367794|5548620|P3|Overall Study|Physician Decision|1
1593900|NCT02367794|5548621|P2|Overall Study|Physician Decision|3
1593901|NCT02367794|5548622|P1|Overall Study|Physician Decision|0
1593902|NCT02367794|5548620|P3|Overall Study|Lost to Follow-up|1
1593903|NCT02367794|5548621|P2|Overall Study|Lost to Follow-up|2
1593904|NCT02367794|5548622|P1|Overall Study|Lost to Follow-up|1
1593905|NCT02367794|5548620|P3|Overall Study|Death|229
1593906|NCT02367794|5548621|P2|Overall Study|Death|223
1593907|NCT02367794|5548622|P1|Overall Study|Death|230
1593908|NCT02367781|5548635|P2|Overall Study|Administrative-Change Facility|0
1593909|NCT02367781|5548636|P1|Overall Study|Administrative-Change Facility|1
1593910|NCT02367781|5548635|P2|Overall Study|Death Prior First Dose|0
1593911|NCT02367781|5548636|P1|Overall Study|Death Prior First Dose|1
1593912|NCT02367781|5548635|P2|Overall Study|Prolonged Hospitalization|0
1593913|NCT02367781|5548636|P1|Overall Study|Prolonged Hospitalization|1
1593914|NCT02367781|5548635|P2|Overall Study|On-going in study|88
1593915|NCT02367781|5548636|P1|Overall Study|On-going in study|214
1593916|NCT02367781|5548635|P2|Overall Study|Death|136
1593917|NCT02367781|5548636|P1|Overall Study|Death|240
1593918|NCT02367781|5548635|P2|Overall Study|Lost to Follow-up|1
1593919|NCT02367781|5548636|P1|Overall Study|Lost to Follow-up|0
1593920|NCT02367781|5548635|P2|Overall Study|Non-Compliance|0
1593921|NCT02367781|5548636|P1|Overall Study|Non-Compliance|1
1593922|NCT02367781|5548635|P2|Overall Study|Randomized in Error|4
1593923|NCT02367781|5548636|P1|Overall Study|Randomized in Error|5
1593924|NCT02367781|5548635|P2|Overall Study|Physician Decision|0
1593925|NCT02367781|5548636|P1|Overall Study|Physician Decision|1
1593926|NCT02367781|5548635|P2|Overall Study|Protocol Violation|1
1593927|NCT02367781|5548636|P1|Overall Study|Protocol Violation|0
1593928|NCT02367781|5548635|P2|Overall Study|Withdrawal by Subject|10
1593929|NCT02367781|5548636|P1|Overall Study|Withdrawal by Subject|19
1593930|NCT02367729|5548646|P2|Overall Study|Withdrawal by Subject|5
1593931|NCT02367729|5548647|P1|Overall Study|Withdrawal by Subject|0
1593932|NCT02367729|5548646|P2|Overall Study|Adverse Event|2
1593933|NCT02367729|5548647|P1|Overall Study|Adverse Event|1
1593934|NCT02367729|5548646|P2|Overall Study|Organic disorder diagnosed|1
1593935|NCT02367729|5548647|P1|Overall Study|Organic disorder diagnosed|2
1593936|NCT02367521|5548665|P2|Overall Study|unable to find transportation|0
1593937|NCT02367521|5548666|P1|Overall Study|unable to find transportation|2
1593938|NCT02367521|5548665|P2|Overall Study|severe headache after intervention|0
1593939|NCT02367521|5548666|P1|Overall Study|severe headache after intervention|2
1593940|NCT02367352|5548744|P3|Overall Study|Adverse Event|0
1593941|NCT02367352|5548745|P2|Overall Study|Adverse Event|0
1593942|NCT02367352|5548746|P1|Overall Study|Adverse Event|1
1593943|NCT02367352|5548744|P3|Overall Study|Participant Received Alternative Therapy|0
1593944|NCT02367352|5548745|P2|Overall Study|Participant Received Alternative Therapy|0
1593945|NCT02367352|5548746|P1|Overall Study|Participant Received Alternative Therapy|1
1593946|NCT02367352|5548744|P3|Overall Study|Progressive disease|0
1593947|NCT02367352|5548745|P2|Overall Study|Progressive disease|0
1593948|NCT02367352|5548746|P1|Overall Study|Progressive disease|7
1593949|NCT02367131|5548796|P1|Overall Study|Other than stated above|20
1593950|NCT02367131|5548796|P1|Overall Study|No change/progressive disease|78
1593951|NCT02367131|5548796|P1|Overall Study|Improvement/remission|2
1593952|NCT02367131|5548796|P1|Overall Study|Request by patient|54
1593953|NCT02367131|5548796|P1|Overall Study|No visit since the first visit|4
1593954|NCT02367131|5548796|P1|Overall Study|Adverse Event|64
1593955|NCT02366936|5548988|P1|Overall Study|Physician Decision|2
1593956|NCT02366936|5548988|P1|Overall Study|Lost to Follow-up|4
1593957|NCT02366936|5548988|P1|Overall Study|Withdrawal by Subject|2
1593958|NCT02366923|5548993|P1|Overall Study|High Astigmatism|3
1593959|NCT02366923|5548993|P1|Overall Study|Positive Slit Lamp Findings|2
1593960|NCT02366923|5548993|P1|Overall Study|Withdrawal by Subject|1
1593961|NCT02366910|5549006|P1|Overall Study|Screen Failure|3
1593962|NCT02366910|5549006|P1|Overall Study|Withdrawal by Subject|2
1593963|NCT02366767|5549035|P2|Overall Study|left for home after 1 day at camp|0
1593964|NCT02366767|5549036|P1|Overall Study|left for home after 1 day at camp|1
1593965|NCT02366689|5549049|P3|Overall Study|Pregnancy|1
1593966|NCT02366689|5549050|P2|Overall Study|Pregnancy|1
1593967|NCT02366689|5549051|P1|Overall Study|Pregnancy|0
1593968|NCT02366689|5549049|P3|Overall Study|Lost to Follow-up|0
1593969|NCT02366689|5549050|P2|Overall Study|Lost to Follow-up|2
1593970|NCT02366689|5549051|P1|Overall Study|Lost to Follow-up|3
1593971|NCT02366689|5549049|P3|Overall Study|Withdrawal by Subject|1
1593972|NCT02366689|5549050|P2|Overall Study|Withdrawal by Subject|0
1593973|NCT02366689|5549051|P1|Overall Study|Withdrawal by Subject|1
1593974|NCT02366637|5549103|P2|Second Intervention Period|Study Terminated by Sponsor|1
1593975|NCT02366637|5549104|P1|Second Intervention Period|Study Terminated by Sponsor|1
1593976|NCT02366637|5549103|P2|First Intervention Period|Study Terminated by Sponsor|4
1593977|NCT02366637|5549104|P1|First Intervention Period|Study Terminated by Sponsor|6
1593978|NCT02366637|5549103|P2|First Intervention Period|Adverse Event|1
1593979|NCT02366637|5549104|P1|First Intervention Period|Adverse Event|0
1593980|NCT02366468|5549130|P2|Overall Study|Other|2
1593981|NCT02366468|5549131|P1|Overall Study|Other|0
1593982|NCT02366468|5549130|P2|Overall Study|Death|2
1593983|NCT02366468|5549131|P1|Overall Study|Death|1
1593984|NCT02366468|5549130|P2|Overall Study|Lost to Follow-up|0
1593985|NCT02366468|5549131|P1|Overall Study|Lost to Follow-up|2
1593986|NCT02366468|5549130|P2|Overall Study|Withdrawal by Subject|5
1593987|NCT02366468|5549131|P1|Overall Study|Withdrawal by Subject|1
1593988|NCT02366468|5549130|P2|Overall Study|Adverse Event|0
1593989|NCT02366468|5549131|P1|Overall Study|Adverse Event|2
1593990|NCT02366195|5549162|P1|Overall Study|Death|26
1593991|NCT02366195|5549162|P1|Overall Study|Lost to Follow-up|1
1593992|NCT02366195|5549162|P1|Overall Study|Withdrawal by Subject|6
1593993|NCT02366195|5549162|P1|Overall Study|Continuing Study|79
1593994|NCT02365636|5549210|P3|Overall Study|Other|0
1593995|NCT02365636|5549211|P2|Overall Study|Other|0
1593996|NCT02365636|5549212|P1|Overall Study|Other|2
1593997|NCT02365636|5549210|P3|Overall Study|Lost to Follow-up|1
1593998|NCT02365636|5549211|P2|Overall Study|Lost to Follow-up|0
1593999|NCT02365636|5549212|P1|Overall Study|Lost to Follow-up|0
1594000|NCT02365636|5549210|P3|Overall Study|Protocol Violation|0
1594001|NCT02365636|5549211|P2|Overall Study|Protocol Violation|4
1594002|NCT02365636|5549212|P1|Overall Study|Protocol Violation|1
1594003|NCT02365636|5549210|P3|Overall Study|Adverse Event|2
1594004|NCT02365636|5549211|P2|Overall Study|Adverse Event|3
1594005|NCT02365636|5549212|P1|Overall Study|Adverse Event|3
1594006|NCT02365584|5549258|P2|Overall Study|Disease Progression|12
1594007|NCT02365584|5549259|P1|Overall Study|Disease Progression|9
1594008|NCT02365584|5549258|P2|Overall Study|Withdrawal by Subject|0
1594009|NCT02365584|5549259|P1|Overall Study|Withdrawal by Subject|1
1594010|NCT02365584|5549258|P2|Overall Study|Adverse Event|2
1594011|NCT02365584|5549259|P1|Overall Study|Adverse Event|2
1594012|NCT02365558|5549283|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
1594013|NCT02365558|5549284|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
1594014|NCT02365558|5549283|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
1594015|NCT02365558|5549284|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
1594016|NCT02365519|5549297|P3|Randomized and Treated|Withdrawal by Subject|1
1594017|NCT02365519|5549298|P2|Randomized and Treated|Withdrawal by Subject|1
1594018|NCT02365519|5549299|P1|Randomized and Treated|Withdrawal by Subject|0
1594019|NCT02365519|5549297|P3|Randomized and Treated|Adverse Event|0
1594020|NCT02365519|5549298|P2|Randomized and Treated|Adverse Event|1
1594021|NCT02365519|5549299|P1|Randomized and Treated|Adverse Event|0
1594022|NCT02365298|5549320|P2|Period 2|Protocol Violation|1
1594023|NCT02365298|5549321|P1|Period 2|Protocol Violation|0
1594024|NCT02365298|5549320|P2|Period 2|Test Article longer available|1
1594025|NCT02365298|5549321|P1|Period 2|Test Article longer available|0
1594026|NCT02365298|5549320|P2|Period 2|Discontinued at request of Sponsor|0
1594027|NCT02365298|5549321|P1|Period 2|Discontinued at request of Sponsor|1
1594028|NCT02365298|5549320|P2|Period 2|incorrect Rx dispensed|0
1594029|NCT02365298|5549321|P1|Period 2|incorrect Rx dispensed|1
1594030|NCT02365285|5549341|P4|Overall Study|Adverse Event|2
1594031|NCT02365285|5549342|P3|Overall Study|Adverse Event|0
1594032|NCT02365285|5549343|P2|Overall Study|Adverse Event|0
1594033|NCT02365285|5549344|P1|Overall Study|Adverse Event|0
1594034|NCT02365285|5549341|P4|Overall Study|Physician Decision|0
1594035|NCT02365285|5549342|P3|Overall Study|Physician Decision|1
1594036|NCT02365285|5549343|P2|Overall Study|Physician Decision|1
1594037|NCT02365285|5549344|P1|Overall Study|Physician Decision|0
1594038|NCT02365233|5549361|P3|Overall Study|IRB withheld the data|2
1594039|NCT02365233|5549362|P2|Overall Study|IRB withheld the data|2
1594040|NCT02365233|5549363|P1|Overall Study|IRB withheld the data|1
1594041|NCT02365207|5549371|P1|Overall Study|Physician Decision|1
1594042|NCT02365207|5549371|P1|Overall Study|Withdrawal by Subject|1
1594043|NCT02364999|5549377|P2|Overall Study|Randomized but did not receive treatment|3
1594044|NCT02364999|5549378|P1|Overall Study|Randomized but did not receive treatment|2
1594045|NCT02364999|5549377|P2|Overall Study|Other|1
1594046|NCT02364999|5549378|P1|Overall Study|Other|0
1594047|NCT02364999|5549377|P2|Overall Study|Withdrawal by Subject|14
1594048|NCT02364999|5549378|P1|Overall Study|Withdrawal by Subject|14
1594049|NCT02364999|5549377|P2|Overall Study|Protocol Violation|2
1594050|NCT02364999|5549378|P1|Overall Study|Protocol Violation|3
1594051|NCT02364999|5549377|P2|Overall Study|Lost to Follow-up|15
1594052|NCT02364999|5549378|P1|Overall Study|Lost to Follow-up|10
1594053|NCT02364999|5549377|P2|Overall Study|Death|138
1594054|NCT02364999|5549378|P1|Overall Study|Death|136
1594055|NCT02364947|5549404|P3|Overall Study|Death|0
1594056|NCT02364947|5549405|P2|Overall Study|Death|1
1594057|NCT02364947|5549406|P1|Overall Study|Death|0
1594058|NCT02364947|5549404|P3|Overall Study|Physician Decision|5
1594059|NCT02364947|5549405|P2|Overall Study|Physician Decision|2
1594060|NCT02364947|5549406|P1|Overall Study|Physician Decision|3
1594061|NCT02364947|5549404|P3|Overall Study|Protocol Violation|1
1594062|NCT02364947|5549405|P2|Overall Study|Protocol Violation|1
1594063|NCT02364947|5549406|P1|Overall Study|Protocol Violation|1
1594064|NCT02364947|5549404|P3|Overall Study|Adverse Event|11
1594065|NCT02364947|5549405|P2|Overall Study|Adverse Event|33
1594066|NCT02364947|5549406|P1|Overall Study|Adverse Event|45
1594067|NCT02364947|5549404|P3|Overall Study|Withdrawal by Subject|9
1594068|NCT02364947|5549405|P2|Overall Study|Withdrawal by Subject|8
1594069|NCT02364947|5549406|P1|Overall Study|Withdrawal by Subject|10
1594070|NCT02364336|5549577|P2|Overall Study|Adverse Event|1
1594071|NCT02364336|5549578|P1|Overall Study|Adverse Event|0
1594072|NCT02364180|5549591|P1|Overall Study|Screen Fail|1
1594073|NCT02364037|5549604|P2|Overall Study|Lost to Follow-up|49
1594074|NCT02364037|5549605|P1|Overall Study|Lost to Follow-up|37
1594075|NCT02364037|5549604|P2|Overall Study|Withdrawal by Subject|4
1594076|NCT02364037|5549605|P1|Overall Study|Withdrawal by Subject|7
1594077|NCT02363959|5549619|P2|Overall Study|Medical instability|0
1594078|NCT02363959|5549620|P1|Overall Study|Medical instability|1
1594079|NCT02363946|5549649|P13|Overall Study|Lost to Follow-up|0
1594080|NCT02363946|5549650|P12|Overall Study|Lost to Follow-up|0
1594081|NCT02363946|5549651|P11|Overall Study|Lost to Follow-up|0
1594082|NCT02363946|5549652|P10|Overall Study|Lost to Follow-up|0
1594083|NCT02363946|5549653|P9|Overall Study|Lost to Follow-up|0
1594084|NCT02363946|5549654|P8|Overall Study|Lost to Follow-up|1
1594085|NCT02363946|5549655|P7|Overall Study|Lost to Follow-up|0
1594086|NCT02363946|5549656|P6|Overall Study|Lost to Follow-up|0
1594087|NCT02363946|5549657|P5|Overall Study|Lost to Follow-up|0
1594088|NCT02363946|5549658|P4|Overall Study|Lost to Follow-up|0
1594089|NCT02363946|5549659|P3|Overall Study|Lost to Follow-up|0
1594090|NCT02363946|5549660|P2|Overall Study|Lost to Follow-up|0
1594091|NCT02363946|5549661|P1|Overall Study|Lost to Follow-up|0
1594092|NCT02363478|5549890|P1|Overall Study|Adverse Event|4
1594093|NCT02363478|5549890|P1|Overall Study|Lost to Follow-up|4
1594094|NCT02363439|5549897|P1|Overall Study|Lack of Efficacy|4
1594095|NCT02363322|5549903|P2|Overall Study|Lost to Follow-up|0
1594096|NCT02363322|5549904|P1|Overall Study|Lost to Follow-up|1
1594097|NCT02362789|5549925|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
1594098|NCT02362789|5549926|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
1594099|NCT02362789|5549927|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
1594100|NCT02362789|5549925|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
1594101|NCT02362789|5549926|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
1594102|NCT02362789|5549927|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
1594103|NCT02362789|5549925|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
1594104|NCT02362789|5549926|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
1594105|NCT02362789|5549927|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
1594106|NCT02362789|5549925|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
1594107|NCT02362789|5549926|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
1594108|NCT02362789|5549927|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
1594109|NCT02362789|5549925|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
1594110|NCT02362789|5549926|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
1594111|NCT02362789|5549927|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
1594112|NCT02362646|5549936|P2|Overall Study|received transplant|14
1594113|NCT02362646|5549937|P1|Overall Study|received transplant|21
1594114|NCT02362646|5549936|P2|Overall Study|Withdrawal by Subject|2
1594115|NCT02362646|5549937|P1|Overall Study|Withdrawal by Subject|2
1594116|NCT02362646|5549936|P2|Overall Study|Death|8
1594117|NCT02362646|5549937|P1|Overall Study|Death|15
1594160|NCT02362425|5550000|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
1594161|NCT02362425|5550001|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
1594162|NCT02362425|5550002|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
1594163|NCT02362425|5550003|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
1594164|NCT02362425|5550000|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
1594165|NCT02362425|5550001|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
1594166|NCT02362425|5550002|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
1594167|NCT02362425|5550003|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
1594168|NCT02362425|5550000|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
1594169|NCT02362425|5550001|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
1594170|NCT02362425|5550002|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
1594171|NCT02362425|5550003|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
1594172|NCT02362425|5550000|P4|Phase 1 (up to 6 Months)|Study closure|0
1594173|NCT02362425|5550001|P3|Phase 1 (up to 6 Months)|Study closure|0
1594174|NCT02362425|5550002|P2|Phase 1 (up to 6 Months)|Study closure|0
1594175|NCT02362425|5550003|P1|Phase 1 (up to 6 Months)|Study closure|9
1594176|NCT02362425|5550000|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
1594177|NCT02362425|5550001|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
1594178|NCT02362425|5550002|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
1594179|NCT02362425|5550003|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
1594180|NCT02362425|5550000|P4|Phase 1 (up to 6 Months)|Screening failure|0
1594181|NCT02362425|5550001|P3|Phase 1 (up to 6 Months)|Screening failure|0
1594182|NCT02362425|5550002|P2|Phase 1 (up to 6 Months)|Screening failure|0
1594183|NCT02362425|5550003|P1|Phase 1 (up to 6 Months)|Screening failure|1
1594184|NCT02362425|5550000|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
1594185|NCT02362425|5550001|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
1594186|NCT02362425|5550002|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
1594187|NCT02362425|5550003|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
1594188|NCT02362425|5550000|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
1594189|NCT02362425|5550001|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
1594190|NCT02362425|5550002|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
1594191|NCT02362425|5550003|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
1594192|NCT02362412|5550121|P2|Treatment Period III|Lost to Follow-up|1
1594193|NCT02362412|5550122|P1|Treatment Period III|Lost to Follow-up|0
1594194|NCT02362360|5550156|P2|Period 1|Withdrawal by Subject|1
1594195|NCT02362360|5550157|P1|Period 1|Withdrawal by Subject|2
1594196|NCT02362360|5550156|P2|Period 1|Lack of Efficacy|0
1594197|NCT02362360|5550157|P1|Period 1|Lack of Efficacy|1
1594198|NCT02362282|5550174|P2|Overall Study|Withdrawal by Subject|0
1594199|NCT02362282|5550175|P1|Overall Study|Withdrawal by Subject|1
1594200|NCT02361762|5550192|P2|Overall Study|Lost to Follow-up|1
1594201|NCT02361762|5550193|P1|Overall Study|Lost to Follow-up|0
1594202|NCT02361762|5550192|P2|Overall Study|Withdrawal by Subject|1
1594203|NCT02361762|5550193|P1|Overall Study|Withdrawal by Subject|0
1594204|NCT02361580|5550244|P2|Overall Study|Lost to Follow-up|3
1594205|NCT02361580|5550245|P1|Overall Study|Lost to Follow-up|6
1594206|NCT02361216|5550274|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
1594207|NCT02361216|5550275|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
1594208|NCT02361216|5550274|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
1594209|NCT02361216|5550275|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
1594210|NCT02361216|5550274|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
1594211|NCT02361216|5550275|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
1594212|NCT02361216|5550274|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
1594213|NCT02361216|5550275|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
1594214|NCT02361216|5550274|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
1594215|NCT02361216|5550275|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
1594216|NCT02361216|5550274|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
1594217|NCT02361216|5550275|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
1594218|NCT02360995|5550290|P3|Overall Study|Withdrawal by Subject|0
1594219|NCT02360995|5550291|P2|Overall Study|Withdrawal by Subject|1
1594220|NCT02360995|5550292|P1|Overall Study|Withdrawal by Subject|0
1594221|NCT02360995|5550290|P3|Overall Study|Lost to Follow-up|2
1594222|NCT02360995|5550291|P2|Overall Study|Lost to Follow-up|0
1594223|NCT02360995|5550292|P1|Overall Study|Lost to Follow-up|2
1594224|NCT02360475|5550347|P4|Overall Study|Migrated/moved from study area|1
1594225|NCT02360475|5550348|P3|Overall Study|Migrated/moved from study area|0
1594226|NCT02360475|5550349|P2|Overall Study|Migrated/moved from study area|0
1594227|NCT02360475|5550350|P1|Overall Study|Migrated/moved from study area|0
1594228|NCT02360475|5550347|P4|Overall Study|Withdrawal by Subject|0
1594229|NCT02360475|5550348|P3|Overall Study|Withdrawal by Subject|2
1594230|NCT02360475|5550349|P2|Overall Study|Withdrawal by Subject|1
1594231|NCT02360475|5550350|P1|Overall Study|Withdrawal by Subject|0
1594232|NCT02360475|5550347|P4|Overall Study|Lost to Follow-up|4
1594233|NCT02360475|5550348|P3|Overall Study|Lost to Follow-up|6
1594234|NCT02360475|5550349|P2|Overall Study|Lost to Follow-up|12
1594235|NCT02360475|5550350|P1|Overall Study|Lost to Follow-up|4
1594236|NCT02360397|5550408|P1|Overall Study|Adverse Event|1
1594237|NCT02360397|5550408|P1|Overall Study|Incomplete screening|3
1594238|NCT02360293|5550417|P2|Overall Study|Excluded|0
1594239|NCT02360293|5550418|P1|Overall Study|Excluded|1
1594240|NCT02360293|5550417|P2|Overall Study|Withdrawal by Subject|1
1594241|NCT02360293|5550418|P1|Overall Study|Withdrawal by Subject|2
1594242|NCT02360293|5550417|P2|Overall Study|Lost to Follow-up|95
1594243|NCT02360293|5550418|P1|Overall Study|Lost to Follow-up|73
1594244|NCT02360280|5550432|P2|Overall Study|Lost to Follow-up|0
1594245|NCT02360280|5550433|P1|Overall Study|Lost to Follow-up|1
1594246|NCT02360280|5550432|P2|Overall Study|Adverse Event|1
1594247|NCT02360280|5550433|P1|Overall Study|Adverse Event|0
1594248|NCT02360280|5550432|P2|Overall Study|Withdrawal by Subject|0
1594249|NCT02360280|5550433|P1|Overall Study|Withdrawal by Subject|2
1594250|NCT02360228|5550448|P3|Overall Study|Unstable symptoms during screening|1
1594251|NCT02360228|5550449|P2|Overall Study|Unstable symptoms during screening|0
1594252|NCT02360228|5550450|P1|Overall Study|Unstable symptoms during screening|0
1594253|NCT02360228|5550448|P3|Overall Study|Self-discontinued medication|0
1594254|NCT02360228|5550449|P2|Overall Study|Self-discontinued medication|1
1594255|NCT02360228|5550450|P1|Overall Study|Self-discontinued medication|0
1594256|NCT02360228|5550448|P3|Overall Study|Withdrawal by Subject|0
1594257|NCT02360228|5550449|P2|Overall Study|Withdrawal by Subject|0
1594258|NCT02360228|5550450|P1|Overall Study|Withdrawal by Subject|1
1594259|NCT02360111|5550492|P1|Overall Study|Death|2
1594260|NCT02359903|5550563|P2|Overall Study|Adverse Event|2
1594261|NCT02359903|5550564|P1|Overall Study|Adverse Event|0
1594262|NCT02359890|5550572|P1|Overall Study|Never treated with study catheter|6
1594263|NCT02359890|5550572|P1|Overall Study|Not meeting eligibility|4
1594264|NCT02359877|5550583|P4|Overall Study|Adverse Event|1
1594265|NCT02359877|5550584|P3|Overall Study|Adverse Event|0
1594266|NCT02359877|5550585|P2|Overall Study|Adverse Event|0
1594267|NCT02359877|5550586|P1|Overall Study|Adverse Event|0
1594268|NCT02359877|5550583|P4|Overall Study|Withdrawal by Subject|2
1594269|NCT02359877|5550584|P3|Overall Study|Withdrawal by Subject|0
1594270|NCT02359877|5550585|P2|Overall Study|Withdrawal by Subject|0
1594271|NCT02359877|5550586|P1|Overall Study|Withdrawal by Subject|1
1594272|NCT02359851|5550636|P1|Overall Study|Disease progression|1
1594273|NCT02359851|5550636|P1|Overall Study|Death|1
1594274|NCT02359435|5550646|P2|Overall Study|Lost to Follow-up|4
1594275|NCT02359435|5550647|P1|Overall Study|Lost to Follow-up|4
1594276|NCT02359045|5550707|P2|Overall Study|Adverse Event|1
1594277|NCT02359045|5550708|P1|Overall Study|Adverse Event|0
1594278|NCT02359045|5550707|P2|Overall Study|Lost to Follow-up|1
1594279|NCT02359045|5550708|P1|Overall Study|Lost to Follow-up|1
1594280|NCT02359045|5550707|P2|Overall Study|Eligibility criteria not fulfilled|1
1594281|NCT02359045|5550708|P1|Overall Study|Eligibility criteria not fulfilled|3
1594282|NCT02358863|5550988|P1|Overall Study|Physician Decision|3
1594283|NCT02358668|5550995|P3|Overall Study|Withdrawal by Subject|0
1594284|NCT02358668|5550996|P2|Overall Study|Withdrawal by Subject|1
1594285|NCT02358668|5550997|P1|Overall Study|Withdrawal by Subject|0
1594286|NCT02358668|5550995|P3|Overall Study|Adverse Event|0
1594287|NCT02358668|5550996|P2|Overall Study|Adverse Event|0
1594288|NCT02358668|5550997|P1|Overall Study|Adverse Event|2
1594289|NCT02358473|5551146|P1|Overall Study|Physician Decision|2
1594290|NCT02358473|5551146|P1|Overall Study|Withdrawal by Subject|2
1594291|NCT02358473|5551146|P1|Overall Study|Adverse Event|3
1594292|NCT02358473|5551146|P1|Overall Study|Disease Progession|6
1594293|NCT02358343|5551160|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1594294|NCT02358343|5551161|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1594295|NCT02358343|5551162|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
1594296|NCT02358343|5551163|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1594297|NCT02358343|5551164|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
1594298|NCT02358343|5551160|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
1594299|NCT02358343|5551161|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
1594300|NCT02358343|5551162|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
1594301|NCT02358343|5551163|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
1594302|NCT02358343|5551164|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
1594303|NCT02358343|5551160|P5|Comparative Efficacy Trial / Observation|Death|0
1594304|NCT02358343|5551161|P4|Comparative Efficacy Trial / Observation|Death|0
1594305|NCT02358343|5551162|P3|Comparative Efficacy Trial / Observation|Death|2
1594306|NCT02358343|5551163|P2|Comparative Efficacy Trial / Observation|Death|0
1594307|NCT02358343|5551164|P1|Comparative Efficacy Trial / Observation|Death|0
1594308|NCT02358343|5551160|P5|Screening Intervention|Determined Ineligible|0
1594309|NCT02358343|5551161|P4|Screening Intervention|Determined Ineligible|0
1594310|NCT02358343|5551162|P3|Screening Intervention|Determined Ineligible|0
1594311|NCT02358343|5551163|P2|Screening Intervention|Determined Ineligible|6
1594312|NCT02358343|5551164|P1|Screening Intervention|Determined Ineligible|5
1594313|NCT02358343|5551160|P5|Screening Intervention|Withdrawal by Subject|0
1594314|NCT02358343|5551161|P4|Screening Intervention|Withdrawal by Subject|0
1594315|NCT02358343|5551162|P3|Screening Intervention|Withdrawal by Subject|0
1594316|NCT02358343|5551163|P2|Screening Intervention|Withdrawal by Subject|0
1594317|NCT02358343|5551164|P1|Screening Intervention|Withdrawal by Subject|1
1594318|NCT02358343|5551160|P5|Screening Intervention|Death|0
1594319|NCT02358343|5551161|P4|Screening Intervention|Death|0
1594320|NCT02358343|5551162|P3|Screening Intervention|Death|0
1594321|NCT02358343|5551163|P2|Screening Intervention|Death|2
1594322|NCT02358343|5551164|P1|Screening Intervention|Death|0
1594323|NCT02358044|5551220|P2|Overall Study|Withdrawal by Subject|4
1594324|NCT02358044|5551221|P1|Overall Study|Withdrawal by Subject|0
1594325|NCT02358044|5551220|P2|Overall Study|Physician Decision|1
1594326|NCT02358044|5551221|P1|Overall Study|Physician Decision|0
1594327|NCT02358044|5551220|P2|Overall Study|Lost to Follow-up|1
1594328|NCT02358044|5551221|P1|Overall Study|Lost to Follow-up|2
1594329|NCT02358044|5551220|P2|Overall Study|Adverse Event|1
1594330|NCT02358044|5551221|P1|Overall Study|Adverse Event|0
1594343|NCT02357940|5551369|P2|Overall Study|Investigator's judgement|1
1594344|NCT02357940|5551370|P1|Overall Study|Investigator's judgement|0
1594345|NCT02357940|5551369|P2|Overall Study|Adverse Event|1
1594346|NCT02357940|5551370|P1|Overall Study|Adverse Event|0
1594347|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
1594348|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
1594423|NCT02357459|5551609|P1|Overall Study|Lost to Follow-up|1
1594349|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
1594350|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
1594351|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1594352|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
1594353|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1594354|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
1594355|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
1594356|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1594357|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
1594358|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
1594359|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1594360|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1594361|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
1594362|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
1594363|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
1594364|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1594365|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
1594366|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
1594367|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1594368|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
1594369|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
1594370|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
1594371|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
1594372|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
1594373|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
1594374|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
1594375|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
1594376|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
1594377|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
1594378|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
1594379|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
1594380|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
1594381|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
1594382|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
1594383|NCT02357901|5551497|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
1594384|NCT02357901|5551498|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
1594385|NCT02357901|5551499|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
1594386|NCT02357901|5551500|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
1594387|NCT02357901|5551497|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1594388|NCT02357901|5551498|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1594389|NCT02357901|5551499|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
1594390|NCT02357901|5551500|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
1594391|NCT02357576|5551565|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
1594392|NCT02357576|5551566|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
1594393|NCT02357576|5551565|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
1594394|NCT02357576|5551566|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
1594395|NCT02357576|5551565|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
1594396|NCT02357576|5551566|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
1594397|NCT02357576|5551565|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
1594398|NCT02357576|5551566|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
1594399|NCT02357576|5551565|P2|Treatment Period|Physician Decision|1
1594400|NCT02357576|5551566|P1|Treatment Period|Physician Decision|0
1594401|NCT02357576|5551565|P2|Treatment Period|Withdrawal by Subject|1
1594402|NCT02357576|5551566|P1|Treatment Period|Withdrawal by Subject|0
1594403|NCT02357459|5551607|P3|Overall Study|Job Commitments|1
1594404|NCT02357459|5551608|P2|Overall Study|Job Commitments|0
1594405|NCT02357459|5551609|P1|Overall Study|Job Commitments|0
1594406|NCT02357459|5551607|P3|Overall Study|Pre-planned Knee surgery|2
1594407|NCT02357459|5551608|P2|Overall Study|Pre-planned Knee surgery|0
1594408|NCT02357459|5551609|P1|Overall Study|Pre-planned Knee surgery|0
1594409|NCT02357459|5551607|P3|Overall Study|Incarceration|1
1594410|NCT02357459|5551608|P2|Overall Study|Incarceration|0
1594411|NCT02357459|5551609|P1|Overall Study|Incarceration|0
1594412|NCT02357459|5551607|P3|Overall Study|Instruction from PCP|0
1594413|NCT02357459|5551608|P2|Overall Study|Instruction from PCP|0
1594414|NCT02357459|5551609|P1|Overall Study|Instruction from PCP|1
1594415|NCT02357459|5551607|P3|Overall Study|Patient Relocated|0
1594416|NCT02357459|5551608|P2|Overall Study|Patient Relocated|0
1594417|NCT02357459|5551609|P1|Overall Study|Patient Relocated|2
1594418|NCT02357459|5551607|P3|Overall Study|Lack of Efficacy|4
1594419|NCT02357459|5551608|P2|Overall Study|Lack of Efficacy|4
1594420|NCT02357459|5551609|P1|Overall Study|Lack of Efficacy|7
1594421|NCT02357459|5551607|P3|Overall Study|Lost to Follow-up|0
1594422|NCT02357459|5551608|P2|Overall Study|Lost to Follow-up|3
1594424|NCT02357459|5551607|P3|Overall Study|Protocol Violation|0
1594425|NCT02357459|5551608|P2|Overall Study|Protocol Violation|1
1594426|NCT02357459|5551609|P1|Overall Study|Protocol Violation|1
1594427|NCT02357459|5551607|P3|Overall Study|Physician Decision|0
1594428|NCT02357459|5551608|P2|Overall Study|Physician Decision|2
1594429|NCT02357459|5551609|P1|Overall Study|Physician Decision|0
1594430|NCT02357459|5551607|P3|Overall Study|Withdrawal by Subject|3
1594431|NCT02357459|5551608|P2|Overall Study|Withdrawal by Subject|3
1594432|NCT02357459|5551609|P1|Overall Study|Withdrawal by Subject|5
1594433|NCT02357459|5551607|P3|Overall Study|Adverse Event|1
1594434|NCT02357459|5551608|P2|Overall Study|Adverse Event|1
1594435|NCT02357459|5551609|P1|Overall Study|Adverse Event|0
1594436|NCT02357420|5551655|P4|Overall Study|Lost to Follow-up|3
1594437|NCT02357420|5551656|P3|Overall Study|Lost to Follow-up|2
1594438|NCT02357420|5551657|P2|Overall Study|Lost to Follow-up|0
1594439|NCT02357420|5551658|P1|Overall Study|Lost to Follow-up|3
1594440|NCT02357420|5551655|P4|Overall Study|Withdrawn Consent|6
1594441|NCT02357420|5551656|P3|Overall Study|Withdrawn Consent|6
1594442|NCT02357420|5551657|P2|Overall Study|Withdrawn Consent|8
1594443|NCT02357420|5551658|P1|Overall Study|Withdrawn Consent|4
1594444|NCT02357420|5551655|P4|Overall Study|Protocol Non-compliance|1
1594445|NCT02357420|5551656|P3|Overall Study|Protocol Non-compliance|0
1594446|NCT02357420|5551657|P2|Overall Study|Protocol Non-compliance|0
1594447|NCT02357420|5551658|P1|Overall Study|Protocol Non-compliance|0
1594448|NCT02357420|5551655|P4|Overall Study|Prohibited Medication|0
1594449|NCT02357420|5551656|P3|Overall Study|Prohibited Medication|0
1594450|NCT02357420|5551657|P2|Overall Study|Prohibited Medication|1
1594451|NCT02357420|5551658|P1|Overall Study|Prohibited Medication|1
1594452|NCT02357420|5551655|P4|Overall Study|Investigator Decision|0
1594453|NCT02357420|5551656|P3|Overall Study|Investigator Decision|0
1594454|NCT02357420|5551657|P2|Overall Study|Investigator Decision|0
1594455|NCT02357420|5551658|P1|Overall Study|Investigator Decision|1
1594456|NCT02357420|5551655|P4|Overall Study|Adverse Event|9
1594457|NCT02357420|5551656|P3|Overall Study|Adverse Event|8
1594458|NCT02357420|5551657|P2|Overall Study|Adverse Event|3
1594459|NCT02357420|5551658|P1|Overall Study|Adverse Event|3
1594460|NCT02357342|5551719|P2|First 6 Months|Death|0
1594461|NCT02357342|5551720|P1|First 6 Months|Death|2
1594462|NCT02356783|5551789|P2|Overall Study|Lost to Follow-up|3
1594463|NCT02356783|5551790|P1|Overall Study|Lost to Follow-up|1
1594464|NCT02356588|5551800|P2|Overall Study|Protocol Violation|1
1594465|NCT02356588|5551801|P1|Overall Study|Protocol Violation|0
1594466|NCT02356588|5551800|P2|Overall Study|Withdrawal by Subject|0
1594467|NCT02356588|5551801|P1|Overall Study|Withdrawal by Subject|1
1594468|NCT02356588|5551800|P2|Overall Study|Adverse Event|2
1594469|NCT02356588|5551801|P1|Overall Study|Adverse Event|0
1594470|NCT02356588|5551800|P2|Overall Study|Lack of Efficacy|10
1594471|NCT02356588|5551801|P1|Overall Study|Lack of Efficacy|4
1594472|NCT02356562|5551918|P2|Overall Study|site closure|0
1594473|NCT02356562|5551919|P1|Overall Study|site closure|1
1594474|NCT02356562|5551918|P2|Overall Study|Re-entered treatment in a previous study|0
1594475|NCT02356562|5551919|P1|Overall Study|Re-entered treatment in a previous study|1
1594476|NCT02356562|5551918|P2|Overall Study|Withdrawal by Subject|1
1594477|NCT02356562|5551919|P1|Overall Study|Withdrawal by Subject|0
1594478|NCT02355743|5552008|P1|Overall Study|Lost to Follow-up|1
1594479|NCT02355743|5552008|P1|Overall Study|Withdrawal by Subject|1
1594480|NCT02355691|5552016|P2|Overall Study|Loss of Research Personnel|9
1594481|NCT02355691|5552017|P1|Overall Study|Loss of Research Personnel|7
1594482|NCT02355665|5552027|P2|Overall Study|Compliance, PI decision, move, eligible|3
1594483|NCT02355665|5552028|P1|Overall Study|Compliance, PI decision, move, eligible|6
1594484|NCT02355665|5552027|P2|Overall Study|Death|2
1594485|NCT02355665|5552028|P1|Overall Study|Death|4
1594486|NCT02355665|5552027|P2|Overall Study|Lost to Follow-up|103
1594487|NCT02355665|5552028|P1|Overall Study|Lost to Follow-up|131
1594488|NCT02355665|5552027|P2|Overall Study|Withdrawal by Subject|100
1594489|NCT02355665|5552028|P1|Overall Study|Withdrawal by Subject|90
1594490|NCT02355665|5552027|P2|Overall Study|Protocol Violation|0
1594491|NCT02355665|5552028|P1|Overall Study|Protocol Violation|2
1594492|NCT02355665|5552027|P2|Overall Study|Adverse Event|24
1594493|NCT02355665|5552028|P1|Overall Study|Adverse Event|16
1594494|NCT02355028|5552486|P2|Overall Study|Deemed ineligible after randomization|4
1594495|NCT02355028|5552487|P1|Overall Study|Deemed ineligible after randomization|8
1594496|NCT02355028|5552486|P2|Overall Study|Withdrawal by Subject|1
1594497|NCT02355028|5552487|P1|Overall Study|Withdrawal by Subject|1
1594498|NCT02355028|5552486|P2|Overall Study|Adverse Event|0
1594499|NCT02355028|5552487|P1|Overall Study|Adverse Event|2
1594500|NCT02354976|5552523|P3|Overall Study|Adverse Event|2
1594501|NCT02354976|5552524|P2|Overall Study|Adverse Event|0
1594502|NCT02354976|5552525|P1|Overall Study|Adverse Event|1
1594503|NCT02354976|5552523|P3|Overall Study|Study-specifc withdrawal criteria|0
1594504|NCT02354976|5552524|P2|Overall Study|Study-specifc withdrawal criteria|1
1594505|NCT02354976|5552525|P1|Overall Study|Study-specifc withdrawal criteria|0
1594506|NCT02354976|5552523|P3|Overall Study|Other - reason not specified|1
1594507|NCT02354976|5552524|P2|Overall Study|Other - reason not specified|0
1594508|NCT02354976|5552525|P1|Overall Study|Other - reason not specified|1
1594509|NCT02354599|5552595|P6|Overall Study|Withdrawal by Subject|0
1594510|NCT02354599|5552596|P5|Overall Study|Withdrawal by Subject|0
1594511|NCT02354599|5552597|P4|Overall Study|Withdrawal by Subject|0
1594512|NCT02354599|5552598|P3|Overall Study|Withdrawal by Subject|0
1594513|NCT02354599|5552599|P2|Overall Study|Withdrawal by Subject|1
1594514|NCT02354599|5552600|P1|Overall Study|Withdrawal by Subject|1
1594515|NCT02354599|5552595|P6|Overall Study|Pretreatment Event/Adverse Event|1
1594516|NCT02354599|5552596|P5|Overall Study|Pretreatment Event/Adverse Event|0
1594517|NCT02354599|5552597|P4|Overall Study|Pretreatment Event/Adverse Event|0
1594518|NCT02354599|5552598|P3|Overall Study|Pretreatment Event/Adverse Event|0
1594519|NCT02354599|5552599|P2|Overall Study|Pretreatment Event/Adverse Event|0
1594520|NCT02354599|5552600|P1|Overall Study|Pretreatment Event/Adverse Event|0
1594521|NCT02354508|5552673|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
1594522|NCT02354508|5552674|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
1594523|NCT02354508|5552675|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
1594524|NCT02354508|5552673|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
1594525|NCT02354508|5552674|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
1594526|NCT02354508|5552675|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
1594527|NCT02354508|5552673|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
1594528|NCT02354508|5552674|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
1594529|NCT02354508|5552675|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
1594530|NCT02354508|5552673|P3|Period 2: Extension Phase|Physician Decision|1
1594531|NCT02354508|5552674|P2|Period 2: Extension Phase|Physician Decision|0
1594532|NCT02354508|5552675|P1|Period 2: Extension Phase|Physician Decision|5
1594533|NCT02354508|5552673|P3|Period 2: Extension Phase|Withdrawal by Subject|0
1594534|NCT02354508|5552674|P2|Period 2: Extension Phase|Withdrawal by Subject|1
1594535|NCT02354508|5552675|P1|Period 2: Extension Phase|Withdrawal by Subject|0
1594536|NCT02354508|5552673|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
1594537|NCT02354508|5552674|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
1594538|NCT02354508|5552675|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
1594539|NCT02354508|5552673|P3|Period 1: Core Phase|Withdrawal by Subject|2
1594540|NCT02354508|5552674|P2|Period 1: Core Phase|Withdrawal by Subject|1
1594541|NCT02354508|5552675|P1|Period 1: Core Phase|Withdrawal by Subject|0
1594542|NCT02354508|5552673|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
1594543|NCT02354508|5552674|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
1594544|NCT02354508|5552675|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
1594545|NCT02354508|5552673|P3|Period 1: Core Phase|Adverse Event|2
1594546|NCT02354508|5552674|P2|Period 1: Core Phase|Adverse Event|1
1594547|NCT02354508|5552675|P1|Period 1: Core Phase|Adverse Event|1
1594548|NCT02354417|5552777|P1|Overall Study|Physician Decision|1
1594549|NCT02354235|5552803|P2|Overall Study|Conflict with the stopping criteria|1
1594550|NCT02354235|5552804|P1|Overall Study|Conflict with the stopping criteria|0
1594551|NCT02354235|5552803|P2|Overall Study|Withdrawal by Subject|3
1594552|NCT02354235|5552804|P1|Overall Study|Withdrawal by Subject|1
1594553|NCT02354235|5552803|P2|Overall Study|Physician Decision|1
1594554|NCT02354235|5552804|P1|Overall Study|Physician Decision|0
1594555|NCT02354235|5552803|P2|Overall Study|Adverse Event|2
1594556|NCT02354235|5552804|P1|Overall Study|Adverse Event|2
1594557|NCT02354222|5552820|P2|Overall Study|Conflict with the stopping criteria|4
1594558|NCT02354222|5552821|P1|Overall Study|Conflict with the stopping criteria|0
1594559|NCT02354222|5552820|P2|Overall Study|Withdrawal by Subject|3
1594560|NCT02354222|5552821|P1|Overall Study|Withdrawal by Subject|2
1594561|NCT02354222|5552820|P2|Overall Study|Pregnancy|0
1594562|NCT02354222|5552821|P1|Overall Study|Pregnancy|1
1594563|NCT02354222|5552820|P2|Overall Study|Physician Decision|1
1594564|NCT02354222|5552821|P1|Overall Study|Physician Decision|1
1594565|NCT02354222|5552820|P2|Overall Study|Adverse Event|3
1594566|NCT02354222|5552821|P1|Overall Study|Adverse Event|0
1594567|NCT02353871|5552852|P2|Overall Study|Lost to Follow-up|0
1594568|NCT02353871|5552853|P1|Overall Study|Lost to Follow-up|2
1594569|NCT02353871|5552852|P2|Overall Study|Consent withdrawn|8
1594570|NCT02353871|5552853|P1|Overall Study|Consent withdrawn|1
1594571|NCT02353871|5552852|P2|Overall Study|Protocol deviation|1
1594572|NCT02353871|5552853|P1|Overall Study|Protocol deviation|0
1594573|NCT02353572|5552906|P1|Overall Study|Study terminated|2
1594574|NCT02353572|5552906|P1|Overall Study|Withdrawal by Subject|1
1594575|NCT02353468|5552910|P1|Overall Study|Study terminated|3
1594576|NCT02353442|5552916|P2|Overall Study|Withdrawal by Subject|4
1594577|NCT02353442|5552917|P1|Overall Study|Withdrawal by Subject|3
1594578|NCT02353169|5552972|P4|Overall Study|Pre-op medication|0
1594579|NCT02353169|5552973|P3|Overall Study|Pre-op medication|1
1594580|NCT02353169|5552974|P2|Overall Study|Pre-op medication|0
1594581|NCT02353169|5552975|P1|Overall Study|Pre-op medication|0
1594582|NCT02353169|5552972|P4|Overall Study|ECG data error|2
1594583|NCT02353169|5552973|P3|Overall Study|ECG data error|2
1594584|NCT02353169|5552974|P2|Overall Study|ECG data error|3
1594585|NCT02353169|5552975|P1|Overall Study|ECG data error|0
1594586|NCT02353169|5552972|P4|Overall Study|Inhalational induction|0
1594587|NCT02353169|5552973|P3|Overall Study|Inhalational induction|0
1594588|NCT02353169|5552974|P2|Overall Study|Inhalational induction|2
1594589|NCT02353169|5552975|P1|Overall Study|Inhalational induction|0
1594590|NCT02353169|5552972|P4|Overall Study|OR team declined|0
1594591|NCT02353169|5552973|P3|Overall Study|OR team declined|0
1594592|NCT02353169|5552974|P2|Overall Study|OR team declined|0
1594593|NCT02353169|5552975|P1|Overall Study|OR team declined|2
1594594|NCT02353169|5552972|P4|Overall Study|QTc > 450 msec|1
1594595|NCT02353169|5552973|P3|Overall Study|QTc > 450 msec|1
1594596|NCT02353169|5552974|P2|Overall Study|QTc > 450 msec|1
1594597|NCT02353169|5552975|P1|Overall Study|QTc > 450 msec|1
1594598|NCT02352948|5552999|P6|Overall Study|Other|0
1594599|NCT02352948|5553000|P5|Overall Study|Other|0
1594600|NCT02352948|5553001|P4|Overall Study|Other|0
1594601|NCT02352948|5553002|P3|Overall Study|Other|2
1594602|NCT02352948|5553003|P2|Overall Study|Other|0
1594603|NCT02352948|5553004|P1|Overall Study|Other|0
1594604|NCT02352948|5552999|P6|Overall Study|Eligibility criteria not fulfilled|0
1594605|NCT02352948|5553000|P5|Overall Study|Eligibility criteria not fulfilled|0
1594606|NCT02352948|5553001|P4|Overall Study|Eligibility criteria not fulfilled|1
1594607|NCT02352948|5553002|P3|Overall Study|Eligibility criteria not fulfilled|0
1594608|NCT02352948|5553003|P2|Overall Study|Eligibility criteria not fulfilled|1
1594609|NCT02352948|5553004|P1|Overall Study|Eligibility criteria not fulfilled|0
1594610|NCT02352948|5552999|P6|Overall Study|Withdrawal by Subject|4
1594611|NCT02352948|5553000|P5|Overall Study|Withdrawal by Subject|9
1594612|NCT02352948|5553001|P4|Overall Study|Withdrawal by Subject|23
1594613|NCT02352948|5553002|P3|Overall Study|Withdrawal by Subject|11
1594614|NCT02352948|5553003|P2|Overall Study|Withdrawal by Subject|10
1594615|NCT02352948|5553004|P1|Overall Study|Withdrawal by Subject|1
1594616|NCT02352948|5552999|P6|Overall Study|Lost to Follow-up|1
1594617|NCT02352948|5553000|P5|Overall Study|Lost to Follow-up|2
1594618|NCT02352948|5553001|P4|Overall Study|Lost to Follow-up|1
1594619|NCT02352948|5553002|P3|Overall Study|Lost to Follow-up|2
1594620|NCT02352948|5553003|P2|Overall Study|Lost to Follow-up|0
1594621|NCT02352948|5553004|P1|Overall Study|Lost to Follow-up|1
1594622|NCT02352948|5552999|P6|Overall Study|Death|44
1594623|NCT02352948|5553000|P5|Overall Study|Death|77
1594624|NCT02352948|5553001|P4|Overall Study|Death|74
1594625|NCT02352948|5553002|P3|Overall Study|Death|114
1594626|NCT02352948|5553003|P2|Overall Study|Death|48
1594627|NCT02352948|5553004|P1|Overall Study|Death|47
1594628|NCT02352779|5553092|P3|Overall Study|No Reason|1
1594629|NCT02352779|5553093|P2|Overall Study|No Reason|0
1594630|NCT02352779|5553094|P1|Overall Study|No Reason|0
1594631|NCT02352779|5553092|P3|Overall Study|Other Medical Reason|1
1594632|NCT02352779|5553093|P2|Overall Study|Other Medical Reason|0
1594633|NCT02352779|5553094|P1|Overall Study|Other Medical Reason|0
1594634|NCT02352779|5553092|P3|Overall Study|Absence of Symptoms|0
1594635|NCT02352779|5553093|P2|Overall Study|Absence of Symptoms|0
1594636|NCT02352779|5553094|P1|Overall Study|Absence of Symptoms|1
1594637|NCT02352779|5553092|P3|Overall Study|Study Related Symptoms|0
1594638|NCT02352779|5553093|P2|Overall Study|Study Related Symptoms|0
1594639|NCT02352779|5553094|P1|Overall Study|Study Related Symptoms|1
1594640|NCT02352779|5553092|P3|Overall Study|Changed Mind|0
1594641|NCT02352779|5553093|P2|Overall Study|Changed Mind|0
1594642|NCT02352779|5553094|P1|Overall Study|Changed Mind|1
1594643|NCT02352779|5553092|P3|Overall Study|Disliked Intervention|0
1594644|NCT02352779|5553093|P2|Overall Study|Disliked Intervention|0
1594645|NCT02352779|5553094|P1|Overall Study|Disliked Intervention|1
1594646|NCT02352779|5553092|P3|Overall Study|Feeling Overwhelmed|0
1594647|NCT02352779|5553093|P2|Overall Study|Feeling Overwhelmed|0
1594648|NCT02352779|5553094|P1|Overall Study|Feeling Overwhelmed|1
1594649|NCT02352779|5553092|P3|Overall Study|Too Many Forms|0
1594650|NCT02352779|5553093|P2|Overall Study|Too Many Forms|0
1594651|NCT02352779|5553094|P1|Overall Study|Too Many Forms|2
1594652|NCT02352779|5553092|P3|Overall Study|Personal Issues|0
1594653|NCT02352779|5553093|P2|Overall Study|Personal Issues|1
1594654|NCT02352779|5553094|P1|Overall Study|Personal Issues|1
1594655|NCT02351960|5553147|P2|Overall Study|Significant Protocol Deviation|5
1594656|NCT02351960|5553148|P1|Overall Study|Significant Protocol Deviation|0
1594657|NCT02351960|5553147|P2|Overall Study|Voluntary Withdrawal|4
1594658|NCT02351960|5553148|P1|Overall Study|Voluntary Withdrawal|5
1594659|NCT02351960|5553147|P2|Overall Study|Pretreatment Event/Adverse Event|3
1594660|NCT02351960|5553148|P1|Overall Study|Pretreatment Event/Adverse Event|6
1594661|NCT02351934|5553169|P2|Follow-Up|2 ERAS Components Noncompliant|4
1594662|NCT02351934|5553170|P1|Follow-Up|2 ERAS Components Noncompliant|0
1594663|NCT02351934|5553169|P2|Follow-Up|1 ERAS Component Noncompliant|6
1594664|NCT02351934|5553170|P1|Follow-Up|1 ERAS Component Noncompliant|0
1594665|NCT02351934|5553169|P2|Follow-Up|No documentation|0
1594666|NCT02351934|5553170|P1|Follow-Up|No documentation|2
1594667|NCT02351934|5553169|P2|Follow-Up|Hypotension|0
1594668|NCT02351934|5553170|P1|Follow-Up|Hypotension|3
1594669|NCT02351934|5553169|P2|Follow-Up|Early dismissal|0
1594670|NCT02351934|5553170|P1|Follow-Up|Early dismissal|3
1594671|NCT02351934|5553169|P2|Follow-Up|Acute Kidney Injury|0
1594672|NCT02351934|5553170|P1|Follow-Up|Acute Kidney Injury|1
1594673|NCT02351934|5553169|P2|Follow-Up|POD weight<pre-op weight|0
1594674|NCT02351934|5553170|P1|Follow-Up|POD weight<pre-op weight|3
1594675|NCT02351934|5553169|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
1594676|NCT02351934|5553170|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
1594677|NCT02351934|5553169|P2|Allocation|Hypotension preventing administration|0
1594678|NCT02351934|5553170|P1|Allocation|Hypotension preventing administration|2
1594679|NCT02351934|5553169|P2|Allocation|POD weight<pre-op weight|0
1594680|NCT02351934|5553170|P1|Allocation|POD weight<pre-op weight|3
1594681|NCT02351817|5553186|P2|Period 2|Protocol Violation|0
1594682|NCT02351817|5553187|P1|Period 2|Protocol Violation|1
1594683|NCT02351817|5553186|P2|Period 2|Adverse Event|2
1594684|NCT02351817|5553187|P1|Period 2|Adverse Event|0
1594685|NCT02351817|5553186|P2|Period 1|Lack of Efficacy|1
1594686|NCT02351817|5553187|P1|Period 1|Lack of Efficacy|0
1594687|NCT02351817|5553186|P2|Period 1|Adverse Event|2
1594688|NCT02351817|5553187|P1|Period 1|Adverse Event|1
1594689|NCT02350478|5553295|P2|Overall Study|Lost to Follow-up|1
1594690|NCT02350478|5553296|P1|Overall Study|Lost to Follow-up|5
1594691|NCT02350309|5553318|P6|Treatment Period 4 (2 Days)|Death in the Family|1
1594692|NCT02350309|5553319|P5|Treatment Period 4 (2 Days)|Death in the Family|0
1594693|NCT02350309|5553320|P4|Treatment Period 4 (2 Days)|Death in the Family|0
1594694|NCT02350309|5553321|P3|Treatment Period 4 (2 Days)|Death in the Family|0
1594695|NCT02350309|5553322|P2|Treatment Period 4 (2 Days)|Death in the Family|0
1594696|NCT02350309|5553323|P1|Treatment Period 4 (2 Days)|Death in the Family|0
1594697|NCT02350309|5553318|P6|Treatment Period 1 (2 Days)|Physician Decision|0
1594698|NCT02350309|5553319|P5|Treatment Period 1 (2 Days)|Physician Decision|0
1594699|NCT02350309|5553320|P4|Treatment Period 1 (2 Days)|Physician Decision|0
1594700|NCT02350309|5553321|P3|Treatment Period 1 (2 Days)|Physician Decision|1
1594701|NCT02350309|5553322|P2|Treatment Period 1 (2 Days)|Physician Decision|0
1594702|NCT02350309|5553323|P1|Treatment Period 1 (2 Days)|Physician Decision|0
1594703|NCT02349789|5553362|P1|Overall Study|Withdrawal by Subject|2
1594704|NCT02349711|5553373|P2|Overall Study|Lost to Follow-up|1
1594705|NCT02349711|5553374|P1|Overall Study|Lost to Follow-up|1
1594706|NCT02349711|5553373|P2|Overall Study|Withdrawal by Subject|1
1594707|NCT02349711|5553374|P1|Overall Study|Withdrawal by Subject|2
1594708|NCT02349542|5553407|P1|Overall Study|Withdrawal by Subject|5
1594709|NCT02349451|5553431|P4|Overall Study|Withdrawal by Subject|1
1594710|NCT02349451|5553432|P3|Overall Study|Withdrawal by Subject|2
1594711|NCT02349451|5553433|P2|Overall Study|Withdrawal by Subject|1
1594712|NCT02349451|5553434|P1|Overall Study|Withdrawal by Subject|0
1594713|NCT02349412|5553483|P2|Overall Study|Withdrawal by Subject|7
1594714|NCT02349412|5553484|P1|Overall Study|Withdrawal by Subject|7
1594715|NCT02349360|5553500|P2|Overall Study|Withdrawal by Subject|1
1594716|NCT02349360|5553501|P1|Overall Study|Withdrawal by Subject|0
1594717|NCT02349295|5553512|P5|IR (Week 16-24)|Lack of Efficacy|1
1594718|NCT02349295|5553513|P4|IR (Week 16-24)|Lack of Efficacy|0
1594719|NCT02349295|5553514|P3|IR (Week 16-24)|Lack of Efficacy|0
1594720|NCT02349295|5553515|P2|IR (Week 16-24)|Lack of Efficacy|0
1594721|NCT02349295|5553516|P1|IR (Week 16-24)|Lack of Efficacy|0
1594722|NCT02349295|5553512|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1594723|NCT02349295|5553513|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1594724|NCT02349295|5553514|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
1594725|NCT02349295|5553515|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1594726|NCT02349295|5553516|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
1594727|NCT02349295|5553512|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1594728|NCT02349295|5553513|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
1594729|NCT02349295|5553514|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
1594730|NCT02349295|5553515|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
1594731|NCT02349295|5553516|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
1594732|NCT02349295|5553512|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1594733|NCT02349295|5553513|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
1594734|NCT02349295|5553514|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1594735|NCT02349295|5553515|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
1594736|NCT02349295|5553516|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
1594737|NCT02349295|5553512|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1594738|NCT02349295|5553513|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
1594739|NCT02349295|5553514|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
1594740|NCT02349295|5553515|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
1594741|NCT02349295|5553516|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
1594742|NCT02349295|5553512|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
1594743|NCT02349295|5553513|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
1594744|NCT02349295|5553514|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
1594745|NCT02349295|5553515|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
1594746|NCT02349295|5553516|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
1594747|NCT02349061|5553633|P2|Overall Study|Other|1
1594748|NCT02349061|5553634|P1|Overall Study|Other|3
1594749|NCT02349061|5553633|P2|Overall Study|Physician Decision|0
1594750|NCT02349061|5553634|P1|Overall Study|Physician Decision|1
1594751|NCT02349061|5553633|P2|Overall Study|Lack of Efficacy|0
1594752|NCT02349061|5553634|P1|Overall Study|Lack of Efficacy|1
1594753|NCT02349061|5553633|P2|Overall Study|Adverse Event|3
1594754|NCT02349061|5553634|P1|Overall Study|Adverse Event|4
1594755|NCT02349048|5553642|P2|Overall Study|Lost to Follow-up|0
1594756|NCT02349048|5553643|P1|Overall Study|Lost to Follow-up|1
1594757|NCT02349048|5553642|P2|Overall Study|Withdrawal by Subject|0
1594758|NCT02349048|5553643|P1|Overall Study|Withdrawal by Subject|4
1594759|NCT02348840|5553704|P4|Overall Study|Withdrawal by Subject|0
1594760|NCT02348840|5553705|P3|Overall Study|Withdrawal by Subject|0
1594761|NCT02348840|5553706|P2|Overall Study|Withdrawal by Subject|1
1594762|NCT02348840|5553707|P1|Overall Study|Withdrawal by Subject|2
1594763|NCT02348723|5553721|P2|Overall Study|Adverse Event|1
1594764|NCT02348723|5553722|P1|Overall Study|Adverse Event|3
1594765|NCT02348723|5553721|P2|Overall Study|Reason other than specified|1
1594766|NCT02348723|5553722|P1|Overall Study|Reason other than specified|1
1594767|NCT02348723|5553721|P2|Overall Study|Consent withdrawn|3
1594768|NCT02348723|5553722|P1|Overall Study|Consent withdrawn|1
1594769|NCT02348723|5553721|P2|Overall Study|Lost to Follow-up|1
1594770|NCT02348723|5553722|P1|Overall Study|Lost to Follow-up|1
1594771|NCT02348723|5553721|P2|Overall Study|Non-compliant with Protocol|0
1594772|NCT02348723|5553722|P1|Overall Study|Non-compliant with Protocol|1
1594773|NCT02348723|5553721|P2|Overall Study|No ablation|20
1594774|NCT02348723|5553722|P1|Overall Study|No ablation|21
1594775|NCT02347943|5553929|P3|Overall Study|Study was cancelled|45
1594776|NCT02347943|5553930|P2|Overall Study|Study was cancelled|67
1594777|NCT02347943|5553931|P1|Overall Study|Study was cancelled|140
1594778|NCT02347787|5553941|P2|9 Month Follow-Up|Withdrawal by Subject|12
1594779|NCT02347787|5553942|P1|9 Month Follow-Up|Withdrawal by Subject|9
1594780|NCT02347787|5553941|P2|9 Month Follow-Up|Lost to Follow-up|59
1594781|NCT02347787|5553942|P1|9 Month Follow-Up|Lost to Follow-up|52
1594782|NCT02347787|5553941|P2|6 Month Follow-Up|Withdrawal by Subject|9
1594783|NCT02347787|5553942|P1|6 Month Follow-Up|Withdrawal by Subject|3
1594784|NCT02347787|5553941|P2|6 Month Follow-Up|Lost to Follow-up|47
1594785|NCT02347787|5553942|P1|6 Month Follow-Up|Lost to Follow-up|63
1594786|NCT02347774|5554004|P3|On Study Treatment|ranomized in error|1
1594787|NCT02347774|5554005|P2|On Study Treatment|ranomized in error|0
1594788|NCT02347774|5554006|P1|On Study Treatment|ranomized in error|0
1594789|NCT02347774|5554004|P3|On Study Treatment|Met Prolonged QT criteria|0
1594790|NCT02347774|5554005|P2|On Study Treatment|Met Prolonged QT criteria|0
1594791|NCT02347774|5554006|P1|On Study Treatment|Met Prolonged QT criteria|1
1594792|NCT02347774|5554004|P3|On Study Treatment|Lost to Follow-up|1
1594793|NCT02347774|5554005|P2|On Study Treatment|Lost to Follow-up|6
1594794|NCT02347774|5554006|P1|On Study Treatment|Lost to Follow-up|2
1594795|NCT02347774|5554004|P3|On Study Treatment|withdrew consent|12
1594796|NCT02347774|5554005|P2|On Study Treatment|withdrew consent|8
1594797|NCT02347774|5554006|P1|On Study Treatment|withdrew consent|9
1594798|NCT02347774|5554004|P3|On Study Treatment|Protocol Violation|1
1594799|NCT02347774|5554005|P2|On Study Treatment|Protocol Violation|0
1594800|NCT02347774|5554006|P1|On Study Treatment|Protocol Violation|0
1594801|NCT02347774|5554004|P3|On Study Treatment|non-complicance with study medication|0
1594802|NCT02347774|5554005|P2|On Study Treatment|non-complicance with study medication|2
1594803|NCT02347774|5554006|P1|On Study Treatment|non-complicance with study medication|0
1594804|NCT02347774|5554004|P3|On Study Treatment|Lack of Efficacy|2
1594805|NCT02347774|5554005|P2|On Study Treatment|Lack of Efficacy|0
1594806|NCT02347774|5554006|P1|On Study Treatment|Lack of Efficacy|3
1594807|NCT02347774|5554004|P3|On Study Treatment|Adverse Event|19
1594808|NCT02347774|5554005|P2|On Study Treatment|Adverse Event|15
1594809|NCT02347774|5554006|P1|On Study Treatment|Adverse Event|9
1594810|NCT02347774|5554004|P3|Study Participation|randomized in error|1
1594811|NCT02347774|5554005|P2|Study Participation|randomized in error|0
1594812|NCT02347774|5554006|P1|Study Participation|randomized in error|0
1594813|NCT02347774|5554004|P3|Study Participation|incarceration|0
1594814|NCT02347774|5554005|P2|Study Participation|incarceration|0
1594815|NCT02347774|5554006|P1|Study Participation|incarceration|1
1594816|NCT02347774|5554004|P3|Study Participation|non-compliance with study drug|0
1594817|NCT02347774|5554005|P2|Study Participation|non-compliance with study drug|1
1594818|NCT02347774|5554006|P1|Study Participation|non-compliance with study drug|0
1594819|NCT02347774|5554004|P3|Study Participation|Met Prolonged QT criteria|0
1594820|NCT02347774|5554005|P2|Study Participation|Met Prolonged QT criteria|0
1594821|NCT02347774|5554006|P1|Study Participation|Met Prolonged QT criteria|1
1594822|NCT02347774|5554004|P3|Study Participation|withdrew consent|1
1594823|NCT02347774|5554005|P2|Study Participation|withdrew consent|1
1594824|NCT02347774|5554006|P1|Study Participation|withdrew consent|1
1594825|NCT02347774|5554004|P3|Study Participation|Adverse Event|6
1594826|NCT02347774|5554005|P2|Study Participation|Adverse Event|4
1594827|NCT02347774|5554006|P1|Study Participation|Adverse Event|1
1594828|NCT02347774|5554004|P3|Study Participation|Withdrawal by Subject|15
1594829|NCT02347774|5554005|P2|Study Participation|Withdrawal by Subject|9
1594830|NCT02347774|5554006|P1|Study Participation|Withdrawal by Subject|8
1594831|NCT02347774|5554004|P3|Study Participation|Lost to Follow-up|2
1594832|NCT02347774|5554005|P2|Study Participation|Lost to Follow-up|6
1594833|NCT02347774|5554006|P1|Study Participation|Lost to Follow-up|3
1594834|NCT02347761|5554062|P3|On Study Treatment|Adverse Event|20
1594835|NCT02347761|5554063|P2|On Study Treatment|Adverse Event|8
1594836|NCT02347761|5554064|P1|On Study Treatment|Adverse Event|10
1594837|NCT02347761|5554062|P3|On Study Treatment|durg not working|1
1594838|NCT02347761|5554063|P2|On Study Treatment|durg not working|1
1594839|NCT02347761|5554064|P1|On Study Treatment|durg not working|0
1594840|NCT02347761|5554062|P3|On Study Treatment|investigator discretion|0
1594841|NCT02347761|5554063|P2|On Study Treatment|investigator discretion|0
1594842|NCT02347761|5554064|P1|On Study Treatment|investigator discretion|2
1594843|NCT02347761|5554062|P3|On Study Treatment|Lost to Follow-up|1
1594844|NCT02347761|5554063|P2|On Study Treatment|Lost to Follow-up|1
1594845|NCT02347761|5554064|P1|On Study Treatment|Lost to Follow-up|2
1594846|NCT02347761|5554062|P3|On Study Treatment|dissastisfaction with device|4
1594847|NCT02347761|5554063|P2|On Study Treatment|dissastisfaction with device|1
1594848|NCT02347761|5554064|P1|On Study Treatment|dissastisfaction with device|2
1594849|NCT02347761|5554062|P3|On Study Treatment|move/travel|5
1594850|NCT02347761|5554063|P2|On Study Treatment|move/travel|6
1594851|NCT02347761|5554064|P1|On Study Treatment|move/travel|2
1594852|NCT02347761|5554062|P3|On Study Treatment|Withdrawal by Subject|5
1594853|NCT02347761|5554063|P2|On Study Treatment|Withdrawal by Subject|3
1594854|NCT02347761|5554064|P1|On Study Treatment|Withdrawal by Subject|7
1594855|NCT02347761|5554062|P3|On Study Treatment|non-compliance with study medication|2
1594856|NCT02347761|5554063|P2|On Study Treatment|non-compliance with study medication|0
1594857|NCT02347761|5554064|P1|On Study Treatment|non-compliance with study medication|0
1594858|NCT02347761|5554062|P3|On Study Treatment|Lack of Efficacy|4
1594859|NCT02347761|5554063|P2|On Study Treatment|Lack of Efficacy|3
1594860|NCT02347761|5554064|P1|On Study Treatment|Lack of Efficacy|2
1594861|NCT02347761|5554062|P3|All Collected|moved/travel|0
1594862|NCT02347761|5554063|P2|All Collected|moved/travel|1
1594863|NCT02347761|5554064|P1|All Collected|moved/travel|0
1594864|NCT02347761|5554062|P3|All Collected|exacerbation of COPD|1
1594865|NCT02347761|5554063|P2|All Collected|exacerbation of COPD|0
1594866|NCT02347761|5554064|P1|All Collected|exacerbation of COPD|0
1594867|NCT02347761|5554062|P3|All Collected|instillation site pain|1
1594868|NCT02347761|5554063|P2|All Collected|instillation site pain|0
1594869|NCT02347761|5554064|P1|All Collected|instillation site pain|0
1594870|NCT02347761|5554062|P3|All Collected|invetigator disretion|0
1594871|NCT02347761|5554063|P2|All Collected|invetigator disretion|0
1594872|NCT02347761|5554064|P1|All Collected|invetigator disretion|2
1594873|NCT02347761|5554062|P3|All Collected|Withdrawal by Subject|22
1594874|NCT02347761|5554063|P2|All Collected|Withdrawal by Subject|11
1594875|NCT02347761|5554064|P1|All Collected|Withdrawal by Subject|11
1594876|NCT02347761|5554062|P3|All Collected|Lost to Follow-up|3
1594877|NCT02347761|5554063|P2|All Collected|Lost to Follow-up|2
1594878|NCT02347761|5554064|P1|All Collected|Lost to Follow-up|3
1594879|NCT02347761|5554062|P3|All Collected|Death|0
1594880|NCT02347761|5554063|P2|All Collected|Death|0
1594881|NCT02347761|5554064|P1|All Collected|Death|1
1594882|NCT02347657|5554125|P2|Overall Study|Other|3
1594883|NCT02347657|5554126|P1|Overall Study|Other|3
1594884|NCT02347657|5554125|P2|Overall Study|Randomized but not treated|0
1594885|NCT02347657|5554126|P1|Overall Study|Randomized but not treated|1
1594886|NCT02347657|5554125|P2|Overall Study|Withdrawal by Subject|7
1594887|NCT02347657|5554126|P1|Overall Study|Withdrawal by Subject|6
1594888|NCT02347657|5554125|P2|Overall Study|Adverse Event|4
1594889|NCT02347657|5554126|P1|Overall Study|Adverse Event|8
1594890|NCT02347657|5554125|P2|Overall Study|Physician Decision|1
1594891|NCT02347657|5554126|P1|Overall Study|Physician Decision|0
1594892|NCT02347332|5554204|P2|Overall Study|Switch Post-Trial program|1
1594893|NCT02347332|5554205|P1|Overall Study|Switch Post-Trial program|0
1594894|NCT02347332|5554204|P2|Overall Study|Protocol requirement|1
1594895|NCT02347332|5554205|P1|Overall Study|Protocol requirement|1
1594896|NCT02347332|5554204|P2|Overall Study|Withdrawal by Subject|14
1594897|NCT02347332|5554205|P1|Overall Study|Withdrawal by Subject|20
1594898|NCT02347332|5554204|P2|Overall Study|Physician Decision|3
1594899|NCT02347332|5554205|P1|Overall Study|Physician Decision|4
1594900|NCT02347332|5554204|P2|Overall Study|Lost to Follow-up|1
1594901|NCT02347332|5554205|P1|Overall Study|Lost to Follow-up|2
1594902|NCT02347332|5554204|P2|Overall Study|Protocol Violation|1
1594903|NCT02347332|5554205|P1|Overall Study|Protocol Violation|1
1594904|NCT02347332|5554204|P2|Overall Study|Death (Unknown, Various reasons)|6
1594905|NCT02347332|5554205|P1|Overall Study|Death (Unknown, Various reasons)|6
1594906|NCT02347332|5554204|P2|Overall Study|Adverse Event|41
1594907|NCT02347332|5554205|P1|Overall Study|Adverse Event|50
1594908|NCT02347332|5554204|P2|Overall Study|Progressive disease|159
1594909|NCT02347332|5554205|P1|Overall Study|Progressive disease|141
1594910|NCT02347332|5554204|P2|Overall Study|Not treated|2
1594911|NCT02347332|5554205|P1|Overall Study|Not treated|5
1594912|NCT02347189|5554219|P1|Overall Study|No primary outcome data available|2
1594913|NCT02347189|5554219|P1|Overall Study|No implant attempted of study device|9
1594914|NCT02347176|5554238|P4|Overall Study|Other|0
1594915|NCT02347176|5554239|P3|Overall Study|Other|2
1594916|NCT02347176|5554240|P2|Overall Study|Other|2
1594917|NCT02347176|5554241|P1|Overall Study|Other|1
1594918|NCT02347176|5554238|P4|Overall Study|Withdrawal by Subject|3
1594919|NCT02347176|5554239|P3|Overall Study|Withdrawal by Subject|5
1594920|NCT02347176|5554240|P2|Overall Study|Withdrawal by Subject|5
1594921|NCT02347176|5554241|P1|Overall Study|Withdrawal by Subject|9
1594922|NCT02347176|5554238|P4|Overall Study|Lost to Follow-up|1
1594923|NCT02347176|5554239|P3|Overall Study|Lost to Follow-up|1
1594924|NCT02347176|5554240|P2|Overall Study|Lost to Follow-up|3
1594925|NCT02347176|5554241|P1|Overall Study|Lost to Follow-up|2
1594926|NCT02347098|5554326|P2|Overall Study|no visit due to illness|1
1594927|NCT02347098|5554327|P1|Overall Study|no visit due to illness|2
1594928|NCT02347098|5554326|P2|Overall Study|Refuse Follow-up Visit|5
1594929|NCT02347098|5554327|P1|Overall Study|Refuse Follow-up Visit|1
1594930|NCT02347098|5554326|P2|Overall Study|Lost to Follow-up|2
1594931|NCT02347098|5554327|P1|Overall Study|Lost to Follow-up|2
1594932|NCT02347098|5554326|P2|Overall Study|Withdrawal by Subject|0
1594933|NCT02347098|5554327|P1|Overall Study|Withdrawal by Subject|1
1594934|NCT02347098|5554326|P2|Overall Study|Death|0
1594935|NCT02347098|5554327|P1|Overall Study|Death|1
1594936|NCT02347085|5554339|P1|Overall Study|Protocol Criteria|2
1594937|NCT02347085|5554339|P1|Overall Study|Lost to Follow-up|1
1594938|NCT02347085|5554339|P1|Overall Study|Withdrawal by Subject|4
1594939|NCT02347085|5554339|P1|Overall Study|Lack of Efficacy|1
1594940|NCT02347085|5554339|P1|Overall Study|Adverse Event|2
1594941|NCT02347072|5554361|P1|Overall Study|Disc due to Protocol-specified Criteria|6
1594942|NCT02347072|5554361|P1|Overall Study|Protocol Violation|1
1594943|NCT02347072|5554361|P1|Overall Study|Lost to Follow-up|2
1594944|NCT02347072|5554361|P1|Overall Study|Physician Decision|1
1594945|NCT02347072|5554361|P1|Overall Study|Withdrawal by Subject|6
1594946|NCT02347072|5554361|P1|Overall Study|Adverse Event|2
1594947|NCT02346877|5554395|P2|Overall Study|Missing|0
1594948|NCT02346877|5554396|P1|Overall Study|Missing|5
1594949|NCT02346877|5554395|P2|Overall Study|Sponsor Decision|0
1594950|NCT02346877|5554396|P1|Overall Study|Sponsor Decision|12
1594951|NCT02346877|5554395|P2|Overall Study|Administrative Decision|0
1594952|NCT02346877|5554396|P1|Overall Study|Administrative Decision|1
1594953|NCT02346877|5554395|P2|Overall Study|Adverse Event|0
1594954|NCT02346877|5554396|P1|Overall Study|Adverse Event|1
1594955|NCT02346721|5554406|P1|Overall Study|Lack of Efficacy|1
1594956|NCT02346721|5554406|P1|Overall Study|Withdrew Consent|3
1594957|NCT02346370|5554445|P3|Overall Study|Physician Decision|0
1594958|NCT02346370|5554446|P2|Overall Study|Physician Decision|1
1594959|NCT02346370|5554447|P1|Overall Study|Physician Decision|0
1594960|NCT02346370|5554445|P3|Overall Study|Radiologic progression|1
1594961|NCT02346370|5554446|P2|Overall Study|Radiologic progression|0
1594962|NCT02346370|5554447|P1|Overall Study|Radiologic progression|0
1594963|NCT02346370|5554445|P3|Overall Study|Sponsor discontinued study|2
1594964|NCT02346370|5554446|P2|Overall Study|Sponsor discontinued study|0
1594965|NCT02346370|5554447|P1|Overall Study|Sponsor discontinued study|5
1594966|NCT02346370|5554445|P3|Overall Study|Death|1
1594967|NCT02346370|5554446|P2|Overall Study|Death|3
1594968|NCT02346370|5554447|P1|Overall Study|Death|1
1594969|NCT02346370|5554445|P3|Overall Study|Withdrawal of consent|0
1594970|NCT02346370|5554446|P2|Overall Study|Withdrawal of consent|0
1594971|NCT02346370|5554447|P1|Overall Study|Withdrawal of consent|1
1594972|NCT02346370|5554445|P3|Overall Study|Not treated|0
1594973|NCT02346370|5554446|P2|Overall Study|Not treated|0
1594974|NCT02346370|5554447|P1|Overall Study|Not treated|1
1594975|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594976|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594977|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|1
1594978|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594979|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594980|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594981|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594982|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594983|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594984|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594985|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594986|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594987|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594988|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594989|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594990|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594991|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
1594992|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1594993|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1594994|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1594995|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1594996|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1594997|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1594998|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Patient’s decisions|1
1594999|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595000|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595001|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595002|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595003|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595004|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595005|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595006|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595007|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595008|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
1595009|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595010|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595011|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595290|NCT02345330|5554750|P1|Overall Study|Progressive Disease|2
1595012|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595013|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595014|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595015|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595016|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|1
1595017|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595018|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595019|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595020|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595021|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595022|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595023|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595024|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595025|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
1595026|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595027|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595028|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1595029|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1595030|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595031|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1595032|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595033|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595034|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
1595035|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595036|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595037|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595038|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595039|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595040|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595041|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595042|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
1595043|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595044|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595045|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595046|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595047|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595048|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595049|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595050|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595051|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595052|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595053|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Moved out of state|1
1595054|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595055|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595056|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595057|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595058|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595059|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Moved out of state|0
1595060|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|4
1595061|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|8
1595062|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
1595063|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
1595064|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595065|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595066|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595067|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595068|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595069|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595070|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595071|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595072|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595073|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595074|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595291|NCT02345330|5554750|P1|Overall Study|Death|1
1595075|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595076|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
1595077|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595078|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1595079|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|4
1595080|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
1595081|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595082|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
1595083|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1595084|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595085|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1595086|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1595087|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1595088|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
1595089|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595090|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595091|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595092|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595093|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
1595094|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595095|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595096|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|1
1595097|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595098|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595099|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595100|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595101|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595102|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595103|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595104|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595105|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595106|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595107|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595108|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595109|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595110|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
1595111|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595112|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|3
1595113|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595114|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595115|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595116|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595117|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595118|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595119|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595120|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595121|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595122|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595123|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595124|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595125|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595126|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595127|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
1595128|NCT02346240|5554496|P17|Finished Wk16 Entered Maintenance Period|Adverse Event|2
1595129|NCT02346240|5554497|P16|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1595130|NCT02346240|5554498|P15|Finished Wk16 Entered Maintenance Period|Adverse Event|4
1595131|NCT02346240|5554499|P14|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1595132|NCT02346240|5554500|P13|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595133|NCT02346240|5554501|P12|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595134|NCT02346240|5554502|P11|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595135|NCT02346240|5554503|P10|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595136|NCT02346240|5554504|P9|Finished Wk16 Entered Maintenance Period|Adverse Event|2
1595137|NCT02346240|5554505|P8|Finished Wk16 Entered Maintenance Period|Adverse Event|1
1595138|NCT02346240|5554506|P7|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595139|NCT02346240|5554507|P6|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595140|NCT02346240|5554508|P5|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595141|NCT02346240|5554509|P4|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595142|NCT02346240|5554510|P3|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595143|NCT02346240|5554511|P2|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595144|NCT02346240|5554512|P1|Finished Wk16 Entered Maintenance Period|Adverse Event|0
1595145|NCT02346240|5554496|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595146|NCT02346240|5554497|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595147|NCT02346240|5554498|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595148|NCT02346240|5554499|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595149|NCT02346240|5554500|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595150|NCT02346240|5554501|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595151|NCT02346240|5554502|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595152|NCT02346240|5554503|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595153|NCT02346240|5554504|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595154|NCT02346240|5554505|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595155|NCT02346240|5554506|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595156|NCT02346240|5554507|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595157|NCT02346240|5554508|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595158|NCT02346240|5554509|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595159|NCT02346240|5554510|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
1595160|NCT02346240|5554511|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595161|NCT02346240|5554512|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
1595162|NCT02346240|5554496|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
1595163|NCT02346240|5554497|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
1595164|NCT02346240|5554498|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
1595165|NCT02346240|5554499|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
1595166|NCT02346240|5554500|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
1595167|NCT02346240|5554501|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
1595168|NCT02346240|5554502|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
1595169|NCT02346240|5554503|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
1595170|NCT02346240|5554504|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
1595171|NCT02346240|5554505|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
1595172|NCT02346240|5554506|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
1595173|NCT02346240|5554507|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
1595174|NCT02346240|5554508|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
1595175|NCT02346240|5554509|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
1595176|NCT02346240|5554510|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
1595177|NCT02346240|5554511|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
1595178|NCT02346240|5554512|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
1595179|NCT02346240|5554496|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595180|NCT02346240|5554497|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595181|NCT02346240|5554498|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595182|NCT02346240|5554499|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595183|NCT02346240|5554500|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595184|NCT02346240|5554501|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595185|NCT02346240|5554502|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595186|NCT02346240|5554503|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595187|NCT02346240|5554504|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595188|NCT02346240|5554505|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595189|NCT02346240|5554506|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595190|NCT02346240|5554507|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595191|NCT02346240|5554508|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
1595192|NCT02346240|5554509|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1595193|NCT02346240|5554510|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
1595194|NCT02346240|5554511|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
1595195|NCT02346240|5554512|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
1595196|NCT02346240|5554496|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595197|NCT02346240|5554497|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595198|NCT02346240|5554498|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595199|NCT02346240|5554499|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595200|NCT02346240|5554500|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595201|NCT02346240|5554501|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595202|NCT02346240|5554502|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595203|NCT02346240|5554503|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595204|NCT02346240|5554504|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595205|NCT02346240|5554505|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595206|NCT02346240|5554506|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595207|NCT02346240|5554507|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595208|NCT02346240|5554508|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
1595209|NCT02346240|5554509|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
1595210|NCT02346240|5554510|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1595211|NCT02346240|5554511|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
1595212|NCT02346240|5554512|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
1595213|NCT02346240|5554496|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595214|NCT02346240|5554497|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595215|NCT02346240|5554498|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595216|NCT02346240|5554499|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595217|NCT02346240|5554500|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595218|NCT02346240|5554501|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595219|NCT02346240|5554502|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595220|NCT02346240|5554503|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595221|NCT02346240|5554504|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595222|NCT02346240|5554505|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595223|NCT02346240|5554506|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595224|NCT02346240|5554507|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595225|NCT02346240|5554508|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595226|NCT02346240|5554509|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595227|NCT02346240|5554510|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595228|NCT02346240|5554511|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
1595229|NCT02346240|5554512|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
1595230|NCT02346240|5554496|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595231|NCT02346240|5554497|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595232|NCT02346240|5554498|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595233|NCT02346240|5554499|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595234|NCT02346240|5554500|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595235|NCT02346240|5554501|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595236|NCT02346240|5554502|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595237|NCT02346240|5554503|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595238|NCT02346240|5554504|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595239|NCT02346240|5554505|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595240|NCT02346240|5554506|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595241|NCT02346240|5554507|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595242|NCT02346240|5554508|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595243|NCT02346240|5554509|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595244|NCT02346240|5554510|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595245|NCT02346240|5554511|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
1595246|NCT02346240|5554512|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
1595247|NCT02346240|5554496|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
1595248|NCT02346240|5554497|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
1595249|NCT02346240|5554498|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
1595250|NCT02346240|5554499|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
1595251|NCT02346240|5554500|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
1595252|NCT02346240|5554501|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
1595253|NCT02346240|5554502|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
1595254|NCT02346240|5554503|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
1595255|NCT02346240|5554504|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
1595256|NCT02346240|5554505|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
1595257|NCT02346240|5554506|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
1595258|NCT02346240|5554507|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
1595259|NCT02346240|5554508|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
1595260|NCT02346240|5554509|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
1595261|NCT02346240|5554510|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
1595262|NCT02346240|5554511|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
1595263|NCT02346240|5554512|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
1595270|NCT02345889|5554585|P4|Overall Study|Cecum not intubated|0
1595271|NCT02345889|5554586|P3|Overall Study|Cecum not intubated|0
1595272|NCT02345889|5554587|P2|Overall Study|Cecum not intubated|0
1595273|NCT02345889|5554588|P1|Overall Study|Cecum not intubated|1
1595274|NCT02345889|5554585|P4|Overall Study|Ulcerative Colitis identified|0
1595275|NCT02345889|5554586|P3|Overall Study|Ulcerative Colitis identified|0
1595276|NCT02345889|5554587|P2|Overall Study|Ulcerative Colitis identified|0
1595277|NCT02345889|5554588|P1|Overall Study|Ulcerative Colitis identified|1
1595278|NCT02345889|5554585|P4|Overall Study|Recognized ineligible post-randomization|1
1595279|NCT02345889|5554586|P3|Overall Study|Recognized ineligible post-randomization|2
1595280|NCT02345889|5554587|P2|Overall Study|Recognized ineligible post-randomization|0
1595281|NCT02345889|5554588|P1|Overall Study|Recognized ineligible post-randomization|1
1595282|NCT02345889|5554585|P4|Overall Study|Polyposis identified during procedure|1
1595283|NCT02345889|5554586|P3|Overall Study|Polyposis identified during procedure|0
1595284|NCT02345889|5554587|P2|Overall Study|Polyposis identified during procedure|1
1595285|NCT02345889|5554588|P1|Overall Study|Polyposis identified during procedure|1
1595286|NCT02345889|5554585|P4|Overall Study|Inadequate Bowel Prep|14
1595287|NCT02345889|5554586|P3|Overall Study|Inadequate Bowel Prep|18
1595288|NCT02345889|5554587|P2|Overall Study|Inadequate Bowel Prep|16
1595289|NCT02345889|5554588|P1|Overall Study|Inadequate Bowel Prep|17
1595292|NCT02345252|5554762|P2|Double-Blind Phase|Randomized but Never Treated|2
1595293|NCT02345252|5554763|P1|Double-Blind Phase|Randomized but Never Treated|0
1595294|NCT02345252|5554762|P2|Double-Blind Phase|Lost to Follow-up|10
1595295|NCT02345252|5554763|P1|Double-Blind Phase|Lost to Follow-up|8
1595296|NCT02345252|5554762|P2|Double-Blind Phase|Withdrew Consent|23
1595297|NCT02345252|5554763|P1|Double-Blind Phase|Withdrew Consent|21
1595298|NCT02345252|5554762|P2|Double-Blind Phase|Protocol Violation|1
1595299|NCT02345252|5554763|P1|Double-Blind Phase|Protocol Violation|2
1595300|NCT02345252|5554762|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
1595301|NCT02345252|5554763|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
1595302|NCT02345252|5554762|P2|Double-Blind Phase|Investigator's Discretion|6
1595303|NCT02345252|5554763|P1|Double-Blind Phase|Investigator's Discretion|4
1595304|NCT02345252|5554762|P2|Double-Blind Phase|Lack of Efficacy|0
1595305|NCT02345252|5554763|P1|Double-Blind Phase|Lack of Efficacy|1
1595306|NCT02345252|5554762|P2|Double-Blind Phase|Death|2
1595307|NCT02345252|5554763|P1|Double-Blind Phase|Death|1
1595308|NCT02345252|5554762|P2|Double-Blind Phase|Adverse Event|3
1595309|NCT02345252|5554763|P1|Double-Blind Phase|Adverse Event|2
1595310|NCT02345226|5554791|P2|Open-Label Extension Phase|Lost to Follow-up|1
1595311|NCT02345226|5554792|P1|Open-Label Extension Phase|Lost to Follow-up|0
1595312|NCT02345226|5554791|P2|Double-Blind Phase|Randomized but Never Treated|4
1595313|NCT02345226|5554792|P1|Double-Blind Phase|Randomized but Never Treated|2
1595314|NCT02345226|5554791|P2|Double-Blind Phase|Lost to Follow-up|16
1595315|NCT02345226|5554792|P1|Double-Blind Phase|Lost to Follow-up|12
1595316|NCT02345226|5554791|P2|Double-Blind Phase|Withdrew Consent|39
1595317|NCT02345226|5554792|P1|Double-Blind Phase|Withdrew Consent|41
1595318|NCT02345226|5554791|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
1595319|NCT02345226|5554792|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
1595320|NCT02345226|5554791|P2|Double-Blind Phase|Investigator's Discretion|3
1595321|NCT02345226|5554792|P1|Double-Blind Phase|Investigator's Discretion|4
1595322|NCT02345226|5554791|P2|Double-Blind Phase|Lack of Efficacy|0
1595323|NCT02345226|5554792|P1|Double-Blind Phase|Lack of Efficacy|1
1595324|NCT02345226|5554791|P2|Double-Blind Phase|Pregnancy|1
1595325|NCT02345226|5554792|P1|Double-Blind Phase|Pregnancy|0
1595326|NCT02345226|5554791|P2|Double-Blind Phase|Death|0
1595327|NCT02345226|5554792|P1|Double-Blind Phase|Death|3
1595328|NCT02345226|5554791|P2|Double-Blind Phase|Adverse Event|6
1595329|NCT02345226|5554792|P1|Double-Blind Phase|Adverse Event|5
1595330|NCT02345161|5554824|P2|Overall Study|Lost to Follow-up|1
1595331|NCT02345161|5554825|P1|Overall Study|Lost to Follow-up|0
1595332|NCT02345161|5554824|P2|Overall Study|Physician Decision|4
1595333|NCT02345161|5554825|P1|Overall Study|Physician Decision|4
1595334|NCT02345161|5554824|P2|Overall Study|Adverse Event|19
1595335|NCT02345161|5554825|P1|Overall Study|Adverse Event|16
1595336|NCT02345161|5554824|P2|Overall Study|Withdrawal by Subject|33
1595337|NCT02345161|5554825|P1|Overall Study|Withdrawal by Subject|25
1595338|NCT02344745|5554946|P2|Overall Study|Data collection sheets were lost|0
1595339|NCT02344745|5554947|P1|Overall Study|Data collection sheets were lost|2
1595340|NCT02344342|5554992|P4|Overall Study|Industry partner dropped out|10
1595341|NCT02344342|5554993|P3|Overall Study|Industry partner dropped out|14
1595342|NCT02344342|5554994|P2|Overall Study|Industry partner dropped out|9
1595343|NCT02344342|5554995|P1|Overall Study|Industry partner dropped out|11
1595344|NCT02344173|5555042|P1|12-month Visit|Lost to Follow-up|58
1595345|NCT02344173|5555042|P1|12-month Visit|Withdrawal by Subject|30
1595346|NCT02344173|5555042|P1|12-month Visit|Death|8
1595347|NCT02344173|5555042|P1|Procedure|Ablation Procedure Not Performed|7
1595362|NCT02343939|5555078|P9|Overall Study|Never Treated With ENTO|0
1595363|NCT02343939|5555079|P8|Overall Study|Never Treated With ENTO|2
1595364|NCT02343939|5555080|P7|Overall Study|Never Treated With ENTO|1
1595365|NCT02343939|5555081|P6|Overall Study|Never Treated With ENTO|0
1595366|NCT02343939|5555082|P5|Overall Study|Never Treated With ENTO|0
1595367|NCT02343939|5555083|P4|Overall Study|Never Treated With ENTO|0
1595368|NCT02343939|5555084|P3|Overall Study|Never Treated With ENTO|0
1595369|NCT02343939|5555085|P2|Overall Study|Never Treated With ENTO|0
1595370|NCT02343939|5555086|P1|Overall Study|Never Treated With ENTO|0
1595371|NCT02343939|5555078|P9|Overall Study|Adverse Event|0
1595372|NCT02343939|5555079|P8|Overall Study|Adverse Event|0
1595373|NCT02343939|5555080|P7|Overall Study|Adverse Event|0
1595374|NCT02343939|5555081|P6|Overall Study|Adverse Event|1
1595375|NCT02343939|5555082|P5|Overall Study|Adverse Event|0
1595376|NCT02343939|5555083|P4|Overall Study|Adverse Event|0
1595377|NCT02343939|5555084|P3|Overall Study|Adverse Event|0
1595378|NCT02343939|5555085|P2|Overall Study|Adverse Event|0
1595379|NCT02343939|5555086|P1|Overall Study|Adverse Event|0
1595380|NCT02343939|5555078|P9|Overall Study|Investigator's discretion|0
1595381|NCT02343939|5555079|P8|Overall Study|Investigator's discretion|0
1595382|NCT02343939|5555080|P7|Overall Study|Investigator's discretion|1
1595383|NCT02343939|5555081|P6|Overall Study|Investigator's discretion|0
1595384|NCT02343939|5555082|P5|Overall Study|Investigator's discretion|0
1595385|NCT02343939|5555083|P4|Overall Study|Investigator's discretion|1
1595386|NCT02343939|5555084|P3|Overall Study|Investigator's discretion|0
1595387|NCT02343939|5555085|P2|Overall Study|Investigator's discretion|0
1595388|NCT02343939|5555086|P1|Overall Study|Investigator's discretion|0
1595389|NCT02343939|5555078|P9|Overall Study|Treatment failure|0
1595390|NCT02343939|5555079|P8|Overall Study|Treatment failure|1
1595391|NCT02343939|5555080|P7|Overall Study|Treatment failure|2
1595392|NCT02343939|5555081|P6|Overall Study|Treatment failure|0
1595393|NCT02343939|5555082|P5|Overall Study|Treatment failure|0
1595394|NCT02343939|5555083|P4|Overall Study|Treatment failure|0
1595395|NCT02343939|5555084|P3|Overall Study|Treatment failure|0
1595396|NCT02343939|5555085|P2|Overall Study|Treatment failure|0
1595397|NCT02343939|5555086|P1|Overall Study|Treatment failure|0
1595398|NCT02343939|5555078|P9|Overall Study|Withdrew consent|6
1595399|NCT02343939|5555079|P8|Overall Study|Withdrew consent|8
1595400|NCT02343939|5555080|P7|Overall Study|Withdrew consent|0
1595401|NCT02343939|5555081|P6|Overall Study|Withdrew consent|0
1595402|NCT02343939|5555082|P5|Overall Study|Withdrew consent|2
1595403|NCT02343939|5555083|P4|Overall Study|Withdrew consent|2
1595404|NCT02343939|5555084|P3|Overall Study|Withdrew consent|1
1595405|NCT02343939|5555085|P2|Overall Study|Withdrew consent|6
1595406|NCT02343939|5555086|P1|Overall Study|Withdrew consent|3
1595407|NCT02343939|5555078|P9|Overall Study|Study terminated by sponsor|0
1595408|NCT02343939|5555079|P8|Overall Study|Study terminated by sponsor|4
1595409|NCT02343939|5555080|P7|Overall Study|Study terminated by sponsor|3
1595410|NCT02343939|5555081|P6|Overall Study|Study terminated by sponsor|5
1595411|NCT02343939|5555082|P5|Overall Study|Study terminated by sponsor|1
1595412|NCT02343939|5555083|P4|Overall Study|Study terminated by sponsor|1
1595413|NCT02343939|5555084|P3|Overall Study|Study terminated by sponsor|0
1595414|NCT02343939|5555085|P2|Overall Study|Study terminated by sponsor|27
1595415|NCT02343939|5555086|P1|Overall Study|Study terminated by sponsor|0
1595416|NCT02343939|5555078|P9|Overall Study|Death|1
1595417|NCT02343939|5555079|P8|Overall Study|Death|22
1595418|NCT02343939|5555080|P7|Overall Study|Death|8
1595419|NCT02343939|5555081|P6|Overall Study|Death|11
1595420|NCT02343939|5555082|P5|Overall Study|Death|5
1595421|NCT02343939|5555083|P4|Overall Study|Death|2
1595422|NCT02343939|5555084|P3|Overall Study|Death|4
1595423|NCT02343939|5555085|P2|Overall Study|Death|15
1595424|NCT02343939|5555086|P1|Overall Study|Death|0
1595425|NCT02343458|5555228|P4|Overall Study|Protocol Specified Criteria|8
1595426|NCT02343458|5555229|P3|Overall Study|Protocol Specified Criteria|14
1595427|NCT02343458|5555230|P2|Overall Study|Protocol Specified Criteria|13
1595428|NCT02343458|5555231|P1|Overall Study|Protocol Specified Criteria|17
1595429|NCT02343458|5555228|P4|Overall Study|Protocol Violation|2
1595430|NCT02343458|5555229|P3|Overall Study|Protocol Violation|2
1595431|NCT02343458|5555230|P2|Overall Study|Protocol Violation|5
1595432|NCT02343458|5555231|P1|Overall Study|Protocol Violation|2
1595433|NCT02343458|5555228|P4|Overall Study|Lost to Follow-up|1
1595434|NCT02343458|5555229|P3|Overall Study|Lost to Follow-up|3
1595435|NCT02343458|5555230|P2|Overall Study|Lost to Follow-up|5
1595436|NCT02343458|5555231|P1|Overall Study|Lost to Follow-up|5
1595437|NCT02343458|5555228|P4|Overall Study|Physician Decision|2
1595438|NCT02343458|5555229|P3|Overall Study|Physician Decision|2
1595439|NCT02343458|5555230|P2|Overall Study|Physician Decision|4
1595440|NCT02343458|5555231|P1|Overall Study|Physician Decision|1
1595441|NCT02343458|5555228|P4|Overall Study|Withdrawal by Subject|14
1595442|NCT02343458|5555229|P3|Overall Study|Withdrawal by Subject|23
1595443|NCT02343458|5555230|P2|Overall Study|Withdrawal by Subject|17
1595444|NCT02343458|5555231|P1|Overall Study|Withdrawal by Subject|18
1595445|NCT02343458|5555228|P4|Overall Study|Lack of Efficacy|8
1595446|NCT02343458|5555229|P3|Overall Study|Lack of Efficacy|4
1595447|NCT02343458|5555230|P2|Overall Study|Lack of Efficacy|8
1595448|NCT02343458|5555231|P1|Overall Study|Lack of Efficacy|3
1595449|NCT02343458|5555228|P4|Overall Study|Adverse Event|3
1595450|NCT02343458|5555229|P3|Overall Study|Adverse Event|15
1595451|NCT02343458|5555230|P2|Overall Study|Adverse Event|14
1595452|NCT02343458|5555231|P1|Overall Study|Adverse Event|15
1595453|NCT02343263|5555340|P3|Overall Study|Physician Decision|1
1595454|NCT02343263|5555341|P2|Overall Study|Physician Decision|3
1595455|NCT02343263|5555342|P1|Overall Study|Physician Decision|5
1595456|NCT02343159|5555371|P3|Overall Study|Enrollment Error|0
1595457|NCT02343159|5555372|P2|Overall Study|Enrollment Error|0
1595458|NCT02343159|5555373|P1|Overall Study|Enrollment Error|1
1595459|NCT02343159|5555371|P3|Overall Study|Sponsor Decision|0
1595460|NCT02343159|5555372|P2|Overall Study|Sponsor Decision|1
1595461|NCT02343159|5555373|P1|Overall Study|Sponsor Decision|0
1595462|NCT02343159|5555371|P3|Overall Study|Adverse Event|2
1595463|NCT02343159|5555372|P2|Overall Study|Adverse Event|4
1595464|NCT02343159|5555373|P1|Overall Study|Adverse Event|4
1595465|NCT02343159|5555371|P3|Overall Study|Lost to Follow-up|2
1595466|NCT02343159|5555372|P2|Overall Study|Lost to Follow-up|2
1595467|NCT02343159|5555373|P1|Overall Study|Lost to Follow-up|0
1595468|NCT02343159|5555371|P3|Overall Study|Withdrawal by Subject|2
1595469|NCT02343159|5555372|P2|Overall Study|Withdrawal by Subject|0
1595470|NCT02343159|5555373|P1|Overall Study|Withdrawal by Subject|3
1595471|NCT02343159|5555371|P3|Overall Study|Physician Decision|1
1595472|NCT02343159|5555372|P2|Overall Study|Physician Decision|0
1595473|NCT02343159|5555373|P1|Overall Study|Physician Decision|2
1595474|NCT02343159|5555371|P3|Overall Study|Early Study Termination|23
1595475|NCT02343159|5555372|P2|Overall Study|Early Study Termination|19
1595476|NCT02343159|5555373|P1|Overall Study|Early Study Termination|16
1595477|NCT02343003|5555417|P2|Overall Study|terminated by sponsor|0
1595478|NCT02343003|5555418|P1|Overall Study|terminated by sponsor|2
1595479|NCT02343003|5555417|P2|Overall Study|exclusion criteria met|1
1595480|NCT02343003|5555418|P1|Overall Study|exclusion criteria met|1
1595481|NCT02343003|5555417|P2|Overall Study|Death|1
1595482|NCT02343003|5555418|P1|Overall Study|Death|0
1595483|NCT02343003|5555417|P2|Overall Study|Protocol Violation|0
1595484|NCT02343003|5555418|P1|Overall Study|Protocol Violation|1
1595485|NCT02343003|5555417|P2|Overall Study|Lost to Follow-up|1
1595486|NCT02343003|5555418|P1|Overall Study|Lost to Follow-up|5
1595487|NCT02343003|5555417|P2|Overall Study|Withdrawal by Subject|4
1595488|NCT02343003|5555418|P1|Overall Study|Withdrawal by Subject|9
1595489|NCT02342886|5555439|P5|Overall Study|Protocol Violation|0
1595490|NCT02342886|5555440|P4|Overall Study|Protocol Violation|2
1595491|NCT02342886|5555441|P3|Overall Study|Protocol Violation|0
1595492|NCT02342886|5555442|P2|Overall Study|Protocol Violation|0
1595493|NCT02342886|5555443|P1|Overall Study|Protocol Violation|0
1595494|NCT02342886|5555439|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
1595495|NCT02342886|5555440|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
1595496|NCT02342886|5555441|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
1595497|NCT02342886|5555442|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
1595498|NCT02342886|5555443|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
1595499|NCT02342886|5555439|P5|Overall Study|Pregnancy|0
1595500|NCT02342886|5555440|P4|Overall Study|Pregnancy|0
1595501|NCT02342886|5555441|P3|Overall Study|Pregnancy|2
1595502|NCT02342886|5555442|P2|Overall Study|Pregnancy|0
1595503|NCT02342886|5555443|P1|Overall Study|Pregnancy|0
1595504|NCT02342886|5555439|P5|Overall Study|Investigator/sponsor decision|1
1595505|NCT02342886|5555440|P4|Overall Study|Investigator/sponsor decision|3
1595506|NCT02342886|5555441|P3|Overall Study|Investigator/sponsor decision|0
1595507|NCT02342886|5555442|P2|Overall Study|Investigator/sponsor decision|2
1595508|NCT02342886|5555443|P1|Overall Study|Investigator/sponsor decision|0
1595509|NCT02342886|5555439|P5|Overall Study|Withdrawal by Subject|0
1595510|NCT02342886|5555440|P4|Overall Study|Withdrawal by Subject|1
1595511|NCT02342886|5555441|P3|Overall Study|Withdrawal by Subject|0
1595512|NCT02342886|5555442|P2|Overall Study|Withdrawal by Subject|1
1595513|NCT02342886|5555443|P1|Overall Study|Withdrawal by Subject|0
1595514|NCT02342886|5555439|P5|Overall Study|Death|1
1595515|NCT02342886|5555440|P4|Overall Study|Death|0
1595516|NCT02342886|5555441|P3|Overall Study|Death|1
1595517|NCT02342886|5555442|P2|Overall Study|Death|2
1595518|NCT02342886|5555443|P1|Overall Study|Death|1
1595519|NCT02342886|5555439|P5|Overall Study|Lost to Follow-up|0
1595520|NCT02342886|5555440|P4|Overall Study|Lost to Follow-up|0
1595521|NCT02342886|5555441|P3|Overall Study|Lost to Follow-up|0
1595522|NCT02342886|5555442|P2|Overall Study|Lost to Follow-up|0
1595523|NCT02342886|5555443|P1|Overall Study|Lost to Follow-up|1
1595524|NCT02342886|5555439|P5|Overall Study|Adverse event/specific toxicity|1
1595525|NCT02342886|5555440|P4|Overall Study|Adverse event/specific toxicity|2
1595526|NCT02342886|5555441|P3|Overall Study|Adverse event/specific toxicity|11
1595527|NCT02342886|5555442|P2|Overall Study|Adverse event/specific toxicity|3
1595528|NCT02342886|5555443|P1|Overall Study|Adverse event/specific toxicity|4
1595529|NCT02342886|5555439|P5|Overall Study|Late exclusion: rifampicin resistance|0
1595530|NCT02342886|5555440|P4|Overall Study|Late exclusion: rifampicin resistance|0
1595531|NCT02342886|5555441|P3|Overall Study|Late exclusion: rifampicin resistance|0
1595532|NCT02342886|5555442|P2|Overall Study|Late exclusion: rifampicin resistance|0
1595533|NCT02342886|5555443|P1|Overall Study|Late exclusion: rifampicin resistance|1
1595534|NCT02342886|5555439|P5|Overall Study|Treatment non-compliance|0
1595535|NCT02342886|5555440|P4|Overall Study|Treatment non-compliance|1
1595536|NCT02342886|5555441|P3|Overall Study|Treatment non-compliance|0
1595537|NCT02342886|5555442|P2|Overall Study|Treatment non-compliance|0
1595538|NCT02342886|5555443|P1|Overall Study|Treatment non-compliance|1
1595539|NCT02342743|5555460|P1|Treatment Period|Change in prophylactic medication|1
1595540|NCT02342743|5555460|P1|Treatment Period|Lost to Follow-up|8
1595541|NCT02342743|5555460|P1|Treatment Period|Withdrawal by Subject|2
1595542|NCT02342743|5555460|P1|Baseline Period|Screening failure regarding baseline|7
1595543|NCT02342743|5555460|P1|Baseline Period|Change in prophylactic medication|3
1595544|NCT02342743|5555460|P1|Baseline Period|Lost to Follow-up|2
1595545|NCT02342743|5555460|P1|Baseline Period|Withdrawal by Subject|3
1595546|NCT02342704|5555473|P2|Overall Study|Adverse Event|3
1595547|NCT02342704|5555474|P1|Overall Study|Adverse Event|1
1595548|NCT02342704|5555473|P2|Overall Study|Lost to Follow-up|1
1595549|NCT02342704|5555474|P1|Overall Study|Lost to Follow-up|2
1595550|NCT02342704|5555473|P2|Overall Study|Withdrawal by Subject|0
1595551|NCT02342704|5555474|P1|Overall Study|Withdrawal by Subject|1
1595552|NCT02342704|5555473|P2|Overall Study|Other|1
1595553|NCT02342704|5555474|P1|Overall Study|Other|0
1595554|NCT02342704|5555473|P2|Overall Study|Sponsor Termination|43
1595555|NCT02342704|5555474|P1|Overall Study|Sponsor Termination|49
1595556|NCT02342704|5555473|P2|Overall Study|Physician Decision|3
1595557|NCT02342704|5555474|P1|Overall Study|Physician Decision|0
1595558|NCT02342678|5555502|P2|Overall Study|Illness/medical reason|1
1595559|NCT02342678|5555503|P1|Overall Study|Illness/medical reason|1
1595560|NCT02342678|5555502|P2|Overall Study|Family illness/emergency|1
1595561|NCT02342678|5555503|P1|Overall Study|Family illness/emergency|0
1595562|NCT02342678|5555502|P2|Overall Study|Too busy to complete study|2
1595563|NCT02342678|5555503|P1|Overall Study|Too busy to complete study|0
1595564|NCT02342678|5555502|P2|Overall Study|Lost to Follow-up|1
1595565|NCT02342678|5555503|P1|Overall Study|Lost to Follow-up|0
1595566|NCT02342548|5555534|P3|Overall Study|Other|1
1595567|NCT02342548|5555535|P2|Overall Study|Other|1
1595568|NCT02342548|5555536|P1|Overall Study|Other|1
1595569|NCT02342548|5555534|P3|Overall Study|Withdrawal by Subject|4
1595570|NCT02342548|5555535|P2|Overall Study|Withdrawal by Subject|3
1595571|NCT02342548|5555536|P1|Overall Study|Withdrawal by Subject|1
1595572|NCT02342548|5555534|P3|Overall Study|Protocol Violation|0
1595573|NCT02342548|5555535|P2|Overall Study|Protocol Violation|1
1595574|NCT02342548|5555536|P1|Overall Study|Protocol Violation|0
1595575|NCT02342548|5555534|P3|Overall Study|Study terminated by sponsor|25
1595576|NCT02342548|5555535|P2|Overall Study|Study terminated by sponsor|39
1595577|NCT02342548|5555536|P1|Overall Study|Study terminated by sponsor|20
1595578|NCT02342548|5555534|P3|Overall Study|Lost to Follow-up|0
1595579|NCT02342548|5555535|P2|Overall Study|Lost to Follow-up|1
1595580|NCT02342548|5555536|P1|Overall Study|Lost to Follow-up|0
1595581|NCT02342548|5555534|P3|Overall Study|Adverse Event|13
1595582|NCT02342548|5555535|P2|Overall Study|Adverse Event|17
1595583|NCT02342548|5555536|P1|Overall Study|Adverse Event|12
1595584|NCT02342418|5555580|P2|Overall Study|Adverse Event|1
1595585|NCT02342418|5555581|P1|Overall Study|Adverse Event|0
1595586|NCT02342288|5555755|P2|Overall Study|coordinator not available|2
1595587|NCT02342288|5555756|P1|Overall Study|coordinator not available|0
1595588|NCT02342288|5555755|P2|Overall Study|subject cannot tolerate numbing drops|1
1595589|NCT02342288|5555756|P1|Overall Study|subject cannot tolerate numbing drops|0
1595590|NCT02342288|5555755|P2|Overall Study|coordinator contaminated with blood|1
1595591|NCT02342288|5555756|P1|Overall Study|coordinator contaminated with blood|0
1595592|NCT02342288|5555755|P2|Overall Study|Withdrawal by Subject|0
1595593|NCT02342288|5555756|P1|Overall Study|Withdrawal by Subject|1
1595594|NCT02342288|5555755|P2|Overall Study|anesthesia leak in system|0
1595595|NCT02342288|5555756|P1|Overall Study|anesthesia leak in system|1
1595596|NCT02342288|5555755|P2|Overall Study|no protocol anesthesiologist available|2
1595597|NCT02342288|5555756|P1|Overall Study|no protocol anesthesiologist available|3
1595598|NCT02342223|5555762|P1|Overall Study|Lost to Follow-up|1
1595599|NCT02342171|5555782|P2|Overall Study|Missing age data|1
1595600|NCT02342171|5555783|P1|Overall Study|Missing age data|0
1595601|NCT02342171|5555782|P2|Overall Study|Unknown outcome|1
1595602|NCT02342171|5555783|P1|Overall Study|Unknown outcome|0
1595603|NCT02342171|5555782|P2|Overall Study|Missing cycle treshold value|0
1595604|NCT02342171|5555783|P1|Overall Study|Missing cycle treshold value|1
1595605|NCT02342171|5555782|P2|Overall Study|Received favipiravir|0
1595606|NCT02342171|5555783|P1|Overall Study|Received favipiravir|10
1595607|NCT02342171|5555782|P2|Overall Study|Death|87
1595608|NCT02342171|5555783|P1|Overall Study|Death|4
1595609|NCT02341482|5556030|P1|Overall Study|Adverse Event|1
1595610|NCT02341456|5556059|P3|Overall Study|Physician Decision|0
1595611|NCT02341456|5556060|P2|Overall Study|Physician Decision|0
1595612|NCT02341456|5556061|P1|Overall Study|Physician Decision|1
1595613|NCT02341456|5556059|P3|Overall Study|Moved to local access programme.|1
1595614|NCT02341456|5556060|P2|Overall Study|Moved to local access programme.|1
1595615|NCT02341456|5556061|P1|Overall Study|Moved to local access programme.|0
1595616|NCT02341456|5556059|P3|Overall Study|Withdrawal by Subject|1
1595617|NCT02341456|5556060|P2|Overall Study|Withdrawal by Subject|1
1595618|NCT02341456|5556061|P1|Overall Study|Withdrawal by Subject|0
1595619|NCT02341456|5556059|P3|Overall Study|Death|1
1595620|NCT02341456|5556060|P2|Overall Study|Death|1
1595621|NCT02341456|5556061|P1|Overall Study|Death|1
1595622|NCT02341456|5556059|P3|Overall Study|Disease progression|1
1595623|NCT02341456|5556060|P2|Overall Study|Disease progression|3
1595624|NCT02341456|5556061|P1|Overall Study|Disease progression|2
1595625|NCT02341417|5556186|P3|Overall Study|Death|1
1595626|NCT02341417|5556187|P2|Overall Study|Death|0
1595627|NCT02341417|5556188|P1|Overall Study|Death|0
1595628|NCT02341417|5556186|P3|Overall Study|Decision by sponsor|0
1595629|NCT02341417|5556187|P2|Overall Study|Decision by sponsor|0
1595630|NCT02341417|5556188|P1|Overall Study|Decision by sponsor|2
1595631|NCT02341417|5556186|P3|Overall Study|Withdrawal by Subject|0
1595632|NCT02341417|5556187|P2|Overall Study|Withdrawal by Subject|2
1595633|NCT02341417|5556188|P1|Overall Study|Withdrawal by Subject|0
1595634|NCT02340962|5556249|P2|Overall Study|Lost to Follow-up|0
1595635|NCT02340962|5556250|P1|Overall Study|Lost to Follow-up|1
1595636|NCT02340819|5556270|P1|Overall Study|Discontinued with other reason|1
1595637|NCT02340819|5556270|P1|Overall Study|Withdrawal by Subject|2
1595638|NCT02340819|5556270|P1|Overall Study|Adverse Event|1
1595639|NCT02340806|5556299|P2|Overall Study|re-dose < 90 min of CSE|3
1595640|NCT02340806|5556300|P1|Overall Study|re-dose < 90 min of CSE|1
1595641|NCT02340806|5556299|P2|Overall Study|history of chronic pain medication|0
1595642|NCT02340806|5556300|P1|Overall Study|history of chronic pain medication|1
1595643|NCT02340806|5556299|P2|Overall Study|epidural catheter replaced|1
1595644|NCT02340806|5556300|P1|Overall Study|epidural catheter replaced|2
1595645|NCT02340806|5556299|P2|Overall Study|Protocol Violation|0
1595646|NCT02340806|5556300|P1|Overall Study|Protocol Violation|2
1595647|NCT02340780|5556326|P1|Overall Study|Ineligible|1
1595648|NCT02340663|5556381|P2|Overall Study|Withdrawal by Subject|1
1595649|NCT02340663|5556382|P1|Overall Study|Withdrawal by Subject|3
1595650|NCT02340663|5556381|P2|Overall Study|Protocol Violation|0
1595651|NCT02340663|5556382|P1|Overall Study|Protocol Violation|1
1595652|NCT02340663|5556381|P2|Overall Study|Lost to Follow-up|0
1595653|NCT02340663|5556382|P1|Overall Study|Lost to Follow-up|1
1595654|NCT02340520|5556438|P1|Overall Study|Withdrawal by Subject|1
1595655|NCT02340520|5556438|P1|Overall Study|Patient did not take drug as specified|1
1595656|NCT02340520|5556438|P1|Overall Study|Lost to Follow-up|1
1595657|NCT02340221|5556481|P2|Overall Study|Continued on study|290
1595658|NCT02340221|5556482|P1|Overall Study|Continued on study|140
1595659|NCT02340221|5556481|P2|Overall Study|Reason Not Specified|1
1595660|NCT02340221|5556482|P1|Overall Study|Reason Not Specified|0
1595661|NCT02340221|5556481|P2|Overall Study|Lost to Follow-up|3
1595662|NCT02340221|5556482|P1|Overall Study|Lost to Follow-up|2
1595663|NCT02340221|5556481|P2|Overall Study|Withdrawal by Participant|22
1595664|NCT02340221|5556482|P1|Overall Study|Withdrawal by Participant|14
1595665|NCT02340221|5556481|P2|Overall Study|Death|101
1595666|NCT02340221|5556482|P1|Overall Study|Death|58
1595667|NCT02340078|5556516|P1|Overall Study|Protocol Violation|1
1595668|NCT02340000|5556523|P2|Time Period 2|Lost to Follow-up|8
1595669|NCT02340000|5556524|P1|Time Period 2|Lost to Follow-up|10
1595670|NCT02340000|5556523|P2|Time Period 2|Withdrawal by Subject|7
1595671|NCT02340000|5556524|P1|Time Period 2|Withdrawal by Subject|9
1595672|NCT02340000|5556523|P2|Time Period 1|Lost to Follow-up|7
1595673|NCT02340000|5556524|P1|Time Period 1|Lost to Follow-up|6
1595674|NCT02340000|5556523|P2|Time Period 1|Withdrawal by Subject|8
1595675|NCT02340000|5556524|P1|Time Period 1|Withdrawal by Subject|6
1595676|NCT02339909|5556554|P3|Overall Study|Became ineligible after randomisation|71
1595677|NCT02339909|5556555|P2|Overall Study|Became ineligible after randomisation|63
1595678|NCT02339909|5556556|P1|Overall Study|Became ineligible after randomisation|89
1595679|NCT02339584|5556594|P2|Overall Study|Withdrawal by Subject|4
1595680|NCT02339584|5556595|P1|Overall Study|Withdrawal by Subject|2
1595681|NCT02339584|5556594|P2|Overall Study|Protocol Violation|1
1595682|NCT02339584|5556595|P1|Overall Study|Protocol Violation|1
1595683|NCT02339584|5556594|P2|Overall Study|Physician Decision|2
1595684|NCT02339584|5556595|P1|Overall Study|Physician Decision|1
1595685|NCT02339584|5556594|P2|Overall Study|Lack of Efficacy|1
1595686|NCT02339584|5556595|P1|Overall Study|Lack of Efficacy|0
1595687|NCT02339584|5556594|P2|Overall Study|Adverse Event|7
1595688|NCT02339584|5556595|P1|Overall Study|Adverse Event|11
1595689|NCT02339506|5556615|P2|Washout (Period 2)|Withdrawal by Subject|0
1595690|NCT02339506|5556616|P1|Washout (Period 2)|Withdrawal by Subject|2
1595691|NCT02339506|5556615|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
1595692|NCT02339506|5556616|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
1595693|NCT02339285|5556643|P3|Overall Study|Protocol Deviation|0
1595694|NCT02339285|5556644|P2|Overall Study|Protocol Deviation|1
1595695|NCT02339285|5556645|P1|Overall Study|Protocol Deviation|0
1595696|NCT02339285|5556643|P3|Overall Study|Lost to Follow-up|1
1595697|NCT02339285|5556644|P2|Overall Study|Lost to Follow-up|1
1595698|NCT02339285|5556645|P1|Overall Study|Lost to Follow-up|1
1595699|NCT02339285|5556643|P3|Overall Study|Withdrawal by Subject|1
1595700|NCT02339285|5556644|P2|Overall Study|Withdrawal by Subject|1
1595701|NCT02339285|5556645|P1|Overall Study|Withdrawal by Subject|0
1595702|NCT02339155|5556691|P2|Overall Study|Withdrawal by Subject|4
1595703|NCT02339155|5556692|P1|Overall Study|Withdrawal by Subject|4
1595704|NCT02339155|5556691|P2|Overall Study|Physician Decision|1
1595705|NCT02339155|5556692|P1|Overall Study|Physician Decision|2
1595706|NCT02339155|5556691|P2|Overall Study|Lost to Follow-up|9
1595707|NCT02339155|5556692|P1|Overall Study|Lost to Follow-up|8
1595708|NCT02339155|5556691|P2|Overall Study|Death|1
1595709|NCT02339155|5556692|P1|Overall Study|Death|1
1595710|NCT02339155|5556691|P2|Overall Study|Adverse Event|6
1595711|NCT02339155|5556692|P1|Overall Study|Adverse Event|0
1595712|NCT02338882|5556898|P2|Overall Study|Lost to Follow-up|3
1595713|NCT02338882|5556899|P1|Overall Study|Lost to Follow-up|6
1595714|NCT02338882|5556898|P2|Overall Study|Death|0
1595715|NCT02338882|5556899|P1|Overall Study|Death|1
1595716|NCT02338843|5556937|P2|Overall Study|Discontinued prior to randomizat|0
1595717|NCT02338843|5556938|P1|Overall Study|Discontinued prior to randomizat|1
1595718|NCT02338843|5556937|P2|Overall Study|Subject Recovered|2
1595719|NCT02338843|5556938|P1|Overall Study|Subject Recovered|0
1595720|NCT02338843|5556937|P2|Overall Study|Withdrawal by Subject|2
1595721|NCT02338843|5556938|P1|Overall Study|Withdrawal by Subject|0
1595722|NCT02338843|5556937|P2|Overall Study|Physician Decision|0
1595723|NCT02338843|5556938|P1|Overall Study|Physician Decision|1
1595724|NCT02338843|5556937|P2|Overall Study|Death|53
1595725|NCT02338843|5556938|P1|Overall Study|Death|40
1595726|NCT02338843|5556937|P2|Overall Study|Adverse Event|1
1595727|NCT02338843|5556938|P1|Overall Study|Adverse Event|2
1595728|NCT02338492|5556966|P1|Overall Study|Reason not captured above|6
1595729|NCT02338492|5556966|P1|Overall Study|Lost to Follow-up|4
1595730|NCT02338492|5556966|P1|Overall Study|Adverse Event|3
1595731|NCT02338492|5556966|P1|Overall Study|Death|32
1595732|NCT02338362|5556982|P2|Overall Study|Withdrawal by Subject|1
1595733|NCT02338362|5556983|P1|Overall Study|Withdrawal by Subject|1
1595734|NCT02338193|5557013|P3|Overall Study|intolerant of side effects|0
1595735|NCT02338193|5557014|P2|Overall Study|intolerant of side effects|0
1595736|NCT02338193|5557015|P1|Overall Study|intolerant of side effects|1
1595737|NCT02338193|5557013|P3|Overall Study|moved out of state|0
1595738|NCT02338193|5557014|P2|Overall Study|moved out of state|1
1595739|NCT02338193|5557015|P1|Overall Study|moved out of state|0
1595740|NCT02338193|5557013|P3|Overall Study|Noncompliant with visits|7
1595741|NCT02338193|5557014|P2|Overall Study|Noncompliant with visits|2
1595742|NCT02338193|5557015|P1|Overall Study|Noncompliant with visits|2
1595743|NCT02338193|5557013|P3|Overall Study|Pregnancy|1
1595744|NCT02338193|5557014|P2|Overall Study|Pregnancy|1
1595745|NCT02338193|5557015|P1|Overall Study|Pregnancy|0
1595746|NCT02338193|5557013|P3|Overall Study|Withdrawal by Subject|2
1595747|NCT02338193|5557014|P2|Overall Study|Withdrawal by Subject|0
1595748|NCT02338193|5557015|P1|Overall Study|Withdrawal by Subject|0
1595749|NCT02338154|5557068|P1|Overall Study|Missing Exit Reason on Exit Form|1
1595750|NCT02338154|5557068|P1|Overall Study|Patients Without Exit Form|47
1595751|NCT02338154|5557068|P1|Overall Study|Other Reason|3
1595752|NCT02338154|5557068|P1|Overall Study|Lost to Follow-up|8
1595753|NCT02338154|5557068|P1|Overall Study|Withdrawal by Subject or by Investigator|10
1595754|NCT02338154|5557068|P1|Overall Study|Valve Explant|11
1595755|NCT02338154|5557068|P1|Overall Study|Valve Implant Failure|17
1595756|NCT02338154|5557068|P1|Overall Study|Death|46
1595757|NCT02337946|5557192|P3|Protocol Treatment 2 Period|Reason not specified|4
1595758|NCT02337946|5557193|P2|Protocol Treatment 2 Period|Reason not specified|4
1595759|NCT02337946|5557194|P1|Protocol Treatment 2 Period|Reason not specified|0
1595760|NCT02337946|5557192|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
1595761|NCT02337946|5557193|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
1595762|NCT02337946|5557194|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
1595763|NCT02337946|5557192|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
1595764|NCT02337946|5557193|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
1595765|NCT02337946|5557194|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
1595766|NCT02337946|5557192|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
1595767|NCT02337946|5557193|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
1595768|NCT02337946|5557194|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
1595769|NCT02337946|5557192|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
1595770|NCT02337946|5557193|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
1595771|NCT02337946|5557194|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
1595772|NCT02337946|5557192|P3|Protocol Treatment 2 Period|Adverse Event|9
1595773|NCT02337946|5557193|P2|Protocol Treatment 2 Period|Adverse Event|9
1595774|NCT02337946|5557194|P1|Protocol Treatment 2 Period|Adverse Event|0
1595775|NCT02337946|5557192|P3|In-between Period|Without Informed Consent|0
1595776|NCT02337946|5557193|P2|In-between Period|Without Informed Consent|0
1595777|NCT02337946|5557194|P1|In-between Period|Without Informed Consent|1
1595778|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Reason not specified|0
1595779|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Reason not specified|0
1595780|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Reason not specified|8
1595781|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
1595782|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
1595783|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
1595784|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
1595785|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
1595786|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
1595787|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
1595788|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
1595789|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
1595790|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
1595791|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
1595792|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
1595793|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
1595794|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
1595795|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
1595796|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
1595797|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
1595798|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
1595799|NCT02337946|5557192|P3|Protocol Treatment 1 Period|Adverse Event|0
1595800|NCT02337946|5557193|P2|Protocol Treatment 1 Period|Adverse Event|0
1595801|NCT02337946|5557194|P1|Protocol Treatment 1 Period|Adverse Event|7
1595802|NCT02337907|5557222|P6|Overall Study|Adverse Event|0
1595803|NCT02337907|5557223|P5|Overall Study|Adverse Event|4
1595804|NCT02337907|5557224|P4|Overall Study|Adverse Event|1
1595805|NCT02337907|5557225|P3|Overall Study|Adverse Event|1
1595806|NCT02337907|5557226|P2|Overall Study|Adverse Event|1
1595807|NCT02337907|5557227|P1|Overall Study|Adverse Event|1
1595808|NCT02337907|5557222|P6|Overall Study|Lost to Follow-up|1
1595809|NCT02337907|5557223|P5|Overall Study|Lost to Follow-up|0
1595810|NCT02337907|5557224|P4|Overall Study|Lost to Follow-up|0
1595811|NCT02337907|5557225|P3|Overall Study|Lost to Follow-up|0
1595812|NCT02337907|5557226|P2|Overall Study|Lost to Follow-up|0
1595813|NCT02337907|5557227|P1|Overall Study|Lost to Follow-up|0
1595814|NCT02337907|5557222|P6|Overall Study|Withdrawal by Subject|0
1595815|NCT02337907|5557223|P5|Overall Study|Withdrawal by Subject|5
1595816|NCT02337907|5557224|P4|Overall Study|Withdrawal by Subject|2
1595817|NCT02337907|5557225|P3|Overall Study|Withdrawal by Subject|0
1595818|NCT02337907|5557226|P2|Overall Study|Withdrawal by Subject|3
1595819|NCT02337907|5557227|P1|Overall Study|Withdrawal by Subject|2
1595820|NCT02337907|5557222|P6|Overall Study|Other than listed|0
1595821|NCT02337907|5557223|P5|Overall Study|Other than listed|1
1595822|NCT02337907|5557224|P4|Overall Study|Other than listed|1
1595823|NCT02337907|5557225|P3|Overall Study|Other than listed|0
1595824|NCT02337907|5557226|P2|Overall Study|Other than listed|0
1595825|NCT02337907|5557227|P1|Overall Study|Other than listed|1
1595826|NCT02337764|5557262|P1|Overall Study|Lack of Efficacy|2
1595827|NCT02337764|5557262|P1|Overall Study|Voluntary Withdrawal|12
1595828|NCT02337764|5557262|P1|Overall Study|Pretreatment Event/Adverse Event|46
1595829|NCT02337751|5557275|P2|Overall Study|Investigator's Judgement|0
1595830|NCT02337751|5557276|P1|Overall Study|Investigator's Judgement|1
1595831|NCT02337751|5557275|P2|Overall Study|Lack of Efficacy|5
1595832|NCT02337751|5557276|P1|Overall Study|Lack of Efficacy|2
1595833|NCT02337751|5557275|P2|Overall Study|Voluntary Withdrawal|8
1595834|NCT02337751|5557276|P1|Overall Study|Voluntary Withdrawal|6
1595835|NCT02337751|5557275|P2|Overall Study|Pretreatment Event/Adverse Event|3
1595836|NCT02337751|5557276|P1|Overall Study|Pretreatment Event/Adverse Event|2
1595837|NCT02337738|5557295|P3|Overall Study|Investigator's Judgment|3
1595838|NCT02337738|5557296|P2|Overall Study|Investigator's Judgment|1
1595839|NCT02337738|5557297|P1|Overall Study|Investigator's Judgment|1
1595840|NCT02337738|5557295|P3|Overall Study|Lack of Efficacy|0
1595841|NCT02337738|5557296|P2|Overall Study|Lack of Efficacy|4
1595842|NCT02337738|5557297|P1|Overall Study|Lack of Efficacy|2
1595843|NCT02337738|5557295|P3|Overall Study|Voluntary Withdrawal|2
1595844|NCT02337738|5557296|P2|Overall Study|Voluntary Withdrawal|5
1595845|NCT02337738|5557297|P1|Overall Study|Voluntary Withdrawal|10
1595846|NCT02337738|5557295|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
1595847|NCT02337738|5557296|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
1595848|NCT02337738|5557297|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
1595849|NCT02337738|5557295|P3|Overall Study|Pretreatment Event/Adverse Event|21
1595850|NCT02337738|5557296|P2|Overall Study|Pretreatment Event/Adverse Event|18
1595851|NCT02337738|5557297|P1|Overall Study|Pretreatment Event/Adverse Event|9
1595852|NCT02337738|5557295|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
1595853|NCT02337738|5557296|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
1595854|NCT02337738|5557297|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
1595855|NCT02337725|5557337|P2|Overall Study|Lack of Efficacy|0
1595856|NCT02337725|5557338|P1|Overall Study|Lack of Efficacy|4
1595857|NCT02337725|5557337|P2|Overall Study|Voluntary Withdrawal|3
1595858|NCT02337725|5557338|P1|Overall Study|Voluntary Withdrawal|14
1595859|NCT02337725|5557337|P2|Overall Study|Major Protocol Deviation|1
1595860|NCT02337725|5557338|P1|Overall Study|Major Protocol Deviation|0
1595861|NCT02337725|5557337|P2|Overall Study|Pretreatment Event/AE in Treatment|3
1595862|NCT02337725|5557338|P1|Overall Study|Pretreatment Event/AE in Treatment|8
1595863|NCT02337725|5557337|P2|Overall Study|Pretreatment Event/AE before Treatment|1
1595864|NCT02337725|5557338|P1|Overall Study|Pretreatment Event/AE before Treatment|0
1595865|NCT02337491|5557362|P2|Overall Study|On Treatment|0
1595866|NCT02337491|5557363|P1|Overall Study|On Treatment|2
1595867|NCT02337491|5557362|P2|Overall Study|Progressive Disease|28
1595868|NCT02337491|5557363|P1|Overall Study|Progressive Disease|44
1595869|NCT02337491|5557362|P2|Overall Study|Withdrawal by Subject|0
1595870|NCT02337491|5557363|P1|Overall Study|Withdrawal by Subject|3
1595871|NCT02337491|5557362|P2|Overall Study|Adverse Event|1
1595872|NCT02337491|5557363|P1|Overall Study|Adverse Event|0
1595873|NCT02337491|5557362|P2|Overall Study|Death|1
1595874|NCT02337491|5557363|P1|Overall Study|Death|1
1595875|NCT02337478|5557377|P1|Overall Study|Lack of Efficacy|5
1595876|NCT02337387|5557387|P4|Overall Study|Sponsor Decision to Terminate Study|3
1595877|NCT02337387|5557388|P3|Overall Study|Sponsor Decision to Terminate Study|3
1595878|NCT02337387|5557389|P2|Overall Study|Sponsor Decision to Terminate Study|7
1595879|NCT02337387|5557390|P1|Overall Study|Sponsor Decision to Terminate Study|14
1595880|NCT02337387|5557387|P4|Overall Study|Adverse Event|0
1595881|NCT02337387|5557388|P3|Overall Study|Adverse Event|0
1595882|NCT02337387|5557389|P2|Overall Study|Adverse Event|1
1595883|NCT02337387|5557390|P1|Overall Study|Adverse Event|0
1595884|NCT02337361|5557408|P2|6-month Follow-up|Lost to Follow-up|4
1595885|NCT02337361|5557409|P1|6-month Follow-up|Lost to Follow-up|2
1595886|NCT02337361|5557408|P2|3-month Follow-up|Lost to Follow-up|14
1595887|NCT02337361|5557409|P1|3-month Follow-up|Lost to Follow-up|19
1595888|NCT02336607|5557471|P4|Overall Study|Withdrawal by Subject|20
1595889|NCT02336607|5557472|P3|Overall Study|Withdrawal by Subject|0
1595890|NCT02336607|5557473|P2|Overall Study|Withdrawal by Subject|2
1595891|NCT02336607|5557474|P1|Overall Study|Withdrawal by Subject|0
1595892|NCT02336607|5557471|P4|Overall Study|Adverse Event|26
1595893|NCT02336607|5557472|P3|Overall Study|Adverse Event|2
1595894|NCT02336607|5557473|P2|Overall Study|Adverse Event|2
1595895|NCT02336607|5557474|P1|Overall Study|Adverse Event|0
1595896|NCT02336607|5557471|P4|Overall Study|Protocol Violation|3
1595897|NCT02336607|5557472|P3|Overall Study|Protocol Violation|1
1595898|NCT02336607|5557473|P2|Overall Study|Protocol Violation|1
1595899|NCT02336607|5557474|P1|Overall Study|Protocol Violation|0
1595900|NCT02336607|5557471|P4|Overall Study|Lost to Follow-up|21
1595901|NCT02336607|5557472|P3|Overall Study|Lost to Follow-up|0
1595902|NCT02336607|5557473|P2|Overall Study|Lost to Follow-up|1
1595903|NCT02336607|5557474|P1|Overall Study|Lost to Follow-up|2
1595904|NCT02336607|5557471|P4|Overall Study|Lack of Efficacy|2
1595905|NCT02336607|5557472|P3|Overall Study|Lack of Efficacy|0
1595906|NCT02336607|5557473|P2|Overall Study|Lack of Efficacy|0
1595907|NCT02336607|5557474|P1|Overall Study|Lack of Efficacy|1
1595908|NCT02336607|5557471|P4|Overall Study|Physician Decision|15
1595909|NCT02336607|5557472|P3|Overall Study|Physician Decision|3
1595910|NCT02336607|5557473|P2|Overall Study|Physician Decision|4
1595911|NCT02336607|5557474|P1|Overall Study|Physician Decision|1
1595912|NCT02336555|5557577|P2|Treatment Period 2 (28 Days)|Adverse Event|1
1595913|NCT02336555|5557578|P1|Treatment Period 2 (28 Days)|Adverse Event|0
1595914|NCT02336555|5557577|P2|Treatment Period 1 (28 Days)|Physician Decision|0
1595915|NCT02336555|5557578|P1|Treatment Period 1 (28 Days)|Physician Decision|2
1595916|NCT02336555|5557577|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1595917|NCT02336555|5557578|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1595948|NCT02336425|5557752|P4|Overall Study|Study terminated.|3
1595949|NCT02336425|5557753|P3|Overall Study|Study terminated.|3
1595950|NCT02336425|5557754|P2|Overall Study|Study terminated.|2
1595951|NCT02336425|5557755|P1|Overall Study|Study terminated.|2
1595952|NCT02336282|5557805|P1|Overall Study|Not enough time to complete sessions|2
1595953|NCT02336282|5557805|P1|Overall Study|Lost to Follow-up|1
1595954|NCT02336282|5557805|P1|Overall Study|Uncomfortable with technology|1
1595955|NCT02336282|5557805|P1|Overall Study|Unrelated illness|1
1595956|NCT02336178|5557829|P1|Overall Study|Other|1
1595957|NCT02336178|5557829|P1|Overall Study|Withdrawal by Subject|1
1595958|NCT02336178|5557829|P1|Overall Study|Protocol Violation|1
1595959|NCT02336178|5557829|P1|Overall Study|Lost to Follow-up|1
1595960|NCT02336165|5557920|P5|Overall Study|Other|0
1595961|NCT02336165|5557921|P4|Overall Study|Other|1
1595962|NCT02336165|5557922|P3|Overall Study|Other|0
1595963|NCT02336165|5557923|P2|Overall Study|Other|0
1595964|NCT02336165|5557924|P1|Overall Study|Other|1
1595965|NCT02336165|5557920|P5|Overall Study|Non-compliance|0
1595966|NCT02336165|5557921|P4|Overall Study|Non-compliance|1
1595967|NCT02336165|5557922|P3|Overall Study|Non-compliance|0
1595968|NCT02336165|5557923|P2|Overall Study|Non-compliance|0
1595969|NCT02336165|5557924|P1|Overall Study|Non-compliance|1
1595970|NCT02336165|5557920|P5|Overall Study|Progressive disease|19
1595971|NCT02336165|5557921|P4|Overall Study|Progressive disease|24
1595972|NCT02336165|5557922|P3|Overall Study|Progressive disease|27
1595973|NCT02336165|5557923|P2|Overall Study|Progressive disease|22
1595974|NCT02336165|5557924|P1|Overall Study|Progressive disease|23
1595975|NCT02336165|5557920|P5|Overall Study|Adverse Event|1
1595976|NCT02336165|5557921|P4|Overall Study|Adverse Event|4
1595977|NCT02336165|5557922|P3|Overall Study|Adverse Event|2
1595978|NCT02336165|5557923|P2|Overall Study|Adverse Event|1
1595979|NCT02336165|5557924|P1|Overall Study|Adverse Event|4
1595980|NCT02336165|5557920|P5|Overall Study|Withdrawal by Subject|1
1595981|NCT02336165|5557921|P4|Overall Study|Withdrawal by Subject|0
1595982|NCT02336165|5557922|P3|Overall Study|Withdrawal by Subject|1
1595983|NCT02336165|5557923|P2|Overall Study|Withdrawal by Subject|0
1595984|NCT02336165|5557924|P1|Overall Study|Withdrawal by Subject|0
1595985|NCT02336165|5557920|P5|Overall Study|Physician Decision|0
1595986|NCT02336165|5557921|P4|Overall Study|Physician Decision|1
1595987|NCT02336165|5557922|P3|Overall Study|Physician Decision|1
1595988|NCT02336165|5557923|P2|Overall Study|Physician Decision|2
1595989|NCT02336165|5557924|P1|Overall Study|Physician Decision|2
1595990|NCT02336165|5557920|P5|Overall Study|Death|1
1595991|NCT02336165|5557921|P4|Overall Study|Death|0
1595992|NCT02336165|5557922|P3|Overall Study|Death|0
1595993|NCT02336165|5557923|P2|Overall Study|Death|0
1595994|NCT02336165|5557924|P1|Overall Study|Death|3
1595995|NCT02336074|5557958|P2|Overall Study|Adverse Event|2
1595996|NCT02336074|5557959|P1|Overall Study|Adverse Event|0
1595997|NCT02335489|5558004|P1|Overall Study|Lack of Efficacy|1
1595998|NCT02335489|5558004|P1|Overall Study|Physician Decision|2
1595999|NCT02335489|5558004|P1|Overall Study|Withdrawal by Subject|2
1596000|NCT02335489|5558004|P1|Overall Study|Lost to Follow-up|1
1596001|NCT02335489|5558004|P1|Overall Study|Sponsor terminated study|4
1596002|NCT02335424|5558008|P1|Overall Study|Not treated|4
1596003|NCT02335424|5558008|P1|Overall Study|Physician Decision|3
1596004|NCT02335424|5558008|P1|Overall Study|Lost to Follow-up|2
1596005|NCT02335424|5558008|P1|Overall Study|Death|239
1596006|NCT02335424|5558008|P1|Overall Study|Adverse Event|25
1596007|NCT02335424|5558008|P1|Overall Study|Ongoing In Study|89
1596008|NCT02335424|5558008|P1|Overall Study|Withdrawal by Subject|12
1596009|NCT02335346|5558041|P1|Overall Study|Withdrawal by Subject|1
1596010|NCT02335346|5558041|P1|Overall Study|Adverse Event|11
1596011|NCT02334423|5558341|P2|Overall Study|Protocol Violation|3
1596012|NCT02334423|5558342|P1|Overall Study|Protocol Violation|10
1596013|NCT02334384|5558356|P2|Overall Study|Lost to Follow-up|1
1596014|NCT02334384|5558357|P1|Overall Study|Lost to Follow-up|1
1596015|NCT02334306|5558369|P2|Double-blind Period|Withdrawal by Subject|1
1596016|NCT02334306|5558370|P1|Double-blind Period|Withdrawal by Subject|1
1596017|NCT02334306|5558369|P2|Double-blind Period|Adverse Event|1
1596018|NCT02334306|5558370|P1|Double-blind Period|Adverse Event|0
1596019|NCT02333383|5558424|P1|Overall Study|Transfer to another hospital|2
1596020|NCT02333383|5558424|P1|Overall Study|Withdrawal by Subject|3
1596021|NCT02333383|5558424|P1|Overall Study|Lost to Follow-up|15
1596022|NCT02333383|5558424|P1|Overall Study|Adalimumab discontinuation|21
1596023|NCT02333331|5558438|P4|Overall Study|Patient/Guardian Decision|1
1596024|NCT02333331|5558439|P3|Overall Study|Patient/Guardian Decision|9
1596025|NCT02333331|5558440|P2|Overall Study|Patient/Guardian Decision|2
1596026|NCT02333331|5558441|P1|Overall Study|Patient/Guardian Decision|1
1596027|NCT02333331|5558438|P4|Overall Study|Protocol Deviation|1
1596028|NCT02333331|5558439|P3|Overall Study|Protocol Deviation|2
1596029|NCT02333331|5558440|P2|Overall Study|Protocol Deviation|3
1596030|NCT02333331|5558441|P1|Overall Study|Protocol Deviation|0
1596031|NCT02333331|5558438|P4|Overall Study|Physician Decision|0
1596032|NCT02333331|5558439|P3|Overall Study|Physician Decision|0
1596033|NCT02333331|5558440|P2|Overall Study|Physician Decision|1
1596034|NCT02333331|5558441|P1|Overall Study|Physician Decision|0
1596035|NCT02333331|5558438|P4|Overall Study|Lost to Follow-up|0
1596036|NCT02333331|5558439|P3|Overall Study|Lost to Follow-up|1
1596037|NCT02333331|5558440|P2|Overall Study|Lost to Follow-up|0
1596038|NCT02333331|5558441|P1|Overall Study|Lost to Follow-up|0
1596039|NCT02333331|5558438|P4|Overall Study|Death|0
1596040|NCT02333331|5558439|P3|Overall Study|Death|2
1596041|NCT02333331|5558440|P2|Overall Study|Death|0
1596042|NCT02333331|5558441|P1|Overall Study|Death|0
1596043|NCT02333331|5558438|P4|Overall Study|Adverse Event|1
1596044|NCT02333331|5558439|P3|Overall Study|Adverse Event|4
1596045|NCT02333331|5558440|P2|Overall Study|Adverse Event|0
1596046|NCT02333331|5558441|P1|Overall Study|Adverse Event|1
1596047|NCT02332889|5558485|P1|Overall Study|Physician Decision|1
1596048|NCT02332876|5558491|P2|Overall Study|Lost to Follow-up|1
1596049|NCT02332876|5558492|P1|Overall Study|Lost to Follow-up|1
1596050|NCT02332824|5558504|P6|Overall Study|Transfer|0
1596051|NCT02332824|5558505|P5|Overall Study|Transfer|0
1596052|NCT02332824|5558506|P4|Overall Study|Transfer|1
1596053|NCT02332824|5558507|P3|Overall Study|Transfer|1
1596054|NCT02332824|5558508|P2|Overall Study|Transfer|0
1596055|NCT02332824|5558509|P1|Overall Study|Transfer|0
1596056|NCT02332824|5558504|P6|Overall Study|Inconvenient schedule|0
1596057|NCT02332824|5558505|P5|Overall Study|Inconvenient schedule|0
1596058|NCT02332824|5558506|P4|Overall Study|Inconvenient schedule|0
1596059|NCT02332824|5558507|P3|Overall Study|Inconvenient schedule|0
1596060|NCT02332824|5558508|P2|Overall Study|Inconvenient schedule|1
1596061|NCT02332824|5558509|P1|Overall Study|Inconvenient schedule|1
1596062|NCT02332824|5558504|P6|Overall Study|Voluntary Withdrawal|0
1596063|NCT02332824|5558505|P5|Overall Study|Voluntary Withdrawal|0
1596064|NCT02332824|5558506|P4|Overall Study|Voluntary Withdrawal|0
1596065|NCT02332824|5558507|P3|Overall Study|Voluntary Withdrawal|0
1596066|NCT02332824|5558508|P2|Overall Study|Voluntary Withdrawal|0
1596067|NCT02332824|5558509|P1|Overall Study|Voluntary Withdrawal|1
1596068|NCT02332824|5558504|P6|Overall Study|Pretreatment Event/Adverse Event|1
1596069|NCT02332824|5558505|P5|Overall Study|Pretreatment Event/Adverse Event|4
1596070|NCT02332824|5558506|P4|Overall Study|Pretreatment Event/Adverse Event|1
1596071|NCT02332824|5558507|P3|Overall Study|Pretreatment Event/Adverse Event|1
1596072|NCT02332824|5558508|P2|Overall Study|Pretreatment Event/Adverse Event|0
1596073|NCT02332824|5558509|P1|Overall Study|Pretreatment Event/Adverse Event|4
1596074|NCT02332798|5558550|P3|Overall Study|Abnormal Laboratory Findings|0
1596075|NCT02332798|5558551|P2|Overall Study|Abnormal Laboratory Findings|0
1596076|NCT02332798|5558552|P1|Overall Study|Abnormal Laboratory Findings|1
1596077|NCT02332798|5558550|P3|Overall Study|Positive Urine Drug Test|0
1596078|NCT02332798|5558551|P2|Overall Study|Positive Urine Drug Test|1
1596079|NCT02332798|5558552|P1|Overall Study|Positive Urine Drug Test|0
1596080|NCT02332798|5558550|P3|Overall Study|Unwilling to Participate in Study|1
1596081|NCT02332798|5558551|P2|Overall Study|Unwilling to Participate in Study|1
1596082|NCT02332798|5558552|P1|Overall Study|Unwilling to Participate in Study|0
1596083|NCT02332720|5558625|P23|Part A and Part B|Withdrawal by Subject|0
1596084|NCT02332720|5558626|P22|Part A and Part B|Withdrawal by Subject|0
1596085|NCT02332720|5558627|P21|Part A and Part B|Withdrawal by Subject|0
1596086|NCT02332720|5558628|P20|Part A and Part B|Withdrawal by Subject|1
1596087|NCT02332720|5558629|P19|Part A and Part B|Withdrawal by Subject|0
1596088|NCT02332720|5558630|P18|Part A and Part B|Withdrawal by Subject|0
1596089|NCT02332720|5558631|P17|Part A and Part B|Withdrawal by Subject|0
1596090|NCT02332720|5558632|P16|Part A and Part B|Withdrawal by Subject|0
1596091|NCT02332720|5558633|P15|Part A and Part B|Withdrawal by Subject|0
1596092|NCT02332720|5558634|P14|Part A and Part B|Withdrawal by Subject|0
1596093|NCT02332720|5558635|P13|Part A and Part B|Withdrawal by Subject|0
1596094|NCT02332720|5558636|P12|Part A and Part B|Withdrawal by Subject|0
1596095|NCT02332720|5558637|P11|Part A and Part B|Withdrawal by Subject|0
1596096|NCT02332720|5558638|P10|Part A and Part B|Withdrawal by Subject|0
1596097|NCT02332720|5558639|P9|Part A and Part B|Withdrawal by Subject|0
1596098|NCT02332720|5558640|P8|Part A and Part B|Withdrawal by Subject|0
1596099|NCT02332720|5558641|P7|Part A and Part B|Withdrawal by Subject|0
1596100|NCT02332720|5558642|P6|Part A and Part B|Withdrawal by Subject|1
1596101|NCT02332720|5558643|P5|Part A and Part B|Withdrawal by Subject|0
1596102|NCT02332720|5558644|P4|Part A and Part B|Withdrawal by Subject|0
1596103|NCT02332720|5558645|P3|Part A and Part B|Withdrawal by Subject|0
1596104|NCT02332720|5558646|P2|Part A and Part B|Withdrawal by Subject|0
1596105|NCT02332720|5558647|P1|Part A and Part B|Withdrawal by Subject|0
1596106|NCT02332720|5558625|P23|Part A and Part B|Physician Decision|0
1596107|NCT02332720|5558626|P22|Part A and Part B|Physician Decision|0
1596108|NCT02332720|5558627|P21|Part A and Part B|Physician Decision|0
1596109|NCT02332720|5558628|P20|Part A and Part B|Physician Decision|0
1596110|NCT02332720|5558629|P19|Part A and Part B|Physician Decision|1
1596111|NCT02332720|5558630|P18|Part A and Part B|Physician Decision|0
1596112|NCT02332720|5558631|P17|Part A and Part B|Physician Decision|0
1596113|NCT02332720|5558632|P16|Part A and Part B|Physician Decision|0
1596114|NCT02332720|5558633|P15|Part A and Part B|Physician Decision|0
1596115|NCT02332720|5558634|P14|Part A and Part B|Physician Decision|0
1596116|NCT02332720|5558635|P13|Part A and Part B|Physician Decision|0
1596117|NCT02332720|5558636|P12|Part A and Part B|Physician Decision|0
1596118|NCT02332720|5558637|P11|Part A and Part B|Physician Decision|0
1596119|NCT02332720|5558638|P10|Part A and Part B|Physician Decision|0
1596120|NCT02332720|5558639|P9|Part A and Part B|Physician Decision|0
1596121|NCT02332720|5558640|P8|Part A and Part B|Physician Decision|0
1596122|NCT02332720|5558641|P7|Part A and Part B|Physician Decision|0
1596123|NCT02332720|5558642|P6|Part A and Part B|Physician Decision|0
1596124|NCT02332720|5558643|P5|Part A and Part B|Physician Decision|0
1596125|NCT02332720|5558644|P4|Part A and Part B|Physician Decision|0
1596126|NCT02332720|5558645|P3|Part A and Part B|Physician Decision|0
1596127|NCT02332720|5558646|P2|Part A and Part B|Physician Decision|0
1596128|NCT02332720|5558647|P1|Part A and Part B|Physician Decision|0
1596129|NCT02332720|5558625|P23|Part A and Part B|Adverse Event|0
1596130|NCT02332720|5558626|P22|Part A and Part B|Adverse Event|0
1596131|NCT02332720|5558627|P21|Part A and Part B|Adverse Event|0
1596132|NCT02332720|5558628|P20|Part A and Part B|Adverse Event|0
1596133|NCT02332720|5558629|P19|Part A and Part B|Adverse Event|0
1596134|NCT02332720|5558630|P18|Part A and Part B|Adverse Event|1
1596135|NCT02332720|5558631|P17|Part A and Part B|Adverse Event|0
1596136|NCT02332720|5558632|P16|Part A and Part B|Adverse Event|0
1596137|NCT02332720|5558633|P15|Part A and Part B|Adverse Event|0
1596138|NCT02332720|5558634|P14|Part A and Part B|Adverse Event|0
1596139|NCT02332720|5558635|P13|Part A and Part B|Adverse Event|0
1596140|NCT02332720|5558636|P12|Part A and Part B|Adverse Event|0
1596141|NCT02332720|5558637|P11|Part A and Part B|Adverse Event|0
1596142|NCT02332720|5558638|P10|Part A and Part B|Adverse Event|0
1596143|NCT02332720|5558639|P9|Part A and Part B|Adverse Event|0
1596144|NCT02332720|5558640|P8|Part A and Part B|Adverse Event|0
1596145|NCT02332720|5558641|P7|Part A and Part B|Adverse Event|0
1596146|NCT02332720|5558642|P6|Part A and Part B|Adverse Event|0
1596147|NCT02332720|5558643|P5|Part A and Part B|Adverse Event|0
1596148|NCT02332720|5558644|P4|Part A and Part B|Adverse Event|0
1596149|NCT02332720|5558645|P3|Part A and Part B|Adverse Event|0
1596150|NCT02332720|5558646|P2|Part A and Part B|Adverse Event|0
1596151|NCT02332720|5558647|P1|Part A and Part B|Adverse Event|0
1596152|NCT02332720|5558625|P23|Part A and Part B|Lost to Follow-up|0
1596153|NCT02332720|5558626|P22|Part A and Part B|Lost to Follow-up|0
1596154|NCT02332720|5558627|P21|Part A and Part B|Lost to Follow-up|0
1596155|NCT02332720|5558628|P20|Part A and Part B|Lost to Follow-up|0
1596156|NCT02332720|5558629|P19|Part A and Part B|Lost to Follow-up|0
1596157|NCT02332720|5558630|P18|Part A and Part B|Lost to Follow-up|0
1596158|NCT02332720|5558631|P17|Part A and Part B|Lost to Follow-up|0
1596159|NCT02332720|5558632|P16|Part A and Part B|Lost to Follow-up|1
1596160|NCT02332720|5558633|P15|Part A and Part B|Lost to Follow-up|0
1596161|NCT02332720|5558634|P14|Part A and Part B|Lost to Follow-up|0
1596162|NCT02332720|5558635|P13|Part A and Part B|Lost to Follow-up|0
1596163|NCT02332720|5558636|P12|Part A and Part B|Lost to Follow-up|0
1596164|NCT02332720|5558637|P11|Part A and Part B|Lost to Follow-up|0
1596165|NCT02332720|5558638|P10|Part A and Part B|Lost to Follow-up|0
1596166|NCT02332720|5558639|P9|Part A and Part B|Lost to Follow-up|0
1596167|NCT02332720|5558640|P8|Part A and Part B|Lost to Follow-up|1
1596168|NCT02332720|5558641|P7|Part A and Part B|Lost to Follow-up|1
1596169|NCT02332720|5558642|P6|Part A and Part B|Lost to Follow-up|2
1596170|NCT02332720|5558643|P5|Part A and Part B|Lost to Follow-up|0
1596171|NCT02332720|5558644|P4|Part A and Part B|Lost to Follow-up|0
1596172|NCT02332720|5558645|P3|Part A and Part B|Lost to Follow-up|0
1596173|NCT02332720|5558646|P2|Part A and Part B|Lost to Follow-up|0
1596174|NCT02332720|5558647|P1|Part A and Part B|Lost to Follow-up|1
1596175|NCT02332707|5558783|P18|Overall Study|Withdrawal by Subject|0
1596176|NCT02332707|5558784|P17|Overall Study|Withdrawal by Subject|0
1596177|NCT02332707|5558785|P16|Overall Study|Withdrawal by Subject|0
1596178|NCT02332707|5558786|P15|Overall Study|Withdrawal by Subject|0
1596179|NCT02332707|5558787|P14|Overall Study|Withdrawal by Subject|0
1596180|NCT02332707|5558788|P13|Overall Study|Withdrawal by Subject|0
1596181|NCT02332707|5558789|P12|Overall Study|Withdrawal by Subject|0
1596182|NCT02332707|5558790|P11|Overall Study|Withdrawal by Subject|0
1596183|NCT02332707|5558791|P10|Overall Study|Withdrawal by Subject|3
1596184|NCT02332707|5558792|P9|Overall Study|Withdrawal by Subject|0
1596185|NCT02332707|5558793|P8|Overall Study|Withdrawal by Subject|0
1596186|NCT02332707|5558794|P7|Overall Study|Withdrawal by Subject|0
1596187|NCT02332707|5558795|P6|Overall Study|Withdrawal by Subject|0
1596188|NCT02332707|5558796|P5|Overall Study|Withdrawal by Subject|0
1596189|NCT02332707|5558797|P4|Overall Study|Withdrawal by Subject|0
1596190|NCT02332707|5558798|P3|Overall Study|Withdrawal by Subject|1
1596191|NCT02332707|5558799|P2|Overall Study|Withdrawal by Subject|0
1596192|NCT02332707|5558800|P1|Overall Study|Withdrawal by Subject|0
1596193|NCT02332707|5558783|P18|Overall Study|Physician Decision|0
1596194|NCT02332707|5558784|P17|Overall Study|Physician Decision|0
1596195|NCT02332707|5558785|P16|Overall Study|Physician Decision|0
1596196|NCT02332707|5558786|P15|Overall Study|Physician Decision|0
1596197|NCT02332707|5558787|P14|Overall Study|Physician Decision|0
1596198|NCT02332707|5558788|P13|Overall Study|Physician Decision|1
1596199|NCT02332707|5558789|P12|Overall Study|Physician Decision|0
1596200|NCT02332707|5558790|P11|Overall Study|Physician Decision|0
1596201|NCT02332707|5558791|P10|Overall Study|Physician Decision|0
1596202|NCT02332707|5558792|P9|Overall Study|Physician Decision|0
1596203|NCT02332707|5558793|P8|Overall Study|Physician Decision|0
1596204|NCT02332707|5558794|P7|Overall Study|Physician Decision|0
1596205|NCT02332707|5558795|P6|Overall Study|Physician Decision|0
1596206|NCT02332707|5558796|P5|Overall Study|Physician Decision|0
1596207|NCT02332707|5558797|P4|Overall Study|Physician Decision|1
1596208|NCT02332707|5558798|P3|Overall Study|Physician Decision|0
1596209|NCT02332707|5558799|P2|Overall Study|Physician Decision|0
1596210|NCT02332707|5558800|P1|Overall Study|Physician Decision|0
1596211|NCT02332707|5558783|P18|Overall Study|Lost to Follow-up|0
1596212|NCT02332707|5558784|P17|Overall Study|Lost to Follow-up|0
1596213|NCT02332707|5558785|P16|Overall Study|Lost to Follow-up|0
1596214|NCT02332707|5558786|P15|Overall Study|Lost to Follow-up|0
1596215|NCT02332707|5558787|P14|Overall Study|Lost to Follow-up|0
1596216|NCT02332707|5558788|P13|Overall Study|Lost to Follow-up|3
1596217|NCT02332707|5558789|P12|Overall Study|Lost to Follow-up|0
1596218|NCT02332707|5558790|P11|Overall Study|Lost to Follow-up|2
1596219|NCT02332707|5558791|P10|Overall Study|Lost to Follow-up|0
1596220|NCT02332707|5558792|P9|Overall Study|Lost to Follow-up|0
1596221|NCT02332707|5558793|P8|Overall Study|Lost to Follow-up|0
1596222|NCT02332707|5558794|P7|Overall Study|Lost to Follow-up|0
1596223|NCT02332707|5558795|P6|Overall Study|Lost to Follow-up|1
1596224|NCT02332707|5558796|P5|Overall Study|Lost to Follow-up|0
1596225|NCT02332707|5558797|P4|Overall Study|Lost to Follow-up|0
1596226|NCT02332707|5558798|P3|Overall Study|Lost to Follow-up|0
1596227|NCT02332707|5558799|P2|Overall Study|Lost to Follow-up|0
1596228|NCT02332707|5558800|P1|Overall Study|Lost to Follow-up|0
1596229|NCT02332707|5558783|P18|Overall Study|Adverse Event|0
1596230|NCT02332707|5558784|P17|Overall Study|Adverse Event|0
1596231|NCT02332707|5558785|P16|Overall Study|Adverse Event|0
1596232|NCT02332707|5558786|P15|Overall Study|Adverse Event|0
1596233|NCT02332707|5558787|P14|Overall Study|Adverse Event|0
1596234|NCT02332707|5558788|P13|Overall Study|Adverse Event|1
1596235|NCT02332707|5558789|P12|Overall Study|Adverse Event|0
1596236|NCT02332707|5558790|P11|Overall Study|Adverse Event|0
1596237|NCT02332707|5558791|P10|Overall Study|Adverse Event|0
1596238|NCT02332707|5558792|P9|Overall Study|Adverse Event|0
1596239|NCT02332707|5558793|P8|Overall Study|Adverse Event|0
1596240|NCT02332707|5558794|P7|Overall Study|Adverse Event|0
1596241|NCT02332707|5558795|P6|Overall Study|Adverse Event|0
1596242|NCT02332707|5558796|P5|Overall Study|Adverse Event|0
1596243|NCT02332707|5558797|P4|Overall Study|Adverse Event|0
1596244|NCT02332707|5558798|P3|Overall Study|Adverse Event|0
1596245|NCT02332707|5558799|P2|Overall Study|Adverse Event|0
1596246|NCT02332707|5558800|P1|Overall Study|Adverse Event|0
1596247|NCT02332590|5558894|P2|Overall Study|Other than specified above|5
1596248|NCT02332590|5558895|P1|Overall Study|Other than specified above|6
1596249|NCT02332590|5558894|P2|Overall Study|Randomized but not treated|0
1596250|NCT02332590|5558895|P1|Overall Study|Randomized but not treated|1
1596251|NCT02332590|5558894|P2|Overall Study|Poor compliance to protocol|1
1596252|NCT02332590|5558895|P1|Overall Study|Poor compliance to protocol|3
1596253|NCT02332590|5558894|P2|Overall Study|Lack of Efficacy|2
1596254|NCT02332590|5558895|P1|Overall Study|Lack of Efficacy|4
1596255|NCT02332590|5558894|P2|Overall Study|Adverse Event|11
1596256|NCT02332590|5558895|P1|Overall Study|Adverse Event|15
1596257|NCT02332239|5558959|P2|Overall Study|Lost to Follow-up|6
1596258|NCT02332239|5558960|P1|Overall Study|Lost to Follow-up|4
1596259|NCT02331680|5558996|P3|Overall Study|Protocol Violation|3
1596260|NCT02331680|5558997|P2|Overall Study|Protocol Violation|0
1596261|NCT02331680|5558998|P1|Overall Study|Protocol Violation|0
1596262|NCT02331680|5558996|P3|Overall Study|Non-compliance with study drug|1
1596263|NCT02331680|5558997|P2|Overall Study|Non-compliance with study drug|0
1596264|NCT02331680|5558998|P1|Overall Study|Non-compliance with study drug|0
1596265|NCT02331680|5558996|P3|Overall Study|Met withdrawal criteria|5
1596266|NCT02331680|5558997|P2|Overall Study|Met withdrawal criteria|2
1596267|NCT02331680|5558998|P1|Overall Study|Met withdrawal criteria|2
1596268|NCT02331680|5558996|P3|Overall Study|Withdrawal by Subject|2
1596269|NCT02331680|5558997|P2|Overall Study|Withdrawal by Subject|1
1596270|NCT02331680|5558998|P1|Overall Study|Withdrawal by Subject|0
1596271|NCT02331680|5558996|P3|Overall Study|Physician Decision|2
1596272|NCT02331680|5558997|P2|Overall Study|Physician Decision|1
1596273|NCT02331680|5558998|P1|Overall Study|Physician Decision|1
1596274|NCT02331680|5558996|P3|Overall Study|Adverse Event|2
1596275|NCT02331680|5558997|P2|Overall Study|Adverse Event|0
1596276|NCT02331680|5558998|P1|Overall Study|Adverse Event|3
1596277|NCT02331446|5559028|P4|Overall Study|Lost before baseline analysis|0
1596278|NCT02331446|5559029|P3|Overall Study|Lost before baseline analysis|1
1596279|NCT02331446|5559030|P2|Overall Study|Lost before baseline analysis|1
1596280|NCT02331446|5559031|P1|Overall Study|Lost before baseline analysis|0
1596281|NCT02331446|5559028|P4|Overall Study|Physician Decision|1
1596282|NCT02331446|5559029|P3|Overall Study|Physician Decision|0
1596283|NCT02331446|5559030|P2|Overall Study|Physician Decision|1
1596284|NCT02331446|5559031|P1|Overall Study|Physician Decision|0
1596285|NCT02331446|5559028|P4|Overall Study|Disease|1
1596286|NCT02331446|5559029|P3|Overall Study|Disease|2
1596287|NCT02331446|5559030|P2|Overall Study|Disease|2
1596288|NCT02331446|5559031|P1|Overall Study|Disease|0
1596289|NCT02331446|5559028|P4|Overall Study|Personal Problem|0
1596290|NCT02331446|5559029|P3|Overall Study|Personal Problem|0
1596291|NCT02331446|5559030|P2|Overall Study|Personal Problem|0
1596292|NCT02331446|5559031|P1|Overall Study|Personal Problem|2
1596293|NCT02331446|5559028|P4|Overall Study|Lost to Follow-up|1
1596294|NCT02331446|5559029|P3|Overall Study|Lost to Follow-up|0
1596295|NCT02331446|5559030|P2|Overall Study|Lost to Follow-up|1
1596296|NCT02331446|5559031|P1|Overall Study|Lost to Follow-up|2
1596297|NCT02331368|5559107|P1|Overall Study|Withdrawal by Subject|3
1596298|NCT02330549|5559186|P2|Overall Study|Failure to meet randomization criteria|0
1596299|NCT02330549|5559187|P1|Overall Study|Failure to meet randomization criteria|1
1596300|NCT02330549|5559186|P2|Overall Study|Subject withdrew consent|1
1596301|NCT02330549|5559187|P1|Overall Study|Subject withdrew consent|2
1596302|NCT02330549|5559186|P2|Overall Study|Adverse Event|0
1596303|NCT02330549|5559187|P1|Overall Study|Adverse Event|1
1596304|NCT02330081|5559362|P1|Overall Study|Protocol Violation|6
1596305|NCT02330081|5559362|P1|Overall Study|Donation did not meet criteria|1
1596306|NCT02330081|5559362|P1|Overall Study|Adverse Event|1
1596307|NCT02330055|5559383|P2|Overall Study|participant did not sleep|1
1596308|NCT02330055|5559384|P1|Overall Study|participant did not sleep|0
1596309|NCT02330055|5559383|P2|Overall Study|data for less than 60 minutes|3
1596310|NCT02330055|5559384|P1|Overall Study|data for less than 60 minutes|3
1596311|NCT02330055|5559383|P2|Overall Study|participant forgot to wear device|5
1596312|NCT02330055|5559384|P1|Overall Study|participant forgot to wear device|5
1596313|NCT02330055|5559383|P2|Overall Study|technical issues|0
1596314|NCT02330055|5559384|P1|Overall Study|technical issues|2
1596315|NCT02329743|5559430|P3|Overall Study|Other|3
1596316|NCT02329743|5559431|P2|Overall Study|Other|2
1596317|NCT02329743|5559432|P1|Overall Study|Other|0
1596318|NCT02329743|5559430|P3|Overall Study|Withdrawal by Subject|1
1596319|NCT02329743|5559431|P2|Overall Study|Withdrawal by Subject|4
1596320|NCT02329743|5559432|P1|Overall Study|Withdrawal by Subject|4
1596321|NCT02329743|5559430|P3|Overall Study|Lost to Follow-up|1
1596322|NCT02329743|5559431|P2|Overall Study|Lost to Follow-up|0
1596323|NCT02329743|5559432|P1|Overall Study|Lost to Follow-up|1
1596324|NCT02329743|5559430|P3|Overall Study|Adverse Event|3
1596325|NCT02329743|5559431|P2|Overall Study|Adverse Event|1
1596326|NCT02329743|5559432|P1|Overall Study|Adverse Event|1
1596327|NCT02329730|5559447|P12|Overall Study|Withdrawal by Subject|0
1596328|NCT02329730|5559448|P11|Overall Study|Withdrawal by Subject|0
1596329|NCT02329730|5559449|P10|Overall Study|Withdrawal by Subject|1
1596330|NCT02329730|5559450|P9|Overall Study|Withdrawal by Subject|1
1596331|NCT02329730|5559451|P8|Overall Study|Withdrawal by Subject|1
1596332|NCT02329730|5559452|P7|Overall Study|Withdrawal by Subject|1
1596333|NCT02329730|5559453|P6|Overall Study|Withdrawal by Subject|0
1596334|NCT02329730|5559454|P5|Overall Study|Withdrawal by Subject|1
1596335|NCT02329730|5559455|P4|Overall Study|Withdrawal by Subject|0
1596336|NCT02329730|5559456|P3|Overall Study|Withdrawal by Subject|0
1596337|NCT02329730|5559457|P2|Overall Study|Withdrawal by Subject|0
1596338|NCT02329730|5559458|P1|Overall Study|Withdrawal by Subject|0
1596339|NCT02329730|5559447|P12|Overall Study|Protocol Violation|0
1596340|NCT02329730|5559448|P11|Overall Study|Protocol Violation|0
1596341|NCT02329730|5559449|P10|Overall Study|Protocol Violation|0
1596342|NCT02329730|5559450|P9|Overall Study|Protocol Violation|0
1596343|NCT02329730|5559451|P8|Overall Study|Protocol Violation|0
1596344|NCT02329730|5559452|P7|Overall Study|Protocol Violation|0
1596345|NCT02329730|5559453|P6|Overall Study|Protocol Violation|2
1596346|NCT02329730|5559454|P5|Overall Study|Protocol Violation|2
1596347|NCT02329730|5559455|P4|Overall Study|Protocol Violation|0
1596348|NCT02329730|5559456|P3|Overall Study|Protocol Violation|0
1596349|NCT02329730|5559457|P2|Overall Study|Protocol Violation|0
1596350|NCT02329730|5559458|P1|Overall Study|Protocol Violation|0
1596351|NCT02329431|5559569|P2|Overall Study|Lost to Follow-up|13
1596352|NCT02329431|5559570|P1|Overall Study|Lost to Follow-up|20
1596353|NCT02329223|5559589|P3|Overall Study|Adverse Event|0
1596354|NCT02329223|5559590|P2|Overall Study|Adverse Event|1
1596355|NCT02329223|5559591|P1|Overall Study|Adverse Event|0
1596356|NCT02329223|5559589|P3|Overall Study|Physician Decision|1
1596357|NCT02329223|5559590|P2|Overall Study|Physician Decision|0
1596358|NCT02329223|5559591|P1|Overall Study|Physician Decision|0
1596359|NCT02329223|5559589|P3|Overall Study|Withdrawal by Subject|5
1596360|NCT02329223|5559590|P2|Overall Study|Withdrawal by Subject|2
1596361|NCT02329223|5559591|P1|Overall Study|Withdrawal by Subject|1
1596362|NCT02328937|5559641|P6|Period 2|Adverse Event|0
1596363|NCT02328937|5559642|P5|Period 2|Adverse Event|0
1596364|NCT02328937|5559643|P4|Period 2|Adverse Event|0
1596365|NCT02328937|5559644|P3|Period 2|Adverse Event|1
1596366|NCT02328937|5559645|P2|Period 2|Adverse Event|0
1596367|NCT02328937|5559646|P1|Period 2|Adverse Event|0
1596368|NCT02328937|5559641|P6|Period 1|Lost to Follow-up|0
1596369|NCT02328937|5559642|P5|Period 1|Lost to Follow-up|0
1596370|NCT02328937|5559643|P4|Period 1|Lost to Follow-up|1
1596371|NCT02328937|5559644|P3|Period 1|Lost to Follow-up|0
1596372|NCT02328937|5559645|P2|Period 1|Lost to Follow-up|0
1596373|NCT02328937|5559646|P1|Period 1|Lost to Follow-up|0
1596374|NCT02328547|5559666|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
1596375|NCT02328547|5559667|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
1596376|NCT02328547|5559666|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
1596377|NCT02328547|5559667|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
1596378|NCT02328105|5559742|P1|Overall Study|Still On Study in Follow-Up|4
1596379|NCT02328105|5559742|P1|Overall Study|Withdrawal by Subject|1
1596380|NCT02328105|5559742|P1|Overall Study|Death|6
1596381|NCT02328040|5559747|P2|First Intervention (2 Days)|Withdrawal by Subject|1
1596382|NCT02328040|5559748|P1|First Intervention (2 Days)|Withdrawal by Subject|1
1596383|NCT02327325|5559779|P3|Overall Study|Excluded by Study Team|1
1596384|NCT02327325|5559780|P2|Overall Study|Excluded by Study Team|0
1596385|NCT02327325|5559781|P1|Overall Study|Excluded by Study Team|0
1596386|NCT02327325|5559779|P3|Overall Study|Withdrawal by Subject|4
1596387|NCT02327325|5559780|P2|Overall Study|Withdrawal by Subject|4
1596388|NCT02327325|5559781|P1|Overall Study|Withdrawal by Subject|1
1596389|NCT02327260|5559804|P3|Overall Study|cognitive concerns|0
1596390|NCT02327260|5559805|P2|Overall Study|cognitive concerns|0
1596391|NCT02327260|5559806|P1|Overall Study|cognitive concerns|1
1596392|NCT02327260|5559804|P3|Overall Study|non-adherence to protocol|0
1596393|NCT02327260|5559805|P2|Overall Study|non-adherence to protocol|0
1596394|NCT02327260|5559806|P1|Overall Study|non-adherence to protocol|2
1596395|NCT02327260|5559804|P3|Overall Study|invalid phone number|0
1596396|NCT02327260|5559805|P2|Overall Study|invalid phone number|1
1596397|NCT02327260|5559806|P1|Overall Study|invalid phone number|1
1596398|NCT02327260|5559804|P3|Overall Study|Lost to Follow-up|2
1596399|NCT02327260|5559805|P2|Overall Study|Lost to Follow-up|3
1596400|NCT02327260|5559806|P1|Overall Study|Lost to Follow-up|2
1596491|NCT02327130|5560097|P1|Overall Study|Met exclusion criteria|3
1596492|NCT02327130|5560097|P1|Overall Study|Incorrectly place ventilator adaptor|1
1596493|NCT02327130|5560097|P1|Overall Study|Unable to provide breath sample|1
1596494|NCT02327130|5560097|P1|Overall Study|Physician Decision|2
1596495|NCT02327130|5560097|P1|Overall Study|Discharged in less than 5 days|5
1596496|NCT02327013|5560116|P5|Overall Study|Withdrawal before treatment|0
1596497|NCT02327013|5560117|P4|Overall Study|Withdrawal before treatment|0
1596498|NCT02327013|5560118|P3|Overall Study|Withdrawal before treatment|5
1596499|NCT02327013|5560119|P2|Overall Study|Withdrawal before treatment|1
1596500|NCT02327013|5560120|P1|Overall Study|Withdrawal before treatment|2
1596501|NCT02327013|5560116|P5|Overall Study|Protocol Violation|1
1596502|NCT02327013|5560117|P4|Overall Study|Protocol Violation|0
1596503|NCT02327013|5560118|P3|Overall Study|Protocol Violation|3
1596504|NCT02327013|5560119|P2|Overall Study|Protocol Violation|0
1596505|NCT02327013|5560120|P1|Overall Study|Protocol Violation|0
1596506|NCT02327013|5560116|P5|Overall Study|Administrative or other reason(s)|1
1596507|NCT02327013|5560117|P4|Overall Study|Administrative or other reason(s)|1
1596508|NCT02327013|5560118|P3|Overall Study|Administrative or other reason(s)|11
1596509|NCT02327013|5560119|P2|Overall Study|Administrative or other reason(s)|5
1596510|NCT02327013|5560120|P1|Overall Study|Administrative or other reason(s)|1
1596511|NCT02327013|5560116|P5|Overall Study|Lost to Follow-up|0
1596512|NCT02327013|5560117|P4|Overall Study|Lost to Follow-up|0
1596513|NCT02327013|5560118|P3|Overall Study|Lost to Follow-up|5
1596514|NCT02327013|5560119|P2|Overall Study|Lost to Follow-up|4
1596515|NCT02327013|5560120|P1|Overall Study|Lost to Follow-up|2
1596516|NCT02327013|5560116|P5|Overall Study|Withdrawal of Consent|0
1596517|NCT02327013|5560117|P4|Overall Study|Withdrawal of Consent|0
1596518|NCT02327013|5560118|P3|Overall Study|Withdrawal of Consent|3
1596519|NCT02327013|5560119|P2|Overall Study|Withdrawal of Consent|0
1596520|NCT02327013|5560120|P1|Overall Study|Withdrawal of Consent|1
1596521|NCT02327013|5560116|P5|Overall Study|Non-compliance with IMP|0
1596522|NCT02327013|5560117|P4|Overall Study|Non-compliance with IMP|0
1596523|NCT02327013|5560118|P3|Overall Study|Non-compliance with IMP|7
1596524|NCT02327013|5560119|P2|Overall Study|Non-compliance with IMP|2
1596525|NCT02327013|5560120|P1|Overall Study|Non-compliance with IMP|1
1596526|NCT02327013|5560116|P5|Overall Study|Lack of Efficacy|1
1596527|NCT02327013|5560117|P4|Overall Study|Lack of Efficacy|0
1596528|NCT02327013|5560118|P3|Overall Study|Lack of Efficacy|5
1596529|NCT02327013|5560119|P2|Overall Study|Lack of Efficacy|0
1596530|NCT02327013|5560120|P1|Overall Study|Lack of Efficacy|2
1596531|NCT02327013|5560116|P5|Overall Study|Adverse Event|1
1596532|NCT02327013|5560117|P4|Overall Study|Adverse Event|0
1596533|NCT02327013|5560118|P3|Overall Study|Adverse Event|3
1596534|NCT02327013|5560119|P2|Overall Study|Adverse Event|4
1596535|NCT02327013|5560120|P1|Overall Study|Adverse Event|4
1596536|NCT02326597|5560306|P2|Overall Study|Lost to Follow-up|32
1596537|NCT02326597|5560307|P1|Overall Study|Lost to Follow-up|42
1596538|NCT02326298|5560328|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
1596539|NCT02326298|5560329|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
1596540|NCT02326298|5560330|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
1596541|NCT02326298|5560331|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596542|NCT02326298|5560332|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596543|NCT02326298|5560333|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596544|NCT02326298|5560334|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596545|NCT02326298|5560335|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596546|NCT02326298|5560336|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596547|NCT02326298|5560337|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596548|NCT02326298|5560338|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596549|NCT02326298|5560339|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596550|NCT02326298|5560340|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596551|NCT02326298|5560341|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596552|NCT02326298|5560328|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
1596553|NCT02326298|5560329|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
1596554|NCT02326298|5560330|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
1596555|NCT02326298|5560331|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596556|NCT02326298|5560332|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596557|NCT02326298|5560333|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596558|NCT02326298|5560334|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596559|NCT02326298|5560335|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596560|NCT02326298|5560336|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596561|NCT02326298|5560337|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596562|NCT02326298|5560338|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596563|NCT02326298|5560339|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596564|NCT02326298|5560340|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596565|NCT02326298|5560341|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596566|NCT02326298|5560328|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
1596567|NCT02326298|5560329|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
1596568|NCT02326298|5560330|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
1596569|NCT02326298|5560331|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596570|NCT02326298|5560332|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596571|NCT02326298|5560333|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596572|NCT02326298|5560334|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596573|NCT02326298|5560335|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596574|NCT02326298|5560336|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596575|NCT02326298|5560337|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596576|NCT02326298|5560338|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596577|NCT02326298|5560339|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596578|NCT02326298|5560340|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596579|NCT02326298|5560341|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596580|NCT02326298|5560328|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
1596581|NCT02326298|5560329|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596582|NCT02326298|5560330|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596583|NCT02326298|5560331|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596584|NCT02326298|5560332|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596585|NCT02326298|5560333|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596586|NCT02326298|5560334|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596587|NCT02326298|5560335|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596588|NCT02326298|5560336|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596589|NCT02326298|5560337|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596590|NCT02326298|5560338|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596591|NCT02326298|5560339|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596592|NCT02326298|5560340|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596593|NCT02326298|5560341|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596594|NCT02326298|5560328|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596595|NCT02326298|5560329|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1596596|NCT02326298|5560330|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1596597|NCT02326298|5560331|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596598|NCT02326298|5560332|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596599|NCT02326298|5560333|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596600|NCT02326298|5560334|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596601|NCT02326298|5560335|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596602|NCT02326298|5560336|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596603|NCT02326298|5560337|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596604|NCT02326298|5560338|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596605|NCT02326298|5560339|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596606|NCT02326298|5560340|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596607|NCT02326298|5560341|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596608|NCT02326298|5560328|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596609|NCT02326298|5560329|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
1596610|NCT02326298|5560330|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
1596611|NCT02326298|5560331|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596612|NCT02326298|5560332|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596613|NCT02326298|5560333|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596614|NCT02326298|5560334|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596615|NCT02326298|5560335|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596616|NCT02326298|5560336|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596617|NCT02326298|5560337|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596618|NCT02326298|5560338|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596619|NCT02326298|5560339|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596620|NCT02326298|5560340|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596621|NCT02326298|5560341|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596622|NCT02326298|5560328|P14|Open-label Period (Week 48 to Week 144)|Death|0
1596623|NCT02326298|5560329|P13|Open-label Period (Week 48 to Week 144)|Death|0
1596624|NCT02326298|5560330|P12|Open-label Period (Week 48 to Week 144)|Death|1
1596625|NCT02326298|5560331|P11|Open-label Period (Week 48 to Week 144)|Death|0
1596626|NCT02326298|5560332|P10|Open-label Period (Week 48 to Week 144)|Death|0
1596627|NCT02326298|5560333|P9|Open-label Period (Week 48 to Week 144)|Death|0
1596628|NCT02326298|5560334|P8|Open-label Period (Week 48 to Week 144)|Death|0
1596629|NCT02326298|5560335|P7|Open-label Period (Week 48 to Week 144)|Death|0
1596630|NCT02326298|5560336|P6|Open-label Period (Week 48 to Week 144)|Death|0
1596631|NCT02326298|5560337|P5|Open-label Period (Week 48 to Week 144)|Death|0
1596632|NCT02326298|5560338|P4|Open-label Period (Week 48 to Week 144)|Death|0
1596633|NCT02326298|5560339|P3|Open-label Period (Week 48 to Week 144)|Death|0
1596634|NCT02326298|5560340|P2|Open-label Period (Week 48 to Week 144)|Death|0
1596635|NCT02326298|5560341|P1|Open-label Period (Week 48 to Week 144)|Death|0
1596636|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596637|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596638|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596639|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596640|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596641|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596642|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596643|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596644|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
1596645|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596646|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596647|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596648|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596649|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
1596650|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596651|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596652|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596653|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596654|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596655|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596656|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1596657|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596658|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596659|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596660|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596661|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596662|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596663|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1596664|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596665|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596666|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596667|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596668|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596669|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596670|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1596671|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
1596672|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596673|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596674|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596675|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596676|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596677|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1596678|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596679|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596680|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596681|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596682|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596683|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596684|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
1596685|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596686|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596687|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596688|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596689|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596690|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596691|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
1596692|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596693|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596694|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596695|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596696|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596697|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596698|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596699|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
1596700|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596701|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596702|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596703|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596704|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596705|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1596706|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596707|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596708|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596709|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596710|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596711|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596712|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596713|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596714|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
1596715|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596716|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596717|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596718|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596719|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
1596720|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1597444|NCT02322749|5561135|P6|Period 2|Withdrawal by Subject|0
1596721|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596722|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596723|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596724|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596725|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
1596726|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596727|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
1596728|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
1596729|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596730|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596731|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596732|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596733|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
1596734|NCT02326298|5560328|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596735|NCT02326298|5560329|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596736|NCT02326298|5560330|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596737|NCT02326298|5560331|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596738|NCT02326298|5560332|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1596739|NCT02326298|5560333|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1596740|NCT02326298|5560334|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1596741|NCT02326298|5560335|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
1596742|NCT02326298|5560336|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1596743|NCT02326298|5560337|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596744|NCT02326298|5560338|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596745|NCT02326298|5560339|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596746|NCT02326298|5560340|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596747|NCT02326298|5560341|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1596748|NCT02326298|5560328|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596749|NCT02326298|5560329|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596750|NCT02326298|5560330|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596751|NCT02326298|5560331|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596752|NCT02326298|5560332|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596753|NCT02326298|5560333|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596754|NCT02326298|5560334|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596755|NCT02326298|5560335|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596756|NCT02326298|5560336|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596757|NCT02326298|5560337|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596758|NCT02326298|5560338|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596759|NCT02326298|5560339|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
1596760|NCT02326298|5560340|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596761|NCT02326298|5560341|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
1596762|NCT02326298|5560328|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596763|NCT02326298|5560329|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596764|NCT02326298|5560330|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596765|NCT02326298|5560331|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596766|NCT02326298|5560332|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596767|NCT02326298|5560333|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596768|NCT02326298|5560334|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596769|NCT02326298|5560335|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596770|NCT02326298|5560336|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596771|NCT02326298|5560337|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596772|NCT02326298|5560338|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596773|NCT02326298|5560339|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1596774|NCT02326298|5560340|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
1596775|NCT02326298|5560341|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
1596776|NCT02326298|5560328|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596777|NCT02326298|5560329|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596778|NCT02326298|5560330|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596779|NCT02326298|5560331|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596780|NCT02326298|5560332|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596781|NCT02326298|5560333|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596782|NCT02326298|5560334|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596783|NCT02326298|5560335|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596784|NCT02326298|5560336|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596785|NCT02326298|5560337|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596786|NCT02326298|5560338|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596787|NCT02326298|5560339|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1596788|NCT02326298|5560340|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1596789|NCT02326298|5560341|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1596790|NCT02326298|5560328|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596791|NCT02326298|5560329|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596792|NCT02326298|5560330|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596793|NCT02326298|5560331|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596794|NCT02326298|5560332|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596795|NCT02326298|5560333|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596796|NCT02326298|5560334|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596797|NCT02326298|5560335|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596798|NCT02326298|5560336|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596799|NCT02326298|5560337|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596800|NCT02326298|5560338|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596801|NCT02326298|5560339|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596802|NCT02326298|5560340|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
1596803|NCT02326298|5560341|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
1596804|NCT02326298|5560328|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596805|NCT02326298|5560329|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596806|NCT02326298|5560330|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596807|NCT02326298|5560331|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596808|NCT02326298|5560332|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596809|NCT02326298|5560333|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596810|NCT02326298|5560334|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596811|NCT02326298|5560335|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596812|NCT02326298|5560336|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596813|NCT02326298|5560337|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596814|NCT02326298|5560338|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596815|NCT02326298|5560339|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
1596816|NCT02326298|5560340|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596817|NCT02326298|5560341|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
1596818|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596819|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596820|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
1596821|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596822|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596823|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596824|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596825|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596826|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596827|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596828|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596829|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596830|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596831|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596832|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
1596833|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596834|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596835|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596836|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
1596837|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596838|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596839|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596840|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596841|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596842|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596843|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596844|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596845|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596846|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596847|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
1596848|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
1596849|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596850|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
1596851|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
1596852|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596853|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596854|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596855|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596856|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596857|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1597445|NCT02322749|5561136|P5|Period 2|Withdrawal by Subject|0
1596858|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596859|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596860|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596861|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596862|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
1596863|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
1596864|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596865|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596866|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
1596867|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596868|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596869|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596870|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596871|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596872|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596873|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596874|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596875|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596876|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596877|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
1596878|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
1596879|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596880|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
1596881|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596882|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
1596883|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596884|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596885|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596886|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596887|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596888|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596889|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596890|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596891|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596892|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
1596893|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596894|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596895|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596896|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
1596897|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596898|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596899|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596900|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596901|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596902|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596903|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596904|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596905|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596906|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596907|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
1596908|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596909|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596910|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1596911|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596912|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
1596913|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596914|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596915|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596916|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596917|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596918|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596919|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596920|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596921|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596922|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
1596923|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
1596924|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596925|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
1596926|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
1596927|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
1596928|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596929|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596930|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596931|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596932|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596933|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596934|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596935|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596936|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596937|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
1596938|NCT02326272|5560364|P15|Open-label Period (Week 48 to Week 144)|Death|0
1596939|NCT02326272|5560365|P14|Open-label Period (Week 48 to Week 144)|Death|0
1596940|NCT02326272|5560366|P13|Open-label Period (Week 48 to Week 144)|Death|1
1596941|NCT02326272|5560367|P12|Open-label Period (Week 48 to Week 144)|Death|0
1596942|NCT02326272|5560368|P11|Open-label Period (Week 48 to Week 144)|Death|0
1596943|NCT02326272|5560369|P10|Open-label Period (Week 48 to Week 144)|Death|0
1596944|NCT02326272|5560370|P9|Open-label Period (Week 48 to Week 144)|Death|0
1596945|NCT02326272|5560371|P8|Open-label Period (Week 48 to Week 144)|Death|0
1596946|NCT02326272|5560372|P7|Open-label Period (Week 48 to Week 144)|Death|0
1596947|NCT02326272|5560373|P6|Open-label Period (Week 48 to Week 144)|Death|0
1596948|NCT02326272|5560374|P5|Open-label Period (Week 48 to Week 144)|Death|0
1596949|NCT02326272|5560375|P4|Open-label Period (Week 48 to Week 144)|Death|0
1596950|NCT02326272|5560376|P3|Open-label Period (Week 48 to Week 144)|Death|0
1596951|NCT02326272|5560377|P2|Open-label Period (Week 48 to Week 144)|Death|0
1596952|NCT02326272|5560378|P1|Open-label Period (Week 48 to Week 144)|Death|0
1596953|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596954|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596955|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596956|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596957|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596958|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596959|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596960|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596961|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
1596962|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596963|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596964|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596965|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596966|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596967|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
1596968|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596969|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596970|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596971|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596972|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596973|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596974|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596975|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596976|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596977|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
1596978|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596979|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596980|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596981|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596982|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
1596983|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596984|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596985|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596986|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596987|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596988|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596989|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1596990|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1596991|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
1596992|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
1596993|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596994|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596995|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596996|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596997|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
1596998|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1596999|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597000|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597001|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597002|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597003|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597004|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
1597005|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597006|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597007|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597008|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597009|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597010|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597011|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597012|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
1597013|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597014|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597015|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597016|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597017|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597018|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597019|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597020|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597021|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
1597022|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597023|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597024|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597025|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597026|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597027|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
1597028|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597029|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597030|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597031|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597032|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597033|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597034|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597035|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
1597036|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597037|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597038|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597039|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597040|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597041|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597042|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
1597043|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597044|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597045|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597046|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597047|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597048|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1597049|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597050|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1597051|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1597052|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
1597053|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597054|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
1597055|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597056|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597057|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
1597058|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597059|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597060|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597061|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597062|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597063|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597064|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597065|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1597066|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597067|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
1597068|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597069|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597070|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597071|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597072|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
1597073|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597074|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597075|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597076|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597077|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597078|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1597079|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1597080|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597081|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
1597082|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
1597083|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597084|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597085|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597086|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597087|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
1597088|NCT02326272|5560364|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597089|NCT02326272|5560365|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597090|NCT02326272|5560366|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597091|NCT02326272|5560367|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597092|NCT02326272|5560368|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597093|NCT02326272|5560369|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597094|NCT02326272|5560370|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
1597095|NCT02326272|5560371|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1597096|NCT02326272|5560372|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
1597097|NCT02326272|5560373|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
1597098|NCT02326272|5560374|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
1597099|NCT02326272|5560375|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597100|NCT02326272|5560376|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597101|NCT02326272|5560377|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597102|NCT02326272|5560378|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
1597103|NCT02326272|5560364|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597104|NCT02326272|5560365|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597105|NCT02326272|5560366|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597106|NCT02326272|5560367|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597107|NCT02326272|5560368|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597108|NCT02326272|5560369|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597109|NCT02326272|5560370|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597110|NCT02326272|5560371|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597111|NCT02326272|5560372|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597112|NCT02326272|5560373|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597113|NCT02326272|5560374|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597114|NCT02326272|5560375|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597115|NCT02326272|5560376|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
1597116|NCT02326272|5560377|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597117|NCT02326272|5560378|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
1597118|NCT02326272|5560364|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597119|NCT02326272|5560365|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597120|NCT02326272|5560366|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597121|NCT02326272|5560367|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597122|NCT02326272|5560368|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597123|NCT02326272|5560369|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597124|NCT02326272|5560370|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597125|NCT02326272|5560371|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597126|NCT02326272|5560372|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597127|NCT02326272|5560373|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597446|NCT02322749|5561137|P4|Period 2|Withdrawal by Subject|1
1597128|NCT02326272|5560374|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597129|NCT02326272|5560375|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597130|NCT02326272|5560376|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
1597131|NCT02326272|5560377|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597132|NCT02326272|5560378|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
1597133|NCT02326272|5560364|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597134|NCT02326272|5560365|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597135|NCT02326272|5560366|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597136|NCT02326272|5560367|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597137|NCT02326272|5560368|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597138|NCT02326272|5560369|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597139|NCT02326272|5560370|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597140|NCT02326272|5560371|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597141|NCT02326272|5560372|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597142|NCT02326272|5560373|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597143|NCT02326272|5560374|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597144|NCT02326272|5560375|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597145|NCT02326272|5560376|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
1597146|NCT02326272|5560377|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597147|NCT02326272|5560378|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
1597148|NCT02326272|5560364|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597149|NCT02326272|5560365|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597150|NCT02326272|5560366|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597151|NCT02326272|5560367|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597152|NCT02326272|5560368|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597153|NCT02326272|5560369|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597154|NCT02326272|5560370|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597155|NCT02326272|5560371|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597156|NCT02326272|5560372|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597157|NCT02326272|5560373|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597158|NCT02326272|5560374|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597159|NCT02326272|5560375|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597160|NCT02326272|5560376|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
1597161|NCT02326272|5560377|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597162|NCT02326272|5560378|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
1597163|NCT02326272|5560364|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597164|NCT02326272|5560365|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597165|NCT02326272|5560366|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597166|NCT02326272|5560367|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597167|NCT02326272|5560368|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597168|NCT02326272|5560369|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597169|NCT02326272|5560370|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597170|NCT02326272|5560371|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597171|NCT02326272|5560372|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597172|NCT02326272|5560373|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597173|NCT02326272|5560374|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597174|NCT02326272|5560375|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
1597175|NCT02326272|5560376|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
1597176|NCT02326272|5560377|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
1597177|NCT02326272|5560378|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
1597178|NCT02326272|5560364|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597179|NCT02326272|5560365|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597180|NCT02326272|5560366|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597181|NCT02326272|5560367|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597182|NCT02326272|5560368|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597183|NCT02326272|5560369|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597184|NCT02326272|5560370|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597185|NCT02326272|5560371|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597186|NCT02326272|5560372|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597187|NCT02326272|5560373|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597188|NCT02326272|5560374|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597189|NCT02326272|5560375|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597190|NCT02326272|5560376|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
1597191|NCT02326272|5560377|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
1597192|NCT02326272|5560378|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
1597193|NCT02326272|5560364|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597194|NCT02326272|5560365|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597195|NCT02326272|5560366|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597196|NCT02326272|5560367|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597197|NCT02326272|5560368|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597198|NCT02326272|5560369|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597199|NCT02326272|5560370|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597200|NCT02326272|5560371|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597201|NCT02326272|5560372|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597202|NCT02326272|5560373|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597203|NCT02326272|5560374|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597204|NCT02326272|5560375|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597205|NCT02326272|5560376|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
1597206|NCT02326272|5560377|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
1597207|NCT02326272|5560378|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
1597208|NCT02326025|5560415|P2|Overall Study|Protocol Violation|1
1597209|NCT02326025|5560416|P1|Overall Study|Protocol Violation|0
1597210|NCT02326025|5560415|P2|Overall Study|Withdrawal by Subject|2
1597211|NCT02326025|5560416|P1|Overall Study|Withdrawal by Subject|0
1597212|NCT02326025|5560415|P2|Overall Study|Physician and Participant Decision|0
1597213|NCT02326025|5560416|P1|Overall Study|Physician and Participant Decision|1
1597214|NCT02326025|5560415|P2|Overall Study|Physician Decision|2
1597215|NCT02326025|5560416|P1|Overall Study|Physician Decision|1
1597216|NCT02326025|5560415|P2|Overall Study|Adverse Event|0
1597217|NCT02326025|5560416|P1|Overall Study|Adverse Event|3
1597218|NCT02325791|5560463|P4|Overall Study|Withdrawal by Subject|16
1597219|NCT02325791|5560464|P3|Overall Study|Withdrawal by Subject|8
1597220|NCT02325791|5560465|P2|Overall Study|Withdrawal by Subject|5
1597221|NCT02325791|5560466|P1|Overall Study|Withdrawal by Subject|0
1597222|NCT02325791|5560463|P4|Overall Study|Protocol Violation|0
1597223|NCT02325791|5560464|P3|Overall Study|Protocol Violation|1
1597224|NCT02325791|5560465|P2|Overall Study|Protocol Violation|0
1597225|NCT02325791|5560466|P1|Overall Study|Protocol Violation|0
1597226|NCT02325791|5560463|P4|Overall Study|Physician Decision|0
1597227|NCT02325791|5560464|P3|Overall Study|Physician Decision|1
1597228|NCT02325791|5560465|P2|Overall Study|Physician Decision|1
1597229|NCT02325791|5560466|P1|Overall Study|Physician Decision|0
1597230|NCT02325791|5560463|P4|Overall Study|Lost to Follow-up|9
1597231|NCT02325791|5560464|P3|Overall Study|Lost to Follow-up|14
1597232|NCT02325791|5560465|P2|Overall Study|Lost to Follow-up|15
1597233|NCT02325791|5560466|P1|Overall Study|Lost to Follow-up|0
1597234|NCT02325791|5560463|P4|Overall Study|Death|1
1597235|NCT02325791|5560464|P3|Overall Study|Death|0
1597236|NCT02325791|5560465|P2|Overall Study|Death|3
1597237|NCT02325791|5560466|P1|Overall Study|Death|0
1597238|NCT02325791|5560463|P4|Overall Study|Adverse Event|0
1597239|NCT02325791|5560464|P3|Overall Study|Adverse Event|1
1597240|NCT02325791|5560465|P2|Overall Study|Adverse Event|1
1597241|NCT02325791|5560466|P1|Overall Study|Adverse Event|0
1597242|NCT02325713|5560501|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597243|NCT02325713|5560502|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597244|NCT02325713|5560503|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597245|NCT02325713|5560504|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597246|NCT02325713|5560505|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597247|NCT02325713|5560506|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597248|NCT02325713|5560507|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
1597249|NCT02325713|5560508|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597250|NCT02325713|5560509|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597251|NCT02325713|5560510|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597252|NCT02325713|5560511|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597253|NCT02325713|5560512|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597254|NCT02325713|5560513|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597255|NCT02325713|5560514|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597256|NCT02325713|5560515|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597257|NCT02325713|5560516|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
1597258|NCT02325713|5560501|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597259|NCT02325713|5560502|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597260|NCT02325713|5560503|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597261|NCT02325713|5560504|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597262|NCT02325713|5560505|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597263|NCT02325713|5560506|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597264|NCT02325713|5560507|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597265|NCT02325713|5560508|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597266|NCT02325713|5560509|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597267|NCT02325713|5560510|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597268|NCT02325713|5560511|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597269|NCT02325713|5560512|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597270|NCT02325713|5560513|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597271|NCT02325713|5560514|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597272|NCT02325713|5560515|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
1597273|NCT02325713|5560516|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
1597274|NCT02325713|5560501|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597275|NCT02325713|5560502|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597276|NCT02325713|5560503|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597277|NCT02325713|5560504|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597278|NCT02325713|5560505|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597279|NCT02325713|5560506|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
1597280|NCT02325713|5560507|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597281|NCT02325713|5560508|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597282|NCT02325713|5560509|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597283|NCT02325713|5560510|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597284|NCT02325713|5560511|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597285|NCT02325713|5560512|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597286|NCT02325713|5560513|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597287|NCT02325713|5560514|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597288|NCT02325713|5560515|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597289|NCT02325713|5560516|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
1597290|NCT02325518|5560611|P2|Overall Study|Withdrawal by Subject|1
1597291|NCT02325518|5560612|P1|Overall Study|Withdrawal by Subject|0
1597292|NCT02325518|5560611|P2|Overall Study|Physician Decision|1
1597293|NCT02325518|5560612|P1|Overall Study|Physician Decision|0
1597294|NCT02325518|5560611|P2|Overall Study|Adverse Event|1
1597295|NCT02325518|5560612|P1|Overall Study|Adverse Event|4
1597296|NCT02324842|5560641|P3|Overall Study|Lost to Follow-up|2
1597297|NCT02324842|5560642|P2|Overall Study|Lost to Follow-up|1
1597298|NCT02324842|5560643|P1|Overall Study|Lost to Follow-up|1
1597299|NCT02324699|5560672|P1|Overall Study|study terminated|1
1597300|NCT02324569|5560792|P2|Overall Study|Inconvenient Schedule|0
1597301|NCT02324569|5560793|P1|Overall Study|Inconvenient Schedule|2
1597302|NCT02324569|5560792|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
1597303|NCT02324569|5560793|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
1597304|NCT02324569|5560792|P2|Overall Study|Lack of Efficacy|3
1597305|NCT02324569|5560793|P1|Overall Study|Lack of Efficacy|2
1597306|NCT02324569|5560792|P2|Overall Study|Voluntary Withdrawal|6
1597307|NCT02324569|5560793|P1|Overall Study|Voluntary Withdrawal|3
1597308|NCT02324569|5560792|P2|Overall Study|Pretreatment Event/Adverse Event|10
1597309|NCT02324569|5560793|P1|Overall Study|Pretreatment Event/Adverse Event|9
1597310|NCT02324465|5560826|P2|Overall Study|device failure|1
1597311|NCT02324465|5560827|P1|Overall Study|device failure|0
1597312|NCT02324205|5560854|P1|Overall Study|Withdrawal by Subject|37
1597313|NCT02324049|5560885|P1|Part C|Study terminated|11
1597314|NCT02323646|5560898|P3|Treatment Course 2|Non-compliance|1
1597315|NCT02323646|5560899|P2|Treatment Course 2|Non-compliance|1
1597316|NCT02323646|5560900|P1|Treatment Course 2|Non-compliance|0
1597317|NCT02323646|5560898|P3|Treatment Course 2|Lost to Follow-up|1
1597318|NCT02323646|5560899|P2|Treatment Course 2|Lost to Follow-up|0
1597319|NCT02323646|5560900|P1|Treatment Course 2|Lost to Follow-up|0
1597320|NCT02323646|5560898|P3|Treatment Course 2|Adverse Event|1
1597321|NCT02323646|5560899|P2|Treatment Course 2|Adverse Event|0
1597322|NCT02323646|5560900|P1|Treatment Course 2|Adverse Event|1
1597323|NCT02323646|5560898|P3|Treatment Course 1|Withdrawal by Subject|0
1597324|NCT02323646|5560899|P2|Treatment Course 1|Withdrawal by Subject|2
1597325|NCT02323646|5560900|P1|Treatment Course 1|Withdrawal by Subject|0
1597326|NCT02323646|5560898|P3|Treatment Course 1|Lost to Follow-up|2
1597327|NCT02323646|5560899|P2|Treatment Course 1|Lost to Follow-up|0
1597328|NCT02323646|5560900|P1|Treatment Course 1|Lost to Follow-up|1
1597329|NCT02323646|5560898|P3|Treatment Course 1|Heavy Bleeding|0
1597330|NCT02323646|5560899|P2|Treatment Course 1|Heavy Bleeding|1
1597331|NCT02323646|5560900|P1|Treatment Course 1|Heavy Bleeding|1
1597332|NCT02323646|5560898|P3|Treatment Course 1|Adverse Event|1
1597333|NCT02323646|5560899|P2|Treatment Course 1|Adverse Event|0
1597334|NCT02323646|5560900|P1|Treatment Course 1|Adverse Event|1
1597335|NCT02323204|5560948|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
1597336|NCT02323204|5560949|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
1597337|NCT02323204|5560950|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
1597338|NCT02323204|5560951|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
1597339|NCT02323204|5560948|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
1597340|NCT02323204|5560949|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
1597341|NCT02323204|5560950|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
1597342|NCT02323204|5560951|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
1597343|NCT02323204|5560948|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
1597344|NCT02323204|5560949|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
1597345|NCT02323204|5560950|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
1597346|NCT02323204|5560951|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
1597347|NCT02323204|5560948|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
1597348|NCT02323204|5560949|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
1597349|NCT02323204|5560950|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
1597350|NCT02323204|5560951|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
1597351|NCT02323204|5560948|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
1597352|NCT02323204|5560949|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
1597353|NCT02323204|5560950|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
1597354|NCT02323204|5560951|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
1597355|NCT02323204|5560948|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
1597356|NCT02323204|5560949|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
1597357|NCT02323204|5560950|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
1597358|NCT02323204|5560951|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
1597359|NCT02323204|5560948|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
1597360|NCT02323204|5560949|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
1597361|NCT02323204|5560950|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
1597362|NCT02323204|5560951|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
1597363|NCT02323204|5560948|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
1597364|NCT02323204|5560949|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
1597365|NCT02323204|5560950|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
1597366|NCT02323204|5560951|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
1597367|NCT02323204|5560948|P4|Baseline Survey Completion|Withdrawal by Subject|3
1597368|NCT02323204|5560949|P3|Baseline Survey Completion|Withdrawal by Subject|5
1597369|NCT02323204|5560950|P2|Baseline Survey Completion|Withdrawal by Subject|9
1597370|NCT02323204|5560951|P1|Baseline Survey Completion|Withdrawal by Subject|10
1597371|NCT02322892|5561024|P2|Overall Study|Protocol Violation|0
1597372|NCT02322892|5561025|P1|Overall Study|Protocol Violation|1
1597373|NCT02322892|5561024|P2|Overall Study|Met exclusion criteria|1
1597374|NCT02322892|5561025|P1|Overall Study|Met exclusion criteria|0
1597375|NCT02322892|5561024|P2|Overall Study|Surgery cancelled|2
1597376|NCT02322892|5561025|P1|Overall Study|Surgery cancelled|1
1597377|NCT02322879|5561041|P2|First Intervention|Physician Decision|0
1597378|NCT02322879|5561042|P1|First Intervention|Physician Decision|1
1597379|NCT02322866|5561050|P2|Overall Study|Other Miscellaneous Reasons|6
1597380|NCT02322866|5561051|P1|Overall Study|Other Miscellaneous Reasons|6
1597381|NCT02322866|5561050|P2|Overall Study|Lack of Efficacy|1
1597382|NCT02322866|5561051|P1|Overall Study|Lack of Efficacy|3
1597383|NCT02322866|5561050|P2|Overall Study|Noncompliance with Treatment|4
1597384|NCT02322866|5561051|P1|Overall Study|Noncompliance with Treatment|3
1597385|NCT02322866|5561050|P2|Overall Study|Protocol Violation|0
1597386|NCT02322866|5561051|P1|Overall Study|Protocol Violation|1
1597387|NCT02322866|5561050|P2|Overall Study|Lost to Follow-up|39
1597388|NCT02322866|5561051|P1|Overall Study|Lost to Follow-up|36
1597389|NCT02322866|5561050|P2|Overall Study|Withdrawal of Consent|25
1597390|NCT02322866|5561051|P1|Overall Study|Withdrawal of Consent|16
1597391|NCT02322866|5561050|P2|Overall Study|Adverse Event|11
1597392|NCT02322866|5561051|P1|Overall Study|Adverse Event|6
1597393|NCT02322814|5561078|P5|Overall Study|Withdrawal by Subject|3
1597394|NCT02322814|5561079|P4|Overall Study|Withdrawal by Subject|1
1597395|NCT02322814|5561080|P3|Overall Study|Withdrawal by Subject|2
1597396|NCT02322814|5561081|P2|Overall Study|Withdrawal by Subject|4
1597397|NCT02322814|5561082|P1|Overall Study|Withdrawal by Subject|5
1597398|NCT02322814|5561078|P5|Overall Study|Death|6
1597399|NCT02322814|5561079|P4|Overall Study|Death|10
1597400|NCT02322814|5561080|P3|Overall Study|Death|30
1597401|NCT02322814|5561081|P2|Overall Study|Death|22
1597402|NCT02322814|5561082|P1|Overall Study|Death|7
1597403|NCT02322814|5561078|P5|Overall Study|Protocol Violation|0
1597404|NCT02322814|5561079|P4|Overall Study|Protocol Violation|0
1597405|NCT02322814|5561080|P3|Overall Study|Protocol Violation|0
1597406|NCT02322814|5561081|P2|Overall Study|Protocol Violation|0
1597407|NCT02322814|5561082|P1|Overall Study|Protocol Violation|1
1597408|NCT02322814|5561078|P5|Overall Study|Other|0
1597409|NCT02322814|5561079|P4|Overall Study|Other|0
1597410|NCT02322814|5561080|P3|Overall Study|Other|0
1597411|NCT02322814|5561081|P2|Overall Study|Other|0
1597412|NCT02322814|5561082|P1|Overall Study|Other|2
1597413|NCT02322814|5561078|P5|Overall Study|Lost to Follow-up|0
1597414|NCT02322814|5561079|P4|Overall Study|Lost to Follow-up|0
1597415|NCT02322814|5561080|P3|Overall Study|Lost to Follow-up|1
1597416|NCT02322814|5561081|P2|Overall Study|Lost to Follow-up|2
1597417|NCT02322814|5561082|P1|Overall Study|Lost to Follow-up|1
1597418|NCT02322814|5561078|P5|Overall Study|Progressive Disease|0
1597419|NCT02322814|5561079|P4|Overall Study|Progressive Disease|1
1597420|NCT02322814|5561080|P3|Overall Study|Progressive Disease|0
1597421|NCT02322814|5561081|P2|Overall Study|Progressive Disease|2
1597422|NCT02322814|5561082|P1|Overall Study|Progressive Disease|0
1597423|NCT02322814|5561078|P5|Overall Study|Ongoing Study|22
1597424|NCT02322814|5561079|P4|Overall Study|Ongoing Study|20
1597425|NCT02322814|5561080|P3|Overall Study|Ongoing Study|14
1597426|NCT02322814|5561081|P2|Overall Study|Ongoing Study|13
1597427|NCT02322814|5561082|P1|Overall Study|Ongoing Study|0
1597428|NCT02322775|5561108|P2|Overall Study|Not willing to perform all FU visits|1
1597429|NCT02322775|5561109|P1|Overall Study|Not willing to perform all FU visits|0
1597430|NCT02322775|5561108|P2|Overall Study|Withdrawal by Subject|4
1597431|NCT02322775|5561109|P1|Overall Study|Withdrawal by Subject|3
1597432|NCT02322775|5561108|P2|Overall Study|Protocol Violation|0
1597433|NCT02322775|5561109|P1|Overall Study|Protocol Violation|1
1597434|NCT02322775|5561108|P2|Overall Study|Lost to Follow-up|1
1597435|NCT02322775|5561109|P1|Overall Study|Lost to Follow-up|0
1597436|NCT02322775|5561108|P2|Overall Study|Adverse Event|0
1597437|NCT02322775|5561109|P1|Overall Study|Adverse Event|1
1597438|NCT02322749|5561135|P6|Period 3|Withdrawal by Subject|0
1597439|NCT02322749|5561136|P5|Period 3|Withdrawal by Subject|0
1597440|NCT02322749|5561137|P4|Period 3|Withdrawal by Subject|0
1597441|NCT02322749|5561138|P3|Period 3|Withdrawal by Subject|1
1597442|NCT02322749|5561139|P2|Period 3|Withdrawal by Subject|0
1597443|NCT02322749|5561140|P1|Period 3|Withdrawal by Subject|0
1597447|NCT02322749|5561138|P3|Period 2|Withdrawal by Subject|0
1597448|NCT02322749|5561139|P2|Period 2|Withdrawal by Subject|0
1597449|NCT02322749|5561140|P1|Period 2|Withdrawal by Subject|0
1597450|NCT02322749|5561135|P6|Period 2|Adverse Event|0
1597451|NCT02322749|5561136|P5|Period 2|Adverse Event|0
1597452|NCT02322749|5561137|P4|Period 2|Adverse Event|1
1597453|NCT02322749|5561138|P3|Period 2|Adverse Event|0
1597454|NCT02322749|5561139|P2|Period 2|Adverse Event|0
1597455|NCT02322749|5561140|P1|Period 2|Adverse Event|0
1597456|NCT02322710|5561165|P2|Overall Study|Protocol Violation|25
1597457|NCT02322710|5561166|P1|Overall Study|Protocol Violation|20
1597458|NCT02322710|5561165|P2|Overall Study|No efficacy assessment post-baseline|1
1597459|NCT02322710|5561166|P1|Overall Study|No efficacy assessment post-baseline|0
1597460|NCT02322411|5561179|P2|Overall Study|Lost to Follow-up|7
1597461|NCT02322411|5561180|P1|Overall Study|Lost to Follow-up|4
1597462|NCT02322281|5561199|P3|Overall Study|Miscellaneous|4
1597463|NCT02322281|5561200|P2|Overall Study|Miscellaneous|0
1597464|NCT02322281|5561201|P1|Overall Study|Miscellaneous|0
1597465|NCT02322281|5561199|P3|Overall Study|Missing|1
1597466|NCT02322281|5561200|P2|Overall Study|Missing|0
1597467|NCT02322281|5561201|P1|Overall Study|Missing|0
1597468|NCT02322281|5561199|P3|Overall Study|Study Terminated by Sponsor|0
1597469|NCT02322281|5561200|P2|Overall Study|Study Terminated by Sponsor|0
1597470|NCT02322281|5561201|P1|Overall Study|Study Terminated by Sponsor|2
1597471|NCT02322281|5561199|P3|Overall Study|Physician Decision|5
1597472|NCT02322281|5561200|P2|Overall Study|Physician Decision|0
1597473|NCT02322281|5561201|P1|Overall Study|Physician Decision|2
1597474|NCT02322281|5561199|P3|Overall Study|Withdrawal by Subject|6
1597475|NCT02322281|5561200|P2|Overall Study|Withdrawal by Subject|1
1597476|NCT02322281|5561201|P1|Overall Study|Withdrawal by Subject|1
1597477|NCT02322281|5561199|P3|Overall Study|Death|3
1597478|NCT02322281|5561200|P2|Overall Study|Death|3
1597479|NCT02322281|5561201|P1|Overall Study|Death|3
1597480|NCT02322281|5561199|P3|Overall Study|Adverse Event|6
1597481|NCT02322281|5561200|P2|Overall Study|Adverse Event|4
1597482|NCT02322281|5561201|P1|Overall Study|Adverse Event|3
1597483|NCT02322281|5561199|P3|Overall Study|Progressive Disease|49
1597484|NCT02322281|5561200|P2|Overall Study|Progressive Disease|14
1597485|NCT02322281|5561201|P1|Overall Study|Progressive Disease|42
1597486|NCT02322229|5561222|P1|Overall Study|Physician Decision|2
1597487|NCT02322216|5561234|P2|Overall Study|Withdrawal by Subject|4
1597488|NCT02322216|5561235|P1|Overall Study|Withdrawal by Subject|1
1597489|NCT02322216|5561234|P2|Overall Study|Adverse Event|0
1597490|NCT02322216|5561235|P1|Overall Study|Adverse Event|1
1597491|NCT02321930|5561242|P1|Overall Study|Lost to Follow-up|1
1597492|NCT02321800|5561252|P2|Overall Study|Other, Miscellaneous|1
1597493|NCT02321800|5561253|P1|Overall Study|Other, Miscellaneous|3
1597494|NCT02321800|5561252|P2|Overall Study|Adverse Event|3
1597495|NCT02321800|5561253|P1|Overall Study|Adverse Event|2
1597496|NCT02321800|5561252|P2|Overall Study|Lost to Follow-up|4
1597497|NCT02321800|5561253|P1|Overall Study|Lost to Follow-up|10
1597498|NCT02321800|5561252|P2|Overall Study|Protocol Violation|0
1597499|NCT02321800|5561253|P1|Overall Study|Protocol Violation|1
1597500|NCT02321800|5561252|P2|Overall Study|Death|0
1597501|NCT02321800|5561253|P1|Overall Study|Death|1
1597502|NCT02321800|5561252|P2|Overall Study|Withdrawal by Subject|3
1597503|NCT02321800|5561253|P1|Overall Study|Withdrawal by Subject|3
1597504|NCT02321462|5561342|P2|Overall Study|Subject withdrawn before any treatment|1
1597505|NCT02321462|5561343|P1|Overall Study|Subject withdrawn before any treatment|1
1597506|NCT02321462|5561342|P2|Overall Study|Withdrawal by Subject|2
1597507|NCT02321462|5561343|P1|Overall Study|Withdrawal by Subject|5
1597508|NCT02321436|5561365|P2|Overall Study|Lost to Follow-up|1
1597509|NCT02321436|5561366|P1|Overall Study|Lost to Follow-up|0
1597510|NCT02321436|5561365|P2|Overall Study|Withdrawal by Subject|0
1597511|NCT02321436|5561366|P1|Overall Study|Withdrawal by Subject|1
1597512|NCT02321098|5561410|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
1597513|NCT02321098|5561411|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
1597514|NCT02321098|5561412|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
1597515|NCT02321098|5561410|P3|Additional 15 Months Treatment|Lost to Follow-up|1
1597516|NCT02321098|5561411|P2|Additional 15 Months Treatment|Lost to Follow-up|0
1597517|NCT02321098|5561412|P1|Additional 15 Months Treatment|Lost to Follow-up|0
1597518|NCT02321098|5561410|P3|Additional 15 Months Treatment|Lack of Efficacy|6
1597519|NCT02321098|5561411|P2|Additional 15 Months Treatment|Lack of Efficacy|0
1597520|NCT02321098|5561412|P1|Additional 15 Months Treatment|Lack of Efficacy|0
1597521|NCT02321098|5561410|P3|12 Weeks Treament|Lost to Follow-up|0
1597522|NCT02321098|5561411|P2|12 Weeks Treament|Lost to Follow-up|1
1597523|NCT02321098|5561412|P1|12 Weeks Treament|Lost to Follow-up|1
1597524|NCT02320903|5561424|P3|Overall Study|Lost to Follow-up|5
1597525|NCT02320903|5561425|P2|Overall Study|Lost to Follow-up|5
1597526|NCT02320903|5561426|P1|Overall Study|Lost to Follow-up|0
1597527|NCT02320903|5561424|P3|Overall Study|Exited therapy; no longer eligible|2
1597528|NCT02320903|5561425|P2|Overall Study|Exited therapy; no longer eligible|2
1597529|NCT02320903|5561426|P1|Overall Study|Exited therapy; no longer eligible|8
1597530|NCT02320903|5561424|P3|Overall Study|Withdrawal by Subject|9
1597531|NCT02320903|5561425|P2|Overall Study|Withdrawal by Subject|9
1597532|NCT02320903|5561426|P1|Overall Study|Withdrawal by Subject|0
1597533|NCT02320721|5561551|P2|Overall Study|Other than specified above|20
1597534|NCT02320721|5561552|P1|Overall Study|Other than specified above|15
1597535|NCT02320721|5561551|P2|Overall Study|Hypoglycemia|0
1597536|NCT02320721|5561552|P1|Overall Study|Hypoglycemia|1
1597537|NCT02320721|5561551|P2|Overall Study|Randomized but not treated|1
1597538|NCT02320721|5561552|P1|Overall Study|Randomized but not treated|0
1597539|NCT02320721|5561551|P2|Overall Study|Poor compliance to protocol|7
1597540|NCT02320721|5561552|P1|Overall Study|Poor compliance to protocol|3
1597541|NCT02320721|5561551|P2|Overall Study|Lack of Efficacy|0
1597542|NCT02320721|5561552|P1|Overall Study|Lack of Efficacy|2
1597543|NCT02320721|5561551|P2|Overall Study|Adverse Event|6
1597544|NCT02320721|5561552|P1|Overall Study|Adverse Event|6
1597545|NCT02320487|5561607|P1|Overall Study|Adverse Event|11
1597546|NCT02320487|5561607|P1|Overall Study|Death|3
1597547|NCT02320487|5561607|P1|Overall Study|Withdrawal by Subject|1
1597548|NCT02320487|5561607|P1|Overall Study|Physician Decision|5
1597549|NCT02320487|5561607|P1|Overall Study|Reason not Specified|1
1597550|NCT02320396|5561627|P2|Overall Study|Withdrawal by Subject|0
1597551|NCT02320396|5561628|P1|Overall Study|Withdrawal by Subject|2
1597552|NCT02320396|5561627|P2|Overall Study|Protocol Violation|1
1597553|NCT02320396|5561628|P1|Overall Study|Protocol Violation|0
1597554|NCT02320396|5561627|P2|Overall Study|Pregnancy|1
1597555|NCT02320396|5561628|P1|Overall Study|Pregnancy|0
1597556|NCT02320396|5561627|P2|Overall Study|Adverse Event|2
1597557|NCT02320396|5561628|P1|Overall Study|Adverse Event|2
1597558|NCT02320149|5561670|P2|Overall Study|Other Miscellaneous Reasons|3
1597559|NCT02320149|5561671|P1|Overall Study|Other Miscellaneous Reasons|2
1597560|NCT02320149|5561670|P2|Overall Study|Lack of Efficacy|1
1597561|NCT02320149|5561671|P1|Overall Study|Lack of Efficacy|0
1597562|NCT02320149|5561670|P2|Overall Study|Noncompliance with Study Treatment|2
1597563|NCT02320149|5561671|P1|Overall Study|Noncompliance with Study Treatment|7
1597564|NCT02320149|5561670|P2|Overall Study|Protocol Violation|1
1597565|NCT02320149|5561671|P1|Overall Study|Protocol Violation|2
1597566|NCT02320149|5561670|P2|Overall Study|Lost to Follow-up|34
1597567|NCT02320149|5561671|P1|Overall Study|Lost to Follow-up|21
1597568|NCT02320149|5561670|P2|Overall Study|Withdrawal of Consent|32
1597569|NCT02320149|5561671|P1|Overall Study|Withdrawal of Consent|28
1597570|NCT02320149|5561670|P2|Overall Study|Adverse Event|7
1597571|NCT02320149|5561671|P1|Overall Study|Adverse Event|3
1597572|NCT02319668|5561778|P2|Overall Study|Other (Not specified)|2
1597573|NCT02319668|5561779|P1|Overall Study|Other (Not specified)|0
1597574|NCT02319642|5561793|P2|Overall Study|Withdrawal by Subject|1
1597575|NCT02319642|5561794|P1|Overall Study|Withdrawal by Subject|1
1597576|NCT02319642|5561793|P2|Overall Study|Lack of Efficacy|1
1597577|NCT02319642|5561794|P1|Overall Study|Lack of Efficacy|1
1597578|NCT02319642|5561793|P2|Overall Study|Adverse Event|4
1597579|NCT02319642|5561794|P1|Overall Study|Adverse Event|2
1597580|NCT02319525|5561814|P2|Overall Study|Withdrawal by Subject|1
1597581|NCT02319525|5561815|P1|Overall Study|Withdrawal by Subject|2
1597582|NCT02319148|5561857|P4|Second Intervention Period|Other|1
1597583|NCT02319148|5561858|P3|Second Intervention Period|Other|0
1597584|NCT02319148|5561859|P2|Second Intervention Period|Other|0
1597585|NCT02319148|5561860|P1|Second Intervention Period|Other|0
1597586|NCT02319148|5561857|P4|Second Intervention Period|No longer willing to participate|0
1597587|NCT02319148|5561858|P3|Second Intervention Period|No longer willing to participate|0
1597588|NCT02319148|5561859|P2|Second Intervention Period|No longer willing to participate|1
1597589|NCT02319148|5561860|P1|Second Intervention Period|No longer willing to participate|0
1597590|NCT02319148|5561857|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
1597591|NCT02319148|5561858|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
1597592|NCT02319148|5561859|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
1597593|NCT02319148|5561860|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
1597612|NCT02319031|5561981|P2|Treatment Period|Death|0
1597613|NCT02319031|5561982|P1|Treatment Period|Death|1
1597614|NCT02318940|5562046|P2|Overall Study|lost the record|0
1597615|NCT02318940|5562047|P1|Overall Study|lost the record|1
1597616|NCT02318797|5562089|P2|Overall Study|Lost to Follow-up|96
1597617|NCT02318797|5562090|P1|Overall Study|Lost to Follow-up|85
1597618|NCT02318797|5562089|P2|Overall Study|Death|6
1597619|NCT02318797|5562090|P1|Overall Study|Death|3
1597620|NCT02318693|5562130|P2|Overall Study|Protocol Violation|1
1597621|NCT02318693|5562131|P1|Overall Study|Protocol Violation|0
1597622|NCT02318667|5562145|P1|Overall Study|Protocol Violation|2
1597623|NCT02318667|5562145|P1|Overall Study|Lack of Efficacy|6
1597624|NCT02318667|5562145|P1|Overall Study|Adverse Event|1
1597625|NCT02318602|5562164|P3|Overall Study|Guardian decision to withdraw|1
1597626|NCT02318602|5562165|P2|Overall Study|Guardian decision to withdraw|0
1597627|NCT02318602|5562166|P1|Overall Study|Guardian decision to withdraw|0
1597628|NCT02318602|5562164|P3|Overall Study|Death|0
1597629|NCT02318602|5562165|P2|Overall Study|Death|0
1597630|NCT02318602|5562166|P1|Overall Study|Death|1
1597631|NCT02318602|5562164|P3|Overall Study|Withdrawal by Subject|0
1597632|NCT02318602|5562165|P2|Overall Study|Withdrawal by Subject|3
1597633|NCT02318602|5562166|P1|Overall Study|Withdrawal by Subject|0
1597634|NCT02318602|5562164|P3|Overall Study|Adverse Event|1
1597635|NCT02318602|5562165|P2|Overall Study|Adverse Event|1
1597636|NCT02318602|5562166|P1|Overall Study|Adverse Event|0
1597637|NCT02317809|5562226|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
1597638|NCT02317809|5562227|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
1597639|NCT02317809|5562226|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
1597640|NCT02317809|5562227|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
1597641|NCT02317614|5562315|P2|Overall Study|Death|1
1597642|NCT02317614|5562316|P1|Overall Study|Death|1
1597643|NCT02317614|5562315|P2|Overall Study|Withdrawal by Subject|0
1597644|NCT02317614|5562316|P1|Overall Study|Withdrawal by Subject|1
1597645|NCT02317614|5562315|P2|Overall Study|Lost to Follow-up|1
1597646|NCT02317614|5562316|P1|Overall Study|Lost to Follow-up|1
1597647|NCT02317510|5562343|P2|Overall Study|Adverse Event|1
1597648|NCT02317510|5562344|P1|Overall Study|Adverse Event|0
1597649|NCT02317016|5562376|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
1597650|NCT02317016|5562376|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
1597651|NCT02317016|5562376|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
1597652|NCT02317016|5562376|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
1597653|NCT02317016|5562376|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
1597654|NCT02317016|5562376|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
1597655|NCT02317016|5562376|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
1597656|NCT02316847|5562404|P2|Overall Study|Withdrawn due to termination by Sponsor|67
1597657|NCT02316847|5562405|P1|Overall Study|Withdrawn due to termination by Sponsor|7
1597658|NCT02316847|5562404|P2|Overall Study|Noncompliance with study drug|3
1597659|NCT02316847|5562405|P1|Overall Study|Noncompliance with study drug|0
1597660|NCT02316847|5562404|P2|Overall Study|Withdrawal by Subject|9
1597661|NCT02316847|5562405|P1|Overall Study|Withdrawal by Subject|2
1597662|NCT02316847|5562404|P2|Overall Study|Pregnancy|1
1597663|NCT02316847|5562405|P1|Overall Study|Pregnancy|0
1597664|NCT02316847|5562404|P2|Overall Study|Physician Decision|1
1597665|NCT02316847|5562405|P1|Overall Study|Physician Decision|0
1597666|NCT02316847|5562404|P2|Overall Study|Lost to Follow-up|2
1597667|NCT02316847|5562405|P1|Overall Study|Lost to Follow-up|0
1597668|NCT02316847|5562404|P2|Overall Study|Adverse Event|3
1597669|NCT02316847|5562405|P1|Overall Study|Adverse Event|0
1597670|NCT02316769|5562416|P2|Overall Study|Withdrawal by Subject|0
1597671|NCT02316769|5562417|P1|Overall Study|Withdrawal by Subject|1
1597672|NCT02316769|5562416|P2|Overall Study|Physician Decision|0
1597673|NCT02316769|5562417|P1|Overall Study|Physician Decision|1
1597698|NCT02316613|5562567|P1|Overall Study|Did not met selection criteria|14
1597699|NCT02316613|5562567|P1|Overall Study|No data and duplicate cases|5
1597700|NCT02316613|5562567|P1|Overall Study|Participant moved/changed medical team|11
1597701|NCT02316613|5562567|P1|Overall Study|Lymphoma transformation|2
1597702|NCT02316613|5562567|P1|Overall Study|Lost to Follow-up|9
1597703|NCT02316613|5562567|P1|Overall Study|Death|63
1597704|NCT02316548|5562606|P2|Overall Study|Protocol Violation|1
1597705|NCT02316548|5562607|P1|Overall Study|Protocol Violation|0
1597706|NCT02316353|5562737|P2|Overall Study|Withdrawal by Subject|2
1597707|NCT02316353|5562738|P1|Overall Study|Withdrawal by Subject|6
1597708|NCT02316353|5562737|P2|Overall Study|Adverse Event|3
1597709|NCT02316353|5562738|P1|Overall Study|Adverse Event|1
1597710|NCT02316353|5562737|P2|Overall Study|Pregnancy|3
1597711|NCT02316353|5562738|P1|Overall Study|Pregnancy|1
1597712|NCT02316171|5562758|P4|Overall Study|difficulties with urinary catheter|0
1597713|NCT02316171|5562759|P3|Overall Study|difficulties with urinary catheter|0
1597714|NCT02316171|5562760|P2|Overall Study|difficulties with urinary catheter|0
1597715|NCT02316171|5562761|P1|Overall Study|difficulties with urinary catheter|1
1597716|NCT02315664|5562825|P2|Overall Study|Withdrawal by Subject|3
1597717|NCT02315664|5562826|P1|Overall Study|Withdrawal by Subject|0
1597718|NCT02315664|5562825|P2|Overall Study|Lost to Follow-up|1
1597719|NCT02315664|5562826|P1|Overall Study|Lost to Follow-up|1
1597720|NCT02315560|5562846|P1|Overall Study|noncompliance by subjects|3
1597721|NCT02314923|5563097|P10|Overall Study|Participant relocation|0
1597722|NCT02314923|5563098|P9|Overall Study|Participant relocation|0
1597723|NCT02314923|5563099|P8|Overall Study|Participant relocation|1
1597724|NCT02314923|5563100|P7|Overall Study|Participant relocation|0
1597725|NCT02314923|5563101|P6|Overall Study|Participant relocation|0
1597726|NCT02314923|5563102|P5|Overall Study|Participant relocation|0
1597727|NCT02314923|5563103|P4|Overall Study|Participant relocation|0
1597728|NCT02314923|5563104|P3|Overall Study|Participant relocation|0
1597729|NCT02314923|5563105|P2|Overall Study|Participant relocation|0
1597730|NCT02314923|5563106|P1|Overall Study|Participant relocation|1
1597731|NCT02314923|5563097|P10|Overall Study|Screen failure|0
1597732|NCT02314923|5563098|P9|Overall Study|Screen failure|0
1597733|NCT02314923|5563099|P8|Overall Study|Screen failure|0
1597734|NCT02314923|5563100|P7|Overall Study|Screen failure|1
1597735|NCT02314923|5563101|P6|Overall Study|Screen failure|0
1597736|NCT02314923|5563102|P5|Overall Study|Screen failure|0
1597737|NCT02314923|5563103|P4|Overall Study|Screen failure|0
1597738|NCT02314923|5563104|P3|Overall Study|Screen failure|0
1597739|NCT02314923|5563105|P2|Overall Study|Screen failure|0
1597740|NCT02314923|5563106|P1|Overall Study|Screen failure|0
1597741|NCT02314923|5563097|P10|Overall Study|Participant unavailable|0
1597742|NCT02314923|5563098|P9|Overall Study|Participant unavailable|0
1597743|NCT02314923|5563099|P8|Overall Study|Participant unavailable|0
1597744|NCT02314923|5563100|P7|Overall Study|Participant unavailable|0
1597745|NCT02314923|5563101|P6|Overall Study|Participant unavailable|1
1597746|NCT02314923|5563102|P5|Overall Study|Participant unavailable|0
1597747|NCT02314923|5563103|P4|Overall Study|Participant unavailable|0
1597748|NCT02314923|5563104|P3|Overall Study|Participant unavailable|0
1597749|NCT02314923|5563105|P2|Overall Study|Participant unavailable|0
1597750|NCT02314923|5563106|P1|Overall Study|Participant unavailable|0
1597751|NCT02314923|5563097|P10|Overall Study|Physician Decision|0
1597752|NCT02314923|5563098|P9|Overall Study|Physician Decision|0
1597753|NCT02314923|5563099|P8|Overall Study|Physician Decision|0
1597754|NCT02314923|5563100|P7|Overall Study|Physician Decision|0
1597755|NCT02314923|5563101|P6|Overall Study|Physician Decision|0
1597756|NCT02314923|5563102|P5|Overall Study|Physician Decision|0
1597757|NCT02314923|5563103|P4|Overall Study|Physician Decision|0
1597758|NCT02314923|5563104|P3|Overall Study|Physician Decision|0
1597759|NCT02314923|5563105|P2|Overall Study|Physician Decision|1
1597760|NCT02314923|5563106|P1|Overall Study|Physician Decision|0
1597761|NCT02314923|5563097|P10|Overall Study|Withdrawal by Subject|0
1597762|NCT02314923|5563098|P9|Overall Study|Withdrawal by Subject|0
1597763|NCT02314923|5563099|P8|Overall Study|Withdrawal by Subject|0
1597764|NCT02314923|5563100|P7|Overall Study|Withdrawal by Subject|1
1597765|NCT02314923|5563101|P6|Overall Study|Withdrawal by Subject|0
1597766|NCT02314923|5563102|P5|Overall Study|Withdrawal by Subject|1
1597767|NCT02314923|5563103|P4|Overall Study|Withdrawal by Subject|0
1597768|NCT02314923|5563104|P3|Overall Study|Withdrawal by Subject|1
1597769|NCT02314923|5563105|P2|Overall Study|Withdrawal by Subject|0
1597770|NCT02314923|5563106|P1|Overall Study|Withdrawal by Subject|0
1597771|NCT02314923|5563097|P10|Overall Study|Lost to Follow-up|0
1597772|NCT02314923|5563098|P9|Overall Study|Lost to Follow-up|2
1597773|NCT02314923|5563099|P8|Overall Study|Lost to Follow-up|4
1597774|NCT02314923|5563100|P7|Overall Study|Lost to Follow-up|3
1597775|NCT02314923|5563101|P6|Overall Study|Lost to Follow-up|0
1597776|NCT02314923|5563102|P5|Overall Study|Lost to Follow-up|0
1597777|NCT02314923|5563103|P4|Overall Study|Lost to Follow-up|0
1597778|NCT02314923|5563104|P3|Overall Study|Lost to Follow-up|1
1597779|NCT02314923|5563105|P2|Overall Study|Lost to Follow-up|3
1597780|NCT02314923|5563106|P1|Overall Study|Lost to Follow-up|2
1597781|NCT02314923|5563097|P10|Overall Study|Death|0
1597782|NCT02314923|5563098|P9|Overall Study|Death|0
1597783|NCT02314923|5563099|P8|Overall Study|Death|0
1597784|NCT02314923|5563100|P7|Overall Study|Death|0
1597785|NCT02314923|5563101|P6|Overall Study|Death|0
1597786|NCT02314923|5563102|P5|Overall Study|Death|0
1597787|NCT02314923|5563103|P4|Overall Study|Death|1
1597788|NCT02314923|5563104|P3|Overall Study|Death|0
1597789|NCT02314923|5563105|P2|Overall Study|Death|0
1597790|NCT02314923|5563106|P1|Overall Study|Death|0
1597791|NCT02314637|5563205|P2|Overall Study|Other Reason|0
1597792|NCT02314637|5563206|P1|Overall Study|Other Reason|1
1597793|NCT02314637|5563205|P2|Overall Study|Withdrawal by Subject|4
1597794|NCT02314637|5563206|P1|Overall Study|Withdrawal by Subject|5
1597795|NCT02314637|5563205|P2|Overall Study|Physician Decision|2
1597796|NCT02314637|5563206|P1|Overall Study|Physician Decision|5
1597797|NCT02314637|5563205|P2|Overall Study|Lack of Efficacy|0
1597798|NCT02314637|5563206|P1|Overall Study|Lack of Efficacy|1
1597799|NCT02314637|5563205|P2|Overall Study|Adverse Event|8
1597800|NCT02314637|5563206|P1|Overall Study|Adverse Event|4
1597801|NCT02314247|5563277|P3|Overall Study|Progression of Disease|0
1597802|NCT02314247|5563278|P2|Overall Study|Progression of Disease|2
1597803|NCT02314247|5563279|P1|Overall Study|Progression of Disease|6
1597804|NCT02314247|5563277|P3|Overall Study|Withdrawal by Subject|1
1597805|NCT02314247|5563278|P2|Overall Study|Withdrawal by Subject|3
1597806|NCT02314247|5563279|P1|Overall Study|Withdrawal by Subject|1
1597807|NCT02314247|5563277|P3|Overall Study|Adverse Event|0
1597808|NCT02314247|5563278|P2|Overall Study|Adverse Event|1
1597809|NCT02314247|5563279|P1|Overall Study|Adverse Event|2
1597810|NCT02314143|5563304|P3|Overall Study|Withdrawal by Subject|1
1597811|NCT02314143|5563305|P2|Overall Study|Withdrawal by Subject|0
1597812|NCT02314143|5563306|P1|Overall Study|Withdrawal by Subject|1
1597813|NCT02314143|5563304|P3|Overall Study|Physician Decision|0
1597814|NCT02314143|5563305|P2|Overall Study|Physician Decision|1
1597815|NCT02314143|5563306|P1|Overall Study|Physician Decision|2
1597816|NCT02314143|5563304|P3|Overall Study|Other (Study Closed/Terminated)|4
1597817|NCT02314143|5563305|P2|Overall Study|Other (Study Closed/Terminated)|3
1597818|NCT02314143|5563306|P1|Overall Study|Other (Study Closed/Terminated)|5
1597819|NCT02314143|5563304|P3|Overall Study|Adverse Event|4
1597820|NCT02314143|5563305|P2|Overall Study|Adverse Event|6
1597821|NCT02314143|5563306|P1|Overall Study|Adverse Event|0
1597822|NCT02314117|5563352|P2|Overall Study|No post-discontinuation follow-up|19
1597823|NCT02314117|5563353|P1|Overall Study|No post-discontinuation follow-up|21
1597824|NCT02314117|5563352|P2|Overall Study|Withdrawal by Subject|2
1597825|NCT02314117|5563353|P1|Overall Study|Withdrawal by Subject|2
1597826|NCT02314117|5563352|P2|Overall Study|On Treatment|6
1597827|NCT02314117|5563353|P1|Overall Study|On Treatment|10
1597828|NCT02314117|5563352|P2|Overall Study|Lost to Follow-up|11
1597829|NCT02314117|5563353|P1|Overall Study|Lost to Follow-up|8
1597830|NCT02314052|5563406|P6|Cycle One|Adverse Event|0
1597831|NCT02314052|5563407|P5|Cycle One|Adverse Event|0
1597832|NCT02314052|5563408|P4|Cycle One|Adverse Event|1
1597833|NCT02314052|5563409|P3|Cycle One|Adverse Event|0
1597834|NCT02314052|5563410|P2|Cycle One|Adverse Event|0
1597835|NCT02314052|5563411|P1|Cycle One|Adverse Event|0
1597836|NCT02314026|5563479|P1|Overall Study|Protocol Violation|28
1597837|NCT02313909|5563497|P2|Overall Study|Lost to Follow-up|17
1597838|NCT02313909|5563498|P1|Overall Study|Lost to Follow-up|24
1597839|NCT02313909|5563497|P2|Overall Study|Consent withdrawn by participant|33
1597840|NCT02313909|5563498|P1|Overall Study|Consent withdrawn by participant|33
1597841|NCT02313766|5563521|P3|Overall Study|Adverse Event|0
1597842|NCT02313766|5563522|P2|Overall Study|Adverse Event|1
1597843|NCT02313766|5563523|P1|Overall Study|Adverse Event|0
1597844|NCT02313766|5563521|P3|Overall Study|Lost to Follow-up|0
1597845|NCT02313766|5563522|P2|Overall Study|Lost to Follow-up|2
1597846|NCT02313766|5563523|P1|Overall Study|Lost to Follow-up|0
1597847|NCT02313766|5563521|P3|Overall Study|surgery cancelled|0
1597848|NCT02313766|5563522|P2|Overall Study|surgery cancelled|0
1597849|NCT02313766|5563523|P1|Overall Study|surgery cancelled|1
1597850|NCT02313558|5563560|P2|Overall Study|Lost to Follow-up|4
1597851|NCT02313558|5563561|P1|Overall Study|Lost to Follow-up|4
1597852|NCT02313558|5563560|P2|Overall Study|Withdrawal by Subject|0
1597853|NCT02313558|5563561|P1|Overall Study|Withdrawal by Subject|2
1597854|NCT02313233|5563607|P2|Overall Study|Administrative reason|1
1597855|NCT02313233|5563608|P1|Overall Study|Administrative reason|1
1597856|NCT02313233|5563607|P2|Overall Study|Withdrawal by Subject|2
1597857|NCT02313233|5563608|P1|Overall Study|Withdrawal by Subject|1
1597858|NCT02313155|5563630|P2|Overall Study|Lost to Follow-up|1
1597859|NCT02313155|5563631|P1|Overall Study|Lost to Follow-up|0
1597860|NCT02312934|5563681|P2|Overall Study|Physician Decision|0
1597861|NCT02312934|5563682|P1|Overall Study|Physician Decision|1
1597862|NCT02312934|5563681|P2|Overall Study|Lost to Follow-up|0
1597863|NCT02312934|5563682|P1|Overall Study|Lost to Follow-up|1
1597864|NCT02312856|5563694|P1|Overall Study|Lost to Follow-up|3
1597865|NCT02312856|5563694|P1|Overall Study|Death|1
1597866|NCT02312687|5563778|P1|Overall Study|Other, Not Specified|1
1597867|NCT02312219|5563837|P2|Overall Study|Not randomized. Ineligible|1
1597868|NCT02312219|5563838|P1|Overall Study|Not randomized. Ineligible|0
1597869|NCT02312219|5563837|P2|Overall Study|Other|1
1597870|NCT02312219|5563838|P1|Overall Study|Other|0
1597871|NCT02312219|5563837|P2|Overall Study|could not schedule imaging in time|2
1597872|NCT02312219|5563838|P1|Overall Study|could not schedule imaging in time|0
1597873|NCT02312219|5563837|P2|Overall Study|Withdrawal by Subject|2
1597874|NCT02312219|5563838|P1|Overall Study|Withdrawal by Subject|1
1597875|NCT02312206|5563848|P2|Overall Study|Subject missed 3 consecutive tx visits|1
1597876|NCT02312206|5563849|P1|Overall Study|Subject missed 3 consecutive tx visits|0
1597877|NCT02312206|5563848|P2|Overall Study|Patient transferred to hospice|1
1597878|NCT02312206|5563849|P1|Overall Study|Patient transferred to hospice|0
1597879|NCT02312206|5563848|P2|Overall Study|Patient progression and new therapy|0
1597880|NCT02312206|5563849|P1|Overall Study|Patient progression and new therapy|1
1597881|NCT02312206|5563848|P2|Overall Study|Disease Progression|0
1597882|NCT02312206|5563849|P1|Overall Study|Disease Progression|1
1597883|NCT02312206|5563848|P2|Overall Study|Study Terminated by Sponsor|74
1597884|NCT02312206|5563849|P1|Overall Study|Study Terminated by Sponsor|81
1597885|NCT02312206|5563848|P2|Overall Study|Death|36
1597886|NCT02312206|5563849|P1|Overall Study|Death|30
1597887|NCT02312206|5563848|P2|Overall Study|Physician Decision|6
1597888|NCT02312206|5563849|P1|Overall Study|Physician Decision|7
1597889|NCT02312206|5563848|P2|Overall Study|Withdrawal by Subject|6
1597890|NCT02312206|5563849|P1|Overall Study|Withdrawal by Subject|7
1597891|NCT02312206|5563848|P2|Overall Study|Adverse Event|6
1597892|NCT02312206|5563849|P1|Overall Study|Adverse Event|3
1597893|NCT02312063|5563872|P2|Overall Study|Withdrawal by Subject|1
1597894|NCT02312063|5563873|P1|Overall Study|Withdrawal by Subject|0
1597895|NCT02311894|5563926|P1|Overall Study|Withdrawal by Subject|1
1597896|NCT02311894|5563926|P1|Overall Study|Adverse Event|1
1597897|NCT02311894|5563926|P1|Overall Study|Lost to Follow-up|1
1597898|NCT02311894|5563926|P1|Overall Study|Discontinued in error|1
1597899|NCT02311881|5563938|P3|Overall Study|Serious Adverse Event|0
1597900|NCT02311881|5563939|P2|Overall Study|Serious Adverse Event|1
1597901|NCT02311881|5563940|P1|Overall Study|Serious Adverse Event|0
1597902|NCT02311881|5563938|P3|Overall Study|Participant taking another medication|1
1597903|NCT02311881|5563939|P2|Overall Study|Participant taking another medication|0
1597904|NCT02311881|5563940|P1|Overall Study|Participant taking another medication|0
1597905|NCT02311881|5563938|P3|Overall Study|Medical Monitor Discretion|1
1597906|NCT02311881|5563939|P2|Overall Study|Medical Monitor Discretion|0
1597907|NCT02311881|5563940|P1|Overall Study|Medical Monitor Discretion|0
1597908|NCT02311881|5563938|P3|Overall Study|Physician Decision|1
1597909|NCT02311881|5563939|P2|Overall Study|Physician Decision|0
1597910|NCT02311881|5563940|P1|Overall Study|Physician Decision|0
1597911|NCT02311881|5563938|P3|Overall Study|Non-Compliance|2
1597912|NCT02311881|5563939|P2|Overall Study|Non-Compliance|0
1597913|NCT02311881|5563940|P1|Overall Study|Non-Compliance|1
1597914|NCT02311881|5563938|P3|Overall Study|Protocol Deviation|0
1597915|NCT02311881|5563939|P2|Overall Study|Protocol Deviation|0
1597916|NCT02311881|5563940|P1|Overall Study|Protocol Deviation|1
1597917|NCT02311881|5563938|P3|Overall Study|Sponsor Decision|1
1597918|NCT02311881|5563939|P2|Overall Study|Sponsor Decision|1
1597919|NCT02311881|5563940|P1|Overall Study|Sponsor Decision|1
1597920|NCT02311881|5563938|P3|Overall Study|Withdrawal by Subject|4
1597921|NCT02311881|5563939|P2|Overall Study|Withdrawal by Subject|1
1597922|NCT02311881|5563940|P1|Overall Study|Withdrawal by Subject|3
1597923|NCT02311881|5563938|P3|Overall Study|Subject has border line pregnancy test|0
1597924|NCT02311881|5563939|P2|Overall Study|Subject has border line pregnancy test|0
1597925|NCT02311881|5563940|P1|Overall Study|Subject has border line pregnancy test|1
1597926|NCT02311881|5563938|P3|Overall Study|Lack of Efficacy|0
1597927|NCT02311881|5563939|P2|Overall Study|Lack of Efficacy|2
1597928|NCT02311881|5563940|P1|Overall Study|Lack of Efficacy|1
1597929|NCT02311881|5563938|P3|Overall Study|Other|1
1597930|NCT02311881|5563939|P2|Overall Study|Other|0
1597931|NCT02311881|5563940|P1|Overall Study|Other|0
1597932|NCT02311881|5563938|P3|Overall Study|Withdrawal of consent|17
1597933|NCT02311881|5563939|P2|Overall Study|Withdrawal of consent|16
1597934|NCT02311881|5563940|P1|Overall Study|Withdrawal of consent|14
1597935|NCT02311881|5563938|P3|Overall Study|Protocol Violation|3
1597936|NCT02311881|5563939|P2|Overall Study|Protocol Violation|2
1597937|NCT02311881|5563940|P1|Overall Study|Protocol Violation|1
1597938|NCT02311881|5563938|P3|Overall Study|Lost to Follow-up|2
1597939|NCT02311881|5563939|P2|Overall Study|Lost to Follow-up|3
1597940|NCT02311881|5563940|P1|Overall Study|Lost to Follow-up|3
1597941|NCT02311881|5563938|P3|Overall Study|Adverse Event|8
1597942|NCT02311881|5563939|P2|Overall Study|Adverse Event|15
1597943|NCT02311881|5563940|P1|Overall Study|Adverse Event|7
1597944|NCT02311881|5563938|P3|Overall Study|Did not meet the study criteria|0
1597945|NCT02311881|5563939|P2|Overall Study|Did not meet the study criteria|2
1597946|NCT02311881|5563940|P1|Overall Study|Did not meet the study criteria|2
1597947|NCT02311478|5563975|P1|Overall Study|Failed IUD Insertion|1
1597948|NCT02311478|5563975|P1|Overall Study|Lost to Follow-up|5
1597949|NCT02311478|5563975|P1|Overall Study|Withdrawal by Subject|1
1597950|NCT02311153|5563998|P2|Overall Study|Lost to Follow-up|7
1597951|NCT02311153|5563999|P1|Overall Study|Lost to Follow-up|5
1597952|NCT02310789|5564015|P1|Overall Study|Adverse Event|1
1597953|NCT02310763|5564027|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
1597954|NCT02310763|5564028|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
1597955|NCT02310763|5564029|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
1597956|NCT02310763|5564027|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
1597957|NCT02310763|5564028|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
1597958|NCT02310763|5564029|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
1597959|NCT02310763|5564027|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
1597960|NCT02310763|5564028|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
1597961|NCT02310763|5564029|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
1597962|NCT02310763|5564027|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
1597963|NCT02310763|5564028|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
1597964|NCT02310763|5564029|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
1597965|NCT02310763|5564027|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
1597966|NCT02310763|5564028|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
1597967|NCT02310763|5564029|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
1597968|NCT02310750|5564232|P16|HP Washout 2|Lost to Follow-up|0
1597969|NCT02310750|5564233|P15|HP Washout 2|Lost to Follow-up|0
1597970|NCT02310750|5564234|P14|HP Washout 2|Lost to Follow-up|0
1597971|NCT02310750|5564235|P13|HP Washout 2|Lost to Follow-up|0
1597972|NCT02310750|5564236|P12|HP Washout 2|Lost to Follow-up|0
1597973|NCT02310750|5564237|P11|HP Washout 2|Lost to Follow-up|0
1597974|NCT02310750|5564238|P10|HP Washout 2|Lost to Follow-up|0
1597975|NCT02310750|5564239|P9|HP Washout 2|Lost to Follow-up|0
1597976|NCT02310750|5564240|P8|HP Washout 2|Lost to Follow-up|0
1597977|NCT02310750|5564241|P7|HP Washout 2|Lost to Follow-up|7
1597978|NCT02310750|5564242|P6|HP Washout 2|Lost to Follow-up|0
1597979|NCT02310750|5564243|P5|HP Washout 2|Lost to Follow-up|1
1597980|NCT02310750|5564244|P4|HP Washout 2|Lost to Follow-up|0
1597981|NCT02310750|5564245|P3|HP Washout 2|Lost to Follow-up|0
1597982|NCT02310750|5564246|P2|HP Washout 2|Lost to Follow-up|0
1597983|NCT02310750|5564247|P1|HP Washout 2|Lost to Follow-up|0
1597984|NCT02310750|5564232|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597985|NCT02310750|5564233|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597986|NCT02310750|5564234|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597987|NCT02310750|5564235|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597988|NCT02310750|5564236|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597989|NCT02310750|5564237|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597990|NCT02310750|5564238|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597991|NCT02310750|5564239|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1597992|NCT02310750|5564240|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
1597993|NCT02310750|5564241|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597994|NCT02310750|5564242|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597995|NCT02310750|5564243|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597996|NCT02310750|5564244|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597997|NCT02310750|5564245|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597998|NCT02310750|5564246|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1597999|NCT02310750|5564247|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
1598000|NCT02310750|5564232|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598001|NCT02310750|5564233|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598002|NCT02310750|5564234|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598003|NCT02310750|5564235|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598004|NCT02310750|5564236|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598005|NCT02310750|5564237|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598006|NCT02310750|5564238|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1598007|NCT02310750|5564239|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1598008|NCT02310750|5564240|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
1598009|NCT02310750|5564241|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598010|NCT02310750|5564242|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598011|NCT02310750|5564243|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598012|NCT02310750|5564244|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598013|NCT02310750|5564245|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598014|NCT02310750|5564246|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598015|NCT02310750|5564247|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
1598016|NCT02310750|5564232|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598017|NCT02310750|5564233|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598018|NCT02310750|5564234|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598019|NCT02310750|5564235|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598020|NCT02310750|5564236|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598021|NCT02310750|5564237|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598022|NCT02310750|5564238|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
1598023|NCT02310750|5564239|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598024|NCT02310750|5564240|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598025|NCT02310750|5564241|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598026|NCT02310750|5564242|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598027|NCT02310750|5564243|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598028|NCT02310750|5564244|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598029|NCT02310750|5564245|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598030|NCT02310750|5564246|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598031|NCT02310750|5564247|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
1598032|NCT02310750|5564232|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598033|NCT02310750|5564233|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598034|NCT02310750|5564234|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598035|NCT02310750|5564235|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598036|NCT02310750|5564236|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598037|NCT02310750|5564237|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598038|NCT02310750|5564238|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1598039|NCT02310750|5564239|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
1598040|NCT02310750|5564240|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598041|NCT02310750|5564241|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598042|NCT02310750|5564242|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
1598043|NCT02310750|5564243|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598044|NCT02310750|5564244|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
1598045|NCT02310750|5564245|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598046|NCT02310750|5564246|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598047|NCT02310750|5564247|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
1598048|NCT02310750|5564232|P16|HP Washout 1|Lost to Follow-up|0
1598049|NCT02310750|5564233|P15|HP Washout 1|Lost to Follow-up|0
1598050|NCT02310750|5564234|P14|HP Washout 1|Lost to Follow-up|0
1598051|NCT02310750|5564235|P13|HP Washout 1|Lost to Follow-up|0
1598052|NCT02310750|5564236|P12|HP Washout 1|Lost to Follow-up|0
1598053|NCT02310750|5564237|P11|HP Washout 1|Lost to Follow-up|0
1598054|NCT02310750|5564238|P10|HP Washout 1|Lost to Follow-up|0
1598055|NCT02310750|5564239|P9|HP Washout 1|Lost to Follow-up|0
1598056|NCT02310750|5564240|P8|HP Washout 1|Lost to Follow-up|0
1598057|NCT02310750|5564241|P7|HP Washout 1|Lost to Follow-up|3
1598058|NCT02310750|5564242|P6|HP Washout 1|Lost to Follow-up|2
1598059|NCT02310750|5564243|P5|HP Washout 1|Lost to Follow-up|2
1598060|NCT02310750|5564244|P4|HP Washout 1|Lost to Follow-up|1
1598061|NCT02310750|5564245|P3|HP Washout 1|Lost to Follow-up|1
1598062|NCT02310750|5564246|P2|HP Washout 1|Lost to Follow-up|0
1598063|NCT02310750|5564247|P1|HP Washout 1|Lost to Follow-up|0
1598064|NCT02310750|5564232|P16|HP Period 1|Withdrawal by Subject|0
1598065|NCT02310750|5564233|P15|HP Period 1|Withdrawal by Subject|0
1598066|NCT02310750|5564234|P14|HP Period 1|Withdrawal by Subject|0
1598067|NCT02310750|5564235|P13|HP Period 1|Withdrawal by Subject|0
1598068|NCT02310750|5564236|P12|HP Period 1|Withdrawal by Subject|0
1598069|NCT02310750|5564237|P11|HP Period 1|Withdrawal by Subject|0
1598070|NCT02310750|5564238|P10|HP Period 1|Withdrawal by Subject|0
1598071|NCT02310750|5564239|P9|HP Period 1|Withdrawal by Subject|0
1598072|NCT02310750|5564240|P8|HP Period 1|Withdrawal by Subject|0
1598073|NCT02310750|5564241|P7|HP Period 1|Withdrawal by Subject|0
1598074|NCT02310750|5564242|P6|HP Period 1|Withdrawal by Subject|0
1598075|NCT02310750|5564243|P5|HP Period 1|Withdrawal by Subject|0
1598076|NCT02310750|5564244|P4|HP Period 1|Withdrawal by Subject|1
1598077|NCT02310750|5564245|P3|HP Period 1|Withdrawal by Subject|0
1598078|NCT02310750|5564246|P2|HP Period 1|Withdrawal by Subject|0
1598079|NCT02310750|5564247|P1|HP Period 1|Withdrawal by Subject|1
1598080|NCT02310750|5564232|P16|HP Period 1|Lost to Follow-up|0
1598081|NCT02310750|5564233|P15|HP Period 1|Lost to Follow-up|0
1598082|NCT02310750|5564234|P14|HP Period 1|Lost to Follow-up|0
1598083|NCT02310750|5564235|P13|HP Period 1|Lost to Follow-up|0
1598084|NCT02310750|5564236|P12|HP Period 1|Lost to Follow-up|0
1598085|NCT02310750|5564237|P11|HP Period 1|Lost to Follow-up|0
1598086|NCT02310750|5564238|P10|HP Period 1|Lost to Follow-up|0
1598087|NCT02310750|5564239|P9|HP Period 1|Lost to Follow-up|0
1598088|NCT02310750|5564240|P8|HP Period 1|Lost to Follow-up|0
1598089|NCT02310750|5564241|P7|HP Period 1|Lost to Follow-up|1
1598090|NCT02310750|5564242|P6|HP Period 1|Lost to Follow-up|0
1598091|NCT02310750|5564243|P5|HP Period 1|Lost to Follow-up|0
1598092|NCT02310750|5564244|P4|HP Period 1|Lost to Follow-up|0
1598093|NCT02310750|5564245|P3|HP Period 1|Lost to Follow-up|0
1598094|NCT02310750|5564246|P2|HP Period 1|Lost to Follow-up|0
1598095|NCT02310750|5564247|P1|HP Period 1|Lost to Follow-up|0
1598096|NCT02310646|5564688|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
1598097|NCT02310646|5564689|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
1598098|NCT02310646|5564688|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
1598099|NCT02310646|5564689|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
1598100|NCT02310581|5564717|P4|Overall Study|Withdrawal by Subject|1
1598101|NCT02310581|5564718|P3|Overall Study|Withdrawal by Subject|0
1598102|NCT02310581|5564719|P2|Overall Study|Withdrawal by Subject|1
1598103|NCT02310581|5564720|P1|Overall Study|Withdrawal by Subject|2
1598104|NCT02310581|5564717|P4|Overall Study|Adverse Event|0
1598105|NCT02310581|5564718|P3|Overall Study|Adverse Event|1
1598106|NCT02310581|5564719|P2|Overall Study|Adverse Event|1
1598107|NCT02310581|5564720|P1|Overall Study|Adverse Event|1
1598108|NCT02310568|5564759|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
1598109|NCT02310568|5564760|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
1598110|NCT02310568|5564761|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
1598111|NCT02310568|5564762|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
1598112|NCT02310568|5564763|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
1598113|NCT02310568|5564759|P5|Stage 2 (4 Weeks)|Protocol Violation|0
1598114|NCT02310568|5564760|P4|Stage 2 (4 Weeks)|Protocol Violation|1
1598115|NCT02310568|5564761|P3|Stage 2 (4 Weeks)|Protocol Violation|0
1598116|NCT02310568|5564762|P2|Stage 2 (4 Weeks)|Protocol Violation|0
1598117|NCT02310568|5564763|P1|Stage 2 (4 Weeks)|Protocol Violation|0
1598118|NCT02310568|5564759|P5|Stage 2 (4 Weeks)|Adverse Event|1
1598119|NCT02310568|5564760|P4|Stage 2 (4 Weeks)|Adverse Event|1
1598120|NCT02310568|5564761|P3|Stage 2 (4 Weeks)|Adverse Event|0
1598121|NCT02310568|5564762|P2|Stage 2 (4 Weeks)|Adverse Event|0
1598122|NCT02310568|5564763|P1|Stage 2 (4 Weeks)|Adverse Event|0
1598123|NCT02310568|5564759|P5|Stage 2 (4 Weeks)|Other|0
1598124|NCT02310568|5564760|P4|Stage 2 (4 Weeks)|Other|0
1598125|NCT02310568|5564761|P3|Stage 2 (4 Weeks)|Other|1
1598126|NCT02310568|5564762|P2|Stage 2 (4 Weeks)|Other|1
1598127|NCT02310568|5564763|P1|Stage 2 (4 Weeks)|Other|0
1598128|NCT02310568|5564759|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1598129|NCT02310568|5564760|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1598130|NCT02310568|5564761|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1598131|NCT02310568|5564762|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1598132|NCT02310568|5564763|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1598133|NCT02310568|5564759|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1598134|NCT02310568|5564760|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
1598135|NCT02310568|5564761|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1598136|NCT02310568|5564762|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1598137|NCT02310568|5564763|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1598138|NCT02310568|5564759|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1598139|NCT02310568|5564760|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
1598140|NCT02310568|5564761|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1598141|NCT02310568|5564762|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1598142|NCT02310568|5564763|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1598143|NCT02310568|5564759|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
1598144|NCT02310568|5564760|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
1598145|NCT02310568|5564761|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
1598146|NCT02310568|5564762|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
1598147|NCT02310568|5564763|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
1598148|NCT02310568|5564759|P5|Stage 1 ( 4 Weeks)|Other|0
1598149|NCT02310568|5564760|P4|Stage 1 ( 4 Weeks)|Other|0
1598150|NCT02310568|5564761|P3|Stage 1 ( 4 Weeks)|Other|0
1598151|NCT02310568|5564762|P2|Stage 1 ( 4 Weeks)|Other|1
1598152|NCT02310568|5564763|P1|Stage 1 ( 4 Weeks)|Other|1
1598153|NCT02310568|5564759|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1598154|NCT02310568|5564760|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1598155|NCT02310568|5564761|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1598156|NCT02310568|5564762|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1598157|NCT02310568|5564763|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
1598158|NCT02310568|5564759|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
1598159|NCT02310568|5564760|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1598160|NCT02310568|5564761|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1598161|NCT02310568|5564762|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1598162|NCT02310568|5564763|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1598163|NCT02310126|5564843|P2|Period 1 (15 Minutes)|Protocol Violation|1
1598164|NCT02310126|5564844|P1|Period 1 (15 Minutes)|Protocol Violation|0
1598165|NCT02310126|5564843|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
1598166|NCT02310126|5564844|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
1598167|NCT02310100|5564850|P1|Overall Study|Lost to Follow-up|2
1598168|NCT02310100|5564850|P1|Overall Study|Visit compliance|1
1598169|NCT02310100|5564850|P1|Overall Study|Unapproved ablation operator|1
1598170|NCT02310100|5564850|P1|Overall Study|Enrollment closure|1
1598171|NCT02310100|5564850|P1|Overall Study|Withdrawal by Subject|10
1598172|NCT02310100|5564850|P1|Overall Study|Physician Decision|3
1598173|NCT02309723|5564858|P3|Overall Study|Withdrawal by Subject|24
1598174|NCT02309723|5564859|P2|Overall Study|Withdrawal by Subject|23
1598175|NCT02309723|5564860|P1|Overall Study|Withdrawal by Subject|24
1598176|NCT02309411|5564903|P3|Overall Study|Withdrawal by Subject|0
1598177|NCT02309411|5564904|P2|Overall Study|Withdrawal by Subject|1
1598178|NCT02309411|5564905|P1|Overall Study|Withdrawal by Subject|1
1598179|NCT02309411|5564903|P3|Overall Study|Physician Decision|0
1598180|NCT02309411|5564904|P2|Overall Study|Physician Decision|0
1598181|NCT02309411|5564905|P1|Overall Study|Physician Decision|1
1598182|NCT02309359|5564929|P5|Overall Study|Other|2
1598183|NCT02309359|5564930|P4|Overall Study|Other|3
1598184|NCT02309359|5564931|P3|Overall Study|Other|2
1598185|NCT02309359|5564932|P2|Overall Study|Other|0
1598186|NCT02309359|5564933|P1|Overall Study|Other|2
1598187|NCT02309359|5564929|P5|Overall Study|Lost to Follow-up|0
1598188|NCT02309359|5564930|P4|Overall Study|Lost to Follow-up|1
1598189|NCT02309359|5564931|P3|Overall Study|Lost to Follow-up|0
1598190|NCT02309359|5564932|P2|Overall Study|Lost to Follow-up|0
1598191|NCT02309359|5564933|P1|Overall Study|Lost to Follow-up|0
1598192|NCT02309359|5564929|P5|Overall Study|Lack of Efficacy|3
1598193|NCT02309359|5564930|P4|Overall Study|Lack of Efficacy|0
1598194|NCT02309359|5564931|P3|Overall Study|Lack of Efficacy|0
1598195|NCT02309359|5564932|P2|Overall Study|Lack of Efficacy|1
1598196|NCT02309359|5564933|P1|Overall Study|Lack of Efficacy|3
1598197|NCT02309359|5564929|P5|Overall Study|Withdrawal by Subject|0
1598198|NCT02309359|5564930|P4|Overall Study|Withdrawal by Subject|4
1598199|NCT02309359|5564931|P3|Overall Study|Withdrawal by Subject|4
1598200|NCT02309359|5564932|P2|Overall Study|Withdrawal by Subject|2
1598201|NCT02309359|5564933|P1|Overall Study|Withdrawal by Subject|2
1598202|NCT02309359|5564929|P5|Overall Study|Death|0
1598203|NCT02309359|5564930|P4|Overall Study|Death|0
1598204|NCT02309359|5564931|P3|Overall Study|Death|0
1598205|NCT02309359|5564932|P2|Overall Study|Death|0
1598206|NCT02309359|5564933|P1|Overall Study|Death|1
1598207|NCT02309359|5564929|P5|Overall Study|Adverse Event|4
1598208|NCT02309359|5564930|P4|Overall Study|Adverse Event|4
1598209|NCT02309359|5564931|P3|Overall Study|Adverse Event|5
1598210|NCT02309359|5564932|P2|Overall Study|Adverse Event|5
1598211|NCT02309359|5564933|P1|Overall Study|Adverse Event|4
1598212|NCT02309294|5565060|P1|Overall Study|Withdrawal by Subject|2
1598213|NCT02309112|5565067|P3|Overall Study|Lost to Follow-up|0
1598214|NCT02309112|5565068|P2|Overall Study|Lost to Follow-up|1
1598215|NCT02309112|5565069|P1|Overall Study|Lost to Follow-up|0
1598216|NCT02309112|5565067|P3|Overall Study|Withdrawal by Subject|1
1598217|NCT02309112|5565068|P2|Overall Study|Withdrawal by Subject|0
1598218|NCT02309112|5565069|P1|Overall Study|Withdrawal by Subject|1
1598219|NCT02309099|5565092|P2|Overall Study|Adverse Event|0
1598220|NCT02309099|5565093|P1|Overall Study|Adverse Event|2
1598221|NCT02308748|5565154|P10|Period 5|Adverse Event|0
1598222|NCT02308748|5565155|P9|Period 5|Adverse Event|1
1598223|NCT02308748|5565156|P8|Period 5|Adverse Event|0
1598224|NCT02308748|5565157|P7|Period 5|Adverse Event|0
1598225|NCT02308748|5565158|P6|Period 5|Adverse Event|0
1598226|NCT02308748|5565159|P5|Period 5|Adverse Event|0
1598227|NCT02308748|5565160|P4|Period 5|Adverse Event|0
1598228|NCT02308748|5565161|P3|Period 5|Adverse Event|0
1598229|NCT02308748|5565162|P2|Period 5|Adverse Event|0
1598230|NCT02308748|5565163|P1|Period 5|Adverse Event|1
1598231|NCT02308748|5565154|P10|Period 3|Protocol Violation|1
1598232|NCT02308748|5565155|P9|Period 3|Protocol Violation|0
1598233|NCT02308748|5565156|P8|Period 3|Protocol Violation|0
1598234|NCT02308748|5565157|P7|Period 3|Protocol Violation|0
1598235|NCT02308748|5565158|P6|Period 3|Protocol Violation|0
1598236|NCT02308748|5565159|P5|Period 3|Protocol Violation|0
1598237|NCT02308748|5565160|P4|Period 3|Protocol Violation|0
1598238|NCT02308748|5565161|P3|Period 3|Protocol Violation|0
1598239|NCT02308748|5565162|P2|Period 3|Protocol Violation|0
1598240|NCT02308748|5565163|P1|Period 3|Protocol Violation|0
1598241|NCT02308748|5565154|P10|Period 2|Adverse Event|0
1598242|NCT02308748|5565155|P9|Period 2|Adverse Event|0
1598243|NCT02308748|5565156|P8|Period 2|Adverse Event|1
1598244|NCT02308748|5565157|P7|Period 2|Adverse Event|0
1598245|NCT02308748|5565158|P6|Period 2|Adverse Event|0
1598246|NCT02308748|5565159|P5|Period 2|Adverse Event|0
1598247|NCT02308748|5565160|P4|Period 2|Adverse Event|0
1598248|NCT02308748|5565161|P3|Period 2|Adverse Event|0
1598249|NCT02308748|5565162|P2|Period 2|Adverse Event|0
1598250|NCT02308748|5565163|P1|Period 2|Adverse Event|0
1598251|NCT02308748|5565154|P10|Period 1|Withdrawal by Subject|0
1598252|NCT02308748|5565155|P9|Period 1|Withdrawal by Subject|0
1598253|NCT02308748|5565156|P8|Period 1|Withdrawal by Subject|0
1598254|NCT02308748|5565157|P7|Period 1|Withdrawal by Subject|0
1598255|NCT02308748|5565158|P6|Period 1|Withdrawal by Subject|0
1598256|NCT02308748|5565159|P5|Period 1|Withdrawal by Subject|0
1598257|NCT02308748|5565160|P4|Period 1|Withdrawal by Subject|0
1598258|NCT02308748|5565161|P3|Period 1|Withdrawal by Subject|1
1598259|NCT02308748|5565162|P2|Period 1|Withdrawal by Subject|0
1598260|NCT02308748|5565163|P1|Period 1|Withdrawal by Subject|0
1598261|NCT02308696|5565177|P2|Overall Study|Moved to a Higher Level of Care|6
1598262|NCT02308696|5565178|P1|Overall Study|Moved to a Higher Level of Care|17
1598263|NCT02308696|5565177|P2|Overall Study|Death|4
1598264|NCT02308696|5565178|P1|Overall Study|Death|8
1598265|NCT02308696|5565177|P2|Overall Study|Lost to Follow-up|21
1598266|NCT02308696|5565178|P1|Overall Study|Lost to Follow-up|28
1598267|NCT02308540|5565212|P6|Overall Study|Lost to Follow-up|1
1598268|NCT02308540|5565213|P5|Overall Study|Lost to Follow-up|0
1598269|NCT02308540|5565214|P4|Overall Study|Lost to Follow-up|0
1598270|NCT02308540|5565215|P3|Overall Study|Lost to Follow-up|0
1598271|NCT02308540|5565216|P2|Overall Study|Lost to Follow-up|0
1598272|NCT02308540|5565217|P1|Overall Study|Lost to Follow-up|0
1598273|NCT02308228|5565306|P2|Overall Study|Withdrawal by Subject|3
1598274|NCT02308228|5565307|P1|Overall Study|Withdrawal by Subject|5
1598275|NCT02308228|5565306|P2|Overall Study|Adverse Event|4
1598276|NCT02308228|5565307|P1|Overall Study|Adverse Event|3
1598277|NCT02308124|5565335|P3|Overall Study|Adverse Event|2
1598278|NCT02308124|5565336|P2|Overall Study|Adverse Event|2
1598279|NCT02308124|5565337|P1|Overall Study|Adverse Event|0
1598280|NCT02308124|5565335|P3|Overall Study|Lost to Follow-up|6
1598281|NCT02308124|5565336|P2|Overall Study|Lost to Follow-up|6
1598282|NCT02308124|5565337|P1|Overall Study|Lost to Follow-up|6
1598283|NCT02308020|5565363|P6|Overall Study|On treatment|0
1598284|NCT02308020|5565364|P5|Overall Study|On treatment|0
1598285|NCT02308020|5565365|P4|Overall Study|On treatment|0
1598286|NCT02308020|5565366|P3|Overall Study|On treatment|0
1598287|NCT02308020|5565367|P2|Overall Study|On treatment|3
1598288|NCT02308020|5565368|P1|Overall Study|On treatment|0
1598289|NCT02308020|5565363|P6|Overall Study|Withdrawal by Subject|0
1598290|NCT02308020|5565364|P5|Overall Study|Withdrawal by Subject|2
1598291|NCT02308020|5565365|P4|Overall Study|Withdrawal by Subject|3
1598292|NCT02308020|5565366|P3|Overall Study|Withdrawal by Subject|0
1598293|NCT02308020|5565367|P2|Overall Study|Withdrawal by Subject|4
1598294|NCT02308020|5565368|P1|Overall Study|Withdrawal by Subject|0
1598295|NCT02308020|5565363|P6|Overall Study|Physician Decision|1
1598296|NCT02308020|5565364|P5|Overall Study|Physician Decision|0
1598297|NCT02308020|5565365|P4|Overall Study|Physician Decision|0
1598298|NCT02308020|5565366|P3|Overall Study|Physician Decision|0
1598299|NCT02308020|5565367|P2|Overall Study|Physician Decision|0
1598300|NCT02308020|5565368|P1|Overall Study|Physician Decision|0
1598301|NCT02308020|5565363|P6|Overall Study|Protocol Violation|0
1598302|NCT02308020|5565364|P5|Overall Study|Protocol Violation|0
1598303|NCT02308020|5565365|P4|Overall Study|Protocol Violation|0
1598304|NCT02308020|5565366|P3|Overall Study|Protocol Violation|1
1598305|NCT02308020|5565367|P2|Overall Study|Protocol Violation|0
1598306|NCT02308020|5565368|P1|Overall Study|Protocol Violation|0
1598307|NCT02308020|5565363|P6|Overall Study|Adverse Event|1
1598308|NCT02308020|5565364|P5|Overall Study|Adverse Event|0
1598309|NCT02308020|5565365|P4|Overall Study|Adverse Event|1
1598310|NCT02308020|5565366|P3|Overall Study|Adverse Event|0
1598311|NCT02308020|5565367|P2|Overall Study|Adverse Event|5
1598312|NCT02308020|5565368|P1|Overall Study|Adverse Event|3
1598313|NCT02307682|5565469|P3|Overall Study|Other|0
1598314|NCT02307682|5565470|P2|Overall Study|Other|1
1598315|NCT02307682|5565471|P1|Overall Study|Other|1
1598316|NCT02307682|5565469|P3|Overall Study|Protocol Deviation|2
1598317|NCT02307682|5565470|P2|Overall Study|Protocol Deviation|0
1598318|NCT02307682|5565471|P1|Overall Study|Protocol Deviation|0
1598319|NCT02307682|5565469|P3|Overall Study|Lost to Follow-up|6
1598320|NCT02307682|5565470|P2|Overall Study|Lost to Follow-up|5
1598321|NCT02307682|5565471|P1|Overall Study|Lost to Follow-up|1
1598322|NCT02307682|5565469|P3|Overall Study|Death|12
1598323|NCT02307682|5565470|P2|Overall Study|Death|7
1598324|NCT02307682|5565471|P1|Overall Study|Death|9
1598325|NCT02307682|5565469|P3|Overall Study|Withdrawal by Subject|23
1598326|NCT02307682|5565470|P2|Overall Study|Withdrawal by Subject|34
1598327|NCT02307682|5565471|P1|Overall Study|Withdrawal by Subject|26
1598328|NCT02307682|5565469|P3|Overall Study|Progressive Disease|0
1598329|NCT02307682|5565470|P2|Overall Study|Progressive Disease|0
1598330|NCT02307682|5565471|P1|Overall Study|Progressive Disease|1
1598331|NCT02307682|5565469|P3|Overall Study|Physician Decision|8
1598332|NCT02307682|5565470|P2|Overall Study|Physician Decision|2
1598333|NCT02307682|5565471|P1|Overall Study|Physician Decision|2
1598334|NCT02307682|5565469|P3|Overall Study|Lack of Efficacy|1
1598335|NCT02307682|5565470|P2|Overall Study|Lack of Efficacy|0
1598336|NCT02307682|5565471|P1|Overall Study|Lack of Efficacy|1
1598337|NCT02307682|5565469|P3|Overall Study|Adverse Event|12
1598338|NCT02307682|5565470|P2|Overall Study|Adverse Event|8
1598339|NCT02307682|5565471|P1|Overall Study|Adverse Event|9
1598340|NCT02307513|5565587|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
1598341|NCT02307513|5565588|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
1598342|NCT02307513|5565587|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
1598343|NCT02307513|5565588|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
1598344|NCT02307513|5565587|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
1598345|NCT02307513|5565588|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
1598346|NCT02307513|5565587|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
1598347|NCT02307513|5565588|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
1598348|NCT02307513|5565587|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
1598349|NCT02307513|5565588|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
1598350|NCT02307513|5565587|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
1598351|NCT02307513|5565588|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
1598352|NCT02307513|5565587|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
1598353|NCT02307513|5565588|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
1598354|NCT02307513|5565587|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
1598355|NCT02307513|5565588|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
1598356|NCT02307513|5565587|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
1598357|NCT02307513|5565588|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
1598358|NCT02307513|5565587|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
1598359|NCT02307513|5565588|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
1598360|NCT02307513|5565587|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
1598361|NCT02307513|5565588|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
1598362|NCT02307513|5565587|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
1598363|NCT02307513|5565588|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
1598364|NCT02307266|5565639|P3|Overall Study|Lost to Follow-up|0
1598365|NCT02307266|5565640|P2|Overall Study|Lost to Follow-up|0
1598366|NCT02307266|5565641|P1|Overall Study|Lost to Follow-up|3
1598367|NCT02307266|5565639|P3|Overall Study|Withdrawal by Subject|1
1598368|NCT02307266|5565640|P2|Overall Study|Withdrawal by Subject|0
1598369|NCT02307266|5565641|P1|Overall Study|Withdrawal by Subject|2
1598370|NCT02307266|5565639|P3|Overall Study|Adverse Event|5
1598371|NCT02307266|5565640|P2|Overall Study|Adverse Event|1
1598372|NCT02307266|5565641|P1|Overall Study|Adverse Event|3
1598373|NCT02306850|5565666|P1|Overall Study|Lack of Efficacy|2
1598374|NCT02306265|5565688|P1|Overall Study|Withdrawal by Subject|1
1598375|NCT02305888|5565697|P3|Overall Study|Adverse Event|0
1598376|NCT02305888|5565698|P2|Overall Study|Adverse Event|1
1598377|NCT02305888|5565699|P1|Overall Study|Adverse Event|0
1598378|NCT02305888|5565697|P3|Overall Study|Lost to Follow-up|1
1598379|NCT02305888|5565698|P2|Overall Study|Lost to Follow-up|0
1598380|NCT02305888|5565699|P1|Overall Study|Lost to Follow-up|0
1598381|NCT02305797|5565718|P2|Overall Study|Reason not collected|1
1598382|NCT02305797|5565719|P1|Overall Study|Reason not collected|0
1598383|NCT02305797|5565718|P2|Overall Study|Noncompliance|12
1598384|NCT02305797|5565719|P1|Overall Study|Noncompliance|14
1598385|NCT02305797|5565718|P2|Overall Study|Pregnancy|2
1598386|NCT02305797|5565719|P1|Overall Study|Pregnancy|0
1598387|NCT02305797|5565718|P2|Overall Study|Lost to Follow-up|11
1598388|NCT02305797|5565719|P1|Overall Study|Lost to Follow-up|5
1598389|NCT02305797|5565718|P2|Overall Study|Lack of Efficacy|0
1598390|NCT02305797|5565719|P1|Overall Study|Lack of Efficacy|6
1598391|NCT02305797|5565718|P2|Overall Study|Withdrawal by Subject|10
1598392|NCT02305797|5565719|P1|Overall Study|Withdrawal by Subject|9
1598393|NCT02305797|5565718|P2|Overall Study|Adverse Event|2
1598394|NCT02305797|5565719|P1|Overall Study|Adverse Event|11
1598395|NCT02305758|5565729|P2|Overall Study|Other, not specified|1
1598396|NCT02305758|5565730|P1|Overall Study|Other, not specified|2
1598397|NCT02305758|5565729|P2|Overall Study|Study Terminated by Sponsor|34
1598398|NCT02305758|5565730|P1|Overall Study|Study Terminated by Sponsor|21
1598399|NCT02305758|5565729|P2|Overall Study|Lost to Follow-up|1
1598400|NCT02305758|5565730|P1|Overall Study|Lost to Follow-up|6
1598401|NCT02305758|5565729|P2|Overall Study|Withdrew consent|2
1598402|NCT02305758|5565730|P1|Overall Study|Withdrew consent|9
1598403|NCT02305758|5565729|P2|Overall Study|Death|27
1598404|NCT02305758|5565730|P1|Overall Study|Death|27
1598405|NCT02305446|5565748|P1|Overall Study|Adverse Event|1
1598406|NCT02305381|5565756|P3|Overall Study|Unclassified|7
1598407|NCT02305381|5565757|P2|Overall Study|Unclassified|5
1598408|NCT02305381|5565758|P1|Overall Study|Unclassified|5
1598409|NCT02305238|5565871|P3|Overall Study|Required procedure failed|0
1598410|NCT02305238|5565872|P2|Overall Study|Required procedure failed|1
1598411|NCT02305238|5565873|P1|Overall Study|Required procedure failed|0
1598412|NCT02305238|5565871|P3|Overall Study|Randomized failure|8
1598413|NCT02305238|5565872|P2|Overall Study|Randomized failure|0
1598414|NCT02305238|5565873|P1|Overall Study|Randomized failure|0
1598415|NCT02305238|5565871|P3|Overall Study|Withdrawal by Subject|0
1598416|NCT02305238|5565872|P2|Overall Study|Withdrawal by Subject|4
1598417|NCT02305238|5565873|P1|Overall Study|Withdrawal by Subject|3
1598418|NCT02305238|5565871|P3|Overall Study|Adverse Event|0
1598419|NCT02305238|5565872|P2|Overall Study|Adverse Event|2
1598420|NCT02305238|5565873|P1|Overall Study|Adverse Event|4
1598421|NCT02305238|5565871|P3|Overall Study|Physician Decision|0
1598422|NCT02305238|5565872|P2|Overall Study|Physician Decision|1
1598423|NCT02305238|5565873|P1|Overall Study|Physician Decision|2
1598424|NCT02305238|5565871|P3|Overall Study|Protocol Violation|0
1598425|NCT02305238|5565872|P2|Overall Study|Protocol Violation|3
1598426|NCT02305238|5565873|P1|Overall Study|Protocol Violation|0
1598427|NCT02305238|5565871|P3|Overall Study|Logistical difficulties|0
1598428|NCT02305238|5565872|P2|Overall Study|Logistical difficulties|3
1598429|NCT02305238|5565873|P1|Overall Study|Logistical difficulties|1
1598430|NCT02305238|5565871|P3|Overall Study|Progressive disease|0
1598431|NCT02305238|5565872|P2|Overall Study|Progressive disease|4
1598432|NCT02305238|5565873|P1|Overall Study|Progressive disease|4
1598433|NCT02305238|5565871|P3|Overall Study|Death|0
1598434|NCT02305238|5565872|P2|Overall Study|Death|1
1598435|NCT02305238|5565873|P1|Overall Study|Death|2
1598436|NCT02304926|5565905|P2|Overall Study|Lost to Follow-up|1
1598437|NCT02304926|5565906|P1|Overall Study|Lost to Follow-up|2
1598438|NCT02304705|5565952|P2|Overall Study|Lost to Follow-up|2
1598439|NCT02304705|5565953|P1|Overall Study|Lost to Follow-up|0
1598440|NCT02304705|5565952|P2|Overall Study|Death|1
1598441|NCT02304705|5565953|P1|Overall Study|Death|0
1598442|NCT02304705|5565952|P2|Overall Study|Physician Decision|4
1598443|NCT02304705|5565953|P1|Overall Study|Physician Decision|2
1598444|NCT02304705|5565952|P2|Overall Study|Withdrawal by Subject|0
1598445|NCT02304705|5565953|P1|Overall Study|Withdrawal by Subject|2
1598446|NCT02304484|5565959|P1|Overall Study|Lost to Follow-up|2
1598447|NCT02304484|5565959|P1|Overall Study|Withdrawal by Subject|14
1598448|NCT02304484|5565959|P1|Overall Study|Death|9
1598449|NCT02303704|5566042|P2|Overall Study|Protocol Violation|9
1598450|NCT02303704|5566043|P1|Overall Study|Protocol Violation|5
1598451|NCT02303574|5566071|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598452|NCT02303574|5566072|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598453|NCT02303574|5566073|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
1598454|NCT02303574|5566074|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598455|NCT02303574|5566075|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598456|NCT02303574|5566076|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598457|NCT02303574|5566077|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598458|NCT02303574|5566078|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598459|NCT02303574|5566079|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598460|NCT02303574|5566080|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
1598461|NCT02303574|5566071|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598462|NCT02303574|5566072|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598463|NCT02303574|5566073|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598464|NCT02303574|5566074|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598465|NCT02303574|5566075|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598466|NCT02303574|5566076|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598467|NCT02303574|5566077|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598468|NCT02303574|5566078|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
1598469|NCT02303574|5566079|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598470|NCT02303574|5566080|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
1598471|NCT02303262|5566301|P1|Overall Study|Withdrawal by Subject|2
1598472|NCT02303041|5566309|P2|Overall Study|Adverse Event|2
1598473|NCT02303041|5566310|P1|Overall Study|Adverse Event|1
1598474|NCT02302859|5566326|P2|Overall Study|Withdrawal by Subject|1
1598475|NCT02302859|5566327|P1|Overall Study|Withdrawal by Subject|0
1598476|NCT02302859|5566326|P2|Overall Study|Lost Phone|1
1598477|NCT02302859|5566327|P1|Overall Study|Lost Phone|1
1598478|NCT02302846|5566333|P1|Overall Study|Withdrawal by Subject|1
1598479|NCT02302807|5566339|P2|Overall Study|Physician Decision|1
1598480|NCT02302807|5566340|P1|Overall Study|Physician Decision|0
1598481|NCT02302807|5566339|P2|Overall Study|Study Terminated By Sponsor|64
1598482|NCT02302807|5566340|P1|Overall Study|Study Terminated By Sponsor|35
1598483|NCT02302807|5566339|P2|Overall Study|Death|385
1598484|NCT02302807|5566340|P1|Overall Study|Death|397
1598485|NCT02302807|5566339|P2|Overall Study|Lost to Follow-up|6
1598486|NCT02302807|5566340|P1|Overall Study|Lost to Follow-up|4
1598487|NCT02302807|5566339|P2|Overall Study|Withdrawal by Subject|11
1598488|NCT02302807|5566340|P1|Overall Study|Withdrawal by Subject|28
1598489|NCT02302716|5566387|P2|Overall Study|Protocol Violation|1
1598490|NCT02302716|5566388|P1|Overall Study|Protocol Violation|0
1598491|NCT02302716|5566387|P2|Overall Study|Withdrawal by Subject|7
1598492|NCT02302716|5566388|P1|Overall Study|Withdrawal by Subject|13
1598493|NCT02302716|5566387|P2|Overall Study|Physician Decision|4
1598494|NCT02302716|5566388|P1|Overall Study|Physician Decision|3
1598495|NCT02302716|5566387|P2|Overall Study|Lost to Follow-up|4
1598496|NCT02302716|5566388|P1|Overall Study|Lost to Follow-up|2
1598497|NCT02302716|5566387|P2|Overall Study|Lack of Efficacy|1
1598498|NCT02302716|5566388|P1|Overall Study|Lack of Efficacy|0
1598499|NCT02302716|5566387|P2|Overall Study|Death|1
1598500|NCT02302716|5566388|P1|Overall Study|Death|0
1598501|NCT02302716|5566387|P2|Overall Study|Adverse Event|1
1598502|NCT02302716|5566388|P1|Overall Study|Adverse Event|1
1598503|NCT02302339|5566436|P4|Overall Study|Withdrawal by Subject|0
1598504|NCT02302339|5566437|P3|Overall Study|Withdrawal by Subject|1
1598505|NCT02302339|5566438|P2|Overall Study|Withdrawal by Subject|2
1598506|NCT02302339|5566439|P1|Overall Study|Withdrawal by Subject|0
1598507|NCT02302339|5566436|P4|Overall Study|Lost to Follow-up|0
1598508|NCT02302339|5566437|P3|Overall Study|Lost to Follow-up|0
1598509|NCT02302339|5566438|P2|Overall Study|Lost to Follow-up|0
1598510|NCT02302339|5566439|P1|Overall Study|Lost to Follow-up|1
1598511|NCT02302222|5566472|P2|Overall Study|Withdrawn prior to any treatment|1
1598512|NCT02302222|5566473|P1|Overall Study|Withdrawn prior to any treatment|0
1598513|NCT02302222|5566472|P2|Overall Study|Treatment discontinued before day 5|1
1598514|NCT02302222|5566473|P1|Overall Study|Treatment discontinued before day 5|0
1598515|NCT02302222|5566472|P2|Overall Study|Lost to Follow-up|0
1598516|NCT02302222|5566473|P1|Overall Study|Lost to Follow-up|1
1598517|NCT02302222|5566472|P2|Overall Study|Physician Decision|4
1598518|NCT02302222|5566473|P1|Overall Study|Physician Decision|0
1598539|NCT02301988|5566559|P2|Overall Study|Adverse Event|1
1598540|NCT02301988|5566560|P1|Overall Study|Adverse Event|1
1598541|NCT02301988|5566559|P2|Overall Study|Death|0
1598542|NCT02301988|5566560|P1|Overall Study|Death|1
1598543|NCT02301988|5566559|P2|Overall Study|Lack of Efficacy|2
1598544|NCT02301988|5566560|P1|Overall Study|Lack of Efficacy|3
1598545|NCT02301988|5566559|P2|Overall Study|Unknown Reason|3
1598546|NCT02301988|5566560|P1|Overall Study|Unknown Reason|1
1598547|NCT02301988|5566559|P2|Overall Study|Physician Decision|2
1598548|NCT02301988|5566560|P1|Overall Study|Physician Decision|2
1598549|NCT02301988|5566559|P2|Overall Study|Withdrawal by Subject|1
1598550|NCT02301988|5566560|P1|Overall Study|Withdrawal by Subject|2
1598551|NCT02301975|5566593|P3|Overall Study|Withdrawal by Subject|11
1598552|NCT02301975|5566594|P2|Overall Study|Withdrawal by Subject|12
1598553|NCT02301975|5566595|P1|Overall Study|Withdrawal by Subject|15
1598554|NCT02301975|5566593|P3|Overall Study|Physician Decision|3
1598555|NCT02301975|5566594|P2|Overall Study|Physician Decision|2
1598556|NCT02301975|5566595|P1|Overall Study|Physician Decision|4
1598557|NCT02301975|5566593|P3|Overall Study|Lost to Follow-up|2
1598558|NCT02301975|5566594|P2|Overall Study|Lost to Follow-up|2
1598559|NCT02301975|5566595|P1|Overall Study|Lost to Follow-up|0
1598560|NCT02301975|5566593|P3|Overall Study|Protocol Violation|3
1598561|NCT02301975|5566594|P2|Overall Study|Protocol Violation|5
1598562|NCT02301975|5566595|P1|Overall Study|Protocol Violation|3
1598563|NCT02301975|5566593|P3|Overall Study|Lack of Efficacy|1
1598564|NCT02301975|5566594|P2|Overall Study|Lack of Efficacy|1
1598565|NCT02301975|5566595|P1|Overall Study|Lack of Efficacy|1
1598566|NCT02301975|5566593|P3|Overall Study|Adverse Event|2
1598567|NCT02301975|5566594|P2|Overall Study|Adverse Event|3
1598568|NCT02301975|5566595|P1|Overall Study|Adverse Event|8
1598569|NCT02301936|5566623|P2|Overall Study|Lost to Follow-up|0
1598570|NCT02301936|5566624|P1|Overall Study|Lost to Follow-up|1
1598571|NCT02301897|5566649|P3|Treatment Course 2|Other Miscellaneous Reasons|0
1598572|NCT02301897|5566650|P2|Treatment Course 2|Other Miscellaneous Reasons|0
1598573|NCT02301897|5566651|P1|Treatment Course 2|Other Miscellaneous Reasons|1
1598574|NCT02301897|5566649|P3|Treatment Course 2|Withdrawal by Subject|0
1598575|NCT02301897|5566650|P2|Treatment Course 2|Withdrawal by Subject|2
1598576|NCT02301897|5566651|P1|Treatment Course 2|Withdrawal by Subject|0
1598577|NCT02301897|5566649|P3|Treatment Course 2|Pregnancy|1
1598578|NCT02301897|5566650|P2|Treatment Course 2|Pregnancy|1
1598579|NCT02301897|5566651|P1|Treatment Course 2|Pregnancy|0
1598580|NCT02301897|5566649|P3|Treatment Course 2|Lost to Follow-up|0
1598581|NCT02301897|5566650|P2|Treatment Course 2|Lost to Follow-up|2
1598582|NCT02301897|5566651|P1|Treatment Course 2|Lost to Follow-up|0
1598583|NCT02301897|5566649|P3|Treatment Course 1|Other Miscellaneous Reasons|0
1598584|NCT02301897|5566650|P2|Treatment Course 1|Other Miscellaneous Reasons|0
1598585|NCT02301897|5566651|P1|Treatment Course 1|Other Miscellaneous Reasons|1
1598586|NCT02301897|5566649|P3|Treatment Course 1|Withdrawal by Subject|2
1598587|NCT02301897|5566650|P2|Treatment Course 1|Withdrawal by Subject|0
1598588|NCT02301897|5566651|P1|Treatment Course 1|Withdrawal by Subject|0
1598589|NCT02301897|5566649|P3|Treatment Course 1|Withdrawal by Sponsor|2
1598590|NCT02301897|5566650|P2|Treatment Course 1|Withdrawal by Sponsor|0
1598591|NCT02301897|5566651|P1|Treatment Course 1|Withdrawal by Sponsor|0
1598592|NCT02301897|5566649|P3|Treatment Course 1|Lost to Follow-up|1
1598593|NCT02301897|5566650|P2|Treatment Course 1|Lost to Follow-up|2
1598594|NCT02301897|5566651|P1|Treatment Course 1|Lost to Follow-up|1
1598595|NCT02301897|5566649|P3|Treatment Course 1|Adverse Event|0
1598596|NCT02301897|5566650|P2|Treatment Course 1|Adverse Event|1
1598597|NCT02301897|5566651|P1|Treatment Course 1|Adverse Event|1
1598598|NCT02301897|5566649|P3|Treatment Course 1|Non-Compliance|1
1598599|NCT02301897|5566650|P2|Treatment Course 1|Non-Compliance|0
1598600|NCT02301897|5566651|P1|Treatment Course 1|Non-Compliance|0
1598601|NCT02301624|5566717|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
1598602|NCT02301624|5566718|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
1598603|NCT02301624|5566717|P2|Open-label Maintenance Phase|Death|1
1598604|NCT02301624|5566718|P1|Open-label Maintenance Phase|Death|2
1598605|NCT02301624|5566717|P2|Open-label Maintenance Phase|Physician Decision|3
1598606|NCT02301624|5566718|P1|Open-label Maintenance Phase|Physician Decision|3
1598607|NCT02301624|5566717|P2|Open-label Maintenance Phase|Adverse Event|5
1598608|NCT02301624|5566718|P1|Open-label Maintenance Phase|Adverse Event|2
1598609|NCT02301624|5566717|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
1598610|NCT02301624|5566718|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
1598611|NCT02301624|5566717|P2|Blind Induction Phase|Withdrawal by Subject|0
1598612|NCT02301624|5566718|P1|Blind Induction Phase|Withdrawal by Subject|1
1598613|NCT02301429|5566727|P1|Overall Study|not acceptable vascular anatomy|3
1598614|NCT02301403|5566773|P2|Overall Study|Withdrawal by Subject|41
1598615|NCT02301403|5566774|P1|Overall Study|Withdrawal by Subject|28
1598616|NCT02301390|5566782|P2|Overall Study|study terminated|0
1598617|NCT02301390|5566783|P1|Overall Study|study terminated|2
1598618|NCT02301390|5566782|P2|Overall Study|Missed multiple visits|1
1598619|NCT02301390|5566783|P1|Overall Study|Missed multiple visits|1
1598620|NCT02301390|5566782|P2|Overall Study|Procedure not completed|4
1598621|NCT02301390|5566783|P1|Overall Study|Procedure not completed|0
1598622|NCT02301390|5566782|P2|Overall Study|Death|2
1598623|NCT02301390|5566783|P1|Overall Study|Death|2
1598624|NCT02301390|5566782|P2|Overall Study|Lost to Follow-up|1
1598625|NCT02301390|5566783|P1|Overall Study|Lost to Follow-up|0
1598626|NCT02301390|5566782|P2|Overall Study|Physician Decision|0
1598627|NCT02301390|5566783|P1|Overall Study|Physician Decision|1
1598628|NCT02301390|5566782|P2|Overall Study|Protocol Violation|0
1598629|NCT02301390|5566783|P1|Overall Study|Protocol Violation|1
1598630|NCT02301390|5566782|P2|Overall Study|Withdrawal by Subject|5
1598631|NCT02301390|5566783|P1|Overall Study|Withdrawal by Subject|3
1598632|NCT02301169|5566824|P2|Overall Study|Adverse Event|0
1598633|NCT02301169|5566825|P1|Overall Study|Adverse Event|1
1598634|NCT02301143|5566839|P2|Investigator's Choice|Unresectable Surgery|1
1598635|NCT02301143|5566840|P1|Investigator's Choice|Unresectable Surgery|0
1598636|NCT02301143|5566839|P2|Investigator's Choice|Other|1
1598637|NCT02301143|5566840|P1|Investigator's Choice|Other|0
1598638|NCT02301143|5566839|P2|Investigator's Choice|Symptomatic Deterioration|1
1598639|NCT02301143|5566840|P1|Investigator's Choice|Symptomatic Deterioration|0
1598640|NCT02301143|5566839|P2|Investigator's Choice|Noncompliance With Study Drug|1
1598641|NCT02301143|5566840|P1|Investigator's Choice|Noncompliance With Study Drug|0
1598642|NCT02301143|5566839|P2|Investigator's Choice|Progressive Disease|3
1598643|NCT02301143|5566840|P1|Investigator's Choice|Progressive Disease|0
1598644|NCT02301143|5566839|P2|Investigator's Choice|Adverse Event|3
1598645|NCT02301143|5566840|P1|Investigator's Choice|Adverse Event|0
1598646|NCT02301143|5566839|P2|Induction Period|Other|0
1598647|NCT02301143|5566840|P1|Induction Period|Other|1
1598648|NCT02301143|5566839|P2|Induction Period|Protocol Violation|0
1598649|NCT02301143|5566840|P1|Induction Period|Protocol Violation|2
1598650|NCT02301143|5566839|P2|Induction Period|Symptomatic Deterioration|0
1598651|NCT02301143|5566840|P1|Induction Period|Symptomatic Deterioration|2
1598652|NCT02301143|5566839|P2|Induction Period|Physician Decision|0
1598653|NCT02301143|5566840|P1|Induction Period|Physician Decision|4
1598654|NCT02301143|5566839|P2|Induction Period|Noncompliance with Study Drug|0
1598655|NCT02301143|5566840|P1|Induction Period|Noncompliance with Study Drug|1
1598656|NCT02301143|5566839|P2|Induction Period|Withdrawal by Subject|0
1598657|NCT02301143|5566840|P1|Induction Period|Withdrawal by Subject|3
1598658|NCT02301143|5566839|P2|Induction Period|Progressive Disease|0
1598659|NCT02301143|5566840|P1|Induction Period|Progressive Disease|8
1598660|NCT02301143|5566839|P2|Induction Period|Adverse Event|0
1598661|NCT02301143|5566840|P1|Induction Period|Adverse Event|22
1598662|NCT02301143|5566839|P2|Induction Period|Death|0
1598663|NCT02301143|5566840|P1|Induction Period|Death|1
1598664|NCT02301143|5566839|P2|Induction Period|Enrolled But Not Treated|0
1598665|NCT02301143|5566840|P1|Induction Period|Enrolled But Not Treated|1
1598666|NCT02300610|5566884|P3|Overall Study|Withdrawal by Subject|1
1598667|NCT02300610|5566885|P2|Overall Study|Withdrawal by Subject|0
1598668|NCT02300610|5566886|P1|Overall Study|Withdrawal by Subject|1
1598669|NCT02300558|5566901|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
1598670|NCT02300558|5566901|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
1598671|NCT02300558|5566901|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
1598672|NCT02300558|5566901|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
1598673|NCT02300311|5566914|P2|Overall Study|Refused to continue taking medication|0
1598674|NCT02300311|5566915|P1|Overall Study|Refused to continue taking medication|18
1598675|NCT02300311|5566914|P2|Overall Study|Other than the reason specified|0
1598676|NCT02300311|5566915|P1|Overall Study|Other than the reason specified|1
1598677|NCT02300298|5566927|P2|Disposition for Docetaxel|other adverse event|4
1598678|NCT02300298|5566928|P1|Disposition for Docetaxel|other adverse event|0
1598679|NCT02300298|5566927|P2|Disposition for Docetaxel|Progressive disease|6
1598680|NCT02300298|5566928|P1|Disposition for Docetaxel|Progressive disease|0
1598681|NCT02300298|5566927|P2|Disposition for Nintedanib|Progressive disease|0
1598682|NCT02300298|5566928|P1|Disposition for Nintedanib|Progressive disease|10
1598683|NCT02300129|5566938|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1598684|NCT02300129|5566939|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1598685|NCT02300129|5566940|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
1598686|NCT02300129|5566941|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
1598687|NCT02300129|5566938|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
1598688|NCT02300129|5566939|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1598689|NCT02300129|5566940|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1598690|NCT02300129|5566941|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
1598691|NCT02300129|5566938|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1598692|NCT02300129|5566939|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1598693|NCT02300129|5566940|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
1598694|NCT02300129|5566941|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
1598695|NCT02300103|5566951|P1|Overall Study|Withdrew Consent|2
1598696|NCT02300103|5566951|P1|Overall Study|Protocol Violation|1
1598697|NCT02300103|5566951|P1|Overall Study|Lack of Efficacy|3
1598698|NCT02299934|5567031|P1|Overall Study|Termination of study|13
1598699|NCT02299635|5567081|P1|Overall Study|Other|3
1598700|NCT02299635|5567081|P1|Overall Study|Withdrawal by Subject|2
1598701|NCT02299635|5567081|P1|Overall Study|Objective progression or relapse|10
1598702|NCT02299635|5567081|P1|Overall Study|Global deterioration of health status|1
1598703|NCT02299635|5567081|P1|Overall Study|Death|1
1598704|NCT02299635|5567081|P1|Overall Study|Adverse Event|2
1598705|NCT02299427|5567121|P2|Overall Study|not adherent to dog website use|0
1598706|NCT02299427|5567122|P1|Overall Study|not adherent to dog website use|21
1598707|NCT02299427|5567121|P2|Overall Study|Lost to Follow-up|3
1598708|NCT02299427|5567122|P1|Overall Study|Lost to Follow-up|1
1598709|NCT02299427|5567121|P2|Overall Study|Withdrawal by Subject|0
1598710|NCT02299427|5567122|P1|Overall Study|Withdrawal by Subject|1
1598711|NCT02299388|5567132|P2|Overall Study|Withdrawal by Subject|1
1598712|NCT02299388|5567133|P1|Overall Study|Withdrawal by Subject|0
1598713|NCT02299375|5567143|P2|Overall Study|Withdrawal by Subject|4
1598714|NCT02299375|5567144|P1|Overall Study|Withdrawal by Subject|1
1598715|NCT02299375|5567143|P2|Overall Study|Physician Decision|1
1598716|NCT02299375|5567144|P1|Overall Study|Physician Decision|1
1598717|NCT02299375|5567143|P2|Overall Study|Lost to Follow-up|2
1598718|NCT02299375|5567144|P1|Overall Study|Lost to Follow-up|0
1598719|NCT02299375|5567143|P2|Overall Study|Other: Study closed/terminated|55
1598720|NCT02299375|5567144|P1|Overall Study|Other: Study closed/terminated|66
1598721|NCT02299375|5567143|P2|Overall Study|Other: Met stopping criteria|0
1598722|NCT02299375|5567144|P1|Overall Study|Other: Met stopping criteria|1
1598723|NCT02299375|5567143|P2|Overall Study|Protocol Violation|3
1598724|NCT02299375|5567144|P1|Overall Study|Protocol Violation|1
1598725|NCT02299375|5567143|P2|Overall Study|Lack of Efficacy|3
1598726|NCT02299375|5567144|P1|Overall Study|Lack of Efficacy|1
1598727|NCT02299375|5567143|P2|Overall Study|Adverse Event, non-fatal|9
1598728|NCT02299375|5567144|P1|Overall Study|Adverse Event, non-fatal|8
1598729|NCT02299375|5567143|P2|Overall Study|Adverse Event, serious fatal|3
1598730|NCT02299375|5567144|P1|Overall Study|Adverse Event, serious fatal|1
1598731|NCT02299336|5567203|P1|Overall Study|Lost to Follow-up|1
1598732|NCT02299336|5567203|P1|Overall Study|Death|1
1598733|NCT02299336|5567203|P1|Overall Study|Adverse Event|1
1598734|NCT02299336|5567203|P1|Overall Study|Withdrawal by Subject|11
1598735|NCT02299206|5567238|P1|Overall Study|Withdrawal by Subject|1
1598736|NCT02299206|5567238|P1|Overall Study|Lost to Follow-up|1
1598737|NCT02299076|5567299|P2|Overall Study|Fraudulent Entries|14
1598738|NCT02299076|5567300|P1|Overall Study|Fraudulent Entries|20
1598739|NCT02298946|5567321|P2|Overall Study|Unevaluable|1
1598740|NCT02298946|5567322|P1|Overall Study|Unevaluable|2
1598741|NCT02298946|5567321|P2|Overall Study|Did not receive treatment|0
1598742|NCT02298946|5567322|P1|Overall Study|Did not receive treatment|2
1598743|NCT02298868|5567350|P1|Overall Study|Patient underwent transplant|1
1598744|NCT02298868|5567350|P1|Overall Study|Death|1
1598745|NCT02298868|5567350|P1|Overall Study|Adverse Event|1
1598746|NCT02298192|5567421|P2|Overall Study|Adverse Event|2
1598747|NCT02298192|5567422|P1|Overall Study|Adverse Event|6
1598748|NCT02298192|5567421|P2|Overall Study|Lost to Follow-up|1
1598749|NCT02298192|5567422|P1|Overall Study|Lost to Follow-up|2
1598750|NCT02298192|5567421|P2|Overall Study|Withdrawal by Subject|1
1598751|NCT02298192|5567422|P1|Overall Study|Withdrawal by Subject|6
1598752|NCT02298192|5567421|P2|Overall Study|Withdrawal criteria|0
1598753|NCT02298192|5567422|P1|Overall Study|Withdrawal criteria|2
1598754|NCT02298192|5567421|P2|Overall Study|Unclassified|2
1598755|NCT02298192|5567422|P1|Overall Study|Unclassified|3
1598756|NCT02298179|5567446|P12|Overall Study|Lost to Follow-up|0
1598757|NCT02298179|5567447|P11|Overall Study|Lost to Follow-up|0
1598758|NCT02298179|5567448|P10|Overall Study|Lost to Follow-up|0
1598759|NCT02298179|5567449|P9|Overall Study|Lost to Follow-up|0
1598760|NCT02298179|5567450|P8|Overall Study|Lost to Follow-up|1
1598761|NCT02298179|5567451|P7|Overall Study|Lost to Follow-up|0
1598762|NCT02298179|5567452|P6|Overall Study|Lost to Follow-up|0
1598763|NCT02298179|5567453|P5|Overall Study|Lost to Follow-up|0
1598764|NCT02298179|5567454|P4|Overall Study|Lost to Follow-up|0
1598765|NCT02298179|5567455|P3|Overall Study|Lost to Follow-up|1
1598766|NCT02298179|5567456|P2|Overall Study|Lost to Follow-up|0
1598767|NCT02298179|5567457|P1|Overall Study|Lost to Follow-up|0
1598768|NCT02297841|5567699|P1|Overall Study|Protocol Violation|7
1598769|NCT02297841|5567699|P1|Overall Study|Withdrawal by Subject|1
1598770|NCT02297815|5567705|P2|Overall Study|Lost to Follow-up|140
1598771|NCT02297815|5567706|P1|Overall Study|Lost to Follow-up|236
1598772|NCT02297516|5567724|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
1598773|NCT02297516|5567725|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
1598774|NCT02297516|5567724|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
1598775|NCT02297516|5567725|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
1598776|NCT02297516|5567724|P2|Single Treatment Phase (6 Months)|Medical reason|0
1598777|NCT02297516|5567725|P1|Single Treatment Phase (6 Months)|Medical reason|1
1598778|NCT02297503|5567746|P2|Overall Study|Medical reason|1
1598779|NCT02297503|5567747|P1|Overall Study|Medical reason|0
1598780|NCT02297503|5567746|P2|Overall Study|Lost to Follow-up|1
1598781|NCT02297503|5567747|P1|Overall Study|Lost to Follow-up|0
1598782|NCT02297503|5567746|P2|Overall Study|Pregnancy|1
1598783|NCT02297503|5567747|P1|Overall Study|Pregnancy|0
1598784|NCT02297503|5567746|P2|Overall Study|Protocol Violation|0
1598785|NCT02297503|5567747|P1|Overall Study|Protocol Violation|1
1598786|NCT02297503|5567746|P2|Overall Study|Withdrawal by Subject|1
1598787|NCT02297503|5567747|P1|Overall Study|Withdrawal by Subject|1
1598788|NCT02297412|5567774|P2|Overall Study|Canceled|1
1598789|NCT02297412|5567775|P1|Overall Study|Canceled|1
1598790|NCT02296931|5567836|P2|Overall Study|Protocol Violation|2
1598791|NCT02296931|5567837|P1|Overall Study|Protocol Violation|0
1598792|NCT02296892|5567846|P3|Overall Study|Lost to Follow-up|1
1598793|NCT02296892|5567847|P2|Overall Study|Lost to Follow-up|0
1598794|NCT02296892|5567848|P1|Overall Study|Lost to Follow-up|5
1598795|NCT02296892|5567846|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
1598796|NCT02296892|5567847|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
1598797|NCT02296892|5567848|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
1598798|NCT02296840|5567867|P2|Overall Study|Lost to Follow-up|17
1598799|NCT02296840|5567868|P1|Overall Study|Lost to Follow-up|6
1598800|NCT02296840|5567867|P2|Overall Study|Protocol Violation|1
1598801|NCT02296840|5567868|P1|Overall Study|Protocol Violation|2
1598802|NCT02296840|5567867|P2|Overall Study|Adverse Event|1
1598803|NCT02296840|5567868|P1|Overall Study|Adverse Event|1
1598804|NCT02296476|5567976|P3|Overall Study|Disease Progression|2
1598805|NCT02296476|5567977|P2|Overall Study|Disease Progression|4
1598806|NCT02296476|5567978|P1|Overall Study|Disease Progression|6
1598807|NCT02296424|5568033|P4|Part 2|Lost to Follow-up|0
1598808|NCT02296424|5568034|P3|Part 2|Lost to Follow-up|1
1598809|NCT02296424|5568035|P2|Part 2|Lost to Follow-up|0
1598810|NCT02296424|5568036|P1|Part 2|Lost to Follow-up|0
1598811|NCT02296424|5568033|P4|Part 2|Adverse Event|0
1598812|NCT02296424|5568034|P3|Part 2|Adverse Event|1
1598813|NCT02296424|5568035|P2|Part 2|Adverse Event|0
1598814|NCT02296424|5568036|P1|Part 2|Adverse Event|0
1598815|NCT02296424|5568033|P4|Part 2|Lack of Efficacy|0
1598816|NCT02296424|5568034|P3|Part 2|Lack of Efficacy|1
1598817|NCT02296424|5568035|P2|Part 2|Lack of Efficacy|0
1598818|NCT02296424|5568036|P1|Part 2|Lack of Efficacy|0
1598819|NCT02296424|5568033|P4|Part 1|16 directly started part II|0
1598820|NCT02296424|5568034|P3|Part 1|16 directly started part II|0
1598821|NCT02296424|5568035|P2|Part 1|16 directly started part II|0
1598822|NCT02296424|5568036|P1|Part 1|16 directly started part II|16
1598823|NCT02296424|5568033|P4|Part 1|Lack of Efficacy|0
1598824|NCT02296424|5568034|P3|Part 1|Lack of Efficacy|0
1598825|NCT02296424|5568035|P2|Part 1|Lack of Efficacy|17
1598826|NCT02296424|5568036|P1|Part 1|Lack of Efficacy|5
1598827|NCT02296424|5568033|P4|Part 1|Adverse Event|0
1598828|NCT02296424|5568034|P3|Part 1|Adverse Event|0
1598829|NCT02296424|5568035|P2|Part 1|Adverse Event|11
1598830|NCT02296424|5568036|P1|Part 1|Adverse Event|2
1598831|NCT02296424|5568033|P4|Part 1|Study terminated by sponsor|0
1598832|NCT02296424|5568034|P3|Part 1|Study terminated by sponsor|0
1598833|NCT02296424|5568035|P2|Part 1|Study terminated by sponsor|1
1598834|NCT02296424|5568036|P1|Part 1|Study terminated by sponsor|0
1598835|NCT02296424|5568033|P4|Part 1|Withdrawal by Subject|0
1598836|NCT02296424|5568034|P3|Part 1|Withdrawal by Subject|0
1598837|NCT02296424|5568035|P2|Part 1|Withdrawal by Subject|2
1598838|NCT02296424|5568036|P1|Part 1|Withdrawal by Subject|0
1598839|NCT02296424|5568033|P4|Part 1|Protocol Violation|0
1598840|NCT02296424|5568034|P3|Part 1|Protocol Violation|0
1598841|NCT02296424|5568035|P2|Part 1|Protocol Violation|1
1598842|NCT02296424|5568036|P1|Part 1|Protocol Violation|0
1598843|NCT02296424|5568033|P4|Part 1|New therapy for study indication|0
1598844|NCT02296424|5568034|P3|Part 1|New therapy for study indication|0
1598845|NCT02296424|5568035|P2|Part 1|New therapy for study indication|1
1598846|NCT02296424|5568036|P1|Part 1|New therapy for study indication|0
1598847|NCT02296320|5568061|P3|Overall Study|Not - specified|1
1598848|NCT02296320|5568062|P2|Overall Study|Not - specified|0
1598849|NCT02296320|5568063|P1|Overall Study|Not - specified|0
1598850|NCT02296320|5568061|P3|Overall Study|Not treated|0
1598851|NCT02296320|5568062|P2|Overall Study|Not treated|0
1598852|NCT02296320|5568063|P1|Overall Study|Not treated|2
1598853|NCT02296320|5568061|P3|Overall Study|Lost to Follow-up|7
1598854|NCT02296320|5568062|P2|Overall Study|Lost to Follow-up|2
1598855|NCT02296320|5568063|P1|Overall Study|Lost to Follow-up|5
1598856|NCT02296320|5568061|P3|Overall Study|Death|27
1598857|NCT02296320|5568062|P2|Overall Study|Death|3
1598858|NCT02296320|5568063|P1|Overall Study|Death|24
1598859|NCT02296320|5568061|P3|Overall Study|Withdrawal by Subject|2
1598860|NCT02296320|5568062|P2|Overall Study|Withdrawal by Subject|0
1598861|NCT02296320|5568063|P1|Overall Study|Withdrawal by Subject|4
1598862|NCT02296242|5568102|P5|Overall Study|Lack of Efficacy|3
1598863|NCT02296242|5568103|P4|Overall Study|Lack of Efficacy|0
1598864|NCT02296242|5568104|P3|Overall Study|Lack of Efficacy|0
1598865|NCT02296242|5568105|P2|Overall Study|Lack of Efficacy|0
1598866|NCT02296242|5568106|P1|Overall Study|Lack of Efficacy|0
1598867|NCT02296242|5568102|P5|Overall Study|Adverse Event|0
1598868|NCT02296242|5568103|P4|Overall Study|Adverse Event|1
1598869|NCT02296242|5568104|P3|Overall Study|Adverse Event|0
1598870|NCT02296242|5568105|P2|Overall Study|Adverse Event|0
1598871|NCT02296242|5568106|P1|Overall Study|Adverse Event|0
1598872|NCT02296242|5568102|P5|Overall Study|Alternative Treatment|0
1598873|NCT02296242|5568103|P4|Overall Study|Alternative Treatment|1
1598874|NCT02296242|5568104|P3|Overall Study|Alternative Treatment|0
1598875|NCT02296242|5568105|P2|Overall Study|Alternative Treatment|0
1598876|NCT02296242|5568106|P1|Overall Study|Alternative Treatment|0
1598877|NCT02296242|5568102|P5|Overall Study|Physician Decision|0
1598878|NCT02296242|5568103|P4|Overall Study|Physician Decision|1
1598879|NCT02296242|5568104|P3|Overall Study|Physician Decision|0
1598880|NCT02296242|5568105|P2|Overall Study|Physician Decision|1
1598881|NCT02296242|5568106|P1|Overall Study|Physician Decision|0
1598882|NCT02296242|5568102|P5|Overall Study|Screened for Other Protocol|0
1598883|NCT02296242|5568103|P4|Overall Study|Screened for Other Protocol|0
1598884|NCT02296242|5568104|P3|Overall Study|Screened for Other Protocol|0
1598885|NCT02296242|5568105|P2|Overall Study|Screened for Other Protocol|1
1598886|NCT02296242|5568106|P1|Overall Study|Screened for Other Protocol|0
1598887|NCT02296242|5568102|P5|Overall Study|Need for Hydroxyurea|0
1598888|NCT02296242|5568103|P4|Overall Study|Need for Hydroxyurea|0
1598889|NCT02296242|5568104|P3|Overall Study|Need for Hydroxyurea|0
1598890|NCT02296242|5568105|P2|Overall Study|Need for Hydroxyurea|0
1598891|NCT02296242|5568106|P1|Overall Study|Need for Hydroxyurea|2
1598892|NCT02296242|5568102|P5|Overall Study|Lost to Follow-up|0
1598893|NCT02296242|5568103|P4|Overall Study|Lost to Follow-up|0
1598894|NCT02296242|5568104|P3|Overall Study|Lost to Follow-up|0
1598895|NCT02296242|5568105|P2|Overall Study|Lost to Follow-up|0
1598896|NCT02296242|5568106|P1|Overall Study|Lost to Follow-up|1
1598897|NCT02296242|5568102|P5|Overall Study|At Least 3 Drug Interruptions|1
1598898|NCT02296242|5568103|P4|Overall Study|At Least 3 Drug Interruptions|1
1598899|NCT02296242|5568104|P3|Overall Study|At Least 3 Drug Interruptions|1
1598900|NCT02296242|5568105|P2|Overall Study|At Least 3 Drug Interruptions|0
1598901|NCT02296242|5568106|P1|Overall Study|At Least 3 Drug Interruptions|0
1598902|NCT02296242|5568102|P5|Overall Study|Patient Condition Changed|1
1598903|NCT02296242|5568103|P4|Overall Study|Patient Condition Changed|0
1598904|NCT02296242|5568104|P3|Overall Study|Patient Condition Changed|2
1598905|NCT02296242|5568105|P2|Overall Study|Patient Condition Changed|0
1598906|NCT02296242|5568106|P1|Overall Study|Patient Condition Changed|0
1598907|NCT02296242|5568102|P5|Overall Study|Unacceptable Toxicity|1
1598908|NCT02296242|5568103|P4|Overall Study|Unacceptable Toxicity|0
1598909|NCT02296242|5568104|P3|Overall Study|Unacceptable Toxicity|0
1598910|NCT02296242|5568105|P2|Overall Study|Unacceptable Toxicity|0
1598911|NCT02296242|5568106|P1|Overall Study|Unacceptable Toxicity|0
1598912|NCT02296242|5568102|P5|Overall Study|Disease Progression|11
1598913|NCT02296242|5568103|P4|Overall Study|Disease Progression|8
1598914|NCT02296242|5568104|P3|Overall Study|Disease Progression|2
1598915|NCT02296242|5568105|P2|Overall Study|Disease Progression|3
1598916|NCT02296242|5568106|P1|Overall Study|Disease Progression|1
1598917|NCT02296242|5568102|P5|Overall Study|Withdrawal by Subject|3
1598918|NCT02296242|5568103|P4|Overall Study|Withdrawal by Subject|1
1598919|NCT02296242|5568104|P3|Overall Study|Withdrawal by Subject|1
1598920|NCT02296242|5568105|P2|Overall Study|Withdrawal by Subject|0
1598921|NCT02296242|5568106|P1|Overall Study|Withdrawal by Subject|0
1598922|NCT02296242|5568102|P5|Overall Study|Death|1
1598923|NCT02296242|5568103|P4|Overall Study|Death|1
1598924|NCT02296242|5568104|P3|Overall Study|Death|1
1598925|NCT02296242|5568105|P2|Overall Study|Death|1
1598926|NCT02296242|5568106|P1|Overall Study|Death|1
1598927|NCT02296138|5568134|P2|Overall Study|Other than specified|13
1598928|NCT02296138|5568135|P1|Overall Study|Other than specified|15
1598929|NCT02296138|5568134|P2|Overall Study|Patients with data irregularities|11
1598930|NCT02296138|5568135|P1|Overall Study|Patients with data irregularities|10
1598931|NCT02296138|5568134|P2|Overall Study|Not Treated|1
1598932|NCT02296138|5568135|P1|Overall Study|Not Treated|1
1598933|NCT02296138|5568134|P2|Overall Study|Withdrawal by Subject|131
1598934|NCT02296138|5568135|P1|Overall Study|Withdrawal by Subject|184
1598935|NCT02296138|5568134|P2|Overall Study|Lost to Follow-up|12
1598936|NCT02296138|5568135|P1|Overall Study|Lost to Follow-up|9
1598937|NCT02296138|5568134|P2|Overall Study|Protocol Violation|36
1598938|NCT02296138|5568135|P1|Overall Study|Protocol Violation|35
1598939|NCT02296138|5568134|P2|Overall Study|Lack of Efficacy|37
1598940|NCT02296138|5568135|P1|Overall Study|Lack of Efficacy|59
1598941|NCT02296138|5568134|P2|Overall Study|Adverse Event|259
1598942|NCT02296138|5568135|P1|Overall Study|Adverse Event|348
1598963|NCT02296112|5568206|P1|Overall Study|Began an alternate therapy|1
1598964|NCT02296112|5568206|P1|Overall Study|Toxicity|1
1598965|NCT02296112|5568206|P1|Overall Study|Disease progression|7
1598966|NCT02295995|5568248|P2|Overall Study|Lost to Follow-up|1
1598967|NCT02295995|5568249|P1|Overall Study|Lost to Follow-up|5
1598968|NCT02295774|5568260|P1|Overall Study|Withdrawal by Subject|2
1598969|NCT02295774|5568260|P1|Overall Study|Physician Decision|1
1598970|NCT02295644|5568269|P4|Overall Study|Did not meet inclusion criterion|2
1598971|NCT02295644|5568270|P3|Overall Study|Did not meet inclusion criterion|1
1598972|NCT02295644|5568271|P2|Overall Study|Did not meet inclusion criterion|0
1598973|NCT02295644|5568272|P1|Overall Study|Did not meet inclusion criterion|0
1598974|NCT02295280|5568321|P2|Overall Study|Adverse Event|1
1598975|NCT02295280|5568322|P1|Overall Study|Adverse Event|0
1598976|NCT02295020|5568330|P2|Overall Study|Withdrawal by Subject|2
1598977|NCT02295020|5568331|P1|Overall Study|Withdrawal by Subject|3
1598978|NCT02295020|5568330|P2|Overall Study|Adverse Event|1
1598979|NCT02295020|5568331|P1|Overall Study|Adverse Event|0
1598980|NCT02294786|5568363|P2|Overall Study|Death|3
1598981|NCT02294786|5568364|P1|Overall Study|Death|2
1598982|NCT02294786|5568363|P2|Overall Study|Adverse Event|1
1598983|NCT02294786|5568364|P1|Overall Study|Adverse Event|1
1598984|NCT02294786|5568363|P2|Overall Study|Protocol Violation|0
1598985|NCT02294786|5568364|P1|Overall Study|Protocol Violation|1
1598986|NCT02294786|5568363|P2|Overall Study|Lost to Follow-up|2
1598987|NCT02294786|5568364|P1|Overall Study|Lost to Follow-up|1
1598988|NCT02294786|5568363|P2|Overall Study|Physician Decision|7
1598989|NCT02294786|5568364|P1|Overall Study|Physician Decision|6
1598990|NCT02294786|5568363|P2|Overall Study|Withdrawal by Subject|1
1598991|NCT02294786|5568364|P1|Overall Study|Withdrawal by Subject|0
1598992|NCT02294773|5568411|P2|Overall Study|Withdrawal by Subject|2
1598993|NCT02294773|5568412|P1|Overall Study|Withdrawal by Subject|0
1598994|NCT02294734|5568428|P2|Overall Study|Withdrawal by Subject|2
1598995|NCT02294734|5568429|P1|Overall Study|Withdrawal by Subject|4
1598996|NCT02294734|5568428|P2|Overall Study|Physician Decision|1
1598997|NCT02294734|5568429|P1|Overall Study|Physician Decision|2
1598998|NCT02294734|5568428|P2|Overall Study|Lost to Follow-up|0
1598999|NCT02294734|5568429|P1|Overall Study|Lost to Follow-up|2
1599000|NCT02294734|5568428|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
1599001|NCT02294734|5568429|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
1599002|NCT02294734|5568428|P2|Overall Study|Adverse Event|5
1599003|NCT02294734|5568429|P1|Overall Study|Adverse Event|5
1599004|NCT02294682|5568481|P2|Overall Study|Could not swallow pills|0
1599005|NCT02294682|5568482|P1|Overall Study|Could not swallow pills|1
1599006|NCT02294604|5568525|P3|Overall Study|Culture contamination|0
1599007|NCT02294604|5568526|P2|Overall Study|Culture contamination|2
1599008|NCT02294604|5568527|P1|Overall Study|Culture contamination|1
1599009|NCT02294604|5568525|P3|Overall Study|Did not provide samples for culture|0
1599010|NCT02294604|5568526|P2|Overall Study|Did not provide samples for culture|1
1599011|NCT02294604|5568527|P1|Overall Study|Did not provide samples for culture|0
1599012|NCT02294474|5568546|P2|Overall Study|Other than specified above|12
1599013|NCT02294474|5568547|P1|Overall Study|Other than specified above|12
1599014|NCT02294474|5568546|P2|Overall Study|Protocol Violation|2
1599015|NCT02294474|5568547|P1|Overall Study|Protocol Violation|4
1599016|NCT02294474|5568546|P2|Overall Study|Lack of Efficacy|1
1599017|NCT02294474|5568547|P1|Overall Study|Lack of Efficacy|2
1599018|NCT02294474|5568546|P2|Overall Study|Adverse Event|7
1599019|NCT02294474|5568547|P1|Overall Study|Adverse Event|7
1599020|NCT02294461|5568571|P2|Overall Study|Miscellaneous|32
1599021|NCT02294461|5568572|P1|Overall Study|Miscellaneous|11
1599022|NCT02294461|5568571|P2|Overall Study|Adverse Event|10
1599023|NCT02294461|5568572|P1|Overall Study|Adverse Event|11
1599024|NCT02294461|5568571|P2|Overall Study|Disease Progression|39
1599025|NCT02294461|5568572|P1|Overall Study|Disease Progression|23
1599026|NCT02294461|5568571|P2|Overall Study|Withdrawal by Subject|45
1599027|NCT02294461|5568572|P1|Overall Study|Withdrawal by Subject|14
1599028|NCT02294461|5568571|P2|Overall Study|Protocol Violation|2
1599029|NCT02294461|5568572|P1|Overall Study|Protocol Violation|0
1599030|NCT02294461|5568571|P2|Overall Study|Death|3
1599031|NCT02294461|5568572|P1|Overall Study|Death|3
1599032|NCT02294396|5568628|P4|Overall Study|Miscellaneous|2
1599033|NCT02294396|5568629|P3|Overall Study|Miscellaneous|5
1599034|NCT02294396|5568630|P2|Overall Study|Miscellaneous|0
1599035|NCT02294396|5568631|P1|Overall Study|Miscellaneous|2
1599036|NCT02294396|5568628|P4|Overall Study|Protocol Deviation|1
1599037|NCT02294396|5568629|P3|Overall Study|Protocol Deviation|2
1599038|NCT02294396|5568630|P2|Overall Study|Protocol Deviation|2
1599039|NCT02294396|5568631|P1|Overall Study|Protocol Deviation|3
1599040|NCT02294396|5568628|P4|Overall Study|Lost to Follow-up|1
1599041|NCT02294396|5568629|P3|Overall Study|Lost to Follow-up|1
1599042|NCT02294396|5568630|P2|Overall Study|Lost to Follow-up|0
1599043|NCT02294396|5568631|P1|Overall Study|Lost to Follow-up|0
1599044|NCT02294396|5568628|P4|Overall Study|Withdrawal by Subject|8
1599045|NCT02294396|5568629|P3|Overall Study|Withdrawal by Subject|6
1599046|NCT02294396|5568630|P2|Overall Study|Withdrawal by Subject|6
1599047|NCT02294396|5568631|P1|Overall Study|Withdrawal by Subject|8
1599048|NCT02294396|5568628|P4|Overall Study|Electrocardiogram adviser's judgment|1
1599049|NCT02294396|5568629|P3|Overall Study|Electrocardiogram adviser's judgment|0
1599050|NCT02294396|5568630|P2|Overall Study|Electrocardiogram adviser's judgment|0
1599051|NCT02294396|5568631|P1|Overall Study|Electrocardiogram adviser's judgment|1
1599052|NCT02294396|5568628|P4|Overall Study|Adverse Event|24
1599053|NCT02294396|5568629|P3|Overall Study|Adverse Event|21
1599054|NCT02294396|5568630|P2|Overall Study|Adverse Event|25
1599055|NCT02294396|5568631|P1|Overall Study|Adverse Event|26
1599056|NCT02294318|5568703|P2|Overall Study|Not exposed to intervention|2
1599057|NCT02294318|5568704|P1|Overall Study|Not exposed to intervention|0
1599058|NCT02294318|5568703|P2|Overall Study|Worsening of drinking|0
1599059|NCT02294318|5568704|P1|Overall Study|Worsening of drinking|3
1599060|NCT02294227|5568719|P3|Overall Study|Adverse Event|2
1599061|NCT02294227|5568720|P2|Overall Study|Adverse Event|8
1599062|NCT02294227|5568721|P1|Overall Study|Adverse Event|6
1599063|NCT02294227|5568719|P3|Overall Study|Lack of Efficacy|8
1599064|NCT02294227|5568720|P2|Overall Study|Lack of Efficacy|12
1599065|NCT02294227|5568721|P1|Overall Study|Lack of Efficacy|11
1599066|NCT02294227|5568719|P3|Overall Study|Lost to Follow-up|0
1599067|NCT02294227|5568720|P2|Overall Study|Lost to Follow-up|0
1599068|NCT02294227|5568721|P1|Overall Study|Lost to Follow-up|1
1599069|NCT02294227|5568719|P3|Overall Study|Physician Decision|1
1599070|NCT02294227|5568720|P2|Overall Study|Physician Decision|2
1599071|NCT02294227|5568721|P1|Overall Study|Physician Decision|1
1599072|NCT02294227|5568719|P3|Overall Study|Subject/Guardian Decision|7
1599073|NCT02294227|5568720|P2|Overall Study|Subject/Guardian Decision|3
1599074|NCT02294227|5568721|P1|Overall Study|Subject/Guardian Decision|6
1599075|NCT02294227|5568719|P3|Overall Study|Death|1
1599076|NCT02294227|5568720|P2|Overall Study|Death|0
1599077|NCT02294227|5568721|P1|Overall Study|Death|0
1599078|NCT02294019|5568745|P1|Overall Study|Withdrawal by Subject|1
1599079|NCT02294019|5568745|P1|Overall Study|Other|1
1599080|NCT02294019|5568745|P1|Overall Study|Lost to Follow-up|31
1599081|NCT02294019|5568745|P1|Overall Study|Protocol Violation|68
1599082|NCT02294019|5568745|P1|Overall Study|Adverse Event|2
1599083|NCT02293902|5568753|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1599084|NCT02293902|5568754|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1599085|NCT02293902|5568755|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1599086|NCT02293902|5568756|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
1599087|NCT02293902|5568757|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
1599088|NCT02293902|5568753|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
1599089|NCT02293902|5568754|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1599090|NCT02293902|5568755|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
1599091|NCT02293902|5568756|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
1599178|NCT02291861|5569306|P1|Overall Study|Noncompliance|1
1599092|NCT02293902|5568757|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
1599093|NCT02293902|5568753|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1599094|NCT02293902|5568754|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1599095|NCT02293902|5568755|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1599096|NCT02293902|5568756|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
1599097|NCT02293902|5568757|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
1599098|NCT02293902|5568753|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1599099|NCT02293902|5568754|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
1599100|NCT02293902|5568755|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
1599101|NCT02293902|5568756|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
1599102|NCT02293902|5568757|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
1599103|NCT02293902|5568753|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
1599104|NCT02293902|5568754|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
1599105|NCT02293902|5568755|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
1599106|NCT02293902|5568756|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
1599107|NCT02293902|5568757|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
1599108|NCT02293863|5568819|P3|Overall Study|Reason Not Specified|2
1599109|NCT02293863|5568820|P2|Overall Study|Reason Not Specified|2
1599110|NCT02293863|5568821|P1|Overall Study|Reason Not Specified|0
1599111|NCT02293863|5568819|P3|Overall Study|Withdrawal by Subject|1
1599112|NCT02293863|5568820|P2|Overall Study|Withdrawal by Subject|3
1599113|NCT02293863|5568821|P1|Overall Study|Withdrawal by Subject|3
1599114|NCT02293863|5568819|P3|Overall Study|Lost to Follow-up|2
1599115|NCT02293863|5568820|P2|Overall Study|Lost to Follow-up|2
1599116|NCT02293863|5568821|P1|Overall Study|Lost to Follow-up|2
1599117|NCT02293863|5568819|P3|Overall Study|Death|4
1599118|NCT02293863|5568820|P2|Overall Study|Death|6
1599119|NCT02293863|5568821|P1|Overall Study|Death|4
1599120|NCT02293538|5568890|P2|Overall Study|Withdrawal by Subject|1
1599121|NCT02293538|5568891|P1|Overall Study|Withdrawal by Subject|0
1599122|NCT02293538|5568890|P2|Overall Study|Lost to Follow-up|0
1599123|NCT02293538|5568891|P1|Overall Study|Lost to Follow-up|1
1599124|NCT02293538|5568890|P2|Overall Study|Adverse Event|1
1599125|NCT02293538|5568891|P1|Overall Study|Adverse Event|0
1599126|NCT02293395|5568923|P2|Overall Study|Withdrawal by Subject|7
1599127|NCT02293395|5568924|P1|Overall Study|Withdrawal by Subject|8
1599128|NCT02293395|5568923|P2|Overall Study|Lost to Follow-up|0
1599129|NCT02293395|5568924|P1|Overall Study|Lost to Follow-up|1
1599130|NCT02292927|5568937|P2|Overall Study|Protocol Violation|7
1599131|NCT02292927|5568938|P1|Overall Study|Protocol Violation|13
1599132|NCT02292849|5568955|P3|Overall Study|Physician Decision|0
1599133|NCT02292849|5568956|P2|Overall Study|Physician Decision|0
1599134|NCT02292849|5568957|P1|Overall Study|Physician Decision|4
1599135|NCT02292849|5568955|P3|Overall Study|Lost to Follow-up|2
1599136|NCT02292849|5568956|P2|Overall Study|Lost to Follow-up|2
1599137|NCT02292849|5568957|P1|Overall Study|Lost to Follow-up|0
1599138|NCT02292771|5568967|P2|Overall Study|Lost to Follow-up|1
1599139|NCT02292771|5568968|P1|Overall Study|Lost to Follow-up|2
1599140|NCT02292771|5568967|P2|Overall Study|Withdrawal by Subject|1
1599141|NCT02292771|5568968|P1|Overall Study|Withdrawal by Subject|2
1599142|NCT02292719|5569064|P6|Overall Study|Subject enrolled in new study.|0
1599143|NCT02292719|5569065|P5|Overall Study|Subject enrolled in new study.|0
1599144|NCT02292719|5569066|P4|Overall Study|Subject enrolled in new study.|0
1599145|NCT02292719|5569067|P3|Overall Study|Subject enrolled in new study.|1
1599146|NCT02292719|5569068|P2|Overall Study|Subject enrolled in new study.|0
1599147|NCT02292719|5569069|P1|Overall Study|Subject enrolled in new study.|0
1599148|NCT02292719|5569064|P6|Overall Study|Withdrawal by Subject|0
1599149|NCT02292719|5569065|P5|Overall Study|Withdrawal by Subject|1
1599150|NCT02292719|5569066|P4|Overall Study|Withdrawal by Subject|1
1599151|NCT02292719|5569067|P3|Overall Study|Withdrawal by Subject|0
1599152|NCT02292719|5569068|P2|Overall Study|Withdrawal by Subject|0
1599153|NCT02292719|5569069|P1|Overall Study|Withdrawal by Subject|0
1599154|NCT02292446|5569132|P1|Overall Study|Withdrawal by Subject|3
1599155|NCT02292446|5569132|P1|Overall Study|Subject/guardian decision|2
1599156|NCT02292446|5569132|P1|Overall Study|Disease progression|2
1599157|NCT02292446|5569132|P1|Overall Study|Death|1
1599158|NCT02292446|5569132|P1|Overall Study|Adverse Event|12
1599159|NCT02292212|5569221|P1|ViE Phase|Protocol Violation|2
1599160|NCT02292212|5569221|P1|ViE Phase|Withdrawal by Subject|1
1599167|NCT02291861|5569303|P4|Overall Study|Other|1
1599168|NCT02291861|5569304|P3|Overall Study|Other|0
1599169|NCT02291861|5569305|P2|Overall Study|Other|0
1599170|NCT02291861|5569306|P1|Overall Study|Other|0
1599171|NCT02291861|5569303|P4|Overall Study|Lost to Follow-up|0
1599172|NCT02291861|5569304|P3|Overall Study|Lost to Follow-up|4
1599173|NCT02291861|5569305|P2|Overall Study|Lost to Follow-up|1
1599174|NCT02291861|5569306|P1|Overall Study|Lost to Follow-up|2
1599175|NCT02291861|5569303|P4|Overall Study|Noncompliance|1
1599176|NCT02291861|5569304|P3|Overall Study|Noncompliance|2
1599177|NCT02291861|5569305|P2|Overall Study|Noncompliance|1
1599179|NCT02291861|5569303|P4|Overall Study|Withdrawal by Subject|4
1599180|NCT02291861|5569304|P3|Overall Study|Withdrawal by Subject|1
1599181|NCT02291861|5569305|P2|Overall Study|Withdrawal by Subject|2
1599182|NCT02291861|5569306|P1|Overall Study|Withdrawal by Subject|1
1599183|NCT02291861|5569303|P4|Overall Study|Protocol Violation|1
1599184|NCT02291861|5569304|P3|Overall Study|Protocol Violation|0
1599185|NCT02291861|5569305|P2|Overall Study|Protocol Violation|0
1599186|NCT02291861|5569306|P1|Overall Study|Protocol Violation|1
1599187|NCT02291861|5569303|P4|Overall Study|Death|1
1599188|NCT02291861|5569304|P3|Overall Study|Death|1
1599189|NCT02291861|5569305|P2|Overall Study|Death|0
1599190|NCT02291861|5569306|P1|Overall Study|Death|0
1599191|NCT02291861|5569303|P4|Overall Study|Adverse Event|2
1599192|NCT02291861|5569304|P3|Overall Study|Adverse Event|1
1599193|NCT02291861|5569305|P2|Overall Study|Adverse Event|4
1599194|NCT02291861|5569306|P1|Overall Study|Adverse Event|2
1599195|NCT02291679|5569369|P3|Overall Study|Other|2
1599196|NCT02291679|5569370|P2|Overall Study|Other|4
1599197|NCT02291679|5569371|P1|Overall Study|Other|2
1599198|NCT02291679|5569369|P3|Overall Study|Insufficient Therapeutic Response|7
1599199|NCT02291679|5569370|P2|Overall Study|Insufficient Therapeutic Response|5
1599200|NCT02291679|5569371|P1|Overall Study|Insufficient Therapeutic Response|5
1599201|NCT02291679|5569369|P3|Overall Study|Lost to Follow-up|9
1599202|NCT02291679|5569370|P2|Overall Study|Lost to Follow-up|10
1599203|NCT02291679|5569371|P1|Overall Study|Lost to Follow-up|12
1599204|NCT02291679|5569369|P3|Overall Study|Withdrew Consent|15
1599205|NCT02291679|5569370|P2|Overall Study|Withdrew Consent|10
1599206|NCT02291679|5569371|P1|Overall Study|Withdrew Consent|18
1599207|NCT02291679|5569369|P3|Overall Study|Protocol Violation|7
1599208|NCT02291679|5569370|P2|Overall Study|Protocol Violation|1
1599209|NCT02291679|5569371|P1|Overall Study|Protocol Violation|5
1599210|NCT02291679|5569369|P3|Overall Study|Adverse Event|19
1599211|NCT02291679|5569370|P2|Overall Study|Adverse Event|12
1599212|NCT02291679|5569371|P1|Overall Study|Adverse Event|2
1599213|NCT02291549|5569402|P2|Overall Study|Withdrawal by Subject|1
1599214|NCT02291549|5569403|P1|Overall Study|Withdrawal by Subject|0
1599215|NCT02291549|5569402|P2|Overall Study|Lost to Follow-up|0
1599216|NCT02291549|5569403|P1|Overall Study|Lost to Follow-up|1
1599217|NCT02291510|5569425|P4|Overall Study|Adverse Event|1
1599218|NCT02291510|5569426|P3|Overall Study|Adverse Event|0
1599219|NCT02291510|5569427|P2|Overall Study|Adverse Event|0
1599220|NCT02291510|5569428|P1|Overall Study|Adverse Event|0
1599221|NCT02291419|5569444|P2|Overall Study|Early study termination|5
1599222|NCT02291419|5569445|P1|Overall Study|Early study termination|1
1599223|NCT02291237|5569463|P2|Overall Study|Subject Required Prohibited Medication|0
1599224|NCT02291237|5569464|P1|Overall Study|Subject Required Prohibited Medication|2
1599225|NCT02291237|5569463|P2|Overall Study|Lost to Follow-up|2
1599226|NCT02291237|5569464|P1|Overall Study|Lost to Follow-up|0
1599227|NCT02291237|5569463|P2|Overall Study|Withdrew Consent|11
1599228|NCT02291237|5569464|P1|Overall Study|Withdrew Consent|11
1599229|NCT02291237|5569463|P2|Overall Study|Investigator's Discretion|3
1599230|NCT02291237|5569464|P1|Overall Study|Investigator's Discretion|0
1599231|NCT02291237|5569463|P2|Overall Study|Adverse Event|3
1599232|NCT02291237|5569464|P1|Overall Study|Adverse Event|1
1599233|NCT02291237|5569463|P2|Overall Study|Study Terminated by Sponsor|67
1599234|NCT02291237|5569464|P1|Overall Study|Study Terminated by Sponsor|72
1599235|NCT02291029|5569486|P6|Overall Study|Adverse Event|0
1599236|NCT02291029|5569487|P5|Overall Study|Adverse Event|0
1599237|NCT02291029|5569488|P4|Overall Study|Adverse Event|0
1599238|NCT02291029|5569489|P3|Overall Study|Adverse Event|0
1599239|NCT02291029|5569490|P2|Overall Study|Adverse Event|1
1599240|NCT02291029|5569491|P1|Overall Study|Adverse Event|0
1599241|NCT02291029|5569486|P6|Overall Study|Withdrawal by Subject|0
1599242|NCT02291029|5569487|P5|Overall Study|Withdrawal by Subject|0
1599243|NCT02291029|5569488|P4|Overall Study|Withdrawal by Subject|0
1599244|NCT02291029|5569489|P3|Overall Study|Withdrawal by Subject|1
1599245|NCT02291029|5569490|P2|Overall Study|Withdrawal by Subject|0
1599246|NCT02291029|5569491|P1|Overall Study|Withdrawal by Subject|0
1599247|NCT02290925|5569562|P2|Second Period of 3 Months|insulin started|1
1599248|NCT02290925|5569563|P1|Second Period of 3 Months|insulin started|0
1599249|NCT02290925|5569562|P2|Second Period of 3 Months|Lost to Follow-up|3
1599250|NCT02290925|5569563|P1|Second Period of 3 Months|Lost to Follow-up|1
1599251|NCT02290925|5569562|P2|First Period of Three Months|Insulin Started|1
1599252|NCT02290925|5569563|P1|First Period of Three Months|Insulin Started|1
1599253|NCT02290925|5569562|P2|First Period of Three Months|Death|0
1599254|NCT02290925|5569563|P1|First Period of Three Months|Death|1
1599255|NCT02290925|5569562|P2|First Period of Three Months|Lost to Follow-up|1
1599256|NCT02290925|5569563|P1|First Period of Three Months|Lost to Follow-up|2
1599257|NCT02290873|5569578|P3|Overall Study|Protocol Violation|1
1599258|NCT02290873|5569579|P2|Overall Study|Protocol Violation|0
1599259|NCT02290873|5569580|P1|Overall Study|Protocol Violation|0
1599260|NCT02290873|5569578|P3|Overall Study|Esophagogastroduodenoscopy was added|0
1599261|NCT02290873|5569579|P2|Overall Study|Esophagogastroduodenoscopy was added|0
1599262|NCT02290873|5569580|P1|Overall Study|Esophagogastroduodenoscopy was added|1
1599263|NCT02290873|5569578|P3|Overall Study|Nellcor device error|0
1599264|NCT02290873|5569579|P2|Overall Study|Nellcor device error|0
1599265|NCT02290873|5569580|P1|Overall Study|Nellcor device error|1
1599266|NCT02290873|5569578|P3|Overall Study|Withdrawal by Subject|1
1599267|NCT02290873|5569579|P2|Overall Study|Withdrawal by Subject|1
1599268|NCT02290873|5569580|P1|Overall Study|Withdrawal by Subject|0
1599269|NCT02290821|5569599|P2|Overall Study|Lost to Follow-up|2
1599270|NCT02290821|5569600|P1|Overall Study|Lost to Follow-up|3
1599271|NCT02290821|5569599|P2|Overall Study|Unable or unwilling to cooperate with|0
1599272|NCT02290821|5569600|P1|Overall Study|Unable or unwilling to cooperate with|2
1599273|NCT02290821|5569599|P2|Overall Study|Withdrawal by Subject|1
1599274|NCT02290821|5569600|P1|Overall Study|Withdrawal by Subject|1
1599275|NCT02290691|5569608|P2|Overall Study|Lost to Follow-up|7
1599276|NCT02290691|5569609|P1|Overall Study|Lost to Follow-up|7
1599277|NCT02290691|5569608|P2|Overall Study|Withdrawal by Subject|1
1599278|NCT02290691|5569609|P1|Overall Study|Withdrawal by Subject|1
1599279|NCT02290691|5569608|P2|Overall Study|Noncompliance|1
1599280|NCT02290691|5569609|P1|Overall Study|Noncompliance|0
1599281|NCT02290431|5569646|P1|Overall Study|Physician Decision|2
1599282|NCT02290431|5569646|P1|Overall Study|Study terminated by Sponsor|1
1599283|NCT02290431|5569646|P1|Overall Study|Progressive disease|4
1599284|NCT02290431|5569646|P1|Overall Study|Adverse Event|20
1599285|NCT02290340|5569669|P4|Overall Study|Other|1
1599286|NCT02290340|5569670|P3|Overall Study|Other|0
1599287|NCT02290340|5569671|P2|Overall Study|Other|0
1599288|NCT02290340|5569672|P1|Overall Study|Other|1
1599289|NCT02290340|5569669|P4|Overall Study|Withdrawal by Subject|0
1599290|NCT02290340|5569670|P3|Overall Study|Withdrawal by Subject|0
1599291|NCT02290340|5569671|P2|Overall Study|Withdrawal by Subject|0
1599292|NCT02290340|5569672|P1|Overall Study|Withdrawal by Subject|1
1599293|NCT02290340|5569669|P4|Overall Study|Lost to Follow-up|1
1599294|NCT02290340|5569670|P3|Overall Study|Lost to Follow-up|0
1599295|NCT02290340|5569671|P2|Overall Study|Lost to Follow-up|0
1599296|NCT02290340|5569672|P1|Overall Study|Lost to Follow-up|0
1599297|NCT02290223|5569717|P2|12 Months|Refusal|1
1599298|NCT02290223|5569718|P1|12 Months|Refusal|0
1599299|NCT02290223|5569717|P2|12 Months|Lost to Follow-up|10
1599300|NCT02290223|5569718|P1|12 Months|Lost to Follow-up|16
1599301|NCT02290223|5569717|P2|6 Months|deceased (not related to study)|0
1599302|NCT02290223|5569718|P1|6 Months|deceased (not related to study)|2
1599303|NCT02290223|5569717|P2|6 Months|Withdrawal by Subject|0
1599304|NCT02290223|5569718|P1|6 Months|Withdrawal by Subject|5
1599305|NCT02290223|5569717|P2|6 Months|Lost to Follow-up|6
1599306|NCT02290223|5569718|P1|6 Months|Lost to Follow-up|9
1599307|NCT02289963|5569833|P2|Overall Study|Other than specified above|2
1599308|NCT02289963|5569834|P1|Overall Study|Other than specified above|0
1599309|NCT02289963|5569833|P2|Overall Study|End treatment visit outside visit window|4
1599310|NCT02289963|5569834|P1|Overall Study|End treatment visit outside visit window|0
1599311|NCT02289963|5569833|P2|Overall Study|Last injection missed|2
1599312|NCT02289963|5569834|P1|Overall Study|Last injection missed|2
1599313|NCT02289963|5569833|P2|Overall Study|Withdrawal by Subject|0
1599314|NCT02289963|5569834|P1|Overall Study|Withdrawal by Subject|1
1599315|NCT02289963|5569833|P2|Overall Study|Poor compliance to protocol|0
1599316|NCT02289963|5569834|P1|Overall Study|Poor compliance to protocol|1
1599317|NCT02289963|5569833|P2|Overall Study|Adverse Event|2
1599318|NCT02289963|5569834|P1|Overall Study|Adverse Event|1
1599319|NCT02289898|5569885|P3|Overall Study|Other|10
1599320|NCT02289898|5569886|P2|Overall Study|Other|7
1599321|NCT02289898|5569887|P1|Overall Study|Other|8
1599322|NCT02289898|5569885|P3|Overall Study|Use of another anticancer therapy|1
1599323|NCT02289898|5569886|P2|Overall Study|Use of another anticancer therapy|0
1599324|NCT02289898|5569887|P1|Overall Study|Use of another anticancer therapy|0
1599325|NCT02289898|5569885|P3|Overall Study|Disease progression|34
1599326|NCT02289898|5569886|P2|Overall Study|Disease progression|28
1599327|NCT02289898|5569887|P1|Overall Study|Disease progression|34
1599328|NCT02289898|5569885|P3|Overall Study|Adverse Event|5
1599329|NCT02289898|5569886|P2|Overall Study|Adverse Event|5
1599330|NCT02289898|5569887|P1|Overall Study|Adverse Event|3
1599331|NCT02289898|5569885|P3|Overall Study|Withdrawal by Subject|1
1599332|NCT02289898|5569886|P2|Overall Study|Withdrawal by Subject|4
1599333|NCT02289898|5569887|P1|Overall Study|Withdrawal by Subject|0
1599334|NCT02289898|5569885|P3|Overall Study|Physician Decision|2
1599335|NCT02289898|5569886|P2|Overall Study|Physician Decision|5
1599336|NCT02289898|5569887|P1|Overall Study|Physician Decision|2
1599337|NCT02289898|5569885|P3|Overall Study|Death|3
1599338|NCT02289898|5569886|P2|Overall Study|Death|4
1599339|NCT02289898|5569887|P1|Overall Study|Death|5
1599340|NCT02289833|5569896|P2|Overall Study|Death|16
1599341|NCT02289833|5569897|P1|Overall Study|Death|23
1599342|NCT02289833|5569896|P2|Overall Study|Lost to Follow-up|0
1599343|NCT02289833|5569897|P1|Overall Study|Lost to Follow-up|4
1599344|NCT02289833|5569896|P2|Overall Study|Study discontinuation|1
1599345|NCT02289833|5569897|P1|Overall Study|Study discontinuation|0
1599346|NCT02289820|5569933|P7|Overall Study|withdrawal of consent|0
1599347|NCT02289820|5569934|P6|Overall Study|withdrawal of consent|0
1599348|NCT02289820|5569935|P5|Overall Study|withdrawal of consent|0
1599349|NCT02289820|5569936|P4|Overall Study|withdrawal of consent|0
1599350|NCT02289820|5569937|P3|Overall Study|withdrawal of consent|0
1599351|NCT02289820|5569938|P2|Overall Study|withdrawal of consent|1
1599352|NCT02289820|5569939|P1|Overall Study|withdrawal of consent|0
1599353|NCT02289820|5569933|P7|Overall Study|Lost to Follow-up|1
1599354|NCT02289820|5569934|P6|Overall Study|Lost to Follow-up|1
1599355|NCT02289820|5569935|P5|Overall Study|Lost to Follow-up|0
1599356|NCT02289820|5569936|P4|Overall Study|Lost to Follow-up|1
1599357|NCT02289820|5569937|P3|Overall Study|Lost to Follow-up|3
1599358|NCT02289820|5569938|P2|Overall Study|Lost to Follow-up|0
1599359|NCT02289820|5569939|P1|Overall Study|Lost to Follow-up|0
1599360|NCT02289820|5569933|P7|Overall Study|Death|0
1599361|NCT02289820|5569934|P6|Overall Study|Death|0
1599362|NCT02289820|5569935|P5|Overall Study|Death|0
1599363|NCT02289820|5569936|P4|Overall Study|Death|0
1599364|NCT02289820|5569937|P3|Overall Study|Death|1
1599365|NCT02289820|5569938|P2|Overall Study|Death|0
1599366|NCT02289820|5569939|P1|Overall Study|Death|0
1599367|NCT02289820|5569933|P7|Overall Study|Withdrawal by Subject|1
1599368|NCT02289820|5569934|P6|Overall Study|Withdrawal by Subject|0
1599369|NCT02289820|5569935|P5|Overall Study|Withdrawal by Subject|0
1599370|NCT02289820|5569936|P4|Overall Study|Withdrawal by Subject|1
1599371|NCT02289820|5569937|P3|Overall Study|Withdrawal by Subject|2
1599372|NCT02289820|5569938|P2|Overall Study|Withdrawal by Subject|1
1599373|NCT02289820|5569939|P1|Overall Study|Withdrawal by Subject|2
1599374|NCT02289742|5570057|P4|Third Wear Period|Reason not given|1
1599375|NCT02289742|5570058|P3|Third Wear Period|Reason not given|0
1599376|NCT02289742|5570059|P2|Third Wear Period|Reason not given|0
1599377|NCT02289742|5570060|P1|Third Wear Period|Reason not given|0
1599378|NCT02289742|5570057|P4|Third Wear Period|Adverse Event|0
1599379|NCT02289742|5570058|P3|Third Wear Period|Adverse Event|0
1599380|NCT02289742|5570059|P2|Third Wear Period|Adverse Event|1
1599381|NCT02289742|5570060|P1|Third Wear Period|Adverse Event|0
1599382|NCT02289742|5570057|P4|First Wear Period|Other prior to treatment|1
1599383|NCT02289742|5570058|P3|First Wear Period|Other prior to treatment|0
1599384|NCT02289742|5570059|P2|First Wear Period|Other prior to treatment|0
1599385|NCT02289742|5570060|P1|First Wear Period|Other prior to treatment|0
1599386|NCT02289742|5570057|P4|First Wear Period|Adverse Event|0
1599387|NCT02289742|5570058|P3|First Wear Period|Adverse Event|1
1599388|NCT02289742|5570059|P2|First Wear Period|Adverse Event|0
1599389|NCT02289742|5570060|P1|First Wear Period|Adverse Event|0
1599390|NCT02289742|5570057|P4|First Wear Period|Adverse event prior to treatment|0
1599391|NCT02289742|5570058|P3|First Wear Period|Adverse event prior to treatment|0
1599392|NCT02289742|5570059|P2|First Wear Period|Adverse event prior to treatment|1
1599393|NCT02289742|5570060|P1|First Wear Period|Adverse event prior to treatment|0
1599394|NCT02289729|5570077|P1|Overall Study|Death|1
1599395|NCT02289729|5570077|P1|Overall Study|Withdrawal by Subject|1
1599396|NCT02289729|5570077|P1|Overall Study|Very Narrow Therapeutic Margin|1
1599397|NCT02289729|5570077|P1|Overall Study|Lack of Efficacy|3
1599398|NCT02289469|5570133|P2|Overall Study|Unable to match a control|0
1599399|NCT02289469|5570134|P1|Overall Study|Unable to match a control|6
1599400|NCT02289456|5570142|P1|Monotherapy Period|Miscellaneous|1
1599401|NCT02289456|5570142|P1|Monotherapy Period|Study Terminated by Sponsor|2
1599402|NCT02289456|5570142|P1|Monotherapy Period|Withdrawal by Subject|2
1599403|NCT02289456|5570142|P1|Monotherapy Period|Symptomatic Deterioration|1
1599404|NCT02289456|5570142|P1|Monotherapy Period|Progressive Disease (PD)|8
1599405|NCT02289456|5570142|P1|Monotherapy Period|Adverse Event|1
1599406|NCT02289456|5570142|P1|Monotherapy Period|Death|1
1599407|NCT02289456|5570142|P1|Induction Period|Miscellaneous|1
1599408|NCT02289456|5570142|P1|Induction Period|Withdrawal by Subject|2
1599409|NCT02289456|5570142|P1|Induction Period|Symptomatic Deterioration|4
1599410|NCT02289456|5570142|P1|Induction Period|Progressive Disease (PD)|4
1599411|NCT02289456|5570142|P1|Induction Period|Adverse Event|11
1599412|NCT02289456|5570142|P1|Induction Period|Death|2
1599413|NCT02289417|5570165|P3|Overall Study|Lack of Efficacy|0
1599414|NCT02289417|5570166|P2|Overall Study|Lack of Efficacy|0
1599415|NCT02289417|5570167|P1|Overall Study|Lack of Efficacy|3
1599416|NCT02289417|5570165|P3|Overall Study|Lost to Follow-up|1
1599417|NCT02289417|5570166|P2|Overall Study|Lost to Follow-up|1
1599418|NCT02289417|5570167|P1|Overall Study|Lost to Follow-up|0
1599419|NCT02289417|5570165|P3|Overall Study|Withdrawal by Subject|0
1599420|NCT02289417|5570166|P2|Overall Study|Withdrawal by Subject|3
1599421|NCT02289417|5570167|P1|Overall Study|Withdrawal by Subject|1
1599422|NCT02289417|5570165|P3|Overall Study|Adverse Event|2
1599423|NCT02289417|5570166|P2|Overall Study|Adverse Event|0
1599424|NCT02289417|5570167|P1|Overall Study|Adverse Event|3
1599425|NCT02289352|5570208|P3|Overall Study|Withdrawal by Subject|0
1599426|NCT02289352|5570209|P2|Overall Study|Withdrawal by Subject|1
1599427|NCT02289352|5570210|P1|Overall Study|Withdrawal by Subject|1
1599428|NCT02289079|5570277|P2|Overall Study|Lost to Follow-up|1
1599429|NCT02289079|5570278|P1|Overall Study|Lost to Follow-up|0
1599430|NCT02289079|5570277|P2|Overall Study|Physician Decision|0
1599431|NCT02289079|5570278|P1|Overall Study|Physician Decision|2
1599432|NCT02288559|5570307|P4|Overall Study|Reason Not Specified|0
1599433|NCT02288559|5570308|P3|Overall Study|Reason Not Specified|3
1599434|NCT02288559|5570309|P2|Overall Study|Reason Not Specified|0
1599435|NCT02288559|5570310|P1|Overall Study|Reason Not Specified|0
1599436|NCT02288559|5570307|P4|Overall Study|Withdrawal by Subject|1
1599437|NCT02288559|5570308|P3|Overall Study|Withdrawal by Subject|2
1599438|NCT02288559|5570309|P2|Overall Study|Withdrawal by Subject|0
1599439|NCT02288559|5570310|P1|Overall Study|Withdrawal by Subject|0
1599440|NCT02288559|5570307|P4|Overall Study|Lost to Follow-up|1
1599441|NCT02288559|5570308|P3|Overall Study|Lost to Follow-up|0
1599442|NCT02288559|5570309|P2|Overall Study|Lost to Follow-up|0
1599443|NCT02288559|5570310|P1|Overall Study|Lost to Follow-up|0
1599444|NCT02288559|5570307|P4|Overall Study|Death|0
1599445|NCT02288559|5570308|P3|Overall Study|Death|1
1599446|NCT02288559|5570309|P2|Overall Study|Death|0
1599447|NCT02288559|5570310|P1|Overall Study|Death|0
1599448|NCT02288559|5570307|P4|Overall Study|Adverse Event|0
1599449|NCT02288559|5570308|P3|Overall Study|Adverse Event|5
1599450|NCT02288559|5570309|P2|Overall Study|Adverse Event|1
1599451|NCT02288559|5570310|P1|Overall Study|Adverse Event|1
1599452|NCT02288325|5570361|P3|Double-blind Treatment Period|Multiple Reasons|2
1599453|NCT02288325|5570362|P2|Double-blind Treatment Period|Multiple Reasons|8
1599454|NCT02288325|5570363|P1|Double-blind Treatment Period|Multiple Reasons|0
1599455|NCT02288325|5570361|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
1599456|NCT02288325|5570362|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
1599457|NCT02288325|5570363|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
1599458|NCT02288325|5570361|P3|Double-blind Treatment Period|Protocol Violation|2
1599459|NCT02288325|5570362|P2|Double-blind Treatment Period|Protocol Violation|1
1599460|NCT02288325|5570363|P1|Double-blind Treatment Period|Protocol Violation|0
1599461|NCT02288325|5570361|P3|Double-blind Treatment Period|Lost to Follow-up|5
1599462|NCT02288325|5570362|P2|Double-blind Treatment Period|Lost to Follow-up|4
1599463|NCT02288325|5570363|P1|Double-blind Treatment Period|Lost to Follow-up|0
1599464|NCT02288325|5570361|P3|Double-blind Treatment Period|Withdrawal of Consent|8
1599465|NCT02288325|5570362|P2|Double-blind Treatment Period|Withdrawal of Consent|8
1599466|NCT02288325|5570363|P1|Double-blind Treatment Period|Withdrawal of Consent|0
1599467|NCT02288325|5570361|P3|Double-blind Treatment Period|Adverse Event|5
1599468|NCT02288325|5570362|P2|Double-blind Treatment Period|Adverse Event|2
1599469|NCT02288325|5570363|P1|Double-blind Treatment Period|Adverse Event|0
1599470|NCT02288325|5570361|P3|Stabilization Period|Reason not Specified|0
1599471|NCT02288325|5570362|P2|Stabilization Period|Reason not Specified|0
1599472|NCT02288325|5570363|P1|Stabilization Period|Reason not Specified|15
1599473|NCT02288325|5570361|P3|Stabilization Period|Non-Compliance With Study Drug|0
1599474|NCT02288325|5570362|P2|Stabilization Period|Non-Compliance With Study Drug|0
1599475|NCT02288325|5570363|P1|Stabilization Period|Non-Compliance With Study Drug|5
1599476|NCT02288325|5570361|P3|Stabilization Period|Protocol Violation|0
1599477|NCT02288325|5570362|P2|Stabilization Period|Protocol Violation|0
1599478|NCT02288325|5570363|P1|Stabilization Period|Protocol Violation|8
1599479|NCT02288325|5570361|P3|Stabilization Period|Lost to Follow-up|0
1599480|NCT02288325|5570362|P2|Stabilization Period|Lost to Follow-up|0
1599481|NCT02288325|5570363|P1|Stabilization Period|Lost to Follow-up|12
1599482|NCT02288325|5570361|P3|Stabilization Period|Withdrawal of Consent|0
1599483|NCT02288325|5570362|P2|Stabilization Period|Withdrawal of Consent|0
1599484|NCT02288325|5570363|P1|Stabilization Period|Withdrawal of Consent|23
1599485|NCT02288325|5570361|P3|Stabilization Period|Lack of Efficacy|0
1599486|NCT02288325|5570362|P2|Stabilization Period|Lack of Efficacy|0
1599487|NCT02288325|5570363|P1|Stabilization Period|Lack of Efficacy|22
1599488|NCT02288325|5570361|P3|Stabilization Period|Adverse Event|0
1599489|NCT02288325|5570362|P2|Stabilization Period|Adverse Event|0
1599490|NCT02288325|5570363|P1|Stabilization Period|Adverse Event|13
1599491|NCT02288325|5570361|P3|Run-in Period|Reason not Specified|0
1599492|NCT02288325|5570362|P2|Run-in Period|Reason not Specified|0
1599493|NCT02288325|5570363|P1|Run-in Period|Reason not Specified|8
1599494|NCT02288325|5570361|P3|Run-in Period|Non-Compliance With Study Drug|0
1599495|NCT02288325|5570362|P2|Run-in Period|Non-Compliance With Study Drug|0
1599496|NCT02288325|5570363|P1|Run-in Period|Non-Compliance With Study Drug|3
1599497|NCT02288325|5570361|P3|Run-in Period|Protocol Violation|0
1599498|NCT02288325|5570362|P2|Run-in Period|Protocol Violation|0
1599499|NCT02288325|5570363|P1|Run-in Period|Protocol Violation|17
1599500|NCT02288325|5570361|P3|Run-in Period|Lost to Follow-up|0
1599501|NCT02288325|5570362|P2|Run-in Period|Lost to Follow-up|0
1599502|NCT02288325|5570363|P1|Run-in Period|Lost to Follow-up|25
1599503|NCT02288325|5570361|P3|Run-in Period|Withdrawal of Consent|0
1599504|NCT02288325|5570362|P2|Run-in Period|Withdrawal of Consent|0
1599505|NCT02288325|5570363|P1|Run-in Period|Withdrawal of Consent|28
1599506|NCT02288325|5570361|P3|Run-in Period|Lack of Efficacy|0
1599507|NCT02288325|5570362|P2|Run-in Period|Lack of Efficacy|0
1599508|NCT02288325|5570363|P1|Run-in Period|Lack of Efficacy|16
1599509|NCT02288325|5570361|P3|Run-in Period|Adverse Event|0
1599510|NCT02288325|5570362|P2|Run-in Period|Adverse Event|0
1599511|NCT02288325|5570363|P1|Run-in Period|Adverse Event|48
1599512|NCT02288312|5570373|P3|Overall Study|Pregnancy|0
1599513|NCT02288312|5570374|P2|Overall Study|Pregnancy|0
1599514|NCT02288312|5570375|P1|Overall Study|Pregnancy|1
1599515|NCT02288182|5570415|P2|Overall Study|Lost to Follow-up|1
1599516|NCT02288182|5570416|P1|Overall Study|Lost to Follow-up|0
1599517|NCT02288182|5570415|P2|Overall Study|Adverse Event|1
1599518|NCT02288182|5570416|P1|Overall Study|Adverse Event|0
1599519|NCT02288091|5570428|P1|Overall Study|Screen fail|7
1599520|NCT02288091|5570428|P1|Overall Study|Lost to Follow-up|1
1599521|NCT02287922|5570440|P4|Overall Study|Other|0
1599522|NCT02287922|5570441|P3|Overall Study|Other|2
1599523|NCT02287922|5570442|P2|Overall Study|Other|0
1599524|NCT02287922|5570443|P1|Overall Study|Other|1
1599525|NCT02287922|5570440|P4|Overall Study|Sponsor's decision|1
1599526|NCT02287922|5570441|P3|Overall Study|Sponsor's decision|0
1599527|NCT02287922|5570442|P2|Overall Study|Sponsor's decision|0
1599528|NCT02287922|5570443|P1|Overall Study|Sponsor's decision|0
1599529|NCT02287922|5570440|P4|Overall Study|Lost to Follow-up|0
1599530|NCT02287922|5570441|P3|Overall Study|Lost to Follow-up|1
1599531|NCT02287922|5570442|P2|Overall Study|Lost to Follow-up|0
1599532|NCT02287922|5570443|P1|Overall Study|Lost to Follow-up|0
1599533|NCT02287922|5570440|P4|Overall Study|Withdrawal by Subject|2
1599534|NCT02287922|5570441|P3|Overall Study|Withdrawal by Subject|1
1599535|NCT02287922|5570442|P2|Overall Study|Withdrawal by Subject|1
1599536|NCT02287922|5570443|P1|Overall Study|Withdrawal by Subject|1
1599537|NCT02287922|5570440|P4|Overall Study|Adverse Event|4
1599538|NCT02287922|5570441|P3|Overall Study|Adverse Event|3
1599539|NCT02287922|5570442|P2|Overall Study|Adverse Event|1
1599540|NCT02287922|5570443|P1|Overall Study|Adverse Event|1
1599541|NCT02287896|5570534|P2|Second Injection Visit|Withdrawal by Subject|1
1599542|NCT02287896|5570535|P1|Second Injection Visit|Withdrawal by Subject|0
1599543|NCT02287883|5570553|P2|Overall Study|Non-response to survey|237
1599544|NCT02287883|5570554|P1|Overall Study|Non-response to survey|229
1599545|NCT02287883|5570553|P2|Overall Study|No longer eligible|182
1599546|NCT02287883|5570554|P1|Overall Study|No longer eligible|222
1599547|NCT02287883|5570553|P2|Overall Study|Death|7
1599548|NCT02287883|5570554|P1|Overall Study|Death|8
1599549|NCT02287623|5570756|P2|Overall Study|Protocol Violation|1
1599550|NCT02287623|5570757|P1|Overall Study|Protocol Violation|0
1599551|NCT02287610|5570773|P1|Overall Study|Excluded-investigator non-responsiveness|5
1599552|NCT02287610|5570773|P1|Overall Study|Withdrawal by Subject|8
1599553|NCT02287610|5570773|P1|Overall Study|Lost to Follow-up|3
1599554|NCT02287467|5570808|P2|Overall Study|Protocol Violation|9
1599555|NCT02287467|5570809|P1|Overall Study|Protocol Violation|12
1599556|NCT02287402|5570857|P1|Follow-up|Voluntary Withdrawal|2
1599557|NCT02287402|5570857|P1|Follow-up|Lost to Follow-up|1
1599558|NCT02287402|5570857|P1|Treatment Period|Voluntary Withdrawal|10
1599559|NCT02287402|5570857|P1|Treatment Period|Adverse Event|17
1599560|NCT02287038|5570962|P2|Overall Study|Abnormal ECG after starting medication|0
1599561|NCT02287038|5570963|P1|Overall Study|Abnormal ECG after starting medication|1
1599562|NCT02287038|5570962|P2|Overall Study|Nausea after starting medication|0
1599563|NCT02287038|5570963|P1|Overall Study|Nausea after starting medication|1
1599564|NCT02287038|5570962|P2|Overall Study|Anxiety after starting medication|1
1599565|NCT02287038|5570963|P1|Overall Study|Anxiety after starting medication|0
1599566|NCT02287038|5570962|P2|Overall Study|Stopped attending appointments|2
1599567|NCT02287038|5570963|P1|Overall Study|Stopped attending appointments|3
1599568|NCT02287025|5570973|P2|Overall Study|Screening failed|1
1599569|NCT02287025|5570974|P1|Overall Study|Screening failed|1
1599570|NCT02287025|5570973|P2|Overall Study|Withdrawal by Subject|2
1599571|NCT02287025|5570974|P1|Overall Study|Withdrawal by Subject|2
1599572|NCT02287025|5570973|P2|Overall Study|Adverse Event|4
1599573|NCT02287025|5570974|P1|Overall Study|Adverse Event|2
1599574|NCT02287025|5570973|P2|Overall Study|Progression of disease|2
1599575|NCT02287025|5570974|P1|Overall Study|Progression of disease|3
1599576|NCT02287025|5570973|P2|Overall Study|Not treated|0
1599577|NCT02287025|5570974|P1|Overall Study|Not treated|2
1599578|NCT02286947|5570983|P1|Overall Study|Withdrawal by Subject|2
1599579|NCT02286895|5571025|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
1599580|NCT02286895|5571026|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
1599581|NCT02286895|5571025|P2|Assessed for Measles Seroconversion|Missing measurement|3
1599582|NCT02286895|5571026|P1|Assessed for Measles Seroconversion|Missing measurement|6
1599583|NCT02286895|5571025|P2|Assessed for Measles Seroconversion|Protocol Violation|4
1599584|NCT02286895|5571026|P1|Assessed for Measles Seroconversion|Protocol Violation|1
1599585|NCT02286713|5571070|P2|Six Month Follow-Up|Lost to Follow-up|27
1599586|NCT02286713|5571071|P1|Six Month Follow-Up|Lost to Follow-up|30
1599587|NCT02286713|5571070|P2|Six Month Follow-Up|Death|0
1599588|NCT02286713|5571071|P1|Six Month Follow-Up|Death|2
1599589|NCT02286713|5571070|P2|Three Month Follow-Up|Withdrawal by Subject|1
1599590|NCT02286713|5571071|P1|Three Month Follow-Up|Withdrawal by Subject|1
1599591|NCT02286713|5571070|P2|Three Month Follow-Up|Lost to Follow-up|24
1599592|NCT02286713|5571071|P1|Three Month Follow-Up|Lost to Follow-up|26
1599593|NCT02286713|5571070|P2|Three Month Follow-Up|Death|1
1599594|NCT02286713|5571071|P1|Three Month Follow-Up|Death|1
1599595|NCT02286713|5571070|P2|One Week Follow-Up|Withdrawal by Subject|3
1599596|NCT02286713|5571071|P1|One Week Follow-Up|Withdrawal by Subject|6
1599597|NCT02286713|5571070|P2|One Week Follow-Up|Lost to Follow-up|21
1599598|NCT02286713|5571071|P1|One Week Follow-Up|Lost to Follow-up|17
1599599|NCT02286713|5571070|P2|One Week Follow-Up|Death|0
1599600|NCT02286713|5571071|P1|One Week Follow-Up|Death|1
1599601|NCT02286466|5571252|P2|Overall Study|Declined Clinician Assessment|1
1599602|NCT02286466|5571253|P1|Overall Study|Declined Clinician Assessment|0
1599603|NCT02286466|5571252|P2|Overall Study|Lost to Follow-up|4
1599604|NCT02286466|5571253|P1|Overall Study|Lost to Follow-up|1
1599605|NCT02286466|5571252|P2|Overall Study|Withdrawal by Subject|2
1599606|NCT02286466|5571253|P1|Overall Study|Withdrawal by Subject|5
1599607|NCT02286466|5571252|P2|Overall Study|Death|3
1599608|NCT02286466|5571253|P1|Overall Study|Death|1
1599609|NCT02286193|5571265|P1|Overall Study|Referred: Declined service|38
1599610|NCT02286193|5571265|P1|Overall Study|Referred: unable to reach/resource sent|104
1599611|NCT02286193|5571265|P1|Overall Study|Referred: CRS unable to make contact|62
1599612|NCT02286102|5571272|P2|Overall Study|Screen Failure|1
1599613|NCT02286102|5571273|P1|Overall Study|Screen Failure|1
1599614|NCT02285998|5571285|P2|Overall Study|Other Reasons|10
1599615|NCT02285998|5571286|P1|Overall Study|Other Reasons|7
1599616|NCT02285998|5571285|P2|Overall Study|Withdrawal by Subject|61
1599617|NCT02285998|5571286|P1|Overall Study|Withdrawal by Subject|53
1599618|NCT02285998|5571285|P2|Overall Study|Lost to Follow-up|172
1599619|NCT02285998|5571286|P1|Overall Study|Lost to Follow-up|176
1599620|NCT02285998|5571285|P2|Overall Study|Physician Decision|2
1599621|NCT02285998|5571286|P1|Overall Study|Physician Decision|1
1599622|NCT02285998|5571285|P2|Overall Study|Adverse Event|8
1599623|NCT02285998|5571286|P1|Overall Study|Adverse Event|9
1599624|NCT02285920|5571314|P4|Overall Study|Death|1
1599625|NCT02285920|5571315|P3|Overall Study|Death|2
1599626|NCT02285920|5571316|P2|Overall Study|Death|0
1599627|NCT02285920|5571317|P1|Overall Study|Death|2
1599628|NCT02285920|5571314|P4|Overall Study|Dialysis discontinuation|0
1599629|NCT02285920|5571315|P3|Overall Study|Dialysis discontinuation|0
1599630|NCT02285920|5571316|P2|Overall Study|Dialysis discontinuation|1
1599631|NCT02285920|5571317|P1|Overall Study|Dialysis discontinuation|0
1599632|NCT02285920|5571314|P4|Overall Study|Transfer to non-participating unit|0
1599633|NCT02285920|5571315|P3|Overall Study|Transfer to non-participating unit|0
1599634|NCT02285920|5571316|P2|Overall Study|Transfer to non-participating unit|1
1599635|NCT02285920|5571317|P1|Overall Study|Transfer to non-participating unit|0
1599636|NCT02285920|5571314|P4|Overall Study|Change to peritoneal dialysis|0
1599637|NCT02285920|5571315|P3|Overall Study|Change to peritoneal dialysis|1
1599638|NCT02285920|5571316|P2|Overall Study|Change to peritoneal dialysis|0
1599639|NCT02285920|5571317|P1|Overall Study|Change to peritoneal dialysis|0
1599640|NCT02285920|5571314|P4|Overall Study|Kidney transplantation|0
1599641|NCT02285920|5571315|P3|Overall Study|Kidney transplantation|2
1599642|NCT02285920|5571316|P2|Overall Study|Kidney transplantation|2
1599643|NCT02285920|5571317|P1|Overall Study|Kidney transplantation|2
1599644|NCT02285855|5571407|P2|Overall Study|Withdrawal by Subject|1
1599645|NCT02285855|5571408|P1|Overall Study|Withdrawal by Subject|2
1599646|NCT02285777|5571416|P2|Overall Study|Lost to Follow-up|2
1599647|NCT02285777|5571417|P1|Overall Study|Lost to Follow-up|4
1599648|NCT02285777|5571416|P2|Overall Study|Withdrawal by Subject|1
1599649|NCT02285777|5571417|P1|Overall Study|Withdrawal by Subject|1
1599650|NCT02285270|5571498|P1|Overall Study|Determined to be ineligible|1
1599651|NCT02285270|5571498|P1|Overall Study|Physician Decision|3
1599652|NCT02285270|5571498|P1|Overall Study|Lost to Follow-up|1
1599653|NCT02285153|5571506|P2|Overall Study|Adverse Event|0
1599654|NCT02285153|5571507|P1|Overall Study|Adverse Event|1
1599655|NCT02285010|5571531|P2|Overall Study|Not spinal anesthesia|1
1599656|NCT02285010|5571532|P1|Overall Study|Not spinal anesthesia|3
1599657|NCT02285010|5571531|P2|Overall Study|not abdominal hysterectomy|0
1599658|NCT02285010|5571532|P1|Overall Study|not abdominal hysterectomy|2
1599659|NCT02284906|5571549|P3|Overall Study|Reason not Specified|0
1599660|NCT02284906|5571550|P2|Overall Study|Reason not Specified|1
1599661|NCT02284906|5571551|P1|Overall Study|Reason not Specified|1
1599662|NCT02284906|5571549|P3|Overall Study|Study Termination|14
1599663|NCT02284906|5571550|P2|Overall Study|Study Termination|11
1599664|NCT02284906|5571551|P1|Overall Study|Study Termination|0
1599665|NCT02284906|5571549|P3|Overall Study|Voluntary Withdrawal|5
1599666|NCT02284906|5571550|P2|Overall Study|Voluntary Withdrawal|4
1599667|NCT02284906|5571551|P1|Overall Study|Voluntary Withdrawal|2
1599668|NCT02284906|5571549|P3|Overall Study|Major Protocol Deviation|0
1599669|NCT02284906|5571550|P2|Overall Study|Major Protocol Deviation|1
1599670|NCT02284906|5571551|P1|Overall Study|Major Protocol Deviation|0
1599671|NCT02284906|5571549|P3|Overall Study|Pretreatment Event/Adverse Event|0
1599672|NCT02284906|5571550|P2|Overall Study|Pretreatment Event/Adverse Event|1
1599673|NCT02284906|5571551|P1|Overall Study|Pretreatment Event/Adverse Event|0
1599674|NCT02284893|5571564|P2|52 Week (Long Term)|Non-Compliance|3
1599675|NCT02284893|5571565|P1|52 Week (Long Term)|Non-Compliance|2
1599676|NCT02284893|5571564|P2|52 Week (Long Term)|Lost to Follow-up|2
1599677|NCT02284893|5571565|P1|52 Week (Long Term)|Lost to Follow-up|2
1599678|NCT02284893|5571564|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
1599679|NCT02284893|5571565|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
1599680|NCT02284893|5571564|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
1599681|NCT02284893|5571565|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
1599682|NCT02284893|5571564|P2|52 Week (Long Term)|Adverse Event|1
1599683|NCT02284893|5571565|P1|52 Week (Long Term)|Adverse Event|3
1599684|NCT02284893|5571564|P2|26 Week (Short Term)|Other|1
1599685|NCT02284893|5571565|P1|26 Week (Short Term)|Other|1
1599686|NCT02284893|5571564|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
1599687|NCT02284893|5571565|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
1599688|NCT02284893|5571564|P2|26 Week (Short Term)|Lost to Follow-up|1
1599689|NCT02284893|5571565|P1|26 Week (Short Term)|Lost to Follow-up|3
1599690|NCT02284893|5571564|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
1599691|NCT02284893|5571565|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
1599692|NCT02284893|5571564|P2|26 Week (Short Term)|Discontinuation by the subject|2
1599693|NCT02284893|5571565|P1|26 Week (Short Term)|Discontinuation by the subject|2
1599694|NCT02284893|5571564|P2|26 Week (Short Term)|Adverse Event|9
1599695|NCT02284893|5571565|P1|26 Week (Short Term)|Adverse Event|1
1599696|NCT02284568|5571642|P3|Overall Study|Withdrew before taking study drug|0
1599697|NCT02284568|5571643|P2|Overall Study|Withdrew before taking study drug|1
1599698|NCT02284568|5571644|P1|Overall Study|Withdrew before taking study drug|0
1599699|NCT02284568|5571642|P3|Overall Study|Other|0
1599700|NCT02284568|5571643|P2|Overall Study|Other|2
1599701|NCT02284568|5571644|P1|Overall Study|Other|1
1599702|NCT02284568|5571642|P3|Overall Study|Lack of Efficacy|0
1599703|NCT02284568|5571643|P2|Overall Study|Lack of Efficacy|7
1599704|NCT02284568|5571644|P1|Overall Study|Lack of Efficacy|4
1599705|NCT02284568|5571642|P3|Overall Study|Lost to Follow-up|0
1599706|NCT02284568|5571643|P2|Overall Study|Lost to Follow-up|3
1599707|NCT02284568|5571644|P1|Overall Study|Lost to Follow-up|0
1599708|NCT02284568|5571642|P3|Overall Study|Sponsor requested patient stop treatment|90
1599709|NCT02284568|5571643|P2|Overall Study|Sponsor requested patient stop treatment|0
1599710|NCT02284568|5571644|P1|Overall Study|Sponsor requested patient stop treatment|0
1599711|NCT02284568|5571642|P3|Overall Study|Protocol Violation|0
1599712|NCT02284568|5571643|P2|Overall Study|Protocol Violation|1
1599713|NCT02284568|5571644|P1|Overall Study|Protocol Violation|0
1599714|NCT02284568|5571642|P3|Overall Study|Noncompliance|0
1599715|NCT02284568|5571643|P2|Overall Study|Noncompliance|0
1599716|NCT02284568|5571644|P1|Overall Study|Noncompliance|1
1599717|NCT02284568|5571642|P3|Overall Study|Noncompliance with study drug admin|0
1599718|NCT02284568|5571643|P2|Overall Study|Noncompliance with study drug admin|2
1599719|NCT02284568|5571644|P1|Overall Study|Noncompliance with study drug admin|1
1599720|NCT02284568|5571642|P3|Overall Study|Withdrawal by Subject|1
1599721|NCT02284568|5571643|P2|Overall Study|Withdrawal by Subject|21
1599722|NCT02284568|5571644|P1|Overall Study|Withdrawal by Subject|22
1599723|NCT02284568|5571642|P3|Overall Study|Adverse Event|4
1599724|NCT02284568|5571643|P2|Overall Study|Adverse Event|9
1599725|NCT02284568|5571644|P1|Overall Study|Adverse Event|2
1599726|NCT02284347|5571706|P1|Overall Study|Withdrawn prior to treatment|1
1599727|NCT02284347|5571706|P1|Overall Study|Lost to Follow-up|2
1599728|NCT02284243|5571714|P2|Overall Study|Adverse Event|0
1599729|NCT02284243|5571715|P1|Overall Study|Adverse Event|1
1599730|NCT02284243|5571714|P2|Overall Study|Lack of Efficacy|3
1599731|NCT02284243|5571715|P1|Overall Study|Lack of Efficacy|3
1599732|NCT02284178|5571735|P2|Overall Study|Met exclusion criteria|54
1599733|NCT02284178|5571736|P1|Overall Study|Met exclusion criteria|49
1599734|NCT02284009|5571779|P2|Overall Study|Withdrawal by Subject|5
1599735|NCT02284009|5571780|P1|Overall Study|Withdrawal by Subject|2
1599736|NCT02284009|5571779|P2|Overall Study|Physician Decision|2
1599737|NCT02284009|5571780|P1|Overall Study|Physician Decision|0
1599738|NCT02284009|5571779|P2|Overall Study|Lost to Follow-up|3
1599739|NCT02284009|5571780|P1|Overall Study|Lost to Follow-up|1
1599740|NCT02284009|5571779|P2|Overall Study|Adverse Event|0
1599741|NCT02284009|5571780|P1|Overall Study|Adverse Event|3
1599742|NCT02283788|5571879|P4|Overall Study|Withdrawal by Subject|1
1599743|NCT02283788|5571880|P3|Overall Study|Withdrawal by Subject|0
1599744|NCT02283788|5571881|P2|Overall Study|Withdrawal by Subject|1
1599745|NCT02283788|5571882|P1|Overall Study|Withdrawal by Subject|0
1599746|NCT02283788|5571879|P4|Overall Study|Adverse Event|1
1599747|NCT02283788|5571880|P3|Overall Study|Adverse Event|5
1599748|NCT02283788|5571881|P2|Overall Study|Adverse Event|3
1599749|NCT02283788|5571882|P1|Overall Study|Adverse Event|1
1599750|NCT02283762|5571894|P2|Long-term Extension Phase (LTE)|Physician Decision|2
1599751|NCT02283762|5571895|P1|Long-term Extension Phase (LTE)|Physician Decision|1
1599752|NCT02283762|5571894|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
1599753|NCT02283762|5571895|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
1599754|NCT02283762|5571894|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
1599755|NCT02283762|5571895|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
1599756|NCT02283762|5571894|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
1599757|NCT02283762|5571895|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
1599758|NCT02283762|5571894|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
1599759|NCT02283762|5571895|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
1599760|NCT02283762|5571894|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
1599761|NCT02283762|5571895|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
1599762|NCT02283762|5571894|P2|Long-term Extension Phase (LTE)|Adverse Event|6
1599763|NCT02283762|5571895|P1|Long-term Extension Phase (LTE)|Adverse Event|2
1599764|NCT02283762|5571894|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
1599765|NCT02283762|5571895|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
1599766|NCT02283762|5571894|P2|Main Treatment Phase (MT)|Pregnancy|1
1599767|NCT02283762|5571895|P1|Main Treatment Phase (MT)|Pregnancy|0
1599768|NCT02283762|5571894|P2|Main Treatment Phase (MT)|Physician Decision|1
1599769|NCT02283762|5571895|P1|Main Treatment Phase (MT)|Physician Decision|1
1599770|NCT02283762|5571894|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
1599771|NCT02283762|5571895|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
1599772|NCT02283762|5571894|P2|Main Treatment Phase (MT)|Adverse Event|9
1599773|NCT02283762|5571895|P1|Main Treatment Phase (MT)|Adverse Event|9
1599774|NCT02283411|5571932|P1|Overall Study|Screen Failed|28
1599775|NCT02283411|5571932|P1|Overall Study|Withdrawal by Subject|3
1599776|NCT02283268|5571940|P1|Overall Study|Withdrawal by Subject|1
1599777|NCT02282982|5572001|P1|Overall Study|Other, not specified|18
1599778|NCT02282982|5572001|P1|Overall Study|Palivizumab is ended|11
1599779|NCT02282982|5572001|P1|Overall Study|Lack of product|156
1599780|NCT02282982|5572001|P1|Overall Study|Death|4
1599781|NCT02282982|5572001|P1|Overall Study|Withdrew consent|2
1599782|NCT02282982|5572001|P1|Overall Study|Lost to Follow-up|15
1599783|NCT02282813|5572024|P3|Overall Study|Administrative reasons|0
1599784|NCT02282813|5572025|P2|Overall Study|Administrative reasons|1
1599785|NCT02282813|5572026|P1|Overall Study|Administrative reasons|0
1599786|NCT02282813|5572024|P3|Overall Study|Lack of Efficacy|0
1599787|NCT02282813|5572025|P2|Overall Study|Lack of Efficacy|0
1599788|NCT02282813|5572026|P1|Overall Study|Lack of Efficacy|1
1599789|NCT02282813|5572024|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
1599790|NCT02282813|5572025|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
1599791|NCT02282813|5572026|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
1599792|NCT02282813|5572024|P3|Overall Study|Lost to Follow-up|1
1599793|NCT02282813|5572025|P2|Overall Study|Lost to Follow-up|0
1599794|NCT02282813|5572026|P1|Overall Study|Lost to Follow-up|2
1599795|NCT02282813|5572024|P3|Overall Study|Physician Decision|1
1599796|NCT02282813|5572025|P2|Overall Study|Physician Decision|3
1599797|NCT02282813|5572026|P1|Overall Study|Physician Decision|0
1599798|NCT02282813|5572024|P3|Overall Study|Subject non-compliance|0
1599799|NCT02282813|5572025|P2|Overall Study|Subject non-compliance|4
1599800|NCT02282813|5572026|P1|Overall Study|Subject non-compliance|1
1599801|NCT02282813|5572024|P3|Overall Study|Adverse Event|1
1599802|NCT02282813|5572025|P2|Overall Study|Adverse Event|10
1599803|NCT02282813|5572026|P1|Overall Study|Adverse Event|3
1599804|NCT02282813|5572024|P3|Overall Study|Withdrawal by Subject|0
1599805|NCT02282813|5572025|P2|Overall Study|Withdrawal by Subject|5
1599806|NCT02282813|5572026|P1|Overall Study|Withdrawal by Subject|4
1599807|NCT02282631|5572072|P2|Overall Study|Lost to Follow-up|0
1599808|NCT02282631|5572073|P1|Overall Study|Lost to Follow-up|2
1599809|NCT02282605|5572114|P3|Overall Study|negative SA result on Day -1|0
1599810|NCT02282605|5572115|P2|Overall Study|negative SA result on Day -1|0
1599811|NCT02282605|5572116|P1|Overall Study|negative SA result on Day -1|3
1599812|NCT02282527|5572138|P2|Overall Study|Lack of home health aid|0
1599813|NCT02282527|5572139|P1|Overall Study|Lack of home health aid|1
1599814|NCT02282527|5572138|P2|Overall Study|Lost to Follow-up|1
1599815|NCT02282527|5572139|P1|Overall Study|Lost to Follow-up|0
1599816|NCT02282293|5572151|P2|Overall Study|Moved out of study area|1
1599817|NCT02282293|5572152|P1|Overall Study|Moved out of study area|0
1599818|NCT02282293|5572151|P2|Overall Study|Unable to comply with study procedures|0
1599819|NCT02282293|5572152|P1|Overall Study|Unable to comply with study procedures|1
1599820|NCT02282293|5572151|P2|Overall Study|Lost to Follow-up|2
1599821|NCT02282293|5572152|P1|Overall Study|Lost to Follow-up|2
1599822|NCT02282020|5572189|P2|Overall Study|Withdrew Consent Prior to Dosing|12
1599823|NCT02282020|5572190|P1|Overall Study|Withdrew Consent Prior to Dosing|0
1599824|NCT02282020|5572189|P2|Overall Study|Developed Discontinuation Criteria|3
1599825|NCT02282020|5572190|P1|Overall Study|Developed Discontinuation Criteria|1
1599826|NCT02282020|5572189|P2|Overall Study|Severe Non-compliance to Protocol|0
1599827|NCT02282020|5572190|P1|Overall Study|Severe Non-compliance to Protocol|1
1599828|NCT02282020|5572189|P2|Overall Study|Miscellaneous|17
1599829|NCT02282020|5572190|P1|Overall Study|Miscellaneous|4
1599830|NCT02282020|5572189|P2|Overall Study|Withdrawal by Subject|10
1599831|NCT02282020|5572190|P1|Overall Study|Withdrawal by Subject|5
1599832|NCT02282020|5572189|P2|Overall Study|Adverse Event|15
1599833|NCT02282020|5572190|P1|Overall Study|Adverse Event|13
1599834|NCT02282020|5572189|P2|Overall Study|Objective Disease Progression|30
1599835|NCT02282020|5572190|P1|Overall Study|Objective Disease Progression|111
1599836|NCT02281773|5572240|P5|Overall Study|Other Reason|1
1599837|NCT02281773|5572241|P4|Overall Study|Other Reason|3
1599838|NCT02281773|5572242|P3|Overall Study|Other Reason|2
1599839|NCT02281773|5572243|P2|Overall Study|Other Reason|4
1599840|NCT02281773|5572244|P1|Overall Study|Other Reason|0
1599841|NCT02281773|5572240|P5|Overall Study|Withdrawal by Subject|8
1599842|NCT02281773|5572241|P4|Overall Study|Withdrawal by Subject|6
1599843|NCT02281773|5572242|P3|Overall Study|Withdrawal by Subject|6
1599844|NCT02281773|5572243|P2|Overall Study|Withdrawal by Subject|8
1599845|NCT02281773|5572244|P1|Overall Study|Withdrawal by Subject|2
1599846|NCT02281773|5572240|P5|Overall Study|Lost to Follow-up|10
1599847|NCT02281773|5572241|P4|Overall Study|Lost to Follow-up|2
1599848|NCT02281773|5572242|P3|Overall Study|Lost to Follow-up|6
1599849|NCT02281773|5572243|P2|Overall Study|Lost to Follow-up|2
1599850|NCT02281773|5572244|P1|Overall Study|Lost to Follow-up|2
1599851|NCT02281773|5572240|P5|Overall Study|Protocol Violation|2
1599852|NCT02281773|5572241|P4|Overall Study|Protocol Violation|2
1599853|NCT02281773|5572242|P3|Overall Study|Protocol Violation|0
1599854|NCT02281773|5572243|P2|Overall Study|Protocol Violation|0
1599855|NCT02281773|5572244|P1|Overall Study|Protocol Violation|1
1599856|NCT02281773|5572240|P5|Overall Study|Adverse Event|9
1599857|NCT02281773|5572241|P4|Overall Study|Adverse Event|8
1599858|NCT02281773|5572242|P3|Overall Study|Adverse Event|4
1599859|NCT02281773|5572243|P2|Overall Study|Adverse Event|1
1599860|NCT02281773|5572244|P1|Overall Study|Adverse Event|6
1599861|NCT02281552|5572332|P2|Overall Study|Adverse Event|9
1599862|NCT02281552|5572333|P1|Overall Study|Adverse Event|3
1599863|NCT02281552|5572332|P2|Overall Study|Insufficient clinical response|1
1599864|NCT02281552|5572333|P1|Overall Study|Insufficient clinical response|0
1599865|NCT02281552|5572332|P2|Overall Study|Medication error|0
1599866|NCT02281552|5572333|P1|Overall Study|Medication error|1
1599867|NCT02281357|5572426|P2|Overall Study|Withdrawal by Subject|3
1599868|NCT02281357|5572427|P1|Overall Study|Withdrawal by Subject|4
1599869|NCT02281357|5572426|P2|Overall Study|Lost to Follow-up|0
1599870|NCT02281357|5572427|P1|Overall Study|Lost to Follow-up|1
1599871|NCT02281357|5572426|P2|Overall Study|Adverse Event|1
1599872|NCT02281357|5572427|P1|Overall Study|Adverse Event|2
1599873|NCT02281318|5572441|P2|Overall Study|Withdrawal by Subject|2
1599874|NCT02281318|5572442|P1|Overall Study|Withdrawal by Subject|6
1599875|NCT02281318|5572441|P2|Overall Study|Physician Decision|0
1599876|NCT02281318|5572442|P1|Overall Study|Physician Decision|2
1599877|NCT02281318|5572441|P2|Overall Study|Lost to Follow-up|1
1599878|NCT02281318|5572442|P1|Overall Study|Lost to Follow-up|2
1599879|NCT02281318|5572441|P2|Overall Study|Lack of Efficacy|0
1599880|NCT02281318|5572442|P1|Overall Study|Lack of Efficacy|2
1599881|NCT02281318|5572441|P2|Overall Study|Adverse Event|2
1599882|NCT02281318|5572442|P1|Overall Study|Adverse Event|2
1599883|NCT02280863|5572488|P2|Integrated Platform|Met stopping criteria|1
1599884|NCT02280863|5572489|P1|Integrated Platform|Met stopping criteria|0
1599885|NCT02280499|5572573|P1|Overall Study|Adverse Event|5
1599886|NCT02280499|5572573|P1|Overall Study|Lost to Follow-up|42
1599887|NCT02280499|5572573|P1|Overall Study|Death|14
1599888|NCT02280473|5572581|P2|Overall Study|Lost to Follow-up|1
1599889|NCT02280473|5572582|P1|Overall Study|Lost to Follow-up|0
1599890|NCT02280473|5572581|P2|Overall Study|Lack of Efficacy|1
1599891|NCT02280473|5572582|P1|Overall Study|Lack of Efficacy|0
1599892|NCT02280473|5572581|P2|Overall Study|Adverse Event|1
1599893|NCT02280473|5572582|P1|Overall Study|Adverse Event|1
1599894|NCT02280421|5572598|P2|Washout (2 Weeks)|Withdrawal by Subject|0
1599895|NCT02280421|5572599|P1|Washout (2 Weeks)|Withdrawal by Subject|1
1599896|NCT02280421|5572598|P2|Washout (2 Weeks)|Adverse Event|1
1599897|NCT02280421|5572599|P1|Washout (2 Weeks)|Adverse Event|0
1599898|NCT02280408|5572665|P4|Overall Study|Lost to Follow-up|0
1599899|NCT02280408|5572666|P3|Overall Study|Lost to Follow-up|0
1599900|NCT02280408|5572667|P2|Overall Study|Lost to Follow-up|2
1599901|NCT02280408|5572668|P1|Overall Study|Lost to Follow-up|0
1599902|NCT02280187|5572760|P1|Overall Study|Lost to Follow-up|218
1599903|NCT02280096|5572788|P2|Overall Study|Lack of attachment|1
1599904|NCT02280096|5572789|P1|Overall Study|Lack of attachment|0
1599905|NCT02280096|5572788|P2|Overall Study|Functional neurological disorder|0
1599906|NCT02280096|5572789|P1|Overall Study|Functional neurological disorder|1
1599907|NCT02280096|5572788|P2|Overall Study|Pregnancy|0
1599908|NCT02280096|5572789|P1|Overall Study|Pregnancy|1
1599909|NCT02280044|5572819|P2|Overall Study|Planned alternate|2
1599910|NCT02280044|5572820|P1|Overall Study|Planned alternate|0
1599911|NCT02279862|5572830|P2|Overall Study|Withdrawal by Subject|0
1599912|NCT02279862|5572831|P1|Overall Study|Withdrawal by Subject|1
1599913|NCT02279862|5572830|P2|Overall Study|Other|2
1599914|NCT02279862|5572831|P1|Overall Study|Other|1
1599915|NCT02279862|5572830|P2|Overall Study|Study closed by sponsor|13
1599916|NCT02279862|5572831|P1|Overall Study|Study closed by sponsor|16
1599917|NCT02279862|5572830|P2|Overall Study|Disease progression|2
1599918|NCT02279862|5572831|P1|Overall Study|Disease progression|5
1599919|NCT02279862|5572830|P2|Overall Study|Administrative reason by sponsor|1
1599920|NCT02279862|5572831|P1|Overall Study|Administrative reason by sponsor|0
1599921|NCT02279862|5572830|P2|Overall Study|No longer meets criteria|1
1599922|NCT02279862|5572831|P1|Overall Study|No longer meets criteria|0
1599923|NCT02279862|5572830|P2|Overall Study|Study drug toxicity|6
1599924|NCT02279862|5572831|P1|Overall Study|Study drug toxicity|3
1599925|NCT02279732|5572849|P2|Overall Study|Other|3
1599926|NCT02279732|5572850|P1|Overall Study|Other|3
1599927|NCT02279732|5572849|P2|Overall Study|Other|67
1599928|NCT02279732|5572850|P1|Overall Study|Other|53
1599929|NCT02279732|5572849|P2|Overall Study|Subject Requested to Discontinue|1
1599930|NCT02279732|5572850|P1|Overall Study|Subject Requested to Discontinue|0
1599931|NCT02279732|5572849|P2|Overall Study|Maximum Clinical Benefit|0
1599932|NCT02279732|5572850|P1|Overall Study|Maximum Clinical Benefit|1
1599933|NCT02279732|5572849|P2|Overall Study|Lost to Follow-up|1
1599934|NCT02279732|5572850|P1|Overall Study|Lost to Follow-up|0
1599935|NCT02279732|5572849|P2|Overall Study|Study Drug Toxicity|0
1599936|NCT02279732|5572850|P1|Overall Study|Study Drug Toxicity|2
1599937|NCT02279732|5572849|P2|Overall Study|Administrative Reason By Sponsor|2
1599938|NCT02279732|5572850|P1|Overall Study|Administrative Reason By Sponsor|0
1599939|NCT02279732|5572849|P2|Overall Study|Adverse Event|2
1599940|NCT02279732|5572850|P1|Overall Study|Adverse Event|1
1599941|NCT02279732|5572849|P2|Overall Study|Withdrawal by Subject|7
1599942|NCT02279732|5572850|P1|Overall Study|Withdrawal by Subject|2
1599943|NCT02279732|5572849|P2|Overall Study|Disease Progression|3
1599944|NCT02279732|5572850|P1|Overall Study|Disease Progression|13
1599945|NCT02279732|5572849|P2|Overall Study|Death|20
1599946|NCT02279732|5572850|P1|Overall Study|Death|23
1599947|NCT02279498|5572942|P2|Overall Study|Undefined|1
1599948|NCT02279498|5572943|P1|Overall Study|Undefined|2
1599949|NCT02279498|5572942|P2|Overall Study|Withdrawal by Subject|2
1599950|NCT02279498|5572943|P1|Overall Study|Withdrawal by Subject|9
1599951|NCT02279498|5572942|P2|Overall Study|Lost to Follow-up|1
1599952|NCT02279498|5572943|P1|Overall Study|Lost to Follow-up|0
1599953|NCT02279498|5572942|P2|Overall Study|Lack of Efficacy|0
1599954|NCT02279498|5572943|P1|Overall Study|Lack of Efficacy|4
1599955|NCT02279498|5572942|P2|Overall Study|Adverse Event|0
1599956|NCT02279498|5572943|P1|Overall Study|Adverse Event|3
1599957|NCT02279420|5572952|P1|Overall Study|Lost to Follow-up|23
1599958|NCT02279407|5572960|P4|Overall Study|Adverse Event|0
1599959|NCT02279407|5572961|P3|Overall Study|Adverse Event|2
1599960|NCT02279407|5572962|P2|Overall Study|Adverse Event|1
1599961|NCT02279407|5572963|P1|Overall Study|Adverse Event|1
1599962|NCT02279407|5572960|P4|Overall Study|Withdrawal by Subject|1
1599963|NCT02279407|5572961|P3|Overall Study|Withdrawal by Subject|1
1599964|NCT02279407|5572962|P2|Overall Study|Withdrawal by Subject|0
1599965|NCT02279407|5572963|P1|Overall Study|Withdrawal by Subject|1
1599966|NCT02279407|5572960|P4|Overall Study|Couldn't swallow IP; noncompliance|0
1599967|NCT02279407|5572961|P3|Overall Study|Couldn't swallow IP; noncompliance|2
1599968|NCT02279407|5572962|P2|Overall Study|Couldn't swallow IP; noncompliance|0
1599969|NCT02279407|5572963|P1|Overall Study|Couldn't swallow IP; noncompliance|0
1599970|NCT02279173|5572974|P1|Overall Study|Enrolled But Did Not Receive Treatment|1
1599971|NCT02279173|5572974|P1|Overall Study|Lost to Follow-up|3
1599972|NCT02279173|5572974|P1|Overall Study|Decision by Sponsor|4
1599973|NCT02279173|5572974|P1|Overall Study|Withdrawal by Subject|17
1599974|NCT02279173|5572974|P1|Overall Study|Protocol-specified Criteria|64
1599975|NCT02279173|5572974|P1|Overall Study|Ongoing|78
1599976|NCT02279043|5573023|P3|Overall Study|Lost to Follow-up|0
1599977|NCT02279043|5573024|P2|Overall Study|Lost to Follow-up|88
1599978|NCT02279043|5573025|P1|Overall Study|Lost to Follow-up|46
1599979|NCT02279043|5573023|P3|Overall Study|Post-rand. exclusion - not eligible|0
1599980|NCT02279043|5573024|P2|Overall Study|Post-rand. exclusion - not eligible|1
1599981|NCT02279043|5573025|P1|Overall Study|Post-rand. exclusion - not eligible|1
1599982|NCT02278952|5573055|P1|Overall Study|Insufficient Sample|6
1599983|NCT02278939|5573067|P2|Overall Study|family emergency unable to commit|0
1599984|NCT02278939|5573068|P1|Overall Study|family emergency unable to commit|2
1599985|NCT02278939|5573067|P2|Overall Study|death in family|0
1599986|NCT02278939|5573068|P1|Overall Study|death in family|1
1599987|NCT02278939|5573067|P2|Overall Study|Lost to Follow-up|1
1599988|NCT02278939|5573068|P1|Overall Study|Lost to Follow-up|1
1599989|NCT02278939|5573067|P2|Overall Study|lack of time|0
1599990|NCT02278939|5573068|P1|Overall Study|lack of time|1
1599991|NCT02278614|5573096|P2|Overall Study|left eye was not eligible|0
1599992|NCT02278614|5573097|P1|Overall Study|left eye was not eligible|1
1599993|NCT02278614|5573096|P2|Overall Study|Adverse Event|0
1599994|NCT02278614|5573097|P1|Overall Study|Adverse Event|1
1599995|NCT02278614|5573096|P2|Overall Study|Withdrawal by Subject|5
1599996|NCT02278614|5573097|P1|Overall Study|Withdrawal by Subject|3
1599997|NCT02278471|5573131|P2|Overall Study|Withdrawal by Subject|3
1599998|NCT02278471|5573132|P1|Overall Study|Withdrawal by Subject|0
1599999|NCT02278471|5573131|P2|Overall Study|Death|2
1600000|NCT02278471|5573132|P1|Overall Study|Death|2
1600001|NCT02278471|5573131|P2|Overall Study|Lost to Follow-up|15
1600002|NCT02278471|5573132|P1|Overall Study|Lost to Follow-up|6
1600003|NCT02278328|5573148|P3|Neuropsych Screening|incomplete consent|2
1600004|NCT02278328|5573149|P2|Neuropsych Screening|incomplete consent|0
1600005|NCT02278328|5573150|P1|Neuropsych Screening|incomplete consent|0
1600006|NCT02278328|5573148|P3|Neuropsych Screening|Withdrawal by Subject|0
1600007|NCT02278328|5573149|P2|Neuropsych Screening|Withdrawal by Subject|1
1600008|NCT02278328|5573150|P1|Neuropsych Screening|Withdrawal by Subject|0
1600009|NCT02278328|5573148|P3|Neuropsych Screening|found ineligible on neuropsych|0
1600010|NCT02278328|5573149|P2|Neuropsych Screening|found ineligible on neuropsych|0
1600011|NCT02278328|5573150|P1|Neuropsych Screening|found ineligible on neuropsych|1
1600012|NCT02278120|5573179|P2|Overall Study|Protocol Violation|2
1600013|NCT02278120|5573180|P1|Overall Study|Protocol Violation|0
1600014|NCT02278120|5573179|P2|Overall Study|Lost to Follow-up|0
1600015|NCT02278120|5573180|P1|Overall Study|Lost to Follow-up|2
1600016|NCT02278120|5573179|P2|Overall Study|Death|3
1600017|NCT02278120|5573180|P1|Overall Study|Death|3
1600018|NCT02278120|5573179|P2|Overall Study|Physician Decision|19
1600019|NCT02278120|5573180|P1|Overall Study|Physician Decision|8
1600020|NCT02278120|5573179|P2|Overall Study|Adverse Event|10
1600021|NCT02278120|5573180|P1|Overall Study|Adverse Event|12
1600022|NCT02278120|5573179|P2|Overall Study|Patient/guardian decision|8
1600023|NCT02278120|5573180|P1|Overall Study|Patient/guardian decision|14
1600024|NCT02278120|5573179|P2|Overall Study|Progressive disease|174
1600025|NCT02278120|5573180|P1|Overall Study|Progressive disease|122
1600026|NCT02278003|5573196|P2|Overall Study|Recognition task improperly completed|0
1600027|NCT02278003|5573197|P1|Overall Study|Recognition task improperly completed|7
1600028|NCT02278003|5573196|P2|Overall Study|Not Treated|0
1600029|NCT02278003|5573197|P1|Overall Study|Not Treated|1
1600030|NCT02278003|5573196|P2|Overall Study|Withdrawal by Subject|0
1600031|NCT02278003|5573197|P1|Overall Study|Withdrawal by Subject|11
1600032|NCT02277990|5573207|P2|Overall Study|Had other reason|32
1600033|NCT02277990|5573208|P1|Overall Study|Had other reason|26
1600034|NCT02277990|5573207|P2|Overall Study|Lost to Follow-up|69
1600035|NCT02277990|5573208|P1|Overall Study|Lost to Follow-up|66
1600036|NCT02277990|5573207|P2|Overall Study|Physician Decision|34
1600037|NCT02277990|5573208|P1|Overall Study|Physician Decision|40
1600038|NCT02277990|5573207|P2|Overall Study|Withdrawal by Subject|53
1600039|NCT02277990|5573208|P1|Overall Study|Withdrawal by Subject|64
1600040|NCT02277990|5573207|P2|Overall Study|Death|188
1600041|NCT02277990|5573208|P1|Overall Study|Death|170
1600042|NCT02277769|5573236|P3|Overall Study|Other than specified above|5
1600043|NCT02277769|5573237|P2|Overall Study|Other than specified above|8
1600044|NCT02277769|5573238|P1|Overall Study|Other than specified above|12
1600045|NCT02277769|5573236|P3|Overall Study|Adverse Event|4
1600046|NCT02277769|5573237|P2|Overall Study|Adverse Event|2
1600047|NCT02277769|5573238|P1|Overall Study|Adverse Event|14
1600048|NCT02277769|5573236|P3|Overall Study|Lack of Efficacy|4
1600049|NCT02277769|5573237|P2|Overall Study|Lack of Efficacy|0
1600050|NCT02277769|5573238|P1|Overall Study|Lack of Efficacy|17
1600051|NCT02277769|5573236|P3|Overall Study|Protocol Violation|5
1600052|NCT02277769|5573237|P2|Overall Study|Protocol Violation|3
1600053|NCT02277769|5573238|P1|Overall Study|Protocol Violation|3
1600054|NCT02277743|5573309|P3|Overall Study|Other than specified above|16
1600055|NCT02277743|5573310|P2|Overall Study|Other than specified above|5
1600056|NCT02277743|5573311|P1|Overall Study|Other than specified above|18
1600057|NCT02277743|5573309|P3|Overall Study|Lack of Efficacy|3
1600058|NCT02277743|5573310|P2|Overall Study|Lack of Efficacy|4
1600059|NCT02277743|5573311|P1|Overall Study|Lack of Efficacy|11
1600060|NCT02277743|5573309|P3|Overall Study|Adverse Event|6
1600061|NCT02277743|5573310|P2|Overall Study|Adverse Event|6
1600062|NCT02277743|5573311|P1|Overall Study|Adverse Event|10
1600063|NCT02277743|5573309|P3|Overall Study|Protocol Violation|1
1600064|NCT02277743|5573310|P2|Overall Study|Protocol Violation|1
1600065|NCT02277743|5573311|P1|Overall Study|Protocol Violation|1
1600066|NCT02277691|5573379|P1|Overall Study|Used Other Antihypertensive Drug|1
1600067|NCT02277691|5573379|P1|Overall Study|Lack of Efficacy|5
1600068|NCT02277691|5573379|P1|Overall Study|Voluntary Withdrawal|7
1600069|NCT02277691|5573379|P1|Overall Study|Pretreatment Event/Adverse Event|33
1600070|NCT02277119|5573453|P3|Overall Study|Protocol Violation|7
1600071|NCT02277119|5573454|P2|Overall Study|Protocol Violation|3
1600072|NCT02277119|5573455|P1|Overall Study|Protocol Violation|2
1600073|NCT02277119|5573453|P3|Overall Study|Lack of Efficacy|1
1600074|NCT02277119|5573454|P2|Overall Study|Lack of Efficacy|1
1600075|NCT02277119|5573455|P1|Overall Study|Lack of Efficacy|1
1600076|NCT02276872|5573493|P3|Overall Study|Adverse Event|0
1600077|NCT02276872|5573494|P2|Overall Study|Adverse Event|0
1600078|NCT02276872|5573495|P1|Overall Study|Adverse Event|1
1600079|NCT02276807|5573571|P2|Overall Study|Lost to Follow-up|10
1600080|NCT02276807|5573572|P1|Overall Study|Lost to Follow-up|10
1600081|NCT02276807|5573571|P2|Overall Study|Withdrawal by Subject|7
1600082|NCT02276807|5573572|P1|Overall Study|Withdrawal by Subject|8
1600083|NCT02276612|5573607|P2|Overall Study|Lost to Follow-up|0
1600084|NCT02276612|5573608|P1|Overall Study|Lost to Follow-up|1
1600085|NCT02276612|5573607|P2|Overall Study|Withdrew Consent|0
1600086|NCT02276612|5573608|P1|Overall Study|Withdrew Consent|1
1600087|NCT02276612|5573607|P2|Overall Study|Pregnancy|0
1600088|NCT02276612|5573608|P1|Overall Study|Pregnancy|1
1600089|NCT02276612|5573607|P2|Overall Study|Death|0
1600090|NCT02276612|5573608|P1|Overall Study|Death|1
1600091|NCT02276560|5573631|P3|Overall Study|Adverse Event|0
1600092|NCT02276560|5573632|P2|Overall Study|Adverse Event|0
1600093|NCT02276560|5573633|P1|Overall Study|Adverse Event|1
1600094|NCT02276482|5573643|P2|Overall Study|Reason not specified|1
1600095|NCT02276482|5573644|P1|Overall Study|Reason not specified|0
1600096|NCT02276482|5573643|P2|Overall Study|Gram-negative infection|0
1600097|NCT02276482|5573644|P1|Overall Study|Gram-negative infection|1
1600098|NCT02276482|5573643|P2|Overall Study|Withdrawal by Subject|0
1600099|NCT02276482|5573644|P1|Overall Study|Withdrawal by Subject|1
1600100|NCT02276482|5573643|P2|Overall Study|Adverse Event|0
1600101|NCT02276482|5573644|P1|Overall Study|Adverse Event|1
1600102|NCT02276222|5573779|P2|Overall Study|subject withdrew after randomization|0
1600103|NCT02276222|5573780|P1|Overall Study|subject withdrew after randomization|1
1600104|NCT02276222|5573779|P2|Overall Study|sheduling conflict|0
1600105|NCT02276222|5573780|P1|Overall Study|sheduling conflict|1
1600106|NCT02276222|5573779|P2|Overall Study|Physician Decision|1
1600107|NCT02276222|5573780|P1|Overall Study|Physician Decision|2
1600108|NCT02276222|5573779|P2|Overall Study|Lost to Follow-up|5
1600109|NCT02276222|5573780|P1|Overall Study|Lost to Follow-up|15
1600110|NCT02276222|5573779|P2|Overall Study|sponsor decision|3
1600111|NCT02276222|5573780|P1|Overall Study|sponsor decision|0
1600112|NCT02276222|5573779|P2|Overall Study|non compliance with study medication|2
1600113|NCT02276222|5573780|P1|Overall Study|non compliance with study medication|6
1600114|NCT02276222|5573779|P2|Overall Study|Withdrawal by Subject|33
1600115|NCT02276222|5573780|P1|Overall Study|Withdrawal by Subject|79
1600116|NCT02276222|5573779|P2|Overall Study|Protocol Violation|2
1600117|NCT02276222|5573780|P1|Overall Study|Protocol Violation|3
1600118|NCT02276222|5573779|P2|Overall Study|Lack of Efficacy|3
1600119|NCT02276222|5573780|P1|Overall Study|Lack of Efficacy|13
1600120|NCT02276222|5573779|P2|Overall Study|Death|4
1600121|NCT02276222|5573780|P1|Overall Study|Death|3
1600122|NCT02276222|5573779|P2|Overall Study|Adverse Event|11
1600123|NCT02276222|5573780|P1|Overall Study|Adverse Event|62
1600124|NCT02276053|5573804|P1|Overall Study|Patient needs to increase baseline AED|1
1600125|NCT02276053|5573804|P1|Overall Study|Patient does not meet selection criteria|3
1600126|NCT02276053|5573804|P1|Overall Study|Withdrawal by Subject|1
1600127|NCT02276053|5573804|P1|Overall Study|Lack of Efficacy|2
1600128|NCT02276053|5573804|P1|Overall Study|Adverse Event|5
1600129|NCT02276053|5573804|P1|Overall Study|Death|2
1600130|NCT02276040|5573820|P1|Overall Study|Physician Decision|15
1600131|NCT02275780|5573831|P2|Extension Study: up to 192 Weeks|Ongoing|233
1600132|NCT02275780|5573832|P1|Extension Study: up to 192 Weeks|Ongoing|260
1600133|NCT02275780|5573831|P2|Base Study: 96 Weeks|Randomized not treated|1
1600134|NCT02275780|5573832|P1|Base Study: 96 Weeks|Randomized not treated|2
1600135|NCT02275780|5573831|P2|Base Study: 96 Weeks|Pregnancy|1
1600136|NCT02275780|5573832|P1|Base Study: 96 Weeks|Pregnancy|2
1600137|NCT02275780|5573831|P2|Base Study: 96 Weeks|Physician Decision|4
1600138|NCT02275780|5573832|P1|Base Study: 96 Weeks|Physician Decision|2
1600139|NCT02275780|5573831|P2|Base Study: 96 Weeks|Noncompliance with drug|6
1600140|NCT02275780|5573832|P1|Base Study: 96 Weeks|Noncompliance with drug|9
1600141|NCT02275780|5573831|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
1600142|NCT02275780|5573832|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
1600143|NCT02275780|5573831|P2|Base Study: 96 Weeks|Protocol Violation|6
1600144|NCT02275780|5573832|P1|Base Study: 96 Weeks|Protocol Violation|1
1600145|NCT02275780|5573831|P2|Base Study: 96 Weeks|Lost to Follow-up|24
1600146|NCT02275780|5573832|P1|Base Study: 96 Weeks|Lost to Follow-up|28
1600147|NCT02275780|5573831|P2|Base Study: 96 Weeks|Lack of Efficacy|32
1600148|NCT02275780|5573832|P1|Base Study: 96 Weeks|Lack of Efficacy|21
1600149|NCT02275780|5573831|P2|Base Study: 96 Weeks|Death|1
1600150|NCT02275780|5573832|P1|Base Study: 96 Weeks|Death|3
1600151|NCT02275780|5573831|P2|Base Study: 96 Weeks|Adverse Event|14
1600152|NCT02275780|5573832|P1|Base Study: 96 Weeks|Adverse Event|6
1600153|NCT02275611|5573888|P4|Inpatient Withdrawal|Withdrawal by Subject|0
1600154|NCT02275611|5573889|P3|Inpatient Withdrawal|Withdrawal by Subject|0
1600155|NCT02275611|5573890|P2|Inpatient Withdrawal|Withdrawal by Subject|0
1600156|NCT02275611|5573891|P1|Inpatient Withdrawal|Withdrawal by Subject|1
1600157|NCT02275546|5573903|P2|Treatment Period 2|Protocol Violation|1
1600158|NCT02275546|5573904|P1|Treatment Period 2|Protocol Violation|0
1600159|NCT02275546|5573903|P2|Treatment Period 2|Withdrawal by Subject|1
1600160|NCT02275546|5573904|P1|Treatment Period 2|Withdrawal by Subject|2
1600161|NCT02275481|5573914|P2|Overall Study|Physician Decision|1
1600162|NCT02275481|5573915|P1|Overall Study|Physician Decision|0
1600163|NCT02275481|5573914|P2|Overall Study|all other reasons combined|1
1600164|NCT02275481|5573915|P1|Overall Study|all other reasons combined|2
1600165|NCT02275481|5573914|P2|Overall Study|Withdrawal by Subject|0
1600166|NCT02275481|5573915|P1|Overall Study|Withdrawal by Subject|3
1600167|NCT02275481|5573914|P2|Overall Study|Lost to Follow-up|0
1600168|NCT02275481|5573915|P1|Overall Study|Lost to Follow-up|2
1600169|NCT02275481|5573914|P2|Overall Study|Death|1
1600170|NCT02275481|5573915|P1|Overall Study|Death|2
1600171|NCT02275364|5573921|P2|Period 1|Other reason|0
1600172|NCT02275364|5573922|P1|Period 1|Other reason|1
1600173|NCT02275364|5573921|P2|Period 1|Withdrawal by Subject|0
1600174|NCT02275364|5573922|P1|Period 1|Withdrawal by Subject|1
1600175|NCT02275338|5573951|P1|Overall Study|Does not meet entry criteria|1
1600176|NCT02275338|5573951|P1|Overall Study|Reason not specified|5
1600177|NCT02275338|5573951|P1|Overall Study|Ineligible to start Phase 2|4
1600178|NCT02275338|5573951|P1|Overall Study|Disease progression (death)|1
1600179|NCT02275338|5573951|P1|Overall Study|Withdrawal by Subject|4
1600180|NCT02275338|5573951|P1|Overall Study|Lack of Efficacy|3
1600181|NCT02275338|5573951|P1|Overall Study|Adverse Event|15
1600182|NCT02275052|5573995|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
1600183|NCT02275052|5573996|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1600184|NCT02275052|5573997|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1600185|NCT02275052|5573998|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1600186|NCT02275052|5573995|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
1600187|NCT02275052|5573996|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1600188|NCT02275052|5573997|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1600189|NCT02275052|5573998|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1600190|NCT02275052|5573995|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
1600191|NCT02275052|5573996|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1600192|NCT02275052|5573997|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1600193|NCT02275052|5573998|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1600194|NCT02275052|5573995|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
1600195|NCT02275052|5573996|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
1600196|NCT02275052|5573997|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1600197|NCT02275052|5573998|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
1600198|NCT02275052|5573995|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
1600199|NCT02275052|5573996|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
1600200|NCT02275052|5573997|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
1600201|NCT02275052|5573998|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
1600202|NCT02275052|5573995|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
1600203|NCT02275052|5573996|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
1600204|NCT02275052|5573997|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
1600205|NCT02275052|5573998|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
1600206|NCT02275052|5573995|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1600207|NCT02275052|5573996|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1600208|NCT02275052|5573997|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
1600209|NCT02275052|5573998|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
1600210|NCT02275052|5573995|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1600211|NCT02275052|5573996|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1600212|NCT02275052|5573997|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
1600213|NCT02275052|5573998|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
1600214|NCT02275052|5573995|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1600215|NCT02275052|5573996|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1600216|NCT02275052|5573997|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
1600217|NCT02275052|5573998|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
1600218|NCT02275052|5573995|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1600219|NCT02275052|5573996|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1600220|NCT02275052|5573997|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
1600221|NCT02275052|5573998|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
1600222|NCT02275052|5573995|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1600223|NCT02275052|5573996|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1600224|NCT02275052|5573997|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1600225|NCT02275052|5573998|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1600226|NCT02274948|5574012|P2|Overall Study|Left the area|3
1600227|NCT02274948|5574013|P1|Overall Study|Left the area|4
1600228|NCT02274948|5574012|P2|Overall Study|Stopped on family Practitioner advice|5
1600229|NCT02274948|5574013|P1|Overall Study|Stopped on family Practitioner advice|2
1600230|NCT02274948|5574012|P2|Overall Study|Withdrawal by Subject|58
1600231|NCT02274948|5574013|P1|Overall Study|Withdrawal by Subject|64
1600232|NCT02274948|5574012|P2|Overall Study|Lost to Follow-up|25
1600233|NCT02274948|5574013|P1|Overall Study|Lost to Follow-up|28
1600234|NCT02274857|5574056|P2|Overall Study|Other|0
1600235|NCT02274857|5574057|P1|Overall Study|Other|2
1600236|NCT02274857|5574056|P2|Overall Study|Withdrawal by Subject|2
1600237|NCT02274857|5574057|P1|Overall Study|Withdrawal by Subject|11
1600238|NCT02274857|5574056|P2|Overall Study|Trial screen failure|2
1600239|NCT02274857|5574057|P1|Overall Study|Trial screen failure|0
1600240|NCT02274857|5574056|P2|Overall Study|Physician Decision|0
1600241|NCT02274857|5574057|P1|Overall Study|Physician Decision|2
1600242|NCT02274857|5574056|P2|Overall Study|Lost to Follow-up|0
1600243|NCT02274857|5574057|P1|Overall Study|Lost to Follow-up|3
1600244|NCT02274857|5574056|P2|Overall Study|Death|2
1600245|NCT02274857|5574057|P1|Overall Study|Death|1
1600246|NCT02274857|5574056|P2|Overall Study|Adverse Event|0
1600247|NCT02274857|5574057|P1|Overall Study|Adverse Event|1
1600248|NCT02274792|5574070|P1|Overall Study|Sponsor Decision|2
1600249|NCT02274792|5574070|P1|Overall Study|Protocol Specified Criteria|2
1600250|NCT02274792|5574070|P1|Overall Study|Lost to Follow-up|8
1600251|NCT02274792|5574070|P1|Overall Study|Withdrawal by Subject|13
1600252|NCT02274766|5574080|P2|Overall Study|Adverse Event|1
1600253|NCT02274766|5574081|P1|Overall Study|Adverse Event|0
1600254|NCT02274766|5574080|P2|Overall Study|Subject Unwilling to Proceed|1
1600255|NCT02274766|5574081|P1|Overall Study|Subject Unwilling to Proceed|0
1600256|NCT02274766|5574080|P2|Overall Study|Did Not Receive Study Drug|1
1600257|NCT02274766|5574081|P1|Overall Study|Did Not Receive Study Drug|1
1600258|NCT02274766|5574080|P2|Overall Study|Withdrawal by Subject|6
1600259|NCT02274766|5574081|P1|Overall Study|Withdrawal by Subject|3
1600260|NCT02274558|5574148|P3|Overall Study|Physician Decision|1
1600261|NCT02274558|5574149|P2|Overall Study|Physician Decision|2
1600262|NCT02274558|5574150|P1|Overall Study|Physician Decision|0
1600263|NCT02274558|5574148|P3|Overall Study|Lost to Follow-up|1
1600264|NCT02274558|5574149|P2|Overall Study|Lost to Follow-up|1
1600265|NCT02274558|5574150|P1|Overall Study|Lost to Follow-up|2
1600266|NCT02274558|5574148|P3|Overall Study|Death|1
1600267|NCT02274558|5574149|P2|Overall Study|Death|0
1600268|NCT02274558|5574150|P1|Overall Study|Death|0
1600269|NCT02274558|5574148|P3|Overall Study|Withdrawal by Subject|4
1600270|NCT02274558|5574149|P2|Overall Study|Withdrawal by Subject|5
1600271|NCT02274558|5574150|P1|Overall Study|Withdrawal by Subject|1
1600272|NCT02274558|5574148|P3|Overall Study|Non-compliance|0
1600273|NCT02274558|5574149|P2|Overall Study|Non-compliance|1
1600274|NCT02274558|5574150|P1|Overall Study|Non-compliance|2
1600275|NCT02274558|5574148|P3|Overall Study|Adverse Event|2
1600276|NCT02274558|5574149|P2|Overall Study|Adverse Event|4
1600277|NCT02274558|5574150|P1|Overall Study|Adverse Event|2
1600278|NCT02274493|5574164|P1|Overall Study|Withdrawal by Subject|1
1600279|NCT02274311|5574171|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
1600280|NCT02273973|5574179|P2|Overall Study|Reason not specified|1
1600281|NCT02273973|5574180|P1|Overall Study|Reason not specified|0
1600282|NCT02273973|5574179|P2|Overall Study|Physician Decision|1
1600283|NCT02273973|5574180|P1|Overall Study|Physician Decision|0
1600284|NCT02273973|5574179|P2|Overall Study|Lost to Follow-up|1
1600285|NCT02273973|5574180|P1|Overall Study|Lost to Follow-up|0
1600286|NCT02273973|5574179|P2|Overall Study|Progression of disease|2
1600287|NCT02273973|5574180|P1|Overall Study|Progression of disease|0
1600288|NCT02273973|5574179|P2|Overall Study|Protocol Violation|0
1600289|NCT02273973|5574180|P1|Overall Study|Protocol Violation|1
1600290|NCT02273973|5574179|P2|Overall Study|Non-compliance|0
1600291|NCT02273973|5574180|P1|Overall Study|Non-compliance|1
1600292|NCT02273973|5574179|P2|Overall Study|Death|0
1600293|NCT02273973|5574180|P1|Overall Study|Death|1
1600294|NCT02273973|5574179|P2|Overall Study|Withdrawal by Subject|3
1600295|NCT02273973|5574180|P1|Overall Study|Withdrawal by Subject|2
1600296|NCT02273973|5574179|P2|Overall Study|Adverse Event|0
1600297|NCT02273973|5574180|P1|Overall Study|Adverse Event|4
1600298|NCT02273960|5574224|P4|Long Term Extension|Death|1
1600299|NCT02273960|5574225|P3|Long Term Extension|Death|0
1600300|NCT02273960|5574226|P2|Long Term Extension|Death|0
1600301|NCT02273960|5574227|P1|Long Term Extension|Death|0
1600302|NCT02273960|5574224|P4|Short Term Period|ST complete, not entering LTE|5
1600303|NCT02273960|5574225|P3|Short Term Period|ST complete, not entering LTE|4
1600304|NCT02273960|5574226|P2|Short Term Period|ST complete, not entering LTE|6
1600305|NCT02273960|5574227|P1|Short Term Period|ST complete, not entering LTE|4
1600306|NCT02273960|5574224|P4|Short Term Period|Lack of Efficacy|1
1600307|NCT02273960|5574225|P3|Short Term Period|Lack of Efficacy|0
1600308|NCT02273960|5574226|P2|Short Term Period|Lack of Efficacy|0
1600309|NCT02273960|5574227|P1|Short Term Period|Lack of Efficacy|0
1600310|NCT02273960|5574224|P4|Short Term Period|Lost to Follow-up|0
1600311|NCT02273960|5574225|P3|Short Term Period|Lost to Follow-up|0
1600312|NCT02273960|5574226|P2|Short Term Period|Lost to Follow-up|0
1600313|NCT02273960|5574227|P1|Short Term Period|Lost to Follow-up|1
1600314|NCT02273908|5574271|P2|Overall Study|Withdrawal by Subject|2
1600315|NCT02273908|5574272|P1|Overall Study|Withdrawal by Subject|4
1600316|NCT02273908|5574271|P2|Overall Study|Did not meet entrance criteria|2
1600317|NCT02273908|5574272|P1|Overall Study|Did not meet entrance criteria|3
1600318|NCT02273908|5574271|P2|Overall Study|Lost to Follow-up|1
1600319|NCT02273908|5574272|P1|Overall Study|Lost to Follow-up|10
1600320|NCT02273908|5574271|P2|Overall Study|Adverse Event|0
1600321|NCT02273908|5574272|P1|Overall Study|Adverse Event|16
1600322|NCT02273752|5574294|P1|Overall Study|Trial was terminated early|2
1600323|NCT02273180|5574338|P2|Overall Study|Other than specified above|10
1600324|NCT02273180|5574339|P1|Overall Study|Other than specified above|21
1600325|NCT02273180|5574338|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
1600326|NCT02273180|5574339|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
1600327|NCT02273180|5574338|P2|Overall Study|Randomized but not treated|0
1600328|NCT02273180|5574339|P1|Overall Study|Randomized but not treated|1
1600329|NCT02273180|5574338|P2|Overall Study|Protocol Violation|7
1600330|NCT02273180|5574339|P1|Overall Study|Protocol Violation|1
1600331|NCT02273180|5574338|P2|Overall Study|Lack of Efficacy|0
1600332|NCT02273180|5574339|P1|Overall Study|Lack of Efficacy|1
1600333|NCT02273180|5574338|P2|Overall Study|Adverse Event|2
1600334|NCT02273180|5574339|P1|Overall Study|Adverse Event|2
1600335|NCT02273167|5574364|P3|Overall Study|Various|8
1600336|NCT02273167|5574365|P2|Overall Study|Various|9
1600337|NCT02273167|5574366|P1|Overall Study|Various|10
1600338|NCT02273167|5574364|P3|Overall Study|Withdrawal by Subject|11
1600339|NCT02273167|5574365|P2|Overall Study|Withdrawal by Subject|12
1600340|NCT02273167|5574366|P1|Overall Study|Withdrawal by Subject|10
1600341|NCT02273167|5574364|P3|Overall Study|Lost to Follow-up|1
1600342|NCT02273167|5574365|P2|Overall Study|Lost to Follow-up|1
1600343|NCT02273167|5574366|P1|Overall Study|Lost to Follow-up|0
1600344|NCT02273167|5574364|P3|Overall Study|Protocol Violation|1
1600345|NCT02273167|5574365|P2|Overall Study|Protocol Violation|1
1600346|NCT02273167|5574366|P1|Overall Study|Protocol Violation|3
1600347|NCT02273167|5574364|P3|Overall Study|Adverse Event|0
1600348|NCT02273167|5574365|P2|Overall Study|Adverse Event|0
1600349|NCT02273167|5574366|P1|Overall Study|Adverse Event|1
1600350|NCT02273141|5574391|P2|Overall Study|Various|6
1600351|NCT02273141|5574392|P1|Overall Study|Various|6
1600352|NCT02273141|5574391|P2|Overall Study|Withdrawal by Subject|15
1600353|NCT02273141|5574392|P1|Overall Study|Withdrawal by Subject|10
1600354|NCT02273141|5574391|P2|Overall Study|Lost to Follow-up|3
1600355|NCT02273141|5574392|P1|Overall Study|Lost to Follow-up|1
1600356|NCT02273141|5574391|P2|Overall Study|Adverse Event|1
1600357|NCT02273141|5574392|P1|Overall Study|Adverse Event|0
1600358|NCT02273050|5574465|P3|Overall Study|Protocol Violation|4
1600359|NCT02273050|5574466|P2|Overall Study|Protocol Violation|1
1600360|NCT02273050|5574467|P1|Overall Study|Protocol Violation|3
1600361|NCT02273050|5574465|P3|Overall Study|Lost to Follow-up|3
1600362|NCT02273050|5574466|P2|Overall Study|Lost to Follow-up|2
1600363|NCT02273050|5574467|P1|Overall Study|Lost to Follow-up|0
1600364|NCT02273050|5574465|P3|Overall Study|Withdrawal by Subject|16
1600365|NCT02273050|5574466|P2|Overall Study|Withdrawal by Subject|14
1600366|NCT02273050|5574467|P1|Overall Study|Withdrawal by Subject|17
1600367|NCT02273050|5574465|P3|Overall Study|Lack of Efficacy|1
1600368|NCT02273050|5574466|P2|Overall Study|Lack of Efficacy|1
1600369|NCT02273050|5574467|P1|Overall Study|Lack of Efficacy|0
1600370|NCT02273050|5574465|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
1600371|NCT02273050|5574466|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
1600372|NCT02273050|5574467|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
1600373|NCT02273050|5574465|P3|Overall Study|Death|1
1600374|NCT02273050|5574466|P2|Overall Study|Death|0
1600375|NCT02273050|5574467|P1|Overall Study|Death|0
1600376|NCT02273050|5574465|P3|Overall Study|Adverse Event|3
1600377|NCT02273050|5574466|P2|Overall Study|Adverse Event|3
1600378|NCT02273050|5574467|P1|Overall Study|Adverse Event|4
1600379|NCT02273037|5574495|P2|Overall Study|Other complication|0
1600380|NCT02273037|5574496|P1|Overall Study|Other complication|2
1600381|NCT02273037|5574495|P2|Overall Study|Multiple delivery|2
1600382|NCT02273037|5574496|P1|Overall Study|Multiple delivery|2
1600383|NCT02273037|5574495|P2|Overall Study|Breech delivery|3
1600384|NCT02273037|5574496|P1|Overall Study|Breech delivery|2
1600385|NCT02273037|5574495|P2|Overall Study|Delivered before monitoring initiated|3
1600386|NCT02273037|5574496|P1|Overall Study|Delivered before monitoring initiated|1
1600387|NCT02273037|5574495|P2|Overall Study|Lost to Follow-up|0
1600388|NCT02273037|5574496|P1|Overall Study|Lost to Follow-up|1
1600389|NCT02272985|5574506|P1|Overall Study|kidney transplantation|1
1600390|NCT02272985|5574506|P1|Overall Study|hip fracture|1
1600391|NCT02272985|5574506|P1|Overall Study|Withdrawal by Subject|1
1600392|NCT02272816|5574511|P1|Overall Study|Adverse Event|1
1600393|NCT02272803|5574519|P2|Overall Study|Withdrawal by Subject|0
1600394|NCT02272803|5574520|P1|Overall Study|Withdrawal by Subject|1
1600395|NCT02272803|5574519|P2|Overall Study|Poor/non-compliance|1
1600396|NCT02272803|5574520|P1|Overall Study|Poor/non-compliance|0
1600397|NCT02272803|5574519|P2|Overall Study|Subject moved to care facility|1
1600398|NCT02272803|5574520|P1|Overall Study|Subject moved to care facility|0
1600399|NCT02272803|5574519|P2|Overall Study|Maximum clinical benefit|1
1600400|NCT02272803|5574520|P1|Overall Study|Maximum clinical benefit|1
1600401|NCT02272803|5574519|P2|Overall Study|Subj request to discontinue study trt|4
1600402|NCT02272803|5574520|P1|Overall Study|Subj request to discontinue study trt|1
1600403|NCT02272803|5574519|P2|Overall Study|Study drug toxicity|4
1600404|NCT02272803|5574520|P1|Overall Study|Study drug toxicity|1
1600405|NCT02272803|5574519|P2|Overall Study|Adverse Event unrelated to study drug|4
1600406|NCT02272803|5574520|P1|Overall Study|Adverse Event unrelated to study drug|1
1600407|NCT02272803|5574519|P2|Overall Study|Disease progression|2
1600408|NCT02272803|5574520|P1|Overall Study|Disease progression|4
1600409|NCT02272790|5574537|P6|Overall Study|Physician Decision|0
1600410|NCT02272790|5574538|P5|Overall Study|Physician Decision|0
1600411|NCT02272790|5574539|P4|Overall Study|Physician Decision|0
1600412|NCT02272790|5574540|P3|Overall Study|Physician Decision|0
1600413|NCT02272790|5574541|P2|Overall Study|Physician Decision|1
1600414|NCT02272790|5574542|P1|Overall Study|Physician Decision|0
1600415|NCT02272777|5574678|P2|Overall Study|Other|0
1600416|NCT02272777|5574679|P1|Overall Study|Other|2
1600417|NCT02272777|5574678|P2|Overall Study|Lost to Follow-up|0
1600418|NCT02272777|5574679|P1|Overall Study|Lost to Follow-up|2
1600419|NCT02272777|5574678|P2|Overall Study|Withdrawal by Subject|3
1600420|NCT02272777|5574679|P1|Overall Study|Withdrawal by Subject|0
1600421|NCT02272777|5574678|P2|Overall Study|Adverse Event|1
1600422|NCT02272777|5574679|P1|Overall Study|Adverse Event|0
1600423|NCT02272725|5574687|P2|Overall Study|equipment malfunction|0
1600424|NCT02272725|5574688|P1|Overall Study|equipment malfunction|2
1600425|NCT02272413|5574705|P2|Post-switch Period|Other than listed|5
1600426|NCT02272413|5574706|P1|Post-switch Period|Other than listed|4
1600427|NCT02272413|5574705|P2|Post-switch Period|Study terminated by sponsor|11
1600428|NCT02272413|5574706|P1|Post-switch Period|Study terminated by sponsor|8
1600429|NCT02272413|5574705|P2|Post-switch Period|Progressive disease|21
1600430|NCT02272413|5574706|P1|Post-switch Period|Progressive disease|21
1600431|NCT02272413|5574705|P2|Post-switch Period|Physician Decision|1
1600432|NCT02272413|5574706|P1|Post-switch Period|Physician Decision|1
1600433|NCT02272413|5574705|P2|Post-switch Period|Withdrawal by Subject|2
1600434|NCT02272413|5574706|P1|Post-switch Period|Withdrawal by Subject|1
1600435|NCT02272413|5574705|P2|Post-switch Period|Death|2
1600436|NCT02272413|5574706|P1|Post-switch Period|Death|3
1600437|NCT02272413|5574705|P2|Post-switch Period|Adverse Event|4
1600438|NCT02272413|5574706|P1|Post-switch Period|Adverse Event|4
1600439|NCT02272413|5574705|P2|Pre-switch Period|Other than listed|11
1600440|NCT02272413|5574706|P1|Pre-switch Period|Other than listed|10
1600441|NCT02272413|5574705|P2|Pre-switch Period|Protocol Violation|0
1600442|NCT02272413|5574706|P1|Pre-switch Period|Protocol Violation|1
1600443|NCT02272413|5574705|P2|Pre-switch Period|Lost to Follow-up|2
1600444|NCT02272413|5574706|P1|Pre-switch Period|Lost to Follow-up|0
1600445|NCT02272413|5574705|P2|Pre-switch Period|Progressive disease|173
1600446|NCT02272413|5574706|P1|Pre-switch Period|Progressive disease|185
1600447|NCT02272413|5574705|P2|Pre-switch Period|Physician Decision|18
1600448|NCT02272413|5574706|P1|Pre-switch Period|Physician Decision|6
1600449|NCT02272413|5574705|P2|Pre-switch Period|Withdrawal by Subject|15
1600450|NCT02272413|5574706|P1|Pre-switch Period|Withdrawal by Subject|27
1600451|NCT02272413|5574705|P2|Pre-switch Period|Death|26
1600452|NCT02272413|5574706|P1|Pre-switch Period|Death|26
1600453|NCT02272413|5574705|P2|Pre-switch Period|Adverse Event|37
1600454|NCT02272413|5574706|P1|Pre-switch Period|Adverse Event|38
1600455|NCT02272413|5574705|P2|Randomized Through Treatment Start|Not treated|5
1600456|NCT02272413|5574706|P1|Randomized Through Treatment Start|Not treated|3
1600457|NCT02271984|5574737|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600458|NCT02271984|5574738|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600459|NCT02271984|5574739|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600460|NCT02271984|5574740|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600461|NCT02271984|5574741|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1600462|NCT02271984|5574742|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600463|NCT02271984|5574743|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
1600464|NCT02271984|5574744|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600465|NCT02271984|5574745|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600466|NCT02271984|5574746|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600467|NCT02271984|5574747|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600468|NCT02271984|5574748|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
1600469|NCT02271945|5574837|P2|Overall Study|Other|1
1600470|NCT02271945|5574838|P1|Overall Study|Other|1
1600471|NCT02271945|5574837|P2|Overall Study|Withdrawal by Subject|1
1600472|NCT02271945|5574838|P1|Overall Study|Withdrawal by Subject|1
1600473|NCT02271945|5574837|P2|Overall Study|Death|3
1600474|NCT02271945|5574838|P1|Overall Study|Death|3
1600475|NCT02271880|5574881|P2|Overall Study|Premature discontinuation of study|4
1600476|NCT02271880|5574882|P1|Overall Study|Premature discontinuation of study|3
1600477|NCT02271854|5574912|P1|Overall Study|Lost to Follow-up|1
1600478|NCT02271854|5574912|P1|Overall Study|Unable or unwilling to cooperate with st|1
1600479|NCT02271854|5574912|P1|Overall Study|Withdrawal by Subject|2
1600480|NCT02271529|5574952|P1|Overall Study|Withdrawal by Subject|1
1600481|NCT02270983|5575073|P3|Overall Study|moved away from study site|0
1600482|NCT02270983|5575074|P2|Overall Study|moved away from study site|1
1600483|NCT02270983|5575075|P1|Overall Study|moved away from study site|0
1600484|NCT02270983|5575073|P3|Overall Study|study procedure non-compliance|0
1600485|NCT02270983|5575074|P2|Overall Study|study procedure non-compliance|0
1600486|NCT02270983|5575075|P1|Overall Study|study procedure non-compliance|1
1600487|NCT02270983|5575073|P3|Overall Study|family emergency|0
1600488|NCT02270983|5575074|P2|Overall Study|family emergency|1
1600489|NCT02270983|5575075|P1|Overall Study|family emergency|0
1600490|NCT02270983|5575073|P3|Overall Study|Protocol Violation|1
1600491|NCT02270983|5575074|P2|Overall Study|Protocol Violation|1
1600492|NCT02270983|5575075|P1|Overall Study|Protocol Violation|1
1600493|NCT02270983|5575073|P3|Overall Study|Lost to Follow-up|2
1600494|NCT02270983|5575074|P2|Overall Study|Lost to Follow-up|1
1600495|NCT02270983|5575075|P1|Overall Study|Lost to Follow-up|1
1600496|NCT02270983|5575073|P3|Overall Study|Withdrawal by Subject|2
1600497|NCT02270983|5575074|P2|Overall Study|Withdrawal by Subject|0
1600498|NCT02270983|5575075|P1|Overall Study|Withdrawal by Subject|1
1600499|NCT02270983|5575073|P3|Overall Study|Lack of Efficacy|1
1600500|NCT02270983|5575074|P2|Overall Study|Lack of Efficacy|1
1600501|NCT02270983|5575075|P1|Overall Study|Lack of Efficacy|2
1600502|NCT02270983|5575073|P3|Overall Study|Adverse Event|6
1600503|NCT02270983|5575074|P2|Overall Study|Adverse Event|2
1600504|NCT02270983|5575075|P1|Overall Study|Adverse Event|3
1600505|NCT02270944|5575100|P2|Overall Study|Withdrawal by Subject|1
1600506|NCT02270944|5575101|P1|Overall Study|Withdrawal by Subject|2
1600507|NCT02270944|5575100|P2|Overall Study|Lost to Follow-up|4
1600508|NCT02270944|5575101|P1|Overall Study|Lost to Follow-up|9
1600509|NCT02270684|5575119|P2|Overall Study|Study terminated|0
1600510|NCT02270684|5575120|P1|Overall Study|Study terminated|1
1600511|NCT02270684|5575119|P2|Overall Study|Lost to Follow-up|3
1600512|NCT02270684|5575120|P1|Overall Study|Lost to Follow-up|0
1600513|NCT02270671|5575128|P2|Overall Study|Lost to Follow-up|1
1600514|NCT02270671|5575129|P1|Overall Study|Lost to Follow-up|2
1600515|NCT02270671|5575128|P2|Overall Study|Missed Post-intervention Data Collection|2
1600516|NCT02270671|5575129|P1|Overall Study|Missed Post-intervention Data Collection|2
1600517|NCT02270671|5575128|P2|Overall Study|Protocol Violation|1
1600518|NCT02270671|5575129|P1|Overall Study|Protocol Violation|0
1600519|NCT02270671|5575128|P2|Overall Study|Withdrawal by Subject|1
1600520|NCT02270671|5575129|P1|Overall Study|Withdrawal by Subject|1
1600521|NCT02270515|5575154|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
1600522|NCT02270515|5575154|P1|Intervention Period 3: 12-18 Months|Death|3
1600523|NCT02270515|5575154|P1|Intervention Period 3: 12-18 Months|Received transplant|2
1600524|NCT02270515|5575154|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
1600525|NCT02270515|5575154|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
1600526|NCT02270515|5575154|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
1600527|NCT02270515|5575154|P1|Intervention Period 2: 6-12 Months|Death|5
1600528|NCT02270515|5575154|P1|Intervention Period 2: 6-12 Months|Received transplant|1
1600529|NCT02270515|5575154|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
1600530|NCT02270515|5575154|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
1600531|NCT02270515|5575154|P1|Intervention Period 1: 0-6 Months|Death|7
1600532|NCT02270515|5575154|P1|Intervention Period 1: 0-6 Months|Received transplant|3
1600533|NCT02270515|5575154|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
1600534|NCT02270515|5575154|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
1600535|NCT02269943|5575213|P2|Follow-Up Survival Period|Alive|8
1600536|NCT02269943|5575214|P1|Follow-Up Survival Period|Alive|2
1600537|NCT02269943|5575213|P2|Follow-Up Survival Period|Lost to Follow-up|2
1600538|NCT02269943|5575214|P1|Follow-Up Survival Period|Lost to Follow-up|0
1600539|NCT02269943|5575213|P2|Follow-Up Survival Period|Death|16
1600540|NCT02269943|5575214|P1|Follow-Up Survival Period|Death|3
1600541|NCT02269943|5575213|P2|Treatment Period|Symptomatic Deterioration|2
1600542|NCT02269943|5575214|P1|Treatment Period|Symptomatic Deterioration|0
1600543|NCT02269943|5575213|P2|Treatment Period|Progressive Disease|17
1600544|NCT02269943|5575214|P1|Treatment Period|Progressive Disease|5
1600545|NCT02269943|5575213|P2|Treatment Period|Adverse Event|10
1600546|NCT02269943|5575214|P1|Treatment Period|Adverse Event|1
1600547|NCT02269943|5575213|P2|Treatment Period|Death|1
1600548|NCT02269943|5575214|P1|Treatment Period|Death|0
1600563|NCT02269787|5575298|P2|Overall Study|Incapacitated|1
1600564|NCT02269787|5575299|P1|Overall Study|Incapacitated|0
1600565|NCT02269787|5575298|P2|Overall Study|Death|3
1600566|NCT02269787|5575299|P1|Overall Study|Death|2
1600567|NCT02269787|5575298|P2|Overall Study|Lost to Follow-up|6
1600568|NCT02269787|5575299|P1|Overall Study|Lost to Follow-up|20
1600569|NCT02269709|5575305|P1|Six Month Follow-up|Lost to Follow-up|12
1600570|NCT02269709|5575305|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
1600571|NCT02269709|5575305|P1|Time of Enrollment|Withdrawal by Subject|3
1600572|NCT02269657|5575310|P1|Overall Study|Protocol Violation|3
1600573|NCT02269475|5575347|P2|Overall Study|Withdrawal by Subject|1
1600574|NCT02269475|5575348|P1|Overall Study|Withdrawal by Subject|0
1600575|NCT02269475|5575347|P2|Overall Study|Meet Exclusion Criteria No. 17|0
1600576|NCT02269475|5575348|P1|Overall Study|Meet Exclusion Criteria No. 17|3
1600577|NCT02269423|5575363|P4|Overall Study|Discontinued due to change in residence|1
1600578|NCT02269423|5575364|P3|Overall Study|Discontinued due to change in residence|0
1600579|NCT02269423|5575365|P2|Overall Study|Discontinued due to change in residence|1
1600580|NCT02269423|5575366|P1|Overall Study|Discontinued due to change in residence|0
1600581|NCT02269241|5575428|P1|Overall Study|Screening failures|546
1600582|NCT02269241|5575428|P1|Overall Study|Several reasons not classified|53
1600583|NCT02269241|5575428|P1|Overall Study|At the specific request of the sponsor|20
1600584|NCT02269241|5575428|P1|Overall Study|Adverse Event|113
1600585|NCT02269241|5575428|P1|Overall Study|Development of an exclusion criteria|16
1600586|NCT02269241|5575428|P1|Overall Study|Wish for pregnancy|5
1600587|NCT02269241|5575428|P1|Overall Study|Pregnancy|15
1600588|NCT02269241|5575428|P1|Overall Study|Physician Decision|7
1600589|NCT02269241|5575428|P1|Overall Study|Protocol Violation|1
1600590|NCT02269241|5575428|P1|Overall Study|Withdrawal by Subject|155
1600591|NCT02269241|5575428|P1|Overall Study|Lost to Follow-up|269
1600592|NCT02269098|5575442|P2|Overall Study|Lost to Follow-up|9
1600593|NCT02269098|5575443|P1|Overall Study|Lost to Follow-up|14
1600594|NCT02268864|5575504|P3|Overall Study|Death|0
1600595|NCT02268864|5575505|P2|Overall Study|Death|1
1600596|NCT02268864|5575506|P1|Overall Study|Death|0
1600597|NCT02268864|5575504|P3|Overall Study|Withdrawal by Subject|0
1600598|NCT02268864|5575505|P2|Overall Study|Withdrawal by Subject|0
1600599|NCT02268864|5575506|P1|Overall Study|Withdrawal by Subject|2
1600600|NCT02268812|5575532|P4|Overall Study|Other|3
1600601|NCT02268812|5575533|P3|Overall Study|Other|1
1600602|NCT02268812|5575534|P2|Overall Study|Other|4
1600603|NCT02268812|5575535|P1|Overall Study|Other|5
1600604|NCT02268812|5575532|P4|Overall Study|Physician Decision|1
1600605|NCT02268812|5575533|P3|Overall Study|Physician Decision|0
1600606|NCT02268812|5575534|P2|Overall Study|Physician Decision|1
1600607|NCT02268812|5575535|P1|Overall Study|Physician Decision|3
1600608|NCT02268812|5575532|P4|Overall Study|Withdrawal by Subject|0
1600609|NCT02268812|5575533|P3|Overall Study|Withdrawal by Subject|0
1600610|NCT02268812|5575534|P2|Overall Study|Withdrawal by Subject|1
1600611|NCT02268812|5575535|P1|Overall Study|Withdrawal by Subject|0
1600612|NCT02268812|5575532|P4|Overall Study|Protocol deviation|0
1600613|NCT02268812|5575533|P3|Overall Study|Protocol deviation|1
1600614|NCT02268812|5575534|P2|Overall Study|Protocol deviation|0
1600615|NCT02268812|5575535|P1|Overall Study|Protocol deviation|0
1600616|NCT02268812|5575532|P4|Overall Study|Adverse Event|10
1600617|NCT02268812|5575533|P3|Overall Study|Adverse Event|7
1600618|NCT02268812|5575534|P2|Overall Study|Adverse Event|26
1600619|NCT02268812|5575535|P1|Overall Study|Adverse Event|8
1600620|NCT02268526|5575568|P3|Overall Study|Subject/guardian decision|3
1600621|NCT02268526|5575569|P2|Overall Study|Subject/guardian decision|7
1600622|NCT02268526|5575570|P1|Overall Study|Subject/guardian decision|0
1600623|NCT02268526|5575568|P3|Overall Study|Physician Decision|1
1600624|NCT02268526|5575569|P2|Overall Study|Physician Decision|0
1600625|NCT02268526|5575570|P1|Overall Study|Physician Decision|0
1600626|NCT02268526|5575568|P3|Overall Study|protocol deviation|0
1600627|NCT02268526|5575569|P2|Overall Study|protocol deviation|1
1600628|NCT02268526|5575570|P1|Overall Study|protocol deviation|0
1600629|NCT02268526|5575568|P3|Overall Study|Death|0
1600630|NCT02268526|5575569|P2|Overall Study|Death|11
1600631|NCT02268526|5575570|P1|Overall Study|Death|1
1600632|NCT02268526|5575568|P3|Overall Study|Adverse Event|1
1600633|NCT02268526|5575569|P2|Overall Study|Adverse Event|2
1600634|NCT02268526|5575570|P1|Overall Study|Adverse Event|0
1600635|NCT02268396|5575591|P1|Overall Study|2 Subjects no Day 29 Assessment|2
1600636|NCT02268396|5575591|P1|Overall Study|Protocol-Specified Criteria|2
1600637|NCT02268396|5575591|P1|Overall Study|Lost to Follow-up|2
1600638|NCT02268396|5575591|P1|Overall Study|Withdrawal by Subject|1
1600639|NCT02268396|5575591|P1|Overall Study|Administrative|2
1600640|NCT02268396|5575591|P1|Overall Study|Adverse Event|3
1600641|NCT02268214|5575603|P3|Overall Study|Not entering long-term period|5
1600642|NCT02268214|5575604|P2|Overall Study|Not entering long-term period|3
1600643|NCT02268214|5575605|P1|Overall Study|Not entering long-term period|2
1600644|NCT02268214|5575603|P3|Overall Study|Other reasons|3
1600645|NCT02268214|5575604|P2|Overall Study|Other reasons|3
1600646|NCT02268214|5575605|P1|Overall Study|Other reasons|7
1600647|NCT02268214|5575603|P3|Overall Study|Poor/non-compliance|2
1600648|NCT02268214|5575604|P2|Overall Study|Poor/non-compliance|1
1600649|NCT02268214|5575605|P1|Overall Study|Poor/non-compliance|2
1600650|NCT02268214|5575603|P3|Overall Study|Subject request to discontinue treatment|6
1600651|NCT02268214|5575604|P2|Overall Study|Subject request to discontinue treatment|8
1600652|NCT02268214|5575605|P1|Overall Study|Subject request to discontinue treatment|10
1600653|NCT02268214|5575603|P3|Overall Study|Withdrawal by Subject|10
1600654|NCT02268214|5575604|P2|Overall Study|Withdrawal by Subject|5
1600655|NCT02268214|5575605|P1|Overall Study|Withdrawal by Subject|4
1600656|NCT02268214|5575603|P3|Overall Study|Adverse Event|9
1600657|NCT02268214|5575604|P2|Overall Study|Adverse Event|14
1600658|NCT02268214|5575605|P1|Overall Study|Adverse Event|11
1600659|NCT02268214|5575603|P3|Overall Study|Lack of Efficacy|2
1600660|NCT02268214|5575604|P2|Overall Study|Lack of Efficacy|0
1600661|NCT02268214|5575605|P1|Overall Study|Lack of Efficacy|1
1600662|NCT02268214|5575603|P3|Overall Study|Lost to Follow-up|4
1600663|NCT02268214|5575604|P2|Overall Study|Lost to Follow-up|3
1600664|NCT02268214|5575605|P1|Overall Study|Lost to Follow-up|3
1600665|NCT02268214|5575603|P3|Overall Study|Pregnancy|1
1600666|NCT02268214|5575604|P2|Overall Study|Pregnancy|2
1600667|NCT02268214|5575605|P1|Overall Study|Pregnancy|2
1600668|NCT02268214|5575603|P3|Overall Study|Subject no longer meets study criteria|0
1600669|NCT02268214|5575604|P2|Overall Study|Subject no longer meets study criteria|2
1600670|NCT02268214|5575605|P1|Overall Study|Subject no longer meets study criteria|0
1600671|NCT02268058|5575652|P4|Overall Study|Protocol Violation|0
1600672|NCT02268058|5575653|P3|Overall Study|Protocol Violation|0
1600673|NCT02268058|5575654|P2|Overall Study|Protocol Violation|0
1600674|NCT02268058|5575655|P1|Overall Study|Protocol Violation|1
1600675|NCT02268045|5575679|P2|Overall Study|Protocol Violation|1
1600676|NCT02268045|5575680|P1|Overall Study|Protocol Violation|1
1600677|NCT02268045|5575679|P2|Overall Study|Physician Decision|1
1600678|NCT02268045|5575680|P1|Overall Study|Physician Decision|0
1600679|NCT02268045|5575679|P2|Overall Study|Withdrawal by Subject|6
1600680|NCT02268045|5575680|P1|Overall Study|Withdrawal by Subject|2
1600681|NCT02268045|5575679|P2|Overall Study|Adverse Event|7
1600682|NCT02268045|5575680|P1|Overall Study|Adverse Event|7
1600683|NCT02268045|5575679|P2|Overall Study|Disease Progression|1
1600684|NCT02268045|5575680|P1|Overall Study|Disease Progression|2
1600685|NCT02268045|5575679|P2|Overall Study|Death|4
1600686|NCT02268045|5575680|P1|Overall Study|Death|4
1600687|NCT02267824|5575722|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
1600688|NCT02267824|5575723|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
1600689|NCT02267824|5575722|P2|Overall Study|Protocol Violation|0
1600690|NCT02267824|5575723|P1|Overall Study|Protocol Violation|3
1600691|NCT02267824|5575722|P2|Overall Study|Lost to Follow-up|0
1600692|NCT02267824|5575723|P1|Overall Study|Lost to Follow-up|4
1600693|NCT02267824|5575722|P2|Overall Study|Pregnancy|1
1600694|NCT02267824|5575723|P1|Overall Study|Pregnancy|1
1600695|NCT02267278|5575809|P1|Overall Study|prescribed prohibited medication|1
1600696|NCT02267278|5575809|P1|Overall Study|Developed new cancer diagnoses|2
1600697|NCT02267278|5575809|P1|Overall Study|transformation to acute leukemia (AML)|1
1600698|NCT02267278|5575809|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
1600699|NCT02267187|5575833|P1|Overall Study|Screen fail|3
1600700|NCT02267187|5575833|P1|Overall Study|Physician Decision|2
1600701|NCT02267135|5575841|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
1600702|NCT02267135|5575842|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
1600703|NCT02267135|5575841|P2|Period 2 (Randomized Set)|Adverse Event|0
1600704|NCT02267135|5575842|P1|Period 2 (Randomized Set)|Adverse Event|2
1600705|NCT02267135|5575841|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
1600706|NCT02267135|5575842|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
1600707|NCT02267135|5575841|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
1600708|NCT02267135|5575842|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
1600709|NCT02267135|5575841|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
1600710|NCT02267135|5575842|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
1600711|NCT02266875|5575886|P2|Overall Study|Lost to Follow-up|0
1600712|NCT02266875|5575887|P1|Overall Study|Lost to Follow-up|2
1600713|NCT02266875|5575886|P2|Overall Study|Withdrawal by Subject|0
1600714|NCT02266875|5575887|P1|Overall Study|Withdrawal by Subject|9
1600715|NCT02266706|5575952|P9|Overall Study|Enrollment in another study|0
1600716|NCT02266706|5575953|P8|Overall Study|Enrollment in another study|0
1600717|NCT02266706|5575954|P7|Overall Study|Enrollment in another study|0
1600718|NCT02266706|5575955|P6|Overall Study|Enrollment in another study|0
1600719|NCT02266706|5575956|P5|Overall Study|Enrollment in another study|0
1600720|NCT02266706|5575957|P4|Overall Study|Enrollment in another study|1
1600721|NCT02266706|5575958|P3|Overall Study|Enrollment in another study|0
1600722|NCT02266706|5575959|P2|Overall Study|Enrollment in another study|0
1600723|NCT02266706|5575960|P1|Overall Study|Enrollment in another study|0
1600724|NCT02266706|5575952|P9|Overall Study|Screen failure|0
1600725|NCT02266706|5575953|P8|Overall Study|Screen failure|0
1600726|NCT02266706|5575954|P7|Overall Study|Screen failure|1
1600727|NCT02266706|5575955|P6|Overall Study|Screen failure|1
1600728|NCT02266706|5575956|P5|Overall Study|Screen failure|0
1600729|NCT02266706|5575957|P4|Overall Study|Screen failure|0
1600730|NCT02266706|5575958|P3|Overall Study|Screen failure|0
1600731|NCT02266706|5575959|P2|Overall Study|Screen failure|0
1600732|NCT02266706|5575960|P1|Overall Study|Screen failure|0
1600733|NCT02266706|5575952|P9|Overall Study|Withdrawal by Subject|0
1600734|NCT02266706|5575953|P8|Overall Study|Withdrawal by Subject|0
1600735|NCT02266706|5575954|P7|Overall Study|Withdrawal by Subject|0
1600736|NCT02266706|5575955|P6|Overall Study|Withdrawal by Subject|1
1600737|NCT02266706|5575956|P5|Overall Study|Withdrawal by Subject|0
1600738|NCT02266706|5575957|P4|Overall Study|Withdrawal by Subject|0
1600739|NCT02266706|5575958|P3|Overall Study|Withdrawal by Subject|1
1600740|NCT02266706|5575959|P2|Overall Study|Withdrawal by Subject|1
1600741|NCT02266706|5575960|P1|Overall Study|Withdrawal by Subject|0
1600742|NCT02266381|5576192|P3|Overall Study|Physician Decision|4
1600743|NCT02266381|5576193|P2|Overall Study|Physician Decision|5
1600744|NCT02266381|5576194|P1|Overall Study|Physician Decision|3
1600745|NCT02266225|5576244|P1|Overall Study|Withdrawal by Subject|13
1600746|NCT02266225|5576244|P1|Overall Study|Death|1
1600747|NCT02266225|5576244|P1|Overall Study|Lost to Follow-up|2
1600748|NCT02265952|5576278|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
1600749|NCT02265952|5576279|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
1600750|NCT02265952|5576278|P2|Open Label Extension (OLE) Period|Physician Decision|7
1600751|NCT02265952|5576279|P1|Open Label Extension (OLE) Period|Physician Decision|0
1600752|NCT02265796|5576322|P2|Overall Study|Withdrawal by Subject|1
1600753|NCT02265796|5576323|P1|Overall Study|Withdrawal by Subject|1
1600754|NCT02265796|5576322|P2|Overall Study|started on excluded medication|0
1600755|NCT02265796|5576323|P1|Overall Study|started on excluded medication|1
1600756|NCT02265796|5576322|P2|Overall Study|Death|0
1600757|NCT02265796|5576323|P1|Overall Study|Death|1
1600758|NCT02265744|5576342|P5|Overall Study|Pregnancy|0
1600759|NCT02265744|5576343|P4|Overall Study|Pregnancy|1
1600760|NCT02265744|5576344|P3|Overall Study|Pregnancy|1
1600761|NCT02265744|5576345|P2|Overall Study|Pregnancy|2
1600762|NCT02265744|5576346|P1|Overall Study|Pregnancy|1
1600763|NCT02265744|5576342|P5|Overall Study|Subject no longer meets study criteria|1
1600764|NCT02265744|5576343|P4|Overall Study|Subject no longer meets study criteria|0
1600765|NCT02265744|5576344|P3|Overall Study|Subject no longer meets study criteria|0
1600766|NCT02265744|5576345|P2|Overall Study|Subject no longer meets study criteria|0
1600767|NCT02265744|5576346|P1|Overall Study|Subject no longer meets study criteria|0
1600768|NCT02265744|5576342|P5|Overall Study|Administrative reason by sponsor|3
1600769|NCT02265744|5576343|P4|Overall Study|Administrative reason by sponsor|3
1600770|NCT02265744|5576344|P3|Overall Study|Administrative reason by sponsor|2
1600771|NCT02265744|5576345|P2|Overall Study|Administrative reason by sponsor|2
1600772|NCT02265744|5576346|P1|Overall Study|Administrative reason by sponsor|3
1600773|NCT02265744|5576342|P5|Overall Study|Reason not provided by Investigator|0
1600774|NCT02265744|5576343|P4|Overall Study|Reason not provided by Investigator|2
1600775|NCT02265744|5576344|P3|Overall Study|Reason not provided by Investigator|0
1600776|NCT02265744|5576345|P2|Overall Study|Reason not provided by Investigator|0
1600777|NCT02265744|5576346|P1|Overall Study|Reason not provided by Investigator|1
1600778|NCT02265744|5576342|P5|Overall Study|Lack of Efficacy|5
1600779|NCT02265744|5576343|P4|Overall Study|Lack of Efficacy|4
1600780|NCT02265744|5576344|P3|Overall Study|Lack of Efficacy|3
1600781|NCT02265744|5576345|P2|Overall Study|Lack of Efficacy|4
1600782|NCT02265744|5576346|P1|Overall Study|Lack of Efficacy|2
1600783|NCT02265744|5576342|P5|Overall Study|Adverse Event|2
1600784|NCT02265744|5576343|P4|Overall Study|Adverse Event|8
1600785|NCT02265744|5576344|P3|Overall Study|Adverse Event|9
1600786|NCT02265744|5576345|P2|Overall Study|Adverse Event|4
1600787|NCT02265744|5576346|P1|Overall Study|Adverse Event|8
1600788|NCT02265744|5576342|P5|Overall Study|Participant request to discontinue|0
1600789|NCT02265744|5576343|P4|Overall Study|Participant request to discontinue|0
1600790|NCT02265744|5576344|P3|Overall Study|Participant request to discontinue|2
1600791|NCT02265744|5576345|P2|Overall Study|Participant request to discontinue|2
1600792|NCT02265744|5576346|P1|Overall Study|Participant request to discontinue|2
1600793|NCT02265744|5576342|P5|Overall Study|Withdrawal by Subject|0
1600794|NCT02265744|5576343|P4|Overall Study|Withdrawal by Subject|2
1600795|NCT02265744|5576344|P3|Overall Study|Withdrawal by Subject|0
1600796|NCT02265744|5576345|P2|Overall Study|Withdrawal by Subject|0
1600797|NCT02265744|5576346|P1|Overall Study|Withdrawal by Subject|2
1600798|NCT02265744|5576342|P5|Overall Study|Death|0
1600799|NCT02265744|5576343|P4|Overall Study|Death|2
1600800|NCT02265744|5576344|P3|Overall Study|Death|0
1600801|NCT02265744|5576345|P2|Overall Study|Death|0
1600802|NCT02265744|5576346|P1|Overall Study|Death|0
1600803|NCT02265744|5576342|P5|Overall Study|Lost to Follow-up|0
1600804|NCT02265744|5576343|P4|Overall Study|Lost to Follow-up|1
1600805|NCT02265744|5576344|P3|Overall Study|Lost to Follow-up|0
1600806|NCT02265744|5576345|P2|Overall Study|Lost to Follow-up|0
1600807|NCT02265744|5576346|P1|Overall Study|Lost to Follow-up|0
1600808|NCT02265744|5576342|P5|Overall Study|Poor/Non-compliance|2
1600809|NCT02265744|5576343|P4|Overall Study|Poor/Non-compliance|0
1600810|NCT02265744|5576344|P3|Overall Study|Poor/Non-compliance|0
1600811|NCT02265744|5576345|P2|Overall Study|Poor/Non-compliance|1
1600812|NCT02265744|5576346|P1|Overall Study|Poor/Non-compliance|1
1600813|NCT02265705|5576525|P7|Follow-up Period|Withdrawal by Subject|1
1600814|NCT02265705|5576526|P6|Follow-up Period|Withdrawal by Subject|0
1600815|NCT02265705|5576527|P5|Follow-up Period|Withdrawal by Subject|0
1600816|NCT02265705|5576528|P4|Follow-up Period|Withdrawal by Subject|0
1600817|NCT02265705|5576529|P3|Follow-up Period|Withdrawal by Subject|0
1600818|NCT02265705|5576530|P2|Follow-up Period|Withdrawal by Subject|0
1600819|NCT02265705|5576531|P1|Follow-up Period|Withdrawal by Subject|0
1600820|NCT02265705|5576525|P7|Follow-up Period|Physician Decision|1
1600821|NCT02265705|5576526|P6|Follow-up Period|Physician Decision|0
1600822|NCT02265705|5576527|P5|Follow-up Period|Physician Decision|0
1600823|NCT02265705|5576528|P4|Follow-up Period|Physician Decision|0
1600824|NCT02265705|5576529|P3|Follow-up Period|Physician Decision|0
1600825|NCT02265705|5576530|P2|Follow-up Period|Physician Decision|0
1600826|NCT02265705|5576531|P1|Follow-up Period|Physician Decision|0
1600827|NCT02265705|5576525|P7|Follow-up Period|Adverse Event|3
1600828|NCT02265705|5576526|P6|Follow-up Period|Adverse Event|0
1600829|NCT02265705|5576527|P5|Follow-up Period|Adverse Event|0
1600830|NCT02265705|5576528|P4|Follow-up Period|Adverse Event|0
1600831|NCT02265705|5576529|P3|Follow-up Period|Adverse Event|0
1600832|NCT02265705|5576530|P2|Follow-up Period|Adverse Event|0
1600833|NCT02265705|5576531|P1|Follow-up Period|Adverse Event|0
1600834|NCT02265705|5576525|P7|Follow-up Period|Sponsor Decision|6
1600835|NCT02265705|5576526|P6|Follow-up Period|Sponsor Decision|1
1600836|NCT02265705|5576527|P5|Follow-up Period|Sponsor Decision|0
1600837|NCT02265705|5576528|P4|Follow-up Period|Sponsor Decision|0
1600838|NCT02265705|5576529|P3|Follow-up Period|Sponsor Decision|0
1600839|NCT02265705|5576530|P2|Follow-up Period|Sponsor Decision|0
1600840|NCT02265705|5576531|P1|Follow-up Period|Sponsor Decision|0
1600841|NCT02265705|5576525|P7|Open Label Period|Withdrawal by Subject|0
1600842|NCT02265705|5576526|P6|Open Label Period|Withdrawal by Subject|0
1600843|NCT02265705|5576527|P5|Open Label Period|Withdrawal by Subject|2
1600844|NCT02265705|5576528|P4|Open Label Period|Withdrawal by Subject|0
1600845|NCT02265705|5576529|P3|Open Label Period|Withdrawal by Subject|0
1600846|NCT02265705|5576530|P2|Open Label Period|Withdrawal by Subject|0
1600847|NCT02265705|5576531|P1|Open Label Period|Withdrawal by Subject|0
1600848|NCT02265705|5576525|P7|Open Label Period|Physician Decision|0
1600849|NCT02265705|5576526|P6|Open Label Period|Physician Decision|0
1600850|NCT02265705|5576527|P5|Open Label Period|Physician Decision|1
1600851|NCT02265705|5576528|P4|Open Label Period|Physician Decision|0
1600852|NCT02265705|5576529|P3|Open Label Period|Physician Decision|0
1600853|NCT02265705|5576530|P2|Open Label Period|Physician Decision|0
1600854|NCT02265705|5576531|P1|Open Label Period|Physician Decision|0
1600855|NCT02265705|5576525|P7|Open Label Period|Adverse Event|0
1600856|NCT02265705|5576526|P6|Open Label Period|Adverse Event|0
1600857|NCT02265705|5576527|P5|Open Label Period|Adverse Event|2
1600858|NCT02265705|5576528|P4|Open Label Period|Adverse Event|2
1600859|NCT02265705|5576529|P3|Open Label Period|Adverse Event|0
1600860|NCT02265705|5576530|P2|Open Label Period|Adverse Event|0
1600861|NCT02265705|5576531|P1|Open Label Period|Adverse Event|0
1600862|NCT02265705|5576525|P7|Rescue Period|Lack of Efficacy|0
1600863|NCT02265705|5576526|P6|Rescue Period|Lack of Efficacy|0
1600864|NCT02265705|5576527|P5|Rescue Period|Lack of Efficacy|0
1600865|NCT02265705|5576528|P4|Rescue Period|Lack of Efficacy|0
1600866|NCT02265705|5576529|P3|Rescue Period|Lack of Efficacy|1
1600867|NCT02265705|5576530|P2|Rescue Period|Lack of Efficacy|0
1600868|NCT02265705|5576531|P1|Rescue Period|Lack of Efficacy|0
1600869|NCT02265705|5576525|P7|Rescue Period|Death|0
1600870|NCT02265705|5576526|P6|Rescue Period|Death|0
1600871|NCT02265705|5576527|P5|Rescue Period|Death|0
1600872|NCT02265705|5576528|P4|Rescue Period|Death|0
1600873|NCT02265705|5576529|P3|Rescue Period|Death|1
1600874|NCT02265705|5576530|P2|Rescue Period|Death|0
1600875|NCT02265705|5576531|P1|Rescue Period|Death|0
1600876|NCT02265705|5576525|P7|Rescue Period|Withdrawal by Subject|0
1600877|NCT02265705|5576526|P6|Rescue Period|Withdrawal by Subject|0
1600878|NCT02265705|5576527|P5|Rescue Period|Withdrawal by Subject|0
1600879|NCT02265705|5576528|P4|Rescue Period|Withdrawal by Subject|0
1600880|NCT02265705|5576529|P3|Rescue Period|Withdrawal by Subject|1
1600881|NCT02265705|5576530|P2|Rescue Period|Withdrawal by Subject|0
1600882|NCT02265705|5576531|P1|Rescue Period|Withdrawal by Subject|0
1600883|NCT02265705|5576525|P7|Treatment Period Week 0-24|Lack of Efficacy|0
1600884|NCT02265705|5576526|P6|Treatment Period Week 0-24|Lack of Efficacy|0
1600885|NCT02265705|5576527|P5|Treatment Period Week 0-24|Lack of Efficacy|0
1600886|NCT02265705|5576528|P4|Treatment Period Week 0-24|Lack of Efficacy|0
1600887|NCT02265705|5576529|P3|Treatment Period Week 0-24|Lack of Efficacy|0
1600888|NCT02265705|5576530|P2|Treatment Period Week 0-24|Lack of Efficacy|1
1600889|NCT02265705|5576531|P1|Treatment Period Week 0-24|Lack of Efficacy|0
1600890|NCT02265705|5576525|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
1600891|NCT02265705|5576526|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
1600892|NCT02265705|5576527|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
1600893|NCT02265705|5576528|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
1600894|NCT02265705|5576529|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
1600895|NCT02265705|5576530|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
1600896|NCT02265705|5576531|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
1600897|NCT02265705|5576525|P7|Treatment Period Week 0-24|Physician Decision|0
1600898|NCT02265705|5576526|P6|Treatment Period Week 0-24|Physician Decision|0
1600899|NCT02265705|5576527|P5|Treatment Period Week 0-24|Physician Decision|0
1600900|NCT02265705|5576528|P4|Treatment Period Week 0-24|Physician Decision|0
1600901|NCT02265705|5576529|P3|Treatment Period Week 0-24|Physician Decision|0
1600902|NCT02265705|5576530|P2|Treatment Period Week 0-24|Physician Decision|0
1600903|NCT02265705|5576531|P1|Treatment Period Week 0-24|Physician Decision|1
1600904|NCT02265705|5576525|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
1600905|NCT02265705|5576526|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
1600906|NCT02265705|5576527|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
1600907|NCT02265705|5576528|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
1600908|NCT02265705|5576529|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
1600909|NCT02265705|5576530|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
1600910|NCT02265705|5576531|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
1600911|NCT02265705|5576525|P7|Treatment Period Week 0-24|Adverse Event|0
1600912|NCT02265705|5576526|P6|Treatment Period Week 0-24|Adverse Event|0
1600913|NCT02265705|5576527|P5|Treatment Period Week 0-24|Adverse Event|0
1600914|NCT02265705|5576528|P4|Treatment Period Week 0-24|Adverse Event|0
1600915|NCT02265705|5576529|P3|Treatment Period Week 0-24|Adverse Event|0
1600916|NCT02265705|5576530|P2|Treatment Period Week 0-24|Adverse Event|2
1600917|NCT02265705|5576531|P1|Treatment Period Week 0-24|Adverse Event|3
1600918|NCT02265237|5576568|P4|As Treated (Overall Study)|Other|1
1600919|NCT02265237|5576569|P3|As Treated (Overall Study)|Other|3
1600920|NCT02265237|5576570|P2|As Treated (Overall Study)|Other|0
1600921|NCT02265237|5576571|P1|As Treated (Overall Study)|Other|2
1600922|NCT02265237|5576568|P4|As Treated (Overall Study)|Lost to Follow-up|0
1600923|NCT02265237|5576569|P3|As Treated (Overall Study)|Lost to Follow-up|6
1600924|NCT02265237|5576570|P2|As Treated (Overall Study)|Lost to Follow-up|2
1600925|NCT02265237|5576571|P1|As Treated (Overall Study)|Lost to Follow-up|1
1600926|NCT02265237|5576568|P4|As Treated (Overall Study)|Withdrawal by Subject|0
1600927|NCT02265237|5576569|P3|As Treated (Overall Study)|Withdrawal by Subject|1
1600928|NCT02265237|5576570|P2|As Treated (Overall Study)|Withdrawal by Subject|0
1600929|NCT02265237|5576571|P1|As Treated (Overall Study)|Withdrawal by Subject|1
1600930|NCT02265237|5576568|P4|As Treated (Overall Study)|Adverse Event|0
1600931|NCT02265237|5576569|P3|As Treated (Overall Study)|Adverse Event|0
1600932|NCT02265237|5576570|P2|As Treated (Overall Study)|Adverse Event|1
1600933|NCT02265237|5576571|P1|As Treated (Overall Study)|Adverse Event|1
1600934|NCT02264821|5576601|P3|Overall Study|Protocol Violation|6
1600935|NCT02264821|5576602|P2|Overall Study|Protocol Violation|3
1600936|NCT02264821|5576603|P1|Overall Study|Protocol Violation|1
1600937|NCT02264574|5576616|P2|Overall Study|various other reasons|3
1600938|NCT02264574|5576617|P1|Overall Study|various other reasons|0
1600939|NCT02264574|5576616|P2|Overall Study|Withdrawal by Subject|5
1600940|NCT02264574|5576617|P1|Overall Study|Withdrawal by Subject|6
1600941|NCT02263547|5576687|P1|Overall Study|Lost to Follow-up|2
1600942|NCT02263547|5576687|P1|Overall Study|Adverse Event|1
1600943|NCT02263365|5576694|P2|Overall Study|Physician Decision|18
1600944|NCT02263365|5576695|P1|Overall Study|Physician Decision|22
1600945|NCT02263326|5576709|P2|Overall Study|Lost to Follow-up|1
1600946|NCT02263326|5576710|P1|Overall Study|Lost to Follow-up|1
1600947|NCT02262754|5576804|P3|Overall Study|Other|2
1600948|NCT02262754|5576805|P2|Overall Study|Other|0
1600949|NCT02262754|5576806|P1|Overall Study|Other|4
1600950|NCT02262754|5576804|P3|Overall Study|Withdrawal by Subject|1
1600951|NCT02262754|5576805|P2|Overall Study|Withdrawal by Subject|0
1600952|NCT02262754|5576806|P1|Overall Study|Withdrawal by Subject|1
1600953|NCT02262754|5576804|P3|Overall Study|Protocol Violation|0
1600954|NCT02262754|5576805|P2|Overall Study|Protocol Violation|0
1600955|NCT02262754|5576806|P1|Overall Study|Protocol Violation|1
1600956|NCT02262754|5576804|P3|Overall Study|Study terminated by sponsor|4
1600957|NCT02262754|5576805|P2|Overall Study|Study terminated by sponsor|4
1600958|NCT02262754|5576806|P1|Overall Study|Study terminated by sponsor|5
1600959|NCT02262754|5576804|P3|Overall Study|No longer meets eligibility criteria|0
1600960|NCT02262754|5576805|P2|Overall Study|No longer meets eligibility criteria|1
1600961|NCT02262754|5576806|P1|Overall Study|No longer meets eligibility criteria|0
1600962|NCT02262754|5576804|P3|Overall Study|Lost to Follow-up|1
1600963|NCT02262754|5576805|P2|Overall Study|Lost to Follow-up|0
1600964|NCT02262754|5576806|P1|Overall Study|Lost to Follow-up|0
1600965|NCT02262754|5576804|P3|Overall Study|Lack of Efficacy|1
1600966|NCT02262754|5576805|P2|Overall Study|Lack of Efficacy|0
1600967|NCT02262754|5576806|P1|Overall Study|Lack of Efficacy|2
1600968|NCT02262754|5576804|P3|Overall Study|Adverse Event|0
1600969|NCT02262754|5576805|P2|Overall Study|Adverse Event|4
1600970|NCT02262754|5576806|P1|Overall Study|Adverse Event|3
1600971|NCT02262728|5576881|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
1600972|NCT02262728|5576882|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
1600973|NCT02262728|5576881|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
1600974|NCT02262728|5576882|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
1600975|NCT02262728|5576881|P2|Follow-up Phase (3 Years)|Death|1
1600976|NCT02262728|5576882|P1|Follow-up Phase (3 Years)|Death|0
1600977|NCT02262377|5576914|P2|Overall Study|Withdrawal by Subject|0
1600978|NCT02262377|5576915|P1|Overall Study|Withdrawal by Subject|4
1600979|NCT02262377|5576914|P2|Overall Study|Found ineligible after enrollment|0
1600980|NCT02262377|5576915|P1|Overall Study|Found ineligible after enrollment|3
1600981|NCT02262377|5576914|P2|Overall Study|Lost to Follow-up|6
1600982|NCT02262377|5576915|P1|Overall Study|Lost to Follow-up|5
1600983|NCT02262364|5576930|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
1600984|NCT02262260|5576939|P2|Overall Study|Protocol deviation|5
1600985|NCT02262260|5576940|P1|Overall Study|Protocol deviation|2
1600986|NCT02262260|5576939|P2|Overall Study|Lost to Follow-up|2
1600987|NCT02262260|5576940|P1|Overall Study|Lost to Follow-up|1
1600988|NCT02262260|5576939|P2|Overall Study|Withdrawal of consent|2
1600989|NCT02262260|5576940|P1|Overall Study|Withdrawal of consent|4
1600990|NCT02262260|5576939|P2|Overall Study|Adverse Event|1
1600991|NCT02262260|5576940|P1|Overall Study|Adverse Event|4
1600992|NCT02261974|5576998|P2|Overall Study|Adverse Event|0
1600993|NCT02261974|5576999|P1|Overall Study|Adverse Event|1
1600994|NCT02261974|5576998|P2|Overall Study|Lost to Follow-up|0
1600995|NCT02261974|5576999|P1|Overall Study|Lost to Follow-up|2
1600996|NCT02261974|5576998|P2|Overall Study|Received partial treatment; FU to 1 mo|1
1600997|NCT02261974|5576999|P1|Overall Study|Received partial treatment; FU to 1 mo|3
1600998|NCT02261974|5576998|P2|Overall Study|Missed treatment cut-off date|3
1600999|NCT02261974|5576999|P1|Overall Study|Missed treatment cut-off date|6
1601000|NCT02261974|5576998|P2|Overall Study|Pregnancy|1
1601001|NCT02261974|5576999|P1|Overall Study|Pregnancy|0
1601002|NCT02261974|5576998|P2|Overall Study|Withdrawal by Subject|2
1601003|NCT02261974|5576999|P1|Overall Study|Withdrawal by Subject|3
1601004|NCT02261493|5577056|P3|Overall Study|Adverse Event|0
1601005|NCT02261493|5577057|P2|Overall Study|Adverse Event|1
1601006|NCT02261493|5577058|P1|Overall Study|Adverse Event|0
1601007|NCT02261493|5577056|P3|Overall Study|Lack of Efficacy|0
1601008|NCT02261493|5577057|P2|Overall Study|Lack of Efficacy|1
1601009|NCT02261493|5577058|P1|Overall Study|Lack of Efficacy|0
1601010|NCT02261493|5577056|P3|Overall Study|Pregnancy|0
1601011|NCT02261493|5577057|P2|Overall Study|Pregnancy|2
1601012|NCT02261493|5577058|P1|Overall Study|Pregnancy|1
1601013|NCT02261493|5577056|P3|Overall Study|Lost to Follow-up|8
1601014|NCT02261493|5577057|P2|Overall Study|Lost to Follow-up|27
1601015|NCT02261493|5577058|P1|Overall Study|Lost to Follow-up|14
1601016|NCT02261493|5577056|P3|Overall Study|Personal Reasons|16
1601017|NCT02261493|5577057|P2|Overall Study|Personal Reasons|14
1601018|NCT02261493|5577058|P1|Overall Study|Personal Reasons|14
1601019|NCT02261493|5577056|P3|Overall Study|Protocol Violation|0
1601020|NCT02261493|5577057|P2|Overall Study|Protocol Violation|0
1601021|NCT02261493|5577058|P1|Overall Study|Protocol Violation|1
1601022|NCT02261493|5577056|P3|Overall Study|Undisclosed alcohol abuse|0
1601023|NCT02261493|5577057|P2|Overall Study|Undisclosed alcohol abuse|1
1601024|NCT02261493|5577058|P1|Overall Study|Undisclosed alcohol abuse|0
1601025|NCT02261493|5577056|P3|Overall Study|Physician Decision|0
1601026|NCT02261493|5577057|P2|Overall Study|Physician Decision|1
1601027|NCT02261493|5577058|P1|Overall Study|Physician Decision|0
1601028|NCT02261493|5577056|P3|Overall Study|Noncompliance|2
1601029|NCT02261493|5577057|P2|Overall Study|Noncompliance|0
1601030|NCT02261493|5577058|P1|Overall Study|Noncompliance|0
1601031|NCT02261467|5577086|P2|Overall Study|Adverse Event|1
1601032|NCT02261467|5577087|P1|Overall Study|Adverse Event|1
1601033|NCT02261467|5577086|P2|Overall Study|Lost to Follow-up|13
1601034|NCT02261467|5577087|P1|Overall Study|Lost to Follow-up|2
1601035|NCT02261467|5577086|P2|Overall Study|Personal Reasons|22
1601036|NCT02261467|5577087|P1|Overall Study|Personal Reasons|17
1601037|NCT02261467|5577086|P2|Overall Study|Protocol Violation|1
1601038|NCT02261467|5577087|P1|Overall Study|Protocol Violation|0
1601039|NCT02261467|5577086|P2|Overall Study|Enrolled in Error|0
1601040|NCT02261467|5577087|P1|Overall Study|Enrolled in Error|1
1601041|NCT02260986|5577129|P3|Overall Study|Pregnancy|0
1601042|NCT02260986|5577130|P2|Overall Study|Pregnancy|0
1601043|NCT02260986|5577131|P1|Overall Study|Pregnancy|2
1601044|NCT02260986|5577129|P3|Overall Study|Lost to Follow-up|3
1601045|NCT02260986|5577130|P2|Overall Study|Lost to Follow-up|0
1601046|NCT02260986|5577131|P1|Overall Study|Lost to Follow-up|4
1601047|NCT02260986|5577129|P3|Overall Study|Lack of investigation product supply|1
1601048|NCT02260986|5577130|P2|Overall Study|Lack of investigation product supply|0
1601049|NCT02260986|5577131|P1|Overall Study|Lack of investigation product supply|2
1601050|NCT02260986|5577129|P3|Overall Study|Incorrect randomization|0
1601051|NCT02260986|5577130|P2|Overall Study|Incorrect randomization|1
1601052|NCT02260986|5577131|P1|Overall Study|Incorrect randomization|0
1601053|NCT02260986|5577129|P3|Overall Study|Withdrawal by Subject|9
1601054|NCT02260986|5577130|P2|Overall Study|Withdrawal by Subject|4
1601055|NCT02260986|5577131|P1|Overall Study|Withdrawal by Subject|17
1601056|NCT02260986|5577129|P3|Overall Study|Car accident|1
1601057|NCT02260986|5577130|P2|Overall Study|Car accident|0
1601058|NCT02260986|5577131|P1|Overall Study|Car accident|0
1601059|NCT02260986|5577129|P3|Overall Study|Protocol Violation|16
1601060|NCT02260986|5577130|P2|Overall Study|Protocol Violation|5
1601061|NCT02260986|5577131|P1|Overall Study|Protocol Violation|14
1601062|NCT02260986|5577129|P3|Overall Study|Lack of Efficacy|0
1601063|NCT02260986|5577130|P2|Overall Study|Lack of Efficacy|3
1601064|NCT02260986|5577131|P1|Overall Study|Lack of Efficacy|27
1601065|NCT02260986|5577129|P3|Overall Study|Adverse Event|11
1601066|NCT02260986|5577130|P2|Overall Study|Adverse Event|0
1601067|NCT02260986|5577131|P1|Overall Study|Adverse Event|24
1601068|NCT02260934|5577249|P2|Overall Study|On Study|11
1601069|NCT02260934|5577250|P1|Overall Study|On Study|10
1601070|NCT02260934|5577249|P2|Overall Study|Participant Relocated|0
1601071|NCT02260934|5577250|P1|Overall Study|Participant Relocated|1
1601072|NCT02260934|5577249|P2|Overall Study|Withdrawal by Subject|2
1601073|NCT02260934|5577250|P1|Overall Study|Withdrawal by Subject|0
1601074|NCT02260934|5577249|P2|Overall Study|Lost to Follow-up|1
1601075|NCT02260934|5577250|P1|Overall Study|Lost to Follow-up|2
1601076|NCT02260882|5577260|P2|Overall Study|Protocol Violation|1
1601077|NCT02260882|5577261|P1|Overall Study|Protocol Violation|0
1601078|NCT02260817|5577285|P2|Overall Study|Protocol Violation|14
1601079|NCT02260817|5577286|P1|Overall Study|Protocol Violation|0
1601080|NCT02260817|5577285|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
1601081|NCT02260817|5577286|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
1601082|NCT02260817|5577285|P2|Overall Study|Observation, no biopsy|1
1601083|NCT02260817|5577286|P1|Overall Study|Observation, no biopsy|0
1601084|NCT02260817|5577285|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
1601085|NCT02260817|5577286|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
1601086|NCT02260817|5577285|P2|Overall Study|Lost to Follow-up|14
1601087|NCT02260817|5577286|P1|Overall Study|Lost to Follow-up|0
1601088|NCT02260791|5577334|P2|Overall Study|Protocol deviation|3
1601089|NCT02260791|5577335|P1|Overall Study|Protocol deviation|2
1601090|NCT02260791|5577334|P2|Overall Study|Screen failure|1
1601091|NCT02260791|5577335|P1|Overall Study|Screen failure|0
1601092|NCT02260791|5577334|P2|Overall Study|Withdrawal by Subject|16
1601093|NCT02260791|5577335|P1|Overall Study|Withdrawal by Subject|11
1601094|NCT02260791|5577334|P2|Overall Study|Death|0
1601095|NCT02260791|5577335|P1|Overall Study|Death|1
1601096|NCT02260791|5577334|P2|Overall Study|Adverse Event|9
1601097|NCT02260791|5577335|P1|Overall Study|Adverse Event|13
1601098|NCT02260791|5577334|P2|Overall Study|Lack of Efficacy|1
1601099|NCT02260791|5577335|P1|Overall Study|Lack of Efficacy|2
1601100|NCT02260791|5577334|P2|Overall Study|Lost to Follow-up|4
1601101|NCT02260791|5577335|P1|Overall Study|Lost to Follow-up|4
1601102|NCT02260648|5577374|P3|Overall Study|Discontinue Due to Study Termination|7
1601103|NCT02260648|5577375|P2|Overall Study|Discontinue Due to Study Termination|12
1601104|NCT02260648|5577376|P1|Overall Study|Discontinue Due to Study Termination|13
1601105|NCT02260648|5577374|P3|Overall Study|Protocol Violation|0
1601106|NCT02260648|5577375|P2|Overall Study|Protocol Violation|0
1601107|NCT02260648|5577376|P1|Overall Study|Protocol Violation|1
1601108|NCT02260648|5577374|P3|Overall Study|Withdrawal by Subject|0
1601109|NCT02260648|5577375|P2|Overall Study|Withdrawal by Subject|1
1601110|NCT02260648|5577376|P1|Overall Study|Withdrawal by Subject|1
1601111|NCT02260648|5577374|P3|Overall Study|Adverse Event|1
1601112|NCT02260648|5577375|P2|Overall Study|Adverse Event|0
1601113|NCT02260648|5577376|P1|Overall Study|Adverse Event|3
1601114|NCT02260635|5577404|P2|Open-Label Extension|Withdrawal by Subject|0
1601115|NCT02260635|5577405|P1|Open-Label Extension|Withdrawal by Subject|1
1601116|NCT02260635|5577404|P2|Open-Label Extension|Study Termination|25
1601117|NCT02260635|5577405|P1|Open-Label Extension|Study Termination|25
1601118|NCT02260635|5577404|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
1601119|NCT02260635|5577405|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
1601120|NCT02260492|5577457|P3|Overall Study|Withdrawal by Subject|2
1601121|NCT02260492|5577458|P2|Overall Study|Withdrawal by Subject|2
1601122|NCT02260492|5577459|P1|Overall Study|Withdrawal by Subject|3
1601123|NCT02260492|5577457|P3|Overall Study|Physician Decision|1
1601124|NCT02260492|5577458|P2|Overall Study|Physician Decision|0
1601125|NCT02260492|5577459|P1|Overall Study|Physician Decision|2
1601126|NCT02260492|5577457|P3|Overall Study|Lost to Follow-up|0
1601127|NCT02260492|5577458|P2|Overall Study|Lost to Follow-up|9
1601128|NCT02260492|5577459|P1|Overall Study|Lost to Follow-up|12
1601129|NCT02260492|5577457|P3|Overall Study|Death|0
1601130|NCT02260492|5577458|P2|Overall Study|Death|1
1601131|NCT02260492|5577459|P1|Overall Study|Death|0
1601132|NCT02260492|5577457|P3|Overall Study|Adverse Event|2
1601133|NCT02260492|5577458|P2|Overall Study|Adverse Event|1
1601134|NCT02260492|5577459|P1|Overall Study|Adverse Event|6
1601135|NCT02260388|5577492|P4|Overall Study|Lost to Follow-up|4
1601136|NCT02260388|5577493|P3|Overall Study|Lost to Follow-up|3
1601137|NCT02260388|5577494|P2|Overall Study|Lost to Follow-up|8
1601138|NCT02260388|5577495|P1|Overall Study|Lost to Follow-up|2
1601139|NCT02260180|5577524|P3|Overall Study|Adverse Event|1
1601140|NCT02260180|5577525|P2|Overall Study|Adverse Event|0
1601141|NCT02260180|5577526|P1|Overall Study|Adverse Event|2
1601142|NCT02260154|5577537|P1|Overall Study|Screening failure|2
1601143|NCT02259582|5577577|P3|Overall Study|Lack of Subject Adherence to Protocol|1
1601144|NCT02259582|5577578|P2|Overall Study|Lack of Subject Adherence to Protocol|1
1601145|NCT02259582|5577579|P1|Overall Study|Lack of Subject Adherence to Protocol|1
1601146|NCT02259582|5577577|P3|Overall Study|Disease progression|17
1601147|NCT02259582|5577578|P2|Overall Study|Disease progression|15
1601148|NCT02259582|5577579|P1|Overall Study|Disease progression|14
1601149|NCT02259582|5577577|P3|Overall Study|Withdrawal by Subject|1
1601150|NCT02259582|5577578|P2|Overall Study|Withdrawal by Subject|0
1601151|NCT02259582|5577579|P1|Overall Study|Withdrawal by Subject|0
1601152|NCT02259582|5577577|P3|Overall Study|Adverse Event|1
1601153|NCT02259582|5577578|P2|Overall Study|Adverse Event|0
1601154|NCT02259582|5577579|P1|Overall Study|Adverse Event|1
1601155|NCT02259582|5577577|P3|Overall Study|Death|1
1601156|NCT02259582|5577578|P2|Overall Study|Death|0
1601157|NCT02259582|5577579|P1|Overall Study|Death|0
1601158|NCT02259582|5577577|P3|Overall Study|Physician Decision|0
1601159|NCT02259582|5577578|P2|Overall Study|Physician Decision|1
1601160|NCT02259582|5577579|P1|Overall Study|Physician Decision|0
1601161|NCT02259400|5577589|P2|Overall Study|Death|2
1601162|NCT02259400|5577590|P1|Overall Study|Death|0
1601163|NCT02259348|5577622|P1|Overall Study|Death|4
1601164|NCT02259348|5577622|P1|Overall Study|Donors|6
1601165|NCT02259114|5577639|P5|Overall Study|Not Treated|0
1601166|NCT02259114|5577640|P4|Overall Study|Not Treated|0
1601167|NCT02259114|5577641|P3|Overall Study|Not Treated|0
1601168|NCT02259114|5577642|P2|Overall Study|Not Treated|0
1601169|NCT02259114|5577643|P1|Overall Study|Not Treated|1
1601170|NCT02259114|5577639|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
1601171|NCT02259114|5577640|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
1601172|NCT02259114|5577641|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
1601173|NCT02259114|5577642|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
1601174|NCT02259114|5577643|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
1601175|NCT02259114|5577639|P5|Overall Study|Withdrawal by Subject|0
1601176|NCT02259114|5577640|P4|Overall Study|Withdrawal by Subject|1
1601177|NCT02259114|5577641|P3|Overall Study|Withdrawal by Subject|1
1601178|NCT02259114|5577642|P2|Overall Study|Withdrawal by Subject|0
1601179|NCT02259114|5577643|P1|Overall Study|Withdrawal by Subject|0
1601180|NCT02259114|5577639|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1601181|NCT02259114|5577640|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1601182|NCT02259114|5577641|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
1601183|NCT02259114|5577642|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1601184|NCT02259114|5577643|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
1601185|NCT02259114|5577639|P5|Overall Study|Death|0
1601186|NCT02259114|5577640|P4|Overall Study|Death|0
1601187|NCT02259114|5577641|P3|Overall Study|Death|1
1601188|NCT02259114|5577642|P2|Overall Study|Death|0
1601189|NCT02259114|5577643|P1|Overall Study|Death|3
1601190|NCT02259114|5577639|P5|Overall Study|Adverse Event|1
1601191|NCT02259114|5577640|P4|Overall Study|Adverse Event|0
1601192|NCT02259114|5577641|P3|Overall Study|Adverse Event|0
1601193|NCT02259114|5577642|P2|Overall Study|Adverse Event|1
1601194|NCT02259114|5577643|P1|Overall Study|Adverse Event|2
1601195|NCT02259114|5577639|P5|Overall Study|Progressive Disease|5
1601196|NCT02259114|5577640|P4|Overall Study|Progressive Disease|2
1601197|NCT02259114|5577641|P3|Overall Study|Progressive Disease|10
1601198|NCT02259114|5577642|P2|Overall Study|Progressive Disease|2
1601199|NCT02259114|5577643|P1|Overall Study|Progressive Disease|14
1601200|NCT02259088|5577702|P2|Overall Study|Subject/guardian decision|8
1601201|NCT02259088|5577703|P1|Overall Study|Subject/guardian decision|8
1601202|NCT02259088|5577702|P2|Overall Study|Protocol deviation|0
1601203|NCT02259088|5577703|P1|Overall Study|Protocol deviation|5
1601204|NCT02259088|5577702|P2|Overall Study|Physician Decision|2
1601205|NCT02259088|5577703|P1|Overall Study|Physician Decision|5
1601206|NCT02259088|5577702|P2|Overall Study|Death|0
1601207|NCT02259088|5577703|P1|Overall Study|Death|2
1601208|NCT02259088|5577702|P2|Overall Study|Lost to Follow-up|0
1601209|NCT02259088|5577703|P1|Overall Study|Lost to Follow-up|2
1601210|NCT02259088|5577702|P2|Overall Study|Adverse Event|4
1601211|NCT02259088|5577703|P1|Overall Study|Adverse Event|6
1601212|NCT02259010|5577748|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
1601213|NCT02258542|5577777|P4|Overall Study|Eligibility criteria not fulfilled|0
1601214|NCT02258542|5577778|P3|Overall Study|Eligibility criteria not fulfilled|0
1601215|NCT02258542|5577779|P2|Overall Study|Eligibility criteria not fulfilled|2
1601216|NCT02258542|5577780|P1|Overall Study|Eligibility criteria not fulfilled|0
1601217|NCT02258542|5577777|P4|Overall Study|Protocol Violation|0
1601218|NCT02258542|5577778|P3|Overall Study|Protocol Violation|0
1601219|NCT02258542|5577779|P2|Overall Study|Protocol Violation|2
1601220|NCT02258542|5577780|P1|Overall Study|Protocol Violation|1
1601221|NCT02258542|5577777|P4|Overall Study|Adverse Event|0
1601222|NCT02258542|5577778|P3|Overall Study|Adverse Event|0
1601223|NCT02258542|5577779|P2|Overall Study|Adverse Event|4
1601224|NCT02258542|5577780|P1|Overall Study|Adverse Event|3
1601225|NCT02258542|5577777|P4|Overall Study|Death|1
1601226|NCT02258542|5577778|P3|Overall Study|Death|0
1601227|NCT02258542|5577779|P2|Overall Study|Death|4
1601228|NCT02258542|5577780|P1|Overall Study|Death|5
1601229|NCT02258542|5577777|P4|Overall Study|Lost to Follow-up|2
1601230|NCT02258542|5577778|P3|Overall Study|Lost to Follow-up|1
1601231|NCT02258542|5577779|P2|Overall Study|Lost to Follow-up|12
1601232|NCT02258542|5577780|P1|Overall Study|Lost to Follow-up|5
1601233|NCT02258542|5577777|P4|Overall Study|Withdrawal by Subject|1
1601234|NCT02258542|5577778|P3|Overall Study|Withdrawal by Subject|7
1601235|NCT02258542|5577779|P2|Overall Study|Withdrawal by Subject|20
1601236|NCT02258542|5577780|P1|Overall Study|Withdrawal by Subject|20
1601237|NCT02258542|5577777|P4|Overall Study|study specific discount. criteria|0
1601238|NCT02258542|5577778|P3|Overall Study|study specific discount. criteria|0
1601239|NCT02258542|5577779|P2|Overall Study|study specific discount. criteria|1
1601240|NCT02258542|5577780|P1|Overall Study|study specific discount. criteria|1
1601241|NCT02258542|5577777|P4|Overall Study|eg. not made to the visit|1
1601242|NCT02258542|5577778|P3|Overall Study|eg. not made to the visit|0
1601243|NCT02258542|5577779|P2|Overall Study|eg. not made to the visit|4
1601244|NCT02258542|5577780|P1|Overall Study|eg. not made to the visit|7
1601245|NCT02258529|5578004|P1|Overall Study|Adverse Event|1
1601246|NCT02258529|5578004|P1|Overall Study|Study Terminated by Sponsor|9
1601247|NCT02258334|5578093|P4|Overall Study|Adverse Event|0
1601248|NCT02258334|5578094|P3|Overall Study|Adverse Event|0
1601249|NCT02258334|5578095|P2|Overall Study|Adverse Event|0
1601250|NCT02258334|5578096|P1|Overall Study|Adverse Event|1
1601251|NCT02257918|5578170|P3|Overall Study|Pregnancy|1
1601252|NCT02257918|5578171|P2|Overall Study|Pregnancy|0
1601253|NCT02257918|5578172|P1|Overall Study|Pregnancy|0
1601254|NCT02257918|5578170|P3|Overall Study|Withdrawal by Subject|1
1601255|NCT02257918|5578171|P2|Overall Study|Withdrawal by Subject|0
1601256|NCT02257918|5578172|P1|Overall Study|Withdrawal by Subject|0
1601257|NCT02257918|5578170|P3|Overall Study|Lost to Follow-up|0
1601258|NCT02257918|5578171|P2|Overall Study|Lost to Follow-up|1
1601259|NCT02257918|5578172|P1|Overall Study|Lost to Follow-up|4
1601260|NCT02257684|5578222|P1|Overall Study|Sponsor's Decision|1
1601261|NCT02257684|5578222|P1|Overall Study|Lack of Efficacy|1
1601262|NCT02257684|5578222|P1|Overall Study|Adverse Event|2
1601263|NCT02257632|5578232|P2|Overall Study|Adverse Event|2
1601264|NCT02257632|5578233|P1|Overall Study|Adverse Event|1
1601265|NCT02257632|5578232|P2|Overall Study|Withdrawal by Subject|1
1601266|NCT02257632|5578233|P1|Overall Study|Withdrawal by Subject|0
1601267|NCT02257489|5578254|P9|Overall Study|Withdrawal by Subject|0
1601268|NCT02257489|5578255|P8|Overall Study|Withdrawal by Subject|0
1601269|NCT02257489|5578256|P7|Overall Study|Withdrawal by Subject|0
1601270|NCT02257489|5578257|P6|Overall Study|Withdrawal by Subject|0
1601271|NCT02257489|5578258|P5|Overall Study|Withdrawal by Subject|0
1601272|NCT02257489|5578259|P4|Overall Study|Withdrawal by Subject|1
1601273|NCT02257489|5578260|P3|Overall Study|Withdrawal by Subject|0
1601274|NCT02257489|5578261|P2|Overall Study|Withdrawal by Subject|0
1601275|NCT02257489|5578262|P1|Overall Study|Withdrawal by Subject|0
1601276|NCT02257385|5578298|P2|Overall Study|Withdrawal by Subject|4
1601277|NCT02257385|5578299|P1|Overall Study|Withdrawal by Subject|4
1601278|NCT02257385|5578298|P2|Overall Study|Lost to Follow-up|1
1601279|NCT02257385|5578299|P1|Overall Study|Lost to Follow-up|0
1601280|NCT02257385|5578298|P2|Overall Study|Protocol Violation|7
1601281|NCT02257385|5578299|P1|Overall Study|Protocol Violation|5
1601282|NCT02257385|5578298|P2|Overall Study|Lack of Efficacy|2
1601283|NCT02257385|5578299|P1|Overall Study|Lack of Efficacy|1
1601284|NCT02257385|5578298|P2|Overall Study|Adverse Event|8
1601285|NCT02257385|5578299|P1|Overall Study|Adverse Event|12
1601286|NCT02257372|5578309|P2|Overall Study|Withdrew consent|0
1601287|NCT02257372|5578310|P1|Overall Study|Withdrew consent|1
1601288|NCT02257372|5578309|P2|Overall Study|Lost to Follow-up|1
1601289|NCT02257372|5578310|P1|Overall Study|Lost to Follow-up|0
1601290|NCT02257372|5578309|P2|Overall Study|Protocol Violation|1
1601291|NCT02257372|5578310|P1|Overall Study|Protocol Violation|1
1601292|NCT02257372|5578309|P2|Overall Study|Lack of Efficacy|1
1601293|NCT02257372|5578310|P1|Overall Study|Lack of Efficacy|2
1601294|NCT02257372|5578309|P2|Overall Study|Adverse Event|7
1601295|NCT02257372|5578310|P1|Overall Study|Adverse Event|3
1601296|NCT02256982|5578327|P2|Overall Study|Disease Progression|1
1601297|NCT02256982|5578328|P1|Overall Study|Disease Progression|0
1601298|NCT02256969|5578337|P3|Overall Study|Screenfailed or withdrew|1
1601299|NCT02256969|5578338|P2|Overall Study|Screenfailed or withdrew|1
1601300|NCT02256969|5578339|P1|Overall Study|Screenfailed or withdrew|2
1601301|NCT02256917|5578356|P1|Prophylactic Treatment Phase II|Discontinued medication|1
1601302|NCT02256917|5578356|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
1601303|NCT02256917|5578356|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
1601304|NCT02256917|5578356|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
1601305|NCT02256917|5578356|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
1601306|NCT02256891|5578377|P2|Overall Study|Equipment Malfunction|1
1601307|NCT02256891|5578378|P1|Overall Study|Equipment Malfunction|0
1601308|NCT02256891|5578377|P2|Overall Study|Screen Fail|4
1601309|NCT02256891|5578378|P1|Overall Study|Screen Fail|5
1601310|NCT02256891|5578377|P2|Overall Study|Physician Decision|3
1601311|NCT02256891|5578378|P1|Overall Study|Physician Decision|7
1601312|NCT02256891|5578377|P2|Overall Study|Lost to Follow-up|3
1601313|NCT02256891|5578378|P1|Overall Study|Lost to Follow-up|0
1601314|NCT02256891|5578377|P2|Overall Study|Death|2
1601315|NCT02256891|5578378|P1|Overall Study|Death|0
1601316|NCT02256839|5578404|P2|Overall Study|Did not meet Eligibility Criteria|3
1601317|NCT02256839|5578405|P1|Overall Study|Did not meet Eligibility Criteria|2
1601318|NCT02256553|5578411|P1|Period III|Adverse Event|3
1601319|NCT02256553|5578411|P1|Period II|Subject Moved|1
1601320|NCT02256553|5578411|P1|Period II|Adverse Event|1
1601321|NCT02256553|5578411|P1|Period I|Protocol Violation|1
1601322|NCT02256553|5578411|P1|Period I|Adverse Event|5
1601323|NCT02256488|5578424|P4|Overall Study|Withdrawal by Subject|2
1601324|NCT02256488|5578425|P3|Overall Study|Withdrawal by Subject|0
1601325|NCT02256488|5578426|P2|Overall Study|Withdrawal by Subject|0
1601326|NCT02256488|5578427|P1|Overall Study|Withdrawal by Subject|1
1601327|NCT02256488|5578424|P4|Overall Study|OTHER|1
1601328|NCT02256488|5578425|P3|Overall Study|OTHER|1
1601329|NCT02256488|5578426|P2|Overall Study|OTHER|0
1601330|NCT02256488|5578427|P1|Overall Study|OTHER|1
1601331|NCT02256488|5578424|P4|Overall Study|Lost to Follow-up|3
1601332|NCT02256488|5578425|P3|Overall Study|Lost to Follow-up|9
1601333|NCT02256488|5578426|P2|Overall Study|Lost to Follow-up|6
1601334|NCT02256488|5578427|P1|Overall Study|Lost to Follow-up|6
1601335|NCT02256436|5578443|P2|Overall Study|Ongoing in Study|67
1601336|NCT02256436|5578444|P1|Overall Study|Ongoing in Study|108
1601337|NCT02256436|5578443|P2|Overall Study|Withdrawal by Subject|30
1601338|NCT02256436|5578444|P1|Overall Study|Withdrawal by Subject|7
1601339|NCT02256436|5578443|P2|Overall Study|Protocol Violation|0
1601340|NCT02256436|5578444|P1|Overall Study|Protocol Violation|1
1601341|NCT02256436|5578443|P2|Overall Study|Physician Decision|3
1601342|NCT02256436|5578444|P1|Overall Study|Physician Decision|1
1601343|NCT02256436|5578443|P2|Overall Study|Lost to Follow-up|1
1601344|NCT02256436|5578444|P1|Overall Study|Lost to Follow-up|1
1601345|NCT02256436|5578443|P2|Overall Study|Death|158
1601346|NCT02256436|5578444|P1|Overall Study|Death|137
1601347|NCT02256436|5578443|P2|Overall Study|Adverse Event|13
1601348|NCT02256436|5578444|P1|Overall Study|Adverse Event|15
1601349|NCT02256267|5578504|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
1601350|NCT02256267|5578504|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
1601351|NCT02255760|5578582|P5|Overall Study|Lost to Follow-up|0
1601352|NCT02255760|5578583|P4|Overall Study|Lost to Follow-up|0
1601353|NCT02255760|5578584|P3|Overall Study|Lost to Follow-up|0
1601354|NCT02255760|5578585|P2|Overall Study|Lost to Follow-up|1
1601355|NCT02255760|5578586|P1|Overall Study|Lost to Follow-up|0
1601356|NCT02255565|5578641|P3|Overall Study|Withdrawal by Subject|0
1601357|NCT02255565|5578642|P2|Overall Study|Withdrawal by Subject|1
1601358|NCT02255565|5578643|P1|Overall Study|Withdrawal by Subject|0
1601359|NCT02255279|5578713|P2|Overall Study|Withdrawal by Subject|6
1601360|NCT02255279|5578714|P1|Overall Study|Withdrawal by Subject|3
1601361|NCT02255279|5578713|P2|Overall Study|Protocol Violation|1
1601362|NCT02255279|5578714|P1|Overall Study|Protocol Violation|0
1601363|NCT02255279|5578713|P2|Overall Study|Lost to Follow-up|2
1601364|NCT02255279|5578714|P1|Overall Study|Lost to Follow-up|2
1601365|NCT02255149|5578767|P1|Overall Study|Implant Failure|1
1601366|NCT02255149|5578767|P1|Overall Study|Withdrawal by PI|1
1601367|NCT02255149|5578767|P1|Overall Study|Withdrawal by Subject|1
1601368|NCT02255149|5578767|P1|Overall Study|Lost to Follow-up|2
1601369|NCT02255097|5578783|P1|Overall Study|Treatment Ongoing|36
1601370|NCT02255097|5578783|P1|Overall Study|Allocated but not treated|1
1601371|NCT02255097|5578783|P1|Overall Study|Withdrawal by Subject|2
1601372|NCT02255097|5578783|P1|Overall Study|Progressive Disease|80
1601373|NCT02255097|5578783|P1|Overall Study|Physician Decision|1
1601374|NCT02255097|5578783|P1|Overall Study|Lost to Follow-up|1
1601375|NCT02255097|5578783|P1|Overall Study|Death|2
1601376|NCT02255097|5578783|P1|Overall Study|Excluded Medication|1
1601377|NCT02255097|5578783|P1|Overall Study|Complete Response|1
1601378|NCT02255097|5578783|P1|Overall Study|Clinical Progression|23
1601379|NCT02255097|5578783|P1|Overall Study|Adverse Event|24
1601380|NCT02254772|5578804|P1|Overall Study|Withdrawal by Subject|1
1601381|NCT02254772|5578804|P1|Overall Study|Ineligible|1
1601382|NCT02254681|5578810|P1|Overall Study|Lack of Efficacy|6
1601383|NCT02254551|5578820|P1|Dose Escalation|Dose-limiting toxicity|2
1601384|NCT02254551|5578820|P1|Dose Escalation|Physician Decision|1
1601385|NCT02254486|5578830|P2|Overall Study|Various|12
1601386|NCT02254486|5578831|P1|Overall Study|Various|12
1601387|NCT02254486|5578830|P2|Overall Study|GFR<60mL/min|21
1601388|NCT02254486|5578831|P1|Overall Study|GFR<60mL/min|16
1601389|NCT02254486|5578830|P2|Overall Study|Withdrawal by Subject|15
1601390|NCT02254486|5578831|P1|Overall Study|Withdrawal by Subject|17
1601391|NCT02254486|5578830|P2|Overall Study|Protocol Violation|2
1601392|NCT02254486|5578831|P1|Overall Study|Protocol Violation|1
1601393|NCT02254486|5578830|P2|Overall Study|Lost to Follow-up|4
1601394|NCT02254486|5578831|P1|Overall Study|Lost to Follow-up|2
1601395|NCT02254486|5578830|P2|Overall Study|Lack of Efficacy|0
1601396|NCT02254486|5578831|P1|Overall Study|Lack of Efficacy|1
1601397|NCT02254486|5578830|P2|Overall Study|Adverse Event|1
1601398|NCT02254486|5578831|P1|Overall Study|Adverse Event|1
1601399|NCT02254460|5578870|P2|Overall Study|Adverse Event|0
1601400|NCT02254460|5578871|P1|Overall Study|Adverse Event|1
1601401|NCT02254421|5578879|P2|Overall Study|Withdrew Consent|1
1601402|NCT02254421|5578880|P1|Overall Study|Withdrew Consent|1
1601403|NCT02254421|5578879|P2|Overall Study|Death|2
1601404|NCT02254421|5578880|P1|Overall Study|Death|0
1601405|NCT02254421|5578879|P2|Overall Study|Randomized but Not Treated|0
1601406|NCT02254421|5578880|P1|Overall Study|Randomized but Not Treated|1
1601407|NCT02254408|5578894|P2|Overall Study|Lost to Follow-up|0
1601408|NCT02254408|5578895|P1|Overall Study|Lost to Follow-up|1
1601409|NCT02254408|5578894|P2|Overall Study|Withdrawal by Subject|3
1601410|NCT02254408|5578895|P1|Overall Study|Withdrawal by Subject|3
1601411|NCT02254408|5578894|P2|Overall Study|Investigator's Discretion|1
1601412|NCT02254408|5578895|P1|Overall Study|Investigator's Discretion|0
1601413|NCT02254408|5578894|P2|Overall Study|Death|3
1601414|NCT02254408|5578895|P1|Overall Study|Death|2
1601415|NCT02254408|5578894|P2|Overall Study|Adverse Event|0
1601416|NCT02254408|5578895|P1|Overall Study|Adverse Event|1
1601417|NCT02254408|5578894|P2|Overall Study|Randomized But Not Treated|3
1601418|NCT02254408|5578895|P1|Overall Study|Randomized But Not Treated|1
1601419|NCT02254304|5578907|P2|Overall Study|Personal decision|0
1601420|NCT02254304|5578908|P1|Overall Study|Personal decision|1
1601421|NCT02254304|5578907|P2|Overall Study|Personal causes|1
1601422|NCT02254304|5578908|P1|Overall Study|Personal causes|4
1601423|NCT02254304|5578907|P2|Overall Study|Injection site pain and Injection fear|0
1601424|NCT02254304|5578908|P1|Overall Study|Injection site pain and Injection fear|1
1601425|NCT02254304|5578907|P2|Overall Study|Withdrawal by Subject|0
1601426|NCT02254304|5578908|P1|Overall Study|Withdrawal by Subject|3
1601427|NCT02254304|5578907|P2|Overall Study|Protocol Violation|0
1601428|NCT02254304|5578908|P1|Overall Study|Protocol Violation|1
1601429|NCT02254304|5578907|P2|Overall Study|Lost to Follow-up|2
1601430|NCT02254304|5578908|P1|Overall Study|Lost to Follow-up|2
1601431|NCT02254304|5578907|P2|Overall Study|Adverse Event|1
1601432|NCT02254304|5578908|P1|Overall Study|Adverse Event|2
1601433|NCT02254291|5578968|P3|Overall Study|Missing follow-up information|1
1601434|NCT02254291|5578969|P2|Overall Study|Missing follow-up information|0
1601435|NCT02254291|5578970|P1|Overall Study|Missing follow-up information|0
1601436|NCT02254291|5578968|P3|Overall Study|Withdrawal by Subject|1
1601437|NCT02254291|5578969|P2|Overall Study|Withdrawal by Subject|3
1601438|NCT02254291|5578970|P1|Overall Study|Withdrawal by Subject|0
1601439|NCT02253654|5579027|P2|Overall Study|Did Not Receive Study Treatment|1
1601440|NCT02253654|5579028|P1|Overall Study|Did Not Receive Study Treatment|4
1601441|NCT02253654|5579027|P2|Overall Study|Death|7
1601442|NCT02253654|5579028|P1|Overall Study|Death|4
1601443|NCT02253654|5579027|P2|Overall Study|Lost to Follow-up|5
1601444|NCT02253654|5579028|P1|Overall Study|Lost to Follow-up|2
1601445|NCT02253654|5579027|P2|Overall Study|Decision by Sponsor|1
1601446|NCT02253654|5579028|P1|Overall Study|Decision by Sponsor|1
1601447|NCT02253654|5579027|P2|Overall Study|Withdrawal by Subject|4
1601448|NCT02253654|5579028|P1|Overall Study|Withdrawal by Subject|12
1601449|NCT02253433|5579054|P2|Overall Study|Medical or Other Concerns|2
1601450|NCT02253433|5579055|P1|Overall Study|Medical or Other Concerns|1
1601451|NCT02253433|5579054|P2|Overall Study|Too Busy|4
1601452|NCT02253433|5579055|P1|Overall Study|Too Busy|0
1601453|NCT02253433|5579054|P2|Overall Study|Unstable Housing/Homeless|7
1601454|NCT02253433|5579055|P1|Overall Study|Unstable Housing/Homeless|0
1601455|NCT02253433|5579054|P2|Overall Study|Uncomfortable with home visitors|3
1601456|NCT02253433|5579055|P1|Overall Study|Uncomfortable with home visitors|0
1601457|NCT02253433|5579054|P2|Overall Study|Out of Study Area|7
1601458|NCT02253433|5579055|P1|Overall Study|Out of Study Area|2
1601459|NCT02253433|5579054|P2|Overall Study|No Longer Interested|15
1601460|NCT02253433|5579055|P1|Overall Study|No Longer Interested|3
1601461|NCT02253433|5579054|P2|Overall Study|Death|1
1601462|NCT02253433|5579055|P1|Overall Study|Death|1
1601463|NCT02253433|5579054|P2|Overall Study|Unable to Contact|16
1601464|NCT02253433|5579055|P1|Overall Study|Unable to Contact|9
1601465|NCT02253147|5579314|P1|Overall Study|Withdrawal by Subject|1
1601466|NCT02253147|5579314|P1|Overall Study|Lost to Follow-up|2
1601467|NCT02253147|5579314|P1|Overall Study|Conditional re-treatment at W52|5
1601468|NCT02253147|5579314|P1|Overall Study|Did not consent to study extension|9
1601469|NCT02253147|5579314|P1|Overall Study|Protocol Violation|30
1601470|NCT02252965|5579348|P2|Overall Study|Other|5
1601471|NCT02252965|5579349|P1|Overall Study|Other|4
1601472|NCT02252965|5579348|P2|Overall Study|Withdrawal by Subject|9
1601473|NCT02252965|5579349|P1|Overall Study|Withdrawal by Subject|7
1601474|NCT02252965|5579348|P2|Overall Study|Lack of Efficacy|2
1601475|NCT02252965|5579349|P1|Overall Study|Lack of Efficacy|0
1601476|NCT02252965|5579348|P2|Overall Study|Protocol Violation|5
1601477|NCT02252965|5579349|P1|Overall Study|Protocol Violation|4
1601478|NCT02252965|5579348|P2|Overall Study|Lost to Follow-up|8
1601479|NCT02252965|5579349|P1|Overall Study|Lost to Follow-up|16
1601480|NCT02252965|5579348|P2|Overall Study|Adverse Event|14
1601481|NCT02252965|5579349|P1|Overall Study|Adverse Event|9
1601482|NCT02252939|5579376|P1|Overall Study|Lost to Follow-up|3
1601483|NCT02252536|5579433|P2|Overall Study|Lost to Follow-up|3
1601484|NCT02252536|5579434|P1|Overall Study|Lost to Follow-up|5
1601485|NCT02252211|5579543|P3|Overall Study|Serious Adverse Event During Screening|1
1601486|NCT02252211|5579544|P2|Overall Study|Serious Adverse Event During Screening|0
1601487|NCT02252211|5579545|P1|Overall Study|Serious Adverse Event During Screening|1
1601488|NCT02252211|5579543|P3|Overall Study|Withdrawal by Subject|0
1601489|NCT02252211|5579544|P2|Overall Study|Withdrawal by Subject|0
1601490|NCT02252211|5579545|P1|Overall Study|Withdrawal by Subject|1
1601491|NCT02252211|5579543|P3|Overall Study|Progressive disease|0
1601492|NCT02252211|5579544|P2|Overall Study|Progressive disease|2
1601493|NCT02252211|5579545|P1|Overall Study|Progressive disease|3
1601494|NCT02252211|5579543|P3|Overall Study|Adverse Event|0
1601495|NCT02252211|5579544|P2|Overall Study|Adverse Event|1
1601496|NCT02252211|5579545|P1|Overall Study|Adverse Event|0
1601497|NCT02252172|5579582|P2|Overall Study|Ongoing|298
1601498|NCT02252172|5579583|P1|Overall Study|Ongoing|276
1601499|NCT02252172|5579582|P2|Overall Study|Lost to Follow-up|1
1601500|NCT02252172|5579583|P1|Overall Study|Lost to Follow-up|3
1601501|NCT02252146|5579595|P1|Overall Study|Inability to travel to study site|1
1601502|NCT02252146|5579595|P1|Overall Study|Entered hospice care|1
1601503|NCT02252146|5579595|P1|Overall Study|Lack of Efficacy|4
1601504|NCT02252042|5579608|P2|Overall Study|Ongoing in study|35
1601505|NCT02252042|5579609|P1|Overall Study|Ongoing in study|64
1601506|NCT02252042|5579608|P2|Overall Study|Withdrawal by Subject|20
1601507|NCT02252042|5579609|P1|Overall Study|Withdrawal by Subject|13
1601508|NCT02252042|5579608|P2|Overall Study|Physician Decision|1
1601509|NCT02252042|5579609|P1|Overall Study|Physician Decision|0
1601510|NCT02252042|5579608|P2|Overall Study|Death|192
1601511|NCT02252042|5579609|P1|Overall Study|Death|170
1601512|NCT02252016|5579649|P2|Overall Study|Withdrawal by Subject|2
1601513|NCT02252016|5579650|P1|Overall Study|Withdrawal by Subject|0
1601514|NCT02252016|5579649|P2|Overall Study|Physician Decision|0
1601515|NCT02252016|5579650|P1|Overall Study|Physician Decision|1
1601516|NCT02252016|5579649|P2|Overall Study|Lost to Follow-up|1
1601517|NCT02252016|5579650|P1|Overall Study|Lost to Follow-up|2
1601518|NCT02251990|5579664|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
1601519|NCT02251990|5579665|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
1601520|NCT02251990|5579664|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
1601521|NCT02251990|5579665|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
1601522|NCT02251990|5579664|P2|Period 1 (Double-blind [DB])|Not Treated|0
1601523|NCT02251990|5579665|P1|Period 1 (Double-blind [DB])|Not Treated|1
1601524|NCT02251990|5579664|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
1601525|NCT02251990|5579665|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
1601526|NCT02251990|5579664|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
1601527|NCT02251990|5579665|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
1601528|NCT02251990|5579664|P2|Period 1 (Double-blind [DB])|Adverse Event|1
1601529|NCT02251990|5579665|P1|Period 1 (Double-blind [DB])|Adverse Event|1
1601530|NCT02251912|5579693|P2|Overall Study|Adverse Event|2
1601531|NCT02251912|5579694|P1|Overall Study|Adverse Event|0
1601532|NCT02251912|5579693|P2|Overall Study|Withdrawal by Subject|3
1601533|NCT02251912|5579694|P1|Overall Study|Withdrawal by Subject|2
1601534|NCT02251717|5579723|P2|Overall Study|Withdrew Consent|0
1601535|NCT02251717|5579724|P1|Overall Study|Withdrew Consent|1
1601536|NCT02251717|5579723|P2|Overall Study|Adverse Event|1
1601537|NCT02251717|5579724|P1|Overall Study|Adverse Event|0
1601538|NCT02251652|5579736|P1|Overall Study|Withdrawal by Subject|1
1601539|NCT02251275|5579786|P5|Overall Study|Withdrawal by Subject|0
1601540|NCT02251275|5579787|P4|Overall Study|Withdrawal by Subject|1
1601541|NCT02251275|5579788|P3|Overall Study|Withdrawal by Subject|35
1601542|NCT02251275|5579789|P2|Overall Study|Withdrawal by Subject|51
1601543|NCT02251275|5579790|P1|Overall Study|Withdrawal by Subject|25
1601544|NCT02251275|5579786|P5|Overall Study|Protocol Deviation|0
1601545|NCT02251275|5579787|P4|Overall Study|Protocol Deviation|0
1601546|NCT02251275|5579788|P3|Overall Study|Protocol Deviation|1
1601547|NCT02251275|5579789|P2|Overall Study|Protocol Deviation|0
1601548|NCT02251275|5579790|P1|Overall Study|Protocol Deviation|0
1601549|NCT02251275|5579786|P5|Overall Study|Physician Decision|1
1601550|NCT02251275|5579787|P4|Overall Study|Physician Decision|0
1601551|NCT02251275|5579788|P3|Overall Study|Physician Decision|26
1601552|NCT02251275|5579789|P2|Overall Study|Physician Decision|30
1601553|NCT02251275|5579790|P1|Overall Study|Physician Decision|19
1601554|NCT02251275|5579786|P5|Overall Study|Lost to Follow-up|0
1601555|NCT02251275|5579787|P4|Overall Study|Lost to Follow-up|0
1601556|NCT02251275|5579788|P3|Overall Study|Lost to Follow-up|4
1601557|NCT02251275|5579789|P2|Overall Study|Lost to Follow-up|6
1601558|NCT02251275|5579790|P1|Overall Study|Lost to Follow-up|5
1601559|NCT02251275|5579786|P5|Overall Study|Adverse Event|0
1601560|NCT02251275|5579787|P4|Overall Study|Adverse Event|0
1601561|NCT02251275|5579788|P3|Overall Study|Adverse Event|28
1601562|NCT02251275|5579789|P2|Overall Study|Adverse Event|60
1601563|NCT02251275|5579790|P1|Overall Study|Adverse Event|23
1601564|NCT02250443|5579863|P1|Overall Study|Adverse Event|3
1601565|NCT02250443|5579863|P1|Overall Study|Administrative problems|7
1601566|NCT02250326|5579892|P3|Follow-Up Period|Lost to Follow-up|3
1601567|NCT02250326|5579893|P2|Follow-Up Period|Lost to Follow-up|1
1601568|NCT02250326|5579894|P1|Follow-Up Period|Lost to Follow-up|1
1601569|NCT02250326|5579892|P3|Follow-Up Period|Unknown or Missing|3
1601570|NCT02250326|5579893|P2|Follow-Up Period|Unknown or Missing|3
1601571|NCT02250326|5579894|P1|Follow-Up Period|Unknown or Missing|2
1601572|NCT02250326|5579892|P3|Follow-Up Period|Death|32
1601573|NCT02250326|5579893|P2|Follow-Up Period|Death|26
1601574|NCT02250326|5579894|P1|Follow-Up Period|Death|46
1601575|NCT02250326|5579892|P3|Treatment Period|Randomized or assigned; not treated|1
1601576|NCT02250326|5579893|P2|Treatment Period|Randomized or assigned; not treated|1
1601577|NCT02250326|5579894|P1|Treatment Period|Randomized or assigned; not treated|2
1601578|NCT02250326|5579892|P3|Treatment Period|Miscellaneous|7
1601579|NCT02250326|5579893|P2|Treatment Period|Miscellaneous|2
1601580|NCT02250326|5579894|P1|Treatment Period|Miscellaneous|8
1601581|NCT02250326|5579892|P3|Treatment Period|Withdrawal by Subject|4
1601582|NCT02250326|5579893|P2|Treatment Period|Withdrawal by Subject|5
1601583|NCT02250326|5579894|P1|Treatment Period|Withdrawal by Subject|11
1601584|NCT02250326|5579892|P3|Treatment Period|Symptomatic Deterioration|10
1601585|NCT02250326|5579893|P2|Treatment Period|Symptomatic Deterioration|4
1601586|NCT02250326|5579894|P1|Treatment Period|Symptomatic Deterioration|9
1601587|NCT02250326|5579892|P3|Treatment Period|Progressive Disease|45
1601588|NCT02250326|5579893|P2|Treatment Period|Progressive Disease|36
1601589|NCT02250326|5579894|P1|Treatment Period|Progressive Disease|42
1601590|NCT02250326|5579892|P3|Treatment Period|Adverse Event|8
1601591|NCT02250326|5579893|P2|Treatment Period|Adverse Event|4
1601592|NCT02250326|5579894|P1|Treatment Period|Adverse Event|8
1601593|NCT02250326|5579892|P3|Treatment Period|Death|2
1601594|NCT02250326|5579893|P2|Treatment Period|Death|12
1601595|NCT02250326|5579894|P1|Treatment Period|Death|1
1601596|NCT02250274|5579927|P2|Overall Study|Insufficient blood draw amount|6
1601597|NCT02250274|5579928|P1|Overall Study|Insufficient blood draw amount|7
1601598|NCT02250183|5579944|P1|Overall Study|Lost to Follow-up|1
1601599|NCT02250183|5579944|P1|Overall Study|Adverse Event|5
1601600|NCT02250183|5579944|P1|Overall Study|Withdrawal by Subject|2
1601601|NCT02249949|5579953|P1|Overall Study|Cancelled prior to treatment|2
1601602|NCT02249832|5579960|P1|Overall Study|Lost to Follow-up|10
1601603|NCT02249832|5579960|P1|Overall Study|Withdrawal by Subject|3
1601604|NCT02249767|5580004|P3|Overall Study|Did not use medication|8
1601605|NCT02249767|5580005|P2|Overall Study|Did not use medication|9
1601606|NCT02249767|5580006|P1|Overall Study|Did not use medication|8
1601607|NCT02249182|5580057|P5|Treatment Phase|Lost to Follow-up|0
1601608|NCT02249182|5580058|P4|Treatment Phase|Lost to Follow-up|0
1601609|NCT02249182|5580059|P3|Treatment Phase|Lost to Follow-up|0
1601610|NCT02249182|5580060|P2|Treatment Phase|Lost to Follow-up|0
1601611|NCT02249182|5580061|P1|Treatment Phase|Lost to Follow-up|4
1601612|NCT02248974|5580211|P2|1-Month Follow-Up|Lost to Follow-up|3
1601613|NCT02248974|5580212|P1|1-Month Follow-Up|Lost to Follow-up|2
1601614|NCT02248974|5580211|P2|1-Week Follow-Up|Lost to Follow-up|8
1601615|NCT02248974|5580212|P1|1-Week Follow-Up|Lost to Follow-up|0
1601616|NCT02248974|5580211|P2|1-Week Follow-Up|Withdrawal by Subject|2
1601617|NCT02248974|5580212|P1|1-Week Follow-Up|Withdrawal by Subject|0
1601618|NCT02248974|5580211|P2|1-Week Follow-Up|Timing: implanted before survey|2
1601619|NCT02248974|5580212|P1|1-Week Follow-Up|Timing: implanted before survey|0
1601620|NCT02248974|5580211|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
1601621|NCT02248974|5580212|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
1601622|NCT02248974|5580211|P2|1-Week Follow-Up|Excluded because of age|1
1601623|NCT02248974|5580212|P1|1-Week Follow-Up|Excluded because of age|0
1601624|NCT02248974|5580211|P2|1-Week Follow-Up|Death|1
1601625|NCT02248974|5580212|P1|1-Week Follow-Up|Death|1
1601626|NCT02248974|5580211|P2|1-Week Follow-Up|Cognitive Difficulty|0
1601627|NCT02248974|5580212|P1|1-Week Follow-Up|Cognitive Difficulty|1
1601628|NCT02248974|5580211|P2|1-Week Follow-Up|Transferred to another facility|0
1601629|NCT02248974|5580212|P1|1-Week Follow-Up|Transferred to another facility|1
1601630|NCT02248974|5580211|P2|1-Week Follow-Up|Enrolled in another study|1
1601631|NCT02248974|5580212|P1|1-Week Follow-Up|Enrolled in another study|1
1601632|NCT02248974|5580211|P2|1-Week Follow-Up|Became ineligible for LVAD|1
1601633|NCT02248974|5580212|P1|1-Week Follow-Up|Became ineligible for LVAD|4
1601634|NCT02248974|5580211|P2|1-Day Follow-Up|Enrolled in another study|0
1601635|NCT02248974|5580212|P1|1-Day Follow-Up|Enrolled in another study|1
1601636|NCT02248974|5580211|P2|1-Day Follow-Up|Withdrawal by Subject|0
1601637|NCT02248974|5580212|P1|1-Day Follow-Up|Withdrawal by Subject|5
1601638|NCT02248974|5580211|P2|1-Day Follow-Up|Lost to Follow-up|0
1601639|NCT02248974|5580212|P1|1-Day Follow-Up|Lost to Follow-up|4
1601640|NCT02248961|5580290|P2|Overall Study|Unmet inclusion/exclusion criteria|0
1601641|NCT02248961|5580291|P1|Overall Study|Unmet inclusion/exclusion criteria|1
1601642|NCT02248961|5580290|P2|Overall Study|Withdrawal by Subject|2
1601643|NCT02248961|5580291|P1|Overall Study|Withdrawal by Subject|1
1601644|NCT02248961|5580290|P2|Overall Study|Adverse Event|0
1601645|NCT02248961|5580291|P1|Overall Study|Adverse Event|1
1601646|NCT02248857|5580326|P3|6 Month|Death|0
1601647|NCT02248857|5580327|P2|6 Month|Death|0
1601648|NCT02248857|5580328|P1|6 Month|Death|1
1601649|NCT02248857|5580326|P3|6 Month|Withdrawal by Subject|2
1601650|NCT02248857|5580327|P2|6 Month|Withdrawal by Subject|2
1601651|NCT02248857|5580328|P1|6 Month|Withdrawal by Subject|0
1601652|NCT02248857|5580326|P3|6 Month|Partially completed, unable to finish|0
1601653|NCT02248857|5580327|P2|6 Month|Partially completed, unable to finish|1
1601654|NCT02248857|5580328|P1|6 Month|Partially completed, unable to finish|0
1601655|NCT02248857|5580326|P3|6 Month|Lost to Follow-up|15
1601656|NCT02248857|5580327|P2|6 Month|Lost to Follow-up|26
1601657|NCT02248857|5580328|P1|6 Month|Lost to Follow-up|27
1601658|NCT02248857|5580326|P3|3 Month|Partially completed, unable to finish|1
1601659|NCT02248857|5580327|P2|3 Month|Partially completed, unable to finish|2
1601660|NCT02248857|5580328|P1|3 Month|Partially completed, unable to finish|2
1601661|NCT02248857|5580326|P3|3 Month|Unable to reach for 3 month|26
1601662|NCT02248857|5580327|P2|3 Month|Unable to reach for 3 month|29
1601663|NCT02248857|5580328|P1|3 Month|Unable to reach for 3 month|35
1601664|NCT02248857|5580326|P3|3 Month|Withdrawal by Subject|4
1601665|NCT02248857|5580327|P2|3 Month|Withdrawal by Subject|3
1601666|NCT02248857|5580328|P1|3 Month|Withdrawal by Subject|9
1601667|NCT02248818|5580365|P9|Randomised Study|Administrative - randomization error|0
1601668|NCT02248818|5580366|P8|Randomised Study|Administrative - randomization error|0
1601669|NCT02248818|5580367|P7|Randomised Study|Administrative - randomization error|0
1601670|NCT02248818|5580368|P6|Randomised Study|Administrative - randomization error|8
1601671|NCT02248818|5580369|P5|Randomised Study|Administrative - randomization error|0
1601672|NCT02248818|5580370|P4|Randomised Study|Administrative - randomization error|0
1601673|NCT02248818|5580371|P3|Randomised Study|Administrative - randomization error|0
1601674|NCT02248818|5580372|P2|Randomised Study|Administrative - randomization error|0
1601675|NCT02248818|5580373|P1|Randomised Study|Administrative - randomization error|0
1601676|NCT02248818|5580365|P9|Screening|Lost to Follow-up|7
1601677|NCT02248818|5580366|P8|Screening|Lost to Follow-up|0
1601678|NCT02248818|5580367|P7|Screening|Lost to Follow-up|0
1601679|NCT02248818|5580368|P6|Screening|Lost to Follow-up|0
1601680|NCT02248818|5580369|P5|Screening|Lost to Follow-up|0
1601681|NCT02248818|5580370|P4|Screening|Lost to Follow-up|0
1601682|NCT02248818|5580371|P3|Screening|Lost to Follow-up|0
1601683|NCT02248818|5580372|P2|Screening|Lost to Follow-up|0
1601684|NCT02248818|5580373|P1|Screening|Lost to Follow-up|0
1601685|NCT02248818|5580365|P9|Screening|Withdrawal by Subject|6
1601686|NCT02248818|5580366|P8|Screening|Withdrawal by Subject|0
1601687|NCT02248818|5580367|P7|Screening|Withdrawal by Subject|0
1601688|NCT02248818|5580368|P6|Screening|Withdrawal by Subject|0
1601689|NCT02248818|5580369|P5|Screening|Withdrawal by Subject|0
1601690|NCT02248818|5580370|P4|Screening|Withdrawal by Subject|0
1601691|NCT02248818|5580371|P3|Screening|Withdrawal by Subject|0
1601692|NCT02248818|5580372|P2|Screening|Withdrawal by Subject|0
1601693|NCT02248818|5580373|P1|Screening|Withdrawal by Subject|0
1601694|NCT02248818|5580365|P9|Screening|Physician Decision|73
1601695|NCT02248818|5580366|P8|Screening|Physician Decision|0
1601696|NCT02248818|5580367|P7|Screening|Physician Decision|0
1601697|NCT02248818|5580368|P6|Screening|Physician Decision|0
1601698|NCT02248818|5580369|P5|Screening|Physician Decision|0
1601699|NCT02248818|5580370|P4|Screening|Physician Decision|0
1601700|NCT02248818|5580371|P3|Screening|Physician Decision|0
1601701|NCT02248818|5580372|P2|Screening|Physician Decision|0
1601702|NCT02248818|5580373|P1|Screening|Physician Decision|0
1601703|NCT02248818|5580365|P9|Screening|Study fully enrolled|14
1601704|NCT02248818|5580366|P8|Screening|Study fully enrolled|0
1601705|NCT02248818|5580367|P7|Screening|Study fully enrolled|0
1601706|NCT02248818|5580368|P6|Screening|Study fully enrolled|0
1601707|NCT02248818|5580369|P5|Screening|Study fully enrolled|0
1601708|NCT02248818|5580370|P4|Screening|Study fully enrolled|0
1601709|NCT02248818|5580371|P3|Screening|Study fully enrolled|0
1601710|NCT02248818|5580372|P2|Screening|Study fully enrolled|0
1601711|NCT02248818|5580373|P1|Screening|Study fully enrolled|0
1601712|NCT02248818|5580365|P9|Screening|Protocol Violation|7
1601713|NCT02248818|5580366|P8|Screening|Protocol Violation|0
1601714|NCT02248818|5580367|P7|Screening|Protocol Violation|0
1601715|NCT02248818|5580368|P6|Screening|Protocol Violation|0
1601716|NCT02248818|5580369|P5|Screening|Protocol Violation|0
1601717|NCT02248818|5580370|P4|Screening|Protocol Violation|0
1601718|NCT02248818|5580371|P3|Screening|Protocol Violation|0
1601719|NCT02248818|5580372|P2|Screening|Protocol Violation|0
1601720|NCT02248818|5580373|P1|Screening|Protocol Violation|0
1601721|NCT02248675|5580588|P2|Overall Study|Lost to Follow-up|1
1601722|NCT02248675|5580589|P1|Overall Study|Lost to Follow-up|3
1601723|NCT02248649|5580616|P2|Overall Study|Lost to Follow-up|10
1601724|NCT02248649|5580617|P1|Overall Study|Lost to Follow-up|14
1601725|NCT02248649|5580616|P2|Overall Study|Death|11
1601726|NCT02248649|5580617|P1|Overall Study|Death|7
1601727|NCT02248480|5580642|P2|Overall Study|Other:Physician Decision|1
1601728|NCT02248480|5580643|P1|Overall Study|Other:Physician Decision|0
1601729|NCT02248480|5580642|P2|Overall Study|Entry Criteria Not Met|1
1601730|NCT02248480|5580643|P1|Overall Study|Entry Criteria Not Met|0
1601731|NCT02248480|5580642|P2|Overall Study|Withdrawal by Subject|4
1601732|NCT02248480|5580643|P1|Overall Study|Withdrawal by Subject|2
1601733|NCT02248480|5580642|P2|Overall Study|Adverse Event|2
1601734|NCT02248480|5580643|P1|Overall Study|Adverse Event|11
1601735|NCT02248480|5580642|P2|Overall Study|Lack of Efficacy|6
1601736|NCT02248480|5580643|P1|Overall Study|Lack of Efficacy|4
1601737|NCT02247960|5580710|P2|Catheter Removed|Lost to Follow-up|10
1601738|NCT02247960|5580711|P1|Catheter Removed|Lost to Follow-up|7
1601739|NCT02247960|5580710|P2|Patient Consent and Randomization|Withdrawal by Subject|4
1601740|NCT02247960|5580711|P1|Patient Consent and Randomization|Withdrawal by Subject|0
1601741|NCT02247960|5580710|P2|Patient Consent and Randomization|Physician Decision|2
1601742|NCT02247960|5580711|P1|Patient Consent and Randomization|Physician Decision|2
1601743|NCT02247531|5580750|P3|Overall Study|Unspecified Reason|4
1601744|NCT02247531|5580751|P2|Overall Study|Unspecified Reason|3
1601745|NCT02247531|5580752|P1|Overall Study|Unspecified Reason|2
1601746|NCT02247531|5580750|P3|Overall Study|Physician Decision|2
1601747|NCT02247531|5580751|P2|Overall Study|Physician Decision|2
1601748|NCT02247531|5580752|P1|Overall Study|Physician Decision|0
1601749|NCT02247531|5580750|P3|Overall Study|Study Terminated by Sponsor|62
1601750|NCT02247531|5580751|P2|Overall Study|Study Terminated by Sponsor|66
1601751|NCT02247531|5580752|P1|Overall Study|Study Terminated by Sponsor|64
1601752|NCT02247531|5580750|P3|Overall Study|Withdrawal by Subject|25
1601753|NCT02247531|5580751|P2|Overall Study|Withdrawal by Subject|31
1601754|NCT02247531|5580752|P1|Overall Study|Withdrawal by Subject|26
1601755|NCT02247531|5580750|P3|Overall Study|Non-compliance|0
1601756|NCT02247531|5580751|P2|Overall Study|Non-compliance|2
1601757|NCT02247531|5580752|P1|Overall Study|Non-compliance|2
1601758|NCT02247531|5580750|P3|Overall Study|Lost to Follow-up|3
1601759|NCT02247531|5580751|P2|Overall Study|Lost to Follow-up|8
1601760|NCT02247531|5580752|P1|Overall Study|Lost to Follow-up|1
1601761|NCT02247531|5580750|P3|Overall Study|Death|5
1601762|NCT02247531|5580751|P2|Overall Study|Death|9
1601763|NCT02247531|5580752|P1|Overall Study|Death|8
1601764|NCT02247531|5580750|P3|Overall Study|Adverse Event|9
1601765|NCT02247531|5580751|P2|Overall Study|Adverse Event|4
1601766|NCT02247531|5580752|P1|Overall Study|Adverse Event|3
1601767|NCT02247479|5580802|P3|Overall Study|Unspecified Reason|2
1601768|NCT02247479|5580803|P2|Overall Study|Unspecified Reason|5
1601769|NCT02247479|5580804|P1|Overall Study|Unspecified Reason|2
1601770|NCT02247479|5580802|P3|Overall Study|Physician Decision|2
1601771|NCT02247479|5580803|P2|Overall Study|Physician Decision|0
1601772|NCT02247479|5580804|P1|Overall Study|Physician Decision|1
1601773|NCT02247479|5580802|P3|Overall Study|Study Terminated by Sponsor|94
1601774|NCT02247479|5580803|P2|Overall Study|Study Terminated by Sponsor|88
1601775|NCT02247479|5580804|P1|Overall Study|Study Terminated by Sponsor|98
1601776|NCT02247479|5580802|P3|Overall Study|Withdrawal by Subject|24
1601777|NCT02247479|5580803|P2|Overall Study|Withdrawal by Subject|29
1601778|NCT02247479|5580804|P1|Overall Study|Withdrawal by Subject|25
1601779|NCT02247479|5580802|P3|Overall Study|Non-compliance|1
1601780|NCT02247479|5580803|P2|Overall Study|Non-compliance|0
1601781|NCT02247479|5580804|P1|Overall Study|Non-compliance|0
1601782|NCT02247479|5580802|P3|Overall Study|Lost to Follow-up|1
1601783|NCT02247479|5580803|P2|Overall Study|Lost to Follow-up|3
1601784|NCT02247479|5580804|P1|Overall Study|Lost to Follow-up|3
1601785|NCT02247479|5580802|P3|Overall Study|Death|6
1601786|NCT02247479|5580803|P2|Overall Study|Death|4
1601787|NCT02247479|5580804|P1|Overall Study|Death|5
1601788|NCT02247479|5580802|P3|Overall Study|Adverse Event|8
1601789|NCT02247479|5580803|P2|Overall Study|Adverse Event|9
1601790|NCT02247479|5580804|P1|Overall Study|Adverse Event|8
1601791|NCT02247466|5580853|P2|Overall Study|Procedure changed to open surgery|3
1601792|NCT02247466|5580854|P1|Overall Study|Procedure changed to open surgery|0
1601793|NCT02247440|5580872|P1|Overall Study|Lack of Efficacy|3
1601794|NCT02247440|5580872|P1|Overall Study|Withdrawal by Subject|1
1601795|NCT02247401|5580885|P3|Overall Study|Lost to Follow-up|1
1601796|NCT02247401|5580886|P2|Overall Study|Lost to Follow-up|1
1601797|NCT02247401|5580887|P1|Overall Study|Lost to Follow-up|1
1601798|NCT02247401|5580885|P3|Overall Study|Withdrawal by Subject|1
1601799|NCT02247401|5580886|P2|Overall Study|Withdrawal by Subject|1
1601800|NCT02247401|5580887|P1|Overall Study|Withdrawal by Subject|4
1601801|NCT02247401|5580885|P3|Overall Study|Adverse Event|0
1601802|NCT02247401|5580886|P2|Overall Study|Adverse Event|0
1601803|NCT02247401|5580887|P1|Overall Study|Adverse Event|1
1601804|NCT02247011|5580934|P1|Overall Study|Poor quality of radiological results|125
1601805|NCT02246998|5580955|P4|Overall Study|Randomized but Never Dosed|1
1601806|NCT02246998|5580956|P3|Overall Study|Randomized but Never Dosed|2
1601807|NCT02246998|5580957|P2|Overall Study|Randomized but Never Dosed|2
1601808|NCT02246998|5580958|P1|Overall Study|Randomized but Never Dosed|1
1601809|NCT02246998|5580955|P4|Overall Study|Lost to Follow-up|1
1601810|NCT02246998|5580956|P3|Overall Study|Lost to Follow-up|0
1601811|NCT02246998|5580957|P2|Overall Study|Lost to Follow-up|0
1601812|NCT02246998|5580958|P1|Overall Study|Lost to Follow-up|1
1601813|NCT02246998|5580955|P4|Overall Study|Adverse Event|0
1601814|NCT02246998|5580956|P3|Overall Study|Adverse Event|1
1601815|NCT02246998|5580957|P2|Overall Study|Adverse Event|1
1601816|NCT02246998|5580958|P1|Overall Study|Adverse Event|0
1601817|NCT02246777|5581068|P1|Overall Study|Change of residence|1
1601818|NCT02246777|5581068|P1|Overall Study|Adverse Event|2
1601819|NCT02246764|5581084|P3|Overall Study|Protocol Violation|1
1601820|NCT02246764|5581085|P2|Overall Study|Protocol Violation|1
1601821|NCT02246764|5581086|P1|Overall Study|Protocol Violation|2
1601822|NCT02246764|5581084|P3|Overall Study|Physician Decision|1
1601823|NCT02246764|5581085|P2|Overall Study|Physician Decision|2
1601824|NCT02246764|5581086|P1|Overall Study|Physician Decision|0
1601825|NCT02246764|5581084|P3|Overall Study|Disallowed Concomitant Medication|0
1601826|NCT02246764|5581085|P2|Overall Study|Disallowed Concomitant Medication|0
1601827|NCT02246764|5581086|P1|Overall Study|Disallowed Concomitant Medication|1
1601828|NCT02246764|5581084|P3|Overall Study|Withdrawal by Subject|1
1601829|NCT02246764|5581085|P2|Overall Study|Withdrawal by Subject|0
1601830|NCT02246764|5581086|P1|Overall Study|Withdrawal by Subject|0
1601831|NCT02246764|5581084|P3|Overall Study|Adverse Event|1
1601832|NCT02246764|5581085|P2|Overall Study|Adverse Event|29
1601833|NCT02246764|5581086|P1|Overall Study|Adverse Event|15
1601834|NCT02246673|5581099|P5|Overall Study|Protocol Violation|0
1601835|NCT02246673|5581100|P4|Overall Study|Protocol Violation|1
1601836|NCT02246673|5581101|P3|Overall Study|Protocol Violation|0
1601837|NCT02246673|5581102|P2|Overall Study|Protocol Violation|0
1601838|NCT02246673|5581103|P1|Overall Study|Protocol Violation|0
1601839|NCT02246673|5581099|P5|Overall Study|Lost to Follow-up|0
1601840|NCT02246673|5581100|P4|Overall Study|Lost to Follow-up|1
1601841|NCT02246673|5581101|P3|Overall Study|Lost to Follow-up|0
1601842|NCT02246673|5581102|P2|Overall Study|Lost to Follow-up|0
1601843|NCT02246673|5581103|P1|Overall Study|Lost to Follow-up|0
1601844|NCT02246673|5581099|P5|Overall Study|Withdrawal by Subject|1
1601845|NCT02246673|5581100|P4|Overall Study|Withdrawal by Subject|0
1601846|NCT02246673|5581101|P3|Overall Study|Withdrawal by Subject|0
1601847|NCT02246673|5581102|P2|Overall Study|Withdrawal by Subject|0
1601848|NCT02246673|5581103|P1|Overall Study|Withdrawal by Subject|0
1601849|NCT02246673|5581099|P5|Overall Study|Sponsor Decision|0
1601850|NCT02246673|5581100|P4|Overall Study|Sponsor Decision|0
1601851|NCT02246673|5581101|P3|Overall Study|Sponsor Decision|0
1601852|NCT02246673|5581102|P2|Overall Study|Sponsor Decision|0
1601853|NCT02246673|5581103|P1|Overall Study|Sponsor Decision|1
1601854|NCT02246660|5581211|P3|Overall Study|Death|1
1601855|NCT02246660|5581212|P2|Overall Study|Death|0
1601856|NCT02246660|5581213|P1|Overall Study|Death|0
1601857|NCT02246660|5581211|P3|Overall Study|Withdrawal by Subject|0
1601858|NCT02246660|5581212|P2|Overall Study|Withdrawal by Subject|1
1601859|NCT02246660|5581213|P1|Overall Study|Withdrawal by Subject|0
1601860|NCT02246647|5581223|P2|Overall Study|Withdrawal by Subject|1
1601861|NCT02246647|5581224|P1|Overall Study|Withdrawal by Subject|1
1601862|NCT02246621|5581258|P2|Overall Study|On Study Treatment/ Follow Up|133
1601863|NCT02246621|5581259|P1|Overall Study|On Study Treatment/ Follow Up|257
1601864|NCT02246621|5581258|P2|Overall Study|Lost to Follow-up|1
1601865|NCT02246621|5581259|P1|Overall Study|Lost to Follow-up|3
1601866|NCT02246621|5581258|P2|Overall Study|Withdrawal by Subject|14
1601867|NCT02246621|5581259|P1|Overall Study|Withdrawal by Subject|36
1601868|NCT02246582|5581296|P2|Overall Study|Withdrawal by Subject|4
1601869|NCT02246582|5581297|P1|Overall Study|Withdrawal by Subject|3
1601870|NCT02246439|5581305|P2|Overall Study|Withdrawal by Subject|0
1601871|NCT02246439|5581306|P1|Overall Study|Withdrawal by Subject|1
1601872|NCT02246439|5581305|P2|Overall Study|Unkonwn|3
1601873|NCT02246439|5581306|P1|Overall Study|Unkonwn|1
1601874|NCT02246439|5581305|P2|Overall Study|Physician Decision|1
1601875|NCT02246439|5581306|P1|Overall Study|Physician Decision|0
1601876|NCT02246439|5581305|P2|Overall Study|Protocol Violation|2
1601877|NCT02246439|5581306|P1|Overall Study|Protocol Violation|0
1601878|NCT02246439|5581305|P2|Overall Study|Lost to Follow-up|5
1601879|NCT02246439|5581306|P1|Overall Study|Lost to Follow-up|7
1601880|NCT02246439|5581305|P2|Overall Study|Adverse Event|0
1601881|NCT02246439|5581306|P1|Overall Study|Adverse Event|3
1601882|NCT02246218|5581357|P2|Overall Study|Lost to Follow-up|0
1601883|NCT02246218|5581358|P1|Overall Study|Lost to Follow-up|1
1601884|NCT02246218|5581357|P2|Overall Study|Adverse Event|1
1601885|NCT02246218|5581358|P1|Overall Study|Adverse Event|1
1601886|NCT02246218|5581357|P2|Overall Study|Stopping Rule: Liver Transplant|4
1601887|NCT02246218|5581358|P1|Overall Study|Stopping Rule: Liver Transplant|2
1601888|NCT02246218|5581357|P2|Overall Study|Withdrawal by Parent/Guardian|1
1601889|NCT02246218|5581358|P1|Overall Study|Withdrawal by Parent/Guardian|0
1601890|NCT02246166|5581418|P2|Overall Study|Protocol Violation|0
1601891|NCT02246166|5581419|P1|Overall Study|Protocol Violation|1
1601892|NCT02246114|5581455|P2|Overall Study|miscarriage|0
1601893|NCT02246114|5581456|P1|Overall Study|miscarriage|1
1601894|NCT02245737|5581507|P3|Overall Study|Sponsor Decision|432
1601895|NCT02245737|5581508|P2|Overall Study|Sponsor Decision|430
1601896|NCT02245737|5581509|P1|Overall Study|Sponsor Decision|445
1601897|NCT02245737|5581507|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
1601898|NCT02245737|5581508|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
1601899|NCT02245737|5581509|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
1601900|NCT02245737|5581507|P3|Overall Study|Withdrawal by Subject|44
1601901|NCT02245737|5581508|P2|Overall Study|Withdrawal by Subject|41
1601902|NCT02245737|5581509|P1|Overall Study|Withdrawal by Subject|40
1601903|NCT02245737|5581507|P3|Overall Study|Protocol Violation|3
1601904|NCT02245737|5581508|P2|Overall Study|Protocol Violation|2
1601905|NCT02245737|5581509|P1|Overall Study|Protocol Violation|3
1601906|NCT02245737|5581507|P3|Overall Study|Physician Decision|6
1601907|NCT02245737|5581508|P2|Overall Study|Physician Decision|3
1601908|NCT02245737|5581509|P1|Overall Study|Physician Decision|6
1601909|NCT02245737|5581507|P3|Overall Study|Other-determined by Investigator|10
1601910|NCT02245737|5581508|P2|Overall Study|Other-determined by Investigator|10
1601911|NCT02245737|5581509|P1|Overall Study|Other-determined by Investigator|9
1601912|NCT02245737|5581507|P3|Overall Study|Lost to Follow-up|4
1601913|NCT02245737|5581508|P2|Overall Study|Lost to Follow-up|5
1601914|NCT02245737|5581509|P1|Overall Study|Lost to Follow-up|2
1601915|NCT02245737|5581507|P3|Overall Study|Initiation of Symptomatic AD medication|0
1601916|NCT02245737|5581508|P2|Overall Study|Initiation of Symptomatic AD medication|0
1601917|NCT02245737|5581509|P1|Overall Study|Initiation of Symptomatic AD medication|2
1601918|NCT02245737|5581507|P3|Overall Study|Eligibility Criteria No Longer Met|4
1601919|NCT02245737|5581508|P2|Overall Study|Eligibility Criteria No Longer Met|4
1601920|NCT02245737|5581509|P1|Overall Study|Eligibility Criteria No Longer Met|2
1601921|NCT02245737|5581507|P3|Overall Study|Death|4
1601922|NCT02245737|5581508|P2|Overall Study|Death|4
1601923|NCT02245737|5581509|P1|Overall Study|Death|2
1601924|NCT02245737|5581507|P3|Overall Study|Condition Worsened|9
1601925|NCT02245737|5581508|P2|Overall Study|Condition Worsened|10
1601926|NCT02245737|5581509|P1|Overall Study|Condition Worsened|9
1601927|NCT02245737|5581507|P3|Overall Study|Adverse Event|33
1601928|NCT02245737|5581508|P2|Overall Study|Adverse Event|26
1601929|NCT02245737|5581509|P1|Overall Study|Adverse Event|23
1601930|NCT02245412|5581567|P3|Follow-Up Period|Other - Terminated by Sponsor|1
1601931|NCT02245412|5581568|P2|Follow-Up Period|Other - Terminated by Sponsor|0
1601932|NCT02245412|5581569|P1|Follow-Up Period|Other - Terminated by Sponsor|0
1601933|NCT02245412|5581567|P3|Follow-Up Period|Physician Decision|0
1601934|NCT02245412|5581568|P2|Follow-Up Period|Physician Decision|0
1601935|NCT02245412|5581569|P1|Follow-Up Period|Physician Decision|1
1601936|NCT02245412|5581567|P3|Follow-Up Period|Death|1
1601937|NCT02245412|5581568|P2|Follow-Up Period|Death|2
1601938|NCT02245412|5581569|P1|Follow-Up Period|Death|4
1601939|NCT02245412|5581567|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
1601940|NCT02245412|5581568|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
1601941|NCT02245412|5581569|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
1601942|NCT02245412|5581567|P3|Treatment Period|Withdrawal by Subject|0
1601943|NCT02245412|5581568|P2|Treatment Period|Withdrawal by Subject|1
1601944|NCT02245412|5581569|P1|Treatment Period|Withdrawal by Subject|2
1601945|NCT02245412|5581567|P3|Treatment Period|Physician Decision|0
1601946|NCT02245412|5581568|P2|Treatment Period|Physician Decision|1
1601947|NCT02245412|5581569|P1|Treatment Period|Physician Decision|1
1601948|NCT02245412|5581567|P3|Treatment Period|Death|0
1601949|NCT02245412|5581568|P2|Treatment Period|Death|1
1601950|NCT02245412|5581569|P1|Treatment Period|Death|1
1601951|NCT02244996|5581616|P2|Overall Study|Lack of Efficacy|6
1601952|NCT02244996|5581617|P1|Overall Study|Lack of Efficacy|2
1601953|NCT02244944|5581629|P1|Overall Study|Study Terminated|1
1601954|NCT02244944|5581629|P1|Overall Study|Withdrawal by Subject|1
1601955|NCT02244619|5581660|P2|Overall Study|Did not receive study intervention|21
1601956|NCT02244619|5581661|P1|Overall Study|Did not receive study intervention|8
1601957|NCT02244580|5581679|P1|Overall Study|No cancer tissues available|241
1601958|NCT02244424|5581689|P2|Overall Study|Lost to Follow-up|10
1601959|NCT02244424|5581690|P1|Overall Study|Lost to Follow-up|20
1601960|NCT02243371|5581735|P2|Overall Study|Withdrawal by Subject|2
1601961|NCT02243371|5581736|P1|Overall Study|Withdrawal by Subject|0
1601962|NCT02243371|5581735|P2|Overall Study|Lack of Clinical Benefit|1
1601963|NCT02243371|5581736|P1|Overall Study|Lack of Clinical Benefit|0
1601964|NCT02243371|5581735|P2|Overall Study|Adverse Event (unrelated)|1
1601965|NCT02243371|5581736|P1|Overall Study|Adverse Event (unrelated)|0
1601966|NCT02243371|5581735|P2|Overall Study|Death (unrelated)|4
1601967|NCT02243371|5581736|P1|Overall Study|Death (unrelated)|2
1601968|NCT02243371|5581735|P2|Overall Study|Progressive Disease (clinic & radio)|24
1601969|NCT02243371|5581736|P1|Overall Study|Progressive Disease (clinic & radio)|35
1601970|NCT02243306|5581756|P2|Overall Study|Physician Decision|1
1601971|NCT02243306|5581757|P1|Overall Study|Physician Decision|0
1601972|NCT02243306|5581756|P2|Overall Study|Other: Reached stopping criteria|1
1601973|NCT02243306|5581757|P1|Overall Study|Other: Reached stopping criteria|0
1601974|NCT02243306|5581756|P2|Overall Study|Adverse Event|1
1601975|NCT02243306|5581757|P1|Overall Study|Adverse Event|0
1601976|NCT02243293|5581832|P22|Overall Study|Randomized but did'nt receive study drug|0
1601977|NCT02243293|5581833|P21|Overall Study|Randomized but did'nt receive study drug|0
1601978|NCT02243293|5581834|P20|Overall Study|Randomized but did'nt receive study drug|1
1601979|NCT02243293|5581835|P19|Overall Study|Randomized but did'nt receive study drug|0
1601980|NCT02243293|5581836|P18|Overall Study|Randomized but did'nt receive study drug|0
1601981|NCT02243293|5581837|P17|Overall Study|Randomized but did'nt receive study drug|0
1601982|NCT02243293|5581838|P16|Overall Study|Randomized but did'nt receive study drug|0
1601983|NCT02243293|5581839|P15|Overall Study|Randomized but did'nt receive study drug|0
1601984|NCT02243293|5581840|P14|Overall Study|Randomized but did'nt receive study drug|0
1601985|NCT02243293|5581841|P13|Overall Study|Randomized but did'nt receive study drug|0
1601986|NCT02243293|5581842|P12|Overall Study|Randomized but did'nt receive study drug|0
1601987|NCT02243293|5581843|P11|Overall Study|Randomized but did'nt receive study drug|0
1601988|NCT02243293|5581844|P10|Overall Study|Randomized but did'nt receive study drug|1
1601989|NCT02243293|5581845|P9|Overall Study|Randomized but did'nt receive study drug|0
1601990|NCT02243293|5581846|P8|Overall Study|Randomized but did'nt receive study drug|0
1601991|NCT02243293|5581847|P7|Overall Study|Randomized but did'nt receive study drug|0
1601992|NCT02243293|5581848|P6|Overall Study|Randomized but did'nt receive study drug|0
1601993|NCT02243293|5581849|P5|Overall Study|Randomized but did'nt receive study drug|1
1601994|NCT02243293|5581850|P4|Overall Study|Randomized but did'nt receive study drug|0
1601995|NCT02243293|5581851|P3|Overall Study|Randomized but did'nt receive study drug|0
1601996|NCT02243293|5581852|P2|Overall Study|Randomized but did'nt receive study drug|0
1601997|NCT02243293|5581853|P1|Overall Study|Randomized but did'nt receive study drug|0
1601998|NCT02243293|5581832|P22|Overall Study|Enrolled into a Re-treatment Study|0
1601999|NCT02243293|5581833|P21|Overall Study|Enrolled into a Re-treatment Study|0
1602000|NCT02243293|5581834|P20|Overall Study|Enrolled into a Re-treatment Study|0
1602001|NCT02243293|5581835|P19|Overall Study|Enrolled into a Re-treatment Study|0
1602002|NCT02243293|5581836|P18|Overall Study|Enrolled into a Re-treatment Study|0
1602003|NCT02243293|5581837|P17|Overall Study|Enrolled into a Re-treatment Study|0
1602004|NCT02243293|5581838|P16|Overall Study|Enrolled into a Re-treatment Study|0
1602005|NCT02243293|5581839|P15|Overall Study|Enrolled into a Re-treatment Study|1
1602006|NCT02243293|5581840|P14|Overall Study|Enrolled into a Re-treatment Study|0
1602007|NCT02243293|5581841|P13|Overall Study|Enrolled into a Re-treatment Study|0
1602008|NCT02243293|5581842|P12|Overall Study|Enrolled into a Re-treatment Study|0
1602009|NCT02243293|5581843|P11|Overall Study|Enrolled into a Re-treatment Study|0
1602010|NCT02243293|5581844|P10|Overall Study|Enrolled into a Re-treatment Study|0
1602011|NCT02243293|5581845|P9|Overall Study|Enrolled into a Re-treatment Study|0
1602012|NCT02243293|5581846|P8|Overall Study|Enrolled into a Re-treatment Study|0
1602013|NCT02243293|5581847|P7|Overall Study|Enrolled into a Re-treatment Study|0
1602014|NCT02243293|5581848|P6|Overall Study|Enrolled into a Re-treatment Study|0
1602015|NCT02243293|5581849|P5|Overall Study|Enrolled into a Re-treatment Study|0
1602016|NCT02243293|5581850|P4|Overall Study|Enrolled into a Re-treatment Study|0
1602017|NCT02243293|5581851|P3|Overall Study|Enrolled into a Re-treatment Study|0
1602018|NCT02243293|5581852|P2|Overall Study|Enrolled into a Re-treatment Study|0
1602019|NCT02243293|5581853|P1|Overall Study|Enrolled into a Re-treatment Study|0
1602020|NCT02243293|5581832|P22|Overall Study|Lost to Follow-up|2
1602021|NCT02243293|5581833|P21|Overall Study|Lost to Follow-up|1
1602022|NCT02243293|5581834|P20|Overall Study|Lost to Follow-up|0
1602023|NCT02243293|5581835|P19|Overall Study|Lost to Follow-up|0
1602024|NCT02243293|5581836|P18|Overall Study|Lost to Follow-up|1
1602025|NCT02243293|5581837|P17|Overall Study|Lost to Follow-up|3
1602026|NCT02243293|5581838|P16|Overall Study|Lost to Follow-up|0
1602027|NCT02243293|5581839|P15|Overall Study|Lost to Follow-up|0
1602028|NCT02243293|5581840|P14|Overall Study|Lost to Follow-up|0
1602029|NCT02243293|5581841|P13|Overall Study|Lost to Follow-up|0
1602030|NCT02243293|5581842|P12|Overall Study|Lost to Follow-up|2
1602031|NCT02243293|5581843|P11|Overall Study|Lost to Follow-up|0
1602032|NCT02243293|5581844|P10|Overall Study|Lost to Follow-up|0
1602033|NCT02243293|5581845|P9|Overall Study|Lost to Follow-up|0
1602034|NCT02243293|5581846|P8|Overall Study|Lost to Follow-up|0
1602035|NCT02243293|5581847|P7|Overall Study|Lost to Follow-up|3
1602036|NCT02243293|5581848|P6|Overall Study|Lost to Follow-up|0
1602037|NCT02243293|5581849|P5|Overall Study|Lost to Follow-up|0
1602038|NCT02243293|5581850|P4|Overall Study|Lost to Follow-up|1
1602039|NCT02243293|5581851|P3|Overall Study|Lost to Follow-up|1
1602040|NCT02243293|5581852|P2|Overall Study|Lost to Follow-up|1
1602041|NCT02243293|5581853|P1|Overall Study|Lost to Follow-up|0
1602042|NCT02243293|5581832|P22|Overall Study|Withdrawal by Subject|1
1602043|NCT02243293|5581833|P21|Overall Study|Withdrawal by Subject|0
1602044|NCT02243293|5581834|P20|Overall Study|Withdrawal by Subject|0
1602045|NCT02243293|5581835|P19|Overall Study|Withdrawal by Subject|0
1602046|NCT02243293|5581836|P18|Overall Study|Withdrawal by Subject|0
1602047|NCT02243293|5581837|P17|Overall Study|Withdrawal by Subject|0
1602048|NCT02243293|5581838|P16|Overall Study|Withdrawal by Subject|0
1602049|NCT02243293|5581839|P15|Overall Study|Withdrawal by Subject|0
1602050|NCT02243293|5581840|P14|Overall Study|Withdrawal by Subject|0
1602051|NCT02243293|5581841|P13|Overall Study|Withdrawal by Subject|0
1602052|NCT02243293|5581842|P12|Overall Study|Withdrawal by Subject|1
1602053|NCT02243293|5581843|P11|Overall Study|Withdrawal by Subject|0
1602054|NCT02243293|5581844|P10|Overall Study|Withdrawal by Subject|1
1602055|NCT02243293|5581845|P9|Overall Study|Withdrawal by Subject|0
1602056|NCT02243293|5581846|P8|Overall Study|Withdrawal by Subject|0
1602057|NCT02243293|5581847|P7|Overall Study|Withdrawal by Subject|0
1602058|NCT02243293|5581848|P6|Overall Study|Withdrawal by Subject|0
1602059|NCT02243293|5581849|P5|Overall Study|Withdrawal by Subject|0
1602060|NCT02243293|5581850|P4|Overall Study|Withdrawal by Subject|0
1602061|NCT02243293|5581851|P3|Overall Study|Withdrawal by Subject|0
1602062|NCT02243293|5581852|P2|Overall Study|Withdrawal by Subject|0
1602063|NCT02243293|5581853|P1|Overall Study|Withdrawal by Subject|1
1602064|NCT02243293|5581832|P22|Overall Study|Adverse Event|0
1602065|NCT02243293|5581833|P21|Overall Study|Adverse Event|1
1602066|NCT02243293|5581834|P20|Overall Study|Adverse Event|0
1602067|NCT02243293|5581835|P19|Overall Study|Adverse Event|0
1602068|NCT02243293|5581836|P18|Overall Study|Adverse Event|0
1602069|NCT02243293|5581837|P17|Overall Study|Adverse Event|0
1602070|NCT02243293|5581838|P16|Overall Study|Adverse Event|1
1602071|NCT02243293|5581839|P15|Overall Study|Adverse Event|0
1602072|NCT02243293|5581840|P14|Overall Study|Adverse Event|0
1602073|NCT02243293|5581841|P13|Overall Study|Adverse Event|0
1602074|NCT02243293|5581842|P12|Overall Study|Adverse Event|0
1602075|NCT02243293|5581843|P11|Overall Study|Adverse Event|0
1602076|NCT02243293|5581844|P10|Overall Study|Adverse Event|0
1602077|NCT02243293|5581845|P9|Overall Study|Adverse Event|0
1602078|NCT02243293|5581846|P8|Overall Study|Adverse Event|0
1602079|NCT02243293|5581847|P7|Overall Study|Adverse Event|0
1602080|NCT02243293|5581848|P6|Overall Study|Adverse Event|0
1602081|NCT02243293|5581849|P5|Overall Study|Adverse Event|0
1602082|NCT02243293|5581850|P4|Overall Study|Adverse Event|0
1602083|NCT02243293|5581851|P3|Overall Study|Adverse Event|0
1602084|NCT02243293|5581852|P2|Overall Study|Adverse Event|0
1602085|NCT02243293|5581853|P1|Overall Study|Adverse Event|1
1602086|NCT02243280|5581952|P11|Treated|Lost to Follow-up|2
1602087|NCT02243280|5581953|P10|Treated|Lost to Follow-up|0
1602088|NCT02243280|5581954|P9|Treated|Lost to Follow-up|1
1602089|NCT02243280|5581955|P8|Treated|Lost to Follow-up|0
1602090|NCT02243280|5581956|P7|Treated|Lost to Follow-up|0
1602091|NCT02243280|5581957|P6|Treated|Lost to Follow-up|0
1602092|NCT02243280|5581958|P5|Treated|Lost to Follow-up|0
1602093|NCT02243280|5581959|P4|Treated|Lost to Follow-up|0
1602094|NCT02243280|5581960|P3|Treated|Lost to Follow-up|0
1602095|NCT02243280|5581961|P2|Treated|Lost to Follow-up|0
1602096|NCT02243280|5581962|P1|Treated|Lost to Follow-up|0
1602097|NCT02243280|5581952|P11|Treated|Adverse Event|1
1602098|NCT02243280|5581953|P10|Treated|Adverse Event|0
1602099|NCT02243280|5581954|P9|Treated|Adverse Event|0
1602100|NCT02243280|5581955|P8|Treated|Adverse Event|0
1602101|NCT02243280|5581956|P7|Treated|Adverse Event|0
1602102|NCT02243280|5581957|P6|Treated|Adverse Event|0
1602103|NCT02243280|5581958|P5|Treated|Adverse Event|0
1602104|NCT02243280|5581959|P4|Treated|Adverse Event|0
1602105|NCT02243280|5581960|P3|Treated|Adverse Event|0
1602106|NCT02243280|5581961|P2|Treated|Adverse Event|0
1602107|NCT02243280|5581962|P1|Treated|Adverse Event|1
1602108|NCT02243202|5582017|P4|Overall Study|Randomized but not received treatment|1
1602109|NCT02243202|5582018|P3|Overall Study|Randomized but not received treatment|0
1602110|NCT02243202|5582019|P2|Overall Study|Randomized but not received treatment|0
1602111|NCT02243202|5582020|P1|Overall Study|Randomized but not received treatment|0
1602112|NCT02243202|5582017|P4|Overall Study|Other|2
1602113|NCT02243202|5582018|P3|Overall Study|Other|1
1602114|NCT02243202|5582019|P2|Overall Study|Other|3
1602115|NCT02243202|5582020|P1|Overall Study|Other|1
1602116|NCT02243202|5582017|P4|Overall Study|Withdrawal by Subject|4
1602117|NCT02243202|5582018|P3|Overall Study|Withdrawal by Subject|4
1602118|NCT02243202|5582019|P2|Overall Study|Withdrawal by Subject|6
1602119|NCT02243202|5582020|P1|Overall Study|Withdrawal by Subject|7
1602120|NCT02243202|5582017|P4|Overall Study|Protocol Violation|1
1602121|NCT02243202|5582018|P3|Overall Study|Protocol Violation|2
1602122|NCT02243202|5582019|P2|Overall Study|Protocol Violation|1
1602123|NCT02243202|5582020|P1|Overall Study|Protocol Violation|3
1602124|NCT02243202|5582017|P4|Overall Study|Lost to Follow-up|11
1602125|NCT02243202|5582018|P3|Overall Study|Lost to Follow-up|14
1602126|NCT02243202|5582019|P2|Overall Study|Lost to Follow-up|9
1602127|NCT02243202|5582020|P1|Overall Study|Lost to Follow-up|9
1602128|NCT02243202|5582017|P4|Overall Study|Adverse Event|4
1602129|NCT02243202|5582018|P3|Overall Study|Adverse Event|10
1602130|NCT02243202|5582019|P2|Overall Study|Adverse Event|6
1602131|NCT02243202|5582020|P1|Overall Study|Adverse Event|5
1602132|NCT02243176|5582056|P2|Overall Study|Adverse Event|2
1602133|NCT02243176|5582057|P1|Overall Study|Adverse Event|2
1602134|NCT02243176|5582056|P2|Overall Study|Withdrawal by Subject|7
1602135|NCT02243176|5582057|P1|Overall Study|Withdrawal by Subject|8
1602136|NCT02243176|5582056|P2|Overall Study|Protocol Violation|1
1602137|NCT02243176|5582057|P1|Overall Study|Protocol Violation|2
1602138|NCT02243176|5582056|P2|Overall Study|protocol specified withdrawal critera|3
1602139|NCT02243176|5582057|P1|Overall Study|protocol specified withdrawal critera|1
1602140|NCT02243176|5582056|P2|Overall Study|Other reason|2
1602141|NCT02243176|5582057|P1|Overall Study|Other reason|1
1602142|NCT02243046|5582082|P3|Overall Study|Lost to Follow-up|4
1602143|NCT02243046|5582083|P2|Overall Study|Lost to Follow-up|1
1602144|NCT02243046|5582084|P1|Overall Study|Lost to Follow-up|1
1602145|NCT02242942|5582151|P3|Overall Study|On-going in Study|11
1602146|NCT02242942|5582152|P2|Overall Study|On-going in Study|186
1602147|NCT02242942|5582153|P1|Overall Study|On-going in Study|190
1602148|NCT02242942|5582151|P3|Overall Study|Withdrawal by Subject|0
1602149|NCT02242942|5582152|P2|Overall Study|Withdrawal by Subject|10
1602150|NCT02242942|5582153|P1|Overall Study|Withdrawal by Subject|8
1602151|NCT02242942|5582151|P3|Overall Study|Physician Decision|0
1602152|NCT02242942|5582152|P2|Overall Study|Physician Decision|0
1602153|NCT02242942|5582153|P1|Overall Study|Physician Decision|1
1602154|NCT02242942|5582151|P3|Overall Study|Death|2
1602155|NCT02242942|5582152|P2|Overall Study|Death|20
1602156|NCT02242942|5582153|P1|Overall Study|Death|17
1602157|NCT02242903|5582187|P7|Overall Study|Withdrawal by Subject|0
1602158|NCT02242903|5582188|P6|Overall Study|Withdrawal by Subject|0
1602159|NCT02242903|5582189|P5|Overall Study|Withdrawal by Subject|0
1602160|NCT02242903|5582190|P4|Overall Study|Withdrawal by Subject|0
1602161|NCT02242903|5582191|P3|Overall Study|Withdrawal by Subject|0
1602162|NCT02242903|5582192|P2|Overall Study|Withdrawal by Subject|0
1602163|NCT02242903|5582193|P1|Overall Study|Withdrawal by Subject|1
1602164|NCT02242643|5582223|P2|Overall Study|Withdrawal by subject at Visit 2|1
1602165|NCT02242643|5582224|P1|Overall Study|Withdrawal by subject at Visit 2|0
1602166|NCT02242643|5582223|P2|Overall Study|Language barrier|0
1602167|NCT02242643|5582224|P1|Overall Study|Language barrier|1
1602168|NCT02242643|5582223|P2|Overall Study|Protocol requirements not followed|0
1602169|NCT02242643|5582224|P1|Overall Study|Protocol requirements not followed|1
1602170|NCT02242643|5582223|P2|Overall Study|Consent withdrawal by parent|0
1602171|NCT02242643|5582224|P1|Overall Study|Consent withdrawal by parent|1
1602172|NCT02242643|5582223|P2|Overall Study|Non-compliance|0
1602173|NCT02242643|5582224|P1|Overall Study|Non-compliance|1
1602174|NCT02242643|5582223|P2|Overall Study|Child placed in foster care by family|1
1602175|NCT02242643|5582224|P1|Overall Study|Child placed in foster care by family|0
1602176|NCT02242643|5582223|P2|Overall Study|Lost to Follow-up|61
1602177|NCT02242643|5582224|P1|Overall Study|Lost to Follow-up|54
1602178|NCT02242643|5582223|P2|Overall Study|Migrated/moved from study area|3
1602179|NCT02242643|5582224|P1|Overall Study|Migrated/moved from study area|1
1602180|NCT02242643|5582223|P2|Overall Study|Withdrawal by Subject|10
1602181|NCT02242643|5582224|P1|Overall Study|Withdrawal by Subject|15
1602182|NCT02242643|5582223|P2|Overall Study|Protocol Violation|2
1602183|NCT02242643|5582224|P1|Overall Study|Protocol Violation|1
1602184|NCT02242487|5582279|P2|Overall Study|Withdrawal by Subject|19
1602185|NCT02242487|5582280|P1|Overall Study|Withdrawal by Subject|37
1602186|NCT02242487|5582279|P2|Overall Study|Other - Miscellaneous|6
1602187|NCT02242487|5582280|P1|Overall Study|Other - Miscellaneous|4
1602188|NCT02242487|5582279|P2|Overall Study|Lost to Follow-up|1
1602189|NCT02242487|5582280|P1|Overall Study|Lost to Follow-up|2
1602190|NCT02242487|5582279|P2|Overall Study|Protocol Violation|0
1602191|NCT02242487|5582280|P1|Overall Study|Protocol Violation|2
1602192|NCT02242487|5582279|P2|Overall Study|Lack of Efficacy|6
1602193|NCT02242487|5582280|P1|Overall Study|Lack of Efficacy|4
1602194|NCT02242487|5582279|P2|Overall Study|Adverse Event|15
1602195|NCT02242487|5582280|P1|Overall Study|Adverse Event|13
1602196|NCT02242305|5582296|P2|Overall Study|Lost to Follow-up|0
1602197|NCT02242305|5582297|P1|Overall Study|Lost to Follow-up|2
1602198|NCT02242305|5582296|P2|Overall Study|Subject withdraws inform consent|4
1602199|NCT02242305|5582297|P1|Overall Study|Subject withdraws inform consent|0
1602200|NCT02242305|5582296|P2|Overall Study|Non-compliance dosing regimen or visit|2
1602201|NCT02242305|5582297|P1|Overall Study|Non-compliance dosing regimen or visit|2
1602202|NCT02242305|5582296|P2|Overall Study|Adverse Event|0
1602203|NCT02242305|5582297|P1|Overall Study|Adverse Event|1
1602204|NCT02242305|5582296|P2|Overall Study|Without spasm-like pain during 3 weeks|4
1602205|NCT02242305|5582297|P1|Overall Study|Without spasm-like pain during 3 weeks|1
1602206|NCT02242201|5582318|P3|Overall Study|preoperative opioid consumption|0
1602207|NCT02242201|5582319|P2|Overall Study|preoperative opioid consumption|1
1602208|NCT02242201|5582320|P1|Overall Study|preoperative opioid consumption|0
1602209|NCT02242201|5582318|P3|Overall Study|postponed surgery|1
1602210|NCT02242201|5582319|P2|Overall Study|postponed surgery|0
1602211|NCT02242201|5582320|P1|Overall Study|postponed surgery|0
1602212|NCT02242201|5582318|P3|Overall Study|changed surgical procedure|0
1602213|NCT02242201|5582319|P2|Overall Study|changed surgical procedure|0
1602214|NCT02242201|5582320|P1|Overall Study|changed surgical procedure|1
1602215|NCT02242201|5582318|P3|Overall Study|planned post-op anticoagulation|0
1602216|NCT02242201|5582319|P2|Overall Study|planned post-op anticoagulation|0
1602217|NCT02242201|5582320|P1|Overall Study|planned post-op anticoagulation|1
1602218|NCT02242201|5582318|P3|Overall Study|preoperative identified neuropathy|0
1602219|NCT02242201|5582319|P2|Overall Study|preoperative identified neuropathy|0
1602220|NCT02242201|5582320|P1|Overall Study|preoperative identified neuropathy|2
1602221|NCT02241889|5582358|P6|Overall Study|Withdrawal by Subject|1
1602222|NCT02241889|5582359|P5|Overall Study|Withdrawal by Subject|0
1602223|NCT02241889|5582360|P4|Overall Study|Withdrawal by Subject|0
1602224|NCT02241889|5582361|P3|Overall Study|Withdrawal by Subject|0
1602225|NCT02241889|5582362|P2|Overall Study|Withdrawal by Subject|0
1602226|NCT02241889|5582363|P1|Overall Study|Withdrawal by Subject|0
1602227|NCT02241889|5582358|P6|Overall Study|device issues|0
1602228|NCT02241889|5582359|P5|Overall Study|device issues|0
1602229|NCT02241889|5582360|P4|Overall Study|device issues|0
1602230|NCT02241889|5582361|P3|Overall Study|device issues|1
1602231|NCT02241889|5582362|P2|Overall Study|device issues|0
1602232|NCT02241889|5582363|P1|Overall Study|device issues|0
1602233|NCT02241785|5582398|P1|Overall Study|Adverse Event|1
1602234|NCT02241785|5582398|P1|Overall Study|Lost to Follow-up|2
1602235|NCT02241785|5582398|P1|Overall Study|Withdrawal by Subject|1
1602236|NCT02241785|5582398|P1|Overall Study|Sponsor Termination|43
1602237|NCT02241733|5582408|P2|Overall Study|Death|2
1602238|NCT02241733|5582409|P1|Overall Study|Death|0
1602239|NCT02241733|5582408|P2|Overall Study|Withdrawal by Subject|2
1602240|NCT02241733|5582409|P1|Overall Study|Withdrawal by Subject|0
1602241|NCT02241733|5582408|P2|Overall Study|Physician Decision|2
1602242|NCT02241733|5582409|P1|Overall Study|Physician Decision|6
1602243|NCT02241733|5582408|P2|Overall Study|Lost to Follow-up|4
1602244|NCT02241733|5582409|P1|Overall Study|Lost to Follow-up|9
1602245|NCT02241551|5582448|P2|Overall Study|Adverse Event|0
1602246|NCT02241551|5582449|P1|Overall Study|Adverse Event|1
1602249|NCT02241187|5582488|P1|Overall Study|Protocol closed due to lack of accrual.|2
1602250|NCT02240693|5582520|P5|Overall Study|Other than specified|0
1602251|NCT02240693|5582521|P4|Overall Study|Other than specified|0
1602252|NCT02240693|5582522|P3|Overall Study|Other than specified|2
1602253|NCT02240693|5582523|P2|Overall Study|Other than specified|0
1602254|NCT02240693|5582524|P1|Overall Study|Other than specified|0
1602255|NCT02240693|5582520|P5|Overall Study|Withdrawal by Subject|0
1602256|NCT02240693|5582521|P4|Overall Study|Withdrawal by Subject|1
1602257|NCT02240693|5582522|P3|Overall Study|Withdrawal by Subject|2
1602258|NCT02240693|5582523|P2|Overall Study|Withdrawal by Subject|0
1602259|NCT02240693|5582524|P1|Overall Study|Withdrawal by Subject|0
1602260|NCT02240693|5582520|P5|Overall Study|Adverse Event|1
1602261|NCT02240693|5582521|P4|Overall Study|Adverse Event|0
1602262|NCT02240693|5582522|P3|Overall Study|Adverse Event|0
1602263|NCT02240693|5582523|P2|Overall Study|Adverse Event|0
1602264|NCT02240693|5582524|P1|Overall Study|Adverse Event|0
1602265|NCT02240680|5582560|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1602266|NCT02240680|5582561|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
1602267|NCT02240680|5582562|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1602268|NCT02240680|5582563|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
1602269|NCT02240680|5582560|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1602270|NCT02240680|5582561|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
1602271|NCT02240680|5582562|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1602272|NCT02240680|5582563|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
1602273|NCT02240680|5582560|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
1602274|NCT02240680|5582561|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
1602275|NCT02240680|5582562|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1602276|NCT02240680|5582563|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
1602277|NCT02240680|5582560|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
1602278|NCT02240680|5582561|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
1602279|NCT02240680|5582562|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
1602280|NCT02240680|5582563|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
1602281|NCT02240680|5582560|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1602282|NCT02240680|5582561|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
1602283|NCT02240680|5582562|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
1602284|NCT02240680|5582563|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
1602285|NCT02240680|5582560|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1602286|NCT02240680|5582561|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1602287|NCT02240680|5582562|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
1602288|NCT02240680|5582563|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
1602289|NCT02240680|5582560|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1602290|NCT02240680|5582561|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
1602291|NCT02240680|5582562|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
1602292|NCT02240680|5582563|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
1602293|NCT02240680|5582560|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
1602294|NCT02240680|5582561|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
1602295|NCT02240680|5582562|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
1602296|NCT02240680|5582563|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
1602297|NCT02240628|5582617|P2|Overall Study|Physician Decision|5
1602298|NCT02240628|5582618|P1|Overall Study|Physician Decision|6
1602299|NCT02240368|5582652|P3|Overall Study|Entropy failed to detect more than 50%|1
1602300|NCT02240368|5582653|P2|Overall Study|Entropy failed to detect more than 50%|0
1602301|NCT02240368|5582654|P1|Overall Study|Entropy failed to detect more than 50%|0
1602302|NCT02240368|5582652|P3|Overall Study|Surgery lasted less then 20 minutes|0
1602303|NCT02240368|5582653|P2|Overall Study|Surgery lasted less then 20 minutes|0
1602304|NCT02240368|5582654|P1|Overall Study|Surgery lasted less then 20 minutes|1
1602305|NCT02240121|5582686|P2|Overall Study|Other than specified|3
1602306|NCT02240121|5582687|P1|Overall Study|Other than specified|1
1602307|NCT02240121|5582686|P2|Overall Study|Lost to Follow-up|4
1602308|NCT02240121|5582687|P1|Overall Study|Lost to Follow-up|3
1602309|NCT02240121|5582686|P2|Overall Study|Withdrawal by Subject|2
1602310|NCT02240121|5582687|P1|Overall Study|Withdrawal by Subject|6
1602311|NCT02240121|5582686|P2|Overall Study|Adverse Event|4
1602312|NCT02240121|5582687|P1|Overall Study|Adverse Event|2
1602313|NCT02240121|5582686|P2|Overall Study|Pregnancy|0
1602314|NCT02240121|5582687|P1|Overall Study|Pregnancy|1
1602315|NCT02240121|5582686|P2|Overall Study|Site closed|1
1602316|NCT02240121|5582687|P1|Overall Study|Site closed|1
1602317|NCT02240121|5582686|P2|Overall Study|Lack of Efficacy|3
1602318|NCT02240121|5582687|P1|Overall Study|Lack of Efficacy|2
1602319|NCT02240121|5582686|P2|Overall Study|Change in protocol interpretation|0
1602320|NCT02240121|5582687|P1|Overall Study|Change in protocol interpretation|1
1602321|NCT02240121|5582686|P2|Overall Study|Physician Decision|1
1602322|NCT02240121|5582687|P1|Overall Study|Physician Decision|0
1602323|NCT02240121|5582686|P2|Overall Study|Protocol Violation|2
1602324|NCT02240121|5582687|P1|Overall Study|Protocol Violation|1
1602325|NCT02240108|5582715|P2|Overall Study|StudyTerminated by Sponsor|1
1602326|NCT02240108|5582716|P1|Overall Study|StudyTerminated by Sponsor|0
1602327|NCT02240108|5582715|P2|Overall Study|Withdrawal by Subject|9
1602328|NCT02240108|5582716|P1|Overall Study|Withdrawal by Subject|4
1602329|NCT02240108|5582715|P2|Overall Study|Pregnancy|0
1602330|NCT02240108|5582716|P1|Overall Study|Pregnancy|1
1602331|NCT02240108|5582715|P2|Overall Study|Adverse Event|9
1602332|NCT02240108|5582716|P1|Overall Study|Adverse Event|1
1602333|NCT02240108|5582715|P2|Overall Study|Other than specified|6
1602334|NCT02240108|5582716|P1|Overall Study|Other than specified|8
1602335|NCT02239978|5582771|P2|Overall Study|Withdrawal by Subject|0
1602336|NCT02239978|5582772|P1|Overall Study|Withdrawal by Subject|2
1602337|NCT02239939|5582789|P2|Overall Study|Lost to Follow-up|1
1602338|NCT02239939|5582790|P1|Overall Study|Lost to Follow-up|0
1602339|NCT02239939|5582789|P2|Overall Study|Withdrawal by Subject|1
1602340|NCT02239939|5582790|P1|Overall Study|Withdrawal by Subject|1
1602341|NCT02239939|5582789|P2|Overall Study|Adverse Event|0
1602342|NCT02239939|5582790|P1|Overall Study|Adverse Event|1
1602343|NCT02239926|5582806|P2|Overall Study|Withdrawal by Subject|1
1602344|NCT02239926|5582807|P1|Overall Study|Withdrawal by Subject|0
1602345|NCT02239692|5582869|P2|Overall Study|Other reason|0
1602346|NCT02239692|5582870|P1|Overall Study|Other reason|1
1602347|NCT02239692|5582869|P2|Overall Study|Withdrawal by Subject|5
1602348|NCT02239692|5582870|P1|Overall Study|Withdrawal by Subject|3
1602349|NCT02239692|5582869|P2|Overall Study|Lost to Follow-up|4
1602350|NCT02239692|5582870|P1|Overall Study|Lost to Follow-up|1
1602351|NCT02239692|5582869|P2|Overall Study|Physician Decision|1
1602352|NCT02239692|5582870|P1|Overall Study|Physician Decision|0
1602353|NCT02239692|5582869|P2|Overall Study|Adverse Event|1
1602354|NCT02239692|5582870|P1|Overall Study|Adverse Event|0
1602355|NCT02239692|5582869|P2|Overall Study|Incomplete colonoscopy|2
1602356|NCT02239692|5582870|P1|Overall Study|Incomplete colonoscopy|1
1602357|NCT02239679|5582889|P3|Overall Study|Withdrawal by Subject|1
1602358|NCT02239679|5582890|P2|Overall Study|Withdrawal by Subject|3
1602359|NCT02239679|5582891|P1|Overall Study|Withdrawal by Subject|2
1602360|NCT02239679|5582889|P3|Overall Study|Lost to Follow-up|0
1602361|NCT02239679|5582890|P2|Overall Study|Lost to Follow-up|0
1602362|NCT02239679|5582891|P1|Overall Study|Lost to Follow-up|1
1602363|NCT02239640|5583103|P1|Overall Study|Death|142
1602364|NCT02239640|5583103|P1|Overall Study|Lost to Follow-up|72
1602365|NCT02239640|5583103|P1|Overall Study|Withdrawal by Subject|3
1602366|NCT02239601|5583115|P2|Overall Study|Protocol Violation|2
1602367|NCT02239601|5583116|P1|Overall Study|Protocol Violation|4
1602368|NCT02239601|5583115|P2|Overall Study|Withdrawal by Subject|4
1602369|NCT02239601|5583116|P1|Overall Study|Withdrawal by Subject|3
1602370|NCT02239510|5583169|P2|Overall Study|Lost to Follow-up|1
1602371|NCT02239510|5583170|P1|Overall Study|Lost to Follow-up|2
1602372|NCT02239328|5583192|P1|Overall Study|Equipment or website malfunction|2
1602373|NCT02239328|5583192|P1|Overall Study|Benign disease noted at time of surgery|6
1602374|NCT02239120|5583217|P2|Overall Study|Lost to Follow-up|14
1602375|NCT02239120|5583218|P1|Overall Study|Lost to Follow-up|19
1602376|NCT02239120|5583217|P2|Overall Study|Death|58
1602377|NCT02239120|5583218|P1|Overall Study|Death|56
1602378|NCT02239094|5583242|P1|Overall Study|Remitted before started|1
1602379|NCT02239094|5583242|P1|Overall Study|Withdrawal by Subject|1
1602380|NCT02238483|5583297|P2|Overall Study|Illness in family member|0
1602381|NCT02238483|5583298|P1|Overall Study|Illness in family member|1
1602382|NCT02238483|5583297|P2|Overall Study|Completion status not recorded|1
1602383|NCT02238483|5583298|P1|Overall Study|Completion status not recorded|1
1602384|NCT02238483|5583297|P2|Overall Study|Withdrawn due to physician decision|0
1602385|NCT02238483|5583298|P1|Overall Study|Withdrawn due to physician decision|1
1602386|NCT02238483|5583297|P2|Overall Study|Adverse Event|3
1602387|NCT02238483|5583298|P1|Overall Study|Adverse Event|7
1602388|NCT02238483|5583297|P2|Overall Study|Death|0
1602389|NCT02238483|5583298|P1|Overall Study|Death|1
1602390|NCT02238483|5583297|P2|Overall Study|Protocol Violation|2
1602391|NCT02238483|5583298|P1|Overall Study|Protocol Violation|1
1602392|NCT02238483|5583297|P2|Overall Study|Lost to Follow-up|1
1602393|NCT02238483|5583298|P1|Overall Study|Lost to Follow-up|1
1602394|NCT02238483|5583297|P2|Overall Study|Withdrawal by Subject|7
1602395|NCT02238483|5583298|P1|Overall Study|Withdrawal by Subject|2
1602396|NCT02238379|5583336|P2|Overall Study|Lost to Follow-up|0
1602397|NCT02238379|5583337|P1|Overall Study|Lost to Follow-up|1
1602398|NCT02238080|5583363|P1|Overall Study|Other|4
1602399|NCT02238080|5583363|P1|Overall Study|Withdrawal by Subject|2
1602400|NCT02238080|5583363|P1|Overall Study|Treatment interrupted|6
1602401|NCT02238080|5583363|P1|Overall Study|Death|13
1602402|NCT02238067|5583377|P1|Overall Study|Not completed survey at Month 6|45
1602403|NCT02237911|5583448|P3|Overall Study|Lost to Follow-up|1
1602404|NCT02237911|5583449|P2|Overall Study|Lost to Follow-up|1
1602405|NCT02237911|5583450|P1|Overall Study|Lost to Follow-up|3
1602406|NCT02237911|5583448|P3|Overall Study|Withdrawal by Subject|2
1602407|NCT02237911|5583449|P2|Overall Study|Withdrawal by Subject|7
1602408|NCT02237911|5583450|P1|Overall Study|Withdrawal by Subject|4
1602409|NCT02237118|5583466|P2|Overall Study|consent withdrawn|0
1602410|NCT02237118|5583467|P1|Overall Study|consent withdrawn|1
1602411|NCT02237118|5583466|P2|Overall Study|Protocol Violation|1
1602412|NCT02237118|5583467|P1|Overall Study|Protocol Violation|0
1602413|NCT02236611|5583504|P2|Overall Study|Withdrew consent|4
1602414|NCT02236611|5583505|P1|Overall Study|Withdrew consent|9
1602415|NCT02236611|5583504|P2|Overall Study|Protocol deviation|5
1602416|NCT02236611|5583505|P1|Overall Study|Protocol deviation|3
1602417|NCT02236611|5583504|P2|Overall Study|Lost to Follow-up|2
1602418|NCT02236611|5583505|P1|Overall Study|Lost to Follow-up|0
1602419|NCT02236611|5583504|P2|Overall Study|Lack of Efficacy|7
1602420|NCT02236611|5583505|P1|Overall Study|Lack of Efficacy|4
1602421|NCT02236611|5583504|P2|Overall Study|Adverse Event|16
1602422|NCT02236611|5583505|P1|Overall Study|Adverse Event|10
1602423|NCT02236598|5583513|P2|Overall Study|Withdrawal by Subject|1
1602424|NCT02236598|5583514|P1|Overall Study|Withdrawal by Subject|0
1602425|NCT02236598|5583513|P2|Overall Study|Adverse Event|1
1602426|NCT02236598|5583514|P1|Overall Study|Adverse Event|0
1602427|NCT02236559|5583528|P2|Overall Study|Withdrawal by Subject|0
1602428|NCT02236559|5583529|P1|Overall Study|Withdrawal by Subject|1
1602429|NCT02236559|5583528|P2|Overall Study|Physician Decision|1
1602430|NCT02236559|5583529|P1|Overall Study|Physician Decision|1
1602431|NCT02236559|5583528|P2|Overall Study|Subject Did Not Consent|2
1602432|NCT02236559|5583529|P1|Overall Study|Subject Did Not Consent|4
1602433|NCT02236559|5583528|P2|Overall Study|Did not Meet Inclusion|3
1602434|NCT02236559|5583529|P1|Overall Study|Did not Meet Inclusion|3
1602435|NCT02236559|5583528|P2|Overall Study|Met Exclusion|6
1602436|NCT02236559|5583529|P1|Overall Study|Met Exclusion|3
1602437|NCT02236520|5583566|P4|Overall Study|Pregnancy|0
1602438|NCT02236520|5583567|P3|Overall Study|Pregnancy|0
1602439|NCT02236520|5583568|P2|Overall Study|Pregnancy|0
1602440|NCT02236520|5583569|P1|Overall Study|Pregnancy|1
1602441|NCT02236520|5583566|P4|Overall Study|Withdrawal by Subject|1
1602442|NCT02236520|5583567|P3|Overall Study|Withdrawal by Subject|0
1602443|NCT02236520|5583568|P2|Overall Study|Withdrawal by Subject|0
1602444|NCT02236520|5583569|P1|Overall Study|Withdrawal by Subject|1
1602445|NCT02236520|5583566|P4|Overall Study|Physician Decision|0
1602446|NCT02236520|5583567|P3|Overall Study|Physician Decision|0
1602447|NCT02236520|5583568|P2|Overall Study|Physician Decision|5
1602448|NCT02236520|5583569|P1|Overall Study|Physician Decision|0
1602449|NCT02236130|5583596|P2|Overall Study|Lost to Follow-up|12
1602450|NCT02236130|5583597|P1|Overall Study|Lost to Follow-up|7
1602451|NCT02235454|5583647|P1|Overall Study|Withdrawal by Subject|2
1602452|NCT02235311|5583653|P2|Overall Study|Protocol Violation|1
1602453|NCT02235311|5583654|P1|Overall Study|Protocol Violation|0
1602454|NCT02235311|5583653|P2|Overall Study|Lost to Follow-up|1
1602455|NCT02235311|5583654|P1|Overall Study|Lost to Follow-up|0
1602456|NCT02235077|5583672|P2|Overall Study|Physician Decision|1
1602457|NCT02235077|5583673|P1|Overall Study|Physician Decision|0
1602458|NCT02235077|5583672|P2|Overall Study|Withdrawal by Subject|5
1602459|NCT02235077|5583673|P1|Overall Study|Withdrawal by Subject|8
1602460|NCT02235077|5583672|P2|Overall Study|Lost to Follow-up|6
1602461|NCT02235077|5583673|P1|Overall Study|Lost to Follow-up|5
1602462|NCT02235077|5583672|P2|Overall Study|Death|7
1602463|NCT02235077|5583673|P1|Overall Study|Death|5
1602464|NCT02234479|5583868|P2|Overall Study|Withdrawal by Subject|3
1602465|NCT02234479|5583869|P1|Overall Study|Withdrawal by Subject|1
1602466|NCT02234362|5583879|P1|Overall Study|Withdrawal by Subject|3
1602467|NCT02234362|5583879|P1|Overall Study|Lost to Follow-up|6
1602468|NCT02234362|5583879|P1|Overall Study|Not eligible after first screening visit|17
1602469|NCT02234284|5583898|P2|Overall Study|Lost to Follow-up|7
1602470|NCT02234284|5583899|P1|Overall Study|Lost to Follow-up|20
1602471|NCT02234284|5583898|P2|Overall Study|Withdrawal by Subject|0
1602472|NCT02234284|5583899|P1|Overall Study|Withdrawal by Subject|1
1602473|NCT02234284|5583898|P2|Overall Study|Death|2
1602474|NCT02234284|5583899|P1|Overall Study|Death|4
1602475|NCT02234141|5583958|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
1602476|NCT02234141|5583959|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
1602477|NCT02234141|5583960|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
1602478|NCT02234141|5583961|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
1602479|NCT02234141|5583962|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
1602480|NCT02234141|5583963|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
1602481|NCT02234141|5583964|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
1602482|NCT02234141|5583958|P7|Long-Term Treatment Period|Withdrew Consent|0
1602483|NCT02234141|5583959|P6|Long-Term Treatment Period|Withdrew Consent|0
1602484|NCT02234141|5583960|P5|Long-Term Treatment Period|Withdrew Consent|0
1602485|NCT02234141|5583961|P4|Long-Term Treatment Period|Withdrew Consent|0
1602486|NCT02234141|5583962|P3|Long-Term Treatment Period|Withdrew Consent|1
1602487|NCT02234141|5583963|P2|Long-Term Treatment Period|Withdrew Consent|1
1602488|NCT02234141|5583964|P1|Long-Term Treatment Period|Withdrew Consent|0
1602489|NCT02234141|5583958|P7|Long-Term Treatment Period|Adverse Event|1
1602490|NCT02234141|5583959|P6|Long-Term Treatment Period|Adverse Event|1
1602491|NCT02234141|5583960|P5|Long-Term Treatment Period|Adverse Event|1
1602492|NCT02234141|5583961|P4|Long-Term Treatment Period|Adverse Event|0
1602493|NCT02234141|5583962|P3|Long-Term Treatment Period|Adverse Event|5
1602494|NCT02234141|5583963|P2|Long-Term Treatment Period|Adverse Event|0
1602495|NCT02234141|5583964|P1|Long-Term Treatment Period|Adverse Event|4
1602496|NCT02234141|5583958|P7|Long-Term Treatment Period|Investigator's discretion|1
1602497|NCT02234141|5583959|P6|Long-Term Treatment Period|Investigator's discretion|0
1602498|NCT02234141|5583960|P5|Long-Term Treatment Period|Investigator's discretion|0
1602499|NCT02234141|5583961|P4|Long-Term Treatment Period|Investigator's discretion|0
1602500|NCT02234141|5583962|P3|Long-Term Treatment Period|Investigator's discretion|2
1602501|NCT02234141|5583963|P2|Long-Term Treatment Period|Investigator's discretion|3
1602502|NCT02234141|5583964|P1|Long-Term Treatment Period|Investigator's discretion|1
1602503|NCT02234141|5583958|P7|Long-Term Treatment Period|Death|0
1602504|NCT02234141|5583959|P6|Long-Term Treatment Period|Death|1
1602505|NCT02234141|5583960|P5|Long-Term Treatment Period|Death|0
1602506|NCT02234141|5583961|P4|Long-Term Treatment Period|Death|0
1602507|NCT02234141|5583962|P3|Long-Term Treatment Period|Death|0
1602508|NCT02234141|5583963|P2|Long-Term Treatment Period|Death|0
1602509|NCT02234141|5583964|P1|Long-Term Treatment Period|Death|0
1602510|NCT02234141|5583958|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
1602511|NCT02234141|5583959|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
1602512|NCT02234141|5583960|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
1602513|NCT02234141|5583961|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
1602514|NCT02234141|5583962|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
1602515|NCT02234141|5583963|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
1602516|NCT02234141|5583964|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
1602517|NCT02234141|5583958|P7|Treatment Period (24 Weeks)|Adverse Event|0
1602518|NCT02234141|5583959|P6|Treatment Period (24 Weeks)|Adverse Event|0
1602519|NCT02234141|5583960|P5|Treatment Period (24 Weeks)|Adverse Event|0
1602520|NCT02234141|5583961|P4|Treatment Period (24 Weeks)|Adverse Event|3
1602521|NCT02234141|5583962|P3|Treatment Period (24 Weeks)|Adverse Event|2
1602522|NCT02234141|5583963|P2|Treatment Period (24 Weeks)|Adverse Event|1
1602523|NCT02234141|5583964|P1|Treatment Period (24 Weeks)|Adverse Event|3
1602524|NCT02234141|5583958|P7|Treatment Period (24 Weeks)|Death|0
1602525|NCT02234141|5583959|P6|Treatment Period (24 Weeks)|Death|0
1602526|NCT02234141|5583960|P5|Treatment Period (24 Weeks)|Death|0
1602527|NCT02234141|5583961|P4|Treatment Period (24 Weeks)|Death|1
1602528|NCT02234141|5583962|P3|Treatment Period (24 Weeks)|Death|0
1602529|NCT02234141|5583963|P2|Treatment Period (24 Weeks)|Death|2
1602530|NCT02234141|5583964|P1|Treatment Period (24 Weeks)|Death|1
1602531|NCT02234141|5583958|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
1602532|NCT02234141|5583959|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
1602533|NCT02234141|5583960|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
1602534|NCT02234141|5583961|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
1602535|NCT02234141|5583962|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
1602536|NCT02234141|5583963|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
1602537|NCT02234141|5583964|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
1602538|NCT02234141|5583958|P7|Treatment Period (24 Weeks)|Protocol Violation|0
1602539|NCT02234141|5583959|P6|Treatment Period (24 Weeks)|Protocol Violation|0
1602540|NCT02234141|5583960|P5|Treatment Period (24 Weeks)|Protocol Violation|0
1602541|NCT02234141|5583961|P4|Treatment Period (24 Weeks)|Protocol Violation|1
1602542|NCT02234141|5583962|P3|Treatment Period (24 Weeks)|Protocol Violation|0
1602543|NCT02234141|5583963|P2|Treatment Period (24 Weeks)|Protocol Violation|0
1602544|NCT02234141|5583964|P1|Treatment Period (24 Weeks)|Protocol Violation|0
1602545|NCT02233803|5584110|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
1602546|NCT02233803|5584111|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
1602547|NCT02233803|5584110|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
1602548|NCT02233803|5584111|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
1602549|NCT02233803|5584110|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
1602550|NCT02233803|5584111|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
1602551|NCT02233803|5584110|P2|Washout Period (4-Wks)|Physician Decision|0
1602552|NCT02233803|5584111|P1|Washout Period (4-Wks)|Physician Decision|1
1602553|NCT02233803|5584110|P2|Washout Period (4-Wks)|Lost to Follow-up|1
1602554|NCT02233803|5584111|P1|Washout Period (4-Wks)|Lost to Follow-up|0
1602555|NCT02233803|5584110|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
1602556|NCT02233803|5584111|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
1602557|NCT02233803|5584110|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
1602558|NCT02233803|5584111|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
1602559|NCT02233803|5584110|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
1602560|NCT02233803|5584111|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
1602561|NCT02233803|5584110|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
1602562|NCT02233803|5584111|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
1602563|NCT02233738|5584144|P2|Overall Study|Did not return after Baseline|2
1602564|NCT02233738|5584145|P1|Overall Study|Did not return after Baseline|3
1602565|NCT02233738|5584144|P2|Overall Study|Withdrawal by Subject|1
1602566|NCT02233738|5584145|P1|Overall Study|Withdrawal by Subject|0
1602567|NCT02233738|5584144|P2|Overall Study|Death|1
1602568|NCT02233738|5584145|P1|Overall Study|Death|0
1602569|NCT02233738|5584144|P2|Overall Study|Lost to Follow-up|12
1602570|NCT02233738|5584145|P1|Overall Study|Lost to Follow-up|5
1602571|NCT02233647|5584315|P1|Overall Study|Adverse Event|1
1602572|NCT02233543|5584344|P2|Period 2|COPD exacerbation|0
1602573|NCT02233543|5584345|P1|Period 2|COPD exacerbation|1
1602574|NCT02233543|5584344|P2|Period 2|Participant required other treatment.|1
1602575|NCT02233543|5584345|P1|Period 2|Participant required other treatment.|0
1602576|NCT02233543|5584344|P2|Period 2|Adverse Event|0
1602577|NCT02233543|5584345|P1|Period 2|Adverse Event|1
1602578|NCT02233543|5584344|P2|Period 1|Participants required other treatment.|3
1602579|NCT02233543|5584345|P1|Period 1|Participants required other treatment.|2
1602580|NCT02233543|5584344|P2|Period 1|Withdrawal by Subject|0
1602581|NCT02233543|5584345|P1|Period 1|Withdrawal by Subject|1
1602582|NCT02233309|5584395|P1|Overall Study|Physician Decision|5
1602583|NCT02232984|5584429|P1|Overall Study|Protocol Violation|1
1602584|NCT02232984|5584429|P1|Overall Study|not disclosed by site|7
1602585|NCT02232984|5584429|P1|Overall Study|Device implant unsuccessful|53
1602586|NCT02232984|5584429|P1|Overall Study|Investigator withdrawal|10
1602587|NCT02232984|5584429|P1|Overall Study|Death|1
1602588|NCT02232984|5584429|P1|Overall Study|Withdrawal by Subject|5
1602589|NCT02232880|5584438|P1|Overall Study|study stopped prior to randomization|1
1602590|NCT02232698|5584447|P2|Overall Study|Withdrawal by Subject|11
1602591|NCT02232698|5584448|P1|Overall Study|Withdrawal by Subject|0
1602592|NCT02232698|5584447|P2|Overall Study|Allocated to control group|3
1602593|NCT02232698|5584448|P1|Overall Study|Allocated to control group|0
1602594|NCT02232698|5584447|P2|Overall Study|Non-compliance with study device|4
1602595|NCT02232698|5584448|P1|Overall Study|Non-compliance with study device|1
1602596|NCT02232698|5584447|P2|Overall Study|Had device-associated symptoms|0
1602597|NCT02232698|5584448|P1|Overall Study|Had device-associated symptoms|7
1602598|NCT02232698|5584447|P2|Overall Study|Met exclusion criteria|1
1602599|NCT02232698|5584448|P1|Overall Study|Met exclusion criteria|1
1602600|NCT02232698|5584447|P2|Overall Study|Pregnancy|1
1602601|NCT02232698|5584448|P1|Overall Study|Pregnancy|1
1602602|NCT02232425|5584471|P2|Overall Study|Lack of Efficacy|0
1602603|NCT02232425|5584472|P1|Overall Study|Lack of Efficacy|1
1602604|NCT02232425|5584471|P2|Overall Study|Withdrawal by Subject|6
1602605|NCT02232425|5584472|P1|Overall Study|Withdrawal by Subject|5
1602606|NCT02232425|5584471|P2|Overall Study|Adverse Event|0
1602607|NCT02232425|5584472|P1|Overall Study|Adverse Event|2
1602608|NCT02232425|5584471|P2|Overall Study|Lost to Follow-up|2
1602609|NCT02232425|5584472|P1|Overall Study|Lost to Follow-up|6
1602610|NCT02232243|5584505|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
1602611|NCT02232243|5584506|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
1602612|NCT02232243|5584507|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
1602613|NCT02232178|5584519|P3|Overall Study|surgical complication|0
1602614|NCT02232178|5584520|P2|Overall Study|surgical complication|0
1602615|NCT02232178|5584521|P1|Overall Study|surgical complication|1
1602616|NCT02232178|5584519|P3|Overall Study|ineligibility|1
1602617|NCT02232178|5584520|P2|Overall Study|ineligibility|0
1602618|NCT02232178|5584521|P1|Overall Study|ineligibility|0
1602619|NCT02232178|5584519|P3|Overall Study|Lost to Follow-up|0
1602620|NCT02232178|5584520|P2|Overall Study|Lost to Follow-up|1
1602621|NCT02232178|5584521|P1|Overall Study|Lost to Follow-up|0
1602622|NCT02232074|5584551|P2|Overall Study|deemed ineligible|1
1602623|NCT02232074|5584552|P1|Overall Study|deemed ineligible|0
1602624|NCT02232074|5584551|P2|Overall Study|No legal concerns at baseline|41
1602625|NCT02232074|5584552|P1|Overall Study|No legal concerns at baseline|36
1602626|NCT02232074|5584551|P2|Overall Study|Withdrawal by Subject|3
1602627|NCT02232074|5584552|P1|Overall Study|Withdrawal by Subject|5
1602628|NCT02231918|5584619|P3|Overall Study|Adverse Event|1
1602629|NCT02231918|5584620|P2|Overall Study|Adverse Event|0
1602630|NCT02231918|5584621|P1|Overall Study|Adverse Event|0
1602631|NCT02231918|5584619|P3|Overall Study|Withdrawal by Subject|0
1602632|NCT02231918|5584620|P2|Overall Study|Withdrawal by Subject|1
1602633|NCT02231918|5584621|P1|Overall Study|Withdrawal by Subject|0
1602655|NCT02231762|5584705|P4|Maintenance Phase|Adverse Event|2
1602656|NCT02231762|5584706|P3|Maintenance Phase|Adverse Event|1
1602657|NCT02231762|5584707|P2|Maintenance Phase|Adverse Event|0
1602658|NCT02231762|5584708|P1|Maintenance Phase|Adverse Event|0
1602659|NCT02231762|5584705|P4|Maintenance Phase|Disease progression|3
1602660|NCT02231762|5584706|P3|Maintenance Phase|Disease progression|4
1602661|NCT02231762|5584707|P2|Maintenance Phase|Disease progression|3
1602662|NCT02231762|5584708|P1|Maintenance Phase|Disease progression|0
1602663|NCT02231762|5584705|P4|Combination Phase|Protocol Violation|0
1602664|NCT02231762|5584706|P3|Combination Phase|Protocol Violation|0
1602665|NCT02231762|5584707|P2|Combination Phase|Protocol Violation|0
1602666|NCT02231762|5584708|P1|Combination Phase|Protocol Violation|1
1602667|NCT02231762|5584705|P4|Combination Phase|Did not meet inclusion criteria|0
1602668|NCT02231762|5584706|P3|Combination Phase|Did not meet inclusion criteria|0
1602669|NCT02231762|5584707|P2|Combination Phase|Did not meet inclusion criteria|0
1602670|NCT02231762|5584708|P1|Combination Phase|Did not meet inclusion criteria|1
1602671|NCT02231762|5584705|P4|Combination Phase|Disease Progression|0
1602672|NCT02231762|5584706|P3|Combination Phase|Disease Progression|0
1602673|NCT02231762|5584707|P2|Combination Phase|Disease Progression|0
1602674|NCT02231762|5584708|P1|Combination Phase|Disease Progression|6
1602675|NCT02231762|5584705|P4|Combination Phase|Withdrawal by Subject|0
1602676|NCT02231762|5584706|P3|Combination Phase|Withdrawal by Subject|0
1602677|NCT02231762|5584707|P2|Combination Phase|Withdrawal by Subject|0
1602678|NCT02231762|5584708|P1|Combination Phase|Withdrawal by Subject|2
1602679|NCT02231762|5584705|P4|Combination Phase|Adverse Event|0
1602680|NCT02231762|5584706|P3|Combination Phase|Adverse Event|0
1602681|NCT02231762|5584707|P2|Combination Phase|Adverse Event|0
1602682|NCT02231762|5584708|P1|Combination Phase|Adverse Event|10
1602683|NCT02231749|5584741|P2|Overall Study|No longer meets Study Criteria|0
1602684|NCT02231749|5584742|P1|Overall Study|No longer meets Study Criteria|1
1602685|NCT02231749|5584741|P2|Overall Study|other|8
1602686|NCT02231749|5584742|P1|Overall Study|other|0
1602687|NCT02231749|5584741|P2|Overall Study|Pregnancy|0
1602688|NCT02231749|5584742|P1|Overall Study|Pregnancy|1
1602689|NCT02231749|5584741|P2|Overall Study|Poor/Non-Compliance|3
1602690|NCT02231749|5584742|P1|Overall Study|Poor/Non-Compliance|0
1602691|NCT02231749|5584741|P2|Overall Study|Maximum Clinical Benefit|8
1602692|NCT02231749|5584742|P1|Overall Study|Maximum Clinical Benefit|5
1602693|NCT02231749|5584741|P2|Overall Study|Lost to Follow-up|2
1602694|NCT02231749|5584742|P1|Overall Study|Lost to Follow-up|1
1602695|NCT02231749|5584741|P2|Overall Study|Participant withdrew Consent|15
1602696|NCT02231749|5584742|P1|Overall Study|Participant withdrew Consent|8
1602697|NCT02231749|5584741|P2|Overall Study|Participant's request to discontinue|21
1602698|NCT02231749|5584742|P1|Overall Study|Participant's request to discontinue|10
1602699|NCT02231749|5584741|P2|Overall Study|AE unrelated to Study drug|31
1602700|NCT02231749|5584742|P1|Overall Study|AE unrelated to Study drug|32
1602701|NCT02231749|5584741|P2|Overall Study|Death|1
1602702|NCT02231749|5584742|P1|Overall Study|Death|1
1602703|NCT02231749|5584741|P2|Overall Study|Study Drug Toxicity|63
1602704|NCT02231749|5584742|P1|Overall Study|Study Drug Toxicity|134
1602705|NCT02231749|5584741|P2|Overall Study|Disease progression|297
1602706|NCT02231749|5584742|P1|Overall Study|Disease progression|229
1602707|NCT02231580|5584760|P2|Overall Study|Adverse Event|0
1602708|NCT02231580|5584761|P1|Overall Study|Adverse Event|5
1602709|NCT02231164|5584878|P2|Overall Study|Withdrawal by Subject|2
1602710|NCT02231164|5584879|P1|Overall Study|Withdrawal by Subject|1
1602711|NCT02231164|5584878|P2|Overall Study|Lack of Efficacy|3
1602712|NCT02231164|5584879|P1|Overall Study|Lack of Efficacy|4
1602713|NCT02231164|5584878|P2|Overall Study|Adverse Event|1
1602714|NCT02231164|5584879|P1|Overall Study|Adverse Event|1
1602715|NCT02230956|5584907|P3|Overall Study|Other Miscellaneous Reason|2
1602716|NCT02230956|5584908|P2|Overall Study|Other Miscellaneous Reason|1
1602717|NCT02230956|5584909|P1|Overall Study|Other Miscellaneous Reason|0
1602718|NCT02230956|5584907|P3|Overall Study|Protocol Violation|1
1602719|NCT02230956|5584908|P2|Overall Study|Protocol Violation|1
1602720|NCT02230956|5584909|P1|Overall Study|Protocol Violation|0
1602721|NCT02230956|5584907|P3|Overall Study|Personal Reasons|1
1602722|NCT02230956|5584908|P2|Overall Study|Personal Reasons|1
1602723|NCT02230956|5584909|P1|Overall Study|Personal Reasons|2
1602724|NCT02230956|5584907|P3|Overall Study|Lost to Follow-up|2
1602725|NCT02230956|5584908|P2|Overall Study|Lost to Follow-up|1
1602726|NCT02230956|5584909|P1|Overall Study|Lost to Follow-up|1
1602727|NCT02230956|5584907|P3|Overall Study|Lack of Efficacy|1
1602728|NCT02230956|5584908|P2|Overall Study|Lack of Efficacy|1
1602729|NCT02230956|5584909|P1|Overall Study|Lack of Efficacy|1
1602730|NCT02230956|5584907|P3|Overall Study|Adverse Event|0
1602731|NCT02230956|5584908|P2|Overall Study|Adverse Event|1
1602732|NCT02230956|5584909|P1|Overall Study|Adverse Event|1
1602733|NCT02230904|5584931|P2|Overall Study|Safety follow up could not take place|1
1602734|NCT02230904|5584932|P1|Overall Study|Safety follow up could not take place|0
1602735|NCT02230683|5584965|P1|Overall Study|Adverse Event|1
1602736|NCT02230670|5584982|P2|Overall Study|Progression to Child-Pugh C|2
1602737|NCT02230670|5584983|P1|Overall Study|Progression to Child-Pugh C|1
1602738|NCT02230670|5584982|P2|Overall Study|Protocol Violation|1
1602739|NCT02230670|5584983|P1|Overall Study|Protocol Violation|0
1602740|NCT02230670|5584982|P2|Overall Study|Physician Decision|1
1602741|NCT02230670|5584983|P1|Overall Study|Physician Decision|0
1602742|NCT02230670|5584982|P2|Overall Study|Withdrawal by Subject|2
1602743|NCT02230670|5584983|P1|Overall Study|Withdrawal by Subject|2
1602744|NCT02230670|5584982|P2|Overall Study|Adverse Event|2
1602745|NCT02230670|5584983|P1|Overall Study|Adverse Event|1
1602746|NCT02230384|5585069|P2|Phase 2 - Switch|Adverse Event|0
1602747|NCT02230384|5585070|P1|Phase 2 - Switch|Adverse Event|2
1602748|NCT02230384|5585069|P2|Phase 2 - Switch|Lost to Follow-up|0
1602749|NCT02230384|5585070|P1|Phase 2 - Switch|Lost to Follow-up|1
1602750|NCT02230384|5585069|P2|Phase 2 - Switch|Withdrawal by Subject|1
1602751|NCT02230384|5585070|P1|Phase 2 - Switch|Withdrawal by Subject|0
1602752|NCT02230384|5585069|P2|Phase 1|Physician Decision|1
1602753|NCT02230384|5585070|P1|Phase 1|Physician Decision|0
1602754|NCT02230384|5585069|P2|Phase 1|Lost to Follow-up|0
1602755|NCT02230384|5585070|P1|Phase 1|Lost to Follow-up|1
1602756|NCT02230332|5585090|P2|Overall Study|Protocol Violation|0
1602757|NCT02230332|5585091|P1|Overall Study|Protocol Violation|1
1602758|NCT02230332|5585090|P2|Overall Study|Lost to Follow-up|0
1602759|NCT02230332|5585091|P1|Overall Study|Lost to Follow-up|1
1602760|NCT02230332|5585090|P2|Overall Study|Adverse Event|1
1602761|NCT02230332|5585091|P1|Overall Study|Adverse Event|2
1602762|NCT02230306|5585107|P1|Overall Study|Did not receive study treatment|1
1602763|NCT02230085|5585118|P1|Overall Study|Withdrawal by Subject|3
1602764|NCT02230085|5585118|P1|Overall Study|Physician Decision|1
1602765|NCT02229864|5585122|P1|3 - Year Visit|Death|2
1602766|NCT02229864|5585122|P1|2 - Year Visit|Missed Visits|1
1602767|NCT02229539|5585177|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
1602768|NCT02229539|5585178|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
1602769|NCT02229539|5585179|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
1602770|NCT02229539|5585177|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
1602771|NCT02229539|5585178|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1602772|NCT02229539|5585179|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
1602773|NCT02229539|5585177|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1602774|NCT02229539|5585178|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
1602775|NCT02229539|5585179|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
1602776|NCT02229539|5585177|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1602777|NCT02229539|5585178|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
1602778|NCT02229539|5585179|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
1602779|NCT02229539|5585177|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
1602780|NCT02229539|5585178|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1602781|NCT02229539|5585179|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
1602782|NCT02229539|5585177|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
1602783|NCT02229539|5585178|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
1602784|NCT02229539|5585179|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
1602785|NCT02229539|5585177|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
1602786|NCT02229539|5585178|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
1602787|NCT02229539|5585179|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
1602788|NCT02229539|5585177|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
1602789|NCT02229539|5585178|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1602790|NCT02229539|5585179|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
1602791|NCT02229539|5585177|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1602792|NCT02229539|5585178|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
1602793|NCT02229539|5585179|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
1602794|NCT02229396|5585310|P3|Overall Study|Withdrew; No Record on Termination Page|1
1602795|NCT02229396|5585311|P2|Overall Study|Withdrew; No Record on Termination Page|0
1602796|NCT02229396|5585312|P1|Overall Study|Withdrew; No Record on Termination Page|2
1602797|NCT02229396|5585310|P3|Overall Study|Study-Specific Withdrawal Criteria|3
1602798|NCT02229396|5585311|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1602799|NCT02229396|5585312|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1602800|NCT02229396|5585310|P3|Overall Study|Withdrawal by Subject|41
1602801|NCT02229396|5585311|P2|Overall Study|Withdrawal by Subject|28
1602802|NCT02229396|5585312|P1|Overall Study|Withdrawal by Subject|42
1602803|NCT02229396|5585310|P3|Overall Study|Other|15
1602804|NCT02229396|5585311|P2|Overall Study|Other|18
1602805|NCT02229396|5585312|P1|Overall Study|Other|10
1602806|NCT02229396|5585310|P3|Overall Study|Patient Incorrectly Randomized|1
1602807|NCT02229396|5585311|P2|Overall Study|Patient Incorrectly Randomized|0
1602808|NCT02229396|5585312|P1|Overall Study|Patient Incorrectly Randomized|0
1602809|NCT02229396|5585310|P3|Overall Study|Protocol Violation|0
1602810|NCT02229396|5585311|P2|Overall Study|Protocol Violation|1
1602811|NCT02229396|5585312|P1|Overall Study|Protocol Violation|2
1602812|NCT02229396|5585310|P3|Overall Study|Lost to Follow-up|21
1602813|NCT02229396|5585311|P2|Overall Study|Lost to Follow-up|14
1602814|NCT02229396|5585312|P1|Overall Study|Lost to Follow-up|14
1602815|NCT02229396|5585310|P3|Overall Study|Death|1
1602816|NCT02229396|5585311|P2|Overall Study|Death|3
1602817|NCT02229396|5585312|P1|Overall Study|Death|2
1602818|NCT02229396|5585310|P3|Overall Study|Adverse Event|12
1602819|NCT02229396|5585311|P2|Overall Study|Adverse Event|12
1602820|NCT02229396|5585312|P1|Overall Study|Adverse Event|6
1602821|NCT02229383|5585343|P2|Overall Study|Other|8
1602822|NCT02229383|5585344|P1|Overall Study|Other|3
1602823|NCT02229383|5585343|P2|Overall Study|Did not receive treatment|0
1602824|NCT02229383|5585344|P1|Overall Study|Did not receive treatment|1
1602825|NCT02229383|5585343|P2|Overall Study|Withdrawal by Subject|6
1602826|NCT02229383|5585344|P1|Overall Study|Withdrawal by Subject|4
1602827|NCT02229383|5585343|P2|Overall Study|Lost to Follow-up|3
1602828|NCT02229383|5585344|P1|Overall Study|Lost to Follow-up|5
1602829|NCT02229383|5585343|P2|Overall Study|Death|1
1602830|NCT02229383|5585344|P1|Overall Study|Death|0
1602831|NCT02229383|5585343|P2|Overall Study|Adverse Event|4
1602832|NCT02229383|5585344|P1|Overall Study|Adverse Event|7
1602833|NCT02229227|5585369|P2|Overall Study|Physician Decision|12
1602834|NCT02229227|5585370|P1|Overall Study|Physician Decision|5
1602835|NCT02229227|5585369|P2|Overall Study|Other|1
1602836|NCT02229227|5585370|P1|Overall Study|Other|0
1602837|NCT02229227|5585369|P2|Overall Study|Withdrawal by Subject|12
1602838|NCT02229227|5585370|P1|Overall Study|Withdrawal by Subject|8
1602839|NCT02229227|5585369|P2|Overall Study|Study terminated by sponsor|11
1602840|NCT02229227|5585370|P1|Overall Study|Study terminated by sponsor|11
1602841|NCT02229227|5585369|P2|Overall Study|Lost to Follow-up|3
1602842|NCT02229227|5585370|P1|Overall Study|Lost to Follow-up|3
1602843|NCT02229227|5585369|P2|Overall Study|Protocol defined stopping criteria|3
1602844|NCT02229227|5585370|P1|Overall Study|Protocol defined stopping criteria|1
1602845|NCT02229227|5585369|P2|Overall Study|Protocol Violation|8
1602846|NCT02229227|5585370|P1|Overall Study|Protocol Violation|6
1602847|NCT02229227|5585369|P2|Overall Study|Lack of Efficacy|3
1602848|NCT02229227|5585370|P1|Overall Study|Lack of Efficacy|3
1602849|NCT02229227|5585369|P2|Overall Study|Adverse Event|9
1602850|NCT02229227|5585370|P1|Overall Study|Adverse Event|14
1602851|NCT02229214|5585455|P2|Overall Study|Withdrawal by Subject|0
1602852|NCT02229214|5585456|P1|Overall Study|Withdrawal by Subject|4
1602853|NCT02229214|5585455|P2|Overall Study|Adverse Event|0
1602854|NCT02229214|5585456|P1|Overall Study|Adverse Event|2
1602855|NCT02228980|5585480|P4|Overall Study|Withdrawal by Subject|3
1602856|NCT02228980|5585481|P3|Overall Study|Withdrawal by Subject|2
1602857|NCT02228980|5585482|P2|Overall Study|Withdrawal by Subject|3
1602858|NCT02228980|5585483|P1|Overall Study|Withdrawal by Subject|3
1602859|NCT02228980|5585480|P4|Overall Study|Protocol Violation|0
1602860|NCT02228980|5585481|P3|Overall Study|Protocol Violation|0
1602861|NCT02228980|5585482|P2|Overall Study|Protocol Violation|0
1602862|NCT02228980|5585483|P1|Overall Study|Protocol Violation|7
1602863|NCT02228980|5585480|P4|Overall Study|Adverse Event|0
1602864|NCT02228980|5585481|P3|Overall Study|Adverse Event|0
1602865|NCT02228980|5585482|P2|Overall Study|Adverse Event|0
1602866|NCT02228980|5585483|P1|Overall Study|Adverse Event|14
1602867|NCT02228967|5585507|P2|Overall Study|Withdrawal by Subject|18
1602868|NCT02228967|5585508|P1|Overall Study|Withdrawal by Subject|13
1602869|NCT02228967|5585507|P2|Overall Study|Lost to Follow-up|142
1602870|NCT02228967|5585508|P1|Overall Study|Lost to Follow-up|146
1602871|NCT02228720|5585545|P1|Open Label - Day 30|Lost to Follow-up|1
1602872|NCT02228460|5585577|P1|Overall Study|Lost to Follow-up|1
1602873|NCT02228460|5585577|P1|Overall Study|Adverse Event|1
1602874|NCT02228395|5585600|P3|First Intervention Period|Unable to comply with study dates|1
1602875|NCT02228395|5585601|P2|First Intervention Period|Unable to comply with study dates|1
1602876|NCT02228395|5585602|P1|First Intervention Period|Unable to comply with study dates|0
1602877|NCT02228395|5585600|P3|First Intervention Period|No longer willing to participate|0
1602878|NCT02228395|5585601|P2|First Intervention Period|No longer willing to participate|0
1602879|NCT02228395|5585602|P1|First Intervention Period|No longer willing to participate|1
1602880|NCT02227849|5585686|P1|Overall Study|Withdrawal by Subject|3
1602881|NCT02227849|5585686|P1|Overall Study|Physician Decision|1
1602882|NCT02227849|5585686|P1|Overall Study|Adverse Event|4
1602883|NCT02227784|5585717|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
1602884|NCT02227784|5585718|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1602885|NCT02227784|5585719|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1602886|NCT02227784|5585720|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1602887|NCT02227784|5585721|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
1602888|NCT02227784|5585717|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
1602889|NCT02227784|5585718|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1602890|NCT02227784|5585719|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1602891|NCT02227784|5585720|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1602892|NCT02227784|5585721|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1602893|NCT02227784|5585717|P5|Open-Label Extension Phase (OLE)|Death|1
1602894|NCT02227784|5585718|P4|Open-Label Extension Phase (OLE)|Death|0
1602895|NCT02227784|5585719|P3|Open-Label Extension Phase (OLE)|Death|0
1602896|NCT02227784|5585720|P2|Open-Label Extension Phase (OLE)|Death|0
1602897|NCT02227784|5585721|P1|Open-Label Extension Phase (OLE)|Death|0
1602898|NCT02227784|5585717|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
1602899|NCT02227784|5585718|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
1602900|NCT02227784|5585719|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
1602901|NCT02227784|5585720|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
1602902|NCT02227784|5585721|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
1602903|NCT02227784|5585717|P5|Double-Blind Phase|Withdrawal by Subject|0
1602904|NCT02227784|5585718|P4|Double-Blind Phase|Withdrawal by Subject|2
1602905|NCT02227784|5585719|P3|Double-Blind Phase|Withdrawal by Subject|5
1602906|NCT02227784|5585720|P2|Double-Blind Phase|Withdrawal by Subject|1
1602907|NCT02227784|5585721|P1|Double-Blind Phase|Withdrawal by Subject|2
1602908|NCT02227784|5585717|P5|Double-Blind Phase|Sponsor Decision|0
1602909|NCT02227784|5585718|P4|Double-Blind Phase|Sponsor Decision|32
1602910|NCT02227784|5585719|P3|Double-Blind Phase|Sponsor Decision|14
1602911|NCT02227784|5585720|P2|Double-Blind Phase|Sponsor Decision|15
1602912|NCT02227784|5585721|P1|Double-Blind Phase|Sponsor Decision|34
1602913|NCT02227784|5585717|P5|Double-Blind Phase|Protocol Violation|0
1602914|NCT02227784|5585718|P4|Double-Blind Phase|Protocol Violation|1
1602915|NCT02227784|5585719|P3|Double-Blind Phase|Protocol Violation|1
1602916|NCT02227784|5585720|P2|Double-Blind Phase|Protocol Violation|0
1602917|NCT02227784|5585721|P1|Double-Blind Phase|Protocol Violation|0
1602918|NCT02227784|5585717|P5|Double-Blind Phase|Physician Decision|0
1602919|NCT02227784|5585718|P4|Double-Blind Phase|Physician Decision|1
1602920|NCT02227784|5585719|P3|Double-Blind Phase|Physician Decision|0
1602921|NCT02227784|5585720|P2|Double-Blind Phase|Physician Decision|0
1602922|NCT02227784|5585721|P1|Double-Blind Phase|Physician Decision|1
1602923|NCT02227784|5585717|P5|Double-Blind Phase|Adverse Event|0
1602924|NCT02227784|5585718|P4|Double-Blind Phase|Adverse Event|3
1602925|NCT02227784|5585719|P3|Double-Blind Phase|Adverse Event|1
1602926|NCT02227784|5585720|P2|Double-Blind Phase|Adverse Event|2
1602927|NCT02227784|5585721|P1|Double-Blind Phase|Adverse Event|3
1602928|NCT02227368|5585850|P2|Overall Study|Adverse Event|0
1602929|NCT02227368|5585851|P1|Overall Study|Adverse Event|1
1602930|NCT02227368|5585850|P2|Overall Study|Lost to Follow-up|0
1602931|NCT02227368|5585851|P1|Overall Study|Lost to Follow-up|1
1602932|NCT02227368|5585850|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
1602933|NCT02227368|5585851|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
1602934|NCT02227238|5585907|P2|Overall Study|Lost to Follow-up|5
1602935|NCT02227238|5585908|P1|Overall Study|Lost to Follow-up|7
1602936|NCT02227238|5585907|P2|Overall Study|Physician Decision|9
1602937|NCT02227238|5585908|P1|Overall Study|Physician Decision|0
1602938|NCT02227238|5585907|P2|Overall Study|Withdrawal by Subject|4
1602939|NCT02227238|5585908|P1|Overall Study|Withdrawal by Subject|5
1602940|NCT02227238|5585907|P2|Overall Study|Protocol Violation|8
1602941|NCT02227238|5585908|P1|Overall Study|Protocol Violation|7
1602942|NCT02227238|5585907|P2|Overall Study|Lack of Efficacy|22
1602943|NCT02227238|5585908|P1|Overall Study|Lack of Efficacy|10
1602944|NCT02227238|5585907|P2|Overall Study|Adverse Event|18
1602945|NCT02227238|5585908|P1|Overall Study|Adverse Event|8
1602946|NCT02227238|5585907|P2|Overall Study|Other: Reached stopping criteria|1
1602947|NCT02227238|5585908|P1|Overall Study|Other: Reached stopping criteria|0
1602948|NCT02227147|5585974|P2|Follow-up Period|Other|5
1602949|NCT02227147|5585975|P1|Follow-up Period|Other|3
1602950|NCT02227147|5585974|P2|Controlled Treatment Period|Other|0
1602951|NCT02227147|5585975|P1|Controlled Treatment Period|Other|2
1602952|NCT02227147|5585974|P2|Controlled Treatment Period|Adverse Event|3
1602953|NCT02227147|5585975|P1|Controlled Treatment Period|Adverse Event|4
1602954|NCT02227108|5586002|P1|Overall Study|Adverse Event|6
1602955|NCT02227108|5586002|P1|Overall Study|Investigator discretion|1
1602956|NCT02227108|5586002|P1|Overall Study|Initiation of alternative therapy|2
1602957|NCT02227108|5586002|P1|Overall Study|Progressive disease|17
1602958|NCT02227108|5586002|P1|Overall Study|Other|3
1602959|NCT02227108|5586002|P1|Overall Study|Did not receive treatment|2
1602960|NCT02226653|5586031|P2|Treatment Period 5 Fed State|Adverse Event|1
1602961|NCT02226653|5586032|P1|Treatment Period 5 Fed State|Adverse Event|0
1602962|NCT02226653|5586031|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
1602963|NCT02226653|5586032|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
1602964|NCT02226562|5586056|P2|Overall Study|Lost to Follow-up|1
1602965|NCT02226562|5586057|P1|Overall Study|Lost to Follow-up|0
1602966|NCT02226549|5586075|P2|Overall Study|Lost to Follow-up|1
1602967|NCT02226549|5586076|P1|Overall Study|Lost to Follow-up|0
1602968|NCT02226549|5586075|P2|Overall Study|Randomized but Never Treated|0
1602969|NCT02226549|5586076|P1|Overall Study|Randomized but Never Treated|1
1602970|NCT02226198|5586086|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1602971|NCT02226198|5586087|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
1602972|NCT02226198|5586088|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
1602973|NCT02226198|5586086|P3|Lead-in Phase|Protocol Violation|0
1602974|NCT02226198|5586087|P2|Lead-in Phase|Protocol Violation|0
1602975|NCT02226198|5586088|P1|Lead-in Phase|Protocol Violation|1
1602976|NCT02226172|5586161|P1|Overall Study|Adverse Event|6
1602977|NCT02226172|5586161|P1|Overall Study|Study terminated by sponsor|1
1602978|NCT02226172|5586161|P1|Overall Study|Death|1
1602979|NCT02226172|5586161|P1|Overall Study|Other|5
1602980|NCT02226172|5586161|P1|Overall Study|Participant refused further follow-up|4
1602981|NCT02226120|5586192|P1|Overall Study|missing treatment disposition pages|2
1602982|NCT02226120|5586192|P1|Overall Study|Protocol deviation|1
1602983|NCT02226120|5586192|P1|Overall Study|Non-compliance with study drug|10
1602984|NCT02226120|5586192|P1|Overall Study|Withdrawal by parent/guardian|36
1602985|NCT02226120|5586192|P1|Overall Study|Physician Decision|21
1602986|NCT02226120|5586192|P1|Overall Study|Lost to Follow-up|13
1602987|NCT02226120|5586192|P1|Overall Study|Technical problems|4
1602988|NCT02226120|5586192|P1|Overall Study|Study terminated by sponsor|1
1602989|NCT02226120|5586192|P1|Overall Study|Death|172
1602990|NCT02226120|5586192|P1|Overall Study|Adverse Event|60
1602991|NCT02226003|5586199|P3|Overall Study|Withdrawal by Subject|3
1602992|NCT02226003|5586200|P2|Overall Study|Withdrawal by Subject|0
1602993|NCT02226003|5586201|P1|Overall Study|Withdrawal by Subject|0
1602994|NCT02226003|5586199|P3|Overall Study|Lost to Follow-up|3
1602995|NCT02226003|5586200|P2|Overall Study|Lost to Follow-up|1
1602996|NCT02226003|5586201|P1|Overall Study|Lost to Follow-up|2
1602997|NCT02225743|5586257|P1|Overall Study|Withdrawal by Subject|18
1602998|NCT02225587|5586263|P2|Overall Study|Withdrawal by Subject|28
1602999|NCT02225587|5586264|P1|Overall Study|Withdrawal by Subject|13
1603000|NCT02225587|5586263|P2|Overall Study|Participant Moved|0
1603001|NCT02225587|5586264|P1|Overall Study|Participant Moved|1
1603002|NCT02225587|5586263|P2|Overall Study|Protocol Violation|0
1603003|NCT02225587|5586264|P1|Overall Study|Protocol Violation|1
1603004|NCT02225587|5586263|P2|Overall Study|Physician Decision|0
1603005|NCT02225587|5586264|P1|Overall Study|Physician Decision|2
1603006|NCT02225587|5586263|P2|Overall Study|Non-Compliance With Study Drug|0
1603007|NCT02225587|5586264|P1|Overall Study|Non-Compliance With Study Drug|1
1603008|NCT02225587|5586263|P2|Overall Study|Lost to Follow-up|5
1603009|NCT02225587|5586264|P1|Overall Study|Lost to Follow-up|5
1603010|NCT02225587|5586263|P2|Overall Study|Adverse Event|5
1603011|NCT02225587|5586264|P1|Overall Study|Adverse Event|5
1603012|NCT02225353|5586293|P3|Overall Study|Protocol Violation|12
1603013|NCT02225353|5586294|P2|Overall Study|Protocol Violation|5
1603014|NCT02225353|5586295|P1|Overall Study|Protocol Violation|4
1603015|NCT02225353|5586293|P3|Overall Study|Lost to Follow-up|3
1603016|NCT02225353|5586294|P2|Overall Study|Lost to Follow-up|1
1603017|NCT02225353|5586295|P1|Overall Study|Lost to Follow-up|0
1603018|NCT02224846|5586336|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
1603019|NCT02224846|5586337|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
1603020|NCT02224846|5586336|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
1603021|NCT02224846|5586337|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
1603022|NCT02224846|5586336|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
1603023|NCT02224846|5586337|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
1603024|NCT02224846|5586336|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
1603025|NCT02224846|5586337|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
1603026|NCT02224846|5586336|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
1603027|NCT02224846|5586337|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
1603028|NCT02224846|5586336|P2|Period 2 (Month 12 to Month 24)|Death|0
1603029|NCT02224846|5586337|P1|Period 2 (Month 12 to Month 24)|Death|1
1603030|NCT02224846|5586336|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
1603031|NCT02224846|5586337|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
1603032|NCT02224846|5586336|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
1603033|NCT02224846|5586337|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
1603034|NCT02224846|5586336|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
1603035|NCT02224846|5586337|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
1603036|NCT02224846|5586336|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
1603037|NCT02224846|5586337|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
1603038|NCT02224846|5586336|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
1603039|NCT02224846|5586337|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
1603040|NCT02224846|5586336|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
1603041|NCT02224846|5586337|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
1603042|NCT02224846|5586336|P2|Period 1 (Month 3)|Sponsor Decision|1
1603043|NCT02224846|5586337|P1|Period 1 (Month 3)|Sponsor Decision|2
1603044|NCT02224846|5586336|P2|Period 1 (Month 3)|Withdrawal by Subject|18
1603045|NCT02224846|5586337|P1|Period 1 (Month 3)|Withdrawal by Subject|8
1603046|NCT02224846|5586336|P2|Period 1 (Month 3)|Protocol Violation|8
1603047|NCT02224846|5586337|P1|Period 1 (Month 3)|Protocol Violation|4
1603048|NCT02224846|5586336|P2|Period 1 (Month 3)|Lost to Follow-up|8
1603049|NCT02224846|5586337|P1|Period 1 (Month 3)|Lost to Follow-up|3
1603050|NCT02224846|5586336|P2|Period 1 (Month 3)|Adverse Event|1
1603051|NCT02224846|5586337|P1|Period 1 (Month 3)|Adverse Event|2
1603052|NCT02224755|5586367|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
1603053|NCT02224755|5586368|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
1603054|NCT02224755|5586367|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
1603055|NCT02224755|5586368|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
1603056|NCT02224755|5586367|P2|Two Year Follow up Post-implant|Heart transplant|119
1603057|NCT02224755|5586368|P1|Two Year Follow up Post-implant|Heart transplant|137
1603058|NCT02224755|5586367|P2|Two Year Follow up Post-implant|Death|98
1603059|NCT02224755|5586368|P1|Two Year Follow up Post-implant|Death|103
1603060|NCT02224755|5586367|P2|Randomization to Device Implant|Withdrawn prior to implant|1
1603061|NCT02224755|5586368|P1|Randomization to Device Implant|Withdrawn prior to implant|7
1603062|NCT02224703|5586403|P3|Overall Study|Lack of Efficacy|0
1603063|NCT02224703|5586404|P2|Overall Study|Lack of Efficacy|0
1603064|NCT02224703|5586405|P1|Overall Study|Lack of Efficacy|1
1603065|NCT02224703|5586403|P3|Overall Study|Withdrawn by parent/guardian|0
1603066|NCT02224703|5586404|P2|Overall Study|Withdrawn by parent/guardian|1
1603067|NCT02224703|5586405|P1|Overall Study|Withdrawn by parent/guardian|0
1603068|NCT02224703|5586403|P3|Overall Study|Advised by medical monitor|0
1603069|NCT02224703|5586404|P2|Overall Study|Advised by medical monitor|0
1603070|NCT02224703|5586405|P1|Overall Study|Advised by medical monitor|1
1603071|NCT02224703|5586403|P3|Overall Study|Withdrawn by investigator|0
1603072|NCT02224703|5586404|P2|Overall Study|Withdrawn by investigator|0
1603073|NCT02224703|5586405|P1|Overall Study|Withdrawn by investigator|1
1603074|NCT02224703|5586403|P3|Overall Study|Adverse Event|0
1603075|NCT02224703|5586404|P2|Overall Study|Adverse Event|5
1603076|NCT02224703|5586405|P1|Overall Study|Adverse Event|0
1603077|NCT02224690|5586424|P2|Overall Study|Did not meet eligibility criteria|0
1603078|NCT02224690|5586425|P1|Overall Study|Did not meet eligibility criteria|1
1603079|NCT02224690|5586424|P2|Overall Study|Use of G-tube|0
1603080|NCT02224690|5586425|P1|Overall Study|Use of G-tube|1
1603081|NCT02224690|5586424|P2|Overall Study|Met Withdrawal Criteria|0
1603082|NCT02224690|5586425|P1|Overall Study|Met Withdrawal Criteria|4
1603083|NCT02224690|5586424|P2|Overall Study|Adverse Event|1
1603084|NCT02224690|5586425|P1|Overall Study|Adverse Event|8
1603085|NCT02224664|5586437|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
1603086|NCT02224664|5586438|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
1603087|NCT02224664|5586439|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1603088|NCT02224664|5586440|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1603089|NCT02224664|5586441|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
1603090|NCT02224664|5586437|P5|Dose Escalation Period (21 Days)|Adverse Event|7
1603091|NCT02224664|5586438|P4|Dose Escalation Period (21 Days)|Adverse Event|2
1603092|NCT02224664|5586439|P3|Dose Escalation Period (21 Days)|Adverse Event|2
1603093|NCT02224664|5586440|P2|Dose Escalation Period (21 Days)|Adverse Event|0
1603094|NCT02224664|5586441|P1|Dose Escalation Period (21 Days)|Adverse Event|0
1603095|NCT02224664|5586437|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1603096|NCT02224664|5586438|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1603097|NCT02224664|5586439|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1603098|NCT02224664|5586440|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
1603099|NCT02224664|5586441|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
1603100|NCT02224638|5586523|P2|Overall Study|Adverse Event|1
1603101|NCT02224638|5586524|P1|Overall Study|Adverse Event|1
1603102|NCT02224625|5586532|P1|Sensitization|Adverse Event|55
1603103|NCT02224625|5586532|P1|Irritation|Adverse Event|6
1603104|NCT02224560|5586556|P3|Overall Study|Withdrawn by Investigator|0
1603105|NCT02224560|5586557|P2|Overall Study|Withdrawn by Investigator|1
1603106|NCT02224560|5586558|P1|Overall Study|Withdrawn by Investigator|1
1603107|NCT02224560|5586556|P3|Overall Study|Adverse Event|1
1603108|NCT02224560|5586557|P2|Overall Study|Adverse Event|1
1603109|NCT02224560|5586558|P1|Overall Study|Adverse Event|4
1603110|NCT02224560|5586556|P3|Overall Study|Met Withdrawal Criteria|0
1603111|NCT02224560|5586557|P2|Overall Study|Met Withdrawal Criteria|0
1603112|NCT02224560|5586558|P1|Overall Study|Met Withdrawal Criteria|1
1603113|NCT02224560|5586556|P3|Overall Study|Withdrawal by Subject|1
1603114|NCT02224560|5586557|P2|Overall Study|Withdrawal by Subject|0
1603115|NCT02224560|5586558|P1|Overall Study|Withdrawal by Subject|2
1603116|NCT02224560|5586556|P3|Overall Study|Protocol Deviation|0
1603117|NCT02224560|5586557|P2|Overall Study|Protocol Deviation|0
1603118|NCT02224560|5586558|P1|Overall Study|Protocol Deviation|1
1603119|NCT02224274|5586595|P2|Overall Study|Death|0
1603120|NCT02224274|5586596|P1|Overall Study|Death|1
1603121|NCT02224157|5586608|P2|Overall Study|Adverse Event|3
1603122|NCT02224157|5586609|P1|Overall Study|Adverse Event|1
1603123|NCT02224157|5586608|P2|Overall Study|Death|1
1603124|NCT02224157|5586609|P1|Overall Study|Death|1
1603125|NCT02224157|5586608|P2|Overall Study|Lost to Follow-up|35
1603126|NCT02224157|5586609|P1|Overall Study|Lost to Follow-up|27
1603127|NCT02224157|5586608|P2|Overall Study|Eligibility criteria not fulfilled|8
1603128|NCT02224157|5586609|P1|Overall Study|Eligibility criteria not fulfilled|4
1603129|NCT02224157|5586608|P2|Overall Study|Prematurely closed site|2
1603130|NCT02224157|5586609|P1|Overall Study|Prematurely closed site|4
1603131|NCT02224157|5586608|P2|Overall Study|Subject decision|50
1603132|NCT02224157|5586609|P1|Overall Study|Subject decision|58
1603133|NCT02224157|5586608|P2|Overall Study|Other|10
1603134|NCT02224157|5586609|P1|Overall Study|Other|13
1603135|NCT02224157|5586608|P2|Overall Study|Severe non-compliance to protocol|2
1603136|NCT02224157|5586609|P1|Overall Study|Severe non-compliance to protocol|2
1603137|NCT02224053|5586633|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
1603138|NCT02224053|5586633|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
1603139|NCT02224053|5586633|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
1603140|NCT02224053|5586633|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
1603141|NCT02224053|5586633|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
1603142|NCT02223858|5586679|P2|Overall Study|Refused|9
1603143|NCT02223858|5586680|P1|Overall Study|Refused|9
1603144|NCT02223858|5586679|P2|Overall Study|Withdrawal by Subject|5
1603145|NCT02223858|5586680|P1|Overall Study|Withdrawal by Subject|8
1603146|NCT02223858|5586679|P2|Overall Study|Lost to Follow-up|11
1603147|NCT02223858|5586680|P1|Overall Study|Lost to Follow-up|6
1603148|NCT02223858|5586679|P2|Overall Study|Death|1
1603149|NCT02223858|5586680|P1|Overall Study|Death|1
1603150|NCT02223793|5586693|P3|Overall Study|Moved/studycenter unable to participate|8
1603151|NCT02223793|5586694|P2|Overall Study|Moved/studycenter unable to participate|6
1603152|NCT02223793|5586695|P1|Overall Study|Moved/studycenter unable to participate|4
1603153|NCT02223793|5586693|P3|Overall Study|Withdrawal by Subject|3
1603154|NCT02223793|5586694|P2|Overall Study|Withdrawal by Subject|2
1603155|NCT02223793|5586695|P1|Overall Study|Withdrawal by Subject|3
1603156|NCT02223793|5586693|P3|Overall Study|Lost to Follow-up|2
1603157|NCT02223793|5586694|P2|Overall Study|Lost to Follow-up|1
1603158|NCT02223793|5586695|P1|Overall Study|Lost to Follow-up|10
1603159|NCT02223754|5586708|P2|Period 2|Test Article No Longer Available|1
1603160|NCT02223754|5586709|P1|Period 2|Test Article No Longer Available|0
1603161|NCT02223754|5586708|P2|Period 2|Lost to Follow-up|0
1603162|NCT02223754|5586709|P1|Period 2|Lost to Follow-up|1
1603163|NCT02223754|5586708|P2|Period 2|Lens Discomfort|1
1603164|NCT02223754|5586709|P1|Period 2|Lens Discomfort|1
1603165|NCT02223754|5586708|P2|Period 2|Protocol Violation|0
1603166|NCT02223754|5586709|P1|Period 2|Protocol Violation|1
1603167|NCT02223754|5586708|P2|Period 2|Adverse Event|1
1603168|NCT02223754|5586709|P1|Period 2|Adverse Event|0
1603169|NCT02223754|5586708|P2|Period 1|Unsatisfactory Visual Response|1
1603170|NCT02223754|5586709|P1|Period 1|Unsatisfactory Visual Response|0
1603171|NCT02223754|5586708|P2|Period 1|Test Article No Longer Available|5
1603172|NCT02223754|5586709|P1|Period 1|Test Article No Longer Available|1
1603173|NCT02223754|5586708|P2|Period 1|Withdrawal by Subject|4
1603174|NCT02223754|5586709|P1|Period 1|Withdrawal by Subject|0
1603175|NCT02223754|5586708|P2|Period 1|Protocol Violation|4
1603176|NCT02223754|5586709|P1|Period 1|Protocol Violation|2
1603177|NCT02223754|5586708|P2|Period 1|Lost to Follow-up|1
1603178|NCT02223754|5586709|P1|Period 1|Lost to Follow-up|0
1603179|NCT02223754|5586708|P2|Period 1|Adverse Event|0
1603180|NCT02223754|5586709|P1|Period 1|Adverse Event|1
1603181|NCT02223715|5586729|P1|Overall Study|Lost to Follow-up|73
1603182|NCT02223715|5586729|P1|Overall Study|Death|31
1603183|NCT02223390|5586858|P2|Overall Study|Lost to Follow-up|4
1603184|NCT02223390|5586859|P1|Overall Study|Lost to Follow-up|9
1603185|NCT02223364|5586870|P3|Overall Study|Physician Decision|0
1603186|NCT02223364|5586871|P2|Overall Study|Physician Decision|0
1603187|NCT02223364|5586872|P1|Overall Study|Physician Decision|1
1603188|NCT02223364|5586870|P3|Overall Study|subject expired before surgery|0
1603189|NCT02223364|5586871|P2|Overall Study|subject expired before surgery|0
1603190|NCT02223364|5586872|P1|Overall Study|subject expired before surgery|1
1603191|NCT02223364|5586870|P3|Overall Study|Protocol Violation|3
1603192|NCT02223364|5586871|P2|Overall Study|Protocol Violation|0
1603193|NCT02223364|5586872|P1|Overall Study|Protocol Violation|3
1603194|NCT02222818|5587048|P2|Period 1|Eligibility criteria not met|3
1603195|NCT02222818|5587049|P1|Period 1|Eligibility criteria not met|0
1603196|NCT02222714|5587061|P5|Overall Study|Withdrawal by Subject|1
1603197|NCT02222714|5587062|P4|Overall Study|Withdrawal by Subject|0
1603198|NCT02222714|5587063|P3|Overall Study|Withdrawal by Subject|1
1603199|NCT02222714|5587064|P2|Overall Study|Withdrawal by Subject|0
1603200|NCT02222714|5587065|P1|Overall Study|Withdrawal by Subject|0
1603201|NCT02222714|5587061|P5|Overall Study|Death|6
1603202|NCT02222714|5587062|P4|Overall Study|Death|4
1603203|NCT02222714|5587063|P3|Overall Study|Death|3
1603204|NCT02222714|5587064|P2|Overall Study|Death|2
1603205|NCT02222714|5587065|P1|Overall Study|Death|0
1603206|NCT02222558|5587104|P6|Period 3|Withdrawal by Subject|1
1603207|NCT02222558|5587105|P5|Period 3|Withdrawal by Subject|0
1603208|NCT02222558|5587106|P4|Period 3|Withdrawal by Subject|0
1603209|NCT02222558|5587107|P3|Period 3|Withdrawal by Subject|0
1603210|NCT02222558|5587108|P2|Period 3|Withdrawal by Subject|0
1603211|NCT02222558|5587109|P1|Period 3|Withdrawal by Subject|0
1603212|NCT02222558|5587104|P6|Period 1: Single Dose|Withdrawal by Subject|0
1603213|NCT02222558|5587105|P5|Period 1: Single Dose|Withdrawal by Subject|0
1603214|NCT02222558|5587106|P4|Period 1: Single Dose|Withdrawal by Subject|0
1603215|NCT02222558|5587107|P3|Period 1: Single Dose|Withdrawal by Subject|0
1603216|NCT02222558|5587108|P2|Period 1: Single Dose|Withdrawal by Subject|0
1603217|NCT02222558|5587109|P1|Period 1: Single Dose|Withdrawal by Subject|4
1603218|NCT02222493|5587125|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
1603219|NCT02222493|5587126|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
1603220|NCT02222493|5587125|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
1603221|NCT02222493|5587126|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
1603222|NCT02222493|5587125|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
1603223|NCT02222493|5587126|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
1603224|NCT02222493|5587125|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
1603225|NCT02222493|5587126|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
1603226|NCT02222493|5587125|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
1603227|NCT02222493|5587126|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
1603228|NCT02222493|5587125|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
1603229|NCT02222493|5587126|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
1603230|NCT02222493|5587125|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1603231|NCT02222493|5587126|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
1603232|NCT02222493|5587125|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
1603233|NCT02222493|5587126|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
1603234|NCT02222493|5587125|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
1603235|NCT02222493|5587126|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
1603236|NCT02222493|5587125|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
1603237|NCT02222493|5587126|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
1603238|NCT02222493|5587125|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
1603239|NCT02222493|5587126|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
1603240|NCT02222493|5587125|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
1603241|NCT02222493|5587126|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
1603242|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
1603243|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
1603244|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
1603245|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
1603246|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
1603247|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
1603248|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
1603249|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
1603250|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
1603251|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
1603252|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
1603253|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
1603254|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
1603255|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
1603256|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
1603257|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
1603258|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
1603259|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
1603260|NCT02222493|5587125|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1603261|NCT02222493|5587126|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
1603262|NCT02222246|5587277|P2|Overall Study|Physician Decision|1
1603263|NCT02222246|5587278|P1|Overall Study|Physician Decision|0
1603264|NCT02222246|5587277|P2|Overall Study|No Emergency Department Visits|26
1603265|NCT02222246|5587278|P1|Overall Study|No Emergency Department Visits|27
1603266|NCT02222207|5587306|P1|Overall Study|Adverse Event|1
1603267|NCT02222207|5587306|P1|Overall Study|Other reasons|2
1603268|NCT02222207|5587306|P1|Overall Study|Death|1
1603269|NCT02221882|5587353|P6|Overall Study|Death|0
1603270|NCT02221882|5587354|P5|Overall Study|Death|0
1603271|NCT02221882|5587355|P4|Overall Study|Death|0
1603272|NCT02221882|5587356|P3|Overall Study|Death|0
1603273|NCT02221882|5587357|P2|Overall Study|Death|1
1603274|NCT02221882|5587358|P1|Overall Study|Death|0
1603275|NCT02221882|5587353|P6|Overall Study|Withdrawal by Subject|2
1603276|NCT02221882|5587354|P5|Overall Study|Withdrawal by Subject|2
1603277|NCT02221882|5587355|P4|Overall Study|Withdrawal by Subject|2
1603278|NCT02221882|5587356|P3|Overall Study|Withdrawal by Subject|4
1603279|NCT02221882|5587357|P2|Overall Study|Withdrawal by Subject|0
1603280|NCT02221882|5587358|P1|Overall Study|Withdrawal by Subject|0
1603281|NCT02221674|5587425|P3|Overall Study|Lost to Follow-up|0
1603282|NCT02221674|5587426|P2|Overall Study|Lost to Follow-up|0
1603283|NCT02221674|5587427|P1|Overall Study|Lost to Follow-up|1
1603284|NCT02221648|5587443|P2|Overall Study|Withdrawal by Subject|3
1603285|NCT02221648|5587444|P1|Overall Study|Withdrawal by Subject|3
1603286|NCT02221284|5587462|P1|Overall Study|Protocol Deviation|5
1603287|NCT02221284|5587462|P1|Overall Study|Case Report Forms Uncollected|56
1603288|NCT02221037|5587494|P4|Overall Study|Physician Decision|0
1603289|NCT02221037|5587495|P3|Overall Study|Physician Decision|1
1603290|NCT02221037|5587496|P2|Overall Study|Physician Decision|0
1603291|NCT02221037|5587497|P1|Overall Study|Physician Decision|0
1603292|NCT02220998|5587583|P2|Overall Study|Lost to Follow-up|4
1603293|NCT02220998|5587584|P1|Overall Study|Lost to Follow-up|4
1603294|NCT02220998|5587583|P2|Overall Study|Lack of Efficacy|5
1603295|NCT02220998|5587584|P1|Overall Study|Lack of Efficacy|0
1603296|NCT02220998|5587583|P2|Overall Study|Death|0
1603297|NCT02220998|5587584|P1|Overall Study|Death|2
1603298|NCT02220998|5587583|P2|Overall Study|Randomized but Never Treated|2
1603299|NCT02220998|5587584|P1|Overall Study|Randomized but Never Treated|1
1603300|NCT02220920|5587602|P2|Overall Study|Conflict with the stopping criteria|2
1603301|NCT02220920|5587603|P1|Overall Study|Conflict with the stopping criteria|1
1603302|NCT02220920|5587602|P2|Overall Study|Withdrawal by Subject|0
1603303|NCT02220920|5587603|P1|Overall Study|Withdrawal by Subject|1
1603304|NCT02220920|5587602|P2|Overall Study|Lack of Efficacy|1
1603305|NCT02220920|5587603|P1|Overall Study|Lack of Efficacy|0
1603306|NCT02220920|5587602|P2|Overall Study|Adverse Event|0
1603307|NCT02220920|5587603|P1|Overall Study|Adverse Event|1
1603308|NCT02220907|5587617|P1|Overall Study|Conflict with the stopping criteria|1
1603309|NCT02220907|5587617|P1|Overall Study|Withdrawal by Subject|2
1603310|NCT02220907|5587617|P1|Overall Study|Physician Decision|1
1603311|NCT02220907|5587617|P1|Overall Study|Adverse Event|7
1603324|NCT02220855|5587653|P1|Overall Study|Withdrawal by Subject|1
1603325|NCT02220855|5587653|P1|Overall Study|Disease Progression|5
1603326|NCT02220855|5587653|P1|Overall Study|Adverse Event|8
1603327|NCT02220764|5587663|P2|Overall Study|Death|0
1603328|NCT02220764|5587664|P1|Overall Study|Death|1
1603329|NCT02220764|5587663|P2|Overall Study|Lost to Follow-up|1
1603330|NCT02220764|5587664|P1|Overall Study|Lost to Follow-up|3
1603331|NCT02220725|5587678|P4|Overall Study|Withdrawal by Subject|1
1603332|NCT02220725|5587679|P3|Overall Study|Withdrawal by Subject|0
1603333|NCT02220725|5587680|P2|Overall Study|Withdrawal by Subject|0
1603334|NCT02220725|5587681|P1|Overall Study|Withdrawal by Subject|0
1603335|NCT02220725|5587678|P4|Overall Study|Lost to Follow-up|1
1603336|NCT02220725|5587679|P3|Overall Study|Lost to Follow-up|0
1603337|NCT02220725|5587680|P2|Overall Study|Lost to Follow-up|0
1603338|NCT02220725|5587681|P1|Overall Study|Lost to Follow-up|0
1603339|NCT02220205|5587711|P2|Overall Study|Withdrawal by Subject|0
1603340|NCT02220205|5587712|P1|Overall Study|Withdrawal by Subject|1
1603341|NCT02219932|5587737|P2|Overall Study|Adverse Event|21
1603342|NCT02219932|5587738|P1|Overall Study|Adverse Event|23
1603343|NCT02219932|5587737|P2|Overall Study|Lost to Follow-up|2
1603344|NCT02219932|5587738|P1|Overall Study|Lost to Follow-up|4
1603345|NCT02219932|5587737|P2|Overall Study|Pregnancy|0
1603346|NCT02219932|5587738|P1|Overall Study|Pregnancy|1
1603347|NCT02219932|5587737|P2|Overall Study|Protocol Violation|6
1603348|NCT02219932|5587738|P1|Overall Study|Protocol Violation|10
1603349|NCT02219932|5587737|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
1603350|NCT02219932|5587738|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
1603351|NCT02219932|5587737|P2|Overall Study|Consent Withdrawn|7
1603352|NCT02219932|5587738|P1|Overall Study|Consent Withdrawn|11
1603353|NCT02219932|5587737|P2|Overall Study|Investigator Decision|1
1603354|NCT02219932|5587738|P1|Overall Study|Investigator Decision|0
1603355|NCT02219932|5587737|P2|Overall Study|Death|1
1603356|NCT02219932|5587738|P1|Overall Study|Death|1
1603357|NCT02219932|5587737|P2|Overall Study|Other|11
1603358|NCT02219932|5587738|P1|Overall Study|Other|5
1603359|NCT02219685|5587754|P2|Blinded Treatment Phase|Withdrew Consent|0
1603360|NCT02219685|5587755|P1|Blinded Treatment Phase|Withdrew Consent|1
1603361|NCT02219685|5587754|P2|Blinded Treatment Phase|Lost to Follow-up|0
1603362|NCT02219685|5587755|P1|Blinded Treatment Phase|Lost to Follow-up|1
1603363|NCT02219477|5587861|P3|Overall Study|Withdrawal by Subject|0
1603364|NCT02219477|5587862|P2|Overall Study|Withdrawal by Subject|1
1603365|NCT02219477|5587863|P1|Overall Study|Withdrawal by Subject|0
1603366|NCT02219477|5587861|P3|Overall Study|Adverse Event|1
1603367|NCT02219477|5587862|P2|Overall Study|Adverse Event|1
1603368|NCT02219477|5587863|P1|Overall Study|Adverse Event|0
1603369|NCT02219464|5587891|P2|Overall Study|catheter malfunction|0
1603370|NCT02219464|5587892|P1|Overall Study|catheter malfunction|1
1603371|NCT02219464|5587891|P2|Overall Study|case cancelled|0
1603372|NCT02219464|5587892|P1|Overall Study|case cancelled|1
1603373|NCT02219464|5587891|P2|Overall Study|Withdrawal by Subject|0
1603374|NCT02219464|5587892|P1|Overall Study|Withdrawal by Subject|1
1603375|NCT02219308|5587902|P2|Overall Study|Withdrawal by Subject|2
1603376|NCT02219308|5587903|P1|Overall Study|Withdrawal by Subject|1
1603377|NCT02219087|5588063|P2|Overall Study|Randomization envelope pulled out of seq|1
1603378|NCT02219087|5588064|P1|Overall Study|Randomization envelope pulled out of seq|0
1603379|NCT02219048|5588084|P2|Overall Study|Other|1
1603380|NCT02219048|5588085|P1|Overall Study|Other|0
1603381|NCT02219048|5588084|P2|Overall Study|Withdrawal by Subject|0
1603382|NCT02219048|5588085|P1|Overall Study|Withdrawal by Subject|2
1603383|NCT02219048|5588084|P2|Overall Study|Study terminated by sponsor|15
1603384|NCT02219048|5588085|P1|Overall Study|Study terminated by sponsor|16
1603385|NCT02219048|5588084|P2|Overall Study|No longer meets eligibility criteria|0
1603386|NCT02219048|5588085|P1|Overall Study|No longer meets eligibility criteria|1
1603387|NCT02219048|5588084|P2|Overall Study|Adverse Event|5
1603388|NCT02219048|5588085|P1|Overall Study|Adverse Event|2
1603389|NCT02219009|5588111|P2|Overall Study|Physician Decision|1
1603390|NCT02219009|5588112|P1|Overall Study|Physician Decision|0
1603391|NCT02219009|5588111|P2|Overall Study|Protocol deviation|0
1603392|NCT02219009|5588112|P1|Overall Study|Protocol deviation|1
1603393|NCT02219009|5588111|P2|Overall Study|Lost to Follow-up|2
1603394|NCT02219009|5588112|P1|Overall Study|Lost to Follow-up|2
1603395|NCT02219009|5588111|P2|Overall Study|Adverse Event|4
1603396|NCT02219009|5588112|P1|Overall Study|Adverse Event|2
1603397|NCT02219009|5588111|P2|Overall Study|Withdrawal by Subject|1
1603398|NCT02219009|5588112|P1|Overall Study|Withdrawal by Subject|5
1603399|NCT02218736|5588124|P2|Overall Study|Protocol Violation|0
1603400|NCT02218736|5588125|P1|Overall Study|Protocol Violation|2
1603401|NCT02218736|5588124|P2|Overall Study|Withdrawal by Subject|9
1603402|NCT02218736|5588125|P1|Overall Study|Withdrawal by Subject|10
1603403|NCT02218697|5588137|P2|Overall Study|Withdrawal by Subject|3
1603404|NCT02218697|5588138|P1|Overall Study|Withdrawal by Subject|2
1603405|NCT02218697|5588137|P2|Overall Study|Unwilling to be vaccinated in left arm|1
1603406|NCT02218697|5588138|P1|Overall Study|Unwilling to be vaccinated in left arm|0
1603407|NCT02218697|5588137|P2|Overall Study|Adverse Event|2
1603408|NCT02218697|5588138|P1|Overall Study|Adverse Event|0
1603409|NCT02218541|5588178|P2|Overall Study|Implant Failure|1
1603410|NCT02218541|5588179|P1|Overall Study|Implant Failure|4
1603411|NCT02218541|5588178|P2|Overall Study|Lost to Follow-up|1
1603412|NCT02218541|5588179|P1|Overall Study|Lost to Follow-up|2
1603413|NCT02218372|5588225|P2|Overall Study|Withdrawal by Parent/Guardian|1
1603414|NCT02218372|5588226|P1|Overall Study|Withdrawal by Parent/Guardian|0
1603415|NCT02218372|5588225|P2|Overall Study|Randomized but did not receive treatment|3
1603416|NCT02218372|5588226|P1|Overall Study|Randomized but did not receive treatment|2
1603417|NCT02218372|5588225|P2|Overall Study|Miscellaneous|1
1603418|NCT02218372|5588226|P1|Overall Study|Miscellaneous|2
1603419|NCT02218372|5588225|P2|Overall Study|Adverse Event|1
1603420|NCT02218372|5588226|P1|Overall Study|Adverse Event|1
1603421|NCT02218268|5588306|P2|24 Hour Washout|Physician Decision|9
1603422|NCT02218268|5588307|P1|24 Hour Washout|Physician Decision|11
1603423|NCT02218216|5588319|P3|Overall Study|Study terminated before completed|0
1603424|NCT02218216|5588320|P2|Overall Study|Study terminated before completed|0
1603425|NCT02218216|5588321|P1|Overall Study|Study terminated before completed|6
1603426|NCT02218008|5588374|P6|Stage 2 (S2)|Lost to Follow-up|1
1603427|NCT02218008|5588375|P5|Stage 2 (S2)|Lost to Follow-up|0
1603428|NCT02218008|5588376|P4|Stage 2 (S2)|Lost to Follow-up|0
1603429|NCT02218008|5588377|P3|Stage 2 (S2)|Lost to Follow-up|0
1603430|NCT02218008|5588378|P2|Stage 2 (S2)|Lost to Follow-up|0
1603431|NCT02218008|5588379|P1|Stage 2 (S2)|Lost to Follow-up|0
1603432|NCT02218008|5588374|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1603433|NCT02218008|5588375|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1603434|NCT02218008|5588376|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
1603435|NCT02218008|5588377|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1603436|NCT02218008|5588378|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1603437|NCT02218008|5588379|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
1603438|NCT02218008|5588374|P6|Stage 2 (S2)|Lack of Efficacy|2
1603439|NCT02218008|5588375|P5|Stage 2 (S2)|Lack of Efficacy|0
1603440|NCT02218008|5588376|P4|Stage 2 (S2)|Lack of Efficacy|0
1603441|NCT02218008|5588377|P3|Stage 2 (S2)|Lack of Efficacy|0
1603442|NCT02218008|5588378|P2|Stage 2 (S2)|Lack of Efficacy|0
1603443|NCT02218008|5588379|P1|Stage 2 (S2)|Lack of Efficacy|0
1603444|NCT02218008|5588374|P6|Stage 2 (S2)|Withdrawal by Subject|0
1603445|NCT02218008|5588375|P5|Stage 2 (S2)|Withdrawal by Subject|1
1603446|NCT02218008|5588376|P4|Stage 2 (S2)|Withdrawal by Subject|1
1603447|NCT02218008|5588377|P3|Stage 2 (S2)|Withdrawal by Subject|0
1603448|NCT02218008|5588378|P2|Stage 2 (S2)|Withdrawal by Subject|0
1603449|NCT02218008|5588379|P1|Stage 2 (S2)|Withdrawal by Subject|0
1603450|NCT02218008|5588374|P6|Stage 2 (S2)|Adverse Event|3
1603451|NCT02218008|5588375|P5|Stage 2 (S2)|Adverse Event|3
1603452|NCT02218008|5588376|P4|Stage 2 (S2)|Adverse Event|2
1603453|NCT02218008|5588377|P3|Stage 2 (S2)|Adverse Event|0
1603454|NCT02218008|5588378|P2|Stage 2 (S2)|Adverse Event|0
1603455|NCT02218008|5588379|P1|Stage 2 (S2)|Adverse Event|0
1603456|NCT02218008|5588374|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1603457|NCT02218008|5588375|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1603458|NCT02218008|5588376|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1603459|NCT02218008|5588377|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1603460|NCT02218008|5588378|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
1603461|NCT02218008|5588379|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
1603462|NCT02218008|5588374|P6|Stage 1 (S1)|Protocol Violation|0
1603463|NCT02218008|5588375|P5|Stage 1 (S1)|Protocol Violation|0
1603464|NCT02218008|5588376|P4|Stage 1 (S1)|Protocol Violation|0
1603465|NCT02218008|5588377|P3|Stage 1 (S1)|Protocol Violation|1
1603466|NCT02218008|5588378|P2|Stage 1 (S1)|Protocol Violation|0
1603467|NCT02218008|5588379|P1|Stage 1 (S1)|Protocol Violation|0
1603468|NCT02218008|5588374|P6|Stage 1 (S1)|Pregnancy|0
1603469|NCT02218008|5588375|P5|Stage 1 (S1)|Pregnancy|0
1603470|NCT02218008|5588376|P4|Stage 1 (S1)|Pregnancy|0
1603471|NCT02218008|5588377|P3|Stage 1 (S1)|Pregnancy|1
1603472|NCT02218008|5588378|P2|Stage 1 (S1)|Pregnancy|0
1603473|NCT02218008|5588379|P1|Stage 1 (S1)|Pregnancy|0
1603474|NCT02218008|5588374|P6|Stage 1 (S1)|Non-compliance; drug use|0
1603475|NCT02218008|5588375|P5|Stage 1 (S1)|Non-compliance; drug use|0
1603476|NCT02218008|5588376|P4|Stage 1 (S1)|Non-compliance; drug use|0
1603477|NCT02218008|5588377|P3|Stage 1 (S1)|Non-compliance; drug use|0
1603478|NCT02218008|5588378|P2|Stage 1 (S1)|Non-compliance; drug use|0
1603479|NCT02218008|5588379|P1|Stage 1 (S1)|Non-compliance; drug use|1
1603480|NCT02218008|5588374|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
1603481|NCT02218008|5588375|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
1603482|NCT02218008|5588376|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
1603483|NCT02218008|5588377|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
1603484|NCT02218008|5588378|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
1603485|NCT02218008|5588379|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
1603486|NCT02218008|5588374|P6|Stage 1 (S1)|Lost to Follow-up|0
1603487|NCT02218008|5588375|P5|Stage 1 (S1)|Lost to Follow-up|0
1603488|NCT02218008|5588376|P4|Stage 1 (S1)|Lost to Follow-up|0
1603489|NCT02218008|5588377|P3|Stage 1 (S1)|Lost to Follow-up|1
1603490|NCT02218008|5588378|P2|Stage 1 (S1)|Lost to Follow-up|0
1603491|NCT02218008|5588379|P1|Stage 1 (S1)|Lost to Follow-up|3
1603492|NCT02218008|5588374|P6|Stage 1 (S1)|Lack of Efficacy|0
1603493|NCT02218008|5588375|P5|Stage 1 (S1)|Lack of Efficacy|0
1603494|NCT02218008|5588376|P4|Stage 1 (S1)|Lack of Efficacy|0
1603495|NCT02218008|5588377|P3|Stage 1 (S1)|Lack of Efficacy|0
1603496|NCT02218008|5588378|P2|Stage 1 (S1)|Lack of Efficacy|0
1603497|NCT02218008|5588379|P1|Stage 1 (S1)|Lack of Efficacy|3
1603498|NCT02218008|5588374|P6|Stage 1 (S1)|Withdrawal by Subject|0
1603499|NCT02218008|5588375|P5|Stage 1 (S1)|Withdrawal by Subject|0
1603500|NCT02218008|5588376|P4|Stage 1 (S1)|Withdrawal by Subject|0
1603501|NCT02218008|5588377|P3|Stage 1 (S1)|Withdrawal by Subject|1
1603502|NCT02218008|5588378|P2|Stage 1 (S1)|Withdrawal by Subject|1
1603503|NCT02218008|5588379|P1|Stage 1 (S1)|Withdrawal by Subject|6
1603504|NCT02218008|5588374|P6|Stage 1 (S1)|Adverse Event|0
1603505|NCT02218008|5588375|P5|Stage 1 (S1)|Adverse Event|0
1603506|NCT02218008|5588376|P4|Stage 1 (S1)|Adverse Event|0
1603507|NCT02218008|5588377|P3|Stage 1 (S1)|Adverse Event|11
1603508|NCT02218008|5588378|P2|Stage 1 (S1)|Adverse Event|5
1603509|NCT02218008|5588379|P1|Stage 1 (S1)|Adverse Event|6
1603510|NCT02217982|5588425|P2|Overall Study|Adverse Event|1
1603511|NCT02217982|5588426|P1|Overall Study|Adverse Event|0
1603512|NCT02217982|5588425|P2|Overall Study|Trial discontinued|0
1603513|NCT02217982|5588426|P1|Overall Study|Trial discontinued|1
1603514|NCT02217878|5588509|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
1603515|NCT02217878|5588510|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
1603516|NCT02217878|5588509|P2|Overall Study|required morphine due to chest pain|2
1603517|NCT02217878|5588510|P1|Overall Study|required morphine due to chest pain|1
1603518|NCT02217566|5588608|P1|Overall Study|Early study termination|6
1603519|NCT02217566|5588608|P1|Overall Study|Death|3
1603520|NCT02217566|5588608|P1|Overall Study|Lost to Follow-up|2
1603521|NCT02217527|5588619|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
1603522|NCT02217527|5588620|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
1603523|NCT02217527|5588619|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
1603524|NCT02217527|5588620|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
1603525|NCT02217475|5588633|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
1603526|NCT02217475|5588634|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
1603527|NCT02217475|5588635|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
1603528|NCT02217475|5588633|P3|Treatment Period 2 (Year 2)|Physician Decision|2
1603529|NCT02217475|5588634|P2|Treatment Period 2 (Year 2)|Physician Decision|0
1603530|NCT02217475|5588635|P1|Treatment Period 2 (Year 2)|Physician Decision|0
1603531|NCT02217475|5588633|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
1603532|NCT02217475|5588634|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
1603533|NCT02217475|5588635|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
1603534|NCT02217475|5588633|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
1603535|NCT02217475|5588634|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
1603536|NCT02217475|5588635|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
1603537|NCT02217475|5588633|P3|Treatment Period 2 (Year 2)|Adverse Event|5
1603538|NCT02217475|5588634|P2|Treatment Period 2 (Year 2)|Adverse Event|1
1603539|NCT02217475|5588635|P1|Treatment Period 2 (Year 2)|Adverse Event|0
1603540|NCT02217475|5588633|P3|Discontinued After Period 1|Physician Decision|1
1603541|NCT02217475|5588634|P2|Discontinued After Period 1|Physician Decision|0
1603542|NCT02217475|5588635|P1|Discontinued After Period 1|Physician Decision|0
1603543|NCT02217475|5588633|P3|Discontinued After Period 1|Participant Withdrew Consent|2
1603544|NCT02217475|5588634|P2|Discontinued After Period 1|Participant Withdrew Consent|1
1603545|NCT02217475|5588635|P1|Discontinued After Period 1|Participant Withdrew Consent|1
1603546|NCT02217475|5588633|P3|Discontinued After Period 1|Adverse Event|0
1603547|NCT02217475|5588634|P2|Discontinued After Period 1|Adverse Event|2
1603548|NCT02217475|5588635|P1|Discontinued After Period 1|Adverse Event|1
1603549|NCT02217475|5588633|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
1603550|NCT02217475|5588634|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
1603551|NCT02217475|5588635|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
1603552|NCT02217475|5588633|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
1603553|NCT02217475|5588634|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
1603554|NCT02217475|5588635|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
1603555|NCT02217475|5588633|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
1603556|NCT02217475|5588634|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
1603557|NCT02217475|5588635|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
1603558|NCT02217475|5588633|P3|Treatment Period 1 (Year 1)|Adverse Event|9
1603559|NCT02217475|5588634|P2|Treatment Period 1 (Year 1)|Adverse Event|5
1603560|NCT02217475|5588635|P1|Treatment Period 1 (Year 1)|Adverse Event|4
1603561|NCT02217475|5588633|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
1603562|NCT02217475|5588634|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
1603563|NCT02217475|5588635|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
1603564|NCT02217436|5588752|P2|Overall Study|Incomplete data|1
1603565|NCT02217436|5588753|P1|Overall Study|Incomplete data|0
1603566|NCT02217436|5588752|P2|Overall Study|Protocol Violation|1
1603567|NCT02217436|5588753|P1|Overall Study|Protocol Violation|1
1603568|NCT02217410|5588764|P3|Overall Study|Physician Decision|0
1603569|NCT02217410|5588765|P2|Overall Study|Physician Decision|3
1603570|NCT02217410|5588766|P1|Overall Study|Physician Decision|1
1603571|NCT02217410|5588764|P3|Overall Study|Lack of Efficacy|0
1603572|NCT02217410|5588765|P2|Overall Study|Lack of Efficacy|1
1603573|NCT02217410|5588766|P1|Overall Study|Lack of Efficacy|0
1603574|NCT02217410|5588764|P3|Overall Study|Lost to Follow-up|1
1603575|NCT02217410|5588765|P2|Overall Study|Lost to Follow-up|0
1603576|NCT02217410|5588766|P1|Overall Study|Lost to Follow-up|0
1603577|NCT02217410|5588764|P3|Overall Study|Withdrawal by Subject|2
1603578|NCT02217410|5588765|P2|Overall Study|Withdrawal by Subject|0
1603579|NCT02217410|5588766|P1|Overall Study|Withdrawal by Subject|0
1603580|NCT02217410|5588764|P3|Overall Study|Graft Loss|2
1603581|NCT02217410|5588765|P2|Overall Study|Graft Loss|0
1603582|NCT02217410|5588766|P1|Overall Study|Graft Loss|0
1603583|NCT02217280|5588789|P1|Overall Study|Post-consent sceen fail|2
1603584|NCT02217280|5588789|P1|Overall Study|Withdrawal by Subject|2
1603585|NCT02216812|5588796|P2|Overall Study|Lost to Follow-up|5
1603586|NCT02216812|5588797|P1|Overall Study|Lost to Follow-up|10
1603587|NCT02216773|5588813|P2|Overall Study|Abandoned|3
1603588|NCT02216773|5588814|P1|Overall Study|Abandoned|4
1603589|NCT02216773|5588813|P2|Overall Study|Insufficient FLRV|0
1603590|NCT02216773|5588814|P1|Overall Study|Insufficient FLRV|4
1603591|NCT02216773|5588813|P2|Overall Study|Disease progression|2
1603592|NCT02216773|5588814|P1|Overall Study|Disease progression|4
1603593|NCT02216591|5588835|P2|Overall Study|Lost to Follow-up|1
1603594|NCT02216591|5588836|P1|Overall Study|Lost to Follow-up|0
1603595|NCT02216526|5588849|P3|Overall Study|Hospitalization|3
1603596|NCT02216526|5588850|P2|Overall Study|Hospitalization|1
1603597|NCT02216526|5588851|P1|Overall Study|Hospitalization|2
1603598|NCT02216526|5588849|P3|Overall Study|Protocol Violation|2
1603599|NCT02216526|5588850|P2|Overall Study|Protocol Violation|0
1603600|NCT02216526|5588851|P1|Overall Study|Protocol Violation|2
1603601|NCT02216526|5588849|P3|Overall Study|Death|3
1603602|NCT02216526|5588850|P2|Overall Study|Death|1
1603603|NCT02216526|5588851|P1|Overall Study|Death|0
1603604|NCT02216526|5588849|P3|Overall Study|Adverse Event|0
1603605|NCT02216526|5588850|P2|Overall Study|Adverse Event|1
1603606|NCT02216526|5588851|P1|Overall Study|Adverse Event|1
1603607|NCT02216357|5588969|P2|Overall Study|Inclusion or exclusion criteria not met|1
1603608|NCT02216357|5588970|P1|Overall Study|Inclusion or exclusion criteria not met|2
1603609|NCT02216214|5588996|P2|Overall Study|Miscellaneous|1
1603610|NCT02216214|5588997|P1|Overall Study|Miscellaneous|1
1603611|NCT02216214|5588996|P2|Overall Study|Study Terminated By Sponsor|1
1603612|NCT02216214|5588997|P1|Overall Study|Study Terminated By Sponsor|0
1603613|NCT02216214|5588996|P2|Overall Study|Withdrawal by Subject|20
1603614|NCT02216214|5588997|P1|Overall Study|Withdrawal by Subject|22
1603615|NCT02216214|5588996|P2|Overall Study|Protocol Violation|2
1603616|NCT02216214|5588997|P1|Overall Study|Protocol Violation|4
1603617|NCT02216214|5588996|P2|Overall Study|Lost to Follow-up|2
1603618|NCT02216214|5588997|P1|Overall Study|Lost to Follow-up|3
1603619|NCT02216214|5588996|P2|Overall Study|Lack of Efficacy|2
1603620|NCT02216214|5588997|P1|Overall Study|Lack of Efficacy|2
1603621|NCT02216214|5588996|P2|Overall Study|Adverse Event|8
1603622|NCT02216214|5588997|P1|Overall Study|Adverse Event|10
1603623|NCT02216214|5588996|P2|Overall Study|Randomized Never Received Study Drug|0
1603624|NCT02216214|5588997|P1|Overall Study|Randomized Never Received Study Drug|1
1603625|NCT02216123|5589068|P2|Overall Study|Withdrawal by Subject|0
1603626|NCT02216123|5589069|P1|Overall Study|Withdrawal by Subject|2
1603627|NCT02216123|5589068|P2|Overall Study|Lost to Follow-up|2
1603628|NCT02216123|5589069|P1|Overall Study|Lost to Follow-up|4
1603629|NCT02215967|5589162|P4|Overall Study|Patient did not get CAR T-Cells|0
1603630|NCT02215967|5589163|P3|Overall Study|Patient did not get CAR T-Cells|1
1603631|NCT02215967|5589164|P2|Overall Study|Patient did not get CAR T-Cells|0
1603632|NCT02215967|5589165|P1|Overall Study|Patient did not get CAR T-Cells|0
1603633|NCT02215967|5589162|P4|Overall Study|Patient became ineligible for treatment|3
1603634|NCT02215967|5589163|P3|Overall Study|Patient became ineligible for treatment|0
1603635|NCT02215967|5589164|P2|Overall Study|Patient became ineligible for treatment|0
1603636|NCT02215967|5589165|P1|Overall Study|Patient became ineligible for treatment|0
1603637|NCT02215954|5589186|P3|Overall Study|Not exposed|3
1603638|NCT02215954|5589187|P2|Overall Study|Not exposed|1
1603639|NCT02215954|5589188|P1|Overall Study|Not exposed|1
1603640|NCT02215954|5589186|P3|Overall Study|Withdrawal by Subject|2
1603641|NCT02215954|5589187|P2|Overall Study|Withdrawal by Subject|0
1603642|NCT02215954|5589188|P1|Overall Study|Withdrawal by Subject|0
1603643|NCT02215954|5589186|P3|Overall Study|Adverse Event|1
1603644|NCT02215954|5589187|P2|Overall Study|Adverse Event|0
1603645|NCT02215954|5589188|P1|Overall Study|Adverse Event|0
1603646|NCT02215616|5589212|P4|Overall Study|Other than specified|1
1603647|NCT02215616|5589213|P3|Overall Study|Other than specified|1
1603648|NCT02215616|5589214|P2|Overall Study|Other than specified|0
1603649|NCT02215616|5589215|P1|Overall Study|Other than specified|1
1603650|NCT02215616|5589212|P4|Overall Study|Lost to Follow-up|1
1603651|NCT02215616|5589213|P3|Overall Study|Lost to Follow-up|0
1603652|NCT02215616|5589214|P2|Overall Study|Lost to Follow-up|1
1603653|NCT02215616|5589215|P1|Overall Study|Lost to Follow-up|1
1603654|NCT02215616|5589212|P4|Overall Study|Protocol Violation|0
1603655|NCT02215616|5589213|P3|Overall Study|Protocol Violation|0
1603656|NCT02215616|5589214|P2|Overall Study|Protocol Violation|2
1603657|NCT02215616|5589215|P1|Overall Study|Protocol Violation|0
1603658|NCT02215616|5589212|P4|Overall Study|Non-compliance|0
1603659|NCT02215616|5589213|P3|Overall Study|Non-compliance|1
1603660|NCT02215616|5589214|P2|Overall Study|Non-compliance|2
1603661|NCT02215616|5589215|P1|Overall Study|Non-compliance|0
1603662|NCT02215616|5589212|P4|Overall Study|Withdrawal by Subject|5
1603663|NCT02215616|5589213|P3|Overall Study|Withdrawal by Subject|2
1603664|NCT02215616|5589214|P2|Overall Study|Withdrawal by Subject|8
1603665|NCT02215616|5589215|P1|Overall Study|Withdrawal by Subject|1
1603666|NCT02215616|5589212|P4|Overall Study|Adverse Event|2
1603667|NCT02215616|5589213|P3|Overall Study|Adverse Event|9
1603668|NCT02215616|5589214|P2|Overall Study|Adverse Event|4
1603669|NCT02215616|5589215|P1|Overall Study|Adverse Event|7
1603670|NCT02215616|5589212|P4|Overall Study|Death|0
1603671|NCT02215616|5589213|P3|Overall Study|Death|0
1603672|NCT02215616|5589214|P2|Overall Study|Death|0
1603673|NCT02215616|5589215|P1|Overall Study|Death|1
1603674|NCT02215616|5589212|P4|Overall Study|Sponsor requested to stop study drug|4
1603675|NCT02215616|5589213|P3|Overall Study|Sponsor requested to stop study drug|1
1603676|NCT02215616|5589214|P2|Overall Study|Sponsor requested to stop study drug|0
1603677|NCT02215616|5589215|P1|Overall Study|Sponsor requested to stop study drug|0
1603678|NCT02215252|5589232|P3|Overall Study|Other|1
1603679|NCT02215252|5589233|P2|Overall Study|Other|1
1603680|NCT02215252|5589234|P1|Overall Study|Other|0
1603681|NCT02215252|5589232|P3|Overall Study|Withdrawal by Subject|0
1603682|NCT02215252|5589233|P2|Overall Study|Withdrawal by Subject|0
1603683|NCT02215252|5589234|P1|Overall Study|Withdrawal by Subject|1
1603684|NCT02215252|5589232|P3|Overall Study|Protocol Violation|0
1603685|NCT02215252|5589233|P2|Overall Study|Protocol Violation|1
1603686|NCT02215252|5589234|P1|Overall Study|Protocol Violation|0
1603687|NCT02215252|5589232|P3|Overall Study|Does not Meet Entrance Criteria|0
1603688|NCT02215252|5589233|P2|Overall Study|Does not Meet Entrance Criteria|1
1603689|NCT02215252|5589234|P1|Overall Study|Does not Meet Entrance Criteria|0
1603690|NCT02215252|5589232|P3|Overall Study|Lost to Follow-up|1
1603691|NCT02215252|5589233|P2|Overall Study|Lost to Follow-up|0
1603692|NCT02215252|5589234|P1|Overall Study|Lost to Follow-up|0
1603693|NCT02215252|5589232|P3|Overall Study|Adverse Event|2
1603694|NCT02215252|5589233|P2|Overall Study|Adverse Event|5
1603695|NCT02215252|5589234|P1|Overall Study|Adverse Event|1
1603696|NCT02214225|5589369|P3|Overall Study|randomized in error, not vaccinated|1
1603697|NCT02214225|5589370|P2|Overall Study|randomized in error, not vaccinated|1
1603698|NCT02214225|5589371|P1|Overall Study|randomized in error, not vaccinated|2
1603699|NCT02214225|5589369|P3|Overall Study|Death|1
1603700|NCT02214225|5589370|P2|Overall Study|Death|0
1603701|NCT02214225|5589371|P1|Overall Study|Death|5
1603702|NCT02214225|5589369|P3|Overall Study|Withdrawal by Subject|2
1603703|NCT02214225|5589370|P2|Overall Study|Withdrawal by Subject|0
1603704|NCT02214225|5589371|P1|Overall Study|Withdrawal by Subject|2
1603705|NCT02214225|5589369|P3|Overall Study|Lost to Follow-up|18
1603706|NCT02214225|5589370|P2|Overall Study|Lost to Follow-up|18
1603707|NCT02214225|5589371|P1|Overall Study|Lost to Follow-up|46
1603708|NCT02214186|5589430|P2|Overall Study|Protocol Violation|1
1603709|NCT02214186|5589431|P1|Overall Study|Protocol Violation|1
1603710|NCT02214186|5589430|P2|Overall Study|Lost to Follow-up|1
1603711|NCT02214186|5589431|P1|Overall Study|Lost to Follow-up|1
1603712|NCT02214121|5589499|P3|Part B|Lost to Follow-up|1
1603713|NCT02214121|5589500|P2|Part B|Lost to Follow-up|0
1603714|NCT02214121|5589501|P1|Part B|Lost to Follow-up|0
1603715|NCT02214121|5589499|P3|Part B|Dev. of study-specific withdrawal crit.|0
1603716|NCT02214121|5589500|P2|Part B|Dev. of study-specific withdrawal crit.|2
1603717|NCT02214121|5589501|P1|Part B|Dev. of study-specific withdrawal crit.|0
1603718|NCT02214121|5589499|P3|Part B|Patient decision|0
1603719|NCT02214121|5589500|P2|Part B|Patient decision|1
1603720|NCT02214121|5589501|P1|Part B|Patient decision|0
1603721|NCT02214121|5589499|P3|Part A|Other|0
1603722|NCT02214121|5589500|P2|Part A|Other|0
1603723|NCT02214121|5589501|P1|Part A|Other|1
1603724|NCT02214121|5589499|P3|Part A|Dev. of study-specific withdrawal crit.|0
1603725|NCT02214121|5589500|P2|Part A|Dev. of study-specific withdrawal crit.|0
1603726|NCT02214121|5589501|P1|Part A|Dev. of study-specific withdrawal crit.|4
1603727|NCT02214121|5589499|P3|Part A|Patient decision|0
1603728|NCT02214121|5589500|P2|Part A|Patient decision|0
1603729|NCT02214121|5589501|P1|Part A|Patient decision|2
1603730|NCT02213666|5589610|P1|Overall Study|Withdrawal by Subject|1
1603731|NCT02213510|5589616|P2|Overall Study|Lost to Follow-up|0
1603732|NCT02213510|5589617|P1|Overall Study|Lost to Follow-up|1
1603733|NCT02213510|5589616|P2|Overall Study|Death|1
1603734|NCT02213510|5589617|P1|Overall Study|Death|0
1603735|NCT02213263|5589645|P2|Overall Study|Adverse Event|3
1603736|NCT02213263|5589646|P1|Overall Study|Adverse Event|1
1603737|NCT02213263|5589645|P2|Overall Study|Protocol Violation|1
1603738|NCT02213263|5589646|P1|Overall Study|Protocol Violation|0
1603739|NCT02213263|5589645|P2|Overall Study|Progressive disease|14
1603740|NCT02213263|5589646|P1|Overall Study|Progressive disease|20
1603741|NCT02213263|5589645|P2|Overall Study|No longer willing to participate|4
1603742|NCT02213263|5589646|P1|Overall Study|No longer willing to participate|3
1603743|NCT02213263|5589645|P2|Overall Study|Lost to Follow-up|1
1603744|NCT02213263|5589646|P1|Overall Study|Lost to Follow-up|0
1603745|NCT02213263|5589645|P2|Overall Study|Insufficient clinical response|3
1603746|NCT02213263|5589646|P1|Overall Study|Insufficient clinical response|4
1603747|NCT02213198|5589714|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
1603748|NCT02213198|5589715|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
1603749|NCT02213198|5589714|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
1603750|NCT02213198|5589715|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
1603751|NCT02213198|5589714|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
1603752|NCT02213198|5589715|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
1603753|NCT02213198|5589714|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
1603754|NCT02213198|5589715|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
1603755|NCT02213198|5589714|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
1603756|NCT02213198|5589715|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
1603757|NCT02213198|5589714|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1603758|NCT02213198|5589715|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
1603759|NCT02213198|5589714|P2|Baseline|incarcerated,violent|1
1603760|NCT02213198|5589715|P1|Baseline|incarcerated,violent|0
1603761|NCT02213198|5589714|P2|Baseline|Lost to Follow-up|21
1603762|NCT02213198|5589715|P1|Baseline|Lost to Follow-up|40
1603763|NCT02213198|5589714|P2|Baseline|transferred out of clinic|9
1603764|NCT02213198|5589715|P1|Baseline|transferred out of clinic|7
1603765|NCT02213198|5589714|P2|Baseline|Withdrawal by Subject|11
1603766|NCT02213198|5589715|P1|Baseline|Withdrawal by Subject|34
1603767|NCT02213198|5589714|P2|Baseline|No show for intake|9
1603768|NCT02213198|5589715|P1|Baseline|No show for intake|7
1603769|NCT02213094|5589725|P2|Overall Study|Adverse Event|0
1603770|NCT02213094|5589726|P1|Overall Study|Adverse Event|1
1603771|NCT02213055|5589734|P2|Overall Study|Did not Return to School|0
1603772|NCT02213055|5589735|P1|Overall Study|Did not Return to School|5
1603773|NCT02213055|5589734|P2|Overall Study|Did not meet Inclusion Criteria|0
1603774|NCT02213055|5589735|P1|Overall Study|Did not meet Inclusion Criteria|6
1603775|NCT02213055|5589734|P2|Overall Study|Had another Treatment during the Study|0
1603776|NCT02213055|5589735|P1|Overall Study|Had another Treatment during the Study|3
1603777|NCT02213055|5589734|P2|Overall Study|Did not have Live Lice|0
1603778|NCT02213055|5589735|P1|Overall Study|Did not have Live Lice|8
1603779|NCT02213055|5589734|P2|Overall Study|Documentation Issue during Study|0
1603780|NCT02213055|5589735|P1|Overall Study|Documentation Issue during Study|10
1603781|NCT02213055|5589734|P2|Overall Study|Documentation Issue at Enrollment|0
1603782|NCT02213055|5589735|P1|Overall Study|Documentation Issue at Enrollment|1
1603783|NCT02213055|5589734|P2|Overall Study|Protocol was not Followed during Study|0
1603784|NCT02213055|5589735|P1|Overall Study|Protocol was not Followed during Study|1
1603785|NCT02213055|5589734|P2|Overall Study|Protocol was not Followed at Enrollment|0
1603786|NCT02213055|5589735|P1|Overall Study|Protocol was not Followed at Enrollment|5
1603787|NCT02212678|5589767|P1|Overall Study|Adverse Event|1
1603788|NCT02212457|5589777|P6|Overall Study|Other|1
1603789|NCT02212457|5589778|P5|Overall Study|Other|0
1603790|NCT02212457|5589779|P4|Overall Study|Other|1
1603791|NCT02212457|5589780|P3|Overall Study|Other|2
1603792|NCT02212457|5589781|P2|Overall Study|Other|1
1603793|NCT02212457|5589782|P1|Overall Study|Other|2
1603794|NCT02212457|5589777|P6|Overall Study|Protocol Violation|3
1603795|NCT02212457|5589778|P5|Overall Study|Protocol Violation|2
1603796|NCT02212457|5589779|P4|Overall Study|Protocol Violation|1
1603797|NCT02212457|5589780|P3|Overall Study|Protocol Violation|0
1603798|NCT02212457|5589781|P2|Overall Study|Protocol Violation|1
1603799|NCT02212457|5589782|P1|Overall Study|Protocol Violation|2
1603800|NCT02212457|5589777|P6|Overall Study|Lost to Follow-up|4
1603801|NCT02212457|5589778|P5|Overall Study|Lost to Follow-up|8
1603802|NCT02212457|5589779|P4|Overall Study|Lost to Follow-up|1
1603803|NCT02212457|5589780|P3|Overall Study|Lost to Follow-up|4
1603804|NCT02212457|5589781|P2|Overall Study|Lost to Follow-up|7
1603805|NCT02212457|5589782|P1|Overall Study|Lost to Follow-up|6
1603806|NCT02212457|5589777|P6|Overall Study|Withdrawal by Subject|4
1603807|NCT02212457|5589778|P5|Overall Study|Withdrawal by Subject|5
1603808|NCT02212457|5589779|P4|Overall Study|Withdrawal by Subject|6
1603809|NCT02212457|5589780|P3|Overall Study|Withdrawal by Subject|8
1603810|NCT02212457|5589781|P2|Overall Study|Withdrawal by Subject|10
1603811|NCT02212457|5589782|P1|Overall Study|Withdrawal by Subject|8
1603812|NCT02212457|5589777|P6|Overall Study|Adverse Event|1
1603813|NCT02212457|5589778|P5|Overall Study|Adverse Event|0
1603814|NCT02212457|5589779|P4|Overall Study|Adverse Event|2
1603815|NCT02212457|5589780|P3|Overall Study|Adverse Event|2
1603816|NCT02212457|5589781|P2|Overall Study|Adverse Event|2
1603817|NCT02212457|5589782|P1|Overall Study|Adverse Event|1
1603818|NCT02212301|5589906|P2|Period 1|Lost to Follow-up|1
1603819|NCT02212301|5589907|P1|Period 1|Lost to Follow-up|0
1603820|NCT02212197|5589918|P3|Overall Study|Need for radiotherapy|0
1603821|NCT02212197|5589919|P2|Overall Study|Need for radiotherapy|0
1603822|NCT02212197|5589920|P1|Overall Study|Need for radiotherapy|1
1603823|NCT02211638|5589973|P1|Overall Study|Protocol Violation|692
1603824|NCT02211638|5589973|P1|Overall Study|Case Report Forms Uncollected|291
1603825|NCT02211313|5590007|P2|Overall Study|No Follow up Questionnaires|1
1603826|NCT02211313|5590008|P1|Overall Study|No Follow up Questionnaires|1
1603827|NCT02211313|5590007|P2|Overall Study|Treatment Failure|2
1603828|NCT02211313|5590008|P1|Overall Study|Treatment Failure|5
1603829|NCT02211261|5590025|P11|Overall Study|Lost to Follow-up|0
1603830|NCT02211261|5590026|P10|Overall Study|Lost to Follow-up|0
1603831|NCT02211261|5590027|P9|Overall Study|Lost to Follow-up|0
1603832|NCT02211261|5590028|P8|Overall Study|Lost to Follow-up|1
1603833|NCT02211261|5590029|P7|Overall Study|Lost to Follow-up|0
1603834|NCT02211261|5590030|P6|Overall Study|Lost to Follow-up|0
1603835|NCT02211261|5590031|P5|Overall Study|Lost to Follow-up|0
1603836|NCT02211261|5590032|P4|Overall Study|Lost to Follow-up|0
1603837|NCT02211261|5590033|P3|Overall Study|Lost to Follow-up|0
1603838|NCT02211261|5590034|P2|Overall Study|Lost to Follow-up|0
1603839|NCT02211261|5590035|P1|Overall Study|Lost to Follow-up|0
1603840|NCT02211261|5590025|P11|Overall Study|Other|0
1603841|NCT02211261|5590026|P10|Overall Study|Other|2
1603842|NCT02211261|5590027|P9|Overall Study|Other|0
1603843|NCT02211261|5590028|P8|Overall Study|Other|0
1603844|NCT02211261|5590029|P7|Overall Study|Other|0
1603845|NCT02211261|5590030|P6|Overall Study|Other|1
1603846|NCT02211261|5590031|P5|Overall Study|Other|0
1603847|NCT02211261|5590032|P4|Overall Study|Other|0
1603848|NCT02211261|5590033|P3|Overall Study|Other|0
1603849|NCT02211261|5590034|P2|Overall Study|Other|0
1603850|NCT02211261|5590035|P1|Overall Study|Other|0
1603851|NCT02211261|5590025|P11|Overall Study|Withdrawal by Subject|0
1603852|NCT02211261|5590026|P10|Overall Study|Withdrawal by Subject|0
1603853|NCT02211261|5590027|P9|Overall Study|Withdrawal by Subject|0
1603854|NCT02211261|5590028|P8|Overall Study|Withdrawal by Subject|0
1603855|NCT02211261|5590029|P7|Overall Study|Withdrawal by Subject|0
1603856|NCT02211261|5590030|P6|Overall Study|Withdrawal by Subject|0
1603857|NCT02211261|5590031|P5|Overall Study|Withdrawal by Subject|2
1603858|NCT02211261|5590032|P4|Overall Study|Withdrawal by Subject|0
1603859|NCT02211261|5590033|P3|Overall Study|Withdrawal by Subject|1
1603860|NCT02211261|5590034|P2|Overall Study|Withdrawal by Subject|0
1603861|NCT02211261|5590035|P1|Overall Study|Withdrawal by Subject|0
1603862|NCT02210689|5590159|P3|Overall Study|Other|8
1603863|NCT02210689|5590160|P2|Overall Study|Other|21
1603864|NCT02210689|5590161|P1|Overall Study|Other|25
1603865|NCT02210689|5590159|P3|Overall Study|Negative Nugent score at baseline|2
1603866|NCT02210689|5590160|P2|Overall Study|Negative Nugent score at baseline|2
1603867|NCT02210689|5590161|P1|Overall Study|Negative Nugent score at baseline|6
1603868|NCT02210689|5590159|P3|Overall Study|Prohibited medication|1
1603869|NCT02210689|5590160|P2|Overall Study|Prohibited medication|8
1603870|NCT02210689|5590161|P1|Overall Study|Prohibited medication|2
1603871|NCT02210689|5590159|P3|Overall Study|Lack of Efficacy|5
1603872|NCT02210689|5590160|P2|Overall Study|Lack of Efficacy|1
1603873|NCT02210689|5590161|P1|Overall Study|Lack of Efficacy|0
1603874|NCT02210689|5590159|P3|Overall Study|Pregnancy|0
1603875|NCT02210689|5590160|P2|Overall Study|Pregnancy|1
1603876|NCT02210689|5590161|P1|Overall Study|Pregnancy|0
1603877|NCT02210689|5590159|P3|Overall Study|Lost to Follow-up|5
1603878|NCT02210689|5590160|P2|Overall Study|Lost to Follow-up|9
1603879|NCT02210689|5590161|P1|Overall Study|Lost to Follow-up|11
1603880|NCT02210689|5590159|P3|Overall Study|Protocol Violation|0
1603881|NCT02210689|5590160|P2|Overall Study|Protocol Violation|0
1603882|NCT02210689|5590161|P1|Overall Study|Protocol Violation|1
1603883|NCT02210689|5590159|P3|Overall Study|Adverse Event|0
1603884|NCT02210689|5590160|P2|Overall Study|Adverse Event|1
1603885|NCT02210689|5590161|P1|Overall Study|Adverse Event|0
1603886|NCT02210689|5590159|P3|Overall Study|Withdrawal by Subject|2
1603887|NCT02210689|5590160|P2|Overall Study|Withdrawal by Subject|4
1603888|NCT02210689|5590161|P1|Overall Study|Withdrawal by Subject|7
1603889|NCT02210208|5590169|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
1603890|NCT02210208|5590169|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
1603891|NCT02210208|5590169|P1|Period A (Graft Site)|Withdrawal by Subject|1
1603892|NCT02210091|5590189|P2|Overall Study|Withdrawal by Sponsor|1
1603893|NCT02210091|5590190|P1|Overall Study|Withdrawal by Sponsor|0
1603894|NCT02210091|5590189|P2|Overall Study|Physician Decision|1
1603895|NCT02210091|5590190|P1|Overall Study|Physician Decision|0
1603896|NCT02210000|5590272|P2|Overall Study|Physician Decision|1
1603897|NCT02210000|5590273|P1|Overall Study|Physician Decision|0
1603898|NCT02210000|5590272|P2|Overall Study|Lost to Follow-up|2
1603899|NCT02210000|5590273|P1|Overall Study|Lost to Follow-up|0
1603900|NCT02210000|5590272|P2|Overall Study|Adverse Event|5
1603901|NCT02210000|5590273|P1|Overall Study|Adverse Event|1
1603902|NCT02210000|5590272|P2|Overall Study|Withdrawal by Subject|1
1603903|NCT02210000|5590273|P1|Overall Study|Withdrawal by Subject|7
1603904|NCT02210000|5590272|P2|Overall Study|Study Terminated|12
1603905|NCT02210000|5590273|P1|Overall Study|Study Terminated|11
1603906|NCT02209766|5590299|P5|Overall Study|Withdrawal by Subject|0
1603907|NCT02209766|5590300|P4|Overall Study|Withdrawal by Subject|1
1603908|NCT02209766|5590301|P3|Overall Study|Withdrawal by Subject|0
1603909|NCT02209766|5590302|P2|Overall Study|Withdrawal by Subject|0
1603910|NCT02209766|5590303|P1|Overall Study|Withdrawal by Subject|0
1603911|NCT02209506|5590386|P5|Overall Study|Withdrawal by Subject|1
1603912|NCT02209506|5590387|P4|Overall Study|Withdrawal by Subject|0
1603913|NCT02209506|5590388|P3|Overall Study|Withdrawal by Subject|0
1603914|NCT02209506|5590389|P2|Overall Study|Withdrawal by Subject|0
1603915|NCT02209506|5590390|P1|Overall Study|Withdrawal by Subject|0
1603916|NCT02209454|5590465|P2|Second Period|Adverse Event|0
1603917|NCT02209454|5590466|P1|Second Period|Adverse Event|1
1603918|NCT02209181|5590516|P4|Overall Study|Withdrawal by Subject|0
1603919|NCT02209181|5590517|P3|Overall Study|Withdrawal by Subject|0
1603920|NCT02209181|5590518|P2|Overall Study|Withdrawal by Subject|1
1603921|NCT02209181|5590519|P1|Overall Study|Withdrawal by Subject|0
1603922|NCT02209181|5590516|P4|Overall Study|Adverse Event|0
1603923|NCT02209181|5590517|P3|Overall Study|Adverse Event|1
1603924|NCT02209181|5590518|P2|Overall Study|Adverse Event|0
1603925|NCT02209181|5590519|P1|Overall Study|Adverse Event|1
1603926|NCT02208999|5590690|P1|Overall Study|Lost to Follow-up|1
1603927|NCT02208843|5590712|P1|Overall Study|Switched to commercial afatinib|20
1603928|NCT02208843|5590712|P1|Overall Study|Withdrawal by Subject|1
1603929|NCT02208843|5590712|P1|Overall Study|Protocol Violation|1
1603930|NCT02208843|5590712|P1|Overall Study|Adverse Event|12
1603931|NCT02208843|5590712|P1|Overall Study|Progression disease according to RECIST|24
1603932|NCT02208843|5590712|P1|Overall Study|Clinical symptoms of progression|2
1603933|NCT02208089|5590764|P2|Overall Study|Lost to Follow-up|0
1603934|NCT02208089|5590765|P1|Overall Study|Lost to Follow-up|6
1603935|NCT02208089|5590764|P2|Overall Study|Withdrawal by Subject|0
1603936|NCT02208089|5590765|P1|Overall Study|Withdrawal by Subject|1
1603945|NCT02207907|5590861|P2|Overall Study|Pregnancy|1
1603946|NCT02207907|5590862|P1|Overall Study|Pregnancy|0
1603947|NCT02207907|5590861|P2|Overall Study|Did not meet study criteria|0
1603948|NCT02207907|5590862|P1|Overall Study|Did not meet study criteria|3
1603949|NCT02207907|5590861|P2|Overall Study|Withdrawal by Subject|6
1603950|NCT02207907|5590862|P1|Overall Study|Withdrawal by Subject|5
1603951|NCT02207907|5590861|P2|Overall Study|Lost to Follow-up|1
1603952|NCT02207907|5590862|P1|Overall Study|Lost to Follow-up|3
1603953|NCT02207829|5590880|P2|Overall Study|Withdrew consent|14
1603954|NCT02207829|5590881|P1|Overall Study|Withdrew consent|18
1603955|NCT02207829|5590880|P2|Overall Study|Protocol deviation|4
1603956|NCT02207829|5590881|P1|Overall Study|Protocol deviation|5
1603957|NCT02207829|5590880|P2|Overall Study|Lost to Follow-up|2
1603958|NCT02207829|5590881|P1|Overall Study|Lost to Follow-up|2
1603959|NCT02207829|5590880|P2|Overall Study|Lack of Efficacy|5
1603960|NCT02207829|5590881|P1|Overall Study|Lack of Efficacy|7
1603961|NCT02207829|5590880|P2|Overall Study|Adverse Event|9
1603962|NCT02207829|5590881|P1|Overall Study|Adverse Event|10
1603963|NCT02207816|5590890|P3|Overall Study|Other|4
1603964|NCT02207816|5590891|P2|Overall Study|Other|2
1603965|NCT02207816|5590892|P1|Overall Study|Other|1
1603966|NCT02207816|5590890|P3|Overall Study|Lost to Follow-up|1
1603967|NCT02207816|5590891|P2|Overall Study|Lost to Follow-up|9
1603968|NCT02207816|5590892|P1|Overall Study|Lost to Follow-up|3
1603969|NCT02207816|5590890|P3|Overall Study|Migrated/Moved From Study Area|51
1603970|NCT02207816|5590891|P2|Overall Study|Migrated/Moved From Study Area|60
1603971|NCT02207816|5590892|P1|Overall Study|Migrated/Moved From Study Area|41
1603972|NCT02207816|5590890|P3|Overall Study|Withdrawal by Subject|7
1603973|NCT02207816|5590891|P2|Overall Study|Withdrawal by Subject|9
1603974|NCT02207816|5590892|P1|Overall Study|Withdrawal by Subject|4
1603975|NCT02207816|5590890|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
1603976|NCT02207816|5590891|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
1603977|NCT02207816|5590892|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
1603978|NCT02207816|5590890|P3|Overall Study|Serious Adverse Event|2
1603979|NCT02207816|5590891|P2|Overall Study|Serious Adverse Event|5
1603980|NCT02207816|5590892|P1|Overall Study|Serious Adverse Event|0
1603981|NCT02207725|5591050|P4|Overall Study|Did Not Receive Treatment|1
1603982|NCT02207725|5591051|P3|Overall Study|Did Not Receive Treatment|1
1603983|NCT02207725|5591052|P2|Overall Study|Did Not Receive Treatment|1
1603984|NCT02207725|5591053|P1|Overall Study|Did Not Receive Treatment|0
1603985|NCT02207634|5591083|P2|Overall Study|Lost to Follow-up|0
1603986|NCT02207634|5591084|P1|Overall Study|Lost to Follow-up|1
1603987|NCT02207634|5591083|P2|Overall Study|Withdrawal by Subject|31
1603988|NCT02207634|5591084|P1|Overall Study|Withdrawal by Subject|21
1603989|NCT02207621|5591099|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
1603990|NCT02207621|5591100|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
1603991|NCT02207621|5591101|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
1603992|NCT02207621|5591099|P3|Overall Study|Death|0
1603993|NCT02207621|5591100|P2|Overall Study|Death|0
1603994|NCT02207621|5591101|P1|Overall Study|Death|2
1603995|NCT02207621|5591099|P3|Overall Study|Protocol Violation|6
1603996|NCT02207621|5591100|P2|Overall Study|Protocol Violation|10
1603997|NCT02207621|5591101|P1|Overall Study|Protocol Violation|4
1603998|NCT02207621|5591099|P3|Overall Study|Physician Decision|2
1603999|NCT02207621|5591100|P2|Overall Study|Physician Decision|2
1604000|NCT02207621|5591101|P1|Overall Study|Physician Decision|1
1604001|NCT02207621|5591099|P3|Overall Study|Disallowed Concurrent Medication|2
1604002|NCT02207621|5591100|P2|Overall Study|Disallowed Concurrent Medication|5
1604003|NCT02207621|5591101|P1|Overall Study|Disallowed Concurrent Medication|2
1604004|NCT02207621|5591099|P3|Overall Study|Lack of Efficacy|4
1604005|NCT02207621|5591100|P2|Overall Study|Lack of Efficacy|2
1604006|NCT02207621|5591101|P1|Overall Study|Lack of Efficacy|10
1604007|NCT02207621|5591099|P3|Overall Study|Lost to Follow-up|3
1604008|NCT02207621|5591100|P2|Overall Study|Lost to Follow-up|0
1604009|NCT02207621|5591101|P1|Overall Study|Lost to Follow-up|1
1604010|NCT02207621|5591099|P3|Overall Study|Non-Compliant|1
1604011|NCT02207621|5591100|P2|Overall Study|Non-Compliant|3
1604012|NCT02207621|5591101|P1|Overall Study|Non-Compliant|3
1604013|NCT02207621|5591099|P3|Overall Study|Withdrawal by Subject|13
1604014|NCT02207621|5591100|P2|Overall Study|Withdrawal by Subject|9
1604015|NCT02207621|5591101|P1|Overall Study|Withdrawal by Subject|9
1604016|NCT02207621|5591099|P3|Overall Study|Adverse Event|132
1604017|NCT02207621|5591100|P2|Overall Study|Adverse Event|15
1604018|NCT02207621|5591101|P1|Overall Study|Adverse Event|71
1604019|NCT02207608|5591114|P2|Overall Study|Adverse Event|0
1604020|NCT02207608|5591115|P1|Overall Study|Adverse Event|1
1604021|NCT02207556|5591141|P2|Overall Study|Death|5
1604022|NCT02207556|5591142|P1|Overall Study|Death|0
1604023|NCT02207556|5591141|P2|Overall Study|Withdrawal by Subject|0
1604024|NCT02207556|5591142|P1|Overall Study|Withdrawal by Subject|1
1604025|NCT02207556|5591141|P2|Overall Study|Physician Decision|0
1604026|NCT02207556|5591142|P1|Overall Study|Physician Decision|1
1604030|NCT02207491|5591161|P2|Overall Study|Protocol Violation|5
1604031|NCT02207491|5591162|P1|Overall Study|Protocol Violation|3
1604032|NCT02207491|5591161|P2|Overall Study|Physician Decision|0
1604033|NCT02207491|5591162|P1|Overall Study|Physician Decision|2
1604034|NCT02207491|5591161|P2|Overall Study|Lack of Efficacy|0
1604035|NCT02207491|5591162|P1|Overall Study|Lack of Efficacy|3
1604036|NCT02207491|5591161|P2|Overall Study|Lost to Follow-up|1
1604037|NCT02207491|5591162|P1|Overall Study|Lost to Follow-up|0
1604038|NCT02207491|5591161|P2|Overall Study|Non-compliant|1
1604039|NCT02207491|5591162|P1|Overall Study|Non-compliant|0
1604040|NCT02207491|5591161|P2|Overall Study|Withdrawal by Subject|2
1604041|NCT02207491|5591162|P1|Overall Study|Withdrawal by Subject|3
1604042|NCT02207491|5591161|P2|Overall Study|Adverse Event|4
1604043|NCT02207491|5591162|P1|Overall Study|Adverse Event|20
1604044|NCT02207413|5591187|P6|Overall Study|Migrated/moved from study area|0
1604045|NCT02207413|5591188|P5|Overall Study|Migrated/moved from study area|1
1604046|NCT02207413|5591189|P4|Overall Study|Migrated/moved from study area|0
1604047|NCT02207413|5591190|P3|Overall Study|Migrated/moved from study area|0
1604048|NCT02207413|5591191|P2|Overall Study|Migrated/moved from study area|0
1604049|NCT02207413|5591192|P1|Overall Study|Migrated/moved from study area|0
1604050|NCT02207413|5591187|P6|Overall Study|Adverse Event|1
1604051|NCT02207413|5591188|P5|Overall Study|Adverse Event|2
1604052|NCT02207413|5591189|P4|Overall Study|Adverse Event|0
1604053|NCT02207413|5591190|P3|Overall Study|Adverse Event|0
1604054|NCT02207413|5591191|P2|Overall Study|Adverse Event|0
1604055|NCT02207413|5591192|P1|Overall Study|Adverse Event|0
1604056|NCT02207413|5591187|P6|Overall Study|Lost to Follow-up|5
1604057|NCT02207413|5591188|P5|Overall Study|Lost to Follow-up|1
1604058|NCT02207413|5591189|P4|Overall Study|Lost to Follow-up|1
1604059|NCT02207413|5591190|P3|Overall Study|Lost to Follow-up|0
1604060|NCT02207413|5591191|P2|Overall Study|Lost to Follow-up|0
1604061|NCT02207413|5591192|P1|Overall Study|Lost to Follow-up|0
1604062|NCT02207413|5591187|P6|Overall Study|Withdrawal by Subject|7
1604063|NCT02207413|5591188|P5|Overall Study|Withdrawal by Subject|3
1604064|NCT02207413|5591189|P4|Overall Study|Withdrawal by Subject|0
1604065|NCT02207413|5591190|P3|Overall Study|Withdrawal by Subject|0
1604066|NCT02207413|5591191|P2|Overall Study|Withdrawal by Subject|0
1604067|NCT02207413|5591192|P1|Overall Study|Withdrawal by Subject|1
1604068|NCT02207400|5591288|P2|Overall Study|Positive Urine Pregnancy Test|1
1604069|NCT02207400|5591289|P1|Overall Study|Positive Urine Pregnancy Test|0
1604070|NCT02207400|5591288|P2|Overall Study|Withdrawal by Subject|4
1604071|NCT02207400|5591289|P1|Overall Study|Withdrawal by Subject|8
1604072|NCT02207400|5591288|P2|Overall Study|Protocol Violation|1
1604073|NCT02207400|5591289|P1|Overall Study|Protocol Violation|1
1604074|NCT02207400|5591288|P2|Overall Study|Lost to Follow-up|7
1604075|NCT02207400|5591289|P1|Overall Study|Lost to Follow-up|6
1604076|NCT02207400|5591288|P2|Overall Study|Adverse Event|1
1604077|NCT02207400|5591289|P1|Overall Study|Adverse Event|1
1604078|NCT02207374|5591310|P3|Overall Study|Missing follow-up information|1
1604079|NCT02207374|5591311|P2|Overall Study|Missing follow-up information|1
1604080|NCT02207374|5591312|P1|Overall Study|Missing follow-up information|0
1604081|NCT02207374|5591310|P3|Overall Study|Death|1
1604082|NCT02207374|5591311|P2|Overall Study|Death|0
1604083|NCT02207374|5591312|P1|Overall Study|Death|1
1604084|NCT02207374|5591310|P3|Overall Study|Withdrawal by Subject|4
1604085|NCT02207374|5591311|P2|Overall Study|Withdrawal by Subject|9
1604086|NCT02207374|5591312|P1|Overall Study|Withdrawal by Subject|5
1604087|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
1604088|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
1604089|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
1604090|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
1604091|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
1604092|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
1604093|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
1604094|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
1604095|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
1604096|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604097|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604098|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
1604099|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604100|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604101|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604102|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604103|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604104|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
1604105|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604106|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604107|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
1604108|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604109|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604110|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604111|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604112|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604113|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
1604114|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
1604115|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
1604116|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
1604117|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1604118|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1604119|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1604120|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1604121|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1604122|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
1604123|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
1604124|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
1604125|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
1604126|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1604127|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1604128|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1604129|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1604130|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1604131|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
1604132|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
1604133|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
1604134|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1604135|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1604136|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1604137|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1604138|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1604139|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1604140|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
1604141|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604142|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
1604143|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604144|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604145|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604146|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604147|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604148|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604149|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
1604150|NCT02207244|5591376|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
1604373|NCT02205333|5591711|P6|Overall Study|Death|3
1604151|NCT02207244|5591377|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
1604152|NCT02207244|5591378|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
1604153|NCT02207244|5591379|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1604154|NCT02207244|5591380|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1604155|NCT02207244|5591381|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1604156|NCT02207244|5591382|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1604157|NCT02207244|5591383|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1604158|NCT02207244|5591384|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
1604159|NCT02207244|5591376|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604160|NCT02207244|5591377|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604161|NCT02207244|5591378|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604162|NCT02207244|5591379|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604163|NCT02207244|5591380|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604164|NCT02207244|5591381|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
1604165|NCT02207244|5591382|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604166|NCT02207244|5591383|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604167|NCT02207244|5591384|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
1604168|NCT02207244|5591376|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1604169|NCT02207244|5591377|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1604170|NCT02207244|5591378|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1604171|NCT02207244|5591379|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
1604172|NCT02207244|5591380|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1604173|NCT02207244|5591381|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
1604174|NCT02207244|5591382|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1604175|NCT02207244|5591383|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1604176|NCT02207244|5591384|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
1604177|NCT02207244|5591376|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1604178|NCT02207244|5591377|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1604179|NCT02207244|5591378|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1604180|NCT02207244|5591379|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
1604181|NCT02207244|5591380|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
1604182|NCT02207244|5591381|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
1604183|NCT02207244|5591382|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1604184|NCT02207244|5591383|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1604185|NCT02207244|5591384|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
1604186|NCT02207244|5591376|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1604187|NCT02207244|5591377|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1604188|NCT02207244|5591378|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1604189|NCT02207244|5591379|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
1604190|NCT02207244|5591380|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
1604191|NCT02207244|5591381|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
1604192|NCT02207244|5591382|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1604193|NCT02207244|5591383|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1604194|NCT02207244|5591384|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
1604195|NCT02207244|5591376|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604196|NCT02207244|5591377|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604197|NCT02207244|5591378|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604198|NCT02207244|5591379|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
1604199|NCT02207244|5591380|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604200|NCT02207244|5591381|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604201|NCT02207244|5591382|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604202|NCT02207244|5591383|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604203|NCT02207244|5591384|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
1604204|NCT02207244|5591376|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1604205|NCT02207244|5591377|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1604206|NCT02207244|5591378|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1604207|NCT02207244|5591379|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
1604208|NCT02207244|5591380|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
1604209|NCT02207244|5591381|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1604210|NCT02207244|5591382|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1604211|NCT02207244|5591383|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1604212|NCT02207244|5591384|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
1604213|NCT02207244|5591376|P9|Placebo Controlled Period: Week 0 - 16|Other|0
1604214|NCT02207244|5591377|P8|Placebo Controlled Period: Week 0 - 16|Other|0
1604215|NCT02207244|5591378|P7|Placebo Controlled Period: Week 0 - 16|Other|0
1604216|NCT02207244|5591379|P6|Placebo Controlled Period: Week 0 - 16|Other|0
1604217|NCT02207244|5591380|P5|Placebo Controlled Period: Week 0 - 16|Other|0
1604218|NCT02207244|5591381|P4|Placebo Controlled Period: Week 0 - 16|Other|0
1604219|NCT02207244|5591382|P3|Placebo Controlled Period: Week 0 - 16|Other|0
1604220|NCT02207244|5591383|P2|Placebo Controlled Period: Week 0 - 16|Other|1
1604221|NCT02207244|5591384|P1|Placebo Controlled Period: Week 0 - 16|Other|0
1604222|NCT02207244|5591376|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1604223|NCT02207244|5591377|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1604224|NCT02207244|5591378|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1604225|NCT02207244|5591379|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1604226|NCT02207244|5591380|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1604227|NCT02207244|5591381|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1604228|NCT02207244|5591382|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
1604229|NCT02207244|5591383|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
1604230|NCT02207244|5591384|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
1604231|NCT02207244|5591376|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604232|NCT02207244|5591377|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604233|NCT02207244|5591378|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604234|NCT02207244|5591379|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604235|NCT02207244|5591380|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604236|NCT02207244|5591381|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604237|NCT02207244|5591382|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1604238|NCT02207244|5591383|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
1604239|NCT02207244|5591384|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1604240|NCT02207244|5591376|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604241|NCT02207244|5591377|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604242|NCT02207244|5591378|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604243|NCT02207244|5591379|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604244|NCT02207244|5591380|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604245|NCT02207244|5591381|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604246|NCT02207244|5591382|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604247|NCT02207244|5591383|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
1604248|NCT02207244|5591384|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
1604249|NCT02207244|5591376|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1604250|NCT02207244|5591377|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1604251|NCT02207244|5591378|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1604252|NCT02207244|5591379|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1604253|NCT02207244|5591380|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1604254|NCT02207244|5591381|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
1604255|NCT02207244|5591382|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
1604256|NCT02207244|5591383|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
1604257|NCT02207244|5591384|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1604258|NCT02207244|5591376|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604259|NCT02207244|5591377|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604260|NCT02207244|5591378|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604261|NCT02207244|5591379|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604262|NCT02207244|5591380|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604263|NCT02207244|5591381|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604264|NCT02207244|5591382|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
1604265|NCT02207244|5591383|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604266|NCT02207244|5591384|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
1604267|NCT02207244|5591376|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1604268|NCT02207244|5591377|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1604269|NCT02207244|5591378|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1604270|NCT02207244|5591379|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1604271|NCT02207244|5591380|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1604272|NCT02207244|5591381|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
1604273|NCT02207244|5591382|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
1604274|NCT02207244|5591383|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
1604275|NCT02207244|5591384|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1604276|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
1604277|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
1604278|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
1604279|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Other|3
1604280|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Other|2
1604281|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Other|0
1604282|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1604283|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
1604284|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
1604285|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
1604286|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
1604287|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
1604288|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
1604289|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
1604290|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
1604291|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
1604292|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
1604293|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
1604294|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
1604295|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
1604296|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
1604297|NCT02207231|5591425|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
1604298|NCT02207231|5591426|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
1604299|NCT02207231|5591427|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
1604300|NCT02207231|5591425|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
1604301|NCT02207231|5591426|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
1604302|NCT02207231|5591427|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
1604303|NCT02207231|5591425|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
1604304|NCT02207231|5591426|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604305|NCT02207231|5591427|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
1604306|NCT02207231|5591425|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
1604307|NCT02207231|5591426|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
1604308|NCT02207231|5591427|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
1604309|NCT02207231|5591425|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1604310|NCT02207231|5591426|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1604311|NCT02207231|5591427|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
1604312|NCT02207231|5591425|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
1604313|NCT02207231|5591426|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
1604314|NCT02207231|5591427|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
1604315|NCT02207231|5591425|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1604316|NCT02207231|5591426|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
1604317|NCT02207231|5591427|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
1604318|NCT02207088|5591459|P1|Overall Study|Adverse Event|2
1604319|NCT02206828|5591465|P1|Overall Study|Lost to Follow-up|7
1604320|NCT02206620|5591501|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
1604321|NCT02206620|5591502|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
1604322|NCT02206620|5591501|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
1604323|NCT02206620|5591502|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
1604324|NCT02206607|5591518|P5|Second Intervention Period|Insufficient Clinical Response|0
1604325|NCT02206607|5591519|P4|Second Intervention Period|Insufficient Clinical Response|1
1604326|NCT02206607|5591520|P3|Second Intervention Period|Insufficient Clinical Response|0
1604327|NCT02206607|5591521|P2|Second Intervention Period|Insufficient Clinical Response|0
1604328|NCT02206607|5591522|P1|Second Intervention Period|Insufficient Clinical Response|0
1604329|NCT02206607|5591518|P5|Open-Label Run-In|Withdrawal by Subject|0
1604330|NCT02206607|5591519|P4|Open-Label Run-In|Withdrawal by Subject|0
1604331|NCT02206607|5591520|P3|Open-Label Run-In|Withdrawal by Subject|0
1604332|NCT02206607|5591521|P2|Open-Label Run-In|Withdrawal by Subject|0
1604333|NCT02206607|5591522|P1|Open-Label Run-In|Withdrawal by Subject|3
1604334|NCT02206152|5591585|P1|Pre-Randomization|Withdrawal by Subject|2
1604335|NCT02205814|5591612|P4|Overall Study|not compliant with study procedures|0
1604336|NCT02205814|5591613|P3|Overall Study|not compliant with study procedures|1
1604337|NCT02205814|5591614|P2|Overall Study|not compliant with study procedures|0
1604338|NCT02205814|5591615|P1|Overall Study|not compliant with study procedures|0
1604339|NCT02205814|5591612|P4|Overall Study|Withdrawal by Subject|1
1604340|NCT02205814|5591613|P3|Overall Study|Withdrawal by Subject|2
1604341|NCT02205814|5591614|P2|Overall Study|Withdrawal by Subject|1
1604342|NCT02205814|5591615|P1|Overall Study|Withdrawal by Subject|0
1604343|NCT02205814|5591612|P4|Overall Study|Protocol Violation|1
1604344|NCT02205814|5591613|P3|Overall Study|Protocol Violation|0
1604345|NCT02205814|5591614|P2|Overall Study|Protocol Violation|0
1604346|NCT02205814|5591615|P1|Overall Study|Protocol Violation|1
1604347|NCT02205814|5591612|P4|Overall Study|Physician Decision|0
1604348|NCT02205814|5591613|P3|Overall Study|Physician Decision|1
1604349|NCT02205814|5591614|P2|Overall Study|Physician Decision|0
1604350|NCT02205814|5591615|P1|Overall Study|Physician Decision|0
1604351|NCT02205814|5591612|P4|Overall Study|Lack of Efficacy|1
1604352|NCT02205814|5591613|P3|Overall Study|Lack of Efficacy|1
1604353|NCT02205814|5591614|P2|Overall Study|Lack of Efficacy|0
1604354|NCT02205814|5591615|P1|Overall Study|Lack of Efficacy|1
1604355|NCT02205814|5591612|P4|Overall Study|Lost to Follow-up|1
1604356|NCT02205814|5591613|P3|Overall Study|Lost to Follow-up|0
1604357|NCT02205814|5591614|P2|Overall Study|Lost to Follow-up|0
1604358|NCT02205814|5591615|P1|Overall Study|Lost to Follow-up|0
1604359|NCT02205476|5591668|P2|Overall Study|Study termination by Sponsor|3
1604360|NCT02205476|5591669|P1|Overall Study|Study termination by Sponsor|7
1604361|NCT02205333|5591708|P9|Overall Study|Withdrawal by Subject|0
1604362|NCT02205333|5591709|P8|Overall Study|Withdrawal by Subject|0
1604363|NCT02205333|5591710|P7|Overall Study|Withdrawal by Subject|2
1604364|NCT02205333|5591711|P6|Overall Study|Withdrawal by Subject|0
1604365|NCT02205333|5591712|P5|Overall Study|Withdrawal by Subject|0
1604366|NCT02205333|5591713|P4|Overall Study|Withdrawal by Subject|1
1604367|NCT02205333|5591714|P3|Overall Study|Withdrawal by Subject|0
1604368|NCT02205333|5591715|P2|Overall Study|Withdrawal by Subject|0
1604369|NCT02205333|5591716|P1|Overall Study|Withdrawal by Subject|1
1604370|NCT02205333|5591708|P9|Overall Study|Death|0
1604371|NCT02205333|5591709|P8|Overall Study|Death|2
1604372|NCT02205333|5591710|P7|Overall Study|Death|3
1604374|NCT02205333|5591712|P5|Overall Study|Death|5
1604375|NCT02205333|5591713|P4|Overall Study|Death|6
1604376|NCT02205333|5591714|P3|Overall Study|Death|2
1604377|NCT02205333|5591715|P2|Overall Study|Death|6
1604378|NCT02205333|5591716|P1|Overall Study|Death|5
1604379|NCT02204982|5591902|P2|Overall Study|Termination of Study bySponsor|1
1604380|NCT02204982|5591903|P1|Overall Study|Termination of Study bySponsor|0
1604381|NCT02204982|5591902|P2|Overall Study|Protocol-Specified Disease Progression|4
1604382|NCT02204982|5591903|P1|Overall Study|Protocol-Specified Disease Progression|0
1604383|NCT02204982|5591902|P2|Overall Study|Physician Decision|2
1604384|NCT02204982|5591903|P1|Overall Study|Physician Decision|0
1604385|NCT02204982|5591902|P2|Overall Study|Adverse Event and Investigator decision|0
1604386|NCT02204982|5591903|P1|Overall Study|Adverse Event and Investigator decision|1
1604387|NCT02204982|5591902|P2|Overall Study|Adverse Event|0
1604388|NCT02204982|5591903|P1|Overall Study|Adverse Event|1
1604389|NCT02204982|5591902|P2|Overall Study|Withdrawal by Subject|0
1604390|NCT02204982|5591903|P1|Overall Study|Withdrawal by Subject|1
1604391|NCT02204982|5591902|P2|Overall Study|Patient ineligible-medical monitor|0
1604392|NCT02204982|5591903|P1|Overall Study|Patient ineligible-medical monitor|1
1604393|NCT02204917|5591911|P1|Overall Study|Protocol Violation|1
1604394|NCT02204579|5591948|P1|Overall Study|Screen failures|2
1604395|NCT02204449|5592006|P2|Overall Study|Withdrawal by Subject|1
1604396|NCT02204449|5592007|P1|Overall Study|Withdrawal by Subject|0
1604397|NCT02204449|5592006|P2|Overall Study|Death|1
1604398|NCT02204449|5592007|P1|Overall Study|Death|0
1604399|NCT02204449|5592006|P2|Overall Study|Lost to Follow-up|9
1604400|NCT02204449|5592007|P1|Overall Study|Lost to Follow-up|7
1604401|NCT02204410|5592017|P1|Overall Study|Withdrawal by Subject|3
1604402|NCT02204410|5592017|P1|Overall Study|Protocol Violation|1
1604403|NCT02204410|5592017|P1|Overall Study|Physician Decision|2
1604404|NCT02204410|5592017|P1|Overall Study|Lost to Follow-up|5
1604405|NCT02204371|5592022|P1|Overall Study|Adverse Event|1
1604406|NCT02204319|5592045|P1|Overall Study|Withdrawal by Subject|2
1604407|NCT02204319|5592045|P1|Overall Study|Pregnancy|1
1604408|NCT02204007|5592106|P2|Overall Study|Surgery Canceled|1
1604409|NCT02204007|5592107|P1|Overall Study|Surgery Canceled|1
1604410|NCT02203916|5592118|P3|Overall Study|Reason Not Specified|1
1604411|NCT02203916|5592119|P2|Overall Study|Reason Not Specified|2
1604412|NCT02203916|5592120|P1|Overall Study|Reason Not Specified|0
1604413|NCT02203916|5592118|P3|Overall Study|Lack of Efficacy|0
1604414|NCT02203916|5592119|P2|Overall Study|Lack of Efficacy|0
1604415|NCT02203916|5592120|P1|Overall Study|Lack of Efficacy|3
1604416|NCT02203916|5592118|P3|Overall Study|Voluntary Withdrawal|8
1604417|NCT02203916|5592119|P2|Overall Study|Voluntary Withdrawal|3
1604418|NCT02203916|5592120|P1|Overall Study|Voluntary Withdrawal|3
1604419|NCT02203916|5592118|P3|Overall Study|Lost to Follow-up|0
1604420|NCT02203916|5592119|P2|Overall Study|Lost to Follow-up|1
1604421|NCT02203916|5592120|P1|Overall Study|Lost to Follow-up|0
1604422|NCT02203916|5592118|P3|Overall Study|Major Protocol Deviation|0
1604423|NCT02203916|5592119|P2|Overall Study|Major Protocol Deviation|1
1604424|NCT02203916|5592120|P1|Overall Study|Major Protocol Deviation|1
1604425|NCT02203916|5592118|P3|Overall Study|Pretreatment Event/Adverse Event|2
1604426|NCT02203916|5592119|P2|Overall Study|Pretreatment Event/Adverse Event|3
1604427|NCT02203916|5592120|P1|Overall Study|Pretreatment Event/Adverse Event|1
1604428|NCT02203851|5592140|P1|Overall Study|Other|1
1604429|NCT02203851|5592140|P1|Overall Study|Withdrawal by Subject|6
1604430|NCT02203851|5592140|P1|Overall Study|Lost to Follow-up|4
1604431|NCT02203838|5592178|P4|Overall Study|Other|0
1604432|NCT02203838|5592179|P3|Overall Study|Other|0
1604433|NCT02203838|5592180|P2|Overall Study|Other|0
1604434|NCT02203838|5592181|P1|Overall Study|Other|1
1604435|NCT02203838|5592178|P4|Overall Study|Physician Decision|3
1604436|NCT02203838|5592179|P3|Overall Study|Physician Decision|2
1604437|NCT02203838|5592180|P2|Overall Study|Physician Decision|0
1604438|NCT02203838|5592181|P1|Overall Study|Physician Decision|27
1604439|NCT02203838|5592178|P4|Overall Study|Withdrawal by Subject|11
1604440|NCT02203838|5592179|P3|Overall Study|Withdrawal by Subject|8
1604441|NCT02203838|5592180|P2|Overall Study|Withdrawal by Subject|10
1604442|NCT02203838|5592181|P1|Overall Study|Withdrawal by Subject|83
1604443|NCT02203838|5592178|P4|Overall Study|Protocol Violation|0
1604444|NCT02203838|5592179|P3|Overall Study|Protocol Violation|0
1604445|NCT02203838|5592180|P2|Overall Study|Protocol Violation|3
1604446|NCT02203838|5592181|P1|Overall Study|Protocol Violation|7
1604447|NCT02203838|5592178|P4|Overall Study|Lost to Follow-up|1
1604448|NCT02203838|5592179|P3|Overall Study|Lost to Follow-up|2
1604449|NCT02203838|5592180|P2|Overall Study|Lost to Follow-up|3
1604450|NCT02203838|5592181|P1|Overall Study|Lost to Follow-up|39
1604451|NCT02203838|5592178|P4|Overall Study|Adverse Event|2
1604452|NCT02203838|5592179|P3|Overall Study|Adverse Event|3
1604453|NCT02203838|5592180|P2|Overall Study|Adverse Event|6
1604454|NCT02203838|5592181|P1|Overall Study|Adverse Event|46
1604455|NCT02203838|5592178|P4|Overall Study|Lack of Efficacy|1
1604456|NCT02203838|5592179|P3|Overall Study|Lack of Efficacy|1
1604457|NCT02203838|5592180|P2|Overall Study|Lack of Efficacy|0
1604458|NCT02203838|5592181|P1|Overall Study|Lack of Efficacy|7
1604459|NCT02203721|5592261|P2|Overall Study|Illness|1
1604460|NCT02203721|5592262|P1|Overall Study|Illness|0
1604461|NCT02203721|5592261|P2|Overall Study|Death|2
1604462|NCT02203721|5592262|P1|Overall Study|Death|0
1604463|NCT02203721|5592261|P2|Overall Study|Lost to Follow-up|0
1604464|NCT02203721|5592262|P1|Overall Study|Lost to Follow-up|1
1604465|NCT02203357|5592362|P3|Overall Study|Lost to Follow-up|70
1604466|NCT02203357|5592363|P2|Overall Study|Lost to Follow-up|66
1604467|NCT02203357|5592364|P1|Overall Study|Lost to Follow-up|58
1604468|NCT02203331|5592387|P6|Overall Study|Lost to Follow-up|0
1604469|NCT02203331|5592388|P5|Overall Study|Lost to Follow-up|1
1604470|NCT02203331|5592389|P4|Overall Study|Lost to Follow-up|0
1604471|NCT02203331|5592390|P3|Overall Study|Lost to Follow-up|0
1604472|NCT02203331|5592391|P2|Overall Study|Lost to Follow-up|0
1604473|NCT02203331|5592392|P1|Overall Study|Lost to Follow-up|0
1604474|NCT02203331|5592387|P6|Overall Study|Protocol Violation|0
1604475|NCT02203331|5592388|P5|Overall Study|Protocol Violation|1
1604476|NCT02203331|5592389|P4|Overall Study|Protocol Violation|1
1604477|NCT02203331|5592390|P3|Overall Study|Protocol Violation|0
1604478|NCT02203331|5592391|P2|Overall Study|Protocol Violation|2
1604479|NCT02203331|5592392|P1|Overall Study|Protocol Violation|0
1604480|NCT02203331|5592387|P6|Overall Study|Lack of Efficacy|1
1604481|NCT02203331|5592388|P5|Overall Study|Lack of Efficacy|0
1604482|NCT02203331|5592389|P4|Overall Study|Lack of Efficacy|0
1604483|NCT02203331|5592390|P3|Overall Study|Lack of Efficacy|1
1604484|NCT02203331|5592391|P2|Overall Study|Lack of Efficacy|2
1604485|NCT02203331|5592392|P1|Overall Study|Lack of Efficacy|0
1604486|NCT02203331|5592387|P6|Overall Study|Other Reasons|0
1604487|NCT02203331|5592388|P5|Overall Study|Other Reasons|0
1604488|NCT02203331|5592389|P4|Overall Study|Other Reasons|2
1604489|NCT02203331|5592390|P3|Overall Study|Other Reasons|0
1604490|NCT02203331|5592391|P2|Overall Study|Other Reasons|2
1604491|NCT02203331|5592392|P1|Overall Study|Other Reasons|1
1604492|NCT02203331|5592387|P6|Overall Study|Adverse Event|3
1604493|NCT02203331|5592388|P5|Overall Study|Adverse Event|3
1604494|NCT02203331|5592389|P4|Overall Study|Adverse Event|4
1604495|NCT02203331|5592390|P3|Overall Study|Adverse Event|3
1604496|NCT02203331|5592391|P2|Overall Study|Adverse Event|8
1604497|NCT02203331|5592392|P1|Overall Study|Adverse Event|4
1604498|NCT02203331|5592387|P6|Overall Study|Withdrawal by Subject|3
1604499|NCT02203331|5592388|P5|Overall Study|Withdrawal by Subject|0
1604500|NCT02203331|5592389|P4|Overall Study|Withdrawal by Subject|0
1604501|NCT02203331|5592390|P3|Overall Study|Withdrawal by Subject|1
1604502|NCT02203331|5592391|P2|Overall Study|Withdrawal by Subject|0
1604503|NCT02203331|5592392|P1|Overall Study|Withdrawal by Subject|1
1604504|NCT02203331|5592387|P6|Overall Study|Pregnancy|0
1604505|NCT02203331|5592388|P5|Overall Study|Pregnancy|2
1604506|NCT02203331|5592389|P4|Overall Study|Pregnancy|0
1604507|NCT02203331|5592390|P3|Overall Study|Pregnancy|0
1604508|NCT02203331|5592391|P2|Overall Study|Pregnancy|0
1604509|NCT02203331|5592392|P1|Overall Study|Pregnancy|1
1604510|NCT02203149|5592451|P5|Part 2|Adverse Event|1
1604511|NCT02203149|5592452|P4|Part 2|Adverse Event|1
1604512|NCT02203149|5592453|P3|Part 2|Adverse Event|0
1604513|NCT02203149|5592454|P2|Part 2|Adverse Event|0
1604514|NCT02203149|5592455|P1|Part 2|Adverse Event|0
1604515|NCT02203149|5592451|P5|Part 2|Withdrawal by Subject|0
1604516|NCT02203149|5592452|P4|Part 2|Withdrawal by Subject|1
1604517|NCT02203149|5592453|P3|Part 2|Withdrawal by Subject|0
1604518|NCT02203149|5592454|P2|Part 2|Withdrawal by Subject|0
1604519|NCT02203149|5592455|P1|Part 2|Withdrawal by Subject|0
1604520|NCT02203149|5592451|P5|Part 2|Death|0
1604521|NCT02203149|5592452|P4|Part 2|Death|1
1604522|NCT02203149|5592453|P3|Part 2|Death|1
1604523|NCT02203149|5592454|P2|Part 2|Death|0
1604524|NCT02203149|5592455|P1|Part 2|Death|0
1604525|NCT02203149|5592451|P5|Part 1|Adverse Event|0
1604526|NCT02203149|5592452|P4|Part 1|Adverse Event|0
1604527|NCT02203149|5592453|P3|Part 1|Adverse Event|0
1604528|NCT02203149|5592454|P2|Part 1|Adverse Event|1
1604529|NCT02203149|5592455|P1|Part 1|Adverse Event|0
1604530|NCT02203032|5592488|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
1604531|NCT02203032|5592489|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
1604532|NCT02203032|5592490|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
1604533|NCT02203032|5592491|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
1604534|NCT02203032|5592488|P4|Blinded Phase (Week 16 to Week 44)|Death|1
1604535|NCT02203032|5592489|P3|Blinded Phase (Week 16 to Week 44)|Death|0
1604536|NCT02203032|5592490|P2|Blinded Phase (Week 16 to Week 44)|Death|0
1604537|NCT02203032|5592491|P1|Blinded Phase (Week 16 to Week 44)|Death|0
1604538|NCT02203032|5592488|P4|Blinded Phase (Week 16 to Week 44)|Other|15
1604539|NCT02203032|5592489|P3|Blinded Phase (Week 16 to Week 44)|Other|1
1604540|NCT02203032|5592490|P2|Blinded Phase (Week 16 to Week 44)|Other|4
1604541|NCT02203032|5592491|P1|Blinded Phase (Week 16 to Week 44)|Other|0
1604542|NCT02203032|5592488|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
1604543|NCT02203032|5592489|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
1604544|NCT02203032|5592490|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
1604545|NCT02203032|5592491|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
1604546|NCT02203032|5592488|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
1604547|NCT02203032|5592489|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
1604548|NCT02203032|5592490|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
1604549|NCT02203032|5592491|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
1604550|NCT02203032|5592488|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1604551|NCT02203032|5592489|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1604552|NCT02203032|5592490|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
1604553|NCT02203032|5592491|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
1604554|NCT02203032|5592488|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
1604555|NCT02203032|5592489|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
1604556|NCT02203032|5592490|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
1604557|NCT02203032|5592491|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
1604558|NCT02203032|5592488|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1604559|NCT02203032|5592489|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1604560|NCT02203032|5592490|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
1604561|NCT02203032|5592491|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
1604562|NCT02203032|5592488|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1604563|NCT02203032|5592489|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1604564|NCT02203032|5592490|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
1604565|NCT02203032|5592491|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
1604566|NCT02203032|5592488|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1604567|NCT02203032|5592489|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1604568|NCT02203032|5592490|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
1604569|NCT02203032|5592491|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
1604570|NCT02203032|5592488|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1604571|NCT02203032|5592489|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1604572|NCT02203032|5592490|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
1604573|NCT02203032|5592491|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
1604574|NCT02203032|5592488|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1604575|NCT02203032|5592489|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1604576|NCT02203032|5592490|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
1604577|NCT02203032|5592491|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
1604578|NCT02202980|5592519|P14|Overall Study|Withdrew Consent|0
1604579|NCT02202980|5592520|P13|Overall Study|Withdrew Consent|0
1604580|NCT02202980|5592521|P12|Overall Study|Withdrew Consent|0
1604581|NCT02202980|5592522|P11|Overall Study|Withdrew Consent|0
1604582|NCT02202980|5592523|P10|Overall Study|Withdrew Consent|0
1604583|NCT02202980|5592524|P9|Overall Study|Withdrew Consent|1
1604584|NCT02202980|5592525|P8|Overall Study|Withdrew Consent|0
1604585|NCT02202980|5592526|P7|Overall Study|Withdrew Consent|0
1604586|NCT02202980|5592527|P6|Overall Study|Withdrew Consent|0
1604587|NCT02202980|5592528|P5|Overall Study|Withdrew Consent|0
1604588|NCT02202980|5592529|P4|Overall Study|Withdrew Consent|0
1604589|NCT02202980|5592530|P3|Overall Study|Withdrew Consent|2
1604590|NCT02202980|5592531|P2|Overall Study|Withdrew Consent|1
1604591|NCT02202980|5592532|P1|Overall Study|Withdrew Consent|0
1604592|NCT02202980|5592519|P14|Overall Study|Lost to Follow-up|0
1604593|NCT02202980|5592520|P13|Overall Study|Lost to Follow-up|1
1604594|NCT02202980|5592521|P12|Overall Study|Lost to Follow-up|0
1604595|NCT02202980|5592522|P11|Overall Study|Lost to Follow-up|0
1604596|NCT02202980|5592523|P10|Overall Study|Lost to Follow-up|0
1604597|NCT02202980|5592524|P9|Overall Study|Lost to Follow-up|1
1604598|NCT02202980|5592525|P8|Overall Study|Lost to Follow-up|1
1604599|NCT02202980|5592526|P7|Overall Study|Lost to Follow-up|0
1604600|NCT02202980|5592527|P6|Overall Study|Lost to Follow-up|0
1604601|NCT02202980|5592528|P5|Overall Study|Lost to Follow-up|0
1604602|NCT02202980|5592529|P4|Overall Study|Lost to Follow-up|1
1604603|NCT02202980|5592530|P3|Overall Study|Lost to Follow-up|1
1604604|NCT02202980|5592531|P2|Overall Study|Lost to Follow-up|1
1604605|NCT02202980|5592532|P1|Overall Study|Lost to Follow-up|0
1604606|NCT02202980|5592519|P14|Overall Study|Protocol Violation|0
1604607|NCT02202980|5592520|P13|Overall Study|Protocol Violation|0
1604608|NCT02202980|5592521|P12|Overall Study|Protocol Violation|0
1604609|NCT02202980|5592522|P11|Overall Study|Protocol Violation|0
1604610|NCT02202980|5592523|P10|Overall Study|Protocol Violation|0
1604611|NCT02202980|5592524|P9|Overall Study|Protocol Violation|0
1604612|NCT02202980|5592525|P8|Overall Study|Protocol Violation|0
1604613|NCT02202980|5592526|P7|Overall Study|Protocol Violation|0
1604614|NCT02202980|5592527|P6|Overall Study|Protocol Violation|0
1604615|NCT02202980|5592528|P5|Overall Study|Protocol Violation|3
1604616|NCT02202980|5592529|P4|Overall Study|Protocol Violation|3
1604617|NCT02202980|5592530|P3|Overall Study|Protocol Violation|0
1604618|NCT02202980|5592531|P2|Overall Study|Protocol Violation|0
1604619|NCT02202980|5592532|P1|Overall Study|Protocol Violation|0
1604620|NCT02202980|5592519|P14|Overall Study|Lack of Efficacy|0
1604621|NCT02202980|5592520|P13|Overall Study|Lack of Efficacy|10
1604622|NCT02202980|5592521|P12|Overall Study|Lack of Efficacy|3
1604623|NCT02202980|5592522|P11|Overall Study|Lack of Efficacy|0
1604624|NCT02202980|5592523|P10|Overall Study|Lack of Efficacy|0
1604625|NCT02202980|5592524|P9|Overall Study|Lack of Efficacy|2
1604626|NCT02202980|5592525|P8|Overall Study|Lack of Efficacy|2
1604627|NCT02202980|5592526|P7|Overall Study|Lack of Efficacy|11
1604628|NCT02202980|5592527|P6|Overall Study|Lack of Efficacy|1
1604629|NCT02202980|5592528|P5|Overall Study|Lack of Efficacy|3
1604630|NCT02202980|5592529|P4|Overall Study|Lack of Efficacy|0
1604631|NCT02202980|5592530|P3|Overall Study|Lack of Efficacy|7
1604632|NCT02202980|5592531|P2|Overall Study|Lack of Efficacy|0
1604633|NCT02202980|5592532|P1|Overall Study|Lack of Efficacy|1
1604634|NCT02202850|5592620|P2|Overall Study|Lost to Follow-up|1
1604635|NCT02202850|5592621|P1|Overall Study|Lost to Follow-up|7
1604636|NCT02202850|5592620|P2|Overall Study|Enbrel treatment discontinued|3
1604637|NCT02202850|5592621|P1|Overall Study|Enbrel treatment discontinued|15
1604638|NCT02202850|5592620|P2|Overall Study|Other|2
1604639|NCT02202850|5592621|P1|Overall Study|Other|2
1604640|NCT02202837|5592673|P2|Overall Study|Lost to Follow-up|1
1604641|NCT02202837|5592674|P1|Overall Study|Lost to Follow-up|7
1604642|NCT02202837|5592673|P2|Overall Study|Other|0
1604643|NCT02202837|5592674|P1|Overall Study|Other|10
1604644|NCT02202837|5592673|P2|Overall Study|Enbrel treatment discontinued|4
1604645|NCT02202837|5592674|P1|Overall Study|Enbrel treatment discontinued|36
1604646|NCT02202785|5592725|P3|Overall Study|Reason not Specified|13
1604647|NCT02202785|5592726|P2|Overall Study|Reason not Specified|7
1604648|NCT02202785|5592727|P1|Overall Study|Reason not Specified|10
1604649|NCT02202785|5592725|P3|Overall Study|Lost to Follow-up|0
1604650|NCT02202785|5592726|P2|Overall Study|Lost to Follow-up|1
1604651|NCT02202785|5592727|P1|Overall Study|Lost to Follow-up|0
1604652|NCT02202785|5592725|P3|Overall Study|Withdrawal by Subject|0
1604653|NCT02202785|5592726|P2|Overall Study|Withdrawal by Subject|1
1604654|NCT02202785|5592727|P1|Overall Study|Withdrawal by Subject|0
1604655|NCT02202785|5592725|P3|Overall Study|Study Terminated by Sponsor|4
1604656|NCT02202785|5592726|P2|Overall Study|Study Terminated by Sponsor|6
1604657|NCT02202785|5592727|P1|Overall Study|Study Terminated by Sponsor|1
1604658|NCT02202759|5592764|P3|Overall Study|Reason not Specified|10
1604659|NCT02202759|5592765|P2|Overall Study|Reason not Specified|11
1604660|NCT02202759|5592766|P1|Overall Study|Reason not Specified|4
1604661|NCT02202759|5592764|P3|Overall Study|Withdrawal by Subject|1
1604662|NCT02202759|5592765|P2|Overall Study|Withdrawal by Subject|1
1604663|NCT02202759|5592766|P1|Overall Study|Withdrawal by Subject|2
1604664|NCT02202759|5592764|P3|Overall Study|Study Terminated by Sponsor|3
1604665|NCT02202759|5592765|P2|Overall Study|Study Terminated by Sponsor|3
1604666|NCT02202759|5592766|P1|Overall Study|Study Terminated by Sponsor|3
1604667|NCT02202616|5592800|P1|Overall Study|Unsatisfactory therapeutic effect|1
1604668|NCT02202616|5592800|P1|Overall Study|Abnormal test procedure result|1
1604669|NCT02202616|5592800|P1|Overall Study|Administrative problems|6
1604670|NCT02202616|5592800|P1|Overall Study|Lost to Follow-up|6
1604671|NCT02202616|5592800|P1|Overall Study|Patient withdrew consent|12
1604672|NCT02202616|5592800|P1|Overall Study|Protocol deviation|18
1604673|NCT02202616|5592800|P1|Overall Study|Adverse Event|32
1604674|NCT02202616|5592800|P1|Overall Study|Screen failed|24
1604675|NCT02202538|5592811|P1|Overall Study|Investigator Decision|1
1604676|NCT02202538|5592811|P1|Overall Study|Did not meet all inclusion criteria|2
1604677|NCT02202538|5592811|P1|Overall Study|Withdrawal by Subject|5
1604678|NCT02202499|5592825|P3|Overall Study|Auto accident|0
1604679|NCT02202499|5592826|P2|Overall Study|Auto accident|0
1604680|NCT02202499|5592827|P1|Overall Study|Auto accident|1
1604681|NCT02202499|5592825|P3|Overall Study|Declined before randomization|0
1604682|NCT02202499|5592826|P2|Overall Study|Declined before randomization|0
1604683|NCT02202499|5592827|P1|Overall Study|Declined before randomization|1
1604684|NCT02202499|5592825|P3|Overall Study|Moved from area|1
1604685|NCT02202499|5592826|P2|Overall Study|Moved from area|0
1604686|NCT02202499|5592827|P1|Overall Study|Moved from area|0
1604687|NCT02202499|5592825|P3|Overall Study|Cancer diagnosis|1
1604688|NCT02202499|5592826|P2|Overall Study|Cancer diagnosis|0
1604689|NCT02202499|5592827|P1|Overall Study|Cancer diagnosis|0
1604690|NCT02202434|5592854|P4|Overall Study|Other|1
1604691|NCT02202434|5592855|P3|Overall Study|Other|0
1604692|NCT02202434|5592856|P2|Overall Study|Other|0
1604693|NCT02202434|5592857|P1|Overall Study|Other|1
1604694|NCT02202434|5592854|P4|Overall Study|Visit Missed|5
1604695|NCT02202434|5592855|P3|Overall Study|Visit Missed|0
1604696|NCT02202434|5592856|P2|Overall Study|Visit Missed|12
1604697|NCT02202434|5592857|P1|Overall Study|Visit Missed|21
1604698|NCT02202434|5592854|P4|Overall Study|Completed Study|0
1604699|NCT02202434|5592855|P3|Overall Study|Completed Study|0
1604700|NCT02202434|5592856|P2|Overall Study|Completed Study|0
1604701|NCT02202434|5592857|P1|Overall Study|Completed Study|1
1604702|NCT02202434|5592854|P4|Overall Study|Withdrawal by Subject|4
1604703|NCT02202434|5592855|P3|Overall Study|Withdrawal by Subject|1
1604704|NCT02202434|5592856|P2|Overall Study|Withdrawal by Subject|14
1604705|NCT02202434|5592857|P1|Overall Study|Withdrawal by Subject|13
1604706|NCT02202434|5592854|P4|Overall Study|Physician Decision|0
1604707|NCT02202434|5592855|P3|Overall Study|Physician Decision|0
1604708|NCT02202434|5592856|P2|Overall Study|Physician Decision|3
1604709|NCT02202434|5592857|P1|Overall Study|Physician Decision|2
1604710|NCT02202434|5592854|P4|Overall Study|Lost to Follow-up|0
1604711|NCT02202434|5592855|P3|Overall Study|Lost to Follow-up|1
1604712|NCT02202434|5592856|P2|Overall Study|Lost to Follow-up|1
1604713|NCT02202434|5592857|P1|Overall Study|Lost to Follow-up|1
1604714|NCT02202434|5592854|P4|Overall Study|Death|27
1604715|NCT02202434|5592855|P3|Overall Study|Death|13
1604716|NCT02202434|5592856|P2|Overall Study|Death|39
1604717|NCT02202434|5592857|P1|Overall Study|Death|70
1604718|NCT02202317|5592981|P1|Overall Study|Lost to Follow-up|1
1604719|NCT02202161|5593008|P8|Overall Study|Withdrawal by Subject|0
1604720|NCT02202161|5593009|P7|Overall Study|Withdrawal by Subject|0
1604721|NCT02202161|5593010|P6|Overall Study|Withdrawal by Subject|0
1604722|NCT02202161|5593011|P5|Overall Study|Withdrawal by Subject|1
1604723|NCT02202161|5593012|P4|Overall Study|Withdrawal by Subject|0
1604724|NCT02202161|5593013|P3|Overall Study|Withdrawal by Subject|0
1604725|NCT02202161|5593014|P2|Overall Study|Withdrawal by Subject|0
1604726|NCT02202161|5593015|P1|Overall Study|Withdrawal by Subject|0
1604727|NCT02202161|5593008|P8|Overall Study|Physician Decision|3
1604728|NCT02202161|5593009|P7|Overall Study|Physician Decision|0
1604729|NCT02202161|5593010|P6|Overall Study|Physician Decision|0
1604730|NCT02202161|5593011|P5|Overall Study|Physician Decision|0
1604731|NCT02202161|5593012|P4|Overall Study|Physician Decision|0
1604732|NCT02202161|5593013|P3|Overall Study|Physician Decision|0
1604733|NCT02202161|5593014|P2|Overall Study|Physician Decision|0
1604734|NCT02202161|5593015|P1|Overall Study|Physician Decision|0
1604735|NCT02202161|5593008|P8|Overall Study|Did not meet continuation criteria|3
1604736|NCT02202161|5593009|P7|Overall Study|Did not meet continuation criteria|0
1604737|NCT02202161|5593010|P6|Overall Study|Did not meet continuation criteria|0
1604738|NCT02202161|5593011|P5|Overall Study|Did not meet continuation criteria|0
1604739|NCT02202161|5593012|P4|Overall Study|Did not meet continuation criteria|0
1604740|NCT02202161|5593013|P3|Overall Study|Did not meet continuation criteria|0
1604741|NCT02202161|5593014|P2|Overall Study|Did not meet continuation criteria|0
1604742|NCT02202161|5593015|P1|Overall Study|Did not meet continuation criteria|0
1604743|NCT02202161|5593008|P8|Overall Study|Adverse Event|0
1604744|NCT02202161|5593009|P7|Overall Study|Adverse Event|0
1604745|NCT02202161|5593010|P6|Overall Study|Adverse Event|1
1604746|NCT02202161|5593011|P5|Overall Study|Adverse Event|0
1604747|NCT02202161|5593012|P4|Overall Study|Adverse Event|0
1604748|NCT02202161|5593013|P3|Overall Study|Adverse Event|0
1604749|NCT02202161|5593014|P2|Overall Study|Adverse Event|1
1604750|NCT02202161|5593015|P1|Overall Study|Adverse Event|1
1604751|NCT02202109|5593175|P2|Overall Study|Withdrawal by Subject|0
1604752|NCT02202109|5593176|P1|Overall Study|Withdrawal by Subject|2
1604753|NCT02202109|5593175|P2|Overall Study|Lost to Follow-up|87
1604754|NCT02202109|5593176|P1|Overall Study|Lost to Follow-up|88
1604755|NCT02202031|5593193|P2|Overall Study|Intolerance/Lack of Improvement|0
1604756|NCT02202031|5593194|P1|Overall Study|Intolerance/Lack of Improvement|3
1604757|NCT02202031|5593193|P2|Overall Study|Illness/Medical Reason|2
1604758|NCT02202031|5593194|P1|Overall Study|Illness/Medical Reason|0
1604759|NCT02202031|5593193|P2|Overall Study|Too Busy|3
1604760|NCT02202031|5593194|P1|Overall Study|Too Busy|1
1604761|NCT02202031|5593193|P2|Overall Study|Lost to Follow-up|0
1604762|NCT02202031|5593194|P1|Overall Study|Lost to Follow-up|1
1604763|NCT02201953|5593242|P2|Overall Study|Death|3
1604764|NCT02201953|5593243|P1|Overall Study|Death|0
1604765|NCT02201953|5593242|P2|Overall Study|Adverse Event|5
1604766|NCT02201953|5593243|P1|Overall Study|Adverse Event|0
1604767|NCT02201953|5593242|P2|Overall Study|Withdrew Consent|5
1604768|NCT02201953|5593243|P1|Overall Study|Withdrew Consent|2
1604769|NCT02201953|5593242|P2|Overall Study|Lost to Follow-up|8
1604770|NCT02201953|5593243|P1|Overall Study|Lost to Follow-up|8
1604771|NCT02201953|5593242|P2|Overall Study|Lack of Efficacy|30
1604772|NCT02201953|5593243|P1|Overall Study|Lack of Efficacy|9
1604773|NCT02201953|5593242|P2|Overall Study|Randomized but Never Treated|5
1604774|NCT02201953|5593243|P1|Overall Study|Randomized but Never Treated|1
1604775|NCT02201940|5593261|P2|Overall Study|Adverse Event|1
1604776|NCT02201940|5593262|P1|Overall Study|Adverse Event|0
1604777|NCT02201940|5593261|P2|Overall Study|Death|0
1604778|NCT02201940|5593262|P1|Overall Study|Death|1
1604779|NCT02201940|5593261|P2|Overall Study|Investigator's Discretion|1
1604780|NCT02201940|5593262|P1|Overall Study|Investigator's Discretion|1
1604781|NCT02201940|5593261|P2|Overall Study|Withdrew Consent|1
1604782|NCT02201940|5593262|P1|Overall Study|Withdrew Consent|2
1604783|NCT02201940|5593261|P2|Overall Study|Lost to Follow-up|0
1604784|NCT02201940|5593262|P1|Overall Study|Lost to Follow-up|5
1604785|NCT02201940|5593261|P2|Overall Study|Lack of Efficacy|113
1604786|NCT02201940|5593262|P1|Overall Study|Lack of Efficacy|2
1604787|NCT02201940|5593261|P2|Overall Study|Randomized/Enrolled but Never Treated|0
1604788|NCT02201940|5593262|P1|Overall Study|Randomized/Enrolled but Never Treated|1
1604789|NCT02201901|5593281|P3|Overall Study|Adverse Event|0
1604790|NCT02201901|5593282|P2|Overall Study|Adverse Event|1
1604791|NCT02201901|5593283|P1|Overall Study|Adverse Event|1
1604792|NCT02201901|5593281|P3|Overall Study|Withdrew Consent|2
1604793|NCT02201901|5593282|P2|Overall Study|Withdrew Consent|0
1604794|NCT02201901|5593283|P1|Overall Study|Withdrew Consent|2
1604795|NCT02201901|5593281|P3|Overall Study|Lost to Follow-up|2
1604796|NCT02201901|5593282|P2|Overall Study|Lost to Follow-up|3
1604797|NCT02201901|5593283|P1|Overall Study|Lost to Follow-up|2
1604798|NCT02201901|5593281|P3|Overall Study|Death|3
1604799|NCT02201901|5593282|P2|Overall Study|Death|3
1604800|NCT02201901|5593283|P1|Overall Study|Death|3
1604801|NCT02201901|5593281|P3|Overall Study|Lack of Efficacy|6
1604802|NCT02201901|5593282|P2|Overall Study|Lack of Efficacy|1
1604803|NCT02201901|5593283|P1|Overall Study|Lack of Efficacy|7
1604804|NCT02201901|5593281|P3|Overall Study|Randomized but never treated|0
1604805|NCT02201901|5593282|P2|Overall Study|Randomized but never treated|1
1604806|NCT02201901|5593283|P1|Overall Study|Randomized but never treated|0
1604807|NCT02201784|5593314|P2|Overall Study|Failure to achieve adequate block|0
1604808|NCT02201784|5593315|P1|Overall Study|Failure to achieve adequate block|2
1604809|NCT02201771|5593332|P3|Overall Study|Protocol Violation|10
1604810|NCT02201771|5593333|P2|Overall Study|Protocol Violation|8
1604811|NCT02201771|5593334|P1|Overall Study|Protocol Violation|10
1604812|NCT02201771|5593332|P3|Overall Study|Death|0
1604813|NCT02201771|5593333|P2|Overall Study|Death|2
1604814|NCT02201771|5593334|P1|Overall Study|Death|3
1604815|NCT02201524|5593361|P4|Overall Study|Other|0
1604816|NCT02201524|5593362|P3|Overall Study|Other|0
1604817|NCT02201524|5593363|P2|Overall Study|Other|1
1604818|NCT02201524|5593364|P1|Overall Study|Other|1
1604819|NCT02201524|5593361|P4|Overall Study|Withdrawal by Subject|1
1604820|NCT02201524|5593362|P3|Overall Study|Withdrawal by Subject|1
1604821|NCT02201524|5593363|P2|Overall Study|Withdrawal by Subject|0
1604822|NCT02201524|5593364|P1|Overall Study|Withdrawal by Subject|0
1604823|NCT02201524|5593361|P4|Overall Study|Protocol Violation|1
1604824|NCT02201524|5593362|P3|Overall Study|Protocol Violation|0
1604825|NCT02201524|5593363|P2|Overall Study|Protocol Violation|0
1604826|NCT02201524|5593364|P1|Overall Study|Protocol Violation|0
1604827|NCT02201524|5593361|P4|Overall Study|No longer meets eligibility criteria|2
1604828|NCT02201524|5593362|P3|Overall Study|No longer meets eligibility criteria|0
1604829|NCT02201524|5593363|P2|Overall Study|No longer meets eligibility criteria|0
1604830|NCT02201524|5593364|P1|Overall Study|No longer meets eligibility criteria|0
1604831|NCT02201524|5593361|P4|Overall Study|Lost to Follow-up|0
1604832|NCT02201524|5593362|P3|Overall Study|Lost to Follow-up|2
1604833|NCT02201524|5593363|P2|Overall Study|Lost to Follow-up|0
1604834|NCT02201524|5593364|P1|Overall Study|Lost to Follow-up|0
1604835|NCT02201524|5593361|P4|Overall Study|Insufficient clinical response|0
1604836|NCT02201524|5593362|P3|Overall Study|Insufficient clinical response|0
1604837|NCT02201524|5593363|P2|Overall Study|Insufficient clinical response|0
1604838|NCT02201524|5593364|P1|Overall Study|Insufficient clinical response|1
1604839|NCT02201524|5593361|P4|Overall Study|Adverse Event|0
1604840|NCT02201524|5593362|P3|Overall Study|Adverse Event|1
1604841|NCT02201524|5593363|P2|Overall Study|Adverse Event|2
1604842|NCT02201524|5593364|P1|Overall Study|Adverse Event|0
1604843|NCT02201329|5593489|P1|Overall Study|Withdrawal by Subject|2
1604844|NCT02201329|5593489|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
1604845|NCT02201290|5593497|P1|Overall Study|Adverse Event|1
1604846|NCT02201290|5593497|P1|Overall Study|Lack of Efficacy|2
1604847|NCT02201290|5593497|P1|Overall Study|Withdrawal by Subject|2
1604848|NCT02201277|5593503|P2|Overall Study|Physician Decision|0
1604849|NCT02201277|5593504|P1|Overall Study|Physician Decision|1
1604850|NCT02201277|5593503|P2|Overall Study|Failed retrieval|0
1604851|NCT02201277|5593504|P1|Overall Study|Failed retrieval|1
1604852|NCT02201277|5593503|P2|Overall Study|Lost to Follow-up|1
1604853|NCT02201277|5593504|P1|Overall Study|Lost to Follow-up|2
1604854|NCT02201277|5593503|P2|Overall Study|Death|4
1604855|NCT02201277|5593504|P1|Overall Study|Death|3
1604856|NCT02200770|5593594|P2|Open-label Period (OLP)|Participants ongoing|162
1604857|NCT02200770|5593595|P1|Open-label Period (OLP)|Participants ongoing|51
1604858|NCT02200770|5593594|P2|Randomized-controlled Period (RCP)|Other|2
1604859|NCT02200770|5593595|P1|Randomized-controlled Period (RCP)|Other|1
1604860|NCT02200770|5593594|P2|Randomized-controlled Period (RCP)|Not treated|1
1604861|NCT02200770|5593595|P1|Randomized-controlled Period (RCP)|Not treated|0
1604862|NCT02200770|5593594|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
1604863|NCT02200770|5593595|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
1604864|NCT02200770|5593594|P2|Randomized-controlled Period (RCP)|Adverse Event|2
1604865|NCT02200770|5593595|P1|Randomized-controlled Period (RCP)|Adverse Event|0
1604888|NCT02200510|5593659|P2|Overall Study|potential COI - joined study team|0
1604889|NCT02200510|5593660|P1|Overall Study|potential COI - joined study team|1
1604890|NCT02200510|5593659|P2|Overall Study|Lost to Follow-up|1
1604891|NCT02200510|5593660|P1|Overall Study|Lost to Follow-up|7
1604892|NCT02200510|5593659|P2|Overall Study|Protocol Violation|1
1604893|NCT02200510|5593660|P1|Overall Study|Protocol Violation|0
1604894|NCT02200510|5593659|P2|Overall Study|Death|1
1604895|NCT02200510|5593660|P1|Overall Study|Death|1
1604896|NCT02200211|5593685|P4|Overall Study|Withdrawal by Subject|0
1604897|NCT02200211|5593686|P3|Overall Study|Withdrawal by Subject|0
1604898|NCT02200211|5593687|P2|Overall Study|Withdrawal by Subject|0
1604899|NCT02200211|5593688|P1|Overall Study|Withdrawal by Subject|1
1604900|NCT02200211|5593685|P4|Overall Study|Lost to Follow-up|2
1604901|NCT02200211|5593686|P3|Overall Study|Lost to Follow-up|1
1604902|NCT02200211|5593687|P2|Overall Study|Lost to Follow-up|7
1604903|NCT02200211|5593688|P1|Overall Study|Lost to Follow-up|7
1604904|NCT02200042|5593801|P2|Overall Study|Withdrawal by Subject|1
1604905|NCT02200042|5593802|P1|Overall Study|Withdrawal by Subject|0
1604906|NCT02199795|5593831|P2|Overall Study|withdrew due to shoulder pain|0
1604907|NCT02199795|5593832|P1|Overall Study|withdrew due to shoulder pain|1
1604908|NCT02199795|5593831|P2|Overall Study|no longer met inclusion criteria|0
1604909|NCT02199795|5593832|P1|Overall Study|no longer met inclusion criteria|1
1604910|NCT02199509|5593873|P2|Overall Study|Misunderstood titration schedule|0
1604911|NCT02199509|5593874|P1|Overall Study|Misunderstood titration schedule|1
1604912|NCT02199509|5593873|P2|Overall Study|Suicidal Ideation|1
1604913|NCT02199509|5593874|P1|Overall Study|Suicidal Ideation|0
1604914|NCT02199080|5593897|P1|Overall Study|Protocol Violation|12
1604915|NCT02199028|5593922|P2|Week 3|Adverse Event|0
1604916|NCT02199028|5593923|P1|Week 3|Adverse Event|1
1604917|NCT02199028|5593922|P2|Week 1|Adverse Event|0
1604918|NCT02199028|5593923|P1|Week 1|Adverse Event|1
1604919|NCT02198963|5593932|P1|Overall Study|Withdrawal by Subject|6
1604920|NCT02198963|5593932|P1|Overall Study|Adverse Event|1
1604921|NCT02198651|5593956|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1604922|NCT02198651|5593957|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
1604923|NCT02198651|5593958|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1604924|NCT02198651|5593959|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1604925|NCT02198651|5593960|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
1604926|NCT02198651|5593956|P5|Open-label Rescue Period|Withdrew consent|0
1604927|NCT02198651|5593957|P4|Open-label Rescue Period|Withdrew consent|2
1604928|NCT02198651|5593958|P3|Open-label Rescue Period|Withdrew consent|0
1604929|NCT02198651|5593959|P2|Open-label Rescue Period|Withdrew consent|0
1604930|NCT02198651|5593960|P1|Open-label Rescue Period|Withdrew consent|0
1604931|NCT02198651|5593956|P5|Double-blind Period|Other, not specified|0
1604932|NCT02198651|5593957|P4|Double-blind Period|Other, not specified|0
1604933|NCT02198651|5593958|P3|Double-blind Period|Other, not specified|1
1604934|NCT02198651|5593959|P2|Double-blind Period|Other, not specified|4
1604935|NCT02198651|5593960|P1|Double-blind Period|Other, not specified|0
1604936|NCT02198651|5593956|P5|Double-blind Period|Adverse Event|0
1604937|NCT02198651|5593957|P4|Double-blind Period|Adverse Event|0
1604938|NCT02198651|5593958|P3|Double-blind Period|Adverse Event|0
1604939|NCT02198651|5593959|P2|Double-blind Period|Adverse Event|1
1604940|NCT02198651|5593960|P1|Double-blind Period|Adverse Event|0
1604941|NCT02198651|5593956|P5|Double-blind Period|Withdrew consent|0
1604942|NCT02198651|5593957|P4|Double-blind Period|Withdrew consent|0
1604943|NCT02198651|5593958|P3|Double-blind Period|Withdrew consent|0
1604944|NCT02198651|5593959|P2|Double-blind Period|Withdrew consent|4
1604945|NCT02198651|5593960|P1|Double-blind Period|Withdrew consent|0
1604946|NCT02198651|5593956|P5|Lead-in Period|Other, not specified|0
1604947|NCT02198651|5593957|P4|Lead-in Period|Other, not specified|0
1604948|NCT02198651|5593958|P3|Lead-in Period|Other, not specified|0
1604949|NCT02198651|5593959|P2|Lead-in Period|Other, not specified|0
1604950|NCT02198651|5593960|P1|Lead-in Period|Other, not specified|22
1604951|NCT02198651|5593956|P5|Lead-in Period|Adverse Event|0
1604952|NCT02198651|5593957|P4|Lead-in Period|Adverse Event|0
1604953|NCT02198651|5593958|P3|Lead-in Period|Adverse Event|0
1604954|NCT02198651|5593959|P2|Lead-in Period|Adverse Event|0
1604955|NCT02198651|5593960|P1|Lead-in Period|Adverse Event|2
1604956|NCT02198651|5593956|P5|Lead-in Period|Withdrew consent|0
1604957|NCT02198651|5593957|P4|Lead-in Period|Withdrew consent|0
1604958|NCT02198651|5593958|P3|Lead-in Period|Withdrew consent|0
1604959|NCT02198651|5593959|P2|Lead-in Period|Withdrew consent|0
1604960|NCT02198651|5593960|P1|Lead-in Period|Withdrew consent|13
1604961|NCT02198235|5594061|P3|Overall Study|Lost to Follow-up|2
1604962|NCT02198235|5594062|P2|Overall Study|Lost to Follow-up|2
1604963|NCT02198235|5594063|P1|Overall Study|Lost to Follow-up|3
1604964|NCT02198040|5594083|P3|Overall Study|Withdrawal by Subject|1
1604965|NCT02198040|5594084|P2|Overall Study|Withdrawal by Subject|0
1604966|NCT02198040|5594085|P1|Overall Study|Withdrawal by Subject|0
1604967|NCT02198040|5594083|P3|Overall Study|Work reasons|0
1604968|NCT02198040|5594084|P2|Overall Study|Work reasons|1
1604969|NCT02198040|5594085|P1|Overall Study|Work reasons|0
1604970|NCT02197806|5594115|P4|Overall Study|Adverse Event|1
1604971|NCT02197806|5594116|P3|Overall Study|Adverse Event|0
1604972|NCT02197806|5594117|P2|Overall Study|Adverse Event|1
1604973|NCT02197806|5594118|P1|Overall Study|Adverse Event|0
1604974|NCT02197520|5594133|P2|Period 2|Withdrawal by Subject|0
1604975|NCT02197520|5594134|P1|Period 2|Withdrawal by Subject|1
1604976|NCT02197520|5594133|P2|Period 2|Adverse Event|2
1604977|NCT02197520|5594134|P1|Period 2|Adverse Event|0
1604978|NCT02197520|5594133|P2|Period 1|Withdrawal by Subject|0
1604979|NCT02197520|5594134|P1|Period 1|Withdrawal by Subject|1
1604980|NCT02197377|5594180|P2|Overall Study|Insertion Failure|3
1604981|NCT02197377|5594181|P1|Overall Study|Insertion Failure|0
1604982|NCT02197247|5594202|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
1604983|NCT02197247|5594202|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
1604984|NCT02197247|5594202|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
1604985|NCT02197247|5594202|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
1604986|NCT02197247|5594202|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
1604987|NCT02197247|5594202|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
1604988|NCT02197247|5594202|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
1604989|NCT02197247|5594202|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
1604990|NCT02197234|5594247|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
1604991|NCT02197234|5594247|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
1604992|NCT02197234|5594247|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
1604993|NCT02197234|5594247|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
1604994|NCT02197234|5594247|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
1604995|NCT02197234|5594247|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
1604996|NCT02197234|5594247|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
1604997|NCT02197130|5594269|P3|Overall Study|Other|3
1604998|NCT02197130|5594270|P2|Overall Study|Other|0
1604999|NCT02197130|5594271|P1|Overall Study|Other|1
1605000|NCT02197130|5594269|P3|Overall Study|Withdrawal by Subject|4
1605001|NCT02197130|5594270|P2|Overall Study|Withdrawal by Subject|3
1605002|NCT02197130|5594271|P1|Overall Study|Withdrawal by Subject|0
1605003|NCT02197130|5594269|P3|Overall Study|Does not meet entrance criteria|1
1605004|NCT02197130|5594270|P2|Overall Study|Does not meet entrance criteria|0
1605005|NCT02197130|5594271|P1|Overall Study|Does not meet entrance criteria|0
1605006|NCT02197130|5594269|P3|Overall Study|Lost to Follow-up|1
1605007|NCT02197130|5594270|P2|Overall Study|Lost to Follow-up|0
1605008|NCT02197130|5594271|P1|Overall Study|Lost to Follow-up|2
1605009|NCT02197130|5594269|P3|Overall Study|Death|0
1605010|NCT02197130|5594270|P2|Overall Study|Death|1
1605011|NCT02197130|5594271|P1|Overall Study|Death|0
1605012|NCT02197130|5594269|P3|Overall Study|Adverse Event|23
1605013|NCT02197130|5594270|P2|Overall Study|Adverse Event|4
1605014|NCT02197130|5594271|P1|Overall Study|Adverse Event|13
1605015|NCT02196714|5594384|P4|Overall Study|Protocol Violation|0
1605016|NCT02196714|5594385|P3|Overall Study|Protocol Violation|1
1605017|NCT02196714|5594386|P2|Overall Study|Protocol Violation|0
1605018|NCT02196714|5594387|P1|Overall Study|Protocol Violation|0
1605019|NCT02196701|5594509|P1|Overall Study|Non-adherence to Protocol|1
1605020|NCT02196701|5594509|P1|Overall Study|Lost to Follow-up|1
1605021|NCT02196701|5594509|P1|Overall Study|Adverse Event|1
1605022|NCT02196675|5594583|P3|Overall Study|Death|1
1605023|NCT02196675|5594584|P2|Overall Study|Death|0
1605024|NCT02196675|5594585|P1|Overall Study|Death|0
1605025|NCT02196675|5594583|P3|Overall Study|Protocol Violation|0
1605026|NCT02196675|5594584|P2|Overall Study|Protocol Violation|1
1605027|NCT02196675|5594585|P1|Overall Study|Protocol Violation|0
1605028|NCT02196675|5594583|P3|Overall Study|Intra-operative surgical exclusion|0
1605029|NCT02196675|5594584|P2|Overall Study|Intra-operative surgical exclusion|1
1605030|NCT02196675|5594585|P1|Overall Study|Intra-operative surgical exclusion|1
1605031|NCT02196675|5594583|P3|Overall Study|Withdrawal by Subject|0
1605032|NCT02196675|5594584|P2|Overall Study|Withdrawal by Subject|0
1605033|NCT02196675|5594585|P1|Overall Study|Withdrawal by Subject|1
1605034|NCT02196506|5594607|P4|Phase A+|Participant withdrawn by investigator|1
1605035|NCT02196506|5594608|P3|Phase A+|Participant withdrawn by investigator|0
1605036|NCT02196506|5594609|P2|Phase A+|Participant withdrawn by investigator|0
1605037|NCT02196506|5594610|P1|Phase A+|Participant withdrawn by investigator|0
1605038|NCT02196506|5594607|P4|Phase A+|Lost to Follow-up|6
1605039|NCT02196506|5594608|P3|Phase A+|Lost to Follow-up|0
1605040|NCT02196506|5594609|P2|Phase A+|Lost to Follow-up|0
1605041|NCT02196506|5594610|P1|Phase A+|Lost to Follow-up|0
1605042|NCT02196506|5594607|P4|Phase A+|Adverse Event|1
1605043|NCT02196506|5594608|P3|Phase A+|Adverse Event|0
1605044|NCT02196506|5594609|P2|Phase A+|Adverse Event|0
1605045|NCT02196506|5594610|P1|Phase A+|Adverse Event|0
1605046|NCT02196506|5594607|P4|Phase A+|Withdrawal by Participant|5
1605047|NCT02196506|5594608|P3|Phase A+|Withdrawal by Participant|0
1605048|NCT02196506|5594609|P2|Phase A+|Withdrawal by Participant|0
1605049|NCT02196506|5594610|P1|Phase A+|Withdrawal by Participant|0
1605050|NCT02196506|5594607|P4|Phase A+|Participant Met Withdrawal Criteria|1
1605051|NCT02196506|5594608|P3|Phase A+|Participant Met Withdrawal Criteria|0
1605052|NCT02196506|5594609|P2|Phase A+|Participant Met Withdrawal Criteria|0
1605053|NCT02196506|5594610|P1|Phase A+|Participant Met Withdrawal Criteria|0
1605054|NCT02196506|5594607|P4|Phase B|Lost to Follow-up|0
1605055|NCT02196506|5594608|P3|Phase B|Lost to Follow-up|1
1605056|NCT02196506|5594609|P2|Phase B|Lost to Follow-up|2
1605057|NCT02196506|5594610|P1|Phase B|Lost to Follow-up|0
1605058|NCT02196506|5594607|P4|Phase B|Adverse Event|0
1605059|NCT02196506|5594608|P3|Phase B|Adverse Event|1
1605060|NCT02196506|5594609|P2|Phase B|Adverse Event|4
1605061|NCT02196506|5594610|P1|Phase B|Adverse Event|0
1605062|NCT02196506|5594607|P4|Phase B|Withdrawal by Participant|0
1605063|NCT02196506|5594608|P3|Phase B|Withdrawal by Participant|1
1605064|NCT02196506|5594609|P2|Phase B|Withdrawal by Participant|8
1605065|NCT02196506|5594610|P1|Phase B|Withdrawal by Participant|0
1605066|NCT02196506|5594607|P4|Phase B|Lack of Efficacy|0
1605067|NCT02196506|5594608|P3|Phase B|Lack of Efficacy|2
1605068|NCT02196506|5594609|P2|Phase B|Lack of Efficacy|1
1605069|NCT02196506|5594610|P1|Phase B|Lack of Efficacy|0
1605070|NCT02196506|5594607|P4|Phase B|Participant Met Withdrawal Criteria|0
1605071|NCT02196506|5594608|P3|Phase B|Participant Met Withdrawal Criteria|1
1605072|NCT02196506|5594609|P2|Phase B|Participant Met Withdrawal Criteria|0
1605073|NCT02196506|5594610|P1|Phase B|Participant Met Withdrawal Criteria|0
1605074|NCT02196506|5594607|P4|Phase A|Participant withdrawn by investigator|0
1605075|NCT02196506|5594608|P3|Phase A|Participant withdrawn by investigator|0
1605076|NCT02196506|5594609|P2|Phase A|Participant withdrawn by investigator|0
1605077|NCT02196506|5594610|P1|Phase A|Participant withdrawn by investigator|10
1605078|NCT02196506|5594607|P4|Phase A|Protocol deviation|0
1605079|NCT02196506|5594608|P3|Phase A|Protocol deviation|0
1605080|NCT02196506|5594609|P2|Phase A|Protocol deviation|0
1605081|NCT02196506|5594610|P1|Phase A|Protocol deviation|12
1605082|NCT02196506|5594607|P4|Phase A|Lost to Follow-up|0
1605083|NCT02196506|5594608|P3|Phase A|Lost to Follow-up|0
1605084|NCT02196506|5594609|P2|Phase A|Lost to Follow-up|0
1605085|NCT02196506|5594610|P1|Phase A|Lost to Follow-up|9
1605086|NCT02196506|5594607|P4|Phase A|Adverse Event|0
1605087|NCT02196506|5594608|P3|Phase A|Adverse Event|0
1605088|NCT02196506|5594609|P2|Phase A|Adverse Event|0
1605089|NCT02196506|5594610|P1|Phase A|Adverse Event|22
1605090|NCT02196506|5594607|P4|Phase A|Withdrawal by Subject|0
1605091|NCT02196506|5594608|P3|Phase A|Withdrawal by Subject|0
1605092|NCT02196506|5594609|P2|Phase A|Withdrawal by Subject|0
1605093|NCT02196506|5594610|P1|Phase A|Withdrawal by Subject|34
1605094|NCT02196506|5594607|P4|Phase A|Participant Met Withdrawal Criteria|0
1605095|NCT02196506|5594608|P3|Phase A|Participant Met Withdrawal Criteria|0
1605096|NCT02196506|5594609|P2|Phase A|Participant Met Withdrawal Criteria|0
1605097|NCT02196506|5594610|P1|Phase A|Participant Met Withdrawal Criteria|34
1605098|NCT02196259|5594625|P3|Overall Study|Partial data analysis|0
1605099|NCT02196259|5594626|P2|Overall Study|Partial data analysis|3
1605100|NCT02196259|5594627|P1|Overall Study|Partial data analysis|0
1605101|NCT02196259|5594625|P3|Overall Study|Researcher choice|1
1605102|NCT02196259|5594626|P2|Overall Study|Researcher choice|0
1605103|NCT02196259|5594627|P1|Overall Study|Researcher choice|0
1605104|NCT02196077|5594655|P1|Overall Study|Protocol Violation|24
1605105|NCT02196077|5594655|P1|Overall Study|Lost to Follow-up|3
1605106|NCT02196077|5594655|P1|Overall Study|Physician Decision|1
1605107|NCT02196077|5594655|P1|Overall Study|Withdrawal by Subject|14
1605108|NCT02196077|5594655|P1|Overall Study|Lack of Efficacy|1
1605109|NCT02196077|5594655|P1|Overall Study|Adverse Event|4
1605110|NCT02195986|5594705|P3|Overall Study|Non-compliance|0
1605111|NCT02195986|5594706|P2|Overall Study|Non-compliance|1
1605112|NCT02195986|5594707|P1|Overall Study|Non-compliance|0
1605113|NCT02195986|5594705|P3|Overall Study|Protocol Violation|1
1605114|NCT02195986|5594706|P2|Overall Study|Protocol Violation|1
1605115|NCT02195986|5594707|P1|Overall Study|Protocol Violation|0
1605116|NCT02195986|5594705|P3|Overall Study|Family Emergency|1
1605117|NCT02195986|5594706|P2|Overall Study|Family Emergency|0
1605118|NCT02195986|5594707|P1|Overall Study|Family Emergency|0
1605119|NCT02195986|5594705|P3|Overall Study|Withdrawal by Subject|0
1605120|NCT02195986|5594706|P2|Overall Study|Withdrawal by Subject|3
1605121|NCT02195986|5594707|P1|Overall Study|Withdrawal by Subject|0
1605122|NCT02195986|5594705|P3|Overall Study|Adverse Event|0
1605123|NCT02195986|5594706|P2|Overall Study|Adverse Event|0
1605124|NCT02195986|5594707|P1|Overall Study|Adverse Event|3
1605125|NCT02195869|5594730|P1|Overall Study|Noncompliance with study drug|2
1605126|NCT02195869|5594730|P1|Overall Study|Study Terminated by Sponsor|7
1605127|NCT02195869|5594730|P1|Overall Study|Physician Decision|4
1605128|NCT02195869|5594730|P1|Overall Study|Withdrawal by Subject|7
1605129|NCT02195869|5594730|P1|Overall Study|Adverse Event|15
1605130|NCT02195869|5594730|P1|Overall Study|Malignancy Progression/relapse|2
1605131|NCT02195869|5594730|P1|Overall Study|cGVHD Progression|5
1605132|NCT02195700|5594752|P2|Overall Study|Lost to Follow-up|1
1605133|NCT02195700|5594753|P1|Overall Study|Lost to Follow-up|1
1605134|NCT02195700|5594752|P2|Overall Study|Withdrawal by Subject|2
1605135|NCT02195700|5594753|P1|Overall Study|Withdrawal by Subject|3
1605136|NCT02195700|5594752|P2|Overall Study|Adverse Event|2
1605137|NCT02195700|5594753|P1|Overall Study|Adverse Event|1
1605138|NCT02195700|5594752|P2|Overall Study|Noncompliance|0
1605139|NCT02195700|5594753|P1|Overall Study|Noncompliance|1
1605140|NCT02195700|5594752|P2|Overall Study|Protocol Violation|2
1605141|NCT02195700|5594753|P1|Overall Study|Protocol Violation|0
1605142|NCT02195687|5594775|P2|Overall Study|Lost to Follow-up|1
1605143|NCT02195687|5594776|P1|Overall Study|Lost to Follow-up|4
1605144|NCT02195687|5594775|P2|Overall Study|Personal Reasons|1
1605145|NCT02195687|5594776|P1|Overall Study|Personal Reasons|1
1605146|NCT02195583|5594801|P1|Overall Study|Other Reason|2
1605147|NCT02195583|5594801|P1|Overall Study|Adverse Event|2
1605148|NCT02195583|5594801|P1|Overall Study|Withdrawal by Subject|4
1605149|NCT02195583|5594801|P1|Overall Study|Lost to Follow-up|1
1605150|NCT02195531|5594836|P3|Overall Study|Withdrawal by Subject|1
1605151|NCT02195531|5594837|P2|Overall Study|Withdrawal by Subject|1
1605152|NCT02195531|5594838|P1|Overall Study|Withdrawal by Subject|1
1605153|NCT02195518|5594863|P1|Overall Study|Lost to Follow-up|1
1605154|NCT02195518|5594863|P1|Overall Study|Withdrawal by Subject|1
1605155|NCT02195518|5594863|P1|Overall Study|Pregnancy|2
1605156|NCT02195518|5594863|P1|Overall Study|Protocol Violation|4
1605157|NCT02195518|5594863|P1|Overall Study|Adverse Event|1
1605158|NCT02195479|5594886|P2|Overall Study|Ongoing|297
1605159|NCT02195479|5594887|P1|Overall Study|Ongoing|291
1605160|NCT02195479|5594886|P2|Overall Study|Other|2
1605161|NCT02195479|5594887|P1|Overall Study|Other|2
1605162|NCT02195479|5594886|P2|Overall Study|Withdrawal by Subject|6
1605163|NCT02195479|5594887|P1|Overall Study|Withdrawal by Subject|11
1605164|NCT02195479|5594886|P2|Overall Study|Physician Decision|0
1605165|NCT02195479|5594887|P1|Overall Study|Physician Decision|1
1605166|NCT02195479|5594886|P2|Overall Study|Death|45
1605167|NCT02195479|5594887|P1|Overall Study|Death|48
1605168|NCT02195479|5594886|P2|Overall Study|Lost to Follow-up|0
1605169|NCT02195479|5594887|P1|Overall Study|Lost to Follow-up|3
1605170|NCT02195427|5594925|P2|Overall Study|Conditional re-treatment at W52|1
1605171|NCT02195427|5594926|P1|Overall Study|Conditional re-treatment at W52|2
1605172|NCT02195427|5594925|P2|Overall Study|Protocol Violation|14
1605173|NCT02195427|5594926|P1|Overall Study|Protocol Violation|7
1605174|NCT02195427|5594925|P2|Overall Study|Lost to Follow-up|1
1605175|NCT02195427|5594926|P1|Overall Study|Lost to Follow-up|0
1605176|NCT02195427|5594925|P2|Overall Study|Withdrawal by Subject|2
1605177|NCT02195427|5594926|P1|Overall Study|Withdrawal by Subject|4
1605178|NCT02195427|5594925|P2|Overall Study|Did not consent to study extension|9
1605179|NCT02195427|5594926|P1|Overall Study|Did not consent to study extension|13
1605180|NCT02195011|5595291|P2|Overall Study|Withdrawal by Subject|0
1605181|NCT02195011|5595292|P1|Overall Study|Withdrawal by Subject|3
1605182|NCT02195011|5595291|P2|Overall Study|Progressive Disease|1
1605183|NCT02195011|5595292|P1|Overall Study|Progressive Disease|18
1605184|NCT02195011|5595291|P2|Overall Study|Adverse Event|0
1605185|NCT02195011|5595292|P1|Overall Study|Adverse Event|4
1605186|NCT02194998|5595308|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
1605187|NCT02194998|5595309|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
1605188|NCT02194998|5595310|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
1605189|NCT02194998|5595311|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
1605190|NCT02194998|5595308|P4|On-HCV Treatment|Did not pick up study medication|0
1605191|NCT02194998|5595309|P3|On-HCV Treatment|Did not pick up study medication|0
1605192|NCT02194998|5595310|P2|On-HCV Treatment|Did not pick up study medication|1
1605193|NCT02194998|5595311|P1|On-HCV Treatment|Did not pick up study medication|0
1605194|NCT02194933|5595375|P2|Overall Study|Lack of Efficacy|2
1605195|NCT02194933|5595376|P1|Overall Study|Lack of Efficacy|1
1605196|NCT02194933|5595375|P2|Overall Study|Withdrawal by Subject|2
1605197|NCT02194933|5595376|P1|Overall Study|Withdrawal by Subject|0
1605198|NCT02194933|5595375|P2|Overall Study|Participant met withdrawal criteria|3
1605199|NCT02194933|5595376|P1|Overall Study|Participant met withdrawal criteria|1
1605200|NCT02194933|5595375|P2|Overall Study|Lost to Follow-up|2
1605201|NCT02194933|5595376|P1|Overall Study|Lost to Follow-up|1
1605202|NCT02194699|5595430|P2|With Potential to Receive 52 Weeks of IP|Other|16
1605203|NCT02194699|5595431|P1|With Potential to Receive 52 Weeks of IP|Other|24
1605204|NCT02194699|5595430|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
1605205|NCT02194699|5595431|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
1605206|NCT02194699|5595430|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1605207|NCT02194699|5595431|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
1605208|NCT02194699|5595430|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
1605209|NCT02194699|5595431|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
1605210|NCT02194699|5595430|P2|With Potential to Receive 52 Weeks of IP|Death|3
1605211|NCT02194699|5595431|P1|With Potential to Receive 52 Weeks of IP|Death|1
1605212|NCT02194699|5595430|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
1605213|NCT02194699|5595431|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
1605214|NCT02194699|5595430|P2|Randomised|Duplicate patient|1
1605215|NCT02194699|5595431|P1|Randomised|Duplicate patient|2
1605216|NCT02194699|5595430|P2|Randomised|Without potential for 52 weeks of IP|5
1605217|NCT02194699|5595431|P1|Randomised|Without potential for 52 weeks of IP|5
1605218|NCT02194699|5595430|P2|Randomised|Did not receive treatment|5
1605219|NCT02194699|5595431|P1|Randomised|Did not receive treatment|1
1605220|NCT02194621|5595539|P3|Overall Study|Withdrawal by Subject|7
1605221|NCT02194621|5595540|P2|Overall Study|Withdrawal by Subject|4
1605222|NCT02194621|5595541|P1|Overall Study|Withdrawal by Subject|4
1605223|NCT02194621|5595539|P3|Overall Study|6 withdrew prior to randomization|2
1605224|NCT02194621|5595540|P2|Overall Study|6 withdrew prior to randomization|2
1605225|NCT02194621|5595541|P1|Overall Study|6 withdrew prior to randomization|2
1605226|NCT02194062|5595574|P3|Overall Study|Lost to Follow-up|5
1605227|NCT02194062|5595575|P2|Overall Study|Lost to Follow-up|2
1605228|NCT02194062|5595576|P1|Overall Study|Lost to Follow-up|2
1605229|NCT02193880|5595587|P1|Overall Study|patients did not collect enough HPC|3
1605230|NCT02193867|5595592|P1|Overall Study|Sponsor Study Termination|2
1605231|NCT02193867|5595592|P1|Overall Study|Death|2
1605232|NCT02193828|5595610|P4|Overall Study|Withdrawal by Subject|1
1605233|NCT02193828|5595611|P3|Overall Study|Withdrawal by Subject|1
1605234|NCT02193828|5595612|P2|Overall Study|Withdrawal by Subject|0
1605235|NCT02193828|5595613|P1|Overall Study|Withdrawal by Subject|0
1605236|NCT02193776|5595690|P4|Overall Study|Adverse event/Specific toxicity|2
1605237|NCT02193776|5595691|P3|Overall Study|Adverse event/Specific toxicity|2
1605238|NCT02193776|5595692|P2|Overall Study|Adverse event/Specific toxicity|5
1605239|NCT02193776|5595693|P1|Overall Study|Adverse event/Specific toxicity|5
1605240|NCT02193776|5595690|P4|Overall Study|Death|0
1605241|NCT02193776|5595691|P3|Overall Study|Death|0
1605242|NCT02193776|5595692|P2|Overall Study|Death|0
1605243|NCT02193776|5595693|P1|Overall Study|Death|1
1605244|NCT02193776|5595690|P4|Overall Study|Investigator/Sponsor decision|0
1605245|NCT02193776|5595691|P3|Overall Study|Investigator/Sponsor decision|0
1605246|NCT02193776|5595692|P2|Overall Study|Investigator/Sponsor decision|1
1605247|NCT02193776|5595693|P1|Overall Study|Investigator/Sponsor decision|1
1605248|NCT02193776|5595690|P4|Overall Study|Failure to comply with protocol|0
1605249|NCT02193776|5595691|P3|Overall Study|Failure to comply with protocol|0
1605250|NCT02193776|5595692|P2|Overall Study|Failure to comply with protocol|1
1605251|NCT02193776|5595693|P1|Overall Study|Failure to comply with protocol|0
1605252|NCT02193776|5595690|P4|Overall Study|Consent withdrawn|0
1605253|NCT02193776|5595691|P3|Overall Study|Consent withdrawn|0
1605254|NCT02193776|5595692|P2|Overall Study|Consent withdrawn|0
1605255|NCT02193776|5595693|P1|Overall Study|Consent withdrawn|1
1605256|NCT02193178|5595720|P1|Overall Study|Dry eyes|1
1605257|NCT02193178|5595720|P1|Overall Study|Lost to Follow-up|1
1605258|NCT02193165|5595770|P3|6 Week Product Use|Lost to Follow-up|0
1605259|NCT02193165|5595771|P2|6 Week Product Use|Lost to Follow-up|1
1605260|NCT02193165|5595772|P1|6 Week Product Use|Lost to Follow-up|0
1605261|NCT02193165|5595770|P3|4 Week Product Use|Lost to Follow-up|1
1605262|NCT02193165|5595771|P2|4 Week Product Use|Lost to Follow-up|1
1605263|NCT02193165|5595772|P1|4 Week Product Use|Lost to Follow-up|1
1605264|NCT02193087|5595799|P4|Overall Study|Did Not Receive Any Vaccination|1
1605265|NCT02193087|5595800|P3|Overall Study|Did Not Receive Any Vaccination|0
1605266|NCT02193087|5595801|P2|Overall Study|Did Not Receive Any Vaccination|3
1605267|NCT02193087|5595802|P1|Overall Study|Did Not Receive Any Vaccination|2
1605268|NCT02193087|5595799|P4|Overall Study|Other Reason Not Specified|9
1605269|NCT02193087|5595800|P3|Overall Study|Other Reason Not Specified|1
1605270|NCT02193087|5595801|P2|Overall Study|Other Reason Not Specified|2
1605271|NCT02193087|5595802|P1|Overall Study|Other Reason Not Specified|7
1605272|NCT02193087|5595799|P4|Overall Study|Withdrawal by Subject|19
1605273|NCT02193087|5595800|P3|Overall Study|Withdrawal by Subject|1
1605274|NCT02193087|5595801|P2|Overall Study|Withdrawal by Subject|3
1605275|NCT02193087|5595802|P1|Overall Study|Withdrawal by Subject|10
1605276|NCT02193087|5595799|P4|Overall Study|Protocol Violation|2
1605277|NCT02193087|5595800|P3|Overall Study|Protocol Violation|1
1605278|NCT02193087|5595801|P2|Overall Study|Protocol Violation|0
1605279|NCT02193087|5595802|P1|Overall Study|Protocol Violation|2
1605280|NCT02193087|5595799|P4|Overall Study|Lost to Follow-up|37
1605281|NCT02193087|5595800|P3|Overall Study|Lost to Follow-up|4
1605282|NCT02193087|5595801|P2|Overall Study|Lost to Follow-up|6
1605283|NCT02193087|5595802|P1|Overall Study|Lost to Follow-up|14
1605284|NCT02193087|5595799|P4|Overall Study|Adverse Event|11
1605285|NCT02193087|5595800|P3|Overall Study|Adverse Event|0
1605286|NCT02193087|5595801|P2|Overall Study|Adverse Event|0
1605287|NCT02193087|5595802|P1|Overall Study|Adverse Event|2
1605288|NCT02193074|5595847|P2|Overall Study|Adverse Event|13
1605289|NCT02193074|5595848|P1|Overall Study|Adverse Event|16
1605290|NCT02193074|5595847|P2|Overall Study|Withdrawal by Subject|2
1605291|NCT02193074|5595848|P1|Overall Study|Withdrawal by Subject|1
1605292|NCT02192905|5595880|P1|Overall Study|Lost to Follow-up|1
1605293|NCT02192606|5595944|P2|Overall Study|3D equipment rep unable to join|1
1605294|NCT02192606|5595945|P1|Overall Study|3D equipment rep unable to join|0
1605295|NCT02192606|5595944|P2|Overall Study|Physician Decision|2
1605296|NCT02192606|5595945|P1|Overall Study|Physician Decision|1
1605297|NCT02192606|5595944|P2|Overall Study|surgery type was changed|1
1605298|NCT02192606|5595945|P1|Overall Study|surgery type was changed|1
1605299|NCT02192190|5595993|P6|Overall Study|Inadequate Pain Relief|0
1605300|NCT02192190|5595994|P5|Overall Study|Inadequate Pain Relief|0
1605301|NCT02192190|5595995|P4|Overall Study|Inadequate Pain Relief|0
1605302|NCT02192190|5595996|P3|Overall Study|Inadequate Pain Relief|1
1605303|NCT02192190|5595997|P2|Overall Study|Inadequate Pain Relief|1
1605304|NCT02192190|5595998|P1|Overall Study|Inadequate Pain Relief|0
1605305|NCT02192190|5595993|P6|Overall Study|Positive Drug Screen|0
1605306|NCT02192190|5595994|P5|Overall Study|Positive Drug Screen|0
1605307|NCT02192190|5595995|P4|Overall Study|Positive Drug Screen|1
1605308|NCT02192190|5595996|P3|Overall Study|Positive Drug Screen|0
1605309|NCT02192190|5595997|P2|Overall Study|Positive Drug Screen|0
1605310|NCT02192190|5595998|P1|Overall Study|Positive Drug Screen|0
1605311|NCT02192190|5595993|P6|Overall Study|Could not Keep Visit Schedule|0
1605312|NCT02192190|5595994|P5|Overall Study|Could not Keep Visit Schedule|0
1605313|NCT02192190|5595995|P4|Overall Study|Could not Keep Visit Schedule|0
1605314|NCT02192190|5595996|P3|Overall Study|Could not Keep Visit Schedule|0
1605315|NCT02192190|5595997|P2|Overall Study|Could not Keep Visit Schedule|0
1605316|NCT02192190|5595998|P1|Overall Study|Could not Keep Visit Schedule|1
1605317|NCT02192190|5595993|P6|Overall Study|Withdrawal by Subject|3
1605318|NCT02192190|5595994|P5|Overall Study|Withdrawal by Subject|5
1605319|NCT02192190|5595995|P4|Overall Study|Withdrawal by Subject|1
1605320|NCT02192190|5595996|P3|Overall Study|Withdrawal by Subject|2
1605321|NCT02192190|5595997|P2|Overall Study|Withdrawal by Subject|1
1605322|NCT02192190|5595998|P1|Overall Study|Withdrawal by Subject|4
1605323|NCT02192190|5595993|P6|Overall Study|Terminated by Sponsor|23
1605324|NCT02192190|5595994|P5|Overall Study|Terminated by Sponsor|21
1605325|NCT02192190|5595995|P4|Overall Study|Terminated by Sponsor|23
1605326|NCT02192190|5595996|P3|Overall Study|Terminated by Sponsor|20
1605327|NCT02192190|5595997|P2|Overall Study|Terminated by Sponsor|23
1605328|NCT02192190|5595998|P1|Overall Study|Terminated by Sponsor|43
1605329|NCT02192190|5595993|P6|Overall Study|Physician Decision|0
1605330|NCT02192190|5595994|P5|Overall Study|Physician Decision|0
1605331|NCT02192190|5595995|P4|Overall Study|Physician Decision|0
1605332|NCT02192190|5595996|P3|Overall Study|Physician Decision|0
1605333|NCT02192190|5595997|P2|Overall Study|Physician Decision|0
1605334|NCT02192190|5595998|P1|Overall Study|Physician Decision|2
1605335|NCT02192190|5595993|P6|Overall Study|Lost to Follow-up|3
1605336|NCT02192190|5595994|P5|Overall Study|Lost to Follow-up|4
1605337|NCT02192190|5595995|P4|Overall Study|Lost to Follow-up|1
1605338|NCT02192190|5595996|P3|Overall Study|Lost to Follow-up|2
1605339|NCT02192190|5595997|P2|Overall Study|Lost to Follow-up|3
1605340|NCT02192190|5595998|P1|Overall Study|Lost to Follow-up|3
1605341|NCT02192190|5595993|P6|Overall Study|Adverse Event|0
1605342|NCT02192190|5595994|P5|Overall Study|Adverse Event|0
1605343|NCT02192190|5595995|P4|Overall Study|Adverse Event|0
1605344|NCT02192190|5595996|P3|Overall Study|Adverse Event|0
1605345|NCT02192190|5595997|P2|Overall Study|Adverse Event|1
1605346|NCT02192190|5595998|P1|Overall Study|Adverse Event|1
1605347|NCT02192164|5596042|P1|Overall Study|Did not meet the exclusion criteria|1
1605348|NCT02192164|5596042|P1|Overall Study|Physician Decision|4
1605349|NCT02192164|5596042|P1|Overall Study|Withdrawal by Subject|1
1605350|NCT02192164|5596042|P1|Overall Study|Other|8
1605351|NCT02192099|5596058|P1|Overall Study|Miscellaneous Reasons|5
1605352|NCT02192099|5596058|P1|Overall Study|Withdrawal by Subject|11
1605353|NCT02192099|5596058|P1|Overall Study|Study Terminated by Sponsor|32
1605354|NCT02192099|5596058|P1|Overall Study|Protocol Violation|8
1605355|NCT02192099|5596058|P1|Overall Study|Pregnancy|1
1605356|NCT02192099|5596058|P1|Overall Study|Physician Decision|1
1605357|NCT02192099|5596058|P1|Overall Study|Lost to Follow-up|2
1605358|NCT02192099|5596058|P1|Overall Study|Adverse Event|1
1605359|NCT02191605|5596092|P5|Overall Study|Lost to Follow-up|4
1605360|NCT02191605|5596093|P4|Overall Study|Lost to Follow-up|3
1605361|NCT02191605|5596094|P3|Overall Study|Lost to Follow-up|7
1605362|NCT02191605|5596095|P2|Overall Study|Lost to Follow-up|4
1605363|NCT02191605|5596096|P1|Overall Study|Lost to Follow-up|9
1605364|NCT02191579|5596115|P2|Treatment 2|Multiple Reasons Specified|25
1605365|NCT02191579|5596116|P1|Treatment 2|Multiple Reasons Specified|0
1605366|NCT02191579|5596115|P2|Treatment 1|Multiple Reasons Specified|58
1605367|NCT02191579|5596116|P1|Treatment 1|Multiple Reasons Specified|27
1605382|NCT02191267|5596192|P3|Overall Study|Withdrawal by Subject|0
1605383|NCT02191267|5596193|P2|Overall Study|Withdrawal by Subject|0
1605384|NCT02191267|5596194|P1|Overall Study|Withdrawal by Subject|1
1605385|NCT02191137|5596205|P1|Follow-up|Adverse Event|1
1605386|NCT02191137|5596205|P1|Follow-up|Ongoing/unknown|2
1605387|NCT02191137|5596205|P1|Follow-up|Lost to Follow-up|2
1605388|NCT02191137|5596205|P1|Treatment|Other|1
1605389|NCT02191137|5596205|P1|Treatment|Adverse Event|2
1605390|NCT02191137|5596205|P1|Treatment|Withdrawal by Subject|3
1605391|NCT02191137|5596205|P1|Treatment|Death|4
1605392|NCT02191046|5596235|P2|Overall Study|low compliance|1
1605393|NCT02191046|5596236|P1|Overall Study|low compliance|5
1605394|NCT02190721|5596267|P3|Overall Study|Patient was out of the city|0
1605395|NCT02190721|5596268|P2|Overall Study|Patient was out of the city|1
1605396|NCT02190721|5596269|P1|Overall Study|Patient was out of the city|0
1605397|NCT02190604|5596392|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605398|NCT02190604|5596393|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605399|NCT02190604|5596394|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605400|NCT02190604|5596395|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605401|NCT02190604|5596396|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605402|NCT02190604|5596397|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
1605403|NCT02190604|5596398|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605404|NCT02190604|5596399|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605405|NCT02190604|5596400|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605406|NCT02190604|5596401|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605407|NCT02190604|5596402|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605408|NCT02190604|5596403|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605409|NCT02190604|5596404|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605410|NCT02190604|5596405|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605411|NCT02190604|5596406|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605412|NCT02190604|5596407|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605413|NCT02190604|5596408|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605414|NCT02190604|5596409|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605415|NCT02190604|5596410|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
1605416|NCT02190604|5596392|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605417|NCT02190604|5596393|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605418|NCT02190604|5596394|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605419|NCT02190604|5596395|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605420|NCT02190604|5596396|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
1605421|NCT02190604|5596397|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605422|NCT02190604|5596398|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605423|NCT02190604|5596399|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605424|NCT02190604|5596400|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605425|NCT02190604|5596401|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605426|NCT02190604|5596402|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605427|NCT02190604|5596403|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605428|NCT02190604|5596404|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605429|NCT02190604|5596405|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605430|NCT02190604|5596406|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605431|NCT02190604|5596407|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605432|NCT02190604|5596408|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605433|NCT02190604|5596409|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605434|NCT02190604|5596410|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
1605435|NCT02190591|5596601|P2|Overall Study|face presentation so she was ineligible|1
1605436|NCT02190591|5596602|P1|Overall Study|face presentation so she was ineligible|0
1605437|NCT02190591|5596601|P2|Overall Study|did not use peanut ball as instructed|2
1605438|NCT02190591|5596602|P1|Overall Study|did not use peanut ball as instructed|0
1605439|NCT02190591|5596601|P2|Overall Study|Protocol Violation|0
1605440|NCT02190591|5596602|P1|Overall Study|Protocol Violation|1
1605441|NCT02190591|5596601|P2|Overall Study|Withdrawal by Subject|8
1605442|NCT02190591|5596602|P1|Overall Study|Withdrawal by Subject|1
1605443|NCT02190435|5596625|P2|Overall Study|3 consented screen fails|0
1605444|NCT02190435|5596626|P1|Overall Study|3 consented screen fails|3
1605445|NCT02190435|5596625|P2|Overall Study|First 12 patients were lead-ins|0
1605446|NCT02190435|5596626|P1|Overall Study|First 12 patients were lead-ins|12
1605447|NCT02190279|5596637|P3|Overall Study|Screening failure|1
1605448|NCT02190279|5596638|P2|Overall Study|Screening failure|0
1605449|NCT02190279|5596639|P1|Overall Study|Screening failure|0
1605450|NCT02190279|5596637|P3|Overall Study|Refused further treatment|1
1605451|NCT02190279|5596638|P2|Overall Study|Refused further treatment|0
1605452|NCT02190279|5596639|P1|Overall Study|Refused further treatment|0
1605453|NCT02190279|5596637|P3|Overall Study|Lost to Follow-up|0
1605454|NCT02190279|5596638|P2|Overall Study|Lost to Follow-up|0
1605455|NCT02190279|5596639|P1|Overall Study|Lost to Follow-up|2
1605456|NCT02190279|5596637|P3|Overall Study|Withdrawal consent|1
1605457|NCT02190279|5596638|P2|Overall Study|Withdrawal consent|0
1605458|NCT02190279|5596639|P1|Overall Study|Withdrawal consent|1
1605459|NCT02189941|5596678|P3|Overall Study|Non-compliance|1
1605460|NCT02189941|5596679|P2|Overall Study|Non-compliance|0
1605461|NCT02189941|5596680|P1|Overall Study|Non-compliance|0
1605462|NCT02189863|5596708|P2|First 2 Weeks|Motion Sickness|2
1605463|NCT02189863|5596709|P1|First 2 Weeks|Motion Sickness|4
1605464|NCT02189837|5596724|P4|Overall Study|Sponsor Decision|1
1605465|NCT02189837|5596725|P3|Overall Study|Sponsor Decision|0
1605466|NCT02189837|5596726|P2|Overall Study|Sponsor Decision|0
1605467|NCT02189837|5596727|P1|Overall Study|Sponsor Decision|0
1605468|NCT02189837|5596724|P4|Overall Study|Withdrawal by Subject|1
1605469|NCT02189837|5596725|P3|Overall Study|Withdrawal by Subject|3
1605470|NCT02189837|5596726|P2|Overall Study|Withdrawal by Subject|1
1605471|NCT02189837|5596727|P1|Overall Study|Withdrawal by Subject|2
1605472|NCT02189759|5596757|P4|Overall Study|Lost to Follow-up|5
1605473|NCT02189759|5596758|P3|Overall Study|Lost to Follow-up|2
1605474|NCT02189759|5596759|P2|Overall Study|Lost to Follow-up|0
1605475|NCT02189759|5596760|P1|Overall Study|Lost to Follow-up|0
1605480|NCT02189252|5596845|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1605481|NCT02189252|5596846|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1605482|NCT02189252|5596847|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
1605483|NCT02189252|5596848|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
1605484|NCT02189252|5596845|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1605485|NCT02189252|5596846|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1605486|NCT02189252|5596847|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
1605487|NCT02189252|5596848|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
1605488|NCT02188849|5596907|P2|Overall Study|Lost to Follow-up|8
1605489|NCT02188849|5596908|P1|Overall Study|Lost to Follow-up|3
1605490|NCT02188784|5596922|P2|Overall Study|Physician Decision|3
1605491|NCT02188784|5596923|P1|Overall Study|Physician Decision|2
1605492|NCT02188784|5596922|P2|Overall Study|Withdrawal by Subject|9
1605493|NCT02188784|5596923|P1|Overall Study|Withdrawal by Subject|3
1605494|NCT02188784|5596922|P2|Overall Study|Lost to Follow-up|0
1605495|NCT02188784|5596923|P1|Overall Study|Lost to Follow-up|1
1605496|NCT02188784|5596922|P2|Overall Study|Death|1
1605497|NCT02188784|5596923|P1|Overall Study|Death|3
1605498|NCT02188589|5596939|P1|Overall Study|Withdrawal by Subject|5
1605499|NCT02187861|5596971|P4|Overall Study|Other|1
1605500|NCT02187861|5596972|P3|Overall Study|Other|7
1605501|NCT02187861|5596973|P2|Overall Study|Other|1
1605502|NCT02187861|5596974|P1|Overall Study|Other|0
1605503|NCT02187861|5596971|P4|Overall Study|Withdrawal by Subject|3
1605504|NCT02187861|5596972|P3|Overall Study|Withdrawal by Subject|3
1605505|NCT02187861|5596973|P2|Overall Study|Withdrawal by Subject|0
1605506|NCT02187861|5596974|P1|Overall Study|Withdrawal by Subject|0
1605507|NCT02187861|5596971|P4|Overall Study|Progressive Disease|22
1605508|NCT02187861|5596972|P3|Overall Study|Progressive Disease|19
1605509|NCT02187861|5596973|P2|Overall Study|Progressive Disease|42
1605510|NCT02187861|5596974|P1|Overall Study|Progressive Disease|4
1605511|NCT02187861|5596971|P4|Overall Study|Physician Decision|3
1605512|NCT02187861|5596972|P3|Overall Study|Physician Decision|0
1605513|NCT02187861|5596973|P2|Overall Study|Physician Decision|1
1605514|NCT02187861|5596974|P1|Overall Study|Physician Decision|0
1605515|NCT02187861|5596971|P4|Overall Study|Death|2
1605516|NCT02187861|5596972|P3|Overall Study|Death|1
1605517|NCT02187861|5596973|P2|Overall Study|Death|3
1605518|NCT02187861|5596974|P1|Overall Study|Death|0
1605519|NCT02187861|5596971|P4|Overall Study|Adverse Event|1
1605520|NCT02187861|5596972|P3|Overall Study|Adverse Event|2
1605521|NCT02187861|5596973|P2|Overall Study|Adverse Event|1
1605522|NCT02187861|5596974|P1|Overall Study|Adverse Event|2
1605523|NCT02187809|5597070|P1|Overall Study|The study was terminated|3
1605524|NCT02187783|5597080|P1|Overall Study|Study terminated by sponsor|1
1605525|NCT02187783|5597080|P1|Overall Study|Withdrawal by Subject|9
1605526|NCT02187783|5597080|P1|Overall Study|Physician Decision|2
1605527|NCT02187783|5597080|P1|Overall Study|Protocol Violation|3
1605528|NCT02187783|5597080|P1|Overall Study|Progressive disease|80
1605529|NCT02187783|5597080|P1|Overall Study|Death|3
1605530|NCT02187783|5597080|P1|Overall Study|Adverse Event|8
1605531|NCT02187744|5597091|P2|Treatment|Participant refused continued treatment|1
1605532|NCT02187744|5597092|P1|Treatment|Participant refused continued treatment|1
1605533|NCT02187744|5597091|P2|Treatment|Other|0
1605534|NCT02187744|5597092|P1|Treatment|Other|2
1605535|NCT02187744|5597091|P2|Treatment|Lost to Follow-up|1
1605536|NCT02187744|5597092|P1|Treatment|Lost to Follow-up|0
1605537|NCT02187744|5597091|P2|Treatment|Related adverse event, not serious|2
1605538|NCT02187744|5597092|P1|Treatment|Related adverse event, not serious|0
1605539|NCT02187744|5597091|P2|Treatment|Related adverse event, serious non-fatal|1
1605540|NCT02187744|5597092|P1|Treatment|Related adverse event, serious non-fatal|0
1605541|NCT02187744|5597091|P2|Treatment|Death|0
1605542|NCT02187744|5597092|P1|Treatment|Death|1
1605543|NCT02187744|5597091|P2|Study|Related adverse event, serious non-fatal|1
1605544|NCT02187744|5597092|P1|Study|Related adverse event, serious non-fatal|0
1605545|NCT02187744|5597091|P2|Study|Death|0
1605546|NCT02187744|5597092|P1|Study|Death|1
1605547|NCT02187744|5597091|P2|Study|Related adverse event, not serious|2
1605548|NCT02187744|5597092|P1|Study|Related adverse event, not serious|0
1605549|NCT02187744|5597091|P2|Study|Lost to Follow-up|2
1605550|NCT02187744|5597092|P1|Study|Lost to Follow-up|0
1605551|NCT02187744|5597091|P2|Study|Other|1
1605552|NCT02187744|5597092|P1|Study|Other|2
1605553|NCT02187744|5597091|P2|Study|Participant refused further follow-up|0
1605554|NCT02187744|5597092|P1|Study|Participant refused further follow-up|1
1605555|NCT02187172|5597110|P2|Overall Study|Physician Decision|1
1605556|NCT02187172|5597111|P1|Overall Study|Physician Decision|1
1605557|NCT02187172|5597110|P2|Overall Study|Adverse Event|1
1605558|NCT02187172|5597111|P1|Overall Study|Adverse Event|0
1605559|NCT02187172|5597110|P2|Overall Study|Lack of Efficacy|2
1605560|NCT02187172|5597111|P1|Overall Study|Lack of Efficacy|1
1605561|NCT02187172|5597110|P2|Overall Study|Lost to Follow-up|2
1605562|NCT02187172|5597111|P1|Overall Study|Lost to Follow-up|1
1605563|NCT02187055|5597278|P3|Overall Study|Death|0
1605564|NCT02187055|5597279|P2|Overall Study|Death|0
1605565|NCT02187055|5597280|P1|Overall Study|Death|2
1605566|NCT02187055|5597278|P3|Overall Study|Adverse Event|36
1605567|NCT02187055|5597279|P2|Overall Study|Adverse Event|26
1605568|NCT02187055|5597280|P1|Overall Study|Adverse Event|21
1605569|NCT02187055|5597278|P3|Overall Study|Withdrawal by Subject|11
1605570|NCT02187055|5597279|P2|Overall Study|Withdrawal by Subject|11
1605571|NCT02187055|5597280|P1|Overall Study|Withdrawal by Subject|11
1605572|NCT02187055|5597278|P3|Overall Study|Pregnancy|0
1605573|NCT02187055|5597279|P2|Overall Study|Pregnancy|1
1605574|NCT02187055|5597280|P1|Overall Study|Pregnancy|3
1605575|NCT02187055|5597278|P3|Overall Study|Protocol Violation|4
1605576|NCT02187055|5597279|P2|Overall Study|Protocol Violation|9
1605577|NCT02187055|5597280|P1|Overall Study|Protocol Violation|9
1605578|NCT02187055|5597278|P3|Overall Study|Other|3
1605579|NCT02187055|5597279|P2|Overall Study|Other|6
1605580|NCT02187055|5597280|P1|Overall Study|Other|5
1605581|NCT02187055|5597278|P3|Overall Study|No longer willing to participate|10
1605582|NCT02187055|5597279|P2|Overall Study|No longer willing to participate|8
1605583|NCT02187055|5597280|P1|Overall Study|No longer willing to participate|6
1605584|NCT02187055|5597278|P3|Overall Study|No longer meets eligibility criteria|0
1605585|NCT02187055|5597279|P2|Overall Study|No longer meets eligibility criteria|2
1605586|NCT02187055|5597280|P1|Overall Study|No longer meets eligibility criteria|0
1605587|NCT02187055|5597278|P3|Overall Study|Lost to Follow-up|3
1605588|NCT02187055|5597279|P2|Overall Study|Lost to Follow-up|7
1605589|NCT02187055|5597280|P1|Overall Study|Lost to Follow-up|2
1605590|NCT02187055|5597278|P3|Overall Study|Lack of Efficacy|7
1605591|NCT02187055|5597279|P2|Overall Study|Lack of Efficacy|3
1605592|NCT02187055|5597280|P1|Overall Study|Lack of Efficacy|10
1605593|NCT02187042|5597380|P2|Overall Study|Progressive disease|8
1605594|NCT02187042|5597381|P1|Overall Study|Progressive disease|4
1605595|NCT02187042|5597380|P2|Overall Study|Doctor choice|0
1605596|NCT02187042|5597381|P1|Overall Study|Doctor choice|1
1605597|NCT02187042|5597380|P2|Overall Study|Participant choice|0
1605598|NCT02187042|5597381|P1|Overall Study|Participant choice|1
1605599|NCT02187042|5597380|P2|Overall Study|Toxicity|5
1605600|NCT02187042|5597381|P1|Overall Study|Toxicity|6
1605601|NCT02187042|5597380|P2|Overall Study|Death|1
1605602|NCT02187042|5597381|P1|Overall Study|Death|1
1605603|NCT02187029|5597427|P4|Overall Study|Withdrawal by Subject|0
1605604|NCT02187029|5597428|P3|Overall Study|Withdrawal by Subject|0
1605605|NCT02187029|5597429|P2|Overall Study|Withdrawal by Subject|0
1605606|NCT02187029|5597430|P1|Overall Study|Withdrawal by Subject|1
1605607|NCT02187029|5597427|P4|Overall Study|Study Terminated by Sponsor|3
1605608|NCT02187029|5597428|P3|Overall Study|Study Terminated by Sponsor|10
1605609|NCT02187029|5597429|P2|Overall Study|Study Terminated by Sponsor|0
1605610|NCT02187029|5597430|P1|Overall Study|Study Terminated by Sponsor|0
1605611|NCT02187029|5597427|P4|Overall Study|Adverse Event|0
1605612|NCT02187029|5597428|P3|Overall Study|Adverse Event|1
1605613|NCT02187029|5597429|P2|Overall Study|Adverse Event|1
1605614|NCT02187029|5597430|P1|Overall Study|Adverse Event|0
1605615|NCT02186873|5597552|P2|Overall Study|Withdrawal by Subject|2
1605616|NCT02186873|5597553|P1|Overall Study|Withdrawal by Subject|7
1605617|NCT02186873|5597552|P2|Overall Study|Lost to Follow-up|2
1605618|NCT02186873|5597553|P1|Overall Study|Lost to Follow-up|1
1605619|NCT02186873|5597552|P2|Overall Study|Lack of Efficacy|1
1605620|NCT02186873|5597553|P1|Overall Study|Lack of Efficacy|0
1605621|NCT02186873|5597552|P2|Overall Study|Adverse Event|3
1605622|NCT02186873|5597553|P1|Overall Study|Adverse Event|1
1605623|NCT02186834|5597576|P6|Treatment at RP2D|Died prior to treatment|1
1605624|NCT02186834|5597577|P5|Treatment at RP2D|Died prior to treatment|0
1605625|NCT02186834|5597578|P4|Treatment at RP2D|Died prior to treatment|0
1605626|NCT02186834|5597579|P3|Treatment at RP2D|Died prior to treatment|0
1605627|NCT02186834|5597580|P2|Treatment at RP2D|Died prior to treatment|0
1605628|NCT02186834|5597581|P1|Treatment at RP2D|Died prior to treatment|0
1605629|NCT02186834|5597576|P6|Dose Escalation|Death|0
1605630|NCT02186834|5597577|P5|Dose Escalation|Death|0
1605631|NCT02186834|5597578|P4|Dose Escalation|Death|1
1605632|NCT02186834|5597579|P3|Dose Escalation|Death|0
1605633|NCT02186834|5597580|P2|Dose Escalation|Death|0
1605634|NCT02186834|5597581|P1|Dose Escalation|Death|0
1605635|NCT02186652|5597617|P2|Overall Study|Lost to Follow-up|0
1605636|NCT02186652|5597618|P1|Overall Study|Lost to Follow-up|2
1605637|NCT02186561|5597651|P1|1- Year Post Index Procedure Visit|Missed|1
1605638|NCT02186561|5597651|P1|1- Year Post Index Procedure Visit|Death|1
1605639|NCT02186561|5597651|P1|30-Day Post Index Procedure Visit|Death|1
1605640|NCT02186561|5597651|P1|Enrollment|Investigator Withdrew Consent|1
1605641|NCT02186561|5597651|P1|Enrollment|Withdrawal by Subject|2
1605642|NCT02186561|5597651|P1|Enrollment|Insurance Denial|2
1605643|NCT02186561|5597651|P1|Enrollment|Enrollment Cap Reached|5
1605644|NCT02186561|5597651|P1|Enrollment|Did Not Meet Inclusion Criteria|46
1605645|NCT02186301|5597671|P3|Overall Study|Other|1
1605646|NCT02186301|5597672|P2|Overall Study|Other|0
1605647|NCT02186301|5597673|P1|Overall Study|Other|0
1605648|NCT02186301|5597671|P3|Overall Study|Missing|2
1605649|NCT02186301|5597672|P2|Overall Study|Missing|0
1605650|NCT02186301|5597673|P1|Overall Study|Missing|0
1605651|NCT02186301|5597671|P3|Overall Study|Protocol Deviation|0
1605652|NCT02186301|5597672|P2|Overall Study|Protocol Deviation|2
1605653|NCT02186301|5597673|P1|Overall Study|Protocol Deviation|0
1605654|NCT02186301|5597671|P3|Overall Study|Study Terminated by Sponsor|11
1605655|NCT02186301|5597672|P2|Overall Study|Study Terminated by Sponsor|0
1605656|NCT02186301|5597673|P1|Overall Study|Study Terminated by Sponsor|1
1605657|NCT02186301|5597671|P3|Overall Study|Physician Decision|1
1605658|NCT02186301|5597672|P2|Overall Study|Physician Decision|0
1605659|NCT02186301|5597673|P1|Overall Study|Physician Decision|1
1605660|NCT02186301|5597671|P3|Overall Study|Withdrawal by Subject|3
1605661|NCT02186301|5597672|P2|Overall Study|Withdrawal by Subject|1
1605662|NCT02186301|5597673|P1|Overall Study|Withdrawal by Subject|5
1605663|NCT02186301|5597671|P3|Overall Study|Death|0
1605664|NCT02186301|5597672|P2|Overall Study|Death|0
1605665|NCT02186301|5597673|P1|Overall Study|Death|1
1605666|NCT02186301|5597671|P3|Overall Study|Adverse Event|5
1605667|NCT02186301|5597672|P2|Overall Study|Adverse Event|5
1605668|NCT02186301|5597673|P1|Overall Study|Adverse Event|5
1605669|NCT02186301|5597671|P3|Overall Study|Progressive Disease|27
1605670|NCT02186301|5597672|P2|Overall Study|Progressive Disease|22
1605671|NCT02186301|5597673|P1|Overall Study|Progressive Disease|7
1605672|NCT02186223|5597689|P1|Overall Study|Device in place less than 48 hours|9
1605673|NCT02186223|5597689|P1|Overall Study|Death|3
1605674|NCT02186223|5597689|P1|Overall Study|Unable to obtain femoral access|3
1605675|NCT02186223|5597689|P1|Overall Study|Not eligible for device placement|6
1605676|NCT02186171|5597711|P2|Overall Study|Protocol-specified Criteria|2
1605677|NCT02186171|5597712|P1|Overall Study|Protocol-specified Criteria|0
1605678|NCT02186171|5597711|P2|Overall Study|Death|2
1605679|NCT02186171|5597712|P1|Overall Study|Death|1
1605680|NCT02186171|5597711|P2|Overall Study|Lost to Follow-up|2
1605681|NCT02186171|5597712|P1|Overall Study|Lost to Follow-up|2
1605682|NCT02186171|5597711|P2|Overall Study|Withdrawal by Subject|9
1605683|NCT02186171|5597712|P1|Overall Study|Withdrawal by Subject|1
1605684|NCT02185534|5597749|P6|First Washout Period|Protocol Violation|1
1605685|NCT02185534|5597750|P5|First Washout Period|Protocol Violation|0
1605686|NCT02185534|5597751|P4|First Washout Period|Protocol Violation|0
1605687|NCT02185534|5597752|P3|First Washout Period|Protocol Violation|0
1605688|NCT02185534|5597753|P2|First Washout Period|Protocol Violation|0
1605689|NCT02185534|5597754|P1|First Washout Period|Protocol Violation|0
1605690|NCT02185534|5597749|P6|First Washout Period|Withdrawal by Subject|0
1605691|NCT02185534|5597750|P5|First Washout Period|Withdrawal by Subject|1
1605692|NCT02185534|5597751|P4|First Washout Period|Withdrawal by Subject|0
1605693|NCT02185534|5597752|P3|First Washout Period|Withdrawal by Subject|0
1605694|NCT02185534|5597753|P2|First Washout Period|Withdrawal by Subject|0
1605695|NCT02185534|5597754|P1|First Washout Period|Withdrawal by Subject|1
1605696|NCT02185534|5597749|P6|First Period|Withdrawal by Subject|0
1605697|NCT02185534|5597750|P5|First Period|Withdrawal by Subject|0
1605698|NCT02185534|5597751|P4|First Period|Withdrawal by Subject|1
1605699|NCT02185534|5597752|P3|First Period|Withdrawal by Subject|0
1605700|NCT02185534|5597753|P2|First Period|Withdrawal by Subject|0
1605701|NCT02185534|5597754|P1|First Period|Withdrawal by Subject|0
1605702|NCT02185521|5597769|P1|Overall Study|Protocol Violation|1
1605703|NCT02185521|5597769|P1|Overall Study|Withdrawal by Subject|1
1605704|NCT02185014|5597857|P1|Overall Study|Other|4
1605705|NCT02185014|5597857|P1|Overall Study|Subject Noncompliance|1
1605706|NCT02185014|5597857|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
1605707|NCT02185014|5597857|P1|Overall Study|Lack of Efficacy|14
1605708|NCT02185014|5597857|P1|Overall Study|Lost to Follow-up|4
1605709|NCT02185014|5597857|P1|Overall Study|Withdrew Consent|8
1605710|NCT02185014|5597857|P1|Overall Study|Adverse Event|18
1605711|NCT02184988|5597861|P1|Overall Study|Lost to Follow-up|32
1605712|NCT02184988|5597861|P1|Overall Study|various other reasons|9
1605713|NCT02184988|5597861|P1|Overall Study|work scheduling issues|4
1605714|NCT02184988|5597861|P1|Overall Study|moving away/travelling/unable to complet|6
1605715|NCT02184988|5597861|P1|Overall Study|Adverse Event|2
1605716|NCT02184988|5597861|P1|Overall Study|Pregnancy|2
1605717|NCT02184611|5597919|P2|Overall Study|Protocol defined stopping criteria|1
1605718|NCT02184611|5597920|P1|Overall Study|Protocol defined stopping criteria|0
1605719|NCT02184611|5597919|P2|Overall Study|Protocol Violation|1
1605720|NCT02184611|5597920|P1|Overall Study|Protocol Violation|1
1605721|NCT02184611|5597919|P2|Overall Study|Adverse Event|5
1605722|NCT02184611|5597920|P1|Overall Study|Adverse Event|4
1605723|NCT02184611|5597919|P2|Overall Study|Withdrawal by Subject|6
1605724|NCT02184611|5597920|P1|Overall Study|Withdrawal by Subject|5
1605725|NCT02184611|5597919|P2|Overall Study|Lack of Efficacy|15
1605726|NCT02184611|5597920|P1|Overall Study|Lack of Efficacy|11
1605727|NCT02184572|5597956|P2|Overall Study|Withdrawal by Subject|9
1605728|NCT02184572|5597957|P1|Overall Study|Withdrawal by Subject|14
1605729|NCT02184572|5597956|P2|Overall Study|Traveling Outside The Country|0
1605730|NCT02184572|5597957|P1|Overall Study|Traveling Outside The Country|1
1605731|NCT02184572|5597956|P2|Overall Study|2nd blooddraw & diary card incomplete|0
1605732|NCT02184572|5597957|P1|Overall Study|2nd blooddraw & diary card incomplete|1
1605733|NCT02184572|5597956|P2|Overall Study|Loss Of Kaiser Insurance|0
1605734|NCT02184572|5597957|P1|Overall Study|Loss Of Kaiser Insurance|1
1605735|NCT02184572|5597956|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
1605736|NCT02184572|5597957|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
1605737|NCT02184572|5597956|P2|Overall Study|Lost to Follow-up|21
1605738|NCT02184572|5597957|P1|Overall Study|Lost to Follow-up|29
1605739|NCT02184455|5598018|P1|Overall Study|Lost to Follow-up|1
1605740|NCT02184442|5598029|P2|Overall Study|Withdrawal by Subject|11
1605741|NCT02184442|5598030|P1|Overall Study|Withdrawal by Subject|3
1605742|NCT02184442|5598029|P2|Overall Study|Death|65
1605743|NCT02184442|5598030|P1|Overall Study|Death|61
1605744|NCT02184195|5598050|P2|Overall Study|Other|2
1605745|NCT02184195|5598051|P1|Overall Study|Other|0
1605746|NCT02184195|5598050|P2|Overall Study|Lost to Follow-up|2
1605747|NCT02184195|5598051|P1|Overall Study|Lost to Follow-up|0
1605748|NCT02184195|5598050|P2|Overall Study|Death|29
1605749|NCT02184195|5598051|P1|Overall Study|Death|40
1605750|NCT02184195|5598050|P2|Overall Study|Eligibility criteria not fulfilled|1
1605751|NCT02184195|5598051|P1|Overall Study|Eligibility criteria not fulfilled|0
1605752|NCT02184195|5598050|P2|Overall Study|Patient decision|1
1605753|NCT02184195|5598051|P1|Overall Study|Patient decision|3
1605754|NCT02184143|5598077|P2|Overall Study|Death|0
1605755|NCT02184143|5598078|P1|Overall Study|Death|1
1605756|NCT02184143|5598077|P2|Overall Study|Lost to Follow-up|3
1605757|NCT02184143|5598078|P1|Overall Study|Lost to Follow-up|5
1605758|NCT02184143|5598077|P2|Overall Study|Withdrawal by Subject|4
1605759|NCT02184143|5598078|P1|Overall Study|Withdrawal by Subject|4
1605760|NCT02183675|5598107|P6|Treatment Period 2 (10 Days)|Adverse Event|2
1605761|NCT02183675|5598108|P5|Treatment Period 2 (10 Days)|Adverse Event|0
1605762|NCT02183675|5598109|P4|Treatment Period 2 (10 Days)|Adverse Event|0
1605763|NCT02183675|5598110|P3|Treatment Period 2 (10 Days)|Adverse Event|0
1605764|NCT02183675|5598111|P2|Treatment Period 2 (10 Days)|Adverse Event|0
1605765|NCT02183675|5598112|P1|Treatment Period 2 (10 Days)|Adverse Event|0
1605766|NCT02183519|5598136|P2|Overall Study|Did not respond to cough inducter|3
1605767|NCT02183519|5598137|P1|Overall Study|Did not respond to cough inducter|0
1605768|NCT02183519|5598136|P2|Overall Study|computer error|0
1605769|NCT02183519|5598137|P1|Overall Study|computer error|3
1605770|NCT02182999|5598145|P2|Overall Study|Physician Decision|0
1605771|NCT02182999|5598146|P1|Overall Study|Physician Decision|1
1605772|NCT02182999|5598145|P2|Overall Study|Adverse Event|3
1605773|NCT02182999|5598146|P1|Overall Study|Adverse Event|4
1605774|NCT02182973|5598162|P2|Overall Study|Withdrawal by Subject|0
1605775|NCT02182973|5598163|P1|Overall Study|Withdrawal by Subject|3
1605776|NCT02182895|5598175|P2|Overall Study|Discharged from hospital within 24 hours|4
1605777|NCT02182895|5598176|P1|Overall Study|Discharged from hospital within 24 hours|2
1605778|NCT02182843|5598196|P1|Overall Study|Adverse Event|1
1605779|NCT02182843|5598196|P1|Overall Study|Lost to Follow-up|2
1605780|NCT02182843|5598196|P1|Overall Study|Withdrawal by Subject|7
1605781|NCT02182830|5598203|P2|Overall Study|Lost to Follow-up|3
1605782|NCT02182830|5598204|P1|Overall Study|Lost to Follow-up|3
1605783|NCT02182830|5598203|P2|Overall Study|Consent withdrawn|8
1605784|NCT02182830|5598204|P1|Overall Study|Consent withdrawn|8
1605785|NCT02182830|5598203|P2|Overall Study|Trial stopped, reason missing|3
1605786|NCT02182830|5598204|P1|Overall Study|Trial stopped, reason missing|3
1605787|NCT02182830|5598203|P2|Overall Study|Not Treated|1
1605788|NCT02182830|5598204|P1|Overall Study|Not Treated|1
1605789|NCT02181842|5598250|P1|Overall Study|Case Report Forms Uncollected|2
1605790|NCT02181816|5598267|P1|Overall Study|Protocol Deviation|21
1605791|NCT02181816|5598267|P1|Overall Study|Case Report Forms Uncollected|38
1605792|NCT02181790|5598275|P2|Overall Study|study terminated|0
1605793|NCT02181790|5598276|P1|Overall Study|study terminated|2
1605794|NCT02181738|5598288|P4|Overall Study|Patient Return to Home Country|0
1605795|NCT02181738|5598289|P3|Overall Study|Patient Return to Home Country|0
1605796|NCT02181738|5598290|P2|Overall Study|Patient Return to Home Country|1
1605797|NCT02181738|5598291|P1|Overall Study|Patient Return to Home Country|0
1605798|NCT02181738|5598288|P4|Overall Study|Lost to Follow-up|0
1605799|NCT02181738|5598289|P3|Overall Study|Lost to Follow-up|2
1605800|NCT02181738|5598290|P2|Overall Study|Lost to Follow-up|4
1605801|NCT02181738|5598291|P1|Overall Study|Lost to Follow-up|0
1605802|NCT02181738|5598288|P4|Overall Study|Subject Withdrew Consent|1
1605803|NCT02181738|5598289|P3|Overall Study|Subject Withdrew Consent|2
1605804|NCT02181738|5598290|P2|Overall Study|Subject Withdrew Consent|3
1605805|NCT02181738|5598291|P1|Overall Study|Subject Withdrew Consent|1
1605806|NCT02181738|5598288|P4|Overall Study|Death|1
1605807|NCT02181738|5598289|P3|Overall Study|Death|6
1605808|NCT02181738|5598290|P2|Overall Study|Death|1
1605809|NCT02181738|5598291|P1|Overall Study|Death|1
1605810|NCT02181673|5598332|P3|Week 24-Week 60|Physician Decision|1
1605811|NCT02181673|5598333|P2|Week 24-Week 60|Physician Decision|0
1605812|NCT02181673|5598334|P1|Week 24-Week 60|Physician Decision|0
1605813|NCT02181673|5598332|P3|Week 24-Week 60|Lost to Follow-up|1
1605814|NCT02181673|5598333|P2|Week 24-Week 60|Lost to Follow-up|0
1605815|NCT02181673|5598334|P1|Week 24-Week 60|Lost to Follow-up|0
1605816|NCT02181673|5598332|P3|Week 24-Week 60|Lack of Efficacy|1
1605817|NCT02181673|5598333|P2|Week 24-Week 60|Lack of Efficacy|0
1605818|NCT02181673|5598334|P1|Week 24-Week 60|Lack of Efficacy|0
1605819|NCT02181673|5598332|P3|Week 24-Week 60|Pregnancy|1
1605820|NCT02181673|5598333|P2|Week 24-Week 60|Pregnancy|0
1605821|NCT02181673|5598334|P1|Week 24-Week 60|Pregnancy|0
1605822|NCT02181673|5598332|P3|Week 24-Week 60|Withdrawal by Subject|2
1605823|NCT02181673|5598333|P2|Week 24-Week 60|Withdrawal by Subject|2
1605824|NCT02181673|5598334|P1|Week 24-Week 60|Withdrawal by Subject|0
1605825|NCT02181673|5598332|P3|Week 24-Week 60|Other|1
1605826|NCT02181673|5598333|P2|Week 24-Week 60|Other|2
1605827|NCT02181673|5598334|P1|Week 24-Week 60|Other|0
1605828|NCT02181673|5598332|P3|Week 24-Week 60|Adverse Event|10
1605829|NCT02181673|5598333|P2|Week 24-Week 60|Adverse Event|4
1605830|NCT02181673|5598334|P1|Week 24-Week 60|Adverse Event|0
1605831|NCT02181673|5598332|P3|Up to Week 24|Randomized not Treated|1
1605832|NCT02181673|5598333|P2|Up to Week 24|Randomized not Treated|0
1605833|NCT02181673|5598334|P1|Up to Week 24|Randomized not Treated|0
1605834|NCT02181673|5598332|P3|Up to Week 24|Other|3
1605835|NCT02181673|5598333|P2|Up to Week 24|Other|0
1605836|NCT02181673|5598334|P1|Up to Week 24|Other|2
1605837|NCT02181673|5598332|P3|Up to Week 24|Withdrawal by Subject|1
1605838|NCT02181673|5598333|P2|Up to Week 24|Withdrawal by Subject|0
1605839|NCT02181673|5598334|P1|Up to Week 24|Withdrawal by Subject|10
1605840|NCT02181673|5598332|P3|Up to Week 24|Physician Decision|3
1605841|NCT02181673|5598333|P2|Up to Week 24|Physician Decision|0
1605842|NCT02181673|5598334|P1|Up to Week 24|Physician Decision|0
1605843|NCT02181673|5598332|P3|Up to Week 24|Lost to Follow-up|0
1605844|NCT02181673|5598333|P2|Up to Week 24|Lost to Follow-up|0
1605845|NCT02181673|5598334|P1|Up to Week 24|Lost to Follow-up|1
1605846|NCT02181673|5598332|P3|Up to Week 24|Lack of Efficacy|0
1605847|NCT02181673|5598333|P2|Up to Week 24|Lack of Efficacy|0
1605848|NCT02181673|5598334|P1|Up to Week 24|Lack of Efficacy|1
1605849|NCT02181673|5598332|P3|Up to Week 24|Death|0
1605850|NCT02181673|5598333|P2|Up to Week 24|Death|0
1605851|NCT02181673|5598334|P1|Up to Week 24|Death|1
1605852|NCT02181673|5598332|P3|Up to Week 24|Adverse Event|3
1605853|NCT02181673|5598333|P2|Up to Week 24|Adverse Event|0
1605854|NCT02181673|5598334|P1|Up to Week 24|Adverse Event|2
1605855|NCT02181634|5598361|P1|Overall Study|Patient opted to proceed to surgery|1
1605856|NCT02181634|5598361|P1|Overall Study|Symptomatic progression|1
1605857|NCT02181634|5598361|P1|Overall Study|Max number of dose reduction|1
1605858|NCT02181634|5598361|P1|Overall Study|Ineligible|1
1605859|NCT02181634|5598361|P1|Overall Study|Treatment delayed greater than 4 weeks|3
1605860|NCT02181634|5598361|P1|Overall Study|Death|2
1605861|NCT02181634|5598361|P1|Overall Study|Withdrawal by Subject|5
1605862|NCT02181634|5598361|P1|Overall Study|Physician Decision|8
1605863|NCT02181634|5598361|P1|Overall Study|Adverse Event|17
1605864|NCT02181634|5598361|P1|Overall Study|Lack of Efficacy|33
1605865|NCT02181504|5598410|P3|Overall Study|Adverse Event|1
1605866|NCT02181504|5598411|P2|Overall Study|Adverse Event|1
1605867|NCT02181504|5598412|P1|Overall Study|Adverse Event|1
1605868|NCT02181413|5598451|P2|Overall Study|Lost to Follow-up|1
1605869|NCT02181413|5598452|P1|Overall Study|Lost to Follow-up|0
1605870|NCT02181413|5598451|P2|Overall Study|Ongoing Study Treatment|1
1605871|NCT02181413|5598452|P1|Overall Study|Ongoing Study Treatment|0
1605872|NCT02181413|5598451|P2|Overall Study|Reason Not Specified|20
1605873|NCT02181413|5598452|P1|Overall Study|Reason Not Specified|19
1605874|NCT02181413|5598451|P2|Overall Study|Withdrawal by Subject|8
1605875|NCT02181413|5598452|P1|Overall Study|Withdrawal by Subject|5
1605876|NCT02181413|5598451|P2|Overall Study|Progressive Disease|143
1605877|NCT02181413|5598452|P1|Overall Study|Progressive Disease|121
1605878|NCT02181413|5598451|P2|Overall Study|Adverse Event|24
1605879|NCT02181413|5598452|P1|Overall Study|Adverse Event|7
1605880|NCT02181296|5598497|P2|Overall Study|Lost to Follow-up|6
1605881|NCT02181296|5598498|P1|Overall Study|Lost to Follow-up|7
1605882|NCT02180659|5598640|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
1605883|NCT02180659|5598641|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
1605884|NCT02180659|5598640|P2|Overall Study|Withdrawal by Subject|2
1605885|NCT02180659|5598641|P1|Overall Study|Withdrawal by Subject|0
1605886|NCT02180659|5598640|P2|Overall Study|Subject incarcerated during conduct|0
1605887|NCT02180659|5598641|P1|Overall Study|Subject incarcerated during conduct|1
1605888|NCT02180659|5598640|P2|Overall Study|Lost to Follow-up|2
1605889|NCT02180659|5598641|P1|Overall Study|Lost to Follow-up|4
1605890|NCT02180659|5598640|P2|Overall Study|Adverse Event|0
1605891|NCT02180659|5598641|P1|Overall Study|Adverse Event|1
1605892|NCT02180438|5598676|P1|Overall Study|Lost to Follow-up|1
1605893|NCT02180165|5598700|P4|Overall Study|Withdrawal by Subject|1
1605894|NCT02180165|5598701|P3|Overall Study|Withdrawal by Subject|2
1605895|NCT02180165|5598702|P2|Overall Study|Withdrawal by Subject|0
1605896|NCT02180165|5598703|P1|Overall Study|Withdrawal by Subject|3
1605897|NCT02180165|5598700|P4|Overall Study|Physician Decision|0
1605898|NCT02180165|5598701|P3|Overall Study|Physician Decision|5
1605899|NCT02180165|5598702|P2|Overall Study|Physician Decision|0
1605900|NCT02180165|5598703|P1|Overall Study|Physician Decision|1
1605901|NCT02180165|5598700|P4|Overall Study|Lack of Efficacy|2
1605902|NCT02180165|5598701|P3|Overall Study|Lack of Efficacy|3
1605903|NCT02180165|5598702|P2|Overall Study|Lack of Efficacy|1
1605904|NCT02180165|5598703|P1|Overall Study|Lack of Efficacy|0
1605905|NCT02180165|5598700|P4|Overall Study|Adverse Event|3
1605906|NCT02180165|5598701|P3|Overall Study|Adverse Event|18
1605907|NCT02180165|5598702|P2|Overall Study|Adverse Event|0
1605908|NCT02180165|5598703|P1|Overall Study|Adverse Event|7
1605909|NCT02180165|5598700|P4|Overall Study|Not Treated|0
1605910|NCT02180165|5598701|P3|Overall Study|Not Treated|1
1605911|NCT02180165|5598702|P2|Overall Study|Not Treated|0
1605912|NCT02180165|5598703|P1|Overall Study|Not Treated|0
1605913|NCT02180061|5598791|P2|Overall Study|Physician Decision|0
1605914|NCT02180061|5598792|P1|Overall Study|Physician Decision|1
1605915|NCT02180061|5598791|P2|Overall Study|Progressive Disease|5
1605916|NCT02180061|5598792|P1|Overall Study|Progressive Disease|15
1605917|NCT02180061|5598791|P2|Overall Study|Clinical Progression|1
1605918|NCT02180061|5598792|P1|Overall Study|Clinical Progression|5
1605919|NCT02180061|5598791|P2|Overall Study|Adverse Event|2
1605920|NCT02180061|5598792|P1|Overall Study|Adverse Event|4
1605921|NCT02179918|5598811|P5|Overall Study|Subject refused further follow-up|1
1605922|NCT02179918|5598812|P4|Overall Study|Subject refused further follow-up|0
1605923|NCT02179918|5598813|P3|Overall Study|Subject refused further follow-up|0
1605924|NCT02179918|5598814|P2|Overall Study|Subject refused further follow-up|1
1605925|NCT02179918|5598815|P1|Overall Study|Subject refused further follow-up|0
1605926|NCT02179918|5598811|P5|Overall Study|Other|1
1605927|NCT02179918|5598812|P4|Overall Study|Other|0
1605928|NCT02179918|5598813|P3|Overall Study|Other|0
1605929|NCT02179918|5598814|P2|Overall Study|Other|1
1605930|NCT02179918|5598815|P1|Overall Study|Other|0
1605931|NCT02179918|5598811|P5|Overall Study|Progressive Disease|6
1605932|NCT02179918|5598812|P4|Overall Study|Progressive Disease|2
1605933|NCT02179918|5598813|P3|Overall Study|Progressive Disease|1
1605934|NCT02179918|5598814|P2|Overall Study|Progressive Disease|1
1605935|NCT02179918|5598815|P1|Overall Study|Progressive Disease|4
1605936|NCT02179918|5598811|P5|Overall Study|Lost to Follow-up|0
1605937|NCT02179918|5598812|P4|Overall Study|Lost to Follow-up|0
1605938|NCT02179918|5598813|P3|Overall Study|Lost to Follow-up|1
1605939|NCT02179918|5598814|P2|Overall Study|Lost to Follow-up|0
1605940|NCT02179918|5598815|P1|Overall Study|Lost to Follow-up|0
1605941|NCT02179918|5598811|P5|Overall Study|Death|0
1605942|NCT02179918|5598812|P4|Overall Study|Death|1
1605943|NCT02179918|5598813|P3|Overall Study|Death|0
1605944|NCT02179918|5598814|P2|Overall Study|Death|0
1605945|NCT02179918|5598815|P1|Overall Study|Death|0
1605946|NCT02179398|5599019|P2|Overall Study|Lost to Follow-up|1
1605947|NCT02179398|5599020|P1|Overall Study|Lost to Follow-up|0
1605948|NCT02179398|5599019|P2|Overall Study|Lack of obligatory data|3
1605949|NCT02179398|5599020|P1|Overall Study|Lack of obligatory data|3
1605950|NCT02179190|5599038|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
1605951|NCT02179190|5599038|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
1605952|NCT02179190|5599038|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
1605953|NCT02179190|5599038|P1|Follow-Up Post Barrel VRD Implanted|Death|3
1605954|NCT02179190|5599038|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
1605955|NCT02179190|5599038|P1|Enrollment|Exit Prior to Device Attempt|11
1605956|NCT02178995|5599077|P9|Open Label|Adverse Event|0
1605957|NCT02178995|5599078|P8|Open Label|Adverse Event|0
1605958|NCT02178995|5599079|P7|Open Label|Adverse Event|0
1605959|NCT02178995|5599080|P6|Open Label|Adverse Event|0
1605960|NCT02178995|5599081|P5|Open Label|Adverse Event|0
1605961|NCT02178995|5599082|P4|Open Label|Adverse Event|0
1605962|NCT02178995|5599083|P3|Open Label|Adverse Event|0
1605963|NCT02178995|5599084|P2|Open Label|Adverse Event|0
1605964|NCT02178995|5599085|P1|Open Label|Adverse Event|2
1605965|NCT02178995|5599077|P9|Double Blind|Lost to Follow-up|0
1605966|NCT02178995|5599078|P8|Double Blind|Lost to Follow-up|1
1605967|NCT02178995|5599079|P7|Double Blind|Lost to Follow-up|0
1605968|NCT02178995|5599080|P6|Double Blind|Lost to Follow-up|0
1605969|NCT02178995|5599081|P5|Double Blind|Lost to Follow-up|0
1605970|NCT02178995|5599082|P4|Double Blind|Lost to Follow-up|0
1605971|NCT02178995|5599083|P3|Double Blind|Lost to Follow-up|0
1605972|NCT02178995|5599084|P2|Double Blind|Lost to Follow-up|1
1605973|NCT02178995|5599085|P1|Double Blind|Lost to Follow-up|0
1605974|NCT02178995|5599077|P9|Double Blind|Adverse Event|1
1605975|NCT02178995|5599078|P8|Double Blind|Adverse Event|1
1605976|NCT02178995|5599079|P7|Double Blind|Adverse Event|0
1605977|NCT02178995|5599080|P6|Double Blind|Adverse Event|1
1605978|NCT02178995|5599081|P5|Double Blind|Adverse Event|0
1605979|NCT02178995|5599082|P4|Double Blind|Adverse Event|0
1605980|NCT02178995|5599083|P3|Double Blind|Adverse Event|0
1605981|NCT02178995|5599084|P2|Double Blind|Adverse Event|0
1605982|NCT02178995|5599085|P1|Double Blind|Adverse Event|0
1605983|NCT02178787|5599192|P2|Overall Study|Physician Decision|0
1605984|NCT02178787|5599193|P1|Overall Study|Physician Decision|1
1605985|NCT02178787|5599192|P2|Overall Study|No TCD window|7
1605986|NCT02178787|5599193|P1|Overall Study|No TCD window|3
1605987|NCT02178787|5599192|P2|Overall Study|Withdrawal by Subject|2
1605988|NCT02178787|5599193|P1|Overall Study|Withdrawal by Subject|0
1605989|NCT02178787|5599192|P2|Overall Study|Lost to Follow-up|0
1605990|NCT02178787|5599193|P1|Overall Study|Lost to Follow-up|1
1605991|NCT02178722|5599206|P5|Overall Study|Participants Ongoing in study|74
1605992|NCT02178722|5599207|P4|Overall Study|Participants Ongoing in study|2
1605993|NCT02178722|5599208|P3|Overall Study|Participants Ongoing in study|4
1605994|NCT02178722|5599209|P2|Overall Study|Participants Ongoing in study|1
1605995|NCT02178722|5599210|P1|Overall Study|Participants Ongoing in study|1
1605996|NCT02178722|5599206|P5|Overall Study|Other Unspecified|1
1605997|NCT02178722|5599207|P4|Overall Study|Other Unspecified|0
1605998|NCT02178722|5599208|P3|Overall Study|Other Unspecified|0
1605999|NCT02178722|5599209|P2|Overall Study|Other Unspecified|0
1606000|NCT02178722|5599210|P1|Overall Study|Other Unspecified|0
1606001|NCT02178722|5599206|P5|Overall Study|Physician Decision|2
1606002|NCT02178722|5599207|P4|Overall Study|Physician Decision|0
1606003|NCT02178722|5599208|P3|Overall Study|Physician Decision|0
1606004|NCT02178722|5599209|P2|Overall Study|Physician Decision|0
1606005|NCT02178722|5599210|P1|Overall Study|Physician Decision|0
1606006|NCT02178722|5599206|P5|Overall Study|Study Terminated by Sponsor|65
1606007|NCT02178722|5599207|P4|Overall Study|Study Terminated by Sponsor|3
1606008|NCT02178722|5599208|P3|Overall Study|Study Terminated by Sponsor|2
1606009|NCT02178722|5599209|P2|Overall Study|Study Terminated by Sponsor|6
1606010|NCT02178722|5599210|P1|Overall Study|Study Terminated by Sponsor|1
1606011|NCT02178722|5599206|P5|Overall Study|Lost to Follow-up|11
1606012|NCT02178722|5599207|P4|Overall Study|Lost to Follow-up|2
1606013|NCT02178722|5599208|P3|Overall Study|Lost to Follow-up|0
1606014|NCT02178722|5599209|P2|Overall Study|Lost to Follow-up|0
1606015|NCT02178722|5599210|P1|Overall Study|Lost to Follow-up|0
1606016|NCT02178722|5599206|P5|Overall Study|Death|199
1606017|NCT02178722|5599207|P4|Overall Study|Death|11
1606018|NCT02178722|5599208|P3|Overall Study|Death|12
1606019|NCT02178722|5599209|P2|Overall Study|Death|13
1606020|NCT02178722|5599210|P1|Overall Study|Death|2
1606021|NCT02178722|5599206|P5|Overall Study|Participant decision|30
1606022|NCT02178722|5599207|P4|Overall Study|Participant decision|2
1606023|NCT02178722|5599208|P3|Overall Study|Participant decision|0
1606024|NCT02178722|5599209|P2|Overall Study|Participant decision|0
1606025|NCT02178722|5599210|P1|Overall Study|Participant decision|0
1606031|NCT02178592|5599249|P2|Overall Study|Physician Decision|0
1606032|NCT02178592|5599250|P1|Overall Study|Physician Decision|1
1606033|NCT02178592|5599249|P2|Overall Study|Lost to Follow-up|3
1606034|NCT02178592|5599250|P1|Overall Study|Lost to Follow-up|11
1606035|NCT02178592|5599249|P2|Overall Study|Withdrawal by Subject|1
1606036|NCT02178592|5599250|P1|Overall Study|Withdrawal by Subject|3
1606037|NCT02178592|5599249|P2|Overall Study|Protocol Violation|2
1606038|NCT02178592|5599250|P1|Overall Study|Protocol Violation|3
1606039|NCT02178592|5599249|P2|Overall Study|Lack of Efficacy|1
1606040|NCT02178592|5599250|P1|Overall Study|Lack of Efficacy|1
1606041|NCT02178592|5599249|P2|Overall Study|Adverse Event|2
1606042|NCT02178592|5599250|P1|Overall Study|Adverse Event|0
1606043|NCT02178553|5599278|P2|Overall Study|Technical problem with injection|3
1606044|NCT02178553|5599279|P1|Overall Study|Technical problem with injection|1
1606045|NCT02178553|5599278|P2|Overall Study|Physician Decision|4
1606046|NCT02178553|5599279|P1|Overall Study|Physician Decision|0
1606047|NCT02178553|5599278|P2|Overall Study|Did not proceed to open thoracotomy|3
1606048|NCT02178553|5599279|P1|Overall Study|Did not proceed to open thoracotomy|7
1606049|NCT02178475|5599298|P1|Overall Study|Protocol-specified Criteria|99
1606050|NCT02178475|5599298|P1|Overall Study|Death|13
1606051|NCT02178475|5599298|P1|Overall Study|Lost to Follow-up|10
1606052|NCT02178475|5599298|P1|Overall Study|Withdrawal by Subject|7
1606053|NCT02178059|5599325|P2|Washout|Physician Decision|0
1606054|NCT02178059|5599326|P1|Washout|Physician Decision|1
1606055|NCT02177942|5599344|P2|Overall Study|Withdrawal by Subject|81
1606056|NCT02177942|5599345|P1|Overall Study|Withdrawal by Subject|71
1606057|NCT02177942|5599344|P2|Overall Study|Protocol Violation|6
1606058|NCT02177942|5599345|P1|Overall Study|Protocol Violation|4
1606059|NCT02177942|5599344|P2|Overall Study|Lost to Follow-up|1
1606060|NCT02177942|5599345|P1|Overall Study|Lost to Follow-up|1
1606061|NCT02177942|5599344|P2|Overall Study|Adverse Event|0
1606062|NCT02177942|5599345|P1|Overall Study|Adverse Event|1
1606063|NCT02177812|5599376|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
1606064|NCT02177812|5599377|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
1606065|NCT02177812|5599378|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
1606066|NCT02177812|5599379|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
1606067|NCT02177812|5599380|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
1606068|NCT02177812|5599381|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
1606069|NCT02177812|5599382|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
1606070|NCT02177812|5599383|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
1606071|NCT02177812|5599384|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
1606072|NCT02177812|5599376|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
1606073|NCT02177812|5599377|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
1606074|NCT02177812|5599378|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
1606075|NCT02177812|5599379|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
1606076|NCT02177812|5599380|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
1606077|NCT02177812|5599381|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
1606078|NCT02177812|5599382|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
1606079|NCT02177812|5599383|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
1606080|NCT02177812|5599384|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
1606081|NCT02177812|5599376|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1606082|NCT02177812|5599377|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
1606083|NCT02177812|5599378|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
1606084|NCT02177812|5599379|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
1606085|NCT02177812|5599380|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1606086|NCT02177812|5599381|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1606087|NCT02177812|5599382|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1606088|NCT02177812|5599383|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1606089|NCT02177812|5599384|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
1606090|NCT02177786|5599601|P4|Overall Study|Missing study completion status|0
1606091|NCT02177786|5599602|P3|Overall Study|Missing study completion status|0
1606092|NCT02177786|5599603|P2|Overall Study|Missing study completion status|1
1606093|NCT02177786|5599604|P1|Overall Study|Missing study completion status|0
1606094|NCT02177786|5599601|P4|Overall Study|Progressive Disease|0
1606095|NCT02177786|5599602|P3|Overall Study|Progressive Disease|0
1606096|NCT02177786|5599603|P2|Overall Study|Progressive Disease|1
1606097|NCT02177786|5599604|P1|Overall Study|Progressive Disease|0
1606098|NCT02177786|5599601|P4|Overall Study|Protocol Violation|0
1606099|NCT02177786|5599602|P3|Overall Study|Protocol Violation|2
1606100|NCT02177786|5599603|P2|Overall Study|Protocol Violation|0
1606101|NCT02177786|5599604|P1|Overall Study|Protocol Violation|0
1606102|NCT02177786|5599601|P4|Overall Study|Non-Compliance with Study Drug|1
1606103|NCT02177786|5599602|P3|Overall Study|Non-Compliance with Study Drug|0
1606104|NCT02177786|5599603|P2|Overall Study|Non-Compliance with Study Drug|1
1606105|NCT02177786|5599604|P1|Overall Study|Non-Compliance with Study Drug|0
1606106|NCT02177786|5599601|P4|Overall Study|Lost to Follow-up|2
1606107|NCT02177786|5599602|P3|Overall Study|Lost to Follow-up|2
1606108|NCT02177786|5599603|P2|Overall Study|Lost to Follow-up|0
1606109|NCT02177786|5599604|P1|Overall Study|Lost to Follow-up|0
1606110|NCT02177786|5599601|P4|Overall Study|Death|1
1606111|NCT02177786|5599602|P3|Overall Study|Death|1
1606112|NCT02177786|5599603|P2|Overall Study|Death|1
1606113|NCT02177786|5599604|P1|Overall Study|Death|1
1606114|NCT02177786|5599601|P4|Overall Study|Adverse Event|3
1606115|NCT02177786|5599602|P3|Overall Study|Adverse Event|2
1606116|NCT02177786|5599603|P2|Overall Study|Adverse Event|1
1606117|NCT02177786|5599604|P1|Overall Study|Adverse Event|1
1606118|NCT02177786|5599601|P4|Overall Study|Progression to End Stage Renal Disease|1
1606119|NCT02177786|5599602|P3|Overall Study|Progression to End Stage Renal Disease|2
1606120|NCT02177786|5599603|P2|Overall Study|Progression to End Stage Renal Disease|3
1606121|NCT02177786|5599604|P1|Overall Study|Progression to End Stage Renal Disease|2
1606122|NCT02177786|5599601|P4|Overall Study|Withdrew Consent|5
1606123|NCT02177786|5599602|P3|Overall Study|Withdrew Consent|9
1606124|NCT02177786|5599603|P2|Overall Study|Withdrew Consent|6
1606125|NCT02177786|5599604|P1|Overall Study|Withdrew Consent|2
1606126|NCT02177266|5599627|P2|Overall Study|Withdrawal by Subject|0
1606127|NCT02177266|5599628|P1|Overall Study|Withdrawal by Subject|1
1606128|NCT02177266|5599627|P2|Overall Study|Adverse Event|1
1606129|NCT02177266|5599628|P1|Overall Study|Adverse Event|0
1606130|NCT02177136|5599650|P3|Overall Study|Protocol Violation|1
1606131|NCT02177136|5599651|P2|Overall Study|Protocol Violation|0
1606132|NCT02177136|5599652|P1|Overall Study|Protocol Violation|0
1606133|NCT02177136|5599650|P3|Overall Study|Adverse Event|3
1606134|NCT02177136|5599651|P2|Overall Study|Adverse Event|2
1606135|NCT02177136|5599652|P1|Overall Study|Adverse Event|3
1606136|NCT02177136|5599650|P3|Overall Study|Discontinued due to pruritus|0
1606137|NCT02177136|5599651|P2|Overall Study|Discontinued due to pruritus|3
1606138|NCT02177136|5599652|P1|Overall Study|Discontinued due to pruritus|1
1606139|NCT02177136|5599650|P3|Overall Study|Withdrawal by Subject|0
1606140|NCT02177136|5599651|P2|Overall Study|Withdrawal by Subject|0
1606141|NCT02177136|5599652|P1|Overall Study|Withdrawal by Subject|2
1606142|NCT02177032|5599685|P4|Overall Study|Withdrawal by Subject|0
1606143|NCT02177032|5599686|P3|Overall Study|Withdrawal by Subject|1
1606144|NCT02177032|5599687|P2|Overall Study|Withdrawal by Subject|0
1606145|NCT02177032|5599688|P1|Overall Study|Withdrawal by Subject|1
1606146|NCT02177032|5599685|P4|Overall Study|OTHER|0
1606147|NCT02177032|5599686|P3|Overall Study|OTHER|1
1606148|NCT02177032|5599687|P2|Overall Study|OTHER|0
1606149|NCT02177032|5599688|P1|Overall Study|OTHER|2
1606150|NCT02177032|5599685|P4|Overall Study|Lost to Follow-up|0
1606151|NCT02177032|5599686|P3|Overall Study|Lost to Follow-up|0
1606152|NCT02177032|5599687|P2|Overall Study|Lost to Follow-up|2
1606153|NCT02177032|5599688|P1|Overall Study|Lost to Follow-up|0
1606154|NCT02177032|5599685|P4|Overall Study|ADMINISTRATIVE REASON|0
1606155|NCT02177032|5599686|P3|Overall Study|ADMINISTRATIVE REASON|1
1606156|NCT02177032|5599687|P2|Overall Study|ADMINISTRATIVE REASON|0
1606157|NCT02177032|5599688|P1|Overall Study|ADMINISTRATIVE REASON|2
1606158|NCT02176655|5599726|P1|Overall Study|Subjects did not treat|6
1606159|NCT02176642|5599749|P2|Overall Study|Withdrawal by Subject|1
1606160|NCT02176642|5599750|P1|Overall Study|Withdrawal by Subject|0
1606161|NCT02176525|5599780|P8|Overall Study|not treated|0
1606162|NCT02176525|5599781|P7|Overall Study|not treated|0
1606163|NCT02176525|5599782|P6|Overall Study|not treated|1
1606164|NCT02176525|5599783|P5|Overall Study|not treated|0
1606165|NCT02176525|5599784|P4|Overall Study|not treated|0
1606166|NCT02176525|5599785|P3|Overall Study|not treated|0
1606167|NCT02176525|5599786|P2|Overall Study|not treated|0
1606168|NCT02176525|5599787|P1|Overall Study|not treated|1
1606169|NCT02176525|5599780|P8|Overall Study|Adverse Event|0
1606170|NCT02176525|5599781|P7|Overall Study|Adverse Event|1
1606171|NCT02176525|5599782|P6|Overall Study|Adverse Event|0
1606172|NCT02176525|5599783|P5|Overall Study|Adverse Event|1
1606173|NCT02176525|5599784|P4|Overall Study|Adverse Event|1
1606174|NCT02176525|5599785|P3|Overall Study|Adverse Event|0
1606175|NCT02176525|5599786|P2|Overall Study|Adverse Event|0
1606176|NCT02176525|5599787|P1|Overall Study|Adverse Event|0
1606177|NCT02176421|5600003|P1|Overall Study|Adverse Event|1
1606178|NCT02176421|5600003|P1|Overall Study|Lost to Follow-up|4
1606179|NCT02176356|5600035|P1|Overall Study|Other Miscellaneous Reasons|2
1606180|NCT02176356|5600035|P1|Overall Study|Personal Reasons|3
1606181|NCT02176356|5600035|P1|Overall Study|Lost to Follow-up|4
1606182|NCT02176356|5600035|P1|Overall Study|Screen Failure|14
1606183|NCT02176291|5600065|P2|Overall Study|Withdrawal by Subject|0
1606184|NCT02176291|5600066|P1|Overall Study|Withdrawal by Subject|2
1606185|NCT02176291|5600065|P2|Overall Study|non compliance with protocol|0
1606186|NCT02176291|5600066|P1|Overall Study|non compliance with protocol|2
1606187|NCT02176291|5600065|P2|Overall Study|Death|0
1606188|NCT02176291|5600066|P1|Overall Study|Death|1
1606189|NCT02176226|5600074|P1|Overall Study|Withdrew prior to treatment|6
1606190|NCT02176226|5600074|P1|Overall Study|Lost to Follow-up|3
1606191|NCT02176018|5600082|P2|Overall Study|Withdrawal by Subject|2
1606192|NCT02176018|5600083|P1|Overall Study|Withdrawal by Subject|1
1606193|NCT02176018|5600082|P2|Overall Study|Protocol Violation|1
1606194|NCT02176018|5600083|P1|Overall Study|Protocol Violation|1
1606195|NCT02176018|5600082|P2|Overall Study|Lost to Follow-up|1
1606196|NCT02176018|5600083|P1|Overall Study|Lost to Follow-up|3
1606197|NCT02176018|5600082|P2|Overall Study|Adverse Event|2
1606198|NCT02176018|5600083|P1|Overall Study|Adverse Event|0
1606199|NCT02175966|5600134|P2|Follow-up Period|Lack of Efficacy|6
1606200|NCT02175966|5600135|P1|Follow-up Period|Lack of Efficacy|10
1606201|NCT02175771|5600163|P9|Treatment Period|Other|0
1606202|NCT02175771|5600164|P8|Treatment Period|Other|2
1606203|NCT02175771|5600165|P7|Treatment Period|Other|0
1606204|NCT02175771|5600166|P6|Treatment Period|Other|0
1606205|NCT02175771|5600167|P5|Treatment Period|Other|1
1606206|NCT02175771|5600168|P4|Treatment Period|Other|3
1606207|NCT02175771|5600169|P3|Treatment Period|Other|0
1606208|NCT02175771|5600170|P2|Treatment Period|Other|1
1606209|NCT02175771|5600171|P1|Treatment Period|Other|0
1606210|NCT02175771|5600163|P9|Treatment Period|Lack of Efficacy|0
1606211|NCT02175771|5600164|P8|Treatment Period|Lack of Efficacy|1
1606212|NCT02175771|5600165|P7|Treatment Period|Lack of Efficacy|0
1606213|NCT02175771|5600166|P6|Treatment Period|Lack of Efficacy|1
1606214|NCT02175771|5600167|P5|Treatment Period|Lack of Efficacy|0
1606215|NCT02175771|5600168|P4|Treatment Period|Lack of Efficacy|0
1606216|NCT02175771|5600169|P3|Treatment Period|Lack of Efficacy|0
1606217|NCT02175771|5600170|P2|Treatment Period|Lack of Efficacy|0
1606218|NCT02175771|5600171|P1|Treatment Period|Lack of Efficacy|0
1606219|NCT02175771|5600163|P9|Treatment Period|Lost to Follow-up|2
1606220|NCT02175771|5600164|P8|Treatment Period|Lost to Follow-up|2
1606221|NCT02175771|5600165|P7|Treatment Period|Lost to Follow-up|1
1606222|NCT02175771|5600166|P6|Treatment Period|Lost to Follow-up|2
1606223|NCT02175771|5600167|P5|Treatment Period|Lost to Follow-up|1
1606224|NCT02175771|5600168|P4|Treatment Period|Lost to Follow-up|3
1606225|NCT02175771|5600169|P3|Treatment Period|Lost to Follow-up|1
1606226|NCT02175771|5600170|P2|Treatment Period|Lost to Follow-up|3
1606227|NCT02175771|5600171|P1|Treatment Period|Lost to Follow-up|0
1606228|NCT02175771|5600163|P9|Treatment Period|Disease progression|0
1606229|NCT02175771|5600164|P8|Treatment Period|Disease progression|2
1606230|NCT02175771|5600165|P7|Treatment Period|Disease progression|0
1606231|NCT02175771|5600166|P6|Treatment Period|Disease progression|0
1606232|NCT02175771|5600167|P5|Treatment Period|Disease progression|0
1606233|NCT02175771|5600168|P4|Treatment Period|Disease progression|0
1606234|NCT02175771|5600169|P3|Treatment Period|Disease progression|0
1606235|NCT02175771|5600170|P2|Treatment Period|Disease progression|0
1606236|NCT02175771|5600171|P1|Treatment Period|Disease progression|0
1606237|NCT02175771|5600163|P9|Treatment Period|Protocol Violation|0
1606238|NCT02175771|5600164|P8|Treatment Period|Protocol Violation|1
1606239|NCT02175771|5600165|P7|Treatment Period|Protocol Violation|0
1606240|NCT02175771|5600166|P6|Treatment Period|Protocol Violation|0
1606241|NCT02175771|5600167|P5|Treatment Period|Protocol Violation|0
1606242|NCT02175771|5600168|P4|Treatment Period|Protocol Violation|0
1606243|NCT02175771|5600169|P3|Treatment Period|Protocol Violation|0
1606244|NCT02175771|5600170|P2|Treatment Period|Protocol Violation|0
1606245|NCT02175771|5600171|P1|Treatment Period|Protocol Violation|0
1606246|NCT02175771|5600163|P9|Treatment Period|Noncompliance|1
1606247|NCT02175771|5600164|P8|Treatment Period|Noncompliance|0
1606248|NCT02175771|5600165|P7|Treatment Period|Noncompliance|0
1606249|NCT02175771|5600166|P6|Treatment Period|Noncompliance|0
1606250|NCT02175771|5600167|P5|Treatment Period|Noncompliance|0
1606251|NCT02175771|5600168|P4|Treatment Period|Noncompliance|0
1606252|NCT02175771|5600169|P3|Treatment Period|Noncompliance|2
1606253|NCT02175771|5600170|P2|Treatment Period|Noncompliance|1
1606254|NCT02175771|5600171|P1|Treatment Period|Noncompliance|0
1606255|NCT02175771|5600163|P9|Treatment Period|Withdrawal by Subject|2
1606256|NCT02175771|5600164|P8|Treatment Period|Withdrawal by Subject|9
1606257|NCT02175771|5600165|P7|Treatment Period|Withdrawal by Subject|2
1606258|NCT02175771|5600166|P6|Treatment Period|Withdrawal by Subject|4
1606259|NCT02175771|5600167|P5|Treatment Period|Withdrawal by Subject|2
1606260|NCT02175771|5600168|P4|Treatment Period|Withdrawal by Subject|6
1606261|NCT02175771|5600169|P3|Treatment Period|Withdrawal by Subject|3
1606262|NCT02175771|5600170|P2|Treatment Period|Withdrawal by Subject|9
1606263|NCT02175771|5600171|P1|Treatment Period|Withdrawal by Subject|0
1606264|NCT02175771|5600163|P9|Treatment Period|Adverse Event|1
1606265|NCT02175771|5600164|P8|Treatment Period|Adverse Event|0
1606266|NCT02175771|5600165|P7|Treatment Period|Adverse Event|2
1606267|NCT02175771|5600166|P6|Treatment Period|Adverse Event|3
1606268|NCT02175771|5600167|P5|Treatment Period|Adverse Event|1
1606269|NCT02175771|5600168|P4|Treatment Period|Adverse Event|1
1606270|NCT02175771|5600169|P3|Treatment Period|Adverse Event|1
1606271|NCT02175771|5600170|P2|Treatment Period|Adverse Event|2
1606272|NCT02175771|5600171|P1|Treatment Period|Adverse Event|0
1606273|NCT02175771|5600163|P9|Run-In Period (Pre-assignment)|Other|0
1606274|NCT02175771|5600164|P8|Run-In Period (Pre-assignment)|Other|0
1606275|NCT02175771|5600165|P7|Run-In Period (Pre-assignment)|Other|0
1606276|NCT02175771|5600166|P6|Run-In Period (Pre-assignment)|Other|0
1606277|NCT02175771|5600167|P5|Run-In Period (Pre-assignment)|Other|0
1606278|NCT02175771|5600168|P4|Run-In Period (Pre-assignment)|Other|0
1606279|NCT02175771|5600169|P3|Run-In Period (Pre-assignment)|Other|0
1606280|NCT02175771|5600170|P2|Run-In Period (Pre-assignment)|Other|0
1606281|NCT02175771|5600171|P1|Run-In Period (Pre-assignment)|Other|8
1606282|NCT02175771|5600163|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606283|NCT02175771|5600164|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606284|NCT02175771|5600165|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606285|NCT02175771|5600166|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606286|NCT02175771|5600167|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606287|NCT02175771|5600168|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606288|NCT02175771|5600169|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606289|NCT02175771|5600170|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1606290|NCT02175771|5600171|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1606291|NCT02175771|5600163|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606292|NCT02175771|5600164|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606293|NCT02175771|5600165|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606294|NCT02175771|5600166|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606295|NCT02175771|5600167|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606296|NCT02175771|5600168|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606297|NCT02175771|5600169|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606298|NCT02175771|5600170|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1606299|NCT02175771|5600171|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
1606300|NCT02175771|5600163|P9|Run-In Period (Pre-assignment)|Adverse Event|0
1606301|NCT02175771|5600164|P8|Run-In Period (Pre-assignment)|Adverse Event|0
1606302|NCT02175771|5600165|P7|Run-In Period (Pre-assignment)|Adverse Event|0
1606303|NCT02175771|5600166|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1606304|NCT02175771|5600167|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1606305|NCT02175771|5600168|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1606306|NCT02175771|5600169|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1606307|NCT02175771|5600170|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1606308|NCT02175771|5600171|P1|Run-In Period (Pre-assignment)|Adverse Event|9
1606309|NCT02175771|5600163|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606310|NCT02175771|5600164|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606311|NCT02175771|5600165|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606312|NCT02175771|5600166|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606313|NCT02175771|5600167|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606314|NCT02175771|5600168|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606315|NCT02175771|5600169|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606316|NCT02175771|5600170|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1606317|NCT02175771|5600171|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
1606318|NCT02175771|5600163|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606319|NCT02175771|5600164|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606320|NCT02175771|5600165|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606321|NCT02175771|5600166|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606322|NCT02175771|5600167|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606323|NCT02175771|5600168|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606324|NCT02175771|5600169|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606325|NCT02175771|5600170|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1606326|NCT02175771|5600171|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
1606327|NCT02175771|5600163|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606328|NCT02175771|5600164|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606329|NCT02175771|5600165|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606330|NCT02175771|5600166|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606331|NCT02175771|5600167|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606332|NCT02175771|5600168|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606333|NCT02175771|5600169|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606334|NCT02175771|5600170|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1606335|NCT02175771|5600171|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
1606336|NCT02175758|5600235|P6|Treatment Phase|Adverse Event|0
1606337|NCT02175758|5600236|P5|Treatment Phase|Adverse Event|1
1606338|NCT02175758|5600237|P4|Treatment Phase|Adverse Event|0
1606339|NCT02175758|5600238|P3|Treatment Phase|Adverse Event|0
1606340|NCT02175758|5600239|P2|Treatment Phase|Adverse Event|0
1606341|NCT02175758|5600240|P1|Treatment Phase|Adverse Event|0
1606342|NCT02175758|5600235|P6|Treatment Phase|Lost to Follow-up|0
1606343|NCT02175758|5600236|P5|Treatment Phase|Lost to Follow-up|0
1606344|NCT02175758|5600237|P4|Treatment Phase|Lost to Follow-up|0
1606345|NCT02175758|5600238|P3|Treatment Phase|Lost to Follow-up|0
1606346|NCT02175758|5600239|P2|Treatment Phase|Lost to Follow-up|1
1606347|NCT02175758|5600240|P1|Treatment Phase|Lost to Follow-up|0
1606348|NCT02175745|5600343|P1|Overall Study|Not Eligible|1
1606349|NCT02175368|5600382|P1|Overall Study|Lost to Follow-up|1
1606350|NCT02175277|5600387|P1|Overall Study|Protocol-specified Criteria|1
1606351|NCT02175225|5600393|P2|Overall Study|Study drug not administered|2
1606352|NCT02175225|5600394|P1|Overall Study|Study drug not administered|1
1606353|NCT02175225|5600393|P2|Overall Study|Lost to Follow-up|7
1606354|NCT02175225|5600394|P1|Overall Study|Lost to Follow-up|6
1606355|NCT02175225|5600393|P2|Overall Study|Withdrawal by Subject|2
1606356|NCT02175225|5600394|P1|Overall Study|Withdrawal by Subject|1
1606357|NCT02175199|5600445|P2|Overall Study|Sponsor Decision|0
1606358|NCT02175199|5600446|P1|Overall Study|Sponsor Decision|1
1606359|NCT02175199|5600445|P2|Overall Study|Randomized in Error|0
1606360|NCT02175199|5600446|P1|Overall Study|Randomized in Error|1
1606361|NCT02175199|5600445|P2|Overall Study|Withdrawal by Subject|5
1606362|NCT02175199|5600446|P1|Overall Study|Withdrawal by Subject|1
1606363|NCT02175121|5600460|P5|Overall Study|Time issues|0
1606364|NCT02175121|5600461|P4|Overall Study|Time issues|0
1606365|NCT02175121|5600462|P3|Overall Study|Time issues|1
1606366|NCT02175121|5600463|P2|Overall Study|Time issues|0
1606367|NCT02175121|5600464|P1|Overall Study|Time issues|0
1606368|NCT02175121|5600460|P5|Overall Study|Schedule conflict|0
1606369|NCT02175121|5600461|P4|Overall Study|Schedule conflict|0
1606370|NCT02175121|5600462|P3|Overall Study|Schedule conflict|1
1606371|NCT02175121|5600463|P2|Overall Study|Schedule conflict|0
1606372|NCT02175121|5600464|P1|Overall Study|Schedule conflict|0
1606373|NCT02175121|5600460|P5|Overall Study|Personal emergency|1
1606374|NCT02175121|5600461|P4|Overall Study|Personal emergency|0
1606375|NCT02175121|5600462|P3|Overall Study|Personal emergency|0
1606376|NCT02175121|5600463|P2|Overall Study|Personal emergency|0
1606377|NCT02175121|5600464|P1|Overall Study|Personal emergency|0
1606378|NCT02175121|5600460|P5|Overall Study|Lost to Follow-up|0
1606379|NCT02175121|5600461|P4|Overall Study|Lost to Follow-up|1
1606380|NCT02175121|5600462|P3|Overall Study|Lost to Follow-up|0
1606381|NCT02175121|5600463|P2|Overall Study|Lost to Follow-up|1
1606382|NCT02175121|5600464|P1|Overall Study|Lost to Follow-up|0
1606383|NCT02175121|5600460|P5|Overall Study|Lack of Efficacy|0
1606384|NCT02175121|5600461|P4|Overall Study|Lack of Efficacy|0
1606385|NCT02175121|5600462|P3|Overall Study|Lack of Efficacy|0
1606386|NCT02175121|5600463|P2|Overall Study|Lack of Efficacy|0
1606387|NCT02175121|5600464|P1|Overall Study|Lack of Efficacy|1
1606388|NCT02174861|5600591|P1|Overall Study|Lost to Follow-up|26
1606389|NCT02174861|5600591|P1|Overall Study|Withdrawal by Subject|124
1606390|NCT02174861|5600591|P1|Overall Study|Decision by sponsor|8
1606391|NCT02174848|5600605|P2|Overall Study|Unable to comply with study requirements|0
1606392|NCT02174848|5600606|P1|Overall Study|Unable to comply with study requirements|1
1606393|NCT02174848|5600605|P2|Overall Study|Worsening of disease|1
1606394|NCT02174848|5600606|P1|Overall Study|Worsening of disease|1
1606395|NCT02174848|5600605|P2|Overall Study|Lost to Follow-up|1
1606396|NCT02174848|5600606|P1|Overall Study|Lost to Follow-up|0
1606397|NCT02174848|5600605|P2|Overall Study|Withdrawal by Subject|3
1606398|NCT02174848|5600606|P1|Overall Study|Withdrawal by Subject|3
1606399|NCT02174848|5600605|P2|Overall Study|Adverse Event|1
1606400|NCT02174848|5600606|P1|Overall Study|Adverse Event|2
1606401|NCT02174731|5600627|P2|Overall Study|Missing|0
1606402|NCT02174731|5600628|P1|Overall Study|Missing|2
1606403|NCT02174731|5600627|P2|Overall Study|Incorrect enrolment before randomization|1
1606404|NCT02174731|5600628|P1|Overall Study|Incorrect enrolment before randomization|0
1606405|NCT02174731|5600627|P2|Overall Study|Participant decision|64
1606406|NCT02174731|5600628|P1|Overall Study|Participant decision|67
1606407|NCT02174627|5600650|P2|Overall Study|Participant decision|128
1606408|NCT02174627|5600651|P1|Overall Study|Participant decision|84
1606409|NCT02174627|5600650|P2|Overall Study|Incorrect enrolment before randomization|1
1606410|NCT02174627|5600651|P1|Overall Study|Incorrect enrolment before randomization|0
1606411|NCT02174627|5600650|P2|Overall Study|Missing|1
1606412|NCT02174627|5600651|P1|Overall Study|Missing|0
1606413|NCT02174523|5600679|P2|Overall Study|Withdrawal by Subject|0
1606414|NCT02174523|5600680|P1|Overall Study|Withdrawal by Subject|1
1606415|NCT02174276|5600748|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
1606416|NCT02174276|5600749|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
1606417|NCT02174276|5600750|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
1606418|NCT02174276|5600751|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
1606419|NCT02174276|5600748|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
1606420|NCT02174276|5600749|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
1606421|NCT02174276|5600750|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
1606422|NCT02174276|5600751|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
1606423|NCT02174276|5600748|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
1606424|NCT02174276|5600749|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
1606425|NCT02174276|5600750|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
1606426|NCT02174276|5600751|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
1606427|NCT02174276|5600748|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
1606428|NCT02174276|5600749|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
1606429|NCT02174276|5600750|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
1606430|NCT02174276|5600751|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
1606431|NCT02174276|5600748|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
1606432|NCT02174276|5600749|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
1606433|NCT02174276|5600750|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
1606434|NCT02174276|5600751|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
1606435|NCT02174276|5600748|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
1606436|NCT02174276|5600749|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
1606437|NCT02174276|5600750|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
1606438|NCT02174276|5600751|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
1606439|NCT02173769|5600858|P1|Overall Study|Protocol Violation|4
1606440|NCT02173704|5600871|P2|Overall Study|Withdrawal by Subject|4
1606441|NCT02173704|5600872|P1|Overall Study|Withdrawal by Subject|9
1606442|NCT02173704|5600871|P2|Overall Study|Protocol Violation|0
1606443|NCT02173704|5600872|P1|Overall Study|Protocol Violation|1
1606444|NCT02173704|5600871|P2|Overall Study|Other|0
1606445|NCT02173704|5600872|P1|Overall Study|Other|1
1606446|NCT02173704|5600871|P2|Overall Study|Lost to Follow-up|0
1606447|NCT02173704|5600872|P1|Overall Study|Lost to Follow-up|1
1606448|NCT02173704|5600871|P2|Overall Study|Adverse Event|0
1606449|NCT02173704|5600872|P1|Overall Study|Adverse Event|1
1606450|NCT02173548|5600898|P2|Overall Study|Withdrawal by Subject|0
1606451|NCT02173548|5600899|P1|Overall Study|Withdrawal by Subject|1
1606452|NCT02173548|5600898|P2|Overall Study|Lost to Follow-up|2
1606453|NCT02173548|5600899|P1|Overall Study|Lost to Follow-up|0
1606454|NCT02173379|5601031|P2|Overall Study|Withdrawn by the physician|1
1606455|NCT02173379|5601032|P1|Overall Study|Withdrawn by the physician|0
1606456|NCT02173379|5601031|P2|Overall Study|Death|1
1606457|NCT02173379|5601032|P1|Overall Study|Death|1
1606458|NCT02173379|5601031|P2|Overall Study|Physician Decision|1
1606459|NCT02173379|5601032|P1|Overall Study|Physician Decision|4
1606460|NCT02173379|5601031|P2|Overall Study|Withdrawal by Subject|4
1606461|NCT02173379|5601032|P1|Overall Study|Withdrawal by Subject|1
1606462|NCT02173379|5601031|P2|Overall Study|Lost to Follow-up|0
1606463|NCT02173379|5601032|P1|Overall Study|Lost to Follow-up|3
1606464|NCT02173158|5601098|P1|Efficacy Phase|Adverse Event|1
1606465|NCT02173054|5601115|P3|Overall Study|Withdrawal by Subject|1
1606466|NCT02173054|5601116|P2|Overall Study|Withdrawal by Subject|0
1606467|NCT02173054|5601117|P1|Overall Study|Withdrawal by Subject|0
1606468|NCT02173054|5601115|P3|Overall Study|lack of compliance|0
1606469|NCT02173054|5601116|P2|Overall Study|lack of compliance|0
1606470|NCT02173054|5601117|P1|Overall Study|lack of compliance|1
1606471|NCT02172664|5601173|P2|Overall Study|Moved out of area|1
1606472|NCT02172664|5601174|P1|Overall Study|Moved out of area|1
1606473|NCT02172664|5601173|P2|Overall Study|Death|1
1606474|NCT02172664|5601174|P1|Overall Study|Death|1
1606475|NCT02172664|5601173|P2|Overall Study|Lost to Follow-up|4
1606476|NCT02172664|5601174|P1|Overall Study|Lost to Follow-up|4
1606477|NCT02172625|5601183|P2|Overall Study|car accident|1
1606478|NCT02172625|5601184|P1|Overall Study|car accident|0
1606479|NCT02172625|5601183|P2|Overall Study|Pregnancy|1
1606480|NCT02172625|5601184|P1|Overall Study|Pregnancy|0
1606481|NCT02172625|5601183|P2|Overall Study|Adverse Event|1
1606482|NCT02172625|5601184|P1|Overall Study|Adverse Event|0
1606483|NCT02172040|5601206|P4|Overall Study|Family emergency abroad|1
1606484|NCT02172040|5601207|P3|Overall Study|Family emergency abroad|0
1606485|NCT02172040|5601208|P2|Overall Study|Family emergency abroad|0
1606486|NCT02172040|5601209|P1|Overall Study|Family emergency abroad|0
1606487|NCT02172040|5601206|P4|Overall Study|Not available for Day 13 & 14 visits|0
1606488|NCT02172040|5601207|P3|Overall Study|Not available for Day 13 & 14 visits|1
1606489|NCT02172040|5601208|P2|Overall Study|Not available for Day 13 & 14 visits|0
1606490|NCT02172040|5601209|P1|Overall Study|Not available for Day 13 & 14 visits|0
1606491|NCT02172040|5601206|P4|Overall Study|Withdrawal by Subject|0
1606492|NCT02172040|5601207|P3|Overall Study|Withdrawal by Subject|1
1606493|NCT02172040|5601208|P2|Overall Study|Withdrawal by Subject|0
1606494|NCT02172040|5601209|P1|Overall Study|Withdrawal by Subject|0
1606495|NCT02172040|5601206|P4|Overall Study|Protocol Violation|0
1606496|NCT02172040|5601207|P3|Overall Study|Protocol Violation|0
1606497|NCT02172040|5601208|P2|Overall Study|Protocol Violation|1
1606498|NCT02172040|5601209|P1|Overall Study|Protocol Violation|0
1606499|NCT02172040|5601206|P4|Overall Study|Adverse Event|0
1606500|NCT02172040|5601207|P3|Overall Study|Adverse Event|0
1606501|NCT02172040|5601208|P2|Overall Study|Adverse Event|2
1606502|NCT02172040|5601209|P1|Overall Study|Adverse Event|0
1606503|NCT02171260|5601372|P4|Overall Study|Evidence of progressive disease|4
1606504|NCT02171260|5601373|P3|Overall Study|Evidence of progressive disease|4
1606505|NCT02171260|5601374|P2|Overall Study|Evidence of progressive disease|6
1606506|NCT02171260|5601375|P1|Overall Study|Evidence of progressive disease|4
1606507|NCT02171260|5601372|P4|Overall Study|Withdrawal by Subject|0
1606508|NCT02171260|5601373|P3|Overall Study|Withdrawal by Subject|0
1606509|NCT02171260|5601374|P2|Overall Study|Withdrawal by Subject|0
1606510|NCT02171260|5601375|P1|Overall Study|Withdrawal by Subject|1
1606511|NCT02171260|5601372|P4|Overall Study|Physician Decision|0
1606512|NCT02171260|5601373|P3|Overall Study|Physician Decision|1
1606513|NCT02171260|5601374|P2|Overall Study|Physician Decision|0
1606514|NCT02171260|5601375|P1|Overall Study|Physician Decision|1
1606515|NCT02171260|5601372|P4|Overall Study|Death|1
1606516|NCT02171260|5601373|P3|Overall Study|Death|0
1606517|NCT02171260|5601374|P2|Overall Study|Death|0
1606518|NCT02171260|5601375|P1|Overall Study|Death|0
1606519|NCT02171130|5601511|P1|Overall Study|Met Exclusion Criteria|1
1606520|NCT02171130|5601511|P1|Overall Study|Lost to Follow-up|1
1606521|NCT02171130|5601511|P1|Overall Study|Physician Decision|1
1606522|NCT02171130|5601511|P1|Overall Study|Withdrawal by Subject|3
1606523|NCT02171130|5601511|P1|Overall Study|Discontinued; Site Termination|5
1606524|NCT02171130|5601511|P1|Overall Study|Discontinued; Clinical Material Issue|16
1606525|NCT02171130|5601511|P1|Overall Study|Death|1
1606526|NCT02170779|5601552|P2|Overall Study|Lost to Follow-up|1
1606527|NCT02170779|5601553|P1|Overall Study|Lost to Follow-up|0
1606528|NCT02170779|5601552|P2|Overall Study|Withdrawal by Subject|0
1606529|NCT02170779|5601553|P1|Overall Study|Withdrawal by Subject|1
1606530|NCT02170727|5601577|P2|Overall Study|Withdrawal by Subject|0
1606531|NCT02170727|5601578|P1|Overall Study|Withdrawal by Subject|2
1606532|NCT02170727|5601577|P2|Overall Study|Lost to Follow-up|0
1606533|NCT02170727|5601578|P1|Overall Study|Lost to Follow-up|1
1606534|NCT02170688|5601609|P5|Overall Study|Physician Decision|0
1606535|NCT02170688|5601610|P4|Overall Study|Physician Decision|0
1606536|NCT02170688|5601611|P3|Overall Study|Physician Decision|1
1606537|NCT02170688|5601612|P2|Overall Study|Physician Decision|0
1606538|NCT02170688|5601613|P1|Overall Study|Physician Decision|0
1606539|NCT02170688|5601609|P5|Overall Study|Full dose not received|0
1606540|NCT02170688|5601610|P4|Overall Study|Full dose not received|0
1606541|NCT02170688|5601611|P3|Overall Study|Full dose not received|0
1606542|NCT02170688|5601612|P2|Overall Study|Full dose not received|1
1606543|NCT02170688|5601613|P1|Overall Study|Full dose not received|0
1606544|NCT02170688|5601609|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
1606545|NCT02170688|5601610|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
1606546|NCT02170688|5601611|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
1606547|NCT02170688|5601612|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
1606548|NCT02170688|5601613|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
1606549|NCT02170389|5601699|P1|Overall Study|Study terminated prior to start of treat|1
1606550|NCT02170298|5601764|P2|Overall Study|unblinded, rerandomized to intervention|0
1606551|NCT02170298|5601765|P1|Overall Study|unblinded, rerandomized to intervention|1
1606552|NCT02170298|5601764|P2|Overall Study|Withdrawal by Subject|1
1606553|NCT02170298|5601765|P1|Overall Study|Withdrawal by Subject|0
1606554|NCT02170207|5601802|P1|Overall Study|Case report forms unavailable|5
1606555|NCT02170077|5601813|P3|Overall Study|Exacerbation of seizures|1
1606556|NCT02170077|5601814|P2|Overall Study|Exacerbation of seizures|2
1606557|NCT02170077|5601815|P1|Overall Study|Exacerbation of seizures|0
1606558|NCT02170077|5601813|P3|Overall Study|Exclusion criteria|5
1606559|NCT02170077|5601814|P2|Overall Study|Exclusion criteria|2
1606560|NCT02170077|5601815|P1|Overall Study|Exclusion criteria|2
1606561|NCT02170077|5601813|P3|Overall Study|Lost to Follow-up|0
1606562|NCT02170077|5601814|P2|Overall Study|Lost to Follow-up|1
1606563|NCT02170077|5601815|P1|Overall Study|Lost to Follow-up|0
1606564|NCT02170077|5601813|P3|Overall Study|Adverse Event|4
1606565|NCT02170077|5601814|P2|Overall Study|Adverse Event|4
1606566|NCT02170077|5601815|P1|Overall Study|Adverse Event|4
1606567|NCT02170077|5601813|P3|Overall Study|Withdrawal by Subject|2
1606568|NCT02170077|5601814|P2|Overall Study|Withdrawal by Subject|4
1606569|NCT02170077|5601815|P1|Overall Study|Withdrawal by Subject|3
1606570|NCT02170064|5601826|P3|Overall Study|Physician Decision|0
1606571|NCT02170064|5601827|P2|Overall Study|Physician Decision|1
1606572|NCT02170064|5601828|P1|Overall Study|Physician Decision|1
1606573|NCT02170064|5601826|P3|Overall Study|Withdrawal by Subject|1
1606574|NCT02170064|5601827|P2|Overall Study|Withdrawal by Subject|1
1606575|NCT02170064|5601828|P1|Overall Study|Withdrawal by Subject|5
1606576|NCT02170025|5601844|P2|Overall Study|Adverse Event|0
1606577|NCT02170025|5601845|P1|Overall Study|Adverse Event|2
1606578|NCT02169674|5601889|P2|Overall Study|Lost to Follow-up|1
1606579|NCT02169674|5601890|P1|Overall Study|Lost to Follow-up|0
1606580|NCT02169674|5601889|P2|Overall Study|Seroprotected|76
1606581|NCT02169674|5601890|P1|Overall Study|Seroprotected|30
1606582|NCT02169674|5601889|P2|Overall Study|Withdrawal by Subject|1
1606583|NCT02169674|5601890|P1|Overall Study|Withdrawal by Subject|2
1606584|NCT02169505|5601904|P1|Overall Study|Withdrawal by Subject|1
1606585|NCT02169414|5602032|P4|Overall Study|Adverse Event|0
1606586|NCT02169414|5602033|P3|Overall Study|Adverse Event|0
1606587|NCT02169414|5602034|P2|Overall Study|Adverse Event|1
1606588|NCT02169414|5602035|P1|Overall Study|Adverse Event|0
1606589|NCT02169414|5602032|P4|Overall Study|Withdrawal by Subject|0
1606590|NCT02169414|5602033|P3|Overall Study|Withdrawal by Subject|0
1606591|NCT02169414|5602034|P2|Overall Study|Withdrawal by Subject|0
1606592|NCT02169414|5602035|P1|Overall Study|Withdrawal by Subject|1
1606593|NCT02169336|5602076|P3|Overall Study|Subject declined to continue dosing|1
1606594|NCT02169336|5602077|P2|Overall Study|Subject declined to continue dosing|0
1606595|NCT02169336|5602078|P1|Overall Study|Subject declined to continue dosing|0
1606596|NCT02169336|5602076|P3|Overall Study|Physician Decision|1
1606597|NCT02169336|5602077|P2|Overall Study|Physician Decision|0
1606598|NCT02169336|5602078|P1|Overall Study|Physician Decision|0
1606599|NCT02169336|5602076|P3|Overall Study|Withdrawal by Subject|0
1606600|NCT02169336|5602077|P2|Overall Study|Withdrawal by Subject|0
1606601|NCT02169336|5602078|P1|Overall Study|Withdrawal by Subject|1
1606602|NCT02169336|5602076|P3|Overall Study|Adverse Event|1
1606603|NCT02169336|5602077|P2|Overall Study|Adverse Event|3
1606604|NCT02169336|5602078|P1|Overall Study|Adverse Event|2
1606605|NCT02169336|5602076|P3|Overall Study|Lack of Efficacy|0
1606606|NCT02169336|5602077|P2|Overall Study|Lack of Efficacy|1
1606607|NCT02169336|5602078|P1|Overall Study|Lack of Efficacy|1
1606608|NCT02169219|5602086|P1|Overall Study|Lack of Efficacy|6
1606609|NCT02168946|5602112|P2|Overall Study|Subject unable to come back for visits|0
1606610|NCT02168946|5602113|P1|Overall Study|Subject unable to come back for visits|1
1606611|NCT02168946|5602112|P2|Overall Study|Lost to Follow-up|0
1606612|NCT02168946|5602113|P1|Overall Study|Lost to Follow-up|3
1606613|NCT02168946|5602112|P2|Overall Study|Adverse Event|5
1606614|NCT02168946|5602113|P1|Overall Study|Adverse Event|8
1606615|NCT02168842|5602159|P2|Overall Study|Physician Decision|2
1606616|NCT02168842|5602160|P1|Overall Study|Physician Decision|1
1606617|NCT02168842|5602159|P2|Overall Study|Death|1
1606618|NCT02168842|5602160|P1|Overall Study|Death|2
1606619|NCT02168842|5602159|P2|Overall Study|Lost to Follow-up|2
1606620|NCT02168842|5602160|P1|Overall Study|Lost to Follow-up|0
1606621|NCT02168842|5602159|P2|Overall Study|Withdrawal by Subject|3
1606622|NCT02168842|5602160|P1|Overall Study|Withdrawal by Subject|5
1606623|NCT02168816|5602218|P2|Overall Study|Lost to Follow-up|2
1606624|NCT02168816|5602219|P1|Overall Study|Lost to Follow-up|2
1606625|NCT02168803|5602230|P3|Overall Study|Sponsor Decision|1
1606626|NCT02168803|5602231|P2|Overall Study|Sponsor Decision|0
1606627|NCT02168803|5602232|P1|Overall Study|Sponsor Decision|0
1606628|NCT02168803|5602230|P3|Overall Study|Death|1
1606629|NCT02168803|5602231|P2|Overall Study|Death|0
1606630|NCT02168803|5602232|P1|Overall Study|Death|0
1606631|NCT02168803|5602230|P3|Overall Study|Adverse Event|1
1606632|NCT02168803|5602231|P2|Overall Study|Adverse Event|1
1606633|NCT02168803|5602232|P1|Overall Study|Adverse Event|0
1606634|NCT02168803|5602230|P3|Overall Study|Physician Decision|0
1606635|NCT02168803|5602231|P2|Overall Study|Physician Decision|1
1606636|NCT02168803|5602232|P1|Overall Study|Physician Decision|0
1606637|NCT02168803|5602230|P3|Overall Study|Withdrawal by Subject|2
1606638|NCT02168803|5602231|P2|Overall Study|Withdrawal by Subject|1
1606639|NCT02168803|5602232|P1|Overall Study|Withdrawal by Subject|1
1606640|NCT02168803|5602230|P3|Overall Study|Lost to Follow-up|1
1606641|NCT02168803|5602231|P2|Overall Study|Lost to Follow-up|0
1606642|NCT02168803|5602232|P1|Overall Study|Lost to Follow-up|1
1606643|NCT02168777|5602262|P3|Overall Study|Other reason|0
1606644|NCT02168777|5602263|P2|Overall Study|Other reason|1
1606645|NCT02168777|5602264|P1|Overall Study|Other reason|0
1606646|NCT02168777|5602262|P3|Overall Study|Clinical disease progression|2
1606647|NCT02168777|5602263|P2|Overall Study|Clinical disease progression|1
1606648|NCT02168777|5602264|P1|Overall Study|Clinical disease progression|0
1606649|NCT02168777|5602262|P3|Overall Study|Radiological disease progression|5
1606650|NCT02168777|5602263|P2|Overall Study|Radiological disease progression|5
1606651|NCT02168777|5602264|P1|Overall Study|Radiological disease progression|0
1606652|NCT02168777|5602262|P3|Overall Study|Disease recurrence|1
1606653|NCT02168777|5602263|P2|Overall Study|Disease recurrence|0
1606654|NCT02168777|5602264|P1|Overall Study|Disease recurrence|0
1606655|NCT02168777|5602262|P3|Overall Study|Adverse Event|1
1606656|NCT02168777|5602263|P2|Overall Study|Adverse Event|0
1606657|NCT02168777|5602264|P1|Overall Study|Adverse Event|1
1606658|NCT02168777|5602262|P3|Overall Study|Withdrawal by Subject|2
1606659|NCT02168777|5602263|P2|Overall Study|Withdrawal by Subject|0
1606660|NCT02168777|5602264|P1|Overall Study|Withdrawal by Subject|1
1606661|NCT02168491|5602360|P1|Overall Study|Withdrawal by Subject|1
1606662|NCT02168478|5602366|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
1606663|NCT02168478|5602366|P1|Overall Study|Did Not Consent to Participation|2
1606664|NCT02168478|5602366|P1|Overall Study|Withdrawal by Subject|1
1606665|NCT02168439|5602372|P2|Overall Study|Protocol Violation|2
1606666|NCT02168439|5602373|P1|Overall Study|Protocol Violation|0
1606667|NCT02168387|5602391|P2|Overall Study|Death|0
1606668|NCT02168387|5602392|P1|Overall Study|Death|1
1606669|NCT02168387|5602391|P2|Overall Study|Planned exubation|3
1606670|NCT02168387|5602392|P1|Overall Study|Planned exubation|6
1606671|NCT02168270|5602424|P1|Overall Study|Lack of Efficacy|4
1606672|NCT02167893|5602448|P1|Overall Study|Case report forms not collected|68
1606673|NCT02167893|5602448|P1|Overall Study|Investigator health reasons|10
1606674|NCT02167893|5602448|P1|Overall Study|Investigator transferred|85
1606675|NCT02167256|5602482|P2|Overall Study|Study partner unable to participate|0
1606676|NCT02167256|5602483|P1|Overall Study|Study partner unable to participate|1
1606677|NCT02167256|5602482|P2|Overall Study|non-compliance|0
1606678|NCT02167256|5602483|P1|Overall Study|non-compliance|3
1606679|NCT02167256|5602482|P2|Overall Study|Withdrawal by Subject|4
1606680|NCT02167256|5602483|P1|Overall Study|Withdrawal by Subject|4
1606681|NCT02167256|5602482|P2|Overall Study|Adverse Event|6
1606682|NCT02167256|5602483|P1|Overall Study|Adverse Event|13
1606683|NCT02167139|5602516|P4|Transition-extension|Lost to Follow-up|0
1606684|NCT02167139|5602517|P3|Transition-extension|Lost to Follow-up|0
1606685|NCT02167139|5602518|P2|Transition-extension|Lost to Follow-up|0
1606686|NCT02167139|5602519|P1|Transition-extension|Lost to Follow-up|1
1606687|NCT02167139|5602516|P4|Transition-extension|Other|0
1606688|NCT02167139|5602517|P3|Transition-extension|Other|1
1606689|NCT02167139|5602518|P2|Transition-extension|Other|0
1606690|NCT02167139|5602519|P1|Transition-extension|Other|1
1606691|NCT02167139|5602516|P4|Transition-extension|Lack of Efficacy|1
1606692|NCT02167139|5602517|P3|Transition-extension|Lack of Efficacy|1
1606693|NCT02167139|5602518|P2|Transition-extension|Lack of Efficacy|0
1606694|NCT02167139|5602519|P1|Transition-extension|Lack of Efficacy|0
1606695|NCT02167139|5602516|P4|Transition-extension|Withdrawal by Subject|1
1606696|NCT02167139|5602517|P3|Transition-extension|Withdrawal by Subject|4
1606697|NCT02167139|5602518|P2|Transition-extension|Withdrawal by Subject|0
1606698|NCT02167139|5602519|P1|Transition-extension|Withdrawal by Subject|2
1606699|NCT02167139|5602516|P4|Transition-extension|Adverse Event|3
1606700|NCT02167139|5602517|P3|Transition-extension|Adverse Event|2
1606701|NCT02167139|5602518|P2|Transition-extension|Adverse Event|0
1606702|NCT02167139|5602519|P1|Transition-extension|Adverse Event|2
1606703|NCT02167139|5602516|P4|Randomised, Double-blind|Other|0
1606704|NCT02167139|5602517|P3|Randomised, Double-blind|Other|0
1606705|NCT02167139|5602518|P2|Randomised, Double-blind|Other|0
1606706|NCT02167139|5602519|P1|Randomised, Double-blind|Other|3
1606707|NCT02167139|5602516|P4|Randomised, Double-blind|Lack of Efficacy|0
1606708|NCT02167139|5602517|P3|Randomised, Double-blind|Lack of Efficacy|0
1606709|NCT02167139|5602518|P2|Randomised, Double-blind|Lack of Efficacy|2
1606710|NCT02167139|5602519|P1|Randomised, Double-blind|Lack of Efficacy|1
1606711|NCT02167139|5602516|P4|Randomised, Double-blind|Adverse Event|0
1606712|NCT02167139|5602517|P3|Randomised, Double-blind|Adverse Event|0
1606713|NCT02167139|5602518|P2|Randomised, Double-blind|Adverse Event|9
1606714|NCT02167139|5602519|P1|Randomised, Double-blind|Adverse Event|2
1606715|NCT02167139|5602516|P4|Randomised, Double-blind|Withdrawal by Subject|0
1606716|NCT02167139|5602517|P3|Randomised, Double-blind|Withdrawal by Subject|0
1606717|NCT02167139|5602518|P2|Randomised, Double-blind|Withdrawal by Subject|8
1606718|NCT02167139|5602519|P1|Randomised, Double-blind|Withdrawal by Subject|11
1606719|NCT02167035|5602535|P2|Overall Study|Randomized to incorrect Study Medication|1
1606720|NCT02167035|5602536|P1|Overall Study|Randomized to incorrect Study Medication|0
1606721|NCT02167035|5602535|P2|Overall Study|Lost to Follow-up|3
1606722|NCT02167035|5602536|P1|Overall Study|Lost to Follow-up|3
1606723|NCT02167035|5602535|P2|Overall Study|Adverse Event|2
1606724|NCT02167035|5602536|P1|Overall Study|Adverse Event|2
1606725|NCT02166697|5602544|P1|Overall Study|Protocol Violation|347
1606726|NCT02166606|5602553|P1|Overall Study|Enrolled after End of Enrollment|4
1606727|NCT02166606|5602553|P1|Overall Study|Device upgrade|1
1606728|NCT02166606|5602553|P1|Overall Study|Physician Decision|1
1606729|NCT02166606|5602553|P1|Overall Study|Withdrawal by Subject|1
1606730|NCT02166606|5602553|P1|Overall Study|Lost to Follow-up|30
1606731|NCT02166606|5602553|P1|Overall Study|Protocol Violation|7
1606732|NCT02166606|5602553|P1|Overall Study|Death|31
1606733|NCT02166606|5602553|P1|Overall Study|Adverse Event|3
1606734|NCT02166476|5602560|P2|Overall Study|Unable to Come for Visit|3
1606735|NCT02166476|5602561|P1|Overall Study|Unable to Come for Visit|0
1606736|NCT02166476|5602560|P2|Overall Study|Physician Decision|0
1606737|NCT02166476|5602561|P1|Overall Study|Physician Decision|1
1606738|NCT02166476|5602560|P2|Overall Study|Lost to Follow-up|10
1606739|NCT02166476|5602561|P1|Overall Study|Lost to Follow-up|5
1606740|NCT02166476|5602560|P2|Overall Study|Adverse Event|3
1606741|NCT02166476|5602561|P1|Overall Study|Adverse Event|3
1606742|NCT02166476|5602560|P2|Overall Study|Withdrawal by Subject|7
1606743|NCT02166476|5602561|P1|Overall Study|Withdrawal by Subject|5
1606744|NCT02165826|5602625|P3|Down-Titration Period|Reason Not Specified|2
1606745|NCT02165826|5602626|P2|Down-Titration Period|Reason Not Specified|0
1606746|NCT02165826|5602627|P1|Down-Titration Period|Reason Not Specified|1
1606747|NCT02165826|5602625|P3|Down-Titration Period|Voluntary Withdrawal|2
1606748|NCT02165826|5602626|P2|Down-Titration Period|Voluntary Withdrawal|1
1606749|NCT02165826|5602627|P1|Down-Titration Period|Voluntary Withdrawal|2
1606750|NCT02165826|5602625|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
1606751|NCT02165826|5602626|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
1606752|NCT02165826|5602627|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
1606753|NCT02165826|5602625|P3|Main Treatment Period|Did Not Receive Study Drug|0
1606754|NCT02165826|5602626|P2|Main Treatment Period|Did Not Receive Study Drug|2
1606755|NCT02165826|5602627|P1|Main Treatment Period|Did Not Receive Study Drug|0
1606756|NCT02165826|5602625|P3|Main Treatment Period|Reason Not Specified|16
1606757|NCT02165826|5602626|P2|Main Treatment Period|Reason Not Specified|5
1606758|NCT02165826|5602627|P1|Main Treatment Period|Reason Not Specified|8
1606759|NCT02165826|5602625|P3|Main Treatment Period|Lack of Efficacy|0
1606760|NCT02165826|5602626|P2|Main Treatment Period|Lack of Efficacy|0
1606761|NCT02165826|5602627|P1|Main Treatment Period|Lack of Efficacy|2
1606762|NCT02165826|5602625|P3|Main Treatment Period|Voluntary Withdrawal|21
1606763|NCT02165826|5602626|P2|Main Treatment Period|Voluntary Withdrawal|23
1606764|NCT02165826|5602627|P1|Main Treatment Period|Voluntary Withdrawal|23
1606765|NCT02165826|5602625|P3|Main Treatment Period|Lost to Follow-up|1
1606766|NCT02165826|5602626|P2|Main Treatment Period|Lost to Follow-up|2
1606767|NCT02165826|5602627|P1|Main Treatment Period|Lost to Follow-up|4
1606768|NCT02165826|5602625|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
1606769|NCT02165826|5602626|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
1606770|NCT02165826|5602627|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
1606771|NCT02165826|5602625|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
1606772|NCT02165826|5602626|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
1606773|NCT02165826|5602627|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
1606774|NCT02165735|5602695|P2|Overall Study|Protocol Violation|1
1606775|NCT02165735|5602696|P1|Overall Study|Protocol Violation|0
1606776|NCT02165735|5602695|P2|Overall Study|Participant indicated lack of time|3
1606777|NCT02165735|5602696|P1|Overall Study|Participant indicated lack of time|1
1606778|NCT02165735|5602695|P2|Overall Study|Withdrawal by Subject|0
1606779|NCT02165735|5602696|P1|Overall Study|Withdrawal by Subject|3
1606780|NCT02165735|5602695|P2|Overall Study|Lost to Follow-up|10
1606781|NCT02165735|5602696|P1|Overall Study|Lost to Follow-up|12
1606782|NCT02165202|5602761|P2|Injection Phase|Participant unwilling to comply|0
1606783|NCT02165202|5602762|P1|Injection Phase|Participant unwilling to comply|1
1606784|NCT02165202|5602761|P2|Injection Phase|No longer interested|1
1606785|NCT02165202|5602762|P1|Injection Phase|No longer interested|0
1606786|NCT02165202|5602761|P2|Injection Phase|Study Product related Toxicity|0
1606787|NCT02165202|5602762|P1|Injection Phase|Study Product related Toxicity|1
1606788|NCT02165202|5602761|P2|Injection Phase|End of Study|1
1606789|NCT02165202|5602762|P1|Injection Phase|End of Study|2
1606790|NCT02165202|5602761|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
1606791|NCT02165202|5602762|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
1606792|NCT02165202|5602761|P2|Injection Phase|Unable to attend within Visit Window|0
1606793|NCT02165202|5602762|P1|Injection Phase|Unable to attend within Visit Window|1
1606794|NCT02165202|5602761|P2|Injection Phase|Reactive HIV or HIV Suspected|2
1606795|NCT02165202|5602762|P1|Injection Phase|Reactive HIV or HIV Suspected|0
1606796|NCT02165202|5602761|P2|Injection Phase|Abnormal Lab Value|1
1606797|NCT02165202|5602762|P1|Injection Phase|Abnormal Lab Value|5
1606798|NCT02165202|5602761|P2|Oral Phase|Abnormal EKG|1
1606799|NCT02165202|5602762|P1|Oral Phase|Abnormal EKG|0
1606800|NCT02165202|5602761|P2|Oral Phase|Relocated, no follow-up planned|0
1606801|NCT02165202|5602762|P1|Oral Phase|Relocated, no follow-up planned|1
1606802|NCT02165202|5602761|P2|Oral Phase|CMC advised termination|0
1606803|NCT02165202|5602762|P1|Oral Phase|CMC advised termination|1
1606804|NCT02165202|5602761|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
1606805|NCT02165202|5602762|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
1606806|NCT02165202|5602761|P2|Oral Phase|Clinical reasons|0
1606807|NCT02165202|5602762|P1|Oral Phase|Clinical reasons|1
1606808|NCT02165202|5602761|P2|Oral Phase|Unable to contact Participant|1
1606809|NCT02165202|5602762|P1|Oral Phase|Unable to contact Participant|1
1606810|NCT02165202|5602761|P2|Oral Phase|Study product Related Toxicity|0
1606811|NCT02165202|5602762|P1|Oral Phase|Study product Related Toxicity|1
1606812|NCT02165202|5602761|P2|Oral Phase|Refused further participation|1
1606813|NCT02165202|5602762|P1|Oral Phase|Refused further participation|5
1606814|NCT02164981|5602799|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
1606815|NCT02164981|5602800|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
1606816|NCT02164981|5602801|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
1606817|NCT02164981|5602799|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
1606818|NCT02164981|5602800|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
1606819|NCT02164981|5602801|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
1606820|NCT02164981|5602799|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
1606821|NCT02164981|5602800|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
1606822|NCT02164981|5602801|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
1606823|NCT02164981|5602799|P3|Started|Adverse Event|0
1606824|NCT02164981|5602800|P2|Started|Adverse Event|2
1606825|NCT02164981|5602801|P1|Started|Adverse Event|1
1606826|NCT02164981|5602799|P3|Started|Protocol Violation|0
1606827|NCT02164981|5602800|P2|Started|Protocol Violation|0
1606828|NCT02164981|5602801|P1|Started|Protocol Violation|2
1606829|NCT02164981|5602799|P3|Started|Withdrawal by Subject|0
1606830|NCT02164981|5602800|P2|Started|Withdrawal by Subject|1
1606831|NCT02164981|5602801|P1|Started|Withdrawal by Subject|2
1606832|NCT02164929|5602874|P4|Overall Study|Failed regional block|0
1606833|NCT02164929|5602875|P3|Overall Study|Failed regional block|1
1606834|NCT02164929|5602876|P2|Overall Study|Failed regional block|0
1606835|NCT02164929|5602877|P1|Overall Study|Failed regional block|0
1606836|NCT02164929|5602874|P4|Overall Study|Converted to open procedure|2
1606837|NCT02164929|5602875|P3|Overall Study|Converted to open procedure|0
1606838|NCT02164929|5602876|P2|Overall Study|Converted to open procedure|0
1606839|NCT02164929|5602877|P1|Overall Study|Converted to open procedure|1
1606840|NCT02164916|5602921|P2|Overall Study|Not eligible|5
1606841|NCT02164916|5602922|P1|Overall Study|Not eligible|2
1606842|NCT02164916|5602921|P2|Overall Study|Reason under review|6
1606843|NCT02164916|5602922|P1|Overall Study|Reason under review|1
1606844|NCT02164916|5602921|P2|Overall Study|Not protocol specified|1
1606845|NCT02164916|5602922|P1|Overall Study|Not protocol specified|5
1606846|NCT02164916|5602921|P2|Overall Study|Progression|26
1606847|NCT02164916|5602922|P1|Overall Study|Progression|37
1606848|NCT02164916|5602921|P2|Overall Study|Refusal unrelated to adverse event|7
1606849|NCT02164916|5602922|P1|Overall Study|Refusal unrelated to adverse event|3
1606850|NCT02164916|5602921|P2|Overall Study|Death|1
1606851|NCT02164916|5602922|P1|Overall Study|Death|1
1606852|NCT02164916|5602921|P2|Overall Study|Adverse Event|8
1606853|NCT02164916|5602922|P1|Overall Study|Adverse Event|3
1606854|NCT02164864|5602942|P3|Overall Study|Other than stated|14
1606855|NCT02164864|5602943|P2|Overall Study|Other than stated|4
1606856|NCT02164864|5602944|P1|Overall Study|Other than stated|3
1606857|NCT02164864|5602942|P3|Overall Study|Consent withdrawn, not due to AE|56
1606858|NCT02164864|5602943|P2|Overall Study|Consent withdrawn, not due to AE|8
1606859|NCT02164864|5602944|P1|Overall Study|Consent withdrawn, not due to AE|21
1606860|NCT02164864|5602942|P3|Overall Study|Lost to Follow-up|2
1606861|NCT02164864|5602943|P2|Overall Study|Lost to Follow-up|3
1606862|NCT02164864|5602944|P1|Overall Study|Lost to Follow-up|4
1606863|NCT02164864|5602942|P3|Overall Study|Protocol Violation|1
1606864|NCT02164864|5602943|P2|Overall Study|Protocol Violation|4
1606865|NCT02164864|5602944|P1|Overall Study|Protocol Violation|2
1606866|NCT02164864|5602942|P3|Overall Study|Other Adverse Event (AE)|49
1606867|NCT02164864|5602943|P2|Overall Study|Other Adverse Event (AE)|32
1606868|NCT02164864|5602944|P1|Overall Study|Other Adverse Event (AE)|52
1606869|NCT02164864|5602942|P3|Overall Study|Other pre-existing disease worsening|9
1606870|NCT02164864|5602943|P2|Overall Study|Other pre-existing disease worsening|4
1606871|NCT02164864|5602944|P1|Overall Study|Other pre-existing disease worsening|6
1606872|NCT02164864|5602942|P3|Overall Study|Trial disease worsening|1
1606873|NCT02164864|5602943|P2|Overall Study|Trial disease worsening|5
1606874|NCT02164864|5602944|P1|Overall Study|Trial disease worsening|7
1606875|NCT02164539|5603009|P7|Treatment Phase C (1 Week)|Physician Decision|1
1606876|NCT02164539|5603010|P6|Treatment Phase C (1 Week)|Physician Decision|0
1606877|NCT02164539|5603011|P5|Treatment Phase C (1 Week)|Physician Decision|0
1606878|NCT02164539|5603012|P4|Treatment Phase C (1 Week)|Physician Decision|0
1606879|NCT02164539|5603013|P3|Treatment Phase C (1 Week)|Physician Decision|0
1606880|NCT02164539|5603014|P2|Treatment Phase C (1 Week)|Physician Decision|0
1606881|NCT02164539|5603015|P1|Treatment Phase C (1 Week)|Physician Decision|0
1606882|NCT02164539|5603009|P7|Treatment Phase C (1 Week)|Adverse Event|1
1606883|NCT02164539|5603010|P6|Treatment Phase C (1 Week)|Adverse Event|0
1606884|NCT02164539|5603011|P5|Treatment Phase C (1 Week)|Adverse Event|0
1606885|NCT02164539|5603012|P4|Treatment Phase C (1 Week)|Adverse Event|0
1606886|NCT02164539|5603013|P3|Treatment Phase C (1 Week)|Adverse Event|0
1606887|NCT02164539|5603014|P2|Treatment Phase C (1 Week)|Adverse Event|0
1606888|NCT02164539|5603015|P1|Treatment Phase C (1 Week)|Adverse Event|0
1606889|NCT02164539|5603009|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1606890|NCT02164539|5603010|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1606891|NCT02164539|5603011|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1606892|NCT02164539|5603012|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1606893|NCT02164539|5603013|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1606894|NCT02164539|5603014|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
1606895|NCT02164539|5603015|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
1606896|NCT02164539|5603009|P7|Treatment Phase B (1 Week)|Physician Decision|1
1606897|NCT02164539|5603010|P6|Treatment Phase B (1 Week)|Physician Decision|0
1606898|NCT02164539|5603011|P5|Treatment Phase B (1 Week)|Physician Decision|1
1606899|NCT02164539|5603012|P4|Treatment Phase B (1 Week)|Physician Decision|0
1606900|NCT02164539|5603013|P3|Treatment Phase B (1 Week)|Physician Decision|0
1606901|NCT02164539|5603014|P2|Treatment Phase B (1 Week)|Physician Decision|0
1606902|NCT02164539|5603015|P1|Treatment Phase B (1 Week)|Physician Decision|0
1606903|NCT02164539|5603009|P7|Treatment Phase B (1 Week)|Adverse Event|0
1606904|NCT02164539|5603010|P6|Treatment Phase B (1 Week)|Adverse Event|0
1606905|NCT02164539|5603011|P5|Treatment Phase B (1 Week)|Adverse Event|2
1606906|NCT02164539|5603012|P4|Treatment Phase B (1 Week)|Adverse Event|0
1606907|NCT02164539|5603013|P3|Treatment Phase B (1 Week)|Adverse Event|0
1606908|NCT02164539|5603014|P2|Treatment Phase B (1 Week)|Adverse Event|0
1606909|NCT02164539|5603015|P1|Treatment Phase B (1 Week)|Adverse Event|0
1606910|NCT02164539|5603009|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1606911|NCT02164539|5603010|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1606912|NCT02164539|5603011|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
1606913|NCT02164539|5603012|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1606914|NCT02164539|5603013|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
1606915|NCT02164539|5603014|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
1606916|NCT02164539|5603015|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
1606917|NCT02164513|5603063|P3|Overall Study|Other: Reason not provided by site|0
1606918|NCT02164513|5603064|P2|Overall Study|Other: Reason not provided by site|0
1606919|NCT02164513|5603065|P1|Overall Study|Other: Reason not provided by site|1
1606920|NCT02164513|5603063|P3|Overall Study|Withdrawal by Subject|130
1606921|NCT02164513|5603064|P2|Overall Study|Withdrawal by Subject|261
1606922|NCT02164513|5603065|P1|Overall Study|Withdrawal by Subject|192
1606923|NCT02164513|5603063|P3|Overall Study|Physician Decision|28
1606924|NCT02164513|5603064|P2|Overall Study|Physician Decision|57
1606925|NCT02164513|5603065|P1|Overall Study|Physician Decision|47
1606926|NCT02164513|5603063|P3|Overall Study|Lost to Follow-up|22
1606927|NCT02164513|5603064|P2|Overall Study|Lost to Follow-up|36
1606928|NCT02164513|5603065|P1|Overall Study|Lost to Follow-up|30
1606929|NCT02164513|5603063|P3|Overall Study|Other: Study Closed or terminated|4
1606930|NCT02164513|5603064|P2|Overall Study|Other: Study Closed or terminated|2
1606931|NCT02164513|5603065|P1|Overall Study|Other: Study Closed or terminated|5
1606932|NCT02164513|5603063|P3|Overall Study|Adverse Event|111
1606933|NCT02164513|5603064|P2|Overall Study|Adverse Event|180
1606934|NCT02164513|5603065|P1|Overall Study|Adverse Event|162
1606935|NCT02164383|5603102|P2|Overall Study|Lost to Follow-up|0
1606936|NCT02164383|5603103|P1|Overall Study|Lost to Follow-up|1
1606937|NCT02164318|5603113|P4|Overall Study|Withdrawal by Subject|1
1606938|NCT02164318|5603114|P3|Overall Study|Withdrawal by Subject|0
1606939|NCT02164318|5603115|P2|Overall Study|Withdrawal by Subject|1
1606940|NCT02164318|5603116|P1|Overall Study|Withdrawal by Subject|0
1606941|NCT02163993|5603151|P5|Post-treatment Period|Withdrawal by Subject|2
1606942|NCT02163993|5603152|P4|Post-treatment Period|Withdrawal by Subject|1
1606943|NCT02163993|5603153|P3|Post-treatment Period|Withdrawal by Subject|0
1606944|NCT02163993|5603154|P2|Post-treatment Period|Withdrawal by Subject|4
1606945|NCT02163993|5603155|P1|Post-treatment Period|Withdrawal by Subject|2
1606946|NCT02163993|5603151|P5|Post-treatment Period|Protocol Violation|1
1606947|NCT02163993|5603152|P4|Post-treatment Period|Protocol Violation|0
1606948|NCT02163993|5603153|P3|Post-treatment Period|Protocol Violation|0
1606949|NCT02163993|5603154|P2|Post-treatment Period|Protocol Violation|0
1606950|NCT02163993|5603155|P1|Post-treatment Period|Protocol Violation|0
1606951|NCT02163993|5603151|P5|Post-treatment Period|Lost to Follow-up|0
1606952|NCT02163993|5603152|P4|Post-treatment Period|Lost to Follow-up|1
1606953|NCT02163993|5603153|P3|Post-treatment Period|Lost to Follow-up|3
1606954|NCT02163993|5603154|P2|Post-treatment Period|Lost to Follow-up|2
1606955|NCT02163993|5603155|P1|Post-treatment Period|Lost to Follow-up|2
1606956|NCT02163993|5603151|P5|Post-treatment Period|Adverse Event|0
1606957|NCT02163993|5603152|P4|Post-treatment Period|Adverse Event|0
1606958|NCT02163993|5603153|P3|Post-treatment Period|Adverse Event|1
1606959|NCT02163993|5603154|P2|Post-treatment Period|Adverse Event|0
1606960|NCT02163993|5603155|P1|Post-treatment Period|Adverse Event|0
1606961|NCT02163993|5603151|P5|Treatment Period|Not treated|2
1606962|NCT02163993|5603152|P4|Treatment Period|Not treated|1
1606963|NCT02163993|5603153|P3|Treatment Period|Not treated|0
1606964|NCT02163993|5603154|P2|Treatment Period|Not treated|0
1606965|NCT02163993|5603155|P1|Treatment Period|Not treated|1
1606966|NCT02163993|5603151|P5|Treatment Period|Withdrawal by Subject|1
1606967|NCT02163993|5603152|P4|Treatment Period|Withdrawal by Subject|4
1606968|NCT02163993|5603153|P3|Treatment Period|Withdrawal by Subject|1
1606969|NCT02163993|5603154|P2|Treatment Period|Withdrawal by Subject|4
1606970|NCT02163993|5603155|P1|Treatment Period|Withdrawal by Subject|6
1606971|NCT02163993|5603151|P5|Treatment Period|Protocol Violation|2
1606972|NCT02163993|5603152|P4|Treatment Period|Protocol Violation|1
1606973|NCT02163993|5603153|P3|Treatment Period|Protocol Violation|0
1606974|NCT02163993|5603154|P2|Treatment Period|Protocol Violation|1
1606975|NCT02163993|5603155|P1|Treatment Period|Protocol Violation|2
1606976|NCT02163993|5603151|P5|Treatment Period|Physician Decision|0
1606977|NCT02163993|5603152|P4|Treatment Period|Physician Decision|0
1606978|NCT02163993|5603153|P3|Treatment Period|Physician Decision|0
1606979|NCT02163993|5603154|P2|Treatment Period|Physician Decision|0
1606980|NCT02163993|5603155|P1|Treatment Period|Physician Decision|1
1606981|NCT02163993|5603151|P5|Treatment Period|Lost to Follow-up|1
1606982|NCT02163993|5603152|P4|Treatment Period|Lost to Follow-up|3
1606983|NCT02163993|5603153|P3|Treatment Period|Lost to Follow-up|1
1606984|NCT02163993|5603154|P2|Treatment Period|Lost to Follow-up|3
1606985|NCT02163993|5603155|P1|Treatment Period|Lost to Follow-up|2
1606986|NCT02163993|5603151|P5|Treatment Period|Adverse Event|1
1606987|NCT02163993|5603152|P4|Treatment Period|Adverse Event|0
1606988|NCT02163993|5603153|P3|Treatment Period|Adverse Event|0
1606989|NCT02163993|5603154|P2|Treatment Period|Adverse Event|1
1606990|NCT02163993|5603155|P1|Treatment Period|Adverse Event|0
1606991|NCT02163915|5603258|P5|Overall Study|Physician Decision|0
1606992|NCT02163915|5603259|P4|Overall Study|Physician Decision|1
1606993|NCT02163915|5603260|P3|Overall Study|Physician Decision|0
1606994|NCT02163915|5603261|P2|Overall Study|Physician Decision|0
1606995|NCT02163915|5603262|P1|Overall Study|Physician Decision|0
1606996|NCT02163915|5603258|P5|Overall Study|Study termination|2
1606997|NCT02163915|5603259|P4|Overall Study|Study termination|0
1606998|NCT02163915|5603260|P3|Overall Study|Study termination|0
1606999|NCT02163915|5603261|P2|Overall Study|Study termination|0
1607000|NCT02163915|5603262|P1|Overall Study|Study termination|1
1607001|NCT02163915|5603258|P5|Overall Study|Withdrawal by Subject|2
1607002|NCT02163915|5603259|P4|Overall Study|Withdrawal by Subject|2
1607003|NCT02163915|5603260|P3|Overall Study|Withdrawal by Subject|2
1607004|NCT02163915|5603261|P2|Overall Study|Withdrawal by Subject|0
1607005|NCT02163915|5603262|P1|Overall Study|Withdrawal by Subject|2
1607012|NCT02163733|5603344|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
1607013|NCT02163733|5603345|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1607014|NCT02163733|5603346|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
1607015|NCT02163733|5603344|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
1607016|NCT02163733|5603345|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
1607017|NCT02163733|5603346|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
1607018|NCT02163538|5603448|P2|Overall Study|Physician Decision|1
1607019|NCT02163538|5603449|P1|Overall Study|Physician Decision|0
1607020|NCT02163538|5603448|P2|Overall Study|Protocol Violation|0
1607021|NCT02163538|5603449|P1|Overall Study|Protocol Violation|1
1607022|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Various reasons|16
1607023|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
1607024|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Subject Compliance|17
1607025|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Death|8
1607026|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Protocol Violation|2
1607027|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
1607028|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Physician Decision|8
1607029|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
1607030|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
1607031|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
1607032|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Hypokalemia|9
1607033|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
1607034|NCT02163499|5603465|P1|Extended Dosing Phase: ZS|Adverse Event|51
1607035|NCT02163499|5603465|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
1607036|NCT02163499|5603465|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
1607037|NCT02163499|5603465|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
1607038|NCT02163499|5603465|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
1607039|NCT02163499|5603465|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
1607040|NCT02163447|5603493|P3|Overall Study|Became HIV infected at time of delivery|0
1607041|NCT02163447|5603494|P2|Overall Study|Became HIV infected at time of delivery|0
1607042|NCT02163447|5603495|P1|Overall Study|Became HIV infected at time of delivery|1
1607043|NCT02163447|5603493|P3|Overall Study|Moved out of study area|2
1607044|NCT02163447|5603494|P2|Overall Study|Moved out of study area|3
1607045|NCT02163447|5603495|P1|Overall Study|Moved out of study area|2
1607046|NCT02163447|5603493|P3|Overall Study|Lost to Follow-up|0
1607047|NCT02163447|5603494|P2|Overall Study|Lost to Follow-up|3
1607048|NCT02163447|5603495|P1|Overall Study|Lost to Follow-up|1
1607049|NCT02163447|5603493|P3|Overall Study|Withdrawal by Subject|1
1607050|NCT02163447|5603494|P2|Overall Study|Withdrawal by Subject|0
1607051|NCT02163447|5603495|P1|Overall Study|Withdrawal by Subject|2
1607052|NCT02163395|5603535|P1|Overall Study|Adverse Event|1
1607053|NCT02163395|5603535|P1|Overall Study|Lost to Follow-up|3
1607054|NCT02163395|5603535|P1|Overall Study|Withdrawal by Subject|1
1607055|NCT02163187|5603544|P2|Overall Study|Progressive disease|0
1607056|NCT02163187|5603545|P1|Overall Study|Progressive disease|1
1607057|NCT02163187|5603544|P2|Overall Study|Device removed|0
1607058|NCT02163187|5603545|P1|Overall Study|Device removed|1
1607059|NCT02162862|5603580|P3|Overall Study|Subject did not feel the med was needed|4
1607060|NCT02162862|5603581|P2|Overall Study|Subject did not feel the med was needed|0
1607061|NCT02162862|5603582|P1|Overall Study|Subject did not feel the med was needed|0
1607062|NCT02162862|5603580|P3|Overall Study|Lost to Follow-up|0
1607063|NCT02162862|5603581|P2|Overall Study|Lost to Follow-up|11
1607064|NCT02162862|5603582|P1|Overall Study|Lost to Follow-up|0
1607065|NCT02162771|5603595|P2|Maintenance Study Period (Part 2)|Stable Disease|1
1607066|NCT02162771|5603596|P1|Maintenance Study Period (Part 2)|Stable Disease|0
1607067|NCT02162771|5603595|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
1607068|NCT02162771|5603596|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
1607069|NCT02162771|5603595|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
1607070|NCT02162771|5603596|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
1607071|NCT02162771|5603595|P2|Maintenance Study Period (Part 2)|Death|1
1607072|NCT02162771|5603596|P1|Maintenance Study Period (Part 2)|Death|2
1607073|NCT02162771|5603595|P2|Maintenance Study Period (Part 2)|Adverse Event|3
1607074|NCT02162771|5603596|P1|Maintenance Study Period (Part 2)|Adverse Event|3
1607075|NCT02162771|5603595|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
1607076|NCT02162771|5603596|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
1607077|NCT02162771|5603595|P2|Core Study Period (Part 2)|Death|0
1607078|NCT02162771|5603596|P1|Core Study Period (Part 2)|Death|1
1607079|NCT02162771|5603595|P2|Core Study Period (Part 2)|Physician Decision|2
1607080|NCT02162771|5603596|P1|Core Study Period (Part 2)|Physician Decision|0
1607081|NCT02162771|5603595|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
1607082|NCT02162771|5603596|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
1607083|NCT02162771|5603595|P2|Core Study Period (Part 2)|Adverse Event|1
1607084|NCT02162771|5603596|P1|Core Study Period (Part 2)|Adverse Event|4
1607085|NCT02162771|5603595|P2|Core Study Period (Part 2)|Progressive Disease|3
1607086|NCT02162771|5603596|P1|Core Study Period (Part 2)|Progressive Disease|2
1607087|NCT02162758|5603610|P2|Overall Study|Study termination|1
1607088|NCT02162758|5603611|P1|Overall Study|Study termination|0
1607089|NCT02161757|5603705|P3|Treatment Through Study Completion|Death|1
1607090|NCT02161757|5603706|P2|Treatment Through Study Completion|Death|1
1607091|NCT02161757|5603707|P1|Treatment Through Study Completion|Death|2
1607092|NCT02161757|5603705|P3|Treatment Through Study Completion|Other|12
1607093|NCT02161757|5603706|P2|Treatment Through Study Completion|Other|19
1607094|NCT02161757|5603707|P1|Treatment Through Study Completion|Other|20
1607095|NCT02161757|5603705|P3|Treatment Through Study Completion|Lost to Follow-up|4
1607096|NCT02161757|5603706|P2|Treatment Through Study Completion|Lost to Follow-up|2
1607097|NCT02161757|5603707|P1|Treatment Through Study Completion|Lost to Follow-up|7
1607098|NCT02161757|5603705|P3|Treatment Through Study Completion|Withdrawal by Subject|20
1607099|NCT02161757|5603706|P2|Treatment Through Study Completion|Withdrawal by Subject|19
1607100|NCT02161757|5603707|P1|Treatment Through Study Completion|Withdrawal by Subject|27
1607101|NCT02161757|5603705|P3|Treatment Through Study Completion|Protocol Violation|2
1607102|NCT02161757|5603706|P2|Treatment Through Study Completion|Protocol Violation|1
1607103|NCT02161757|5603707|P1|Treatment Through Study Completion|Protocol Violation|0
1607104|NCT02161757|5603705|P3|Treatment Through Study Completion|Adverse Event|0
1607105|NCT02161757|5603706|P2|Treatment Through Study Completion|Adverse Event|1
1607106|NCT02161757|5603707|P1|Treatment Through Study Completion|Adverse Event|1
1607107|NCT02161757|5603705|P3|Randomised Through Start Treatment|Did not receive treatment|0
1607108|NCT02161757|5603706|P2|Randomised Through Start Treatment|Did not receive treatment|2
1607109|NCT02161757|5603707|P1|Randomised Through Start Treatment|Did not receive treatment|3
1607110|NCT02161731|5603765|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
1607111|NCT02161731|5603766|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
1607112|NCT02161731|5603765|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
1607113|NCT02161731|5603766|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
1607114|NCT02161575|5603783|P1|Overall Study|Adverse Event|2
1607115|NCT02161575|5603783|P1|Overall Study|Lack of Efficacy|1
1607116|NCT02161575|5603783|P1|Overall Study|Protocol Violation|8
1607117|NCT02161562|5603803|P2|Overall Study|Participant moved out of province|0
1607118|NCT02161562|5603804|P1|Overall Study|Participant moved out of province|1
1607119|NCT02161562|5603803|P2|Overall Study|Withdrew due to being out of the country|0
1607120|NCT02161562|5603804|P1|Overall Study|Withdrew due to being out of the country|1
1607121|NCT02161562|5603803|P2|Overall Study|Participant moved back to home country|0
1607122|NCT02161562|5603804|P1|Overall Study|Participant moved back to home country|1
1607123|NCT02161562|5603803|P2|Overall Study|Adverse Event|1
1607124|NCT02161562|5603804|P1|Overall Study|Adverse Event|1
1607125|NCT02161562|5603803|P2|Overall Study|Lack of Efficacy|1
1607126|NCT02161562|5603804|P1|Overall Study|Lack of Efficacy|4
1607127|NCT02161562|5603803|P2|Overall Study|Lost to Follow-up|1
1607128|NCT02161562|5603804|P1|Overall Study|Lost to Follow-up|3
1607129|NCT02161562|5603803|P2|Overall Study|Pregnancy|2
1607130|NCT02161562|5603804|P1|Overall Study|Pregnancy|1
1607131|NCT02161562|5603803|P2|Overall Study|Protocol Violation|4
1607132|NCT02161562|5603804|P1|Overall Study|Protocol Violation|9
1607133|NCT02161562|5603803|P2|Overall Study|Withdrawal by Subject|8
1607134|NCT02161562|5603804|P1|Overall Study|Withdrawal by Subject|5
1607135|NCT02161549|5603832|P2|Overall Study|Physician Decision|2
1607136|NCT02161549|5603833|P1|Overall Study|Physician Decision|6
1607137|NCT02161458|5603881|P4|Overall Study|Lost to Follow-up|0
1607138|NCT02161458|5603882|P3|Overall Study|Lost to Follow-up|1
1607139|NCT02161458|5603883|P2|Overall Study|Lost to Follow-up|2
1607140|NCT02161458|5603884|P1|Overall Study|Lost to Follow-up|0
1607141|NCT02161458|5603881|P4|Overall Study|Withdrawal by Subject|0
1607142|NCT02161458|5603882|P3|Overall Study|Withdrawal by Subject|4
1607143|NCT02161458|5603883|P2|Overall Study|Withdrawal by Subject|4
1607144|NCT02161458|5603884|P1|Overall Study|Withdrawal by Subject|0
1607157|NCT02161185|5603971|P1|Treatment Phase|Administrative/Other|7
1607158|NCT02161146|5603981|P5|Overall Study|Other Miscellaneous Reasons|0
1607159|NCT02161146|5603982|P4|Overall Study|Other Miscellaneous Reasons|0
1607160|NCT02161146|5603983|P3|Overall Study|Other Miscellaneous Reasons|0
1607161|NCT02161146|5603984|P2|Overall Study|Other Miscellaneous Reasons|1
1607162|NCT02161146|5603985|P1|Overall Study|Other Miscellaneous Reasons|0
1607163|NCT02161146|5603981|P5|Overall Study|Personal Reasons|1
1607164|NCT02161146|5603982|P4|Overall Study|Personal Reasons|2
1607165|NCT02161146|5603983|P3|Overall Study|Personal Reasons|0
1607166|NCT02161146|5603984|P2|Overall Study|Personal Reasons|1
1607167|NCT02161146|5603985|P1|Overall Study|Personal Reasons|0
1607168|NCT02161146|5603981|P5|Overall Study|Lost to Follow-up|0
1607169|NCT02161146|5603982|P4|Overall Study|Lost to Follow-up|0
1607170|NCT02161146|5603983|P3|Overall Study|Lost to Follow-up|0
1607171|NCT02161146|5603984|P2|Overall Study|Lost to Follow-up|1
1607172|NCT02161146|5603985|P1|Overall Study|Lost to Follow-up|0
1607173|NCT02161146|5603981|P5|Overall Study|Adverse Event|0
1607174|NCT02161146|5603982|P4|Overall Study|Adverse Event|1
1607175|NCT02161146|5603983|P3|Overall Study|Adverse Event|0
1607176|NCT02161146|5603984|P2|Overall Study|Adverse Event|1
1607177|NCT02161146|5603985|P1|Overall Study|Adverse Event|1
1607178|NCT02161016|5603998|P1|Overall Study|withdrawn by IRB|1
1607179|NCT02160977|5604029|P2|Six Months After Surgery|Lost to Follow-up|1
1607180|NCT02160977|5604030|P1|Six Months After Surgery|Lost to Follow-up|2
1607181|NCT02160977|5604029|P2|Three Months After Surgery|Lost to Follow-up|2
1607182|NCT02160977|5604030|P1|Three Months After Surgery|Lost to Follow-up|0
1607183|NCT02160977|5604029|P2|Six Weeks After Surgery|Lost to Follow-up|0
1607184|NCT02160977|5604030|P1|Six Weeks After Surgery|Lost to Follow-up|1
1607185|NCT02160899|5604046|P6|Overall Study|Adverse Event or Serious Adverse Event|0
1607186|NCT02160899|5604047|P5|Overall Study|Adverse Event or Serious Adverse Event|2
1607187|NCT02160899|5604048|P4|Overall Study|Adverse Event or Serious Adverse Event|1
1607188|NCT02160899|5604049|P3|Overall Study|Adverse Event or Serious Adverse Event|0
1607189|NCT02160899|5604050|P2|Overall Study|Adverse Event or Serious Adverse Event|1
1607190|NCT02160899|5604051|P1|Overall Study|Adverse Event or Serious Adverse Event|0
1607191|NCT02160626|5604100|P3|Overall Study|Withdrawal by Subject|0
1607192|NCT02160626|5604101|P2|Overall Study|Withdrawal by Subject|1
1607193|NCT02160626|5604102|P1|Overall Study|Withdrawal by Subject|0
1607194|NCT02160626|5604100|P3|Overall Study|Schedule not conducive to study visits|1
1607195|NCT02160626|5604101|P2|Overall Study|Schedule not conducive to study visits|0
1607196|NCT02160626|5604102|P1|Overall Study|Schedule not conducive to study visits|0
1607197|NCT02160626|5604100|P3|Overall Study|Adverse Event|0
1607198|NCT02160626|5604101|P2|Overall Study|Adverse Event|0
1607199|NCT02160626|5604102|P1|Overall Study|Adverse Event|1
1607200|NCT02160314|5604125|P2|Overall Study|Lost to Follow-up|1
1607201|NCT02160314|5604126|P1|Overall Study|Lost to Follow-up|0
1607202|NCT02160314|5604125|P2|Overall Study|Withdrawal by Subject|2
1607203|NCT02160314|5604126|P1|Overall Study|Withdrawal by Subject|1
1607204|NCT02160314|5604125|P2|Overall Study|Protocol Violation|4
1607205|NCT02160314|5604126|P1|Overall Study|Protocol Violation|0
1607206|NCT02160314|5604125|P2|Overall Study|Adverse Event|6
1607207|NCT02160314|5604126|P1|Overall Study|Adverse Event|0
1607208|NCT02160145|5604134|P3|Randomized Double-blind Period|Physician Decision|5
1607209|NCT02160145|5604135|P2|Randomized Double-blind Period|Physician Decision|7
1607210|NCT02160145|5604136|P1|Randomized Double-blind Period|Physician Decision|0
1607211|NCT02160145|5604134|P3|Randomized Double-blind Period|Lost to Follow-up|3
1607212|NCT02160145|5604135|P2|Randomized Double-blind Period|Lost to Follow-up|1
1607213|NCT02160145|5604136|P1|Randomized Double-blind Period|Lost to Follow-up|0
1607214|NCT02160145|5604134|P3|Randomized Double-blind Period|Subject decision|20
1607215|NCT02160145|5604135|P2|Randomized Double-blind Period|Subject decision|21
1607216|NCT02160145|5604136|P1|Randomized Double-blind Period|Subject decision|0
1607217|NCT02160145|5604134|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1607218|NCT02160145|5604135|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
1607219|NCT02160145|5604136|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
1607220|NCT02160145|5604134|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
1607221|NCT02160145|5604135|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
1607222|NCT02160145|5604136|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
1607223|NCT02160041|5604149|P1|Overall Study|study terminated by by sponsor|1
1607224|NCT02160041|5604149|P1|Overall Study|Withdrawal by Subject|8
1607225|NCT02160041|5604149|P1|Overall Study|Physician Decision|3
1607226|NCT02160041|5604149|P1|Overall Study|non-compliance with study|1
1607227|NCT02160041|5604149|P1|Overall Study|Protocol Violation|1
1607228|NCT02160041|5604149|P1|Overall Study|disease progression|57
1607229|NCT02160041|5604149|P1|Overall Study|Death|2
1607230|NCT02160041|5604149|P1|Overall Study|Adverse Event|11
1607231|NCT02160002|5604161|P2|Overall Study|Withdrawal by Subject|1
1607232|NCT02160002|5604162|P1|Overall Study|Withdrawal by Subject|2
1607233|NCT02159950|5604209|P2|Overall Study|Progression|1
1607234|NCT02159950|5604210|P1|Overall Study|Progression|0
1607235|NCT02159950|5604209|P2|Overall Study|Adverse Event|1
1607236|NCT02159950|5604210|P1|Overall Study|Adverse Event|0
1607237|NCT02159807|5604269|P3|Overall Study|elevated blood pressure|1
1607238|NCT02159807|5604270|P2|Overall Study|elevated blood pressure|0
1607239|NCT02159807|5604271|P1|Overall Study|elevated blood pressure|0
1607240|NCT02159807|5604269|P3|Overall Study|No CSF|1
1607241|NCT02159807|5604270|P2|Overall Study|No CSF|1
1607242|NCT02159807|5604271|P1|Overall Study|No CSF|1
1607243|NCT02159807|5604269|P3|Overall Study|Adverse Event|1
1607244|NCT02159807|5604270|P2|Overall Study|Adverse Event|0
1607245|NCT02159807|5604271|P1|Overall Study|Adverse Event|0
1607261|NCT02159482|5604341|P1|Overall Study|Physician Decision|3
1607262|NCT02159482|5604341|P1|Overall Study|Withdrawal by Subject|2
1607263|NCT02159469|5604346|P1|Overall Study|Multiple|29
1607264|NCT02159469|5604346|P1|Overall Study|Other|1
1607265|NCT02159469|5604346|P1|Overall Study|Met Stopping Criteria|3
1607266|NCT02159469|5604346|P1|Overall Study|Sponsor's request|2
1607267|NCT02159469|5604346|P1|Overall Study|Lost to Follow-up|1
1607268|NCT02159469|5604346|P1|Overall Study|Withdrawal by Subject|9
1607269|NCT02159469|5604346|P1|Overall Study|Non-compliance|2
1607270|NCT02159469|5604346|P1|Overall Study|Adverse Event|5
1607271|NCT02159469|5604346|P1|Overall Study|Missing Completion status|1
1607272|NCT02159365|5604351|P1|Overall Study|Lost to Follow-up|1
1607273|NCT02159365|5604351|P1|Overall Study|Death|1
1607274|NCT02159365|5604351|P1|Overall Study|Subject withdrew consent|3
1607275|NCT02159365|5604351|P1|Overall Study|Subject request to discontinue treatment|3
1607276|NCT02159365|5604351|P1|Overall Study|Maximum clinical benefit|3
1607277|NCT02159365|5604351|P1|Overall Study|Study drug toxicity|7
1607278|NCT02159365|5604351|P1|Overall Study|Adverse Event unrelated to study drug|9
1607279|NCT02159365|5604351|P1|Overall Study|Administrative reason by Sponsor|9
1607280|NCT02159365|5604351|P1|Overall Study|Other reasons|11
1607281|NCT02159365|5604351|P1|Overall Study|Disease Progression|23
1607282|NCT02159352|5604358|P2|Overall Study|Withdrawal by Subject|1
1607283|NCT02159352|5604359|P1|Overall Study|Withdrawal by Subject|0
1607284|NCT02159352|5604358|P2|Overall Study|Adverse Event|1
1607285|NCT02159352|5604359|P1|Overall Study|Adverse Event|3
1607286|NCT02159183|5604411|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
1607287|NCT02159183|5604412|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
1607288|NCT02159183|5604411|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
1607289|NCT02159183|5604412|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
1607290|NCT02159183|5604411|P2|Analysis After the 36 Months Follow-up|Death|1
1607291|NCT02159183|5604412|P1|Analysis After the 36 Months Follow-up|Death|0
1607292|NCT02159183|5604411|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
1607293|NCT02159183|5604412|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
1607294|NCT02159183|5604411|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
1607295|NCT02159183|5604412|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
1607296|NCT02159053|5604485|P3|Overall Study|Participants/guardian decision|6
1607297|NCT02159053|5604486|P2|Overall Study|Participants/guardian decision|10
1607298|NCT02159053|5604487|P1|Overall Study|Participants/guardian decision|8
1607299|NCT02159053|5604485|P3|Overall Study|Adverse Event|5
1607300|NCT02159053|5604486|P2|Overall Study|Adverse Event|6
1607301|NCT02159053|5604487|P1|Overall Study|Adverse Event|7
1607302|NCT02159053|5604485|P3|Overall Study|Lack of Efficacy|7
1607303|NCT02159053|5604486|P2|Overall Study|Lack of Efficacy|4
1607304|NCT02159053|5604487|P1|Overall Study|Lack of Efficacy|3
1607305|NCT02159053|5604485|P3|Overall Study|Physician Decision|1
1607306|NCT02159053|5604486|P2|Overall Study|Physician Decision|1
1607307|NCT02159053|5604487|P1|Overall Study|Physician Decision|0
1607308|NCT02159053|5604485|P3|Overall Study|Death|1
1607309|NCT02159053|5604486|P2|Overall Study|Death|0
1607310|NCT02159053|5604487|P1|Overall Study|Death|2
1607311|NCT02159040|5604524|P1|Overall Study|Death|1
1607312|NCT02158975|5604537|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
1607313|NCT02158936|5604547|P2|Overall Study|Lost to Follow-up|1
1607314|NCT02158936|5604548|P1|Overall Study|Lost to Follow-up|0
1607315|NCT02158936|5604547|P2|Overall Study|Physician Decision|13
1607316|NCT02158936|5604548|P1|Overall Study|Physician Decision|15
1607317|NCT02158936|5604547|P2|Overall Study|Withdrawal by Subject|16
1607318|NCT02158936|5604548|P1|Overall Study|Withdrawal by Subject|15
1607319|NCT02158936|5604547|P2|Overall Study|Adverse Event|24
1607320|NCT02158936|5604548|P1|Overall Study|Adverse Event|39
1607321|NCT02158936|5604547|P2|Overall Study|Azacitidine tx discontinued|46
1607322|NCT02158936|5604548|P1|Overall Study|Azacitidine tx discontinued|53
1607323|NCT02158936|5604547|P2|Overall Study|Study closed/ terminated|77
1607324|NCT02158936|5604548|P1|Overall Study|Study closed/ terminated|57
1607325|NCT02158884|5604590|P1|12 Month Assessment|Missed SMFA|17
1607326|NCT02158884|5604590|P1|6 Month Assessment|Missed SMFA|20
1607327|NCT02158884|5604590|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
1607328|NCT02158884|5604590|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
1607329|NCT02158884|5604590|P1|Baseline Assessment|Missed SMFA|1
1607330|NCT02158884|5604590|P1|Baseline Assessment|Missed performance assessment|3
1607331|NCT02158806|5604625|P2|Overall Study|Transferred to palliative care|1
1607332|NCT02158806|5604626|P1|Overall Study|Transferred to palliative care|0
1607333|NCT02158806|5604625|P2|Overall Study|Moved out of area|1
1607334|NCT02158806|5604626|P1|Overall Study|Moved out of area|0
1607335|NCT02158806|5604625|P2|Overall Study|Lost to Follow-up|3
1607336|NCT02158806|5604626|P1|Overall Study|Lost to Follow-up|0
1607337|NCT02158806|5604625|P2|Overall Study|Withdrawal by Subject|0
1607338|NCT02158806|5604626|P1|Overall Study|Withdrawal by Subject|2
1607339|NCT02158806|5604625|P2|Overall Study|Death|0
1607340|NCT02158806|5604626|P1|Overall Study|Death|2
1607341|NCT02158728|5604646|P1|Overall Study|no qualified dataset|24
1607342|NCT02158728|5604646|P1|Overall Study|no procedure according to CIP done|3
1607343|NCT02158546|5604665|P4|Overall Study|Site Excluded|4
1607344|NCT02158546|5604666|P3|Overall Study|Site Excluded|3
1607345|NCT02158546|5604667|P2|Overall Study|Site Excluded|5
1607346|NCT02158546|5604668|P1|Overall Study|Site Excluded|5
1607347|NCT02158546|5604665|P4|Overall Study|Lost to Follow-up|1
1607348|NCT02158546|5604666|P3|Overall Study|Lost to Follow-up|0
1607349|NCT02158546|5604667|P2|Overall Study|Lost to Follow-up|4
1607350|NCT02158546|5604668|P1|Overall Study|Lost to Follow-up|5
1607351|NCT02158546|5604665|P4|Overall Study|Withdrawal by Subject|0
1607352|NCT02158546|5604666|P3|Overall Study|Withdrawal by Subject|1
1607353|NCT02158546|5604667|P2|Overall Study|Withdrawal by Subject|2
1607354|NCT02158546|5604668|P1|Overall Study|Withdrawal by Subject|6
1607355|NCT02158546|5604665|P4|Overall Study|Adverse Event|0
1607356|NCT02158546|5604666|P3|Overall Study|Adverse Event|0
1607357|NCT02158546|5604667|P2|Overall Study|Adverse Event|2
1607358|NCT02158546|5604668|P1|Overall Study|Adverse Event|2
1607359|NCT02158546|5604665|P4|Overall Study|Lack of Efficacy|0
1607360|NCT02158546|5604666|P3|Overall Study|Lack of Efficacy|0
1607361|NCT02158546|5604667|P2|Overall Study|Lack of Efficacy|1
1607362|NCT02158546|5604668|P1|Overall Study|Lack of Efficacy|1
1607363|NCT02158546|5604665|P4|Overall Study|Failure to meet eligibility criteria|0
1607364|NCT02158546|5604666|P3|Overall Study|Failure to meet eligibility criteria|0
1607365|NCT02158546|5604667|P2|Overall Study|Failure to meet eligibility criteria|1
1607366|NCT02158546|5604668|P1|Overall Study|Failure to meet eligibility criteria|0
1607367|NCT02158546|5604665|P4|Overall Study|Non-compliance|1
1607368|NCT02158546|5604666|P3|Overall Study|Non-compliance|0
1607369|NCT02158546|5604667|P2|Overall Study|Non-compliance|1
1607370|NCT02158546|5604668|P1|Overall Study|Non-compliance|0
1607371|NCT02158546|5604665|P4|Overall Study|Physician Decision|0
1607372|NCT02158546|5604666|P3|Overall Study|Physician Decision|0
1607373|NCT02158546|5604667|P2|Overall Study|Physician Decision|1
1607374|NCT02158546|5604668|P1|Overall Study|Physician Decision|0
1607375|NCT02158533|5604687|P6|Stage 2|Non-adherence with study visits|1
1607376|NCT02158533|5604688|P5|Stage 2|Non-adherence with study visits|0
1607377|NCT02158533|5604689|P4|Stage 2|Non-adherence with study visits|0
1607378|NCT02158533|5604690|P3|Stage 2|Non-adherence with study visits|0
1607379|NCT02158533|5604691|P2|Stage 2|Non-adherence with study visits|0
1607380|NCT02158533|5604692|P1|Stage 2|Non-adherence with study visits|0
1607381|NCT02158533|5604687|P6|Stage 2|Psychiatrist decision to try new tx|0
1607382|NCT02158533|5604688|P5|Stage 2|Psychiatrist decision to try new tx|0
1607383|NCT02158533|5604689|P4|Stage 2|Psychiatrist decision to try new tx|1
1607384|NCT02158533|5604690|P3|Stage 2|Psychiatrist decision to try new tx|0
1607385|NCT02158533|5604691|P2|Stage 2|Psychiatrist decision to try new tx|0
1607386|NCT02158533|5604692|P1|Stage 2|Psychiatrist decision to try new tx|0
1607387|NCT02158533|5604687|P6|Stage 2|Pregnancy|0
1607388|NCT02158533|5604688|P5|Stage 2|Pregnancy|0
1607389|NCT02158533|5604689|P4|Stage 2|Pregnancy|1
1607390|NCT02158533|5604690|P3|Stage 2|Pregnancy|0
1607391|NCT02158533|5604691|P2|Stage 2|Pregnancy|0
1607392|NCT02158533|5604692|P1|Stage 2|Pregnancy|0
1607393|NCT02158533|5604687|P6|Stage 2|Physician Decision|0
1607394|NCT02158533|5604688|P5|Stage 2|Physician Decision|1
1607395|NCT02158533|5604689|P4|Stage 2|Physician Decision|0
1607396|NCT02158533|5604690|P3|Stage 2|Physician Decision|0
1607397|NCT02158533|5604691|P2|Stage 2|Physician Decision|0
1607398|NCT02158533|5604692|P1|Stage 2|Physician Decision|0
1607399|NCT02158533|5604687|P6|Stage 2|Withdrawal by Subject|2
1607400|NCT02158533|5604688|P5|Stage 2|Withdrawal by Subject|1
1607401|NCT02158533|5604689|P4|Stage 2|Withdrawal by Subject|0
1607402|NCT02158533|5604690|P3|Stage 2|Withdrawal by Subject|0
1607403|NCT02158533|5604691|P2|Stage 2|Withdrawal by Subject|0
1607404|NCT02158533|5604692|P1|Stage 2|Withdrawal by Subject|0
1607405|NCT02158533|5604687|P6|Stage 2|Lost to Follow-up|2
1607406|NCT02158533|5604688|P5|Stage 2|Lost to Follow-up|1
1607407|NCT02158533|5604689|P4|Stage 2|Lost to Follow-up|1
1607408|NCT02158533|5604690|P3|Stage 2|Lost to Follow-up|0
1607409|NCT02158533|5604691|P2|Stage 2|Lost to Follow-up|0
1607410|NCT02158533|5604692|P1|Stage 2|Lost to Follow-up|0
1607411|NCT02158533|5604687|P6|Stage 2|Lack of Efficacy|0
1607412|NCT02158533|5604688|P5|Stage 2|Lack of Efficacy|1
1607413|NCT02158533|5604689|P4|Stage 2|Lack of Efficacy|0
1607414|NCT02158533|5604690|P3|Stage 2|Lack of Efficacy|0
1607415|NCT02158533|5604691|P2|Stage 2|Lack of Efficacy|0
1607416|NCT02158533|5604692|P1|Stage 2|Lack of Efficacy|0
1607417|NCT02158533|5604687|P6|Stage 2|Adverse Event|1
1607418|NCT02158533|5604688|P5|Stage 2|Adverse Event|0
1607419|NCT02158533|5604689|P4|Stage 2|Adverse Event|0
1607420|NCT02158533|5604690|P3|Stage 2|Adverse Event|0
1607421|NCT02158533|5604691|P2|Stage 2|Adverse Event|0
1607422|NCT02158533|5604692|P1|Stage 2|Adverse Event|0
1607423|NCT02158533|5604687|P6|Stage 1|Non-compliance with study visits|0
1607424|NCT02158533|5604688|P5|Stage 1|Non-compliance with study visits|0
1607425|NCT02158533|5604689|P4|Stage 1|Non-compliance with study visits|0
1607426|NCT02158533|5604690|P3|Stage 1|Non-compliance with study visits|0
1607427|NCT02158533|5604691|P2|Stage 1|Non-compliance with study visits|0
1607428|NCT02158533|5604692|P1|Stage 1|Non-compliance with study visits|1
1607429|NCT02158533|5604687|P6|Stage 1|Failure to Meet Eligibility Criteria|0
1607430|NCT02158533|5604688|P5|Stage 1|Failure to Meet Eligibility Criteria|0
1607431|NCT02158533|5604689|P4|Stage 1|Failure to Meet Eligibility Criteria|0
1607432|NCT02158533|5604690|P3|Stage 1|Failure to Meet Eligibility Criteria|0
1607433|NCT02158533|5604691|P2|Stage 1|Failure to Meet Eligibility Criteria|1
1607434|NCT02158533|5604692|P1|Stage 1|Failure to Meet Eligibility Criteria|0
1607435|NCT02158533|5604687|P6|Stage 1|Lost to Follow-up|0
1607436|NCT02158533|5604688|P5|Stage 1|Lost to Follow-up|0
1607437|NCT02158533|5604689|P4|Stage 1|Lost to Follow-up|0
1607438|NCT02158533|5604690|P3|Stage 1|Lost to Follow-up|0
1607439|NCT02158533|5604691|P2|Stage 1|Lost to Follow-up|1
1607440|NCT02158533|5604692|P1|Stage 1|Lost to Follow-up|3
1607441|NCT02158533|5604687|P6|Stage 1|Lack of Efficacy|0
1607442|NCT02158533|5604688|P5|Stage 1|Lack of Efficacy|0
1607443|NCT02158533|5604689|P4|Stage 1|Lack of Efficacy|0
1607444|NCT02158533|5604690|P3|Stage 1|Lack of Efficacy|0
1607445|NCT02158533|5604691|P2|Stage 1|Lack of Efficacy|0
1607446|NCT02158533|5604692|P1|Stage 1|Lack of Efficacy|1
1607447|NCT02158533|5604687|P6|Stage 1|Withdrawal by Subject|0
1607448|NCT02158533|5604688|P5|Stage 1|Withdrawal by Subject|0
1607449|NCT02158533|5604689|P4|Stage 1|Withdrawal by Subject|0
1607450|NCT02158533|5604690|P3|Stage 1|Withdrawal by Subject|1
1607451|NCT02158533|5604691|P2|Stage 1|Withdrawal by Subject|2
1607452|NCT02158533|5604692|P1|Stage 1|Withdrawal by Subject|3
1607453|NCT02158533|5604687|P6|Stage 1|Adverse Event|0
1607454|NCT02158533|5604688|P5|Stage 1|Adverse Event|0
1607455|NCT02158533|5604689|P4|Stage 1|Adverse Event|0
1607456|NCT02158533|5604690|P3|Stage 1|Adverse Event|7
1607457|NCT02158533|5604691|P2|Stage 1|Adverse Event|4
1607458|NCT02158533|5604692|P1|Stage 1|Adverse Event|6
1607459|NCT02158442|5604768|P2|Overall Study|Perfusion staff not available|0
1607460|NCT02158442|5604769|P1|Overall Study|Perfusion staff not available|1
1607461|NCT02158442|5604768|P2|Overall Study|Withdrawal by Subject|0
1607462|NCT02158442|5604769|P1|Overall Study|Withdrawal by Subject|1
1607463|NCT02158364|5604775|P1|Overall Study|Protocol Deviation|50
1607464|NCT02158364|5604775|P1|Overall Study|Case report forms uncollected|10
1607465|NCT02158247|5604793|P1|Overall Study|Invisible vocal cords|5
1607466|NCT02158091|5604812|P3|Overall Study|DLT|0
1607467|NCT02158091|5604813|P2|Overall Study|DLT|1
1607468|NCT02158091|5604814|P1|Overall Study|DLT|2
1607469|NCT02158039|5604822|P1|Overall Study|Screen Failure|9
1607470|NCT02158039|5604822|P1|Overall Study|Withdrawal by Subject|1
1607471|NCT02157948|5604829|P2|Overall Study|Decision by Sponsor|1
1607472|NCT02157948|5604830|P1|Overall Study|Decision by Sponsor|0
1607473|NCT02157948|5604829|P2|Overall Study|Protocol Specified Criteria|1
1607474|NCT02157948|5604830|P1|Overall Study|Protocol Specified Criteria|2
1607475|NCT02157948|5604829|P2|Overall Study|Lost to Follow-up|2
1607476|NCT02157948|5604830|P1|Overall Study|Lost to Follow-up|3
1607477|NCT02157948|5604829|P2|Overall Study|Withdrawal by Subject|5
1607478|NCT02157948|5604830|P1|Overall Study|Withdrawal by Subject|4
1607479|NCT02157935|5604842|P2|Overall Study|Adverse Event|5
1607480|NCT02157935|5604843|P1|Overall Study|Adverse Event|3
1607481|NCT02157935|5604842|P2|Overall Study|Death|4
1607482|NCT02157935|5604843|P1|Overall Study|Death|4
1607483|NCT02157935|5604842|P2|Overall Study|Lack of Efficacy|1
1607484|NCT02157935|5604843|P1|Overall Study|Lack of Efficacy|0
1607485|NCT02157935|5604842|P2|Overall Study|Other|12
1607486|NCT02157935|5604843|P1|Overall Study|Other|5
1607487|NCT02157935|5604842|P2|Overall Study|Progressive disease|2
1607488|NCT02157935|5604843|P1|Overall Study|Progressive disease|0
1607489|NCT02157935|5604842|P2|Overall Study|Protocol Violation|0
1607490|NCT02157935|5604843|P1|Overall Study|Protocol Violation|1
1607491|NCT02157935|5604842|P2|Overall Study|Screen failure|2
1607492|NCT02157935|5604843|P1|Overall Study|Screen failure|1
1607493|NCT02157935|5604842|P2|Overall Study|Withdrawal by Subject|39
1607494|NCT02157935|5604843|P1|Overall Study|Withdrawal by Subject|25
1607495|NCT02157883|5604869|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
1607496|NCT02157883|5604869|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
1607497|NCT02157883|5604869|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
1607498|NCT02157883|5604869|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
1607499|NCT02157883|5604869|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
1607500|NCT02157623|5604900|P2|Overall Study|Physician Decision|3
1607501|NCT02157623|5604901|P1|Overall Study|Physician Decision|4
1607502|NCT02157519|5604909|P2|Overall Study|Lost to Follow-up|0
1607503|NCT02157519|5604910|P1|Overall Study|Lost to Follow-up|1
1607504|NCT02157519|5604909|P2|Overall Study|Withdrawal by Subject|0
1607505|NCT02157519|5604910|P1|Overall Study|Withdrawal by Subject|7
1607506|NCT02157519|5604909|P2|Overall Study|Death|1
1607507|NCT02157519|5604910|P1|Overall Study|Death|3
1607508|NCT02157506|5604933|P5|Overall Study|Lost to Follow-up|0
1607509|NCT02157506|5604934|P4|Overall Study|Lost to Follow-up|0
1607510|NCT02157506|5604935|P3|Overall Study|Lost to Follow-up|1
1607511|NCT02157506|5604936|P2|Overall Study|Lost to Follow-up|0
1607512|NCT02157506|5604937|P1|Overall Study|Lost to Follow-up|0
1607513|NCT02157506|5604933|P5|Overall Study|Adverse Event|0
1607514|NCT02157506|5604934|P4|Overall Study|Adverse Event|0
1607515|NCT02157506|5604935|P3|Overall Study|Adverse Event|0
1607516|NCT02157506|5604936|P2|Overall Study|Adverse Event|1
1607517|NCT02157506|5604937|P1|Overall Study|Adverse Event|0
1607518|NCT02157376|5604996|P2|Overall Study|Investigator's misjudgement|2
1607519|NCT02157376|5604997|P1|Overall Study|Investigator's misjudgement|1
1607520|NCT02157376|5604996|P2|Overall Study|Not treated|3
1607521|NCT02157376|5604997|P1|Overall Study|Not treated|8
1607522|NCT02157376|5604996|P2|Overall Study|Withdrawal by Subject|8
1607523|NCT02157376|5604997|P1|Overall Study|Withdrawal by Subject|3
1607524|NCT02157376|5604996|P2|Overall Study|Eligibility criteria not fulfilled|1
1607525|NCT02157376|5604997|P1|Overall Study|Eligibility criteria not fulfilled|0
1607526|NCT02157376|5604996|P2|Overall Study|Death|4
1607527|NCT02157376|5604997|P1|Overall Study|Death|10
1607528|NCT02157298|5605007|P2|Overall Study|Withdrawal by Subject|0
1607529|NCT02157298|5605008|P1|Overall Study|Withdrawal by Subject|1
1607530|NCT02157298|5605007|P2|Overall Study|Poor/Non-compliance|0
1607531|NCT02157298|5605008|P1|Overall Study|Poor/Non-compliance|1
1607532|NCT02157298|5605007|P2|Overall Study|Subject no longer meets study criteria|2
1607533|NCT02157298|5605008|P1|Overall Study|Subject no longer meets study criteria|1
1607534|NCT02157298|5605007|P2|Overall Study|Adverse Event|0
1607535|NCT02157298|5605008|P1|Overall Study|Adverse Event|1
1607536|NCT02157116|5605047|P1|Overall Study|Failed Screening|2
1607537|NCT02157116|5605047|P1|Overall Study|Physician Decision|3
1607538|NCT02157116|5605047|P1|Overall Study|Withdrawal by Subject|4
1607540|NCT02156492|5605073|P3|Period 3|Adverse Event|0
1607541|NCT02156492|5605074|P2|Period 3|Adverse Event|1
1607542|NCT02156492|5605075|P1|Period 3|Adverse Event|0
1607543|NCT02156492|5605073|P3|Period 1|No Reason Given|0
1607544|NCT02156492|5605074|P2|Period 1|No Reason Given|1
1607545|NCT02156492|5605075|P1|Period 1|No Reason Given|0
1607546|NCT02156466|5605101|P5|Overall Study|Quantiferon Positivity|0
1607547|NCT02156466|5605102|P4|Overall Study|Quantiferon Positivity|1
1607548|NCT02156466|5605103|P3|Overall Study|Quantiferon Positivity|0
1607549|NCT02156466|5605104|P2|Overall Study|Quantiferon Positivity|0
1607550|NCT02156466|5605105|P1|Overall Study|Quantiferon Positivity|0
1607551|NCT02156466|5605101|P5|Overall Study|Adverse Event|0
1607552|NCT02156466|5605102|P4|Overall Study|Adverse Event|1
1607553|NCT02156466|5605103|P3|Overall Study|Adverse Event|1
1607554|NCT02156466|5605104|P2|Overall Study|Adverse Event|0
1607555|NCT02156466|5605105|P1|Overall Study|Adverse Event|0
1607556|NCT02156271|5605286|P2|Overall Study|Physician Decision|3
1607557|NCT02156271|5605287|P1|Overall Study|Physician Decision|4
1607558|NCT02156076|5605327|P4|Follow-up Period|Withdrawal by Subject|0
1607559|NCT02156076|5605328|P3|Follow-up Period|Withdrawal by Subject|0
1607560|NCT02156076|5605329|P2|Follow-up Period|Withdrawal by Subject|0
1607561|NCT02156076|5605330|P1|Follow-up Period|Withdrawal by Subject|1
1607562|NCT02156076|5605327|P4|Treatment Period|Adverse Event|1
1607563|NCT02156076|5605328|P3|Treatment Period|Adverse Event|0
1607564|NCT02156076|5605329|P2|Treatment Period|Adverse Event|0
1607565|NCT02156076|5605330|P1|Treatment Period|Adverse Event|0
1607566|NCT02156076|5605327|P4|Treatment Period|Subject request to discontinue treatment|0
1607567|NCT02156076|5605328|P3|Treatment Period|Subject request to discontinue treatment|0
1607568|NCT02156076|5605329|P2|Treatment Period|Subject request to discontinue treatment|1
1607569|NCT02156076|5605330|P1|Treatment Period|Subject request to discontinue treatment|0
1607570|NCT02156076|5605327|P4|Treatment Period|Withdrawal by Subject|0
1607571|NCT02156076|5605328|P3|Treatment Period|Withdrawal by Subject|1
1607572|NCT02156076|5605329|P2|Treatment Period|Withdrawal by Subject|0
1607573|NCT02156076|5605330|P1|Treatment Period|Withdrawal by Subject|0
1607574|NCT02156076|5605327|P4|Treatment Period|Lost to Follow-up|1
1607575|NCT02156076|5605328|P3|Treatment Period|Lost to Follow-up|0
1607576|NCT02156076|5605329|P2|Treatment Period|Lost to Follow-up|0
1607577|NCT02156076|5605330|P1|Treatment Period|Lost to Follow-up|0
1607578|NCT02156076|5605327|P4|Treatment Period|Poor/non-compliance|0
1607579|NCT02156076|5605328|P3|Treatment Period|Poor/non-compliance|0
1607580|NCT02156076|5605329|P2|Treatment Period|Poor/non-compliance|1
1607581|NCT02156076|5605330|P1|Treatment Period|Poor/non-compliance|0
1607582|NCT02156076|5605327|P4|Treatment Period|no longer meets study criteria|0
1607583|NCT02156076|5605328|P3|Treatment Period|no longer meets study criteria|1
1607584|NCT02156076|5605329|P2|Treatment Period|no longer meets study criteria|0
1607585|NCT02156076|5605330|P1|Treatment Period|no longer meets study criteria|0
1607586|NCT02155985|5605387|P3|Overall Study|Lost to Follow-up|0
1607587|NCT02155985|5605388|P2|Overall Study|Lost to Follow-up|0
1607588|NCT02155985|5605389|P1|Overall Study|Lost to Follow-up|1
1607589|NCT02155985|5605387|P3|Overall Study|Withdrawal by Subject|1
1607590|NCT02155985|5605388|P2|Overall Study|Withdrawal by Subject|0
1607591|NCT02155985|5605389|P1|Overall Study|Withdrawal by Subject|0
1607592|NCT02155881|5605456|P2|Overall Study|Inappropriately randomized|2
1607593|NCT02155881|5605457|P1|Overall Study|Inappropriately randomized|2
1607594|NCT02155881|5605456|P2|Overall Study|Withdrawal by Subject|2
1607595|NCT02155881|5605457|P1|Overall Study|Withdrawal by Subject|0
1607596|NCT02155738|5605481|P4|Overall Study|Missing critical information|1
1607597|NCT02155738|5605482|P3|Overall Study|Missing critical information|0
1607598|NCT02155738|5605483|P2|Overall Study|Missing critical information|0
1607599|NCT02155738|5605484|P1|Overall Study|Missing critical information|1
1607600|NCT02155712|5605504|P2|Primary Objective|Withdrawal by Subject|0
1607601|NCT02155712|5605505|P1|Primary Objective|Withdrawal by Subject|21
1607602|NCT02155712|5605504|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
1607603|NCT02155712|5605505|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
1607604|NCT02155712|5605504|P2|Primary Objective|No 2-Year Forms but not Terminated|0
1607605|NCT02155712|5605505|P1|Primary Objective|No 2-Year Forms but not Terminated|13
1607606|NCT02155712|5605504|P2|Primary Objective|Lost to Follow-up|0
1607607|NCT02155712|5605505|P1|Primary Objective|Lost to Follow-up|22
1607608|NCT02155712|5605504|P2|Primary Objective|Death|0
1607609|NCT02155712|5605505|P1|Primary Objective|Death|3
1607610|NCT02155660|5605515|P4|Overall Study|Withdrawal by Subject|21
1607611|NCT02155660|5605516|P3|Overall Study|Withdrawal by Subject|24
1607612|NCT02155660|5605517|P2|Overall Study|Withdrawal by Subject|31
1607613|NCT02155660|5605518|P1|Overall Study|Withdrawal by Subject|28
1607614|NCT02155660|5605515|P4|Overall Study|Death|19
1607615|NCT02155660|5605516|P3|Overall Study|Death|17
1607616|NCT02155660|5605517|P2|Overall Study|Death|19
1607617|NCT02155660|5605518|P1|Overall Study|Death|17
1607618|NCT02155660|5605515|P4|Overall Study|Lost to Follow-up|8
1607619|NCT02155660|5605516|P3|Overall Study|Lost to Follow-up|5
1607620|NCT02155660|5605517|P2|Overall Study|Lost to Follow-up|6
1607621|NCT02155660|5605518|P1|Overall Study|Lost to Follow-up|3
1607622|NCT02155660|5605515|P4|Overall Study|Adverse Event|1
1607623|NCT02155660|5605516|P3|Overall Study|Adverse Event|3
1607624|NCT02155660|5605517|P2|Overall Study|Adverse Event|6
1607625|NCT02155660|5605518|P1|Overall Study|Adverse Event|2
1607626|NCT02155660|5605515|P4|Overall Study|Severe non-compliance|1
1607627|NCT02155660|5605516|P3|Overall Study|Severe non-compliance|0
1607628|NCT02155660|5605517|P2|Overall Study|Severe non-compliance|4
1607629|NCT02155660|5605518|P1|Overall Study|Severe non-compliance|0
1607630|NCT02155660|5605515|P4|Overall Study|Study-specific withdrawal criteria|1
1607631|NCT02155660|5605516|P3|Overall Study|Study-specific withdrawal criteria|1
1607632|NCT02155660|5605517|P2|Overall Study|Study-specific withdrawal criteria|1
1607633|NCT02155660|5605518|P1|Overall Study|Study-specific withdrawal criteria|0
1607634|NCT02155660|5605515|P4|Overall Study|Other Reason|10
1607635|NCT02155660|5605516|P3|Overall Study|Other Reason|10
1607636|NCT02155660|5605517|P2|Overall Study|Other Reason|6
1607637|NCT02155660|5605518|P1|Overall Study|Other Reason|8
1607638|NCT02155608|5605601|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
1607639|NCT02155608|5605602|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
1607640|NCT02155608|5605601|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
1607641|NCT02155608|5605602|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
1607642|NCT02155322|5605699|P1|Overall Study|Withdrawal by Subject|4
1607643|NCT02155322|5605699|P1|Overall Study|Relapse/Recurrence|8
1607644|NCT02155322|5605699|P1|Overall Study|Physician Decision|1
1607645|NCT02155322|5605699|P1|Overall Study|Adverse Event|1
1607646|NCT02155309|5605706|P3|Overall Study|Protocol Violation|1
1607647|NCT02155309|5605707|P2|Overall Study|Protocol Violation|0
1607648|NCT02155309|5605708|P1|Overall Study|Protocol Violation|0
1607649|NCT02155283|5605715|P1|Overall Study|Protocol Violation|3
1607650|NCT02155283|5605715|P1|Overall Study|Withdrawal by Subject|1
1607651|NCT02155283|5605715|P1|Overall Study|Lost to Follow-up|3
1607652|NCT02154581|5605891|P2|Overall Study|Lost to Follow-up|8
1607653|NCT02154581|5605892|P1|Overall Study|Lost to Follow-up|7
1607654|NCT02154425|5605917|P1|Screening Period|Adverse Event|1
1607655|NCT02154347|5605962|P2|Open-label Period|Withdrawal by Subject|1
1607656|NCT02154347|5605963|P1|Open-label Period|Withdrawal by Subject|0
1607657|NCT02154347|5605962|P2|Open-label Period|Protocol Violation|1
1607658|NCT02154347|5605963|P1|Open-label Period|Protocol Violation|0
1607659|NCT02154347|5605962|P2|Open-label Period|Lack of Efficacy|19
1607660|NCT02154347|5605963|P1|Open-label Period|Lack of Efficacy|4
1607661|NCT02154347|5605962|P2|Open-label Period|Adverse Event|4
1607662|NCT02154347|5605963|P1|Open-label Period|Adverse Event|3
1607663|NCT02154347|5605962|P2|Double-blind Period|Withdrawal by Subject|1
1607664|NCT02154347|5605963|P1|Double-blind Period|Withdrawal by Subject|1
1607665|NCT02154347|5605962|P2|Double-blind Period|Physician Decision|1
1607666|NCT02154347|5605963|P1|Double-blind Period|Physician Decision|0
1607667|NCT02154347|5605962|P2|Double-blind Period|Lack of Efficacy|0
1607668|NCT02154347|5605963|P1|Double-blind Period|Lack of Efficacy|1
1607669|NCT02154347|5605962|P2|Double-blind Period|Adverse Event|2
1607670|NCT02154347|5605963|P1|Double-blind Period|Adverse Event|1
1607671|NCT02154139|5605986|P1|Overall Study|Investigator transferred|3
1607672|NCT02154139|5605986|P1|Overall Study|Other|2
1607673|NCT02154139|5605986|P1|Overall Study|Injection not administered|2
1607674|NCT02154087|5605994|P1|Overall Study|Study Termination|1
1607675|NCT02154061|5606000|P2|Overall Study|enrolled but not vaccinated|0
1607676|NCT02154061|5606001|P1|Overall Study|enrolled but not vaccinated|1
1607677|NCT02154061|5606000|P2|Overall Study|Pregnancy|0
1607678|NCT02154061|5606001|P1|Overall Study|Pregnancy|1
1607679|NCT02153918|5606048|P1|Overall Study|Refused further treatment|1
1607680|NCT02153905|5606059|P2|Overall Study|Death|0
1607681|NCT02153905|5606060|P1|Overall Study|Death|1
1607682|NCT02153827|5606078|P2|Overall Study|Lost to Follow-up|9
1607683|NCT02153827|5606079|P1|Overall Study|Lost to Follow-up|3
1607684|NCT02153788|5606095|P2|Overall Study|Physician Decision|1
1607685|NCT02153788|5606096|P1|Overall Study|Physician Decision|2
1607686|NCT02153736|5606116|P2|Overall Study|Withdrawal by Subject|1
1607687|NCT02153736|5606117|P1|Overall Study|Withdrawal by Subject|0
1607688|NCT02153736|5606116|P2|Overall Study|Death|1
1607689|NCT02153736|5606117|P1|Overall Study|Death|0
1607690|NCT02153736|5606116|P2|Overall Study|Medical status change made ineligible|0
1607691|NCT02153736|5606117|P1|Overall Study|Medical status change made ineligible|1
1607692|NCT02153736|5606116|P2|Overall Study|Lost to Follow-up|0
1607693|NCT02153736|5606117|P1|Overall Study|Lost to Follow-up|1
1607694|NCT02153398|5606344|P5|Overall Study|Adverse Event|0
1607695|NCT02153398|5606345|P4|Overall Study|Adverse Event|1
1607696|NCT02153398|5606346|P3|Overall Study|Adverse Event|1
1607697|NCT02153398|5606347|P2|Overall Study|Adverse Event|0
1607698|NCT02153398|5606348|P1|Overall Study|Adverse Event|0
1607699|NCT02153398|5606344|P5|Overall Study|Withdrawal by Subject|0
1607700|NCT02153398|5606345|P4|Overall Study|Withdrawal by Subject|0
1607701|NCT02153398|5606346|P3|Overall Study|Withdrawal by Subject|0
1607702|NCT02153398|5606347|P2|Overall Study|Withdrawal by Subject|0
1607703|NCT02153398|5606348|P1|Overall Study|Withdrawal by Subject|1
1607704|NCT02153359|5606470|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
1607705|NCT02153359|5606471|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
1607706|NCT02153346|5606505|P1|Overall Study|Lost to Follow-up|11
1607707|NCT02153112|5606522|P10|Overall Study|Reason not Specified|1
1607708|NCT02153112|5606523|P9|Overall Study|Reason not Specified|1
1607709|NCT02153112|5606524|P8|Overall Study|Reason not Specified|0
1607710|NCT02153112|5606525|P7|Overall Study|Reason not Specified|0
1607711|NCT02153112|5606526|P6|Overall Study|Reason not Specified|0
1607712|NCT02153112|5606527|P5|Overall Study|Reason not Specified|0
1607713|NCT02153112|5606528|P4|Overall Study|Reason not Specified|0
1607714|NCT02153112|5606529|P3|Overall Study|Reason not Specified|0
1607715|NCT02153112|5606530|P2|Overall Study|Reason not Specified|0
1607716|NCT02153112|5606531|P1|Overall Study|Reason not Specified|0
1607717|NCT02153112|5606522|P10|Overall Study|Withdrawal by Subject|12
1607718|NCT02153112|5606523|P9|Overall Study|Withdrawal by Subject|13
1607719|NCT02153112|5606524|P8|Overall Study|Withdrawal by Subject|2
1607720|NCT02153112|5606525|P7|Overall Study|Withdrawal by Subject|7
1607721|NCT02153112|5606526|P6|Overall Study|Withdrawal by Subject|1
1607722|NCT02153112|5606527|P5|Overall Study|Withdrawal by Subject|1
1607723|NCT02153112|5606528|P4|Overall Study|Withdrawal by Subject|2
1607724|NCT02153112|5606529|P3|Overall Study|Withdrawal by Subject|2
1607725|NCT02153112|5606530|P2|Overall Study|Withdrawal by Subject|1
1607726|NCT02153112|5606531|P1|Overall Study|Withdrawal by Subject|3
1607727|NCT02153112|5606522|P10|Overall Study|Lost to Follow-up|1
1607728|NCT02153112|5606523|P9|Overall Study|Lost to Follow-up|1
1607729|NCT02153112|5606524|P8|Overall Study|Lost to Follow-up|0
1607730|NCT02153112|5606525|P7|Overall Study|Lost to Follow-up|1
1607731|NCT02153112|5606526|P6|Overall Study|Lost to Follow-up|1
1607732|NCT02153112|5606527|P5|Overall Study|Lost to Follow-up|2
1607733|NCT02153112|5606528|P4|Overall Study|Lost to Follow-up|0
1607734|NCT02153112|5606529|P3|Overall Study|Lost to Follow-up|0
1607735|NCT02153112|5606530|P2|Overall Study|Lost to Follow-up|1
1607736|NCT02153112|5606531|P1|Overall Study|Lost to Follow-up|1
1607737|NCT02153112|5606522|P10|Overall Study|Adverse Event|0
1607738|NCT02153112|5606523|P9|Overall Study|Adverse Event|0
1607739|NCT02153112|5606524|P8|Overall Study|Adverse Event|0
1607740|NCT02153112|5606525|P7|Overall Study|Adverse Event|0
1607741|NCT02153112|5606526|P6|Overall Study|Adverse Event|0
1607742|NCT02153112|5606527|P5|Overall Study|Adverse Event|0
1607743|NCT02153112|5606528|P4|Overall Study|Adverse Event|0
1607744|NCT02153112|5606529|P3|Overall Study|Adverse Event|1
1607745|NCT02153112|5606530|P2|Overall Study|Adverse Event|0
1607746|NCT02153112|5606531|P1|Overall Study|Adverse Event|0
1607747|NCT02153086|5606870|P1|Overall Study|Other|2
1607748|NCT02153086|5606870|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
1607749|NCT02153073|5606884|P1|Overall Study|Protocol Deviation|68
1607750|NCT02153073|5606884|P1|Overall Study|Case Report Forms Uncollected|230
1607751|NCT02152631|5606899|P2|Overall Study|On Treatment|3
1607752|NCT02152631|5606900|P1|Overall Study|On Treatment|19
1607753|NCT02152631|5606899|P2|Overall Study|Lost to Follow-up|1
1607754|NCT02152631|5606900|P1|Overall Study|Lost to Follow-up|0
1607755|NCT02152631|5606899|P2|Overall Study|Physician Decision|2
1607756|NCT02152631|5606900|P1|Overall Study|Physician Decision|1
1607757|NCT02152631|5606899|P2|Overall Study|Noncompliance with study drug|0
1607758|NCT02152631|5606900|P1|Overall Study|Noncompliance with study drug|1
1607759|NCT02152631|5606899|P2|Overall Study|Withdrawal by Subject|16
1607760|NCT02152631|5606900|P1|Overall Study|Withdrawal by Subject|13
1607761|NCT02152631|5606899|P2|Overall Study|Adverse Event|4
1607762|NCT02152631|5606900|P1|Overall Study|Adverse Event|32
1607763|NCT02152605|5606919|P2|Overall Study|Withdrew consent|2
1607764|NCT02152605|5606920|P1|Overall Study|Withdrew consent|4
1607765|NCT02152605|5606919|P2|Overall Study|Lost to Follow-up|0
1607766|NCT02152605|5606920|P1|Overall Study|Lost to Follow-up|1
1607767|NCT02152605|5606919|P2|Overall Study|Protocol deviation|4
1607768|NCT02152605|5606920|P1|Overall Study|Protocol deviation|1
1607769|NCT02152605|5606919|P2|Overall Study|Lack of Efficacy|4
1607770|NCT02152605|5606920|P1|Overall Study|Lack of Efficacy|7
1607771|NCT02152605|5606919|P2|Overall Study|Adverse Event|8
1607772|NCT02152605|5606920|P1|Overall Study|Adverse Event|6
1607773|NCT02152566|5606930|P1|Overall Study|Withdrawal by Subject|2
1607774|NCT02152566|5606930|P1|Overall Study|Lost to Follow-up|1
1607775|NCT02152384|5606943|P2|Period 1|Adverse Event|1
1607776|NCT02152384|5606944|P1|Period 1|Adverse Event|1
1607777|NCT02152384|5606943|P2|Period 1|Withdrawal by Subject|1
1607778|NCT02152384|5606944|P1|Period 1|Withdrawal by Subject|0
1607779|NCT02152371|5606964|P2|Overall Study|Reason Not Given|1
1607780|NCT02152371|5606965|P1|Overall Study|Reason Not Given|0
1607781|NCT02152371|5606964|P2|Overall Study|Physician Decision|2
1607782|NCT02152371|5606965|P1|Overall Study|Physician Decision|0
1607783|NCT02152371|5606964|P2|Overall Study|Lack of Efficacy|1
1607784|NCT02152371|5606965|P1|Overall Study|Lack of Efficacy|0
1607785|NCT02152371|5606964|P2|Overall Study|Lost to Follow-up|0
1607786|NCT02152371|5606965|P1|Overall Study|Lost to Follow-up|1
1607787|NCT02152371|5606964|P2|Overall Study|Protocol Violation|3
1607788|NCT02152371|5606965|P1|Overall Study|Protocol Violation|2
1607789|NCT02152371|5606964|P2|Overall Study|Withdrawal by Subject|7
1607790|NCT02152371|5606965|P1|Overall Study|Withdrawal by Subject|3
1607791|NCT02152371|5606964|P2|Overall Study|Adverse Event|2
1607792|NCT02152371|5606965|P1|Overall Study|Adverse Event|6
1607793|NCT02152345|5607003|P2|Overall Study|Withdrawal by Subject|1
1607794|NCT02152345|5607004|P1|Overall Study|Withdrawal by Subject|2
1607795|NCT02152345|5607003|P2|Overall Study|Case Cancellations|4
1607796|NCT02152345|5607004|P1|Overall Study|Case Cancellations|2
1607797|NCT02152137|5607016|P1|Overall Study|Originally assigned to Arm B|3
1607798|NCT02152137|5607016|P1|Overall Study|Withdrawal by Subject|1
1607799|NCT02152007|5607024|P1|Overall Study|Withdrawal by Subject|1
1607810|NCT02151851|5607104|P2|Overall Study|Adverse Event|28
1607811|NCT02151851|5607105|P1|Overall Study|Adverse Event|6
1607812|NCT02151851|5607104|P2|Overall Study|Subject entered into study in error|1
1607813|NCT02151851|5607105|P1|Overall Study|Subject entered into study in error|0
1607814|NCT02151851|5607104|P2|Overall Study|Low compliance to study visits|1
1607815|NCT02151851|5607105|P1|Overall Study|Low compliance to study visits|0
1607816|NCT02151851|5607104|P2|Overall Study|Medical impairment|0
1607817|NCT02151851|5607105|P1|Overall Study|Medical impairment|1
1607818|NCT02151851|5607104|P2|Overall Study|Withdrawal by Subject|5
1607819|NCT02151851|5607105|P1|Overall Study|Withdrawal by Subject|2
1607820|NCT02151851|5607104|P2|Overall Study|Protocol Violation|1
1607821|NCT02151851|5607105|P1|Overall Study|Protocol Violation|0
1607822|NCT02151851|5607104|P2|Overall Study|Lack of Efficacy|94
1607823|NCT02151851|5607105|P1|Overall Study|Lack of Efficacy|67
1607824|NCT02151786|5607117|P1|Overall Study|Unavailability of Information|8
1607825|NCT02151786|5607117|P1|Overall Study|Randomized, not Treated|1
1607826|NCT02151786|5607117|P1|Overall Study|Outside the Contract Period|1
1607827|NCT02151786|5607117|P1|Overall Study|Unavailability of Case Report Form|26
1607828|NCT02151773|5607128|P1|Overall Study|Protocol Deviation|64
1607829|NCT02151682|5607135|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
1607830|NCT02151682|5607136|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1607831|NCT02151682|5607137|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1607832|NCT02151682|5607138|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1607833|NCT02151682|5607139|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1607834|NCT02151682|5607140|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
1607835|NCT02151682|5607135|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
1607836|NCT02151682|5607136|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1607837|NCT02151682|5607137|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1607838|NCT02151682|5607138|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1607839|NCT02151682|5607139|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1607840|NCT02151682|5607140|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
1607841|NCT02151682|5607135|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
1607842|NCT02151682|5607136|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
1607843|NCT02151682|5607137|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
1607844|NCT02151682|5607138|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
1607845|NCT02151682|5607139|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
1607846|NCT02151682|5607140|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
1607847|NCT02151682|5607135|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
1607848|NCT02151682|5607136|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1607849|NCT02151682|5607137|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1607850|NCT02151682|5607138|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1607851|NCT02151682|5607139|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1607852|NCT02151682|5607140|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
1607853|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1607854|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1607855|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1607856|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
1607857|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1607858|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
1607859|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Various other|0
1607860|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Various other|0
1607861|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Various other|0
1607862|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Various other|6
1607863|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Various other|0
1607864|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Various other|0
1607865|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Missing|0
1607866|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Missing|0
1607867|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Missing|1
1607868|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Missing|0
1607869|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Missing|0
1607870|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Missing|0
1607871|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
1607872|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
1607873|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
1607874|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
1607875|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
1607876|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
1607877|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1607878|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1607879|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1607880|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
1607881|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1607882|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
1607883|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1607884|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1607885|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1607886|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
1607887|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1607888|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
1607889|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1607890|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1607891|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
1607892|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
1607893|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1607894|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
1607895|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Death|0
1607896|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Death|0
1607897|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Death|2
1607898|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Death|0
1607899|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Death|0
1607900|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Death|0
1607901|NCT02151682|5607135|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
1607902|NCT02151682|5607136|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
1607903|NCT02151682|5607137|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
1607904|NCT02151682|5607138|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
1607905|NCT02151682|5607139|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
1607906|NCT02151682|5607140|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
1607907|NCT02151682|5607135|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1607908|NCT02151682|5607136|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1607909|NCT02151682|5607137|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1607910|NCT02151682|5607138|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1607911|NCT02151682|5607139|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
1607912|NCT02151682|5607140|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
1607913|NCT02151682|5607135|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1607914|NCT02151682|5607136|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1607915|NCT02151682|5607137|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1607916|NCT02151682|5607138|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
1607917|NCT02151682|5607139|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
1607918|NCT02151682|5607140|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
1607919|NCT02151682|5607135|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1607920|NCT02151682|5607136|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1607921|NCT02151682|5607137|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1607922|NCT02151682|5607138|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1607923|NCT02151682|5607139|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
1607924|NCT02151682|5607140|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
1607925|NCT02151682|5607135|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1607926|NCT02151682|5607136|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1607927|NCT02151682|5607137|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1607928|NCT02151682|5607138|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1607929|NCT02151682|5607139|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
1607930|NCT02151682|5607140|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
1607931|NCT02151682|5607135|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1607932|NCT02151682|5607136|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1607933|NCT02151682|5607137|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1607934|NCT02151682|5607138|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1607935|NCT02151682|5607139|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
1607936|NCT02151682|5607140|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
1607937|NCT02151643|5607190|P5|Overall Study|High Ferritin levels|1
1607938|NCT02151643|5607191|P4|Overall Study|High Ferritin levels|2
1607939|NCT02151643|5607192|P3|Overall Study|High Ferritin levels|2
1607940|NCT02151643|5607193|P2|Overall Study|High Ferritin levels|3
1607941|NCT02151643|5607194|P1|Overall Study|High Ferritin levels|3
1607942|NCT02151643|5607190|P5|Overall Study|Hyperphosphataemia|1
1607943|NCT02151643|5607191|P4|Overall Study|Hyperphosphataemia|0
1607944|NCT02151643|5607192|P3|Overall Study|Hyperphosphataemia|0
1607945|NCT02151643|5607193|P2|Overall Study|Hyperphosphataemia|0
1607946|NCT02151643|5607194|P1|Overall Study|Hyperphosphataemia|1
1607947|NCT02151643|5607190|P5|Overall Study|Withdrawal by Subject|1
1607948|NCT02151643|5607191|P4|Overall Study|Withdrawal by Subject|1
1607949|NCT02151643|5607192|P3|Overall Study|Withdrawal by Subject|1
1607950|NCT02151643|5607193|P2|Overall Study|Withdrawal by Subject|1
1607951|NCT02151643|5607194|P1|Overall Study|Withdrawal by Subject|0
1607952|NCT02151643|5607190|P5|Overall Study|Adverse Event|0
1607953|NCT02151643|5607191|P4|Overall Study|Adverse Event|4
1607954|NCT02151643|5607192|P3|Overall Study|Adverse Event|1
1607955|NCT02151643|5607193|P2|Overall Study|Adverse Event|0
1607956|NCT02151643|5607194|P1|Overall Study|Adverse Event|2
1607959|NCT02151461|5607269|P4|Overall Study|Treatment discontinuation|0
1607960|NCT02151461|5607270|P3|Overall Study|Treatment discontinuation|1
1607961|NCT02151461|5607271|P2|Overall Study|Treatment discontinuation|0
1607962|NCT02151461|5607272|P1|Overall Study|Treatment discontinuation|0
1607963|NCT02151461|5607269|P4|Overall Study|Withdrawal by Subject|1
1607964|NCT02151461|5607270|P3|Overall Study|Withdrawal by Subject|1
1607965|NCT02151461|5607271|P2|Overall Study|Withdrawal by Subject|0
1607966|NCT02151461|5607272|P1|Overall Study|Withdrawal by Subject|1
1607967|NCT02151461|5607269|P4|Overall Study|Lost to Follow-up|1
1607968|NCT02151461|5607270|P3|Overall Study|Lost to Follow-up|1
1607969|NCT02151461|5607271|P2|Overall Study|Lost to Follow-up|0
1607970|NCT02151461|5607272|P1|Overall Study|Lost to Follow-up|0
1607971|NCT02151461|5607269|P4|Overall Study|Adverse Event|2
1607972|NCT02151461|5607270|P3|Overall Study|Adverse Event|0
1607973|NCT02151461|5607271|P2|Overall Study|Adverse Event|1
1607974|NCT02151461|5607272|P1|Overall Study|Adverse Event|5
1607975|NCT02151266|5607404|P3|Overall Study|Not able to exercise|4
1607976|NCT02151266|5607405|P2|Overall Study|Not able to exercise|5
1607977|NCT02151266|5607406|P1|Overall Study|Not able to exercise|4
1607978|NCT02151266|5607404|P3|Overall Study|Did NOT receive intervention|2
1607979|NCT02151266|5607405|P2|Overall Study|Did NOT receive intervention|6
1607980|NCT02151266|5607406|P1|Overall Study|Did NOT receive intervention|3
1607981|NCT02151266|5607404|P3|Overall Study|Lost to Follow-up|1
1607982|NCT02151266|5607405|P2|Overall Study|Lost to Follow-up|4
1607983|NCT02151266|5607406|P1|Overall Study|Lost to Follow-up|1
1607984|NCT02151149|5607449|P2|Follow-Up Period|Death|34
1607985|NCT02151149|5607450|P1|Follow-Up Period|Death|37
1607986|NCT02151149|5607449|P2|Follow-Up Period|Lost to Follow-up|3
1607987|NCT02151149|5607450|P1|Follow-Up Period|Lost to Follow-up|2
1607988|NCT02151149|5607449|P2|Treatment Period|Participants randomized but not treated|2
1607989|NCT02151149|5607450|P1|Treatment Period|Participants randomized but not treated|3
1607990|NCT02151149|5607449|P2|Treatment Period|Miscellaneous|7
1607991|NCT02151149|5607450|P1|Treatment Period|Miscellaneous|8
1607992|NCT02151149|5607449|P2|Treatment Period|Withdrawal by Subject|11
1607993|NCT02151149|5607450|P1|Treatment Period|Withdrawal by Subject|13
1607994|NCT02151149|5607449|P2|Treatment Period|Symptomatic Deterioration|10
1607995|NCT02151149|5607450|P1|Treatment Period|Symptomatic Deterioration|2
1607996|NCT02151149|5607449|P2|Treatment Period|Progressive Disease|24
1607997|NCT02151149|5607450|P1|Treatment Period|Progressive Disease|25
1607998|NCT02151149|5607449|P2|Treatment Period|Adverse Event|14
1607999|NCT02151149|5607450|P1|Treatment Period|Adverse Event|17
1608000|NCT02151149|5607449|P2|Treatment Period|Death|3
1608001|NCT02151149|5607450|P1|Treatment Period|Death|2
1608002|NCT02151110|5607482|P8|Overall Study|Lost to Follow-up|2
1608003|NCT02151110|5607483|P7|Overall Study|Lost to Follow-up|0
1608004|NCT02151110|5607484|P6|Overall Study|Lost to Follow-up|0
1608005|NCT02151110|5607485|P5|Overall Study|Lost to Follow-up|0
1608006|NCT02151110|5607486|P4|Overall Study|Lost to Follow-up|0
1608007|NCT02151110|5607487|P3|Overall Study|Lost to Follow-up|0
1608008|NCT02151110|5607488|P2|Overall Study|Lost to Follow-up|0
1608009|NCT02151110|5607489|P1|Overall Study|Lost to Follow-up|0
1608010|NCT02151110|5607482|P8|Overall Study|Withdrawal by Subject|1
1608011|NCT02151110|5607483|P7|Overall Study|Withdrawal by Subject|0
1608012|NCT02151110|5607484|P6|Overall Study|Withdrawal by Subject|0
1608013|NCT02151110|5607485|P5|Overall Study|Withdrawal by Subject|0
1608014|NCT02151110|5607486|P4|Overall Study|Withdrawal by Subject|0
1608015|NCT02151110|5607487|P3|Overall Study|Withdrawal by Subject|0
1608016|NCT02151110|5607488|P2|Overall Study|Withdrawal by Subject|0
1608017|NCT02151110|5607489|P1|Overall Study|Withdrawal by Subject|0
1608018|NCT02151058|5607582|P3|Overall Study|Lost to Follow-up|2
1608019|NCT02151058|5607583|P2|Overall Study|Lost to Follow-up|0
1608020|NCT02151058|5607584|P1|Overall Study|Lost to Follow-up|1
1608021|NCT02151058|5607582|P3|Overall Study|Withdrawal by Subject|3
1608022|NCT02151058|5607583|P2|Overall Study|Withdrawal by Subject|1
1608023|NCT02151058|5607584|P1|Overall Study|Withdrawal by Subject|1
1608024|NCT02150954|5607618|P2|Overall Study|Protocol Violation|0
1608025|NCT02150954|5607619|P1|Overall Study|Protocol Violation|1
1608026|NCT02150863|5607644|P3|Overall Study|Lost to Follow-up|0
1608027|NCT02150863|5607645|P2|Overall Study|Lost to Follow-up|1
1608028|NCT02150863|5607646|P1|Overall Study|Lost to Follow-up|0
1608029|NCT02150343|5607892|P4|Overall Study|Other|2
1608030|NCT02150343|5607893|P3|Overall Study|Other|0
1608031|NCT02150343|5607894|P2|Overall Study|Other|6
1608032|NCT02150343|5607895|P1|Overall Study|Other|2
1608033|NCT02150343|5607892|P4|Overall Study|Lost to Follow-up|3
1608034|NCT02150343|5607893|P3|Overall Study|Lost to Follow-up|2
1608035|NCT02150343|5607894|P2|Overall Study|Lost to Follow-up|4
1608036|NCT02150343|5607895|P1|Overall Study|Lost to Follow-up|4
1608037|NCT02150343|5607892|P4|Overall Study|Withdrawal by Subject|4
1608038|NCT02150343|5607893|P3|Overall Study|Withdrawal by Subject|9
1608039|NCT02150343|5607894|P2|Overall Study|Withdrawal by Subject|10
1608040|NCT02150343|5607895|P1|Overall Study|Withdrawal by Subject|13
1608041|NCT02150343|5607892|P4|Overall Study|Adverse Event|1
1608042|NCT02150343|5607893|P3|Overall Study|Adverse Event|1
1608043|NCT02150343|5607894|P2|Overall Study|Adverse Event|0
1608044|NCT02150343|5607895|P1|Overall Study|Adverse Event|2
1608045|NCT02150213|5607933|P1|Overall Study|Withdrawal by Subject|1
1608046|NCT02150213|5607933|P1|Overall Study|Lost to Follow-up|1
1608047|NCT02150057|5607952|P2|Overall Study|Lost to Follow-up|4
1608048|NCT02150057|5607953|P1|Overall Study|Lost to Follow-up|6
1608049|NCT02149875|5607968|P3|Overall Study|Physician Decision|2
1608050|NCT02149875|5607969|P2|Overall Study|Physician Decision|2
1608051|NCT02149875|5607970|P1|Overall Study|Physician Decision|1
1608052|NCT02149875|5607968|P3|Overall Study|Withdrawal by Subject|2
1608053|NCT02149875|5607969|P2|Overall Study|Withdrawal by Subject|2
1608054|NCT02149875|5607970|P1|Overall Study|Withdrawal by Subject|3
1608055|NCT02149875|5607968|P3|Overall Study|Lost to Follow-up|5
1608056|NCT02149875|5607969|P2|Overall Study|Lost to Follow-up|4
1608057|NCT02149875|5607970|P1|Overall Study|Lost to Follow-up|3
1608058|NCT02149836|5607981|P1|Overall Study|Withdrawal by Subject|1
1608059|NCT02149420|5608008|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
1608060|NCT02149420|5608009|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
1608061|NCT02149420|5608010|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
1608062|NCT02149420|5608008|P3|Core Study|Administrative problems|2
1608063|NCT02149420|5608009|P2|Core Study|Administrative problems|1
1608064|NCT02149420|5608010|P1|Core Study|Administrative problems|0
1608065|NCT02149264|5608078|P1|Overall Study|Protocol Violation|1
1608066|NCT02149264|5608078|P1|Overall Study|Physician Decision|3
1608067|NCT02149264|5608078|P1|Overall Study|Adverse Event|7
1608068|NCT02149264|5608078|P1|Overall Study|Withdrawal by Subject|9
1608069|NCT02149199|5608094|P3|Overall Study|Adverse Event|9
1608070|NCT02149199|5608095|P2|Overall Study|Adverse Event|15
1608071|NCT02149199|5608096|P1|Overall Study|Adverse Event|6
1608072|NCT02149199|5608094|P3|Overall Study|Death|1
1608073|NCT02149199|5608095|P2|Overall Study|Death|0
1608074|NCT02149199|5608096|P1|Overall Study|Death|0
1608075|NCT02149199|5608094|P3|Overall Study|Lost to Follow-up|11
1608076|NCT02149199|5608095|P2|Overall Study|Lost to Follow-up|12
1608077|NCT02149199|5608096|P1|Overall Study|Lost to Follow-up|3
1608078|NCT02149199|5608094|P3|Overall Study|Protocol Violation|15
1608079|NCT02149199|5608095|P2|Overall Study|Protocol Violation|13
1608080|NCT02149199|5608096|P1|Overall Study|Protocol Violation|16
1608081|NCT02149199|5608094|P3|Overall Study|Withdrawal by Subject|77
1608082|NCT02149199|5608095|P2|Overall Study|Withdrawal by Subject|93
1608083|NCT02149199|5608096|P1|Overall Study|Withdrawal by Subject|75
1608084|NCT02149199|5608094|P3|Overall Study|Eligibility criteria not fulfilled|8
1608085|NCT02149199|5608095|P2|Overall Study|Eligibility criteria not fulfilled|14
1608086|NCT02149199|5608096|P1|Overall Study|Eligibility criteria not fulfilled|9
1608087|NCT02149199|5608094|P3|Overall Study|Other|20
1608088|NCT02149199|5608095|P2|Overall Study|Other|25
1608089|NCT02149199|5608096|P1|Overall Study|Other|20
1608090|NCT02149199|5608094|P3|Overall Study|Study specific withdrawal criteria|6
1608091|NCT02149199|5608095|P2|Overall Study|Study specific withdrawal criteria|21
1608092|NCT02149199|5608096|P1|Overall Study|Study specific withdrawal criteria|4
1608093|NCT02149108|5608175|P2|Overall Study|Lost to Follow-up|0
1608094|NCT02149108|5608176|P1|Overall Study|Lost to Follow-up|1
1608095|NCT02149108|5608175|P2|Overall Study|Refusal to continue trial medication|11
1608096|NCT02149108|5608176|P1|Overall Study|Refusal to continue trial medication|15
1608097|NCT02149108|5608175|P2|Overall Study|Other not defined above|2
1608098|NCT02149108|5608176|P1|Overall Study|Other not defined above|0
1608099|NCT02149108|5608175|P2|Overall Study|Other Adverse Event (AE)|18
1608100|NCT02149108|5608176|P1|Overall Study|Other Adverse Event (AE)|8
1608101|NCT02149108|5608175|P2|Overall Study|Worsening/adverse event cancer disease|32
1608102|NCT02149108|5608176|P1|Overall Study|Worsening/adverse event cancer disease|31
1608103|NCT02149108|5608175|P2|Overall Study|Progressive Disease (PD)|318
1608104|NCT02149108|5608176|P1|Overall Study|Progressive Disease (PD)|324
1608105|NCT02149108|5608175|P2|Overall Study|Not treated|2
1608106|NCT02149108|5608176|P1|Overall Study|Not treated|1
1608107|NCT02148952|5608190|P2|Follow-Up|Withdrawal by Subject|48
1608108|NCT02148952|5608191|P1|Follow-Up|Withdrawal by Subject|46
1608109|NCT02148952|5608190|P2|Follow-Up|Lost to Follow-up|231
1608110|NCT02148952|5608191|P1|Follow-Up|Lost to Follow-up|219
1608111|NCT02148952|5608190|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
1608112|NCT02148952|5608191|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
1608113|NCT02148952|5608190|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
1608114|NCT02148952|5608191|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
1608115|NCT02148718|5608274|P1|Overall Study|Discontinued Study Prematurely|5
1608116|NCT02148718|5608274|P1|Overall Study|Protocol Violation|26
1608117|NCT02148445|5608322|P2|Overall Study|Death|3
1608118|NCT02148445|5608323|P1|Overall Study|Death|1
1608119|NCT02148133|5608359|P1|Overall Study|Protocol-defined stopping criteria|2
1608120|NCT02148133|5608359|P1|Overall Study|Protocol deviation|1
1608121|NCT02148133|5608359|P1|Overall Study|Lack of Efficacy|1
1608122|NCT02148133|5608359|P1|Overall Study|Investigator discretion|1
1608123|NCT02147691|5608430|P2|Overall Study|Lost to Follow-up|1
1608124|NCT02147691|5608431|P1|Overall Study|Lost to Follow-up|0
1608125|NCT02147691|5608430|P2|Overall Study|Adverse Event|0
1608126|NCT02147691|5608431|P1|Overall Study|Adverse Event|2
1608127|NCT02147691|5608430|P2|Overall Study|Withdrawal by Subject|0
1608128|NCT02147691|5608431|P1|Overall Study|Withdrawal by Subject|2
1608129|NCT02147587|5608490|P2|Overall Study|Lack of Efficacy|1
1608130|NCT02147587|5608491|P1|Overall Study|Lack of Efficacy|2
1608131|NCT02147587|5608490|P2|Overall Study|Adverse Event|4
1608132|NCT02147587|5608491|P1|Overall Study|Adverse Event|9
1608133|NCT02147561|5608511|P1|Overall Study|Subjects who didn’t receive BOTOX|1
1608134|NCT02147561|5608511|P1|Overall Study|Lost to Follow-up|3
1608135|NCT02147353|5608532|P2|Overall Study|medication noncompliance|0
1608136|NCT02147353|5608533|P1|Overall Study|medication noncompliance|3
1608137|NCT02147353|5608532|P2|Overall Study|unable to make visits|0
1608138|NCT02147353|5608533|P1|Overall Study|unable to make visits|4
1608139|NCT02147353|5608532|P2|Overall Study|Lost to Follow-up|0
1608140|NCT02147353|5608533|P1|Overall Study|Lost to Follow-up|2
1608141|NCT02147288|5608566|P10|Overall Study|complications from concurrent hernia rep|0
1608142|NCT02147288|5608567|P9|Overall Study|complications from concurrent hernia rep|0
1608143|NCT02147288|5608568|P8|Overall Study|complications from concurrent hernia rep|0
1608144|NCT02147288|5608569|P7|Overall Study|complications from concurrent hernia rep|0
1608145|NCT02147288|5608570|P6|Overall Study|complications from concurrent hernia rep|0
1608146|NCT02147288|5608571|P5|Overall Study|complications from concurrent hernia rep|0
1608147|NCT02147288|5608572|P4|Overall Study|complications from concurrent hernia rep|0
1608148|NCT02147288|5608573|P3|Overall Study|complications from concurrent hernia rep|0
1608149|NCT02147288|5608574|P2|Overall Study|complications from concurrent hernia rep|1
1608150|NCT02147288|5608575|P1|Overall Study|complications from concurrent hernia rep|0
1608151|NCT02147288|5608566|P10|Overall Study|post-operative hematoma|0
1608152|NCT02147288|5608567|P9|Overall Study|post-operative hematoma|0
1608153|NCT02147288|5608568|P8|Overall Study|post-operative hematoma|0
1608154|NCT02147288|5608569|P7|Overall Study|post-operative hematoma|0
1608155|NCT02147288|5608570|P6|Overall Study|post-operative hematoma|0
1608156|NCT02147288|5608571|P5|Overall Study|post-operative hematoma|0
1608157|NCT02147288|5608572|P4|Overall Study|post-operative hematoma|0
1608158|NCT02147288|5608573|P3|Overall Study|post-operative hematoma|0
1608159|NCT02147288|5608574|P2|Overall Study|post-operative hematoma|1
1608160|NCT02147288|5608575|P1|Overall Study|post-operative hematoma|1
1608161|NCT02147197|5608584|P3|Overall Study|Other Miscellaneous Reasons|3
1608162|NCT02147197|5608585|P2|Overall Study|Other Miscellaneous Reasons|0
1608163|NCT02147197|5608586|P1|Overall Study|Other Miscellaneous Reasons|1
1608164|NCT02147197|5608584|P3|Overall Study|Protocol Violation|3
1608165|NCT02147197|5608585|P2|Overall Study|Protocol Violation|0
1608166|NCT02147197|5608586|P1|Overall Study|Protocol Violation|1
1608167|NCT02147197|5608584|P3|Overall Study|Lost to Follow-up|1
1608168|NCT02147197|5608585|P2|Overall Study|Lost to Follow-up|3
1608169|NCT02147197|5608586|P1|Overall Study|Lost to Follow-up|2
1608170|NCT02147197|5608584|P3|Overall Study|Withdrawal of Consent|2
1608171|NCT02147197|5608585|P2|Overall Study|Withdrawal of Consent|3
1608172|NCT02147197|5608586|P1|Overall Study|Withdrawal of Consent|4
1608173|NCT02147197|5608584|P3|Overall Study|Adverse Event|0
1608174|NCT02147197|5608585|P2|Overall Study|Adverse Event|0
1608175|NCT02147197|5608586|P1|Overall Study|Adverse Event|1
1608176|NCT02147184|5608605|P2|Overall Study|Other|0
1608177|NCT02147184|5608606|P1|Overall Study|Other|1
1608178|NCT02147184|5608605|P2|Overall Study|Physician Decision|2
1608179|NCT02147184|5608606|P1|Overall Study|Physician Decision|0
1608180|NCT02147184|5608605|P2|Overall Study|Moved out of state|3
1608181|NCT02147184|5608606|P1|Overall Study|Moved out of state|3
1608182|NCT02147184|5608605|P2|Overall Study|Pregnancy|0
1608183|NCT02147184|5608606|P1|Overall Study|Pregnancy|6
1608184|NCT02147184|5608605|P2|Overall Study|Study Burden|7
1608185|NCT02147184|5608606|P1|Overall Study|Study Burden|11
1608186|NCT02147184|5608605|P2|Overall Study|Lost to Follow-up|15
1608187|NCT02147184|5608606|P1|Overall Study|Lost to Follow-up|28
1608188|NCT02147158|5608630|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
1608189|NCT02147158|5608631|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
1608190|NCT02147158|5608632|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
1608191|NCT02147158|5608633|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
1608192|NCT02147158|5608634|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
1608193|NCT02147158|5608635|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
1608194|NCT02147158|5608630|P6|Off-Treatment Interval 2|Protocol Violation|0
1608195|NCT02147158|5608631|P5|Off-Treatment Interval 2|Protocol Violation|0
1608196|NCT02147158|5608632|P4|Off-Treatment Interval 2|Protocol Violation|1
1608197|NCT02147158|5608633|P3|Off-Treatment Interval 2|Protocol Violation|0
1608198|NCT02147158|5608634|P2|Off-Treatment Interval 2|Protocol Violation|0
1608199|NCT02147158|5608635|P1|Off-Treatment Interval 2|Protocol Violation|0
1608200|NCT02147158|5608630|P6|Off-Treatment Interval 2|Lost to Follow-up|2
1608201|NCT02147158|5608631|P5|Off-Treatment Interval 2|Lost to Follow-up|2
1608202|NCT02147158|5608632|P4|Off-Treatment Interval 2|Lost to Follow-up|2
1608203|NCT02147158|5608633|P3|Off-Treatment Interval 2|Lost to Follow-up|3
1608204|NCT02147158|5608634|P2|Off-Treatment Interval 2|Lost to Follow-up|0
1608205|NCT02147158|5608635|P1|Off-Treatment Interval 2|Lost to Follow-up|0
1608206|NCT02147158|5608630|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
1608207|NCT02147158|5608631|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
1608208|NCT02147158|5608632|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
1608209|NCT02147158|5608633|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
1608210|NCT02147158|5608634|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
1608211|NCT02147158|5608635|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
1608212|NCT02147158|5608630|P6|Off-Treatment Interval 2|Lack of Efficacy|0
1608213|NCT02147158|5608631|P5|Off-Treatment Interval 2|Lack of Efficacy|0
1608214|NCT02147158|5608632|P4|Off-Treatment Interval 2|Lack of Efficacy|0
1608215|NCT02147158|5608633|P3|Off-Treatment Interval 2|Lack of Efficacy|1
1608216|NCT02147158|5608634|P2|Off-Treatment Interval 2|Lack of Efficacy|1
1608217|NCT02147158|5608635|P1|Off-Treatment Interval 2|Lack of Efficacy|0
1608218|NCT02147158|5608630|P6|Treatment Course 2|Lost to Follow-up|1
1608219|NCT02147158|5608631|P5|Treatment Course 2|Lost to Follow-up|0
1608220|NCT02147158|5608632|P4|Treatment Course 2|Lost to Follow-up|1
1608221|NCT02147158|5608633|P3|Treatment Course 2|Lost to Follow-up|1
1608222|NCT02147158|5608634|P2|Treatment Course 2|Lost to Follow-up|0
1608223|NCT02147158|5608635|P1|Treatment Course 2|Lost to Follow-up|1
1608224|NCT02147158|5608630|P6|Treatment Course 2|Withdrawal of Consent|0
1608225|NCT02147158|5608631|P5|Treatment Course 2|Withdrawal of Consent|0
1608226|NCT02147158|5608632|P4|Treatment Course 2|Withdrawal of Consent|3
1608227|NCT02147158|5608633|P3|Treatment Course 2|Withdrawal of Consent|2
1608228|NCT02147158|5608634|P2|Treatment Course 2|Withdrawal of Consent|1
1608229|NCT02147158|5608635|P1|Treatment Course 2|Withdrawal of Consent|0
1608230|NCT02147158|5608630|P6|Treatment Course 2|Adverse Event|1
1608231|NCT02147158|5608631|P5|Treatment Course 2|Adverse Event|0
1608232|NCT02147158|5608632|P4|Treatment Course 2|Adverse Event|1
1608233|NCT02147158|5608633|P3|Treatment Course 2|Adverse Event|2
1608234|NCT02147158|5608634|P2|Treatment Course 2|Adverse Event|4
1608235|NCT02147158|5608635|P1|Treatment Course 2|Adverse Event|0
1608236|NCT02147158|5608630|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
1608237|NCT02147158|5608631|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
1608238|NCT02147158|5608632|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
1608239|NCT02147158|5608633|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
1608240|NCT02147158|5608634|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
1608241|NCT02147158|5608635|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
1608242|NCT02147158|5608630|P6|Off-Treatment Interval 1|Lack of Efficacy|0
1608243|NCT02147158|5608631|P5|Off-Treatment Interval 1|Lack of Efficacy|1
1608244|NCT02147158|5608632|P4|Off-Treatment Interval 1|Lack of Efficacy|0
1608245|NCT02147158|5608633|P3|Off-Treatment Interval 1|Lack of Efficacy|2
1608246|NCT02147158|5608634|P2|Off-Treatment Interval 1|Lack of Efficacy|0
1608247|NCT02147158|5608635|P1|Off-Treatment Interval 1|Lack of Efficacy|0
1608248|NCT02147158|5608630|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
1608249|NCT02147158|5608631|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
1608250|NCT02147158|5608632|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
1608251|NCT02147158|5608633|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
1608252|NCT02147158|5608634|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
1608253|NCT02147158|5608635|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
1608254|NCT02147158|5608630|P6|Off-Treatment Interval 1|Protocol Violation|0
1608255|NCT02147158|5608631|P5|Off-Treatment Interval 1|Protocol Violation|1
1608256|NCT02147158|5608632|P4|Off-Treatment Interval 1|Protocol Violation|0
1608257|NCT02147158|5608633|P3|Off-Treatment Interval 1|Protocol Violation|2
1608258|NCT02147158|5608634|P2|Off-Treatment Interval 1|Protocol Violation|0
1608259|NCT02147158|5608635|P1|Off-Treatment Interval 1|Protocol Violation|1
1608260|NCT02147158|5608630|P6|Off-Treatment Interval 1|Lost to Follow-up|2
1608261|NCT02147158|5608631|P5|Off-Treatment Interval 1|Lost to Follow-up|4
1608262|NCT02147158|5608632|P4|Off-Treatment Interval 1|Lost to Follow-up|2
1608263|NCT02147158|5608633|P3|Off-Treatment Interval 1|Lost to Follow-up|3
1608264|NCT02147158|5608634|P2|Off-Treatment Interval 1|Lost to Follow-up|1
1608265|NCT02147158|5608635|P1|Off-Treatment Interval 1|Lost to Follow-up|2
1608266|NCT02147158|5608630|P6|Off-Treatment Interval 1|Adverse Event|0
1608267|NCT02147158|5608631|P5|Off-Treatment Interval 1|Adverse Event|0
1608268|NCT02147158|5608632|P4|Off-Treatment Interval 1|Adverse Event|1
1608269|NCT02147158|5608633|P3|Off-Treatment Interval 1|Adverse Event|0
1608270|NCT02147158|5608634|P2|Off-Treatment Interval 1|Adverse Event|0
1608271|NCT02147158|5608635|P1|Off-Treatment Interval 1|Adverse Event|1
1608272|NCT02147158|5608630|P6|Treatment Course 1|Withdrawal of Consent|2
1608273|NCT02147158|5608631|P5|Treatment Course 1|Withdrawal of Consent|3
1608274|NCT02147158|5608632|P4|Treatment Course 1|Withdrawal of Consent|5
1608275|NCT02147158|5608633|P3|Treatment Course 1|Withdrawal of Consent|1
1608276|NCT02147158|5608634|P2|Treatment Course 1|Withdrawal of Consent|1
1608277|NCT02147158|5608635|P1|Treatment Course 1|Withdrawal of Consent|1
1608278|NCT02147158|5608630|P6|Treatment Course 1|Protocol Violation|0
1608279|NCT02147158|5608631|P5|Treatment Course 1|Protocol Violation|0
1608280|NCT02147158|5608632|P4|Treatment Course 1|Protocol Violation|1
1608281|NCT02147158|5608633|P3|Treatment Course 1|Protocol Violation|1
1608282|NCT02147158|5608634|P2|Treatment Course 1|Protocol Violation|0
1608283|NCT02147158|5608635|P1|Treatment Course 1|Protocol Violation|0
1608284|NCT02147158|5608630|P6|Treatment Course 1|Lost to Follow-up|4
1608285|NCT02147158|5608631|P5|Treatment Course 1|Lost to Follow-up|2
1608286|NCT02147158|5608632|P4|Treatment Course 1|Lost to Follow-up|3
1608287|NCT02147158|5608633|P3|Treatment Course 1|Lost to Follow-up|3
1608288|NCT02147158|5608634|P2|Treatment Course 1|Lost to Follow-up|4
1608289|NCT02147158|5608635|P1|Treatment Course 1|Lost to Follow-up|2
1608290|NCT02147158|5608630|P6|Treatment Course 1|Adverse Event|2
1608291|NCT02147158|5608631|P5|Treatment Course 1|Adverse Event|1
1608292|NCT02147158|5608632|P4|Treatment Course 1|Adverse Event|4
1608293|NCT02147158|5608633|P3|Treatment Course 1|Adverse Event|3
1608294|NCT02147158|5608634|P2|Treatment Course 1|Adverse Event|4
1608295|NCT02147158|5608635|P1|Treatment Course 1|Adverse Event|1
1608296|NCT02147132|5608664|P4|Overall Study|Lost to Follow-up|0
1608297|NCT02147132|5608665|P3|Overall Study|Lost to Follow-up|0
1608298|NCT02147132|5608666|P2|Overall Study|Lost to Follow-up|0
1608299|NCT02147132|5608667|P1|Overall Study|Lost to Follow-up|1
1608300|NCT02147093|5608687|P2|Period 2|Protocol Violation|0
1608301|NCT02147093|5608688|P1|Period 2|Protocol Violation|2
1608302|NCT02147093|5608687|P2|Period 1|Lost to Follow-up|1
1608303|NCT02147093|5608688|P1|Period 1|Lost to Follow-up|0
1608304|NCT02147067|5608698|P2|Overall Study|Withdrawal by Subject|2
1608305|NCT02147067|5608699|P1|Overall Study|Withdrawal by Subject|2
1608306|NCT02146599|5608725|P1|Overall Study|Failed to meet inclusion criteria|5
1608339|NCT02146352|5608877|P1|Overall Study|Patient entered hospice care|1
1608340|NCT02146352|5608877|P1|Overall Study|Death|1
1608341|NCT02146326|5608895|P4|Overall Study|Unable to complete interview|6
1608342|NCT02146326|5608896|P3|Overall Study|Unable to complete interview|10
1608343|NCT02146326|5608897|P2|Overall Study|Unable to complete interview|0
1608344|NCT02146326|5608898|P1|Overall Study|Unable to complete interview|0
1608345|NCT02146326|5608895|P4|Overall Study|Death|4
1608346|NCT02146326|5608896|P3|Overall Study|Death|4
1608347|NCT02146326|5608897|P2|Overall Study|Death|0
1608348|NCT02146326|5608898|P1|Overall Study|Death|0
1608349|NCT02146326|5608895|P4|Overall Study|Incarcerated|8
1608350|NCT02146326|5608896|P3|Overall Study|Incarcerated|3
1608351|NCT02146326|5608897|P2|Overall Study|Incarcerated|0
1608352|NCT02146326|5608898|P1|Overall Study|Incarcerated|0
1608353|NCT02146326|5608895|P4|Overall Study|Separated from mental health center|0
1608354|NCT02146326|5608896|P3|Overall Study|Separated from mental health center|0
1608355|NCT02146326|5608897|P2|Overall Study|Separated from mental health center|33
1608356|NCT02146326|5608898|P1|Overall Study|Separated from mental health center|23
1608357|NCT02146326|5608895|P4|Overall Study|Withdrawal by Subject|11
1608358|NCT02146326|5608896|P3|Overall Study|Withdrawal by Subject|15
1608359|NCT02146326|5608897|P2|Overall Study|Withdrawal by Subject|1
1608360|NCT02146326|5608898|P1|Overall Study|Withdrawal by Subject|2
1608361|NCT02146326|5608895|P4|Overall Study|Lost to Follow-up|19
1608362|NCT02146326|5608896|P3|Overall Study|Lost to Follow-up|11
1608363|NCT02146326|5608897|P2|Overall Study|Lost to Follow-up|3
1608364|NCT02146326|5608898|P1|Overall Study|Lost to Follow-up|3
1608365|NCT02146274|5609060|P1|Overall Study|Protocol Violation|73
1608366|NCT02146248|5609067|P1|Overall Study|Withdrawal by Subject|2
1608367|NCT02146131|5609077|P2|Overall Study|Physician Decision|56
1608368|NCT02146131|5609078|P1|Overall Study|Physician Decision|61
1608369|NCT02146105|5609084|P1|Overall Study|Withdrawal by Subject|5
1608370|NCT02146105|5609084|P1|Overall Study|Adverse Event|1
1608371|NCT02145468|5609135|P2|Overall Study|Withdrawal by Subject|8
1608372|NCT02145468|5609136|P1|Overall Study|Withdrawal by Subject|5
1608373|NCT02145429|5609194|P2|Overall Study|Withdrawal by Subject|3
1608374|NCT02145429|5609195|P1|Overall Study|Withdrawal by Subject|8
1608375|NCT02145429|5609194|P2|Overall Study|Lost to Follow-up|3
1608376|NCT02145429|5609195|P1|Overall Study|Lost to Follow-up|4
1608377|NCT02145429|5609194|P2|Overall Study|Death|5
1608378|NCT02145429|5609195|P1|Overall Study|Death|4
1608379|NCT02145390|5609226|P1|Overall Study|Withdrawal by Subject|1
1608380|NCT02145182|5609275|P2|Overall Study|Withdrawal by Subject|4
1608381|NCT02145182|5609276|P1|Overall Study|Withdrawal by Subject|5
1608382|NCT02145182|5609275|P2|Overall Study|Pre-transplant Withdrawal|2
1608383|NCT02145182|5609276|P1|Overall Study|Pre-transplant Withdrawal|0
1608384|NCT02145182|5609275|P2|Overall Study|Lost to Follow-up|2
1608385|NCT02145182|5609276|P1|Overall Study|Lost to Follow-up|2
1608386|NCT02145182|5609275|P2|Overall Study|Death|7
1608387|NCT02145182|5609276|P1|Overall Study|Death|7
1608388|NCT02145182|5609275|P2|Overall Study|Adverse Event|1
1608389|NCT02145182|5609276|P1|Overall Study|Adverse Event|4
1608390|NCT02145156|5609293|P3|Overall Study|No match to vaccination records|41
1608391|NCT02145156|5609294|P2|Overall Study|No match to vaccination records|52
1608392|NCT02145156|5609295|P1|Overall Study|No match to vaccination records|60
1608393|NCT02144701|5609369|P2|Overall Study|development of relapse, GVHD or death|3
1608394|NCT02144701|5609370|P1|Overall Study|development of relapse, GVHD or death|9
1608395|NCT02144610|5609397|P2|Overall Study|Other|1
1608396|NCT02144610|5609398|P1|Overall Study|Other|0
1608397|NCT02144610|5609397|P2|Overall Study|Study Discontinuation by Sponsor|14
1608398|NCT02144610|5609398|P1|Overall Study|Study Discontinuation by Sponsor|19
1608399|NCT02144610|5609397|P2|Overall Study|Death|2
1608400|NCT02144610|5609398|P1|Overall Study|Death|2
1608401|NCT02144610|5609397|P2|Overall Study|Withdrawal by Subject|5
1608402|NCT02144610|5609398|P1|Overall Study|Withdrawal by Subject|1
1608403|NCT02144610|5609397|P2|Overall Study|Physician Decision|0
1608404|NCT02144610|5609398|P1|Overall Study|Physician Decision|1
1608405|NCT02144337|5609439|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
1608406|NCT02144337|5609440|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
1608407|NCT02144337|5609439|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
1608408|NCT02144337|5609440|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
1608409|NCT02144337|5609439|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
1608410|NCT02144337|5609440|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
1608411|NCT02144337|5609439|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
1608412|NCT02144337|5609440|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
1608413|NCT02144337|5609439|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1608414|NCT02144337|5609440|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
1608415|NCT02144285|5609460|P10|Overall Study|Withdrawal by Subject|0
1608416|NCT02144285|5609461|P9|Overall Study|Withdrawal by Subject|0
1608417|NCT02144285|5609462|P8|Overall Study|Withdrawal by Subject|0
1608418|NCT02144285|5609463|P7|Overall Study|Withdrawal by Subject|0
1608419|NCT02144285|5609464|P6|Overall Study|Withdrawal by Subject|0
1608420|NCT02144285|5609465|P5|Overall Study|Withdrawal by Subject|1
1608421|NCT02144285|5609466|P4|Overall Study|Withdrawal by Subject|0
1608422|NCT02144285|5609467|P3|Overall Study|Withdrawal by Subject|0
1608423|NCT02144285|5609468|P2|Overall Study|Withdrawal by Subject|0
1608424|NCT02144285|5609469|P1|Overall Study|Withdrawal by Subject|0
1608425|NCT02144220|5609558|P1|Overall Study|Protocol Violation|1
1608426|NCT02144220|5609558|P1|Overall Study|Withdrawal by Subject|2
1608427|NCT02144220|5609558|P1|Overall Study|Physician Decision|3
1608428|NCT02144220|5609558|P1|Overall Study|Lack of Efficacy|4
1608429|NCT02144220|5609558|P1|Overall Study|technology incompatibility|9
1608430|NCT02144077|5609577|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
1608431|NCT02144077|5609578|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
1608432|NCT02144077|5609577|P2|Overall Study|Death|1
1608433|NCT02144077|5609578|P1|Overall Study|Death|0
1608434|NCT02144077|5609577|P2|Overall Study|Protocol Violation|2
1608435|NCT02144077|5609578|P1|Overall Study|Protocol Violation|1
1608436|NCT02144077|5609577|P2|Overall Study|Lost to Follow-up|2
1608437|NCT02144077|5609578|P1|Overall Study|Lost to Follow-up|2
1608438|NCT02144077|5609577|P2|Overall Study|Adverse Event|3
1608439|NCT02144077|5609578|P1|Overall Study|Adverse Event|2
1608440|NCT02144077|5609577|P2|Overall Study|Withdrawal by Subject|3
1608441|NCT02144077|5609578|P1|Overall Study|Withdrawal by Subject|3
1608442|NCT02144012|5609596|P2|Overall Study|Other|0
1608443|NCT02144012|5609597|P1|Overall Study|Other|3
1608444|NCT02144012|5609596|P2|Overall Study|Study Terminated by Sponsor|12
1608445|NCT02144012|5609597|P1|Overall Study|Study Terminated by Sponsor|18
1608446|NCT02144012|5609596|P2|Overall Study|Withdrawal by Subject|3
1608447|NCT02144012|5609597|P1|Overall Study|Withdrawal by Subject|11
1608448|NCT02144012|5609596|P2|Overall Study|Death|0
1608449|NCT02144012|5609597|P1|Overall Study|Death|1
1608450|NCT02144012|5609596|P2|Overall Study|Adverse Event|0
1608451|NCT02144012|5609597|P1|Overall Study|Adverse Event|1
1608452|NCT02143947|5609634|P2|Overall Study|Lost to Follow-up|2
1608453|NCT02143947|5609635|P1|Overall Study|Lost to Follow-up|4
1608454|NCT02143843|5609647|P1|Overall Study|Withdrawal by Subject|2
1608455|NCT02143843|5609647|P1|Overall Study|Lack of Efficacy|2
1608456|NCT02143843|5609647|P1|Overall Study|Adverse Event|8
1608457|NCT02143778|5609652|P1|Overall Study|Device malfunction|1
1608458|NCT02143778|5609652|P1|Overall Study|Withdrawal by Subject|2
1608459|NCT02143713|5609661|P4|Post-treatment Follow-up (12 Months)|Other|7
1608460|NCT02143713|5609662|P3|Post-treatment Follow-up (12 Months)|Other|7
1608461|NCT02143713|5609663|P2|Post-treatment Follow-up (12 Months)|Other|4
1608462|NCT02143713|5609664|P1|Post-treatment Follow-up (12 Months)|Other|3
1608463|NCT02143713|5609661|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
1608464|NCT02143713|5609662|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
1608465|NCT02143713|5609663|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
1608466|NCT02143713|5609664|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
1608467|NCT02143713|5609661|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
1608468|NCT02143713|5609662|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
1608469|NCT02143713|5609663|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
1608470|NCT02143713|5609664|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
1608471|NCT02143713|5609661|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
1608472|NCT02143713|5609662|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
1608473|NCT02143713|5609663|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
1608474|NCT02143713|5609664|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
1608475|NCT02143713|5609661|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
1608476|NCT02143713|5609662|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
1608477|NCT02143713|5609663|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
1608478|NCT02143713|5609664|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
1608479|NCT02143713|5609661|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
1608480|NCT02143713|5609662|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1608481|NCT02143713|5609663|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
1608482|NCT02143713|5609664|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
1608483|NCT02143713|5609661|P4|Treatment Period (6 Months)|Lack of Efficacy|1
1608484|NCT02143713|5609662|P3|Treatment Period (6 Months)|Lack of Efficacy|0
1608485|NCT02143713|5609663|P2|Treatment Period (6 Months)|Lack of Efficacy|0
1608486|NCT02143713|5609664|P1|Treatment Period (6 Months)|Lack of Efficacy|1
1608487|NCT02143713|5609661|P4|Treatment Period (6 Months)|Exclusionary Medication|0
1608488|NCT02143713|5609662|P3|Treatment Period (6 Months)|Exclusionary Medication|0
1608489|NCT02143713|5609663|P2|Treatment Period (6 Months)|Exclusionary Medication|0
1608490|NCT02143713|5609664|P1|Treatment Period (6 Months)|Exclusionary Medication|2
1608491|NCT02143713|5609661|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
1608492|NCT02143713|5609662|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1608493|NCT02143713|5609663|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1608494|NCT02143713|5609664|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
1608495|NCT02143713|5609661|P4|Treatment Period (6 Months)|Other|2
1608496|NCT02143713|5609662|P3|Treatment Period (6 Months)|Other|3
1608497|NCT02143713|5609663|P2|Treatment Period (6 Months)|Other|0
1608498|NCT02143713|5609664|P1|Treatment Period (6 Months)|Other|3
1608499|NCT02143713|5609661|P4|Treatment Period (6 Months)|Non-compliance|3
1608500|NCT02143713|5609662|P3|Treatment Period (6 Months)|Non-compliance|0
1608501|NCT02143713|5609663|P2|Treatment Period (6 Months)|Non-compliance|0
1608502|NCT02143713|5609664|P1|Treatment Period (6 Months)|Non-compliance|1
1608503|NCT02143713|5609661|P4|Treatment Period (6 Months)|Pregnancy|0
1608504|NCT02143713|5609662|P3|Treatment Period (6 Months)|Pregnancy|2
1608505|NCT02143713|5609663|P2|Treatment Period (6 Months)|Pregnancy|2
1608506|NCT02143713|5609664|P1|Treatment Period (6 Months)|Pregnancy|0
1608507|NCT02143713|5609661|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
1608508|NCT02143713|5609662|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
1608509|NCT02143713|5609663|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
1608510|NCT02143713|5609664|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
1608511|NCT02143713|5609661|P4|Treatment Period (6 Months)|Lost to Follow-up|3
1608512|NCT02143713|5609662|P3|Treatment Period (6 Months)|Lost to Follow-up|4
1608513|NCT02143713|5609663|P2|Treatment Period (6 Months)|Lost to Follow-up|0
1608514|NCT02143713|5609664|P1|Treatment Period (6 Months)|Lost to Follow-up|3
1608515|NCT02143713|5609661|P4|Treatment Period (6 Months)|Adverse Event|9
1608516|NCT02143713|5609662|P3|Treatment Period (6 Months)|Adverse Event|8
1608517|NCT02143713|5609663|P2|Treatment Period (6 Months)|Adverse Event|8
1608518|NCT02143713|5609664|P1|Treatment Period (6 Months)|Adverse Event|7
1608519|NCT02143713|5609661|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
1608520|NCT02143713|5609662|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
1608521|NCT02143713|5609663|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
1608522|NCT02143713|5609664|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
1608523|NCT02143583|5609745|P3|Overall Study|husband illness|1
1608524|NCT02143583|5609746|P2|Overall Study|husband illness|0
1608525|NCT02143583|5609747|P1|Overall Study|husband illness|0
1608526|NCT02143583|5609745|P3|Overall Study|Withdrawal by Subject|1
1608527|NCT02143583|5609746|P2|Overall Study|Withdrawal by Subject|0
1608528|NCT02143583|5609747|P1|Overall Study|Withdrawal by Subject|1
1608529|NCT02143141|5609770|P2|Overall Study|pain scores at 24 hours not collected|0
1608530|NCT02143141|5609771|P1|Overall Study|pain scores at 24 hours not collected|1
1608531|NCT02143102|5609783|P2|Overall Study|Lost to Follow-up|0
1608532|NCT02143102|5609784|P1|Overall Study|Lost to Follow-up|11
1608533|NCT02143024|5609794|P2|Overall Study|Withdrawal by Subject|0
1608534|NCT02143024|5609795|P1|Overall Study|Withdrawal by Subject|1
1608535|NCT02143024|5609794|P2|Overall Study|Lost to Follow-up|1
1608536|NCT02143024|5609795|P1|Overall Study|Lost to Follow-up|1
1608537|NCT02142894|5609801|P1|Overall Study|Protocol Violation|8
1608538|NCT02142738|5609807|P2|Overall Study|Ongoing in Study|82
1608539|NCT02142738|5609808|P1|Overall Study|Ongoing in Study|107
1608540|NCT02142738|5609807|P2|Overall Study|Withdrawal by Subject|5
1608541|NCT02142738|5609808|P1|Overall Study|Withdrawal by Subject|5
1608542|NCT02142738|5609807|P2|Overall Study|Progressive Disease|1
1608543|NCT02142738|5609808|P1|Overall Study|Progressive Disease|0
1608544|NCT02142738|5609807|P2|Overall Study|Death|55
1608545|NCT02142738|5609808|P1|Overall Study|Death|33
1608546|NCT02142738|5609807|P2|Overall Study|Adverse Event|8
1608547|NCT02142738|5609808|P1|Overall Study|Adverse Event|9
1608548|NCT02142712|5609821|P4|Overall Study|Lost to Follow-up|0
1608549|NCT02142712|5609822|P3|Overall Study|Lost to Follow-up|1
1608550|NCT02142712|5609823|P2|Overall Study|Lost to Follow-up|1
1608551|NCT02142712|5609824|P1|Overall Study|Lost to Follow-up|1
1608552|NCT02142504|5609847|P3|Overall Study|Reason Not Specified|4
1608553|NCT02142504|5609848|P2|Overall Study|Reason Not Specified|5
1608554|NCT02142504|5609849|P1|Overall Study|Reason Not Specified|4
1608555|NCT02142504|5609847|P3|Overall Study|Physician Decision|3
1608556|NCT02142504|5609848|P2|Overall Study|Physician Decision|1
1608557|NCT02142504|5609849|P1|Overall Study|Physician Decision|0
1608558|NCT02142504|5609847|P3|Overall Study|Pregnancy|2
1608559|NCT02142504|5609848|P2|Overall Study|Pregnancy|4
1608560|NCT02142504|5609849|P1|Overall Study|Pregnancy|4
1608561|NCT02142504|5609847|P3|Overall Study|Withdrawal by Subject|11
1608562|NCT02142504|5609848|P2|Overall Study|Withdrawal by Subject|9
1608563|NCT02142504|5609849|P1|Overall Study|Withdrawal by Subject|7
1608564|NCT02142504|5609847|P3|Overall Study|Lost to Follow-up|17
1608565|NCT02142504|5609848|P2|Overall Study|Lost to Follow-up|19
1608566|NCT02142504|5609849|P1|Overall Study|Lost to Follow-up|12
1608567|NCT02142504|5609847|P3|Overall Study|Adverse Event|4
1608568|NCT02142504|5609848|P2|Overall Study|Adverse Event|3
1608569|NCT02142504|5609849|P1|Overall Study|Adverse Event|2
1608570|NCT02142504|5609847|P3|Overall Study|Protocol Violation|2
1608571|NCT02142504|5609848|P2|Overall Study|Protocol Violation|1
1608572|NCT02142504|5609849|P1|Overall Study|Protocol Violation|2
1608573|NCT02142283|5610038|P2|Overall Study|Withdrawal by Subject|3
1608574|NCT02142283|5610039|P1|Overall Study|Withdrawal by Subject|1
1608575|NCT02142283|5610038|P2|Overall Study|Death|18
1608576|NCT02142283|5610039|P1|Overall Study|Death|20
1608577|NCT02141997|5610148|P4|Overall Study|Other|0
1608578|NCT02141997|5610149|P3|Overall Study|Other|0
1608579|NCT02141997|5610150|P2|Overall Study|Other|4
1608580|NCT02141997|5610151|P1|Overall Study|Other|1
1608581|NCT02141997|5610148|P4|Overall Study|Withdrew consent|0
1608582|NCT02141997|5610149|P3|Overall Study|Withdrew consent|3
1608583|NCT02141997|5610150|P2|Overall Study|Withdrew consent|0
1608584|NCT02141997|5610151|P1|Overall Study|Withdrew consent|1
1608585|NCT02141997|5610148|P4|Overall Study|Participant noncompliance|0
1608586|NCT02141997|5610149|P3|Overall Study|Participant noncompliance|0
1608587|NCT02141997|5610150|P2|Overall Study|Participant noncompliance|0
1608588|NCT02141997|5610151|P1|Overall Study|Participant noncompliance|1
1608589|NCT02141997|5610148|P4|Overall Study|Adverse Event|1
1608590|NCT02141997|5610149|P3|Overall Study|Adverse Event|0
1608591|NCT02141997|5610150|P2|Overall Study|Adverse Event|2
1608592|NCT02141997|5610151|P1|Overall Study|Adverse Event|0
1608593|NCT02141984|5610189|P1|Overall Study|Lack of Efficacy|2
1608594|NCT02141854|5610208|P6|Treatment Period|Lost to Follow-up|1
1608595|NCT02141854|5610209|P5|Treatment Period|Lost to Follow-up|0
1608596|NCT02141854|5610210|P4|Treatment Period|Lost to Follow-up|1
1608597|NCT02141854|5610211|P3|Treatment Period|Lost to Follow-up|1
1608598|NCT02141854|5610212|P2|Treatment Period|Lost to Follow-up|1
1608599|NCT02141854|5610213|P1|Treatment Period|Lost to Follow-up|0
1608600|NCT02141854|5610208|P6|Treatment Period|Disease progression|18
1608601|NCT02141854|5610209|P5|Treatment Period|Disease progression|0
1608602|NCT02141854|5610210|P4|Treatment Period|Disease progression|3
1608603|NCT02141854|5610211|P3|Treatment Period|Disease progression|1
1608604|NCT02141854|5610212|P2|Treatment Period|Disease progression|2
1608605|NCT02141854|5610213|P1|Treatment Period|Disease progression|0
1608606|NCT02141854|5610208|P6|Treatment Period|Withdrawal by Subject|7
1608607|NCT02141854|5610209|P5|Treatment Period|Withdrawal by Subject|4
1608608|NCT02141854|5610210|P4|Treatment Period|Withdrawal by Subject|3
1608609|NCT02141854|5610211|P3|Treatment Period|Withdrawal by Subject|3
1608610|NCT02141854|5610212|P2|Treatment Period|Withdrawal by Subject|2
1608611|NCT02141854|5610213|P1|Treatment Period|Withdrawal by Subject|0
1608612|NCT02141854|5610208|P6|Treatment Period|Adverse Event|2
1608613|NCT02141854|5610209|P5|Treatment Period|Adverse Event|2
1608614|NCT02141854|5610210|P4|Treatment Period|Adverse Event|0
1608615|NCT02141854|5610211|P3|Treatment Period|Adverse Event|2
1608616|NCT02141854|5610212|P2|Treatment Period|Adverse Event|2
1608617|NCT02141854|5610213|P1|Treatment Period|Adverse Event|0
1608618|NCT02141854|5610208|P6|Treatment Period|Other|2
1608619|NCT02141854|5610209|P5|Treatment Period|Other|1
1608620|NCT02141854|5610210|P4|Treatment Period|Other|0
1608621|NCT02141854|5610211|P3|Treatment Period|Other|2
1608622|NCT02141854|5610212|P2|Treatment Period|Other|1
1608623|NCT02141854|5610213|P1|Treatment Period|Other|0
1608624|NCT02141854|5610208|P6|Treatment Period|Pregnancy|0
1608625|NCT02141854|5610209|P5|Treatment Period|Pregnancy|0
1608626|NCT02141854|5610210|P4|Treatment Period|Pregnancy|0
1608627|NCT02141854|5610211|P3|Treatment Period|Pregnancy|0
1608628|NCT02141854|5610212|P2|Treatment Period|Pregnancy|1
1608629|NCT02141854|5610213|P1|Treatment Period|Pregnancy|0
1608630|NCT02141854|5610208|P6|Treatment Period|Lack of Efficacy|7
1608631|NCT02141854|5610209|P5|Treatment Period|Lack of Efficacy|1
1608632|NCT02141854|5610210|P4|Treatment Period|Lack of Efficacy|1
1608633|NCT02141854|5610211|P3|Treatment Period|Lack of Efficacy|0
1608634|NCT02141854|5610212|P2|Treatment Period|Lack of Efficacy|0
1608635|NCT02141854|5610213|P1|Treatment Period|Lack of Efficacy|0
1608636|NCT02141854|5610208|P6|Treatment Period|Noncompliance|0
1608637|NCT02141854|5610209|P5|Treatment Period|Noncompliance|0
1608638|NCT02141854|5610210|P4|Treatment Period|Noncompliance|1
1608639|NCT02141854|5610211|P3|Treatment Period|Noncompliance|0
1608640|NCT02141854|5610212|P2|Treatment Period|Noncompliance|0
1608641|NCT02141854|5610213|P1|Treatment Period|Noncompliance|0
1608642|NCT02141854|5610208|P6|Treatment Period|Protocol Violation|1
1608643|NCT02141854|5610209|P5|Treatment Period|Protocol Violation|2
1608644|NCT02141854|5610210|P4|Treatment Period|Protocol Violation|2
1608645|NCT02141854|5610211|P3|Treatment Period|Protocol Violation|0
1608646|NCT02141854|5610212|P2|Treatment Period|Protocol Violation|1
1608647|NCT02141854|5610213|P1|Treatment Period|Protocol Violation|0
1608648|NCT02141854|5610208|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608649|NCT02141854|5610209|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608650|NCT02141854|5610210|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608651|NCT02141854|5610211|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608652|NCT02141854|5610212|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608653|NCT02141854|5610213|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
1608654|NCT02141854|5610208|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608655|NCT02141854|5610209|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608656|NCT02141854|5610210|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608657|NCT02141854|5610211|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608658|NCT02141854|5610212|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608659|NCT02141854|5610213|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
1608660|NCT02141854|5610208|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1608661|NCT02141854|5610209|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1608662|NCT02141854|5610210|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1608663|NCT02141854|5610211|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1608664|NCT02141854|5610212|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1608665|NCT02141854|5610213|P1|Run-In Period (Pre-assignment)|Adverse Event|10
1608666|NCT02141854|5610208|P6|Run-In Period (Pre-assignment)|Other|0
1608667|NCT02141854|5610209|P5|Run-In Period (Pre-assignment)|Other|0
1608668|NCT02141854|5610210|P4|Run-In Period (Pre-assignment)|Other|0
1608669|NCT02141854|5610211|P3|Run-In Period (Pre-assignment)|Other|0
1608670|NCT02141854|5610212|P2|Run-In Period (Pre-assignment)|Other|0
1608671|NCT02141854|5610213|P1|Run-In Period (Pre-assignment)|Other|14
1608672|NCT02141854|5610208|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608673|NCT02141854|5610209|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608674|NCT02141854|5610210|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608675|NCT02141854|5610211|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608676|NCT02141854|5610212|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608677|NCT02141854|5610213|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
1608678|NCT02141854|5610208|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608679|NCT02141854|5610209|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608680|NCT02141854|5610210|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608681|NCT02141854|5610211|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608682|NCT02141854|5610212|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608683|NCT02141854|5610213|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
1608684|NCT02141854|5610208|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608685|NCT02141854|5610209|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608686|NCT02141854|5610210|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608687|NCT02141854|5610211|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608688|NCT02141854|5610212|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608689|NCT02141854|5610213|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
1608690|NCT02141659|5610271|P6|Overall Study|Pretreatment Event/ Adverse Event|1
1608691|NCT02141659|5610272|P5|Overall Study|Pretreatment Event/ Adverse Event|2
1608692|NCT02141659|5610273|P4|Overall Study|Pretreatment Event/ Adverse Event|0
1608693|NCT02141659|5610274|P3|Overall Study|Pretreatment Event/ Adverse Event|0
1608694|NCT02141659|5610275|P2|Overall Study|Pretreatment Event/ Adverse Event|0
1608695|NCT02141659|5610276|P1|Overall Study|Pretreatment Event/ Adverse Event|0
1608696|NCT02141659|5610271|P6|Overall Study|Lack of Efficacy|1
1608697|NCT02141659|5610272|P5|Overall Study|Lack of Efficacy|0
1608698|NCT02141659|5610273|P4|Overall Study|Lack of Efficacy|0
1608699|NCT02141659|5610274|P3|Overall Study|Lack of Efficacy|0
1608700|NCT02141659|5610275|P2|Overall Study|Lack of Efficacy|0
1608701|NCT02141659|5610276|P1|Overall Study|Lack of Efficacy|0
1608702|NCT02141659|5610271|P6|Overall Study|Major Protocol Deviation|0
1608703|NCT02141659|5610272|P5|Overall Study|Major Protocol Deviation|0
1608704|NCT02141659|5610273|P4|Overall Study|Major Protocol Deviation|0
1608705|NCT02141659|5610274|P3|Overall Study|Major Protocol Deviation|0
1608706|NCT02141659|5610275|P2|Overall Study|Major Protocol Deviation|1
1608707|NCT02141659|5610276|P1|Overall Study|Major Protocol Deviation|0
1608708|NCT02141633|5610332|P2|Overall Study|Physician Decision|0
1608709|NCT02141633|5610333|P1|Overall Study|Physician Decision|1
1608710|NCT02141620|5610341|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
1608711|NCT02141620|5610342|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
1608712|NCT02141516|5610434|P3|Overall Study|Other|0
1608713|NCT02141516|5610435|P2|Overall Study|Other|3
1608714|NCT02141516|5610436|P1|Overall Study|Other|0
1608715|NCT02141516|5610434|P3|Overall Study|Lost to Follow-up|0
1608716|NCT02141516|5610435|P2|Overall Study|Lost to Follow-up|1
1608717|NCT02141516|5610436|P1|Overall Study|Lost to Follow-up|0
1608718|NCT02141516|5610434|P3|Overall Study|Adverse Event|0
1608719|NCT02141516|5610435|P2|Overall Study|Adverse Event|1
1608720|NCT02141516|5610436|P1|Overall Study|Adverse Event|0
1608721|NCT02141490|5610487|P3|Overall Study|Screening failures|0
1608722|NCT02141490|5610488|P2|Overall Study|Screening failures|0
1608723|NCT02141490|5610489|P1|Overall Study|Screening failures|4
1608724|NCT02141399|5610534|P1|Overall Study|Failure to meet eligibility criteria|14
1608725|NCT02141399|5610534|P1|Overall Study|Withdrawal by Subject|238
1608726|NCT02141399|5610534|P1|Overall Study|Protocol Violation|38
1608727|NCT02141399|5610534|P1|Overall Study|Pregnancy|3
1608728|NCT02141399|5610534|P1|Overall Study|Physician Decision|17
1608729|NCT02141399|5610534|P1|Overall Study|Other|45
1608730|NCT02141399|5610534|P1|Overall Study|Non-compliance with study drug|18
1608731|NCT02141399|5610534|P1|Overall Study|Lost to Follow-up|151
1608732|NCT02141399|5610534|P1|Overall Study|Lack of Efficacy|62
1608733|NCT02141399|5610534|P1|Overall Study|Adverse Event|158
1608734|NCT02141360|5610540|P3|Overall Study|Study Terminated before Visit|0
1608735|NCT02141360|5610541|P2|Overall Study|Study Terminated before Visit|0
1608736|NCT02141360|5610542|P1|Overall Study|Study Terminated before Visit|1
1608737|NCT02141360|5610540|P3|Overall Study|Withdrawal by Subject|0
1608738|NCT02141360|5610541|P2|Overall Study|Withdrawal by Subject|0
1608739|NCT02141360|5610542|P1|Overall Study|Withdrawal by Subject|6
1608740|NCT02141217|5610552|P2|Overall Study|Surgical Intervention|1
1608741|NCT02141217|5610553|P1|Overall Study|Surgical Intervention|1
1608742|NCT02141217|5610552|P2|Overall Study|Physician Decision|0
1608743|NCT02141217|5610553|P1|Overall Study|Physician Decision|1
1608744|NCT02141217|5610552|P2|Overall Study|Lost to Follow-up|1
1608745|NCT02141217|5610553|P1|Overall Study|Lost to Follow-up|1
1608746|NCT02141217|5610552|P2|Overall Study|Withdrawal by Subject|0
1608747|NCT02141217|5610553|P1|Overall Study|Withdrawal by Subject|6
1608748|NCT02141217|5610552|P2|Overall Study|Protocol Violation|4
1608749|NCT02141217|5610553|P1|Overall Study|Protocol Violation|1
1608750|NCT02141217|5610552|P2|Overall Study|Adverse Event|2
1608751|NCT02141217|5610553|P1|Overall Study|Adverse Event|1
1608752|NCT02140762|5610615|P2|Overall Study|Other|1
1608753|NCT02140762|5610616|P1|Overall Study|Other|0
1608754|NCT02140762|5610615|P2|Overall Study|Withdrawal by Subject|4
1608755|NCT02140762|5610616|P1|Overall Study|Withdrawal by Subject|6
1608756|NCT02140762|5610615|P2|Overall Study|Protocol Violation|1
1608757|NCT02140762|5610616|P1|Overall Study|Protocol Violation|1
1608758|NCT02140762|5610615|P2|Overall Study|Lost to Follow-up|5
1608759|NCT02140762|5610616|P1|Overall Study|Lost to Follow-up|9
1608760|NCT02140762|5610615|P2|Overall Study|Adverse Event|1
1608761|NCT02140762|5610616|P1|Overall Study|Adverse Event|1
1608762|NCT02140645|5610682|P6|Overall Study|Not linked|70896
1608763|NCT02140645|5610683|P5|Overall Study|Not linked|3286
1608764|NCT02140645|5610684|P4|Overall Study|Not linked|13833
1608765|NCT02140645|5610685|P3|Overall Study|Not linked|4236
1608766|NCT02140645|5610686|P2|Overall Study|Not linked|61654
1608767|NCT02140645|5610687|P1|Overall Study|Not linked|5489
1608768|NCT02140567|5610785|P1|Overall Study|Problems with recording equipment|6
1608769|NCT02140411|5610790|P1|Overall Study|Adverse Event|1
1608770|NCT02140164|5610810|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
1608771|NCT02140060|5610831|P6|Overall Study|Lack of Efficacy|0
1608772|NCT02140060|5610832|P5|Overall Study|Lack of Efficacy|0
1608773|NCT02140060|5610833|P4|Overall Study|Lack of Efficacy|1
1608774|NCT02140060|5610834|P3|Overall Study|Lack of Efficacy|0
1608775|NCT02140060|5610835|P2|Overall Study|Lack of Efficacy|0
1608776|NCT02140060|5610836|P1|Overall Study|Lack of Efficacy|0
1608777|NCT02140060|5610831|P6|Overall Study|Adverse Event|1
1608778|NCT02140060|5610832|P5|Overall Study|Adverse Event|1
1608779|NCT02140060|5610833|P4|Overall Study|Adverse Event|1
1608780|NCT02140060|5610834|P3|Overall Study|Adverse Event|0
1608781|NCT02140060|5610835|P2|Overall Study|Adverse Event|0
1608782|NCT02140060|5610836|P1|Overall Study|Adverse Event|0
1608783|NCT02139982|5610861|P10|Overall Study|Lack of Efficacy|0
1608784|NCT02139982|5610862|P9|Overall Study|Lack of Efficacy|0
1608785|NCT02139982|5610863|P8|Overall Study|Lack of Efficacy|0
1608786|NCT02139982|5610864|P7|Overall Study|Lack of Efficacy|0
1608787|NCT02139982|5610865|P6|Overall Study|Lack of Efficacy|0
1608788|NCT02139982|5610866|P5|Overall Study|Lack of Efficacy|0
1608789|NCT02139982|5610867|P4|Overall Study|Lack of Efficacy|1
1608790|NCT02139982|5610868|P3|Overall Study|Lack of Efficacy|0
1608791|NCT02139982|5610869|P2|Overall Study|Lack of Efficacy|1
1608792|NCT02139982|5610870|P1|Overall Study|Lack of Efficacy|0
1608793|NCT02139943|5610915|P3|Overall Study|eGFR Withdrawal Criteria|1
1608794|NCT02139943|5610916|P2|Overall Study|eGFR Withdrawal Criteria|0
1608795|NCT02139943|5610917|P1|Overall Study|eGFR Withdrawal Criteria|0
1608796|NCT02139943|5610915|P3|Overall Study|Participant in Poor Compliance|1
1608797|NCT02139943|5610916|P2|Overall Study|Participant in Poor Compliance|0
1608798|NCT02139943|5610917|P1|Overall Study|Participant in Poor Compliance|1
1608799|NCT02139943|5610915|P3|Overall Study|Participant wishes to discontinue|0
1608800|NCT02139943|5610916|P2|Overall Study|Participant wishes to discontinue|0
1608801|NCT02139943|5610917|P1|Overall Study|Participant wishes to discontinue|2
1608802|NCT02139943|5610915|P3|Overall Study|Other|1
1608803|NCT02139943|5610916|P2|Overall Study|Other|0
1608804|NCT02139943|5610917|P1|Overall Study|Other|0
1608805|NCT02139943|5610915|P3|Overall Study|Withdrawal by Subject|0
1608806|NCT02139943|5610916|P2|Overall Study|Withdrawal by Subject|3
1608807|NCT02139943|5610917|P1|Overall Study|Withdrawal by Subject|4
1608808|NCT02139943|5610915|P3|Overall Study|Lost to Follow-up|2
1608809|NCT02139943|5610916|P2|Overall Study|Lost to Follow-up|2
1608810|NCT02139943|5610917|P1|Overall Study|Lost to Follow-up|3
1608811|NCT02139943|5610915|P3|Overall Study|Adverse Event|2
1608812|NCT02139943|5610916|P2|Overall Study|Adverse Event|1
1608813|NCT02139943|5610917|P1|Overall Study|Adverse Event|0
1608814|NCT02139644|5610942|P6|Treatment Period|Other|1
1608815|NCT02139644|5610943|P5|Treatment Period|Other|0
1608816|NCT02139644|5610944|P4|Treatment Period|Other|1
1608817|NCT02139644|5610945|P3|Treatment Period|Other|1
1608818|NCT02139644|5610946|P2|Treatment Period|Other|3
1608819|NCT02139644|5610947|P1|Treatment Period|Other|0
1608820|NCT02139644|5610942|P6|Treatment Period|Lack of Efficacy|4
1608821|NCT02139644|5610943|P5|Treatment Period|Lack of Efficacy|1
1608822|NCT02139644|5610944|P4|Treatment Period|Lack of Efficacy|0
1608823|NCT02139644|5610945|P3|Treatment Period|Lack of Efficacy|1
1608824|NCT02139644|5610946|P2|Treatment Period|Lack of Efficacy|0
1608825|NCT02139644|5610947|P1|Treatment Period|Lack of Efficacy|0
1608826|NCT02139644|5610942|P6|Treatment Period|Lost to Follow-up|1
1608827|NCT02139644|5610943|P5|Treatment Period|Lost to Follow-up|1
1608828|NCT02139644|5610944|P4|Treatment Period|Lost to Follow-up|1
1608829|NCT02139644|5610945|P3|Treatment Period|Lost to Follow-up|1
1608830|NCT02139644|5610946|P2|Treatment Period|Lost to Follow-up|0
1608831|NCT02139644|5610947|P1|Treatment Period|Lost to Follow-up|0
1608832|NCT02139644|5610942|P6|Treatment Period|Disease progression|2
1608833|NCT02139644|5610943|P5|Treatment Period|Disease progression|1
1608834|NCT02139644|5610944|P4|Treatment Period|Disease progression|1
1608835|NCT02139644|5610945|P3|Treatment Period|Disease progression|0
1608836|NCT02139644|5610946|P2|Treatment Period|Disease progression|0
1608837|NCT02139644|5610947|P1|Treatment Period|Disease progression|0
1608838|NCT02139644|5610942|P6|Treatment Period|Protocol Violation|1
1608839|NCT02139644|5610943|P5|Treatment Period|Protocol Violation|1
1608840|NCT02139644|5610944|P4|Treatment Period|Protocol Violation|1
1608841|NCT02139644|5610945|P3|Treatment Period|Protocol Violation|0
1608842|NCT02139644|5610946|P2|Treatment Period|Protocol Violation|0
1608843|NCT02139644|5610947|P1|Treatment Period|Protocol Violation|0
1608844|NCT02139644|5610942|P6|Treatment Period|Non-compliance|0
1608845|NCT02139644|5610943|P5|Treatment Period|Non-compliance|0
1608846|NCT02139644|5610944|P4|Treatment Period|Non-compliance|1
1608847|NCT02139644|5610945|P3|Treatment Period|Non-compliance|0
1608848|NCT02139644|5610946|P2|Treatment Period|Non-compliance|0
1608849|NCT02139644|5610947|P1|Treatment Period|Non-compliance|0
1608850|NCT02139644|5610942|P6|Treatment Period|Withdrawal by Subject|2
1608851|NCT02139644|5610943|P5|Treatment Period|Withdrawal by Subject|3
1608852|NCT02139644|5610944|P4|Treatment Period|Withdrawal by Subject|2
1608853|NCT02139644|5610945|P3|Treatment Period|Withdrawal by Subject|2
1608854|NCT02139644|5610946|P2|Treatment Period|Withdrawal by Subject|0
1608855|NCT02139644|5610947|P1|Treatment Period|Withdrawal by Subject|0
1608856|NCT02139644|5610942|P6|Treatment Period|Adverse Event|6
1608857|NCT02139644|5610943|P5|Treatment Period|Adverse Event|1
1608858|NCT02139644|5610944|P4|Treatment Period|Adverse Event|2
1608859|NCT02139644|5610945|P3|Treatment Period|Adverse Event|3
1608860|NCT02139644|5610946|P2|Treatment Period|Adverse Event|0
1608861|NCT02139644|5610947|P1|Treatment Period|Adverse Event|0
1608862|NCT02139644|5610942|P6|Run-In Period (Pre-assignment)|Other|0
1608863|NCT02139644|5610943|P5|Run-In Period (Pre-assignment)|Other|0
1608864|NCT02139644|5610944|P4|Run-In Period (Pre-assignment)|Other|0
1608865|NCT02139644|5610945|P3|Run-In Period (Pre-assignment)|Other|0
1608866|NCT02139644|5610946|P2|Run-In Period (Pre-assignment)|Other|0
1608867|NCT02139644|5610947|P1|Run-In Period (Pre-assignment)|Other|6
1608868|NCT02139644|5610942|P6|Run-In Period (Pre-assignment)|Adverse Event|0
1608869|NCT02139644|5610943|P5|Run-In Period (Pre-assignment)|Adverse Event|0
1608870|NCT02139644|5610944|P4|Run-In Period (Pre-assignment)|Adverse Event|0
1608871|NCT02139644|5610945|P3|Run-In Period (Pre-assignment)|Adverse Event|0
1608872|NCT02139644|5610946|P2|Run-In Period (Pre-assignment)|Adverse Event|0
1608873|NCT02139644|5610947|P1|Run-In Period (Pre-assignment)|Adverse Event|3
1608874|NCT02139644|5610942|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608875|NCT02139644|5610943|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608876|NCT02139644|5610944|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608877|NCT02139644|5610945|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608878|NCT02139644|5610946|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
1608879|NCT02139644|5610947|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
1608880|NCT02139644|5610942|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608881|NCT02139644|5610943|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608882|NCT02139644|5610944|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608883|NCT02139644|5610945|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608884|NCT02139644|5610946|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
1608885|NCT02139644|5610947|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
1608886|NCT02139644|5610942|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608887|NCT02139644|5610943|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608888|NCT02139644|5610944|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608889|NCT02139644|5610945|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608890|NCT02139644|5610946|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
1608891|NCT02139644|5610947|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
1608892|NCT02139644|5610942|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608893|NCT02139644|5610943|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608894|NCT02139644|5610944|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608895|NCT02139644|5610945|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608896|NCT02139644|5610946|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
1608897|NCT02139644|5610947|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
1608898|NCT02139644|5610942|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608899|NCT02139644|5610943|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608900|NCT02139644|5610944|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608901|NCT02139644|5610945|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608902|NCT02139644|5610946|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
1608903|NCT02139644|5610947|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
1608904|NCT02139592|5610999|P1|Overall Study|Case Report Forms Uncollected|8
1608905|NCT02139124|5611069|P5|Overall Study|Lost to Follow-up|4
1608906|NCT02139124|5611070|P4|Overall Study|Lost to Follow-up|5
1608907|NCT02139124|5611071|P3|Overall Study|Lost to Follow-up|0
1608908|NCT02139124|5611072|P2|Overall Study|Lost to Follow-up|2
1608909|NCT02139124|5611073|P1|Overall Study|Lost to Follow-up|3
1608910|NCT02139124|5611069|P5|Overall Study|subject moved|0
1608911|NCT02139124|5611070|P4|Overall Study|subject moved|0
1608912|NCT02139124|5611071|P3|Overall Study|subject moved|0
1608913|NCT02139124|5611072|P2|Overall Study|subject moved|0
1608914|NCT02139124|5611073|P1|Overall Study|subject moved|1
1608915|NCT02139124|5611069|P5|Overall Study|incarceration|0
1608916|NCT02139124|5611070|P4|Overall Study|incarceration|0
1608917|NCT02139124|5611071|P3|Overall Study|incarceration|1
1608918|NCT02139124|5611072|P2|Overall Study|incarceration|0
1608919|NCT02139124|5611073|P1|Overall Study|incarceration|0
1608920|NCT02139124|5611069|P5|Overall Study|non-compliant|0
1608921|NCT02139124|5611070|P4|Overall Study|non-compliant|2
1608922|NCT02139124|5611071|P3|Overall Study|non-compliant|0
1608923|NCT02139124|5611072|P2|Overall Study|non-compliant|0
1608924|NCT02139124|5611073|P1|Overall Study|non-compliant|1
1608925|NCT02139124|5611069|P5|Overall Study|Protocol Violation|1
1608926|NCT02139124|5611070|P4|Overall Study|Protocol Violation|1
1608927|NCT02139124|5611071|P3|Overall Study|Protocol Violation|0
1608928|NCT02139124|5611072|P2|Overall Study|Protocol Violation|0
1608929|NCT02139124|5611073|P1|Overall Study|Protocol Violation|0
1608930|NCT02139124|5611069|P5|Overall Study|Withdrawal by Subject|3
1608931|NCT02139124|5611070|P4|Overall Study|Withdrawal by Subject|2
1608932|NCT02139124|5611071|P3|Overall Study|Withdrawal by Subject|2
1608933|NCT02139124|5611072|P2|Overall Study|Withdrawal by Subject|2
1608934|NCT02139124|5611073|P1|Overall Study|Withdrawal by Subject|2
1608935|NCT02139124|5611069|P5|Overall Study|Adverse Event|5
1608936|NCT02139124|5611070|P4|Overall Study|Adverse Event|2
1608937|NCT02139124|5611071|P3|Overall Study|Adverse Event|1
1608938|NCT02139124|5611072|P2|Overall Study|Adverse Event|0
1608939|NCT02139124|5611073|P1|Overall Study|Adverse Event|2
1608940|NCT02139046|5611090|P5|Overall Study|Other Miscellaneous Reasons|12
1608941|NCT02139046|5611091|P4|Overall Study|Other Miscellaneous Reasons|9
1608942|NCT02139046|5611092|P3|Overall Study|Other Miscellaneous Reasons|4
1608943|NCT02139046|5611093|P2|Overall Study|Other Miscellaneous Reasons|9
1608944|NCT02139046|5611094|P1|Overall Study|Other Miscellaneous Reasons|10
1608945|NCT02139046|5611090|P5|Overall Study|Withdrawal due to a Gout Flare|1
1608946|NCT02139046|5611091|P4|Overall Study|Withdrawal due to a Gout Flare|0
1608947|NCT02139046|5611092|P3|Overall Study|Withdrawal due to a Gout Flare|1
1608948|NCT02139046|5611093|P2|Overall Study|Withdrawal due to a Gout Flare|1
1608949|NCT02139046|5611094|P1|Overall Study|Withdrawal due to a Gout Flare|1
1608950|NCT02139046|5611090|P5|Overall Study|Lack of Efficacy|2
1608951|NCT02139046|5611091|P4|Overall Study|Lack of Efficacy|1
1608952|NCT02139046|5611092|P3|Overall Study|Lack of Efficacy|2
1608953|NCT02139046|5611093|P2|Overall Study|Lack of Efficacy|1
1608954|NCT02139046|5611094|P1|Overall Study|Lack of Efficacy|0
1608955|NCT02139046|5611090|P5|Overall Study|Voluntary Withdrawal|16
1608956|NCT02139046|5611091|P4|Overall Study|Voluntary Withdrawal|15
1608957|NCT02139046|5611092|P3|Overall Study|Voluntary Withdrawal|10
1608958|NCT02139046|5611093|P2|Overall Study|Voluntary Withdrawal|8
1608959|NCT02139046|5611094|P1|Overall Study|Voluntary Withdrawal|20
1608960|NCT02139046|5611090|P5|Overall Study|Lost to Follow-up|13
1608961|NCT02139046|5611091|P4|Overall Study|Lost to Follow-up|18
1608962|NCT02139046|5611092|P3|Overall Study|Lost to Follow-up|16
1608963|NCT02139046|5611093|P2|Overall Study|Lost to Follow-up|16
1608964|NCT02139046|5611094|P1|Overall Study|Lost to Follow-up|13
1608965|NCT02139046|5611090|P5|Overall Study|Major Protocol Deviation|6
1608966|NCT02139046|5611091|P4|Overall Study|Major Protocol Deviation|12
1608967|NCT02139046|5611092|P3|Overall Study|Major Protocol Deviation|16
1608968|NCT02139046|5611093|P2|Overall Study|Major Protocol Deviation|10
1608969|NCT02139046|5611094|P1|Overall Study|Major Protocol Deviation|9
1608970|NCT02139046|5611090|P5|Overall Study|Pretreatment Event/Adverse Event|7
1608971|NCT02139046|5611091|P4|Overall Study|Pretreatment Event/Adverse Event|13
1608972|NCT02139046|5611092|P3|Overall Study|Pretreatment Event/Adverse Event|10
1608973|NCT02139046|5611093|P2|Overall Study|Pretreatment Event/Adverse Event|9
1608974|NCT02139046|5611094|P1|Overall Study|Pretreatment Event/Adverse Event|9
1608975|NCT02138916|5611135|P3|Overall Study|Adverse Event|3
1608976|NCT02138916|5611136|P2|Overall Study|Adverse Event|4
1608977|NCT02138916|5611137|P1|Overall Study|Adverse Event|4
1608978|NCT02138916|5611135|P3|Overall Study|Lost to Follow-up|3
1608979|NCT02138916|5611136|P2|Overall Study|Lost to Follow-up|2
1608980|NCT02138916|5611137|P1|Overall Study|Lost to Follow-up|4
1608981|NCT02138916|5611135|P3|Overall Study|Severe non-compliance|1
1608982|NCT02138916|5611136|P2|Overall Study|Severe non-compliance|2
1608983|NCT02138916|5611137|P1|Overall Study|Severe non-compliance|1
1608984|NCT02138916|5611135|P3|Overall Study|incorrect enrolment|0
1608985|NCT02138916|5611136|P2|Overall Study|incorrect enrolment|1
1608986|NCT02138916|5611137|P1|Overall Study|incorrect enrolment|1
1608987|NCT02138916|5611135|P3|Overall Study|Study specific withdrawal criteria|1
1608988|NCT02138916|5611136|P2|Overall Study|Study specific withdrawal criteria|0
1608989|NCT02138916|5611137|P1|Overall Study|Study specific withdrawal criteria|0
1608990|NCT02138916|5611135|P3|Overall Study|Withdrawal by Subject|32
1608991|NCT02138916|5611136|P2|Overall Study|Withdrawal by Subject|31
1608992|NCT02138916|5611137|P1|Overall Study|Withdrawal by Subject|27
1608993|NCT02138916|5611135|P3|Overall Study|Death|12
1608994|NCT02138916|5611136|P2|Overall Study|Death|11
1608995|NCT02138916|5611137|P1|Overall Study|Death|14
1608996|NCT02138916|5611135|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
1608997|NCT02138916|5611136|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
1608998|NCT02138916|5611137|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
1608999|NCT02138890|5611200|P2|Overall Study|Adverse Event|0
1609000|NCT02138890|5611201|P1|Overall Study|Adverse Event|1
1609001|NCT02138838|5611243|P2|Overall Study|Withdrawal by Subject|5
1609002|NCT02138838|5611244|P1|Overall Study|Withdrawal by Subject|1
1609003|NCT02138838|5611243|P2|Overall Study|Study Closure|6
1609004|NCT02138838|5611244|P1|Overall Study|Study Closure|7
1609005|NCT02138825|5611262|P2|Safety Follow-up|withdrawn due to lung transplant|1
1609006|NCT02138825|5611263|P1|Safety Follow-up|withdrawn due to lung transplant|0
1609007|NCT02138825|5611262|P2|Safety Follow-up|treatment unblinded|1
1609008|NCT02138825|5611263|P1|Safety Follow-up|treatment unblinded|0
1609009|NCT02138825|5611262|P2|Safety Follow-up|too unwell to attend the visit|1
1609010|NCT02138825|5611263|P1|Safety Follow-up|too unwell to attend the visit|0
1609011|NCT02138825|5611262|P2|Safety Follow-up|progressive disease|2
1609012|NCT02138825|5611263|P1|Safety Follow-up|progressive disease|0
1609013|NCT02138825|5611262|P2|Safety Follow-up|logistical difficulties|1
1609014|NCT02138825|5611263|P1|Safety Follow-up|logistical difficulties|0
1609015|NCT02138825|5611262|P2|Safety Follow-up|withdrawal by PI|0
1609016|NCT02138825|5611263|P1|Safety Follow-up|withdrawal by PI|1
1609017|NCT02138825|5611262|P2|Safety Follow-up|clinic worsening|0
1609018|NCT02138825|5611263|P1|Safety Follow-up|clinic worsening|1
1609019|NCT02138825|5611262|P2|Safety Follow-up|Withdrawal by Subject|3
1609020|NCT02138825|5611263|P1|Safety Follow-up|Withdrawal by Subject|5
1609021|NCT02138825|5611262|P2|Safety Follow-up|Death|5
1609022|NCT02138825|5611263|P1|Safety Follow-up|Death|11
1609023|NCT02138825|5611262|P2|Safety Follow-up|Adverse Event|3
1609024|NCT02138825|5611263|P1|Safety Follow-up|Adverse Event|4
1609025|NCT02138825|5611262|P2|Long-term Extension|Study termination by sponsor|38
1609026|NCT02138825|5611263|P1|Long-term Extension|Study termination by sponsor|32
1609027|NCT02138825|5611262|P2|Main Study Treatment|Medical decision|0
1609028|NCT02138825|5611263|P1|Main Study Treatment|Medical decision|1
1609029|NCT02138825|5611262|P2|Main Study Treatment|Withdrawal by Subject|1
1609030|NCT02138825|5611263|P1|Main Study Treatment|Withdrawal by Subject|3
1609031|NCT02138825|5611262|P2|Main Study Treatment|Study terminated by sponsor|9
1609032|NCT02138825|5611263|P1|Main Study Treatment|Study terminated by sponsor|10
1609033|NCT02138825|5611262|P2|Main Study Treatment|Sponsor decision|18
1609034|NCT02138825|5611263|P1|Main Study Treatment|Sponsor decision|12
1609035|NCT02138825|5611262|P2|Main Study Treatment|Protocol Violation|2
1609036|NCT02138825|5611263|P1|Main Study Treatment|Protocol Violation|2
1609037|NCT02138825|5611262|P2|Main Study Treatment|Death|2
1609038|NCT02138825|5611263|P1|Main Study Treatment|Death|1
1609039|NCT02138825|5611262|P2|Main Study Treatment|Adverse Event|3
1609040|NCT02138825|5611263|P1|Main Study Treatment|Adverse Event|11
1609041|NCT02138786|5611280|P3|Overall Study|Non-Compliance|1
1609042|NCT02138786|5611281|P2|Overall Study|Non-Compliance|0
1609043|NCT02138786|5611282|P1|Overall Study|Non-Compliance|0
1609044|NCT02138786|5611280|P3|Overall Study|Sponsor Terminated Study|1
1609045|NCT02138786|5611281|P2|Overall Study|Sponsor Terminated Study|1
1609046|NCT02138786|5611282|P1|Overall Study|Sponsor Terminated Study|0
1609047|NCT02138786|5611280|P3|Overall Study|Patient's Wish|0
1609048|NCT02138786|5611281|P2|Overall Study|Patient's Wish|2
1609049|NCT02138786|5611282|P1|Overall Study|Patient's Wish|0
1609050|NCT02138786|5611280|P3|Overall Study|Withdrawal by Subject|0
1609051|NCT02138786|5611281|P2|Overall Study|Withdrawal by Subject|2
1609052|NCT02138786|5611282|P1|Overall Study|Withdrawal by Subject|1
1609053|NCT02138786|5611280|P3|Overall Study|Disease Progression|3
1609054|NCT02138786|5611281|P2|Overall Study|Disease Progression|1
1609055|NCT02138786|5611282|P1|Overall Study|Disease Progression|1
1609056|NCT02138786|5611280|P3|Overall Study|Death|2
1609057|NCT02138786|5611281|P2|Overall Study|Death|7
1609058|NCT02138786|5611282|P1|Overall Study|Death|1
1609059|NCT02138786|5611280|P3|Overall Study|Adverse Event|1
1609060|NCT02138786|5611281|P2|Overall Study|Adverse Event|2
1609061|NCT02138786|5611282|P1|Overall Study|Adverse Event|0
1609102|NCT02138253|5611376|P2|Overall Study|Withdrawal by Subject|0
1609103|NCT02138253|5611377|P1|Overall Study|Withdrawal by Subject|1
1609104|NCT02138253|5611376|P2|Overall Study|Non compliance|0
1609105|NCT02138253|5611377|P1|Overall Study|Non compliance|1
1609106|NCT02138253|5611376|P2|Overall Study|Physician Decision|0
1609107|NCT02138253|5611377|P1|Overall Study|Physician Decision|2
1609108|NCT02138253|5611376|P2|Overall Study|Lost to Follow-up|1
1609109|NCT02138253|5611377|P1|Overall Study|Lost to Follow-up|2
1609110|NCT02138253|5611376|P2|Overall Study|Adverse Event|3
1609111|NCT02138253|5611377|P1|Overall Study|Adverse Event|3
1609112|NCT02138136|5611449|P1|Overall Study|Withdrawn by Sponsor|5
1609113|NCT02138136|5611449|P1|Overall Study|Lost to Follow-up|32
1609114|NCT02138136|5611449|P1|Overall Study|Withdrawal by Subject|36
1609115|NCT02138136|5611449|P1|Overall Study|Adverse Event|18
1609116|NCT02138136|5611449|P1|Overall Study|Pregnancy|2
1609117|NCT02138136|5611449|P1|Overall Study|Lack of Efficacy|35
1609118|NCT02138136|5611449|P1|Overall Study|Physician Decision|7
1609119|NCT02138136|5611449|P1|Overall Study|Protocol Violation|4
1609120|NCT02138110|5611456|P1|Overall Scaffold Implantation|Death|3
1609121|NCT02138110|5611456|P1|Enrolled for Scaffold Implantation|Physician Decision|1
1609122|NCT02137785|5611688|P2|Overall Study|subject moved out of state|0
1609123|NCT02137785|5611689|P1|Overall Study|subject moved out of state|1
1609124|NCT02137785|5611688|P2|Overall Study|Withdrawal by Subject|4
1609125|NCT02137785|5611689|P1|Overall Study|Withdrawal by Subject|1
1609126|NCT02137785|5611688|P2|Overall Study|Lost to Follow-up|0
1609127|NCT02137785|5611689|P1|Overall Study|Lost to Follow-up|1
1609128|NCT02137772|5611797|P2|Overall Study|Not treated|2
1609129|NCT02137772|5611798|P1|Overall Study|Not treated|3
1609130|NCT02137772|5611797|P2|Overall Study|Non-compliance with study drug|0
1609131|NCT02137772|5611798|P1|Overall Study|Non-compliance with study drug|1
1609132|NCT02137772|5611797|P2|Overall Study|Withdrawal by Subject|17
1609133|NCT02137772|5611798|P1|Overall Study|Withdrawal by Subject|28
1609134|NCT02137772|5611797|P2|Overall Study|Physician Decision|5
1609135|NCT02137772|5611798|P1|Overall Study|Physician Decision|15
1609136|NCT02137772|5611797|P2|Overall Study|Lost to Follow-up|4
1609137|NCT02137772|5611798|P1|Overall Study|Lost to Follow-up|8
1609138|NCT02137772|5611797|P2|Overall Study|Death|44
1609139|NCT02137772|5611798|P1|Overall Study|Death|71
1609140|NCT02137772|5611797|P2|Overall Study|Adverse Event|3
1609141|NCT02137772|5611798|P1|Overall Study|Adverse Event|6
1609142|NCT02137226|5612056|P5|Period 2 (Re - Randomization)|Other Reason|1
1609143|NCT02137226|5612057|P4|Period 2 (Re - Randomization)|Other Reason|1
1609144|NCT02137226|5612058|P3|Period 2 (Re - Randomization)|Other Reason|1
1609145|NCT02137226|5612059|P2|Period 2 (Re - Randomization)|Other Reason|0
1609146|NCT02137226|5612060|P1|Period 2 (Re - Randomization)|Other Reason|0
1609147|NCT02137226|5612056|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
1609148|NCT02137226|5612057|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
1609149|NCT02137226|5612058|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
1609150|NCT02137226|5612059|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
1609151|NCT02137226|5612060|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
1609152|NCT02137226|5612056|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
1609153|NCT02137226|5612057|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
1609154|NCT02137226|5612058|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
1609155|NCT02137226|5612059|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
1609156|NCT02137226|5612060|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
1609157|NCT02137226|5612056|P5|Period 2 (Re - Randomization)|Physician Decision|0
1609158|NCT02137226|5612057|P4|Period 2 (Re - Randomization)|Physician Decision|1
1609159|NCT02137226|5612058|P3|Period 2 (Re - Randomization)|Physician Decision|0
1609160|NCT02137226|5612059|P2|Period 2 (Re - Randomization)|Physician Decision|0
1609161|NCT02137226|5612060|P1|Period 2 (Re - Randomization)|Physician Decision|0
1609162|NCT02137226|5612056|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
1609163|NCT02137226|5612057|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
1609164|NCT02137226|5612058|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
1609165|NCT02137226|5612059|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1609166|NCT02137226|5612060|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
1609167|NCT02137226|5612056|P5|Period 2 (Re - Randomization)|Adverse Event|4
1609168|NCT02137226|5612057|P4|Period 2 (Re - Randomization)|Adverse Event|1
1609169|NCT02137226|5612058|P3|Period 2 (Re - Randomization)|Adverse Event|3
1609170|NCT02137226|5612059|P2|Period 2 (Re - Randomization)|Adverse Event|0
1609171|NCT02137226|5612060|P1|Period 2 (Re - Randomization)|Adverse Event|0
1609172|NCT02137226|5612056|P5|Period 1 (Initial Randomization)|Other Reason|0
1609173|NCT02137226|5612057|P4|Period 1 (Initial Randomization)|Other Reason|0
1609174|NCT02137226|5612058|P3|Period 1 (Initial Randomization)|Other Reason|0
1609175|NCT02137226|5612059|P2|Period 1 (Initial Randomization)|Other Reason|3
1609176|NCT02137226|5612060|P1|Period 1 (Initial Randomization)|Other Reason|1
1609177|NCT02137226|5612056|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
1609178|NCT02137226|5612057|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
1609179|NCT02137226|5612058|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
1609180|NCT02137226|5612059|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
1609181|NCT02137226|5612060|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
1609182|NCT02137226|5612056|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
1609183|NCT02137226|5612057|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
1609184|NCT02137226|5612058|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
1609185|NCT02137226|5612059|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
1609186|NCT02137226|5612060|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
1609187|NCT02137226|5612056|P5|Period 1 (Initial Randomization)|Physician Decision|0
1609188|NCT02137226|5612057|P4|Period 1 (Initial Randomization)|Physician Decision|0
1609189|NCT02137226|5612058|P3|Period 1 (Initial Randomization)|Physician Decision|0
1609190|NCT02137226|5612059|P2|Period 1 (Initial Randomization)|Physician Decision|3
1609191|NCT02137226|5612060|P1|Period 1 (Initial Randomization)|Physician Decision|1
1609192|NCT02137226|5612056|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1609193|NCT02137226|5612057|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1609194|NCT02137226|5612058|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
1609195|NCT02137226|5612059|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
1609196|NCT02137226|5612060|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
1609197|NCT02137226|5612056|P5|Period 1 (Initial Randomization)|Adverse Event|0
1609198|NCT02137226|5612057|P4|Period 1 (Initial Randomization)|Adverse Event|0
1609199|NCT02137226|5612058|P3|Period 1 (Initial Randomization)|Adverse Event|0
1609200|NCT02137226|5612059|P2|Period 1 (Initial Randomization)|Adverse Event|3
1609201|NCT02137226|5612060|P1|Period 1 (Initial Randomization)|Adverse Event|3
1609202|NCT02136914|5612078|P2|Overall Study|Death|1
1609203|NCT02136914|5612079|P1|Overall Study|Death|0
1609204|NCT02136914|5612078|P2|Overall Study|Lack of Efficacy|0
1609205|NCT02136914|5612079|P1|Overall Study|Lack of Efficacy|1
1609206|NCT02136914|5612078|P2|Overall Study|Did Not Receive Study Drug|0
1609207|NCT02136914|5612079|P1|Overall Study|Did Not Receive Study Drug|2
1609208|NCT02136914|5612078|P2|Overall Study|Lost to Follow-up|1
1609209|NCT02136914|5612079|P1|Overall Study|Lost to Follow-up|1
1609210|NCT02136914|5612078|P2|Overall Study|Subject Unwilling to Proceed|2
1609211|NCT02136914|5612079|P1|Overall Study|Subject Unwilling to Proceed|7
1609212|NCT02136914|5612078|P2|Overall Study|Withdrawal by Subject|10
1609213|NCT02136914|5612079|P1|Overall Study|Withdrawal by Subject|3
1609214|NCT02136914|5612078|P2|Overall Study|Sponsor's Decision to Stop the Study|7
1609215|NCT02136914|5612079|P1|Overall Study|Sponsor's Decision to Stop the Study|7
1609216|NCT02136680|5612099|P2|Overall Study|Study ended before interview due|3
1609217|NCT02136680|5612100|P1|Overall Study|Study ended before interview due|6
1609218|NCT02136680|5612099|P2|Overall Study|Unable to schedule|16
1609219|NCT02136680|5612100|P1|Overall Study|Unable to schedule|17
1609220|NCT02136680|5612099|P2|Overall Study|Moved away|4
1609221|NCT02136680|5612100|P1|Overall Study|Moved away|5
1609222|NCT02136680|5612099|P2|Overall Study|No longer receiving care at clinic|5
1609223|NCT02136680|5612100|P1|Overall Study|No longer receiving care at clinic|3
1609224|NCT02136680|5612099|P2|Overall Study|No Longer Interested|1
1609225|NCT02136680|5612100|P1|Overall Study|No Longer Interested|1
1609226|NCT02136134|5612175|P2|Overall Study|Subjects randomized but not treated|8
1609227|NCT02136134|5612176|P1|Overall Study|Subjects randomized but not treated|10
1609228|NCT02136134|5612175|P2|Overall Study|Ongoing|207
1609229|NCT02136134|5612176|P1|Overall Study|Ongoing|185
1609230|NCT02136134|5612175|P2|Overall Study|Other|3
1609231|NCT02136134|5612176|P1|Overall Study|Other|3
1609232|NCT02136134|5612175|P2|Overall Study|Withdrawal by Subject|4
1609233|NCT02136134|5612176|P1|Overall Study|Withdrawal by Subject|14
1609234|NCT02136134|5612175|P2|Overall Study|Death|29
1609235|NCT02136134|5612176|P1|Overall Study|Death|35
1609236|NCT02135848|5612238|P2|Overall Study|Withdrawal by Subject|1
1609237|NCT02135848|5612239|P1|Overall Study|Withdrawal by Subject|1
1609238|NCT02135848|5612238|P2|Overall Study|Adverse Event|0
1609239|NCT02135848|5612239|P1|Overall Study|Adverse Event|2
1609240|NCT02135692|5612297|P1|Overall Study|Withdrawal by Subject|15
1609241|NCT02135692|5612297|P1|Overall Study|Lost to Follow-up|4
1609242|NCT02135692|5612297|P1|Overall Study|Study closed/terminated|153
1609243|NCT02135692|5612297|P1|Overall Study|Product commercially available|159
1609244|NCT02135692|5612297|P1|Overall Study|Subject met Liver Stopping Criteria|1
1609245|NCT02135692|5612297|P1|Overall Study|Protocol Violation|2
1609246|NCT02135692|5612297|P1|Overall Study|Lack of Efficacy|2
1609247|NCT02135692|5612297|P1|Overall Study|Adverse Event|3
1609248|NCT02135614|5612316|P2|Overall Study|Lost to Follow-up|0
1609249|NCT02135614|5612317|P1|Overall Study|Lost to Follow-up|3
1609250|NCT02135614|5612316|P2|Overall Study|Withdrew Consent|2
1609251|NCT02135614|5612317|P1|Overall Study|Withdrew Consent|2
1609252|NCT02135614|5612316|P2|Overall Study|Investigator's Discretion|1
1609253|NCT02135614|5612317|P1|Overall Study|Investigator's Discretion|0
1609254|NCT02135614|5612316|P2|Overall Study|Death|0
1609255|NCT02135614|5612317|P1|Overall Study|Death|1
1609256|NCT02135614|5612316|P2|Overall Study|Adverse Event|1
1609257|NCT02135614|5612317|P1|Overall Study|Adverse Event|0
1609258|NCT02135614|5612316|P2|Overall Study|Randomized but Not Treated|1
1609259|NCT02135614|5612317|P1|Overall Study|Randomized but Not Treated|2
1609260|NCT02135445|5612331|P2|Overall Study|Withdrawal by Subject|0
1609261|NCT02135445|5612332|P1|Overall Study|Withdrawal by Subject|1
1609262|NCT02135445|5612331|P2|Overall Study|Lost to Follow-up|0
1609263|NCT02135445|5612332|P1|Overall Study|Lost to Follow-up|1
1609264|NCT02135107|5612398|P4|Maintenance Therapy Period|Other|8
1609265|NCT02135107|5612399|P3|Maintenance Therapy Period|Other|7
1609266|NCT02135107|5612400|P2|Maintenance Therapy Period|Other|0
1609267|NCT02135107|5612401|P1|Maintenance Therapy Period|Other|0
1609268|NCT02135107|5612398|P4|Maintenance Therapy Period|Pregnancy|1
1609269|NCT02135107|5612399|P3|Maintenance Therapy Period|Pregnancy|0
1609270|NCT02135107|5612400|P2|Maintenance Therapy Period|Pregnancy|0
1609271|NCT02135107|5612401|P1|Maintenance Therapy Period|Pregnancy|0
1609272|NCT02135107|5612398|P4|Maintenance Therapy Period|Withdrawal by Subject|4
1609273|NCT02135107|5612399|P3|Maintenance Therapy Period|Withdrawal by Subject|5
1609274|NCT02135107|5612400|P2|Maintenance Therapy Period|Withdrawal by Subject|0
1609275|NCT02135107|5612401|P1|Maintenance Therapy Period|Withdrawal by Subject|0
1609276|NCT02135107|5612398|P4|Maintenance Therapy Period|Adverse Event|7
1609277|NCT02135107|5612399|P3|Maintenance Therapy Period|Adverse Event|3
1609278|NCT02135107|5612400|P2|Maintenance Therapy Period|Adverse Event|0
1609279|NCT02135107|5612401|P1|Maintenance Therapy Period|Adverse Event|0
1609280|NCT02135107|5612398|P4|Treatment Period|Other|0
1609281|NCT02135107|5612399|P3|Treatment Period|Other|0
1609282|NCT02135107|5612400|P2|Treatment Period|Other|24
1609283|NCT02135107|5612401|P1|Treatment Period|Other|115
1609284|NCT02135107|5612398|P4|Treatment Period|Pregnancy|0
1609285|NCT02135107|5612399|P3|Treatment Period|Pregnancy|0
1609286|NCT02135107|5612400|P2|Treatment Period|Pregnancy|0
1609287|NCT02135107|5612401|P1|Treatment Period|Pregnancy|1
1609288|NCT02135107|5612398|P4|Treatment Period|Adverse Event|0
1609289|NCT02135107|5612399|P3|Treatment Period|Adverse Event|0
1609290|NCT02135107|5612400|P2|Treatment Period|Adverse Event|2
1609291|NCT02135107|5612401|P1|Treatment Period|Adverse Event|5
1609292|NCT02135107|5612398|P4|Treatment Period|Withdrawal by Subject|0
1609293|NCT02135107|5612399|P3|Treatment Period|Withdrawal by Subject|0
1609294|NCT02135107|5612400|P2|Treatment Period|Withdrawal by Subject|0
1609295|NCT02135107|5612401|P1|Treatment Period|Withdrawal by Subject|11
1609296|NCT02135029|5612447|P3|Overall Study|Death|0
1609297|NCT02135029|5612448|P2|Overall Study|Death|1
1609298|NCT02135029|5612449|P1|Overall Study|Death|0
1609299|NCT02135029|5612447|P3|Overall Study|Other|0
1609300|NCT02135029|5612448|P2|Overall Study|Other|1
1609301|NCT02135029|5612449|P1|Overall Study|Other|0
1609302|NCT02135029|5612447|P3|Overall Study|Withdrawal by Subject|1
1609303|NCT02135029|5612448|P2|Overall Study|Withdrawal by Subject|0
1609304|NCT02135029|5612449|P1|Overall Study|Withdrawal by Subject|2
1609305|NCT02135029|5612447|P3|Overall Study|Lost to Follow-up|0
1609306|NCT02135029|5612448|P2|Overall Study|Lost to Follow-up|1
1609307|NCT02135029|5612449|P1|Overall Study|Lost to Follow-up|0
1609308|NCT02135029|5612447|P3|Overall Study|Adverse Event|2
1609309|NCT02135029|5612448|P2|Overall Study|Adverse Event|2
1609310|NCT02135029|5612449|P1|Overall Study|Adverse Event|2
1609311|NCT02134977|5612554|P1|Overall Study|Protocol Deviation|102
1609312|NCT02134925|5612588|P2|Overall Study|Cancel|6
1609313|NCT02134925|5612589|P1|Overall Study|Cancel|1
1609314|NCT02134925|5612588|P2|Overall Study|Withdrawal by Subject|0
1609315|NCT02134925|5612589|P1|Overall Study|Withdrawal by Subject|1
1609316|NCT02134587|5612622|P1|Overall Study|Did not completed all meetings|30
1609317|NCT02134015|5612761|P2|Overall Study|Withdrawal by Subject|7
1609318|NCT02134015|5612762|P1|Overall Study|Withdrawal by Subject|3
1609319|NCT02134015|5612761|P2|Overall Study|Adverse Event|10
1609320|NCT02134015|5612762|P1|Overall Study|Adverse Event|9
1609321|NCT02134015|5612761|P2|Overall Study|Study terminated by sponsor|3
1609322|NCT02134015|5612762|P1|Overall Study|Study terminated by sponsor|2
1609323|NCT02134015|5612761|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
1609324|NCT02134015|5612762|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
1609325|NCT02134015|5612761|P2|Overall Study|Clinical progression|7
1609326|NCT02134015|5612762|P1|Overall Study|Clinical progression|14
1609327|NCT02134015|5612761|P2|Overall Study|Reason not provided|2
1609328|NCT02134015|5612762|P1|Overall Study|Reason not provided|1
1609329|NCT02134015|5612761|P2|Overall Study|Death|1
1609330|NCT02134015|5612762|P1|Overall Study|Death|2
1609331|NCT02134015|5612761|P2|Overall Study|Protocol Violation|1
1609332|NCT02134015|5612762|P1|Overall Study|Protocol Violation|0
1609337|NCT02133664|5612817|P2|Overall Study|Adverse Event|6
1609338|NCT02133664|5612818|P1|Overall Study|Adverse Event|3
1609339|NCT02133664|5612817|P2|Overall Study|Lost to Follow-up|1
1609340|NCT02133664|5612818|P1|Overall Study|Lost to Follow-up|2
1609341|NCT02133508|5612834|P1|Overall Study|Lost to Follow-up|2
1609342|NCT02133508|5612834|P1|Overall Study|Death|12
1609343|NCT02133508|5612834|P1|Overall Study|Decision of Investigator or Sponsor|1
1609344|NCT02133352|5612842|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
1609345|NCT02133131|5612873|P7|Overall Study|Protocol Violation|1
1609346|NCT02133131|5612874|P6|Overall Study|Protocol Violation|0
1609347|NCT02133131|5612875|P5|Overall Study|Protocol Violation|0
1609348|NCT02133131|5612876|P4|Overall Study|Protocol Violation|0
1609349|NCT02133131|5612877|P3|Overall Study|Protocol Violation|0
1609350|NCT02133131|5612878|P2|Overall Study|Protocol Violation|0
1609351|NCT02133131|5612879|P1|Overall Study|Protocol Violation|0
1609352|NCT02133131|5612873|P7|Overall Study|Ongoing in study|11
1609353|NCT02133131|5612874|P6|Overall Study|Ongoing in study|14
1609354|NCT02133131|5612875|P5|Overall Study|Ongoing in study|15
1609355|NCT02133131|5612876|P4|Overall Study|Ongoing in study|0
1609356|NCT02133131|5612877|P3|Overall Study|Ongoing in study|0
1609357|NCT02133131|5612878|P2|Overall Study|Ongoing in study|0
1609358|NCT02133131|5612879|P1|Overall Study|Ongoing in study|0
1609359|NCT02133131|5612873|P7|Overall Study|Status not recorded|0
1609360|NCT02133131|5612874|P6|Overall Study|Status not recorded|0
1609361|NCT02133131|5612875|P5|Overall Study|Status not recorded|0
1609362|NCT02133131|5612876|P4|Overall Study|Status not recorded|4
1609363|NCT02133131|5612877|P3|Overall Study|Status not recorded|1
1609364|NCT02133131|5612878|P2|Overall Study|Status not recorded|5
1609365|NCT02133131|5612879|P1|Overall Study|Status not recorded|4
1609366|NCT02133131|5612873|P7|Overall Study|Lost to Follow-up|0
1609367|NCT02133131|5612874|P6|Overall Study|Lost to Follow-up|0
1609368|NCT02133131|5612875|P5|Overall Study|Lost to Follow-up|0
1609369|NCT02133131|5612876|P4|Overall Study|Lost to Follow-up|1
1609370|NCT02133131|5612877|P3|Overall Study|Lost to Follow-up|0
1609371|NCT02133131|5612878|P2|Overall Study|Lost to Follow-up|0
1609372|NCT02133131|5612879|P1|Overall Study|Lost to Follow-up|1
1609373|NCT02133131|5612873|P7|Overall Study|Adverse Event|0
1609374|NCT02133131|5612874|P6|Overall Study|Adverse Event|0
1609375|NCT02133131|5612875|P5|Overall Study|Adverse Event|0
1609376|NCT02133131|5612876|P4|Overall Study|Adverse Event|1
1609377|NCT02133131|5612877|P3|Overall Study|Adverse Event|0
1609378|NCT02133131|5612878|P2|Overall Study|Adverse Event|0
1609379|NCT02133131|5612879|P1|Overall Study|Adverse Event|0
1609380|NCT02133001|5612933|P2|Follow-Up Phase (Day 26-81)|Other|1
1609381|NCT02133001|5612934|P1|Follow-Up Phase (Day 26-81)|Other|0
1609382|NCT02133001|5612933|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
1609383|NCT02133001|5612934|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
1609384|NCT02133001|5612933|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
1609385|NCT02133001|5612934|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
1609386|NCT02133001|5612933|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
1609387|NCT02133001|5612934|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
1609388|NCT02133001|5612933|P2|Double Blind (Day 1-25)|Other|2
1609389|NCT02133001|5612934|P1|Double Blind (Day 1-25)|Other|2
1609390|NCT02133001|5612933|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
1609391|NCT02133001|5612934|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
1609392|NCT02133001|5612933|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
1609393|NCT02133001|5612934|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
1609394|NCT02133001|5612933|P2|Double Blind (Day 1-25)|Adverse Event|5
1609395|NCT02133001|5612934|P1|Double Blind (Day 1-25)|Adverse Event|1
1609396|NCT02132949|5612982|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
1609397|NCT02132949|5612983|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
1609398|NCT02132949|5612982|P2|Adjuvant Treatment Period|Protocol Deviation|0
1609399|NCT02132949|5612983|P1|Adjuvant Treatment Period|Protocol Deviation|1
1609400|NCT02132949|5612982|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
1609401|NCT02132949|5612983|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
1609402|NCT02132949|5612982|P2|Adjuvant Treatment Period|Physician Decision|0
1609403|NCT02132949|5612983|P1|Adjuvant Treatment Period|Physician Decision|1
1609404|NCT02132949|5612982|P2|Adjuvant Treatment Period|Disease Relapse|1
1609405|NCT02132949|5612983|P1|Adjuvant Treatment Period|Disease Relapse|0
1609406|NCT02132949|5612982|P2|Adjuvant Treatment Period|Disease Progression|1
1609407|NCT02132949|5612983|P1|Adjuvant Treatment Period|Disease Progression|0
1609408|NCT02132949|5612982|P2|Adjuvant Treatment Period|Reason unspecified|1
1609409|NCT02132949|5612983|P1|Adjuvant Treatment Period|Reason unspecified|0
1609410|NCT02132949|5612982|P2|Adjuvant Treatment Period|Adverse Event|6
1609411|NCT02132949|5612983|P1|Adjuvant Treatment Period|Adverse Event|4
1609412|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
1609413|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
1609414|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Adverse Event|3
1609415|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Adverse Event|6
1609416|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Disease Progression|1
1609417|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Disease Progression|1
1609418|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
1609419|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
1609420|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Physician Decision|0
1609421|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Physician Decision|2
1609422|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
1609423|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
1609424|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Reason unspecified|1
1609425|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Reason unspecified|3
1609426|NCT02132949|5612982|P2|Neoadjuvant Treatment Period|Early surgery|3
1609427|NCT02132949|5612983|P1|Neoadjuvant Treatment Period|Early surgery|4
1609428|NCT02132767|5613095|P2|Overall Study|Lost to Follow-up|4
1609429|NCT02132767|5613096|P1|Overall Study|Lost to Follow-up|4
1609430|NCT02132767|5613095|P2|Overall Study|Withdrawal by Subject|9
1609431|NCT02132767|5613096|P1|Overall Study|Withdrawal by Subject|10
1609432|NCT02132767|5613095|P2|Overall Study|Death|2
1609433|NCT02132767|5613096|P1|Overall Study|Death|3
1609434|NCT02132637|5613118|P2|Study Period 2 (Crossover)|Physician Decision|0
1609435|NCT02132637|5613119|P1|Study Period 2 (Crossover)|Physician Decision|2
1609436|NCT02132637|5613118|P2|Study Period 2 (Crossover)|Adverse Event|1
1609437|NCT02132637|5613119|P1|Study Period 2 (Crossover)|Adverse Event|0
1609438|NCT02132637|5613118|P2|Study Period 1|Physician Decision|0
1609439|NCT02132637|5613119|P1|Study Period 1|Physician Decision|1
1609440|NCT02132637|5613118|P2|Study Period 1|Withdrawal by Subject|4
1609441|NCT02132637|5613119|P1|Study Period 1|Withdrawal by Subject|0
1609442|NCT02132611|5613143|P1|Overall Study|Death|2
1609443|NCT02132247|5613194|P2|Overall Study|Protocol Violation|0
1609444|NCT02132247|5613195|P1|Overall Study|Protocol Violation|1
1609445|NCT02132195|5613210|P3|Rescue Therapy|Adverse Event|2
1609446|NCT02132195|5613211|P2|Rescue Therapy|Adverse Event|0
1609447|NCT02132195|5613212|P1|Rescue Therapy|Adverse Event|0
1609448|NCT02132195|5613210|P3|Rescue Therapy|Withdrawal by Subject|1
1609449|NCT02132195|5613211|P2|Rescue Therapy|Withdrawal by Subject|0
1609450|NCT02132195|5613212|P1|Rescue Therapy|Withdrawal by Subject|0
1609451|NCT02132195|5613210|P3|Rescue Therapy|Physician Decision|1
1609452|NCT02132195|5613211|P2|Rescue Therapy|Physician Decision|0
1609453|NCT02132195|5613212|P1|Rescue Therapy|Physician Decision|0
1609454|NCT02132195|5613210|P3|Rescue Therapy|Relapsed|7
1609455|NCT02132195|5613211|P2|Rescue Therapy|Relapsed|0
1609456|NCT02132195|5613212|P1|Rescue Therapy|Relapsed|0
1609457|NCT02132195|5613210|P3|Initial Assignment|Relapsed|0
1609458|NCT02132195|5613211|P2|Initial Assignment|Relapsed|0
1609459|NCT02132195|5613212|P1|Initial Assignment|Relapsed|14
1609460|NCT02132117|5613243|P2|Overall Study|Other Miscellaneous Reasons|0
1609461|NCT02132117|5613244|P1|Overall Study|Other Miscellaneous Reasons|2
1609462|NCT02132117|5613243|P2|Overall Study|Personal Reasons|2
1609463|NCT02132117|5613244|P1|Overall Study|Personal Reasons|1
1609464|NCT02132117|5613243|P2|Overall Study|Lost to Follow-up|2
1609465|NCT02132117|5613244|P1|Overall Study|Lost to Follow-up|2
1609466|NCT02132117|5613243|P2|Overall Study|Adverse Event|1
1609467|NCT02132117|5613244|P1|Overall Study|Adverse Event|6
1609468|NCT02131662|5613265|P5|Overall Study|Not treated|3
1609469|NCT02131662|5613266|P4|Overall Study|Not treated|2
1609470|NCT02131662|5613267|P3|Overall Study|Not treated|2
1609471|NCT02131662|5613268|P2|Overall Study|Not treated|0
1609472|NCT02131662|5613269|P1|Overall Study|Not treated|2
1609473|NCT02131662|5613265|P5|Overall Study|Lost to Follow-up|0
1609474|NCT02131662|5613266|P4|Overall Study|Lost to Follow-up|9
1609475|NCT02131662|5613267|P3|Overall Study|Lost to Follow-up|0
1609476|NCT02131662|5613268|P2|Overall Study|Lost to Follow-up|3
1609477|NCT02131662|5613269|P1|Overall Study|Lost to Follow-up|1
1609478|NCT02131662|5613265|P5|Overall Study|Withdrawal by Subject|6
1609479|NCT02131662|5613266|P4|Overall Study|Withdrawal by Subject|5
1609480|NCT02131662|5613267|P3|Overall Study|Withdrawal by Subject|1
1609481|NCT02131662|5613268|P2|Overall Study|Withdrawal by Subject|5
1609482|NCT02131662|5613269|P1|Overall Study|Withdrawal by Subject|1
1609483|NCT02131662|5613265|P5|Overall Study|Lack of Efficacy|1
1609484|NCT02131662|5613266|P4|Overall Study|Lack of Efficacy|0
1609485|NCT02131662|5613267|P3|Overall Study|Lack of Efficacy|0
1609486|NCT02131662|5613268|P2|Overall Study|Lack of Efficacy|0
1609487|NCT02131662|5613269|P1|Overall Study|Lack of Efficacy|1
1609488|NCT02131662|5613265|P5|Overall Study|Wish for pregnancy|1
1609489|NCT02131662|5613266|P4|Overall Study|Wish for pregnancy|0
1609490|NCT02131662|5613267|P3|Overall Study|Wish for pregnancy|0
1609491|NCT02131662|5613268|P2|Overall Study|Wish for pregnancy|0
1609492|NCT02131662|5613269|P1|Overall Study|Wish for pregnancy|0
1609493|NCT02131662|5613265|P5|Overall Study|Pregnancy|0
1609494|NCT02131662|5613266|P4|Overall Study|Pregnancy|1
1609495|NCT02131662|5613267|P3|Overall Study|Pregnancy|0
1609496|NCT02131662|5613268|P2|Overall Study|Pregnancy|1
1609497|NCT02131662|5613269|P1|Overall Study|Pregnancy|0
1609498|NCT02131662|5613265|P5|Overall Study|Adverse Event|3
1609499|NCT02131662|5613266|P4|Overall Study|Adverse Event|1
1609500|NCT02131662|5613267|P3|Overall Study|Adverse Event|1
1609501|NCT02131662|5613268|P2|Overall Study|Adverse Event|1
1609502|NCT02131662|5613269|P1|Overall Study|Adverse Event|0
1609503|NCT02131662|5613265|P5|Overall Study|Other|4
1609504|NCT02131662|5613266|P4|Overall Study|Other|3
1609505|NCT02131662|5613267|P3|Overall Study|Other|3
1609506|NCT02131662|5613268|P2|Overall Study|Other|4
1609507|NCT02131662|5613269|P1|Overall Study|Other|2
1609508|NCT02131662|5613265|P5|Overall Study|Protocol Violation|0
1609509|NCT02131662|5613266|P4|Overall Study|Protocol Violation|0
1609510|NCT02131662|5613267|P3|Overall Study|Protocol Violation|0
1609511|NCT02131662|5613268|P2|Overall Study|Protocol Violation|0
1609512|NCT02131662|5613269|P1|Overall Study|Protocol Violation|1
1609513|NCT02131636|5613315|P2|Overall Study|Adverse Event|1
1609514|NCT02131636|5613316|P1|Overall Study|Adverse Event|4
1609515|NCT02131636|5613315|P2|Overall Study|Lost to Follow-up|0
1609516|NCT02131636|5613316|P1|Overall Study|Lost to Follow-up|4
1609517|NCT02131636|5613315|P2|Overall Study|Personal Reasons|4
1609518|NCT02131636|5613316|P1|Overall Study|Personal Reasons|4
1609519|NCT02131532|5613332|P1|Overall Study|Other health conditions|2
1609520|NCT02131532|5613332|P1|Overall Study|Physician Decision|1
1609521|NCT02131532|5613332|P1|Overall Study|Withdrawal by Subject|1
1609522|NCT02131324|5613424|P2|Overall Study|Lost to Follow-up|1
1609523|NCT02131324|5613425|P1|Overall Study|Lost to Follow-up|1
1609524|NCT02131324|5613424|P2|Overall Study|Withdrawal by Subject|2
1609525|NCT02131324|5613425|P1|Overall Study|Withdrawal by Subject|1
1609526|NCT02131311|5613431|P1|Overall Study|Lost to Follow-up|1
1609527|NCT02131311|5613431|P1|Overall Study|Protocol Violation|1
1609528|NCT02131311|5613431|P1|Overall Study|Adverse Event|2
1609529|NCT02131272|5613443|P2|Overall Study|Withdrawal Criteria|0
1609530|NCT02131272|5613444|P1|Overall Study|Withdrawal Criteria|1
1609531|NCT02131272|5613443|P2|Overall Study|Withdrawal by Subject|1
1609532|NCT02131272|5613444|P1|Overall Study|Withdrawal by Subject|0
1609533|NCT02131272|5613443|P2|Overall Study|Withdrawal by parent|1
1609534|NCT02131272|5613444|P1|Overall Study|Withdrawal by parent|0
1609535|NCT02131259|5613462|P1|Overall Study|Missing|3
1609536|NCT02131259|5613462|P1|Overall Study|Progressive disease/AE/other|1
1609537|NCT02131259|5613462|P1|Overall Study|AE/other|1
1609538|NCT02131259|5613462|P1|Overall Study|AE/lost to follow-up|1
1609539|NCT02131259|5613462|P1|Overall Study|Progressive disease/other|2
1609540|NCT02131259|5613462|P1|Overall Study|Progressive disease/relocation|1
1609541|NCT02131259|5613462|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
1609542|NCT02131259|5613462|P1|Overall Study|Other|63
1609543|NCT02131259|5613462|P1|Overall Study|Relocation|32
1609544|NCT02131259|5613462|P1|Overall Study|Lost to Follow-up|7
1609545|NCT02131259|5613462|P1|Overall Study|Adverse Event|341
1609546|NCT02131259|5613462|P1|Overall Study|Progressive disease|751
1609547|NCT02131233|5613469|P2|Overall Study|Withdrawal by Subject|11
1609548|NCT02131233|5613470|P1|Overall Study|Withdrawal by Subject|18
1609549|NCT02131233|5613469|P2|Overall Study|Pregnancy|0
1609550|NCT02131233|5613470|P1|Overall Study|Pregnancy|4
1609551|NCT02131233|5613469|P2|Overall Study|Physician Decision|0
1609552|NCT02131233|5613470|P1|Overall Study|Physician Decision|7
1609553|NCT02131233|5613469|P2|Overall Study|Non-Compliance With Study Drug|5
1609554|NCT02131233|5613470|P1|Overall Study|Non-Compliance With Study Drug|8
1609555|NCT02131233|5613469|P2|Overall Study|Lost to Follow-up|13
1609556|NCT02131233|5613470|P1|Overall Study|Lost to Follow-up|14
1609557|NCT02131233|5613469|P2|Overall Study|Lack of Efficacy|3
1609558|NCT02131233|5613470|P1|Overall Study|Lack of Efficacy|6
1609559|NCT02131233|5613469|P2|Overall Study|Death|1
1609560|NCT02131233|5613470|P1|Overall Study|Death|0
1609561|NCT02131233|5613469|P2|Overall Study|Adverse Event|6
1609562|NCT02131233|5613470|P1|Overall Study|Adverse Event|7
1609563|NCT02131233|5613469|P2|Overall Study|Not Treated|3
1609564|NCT02131233|5613470|P1|Overall Study|Not Treated|2
1609565|NCT02131155|5613504|P2|Overall Study|Study early termination|10
1609566|NCT02131155|5613505|P1|Overall Study|Study early termination|20
1609567|NCT02131155|5613504|P2|Overall Study|Refused to continue study medication|0
1609568|NCT02131155|5613505|P1|Overall Study|Refused to continue study medication|1
1609569|NCT02131155|5613504|P2|Overall Study|Primary tumour recurrence|1
1609570|NCT02131155|5613505|P1|Overall Study|Primary tumour recurrence|2
1609571|NCT02131155|5613504|P2|Overall Study|Treatment completed|0
1609572|NCT02131155|5613505|P1|Overall Study|Treatment completed|1
1609573|NCT02131155|5613504|P2|Overall Study|Adverse Event|0
1609574|NCT02131155|5613505|P1|Overall Study|Adverse Event|1
1609575|NCT02131129|5613519|P2|Overall Study|Withdrawal by Subject|0
1609576|NCT02131129|5613520|P1|Overall Study|Withdrawal by Subject|1
1609577|NCT02131064|5613538|P2|Overall Study|Other|2
1609578|NCT02131064|5613539|P1|Overall Study|Other|2
1609579|NCT02131064|5613538|P2|Overall Study|Withdrawal by Subject|18
1609580|NCT02131064|5613539|P1|Overall Study|Withdrawal by Subject|14
1609581|NCT02131064|5613538|P2|Overall Study|Lost to Follow-up|8
1609582|NCT02131064|5613539|P1|Overall Study|Lost to Follow-up|4
1609583|NCT02131064|5613538|P2|Overall Study|Death|6
1609584|NCT02131064|5613539|P1|Overall Study|Death|5
1609585|NCT02130986|5613608|P2|Overall Study|Lost to Follow-up|160
1609586|NCT02130986|5613609|P1|Overall Study|Lost to Follow-up|151
1609587|NCT02130986|5613608|P2|Overall Study|Withdrawal by Subject|4
1609588|NCT02130986|5613609|P1|Overall Study|Withdrawal by Subject|4
1609589|NCT02130765|5613623|P4|Overall Study|Did not receive treatment|0
1609590|NCT02130765|5613624|P3|Overall Study|Did not receive treatment|0
1609591|NCT02130765|5613625|P2|Overall Study|Did not receive treatment|0
1609592|NCT02130765|5613626|P1|Overall Study|Did not receive treatment|4
1609593|NCT02130570|5613872|P2|Overall Study|Part of practice that discontinued study|5
1609594|NCT02130570|5613873|P1|Overall Study|Part of practice that discontinued study|0
1609595|NCT02130570|5613872|P2|Overall Study|Withdrawal by Subject|3
1609596|NCT02130570|5613873|P1|Overall Study|Withdrawal by Subject|6
1609597|NCT02130570|5613872|P2|Overall Study|Death|5
1609598|NCT02130570|5613873|P1|Overall Study|Death|3
1609599|NCT02130557|5613891|P2|Overall Study|Ongoing|255
1609600|NCT02130557|5613892|P1|Overall Study|Ongoing|260
1609601|NCT02130557|5613891|P2|Overall Study|Deceased|6
1609602|NCT02130557|5613892|P1|Overall Study|Deceased|1
1609603|NCT02130557|5613891|P2|Overall Study|Lost to Follow-up|2
1609604|NCT02130557|5613892|P1|Overall Study|Lost to Follow-up|2
1609605|NCT02130557|5613891|P2|Overall Study|Withdrawal by Subject|2
1609606|NCT02130557|5613892|P1|Overall Study|Withdrawal by Subject|5
1609607|NCT02130557|5613891|P2|Overall Study|Randomized, not treated|3
1609608|NCT02130557|5613892|P1|Overall Study|Randomized, not treated|0
1609609|NCT02130284|5613924|P1|Overall Study|Screen Failure|1
1609610|NCT02130284|5613924|P1|Overall Study|Subject was screened as backup for study|3
1609611|NCT02130284|5613924|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
1609612|NCT02130284|5613924|P1|Overall Study|Subject Withdrew Consent|1
1609613|NCT02130284|5613924|P1|Overall Study|Withdrawal by Subject|3
1609614|NCT02130193|5613950|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1609615|NCT02130193|5613951|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
1609616|NCT02130193|5613952|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
1609617|NCT02130193|5613950|P3|Part B: 52-week Double-blind Period|Physician Decision|1
1609618|NCT02130193|5613951|P2|Part B: 52-week Double-blind Period|Physician Decision|0
1609619|NCT02130193|5613952|P1|Part B: 52-week Double-blind Period|Physician Decision|0
1609620|NCT02130193|5613950|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
1609621|NCT02130193|5613951|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
1609622|NCT02130193|5613952|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
1609623|NCT02130193|5613950|P3|Part B: 52-week Double-blind Period|Adverse Event|3
1609624|NCT02130193|5613951|P2|Part B: 52-week Double-blind Period|Adverse Event|5
1609625|NCT02130193|5613952|P1|Part B: 52-week Double-blind Period|Adverse Event|0
1609626|NCT02130024|5614033|P2|Overall Study|Subject Withdrew Consent|14
1609627|NCT02130024|5614034|P1|Overall Study|Subject Withdrew Consent|6
1609628|NCT02130024|5614033|P2|Overall Study|Site Administration Problems|0
1609629|NCT02130024|5614034|P1|Overall Study|Site Administration Problems|1
1609630|NCT02130024|5614033|P2|Overall Study|Protocol Deviation|0
1609631|NCT02130024|5614034|P1|Overall Study|Protocol Deviation|4
1609632|NCT02130024|5614033|P2|Overall Study|Physician Decision|3
1609633|NCT02130024|5614034|P1|Overall Study|Physician Decision|1
1609634|NCT02130024|5614033|P2|Overall Study|Lost to Follow-up|1
1609635|NCT02130024|5614034|P1|Overall Study|Lost to Follow-up|1
1609636|NCT02130024|5614033|P2|Overall Study|Death|2
1609637|NCT02130024|5614034|P1|Overall Study|Death|2
1609638|NCT02130024|5614033|P2|Overall Study|Adverse Event|11
1609639|NCT02130024|5614034|P1|Overall Study|Adverse Event|10
1609640|NCT02129777|5614071|P7|Open-Label Period|Study Termination|39
1609641|NCT02129777|5614072|P6|Open-Label Period|Study Termination|10
1609642|NCT02129777|5614073|P5|Open-Label Period|Study Termination|0
1609643|NCT02129777|5614074|P4|Open-Label Period|Study Termination|0
1609644|NCT02129777|5614075|P3|Open-Label Period|Study Termination|0
1609645|NCT02129777|5614076|P2|Open-Label Period|Study Termination|0
1609646|NCT02129777|5614077|P1|Open-Label Period|Study Termination|0
1609647|NCT02129777|5614071|P7|Open-Label Period|Withdrawal by Subject|3
1609648|NCT02129777|5614072|P6|Open-Label Period|Withdrawal by Subject|1
1609649|NCT02129777|5614073|P5|Open-Label Period|Withdrawal by Subject|0
1609650|NCT02129777|5614074|P4|Open-Label Period|Withdrawal by Subject|0
1609651|NCT02129777|5614075|P3|Open-Label Period|Withdrawal by Subject|0
1609652|NCT02129777|5614076|P2|Open-Label Period|Withdrawal by Subject|0
1609653|NCT02129777|5614077|P1|Open-Label Period|Withdrawal by Subject|0
1609654|NCT02129777|5614071|P7|Open-Label Period|Lost to Follow-up|1
1609655|NCT02129777|5614072|P6|Open-Label Period|Lost to Follow-up|1
1609656|NCT02129777|5614073|P5|Open-Label Period|Lost to Follow-up|0
1609657|NCT02129777|5614074|P4|Open-Label Period|Lost to Follow-up|0
1609658|NCT02129777|5614075|P3|Open-Label Period|Lost to Follow-up|0
1609659|NCT02129777|5614076|P2|Open-Label Period|Lost to Follow-up|0
1609660|NCT02129777|5614077|P1|Open-Label Period|Lost to Follow-up|0
1609661|NCT02129777|5614071|P7|Open-Label Period|Lack of Efficacy|5
1609662|NCT02129777|5614072|P6|Open-Label Period|Lack of Efficacy|0
1609663|NCT02129777|5614073|P5|Open-Label Period|Lack of Efficacy|0
1609664|NCT02129777|5614074|P4|Open-Label Period|Lack of Efficacy|0
1609665|NCT02129777|5614075|P3|Open-Label Period|Lack of Efficacy|0
1609666|NCT02129777|5614076|P2|Open-Label Period|Lack of Efficacy|0
1609667|NCT02129777|5614077|P1|Open-Label Period|Lack of Efficacy|0
1609668|NCT02129777|5614071|P7|Double-Blind Period|Other|0
1609669|NCT02129777|5614072|P6|Double-Blind Period|Other|0
1609670|NCT02129777|5614073|P5|Double-Blind Period|Other|0
1609671|NCT02129777|5614074|P4|Double-Blind Period|Other|0
1609672|NCT02129777|5614075|P3|Double-Blind Period|Other|0
1609673|NCT02129777|5614076|P2|Double-Blind Period|Other|2
1609674|NCT02129777|5614077|P1|Double-Blind Period|Other|1
1609675|NCT02129777|5614071|P7|Double-Blind Period|Lack of Efficacy|0
1609676|NCT02129777|5614072|P6|Double-Blind Period|Lack of Efficacy|0
1609677|NCT02129777|5614073|P5|Double-Blind Period|Lack of Efficacy|2
1609678|NCT02129777|5614074|P4|Double-Blind Period|Lack of Efficacy|3
1609679|NCT02129777|5614075|P3|Double-Blind Period|Lack of Efficacy|0
1609680|NCT02129777|5614076|P2|Double-Blind Period|Lack of Efficacy|1
1609681|NCT02129777|5614077|P1|Double-Blind Period|Lack of Efficacy|3
1609682|NCT02129777|5614071|P7|Double-Blind Period|Pregnancy|0
1609683|NCT02129777|5614072|P6|Double-Blind Period|Pregnancy|0
1609684|NCT02129777|5614073|P5|Double-Blind Period|Pregnancy|1
1609685|NCT02129777|5614074|P4|Double-Blind Period|Pregnancy|0
1609686|NCT02129777|5614075|P3|Double-Blind Period|Pregnancy|0
1609687|NCT02129777|5614076|P2|Double-Blind Period|Pregnancy|0
1609688|NCT02129777|5614077|P1|Double-Blind Period|Pregnancy|0
1609689|NCT02129777|5614071|P7|Double-Blind Period|Withdrawal by Subject|0
1609690|NCT02129777|5614072|P6|Double-Blind Period|Withdrawal by Subject|0
1609691|NCT02129777|5614073|P5|Double-Blind Period|Withdrawal by Subject|3
1609692|NCT02129777|5614074|P4|Double-Blind Period|Withdrawal by Subject|2
1609693|NCT02129777|5614075|P3|Double-Blind Period|Withdrawal by Subject|3
1609694|NCT02129777|5614076|P2|Double-Blind Period|Withdrawal by Subject|4
1609695|NCT02129777|5614077|P1|Double-Blind Period|Withdrawal by Subject|2
1609696|NCT02129777|5614071|P7|Double-Blind Period|Lost to Follow-up|0
1609697|NCT02129777|5614072|P6|Double-Blind Period|Lost to Follow-up|0
1609698|NCT02129777|5614073|P5|Double-Blind Period|Lost to Follow-up|0
1609699|NCT02129777|5614074|P4|Double-Blind Period|Lost to Follow-up|2
1609700|NCT02129777|5614075|P3|Double-Blind Period|Lost to Follow-up|1
1609701|NCT02129777|5614076|P2|Double-Blind Period|Lost to Follow-up|1
1609702|NCT02129777|5614077|P1|Double-Blind Period|Lost to Follow-up|1
1609703|NCT02129777|5614071|P7|Double-Blind Period|Adverse Event|0
1609704|NCT02129777|5614072|P6|Double-Blind Period|Adverse Event|0
1609705|NCT02129777|5614073|P5|Double-Blind Period|Adverse Event|1
1609706|NCT02129777|5614074|P4|Double-Blind Period|Adverse Event|0
1609707|NCT02129777|5614075|P3|Double-Blind Period|Adverse Event|0
1609708|NCT02129777|5614076|P2|Double-Blind Period|Adverse Event|0
1609709|NCT02129777|5614077|P1|Double-Blind Period|Adverse Event|0
1609710|NCT02129608|5614244|P3|Overall Study|Withdrawal by Subject|2
1609711|NCT02129608|5614245|P2|Overall Study|Withdrawal by Subject|0
1609712|NCT02129608|5614246|P1|Overall Study|Withdrawal by Subject|0
1609713|NCT02129608|5614244|P3|Overall Study|Lost to Follow-up|1
1609714|NCT02129608|5614245|P2|Overall Study|Lost to Follow-up|1
1609715|NCT02129608|5614246|P1|Overall Study|Lost to Follow-up|0
1609716|NCT02129205|5614297|P10|Overall Study|Other|0
1609717|NCT02129205|5614298|P9|Overall Study|Other|1
1609718|NCT02129205|5614299|P8|Overall Study|Other|2
1609719|NCT02129205|5614300|P7|Overall Study|Other|3
1609720|NCT02129205|5614301|P6|Overall Study|Other|3
1609721|NCT02129205|5614302|P5|Overall Study|Other|2
1609722|NCT02129205|5614303|P4|Overall Study|Other|0
1609723|NCT02129205|5614304|P3|Overall Study|Other|0
1609724|NCT02129205|5614305|P2|Overall Study|Other|0
1609725|NCT02129205|5614306|P1|Overall Study|Other|1
1609726|NCT02129205|5614297|P10|Overall Study|Withdrawal by Subject|0
1609727|NCT02129205|5614298|P9|Overall Study|Withdrawal by Subject|1
1609728|NCT02129205|5614299|P8|Overall Study|Withdrawal by Subject|0
1609729|NCT02129205|5614300|P7|Overall Study|Withdrawal by Subject|1
1609730|NCT02129205|5614301|P6|Overall Study|Withdrawal by Subject|1
1609731|NCT02129205|5614302|P5|Overall Study|Withdrawal by Subject|1
1609732|NCT02129205|5614303|P4|Overall Study|Withdrawal by Subject|0
1609733|NCT02129205|5614304|P3|Overall Study|Withdrawal by Subject|0
1609734|NCT02129205|5614305|P2|Overall Study|Withdrawal by Subject|0
1609735|NCT02129205|5614306|P1|Overall Study|Withdrawal by Subject|0
1609736|NCT02129192|5614459|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
1609737|NCT02129192|5614460|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
1609738|NCT02129062|5614477|P1|Overall Study|Disease Progression|2
1609739|NCT02129062|5614477|P1|Overall Study|Death|1
1609740|NCT02128997|5614484|P2|Overall Study|Lost to Follow-up|11
1609741|NCT02128997|5614485|P1|Overall Study|Lost to Follow-up|6
1609742|NCT02128932|5614500|P3|Overall Study|No reason for withdrawal|7
1609743|NCT02128932|5614501|P2|Overall Study|No reason for withdrawal|11
1609744|NCT02128932|5614502|P1|Overall Study|No reason for withdrawal|12
1609745|NCT02128932|5614500|P3|Overall Study|Lost to Follow-up|1
1609746|NCT02128932|5614501|P2|Overall Study|Lost to Follow-up|1
1609747|NCT02128932|5614502|P1|Overall Study|Lost to Follow-up|2
1609748|NCT02128932|5614500|P3|Overall Study|Death|2
1609749|NCT02128932|5614501|P2|Overall Study|Death|0
1609750|NCT02128932|5614502|P1|Overall Study|Death|2
1609751|NCT02128932|5614500|P3|Overall Study|Withdrawal by Subject|8
1609752|NCT02128932|5614501|P2|Overall Study|Withdrawal by Subject|7
1609753|NCT02128932|5614502|P1|Overall Study|Withdrawal by Subject|11
1609754|NCT02128763|5614559|P2|Overall Study|Lost to Follow-up|16
1609755|NCT02128763|5614560|P1|Overall Study|Lost to Follow-up|19
1609756|NCT02128763|5614559|P2|Overall Study|Death|0
1609757|NCT02128763|5614560|P1|Overall Study|Death|1
1609758|NCT02128724|5614606|P4|Overall Study|Withdrawal by Subject|1
1609759|NCT02128724|5614607|P3|Overall Study|Withdrawal by Subject|0
1609760|NCT02128724|5614608|P2|Overall Study|Withdrawal by Subject|0
1609761|NCT02128724|5614609|P1|Overall Study|Withdrawal by Subject|0
1609762|NCT02128724|5614606|P4|Overall Study|Physician Decision|2
1609763|NCT02128724|5614607|P3|Overall Study|Physician Decision|0
1609764|NCT02128724|5614608|P2|Overall Study|Physician Decision|0
1609765|NCT02128724|5614609|P1|Overall Study|Physician Decision|0
1609766|NCT02128724|5614606|P4|Overall Study|Adverse Event|0
1609767|NCT02128724|5614607|P3|Overall Study|Adverse Event|0
1609768|NCT02128724|5614608|P2|Overall Study|Adverse Event|1
1609769|NCT02128724|5614609|P1|Overall Study|Adverse Event|0
1609770|NCT02128724|5614606|P4|Overall Study|Death|0
1609771|NCT02128724|5614607|P3|Overall Study|Death|0
1609772|NCT02128724|5614608|P2|Overall Study|Death|0
1609773|NCT02128724|5614609|P1|Overall Study|Death|1
1609774|NCT02128542|5614664|P2|Overall Study|Withdrew Consent|0
1609775|NCT02128542|5614665|P1|Overall Study|Withdrew Consent|1
1609776|NCT02128542|5614664|P2|Overall Study|Lost to Follow-up|0
1609777|NCT02128542|5614665|P1|Overall Study|Lost to Follow-up|3
1609778|NCT02128490|5614683|P5|Overall Study|Other Miscellaneous Reasons|1
1609779|NCT02128490|5614684|P4|Overall Study|Other Miscellaneous Reasons|1
1609780|NCT02128490|5614685|P3|Overall Study|Other Miscellaneous Reasons|2
1609781|NCT02128490|5614686|P2|Overall Study|Other Miscellaneous Reasons|0
1609782|NCT02128490|5614687|P1|Overall Study|Other Miscellaneous Reasons|0
1609783|NCT02128490|5614683|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
1609784|NCT02128490|5614684|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
1609785|NCT02128490|5614685|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
1609786|NCT02128490|5614686|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
1609787|NCT02128490|5614687|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
1609788|NCT02128490|5614683|P5|Overall Study|Lack of Efficacy|0
1609789|NCT02128490|5614684|P4|Overall Study|Lack of Efficacy|0
1609790|NCT02128490|5614685|P3|Overall Study|Lack of Efficacy|0
1609791|NCT02128490|5614686|P2|Overall Study|Lack of Efficacy|1
1609792|NCT02128490|5614687|P1|Overall Study|Lack of Efficacy|0
1609793|NCT02128490|5614683|P5|Overall Study|Voluntary Withdrawal|2
1609794|NCT02128490|5614684|P4|Overall Study|Voluntary Withdrawal|1
1609795|NCT02128490|5614685|P3|Overall Study|Voluntary Withdrawal|1
1609796|NCT02128490|5614686|P2|Overall Study|Voluntary Withdrawal|3
1609797|NCT02128490|5614687|P1|Overall Study|Voluntary Withdrawal|3
1609798|NCT02128490|5614683|P5|Overall Study|Lost to Follow-up|1
1609799|NCT02128490|5614684|P4|Overall Study|Lost to Follow-up|1
1609800|NCT02128490|5614685|P3|Overall Study|Lost to Follow-up|1
1609801|NCT02128490|5614686|P2|Overall Study|Lost to Follow-up|0
1609802|NCT02128490|5614687|P1|Overall Study|Lost to Follow-up|0
1609803|NCT02128490|5614683|P5|Overall Study|Major Protocol Deviation|2
1609804|NCT02128490|5614684|P4|Overall Study|Major Protocol Deviation|2
1609805|NCT02128490|5614685|P3|Overall Study|Major Protocol Deviation|0
1609806|NCT02128490|5614686|P2|Overall Study|Major Protocol Deviation|2
1609807|NCT02128490|5614687|P1|Overall Study|Major Protocol Deviation|1
1609808|NCT02128490|5614683|P5|Overall Study|Pretreatment Event/Adverse Event|0
1609809|NCT02128490|5614684|P4|Overall Study|Pretreatment Event/Adverse Event|1
1609810|NCT02128490|5614685|P3|Overall Study|Pretreatment Event/Adverse Event|1
1609811|NCT02128490|5614686|P2|Overall Study|Pretreatment Event/Adverse Event|0
1609812|NCT02128490|5614687|P1|Overall Study|Pretreatment Event/Adverse Event|1
1609813|NCT02128269|5614709|P1|Treatment Period|Physician Decision|1
1609814|NCT02128269|5614709|P1|Treatment Period|Adverse Event|1
1609815|NCT02128217|5614715|P2|Overall Study|Lost to Follow-up|1
1609816|NCT02128217|5614716|P1|Overall Study|Lost to Follow-up|0
1609817|NCT02127970|5614764|P2|Overall Study|Subject Withdrew Consent|3
1609818|NCT02127970|5614765|P1|Overall Study|Subject Withdrew Consent|5
1609819|NCT02127970|5614764|P2|Overall Study|Pregnancy|1
1609820|NCT02127970|5614765|P1|Overall Study|Pregnancy|0
1609821|NCT02127970|5614764|P2|Overall Study|Reason not Specified|7
1609822|NCT02127970|5614765|P1|Overall Study|Reason not Specified|4
1609823|NCT02127970|5614764|P2|Overall Study|Lost to Follow-up|14
1609824|NCT02127970|5614765|P1|Overall Study|Lost to Follow-up|14
1609825|NCT02127970|5614764|P2|Overall Study|Death|1
1609826|NCT02127970|5614765|P1|Overall Study|Death|1
1609827|NCT02127970|5614764|P2|Overall Study|Adverse Event|1
1609828|NCT02127970|5614765|P1|Overall Study|Adverse Event|2
1609829|NCT02127931|5614787|P1|Overall Study|Glitch in Game|1
1609830|NCT02127372|5614906|P2|Overall Study|Withdrawal by Subject|0
1609831|NCT02127372|5614907|P1|Overall Study|Withdrawal by Subject|1
1609832|NCT02127307|5614917|P1|Overall Study|Other than specified above|169
1609833|NCT02127307|5614917|P1|Overall Study|Death|101
1609834|NCT02127307|5614917|P1|Overall Study|Lost to Follow-up|2
1609835|NCT02127307|5614917|P1|Overall Study|Protocol Violation|36
1609836|NCT02127281|5614923|P2|Overall Study|Lost to Follow-up|0
1609837|NCT02127281|5614924|P1|Overall Study|Lost to Follow-up|1
1609838|NCT02126969|5614952|P2|Overall Study|Withdrawal by Subject|2
1609839|NCT02126969|5614953|P1|Overall Study|Withdrawal by Subject|1
1609840|NCT02126839|5614963|P2|Overall Study|Other|5
1609841|NCT02126839|5614964|P1|Overall Study|Other|5
1609842|NCT02126839|5614963|P2|Overall Study|Lost to Follow-up|4
1609843|NCT02126839|5614964|P1|Overall Study|Lost to Follow-up|1
1609844|NCT02126839|5614963|P2|Overall Study|Sponsor request|1
1609845|NCT02126839|5614964|P1|Overall Study|Sponsor request|0
1609846|NCT02126839|5614963|P2|Overall Study|Protocol Violation|3
1609847|NCT02126839|5614964|P1|Overall Study|Protocol Violation|2
1609848|NCT02126839|5614963|P2|Overall Study|Withdrawal by parent/guardian|0
1609849|NCT02126839|5614964|P1|Overall Study|Withdrawal by parent/guardian|1
1609850|NCT02126839|5614963|P2|Overall Study|Withdrawal by Subject|0
1609851|NCT02126839|5614964|P1|Overall Study|Withdrawal by Subject|1
1609852|NCT02126839|5614963|P2|Overall Study|Adverse Event|1
1609853|NCT02126839|5614964|P1|Overall Study|Adverse Event|0
1609854|NCT02126826|5614981|P7|Overall Study|Withdrawal by Subject|0
1609855|NCT02126826|5614982|P6|Overall Study|Withdrawal by Subject|0
1609856|NCT02126826|5614983|P5|Overall Study|Withdrawal by Subject|0
1609857|NCT02126826|5614984|P4|Overall Study|Withdrawal by Subject|1
1609858|NCT02126826|5614985|P3|Overall Study|Withdrawal by Subject|0
1609859|NCT02126826|5614986|P2|Overall Study|Withdrawal by Subject|0
1609860|NCT02126826|5614987|P1|Overall Study|Withdrawal by Subject|0
1609861|NCT02126670|5615055|P4|Overall Study|Withdrawal by Subject|1
1609862|NCT02126670|5615056|P3|Overall Study|Withdrawal by Subject|0
1609863|NCT02126670|5615057|P2|Overall Study|Withdrawal by Subject|0
1609864|NCT02126670|5615058|P1|Overall Study|Withdrawal by Subject|1
1609865|NCT02125877|5615110|P2|Overall Study|Adverse Event|4
1609866|NCT02125877|5615111|P1|Overall Study|Adverse Event|6
1609867|NCT02125877|5615110|P2|Overall Study|Protocol deviation|1
1609868|NCT02125877|5615111|P1|Overall Study|Protocol deviation|4
1609869|NCT02125877|5615110|P2|Overall Study|Withdrawal by Subject|1
1609870|NCT02125877|5615111|P1|Overall Study|Withdrawal by Subject|2
1609871|NCT02125877|5615110|P2|Overall Study|Participant/guardian decision|2
1609872|NCT02125877|5615111|P1|Overall Study|Participant/guardian decision|0
1609873|NCT02125877|5615110|P2|Overall Study|Administrative problems|1
1609874|NCT02125877|5615111|P1|Overall Study|Administrative problems|0
1609875|NCT02125877|5615110|P2|Overall Study|Death|1
1609876|NCT02125877|5615111|P1|Overall Study|Death|0
1609877|NCT02125877|5615110|P2|Overall Study|Physician Decision|0
1609878|NCT02125877|5615111|P1|Overall Study|Physician Decision|1
1609879|NCT02125838|5615141|P2|Overall Study|Lost to Follow-up|4
1609880|NCT02125838|5615142|P1|Overall Study|Lost to Follow-up|4
1609881|NCT02125734|5615160|P2|Period 2|Adverse Event|1
1609882|NCT02125734|5615161|P1|Period 2|Adverse Event|0
1609883|NCT02125604|5615171|P1|Overall Study|Adverse Event|20
1609884|NCT02125604|5615171|P1|Overall Study|Consent Withdrawn|4
1609885|NCT02125604|5615171|P1|Overall Study|Lost to Follow-up|2
1609886|NCT02125604|5615171|P1|Overall Study|Investigator Decision|1
1609887|NCT02125604|5615171|P1|Overall Study|Other|4
1609888|NCT02125461|5615187|P2|Overall Study|Death|115
1609889|NCT02125461|5615188|P1|Overall Study|Death|180
1609890|NCT02125461|5615187|P2|Overall Study|Lost to Follow-up|0
1609891|NCT02125461|5615188|P1|Overall Study|Lost to Follow-up|1
1609892|NCT02125461|5615187|P2|Overall Study|Withdrawal by Subject|14
1609893|NCT02125461|5615188|P1|Overall Study|Withdrawal by Subject|22
1609894|NCT02125279|5615243|P1|Overall Study|Lost to Follow-up|4
1609895|NCT02125279|5615243|P1|Overall Study|Protocol Violation|1
1609896|NCT02125279|5615243|P1|Overall Study|Withdrawal by Subject|6
1609897|NCT02125279|5615243|P1|Overall Study|Lack of Efficacy|2
1609898|NCT02124811|5615287|P2|Overall Study|Withdrawal by Subject|0
1609899|NCT02124811|5615288|P1|Overall Study|Withdrawal by Subject|1
1609900|NCT02124811|5615287|P2|Overall Study|Early termination|2
1609901|NCT02124811|5615288|P1|Overall Study|Early termination|2
1609902|NCT02124798|5615304|P1|Overall Study|Lost to Follow-up|1
1609903|NCT02124798|5615304|P1|Overall Study|Adverse Event|3
1609904|NCT02124564|5615316|P1|Treatment Period|Withdrawal by Subject|2
1609905|NCT02124564|5615316|P1|Treatment Period|Lack of Efficacy|3
1609906|NCT02124564|5615316|P1|Treatment Period|Adverse Event|2
1609907|NCT02124265|5615381|P1|Overall Study|Adverse Event|1
1609908|NCT02124161|5615387|P2|Overall Study|Lost to Follow-up|4
1609909|NCT02124161|5615388|P1|Overall Study|Lost to Follow-up|3
1609910|NCT02124161|5615387|P2|Overall Study|No longer meets eligibility criteria|4
1609911|NCT02124161|5615388|P1|Overall Study|No longer meets eligibility criteria|5
1609912|NCT02124161|5615387|P2|Overall Study|Does not meet entrance criteria|3
1609913|NCT02124161|5615388|P1|Overall Study|Does not meet entrance criteria|2
1609914|NCT02124161|5615387|P2|Overall Study|Adverse Event|0
1609915|NCT02124161|5615388|P1|Overall Study|Adverse Event|2
1609916|NCT02124161|5615387|P2|Overall Study|Withdrawal by Subject|2
1609917|NCT02124161|5615388|P1|Overall Study|Withdrawal by Subject|1
1609918|NCT02124161|5615387|P2|Overall Study|Protocol Violation|1
1609919|NCT02124161|5615388|P1|Overall Study|Protocol Violation|2
1609920|NCT02124161|5615387|P2|Overall Study|Death|0
1609921|NCT02124161|5615388|P1|Overall Study|Death|1
1609922|NCT02124161|5615387|P2|Overall Study|Other unspecified|1
1609923|NCT02124161|5615388|P1|Overall Study|Other unspecified|0
1609924|NCT02123966|5615463|P1|Overall Study|Intercurrent Illness|1
1609925|NCT02123576|5615505|P2|Overall Study|Adverse Event|0
1609926|NCT02123576|5615506|P1|Overall Study|Adverse Event|1
1609927|NCT02123511|5615524|P2|Overall Study|Ineligible|1
1609928|NCT02123511|5615525|P1|Overall Study|Ineligible|0
1609929|NCT02123511|5615524|P2|Overall Study|Incomplete data|3
1609930|NCT02123511|5615525|P1|Overall Study|Incomplete data|1
1609931|NCT02123511|5615524|P2|Overall Study|Cancelled treatment|0
1609932|NCT02123511|5615525|P1|Overall Study|Cancelled treatment|1
1609933|NCT02123472|5615549|P2|Period 2 (7 Days)|Withdrawal by Subject|1
1609934|NCT02123472|5615550|P1|Period 2 (7 Days)|Withdrawal by Subject|0
1609935|NCT02123459|5615560|P2|Washout Period (1 Day)|Adverse Event|0
1609936|NCT02123459|5615561|P1|Washout Period (1 Day)|Adverse Event|1
1609937|NCT02123446|5615571|P2|Washout Period (1 Day)|Physician Decision|0
1609938|NCT02123446|5615572|P1|Washout Period (1 Day)|Physician Decision|1
1609939|NCT02123251|5615613|P2|Overall Study|Switched Managed Care Organization (MCO)|4
1609940|NCT02123251|5615614|P1|Overall Study|Switched Managed Care Organization (MCO)|4
1609941|NCT02123251|5615613|P2|Overall Study|Lost Medicaid eligibility|22
1609942|NCT02123251|5615614|P1|Overall Study|Lost Medicaid eligibility|29
1609943|NCT02123251|5615613|P2|Overall Study|Withdrawal by Subject|3
1609944|NCT02123251|5615614|P1|Overall Study|Withdrawal by Subject|0
1609945|NCT02123251|5615613|P2|Overall Study|Death|1
1609946|NCT02123251|5615614|P1|Overall Study|Death|1
1609951|NCT02122887|5615698|P2|Overall Study|Withdrawal by Subject|2
1609952|NCT02122887|5615699|P1|Overall Study|Withdrawal by Subject|20
1609953|NCT02122770|5615735|P6|Part B: Standard of Care|Progressive Disease|8
1609954|NCT02122770|5615736|P5|Part B: Standard of Care|Progressive Disease|10
1609955|NCT02122770|5615737|P4|Part B: Standard of Care|Progressive Disease|0
1609956|NCT02122770|5615738|P3|Part B: Standard of Care|Progressive Disease|0
1609957|NCT02122770|5615739|P2|Part B: Standard of Care|Progressive Disease|0
1609958|NCT02122770|5615740|P1|Part B: Standard of Care|Progressive Disease|0
1609959|NCT02122770|5615735|P6|Part B: Standard of Care|Symptomatic Deterioration|0
1609960|NCT02122770|5615736|P5|Part B: Standard of Care|Symptomatic Deterioration|5
1609961|NCT02122770|5615737|P4|Part B: Standard of Care|Symptomatic Deterioration|0
1609962|NCT02122770|5615738|P3|Part B: Standard of Care|Symptomatic Deterioration|0
1609963|NCT02122770|5615739|P2|Part B: Standard of Care|Symptomatic Deterioration|0
1609964|NCT02122770|5615740|P1|Part B: Standard of Care|Symptomatic Deterioration|0
1609965|NCT02122770|5615735|P6|Part B: Standard of Care|Withdrawal by Subject|2
1609966|NCT02122770|5615736|P5|Part B: Standard of Care|Withdrawal by Subject|4
1609967|NCT02122770|5615737|P4|Part B: Standard of Care|Withdrawal by Subject|0
1609968|NCT02122770|5615738|P3|Part B: Standard of Care|Withdrawal by Subject|0
1609969|NCT02122770|5615739|P2|Part B: Standard of Care|Withdrawal by Subject|0
1609970|NCT02122770|5615740|P1|Part B: Standard of Care|Withdrawal by Subject|0
1609971|NCT02122770|5615735|P6|Part B: Standard of Care|Other|2
1609972|NCT02122770|5615736|P5|Part B: Standard of Care|Other|0
1609973|NCT02122770|5615737|P4|Part B: Standard of Care|Other|0
1609974|NCT02122770|5615738|P3|Part B: Standard of Care|Other|0
1609975|NCT02122770|5615739|P2|Part B: Standard of Care|Other|0
1609976|NCT02122770|5615740|P1|Part B: Standard of Care|Other|0
1609977|NCT02122770|5615735|P6|Part B: Standard of Care|Adverse Event|1
1609978|NCT02122770|5615736|P5|Part B: Standard of Care|Adverse Event|4
1609979|NCT02122770|5615737|P4|Part B: Standard of Care|Adverse Event|0
1609980|NCT02122770|5615738|P3|Part B: Standard of Care|Adverse Event|0
1609981|NCT02122770|5615739|P2|Part B: Standard of Care|Adverse Event|0
1609982|NCT02122770|5615740|P1|Part B: Standard of Care|Adverse Event|0
1609983|NCT02122770|5615735|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
1609984|NCT02122770|5615736|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
1609985|NCT02122770|5615737|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
1609986|NCT02122770|5615738|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
1609987|NCT02122770|5615739|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
1609988|NCT02122770|5615740|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
1609989|NCT02122770|5615735|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1609990|NCT02122770|5615736|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1609991|NCT02122770|5615737|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1609992|NCT02122770|5615738|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1609993|NCT02122770|5615739|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
1609994|NCT02122770|5615740|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
1609995|NCT02122770|5615735|P6|Part A: Drug-drug Interaction 2|Other|0
1609996|NCT02122770|5615736|P5|Part A: Drug-drug Interaction 2|Other|0
1609997|NCT02122770|5615737|P4|Part A: Drug-drug Interaction 2|Other|0
1609998|NCT02122770|5615738|P3|Part A: Drug-drug Interaction 2|Other|1
1609999|NCT02122770|5615739|P2|Part A: Drug-drug Interaction 2|Other|0
1610000|NCT02122770|5615740|P1|Part A: Drug-drug Interaction 2|Other|0
1610001|NCT02122770|5615735|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
1610002|NCT02122770|5615736|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
1610003|NCT02122770|5615737|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
1610004|NCT02122770|5615738|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
1610005|NCT02122770|5615739|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
1610006|NCT02122770|5615740|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
1610007|NCT02122146|5615883|P8|Part 1: Dose Escalation|Other|2
1610008|NCT02122146|5615884|P7|Part 1: Dose Escalation|Other|1
1610009|NCT02122146|5615885|P6|Part 1: Dose Escalation|Other|1
1610010|NCT02122146|5615886|P5|Part 1: Dose Escalation|Other|0
1610011|NCT02122146|5615887|P4|Part 1: Dose Escalation|Other|0
1610012|NCT02122146|5615888|P3|Part 1: Dose Escalation|Other|0
1610013|NCT02122146|5615889|P2|Part 1: Dose Escalation|Other|0
1610014|NCT02122146|5615890|P1|Part 1: Dose Escalation|Other|1
1610015|NCT02122146|5615883|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
1610016|NCT02122146|5615884|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
1610017|NCT02122146|5615885|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
1610018|NCT02122146|5615886|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
1610019|NCT02122146|5615887|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
1610020|NCT02122146|5615888|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
1610021|NCT02122146|5615889|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
1610022|NCT02122146|5615890|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
1610023|NCT02122146|5615883|P8|Part 1: Dose Escalation|Lost to Follow-up|0
1610024|NCT02122146|5615884|P7|Part 1: Dose Escalation|Lost to Follow-up|0
1610025|NCT02122146|5615885|P6|Part 1: Dose Escalation|Lost to Follow-up|0
1610026|NCT02122146|5615886|P5|Part 1: Dose Escalation|Lost to Follow-up|1
1610027|NCT02122146|5615887|P4|Part 1: Dose Escalation|Lost to Follow-up|0
1610028|NCT02122146|5615888|P3|Part 1: Dose Escalation|Lost to Follow-up|1
1610029|NCT02122146|5615889|P2|Part 1: Dose Escalation|Lost to Follow-up|0
1610030|NCT02122146|5615890|P1|Part 1: Dose Escalation|Lost to Follow-up|0
1610031|NCT02122146|5615883|P8|Part 1: Dose Escalation|Death|0
1610032|NCT02122146|5615884|P7|Part 1: Dose Escalation|Death|0
1610033|NCT02122146|5615885|P6|Part 1: Dose Escalation|Death|0
1610034|NCT02122146|5615886|P5|Part 1: Dose Escalation|Death|0
1610035|NCT02122146|5615887|P4|Part 1: Dose Escalation|Death|0
1610036|NCT02122146|5615888|P3|Part 1: Dose Escalation|Death|1
1610037|NCT02122146|5615889|P2|Part 1: Dose Escalation|Death|1
1610038|NCT02122146|5615890|P1|Part 1: Dose Escalation|Death|0
1610039|NCT02121847|5616164|P1|Overall Study|Adverse Event|2
1610040|NCT02121847|5616164|P1|Overall Study|Administrative Reasons|1
1610041|NCT02121834|5616190|P7|Overall Study|Lost to Follow-up|0
1610042|NCT02121834|5616191|P6|Overall Study|Lost to Follow-up|0
1610043|NCT02121834|5616192|P5|Overall Study|Lost to Follow-up|0
1610044|NCT02121834|5616193|P4|Overall Study|Lost to Follow-up|0
1610045|NCT02121834|5616194|P3|Overall Study|Lost to Follow-up|1
1610046|NCT02121834|5616195|P2|Overall Study|Lost to Follow-up|0
1610047|NCT02121834|5616196|P1|Overall Study|Lost to Follow-up|0
1610048|NCT02121834|5616190|P7|Overall Study|Withdrawal by Subject|0
1610049|NCT02121834|5616191|P6|Overall Study|Withdrawal by Subject|0
1610050|NCT02121834|5616192|P5|Overall Study|Withdrawal by Subject|0
1610051|NCT02121834|5616193|P4|Overall Study|Withdrawal by Subject|0
1610052|NCT02121834|5616194|P3|Overall Study|Withdrawal by Subject|1
1610053|NCT02121834|5616195|P2|Overall Study|Withdrawal by Subject|1
1610054|NCT02121834|5616196|P1|Overall Study|Withdrawal by Subject|0
1610055|NCT02121834|5616190|P7|Overall Study|Protocol Violation|0
1610056|NCT02121834|5616191|P6|Overall Study|Protocol Violation|0
1610057|NCT02121834|5616192|P5|Overall Study|Protocol Violation|0
1610058|NCT02121834|5616193|P4|Overall Study|Protocol Violation|0
1610059|NCT02121834|5616194|P3|Overall Study|Protocol Violation|0
1610060|NCT02121834|5616195|P2|Overall Study|Protocol Violation|1
1610061|NCT02121834|5616196|P1|Overall Study|Protocol Violation|0
1610062|NCT02121808|5616222|P1|Overall Study|Technical problem|3
1610063|NCT02121795|5616233|P2|Overall Study|Still in Study up to the Data Cut Date|316
1610064|NCT02121795|5616234|P1|Overall Study|Still in Study up to the Data Cut Date|315
1610065|NCT02121795|5616233|P2|Overall Study|Lost to Follow-up|1
1610066|NCT02121795|5616234|P1|Overall Study|Lost to Follow-up|2
1610067|NCT02121795|5616233|P2|Overall Study|Withdrew Consent|10
1610068|NCT02121795|5616234|P1|Overall Study|Withdrew Consent|10
1610069|NCT02121795|5616233|P2|Overall Study|Protocol Violation|2
1610070|NCT02121795|5616234|P1|Overall Study|Protocol Violation|0
1610071|NCT02121795|5616233|P2|Overall Study|Non-Compliance with Study Drug|1
1610072|NCT02121795|5616234|P1|Overall Study|Non-Compliance with Study Drug|1
1610073|NCT02121795|5616233|P2|Overall Study|Investigator's Discretion|0
1610074|NCT02121795|5616234|P1|Overall Study|Investigator's Discretion|1
1610075|NCT02121795|5616233|P2|Overall Study|Adverse Event|0
1610076|NCT02121795|5616234|P1|Overall Study|Adverse Event|4
1610077|NCT02121795|5616233|P2|Overall Study|Randomized but Never Treated|4
1610078|NCT02121795|5616234|P1|Overall Study|Randomized but Never Treated|1
1610079|NCT02121756|5616250|P2|Overall Study|Physician Decision|1
1610080|NCT02121756|5616251|P1|Overall Study|Physician Decision|2
1610081|NCT02121756|5616250|P2|Overall Study|Protocol Violation|1
1610082|NCT02121756|5616251|P1|Overall Study|Protocol Violation|1
1610083|NCT02121756|5616250|P2|Overall Study|Adverse Event|0
1610084|NCT02121756|5616251|P1|Overall Study|Adverse Event|3
1610085|NCT02121535|5616288|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
1610086|NCT02121535|5616289|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
1610087|NCT02121535|5616288|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
1610088|NCT02121535|5616289|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
1610089|NCT02121522|5616312|P1|Overall Study|Adverse Event|1
1610090|NCT02121509|5616319|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
1610091|NCT02121509|5616320|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
1610092|NCT02121509|5616321|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
1610093|NCT02121509|5616322|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
1610094|NCT02121509|5616319|P4|Washout Period (35 Days)|Withdrawal by Subject|0
1610095|NCT02121509|5616320|P3|Washout Period (35 Days)|Withdrawal by Subject|0
1610096|NCT02121509|5616321|P2|Washout Period (35 Days)|Withdrawal by Subject|3
1610097|NCT02121509|5616322|P1|Washout Period (35 Days)|Withdrawal by Subject|0
1610098|NCT02121509|5616319|P4|Washout Period (35 Days)|Adverse Event|0
1610099|NCT02121509|5616320|P3|Washout Period (35 Days)|Adverse Event|0
1610100|NCT02121509|5616321|P2|Washout Period (35 Days)|Adverse Event|1
1610101|NCT02121509|5616322|P1|Washout Period (35 Days)|Adverse Event|1
1610102|NCT02121210|5616393|P2|Overall Study|Other than specified above|2
1610103|NCT02121210|5616394|P1|Overall Study|Other than specified above|0
1610104|NCT02121210|5616393|P2|Overall Study|Lack of Efficacy|0
1610105|NCT02121210|5616394|P1|Overall Study|Lack of Efficacy|2
1610106|NCT02121210|5616393|P2|Overall Study|Adverse Event|7
1610107|NCT02121210|5616394|P1|Overall Study|Adverse Event|5
1610108|NCT02120950|5616419|P3|Overall Study|Lost to Follow-up|1
1610109|NCT02120950|5616420|P2|Overall Study|Lost to Follow-up|2
1610110|NCT02120950|5616421|P1|Overall Study|Lost to Follow-up|0
1610111|NCT02120950|5616419|P3|Overall Study|Other reasons|1
1610112|NCT02120950|5616420|P2|Overall Study|Other reasons|4
1610113|NCT02120950|5616421|P1|Overall Study|Other reasons|5
1610114|NCT02120950|5616419|P3|Overall Study|Protocol Violation|7
1610115|NCT02120950|5616420|P2|Overall Study|Protocol Violation|1
1610116|NCT02120950|5616421|P1|Overall Study|Protocol Violation|1
1610117|NCT02120950|5616419|P3|Overall Study|Withdrawal by Subject|2
1610118|NCT02120950|5616420|P2|Overall Study|Withdrawal by Subject|3
1610119|NCT02120950|5616421|P1|Overall Study|Withdrawal by Subject|6
1610120|NCT02120950|5616419|P3|Overall Study|Death|1
1610121|NCT02120950|5616420|P2|Overall Study|Death|0
1610122|NCT02120950|5616421|P1|Overall Study|Death|3
1610123|NCT02120950|5616419|P3|Overall Study|Adverse Event|3
1610124|NCT02120950|5616420|P2|Overall Study|Adverse Event|4
1610125|NCT02120950|5616421|P1|Overall Study|Adverse Event|5
1610126|NCT02120898|5616457|P3|Overall Study|Lost to Follow-up|1
1610127|NCT02120898|5616458|P2|Overall Study|Lost to Follow-up|0
1610128|NCT02120898|5616459|P1|Overall Study|Lost to Follow-up|0
1610129|NCT02120898|5616457|P3|Overall Study|Protocol Violation|0
1610130|NCT02120898|5616458|P2|Overall Study|Protocol Violation|2
1610131|NCT02120898|5616459|P1|Overall Study|Protocol Violation|1
1610132|NCT02120898|5616457|P3|Overall Study|Adverse Event|1
1610133|NCT02120898|5616458|P2|Overall Study|Adverse Event|2
1610134|NCT02120898|5616459|P1|Overall Study|Adverse Event|1
1610135|NCT02120898|5616457|P3|Overall Study|Non-compliance with study drug|0
1610136|NCT02120898|5616458|P2|Overall Study|Non-compliance with study drug|0
1610137|NCT02120898|5616459|P1|Overall Study|Non-compliance with study drug|3
1610138|NCT02120898|5616457|P3|Overall Study|Withdrawal by Subject|2
1610139|NCT02120898|5616458|P2|Overall Study|Withdrawal by Subject|2
1610140|NCT02120898|5616459|P1|Overall Study|Withdrawal by Subject|4
1610141|NCT02120833|5616481|P2|Overall Study|Lost to Follow-up|1
1610142|NCT02120833|5616482|P1|Overall Study|Lost to Follow-up|1
1610143|NCT02120833|5616481|P2|Overall Study|Withdrawal by Subject|0
1610144|NCT02120833|5616482|P1|Overall Study|Withdrawal by Subject|2
1610145|NCT02120833|5616481|P2|Overall Study|Adverse Event|0
1610146|NCT02120833|5616482|P1|Overall Study|Adverse Event|1
1610147|NCT02120794|5616636|P1|Overall Study|Due to insurance coverage|1
1610148|NCT02120794|5616636|P1|Overall Study|Physician Decision|4
1610149|NCT02120794|5616636|P1|Overall Study|Adverse Event|10
1610150|NCT02120794|5616636|P1|Overall Study|Withdrawal by Subject|43
1610151|NCT02120664|5616660|P5|Overall Study|Withdrawal by Subject|0
1610152|NCT02120664|5616661|P4|Overall Study|Withdrawal by Subject|1
1610153|NCT02120664|5616662|P3|Overall Study|Withdrawal by Subject|0
1610154|NCT02120664|5616663|P2|Overall Study|Withdrawal by Subject|0
1610155|NCT02120664|5616664|P1|Overall Study|Withdrawal by Subject|0
1610156|NCT02120625|5616682|P1|Overall Study|Physician Decision|2
1610157|NCT02120456|5616698|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
1610158|NCT02120456|5616699|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610159|NCT02120456|5616700|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610160|NCT02120456|5616701|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610161|NCT02120456|5616702|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610162|NCT02120456|5616703|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610163|NCT02120456|5616704|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610164|NCT02120456|5616705|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610165|NCT02120456|5616706|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
1610166|NCT02120456|5616698|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
1610167|NCT02120456|5616699|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
1610168|NCT02120456|5616700|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
1610169|NCT02120456|5616701|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
1610170|NCT02120456|5616702|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
1610171|NCT02120456|5616703|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
1610172|NCT02120456|5616704|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
1610173|NCT02120456|5616705|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
1610174|NCT02120456|5616706|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
1610175|NCT02120456|5616698|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
1610176|NCT02120456|5616699|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
1610177|NCT02120456|5616700|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
1610178|NCT02120456|5616701|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
1610179|NCT02120456|5616702|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
1610180|NCT02120456|5616703|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
1610181|NCT02120456|5616704|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
1610182|NCT02120456|5616705|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
1610183|NCT02120456|5616706|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
1610184|NCT02120417|5616740|P2|Overall Study|Other unspecified|4
1610185|NCT02120417|5616741|P1|Overall Study|Other unspecified|5
1610186|NCT02120417|5616740|P2|Overall Study|Physician Decision|3
1610187|NCT02120417|5616741|P1|Overall Study|Physician Decision|2
1610188|NCT02120417|5616740|P2|Overall Study|Noncompliance with study treatment|2
1610189|NCT02120417|5616741|P1|Overall Study|Noncompliance with study treatment|0
1610190|NCT02120417|5616740|P2|Overall Study|Disease progression|45
1610191|NCT02120417|5616741|P1|Overall Study|Disease progression|41
1610192|NCT02120417|5616740|P2|Overall Study|Participant decision|4
1610193|NCT02120417|5616741|P1|Overall Study|Participant decision|4
1610194|NCT02120417|5616740|P2|Overall Study|Adverse Event|9
1610195|NCT02120417|5616741|P1|Overall Study|Adverse Event|3
1610196|NCT02120417|5616740|P2|Overall Study|Death|1
1610197|NCT02120417|5616741|P1|Overall Study|Death|5
1610198|NCT02120300|5616763|P4|Overall Study|Lost to Follow-up|0
1610199|NCT02120300|5616764|P3|Overall Study|Lost to Follow-up|0
1610200|NCT02120300|5616765|P2|Overall Study|Lost to Follow-up|0
1610201|NCT02120300|5616766|P1|Overall Study|Lost to Follow-up|1
1610202|NCT02120300|5616763|P4|Overall Study|Lack of Efficacy|1
1610203|NCT02120300|5616764|P3|Overall Study|Lack of Efficacy|0
1610204|NCT02120300|5616765|P2|Overall Study|Lack of Efficacy|0
1610205|NCT02120300|5616766|P1|Overall Study|Lack of Efficacy|0
1610206|NCT02120300|5616763|P4|Overall Study|Enrolled but Never Treated|0
1610207|NCT02120300|5616764|P3|Overall Study|Enrolled but Never Treated|0
1610208|NCT02120300|5616765|P2|Overall Study|Enrolled but Never Treated|0
1610209|NCT02120300|5616766|P1|Overall Study|Enrolled but Never Treated|2
1610210|NCT02120157|5616837|P2|Overall Study|Graft Failure before Day 100|0
1610211|NCT02120157|5616838|P1|Overall Study|Graft Failure before Day 100|2
1610212|NCT02120157|5616837|P2|Overall Study|Death|2
1610213|NCT02120157|5616838|P1|Overall Study|Death|4
1610214|NCT02120027|5616848|P2|Overall Study|Withdrawal by Subject|25
1610215|NCT02120027|5616849|P1|Overall Study|Withdrawal by Subject|33
1610216|NCT02120027|5616848|P2|Overall Study|Study terminated by Sponsor|47
1610217|NCT02120027|5616849|P1|Overall Study|Study terminated by Sponsor|45
1610218|NCT02120027|5616848|P2|Overall Study|Protocol Violation|21
1610219|NCT02120027|5616849|P1|Overall Study|Protocol Violation|18
1610220|NCT02120027|5616848|P2|Overall Study|Physician Decision|3
1610221|NCT02120027|5616849|P1|Overall Study|Physician Decision|4
1610222|NCT02120027|5616848|P2|Overall Study|Other|0
1610223|NCT02120027|5616849|P1|Overall Study|Other|4
1610224|NCT02120027|5616848|P2|Overall Study|Lost to Follow-up|13
1610225|NCT02120027|5616849|P1|Overall Study|Lost to Follow-up|5
1610226|NCT02120027|5616848|P2|Overall Study|Lack of Efficacy|5
1610227|NCT02120027|5616849|P1|Overall Study|Lack of Efficacy|3
1610228|NCT02120027|5616848|P2|Overall Study|Adverse Event|5
1610229|NCT02120027|5616849|P1|Overall Study|Adverse Event|4
1610230|NCT02119936|5616874|P1|Overall Study|Lost to Follow-up|10
1610231|NCT02119676|5616908|P4|Overall Study|Did not receive study med|5
1610232|NCT02119676|5616909|P3|Overall Study|Did not receive study med|4
1610233|NCT02119676|5616910|P2|Overall Study|Did not receive study med|2
1610234|NCT02119676|5616911|P1|Overall Study|Did not receive study med|2
1610235|NCT02119676|5616908|P4|Overall Study|Other, unspecified|4
1610236|NCT02119676|5616909|P3|Overall Study|Other, unspecified|3
1610237|NCT02119676|5616910|P2|Overall Study|Other, unspecified|1
1610238|NCT02119676|5616911|P1|Overall Study|Other, unspecified|2
1610239|NCT02119676|5616908|P4|Overall Study|Protocol deviation|0
1610240|NCT02119676|5616909|P3|Overall Study|Protocol deviation|1
1610241|NCT02119676|5616910|P2|Overall Study|Protocol deviation|0
1610242|NCT02119676|5616911|P1|Overall Study|Protocol deviation|0
1610243|NCT02119676|5616908|P4|Overall Study|Lost to Follow-up|0
1610244|NCT02119676|5616909|P3|Overall Study|Lost to Follow-up|1
1610245|NCT02119676|5616910|P2|Overall Study|Lost to Follow-up|0
1610246|NCT02119676|5616911|P1|Overall Study|Lost to Follow-up|0
1610247|NCT02119676|5616908|P4|Overall Study|Noncompliance|0
1610248|NCT02119676|5616909|P3|Overall Study|Noncompliance|0
1610249|NCT02119676|5616910|P2|Overall Study|Noncompliance|1
1610250|NCT02119676|5616911|P1|Overall Study|Noncompliance|0
1610251|NCT02119676|5616908|P4|Overall Study|Death|1
1610252|NCT02119676|5616909|P3|Overall Study|Death|2
1610253|NCT02119676|5616910|P2|Overall Study|Death|3
1610254|NCT02119676|5616911|P1|Overall Study|Death|9
1610255|NCT02119676|5616908|P4|Overall Study|Physician Decision|2
1610256|NCT02119676|5616909|P3|Overall Study|Physician Decision|3
1610257|NCT02119676|5616910|P2|Overall Study|Physician Decision|2
1610258|NCT02119676|5616911|P1|Overall Study|Physician Decision|4
1610259|NCT02119676|5616908|P4|Overall Study|Patient decision, inc. consent withdrawn|6
1610260|NCT02119676|5616909|P3|Overall Study|Patient decision, inc. consent withdrawn|5
1610261|NCT02119676|5616910|P2|Overall Study|Patient decision, inc. consent withdrawn|5
1610262|NCT02119676|5616911|P1|Overall Study|Patient decision, inc. consent withdrawn|4
1610263|NCT02119676|5616908|P4|Overall Study|Disease progression|73
1610264|NCT02119676|5616909|P3|Overall Study|Disease progression|68
1610265|NCT02119676|5616910|P2|Overall Study|Disease progression|55
1610266|NCT02119676|5616911|P1|Overall Study|Disease progression|53
1610267|NCT02119676|5616908|P4|Overall Study|Adverse Event|10
1610268|NCT02119676|5616909|P3|Overall Study|Adverse Event|10
1610269|NCT02119676|5616910|P2|Overall Study|Adverse Event|17
1610270|NCT02119676|5616911|P1|Overall Study|Adverse Event|9
1610271|NCT02119663|5616943|P2|Overall Study|Study Terminated by the Sponsor|4
1610272|NCT02119663|5616944|P1|Overall Study|Study Terminated by the Sponsor|3
1610273|NCT02119663|5616943|P2|Overall Study|Subject decision|1
1610274|NCT02119663|5616944|P1|Overall Study|Subject decision|0
1610275|NCT02119663|5616943|P2|Overall Study|Other unspecified|0
1610276|NCT02119663|5616944|P1|Overall Study|Other unspecified|2
1610277|NCT02119663|5616943|P2|Overall Study|Physician Decision|2
1610278|NCT02119663|5616944|P1|Overall Study|Physician Decision|1
1610279|NCT02119663|5616943|P2|Overall Study|Death|2
1610280|NCT02119663|5616944|P1|Overall Study|Death|3
1610281|NCT02119663|5616943|P2|Overall Study|Adverse Event|5
1610282|NCT02119663|5616944|P1|Overall Study|Adverse Event|5
1610283|NCT02119663|5616943|P2|Overall Study|Disease progression|27
1610284|NCT02119663|5616944|P1|Overall Study|Disease progression|26
1610285|NCT02119650|5616962|P2|Overall Study|Multiple reasons for termination|1
1610286|NCT02119650|5616963|P1|Overall Study|Multiple reasons for termination|2
1610287|NCT02119650|5616962|P2|Overall Study|Physician Decision|2
1610288|NCT02119650|5616963|P1|Overall Study|Physician Decision|0
1610289|NCT02119650|5616962|P2|Overall Study|Study terminated by the sponsor|0
1610290|NCT02119650|5616963|P1|Overall Study|Study terminated by the sponsor|1
1610291|NCT02119650|5616962|P2|Overall Study|Noncompliance with study treatment|1
1610292|NCT02119650|5616963|P1|Overall Study|Noncompliance with study treatment|1
1610293|NCT02119650|5616962|P2|Overall Study|Death|1
1610294|NCT02119650|5616963|P1|Overall Study|Death|5
1610295|NCT02119650|5616962|P2|Overall Study|Disease progression|14
1610296|NCT02119650|5616963|P1|Overall Study|Disease progression|11
1610297|NCT02119650|5616962|P2|Overall Study|Subject decision|3
1610298|NCT02119650|5616963|P1|Overall Study|Subject decision|2
1610299|NCT02119650|5616962|P2|Overall Study|Adverse Event|4
1610300|NCT02119650|5616963|P1|Overall Study|Adverse Event|3
1610301|NCT02119325|5616998|P2|Washout Period 1|Adverse Event|1
1610302|NCT02119325|5616999|P1|Washout Period 1|Adverse Event|0
1610303|NCT02119299|5617043|P1|Overall Study|Pregnancy|1
1610304|NCT02119299|5617043|P1|Overall Study|Lack of Efficacy|1
1610305|NCT02119299|5617043|P1|Overall Study|Withdrawal by Subject|7
1610306|NCT02119286|5617057|P3|Overall Study|Withdrawal by Subject|0
1610307|NCT02119286|5617058|P2|Overall Study|Withdrawal by Subject|1
1610308|NCT02119286|5617059|P1|Overall Study|Withdrawal by Subject|4
1610309|NCT02119286|5617057|P3|Overall Study|Lost to Follow-up|1
1610310|NCT02119286|5617058|P2|Overall Study|Lost to Follow-up|0
1610311|NCT02119286|5617059|P1|Overall Study|Lost to Follow-up|2
1610312|NCT02119286|5617057|P3|Overall Study|Lack of Efficacy|4
1610313|NCT02119286|5617058|P2|Overall Study|Lack of Efficacy|3
1610314|NCT02119286|5617059|P1|Overall Study|Lack of Efficacy|11
1610315|NCT02119286|5617057|P3|Overall Study|Adverse Event|2
1610316|NCT02119286|5617058|P2|Overall Study|Adverse Event|7
1610317|NCT02119286|5617059|P1|Overall Study|Adverse Event|9
1610318|NCT02119260|5617077|P7|Overall Study|Withdrew consent|0
1610319|NCT02119260|5617078|P6|Overall Study|Withdrew consent|0
1610320|NCT02119260|5617079|P5|Overall Study|Withdrew consent|0
1610321|NCT02119260|5617080|P4|Overall Study|Withdrew consent|0
1610322|NCT02119260|5617081|P3|Overall Study|Withdrew consent|1
1610323|NCT02119260|5617082|P2|Overall Study|Withdrew consent|1
1610324|NCT02119260|5617083|P1|Overall Study|Withdrew consent|0
1610325|NCT02119260|5617077|P7|Overall Study|Adverse Event|0
1610326|NCT02119260|5617078|P6|Overall Study|Adverse Event|0
1610327|NCT02119260|5617079|P5|Overall Study|Adverse Event|0
1610328|NCT02119260|5617080|P4|Overall Study|Adverse Event|0
1610329|NCT02119260|5617081|P3|Overall Study|Adverse Event|0
1610330|NCT02119260|5617082|P2|Overall Study|Adverse Event|0
1610331|NCT02119260|5617083|P1|Overall Study|Adverse Event|1
1610332|NCT02119156|5617156|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
1610333|NCT02119156|5617157|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
1610334|NCT02119156|5617158|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
1610335|NCT02119156|5617156|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
1610336|NCT02119156|5617157|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
1610337|NCT02119156|5617158|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
1610338|NCT02119156|5617156|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
1610339|NCT02119156|5617157|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
1610340|NCT02119156|5617158|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
1610341|NCT02119156|5617156|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
1610342|NCT02119156|5617157|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
1610343|NCT02119156|5617158|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
1610344|NCT02119156|5617156|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
1610345|NCT02119156|5617157|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
1610346|NCT02119156|5617158|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
1610347|NCT02119104|5617216|P1|Overall Study|Protocol Violation|16
1610348|NCT02119026|5617222|P2|2nd-line Treatment|Adverse Event|1
1610349|NCT02119026|5617223|P1|2nd-line Treatment|Adverse Event|4
1610350|NCT02119026|5617222|P2|2nd-line Treatment|Withdrawal by Subject|1
1610351|NCT02119026|5617223|P1|2nd-line Treatment|Withdrawal by Subject|3
1610352|NCT02119026|5617222|P2|2nd-line Treatment|Lost to Follow-up|0
1610353|NCT02119026|5617223|P1|2nd-line Treatment|Lost to Follow-up|2
1610354|NCT02119026|5617222|P2|1st-line Treatment|Death|1
1610355|NCT02119026|5617223|P1|1st-line Treatment|Death|2
1610356|NCT02119026|5617222|P2|1st-line Treatment|Surgery of metastases|1
1610357|NCT02119026|5617223|P1|1st-line Treatment|Surgery of metastases|2
1610358|NCT02119026|5617222|P2|1st-line Treatment|Patient condition or compliance|4
1610359|NCT02119026|5617223|P1|1st-line Treatment|Patient condition or compliance|6
1610360|NCT02119026|5617222|P2|1st-line Treatment|Withdrawal by Subject|10
1610361|NCT02119026|5617223|P1|1st-line Treatment|Withdrawal by Subject|4
1610362|NCT02119026|5617222|P2|1st-line Treatment|Physician Decision|8
1610363|NCT02119026|5617223|P1|1st-line Treatment|Physician Decision|3
1610364|NCT02119026|5617222|P2|1st-line Treatment|Adverse Event|14
1610365|NCT02119026|5617223|P1|1st-line Treatment|Adverse Event|9
1610366|NCT02118961|5617247|P2|Overall Study|Withdrawal by Subject|0
1610367|NCT02118961|5617248|P1|Overall Study|Withdrawal by Subject|1
1610368|NCT02118896|5617276|P10|Overall Study|Miscellaneous|0
1610369|NCT02118896|5617277|P9|Overall Study|Miscellaneous|0
1610370|NCT02118896|5617278|P8|Overall Study|Miscellaneous|0
1610371|NCT02118896|5617279|P7|Overall Study|Miscellaneous|0
1610372|NCT02118896|5617280|P6|Overall Study|Miscellaneous|4
1610373|NCT02118896|5617281|P5|Overall Study|Miscellaneous|0
1610374|NCT02118896|5617282|P4|Overall Study|Miscellaneous|2
1610375|NCT02118896|5617283|P3|Overall Study|Miscellaneous|0
1610376|NCT02118896|5617284|P2|Overall Study|Miscellaneous|2
1610377|NCT02118896|5617285|P1|Overall Study|Miscellaneous|1
1610378|NCT02118896|5617276|P10|Overall Study|Prohibited medication|0
1610379|NCT02118896|5617277|P9|Overall Study|Prohibited medication|0
1610380|NCT02118896|5617278|P8|Overall Study|Prohibited medication|0
1610381|NCT02118896|5617279|P7|Overall Study|Prohibited medication|0
1610382|NCT02118896|5617280|P6|Overall Study|Prohibited medication|3
1610383|NCT02118896|5617281|P5|Overall Study|Prohibited medication|1
1610384|NCT02118896|5617282|P4|Overall Study|Prohibited medication|0
1610385|NCT02118896|5617283|P3|Overall Study|Prohibited medication|0
1610386|NCT02118896|5617284|P2|Overall Study|Prohibited medication|0
1610387|NCT02118896|5617285|P1|Overall Study|Prohibited medication|0
1610388|NCT02118896|5617276|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
1610389|NCT02118896|5617277|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
1610390|NCT02118896|5617278|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
1610391|NCT02118896|5617279|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
1610392|NCT02118896|5617280|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
1610393|NCT02118896|5617281|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
1610394|NCT02118896|5617282|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
1610395|NCT02118896|5617283|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
1610396|NCT02118896|5617284|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
1610397|NCT02118896|5617285|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
1610398|NCT02118896|5617276|P10|Overall Study|Lost to Follow-up|0
1610399|NCT02118896|5617277|P9|Overall Study|Lost to Follow-up|0
1610400|NCT02118896|5617278|P8|Overall Study|Lost to Follow-up|0
1610401|NCT02118896|5617279|P7|Overall Study|Lost to Follow-up|0
1610402|NCT02118896|5617280|P6|Overall Study|Lost to Follow-up|1
1610403|NCT02118896|5617281|P5|Overall Study|Lost to Follow-up|2
1610404|NCT02118896|5617282|P4|Overall Study|Lost to Follow-up|0
1610405|NCT02118896|5617283|P3|Overall Study|Lost to Follow-up|1
1610406|NCT02118896|5617284|P2|Overall Study|Lost to Follow-up|2
1610407|NCT02118896|5617285|P1|Overall Study|Lost to Follow-up|1
1610408|NCT02118896|5617276|P10|Overall Study|Pregnancy|0
1610409|NCT02118896|5617277|P9|Overall Study|Pregnancy|0
1610410|NCT02118896|5617278|P8|Overall Study|Pregnancy|0
1610411|NCT02118896|5617279|P7|Overall Study|Pregnancy|1
1610412|NCT02118896|5617280|P6|Overall Study|Pregnancy|3
1610413|NCT02118896|5617281|P5|Overall Study|Pregnancy|1
1610414|NCT02118896|5617282|P4|Overall Study|Pregnancy|0
1610415|NCT02118896|5617283|P3|Overall Study|Pregnancy|0
1610416|NCT02118896|5617284|P2|Overall Study|Pregnancy|1
1610417|NCT02118896|5617285|P1|Overall Study|Pregnancy|1
1610418|NCT02118896|5617276|P10|Overall Study|Non-compliance|0
1610419|NCT02118896|5617277|P9|Overall Study|Non-compliance|0
1610420|NCT02118896|5617278|P8|Overall Study|Non-compliance|1
1610421|NCT02118896|5617279|P7|Overall Study|Non-compliance|0
1610422|NCT02118896|5617280|P6|Overall Study|Non-compliance|1
1610423|NCT02118896|5617281|P5|Overall Study|Non-compliance|0
1610424|NCT02118896|5617282|P4|Overall Study|Non-compliance|5
1610425|NCT02118896|5617283|P3|Overall Study|Non-compliance|1
1610426|NCT02118896|5617284|P2|Overall Study|Non-compliance|1
1610427|NCT02118896|5617285|P1|Overall Study|Non-compliance|2
1610428|NCT02118896|5617276|P10|Overall Study|Consent withdrawn|0
1610429|NCT02118896|5617277|P9|Overall Study|Consent withdrawn|0
1610430|NCT02118896|5617278|P8|Overall Study|Consent withdrawn|0
1610431|NCT02118896|5617279|P7|Overall Study|Consent withdrawn|0
1610432|NCT02118896|5617280|P6|Overall Study|Consent withdrawn|4
1610433|NCT02118896|5617281|P5|Overall Study|Consent withdrawn|1
1610434|NCT02118896|5617282|P4|Overall Study|Consent withdrawn|4
1610435|NCT02118896|5617283|P3|Overall Study|Consent withdrawn|3
1610436|NCT02118896|5617284|P2|Overall Study|Consent withdrawn|0
1610437|NCT02118896|5617285|P1|Overall Study|Consent withdrawn|2
1610438|NCT02118896|5617276|P10|Overall Study|Adverse Event|0
1610439|NCT02118896|5617277|P9|Overall Study|Adverse Event|4
1610440|NCT02118896|5617278|P8|Overall Study|Adverse Event|1
1610441|NCT02118896|5617279|P7|Overall Study|Adverse Event|1
1610442|NCT02118896|5617280|P6|Overall Study|Adverse Event|9
1610443|NCT02118896|5617281|P5|Overall Study|Adverse Event|5
1610444|NCT02118896|5617282|P4|Overall Study|Adverse Event|5
1610445|NCT02118896|5617283|P3|Overall Study|Adverse Event|4
1610446|NCT02118896|5617284|P2|Overall Study|Adverse Event|4
1610447|NCT02118896|5617285|P1|Overall Study|Adverse Event|5
1610448|NCT02118896|5617276|P10|Overall Study|Death|0
1610449|NCT02118896|5617277|P9|Overall Study|Death|0
1610450|NCT02118896|5617278|P8|Overall Study|Death|0
1610451|NCT02118896|5617279|P7|Overall Study|Death|0
1610452|NCT02118896|5617280|P6|Overall Study|Death|1
1610453|NCT02118896|5617281|P5|Overall Study|Death|3
1610454|NCT02118896|5617282|P4|Overall Study|Death|6
1610455|NCT02118896|5617283|P3|Overall Study|Death|4
1610456|NCT02118896|5617284|P2|Overall Study|Death|0
1610457|NCT02118896|5617285|P1|Overall Study|Death|4
1610458|NCT02118792|5617375|P2|Overall Study|Randomised but not treated|0
1610459|NCT02118792|5617376|P1|Overall Study|Randomised but not treated|1
1610460|NCT02118792|5617375|P2|Overall Study|Other|6
1610461|NCT02118792|5617376|P1|Overall Study|Other|1
1610462|NCT02118792|5617375|P2|Overall Study|Withdrawal by parent/guardian|20
1610463|NCT02118792|5617376|P1|Overall Study|Withdrawal by parent/guardian|14
1610464|NCT02118792|5617375|P2|Overall Study|Adverse Event|4
1610465|NCT02118792|5617376|P1|Overall Study|Adverse Event|5
1610466|NCT02118792|5617375|P2|Overall Study|Lost to Follow-up|4
1610467|NCT02118792|5617376|P1|Overall Study|Lost to Follow-up|4
1610468|NCT02118792|5617375|P2|Overall Study|Withdrawal by Subject|3
1610469|NCT02118792|5617376|P1|Overall Study|Withdrawal by Subject|6
1610470|NCT02118766|5617418|P2|Overall Study|Other|1
1610471|NCT02118766|5617419|P1|Overall Study|Other|3
1610472|NCT02118766|5617418|P2|Overall Study|Withdrawal by parent/guardian|18
1610473|NCT02118766|5617419|P1|Overall Study|Withdrawal by parent/guardian|12
1610474|NCT02118766|5617418|P2|Overall Study|Lost to Follow-up|4
1610475|NCT02118766|5617419|P1|Overall Study|Lost to Follow-up|5
1610476|NCT02118766|5617418|P2|Overall Study|Withdrawal by Subject|6
1610477|NCT02118766|5617419|P1|Overall Study|Withdrawal by Subject|3
1610478|NCT02118766|5617418|P2|Overall Study|Adverse Event|2
1610479|NCT02118766|5617419|P1|Overall Study|Adverse Event|7
1610480|NCT02118714|5617441|P1|Overall Study|Protocol Violation|1
1610481|NCT02118714|5617441|P1|Overall Study|Lost to Follow-up|2
1610482|NCT02118597|5617455|P1|Overall Study|Investigator's decision|1
1610483|NCT02118597|5617455|P1|Overall Study|Serious Adverse Event|1
1610484|NCT02118597|5617455|P1|Overall Study|Sponsor terminated the study|14
1610485|NCT02118428|5617486|P3|Overall Study|Screen Failure or Became Inelegible|1
1610486|NCT02118428|5617487|P2|Overall Study|Screen Failure or Became Inelegible|0
1610487|NCT02118428|5617488|P1|Overall Study|Screen Failure or Became Inelegible|1
1610488|NCT02118428|5617486|P3|Overall Study|Lost to Follow-up|0
1610489|NCT02118428|5617487|P2|Overall Study|Lost to Follow-up|1
1610490|NCT02118428|5617488|P1|Overall Study|Lost to Follow-up|3
1610491|NCT02118428|5617486|P3|Overall Study|Death|0
1610492|NCT02118428|5617487|P2|Overall Study|Death|5
1610493|NCT02118428|5617488|P1|Overall Study|Death|7
1610494|NCT02118428|5617486|P3|Overall Study|Withdrawal by Subject|0
1610495|NCT02118428|5617487|P2|Overall Study|Withdrawal by Subject|2
1610496|NCT02118428|5617488|P1|Overall Study|Withdrawal by Subject|2
1610497|NCT02118428|5617486|P3|Overall Study|Physician Decision|0
1610498|NCT02118428|5617487|P2|Overall Study|Physician Decision|1
1610499|NCT02118428|5617488|P1|Overall Study|Physician Decision|0
1610500|NCT02117687|5617558|P2|Overall Study|Other Reasons|1
1610501|NCT02117687|5617559|P1|Overall Study|Other Reasons|1
1610502|NCT02117687|5617558|P2|Overall Study|Adverse Event|2
1610503|NCT02117687|5617559|P1|Overall Study|Adverse Event|0
1610504|NCT02117687|5617558|P2|Overall Study|Lost to Follow-up|1
1610505|NCT02117687|5617559|P1|Overall Study|Lost to Follow-up|0
1610506|NCT02117648|5617591|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
1610507|NCT02117648|5617591|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
1610508|NCT02117648|5617591|P1|Abemaciclib Safety-Extension Phase|Death|3
1610509|NCT02117648|5617591|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
1610510|NCT02117648|5617591|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
1610511|NCT02117648|5617591|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
1610512|NCT02117648|5617591|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
1610513|NCT02117648|5617591|P1|Abemaciclib + Clarithromycin Period 2|Death|1
1610514|NCT02117648|5617591|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
1610515|NCT02117648|5617591|P1|Abemaciclib Alone Period 1|Adverse Event|1
1610516|NCT02117648|5617591|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
1610517|NCT02117570|5617604|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1610518|NCT02117570|5617605|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
1610519|NCT02117570|5617606|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
1610520|NCT02117570|5617604|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1610521|NCT02117570|5617605|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
1610522|NCT02117570|5617606|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
1610523|NCT02117570|5617604|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
1610524|NCT02117570|5617605|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1610525|NCT02117570|5617606|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
1610526|NCT02117570|5617604|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
1610527|NCT02117570|5617605|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
1610528|NCT02117570|5617606|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
1610529|NCT02117570|5617604|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
1610530|NCT02117570|5617605|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1610531|NCT02117570|5617606|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
1610532|NCT02117570|5617604|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
1610533|NCT02117570|5617605|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1610534|NCT02117570|5617606|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
1610535|NCT02117570|5617604|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
1610536|NCT02117570|5617605|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
1610537|NCT02117570|5617606|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
1610538|NCT02117544|5617656|P2|Period 1|Lost to follow-up (prior to treatment)|0
1610539|NCT02117544|5617657|P1|Period 1|Lost to follow-up (prior to treatment)|2
1610540|NCT02117479|5617672|P2|Overall Study|Other unspecified|7
1610541|NCT02117479|5617673|P1|Overall Study|Other unspecified|11
1610542|NCT02117479|5617672|P2|Overall Study|Physician Decision|2
1610543|NCT02117479|5617673|P1|Overall Study|Physician Decision|7
1610544|NCT02117479|5617672|P2|Overall Study|Study terminated by the sponsor|6
1610545|NCT02117479|5617673|P1|Overall Study|Study terminated by the sponsor|4
1610546|NCT02117479|5617672|P2|Overall Study|Noncompliance with study treatment|0
1610547|NCT02117479|5617673|P1|Overall Study|Noncompliance with study treatment|1
1610548|NCT02117479|5617672|P2|Overall Study|Disease progression|108
1610549|NCT02117479|5617673|P1|Overall Study|Disease progression|104
1610550|NCT02117479|5617672|P2|Overall Study|Subject decision|9
1610551|NCT02117479|5617673|P1|Overall Study|Subject decision|8
1610552|NCT02117479|5617672|P2|Overall Study|Adverse Event|16
1610553|NCT02117479|5617673|P1|Overall Study|Adverse Event|8
1610554|NCT02117479|5617672|P2|Overall Study|Death|8
1610555|NCT02117479|5617673|P1|Overall Study|Death|13
1610556|NCT02117427|5617692|P3|Overall Study|Death|0
1610557|NCT02117427|5617693|P2|Overall Study|Death|1
1610558|NCT02117427|5617694|P1|Overall Study|Death|0
1610559|NCT02117427|5617692|P3|Overall Study|No longer meets inclusion criteria|0
1610560|NCT02117427|5617693|P2|Overall Study|No longer meets inclusion criteria|1
1610561|NCT02117427|5617694|P1|Overall Study|No longer meets inclusion criteria|0
1610562|NCT02117427|5617692|P3|Overall Study|Physician Decision|0
1610563|NCT02117427|5617693|P2|Overall Study|Physician Decision|2
1610564|NCT02117427|5617694|P1|Overall Study|Physician Decision|0
1610565|NCT02117427|5617692|P3|Overall Study|Permanent need for exogenous ESA Tx|0
1610566|NCT02117427|5617693|P2|Overall Study|Permanent need for exogenous ESA Tx|1
1610567|NCT02117427|5617694|P1|Overall Study|Permanent need for exogenous ESA Tx|3
1610568|NCT02117427|5617692|P3|Overall Study|Permanent need for exogenous EPO Tx|0
1610569|NCT02117427|5617693|P2|Overall Study|Permanent need for exogenous EPO Tx|0
1610570|NCT02117427|5617694|P1|Overall Study|Permanent need for exogenous EPO Tx|2
1610571|NCT02117414|5617704|P2|Overall Study|Withdrawal by Subject|4
1610572|NCT02117414|5617705|P1|Overall Study|Withdrawal by Subject|10
1610573|NCT02117414|5617704|P2|Overall Study|Death|2
1610574|NCT02117414|5617705|P1|Overall Study|Death|5
1610575|NCT02117349|5617725|P2|Overall Study|Death|0
1610576|NCT02117349|5617726|P1|Overall Study|Death|1
1610577|NCT02117349|5617725|P2|Overall Study|Lost to Follow-up|1
1610578|NCT02117349|5617726|P1|Overall Study|Lost to Follow-up|1
1610579|NCT02117349|5617725|P2|Overall Study|Withdrawal by Subject|0
1610580|NCT02117349|5617726|P1|Overall Study|Withdrawal by Subject|1
1610581|NCT02117050|5617762|P1|Overall Study|Subject Enrolled but not Dosed|1
1610582|NCT02117024|5617776|P2|Overall Study|Physician Decision|2
1610583|NCT02117024|5617777|P1|Overall Study|Physician Decision|0
1610584|NCT02117024|5617776|P2|Overall Study|Patient took treatment break|1
1610585|NCT02117024|5617777|P1|Overall Study|Patient took treatment break|0
1610586|NCT02117024|5617776|P2|Overall Study|Patient returned to primary oncologist|1
1610587|NCT02117024|5617777|P1|Overall Study|Patient returned to primary oncologist|0
1610588|NCT02117024|5617776|P2|Overall Study|Randomized in Error|0
1610589|NCT02117024|5617777|P1|Overall Study|Randomized in Error|1
1610590|NCT02117024|5617776|P2|Overall Study|Adverse Event|2
1610591|NCT02117024|5617777|P1|Overall Study|Adverse Event|1
1610592|NCT02117024|5617776|P2|Overall Study|Protocol Violation|0
1610593|NCT02117024|5617777|P1|Overall Study|Protocol Violation|1
1610594|NCT02117024|5617776|P2|Overall Study|Withdrawal by Subject|1
1610595|NCT02117024|5617777|P1|Overall Study|Withdrawal by Subject|3
1610596|NCT02117024|5617776|P2|Overall Study|Death|0
1610597|NCT02117024|5617777|P1|Overall Study|Death|5
1610598|NCT02117024|5617776|P2|Overall Study|Significant Clinical Progression|4
1610599|NCT02117024|5617777|P1|Overall Study|Significant Clinical Progression|7
1610600|NCT02117024|5617776|P2|Overall Study|Progressive Disease|9
1610601|NCT02117024|5617777|P1|Overall Study|Progressive Disease|26
1610602|NCT02116972|5617804|P3|Overall Study|scheduling conflicts and relocation|6
1610603|NCT02116972|5617805|P2|Overall Study|scheduling conflicts and relocation|3
1610604|NCT02116972|5617806|P1|Overall Study|scheduling conflicts and relocation|3
1610605|NCT02116972|5617804|P3|Overall Study|Lack of Efficacy|5
1610606|NCT02116972|5617805|P2|Overall Study|Lack of Efficacy|6
1610607|NCT02116972|5617806|P1|Overall Study|Lack of Efficacy|6
1610608|NCT02116972|5617804|P3|Overall Study|Lost to Follow-up|1
1610609|NCT02116972|5617805|P2|Overall Study|Lost to Follow-up|3
1610610|NCT02116972|5617806|P1|Overall Study|Lost to Follow-up|4
1610611|NCT02116972|5617804|P3|Overall Study|Protocol Violation|1
1610612|NCT02116972|5617805|P2|Overall Study|Protocol Violation|0
1610613|NCT02116972|5617806|P1|Overall Study|Protocol Violation|1
1610614|NCT02116972|5617804|P3|Overall Study|Withdrawal by Subject|5
1610615|NCT02116972|5617805|P2|Overall Study|Withdrawal by Subject|1
1610616|NCT02116972|5617806|P1|Overall Study|Withdrawal by Subject|1
1610617|NCT02116972|5617804|P3|Overall Study|Adverse Event|1
1610618|NCT02116972|5617805|P2|Overall Study|Adverse Event|4
1610619|NCT02116972|5617806|P1|Overall Study|Adverse Event|4
1610620|NCT02116803|5617838|P2|Overall Study|Death|0
1610621|NCT02116803|5617839|P1|Overall Study|Death|1
1610622|NCT02116803|5617838|P2|Overall Study|Study terminated by sponsor|1
1610623|NCT02116803|5617839|P1|Overall Study|Study terminated by sponsor|2
1610624|NCT02116803|5617838|P2|Overall Study|Progressive disease|0
1610625|NCT02116803|5617839|P1|Overall Study|Progressive disease|4
1610626|NCT02116803|5617838|P2|Overall Study|Physician Decision|0
1610627|NCT02116803|5617839|P1|Overall Study|Physician Decision|1
1610628|NCT02116803|5617838|P2|Overall Study|Adverse Event|1
1610629|NCT02116803|5617839|P1|Overall Study|Adverse Event|2
1610630|NCT02116660|5617847|P2|Overall Study|Organization reason|0
1610631|NCT02116660|5617848|P1|Overall Study|Organization reason|1
1610632|NCT02116660|5617847|P2|Overall Study|Withdrawal by Subject|2
1610633|NCT02116660|5617848|P1|Overall Study|Withdrawal by Subject|0
1610634|NCT02116660|5617847|P2|Overall Study|Adverse Event|1
1610635|NCT02116660|5617848|P1|Overall Study|Adverse Event|1
1610636|NCT02116660|5617847|P2|Overall Study|Deteriorating renal function|1
1610637|NCT02116660|5617848|P1|Overall Study|Deteriorating renal function|0
1610638|NCT02116621|5617892|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
1610639|NCT02116621|5617893|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
1610640|NCT02116621|5617892|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
1610641|NCT02116621|5617893|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
1610642|NCT02116621|5617892|P2|Twelve Month Follow-up|Lost to Follow-up|1
1610643|NCT02116621|5617893|P1|Twelve Month Follow-up|Lost to Follow-up|0
1610644|NCT02116621|5617892|P2|Twelve Month Follow-up|Withdrawal by Subject|0
1610645|NCT02116621|5617893|P1|Twelve Month Follow-up|Withdrawal by Subject|1
1610646|NCT02116621|5617892|P2|Six Month Follow-up|Did not complete follow-up survey|1
1610647|NCT02116621|5617893|P1|Six Month Follow-up|Did not complete follow-up survey|1
1610648|NCT02116621|5617892|P2|Six Month Follow-up|Lost to Follow-up|1
1610649|NCT02116621|5617893|P1|Six Month Follow-up|Lost to Follow-up|2
1610650|NCT02116621|5617892|P2|Six Month Follow-up|Withdrawal by Subject|1
1610651|NCT02116621|5617893|P1|Six Month Follow-up|Withdrawal by Subject|1
1610652|NCT02116621|5617892|P2|Three Month Follow-up|Did not complete follow-up survey|4
1610653|NCT02116621|5617893|P1|Three Month Follow-up|Did not complete follow-up survey|14
1610654|NCT02116621|5617892|P2|Three Month Follow-up|Lost to Follow-up|1
1610655|NCT02116621|5617893|P1|Three Month Follow-up|Lost to Follow-up|0
1610656|NCT02116621|5617892|P2|Three Month Follow-up|Withdrawal by Subject|1
1610657|NCT02116621|5617893|P1|Three Month Follow-up|Withdrawal by Subject|4
1610658|NCT02116621|5617892|P2|Three Month Follow-up|Death|1
1610659|NCT02116621|5617893|P1|Three Month Follow-up|Death|1
1610660|NCT02116621|5617892|P2|Baseline|Withdrawal by Subject|4
1610661|NCT02116621|5617893|P1|Baseline|Withdrawal by Subject|0
1610662|NCT02116582|5617981|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
1610663|NCT02116582|5617981|P1|Overall Study|Lost to Follow-up|1
1610664|NCT02116582|5617981|P1|Overall Study|Other: Miscellaneous|11
1610665|NCT02116582|5617981|P1|Overall Study|Withdrawal by Subject|8
1610666|NCT02116582|5617981|P1|Overall Study|Protocol Violation|3
1610667|NCT02116582|5617981|P1|Overall Study|Progressive Disease|148
1610668|NCT02116582|5617981|P1|Overall Study|Death|9
1610669|NCT02116582|5617981|P1|Overall Study|Adverse Event|22
1610670|NCT02116582|5617981|P1|Overall Study|Enrolled but Never Received Study Drug|1
1610671|NCT02116530|5617991|P2|Overall Study|Other Medical Problems|2
1610672|NCT02116530|5617992|P1|Overall Study|Other Medical Problems|2
1610673|NCT02116530|5617991|P2|Overall Study|Lost to Follow-up|0
1610674|NCT02116530|5617992|P1|Overall Study|Lost to Follow-up|1
1610675|NCT02116530|5617991|P2|Overall Study|Physician Decision|0
1610676|NCT02116530|5617992|P1|Overall Study|Physician Decision|1
1610677|NCT02116530|5617991|P2|Overall Study|Adverse Event|0
1610678|NCT02116530|5617992|P1|Overall Study|Adverse Event|4
1610679|NCT02116530|5617991|P2|Overall Study|Withdrawal by Subject|2
1610680|NCT02116530|5617992|P1|Overall Study|Withdrawal by Subject|1
1610681|NCT02116361|5618010|P4|Overall Study|Investigator Decision - Relapse|5
1610682|NCT02116361|5618011|P3|Overall Study|Investigator Decision - Relapse|8
1610683|NCT02116361|5618012|P2|Overall Study|Investigator Decision - Relapse|7
1610684|NCT02116361|5618013|P1|Overall Study|Investigator Decision - Relapse|9
1610685|NCT02116361|5618010|P4|Overall Study|Personal Reasons|9
1610686|NCT02116361|5618011|P3|Overall Study|Personal Reasons|4
1610687|NCT02116361|5618012|P2|Overall Study|Personal Reasons|6
1610688|NCT02116361|5618013|P1|Overall Study|Personal Reasons|6
1610689|NCT02116361|5618010|P4|Overall Study|Lost to Follow-up|5
1610690|NCT02116361|5618011|P3|Overall Study|Lost to Follow-up|7
1610691|NCT02116361|5618012|P2|Overall Study|Lost to Follow-up|5
1610692|NCT02116361|5618013|P1|Overall Study|Lost to Follow-up|4
1610693|NCT02116361|5618010|P4|Overall Study|Lack of Efficacy|3
1610694|NCT02116361|5618011|P3|Overall Study|Lack of Efficacy|4
1610695|NCT02116361|5618012|P2|Overall Study|Lack of Efficacy|7
1610696|NCT02116361|5618013|P1|Overall Study|Lack of Efficacy|5
1610697|NCT02116361|5618010|P4|Overall Study|Other Reasons|3
1610698|NCT02116361|5618011|P3|Overall Study|Other Reasons|3
1610699|NCT02116361|5618012|P2|Overall Study|Other Reasons|3
1610700|NCT02116361|5618013|P1|Overall Study|Other Reasons|3
1610701|NCT02116361|5618010|P4|Overall Study|Adverse Event|3
1610702|NCT02116361|5618011|P3|Overall Study|Adverse Event|0
1610703|NCT02116361|5618012|P2|Overall Study|Adverse Event|0
1610704|NCT02116361|5618013|P1|Overall Study|Adverse Event|1
1610705|NCT02116361|5618010|P4|Overall Study|Physician Decision|0
1610706|NCT02116361|5618011|P3|Overall Study|Physician Decision|0
1610707|NCT02116361|5618012|P2|Overall Study|Physician Decision|3
1610708|NCT02116361|5618013|P1|Overall Study|Physician Decision|2
1610709|NCT02116361|5618010|P4|Overall Study|Protocol Violation|2
1610710|NCT02116361|5618011|P3|Overall Study|Protocol Violation|0
1610711|NCT02116361|5618012|P2|Overall Study|Protocol Violation|0
1610712|NCT02116361|5618013|P1|Overall Study|Protocol Violation|1
1610713|NCT02116361|5618010|P4|Overall Study|Pregnancy|1
1610714|NCT02116361|5618011|P3|Overall Study|Pregnancy|0
1610715|NCT02116361|5618012|P2|Overall Study|Pregnancy|0
1610716|NCT02116361|5618013|P1|Overall Study|Pregnancy|0
1610717|NCT02116309|5618050|P2|Overall Study|Lost to Follow-up|1
1610718|NCT02116309|5618051|P1|Overall Study|Lost to Follow-up|0
1610719|NCT02115815|5618083|P7|Overall Study|Missed appointment, randomized in error|0
1610720|NCT02115815|5618084|P6|Overall Study|Missed appointment, randomized in error|1
1610721|NCT02115815|5618085|P5|Overall Study|Missed appointment, randomized in error|0
1610722|NCT02115815|5618086|P4|Overall Study|Missed appointment, randomized in error|0
1610723|NCT02115815|5618087|P3|Overall Study|Missed appointment, randomized in error|0
1610724|NCT02115815|5618088|P2|Overall Study|Missed appointment, randomized in error|0
1610725|NCT02115815|5618089|P1|Overall Study|Missed appointment, randomized in error|0
1610726|NCT02115815|5618083|P7|Overall Study|Not enough drug to dose participant|0
1610727|NCT02115815|5618084|P6|Overall Study|Not enough drug to dose participant|1
1610728|NCT02115815|5618085|P5|Overall Study|Not enough drug to dose participant|0
1610729|NCT02115815|5618086|P4|Overall Study|Not enough drug to dose participant|0
1610730|NCT02115815|5618087|P3|Overall Study|Not enough drug to dose participant|0
1610731|NCT02115815|5618088|P2|Overall Study|Not enough drug to dose participant|0
1610732|NCT02115815|5618089|P1|Overall Study|Not enough drug to dose participant|0
1610733|NCT02115815|5618083|P7|Overall Study|Withdrawal by Subject|0
1610734|NCT02115815|5618084|P6|Overall Study|Withdrawal by Subject|0
1610735|NCT02115815|5618085|P5|Overall Study|Withdrawal by Subject|0
1610736|NCT02115815|5618086|P4|Overall Study|Withdrawal by Subject|0
1610737|NCT02115815|5618087|P3|Overall Study|Withdrawal by Subject|0
1610738|NCT02115815|5618088|P2|Overall Study|Withdrawal by Subject|0
1610739|NCT02115815|5618089|P1|Overall Study|Withdrawal by Subject|2
1610740|NCT02115607|5618231|P1|Overall Study|Withdrawal by Subject|1
1610741|NCT02115386|5618257|P1|Overall Study|Administrative - trial was terminated|6
1610742|NCT02115386|5618257|P1|Overall Study|Protocol Violation|1
1610743|NCT02115321|5618360|P2|Overall Study|Death|0
1610744|NCT02115321|5618361|P1|Overall Study|Death|1
1610745|NCT02115308|5618383|P2|Overall Study|Safety Screening|2
1610746|NCT02115308|5618384|P1|Overall Study|Safety Screening|2
1610747|NCT02115269|5618400|P1|Overall Study|Didn't take study drug|2
1610748|NCT02115269|5618400|P1|Overall Study|Withdrawal by Subject|2
1610749|NCT02115269|5618400|P1|Overall Study|Moved to another city|7
1610750|NCT02115269|5618400|P1|Overall Study|Did not complete patient diary|3
1610751|NCT02115269|5618400|P1|Overall Study|Lost to Follow-up|43
1610752|NCT02115256|5618420|P2|Overall Study|Withdrawal by Subject|1
1610753|NCT02115256|5618421|P1|Overall Study|Withdrawal by Subject|0
1610754|NCT02115113|5618433|P3|Participants Randomized|Death|0
1610755|NCT02115113|5618434|P2|Participants Randomized|Death|0
1610756|NCT02115113|5618435|P1|Participants Randomized|Death|1
1610757|NCT02115113|5618433|P3|Participants Randomized|Lost to Follow-up|0
1610758|NCT02115113|5618434|P2|Participants Randomized|Lost to Follow-up|0
1610759|NCT02115113|5618435|P1|Participants Randomized|Lost to Follow-up|1
1610760|NCT02115113|5618433|P3|Participants in Run-in Period|Withdrawal by Subject|3
1610761|NCT02115113|5618434|P2|Participants in Run-in Period|Withdrawal by Subject|0
1610762|NCT02115113|5618435|P1|Participants in Run-in Period|Withdrawal by Subject|0
1610763|NCT02115113|5618433|P3|Participants in Run-in Period|Lost to Follow-up|5
1610764|NCT02115113|5618434|P2|Participants in Run-in Period|Lost to Follow-up|0
1610765|NCT02115113|5618435|P1|Participants in Run-in Period|Lost to Follow-up|0
1610766|NCT02115113|5618433|P3|Participants in Run-in Period|Administrative problems|1
1610767|NCT02115113|5618434|P2|Participants in Run-in Period|Administrative problems|0
1610768|NCT02115113|5618435|P1|Participants in Run-in Period|Administrative problems|0
1610769|NCT02115113|5618433|P3|Participants in Run-in Period|Death|1
1610770|NCT02115113|5618434|P2|Participants in Run-in Period|Death|0
1610771|NCT02115113|5618435|P1|Participants in Run-in Period|Death|0
1610772|NCT02114931|5618467|P2|Overall Study|Other|1
1610773|NCT02114931|5618468|P1|Overall Study|Other|2
1610774|NCT02114931|5618467|P2|Overall Study|Physician Decision|2
1610775|NCT02114931|5618468|P1|Overall Study|Physician Decision|1
1610776|NCT02114931|5618467|P2|Overall Study|Lost to Follow-up|3
1610777|NCT02114931|5618468|P1|Overall Study|Lost to Follow-up|3
1610778|NCT02114931|5618467|P2|Overall Study|Adverse Event|6
1610779|NCT02114931|5618468|P1|Overall Study|Adverse Event|4
1610780|NCT02114931|5618467|P2|Overall Study|Withdrawal by Subject|18
1610781|NCT02114931|5618468|P1|Overall Study|Withdrawal by Subject|15
1610782|NCT02114892|5618484|P2|Overall Study|Lost to Follow-up|2
1610783|NCT02114892|5618485|P1|Overall Study|Lost to Follow-up|1
1610784|NCT02114697|5618521|P2|Overall Study|Study terminated|4
1610785|NCT02114697|5618522|P1|Overall Study|Study terminated|5
1610786|NCT02114684|5618530|P2|Overall Study|Patient Incarcerated|0
1610787|NCT02114684|5618531|P1|Overall Study|Patient Incarcerated|1
1610788|NCT02114684|5618530|P2|Overall Study|Rifampicin resistant on culture|1
1610789|NCT02114684|5618531|P1|Overall Study|Rifampicin resistant on culture|0
1610790|NCT02114684|5618530|P2|Overall Study|Relocation|1
1610791|NCT02114684|5618531|P1|Overall Study|Relocation|3
1610792|NCT02114684|5618530|P2|Overall Study|Withdrawal by Subject|2
1610793|NCT02114684|5618531|P1|Overall Study|Withdrawal by Subject|1
1610794|NCT02114684|5618530|P2|Overall Study|Lost to Follow-up|2
1610795|NCT02114684|5618531|P1|Overall Study|Lost to Follow-up|1
1610796|NCT02114684|5618530|P2|Overall Study|Death|4
1610797|NCT02114684|5618531|P1|Overall Study|Death|6
1610798|NCT02114515|5618549|P2|Overall Study|Other|61
1610799|NCT02114515|5618550|P1|Overall Study|Other|65
1610800|NCT02114515|5618549|P2|Overall Study|Withdrawal by Subject|22
1610801|NCT02114515|5618550|P1|Overall Study|Withdrawal by Subject|4
1610802|NCT02114515|5618549|P2|Overall Study|Death|12
1610803|NCT02114515|5618550|P1|Overall Study|Death|12
1610804|NCT02114515|5618549|P2|Overall Study|Lost to Follow-up|55
1610805|NCT02114515|5618550|P1|Overall Study|Lost to Follow-up|52
1610806|NCT02114385|5618596|P2|Overall Study|Lost to Follow-up|6
1610807|NCT02114385|5618597|P1|Overall Study|Lost to Follow-up|0
1610808|NCT02114385|5618596|P2|Overall Study|Withdrawal by Subject|2
1610809|NCT02114385|5618597|P1|Overall Study|Withdrawal by Subject|3
1610810|NCT02114268|5618638|P6|Overall Study|Withdrawn by site due to noncompliance|0
1610811|NCT02114268|5618639|P5|Overall Study|Withdrawn by site due to noncompliance|0
1610812|NCT02114268|5618640|P4|Overall Study|Withdrawn by site due to noncompliance|0
1610813|NCT02114268|5618641|P3|Overall Study|Withdrawn by site due to noncompliance|0
1610814|NCT02114268|5618642|P2|Overall Study|Withdrawn by site due to noncompliance|0
1610815|NCT02114268|5618643|P1|Overall Study|Withdrawn by site due to noncompliance|1
1610816|NCT02114268|5618638|P6|Overall Study|Withdrawal by Subject|1
1610817|NCT02114268|5618639|P5|Overall Study|Withdrawal by Subject|0
1610818|NCT02114268|5618640|P4|Overall Study|Withdrawal by Subject|0
1610819|NCT02114268|5618641|P3|Overall Study|Withdrawal by Subject|0
1610820|NCT02114268|5618642|P2|Overall Study|Withdrawal by Subject|0
1610821|NCT02114268|5618643|P1|Overall Study|Withdrawal by Subject|1
1610822|NCT02114268|5618638|P6|Overall Study|Lost to Follow-up|2
1610823|NCT02114268|5618639|P5|Overall Study|Lost to Follow-up|0
1610824|NCT02114268|5618640|P4|Overall Study|Lost to Follow-up|0
1610825|NCT02114268|5618641|P3|Overall Study|Lost to Follow-up|1
1610826|NCT02114268|5618642|P2|Overall Study|Lost to Follow-up|1
1610827|NCT02114268|5618643|P1|Overall Study|Lost to Follow-up|4
1610828|NCT02114203|5618712|P3|Overall Study|Withdrawal by Subject|0
1610829|NCT02114203|5618713|P2|Overall Study|Withdrawal by Subject|1
1610830|NCT02114203|5618714|P1|Overall Study|Withdrawal by Subject|0
1610831|NCT02114203|5618712|P3|Overall Study|Adverse Event|0
1610832|NCT02114203|5618713|P2|Overall Study|Adverse Event|1
1610833|NCT02114203|5618714|P1|Overall Study|Adverse Event|0
1610834|NCT02114177|5618748|P2|Overall Study|Other|1
1610835|NCT02114177|5618749|P1|Overall Study|Other|2
1610836|NCT02114177|5618748|P2|Overall Study|Withdrawal by Subject|1
1610837|NCT02114177|5618749|P1|Overall Study|Withdrawal by Subject|6
1610838|NCT02114177|5618748|P2|Overall Study|Lost to Follow-up|2
1610839|NCT02114177|5618749|P1|Overall Study|Lost to Follow-up|1
1610840|NCT02114151|5618773|P1|Overall Study|Withdrawal by Subject|5
1610841|NCT02114151|5618773|P1|Overall Study|Lost to Follow-up|1
1610842|NCT02114151|5618773|P1|Overall Study|Death|1
1610843|NCT02113956|5618790|P2|3 Month Post-intervention|Lost to Follow-up|2
1610844|NCT02113956|5618791|P1|3 Month Post-intervention|Lost to Follow-up|4
1610845|NCT02113956|5618790|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
1610846|NCT02113956|5618791|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
1610847|NCT02113956|5618790|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
1610848|NCT02113956|5618791|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
1610849|NCT02113579|5618825|P2|Overall Study|Lost to Follow-up|2
1610850|NCT02113579|5618826|P1|Overall Study|Lost to Follow-up|6
1610851|NCT02113579|5618825|P2|Overall Study|Withdrawal by Subject|2
1610852|NCT02113579|5618826|P1|Overall Study|Withdrawal by Subject|3
1610853|NCT02113579|5618825|P2|Overall Study|Adverse Event|0
1610854|NCT02113579|5618826|P1|Overall Study|Adverse Event|1
1610855|NCT02113449|5618850|P1|Overall Study|Adverse Event|4
1610856|NCT02113436|5618866|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
1610857|NCT02113436|5618867|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
1610858|NCT02113436|5618868|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
1610859|NCT02113436|5618869|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
1610860|NCT02113436|5618866|P4|Period 2: 16 Weeks|Physician Decision|0
1610861|NCT02113436|5618867|P3|Period 2: 16 Weeks|Physician Decision|2
1610862|NCT02113436|5618868|P2|Period 2: 16 Weeks|Physician Decision|0
1610863|NCT02113436|5618869|P1|Period 2: 16 Weeks|Physician Decision|0
1610864|NCT02113436|5618866|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
1610865|NCT02113436|5618867|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
1610866|NCT02113436|5618868|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1610867|NCT02113436|5618869|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
1610868|NCT02113436|5618866|P4|Period 2: 16 Weeks|Adverse Event|5
1610869|NCT02113436|5618867|P3|Period 2: 16 Weeks|Adverse Event|4
1610870|NCT02113436|5618868|P2|Period 2: 16 Weeks|Adverse Event|0
1610871|NCT02113436|5618869|P1|Period 2: 16 Weeks|Adverse Event|0
1610872|NCT02113436|5618866|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
1610873|NCT02113436|5618867|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
1610874|NCT02113436|5618868|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
1610875|NCT02113436|5618869|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
1610876|NCT02113436|5618866|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1610877|NCT02113436|5618867|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
1610878|NCT02113436|5618868|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
1610879|NCT02113436|5618869|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
1610880|NCT02113436|5618866|P4|Period 1: 8 Weeks|Protocol Violation|0
1610881|NCT02113436|5618867|P3|Period 1: 8 Weeks|Protocol Violation|0
1610882|NCT02113436|5618868|P2|Period 1: 8 Weeks|Protocol Violation|0
1610883|NCT02113436|5618869|P1|Period 1: 8 Weeks|Protocol Violation|1
1610884|NCT02113436|5618866|P4|Period 1: 8 Weeks|Adverse Event|0
1610885|NCT02113436|5618867|P3|Period 1: 8 Weeks|Adverse Event|0
1610886|NCT02113436|5618868|P2|Period 1: 8 Weeks|Adverse Event|0
1610887|NCT02113436|5618869|P1|Period 1: 8 Weeks|Adverse Event|1
1610888|NCT02113189|5618920|P3|Overall Study|Lost to follow up|3
1610889|NCT02113189|5618921|P2|Overall Study|Lost to follow up|1
1610890|NCT02113189|5618922|P1|Overall Study|Lost to follow up|2
1610891|NCT02113124|5618938|P2|Overall Study|Unable to retrieve blood sample|1
1610892|NCT02113124|5618939|P1|Overall Study|Unable to retrieve blood sample|1
1610893|NCT02113007|5618945|P1|Overall Study|Progressive disease|2
1610894|NCT02112994|5618951|P3|Overall Study|Withdrawal by Subject|1
1610895|NCT02112994|5618952|P2|Overall Study|Withdrawal by Subject|0
1610896|NCT02112994|5618953|P1|Overall Study|Withdrawal by Subject|0
1610897|NCT02112994|5618951|P3|Overall Study|Liver Transplant|0
1610898|NCT02112994|5618952|P2|Overall Study|Liver Transplant|1
1610899|NCT02112994|5618953|P1|Overall Study|Liver Transplant|0
1610900|NCT02112994|5618951|P3|Overall Study|Pregnancy|1
1610901|NCT02112994|5618952|P2|Overall Study|Pregnancy|1
1610902|NCT02112994|5618953|P1|Overall Study|Pregnancy|0
1610903|NCT02112994|5618951|P3|Overall Study|Progressive Disease|1
1610904|NCT02112994|5618952|P2|Overall Study|Progressive Disease|0
1610905|NCT02112994|5618953|P1|Overall Study|Progressive Disease|0
1610906|NCT02112877|5618971|P2|Overall Study|Visit Missed|6
1610907|NCT02112877|5618972|P1|Overall Study|Visit Missed|1
1610908|NCT02112877|5618971|P2|Overall Study|Withdrawal by Subject|7
1610909|NCT02112877|5618972|P1|Overall Study|Withdrawal by Subject|1
1610910|NCT02112448|5619051|P2|Overall Study|required heparin so could not use ketoro|0
1610911|NCT02112448|5619052|P1|Overall Study|required heparin so could not use ketoro|1
1610912|NCT02112448|5619051|P2|Overall Study|Physician Decision|6
1610913|NCT02112448|5619052|P1|Overall Study|Physician Decision|4
1610914|NCT02112448|5619051|P2|Overall Study|Protocol Violation|2
1610915|NCT02112448|5619052|P1|Overall Study|Protocol Violation|1
1610916|NCT02112448|5619051|P2|Overall Study|lab values precluding use of ketorolac|2
1610917|NCT02112448|5619052|P1|Overall Study|lab values precluding use of ketorolac|2
1610918|NCT02112045|5619085|P2|Overall Study|Withdrawal by Subject|0
1610919|NCT02112045|5619086|P1|Overall Study|Withdrawal by Subject|1
1610920|NCT02111993|5619106|P2|Overall Study|Physician Decision|4
1610921|NCT02111993|5619107|P1|Overall Study|Physician Decision|5
1610922|NCT02111785|5619150|P4|Overall Study|Death|0
1610923|NCT02111785|5619151|P3|Overall Study|Death|0
1610924|NCT02111785|5619152|P2|Overall Study|Death|1
1610925|NCT02111785|5619153|P1|Overall Study|Death|0
1610926|NCT02111603|5619215|P1|Overall Study|Withdrawal by Subject|1
1610927|NCT02111564|5619226|P2|Overall Study|Withdrawal by Subject|20
1610928|NCT02111564|5619227|P1|Overall Study|Withdrawal by Subject|20
1610929|NCT02111564|5619226|P2|Overall Study|Lost to Follow-up|3
1610930|NCT02111564|5619227|P1|Overall Study|Lost to Follow-up|2
1610931|NCT02111564|5619226|P2|Overall Study|Death|120
1610932|NCT02111564|5619227|P1|Overall Study|Death|109
1610933|NCT02111369|5619266|P1|Overall Study|Withdrawal by Subject|1
1610934|NCT02111369|5619266|P1|Overall Study|Lost to Follow-up|2
1610935|NCT02111213|5619290|P2|Overall Study|Lost to Follow-up|4
1610936|NCT02111213|5619291|P1|Overall Study|Lost to Follow-up|3
1610937|NCT02111213|5619290|P2|Overall Study|Withdrawal by Subject|2
1610938|NCT02111213|5619291|P1|Overall Study|Withdrawal by Subject|3
1610939|NCT02111174|5619335|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
1610940|NCT02111174|5619336|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
1610941|NCT02111174|5619335|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
1610942|NCT02111174|5619336|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
1610943|NCT02111174|5619335|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
1610944|NCT02111174|5619336|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
1610945|NCT02111174|5619335|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
1610946|NCT02111174|5619336|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
1610947|NCT02111096|5619365|P3|Overall Study|Withdrawal by Subject|8
1610948|NCT02111096|5619366|P2|Overall Study|Withdrawal by Subject|2
1610949|NCT02111096|5619367|P1|Overall Study|Withdrawal by Subject|4
1610950|NCT02111096|5619365|P3|Overall Study|Terminated by Sponsor|54
1610951|NCT02111096|5619366|P2|Overall Study|Terminated by Sponsor|35
1610952|NCT02111096|5619367|P1|Overall Study|Terminated by Sponsor|53
1610953|NCT02111096|5619365|P3|Overall Study|Protocol Violation|1
1610954|NCT02111096|5619366|P2|Overall Study|Protocol Violation|0
1610955|NCT02111096|5619367|P1|Overall Study|Protocol Violation|1
1610956|NCT02111096|5619365|P3|Overall Study|Physician Decision|0
1610957|NCT02111096|5619366|P2|Overall Study|Physician Decision|1
1610958|NCT02111096|5619367|P1|Overall Study|Physician Decision|0
1610959|NCT02111096|5619365|P3|Overall Study|Lost to Follow Up|1
1610960|NCT02111096|5619366|P2|Overall Study|Lost to Follow Up|1
1610961|NCT02111096|5619367|P1|Overall Study|Lost to Follow Up|1
1610962|NCT02111096|5619365|P3|Overall Study|Non-Compliance with Study Drug|0
1610963|NCT02111096|5619366|P2|Overall Study|Non-Compliance with Study Drug|1
1610964|NCT02111096|5619367|P1|Overall Study|Non-Compliance with Study Drug|1
1610965|NCT02111096|5619365|P3|Overall Study|Adverse Event|2
1610966|NCT02111096|5619366|P2|Overall Study|Adverse Event|1
1610967|NCT02111096|5619367|P1|Overall Study|Adverse Event|4
1610968|NCT02111083|5619415|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
1610969|NCT02111083|5619416|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
1610970|NCT02110901|5619436|P2|Overall Study|received a kidney transplant|0
1610971|NCT02110901|5619437|P1|Overall Study|received a kidney transplant|5
1610972|NCT02110901|5619436|P2|Overall Study|Withdrawal by Subject|3
1610973|NCT02110901|5619437|P1|Overall Study|Withdrawal by Subject|7
1610974|NCT02110901|5619436|P2|Overall Study|Lost to Follow-up|8
1610975|NCT02110901|5619437|P1|Overall Study|Lost to Follow-up|12
1610976|NCT02110901|5619436|P2|Overall Study|Death|3
1610977|NCT02110901|5619437|P1|Overall Study|Death|6
1610978|NCT02110706|5619451|P2|Overall Study|Patients who didn't receive 2nd infusion|1
1610979|NCT02110706|5619452|P1|Overall Study|Patients who didn't receive 2nd infusion|3
1610980|NCT02110706|5619451|P2|Overall Study|Adverse Event|3
1610981|NCT02110706|5619452|P1|Overall Study|Adverse Event|2
1610982|NCT02110693|5619464|P2|Overall Study|Other|0
1610983|NCT02110693|5619465|P1|Overall Study|Other|1
1610984|NCT02110693|5619464|P2|Overall Study|technical difficulties|4
1610985|NCT02110693|5619465|P1|Overall Study|technical difficulties|6
1610986|NCT02110693|5619464|P2|Overall Study|skipped assessment|18
1610987|NCT02110693|5619465|P1|Overall Study|skipped assessment|15
1610988|NCT02110693|5619464|P2|Overall Study|Withdrawal by Subject|7
1610989|NCT02110693|5619465|P1|Overall Study|Withdrawal by Subject|6
1610990|NCT02110238|5619546|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
1610991|NCT02110238|5619547|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
1610992|NCT02110238|5619546|P2|14 Week Blinded Extension Phase|Protocol Violation|3
1610993|NCT02110238|5619547|P1|14 Week Blinded Extension Phase|Protocol Violation|2
1610994|NCT02110238|5619546|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
1610995|NCT02110238|5619547|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
1610996|NCT02110238|5619546|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
1610997|NCT02110238|5619547|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
1610998|NCT02110238|5619546|P2|14 Week Blinded Extension Phase|Adverse Event|1
1610999|NCT02110238|5619547|P1|14 Week Blinded Extension Phase|Adverse Event|1
1611000|NCT02110238|5619546|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
1611001|NCT02110238|5619547|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
1611002|NCT02110238|5619546|P2|12 Week Pivotal Phase|Protocol Violation|1
1611003|NCT02110238|5619547|P1|12 Week Pivotal Phase|Protocol Violation|0
1611004|NCT02110238|5619546|P2|12 Week Pivotal Phase|Physician Decision|2
1611005|NCT02110238|5619547|P1|12 Week Pivotal Phase|Physician Decision|0
1611006|NCT02110238|5619546|P2|12 Week Pivotal Phase|Lost to Follow-up|0
1611007|NCT02110238|5619547|P1|12 Week Pivotal Phase|Lost to Follow-up|2
1611008|NCT02110238|5619546|P2|12 Week Pivotal Phase|Lack of Efficacy|3
1611009|NCT02110238|5619547|P1|12 Week Pivotal Phase|Lack of Efficacy|2
1611010|NCT02110238|5619546|P2|12 Week Pivotal Phase|Adverse Event|0
1611011|NCT02110238|5619547|P1|12 Week Pivotal Phase|Adverse Event|3
1611012|NCT02110225|5619556|P3|Overall Study|Lost to Follow-up|0
1611013|NCT02110225|5619557|P2|Overall Study|Lost to Follow-up|1
1611014|NCT02110225|5619558|P1|Overall Study|Lost to Follow-up|0
1611015|NCT02109562|5619668|P3|Overall Study|Physician Decision|5
1611016|NCT02109562|5619669|P2|Overall Study|Physician Decision|4
1611017|NCT02109562|5619670|P1|Overall Study|Physician Decision|3
1611018|NCT02109562|5619668|P3|Overall Study|Withdrawal by Subject|21
1611019|NCT02109562|5619669|P2|Overall Study|Withdrawal by Subject|25
1611020|NCT02109562|5619670|P1|Overall Study|Withdrawal by Subject|20
1611021|NCT02109562|5619668|P3|Overall Study|Protocol Violation|1
1611022|NCT02109562|5619669|P2|Overall Study|Protocol Violation|3
1611023|NCT02109562|5619670|P1|Overall Study|Protocol Violation|0
1611024|NCT02109562|5619668|P3|Overall Study|Lost to Follow-up|1
1611025|NCT02109562|5619669|P2|Overall Study|Lost to Follow-up|0
1611026|NCT02109562|5619670|P1|Overall Study|Lost to Follow-up|1
1611027|NCT02109562|5619668|P3|Overall Study|Adverse Event|3
1611028|NCT02109562|5619669|P2|Overall Study|Adverse Event|2
1611029|NCT02109562|5619670|P1|Overall Study|Adverse Event|0
1611030|NCT02109562|5619668|P3|Overall Study|Insufficient clinical response|4
1611031|NCT02109562|5619669|P2|Overall Study|Insufficient clinical response|0
1611032|NCT02109562|5619670|P1|Overall Study|Insufficient clinical response|2
1611033|NCT02109484|5619697|P8|Overall Study|Moved away from study area|1
1611034|NCT02109484|5619698|P7|Overall Study|Moved away from study area|1
1611035|NCT02109484|5619699|P6|Overall Study|Moved away from study area|0
1611036|NCT02109484|5619700|P5|Overall Study|Moved away from study area|0
1611037|NCT02109484|5619701|P4|Overall Study|Moved away from study area|0
1611038|NCT02109484|5619702|P3|Overall Study|Moved away from study area|0
1611039|NCT02109484|5619703|P2|Overall Study|Moved away from study area|0
1611040|NCT02109484|5619704|P1|Overall Study|Moved away from study area|0
1611041|NCT02109484|5619697|P8|Overall Study|Death|2
1611042|NCT02109484|5619698|P7|Overall Study|Death|0
1611043|NCT02109484|5619699|P6|Overall Study|Death|0
1611044|NCT02109484|5619700|P5|Overall Study|Death|0
1611045|NCT02109484|5619701|P4|Overall Study|Death|0
1611046|NCT02109484|5619702|P3|Overall Study|Death|0
1611047|NCT02109484|5619703|P2|Overall Study|Death|0
1611048|NCT02109484|5619704|P1|Overall Study|Death|0
1611049|NCT02109484|5619697|P8|Overall Study|Physician Decision|0
1611050|NCT02109484|5619698|P7|Overall Study|Physician Decision|0
1611051|NCT02109484|5619699|P6|Overall Study|Physician Decision|0
1611052|NCT02109484|5619700|P5|Overall Study|Physician Decision|2
1611053|NCT02109484|5619701|P4|Overall Study|Physician Decision|0
1611054|NCT02109484|5619702|P3|Overall Study|Physician Decision|0
1611055|NCT02109484|5619703|P2|Overall Study|Physician Decision|0
1611056|NCT02109484|5619704|P1|Overall Study|Physician Decision|0
1611057|NCT02109484|5619697|P8|Overall Study|Withdrawal by Subject|0
1611058|NCT02109484|5619698|P7|Overall Study|Withdrawal by Subject|1
1611059|NCT02109484|5619699|P6|Overall Study|Withdrawal by Subject|1
1611060|NCT02109484|5619700|P5|Overall Study|Withdrawal by Subject|1
1611061|NCT02109484|5619701|P4|Overall Study|Withdrawal by Subject|0
1611062|NCT02109484|5619702|P3|Overall Study|Withdrawal by Subject|0
1611063|NCT02109484|5619703|P2|Overall Study|Withdrawal by Subject|0
1611064|NCT02109484|5619704|P1|Overall Study|Withdrawal by Subject|0
1611065|NCT02109484|5619697|P8|Overall Study|Lost to Follow-up|0
1611066|NCT02109484|5619698|P7|Overall Study|Lost to Follow-up|1
1611067|NCT02109484|5619699|P6|Overall Study|Lost to Follow-up|0
1611068|NCT02109484|5619700|P5|Overall Study|Lost to Follow-up|1
1611069|NCT02109484|5619701|P4|Overall Study|Lost to Follow-up|1
1611070|NCT02109484|5619702|P3|Overall Study|Lost to Follow-up|0
1611071|NCT02109484|5619703|P2|Overall Study|Lost to Follow-up|0
1611072|NCT02109484|5619704|P1|Overall Study|Lost to Follow-up|0
1611073|NCT02109445|5619760|P1|Overall Study|Adverse Event|1
1611074|NCT02109445|5619760|P1|Overall Study|Symptomatic deterioration|2
1611075|NCT02109432|5619793|P1|Overall Study|Withdrawal by Subject|1
1611076|NCT02109172|5619803|P6|Overall Study|Death|0
1611077|NCT02109172|5619804|P5|Overall Study|Death|1
1611078|NCT02109172|5619805|P4|Overall Study|Death|0
1611079|NCT02109172|5619806|P3|Overall Study|Death|0
1611080|NCT02109172|5619807|P2|Overall Study|Death|0
1611081|NCT02109172|5619808|P1|Overall Study|Death|0
1611082|NCT02109172|5619803|P6|Overall Study|Adverse Event|1
1611083|NCT02109172|5619804|P5|Overall Study|Adverse Event|0
1611084|NCT02109172|5619805|P4|Overall Study|Adverse Event|0
1611085|NCT02109172|5619806|P3|Overall Study|Adverse Event|1
1611086|NCT02109172|5619807|P2|Overall Study|Adverse Event|0
1611087|NCT02109172|5619808|P1|Overall Study|Adverse Event|0
1611088|NCT02109172|5619803|P6|Overall Study|Withdrawal by Subject|0
1611089|NCT02109172|5619804|P5|Overall Study|Withdrawal by Subject|0
1611090|NCT02109172|5619805|P4|Overall Study|Withdrawal by Subject|1
1611091|NCT02109172|5619806|P3|Overall Study|Withdrawal by Subject|0
1611092|NCT02109172|5619807|P2|Overall Study|Withdrawal by Subject|0
1611093|NCT02109172|5619808|P1|Overall Study|Withdrawal by Subject|1
1611094|NCT02109133|5619829|P2|Overall Study|Lost to Follow-up|0
1611095|NCT02109133|5619830|P1|Overall Study|Lost to Follow-up|1
1611096|NCT02109107|5619842|P1|Overall Study|Lost to Follow-up|2
1611097|NCT02109042|5619849|P1|Overall Study|Sponsor Decision|15
1611098|NCT02109029|5619858|P6|Part B|Adverse Event|1
1611099|NCT02109029|5619859|P5|Part B|Adverse Event|1
1611100|NCT02109029|5619860|P4|Part B|Adverse Event|0
1611101|NCT02109029|5619861|P3|Part B|Adverse Event|0
1611102|NCT02109029|5619862|P2|Part B|Adverse Event|0
1611103|NCT02109029|5619863|P1|Part B|Adverse Event|0
1611104|NCT02108951|5619892|P1|Overall Study|Study Terminated by Sponsor|14
1611105|NCT02108951|5619892|P1|Overall Study|Patient's/guardian's decision|1
1611106|NCT02108951|5619892|P1|Overall Study|Lost to Follow-up|1
1611107|NCT02108912|5619911|P2|Overall Study|high blood pressure|0
1611108|NCT02108912|5619912|P1|Overall Study|high blood pressure|1
1611109|NCT02108912|5619911|P2|Overall Study|lack of transportation|0
1611110|NCT02108912|5619912|P1|Overall Study|lack of transportation|1
1611111|NCT02108912|5619911|P2|Overall Study|Lost to Follow-up|1
1611112|NCT02108912|5619912|P1|Overall Study|Lost to Follow-up|1
1611113|NCT02108652|5619941|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
1611114|NCT02108652|5619941|P1|Overall Study|Withdrawal by Subject|8
1611115|NCT02108652|5619941|P1|Overall Study|Lost to Follow-up|2
1611116|NCT02108652|5619941|P1|Overall Study|Death|226
1611117|NCT02107898|5620119|P2|Overall Study|Randomized but not treated|1
1611118|NCT02107898|5620120|P1|Overall Study|Randomized but not treated|0
1611119|NCT02107898|5620119|P2|Overall Study|Consent withdrawn by participant|1
1611120|NCT02107898|5620120|P1|Overall Study|Consent withdrawn by participant|2
1611121|NCT02107898|5620119|P2|Overall Study|Participant moved|2
1611122|NCT02107898|5620120|P1|Overall Study|Participant moved|0
1611123|NCT02107898|5620119|P2|Overall Study|Poor compliance to protocol|1
1611124|NCT02107898|5620120|P1|Overall Study|Poor compliance to protocol|0
1611125|NCT02107898|5620119|P2|Overall Study|Adverse Event|7
1611126|NCT02107898|5620120|P1|Overall Study|Adverse Event|4
1611127|NCT02107703|5620174|P2|Overall Study|On study treatment/follow up|152
1611128|NCT02107703|5620175|P1|Overall Study|On study treatment/follow up|319
1611129|NCT02107703|5620174|P2|Overall Study|Lost to Follow-up|4
1611130|NCT02107703|5620175|P1|Overall Study|Lost to Follow-up|6
1611131|NCT02107703|5620174|P2|Overall Study|Withdrawal by Subject|19
1611132|NCT02107703|5620175|P1|Overall Study|Withdrawal by Subject|36
1611133|NCT02107482|5620207|P1|Overall Study|Lack of Efficacy|1
1611134|NCT02107482|5620207|P1|Overall Study|Lost to Follow-up|1
1611135|NCT02107482|5620207|P1|Overall Study|inconveinence|2
1611136|NCT02107443|5620215|P2|Overall Study|Withdrawal: Personal Issues|3
1611137|NCT02107443|5620216|P1|Overall Study|Withdrawal: Personal Issues|0
1611138|NCT02107443|5620215|P2|Overall Study|Withdrawal: Disease Progression|2
1611139|NCT02107443|5620216|P1|Overall Study|Withdrawal: Disease Progression|4
1611140|NCT02107443|5620215|P2|Overall Study|Withdrawal: Other Medical|5
1611141|NCT02107443|5620216|P1|Overall Study|Withdrawal: Other Medical|9
1611142|NCT02107443|5620215|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
1611143|NCT02107443|5620216|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
1611144|NCT02107443|5620215|P2|Overall Study|Withdrawal: Too Time Consuming|6
1611145|NCT02107443|5620216|P1|Overall Study|Withdrawal: Too Time Consuming|3
1611146|NCT02107443|5620215|P2|Overall Study|Withdrawal: Too Many Forms|1
1611147|NCT02107443|5620216|P1|Overall Study|Withdrawal: Too Many Forms|3
1611148|NCT02107443|5620215|P2|Overall Study|Withdrawal: Changed MD/Facility|3
1611149|NCT02107443|5620216|P1|Overall Study|Withdrawal: Changed MD/Facility|1
1611150|NCT02107443|5620215|P2|Overall Study|Withdrawal: Changed Mind|0
1611151|NCT02107443|5620216|P1|Overall Study|Withdrawal: Changed Mind|2
1611152|NCT02107443|5620215|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
1611153|NCT02107443|5620216|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
1611154|NCT02107443|5620215|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
1611155|NCT02107443|5620216|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
1611156|NCT02107443|5620215|P2|Overall Study|Registered but Not Eligible|1
1611157|NCT02107443|5620216|P1|Overall Study|Registered but Not Eligible|0
1611158|NCT02107443|5620215|P2|Overall Study|Study Protocol Violation|1
1611159|NCT02107443|5620216|P1|Overall Study|Study Protocol Violation|3
1611160|NCT02107443|5620215|P2|Overall Study|Death|30
1611161|NCT02107443|5620216|P1|Overall Study|Death|42
1611162|NCT02107313|5620263|P2|Overall Study|One participant did not do the FED cohor|1
1611163|NCT02107313|5620264|P1|Overall Study|One participant did not do the FED cohor|0
1611164|NCT02107274|5620285|P2|Control Phase|Adverse Event|1
1611165|NCT02107274|5620286|P1|Control Phase|Adverse Event|0
1611166|NCT02107274|5620285|P2|Control Phase|Death|0
1611167|NCT02107274|5620286|P1|Control Phase|Death|2
1611168|NCT02107274|5620285|P2|Control Phase|Lost to Follow-up|1
1611169|NCT02107274|5620286|P1|Control Phase|Lost to Follow-up|1
1611170|NCT02107274|5620285|P2|Treatment vs. Placebo|Lost to Follow-up|2
1611171|NCT02107274|5620286|P1|Treatment vs. Placebo|Lost to Follow-up|0
1611172|NCT02107274|5620285|P2|Treatment vs. Placebo|Adverse Event|0
1611173|NCT02107274|5620286|P1|Treatment vs. Placebo|Adverse Event|3
1611174|NCT02107196|5620300|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
1611175|NCT02107196|5620301|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
1611176|NCT02107196|5620300|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
1611177|NCT02107196|5620301|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
1611178|NCT02107196|5620300|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
1611179|NCT02107196|5620301|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
1611180|NCT02107196|5620300|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
1611181|NCT02107196|5620301|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
1611182|NCT02107196|5620300|P2|12-week Treatment Period|Reason Missing|8
1611183|NCT02107196|5620301|P1|12-week Treatment Period|Reason Missing|11
1611184|NCT02107196|5620300|P2|12-week Treatment Period|Protocol Violation|8
1611185|NCT02107196|5620301|P1|12-week Treatment Period|Protocol Violation|7
1611186|NCT02107196|5620300|P2|12-week Treatment Period|Withdrawal by Subject|12
1611187|NCT02107196|5620301|P1|12-week Treatment Period|Withdrawal by Subject|15
1611188|NCT02107196|5620300|P2|12-week Treatment Period|Physician Decision|1
1611189|NCT02107196|5620301|P1|12-week Treatment Period|Physician Decision|0
1611190|NCT02107196|5620300|P2|12-week Treatment Period|Lost to Follow-up|6
1611191|NCT02107196|5620301|P1|12-week Treatment Period|Lost to Follow-up|3
1611192|NCT02107196|5620300|P2|12-week Treatment Period|Lack of Efficacy|1
1611193|NCT02107196|5620301|P1|12-week Treatment Period|Lack of Efficacy|2
1611194|NCT02107196|5620300|P2|12-week Treatment Period|Adverse Event|3
1611195|NCT02107196|5620301|P1|12-week Treatment Period|Adverse Event|6
1611196|NCT02107131|5620316|P2|Overall Study|Protocol Violation|4
1611197|NCT02107131|5620317|P1|Overall Study|Protocol Violation|0
1611198|NCT02107131|5620316|P2|Overall Study|Death|1
1611199|NCT02107131|5620317|P1|Overall Study|Death|0
1611200|NCT02107131|5620316|P2|Overall Study|mental instability|0
1611201|NCT02107131|5620317|P1|Overall Study|mental instability|1
1611202|NCT02107131|5620316|P2|Overall Study|Withdrawal by Subject|0
1611203|NCT02107131|5620317|P1|Overall Study|Withdrawal by Subject|2
1611204|NCT02107131|5620316|P2|Overall Study|Physician Decision|0
1611205|NCT02107131|5620317|P1|Overall Study|Physician Decision|1
1611206|NCT02107131|5620316|P2|Overall Study|Lost to Follow-up|4
1611207|NCT02107131|5620317|P1|Overall Study|Lost to Follow-up|4
1611208|NCT02107092|5620329|P1|Overall Study|Expected progression of CKD|12
1611209|NCT02107092|5620329|P1|Overall Study|Adverse Event|7
1611210|NCT02107092|5620329|P1|Overall Study|Withdrawal by Subject|9
1611211|NCT02107092|5620329|P1|Overall Study|Lost to Follow-up|2
1611212|NCT02107092|5620329|P1|Overall Study|Physician Decision|3
1611213|NCT02107092|5620329|P1|Overall Study|Met ECG withdrawal criteria|3
1611214|NCT02107092|5620329|P1|Overall Study|Hypo-or hyperkalemia|2
1611215|NCT02107092|5620329|P1|Overall Study|Subject compliance|3
1611216|NCT02107092|5620329|P1|Overall Study|Miscellaneous|3
1611217|NCT02107014|5620334|P1|Overall Study|Withdrew before drug: moving interstate|1
1611218|NCT02106975|5620404|P2|Overall Study|Death|39
1611219|NCT02106975|5620405|P1|Overall Study|Death|25
1611220|NCT02106923|5620465|P6|Overall Study|Protocol Violation|1
1611221|NCT02106923|5620466|P5|Overall Study|Protocol Violation|0
1611222|NCT02106923|5620467|P4|Overall Study|Protocol Violation|0
1611223|NCT02106923|5620468|P3|Overall Study|Protocol Violation|0
1611224|NCT02106923|5620469|P2|Overall Study|Protocol Violation|0
1611225|NCT02106923|5620470|P1|Overall Study|Protocol Violation|0
1611226|NCT02106884|5620516|P2|Overall Study|Change of diagnosis/exclusion|1
1611227|NCT02106884|5620517|P1|Overall Study|Change of diagnosis/exclusion|0
1611228|NCT02106832|5620541|P4|Overall Study|Technical problems|0
1611229|NCT02106832|5620542|P3|Overall Study|Technical problems|0
1611230|NCT02106832|5620543|P2|Overall Study|Technical problems|1
1611231|NCT02106832|5620544|P1|Overall Study|Technical problems|0
1611232|NCT02106832|5620541|P4|Overall Study|Withdrawal by Subject|7
1611233|NCT02106832|5620542|P3|Overall Study|Withdrawal by Subject|10
1611234|NCT02106832|5620543|P2|Overall Study|Withdrawal by Subject|17
1611235|NCT02106832|5620544|P1|Overall Study|Withdrawal by Subject|17
1611236|NCT02106832|5620541|P4|Overall Study|Protocol Violation|1
1611237|NCT02106832|5620542|P3|Overall Study|Protocol Violation|0
1611238|NCT02106832|5620543|P2|Overall Study|Protocol Violation|0
1611239|NCT02106832|5620544|P1|Overall Study|Protocol Violation|0
1611240|NCT02106832|5620541|P4|Overall Study|Physician Decision|0
1611241|NCT02106832|5620542|P3|Overall Study|Physician Decision|0
1611242|NCT02106832|5620543|P2|Overall Study|Physician Decision|0
1611243|NCT02106832|5620544|P1|Overall Study|Physician Decision|1
1611244|NCT02106832|5620541|P4|Overall Study|Lost to Follow-up|3
1611245|NCT02106832|5620542|P3|Overall Study|Lost to Follow-up|1
1611246|NCT02106832|5620543|P2|Overall Study|Lost to Follow-up|1
1611247|NCT02106832|5620544|P1|Overall Study|Lost to Follow-up|0
1611248|NCT02106832|5620541|P4|Overall Study|Deterioration of general conditions|0
1611249|NCT02106832|5620542|P3|Overall Study|Deterioration of general conditions|1
1611250|NCT02106832|5620543|P2|Overall Study|Deterioration of general conditions|0
1611251|NCT02106832|5620544|P1|Overall Study|Deterioration of general conditions|0
1611252|NCT02106832|5620541|P4|Overall Study|Death|4
1611253|NCT02106832|5620542|P3|Overall Study|Death|1
1611254|NCT02106832|5620543|P2|Overall Study|Death|4
1611255|NCT02106832|5620544|P1|Overall Study|Death|4
1611256|NCT02106832|5620541|P4|Overall Study|Adverse Event|0
1611257|NCT02106832|5620542|P3|Overall Study|Adverse Event|3
1611258|NCT02106832|5620543|P2|Overall Study|Adverse Event|2
1611259|NCT02106832|5620544|P1|Overall Study|Adverse Event|1
1611260|NCT02106455|5620611|P1|Overall Study|Protocol Deviation|2
1611261|NCT02106455|5620611|P1|Overall Study|Case Report Form Uncollected|6
1611262|NCT02106442|5620625|P1|Overall Study|Protocol Deviation|30
1611263|NCT02106442|5620625|P1|Overall Study|Case Report Forms Uncollected|7
1611264|NCT02106403|5620643|P6|Follow-Up Visit 3|Other Reason|1
1611265|NCT02106403|5620644|P5|Follow-Up Visit 3|Other Reason|0
1611266|NCT02106403|5620645|P4|Follow-Up Visit 3|Other Reason|0
1611267|NCT02106403|5620646|P3|Follow-Up Visit 3|Other Reason|0
1611268|NCT02106403|5620647|P2|Follow-Up Visit 3|Other Reason|0
1611269|NCT02106403|5620648|P1|Follow-Up Visit 3|Other Reason|0
1611270|NCT02106390|5620671|P3|Overall Study|Protocol Violation|0
1611271|NCT02106390|5620672|P2|Overall Study|Protocol Violation|1
1611272|NCT02106390|5620673|P1|Overall Study|Protocol Violation|0
1611273|NCT02106390|5620671|P3|Overall Study|Adverse Event|1
1611274|NCT02106390|5620672|P2|Overall Study|Adverse Event|2
1611275|NCT02106390|5620673|P1|Overall Study|Adverse Event|0
1611276|NCT02106390|5620671|P3|Overall Study|Other: Unspecified|2
1611277|NCT02106390|5620672|P2|Overall Study|Other: Unspecified|4
1611278|NCT02106390|5620673|P1|Overall Study|Other: Unspecified|1
1611279|NCT02106390|5620671|P3|Overall Study|Other: Administrative Reason|12
1611280|NCT02106390|5620672|P2|Overall Study|Other: Administrative Reason|5
1611281|NCT02106390|5620673|P1|Overall Study|Other: Administrative Reason|8
1611282|NCT02106390|5620671|P3|Overall Study|Lost to Follow-up|13
1611283|NCT02106390|5620672|P2|Overall Study|Lost to Follow-up|20
1611284|NCT02106390|5620673|P1|Overall Study|Lost to Follow-up|25
1611285|NCT02106390|5620671|P3|Overall Study|Withdrawal by Subject|15
1611286|NCT02106390|5620672|P2|Overall Study|Withdrawal by Subject|16
1611287|NCT02106390|5620673|P1|Overall Study|Withdrawal by Subject|15
1611288|NCT02106351|5620750|P3|Treatment Cycle 4|Other|0
1611289|NCT02106351|5620751|P2|Treatment Cycle 4|Other|1
1611290|NCT02106351|5620752|P1|Treatment Cycle 4|Other|0
1611291|NCT02106351|5620750|P3|Treatment Cycle 4|Consent withdrawn|2
1611292|NCT02106351|5620751|P2|Treatment Cycle 4|Consent withdrawn|0
1611293|NCT02106351|5620752|P1|Treatment Cycle 4|Consent withdrawn|0
1611294|NCT02106351|5620750|P3|Treatment Cycle 3|Other|3
1611295|NCT02106351|5620751|P2|Treatment Cycle 3|Other|2
1611296|NCT02106351|5620752|P1|Treatment Cycle 3|Other|0
1611297|NCT02106351|5620750|P3|Treatment Cycle 3|Lost to Follow-up|0
1611298|NCT02106351|5620751|P2|Treatment Cycle 3|Lost to Follow-up|1
1611299|NCT02106351|5620752|P1|Treatment Cycle 3|Lost to Follow-up|0
1611300|NCT02106351|5620750|P3|Treatment Cycle 3|Consent withdrawn|2
1611301|NCT02106351|5620751|P2|Treatment Cycle 3|Consent withdrawn|0
1611302|NCT02106351|5620752|P1|Treatment Cycle 3|Consent withdrawn|0
1611303|NCT02106351|5620750|P3|Treatment Cycle 3|Adverse Event|0
1611304|NCT02106351|5620751|P2|Treatment Cycle 3|Adverse Event|1
1611305|NCT02106351|5620752|P1|Treatment Cycle 3|Adverse Event|0
1611306|NCT02106351|5620750|P3|Treatment Cycle 2|Other|2
1611307|NCT02106351|5620751|P2|Treatment Cycle 2|Other|2
1611308|NCT02106351|5620752|P1|Treatment Cycle 2|Other|0
1611309|NCT02106351|5620750|P3|Treatment Cycle 2|Consent withdrawn|1
1611310|NCT02106351|5620751|P2|Treatment Cycle 2|Consent withdrawn|1
1611311|NCT02106351|5620752|P1|Treatment Cycle 2|Consent withdrawn|0
1611312|NCT02106351|5620750|P3|Treatment Cycle 2|Adverse Event|0
1611313|NCT02106351|5620751|P2|Treatment Cycle 2|Adverse Event|2
1611314|NCT02106351|5620752|P1|Treatment Cycle 2|Adverse Event|0
1611315|NCT02106351|5620750|P3|Treatment Cycle 1|Randomised but not treated|1
1611316|NCT02106351|5620751|P2|Treatment Cycle 1|Randomised but not treated|0
1611317|NCT02106351|5620752|P1|Treatment Cycle 1|Randomised but not treated|1
1611318|NCT02106351|5620750|P3|Treatment Cycle 1|Other|1
1611319|NCT02106351|5620751|P2|Treatment Cycle 1|Other|3
1611320|NCT02106351|5620752|P1|Treatment Cycle 1|Other|0
1611321|NCT02106351|5620750|P3|Treatment Cycle 1|Lost to Follow-up|0
1611322|NCT02106351|5620751|P2|Treatment Cycle 1|Lost to Follow-up|0
1611323|NCT02106351|5620752|P1|Treatment Cycle 1|Lost to Follow-up|1
1611324|NCT02106351|5620750|P3|Treatment Cycle 1|Consent withdrawn|2
1611325|NCT02106351|5620751|P2|Treatment Cycle 1|Consent withdrawn|0
1611326|NCT02106351|5620752|P1|Treatment Cycle 1|Consent withdrawn|1
1611327|NCT02106351|5620750|P3|Treatment Cycle 1|Adverse Event|0
1611328|NCT02106351|5620751|P2|Treatment Cycle 1|Adverse Event|0
1611329|NCT02106351|5620752|P1|Treatment Cycle 1|Adverse Event|2
1611330|NCT02106325|5620795|P2|Phase 3|Lost to Follow-up|1
1611331|NCT02106325|5620796|P1|Phase 3|Lost to Follow-up|2
1611332|NCT02106325|5620795|P2|Phase 2|Lost to Follow-up|3
1611333|NCT02106325|5620796|P1|Phase 2|Lost to Follow-up|2
1611334|NCT02106325|5620795|P2|Phase 1|Lost to Follow-up|2
1611335|NCT02106325|5620796|P1|Phase 1|Lost to Follow-up|2
1611336|NCT02106156|5620821|P3|Overall Study|Relocation/Change of Physician|0
1611337|NCT02106156|5620822|P2|Overall Study|Relocation/Change of Physician|1
1611338|NCT02106156|5620823|P1|Overall Study|Relocation/Change of Physician|40
1611339|NCT02106156|5620821|P3|Overall Study|Hospitalization/Surgical Intervention|0
1611340|NCT02106156|5620822|P2|Overall Study|Hospitalization/Surgical Intervention|0
1611341|NCT02106156|5620823|P1|Overall Study|Hospitalization/Surgical Intervention|6
1611342|NCT02106156|5620821|P3|Overall Study|Change of Laboratory Parameter|0
1611343|NCT02106156|5620822|P2|Overall Study|Change of Laboratory Parameter|0
1611344|NCT02106156|5620823|P1|Overall Study|Change of Laboratory Parameter|10
1611345|NCT02106156|5620821|P3|Overall Study|Unplanned Event|0
1611346|NCT02106156|5620822|P2|Overall Study|Unplanned Event|2
1611347|NCT02106156|5620823|P1|Overall Study|Unplanned Event|82
1611348|NCT02106156|5620821|P3|Overall Study|Lost to Follow-up|0
1611349|NCT02106156|5620822|P2|Overall Study|Lost to Follow-up|8
1611350|NCT02106156|5620823|P1|Overall Study|Lost to Follow-up|451
1611351|NCT02106156|5620821|P3|Overall Study|Patients Request|0
1611352|NCT02106156|5620822|P2|Overall Study|Patients Request|9
1611353|NCT02106156|5620823|P1|Overall Study|Patients Request|307
1611354|NCT02106156|5620821|P3|Overall Study|Lack of Compliance|0
1611355|NCT02106156|5620822|P2|Overall Study|Lack of Compliance|7
1611356|NCT02106156|5620823|P1|Overall Study|Lack of Compliance|211
1611357|NCT02106156|5620821|P3|Overall Study|Concomitant Disease|0
1611358|NCT02106156|5620822|P2|Overall Study|Concomitant Disease|2
1611359|NCT02106156|5620823|P1|Overall Study|Concomitant Disease|74
1611360|NCT02106156|5620821|P3|Overall Study|Lack of Virological Response|0
1611361|NCT02106156|5620822|P2|Overall Study|Lack of Virological Response|8
1611362|NCT02106156|5620823|P1|Overall Study|Lack of Virological Response|1044
1611363|NCT02106156|5620821|P3|Overall Study|Lack of Tolerability|0
1611364|NCT02106156|5620822|P2|Overall Study|Lack of Tolerability|3
1611365|NCT02106156|5620823|P1|Overall Study|Lack of Tolerability|305
1611366|NCT02106156|5620821|P3|Overall Study|Patient Died|0
1611367|NCT02106156|5620822|P2|Overall Study|Patient Died|0
1611368|NCT02106156|5620823|P1|Overall Study|Patient Died|19
1611369|NCT02105987|5620847|P6|Continuation Phase|Protocol Violation|0
1611370|NCT02105987|5620848|P5|Continuation Phase|Protocol Violation|1
1611371|NCT02105987|5620849|P4|Continuation Phase|Protocol Violation|0
1611372|NCT02105987|5620850|P3|Continuation Phase|Protocol Violation|0
1611373|NCT02105987|5620851|P2|Continuation Phase|Protocol Violation|0
1611374|NCT02105987|5620852|P1|Continuation Phase|Protocol Violation|0
1611375|NCT02105987|5620847|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
1611376|NCT02105987|5620848|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
1611377|NCT02105987|5620849|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
1611378|NCT02105987|5620850|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
1611379|NCT02105987|5620851|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
1611380|NCT02105987|5620852|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
1611381|NCT02105987|5620847|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1611382|NCT02105987|5620848|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1611383|NCT02105987|5620849|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
1611384|NCT02105987|5620850|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1611385|NCT02105987|5620851|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1611386|NCT02105987|5620852|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
1611387|NCT02105987|5620847|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
1611388|NCT02105987|5620848|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
1611389|NCT02105987|5620849|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
1611390|NCT02105987|5620850|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
1611391|NCT02105987|5620851|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
1611392|NCT02105987|5620852|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
1611393|NCT02105987|5620847|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1611394|NCT02105987|5620848|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1611395|NCT02105987|5620849|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
1611396|NCT02105987|5620850|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
1611397|NCT02105987|5620851|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1611398|NCT02105987|5620852|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
1611399|NCT02105987|5620847|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611400|NCT02105987|5620848|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611401|NCT02105987|5620849|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
1611402|NCT02105987|5620850|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
1611403|NCT02105987|5620851|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611404|NCT02105987|5620852|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611405|NCT02105987|5620847|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
1611406|NCT02105987|5620848|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
1611407|NCT02105987|5620849|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
1611408|NCT02105987|5620850|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
1611409|NCT02105987|5620851|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
1611410|NCT02105987|5620852|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
1611411|NCT02105987|5620847|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
1611412|NCT02105987|5620848|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
1611413|NCT02105987|5620849|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
1611414|NCT02105987|5620850|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
1611415|NCT02105987|5620851|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
1611416|NCT02105987|5620852|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
1611417|NCT02105987|5620847|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1611418|NCT02105987|5620848|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1611419|NCT02105987|5620849|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1611420|NCT02105987|5620850|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1611421|NCT02105987|5620851|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
1611422|NCT02105987|5620852|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
1611423|NCT02105987|5620847|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
1611424|NCT02105987|5620848|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
1611425|NCT02105987|5620849|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
1611426|NCT02105987|5620850|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
1611427|NCT02105987|5620851|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
1611428|NCT02105987|5620852|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
1611429|NCT02105987|5620847|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1611430|NCT02105987|5620848|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1611431|NCT02105987|5620849|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1611432|NCT02105987|5620850|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
1611433|NCT02105987|5620851|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1611434|NCT02105987|5620852|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
1611435|NCT02105987|5620847|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611436|NCT02105987|5620848|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611437|NCT02105987|5620849|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611438|NCT02105987|5620850|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
1611439|NCT02105987|5620851|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
1611440|NCT02105987|5620852|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
1611441|NCT02105987|5620847|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
1611442|NCT02105987|5620848|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
1611443|NCT02105987|5620849|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
1611444|NCT02105987|5620850|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
1611445|NCT02105987|5620851|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
1611446|NCT02105987|5620852|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
1611447|NCT02105987|5620847|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
1611448|NCT02105987|5620848|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
1611449|NCT02105987|5620849|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
1611450|NCT02105987|5620850|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
1611451|NCT02105987|5620851|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
1611452|NCT02105987|5620852|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
1611453|NCT02105974|5620906|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
1611454|NCT02105974|5620907|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
1611455|NCT02105974|5620908|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
1611456|NCT02105974|5620906|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
1611457|NCT02105974|5620907|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
1611458|NCT02105974|5620908|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
1611459|NCT02105974|5620906|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
1611460|NCT02105974|5620907|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1611461|NCT02105974|5620908|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
1611462|NCT02105974|5620906|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
1611463|NCT02105974|5620907|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
1611464|NCT02105974|5620908|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
1611465|NCT02105974|5620906|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
1611466|NCT02105974|5620907|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
1611467|NCT02105974|5620908|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
1611468|NCT02105974|5620906|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
1611469|NCT02105974|5620907|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
1611470|NCT02105974|5620908|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
1611471|NCT02105974|5620906|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
1611472|NCT02105974|5620907|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
1611473|NCT02105974|5620908|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
1611474|NCT02105974|5620906|P3|2 Week Run-in Period|Investigator discretion|0
1611475|NCT02105974|5620907|P2|2 Week Run-in Period|Investigator discretion|0
1611476|NCT02105974|5620908|P1|2 Week Run-in Period|Investigator discretion|8
1611477|NCT02105974|5620906|P3|2 Week Run-in Period|Withdrew consent|0
1611478|NCT02105974|5620907|P2|2 Week Run-in Period|Withdrew consent|0
1611479|NCT02105974|5620908|P1|2 Week Run-in Period|Withdrew consent|23
1611480|NCT02105974|5620906|P3|2 Week Run-in Period|Lost to Follow-up|0
1611481|NCT02105974|5620907|P2|2 Week Run-in Period|Lost to Follow-up|0
1611482|NCT02105974|5620908|P1|2 Week Run-in Period|Lost to Follow-up|2
1611483|NCT02105974|5620906|P3|2 Week Run-in Period|Study closed/terminated|0
1611484|NCT02105974|5620907|P2|2 Week Run-in Period|Study closed/terminated|0
1611485|NCT02105974|5620908|P1|2 Week Run-in Period|Study closed/terminated|1
1611486|NCT02105974|5620906|P3|2 Week Run-in Period|Adverse Event|0
1611487|NCT02105974|5620907|P2|2 Week Run-in Period|Adverse Event|0
1611488|NCT02105974|5620908|P1|2 Week Run-in Period|Adverse Event|6
1611489|NCT02105974|5620906|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1611490|NCT02105974|5620907|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
1611491|NCT02105974|5620908|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
1611492|NCT02105974|5620906|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
1611493|NCT02105974|5620907|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
1611494|NCT02105974|5620908|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
1611495|NCT02105961|5620921|P3|Overall Study|Withdrawal by Subject|11
1611496|NCT02105961|5620922|P2|Overall Study|Withdrawal by Subject|7
1611497|NCT02105961|5620923|P1|Overall Study|Withdrawal by Subject|15
1611498|NCT02105961|5620921|P3|Overall Study|Physician Decision|2
1611499|NCT02105961|5620922|P2|Overall Study|Physician Decision|3
1611500|NCT02105961|5620923|P1|Overall Study|Physician Decision|3
1611501|NCT02105961|5620921|P3|Overall Study|Lost to Follow-up|1
1611502|NCT02105961|5620922|P2|Overall Study|Lost to Follow-up|0
1611503|NCT02105961|5620923|P1|Overall Study|Lost to Follow-up|2
1611504|NCT02105961|5620921|P3|Overall Study|Lack of Efficacy|3
1611505|NCT02105961|5620922|P2|Overall Study|Lack of Efficacy|0
1611506|NCT02105961|5620923|P1|Overall Study|Lack of Efficacy|3
1611507|NCT02105961|5620921|P3|Overall Study|Adverse Event|13
1611508|NCT02105961|5620922|P2|Overall Study|Adverse Event|7
1611509|NCT02105961|5620923|P1|Overall Study|Adverse Event|18
1611510|NCT02105948|5620947|P4|Overall Study|Withdrawal by Subject|11
1611511|NCT02105948|5620948|P3|Overall Study|Withdrawal by Subject|10
1611512|NCT02105948|5620949|P2|Overall Study|Withdrawal by Subject|10
1611513|NCT02105948|5620950|P1|Overall Study|Withdrawal by Subject|15
1611514|NCT02105948|5620947|P4|Overall Study|Physician Decision|2
1611515|NCT02105948|5620948|P3|Overall Study|Physician Decision|2
1611516|NCT02105948|5620949|P2|Overall Study|Physician Decision|2
1611517|NCT02105948|5620950|P1|Overall Study|Physician Decision|2
1611518|NCT02105948|5620947|P4|Overall Study|Lost to Follow-up|1
1611519|NCT02105948|5620948|P3|Overall Study|Lost to Follow-up|2
1611520|NCT02105948|5620949|P2|Overall Study|Lost to Follow-up|0
1611521|NCT02105948|5620950|P1|Overall Study|Lost to Follow-up|0
1611522|NCT02105948|5620947|P4|Overall Study|Lack of Efficacy|2
1611523|NCT02105948|5620948|P3|Overall Study|Lack of Efficacy|3
1611524|NCT02105948|5620949|P2|Overall Study|Lack of Efficacy|1
1611525|NCT02105948|5620950|P1|Overall Study|Lack of Efficacy|0
1611526|NCT02105948|5620947|P4|Overall Study|Adverse Event|11
1611527|NCT02105948|5620948|P3|Overall Study|Adverse Event|11
1611528|NCT02105948|5620949|P2|Overall Study|Adverse Event|7
1611529|NCT02105948|5620950|P1|Overall Study|Adverse Event|10
1611530|NCT02105701|5620991|P4|Overall Study|Death|0
1611531|NCT02105701|5620992|P3|Overall Study|Death|0
1611532|NCT02105701|5620993|P2|Overall Study|Death|0
1611533|NCT02105701|5620994|P1|Overall Study|Death|1
1611534|NCT02105701|5620991|P4|Overall Study|Withdrawal by Subject|1
1611535|NCT02105701|5620992|P3|Overall Study|Withdrawal by Subject|0
1611536|NCT02105701|5620993|P2|Overall Study|Withdrawal by Subject|1
1611537|NCT02105701|5620994|P1|Overall Study|Withdrawal by Subject|2
1611538|NCT02105701|5620991|P4|Overall Study|Protocol Violation|0
1611539|NCT02105701|5620992|P3|Overall Study|Protocol Violation|1
1611540|NCT02105701|5620993|P2|Overall Study|Protocol Violation|0
1611541|NCT02105701|5620994|P1|Overall Study|Protocol Violation|0
1611542|NCT02105701|5620991|P4|Overall Study|Lost to Follow-up|1
1611543|NCT02105701|5620992|P3|Overall Study|Lost to Follow-up|2
1611544|NCT02105701|5620993|P2|Overall Study|Lost to Follow-up|0
1611545|NCT02105701|5620994|P1|Overall Study|Lost to Follow-up|1
1611546|NCT02105688|5621018|P2|Part B: Observational Follow-up|Physician Decision|1
1611547|NCT02105688|5621019|P1|Part B: Observational Follow-up|Physician Decision|3
1611548|NCT02105688|5621018|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
1611549|NCT02105688|5621019|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
1611550|NCT02105688|5621018|P2|Part B: Observational Follow-up|Lost to Follow-up|15
1611551|NCT02105688|5621019|P1|Part B: Observational Follow-up|Lost to Follow-up|23
1611552|NCT02105688|5621018|P2|Part B: Observational Follow-up|Death|1
1611553|NCT02105688|5621019|P1|Part B: Observational Follow-up|Death|2
1611554|NCT02105688|5621018|P2|Part A: Double-Blind|Withdrawal by Subject|2
1611555|NCT02105688|5621019|P1|Part A: Double-Blind|Withdrawal by Subject|4
1611556|NCT02105688|5621018|P2|Part A: Double-Blind|Status Unknown|2
1611557|NCT02105688|5621019|P1|Part A: Double-Blind|Status Unknown|0
1611558|NCT02105688|5621018|P2|Part A: Double-Blind|Physician Decision|1
1611559|NCT02105688|5621019|P1|Part A: Double-Blind|Physician Decision|0
1611560|NCT02105688|5621018|P2|Part A: Double-Blind|Lost to Follow-up|11
1611561|NCT02105688|5621019|P1|Part A: Double-Blind|Lost to Follow-up|15
1611562|NCT02105688|5621018|P2|Part A: Double-Blind|Death|1
1611563|NCT02105688|5621019|P1|Part A: Double-Blind|Death|0
1611564|NCT02105688|5621018|P2|Part A: Double-Blind|Adverse Event|0
1611565|NCT02105688|5621019|P1|Part A: Double-Blind|Adverse Event|1
1611566|NCT02105662|5621032|P1|Overall Study|Withdrawal by Subject|1
1611567|NCT02105662|5621032|P1|Overall Study|Lost to Follow-up|5
1611568|NCT02105636|5621041|P2|Overall Study|Not Reported|0
1611569|NCT02105636|5621042|P1|Overall Study|Not Reported|3
1611570|NCT02105636|5621041|P2|Overall Study|Reason Not Specified|2
1611571|NCT02105636|5621042|P1|Overall Study|Reason Not Specified|0
1611572|NCT02105636|5621041|P2|Overall Study|Poor/Non-compliance|1
1611573|NCT02105636|5621042|P1|Overall Study|Poor/Non-compliance|0
1611574|NCT02105636|5621041|P2|Overall Study|Maximum Clinical Benefit|1
1611575|NCT02105636|5621042|P1|Overall Study|Maximum Clinical Benefit|1
1611576|NCT02105636|5621041|P2|Overall Study|Subject Withdrew Consent|1
1611577|NCT02105636|5621042|P1|Overall Study|Subject Withdrew Consent|4
1611578|NCT02105636|5621041|P2|Overall Study|Subject Request to Discontinue Treatment|6
1611579|NCT02105636|5621042|P1|Overall Study|Subject Request to Discontinue Treatment|4
1611580|NCT02105636|5621041|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1611581|NCT02105636|5621042|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
1611582|NCT02105636|5621041|P2|Overall Study|Study Drug Toxicity|11
1611583|NCT02105636|5621042|P1|Overall Study|Study Drug Toxicity|9
1611584|NCT02105636|5621041|P2|Overall Study|Disease Progression|83
1611585|NCT02105636|5621042|P1|Overall Study|Disease Progression|162
1611586|NCT02105467|5621085|P2|Period 3|Lost to Follow-up|1
1611587|NCT02105467|5621086|P1|Period 3|Lost to Follow-up|0
1611588|NCT02105467|5621085|P2|Period 2|Withdrawal by Subject|2
1611589|NCT02105467|5621086|P1|Period 2|Withdrawal by Subject|0
1611590|NCT02105467|5621085|P2|Period 2|Death|0
1611591|NCT02105467|5621086|P1|Period 2|Death|1
1611592|NCT02105467|5621085|P2|Period 2|Lost to Follow-up|0
1611593|NCT02105467|5621086|P1|Period 2|Lost to Follow-up|1
1611594|NCT02105467|5621085|P2|Period 1|Death|0
1611595|NCT02105467|5621086|P1|Period 1|Death|1
1611596|NCT02105467|5621085|P2|Period 1|Lost to Follow-up|0
1611597|NCT02105467|5621086|P1|Period 1|Lost to Follow-up|1
1611598|NCT02105454|5621098|P1|Overall Study|Withdrawal by Subject|1
1611599|NCT02105285|5621210|P3|Overall Study|Withdrawal by Subject|0
1611600|NCT02105285|5621211|P2|Overall Study|Withdrawal by Subject|0
1611601|NCT02105285|5621212|P1|Overall Study|Withdrawal by Subject|1
1611602|NCT02105285|5621210|P3|Overall Study|Protocol Violation|0
1611603|NCT02105285|5621211|P2|Overall Study|Protocol Violation|1
1611604|NCT02105285|5621212|P1|Overall Study|Protocol Violation|0
1611605|NCT02105285|5621210|P3|Overall Study|Adverse Event|0
1611606|NCT02105285|5621211|P2|Overall Study|Adverse Event|1
1611607|NCT02105285|5621212|P1|Overall Study|Adverse Event|1
1611608|NCT02105272|5621231|P2|Overall Study|Withdrawal by Subject|0
1611609|NCT02105272|5621232|P1|Overall Study|Withdrawal by Subject|2
1611610|NCT02105272|5621231|P2|Overall Study|Protocol Violation|0
1611611|NCT02105272|5621232|P1|Overall Study|Protocol Violation|2
1611612|NCT02105272|5621231|P2|Overall Study|Physician Decision|1
1611613|NCT02105272|5621232|P1|Overall Study|Physician Decision|0
1611614|NCT02105272|5621231|P2|Overall Study|Adverse Event|2
1611615|NCT02105272|5621232|P1|Overall Study|Adverse Event|1
1611616|NCT02105116|5621261|P1|Overall Study|Death|1
1611617|NCT02105116|5621261|P1|Overall Study|not eligible for step 2 of trial|5
1611618|NCT02105012|5621268|P1|Overall Study|Lack of Efficacy|1
1611619|NCT02105012|5621268|P1|Overall Study|Adverse Event|1
1611620|NCT02105012|5621268|P1|Overall Study|Physician Decision|3
1611621|NCT02105012|5621268|P1|Overall Study|Protocol Violation|4
1611622|NCT02105012|5621268|P1|Overall Study|Lost to Follow-up|4
1611623|NCT02105012|5621268|P1|Overall Study|Protocol Specified Criteria|9
1611624|NCT02105012|5621268|P1|Overall Study|Withdrawal by Subject|11
1611625|NCT02104947|5621302|P2|Overall Study|Other than stated above|3
1611626|NCT02104947|5621303|P1|Overall Study|Other than stated above|2
1611627|NCT02104947|5621302|P2|Overall Study|Adverse Event|38
1611628|NCT02104947|5621303|P1|Overall Study|Adverse Event|57
1611629|NCT02104947|5621302|P2|Overall Study|Protocol Violation|8
1611630|NCT02104947|5621303|P1|Overall Study|Protocol Violation|6
1611631|NCT02104947|5621302|P2|Overall Study|Lost to Follow-up|4
1611632|NCT02104947|5621303|P1|Overall Study|Lost to Follow-up|4
1611633|NCT02104947|5621302|P2|Overall Study|Withdrawal by Subject|3
1611634|NCT02104947|5621303|P1|Overall Study|Withdrawal by Subject|10
1611635|NCT02104895|5621321|P2|Overall Study|Withdrawal by Subject|14
1611636|NCT02104895|5621322|P1|Overall Study|Withdrawal by Subject|0
1611637|NCT02104804|5621362|P2|Overall Study|Withdrawal by Subject|12
1611638|NCT02104804|5621363|P1|Overall Study|Withdrawal by Subject|4
1611639|NCT02104804|5621362|P2|Overall Study|Adverse Event|3
1611640|NCT02104804|5621363|P1|Overall Study|Adverse Event|4
1611641|NCT02104804|5621362|P2|Overall Study|Protocol Violation|1
1611642|NCT02104804|5621363|P1|Overall Study|Protocol Violation|0
1611643|NCT02104804|5621362|P2|Overall Study|Other listed|1
1611644|NCT02104804|5621363|P1|Overall Study|Other listed|2
1611645|NCT02104804|5621362|P2|Overall Study|Study specific discontinuation criteria|1
1611646|NCT02104804|5621363|P1|Overall Study|Study specific discontinuation criteria|6
1611647|NCT02104804|5621362|P2|Overall Study|Did not take study medication|1
1611648|NCT02104804|5621363|P1|Overall Study|Did not take study medication|0
1611649|NCT02104765|5621386|P7|Overall Study|Withdrawal by Subject|1
1611650|NCT02104765|5621387|P6|Overall Study|Withdrawal by Subject|0
1611651|NCT02104765|5621388|P5|Overall Study|Withdrawal by Subject|1
1611652|NCT02104765|5621389|P4|Overall Study|Withdrawal by Subject|1
1611653|NCT02104765|5621390|P3|Overall Study|Withdrawal by Subject|0
1611654|NCT02104765|5621391|P2|Overall Study|Withdrawal by Subject|0
1611655|NCT02104765|5621392|P1|Overall Study|Withdrawal by Subject|0
1611656|NCT02104765|5621386|P7|Overall Study|Lost to Follow-up|0
1611657|NCT02104765|5621387|P6|Overall Study|Lost to Follow-up|0
1611658|NCT02104765|5621388|P5|Overall Study|Lost to Follow-up|0
1611659|NCT02104765|5621389|P4|Overall Study|Lost to Follow-up|0
1611660|NCT02104765|5621390|P3|Overall Study|Lost to Follow-up|1
1611661|NCT02104765|5621391|P2|Overall Study|Lost to Follow-up|0
1611662|NCT02104765|5621392|P1|Overall Study|Lost to Follow-up|0
1611663|NCT02104752|5621420|P2|Overall Study|Weight gain; unrelated anxiety|2
1611664|NCT02104752|5621421|P1|Overall Study|Weight gain; unrelated anxiety|0
1611665|NCT02104752|5621420|P2|Overall Study|Withdrawal by Subject|0
1611666|NCT02104752|5621421|P1|Overall Study|Withdrawal by Subject|1
1611667|NCT02104583|5621504|P5|Overall Study|Randomized but Never Treated|0
1611668|NCT02104583|5621505|P4|Overall Study|Randomized but Never Treated|1
1611669|NCT02104583|5621506|P3|Overall Study|Randomized but Never Treated|0
1611670|NCT02104583|5621507|P2|Overall Study|Randomized but Never Treated|0
1611671|NCT02104583|5621508|P1|Overall Study|Randomized but Never Treated|0
1611672|NCT02104583|5621504|P5|Overall Study|Lost to Follow-up|0
1611673|NCT02104583|5621505|P4|Overall Study|Lost to Follow-up|0
1611674|NCT02104583|5621506|P3|Overall Study|Lost to Follow-up|0
1611675|NCT02104583|5621507|P2|Overall Study|Lost to Follow-up|0
1611676|NCT02104583|5621508|P1|Overall Study|Lost to Follow-up|1
1611677|NCT02104583|5621504|P5|Overall Study|Adverse Event|1
1611678|NCT02104583|5621505|P4|Overall Study|Adverse Event|6
1611679|NCT02104583|5621506|P3|Overall Study|Adverse Event|6
1611680|NCT02104583|5621507|P2|Overall Study|Adverse Event|3
1611681|NCT02104583|5621508|P1|Overall Study|Adverse Event|3
1611682|NCT02104583|5621504|P5|Overall Study|Protocol Violation|0
1611683|NCT02104583|5621505|P4|Overall Study|Protocol Violation|0
1611684|NCT02104583|5621506|P3|Overall Study|Protocol Violation|1
1611685|NCT02104583|5621507|P2|Overall Study|Protocol Violation|0
1611686|NCT02104583|5621508|P1|Overall Study|Protocol Violation|0
1611687|NCT02104583|5621504|P5|Overall Study|Investigator's Discretion|0
1611688|NCT02104583|5621505|P4|Overall Study|Investigator's Discretion|0
1611689|NCT02104583|5621506|P3|Overall Study|Investigator's Discretion|0
1611690|NCT02104583|5621507|P2|Overall Study|Investigator's Discretion|0
1611691|NCT02104583|5621508|P1|Overall Study|Investigator's Discretion|1
1611692|NCT02104583|5621504|P5|Overall Study|Withdrew Consent|1
1611693|NCT02104583|5621505|P4|Overall Study|Withdrew Consent|2
1611694|NCT02104583|5621506|P3|Overall Study|Withdrew Consent|0
1611695|NCT02104583|5621507|P2|Overall Study|Withdrew Consent|2
1611696|NCT02104583|5621508|P1|Overall Study|Withdrew Consent|3
1611697|NCT02104583|5621504|P5|Overall Study|Subject required prohibited medication|1
1611698|NCT02104583|5621505|P4|Overall Study|Subject required prohibited medication|0
1611699|NCT02104583|5621506|P3|Overall Study|Subject required prohibited medication|1
1611700|NCT02104583|5621507|P2|Overall Study|Subject required prohibited medication|1
1611701|NCT02104583|5621508|P1|Overall Study|Subject required prohibited medication|0
1611702|NCT02104583|5621504|P5|Overall Study|Subject required cardiac ablation|4
1611703|NCT02104583|5621505|P4|Overall Study|Subject required cardiac ablation|5
1611704|NCT02104583|5621506|P3|Overall Study|Subject required cardiac ablation|4
1611705|NCT02104583|5621507|P2|Overall Study|Subject required cardiac ablation|4
1611706|NCT02104583|5621508|P1|Overall Study|Subject required cardiac ablation|6
1611707|NCT02104583|5621504|P5|Overall Study|Death|5
1611708|NCT02104583|5621505|P4|Overall Study|Death|3
1611709|NCT02104583|5621506|P3|Overall Study|Death|3
1611710|NCT02104583|5621507|P2|Overall Study|Death|1
1611711|NCT02104583|5621508|P1|Overall Study|Death|2
1611712|NCT02104583|5621504|P5|Overall Study|New ICD or CRT-D implanted|0
1611713|NCT02104583|5621505|P4|Overall Study|New ICD or CRT-D implanted|0
1611714|NCT02104583|5621506|P3|Overall Study|New ICD or CRT-D implanted|1
1611715|NCT02104583|5621507|P2|Overall Study|New ICD or CRT-D implanted|0
1611716|NCT02104583|5621508|P1|Overall Study|New ICD or CRT-D implanted|2
1611717|NCT02104505|5621571|P2|Second Intervention (14 Days)|Adverse Event|0
1611718|NCT02104505|5621572|P1|Second Intervention (14 Days)|Adverse Event|2
1611719|NCT02104505|5621571|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1611720|NCT02104505|5621572|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1611721|NCT02104505|5621571|P2|First Intervention (14 Days)|exclusionary condition|1
1611722|NCT02104505|5621572|P1|First Intervention (14 Days)|exclusionary condition|0
1611723|NCT02104505|5621571|P2|First Intervention (14 Days)|Lost to Follow-up|1
1611724|NCT02104505|5621572|P1|First Intervention (14 Days)|Lost to Follow-up|0
1611725|NCT02104505|5621571|P2|First Intervention (14 Days)|Withdrawal by Subject|1
1611726|NCT02104505|5621572|P1|First Intervention (14 Days)|Withdrawal by Subject|0
1611727|NCT02104505|5621571|P2|First Intervention (14 Days)|Adverse Event|0
1611728|NCT02104505|5621572|P1|First Intervention (14 Days)|Adverse Event|2
1611729|NCT02104180|5621644|P2|Overall Study|Protocol Violation|0
1611730|NCT02104180|5621645|P1|Overall Study|Protocol Violation|1
1611731|NCT02103439|5621675|P2|Overall Study|Withdrawal by Subject|1
1611732|NCT02103439|5621676|P1|Overall Study|Withdrawal by Subject|3
1611733|NCT02103439|5621675|P2|Overall Study|Adverse Event|2
1611734|NCT02103439|5621676|P1|Overall Study|Adverse Event|0
1611735|NCT02103062|5621835|P2|Overall Study|Death|1
1611736|NCT02103062|5621836|P1|Overall Study|Death|0
1611737|NCT02103062|5621835|P2|Overall Study|Progressive Disease|20
1611738|NCT02103062|5621836|P1|Overall Study|Progressive Disease|17
1611739|NCT02103062|5621835|P2|Overall Study|Adverse Event|2
1611740|NCT02103062|5621836|P1|Overall Study|Adverse Event|1
1611741|NCT02102724|5621929|P2|Overall Study|surgery for brain aneurysm|1
1611742|NCT02102724|5621930|P1|Overall Study|surgery for brain aneurysm|1
1611743|NCT02102724|5621929|P2|Overall Study|Lost to Follow-up|0
1611744|NCT02102724|5621930|P1|Overall Study|Lost to Follow-up|1
1611745|NCT02102490|5621936|P1|Overall Study|Lost to Follow-up|1
1611746|NCT02102490|5621936|P1|Overall Study|Death|6
1611747|NCT02102464|5621950|P3|Randomized Study|Withdrawal by Subject|0
1611748|NCT02102464|5621951|P2|Randomized Study|Withdrawal by Subject|1
1611749|NCT02102464|5621952|P1|Randomized Study|Withdrawal by Subject|0
1611750|NCT02102399|5621971|P2|Overall Study|Withdrawal by Subject|4
1611751|NCT02102399|5621972|P1|Overall Study|Withdrawal by Subject|6
1611752|NCT02102204|5622042|P1|Overall Study|Ongoing|5
1611753|NCT02102204|5622042|P1|Overall Study|Sponsor Decision|5
1611754|NCT02102204|5622042|P1|Overall Study|Lost to Follow-up|65
1611755|NCT02102204|5622042|P1|Overall Study|Death|92
1611756|NCT02102204|5622042|P1|Overall Study|Withdrawal by Subject|137
1611757|NCT02101983|5622062|P2|Overall Study|Physician Decision|0
1611758|NCT02101983|5622063|P1|Overall Study|Physician Decision|1
1611759|NCT02101359|5622146|P2|Overall Study|Protocol Violation|2
1611760|NCT02101359|5622147|P1|Overall Study|Protocol Violation|0
1611761|NCT02101359|5622146|P2|Overall Study|Lost to Follow-up|0
1611762|NCT02101359|5622147|P1|Overall Study|Lost to Follow-up|1
1611763|NCT02101359|5622146|P2|Overall Study|Withdrawal by Subject|4
1611764|NCT02101359|5622147|P1|Overall Study|Withdrawal by Subject|5
1611765|NCT02101359|5622146|P2|Overall Study|Not included|13
1611766|NCT02101359|5622147|P1|Overall Study|Not included|23
1611767|NCT02101294|5622153|P1|Overall Study|Lost to Follow-up|6
1611768|NCT02101294|5622153|P1|Overall Study|Withdrawal by Subject|5
1611769|NCT02101281|5622162|P2|Overall Study|Adverse Event|1
1611770|NCT02101281|5622163|P1|Overall Study|Adverse Event|0
1611771|NCT02101112|5622216|P6|Overall Study|Withdrawal by Subject|0
1611772|NCT02101112|5622217|P5|Overall Study|Withdrawal by Subject|1
1611773|NCT02101112|5622218|P4|Overall Study|Withdrawal by Subject|0
1611774|NCT02101112|5622219|P3|Overall Study|Withdrawal by Subject|0
1611775|NCT02101112|5622220|P2|Overall Study|Withdrawal by Subject|0
1611776|NCT02101112|5622221|P1|Overall Study|Withdrawal by Subject|0
1611777|NCT02101112|5622216|P6|Overall Study|Adverse Event|0
1611778|NCT02101112|5622217|P5|Overall Study|Adverse Event|0
1611779|NCT02101112|5622218|P4|Overall Study|Adverse Event|0
1611780|NCT02101112|5622219|P3|Overall Study|Adverse Event|1
1611781|NCT02101112|5622220|P2|Overall Study|Adverse Event|0
1611782|NCT02101112|5622221|P1|Overall Study|Adverse Event|0
1611783|NCT02101021|5622251|P5|Overall Study|Study Terminated by Sponsor|1
1611784|NCT02101021|5622252|P4|Overall Study|Study Terminated by Sponsor|1
1611785|NCT02101021|5622253|P3|Overall Study|Study Terminated by Sponsor|1
1611786|NCT02101021|5622254|P2|Overall Study|Study Terminated by Sponsor|0
1611787|NCT02101021|5622255|P1|Overall Study|Study Terminated by Sponsor|1
1611788|NCT02101021|5622251|P5|Overall Study|Lost to Follow-up|0
1611789|NCT02101021|5622252|P4|Overall Study|Lost to Follow-up|0
1611790|NCT02101021|5622253|P3|Overall Study|Lost to Follow-up|0
1611791|NCT02101021|5622254|P2|Overall Study|Lost to Follow-up|0
1611792|NCT02101021|5622255|P1|Overall Study|Lost to Follow-up|1
1611793|NCT02101021|5622251|P5|Overall Study|Withdrew Consent from study|0
1611794|NCT02101021|5622252|P4|Overall Study|Withdrew Consent from study|2
1611795|NCT02101021|5622253|P3|Overall Study|Withdrew Consent from study|0
1611796|NCT02101021|5622254|P2|Overall Study|Withdrew Consent from study|1
1611797|NCT02101021|5622255|P1|Overall Study|Withdrew Consent from study|1
1611798|NCT02101021|5622251|P5|Overall Study|Death|3
1611799|NCT02101021|5622252|P4|Overall Study|Death|0
1611800|NCT02101021|5622253|P3|Overall Study|Death|6
1611801|NCT02101021|5622254|P2|Overall Study|Death|3
1611802|NCT02101021|5622255|P1|Overall Study|Death|4
1611803|NCT02100969|5622302|P1|Overall Study|Did not pass screening phase|1
1611804|NCT02100839|5622316|P2|Multiple Ascending Dose|Withdrawal by Subject|0
1611805|NCT02100839|5622317|P1|Multiple Ascending Dose|Withdrawal by Subject|2
1611806|NCT02100839|5622316|P2|Multiple Ascending Dose|Adverse Event|0
1611807|NCT02100839|5622317|P1|Multiple Ascending Dose|Adverse Event|2
1611808|NCT02100813|5622348|P8|Overall Study|Adverse Event|1
1611809|NCT02100813|5622349|P7|Overall Study|Adverse Event|0
1611810|NCT02100813|5622350|P6|Overall Study|Adverse Event|0
1611811|NCT02100813|5622351|P5|Overall Study|Adverse Event|0
1611812|NCT02100813|5622352|P4|Overall Study|Adverse Event|0
1611813|NCT02100813|5622353|P3|Overall Study|Adverse Event|0
1611814|NCT02100813|5622354|P2|Overall Study|Adverse Event|0
1611815|NCT02100813|5622355|P1|Overall Study|Adverse Event|0
1611816|NCT02100670|5622383|P4|Overall Study|Withdrawal by Subject|0
1611817|NCT02100670|5622384|P3|Overall Study|Withdrawal by Subject|0
1611818|NCT02100670|5622385|P2|Overall Study|Withdrawal by Subject|0
1611819|NCT02100670|5622386|P1|Overall Study|Withdrawal by Subject|1
1611820|NCT02100670|5622383|P4|Overall Study|Physician Decision|0
1611821|NCT02100670|5622384|P3|Overall Study|Physician Decision|0
1611822|NCT02100670|5622385|P2|Overall Study|Physician Decision|1
1611823|NCT02100670|5622386|P1|Overall Study|Physician Decision|0
1611824|NCT02100670|5622383|P4|Overall Study|Poor Efficacy|0
1611825|NCT02100670|5622384|P3|Overall Study|Poor Efficacy|0
1611826|NCT02100670|5622385|P2|Overall Study|Poor Efficacy|1
1611827|NCT02100670|5622386|P1|Overall Study|Poor Efficacy|0
1611828|NCT02100670|5622383|P4|Overall Study|No swelling no pain|0
1611829|NCT02100670|5622384|P3|Overall Study|No swelling no pain|0
1611830|NCT02100670|5622385|P2|Overall Study|No swelling no pain|0
1611831|NCT02100670|5622386|P1|Overall Study|No swelling no pain|1
1611832|NCT02100670|5622383|P4|Overall Study|Withdrawal of Consent|0
1611833|NCT02100670|5622384|P3|Overall Study|Withdrawal of Consent|1
1611834|NCT02100670|5622385|P2|Overall Study|Withdrawal of Consent|1
1611835|NCT02100670|5622386|P1|Overall Study|Withdrawal of Consent|0
1611836|NCT02100670|5622383|P4|Overall Study|Protocol Violation|1
1611837|NCT02100670|5622384|P3|Overall Study|Protocol Violation|0
1611838|NCT02100670|5622385|P2|Overall Study|Protocol Violation|1
1611839|NCT02100670|5622386|P1|Overall Study|Protocol Violation|0
1611840|NCT02100670|5622383|P4|Overall Study|Lost to Follow-up|0
1611841|NCT02100670|5622384|P3|Overall Study|Lost to Follow-up|0
1611842|NCT02100670|5622385|P2|Overall Study|Lost to Follow-up|0
1611843|NCT02100670|5622386|P1|Overall Study|Lost to Follow-up|1
1611844|NCT02100670|5622383|P4|Overall Study|Adverse Event|0
1611845|NCT02100670|5622384|P3|Overall Study|Adverse Event|3
1611846|NCT02100670|5622385|P2|Overall Study|Adverse Event|3
1611847|NCT02100670|5622386|P1|Overall Study|Adverse Event|10
1611848|NCT02100644|5622446|P3|LTG Escalation Phase|Withdrawal by Subject|0
1611849|NCT02100644|5622447|P2|LTG Escalation Phase|Withdrawal by Subject|0
1611850|NCT02100644|5622448|P1|LTG Escalation Phase|Withdrawal by Subject|3
1611851|NCT02100644|5622446|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1611852|NCT02100644|5622447|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
1611853|NCT02100644|5622448|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
1611854|NCT02100644|5622446|P3|LTG Escalation Phase|Adverse Event|0
1611855|NCT02100644|5622447|P2|LTG Escalation Phase|Adverse Event|0
1611856|NCT02100644|5622448|P1|LTG Escalation Phase|Adverse Event|9
1611857|NCT02100514|5622473|P5|Extension Period|Withdrew consent|0
1611858|NCT02100514|5622474|P4|Extension Period|Withdrew consent|0
1611859|NCT02100514|5622475|P3|Extension Period|Withdrew consent|2
1611860|NCT02100514|5622476|P2|Extension Period|Withdrew consent|0
1611861|NCT02100514|5622477|P1|Extension Period|Withdrew consent|0
1611862|NCT02100514|5622473|P5|Treatment Period|Other|0
1611863|NCT02100514|5622474|P4|Treatment Period|Other|0
1611864|NCT02100514|5622475|P3|Treatment Period|Other|0
1611865|NCT02100514|5622476|P2|Treatment Period|Other|11
1611866|NCT02100514|5622477|P1|Treatment Period|Other|9
1611867|NCT02100514|5622473|P5|Treatment Period|Withdrawal by Subject|0
1611868|NCT02100514|5622474|P4|Treatment Period|Withdrawal by Subject|0
1611869|NCT02100514|5622475|P3|Treatment Period|Withdrawal by Subject|0
1611870|NCT02100514|5622476|P2|Treatment Period|Withdrawal by Subject|37
1611871|NCT02100514|5622477|P1|Treatment Period|Withdrawal by Subject|12
1611872|NCT02100514|5622473|P5|Treatment Period|Protocol Violation|0
1611873|NCT02100514|5622474|P4|Treatment Period|Protocol Violation|0
1611874|NCT02100514|5622475|P3|Treatment Period|Protocol Violation|0
1611875|NCT02100514|5622476|P2|Treatment Period|Protocol Violation|1
1611876|NCT02100514|5622477|P1|Treatment Period|Protocol Violation|1
1611877|NCT02100514|5622473|P5|Treatment Period|Did Not Meet Entrance Criteria|0
1611878|NCT02100514|5622474|P4|Treatment Period|Did Not Meet Entrance Criteria|0
1611879|NCT02100514|5622475|P3|Treatment Period|Did Not Meet Entrance Criteria|0
1611880|NCT02100514|5622476|P2|Treatment Period|Did Not Meet Entrance Criteria|1
1611881|NCT02100514|5622477|P1|Treatment Period|Did Not Meet Entrance Criteria|0
1611882|NCT02100514|5622473|P5|Treatment Period|Lost to Follow-up|0
1611883|NCT02100514|5622474|P4|Treatment Period|Lost to Follow-up|0
1611884|NCT02100514|5622475|P3|Treatment Period|Lost to Follow-up|0
1611885|NCT02100514|5622476|P2|Treatment Period|Lost to Follow-up|17
1611886|NCT02100514|5622477|P1|Treatment Period|Lost to Follow-up|5
1611887|NCT02100514|5622473|P5|Treatment Period|Death|0
1611888|NCT02100514|5622474|P4|Treatment Period|Death|0
1611889|NCT02100514|5622475|P3|Treatment Period|Death|0
1611890|NCT02100514|5622476|P2|Treatment Period|Death|2
1611891|NCT02100514|5622477|P1|Treatment Period|Death|2
1611892|NCT02100514|5622473|P5|Treatment Period|Adverse Event|0
1611893|NCT02100514|5622474|P4|Treatment Period|Adverse Event|0
1611894|NCT02100514|5622475|P3|Treatment Period|Adverse Event|0
1611895|NCT02100514|5622476|P2|Treatment Period|Adverse Event|5
1611896|NCT02100514|5622477|P1|Treatment Period|Adverse Event|0
1611897|NCT02100475|5622545|P2|Overall Study|Withdrawal criteria|0
1611898|NCT02100475|5622546|P1|Overall Study|Withdrawal criteria|1
1611899|NCT02100475|5622545|P2|Overall Study|Unclassified|2
1611900|NCT02100475|5622546|P1|Overall Study|Unclassified|1
1611901|NCT02100319|5622577|P1|Overall Study|Protocol Deviation|5
1611902|NCT02100319|5622577|P1|Overall Study|Case Report Forms Uncollected|11
1611903|NCT02100228|5622605|P2|Overall Study|Death|1
1611904|NCT02100228|5622606|P1|Overall Study|Death|1
1611905|NCT02100228|5622605|P2|Overall Study|Adverse Event|12
1611906|NCT02100228|5622606|P1|Overall Study|Adverse Event|16
1611907|NCT02100228|5622605|P2|Overall Study|Withdrawal by Subject|37
1611908|NCT02100228|5622606|P1|Overall Study|Withdrawal by Subject|27
1611909|NCT02100228|5622605|P2|Overall Study|Lost to Follow-up|1
1611910|NCT02100228|5622606|P1|Overall Study|Lost to Follow-up|0
1611911|NCT02100228|5622605|P2|Overall Study|Non-compliance|3
1611912|NCT02100228|5622606|P1|Overall Study|Non-compliance|0
1611913|NCT02100228|5622605|P2|Overall Study|Inclusion/Exclusion criteria not met|16
1611914|NCT02100228|5622606|P1|Overall Study|Inclusion/Exclusion criteria not met|12
1611915|NCT02100228|5622605|P2|Overall Study|Administrative reason|1
1611916|NCT02100228|5622606|P1|Overall Study|Administrative reason|0
1611917|NCT02100228|5622605|P2|Overall Study|Other|19
1611918|NCT02100228|5622606|P1|Overall Study|Other|19
1611919|NCT02100124|5622642|P3|Overall Study|Withdrawal by Subject|0
1611920|NCT02100124|5622643|P2|Overall Study|Withdrawal by Subject|0
1611921|NCT02100124|5622644|P1|Overall Study|Withdrawal by Subject|1
1611922|NCT02100124|5622642|P3|Overall Study|Lost to Follow-up|3
1611923|NCT02100124|5622643|P2|Overall Study|Lost to Follow-up|11
1611924|NCT02100124|5622644|P1|Overall Study|Lost to Follow-up|5
1611925|NCT02099838|5622674|P2|Overall Study|Withdrawal by Subject|1
1611926|NCT02099838|5622675|P1|Overall Study|Withdrawal by Subject|0
1611927|NCT02099838|5622674|P2|Overall Study|Lost to Follow-up|1
1611928|NCT02099838|5622675|P1|Overall Study|Lost to Follow-up|3
1611929|NCT02099838|5622674|P2|Overall Study|Death|0
1611930|NCT02099838|5622675|P1|Overall Study|Death|1
1611931|NCT02099708|5622720|P1|Overall Study|Other|29
1611932|NCT02099708|5622720|P1|Overall Study|Lost to Follow-up|141
1611933|NCT02099708|5622720|P1|Overall Study|Data Not Available|30
1611934|NCT02099682|5622731|P1|Overall Study|Other|29
1611935|NCT02099682|5622731|P1|Overall Study|Lost to Follow-up|31
1611936|NCT02099682|5622731|P1|Overall Study|Data Not Available|51
1611937|NCT02099344|5622757|P2|Overall Study|Physician Decision|0
1611938|NCT02099344|5622758|P1|Overall Study|Physician Decision|1
1611939|NCT02099110|5622795|P5|Overall Study|Physician Decision|1
1611940|NCT02099110|5622796|P4|Overall Study|Physician Decision|2
1611941|NCT02099110|5622797|P3|Overall Study|Physician Decision|1
1611942|NCT02099110|5622798|P2|Overall Study|Physician Decision|0
1611943|NCT02099110|5622799|P1|Overall Study|Physician Decision|3
1611944|NCT02099110|5622795|P5|Overall Study|Non-compliance with study drug|1
1611945|NCT02099110|5622796|P4|Overall Study|Non-compliance with study drug|0
1611946|NCT02099110|5622797|P3|Overall Study|Non-compliance with study drug|0
1611947|NCT02099110|5622798|P2|Overall Study|Non-compliance with study drug|0
1611948|NCT02099110|5622799|P1|Overall Study|Non-compliance with study drug|2
1611949|NCT02099110|5622795|P5|Overall Study|Screen failure|1
1611950|NCT02099110|5622796|P4|Overall Study|Screen failure|0
1611951|NCT02099110|5622797|P3|Overall Study|Screen failure|0
1611952|NCT02099110|5622798|P2|Overall Study|Screen failure|0
1611953|NCT02099110|5622799|P1|Overall Study|Screen failure|0
1611954|NCT02099110|5622795|P5|Overall Study|Death|0
1611955|NCT02099110|5622796|P4|Overall Study|Death|0
1611956|NCT02099110|5622797|P3|Overall Study|Death|0
1611957|NCT02099110|5622798|P2|Overall Study|Death|1
1611958|NCT02099110|5622799|P1|Overall Study|Death|0
1611959|NCT02099110|5622795|P5|Overall Study|Lost to Follow-up|6
1611960|NCT02099110|5622796|P4|Overall Study|Lost to Follow-up|5
1611961|NCT02099110|5622797|P3|Overall Study|Lost to Follow-up|11
1611962|NCT02099110|5622798|P2|Overall Study|Lost to Follow-up|12
1611963|NCT02099110|5622799|P1|Overall Study|Lost to Follow-up|6
1611964|NCT02099110|5622795|P5|Overall Study|Adverse Event|2
1611965|NCT02099110|5622796|P4|Overall Study|Adverse Event|3
1611966|NCT02099110|5622797|P3|Overall Study|Adverse Event|2
1611967|NCT02099110|5622798|P2|Overall Study|Adverse Event|5
1611968|NCT02099110|5622799|P1|Overall Study|Adverse Event|3
1611969|NCT02099110|5622795|P5|Overall Study|Withdrawal by Subject|13
1611970|NCT02099110|5622796|P4|Overall Study|Withdrawal by Subject|9
1611971|NCT02099110|5622797|P3|Overall Study|Withdrawal by Subject|13
1611972|NCT02099110|5622798|P2|Overall Study|Withdrawal by Subject|11
1611973|NCT02099110|5622799|P1|Overall Study|Withdrawal by Subject|7
1611974|NCT02099110|5622795|P5|Overall Study|Participant moved|2
1611975|NCT02099110|5622796|P4|Overall Study|Participant moved|0
1611976|NCT02099110|5622797|P3|Overall Study|Participant moved|1
1611977|NCT02099110|5622798|P2|Overall Study|Participant moved|1
1611978|NCT02099110|5622799|P1|Overall Study|Participant moved|1
1611979|NCT02099110|5622795|P5|Overall Study|Protocol Violation|1
1611980|NCT02099110|5622796|P4|Overall Study|Protocol Violation|3
1611981|NCT02099110|5622797|P3|Overall Study|Protocol Violation|0
1611982|NCT02099110|5622798|P2|Overall Study|Protocol Violation|1
1611983|NCT02099110|5622799|P1|Overall Study|Protocol Violation|2
1611984|NCT02098746|5622900|P1|Overall Study|Data Not Available After Treatment|1
1611985|NCT02098746|5622900|P1|Overall Study|Enrolled 15 Days After the First Dose|1
1611986|NCT02098746|5622900|P1|Overall Study|Other Miscellaneous Reasons|1
1611987|NCT02098746|5622900|P1|Overall Study|Changes of Investigator|2
1611988|NCT02098733|5622908|P1|Overall Study|Lost to Follow-up|5
1611989|NCT02098733|5622908|P1|Overall Study|Data Not Available|5
1611990|NCT02098395|5622922|P4|Overall Study|Unclassified|2
1611991|NCT02098395|5622923|P3|Overall Study|Unclassified|3
1611992|NCT02098395|5622924|P2|Overall Study|Unclassified|0
1611993|NCT02098395|5622925|P1|Overall Study|Unclassified|0
1611994|NCT02098395|5622922|P4|Overall Study|Lost to Follow-up|3
1611995|NCT02098395|5622923|P3|Overall Study|Lost to Follow-up|0
1611996|NCT02098395|5622924|P2|Overall Study|Lost to Follow-up|1
1611997|NCT02098395|5622925|P1|Overall Study|Lost to Follow-up|2
1611998|NCT02098395|5622922|P4|Overall Study|Adverse Event|2
1611999|NCT02098395|5622923|P3|Overall Study|Adverse Event|34
1612000|NCT02098395|5622924|P2|Overall Study|Adverse Event|19
1612001|NCT02098395|5622925|P1|Overall Study|Adverse Event|12
1612002|NCT02098395|5622922|P4|Overall Study|Withdrawal by Subject|13
1612003|NCT02098395|5622923|P3|Overall Study|Withdrawal by Subject|5
1612004|NCT02098395|5622924|P2|Overall Study|Withdrawal by Subject|10
1612005|NCT02098395|5622925|P1|Overall Study|Withdrawal by Subject|10
1612006|NCT02098395|5622922|P4|Overall Study|Protocol Violation|7
1612007|NCT02098395|5622923|P3|Overall Study|Protocol Violation|0
1612008|NCT02098395|5622924|P2|Overall Study|Protocol Violation|2
1612009|NCT02098395|5622925|P1|Overall Study|Protocol Violation|2
1612010|NCT02098369|5622946|P3|Overall Study|Other|1
1612011|NCT02098369|5622947|P2|Overall Study|Other|2
1612012|NCT02098369|5622948|P1|Overall Study|Other|0
1612013|NCT02098369|5622946|P3|Overall Study|Death|1
1612014|NCT02098369|5622947|P2|Overall Study|Death|1
1612015|NCT02098369|5622948|P1|Overall Study|Death|1
1612016|NCT02098369|5622946|P3|Overall Study|Lost to Follow-up|3
1612017|NCT02098369|5622947|P2|Overall Study|Lost to Follow-up|1
1612018|NCT02098369|5622948|P1|Overall Study|Lost to Follow-up|5
1612019|NCT02098369|5622946|P3|Overall Study|Withdrawal by Subject|0
1612020|NCT02098369|5622947|P2|Overall Study|Withdrawal by Subject|5
1612021|NCT02098369|5622948|P1|Overall Study|Withdrawal by Subject|1
1612022|NCT02098109|5622986|P2|Overall Study|Protocol Violation|0
1612023|NCT02098109|5622987|P1|Overall Study|Protocol Violation|3
1612024|NCT02097823|5623065|P2|Overall Study|Withdrawal by Subject|1
1612025|NCT02097823|5623066|P1|Overall Study|Withdrawal by Subject|1
1612026|NCT02097745|5623081|P1|Overall Study|Reason Not Specified|96
1612027|NCT02097745|5623081|P1|Overall Study|Administrative/Other|27
1612028|NCT02097745|5623081|P1|Overall Study|Failure to Return|14
1612029|NCT02097745|5623081|P1|Overall Study|Death|16
1612030|NCT02097745|5623081|P1|Overall Study|Adverse Event|25
1612031|NCT02097719|5623119|P2|Overall Study|Adverse Event|0
1612032|NCT02097719|5623120|P1|Overall Study|Adverse Event|2
1612033|NCT02097719|5623119|P2|Overall Study|Lost to Follow-up|1
1612034|NCT02097719|5623120|P1|Overall Study|Lost to Follow-up|0
1612035|NCT02097719|5623119|P2|Overall Study|Subject Withdrew Consent|0
1612036|NCT02097719|5623120|P1|Overall Study|Subject Withdrew Consent|1
1612037|NCT02097472|5623185|P8|Received Vaccination 2|Adverse Event|0
1612038|NCT02097472|5623186|P7|Received Vaccination 2|Adverse Event|1
1612039|NCT02097472|5623187|P6|Received Vaccination 2|Adverse Event|0
1612040|NCT02097472|5623188|P5|Received Vaccination 2|Adverse Event|0
1612041|NCT02097472|5623189|P4|Received Vaccination 2|Adverse Event|0
1612042|NCT02097472|5623190|P3|Received Vaccination 2|Adverse Event|0
1612043|NCT02097472|5623191|P2|Received Vaccination 2|Adverse Event|0
1612044|NCT02097472|5623192|P1|Received Vaccination 2|Adverse Event|0
1612045|NCT02097290|5623623|P1|Overall Study|Attempt|8
1612046|NCT02097290|5623623|P1|Overall Study|Total Withdrawals|3
1612047|NCT02097290|5623623|P1|Overall Study|Death|6
1612048|NCT02097277|5623638|P5|Overall Study|Adverse Event|0
1612049|NCT02097277|5623639|P4|Overall Study|Adverse Event|2
1612050|NCT02097277|5623640|P3|Overall Study|Adverse Event|1
1612051|NCT02097277|5623641|P2|Overall Study|Adverse Event|0
1612052|NCT02097277|5623642|P1|Overall Study|Adverse Event|0
1612053|NCT02097277|5623638|P5|Overall Study|Withdrawal by Subject|0
1612054|NCT02097277|5623639|P4|Overall Study|Withdrawal by Subject|1
1612055|NCT02097277|5623640|P3|Overall Study|Withdrawal by Subject|0
1612056|NCT02097277|5623641|P2|Overall Study|Withdrawal by Subject|1
1612057|NCT02097277|5623642|P1|Overall Study|Withdrawal by Subject|2
1612058|NCT02097277|5623638|P5|Overall Study|Lost to Follow-up|0
1612059|NCT02097277|5623639|P4|Overall Study|Lost to Follow-up|0
1612060|NCT02097277|5623640|P3|Overall Study|Lost to Follow-up|1
1612061|NCT02097277|5623641|P2|Overall Study|Lost to Follow-up|1
1612062|NCT02097277|5623642|P1|Overall Study|Lost to Follow-up|0
1612063|NCT02097277|5623638|P5|Overall Study|Subject request to discontinue treatment|1
1612064|NCT02097277|5623639|P4|Overall Study|Subject request to discontinue treatment|0
1612065|NCT02097277|5623640|P3|Overall Study|Subject request to discontinue treatment|0
1612066|NCT02097277|5623641|P2|Overall Study|Subject request to discontinue treatment|0
1612067|NCT02097277|5623642|P1|Overall Study|Subject request to discontinue treatment|0
1612068|NCT02097277|5623638|P5|Overall Study|Subject no longer meets study criteria|0
1612069|NCT02097277|5623639|P4|Overall Study|Subject no longer meets study criteria|1
1612070|NCT02097277|5623640|P3|Overall Study|Subject no longer meets study criteria|0
1612071|NCT02097277|5623641|P2|Overall Study|Subject no longer meets study criteria|1
1612072|NCT02097277|5623642|P1|Overall Study|Subject no longer meets study criteria|0
1612073|NCT02097238|5623725|P1|Overall Study|Progressive Disease|17
1612074|NCT02097238|5623725|P1|Overall Study|Physician Decision|1
1612075|NCT02097238|5623725|P1|Overall Study|Death|1
1612076|NCT02097134|5623731|P1|Overall Study|Refusal of Further Protocol Therapy|1
1612077|NCT02097134|5623731|P1|Overall Study|Progressive Disease|3
1612078|NCT02097134|5623731|P1|Overall Study|Non-Protocol Therapy|1
1612079|NCT02097134|5623731|P1|Overall Study|Physician Decision|4
1612080|NCT02097108|5623739|P1|Overall Study|patient was abroad for 6 months|1
1612081|NCT02097108|5623739|P1|Overall Study|Adverse Event|1
1612082|NCT02097056|5623746|P1|Overall Study|Other|2
1612083|NCT02097056|5623746|P1|Overall Study|Adverse Event|37
1612084|NCT02097056|5623746|P1|Overall Study|Lost to Follow-up|2
1612085|NCT02097056|5623746|P1|Overall Study|Withdrawal by Subject|15
1612086|NCT02097056|5623746|P1|Overall Study|Protocol Violation|2
1612087|NCT02097030|5623754|P2|First Intervention (3 Days)|Visual Acuity|1
1612088|NCT02097030|5623755|P1|First Intervention (3 Days)|Visual Acuity|0
1612089|NCT02097030|5623754|P2|First Intervention (3 Days)|Lost to Follow-up|0
1612090|NCT02097030|5623755|P1|First Intervention (3 Days)|Lost to Follow-up|1
1612091|NCT02096952|5623816|P1|Overall Study|Adverse Event|1
1612092|NCT02096900|5623822|P2|Overall Study|Surgery cancelled- medication received|1
1612093|NCT02096900|5623823|P1|Overall Study|Surgery cancelled- medication received|1
1612094|NCT02096900|5623822|P2|Overall Study|Did not receive medication|1
1612095|NCT02096900|5623823|P1|Overall Study|Did not receive medication|3
1612096|NCT02096835|5623875|P3|Overall Study|Lost to Follow-up|1
1612097|NCT02096835|5623876|P2|Overall Study|Lost to Follow-up|0
1612098|NCT02096835|5623877|P1|Overall Study|Lost to Follow-up|1
1612099|NCT02096835|5623875|P3|Overall Study|converted to open procedures|0
1612100|NCT02096835|5623876|P2|Overall Study|converted to open procedures|0
1612101|NCT02096835|5623877|P1|Overall Study|converted to open procedures|1
1612102|NCT02096835|5623875|P3|Overall Study|Withdrawal by Subject|0
1612103|NCT02096835|5623876|P2|Overall Study|Withdrawal by Subject|0
1612104|NCT02096835|5623877|P1|Overall Study|Withdrawal by Subject|1
1612105|NCT02096744|5623894|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
1612106|NCT02096744|5623895|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
1612107|NCT02096744|5623894|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
1612108|NCT02096744|5623895|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
1612109|NCT02096744|5623894|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
1612110|NCT02096744|5623895|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
1612111|NCT02096705|5623949|P2|Follow-up|Subjects not reporting status|2
1612112|NCT02096705|5623950|P1|Follow-up|Subjects not reporting status|1
1612113|NCT02096705|5623949|P2|Follow-up|Adverse Event|2
1612114|NCT02096705|5623950|P1|Follow-up|Adverse Event|2
1612115|NCT02096705|5623949|P2|Follow-up|Withdrawal by Subject|0
1612116|NCT02096705|5623950|P1|Follow-up|Withdrawal by Subject|1
1612117|NCT02096705|5623949|P2|Treatment|Other|1
1612118|NCT02096705|5623950|P1|Treatment|Other|1
1612119|NCT02096705|5623949|P2|Treatment|Withdrawal by Subject|0
1612120|NCT02096705|5623950|P1|Treatment|Withdrawal by Subject|1
1612121|NCT02096705|5623949|P2|Treatment|Subject request to discontinue treatment|1
1612122|NCT02096705|5623950|P1|Treatment|Subject request to discontinue treatment|1
1612123|NCT02096705|5623949|P2|Treatment|Adverse Event|3
1612124|NCT02096705|5623950|P1|Treatment|Adverse Event|6
1612125|NCT02096588|5623993|P2|Overall Study|Withdrawal by Subject|1
1612126|NCT02096588|5623994|P1|Overall Study|Withdrawal by Subject|0
1612127|NCT02096588|5623993|P2|Overall Study|Lack of Efficacy|0
1612128|NCT02096588|5623994|P1|Overall Study|Lack of Efficacy|2
1612129|NCT02096471|5624020|P1|Overall Study|Non-Compliant|2
1612130|NCT02096471|5624020|P1|Overall Study|Withdrawal by Subject|3
1612131|NCT02096471|5624020|P1|Overall Study|Lack of Efficacy|7
1612132|NCT02096471|5624020|P1|Overall Study|Adverse Event|1
1612133|NCT02096263|5624038|P3|Overall Study|Withdrawal by Subject|8
1612134|NCT02096263|5624039|P2|Overall Study|Withdrawal by Subject|7
1612135|NCT02096263|5624040|P1|Overall Study|Withdrawal by Subject|5
1612136|NCT02096263|5624038|P3|Overall Study|Protocol Violation|8
1612137|NCT02096263|5624039|P2|Overall Study|Protocol Violation|2
1612138|NCT02096263|5624040|P1|Overall Study|Protocol Violation|7
1612139|NCT02096263|5624038|P3|Overall Study|Sponsor study termination|1
1612140|NCT02096263|5624039|P2|Overall Study|Sponsor study termination|0
1612141|NCT02096263|5624040|P1|Overall Study|Sponsor study termination|0
1612142|NCT02096263|5624038|P3|Overall Study|Other|6
1612143|NCT02096263|5624039|P2|Overall Study|Other|9
1612144|NCT02096263|5624040|P1|Overall Study|Other|7
1612145|NCT02096263|5624038|P3|Overall Study|Lost to Follow-up|15
1612146|NCT02096263|5624039|P2|Overall Study|Lost to Follow-up|18
1612147|NCT02096263|5624040|P1|Overall Study|Lost to Follow-up|14
1612148|NCT02096263|5624038|P3|Overall Study|Adverse Event|1
1612149|NCT02096263|5624039|P2|Overall Study|Adverse Event|0
1612150|NCT02096263|5624040|P1|Overall Study|Adverse Event|1
1612151|NCT02096042|5624228|P3|Overall Study|Disease Progression|0
1612152|NCT02096042|5624229|P2|Overall Study|Disease Progression|0
1612153|NCT02096042|5624230|P1|Overall Study|Disease Progression|1
1612154|NCT02096003|5624252|P2|Overall Study|additional surgery|1
1612155|NCT02096003|5624253|P1|Overall Study|additional surgery|2
1612156|NCT02096003|5624252|P2|Overall Study|Protocol Violation|2
1612157|NCT02096003|5624253|P1|Overall Study|Protocol Violation|0
1612158|NCT02095951|5624269|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
1612159|NCT02095951|5624270|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
1612160|NCT02095873|5624290|P2|Second Intervention (8 Weeks)|Protocol Violation|0
1612161|NCT02095873|5624291|P1|Second Intervention (8 Weeks)|Protocol Violation|1
1612162|NCT02095873|5624290|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1612163|NCT02095873|5624291|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1612164|NCT02095873|5624290|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
1612165|NCT02095873|5624291|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
1612166|NCT02095691|5624303|P1|Overall Study|Physician Decision|1
1612167|NCT02095535|5624335|P1|Recruitment|Protocol Violation|2
1612168|NCT02095223|5624341|P2|Overall Study|Withdrawal by Subject|0
1612169|NCT02095223|5624342|P1|Overall Study|Withdrawal by Subject|1
1612170|NCT02095197|5624352|P2|Overall Study|Lost to Follow-up|3
1612171|NCT02095197|5624353|P1|Overall Study|Lost to Follow-up|0
1612172|NCT02095158|5624365|P1|Overall Study|Other Miscellaneous Reasons|1
1612173|NCT02095158|5624365|P1|Overall Study|Protocol Violation|1
1612174|NCT02095158|5624365|P1|Overall Study|Personal Reasons|35
1612175|NCT02095158|5624365|P1|Overall Study|Lost to Follow-up|20
1612176|NCT02095158|5624365|P1|Overall Study|Pregnancy|1
1612177|NCT02095158|5624365|P1|Overall Study|Lack of Efficacy|3
1612178|NCT02095158|5624365|P1|Overall Study|Adverse Event|14
1612179|NCT02095145|5624372|P2|Overall Study|Withdrawal by Subject|0
1612180|NCT02095145|5624373|P1|Overall Study|Withdrawal by Subject|1
1612181|NCT02095106|5624419|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1612182|NCT02095106|5624420|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1612183|NCT02094937|5624436|P4|12 Weeks in Period 2|Randomized incorrectly|0
1612184|NCT02094937|5624437|P3|12 Weeks in Period 2|Randomized incorrectly|0
1612185|NCT02094937|5624438|P2|12 Weeks in Period 2|Randomized incorrectly|1
1612186|NCT02094937|5624439|P1|12 Weeks in Period 2|Randomized incorrectly|0
1612187|NCT02094937|5624436|P4|12 Weeks in Period 2|Withdrawal by Subject|0
1612188|NCT02094937|5624437|P3|12 Weeks in Period 2|Withdrawal by Subject|2
1612189|NCT02094937|5624438|P2|12 Weeks in Period 2|Withdrawal by Subject|2
1612190|NCT02094937|5624439|P1|12 Weeks in Period 2|Withdrawal by Subject|0
1612191|NCT02094937|5624436|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
1612192|NCT02094937|5624437|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
1612193|NCT02094937|5624438|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
1612194|NCT02094937|5624439|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
1612195|NCT02094937|5624436|P4|12 Weeks in Period 2|Lack of Efficacy|0
1612196|NCT02094937|5624437|P3|12 Weeks in Period 2|Lack of Efficacy|0
1612197|NCT02094937|5624438|P2|12 Weeks in Period 2|Lack of Efficacy|1
1612198|NCT02094937|5624439|P1|12 Weeks in Period 2|Lack of Efficacy|0
1612199|NCT02094937|5624436|P4|12 Weeks in Period 2|Adverse Event|1
1612200|NCT02094937|5624437|P3|12 Weeks in Period 2|Adverse Event|4
1612201|NCT02094937|5624438|P2|12 Weeks in Period 2|Adverse Event|2
1612202|NCT02094937|5624439|P1|12 Weeks in Period 2|Adverse Event|0
1612203|NCT02094937|5624436|P4|8 Weeks in Period 1|Withdrawal by Subject|0
1612204|NCT02094937|5624437|P3|8 Weeks in Period 1|Withdrawal by Subject|0
1612205|NCT02094937|5624438|P2|8 Weeks in Period 1|Withdrawal by Subject|0
1612206|NCT02094937|5624439|P1|8 Weeks in Period 1|Withdrawal by Subject|4
1612207|NCT02094937|5624436|P4|8 Weeks in Period 1|Physician Decision|0
1612208|NCT02094937|5624437|P3|8 Weeks in Period 1|Physician Decision|0
1612209|NCT02094937|5624438|P2|8 Weeks in Period 1|Physician Decision|0
1612210|NCT02094937|5624439|P1|8 Weeks in Period 1|Physician Decision|1
1612211|NCT02094937|5624436|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
1612212|NCT02094937|5624437|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
1612213|NCT02094937|5624438|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
1612214|NCT02094937|5624439|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
1612215|NCT02094937|5624436|P4|8 Weeks in Period 1|Protocol Violation|0
1612216|NCT02094937|5624437|P3|8 Weeks in Period 1|Protocol Violation|0
1612217|NCT02094937|5624438|P2|8 Weeks in Period 1|Protocol Violation|0
1612218|NCT02094937|5624439|P1|8 Weeks in Period 1|Protocol Violation|2
1612219|NCT02094937|5624436|P4|8 Weeks in Period 1|Lack of Efficacy|0
1612220|NCT02094937|5624437|P3|8 Weeks in Period 1|Lack of Efficacy|0
1612221|NCT02094937|5624438|P2|8 Weeks in Period 1|Lack of Efficacy|0
1612222|NCT02094937|5624439|P1|8 Weeks in Period 1|Lack of Efficacy|3
1612223|NCT02094937|5624436|P4|8 Weeks in Period 1|Adverse Event|0
1612224|NCT02094937|5624437|P3|8 Weeks in Period 1|Adverse Event|0
1612225|NCT02094937|5624438|P2|8 Weeks in Period 1|Adverse Event|0
1612226|NCT02094937|5624439|P1|8 Weeks in Period 1|Adverse Event|9
1612227|NCT02094898|5624469|P1|Overall Study|Lack of Efficacy|1
1612228|NCT02094898|5624469|P1|Overall Study|Adverse Event|2
1612229|NCT02094898|5624469|P1|Overall Study|Clinical Worsening|2
1612230|NCT02094885|5624516|P2|Overall Study|Withdrawn due to age|0
1612231|NCT02094885|5624517|P1|Overall Study|Withdrawn due to age|1
1612232|NCT02094885|5624516|P2|Overall Study|Death|5
1612233|NCT02094885|5624517|P1|Overall Study|Death|1
1612234|NCT02094677|5624540|P2|Overall Study|Screening|1
1612235|NCT02094677|5624541|P1|Overall Study|Screening|3
1612236|NCT02094612|5624620|P2|Overall Study|Never started ADHD medication|23
1612237|NCT02094612|5624621|P1|Overall Study|Never started ADHD medication|32
1612238|NCT02094612|5624620|P2|Overall Study|Lost to Follow-up|47
1612239|NCT02094612|5624621|P1|Overall Study|Lost to Follow-up|47
1612240|NCT02094573|5624641|P2|Overall Study|Ongoing|76
1612241|NCT02094573|5624642|P1|Overall Study|Ongoing|64
1612242|NCT02094573|5624641|P2|Overall Study|Randomized but not treated|0
1612243|NCT02094573|5624642|P1|Overall Study|Randomized but not treated|3
1612244|NCT02094573|5624641|P2|Overall Study|Withdrawal by Subject|4
1612245|NCT02094573|5624642|P1|Overall Study|Withdrawal by Subject|2
1612246|NCT02094573|5624641|P2|Overall Study|Non-compliance with study drug|1
1612247|NCT02094573|5624642|P1|Overall Study|Non-compliance with study drug|0
1612248|NCT02094573|5624641|P2|Overall Study|Death|1
1612249|NCT02094573|5624642|P1|Overall Study|Death|7
1612250|NCT02094573|5624641|P2|Overall Study|Adverse Event|9
1612251|NCT02094573|5624642|P1|Overall Study|Adverse Event|3
1612252|NCT02094573|5624641|P2|Overall Study|Clinical Progressive Disease|3
1612253|NCT02094573|5624642|P1|Overall Study|Clinical Progressive Disease|4
1612254|NCT02094573|5624641|P2|Overall Study|Documented Progressive Disease|16
1612255|NCT02094573|5624642|P1|Overall Study|Documented Progressive Disease|29
1612256|NCT02094300|5624724|P1|Overall Study|Still be eligible for follow-up|3
1612257|NCT02094300|5624724|P1|Overall Study|Lost to Follow-up|10
1612258|NCT02094300|5624724|P1|Overall Study|Death|7
1612259|NCT02094261|5624728|P1|Overall Study|Ongoing Study at Data Cut-off|181
1612260|NCT02094261|5624728|P1|Overall Study|Withdrawal by Subject|4
1612261|NCT02094261|5624728|P1|Overall Study|Lost to Follow-up|1
1612262|NCT02094261|5624728|P1|Overall Study|Death|24
1612263|NCT02093923|5624770|P5|Overall Study|Screen failure after randomization|0
1612264|NCT02093923|5624771|P4|Overall Study|Screen failure after randomization|1
1612265|NCT02093923|5624772|P3|Overall Study|Screen failure after randomization|0
1612266|NCT02093923|5624773|P2|Overall Study|Screen failure after randomization|0
1612267|NCT02093923|5624774|P1|Overall Study|Screen failure after randomization|0
1612268|NCT02093923|5624770|P5|Overall Study|Lost to Follow-up|0
1612269|NCT02093923|5624771|P4|Overall Study|Lost to Follow-up|1
1612270|NCT02093923|5624772|P3|Overall Study|Lost to Follow-up|0
1612271|NCT02093923|5624773|P2|Overall Study|Lost to Follow-up|0
1612272|NCT02093923|5624774|P1|Overall Study|Lost to Follow-up|0
1612273|NCT02093897|5624829|P1|Overall Study|Adverse event, non-fatal|1
1612274|NCT02093897|5624829|P1|Overall Study|Planned age group closure - no's reached|17
1612275|NCT02093897|5624829|P1|Overall Study|Physician Decision|1
1612276|NCT02093689|5624932|P3|Overall Study|Physician Decision|0
1612277|NCT02093689|5624933|P2|Overall Study|Physician Decision|0
1612278|NCT02093689|5624934|P1|Overall Study|Physician Decision|4
1612279|NCT02093663|5624940|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
1612280|NCT02093663|5624941|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1612281|NCT02093663|5624942|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1612282|NCT02093663|5624943|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1612283|NCT02093663|5624944|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
1612284|NCT02093663|5624940|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
1612285|NCT02093663|5624941|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
1612286|NCT02093663|5624942|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
1612287|NCT02093663|5624943|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
1612288|NCT02093663|5624944|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
1612289|NCT02093663|5624940|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
1612290|NCT02093663|5624941|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
1612291|NCT02093663|5624942|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
1612292|NCT02093663|5624943|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
1612293|NCT02093663|5624944|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
1612294|NCT02093663|5624940|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
1612295|NCT02093663|5624941|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
1612296|NCT02093663|5624942|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
1612297|NCT02093663|5624943|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
1612298|NCT02093663|5624944|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
1612299|NCT02093663|5624940|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1612300|NCT02093663|5624941|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1612301|NCT02093663|5624942|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
1612302|NCT02093663|5624943|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1612303|NCT02093663|5624944|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
1612304|NCT02093663|5624940|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1612305|NCT02093663|5624941|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1612306|NCT02093663|5624942|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
1612307|NCT02093663|5624943|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1612308|NCT02093663|5624944|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
1612309|NCT02093663|5624940|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
1612310|NCT02093663|5624941|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
1612311|NCT02093663|5624942|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
1612312|NCT02093663|5624943|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
1612313|NCT02093663|5624944|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
1612314|NCT02093663|5624940|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1612315|NCT02093663|5624941|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1612316|NCT02093663|5624942|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1612317|NCT02093663|5624943|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
1612318|NCT02093663|5624944|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
1612319|NCT02093663|5624940|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1612320|NCT02093663|5624941|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1612321|NCT02093663|5624942|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1612322|NCT02093663|5624943|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
1612323|NCT02093663|5624944|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
1612324|NCT02093520|5624973|P2|Overall Study|Not treated|22
1612325|NCT02093520|5624974|P1|Overall Study|Not treated|6
1612326|NCT02093390|5624986|P2|Overall Study|Withdrawal by Subject|1
1612327|NCT02093390|5624987|P1|Overall Study|Withdrawal by Subject|0
1612328|NCT02093351|5625026|P4|Part B|Death|1
1612329|NCT02093351|5625027|P3|Part B|Death|0
1612330|NCT02093351|5625028|P2|Part B|Death|0
1612331|NCT02093351|5625029|P1|Part B|Death|0
1612332|NCT02093351|5625026|P4|Part B|Adverse Event|2
1612333|NCT02093351|5625027|P3|Part B|Adverse Event|0
1612334|NCT02093351|5625028|P2|Part B|Adverse Event|0
1612335|NCT02093351|5625029|P1|Part B|Adverse Event|0
1612336|NCT02093351|5625026|P4|Part B|Condition under investigation worsened|39
1612337|NCT02093351|5625027|P3|Part B|Condition under investigation worsened|0
1612338|NCT02093351|5625028|P2|Part B|Condition under investigation worsened|0
1612339|NCT02093351|5625029|P1|Part B|Condition under investigation worsened|0
1612340|NCT02093351|5625026|P4|Part B|Lack of therapeutic response|12
1612341|NCT02093351|5625027|P3|Part B|Lack of therapeutic response|0
1612342|NCT02093351|5625028|P2|Part B|Lack of therapeutic response|0
1612343|NCT02093351|5625029|P1|Part B|Lack of therapeutic response|0
1612344|NCT02093351|5625026|P4|Part B|Adverse event + disease progression|1
1612345|NCT02093351|5625027|P3|Part B|Adverse event + disease progression|0
1612346|NCT02093351|5625028|P2|Part B|Adverse event + disease progression|0
1612347|NCT02093351|5625029|P1|Part B|Adverse event + disease progression|0
1612348|NCT02093351|5625026|P4|Part B|Complete response|1
1612349|NCT02093351|5625027|P3|Part B|Complete response|0
1612350|NCT02093351|5625028|P2|Part B|Complete response|0
1612351|NCT02093351|5625029|P1|Part B|Complete response|0
1612352|NCT02093351|5625026|P4|Part B|Disease progression|4
1612353|NCT02093351|5625027|P3|Part B|Disease progression|0
1612354|NCT02093351|5625028|P2|Part B|Disease progression|0
1612355|NCT02093351|5625029|P1|Part B|Disease progression|0
1612356|NCT02093351|5625026|P4|Part B|Patient decision|3
1612357|NCT02093351|5625027|P3|Part B|Patient decision|0
1612358|NCT02093351|5625028|P2|Part B|Patient decision|0
1612359|NCT02093351|5625029|P1|Part B|Patient decision|0
1612360|NCT02093351|5625026|P4|Part A|Death|0
1612361|NCT02093351|5625027|P3|Part A|Death|0
1612362|NCT02093351|5625028|P2|Part A|Death|1
1612363|NCT02093351|5625029|P1|Part A|Death|0
1612364|NCT02093351|5625026|P4|Part A|Condition under investigation worsened|0
1612365|NCT02093351|5625027|P3|Part A|Condition under investigation worsened|2
1612366|NCT02093351|5625028|P2|Part A|Condition under investigation worsened|0
1612367|NCT02093351|5625029|P1|Part A|Condition under investigation worsened|2
1612368|NCT02093351|5625026|P4|Part A|Adverse Event|0
1612369|NCT02093351|5625027|P3|Part A|Adverse Event|1
1612370|NCT02093351|5625028|P2|Part A|Adverse Event|1
1612371|NCT02093351|5625029|P1|Part A|Adverse Event|0
1612372|NCT02093221|5625086|P5|Overall Study|Study termination|7
1612373|NCT02093221|5625087|P4|Overall Study|Study termination|6
1612374|NCT02093221|5625088|P3|Overall Study|Study termination|4
1612375|NCT02093221|5625089|P2|Overall Study|Study termination|5
1612376|NCT02093221|5625090|P1|Overall Study|Study termination|6
1612377|NCT02093221|5625086|P5|Overall Study|Protocol Violation|0
1612378|NCT02093221|5625087|P4|Overall Study|Protocol Violation|0
1612379|NCT02093221|5625088|P3|Overall Study|Protocol Violation|0
1612380|NCT02093221|5625089|P2|Overall Study|Protocol Violation|1
1612381|NCT02093221|5625090|P1|Overall Study|Protocol Violation|0
1612382|NCT02093221|5625086|P5|Overall Study|Death|0
1612383|NCT02093221|5625087|P4|Overall Study|Death|0
1612384|NCT02093221|5625088|P3|Overall Study|Death|0
1612385|NCT02093221|5625089|P2|Overall Study|Death|1
1612386|NCT02093221|5625090|P1|Overall Study|Death|0
1612387|NCT02093221|5625086|P5|Overall Study|Lost to Follow-up|0
1612388|NCT02093221|5625087|P4|Overall Study|Lost to Follow-up|1
1612389|NCT02093221|5625088|P3|Overall Study|Lost to Follow-up|1
1612390|NCT02093221|5625089|P2|Overall Study|Lost to Follow-up|0
1612391|NCT02093221|5625090|P1|Overall Study|Lost to Follow-up|2
1612392|NCT02093221|5625086|P5|Overall Study|Withdrawal by Subject|1
1612393|NCT02093221|5625087|P4|Overall Study|Withdrawal by Subject|1
1612394|NCT02093221|5625088|P3|Overall Study|Withdrawal by Subject|4
1612395|NCT02093221|5625089|P2|Overall Study|Withdrawal by Subject|1
1612396|NCT02093221|5625090|P1|Overall Study|Withdrawal by Subject|1
1612397|NCT02093221|5625086|P5|Overall Study|Adverse Event|0
1612398|NCT02093221|5625087|P4|Overall Study|Adverse Event|0
1612399|NCT02093221|5625088|P3|Overall Study|Adverse Event|0
1612400|NCT02093221|5625089|P2|Overall Study|Adverse Event|0
1612401|NCT02093221|5625090|P1|Overall Study|Adverse Event|1
1612402|NCT02093026|5625127|P1|Overall Study|Other|157
1612403|NCT02093026|5625127|P1|Overall Study|Death|10
1612404|NCT02093026|5625127|P1|Overall Study|Adverse Event|26
1612405|NCT02092961|5625149|P3|Overall Study|Adverse Event|0
1612406|NCT02092961|5625150|P2|Overall Study|Adverse Event|4
1612407|NCT02092961|5625151|P1|Overall Study|Adverse Event|2
1612408|NCT02092961|5625149|P3|Overall Study|Dev. of study specific discont. criteria|0
1612409|NCT02092961|5625150|P2|Overall Study|Dev. of study specific discont. criteria|0
1612410|NCT02092961|5625151|P1|Overall Study|Dev. of study specific discont. criteria|3
1612411|NCT02092961|5625149|P3|Overall Study|Lack of therapeutic response|3
1612412|NCT02092961|5625150|P2|Overall Study|Lack of therapeutic response|1
1612413|NCT02092961|5625151|P1|Overall Study|Lack of therapeutic response|2
1612414|NCT02092961|5625149|P3|Overall Study|Study stopped|12
1612415|NCT02092961|5625150|P2|Overall Study|Study stopped|9
1612416|NCT02092961|5625151|P1|Overall Study|Study stopped|13
1612417|NCT02092961|5625149|P3|Overall Study|Not reported|1
1612418|NCT02092961|5625150|P2|Overall Study|Not reported|0
1612419|NCT02092961|5625151|P1|Overall Study|Not reported|1
1612420|NCT02092909|5625176|P4|Overall Study|Miscellaneous|1
1612421|NCT02092909|5625177|P3|Overall Study|Miscellaneous|2
1612422|NCT02092909|5625178|P2|Overall Study|Miscellaneous|1
1612423|NCT02092909|5625179|P1|Overall Study|Miscellaneous|1
1612424|NCT02092909|5625176|P4|Overall Study|Study terminated by Sponsor|2
1612425|NCT02092909|5625177|P3|Overall Study|Study terminated by Sponsor|0
1612426|NCT02092909|5625178|P2|Overall Study|Study terminated by Sponsor|0
1612427|NCT02092909|5625179|P1|Overall Study|Study terminated by Sponsor|0
1612428|NCT02092909|5625176|P4|Overall Study|Withdrawal by Subject|1
1612429|NCT02092909|5625177|P3|Overall Study|Withdrawal by Subject|2
1612430|NCT02092909|5625178|P2|Overall Study|Withdrawal by Subject|0
1612431|NCT02092909|5625179|P1|Overall Study|Withdrawal by Subject|0
1612432|NCT02092909|5625176|P4|Overall Study|Lack of Efficacy|0
1612433|NCT02092909|5625177|P3|Overall Study|Lack of Efficacy|1
1612434|NCT02092909|5625178|P2|Overall Study|Lack of Efficacy|2
1612435|NCT02092909|5625179|P1|Overall Study|Lack of Efficacy|0
1612436|NCT02092909|5625176|P4|Overall Study|Adverse Event|2
1612437|NCT02092909|5625177|P3|Overall Study|Adverse Event|4
1612438|NCT02092909|5625178|P2|Overall Study|Adverse Event|0
1612439|NCT02092909|5625179|P1|Overall Study|Adverse Event|0
1612440|NCT02092662|5625220|P2|Overall Study|Lost to Follow-up|0
1612441|NCT02092662|5625221|P1|Overall Study|Lost to Follow-up|13
1612442|NCT02092389|5625280|P1|Overall Study|Other|5
1612443|NCT02092389|5625280|P1|Overall Study|Adverse Event|1
1612444|NCT02092350|5625292|P2|Overall Study|Withdrawal by Subject|2
1612445|NCT02092350|5625293|P1|Overall Study|Withdrawal by Subject|2
1612446|NCT02092350|5625292|P2|Overall Study|Screen Failure|0
1612447|NCT02092350|5625293|P1|Overall Study|Screen Failure|1
1612448|NCT02092350|5625292|P2|Overall Study|Physician Decision|1
1612449|NCT02092350|5625293|P1|Overall Study|Physician Decision|1
1612450|NCT02092350|5625292|P2|Overall Study|Protocol Violation|0
1612451|NCT02092350|5625293|P1|Overall Study|Protocol Violation|1
1612452|NCT02092350|5625292|P2|Overall Study|Lost to Follow-up|1
1612453|NCT02092350|5625293|P1|Overall Study|Lost to Follow-up|3
1612454|NCT02092350|5625292|P2|Overall Study|Death|5
1612455|NCT02092350|5625293|P1|Overall Study|Death|2
1612456|NCT02092350|5625292|P2|Overall Study|Adverse Event|3
1612457|NCT02092350|5625293|P1|Overall Study|Adverse Event|0
1612458|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
1612459|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
1612460|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
1612461|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Protocol Violation|11
1612462|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Pregnancy|1
1612463|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Physician Decision|10
1612464|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
1612465|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
1612466|NCT02092285|5625321|P1|Maintenance Phase & Follow-up|Adverse Event|22
1612467|NCT02092285|5625321|P1|Induction Phase|Lack of Efficacy|14
1612468|NCT02092285|5625321|P1|Induction Phase|Withdrawal by Subject|2
1612469|NCT02092285|5625321|P1|Induction Phase|Relapse/Recurrence|7
1612470|NCT02092285|5625321|P1|Induction Phase|Pregnancy|1
1612471|NCT02092285|5625321|P1|Induction Phase|Physician Decision|4
1612472|NCT02092285|5625321|P1|Induction Phase|Adverse Event|7
1612473|NCT02092220|5625325|P2|Period 2|Nausea, Anxiety, Inconvenience|1
1612474|NCT02092220|5625326|P1|Period 2|Nausea, Anxiety, Inconvenience|0
1612475|NCT02092220|5625325|P2|Period 2|Severe Hypoglycaemia|0
1612476|NCT02092220|5625326|P1|Period 2|Severe Hypoglycaemia|1
1612477|NCT02092220|5625325|P2|Period 1|Unrelated Illness|2
1612478|NCT02092220|5625326|P1|Period 1|Unrelated Illness|0
1612479|NCT02092116|5625399|P2|Overall Study|Adverse Event|1
1612480|NCT02092116|5625400|P1|Overall Study|Adverse Event|0
1612481|NCT02092116|5625399|P2|Overall Study|Withdrawal by Subject|3
1612482|NCT02092116|5625400|P1|Overall Study|Withdrawal by Subject|0
1612483|NCT02092025|5625409|P1|Overall Study|Protocol Deviation|24
1612484|NCT02092025|5625409|P1|Overall Study|Case Report Forms Uncollected|44
1612485|NCT02091986|5625418|P3|Overall Study|Adverse Event|2
1612486|NCT02091986|5625419|P2|Overall Study|Adverse Event|0
1612487|NCT02091986|5625420|P1|Overall Study|Adverse Event|0
1612488|NCT02091986|5625418|P3|Overall Study|Withdrawal by Subject|3
1612489|NCT02091986|5625419|P2|Overall Study|Withdrawal by Subject|8
1612490|NCT02091986|5625420|P1|Overall Study|Withdrawal by Subject|4
1612491|NCT02091986|5625418|P3|Overall Study|Lost to Follow-up|0
1612492|NCT02091986|5625419|P2|Overall Study|Lost to Follow-up|0
1612493|NCT02091986|5625420|P1|Overall Study|Lost to Follow-up|1
1612494|NCT02091986|5625418|P3|Overall Study|7 rand in error 1 patient decision|3
1612495|NCT02091986|5625419|P2|Overall Study|7 rand in error 1 patient decision|3
1612496|NCT02091986|5625420|P1|Overall Study|7 rand in error 1 patient decision|2
1612497|NCT02091960|5625467|P1|Overall Study|On Study at Data Cut-off|12
1612498|NCT02091960|5625467|P1|Overall Study|Miscellaneous Reasons|31
1612499|NCT02091960|5625467|P1|Overall Study|Withdrawal by Subject|1
1612500|NCT02091960|5625467|P1|Overall Study|Death|7
1612501|NCT02091921|5625478|P1|Overall Study|Adverse Event|3
1612502|NCT02091869|5625487|P2|Overall Study|Withdrawal by Subject|3
1612503|NCT02091869|5625488|P1|Overall Study|Withdrawal by Subject|0
1612504|NCT02091752|5625529|P1|Overall Study|Adverse Event|1
1612505|NCT02091752|5625529|P1|Overall Study|Study terminated by Sponsor|2
1612506|NCT02091739|5625543|P5|EP: 48 Weeks|Withdrawal by Subject|6
1612507|NCT02091739|5625544|P4|EP: 48 Weeks|Withdrawal by Subject|2
1612508|NCT02091739|5625545|P3|EP: 48 Weeks|Withdrawal by Subject|0
1612509|NCT02091739|5625546|P2|EP: 48 Weeks|Withdrawal by Subject|0
1612510|NCT02091739|5625547|P1|EP: 48 Weeks|Withdrawal by Subject|0
1612511|NCT02091739|5625543|P5|EP: 48 Weeks|Adverse Event|6
1612512|NCT02091739|5625544|P4|EP: 48 Weeks|Adverse Event|2
1612513|NCT02091739|5625545|P3|EP: 48 Weeks|Adverse Event|0
1612514|NCT02091739|5625546|P2|EP: 48 Weeks|Adverse Event|0
1612515|NCT02091739|5625547|P1|EP: 48 Weeks|Adverse Event|0
1612516|NCT02091739|5625543|P5|EP: 48 Weeks|Death|2
1612517|NCT02091739|5625544|P4|EP: 48 Weeks|Death|3
1612518|NCT02091739|5625545|P3|EP: 48 Weeks|Death|0
1612519|NCT02091739|5625546|P2|EP: 48 Weeks|Death|0
1612520|NCT02091739|5625547|P1|EP: 48 Weeks|Death|0
1612521|NCT02091739|5625543|P5|EP: 48 Weeks|Other|0
1612522|NCT02091739|5625544|P4|EP: 48 Weeks|Other|1
1612523|NCT02091739|5625545|P3|EP: 48 Weeks|Other|0
1612524|NCT02091739|5625546|P2|EP: 48 Weeks|Other|0
1612525|NCT02091739|5625547|P1|EP: 48 Weeks|Other|0
1612526|NCT02091739|5625543|P5|MP: 16 Weeks|Lost to Follow-up|0
1612527|NCT02091739|5625544|P4|MP: 16 Weeks|Lost to Follow-up|0
1612528|NCT02091739|5625545|P3|MP: 16 Weeks|Lost to Follow-up|1
1612529|NCT02091739|5625546|P2|MP: 16 Weeks|Lost to Follow-up|0
1612530|NCT02091739|5625547|P1|MP: 16 Weeks|Lost to Follow-up|0
1612531|NCT02091739|5625543|P5|MP: 16 Weeks|Withdrawal by Subject|0
1612532|NCT02091739|5625544|P4|MP: 16 Weeks|Withdrawal by Subject|0
1612533|NCT02091739|5625545|P3|MP: 16 Weeks|Withdrawal by Subject|0
1612534|NCT02091739|5625546|P2|MP: 16 Weeks|Withdrawal by Subject|4
1612535|NCT02091739|5625547|P1|MP: 16 Weeks|Withdrawal by Subject|3
1612536|NCT02091739|5625543|P5|MP: 16 Weeks|Adverse Event|0
1612537|NCT02091739|5625544|P4|MP: 16 Weeks|Adverse Event|0
1612538|NCT02091739|5625545|P3|MP: 16 Weeks|Adverse Event|1
1612539|NCT02091739|5625546|P2|MP: 16 Weeks|Adverse Event|1
1612540|NCT02091739|5625547|P1|MP: 16 Weeks|Adverse Event|1
1612541|NCT02091726|5625566|P1|Overall Study|Lost to Follow-up|6
1612542|NCT02091440|5625589|P1|Overall Study|Death|2
1612543|NCT02091414|5625599|P1|Overall Study|Death|2
1612544|NCT02091414|5625599|P1|Overall Study|Withdrawal by Subject|2
1612545|NCT02091375|5625613|P2|Overall Study|Withdrawn by the investigator|0
1612546|NCT02091375|5625614|P1|Overall Study|Withdrawn by the investigator|1
1612547|NCT02091375|5625613|P2|Overall Study|Withdrawal by Subject|1
1612548|NCT02091375|5625614|P1|Overall Study|Withdrawal by Subject|0
1612549|NCT02091375|5625613|P2|Overall Study|Lost to Follow-up|1
1612550|NCT02091375|5625614|P1|Overall Study|Lost to Follow-up|0
1612551|NCT02091375|5625613|P2|Overall Study|Adverse Event|1
1612552|NCT02091375|5625614|P1|Overall Study|Adverse Event|8
1612553|NCT02091362|5625644|P2|Period 2|Withdrawal by Subject|1
1612554|NCT02091362|5625645|P1|Period 2|Withdrawal by Subject|1
1612555|NCT02091362|5625644|P2|Period 2|Lost to Follow-up|1
1612556|NCT02091362|5625645|P1|Period 2|Lost to Follow-up|0
1612557|NCT02091362|5625644|P2|Period 2|Adverse Event|0
1612558|NCT02091362|5625645|P1|Period 2|Adverse Event|1
1612559|NCT02091362|5625644|P2|Wash-out|Withdrawal by Subject|2
1612560|NCT02091362|5625645|P1|Wash-out|Withdrawal by Subject|0
1612561|NCT02091362|5625644|P2|Wash-out|Lost to Follow-up|1
1612562|NCT02091362|5625645|P1|Wash-out|Lost to Follow-up|1
1612563|NCT02091362|5625644|P2|Period 1|Adverse Event|0
1612564|NCT02091362|5625645|P1|Period 1|Adverse Event|2
1612565|NCT02091362|5625644|P2|Period 1|Lost to Follow-up|1
1612566|NCT02091362|5625645|P1|Period 1|Lost to Follow-up|0
1612567|NCT02091362|5625644|P2|Period 1|Withdrawal by Subject|3
1612568|NCT02091362|5625645|P1|Period 1|Withdrawal by Subject|2
1612569|NCT02091362|5625644|P2|Period 1|Protocol Violation|0
1612570|NCT02091362|5625645|P1|Period 1|Protocol Violation|1
1612571|NCT02091284|5625667|P2|Overall Study|unreliable data|0
1612572|NCT02091284|5625668|P1|Overall Study|unreliable data|1
1612573|NCT02091284|5625667|P2|Overall Study|Withdrawal by Subject|1
1612574|NCT02091284|5625668|P1|Overall Study|Withdrawal by Subject|2
1612575|NCT02091206|5625690|P4|Taper Period|Lost to Follow-up|1
1612576|NCT02091206|5625691|P3|Taper Period|Lost to Follow-up|0
1612577|NCT02091206|5625692|P2|Taper Period|Lost to Follow-up|0
1612578|NCT02091206|5625693|P1|Taper Period|Lost to Follow-up|0
1612579|NCT02091206|5625690|P4|Taper Period|Participant refused study drug|1
1612580|NCT02091206|5625691|P3|Taper Period|Participant refused study drug|0
1612581|NCT02091206|5625692|P2|Taper Period|Participant refused study drug|0
1612582|NCT02091206|5625693|P1|Taper Period|Participant refused study drug|1
1612583|NCT02091206|5625690|P4|Treatment Period|Met withdrawal criteria|0
1612584|NCT02091206|5625691|P3|Treatment Period|Met withdrawal criteria|1
1612585|NCT02091206|5625692|P2|Treatment Period|Met withdrawal criteria|0
1612586|NCT02091206|5625693|P1|Treatment Period|Met withdrawal criteria|0
1612587|NCT02091206|5625690|P4|Treatment Period|Adverse Event|0
1612588|NCT02091206|5625691|P3|Treatment Period|Adverse Event|0
1612589|NCT02091206|5625692|P2|Treatment Period|Adverse Event|1
1612590|NCT02091206|5625693|P1|Treatment Period|Adverse Event|0
1612591|NCT02091167|5625712|P2|Overall Study|Lost to Follow-up|2
1612592|NCT02091167|5625713|P1|Overall Study|Lost to Follow-up|0
1612593|NCT02090855|5625726|P1|Overall Study|no evaluable Standard of Truth results|2
1612594|NCT02090764|5625739|P2|Overall Study|Lost to Follow-up|2
1612595|NCT02090764|5625740|P1|Overall Study|Lost to Follow-up|2
1612596|NCT02090764|5625739|P2|Overall Study|Intercurrent illness and other|1
1612597|NCT02090764|5625740|P1|Overall Study|Intercurrent illness and other|1
1612598|NCT02090764|5625739|P2|Overall Study|Withdrawal by Subject|1
1612599|NCT02090764|5625740|P1|Overall Study|Withdrawal by Subject|2
1612600|NCT02090764|5625739|P2|Overall Study|Lack of Efficacy|13
1612601|NCT02090764|5625740|P1|Overall Study|Lack of Efficacy|0
1612602|NCT02090764|5625739|P2|Overall Study|Adverse Event|3
1612603|NCT02090764|5625740|P1|Overall Study|Adverse Event|1
1612604|NCT02090725|5625746|P1|Overall Study|participants moved from area|3
1612605|NCT02090725|5625746|P1|Overall Study|Withdrawal by Subject|1
1612606|NCT02090413|5625753|P3|Overall Study|Lost to Follow-up|0
1612607|NCT02090413|5625754|P2|Overall Study|Lost to Follow-up|1
1612608|NCT02090413|5625755|P1|Overall Study|Lost to Follow-up|1
1612609|NCT02090413|5625753|P3|Overall Study|Other|0
1612610|NCT02090413|5625754|P2|Overall Study|Other|1
1612611|NCT02090413|5625755|P1|Overall Study|Other|2
1612612|NCT02090413|5625753|P3|Overall Study|Investigator Decision|0
1612613|NCT02090413|5625754|P2|Overall Study|Investigator Decision|1
1612614|NCT02090413|5625755|P1|Overall Study|Investigator Decision|1
1612615|NCT02090413|5625753|P3|Overall Study|Withdrawal by Subject|2
1612616|NCT02090413|5625754|P2|Overall Study|Withdrawal by Subject|2
1612617|NCT02090413|5625755|P1|Overall Study|Withdrawal by Subject|2
1612618|NCT02090413|5625753|P3|Overall Study|Flushing event|1
1612619|NCT02090413|5625754|P2|Overall Study|Flushing event|0
1612620|NCT02090413|5625755|P1|Overall Study|Flushing event|2
1612621|NCT02090413|5625753|P3|Overall Study|Adverse Event|20
1612622|NCT02090413|5625754|P2|Overall Study|Adverse Event|15
1612623|NCT02090413|5625755|P1|Overall Study|Adverse Event|11
1612624|NCT02090283|5625832|P3|Overall Study|Protocol Violation|0
1612625|NCT02090283|5625833|P2|Overall Study|Protocol Violation|0
1612626|NCT02090283|5625834|P1|Overall Study|Protocol Violation|2
1612627|NCT02090283|5625832|P3|Overall Study|Adverse Event|0
1612628|NCT02090283|5625833|P2|Overall Study|Adverse Event|1
1612629|NCT02090283|5625834|P1|Overall Study|Adverse Event|1
1612630|NCT02090283|5625832|P3|Overall Study|Lost to Follow-up|3
1612631|NCT02090283|5625833|P2|Overall Study|Lost to Follow-up|2
1612632|NCT02090283|5625834|P1|Overall Study|Lost to Follow-up|2
1612633|NCT02090283|5625832|P3|Overall Study|Sponsor Terminated Study|1
1612634|NCT02090283|5625833|P2|Overall Study|Sponsor Terminated Study|6
1612635|NCT02090283|5625834|P1|Overall Study|Sponsor Terminated Study|6
1612636|NCT02090283|5625832|P3|Overall Study|Withdrawal by Subject|6
1612637|NCT02090283|5625833|P2|Overall Study|Withdrawal by Subject|6
1612638|NCT02090283|5625834|P1|Overall Study|Withdrawal by Subject|6
1612639|NCT02089997|5625868|P1|Overall Study|Protocol Violation|147
1612640|NCT02089997|5625868|P1|Overall Study|Case report forms uncollected|99
1612641|NCT02089737|5625883|P1|Overall Study|Not treated|1
1612642|NCT02089737|5625883|P1|Overall Study|Survey form not completed|5
1612643|NCT02089347|5625908|P2|Overall Study|Protocol Violation|0
1612644|NCT02089347|5625909|P1|Overall Study|Protocol Violation|1
1612645|NCT02088957|5625951|P2|Overall Study|Lack of Efficacy|0
1612646|NCT02088957|5625952|P1|Overall Study|Lack of Efficacy|1
1612647|NCT02088905|5625970|P2|Overall Study|Withdrawal by Subject|1
1612648|NCT02088905|5625971|P1|Overall Study|Withdrawal by Subject|5
1612649|NCT02088177|5626042|P1|Overall Study|Lost to Follow-up|3
1612650|NCT02088073|5626052|P5|Maintanance Phase|Subject compliance|0
1612651|NCT02088073|5626053|P4|Maintanance Phase|Subject compliance|0
1612652|NCT02088073|5626054|P3|Maintanance Phase|Subject compliance|0
1612653|NCT02088073|5626055|P2|Maintanance Phase|Subject compliance|1
1612654|NCT02088073|5626056|P1|Maintanance Phase|Subject compliance|0
1612655|NCT02088073|5626052|P5|Maintanance Phase|Met ECG withdrawal criteria|2
1612656|NCT02088073|5626053|P4|Maintanance Phase|Met ECG withdrawal criteria|0
1612657|NCT02088073|5626054|P3|Maintanance Phase|Met ECG withdrawal criteria|1
1612658|NCT02088073|5626055|P2|Maintanance Phase|Met ECG withdrawal criteria|0
1612659|NCT02088073|5626056|P1|Maintanance Phase|Met ECG withdrawal criteria|0
1612660|NCT02088073|5626052|P5|Maintanance Phase|Miscellaneous|1
1612661|NCT02088073|5626053|P4|Maintanance Phase|Miscellaneous|2
1612662|NCT02088073|5626054|P3|Maintanance Phase|Miscellaneous|1
1612663|NCT02088073|5626055|P2|Maintanance Phase|Miscellaneous|2
1612664|NCT02088073|5626056|P1|Maintanance Phase|Miscellaneous|0
1612665|NCT02088073|5626052|P5|Maintanance Phase|Hypo- or hyperkalemia|1
1612666|NCT02088073|5626053|P4|Maintanance Phase|Hypo- or hyperkalemia|3
1612667|NCT02088073|5626054|P3|Maintanance Phase|Hypo- or hyperkalemia|0
1612668|NCT02088073|5626055|P2|Maintanance Phase|Hypo- or hyperkalemia|3
1612669|NCT02088073|5626056|P1|Maintanance Phase|Hypo- or hyperkalemia|0
1612670|NCT02088073|5626052|P5|Maintanance Phase|Sponsor's decision|1
1612671|NCT02088073|5626053|P4|Maintanance Phase|Sponsor's decision|2
1612672|NCT02088073|5626054|P3|Maintanance Phase|Sponsor's decision|0
1612673|NCT02088073|5626055|P2|Maintanance Phase|Sponsor's decision|2
1612674|NCT02088073|5626056|P1|Maintanance Phase|Sponsor's decision|0
1612675|NCT02088073|5626052|P5|Maintanance Phase|Physician Decision|1
1612676|NCT02088073|5626053|P4|Maintanance Phase|Physician Decision|0
1612677|NCT02088073|5626054|P3|Maintanance Phase|Physician Decision|0
1612678|NCT02088073|5626055|P2|Maintanance Phase|Physician Decision|0
1612679|NCT02088073|5626056|P1|Maintanance Phase|Physician Decision|0
1612680|NCT02088073|5626052|P5|Maintanance Phase|Adverse Event|1
1612681|NCT02088073|5626053|P4|Maintanance Phase|Adverse Event|0
1612682|NCT02088073|5626054|P3|Maintanance Phase|Adverse Event|3
1612683|NCT02088073|5626055|P2|Maintanance Phase|Adverse Event|0
1612684|NCT02088073|5626056|P1|Maintanance Phase|Adverse Event|0
1612685|NCT02088073|5626052|P5|Maintanance Phase|Withdrawal by Subject|0
1612686|NCT02088073|5626053|P4|Maintanance Phase|Withdrawal by Subject|0
1612687|NCT02088073|5626054|P3|Maintanance Phase|Withdrawal by Subject|0
1612688|NCT02088073|5626055|P2|Maintanance Phase|Withdrawal by Subject|2
1612689|NCT02088073|5626056|P1|Maintanance Phase|Withdrawal by Subject|0
1612690|NCT02088073|5626052|P5|Acute Phase|Hyperkalemia|0
1612691|NCT02088073|5626053|P4|Acute Phase|Hyperkalemia|0
1612692|NCT02088073|5626054|P3|Acute Phase|Hyperkalemia|0
1612693|NCT02088073|5626055|P2|Acute Phase|Hyperkalemia|0
1612694|NCT02088073|5626056|P1|Acute Phase|Hyperkalemia|2
1612695|NCT02088073|5626052|P5|Acute Phase|Withdrawal by Subject|0
1612696|NCT02088073|5626053|P4|Acute Phase|Withdrawal by Subject|0
1612697|NCT02088073|5626054|P3|Acute Phase|Withdrawal by Subject|0
1612698|NCT02088073|5626055|P2|Acute Phase|Withdrawal by Subject|0
1612699|NCT02088073|5626056|P1|Acute Phase|Withdrawal by Subject|5
1612700|NCT02087943|5626130|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
1612701|NCT02087943|5626131|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
1612702|NCT02087943|5626132|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
1612703|NCT02087943|5626133|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
1612704|NCT02087943|5626134|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
1612705|NCT02087943|5626130|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
1612706|NCT02087943|5626131|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1612707|NCT02087943|5626132|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1612708|NCT02087943|5626133|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1612709|NCT02087943|5626134|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
1612710|NCT02087943|5626130|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1612711|NCT02087943|5626131|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1612712|NCT02087943|5626132|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
1612713|NCT02087943|5626133|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1612714|NCT02087943|5626134|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
1612715|NCT02087943|5626130|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
1612716|NCT02087943|5626131|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1612717|NCT02087943|5626132|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
1612718|NCT02087943|5626133|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
1612719|NCT02087943|5626134|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
1612720|NCT02087943|5626130|P5|Active Treatment Phase Week 12-24|Adverse Event|1
1612721|NCT02087943|5626131|P4|Active Treatment Phase Week 12-24|Adverse Event|0
1612722|NCT02087943|5626132|P3|Active Treatment Phase Week 12-24|Adverse Event|2
1612723|NCT02087943|5626133|P2|Active Treatment Phase Week 12-24|Adverse Event|1
1612724|NCT02087943|5626134|P1|Active Treatment Phase Week 12-24|Adverse Event|0
1612725|NCT02087943|5626130|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1612726|NCT02087943|5626131|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1612727|NCT02087943|5626132|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1612728|NCT02087943|5626133|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
1612729|NCT02087943|5626134|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
1612730|NCT02087943|5626130|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1612731|NCT02087943|5626131|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1612732|NCT02087943|5626132|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1612733|NCT02087943|5626133|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
1612734|NCT02087943|5626134|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
1612735|NCT02087943|5626130|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1612736|NCT02087943|5626131|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
1612737|NCT02087943|5626132|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1612738|NCT02087943|5626133|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
1612739|NCT02087943|5626134|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
1612740|NCT02087943|5626130|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1612741|NCT02087943|5626131|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
1612742|NCT02087943|5626132|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
1612743|NCT02087943|5626133|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
1612744|NCT02087943|5626134|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
1612745|NCT02087943|5626130|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1612746|NCT02087943|5626131|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
1612747|NCT02087943|5626132|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
1612748|NCT02087943|5626133|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
1612749|NCT02087943|5626134|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
1612750|NCT02087904|5626162|P4|Overall Study|Lost to Follow-up|2
1612751|NCT02087904|5626163|P3|Overall Study|Lost to Follow-up|2
1612752|NCT02087904|5626164|P2|Overall Study|Lost to Follow-up|4
1612753|NCT02087904|5626165|P1|Overall Study|Lost to Follow-up|0
1612754|NCT02087904|5626162|P4|Overall Study|Withdrawal by Subject|4
1612755|NCT02087904|5626163|P3|Overall Study|Withdrawal by Subject|7
1612756|NCT02087904|5626164|P2|Overall Study|Withdrawal by Subject|3
1612757|NCT02087904|5626165|P1|Overall Study|Withdrawal by Subject|8
1612758|NCT02087904|5626162|P4|Overall Study|Other|4
1612759|NCT02087904|5626163|P3|Overall Study|Other|4
1612760|NCT02087904|5626164|P2|Overall Study|Other|2
1612761|NCT02087904|5626165|P1|Overall Study|Other|6
1612762|NCT02087904|5626162|P4|Overall Study|Lack of Efficacy|2
1612763|NCT02087904|5626163|P3|Overall Study|Lack of Efficacy|3
1612764|NCT02087904|5626164|P2|Overall Study|Lack of Efficacy|6
1612765|NCT02087904|5626165|P1|Overall Study|Lack of Efficacy|3
1612766|NCT02087904|5626162|P4|Overall Study|Adverse Event|12
1612767|NCT02087904|5626163|P3|Overall Study|Adverse Event|4
1612768|NCT02087904|5626164|P2|Overall Study|Adverse Event|4
1612769|NCT02087904|5626165|P1|Overall Study|Adverse Event|8
1612770|NCT02087904|5626162|P4|Overall Study|Did Not Receive Study Drug|1
1612771|NCT02087904|5626163|P3|Overall Study|Did Not Receive Study Drug|2
1612772|NCT02087904|5626164|P2|Overall Study|Did Not Receive Study Drug|0
1612773|NCT02087904|5626165|P1|Overall Study|Did Not Receive Study Drug|0
1612774|NCT02087774|5626281|P2|Overall Study|Were absent day of data collection|20
1612775|NCT02087774|5626282|P1|Overall Study|Were absent day of data collection|8
1612776|NCT02087670|5626302|P2|Overall Study|Withdrawal by Subject|2
1612777|NCT02087670|5626303|P1|Overall Study|Withdrawal by Subject|3
1612778|NCT02087423|5626339|P3|Overall Study|Terminated from study at final DCO|25
1612869|NCT02086162|5626532|P2|Overall Study|Withdrawal by Subject|4
1612779|NCT02087423|5626340|P2|Overall Study|Terminated from study at final DCO|36
1612780|NCT02087423|5626341|P1|Overall Study|Terminated from study at final DCO|23
1612781|NCT02087423|5626339|P3|Overall Study|Lost to Follow-up|0
1612782|NCT02087423|5626340|P2|Overall Study|Lost to Follow-up|2
1612783|NCT02087423|5626341|P1|Overall Study|Lost to Follow-up|0
1612784|NCT02087423|5626339|P3|Overall Study|Death|40
1612785|NCT02087423|5626340|P2|Overall Study|Death|207
1612786|NCT02087423|5626341|P1|Overall Study|Death|68
1612787|NCT02087423|5626339|P3|Overall Study|Withdrawal by Subject|3
1612788|NCT02087423|5626340|P2|Overall Study|Withdrawal by Subject|20
1612789|NCT02087423|5626341|P1|Overall Study|Withdrawal by Subject|20
1612790|NCT02087241|5626370|P4|Overall Study|Study Terminated by Sponsor|4
1612791|NCT02087241|5626371|P3|Overall Study|Study Terminated by Sponsor|0
1612792|NCT02087241|5626372|P2|Overall Study|Study Terminated by Sponsor|2
1612793|NCT02087241|5626373|P1|Overall Study|Study Terminated by Sponsor|0
1612794|NCT02087241|5626370|P4|Overall Study|Progressive Disease|1
1612795|NCT02087241|5626371|P3|Overall Study|Progressive Disease|0
1612796|NCT02087241|5626372|P2|Overall Study|Progressive Disease|0
1612797|NCT02087241|5626373|P1|Overall Study|Progressive Disease|0
1612798|NCT02087241|5626370|P4|Overall Study|Withdrawal by Subject|1
1612799|NCT02087241|5626371|P3|Overall Study|Withdrawal by Subject|0
1612800|NCT02087241|5626372|P2|Overall Study|Withdrawal by Subject|0
1612801|NCT02087241|5626373|P1|Overall Study|Withdrawal by Subject|1
1612802|NCT02087241|5626370|P4|Overall Study|Death|1
1612803|NCT02087241|5626371|P3|Overall Study|Death|1
1612804|NCT02087241|5626372|P2|Overall Study|Death|1
1612805|NCT02087241|5626373|P1|Overall Study|Death|2
1612806|NCT02087176|5626399|P1|Overall Study|Study Terminated by Sponsor|2
1612807|NCT02087176|5626399|P1|Overall Study|Censored|19
1612808|NCT02087176|5626399|P1|Overall Study|Death|10
1612809|NCT02087176|5626399|P1|Overall Study|Withdrawal by Subject|1
1612810|NCT02087150|5626412|P3|Overall Study|Pt moved out of town|0
1612811|NCT02087150|5626413|P2|Overall Study|Pt moved out of town|1
1612812|NCT02087150|5626414|P1|Overall Study|Pt moved out of town|0
1612813|NCT02087150|5626412|P3|Overall Study|Other|0
1612814|NCT02087150|5626413|P2|Overall Study|Other|0
1612815|NCT02087150|5626414|P1|Overall Study|Other|1
1612816|NCT02087150|5626412|P3|Overall Study|F/U not completed w/in study window|1
1612817|NCT02087150|5626413|P2|Overall Study|F/U not completed w/in study window|0
1612818|NCT02087150|5626414|P1|Overall Study|F/U not completed w/in study window|0
1612819|NCT02087150|5626412|P3|Overall Study|Procedure not done|0
1612820|NCT02087150|5626413|P2|Overall Study|Procedure not done|13
1612821|NCT02087150|5626414|P1|Overall Study|Procedure not done|1
1612822|NCT02087150|5626412|P3|Overall Study|Physician Decision|0
1612823|NCT02087150|5626413|P2|Overall Study|Physician Decision|1
1612824|NCT02087150|5626414|P1|Overall Study|Physician Decision|0
1612825|NCT02087150|5626412|P3|Overall Study|Withdrawal by Subject|3
1612826|NCT02087150|5626413|P2|Overall Study|Withdrawal by Subject|5
1612827|NCT02087150|5626414|P1|Overall Study|Withdrawal by Subject|2
1612828|NCT02087150|5626412|P3|Overall Study|Lost to Follow-up|7
1612829|NCT02087150|5626413|P2|Overall Study|Lost to Follow-up|13
1612830|NCT02087150|5626414|P1|Overall Study|Lost to Follow-up|6
1612831|NCT02087150|5626412|P3|Overall Study|Death|0
1612832|NCT02087150|5626413|P2|Overall Study|Death|1
1612833|NCT02087150|5626414|P1|Overall Study|Death|0
1612834|NCT02087085|5626433|P2|Overall Study|Other Miscellaneous Reasons|4
1612835|NCT02087085|5626434|P1|Overall Study|Other Miscellaneous Reasons|3
1612836|NCT02087085|5626433|P2|Overall Study|Study Terminated by Sponsor|80
1612837|NCT02087085|5626434|P1|Overall Study|Study Terminated by Sponsor|87
1612838|NCT02087085|5626433|P2|Overall Study|Protocol Violation|0
1612839|NCT02087085|5626434|P1|Overall Study|Protocol Violation|1
1612840|NCT02087085|5626433|P2|Overall Study|Withdrawal by Subject|11
1612841|NCT02087085|5626434|P1|Overall Study|Withdrawal by Subject|9
1612842|NCT02087085|5626433|P2|Overall Study|Lost to Follow-up|4
1612843|NCT02087085|5626434|P1|Overall Study|Lost to Follow-up|6
1612844|NCT02087085|5626433|P2|Overall Study|Lack of Efficacy|3
1612845|NCT02087085|5626434|P1|Overall Study|Lack of Efficacy|4
1612846|NCT02087085|5626433|P2|Overall Study|Adverse Event|14
1612847|NCT02087085|5626434|P1|Overall Study|Adverse Event|10
1612848|NCT02087059|5626444|P1|Overall Study|Lost to Follow-up|1
1612849|NCT02087059|5626444|P1|Overall Study|Adverse Event|5
1612850|NCT02087059|5626444|P1|Overall Study|Disease Progression|1
1612851|NCT02086591|5626500|P1|Overall Study|protocol terminated|3
1612852|NCT02086591|5626500|P1|Overall Study|Withdrawal by Subject|1
1612853|NCT02086591|5626500|P1|Overall Study|Adverse Event|1
1612854|NCT02086565|5626508|P2|Overall Study|withdrawn by research team|2
1612855|NCT02086565|5626509|P1|Overall Study|withdrawn by research team|2
1612856|NCT02086565|5626508|P2|Overall Study|Death|2
1612857|NCT02086565|5626509|P1|Overall Study|Death|3
1612858|NCT02086565|5626508|P2|Overall Study|Withdrawal by Subject|1
1612859|NCT02086565|5626509|P1|Overall Study|Withdrawal by Subject|2
1612860|NCT02086565|5626508|P2|Overall Study|Lost to Follow-up|7
1612861|NCT02086565|5626509|P1|Overall Study|Lost to Follow-up|9
1612862|NCT02086552|5626523|P1|Overall Study|Withdrawal by Subject|1
1612863|NCT02086162|5626532|P2|Overall Study|Death|0
1612864|NCT02086162|5626533|P1|Overall Study|Death|1
1612865|NCT02086162|5626532|P2|Overall Study|Lost to Follow-up|2
1612866|NCT02086162|5626533|P1|Overall Study|Lost to Follow-up|4
1612867|NCT02086162|5626532|P2|Overall Study|moved|1
1612868|NCT02086162|5626533|P1|Overall Study|moved|1
1612870|NCT02086162|5626533|P1|Overall Study|Withdrawal by Subject|4
1612871|NCT02086110|5626545|P2|Overall Study|Withdrawal by Subject|1
1612872|NCT02086110|5626546|P1|Overall Study|Withdrawal by Subject|1
1612873|NCT02085785|5626557|P2|Overall Study|Lost to Follow-up|1
1612874|NCT02085785|5626558|P1|Overall Study|Lost to Follow-up|0
1612875|NCT02085785|5626557|P2|Overall Study|Withdrawal by Subject|1
1612876|NCT02085785|5626558|P1|Overall Study|Withdrawal by Subject|2
1612877|NCT02085252|5626707|P2|Overall Study|Reason Unknown|1
1612878|NCT02085252|5626708|P1|Overall Study|Reason Unknown|0
1612879|NCT02085252|5626707|P2|Overall Study|Reason Not Specified|1
1612880|NCT02085252|5626708|P1|Overall Study|Reason Not Specified|0
1612881|NCT02085252|5626707|P2|Overall Study|Discontinuation Due to Patient Decision|1
1612882|NCT02085252|5626708|P1|Overall Study|Discontinuation Due to Patient Decision|0
1612883|NCT02085252|5626707|P2|Overall Study|Adverse Event|1
1612884|NCT02085252|5626708|P1|Overall Study|Adverse Event|0
1612885|NCT02085252|5626707|P2|Overall Study|Withdrawal of Consent|0
1612886|NCT02085252|5626708|P1|Overall Study|Withdrawal of Consent|1
1612887|NCT02085161|5626732|P4|Overall Study|Other Reason|1
1612888|NCT02085161|5626733|P3|Overall Study|Other Reason|1
1612889|NCT02085161|5626734|P2|Overall Study|Other Reason|0
1612890|NCT02085161|5626735|P1|Overall Study|Other Reason|1
1612891|NCT02085161|5626732|P4|Overall Study|Withdrawal by Subject|3
1612892|NCT02085161|5626733|P3|Overall Study|Withdrawal by Subject|0
1612893|NCT02085161|5626734|P2|Overall Study|Withdrawal by Subject|4
1612894|NCT02085161|5626735|P1|Overall Study|Withdrawal by Subject|2
1612895|NCT02085161|5626732|P4|Overall Study|Protocol Violation|1
1612896|NCT02085161|5626733|P3|Overall Study|Protocol Violation|0
1612897|NCT02085161|5626734|P2|Overall Study|Protocol Violation|1
1612898|NCT02085161|5626735|P1|Overall Study|Protocol Violation|0
1612899|NCT02085161|5626732|P4|Overall Study|Adverse Event|5
1612900|NCT02085161|5626733|P3|Overall Study|Adverse Event|4
1612901|NCT02085161|5626734|P2|Overall Study|Adverse Event|5
1612902|NCT02085161|5626735|P1|Overall Study|Adverse Event|8
1612903|NCT02085161|5626732|P4|Overall Study|Not Treated|0
1612904|NCT02085161|5626733|P3|Overall Study|Not Treated|0
1612905|NCT02085161|5626734|P2|Overall Study|Not Treated|0
1612906|NCT02085161|5626735|P1|Overall Study|Not Treated|1
1612907|NCT02085135|5626776|P2|Overall Study|Lack of Efficacy|0
1612908|NCT02085135|5626777|P1|Overall Study|Lack of Efficacy|2
1612909|NCT02085135|5626776|P2|Overall Study|Withdrawal by Subject|0
1612910|NCT02085135|5626777|P1|Overall Study|Withdrawal by Subject|3
1612911|NCT02085135|5626776|P2|Overall Study|Lost to Follow-up|2
1612912|NCT02085135|5626777|P1|Overall Study|Lost to Follow-up|2
1612913|NCT02085135|5626776|P2|Overall Study|Adverse Event|7
1612914|NCT02085135|5626777|P1|Overall Study|Adverse Event|4
1612915|NCT02084238|5626849|P1|Overall Study|Lost to Follow-up|2
1612916|NCT02084134|5626874|P2|Overall Study|Death|1
1612917|NCT02084134|5626875|P1|Overall Study|Death|0
1612918|NCT02084134|5626874|P2|Overall Study|Protocol Violation|2
1612919|NCT02084134|5626875|P1|Overall Study|Protocol Violation|4
1612920|NCT02084082|5626885|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1612921|NCT02084082|5626886|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1612922|NCT02084082|5626887|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1612923|NCT02084082|5626888|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1612924|NCT02084082|5626885|P4|Washout Period 1 (35 Days)|Adverse Event|1
1612925|NCT02084082|5626886|P3|Washout Period 1 (35 Days)|Adverse Event|1
1612926|NCT02084082|5626887|P2|Washout Period 1 (35 Days)|Adverse Event|0
1612927|NCT02084082|5626888|P1|Washout Period 1 (35 Days)|Adverse Event|0
1612928|NCT02084056|5626929|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1612929|NCT02084056|5626930|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1612930|NCT02084056|5626931|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
1612931|NCT02084056|5626932|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
1612932|NCT02084056|5626929|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1612933|NCT02084056|5626930|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1612934|NCT02084056|5626931|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1612935|NCT02084056|5626932|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1612936|NCT02083965|5626964|P2|Treatment Period|Other|0
1612937|NCT02083965|5626965|P1|Treatment Period|Other|1
1612938|NCT02083653|5627060|P3|Overall Study|Reason Missing|4
1612939|NCT02083653|5627061|P2|Overall Study|Reason Missing|0
1612940|NCT02083653|5627062|P1|Overall Study|Reason Missing|0
1612941|NCT02083653|5627060|P3|Overall Study|Other Events|2
1612942|NCT02083653|5627061|P2|Overall Study|Other Events|2
1612943|NCT02083653|5627062|P1|Overall Study|Other Events|0
1612944|NCT02083653|5627060|P3|Overall Study|Withdrawal by Subject|2
1612945|NCT02083653|5627061|P2|Overall Study|Withdrawal by Subject|1
1612946|NCT02083653|5627062|P1|Overall Study|Withdrawal by Subject|2
1612947|NCT02083653|5627060|P3|Overall Study|Progressive Disease|63
1612948|NCT02083653|5627061|P2|Overall Study|Progressive Disease|73
1612949|NCT02083653|5627062|P1|Overall Study|Progressive Disease|65
1612950|NCT02083653|5627060|P3|Overall Study|Death|2
1612951|NCT02083653|5627061|P2|Overall Study|Death|2
1612952|NCT02083653|5627062|P1|Overall Study|Death|2
1612953|NCT02083653|5627060|P3|Overall Study|Lost to Follow-up|0
1612954|NCT02083653|5627061|P2|Overall Study|Lost to Follow-up|0
1612955|NCT02083653|5627062|P1|Overall Study|Lost to Follow-up|1
1612956|NCT02083653|5627060|P3|Overall Study|Adverse Event|4
1612957|NCT02083653|5627061|P2|Overall Study|Adverse Event|5
1612958|NCT02083653|5627062|P1|Overall Study|Adverse Event|12
1612959|NCT02083653|5627060|P3|Overall Study|Randomized but not Treated|7
1612960|NCT02083653|5627061|P2|Overall Study|Randomized but not Treated|2
1612961|NCT02083653|5627062|P1|Overall Study|Randomized but not Treated|0
1612962|NCT02083380|5627130|P3|Overall Study|Other|6
1612963|NCT02083380|5627131|P2|Overall Study|Other|4
1612964|NCT02083380|5627132|P1|Overall Study|Other|8
1612965|NCT02083380|5627130|P3|Overall Study|Lost to Follow-up|3
1612966|NCT02083380|5627131|P2|Overall Study|Lost to Follow-up|3
1612967|NCT02083380|5627132|P1|Overall Study|Lost to Follow-up|5
1612968|NCT02083380|5627130|P3|Overall Study|Adverse Event|1
1612969|NCT02083380|5627131|P2|Overall Study|Adverse Event|0
1612970|NCT02083380|5627132|P1|Overall Study|Adverse Event|0
1612971|NCT02083380|5627130|P3|Overall Study|Physician Decision|3
1612972|NCT02083380|5627131|P2|Overall Study|Physician Decision|6
1612973|NCT02083380|5627132|P1|Overall Study|Physician Decision|1
1612974|NCT02083380|5627130|P3|Overall Study|Withdrawal by Subject|7
1612975|NCT02083380|5627131|P2|Overall Study|Withdrawal by Subject|3
1612976|NCT02083380|5627132|P1|Overall Study|Withdrawal by Subject|9
1612977|NCT02083380|5627130|P3|Overall Study|Lack of Efficacy|64
1612978|NCT02083380|5627131|P2|Overall Study|Lack of Efficacy|79
1612979|NCT02083380|5627132|P1|Overall Study|Lack of Efficacy|68
1612980|NCT02083185|5627237|P3|Overall Study|Did not Receive Study Drug|0
1612981|NCT02083185|5627238|P2|Overall Study|Did not Receive Study Drug|2
1612982|NCT02083185|5627239|P1|Overall Study|Did not Receive Study Drug|0
1612983|NCT02083185|5627237|P3|Overall Study|Study Terminated by Sponsor|0
1612984|NCT02083185|5627238|P2|Overall Study|Study Terminated by Sponsor|1
1612985|NCT02083185|5627239|P1|Overall Study|Study Terminated by Sponsor|0
1612986|NCT02083185|5627237|P3|Overall Study|Reason not Specified|5
1612987|NCT02083185|5627238|P2|Overall Study|Reason not Specified|6
1612988|NCT02083185|5627239|P1|Overall Study|Reason not Specified|9
1612989|NCT02083185|5627237|P3|Overall Study|Death|1
1612990|NCT02083185|5627238|P2|Overall Study|Death|2
1612991|NCT02083185|5627239|P1|Overall Study|Death|2
1612992|NCT02083185|5627237|P3|Overall Study|Withdrawal by Subject|1
1612993|NCT02083185|5627238|P2|Overall Study|Withdrawal by Subject|15
1612994|NCT02083185|5627239|P1|Overall Study|Withdrawal by Subject|9
1612995|NCT02083185|5627237|P3|Overall Study|Lost to Follow-up|0
1612996|NCT02083185|5627238|P2|Overall Study|Lost to Follow-up|3
1612997|NCT02083185|5627239|P1|Overall Study|Lost to Follow-up|0
1613048|NCT02082912|5627607|P2|Overall Study|Physician Decision|1
1613049|NCT02082912|5627608|P1|Overall Study|Physician Decision|0
1613050|NCT02082522|5627643|P2|Overall Study|Chemotherapy change|3
1613051|NCT02082522|5627644|P1|Overall Study|Chemotherapy change|1
1613052|NCT02082522|5627643|P2|Overall Study|Disease progression|2
1613053|NCT02082522|5627644|P1|Overall Study|Disease progression|2
1613054|NCT02082522|5627643|P2|Overall Study|Physician Decision|1
1613055|NCT02082522|5627644|P1|Overall Study|Physician Decision|3
1613056|NCT02082522|5627643|P2|Overall Study|Lost to Follow-up|0
1613057|NCT02082522|5627644|P1|Overall Study|Lost to Follow-up|1
1613058|NCT02082522|5627643|P2|Overall Study|Death|0
1613059|NCT02082522|5627644|P1|Overall Study|Death|1
1613060|NCT02082522|5627643|P2|Overall Study|Withdrawal by Subject|4
1613061|NCT02082522|5627644|P1|Overall Study|Withdrawal by Subject|2
1613062|NCT02082522|5627643|P2|Overall Study|Sponsor termination|3
1613063|NCT02082522|5627644|P1|Overall Study|Sponsor termination|5
1613064|NCT02082483|5627694|P2|Overall Study|Death|3
1613065|NCT02082483|5627695|P1|Overall Study|Death|2
1613066|NCT02082483|5627694|P2|Overall Study|Physician Decision|1
1613067|NCT02082483|5627695|P1|Overall Study|Physician Decision|1
1613068|NCT02082483|5627694|P2|Overall Study|Withdrawal by Subject|1
1613069|NCT02082483|5627695|P1|Overall Study|Withdrawal by Subject|2
1613070|NCT02082483|5627694|P2|Overall Study|Lost to Follow-up|1
1613071|NCT02082483|5627695|P1|Overall Study|Lost to Follow-up|1
1613074|NCT02082262|5627758|P1|Overall Study|Adverse Event|48
1613075|NCT02082262|5627758|P1|Overall Study|Withdrawal by Subject|3
1613076|NCT02082184|5627764|P2|Overall Study|Subject non-compliance|1
1613077|NCT02082184|5627765|P1|Overall Study|Subject non-compliance|0
1613078|NCT02082184|5627764|P2|Overall Study|Lost to Follow-up|2
1613079|NCT02082184|5627765|P1|Overall Study|Lost to Follow-up|0
1613080|NCT02082184|5627764|P2|Overall Study|Protocol Violation|6
1613081|NCT02082184|5627765|P1|Overall Study|Protocol Violation|0
1613082|NCT02082184|5627764|P2|Overall Study|Withdrawal by Subject|2
1613083|NCT02082184|5627765|P1|Overall Study|Withdrawal by Subject|3
1613084|NCT02082184|5627764|P2|Overall Study|Device associated symptoms|0
1613085|NCT02082184|5627765|P1|Overall Study|Device associated symptoms|5
1613086|NCT02082184|5627764|P2|Overall Study|Medical diagnosis|2
1613087|NCT02082184|5627765|P1|Overall Study|Medical diagnosis|1
1613088|NCT02082184|5627764|P2|Overall Study|Adverse Event|0
1613089|NCT02082184|5627765|P1|Overall Study|Adverse Event|1
1613090|NCT02082158|5627790|P6|Overall Study|Failed Fit-testing|7
1613091|NCT02082158|5627791|P5|Overall Study|Failed Fit-testing|3
1613092|NCT02082158|5627792|P4|Overall Study|Failed Fit-testing|4
1613093|NCT02082158|5627793|P3|Overall Study|Failed Fit-testing|14
1613094|NCT02082158|5627794|P2|Overall Study|Failed Fit-testing|8
1613095|NCT02082158|5627795|P1|Overall Study|Failed Fit-testing|8
1613096|NCT02082158|5627790|P6|Overall Study|Withdrawal by Subject|0
1613097|NCT02082158|5627791|P5|Overall Study|Withdrawal by Subject|1
1613098|NCT02082158|5627792|P4|Overall Study|Withdrawal by Subject|0
1613099|NCT02082158|5627793|P3|Overall Study|Withdrawal by Subject|0
1613100|NCT02082158|5627794|P2|Overall Study|Withdrawal by Subject|0
1613101|NCT02082158|5627795|P1|Overall Study|Withdrawal by Subject|0
1613102|NCT02081859|5627849|P2|Overall Study|Other reasons|0
1613103|NCT02081859|5627850|P1|Overall Study|Other reasons|2
1613104|NCT02081859|5627849|P2|Overall Study|< 4 embryos|23
1613105|NCT02081859|5627850|P1|Overall Study|< 4 embryos|27
1613106|NCT02081859|5627849|P2|Overall Study|Unanticipated freeze all cycle|6
1613107|NCT02081859|5627850|P1|Overall Study|Unanticipated freeze all cycle|2
1613108|NCT02081859|5627849|P2|Overall Study|No sperm|0
1613109|NCT02081859|5627850|P1|Overall Study|No sperm|1
1613110|NCT02081859|5627849|P2|Overall Study|No fertilization|2
1613111|NCT02081859|5627850|P1|Overall Study|No fertilization|2
1613112|NCT02081846|5627860|P2|Overall Study|invalid consent|0
1613113|NCT02081846|5627861|P1|Overall Study|invalid consent|1
1613114|NCT02081846|5627860|P2|Overall Study|Withdrawal by Subject|0
1613115|NCT02081846|5627861|P1|Overall Study|Withdrawal by Subject|1
1613116|NCT02081690|5628030|P1|Overall Study|Withdrawal by Subject|1
1613117|NCT02081690|5628030|P1|Overall Study|Physician Decision|3
1613118|NCT02081690|5628030|P1|Overall Study|Death|3
1613119|NCT02081677|5628041|P4|Overall Study|Unsatisfactory Lens Fitting|0
1613120|NCT02081677|5628042|P3|Overall Study|Unsatisfactory Lens Fitting|0
1613121|NCT02081677|5628043|P2|Overall Study|Unsatisfactory Lens Fitting|1
1613122|NCT02081677|5628044|P1|Overall Study|Unsatisfactory Lens Fitting|0
1613123|NCT02081677|5628041|P4|Overall Study|Not comfortable with lens care system|0
1613124|NCT02081677|5628042|P3|Overall Study|Not comfortable with lens care system|0
1613125|NCT02081677|5628043|P2|Overall Study|Not comfortable with lens care system|0
1613126|NCT02081677|5628044|P1|Overall Study|Not comfortable with lens care system|1
1613127|NCT02081677|5628041|P4|Overall Study|No Longer Meets Eligibility Criteria|0
1613128|NCT02081677|5628042|P3|Overall Study|No Longer Meets Eligibility Criteria|1
1613129|NCT02081677|5628043|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1613130|NCT02081677|5628044|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1613131|NCT02081677|5628041|P4|Overall Study|Adverse Event|0
1613132|NCT02081677|5628042|P3|Overall Study|Adverse Event|1
1613133|NCT02081677|5628043|P2|Overall Study|Adverse Event|0
1613134|NCT02081677|5628044|P1|Overall Study|Adverse Event|0
1613135|NCT02081599|5628136|P2|Period 2：Open-label Period|Withdrawal by Subject|0
1613136|NCT02081599|5628137|P1|Period 2：Open-label Period|Withdrawal by Subject|2
1613137|NCT02081599|5628136|P2|Period 2：Open-label Period|Physician Decision|0
1613138|NCT02081599|5628137|P1|Period 2：Open-label Period|Physician Decision|1
1613139|NCT02081599|5628136|P2|Period 2：Open-label Period|Lack of Efficacy|4
1613140|NCT02081599|5628137|P1|Period 2：Open-label Period|Lack of Efficacy|2
1613141|NCT02081599|5628136|P2|Period 2：Open-label Period|Adverse Event|0
1613142|NCT02081599|5628137|P1|Period 2：Open-label Period|Adverse Event|1
1613143|NCT02081599|5628136|P2|Period 1：Double-blind Period|stopping criteria|0
1613144|NCT02081599|5628137|P1|Period 1：Double-blind Period|stopping criteria|1
1613145|NCT02081599|5628136|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
1613146|NCT02081599|5628137|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
1613147|NCT02081599|5628136|P2|Period 1：Double-blind Period|Protocol Violation|1
1613148|NCT02081599|5628137|P1|Period 1：Double-blind Period|Protocol Violation|0
1613149|NCT02081599|5628136|P2|Period 1：Double-blind Period|Physician Decision|0
1613150|NCT02081599|5628137|P1|Period 1：Double-blind Period|Physician Decision|1
1613151|NCT02081599|5628136|P2|Period 1：Double-blind Period|Lack of Efficacy|1
1613152|NCT02081599|5628137|P1|Period 1：Double-blind Period|Lack of Efficacy|2
1613153|NCT02081599|5628136|P2|Period 1：Double-blind Period|Adverse Event|0
1613154|NCT02081599|5628137|P1|Period 1：Double-blind Period|Adverse Event|3
1613155|NCT02081586|5628155|P4|Overall Study|Head injury not related to study|0
1613156|NCT02081586|5628156|P3|Overall Study|Head injury not related to study|1
1613157|NCT02081586|5628157|P2|Overall Study|Head injury not related to study|0
1613158|NCT02081586|5628158|P1|Overall Study|Head injury not related to study|0
1613159|NCT02081586|5628155|P4|Overall Study|Lost to Follow-up|1
1613160|NCT02081586|5628156|P3|Overall Study|Lost to Follow-up|0
1613161|NCT02081586|5628157|P2|Overall Study|Lost to Follow-up|1
1613162|NCT02081586|5628158|P1|Overall Study|Lost to Follow-up|0
1613163|NCT02081417|5628224|P2|Overall Study|Did not start treatment|21
1613164|NCT02081417|5628225|P1|Overall Study|Did not start treatment|17
1613165|NCT02081417|5628224|P2|Overall Study|Admitted to Residential Treatment|0
1613166|NCT02081417|5628225|P1|Overall Study|Admitted to Residential Treatment|2
1613167|NCT02081417|5628224|P2|Overall Study|Withdrawal by Subject|0
1613168|NCT02081417|5628225|P1|Overall Study|Withdrawal by Subject|4
1613169|NCT02081417|5628224|P2|Overall Study|Death|3
1613170|NCT02081417|5628225|P1|Overall Study|Death|4
1613171|NCT02081417|5628224|P2|Overall Study|Incarcerated|2
1613172|NCT02081417|5628225|P1|Overall Study|Incarcerated|2
1613173|NCT02081417|5628224|P2|Overall Study|Moved Away|2
1613174|NCT02081417|5628225|P1|Overall Study|Moved Away|1
1613175|NCT02081417|5628224|P2|Overall Study|Lost to Follow-up|23
1613176|NCT02081417|5628225|P1|Overall Study|Lost to Follow-up|26
1613177|NCT02081391|5628245|P4|24-hour Treatment and Trial Completion|Further reasons|0
1613178|NCT02081391|5628246|P3|24-hour Treatment and Trial Completion|Further reasons|0
1613179|NCT02081391|5628247|P2|24-hour Treatment and Trial Completion|Further reasons|4
1613180|NCT02081391|5628248|P1|24-hour Treatment and Trial Completion|Further reasons|3
1613181|NCT02081391|5628245|P4|24-hour Treatment and Trial Completion|Technical Problems|0
1613182|NCT02081391|5628246|P3|24-hour Treatment and Trial Completion|Technical Problems|0
1613183|NCT02081391|5628247|P2|24-hour Treatment and Trial Completion|Technical Problems|1
1613184|NCT02081391|5628248|P1|24-hour Treatment and Trial Completion|Technical Problems|1
1613185|NCT02081391|5628245|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
1613186|NCT02081391|5628246|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
1613187|NCT02081391|5628247|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
1613188|NCT02081391|5628248|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
1613189|NCT02081391|5628245|P4|24-hour Treatment and Trial Completion|Adverse Event|0
1613190|NCT02081391|5628246|P3|24-hour Treatment and Trial Completion|Adverse Event|0
1613191|NCT02081391|5628247|P2|24-hour Treatment and Trial Completion|Adverse Event|0
1613192|NCT02081391|5628248|P1|24-hour Treatment and Trial Completion|Adverse Event|1
1613193|NCT02081391|5628245|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
1613194|NCT02081391|5628246|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
1613195|NCT02081391|5628247|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
1613196|NCT02081391|5628248|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
1613197|NCT02081391|5628245|P4|24-hour Treatment and Trial Completion|Physician Decision|0
1613198|NCT02081391|5628246|P3|24-hour Treatment and Trial Completion|Physician Decision|0
1613199|NCT02081391|5628247|P2|24-hour Treatment and Trial Completion|Physician Decision|5
1613200|NCT02081391|5628248|P1|24-hour Treatment and Trial Completion|Physician Decision|10
1613201|NCT02081391|5628245|P4|12-hour Treatment|Further reasons|0
1613202|NCT02081391|5628246|P3|12-hour Treatment|Further reasons|0
1613203|NCT02081391|5628247|P2|12-hour Treatment|Further reasons|1
1613204|NCT02081391|5628248|P1|12-hour Treatment|Further reasons|2
1613205|NCT02081391|5628245|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
1613206|NCT02081391|5628246|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
1613207|NCT02081391|5628247|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
1613208|NCT02081391|5628248|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
1613209|NCT02081391|5628245|P4|12-hour Treatment|Adverse Event|0
1613210|NCT02081391|5628246|P3|12-hour Treatment|Adverse Event|0
1613211|NCT02081391|5628247|P2|12-hour Treatment|Adverse Event|2
1613212|NCT02081391|5628248|P1|12-hour Treatment|Adverse Event|4
1613213|NCT02081391|5628245|P4|12-hour Treatment|Lack of Efficacy|0
1613214|NCT02081391|5628246|P3|12-hour Treatment|Lack of Efficacy|0
1613215|NCT02081391|5628247|P2|12-hour Treatment|Lack of Efficacy|0
1613216|NCT02081391|5628248|P1|12-hour Treatment|Lack of Efficacy|3
1613217|NCT02081391|5628245|P4|12-hour Treatment|Physician Decision|0
1613218|NCT02081391|5628246|P3|12-hour Treatment|Physician Decision|0
1613219|NCT02081391|5628247|P2|12-hour Treatment|Physician Decision|1
1613220|NCT02081391|5628248|P1|12-hour Treatment|Physician Decision|4
1613221|NCT02081391|5628245|P4|12-hour Treatment|Withdrawal by Subject|0
1613222|NCT02081391|5628246|P3|12-hour Treatment|Withdrawal by Subject|0
1613223|NCT02081391|5628247|P2|12-hour Treatment|Withdrawal by Subject|2
1613224|NCT02081391|5628248|P1|12-hour Treatment|Withdrawal by Subject|3
1613225|NCT02081183|5628342|P2|Overall Study|Other|3
1613226|NCT02081183|5628343|P1|Overall Study|Other|3
1613227|NCT02081183|5628342|P2|Overall Study|Protocol Violation|0
1613228|NCT02081183|5628343|P1|Overall Study|Protocol Violation|1
1613229|NCT02081183|5628342|P2|Overall Study|Lost to Follow-up|1
1613230|NCT02081183|5628343|P1|Overall Study|Lost to Follow-up|0
1613231|NCT02081079|5628359|P2|Overall Study|Lost to Follow-up|0
1613232|NCT02081079|5628360|P1|Overall Study|Lost to Follow-up|1
1613233|NCT02081079|5628359|P2|Overall Study|Lack of Efficacy|2
1613234|NCT02081079|5628360|P1|Overall Study|Lack of Efficacy|3
1613235|NCT02081001|5628433|P12|Overall Study|Adverse Event|0
1613236|NCT02081001|5628434|P11|Overall Study|Adverse Event|0
1613237|NCT02081001|5628435|P10|Overall Study|Adverse Event|0
1613238|NCT02081001|5628436|P9|Overall Study|Adverse Event|0
1613239|NCT02081001|5628437|P8|Overall Study|Adverse Event|0
1613240|NCT02081001|5628438|P7|Overall Study|Adverse Event|0
1613241|NCT02081001|5628439|P6|Overall Study|Adverse Event|0
1613242|NCT02081001|5628440|P5|Overall Study|Adverse Event|1
1613243|NCT02081001|5628441|P4|Overall Study|Adverse Event|0
1613244|NCT02081001|5628442|P3|Overall Study|Adverse Event|0
1613245|NCT02081001|5628443|P2|Overall Study|Adverse Event|0
1613246|NCT02081001|5628444|P1|Overall Study|Adverse Event|0
1613247|NCT02080871|5628508|P1|Overall Study|Lost to Follow-up|1
1613248|NCT02080871|5628508|P1|Overall Study|Death|1
1613249|NCT02080832|5628592|P3|Overall Study|Lost to Follow-up|2
1613250|NCT02080832|5628593|P2|Overall Study|Lost to Follow-up|2
1613251|NCT02080832|5628594|P1|Overall Study|Lost to Follow-up|0
1613252|NCT02080832|5628592|P3|Overall Study|Excluded from analysis by MRI|14
1613253|NCT02080832|5628593|P2|Overall Study|Excluded from analysis by MRI|10
1613254|NCT02080832|5628594|P1|Overall Study|Excluded from analysis by MRI|9
1613255|NCT02080481|5628666|P2|Overall Study|Never received a block.|0
1613256|NCT02080481|5628667|P1|Overall Study|Never received a block.|1
1613257|NCT02080260|5628786|P1|Overall Study|Withdrawal by Subject|1
1613258|NCT02080260|5628786|P1|Overall Study|Death|18
1613259|NCT02080091|5628803|P1|Overall Study|Other|1
1613260|NCT02080091|5628803|P1|Overall Study|Withdrawal by Subject|1
1613261|NCT02080091|5628803|P1|Overall Study|Death|1
1613262|NCT02080091|5628803|P1|Overall Study|Study Terminated|22
1613263|NCT02079909|5628831|P3|Overall Study|Relocation etc.|3
1613264|NCT02079909|5628832|P2|Overall Study|Relocation etc.|2
1613265|NCT02079909|5628833|P1|Overall Study|Relocation etc.|2
1613266|NCT02079909|5628831|P3|Overall Study|Physician Decision|1
1613267|NCT02079909|5628832|P2|Overall Study|Physician Decision|1
1613268|NCT02079909|5628833|P1|Overall Study|Physician Decision|0
1613269|NCT02079909|5628831|P3|Overall Study|Protocol Violation|1
1613270|NCT02079909|5628832|P2|Overall Study|Protocol Violation|1
1613271|NCT02079909|5628833|P1|Overall Study|Protocol Violation|0
1613272|NCT02079909|5628831|P3|Overall Study|Lack of Efficacy|1
1613273|NCT02079909|5628832|P2|Overall Study|Lack of Efficacy|0
1613274|NCT02079909|5628833|P1|Overall Study|Lack of Efficacy|0
1613275|NCT02079909|5628831|P3|Overall Study|Death|0
1613276|NCT02079909|5628832|P2|Overall Study|Death|2
1613277|NCT02079909|5628833|P1|Overall Study|Death|2
1613278|NCT02079909|5628831|P3|Overall Study|Lost to Follow-up|1
1613279|NCT02079909|5628832|P2|Overall Study|Lost to Follow-up|3
1613280|NCT02079909|5628833|P1|Overall Study|Lost to Follow-up|2
1613281|NCT02079909|5628831|P3|Overall Study|Withdrawal by Subject|4
1613282|NCT02079909|5628832|P2|Overall Study|Withdrawal by Subject|17
1613283|NCT02079909|5628833|P1|Overall Study|Withdrawal by Subject|9
1613284|NCT02079909|5628831|P3|Overall Study|Adverse Event|7
1613285|NCT02079909|5628832|P2|Overall Study|Adverse Event|23
1613286|NCT02079909|5628833|P1|Overall Study|Adverse Event|23
1613287|NCT02079844|5628850|P3|Treatment Period 2|Voluntary Withdrawal|0
1613288|NCT02079844|5628851|P2|Treatment Period 2|Voluntary Withdrawal|1
1613289|NCT02079844|5628852|P1|Treatment Period 2|Voluntary Withdrawal|0
1613290|NCT02079844|5628850|P3|Treatment Period 1|Voluntary Withdrawal|2
1613291|NCT02079844|5628851|P2|Treatment Period 1|Voluntary Withdrawal|0
1613292|NCT02079844|5628852|P1|Treatment Period 1|Voluntary Withdrawal|0
1613293|NCT02079805|5628910|P2|Overall Study|Voluntary Withdrawal|1
1613294|NCT02079805|5628911|P1|Overall Study|Voluntary Withdrawal|0
1613295|NCT02079805|5628910|P2|Overall Study|Pretreatment Event/Adverse Event|1
1613296|NCT02079805|5628911|P1|Overall Study|Pretreatment Event/Adverse Event|0
1613297|NCT02079649|5628933|P4|Overall Study|Randomization error (prior to treatment)|0
1613298|NCT02079649|5628934|P3|Overall Study|Randomization error (prior to treatment)|1
1613299|NCT02079649|5628935|P2|Overall Study|Randomization error (prior to treatment)|0
1613300|NCT02079649|5628936|P1|Overall Study|Randomization error (prior to treatment)|1
1613301|NCT02079649|5628933|P4|Overall Study|Withdrawal by Subject|1
1613302|NCT02079649|5628934|P3|Overall Study|Withdrawal by Subject|0
1613303|NCT02079649|5628935|P2|Overall Study|Withdrawal by Subject|0
1613304|NCT02079649|5628936|P1|Overall Study|Withdrawal by Subject|0
1613305|NCT02079649|5628933|P4|Overall Study|Lost to Follow-up|1
1613306|NCT02079649|5628934|P3|Overall Study|Lost to Follow-up|0
1613307|NCT02079649|5628935|P2|Overall Study|Lost to Follow-up|0
1613308|NCT02079649|5628936|P1|Overall Study|Lost to Follow-up|0
1613309|NCT02079610|5628953|P2|Overall Study|Withdrawal by Subject|1
1613310|NCT02079610|5628954|P1|Overall Study|Withdrawal by Subject|1
1613311|NCT02079532|5628964|P1|Overall Study|Other|3
1613312|NCT02079532|5628964|P1|Overall Study|Inclusion into ReFIRST|3
1613313|NCT02079532|5628964|P1|Overall Study|Administrative problems|1
1613314|NCT02079532|5628964|P1|Overall Study|Withdrawal by Subject|1
1613315|NCT02079532|5628964|P1|Overall Study|Protocol Violation|3
1613316|NCT02079532|5628964|P1|Overall Study|Lack of Efficacy|9
1613317|NCT02079532|5628964|P1|Overall Study|Additional or changed therapy|2
1613318|NCT02079532|5628964|P1|Overall Study|Adverse Event|7
1613319|NCT02079519|5628986|P1|Overall Study|Adverse Event|1
1613320|NCT02079519|5628986|P1|Overall Study|Disease Progression|9
1613321|NCT02079246|5628999|P2|OLEX-MEM|Other: Moved to nursing home|3
1613322|NCT02079246|5629000|P1|OLEX-MEM|Other: Moved to nursing home|0
1613323|NCT02079246|5628999|P2|OLEX-MEM|Lost to Follow-up|1
1613324|NCT02079246|5629000|P1|OLEX-MEM|Lost to Follow-up|0
1613325|NCT02079246|5628999|P2|OLEX-MEM|Protocol Violation|2
1613326|NCT02079246|5629000|P1|OLEX-MEM|Protocol Violation|0
1613327|NCT02079246|5628999|P2|OLEX-MEM|Withdrawal by Subject|7
1613328|NCT02079246|5629000|P1|OLEX-MEM|Withdrawal by Subject|0
1613329|NCT02079246|5628999|P2|OLEX-MEM|Adverse Event|6
1613330|NCT02079246|5629000|P1|OLEX-MEM|Adverse Event|0
1613331|NCT02079246|5628999|P2|OLEX|Other: Withdrawal of caregiver consent|0
1613332|NCT02079246|5629000|P1|OLEX|Other: Withdrawal of caregiver consent|1
1613333|NCT02079246|5628999|P2|OLEX|Other: Moved to nursing home|0
1613334|NCT02079246|5629000|P1|OLEX|Other: Moved to nursing home|1
1613335|NCT02079246|5628999|P2|OLEX|Other: Worsening of condition|0
1613336|NCT02079246|5629000|P1|OLEX|Other: Worsening of condition|1
1613337|NCT02079246|5628999|P2|OLEX|Other: Coordinator decision|0
1613338|NCT02079246|5629000|P1|OLEX|Other: Coordinator decision|1
1613339|NCT02079246|5628999|P2|OLEX|Other: Caregiver unavailable|0
1613340|NCT02079246|5629000|P1|OLEX|Other: Caregiver unavailable|3
1613341|NCT02079246|5628999|P2|OLEX|Other: Insufficient compliance|0
1613342|NCT02079246|5629000|P1|OLEX|Other: Insufficient compliance|2
1613343|NCT02079246|5628999|P2|OLEX|Other: Disallowed medication|0
1613344|NCT02079246|5629000|P1|OLEX|Other: Disallowed medication|8
1613345|NCT02079246|5628999|P2|OLEX|Results of the lead-in studies|0
1613346|NCT02079246|5629000|P1|OLEX|Results of the lead-in studies|58
1613347|NCT02079246|5628999|P2|OLEX|Lack of Efficacy|0
1613348|NCT02079246|5629000|P1|OLEX|Lack of Efficacy|3
1613349|NCT02079246|5628999|P2|OLEX|Protocol Violation|0
1613350|NCT02079246|5629000|P1|OLEX|Protocol Violation|6
1613351|NCT02079246|5628999|P2|OLEX|Lost to Follow-up|0
1613352|NCT02079246|5629000|P1|OLEX|Lost to Follow-up|6
1613353|NCT02079246|5628999|P2|OLEX|Withdrawal by Subject|0
1613354|NCT02079246|5629000|P1|OLEX|Withdrawal by Subject|60
1613355|NCT02079246|5628999|P2|OLEX|Adverse Event|0
1613356|NCT02079246|5629000|P1|OLEX|Adverse Event|66
1613357|NCT02079246|5628999|P2|OLEX|Death|0
1613358|NCT02079246|5629000|P1|OLEX|Death|11
1613359|NCT02079246|5628999|P2|OLEX|Withdrawal before treatment|0
1613360|NCT02079246|5629000|P1|OLEX|Withdrawal before treatment|1
1613361|NCT02079077|5629019|P2|Overall Study|Became STIs Positive|2
1613362|NCT02079077|5629020|P1|Overall Study|Became STIs Positive|1
1613363|NCT02079077|5629019|P2|Overall Study|Lost to Follow-up|7
1613364|NCT02079077|5629020|P1|Overall Study|Lost to Follow-up|5
1613365|NCT02078960|5629043|P3|Follow-up Period|Lost to Follow-up|0
1613366|NCT02078960|5629044|P2|Follow-up Period|Lost to Follow-up|1
1613367|NCT02078960|5629045|P1|Follow-up Period|Lost to Follow-up|0
1613368|NCT02078960|5629043|P3|Follow-up Period|Death|0
1613369|NCT02078960|5629044|P2|Follow-up Period|Death|0
1613370|NCT02078960|5629045|P1|Follow-up Period|Death|2
1613371|NCT02078960|5629043|P3|Treatment Period|Death|1
1613372|NCT02078960|5629044|P2|Treatment Period|Death|0
1613373|NCT02078960|5629045|P1|Treatment Period|Death|0
1613374|NCT02078960|5629043|P3|Treatment Period|Adverse Event|0
1613375|NCT02078960|5629044|P2|Treatment Period|Adverse Event|0
1613376|NCT02078960|5629045|P1|Treatment Period|Adverse Event|1
1613377|NCT02078960|5629043|P3|Treatment Period|Withdrawal by Subject|1
1613378|NCT02078960|5629044|P2|Treatment Period|Withdrawal by Subject|1
1613379|NCT02078960|5629045|P1|Treatment Period|Withdrawal by Subject|0
1613380|NCT02078960|5629043|P3|Treatment Period|Disease progression - blast phase|0
1613381|NCT02078960|5629044|P2|Treatment Period|Disease progression - blast phase|0
1613382|NCT02078960|5629045|P1|Treatment Period|Disease progression - blast phase|1
1613383|NCT02078960|5629043|P3|Treatment Period|Disease progression - accelerated phase|0
1613384|NCT02078960|5629044|P2|Treatment Period|Disease progression - accelerated phase|1
1613385|NCT02078960|5629045|P1|Treatment Period|Disease progression - accelerated phase|0
1613386|NCT02078960|5629043|P3|Treatment Period|Lack of Efficacy|0
1613387|NCT02078960|5629044|P2|Treatment Period|Lack of Efficacy|1
1613388|NCT02078960|5629045|P1|Treatment Period|Lack of Efficacy|0
1613389|NCT02078960|5629043|P3|Treatment Period|Other|1
1613390|NCT02078960|5629044|P2|Treatment Period|Other|0
1613391|NCT02078960|5629045|P1|Treatment Period|Other|0
1613392|NCT02078817|5629067|P1|Overall Study|Withdrawal by Subject|1
1613393|NCT02078752|5629089|P10|Overall Study|Study terminated by sponsor|5
1613394|NCT02078752|5629090|P9|Overall Study|Study terminated by sponsor|0
1613395|NCT02078752|5629091|P8|Overall Study|Study terminated by sponsor|0
1613396|NCT02078752|5629092|P7|Overall Study|Study terminated by sponsor|0
1613397|NCT02078752|5629093|P6|Overall Study|Study terminated by sponsor|0
1613398|NCT02078752|5629094|P5|Overall Study|Study terminated by sponsor|0
1613399|NCT02078752|5629095|P4|Overall Study|Study terminated by sponsor|0
1613400|NCT02078752|5629096|P3|Overall Study|Study terminated by sponsor|0
1613401|NCT02078752|5629097|P2|Overall Study|Study terminated by sponsor|0
1613402|NCT02078752|5629098|P1|Overall Study|Study terminated by sponsor|0
1613403|NCT02078752|5629089|P10|Overall Study|Other|0
1613404|NCT02078752|5629090|P9|Overall Study|Other|0
1613405|NCT02078752|5629091|P8|Overall Study|Other|1
1613406|NCT02078752|5629092|P7|Overall Study|Other|0
1613407|NCT02078752|5629093|P6|Overall Study|Other|0
1613408|NCT02078752|5629094|P5|Overall Study|Other|1
1613409|NCT02078752|5629095|P4|Overall Study|Other|0
1613410|NCT02078752|5629096|P3|Overall Study|Other|0
1613411|NCT02078752|5629097|P2|Overall Study|Other|3
1613412|NCT02078752|5629098|P1|Overall Study|Other|0
1613413|NCT02078752|5629089|P10|Overall Study|Withdrawal by Subject|1
1613414|NCT02078752|5629090|P9|Overall Study|Withdrawal by Subject|0
1613415|NCT02078752|5629091|P8|Overall Study|Withdrawal by Subject|1
1613416|NCT02078752|5629092|P7|Overall Study|Withdrawal by Subject|2
1613417|NCT02078752|5629093|P6|Overall Study|Withdrawal by Subject|3
1613418|NCT02078752|5629094|P5|Overall Study|Withdrawal by Subject|0
1613419|NCT02078752|5629095|P4|Overall Study|Withdrawal by Subject|1
1613420|NCT02078752|5629096|P3|Overall Study|Withdrawal by Subject|1
1613421|NCT02078752|5629097|P2|Overall Study|Withdrawal by Subject|1
1613422|NCT02078752|5629098|P1|Overall Study|Withdrawal by Subject|1
1613423|NCT02078752|5629089|P10|Overall Study|Lost to Follow-up|0
1613424|NCT02078752|5629090|P9|Overall Study|Lost to Follow-up|0
1613425|NCT02078752|5629091|P8|Overall Study|Lost to Follow-up|0
1613426|NCT02078752|5629092|P7|Overall Study|Lost to Follow-up|0
1613427|NCT02078752|5629093|P6|Overall Study|Lost to Follow-up|0
1613428|NCT02078752|5629094|P5|Overall Study|Lost to Follow-up|0
1613429|NCT02078752|5629095|P4|Overall Study|Lost to Follow-up|1
1613430|NCT02078752|5629096|P3|Overall Study|Lost to Follow-up|0
1613431|NCT02078752|5629097|P2|Overall Study|Lost to Follow-up|0
1613432|NCT02078752|5629098|P1|Overall Study|Lost to Follow-up|1
1613433|NCT02078752|5629089|P10|Overall Study|Death|4
1613434|NCT02078752|5629090|P9|Overall Study|Death|0
1613435|NCT02078752|5629091|P8|Overall Study|Death|1
1613436|NCT02078752|5629092|P7|Overall Study|Death|0
1613437|NCT02078752|5629093|P6|Overall Study|Death|1
1613438|NCT02078752|5629094|P5|Overall Study|Death|0
1613439|NCT02078752|5629095|P4|Overall Study|Death|0
1613440|NCT02078752|5629096|P3|Overall Study|Death|0
1613441|NCT02078752|5629097|P2|Overall Study|Death|3
1613442|NCT02078752|5629098|P1|Overall Study|Death|0
1613443|NCT02078713|5629374|P4|Overall Study|Enrolled twice|0
1613444|NCT02078713|5629375|P3|Overall Study|Enrolled twice|0
1613445|NCT02078713|5629376|P2|Overall Study|Enrolled twice|1
1613446|NCT02078713|5629377|P1|Overall Study|Enrolled twice|0
1613447|NCT02078713|5629374|P4|Overall Study|Pregnant at baseline|0
1613448|NCT02078713|5629375|P3|Overall Study|Pregnant at baseline|0
1613449|NCT02078713|5629376|P2|Overall Study|Pregnant at baseline|5
1613450|NCT02078713|5629377|P1|Overall Study|Pregnant at baseline|3
1613451|NCT02078713|5629374|P4|Overall Study|Lost to Follow-up|0
1613452|NCT02078713|5629375|P3|Overall Study|Lost to Follow-up|0
1613453|NCT02078713|5629376|P2|Overall Study|Lost to Follow-up|55
1613454|NCT02078713|5629377|P1|Overall Study|Lost to Follow-up|49
1613455|NCT02078219|5629462|P5|Overall Study|Adverse Event|0
1613456|NCT02078219|5629463|P4|Overall Study|Adverse Event|1
1613457|NCT02078219|5629464|P3|Overall Study|Adverse Event|3
1613458|NCT02078219|5629465|P2|Overall Study|Adverse Event|1
1613459|NCT02078219|5629466|P1|Overall Study|Adverse Event|1
1613460|NCT02078219|5629462|P5|Overall Study|Death|0
1613461|NCT02078219|5629463|P4|Overall Study|Death|1
1613462|NCT02078219|5629464|P3|Overall Study|Death|0
1613463|NCT02078219|5629465|P2|Overall Study|Death|0
1613464|NCT02078219|5629466|P1|Overall Study|Death|0
1613465|NCT02078219|5629462|P5|Overall Study|Protocol Violation|0
1613466|NCT02078219|5629463|P4|Overall Study|Protocol Violation|1
1613467|NCT02078219|5629464|P3|Overall Study|Protocol Violation|0
1613468|NCT02078219|5629465|P2|Overall Study|Protocol Violation|0
1613469|NCT02078219|5629466|P1|Overall Study|Protocol Violation|0
1613470|NCT02078219|5629462|P5|Overall Study|Withdrawal by Subject|1
1613471|NCT02078219|5629463|P4|Overall Study|Withdrawal by Subject|1
1613472|NCT02078219|5629464|P3|Overall Study|Withdrawal by Subject|0
1613473|NCT02078219|5629465|P2|Overall Study|Withdrawal by Subject|1
1613474|NCT02078219|5629466|P1|Overall Study|Withdrawal by Subject|0
1613475|NCT02078219|5629462|P5|Overall Study|Other|1
1613476|NCT02078219|5629463|P4|Overall Study|Other|0
1613477|NCT02078219|5629464|P3|Overall Study|Other|3
1613478|NCT02078219|5629465|P2|Overall Study|Other|2
1613479|NCT02078219|5629466|P1|Overall Study|Other|2
1613480|NCT02077374|5629516|P2|Overall Study|Protocol Violation|1
1613481|NCT02077374|5629517|P1|Overall Study|Protocol Violation|0
1613482|NCT02077374|5629516|P2|Overall Study|Withdrawal by Subject|1
1613483|NCT02077374|5629517|P1|Overall Study|Withdrawal by Subject|0
1613484|NCT02077140|5629538|P5|Overall Study|Withdrawal by Subject|2
1613485|NCT02077140|5629539|P4|Overall Study|Withdrawal by Subject|2
1613486|NCT02077140|5629540|P3|Overall Study|Withdrawal by Subject|0
1613487|NCT02077140|5629541|P2|Overall Study|Withdrawal by Subject|1
1613488|NCT02077140|5629542|P1|Overall Study|Withdrawal by Subject|0
1613489|NCT02077140|5629538|P5|Overall Study|Lost to Follow-up|3
1613490|NCT02077140|5629539|P4|Overall Study|Lost to Follow-up|2
1613491|NCT02077140|5629540|P3|Overall Study|Lost to Follow-up|2
1613492|NCT02077140|5629541|P2|Overall Study|Lost to Follow-up|1
1613493|NCT02077140|5629542|P1|Overall Study|Lost to Follow-up|4
1613494|NCT02076334|5629820|P4|Overall Study|muscle soreness|1
1613495|NCT02076334|5629821|P3|Overall Study|muscle soreness|0
1613496|NCT02076334|5629822|P2|Overall Study|muscle soreness|0
1613497|NCT02076334|5629823|P1|Overall Study|muscle soreness|0
1613498|NCT02076334|5629820|P4|Overall Study|Lost to Follow-up|0
1613499|NCT02076334|5629821|P3|Overall Study|Lost to Follow-up|1
1613500|NCT02076334|5629822|P2|Overall Study|Lost to Follow-up|1
1613501|NCT02076334|5629823|P1|Overall Study|Lost to Follow-up|0
1613502|NCT02076334|5629820|P4|Overall Study|Protocol Violation|0
1613503|NCT02076334|5629821|P3|Overall Study|Protocol Violation|0
1613504|NCT02076334|5629822|P2|Overall Study|Protocol Violation|0
1613505|NCT02076334|5629823|P1|Overall Study|Protocol Violation|1
1613506|NCT02076178|5629856|P2|Injection Phase|Lost to Follow-up|1
1613507|NCT02076178|5629857|P1|Injection Phase|Lost to Follow-up|0
1613508|NCT02076178|5629856|P2|Injection Phase|Physician Decision|3
1613509|NCT02076178|5629857|P1|Injection Phase|Physician Decision|0
1613510|NCT02076178|5629856|P2|Injection Phase|Withdrawal by Subject|3
1613511|NCT02076178|5629857|P1|Injection Phase|Withdrawal by Subject|0
1613512|NCT02076178|5629856|P2|Injection Phase|Protocol defined stopping criteria|0
1613513|NCT02076178|5629857|P1|Injection Phase|Protocol defined stopping criteria|1
1613514|NCT02076178|5629856|P2|Oral Phase|Physician Decision|1
1613515|NCT02076178|5629857|P1|Oral Phase|Physician Decision|0
1613516|NCT02076178|5629856|P2|Oral Phase|Withdrawal by Subject|4
1613517|NCT02076178|5629857|P1|Oral Phase|Withdrawal by Subject|0
1613518|NCT02076178|5629856|P2|Oral Phase|Adverse Event|7
1613519|NCT02076178|5629857|P1|Oral Phase|Adverse Event|0
1613520|NCT02076165|5629891|P2|Overall Study|Refused follow-up assessment|1
1613521|NCT02076165|5629892|P1|Overall Study|Refused follow-up assessment|1
1613522|NCT02076165|5629891|P2|Overall Study|Lost to Follow-up|5
1613523|NCT02076165|5629892|P1|Overall Study|Lost to Follow-up|7
1613524|NCT02076022|5629962|P2|Overall Study|Withdrawal by Subject|0
1613525|NCT02076022|5629963|P1|Overall Study|Withdrawal by Subject|2
1613526|NCT02076009|5629975|P2|Overall Study|Subjects randomized but not treated|3
1613527|NCT02076009|5629976|P1|Overall Study|Subjects randomized but not treated|2
1613528|NCT02076009|5629975|P2|Overall Study|Ongoing|249
1613529|NCT02076009|5629976|P1|Overall Study|Ongoing|226
1613530|NCT02076009|5629975|P2|Overall Study|Progressive disease|0
1613531|NCT02076009|5629976|P1|Overall Study|Progressive disease|1
1613532|NCT02076009|5629975|P2|Overall Study|Lost to Follow-up|1
1613533|NCT02076009|5629976|P1|Overall Study|Lost to Follow-up|1
1613534|NCT02076009|5629975|P2|Overall Study|Withdrawal by Subject|3
1613535|NCT02076009|5629976|P1|Overall Study|Withdrawal by Subject|9
1613536|NCT02076009|5629975|P2|Overall Study|Death|30
1613537|NCT02076009|5629976|P1|Overall Study|Death|44
1613538|NCT02075840|5629998|P2|Overall Study|Ongoing at CCOD|82
1613539|NCT02075840|5629999|P1|Overall Study|Ongoing at CCOD|99
1613540|NCT02075840|5629998|P2|Overall Study|Physician Decision|3
1613541|NCT02075840|5629999|P1|Overall Study|Physician Decision|1
1613542|NCT02075840|5629998|P2|Overall Study|Lost to Follow-up|2
1613543|NCT02075840|5629999|P1|Overall Study|Lost to Follow-up|3
1613544|NCT02075840|5629998|P2|Overall Study|Death|40
1613545|NCT02075840|5629999|P1|Overall Study|Death|35
1613546|NCT02075840|5629998|P2|Overall Study|Adverse Event|2
1613547|NCT02075840|5629999|P1|Overall Study|Adverse Event|0
1613548|NCT02075840|5629998|P2|Overall Study|Reason not specified|0
1613549|NCT02075840|5629999|P1|Overall Study|Reason not specified|1
1613550|NCT02075840|5629998|P2|Overall Study|Withdrawal by Subject|22
1613551|NCT02075840|5629999|P1|Overall Study|Withdrawal by Subject|13
1613552|NCT02075658|5630055|P2|Overall Study|Physician Decision|2
1613553|NCT02075658|5630056|P1|Overall Study|Physician Decision|2
1613554|NCT02075632|5630066|P2|Overall Study|Withdrawal by Subject|1
1613555|NCT02075632|5630067|P1|Overall Study|Withdrawal by Subject|0
1613556|NCT02075632|5630066|P2|Overall Study|Lost to Follow-up|3
1613557|NCT02075632|5630067|P1|Overall Study|Lost to Follow-up|0
1613558|NCT02075632|5630066|P2|Overall Study|Adverse Event|1
1613559|NCT02075632|5630067|P1|Overall Study|Adverse Event|1
1613560|NCT02075606|5630077|P1|Overall Study|Increasing Symptoms|1
1613561|NCT02075606|5630077|P1|Overall Study|Symptom management|1
1613562|NCT02075606|5630077|P1|Overall Study|Investigator's decision|1
1613563|NCT02075606|5630077|P1|Overall Study|Death|1
1613564|NCT02075606|5630077|P1|Overall Study|Withdrawal by Subject|1
1613565|NCT02075606|5630077|P1|Overall Study|Adverse Event|5
1613566|NCT02075541|5630101|P2|Overall Study|Other- unable to perform study procedure|0
1613567|NCT02075541|5630102|P1|Overall Study|Other- unable to perform study procedure|1
1613568|NCT02075541|5630101|P2|Overall Study|Sponsor study termination|1
1613569|NCT02075541|5630102|P1|Overall Study|Sponsor study termination|0
1613570|NCT02075541|5630101|P2|Overall Study|Withdrawal by Subject|3
1613571|NCT02075541|5630102|P1|Overall Study|Withdrawal by Subject|1
1613572|NCT02075541|5630101|P2|Overall Study|Protocol Violation|0
1613573|NCT02075541|5630102|P1|Overall Study|Protocol Violation|1
1613574|NCT02075541|5630101|P2|Overall Study|Serious Adverse Event|4
1613575|NCT02075541|5630102|P1|Overall Study|Serious Adverse Event|1
1613576|NCT02075515|5630151|P3|Overall Study|Lost to Follow-up|6
1613577|NCT02075515|5630152|P2|Overall Study|Lost to Follow-up|3
1613578|NCT02075515|5630153|P1|Overall Study|Lost to Follow-up|1
1613579|NCT02075515|5630151|P3|Overall Study|Withdrawal by Subject|1
1613580|NCT02075515|5630152|P2|Overall Study|Withdrawal by Subject|0
1613581|NCT02075515|5630153|P1|Overall Study|Withdrawal by Subject|2
1613582|NCT02075515|5630151|P3|Overall Study|Non-Serious Adverse Event|0
1613583|NCT02075515|5630152|P2|Overall Study|Non-Serious Adverse Event|1
1613584|NCT02075515|5630153|P1|Overall Study|Non-Serious Adverse Event|0
1613585|NCT02075515|5630151|P3|Overall Study|Serious Adverse Event|1
1613586|NCT02075515|5630152|P2|Overall Study|Serious Adverse Event|1
1613587|NCT02075515|5630153|P1|Overall Study|Serious Adverse Event|1
1613588|NCT02075463|5630188|P1|Overall Study|Withdrawal by Subject|1
1613589|NCT02075463|5630188|P1|Overall Study|Par. reached stopping criteria|4
1613590|NCT02075463|5630188|P1|Overall Study|Adverse Event|3
1613591|NCT02075320|5630238|P1|Overall Study|Withdrawal by Subject|2
1613592|NCT02075255|5630248|P3|Overall Study|Death|0
1613593|NCT02075255|5630249|P2|Overall Study|Death|2
1613594|NCT02075255|5630250|P1|Overall Study|Death|0
1613595|NCT02075255|5630248|P3|Overall Study|Adverse Event|1
1613596|NCT02075255|5630249|P2|Overall Study|Adverse Event|0
1613597|NCT02075255|5630250|P1|Overall Study|Adverse Event|0
1613598|NCT02075255|5630248|P3|Overall Study|Lost to Follow-up|1
1613599|NCT02075255|5630249|P2|Overall Study|Lost to Follow-up|0
1613600|NCT02075255|5630250|P1|Overall Study|Lost to Follow-up|0
1613601|NCT02075255|5630248|P3|Overall Study|Withdrawal by Subject|0
1613602|NCT02075255|5630249|P2|Overall Study|Withdrawal by Subject|1
1613603|NCT02075255|5630250|P1|Overall Study|Withdrawal by Subject|4
1613604|NCT02075255|5630248|P3|Overall Study|Study specific withdrawal criteria|1
1613605|NCT02075255|5630249|P2|Overall Study|Study specific withdrawal criteria|1
1613606|NCT02075255|5630250|P1|Overall Study|Study specific withdrawal criteria|0
1613607|NCT02075203|5630360|P3|Overall Study|participant refused to use contraception|0
1613608|NCT02075203|5630361|P2|Overall Study|participant refused to use contraception|0
1613609|NCT02075203|5630362|P1|Overall Study|participant refused to use contraception|1
1613610|NCT02075203|5630360|P3|Overall Study|Adverse Event|0
1613611|NCT02075203|5630361|P2|Overall Study|Adverse Event|0
1613612|NCT02075203|5630362|P1|Overall Study|Adverse Event|1
1613613|NCT02075203|5630360|P3|Overall Study|Withdrawal by Subject|1
1613614|NCT02075203|5630361|P2|Overall Study|Withdrawal by Subject|0
1613615|NCT02075203|5630362|P1|Overall Study|Withdrawal by Subject|1
1613616|NCT02075073|5630403|P3|Overall Study|Withdrawal by Subject|0
1613617|NCT02075073|5630404|P2|Overall Study|Withdrawal by Subject|1
1613618|NCT02075073|5630405|P1|Overall Study|Withdrawal by Subject|0
1613619|NCT02075008|5630427|P1|Overall Study|Study terminated by Sponsor|159
1613620|NCT02075008|5630427|P1|Overall Study|Withdrawal by Subject|6
1613621|NCT02075008|5630427|P1|Overall Study|Adverse Event|5
1613622|NCT02075008|5630427|P1|Overall Study|Death|1
1613623|NCT02075008|5630427|P1|Overall Study|Lack of Efficacy|1
1613624|NCT02075008|5630427|P1|Overall Study|Lost to Follow-up|1
1613625|NCT02075008|5630427|P1|Overall Study|Physician Decision|1
1613626|NCT02075008|5630427|P1|Overall Study|Pregnancy|1
1613627|NCT02075008|5630427|P1|Overall Study|Technical problems|1
1613628|NCT02074982|5630450|P2|Overall Study|Death|2
1613629|NCT02074982|5630451|P1|Overall Study|Death|0
1613630|NCT02074982|5630450|P2|Overall Study|Subject/guardian decision|24
1613631|NCT02074982|5630451|P1|Overall Study|Subject/guardian decision|15
1613632|NCT02074982|5630450|P2|Overall Study|Technical problems|2
1613633|NCT02074982|5630451|P1|Overall Study|Technical problems|0
1613634|NCT02074982|5630450|P2|Overall Study|Protocol deviation|3
1613635|NCT02074982|5630451|P1|Overall Study|Protocol deviation|4
1613636|NCT02074982|5630450|P2|Overall Study|Pregnancy|2
1613637|NCT02074982|5630451|P1|Overall Study|Pregnancy|1
1613638|NCT02074982|5630450|P2|Overall Study|Physician Decision|1
1613639|NCT02074982|5630451|P1|Overall Study|Physician Decision|1
1613640|NCT02074982|5630450|P2|Overall Study|Non-compliance with study treatment|2
1613641|NCT02074982|5630451|P1|Overall Study|Non-compliance with study treatment|0
1613642|NCT02074982|5630450|P2|Overall Study|Lost to Follow-up|10
1613643|NCT02074982|5630451|P1|Overall Study|Lost to Follow-up|9
1613644|NCT02074982|5630450|P2|Overall Study|Lack of Efficacy|1
1613645|NCT02074982|5630451|P1|Overall Study|Lack of Efficacy|6
1613646|NCT02074982|5630450|P2|Overall Study|Adverse Event|7
1613647|NCT02074982|5630451|P1|Overall Study|Adverse Event|15
1613648|NCT02074553|5630498|P8|Washout Period 3|Physician Decision|1
1613649|NCT02074553|5630499|P7|Washout Period 3|Physician Decision|0
1613650|NCT02074553|5630500|P6|Washout Period 3|Physician Decision|0
1613651|NCT02074553|5630501|P5|Washout Period 3|Physician Decision|0
1613652|NCT02074553|5630502|P4|Washout Period 3|Physician Decision|0
1613653|NCT02074553|5630503|P3|Washout Period 3|Physician Decision|0
1613654|NCT02074553|5630504|P2|Washout Period 3|Physician Decision|0
1613655|NCT02074553|5630505|P1|Washout Period 3|Physician Decision|0
1613656|NCT02074553|5630498|P8|Washout Period 2|Lost to Follow-up|0
1613657|NCT02074553|5630499|P7|Washout Period 2|Lost to Follow-up|0
1613658|NCT02074553|5630500|P6|Washout Period 2|Lost to Follow-up|0
1613659|NCT02074553|5630501|P5|Washout Period 2|Lost to Follow-up|0
1613660|NCT02074553|5630502|P4|Washout Period 2|Lost to Follow-up|0
1613661|NCT02074553|5630503|P3|Washout Period 2|Lost to Follow-up|1
1613662|NCT02074553|5630504|P2|Washout Period 2|Lost to Follow-up|0
1613663|NCT02074553|5630505|P1|Washout Period 2|Lost to Follow-up|0
1613664|NCT02074553|5630498|P8|Washout Period 2|Physician Decision|0
1613665|NCT02074553|5630499|P7|Washout Period 2|Physician Decision|0
1613666|NCT02074553|5630500|P6|Washout Period 2|Physician Decision|1
1613667|NCT02074553|5630501|P5|Washout Period 2|Physician Decision|0
1613668|NCT02074553|5630502|P4|Washout Period 2|Physician Decision|0
1613669|NCT02074553|5630503|P3|Washout Period 2|Physician Decision|0
1613670|NCT02074553|5630504|P2|Washout Period 2|Physician Decision|0
1613671|NCT02074553|5630505|P1|Washout Period 2|Physician Decision|0
1613672|NCT02074553|5630498|P8|Washout Period 2|Adverse Event|0
1613673|NCT02074553|5630499|P7|Washout Period 2|Adverse Event|1
1613674|NCT02074553|5630500|P6|Washout Period 2|Adverse Event|0
1613675|NCT02074553|5630501|P5|Washout Period 2|Adverse Event|0
1613676|NCT02074553|5630502|P4|Washout Period 2|Adverse Event|0
1613677|NCT02074553|5630503|P3|Washout Period 2|Adverse Event|0
1613678|NCT02074553|5630504|P2|Washout Period 2|Adverse Event|0
1613679|NCT02074553|5630505|P1|Washout Period 2|Adverse Event|0
1613680|NCT02074553|5630498|P8|Washout Period 1|Other|0
1613681|NCT02074553|5630499|P7|Washout Period 1|Other|0
1613682|NCT02074553|5630500|P6|Washout Period 1|Other|1
1613683|NCT02074553|5630501|P5|Washout Period 1|Other|0
1613684|NCT02074553|5630502|P4|Washout Period 1|Other|0
1613685|NCT02074553|5630503|P3|Washout Period 1|Other|0
1613686|NCT02074553|5630504|P2|Washout Period 1|Other|0
1613687|NCT02074553|5630505|P1|Washout Period 1|Other|0
1613688|NCT02074553|5630498|P8|Washout Period 1|Physician Decision|0
1613689|NCT02074553|5630499|P7|Washout Period 1|Physician Decision|0
1613690|NCT02074553|5630500|P6|Washout Period 1|Physician Decision|0
1613691|NCT02074553|5630501|P5|Washout Period 1|Physician Decision|0
1613692|NCT02074553|5630502|P4|Washout Period 1|Physician Decision|1
1613693|NCT02074553|5630503|P3|Washout Period 1|Physician Decision|0
1613694|NCT02074553|5630504|P2|Washout Period 1|Physician Decision|0
1613695|NCT02074553|5630505|P1|Washout Period 1|Physician Decision|0
1613696|NCT02074553|5630498|P8|Washout Period 1|Adverse Event|0
1613697|NCT02074553|5630499|P7|Washout Period 1|Adverse Event|0
1613698|NCT02074553|5630500|P6|Washout Period 1|Adverse Event|0
1613699|NCT02074553|5630501|P5|Washout Period 1|Adverse Event|0
1613700|NCT02074553|5630502|P4|Washout Period 1|Adverse Event|0
1613701|NCT02074553|5630503|P3|Washout Period 1|Adverse Event|0
1613702|NCT02074553|5630504|P2|Washout Period 1|Adverse Event|0
1613703|NCT02074553|5630505|P1|Washout Period 1|Adverse Event|1
1613704|NCT02074553|5630498|P8|Intervention Period 1|Family Emergency|0
1613705|NCT02074553|5630499|P7|Intervention Period 1|Family Emergency|0
1613706|NCT02074553|5630500|P6|Intervention Period 1|Family Emergency|0
1613707|NCT02074553|5630501|P5|Intervention Period 1|Family Emergency|0
1613708|NCT02074553|5630502|P4|Intervention Period 1|Family Emergency|1
1613709|NCT02074553|5630503|P3|Intervention Period 1|Family Emergency|0
1613710|NCT02074553|5630504|P2|Intervention Period 1|Family Emergency|0
1613711|NCT02074553|5630505|P1|Intervention Period 1|Family Emergency|0
1613712|NCT02074514|5630687|P2|Overall Study|Withdrew Consent|1
1613713|NCT02074514|5630688|P1|Overall Study|Withdrew Consent|0
1613714|NCT02074514|5630687|P2|Overall Study|Lost to Follow-up|1
1613715|NCT02074514|5630688|P1|Overall Study|Lost to Follow-up|0
1613716|NCT02074514|5630687|P2|Overall Study|Lack of Efficacy|2
1613717|NCT02074514|5630688|P1|Overall Study|Lack of Efficacy|3
1613718|NCT02074059|5630829|P6|Overall Study|Death|1
1613719|NCT02074059|5630830|P5|Overall Study|Death|1
1613720|NCT02074059|5630831|P4|Overall Study|Death|0
1613721|NCT02074059|5630832|P3|Overall Study|Death|0
1613722|NCT02074059|5630833|P2|Overall Study|Death|0
1613723|NCT02074059|5630834|P1|Overall Study|Death|0
1613724|NCT02073929|5630878|P2|Overall Study|Withdrawal by Subject|1
1613725|NCT02073929|5630879|P1|Overall Study|Withdrawal by Subject|0
1613726|NCT02073929|5630878|P2|Overall Study|Adverse Event|1
1613727|NCT02073929|5630879|P1|Overall Study|Adverse Event|2
1613728|NCT02073929|5630878|P2|Overall Study|Lost to Follow-up|1
1613729|NCT02073929|5630879|P1|Overall Study|Lost to Follow-up|2
1613730|NCT02073682|5630916|P2|Overall Study|ID: Benefit/Risk Judgment|46
1613731|NCT02073682|5630917|P1|Overall Study|ID: Benefit/Risk Judgment|32
1613732|NCT02073682|5630916|P2|Overall Study|Lost to Follow-up|1
1613733|NCT02073682|5630917|P1|Overall Study|Lost to Follow-up|1
1613734|NCT02073682|5630916|P2|Overall Study|PD: Inconvenience of Dosing|78
1613735|NCT02073682|5630917|P1|Overall Study|PD: Inconvenience of Dosing|21
1613736|NCT02073682|5630916|P2|Overall Study|No reason provided|9
1613737|NCT02073682|5630917|P1|Overall Study|No reason provided|11
1613738|NCT02073682|5630916|P2|Overall Study|Adverse Event|62
1613739|NCT02073682|5630917|P1|Overall Study|Adverse Event|79
1613740|NCT02073682|5630916|P2|Overall Study|Protocol Violation|0
1613741|NCT02073682|5630917|P1|Overall Study|Protocol Violation|1
1613742|NCT02073682|5630916|P2|Overall Study|Cancer Progression|33
1613743|NCT02073682|5630917|P1|Overall Study|Cancer Progression|53
1613744|NCT02073682|5630916|P2|Overall Study|Start of New Chemotherapy Regimen|3
1613745|NCT02073682|5630917|P1|Overall Study|Start of New Chemotherapy Regimen|6
1613746|NCT02073682|5630916|P2|Overall Study|Withdrawal by Subject|8
1613747|NCT02073682|5630917|P1|Overall Study|Withdrawal by Subject|6
1613748|NCT02073682|5630916|P2|Overall Study|Surgery/Medical Procedure|1
1613749|NCT02073682|5630917|P1|Overall Study|Surgery/Medical Procedure|3
1613750|NCT02073682|5630916|P2|Overall Study|Platelet Count <50,000/mL|2
1613751|NCT02073682|5630917|P1|Overall Study|Platelet Count <50,000/mL|1
1613752|NCT02073682|5630916|P2|Overall Study|Prohibited Concomitant Medication Use|1
1613753|NCT02073682|5630917|P1|Overall Study|Prohibited Concomitant Medication Use|0
1613754|NCT02073682|5630916|P2|Overall Study|ID: Palliative Treatment Only|7
1613755|NCT02073682|5630917|P1|Overall Study|ID: Palliative Treatment Only|10
1613756|NCT02073682|5630916|P2|Overall Study|ID: Patient Noncompliance|2
1613757|NCT02073682|5630917|P1|Overall Study|ID: Patient Noncompliance|1
1613758|NCT02073682|5630916|P2|Overall Study|Cancer Cured|15
1613759|NCT02073682|5630917|P1|Overall Study|Cancer Cured|10
1613760|NCT02073682|5630916|P2|Overall Study|Death|100
1613761|NCT02073682|5630917|P1|Overall Study|Death|86
1613762|NCT02073682|5630916|P2|Overall Study|Low Creatinine Clearance|2
1613763|NCT02073682|5630917|P1|Overall Study|Low Creatinine Clearance|1
1613764|NCT02073656|5630935|P1|Primary Study|Withdrew Consent|1
1613765|NCT02073656|5630935|P1|Primary Study|Death|1
1613766|NCT02073656|5630935|P1|Primary Study|Lost to Follow-up|6
1613767|NCT02073643|5630951|P1|Overall Study|Lost to Follow-up|24
1613768|NCT02073565|5630962|P2|Cohort C|Lost to Follow-up|2
1613769|NCT02073565|5630963|P1|Cohort C|Lost to Follow-up|0
1613770|NCT02073565|5630962|P2|Cohort C|Withdrawal by Subject|2
1613771|NCT02073565|5630963|P1|Cohort C|Withdrawal by Subject|0
1613772|NCT02073565|5630962|P2|Cohort B|Withdrawal by Subject|2
1613773|NCT02073565|5630963|P1|Cohort B|Withdrawal by Subject|1
1613774|NCT02073565|5630962|P2|Cohort A|Withdrawal by Subject|0
1613775|NCT02073565|5630963|P1|Cohort A|Withdrawal by Subject|1
1613776|NCT02072980|5631083|P2|Period 2, Second Wear|Adverse Event|1
1613777|NCT02072980|5631084|P1|Period 2, Second Wear|Adverse Event|0
1613778|NCT02072941|5631092|P2|Overall Study|Removed by Study Staff|2
1613779|NCT02072941|5631093|P1|Overall Study|Removed by Study Staff|2
1613780|NCT02072941|5631092|P2|Overall Study|Death|2
1613781|NCT02072941|5631093|P1|Overall Study|Death|3
1613782|NCT02072941|5631092|P2|Overall Study|Lost to Follow-up|4
1613783|NCT02072941|5631093|P1|Overall Study|Lost to Follow-up|4
1613784|NCT02072941|5631092|P2|Overall Study|Withdrawal by Subject|21
1613785|NCT02072941|5631093|P1|Overall Study|Withdrawal by Subject|29
1613786|NCT02072824|5631108|P3|Overall Study|Adverse Event|1
1613787|NCT02072824|5631109|P2|Overall Study|Adverse Event|0
1613788|NCT02072824|5631110|P1|Overall Study|Adverse Event|0
1613789|NCT02072824|5631108|P3|Overall Study|Medication error|0
1613790|NCT02072824|5631109|P2|Overall Study|Medication error|1
1613791|NCT02072824|5631110|P1|Overall Study|Medication error|0
1613792|NCT02072824|5631108|P3|Overall Study|No longer willing to participate|1
1613793|NCT02072824|5631109|P2|Overall Study|No longer willing to participate|0
1613794|NCT02072824|5631110|P1|Overall Study|No longer willing to participate|1
1613795|NCT02072824|5631108|P3|Overall Study|Insufficient clinical response|1
1613796|NCT02072824|5631109|P2|Overall Study|Insufficient clinical response|0
1613797|NCT02072824|5631110|P1|Overall Study|Insufficient clinical response|1
1613798|NCT02072434|5631147|P2|Overall Study|Lost to Follow-up|1
1613799|NCT02072434|5631148|P1|Overall Study|Lost to Follow-up|0
1613800|NCT02072434|5631147|P2|Overall Study|Other|29
1613801|NCT02072434|5631148|P1|Overall Study|Other|14
1613802|NCT02072434|5631147|P2|Overall Study|Withdrawal by Subject|29
1613803|NCT02072434|5631148|P1|Overall Study|Withdrawal by Subject|17
1613804|NCT02072434|5631147|P2|Overall Study|Adverse Event|6
1613805|NCT02072434|5631148|P1|Overall Study|Adverse Event|7
1613806|NCT02072434|5631147|P2|Overall Study|Adverse event, serious fatal|6
1613807|NCT02072434|5631148|P1|Overall Study|Adverse event, serious fatal|1
1613808|NCT02072434|5631147|P2|Overall Study|Physician Decision|10
1613809|NCT02072434|5631148|P1|Overall Study|Physician Decision|5
1613810|NCT02072434|5631147|P2|Overall Study|Protocol Violation|9
1613811|NCT02072434|5631148|P1|Overall Study|Protocol Violation|10
1613812|NCT02072226|5631168|P2|Overall Study|Patient Withdrawal of Consent|0
1613813|NCT02072226|5631169|P1|Overall Study|Patient Withdrawal of Consent|1
1613814|NCT02072226|5631168|P2|Overall Study|Death|0
1613815|NCT02072226|5631169|P1|Overall Study|Death|1
1613816|NCT02072226|5631168|P2|Overall Study|Patient Non-compliance|3
1613817|NCT02072226|5631169|P1|Overall Study|Patient Non-compliance|2
1613818|NCT02072226|5631168|P2|Overall Study|Lost to Follow-up|7
1613819|NCT02072226|5631169|P1|Overall Study|Lost to Follow-up|11
1613820|NCT02072174|5631199|P2|Overall Study|Non-compliance with protocol requirement|0
1613821|NCT02072174|5631200|P1|Overall Study|Non-compliance with protocol requirement|2
1613822|NCT02072174|5631199|P2|Overall Study|Physician Decision|1
1613823|NCT02072174|5631200|P1|Overall Study|Physician Decision|0
1613824|NCT02072174|5631199|P2|Overall Study|Protocol Violation|23
1613825|NCT02072174|5631200|P1|Overall Study|Protocol Violation|16
1613826|NCT02072174|5631199|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
1613827|NCT02072174|5631200|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
1613828|NCT02072096|5631224|P2|Overall Study|Lost to Follow-up|0
1613829|NCT02072096|5631225|P1|Overall Study|Lost to Follow-up|1
1613830|NCT02072096|5631224|P2|Overall Study|Study Terminated by Sponsor|30
1613831|NCT02072096|5631225|P1|Overall Study|Study Terminated by Sponsor|43
1613832|NCT02072096|5631224|P2|Overall Study|Physician Decision|1
1613833|NCT02072096|5631225|P1|Overall Study|Physician Decision|0
1613834|NCT02072096|5631224|P2|Overall Study|Death|0
1613835|NCT02072096|5631225|P1|Overall Study|Death|2
1613836|NCT02072096|5631224|P2|Overall Study|No Reason Provided|2
1613837|NCT02072096|5631225|P1|Overall Study|No Reason Provided|4
1613838|NCT02072096|5631224|P2|Overall Study|Adverse Event|2
1613839|NCT02072096|5631225|P1|Overall Study|Adverse Event|5
1613840|NCT02072096|5631224|P2|Overall Study|Withdrawal by Subject|7
1613841|NCT02072096|5631225|P1|Overall Study|Withdrawal by Subject|5
1613842|NCT02072096|5631224|P2|Overall Study|Protocol Violation|7
1613843|NCT02072096|5631225|P1|Overall Study|Protocol Violation|7
1613844|NCT02072096|5631224|P2|Overall Study|Lack of Efficacy|29
1613845|NCT02072096|5631225|P1|Overall Study|Lack of Efficacy|18
1613846|NCT02071849|5631247|P1|2-year Extended Follow-up|Adverse Event|1
1613847|NCT02071849|5631247|P1|6-month Primary Endpoint|Adverse Event|1
1613848|NCT02071849|5631247|P1|6-month Primary Endpoint|Did not receive device|4
1613849|NCT02071771|5631313|P2|Period 1: First 10 Days|Unavailable lens power|0
1613850|NCT02071771|5631314|P1|Period 1: First 10 Days|Unavailable lens power|1
1613851|NCT02071771|5631313|P2|Period 1: First 10 Days|Unacceptable lens fit|0
1613852|NCT02071771|5631314|P1|Period 1: First 10 Days|Unacceptable lens fit|1
1613853|NCT02071706|5631322|P1|Overall Study|Withdrawal by Subject|2
1613854|NCT02071706|5631322|P1|Overall Study|Adverse Event|1
1613855|NCT02071290|5631338|P2|Overall Study|Physician Decision|1
1613856|NCT02071290|5631339|P1|Overall Study|Physician Decision|0
1613857|NCT02071290|5631338|P2|Overall Study|Protocol Violation|5
1613858|NCT02071290|5631339|P1|Overall Study|Protocol Violation|3
1613859|NCT02071290|5631338|P2|Overall Study|Withdrawal by Subject|1
1613860|NCT02071290|5631339|P1|Overall Study|Withdrawal by Subject|0
1613861|NCT02071290|5631338|P2|Overall Study|Death|0
1613862|NCT02071290|5631339|P1|Overall Study|Death|1
1613863|NCT02071225|5631393|P1|Overall Study|Death|25
1613864|NCT02071225|5631393|P1|Overall Study|Lost to Follow-up|2
1613865|NCT02071225|5631393|P1|Overall Study|Protocol Deviation|1
1613866|NCT02071225|5631393|P1|Overall Study|Withdrawal of Consent|2
1613867|NCT02071082|5631449|P2|Overall Study|Lost to Follow-up|1
1613868|NCT02071082|5631450|P1|Overall Study|Lost to Follow-up|1
1613869|NCT02071082|5631449|P2|Overall Study|Withdrew Consent|4
1613870|NCT02071082|5631450|P1|Overall Study|Withdrew Consent|0
1613871|NCT02071082|5631449|P2|Overall Study|Adverse Event|1
1613872|NCT02071082|5631450|P1|Overall Study|Adverse Event|0
1613873|NCT02071082|5631449|P2|Overall Study|Enrolled and Never Treated|1
1613874|NCT02071082|5631450|P1|Overall Study|Enrolled and Never Treated|1
1613875|NCT02070991|5631480|P2|Overall Study|Withdrawal by Subject|0
1613876|NCT02070991|5631481|P1|Overall Study|Withdrawal by Subject|1
1613877|NCT02070991|5631480|P2|Overall Study|Death|0
1613878|NCT02070991|5631481|P1|Overall Study|Death|2
1613879|NCT02070978|5631504|P3|Overall Study|Terminated by Sponsor|39
1613880|NCT02070978|5631505|P2|Overall Study|Terminated by Sponsor|40
1613881|NCT02070978|5631506|P1|Overall Study|Terminated by Sponsor|33
1613882|NCT02070978|5631504|P3|Overall Study|Un-specified|2
1613883|NCT02070978|5631505|P2|Overall Study|Un-specified|2
1613884|NCT02070978|5631506|P1|Overall Study|Un-specified|3
1613885|NCT02070978|5631504|P3|Overall Study|Death|2
1613886|NCT02070978|5631505|P2|Overall Study|Death|0
1613887|NCT02070978|5631506|P1|Overall Study|Death|0
1613888|NCT02070978|5631504|P3|Overall Study|Lack of Efficacy|0
1613889|NCT02070978|5631505|P2|Overall Study|Lack of Efficacy|1
1613890|NCT02070978|5631506|P1|Overall Study|Lack of Efficacy|0
1613891|NCT02070978|5631504|P3|Overall Study|Protocol Violation|3
1613892|NCT02070978|5631505|P2|Overall Study|Protocol Violation|0
1613893|NCT02070978|5631506|P1|Overall Study|Protocol Violation|1
1613894|NCT02070978|5631504|P3|Overall Study|Withdrawal by Subject|3
1613895|NCT02070978|5631505|P2|Overall Study|Withdrawal by Subject|5
1613896|NCT02070978|5631506|P1|Overall Study|Withdrawal by Subject|3
1613897|NCT02070978|5631504|P3|Overall Study|Lost to Follow-up|4
1613898|NCT02070978|5631505|P2|Overall Study|Lost to Follow-up|3
1613899|NCT02070978|5631506|P1|Overall Study|Lost to Follow-up|1
1613900|NCT02070978|5631504|P3|Overall Study|Adverse Event|0
1613901|NCT02070978|5631505|P2|Overall Study|Adverse Event|2
1613902|NCT02070978|5631506|P1|Overall Study|Adverse Event|6
1613903|NCT02070965|5631568|P3|Overall Study|Subject moved|0
1613904|NCT02070965|5631569|P2|Overall Study|Subject moved|0
1613905|NCT02070965|5631570|P1|Overall Study|Subject moved|1
1613906|NCT02070965|5631568|P3|Overall Study|Withdrawal by Subject|1
1613907|NCT02070965|5631569|P2|Overall Study|Withdrawal by Subject|1
1613908|NCT02070965|5631570|P1|Overall Study|Withdrawal by Subject|1
1613909|NCT02070965|5631568|P3|Overall Study|Lost to Follow-up|0
1613910|NCT02070965|5631569|P2|Overall Study|Lost to Follow-up|1
1613911|NCT02070965|5631570|P1|Overall Study|Lost to Follow-up|0
1613912|NCT02070757|5631580|P2|Overall Study|Discharged from Study Hospital|2
1613913|NCT02070757|5631581|P1|Overall Study|Discharged from Study Hospital|2
1613914|NCT02070757|5631580|P2|Overall Study|Investigator Decision|2
1613915|NCT02070757|5631581|P1|Overall Study|Investigator Decision|0
1613916|NCT02070757|5631580|P2|Overall Study|Withdrawal by Subject|3
1613917|NCT02070757|5631581|P1|Overall Study|Withdrawal by Subject|1
1613918|NCT02070757|5631580|P2|Overall Study|Protocol Violation|4
1613919|NCT02070757|5631581|P1|Overall Study|Protocol Violation|0
1613920|NCT02070757|5631580|P2|Overall Study|Lost to Follow-up|4
1613921|NCT02070757|5631581|P1|Overall Study|Lost to Follow-up|7
1613922|NCT02070757|5631580|P2|Overall Study|Adverse Event|99
1613923|NCT02070757|5631581|P1|Overall Study|Adverse Event|107
1613924|NCT02070744|5631615|P5|OLE Phase (48 Weeks)|Other|1
1613925|NCT02070744|5631616|P4|OLE Phase (48 Weeks)|Other|0
1613926|NCT02070744|5631617|P3|OLE Phase (48 Weeks)|Other|0
1613927|NCT02070744|5631618|P2|OLE Phase (48 Weeks)|Other|0
1613928|NCT02070744|5631619|P1|OLE Phase (48 Weeks)|Other|0
1613929|NCT02070744|5631615|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
1613930|NCT02070744|5631616|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1613931|NCT02070744|5631617|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1613932|NCT02070744|5631618|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1613933|NCT02070744|5631619|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
1613934|NCT02070744|5631615|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
1613935|NCT02070744|5631616|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
1613936|NCT02070744|5631617|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
1613937|NCT02070744|5631618|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
1613938|NCT02070744|5631619|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
1613939|NCT02070588|5631702|P3|Overall Study|Adverse Event|0
1613940|NCT02070588|5631703|P2|Overall Study|Adverse Event|0
1613941|NCT02070588|5631704|P1|Overall Study|Adverse Event|1
1613942|NCT02070588|5631702|P3|Overall Study|Writhdrawal due to early termination|0
1613943|NCT02070588|5631703|P2|Overall Study|Writhdrawal due to early termination|0
1613944|NCT02070588|5631704|P1|Overall Study|Writhdrawal due to early termination|9
1613945|NCT02070588|5631702|P3|Overall Study|Withdrawal by Subject|0
1613946|NCT02070588|5631703|P2|Overall Study|Withdrawal by Subject|1
1613947|NCT02070588|5631704|P1|Overall Study|Withdrawal by Subject|29
1613948|NCT02070484|5631720|P2|Overall Study|Withdrawal by Subject|0
1613949|NCT02070484|5631721|P1|Overall Study|Withdrawal by Subject|1
1613950|NCT02070380|5631743|P4|Second Injection|Protocol Violation|5
1613951|NCT02070380|5631744|P3|Second Injection|Protocol Violation|1
1613952|NCT02070380|5631745|P2|Second Injection|Protocol Violation|1
1613953|NCT02070380|5631746|P1|Second Injection|Protocol Violation|0
1613954|NCT02070380|5631743|P4|Second Injection|Image sets missing or technically inadeq|0
1613955|NCT02070380|5631744|P3|Second Injection|Image sets missing or technically inadeq|0
1613956|NCT02070380|5631745|P2|Second Injection|Image sets missing or technically inadeq|1
1613957|NCT02070380|5631746|P1|Second Injection|Image sets missing or technically inadeq|0
1613958|NCT02070380|5631743|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
1613959|NCT02070380|5631744|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
1613960|NCT02070380|5631745|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
1613961|NCT02070380|5631746|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
1613962|NCT02069392|5631878|P2|Overall Study|Withdrawal by Subject|2
1613963|NCT02069392|5631879|P1|Overall Study|Withdrawal by Subject|4
1613964|NCT02069379|5631903|P4|Second Treatment Arm|Lost to Follow-up|0
1613965|NCT02069379|5631904|P3|Second Treatment Arm|Lost to Follow-up|1
1613966|NCT02069379|5631905|P2|Second Treatment Arm|Lost to Follow-up|0
1613967|NCT02069379|5631906|P1|Second Treatment Arm|Lost to Follow-up|0
1613968|NCT02069379|5631903|P4|Washout Period (4 Weeks)|Unrelated event|0
1613969|NCT02069379|5631904|P3|Washout Period (4 Weeks)|Unrelated event|0
1613970|NCT02069379|5631905|P2|Washout Period (4 Weeks)|Unrelated event|1
1613971|NCT02069379|5631906|P1|Washout Period (4 Weeks)|Unrelated event|0
1613972|NCT02069379|5631903|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
1613973|NCT02069379|5631904|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
1613974|NCT02069379|5631905|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
1613975|NCT02069379|5631906|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
1613976|NCT02069379|5631903|P4|First Treatment Arm|Lost to Follow-up|0
1613977|NCT02069379|5631904|P3|First Treatment Arm|Lost to Follow-up|1
1613978|NCT02069379|5631905|P2|First Treatment Arm|Lost to Follow-up|1
1613979|NCT02069379|5631906|P1|First Treatment Arm|Lost to Follow-up|0
1613980|NCT02069379|5631903|P4|Baseline Measurements|Ineligible based on initial assessments|2
1613981|NCT02069379|5631904|P3|Baseline Measurements|Ineligible based on initial assessments|0
1613982|NCT02069379|5631905|P2|Baseline Measurements|Ineligible based on initial assessments|0
1613983|NCT02069379|5631906|P1|Baseline Measurements|Ineligible based on initial assessments|2
1613984|NCT02069379|5631903|P4|Baseline Measurements|Lost to Follow-up|0
1613985|NCT02069379|5631904|P3|Baseline Measurements|Lost to Follow-up|0
1613986|NCT02069379|5631905|P2|Baseline Measurements|Lost to Follow-up|0
1613987|NCT02069379|5631906|P1|Baseline Measurements|Lost to Follow-up|1
1613988|NCT02069093|5631993|P1|Overall Study|Adverse Event|10
1613989|NCT02069093|5631993|P1|Overall Study|Abnormal laboratory values|1
1613990|NCT02069093|5631993|P1|Overall Study|Withdrawal by Subject|2
1613991|NCT02069093|5631993|P1|Overall Study|Administrative problems|1
1613992|NCT02069093|5631993|P1|Overall Study|Death|1
1613993|NCT02069093|5631993|P1|Overall Study|New cancer therapy|1
1613994|NCT02069093|5631993|P1|Overall Study|Disease progression|14
1613995|NCT02068768|5632043|P1|Overall Study|Early Termination by Sponsor|2
1613996|NCT02068768|5632043|P1|Overall Study|Lost to Follow-up|5
1613997|NCT02068599|5632052|P3|Overall Study|Noncompliance|1
1613998|NCT02068599|5632053|P2|Overall Study|Noncompliance|0
1613999|NCT02068599|5632054|P1|Overall Study|Noncompliance|0
1614000|NCT02068599|5632052|P3|Overall Study|Lack of Efficacy|3
1614001|NCT02068599|5632053|P2|Overall Study|Lack of Efficacy|0
1614002|NCT02068599|5632054|P1|Overall Study|Lack of Efficacy|0
1614003|NCT02068599|5632052|P3|Overall Study|Lost to Follow-up|0
1614004|NCT02068599|5632053|P2|Overall Study|Lost to Follow-up|0
1614005|NCT02068599|5632054|P1|Overall Study|Lost to Follow-up|1
1614006|NCT02068599|5632052|P3|Overall Study|Protocol Violation|3
1614007|NCT02068599|5632053|P2|Overall Study|Protocol Violation|2
1614008|NCT02068599|5632054|P1|Overall Study|Protocol Violation|4
1614009|NCT02068599|5632052|P3|Overall Study|Withdrawal by Subject|5
1614010|NCT02068599|5632053|P2|Overall Study|Withdrawal by Subject|7
1614011|NCT02068599|5632054|P1|Overall Study|Withdrawal by Subject|2
1614012|NCT02068599|5632052|P3|Overall Study|Adverse Event|1
1614013|NCT02068599|5632053|P2|Overall Study|Adverse Event|1
1614014|NCT02068599|5632054|P1|Overall Study|Adverse Event|4
1614015|NCT02068547|5632094|P2|Overall Study|Physician Decision|0
1614016|NCT02068547|5632095|P1|Overall Study|Physician Decision|1
1614017|NCT02068547|5632094|P2|Overall Study|Lost to Follow-up|3
1614018|NCT02068547|5632095|P1|Overall Study|Lost to Follow-up|3
1614019|NCT02068508|5632105|P1|Overall Study|Protocol Violation|4
1614020|NCT02068508|5632105|P1|Overall Study|Patient did not visit the study site|1
1614021|NCT02068508|5632105|P1|Overall Study|Case report forms uncollected|27
1614022|NCT02068495|5632115|P1|Overall Study|Protocol Deviation|49
1614023|NCT02068495|5632115|P1|Overall Study|Case Report Forms Uncollected|60
1614024|NCT02068443|5632127|P3|Overall Study|Other Reason Not Specified|0
1614025|NCT02068443|5632128|P2|Overall Study|Other Reason Not Specified|0
1614026|NCT02068443|5632129|P1|Overall Study|Other Reason Not Specified|1
1614027|NCT02068443|5632127|P3|Overall Study|Lack of Efficacy|0
1614028|NCT02068443|5632128|P2|Overall Study|Lack of Efficacy|1
1614029|NCT02068443|5632129|P1|Overall Study|Lack of Efficacy|2
1614030|NCT02068443|5632127|P3|Overall Study|Voluntary Withdrawal|1
1614031|NCT02068443|5632128|P2|Overall Study|Voluntary Withdrawal|0
1614032|NCT02068443|5632129|P1|Overall Study|Voluntary Withdrawal|4
1614033|NCT02068443|5632127|P3|Overall Study|Pretreatment Event/Adverse Event|2
1614034|NCT02068443|5632128|P2|Overall Study|Pretreatment Event/Adverse Event|5
1614035|NCT02068443|5632129|P1|Overall Study|Pretreatment Event/Adverse Event|0
1614036|NCT02068222|5632164|P1|Overall Study|Lost to Follow-up|1
1614037|NCT02067728|5632195|P2|6 Month Measurements|Unable to attend|97
1614038|NCT02067728|5632196|P1|6 Month Measurements|Unable to attend|114
1614039|NCT02067728|5632195|P2|6 Month Follow up Survey|Lost to Follow-up|60
1614040|NCT02067728|5632196|P1|6 Month Follow up Survey|Lost to Follow-up|48
1614041|NCT02067728|5632195|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
1614042|NCT02067728|5632196|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
1614043|NCT02067676|5632230|P6|Overall Study|Withdrawal by Subject|0
1614044|NCT02067676|5632231|P5|Overall Study|Withdrawal by Subject|0
1614045|NCT02067676|5632232|P4|Overall Study|Withdrawal by Subject|0
1614046|NCT02067676|5632233|P3|Overall Study|Withdrawal by Subject|0
1614047|NCT02067676|5632234|P2|Overall Study|Withdrawal by Subject|0
1614048|NCT02067676|5632235|P1|Overall Study|Withdrawal by Subject|1
1614049|NCT02067663|5632275|P2|Overall Study|Lost to Follow-up|14
1614050|NCT02067663|5632276|P1|Overall Study|Lost to Follow-up|13
1614051|NCT02067533|5632375|P2|Overall Study|Lost to Follow-up|2
1614052|NCT02067533|5632376|P1|Overall Study|Lost to Follow-up|4
1614053|NCT02067104|5632427|P2|Overall Study|Study termination due to low accrual|5
1614054|NCT02067104|5632428|P1|Overall Study|Study termination due to low accrual|4
1614055|NCT02066922|5632436|P1|Overall Study|Adverse Event|1
1614056|NCT02066467|5632488|P1|Overall Study|Not defined|4
1614057|NCT02066467|5632488|P1|Overall Study|Physician Decision|2
1614058|NCT02066467|5632488|P1|Overall Study|Withdrawal by Subject|16
1614059|NCT02066467|5632488|P1|Overall Study|Adverse Event|20
1614060|NCT02066467|5632488|P1|Overall Study|Lost to Follow-up|51
1614061|NCT02066467|5632488|P1|Overall Study|Death|54
1614062|NCT02066467|5632488|P1|Overall Study|Consent ineligible|1
1614063|NCT02066467|5632488|P1|Overall Study|Attempted to implant withoput success|43
1614064|NCT02066467|5632488|P1|Overall Study|Did not undergo implant procedure|24
1614065|NCT02066415|5632497|P3|Overall Study|Lost to Follow-up|2
1614066|NCT02066415|5632498|P2|Overall Study|Lost to Follow-up|2
1614067|NCT02066415|5632499|P1|Overall Study|Lost to Follow-up|7
1614068|NCT02066415|5632497|P3|Overall Study|Withdrawal by Subject|4
1614069|NCT02066415|5632498|P2|Overall Study|Withdrawal by Subject|1
1614070|NCT02066415|5632499|P1|Overall Study|Withdrawal by Subject|9
1614071|NCT02066415|5632497|P3|Overall Study|Decision by Sponsor|2
1614072|NCT02066415|5632498|P2|Overall Study|Decision by Sponsor|4
1614073|NCT02066415|5632499|P1|Overall Study|Decision by Sponsor|5
1614074|NCT02066402|5632524|P2|Overall Study|Protocol driven decision point|1
1614075|NCT02066402|5632525|P1|Overall Study|Protocol driven decision point|0
1614076|NCT02066402|5632524|P2|Overall Study|Progressive disease-clinical progression|1
1614077|NCT02066402|5632525|P1|Overall Study|Progressive disease-clinical progression|0
1614078|NCT02066402|5632524|P2|Overall Study|Withdrawal by Subject|11
1614079|NCT02066402|5632525|P1|Overall Study|Withdrawal by Subject|14
1614080|NCT02066402|5632524|P2|Overall Study|Lost to Follow-up|8
1614081|NCT02066402|5632525|P1|Overall Study|Lost to Follow-up|11
1614082|NCT02066402|5632524|P2|Overall Study|Adverse Event|2
1614083|NCT02066402|5632525|P1|Overall Study|Adverse Event|1
1614084|NCT02066389|5632557|P6|Overall Study|Randomized in Error|1
1614085|NCT02066389|5632558|P5|Overall Study|Randomized in Error|0
1614086|NCT02066389|5632559|P4|Overall Study|Randomized in Error|0
1614087|NCT02066389|5632560|P3|Overall Study|Randomized in Error|0
1614088|NCT02066389|5632561|P2|Overall Study|Randomized in Error|0
1614089|NCT02066389|5632562|P1|Overall Study|Randomized in Error|0
1614090|NCT02066389|5632557|P6|Overall Study|Lost to Follow-up|1
1614091|NCT02066389|5632558|P5|Overall Study|Lost to Follow-up|1
1614092|NCT02066389|5632559|P4|Overall Study|Lost to Follow-up|1
1614093|NCT02066389|5632560|P3|Overall Study|Lost to Follow-up|0
1614094|NCT02066389|5632561|P2|Overall Study|Lost to Follow-up|0
1614095|NCT02066389|5632562|P1|Overall Study|Lost to Follow-up|0
1614096|NCT02066389|5632557|P6|Overall Study|Withdrawal by Subject|2
1614097|NCT02066389|5632558|P5|Overall Study|Withdrawal by Subject|1
1614098|NCT02066389|5632559|P4|Overall Study|Withdrawal by Subject|1
1614099|NCT02066389|5632560|P3|Overall Study|Withdrawal by Subject|5
1614100|NCT02066389|5632561|P2|Overall Study|Withdrawal by Subject|0
1614101|NCT02066389|5632562|P1|Overall Study|Withdrawal by Subject|4
1614102|NCT02066389|5632557|P6|Overall Study|Adverse Event|1
1614103|NCT02066389|5632558|P5|Overall Study|Adverse Event|5
1614104|NCT02066389|5632559|P4|Overall Study|Adverse Event|1
1614105|NCT02066389|5632560|P3|Overall Study|Adverse Event|1
1614106|NCT02066389|5632561|P2|Overall Study|Adverse Event|1
1614107|NCT02066389|5632562|P1|Overall Study|Adverse Event|1
1614110|NCT02066298|5632622|P6|Overall Study|Physician Decision|0
1614111|NCT02066298|5632623|P5|Overall Study|Physician Decision|1
1614112|NCT02066298|5632624|P4|Overall Study|Physician Decision|0
1614113|NCT02066298|5632625|P3|Overall Study|Physician Decision|1
1614114|NCT02066298|5632626|P2|Overall Study|Physician Decision|0
1614115|NCT02066298|5632627|P1|Overall Study|Physician Decision|0
1614116|NCT02066298|5632622|P6|Overall Study|Withdrawal by Subject|8
1614117|NCT02066298|5632623|P5|Overall Study|Withdrawal by Subject|5
1614118|NCT02066298|5632624|P4|Overall Study|Withdrawal by Subject|4
1614119|NCT02066298|5632625|P3|Overall Study|Withdrawal by Subject|6
1614120|NCT02066298|5632626|P2|Overall Study|Withdrawal by Subject|6
1614121|NCT02066298|5632627|P1|Overall Study|Withdrawal by Subject|6
1614122|NCT02066298|5632622|P6|Overall Study|Lost to Follow-up|4
1614123|NCT02066298|5632623|P5|Overall Study|Lost to Follow-up|3
1614124|NCT02066298|5632624|P4|Overall Study|Lost to Follow-up|2
1614125|NCT02066298|5632625|P3|Overall Study|Lost to Follow-up|3
1614126|NCT02066298|5632626|P2|Overall Study|Lost to Follow-up|2
1614127|NCT02066298|5632627|P1|Overall Study|Lost to Follow-up|3
1614128|NCT02066233|5632651|P2|EG Scan II (Day 1)|difficulty intubating subject|6
1614129|NCT02066233|5632652|P1|EG Scan II (Day 1)|difficulty intubating subject|6
1614130|NCT02066181|5632662|P2|Overall Study|Withdrawal by Subject|1
1614131|NCT02066181|5632663|P1|Overall Study|Withdrawal by Subject|1
1614132|NCT02066129|5632685|P2|Overall Study|Physician Decision|1
1614133|NCT02066129|5632686|P1|Overall Study|Physician Decision|1
1614134|NCT02066129|5632685|P2|Overall Study|Lack of Efficacy|10
1614135|NCT02066129|5632686|P1|Overall Study|Lack of Efficacy|8
1614136|NCT02066129|5632685|P2|Overall Study|Withdrawal by Subject|10
1614137|NCT02066129|5632686|P1|Overall Study|Withdrawal by Subject|7
1614138|NCT02066129|5632685|P2|Overall Study|Lost to Follow-up|12
1614139|NCT02066129|5632686|P1|Overall Study|Lost to Follow-up|13
1614140|NCT02066051|5632700|P1|Overall Study|Subject developed active GVHD|1
1614141|NCT02065895|5632705|P6|Overall Study|Scheduling conflicts|0
1614142|NCT02065895|5632706|P5|Overall Study|Scheduling conflicts|0
1614143|NCT02065895|5632707|P4|Overall Study|Scheduling conflicts|0
1614144|NCT02065895|5632708|P3|Overall Study|Scheduling conflicts|0
1614145|NCT02065895|5632709|P2|Overall Study|Scheduling conflicts|1
1614146|NCT02065895|5632710|P1|Overall Study|Scheduling conflicts|0
1614147|NCT02065895|5632705|P6|Overall Study|Protocol Violation|0
1614148|NCT02065895|5632706|P5|Overall Study|Protocol Violation|0
1614149|NCT02065895|5632707|P4|Overall Study|Protocol Violation|1
1614150|NCT02065895|5632708|P3|Overall Study|Protocol Violation|0
1614151|NCT02065895|5632709|P2|Overall Study|Protocol Violation|0
1614152|NCT02065895|5632710|P1|Overall Study|Protocol Violation|1
1614153|NCT02065791|5632729|P2|Overall Study|Lost to Follow-up|9
1614154|NCT02065791|5632730|P1|Overall Study|Lost to Follow-up|13
1614155|NCT02065791|5632729|P2|Overall Study|Withdrawal by Subject|5
1614156|NCT02065791|5632730|P1|Overall Study|Withdrawal by Subject|11
1614157|NCT02065791|5632729|P2|Overall Study|Closed Site|1
1614158|NCT02065791|5632730|P1|Overall Study|Closed Site|1
1614159|NCT02065518|5632754|P4|Overall Study|Withdrawal by Subject|2
1614160|NCT02065518|5632755|P3|Overall Study|Withdrawal by Subject|9
1614161|NCT02065518|5632756|P2|Overall Study|Withdrawal by Subject|4
1614162|NCT02065518|5632757|P1|Overall Study|Withdrawal by Subject|3
1614163|NCT02065518|5632754|P4|Overall Study|Lost to Follow-up|3
1614164|NCT02065518|5632755|P3|Overall Study|Lost to Follow-up|0
1614165|NCT02065518|5632756|P2|Overall Study|Lost to Follow-up|4
1614166|NCT02065518|5632757|P1|Overall Study|Lost to Follow-up|3
1614167|NCT02065336|5632823|P10|Extension Phase|Study Terminated by Sponsor|8
1614168|NCT02065336|5632824|P9|Extension Phase|Study Terminated by Sponsor|2
1614169|NCT02065336|5632825|P8|Extension Phase|Study Terminated by Sponsor|0
1614170|NCT02065336|5632826|P7|Extension Phase|Study Terminated by Sponsor|0
1614171|NCT02065336|5632827|P6|Extension Phase|Study Terminated by Sponsor|0
1614172|NCT02065336|5632828|P5|Extension Phase|Study Terminated by Sponsor|0
1614173|NCT02065336|5632829|P4|Extension Phase|Study Terminated by Sponsor|0
1614174|NCT02065336|5632830|P3|Extension Phase|Study Terminated by Sponsor|0
1614175|NCT02065336|5632831|P2|Extension Phase|Study Terminated by Sponsor|0
1614176|NCT02065336|5632832|P1|Extension Phase|Study Terminated by Sponsor|0
1614177|NCT02064920|5633092|P2|Overall Study|Withdrawal by Subject|3
1614178|NCT02064920|5633093|P1|Overall Study|Withdrawal by Subject|1
1614179|NCT02064920|5633092|P2|Overall Study|Technical Problems|1
1614180|NCT02064920|5633093|P1|Overall Study|Technical Problems|0
1614181|NCT02064920|5633092|P2|Overall Study|Physician Decision|1
1614182|NCT02064920|5633093|P1|Overall Study|Physician Decision|0
1614183|NCT02064920|5633092|P2|Overall Study|Adverse Event|4
1614184|NCT02064920|5633093|P1|Overall Study|Adverse Event|0
1614185|NCT02064894|5633123|P3|Overall Study|Withdrawal by Subject|115
1614186|NCT02064894|5633124|P2|Overall Study|Withdrawal by Subject|102
1614187|NCT02064894|5633125|P1|Overall Study|Withdrawal by Subject|43
1614188|NCT02064868|5633138|P2|Overall Study|Technical Problems or Missing|2
1614189|NCT02064868|5633139|P1|Overall Study|Technical Problems or Missing|5
1614190|NCT02064868|5633138|P2|Overall Study|Withdrawal by Subject|3
1614191|NCT02064868|5633139|P1|Overall Study|Withdrawal by Subject|14
1614192|NCT02064868|5633138|P2|Overall Study|Physician Decision|0
1614193|NCT02064868|5633139|P1|Overall Study|Physician Decision|1
1614194|NCT02064868|5633138|P2|Overall Study|Lost to Follow-up|8
1614195|NCT02064868|5633139|P1|Overall Study|Lost to Follow-up|14
1614196|NCT02064816|5633159|P2|Overall Study|Other|3
1614197|NCT02064816|5633160|P1|Overall Study|Other|1
1614198|NCT02064816|5633159|P2|Overall Study|Therapeutic failure|1
1614199|NCT02064816|5633160|P1|Overall Study|Therapeutic failure|0
1614200|NCT02064816|5633159|P2|Overall Study|Lost to Follow-up|1
1614201|NCT02064816|5633160|P1|Overall Study|Lost to Follow-up|2
1614202|NCT02064816|5633159|P2|Overall Study|Withdrawal by Subject|1
1614203|NCT02064816|5633160|P1|Overall Study|Withdrawal by Subject|2
1614204|NCT02064816|5633159|P2|Overall Study|Adverse Event|2
1614205|NCT02064816|5633160|P1|Overall Study|Adverse Event|3
1614206|NCT02064439|5633201|P3|Overall Study|Other|7
1614207|NCT02064439|5633202|P2|Overall Study|Other|2
1614208|NCT02064439|5633203|P1|Overall Study|Other|2
1614209|NCT02064439|5633201|P3|Overall Study|Safety outcome reached|10
1614210|NCT02064439|5633202|P2|Overall Study|Safety outcome reached|20
1614211|NCT02064439|5633203|P1|Overall Study|Safety outcome reached|12
1614212|NCT02064439|5633201|P3|Overall Study|Efficacy outcome reached|57
1614213|NCT02064439|5633202|P2|Overall Study|Efficacy outcome reached|16
1614214|NCT02064439|5633203|P1|Overall Study|Efficacy outcome reached|18
1614215|NCT02064439|5633201|P3|Overall Study|Logistical difficulties|2
1614216|NCT02064439|5633202|P2|Overall Study|Logistical difficulties|5
1614217|NCT02064439|5633203|P1|Overall Study|Logistical difficulties|6
1614218|NCT02064439|5633201|P3|Overall Study|Physician Decision|1
1614219|NCT02064439|5633202|P2|Overall Study|Physician Decision|1
1614220|NCT02064439|5633203|P1|Overall Study|Physician Decision|0
1614221|NCT02064439|5633201|P3|Overall Study|Non-compliance with study medication|23
1614222|NCT02064439|5633202|P2|Overall Study|Non-compliance with study medication|19
1614223|NCT02064439|5633203|P1|Overall Study|Non-compliance with study medication|21
1614224|NCT02064439|5633201|P3|Overall Study|Lost to Follow-up|4
1614225|NCT02064439|5633202|P2|Overall Study|Lost to Follow-up|3
1614226|NCT02064439|5633203|P1|Overall Study|Lost to Follow-up|1
1614227|NCT02064439|5633201|P3|Overall Study|Protocol Violation|3
1614228|NCT02064439|5633202|P2|Overall Study|Protocol Violation|5
1614229|NCT02064439|5633203|P1|Overall Study|Protocol Violation|3
1614230|NCT02064439|5633201|P3|Overall Study|Withdrawal by Subject|26
1614231|NCT02064439|5633202|P2|Overall Study|Withdrawal by Subject|18
1614232|NCT02064439|5633203|P1|Overall Study|Withdrawal by Subject|29
1614233|NCT02064439|5633201|P3|Overall Study|Death|3
1614234|NCT02064439|5633202|P2|Overall Study|Death|2
1614235|NCT02064439|5633203|P1|Overall Study|Death|0
1614236|NCT02064439|5633201|P3|Overall Study|Adverse Event|46
1614237|NCT02064439|5633202|P2|Overall Study|Adverse Event|47
1614238|NCT02064439|5633203|P1|Overall Study|Adverse Event|51
1614239|NCT02064387|5633231|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|8
1614240|NCT02064387|5633232|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614241|NCT02064387|5633233|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614242|NCT02064387|5633234|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614243|NCT02064387|5633235|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614244|NCT02064387|5633236|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614245|NCT02064387|5633237|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614246|NCT02064387|5633238|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614247|NCT02064387|5633239|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614248|NCT02064387|5633240|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614249|NCT02064387|5633241|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614250|NCT02064387|5633231|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|1
1614251|NCT02064387|5633232|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614252|NCT02064387|5633233|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614253|NCT02064387|5633234|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614254|NCT02064387|5633235|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614255|NCT02064387|5633236|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614256|NCT02064387|5633237|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614257|NCT02064387|5633238|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614258|NCT02064387|5633239|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614259|NCT02064387|5633240|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614260|NCT02064387|5633241|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
1614261|NCT02064387|5633231|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Death|4
1614262|NCT02064387|5633232|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614263|NCT02064387|5633233|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614264|NCT02064387|5633234|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614265|NCT02064387|5633235|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614266|NCT02064387|5633236|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614267|NCT02064387|5633237|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614268|NCT02064387|5633238|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614269|NCT02064387|5633239|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614270|NCT02064387|5633240|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614271|NCT02064387|5633241|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
1614272|NCT02064387|5633231|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614273|NCT02064387|5633232|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614274|NCT02064387|5633233|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|1
1614275|NCT02064387|5633234|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614276|NCT02064387|5633235|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614277|NCT02064387|5633236|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614278|NCT02064387|5633237|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614279|NCT02064387|5633238|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614280|NCT02064387|5633239|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614281|NCT02064387|5633240|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614282|NCT02064387|5633241|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
1614283|NCT02064387|5633231|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614284|NCT02064387|5633232|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614285|NCT02064387|5633233|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614286|NCT02064387|5633234|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|1
1614287|NCT02064387|5633235|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614288|NCT02064387|5633236|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614289|NCT02064387|5633237|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614290|NCT02064387|5633238|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614291|NCT02064387|5633239|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614292|NCT02064387|5633240|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614293|NCT02064387|5633241|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
1614294|NCT02064387|5633231|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614295|NCT02064387|5633232|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614296|NCT02064387|5633233|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614297|NCT02064387|5633234|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|1
1614298|NCT02064387|5633235|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614299|NCT02064387|5633236|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614300|NCT02064387|5633237|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614301|NCT02064387|5633238|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614302|NCT02064387|5633239|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614303|NCT02064387|5633240|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614304|NCT02064387|5633241|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
1614305|NCT02064387|5633231|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614306|NCT02064387|5633232|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
1614307|NCT02064387|5633233|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614308|NCT02064387|5633234|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
1614309|NCT02064387|5633235|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614310|NCT02064387|5633236|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614311|NCT02064387|5633237|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614312|NCT02064387|5633238|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614313|NCT02064387|5633239|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614314|NCT02064387|5633240|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614315|NCT02064387|5633241|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
1614316|NCT02064231|5633556|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1614317|NCT02064231|5633557|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
1614318|NCT02064231|5633558|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1614319|NCT02064231|5633559|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
1614320|NCT02064231|5633556|P4|First Test Period (Test A or Test C)|Adverse Event|0
1614321|NCT02064231|5633557|P3|First Test Period (Test A or Test C)|Adverse Event|1
1614322|NCT02064231|5633558|P2|First Test Period (Test A or Test C)|Adverse Event|0
1614323|NCT02064231|5633559|P1|First Test Period (Test A or Test C)|Adverse Event|1
1614324|NCT02064231|5633556|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1614325|NCT02064231|5633557|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
1614326|NCT02064231|5633558|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1614327|NCT02064231|5633559|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
1614328|NCT02064231|5633556|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
1614329|NCT02064231|5633557|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
1614330|NCT02064231|5633558|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
1614331|NCT02064231|5633559|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
1614332|NCT02064205|5633571|P1|Overall Study|Withdrawal by Subject|1
1614333|NCT02064166|5633589|P2|Overall Study|Adverse Event|0
1614334|NCT02064166|5633590|P1|Overall Study|Adverse Event|1
1614335|NCT02063880|5633620|P2|Overall Study|Ineligible|2
1614336|NCT02063880|5633621|P1|Overall Study|Ineligible|0
1614337|NCT02063880|5633620|P2|Overall Study|Lost to Follow-up|7
1614338|NCT02063880|5633621|P1|Overall Study|Lost to Follow-up|7
1614339|NCT02063880|5633620|P2|Overall Study|Death|18
1614340|NCT02063880|5633621|P1|Overall Study|Death|21
1614341|NCT02063854|5633659|P7|Overall Study|Did Not Receive Study Drug|0
1614342|NCT02063854|5633660|P6|Overall Study|Did Not Receive Study Drug|1
1614343|NCT02063854|5633661|P5|Overall Study|Did Not Receive Study Drug|0
1614344|NCT02063854|5633662|P4|Overall Study|Did Not Receive Study Drug|0
1614345|NCT02063854|5633663|P3|Overall Study|Did Not Receive Study Drug|0
1614346|NCT02063854|5633664|P2|Overall Study|Did Not Receive Study Drug|0
1614347|NCT02063854|5633665|P1|Overall Study|Did Not Receive Study Drug|0
1614348|NCT02063854|5633659|P7|Overall Study|Reason Not Specified|0
1614349|NCT02063854|5633660|P6|Overall Study|Reason Not Specified|0
1614350|NCT02063854|5633661|P5|Overall Study|Reason Not Specified|0
1614351|NCT02063854|5633662|P4|Overall Study|Reason Not Specified|0
1614352|NCT02063854|5633663|P3|Overall Study|Reason Not Specified|0
1614353|NCT02063854|5633664|P2|Overall Study|Reason Not Specified|0
1614354|NCT02063854|5633665|P1|Overall Study|Reason Not Specified|1
1614355|NCT02063854|5633659|P7|Overall Study|Surgical Dental Work Performed/Planned|1
1614356|NCT02063854|5633660|P6|Overall Study|Surgical Dental Work Performed/Planned|6
1614357|NCT02063854|5633661|P5|Overall Study|Surgical Dental Work Performed/Planned|1
1614358|NCT02063854|5633662|P4|Overall Study|Surgical Dental Work Performed/Planned|1
1614359|NCT02063854|5633663|P3|Overall Study|Surgical Dental Work Performed/Planned|6
1614360|NCT02063854|5633664|P2|Overall Study|Surgical Dental Work Performed/Planned|2
1614361|NCT02063854|5633665|P1|Overall Study|Surgical Dental Work Performed/Planned|5
1614362|NCT02063854|5633659|P7|Overall Study|Voluntary Withdrawal|1
1614363|NCT02063854|5633660|P6|Overall Study|Voluntary Withdrawal|6
1614364|NCT02063854|5633661|P5|Overall Study|Voluntary Withdrawal|3
1614365|NCT02063854|5633662|P4|Overall Study|Voluntary Withdrawal|1
1614366|NCT02063854|5633663|P3|Overall Study|Voluntary Withdrawal|8
1614367|NCT02063854|5633664|P2|Overall Study|Voluntary Withdrawal|0
1614368|NCT02063854|5633665|P1|Overall Study|Voluntary Withdrawal|2
1614369|NCT02063854|5633659|P7|Overall Study|Major Protocol Deviation|0
1614370|NCT02063854|5633660|P6|Overall Study|Major Protocol Deviation|0
1614371|NCT02063854|5633661|P5|Overall Study|Major Protocol Deviation|0
1614372|NCT02063854|5633662|P4|Overall Study|Major Protocol Deviation|0
1614373|NCT02063854|5633663|P3|Overall Study|Major Protocol Deviation|3
1614374|NCT02063854|5633664|P2|Overall Study|Major Protocol Deviation|0
1614375|NCT02063854|5633665|P1|Overall Study|Major Protocol Deviation|0
1614376|NCT02063854|5633659|P7|Overall Study|Pretreatment Event/Adverse Event|4
1614377|NCT02063854|5633660|P6|Overall Study|Pretreatment Event/Adverse Event|18
1614378|NCT02063854|5633661|P5|Overall Study|Pretreatment Event/Adverse Event|7
1614379|NCT02063854|5633662|P4|Overall Study|Pretreatment Event/Adverse Event|8
1614380|NCT02063854|5633663|P3|Overall Study|Pretreatment Event/Adverse Event|13
1614381|NCT02063854|5633664|P2|Overall Study|Pretreatment Event/Adverse Event|10
1614382|NCT02063854|5633665|P1|Overall Study|Pretreatment Event/Adverse Event|13
1614383|NCT02063737|5633749|P2|Overall Study|Lost to Follow-up|4
1614384|NCT02063737|5633750|P1|Overall Study|Lost to Follow-up|11
1614385|NCT02063724|5633782|P1|Overall Study|Disease progression|1
1614386|NCT02063698|5633790|P2|Overall Study|did not complete booklet for days 2-8|2
1614387|NCT02063698|5633791|P1|Overall Study|did not complete booklet for days 2-8|1
1614388|NCT02063672|5633815|P2|Overall Study|Withdrawal by Subject|2
1614389|NCT02063672|5633816|P1|Overall Study|Withdrawal by Subject|2
1614390|NCT02063672|5633815|P2|Overall Study|Lost to Follow-up|3
1614391|NCT02063672|5633816|P1|Overall Study|Lost to Follow-up|1
1614392|NCT02063672|5633815|P2|Overall Study|Death|3
1614393|NCT02063672|5633816|P1|Overall Study|Death|5
1614394|NCT02063672|5633815|P2|Overall Study|Ongoing Follow-up|14
1614395|NCT02063672|5633816|P1|Overall Study|Ongoing Follow-up|27
1614396|NCT02063659|5633863|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
1614397|NCT02063659|5633864|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
1614398|NCT02063659|5633865|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
1614399|NCT02063659|5633866|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
1614400|NCT02063659|5633863|P4|Open-Label Extension Period (OLE)|Adverse Event|7
1614401|NCT02063659|5633864|P3|Open-Label Extension Period (OLE)|Adverse Event|0
1614402|NCT02063659|5633865|P2|Open-Label Extension Period (OLE)|Adverse Event|0
1614403|NCT02063659|5633866|P1|Open-Label Extension Period (OLE)|Adverse Event|0
1614404|NCT02063659|5633863|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
1614405|NCT02063659|5633864|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1614406|NCT02063659|5633865|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1614407|NCT02063659|5633866|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1614408|NCT02063659|5633863|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1614495|NCT02060383|5634701|P2|Extension Phase|Protocol Violation|0
1614409|NCT02063659|5633864|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1614410|NCT02063659|5633865|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1614411|NCT02063659|5633866|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1614412|NCT02063659|5633863|P4|Open-Label Extension Period (OLE)|Physician Decision|1
1614413|NCT02063659|5633864|P3|Open-Label Extension Period (OLE)|Physician Decision|0
1614414|NCT02063659|5633865|P2|Open-Label Extension Period (OLE)|Physician Decision|0
1614415|NCT02063659|5633866|P1|Open-Label Extension Period (OLE)|Physician Decision|0
1614416|NCT02063659|5633863|P4|Double-Blind Treatment Period|Withdrawal of consent|0
1614417|NCT02063659|5633864|P3|Double-Blind Treatment Period|Withdrawal of consent|3
1614418|NCT02063659|5633865|P2|Double-Blind Treatment Period|Withdrawal of consent|1
1614419|NCT02063659|5633866|P1|Double-Blind Treatment Period|Withdrawal of consent|0
1614420|NCT02063659|5633863|P4|Double-Blind Treatment Period|Physician Decision|0
1614421|NCT02063659|5633864|P3|Double-Blind Treatment Period|Physician Decision|0
1614422|NCT02063659|5633865|P2|Double-Blind Treatment Period|Physician Decision|0
1614423|NCT02063659|5633866|P1|Double-Blind Treatment Period|Physician Decision|1
1614424|NCT02063659|5633863|P4|Double-Blind Treatment Period|Adverse Event|0
1614425|NCT02063659|5633864|P3|Double-Blind Treatment Period|Adverse Event|0
1614426|NCT02063659|5633865|P2|Double-Blind Treatment Period|Adverse Event|2
1614427|NCT02063659|5633866|P1|Double-Blind Treatment Period|Adverse Event|1
1614428|NCT02063217|5633949|P3|Overall Study|Withdrawal by Subject|0
1614429|NCT02063217|5633950|P2|Overall Study|Withdrawal by Subject|0
1614430|NCT02063217|5633951|P1|Overall Study|Withdrawal by Subject|1
1614431|NCT02062879|5634027|P2|Overall Study|Withdrawal by Subject|1
1614432|NCT02062879|5634028|P1|Overall Study|Withdrawal by Subject|4
1614433|NCT02062658|5634064|P1|Overall Study|Lack of Efficacy|1
1614434|NCT02062658|5634064|P1|Overall Study|Withdrawal by Subject|1
1614435|NCT02062645|5634068|P1|Overall Study|Lost to Follow-up|5
1614436|NCT02062645|5634068|P1|Overall Study|Protocol Violation|8
1614437|NCT02062645|5634068|P1|Overall Study|Adverse Event|2
1614438|NCT02062632|5634076|P1|Overall Study|No treatment data|1
1614439|NCT02062450|5634117|P1|Overall Study|No follow-up visit|124
1614440|NCT02062437|5634131|P1|Overall Study|Pt. couldn't come due to med. condition|1
1614441|NCT02062437|5634131|P1|Overall Study|Death|2
1614442|NCT02062437|5634131|P1|Overall Study|Patient not available for the 2y visit|18
1614443|NCT02062437|5634131|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
1614444|NCT02062398|5634140|P1|Overall Study|Implant removal|1
1614445|NCT02062385|5634152|P4|Overall Study|Lost to Follow-up|0
1614446|NCT02062385|5634153|P3|Overall Study|Lost to Follow-up|1
1614447|NCT02062385|5634154|P2|Overall Study|Lost to Follow-up|0
1614448|NCT02062385|5634155|P1|Overall Study|Lost to Follow-up|0
1614449|NCT02062385|5634152|P4|Overall Study|Death|1
1614450|NCT02062385|5634153|P3|Overall Study|Death|0
1614451|NCT02062385|5634154|P2|Overall Study|Death|0
1614452|NCT02062385|5634155|P1|Overall Study|Death|0
1614453|NCT02062385|5634152|P4|Overall Study|Withdrawn by parent/guardian|8
1614454|NCT02062385|5634153|P3|Overall Study|Withdrawn by parent/guardian|9
1614455|NCT02062385|5634154|P2|Overall Study|Withdrawn by parent/guardian|41
1614456|NCT02062385|5634155|P1|Overall Study|Withdrawn by parent/guardian|46
1614457|NCT02062385|5634152|P4|Overall Study|Moved|0
1614458|NCT02062385|5634153|P3|Overall Study|Moved|1
1614459|NCT02062385|5634154|P2|Overall Study|Moved|11
1614460|NCT02062385|5634155|P1|Overall Study|Moved|10
1614461|NCT02062385|5634152|P4|Overall Study|Incomplete EPI by database lock|0
1614462|NCT02062385|5634153|P3|Overall Study|Incomplete EPI by database lock|0
1614463|NCT02062385|5634154|P2|Overall Study|Incomplete EPI by database lock|0
1614464|NCT02062385|5634155|P1|Overall Study|Incomplete EPI by database lock|2
1614465|NCT02062385|5634152|P4|Overall Study|Protocol Violation|0
1614466|NCT02062385|5634153|P3|Overall Study|Protocol Violation|0
1614467|NCT02062385|5634154|P2|Overall Study|Protocol Violation|0
1614468|NCT02062385|5634155|P1|Overall Study|Protocol Violation|1
1614469|NCT02062385|5634152|P4|Overall Study|Adverse Event|0
1614470|NCT02062385|5634153|P3|Overall Study|Adverse Event|1
1614471|NCT02062385|5634154|P2|Overall Study|Adverse Event|13
1614472|NCT02062385|5634155|P1|Overall Study|Adverse Event|19
1614473|NCT02062151|5634199|P1|Overall Study|screen failure|1
1614474|NCT02061592|5634344|P2|Period 2|Lost to Follow-up|1
1614475|NCT02061592|5634345|P1|Period 2|Lost to Follow-up|0
1614476|NCT02061592|5634344|P2|Period 1|Protocol Violation|0
1614477|NCT02061592|5634345|P1|Period 1|Protocol Violation|1
1614478|NCT02061592|5634344|P2|Period 1|Withdrawal by Subject|0
1614479|NCT02061592|5634345|P1|Period 1|Withdrawal by Subject|1
1614480|NCT02061540|5634357|P1|Overall Study|Withdrawal by Subject|2
1614481|NCT02061540|5634357|P1|Overall Study|Adverse Event|2
1614482|NCT02061280|5634525|P2|Overall Study|Lost to Follow-up|1
1614483|NCT02061280|5634526|P1|Overall Study|Lost to Follow-up|5
1614484|NCT02061280|5634525|P2|Overall Study|Withdrawal by Subject|2
1614485|NCT02061280|5634526|P1|Overall Study|Withdrawal by Subject|1
1614486|NCT02061280|5634525|P2|Overall Study|moved out of state|1
1614487|NCT02061280|5634526|P1|Overall Study|moved out of state|0
1614488|NCT02061280|5634525|P2|Overall Study|Protocol Violation|8
1614489|NCT02061280|5634526|P1|Overall Study|Protocol Violation|12
1614490|NCT02061202|5634558|P2|Overall Study|Lost to Follow-up|1
1614491|NCT02061202|5634559|P1|Overall Study|Lost to Follow-up|1
1614492|NCT02060383|5634698|P5|Extension Phase|Protocol Violation|1
1614493|NCT02060383|5634699|P4|Extension Phase|Protocol Violation|0
1614494|NCT02060383|5634700|P3|Extension Phase|Protocol Violation|0
1614496|NCT02060383|5634702|P1|Extension Phase|Protocol Violation|0
1614497|NCT02060383|5634698|P5|Extension Phase|Death|1
1614498|NCT02060383|5634699|P4|Extension Phase|Death|0
1614499|NCT02060383|5634700|P3|Extension Phase|Death|1
1614500|NCT02060383|5634701|P2|Extension Phase|Death|0
1614501|NCT02060383|5634702|P1|Extension Phase|Death|0
1614502|NCT02060383|5634698|P5|Extension Phase|Administrative problems|0
1614503|NCT02060383|5634699|P4|Extension Phase|Administrative problems|0
1614504|NCT02060383|5634700|P3|Extension Phase|Administrative problems|0
1614505|NCT02060383|5634701|P2|Extension Phase|Administrative problems|0
1614506|NCT02060383|5634702|P1|Extension Phase|Administrative problems|1
1614507|NCT02060383|5634698|P5|Extension Phase|Withdrawal by Subject|2
1614508|NCT02060383|5634699|P4|Extension Phase|Withdrawal by Subject|0
1614509|NCT02060383|5634700|P3|Extension Phase|Withdrawal by Subject|0
1614510|NCT02060383|5634701|P2|Extension Phase|Withdrawal by Subject|1
1614511|NCT02060383|5634702|P1|Extension Phase|Withdrawal by Subject|0
1614512|NCT02060383|5634698|P5|Extension Phase|Adverse Event|1
1614513|NCT02060383|5634699|P4|Extension Phase|Adverse Event|0
1614514|NCT02060383|5634700|P3|Extension Phase|Adverse Event|2
1614515|NCT02060383|5634701|P2|Extension Phase|Adverse Event|1
1614516|NCT02060383|5634702|P1|Extension Phase|Adverse Event|1
1614517|NCT02060383|5634698|P5|Extension Phase|Unsatisfactory therapeutic effect|2
1614518|NCT02060383|5634699|P4|Extension Phase|Unsatisfactory therapeutic effect|2
1614519|NCT02060383|5634700|P3|Extension Phase|Unsatisfactory therapeutic effect|0
1614520|NCT02060383|5634701|P2|Extension Phase|Unsatisfactory therapeutic effect|1
1614521|NCT02060383|5634702|P1|Extension Phase|Unsatisfactory therapeutic effect|1
1614522|NCT02060383|5634698|P5|Core Phase|Withdrawal by Subject|2
1614523|NCT02060383|5634699|P4|Core Phase|Withdrawal by Subject|4
1614524|NCT02060383|5634700|P3|Core Phase|Withdrawal by Subject|0
1614525|NCT02060383|5634701|P2|Core Phase|Withdrawal by Subject|0
1614526|NCT02060383|5634702|P1|Core Phase|Withdrawal by Subject|0
1614527|NCT02060383|5634698|P5|Core Phase|Protocol Violation|0
1614528|NCT02060383|5634699|P4|Core Phase|Protocol Violation|1
1614529|NCT02060383|5634700|P3|Core Phase|Protocol Violation|0
1614530|NCT02060383|5634701|P2|Core Phase|Protocol Violation|0
1614531|NCT02060383|5634702|P1|Core Phase|Protocol Violation|0
1614532|NCT02060383|5634698|P5|Core Phase|Administrative problems|0
1614533|NCT02060383|5634699|P4|Core Phase|Administrative problems|0
1614534|NCT02060383|5634700|P3|Core Phase|Administrative problems|0
1614535|NCT02060383|5634701|P2|Core Phase|Administrative problems|1
1614536|NCT02060383|5634702|P1|Core Phase|Administrative problems|0
1614537|NCT02060383|5634698|P5|Core Phase|Adverse Event|6
1614538|NCT02060383|5634699|P4|Core Phase|Adverse Event|2
1614539|NCT02060383|5634700|P3|Core Phase|Adverse Event|0
1614540|NCT02060383|5634701|P2|Core Phase|Adverse Event|0
1614541|NCT02060383|5634702|P1|Core Phase|Adverse Event|2
1614542|NCT02060383|5634698|P5|Core Phase|Unsatisfactory therapeutic effect|0
1614543|NCT02060383|5634699|P4|Core Phase|Unsatisfactory therapeutic effect|0
1614544|NCT02060383|5634700|P3|Core Phase|Unsatisfactory therapeutic effect|0
1614545|NCT02060383|5634701|P2|Core Phase|Unsatisfactory therapeutic effect|5
1614546|NCT02060383|5634702|P1|Core Phase|Unsatisfactory therapeutic effect|1
1614547|NCT02059980|5634758|P2|Overall Study|Lost to Follow-up|1
1614548|NCT02059980|5634759|P1|Overall Study|Lost to Follow-up|2
1614549|NCT02059434|5634804|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
1614550|NCT02059434|5634805|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614551|NCT02059434|5634806|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614552|NCT02059434|5634807|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614553|NCT02059434|5634808|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614554|NCT02059434|5634809|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614555|NCT02059434|5634810|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614556|NCT02059434|5634811|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614557|NCT02059434|5634812|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
1614558|NCT02059434|5634804|P9|Washout Between Periods 7 and 8|Adverse Event|1
1614559|NCT02059434|5634805|P8|Washout Between Periods 7 and 8|Adverse Event|0
1614560|NCT02059434|5634806|P7|Washout Between Periods 7 and 8|Adverse Event|0
1614561|NCT02059434|5634807|P6|Washout Between Periods 7 and 8|Adverse Event|0
1614562|NCT02059434|5634808|P5|Washout Between Periods 7 and 8|Adverse Event|0
1614563|NCT02059434|5634809|P4|Washout Between Periods 7 and 8|Adverse Event|0
1614564|NCT02059434|5634810|P3|Washout Between Periods 7 and 8|Adverse Event|0
1614565|NCT02059434|5634811|P2|Washout Between Periods 7 and 8|Adverse Event|0
1614566|NCT02059434|5634812|P1|Washout Between Periods 7 and 8|Adverse Event|0
1614567|NCT02059434|5634804|P9|Washout Between Periods 6 and 7|Physician Decision|1
1614568|NCT02059434|5634805|P8|Washout Between Periods 6 and 7|Physician Decision|0
1614569|NCT02059434|5634806|P7|Washout Between Periods 6 and 7|Physician Decision|0
1614570|NCT02059434|5634807|P6|Washout Between Periods 6 and 7|Physician Decision|0
1614571|NCT02059434|5634808|P5|Washout Between Periods 6 and 7|Physician Decision|0
1614572|NCT02059434|5634809|P4|Washout Between Periods 6 and 7|Physician Decision|0
1614573|NCT02059434|5634810|P3|Washout Between Periods 6 and 7|Physician Decision|0
1614574|NCT02059434|5634811|P2|Washout Between Periods 6 and 7|Physician Decision|0
1614575|NCT02059434|5634812|P1|Washout Between Periods 6 and 7|Physician Decision|0
1614576|NCT02059434|5634804|P9|Washout Between Periods 4 and 5|Adverse Event|1
1614577|NCT02059434|5634805|P8|Washout Between Periods 4 and 5|Adverse Event|0
1614578|NCT02059434|5634806|P7|Washout Between Periods 4 and 5|Adverse Event|0
1614579|NCT02059434|5634807|P6|Washout Between Periods 4 and 5|Adverse Event|0
1614580|NCT02059434|5634808|P5|Washout Between Periods 4 and 5|Adverse Event|0
1614581|NCT02059434|5634809|P4|Washout Between Periods 4 and 5|Adverse Event|0
1614582|NCT02059434|5634810|P3|Washout Between Periods 4 and 5|Adverse Event|0
1614583|NCT02059434|5634811|P2|Washout Between Periods 4 and 5|Adverse Event|0
1614584|NCT02059434|5634812|P1|Washout Between Periods 4 and 5|Adverse Event|0
1614585|NCT02059434|5634804|P9|Washout Between Periods 1 and 2|Physician Decision|0
1614586|NCT02059434|5634805|P8|Washout Between Periods 1 and 2|Physician Decision|1
1614587|NCT02059434|5634806|P7|Washout Between Periods 1 and 2|Physician Decision|0
1614588|NCT02059434|5634807|P6|Washout Between Periods 1 and 2|Physician Decision|0
1614589|NCT02059434|5634808|P5|Washout Between Periods 1 and 2|Physician Decision|0
1614590|NCT02059434|5634809|P4|Washout Between Periods 1 and 2|Physician Decision|0
1614591|NCT02059434|5634810|P3|Washout Between Periods 1 and 2|Physician Decision|0
1614592|NCT02059434|5634811|P2|Washout Between Periods 1 and 2|Physician Decision|0
1614593|NCT02059434|5634812|P1|Washout Between Periods 1 and 2|Physician Decision|0
1614594|NCT02059408|5634877|P3|Overall Study|Did not get tested|358
1614595|NCT02059408|5634878|P2|Overall Study|Did not get tested|330
1614596|NCT02059408|5634879|P1|Overall Study|Did not get tested|0
1614597|NCT02059395|5634898|P2|Overall Study|Lost to Follow-up|4
1614598|NCT02059395|5634899|P1|Overall Study|Lost to Follow-up|2
1614599|NCT02059291|5634914|P25|Epoch 4|Lack of Efficacy|0
1614600|NCT02059291|5634915|P24|Epoch 4|Lack of Efficacy|1
1614601|NCT02059291|5634916|P23|Epoch 4|Lack of Efficacy|0
1614602|NCT02059291|5634917|P22|Epoch 4|Lack of Efficacy|0
1614603|NCT02059291|5634918|P21|Epoch 4|Lack of Efficacy|0
1614604|NCT02059291|5634919|P20|Epoch 4|Lack of Efficacy|0
1614605|NCT02059291|5634920|P19|Epoch 4|Lack of Efficacy|0
1614606|NCT02059291|5634921|P18|Epoch 4|Lack of Efficacy|0
1614607|NCT02059291|5634922|P17|Epoch 4|Lack of Efficacy|0
1614608|NCT02059291|5634923|P16|Epoch 4|Lack of Efficacy|0
1614609|NCT02059291|5634924|P15|Epoch 4|Lack of Efficacy|0
1614610|NCT02059291|5634925|P14|Epoch 4|Lack of Efficacy|0
1614611|NCT02059291|5634926|P13|Epoch 4|Lack of Efficacy|0
1614612|NCT02059291|5634927|P12|Epoch 4|Lack of Efficacy|0
1614613|NCT02059291|5634928|P11|Epoch 4|Lack of Efficacy|0
1614614|NCT02059291|5634929|P10|Epoch 4|Lack of Efficacy|0
1614615|NCT02059291|5634930|P9|Epoch 4|Lack of Efficacy|0
1614616|NCT02059291|5634931|P8|Epoch 4|Lack of Efficacy|0
1614617|NCT02059291|5634932|P7|Epoch 4|Lack of Efficacy|0
1614618|NCT02059291|5634933|P6|Epoch 4|Lack of Efficacy|0
1614619|NCT02059291|5634934|P5|Epoch 4|Lack of Efficacy|0
1614620|NCT02059291|5634935|P4|Epoch 4|Lack of Efficacy|0
1614621|NCT02059291|5634936|P3|Epoch 4|Lack of Efficacy|0
1614622|NCT02059291|5634937|P2|Epoch 4|Lack of Efficacy|0
1614623|NCT02059291|5634938|P1|Epoch 4|Lack of Efficacy|0
1614624|NCT02059291|5634914|P25|Epoch 4|Withdrawal by Subject|0
1614625|NCT02059291|5634915|P24|Epoch 4|Withdrawal by Subject|0
1614626|NCT02059291|5634916|P23|Epoch 4|Withdrawal by Subject|0
1614627|NCT02059291|5634917|P22|Epoch 4|Withdrawal by Subject|0
1614628|NCT02059291|5634918|P21|Epoch 4|Withdrawal by Subject|1
1614629|NCT02059291|5634919|P20|Epoch 4|Withdrawal by Subject|0
1614630|NCT02059291|5634920|P19|Epoch 4|Withdrawal by Subject|0
1614631|NCT02059291|5634921|P18|Epoch 4|Withdrawal by Subject|0
1614632|NCT02059291|5634922|P17|Epoch 4|Withdrawal by Subject|0
1614633|NCT02059291|5634923|P16|Epoch 4|Withdrawal by Subject|0
1614634|NCT02059291|5634924|P15|Epoch 4|Withdrawal by Subject|0
1614635|NCT02059291|5634925|P14|Epoch 4|Withdrawal by Subject|0
1614636|NCT02059291|5634926|P13|Epoch 4|Withdrawal by Subject|0
1614637|NCT02059291|5634927|P12|Epoch 4|Withdrawal by Subject|0
1614638|NCT02059291|5634928|P11|Epoch 4|Withdrawal by Subject|0
1614639|NCT02059291|5634929|P10|Epoch 4|Withdrawal by Subject|0
1614640|NCT02059291|5634930|P9|Epoch 4|Withdrawal by Subject|0
1614641|NCT02059291|5634931|P8|Epoch 4|Withdrawal by Subject|0
1614642|NCT02059291|5634932|P7|Epoch 4|Withdrawal by Subject|0
1614643|NCT02059291|5634933|P6|Epoch 4|Withdrawal by Subject|0
1614644|NCT02059291|5634934|P5|Epoch 4|Withdrawal by Subject|0
1614645|NCT02059291|5634935|P4|Epoch 4|Withdrawal by Subject|0
1614646|NCT02059291|5634936|P3|Epoch 4|Withdrawal by Subject|0
1614647|NCT02059291|5634937|P2|Epoch 4|Withdrawal by Subject|0
1614648|NCT02059291|5634938|P1|Epoch 4|Withdrawal by Subject|0
1614649|NCT02059291|5634914|P25|Epoch 4|Pregnancy|0
1614650|NCT02059291|5634915|P24|Epoch 4|Pregnancy|0
1614651|NCT02059291|5634916|P23|Epoch 4|Pregnancy|0
1614652|NCT02059291|5634917|P22|Epoch 4|Pregnancy|0
1614653|NCT02059291|5634918|P21|Epoch 4|Pregnancy|0
1614654|NCT02059291|5634919|P20|Epoch 4|Pregnancy|0
1614655|NCT02059291|5634920|P19|Epoch 4|Pregnancy|0
1614656|NCT02059291|5634921|P18|Epoch 4|Pregnancy|0
1614657|NCT02059291|5634922|P17|Epoch 4|Pregnancy|1
1614658|NCT02059291|5634923|P16|Epoch 4|Pregnancy|0
1614659|NCT02059291|5634924|P15|Epoch 4|Pregnancy|0
1614660|NCT02059291|5634925|P14|Epoch 4|Pregnancy|0
1614661|NCT02059291|5634926|P13|Epoch 4|Pregnancy|0
1614662|NCT02059291|5634927|P12|Epoch 4|Pregnancy|0
1614663|NCT02059291|5634928|P11|Epoch 4|Pregnancy|0
1614664|NCT02059291|5634929|P10|Epoch 4|Pregnancy|0
1614665|NCT02059291|5634930|P9|Epoch 4|Pregnancy|0
1614666|NCT02059291|5634931|P8|Epoch 4|Pregnancy|0
1614667|NCT02059291|5634932|P7|Epoch 4|Pregnancy|0
1614668|NCT02059291|5634933|P6|Epoch 4|Pregnancy|0
1614669|NCT02059291|5634934|P5|Epoch 4|Pregnancy|0
1614670|NCT02059291|5634935|P4|Epoch 4|Pregnancy|0
1614671|NCT02059291|5634936|P3|Epoch 4|Pregnancy|0
1614672|NCT02059291|5634937|P2|Epoch 4|Pregnancy|0
1614673|NCT02059291|5634938|P1|Epoch 4|Pregnancy|0
1614674|NCT02059291|5634914|P25|Epoch 4|Adverse Event|0
1614675|NCT02059291|5634915|P24|Epoch 4|Adverse Event|0
1614676|NCT02059291|5634916|P23|Epoch 4|Adverse Event|1
1614677|NCT02059291|5634917|P22|Epoch 4|Adverse Event|0
1614678|NCT02059291|5634918|P21|Epoch 4|Adverse Event|0
1614679|NCT02059291|5634919|P20|Epoch 4|Adverse Event|0
1614680|NCT02059291|5634920|P19|Epoch 4|Adverse Event|0
1614681|NCT02059291|5634921|P18|Epoch 4|Adverse Event|0
1614682|NCT02059291|5634922|P17|Epoch 4|Adverse Event|1
1614683|NCT02059291|5634923|P16|Epoch 4|Adverse Event|0
1614684|NCT02059291|5634924|P15|Epoch 4|Adverse Event|0
1614685|NCT02059291|5634925|P14|Epoch 4|Adverse Event|0
1614686|NCT02059291|5634926|P13|Epoch 4|Adverse Event|0
1614687|NCT02059291|5634927|P12|Epoch 4|Adverse Event|0
1614688|NCT02059291|5634928|P11|Epoch 4|Adverse Event|0
1614689|NCT02059291|5634929|P10|Epoch 4|Adverse Event|0
1614690|NCT02059291|5634930|P9|Epoch 4|Adverse Event|0
1614691|NCT02059291|5634931|P8|Epoch 4|Adverse Event|0
1614692|NCT02059291|5634932|P7|Epoch 4|Adverse Event|0
1614693|NCT02059291|5634933|P6|Epoch 4|Adverse Event|0
1614694|NCT02059291|5634934|P5|Epoch 4|Adverse Event|0
1614695|NCT02059291|5634935|P4|Epoch 4|Adverse Event|0
1614696|NCT02059291|5634936|P3|Epoch 4|Adverse Event|0
1614697|NCT02059291|5634937|P2|Epoch 4|Adverse Event|0
1614698|NCT02059291|5634938|P1|Epoch 4|Adverse Event|0
1614699|NCT02059291|5634914|P25|Epoch 3|Withdrawal by Subject|0
1614700|NCT02059291|5634915|P24|Epoch 3|Withdrawal by Subject|0
1614701|NCT02059291|5634916|P23|Epoch 3|Withdrawal by Subject|0
1614702|NCT02059291|5634917|P22|Epoch 3|Withdrawal by Subject|0
1614703|NCT02059291|5634918|P21|Epoch 3|Withdrawal by Subject|0
1614704|NCT02059291|5634919|P20|Epoch 3|Withdrawal by Subject|0
1614705|NCT02059291|5634920|P19|Epoch 3|Withdrawal by Subject|0
1614706|NCT02059291|5634921|P18|Epoch 3|Withdrawal by Subject|0
1614707|NCT02059291|5634922|P17|Epoch 3|Withdrawal by Subject|0
1614708|NCT02059291|5634923|P16|Epoch 3|Withdrawal by Subject|1
1614709|NCT02059291|5634924|P15|Epoch 3|Withdrawal by Subject|0
1614710|NCT02059291|5634925|P14|Epoch 3|Withdrawal by Subject|0
1614711|NCT02059291|5634926|P13|Epoch 3|Withdrawal by Subject|0
1614712|NCT02059291|5634927|P12|Epoch 3|Withdrawal by Subject|0
1614713|NCT02059291|5634928|P11|Epoch 3|Withdrawal by Subject|0
1614714|NCT02059291|5634929|P10|Epoch 3|Withdrawal by Subject|0
1614715|NCT02059291|5634930|P9|Epoch 3|Withdrawal by Subject|0
1614716|NCT02059291|5634931|P8|Epoch 3|Withdrawal by Subject|0
1614717|NCT02059291|5634932|P7|Epoch 3|Withdrawal by Subject|0
1614718|NCT02059291|5634933|P6|Epoch 3|Withdrawal by Subject|0
1614719|NCT02059291|5634934|P5|Epoch 3|Withdrawal by Subject|0
1614720|NCT02059291|5634935|P4|Epoch 3|Withdrawal by Subject|0
1614721|NCT02059291|5634936|P3|Epoch 3|Withdrawal by Subject|0
1614722|NCT02059291|5634937|P2|Epoch 3|Withdrawal by Subject|0
1614723|NCT02059291|5634938|P1|Epoch 3|Withdrawal by Subject|0
1614724|NCT02059291|5634914|P25|Epoch 3|Lack of Efficacy|0
1614725|NCT02059291|5634915|P24|Epoch 3|Lack of Efficacy|0
1614726|NCT02059291|5634916|P23|Epoch 3|Lack of Efficacy|0
1614727|NCT02059291|5634917|P22|Epoch 3|Lack of Efficacy|0
1614728|NCT02059291|5634918|P21|Epoch 3|Lack of Efficacy|0
1614729|NCT02059291|5634919|P20|Epoch 3|Lack of Efficacy|0
1614730|NCT02059291|5634920|P19|Epoch 3|Lack of Efficacy|0
1614731|NCT02059291|5634921|P18|Epoch 3|Lack of Efficacy|0
1614732|NCT02059291|5634922|P17|Epoch 3|Lack of Efficacy|0
1614733|NCT02059291|5634923|P16|Epoch 3|Lack of Efficacy|3
1614734|NCT02059291|5634924|P15|Epoch 3|Lack of Efficacy|0
1614735|NCT02059291|5634925|P14|Epoch 3|Lack of Efficacy|0
1614736|NCT02059291|5634926|P13|Epoch 3|Lack of Efficacy|0
1614737|NCT02059291|5634927|P12|Epoch 3|Lack of Efficacy|0
1614738|NCT02059291|5634928|P11|Epoch 3|Lack of Efficacy|0
1614739|NCT02059291|5634929|P10|Epoch 3|Lack of Efficacy|0
1614740|NCT02059291|5634930|P9|Epoch 3|Lack of Efficacy|0
1614741|NCT02059291|5634931|P8|Epoch 3|Lack of Efficacy|0
1614742|NCT02059291|5634932|P7|Epoch 3|Lack of Efficacy|0
1614743|NCT02059291|5634933|P6|Epoch 3|Lack of Efficacy|0
1614744|NCT02059291|5634934|P5|Epoch 3|Lack of Efficacy|0
1614745|NCT02059291|5634935|P4|Epoch 3|Lack of Efficacy|0
1614746|NCT02059291|5634936|P3|Epoch 3|Lack of Efficacy|0
1614747|NCT02059291|5634937|P2|Epoch 3|Lack of Efficacy|0
1614748|NCT02059291|5634938|P1|Epoch 3|Lack of Efficacy|0
1614749|NCT02059291|5634914|P25|Epoch 3|Adverse Event|0
1614750|NCT02059291|5634915|P24|Epoch 3|Adverse Event|0
1614751|NCT02059291|5634916|P23|Epoch 3|Adverse Event|0
1614752|NCT02059291|5634917|P22|Epoch 3|Adverse Event|0
1614753|NCT02059291|5634918|P21|Epoch 3|Adverse Event|0
1614754|NCT02059291|5634919|P20|Epoch 3|Adverse Event|0
1614755|NCT02059291|5634920|P19|Epoch 3|Adverse Event|0
1614756|NCT02059291|5634921|P18|Epoch 3|Adverse Event|0
1614757|NCT02059291|5634922|P17|Epoch 3|Adverse Event|0
1614758|NCT02059291|5634923|P16|Epoch 3|Adverse Event|1
1614759|NCT02059291|5634924|P15|Epoch 3|Adverse Event|0
1614760|NCT02059291|5634925|P14|Epoch 3|Adverse Event|0
1614761|NCT02059291|5634926|P13|Epoch 3|Adverse Event|0
1614762|NCT02059291|5634927|P12|Epoch 3|Adverse Event|0
1614763|NCT02059291|5634928|P11|Epoch 3|Adverse Event|0
1614764|NCT02059291|5634929|P10|Epoch 3|Adverse Event|0
1614765|NCT02059291|5634930|P9|Epoch 3|Adverse Event|0
1614766|NCT02059291|5634931|P8|Epoch 3|Adverse Event|0
1614767|NCT02059291|5634932|P7|Epoch 3|Adverse Event|0
1614768|NCT02059291|5634933|P6|Epoch 3|Adverse Event|0
1614769|NCT02059291|5634934|P5|Epoch 3|Adverse Event|0
1614770|NCT02059291|5634935|P4|Epoch 3|Adverse Event|0
1614771|NCT02059291|5634936|P3|Epoch 3|Adverse Event|0
1614772|NCT02059291|5634937|P2|Epoch 3|Adverse Event|0
1614773|NCT02059291|5634938|P1|Epoch 3|Adverse Event|0
1614774|NCT02059291|5634914|P25|Epoch 3|Physician Decision|0
1614775|NCT02059291|5634915|P24|Epoch 3|Physician Decision|0
1614776|NCT02059291|5634916|P23|Epoch 3|Physician Decision|0
1614777|NCT02059291|5634917|P22|Epoch 3|Physician Decision|0
1614778|NCT02059291|5634918|P21|Epoch 3|Physician Decision|0
1614779|NCT02059291|5634919|P20|Epoch 3|Physician Decision|0
1614780|NCT02059291|5634920|P19|Epoch 3|Physician Decision|0
1614781|NCT02059291|5634921|P18|Epoch 3|Physician Decision|0
1614782|NCT02059291|5634922|P17|Epoch 3|Physician Decision|0
1614783|NCT02059291|5634923|P16|Epoch 3|Physician Decision|1
1614784|NCT02059291|5634924|P15|Epoch 3|Physician Decision|0
1614785|NCT02059291|5634925|P14|Epoch 3|Physician Decision|1
1614786|NCT02059291|5634926|P13|Epoch 3|Physician Decision|0
1614787|NCT02059291|5634927|P12|Epoch 3|Physician Decision|0
1614788|NCT02059291|5634928|P11|Epoch 3|Physician Decision|0
1614789|NCT02059291|5634929|P10|Epoch 3|Physician Decision|0
1614790|NCT02059291|5634930|P9|Epoch 3|Physician Decision|0
1614791|NCT02059291|5634931|P8|Epoch 3|Physician Decision|0
1614792|NCT02059291|5634932|P7|Epoch 3|Physician Decision|0
1614793|NCT02059291|5634933|P6|Epoch 3|Physician Decision|0
1614794|NCT02059291|5634934|P5|Epoch 3|Physician Decision|0
1614795|NCT02059291|5634935|P4|Epoch 3|Physician Decision|0
1614796|NCT02059291|5634936|P3|Epoch 3|Physician Decision|0
1614797|NCT02059291|5634937|P2|Epoch 3|Physician Decision|0
1614798|NCT02059291|5634938|P1|Epoch 3|Physician Decision|0
1614799|NCT02059291|5634914|P25|Epoch 2|Withdrawal by Subject|0
1614800|NCT02059291|5634915|P24|Epoch 2|Withdrawal by Subject|0
1614801|NCT02059291|5634916|P23|Epoch 2|Withdrawal by Subject|0
1614802|NCT02059291|5634917|P22|Epoch 2|Withdrawal by Subject|0
1614803|NCT02059291|5634918|P21|Epoch 2|Withdrawal by Subject|0
1614804|NCT02059291|5634919|P20|Epoch 2|Withdrawal by Subject|0
1614805|NCT02059291|5634920|P19|Epoch 2|Withdrawal by Subject|0
1614806|NCT02059291|5634921|P18|Epoch 2|Withdrawal by Subject|0
1614807|NCT02059291|5634922|P17|Epoch 2|Withdrawal by Subject|0
1614808|NCT02059291|5634923|P16|Epoch 2|Withdrawal by Subject|0
1614809|NCT02059291|5634924|P15|Epoch 2|Withdrawal by Subject|0
1614810|NCT02059291|5634925|P14|Epoch 2|Withdrawal by Subject|0
1614811|NCT02059291|5634926|P13|Epoch 2|Withdrawal by Subject|0
1614812|NCT02059291|5634927|P12|Epoch 2|Withdrawal by Subject|0
1614813|NCT02059291|5634928|P11|Epoch 2|Withdrawal by Subject|0
1614814|NCT02059291|5634929|P10|Epoch 2|Withdrawal by Subject|0
1614815|NCT02059291|5634930|P9|Epoch 2|Withdrawal by Subject|1
1614816|NCT02059291|5634931|P8|Epoch 2|Withdrawal by Subject|0
1614817|NCT02059291|5634932|P7|Epoch 2|Withdrawal by Subject|0
1614818|NCT02059291|5634933|P6|Epoch 2|Withdrawal by Subject|1
1614819|NCT02059291|5634934|P5|Epoch 2|Withdrawal by Subject|0
1614820|NCT02059291|5634935|P4|Epoch 2|Withdrawal by Subject|0
1614821|NCT02059291|5634936|P3|Epoch 2|Withdrawal by Subject|0
1614822|NCT02059291|5634937|P2|Epoch 2|Withdrawal by Subject|1
1614823|NCT02059291|5634938|P1|Epoch 2|Withdrawal by Subject|0
1614824|NCT02059291|5634914|P25|Epoch 2|Adverse Event|0
1614825|NCT02059291|5634915|P24|Epoch 2|Adverse Event|0
1614826|NCT02059291|5634916|P23|Epoch 2|Adverse Event|0
1614827|NCT02059291|5634917|P22|Epoch 2|Adverse Event|0
1614828|NCT02059291|5634918|P21|Epoch 2|Adverse Event|0
1614829|NCT02059291|5634919|P20|Epoch 2|Adverse Event|0
1614830|NCT02059291|5634920|P19|Epoch 2|Adverse Event|0
1614831|NCT02059291|5634921|P18|Epoch 2|Adverse Event|0
1614832|NCT02059291|5634922|P17|Epoch 2|Adverse Event|0
1614833|NCT02059291|5634923|P16|Epoch 2|Adverse Event|0
1614834|NCT02059291|5634924|P15|Epoch 2|Adverse Event|0
1614835|NCT02059291|5634925|P14|Epoch 2|Adverse Event|0
1614836|NCT02059291|5634926|P13|Epoch 2|Adverse Event|0
1614837|NCT02059291|5634927|P12|Epoch 2|Adverse Event|0
1614838|NCT02059291|5634928|P11|Epoch 2|Adverse Event|0
1614839|NCT02059291|5634929|P10|Epoch 2|Adverse Event|0
1614840|NCT02059291|5634930|P9|Epoch 2|Adverse Event|1
1614841|NCT02059291|5634931|P8|Epoch 2|Adverse Event|1
1614842|NCT02059291|5634932|P7|Epoch 2|Adverse Event|0
1614843|NCT02059291|5634933|P6|Epoch 2|Adverse Event|0
1614844|NCT02059291|5634934|P5|Epoch 2|Adverse Event|0
1614845|NCT02059291|5634935|P4|Epoch 2|Adverse Event|1
1614846|NCT02059291|5634936|P3|Epoch 2|Adverse Event|1
1614847|NCT02059291|5634937|P2|Epoch 2|Adverse Event|0
1614848|NCT02059291|5634938|P1|Epoch 2|Adverse Event|0
1614849|NCT02059291|5634914|P25|Epoch 2|Lack of Efficacy|0
1614850|NCT02059291|5634915|P24|Epoch 2|Lack of Efficacy|0
1614851|NCT02059291|5634916|P23|Epoch 2|Lack of Efficacy|0
1614852|NCT02059291|5634917|P22|Epoch 2|Lack of Efficacy|0
1614853|NCT02059291|5634918|P21|Epoch 2|Lack of Efficacy|0
1614854|NCT02059291|5634919|P20|Epoch 2|Lack of Efficacy|0
1614855|NCT02059291|5634920|P19|Epoch 2|Lack of Efficacy|0
1614856|NCT02059291|5634921|P18|Epoch 2|Lack of Efficacy|0
1614857|NCT02059291|5634922|P17|Epoch 2|Lack of Efficacy|0
1614858|NCT02059291|5634923|P16|Epoch 2|Lack of Efficacy|0
1614859|NCT02059291|5634924|P15|Epoch 2|Lack of Efficacy|0
1614860|NCT02059291|5634925|P14|Epoch 2|Lack of Efficacy|0
1614861|NCT02059291|5634926|P13|Epoch 2|Lack of Efficacy|0
1614862|NCT02059291|5634927|P12|Epoch 2|Lack of Efficacy|0
1614863|NCT02059291|5634928|P11|Epoch 2|Lack of Efficacy|0
1614864|NCT02059291|5634929|P10|Epoch 2|Lack of Efficacy|0
1614865|NCT02059291|5634930|P9|Epoch 2|Lack of Efficacy|0
1614866|NCT02059291|5634931|P8|Epoch 2|Lack of Efficacy|0
1614867|NCT02059291|5634932|P7|Epoch 2|Lack of Efficacy|0
1614868|NCT02059291|5634933|P6|Epoch 2|Lack of Efficacy|1
1614869|NCT02059291|5634934|P5|Epoch 2|Lack of Efficacy|0
1614870|NCT02059291|5634935|P4|Epoch 2|Lack of Efficacy|1
1614871|NCT02059291|5634936|P3|Epoch 2|Lack of Efficacy|0
1614872|NCT02059291|5634937|P2|Epoch 2|Lack of Efficacy|0
1614873|NCT02059291|5634938|P1|Epoch 2|Lack of Efficacy|0
1614874|NCT02059278|5634992|P2|Overall Study|Ran out of IP and decided to discontinue|0
1614875|NCT02059278|5634993|P1|Overall Study|Ran out of IP and decided to discontinue|1
1614876|NCT02059278|5634992|P2|Overall Study|Withdrawal by Subject|3
1614877|NCT02059278|5634993|P1|Overall Study|Withdrawal by Subject|0
1614878|NCT02059278|5634992|P2|Overall Study|Lost to Follow-up|0
1614879|NCT02059278|5634993|P1|Overall Study|Lost to Follow-up|1
1614880|NCT02059278|5634992|P2|Overall Study|Adverse Event|1
1614881|NCT02059278|5634993|P1|Overall Study|Adverse Event|1
1614882|NCT02059265|5635007|P1|Overall Study|Ineligible|4
1614883|NCT02059187|5635026|P2|Overall Study|Withdrawal by Subject|8
1614884|NCT02059187|5635027|P1|Overall Study|Withdrawal by Subject|12
1614885|NCT02059187|5635026|P2|Overall Study|Protocol Violation|0
1614886|NCT02059187|5635027|P1|Overall Study|Protocol Violation|1
1614887|NCT02059187|5635026|P2|Overall Study|Physician Decision|2
1614888|NCT02059187|5635027|P1|Overall Study|Physician Decision|1
1614889|NCT02059187|5635026|P2|Overall Study|Non-compliance with study drug|0
1614890|NCT02059187|5635027|P1|Overall Study|Non-compliance with study drug|1
1614891|NCT02059187|5635026|P2|Overall Study|Lost to Follow-up|8
1614892|NCT02059187|5635027|P1|Overall Study|Lost to Follow-up|9
1614893|NCT02059187|5635026|P2|Overall Study|Death|1
1614894|NCT02059187|5635027|P1|Overall Study|Death|1
1614895|NCT02059187|5635026|P2|Overall Study|Adverse Event|3
1614896|NCT02059187|5635027|P1|Overall Study|Adverse Event|0
1614897|NCT02059174|5635053|P2|Period 3|Physician Decision|0
1614898|NCT02059174|5635054|P1|Period 3|Physician Decision|1
1614899|NCT02059174|5635053|P2|Period 2|Protocol Violation|0
1614900|NCT02059174|5635054|P1|Period 2|Protocol Violation|1
1614901|NCT02059174|5635053|P2|Period 2|Withdrawal by Subject|2
1614902|NCT02059174|5635054|P1|Period 2|Withdrawal by Subject|0
1614903|NCT02059174|5635053|P2|Period 1|Withdrawal by Subject|2
1614904|NCT02059174|5635054|P1|Period 1|Withdrawal by Subject|0
1614905|NCT02059161|5635078|P2|Overall Study|Non-compliance with study drug|2
1614906|NCT02059161|5635079|P1|Overall Study|Non-compliance with study drug|6
1614907|NCT02059161|5635078|P2|Overall Study|Randomized in error, no study drug|1
1614908|NCT02059161|5635079|P1|Overall Study|Randomized in error, no study drug|0
1614909|NCT02059161|5635078|P2|Overall Study|Withdrawal by Subject|13
1614910|NCT02059161|5635079|P1|Overall Study|Withdrawal by Subject|16
1614911|NCT02059161|5635078|P2|Overall Study|Protocol Violation|1
1614912|NCT02059161|5635079|P1|Overall Study|Protocol Violation|1
1614913|NCT02059161|5635078|P2|Overall Study|Physician Decision|4
1614914|NCT02059161|5635079|P1|Overall Study|Physician Decision|4
1614915|NCT02059161|5635078|P2|Overall Study|Lost to Follow-up|12
1614916|NCT02059161|5635079|P1|Overall Study|Lost to Follow-up|20
1614917|NCT02059161|5635078|P2|Overall Study|Adverse Event|6
1614918|NCT02059161|5635079|P1|Overall Study|Adverse Event|2
1614919|NCT02059161|5635078|P2|Overall Study|Pregnancy|2
1614920|NCT02059161|5635079|P1|Overall Study|Pregnancy|0
1614921|NCT02059148|5635139|P6|Treatment 1|Protocol Violation|1
1614922|NCT02059148|5635140|P5|Treatment 1|Protocol Violation|0
1614923|NCT02059148|5635141|P4|Treatment 1|Protocol Violation|0
1614924|NCT02059148|5635142|P3|Treatment 1|Protocol Violation|0
1614925|NCT02059148|5635143|P2|Treatment 1|Protocol Violation|0
1614926|NCT02059148|5635144|P1|Treatment 1|Protocol Violation|0
1614927|NCT02059135|5635163|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
1614928|NCT02059135|5635164|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
1614929|NCT02059135|5635163|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
1614930|NCT02059135|5635164|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
1614931|NCT02059135|5635163|P2|Neonatal Follow-up (Safety Population)|Death|2
1614932|NCT02059135|5635164|P1|Neonatal Follow-up (Safety Population)|Death|3
1614933|NCT02059135|5635163|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
1614934|NCT02059135|5635164|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
1614935|NCT02059135|5635163|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
1614936|NCT02059135|5635164|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
1614937|NCT02059135|5635163|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
1614938|NCT02059135|5635164|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
1614939|NCT02059135|5635163|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
1614940|NCT02059135|5635164|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
1614941|NCT02059135|5635163|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
1614942|NCT02059135|5635164|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
1614943|NCT02059005|5635200|P2|Overall Study|Inpatient|1
1614944|NCT02059005|5635201|P1|Overall Study|Inpatient|0
1614945|NCT02059005|5635200|P2|Overall Study|Incarceration|1
1614946|NCT02059005|5635201|P1|Overall Study|Incarceration|0
1614947|NCT02059005|5635200|P2|Overall Study|Lost to Follow-up|19
1614948|NCT02059005|5635201|P1|Overall Study|Lost to Follow-up|19
1614949|NCT02059005|5635200|P2|Overall Study|Death|3
1614950|NCT02059005|5635201|P1|Overall Study|Death|1
1614951|NCT02058992|5635211|P1|Overall Study|CRF Uncollected|20
1614952|NCT02058992|5635211|P1|Overall Study|Protocol Violation|92
1614953|NCT02058992|5635211|P1|Overall Study|Lost to Follow-up|4
1614954|NCT02058966|5635220|P1|First Intervention|Withdrawal by Subject|1
1614955|NCT02058966|5635220|P1|Open-Label Methamphetamine|Adverse Event|1
1614956|NCT02058940|5635247|P1|Overall Study|Discharged from Critical Care Unit|1
1614957|NCT02058849|5635271|P2|Overall Study|Withdrawal by Subject|0
1614958|NCT02058849|5635272|P1|Overall Study|Withdrawal by Subject|4
1614959|NCT02058849|5635271|P2|Overall Study|Lost to Follow-up|0
1614960|NCT02058849|5635272|P1|Overall Study|Lost to Follow-up|1
1614961|NCT02058849|5635271|P2|Overall Study|Death|0
1614962|NCT02058849|5635272|P1|Overall Study|Death|1
1614963|NCT02058849|5635271|P2|Overall Study|Hospitalization|1
1614964|NCT02058849|5635272|P1|Overall Study|Hospitalization|1
1614965|NCT02058836|5635300|P2|Overall Study|Withdrawal by Subject|1
1614966|NCT02058836|5635301|P1|Overall Study|Withdrawal by Subject|1
1614967|NCT02058628|5635331|P2|Overall Study|Non compliance|0
1614968|NCT02058628|5635332|P1|Overall Study|Non compliance|1
1614969|NCT02058628|5635331|P2|Overall Study|A lot of time for study for participant|0
1614970|NCT02058628|5635332|P1|Overall Study|A lot of time for study for participant|1
1614971|NCT02058628|5635331|P2|Overall Study|The visit date was not in timeline|1
1614972|NCT02058628|5635332|P1|Overall Study|The visit date was not in timeline|0
1614973|NCT02058628|5635331|P2|Overall Study|Not in time schedule|1
1614974|NCT02058628|5635332|P1|Overall Study|Not in time schedule|0
1614975|NCT02058628|5635331|P2|Overall Study|Lost to Follow-up|4
1614976|NCT02058628|5635332|P1|Overall Study|Lost to Follow-up|2
1614977|NCT02058628|5635331|P2|Overall Study|Withdrawal by Subject|2
1614978|NCT02058628|5635332|P1|Overall Study|Withdrawal by Subject|2
1614979|NCT02058628|5635331|P2|Overall Study|Adverse Event|0
1614980|NCT02058628|5635332|P1|Overall Study|Adverse Event|1
1614981|NCT02058589|5635364|P2|Overall Study|Withdrawal by Subject|1
1614982|NCT02058589|5635365|P1|Overall Study|Withdrawal by Subject|0
1614983|NCT02058589|5635364|P2|Overall Study|Non-Serious Adverse Event|0
1614984|NCT02058589|5635365|P1|Overall Study|Non-Serious Adverse Event|1
1614985|NCT02058589|5635364|P2|Overall Study|Serious Adverse Event|1
1614986|NCT02058589|5635365|P1|Overall Study|Serious Adverse Event|1
1614987|NCT02058563|5635407|P2|Overall Study|Other (patient incarcerated)|1
1614988|NCT02058563|5635408|P1|Overall Study|Other (patient incarcerated)|0
1614989|NCT02058563|5635407|P2|Overall Study|Consent Withdrawal|1
1614990|NCT02058563|5635408|P1|Overall Study|Consent Withdrawal|1
1614991|NCT02058563|5635407|P2|Overall Study|Other (vaccinated later as new subject)|0
1614992|NCT02058563|5635408|P1|Overall Study|Other (vaccinated later as new subject)|1
1614993|NCT02058563|5635407|P2|Overall Study|Lost to Follow-up|22
1614994|NCT02058563|5635408|P1|Overall Study|Lost to Follow-up|26
1614995|NCT02058537|5635444|P1|Overall Study|Withdrawal by Subject|1
1614996|NCT02058498|5635455|P1|Overall Study|Withdrawal by Subject|4
1614997|NCT02058368|5635463|P2|Overall Study|Withdrawal by Subject|26
1614998|NCT02058368|5635464|P1|Overall Study|Withdrawal by Subject|22
1614999|NCT02058368|5635463|P2|Overall Study|Physician Decision|3
1615000|NCT02058368|5635464|P1|Overall Study|Physician Decision|2
1615001|NCT02058368|5635463|P2|Overall Study|Lost to Follow-up|0
1615002|NCT02058368|5635464|P1|Overall Study|Lost to Follow-up|2
1615003|NCT02058368|5635463|P2|Overall Study|Protocol Violation|4
1615004|NCT02058368|5635464|P1|Overall Study|Protocol Violation|0
1615005|NCT02058368|5635463|P2|Overall Study|Lack of Efficacy|1
1615006|NCT02058368|5635464|P1|Overall Study|Lack of Efficacy|0
1615007|NCT02058368|5635463|P2|Overall Study|Adverse Event|20
1615008|NCT02058368|5635464|P1|Overall Study|Adverse Event|15
1615009|NCT02058290|5635516|P2|Overall Study|Withdrawal by Subject|1
1615010|NCT02058290|5635517|P1|Overall Study|Withdrawal by Subject|0
1615011|NCT02058290|5635516|P2|Overall Study|Didn't meet intraoperative criteria|7
1615012|NCT02058290|5635517|P1|Overall Study|Didn't meet intraoperative criteria|8
1615013|NCT02058290|5635516|P2|Overall Study|Physician Decision|0
1615014|NCT02058290|5635517|P1|Overall Study|Physician Decision|1
1615015|NCT02058290|5635516|P2|Overall Study|Protocol Violation|1
1615016|NCT02058290|5635517|P1|Overall Study|Protocol Violation|2
1615017|NCT02058160|5635544|P2|Overall Study|Other than specified above|6
1615018|NCT02058160|5635545|P1|Overall Study|Other than specified above|12
1615019|NCT02058160|5635544|P2|Overall Study|Lost to Follow-up|0
1615020|NCT02058160|5635545|P1|Overall Study|Lost to Follow-up|1
1615021|NCT02058160|5635544|P2|Overall Study|Adverse Event|3
1615022|NCT02058160|5635545|P1|Overall Study|Adverse Event|12
1615023|NCT02058160|5635544|P2|Overall Study|Poor compliance to protocol|1
1615024|NCT02058160|5635545|P1|Overall Study|Poor compliance to protocol|4
1615025|NCT02058160|5635544|P2|Overall Study|Randomized but not treated|4
1615026|NCT02058160|5635545|P1|Overall Study|Randomized but not treated|2
1615027|NCT02058147|5635582|P3|Overall Study|Other than specified|0
1615028|NCT02058147|5635583|P2|Overall Study|Other than specified|9
1615029|NCT02058147|5635584|P1|Overall Study|Other than specified|8
1615030|NCT02058147|5635582|P3|Overall Study|Poor compliance to protocol|4
1615031|NCT02058147|5635583|P2|Overall Study|Poor compliance to protocol|9
1615032|NCT02058147|5635584|P1|Overall Study|Poor compliance to protocol|8
1615033|NCT02058147|5635582|P3|Overall Study|Lack of Efficacy|3
1615034|NCT02058147|5635583|P2|Overall Study|Lack of Efficacy|0
1615035|NCT02058147|5635584|P1|Overall Study|Lack of Efficacy|1
1615036|NCT02058147|5635582|P3|Overall Study|Adverse Event|21
1615037|NCT02058147|5635583|P2|Overall Study|Adverse Event|9
1615038|NCT02058147|5635584|P1|Overall Study|Adverse Event|12
1615039|NCT02058147|5635582|P3|Overall Study|Randomized but not treated|1
1615040|NCT02058147|5635583|P2|Overall Study|Randomized but not treated|0
1615041|NCT02058147|5635584|P1|Overall Study|Randomized but not treated|0
1615042|NCT02058108|5635635|P2|Overall Study|Protocol Violation|1
1615043|NCT02058108|5635636|P1|Overall Study|Protocol Violation|0
1615044|NCT02058108|5635635|P2|Overall Study|Administrative problems|3
1615045|NCT02058108|5635636|P1|Overall Study|Administrative problems|3
1615046|NCT02058108|5635635|P2|Overall Study|Withdrawal by Subject|0
1615047|NCT02058108|5635636|P1|Overall Study|Withdrawal by Subject|1
1615048|NCT02058108|5635635|P2|Overall Study|No longer requires study drug|1
1615049|NCT02058108|5635636|P1|Overall Study|No longer requires study drug|0
1615050|NCT02058108|5635635|P2|Overall Study|Unsatisfactory therapeutic effect|4
1615051|NCT02058108|5635636|P1|Overall Study|Unsatisfactory therapeutic effect|37
1615052|NCT02058108|5635635|P2|Overall Study|Abnormal Laboratory Values|1
1615053|NCT02058108|5635636|P1|Overall Study|Abnormal Laboratory Values|0
1615054|NCT02058069|5635660|P1|Overall Study|Withdrawal by Subject|6
1615055|NCT02058069|5635660|P1|Overall Study|Exclusion due to implant size|5
1615056|NCT02057874|5635719|P1|Overall Study|participant did not return for scan|1
1615057|NCT02057835|5635737|P10|Overall Study|Withdrawal by Subject|0
1615058|NCT02057835|5635738|P9|Overall Study|Withdrawal by Subject|0
1615059|NCT02057835|5635739|P8|Overall Study|Withdrawal by Subject|0
1615060|NCT02057835|5635740|P7|Overall Study|Withdrawal by Subject|0
1615061|NCT02057835|5635741|P6|Overall Study|Withdrawal by Subject|0
1615062|NCT02057835|5635742|P5|Overall Study|Withdrawal by Subject|0
1615063|NCT02057835|5635743|P4|Overall Study|Withdrawal by Subject|0
1615064|NCT02057835|5635744|P3|Overall Study|Withdrawal by Subject|0
1615065|NCT02057835|5635745|P2|Overall Study|Withdrawal by Subject|2
1615066|NCT02057835|5635746|P1|Overall Study|Withdrawal by Subject|0
1615067|NCT02057757|5635825|P2|Overall Study|Non-compliance|0
1615068|NCT02057757|5635826|P1|Overall Study|Non-compliance|1
1615069|NCT02057757|5635825|P2|Overall Study|Lost to Follow-up|3
1615070|NCT02057757|5635826|P1|Overall Study|Lost to Follow-up|8
1615071|NCT02057757|5635825|P2|Overall Study|Death|0
1615072|NCT02057757|5635826|P1|Overall Study|Death|2
1615073|NCT02057757|5635825|P2|Overall Study|Withdrawal by Subject|5
1615074|NCT02057757|5635826|P1|Overall Study|Withdrawal by Subject|3
1615075|NCT02057692|5635880|P4|Overall Study|Lost to Follow-up|1
1615076|NCT02057692|5635881|P3|Overall Study|Lost to Follow-up|0
1615077|NCT02057692|5635882|P2|Overall Study|Lost to Follow-up|0
1615078|NCT02057692|5635883|P1|Overall Study|Lost to Follow-up|0
1615079|NCT02057692|5635880|P4|Overall Study|Adverse Event|0
1615080|NCT02057692|5635881|P3|Overall Study|Adverse Event|0
1615081|NCT02057692|5635882|P2|Overall Study|Adverse Event|0
1615082|NCT02057692|5635883|P1|Overall Study|Adverse Event|1
1615083|NCT02057575|5635929|P4|Overall Study|Protocol Violation|0
1615084|NCT02057575|5635930|P3|Overall Study|Protocol Violation|0
1615085|NCT02057575|5635931|P2|Overall Study|Protocol Violation|1
1615086|NCT02057575|5635932|P1|Overall Study|Protocol Violation|0
1615087|NCT02057575|5635929|P4|Overall Study|Dissallowed Concurrent Medication|0
1615088|NCT02057575|5635930|P3|Overall Study|Dissallowed Concurrent Medication|0
1615089|NCT02057575|5635931|P2|Overall Study|Dissallowed Concurrent Medication|1
1615090|NCT02057575|5635932|P1|Overall Study|Dissallowed Concurrent Medication|0
1615091|NCT02057575|5635929|P4|Overall Study|Withdrawal by Subject|0
1615092|NCT02057575|5635930|P3|Overall Study|Withdrawal by Subject|0
1615093|NCT02057575|5635931|P2|Overall Study|Withdrawal by Subject|0
1615094|NCT02057575|5635932|P1|Overall Study|Withdrawal by Subject|1
1615095|NCT02057575|5635929|P4|Overall Study|Adverse Event|1
1615096|NCT02057575|5635930|P3|Overall Study|Adverse Event|0
1615097|NCT02057575|5635931|P2|Overall Study|Adverse Event|2
1615098|NCT02057575|5635932|P1|Overall Study|Adverse Event|0
1615099|NCT02057549|5635944|P2|Overall Study|Withdrawal by Subject|0
1615100|NCT02057549|5635945|P1|Overall Study|Withdrawal by Subject|1
1615101|NCT02057549|5635944|P2|Overall Study|Physician Decision|0
1615102|NCT02057549|5635945|P1|Overall Study|Physician Decision|1
1615103|NCT02057549|5635944|P2|Overall Study|Lost to Follow-up|0
1615104|NCT02057549|5635945|P1|Overall Study|Lost to Follow-up|1
1615105|NCT02057406|5635968|P3|Overall Study|Patient transportation issues|1
1615106|NCT02057406|5635969|P2|Overall Study|Patient transportation issues|0
1615107|NCT02057406|5635970|P1|Overall Study|Patient transportation issues|0
1615108|NCT02057406|5635968|P3|Overall Study|Protocol Violation|0
1615109|NCT02057406|5635969|P2|Overall Study|Protocol Violation|1
1615110|NCT02057406|5635970|P1|Overall Study|Protocol Violation|0
1615111|NCT02057406|5635968|P3|Overall Study|Death|0
1615112|NCT02057406|5635969|P2|Overall Study|Death|0
1615113|NCT02057406|5635970|P1|Overall Study|Death|1
1615114|NCT02057406|5635968|P3|Overall Study|Lost to Follow-up|1
1615115|NCT02057406|5635969|P2|Overall Study|Lost to Follow-up|0
1615116|NCT02057406|5635970|P1|Overall Study|Lost to Follow-up|0
1615117|NCT02057406|5635968|P3|Overall Study|Withdrawal by Subject|0
1615118|NCT02057406|5635969|P2|Overall Study|Withdrawal by Subject|2
1615119|NCT02057406|5635970|P1|Overall Study|Withdrawal by Subject|0
1615120|NCT02057406|5635968|P3|Overall Study|Physician Decision|2
1615121|NCT02057406|5635969|P2|Overall Study|Physician Decision|0
1615122|NCT02057406|5635970|P1|Overall Study|Physician Decision|0
1615123|NCT02057393|5635981|P1|Overall Study|Patient did not meet criteria|1
1615124|NCT02057393|5635981|P1|Overall Study|Withdrawal by Subject|1
1615125|NCT02057250|5636002|P5|Extension Phase|Other than specified above|7
1615126|NCT02057250|5636003|P4|Extension Phase|Other than specified above|0
1615127|NCT02057250|5636004|P3|Extension Phase|Other than specified above|0
1615128|NCT02057250|5636005|P2|Extension Phase|Other than specified above|0
1615129|NCT02057250|5636006|P1|Extension Phase|Other than specified above|0
1615130|NCT02057250|5636002|P5|Extension Phase|Entered in this period but not treated|4
1615131|NCT02057250|5636003|P4|Extension Phase|Entered in this period but not treated|0
1615132|NCT02057250|5636004|P3|Extension Phase|Entered in this period but not treated|0
1615133|NCT02057250|5636005|P2|Extension Phase|Entered in this period but not treated|0
1615134|NCT02057250|5636006|P1|Extension Phase|Entered in this period but not treated|0
1615135|NCT02057250|5636002|P5|Extension Phase|Lack of Efficacy|10
1615136|NCT02057250|5636003|P4|Extension Phase|Lack of Efficacy|0
1615137|NCT02057250|5636004|P3|Extension Phase|Lack of Efficacy|0
1615138|NCT02057250|5636005|P2|Extension Phase|Lack of Efficacy|0
1615139|NCT02057250|5636006|P1|Extension Phase|Lack of Efficacy|0
1615140|NCT02057250|5636002|P5|Extension Phase|Adverse Event|15
1615141|NCT02057250|5636003|P4|Extension Phase|Adverse Event|0
1615142|NCT02057250|5636004|P3|Extension Phase|Adverse Event|0
1615143|NCT02057250|5636005|P2|Extension Phase|Adverse Event|0
1615144|NCT02057250|5636006|P1|Extension Phase|Adverse Event|0
1615145|NCT02057250|5636002|P5|AID Assessment Phase|Other than specified above|0
1615146|NCT02057250|5636003|P4|AID Assessment Phase|Other than specified above|1
1615147|NCT02057250|5636004|P3|AID Assessment Phase|Other than specified above|1
1615148|NCT02057250|5636005|P2|AID Assessment Phase|Other than specified above|1
1615149|NCT02057250|5636006|P1|AID Assessment Phase|Other than specified above|1
1615150|NCT02057250|5636002|P5|AID Assessment Phase|Adverse Event|0
1615151|NCT02057250|5636003|P4|AID Assessment Phase|Adverse Event|1
1615152|NCT02057250|5636004|P3|AID Assessment Phase|Adverse Event|6
1615153|NCT02057250|5636005|P2|AID Assessment Phase|Adverse Event|2
1615154|NCT02057250|5636006|P1|AID Assessment Phase|Adverse Event|3
1615155|NCT02057198|5636027|P3|Overall Study|Discharged early; lost to followup|0
1615156|NCT02057198|5636028|P2|Overall Study|Discharged early; lost to followup|1
1615157|NCT02057198|5636029|P1|Overall Study|Discharged early; lost to followup|0
1615158|NCT02057198|5636027|P3|Overall Study|Death|1
1615159|NCT02057198|5636028|P2|Overall Study|Death|0
1615160|NCT02057198|5636029|P1|Overall Study|Death|0
1615161|NCT02057068|5636054|P2|Overall Study|Lost to Follow-up|2
1615162|NCT02057068|5636055|P1|Overall Study|Lost to Follow-up|2
1615163|NCT02057068|5636054|P2|Overall Study|Carepartner (CP) Health|2
1615164|NCT02057068|5636055|P1|Overall Study|Carepartner (CP) Health|4
1615165|NCT02057068|5636054|P2|Overall Study|Caregiver (CG) Health|2
1615166|NCT02057068|5636055|P1|Overall Study|Caregiver (CG) Health|0
1615167|NCT02057068|5636054|P2|Overall Study|Withdrawal by Subject|2
1615168|NCT02057068|5636055|P1|Overall Study|Withdrawal by Subject|2
1615169|NCT02056834|5636084|P1|Overall Study|Lost to Follow-up|7
1615170|NCT02056652|5636105|P2|Overall Study|Lost to Follow-up|3
1615171|NCT02056652|5636106|P1|Overall Study|Lost to Follow-up|0
1615172|NCT02056652|5636105|P2|Overall Study|Withdrawal by Subject|0
1615173|NCT02056652|5636106|P1|Overall Study|Withdrawal by Subject|1
1615174|NCT02056626|5636143|P4|Overall Study|patient did not follow directions|0
1615175|NCT02056626|5636144|P3|Overall Study|patient did not follow directions|0
1615176|NCT02056626|5636145|P2|Overall Study|patient did not follow directions|1
1615177|NCT02056626|5636146|P1|Overall Study|patient did not follow directions|3
1615178|NCT02056392|5636181|P6|Overall Study|Withdrawal by Subject|0
1615179|NCT02056392|5636182|P5|Overall Study|Withdrawal by Subject|1
1615180|NCT02056392|5636183|P4|Overall Study|Withdrawal by Subject|0
1615181|NCT02056392|5636184|P3|Overall Study|Withdrawal by Subject|0
1615182|NCT02056392|5636185|P2|Overall Study|Withdrawal by Subject|0
1615183|NCT02056392|5636186|P1|Overall Study|Withdrawal by Subject|1
1615184|NCT02056392|5636181|P6|Overall Study|Protocol Violation|0
1615185|NCT02056392|5636182|P5|Overall Study|Protocol Violation|0
1615186|NCT02056392|5636183|P4|Overall Study|Protocol Violation|0
1615187|NCT02056392|5636184|P3|Overall Study|Protocol Violation|1
1615188|NCT02056392|5636185|P2|Overall Study|Protocol Violation|0
1615189|NCT02056392|5636186|P1|Overall Study|Protocol Violation|1
1615190|NCT02056392|5636181|P6|Overall Study|Lost to Follow-up|0
1615191|NCT02056392|5636182|P5|Overall Study|Lost to Follow-up|0
1615192|NCT02056392|5636183|P4|Overall Study|Lost to Follow-up|0
1615193|NCT02056392|5636184|P3|Overall Study|Lost to Follow-up|2
1615194|NCT02056392|5636185|P2|Overall Study|Lost to Follow-up|1
1615195|NCT02056392|5636186|P1|Overall Study|Lost to Follow-up|0
1615196|NCT02056340|5636223|P2|Overall Study|Withdrawal by Subject|6
1615197|NCT02056340|5636224|P1|Overall Study|Withdrawal by Subject|2
1615198|NCT02056340|5636223|P2|Overall Study|Lost to Follow-up|5
1615199|NCT02056340|5636224|P1|Overall Study|Lost to Follow-up|5
1615200|NCT02055976|5636254|P9|Overall Study|Lost to Follow-up|0
1615201|NCT02055976|5636255|P8|Overall Study|Lost to Follow-up|0
1615202|NCT02055976|5636256|P7|Overall Study|Lost to Follow-up|0
1615203|NCT02055976|5636257|P6|Overall Study|Lost to Follow-up|0
1615204|NCT02055976|5636258|P5|Overall Study|Lost to Follow-up|0
1615205|NCT02055976|5636259|P4|Overall Study|Lost to Follow-up|1
1615206|NCT02055976|5636260|P3|Overall Study|Lost to Follow-up|0
1615207|NCT02055976|5636261|P2|Overall Study|Lost to Follow-up|0
1615208|NCT02055976|5636262|P1|Overall Study|Lost to Follow-up|0
1615209|NCT02055976|5636254|P9|Overall Study|Does not meet entrance criteria|0
1615210|NCT02055976|5636255|P8|Overall Study|Does not meet entrance criteria|0
1615211|NCT02055976|5636256|P7|Overall Study|Does not meet entrance criteria|1
1615212|NCT02055976|5636257|P6|Overall Study|Does not meet entrance criteria|0
1615213|NCT02055976|5636258|P5|Overall Study|Does not meet entrance criteria|0
1615214|NCT02055976|5636259|P4|Overall Study|Does not meet entrance criteria|0
1615215|NCT02055976|5636260|P3|Overall Study|Does not meet entrance criteria|0
1615216|NCT02055976|5636261|P2|Overall Study|Does not meet entrance criteria|0
1615217|NCT02055976|5636262|P1|Overall Study|Does not meet entrance criteria|0
1615218|NCT02055976|5636254|P9|Overall Study|Adverse Event|0
1615219|NCT02055976|5636255|P8|Overall Study|Adverse Event|0
1615220|NCT02055976|5636256|P7|Overall Study|Adverse Event|1
1615221|NCT02055976|5636257|P6|Overall Study|Adverse Event|1
1615222|NCT02055976|5636258|P5|Overall Study|Adverse Event|0
1615223|NCT02055976|5636259|P4|Overall Study|Adverse Event|0
1615224|NCT02055976|5636260|P3|Overall Study|Adverse Event|0
1615225|NCT02055976|5636261|P2|Overall Study|Adverse Event|0
1615226|NCT02055976|5636262|P1|Overall Study|Adverse Event|0
1615227|NCT02055976|5636254|P9|Overall Study|Other|0
1615228|NCT02055976|5636255|P8|Overall Study|Other|0
1615229|NCT02055976|5636256|P7|Overall Study|Other|0
1615230|NCT02055976|5636257|P6|Overall Study|Other|0
1615231|NCT02055976|5636258|P5|Overall Study|Other|0
1615232|NCT02055976|5636259|P4|Overall Study|Other|0
1615233|NCT02055976|5636260|P3|Overall Study|Other|1
1615234|NCT02055976|5636261|P2|Overall Study|Other|0
1615235|NCT02055976|5636262|P1|Overall Study|Other|0
1615236|NCT02055820|5636691|P10|Phase II: Expansion|Death|0
1615237|NCT02055820|5636692|P9|Phase II: Expansion|Death|0
1615238|NCT02055820|5636693|P8|Phase II: Expansion|Death|0
1615239|NCT02055820|5636694|P7|Phase II: Expansion|Death|0
1615240|NCT02055820|5636695|P6|Phase II: Expansion|Death|0
1615241|NCT02055820|5636696|P5|Phase II: Expansion|Death|15
1615242|NCT02055820|5636697|P4|Phase II: Expansion|Death|0
1615243|NCT02055820|5636698|P3|Phase II: Expansion|Death|0
1615244|NCT02055820|5636699|P2|Phase II: Expansion|Death|0
1615245|NCT02055820|5636700|P1|Phase II: Expansion|Death|0
1615246|NCT02055820|5636691|P10|Phase II: Expansion|Withdrawal by Subject|0
1615247|NCT02055820|5636692|P9|Phase II: Expansion|Withdrawal by Subject|0
1615248|NCT02055820|5636693|P8|Phase II: Expansion|Withdrawal by Subject|0
1615249|NCT02055820|5636694|P7|Phase II: Expansion|Withdrawal by Subject|0
1615250|NCT02055820|5636695|P6|Phase II: Expansion|Withdrawal by Subject|0
1615251|NCT02055820|5636696|P5|Phase II: Expansion|Withdrawal by Subject|10
1615252|NCT02055820|5636697|P4|Phase II: Expansion|Withdrawal by Subject|0
1615253|NCT02055820|5636698|P3|Phase II: Expansion|Withdrawal by Subject|0
1615254|NCT02055820|5636699|P2|Phase II: Expansion|Withdrawal by Subject|0
1615255|NCT02055820|5636700|P1|Phase II: Expansion|Withdrawal by Subject|0
1615256|NCT02055820|5636691|P10|Phase II: Expansion|Lost to Follow-up|0
1615257|NCT02055820|5636692|P9|Phase II: Expansion|Lost to Follow-up|0
1615258|NCT02055820|5636693|P8|Phase II: Expansion|Lost to Follow-up|0
1615259|NCT02055820|5636694|P7|Phase II: Expansion|Lost to Follow-up|0
1615260|NCT02055820|5636695|P6|Phase II: Expansion|Lost to Follow-up|0
1615261|NCT02055820|5636696|P5|Phase II: Expansion|Lost to Follow-up|3
1615262|NCT02055820|5636697|P4|Phase II: Expansion|Lost to Follow-up|0
1615263|NCT02055820|5636698|P3|Phase II: Expansion|Lost to Follow-up|0
1615264|NCT02055820|5636699|P2|Phase II: Expansion|Lost to Follow-up|0
1615265|NCT02055820|5636700|P1|Phase II: Expansion|Lost to Follow-up|0
1615266|NCT02055820|5636691|P10|Phase II: Expansion|Participants still in study|0
1615267|NCT02055820|5636692|P9|Phase II: Expansion|Participants still in study|0
1615268|NCT02055820|5636693|P8|Phase II: Expansion|Participants still in study|0
1615269|NCT02055820|5636694|P7|Phase II: Expansion|Participants still in study|0
1615270|NCT02055820|5636695|P6|Phase II: Expansion|Participants still in study|0
1615271|NCT02055820|5636696|P5|Phase II: Expansion|Participants still in study|177
1615272|NCT02055820|5636697|P4|Phase II: Expansion|Participants still in study|0
1615273|NCT02055820|5636698|P3|Phase II: Expansion|Participants still in study|0
1615274|NCT02055820|5636699|P2|Phase II: Expansion|Participants still in study|0
1615275|NCT02055820|5636700|P1|Phase II: Expansion|Participants still in study|0
1615276|NCT02055820|5636691|P10|Phase II: Expansion|Unspecified Reason|0
1615277|NCT02055820|5636692|P9|Phase II: Expansion|Unspecified Reason|0
1615278|NCT02055820|5636693|P8|Phase II: Expansion|Unspecified Reason|0
1615279|NCT02055820|5636694|P7|Phase II: Expansion|Unspecified Reason|0
1615280|NCT02055820|5636695|P6|Phase II: Expansion|Unspecified Reason|0
1615281|NCT02055820|5636696|P5|Phase II: Expansion|Unspecified Reason|3
1615282|NCT02055820|5636697|P4|Phase II: Expansion|Unspecified Reason|0
1615283|NCT02055820|5636698|P3|Phase II: Expansion|Unspecified Reason|0
1615284|NCT02055820|5636699|P2|Phase II: Expansion|Unspecified Reason|0
1615285|NCT02055820|5636700|P1|Phase II: Expansion|Unspecified Reason|0
1615286|NCT02055820|5636691|P10|Phase I: Dose-Finding|Participants still in study|6
1615287|NCT02055820|5636692|P9|Phase I: Dose-Finding|Participants still in study|6
1615288|NCT02055820|5636693|P8|Phase I: Dose-Finding|Participants still in study|6
1615289|NCT02055820|5636694|P7|Phase I: Dose-Finding|Participants still in study|7
1615290|NCT02055820|5636695|P6|Phase I: Dose-Finding|Participants still in study|6
1615291|NCT02055820|5636696|P5|Phase I: Dose-Finding|Participants still in study|0
1615292|NCT02055820|5636697|P4|Phase I: Dose-Finding|Participants still in study|4
1615293|NCT02055820|5636698|P3|Phase I: Dose-Finding|Participants still in study|7
1615294|NCT02055820|5636699|P2|Phase I: Dose-Finding|Participants still in study|3
1615295|NCT02055820|5636700|P1|Phase I: Dose-Finding|Participants still in study|6
1615296|NCT02055820|5636691|P10|Phase I: Dose-Finding|Death|0
1615297|NCT02055820|5636692|P9|Phase I: Dose-Finding|Death|0
1615298|NCT02055820|5636693|P8|Phase I: Dose-Finding|Death|0
1615299|NCT02055820|5636694|P7|Phase I: Dose-Finding|Death|0
1615300|NCT02055820|5636695|P6|Phase I: Dose-Finding|Death|0
1615301|NCT02055820|5636696|P5|Phase I: Dose-Finding|Death|0
1615302|NCT02055820|5636697|P4|Phase I: Dose-Finding|Death|2
1615303|NCT02055820|5636698|P3|Phase I: Dose-Finding|Death|1
1615304|NCT02055820|5636699|P2|Phase I: Dose-Finding|Death|0
1615305|NCT02055820|5636700|P1|Phase I: Dose-Finding|Death|1
1615306|NCT02055820|5636691|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
1615307|NCT02055820|5636692|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
1615308|NCT02055820|5636693|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
1615309|NCT02055820|5636694|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
1615310|NCT02055820|5636695|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
1615311|NCT02055820|5636696|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
1615312|NCT02055820|5636697|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
1615313|NCT02055820|5636698|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
1615314|NCT02055820|5636699|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
1615315|NCT02055820|5636700|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
1615316|NCT02055365|5636833|P1|Overall Study|Prematurely Withdrawn|1
1615317|NCT02055352|5636846|P2|Overall Study|Reason unknown|5
1615318|NCT02055352|5636847|P1|Overall Study|Reason unknown|1
1615319|NCT02055352|5636846|P2|Overall Study|Withdrawal of informed consent|0
1615320|NCT02055352|5636847|P1|Overall Study|Withdrawal of informed consent|1
1615321|NCT02055352|5636846|P2|Overall Study|AE, study drug would be detrimental|3
1615322|NCT02055352|5636847|P1|Overall Study|AE, study drug would be detrimental|1
1615323|NCT02055352|5636846|P2|Overall Study|Use of prohibited treatment|3
1615324|NCT02055352|5636847|P1|Overall Study|Use of prohibited treatment|0
1615325|NCT02055352|5636846|P2|Overall Study|Patient decision|1
1615326|NCT02055352|5636847|P1|Overall Study|Patient decision|1
1615327|NCT02055352|5636846|P2|Overall Study|Death|2
1615328|NCT02055352|5636847|P1|Overall Study|Death|1
1615329|NCT02055352|5636846|P2|Overall Study|Poor compliance|1
1615330|NCT02055352|5636847|P1|Overall Study|Poor compliance|1
1615331|NCT02055352|5636846|P2|Overall Study|Non-eligible|1
1615332|NCT02055352|5636847|P1|Overall Study|Non-eligible|0
1615333|NCT02055352|5636846|P2|Overall Study|Adverse Event|1
1615334|NCT02055352|5636847|P1|Overall Study|Adverse Event|0
1615335|NCT02055118|5636864|P3|Overall Study|Withdrawal by Subject|0
1615336|NCT02055118|5636865|P2|Overall Study|Withdrawal by Subject|2
1615337|NCT02055118|5636866|P1|Overall Study|Withdrawal by Subject|0
1615338|NCT02054910|5636925|P2|Overall Study|Lost to Follow-up|1
1615339|NCT02054910|5636926|P1|Overall Study|Lost to Follow-up|4
1615340|NCT02054897|5636945|P3|Overall Study|Randomized but not exposed|0
1615341|NCT02054897|5636946|P2|Overall Study|Randomized but not exposed|0
1615342|NCT02054897|5636947|P1|Overall Study|Randomized but not exposed|1
1615343|NCT02054897|5636945|P3|Overall Study|Lost to Follow-up|7
1615344|NCT02054897|5636946|P2|Overall Study|Lost to Follow-up|2
1615345|NCT02054897|5636947|P1|Overall Study|Lost to Follow-up|4
1615346|NCT02054897|5636945|P3|Overall Study|Missing follow-up information|3
1615347|NCT02054897|5636946|P2|Overall Study|Missing follow-up information|5
1615348|NCT02054897|5636947|P1|Overall Study|Missing follow-up information|3
1615349|NCT02054897|5636945|P3|Overall Study|Withdrawal by Subject|2
1615350|NCT02054897|5636946|P2|Overall Study|Withdrawal by Subject|0
1615351|NCT02054897|5636947|P1|Overall Study|Withdrawal by Subject|2
1615352|NCT02054715|5636994|P2|Follow-up 2|Treatment Change or Delay|0
1615353|NCT02054715|5636995|P1|Follow-up 2|Treatment Change or Delay|1
1615354|NCT02054715|5636994|P2|Follow-up 2|No Reason|0
1615355|NCT02054715|5636995|P1|Follow-up 2|No Reason|2
1615356|NCT02054715|5636994|P2|Follow-up 2|Changed Mind|1
1615357|NCT02054715|5636995|P1|Follow-up 2|Changed Mind|0
1615358|NCT02054715|5636994|P2|Follow-up 2|Changed MD/Facility|1
1615359|NCT02054715|5636995|P1|Follow-up 2|Changed MD/Facility|0
1615360|NCT02054715|5636994|P2|Follow-up 2|Hospitalization|2
1615361|NCT02054715|5636995|P1|Follow-up 2|Hospitalization|0
1615362|NCT02054715|5636994|P2|Follow-up 2|Death|3
1615363|NCT02054715|5636995|P1|Follow-up 2|Death|3
1615364|NCT02054715|5636994|P2|Follow-up 2|Ineligible|5
1615365|NCT02054715|5636995|P1|Follow-up 2|Ineligible|4
1615366|NCT02054715|5636994|P2|Follow-up 2|Followup Not Completed|4
1615367|NCT02054715|5636995|P1|Follow-up 2|Followup Not Completed|3
1615368|NCT02054715|5636994|P2|Follow-up 2|Refused|2
1615369|NCT02054715|5636995|P1|Follow-up 2|Refused|3
1615370|NCT02054715|5636994|P2|Follow-up 2|Lost to Followup|1
1615371|NCT02054715|5636995|P1|Follow-up 2|Lost to Followup|3
1615372|NCT02054715|5636994|P2|Baseline/Follow-up 1|Changed Mind|0
1615373|NCT02054715|5636995|P1|Baseline/Follow-up 1|Changed Mind|1
1615374|NCT02054715|5636994|P2|Baseline/Follow-up 1|Hospitalization|0
1615375|NCT02054715|5636995|P1|Baseline/Follow-up 1|Hospitalization|1
1615376|NCT02054715|5636994|P2|Baseline/Follow-up 1|Ineligible|0
1615377|NCT02054715|5636995|P1|Baseline/Follow-up 1|Ineligible|3
1615378|NCT02054715|5636994|P2|Baseline/Follow-up 1|Overwhelmed|0
1615379|NCT02054715|5636995|P1|Baseline/Follow-up 1|Overwhelmed|2
1615380|NCT02054715|5636994|P2|Baseline/Follow-up 1|No Reason|1
1615381|NCT02054715|5636995|P1|Baseline/Follow-up 1|No Reason|0
1615382|NCT02054715|5636994|P2|Baseline/Follow-up 1|Disliked Procedure|1
1615383|NCT02054715|5636995|P1|Baseline/Follow-up 1|Disliked Procedure|0
1615384|NCT02054715|5636994|P2|Baseline/Follow-up 1|Changed MD/Facility|1
1615385|NCT02054715|5636995|P1|Baseline/Follow-up 1|Changed MD/Facility|0
1615386|NCT02054715|5636994|P2|Baseline/Follow-up 1|Medical|1
1615387|NCT02054715|5636995|P1|Baseline/Follow-up 1|Medical|0
1615388|NCT02054715|5636994|P2|Baseline/Follow-up 1|Refused|3
1615389|NCT02054715|5636995|P1|Baseline/Follow-up 1|Refused|1
1615390|NCT02054702|5637009|P2|Overall Study|Withdrawal by Subject|4
1615391|NCT02054702|5637010|P1|Overall Study|Withdrawal by Subject|14
1615392|NCT02054702|5637009|P2|Overall Study|Physician Decision|1
1615393|NCT02054702|5637010|P1|Overall Study|Physician Decision|0
1615394|NCT02054702|5637009|P2|Overall Study|Met Withdrawal Criteria|1
1615395|NCT02054702|5637010|P1|Overall Study|Met Withdrawal Criteria|4
1615396|NCT02054702|5637009|P2|Overall Study|Adverse Event|1
1615397|NCT02054702|5637010|P1|Overall Study|Adverse Event|3
1615398|NCT02054702|5637009|P2|Overall Study|Lost to Follow-up|5
1615399|NCT02054702|5637010|P1|Overall Study|Lost to Follow-up|3
1615400|NCT02054481|5637065|P4|Overall Study|Other reason|0
1615401|NCT02054481|5637066|P3|Overall Study|Other reason|2
1615402|NCT02054481|5637067|P2|Overall Study|Other reason|1
1615403|NCT02054481|5637068|P1|Overall Study|Other reason|2
1615404|NCT02054481|5637065|P4|Overall Study|Lost to Follow-up|0
1615405|NCT02054481|5637066|P3|Overall Study|Lost to Follow-up|0
1615406|NCT02054481|5637067|P2|Overall Study|Lost to Follow-up|0
1615407|NCT02054481|5637068|P1|Overall Study|Lost to Follow-up|1
1615408|NCT02054481|5637065|P4|Overall Study|Adverse Event|1
1615409|NCT02054481|5637066|P3|Overall Study|Adverse Event|0
1615410|NCT02054481|5637067|P2|Overall Study|Adverse Event|1
1615411|NCT02054481|5637068|P1|Overall Study|Adverse Event|1
1615412|NCT02054325|5637129|P2|Overall Study|Lost to Follow-up|5
1615413|NCT02054325|5637130|P1|Overall Study|Lost to Follow-up|8
1615414|NCT02054130|5637157|P4|Overall Study|Missed dose|10
1615415|NCT02054130|5637158|P3|Overall Study|Missed dose|7
1615416|NCT02054130|5637159|P2|Overall Study|Missed dose|6
1615417|NCT02054130|5637160|P1|Overall Study|Missed dose|4
1615418|NCT02054130|5637157|P4|Overall Study|Lost to Follow-up|2
1615419|NCT02054130|5637158|P3|Overall Study|Lost to Follow-up|1
1615420|NCT02054130|5637159|P2|Overall Study|Lost to Follow-up|0
1615421|NCT02054130|5637160|P1|Overall Study|Lost to Follow-up|0
1615422|NCT02054130|5637157|P4|Overall Study|Death|0
1615423|NCT02054130|5637158|P3|Overall Study|Death|0
1615424|NCT02054130|5637159|P2|Overall Study|Death|1
1615425|NCT02054130|5637160|P1|Overall Study|Death|0
1615426|NCT02054130|5637157|P4|Overall Study|Withdrawal by Subject|10
1615427|NCT02054130|5637158|P3|Overall Study|Withdrawal by Subject|7
1615428|NCT02054130|5637159|P2|Overall Study|Withdrawal by Subject|4
1615429|NCT02054130|5637160|P1|Overall Study|Withdrawal by Subject|4
1615430|NCT02053753|5637254|P2|Overall Study|Lost to Follow-up|3
1615431|NCT02053753|5637255|P1|Overall Study|Lost to Follow-up|4
1615432|NCT02053753|5637254|P2|Overall Study|Decision by Sponsor|1
1615433|NCT02053753|5637255|P1|Overall Study|Decision by Sponsor|1
1615434|NCT02053753|5637254|P2|Overall Study|Withdrawal by Subject|4
1615435|NCT02053753|5637255|P1|Overall Study|Withdrawal by Subject|2
1615436|NCT02053610|5637279|P2|Overall Study|Violation of Selection Criteria|0
1615437|NCT02053610|5637280|P1|Overall Study|Violation of Selection Criteria|1
1615438|NCT02053610|5637279|P2|Overall Study|Insufficient Therapeutic Response|1
1615439|NCT02053610|5637280|P1|Overall Study|Insufficient Therapeutic Response|1
1615440|NCT02053610|5637279|P2|Overall Study|Did not Receive Treatment|2
1615441|NCT02053610|5637280|P1|Overall Study|Did not Receive Treatment|4
1615442|NCT02053610|5637279|P2|Overall Study|Refused treatment/Did not cooperate|3
1615443|NCT02053610|5637280|P1|Overall Study|Refused treatment/Did not cooperate|1
1615444|NCT02053610|5637279|P2|Overall Study|Disease Progression|3
1615445|NCT02053610|5637280|P1|Overall Study|Disease Progression|2
1615446|NCT02053610|5637279|P2|Overall Study|Administrative/Other|1
1615447|NCT02053610|5637280|P1|Overall Study|Administrative/Other|1
1615448|NCT02053610|5637279|P2|Overall Study|Death|5
1615449|NCT02053610|5637280|P1|Overall Study|Death|5
1615450|NCT02053610|5637279|P2|Overall Study|Withdrew Consent|9
1615451|NCT02053610|5637280|P1|Overall Study|Withdrew Consent|2
1615452|NCT02053610|5637279|P2|Overall Study|Adverse Event/Intercurrent Illness|43
1615453|NCT02053610|5637280|P1|Overall Study|Adverse Event/Intercurrent Illness|25
1615454|NCT02053493|5637312|P2|Overall Study|Withdrawal by Subject|1
1615455|NCT02053493|5637313|P1|Overall Study|Withdrawal by Subject|1
1615456|NCT02053168|5637362|P1|Overall Study|Lost to Follow-up|1
1615457|NCT02053168|5637362|P1|Overall Study|Physician Decision|1
1615458|NCT02053168|5637362|P1|Overall Study|Withdrawal by Subject|1
1615459|NCT02052596|5637441|P2|Safety Phase|Lost due to Crohn`s disease|1
1615460|NCT02052596|5637442|P1|Safety Phase|Lost due to Crohn`s disease|0
1615461|NCT02052596|5637441|P2|Safety Phase|Enrolled in error|0
1615462|NCT02052596|5637442|P1|Safety Phase|Enrolled in error|1
1615463|NCT02052596|5637441|P2|Safety Phase|Withdrawal by Subject|11
1615464|NCT02052596|5637442|P1|Safety Phase|Withdrawal by Subject|8
1615465|NCT02052596|5637441|P2|Safety Phase|Protocol Violation|2
1615466|NCT02052596|5637442|P1|Safety Phase|Protocol Violation|1
1615467|NCT02052596|5637441|P2|Safety Phase|Lost to Follow-up|18
1615468|NCT02052596|5637442|P1|Safety Phase|Lost to Follow-up|11
1615469|NCT02052596|5637441|P2|Safety Phase|Adverse Event|3
1615470|NCT02052596|5637442|P1|Safety Phase|Adverse Event|6
1615471|NCT02052596|5637441|P2|Active Phase|Lost due to Crohn`s disease|1
1615472|NCT02052596|5637442|P1|Active Phase|Lost due to Crohn`s disease|0
1615473|NCT02052596|5637441|P2|Active Phase|Enrolled in error|0
1615474|NCT02052596|5637442|P1|Active Phase|Enrolled in error|1
1615475|NCT02052596|5637441|P2|Active Phase|Withdrawal by Subject|4
1615476|NCT02052596|5637442|P1|Active Phase|Withdrawal by Subject|3
1615477|NCT02052596|5637441|P2|Active Phase|Protocol Violation|2
1615478|NCT02052596|5637442|P1|Active Phase|Protocol Violation|1
1615479|NCT02052596|5637441|P2|Active Phase|Lost to Follow-up|11
1615480|NCT02052596|5637442|P1|Active Phase|Lost to Follow-up|8
1615481|NCT02052596|5637441|P2|Active Phase|Adverse Event|2
1615482|NCT02052596|5637442|P1|Active Phase|Adverse Event|3
1615483|NCT02052466|5637472|P1|Overall Study|Acromial fracture|1
1615484|NCT02052466|5637472|P1|Overall Study|Withdrawal by Subject|1
1615485|NCT02052440|5637489|P2|Overall Study|Withdrawal by Subject|1
1615486|NCT02052440|5637490|P1|Overall Study|Withdrawal by Subject|0
1615487|NCT02052414|5637502|P1|Overall Study|Withdrawal by Subject|3
1615488|NCT02052414|5637502|P1|Overall Study|Lack of Efficacy|2
1615489|NCT02052414|5637502|P1|Overall Study|Adverse Event|12
1615490|NCT02052011|5637537|P2|Overall Study|Withdrawal by Subject|2
1615491|NCT02052011|5637538|P1|Overall Study|Withdrawal by Subject|1
1615492|NCT02052011|5637537|P2|Overall Study|Lost to Follow-up|0
1615493|NCT02052011|5637538|P1|Overall Study|Lost to Follow-up|3
1615494|NCT02051296|5637693|P2|Overall Study|withdraw prior to treatment|7
1615495|NCT02051296|5637694|P1|Overall Study|withdraw prior to treatment|7
1615496|NCT02051296|5637693|P2|Overall Study|Lost to Follow-up|2
1615497|NCT02051296|5637694|P1|Overall Study|Lost to Follow-up|1
1615498|NCT02050321|5637750|P1|Overall Study|Adverse Event|1
1615499|NCT02050321|5637750|P1|Overall Study|Withdrawal by Subject|1
1615500|NCT02050048|5637766|P2|Overall Study|Ineligible after ERCP|1
1615501|NCT02050048|5637767|P1|Overall Study|Ineligible after ERCP|4
1615502|NCT02050048|5637766|P2|Overall Study|Death|0
1615503|NCT02050048|5637767|P1|Overall Study|Death|1
1615504|NCT02050048|5637766|P2|Overall Study|Lost to Follow-up|1
1615505|NCT02050048|5637767|P1|Overall Study|Lost to Follow-up|0
1615506|NCT02049957|5637782|P9|Overall Study|Physician Decision|0
1615507|NCT02049957|5637783|P8|Overall Study|Physician Decision|0
1615508|NCT02049957|5637784|P7|Overall Study|Physician Decision|0
1615509|NCT02049957|5637785|P6|Overall Study|Physician Decision|1
1615510|NCT02049957|5637786|P5|Overall Study|Physician Decision|0
1615511|NCT02049957|5637787|P4|Overall Study|Physician Decision|0
1615512|NCT02049957|5637788|P3|Overall Study|Physician Decision|0
1615513|NCT02049957|5637789|P2|Overall Study|Physician Decision|0
1615514|NCT02049957|5637790|P1|Overall Study|Physician Decision|0
1615515|NCT02049957|5637782|P9|Overall Study|Withdrawal by Subject|1
1615516|NCT02049957|5637783|P8|Overall Study|Withdrawal by Subject|3
1615517|NCT02049957|5637784|P7|Overall Study|Withdrawal by Subject|0
1615518|NCT02049957|5637785|P6|Overall Study|Withdrawal by Subject|2
1615519|NCT02049957|5637786|P5|Overall Study|Withdrawal by Subject|0
1615520|NCT02049957|5637787|P4|Overall Study|Withdrawal by Subject|1
1615521|NCT02049957|5637788|P3|Overall Study|Withdrawal by Subject|0
1615522|NCT02049957|5637789|P2|Overall Study|Withdrawal by Subject|0
1615523|NCT02049957|5637790|P1|Overall Study|Withdrawal by Subject|0
1615524|NCT02049957|5637782|P9|Overall Study|Study Terminated by Sponsor|0
1615525|NCT02049957|5637783|P8|Overall Study|Study Terminated by Sponsor|0
1615526|NCT02049957|5637784|P7|Overall Study|Study Terminated by Sponsor|1
1615527|NCT02049957|5637785|P6|Overall Study|Study Terminated by Sponsor|0
1615528|NCT02049957|5637786|P5|Overall Study|Study Terminated by Sponsor|0
1615529|NCT02049957|5637787|P4|Overall Study|Study Terminated by Sponsor|0
1615530|NCT02049957|5637788|P3|Overall Study|Study Terminated by Sponsor|0
1615531|NCT02049957|5637789|P2|Overall Study|Study Terminated by Sponsor|1
1615532|NCT02049957|5637790|P1|Overall Study|Study Terminated by Sponsor|0
1615533|NCT02049957|5637782|P9|Overall Study|Adverse Event|1
1615534|NCT02049957|5637783|P8|Overall Study|Adverse Event|6
1615535|NCT02049957|5637784|P7|Overall Study|Adverse Event|0
1615536|NCT02049957|5637785|P6|Overall Study|Adverse Event|5
1615537|NCT02049957|5637786|P5|Overall Study|Adverse Event|0
1615538|NCT02049957|5637787|P4|Overall Study|Adverse Event|0
1615539|NCT02049957|5637788|P3|Overall Study|Adverse Event|1
1615540|NCT02049957|5637789|P2|Overall Study|Adverse Event|1
1615541|NCT02049957|5637790|P1|Overall Study|Adverse Event|1
1615542|NCT02049957|5637782|P9|Overall Study|Progressive Disease|6
1615543|NCT02049957|5637783|P8|Overall Study|Progressive Disease|26
1615544|NCT02049957|5637784|P7|Overall Study|Progressive Disease|7
1615545|NCT02049957|5637785|P6|Overall Study|Progressive Disease|35
1615546|NCT02049957|5637786|P5|Overall Study|Progressive Disease|6
1615547|NCT02049957|5637787|P4|Overall Study|Progressive Disease|2
1615548|NCT02049957|5637788|P3|Overall Study|Progressive Disease|2
1615549|NCT02049957|5637789|P2|Overall Study|Progressive Disease|4
1615550|NCT02049957|5637790|P1|Overall Study|Progressive Disease|5
1615551|NCT02049814|5637882|P2|Overall Study|Voluntary withdrawal|8
1615552|NCT02049814|5637883|P1|Overall Study|Voluntary withdrawal|9
1615553|NCT02049814|5637882|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
1615554|NCT02049814|5637883|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
1615555|NCT02049814|5637882|P2|Overall Study|Study Termination|1
1615556|NCT02049814|5637883|P1|Overall Study|Study Termination|0
1615557|NCT02049814|5637882|P2|Overall Study|Serious Protocol Violation|7
1615558|NCT02049814|5637883|P1|Overall Study|Serious Protocol Violation|5
1615559|NCT02049814|5637882|P2|Overall Study|Lost to Follow-up|3
1615560|NCT02049814|5637883|P1|Overall Study|Lost to Follow-up|2
1615561|NCT02049814|5637882|P2|Overall Study|Pregnancy|0
1615562|NCT02049814|5637883|P1|Overall Study|Pregnancy|1
1615563|NCT02049814|5637882|P2|Overall Study|Reason not Specified|3
1615564|NCT02049814|5637883|P1|Overall Study|Reason not Specified|4
1615565|NCT02049450|5637932|P1|Overall Study|Patients/guardian decision|1
1615566|NCT02049450|5637932|P1|Overall Study|Withdrawal by Subject|1
1615567|NCT02049450|5637932|P1|Overall Study|Adverse Event|2
1615568|NCT02048904|5637981|P1|Overall Study|Physician Decision|70
1615569|NCT02048904|5637981|P1|Overall Study|Withdrawal by Subject|7
1615570|NCT02048241|5638026|P2|Overall Study|Withdrawal by Subject|1
1615571|NCT02048241|5638027|P1|Overall Study|Withdrawal by Subject|0
1615572|NCT02048072|5638033|P1|Overall Study|Lost to Follow-up|1
1615573|NCT02048072|5638033|P1|Overall Study|Adverse Event|3
1615574|NCT02047903|5638072|P1|Overall Study|Not Treated|9
1615575|NCT02047903|5638072|P1|Overall Study|Reason not listed|6
1615576|NCT02047903|5638072|P1|Overall Study|Lost to Follow-up|4
1615577|NCT02047903|5638072|P1|Overall Study|Withdrawal by Subject|16
1615578|NCT02047903|5638072|P1|Overall Study|Serious adverse event|10
1615579|NCT02047903|5638072|P1|Overall Study|Adverse Event|14
1615580|NCT02047253|5638123|P1|Overall Study|Lost to Follow-up|8
1615581|NCT02047227|5638133|P2|Overall Study|Other|9
1615582|NCT02047227|5638134|P1|Overall Study|Other|10
1615583|NCT02047227|5638133|P2|Overall Study|All embryos discarded|11
1615584|NCT02047227|5638134|P1|Overall Study|All embryos discarded|12
1615585|NCT02047227|5638133|P2|Overall Study|Intention to freeze all embryos|0
1615586|NCT02047227|5638134|P1|Overall Study|Intention to freeze all embryos|1
1615587|NCT02047227|5638133|P2|Overall Study|No fertilization|51
1615588|NCT02047227|5638134|P1|Overall Study|No fertilization|61
1615589|NCT02047227|5638133|P2|Overall Study|No oocytes retrieved|20
1615590|NCT02047227|5638134|P1|Overall Study|No oocytes retrieved|21
1615591|NCT02047227|5638133|P2|Overall Study|Lack of ovarian response to stimulation|32
1615592|NCT02047227|5638134|P1|Overall Study|Lack of ovarian response to stimulation|35
1615593|NCT02047227|5638133|P2|Overall Study|Spontaneous pregnancy|0
1615594|NCT02047227|5638134|P1|Overall Study|Spontaneous pregnancy|1
1615595|NCT02047227|5638133|P2|Overall Study|Protocol Violation|0
1615596|NCT02047227|5638134|P1|Overall Study|Protocol Violation|1
1615597|NCT02047227|5638133|P2|Overall Study|Lost to Follow-up|3
1615598|NCT02047227|5638134|P1|Overall Study|Lost to Follow-up|0
1615599|NCT02047227|5638133|P2|Overall Study|Adverse Event|4
1615600|NCT02047227|5638134|P1|Overall Study|Adverse Event|2
1615601|NCT02047110|5638154|P4|OLE Treatment Period|Other than specified|0
1615602|NCT02047110|5638155|P3|OLE Treatment Period|Other than specified|1
1615603|NCT02047110|5638156|P2|OLE Treatment Period|Other than specified|0
1615604|NCT02047110|5638157|P1|OLE Treatment Period|Other than specified|0
1615605|NCT02047110|5638154|P4|Escape Treatment Period|Other than specified|1
1615606|NCT02047110|5638155|P3|Escape Treatment Period|Other than specified|0
1615607|NCT02047110|5638156|P2|Escape Treatment Period|Other than specified|2
1615608|NCT02047110|5638157|P1|Escape Treatment Period|Other than specified|1
1615609|NCT02047110|5638154|P4|Escape Treatment Period|Adverse Event|0
1615610|NCT02047110|5638155|P3|Escape Treatment Period|Adverse Event|2
1615611|NCT02047110|5638156|P2|Escape Treatment Period|Adverse Event|2
1615612|NCT02047110|5638157|P1|Escape Treatment Period|Adverse Event|1
1615613|NCT02047110|5638154|P4|Escape Treatment Period|Withdrawal by Subject|1
1615614|NCT02047110|5638155|P3|Escape Treatment Period|Withdrawal by Subject|1
1615615|NCT02047110|5638156|P2|Escape Treatment Period|Withdrawal by Subject|2
1615616|NCT02047110|5638157|P1|Escape Treatment Period|Withdrawal by Subject|1
1615617|NCT02047110|5638154|P4|DB (Week 12 up to Week 24)|Other than specified|0
1615618|NCT02047110|5638155|P3|DB (Week 12 up to Week 24)|Other than specified|1
1615619|NCT02047110|5638156|P2|DB (Week 12 up to Week 24)|Other than specified|1
1615620|NCT02047110|5638157|P1|DB (Week 12 up to Week 24)|Other than specified|0
1615621|NCT02047110|5638154|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
1615622|NCT02047110|5638155|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
1615623|NCT02047110|5638156|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
1615624|NCT02047110|5638157|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
1615625|NCT02047110|5638154|P4|DB Treatment Period up to Week 24|Other than specified|1
1615626|NCT02047110|5638155|P3|DB Treatment Period up to Week 24|Other than specified|3
1615627|NCT02047110|5638156|P2|DB Treatment Period up to Week 24|Other than specified|2
1615628|NCT02047110|5638157|P1|DB Treatment Period up to Week 24|Other than specified|1
1615629|NCT02047110|5638154|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
1615630|NCT02047110|5638155|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
1615631|NCT02047110|5638156|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
1615632|NCT02047110|5638157|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
1615633|NCT02047110|5638154|P4|DB Treatment Period up to Week 24|Protocol Violation|0
1615634|NCT02047110|5638155|P3|DB Treatment Period up to Week 24|Protocol Violation|0
1615635|NCT02047110|5638156|P2|DB Treatment Period up to Week 24|Protocol Violation|0
1615636|NCT02047110|5638157|P1|DB Treatment Period up to Week 24|Protocol Violation|1
1615637|NCT02047110|5638154|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
1615638|NCT02047110|5638155|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
1615639|NCT02047110|5638156|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
1615640|NCT02047110|5638157|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
1615641|NCT02047110|5638154|P4|DB Treatment Period up to Week 24|Adverse Event|0
1615642|NCT02047110|5638155|P3|DB Treatment Period up to Week 24|Adverse Event|0
1615643|NCT02047110|5638156|P2|DB Treatment Period up to Week 24|Adverse Event|0
1615644|NCT02047110|5638157|P1|DB Treatment Period up to Week 24|Adverse Event|1
1615645|NCT02047045|5638200|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|2
1615646|NCT02047045|5638201|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|4
1615647|NCT02047045|5638200|P2|Treatment Period (8 Weeks )|Lost to Follow-up|0
1615648|NCT02047045|5638201|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
1615649|NCT02047045|5638200|P2|Treatment Period (8 Weeks )|Adverse Event|1
1615650|NCT02047045|5638201|P1|Treatment Period (8 Weeks )|Adverse Event|2
1615651|NCT02047045|5638200|P2|Baseline|Withdrawal by Subject|15
1615652|NCT02047045|5638201|P1|Baseline|Withdrawal by Subject|8
1615653|NCT02046993|5638265|P2|Overall Study|Lost to Follow-up|1
1615654|NCT02046993|5638266|P1|Overall Study|Lost to Follow-up|1
1615655|NCT02046993|5638265|P2|Overall Study|Withdrawal by Subject|10
1615656|NCT02046993|5638266|P1|Overall Study|Withdrawal by Subject|2
1615657|NCT02046616|5638338|P1|8-Week FU Period|Lost to Follow-up|1
1615658|NCT02046616|5638338|P1|24-Week Treatment Period|Other|1
1615659|NCT02046616|5638338|P1|24-Week Treatment Period|Physician Decision|3
1615660|NCT02046616|5638338|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
1615661|NCT02046616|5638338|P1|24-Week Treatment Period|Any Other Adverse Event|13
1615662|NCT02046616|5638338|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
1615663|NCT02046603|5638360|P2|Overall Study|Adverse Event|1
1615664|NCT02046603|5638361|P1|Overall Study|Adverse Event|0
1615665|NCT02046603|5638360|P2|Overall Study|Death|1
1615666|NCT02046603|5638361|P1|Overall Study|Death|0
1615667|NCT02046603|5638360|P2|Overall Study|Lost to Follow-up|2
1615668|NCT02046603|5638361|P1|Overall Study|Lost to Follow-up|1
1615669|NCT02046603|5638360|P2|Overall Study|Physician Decision|1
1615670|NCT02046603|5638361|P1|Overall Study|Physician Decision|2
1615671|NCT02046603|5638360|P2|Overall Study|Participant/legal guardian decision|3
1615672|NCT02046603|5638361|P1|Overall Study|Participant/legal guardian decision|1
1615673|NCT02046603|5638360|P2|Overall Study|Protocol Violation|1
1615674|NCT02046603|5638361|P1|Overall Study|Protocol Violation|0
1615675|NCT02046603|5638360|P2|Overall Study|Other|66
1615676|NCT02046603|5638361|P1|Overall Study|Other|11
1615677|NCT02046564|5638440|P2|Overall Study|Subject met withdrawal criteria|5
1615678|NCT02046564|5638441|P1|Overall Study|Subject met withdrawal criteria|2
1615679|NCT02046564|5638440|P2|Overall Study|Withdrawal by Subject|10
1615680|NCT02046564|5638441|P1|Overall Study|Withdrawal by Subject|4
1615681|NCT02046564|5638440|P2|Overall Study|Protocol Violation|1
1615682|NCT02046564|5638441|P1|Overall Study|Protocol Violation|3
1615683|NCT02046564|5638440|P2|Overall Study|Physician Decision|1
1615684|NCT02046564|5638441|P1|Overall Study|Physician Decision|0
1615685|NCT02046564|5638440|P2|Overall Study|Adverse Event|3
1615686|NCT02046564|5638441|P1|Overall Study|Adverse Event|6
1615687|NCT02046369|5638489|P2|Overall Study|non compliance|0
1615688|NCT02046369|5638490|P1|Overall Study|non compliance|1
1615689|NCT02046369|5638489|P2|Overall Study|never received study drug|1
1615690|NCT02046369|5638490|P1|Overall Study|never received study drug|0
1615691|NCT02046369|5638489|P2|Overall Study|Withdrawal by Subject|6
1615692|NCT02046369|5638490|P1|Overall Study|Withdrawal by Subject|3
1615693|NCT02046369|5638489|P2|Overall Study|Protocol Violation|2
1615694|NCT02046369|5638490|P1|Overall Study|Protocol Violation|1
1615695|NCT02046369|5638489|P2|Overall Study|Lost to Follow-up|3
1615696|NCT02046369|5638490|P1|Overall Study|Lost to Follow-up|3
1615697|NCT02046369|5638489|P2|Overall Study|Lack of Efficacy|3
1615698|NCT02046369|5638490|P1|Overall Study|Lack of Efficacy|3
1615699|NCT02046369|5638489|P2|Overall Study|Adverse Event|3
1615700|NCT02046369|5638490|P1|Overall Study|Adverse Event|3
1615701|NCT02046226|5638534|P1|Overall Study|Lost to Follow-up|7
1615702|NCT02046148|5638582|P2|Overall Study|Withdrawal by Subject|2
1615703|NCT02046148|5638583|P1|Overall Study|Withdrawal by Subject|0
1615704|NCT02046148|5638582|P2|Overall Study|Lost to Follow-up|1
1615705|NCT02046148|5638583|P1|Overall Study|Lost to Follow-up|1
1615706|NCT02046122|5638643|P1|Overall Study|Withdrawal by Subject|1
1615707|NCT02046122|5638643|P1|Overall Study|Physician Decision|8
1615708|NCT02046070|5638653|P3|Overall Study|Reason not Specified|6
1615709|NCT02046070|5638654|P2|Overall Study|Reason not Specified|4
1615710|NCT02046070|5638655|P1|Overall Study|Reason not Specified|4
1615711|NCT02046070|5638653|P3|Overall Study|Study Terminated by Sponsor|1
1615712|NCT02046070|5638654|P2|Overall Study|Study Terminated by Sponsor|1
1615713|NCT02046070|5638655|P1|Overall Study|Study Terminated by Sponsor|1
1615714|NCT02046070|5638653|P3|Overall Study|Withdrawal by Subject|6
1615715|NCT02046070|5638654|P2|Overall Study|Withdrawal by Subject|2
1615716|NCT02046070|5638655|P1|Overall Study|Withdrawal by Subject|1
1615717|NCT02046070|5638653|P3|Overall Study|Adverse Event|17
1615718|NCT02046070|5638654|P2|Overall Study|Adverse Event|10
1615719|NCT02046070|5638655|P1|Overall Study|Adverse Event|8
1615720|NCT02046070|5638653|P3|Overall Study|Progressive Disease|40
1615721|NCT02046070|5638654|P2|Overall Study|Progressive Disease|11
1615722|NCT02046070|5638655|P1|Overall Study|Progressive Disease|18
1615723|NCT02045979|5638715|P3|Overall Study|not specified above|0
1615724|NCT02045979|5638716|P2|Overall Study|not specified above|1
1615725|NCT02045979|5638717|P1|Overall Study|not specified above|0
1615726|NCT02045979|5638715|P3|Overall Study|Informed Consent Withdrawn|1
1615727|NCT02045979|5638716|P2|Overall Study|Informed Consent Withdrawn|0
1615728|NCT02045979|5638717|P1|Overall Study|Informed Consent Withdrawn|2
1615729|NCT02045875|5638754|P2|Overall Study|Withdrawal by Subject|3
1615730|NCT02045875|5638755|P1|Overall Study|Withdrawal by Subject|4
1615731|NCT02045875|5638754|P2|Overall Study|Lost to Follow-up|0
1615732|NCT02045875|5638755|P1|Overall Study|Lost to Follow-up|3
1615733|NCT02045862|5638766|P3|Overall Study|Lost to Follow-up|6
1615734|NCT02045862|5638767|P2|Overall Study|Lost to Follow-up|2
1615735|NCT02045862|5638768|P1|Overall Study|Lost to Follow-up|1
1615736|NCT02045862|5638766|P3|Overall Study|Adverse Event|27
1615737|NCT02045862|5638767|P2|Overall Study|Adverse Event|5
1615738|NCT02045862|5638768|P1|Overall Study|Adverse Event|7
1615739|NCT02045862|5638766|P3|Overall Study|Randomized but not Received Study Drug|8
1615740|NCT02045862|5638767|P2|Overall Study|Randomized but not Received Study Drug|2
1615741|NCT02045862|5638768|P1|Overall Study|Randomized but not Received Study Drug|0
1615742|NCT02045862|5638766|P3|Overall Study|Lack of Efficacy|13
1615743|NCT02045862|5638767|P2|Overall Study|Lack of Efficacy|4
1615744|NCT02045862|5638768|P1|Overall Study|Lack of Efficacy|8
1615745|NCT02045862|5638766|P3|Overall Study|Protocol Violation|6
1615746|NCT02045862|5638767|P2|Overall Study|Protocol Violation|0
1615747|NCT02045862|5638768|P1|Overall Study|Protocol Violation|0
1615748|NCT02045862|5638766|P3|Overall Study|Withdrawal by Patient|57
1615749|NCT02045862|5638767|P2|Overall Study|Withdrawal by Patient|27
1615750|NCT02045862|5638768|P1|Overall Study|Withdrawal by Patient|18
1615751|NCT02045862|5638766|P3|Overall Study|Miscellaneous|8
1615752|NCT02045862|5638767|P2|Overall Study|Miscellaneous|0
1615753|NCT02045862|5638768|P1|Overall Study|Miscellaneous|5
1615754|NCT02045862|5638766|P3|Overall Study|Death|1
1615755|NCT02045862|5638767|P2|Overall Study|Death|0
1615756|NCT02045862|5638768|P1|Overall Study|Death|0
1615757|NCT02045836|5638949|P2|Overall Study|Migrated from study area|2
1615758|NCT02045836|5638950|P1|Overall Study|Migrated from study area|0
1615759|NCT02045836|5638949|P2|Overall Study|Lost to Follow-up|7
1615760|NCT02045836|5638950|P1|Overall Study|Lost to Follow-up|4
1615761|NCT02045836|5638949|P2|Overall Study|Withdrawal by Subject|1
1615762|NCT02045836|5638950|P1|Overall Study|Withdrawal by Subject|1
1615763|NCT02045836|5638949|P2|Overall Study|Adverse Event|4
1615764|NCT02045836|5638950|P1|Overall Study|Adverse Event|4
1615765|NCT02045797|5638982|P3|Overall Study|Withdrawal by Subject|0
1615766|NCT02045797|5638983|P2|Overall Study|Withdrawal by Subject|2
1615767|NCT02045797|5638984|P1|Overall Study|Withdrawal by Subject|1
1615768|NCT02045797|5638982|P3|Overall Study|Physician Decision|0
1615769|NCT02045797|5638983|P2|Overall Study|Physician Decision|1
1615770|NCT02045797|5638984|P1|Overall Study|Physician Decision|0
1615771|NCT02045797|5638982|P3|Overall Study|Lost to Follow-up|1
1615772|NCT02045797|5638983|P2|Overall Study|Lost to Follow-up|3
1615773|NCT02045797|5638984|P1|Overall Study|Lost to Follow-up|2
1615774|NCT02045797|5638982|P3|Overall Study|Lack of Efficacy|0
1615775|NCT02045797|5638983|P2|Overall Study|Lack of Efficacy|0
1615776|NCT02045797|5638984|P1|Overall Study|Lack of Efficacy|1
1615777|NCT02045797|5638982|P3|Overall Study|Adverse Event|0
1615778|NCT02045797|5638983|P2|Overall Study|Adverse Event|1
1615779|NCT02045797|5638984|P1|Overall Study|Adverse Event|3
1615780|NCT02045732|5639129|P2|Overall Study|At the discretion of the investigator|1
1615781|NCT02045732|5639130|P1|Overall Study|At the discretion of the investigator|1
1615782|NCT02045433|5639167|P1|Overall Study|Withdrawal by Subject|1
1615783|NCT02045212|5639199|P2|Overall Study|Finished 13 weeks, chose not to extend|0
1615784|NCT02045212|5639200|P1|Overall Study|Finished 13 weeks, chose not to extend|1
1615785|NCT02045212|5639199|P2|Overall Study|Withdrawal by Subject|0
1615786|NCT02045212|5639200|P1|Overall Study|Withdrawal by Subject|1
1615787|NCT02045212|5639199|P2|Overall Study|Adverse Event|1
1615788|NCT02045212|5639200|P1|Overall Study|Adverse Event|0
1615789|NCT02045095|5639265|P7|Overall Study|Adverse Event|0
1615790|NCT02045095|5639266|P6|Overall Study|Adverse Event|2
1615791|NCT02045095|5639267|P5|Overall Study|Adverse Event|0
1615792|NCT02045095|5639268|P4|Overall Study|Adverse Event|0
1615793|NCT02045095|5639269|P3|Overall Study|Adverse Event|1
1615794|NCT02045095|5639270|P2|Overall Study|Adverse Event|1
1615795|NCT02045095|5639271|P1|Overall Study|Adverse Event|0
1615796|NCT02045095|5639265|P7|Overall Study|Withdrawal by Subject|0
1615797|NCT02045095|5639266|P6|Overall Study|Withdrawal by Subject|0
1615798|NCT02045095|5639267|P5|Overall Study|Withdrawal by Subject|3
1615799|NCT02045095|5639268|P4|Overall Study|Withdrawal by Subject|0
1615800|NCT02045095|5639269|P3|Overall Study|Withdrawal by Subject|0
1615801|NCT02045095|5639270|P2|Overall Study|Withdrawal by Subject|0
1615802|NCT02045095|5639271|P1|Overall Study|Withdrawal by Subject|0
1615803|NCT02045095|5639265|P7|Overall Study|Progressive Disease|1
1615804|NCT02045095|5639266|P6|Overall Study|Progressive Disease|4
1615805|NCT02045095|5639267|P5|Overall Study|Progressive Disease|2
1615806|NCT02045095|5639268|P4|Overall Study|Progressive Disease|4
1615807|NCT02045095|5639269|P3|Overall Study|Progressive Disease|2
1615808|NCT02045095|5639270|P2|Overall Study|Progressive Disease|3
1615809|NCT02045095|5639271|P1|Overall Study|Progressive Disease|3
1615810|NCT02045095|5639265|P7|Overall Study|Other|0
1615811|NCT02045095|5639266|P6|Overall Study|Other|2
1615812|NCT02045095|5639267|P5|Overall Study|Other|0
1615813|NCT02045095|5639268|P4|Overall Study|Other|0
1615814|NCT02045095|5639269|P3|Overall Study|Other|1
1615815|NCT02045095|5639270|P2|Overall Study|Other|0
1615816|NCT02045095|5639271|P1|Overall Study|Other|0
1615817|NCT02044874|5639429|P3|Overall Study|Other|8
1615818|NCT02044874|5639430|P2|Overall Study|Other|3
1615819|NCT02044874|5639431|P1|Overall Study|Other|7
1615820|NCT02044874|5639429|P3|Overall Study|Sponsor Decision|1
1615821|NCT02044874|5639430|P2|Overall Study|Sponsor Decision|1
1615822|NCT02044874|5639431|P1|Overall Study|Sponsor Decision|0
1615823|NCT02044874|5639429|P3|Overall Study|Lost to Follow-up|21
1615824|NCT02044874|5639430|P2|Overall Study|Lost to Follow-up|27
1615825|NCT02044874|5639431|P1|Overall Study|Lost to Follow-up|10
1615826|NCT02044874|5639429|P3|Overall Study|Physician Decision|1
1615827|NCT02044874|5639430|P2|Overall Study|Physician Decision|2
1615828|NCT02044874|5639431|P1|Overall Study|Physician Decision|0
1615829|NCT02044874|5639429|P3|Overall Study|Withdrawal by Subject|23
1615830|NCT02044874|5639430|P2|Overall Study|Withdrawal by Subject|16
1615831|NCT02044874|5639431|P1|Overall Study|Withdrawal by Subject|8
1615832|NCT02044874|5639429|P3|Overall Study|Adverse Event|6
1615833|NCT02044874|5639430|P2|Overall Study|Adverse Event|6
1615834|NCT02044874|5639431|P1|Overall Study|Adverse Event|5
1615835|NCT02044848|5639453|P2|Overall Study|Administrative Problems|3
1615836|NCT02044848|5639454|P1|Overall Study|Administrative Problems|2
1615837|NCT02044822|5639460|P1|Overall Study|Lost to Follow-up|1
1615838|NCT02044822|5639460|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
1615839|NCT02044822|5639460|P1|Overall Study|Withdrew Consent|3
1615840|NCT02044822|5639460|P1|Overall Study|Investigator's Discretion|10
1615841|NCT02044822|5639460|P1|Overall Study|Study Terminated by Sponsor|77
1615842|NCT02044510|5639502|P2|Overall Study|Adverse Event|2
1615843|NCT02044510|5639503|P1|Overall Study|Adverse Event|1
1615844|NCT02044458|5639511|P2|Overall Study|Protocol Violation|8
1615845|NCT02044458|5639512|P1|Overall Study|Protocol Violation|3
1615846|NCT02044302|5639598|P2|Overall Study|study terminated|0
1615847|NCT02044302|5639599|P1|Overall Study|study terminated|2
1615848|NCT02044159|5639607|P2|Overall Study|Nurse declined to give study drug|0
1615849|NCT02044159|5639608|P1|Overall Study|Nurse declined to give study drug|1
1615850|NCT02044159|5639607|P2|Overall Study|No longer eligible, drug not given|0
1615851|NCT02044159|5639608|P1|Overall Study|No longer eligible, drug not given|1
1615852|NCT02044159|5639607|P2|Overall Study|Consent declined (deferred consent)|4
1615853|NCT02044159|5639608|P1|Overall Study|Consent declined (deferred consent)|2
1615854|NCT02044094|5639621|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
1615855|NCT02044094|5639621|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
1615856|NCT02044094|5639621|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
1615857|NCT02044094|5639621|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
1615858|NCT02044094|5639621|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
1615859|NCT02044094|5639621|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
1615860|NCT02044094|5639621|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
1615861|NCT02044094|5639621|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
1615862|NCT02043938|5639678|P1|Overall Study|Investigator decision|1
1615863|NCT02043938|5639678|P1|Overall Study|No show by subject|1
1615864|NCT02043938|5639678|P1|Overall Study|Unable to place EEG sensors on patient|1
1615865|NCT02043938|5639678|P1|Overall Study|Withdrawal by Subject|7
1615866|NCT02043782|5639733|P6|Period 1|Adverse Event|0
1615867|NCT02043782|5639734|P5|Period 1|Adverse Event|0
1615868|NCT02043782|5639735|P4|Period 1|Adverse Event|0
1615869|NCT02043782|5639736|P3|Period 1|Adverse Event|1
1615870|NCT02043782|5639737|P2|Period 1|Adverse Event|0
1615871|NCT02043782|5639738|P1|Period 1|Adverse Event|0
1615872|NCT02043678|5639781|P2|Overall Study|Ongoing with treatment|104
1615873|NCT02043678|5639782|P1|Overall Study|Ongoing with treatment|87
1615874|NCT02043678|5639781|P2|Overall Study|Withdrawal by Subject|13
1615875|NCT02043678|5639782|P1|Overall Study|Withdrawal by Subject|10
1615876|NCT02043678|5639781|P2|Overall Study|Protocol-driven decision point|45
1615877|NCT02043678|5639782|P1|Overall Study|Protocol-driven decision point|53
1615878|NCT02043678|5639781|P2|Overall Study|Radiological PD|67
1615879|NCT02043678|5639782|P1|Overall Study|Radiological PD|78
1615880|NCT02043678|5639781|P2|Overall Study|Clinical PD|112
1615881|NCT02043678|5639782|P1|Overall Study|Clinical PD|88
1615882|NCT02043678|5639781|P2|Overall Study|Other|8
1615883|NCT02043678|5639782|P1|Overall Study|Other|15
1615884|NCT02043678|5639781|P2|Overall Study|Lost to Follow-up|1
1615885|NCT02043678|5639782|P1|Overall Study|Lost to Follow-up|1
1615886|NCT02043678|5639781|P2|Overall Study|AE without clinical PD|31
1615887|NCT02043678|5639782|P1|Overall Study|AE without clinical PD|41
1615888|NCT02043678|5639781|P2|Overall Study|AE with clinical progressive disease(PD)|15
1615889|NCT02043678|5639782|P1|Overall Study|AE with clinical progressive disease(PD)|17
1615890|NCT02043678|5639781|P2|Overall Study|Never treated|9
1615891|NCT02043678|5639782|P1|Overall Study|Never treated|11
1615892|NCT02043509|5639818|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
1615893|NCT02043509|5639819|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
1615894|NCT02043509|5639818|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
1615895|NCT02043509|5639819|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
1615896|NCT02043509|5639818|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
1615897|NCT02043509|5639819|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
1615898|NCT02043509|5639818|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
1615899|NCT02043509|5639819|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
1615900|NCT02043366|5639907|P6|Overall Study|Lost to Follow-up|2
1615901|NCT02043366|5639908|P5|Overall Study|Lost to Follow-up|2
1615902|NCT02043366|5639909|P4|Overall Study|Lost to Follow-up|2
1615903|NCT02043366|5639910|P3|Overall Study|Lost to Follow-up|2
1615904|NCT02043366|5639911|P2|Overall Study|Lost to Follow-up|2
1615905|NCT02043366|5639912|P1|Overall Study|Lost to Follow-up|2
1615906|NCT02043301|5639935|P3|Overall Study|Discontinued|0
1615907|NCT02043301|5639936|P2|Overall Study|Discontinued|1
1615908|NCT02043301|5639937|P1|Overall Study|Discontinued|0
1615909|NCT02043132|5640034|P2|Overall Study|screen failures|8
1615910|NCT02043132|5640035|P1|Overall Study|screen failures|4
1615911|NCT02043132|5640034|P2|Overall Study|Lost to Follow-up|1
1615912|NCT02043132|5640035|P1|Overall Study|Lost to Follow-up|1
1615913|NCT02043015|5640055|P1|Overall Study|Incarceration|1
1615914|NCT02043015|5640055|P1|Overall Study|Participant moved away from study city|4
1615915|NCT02043015|5640055|P1|Overall Study|Removed once target enrollment reached|15
1615916|NCT02043015|5640055|P1|Overall Study|Withdrawal by Subject|4
1615917|NCT02043015|5640055|P1|Overall Study|Lost to Follow-up|4
1615918|NCT02042950|5640068|P1|Overall Study|Progressive Disease|4
1615919|NCT02042924|5640074|P1|Overall Study|Early Death|1
1615920|NCT02042443|5640122|P2|Overall Study|Not eligible/not analyzable|6
1615921|NCT02042443|5640123|P1|Overall Study|Not eligible/not analyzable|3
1615922|NCT02042443|5640122|P2|Overall Study|not protocol specified|1
1615923|NCT02042443|5640123|P1|Overall Study|not protocol specified|1
1615924|NCT02042443|5640122|P2|Overall Study|Progression|17
1615925|NCT02042443|5640123|P1|Overall Study|Progression|21
1615926|NCT02042443|5640122|P2|Overall Study|Withdrawal by Subject|1
1615927|NCT02042443|5640123|P1|Overall Study|Withdrawal by Subject|0
1615928|NCT02042443|5640122|P2|Overall Study|Adverse Event|1
1615929|NCT02042443|5640123|P1|Overall Study|Adverse Event|2
1615930|NCT02042404|5640135|P2|Overall Study|Inability to meet time requirements|0
1615931|NCT02042404|5640136|P1|Overall Study|Inability to meet time requirements|1
1615932|NCT02042404|5640135|P2|Overall Study|Unrelated Adverse Event|0
1615933|NCT02042404|5640136|P1|Overall Study|Unrelated Adverse Event|3
1615934|NCT02042404|5640135|P2|Overall Study|Death|0
1615935|NCT02042404|5640136|P1|Overall Study|Death|1
1615936|NCT02042014|5640174|P1|Overall Study|Physician Decision|7
1615937|NCT02042014|5640174|P1|Overall Study|Adverse Event|1
1615938|NCT02041962|5640180|P2|Overall Study|Withdrawal by Subject|11
1615939|NCT02041962|5640181|P1|Overall Study|Withdrawal by Subject|0
1615940|NCT02041962|5640180|P2|Overall Study|Lost to Follow-up|32
1615941|NCT02041962|5640181|P1|Overall Study|Lost to Follow-up|37
1615942|NCT02041962|5640180|P2|Overall Study|Death|1
1615943|NCT02041962|5640181|P1|Overall Study|Death|1
1615944|NCT02041962|5640180|P2|Overall Study|Lost Aetna Coverage|40
1615945|NCT02041962|5640181|P1|Overall Study|Lost Aetna Coverage|43
1615946|NCT02041702|5640191|P2|Overall Study|Cardiac Resynchronization Therapy|0
1615947|NCT02041702|5640192|P1|Overall Study|Cardiac Resynchronization Therapy|1
1615948|NCT02041702|5640191|P2|Overall Study|Patient not confirmed as MRI compatible|0
1615949|NCT02041702|5640192|P1|Overall Study|Patient not confirmed as MRI compatible|1
1615950|NCT02041702|5640191|P2|Overall Study|Withdrawal by Subject|3
1615951|NCT02041702|5640192|P1|Overall Study|Withdrawal by Subject|4
1615952|NCT02041702|5640191|P2|Overall Study|Death|0
1615953|NCT02041702|5640192|P1|Overall Study|Death|4
1615954|NCT02041702|5640191|P2|Overall Study|Lost to Follow-up|6
1615955|NCT02041702|5640192|P1|Overall Study|Lost to Follow-up|1
1615956|NCT02041533|5640207|P2|Overall Study|Randomized, not treated|7
1615957|NCT02041533|5640208|P1|Overall Study|Randomized, not treated|4
1615958|NCT02041533|5640207|P2|Overall Study|Completed max number of chemo cycles|29
1615959|NCT02041533|5640208|P1|Overall Study|Completed max number of chemo cycles|0
1615960|NCT02041533|5640207|P2|Overall Study|Other reasons|1
1615961|NCT02041533|5640208|P1|Overall Study|Other reasons|0
1615962|NCT02041533|5640207|P2|Overall Study|Poor/non-compliance|0
1615963|NCT02041533|5640208|P1|Overall Study|Poor/non-compliance|1
1615964|NCT02041533|5640207|P2|Overall Study|Maximum clinical benefit|18
1615965|NCT02041533|5640208|P1|Overall Study|Maximum clinical benefit|0
1615966|NCT02041533|5640207|P2|Overall Study|Withdrawal by Subject|1
1615967|NCT02041533|5640208|P1|Overall Study|Withdrawal by Subject|2
1615968|NCT02041533|5640207|P2|Overall Study|Subject request to discontinue treatment|9
1615969|NCT02041533|5640208|P1|Overall Study|Subject request to discontinue treatment|5
1615970|NCT02041533|5640207|P2|Overall Study|Adverse Event unrelated to study drug|21
1615971|NCT02041533|5640208|P1|Overall Study|Adverse Event unrelated to study drug|20
1615972|NCT02041533|5640207|P2|Overall Study|Death|0
1615973|NCT02041533|5640208|P1|Overall Study|Death|1
1615974|NCT02041533|5640207|P2|Overall Study|Study drug toxicity|30
1615975|NCT02041533|5640208|P1|Overall Study|Study drug toxicity|27
1615976|NCT02041533|5640207|P2|Overall Study|Disease Progression|142
1615977|NCT02041533|5640208|P1|Overall Study|Disease Progression|168
1615978|NCT02041520|5640230|P2|Overall Study|Hypothiroidism identified during follow-|1
1615979|NCT02041520|5640231|P1|Overall Study|Hypothiroidism identified during follow-|0
1615980|NCT02041520|5640230|P2|Overall Study|Lost to Follow-up|1
1615981|NCT02041520|5640231|P1|Overall Study|Lost to Follow-up|0
1615982|NCT02041520|5640230|P2|Overall Study|Protocol Violation|0
1615983|NCT02041520|5640231|P1|Overall Study|Protocol Violation|1
1615984|NCT02041520|5640230|P2|Overall Study|Withdrawal by Subject|4
1615985|NCT02041520|5640231|P1|Overall Study|Withdrawal by Subject|3
1615986|NCT02041520|5640230|P2|Overall Study|Adverse Event|1
1615987|NCT02041520|5640231|P1|Overall Study|Adverse Event|2
1615988|NCT02041286|5640274|P1|Overall Study|Adverse Event|1
1615989|NCT02041104|5640309|P2|Overall Study|discomfort during OGTT|3
1615990|NCT02041104|5640310|P1|Overall Study|discomfort during OGTT|0
1615991|NCT02041104|5640309|P2|Overall Study|Lost to Follow-up|4
1615992|NCT02041104|5640310|P1|Overall Study|Lost to Follow-up|1
1615993|NCT02041091|5640350|P2|Optional Safety Extension Period|Lost to Follow-up|3
1615994|NCT02041091|5640351|P1|Optional Safety Extension Period|Lost to Follow-up|2
1615995|NCT02041091|5640350|P2|Optional Safety Extension Period|Sponsor Decision|74
1615996|NCT02041091|5640351|P1|Optional Safety Extension Period|Sponsor Decision|70
1615997|NCT02041091|5640350|P2|Optional Safety Extension Period|Physician Decision|1
1615998|NCT02041091|5640351|P1|Optional Safety Extension Period|Physician Decision|2
1615999|NCT02041091|5640350|P2|Optional Safety Extension Period|Protocol Violation|0
1616000|NCT02041091|5640351|P1|Optional Safety Extension Period|Protocol Violation|2
1616001|NCT02041091|5640350|P2|Optional Safety Extension Period|Withdrawal by Subject|2
1616002|NCT02041091|5640351|P1|Optional Safety Extension Period|Withdrawal by Subject|5
1616003|NCT02041091|5640350|P2|Optional Safety Extension Period|Adverse Event|2
1616004|NCT02041091|5640351|P1|Optional Safety Extension Period|Adverse Event|4
1616005|NCT02041091|5640350|P2|Treatment|Lost to Follow-up|0
1616006|NCT02041091|5640351|P1|Treatment|Lost to Follow-up|1
1616007|NCT02041091|5640350|P2|Treatment|Sponsor Decision|16
1616008|NCT02041091|5640351|P1|Treatment|Sponsor Decision|15
1616009|NCT02041091|5640350|P2|Treatment|Physician Decision|0
1616010|NCT02041091|5640351|P1|Treatment|Physician Decision|1
1616011|NCT02041091|5640350|P2|Treatment|Withdrawal by Subject|4
1616012|NCT02041091|5640351|P1|Treatment|Withdrawal by Subject|2
1616013|NCT02041091|5640350|P2|Treatment|Adverse Event|3
1616014|NCT02041091|5640351|P1|Treatment|Adverse Event|3
1616015|NCT02040870|5640373|P1|Overall Study|Death|13
1616016|NCT02040870|5640373|P1|Overall Study|Lost to Follow-up|3
1616017|NCT02040870|5640373|P1|Overall Study|Subject/guardian decision|10
1616018|NCT02040870|5640373|P1|Overall Study|Physician Decision|6
1616019|NCT02040870|5640373|P1|Overall Study|Progressive disease|58
1616020|NCT02040870|5640373|P1|Overall Study|Adverse Event|7
1616021|NCT02040870|5640373|P1|Overall Study|Completed treatment phase|6
1616022|NCT02040844|5640397|P3|Overall Study|Concomitant medication|1
1616023|NCT02040844|5640398|P2|Overall Study|Concomitant medication|3
1616024|NCT02040844|5640399|P1|Overall Study|Concomitant medication|1
1616025|NCT02040844|5640397|P3|Overall Study|Non-specified|5
1616026|NCT02040844|5640398|P2|Overall Study|Non-specified|2
1616027|NCT02040844|5640399|P1|Overall Study|Non-specified|8
1616028|NCT02040844|5640397|P3|Overall Study|Missing|2
1616029|NCT02040844|5640398|P2|Overall Study|Missing|3
1616030|NCT02040844|5640399|P1|Overall Study|Missing|13
1616031|NCT02040844|5640397|P3|Overall Study|Lost to Follow-up|13
1616032|NCT02040844|5640398|P2|Overall Study|Lost to Follow-up|9
1616033|NCT02040844|5640399|P1|Overall Study|Lost to Follow-up|12
1616034|NCT02040844|5640397|P3|Overall Study|Withdrawal by Subject|25
1616035|NCT02040844|5640398|P2|Overall Study|Withdrawal by Subject|22
1616036|NCT02040844|5640399|P1|Overall Study|Withdrawal by Subject|16
1616037|NCT02040844|5640397|P3|Overall Study|Adverse Event|1
1616038|NCT02040844|5640398|P2|Overall Study|Adverse Event|0
1616039|NCT02040844|5640399|P1|Overall Study|Adverse Event|0
1616040|NCT02040805|5640424|P2|Overall Study|Withdrawal by Subject|41
1616041|NCT02040805|5640425|P1|Overall Study|Withdrawal by Subject|28
1616042|NCT02040805|5640424|P2|Overall Study|Lost to Follow-up|9
1616043|NCT02040805|5640425|P1|Overall Study|Lost to Follow-up|14
1616044|NCT02040779|5640461|P3|Overall Study|Lack of Efficacy|0
1616045|NCT02040779|5640462|P2|Overall Study|Lack of Efficacy|2
1616046|NCT02040779|5640463|P1|Overall Study|Lack of Efficacy|4
1616047|NCT02040779|5640461|P3|Overall Study|Lost to Follow-up|1
1616048|NCT02040779|5640462|P2|Overall Study|Lost to Follow-up|2
1616049|NCT02040779|5640463|P1|Overall Study|Lost to Follow-up|1
1616050|NCT02040779|5640461|P3|Overall Study|Protocol Violation|0
1616051|NCT02040779|5640462|P2|Overall Study|Protocol Violation|1
1616052|NCT02040779|5640463|P1|Overall Study|Protocol Violation|2
1616053|NCT02040779|5640461|P3|Overall Study|Non-compliance|0
1616054|NCT02040779|5640462|P2|Overall Study|Non-compliance|1
1616055|NCT02040779|5640463|P1|Overall Study|Non-compliance|0
1616056|NCT02040779|5640461|P3|Overall Study|Withdrawal by Subject|3
1616057|NCT02040779|5640462|P2|Overall Study|Withdrawal by Subject|1
1616058|NCT02040779|5640463|P1|Overall Study|Withdrawal by Subject|4
1616059|NCT02040779|5640461|P3|Overall Study|Adverse Event|0
1616060|NCT02040779|5640462|P2|Overall Study|Adverse Event|0
1616061|NCT02040779|5640463|P1|Overall Study|Adverse Event|1
1616062|NCT02040766|5640503|P5|Overall Study|Lack of Efficacy|5
1616063|NCT02040766|5640504|P4|Overall Study|Lack of Efficacy|6
1616064|NCT02040766|5640505|P3|Overall Study|Lack of Efficacy|4
1616065|NCT02040766|5640506|P2|Overall Study|Lack of Efficacy|3
1616066|NCT02040766|5640507|P1|Overall Study|Lack of Efficacy|6
1616067|NCT02040766|5640503|P5|Overall Study|Not reported|0
1616068|NCT02040766|5640504|P4|Overall Study|Not reported|0
1616069|NCT02040766|5640505|P3|Overall Study|Not reported|0
1616070|NCT02040766|5640506|P2|Overall Study|Not reported|0
1616071|NCT02040766|5640507|P1|Overall Study|Not reported|1
1616072|NCT02040766|5640503|P5|Overall Study|Lost to Follow-up|4
1616073|NCT02040766|5640504|P4|Overall Study|Lost to Follow-up|1
1616074|NCT02040766|5640505|P3|Overall Study|Lost to Follow-up|3
1616075|NCT02040766|5640506|P2|Overall Study|Lost to Follow-up|1
1616076|NCT02040766|5640507|P1|Overall Study|Lost to Follow-up|4
1616077|NCT02040766|5640503|P5|Overall Study|Protocol Violation|0
1616078|NCT02040766|5640504|P4|Overall Study|Protocol Violation|3
1616079|NCT02040766|5640505|P3|Overall Study|Protocol Violation|2
1616080|NCT02040766|5640506|P2|Overall Study|Protocol Violation|1
1616081|NCT02040766|5640507|P1|Overall Study|Protocol Violation|2
1616082|NCT02040766|5640503|P5|Overall Study|Non-compliance|0
1616083|NCT02040766|5640504|P4|Overall Study|Non-compliance|0
1616084|NCT02040766|5640505|P3|Overall Study|Non-compliance|0
1616085|NCT02040766|5640506|P2|Overall Study|Non-compliance|1
1616086|NCT02040766|5640507|P1|Overall Study|Non-compliance|0
1616087|NCT02040766|5640503|P5|Overall Study|Withdrawal by Subject|2
1616088|NCT02040766|5640504|P4|Overall Study|Withdrawal by Subject|3
1616089|NCT02040766|5640505|P3|Overall Study|Withdrawal by Subject|2
1616090|NCT02040766|5640506|P2|Overall Study|Withdrawal by Subject|3
1616091|NCT02040766|5640507|P1|Overall Study|Withdrawal by Subject|4
1616092|NCT02040766|5640503|P5|Overall Study|Adverse Event|2
1616093|NCT02040766|5640504|P4|Overall Study|Adverse Event|0
1616094|NCT02040766|5640505|P3|Overall Study|Adverse Event|1
1616095|NCT02040766|5640506|P2|Overall Study|Adverse Event|1
1616096|NCT02040766|5640507|P1|Overall Study|Adverse Event|1
1616097|NCT02040584|5640560|P2|Overall Study|Immunosuppressant/prohibited med use|10
1616098|NCT02040584|5640561|P1|Overall Study|Immunosuppressant/prohibited med use|7
1616099|NCT02040584|5640560|P2|Overall Study|Transplant rejection/retransplant|1
1616100|NCT02040584|5640561|P1|Overall Study|Transplant rejection/retransplant|0
1616101|NCT02040584|5640560|P2|Overall Study|Death|3
1616102|NCT02040584|5640561|P1|Overall Study|Death|6
1616103|NCT02040584|5640560|P2|Overall Study|Unsatisfactory therapeutic effect|1
1616104|NCT02040584|5640561|P1|Overall Study|Unsatisfactory therapeutic effect|0
1616105|NCT02040584|5640560|P2|Overall Study|Protocol Violation|11
1616106|NCT02040584|5640561|P1|Overall Study|Protocol Violation|9
1616107|NCT02040584|5640560|P2|Overall Study|Adverse Event|6
1616108|NCT02040584|5640561|P1|Overall Study|Adverse Event|13
1616109|NCT02040532|5640594|P1|Overall Study|Withdrawal by Subject|3
1616110|NCT02040532|5640594|P1|Overall Study|Adverse Event|4
1616111|NCT02040532|5640594|P1|Overall Study|Physician Decision|4
1616112|NCT02040532|5640594|P1|Overall Study|Lost to Follow-up|1
1616113|NCT02040428|5640607|P2|Overall Study|Withdrawal by Subject|1
1616114|NCT02040428|5640608|P1|Overall Study|Withdrawal by Subject|1
1616115|NCT02040428|5640607|P2|Overall Study|Death|3
1616116|NCT02040428|5640608|P1|Overall Study|Death|4
1616117|NCT02039908|5640686|P4|Phase 2-School Year|Withdrawal by Subject|5
1616118|NCT02039908|5640687|P3|Phase 2-School Year|Withdrawal by Subject|8
1616119|NCT02039908|5640688|P2|Phase 2-School Year|Withdrawal by Subject|0
1616120|NCT02039908|5640689|P1|Phase 2-School Year|Withdrawal by Subject|0
1616121|NCT02039908|5640686|P4|Phase 2-School Year|Protocol Violation|0
1616122|NCT02039908|5640687|P3|Phase 2-School Year|Protocol Violation|3
1616123|NCT02039908|5640688|P2|Phase 2-School Year|Protocol Violation|0
1616124|NCT02039908|5640689|P1|Phase 2-School Year|Protocol Violation|0
1616125|NCT02039908|5640686|P4|Phase 2-School Year|Lost to Follow-up|3
1616126|NCT02039908|5640687|P3|Phase 2-School Year|Lost to Follow-up|1
1616127|NCT02039908|5640688|P2|Phase 2-School Year|Lost to Follow-up|0
1616128|NCT02039908|5640689|P1|Phase 2-School Year|Lost to Follow-up|0
1616129|NCT02039908|5640686|P4|Phase 1-Summer|Protocol Violation|0
1616130|NCT02039908|5640687|P3|Phase 1-Summer|Protocol Violation|0
1616131|NCT02039908|5640688|P2|Phase 1-Summer|Protocol Violation|0
1616132|NCT02039908|5640689|P1|Phase 1-Summer|Protocol Violation|6
1616133|NCT02039908|5640686|P4|Phase 1-Summer|Withdrawal by Subject|0
1616134|NCT02039908|5640687|P3|Phase 1-Summer|Withdrawal by Subject|0
1616135|NCT02039908|5640688|P2|Phase 1-Summer|Withdrawal by Subject|6
1616136|NCT02039908|5640689|P1|Phase 1-Summer|Withdrawal by Subject|7
1616137|NCT02039856|5640703|P2|Overall Study|Withdrawal by Subject|618
1616138|NCT02039856|5640704|P1|Overall Study|Withdrawal by Subject|1573
1616139|NCT02039856|5640703|P2|Overall Study|Lost to Follow-up|206
1616140|NCT02039856|5640704|P1|Overall Study|Lost to Follow-up|388
1616141|NCT02039856|5640703|P2|Overall Study|Partial survey completion|26
1616142|NCT02039856|5640704|P1|Overall Study|Partial survey completion|61
1616143|NCT02039856|5640703|P2|Overall Study|Death|3
1616144|NCT02039856|5640704|P1|Overall Study|Death|5
1616145|NCT02039778|5640736|P1|Overall Study|Never started the protocol treatment|1
1616146|NCT02039778|5640736|P1|Overall Study|Withdrawal by Subject|1
1616147|NCT02039778|5640736|P1|Overall Study|Death|2
1616148|NCT02039687|5640759|P4|Overall Study|treatment assignment could not be confir|0
1616149|NCT02039687|5640760|P3|Overall Study|treatment assignment could not be confir|2
1616150|NCT02039687|5640761|P2|Overall Study|treatment assignment could not be confir|0
1616151|NCT02039687|5640762|P1|Overall Study|treatment assignment could not be confir|0
1616152|NCT02039687|5640759|P4|Overall Study|Withdrawal by Subject|0
1616153|NCT02039687|5640760|P3|Overall Study|Withdrawal by Subject|0
1616154|NCT02039687|5640761|P2|Overall Study|Withdrawal by Subject|1
1616155|NCT02039687|5640762|P1|Overall Study|Withdrawal by Subject|0
1616156|NCT02039687|5640759|P4|Overall Study|Adverse Event|0
1616157|NCT02039687|5640760|P3|Overall Study|Adverse Event|1
1616158|NCT02039687|5640761|P2|Overall Study|Adverse Event|0
1616159|NCT02039687|5640762|P1|Overall Study|Adverse Event|0
1616160|NCT02039674|5640802|P14|Overall Study|Ongoing in Study|3
1616161|NCT02039674|5640803|P13|Overall Study|Ongoing in Study|33
1616162|NCT02039674|5640804|P12|Overall Study|Ongoing in Study|34
1616163|NCT02039674|5640805|P11|Overall Study|Ongoing in Study|1
1616164|NCT02039674|5640806|P10|Overall Study|Ongoing in Study|6
1616165|NCT02039674|5640807|P9|Overall Study|Ongoing in Study|1
1616166|NCT02039674|5640808|P8|Overall Study|Ongoing in Study|0
1616167|NCT02039674|5640809|P7|Overall Study|Ongoing in Study|2
1616168|NCT02039674|5640810|P6|Overall Study|Ongoing in Study|1
1616169|NCT02039674|5640811|P5|Overall Study|Ongoing in Study|3
1616170|NCT02039674|5640812|P4|Overall Study|Ongoing in Study|2
1616171|NCT02039674|5640813|P3|Overall Study|Ongoing in Study|3
1616172|NCT02039674|5640814|P2|Overall Study|Ongoing in Study|2
1616173|NCT02039674|5640815|P1|Overall Study|Ongoing in Study|5
1616174|NCT02039674|5640802|P14|Overall Study|Withdrawal by Subject|2
1616175|NCT02039674|5640803|P13|Overall Study|Withdrawal by Subject|5
1616176|NCT02039674|5640804|P12|Overall Study|Withdrawal by Subject|3
1616177|NCT02039674|5640805|P11|Overall Study|Withdrawal by Subject|1
1616178|NCT02039674|5640806|P10|Overall Study|Withdrawal by Subject|2
1616179|NCT02039674|5640807|P9|Overall Study|Withdrawal by Subject|0
1616180|NCT02039674|5640808|P8|Overall Study|Withdrawal by Subject|0
1616181|NCT02039674|5640809|P7|Overall Study|Withdrawal by Subject|0
1616182|NCT02039674|5640810|P6|Overall Study|Withdrawal by Subject|0
1616183|NCT02039674|5640811|P5|Overall Study|Withdrawal by Subject|1
1616184|NCT02039674|5640812|P4|Overall Study|Withdrawal by Subject|0
1616185|NCT02039674|5640813|P3|Overall Study|Withdrawal by Subject|1
1616186|NCT02039674|5640814|P2|Overall Study|Withdrawal by Subject|2
1616187|NCT02039674|5640815|P1|Overall Study|Withdrawal by Subject|0
1616188|NCT02039674|5640802|P14|Overall Study|Progressive Disease|16
1616189|NCT02039674|5640803|P13|Overall Study|Progressive Disease|18
1616190|NCT02039674|5640804|P12|Overall Study|Progressive Disease|17
1616191|NCT02039674|5640805|P11|Overall Study|Progressive Disease|0
1616192|NCT02039674|5640806|P10|Overall Study|Progressive Disease|2
1616193|NCT02039674|5640807|P9|Overall Study|Progressive Disease|7
1616194|NCT02039674|5640808|P8|Overall Study|Progressive Disease|3
1616195|NCT02039674|5640809|P7|Overall Study|Progressive Disease|1
1616196|NCT02039674|5640810|P6|Overall Study|Progressive Disease|10
1616197|NCT02039674|5640811|P5|Overall Study|Progressive Disease|8
1616198|NCT02039674|5640812|P4|Overall Study|Progressive Disease|7
1616199|NCT02039674|5640813|P3|Overall Study|Progressive Disease|6
1616200|NCT02039674|5640814|P2|Overall Study|Progressive Disease|7
1616201|NCT02039674|5640815|P1|Overall Study|Progressive Disease|6
1616202|NCT02039674|5640802|P14|Overall Study|Physician Decision|0
1616203|NCT02039674|5640803|P13|Overall Study|Physician Decision|0
1616204|NCT02039674|5640804|P12|Overall Study|Physician Decision|1
1616205|NCT02039674|5640805|P11|Overall Study|Physician Decision|0
1616206|NCT02039674|5640806|P10|Overall Study|Physician Decision|0
1616207|NCT02039674|5640807|P9|Overall Study|Physician Decision|0
1616208|NCT02039674|5640808|P8|Overall Study|Physician Decision|0
1616209|NCT02039674|5640809|P7|Overall Study|Physician Decision|0
1616210|NCT02039674|5640810|P6|Overall Study|Physician Decision|0
1616211|NCT02039674|5640811|P5|Overall Study|Physician Decision|0
1616212|NCT02039674|5640812|P4|Overall Study|Physician Decision|0
1616213|NCT02039674|5640813|P3|Overall Study|Physician Decision|0
1616214|NCT02039674|5640814|P2|Overall Study|Physician Decision|0
1616215|NCT02039674|5640815|P1|Overall Study|Physician Decision|0
1616216|NCT02039674|5640802|P14|Overall Study|Lost to Follow-up|0
1616217|NCT02039674|5640803|P13|Overall Study|Lost to Follow-up|1
1616218|NCT02039674|5640804|P12|Overall Study|Lost to Follow-up|0
1616219|NCT02039674|5640805|P11|Overall Study|Lost to Follow-up|0
1616220|NCT02039674|5640806|P10|Overall Study|Lost to Follow-up|0
1616221|NCT02039674|5640807|P9|Overall Study|Lost to Follow-up|0
1616222|NCT02039674|5640808|P8|Overall Study|Lost to Follow-up|0
1616223|NCT02039674|5640809|P7|Overall Study|Lost to Follow-up|0
1616224|NCT02039674|5640810|P6|Overall Study|Lost to Follow-up|0
1616225|NCT02039674|5640811|P5|Overall Study|Lost to Follow-up|0
1616226|NCT02039674|5640812|P4|Overall Study|Lost to Follow-up|0
1616227|NCT02039674|5640813|P3|Overall Study|Lost to Follow-up|0
1616228|NCT02039674|5640814|P2|Overall Study|Lost to Follow-up|0
1616229|NCT02039674|5640815|P1|Overall Study|Lost to Follow-up|0
1616230|NCT02039674|5640802|P14|Overall Study|Excluded Medication|3
1616231|NCT02039674|5640803|P13|Overall Study|Excluded Medication|4
1616232|NCT02039674|5640804|P12|Overall Study|Excluded Medication|2
1616233|NCT02039674|5640805|P11|Overall Study|Excluded Medication|4
1616234|NCT02039674|5640806|P10|Overall Study|Excluded Medication|2
1616235|NCT02039674|5640807|P9|Overall Study|Excluded Medication|2
1616236|NCT02039674|5640808|P8|Overall Study|Excluded Medication|0
1616237|NCT02039674|5640809|P7|Overall Study|Excluded Medication|0
1616238|NCT02039674|5640810|P6|Overall Study|Excluded Medication|1
1616239|NCT02039674|5640811|P5|Overall Study|Excluded Medication|0
1616240|NCT02039674|5640812|P4|Overall Study|Excluded Medication|1
1616241|NCT02039674|5640813|P3|Overall Study|Excluded Medication|0
1616242|NCT02039674|5640814|P2|Overall Study|Excluded Medication|1
1616243|NCT02039674|5640815|P1|Overall Study|Excluded Medication|1
1616244|NCT02039674|5640802|P14|Overall Study|Death|8
1616245|NCT02039674|5640803|P13|Overall Study|Death|0
1616246|NCT02039674|5640804|P12|Overall Study|Death|1
1616247|NCT02039674|5640805|P11|Overall Study|Death|1
1616248|NCT02039674|5640806|P10|Overall Study|Death|0
1616249|NCT02039674|5640807|P9|Overall Study|Death|0
1616250|NCT02039674|5640808|P8|Overall Study|Death|0
1616251|NCT02039674|5640809|P7|Overall Study|Death|0
1616252|NCT02039674|5640810|P6|Overall Study|Death|0
1616253|NCT02039674|5640811|P5|Overall Study|Death|0
1616254|NCT02039674|5640812|P4|Overall Study|Death|2
1616255|NCT02039674|5640813|P3|Overall Study|Death|1
1616256|NCT02039674|5640814|P2|Overall Study|Death|0
1616257|NCT02039674|5640815|P1|Overall Study|Death|0
1616258|NCT02039674|5640802|P14|Overall Study|Adverse Event|1
1616259|NCT02039674|5640803|P13|Overall Study|Adverse Event|2
1616260|NCT02039674|5640804|P12|Overall Study|Adverse Event|2
1616261|NCT02039674|5640805|P11|Overall Study|Adverse Event|0
1616262|NCT02039674|5640806|P10|Overall Study|Adverse Event|0
1616263|NCT02039674|5640807|P9|Overall Study|Adverse Event|2
1616264|NCT02039674|5640808|P8|Overall Study|Adverse Event|0
1616265|NCT02039674|5640809|P7|Overall Study|Adverse Event|0
1616266|NCT02039674|5640810|P6|Overall Study|Adverse Event|0
1616267|NCT02039674|5640811|P5|Overall Study|Adverse Event|0
1616268|NCT02039674|5640812|P4|Overall Study|Adverse Event|1
1616269|NCT02039674|5640813|P3|Overall Study|Adverse Event|1
1616270|NCT02039674|5640814|P2|Overall Study|Adverse Event|0
1616271|NCT02039674|5640815|P1|Overall Study|Adverse Event|0
1616272|NCT02039505|5640857|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
1616273|NCT02039505|5640858|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1616274|NCT02039505|5640859|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1616275|NCT02039505|5640860|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1616276|NCT02039505|5640861|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1616277|NCT02039505|5640862|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1616278|NCT02039505|5640863|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
1616279|NCT02039505|5640857|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
1616280|NCT02039505|5640858|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1616281|NCT02039505|5640859|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1616282|NCT02039505|5640860|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1616283|NCT02039505|5640861|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1616284|NCT02039505|5640862|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1616285|NCT02039505|5640863|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
1616286|NCT02039505|5640857|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
1616287|NCT02039505|5640858|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1616288|NCT02039505|5640859|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1616289|NCT02039505|5640860|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1616290|NCT02039505|5640861|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1616291|NCT02039505|5640862|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1616292|NCT02039505|5640863|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
1616293|NCT02039505|5640857|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
1616294|NCT02039505|5640858|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1616295|NCT02039505|5640859|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1616296|NCT02039505|5640860|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1616297|NCT02039505|5640861|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1616298|NCT02039505|5640862|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1616299|NCT02039505|5640863|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
1616300|NCT02039505|5640857|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1616301|NCT02039505|5640858|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1616302|NCT02039505|5640859|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1616303|NCT02039505|5640860|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
1616304|NCT02039505|5640861|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1616305|NCT02039505|5640862|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1616306|NCT02039505|5640863|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
1616307|NCT02039505|5640857|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1616308|NCT02039505|5640858|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
1616309|NCT02039505|5640859|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
1616310|NCT02039505|5640860|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
1616311|NCT02039505|5640861|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1616312|NCT02039505|5640862|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1616313|NCT02039505|5640863|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
1616314|NCT02039505|5640857|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1616315|NCT02039505|5640858|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
1616316|NCT02039505|5640859|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
1616317|NCT02039505|5640860|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
1616318|NCT02039505|5640861|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1616319|NCT02039505|5640862|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1616320|NCT02039505|5640863|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
1616321|NCT02039505|5640857|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1616322|NCT02039505|5640858|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
1616323|NCT02039505|5640859|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
1616324|NCT02039505|5640860|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
1616481|NCT02038907|5641171|P11|Overall Study|Withdrawal by Subject|1
1616325|NCT02039505|5640861|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1616326|NCT02039505|5640862|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1616327|NCT02039505|5640863|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
1616328|NCT02039505|5640857|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1616329|NCT02039505|5640858|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1616330|NCT02039505|5640859|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1616331|NCT02039505|5640860|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1616332|NCT02039505|5640861|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1616333|NCT02039505|5640862|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
1616334|NCT02039505|5640863|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
1616335|NCT02039505|5640857|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1616336|NCT02039505|5640858|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1616337|NCT02039505|5640859|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1616338|NCT02039505|5640860|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
1616339|NCT02039505|5640861|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
1616340|NCT02039505|5640862|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
1616341|NCT02039505|5640863|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
1616342|NCT02039505|5640857|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1616343|NCT02039505|5640858|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1616344|NCT02039505|5640859|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1616345|NCT02039505|5640860|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
1616346|NCT02039505|5640861|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
1616347|NCT02039505|5640862|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
1616348|NCT02039505|5640863|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
1616349|NCT02039427|5640939|P4|Overall Study|Steroid Use|0
1616350|NCT02039427|5640940|P3|Overall Study|Steroid Use|0
1616351|NCT02039427|5640941|P2|Overall Study|Steroid Use|0
1616352|NCT02039427|5640942|P1|Overall Study|Steroid Use|1
1616353|NCT02039427|5640939|P4|Overall Study|Loss of follow - up|4
1616354|NCT02039427|5640940|P3|Overall Study|Loss of follow - up|2
1616355|NCT02039427|5640941|P2|Overall Study|Loss of follow - up|0
1616356|NCT02039427|5640942|P1|Overall Study|Loss of follow - up|1
1616357|NCT02039427|5640939|P4|Overall Study|Cancellation of surgery|0
1616358|NCT02039427|5640940|P3|Overall Study|Cancellation of surgery|1
1616359|NCT02039427|5640941|P2|Overall Study|Cancellation of surgery|0
1616360|NCT02039427|5640942|P1|Overall Study|Cancellation of surgery|0
1616361|NCT02039427|5640939|P4|Overall Study|Withdrawal on concent|1
1616362|NCT02039427|5640940|P3|Overall Study|Withdrawal on concent|0
1616363|NCT02039427|5640941|P2|Overall Study|Withdrawal on concent|0
1616364|NCT02039427|5640942|P1|Overall Study|Withdrawal on concent|0
1616365|NCT02039427|5640939|P4|Overall Study|Duration of surgery > 3h|0
1616366|NCT02039427|5640940|P3|Overall Study|Duration of surgery > 3h|0
1616367|NCT02039427|5640941|P2|Overall Study|Duration of surgery > 3h|1
1616368|NCT02039427|5640942|P1|Overall Study|Duration of surgery > 3h|1
1616369|NCT02039414|5640962|P2|Overall Study|Protocol Violation|1
1616370|NCT02039414|5640963|P1|Overall Study|Protocol Violation|3
1616371|NCT02039414|5640962|P2|Overall Study|Lost to Follow-up|0
1616372|NCT02039414|5640963|P1|Overall Study|Lost to Follow-up|2
1616373|NCT02039414|5640962|P2|Overall Study|Delivered|1
1616374|NCT02039414|5640963|P1|Overall Study|Delivered|1
1616375|NCT02039219|5640977|P2|Follow up|Adverse Event|1
1616376|NCT02039219|5640978|P1|Follow up|Adverse Event|0
1616377|NCT02039219|5640977|P2|Treatment|Death|0
1616378|NCT02039219|5640978|P1|Treatment|Death|1
1616379|NCT02039219|5640977|P2|Treatment|Protocol Violation|0
1616380|NCT02039219|5640978|P1|Treatment|Protocol Violation|1
1616381|NCT02039219|5640977|P2|Treatment|Lost to Follow-up|1
1616382|NCT02039219|5640978|P1|Treatment|Lost to Follow-up|0
1616383|NCT02039219|5640977|P2|Treatment|Physician Decision|0
1616384|NCT02039219|5640978|P1|Treatment|Physician Decision|1
1616385|NCT02039219|5640977|P2|Treatment|Adverse Event|1
1616386|NCT02039219|5640978|P1|Treatment|Adverse Event|0
1616387|NCT02039219|5640977|P2|Treatment|Withdrawal by Subject|0
1616388|NCT02039219|5640978|P1|Treatment|Withdrawal by Subject|1
1616389|NCT02038959|5641027|P2|Overall Study|Withdrawal by Subject|8
1616390|NCT02038959|5641028|P1|Overall Study|Withdrawal by Subject|6
1616391|NCT02038946|5641054|P1|Overall Study|Other reasons|1
1616392|NCT02038946|5641054|P1|Overall Study|Lost to Follow-up|2
1616393|NCT02038946|5641054|P1|Overall Study|Withdrawal by Subject|3
1616394|NCT02038946|5641054|P1|Overall Study|Death|5
1616395|NCT02038933|5641065|P1|Follow-up|Disease Progression|2
1616396|NCT02038933|5641065|P1|Follow-up|Withdrawal by Subject|1
1616397|NCT02038933|5641065|P1|Follow-up|Lost to Follow-up|1
1616398|NCT02038933|5641065|P1|Follow-up|Adverse event unrelated to study drug|4
1616399|NCT02038933|5641065|P1|Follow-up|Death|11
1616400|NCT02038933|5641065|P1|Treatment|Withdrawal by Subject|1
1616401|NCT02038933|5641065|P1|Treatment|Disease Progression|101
1616402|NCT02038933|5641065|P1|Treatment|Study Drug Toxicity|4
1616403|NCT02038933|5641065|P1|Treatment|Adverse Event Unrelated to Study Drug|6
1616404|NCT02038933|5641065|P1|Treatment|Lost to Follow-up|1
1616405|NCT02038933|5641065|P1|Treatment|No longer meets study criteria|1
1616406|NCT02038920|5641086|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
1616407|NCT02038920|5641087|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1616408|NCT02038920|5641088|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1616409|NCT02038920|5641089|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1616410|NCT02038920|5641090|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1616411|NCT02038920|5641091|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
1616412|NCT02038920|5641086|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
1616413|NCT02038920|5641087|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1616414|NCT02038920|5641088|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1616415|NCT02038920|5641089|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1616416|NCT02038920|5641090|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1616417|NCT02038920|5641091|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
1616418|NCT02038920|5641086|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
1616419|NCT02038920|5641087|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1616420|NCT02038920|5641088|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1616421|NCT02038920|5641089|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1616422|NCT02038920|5641090|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1616423|NCT02038920|5641091|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
1616424|NCT02038920|5641086|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
1616425|NCT02038920|5641087|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1616426|NCT02038920|5641088|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1616427|NCT02038920|5641089|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1616428|NCT02038920|5641090|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1616429|NCT02038920|5641091|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
1616430|NCT02038920|5641086|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
1616431|NCT02038920|5641087|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1616432|NCT02038920|5641088|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1616433|NCT02038920|5641089|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1616434|NCT02038920|5641090|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1616435|NCT02038920|5641091|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
1616436|NCT02038920|5641086|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
1616437|NCT02038920|5641087|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1616438|NCT02038920|5641088|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1616439|NCT02038920|5641089|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1616440|NCT02038920|5641090|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1616441|NCT02038920|5641091|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
1616442|NCT02038920|5641086|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
1616443|NCT02038920|5641087|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
1616444|NCT02038920|5641088|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
1616445|NCT02038920|5641089|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
1616446|NCT02038920|5641090|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
1616447|NCT02038920|5641091|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
1616448|NCT02038920|5641086|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1616449|NCT02038920|5641087|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1616450|NCT02038920|5641088|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1616451|NCT02038920|5641089|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
1616452|NCT02038920|5641090|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1616453|NCT02038920|5641091|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
1616454|NCT02038920|5641086|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
1616455|NCT02038920|5641087|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
1616456|NCT02038920|5641088|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
1616457|NCT02038920|5641089|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
1616458|NCT02038920|5641090|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
1616459|NCT02038920|5641091|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
1616460|NCT02038920|5641086|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1616461|NCT02038920|5641087|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1616462|NCT02038920|5641088|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1616463|NCT02038920|5641089|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
1616464|NCT02038920|5641090|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
1616465|NCT02038920|5641091|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
1616466|NCT02038920|5641086|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1616467|NCT02038920|5641087|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1616468|NCT02038920|5641088|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1616469|NCT02038920|5641089|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1616470|NCT02038920|5641090|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
1616471|NCT02038920|5641091|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
1616472|NCT02038920|5641086|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1616473|NCT02038920|5641087|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1616474|NCT02038920|5641088|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1616475|NCT02038920|5641089|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
1616476|NCT02038920|5641090|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
1616477|NCT02038920|5641091|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
1616478|NCT02038907|5641168|P14|Overall Study|Withdrawal by Subject|0
1616479|NCT02038907|5641169|P13|Overall Study|Withdrawal by Subject|0
1616480|NCT02038907|5641170|P12|Overall Study|Withdrawal by Subject|0
1616482|NCT02038907|5641172|P10|Overall Study|Withdrawal by Subject|0
1616483|NCT02038907|5641173|P9|Overall Study|Withdrawal by Subject|0
1616484|NCT02038907|5641174|P8|Overall Study|Withdrawal by Subject|0
1616485|NCT02038907|5641175|P7|Overall Study|Withdrawal by Subject|0
1616486|NCT02038907|5641176|P6|Overall Study|Withdrawal by Subject|0
1616487|NCT02038907|5641177|P5|Overall Study|Withdrawal by Subject|0
1616488|NCT02038907|5641178|P4|Overall Study|Withdrawal by Subject|0
1616489|NCT02038907|5641179|P3|Overall Study|Withdrawal by Subject|0
1616490|NCT02038907|5641180|P2|Overall Study|Withdrawal by Subject|0
1616491|NCT02038907|5641181|P1|Overall Study|Withdrawal by Subject|0
1616492|NCT02038907|5641168|P14|Overall Study|Protocol Violation|0
1616493|NCT02038907|5641169|P13|Overall Study|Protocol Violation|0
1616494|NCT02038907|5641170|P12|Overall Study|Protocol Violation|0
1616495|NCT02038907|5641171|P11|Overall Study|Protocol Violation|1
1616496|NCT02038907|5641172|P10|Overall Study|Protocol Violation|0
1616497|NCT02038907|5641173|P9|Overall Study|Protocol Violation|0
1616498|NCT02038907|5641174|P8|Overall Study|Protocol Violation|0
1616499|NCT02038907|5641175|P7|Overall Study|Protocol Violation|0
1616500|NCT02038907|5641176|P6|Overall Study|Protocol Violation|0
1616501|NCT02038907|5641177|P5|Overall Study|Protocol Violation|0
1616502|NCT02038907|5641178|P4|Overall Study|Protocol Violation|0
1616503|NCT02038907|5641179|P3|Overall Study|Protocol Violation|0
1616504|NCT02038907|5641180|P2|Overall Study|Protocol Violation|0
1616505|NCT02038907|5641181|P1|Overall Study|Protocol Violation|0
1616506|NCT02038829|5641709|P12|Treatment Period 6|Adverse Event|0
1616507|NCT02038829|5641710|P11|Treatment Period 6|Adverse Event|0
1616508|NCT02038829|5641711|P10|Treatment Period 6|Adverse Event|0
1616509|NCT02038829|5641712|P9|Treatment Period 6|Adverse Event|0
1616510|NCT02038829|5641713|P8|Treatment Period 6|Adverse Event|0
1616511|NCT02038829|5641714|P7|Treatment Period 6|Adverse Event|0
1616512|NCT02038829|5641715|P6|Treatment Period 6|Adverse Event|0
1616513|NCT02038829|5641716|P5|Treatment Period 6|Adverse Event|0
1616514|NCT02038829|5641717|P4|Treatment Period 6|Adverse Event|0
1616515|NCT02038829|5641718|P3|Treatment Period 6|Adverse Event|1
1616516|NCT02038829|5641719|P2|Treatment Period 6|Adverse Event|0
1616517|NCT02038829|5641720|P1|Treatment Period 6|Adverse Event|0
1616518|NCT02038829|5641709|P12|Washout Period 4|Adverse Event|0
1616519|NCT02038829|5641710|P11|Washout Period 4|Adverse Event|0
1616520|NCT02038829|5641711|P10|Washout Period 4|Adverse Event|0
1616521|NCT02038829|5641712|P9|Washout Period 4|Adverse Event|0
1616522|NCT02038829|5641713|P8|Washout Period 4|Adverse Event|0
1616523|NCT02038829|5641714|P7|Washout Period 4|Adverse Event|1
1616524|NCT02038829|5641715|P6|Washout Period 4|Adverse Event|0
1616525|NCT02038829|5641716|P5|Washout Period 4|Adverse Event|0
1616526|NCT02038829|5641717|P4|Washout Period 4|Adverse Event|0
1616527|NCT02038829|5641718|P3|Washout Period 4|Adverse Event|0
1616528|NCT02038829|5641719|P2|Washout Period 4|Adverse Event|0
1616529|NCT02038829|5641720|P1|Washout Period 4|Adverse Event|0
1616530|NCT02038829|5641709|P12|Treatment Period 4|Adverse Event|0
1616531|NCT02038829|5641710|P11|Treatment Period 4|Adverse Event|0
1616532|NCT02038829|5641711|P10|Treatment Period 4|Adverse Event|0
1616533|NCT02038829|5641712|P9|Treatment Period 4|Adverse Event|0
1616534|NCT02038829|5641713|P8|Treatment Period 4|Adverse Event|0
1616535|NCT02038829|5641714|P7|Treatment Period 4|Adverse Event|0
1616536|NCT02038829|5641715|P6|Treatment Period 4|Adverse Event|0
1616537|NCT02038829|5641716|P5|Treatment Period 4|Adverse Event|0
1616538|NCT02038829|5641717|P4|Treatment Period 4|Adverse Event|0
1616539|NCT02038829|5641718|P3|Treatment Period 4|Adverse Event|0
1616540|NCT02038829|5641719|P2|Treatment Period 4|Adverse Event|1
1616541|NCT02038829|5641720|P1|Treatment Period 4|Adverse Event|0
1616542|NCT02038829|5641709|P12|Washout Period 2|Withdrawal by Subject|0
1616543|NCT02038829|5641710|P11|Washout Period 2|Withdrawal by Subject|0
1616544|NCT02038829|5641711|P10|Washout Period 2|Withdrawal by Subject|0
1616545|NCT02038829|5641712|P9|Washout Period 2|Withdrawal by Subject|0
1616546|NCT02038829|5641713|P8|Washout Period 2|Withdrawal by Subject|0
1616547|NCT02038829|5641714|P7|Washout Period 2|Withdrawal by Subject|0
1616548|NCT02038829|5641715|P6|Washout Period 2|Withdrawal by Subject|1
1616549|NCT02038829|5641716|P5|Washout Period 2|Withdrawal by Subject|0
1616550|NCT02038829|5641717|P4|Washout Period 2|Withdrawal by Subject|0
1616551|NCT02038829|5641718|P3|Washout Period 2|Withdrawal by Subject|0
1616552|NCT02038829|5641719|P2|Washout Period 2|Withdrawal by Subject|0
1616553|NCT02038829|5641720|P1|Washout Period 2|Withdrawal by Subject|0
1616554|NCT02038829|5641709|P12|Washout Period 2|Adverse Event|0
1616555|NCT02038829|5641710|P11|Washout Period 2|Adverse Event|0
1616556|NCT02038829|5641711|P10|Washout Period 2|Adverse Event|0
1616557|NCT02038829|5641712|P9|Washout Period 2|Adverse Event|1
1616558|NCT02038829|5641713|P8|Washout Period 2|Adverse Event|0
1616559|NCT02038829|5641714|P7|Washout Period 2|Adverse Event|0
1616560|NCT02038829|5641715|P6|Washout Period 2|Adverse Event|0
1616561|NCT02038829|5641716|P5|Washout Period 2|Adverse Event|0
1616562|NCT02038829|5641717|P4|Washout Period 2|Adverse Event|0
1616563|NCT02038829|5641718|P3|Washout Period 2|Adverse Event|0
1616564|NCT02038829|5641719|P2|Washout Period 2|Adverse Event|0
1616565|NCT02038829|5641720|P1|Washout Period 2|Adverse Event|0
1616566|NCT02038829|5641709|P12|Treatment Period 2|Withdrawal by Subject|0
1616567|NCT02038829|5641710|P11|Treatment Period 2|Withdrawal by Subject|0
1616568|NCT02038829|5641711|P10|Treatment Period 2|Withdrawal by Subject|0
1616569|NCT02038829|5641712|P9|Treatment Period 2|Withdrawal by Subject|0
1616570|NCT02038829|5641713|P8|Treatment Period 2|Withdrawal by Subject|0
1616571|NCT02038829|5641714|P7|Treatment Period 2|Withdrawal by Subject|0
1616572|NCT02038829|5641715|P6|Treatment Period 2|Withdrawal by Subject|0
1616573|NCT02038829|5641716|P5|Treatment Period 2|Withdrawal by Subject|0
1616574|NCT02038829|5641717|P4|Treatment Period 2|Withdrawal by Subject|0
1616575|NCT02038829|5641718|P3|Treatment Period 2|Withdrawal by Subject|0
1616576|NCT02038829|5641719|P2|Treatment Period 2|Withdrawal by Subject|0
1616577|NCT02038829|5641720|P1|Treatment Period 2|Withdrawal by Subject|1
1616578|NCT02038829|5641709|P12|Treatment Period 2|Adverse Event|0
1616579|NCT02038829|5641710|P11|Treatment Period 2|Adverse Event|1
1616580|NCT02038829|5641711|P10|Treatment Period 2|Adverse Event|0
1616581|NCT02038829|5641712|P9|Treatment Period 2|Adverse Event|0
1616582|NCT02038829|5641713|P8|Treatment Period 2|Adverse Event|0
1616583|NCT02038829|5641714|P7|Treatment Period 2|Adverse Event|0
1616584|NCT02038829|5641715|P6|Treatment Period 2|Adverse Event|0
1616585|NCT02038829|5641716|P5|Treatment Period 2|Adverse Event|0
1616586|NCT02038829|5641717|P4|Treatment Period 2|Adverse Event|0
1616587|NCT02038829|5641718|P3|Treatment Period 2|Adverse Event|0
1616588|NCT02038829|5641719|P2|Treatment Period 2|Adverse Event|0
1616589|NCT02038829|5641720|P1|Treatment Period 2|Adverse Event|0
1616590|NCT02038829|5641709|P12|Washout Period 1|Death|0
1616591|NCT02038829|5641710|P11|Washout Period 1|Death|0
1616592|NCT02038829|5641711|P10|Washout Period 1|Death|0
1616593|NCT02038829|5641712|P9|Washout Period 1|Death|0
1616594|NCT02038829|5641713|P8|Washout Period 1|Death|0
1616595|NCT02038829|5641714|P7|Washout Period 1|Death|0
1616596|NCT02038829|5641715|P6|Washout Period 1|Death|0
1616597|NCT02038829|5641716|P5|Washout Period 1|Death|1
1616598|NCT02038829|5641717|P4|Washout Period 1|Death|0
1616599|NCT02038829|5641718|P3|Washout Period 1|Death|0
1616600|NCT02038829|5641719|P2|Washout Period 1|Death|0
1616601|NCT02038829|5641720|P1|Washout Period 1|Death|0
1616602|NCT02038790|5641754|P2|Day 0 - First Treatment|Withdrawal by Subject|1
1616603|NCT02038790|5641755|P1|Day 0 - First Treatment|Withdrawal by Subject|1
1616604|NCT02038764|5641791|P5|Overall Study|Other|0
1616605|NCT02038764|5641792|P4|Overall Study|Other|0
1616606|NCT02038764|5641793|P3|Overall Study|Other|1
1616607|NCT02038764|5641794|P2|Overall Study|Other|0
1616608|NCT02038764|5641795|P1|Overall Study|Other|1
1616609|NCT02038764|5641791|P5|Overall Study|Withdrawal by Subject|1
1616610|NCT02038764|5641792|P4|Overall Study|Withdrawal by Subject|0
1616611|NCT02038764|5641793|P3|Overall Study|Withdrawal by Subject|0
1616612|NCT02038764|5641794|P2|Overall Study|Withdrawal by Subject|0
1616613|NCT02038764|5641795|P1|Overall Study|Withdrawal by Subject|0
1616614|NCT02038764|5641791|P5|Overall Study|Lost to Follow-up|0
1616615|NCT02038764|5641792|P4|Overall Study|Lost to Follow-up|0
1616616|NCT02038764|5641793|P3|Overall Study|Lost to Follow-up|0
1616617|NCT02038764|5641794|P2|Overall Study|Lost to Follow-up|1
1616618|NCT02038764|5641795|P1|Overall Study|Lost to Follow-up|0
1616619|NCT02038764|5641791|P5|Overall Study|Adverse Event|0
1616620|NCT02038764|5641792|P4|Overall Study|Adverse Event|0
1616621|NCT02038764|5641793|P3|Overall Study|Adverse Event|1
1616622|NCT02038764|5641794|P2|Overall Study|Adverse Event|0
1616623|NCT02038764|5641795|P1|Overall Study|Adverse Event|0
1616624|NCT02038647|5641897|P2|Overall Study|Ongoing at Datacut|10
1616625|NCT02038647|5641898|P1|Overall Study|Ongoing at Datacut|9
1616626|NCT02038647|5641897|P2|Overall Study|Not Reported|1
1616627|NCT02038647|5641898|P1|Overall Study|Not Reported|0
1616628|NCT02038647|5641897|P2|Overall Study|Withdrawal by Subject|2
1616629|NCT02038647|5641898|P1|Overall Study|Withdrawal by Subject|5
1616630|NCT02038647|5641897|P2|Overall Study|Symptomatic Deterioration|7
1616631|NCT02038647|5641898|P1|Overall Study|Symptomatic Deterioration|7
1616632|NCT02038647|5641897|P2|Overall Study|Adverse Event|10
1616633|NCT02038647|5641898|P1|Overall Study|Adverse Event|18
1616634|NCT02038647|5641897|P2|Overall Study|Progressive Disease|59
1616635|NCT02038647|5641898|P1|Overall Study|Progressive Disease|50
1616636|NCT02038543|5641961|P4|Overall Study|Withdrawal by Subject|1
1616637|NCT02038543|5641962|P3|Overall Study|Withdrawal by Subject|0
1616638|NCT02038543|5641963|P2|Overall Study|Withdrawal by Subject|0
1616639|NCT02038543|5641964|P1|Overall Study|Withdrawal by Subject|0
1616640|NCT02038543|5641961|P4|Overall Study|Screen Failure|1
1616641|NCT02038543|5641962|P3|Overall Study|Screen Failure|0
1616642|NCT02038543|5641963|P2|Overall Study|Screen Failure|0
1616643|NCT02038543|5641964|P1|Overall Study|Screen Failure|0
1616644|NCT02038075|5641980|P2|Overall Study|Withdrawal by Subject|0
1616645|NCT02038075|5641981|P1|Overall Study|Withdrawal by Subject|3
1616646|NCT02038049|5641989|P2|Overall Study|Lost to Follow-up|0
1616647|NCT02038049|5641990|P1|Overall Study|Lost to Follow-up|1
1616648|NCT02037984|5642027|P8|Overall Study|Withdrawal by Subject|1
1616649|NCT02037984|5642028|P7|Overall Study|Withdrawal by Subject|0
1616650|NCT02037984|5642029|P6|Overall Study|Withdrawal by Subject|3
1616651|NCT02037984|5642030|P5|Overall Study|Withdrawal by Subject|1
1616652|NCT02037984|5642031|P4|Overall Study|Withdrawal by Subject|1
1616653|NCT02037984|5642032|P3|Overall Study|Withdrawal by Subject|0
1616654|NCT02037984|5642033|P2|Overall Study|Withdrawal by Subject|0
1616655|NCT02037984|5642034|P1|Overall Study|Withdrawal by Subject|0
1616656|NCT02037984|5642027|P8|Overall Study|Withdrawal by Parent/Guardian|2
1616657|NCT02037984|5642028|P7|Overall Study|Withdrawal by Parent/Guardian|4
1616658|NCT02037984|5642029|P6|Overall Study|Withdrawal by Parent/Guardian|1
1616659|NCT02037984|5642030|P5|Overall Study|Withdrawal by Parent/Guardian|5
1616660|NCT02037984|5642031|P4|Overall Study|Withdrawal by Parent/Guardian|2
1616661|NCT02037984|5642032|P3|Overall Study|Withdrawal by Parent/Guardian|3
1616662|NCT02037984|5642033|P2|Overall Study|Withdrawal by Parent/Guardian|0
1616663|NCT02037984|5642034|P1|Overall Study|Withdrawal by Parent/Guardian|0
1616664|NCT02037984|5642027|P8|Overall Study|Technical Problems|2
1616665|NCT02037984|5642028|P7|Overall Study|Technical Problems|4
1616666|NCT02037984|5642029|P6|Overall Study|Technical Problems|3
1616667|NCT02037984|5642030|P5|Overall Study|Technical Problems|2
1616668|NCT02037984|5642031|P4|Overall Study|Technical Problems|3
1616669|NCT02037984|5642032|P3|Overall Study|Technical Problems|3
1616670|NCT02037984|5642033|P2|Overall Study|Technical Problems|0
1616671|NCT02037984|5642034|P1|Overall Study|Technical Problems|0
1616672|NCT02037984|5642027|P8|Overall Study|Protocol Violation|0
1616673|NCT02037984|5642028|P7|Overall Study|Protocol Violation|2
1616674|NCT02037984|5642029|P6|Overall Study|Protocol Violation|1
1616675|NCT02037984|5642030|P5|Overall Study|Protocol Violation|0
1616676|NCT02037984|5642031|P4|Overall Study|Protocol Violation|0
1616677|NCT02037984|5642032|P3|Overall Study|Protocol Violation|0
1616678|NCT02037984|5642033|P2|Overall Study|Protocol Violation|0
1616679|NCT02037984|5642034|P1|Overall Study|Protocol Violation|0
1616680|NCT02037984|5642027|P8|Overall Study|Physician Decision|0
1616681|NCT02037984|5642028|P7|Overall Study|Physician Decision|1
1616682|NCT02037984|5642029|P6|Overall Study|Physician Decision|0
1616683|NCT02037984|5642030|P5|Overall Study|Physician Decision|0
1616684|NCT02037984|5642031|P4|Overall Study|Physician Decision|0
1616685|NCT02037984|5642032|P3|Overall Study|Physician Decision|0
1616686|NCT02037984|5642033|P2|Overall Study|Physician Decision|0
1616687|NCT02037984|5642034|P1|Overall Study|Physician Decision|0
1616688|NCT02037984|5642027|P8|Overall Study|Lost to Follow-up|4
1616689|NCT02037984|5642028|P7|Overall Study|Lost to Follow-up|2
1616690|NCT02037984|5642029|P6|Overall Study|Lost to Follow-up|2
1616691|NCT02037984|5642030|P5|Overall Study|Lost to Follow-up|2
1616692|NCT02037984|5642031|P4|Overall Study|Lost to Follow-up|5
1616693|NCT02037984|5642032|P3|Overall Study|Lost to Follow-up|3
1616694|NCT02037984|5642033|P2|Overall Study|Lost to Follow-up|0
1616695|NCT02037984|5642034|P1|Overall Study|Lost to Follow-up|1
1616696|NCT02037984|5642027|P8|Overall Study|Lack of Efficacy|3
1616697|NCT02037984|5642028|P7|Overall Study|Lack of Efficacy|4
1616698|NCT02037984|5642029|P6|Overall Study|Lack of Efficacy|2
1616699|NCT02037984|5642030|P5|Overall Study|Lack of Efficacy|2
1616700|NCT02037984|5642031|P4|Overall Study|Lack of Efficacy|10
1616701|NCT02037984|5642032|P3|Overall Study|Lack of Efficacy|3
1616702|NCT02037984|5642033|P2|Overall Study|Lack of Efficacy|0
1616703|NCT02037984|5642034|P1|Overall Study|Lack of Efficacy|0
1616704|NCT02037568|5642179|P2|Overall Study|Patient did not receive transplant|1
1616705|NCT02037568|5642180|P1|Overall Study|Patient did not receive transplant|0
1616706|NCT02037568|5642179|P2|Overall Study|Screen Failure|1
1616707|NCT02037568|5642180|P1|Overall Study|Screen Failure|3
1616708|NCT02037568|5642179|P2|Overall Study|Lost to Follow-up|13
1616709|NCT02037568|5642180|P1|Overall Study|Lost to Follow-up|16
1616710|NCT02037568|5642179|P2|Overall Study|Withdrawal by Subject|24
1616711|NCT02037568|5642180|P1|Overall Study|Withdrawal by Subject|17
1616712|NCT02037477|5642215|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1616713|NCT02037477|5642216|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
1616714|NCT02037477|5642217|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1616715|NCT02037477|5642218|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
1616716|NCT02037165|5642345|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
1616717|NCT02037165|5642346|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1616718|NCT02037165|5642347|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1616719|NCT02037165|5642348|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1616720|NCT02037165|5642349|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
1616721|NCT02036775|5642409|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
1616722|NCT02036775|5642410|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1616723|NCT02036775|5642411|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1616724|NCT02036775|5642412|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1616725|NCT02036775|5642413|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1616726|NCT02036775|5642414|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
1616727|NCT02036645|5642464|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616728|NCT02036645|5642465|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616729|NCT02036645|5642466|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616730|NCT02036645|5642467|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616731|NCT02036645|5642468|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616732|NCT02036645|5642469|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616733|NCT02036645|5642470|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616734|NCT02036645|5642471|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616735|NCT02036645|5642472|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
1616736|NCT02036645|5642473|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616737|NCT02036645|5642474|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616738|NCT02036645|5642475|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
1616739|NCT02036645|5642464|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616740|NCT02036645|5642465|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616829|NCT02035202|5642858|P3|Overall Study|Lost to Follow-up|2
1616741|NCT02036645|5642466|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616742|NCT02036645|5642467|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616743|NCT02036645|5642468|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616744|NCT02036645|5642469|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
1616745|NCT02036645|5642470|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616746|NCT02036645|5642471|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616747|NCT02036645|5642472|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616748|NCT02036645|5642473|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616749|NCT02036645|5642474|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616750|NCT02036645|5642475|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
1616751|NCT02036580|5642580|P3|Overall Study|Adverse Event|0
1616752|NCT02036580|5642581|P2|Overall Study|Adverse Event|0
1616753|NCT02036580|5642582|P1|Overall Study|Adverse Event|1
1616754|NCT02036580|5642580|P3|Overall Study|Withdrawal by Subject|0
1616755|NCT02036580|5642581|P2|Overall Study|Withdrawal by Subject|1
1616756|NCT02036580|5642582|P1|Overall Study|Withdrawal by Subject|0
1616757|NCT02036515|5642603|P3|Overall Study|Hyperglycemia|1
1616758|NCT02036515|5642604|P2|Overall Study|Hyperglycemia|0
1616759|NCT02036515|5642605|P1|Overall Study|Hyperglycemia|0
1616760|NCT02036515|5642603|P3|Overall Study|Withdrawal by Subject|9
1616761|NCT02036515|5642604|P2|Overall Study|Withdrawal by Subject|7
1616762|NCT02036515|5642605|P1|Overall Study|Withdrawal by Subject|4
1616763|NCT02036515|5642603|P3|Overall Study|Screen failure|0
1616764|NCT02036515|5642604|P2|Overall Study|Screen failure|2
1616765|NCT02036515|5642605|P1|Overall Study|Screen failure|0
1616766|NCT02036515|5642603|P3|Overall Study|Non-compliance with study drug|2
1616767|NCT02036515|5642604|P2|Overall Study|Non-compliance with study drug|0
1616768|NCT02036515|5642605|P1|Overall Study|Non-compliance with study drug|0
1616769|NCT02036515|5642603|P3|Overall Study|Lost to Follow-up|0
1616770|NCT02036515|5642604|P2|Overall Study|Lost to Follow-up|2
1616771|NCT02036515|5642605|P1|Overall Study|Lost to Follow-up|0
1616772|NCT02036515|5642603|P3|Overall Study|Adverse Event|2
1616773|NCT02036515|5642604|P2|Overall Study|Adverse Event|1
1616774|NCT02036515|5642605|P1|Overall Study|Adverse Event|1
1616775|NCT02036294|5642706|P2|Overall Study|Withdrawal by Subject|3
1616776|NCT02036294|5642707|P1|Overall Study|Withdrawal by Subject|2
1616777|NCT02036294|5642706|P2|Overall Study|Death|8
1616778|NCT02036294|5642707|P1|Overall Study|Death|7
1616779|NCT02035748|5642723|P1|Overall Study|Progressive Disease|1
1616780|NCT02035748|5642723|P1|Overall Study|Withdrawal by Subject|6
1616781|NCT02035748|5642723|P1|Overall Study|Physician Decision|3
1616782|NCT02035748|5642723|P1|Overall Study|Lost to Follow-up|2
1616783|NCT02035748|5642723|P1|Overall Study|Death|3
1616784|NCT02035748|5642723|P1|Overall Study|Adverse Event|5
1616785|NCT02035696|5642737|P4|Overall Study|Withdrawal by Subject|1
1616786|NCT02035696|5642738|P3|Overall Study|Withdrawal by Subject|2
1616787|NCT02035696|5642739|P2|Overall Study|Withdrawal by Subject|0
1616788|NCT02035696|5642740|P1|Overall Study|Withdrawal by Subject|3
1616789|NCT02035696|5642737|P4|Overall Study|Lost to Follow-up|2
1616790|NCT02035696|5642738|P3|Overall Study|Lost to Follow-up|1
1616791|NCT02035696|5642739|P2|Overall Study|Lost to Follow-up|3
1616792|NCT02035696|5642740|P1|Overall Study|Lost to Follow-up|0
1616793|NCT02035553|5642796|P2|Overall Study|Other Reason|4
1616794|NCT02035553|5642797|P1|Overall Study|Other Reason|0
1616795|NCT02035553|5642796|P2|Overall Study|Lost to Follow-up|1
1616796|NCT02035553|5642797|P1|Overall Study|Lost to Follow-up|0
1616797|NCT02035553|5642796|P2|Overall Study|Non-compliance with Study Drug|1
1616798|NCT02035553|5642797|P1|Overall Study|Non-compliance with Study Drug|0
1616799|NCT02035553|5642796|P2|Overall Study|Withdrawal by Subject|7
1616800|NCT02035553|5642797|P1|Overall Study|Withdrawal by Subject|4
1616801|NCT02035553|5642796|P2|Overall Study|Lack of Efficacy|1
1616802|NCT02035553|5642797|P1|Overall Study|Lack of Efficacy|1
1616803|NCT02035553|5642796|P2|Overall Study|Physician Decision|2
1616804|NCT02035553|5642797|P1|Overall Study|Physician Decision|3
1616805|NCT02035553|5642796|P2|Overall Study|Adverse Event|6
1616806|NCT02035553|5642797|P1|Overall Study|Adverse Event|10
1616807|NCT02035553|5642796|P2|Overall Study|Death (See All-Cause Mortality Table)|1
1616808|NCT02035553|5642797|P1|Overall Study|Death (See All-Cause Mortality Table)|0
1616809|NCT02035475|5642803|P1|Overall Study|Equipment Error|1
1616810|NCT02035475|5642803|P1|Overall Study|Physician Decision|1
1616811|NCT02035475|5642803|P1|Overall Study|Withdrawal by Subject|4
1616812|NCT02035332|5642814|P1|Overall Study|Procedure Aborted due to Uterine Width|1
1616830|NCT02035202|5642859|P2|Overall Study|Lost to Follow-up|16
1616831|NCT02035202|5642860|P1|Overall Study|Lost to Follow-up|8
1616832|NCT02034916|5642876|P2|Overall Study|Study terminated by sponsor|5
1616833|NCT02034916|5642877|P1|Overall Study|Study terminated by sponsor|4
1616834|NCT02034916|5642876|P2|Overall Study|Lost to Follow-up|1
1616835|NCT02034916|5642877|P1|Overall Study|Lost to Follow-up|4
1616836|NCT02034916|5642876|P2|Overall Study|Withdrawal by Subject|1
1616837|NCT02034916|5642877|P1|Overall Study|Withdrawal by Subject|2
1616838|NCT02034916|5642876|P2|Overall Study|Death|28
1616839|NCT02034916|5642877|P1|Overall Study|Death|39
1616840|NCT02034877|5642914|P2|Overall Study|No Longer Willing to Participate|3
1616841|NCT02034877|5642915|P1|Overall Study|No Longer Willing to Participate|0
1616842|NCT02034877|5642914|P2|Overall Study|Lost to Follow-up|3
1616843|NCT02034877|5642915|P1|Overall Study|Lost to Follow-up|0
1616844|NCT02034799|5642933|P2|Overall Study|Death|1
1616845|NCT02034799|5642934|P1|Overall Study|Death|2
1616846|NCT02034799|5642933|P2|Overall Study|Lost to Follow-up|1
1616847|NCT02034799|5642934|P1|Overall Study|Lost to Follow-up|0
1616848|NCT02034799|5642933|P2|Overall Study|Withdrawal by Subject|2
1616849|NCT02034799|5642934|P1|Overall Study|Withdrawal by Subject|0
1616850|NCT02034708|5642948|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
1616851|NCT02034708|5642949|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
1616852|NCT02034708|5642948|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1616853|NCT02034708|5642949|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
1616854|NCT02034708|5642948|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
1616855|NCT02034708|5642949|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
1616856|NCT02034708|5642948|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
1616857|NCT02034708|5642949|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
1616858|NCT02034591|5642960|P6|Overall Study|Withdrawal by Subject|0
1616859|NCT02034591|5642961|P5|Overall Study|Withdrawal by Subject|1
1616860|NCT02034591|5642962|P4|Overall Study|Withdrawal by Subject|0
1616861|NCT02034591|5642963|P3|Overall Study|Withdrawal by Subject|0
1616862|NCT02034591|5642964|P2|Overall Study|Withdrawal by Subject|0
1616863|NCT02034591|5642965|P1|Overall Study|Withdrawal by Subject|0
1616864|NCT02034565|5643020|P2|Overall Study|Adverse Event|0
1616865|NCT02034565|5643021|P1|Overall Study|Adverse Event|1
1616866|NCT02034552|5643038|P3|Overall Study|Clinical progression|9
1616867|NCT02034552|5643039|P2|Overall Study|Clinical progression|7
1616868|NCT02034552|5643040|P1|Overall Study|Clinical progression|5
1616869|NCT02034552|5643038|P3|Overall Study|Non-compliance with study drug|1
1616870|NCT02034552|5643039|P2|Overall Study|Non-compliance with study drug|0
1616871|NCT02034552|5643040|P1|Overall Study|Non-compliance with study drug|0
1616872|NCT02034552|5643038|P3|Overall Study|Withdrawal by Subject|1
1616873|NCT02034552|5643039|P2|Overall Study|Withdrawal by Subject|1
1616874|NCT02034552|5643040|P1|Overall Study|Withdrawal by Subject|2
1616875|NCT02034552|5643038|P3|Overall Study|AE associated with disease progression|0
1616876|NCT02034552|5643039|P2|Overall Study|AE associated with disease progression|1
1616877|NCT02034552|5643040|P1|Overall Study|AE associated with disease progression|0
1616878|NCT02034552|5643038|P3|Overall Study|AE not assoc. with disease progression|2
1616879|NCT02034552|5643039|P2|Overall Study|AE not assoc. with disease progression|4
1616880|NCT02034552|5643040|P1|Overall Study|AE not assoc. with disease progression|1
1616881|NCT02034552|5643038|P3|Overall Study|Radiological progression|4
1616882|NCT02034552|5643039|P2|Overall Study|Radiological progression|5
1616883|NCT02034552|5643040|P1|Overall Study|Radiological progression|3
1616884|NCT02034552|5643038|P3|Overall Study|Never treated|0
1616885|NCT02034552|5643039|P2|Overall Study|Never treated|2
1616886|NCT02034552|5643040|P1|Overall Study|Never treated|3
1616887|NCT02034513|5643071|P2|Overall Study|Unclassified|1
1616888|NCT02034513|5643072|P1|Overall Study|Unclassified|0
1616889|NCT02034513|5643071|P2|Overall Study|Withdrawal by Subject|25
1616890|NCT02034513|5643072|P1|Overall Study|Withdrawal by Subject|25
1616891|NCT02034513|5643071|P2|Overall Study|Protocol Violation|10
1616892|NCT02034513|5643072|P1|Overall Study|Protocol Violation|7
1616893|NCT02034513|5643071|P2|Overall Study|Pregnancy|3
1616894|NCT02034513|5643072|P1|Overall Study|Pregnancy|0
1616895|NCT02034513|5643071|P2|Overall Study|Lost to Follow-up|7
1616896|NCT02034513|5643072|P1|Overall Study|Lost to Follow-up|6
1616897|NCT02034513|5643071|P2|Overall Study|Lack of Efficacy|1
1616898|NCT02034513|5643072|P1|Overall Study|Lack of Efficacy|0
1616899|NCT02034513|5643071|P2|Overall Study|Adverse Event|10
1616900|NCT02034513|5643072|P1|Overall Study|Adverse Event|11
1616901|NCT02034474|5643090|P2|Overall Study|Withdrawal by Subject|2
1616902|NCT02034474|5643091|P1|Overall Study|Withdrawal by Subject|1
1616903|NCT02034474|5643090|P2|Overall Study|Adverse Event|2
1616904|NCT02034474|5643091|P1|Overall Study|Adverse Event|3
1616905|NCT02034162|5643107|P3|Double-blind|Withdrawal by Subject|0
1616906|NCT02034162|5643108|P2|Double-blind|Withdrawal by Subject|7
1616907|NCT02034162|5643109|P1|Double-blind|Withdrawal by Subject|5
1616908|NCT02034162|5643107|P3|Double-blind|Protocol Violation|0
1616909|NCT02034162|5643108|P2|Double-blind|Protocol Violation|1
1616910|NCT02034162|5643109|P1|Double-blind|Protocol Violation|0
1616911|NCT02034162|5643107|P3|Double-blind|Physician Decision|0
1616912|NCT02034162|5643108|P2|Double-blind|Physician Decision|0
1616913|NCT02034162|5643109|P1|Double-blind|Physician Decision|1
1616914|NCT02034162|5643107|P3|Double-blind|Lost to Follow-up|0
1616915|NCT02034162|5643108|P2|Double-blind|Lost to Follow-up|0
1616916|NCT02034162|5643109|P1|Double-blind|Lost to Follow-up|3
1616917|NCT02034123|5643155|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616918|NCT02034123|5643156|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616919|NCT02034123|5643157|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616920|NCT02034123|5643158|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616921|NCT02034123|5643159|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616922|NCT02034123|5643160|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616923|NCT02034123|5643161|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616924|NCT02034123|5643162|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616925|NCT02034123|5643163|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616926|NCT02034123|5643164|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616927|NCT02034123|5643165|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616928|NCT02034123|5643166|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616929|NCT02034123|5643167|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616930|NCT02034123|5643168|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
1616931|NCT02034123|5643169|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
1616932|NCT02034123|5643170|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616933|NCT02034123|5643171|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616934|NCT02034123|5643172|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
1616935|NCT02034123|5643155|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616936|NCT02034123|5643156|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616937|NCT02034123|5643157|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616938|NCT02034123|5643158|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616939|NCT02034123|5643159|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616940|NCT02034123|5643160|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616941|NCT02034123|5643161|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616942|NCT02034123|5643162|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616943|NCT02034123|5643163|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616944|NCT02034123|5643164|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
1616945|NCT02034123|5643165|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616946|NCT02034123|5643166|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616947|NCT02034123|5643167|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616948|NCT02034123|5643168|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616949|NCT02034123|5643169|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616950|NCT02034123|5643170|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616951|NCT02034123|5643171|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616952|NCT02034123|5643172|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
1616953|NCT02034123|5643155|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616954|NCT02034123|5643156|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616955|NCT02034123|5643157|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616956|NCT02034123|5643158|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616957|NCT02034123|5643159|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616958|NCT02034123|5643160|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616959|NCT02034123|5643161|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616960|NCT02034123|5643162|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616961|NCT02034123|5643163|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616962|NCT02034123|5643164|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616963|NCT02034123|5643165|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616964|NCT02034123|5643166|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616965|NCT02034123|5643167|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616966|NCT02034123|5643168|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616967|NCT02034123|5643169|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
1616968|NCT02034123|5643170|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616969|NCT02034123|5643171|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616970|NCT02034123|5643172|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
1616971|NCT02034123|5643155|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616972|NCT02034123|5643156|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616973|NCT02034123|5643157|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616974|NCT02034123|5643158|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616975|NCT02034123|5643159|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616976|NCT02034123|5643160|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616977|NCT02034123|5643161|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616978|NCT02034123|5643162|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616979|NCT02034123|5643163|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616980|NCT02034123|5643164|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
1616981|NCT02034123|5643165|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
1617068|NCT02031679|5644119|P2|Overall Study|Lack of Efficacy|1
1616982|NCT02034123|5643166|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616983|NCT02034123|5643167|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616984|NCT02034123|5643168|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
1616985|NCT02034123|5643169|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616986|NCT02034123|5643170|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616987|NCT02034123|5643171|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616988|NCT02034123|5643172|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
1616989|NCT02034058|5643491|P1|Overall Study|Death|3
1616990|NCT02034006|5643512|P1|Overall Study|Pregnancy|1
1616991|NCT02034006|5643512|P1|Overall Study|Death|1
1616992|NCT02034006|5643512|P1|Overall Study|Lost to Follow-up|5
1616993|NCT02034006|5643512|P1|Overall Study|Withdrawal by Subject|7
1616994|NCT02033889|5643563|P3|Overall Study|Withdrawal by Subject|13
1616995|NCT02033889|5643564|P2|Overall Study|Withdrawal by Subject|10
1616996|NCT02033889|5643565|P1|Overall Study|Withdrawal by Subject|18
1616997|NCT02033889|5643563|P3|Overall Study|Participant moved|0
1616998|NCT02033889|5643564|P2|Overall Study|Participant moved|1
1616999|NCT02033889|5643565|P1|Overall Study|Participant moved|0
1617000|NCT02033889|5643563|P3|Overall Study|Physician Decision|1
1617001|NCT02033889|5643564|P2|Overall Study|Physician Decision|1
1617002|NCT02033889|5643565|P1|Overall Study|Physician Decision|0
1617003|NCT02033889|5643563|P3|Overall Study|Non-Compliance With Study Drug|0
1617004|NCT02033889|5643564|P2|Overall Study|Non-Compliance With Study Drug|0
1617005|NCT02033889|5643565|P1|Overall Study|Non-Compliance With Study Drug|1
1617006|NCT02033889|5643563|P3|Overall Study|Lost to Follow-up|6
1617007|NCT02033889|5643564|P2|Overall Study|Lost to Follow-up|5
1617008|NCT02033889|5643565|P1|Overall Study|Lost to Follow-up|8
1617009|NCT02033889|5643563|P3|Overall Study|Excluded Medication|0
1617010|NCT02033889|5643564|P2|Overall Study|Excluded Medication|1
1617011|NCT02033889|5643565|P1|Overall Study|Excluded Medication|1
1617012|NCT02033889|5643563|P3|Overall Study|Death|2
1617013|NCT02033889|5643564|P2|Overall Study|Death|1
1617014|NCT02033889|5643565|P1|Overall Study|Death|3
1617015|NCT02033889|5643563|P3|Overall Study|Adverse Event|3
1617016|NCT02033889|5643564|P2|Overall Study|Adverse Event|1
1617017|NCT02033889|5643565|P1|Overall Study|Adverse Event|3
1617018|NCT02033850|5643742|P2|Overall Study|unrelated medical reason|1
1617019|NCT02033850|5643743|P1|Overall Study|unrelated medical reason|1
1617020|NCT02033850|5643742|P2|Overall Study|Death|0
1617021|NCT02033850|5643743|P1|Overall Study|Death|1
1617022|NCT02033369|5643810|P2|Overall Study|Protocol Violation|0
1617023|NCT02033369|5643811|P1|Overall Study|Protocol Violation|2
1617024|NCT02033369|5643810|P2|Overall Study|Lost to Follow-up|0
1617025|NCT02033369|5643811|P1|Overall Study|Lost to Follow-up|1
1617026|NCT02033369|5643810|P2|Overall Study|Withdrawal by Subject|1
1617027|NCT02033369|5643811|P1|Overall Study|Withdrawal by Subject|1
1617028|NCT02033369|5643810|P2|Overall Study|Not a good demographic match|2
1617029|NCT02033369|5643811|P1|Overall Study|Not a good demographic match|0
1617030|NCT02033369|5643810|P2|Overall Study|Physician Decision|2
1617031|NCT02033369|5643811|P1|Overall Study|Physician Decision|1
1617032|NCT02032901|5643905|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
1617033|NCT02032901|5643906|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
1617034|NCT02032901|5643905|P2|Treatment Period (12 Weeks)|Pregnancy|0
1617035|NCT02032901|5643906|P1|Treatment Period (12 Weeks)|Pregnancy|1
1617036|NCT02032888|5643930|P3|Follow-up Period|Other|0
1617037|NCT02032888|5643931|P2|Follow-up Period|Other|0
1617038|NCT02032888|5643932|P1|Follow-up Period|Other|1
1617039|NCT02032888|5643930|P3|Follow-up Period|Death|0
1617040|NCT02032888|5643931|P2|Follow-up Period|Death|1
1617041|NCT02032888|5643932|P1|Follow-up Period|Death|1
1617042|NCT02032888|5643930|P3|Follow-up Period|Lost to Follow-up|0
1617043|NCT02032888|5643931|P2|Follow-up Period|Lost to Follow-up|1
1617044|NCT02032888|5643932|P1|Follow-up Period|Lost to Follow-up|1
1617045|NCT02032888|5643930|P3|Treatment Period|Other|0
1617046|NCT02032888|5643931|P2|Treatment Period|Other|1
1617047|NCT02032888|5643932|P1|Treatment Period|Other|1
1617048|NCT02032888|5643930|P3|Treatment Period|Poor compliance/noncompliance|0
1617049|NCT02032888|5643931|P2|Treatment Period|Poor compliance/noncompliance|1
1617050|NCT02032888|5643932|P1|Treatment Period|Poor compliance/noncompliance|1
1617051|NCT02032875|5643963|P2|Follow-up Period|Virologic Relapse|10
1617052|NCT02032875|5643964|P1|Follow-up Period|Virologic Relapse|3
1617053|NCT02032875|5643963|P2|Follow-up Period|Death|1
1617054|NCT02032875|5643964|P1|Follow-up Period|Death|0
1617055|NCT02032875|5643963|P2|Treatment Period|Liver transplant, Treatment extension|3
1617056|NCT02032875|5643964|P1|Treatment Period|Liver transplant, Treatment extension|0
1617057|NCT02032875|5643963|P2|Treatment Period|Liver transplant, No extension needed|1
1617058|NCT02032875|5643964|P1|Treatment Period|Liver transplant, No extension needed|0
1617059|NCT02032875|5643963|P2|Treatment Period|Adverse Event|0
1617060|NCT02032875|5643964|P1|Treatment Period|Adverse Event|1
1617061|NCT02032706|5644007|P1|Overall Study|Protocol Violation|1
1617062|NCT02032706|5644007|P1|Overall Study|Did not qualify|5
1617063|NCT02032407|5644064|P1|Overall Study|Other Miscellaneous Reasons|2
1617064|NCT02032407|5644064|P1|Overall Study|Pregnancy|1
1617065|NCT02032407|5644064|P1|Overall Study|Lost to Follow-up|2
1617066|NCT02032238|5644077|P2|Overall Study|Lost to Follow-up|0
1617067|NCT02032238|5644078|P1|Overall Study|Lost to Follow-up|2
1617069|NCT02031679|5644120|P1|Overall Study|Lack of Efficacy|0
1617070|NCT02031679|5644119|P2|Overall Study|Protocol Violation|1
1617071|NCT02031679|5644120|P1|Overall Study|Protocol Violation|0
1617072|NCT02031640|5644135|P6|Double-blind Treatment Period|Lost to Follow-up|0
1617073|NCT02031640|5644136|P5|Double-blind Treatment Period|Lost to Follow-up|1
1617074|NCT02031640|5644137|P4|Double-blind Treatment Period|Lost to Follow-up|0
1617075|NCT02031640|5644138|P3|Double-blind Treatment Period|Lost to Follow-up|0
1617076|NCT02031640|5644139|P2|Double-blind Treatment Period|Lost to Follow-up|3
1617077|NCT02031640|5644140|P1|Double-blind Treatment Period|Lost to Follow-up|0
1617078|NCT02031640|5644135|P6|Double-blind Treatment Period|Withdrawal by Subject|1
1617079|NCT02031640|5644136|P5|Double-blind Treatment Period|Withdrawal by Subject|1
1617080|NCT02031640|5644137|P4|Double-blind Treatment Period|Withdrawal by Subject|1
1617081|NCT02031640|5644138|P3|Double-blind Treatment Period|Withdrawal by Subject|3
1617082|NCT02031640|5644139|P2|Double-blind Treatment Period|Withdrawal by Subject|2
1617083|NCT02031640|5644140|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1617084|NCT02031640|5644135|P6|Double-blind Treatment Period|Adverse Event|0
1617085|NCT02031640|5644136|P5|Double-blind Treatment Period|Adverse Event|0
1617086|NCT02031640|5644137|P4|Double-blind Treatment Period|Adverse Event|2
1617087|NCT02031640|5644138|P3|Double-blind Treatment Period|Adverse Event|0
1617088|NCT02031640|5644139|P2|Double-blind Treatment Period|Adverse Event|0
1617089|NCT02031640|5644140|P1|Double-blind Treatment Period|Adverse Event|0
1617090|NCT02031640|5644135|P6|Double-blind Treatment Period|Non-compliance|0
1617091|NCT02031640|5644136|P5|Double-blind Treatment Period|Non-compliance|1
1617092|NCT02031640|5644137|P4|Double-blind Treatment Period|Non-compliance|1
1617093|NCT02031640|5644138|P3|Double-blind Treatment Period|Non-compliance|0
1617094|NCT02031640|5644139|P2|Double-blind Treatment Period|Non-compliance|1
1617095|NCT02031640|5644140|P1|Double-blind Treatment Period|Non-compliance|0
1617096|NCT02031640|5644135|P6|Double-blind Treatment Period|Lack of Efficacy|1
1617097|NCT02031640|5644136|P5|Double-blind Treatment Period|Lack of Efficacy|5
1617098|NCT02031640|5644137|P4|Double-blind Treatment Period|Lack of Efficacy|2
1617099|NCT02031640|5644138|P3|Double-blind Treatment Period|Lack of Efficacy|3
1617100|NCT02031640|5644139|P2|Double-blind Treatment Period|Lack of Efficacy|14
1617101|NCT02031640|5644140|P1|Double-blind Treatment Period|Lack of Efficacy|0
1617102|NCT02031640|5644135|P6|Double-blind Treatment Period|Protocol deviation|1
1617103|NCT02031640|5644136|P5|Double-blind Treatment Period|Protocol deviation|3
1617104|NCT02031640|5644137|P4|Double-blind Treatment Period|Protocol deviation|1
1617105|NCT02031640|5644138|P3|Double-blind Treatment Period|Protocol deviation|0
1617106|NCT02031640|5644139|P2|Double-blind Treatment Period|Protocol deviation|2
1617107|NCT02031640|5644140|P1|Double-blind Treatment Period|Protocol deviation|0
1617108|NCT02031640|5644135|P6|Run-In Period|Various administrative reasons|0
1617109|NCT02031640|5644136|P5|Run-In Period|Various administrative reasons|0
1617110|NCT02031640|5644137|P4|Run-In Period|Various administrative reasons|0
1617111|NCT02031640|5644138|P3|Run-In Period|Various administrative reasons|0
1617112|NCT02031640|5644139|P2|Run-In Period|Various administrative reasons|0
1617113|NCT02031640|5644140|P1|Run-In Period|Various administrative reasons|17
1617114|NCT02031640|5644135|P6|Run-In Period|Randomization criteria not met|0
1617115|NCT02031640|5644136|P5|Run-In Period|Randomization criteria not met|0
1617116|NCT02031640|5644137|P4|Run-In Period|Randomization criteria not met|0
1617117|NCT02031640|5644138|P3|Run-In Period|Randomization criteria not met|0
1617118|NCT02031640|5644139|P2|Run-In Period|Randomization criteria not met|0
1617119|NCT02031640|5644140|P1|Run-In Period|Randomization criteria not met|85
1617120|NCT02031640|5644135|P6|Run-In Period|Exclusion criteria met|0
1617121|NCT02031640|5644136|P5|Run-In Period|Exclusion criteria met|0
1617122|NCT02031640|5644137|P4|Run-In Period|Exclusion criteria met|0
1617123|NCT02031640|5644138|P3|Run-In Period|Exclusion criteria met|0
1617124|NCT02031640|5644139|P2|Run-In Period|Exclusion criteria met|0
1617125|NCT02031640|5644140|P1|Run-In Period|Exclusion criteria met|8
1617126|NCT02031640|5644135|P6|Run-In Period|Inclusion criteria not met|0
1617127|NCT02031640|5644136|P5|Run-In Period|Inclusion criteria not met|0
1617128|NCT02031640|5644137|P4|Run-In Period|Inclusion criteria not met|0
1617129|NCT02031640|5644138|P3|Run-In Period|Inclusion criteria not met|0
1617130|NCT02031640|5644139|P2|Run-In Period|Inclusion criteria not met|0
1617131|NCT02031640|5644140|P1|Run-In Period|Inclusion criteria not met|38
1617132|NCT02031640|5644135|P6|Run-In Period|Withdrawal by Subject|0
1617133|NCT02031640|5644136|P5|Run-In Period|Withdrawal by Subject|0
1617134|NCT02031640|5644137|P4|Run-In Period|Withdrawal by Subject|0
1617135|NCT02031640|5644138|P3|Run-In Period|Withdrawal by Subject|0
1617136|NCT02031640|5644139|P2|Run-In Period|Withdrawal by Subject|0
1617137|NCT02031640|5644140|P1|Run-In Period|Withdrawal by Subject|17
1617138|NCT02031640|5644135|P6|Run-In Period|Adverse Event|0
1617139|NCT02031640|5644136|P5|Run-In Period|Adverse Event|0
1617140|NCT02031640|5644137|P4|Run-In Period|Adverse Event|0
1617141|NCT02031640|5644138|P3|Run-In Period|Adverse Event|0
1617142|NCT02031640|5644139|P2|Run-In Period|Adverse Event|0
1617143|NCT02031640|5644140|P1|Run-In Period|Adverse Event|4
1617144|NCT02031640|5644135|P6|Screening Period|Enrollment closed|0
1617145|NCT02031640|5644136|P5|Screening Period|Enrollment closed|0
1617146|NCT02031640|5644137|P4|Screening Period|Enrollment closed|0
1617147|NCT02031640|5644138|P3|Screening Period|Enrollment closed|0
1617148|NCT02031640|5644139|P2|Screening Period|Enrollment closed|0
1617149|NCT02031640|5644140|P1|Screening Period|Enrollment closed|26
1617150|NCT02031640|5644135|P6|Screening Period|Lost to Follow-up|0
1617151|NCT02031640|5644136|P5|Screening Period|Lost to Follow-up|0
1617152|NCT02031640|5644137|P4|Screening Period|Lost to Follow-up|0
1617153|NCT02031640|5644138|P3|Screening Period|Lost to Follow-up|0
1617154|NCT02031640|5644139|P2|Screening Period|Lost to Follow-up|0
1617155|NCT02031640|5644140|P1|Screening Period|Lost to Follow-up|14
1617156|NCT02031640|5644135|P6|Screening Period|Exclusion criteria met|0
1617157|NCT02031640|5644136|P5|Screening Period|Exclusion criteria met|0
1617158|NCT02031640|5644137|P4|Screening Period|Exclusion criteria met|0
1617159|NCT02031640|5644138|P3|Screening Period|Exclusion criteria met|0
1617160|NCT02031640|5644139|P2|Screening Period|Exclusion criteria met|0
1617161|NCT02031640|5644140|P1|Screening Period|Exclusion criteria met|30
1617162|NCT02031640|5644135|P6|Screening Period|Inclusion criteria not met|0
1617163|NCT02031640|5644136|P5|Screening Period|Inclusion criteria not met|0
1617164|NCT02031640|5644137|P4|Screening Period|Inclusion criteria not met|0
1617165|NCT02031640|5644138|P3|Screening Period|Inclusion criteria not met|0
1617166|NCT02031640|5644139|P2|Screening Period|Inclusion criteria not met|0
1617167|NCT02031640|5644140|P1|Screening Period|Inclusion criteria not met|312
1617168|NCT02031640|5644135|P6|Screening Period|Withdrawal by Subject|0
1617169|NCT02031640|5644136|P5|Screening Period|Withdrawal by Subject|0
1617170|NCT02031640|5644137|P4|Screening Period|Withdrawal by Subject|0
1617171|NCT02031640|5644138|P3|Screening Period|Withdrawal by Subject|0
1617172|NCT02031640|5644139|P2|Screening Period|Withdrawal by Subject|0
1617173|NCT02031640|5644140|P1|Screening Period|Withdrawal by Subject|29
1617174|NCT02031640|5644135|P6|Screening Period|Adverse Event|0
1617175|NCT02031640|5644136|P5|Screening Period|Adverse Event|0
1617176|NCT02031640|5644137|P4|Screening Period|Adverse Event|0
1617177|NCT02031640|5644138|P3|Screening Period|Adverse Event|0
1617178|NCT02031640|5644139|P2|Screening Period|Adverse Event|0
1617179|NCT02031640|5644140|P1|Screening Period|Adverse Event|1
1617180|NCT02031471|5644183|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
1617181|NCT02031471|5644183|P1|Long Term Extension (LTE) Period|Adverse Event|1
1617182|NCT02031471|5644183|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
1617183|NCT02031471|5644183|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
1617184|NCT02031471|5644183|P1|24 Week Treatment Period|Protocol Violation|1
1617185|NCT02031471|5644183|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
1617186|NCT02031471|5644183|P1|24 Week Treatment Period|Adverse Event|6
1617187|NCT02031458|5644216|P3|Baseline to May 8, 2015|Lost to Follow-up|2
1617188|NCT02031458|5644217|P2|Baseline to May 8, 2015|Lost to Follow-up|1
1617189|NCT02031458|5644218|P1|Baseline to May 8, 2015|Lost to Follow-up|1
1617190|NCT02031458|5644216|P3|Baseline to May 8, 2015|On Treatment|73
1617191|NCT02031458|5644217|P2|Baseline to May 8, 2015|On Treatment|81
1617192|NCT02031458|5644218|P1|Baseline to May 8, 2015|On Treatment|43
1617193|NCT02031458|5644216|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
1617194|NCT02031458|5644217|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
1617195|NCT02031458|5644218|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
1617196|NCT02031458|5644216|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
1617197|NCT02031458|5644217|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
1617198|NCT02031458|5644218|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
1617199|NCT02031458|5644216|P3|Baseline to May 8, 2015|Unknown Reason|2
1617200|NCT02031458|5644217|P2|Baseline to May 8, 2015|Unknown Reason|1
1617201|NCT02031458|5644218|P1|Baseline to May 8, 2015|Unknown Reason|0
1617202|NCT02031458|5644216|P3|Baseline to May 8, 2015|Physician Decision|0
1617203|NCT02031458|5644217|P2|Baseline to May 8, 2015|Physician Decision|1
1617204|NCT02031458|5644218|P1|Baseline to May 8, 2015|Physician Decision|0
1617205|NCT02031458|5644216|P3|Baseline to May 8, 2015|Protocol Violation|0
1617206|NCT02031458|5644217|P2|Baseline to May 8, 2015|Protocol Violation|4
1617207|NCT02031458|5644218|P1|Baseline to May 8, 2015|Protocol Violation|7
1617208|NCT02031458|5644216|P3|Baseline to May 8, 2015|Death|100
1617209|NCT02031458|5644217|P2|Baseline to May 8, 2015|Death|87
1617210|NCT02031458|5644218|P1|Baseline to May 8, 2015|Death|36
1617211|NCT02031458|5644216|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
1617212|NCT02031458|5644217|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
1617213|NCT02031458|5644218|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
1617214|NCT02031458|5644216|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
1617215|NCT02031458|5644217|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
1617216|NCT02031458|5644218|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
1617217|NCT02031458|5644216|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
1617218|NCT02031458|5644217|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
1617219|NCT02031458|5644218|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
1617220|NCT02031458|5644216|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
1617221|NCT02031458|5644217|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
1617222|NCT02031458|5644218|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
1617223|NCT02031458|5644216|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
1617224|NCT02031458|5644217|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
1617225|NCT02031458|5644218|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
1617226|NCT02031458|5644216|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
1617227|NCT02031458|5644217|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
1617228|NCT02031458|5644218|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
1617229|NCT02031458|5644216|P3|May 8, 2015 to January 11, 2019|Death|198
1617230|NCT02031458|5644217|P2|May 8, 2015 to January 11, 2019|Death|193
1617231|NCT02031458|5644218|P1|May 8, 2015 to January 11, 2019|Death|89
1617232|NCT02031432|5644312|P1|Overall Study|Death|10
1617233|NCT02031432|5644312|P1|Overall Study|Inclusion/Exclusion criteria not met|5
1617234|NCT02031432|5644312|P1|Overall Study|Lost to Follow-up|1
1617235|NCT02031432|5644312|P1|Overall Study|Withdrawal by Subject|5
1617236|NCT02031432|5644312|P1|Overall Study|Adverse Event|8
1617237|NCT02031432|5644312|P1|Overall Study|Withdrawn as forbidden meds required|1
1617238|NCT02031432|5644312|P1|Overall Study|Cancer Progression|2
1617239|NCT02031432|5644312|P1|Overall Study|Lack of Efficacy|5
1617240|NCT02031432|5644312|P1|Overall Study|Protocol Violation|1
1617241|NCT02031302|5644339|P2|Overall Study|Lost to Follow-up|0
1617242|NCT02031302|5644340|P1|Overall Study|Lost to Follow-up|4
1617243|NCT02031302|5644339|P2|Overall Study|Missed Follow Up|0
1617244|NCT02031302|5644340|P1|Overall Study|Missed Follow Up|27
1617245|NCT02031302|5644339|P2|Overall Study|Not treated with study valve system|0
1617246|NCT02031302|5644340|P1|Overall Study|Not treated with study valve system|18
1617247|NCT02031302|5644339|P2|Overall Study|Death|0
1617248|NCT02031302|5644340|P1|Overall Study|Death|115
1617249|NCT02031276|5644361|P3|Period 3 Open-label Risankizumab SC|Other|1
1617250|NCT02031276|5644362|P2|Period 3 Open-label Risankizumab SC|Other|0
1617251|NCT02031276|5644363|P1|Period 3 Open-label Risankizumab SC|Other|0
1617252|NCT02031276|5644361|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1617253|NCT02031276|5644362|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1617254|NCT02031276|5644363|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
1617255|NCT02031276|5644361|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
1617256|NCT02031276|5644362|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
1617257|NCT02031276|5644363|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
1617258|NCT02031276|5644361|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
1617259|NCT02031276|5644362|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
1617260|NCT02031276|5644363|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
1617261|NCT02031276|5644361|P3|Period 2 Open-label Risankizumab IV|Other|1
1617262|NCT02031276|5644362|P2|Period 2 Open-label Risankizumab IV|Other|2
1617263|NCT02031276|5644363|P1|Period 2 Open-label Risankizumab IV|Other|0
1617264|NCT02031276|5644361|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
1617265|NCT02031276|5644362|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
1617266|NCT02031276|5644363|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
1617267|NCT02031276|5644361|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
1617268|NCT02031276|5644362|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
1617269|NCT02031276|5644363|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
1617270|NCT02031276|5644361|P3|Period 1 Double-blind IV|Other|0
1617271|NCT02031276|5644362|P2|Period 1 Double-blind IV|Other|1
1617272|NCT02031276|5644363|P1|Period 1 Double-blind IV|Other|0
1617273|NCT02031276|5644361|P3|Period 1 Double-blind IV|Adverse Event|1
1617274|NCT02031276|5644362|P2|Period 1 Double-blind IV|Adverse Event|5
1617275|NCT02031276|5644363|P1|Period 1 Double-blind IV|Adverse Event|6
1617276|NCT02031237|5644397|P3|Overall Study|Alternate Treatment Given|3
1617277|NCT02031237|5644398|P2|Overall Study|Alternate Treatment Given|0
1617278|NCT02031237|5644399|P1|Overall Study|Alternate Treatment Given|0
1617279|NCT02031237|5644397|P3|Overall Study|Protocol Violation|0
1617280|NCT02031237|5644398|P2|Overall Study|Protocol Violation|6
1617281|NCT02031237|5644399|P1|Overall Study|Protocol Violation|2
1617282|NCT02031237|5644397|P3|Overall Study|Withdrawal by Subject|0
1617283|NCT02031237|5644398|P2|Overall Study|Withdrawal by Subject|2
1617284|NCT02031237|5644399|P1|Overall Study|Withdrawal by Subject|2
1617285|NCT02031237|5644397|P3|Overall Study|Physician Decision|0
1617286|NCT02031237|5644398|P2|Overall Study|Physician Decision|1
1617287|NCT02031237|5644399|P1|Overall Study|Physician Decision|0
1617288|NCT02031237|5644397|P3|Overall Study|Death|0
1617289|NCT02031237|5644398|P2|Overall Study|Death|5
1617290|NCT02031237|5644399|P1|Overall Study|Death|1
1617291|NCT02030847|5644406|P1|Overall Study|Withdrawal by Subject|1
1617292|NCT02030847|5644406|P1|Overall Study|Physician Decision|3
1617293|NCT02030847|5644406|P1|Overall Study|New Cancer Therapy|8
1617294|NCT02030847|5644406|P1|Overall Study|Disease Progression|15
1617295|NCT02030847|5644406|P1|Overall Study|Death|10
1617296|NCT02030821|5644415|P4|Overall Study|Physician Decision|2
1617297|NCT02030821|5644416|P3|Overall Study|Physician Decision|5
1617298|NCT02030821|5644417|P2|Overall Study|Physician Decision|2
1617299|NCT02030821|5644418|P1|Overall Study|Physician Decision|2
1617300|NCT02030600|5644446|P2|Treatment Period 2|Unclassified|0
1617301|NCT02030600|5644447|P1|Treatment Period 2|Unclassified|1
1617302|NCT02030600|5644446|P2|Treatment Period 2|Withdrawal by Subject|9
1617303|NCT02030600|5644447|P1|Treatment Period 2|Withdrawal by Subject|13
1617304|NCT02030600|5644446|P2|Treatment Period 2|Protocol Violation|2
1617305|NCT02030600|5644447|P1|Treatment Period 2|Protocol Violation|1
1617306|NCT02030600|5644446|P2|Treatment Period 2|Lost to Follow-up|2
1617307|NCT02030600|5644447|P1|Treatment Period 2|Lost to Follow-up|4
1617308|NCT02030600|5644446|P2|Treatment Period 2|Lack of Efficacy|1
1617309|NCT02030600|5644447|P1|Treatment Period 2|Lack of Efficacy|2
1617310|NCT02030600|5644446|P2|Treatment Period 2|Adverse Event|4
1617311|NCT02030600|5644447|P1|Treatment Period 2|Adverse Event|4
1617312|NCT02030600|5644446|P2|Treatment Period 1|Unclassified|0
1617313|NCT02030600|5644447|P1|Treatment Period 1|Unclassified|1
1617314|NCT02030600|5644446|P2|Treatment Period 1|Casebook Unsigned|0
1617315|NCT02030600|5644447|P1|Treatment Period 1|Casebook Unsigned|1
1617316|NCT02030600|5644446|P2|Treatment Period 1|Withdrawal by Subject|17
1617317|NCT02030600|5644447|P1|Treatment Period 1|Withdrawal by Subject|13
1617318|NCT02030600|5644446|P2|Treatment Period 1|Protocol Violation|17
1617319|NCT02030600|5644447|P1|Treatment Period 1|Protocol Violation|22
1617320|NCT02030600|5644446|P2|Treatment Period 1|Lost to Follow-up|3
1617321|NCT02030600|5644447|P1|Treatment Period 1|Lost to Follow-up|11
1617322|NCT02030600|5644446|P2|Treatment Period 1|Lack of Efficacy|1
1617323|NCT02030600|5644447|P1|Treatment Period 1|Lack of Efficacy|0
1617324|NCT02030600|5644446|P2|Treatment Period 1|Adverse Event|7
1617325|NCT02030600|5644447|P1|Treatment Period 1|Adverse Event|5
1617326|NCT02030535|5644468|P1|Washout Period 1 (21 Days)|Adverse Event|1
1617327|NCT02030405|5644536|P1|Overall Study|Lost to Follow-up|1
1617328|NCT02030405|5644536|P1|Overall Study|Withdrawal by Subject|1
1617329|NCT02030119|5644547|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
1617330|NCT02030119|5644548|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
1617331|NCT02030119|5644549|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
1617332|NCT02030119|5644550|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
1617333|NCT02030119|5644547|P4|Overall Study|Withdrawal by Subject|3
1617334|NCT02030119|5644548|P3|Overall Study|Withdrawal by Subject|5
1617335|NCT02030119|5644549|P2|Overall Study|Withdrawal by Subject|1
1617336|NCT02030119|5644550|P1|Overall Study|Withdrawal by Subject|3
1617337|NCT02030041|5644588|P3|Overall Study|Withdrawal by Subject|1
1617338|NCT02030041|5644589|P2|Overall Study|Withdrawal by Subject|2
1617339|NCT02030041|5644590|P1|Overall Study|Withdrawal by Subject|2
1617340|NCT02029989|5644603|P2|Overall Study|Protocol Violation|0
1617341|NCT02029989|5644604|P1|Overall Study|Protocol Violation|1
1617342|NCT02029989|5644603|P2|Overall Study|Death|1
1617343|NCT02029989|5644604|P1|Overall Study|Death|0
1617344|NCT02029989|5644603|P2|Overall Study|Lost to Follow-up|7
1617345|NCT02029989|5644604|P1|Overall Study|Lost to Follow-up|9
1617346|NCT02029989|5644603|P2|Overall Study|Physician Decision|0
1617347|NCT02029989|5644604|P1|Overall Study|Physician Decision|2
1617348|NCT02029989|5644603|P2|Overall Study|Change of location|3
1617349|NCT02029989|5644604|P1|Overall Study|Change of location|2
1617350|NCT02029989|5644603|P2|Overall Study|Withdrawal: Fear of needles|0
1617351|NCT02029989|5644604|P1|Overall Study|Withdrawal: Fear of needles|1
1617352|NCT02029989|5644603|P2|Overall Study|Withdrawal by Subject|0
1617353|NCT02029989|5644604|P1|Overall Study|Withdrawal by Subject|1
1617354|NCT02029846|5644627|P2|Overall Study|n=1 each arm|1
1617355|NCT02029846|5644628|P1|Overall Study|n=1 each arm|1
1617356|NCT02029638|5644666|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
1617357|NCT02029638|5644667|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
1617358|NCT02029638|5644668|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
1617359|NCT02029638|5644666|P3|Overall Study|Death|1
1617360|NCT02029638|5644667|P2|Overall Study|Death|0
1617361|NCT02029638|5644668|P1|Overall Study|Death|0
1617362|NCT02029521|5644697|P2|Overall Study|Withdrawal by Subject|1
1617363|NCT02029521|5644698|P1|Overall Study|Withdrawal by Subject|1
1617364|NCT02029521|5644697|P2|Overall Study|Protocol Violation|0
1617365|NCT02029521|5644698|P1|Overall Study|Protocol Violation|1
1617366|NCT02029417|5644796|P1|Overall Study|Adverse Event|1
1617367|NCT02029417|5644796|P1|Overall Study|Death|1
1617368|NCT02029274|5644805|P4|Overall Study|Adverse Event|2
1617369|NCT02029274|5644806|P3|Overall Study|Adverse Event|2
1617370|NCT02029274|5644807|P2|Overall Study|Adverse Event|0
1617371|NCT02029274|5644808|P1|Overall Study|Adverse Event|1
1617372|NCT02029235|5644840|P2|Overall Study|Non-compliance with study meds or diary|1
1617373|NCT02029235|5644841|P1|Overall Study|Non-compliance with study meds or diary|4
1617374|NCT02028871|5644873|P2|Overall Study|Current Illness|0
1617375|NCT02028871|5644874|P1|Overall Study|Current Illness|1
1617376|NCT02028871|5644873|P2|Overall Study|IV placement difficulty|0
1617377|NCT02028871|5644874|P1|Overall Study|IV placement difficulty|1
1617378|NCT02028871|5644873|P2|Overall Study|Withdrawal by Subject|2
1617379|NCT02028871|5644874|P1|Overall Study|Withdrawal by Subject|1
1617380|NCT02028871|5644873|P2|Overall Study|Positive urine drug screen|1
1617381|NCT02028871|5644874|P1|Overall Study|Positive urine drug screen|1
1617382|NCT02028767|5644971|P2|Treatment Period 2|Reason other than those specified above|0
1617383|NCT02028767|5644972|P1|Treatment Period 2|Reason other than those specified above|1
1617384|NCT02028767|5644971|P2|Treatment Period 2|Non compliant with protocol|0
1617385|NCT02028767|5644972|P1|Treatment Period 2|Non compliant with protocol|1
1617386|NCT02028715|5645005|P2|Overall Study|Did not complete satisfaction surveys|2
1617387|NCT02028715|5645006|P1|Overall Study|Did not complete satisfaction surveys|2
1617388|NCT02028715|5645005|P2|Overall Study|Physician Decision|0
1617389|NCT02028715|5645006|P1|Overall Study|Physician Decision|1
1617390|NCT02028715|5645005|P2|Overall Study|Adverse Event|2
1617391|NCT02028715|5645006|P1|Overall Study|Adverse Event|2
1617392|NCT02028169|5645218|P1|Overall Study|Concomitant Medication Usage|1
1617393|NCT02028169|5645218|P1|Overall Study|Cessation of Drug|1
1617394|NCT02028169|5645218|P1|Overall Study|Adverse Event|1
1617395|NCT02028169|5645218|P1|Overall Study|Withdrawal by Subject|2
1617396|NCT02028169|5645218|P1|Overall Study|Lack of Efficacy|2
1617397|NCT02028169|5645218|P1|Overall Study|Lost to Follow-up|21
1617398|NCT02028065|5645244|P3|Treatment Through Study Completion|Adverse Event|5
1617399|NCT02028065|5645245|P2|Treatment Through Study Completion|Adverse Event|3
1617400|NCT02028065|5645246|P1|Treatment Through Study Completion|Adverse Event|3
1617401|NCT02028065|5645244|P3|Treatment Through Study Completion|Withdrawal by Subject|3
1617402|NCT02028065|5645245|P2|Treatment Through Study Completion|Withdrawal by Subject|4
1617403|NCT02028065|5645246|P1|Treatment Through Study Completion|Withdrawal by Subject|5
1617404|NCT02028065|5645244|P3|Treatment Through Study Completion|Protocol Violation|0
1617405|NCT02028065|5645245|P2|Treatment Through Study Completion|Protocol Violation|4
1617406|NCT02028065|5645246|P1|Treatment Through Study Completion|Protocol Violation|1
1617407|NCT02028065|5645244|P3|Treatment Through Study Completion|Physician Decision|0
1617408|NCT02028065|5645245|P2|Treatment Through Study Completion|Physician Decision|0
1617409|NCT02028065|5645246|P1|Treatment Through Study Completion|Physician Decision|1
1617410|NCT02028065|5645244|P3|Treatment Through Study Completion|Lost to Follow-up|6
1617411|NCT02028065|5645245|P2|Treatment Through Study Completion|Lost to Follow-up|4
1617412|NCT02028065|5645246|P1|Treatment Through Study Completion|Lost to Follow-up|2
1617413|NCT02028065|5645244|P3|Randomization Through Start Treatment|Not treated|3
1617414|NCT02028065|5645245|P2|Randomization Through Start Treatment|Not treated|3
1617415|NCT02028065|5645246|P1|Randomization Through Start Treatment|Not treated|1
1617416|NCT02027844|5645273|P3|Overall Study|Incomlete data|0
1617417|NCT02027844|5645274|P2|Overall Study|Incomlete data|0
1617418|NCT02027844|5645275|P1|Overall Study|Incomlete data|2
1617419|NCT02027844|5645273|P3|Overall Study|Protocol Violation|0
1617420|NCT02027844|5645274|P2|Overall Study|Protocol Violation|2
1617421|NCT02027844|5645275|P1|Overall Study|Protocol Violation|0
1617422|NCT02027844|5645273|P3|Overall Study|Lost to Follow-up|1
1617423|NCT02027844|5645274|P2|Overall Study|Lost to Follow-up|2
1617424|NCT02027844|5645275|P1|Overall Study|Lost to Follow-up|0
1617425|NCT02027844|5645273|P3|Overall Study|Withdrawal by Subject|1
1617426|NCT02027844|5645274|P2|Overall Study|Withdrawal by Subject|2
1617427|NCT02027844|5645275|P1|Overall Study|Withdrawal by Subject|3
1617428|NCT02027701|5645292|P1|Overall Study|Withdrawal by Subject|3
1617429|NCT02027701|5645292|P1|Overall Study|Physician Decision|2
1617430|NCT02027701|5645292|P1|Overall Study|Lack of Efficacy|8
1617431|NCT02027701|5645292|P1|Overall Study|Adverse Event|3
1617432|NCT02027623|5645310|P2|Overall Study|Withdrawal by Subject|9
1617433|NCT02027623|5645311|P1|Overall Study|Withdrawal by Subject|6
1617434|NCT02027623|5645310|P2|Overall Study|Lost to Follow-up|3
1617435|NCT02027623|5645311|P1|Overall Study|Lost to Follow-up|3
1617436|NCT02027558|5645403|P2|Overall Study|Refused assessment|0
1617437|NCT02027558|5645404|P1|Overall Study|Refused assessment|3
1617438|NCT02027558|5645403|P2|Overall Study|Lost to Follow-up|1
1617439|NCT02027558|5645404|P1|Overall Study|Lost to Follow-up|4
1617440|NCT02027558|5645403|P2|Overall Study|Withdrawal by Subject|0
1617441|NCT02027558|5645404|P1|Overall Study|Withdrawal by Subject|2
1617442|NCT02027558|5645403|P2|Overall Study|Death|1
1617443|NCT02027558|5645404|P1|Overall Study|Death|0
1617444|NCT02027545|5645422|P2|Overall Study|Failed to attend study visit|0
1617445|NCT02027545|5645423|P1|Overall Study|Failed to attend study visit|2
1617446|NCT02027545|5645422|P2|Overall Study|Failed to sign HIPAA|2
1617447|NCT02027545|5645423|P1|Overall Study|Failed to sign HIPAA|0
1617448|NCT02027428|5645435|P3|Survival Follow-up|Lost to Follow-up|0
1617449|NCT02027428|5645436|P2|Survival Follow-up|Lost to Follow-up|1
1617450|NCT02027428|5645437|P1|Survival Follow-up|Lost to Follow-up|0
1617451|NCT02027428|5645435|P3|Survival Follow-up|Death|30
1617452|NCT02027428|5645436|P2|Survival Follow-up|Death|47
1617453|NCT02027428|5645437|P1|Survival Follow-up|Death|0
1617454|NCT02027428|5645435|P3|Maintenance|Other|3
1617455|NCT02027428|5645436|P2|Maintenance|Other|6
1617456|NCT02027428|5645437|P1|Maintenance|Other|0
1617457|NCT02027428|5645435|P3|Maintenance|Protocol Violation|1
1617458|NCT02027428|5645436|P2|Maintenance|Protocol Violation|0
1617459|NCT02027428|5645437|P1|Maintenance|Protocol Violation|0
1617460|NCT02027428|5645435|P3|Maintenance|Withdrawal by Subject|5
1617461|NCT02027428|5645436|P2|Maintenance|Withdrawal by Subject|6
1617462|NCT02027428|5645437|P1|Maintenance|Withdrawal by Subject|0
1617463|NCT02027428|5645435|P3|Maintenance|Symptomatic deterioration|1
1617464|NCT02027428|5645436|P2|Maintenance|Symptomatic deterioration|4
1617465|NCT02027428|5645437|P1|Maintenance|Symptomatic deterioration|0
1617466|NCT02027428|5645435|P3|Maintenance|Progressive disease|47
1617467|NCT02027428|5645436|P2|Maintenance|Progressive disease|84
1617468|NCT02027428|5645437|P1|Maintenance|Progressive disease|0
1617469|NCT02027428|5645435|P3|Maintenance|Adverse Event|1
1617470|NCT02027428|5645436|P2|Maintenance|Adverse Event|21
1617471|NCT02027428|5645437|P1|Maintenance|Adverse Event|0
1617472|NCT02027428|5645435|P3|Maintenance|Death|2
1617473|NCT02027428|5645436|P2|Maintenance|Death|3
1617474|NCT02027428|5645437|P1|Maintenance|Death|0
1617475|NCT02027428|5645435|P3|Induction|Induction treatment ongoing|0
1617476|NCT02027428|5645436|P2|Induction|Induction treatment ongoing|0
1617477|NCT02027428|5645437|P1|Induction|Induction treatment ongoing|4
1617478|NCT02027428|5645435|P3|Induction|Protocol Violation|0
1617479|NCT02027428|5645436|P2|Induction|Protocol Violation|0
1617480|NCT02027428|5645437|P1|Induction|Protocol Violation|1
1617481|NCT02027428|5645435|P3|Induction|Study terminated by sponsor|0
1617482|NCT02027428|5645436|P2|Induction|Study terminated by sponsor|0
1617483|NCT02027428|5645437|P1|Induction|Study terminated by sponsor|12
1617484|NCT02027428|5645435|P3|Induction|Other|0
1617485|NCT02027428|5645436|P2|Induction|Other|0
1617486|NCT02027428|5645437|P1|Induction|Other|14
1617487|NCT02027428|5645435|P3|Induction|Symptomatic deterioration|0
1617488|NCT02027428|5645436|P2|Induction|Symptomatic deterioration|0
1617489|NCT02027428|5645437|P1|Induction|Symptomatic deterioration|16
1617490|NCT02027428|5645435|P3|Induction|Death|0
1617491|NCT02027428|5645436|P2|Induction|Death|0
1617492|NCT02027428|5645437|P1|Induction|Death|21
1617493|NCT02027428|5645435|P3|Induction|Withdrawal by Subject|0
1617494|NCT02027428|5645436|P2|Induction|Withdrawal by Subject|0
1617495|NCT02027428|5645437|P1|Induction|Withdrawal by Subject|22
1617496|NCT02027428|5645435|P3|Induction|Adverse Event|0
1617497|NCT02027428|5645436|P2|Induction|Adverse Event|0
1617498|NCT02027428|5645437|P1|Induction|Adverse Event|51
1617499|NCT02027428|5645435|P3|Induction|Progressive disease|0
1617500|NCT02027428|5645436|P2|Induction|Progressive disease|0
1617501|NCT02027428|5645437|P1|Induction|Progressive disease|77
1617502|NCT02027428|5645435|P3|Induction|Never treated|0
1617503|NCT02027428|5645436|P2|Induction|Never treated|0
1617504|NCT02027428|5645437|P1|Induction|Never treated|7
1617505|NCT02027402|5645475|P2|Overall Study|Withdrawal by Subject|1
1617506|NCT02027402|5645476|P1|Overall Study|Withdrawal by Subject|4
1617507|NCT02027376|5645488|P3|Overall Study|Death|0
1617508|NCT02027376|5645489|P2|Overall Study|Death|0
1617509|NCT02027376|5645490|P1|Overall Study|Death|1
1617510|NCT02027311|5645516|P2|Overall Study|Protocol Violation|2
1617511|NCT02027311|5645517|P1|Overall Study|Protocol Violation|3
1617512|NCT02027025|5645537|P3|Overall Study|Sponsor's decision|0
1617513|NCT02027025|5645538|P2|Overall Study|Sponsor's decision|1
1617514|NCT02027025|5645539|P1|Overall Study|Sponsor's decision|0
1617515|NCT02027025|5645537|P3|Overall Study|Withdrawal by Subject|0
1617516|NCT02027025|5645538|P2|Overall Study|Withdrawal by Subject|1
1617517|NCT02027025|5645539|P1|Overall Study|Withdrawal by Subject|0
1617518|NCT02027025|5645537|P3|Overall Study|Lost to Follow-up|0
1617519|NCT02027025|5645538|P2|Overall Study|Lost to Follow-up|2
1617520|NCT02027025|5645539|P1|Overall Study|Lost to Follow-up|0
1617521|NCT02027025|5645537|P3|Overall Study|Protocol Violation|0
1617522|NCT02027025|5645538|P2|Overall Study|Protocol Violation|0
1617523|NCT02027025|5645539|P1|Overall Study|Protocol Violation|1
1617524|NCT02027025|5645537|P3|Overall Study|Adverse Event|1
1617525|NCT02027025|5645538|P2|Overall Study|Adverse Event|1
1617526|NCT02027025|5645539|P1|Overall Study|Adverse Event|0
1617527|NCT02026258|5645589|P2|Recieved Allocated Intervention|Lost to Follow-up|1
1617528|NCT02026258|5645590|P1|Recieved Allocated Intervention|Lost to Follow-up|0
1617529|NCT02026258|5645589|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
1617530|NCT02026258|5645590|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
1617531|NCT02026258|5645589|P2|Randomized|Presence of periodontal disease|1
1617532|NCT02026258|5645590|P1|Randomized|Presence of periodontal disease|1
1617533|NCT02026258|5645589|P2|Randomized|Change in treatment plan|0
1617534|NCT02026258|5645590|P1|Randomized|Change in treatment plan|1
1617535|NCT02026258|5645589|P2|Randomized|Did not start treatment|1
1617536|NCT02026258|5645590|P1|Randomized|Did not start treatment|2
1617537|NCT02026141|5645624|P2|Overall Study|Protocol Violation|1
1617538|NCT02026141|5645625|P1|Overall Study|Protocol Violation|0
1617539|NCT02026063|5645633|P2|Overall Study|Reason not Specified|7
1617540|NCT02026063|5645634|P1|Overall Study|Reason not Specified|2
1617541|NCT02026063|5645633|P2|Overall Study|Lost to Follow-up|1
1617542|NCT02026063|5645634|P1|Overall Study|Lost to Follow-up|0
1617543|NCT02026063|5645633|P2|Overall Study|Lack of Efficacy|4
1617544|NCT02026063|5645634|P1|Overall Study|Lack of Efficacy|0
1617545|NCT02026063|5645633|P2|Overall Study|Adverse Event|20
1617546|NCT02026063|5645634|P1|Overall Study|Adverse Event|5
1617547|NCT02026063|5645633|P2|Overall Study|Withdrawal of Consent|6
1617548|NCT02026063|5645634|P1|Overall Study|Withdrawal of Consent|1
1617549|NCT02026063|5645633|P2|Overall Study|Noncompliance with Study Drug|1
1617550|NCT02026063|5645634|P1|Overall Study|Noncompliance with Study Drug|1
1617551|NCT02026063|5645633|P2|Overall Study|Physician Decision|10
1617552|NCT02026063|5645634|P1|Overall Study|Physician Decision|0
1617553|NCT02026011|5645646|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
1617554|NCT02026011|5645647|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
1617555|NCT02026011|5645646|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
1617556|NCT02026011|5645647|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
1617557|NCT02026011|5645646|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
1617558|NCT02026011|5645647|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
1617559|NCT02026011|5645646|P2|Allocation 1 (First Set of Medication)|Side Effects|0
1617560|NCT02026011|5645647|P1|Allocation 1 (First Set of Medication)|Side Effects|6
1617561|NCT02025907|5645673|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
1617562|NCT02025907|5645674|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
1617563|NCT02025907|5645673|P2|Overall Study|Adverse Event|1
1617564|NCT02025907|5645674|P1|Overall Study|Adverse Event|3
1617565|NCT02025907|5645673|P2|Overall Study|Lost to Follow-up|2
1617566|NCT02025907|5645674|P1|Overall Study|Lost to Follow-up|2
1617567|NCT02025907|5645673|P2|Overall Study|Physician Decision|0
1617568|NCT02025907|5645674|P1|Overall Study|Physician Decision|2
1617569|NCT02025907|5645673|P2|Overall Study|Protocol Violation|0
1617570|NCT02025907|5645674|P1|Overall Study|Protocol Violation|2
1617571|NCT02025907|5645673|P2|Overall Study|Withdrawal by Subject|8
1617572|NCT02025907|5645674|P1|Overall Study|Withdrawal by Subject|15
1617573|NCT02025907|5645673|P2|Overall Study|Lack of Efficacy|0
1617574|NCT02025907|5645674|P1|Overall Study|Lack of Efficacy|1
1617575|NCT02025725|5645702|P2|Overall Study|Post-dose QTcB > 270 msec|1
1617576|NCT02025725|5645703|P1|Overall Study|Post-dose QTcB > 270 msec|0
1617577|NCT02025725|5645702|P2|Overall Study|Withdrawal by Subject|2
1617578|NCT02025725|5645703|P1|Overall Study|Withdrawal by Subject|3
1617579|NCT02025725|5645702|P2|Overall Study|Protocol Violation|1
1617580|NCT02025725|5645703|P1|Overall Study|Protocol Violation|1
1617581|NCT02025725|5645702|P2|Overall Study|Lost to Follow-up|0
1617582|NCT02025725|5645703|P1|Overall Study|Lost to Follow-up|2
1617583|NCT02025725|5645702|P2|Overall Study|Adverse Event|0
1617584|NCT02025725|5645703|P1|Overall Study|Adverse Event|5
1617585|NCT02025621|5645740|P2|Overall Study|Surgery initiated before infusion|3
1617586|NCT02025621|5645741|P1|Overall Study|Surgery initiated before infusion|3
1617587|NCT02025621|5645740|P2|Overall Study|No longer eligible|15
1617588|NCT02025621|5645741|P1|Overall Study|No longer eligible|10
1617589|NCT02025621|5645740|P2|Overall Study|Death|1
1617590|NCT02025621|5645741|P1|Overall Study|Death|0
1617591|NCT02025621|5645740|P2|Overall Study|Withdrawal by Subject|0
1617592|NCT02025621|5645741|P1|Overall Study|Withdrawal by Subject|1
1617593|NCT02025530|5645761|P2|Overall Study|No longer met elligibility criteria|1
1617594|NCT02025530|5645762|P1|Overall Study|No longer met elligibility criteria|5
1617595|NCT02025205|5645774|P2|Overall Study|Death|1
1617596|NCT02025205|5645775|P1|Overall Study|Death|0
1617597|NCT02025205|5645774|P2|Overall Study|Protocol Violation|1
1617598|NCT02025205|5645775|P1|Overall Study|Protocol Violation|2
1617599|NCT02025205|5645774|P2|Overall Study|Withdrawal by Subject|1
1617600|NCT02025205|5645775|P1|Overall Study|Withdrawal by Subject|1
1617601|NCT02025179|5645819|P3|Overall Study|Lost to Follow-up|1
1617602|NCT02025179|5645820|P2|Overall Study|Lost to Follow-up|0
1617603|NCT02025179|5645821|P1|Overall Study|Lost to Follow-up|0
1617604|NCT02024971|5645871|P1|Overall Study|Lost to Follow-up|6
1617605|NCT02024971|5645871|P1|Overall Study|Data Not Available|30
1617606|NCT02024932|5645884|P6|Overall Study|Abnormal laboratory value|0
1617607|NCT02024932|5645885|P5|Overall Study|Abnormal laboratory value|0
1617608|NCT02024932|5645886|P4|Overall Study|Abnormal laboratory value|2
1617609|NCT02024932|5645887|P3|Overall Study|Abnormal laboratory value|0
1617610|NCT02024932|5645888|P2|Overall Study|Abnormal laboratory value|0
1617611|NCT02024932|5645889|P1|Overall Study|Abnormal laboratory value|0
1617612|NCT02024932|5645884|P6|Overall Study|Adverse Event|0
1617613|NCT02024932|5645885|P5|Overall Study|Adverse Event|2
1617614|NCT02024932|5645886|P4|Overall Study|Adverse Event|0
1617615|NCT02024932|5645887|P3|Overall Study|Adverse Event|0
1617616|NCT02024932|5645888|P2|Overall Study|Adverse Event|3
1617617|NCT02024932|5645889|P1|Overall Study|Adverse Event|2
1617618|NCT02024867|5645948|P2|Overall Study|Lost to Follow-up|4
1617619|NCT02024867|5645949|P1|Overall Study|Lost to Follow-up|6
1617620|NCT02024867|5645948|P2|Overall Study|Protocol Violation|3
1617621|NCT02024867|5645949|P1|Overall Study|Protocol Violation|3
1617622|NCT02024750|5645967|P2|Overall Study|Withdrawal by Subject|1
1617623|NCT02024750|5645968|P1|Overall Study|Withdrawal by Subject|2
1617624|NCT02024698|5645989|P2|First Intervention (7 Days)|Withdrawal by Subject|1
1617625|NCT02024698|5645990|P1|First Intervention (7 Days)|Withdrawal by Subject|0
1617626|NCT02023879|5646100|P3|Extension Open Label Treatment|Other than specified above|2
1617627|NCT02023879|5646101|P2|Extension Open Label Treatment|Other than specified above|7
1617628|NCT02023879|5646102|P1|Extension Open Label Treatment|Other than specified above|2
1617629|NCT02023879|5646100|P3|Extension Open Label Treatment|Participant moved|0
1617630|NCT02023879|5646101|P2|Extension Open Label Treatment|Participant moved|2
1617631|NCT02023879|5646102|P1|Extension Open Label Treatment|Participant moved|1
1617632|NCT02023879|5646100|P3|Extension Open Label Treatment|Poor compliance to protocol|0
1617633|NCT02023879|5646101|P2|Extension Open Label Treatment|Poor compliance to protocol|1
1617634|NCT02023879|5646102|P1|Extension Open Label Treatment|Poor compliance to protocol|1
1617635|NCT02023879|5646100|P3|Extension Open Label Treatment|Adverse Event|3
1617636|NCT02023879|5646101|P2|Extension Open Label Treatment|Adverse Event|7
1617637|NCT02023879|5646102|P1|Extension Open Label Treatment|Adverse Event|1
1617638|NCT02023879|5646100|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1617639|NCT02023879|5646101|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
1617640|NCT02023879|5646102|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
1617641|NCT02023879|5646100|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1617642|NCT02023879|5646101|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
1617643|NCT02023879|5646102|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
1617644|NCT02023879|5646100|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1617645|NCT02023879|5646101|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
1617646|NCT02023879|5646102|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
1617647|NCT02023879|5646100|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1617648|NCT02023879|5646101|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
1617649|NCT02023879|5646102|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
1617650|NCT02023879|5646100|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
1617651|NCT02023879|5646101|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
1617733|NCT02023112|5646422|P2|Overall Study|Withdrawal by Subject|1
1617652|NCT02023879|5646102|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
1617653|NCT02023879|5646100|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
1617654|NCT02023879|5646101|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1617655|NCT02023879|5646102|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
1617656|NCT02023866|5646191|P1|Overall Study|Withdrawal by Subject|1
1617657|NCT02023866|5646191|P1|Overall Study|Adverse Event|3
1617658|NCT02023866|5646191|P1|Overall Study|Non-compliance|2
1617659|NCT02023697|5646213|P3|Long-term Follow-up Period|Other unspecified|5
1617660|NCT02023697|5646214|P2|Long-term Follow-up Period|Other unspecified|3
1617661|NCT02023697|5646215|P1|Long-term Follow-up Period|Other unspecified|6
1617662|NCT02023697|5646213|P3|Long-term Follow-up Period|Technical problems|1
1617663|NCT02023697|5646214|P2|Long-term Follow-up Period|Technical problems|0
1617664|NCT02023697|5646215|P1|Long-term Follow-up Period|Technical problems|0
1617665|NCT02023697|5646213|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
1617666|NCT02023697|5646214|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
1617667|NCT02023697|5646215|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
1617668|NCT02023697|5646213|P3|Long-term Follow-up Period|Lost to Follow-up|1
1617669|NCT02023697|5646214|P2|Long-term Follow-up Period|Lost to Follow-up|0
1617670|NCT02023697|5646215|P1|Long-term Follow-up Period|Lost to Follow-up|1
1617671|NCT02023697|5646213|P3|Long-term Follow-up Period|Withdrawal by Subject|0
1617672|NCT02023697|5646214|P2|Long-term Follow-up Period|Withdrawal by Subject|3
1617673|NCT02023697|5646215|P1|Long-term Follow-up Period|Withdrawal by Subject|6
1617674|NCT02023697|5646213|P3|Long-term Follow-up Period|Death|4
1617675|NCT02023697|5646214|P2|Long-term Follow-up Period|Death|6
1617676|NCT02023697|5646215|P1|Long-term Follow-up Period|Death|9
1617677|NCT02023697|5646213|P3|Active Follow-up Period|Death|87
1617678|NCT02023697|5646214|P2|Active Follow-up Period|Death|82
1617679|NCT02023697|5646215|P1|Active Follow-up Period|Death|83
1617680|NCT02023697|5646213|P3|Active Follow-up Period|Radiological progression|1
1617681|NCT02023697|5646214|P2|Active Follow-up Period|Radiological progression|0
1617682|NCT02023697|5646215|P1|Active Follow-up Period|Radiological progression|0
1617683|NCT02023697|5646213|P3|Active Follow-up Period|Clinical progression|1
1617684|NCT02023697|5646214|P2|Active Follow-up Period|Clinical progression|2
1617685|NCT02023697|5646215|P1|Active Follow-up Period|Clinical progression|0
1617686|NCT02023697|5646213|P3|Active Follow-up Period|Other unspecified|1
1617687|NCT02023697|5646214|P2|Active Follow-up Period|Other unspecified|0
1617688|NCT02023697|5646215|P1|Active Follow-up Period|Other unspecified|2
1617689|NCT02023697|5646213|P3|Active Follow-up Period|Deterioration of general condition|1
1617690|NCT02023697|5646214|P2|Active Follow-up Period|Deterioration of general condition|1
1617691|NCT02023697|5646215|P1|Active Follow-up Period|Deterioration of general condition|1
1617692|NCT02023697|5646213|P3|Active Follow-up Period|Lost to Follow-up|1
1617693|NCT02023697|5646214|P2|Active Follow-up Period|Lost to Follow-up|1
1617694|NCT02023697|5646215|P1|Active Follow-up Period|Lost to Follow-up|1
1617695|NCT02023697|5646213|P3|Active Follow-up Period|Withdrawal by Subject|7
1617696|NCT02023697|5646214|P2|Active Follow-up Period|Withdrawal by Subject|13
1617697|NCT02023697|5646215|P1|Active Follow-up Period|Withdrawal by Subject|5
1617698|NCT02023697|5646213|P3|Treatment Period|Physician Decision|1
1617699|NCT02023697|5646214|P2|Treatment Period|Physician Decision|0
1617700|NCT02023697|5646215|P1|Treatment Period|Physician Decision|0
1617701|NCT02023697|5646213|P3|Treatment Period|Safety outcome reached|0
1617702|NCT02023697|5646214|P2|Treatment Period|Safety outcome reached|1
1617703|NCT02023697|5646215|P1|Treatment Period|Safety outcome reached|0
1617704|NCT02023697|5646213|P3|Treatment Period|Withdrawal by Subject|13
1617705|NCT02023697|5646214|P2|Treatment Period|Withdrawal by Subject|5
1617706|NCT02023697|5646215|P1|Treatment Period|Withdrawal by Subject|4
1617707|NCT02023697|5646213|P3|Treatment Period|Clinical progression|28
1617708|NCT02023697|5646214|P2|Treatment Period|Clinical progression|8
1617709|NCT02023697|5646215|P1|Treatment Period|Clinical progression|10
1617710|NCT02023697|5646213|P3|Treatment Period|Logistical difficulties|1
1617711|NCT02023697|5646214|P2|Treatment Period|Logistical difficulties|1
1617712|NCT02023697|5646215|P1|Treatment Period|Logistical difficulties|1
1617713|NCT02023697|5646213|P3|Treatment Period|Adverse Event|23
1617714|NCT02023697|5646214|P2|Treatment Period|Adverse Event|25
1617715|NCT02023697|5646215|P1|Treatment Period|Adverse Event|13
1617716|NCT02023697|5646213|P3|Treatment Period|Never Treated|10
1617717|NCT02023697|5646214|P2|Treatment Period|Never Treated|6
1617718|NCT02023697|5646215|P1|Treatment Period|Never Treated|5
1617719|NCT02023697|5646213|P3|Treatment Period|Radiological progression|26
1617720|NCT02023697|5646214|P2|Treatment Period|Radiological progression|17
1617721|NCT02023697|5646215|P1|Treatment Period|Radiological progression|13
1617722|NCT02023268|5646328|P2|Overall Study|Withdrawal by Subject|1
1617723|NCT02023268|5646329|P1|Overall Study|Withdrawal by Subject|0
1617724|NCT02023268|5646328|P2|Overall Study|Adverse Event|2
1617725|NCT02023268|5646329|P1|Overall Study|Adverse Event|0
1617726|NCT02023268|5646328|P2|Overall Study|Lack of Efficacy|1
1617727|NCT02023268|5646329|P1|Overall Study|Lack of Efficacy|0
1617728|NCT02023242|5646337|P2|Overall Study|Death|1
1617729|NCT02023242|5646338|P1|Overall Study|Death|0
1617730|NCT02023242|5646337|P2|Overall Study|Lost to Follow-up|1
1617731|NCT02023242|5646338|P1|Overall Study|Lost to Follow-up|3
1617732|NCT02023151|5646352|P1|Overall Study|Lost to Follow-up|4
1617734|NCT02023112|5646423|P1|Overall Study|Withdrawal by Subject|2
1617735|NCT02023099|5646444|P3|Overall Study|Non-treatment-emergent Fatal AE|1
1617736|NCT02023099|5646445|P2|Overall Study|Non-treatment-emergent Fatal AE|0
1617737|NCT02023099|5646446|P1|Overall Study|Non-treatment-emergent Fatal AE|0
1617738|NCT02023099|5646444|P3|Overall Study|Withdrawn Consent|1
1617739|NCT02023099|5646445|P2|Overall Study|Withdrawn Consent|0
1617740|NCT02023099|5646446|P1|Overall Study|Withdrawn Consent|3
1617741|NCT02023099|5646444|P3|Overall Study|Non-fatal Adverse Event (AE)|1
1617742|NCT02023099|5646445|P2|Overall Study|Non-fatal Adverse Event (AE)|0
1617743|NCT02023099|5646446|P1|Overall Study|Non-fatal Adverse Event (AE)|0
1617744|NCT02022748|5646469|P3|Overall Study|Withdrawal by Subject|0
1617745|NCT02022748|5646470|P2|Overall Study|Withdrawal by Subject|1
1617746|NCT02022748|5646471|P1|Overall Study|Withdrawal by Subject|0
1617747|NCT02022748|5646469|P3|Overall Study|Adverse Event|0
1617748|NCT02022748|5646470|P2|Overall Study|Adverse Event|1
1617749|NCT02022748|5646471|P1|Overall Study|Adverse Event|1
1617750|NCT02022670|5646497|P3|Overall Study|Adverse Event|1
1617751|NCT02022670|5646498|P2|Overall Study|Adverse Event|0
1617752|NCT02022670|5646499|P1|Overall Study|Adverse Event|1
1617753|NCT02022657|5646513|P6|Overall Study|Physician Decision|1
1617754|NCT02022657|5646514|P5|Overall Study|Physician Decision|0
1617755|NCT02022657|5646515|P4|Overall Study|Physician Decision|0
1617756|NCT02022657|5646516|P3|Overall Study|Physician Decision|0
1617757|NCT02022657|5646517|P2|Overall Study|Physician Decision|0
1617758|NCT02022657|5646518|P1|Overall Study|Physician Decision|0
1617759|NCT02022657|5646513|P6|Overall Study|Withdrawal by Subject|0
1617760|NCT02022657|5646514|P5|Overall Study|Withdrawal by Subject|0
1617761|NCT02022657|5646515|P4|Overall Study|Withdrawal by Subject|0
1617762|NCT02022657|5646516|P3|Overall Study|Withdrawal by Subject|1
1617763|NCT02022657|5646517|P2|Overall Study|Withdrawal by Subject|0
1617764|NCT02022657|5646518|P1|Overall Study|Withdrawal by Subject|2
1617765|NCT02022007|5646559|P3|Overall Study|Noncompliant|1
1617766|NCT02022007|5646560|P2|Overall Study|Noncompliant|0
1617767|NCT02022007|5646561|P1|Overall Study|Noncompliant|0
1617768|NCT02022007|5646559|P3|Overall Study|Withdrawal by Subject|1
1617769|NCT02022007|5646560|P2|Overall Study|Withdrawal by Subject|1
1617770|NCT02022007|5646561|P1|Overall Study|Withdrawal by Subject|1
1617771|NCT02021656|5646644|P1|Overall Study|Withdrew Consent|2
1617772|NCT02021656|5646644|P1|Overall Study|Lost to Follow-up|1
1617773|NCT02021656|5646644|P1|Overall Study|Lack of Efficacy|2
1617774|NCT02021656|5646644|P1|Overall Study|Adverse Event|1
1617775|NCT02021643|5646664|P4|Overall Study|Withdrew Consent|0
1617776|NCT02021643|5646665|P3|Overall Study|Withdrew Consent|0
1617777|NCT02021643|5646666|P2|Overall Study|Withdrew Consent|1
1617778|NCT02021643|5646667|P1|Overall Study|Withdrew Consent|0
1617779|NCT02021643|5646664|P4|Overall Study|Lost to Follow-up|0
1617780|NCT02021643|5646665|P3|Overall Study|Lost to Follow-up|0
1617781|NCT02021643|5646666|P2|Overall Study|Lost to Follow-up|1
1617782|NCT02021643|5646667|P1|Overall Study|Lost to Follow-up|0
1617783|NCT02021643|5646664|P4|Overall Study|Lack of Efficacy|12
1617784|NCT02021643|5646665|P3|Overall Study|Lack of Efficacy|0
1617785|NCT02021643|5646666|P2|Overall Study|Lack of Efficacy|6
1617786|NCT02021643|5646667|P1|Overall Study|Lack of Efficacy|7
1617787|NCT02021643|5646664|P4|Overall Study|Investigator's Discretion|0
1617788|NCT02021643|5646665|P3|Overall Study|Investigator's Discretion|0
1617789|NCT02021643|5646666|P2|Overall Study|Investigator's Discretion|0
1617790|NCT02021643|5646667|P1|Overall Study|Investigator's Discretion|1
1617791|NCT02021643|5646664|P4|Overall Study|Death|0
1617792|NCT02021643|5646665|P3|Overall Study|Death|0
1617793|NCT02021643|5646666|P2|Overall Study|Death|1
1617794|NCT02021643|5646667|P1|Overall Study|Death|0
1617795|NCT02021643|5646664|P4|Overall Study|Adverse Event|0
1617796|NCT02021643|5646665|P3|Overall Study|Adverse Event|0
1617797|NCT02021643|5646666|P2|Overall Study|Adverse Event|1
1617798|NCT02021643|5646667|P1|Overall Study|Adverse Event|0
1617799|NCT02021643|5646664|P4|Overall Study|Enrolled but Never Treated|0
1617800|NCT02021643|5646665|P3|Overall Study|Enrolled but Never Treated|0
1617801|NCT02021643|5646666|P2|Overall Study|Enrolled but Never Treated|0
1617802|NCT02021643|5646667|P1|Overall Study|Enrolled but Never Treated|1
1617803|NCT02021565|5646709|P2|3-month Follow-up|Protocol Violation|2
1617804|NCT02021565|5646710|P1|3-month Follow-up|Protocol Violation|3
1617805|NCT02021565|5646709|P2|3-month Follow-up|Withdrawal by Subject|0
1617806|NCT02021565|5646710|P1|3-month Follow-up|Withdrawal by Subject|4
1617807|NCT02021565|5646709|P2|3-month Follow-up|Death|0
1617808|NCT02021565|5646710|P1|3-month Follow-up|Death|3
1617809|NCT02021565|5646709|P2|Baseline Through Intervention|Lost to Follow-up|2
1617810|NCT02021565|5646710|P1|Baseline Through Intervention|Lost to Follow-up|4
1617811|NCT02021565|5646709|P2|Baseline Through Intervention|Protocol Violation|7
1617812|NCT02021565|5646710|P1|Baseline Through Intervention|Protocol Violation|0
1617813|NCT02021565|5646709|P2|Baseline Through Intervention|Withdrawal by Subject|8
1617814|NCT02021565|5646710|P1|Baseline Through Intervention|Withdrawal by Subject|8
1617815|NCT02021565|5646709|P2|Baseline Through Intervention|Death|1
1617816|NCT02021565|5646710|P1|Baseline Through Intervention|Death|0
1617817|NCT02021331|5646730|P2|Overall Study|Adverse Event|2
1617818|NCT02021331|5646731|P1|Overall Study|Adverse Event|0
1617819|NCT02021292|5646743|P2|Overall Study|Death|1
1617820|NCT02021292|5646744|P1|Overall Study|Death|0
1617821|NCT02021292|5646743|P2|Overall Study|Lost to Follow-up|1
1617822|NCT02021292|5646744|P1|Overall Study|Lost to Follow-up|0
1617823|NCT02021292|5646743|P2|Overall Study|Physician Decision|1
1617824|NCT02021292|5646744|P1|Overall Study|Physician Decision|0
1617825|NCT02020941|5646770|P1|Overall Study|Disease Progression|4
1617826|NCT02020941|5646770|P1|Overall Study|Withdrawal by Subject|1
1617827|NCT02020941|5646770|P1|Overall Study|Physician Decision|2
1617828|NCT02020941|5646770|P1|Overall Study|Adverse Event|1
1617829|NCT02020889|5646781|P2|Overall Study|Withdrawal by Subject|2
1617830|NCT02020889|5646782|P1|Overall Study|Withdrawal by Subject|3
1617831|NCT02020889|5646781|P2|Overall Study|Physician Decision|0
1617832|NCT02020889|5646782|P1|Overall Study|Physician Decision|2
1617833|NCT02020889|5646781|P2|Overall Study|Lost to Follow-up|0
1617834|NCT02020889|5646782|P1|Overall Study|Lost to Follow-up|1
1617835|NCT02020889|5646781|P2|Overall Study|Lack of Efficacy|0
1617836|NCT02020889|5646782|P1|Overall Study|Lack of Efficacy|1
1617837|NCT02020889|5646781|P2|Overall Study|Adverse Event|1
1617838|NCT02020889|5646782|P1|Overall Study|Adverse Event|0
1617839|NCT02020863|5646836|P1|Overall Study|Team chose not to place an a line|1
1617840|NCT02020863|5646836|P1|Overall Study|Discovery of Metastatic disease|4
1617841|NCT02020616|5646866|P7|Overall Study|Lack of Efficacy|0
1617842|NCT02020616|5646867|P6|Overall Study|Lack of Efficacy|0
1617843|NCT02020616|5646868|P5|Overall Study|Lack of Efficacy|1
1617844|NCT02020616|5646869|P4|Overall Study|Lack of Efficacy|0
1617845|NCT02020616|5646870|P3|Overall Study|Lack of Efficacy|0
1617846|NCT02020616|5646871|P2|Overall Study|Lack of Efficacy|0
1617847|NCT02020616|5646872|P1|Overall Study|Lack of Efficacy|0
1617848|NCT02020616|5646866|P7|Overall Study|Randomized in Error|0
1617849|NCT02020616|5646867|P6|Overall Study|Randomized in Error|0
1617850|NCT02020616|5646868|P5|Overall Study|Randomized in Error|0
1617851|NCT02020616|5646869|P4|Overall Study|Randomized in Error|1
1617852|NCT02020616|5646870|P3|Overall Study|Randomized in Error|0
1617853|NCT02020616|5646871|P2|Overall Study|Randomized in Error|0
1617854|NCT02020616|5646872|P1|Overall Study|Randomized in Error|0
1617855|NCT02020616|5646866|P7|Overall Study|Early Termination Criteria Met|0
1617856|NCT02020616|5646867|P6|Overall Study|Early Termination Criteria Met|1
1617857|NCT02020616|5646868|P5|Overall Study|Early Termination Criteria Met|0
1617858|NCT02020616|5646869|P4|Overall Study|Early Termination Criteria Met|0
1617859|NCT02020616|5646870|P3|Overall Study|Early Termination Criteria Met|1
1617860|NCT02020616|5646871|P2|Overall Study|Early Termination Criteria Met|0
1617861|NCT02020616|5646872|P1|Overall Study|Early Termination Criteria Met|0
1617862|NCT02020616|5646866|P7|Overall Study|Lost to Follow-up|0
1617863|NCT02020616|5646867|P6|Overall Study|Lost to Follow-up|1
1617864|NCT02020616|5646868|P5|Overall Study|Lost to Follow-up|1
1617865|NCT02020616|5646869|P4|Overall Study|Lost to Follow-up|1
1617866|NCT02020616|5646870|P3|Overall Study|Lost to Follow-up|0
1617867|NCT02020616|5646871|P2|Overall Study|Lost to Follow-up|1
1617868|NCT02020616|5646872|P1|Overall Study|Lost to Follow-up|0
1617869|NCT02020616|5646866|P7|Overall Study|Withdrawal by Subject|1
1617870|NCT02020616|5646867|P6|Overall Study|Withdrawal by Subject|1
1617871|NCT02020616|5646868|P5|Overall Study|Withdrawal by Subject|0
1617872|NCT02020616|5646869|P4|Overall Study|Withdrawal by Subject|0
1617873|NCT02020616|5646870|P3|Overall Study|Withdrawal by Subject|1
1617874|NCT02020616|5646871|P2|Overall Study|Withdrawal by Subject|0
1617875|NCT02020616|5646872|P1|Overall Study|Withdrawal by Subject|0
1617876|NCT02020616|5646866|P7|Overall Study|Physician Decision|2
1617877|NCT02020616|5646867|P6|Overall Study|Physician Decision|1
1617878|NCT02020616|5646868|P5|Overall Study|Physician Decision|0
1617879|NCT02020616|5646869|P4|Overall Study|Physician Decision|0
1617880|NCT02020616|5646870|P3|Overall Study|Physician Decision|0
1617881|NCT02020616|5646871|P2|Overall Study|Physician Decision|0
1617882|NCT02020616|5646872|P1|Overall Study|Physician Decision|0
1617883|NCT02020616|5646866|P7|Overall Study|Adverse Event|1
1617884|NCT02020616|5646867|P6|Overall Study|Adverse Event|1
1617885|NCT02020616|5646868|P5|Overall Study|Adverse Event|0
1617886|NCT02020616|5646869|P4|Overall Study|Adverse Event|0
1617887|NCT02020616|5646870|P3|Overall Study|Adverse Event|0
1617888|NCT02020616|5646871|P2|Overall Study|Adverse Event|0
1617889|NCT02020616|5646872|P1|Overall Study|Adverse Event|0
1617890|NCT02020577|5646965|P2|Overall Study|Other than stated above|1
1617891|NCT02020577|5646966|P1|Overall Study|Other than stated above|0
1617892|NCT02020577|5646965|P2|Overall Study|Withdrawal by Subject|1
1617893|NCT02020577|5646966|P1|Overall Study|Withdrawal by Subject|0
1617894|NCT02020577|5646965|P2|Overall Study|Other AE or clinical progression|15
1617895|NCT02020577|5646966|P1|Overall Study|Other AE or clinical progression|0
1617896|NCT02020577|5646965|P2|Overall Study|Progressive disease|38
1617897|NCT02020577|5646966|P1|Overall Study|Progressive disease|3
1617898|NCT02020512|5646993|P1|Overall Study|Protocol Violation|4
1617899|NCT02020512|5646993|P1|Overall Study|Lost to Follow-up|3
1617900|NCT02020512|5646993|P1|Overall Study|Adverse Event|1
1617901|NCT02020031|5647045|P2|Overall Study|Physician Decision|1
1617902|NCT02020031|5647046|P1|Overall Study|Physician Decision|1
1617903|NCT02019979|5647067|P1|Overall Study|study terminated|14
1617904|NCT02019927|5647079|P6|Overall Study|Lost to Follow-up|1
1617905|NCT02019927|5647080|P5|Overall Study|Lost to Follow-up|3
1617906|NCT02019927|5647081|P4|Overall Study|Lost to Follow-up|2
1617907|NCT02019927|5647082|P3|Overall Study|Lost to Follow-up|1
1617908|NCT02019927|5647083|P2|Overall Study|Lost to Follow-up|4
1617909|NCT02019927|5647084|P1|Overall Study|Lost to Follow-up|2
1617910|NCT02019719|5647176|P5|Overall Study|Physician Decision|0
1617911|NCT02019719|5647177|P4|Overall Study|Physician Decision|0
1617912|NCT02019719|5647178|P3|Overall Study|Physician Decision|0
1617913|NCT02019719|5647179|P2|Overall Study|Physician Decision|0
1617914|NCT02019719|5647180|P1|Overall Study|Physician Decision|2
1617915|NCT02019719|5647176|P5|Overall Study|Protocol defined stopping criteria|1
1617916|NCT02019719|5647177|P4|Overall Study|Protocol defined stopping criteria|1
1617917|NCT02019719|5647178|P3|Overall Study|Protocol defined stopping criteria|0
1617918|NCT02019719|5647179|P2|Overall Study|Protocol defined stopping criteria|0
1617919|NCT02019719|5647180|P1|Overall Study|Protocol defined stopping criteria|2
1617920|NCT02019719|5647176|P5|Overall Study|Protocol Violation|0
1617921|NCT02019719|5647177|P4|Overall Study|Protocol Violation|0
1617922|NCT02019719|5647178|P3|Overall Study|Protocol Violation|0
1617923|NCT02019719|5647179|P2|Overall Study|Protocol Violation|1
1617924|NCT02019719|5647180|P1|Overall Study|Protocol Violation|1
1617925|NCT02019719|5647176|P5|Overall Study|Adverse Event|1
1617926|NCT02019719|5647177|P4|Overall Study|Adverse Event|1
1617927|NCT02019719|5647178|P3|Overall Study|Adverse Event|0
1617928|NCT02019719|5647179|P2|Overall Study|Adverse Event|0
1617929|NCT02019719|5647180|P1|Overall Study|Adverse Event|1
1617936|NCT02019602|5647298|P2|Screening Period|Adverse Event|0
1617937|NCT02019602|5647299|P1|Screening Period|Adverse Event|1
1617938|NCT02019602|5647298|P2|Screening Period|Ineligibility|0
1617939|NCT02019602|5647299|P1|Screening Period|Ineligibility|4
1617940|NCT02019550|5647328|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
1617941|NCT02019550|5647329|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
1617942|NCT02019472|5647370|P3|Overall Study|Other|6
1617943|NCT02019472|5647371|P2|Overall Study|Other|8
1617944|NCT02019472|5647372|P1|Overall Study|Other|3
1617945|NCT02019472|5647370|P3|Overall Study|Withdrawal by Subject|11
1617946|NCT02019472|5647371|P2|Overall Study|Withdrawal by Subject|10
1617947|NCT02019472|5647372|P1|Overall Study|Withdrawal by Subject|11
1617948|NCT02019472|5647370|P3|Overall Study|Pregnancy|2
1617949|NCT02019472|5647371|P2|Overall Study|Pregnancy|2
1617950|NCT02019472|5647372|P1|Overall Study|Pregnancy|1
1617951|NCT02019472|5647370|P3|Overall Study|Physician Decision|0
1617952|NCT02019472|5647371|P2|Overall Study|Physician Decision|2
1617953|NCT02019472|5647372|P1|Overall Study|Physician Decision|1
1617954|NCT02019472|5647370|P3|Overall Study|Lost to Follow-up|1
1617955|NCT02019472|5647371|P2|Overall Study|Lost to Follow-up|2
1617956|NCT02019472|5647372|P1|Overall Study|Lost to Follow-up|0
1617957|NCT02019472|5647370|P3|Overall Study|Lack of Efficacy|4
1617958|NCT02019472|5647371|P2|Overall Study|Lack of Efficacy|4
1617959|NCT02019472|5647372|P1|Overall Study|Lack of Efficacy|7
1617960|NCT02019472|5647370|P3|Overall Study|Death|1
1617961|NCT02019472|5647371|P2|Overall Study|Death|1
1617962|NCT02019472|5647372|P1|Overall Study|Death|0
1617963|NCT02019472|5647370|P3|Overall Study|Adverse Event|17
1617964|NCT02019472|5647371|P2|Overall Study|Adverse Event|23
1617965|NCT02019472|5647372|P1|Overall Study|Adverse Event|14
1617966|NCT02019420|5647395|P2|Overall Study|Transferred to other care facility|1
1617967|NCT02019420|5647396|P1|Overall Study|Transferred to other care facility|1
1617968|NCT02019420|5647395|P2|Overall Study|Death|99
1617969|NCT02019420|5647396|P1|Overall Study|Death|104
1617970|NCT02019420|5647395|P2|Overall Study|At request of sponsor or investigator|1
1617971|NCT02019420|5647396|P1|Overall Study|At request of sponsor or investigator|0
1617972|NCT02019420|5647395|P2|Overall Study|Withdrawal by Subject|3
1617973|NCT02019420|5647396|P1|Overall Study|Withdrawal by Subject|1
1617974|NCT02019420|5647395|P2|Overall Study|Did not receive study drug|2
1617975|NCT02019420|5647396|P1|Overall Study|Did not receive study drug|2
1617976|NCT02019277|5647424|P1|Overall Study|Adverse Event|1
1617977|NCT02019277|5647424|P1|Overall Study|Did no Cooperate|1
1617978|NCT02019277|5647424|P1|Overall Study|Death|7
1617979|NCT02019277|5647424|P1|Overall Study|Withdrawal by Subject|3
1617980|NCT02019264|5647443|P2|Overall Study|Missing|11
1617981|NCT02019264|5647444|P1|Overall Study|Missing|14
1617982|NCT02019264|5647443|P2|Overall Study|Administrative reason|28
1617983|NCT02019264|5647444|P1|Overall Study|Administrative reason|36
1617984|NCT02019264|5647443|P2|Overall Study|Withdrawal by Subject|117
1617985|NCT02019264|5647444|P1|Overall Study|Withdrawal by Subject|142
1617986|NCT02019264|5647443|P2|Overall Study|Lost to Follow-up|47
1617987|NCT02019264|5647444|P1|Overall Study|Lost to Follow-up|50
1617988|NCT02019264|5647443|P2|Overall Study|Not treated|4
1617989|NCT02019264|5647444|P1|Overall Study|Not treated|6
1617990|NCT02019108|5647480|P2|Overall Study|Lost to Follow-up|7
1617991|NCT02019108|5647481|P1|Overall Study|Lost to Follow-up|5
1617992|NCT02018887|5647523|P11|Part C: Cohort 8 Overall|Physician Decision|1
1617993|NCT02018887|5647524|P10|Part C: Cohort 8 Overall|Physician Decision|0
1617994|NCT02018887|5647525|P9|Part C: Cohort 8 Overall|Physician Decision|2
1617995|NCT02018887|5647526|P8|Part C: Cohort 8 Overall|Physician Decision|0
1617996|NCT02018887|5647527|P7|Part C: Cohort 8 Overall|Physician Decision|0
1617997|NCT02018887|5647528|P6|Part C: Cohort 8 Overall|Physician Decision|0
1617998|NCT02018887|5647529|P5|Part C: Cohort 8 Overall|Physician Decision|0
1617999|NCT02018887|5647530|P4|Part C: Cohort 8 Overall|Physician Decision|0
1618000|NCT02018887|5647531|P3|Part C: Cohort 8 Overall|Physician Decision|0
1618001|NCT02018887|5647532|P2|Part C: Cohort 8 Overall|Physician Decision|0
1618002|NCT02018887|5647533|P1|Part C: Cohort 8 Overall|Physician Decision|0
1618003|NCT02018887|5647523|P11|Part C: Cohort 8 Overall|Adverse Event|0
1618004|NCT02018887|5647524|P10|Part C: Cohort 8 Overall|Adverse Event|3
1618005|NCT02018887|5647525|P9|Part C: Cohort 8 Overall|Adverse Event|1
1618006|NCT02018887|5647526|P8|Part C: Cohort 8 Overall|Adverse Event|0
1618007|NCT02018887|5647527|P7|Part C: Cohort 8 Overall|Adverse Event|0
1618008|NCT02018887|5647528|P6|Part C: Cohort 8 Overall|Adverse Event|0
1618009|NCT02018887|5647529|P5|Part C: Cohort 8 Overall|Adverse Event|0
1618010|NCT02018887|5647530|P4|Part C: Cohort 8 Overall|Adverse Event|0
1618011|NCT02018887|5647531|P3|Part C: Cohort 8 Overall|Adverse Event|0
1618012|NCT02018887|5647532|P2|Part C: Cohort 8 Overall|Adverse Event|0
1618013|NCT02018887|5647533|P1|Part C: Cohort 8 Overall|Adverse Event|0
1618014|NCT02018887|5647523|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618015|NCT02018887|5647524|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618016|NCT02018887|5647525|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618017|NCT02018887|5647526|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
1618018|NCT02018887|5647527|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
1618019|NCT02018887|5647528|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618020|NCT02018887|5647529|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
1618021|NCT02018887|5647530|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618022|NCT02018887|5647531|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618023|NCT02018887|5647532|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618024|NCT02018887|5647533|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
1618025|NCT02018887|5647523|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618026|NCT02018887|5647524|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618027|NCT02018887|5647525|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618028|NCT02018887|5647526|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618029|NCT02018887|5647527|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618030|NCT02018887|5647528|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618031|NCT02018887|5647529|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618032|NCT02018887|5647530|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618033|NCT02018887|5647531|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618034|NCT02018887|5647532|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
1618035|NCT02018887|5647533|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
1618036|NCT02018822|5647622|P3|Overall Study|Lost to Follow-up|5
1618037|NCT02018822|5647623|P2|Overall Study|Lost to Follow-up|6
1618038|NCT02018822|5647624|P1|Overall Study|Lost to Follow-up|6
1618039|NCT02018822|5647622|P3|Overall Study|Physician Decision|1
1618040|NCT02018822|5647623|P2|Overall Study|Physician Decision|1
1618041|NCT02018822|5647624|P1|Overall Study|Physician Decision|0
1618042|NCT02018822|5647622|P3|Overall Study|filling replaced by crown|0
1618043|NCT02018822|5647623|P2|Overall Study|filling replaced by crown|1
1618044|NCT02018822|5647624|P1|Overall Study|filling replaced by crown|0
1618045|NCT02018562|5647704|P2|Overall Study|Discharged prior to study completion|0
1618046|NCT02018562|5647705|P1|Overall Study|Discharged prior to study completion|1
1618047|NCT02018562|5647704|P2|Overall Study|Withdrawal by Subject|0
1618048|NCT02018562|5647705|P1|Overall Study|Withdrawal by Subject|2
1618049|NCT02018042|5647739|P1|Overall Study|Withdrawal by Subject|1
1618050|NCT02017964|5647745|P1|Overall Study|Patient deemed ineligible|1
1618051|NCT02017899|5647759|P6|Overall Study|Withdrawal by Subject|0
1618052|NCT02017899|5647760|P5|Overall Study|Withdrawal by Subject|1
1618053|NCT02017899|5647761|P4|Overall Study|Withdrawal by Subject|1
1618054|NCT02017899|5647762|P3|Overall Study|Withdrawal by Subject|0
1618055|NCT02017899|5647763|P2|Overall Study|Withdrawal by Subject|0
1618056|NCT02017899|5647764|P1|Overall Study|Withdrawal by Subject|0
1618057|NCT02017522|5647849|P1|Overall Study|Withdrawal by Subject|1
1618058|NCT02017223|5647854|P1|Overall Study|Algorithm problems|2
1618059|NCT02017015|5647909|P1|Overall Study|Physician Decision|2
1618060|NCT02017015|5647909|P1|Overall Study|Non-compliance with study drug|2
1618061|NCT02017015|5647909|P1|Overall Study|Progressive Disease|31
1618062|NCT02017015|5647909|P1|Overall Study|Death|4
1618063|NCT02017015|5647909|P1|Overall Study|Withdrawal by Subject|21
1618064|NCT02017015|5647909|P1|Overall Study|Adverse Event|9
1618065|NCT02016898|5647934|P2|Overall Study|Lost to Follow-up|4
1618066|NCT02016898|5647935|P1|Overall Study|Lost to Follow-up|4
1618067|NCT02016898|5647934|P2|Overall Study|Death|1
1618068|NCT02016898|5647935|P1|Overall Study|Death|1
1618069|NCT02016716|5647992|P3|Overall Study|Lost to Follow-up|1
1618070|NCT02016716|5647993|P2|Overall Study|Lost to Follow-up|2
1618071|NCT02016716|5647994|P1|Overall Study|Lost to Follow-up|1
1618072|NCT02016716|5647992|P3|Overall Study|Protocol-specified Criteria|0
1618073|NCT02016716|5647993|P2|Overall Study|Protocol-specified Criteria|1
1618074|NCT02016716|5647994|P1|Overall Study|Protocol-specified Criteria|0
1618075|NCT02016716|5647992|P3|Overall Study|Withdrawal by Subject|5
1618076|NCT02016716|5647993|P2|Overall Study|Withdrawal by Subject|5
1618077|NCT02016716|5647994|P1|Overall Study|Withdrawal by Subject|5
1618078|NCT02016690|5648015|P1|Overall Study|Hospitalized for RSV at study start|3
1618079|NCT02016690|5648015|P1|Overall Study|Did not meet inclusion criteria|13
1618080|NCT02016690|5648015|P1|Overall Study|Excluded from SAS: Ineligible for study|2
1618081|NCT02016690|5648015|P1|Overall Study|Excluded from SAS: Early treatment|2
1618082|NCT02016690|5648015|P1|Overall Study|Excluded from SAS: Duplication|2
1618083|NCT02016690|5648015|P1|Overall Study|Excluded from SAS: Enrollment violation|2
1618084|NCT02016625|5648028|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
1618085|NCT02016625|5648029|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
1618086|NCT02016625|5648028|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
1618087|NCT02016625|5648029|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
1618088|NCT02016625|5648028|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
1618089|NCT02016625|5648029|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
1618090|NCT02016482|5648084|P2|Period B|Required Alternative/Prohibited Therapy|2
1618091|NCT02016482|5648085|P1|Period B|Required Alternative/Prohibited Therapy|0
1618092|NCT02016482|5648084|P2|Period B|Other|0
1618093|NCT02016482|5648085|P1|Period B|Other|4
1618094|NCT02016482|5648084|P2|Period B|Lack of Efficacy|4
1618095|NCT02016482|5648085|P1|Period B|Lack of Efficacy|6
1618096|NCT02016482|5648084|P2|Period B|Lost to Follow-up|0
1618097|NCT02016482|5648085|P1|Period B|Lost to Follow-up|2
1618098|NCT02016482|5648084|P2|Period B|Withdrawal by Subject|1
1618099|NCT02016482|5648085|P1|Period B|Withdrawal by Subject|1
1618100|NCT02016482|5648084|P2|Period A|Required Alternative/Prohibited Therapy|1
1618101|NCT02016482|5648085|P1|Period A|Required Alternative/Prohibited Therapy|0
1618102|NCT02016482|5648084|P2|Period A|Protocol Violation|1
1618103|NCT02016482|5648085|P1|Period A|Protocol Violation|0
1618104|NCT02016482|5648084|P2|Period A|Other|0
1618105|NCT02016482|5648085|P1|Period A|Other|3
1618106|NCT02016482|5648084|P2|Period A|Lack of Efficacy|1
1618107|NCT02016482|5648085|P1|Period A|Lack of Efficacy|2
1618108|NCT02016482|5648084|P2|Period A|Lost to Follow-up|3
1618109|NCT02016482|5648085|P1|Period A|Lost to Follow-up|3
1618110|NCT02016482|5648084|P2|Period A|Withdrawal by Subject|4
1618111|NCT02016482|5648085|P1|Period A|Withdrawal by Subject|3
1618112|NCT02016482|5648084|P2|Period A|Adverse Event|5
1618113|NCT02016482|5648085|P1|Period A|Adverse Event|3
1618114|NCT02016300|5648175|P2|Overall Study|Lost to Follow-up|3
1618115|NCT02016300|5648176|P1|Overall Study|Lost to Follow-up|0
1618116|NCT02016183|5648194|P1|Overall Study|Protocol Violation|52
1618117|NCT02016183|5648194|P1|Overall Study|Case Report Forms Uncollected|13
1618118|NCT02016170|5648204|P3|Overall Study|Protocol Violation|0
1618119|NCT02016170|5648205|P2|Overall Study|Protocol Violation|0
1618120|NCT02016170|5648206|P1|Overall Study|Protocol Violation|1
1618121|NCT02016170|5648204|P3|Overall Study|Adverse Event|0
1618122|NCT02016170|5648205|P2|Overall Study|Adverse Event|1
1618123|NCT02016170|5648206|P1|Overall Study|Adverse Event|1
1618124|NCT02016105|5648217|P6|EXTENSION PERIOD|Lost to Follow-up|2
1618125|NCT02016105|5648218|P5|EXTENSION PERIOD|Lost to Follow-up|0
1618126|NCT02016105|5648219|P4|EXTENSION PERIOD|Lost to Follow-up|0
1618127|NCT02016105|5648220|P3|EXTENSION PERIOD|Lost to Follow-up|0
1618128|NCT02016105|5648221|P2|EXTENSION PERIOD|Lost to Follow-up|0
1618129|NCT02016105|5648222|P1|EXTENSION PERIOD|Lost to Follow-up|0
1618130|NCT02016105|5648217|P6|EXTENSION PERIOD|Non-compliance with study indication|0
1618131|NCT02016105|5648218|P5|EXTENSION PERIOD|Non-compliance with study indication|1
1618132|NCT02016105|5648219|P4|EXTENSION PERIOD|Non-compliance with study indication|0
1618133|NCT02016105|5648220|P3|EXTENSION PERIOD|Non-compliance with study indication|0
1618134|NCT02016105|5648221|P2|EXTENSION PERIOD|Non-compliance with study indication|0
1618135|NCT02016105|5648222|P1|EXTENSION PERIOD|Non-compliance with study indication|0
1618136|NCT02016105|5648217|P6|EXTENSION PERIOD|Withdrawal by Subject|2
1618137|NCT02016105|5648218|P5|EXTENSION PERIOD|Withdrawal by Subject|2
1618138|NCT02016105|5648219|P4|EXTENSION PERIOD|Withdrawal by Subject|2
1618139|NCT02016105|5648220|P3|EXTENSION PERIOD|Withdrawal by Subject|2
1618140|NCT02016105|5648221|P2|EXTENSION PERIOD|Withdrawal by Subject|0
1618141|NCT02016105|5648222|P1|EXTENSION PERIOD|Withdrawal by Subject|0
1618142|NCT02016105|5648217|P6|EXTENSION PERIOD|Adverse Event|0
1618143|NCT02016105|5648218|P5|EXTENSION PERIOD|Adverse Event|1
1618144|NCT02016105|5648219|P4|EXTENSION PERIOD|Adverse Event|0
1618145|NCT02016105|5648220|P3|EXTENSION PERIOD|Adverse Event|2
1618146|NCT02016105|5648221|P2|EXTENSION PERIOD|Adverse Event|0
1618147|NCT02016105|5648222|P1|EXTENSION PERIOD|Adverse Event|0
1618148|NCT02016105|5648217|P6|EXTENSION PERIOD|Lack of Efficacy|1
1618149|NCT02016105|5648218|P5|EXTENSION PERIOD|Lack of Efficacy|1
1618150|NCT02016105|5648219|P4|EXTENSION PERIOD|Lack of Efficacy|3
1618151|NCT02016105|5648220|P3|EXTENSION PERIOD|Lack of Efficacy|1
1618152|NCT02016105|5648221|P2|EXTENSION PERIOD|Lack of Efficacy|0
1618153|NCT02016105|5648222|P1|EXTENSION PERIOD|Lack of Efficacy|0
1618154|NCT02016105|5648217|P6|EXTENSION PERIOD|New therapy for study indication|1
1618155|NCT02016105|5648218|P5|EXTENSION PERIOD|New therapy for study indication|1
1618156|NCT02016105|5648219|P4|EXTENSION PERIOD|New therapy for study indication|0
1618157|NCT02016105|5648220|P3|EXTENSION PERIOD|New therapy for study indication|0
1618158|NCT02016105|5648221|P2|EXTENSION PERIOD|New therapy for study indication|0
1618159|NCT02016105|5648222|P1|EXTENSION PERIOD|New therapy for study indication|0
1618160|NCT02016105|5648217|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
1618161|NCT02016105|5648218|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
1618162|NCT02016105|5648219|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
1618163|NCT02016105|5648220|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
1618164|NCT02016105|5648221|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
1618165|NCT02016105|5648222|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
1618166|NCT02016105|5648217|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
1618167|NCT02016105|5648218|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
1618168|NCT02016105|5648219|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
1618169|NCT02016105|5648220|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
1618170|NCT02016105|5648221|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
1618171|NCT02016105|5648222|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
1618172|NCT02016105|5648217|P6|TREATMENT PERIOD 2|Adverse Event|1
1618173|NCT02016105|5648218|P5|TREATMENT PERIOD 2|Adverse Event|0
1618174|NCT02016105|5648219|P4|TREATMENT PERIOD 2|Adverse Event|4
1618175|NCT02016105|5648220|P3|TREATMENT PERIOD 2|Adverse Event|0
1618176|NCT02016105|5648221|P2|TREATMENT PERIOD 2|Adverse Event|0
1618177|NCT02016105|5648222|P1|TREATMENT PERIOD 2|Adverse Event|0
1618178|NCT02016105|5648217|P6|TREATMENT PERIOD 2|Death|1
1618179|NCT02016105|5648218|P5|TREATMENT PERIOD 2|Death|0
1618180|NCT02016105|5648219|P4|TREATMENT PERIOD 2|Death|0
1618181|NCT02016105|5648220|P3|TREATMENT PERIOD 2|Death|0
1618182|NCT02016105|5648221|P2|TREATMENT PERIOD 2|Death|0
1618183|NCT02016105|5648222|P1|TREATMENT PERIOD 2|Death|0
1618184|NCT02016105|5648217|P6|TREATMENT PERIOD 2|Pregnancy|1
1618185|NCT02016105|5648218|P5|TREATMENT PERIOD 2|Pregnancy|0
1618186|NCT02016105|5648219|P4|TREATMENT PERIOD 2|Pregnancy|0
1618187|NCT02016105|5648220|P3|TREATMENT PERIOD 2|Pregnancy|0
1618188|NCT02016105|5648221|P2|TREATMENT PERIOD 2|Pregnancy|0
1618189|NCT02016105|5648222|P1|TREATMENT PERIOD 2|Pregnancy|0
1618190|NCT02016105|5648217|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
1618191|NCT02016105|5648218|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
1618192|NCT02016105|5648219|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
1618193|NCT02016105|5648220|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
1618194|NCT02016105|5648221|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
1618195|NCT02016105|5648222|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
1618196|NCT02016105|5648217|P6|TREATMENT PERIOD 2|Non compliance study medication|1
1618197|NCT02016105|5648218|P5|TREATMENT PERIOD 2|Non compliance study medication|0
1618198|NCT02016105|5648219|P4|TREATMENT PERIOD 2|Non compliance study medication|0
1618199|NCT02016105|5648220|P3|TREATMENT PERIOD 2|Non compliance study medication|0
1618200|NCT02016105|5648221|P2|TREATMENT PERIOD 2|Non compliance study medication|0
1618201|NCT02016105|5648222|P1|TREATMENT PERIOD 2|Non compliance study medication|0
1618202|NCT02016105|5648217|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
1618203|NCT02016105|5648218|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
1618204|NCT02016105|5648219|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
1618205|NCT02016105|5648220|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
1618206|NCT02016105|5648221|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
1618207|NCT02016105|5648222|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
1618208|NCT02016105|5648217|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
1618209|NCT02016105|5648218|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
1618210|NCT02016105|5648219|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
1618211|NCT02016105|5648220|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
1618212|NCT02016105|5648221|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
1618213|NCT02016105|5648222|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
1618214|NCT02016105|5648217|P6|TREATMENT PERIOD 1|Adverse Event|0
1618215|NCT02016105|5648218|P5|TREATMENT PERIOD 1|Adverse Event|0
1618216|NCT02016105|5648219|P4|TREATMENT PERIOD 1|Adverse Event|0
1618217|NCT02016105|5648220|P3|TREATMENT PERIOD 1|Adverse Event|0
1618218|NCT02016105|5648221|P2|TREATMENT PERIOD 1|Adverse Event|5
1618219|NCT02016105|5648222|P1|TREATMENT PERIOD 1|Adverse Event|3
1618220|NCT02016105|5648217|P6|TREATMENT PERIOD 1|Pregnancy|0
1618221|NCT02016105|5648218|P5|TREATMENT PERIOD 1|Pregnancy|0
1618222|NCT02016105|5648219|P4|TREATMENT PERIOD 1|Pregnancy|0
1618223|NCT02016105|5648220|P3|TREATMENT PERIOD 1|Pregnancy|0
1618224|NCT02016105|5648221|P2|TREATMENT PERIOD 1|Pregnancy|1
1618225|NCT02016105|5648222|P1|TREATMENT PERIOD 1|Pregnancy|0
1618226|NCT02016105|5648217|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
1618227|NCT02016105|5648218|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
1618228|NCT02016105|5648219|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
1618229|NCT02016105|5648220|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
1618230|NCT02016105|5648221|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
1618231|NCT02016105|5648222|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
1618232|NCT02016105|5648217|P6|TREATMENT PERIOD 1|Physician Decision|0
1618233|NCT02016105|5648218|P5|TREATMENT PERIOD 1|Physician Decision|0
1618234|NCT02016105|5648219|P4|TREATMENT PERIOD 1|Physician Decision|0
1618235|NCT02016105|5648220|P3|TREATMENT PERIOD 1|Physician Decision|0
1618236|NCT02016105|5648221|P2|TREATMENT PERIOD 1|Physician Decision|2
1618237|NCT02016105|5648222|P1|TREATMENT PERIOD 1|Physician Decision|0
1618238|NCT02016105|5648217|P6|TREATMENT PERIOD 1|Protocol Violation|0
1618239|NCT02016105|5648218|P5|TREATMENT PERIOD 1|Protocol Violation|0
1618240|NCT02016105|5648219|P4|TREATMENT PERIOD 1|Protocol Violation|0
1618241|NCT02016105|5648220|P3|TREATMENT PERIOD 1|Protocol Violation|0
1618242|NCT02016105|5648221|P2|TREATMENT PERIOD 1|Protocol Violation|8
1618243|NCT02016105|5648222|P1|TREATMENT PERIOD 1|Protocol Violation|2
1618244|NCT02015793|5648281|P2|Overall Study|Withdrawal by Subject|1
1618245|NCT02015793|5648282|P1|Overall Study|Withdrawal by Subject|1
1618246|NCT02015793|5648281|P2|Overall Study|Adverse Event|3
1618247|NCT02015793|5648282|P1|Overall Study|Adverse Event|3
1618248|NCT02015754|5648312|P1|Overall Study|Lost to Follow-up|1
1618249|NCT02015754|5648312|P1|Overall Study|Change in treatment modality|5
1618250|NCT02015754|5648312|P1|Overall Study|Disease progression|5
1618251|NCT02015676|5648332|P3|Overall Study|Disease progression|1
1618252|NCT02015676|5648333|P2|Overall Study|Disease progression|1
1618253|NCT02015676|5648334|P1|Overall Study|Disease progression|3
1618254|NCT02015676|5648332|P3|Overall Study|Death|0
1618255|NCT02015676|5648333|P2|Overall Study|Death|1
1618256|NCT02015676|5648334|P1|Overall Study|Death|0
1618257|NCT02015676|5648332|P3|Overall Study|Administrative reasons|1
1618258|NCT02015676|5648333|P2|Overall Study|Administrative reasons|3
1618259|NCT02015676|5648334|P1|Overall Study|Administrative reasons|0
1618260|NCT02015676|5648332|P3|Overall Study|Withdrawal by Subject|1
1618261|NCT02015676|5648333|P2|Overall Study|Withdrawal by Subject|7
1618262|NCT02015676|5648334|P1|Overall Study|Withdrawal by Subject|1
1618263|NCT02015676|5648332|P3|Overall Study|Protocol Violation|0
1618264|NCT02015676|5648333|P2|Overall Study|Protocol Violation|0
1618265|NCT02015676|5648334|P1|Overall Study|Protocol Violation|1
1618266|NCT02015676|5648332|P3|Overall Study|Lack of Efficacy|0
1618267|NCT02015676|5648333|P2|Overall Study|Lack of Efficacy|4
1618268|NCT02015676|5648334|P1|Overall Study|Lack of Efficacy|2
1618269|NCT02015676|5648332|P3|Overall Study|Adverse Event|0
1618270|NCT02015676|5648333|P2|Overall Study|Adverse Event|18
1618271|NCT02015676|5648334|P1|Overall Study|Adverse Event|2
1618272|NCT02015663|5648350|P2|Overall Study|Administrative problems|11
1618273|NCT02015663|5648351|P1|Overall Study|Administrative problems|10
1618274|NCT02015663|5648350|P2|Overall Study|Adverse Event|0
1618275|NCT02015663|5648351|P1|Overall Study|Adverse Event|3
1618276|NCT02015663|5648350|P2|Overall Study|Protocol Violation|1
1618277|NCT02015663|5648351|P1|Overall Study|Protocol Violation|0
1618278|NCT02015663|5648350|P2|Overall Study|Withdrawal by Subject|0
1618279|NCT02015663|5648351|P1|Overall Study|Withdrawal by Subject|1
1618280|NCT02015663|5648350|P2|Overall Study|unsatisfactory therapeutic effect|0
1618281|NCT02015663|5648351|P1|Overall Study|unsatisfactory therapeutic effect|1
1618282|NCT02015637|5648382|P2|Overall Study|Did not take study drug|0
1618283|NCT02015637|5648383|P1|Overall Study|Did not take study drug|2
1618284|NCT02015637|5648382|P2|Overall Study|Adverse Event|0
1618285|NCT02015637|5648383|P1|Overall Study|Adverse Event|3
1618286|NCT02015637|5648382|P2|Overall Study|Lost to Follow-up|5
1618287|NCT02015637|5648383|P1|Overall Study|Lost to Follow-up|3
1618288|NCT02015546|5648394|P3|Overall Study|Screem Failure|3
1618289|NCT02015546|5648395|P2|Overall Study|Screem Failure|1
1618290|NCT02015546|5648396|P1|Overall Study|Screem Failure|2
1618291|NCT02015546|5648394|P3|Overall Study|Withdrawal by Subject|1
1618292|NCT02015546|5648395|P2|Overall Study|Withdrawal by Subject|1
1618293|NCT02015546|5648396|P1|Overall Study|Withdrawal by Subject|1
1618294|NCT02015481|5648428|P1|Overall Study|Death|1
1618295|NCT02015221|5648461|P2|Overall Study|Lost to Follow-up|0
1618296|NCT02015221|5648462|P1|Overall Study|Lost to Follow-up|1
1618297|NCT02015221|5648461|P2|Overall Study|Withdrawal by Subject|6
1618298|NCT02015221|5648462|P1|Overall Study|Withdrawal by Subject|8
1618299|NCT02015195|5648475|P7|Overall Study|Adverse Event|0
1618300|NCT02015195|5648476|P6|Overall Study|Adverse Event|0
1618301|NCT02015195|5648477|P5|Overall Study|Adverse Event|0
1618302|NCT02015195|5648478|P4|Overall Study|Adverse Event|1
1618303|NCT02015195|5648479|P3|Overall Study|Adverse Event|0
1618304|NCT02015195|5648480|P2|Overall Study|Adverse Event|0
1618305|NCT02015195|5648481|P1|Overall Study|Adverse Event|0
1618306|NCT02015104|5648504|P2|Overall Study|Withdrew consent prior to treatment|1
1618307|NCT02015104|5648505|P1|Overall Study|Withdrew consent prior to treatment|0
1618308|NCT02015104|5648504|P2|Overall Study|Withdrew consent after first dose drug|0
1618309|NCT02015104|5648505|P1|Overall Study|Withdrew consent after first dose drug|1
1618310|NCT02015065|5648522|P3|Overall Study|Death on study|1
1618311|NCT02015065|5648523|P2|Overall Study|Death on study|2
1618312|NCT02015065|5648524|P1|Overall Study|Death on study|1
1618313|NCT02015039|5648543|P2|Overall Study|Not eligible|1
1618314|NCT02015039|5648544|P1|Overall Study|Not eligible|0
1618315|NCT02014740|5648564|P2|Overall Study|Withdrawal by Subject|1
1618316|NCT02014740|5648565|P1|Overall Study|Withdrawal by Subject|2
1618317|NCT02014740|5648564|P2|Overall Study|Lost to Follow-up|4
1618318|NCT02014740|5648565|P1|Overall Study|Lost to Follow-up|4
1618319|NCT02014584|5648573|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1618320|NCT02014584|5648574|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
1618321|NCT02014584|5648575|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1618322|NCT02014584|5648576|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1618323|NCT02014584|5648577|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1618324|NCT02014584|5648578|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
1618325|NCT02014584|5648573|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1618326|NCT02014584|5648574|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1618327|NCT02014584|5648575|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
1618328|NCT02014584|5648576|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
1618329|NCT02014584|5648577|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1618330|NCT02014584|5648578|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
1618331|NCT02014584|5648573|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1618332|NCT02014584|5648574|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1618333|NCT02014584|5648575|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1618334|NCT02014584|5648576|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
1618335|NCT02014584|5648577|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1618336|NCT02014584|5648578|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
1618337|NCT02014584|5648573|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1618338|NCT02014584|5648574|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1618339|NCT02014584|5648575|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1618340|NCT02014584|5648576|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
1618341|NCT02014584|5648577|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
1618342|NCT02014584|5648578|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
1618343|NCT02014584|5648573|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
1618344|NCT02014584|5648574|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
1618345|NCT02014584|5648575|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
1618346|NCT02014584|5648576|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
1618347|NCT02014584|5648577|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
1618348|NCT02014584|5648578|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
1618349|NCT02014558|5648708|P13|Overall Study|Miscellaneous|1
1618350|NCT02014558|5648709|P12|Overall Study|Miscellaneous|11
1618351|NCT02014558|5648710|P11|Overall Study|Miscellaneous|12
1618352|NCT02014558|5648711|P10|Overall Study|Miscellaneous|3
1618353|NCT02014558|5648712|P9|Overall Study|Miscellaneous|1
1618354|NCT02014558|5648713|P8|Overall Study|Miscellaneous|1
1618355|NCT02014558|5648714|P7|Overall Study|Miscellaneous|0
1618356|NCT02014558|5648715|P6|Overall Study|Miscellaneous|1
1618357|NCT02014558|5648716|P5|Overall Study|Miscellaneous|0
1618358|NCT02014558|5648717|P4|Overall Study|Miscellaneous|1
1618359|NCT02014558|5648718|P3|Overall Study|Miscellaneous|1
1618360|NCT02014558|5648719|P2|Overall Study|Miscellaneous|1
1618361|NCT02014558|5648720|P1|Overall Study|Miscellaneous|2
1618362|NCT02014558|5648708|P13|Overall Study|Withdrawal by Subject|0
1618363|NCT02014558|5648709|P12|Overall Study|Withdrawal by Subject|10
1618364|NCT02014558|5648710|P11|Overall Study|Withdrawal by Subject|6
1618365|NCT02014558|5648711|P10|Overall Study|Withdrawal by Subject|2
1618366|NCT02014558|5648712|P9|Overall Study|Withdrawal by Subject|0
1618367|NCT02014558|5648713|P8|Overall Study|Withdrawal by Subject|0
1618368|NCT02014558|5648714|P7|Overall Study|Withdrawal by Subject|0
1618369|NCT02014558|5648715|P6|Overall Study|Withdrawal by Subject|0
1618370|NCT02014558|5648716|P5|Overall Study|Withdrawal by Subject|1
1618371|NCT02014558|5648717|P4|Overall Study|Withdrawal by Subject|0
1618372|NCT02014558|5648718|P3|Overall Study|Withdrawal by Subject|0
1618373|NCT02014558|5648719|P2|Overall Study|Withdrawal by Subject|0
1618374|NCT02014558|5648720|P1|Overall Study|Withdrawal by Subject|0
1618375|NCT02014558|5648708|P13|Overall Study|Progressive Disease|6
1618376|NCT02014558|5648709|P12|Overall Study|Progressive Disease|31
1618377|NCT02014558|5648710|P11|Overall Study|Progressive Disease|22
1618378|NCT02014558|5648711|P10|Overall Study|Progressive Disease|6
1618379|NCT02014558|5648712|P9|Overall Study|Progressive Disease|5
1618380|NCT02014558|5648713|P8|Overall Study|Progressive Disease|6
1618381|NCT02014558|5648714|P7|Overall Study|Progressive Disease|1
1618382|NCT02014558|5648715|P6|Overall Study|Progressive Disease|2
1618383|NCT02014558|5648716|P5|Overall Study|Progressive Disease|1
1618384|NCT02014558|5648717|P4|Overall Study|Progressive Disease|1
1618385|NCT02014558|5648718|P3|Overall Study|Progressive Disease|1
1618386|NCT02014558|5648719|P2|Overall Study|Progressive Disease|0
1618387|NCT02014558|5648720|P1|Overall Study|Progressive Disease|1
1618388|NCT02014558|5648708|P13|Overall Study|Lost to Follow-up|0
1618389|NCT02014558|5648709|P12|Overall Study|Lost to Follow-up|0
1618390|NCT02014558|5648710|P11|Overall Study|Lost to Follow-up|1
1618391|NCT02014558|5648711|P10|Overall Study|Lost to Follow-up|0
1618392|NCT02014558|5648712|P9|Overall Study|Lost to Follow-up|0
1618393|NCT02014558|5648713|P8|Overall Study|Lost to Follow-up|0
1618394|NCT02014558|5648714|P7|Overall Study|Lost to Follow-up|0
1618395|NCT02014558|5648715|P6|Overall Study|Lost to Follow-up|0
1618396|NCT02014558|5648716|P5|Overall Study|Lost to Follow-up|0
1618397|NCT02014558|5648717|P4|Overall Study|Lost to Follow-up|0
1618398|NCT02014558|5648718|P3|Overall Study|Lost to Follow-up|0
1618399|NCT02014558|5648719|P2|Overall Study|Lost to Follow-up|0
1618400|NCT02014558|5648720|P1|Overall Study|Lost to Follow-up|0
1618401|NCT02014558|5648708|P13|Overall Study|Lack of Efficacy|5
1618402|NCT02014558|5648709|P12|Overall Study|Lack of Efficacy|8
1618403|NCT02014558|5648710|P11|Overall Study|Lack of Efficacy|16
1618404|NCT02014558|5648711|P10|Overall Study|Lack of Efficacy|3
1618405|NCT02014558|5648712|P9|Overall Study|Lack of Efficacy|3
1618406|NCT02014558|5648713|P8|Overall Study|Lack of Efficacy|3
1618407|NCT02014558|5648714|P7|Overall Study|Lack of Efficacy|1
1618408|NCT02014558|5648715|P6|Overall Study|Lack of Efficacy|0
1618409|NCT02014558|5648716|P5|Overall Study|Lack of Efficacy|0
1618410|NCT02014558|5648717|P4|Overall Study|Lack of Efficacy|1
1618411|NCT02014558|5648718|P3|Overall Study|Lack of Efficacy|1
1618412|NCT02014558|5648719|P2|Overall Study|Lack of Efficacy|2
1618413|NCT02014558|5648720|P1|Overall Study|Lack of Efficacy|1
1618414|NCT02014558|5648708|P13|Overall Study|Death|2
1618415|NCT02014558|5648709|P12|Overall Study|Death|19
1618416|NCT02014558|5648710|P11|Overall Study|Death|5
1618417|NCT02014558|5648711|P10|Overall Study|Death|5
1618418|NCT02014558|5648712|P9|Overall Study|Death|2
1618419|NCT02014558|5648713|P8|Overall Study|Death|1
1618420|NCT02014558|5648714|P7|Overall Study|Death|1
1618421|NCT02014558|5648715|P6|Overall Study|Death|0
1618422|NCT02014558|5648716|P5|Overall Study|Death|0
1618423|NCT02014558|5648717|P4|Overall Study|Death|0
1618424|NCT02014558|5648718|P3|Overall Study|Death|0
1618425|NCT02014558|5648719|P2|Overall Study|Death|0
1618426|NCT02014558|5648720|P1|Overall Study|Death|1
1618427|NCT02014558|5648708|P13|Overall Study|Adverse Event|3
1618428|NCT02014558|5648709|P12|Overall Study|Adverse Event|21
1618429|NCT02014558|5648710|P11|Overall Study|Adverse Event|5
1618430|NCT02014558|5648711|P10|Overall Study|Adverse Event|2
1618431|NCT02014558|5648712|P9|Overall Study|Adverse Event|2
1618432|NCT02014558|5648713|P8|Overall Study|Adverse Event|0
1618433|NCT02014558|5648714|P7|Overall Study|Adverse Event|0
1618434|NCT02014558|5648715|P6|Overall Study|Adverse Event|0
1618435|NCT02014558|5648716|P5|Overall Study|Adverse Event|1
1618436|NCT02014558|5648717|P4|Overall Study|Adverse Event|0
1618437|NCT02014558|5648718|P3|Overall Study|Adverse Event|0
1618438|NCT02014558|5648719|P2|Overall Study|Adverse Event|0
1618439|NCT02014558|5648720|P1|Overall Study|Adverse Event|0
1618440|NCT02014558|5648708|P13|Overall Study|Never Received Study Drug|0
1618441|NCT02014558|5648709|P12|Overall Study|Never Received Study Drug|2
1618442|NCT02014558|5648710|P11|Overall Study|Never Received Study Drug|2
1618443|NCT02014558|5648711|P10|Overall Study|Never Received Study Drug|0
1618444|NCT02014558|5648712|P9|Overall Study|Never Received Study Drug|2
1618445|NCT02014558|5648713|P8|Overall Study|Never Received Study Drug|0
1618446|NCT02014558|5648714|P7|Overall Study|Never Received Study Drug|1
1618447|NCT02014558|5648715|P6|Overall Study|Never Received Study Drug|0
1618448|NCT02014558|5648716|P5|Overall Study|Never Received Study Drug|1
1618449|NCT02014558|5648717|P4|Overall Study|Never Received Study Drug|0
1618450|NCT02014558|5648718|P3|Overall Study|Never Received Study Drug|0
1618451|NCT02014558|5648719|P2|Overall Study|Never Received Study Drug|0
1618452|NCT02014558|5648720|P1|Overall Study|Never Received Study Drug|0
1618453|NCT02014480|5649085|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
1618454|NCT02014480|5649086|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1618455|NCT02014480|5649087|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1618456|NCT02014480|5649088|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1618457|NCT02014480|5649089|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1618458|NCT02014480|5649090|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1618459|NCT02014480|5649085|P6|Treatment Period 3 (14 Days)|Adverse Event|1
1618460|NCT02014480|5649086|P5|Treatment Period 3 (14 Days)|Adverse Event|0
1618461|NCT02014480|5649087|P4|Treatment Period 3 (14 Days)|Adverse Event|0
1618462|NCT02014480|5649088|P3|Treatment Period 3 (14 Days)|Adverse Event|1
1618463|NCT02014480|5649089|P2|Treatment Period 3 (14 Days)|Adverse Event|0
1618464|NCT02014480|5649090|P1|Treatment Period 3 (14 Days)|Adverse Event|0
1618465|NCT02014480|5649085|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1618466|NCT02014480|5649086|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1618467|NCT02014480|5649087|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1618468|NCT02014480|5649088|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1618469|NCT02014480|5649089|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1618470|NCT02014480|5649090|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1618471|NCT02014480|5649085|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
1618472|NCT02014480|5649086|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
1618473|NCT02014480|5649087|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
1618474|NCT02014480|5649088|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
1618475|NCT02014480|5649089|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
1618476|NCT02014480|5649090|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
1618477|NCT02014480|5649085|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1618478|NCT02014480|5649086|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1618479|NCT02014480|5649087|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1618480|NCT02014480|5649088|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1618481|NCT02014480|5649089|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1618482|NCT02014480|5649090|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1618483|NCT02014480|5649085|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1618484|NCT02014480|5649086|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1618485|NCT02014480|5649087|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1618486|NCT02014480|5649088|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1618487|NCT02014480|5649089|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1618488|NCT02014480|5649090|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1618489|NCT02014480|5649085|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1618490|NCT02014480|5649086|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1618491|NCT02014480|5649087|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1618492|NCT02014480|5649088|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
1618493|NCT02014480|5649089|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1618494|NCT02014480|5649090|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
1618495|NCT02014467|5649109|P2|Overall Study|Withdrawal by Subject|4
1618496|NCT02014467|5649110|P1|Overall Study|Withdrawal by Subject|16
1618497|NCT02014467|5649109|P2|Overall Study|Physician Decision|3
1618498|NCT02014467|5649110|P1|Overall Study|Physician Decision|2
1618499|NCT02014467|5649109|P2|Overall Study|Protocol Violation|0
1618500|NCT02014467|5649110|P1|Overall Study|Protocol Violation|3
1618501|NCT02014467|5649109|P2|Overall Study|Adverse Event|0
1618502|NCT02014467|5649110|P1|Overall Study|Adverse Event|4
1618503|NCT02014441|5649170|P1|Overall Study|Withdrawal by Subject|12
1618504|NCT02014402|5649266|P4|Overall Study|Lost to Follow-up|2
1618505|NCT02014402|5649267|P3|Overall Study|Lost to Follow-up|1
1618506|NCT02014402|5649268|P2|Overall Study|Lost to Follow-up|0
1618507|NCT02014402|5649269|P1|Overall Study|Lost to Follow-up|0
1618508|NCT02014402|5649266|P4|Overall Study|Subject did not have transportation|0
1618509|NCT02014402|5649267|P3|Overall Study|Subject did not have transportation|0
1618510|NCT02014402|5649268|P2|Overall Study|Subject did not have transportation|1
1618511|NCT02014402|5649269|P1|Overall Study|Subject did not have transportation|0
1618512|NCT02014402|5649266|P4|Overall Study|Withdrawal by Subject|1
1618513|NCT02014402|5649267|P3|Overall Study|Withdrawal by Subject|2
1618514|NCT02014402|5649268|P2|Overall Study|Withdrawal by Subject|2
1618515|NCT02014402|5649269|P1|Overall Study|Withdrawal by Subject|1
1618516|NCT02014402|5649266|P4|Overall Study|Adverse Event|0
1618517|NCT02014402|5649267|P3|Overall Study|Adverse Event|0
1618518|NCT02014402|5649268|P2|Overall Study|Adverse Event|0
1618519|NCT02014402|5649269|P1|Overall Study|Adverse Event|1
1618520|NCT02014376|5649299|P3|Overall Study|Lost to Follow-up|0
1618521|NCT02014376|5649300|P2|Overall Study|Lost to Follow-up|0
1618522|NCT02014376|5649301|P1|Overall Study|Lost to Follow-up|2
1618523|NCT02014376|5649299|P3|Overall Study|Adverse Event|0
1618524|NCT02014376|5649300|P2|Overall Study|Adverse Event|1
1618525|NCT02014376|5649301|P1|Overall Study|Adverse Event|1
1618526|NCT02014272|5649337|P2|Intervention Period 1|Adverse Event|1
1618527|NCT02014272|5649338|P1|Intervention Period 1|Adverse Event|0
1618528|NCT02014272|5649337|P2|Intervention Period 1|Withdrawal by Subject|0
1618529|NCT02014272|5649338|P1|Intervention Period 1|Withdrawal by Subject|1
1618530|NCT02014116|5649365|P9|Overall Study|Physician Decision|1
1618531|NCT02014116|5649366|P8|Overall Study|Physician Decision|0
1618532|NCT02014116|5649367|P7|Overall Study|Physician Decision|0
1618533|NCT02014116|5649368|P6|Overall Study|Physician Decision|0
1618534|NCT02014116|5649369|P5|Overall Study|Physician Decision|0
1618535|NCT02014116|5649370|P4|Overall Study|Physician Decision|0
1618536|NCT02014116|5649371|P3|Overall Study|Physician Decision|0
1618537|NCT02014116|5649372|P2|Overall Study|Physician Decision|0
1618538|NCT02014116|5649373|P1|Overall Study|Physician Decision|0
1618539|NCT02014116|5649365|P9|Overall Study|Withdrawal Caregiver Decision|0
1618540|NCT02014116|5649366|P8|Overall Study|Withdrawal Caregiver Decision|0
1618541|NCT02014116|5649367|P7|Overall Study|Withdrawal Caregiver Decision|0
1618542|NCT02014116|5649368|P6|Overall Study|Withdrawal Caregiver Decision|1
1618543|NCT02014116|5649369|P5|Overall Study|Withdrawal Caregiver Decision|0
1618544|NCT02014116|5649370|P4|Overall Study|Withdrawal Caregiver Decision|0
1618545|NCT02014116|5649371|P3|Overall Study|Withdrawal Caregiver Decision|0
1618546|NCT02014116|5649372|P2|Overall Study|Withdrawal Caregiver Decision|0
1618547|NCT02014116|5649373|P1|Overall Study|Withdrawal Caregiver Decision|0
1618548|NCT02014116|5649365|P9|Overall Study|Withdrawal by Subject|0
1618549|NCT02014116|5649366|P8|Overall Study|Withdrawal by Subject|0
1618550|NCT02014116|5649367|P7|Overall Study|Withdrawal by Subject|0
1618551|NCT02014116|5649368|P6|Overall Study|Withdrawal by Subject|1
1618552|NCT02014116|5649369|P5|Overall Study|Withdrawal by Subject|0
1618553|NCT02014116|5649370|P4|Overall Study|Withdrawal by Subject|1
1618554|NCT02014116|5649371|P3|Overall Study|Withdrawal by Subject|1
1618555|NCT02014116|5649372|P2|Overall Study|Withdrawal by Subject|0
1618556|NCT02014116|5649373|P1|Overall Study|Withdrawal by Subject|0
1618557|NCT02014116|5649365|P9|Overall Study|Death|1
1618558|NCT02014116|5649366|P8|Overall Study|Death|1
1618559|NCT02014116|5649367|P7|Overall Study|Death|0
1618560|NCT02014116|5649368|P6|Overall Study|Death|0
1618561|NCT02014116|5649369|P5|Overall Study|Death|0
1618562|NCT02014116|5649370|P4|Overall Study|Death|0
1618563|NCT02014116|5649371|P3|Overall Study|Death|0
1618564|NCT02014116|5649372|P2|Overall Study|Death|0
1618565|NCT02014116|5649373|P1|Overall Study|Death|0
1618566|NCT02014116|5649365|P9|Overall Study|Lost to Follow-up|1
1618567|NCT02014116|5649366|P8|Overall Study|Lost to Follow-up|0
1618568|NCT02014116|5649367|P7|Overall Study|Lost to Follow-up|0
1618569|NCT02014116|5649368|P6|Overall Study|Lost to Follow-up|1
1618570|NCT02014116|5649369|P5|Overall Study|Lost to Follow-up|0
1618571|NCT02014116|5649370|P4|Overall Study|Lost to Follow-up|0
1618572|NCT02014116|5649371|P3|Overall Study|Lost to Follow-up|0
1618573|NCT02014116|5649372|P2|Overall Study|Lost to Follow-up|0
1618574|NCT02014116|5649373|P1|Overall Study|Lost to Follow-up|0
1618575|NCT02014116|5649365|P9|Overall Study|Adverse Event|0
1618576|NCT02014116|5649366|P8|Overall Study|Adverse Event|1
1618577|NCT02014116|5649367|P7|Overall Study|Adverse Event|0
1618578|NCT02014116|5649368|P6|Overall Study|Adverse Event|0
1618579|NCT02014116|5649369|P5|Overall Study|Adverse Event|1
1618580|NCT02014116|5649370|P4|Overall Study|Adverse Event|0
1618581|NCT02014116|5649371|P3|Overall Study|Adverse Event|0
1618582|NCT02014116|5649372|P2|Overall Study|Adverse Event|0
1618583|NCT02014116|5649373|P1|Overall Study|Adverse Event|0
1618584|NCT02014116|5649365|P9|Overall Study|Progressive Disease|7
1618585|NCT02014116|5649366|P8|Overall Study|Progressive Disease|3
1618586|NCT02014116|5649367|P7|Overall Study|Progressive Disease|1
1618587|NCT02014116|5649368|P6|Overall Study|Progressive Disease|13
1618588|NCT02014116|5649369|P5|Overall Study|Progressive Disease|1
1618589|NCT02014116|5649370|P4|Overall Study|Progressive Disease|6
1618590|NCT02014116|5649371|P3|Overall Study|Progressive Disease|2
1618591|NCT02014116|5649372|P2|Overall Study|Progressive Disease|4
1618592|NCT02014116|5649373|P1|Overall Study|Progressive Disease|3
1618593|NCT02013830|5649438|P1|Overall Study|Refused treatment|1
1618594|NCT02013830|5649438|P1|Overall Study|Insufficient therapeutic response|25
1618595|NCT02013830|5649438|P1|Overall Study|Death|1
1618596|NCT02013830|5649438|P1|Overall Study|Adverse Event|3
1618597|NCT02013817|5649449|P1|Overall Study|Other|9
1618598|NCT02013817|5649449|P1|Overall Study|Death|2
1618599|NCT02013817|5649449|P1|Overall Study|Withdrawal by Subject|4
1618600|NCT02013817|5649449|P1|Overall Study|Adverse Event|12
1618601|NCT02013791|5649467|P9|Period 1|Other Miscellaneous Reasons|0
1618602|NCT02013791|5649468|P8|Period 1|Other Miscellaneous Reasons|0
1618603|NCT02013791|5649469|P7|Period 1|Other Miscellaneous Reasons|0
1618604|NCT02013791|5649470|P6|Period 1|Other Miscellaneous Reasons|0
1618605|NCT02013791|5649471|P5|Period 1|Other Miscellaneous Reasons|0
1618606|NCT02013791|5649472|P4|Period 1|Other Miscellaneous Reasons|0
1618607|NCT02013791|5649473|P3|Period 1|Other Miscellaneous Reasons|0
1618608|NCT02013791|5649474|P2|Period 1|Other Miscellaneous Reasons|2
1618609|NCT02013791|5649475|P1|Period 1|Other Miscellaneous Reasons|0
1618610|NCT02013791|5649467|P9|Period 1|Lost to Follow-up|0
1618611|NCT02013791|5649468|P8|Period 1|Lost to Follow-up|1
1618612|NCT02013791|5649469|P7|Period 1|Lost to Follow-up|1
1618613|NCT02013791|5649470|P6|Period 1|Lost to Follow-up|0
1618614|NCT02013791|5649471|P5|Period 1|Lost to Follow-up|0
1618615|NCT02013791|5649472|P4|Period 1|Lost to Follow-up|1
1618616|NCT02013791|5649473|P3|Period 1|Lost to Follow-up|0
1618617|NCT02013791|5649474|P2|Period 1|Lost to Follow-up|0
1618618|NCT02013791|5649475|P1|Period 1|Lost to Follow-up|0
1618619|NCT02013765|5649496|P1|Overall Study|Trial was terminated by sponsor|1
1618620|NCT02013687|5649510|P4|Overall Study|Missed visits due to patient travel|0
1618621|NCT02013687|5649511|P3|Overall Study|Missed visits due to patient travel|1
1618622|NCT02013687|5649512|P2|Overall Study|Missed visits due to patient travel|0
1618623|NCT02013687|5649513|P1|Overall Study|Missed visits due to patient travel|0
1618624|NCT02013687|5649510|P4|Overall Study|Withdrawal by Subject|1
1618625|NCT02013687|5649511|P3|Overall Study|Withdrawal by Subject|0
1618626|NCT02013687|5649512|P2|Overall Study|Withdrawal by Subject|0
1618627|NCT02013687|5649513|P1|Overall Study|Withdrawal by Subject|0
1618628|NCT02013687|5649510|P4|Overall Study|Protocol Violation|1
1618629|NCT02013687|5649511|P3|Overall Study|Protocol Violation|0
1618630|NCT02013687|5649512|P2|Overall Study|Protocol Violation|0
1618631|NCT02013687|5649513|P1|Overall Study|Protocol Violation|0
1618632|NCT02013687|5649510|P4|Overall Study|Lost to Follow-up|0
1618633|NCT02013687|5649511|P3|Overall Study|Lost to Follow-up|1
1618634|NCT02013687|5649512|P2|Overall Study|Lost to Follow-up|0
1618635|NCT02013687|5649513|P1|Overall Study|Lost to Follow-up|0
1618636|NCT02013674|5649545|P2|Overall Study|Lost to Follow-up|0
1618637|NCT02013674|5649546|P1|Overall Study|Lost to Follow-up|1
1618638|NCT02013674|5649545|P2|Overall Study|Death|1
1618639|NCT02013674|5649546|P1|Overall Study|Death|0
1618640|NCT02013622|5649596|P1|Overall Study|Lack of Efficacy|1
1618641|NCT02013622|5649596|P1|Overall Study|Protocol Deviation|1
1618642|NCT02013622|5649596|P1|Overall Study|Withdrawal by Subject|6
1618643|NCT02013622|5649596|P1|Overall Study|Met Withdrawal Criteria|3
1618644|NCT02013622|5649596|P1|Overall Study|Adverse Event|3
1618645|NCT02013622|5649596|P1|Overall Study|Lost to Follow-up|10
1618646|NCT02013609|5649616|P1|Overall Study|Met Withdrawal Criteria|3
1618647|NCT02013609|5649616|P1|Overall Study|Adverse Event|3
1618648|NCT02013609|5649616|P1|Overall Study|Lost to Follow-up|3
1618649|NCT02013609|5649616|P1|Overall Study|Withdrawal by Subject|9
1618650|NCT02013544|5649641|P2|Overall Study|Entry criteria not met/non-compliance|3
1618651|NCT02013544|5649642|P1|Overall Study|Entry criteria not met/non-compliance|2
1618652|NCT02013544|5649641|P2|Overall Study|Physician Decision|1
1618653|NCT02013544|5649642|P1|Overall Study|Physician Decision|0
1618654|NCT02013544|5649641|P2|Overall Study|Withdrawal by Subject|8
1618655|NCT02013544|5649642|P1|Overall Study|Withdrawal by Subject|2
1618656|NCT02013544|5649641|P2|Overall Study|Lost to Follow-up|3
1618657|NCT02013544|5649642|P1|Overall Study|Lost to Follow-up|2
1618658|NCT02013544|5649641|P2|Overall Study|Adverse Event|5
1618659|NCT02013544|5649642|P1|Overall Study|Adverse Event|5
1618660|NCT02013531|5649664|P1|Overall Study|Withdrawal by Subject|1
1618661|NCT02013531|5649664|P1|Overall Study|Met Withdrawal Criteria|1
1618662|NCT02013531|5649664|P1|Overall Study|Lost to Follow-up|3
1618663|NCT02013388|5649700|P8|Overall Study|work emergency|0
1618664|NCT02013388|5649701|P7|Overall Study|work emergency|0
1618665|NCT02013388|5649702|P6|Overall Study|work emergency|0
1618666|NCT02013388|5649703|P5|Overall Study|work emergency|1
1618667|NCT02013388|5649704|P4|Overall Study|work emergency|0
1618668|NCT02013388|5649705|P3|Overall Study|work emergency|0
1618669|NCT02013388|5649706|P2|Overall Study|work emergency|0
1618670|NCT02013388|5649707|P1|Overall Study|work emergency|1
1618671|NCT02013375|5649741|P1|Overall Study|Did not engraft|1
1618672|NCT02013375|5649741|P1|Overall Study|Did not engraft|1
1618673|NCT02013206|5649771|P2|Overall Study|Other reasons off treatment|2
1618674|NCT02013206|5649772|P1|Overall Study|Other reasons off treatment|5
1618675|NCT02013206|5649771|P2|Overall Study|Death|2
1618676|NCT02013206|5649772|P1|Overall Study|Death|1
1618677|NCT02013206|5649771|P2|Overall Study|Patient non-compliance|0
1618678|NCT02013206|5649772|P1|Overall Study|Patient non-compliance|1
1618679|NCT02013206|5649771|P2|Overall Study|Patient refusal|0
1618680|NCT02013206|5649772|P1|Overall Study|Patient refusal|2
1618681|NCT02013206|5649771|P2|Overall Study|Adverse Event|0
1618682|NCT02013206|5649772|P1|Overall Study|Adverse Event|1
1618683|NCT02013206|5649771|P2|Overall Study|Symptomatic deterioration|1
1618684|NCT02013206|5649772|P1|Overall Study|Symptomatic deterioration|3
1618685|NCT02013206|5649771|P2|Overall Study|Progressive disease (PD)|17
1618686|NCT02013206|5649772|P1|Overall Study|Progressive disease (PD)|14
1618687|NCT02013167|5649803|P2|Overall Study|Death|160
1618688|NCT02013167|5649804|P1|Overall Study|Death|85
1618689|NCT02013167|5649803|P2|Overall Study|Lost to Follow-up|1
1618690|NCT02013167|5649804|P1|Overall Study|Lost to Follow-up|0
1618691|NCT02013167|5649803|P2|Overall Study|Sponsor Decision|3
1618692|NCT02013167|5649804|P1|Overall Study|Sponsor Decision|1
1618693|NCT02013167|5649803|P2|Overall Study|Withdrawal by Subject|14
1618694|NCT02013167|5649804|P1|Overall Study|Withdrawal by Subject|15
1618695|NCT02012959|5649880|P5|Treatment Phase A|Adverse Event|0
1618696|NCT02012959|5649881|P4|Treatment Phase A|Adverse Event|0
1618697|NCT02012959|5649882|P3|Treatment Phase A|Adverse Event|0
1618698|NCT02012959|5649883|P2|Treatment Phase A|Adverse Event|0
1618699|NCT02012959|5649884|P1|Treatment Phase A|Adverse Event|2
1618700|NCT02012686|5649897|P2|Overall Study|electrocardiography monitoring noise|1
1618701|NCT02012686|5649898|P1|Overall Study|electrocardiography monitoring noise|0
1618702|NCT02012686|5649897|P2|Overall Study|muscle contraction|1
1618703|NCT02012686|5649898|P1|Overall Study|muscle contraction|0
1618704|NCT02012491|5649960|P2|Overall Study|Withdrawal by Subject|0
1618705|NCT02012491|5649961|P1|Overall Study|Withdrawal by Subject|1
1618706|NCT02012491|5649960|P2|Overall Study|Protocol Violation|1
1618707|NCT02012491|5649961|P1|Overall Study|Protocol Violation|0
1618708|NCT02012491|5649960|P2|Overall Study|Lost to Follow-up|0
1618709|NCT02012491|5649961|P1|Overall Study|Lost to Follow-up|1
1618710|NCT02012452|5649979|P2|Overall Study|Withdrawal by Subject|0
1618711|NCT02012452|5649980|P1|Overall Study|Withdrawal by Subject|4
1618712|NCT02012452|5649979|P2|Overall Study|Lost to Follow-up|1
1618713|NCT02012452|5649980|P1|Overall Study|Lost to Follow-up|2
1618714|NCT02012218|5650023|P5|Overall Study|Protocol Deviation|0
1618715|NCT02012218|5650024|P4|Overall Study|Protocol Deviation|0
1618716|NCT02012218|5650025|P3|Overall Study|Protocol Deviation|0
1618717|NCT02012218|5650026|P2|Overall Study|Protocol Deviation|0
1618718|NCT02012218|5650027|P1|Overall Study|Protocol Deviation|1
1618719|NCT02012218|5650023|P5|Overall Study|Protocol Specified|0
1618720|NCT02012218|5650024|P4|Overall Study|Protocol Specified|0
1618721|NCT02012218|5650025|P3|Overall Study|Protocol Specified|0
1618722|NCT02012218|5650026|P2|Overall Study|Protocol Specified|0
1618723|NCT02012218|5650027|P1|Overall Study|Protocol Specified|1
1618724|NCT02012218|5650023|P5|Overall Study|Lost to Follow-up|0
1618725|NCT02012218|5650024|P4|Overall Study|Lost to Follow-up|0
1618726|NCT02012218|5650025|P3|Overall Study|Lost to Follow-up|1
1618727|NCT02012218|5650026|P2|Overall Study|Lost to Follow-up|1
1618728|NCT02012218|5650027|P1|Overall Study|Lost to Follow-up|0
1618729|NCT02012218|5650023|P5|Overall Study|Adverse Event|0
1618730|NCT02012218|5650024|P4|Overall Study|Adverse Event|1
1618731|NCT02012218|5650025|P3|Overall Study|Adverse Event|0
1618732|NCT02012218|5650026|P2|Overall Study|Adverse Event|0
1618733|NCT02012218|5650027|P1|Overall Study|Adverse Event|1
1618734|NCT02012218|5650023|P5|Overall Study|Withdrawal by Subject|1
1618735|NCT02012218|5650024|P4|Overall Study|Withdrawal by Subject|1
1618736|NCT02012218|5650025|P3|Overall Study|Withdrawal by Subject|1
1618737|NCT02012218|5650026|P2|Overall Study|Withdrawal by Subject|0
1618738|NCT02012218|5650027|P1|Overall Study|Withdrawal by Subject|1
1618760|NCT02011893|5650130|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
1618761|NCT02011893|5650131|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1618762|NCT02011893|5650132|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
1618763|NCT02011893|5650130|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
1618764|NCT02011893|5650131|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1618765|NCT02011893|5650132|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
1618766|NCT02011893|5650130|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
1618767|NCT02011893|5650131|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1618768|NCT02011893|5650132|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
1618769|NCT02011893|5650130|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
1618770|NCT02011893|5650131|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
1618771|NCT02011893|5650132|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
1618772|NCT02011893|5650130|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1618773|NCT02011893|5650131|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
1618774|NCT02011893|5650132|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
1618775|NCT02011893|5650130|P3|Enrollment to Randomization|Screening Failure|0
1618776|NCT02011893|5650131|P2|Enrollment to Randomization|Screening Failure|0
1618777|NCT02011893|5650132|P1|Enrollment to Randomization|Screening Failure|29
1618778|NCT02011893|5650130|P3|Enrollment to Randomization|Withdrawal by Subject|0
1618779|NCT02011893|5650131|P2|Enrollment to Randomization|Withdrawal by Subject|0
1618780|NCT02011893|5650132|P1|Enrollment to Randomization|Withdrawal by Subject|21
1618781|NCT02011893|5650130|P3|Enrollment to Randomization|Physician Decision|0
1618782|NCT02011893|5650131|P2|Enrollment to Randomization|Physician Decision|0
1618783|NCT02011893|5650132|P1|Enrollment to Randomization|Physician Decision|10
1618784|NCT02011893|5650130|P3|Enrollment to Randomization|Adverse Event|0
1618785|NCT02011893|5650131|P2|Enrollment to Randomization|Adverse Event|0
1618786|NCT02011893|5650132|P1|Enrollment to Randomization|Adverse Event|2
1618787|NCT02011542|5650143|P1|Overall Study|Physician Decision|1
1618788|NCT02011113|5650274|P1|Overall Study|Study terminated by sponsor|11
1618789|NCT02011113|5650274|P1|Overall Study|Investigator's judgement- DP|3
1618790|NCT02011113|5650274|P1|Overall Study|Insufficient effect of Pomalidomide|1
1618791|NCT02011113|5650274|P1|Overall Study|Death|1
1618792|NCT02011113|5650274|P1|Overall Study|Disease Progression (DP)|16
1618793|NCT02011113|5650274|P1|Overall Study|Adverse Event|4
1618794|NCT02010775|5650306|P5|Overall Study|Personal Reasons|4
1618795|NCT02010775|5650307|P4|Overall Study|Personal Reasons|2
1618796|NCT02010775|5650308|P3|Overall Study|Personal Reasons|1
1618797|NCT02010775|5650309|P2|Overall Study|Personal Reasons|3
1618798|NCT02010775|5650310|P1|Overall Study|Personal Reasons|3
1618799|NCT02010775|5650306|P5|Overall Study|Lost to Follow-up|1
1618800|NCT02010775|5650307|P4|Overall Study|Lost to Follow-up|1
1618801|NCT02010775|5650308|P3|Overall Study|Lost to Follow-up|0
1618802|NCT02010775|5650309|P2|Overall Study|Lost to Follow-up|0
1618803|NCT02010775|5650310|P1|Overall Study|Lost to Follow-up|2
1618804|NCT02010775|5650306|P5|Overall Study|Pregnancy|0
1618805|NCT02010775|5650307|P4|Overall Study|Pregnancy|0
1618806|NCT02010775|5650308|P3|Overall Study|Pregnancy|2
1618807|NCT02010775|5650309|P2|Overall Study|Pregnancy|0
1618808|NCT02010775|5650310|P1|Overall Study|Pregnancy|0
1618809|NCT02010775|5650306|P5|Overall Study|Adverse Event|1
1618810|NCT02010775|5650307|P4|Overall Study|Adverse Event|0
1618811|NCT02010775|5650308|P3|Overall Study|Adverse Event|0
1618812|NCT02010775|5650309|P2|Overall Study|Adverse Event|0
1618813|NCT02010775|5650310|P1|Overall Study|Adverse Event|0
1618814|NCT02010684|5650351|P2|Overall Study|Withdrawal by Subject|5
1618815|NCT02010684|5650352|P1|Overall Study|Withdrawal by Subject|4
1618816|NCT02010684|5650351|P2|Overall Study|Lost to Follow-up|18
1618817|NCT02010684|5650352|P1|Overall Study|Lost to Follow-up|8
1618818|NCT02010632|5650374|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
1618819|NCT02010632|5650375|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
1618820|NCT02010567|5650386|P5|Overall Study|Adverse Event|1
1618821|NCT02010567|5650387|P4|Overall Study|Adverse Event|0
1618822|NCT02010567|5650388|P3|Overall Study|Adverse Event|1
1618823|NCT02010567|5650389|P2|Overall Study|Adverse Event|0
1618824|NCT02010567|5650390|P1|Overall Study|Adverse Event|0
1618825|NCT02010255|5650442|P14|Overall Study|Randomized but Not Treated|1
1618826|NCT02010255|5650443|P13|Overall Study|Randomized but Not Treated|0
1618827|NCT02010255|5650444|P12|Overall Study|Randomized but Not Treated|0
1618828|NCT02010255|5650445|P11|Overall Study|Randomized but Not Treated|0
1618829|NCT02010255|5650446|P10|Overall Study|Randomized but Not Treated|0
1618830|NCT02010255|5650447|P9|Overall Study|Randomized but Not Treated|0
1618831|NCT02010255|5650448|P8|Overall Study|Randomized but Not Treated|0
1618832|NCT02010255|5650449|P7|Overall Study|Randomized but Not Treated|0
1618833|NCT02010255|5650450|P6|Overall Study|Randomized but Not Treated|0
1618834|NCT02010255|5650451|P5|Overall Study|Randomized but Not Treated|0
1618835|NCT02010255|5650452|P4|Overall Study|Randomized but Not Treated|0
1618836|NCT02010255|5650453|P3|Overall Study|Randomized but Not Treated|0
1618837|NCT02010255|5650454|P2|Overall Study|Randomized but Not Treated|0
1618838|NCT02010255|5650455|P1|Overall Study|Randomized but Not Treated|0
1618839|NCT02010255|5650442|P14|Overall Study|Lost to Follow-up|0
1618840|NCT02010255|5650443|P13|Overall Study|Lost to Follow-up|0
1618841|NCT02010255|5650444|P12|Overall Study|Lost to Follow-up|0
1618842|NCT02010255|5650445|P11|Overall Study|Lost to Follow-up|0
1618843|NCT02010255|5650446|P10|Overall Study|Lost to Follow-up|0
1618844|NCT02010255|5650447|P9|Overall Study|Lost to Follow-up|0
1618845|NCT02010255|5650448|P8|Overall Study|Lost to Follow-up|0
1618846|NCT02010255|5650449|P7|Overall Study|Lost to Follow-up|0
1618847|NCT02010255|5650450|P6|Overall Study|Lost to Follow-up|0
1618848|NCT02010255|5650451|P5|Overall Study|Lost to Follow-up|1
1618849|NCT02010255|5650452|P4|Overall Study|Lost to Follow-up|0
1618850|NCT02010255|5650453|P3|Overall Study|Lost to Follow-up|1
1618851|NCT02010255|5650454|P2|Overall Study|Lost to Follow-up|0
1618852|NCT02010255|5650455|P1|Overall Study|Lost to Follow-up|0
1618853|NCT02010255|5650442|P14|Overall Study|Adverse Event|0
1618854|NCT02010255|5650443|P13|Overall Study|Adverse Event|0
1618855|NCT02010255|5650444|P12|Overall Study|Adverse Event|0
1618856|NCT02010255|5650445|P11|Overall Study|Adverse Event|0
1618857|NCT02010255|5650446|P10|Overall Study|Adverse Event|0
1618858|NCT02010255|5650447|P9|Overall Study|Adverse Event|0
1618859|NCT02010255|5650448|P8|Overall Study|Adverse Event|0
1618860|NCT02010255|5650449|P7|Overall Study|Adverse Event|0
1618861|NCT02010255|5650450|P6|Overall Study|Adverse Event|0
1618862|NCT02010255|5650451|P5|Overall Study|Adverse Event|0
1618863|NCT02010255|5650452|P4|Overall Study|Adverse Event|0
1618864|NCT02010255|5650453|P3|Overall Study|Adverse Event|0
1618865|NCT02010255|5650454|P2|Overall Study|Adverse Event|0
1618866|NCT02010255|5650455|P1|Overall Study|Adverse Event|1
1618867|NCT02010255|5650442|P14|Overall Study|Withdrew Consent|0
1618868|NCT02010255|5650443|P13|Overall Study|Withdrew Consent|0
1618869|NCT02010255|5650444|P12|Overall Study|Withdrew Consent|0
1618870|NCT02010255|5650445|P11|Overall Study|Withdrew Consent|0
1618871|NCT02010255|5650446|P10|Overall Study|Withdrew Consent|0
1618872|NCT02010255|5650447|P9|Overall Study|Withdrew Consent|0
1618873|NCT02010255|5650448|P8|Overall Study|Withdrew Consent|0
1618874|NCT02010255|5650449|P7|Overall Study|Withdrew Consent|0
1618875|NCT02010255|5650450|P6|Overall Study|Withdrew Consent|0
1618876|NCT02010255|5650451|P5|Overall Study|Withdrew Consent|0
1618877|NCT02010255|5650452|P4|Overall Study|Withdrew Consent|1
1618878|NCT02010255|5650453|P3|Overall Study|Withdrew Consent|0
1618879|NCT02010255|5650454|P2|Overall Study|Withdrew Consent|0
1618880|NCT02010255|5650455|P1|Overall Study|Withdrew Consent|1
1618881|NCT02010255|5650442|P14|Overall Study|Lack of Efficacy|0
1618882|NCT02010255|5650443|P13|Overall Study|Lack of Efficacy|0
1618883|NCT02010255|5650444|P12|Overall Study|Lack of Efficacy|0
1618884|NCT02010255|5650445|P11|Overall Study|Lack of Efficacy|1
1618885|NCT02010255|5650446|P10|Overall Study|Lack of Efficacy|0
1618886|NCT02010255|5650447|P9|Overall Study|Lack of Efficacy|0
1618887|NCT02010255|5650448|P8|Overall Study|Lack of Efficacy|0
1618888|NCT02010255|5650449|P7|Overall Study|Lack of Efficacy|0
1618889|NCT02010255|5650450|P6|Overall Study|Lack of Efficacy|0
1618890|NCT02010255|5650451|P5|Overall Study|Lack of Efficacy|1
1618891|NCT02010255|5650452|P4|Overall Study|Lack of Efficacy|1
1618892|NCT02010255|5650453|P3|Overall Study|Lack of Efficacy|2
1618893|NCT02010255|5650454|P2|Overall Study|Lack of Efficacy|1
1618894|NCT02010255|5650455|P1|Overall Study|Lack of Efficacy|4
1618895|NCT02010255|5650442|P14|Overall Study|Death|0
1618896|NCT02010255|5650443|P13|Overall Study|Death|0
1618897|NCT02010255|5650444|P12|Overall Study|Death|1
1618898|NCT02010255|5650445|P11|Overall Study|Death|1
1618899|NCT02010255|5650446|P10|Overall Study|Death|0
1618900|NCT02010255|5650447|P9|Overall Study|Death|1
1618901|NCT02010255|5650448|P8|Overall Study|Death|1
1618902|NCT02010255|5650449|P7|Overall Study|Death|1
1618903|NCT02010255|5650450|P6|Overall Study|Death|0
1618904|NCT02010255|5650451|P5|Overall Study|Death|2
1618905|NCT02010255|5650452|P4|Overall Study|Death|4
1618906|NCT02010255|5650453|P3|Overall Study|Death|4
1618907|NCT02010255|5650454|P2|Overall Study|Death|1
1618908|NCT02010255|5650455|P1|Overall Study|Death|0
1618909|NCT02009878|5650890|P3|Overall Study|Participant Met Withdrawal Criteria|0
1618910|NCT02009878|5650891|P2|Overall Study|Participant Met Withdrawal Criteria|1
1618911|NCT02009878|5650892|P1|Overall Study|Participant Met Withdrawal Criteria|0
1618912|NCT02009865|5650926|P2|Overall Study|Withdrawal by Subject|1
1618913|NCT02009865|5650927|P1|Overall Study|Withdrawal by Subject|1
1618914|NCT02009865|5650926|P2|Overall Study|Protocol Violation|2
1618915|NCT02009865|5650927|P1|Overall Study|Protocol Violation|0
1618916|NCT02009865|5650926|P2|Overall Study|Adverse Event|2
1618917|NCT02009865|5650927|P1|Overall Study|Adverse Event|0
1618918|NCT02009722|5650943|P2|Overall Study|Did not receive intervention|1
1618919|NCT02009722|5650944|P1|Overall Study|Did not receive intervention|0
1618920|NCT02009722|5650943|P2|Overall Study|Protocol Violation|2
1618921|NCT02009722|5650944|P1|Overall Study|Protocol Violation|1
1618922|NCT02009696|5650968|P1|Overall Study|Withdrawal by Subject|2
1618923|NCT02009163|5650985|P3|Randomized-withdrawal Period|Other|5
1618924|NCT02009163|5650986|P2|Randomized-withdrawal Period|Other|9
1618925|NCT02009163|5650987|P1|Randomized-withdrawal Period|Other|0
1618926|NCT02009163|5650985|P3|Randomized-withdrawal Period|Pregnancy|2
1618927|NCT02009163|5650986|P2|Randomized-withdrawal Period|Pregnancy|0
1618928|NCT02009163|5650987|P1|Randomized-withdrawal Period|Pregnancy|0
1618929|NCT02009163|5650985|P3|Randomized-withdrawal Period|Protocol Violation|2
1618930|NCT02009163|5650986|P2|Randomized-withdrawal Period|Protocol Violation|1
1618931|NCT02009163|5650987|P1|Randomized-withdrawal Period|Protocol Violation|0
1618932|NCT02009163|5650985|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
1618933|NCT02009163|5650986|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
1618934|NCT02009163|5650987|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
1618935|NCT02009163|5650985|P3|Randomized-withdrawal Period|Adverse Event|6
1618936|NCT02009163|5650986|P2|Randomized-withdrawal Period|Adverse Event|0
1618937|NCT02009163|5650987|P1|Randomized-withdrawal Period|Adverse Event|0
1618938|NCT02009163|5650985|P3|Randomized-withdrawal Period|Lost to Follow-up|6
1618939|NCT02009163|5650986|P2|Randomized-withdrawal Period|Lost to Follow-up|13
1618940|NCT02009163|5650987|P1|Randomized-withdrawal Period|Lost to Follow-up|0
1618941|NCT02009163|5650985|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
1618942|NCT02009163|5650986|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
1618943|NCT02009163|5650987|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
1618944|NCT02009163|5650985|P3|Open-label Period (Non-randomized)|Other|0
1618945|NCT02009163|5650986|P2|Open-label Period (Non-randomized)|Other|0
1618946|NCT02009163|5650987|P1|Open-label Period (Non-randomized)|Other|13
1618947|NCT02009163|5650985|P3|Open-label Period (Non-randomized)|Pregnancy|0
1618948|NCT02009163|5650986|P2|Open-label Period (Non-randomized)|Pregnancy|0
1618949|NCT02009163|5650987|P1|Open-label Period (Non-randomized)|Pregnancy|1
1618950|NCT02009163|5650985|P3|Open-label Period (Non-randomized)|Protocol Violation|0
1618951|NCT02009163|5650986|P2|Open-label Period (Non-randomized)|Protocol Violation|0
1618952|NCT02009163|5650987|P1|Open-label Period (Non-randomized)|Protocol Violation|10
1618953|NCT02009163|5650985|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
1618954|NCT02009163|5650986|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
1618955|NCT02009163|5650987|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
1618956|NCT02009163|5650985|P3|Open-label Period (Non-randomized)|Adverse Event|0
1618957|NCT02009163|5650986|P2|Open-label Period (Non-randomized)|Adverse Event|0
1618958|NCT02009163|5650987|P1|Open-label Period (Non-randomized)|Adverse Event|22
1618959|NCT02009163|5650985|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1618960|NCT02009163|5650986|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
1618961|NCT02009163|5650987|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
1618962|NCT02009163|5650985|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1618963|NCT02009163|5650986|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
1618964|NCT02009163|5650987|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
1618965|NCT02009046|5651022|P2|Overall Study|Lost to Follow-up|206
1618966|NCT02009046|5651023|P1|Overall Study|Lost to Follow-up|256
1618967|NCT02008916|5651083|P3|Week 16 - 156|Physician Decision|0
1618968|NCT02008916|5651084|P2|Week 16 - 156|Physician Decision|1
1618969|NCT02008916|5651085|P1|Week 16 - 156|Physician Decision|0
1618970|NCT02008916|5651083|P3|Week 16 - 156|Pregnancy|0
1618971|NCT02008916|5651084|P2|Week 16 - 156|Pregnancy|1
1618972|NCT02008916|5651085|P1|Week 16 - 156|Pregnancy|0
1618973|NCT02008916|5651083|P3|Week 16 - 156|Lack of Efficacy|2
1618974|NCT02008916|5651084|P2|Week 16 - 156|Lack of Efficacy|5
1618975|NCT02008916|5651085|P1|Week 16 - 156|Lack of Efficacy|3
1618976|NCT02008916|5651083|P3|Week 16 - 156|Lost to Follow-up|0
1618977|NCT02008916|5651084|P2|Week 16 - 156|Lost to Follow-up|0
1618978|NCT02008916|5651085|P1|Week 16 - 156|Lost to Follow-up|5
1618979|NCT02008916|5651083|P3|Week 16 - 156|No longer requires treatment|0
1618980|NCT02008916|5651084|P2|Week 16 - 156|No longer requires treatment|1
1618981|NCT02008916|5651085|P1|Week 16 - 156|No longer requires treatment|0
1618982|NCT02008916|5651083|P3|Week 16 - 156|Withdrawal by Subject|5
1618983|NCT02008916|5651084|P2|Week 16 - 156|Withdrawal by Subject|3
1618984|NCT02008916|5651085|P1|Week 16 - 156|Withdrawal by Subject|7
1618985|NCT02008916|5651083|P3|Week 16 - 156|Adverse Event|3
1618986|NCT02008916|5651084|P2|Week 16 - 156|Adverse Event|2
1618987|NCT02008916|5651085|P1|Week 16 - 156|Adverse Event|4
1618988|NCT02008916|5651083|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
1618989|NCT02008916|5651084|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
1618990|NCT02008916|5651085|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
1618991|NCT02008890|5651121|P5|Extension Period|Adverse Event|2
1618992|NCT02008890|5651122|P4|Extension Period|Adverse Event|0
1618993|NCT02008890|5651123|P3|Extension Period|Adverse Event|0
1618994|NCT02008890|5651124|P2|Extension Period|Adverse Event|3
1618995|NCT02008890|5651125|P1|Extension Period|Adverse Event|1
1618996|NCT02008890|5651121|P5|Extension Period|Lost to Follow-up|0
1618997|NCT02008890|5651122|P4|Extension Period|Lost to Follow-up|0
1618998|NCT02008890|5651123|P3|Extension Period|Lost to Follow-up|0
1618999|NCT02008890|5651124|P2|Extension Period|Lost to Follow-up|0
1619000|NCT02008890|5651125|P1|Extension Period|Lost to Follow-up|1
1619001|NCT02008890|5651121|P5|Extension Period|Withdrawal by Subject|2
1619002|NCT02008890|5651122|P4|Extension Period|Withdrawal by Subject|4
1619003|NCT02008890|5651123|P3|Extension Period|Withdrawal by Subject|0
1619004|NCT02008890|5651124|P2|Extension Period|Withdrawal by Subject|2
1619005|NCT02008890|5651125|P1|Extension Period|Withdrawal by Subject|3
1619006|NCT02008890|5651121|P5|Period 2|Lost to Follow-up|0
1619007|NCT02008890|5651122|P4|Period 2|Lost to Follow-up|0
1619008|NCT02008890|5651123|P3|Period 2|Lost to Follow-up|1
1619009|NCT02008890|5651124|P2|Period 2|Lost to Follow-up|0
1619010|NCT02008890|5651125|P1|Period 2|Lost to Follow-up|0
1619011|NCT02008890|5651121|P5|Period 2|Physician Decision|1
1619012|NCT02008890|5651122|P4|Period 2|Physician Decision|2
1619013|NCT02008890|5651123|P3|Period 2|Physician Decision|0
1619014|NCT02008890|5651124|P2|Period 2|Physician Decision|0
1619015|NCT02008890|5651125|P1|Period 2|Physician Decision|4
1619016|NCT02008890|5651121|P5|Period 2|Withdrawal by Subject|2
1619017|NCT02008890|5651122|P4|Period 2|Withdrawal by Subject|7
1619018|NCT02008890|5651123|P3|Period 2|Withdrawal by Subject|0
1619019|NCT02008890|5651124|P2|Period 2|Withdrawal by Subject|8
1619020|NCT02008890|5651125|P1|Period 2|Withdrawal by Subject|11
1619021|NCT02008890|5651121|P5|Period 2|Adverse Event|5
1619022|NCT02008890|5651122|P4|Period 2|Adverse Event|5
1619023|NCT02008890|5651123|P3|Period 2|Adverse Event|0
1619024|NCT02008890|5651124|P2|Period 2|Adverse Event|7
1619025|NCT02008890|5651125|P1|Period 2|Adverse Event|12
1619026|NCT02008890|5651121|P5|Period 1|Adverse Event|0
1619027|NCT02008890|5651122|P4|Period 1|Adverse Event|0
1619028|NCT02008890|5651123|P3|Period 1|Adverse Event|6
1619029|NCT02008890|5651124|P2|Period 1|Adverse Event|8
1619030|NCT02008890|5651125|P1|Period 1|Adverse Event|6
1619031|NCT02008890|5651121|P5|Period 1|Physician Decision|0
1619032|NCT02008890|5651122|P4|Period 1|Physician Decision|0
1619033|NCT02008890|5651123|P3|Period 1|Physician Decision|1
1619034|NCT02008890|5651124|P2|Period 1|Physician Decision|0
1619035|NCT02008890|5651125|P1|Period 1|Physician Decision|1
1619036|NCT02008890|5651121|P5|Period 1|Pregnancy|0
1619037|NCT02008890|5651122|P4|Period 1|Pregnancy|0
1619038|NCT02008890|5651123|P3|Period 1|Pregnancy|0
1619039|NCT02008890|5651124|P2|Period 1|Pregnancy|0
1619040|NCT02008890|5651125|P1|Period 1|Pregnancy|1
1619041|NCT02008890|5651121|P5|Period 1|Withdrawal by Subject|0
1619042|NCT02008890|5651122|P4|Period 1|Withdrawal by Subject|0
1619043|NCT02008890|5651123|P3|Period 1|Withdrawal by Subject|5
1619044|NCT02008890|5651124|P2|Period 1|Withdrawal by Subject|7
1619045|NCT02008890|5651125|P1|Period 1|Withdrawal by Subject|7
1619046|NCT02008877|5651161|P3|Overall Study|Inevaluable|0
1619047|NCT02008877|5651162|P2|Overall Study|Inevaluable|1
1619048|NCT02008877|5651163|P1|Overall Study|Inevaluable|0
1619049|NCT02008773|5651182|P4|Overall Study|Lost to Follow-up|2
1619050|NCT02008773|5651183|P3|Overall Study|Lost to Follow-up|3
1619051|NCT02008773|5651184|P2|Overall Study|Lost to Follow-up|1
1619052|NCT02008773|5651185|P1|Overall Study|Lost to Follow-up|0
1619053|NCT02008773|5651182|P4|Overall Study|Withdrawal by Subject|6
1619054|NCT02008773|5651183|P3|Overall Study|Withdrawal by Subject|7
1619055|NCT02008773|5651184|P2|Overall Study|Withdrawal by Subject|4
1619056|NCT02008773|5651185|P1|Overall Study|Withdrawal by Subject|8
1619057|NCT02008773|5651182|P4|Overall Study|Medication Non-compliance|2
1619058|NCT02008773|5651183|P3|Overall Study|Medication Non-compliance|3
1619059|NCT02008773|5651184|P2|Overall Study|Medication Non-compliance|1
1619060|NCT02008773|5651185|P1|Overall Study|Medication Non-compliance|2
1619061|NCT02008773|5651182|P4|Overall Study|Adverse Event|2
1619062|NCT02008773|5651183|P3|Overall Study|Adverse Event|1
1619063|NCT02008773|5651184|P2|Overall Study|Adverse Event|3
1619064|NCT02008773|5651185|P1|Overall Study|Adverse Event|3
1619065|NCT02008565|5651251|P4|Overall Study|Protocol Violation|0
1619066|NCT02008565|5651252|P3|Overall Study|Protocol Violation|2
1619067|NCT02008565|5651253|P2|Overall Study|Protocol Violation|1
1619068|NCT02008565|5651254|P1|Overall Study|Protocol Violation|1
1619069|NCT02008526|5651315|P3|Overall Study|Lost to Follow-up|6
1619070|NCT02008526|5651316|P2|Overall Study|Lost to Follow-up|9
1619071|NCT02008526|5651317|P1|Overall Study|Lost to Follow-up|5
1619072|NCT02008526|5651315|P3|Overall Study|Withdrawal by Subject|2
1619073|NCT02008526|5651316|P2|Overall Study|Withdrawal by Subject|3
1619074|NCT02008526|5651317|P1|Overall Study|Withdrawal by Subject|3
1619075|NCT02008526|5651315|P3|Overall Study|Death|1
1619076|NCT02008526|5651316|P2|Overall Study|Death|2
1619077|NCT02008526|5651317|P1|Overall Study|Death|0
1619078|NCT02008370|5651328|P1|Overall Study|Lost to Follow-up|7
1619079|NCT02008318|5651336|P2|Overall Study|Withdrawal by Subject|0
1619080|NCT02008318|5651337|P1|Overall Study|Withdrawal by Subject|3
1619081|NCT02008318|5651336|P2|Overall Study|Protocol Violation|1
1619082|NCT02008318|5651337|P1|Overall Study|Protocol Violation|1
1619083|NCT02008318|5651336|P2|Overall Study|Progressive Disease|0
1619084|NCT02008318|5651337|P1|Overall Study|Progressive Disease|2
1619085|NCT02008318|5651336|P2|Overall Study|Physician Decision|0
1619086|NCT02008318|5651337|P1|Overall Study|Physician Decision|2
1619087|NCT02008318|5651336|P2|Overall Study|Adverse Event|0
1619088|NCT02008318|5651337|P1|Overall Study|Adverse Event|4
1619089|NCT02008227|5651358|P2|Overall Study|Study Terminated By Sponsor|83
1619090|NCT02008227|5651359|P1|Overall Study|Study Terminated By Sponsor|44
1619091|NCT02008227|5651358|P2|Overall Study|Withdrawal by Subject|36
1619092|NCT02008227|5651359|P1|Overall Study|Withdrawal by Subject|67
1619093|NCT02008227|5651358|P2|Overall Study|Death|485
1619094|NCT02008227|5651359|P1|Overall Study|Death|494
1619095|NCT02008227|5651358|P2|Overall Study|Lost to Follow-up|9
1619096|NCT02008227|5651359|P1|Overall Study|Lost to Follow-up|7
1619097|NCT02007954|5651447|P1|Overall Study|Death|1
1619098|NCT02007954|5651447|P1|Overall Study|Disease progression and unrelated AE|1
1619099|NCT02007954|5651447|P1|Overall Study|Switch in treatment modality|2
1619100|NCT02007954|5651447|P1|Overall Study|Received liver transplant|3
1619101|NCT02007720|5651466|P2|Overall Study|patient followd less than 165 days|5
1619102|NCT02007720|5651467|P1|Overall Study|patient followd less than 165 days|11
1619103|NCT02007720|5651466|P2|Overall Study|technical problem|2
1619104|NCT02007720|5651467|P1|Overall Study|technical problem|4
1619105|NCT02007720|5651466|P2|Overall Study|study terminated by sponsor|54
1619106|NCT02007720|5651467|P1|Overall Study|study terminated by sponsor|58
1619107|NCT02007720|5651466|P2|Overall Study|Withdrawal by Subject|11
1619108|NCT02007720|5651467|P1|Overall Study|Withdrawal by Subject|9
1619109|NCT02007577|5651502|P2|Overall Study|Withdrawal by Subject|1
1619110|NCT02007577|5651503|P1|Overall Study|Withdrawal by Subject|0
1619111|NCT02007577|5651502|P2|Overall Study|Adverse Event|0
1619112|NCT02007577|5651503|P1|Overall Study|Adverse Event|1
1619113|NCT02007512|5651515|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1619114|NCT02007512|5651516|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1619115|NCT02007512|5651517|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
1619116|NCT02007512|5651518|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
1619117|NCT02007512|5651515|P4|Open Label Treatment Period|Disease progression|11
1619118|NCT02007512|5651516|P3|Open Label Treatment Period|Disease progression|0
1619119|NCT02007512|5651517|P2|Open Label Treatment Period|Disease progression|17
1619120|NCT02007512|5651518|P1|Open Label Treatment Period|Disease progression|0
1619121|NCT02007512|5651515|P4|Open Label Treatment Period|Other|1
1619122|NCT02007512|5651516|P3|Open Label Treatment Period|Other|0
1619123|NCT02007512|5651517|P2|Open Label Treatment Period|Other|0
1619124|NCT02007512|5651518|P1|Open Label Treatment Period|Other|0
1619125|NCT02007512|5651515|P4|Open Label Treatment Period|Adverse Event|0
1619126|NCT02007512|5651516|P3|Open Label Treatment Period|Adverse Event|0
1619127|NCT02007512|5651517|P2|Open Label Treatment Period|Adverse Event|1
1619128|NCT02007512|5651518|P1|Open Label Treatment Period|Adverse Event|0
1619129|NCT02007512|5651515|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
1619130|NCT02007512|5651516|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
1619131|NCT02007512|5651517|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
1619132|NCT02007512|5651518|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
1619133|NCT02007512|5651515|P4|Double Blind Treatment Period|Other|2
1619134|NCT02007512|5651516|P3|Double Blind Treatment Period|Other|1
1619135|NCT02007512|5651517|P2|Double Blind Treatment Period|Other|0
1619136|NCT02007512|5651518|P1|Double Blind Treatment Period|Other|0
1619137|NCT02007512|5651515|P4|Double Blind Treatment Period|Protocol Violation|1
1619138|NCT02007512|5651516|P3|Double Blind Treatment Period|Protocol Violation|0
1619139|NCT02007512|5651517|P2|Double Blind Treatment Period|Protocol Violation|0
1619140|NCT02007512|5651518|P1|Double Blind Treatment Period|Protocol Violation|0
1619141|NCT02007512|5651515|P4|Double Blind Treatment Period|Withdrawal by Subject|3
1619142|NCT02007512|5651516|P3|Double Blind Treatment Period|Withdrawal by Subject|3
1619143|NCT02007512|5651517|P2|Double Blind Treatment Period|Withdrawal by Subject|2
1619144|NCT02007512|5651518|P1|Double Blind Treatment Period|Withdrawal by Subject|4
1619145|NCT02007512|5651515|P4|Double Blind Treatment Period|Disease progression|51
1619146|NCT02007512|5651516|P3|Double Blind Treatment Period|Disease progression|45
1619147|NCT02007512|5651517|P2|Double Blind Treatment Period|Disease progression|49
1619148|NCT02007512|5651518|P1|Double Blind Treatment Period|Disease progression|44
1619149|NCT02007512|5651515|P4|Double Blind Treatment Period|Death|0
1619150|NCT02007512|5651516|P3|Double Blind Treatment Period|Death|0
1619151|NCT02007512|5651517|P2|Double Blind Treatment Period|Death|0
1619152|NCT02007512|5651518|P1|Double Blind Treatment Period|Death|1
1619153|NCT02007512|5651515|P4|Double Blind Treatment Period|Adverse Event|2
1619154|NCT02007512|5651516|P3|Double Blind Treatment Period|Adverse Event|6
1619155|NCT02007512|5651517|P2|Double Blind Treatment Period|Adverse Event|2
1619156|NCT02007512|5651518|P1|Double Blind Treatment Period|Adverse Event|4
1619157|NCT02007434|5651596|P8|Overall Study|Non-compliance|0
1619158|NCT02007434|5651597|P7|Overall Study|Non-compliance|0
1619159|NCT02007434|5651598|P6|Overall Study|Non-compliance|0
1619160|NCT02007434|5651599|P5|Overall Study|Non-compliance|0
1619161|NCT02007434|5651600|P4|Overall Study|Non-compliance|0
1619162|NCT02007434|5651601|P3|Overall Study|Non-compliance|1
1619163|NCT02007434|5651602|P2|Overall Study|Non-compliance|0
1619164|NCT02007434|5651603|P1|Overall Study|Non-compliance|1
1619165|NCT02007434|5651596|P8|Overall Study|Lost to Follow-up|0
1619166|NCT02007434|5651597|P7|Overall Study|Lost to Follow-up|0
1619167|NCT02007434|5651598|P6|Overall Study|Lost to Follow-up|0
1619168|NCT02007434|5651599|P5|Overall Study|Lost to Follow-up|0
1619169|NCT02007434|5651600|P4|Overall Study|Lost to Follow-up|0
1619170|NCT02007434|5651601|P3|Overall Study|Lost to Follow-up|0
1619171|NCT02007434|5651602|P2|Overall Study|Lost to Follow-up|1
1619172|NCT02007434|5651603|P1|Overall Study|Lost to Follow-up|0
1619173|NCT02007278|5651734|P2|Overall Study|Mis-randomization|1
1619174|NCT02007278|5651735|P1|Overall Study|Mis-randomization|1
1619175|NCT02007278|5651734|P2|Overall Study|Incorrect medication administration|0
1619176|NCT02007278|5651735|P1|Overall Study|Incorrect medication administration|1
1619177|NCT02007278|5651734|P2|Overall Study|Ingestion of drugs not allowed in study|1
1619178|NCT02007278|5651735|P1|Overall Study|Ingestion of drugs not allowed in study|0
1619179|NCT02007278|5651734|P2|Overall Study|Failure to comply with an eligibility|1
1619180|NCT02007278|5651735|P1|Overall Study|Failure to comply with an eligibility|0
1619181|NCT02007252|5651757|P2|Overall Study|Adverse Event|4
1619182|NCT02007252|5651758|P1|Overall Study|Adverse Event|7
1619183|NCT02007252|5651757|P2|Overall Study|Abnormal laboratory value(s)|0
1619184|NCT02007252|5651758|P1|Overall Study|Abnormal laboratory value(s)|1
1619185|NCT02007252|5651757|P2|Overall Study|Administrative problems|7
1619186|NCT02007252|5651758|P1|Overall Study|Administrative problems|3
1619187|NCT02007096|5651773|P2|Overall Study|no mesh placed|1
1619188|NCT02007096|5651774|P1|Overall Study|no mesh placed|0
1619189|NCT02007096|5651773|P2|Overall Study|converted to open surgery|1
1619190|NCT02007096|5651774|P1|Overall Study|converted to open surgery|1
1619191|NCT02007096|5651773|P2|Overall Study|did not follow postoperative protocol|11
1619192|NCT02007096|5651774|P1|Overall Study|did not follow postoperative protocol|8
1619193|NCT02007096|5651773|P2|Overall Study|did not inject saline|3
1619194|NCT02007096|5651774|P1|Overall Study|did not inject saline|0
1619195|NCT02007096|5651773|P2|Overall Study|medication not available|0
1619196|NCT02007096|5651774|P1|Overall Study|medication not available|2
1619197|NCT02007070|5651786|P1|Overall Study|Progressive Disease|21
1619198|NCT02007070|5651786|P1|Overall Study|Physician Decision|1
1619199|NCT02007070|5651786|P1|Overall Study|Protocol Violation|2
1619200|NCT02007070|5651786|P1|Overall Study|Death|1
1619201|NCT02007070|5651786|P1|Overall Study|Clinical Progression|4
1619202|NCT02007070|5651786|P1|Overall Study|Adverse Event|4
1619203|NCT02006979|5651807|P2|Overall Study|Protocol Violation|1
1619204|NCT02006979|5651808|P1|Overall Study|Protocol Violation|0
1619205|NCT02006979|5651807|P2|Overall Study|Withdrawal by Subject|1
1619206|NCT02006979|5651808|P1|Overall Study|Withdrawal by Subject|1
1619207|NCT02006758|5651854|P1|Overall Study|Other|2
1619208|NCT02006758|5651854|P1|Overall Study|Procedurally excluded|1
1619209|NCT02006758|5651854|P1|Overall Study|Withdrawal by Subject|4
1619210|NCT02006758|5651854|P1|Overall Study|Lost to Follow-up|4
1619211|NCT02006758|5651854|P1|Overall Study|Death|1
1619212|NCT02006758|5651854|P1|Overall Study|Protocol Violation|1
1619213|NCT02006732|5651885|P4|Overall Study|Withdrawal by Subject|1
1619214|NCT02006732|5651886|P3|Overall Study|Withdrawal by Subject|4
1619215|NCT02006732|5651887|P2|Overall Study|Withdrawal by Subject|0
1619216|NCT02006732|5651888|P1|Overall Study|Withdrawal by Subject|3
1619217|NCT02006732|5651885|P4|Overall Study|Lost to Follow-up|0
1619218|NCT02006732|5651886|P3|Overall Study|Lost to Follow-up|0
1619219|NCT02006732|5651887|P2|Overall Study|Lost to Follow-up|1
1619220|NCT02006732|5651888|P1|Overall Study|Lost to Follow-up|0
1619221|NCT02006732|5651885|P4|Overall Study|Protocol Violation|0
1619222|NCT02006732|5651886|P3|Overall Study|Protocol Violation|0
1619223|NCT02006732|5651887|P2|Overall Study|Protocol Violation|1
1619224|NCT02006732|5651888|P1|Overall Study|Protocol Violation|1
1619225|NCT02006732|5651885|P4|Overall Study|Lack of Efficacy|1
1619226|NCT02006732|5651886|P3|Overall Study|Lack of Efficacy|1
1619227|NCT02006732|5651887|P2|Overall Study|Lack of Efficacy|3
1619228|NCT02006732|5651888|P1|Overall Study|Lack of Efficacy|6
1619229|NCT02006732|5651885|P4|Overall Study|Adverse Event|2
1619230|NCT02006732|5651886|P3|Overall Study|Adverse Event|4
1619231|NCT02006732|5651887|P2|Overall Study|Adverse Event|7
1619232|NCT02006732|5651888|P1|Overall Study|Adverse Event|10
1619233|NCT02006719|5651928|P2|Overall Study|Other/Unknown|1
1619234|NCT02006719|5651929|P1|Overall Study|Other/Unknown|0
1619235|NCT02006719|5651928|P2|Overall Study|Adverse Event|1
1619236|NCT02006719|5651929|P1|Overall Study|Adverse Event|1
1619237|NCT02006719|5651928|P2|Overall Study|Protocol Violation|0
1619238|NCT02006719|5651929|P1|Overall Study|Protocol Violation|2
1619239|NCT02006719|5651928|P2|Overall Study|Lost to Follow-up|1
1619240|NCT02006719|5651929|P1|Overall Study|Lost to Follow-up|5
1619241|NCT02006719|5651928|P2|Overall Study|Withdrawal by Subject|2
1619242|NCT02006719|5651929|P1|Overall Study|Withdrawal by Subject|10
1619243|NCT02006706|5651959|P1|Overall Study|Lost to Follow-up|1
1619244|NCT02006693|5651966|P2|Overall Study|Patient Decision|0
1619245|NCT02006693|5651967|P1|Overall Study|Patient Decision|4
1619246|NCT02006693|5651966|P2|Overall Study|Lost to Follow-up|1
1619247|NCT02006693|5651967|P1|Overall Study|Lost to Follow-up|4
1619248|NCT02006693|5651966|P2|Overall Study|Death|2
1619249|NCT02006693|5651967|P1|Overall Study|Death|2
1619250|NCT02006693|5651966|P2|Overall Study|XEN Implant Explantation|1
1619251|NCT02006693|5651967|P1|Overall Study|XEN Implant Explantation|0
1619252|NCT02006693|5651966|P2|Overall Study|Another Glaucoma-related Surgery|1
1619253|NCT02006693|5651967|P1|Overall Study|Another Glaucoma-related Surgery|12
1619254|NCT02006693|5651966|P2|Overall Study|No Reason Specified|8
1619255|NCT02006693|5651967|P1|Overall Study|No Reason Specified|6
1619256|NCT02006667|5651979|P1|Overall Study|Withdrawal by Subject|1
1619257|NCT02006667|5651979|P1|Overall Study|Death|2
1619258|NCT02006667|5651979|P1|Overall Study|Adverse Event|3
1619259|NCT02006654|5651991|P2|Overall Study|moving out of state|1
1619260|NCT02006654|5651992|P1|Overall Study|moving out of state|0
1619261|NCT02006654|5651991|P2|Overall Study|disallowed medication|0
1619262|NCT02006654|5651992|P1|Overall Study|disallowed medication|1
1619263|NCT02006654|5651991|P2|Overall Study|mood disorder|1
1619264|NCT02006654|5651992|P1|Overall Study|mood disorder|0
1619265|NCT02006654|5651991|P2|Overall Study|faecal incontinence|1
1619266|NCT02006654|5651992|P1|Overall Study|faecal incontinence|0
1619267|NCT02006654|5651991|P2|Overall Study|worsening cognitive condition|1
1619268|NCT02006654|5651992|P1|Overall Study|worsening cognitive condition|0
1619269|NCT02006654|5651991|P2|Overall Study|insufficient compliance|0
1619270|NCT02006654|5651992|P1|Overall Study|insufficient compliance|1
1619271|NCT02006654|5651991|P2|Overall Study|patient's will|1
1619272|NCT02006654|5651992|P1|Overall Study|patient's will|2
1619273|NCT02006654|5651991|P2|Overall Study|Lost to Follow-up|0
1619274|NCT02006654|5651992|P1|Overall Study|Lost to Follow-up|1
1619275|NCT02006654|5651991|P2|Overall Study|Protocol Violation|8
1619276|NCT02006654|5651992|P1|Overall Study|Protocol Violation|5
1619277|NCT02006654|5651991|P2|Overall Study|Withdrawal by Subject|12
1619278|NCT02006654|5651992|P1|Overall Study|Withdrawal by Subject|14
1619279|NCT02006654|5651991|P2|Overall Study|Death|0
1619280|NCT02006654|5651992|P1|Overall Study|Death|1
1619281|NCT02006654|5651991|P2|Overall Study|Adverse Event|17
1619282|NCT02006654|5651992|P1|Overall Study|Adverse Event|16
1619283|NCT02006654|5651991|P2|Overall Study|Withdrawal before treatment|2
1619284|NCT02006654|5651992|P1|Overall Study|Withdrawal before treatment|4
1619285|NCT02006641|5652021|P3|Overall Study|Other reason: protocol non-compliance|1
1619286|NCT02006641|5652022|P2|Overall Study|Other reason: protocol non-compliance|0
1619287|NCT02006641|5652023|P1|Overall Study|Other reason: protocol non-compliance|0
1619288|NCT02006641|5652021|P3|Overall Study|Other reason: caregiver impossibility|1
1619289|NCT02006641|5652022|P2|Overall Study|Other reason: caregiver impossibility|0
1619290|NCT02006641|5652023|P1|Overall Study|Other reason: caregiver impossibility|0
1619291|NCT02006641|5652021|P3|Overall Study|Other reason: hospitalisation|0
1619292|NCT02006641|5652022|P2|Overall Study|Other reason: hospitalisation|1
1619293|NCT02006641|5652023|P1|Overall Study|Other reason: hospitalisation|0
1619294|NCT02006641|5652021|P3|Overall Study|Other reason: patient's wife has died|1
1619295|NCT02006641|5652022|P2|Overall Study|Other reason: patient's wife has died|0
1619296|NCT02006641|5652023|P1|Overall Study|Other reason: patient's wife has died|0
1619297|NCT02006641|5652021|P3|Overall Study|Other reason: caregiver in hospital|0
1619298|NCT02006641|5652022|P2|Overall Study|Other reason: caregiver in hospital|1
1619299|NCT02006641|5652023|P1|Overall Study|Other reason: caregiver in hospital|0
1619300|NCT02006641|5652021|P3|Overall Study|Other reason: patient has moved|1
1619301|NCT02006641|5652022|P2|Overall Study|Other reason: patient has moved|0
1619302|NCT02006641|5652023|P1|Overall Study|Other reason: patient has moved|1
1619303|NCT02006641|5652021|P3|Overall Study|Other reason:patient didn't want to come|1
1619304|NCT02006641|5652022|P2|Overall Study|Other reason:patient didn't want to come|0
1619305|NCT02006641|5652023|P1|Overall Study|Other reason:patient didn't want to come|0
1619306|NCT02006641|5652021|P3|Overall Study|Other reason: patient didn't show up|0
1619307|NCT02006641|5652022|P2|Overall Study|Other reason: patient didn't show up|0
1619308|NCT02006641|5652023|P1|Overall Study|Other reason: patient didn't show up|1
1619309|NCT02006641|5652021|P3|Overall Study|Withdrawal by Subject|11
1619310|NCT02006641|5652022|P2|Overall Study|Withdrawal by Subject|12
1619311|NCT02006641|5652023|P1|Overall Study|Withdrawal by Subject|7
1619312|NCT02006641|5652021|P3|Overall Study|Lost to Follow-up|0
1619313|NCT02006641|5652022|P2|Overall Study|Lost to Follow-up|1
1619314|NCT02006641|5652023|P1|Overall Study|Lost to Follow-up|0
1619315|NCT02006641|5652021|P3|Overall Study|Protocol Violation|2
1619316|NCT02006641|5652022|P2|Overall Study|Protocol Violation|2
1619317|NCT02006641|5652023|P1|Overall Study|Protocol Violation|0
1619318|NCT02006641|5652021|P3|Overall Study|Adverse Event|15
1619319|NCT02006641|5652022|P2|Overall Study|Adverse Event|11
1619320|NCT02006641|5652023|P1|Overall Study|Adverse Event|15
1619321|NCT02006641|5652021|P3|Overall Study|Withdrawal before treatment|3
1619322|NCT02006641|5652022|P2|Overall Study|Withdrawal before treatment|5
1619323|NCT02006641|5652023|P1|Overall Study|Withdrawal before treatment|2
1619324|NCT02006628|5652063|P2|Overall Study|Withdrawal by Subject|1
1619325|NCT02006628|5652064|P1|Overall Study|Withdrawal by Subject|2
1619326|NCT02006628|5652063|P2|Overall Study|Adverse Event|1
1619327|NCT02006628|5652064|P1|Overall Study|Adverse Event|1
1619328|NCT02006576|5652089|P3|Overall Study|Screen Failure, too sick, other|13
1619329|NCT02006576|5652090|P2|Overall Study|Screen Failure, too sick, other|1
1619330|NCT02006576|5652091|P1|Overall Study|Screen Failure, too sick, other|13
1619331|NCT02006576|5652089|P3|Overall Study|Lost to Follow-up|1
1619332|NCT02006576|5652090|P2|Overall Study|Lost to Follow-up|0
1619333|NCT02006576|5652091|P1|Overall Study|Lost to Follow-up|1
1619334|NCT02006576|5652089|P3|Overall Study|Death|1
1619335|NCT02006576|5652090|P2|Overall Study|Death|0
1619336|NCT02006576|5652091|P1|Overall Study|Death|0
1619337|NCT02006576|5652089|P3|Overall Study|Withdrawal by Subject|2
1619338|NCT02006576|5652090|P2|Overall Study|Withdrawal by Subject|6
1619339|NCT02006576|5652091|P1|Overall Study|Withdrawal by Subject|4
1619340|NCT02006121|5652174|P2|Open Label Phase|Non-compliance with study drug|0
1619341|NCT02006121|5652175|P1|Open Label Phase|Non-compliance with study drug|3
1619342|NCT02006121|5652174|P2|Open Label Phase|Withdrawal by Subject|0
1619343|NCT02006121|5652175|P1|Open Label Phase|Withdrawal by Subject|3
1619344|NCT02006121|5652174|P2|Open Label Phase|Protocol Violation|0
1619345|NCT02006121|5652175|P1|Open Label Phase|Protocol Violation|2
1619346|NCT02006121|5652174|P2|Open Label Phase|Lack of Efficacy|0
1619347|NCT02006121|5652175|P1|Open Label Phase|Lack of Efficacy|2
1619348|NCT02006121|5652174|P2|Open Label Phase|Adverse Event|0
1619349|NCT02006121|5652175|P1|Open Label Phase|Adverse Event|15
1619350|NCT02006121|5652174|P2|Double Blind Phase|Inconvenience of infusion system|1
1619351|NCT02006121|5652175|P1|Double Blind Phase|Inconvenience of infusion system|0
1619352|NCT02006121|5652174|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
1619353|NCT02006121|5652175|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
1619354|NCT02006121|5652174|P2|Double Blind Phase|Non-compliance with study drug|3
1619355|NCT02006121|5652175|P1|Double Blind Phase|Non-compliance with study drug|1
1619356|NCT02006121|5652174|P2|Double Blind Phase|Withdrawal by Subject|4
1619357|NCT02006121|5652175|P1|Double Blind Phase|Withdrawal by Subject|3
1619358|NCT02006121|5652174|P2|Double Blind Phase|Lack of Efficacy|16
1619359|NCT02006121|5652175|P1|Double Blind Phase|Lack of Efficacy|1
1619360|NCT02006121|5652174|P2|Double Blind Phase|Adverse Event|0
1619361|NCT02006121|5652175|P1|Double Blind Phase|Adverse Event|6
1619362|NCT02005887|5652208|P2|Overall Study|Protocol Violation|2
1619363|NCT02005887|5652209|P1|Overall Study|Protocol Violation|0
1619364|NCT02005692|5652227|P1|Overall Study|Discharged earlier than anticipated|5
1619365|NCT02005692|5652227|P1|Overall Study|Withdrawal by Subject|1
1619366|NCT02005692|5652227|P1|Overall Study|Protocol Violation|1
1619367|NCT02005627|5652234|P2|Overall Study|Withdrawal by Subject|2
1619368|NCT02005627|5652235|P1|Overall Study|Withdrawal by Subject|1
1619369|NCT02005627|5652234|P2|Overall Study|Lost to Follow-up|2
1619370|NCT02005627|5652235|P1|Overall Study|Lost to Follow-up|1
1619371|NCT02005562|5652264|P2|Overall Study|Physician Decision|1
1619372|NCT02005562|5652265|P1|Overall Study|Physician Decision|0
1619373|NCT02005562|5652264|P2|Overall Study|No transplant|4
1619374|NCT02005562|5652265|P1|Overall Study|No transplant|1
1619375|NCT02005562|5652264|P2|Overall Study|Withdrawal by Subject|2
1619376|NCT02005562|5652265|P1|Overall Study|Withdrawal by Subject|2
1619377|NCT02005562|5652264|P2|Overall Study|Graft loss|6
1619378|NCT02005562|5652265|P1|Overall Study|Graft loss|7
1619379|NCT02005562|5652264|P2|Overall Study|Death|2
1619380|NCT02005562|5652265|P1|Overall Study|Death|2
1619381|NCT02005484|5652307|P1|Overall Study|Sponsor decision|1
1619382|NCT02005484|5652307|P1|Overall Study|Changed to a Different Study|1
1619383|NCT02005484|5652307|P1|Overall Study|Disease progression|1
1619384|NCT02005484|5652307|P1|Overall Study|Death|1
1619399|NCT02005445|5652375|P2|Overall Study|Dual study enrollment|1
1619400|NCT02005445|5652376|P1|Overall Study|Dual study enrollment|0
1619401|NCT02005276|5652399|P4|Overall Study|No longer interested|3
1619402|NCT02005276|5652400|P3|Overall Study|No longer interested|3
1619403|NCT02005276|5652401|P2|Overall Study|No longer interested|2
1619404|NCT02005276|5652402|P1|Overall Study|No longer interested|5
1619405|NCT02005211|5652423|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1619406|NCT02005211|5652424|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1619407|NCT02005211|5652425|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
1619408|NCT02005211|5652426|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1619409|NCT02005211|5652427|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1619410|NCT02005211|5652428|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1619411|NCT02005211|5652429|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
1619412|NCT02005029|5652464|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
1619413|NCT02005029|5652465|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
1619414|NCT02004886|5652522|P4|Overall Study|Unable to attend future visits|0
1619415|NCT02004886|5652523|P3|Overall Study|Unable to attend future visits|0
1619416|NCT02004886|5652524|P2|Overall Study|Unable to attend future visits|0
1619417|NCT02004886|5652525|P1|Overall Study|Unable to attend future visits|1
1619418|NCT02004886|5652522|P4|Overall Study|Adverse Event|0
1619419|NCT02004886|5652523|P3|Overall Study|Adverse Event|0
1619420|NCT02004886|5652524|P2|Overall Study|Adverse Event|1
1619421|NCT02004886|5652525|P1|Overall Study|Adverse Event|0
1619422|NCT02004873|5652575|P1|Overall Study|Withdrawal by Subject|1
1619423|NCT02004873|5652575|P1|Overall Study|Death|23
1619424|NCT02004873|5652575|P1|Overall Study|Missed 6-month visit|4
1619425|NCT02004873|5652575|P1|Overall Study|Awaiting 6-month visit|390
1619426|NCT02004873|5652575|P1|Overall Study|Implant unsuccessful|6
1619427|NCT02004847|5652584|P2|Overall Study|Protocol Violation|1
1619428|NCT02004847|5652585|P1|Overall Study|Protocol Violation|1
1619429|NCT02004522|5652631|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
1619430|NCT02004522|5652632|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
1619431|NCT02004522|5652631|P2|Overall Study|Disease Progression|31
1619432|NCT02004522|5652632|P1|Overall Study|Disease Progression|35
1619433|NCT02004522|5652631|P2|Overall Study|Never Dosed|4
1619434|NCT02004522|5652632|P1|Overall Study|Never Dosed|2
1619435|NCT02004522|5652631|P2|Overall Study|Other is reason listed by PI.|1
1619436|NCT02004522|5652632|P1|Overall Study|Other is reason listed by PI.|4
1619437|NCT02004522|5652631|P2|Overall Study|Protocol Violation|0
1619438|NCT02004522|5652632|P1|Overall Study|Protocol Violation|1
1619439|NCT02004522|5652631|P2|Overall Study|Physician Decision|4
1619440|NCT02004522|5652632|P1|Overall Study|Physician Decision|3
1619441|NCT02004522|5652631|P2|Overall Study|Death|3
1619442|NCT02004522|5652632|P1|Overall Study|Death|12
1619443|NCT02004522|5652631|P2|Overall Study|Withdrawal by Subject|7
1619444|NCT02004522|5652632|P1|Overall Study|Withdrawal by Subject|13
1619445|NCT02004522|5652631|P2|Overall Study|Adverse Event|6
1619446|NCT02004522|5652632|P1|Overall Study|Adverse Event|55
1619447|NCT02004262|5652753|P6|Overall Study|Study Terminated by Sponsor|5
1619448|NCT02004262|5652754|P5|Overall Study|Study Terminated by Sponsor|1
1619449|NCT02004262|5652755|P4|Overall Study|Study Terminated by Sponsor|1
1619450|NCT02004262|5652756|P3|Overall Study|Study Terminated by Sponsor|2
1619451|NCT02004262|5652757|P2|Overall Study|Study Terminated by Sponsor|3
1619452|NCT02004262|5652758|P1|Overall Study|Study Terminated by Sponsor|4
1619453|NCT02004262|5652753|P6|Overall Study|Lost to Follow-up|0
1619454|NCT02004262|5652754|P5|Overall Study|Lost to Follow-up|0
1619455|NCT02004262|5652755|P4|Overall Study|Lost to Follow-up|0
1619456|NCT02004262|5652756|P3|Overall Study|Lost to Follow-up|0
1619457|NCT02004262|5652757|P2|Overall Study|Lost to Follow-up|1
1619458|NCT02004262|5652758|P1|Overall Study|Lost to Follow-up|1
1619459|NCT02004262|5652753|P6|Overall Study|Withdrawal by Subject|3
1619460|NCT02004262|5652754|P5|Overall Study|Withdrawal by Subject|1
1619461|NCT02004262|5652755|P4|Overall Study|Withdrawal by Subject|0
1619462|NCT02004262|5652756|P3|Overall Study|Withdrawal by Subject|4
1619463|NCT02004262|5652757|P2|Overall Study|Withdrawal by Subject|0
1619464|NCT02004262|5652758|P1|Overall Study|Withdrawal by Subject|1
1619465|NCT02004262|5652753|P6|Overall Study|Death|22
1619466|NCT02004262|5652754|P5|Overall Study|Death|29
1619467|NCT02004262|5652755|P4|Overall Study|Death|28
1619468|NCT02004262|5652756|P3|Overall Study|Death|66
1619469|NCT02004262|5652757|P2|Overall Study|Death|64
1619470|NCT02004262|5652758|P1|Overall Study|Death|67
1619471|NCT02004236|5652778|P3|Overall Study|Lack of Efficacy|16
1619472|NCT02004236|5652779|P2|Overall Study|Lack of Efficacy|0
1619473|NCT02004236|5652780|P1|Overall Study|Lack of Efficacy|0
1619474|NCT02004093|5652840|P2|Overall Study|Other|1
1619475|NCT02004093|5652841|P1|Overall Study|Other|3
1619476|NCT02004093|5652840|P2|Overall Study|Withdrawal by Subject|7
1619477|NCT02004093|5652841|P1|Overall Study|Withdrawal by Subject|3
1619478|NCT02004093|5652840|P2|Overall Study|Lost to Follow-up|1
1619479|NCT02004093|5652841|P1|Overall Study|Lost to Follow-up|0
1619480|NCT02004093|5652840|P2|Overall Study|Protocol Violation|1
1619481|NCT02004093|5652841|P1|Overall Study|Protocol Violation|0
1619482|NCT02004093|5652840|P2|Overall Study|Lack of Efficacy|62
1619483|NCT02004093|5652841|P1|Overall Study|Lack of Efficacy|66
1619484|NCT02004093|5652840|P2|Overall Study|Death|1
1619485|NCT02004093|5652841|P1|Overall Study|Death|2
1619486|NCT02003963|5652873|P2|Overall Study|Lost to Follow-up|1
1619487|NCT02003963|5652874|P1|Overall Study|Lost to Follow-up|2
1619488|NCT02003924|5652896|P2|Overall Study|Adverse Event|29
1619489|NCT02003924|5652897|P1|Overall Study|Adverse Event|91
1619490|NCT02003924|5652896|P2|Overall Study|Withdrawal by Subject|34
1619491|NCT02003924|5652897|P1|Overall Study|Withdrawal by Subject|49
1619492|NCT02003924|5652896|P2|Overall Study|Other than specified|19
1619493|NCT02003924|5652897|P1|Overall Study|Other than specified|18
1619494|NCT02003924|5652896|P2|Overall Study|Lost to Follow-up|1
1619495|NCT02003924|5652897|P1|Overall Study|Lost to Follow-up|2
1619496|NCT02003924|5652896|P2|Overall Study|Protocol Violation|2
1619497|NCT02003924|5652897|P1|Overall Study|Protocol Violation|1
1619498|NCT02003924|5652896|P2|Overall Study|Disease progression|207
1619499|NCT02003924|5652897|P1|Overall Study|Disease progression|138
1619500|NCT02003924|5652896|P2|Overall Study|Ongoing in study|176
1619501|NCT02003924|5652897|P1|Overall Study|Ongoing in study|634
1619502|NCT02003898|5652995|P1|Overall Study|Withdrawal by Subject|52
1619503|NCT02003898|5652995|P1|Overall Study|Lost to Follow-up|12
1619504|NCT02003898|5652995|P1|Overall Study|Death|3
1619505|NCT02003638|5653004|P2|Overall Study|Withdrawal by Subject|0
1619506|NCT02003638|5653005|P1|Overall Study|Withdrawal by Subject|1
1619507|NCT02003573|5653014|P3|Overall Study|Other than specified|3
1619508|NCT02003573|5653015|P2|Overall Study|Other than specified|2
1619509|NCT02003573|5653016|P1|Overall Study|Other than specified|1
1619510|NCT02003573|5653014|P3|Overall Study|Refuse to take trial medication|1
1619511|NCT02003573|5653015|P2|Overall Study|Refuse to take trial medication|1
1619512|NCT02003573|5653016|P1|Overall Study|Refuse to take trial medication|0
1619513|NCT02003573|5653014|P3|Overall Study|Other Adverse event|1
1619514|NCT02003573|5653015|P2|Overall Study|Other Adverse event|1
1619515|NCT02003573|5653016|P1|Overall Study|Other Adverse event|0
1619516|NCT02003573|5653014|P3|Overall Study|Progressive disease|1
1619517|NCT02003573|5653015|P2|Overall Study|Progressive disease|0
1619518|NCT02003573|5653016|P1|Overall Study|Progressive disease|2
1619519|NCT02003534|5653026|P1|Overall Study|Lost to Follow-up|47
1619520|NCT02003391|5653038|P2|Overall Study|Adverse Event|0
1619521|NCT02003391|5653039|P1|Overall Study|Adverse Event|1
1619522|NCT02003391|5653038|P2|Overall Study|Protocol Violation|1
1619523|NCT02003391|5653039|P1|Overall Study|Protocol Violation|0
1619524|NCT02003391|5653038|P2|Overall Study|Withdrawal by Subject|1
1619525|NCT02003391|5653039|P1|Overall Study|Withdrawal by Subject|2
1619526|NCT02003365|5653052|P3|Overall Study|Lost to Follow-up|1
1619527|NCT02003365|5653053|P2|Overall Study|Lost to Follow-up|0
1619528|NCT02003365|5653054|P1|Overall Study|Lost to Follow-up|0
1619529|NCT02003183|5653071|P2|Overall Study|Lost to Follow-up|2
1619530|NCT02003183|5653072|P1|Overall Study|Lost to Follow-up|0
1619531|NCT02003014|5653087|P1|Overall Study|Investigator's transfer|4
1619532|NCT02003014|5653087|P1|Overall Study|Patient did not visit the study site|5
1619533|NCT02003014|5653087|P1|Overall Study|Treatment started after contract period|1
1619534|NCT02003014|5653087|P1|Overall Study|Case report forms uncollected|9
1619535|NCT02002975|5653097|P1|Overall Study|Protocol Deviation|437
1619536|NCT02002975|5653097|P1|Overall Study|Case Report Forms Uncollected|135
1619537|NCT02002689|5653196|P1|Overall Study|Adverse Event|3
1619538|NCT02002689|5653196|P1|Overall Study|Disease Progression|7
1619539|NCT02002533|5653215|P2|Overall Study|Lost to Follow-up|1
1619540|NCT02002533|5653216|P1|Overall Study|Lost to Follow-up|0
1619541|NCT02002533|5653215|P2|Overall Study|Adverse Event|3
1619542|NCT02002533|5653216|P1|Overall Study|Adverse Event|0
1619543|NCT02002533|5653215|P2|Overall Study|Protocol Violation|1
1619544|NCT02002533|5653216|P1|Overall Study|Protocol Violation|0
1619545|NCT02002533|5653215|P2|Overall Study|Withdrawal by Subject|13
1619546|NCT02002533|5653216|P1|Overall Study|Withdrawal by Subject|6
1619547|NCT02002221|5653241|P2|Overall Study|Patient withdrew consent|1
1619548|NCT02002221|5653242|P1|Overall Study|Patient withdrew consent|0
1619549|NCT02002221|5653241|P2|Overall Study|Unsatisfactory therapeutic effect|1
1619550|NCT02002221|5653242|P1|Overall Study|Unsatisfactory therapeutic effect|0
1619551|NCT02002221|5653241|P2|Overall Study|Adverse Event|1
1619552|NCT02002221|5653242|P1|Overall Study|Adverse Event|2
1619553|NCT02002091|5653269|P2|Screening|Death|2
1619554|NCT02002091|5653270|P1|Screening|Death|3
1619555|NCT02002091|5653269|P2|Screening|Lost to Follow-up|12
1619556|NCT02002091|5653270|P1|Screening|Lost to Follow-up|10
1619557|NCT02001987|5653305|P1|LTE Period (52 Weeks)|Other|3
1619558|NCT02001987|5653305|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
1619559|NCT02001987|5653305|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
1619560|NCT02001987|5653305|P1|LTE Period (52 Weeks)|Physician Decision|2
1619561|NCT02001987|5653305|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
1619562|NCT02001987|5653305|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
1619563|NCT02001987|5653305|P1|Core Study Period (24 Weeks)|Protocol Violation|3
1619564|NCT02001987|5653305|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
1619565|NCT02001987|5653305|P1|Core Study Period (24 Weeks)|Physician Decision|1
1619566|NCT02001987|5653305|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
1619567|NCT02001987|5653305|P1|Core Study Period (24 Weeks)|Death|1
1619568|NCT02001987|5653305|P1|Core Study Period (24 Weeks)|Adverse Event|9
1619569|NCT02001688|5653391|P3|Overall Study|Adverse Event|0
1619570|NCT02001688|5653392|P2|Overall Study|Adverse Event|1
1619571|NCT02001688|5653393|P1|Overall Study|Adverse Event|0
1619572|NCT02001688|5653391|P3|Overall Study|Withdrawal by Subject|1
1619573|NCT02001688|5653392|P2|Overall Study|Withdrawal by Subject|0
1619574|NCT02001688|5653393|P1|Overall Study|Withdrawal by Subject|0
1619575|NCT02001558|5653412|P2|Overall Study|Lost to Follow-up|14
1619576|NCT02001558|5653413|P1|Overall Study|Lost to Follow-up|8
1619577|NCT02001194|5653449|P4|Follow-Up Period (13 Weeks)|No longer interested|0
1619578|NCT02001194|5653450|P3|Follow-Up Period (13 Weeks)|No longer interested|1
1619579|NCT02001194|5653451|P2|Follow-Up Period (13 Weeks)|No longer interested|2
1619580|NCT02001194|5653452|P1|Follow-Up Period (13 Weeks)|No longer interested|3
1619581|NCT02001194|5653449|P4|Intervention Period (13 Weeks)|No longer interested|2
1619582|NCT02001194|5653450|P3|Intervention Period (13 Weeks)|No longer interested|2
1619583|NCT02001194|5653451|P2|Intervention Period (13 Weeks)|No longer interested|0
1619584|NCT02001194|5653452|P1|Intervention Period (13 Weeks)|No longer interested|1
1619585|NCT02001181|5653468|P2|Overall Study|Withdrawal by Subject|1
1619586|NCT02001181|5653469|P1|Overall Study|Withdrawal by Subject|0
1619587|NCT02001181|5653468|P2|Overall Study|Lost to Follow-up|0
1619588|NCT02001181|5653469|P1|Overall Study|Lost to Follow-up|1
1619589|NCT02001181|5653468|P2|Overall Study|Adverse Event|2
1619590|NCT02001181|5653469|P1|Overall Study|Adverse Event|0
1619591|NCT02001051|5653485|P2|Overall Study|Deemed not eligible following enrollment|1
1619592|NCT02001051|5653486|P1|Overall Study|Deemed not eligible following enrollment|0
1619593|NCT02000921|5653538|P3|Overall Study|Physician Decision|0
1619594|NCT02000921|5653539|P2|Overall Study|Physician Decision|2
1619595|NCT02000921|5653540|P1|Overall Study|Physician Decision|0
1619596|NCT02000921|5653538|P3|Overall Study|Lost to Follow-up|5
1619597|NCT02000921|5653539|P2|Overall Study|Lost to Follow-up|4
1619598|NCT02000921|5653540|P1|Overall Study|Lost to Follow-up|2
1619599|NCT02000921|5653538|P3|Overall Study|Withdrawal by Subject|5
1619600|NCT02000921|5653539|P2|Overall Study|Withdrawal by Subject|10
1619601|NCT02000921|5653540|P1|Overall Study|Withdrawal by Subject|3
1619602|NCT02000817|5653570|P4|Overall Study|Lost to Follow-up|0
1619603|NCT02000817|5653571|P3|Overall Study|Lost to Follow-up|1
1619604|NCT02000817|5653572|P2|Overall Study|Lost to Follow-up|0
1619605|NCT02000817|5653573|P1|Overall Study|Lost to Follow-up|0
1619606|NCT02000817|5653570|P4|Overall Study|Adverse Event|0
1619607|NCT02000817|5653571|P3|Overall Study|Adverse Event|0
1619608|NCT02000817|5653572|P2|Overall Study|Adverse Event|1
1619609|NCT02000817|5653573|P1|Overall Study|Adverse Event|0
1619610|NCT02000817|5653570|P4|Overall Study|Withdrawal by Subject|0
1619611|NCT02000817|5653571|P3|Overall Study|Withdrawal by Subject|0
1619612|NCT02000817|5653572|P2|Overall Study|Withdrawal by Subject|0
1619613|NCT02000817|5653573|P1|Overall Study|Withdrawal by Subject|2
1619614|NCT02000752|5653668|P2|Overall Study|Shift Changes|5
1619615|NCT02000752|5653669|P1|Overall Study|Shift Changes|12
1619616|NCT02000752|5653668|P2|Overall Study|Dystocic delivery|8
1619617|NCT02000752|5653669|P1|Overall Study|Dystocic delivery|19
1619626|NCT02000531|5653706|P2|Overall Study|Discontinued due to data cut-off|8
1619627|NCT02000531|5653707|P1|Overall Study|Discontinued due to data cut-off|3
1619628|NCT02000531|5653706|P2|Overall Study|Lost to Follow-up|0
1619629|NCT02000531|5653707|P1|Overall Study|Lost to Follow-up|1
1619630|NCT02000440|5653715|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
1619631|NCT02000440|5653715|P1|Overall Study|Adverse Event|3
1619632|NCT02000427|5653735|P1|Overall Study|Death|22
1619633|NCT01999972|5653789|P6|Dose Expansion Part|Death|1
1619634|NCT01999972|5653790|P5|Dose Expansion Part|Death|2
1619635|NCT01999972|5653791|P4|Dose Expansion Part|Death|0
1619636|NCT01999972|5653792|P3|Dose Expansion Part|Death|0
1619637|NCT01999972|5653793|P2|Dose Expansion Part|Death|0
1619638|NCT01999972|5653794|P1|Dose Expansion Part|Death|0
1619639|NCT01999972|5653789|P6|Dose Expansion Part|Ongoing at data cut-off date|2
1619640|NCT01999972|5653790|P5|Dose Expansion Part|Ongoing at data cut-off date|8
1619641|NCT01999972|5653791|P4|Dose Expansion Part|Ongoing at data cut-off date|0
1619642|NCT01999972|5653792|P3|Dose Expansion Part|Ongoing at data cut-off date|0
1619643|NCT01999972|5653793|P2|Dose Expansion Part|Ongoing at data cut-off date|0
1619644|NCT01999972|5653794|P1|Dose Expansion Part|Ongoing at data cut-off date|0
1619645|NCT01999972|5653789|P6|Dose Expansion Part|Disease progression|4
1619646|NCT01999972|5653790|P5|Dose Expansion Part|Disease progression|11
1619647|NCT01999972|5653791|P4|Dose Expansion Part|Disease progression|0
1619648|NCT01999972|5653792|P3|Dose Expansion Part|Disease progression|0
1619649|NCT01999972|5653793|P2|Dose Expansion Part|Disease progression|0
1619650|NCT01999972|5653794|P1|Dose Expansion Part|Disease progression|0
1619651|NCT01999972|5653789|P6|Dose Escalation Part|Enrolled but not treated|0
1619652|NCT01999972|5653790|P5|Dose Escalation Part|Enrolled but not treated|0
1619653|NCT01999972|5653791|P4|Dose Escalation Part|Enrolled but not treated|1
1619654|NCT01999972|5653792|P3|Dose Escalation Part|Enrolled but not treated|1
1619655|NCT01999972|5653793|P2|Dose Escalation Part|Enrolled but not treated|0
1619656|NCT01999972|5653794|P1|Dose Escalation Part|Enrolled but not treated|0
1619657|NCT01999972|5653789|P6|Dose Escalation Part|Death|0
1619658|NCT01999972|5653790|P5|Dose Escalation Part|Death|0
1619659|NCT01999972|5653791|P4|Dose Escalation Part|Death|0
1619660|NCT01999972|5653792|P3|Dose Escalation Part|Death|0
1619661|NCT01999972|5653793|P2|Dose Escalation Part|Death|1
1619662|NCT01999972|5653794|P1|Dose Escalation Part|Death|0
1619663|NCT01999972|5653789|P6|Dose Escalation Part|Ongoing at data cut-off date|0
1619664|NCT01999972|5653790|P5|Dose Escalation Part|Ongoing at data cut-off date|0
1619665|NCT01999972|5653791|P4|Dose Escalation Part|Ongoing at data cut-off date|1
1619666|NCT01999972|5653792|P3|Dose Escalation Part|Ongoing at data cut-off date|1
1619667|NCT01999972|5653793|P2|Dose Escalation Part|Ongoing at data cut-off date|0
1619668|NCT01999972|5653794|P1|Dose Escalation Part|Ongoing at data cut-off date|0
1619669|NCT01999972|5653789|P6|Dose Escalation Part|Disease progression|0
1619670|NCT01999972|5653790|P5|Dose Escalation Part|Disease progression|0
1619671|NCT01999972|5653791|P4|Dose Escalation Part|Disease progression|8
1619672|NCT01999972|5653792|P3|Dose Escalation Part|Disease progression|3
1619673|NCT01999972|5653793|P2|Dose Escalation Part|Disease progression|2
1619674|NCT01999972|5653794|P1|Dose Escalation Part|Disease progression|4
1619675|NCT01999972|5653789|P6|Dose Escalation Part|Participant refused further follow-up|0
1619676|NCT01999972|5653790|P5|Dose Escalation Part|Participant refused further follow-up|0
1619677|NCT01999972|5653791|P4|Dose Escalation Part|Participant refused further follow-up|1
1619678|NCT01999972|5653792|P3|Dose Escalation Part|Participant refused further follow-up|0
1619679|NCT01999972|5653793|P2|Dose Escalation Part|Participant refused further follow-up|0
1619680|NCT01999972|5653794|P1|Dose Escalation Part|Participant refused further follow-up|1
1619681|NCT01999894|5653925|P1|Overall Study|Inclusion/exclusion criteria not met|1
1619682|NCT01999894|5653925|P1|Overall Study|Other Reason|3
1619683|NCT01999894|5653925|P1|Overall Study|Lost to Follow-up|10
1619684|NCT01999894|5653925|P1|Overall Study|Withdrawal by Subject|7
1619685|NCT01999894|5653925|P1|Overall Study|Protocol Violation|1
1619686|NCT01999894|5653925|P1|Overall Study|Lack of Efficacy|5
1619687|NCT01999894|5653925|P1|Overall Study|Adverse Event|9
1619688|NCT01999868|5653933|P3|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|0
1619689|NCT01999868|5653934|P2|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|4
1619690|NCT01999868|5653935|P1|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|12
1619691|NCT01999868|5653933|P3|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
1619692|NCT01999868|5653934|P2|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|2
1619693|NCT01999868|5653935|P1|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
1619694|NCT01999868|5653933|P3|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|0
1619695|NCT01999868|5653934|P2|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|19
1619696|NCT01999868|5653935|P1|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|10
1619697|NCT01999868|5653933|P3|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|0
1619698|NCT01999868|5653934|P2|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|2
1619699|NCT01999868|5653935|P1|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|1
1619700|NCT01999868|5653933|P3|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
1619701|NCT01999868|5653934|P2|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|1
1619702|NCT01999868|5653935|P1|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
1619703|NCT01999868|5653933|P3|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
1619704|NCT01999868|5653934|P2|Blinded Observation Phase (Week 40 – 88)|Adverse Event|1
1619705|NCT01999868|5653935|P1|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
1619706|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
1619707|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
1619708|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|4
1619709|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
1619710|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
1619711|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|1
1619712|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|0
1619713|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|1
1619714|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|8
1619715|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|0
1619716|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|2
1619717|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|1
1619718|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
1619719|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|2
1619720|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
1619721|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
1619722|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|1
1619723|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
1619724|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|0
1619725|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|4
1619726|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|3
1619727|NCT01999868|5653933|P3|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|0
1619728|NCT01999868|5653934|P2|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
1619729|NCT01999868|5653935|P1|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
1619730|NCT01999868|5653933|P3|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|5
1619731|NCT01999868|5653934|P2|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
1619732|NCT01999868|5653935|P1|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
1619733|NCT01999465|5653986|P2|Overall Study|Protocol Violation|1
1619734|NCT01999465|5653987|P1|Overall Study|Protocol Violation|0
1619735|NCT01999465|5653986|P2|Overall Study|Lost to Follow-up|2
1619736|NCT01999465|5653987|P1|Overall Study|Lost to Follow-up|0
1619737|NCT01999322|5654032|P2|Overall Study|Adverse Event|0
1619738|NCT01999322|5654033|P1|Overall Study|Adverse Event|1
1619739|NCT01999218|5654085|P3|Overall Study|Treated but excluded at 1 trial site|2
1619740|NCT01999218|5654086|P2|Overall Study|Treated but excluded at 1 trial site|5
1619741|NCT01999218|5654087|P1|Overall Study|Treated but excluded at 1 trial site|3
1619742|NCT01999218|5654085|P3|Overall Study|Adverse Event|7
1619743|NCT01999218|5654086|P2|Overall Study|Adverse Event|7
1619744|NCT01999218|5654087|P1|Overall Study|Adverse Event|9
1619745|NCT01999218|5654085|P3|Overall Study|Excluded Medication|2
1619746|NCT01999218|5654086|P2|Overall Study|Excluded Medication|1
1619747|NCT01999218|5654087|P1|Overall Study|Excluded Medication|1
1619748|NCT01999218|5654085|P3|Overall Study|Death|2
1619749|NCT01999218|5654086|P2|Overall Study|Death|1
1619750|NCT01999218|5654087|P1|Overall Study|Death|7
1619751|NCT01999218|5654085|P3|Overall Study|Creatinine/eGFR|1
1619752|NCT01999218|5654086|P2|Overall Study|Creatinine/eGFR|0
1619753|NCT01999218|5654087|P1|Overall Study|Creatinine/eGFR|0
1619754|NCT01999218|5654085|P3|Overall Study|Withdrawal by Subject|34
1619755|NCT01999218|5654086|P2|Overall Study|Withdrawal by Subject|29
1619756|NCT01999218|5654087|P1|Overall Study|Withdrawal by Subject|28
1619757|NCT01999218|5654085|P3|Overall Study|Participant moves|3
1619758|NCT01999218|5654086|P2|Overall Study|Participant moves|5
1619759|NCT01999218|5654087|P1|Overall Study|Participant moves|2
1619760|NCT01999218|5654085|P3|Overall Study|Study Terminated By Sponsor|12
1619761|NCT01999218|5654086|P2|Overall Study|Study Terminated By Sponsor|5
1619762|NCT01999218|5654087|P1|Overall Study|Study Terminated By Sponsor|7
1619763|NCT01999218|5654085|P3|Overall Study|Screen failure|0
1619764|NCT01999218|5654086|P2|Overall Study|Screen failure|1
1619765|NCT01999218|5654087|P1|Overall Study|Screen failure|0
1619766|NCT01999218|5654085|P3|Overall Study|Protocol Violation|4
1619767|NCT01999218|5654086|P2|Overall Study|Protocol Violation|5
1619768|NCT01999218|5654087|P1|Overall Study|Protocol Violation|4
1619769|NCT01999218|5654085|P3|Overall Study|Physician Decision|6
1619770|NCT01999218|5654086|P2|Overall Study|Physician Decision|4
1619771|NCT01999218|5654087|P1|Overall Study|Physician Decision|1
1619772|NCT01999218|5654085|P3|Overall Study|Non-Compliance With Study Drug|1
1619773|NCT01999218|5654086|P2|Overall Study|Non-Compliance With Study Drug|4
1619774|NCT01999218|5654087|P1|Overall Study|Non-Compliance With Study Drug|6
1619775|NCT01999218|5654085|P3|Overall Study|Lost to Follow-up|18
1619776|NCT01999218|5654086|P2|Overall Study|Lost to Follow-up|17
1619777|NCT01999218|5654087|P1|Overall Study|Lost to Follow-up|22
1619778|NCT01999218|5654085|P3|Overall Study|Lack of Efficacy|1
1619779|NCT01999218|5654086|P2|Overall Study|Lack of Efficacy|0
1619780|NCT01999218|5654087|P1|Overall Study|Lack of Efficacy|1
1619781|NCT01999218|5654085|P3|Overall Study|Hyperglycemia|17
1619782|NCT01999218|5654086|P2|Overall Study|Hyperglycemia|17
1619783|NCT01999218|5654087|P1|Overall Study|Hyperglycemia|18
1619784|NCT01999114|5654132|P5|Overall Study|Administrative|2
1619785|NCT01999114|5654133|P4|Overall Study|Administrative|1
1619786|NCT01999114|5654134|P3|Overall Study|Administrative|1
1619787|NCT01999114|5654135|P2|Overall Study|Administrative|0
1619788|NCT01999114|5654136|P1|Overall Study|Administrative|0
1619789|NCT01999114|5654132|P5|Overall Study|Lost to Follow-up|0
1619790|NCT01999114|5654133|P4|Overall Study|Lost to Follow-up|0
1619791|NCT01999114|5654134|P3|Overall Study|Lost to Follow-up|1
1619792|NCT01999114|5654135|P2|Overall Study|Lost to Follow-up|0
1619793|NCT01999114|5654136|P1|Overall Study|Lost to Follow-up|0
1619794|NCT01999114|5654132|P5|Overall Study|Withdrawal by Subject|1
1619795|NCT01999114|5654133|P4|Overall Study|Withdrawal by Subject|0
1619796|NCT01999114|5654134|P3|Overall Study|Withdrawal by Subject|1
1619797|NCT01999114|5654135|P2|Overall Study|Withdrawal by Subject|0
1619798|NCT01999114|5654136|P1|Overall Study|Withdrawal by Subject|0
1619799|NCT01999114|5654132|P5|Overall Study|Adverse Event|1
1619800|NCT01999114|5654133|P4|Overall Study|Adverse Event|2
1619801|NCT01999114|5654134|P3|Overall Study|Adverse Event|2
1619802|NCT01999114|5654135|P2|Overall Study|Adverse Event|7
1619803|NCT01999114|5654136|P1|Overall Study|Adverse Event|8
1619804|NCT01998984|5654204|P4|Overall Study|Other|1
1619805|NCT01998984|5654205|P3|Overall Study|Other|0
1619806|NCT01998984|5654206|P2|Overall Study|Other|0
1619807|NCT01998984|5654207|P1|Overall Study|Other|0
1619808|NCT01998984|5654204|P4|Overall Study|Withdrawal by Subject|0
1619809|NCT01998984|5654205|P3|Overall Study|Withdrawal by Subject|1
1619810|NCT01998984|5654206|P2|Overall Study|Withdrawal by Subject|0
1619811|NCT01998984|5654207|P1|Overall Study|Withdrawal by Subject|0
1619812|NCT01998984|5654204|P4|Overall Study|Lost to Follow-up|1
1619813|NCT01998984|5654205|P3|Overall Study|Lost to Follow-up|0
1619814|NCT01998984|5654206|P2|Overall Study|Lost to Follow-up|1
1619815|NCT01998984|5654207|P1|Overall Study|Lost to Follow-up|0
1619816|NCT01998984|5654204|P4|Overall Study|Adverse Event|1
1619817|NCT01998984|5654205|P3|Overall Study|Adverse Event|0
1619818|NCT01998984|5654206|P2|Overall Study|Adverse Event|0
1619819|NCT01998984|5654207|P1|Overall Study|Adverse Event|0
1619820|NCT01998958|5654232|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
1619821|NCT01998958|5654233|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
1619822|NCT01998958|5654234|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
1619823|NCT01998958|5654235|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
1619824|NCT01998958|5654236|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
1619825|NCT01998958|5654237|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
1619826|NCT01998958|5654238|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
1619827|NCT01998958|5654239|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
1619828|NCT01998958|5654240|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
1619829|NCT01998958|5654241|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
1619830|NCT01998958|5654242|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
1619831|NCT01998958|5654243|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
1619832|NCT01998958|5654244|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
1619833|NCT01998958|5654245|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
1619834|NCT01998958|5654246|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
1619835|NCT01998958|5654247|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
1619836|NCT01998958|5654248|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
1619837|NCT01998958|5654249|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
1619838|NCT01998958|5654250|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
1619839|NCT01998958|5654251|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
1619840|NCT01998958|5654252|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
1619841|NCT01998958|5654253|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
1619842|NCT01998958|5654254|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
1619843|NCT01998958|5654255|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
1619844|NCT01998958|5654256|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
1619845|NCT01998958|5654257|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
1619846|NCT01998958|5654258|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
1619847|NCT01998958|5654259|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
1619848|NCT01998958|5654260|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
1619849|NCT01998958|5654261|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
1619850|NCT01998958|5654262|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
1619851|NCT01998958|5654263|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
1619852|NCT01998958|5654232|P32|Open Label Phase (Optional)|Lack of Efficacy|0
1619853|NCT01998958|5654233|P31|Open Label Phase (Optional)|Lack of Efficacy|0
1619854|NCT01998958|5654234|P30|Open Label Phase (Optional)|Lack of Efficacy|0
1619855|NCT01998958|5654235|P29|Open Label Phase (Optional)|Lack of Efficacy|0
1619856|NCT01998958|5654236|P28|Open Label Phase (Optional)|Lack of Efficacy|0
1619857|NCT01998958|5654237|P27|Open Label Phase (Optional)|Lack of Efficacy|0
1619858|NCT01998958|5654238|P26|Open Label Phase (Optional)|Lack of Efficacy|0
1619859|NCT01998958|5654239|P25|Open Label Phase (Optional)|Lack of Efficacy|0
1619860|NCT01998958|5654240|P24|Open Label Phase (Optional)|Lack of Efficacy|0
1619861|NCT01998958|5654241|P23|Open Label Phase (Optional)|Lack of Efficacy|2
1619862|NCT01998958|5654242|P22|Open Label Phase (Optional)|Lack of Efficacy|1
1619863|NCT01998958|5654243|P21|Open Label Phase (Optional)|Lack of Efficacy|0
1619864|NCT01998958|5654244|P20|Open Label Phase (Optional)|Lack of Efficacy|0
1619865|NCT01998958|5654245|P19|Open Label Phase (Optional)|Lack of Efficacy|0
1619866|NCT01998958|5654246|P18|Open Label Phase (Optional)|Lack of Efficacy|0
1619867|NCT01998958|5654247|P17|Open Label Phase (Optional)|Lack of Efficacy|0
1619868|NCT01998958|5654248|P16|Open Label Phase (Optional)|Lack of Efficacy|0
1619869|NCT01998958|5654249|P15|Open Label Phase (Optional)|Lack of Efficacy|0
1619870|NCT01998958|5654250|P14|Open Label Phase (Optional)|Lack of Efficacy|0
1619871|NCT01998958|5654251|P13|Open Label Phase (Optional)|Lack of Efficacy|0
1619872|NCT01998958|5654252|P12|Open Label Phase (Optional)|Lack of Efficacy|0
1619873|NCT01998958|5654253|P11|Open Label Phase (Optional)|Lack of Efficacy|0
1619874|NCT01998958|5654254|P10|Open Label Phase (Optional)|Lack of Efficacy|0
1619875|NCT01998958|5654255|P9|Open Label Phase (Optional)|Lack of Efficacy|0
1619876|NCT01998958|5654256|P8|Open Label Phase (Optional)|Lack of Efficacy|0
1619877|NCT01998958|5654257|P7|Open Label Phase (Optional)|Lack of Efficacy|0
1619878|NCT01998958|5654258|P6|Open Label Phase (Optional)|Lack of Efficacy|0
1619879|NCT01998958|5654259|P5|Open Label Phase (Optional)|Lack of Efficacy|0
1619880|NCT01998958|5654260|P4|Open Label Phase (Optional)|Lack of Efficacy|0
1619881|NCT01998958|5654261|P3|Open Label Phase (Optional)|Lack of Efficacy|0
1619882|NCT01998958|5654262|P2|Open Label Phase (Optional)|Lack of Efficacy|0
1619883|NCT01998958|5654263|P1|Open Label Phase (Optional)|Lack of Efficacy|0
1619884|NCT01998958|5654232|P32|Open Label Phase (Optional)|Lost to Follow-up|0
1619885|NCT01998958|5654233|P31|Open Label Phase (Optional)|Lost to Follow-up|0
1619886|NCT01998958|5654234|P30|Open Label Phase (Optional)|Lost to Follow-up|0
1619887|NCT01998958|5654235|P29|Open Label Phase (Optional)|Lost to Follow-up|0
1619888|NCT01998958|5654236|P28|Open Label Phase (Optional)|Lost to Follow-up|0
1619889|NCT01998958|5654237|P27|Open Label Phase (Optional)|Lost to Follow-up|0
1619890|NCT01998958|5654238|P26|Open Label Phase (Optional)|Lost to Follow-up|0
1619891|NCT01998958|5654239|P25|Open Label Phase (Optional)|Lost to Follow-up|0
1619892|NCT01998958|5654240|P24|Open Label Phase (Optional)|Lost to Follow-up|0
1619893|NCT01998958|5654241|P23|Open Label Phase (Optional)|Lost to Follow-up|1
1619894|NCT01998958|5654242|P22|Open Label Phase (Optional)|Lost to Follow-up|0
1619895|NCT01998958|5654243|P21|Open Label Phase (Optional)|Lost to Follow-up|0
1619896|NCT01998958|5654244|P20|Open Label Phase (Optional)|Lost to Follow-up|0
1619897|NCT01998958|5654245|P19|Open Label Phase (Optional)|Lost to Follow-up|0
1619898|NCT01998958|5654246|P18|Open Label Phase (Optional)|Lost to Follow-up|0
1619899|NCT01998958|5654247|P17|Open Label Phase (Optional)|Lost to Follow-up|0
1619900|NCT01998958|5654248|P16|Open Label Phase (Optional)|Lost to Follow-up|0
1619901|NCT01998958|5654249|P15|Open Label Phase (Optional)|Lost to Follow-up|0
1619902|NCT01998958|5654250|P14|Open Label Phase (Optional)|Lost to Follow-up|0
1619903|NCT01998958|5654251|P13|Open Label Phase (Optional)|Lost to Follow-up|0
1619904|NCT01998958|5654252|P12|Open Label Phase (Optional)|Lost to Follow-up|0
1619905|NCT01998958|5654253|P11|Open Label Phase (Optional)|Lost to Follow-up|0
1619906|NCT01998958|5654254|P10|Open Label Phase (Optional)|Lost to Follow-up|0
1619907|NCT01998958|5654255|P9|Open Label Phase (Optional)|Lost to Follow-up|0
1619908|NCT01998958|5654256|P8|Open Label Phase (Optional)|Lost to Follow-up|0
1619909|NCT01998958|5654257|P7|Open Label Phase (Optional)|Lost to Follow-up|0
1619910|NCT01998958|5654258|P6|Open Label Phase (Optional)|Lost to Follow-up|0
1619911|NCT01998958|5654259|P5|Open Label Phase (Optional)|Lost to Follow-up|0
1619912|NCT01998958|5654260|P4|Open Label Phase (Optional)|Lost to Follow-up|0
1619913|NCT01998958|5654261|P3|Open Label Phase (Optional)|Lost to Follow-up|0
1619914|NCT01998958|5654262|P2|Open Label Phase (Optional)|Lost to Follow-up|0
1619915|NCT01998958|5654263|P1|Open Label Phase (Optional)|Lost to Follow-up|0
1619916|NCT01998958|5654232|P32|Open Label Phase (Optional)|Other|0
1619917|NCT01998958|5654233|P31|Open Label Phase (Optional)|Other|0
1619918|NCT01998958|5654234|P30|Open Label Phase (Optional)|Other|0
1619919|NCT01998958|5654235|P29|Open Label Phase (Optional)|Other|0
1619920|NCT01998958|5654236|P28|Open Label Phase (Optional)|Other|0
1619921|NCT01998958|5654237|P27|Open Label Phase (Optional)|Other|0
1619922|NCT01998958|5654238|P26|Open Label Phase (Optional)|Other|0
1619923|NCT01998958|5654239|P25|Open Label Phase (Optional)|Other|0
1619924|NCT01998958|5654240|P24|Open Label Phase (Optional)|Other|1
1619925|NCT01998958|5654241|P23|Open Label Phase (Optional)|Other|5
1619926|NCT01998958|5654242|P22|Open Label Phase (Optional)|Other|0
1619927|NCT01998958|5654243|P21|Open Label Phase (Optional)|Other|0
1619928|NCT01998958|5654244|P20|Open Label Phase (Optional)|Other|0
1619929|NCT01998958|5654245|P19|Open Label Phase (Optional)|Other|0
1619930|NCT01998958|5654246|P18|Open Label Phase (Optional)|Other|0
1619931|NCT01998958|5654247|P17|Open Label Phase (Optional)|Other|0
1619932|NCT01998958|5654248|P16|Open Label Phase (Optional)|Other|0
1619933|NCT01998958|5654249|P15|Open Label Phase (Optional)|Other|0
1619934|NCT01998958|5654250|P14|Open Label Phase (Optional)|Other|0
1619935|NCT01998958|5654251|P13|Open Label Phase (Optional)|Other|0
1619936|NCT01998958|5654252|P12|Open Label Phase (Optional)|Other|0
1619937|NCT01998958|5654253|P11|Open Label Phase (Optional)|Other|0
1619938|NCT01998958|5654254|P10|Open Label Phase (Optional)|Other|0
1619939|NCT01998958|5654255|P9|Open Label Phase (Optional)|Other|0
1619940|NCT01998958|5654256|P8|Open Label Phase (Optional)|Other|0
1619941|NCT01998958|5654257|P7|Open Label Phase (Optional)|Other|0
1619942|NCT01998958|5654258|P6|Open Label Phase (Optional)|Other|0
1619943|NCT01998958|5654259|P5|Open Label Phase (Optional)|Other|0
1619944|NCT01998958|5654260|P4|Open Label Phase (Optional)|Other|0
1619945|NCT01998958|5654261|P3|Open Label Phase (Optional)|Other|0
1619946|NCT01998958|5654262|P2|Open Label Phase (Optional)|Other|0
1619947|NCT01998958|5654263|P1|Open Label Phase (Optional)|Other|0
1619948|NCT01998958|5654232|P32|Open Label Phase (Optional)|Adverse Event|0
1619949|NCT01998958|5654233|P31|Open Label Phase (Optional)|Adverse Event|0
1619950|NCT01998958|5654234|P30|Open Label Phase (Optional)|Adverse Event|0
1619951|NCT01998958|5654235|P29|Open Label Phase (Optional)|Adverse Event|0
1619952|NCT01998958|5654236|P28|Open Label Phase (Optional)|Adverse Event|0
1619953|NCT01998958|5654237|P27|Open Label Phase (Optional)|Adverse Event|0
1619954|NCT01998958|5654238|P26|Open Label Phase (Optional)|Adverse Event|0
1619955|NCT01998958|5654239|P25|Open Label Phase (Optional)|Adverse Event|0
1619956|NCT01998958|5654240|P24|Open Label Phase (Optional)|Adverse Event|1
1619957|NCT01998958|5654241|P23|Open Label Phase (Optional)|Adverse Event|0
1619958|NCT01998958|5654242|P22|Open Label Phase (Optional)|Adverse Event|0
1619959|NCT01998958|5654243|P21|Open Label Phase (Optional)|Adverse Event|0
1619960|NCT01998958|5654244|P20|Open Label Phase (Optional)|Adverse Event|0
1619961|NCT01998958|5654245|P19|Open Label Phase (Optional)|Adverse Event|0
1619962|NCT01998958|5654246|P18|Open Label Phase (Optional)|Adverse Event|0
1619963|NCT01998958|5654247|P17|Open Label Phase (Optional)|Adverse Event|0
1619964|NCT01998958|5654248|P16|Open Label Phase (Optional)|Adverse Event|0
1619965|NCT01998958|5654249|P15|Open Label Phase (Optional)|Adverse Event|0
1619966|NCT01998958|5654250|P14|Open Label Phase (Optional)|Adverse Event|0
1619967|NCT01998958|5654251|P13|Open Label Phase (Optional)|Adverse Event|0
1619968|NCT01998958|5654252|P12|Open Label Phase (Optional)|Adverse Event|0
1619969|NCT01998958|5654253|P11|Open Label Phase (Optional)|Adverse Event|0
1619970|NCT01998958|5654254|P10|Open Label Phase (Optional)|Adverse Event|0
1619971|NCT01998958|5654255|P9|Open Label Phase (Optional)|Adverse Event|0
1619972|NCT01998958|5654256|P8|Open Label Phase (Optional)|Adverse Event|0
1619973|NCT01998958|5654257|P7|Open Label Phase (Optional)|Adverse Event|0
1619974|NCT01998958|5654258|P6|Open Label Phase (Optional)|Adverse Event|0
1619975|NCT01998958|5654259|P5|Open Label Phase (Optional)|Adverse Event|0
1619976|NCT01998958|5654260|P4|Open Label Phase (Optional)|Adverse Event|0
1619977|NCT01998958|5654261|P3|Open Label Phase (Optional)|Adverse Event|0
1619978|NCT01998958|5654262|P2|Open Label Phase (Optional)|Adverse Event|0
1619979|NCT01998958|5654263|P1|Open Label Phase (Optional)|Adverse Event|0
1619980|NCT01998958|5654232|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619981|NCT01998958|5654233|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619982|NCT01998958|5654234|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619983|NCT01998958|5654235|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619984|NCT01998958|5654236|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619985|NCT01998958|5654237|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619986|NCT01998958|5654238|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619987|NCT01998958|5654239|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619988|NCT01998958|5654240|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619989|NCT01998958|5654241|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619990|NCT01998958|5654242|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619991|NCT01998958|5654243|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619992|NCT01998958|5654244|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619993|NCT01998958|5654245|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
1619994|NCT01998958|5654246|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619995|NCT01998958|5654247|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619996|NCT01998958|5654248|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619997|NCT01998958|5654249|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
1619998|NCT01998958|5654250|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
1619999|NCT01998958|5654251|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620000|NCT01998958|5654252|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620001|NCT01998958|5654253|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620002|NCT01998958|5654254|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620003|NCT01998958|5654255|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620004|NCT01998958|5654256|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620005|NCT01998958|5654257|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620006|NCT01998958|5654258|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620007|NCT01998958|5654259|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620008|NCT01998958|5654260|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620009|NCT01998958|5654261|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620010|NCT01998958|5654262|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620011|NCT01998958|5654263|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
1620012|NCT01998958|5654232|P32|Period 2 (Panel A and B)|Adverse Event|0
1620013|NCT01998958|5654233|P31|Period 2 (Panel A and B)|Adverse Event|0
1620014|NCT01998958|5654234|P30|Period 2 (Panel A and B)|Adverse Event|0
1620015|NCT01998958|5654235|P29|Period 2 (Panel A and B)|Adverse Event|0
1620016|NCT01998958|5654236|P28|Period 2 (Panel A and B)|Adverse Event|0
1620017|NCT01998958|5654237|P27|Period 2 (Panel A and B)|Adverse Event|0
1620018|NCT01998958|5654238|P26|Period 2 (Panel A and B)|Adverse Event|0
1620019|NCT01998958|5654239|P25|Period 2 (Panel A and B)|Adverse Event|0
1620020|NCT01998958|5654240|P24|Period 2 (Panel A and B)|Adverse Event|0
1620021|NCT01998958|5654241|P23|Period 2 (Panel A and B)|Adverse Event|0
1620022|NCT01998958|5654242|P22|Period 2 (Panel A and B)|Adverse Event|0
1620023|NCT01998958|5654243|P21|Period 2 (Panel A and B)|Adverse Event|0
1620024|NCT01998958|5654244|P20|Period 2 (Panel A and B)|Adverse Event|0
1620025|NCT01998958|5654245|P19|Period 2 (Panel A and B)|Adverse Event|0
1620026|NCT01998958|5654246|P18|Period 2 (Panel A and B)|Adverse Event|0
1620027|NCT01998958|5654247|P17|Period 2 (Panel A and B)|Adverse Event|0
1620028|NCT01998958|5654248|P16|Period 2 (Panel A and B)|Adverse Event|0
1620029|NCT01998958|5654249|P15|Period 2 (Panel A and B)|Adverse Event|1
1620030|NCT01998958|5654250|P14|Period 2 (Panel A and B)|Adverse Event|0
1620031|NCT01998958|5654251|P13|Period 2 (Panel A and B)|Adverse Event|0
1620032|NCT01998958|5654252|P12|Period 2 (Panel A and B)|Adverse Event|0
1620033|NCT01998958|5654253|P11|Period 2 (Panel A and B)|Adverse Event|1
1620034|NCT01998958|5654254|P10|Period 2 (Panel A and B)|Adverse Event|0
1620035|NCT01998958|5654255|P9|Period 2 (Panel A and B)|Adverse Event|0
1620036|NCT01998958|5654256|P8|Period 2 (Panel A and B)|Adverse Event|0
1620037|NCT01998958|5654257|P7|Period 2 (Panel A and B)|Adverse Event|0
1620038|NCT01998958|5654258|P6|Period 2 (Panel A and B)|Adverse Event|0
1620039|NCT01998958|5654259|P5|Period 2 (Panel A and B)|Adverse Event|0
1620040|NCT01998958|5654260|P4|Period 2 (Panel A and B)|Adverse Event|0
1620041|NCT01998958|5654261|P3|Period 2 (Panel A and B)|Adverse Event|0
1620042|NCT01998958|5654262|P2|Period 2 (Panel A and B)|Adverse Event|0
1620043|NCT01998958|5654263|P1|Period 2 (Panel A and B)|Adverse Event|0
1620044|NCT01998958|5654232|P32|Period 1 (Panel A and B)|Other|0
1620045|NCT01998958|5654233|P31|Period 1 (Panel A and B)|Other|0
1620046|NCT01998958|5654234|P30|Period 1 (Panel A and B)|Other|0
1620047|NCT01998958|5654235|P29|Period 1 (Panel A and B)|Other|0
1620048|NCT01998958|5654236|P28|Period 1 (Panel A and B)|Other|0
1620049|NCT01998958|5654237|P27|Period 1 (Panel A and B)|Other|0
1620050|NCT01998958|5654238|P26|Period 1 (Panel A and B)|Other|0
1620051|NCT01998958|5654239|P25|Period 1 (Panel A and B)|Other|0
1620052|NCT01998958|5654240|P24|Period 1 (Panel A and B)|Other|0
1620053|NCT01998958|5654241|P23|Period 1 (Panel A and B)|Other|0
1620054|NCT01998958|5654242|P22|Period 1 (Panel A and B)|Other|0
1620055|NCT01998958|5654243|P21|Period 1 (Panel A and B)|Other|0
1620056|NCT01998958|5654244|P20|Period 1 (Panel A and B)|Other|0
1620057|NCT01998958|5654245|P19|Period 1 (Panel A and B)|Other|0
1620058|NCT01998958|5654246|P18|Period 1 (Panel A and B)|Other|0
1620059|NCT01998958|5654247|P17|Period 1 (Panel A and B)|Other|0
1620060|NCT01998958|5654248|P16|Period 1 (Panel A and B)|Other|0
1620061|NCT01998958|5654249|P15|Period 1 (Panel A and B)|Other|0
1620062|NCT01998958|5654250|P14|Period 1 (Panel A and B)|Other|0
1620063|NCT01998958|5654251|P13|Period 1 (Panel A and B)|Other|0
1620064|NCT01998958|5654252|P12|Period 1 (Panel A and B)|Other|0
1620065|NCT01998958|5654253|P11|Period 1 (Panel A and B)|Other|0
1620066|NCT01998958|5654254|P10|Period 1 (Panel A and B)|Other|0
1620067|NCT01998958|5654255|P9|Period 1 (Panel A and B)|Other|0
1620068|NCT01998958|5654256|P8|Period 1 (Panel A and B)|Other|0
1620069|NCT01998958|5654257|P7|Period 1 (Panel A and B)|Other|0
1620070|NCT01998958|5654258|P6|Period 1 (Panel A and B)|Other|0
1620071|NCT01998958|5654259|P5|Period 1 (Panel A and B)|Other|0
1620072|NCT01998958|5654260|P4|Period 1 (Panel A and B)|Other|0
1620073|NCT01998958|5654261|P3|Period 1 (Panel A and B)|Other|0
1620074|NCT01998958|5654262|P2|Period 1 (Panel A and B)|Other|0
1620075|NCT01998958|5654263|P1|Period 1 (Panel A and B)|Other|1
1620076|NCT01998958|5654232|P32|Period 1 (Panel A and B)|Adverse Event|0
1620077|NCT01998958|5654233|P31|Period 1 (Panel A and B)|Adverse Event|0
1620078|NCT01998958|5654234|P30|Period 1 (Panel A and B)|Adverse Event|0
1620079|NCT01998958|5654235|P29|Period 1 (Panel A and B)|Adverse Event|0
1620080|NCT01998958|5654236|P28|Period 1 (Panel A and B)|Adverse Event|0
1620081|NCT01998958|5654237|P27|Period 1 (Panel A and B)|Adverse Event|0
1620082|NCT01998958|5654238|P26|Period 1 (Panel A and B)|Adverse Event|0
1620083|NCT01998958|5654239|P25|Period 1 (Panel A and B)|Adverse Event|0
1620084|NCT01998958|5654240|P24|Period 1 (Panel A and B)|Adverse Event|0
1620085|NCT01998958|5654241|P23|Period 1 (Panel A and B)|Adverse Event|0
1620086|NCT01998958|5654242|P22|Period 1 (Panel A and B)|Adverse Event|0
1620087|NCT01998958|5654243|P21|Period 1 (Panel A and B)|Adverse Event|0
1620088|NCT01998958|5654244|P20|Period 1 (Panel A and B)|Adverse Event|0
1620089|NCT01998958|5654245|P19|Period 1 (Panel A and B)|Adverse Event|0
1620090|NCT01998958|5654246|P18|Period 1 (Panel A and B)|Adverse Event|0
1620091|NCT01998958|5654247|P17|Period 1 (Panel A and B)|Adverse Event|0
1620092|NCT01998958|5654248|P16|Period 1 (Panel A and B)|Adverse Event|0
1620093|NCT01998958|5654249|P15|Period 1 (Panel A and B)|Adverse Event|0
1620094|NCT01998958|5654250|P14|Period 1 (Panel A and B)|Adverse Event|0
1620095|NCT01998958|5654251|P13|Period 1 (Panel A and B)|Adverse Event|0
1620096|NCT01998958|5654252|P12|Period 1 (Panel A and B)|Adverse Event|0
1620097|NCT01998958|5654253|P11|Period 1 (Panel A and B)|Adverse Event|0
1620098|NCT01998958|5654254|P10|Period 1 (Panel A and B)|Adverse Event|0
1620099|NCT01998958|5654255|P9|Period 1 (Panel A and B)|Adverse Event|0
1620100|NCT01998958|5654256|P8|Period 1 (Panel A and B)|Adverse Event|0
1620101|NCT01998958|5654257|P7|Period 1 (Panel A and B)|Adverse Event|0
1620102|NCT01998958|5654258|P6|Period 1 (Panel A and B)|Adverse Event|0
1620103|NCT01998958|5654259|P5|Period 1 (Panel A and B)|Adverse Event|0
1620104|NCT01998958|5654260|P4|Period 1 (Panel A and B)|Adverse Event|0
1620105|NCT01998958|5654261|P3|Period 1 (Panel A and B)|Adverse Event|0
1620106|NCT01998958|5654262|P2|Period 1 (Panel A and B)|Adverse Event|1
1620107|NCT01998958|5654263|P1|Period 1 (Panel A and B)|Adverse Event|0
1620108|NCT01998958|5654232|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
1620109|NCT01998958|5654233|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
1620110|NCT01998958|5654234|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
1620111|NCT01998958|5654235|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
1620112|NCT01998958|5654236|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
1620113|NCT01998958|5654237|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
1620114|NCT01998958|5654238|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
1620115|NCT01998958|5654239|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
1620116|NCT01998958|5654240|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
1620117|NCT01998958|5654241|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
1620118|NCT01998958|5654242|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
1620119|NCT01998958|5654243|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
1620120|NCT01998958|5654244|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
1620121|NCT01998958|5654245|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
1620122|NCT01998958|5654246|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
1620123|NCT01998958|5654247|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
1620124|NCT01998958|5654248|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
1620125|NCT01998958|5654249|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
1620126|NCT01998958|5654250|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
1620127|NCT01998958|5654251|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
1620128|NCT01998958|5654252|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
1620129|NCT01998958|5654253|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
1620130|NCT01998958|5654254|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
1620131|NCT01998958|5654255|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
1620132|NCT01998958|5654256|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
1620133|NCT01998958|5654257|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
1620134|NCT01998958|5654258|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
1620135|NCT01998958|5654259|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
1620136|NCT01998958|5654260|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
1620137|NCT01998958|5654261|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
1620138|NCT01998958|5654262|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
1620139|NCT01998958|5654263|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
1620140|NCT01998958|5654232|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620141|NCT01998958|5654233|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620142|NCT01998958|5654234|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620143|NCT01998958|5654235|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620144|NCT01998958|5654236|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620145|NCT01998958|5654237|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620146|NCT01998958|5654238|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620147|NCT01998958|5654239|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620148|NCT01998958|5654240|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620149|NCT01998958|5654241|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620150|NCT01998958|5654242|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620151|NCT01998958|5654243|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620152|NCT01998958|5654244|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620153|NCT01998958|5654245|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620154|NCT01998958|5654246|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620155|NCT01998958|5654247|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620156|NCT01998958|5654248|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620157|NCT01998958|5654249|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620158|NCT01998958|5654250|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620159|NCT01998958|5654251|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620160|NCT01998958|5654252|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620161|NCT01998958|5654253|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620162|NCT01998958|5654254|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620163|NCT01998958|5654255|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620164|NCT01998958|5654256|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620165|NCT01998958|5654257|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620166|NCT01998958|5654258|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620167|NCT01998958|5654259|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620168|NCT01998958|5654260|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620169|NCT01998958|5654261|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620170|NCT01998958|5654262|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
1620171|NCT01998958|5654263|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
1620172|NCT01998919|5654402|P2|Overall Study|Other|2
1620173|NCT01998919|5654403|P1|Overall Study|Other|5
1620174|NCT01998919|5654402|P2|Overall Study|Lost to Follow-up|0
1620175|NCT01998919|5654403|P1|Overall Study|Lost to Follow-up|2
1620176|NCT01998919|5654402|P2|Overall Study|Withdrawal by Subject|4
1620177|NCT01998919|5654403|P1|Overall Study|Withdrawal by Subject|2
1620178|NCT01998919|5654402|P2|Overall Study|Disease progression|22
1620179|NCT01998919|5654403|P1|Overall Study|Disease progression|31
1620180|NCT01998919|5654402|P2|Overall Study|Adverse Event|5
1620181|NCT01998919|5654403|P1|Overall Study|Adverse Event|0
1620182|NCT01998919|5654402|P2|Overall Study|Death|2
1620183|NCT01998919|5654403|P1|Overall Study|Death|2
1620184|NCT01998906|5654424|P3|Overall Study|Other|4
1620185|NCT01998906|5654425|P2|Overall Study|Other|8
1620186|NCT01998906|5654426|P1|Overall Study|Other|3
1620187|NCT01998906|5654424|P3|Overall Study|Administrative/Other|3
1620188|NCT01998906|5654425|P2|Overall Study|Administrative/Other|1
1620189|NCT01998906|5654426|P1|Overall Study|Administrative/Other|2
1620190|NCT01998906|5654424|P3|Overall Study|Withdrawal by Subject|3
1620191|NCT01998906|5654425|P2|Overall Study|Withdrawal by Subject|4
1620192|NCT01998906|5654426|P1|Overall Study|Withdrawal by Subject|1
1620193|NCT01998906|5654424|P3|Overall Study|Violation of Selection Criteria|1
1620194|NCT01998906|5654425|P2|Overall Study|Violation of Selection Criteria|0
1620195|NCT01998906|5654426|P1|Overall Study|Violation of Selection Criteria|0
1620196|NCT01998906|5654424|P3|Overall Study|Failure to return|4
1620197|NCT01998906|5654425|P2|Overall Study|Failure to return|2
1620198|NCT01998906|5654426|P1|Overall Study|Failure to return|0
1620199|NCT01998906|5654424|P3|Overall Study|Lack of Efficacy|8
1620200|NCT01998906|5654425|P2|Overall Study|Lack of Efficacy|9
1620201|NCT01998906|5654426|P1|Overall Study|Lack of Efficacy|10
1620202|NCT01998906|5654424|P3|Overall Study|Death|17
1620203|NCT01998906|5654425|P2|Overall Study|Death|30
1620204|NCT01998906|5654426|P1|Overall Study|Death|21
1620205|NCT01998906|5654424|P3|Overall Study|Participants ongoing in follow−up|58
1620206|NCT01998906|5654425|P2|Overall Study|Participants ongoing in follow−up|60
1620207|NCT01998906|5654426|P1|Overall Study|Participants ongoing in follow−up|77
1620208|NCT01998893|5654470|P1|Overall Study|Transformation to high-grade lymphoma|1
1620209|NCT01998893|5654470|P1|Overall Study|Withdrawal by Subject|1
1620210|NCT01998893|5654470|P1|Overall Study|Protocol Violation|2
1620211|NCT01998893|5654470|P1|Overall Study|Physician Decision|2
1620212|NCT01998893|5654470|P1|Overall Study|Lost to Follow-up|8
1620213|NCT01998893|5654470|P1|Overall Study|Death|1
1620214|NCT01998893|5654470|P1|Overall Study|Adverse Event|2
1620215|NCT01998880|5654482|P2|Overall Study|Did Not Receive Treatment|2
1620216|NCT01998880|5654483|P1|Overall Study|Did Not Receive Treatment|3
1620217|NCT01998880|5654482|P2|Overall Study|Violation of Selection Criteria at Entry|1
1620218|NCT01998880|5654483|P1|Overall Study|Violation of Selection Criteria at Entry|0
1620219|NCT01998880|5654482|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1620220|NCT01998880|5654483|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
1620221|NCT01998880|5654482|P2|Overall Study|Administrative/Other|1
1620222|NCT01998880|5654483|P1|Overall Study|Administrative/Other|1
1620223|NCT01998880|5654482|P2|Overall Study|Insufficient Therapeutic Response|5
1620224|NCT01998880|5654483|P1|Overall Study|Insufficient Therapeutic Response|1
1620225|NCT01998880|5654482|P2|Overall Study|Death|6
1620226|NCT01998880|5654483|P1|Overall Study|Death|3
1620227|NCT01998880|5654482|P2|Overall Study|Withdrew Consent|1
1620228|NCT01998880|5654483|P1|Overall Study|Withdrew Consent|2
1620229|NCT01998880|5654482|P2|Overall Study|Disease Progression|8
1620230|NCT01998880|5654483|P1|Overall Study|Disease Progression|1
1620231|NCT01998880|5654482|P2|Overall Study|Adverse Events or Intercurrent Illness|16
1620232|NCT01998880|5654483|P1|Overall Study|Adverse Events or Intercurrent Illness|16
1620233|NCT01998737|5654515|P2|Overall Study|Corrupted database|0
1620234|NCT01998737|5654516|P1|Overall Study|Corrupted database|23
1620235|NCT01998633|5654528|P1|Overall Study|Death|1
1620236|NCT01998581|5654546|P2|Overall Study|Randomized but withdrew before treatment|0
1620237|NCT01998581|5654547|P1|Overall Study|Randomized but withdrew before treatment|1
1620238|NCT01998581|5654546|P2|Overall Study|Other reasons|2
1620239|NCT01998581|5654547|P1|Overall Study|Other reasons|3
1620240|NCT01998581|5654546|P2|Overall Study|Adverse Event|1
1620241|NCT01998581|5654547|P1|Overall Study|Adverse Event|1
1620242|NCT01998581|5654546|P2|Overall Study|Lost to Follow-up|4
1620243|NCT01998581|5654547|P1|Overall Study|Lost to Follow-up|12
1620244|NCT01998581|5654546|P2|Overall Study|Withdrawal by Subject|1
1620245|NCT01998581|5654547|P1|Overall Study|Withdrawal by Subject|8
1620246|NCT01998581|5654546|P2|Overall Study|Protocol Violation|0
1620247|NCT01998581|5654547|P1|Overall Study|Protocol Violation|1
1620248|NCT01998581|5654546|P2|Overall Study|Refused repeat treatment|4
1620249|NCT01998581|5654547|P1|Overall Study|Refused repeat treatment|20
1620250|NCT01998477|5654560|P2|Overall Study|Withdrawal by Subject|0
1620251|NCT01998477|5654561|P1|Overall Study|Withdrawal by Subject|6
1620252|NCT01998477|5654560|P2|Overall Study|Lost to Follow-up|5
1620253|NCT01998477|5654561|P1|Overall Study|Lost to Follow-up|4
1620254|NCT01998399|5654607|P2|Overall Study|Withdrawal by Subject|1
1620255|NCT01998399|5654608|P1|Overall Study|Withdrawal by Subject|0
1620256|NCT01998399|5654607|P2|Overall Study|Study stopped before dosing completed|3
1620257|NCT01998399|5654608|P1|Overall Study|Study stopped before dosing completed|3
1620258|NCT01998399|5654607|P2|Overall Study|Death|2
1620259|NCT01998399|5654608|P1|Overall Study|Death|4
1620260|NCT01998399|5654607|P2|Overall Study|Lost to Follow-up|3
1620261|NCT01998399|5654608|P1|Overall Study|Lost to Follow-up|1
1620262|NCT01998243|5654663|P2|Overall Study|Withdrawal by Subject|4
1620263|NCT01998243|5654664|P1|Overall Study|Withdrawal by Subject|3
1620264|NCT01998243|5654663|P2|Overall Study|Protocol Violation|2
1620265|NCT01998243|5654664|P1|Overall Study|Protocol Violation|5
1620266|NCT01998243|5654663|P2|Overall Study|Pregnancy|1
1620267|NCT01998243|5654664|P1|Overall Study|Pregnancy|0
1620268|NCT01997892|5654687|P1|Overall Study|Study completion data not recorded|35
1620269|NCT01997892|5654687|P1|Overall Study|Other|3
1620270|NCT01997892|5654687|P1|Overall Study|Renal transplant|8
1620271|NCT01997892|5654687|P1|Overall Study|Death|14
1620272|NCT01997892|5654687|P1|Overall Study|Lost to Follow-up|6
1620273|NCT01997892|5654687|P1|Overall Study|Physician Decision|2
1620274|NCT01997333|5654861|P2|Survival Follow up|Various|2
1620275|NCT01997333|5654862|P1|Survival Follow up|Various|1
1620276|NCT01997333|5654861|P2|Survival Follow up|Lost to Follow-up|6
1620277|NCT01997333|5654862|P1|Survival Follow up|Lost to Follow-up|0
1620278|NCT01997333|5654861|P2|Survival Follow up|Withdrawal by Subject|6
1620279|NCT01997333|5654862|P1|Survival Follow up|Withdrawal by Subject|15
1620280|NCT01997333|5654861|P2|Randomization and Treatment|Did not receive treatment|5
1620281|NCT01997333|5654862|P1|Randomization and Treatment|Did not receive treatment|17
1620282|NCT01997333|5654861|P2|Randomization and Treatment|Withdrawal by Subject|3
1620283|NCT01997333|5654862|P1|Randomization and Treatment|Withdrawal by Subject|6
1620284|NCT01997333|5654861|P2|Randomization and Treatment|Physician Decision|4
1620285|NCT01997333|5654862|P1|Randomization and Treatment|Physician Decision|0
1620286|NCT01997333|5654861|P2|Randomization and Treatment|Adverse Event|32
1620287|NCT01997333|5654862|P1|Randomization and Treatment|Adverse Event|10
1620288|NCT01997333|5654861|P2|Randomization and Treatment|Disease Progression|159
1620289|NCT01997333|5654862|P1|Randomization and Treatment|Disease Progression|70
1620290|NCT01996982|5654897|P1|Overall Study|PI/team left institution|7
1620291|NCT01996904|5654913|P2|Overall Study|Lost to Follow-up|27
1620292|NCT01996904|5654914|P1|Overall Study|Lost to Follow-up|38
1620293|NCT01996748|5654982|P2|Overall Study|Lost to Follow-up|1
1620294|NCT01996748|5654983|P1|Overall Study|Lost to Follow-up|4
1620295|NCT01996748|5654982|P2|Overall Study|Withdrawal by Subject|1
1620296|NCT01996748|5654983|P1|Overall Study|Withdrawal by Subject|0
1620297|NCT01996748|5654982|P2|Overall Study|Adverse Event|4
1620298|NCT01996748|5654983|P1|Overall Study|Adverse Event|1
1620299|NCT01996748|5654982|P2|Overall Study|Physician Decision|0
1620300|NCT01996748|5654983|P1|Overall Study|Physician Decision|2
1620301|NCT01996748|5654982|P2|Overall Study|Personal reason|0
1620302|NCT01996748|5654983|P1|Overall Study|Personal reason|1
1620303|NCT01996709|5654997|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
1620304|NCT01996709|5654998|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
1620305|NCT01996709|5654997|P2|Overall Study|Subject Non-Compliant|0
1620306|NCT01996709|5654998|P1|Overall Study|Subject Non-Compliant|1
1620307|NCT01996709|5654997|P2|Overall Study|Lost to Follow-up|0
1620308|NCT01996709|5654998|P1|Overall Study|Lost to Follow-up|3
1620309|NCT01996709|5654997|P2|Overall Study|Withdrawal by Subject|0
1620310|NCT01996709|5654998|P1|Overall Study|Withdrawal by Subject|1
1620311|NCT01996592|5655045|P1|Overall Study|change in mode of delivery|4
1620312|NCT01996592|5655045|P1|Overall Study|Withdrawal by Subject|5
1620313|NCT01996592|5655045|P1|Overall Study|change in surgical date|4
1620314|NCT01996592|5655045|P1|Overall Study|no response to text/no diary entry|32
1620315|NCT01996332|5655081|P1|Overall Study|Lost to Follow-up|34
1620316|NCT01996332|5655081|P1|Overall Study|Physician Decision|17
1620317|NCT01996332|5655081|P1|Overall Study|Clinical Deterioration|28
1620318|NCT01996332|5655081|P1|Overall Study|Other|20
1620319|NCT01996332|5655081|P1|Overall Study|Withdrawal by Subject|71
1620320|NCT01996332|5655081|P1|Overall Study|Protocol Violation|9
1620321|NCT01996332|5655081|P1|Overall Study|Death|264
1620322|NCT01996332|5655081|P1|Overall Study|Lack of Efficacy|1245
1620323|NCT01996332|5655081|P1|Overall Study|Adverse Event|117
1620324|NCT01996319|5655089|P2|Overall Study|Adverse Event|2
1620325|NCT01996319|5655090|P1|Overall Study|Adverse Event|2
1620326|NCT01996319|5655089|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
1620327|NCT01996319|5655090|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
1620328|NCT01996319|5655089|P2|Overall Study|Protocol Violation|0
1620329|NCT01996319|5655090|P1|Overall Study|Protocol Violation|1
1620330|NCT01996241|5655112|P2|Overall Study|Lost to Follow-up|235
1620331|NCT01996241|5655113|P1|Overall Study|Lost to Follow-up|252
1620332|NCT01996033|5655129|P1|Overall Study|Lost to Follow-up|3
1620333|NCT01996033|5655129|P1|Overall Study|Withdrawal by Subject|4
1620334|NCT01996033|5655129|P1|Overall Study|Physician Decision|1
1620335|NCT01996033|5655129|P1|Overall Study|Death|1
1620336|NCT01995838|5655149|P7|Overall Study|Other|2
1620337|NCT01995838|5655150|P6|Overall Study|Other|1
1620338|NCT01995838|5655151|P5|Overall Study|Other|1
1620339|NCT01995838|5655152|P4|Overall Study|Other|2
1620340|NCT01995838|5655153|P3|Overall Study|Other|0
1620341|NCT01995838|5655154|P2|Overall Study|Other|1
1620342|NCT01995838|5655155|P1|Overall Study|Other|3
1620343|NCT01995838|5655149|P7|Overall Study|Withdrawal by Subject|0
1620344|NCT01995838|5655150|P6|Overall Study|Withdrawal by Subject|0
1620345|NCT01995838|5655151|P5|Overall Study|Withdrawal by Subject|1
1620346|NCT01995838|5655152|P4|Overall Study|Withdrawal by Subject|0
1620347|NCT01995838|5655153|P3|Overall Study|Withdrawal by Subject|0
1620348|NCT01995838|5655154|P2|Overall Study|Withdrawal by Subject|0
1620349|NCT01995838|5655155|P1|Overall Study|Withdrawal by Subject|0
1620350|NCT01995838|5655149|P7|Overall Study|Adverse Event|1
1620351|NCT01995838|5655150|P6|Overall Study|Adverse Event|0
1620352|NCT01995838|5655151|P5|Overall Study|Adverse Event|0
1620353|NCT01995838|5655152|P4|Overall Study|Adverse Event|0
1620354|NCT01995838|5655153|P3|Overall Study|Adverse Event|0
1620355|NCT01995838|5655154|P2|Overall Study|Adverse Event|0
1620356|NCT01995838|5655155|P1|Overall Study|Adverse Event|0
1620357|NCT01995838|5655149|P7|Overall Study|Participant choice|1
1620358|NCT01995838|5655150|P6|Overall Study|Participant choice|1
1620359|NCT01995838|5655151|P5|Overall Study|Participant choice|0
1620360|NCT01995838|5655152|P4|Overall Study|Participant choice|0
1620361|NCT01995838|5655153|P3|Overall Study|Participant choice|0
1620362|NCT01995838|5655154|P2|Overall Study|Participant choice|0
1620363|NCT01995838|5655155|P1|Overall Study|Participant choice|2
1620364|NCT01995838|5655149|P7|Overall Study|Lost to Follow-up|1
1620365|NCT01995838|5655150|P6|Overall Study|Lost to Follow-up|0
1620366|NCT01995838|5655151|P5|Overall Study|Lost to Follow-up|0
1620367|NCT01995838|5655152|P4|Overall Study|Lost to Follow-up|0
1620368|NCT01995838|5655153|P3|Overall Study|Lost to Follow-up|0
1620369|NCT01995838|5655154|P2|Overall Study|Lost to Follow-up|1
1620370|NCT01995838|5655155|P1|Overall Study|Lost to Follow-up|0
1620371|NCT01995552|5655254|P1|Overall Study|Death|1
1620372|NCT01995552|5655254|P1|Overall Study|Lack of Efficacy|15
1620373|NCT01995552|5655254|P1|Overall Study|Protocol Violation|1
1620374|NCT01995539|5655260|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
1620375|NCT01995539|5655260|P1|Overall Study|Lost to Follow-up|5
1620376|NCT01995539|5655260|P1|Overall Study|Withdrawal by Subject|11
1620377|NCT01995539|5655260|P1|Overall Study|Withdrawal by Investigator|15
1620378|NCT01995539|5655260|P1|Overall Study|Screening Failure|1
1620379|NCT01995526|5655265|P1|Overall Study|Physician Decision|1
1620380|NCT01995513|5655273|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
1620381|NCT01995513|5655274|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
1620382|NCT01995513|5655275|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1620383|NCT01995513|5655273|P3|Double Blind Treatment Period|Disease Progression|93
1620384|NCT01995513|5655274|P2|Double Blind Treatment Period|Disease Progression|82
1620385|NCT01995513|5655275|P1|Double Blind Treatment Period|Disease Progression|0
1620386|NCT01995513|5655273|P3|Double Blind Treatment Period|Death|1
1620387|NCT01995513|5655274|P2|Double Blind Treatment Period|Death|0
1620388|NCT01995513|5655275|P1|Double Blind Treatment Period|Death|0
1620389|NCT01995513|5655273|P3|Double Blind Treatment Period|Withdrawal by Subject|6
1620390|NCT01995513|5655274|P2|Double Blind Treatment Period|Withdrawal by Subject|4
1620391|NCT01995513|5655275|P1|Double Blind Treatment Period|Withdrawal by Subject|0
1620392|NCT01995513|5655273|P3|Double Blind Treatment Period|Other|2
1620393|NCT01995513|5655274|P2|Double Blind Treatment Period|Other|1
1620394|NCT01995513|5655275|P1|Double Blind Treatment Period|Other|0
1620395|NCT01995513|5655273|P3|Double Blind Treatment Period|Adverse Event|5
1620396|NCT01995513|5655274|P2|Double Blind Treatment Period|Adverse Event|12
1620397|NCT01995513|5655275|P1|Double Blind Treatment Period|Adverse Event|0
1620398|NCT01995513|5655273|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1620399|NCT01995513|5655274|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
1620400|NCT01995513|5655275|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
1620401|NCT01995513|5655273|P3|Open Label Treatment Period|Death|0
1620402|NCT01995513|5655274|P2|Open Label Treatment Period|Death|0
1620403|NCT01995513|5655275|P1|Open Label Treatment Period|Death|8
1620404|NCT01995513|5655273|P3|Open Label Treatment Period|Adverse Event|0
1620405|NCT01995513|5655274|P2|Open Label Treatment Period|Adverse Event|0
1620406|NCT01995513|5655275|P1|Open Label Treatment Period|Adverse Event|35
1620407|NCT01995513|5655273|P3|Open Label Treatment Period|No PSA response at week 13|0
1620408|NCT01995513|5655274|P2|Open Label Treatment Period|No PSA response at week 13|0
1620409|NCT01995513|5655275|P1|Open Label Treatment Period|No PSA response at week 13|43
1620410|NCT01995513|5655273|P3|Open Label Treatment Period|Disease Progression|0
1620411|NCT01995513|5655274|P2|Open Label Treatment Period|Disease Progression|0
1620412|NCT01995513|5655275|P1|Open Label Treatment Period|Disease Progression|64
1620413|NCT01995513|5655273|P3|Open Label Treatment Period|Protocol Violation|0
1620414|NCT01995513|5655274|P2|Open Label Treatment Period|Protocol Violation|0
1620415|NCT01995513|5655275|P1|Open Label Treatment Period|Protocol Violation|1
1620416|NCT01995513|5655273|P3|Open Label Treatment Period|Withdrawal by Subject|0
1620417|NCT01995513|5655274|P2|Open Label Treatment Period|Withdrawal by Subject|0
1620418|NCT01995513|5655275|P1|Open Label Treatment Period|Withdrawal by Subject|14
1620419|NCT01995513|5655273|P3|Open Label Treatment Period|Other|0
1620420|NCT01995513|5655274|P2|Open Label Treatment Period|Other|0
1620421|NCT01995513|5655275|P1|Open Label Treatment Period|Other|9
1620422|NCT01995461|5655318|P1|Overall Study|Withdrawal by Subject|2
1620423|NCT01995461|5655318|P1|Overall Study|Lost to Follow-up|2
1620424|NCT01995461|5655318|P1|Overall Study|Death|1
1620425|NCT01995357|5655324|P6|Period 5|Adverse Event|0
1620426|NCT01995357|5655325|P5|Period 5|Adverse Event|0
1620427|NCT01995357|5655326|P4|Period 5|Adverse Event|0
1620428|NCT01995357|5655327|P3|Period 5|Adverse Event|1
1620429|NCT01995357|5655328|P2|Period 5|Adverse Event|0
1620430|NCT01995357|5655329|P1|Period 5|Adverse Event|1
1620431|NCT01995357|5655324|P6|Period 5|Lack of Efficacy|0
1620432|NCT01995357|5655325|P5|Period 5|Lack of Efficacy|0
1620433|NCT01995357|5655326|P4|Period 5|Lack of Efficacy|0
1620434|NCT01995357|5655327|P3|Period 5|Lack of Efficacy|0
1620435|NCT01995357|5655328|P2|Period 5|Lack of Efficacy|0
1620436|NCT01995357|5655329|P1|Period 5|Lack of Efficacy|1
1620437|NCT01995266|5655345|P1|Overall Study|Adverse Event|2
1620438|NCT01995266|5655345|P1|Overall Study|Lack of Efficacy|6
1620439|NCT01995266|5655345|P1|Overall Study|Death|1
1620440|NCT01995201|5655360|P7|From Week 24 Until Week 48|Protocol Violation|0
1620441|NCT01995201|5655361|P6|From Week 24 Until Week 48|Protocol Violation|0
1620442|NCT01995201|5655362|P5|From Week 24 Until Week 48|Protocol Violation|2
1620443|NCT01995201|5655363|P4|From Week 24 Until Week 48|Protocol Violation|0
1620444|NCT01995201|5655364|P3|From Week 24 Until Week 48|Protocol Violation|1
1620445|NCT01995201|5655365|P2|From Week 24 Until Week 48|Protocol Violation|0
1620446|NCT01995201|5655366|P1|From Week 24 Until Week 48|Protocol Violation|0
1620447|NCT01995201|5655360|P7|From Week 24 Until Week 48|Physician Decision|0
1620448|NCT01995201|5655361|P6|From Week 24 Until Week 48|Physician Decision|0
1620449|NCT01995201|5655362|P5|From Week 24 Until Week 48|Physician Decision|1
1620450|NCT01995201|5655363|P4|From Week 24 Until Week 48|Physician Decision|0
1620451|NCT01995201|5655364|P3|From Week 24 Until Week 48|Physician Decision|0
1620452|NCT01995201|5655365|P2|From Week 24 Until Week 48|Physician Decision|0
1620453|NCT01995201|5655366|P1|From Week 24 Until Week 48|Physician Decision|0
1620454|NCT01995201|5655360|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
1620455|NCT01995201|5655361|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
1620456|NCT01995201|5655362|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
1620457|NCT01995201|5655363|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
1620458|NCT01995201|5655364|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
1620459|NCT01995201|5655365|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
1620460|NCT01995201|5655366|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
1620461|NCT01995201|5655360|P7|From Week 24 Until Week 48|Lost to Follow-up|0
1620462|NCT01995201|5655361|P6|From Week 24 Until Week 48|Lost to Follow-up|1
1620463|NCT01995201|5655362|P5|From Week 24 Until Week 48|Lost to Follow-up|1
1620464|NCT01995201|5655363|P4|From Week 24 Until Week 48|Lost to Follow-up|0
1620465|NCT01995201|5655364|P3|From Week 24 Until Week 48|Lost to Follow-up|0
1620466|NCT01995201|5655365|P2|From Week 24 Until Week 48|Lost to Follow-up|0
1620467|NCT01995201|5655366|P1|From Week 24 Until Week 48|Lost to Follow-up|0
1620468|NCT01995201|5655360|P7|From Week 24 Until Week 48|Lack of Efficacy|1
1620469|NCT01995201|5655361|P6|From Week 24 Until Week 48|Lack of Efficacy|2
1620470|NCT01995201|5655362|P5|From Week 24 Until Week 48|Lack of Efficacy|0
1620471|NCT01995201|5655363|P4|From Week 24 Until Week 48|Lack of Efficacy|0
1620472|NCT01995201|5655364|P3|From Week 24 Until Week 48|Lack of Efficacy|1
1620473|NCT01995201|5655365|P2|From Week 24 Until Week 48|Lack of Efficacy|0
1620474|NCT01995201|5655366|P1|From Week 24 Until Week 48|Lack of Efficacy|0
1620475|NCT01995201|5655360|P7|From Week 24 Until Week 48|Death|0
1620476|NCT01995201|5655361|P6|From Week 24 Until Week 48|Death|2
1620477|NCT01995201|5655362|P5|From Week 24 Until Week 48|Death|0
1620478|NCT01995201|5655363|P4|From Week 24 Until Week 48|Death|0
1620479|NCT01995201|5655364|P3|From Week 24 Until Week 48|Death|0
1620480|NCT01995201|5655365|P2|From Week 24 Until Week 48|Death|0
1620481|NCT01995201|5655366|P1|From Week 24 Until Week 48|Death|0
1620482|NCT01995201|5655360|P7|From Week 24 Until Week 48|Adverse Event|1
1620483|NCT01995201|5655361|P6|From Week 24 Until Week 48|Adverse Event|3
1620484|NCT01995201|5655362|P5|From Week 24 Until Week 48|Adverse Event|1
1620485|NCT01995201|5655363|P4|From Week 24 Until Week 48|Adverse Event|1
1620486|NCT01995201|5655364|P3|From Week 24 Until Week 48|Adverse Event|2
1620487|NCT01995201|5655365|P2|From Week 24 Until Week 48|Adverse Event|0
1620488|NCT01995201|5655366|P1|From Week 24 Until Week 48|Adverse Event|0
1620489|NCT01995201|5655360|P7|From Baseline Until Week 24|Protocol Violation|0
1620490|NCT01995201|5655361|P6|From Baseline Until Week 24|Protocol Violation|0
1620491|NCT01995201|5655362|P5|From Baseline Until Week 24|Protocol Violation|0
1620492|NCT01995201|5655363|P4|From Baseline Until Week 24|Protocol Violation|0
1620493|NCT01995201|5655364|P3|From Baseline Until Week 24|Protocol Violation|0
1620494|NCT01995201|5655365|P2|From Baseline Until Week 24|Protocol Violation|9
1620495|NCT01995201|5655366|P1|From Baseline Until Week 24|Protocol Violation|0
1620496|NCT01995201|5655360|P7|From Baseline Until Week 24|Physician Decision|0
1620497|NCT01995201|5655361|P6|From Baseline Until Week 24|Physician Decision|0
1620498|NCT01995201|5655362|P5|From Baseline Until Week 24|Physician Decision|0
1620499|NCT01995201|5655363|P4|From Baseline Until Week 24|Physician Decision|0
1620500|NCT01995201|5655364|P3|From Baseline Until Week 24|Physician Decision|0
1620501|NCT01995201|5655365|P2|From Baseline Until Week 24|Physician Decision|2
1620502|NCT01995201|5655366|P1|From Baseline Until Week 24|Physician Decision|0
1620503|NCT01995201|5655360|P7|From Baseline Until Week 24|Withdrawal by Subject|0
1620504|NCT01995201|5655361|P6|From Baseline Until Week 24|Withdrawal by Subject|0
1620505|NCT01995201|5655362|P5|From Baseline Until Week 24|Withdrawal by Subject|0
1620506|NCT01995201|5655363|P4|From Baseline Until Week 24|Withdrawal by Subject|0
1620507|NCT01995201|5655364|P3|From Baseline Until Week 24|Withdrawal by Subject|0
1620508|NCT01995201|5655365|P2|From Baseline Until Week 24|Withdrawal by Subject|8
1620509|NCT01995201|5655366|P1|From Baseline Until Week 24|Withdrawal by Subject|2
1620510|NCT01995201|5655360|P7|From Baseline Until Week 24|Lost to Follow-up|0
1620511|NCT01995201|5655361|P6|From Baseline Until Week 24|Lost to Follow-up|0
1620512|NCT01995201|5655362|P5|From Baseline Until Week 24|Lost to Follow-up|0
1620513|NCT01995201|5655363|P4|From Baseline Until Week 24|Lost to Follow-up|0
1620514|NCT01995201|5655364|P3|From Baseline Until Week 24|Lost to Follow-up|0
1620515|NCT01995201|5655365|P2|From Baseline Until Week 24|Lost to Follow-up|3
1620516|NCT01995201|5655366|P1|From Baseline Until Week 24|Lost to Follow-up|2
1620517|NCT01995201|5655360|P7|From Baseline Until Week 24|Lack of Efficacy|0
1620518|NCT01995201|5655361|P6|From Baseline Until Week 24|Lack of Efficacy|0
1620519|NCT01995201|5655362|P5|From Baseline Until Week 24|Lack of Efficacy|0
1620520|NCT01995201|5655363|P4|From Baseline Until Week 24|Lack of Efficacy|0
1620521|NCT01995201|5655364|P3|From Baseline Until Week 24|Lack of Efficacy|0
1620522|NCT01995201|5655365|P2|From Baseline Until Week 24|Lack of Efficacy|5
1620523|NCT01995201|5655366|P1|From Baseline Until Week 24|Lack of Efficacy|2
1620524|NCT01995201|5655360|P7|From Baseline Until Week 24|Death|0
1620525|NCT01995201|5655361|P6|From Baseline Until Week 24|Death|0
1620526|NCT01995201|5655362|P5|From Baseline Until Week 24|Death|0
1620527|NCT01995201|5655363|P4|From Baseline Until Week 24|Death|0
1620528|NCT01995201|5655364|P3|From Baseline Until Week 24|Death|0
1620529|NCT01995201|5655365|P2|From Baseline Until Week 24|Death|1
1620530|NCT01995201|5655366|P1|From Baseline Until Week 24|Death|0
1620531|NCT01995201|5655360|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1620532|NCT01995201|5655361|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1620533|NCT01995201|5655362|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1620534|NCT01995201|5655363|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1620535|NCT01995201|5655364|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1620536|NCT01995201|5655365|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
1620537|NCT01995201|5655366|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
1620538|NCT01995201|5655360|P7|From Baseline Until Week 24|Adverse Event|0
1620539|NCT01995201|5655361|P6|From Baseline Until Week 24|Adverse Event|0
1620540|NCT01995201|5655362|P5|From Baseline Until Week 24|Adverse Event|0
1620541|NCT01995201|5655363|P4|From Baseline Until Week 24|Adverse Event|0
1620542|NCT01995201|5655364|P3|From Baseline Until Week 24|Adverse Event|0
1620543|NCT01995201|5655365|P2|From Baseline Until Week 24|Adverse Event|15
1620544|NCT01995201|5655366|P1|From Baseline Until Week 24|Adverse Event|4
1620545|NCT01995175|5655475|P1|Overall Study|Migrated / moved from the study area|49
1620546|NCT01995175|5655475|P1|Overall Study|Other|67
1620547|NCT01995175|5655475|P1|Overall Study|Lost to Follow-up|102
1620548|NCT01995175|5655475|P1|Overall Study|Withdrawal by Subject|35
1620549|NCT01995136|5655485|P1|Overall Study|Change in residence|1
1620550|NCT01995071|5655501|P12|Overall Study|Incarcerated|0
1620551|NCT01995071|5655502|P11|Overall Study|Incarcerated|0
1620552|NCT01995071|5655503|P10|Overall Study|Incarcerated|0
1620553|NCT01995071|5655504|P9|Overall Study|Incarcerated|0
1620554|NCT01995071|5655505|P8|Overall Study|Incarcerated|1
1620555|NCT01995071|5655506|P7|Overall Study|Incarcerated|0
1620556|NCT01995071|5655507|P6|Overall Study|Incarcerated|0
1620557|NCT01995071|5655508|P5|Overall Study|Incarcerated|0
1620558|NCT01995071|5655509|P4|Overall Study|Incarcerated|0
1620559|NCT01995071|5655510|P3|Overall Study|Incarcerated|0
1620560|NCT01995071|5655511|P2|Overall Study|Incarcerated|0
1620561|NCT01995071|5655512|P1|Overall Study|Incarcerated|0
1620562|NCT01995071|5655501|P12|Overall Study|Lost to Follow-up|0
1620563|NCT01995071|5655502|P11|Overall Study|Lost to Follow-up|0
1620564|NCT01995071|5655503|P10|Overall Study|Lost to Follow-up|0
1620565|NCT01995071|5655504|P9|Overall Study|Lost to Follow-up|1
1620566|NCT01995071|5655505|P8|Overall Study|Lost to Follow-up|1
1620567|NCT01995071|5655506|P7|Overall Study|Lost to Follow-up|0
1620568|NCT01995071|5655507|P6|Overall Study|Lost to Follow-up|0
1620569|NCT01995071|5655508|P5|Overall Study|Lost to Follow-up|0
1620570|NCT01995071|5655509|P4|Overall Study|Lost to Follow-up|0
1620571|NCT01995071|5655510|P3|Overall Study|Lost to Follow-up|0
1620572|NCT01995071|5655511|P2|Overall Study|Lost to Follow-up|0
1620573|NCT01995071|5655512|P1|Overall Study|Lost to Follow-up|1
1620574|NCT01995071|5655501|P12|Overall Study|Moved|0
1620575|NCT01995071|5655502|P11|Overall Study|Moved|1
1620576|NCT01995071|5655503|P10|Overall Study|Moved|0
1620577|NCT01995071|5655504|P9|Overall Study|Moved|0
1620578|NCT01995071|5655505|P8|Overall Study|Moved|0
1620579|NCT01995071|5655506|P7|Overall Study|Moved|0
1620580|NCT01995071|5655507|P6|Overall Study|Moved|0
1620581|NCT01995071|5655508|P5|Overall Study|Moved|1
1620582|NCT01995071|5655509|P4|Overall Study|Moved|0
1620583|NCT01995071|5655510|P3|Overall Study|Moved|1
1620584|NCT01995071|5655511|P2|Overall Study|Moved|0
1620585|NCT01995071|5655512|P1|Overall Study|Moved|0
1620586|NCT01995071|5655501|P12|Overall Study|Adverse Event|0
1620587|NCT01995071|5655502|P11|Overall Study|Adverse Event|0
1620588|NCT01995071|5655503|P10|Overall Study|Adverse Event|0
1620589|NCT01995071|5655504|P9|Overall Study|Adverse Event|0
1620590|NCT01995071|5655505|P8|Overall Study|Adverse Event|0
1620591|NCT01995071|5655506|P7|Overall Study|Adverse Event|1
1620592|NCT01995071|5655507|P6|Overall Study|Adverse Event|0
1620593|NCT01995071|5655508|P5|Overall Study|Adverse Event|0
1620594|NCT01995071|5655509|P4|Overall Study|Adverse Event|0
1620595|NCT01995071|5655510|P3|Overall Study|Adverse Event|0
1620596|NCT01995071|5655511|P2|Overall Study|Adverse Event|0
1620597|NCT01995071|5655512|P1|Overall Study|Adverse Event|0
1620598|NCT01994954|5655649|P2|Overall Study|6 Month Follow-up Not Complete|4
1620599|NCT01994954|5655650|P1|Overall Study|6 Month Follow-up Not Complete|5
1620600|NCT01994954|5655649|P2|Overall Study|Lost to Follow-up|10
1620601|NCT01994954|5655650|P1|Overall Study|Lost to Follow-up|8
1620602|NCT01994954|5655649|P2|Overall Study|Physician Decision|2
1620603|NCT01994954|5655650|P1|Overall Study|Physician Decision|2
1620604|NCT01994954|5655649|P2|Overall Study|Withdrawal by Subject|14
1620605|NCT01994954|5655650|P1|Overall Study|Withdrawal by Subject|9
1620606|NCT01994954|5655649|P2|Overall Study|Death|0
1620607|NCT01994954|5655650|P1|Overall Study|Death|1
1620608|NCT01994902|5655668|P2|Test Period 2|Other|3
1620609|NCT01994902|5655669|P1|Test Period 2|Other|0
1620610|NCT01994902|5655668|P2|Test Period 2|Lack of Efficacy|1
1620611|NCT01994902|5655669|P1|Test Period 2|Lack of Efficacy|0
1620612|NCT01994902|5655668|P2|Test Period 2|Withdrawal by Subject|2
1620613|NCT01994902|5655669|P1|Test Period 2|Withdrawal by Subject|0
1620614|NCT01994902|5655668|P2|Test Period 1|bag too small|0
1620615|NCT01994902|5655669|P1|Test Period 1|bag too small|1
1620616|NCT01994902|5655668|P2|Test Period 1|Lack of Efficacy|1
1620617|NCT01994902|5655669|P1|Test Period 1|Lack of Efficacy|0
1620618|NCT01994902|5655668|P2|Test Period 1|Adverse Event|1
1620619|NCT01994902|5655669|P1|Test Period 1|Adverse Event|2
1620620|NCT01994902|5655668|P2|Test Period 1|device deficiency with adverse event|1
1620621|NCT01994902|5655669|P1|Test Period 1|device deficiency with adverse event|0
1620622|NCT01994902|5655668|P2|Test Period 1|Withdrawal by Subject|0
1620623|NCT01994902|5655669|P1|Test Period 1|Withdrawal by Subject|3
1620624|NCT01994889|5655678|P3|Overall Study|Death|38
1620625|NCT01994889|5655679|P2|Overall Study|Death|25
1620626|NCT01994889|5655680|P1|Overall Study|Death|14
1620627|NCT01994889|5655678|P3|Overall Study|Protocol Violation|1
1620628|NCT01994889|5655679|P2|Overall Study|Protocol Violation|1
1620629|NCT01994889|5655680|P1|Overall Study|Protocol Violation|0
1620630|NCT01994889|5655678|P3|Overall Study|Lost to Follow-up|0
1620631|NCT01994889|5655679|P2|Overall Study|Lost to Follow-up|1
1620632|NCT01994889|5655680|P1|Overall Study|Lost to Follow-up|0
1620633|NCT01994889|5655678|P3|Overall Study|No longer willing to participate|37
1620634|NCT01994889|5655679|P2|Overall Study|No longer willing to participate|17
1620635|NCT01994889|5655680|P1|Overall Study|No longer willing to participate|8
1620636|NCT01994889|5655678|P3|Overall Study|Organ Transplantation|5
1620637|NCT01994889|5655679|P2|Overall Study|Organ Transplantation|5
1620638|NCT01994889|5655680|P1|Overall Study|Organ Transplantation|1
1620639|NCT01994889|5655678|P3|Overall Study|Cardiac Device Implantation|0
1620640|NCT01994889|5655679|P2|Overall Study|Cardiac Device Implantation|2
1620641|NCT01994889|5655680|P1|Overall Study|Cardiac Device Implantation|0
1620642|NCT01994889|5655678|P3|Overall Study|Adverse Event|11
1620643|NCT01994889|5655679|P2|Overall Study|Adverse Event|12
1620644|NCT01994889|5655680|P1|Overall Study|Adverse Event|5
1620645|NCT01994876|5655699|P2|Test Period 2|Protocol Violation|1
1620646|NCT01994876|5655700|P1|Test Period 2|Protocol Violation|0
1620647|NCT01994876|5655699|P2|Test Period 2|Adverse Event|0
1620648|NCT01994876|5655700|P1|Test Period 2|Adverse Event|1
1620649|NCT01994876|5655699|P2|Test Period 1|Adverse Event|1
1620650|NCT01994876|5655700|P1|Test Period 1|Adverse Event|0
1620651|NCT01994876|5655699|P2|Test Period 1|Withdrawal by Subject|1
1620652|NCT01994876|5655700|P1|Test Period 1|Withdrawal by Subject|0
1620653|NCT01994863|5655708|P2|Period 2|Withdrawal by Subject|1
1620654|NCT01994863|5655709|P1|Period 2|Withdrawal by Subject|1
1620655|NCT01994863|5655708|P2|Period 2|Lack of Efficacy|2
1620656|NCT01994863|5655709|P1|Period 2|Lack of Efficacy|0
1620657|NCT01994863|5655708|P2|Period 2|Adverse Event|1
1620658|NCT01994863|5655709|P1|Period 2|Adverse Event|0
1620659|NCT01994863|5655708|P2|Period 1|Lack of Efficacy|0
1620660|NCT01994863|5655709|P1|Period 1|Lack of Efficacy|1
1620661|NCT01994863|5655708|P2|Period 1|Trial stopped by sponsor|3
1620662|NCT01994863|5655709|P1|Period 1|Trial stopped by sponsor|1
1620663|NCT01994863|5655708|P2|Period 1|Withdrawal by Subject|0
1620664|NCT01994863|5655709|P1|Period 1|Withdrawal by Subject|1
1620665|NCT01994863|5655708|P2|Period 1|Adverse Event|0
1620666|NCT01994863|5655709|P1|Period 1|Adverse Event|4
1620667|NCT01994850|5655715|P1|Overall Study|Withdrawal by Subject|1
1620668|NCT01994850|5655715|P1|Overall Study|Physician Decision|1
1620669|NCT01994837|5655720|P1|Overall Study|Removed from study due to no response|1
1620670|NCT01994837|5655720|P1|Overall Study|Proceeded to transplant|1
1620671|NCT01994837|5655720|P1|Overall Study|Chose palliative care|1
1620672|NCT01994837|5655720|P1|Overall Study|Adverse event not related to progression|1
1620673|NCT01994837|5655720|P1|Overall Study|Fatal progressive disease|2
1620674|NCT01994837|5655720|P1|Overall Study|Adv event related to progressive disease|3
1620675|NCT01994837|5655720|P1|Overall Study|Progressive disease per protocol|23
1620676|NCT01994720|5655777|P2|Overall Study|Withdrawal by Subject|56
1620677|NCT01994720|5655778|P1|Overall Study|Withdrawal by Subject|46
1620678|NCT01994629|5655820|P2|Overall Study|Lost to Follow-up|3
1620679|NCT01994629|5655821|P1|Overall Study|Lost to Follow-up|0
1620680|NCT01994629|5655820|P2|Overall Study|Withdrawal by Subject|0
1620681|NCT01994629|5655821|P1|Overall Study|Withdrawal by Subject|1
1620682|NCT01994590|5655845|P1|Overall Study|Trial Terminated|1
1620683|NCT01994590|5655845|P1|Overall Study|Adverse Event|1
1620684|NCT01994395|5655860|P2|Overall Study|Withdrawal by Subject|2
1620685|NCT01994395|5655861|P1|Overall Study|Withdrawal by Subject|1
1620686|NCT01994291|5655886|P3|Overall Study|Other|0
1620687|NCT01994291|5655887|P2|Overall Study|Other|2
1620688|NCT01994291|5655888|P1|Overall Study|Other|1
1620689|NCT01994291|5655886|P3|Overall Study|Withdrawal by Subject|5
1620690|NCT01994291|5655887|P2|Overall Study|Withdrawal by Subject|3
1620691|NCT01994291|5655888|P1|Overall Study|Withdrawal by Subject|6
1620692|NCT01994291|5655886|P3|Overall Study|Protocol Violation|0
1620693|NCT01994291|5655887|P2|Overall Study|Protocol Violation|0
1620694|NCT01994291|5655888|P1|Overall Study|Protocol Violation|1
1620695|NCT01994291|5655886|P3|Overall Study|Medication error without associated AE|1
1620696|NCT01994291|5655887|P2|Overall Study|Medication error without associated AE|0
1620697|NCT01994291|5655888|P1|Overall Study|Medication error without associated AE|1
1620698|NCT01994291|5655886|P3|Overall Study|Does not meet entrance criteria|0
1620699|NCT01994291|5655887|P2|Overall Study|Does not meet entrance criteria|0
1620700|NCT01994291|5655888|P1|Overall Study|Does not meet entrance criteria|1
1620701|NCT01994291|5655886|P3|Overall Study|Lost to Follow-up|0
1620702|NCT01994291|5655887|P2|Overall Study|Lost to Follow-up|1
1620703|NCT01994291|5655888|P1|Overall Study|Lost to Follow-up|1
1620704|NCT01994291|5655886|P3|Overall Study|Adverse Event|3
1620705|NCT01994291|5655887|P2|Overall Study|Adverse Event|1
1620706|NCT01994291|5655888|P1|Overall Study|Adverse Event|4
1620707|NCT01994226|5655944|P2|Overall Study|Early Cessation of treatment|11
1620708|NCT01994226|5655945|P1|Overall Study|Early Cessation of treatment|6
1620709|NCT01994226|5655944|P2|Overall Study|Protocol Violation|10
1620710|NCT01994226|5655945|P1|Overall Study|Protocol Violation|13
1620711|NCT01993940|5655971|P2|Overall Study|Other - Miscellaneous|1
1620712|NCT01993940|5655972|P1|Overall Study|Other - Miscellaneous|1
1620713|NCT01993940|5655971|P2|Overall Study|Death|0
1620714|NCT01993940|5655972|P1|Overall Study|Death|1
1620715|NCT01993940|5655971|P2|Overall Study|Protocol Violation|8
1620716|NCT01993940|5655972|P1|Overall Study|Protocol Violation|5
1620717|NCT01993940|5655971|P2|Overall Study|Lost to Follow-up|5
1620718|NCT01993940|5655972|P1|Overall Study|Lost to Follow-up|2
1620719|NCT01993940|5655971|P2|Overall Study|Withdrawal by Subject|19
1620720|NCT01993940|5655972|P1|Overall Study|Withdrawal by Subject|15
1620721|NCT01993940|5655971|P2|Overall Study|Adverse Event|11
1620722|NCT01993940|5655972|P1|Overall Study|Adverse Event|16
1620723|NCT01993927|5655986|P1|Overall Study|Protocol Violation|11
1620724|NCT01993927|5655986|P1|Overall Study|Case Report Forms Uncollected|18
1620725|NCT01993888|5655994|P2|Overall Study|Withdrawal by Subject|1
1620726|NCT01993888|5655995|P1|Overall Study|Withdrawal by Subject|0
1620727|NCT01993888|5655994|P2|Overall Study|Lost to Follow-up|1
1620728|NCT01993888|5655995|P1|Overall Study|Lost to Follow-up|1
1620729|NCT01993888|5655994|P2|Overall Study|Death|1
1620730|NCT01993888|5655995|P1|Overall Study|Death|1
1620731|NCT01993823|5656043|P2|Overall Study|Lost to Follow-up|4
1620732|NCT01993823|5656044|P1|Overall Study|Lost to Follow-up|1
1620733|NCT01993823|5656043|P2|Overall Study|Protocol Violation|1
1620734|NCT01993823|5656044|P1|Overall Study|Protocol Violation|0
1620735|NCT01993823|5656043|P2|Overall Study|Requested by the patient|11
1620736|NCT01993823|5656044|P1|Overall Study|Requested by the patient|6
1620737|NCT01993667|5656054|P2|Overall Study|Lost to Follow-up|2
1620738|NCT01993667|5656055|P1|Overall Study|Lost to Follow-up|2
1620739|NCT01993667|5656054|P2|Overall Study|Insufficient altitude reached|1
1620740|NCT01993667|5656055|P1|Overall Study|Insufficient altitude reached|3
1620741|NCT01993667|5656054|P2|Overall Study|Insufficient data to analyze|16
1620742|NCT01993667|5656055|P1|Overall Study|Insufficient data to analyze|16
1620743|NCT01993030|5656102|P2|Overall Study|Adverse Event|4
1620744|NCT01993030|5656103|P1|Overall Study|Adverse Event|0
1620745|NCT01993017|5656120|P3|Overall Study|Ineligible after randomization|5
1620746|NCT01993017|5656121|P2|Overall Study|Ineligible after randomization|5
1620747|NCT01993017|5656122|P1|Overall Study|Ineligible after randomization|4
1620748|NCT01993017|5656120|P3|Overall Study|Other reasons|7
1620749|NCT01993017|5656121|P2|Overall Study|Other reasons|11
1620750|NCT01993017|5656122|P1|Overall Study|Other reasons|17
1620751|NCT01993017|5656120|P3|Overall Study|Dropped out|11
1620752|NCT01993017|5656121|P2|Overall Study|Dropped out|6
1620753|NCT01993017|5656122|P1|Overall Study|Dropped out|19
1620754|NCT01993017|5656120|P3|Overall Study|Could not be contacted|38
1620755|NCT01993017|5656121|P2|Overall Study|Could not be contacted|42
1620756|NCT01993017|5656122|P1|Overall Study|Could not be contacted|43
1620757|NCT01993017|5656120|P3|Overall Study|Death|18
1620758|NCT01993017|5656121|P2|Overall Study|Death|26
1620759|NCT01993017|5656122|P1|Overall Study|Death|23
1620760|NCT01992757|5656163|P1|Overall Study|2 patients excluded due to FFP given.|2
1620761|NCT01992549|5656168|P1|Overall Study|Product Switch to Extend Half Life|1
1620762|NCT01992549|5656168|P1|Overall Study|Serious Adverse Event|1
1620763|NCT01992549|5656168|P1|Overall Study|Lost to Follow-up|2
1620764|NCT01992536|5656188|P10|Overall Study|Withdrawal by Subject|0
1620765|NCT01992536|5656189|P9|Overall Study|Withdrawal by Subject|0
1620766|NCT01992536|5656190|P8|Overall Study|Withdrawal by Subject|0
1620767|NCT01992536|5656191|P7|Overall Study|Withdrawal by Subject|0
1620768|NCT01992536|5656192|P6|Overall Study|Withdrawal by Subject|0
1620769|NCT01992536|5656193|P5|Overall Study|Withdrawal by Subject|0
1620770|NCT01992536|5656194|P4|Overall Study|Withdrawal by Subject|2
1620771|NCT01992536|5656195|P3|Overall Study|Withdrawal by Subject|0
1620772|NCT01992536|5656196|P2|Overall Study|Withdrawal by Subject|1
1620773|NCT01992536|5656197|P1|Overall Study|Withdrawal by Subject|0
1620774|NCT01992536|5656188|P10|Overall Study|Lost to Follow-up|1
1620775|NCT01992536|5656189|P9|Overall Study|Lost to Follow-up|1
1620776|NCT01992536|5656190|P8|Overall Study|Lost to Follow-up|0
1620777|NCT01992536|5656191|P7|Overall Study|Lost to Follow-up|0
1620778|NCT01992536|5656192|P6|Overall Study|Lost to Follow-up|1
1620779|NCT01992536|5656193|P5|Overall Study|Lost to Follow-up|0
1620780|NCT01992536|5656194|P4|Overall Study|Lost to Follow-up|0
1620781|NCT01992536|5656195|P3|Overall Study|Lost to Follow-up|1
1620782|NCT01992536|5656196|P2|Overall Study|Lost to Follow-up|2
1620783|NCT01992536|5656197|P1|Overall Study|Lost to Follow-up|4
1620784|NCT01992536|5656188|P10|Overall Study|Administrative Reason|0
1620785|NCT01992536|5656189|P9|Overall Study|Administrative Reason|0
1620786|NCT01992536|5656190|P8|Overall Study|Administrative Reason|0
1620787|NCT01992536|5656191|P7|Overall Study|Administrative Reason|7
1620788|NCT01992536|5656192|P6|Overall Study|Administrative Reason|0
1620789|NCT01992536|5656193|P5|Overall Study|Administrative Reason|0
1620790|NCT01992536|5656194|P4|Overall Study|Administrative Reason|0
1620791|NCT01992536|5656195|P3|Overall Study|Administrative Reason|0
1620792|NCT01992536|5656196|P2|Overall Study|Administrative Reason|0
1620793|NCT01992536|5656197|P1|Overall Study|Administrative Reason|0
1620794|NCT01992159|5656454|P4|Overall Study|Death|0
1620795|NCT01992159|5656455|P3|Overall Study|Death|1
1620796|NCT01992159|5656456|P2|Overall Study|Death|0
1620797|NCT01992159|5656457|P1|Overall Study|Death|0
1620798|NCT01992159|5656454|P4|Overall Study|Adverse Event|1
1620799|NCT01992159|5656455|P3|Overall Study|Adverse Event|0
1620800|NCT01992159|5656456|P2|Overall Study|Adverse Event|1
1620801|NCT01992159|5656457|P1|Overall Study|Adverse Event|0
1620802|NCT01992159|5656454|P4|Overall Study|Withdrawal by Subject|3
1620803|NCT01992159|5656455|P3|Overall Study|Withdrawal by Subject|0
1620804|NCT01992159|5656456|P2|Overall Study|Withdrawal by Subject|7
1620805|NCT01992159|5656457|P1|Overall Study|Withdrawal by Subject|4
1620806|NCT01992107|5656510|P3|Overall Study|Withdrawal by Subject|8
1620807|NCT01992107|5656511|P2|Overall Study|Withdrawal by Subject|7
1620808|NCT01992107|5656512|P1|Overall Study|Withdrawal by Subject|13
1620809|NCT01992107|5656510|P3|Overall Study|noncompliance and were unavailable|2
1620810|NCT01992107|5656511|P2|Overall Study|noncompliance and were unavailable|3
1620811|NCT01992107|5656512|P1|Overall Study|noncompliance and were unavailable|7
1620812|NCT01992107|5656510|P3|Overall Study|Lost to Follow-up|26
1620813|NCT01992107|5656511|P2|Overall Study|Lost to Follow-up|22
1620814|NCT01992107|5656512|P1|Overall Study|Lost to Follow-up|46
1620815|NCT01992107|5656510|P3|Overall Study|Adverse Event|0
1620816|NCT01992107|5656511|P2|Overall Study|Adverse Event|1
1620817|NCT01992107|5656512|P1|Overall Study|Adverse Event|0
1620818|NCT01992107|5656510|P3|Overall Study|Administrative reasons|0
1620819|NCT01992107|5656511|P2|Overall Study|Administrative reasons|0
1620820|NCT01992107|5656512|P1|Overall Study|Administrative reasons|2
1620821|NCT01992094|5656568|P3|Overall Study|Withdrawal by Subject|4
1620822|NCT01992094|5656569|P2|Overall Study|Withdrawal by Subject|3
1620823|NCT01992094|5656570|P1|Overall Study|Withdrawal by Subject|7
1620824|NCT01992094|5656568|P3|Overall Study|Protocol Violation|1
1620825|NCT01992094|5656569|P2|Overall Study|Protocol Violation|0
1620826|NCT01992094|5656570|P1|Overall Study|Protocol Violation|1
1620827|NCT01992094|5656568|P3|Overall Study|OTHER|0
1620828|NCT01992094|5656569|P2|Overall Study|OTHER|0
1620829|NCT01992094|5656570|P1|Overall Study|OTHER|4
1620830|NCT01992094|5656568|P3|Overall Study|Lost to Follow-up|13
1620831|NCT01992094|5656569|P2|Overall Study|Lost to Follow-up|9
1620832|NCT01992094|5656570|P1|Overall Study|Lost to Follow-up|26
1620833|NCT01992094|5656568|P3|Overall Study|Death|2
1620834|NCT01992094|5656569|P2|Overall Study|Death|5
1620835|NCT01992094|5656570|P1|Overall Study|Death|5
1620836|NCT01992094|5656568|P3|Overall Study|Adverse Event|0
1620837|NCT01992094|5656569|P2|Overall Study|Adverse Event|0
1620838|NCT01992094|5656570|P1|Overall Study|Adverse Event|1
1620839|NCT01992094|5656568|P3|Overall Study|ADMINISTRATIVE REASON|1
1620840|NCT01992094|5656569|P2|Overall Study|ADMINISTRATIVE REASON|7
1620841|NCT01992094|5656570|P1|Overall Study|ADMINISTRATIVE REASON|6
1620842|NCT01991743|5656728|P4|Overall Study|external cephalic version not performed|0
1620843|NCT01991743|5656729|P3|Overall Study|external cephalic version not performed|1
1620844|NCT01991743|5656730|P2|Overall Study|external cephalic version not performed|0
1620845|NCT01991743|5656731|P1|Overall Study|external cephalic version not performed|0
1620846|NCT01991483|5656776|P4|Dose Level 1000 mg|Protocol Violation|1
1620847|NCT01991483|5656777|P3|Dose Level 1000 mg|Protocol Violation|0
1620848|NCT01991483|5656778|P2|Dose Level 1000 mg|Protocol Violation|0
1620849|NCT01991483|5656779|P1|Dose Level 1000 mg|Protocol Violation|0
1620850|NCT01991483|5656776|P4|Dose Level 600 mg|Physician Decision|0
1620851|NCT01991483|5656777|P3|Dose Level 600 mg|Physician Decision|1
1620852|NCT01991483|5656778|P2|Dose Level 600 mg|Physician Decision|0
1620853|NCT01991483|5656779|P1|Dose Level 600 mg|Physician Decision|0
1620854|NCT01991483|5656776|P4|Dose Level 600 mg|Withdrawal by Subject|0
1620855|NCT01991483|5656777|P3|Dose Level 600 mg|Withdrawal by Subject|1
1620856|NCT01991483|5656778|P2|Dose Level 600 mg|Withdrawal by Subject|0
1620857|NCT01991483|5656779|P1|Dose Level 600 mg|Withdrawal by Subject|0
1620858|NCT01991470|5656845|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
1620859|NCT01991470|5656845|P1|Enlite 3 Period|Physician Decision|8
1620860|NCT01991470|5656845|P1|Enlite 3 Period|Physician Decision|2
1620861|NCT01991470|5656845|P1|Enlite 3 Period|Lost to Follow-up|1
1620862|NCT01991470|5656845|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
1620863|NCT01991470|5656845|P1|Enlite 1 Period|Adverse Event|1
1620864|NCT01991470|5656845|P1|Enlite 1 Period|Withdrawal by Subject|18
1620865|NCT01991314|5656859|P2|Overall Study|Lost to Follow-up|10
1620866|NCT01991314|5656860|P1|Overall Study|Lost to Follow-up|6
1620867|NCT01991314|5656859|P2|Overall Study|Adverse Event|1
1620868|NCT01991314|5656860|P1|Overall Study|Adverse Event|5
1620869|NCT01990859|5656882|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
1620870|NCT01990859|5656882|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
1620871|NCT01990768|5657017|P3|6-Month Follow-up|Patient at psychiatric hospital|0
1620872|NCT01990768|5657018|P2|6-Month Follow-up|Patient at psychiatric hospital|0
1620873|NCT01990768|5657019|P1|6-Month Follow-up|Patient at psychiatric hospital|1
1620874|NCT01990768|5657017|P3|6-Month Follow-up|Prisoner at time of follow-up|0
1620875|NCT01990768|5657018|P2|6-Month Follow-up|Prisoner at time of follow-up|2
1620876|NCT01990768|5657019|P1|6-Month Follow-up|Prisoner at time of follow-up|0
1620877|NCT01990768|5657017|P3|6-Month Follow-up|Prisoner at time of enrollment|1
1620878|NCT01990768|5657018|P2|6-Month Follow-up|Prisoner at time of enrollment|0
1620879|NCT01990768|5657019|P1|6-Month Follow-up|Prisoner at time of enrollment|0
1620880|NCT01990768|5657017|P3|6-Month Follow-up|Homeless|6
1620881|NCT01990768|5657018|P2|6-Month Follow-up|Homeless|3
1620882|NCT01990768|5657019|P1|6-Month Follow-up|Homeless|4
1620883|NCT01990768|5657017|P3|6-Month Follow-up|No contact information|5
1620884|NCT01990768|5657018|P2|6-Month Follow-up|No contact information|6
1620885|NCT01990768|5657019|P1|6-Month Follow-up|No contact information|5
1620886|NCT01990768|5657017|P3|6-Month Follow-up|Calls unreturned or refused contact|20
1620887|NCT01990768|5657018|P2|6-Month Follow-up|Calls unreturned or refused contact|15
1620888|NCT01990768|5657019|P1|6-Month Follow-up|Calls unreturned or refused contact|4
1620889|NCT01990768|5657017|P3|6-Month Follow-up|Withdrawal by Subject|26
1620890|NCT01990768|5657018|P2|6-Month Follow-up|Withdrawal by Subject|25
1620891|NCT01990768|5657019|P1|6-Month Follow-up|Withdrawal by Subject|25
1620892|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
1620893|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
1620894|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
1620895|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
1620896|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
1620897|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
1620898|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
1620899|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
1620900|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
1620901|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
1620902|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
1620903|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
1620904|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
1620905|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
1620906|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
1620907|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Other safety concern|3
1620908|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Other safety concern|2
1620909|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Other safety concern|4
1620910|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Required CPR|1
1620911|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Required CPR|7
1620912|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Required CPR|3
1620913|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
1620914|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
1620915|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
1620916|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
1620917|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
1620918|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
1620919|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
1620920|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
1620921|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
1620922|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
1620923|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
1620924|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
1620925|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
1620926|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
1620927|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
1620928|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
1620929|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
1620930|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
1620931|NCT01990768|5657017|P3|In-Hospital Study Drug Infusion|Discharged|13
1620932|NCT01990768|5657018|P2|In-Hospital Study Drug Infusion|Discharged|18
1620933|NCT01990768|5657019|P1|In-Hospital Study Drug Infusion|Discharged|19
1620934|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Unknown if completed|2
1620935|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Unknown if completed|4
1620936|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Unknown if completed|1
1620937|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
1620938|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
1620939|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
1620940|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
1620941|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
1620942|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
1620943|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Discharged|0
1620944|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Discharged|1
1620945|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Discharged|2
1620946|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Death|1
1620947|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Death|1
1620948|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Death|3
1620949|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Other safety concern|1
1620950|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Other safety concern|1
1620951|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Other safety concern|2
1620952|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Required CPR|0
1620953|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Required CPR|6
1620954|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Required CPR|2
1620955|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
1620956|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
1620957|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
1620958|NCT01990768|5657017|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
1620959|NCT01990768|5657018|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
1620960|NCT01990768|5657019|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
1620961|NCT01990768|5657017|P3|Intervention Started|Discovered to be pregnant|0
1620962|NCT01990768|5657018|P2|Intervention Started|Discovered to be pregnant|1
1620963|NCT01990768|5657019|P1|Intervention Started|Discovered to be pregnant|0
1620964|NCT01990768|5657017|P3|Intervention Started|Seizure or hx of seizure|2
1620965|NCT01990768|5657018|P2|Intervention Started|Seizure or hx of seizure|0
1620966|NCT01990768|5657019|P1|Intervention Started|Seizure or hx of seizure|0
1620967|NCT01990768|5657017|P3|Intervention Started|Required CPR|0
1620968|NCT01990768|5657018|P2|Intervention Started|Required CPR|1
1620969|NCT01990768|5657019|P1|Intervention Started|Required CPR|1
1620970|NCT01990768|5657017|P3|Intervention Started|IV lost|2
1620971|NCT01990768|5657018|P2|Intervention Started|IV lost|2
1620972|NCT01990768|5657019|P1|Intervention Started|IV lost|2
1620973|NCT01990768|5657017|P3|Intervention Started|Patient care priority|3
1620974|NCT01990768|5657018|P2|Intervention Started|Patient care priority|2
1620975|NCT01990768|5657019|P1|Intervention Started|Patient care priority|1
1620976|NCT01990768|5657017|P3|Intervention Started|Not enough time for EMS to enroll|0
1620977|NCT01990768|5657018|P2|Intervention Started|Not enough time for EMS to enroll|3
1620978|NCT01990768|5657019|P1|Intervention Started|Not enough time for EMS to enroll|4
1620979|NCT01990768|5657017|P3|Intervention Started|Patient became ineligible due to vitals|2
1620980|NCT01990768|5657018|P2|Intervention Started|Patient became ineligible due to vitals|5
1620981|NCT01990768|5657019|P1|Intervention Started|Patient became ineligible due to vitals|5
1620982|NCT01990768|5657017|P3|Intervention Started|Study drug issue or kit malfunction|7
1620983|NCT01990768|5657018|P2|Intervention Started|Study drug issue or kit malfunction|6
1620984|NCT01990768|5657019|P1|Intervention Started|Study drug issue or kit malfunction|9
1620985|NCT01990768|5657017|P3|Intervention Started|Found to be ineligible|11
1620986|NCT01990768|5657018|P2|Intervention Started|Found to be ineligible|13
1620987|NCT01990768|5657019|P1|Intervention Started|Found to be ineligible|14
1620988|NCT01990742|5657084|P2|Overall Study|Facility closed|270
1620989|NCT01990742|5657085|P1|Overall Study|Facility closed|0
1620990|NCT01990742|5657084|P2|Overall Study|Withdrawal by facility|1083
1620991|NCT01990742|5657085|P1|Overall Study|Withdrawal by facility|407
1620992|NCT01990664|5657121|P2|Overall Study|Unsatisfactory Visual Response|1
1620993|NCT01990664|5657122|P1|Overall Study|Unsatisfactory Visual Response|0
1620994|NCT01990664|5657121|P2|Overall Study|Lens Handling Difficulties|0
1620995|NCT01990664|5657122|P1|Overall Study|Lens Handling Difficulties|1
1620996|NCT01990664|5657121|P2|Overall Study|Lens Discomfort|1
1620997|NCT01990664|5657122|P1|Overall Study|Lens Discomfort|1
1620998|NCT01990664|5657121|P2|Overall Study|Protocol Violation|0
1620999|NCT01990664|5657122|P1|Overall Study|Protocol Violation|1
1621000|NCT01990664|5657121|P2|Overall Study|Withdrawal by Subject|3
1621001|NCT01990664|5657122|P1|Overall Study|Withdrawal by Subject|2
1621002|NCT01990664|5657121|P2|Overall Study|Lost to Follow-up|6
1621003|NCT01990664|5657122|P1|Overall Study|Lost to Follow-up|2
1621004|NCT01990612|5657130|P2|Overall Study|Withdrawal by Subject|2
1621005|NCT01990612|5657131|P1|Overall Study|Withdrawal by Subject|5
1621006|NCT01990612|5657130|P2|Overall Study|Lost to Follow-up|1
1621007|NCT01990612|5657131|P1|Overall Study|Lost to Follow-up|2
1621008|NCT01990573|5657212|P3|Overall Study|Physician Decision|1
1621009|NCT01990573|5657213|P2|Overall Study|Physician Decision|0
1621010|NCT01990573|5657214|P1|Overall Study|Physician Decision|0
1621011|NCT01990560|5657227|P1|Overall Study|Withdrawal by Subject|1
1621012|NCT01990534|5657241|P1|Overall Study|Overall Survival Follow-up|25
1621013|NCT01990534|5657241|P1|Overall Study|Progression Free Survival Follow-up|11
1621014|NCT01990534|5657241|P1|Overall Study|Reason Not Specified|2
1621015|NCT01990534|5657241|P1|Overall Study|Withdrawal by Subject|3
1621016|NCT01990534|5657241|P1|Overall Study|Symptomatic Deterioration|1
1621017|NCT01990534|5657241|P1|Overall Study|Withdrawal of Informed Consent|2
1621018|NCT01990534|5657241|P1|Overall Study|Protocol Violation|1
1621019|NCT01990534|5657241|P1|Overall Study|Progressive disease|3
1621020|NCT01990534|5657241|P1|Overall Study|Death|12
1621021|NCT01990339|5657257|P1|Overall Study|Lost to Follow-up|861
1621022|NCT01990339|5657257|P1|Overall Study|Voluntary Withdrawal|1402
1621023|NCT01990339|5657257|P1|Overall Study|Data Not Available|49
1621024|NCT01990313|5657262|P1|Overall Study|Lost to Follow-up|1
1621025|NCT01990300|5657267|P1|Overall Study|Protocol Deviation|53
1621026|NCT01990300|5657267|P1|Overall Study|Case Report Forms Uncollected|89
1621027|NCT01990261|5657273|P1|Overall Study|Lost to Follow-up|2
1621028|NCT01990261|5657273|P1|Overall Study|Dossier not Approved|1
1621029|NCT01990261|5657273|P1|Overall Study|PD Before Treatment Start|1
1621030|NCT01990261|5657273|P1|Overall Study|Disease Progression (PD)|8
1621031|NCT01990261|5657273|P1|Overall Study|Death From other Causes|1
1621032|NCT01990261|5657273|P1|Overall Study|Death due to Disease Progression (PD)|10
1621033|NCT01990261|5657273|P1|Overall Study|Death Before Treatment Start|2
1621034|NCT01989754|5657330|P2|Overall Study|Closed Site|1
1621035|NCT01989754|5657331|P1|Overall Study|Closed Site|1
1621036|NCT01989754|5657330|P2|Overall Study|Lost to Follow-up|20
1621037|NCT01989754|5657331|P1|Overall Study|Lost to Follow-up|28
1621038|NCT01989754|5657330|P2|Overall Study|Withdrawal by Subject|14
1621039|NCT01989754|5657331|P1|Overall Study|Withdrawal by Subject|10
1621040|NCT01989689|5657343|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
1621041|NCT01989689|5657344|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
1621042|NCT01989689|5657343|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
1621043|NCT01989689|5657344|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
1621044|NCT01989676|5657356|P2|Overall Study|Discontinued|68
1621045|NCT01989676|5657357|P1|Overall Study|Discontinued|59
1621046|NCT01989676|5657356|P2|Overall Study|Ongoing at data cutoff|279
1621047|NCT01989676|5657357|P1|Overall Study|Ongoing at data cutoff|279
1621048|NCT01989572|5657383|P6|Overall Study|alternative therapy|3
1621049|NCT01989572|5657384|P5|Overall Study|alternative therapy|1
1621050|NCT01989572|5657385|P4|Overall Study|alternative therapy|0
1621051|NCT01989572|5657386|P3|Overall Study|alternative therapy|0
1621052|NCT01989572|5657387|P2|Overall Study|alternative therapy|0
1621053|NCT01989572|5657388|P1|Overall Study|alternative therapy|3
1621054|NCT01989572|5657383|P6|Overall Study|not start protocol therapy|18
1621055|NCT01989572|5657384|P5|Overall Study|not start protocol therapy|4
1621056|NCT01989572|5657385|P4|Overall Study|not start protocol therapy|3
1621057|NCT01989572|5657386|P3|Overall Study|not start protocol therapy|2
1621058|NCT01989572|5657387|P2|Overall Study|not start protocol therapy|1
1621059|NCT01989572|5657388|P1|Overall Study|not start protocol therapy|5
1621060|NCT01989572|5657383|P6|Overall Study|unknown/not specify|5
1621061|NCT01989572|5657384|P5|Overall Study|unknown/not specify|3
1621062|NCT01989572|5657385|P4|Overall Study|unknown/not specify|3
1621063|NCT01989572|5657386|P3|Overall Study|unknown/not specify|1
1621064|NCT01989572|5657387|P2|Overall Study|unknown/not specify|4
1621065|NCT01989572|5657388|P1|Overall Study|unknown/not specify|3
1621066|NCT01989572|5657383|P6|Overall Study|maximum dose reached|0
1621067|NCT01989572|5657384|P5|Overall Study|maximum dose reached|1
1621068|NCT01989572|5657385|P4|Overall Study|maximum dose reached|0
1621069|NCT01989572|5657386|P3|Overall Study|maximum dose reached|0
1621070|NCT01989572|5657387|P2|Overall Study|maximum dose reached|1
1621071|NCT01989572|5657388|P1|Overall Study|maximum dose reached|0
1621072|NCT01989572|5657383|P6|Overall Study|error|1
1621073|NCT01989572|5657384|P5|Overall Study|error|1
1621074|NCT01989572|5657385|P4|Overall Study|error|1
1621075|NCT01989572|5657386|P3|Overall Study|error|1
1621076|NCT01989572|5657387|P2|Overall Study|error|1
1621077|NCT01989572|5657388|P1|Overall Study|error|2
1621078|NCT01989572|5657383|P6|Overall Study|complicating disease|0
1621079|NCT01989572|5657384|P5|Overall Study|complicating disease|1
1621080|NCT01989572|5657385|P4|Overall Study|complicating disease|0
1621081|NCT01989572|5657386|P3|Overall Study|complicating disease|2
1621082|NCT01989572|5657387|P2|Overall Study|complicating disease|1
1621083|NCT01989572|5657388|P1|Overall Study|complicating disease|1
1621084|NCT01989572|5657383|P6|Overall Study|Withdrawal by Subject|4
1621085|NCT01989572|5657384|P5|Overall Study|Withdrawal by Subject|12
1621086|NCT01989572|5657385|P4|Overall Study|Withdrawal by Subject|1
1621087|NCT01989572|5657386|P3|Overall Study|Withdrawal by Subject|5
1621088|NCT01989572|5657387|P2|Overall Study|Withdrawal by Subject|1
1621089|NCT01989572|5657388|P1|Overall Study|Withdrawal by Subject|4
1621090|NCT01989572|5657383|P6|Overall Study|Death|0
1621091|NCT01989572|5657384|P5|Overall Study|Death|1
1621092|NCT01989572|5657385|P4|Overall Study|Death|0
1621093|NCT01989572|5657386|P3|Overall Study|Death|0
1621094|NCT01989572|5657387|P2|Overall Study|Death|0
1621095|NCT01989572|5657388|P1|Overall Study|Death|0
1621096|NCT01989572|5657383|P6|Overall Study|Adverse Event|0
1621097|NCT01989572|5657384|P5|Overall Study|Adverse Event|3
1621098|NCT01989572|5657385|P4|Overall Study|Adverse Event|0
1621099|NCT01989572|5657386|P3|Overall Study|Adverse Event|3
1621100|NCT01989572|5657387|P2|Overall Study|Adverse Event|1
1621101|NCT01989572|5657388|P1|Overall Study|Adverse Event|2
1621102|NCT01989572|5657383|P6|Overall Study|Lack of Efficacy|79
1621103|NCT01989572|5657384|P5|Overall Study|Lack of Efficacy|71
1621104|NCT01989572|5657385|P4|Overall Study|Lack of Efficacy|43
1621105|NCT01989572|5657386|P3|Overall Study|Lack of Efficacy|48
1621106|NCT01989572|5657387|P2|Overall Study|Lack of Efficacy|48
1621107|NCT01989572|5657388|P1|Overall Study|Lack of Efficacy|35
1621108|NCT01989468|5657419|P5|Overall Study|Death|0
1621109|NCT01989468|5657420|P4|Overall Study|Death|0
1621110|NCT01989468|5657421|P3|Overall Study|Death|1
1621111|NCT01989468|5657422|P2|Overall Study|Death|0
1621112|NCT01989468|5657423|P1|Overall Study|Death|3
1621113|NCT01989468|5657419|P5|Overall Study|Subject Guardian Decision|1
1621114|NCT01989468|5657420|P4|Overall Study|Subject Guardian Decision|4
1621115|NCT01989468|5657421|P3|Overall Study|Subject Guardian Decision|4
1621116|NCT01989468|5657422|P2|Overall Study|Subject Guardian Decision|6
1621117|NCT01989468|5657423|P1|Overall Study|Subject Guardian Decision|11
1621118|NCT01989468|5657419|P5|Overall Study|Technical Problems|0
1621119|NCT01989468|5657420|P4|Overall Study|Technical Problems|1
1621120|NCT01989468|5657421|P3|Overall Study|Technical Problems|3
1621121|NCT01989468|5657422|P2|Overall Study|Technical Problems|1
1621122|NCT01989468|5657423|P1|Overall Study|Technical Problems|3
1621123|NCT01989468|5657419|P5|Overall Study|Pregnancy|0
1621124|NCT01989468|5657420|P4|Overall Study|Pregnancy|0
1621125|NCT01989468|5657421|P3|Overall Study|Pregnancy|0
1621126|NCT01989468|5657422|P2|Overall Study|Pregnancy|1
1621127|NCT01989468|5657423|P1|Overall Study|Pregnancy|0
1621128|NCT01989468|5657419|P5|Overall Study|Physician Decision|0
1621129|NCT01989468|5657420|P4|Overall Study|Physician Decision|1
1621130|NCT01989468|5657421|P3|Overall Study|Physician Decision|0
1621131|NCT01989468|5657422|P2|Overall Study|Physician Decision|1
1621132|NCT01989468|5657423|P1|Overall Study|Physician Decision|4
1621133|NCT01989468|5657419|P5|Overall Study|Lost to Follow-up|1
1621134|NCT01989468|5657420|P4|Overall Study|Lost to Follow-up|1
1621135|NCT01989468|5657421|P3|Overall Study|Lost to Follow-up|0
1621136|NCT01989468|5657422|P2|Overall Study|Lost to Follow-up|2
1621137|NCT01989468|5657423|P1|Overall Study|Lost to Follow-up|5
1621138|NCT01989468|5657419|P5|Overall Study|Lack of Efficacy|2
1621139|NCT01989468|5657420|P4|Overall Study|Lack of Efficacy|4
1621140|NCT01989468|5657421|P3|Overall Study|Lack of Efficacy|7
1621141|NCT01989468|5657422|P2|Overall Study|Lack of Efficacy|11
1621142|NCT01989468|5657423|P1|Overall Study|Lack of Efficacy|11
1621143|NCT01989468|5657419|P5|Overall Study|Adverse Event|4
1621144|NCT01989468|5657420|P4|Overall Study|Adverse Event|5
1621145|NCT01989468|5657421|P3|Overall Study|Adverse Event|4
1621146|NCT01989468|5657422|P2|Overall Study|Adverse Event|15
1621147|NCT01989468|5657423|P1|Overall Study|Adverse Event|10
1621148|NCT01989455|5657465|P5|Overall Study|Technical problems with infusion|1
1621149|NCT01989455|5657466|P4|Overall Study|Technical problems with infusion|0
1621150|NCT01989455|5657467|P3|Overall Study|Technical problems with infusion|1
1621151|NCT01989455|5657468|P2|Overall Study|Technical problems with infusion|0
1621152|NCT01989455|5657469|P1|Overall Study|Technical problems with infusion|0
1621153|NCT01989455|5657465|P5|Overall Study|Withdrawal by Subject|0
1621154|NCT01989455|5657466|P4|Overall Study|Withdrawal by Subject|0
1621155|NCT01989455|5657467|P3|Overall Study|Withdrawal by Subject|0
1621156|NCT01989455|5657468|P2|Overall Study|Withdrawal by Subject|1
1621157|NCT01989455|5657469|P1|Overall Study|Withdrawal by Subject|0
1621158|NCT01989455|5657465|P5|Overall Study|Adverse Event|0
1621159|NCT01989455|5657466|P4|Overall Study|Adverse Event|0
1621160|NCT01989455|5657467|P3|Overall Study|Adverse Event|0
1621161|NCT01989455|5657468|P2|Overall Study|Adverse Event|1
1621162|NCT01989455|5657469|P1|Overall Study|Adverse Event|0
1621163|NCT01989169|5657513|P2|Period 2|Adverse Event|1
1621164|NCT01989169|5657514|P1|Period 2|Adverse Event|0
1621165|NCT01989156|5657527|P3|End of Study (Population at Day 90)|Employment Conflict|0
1621166|NCT01989156|5657528|P2|End of Study (Population at Day 90)|Employment Conflict|1
1621167|NCT01989156|5657529|P1|End of Study (Population at Day 90)|Employment Conflict|0
1621168|NCT01989156|5657527|P3|End of Study (Population at Day 90)|Moved out of state|0
1621169|NCT01989156|5657528|P2|End of Study (Population at Day 90)|Moved out of state|0
1621170|NCT01989156|5657529|P1|End of Study (Population at Day 90)|Moved out of state|1
1621171|NCT01989156|5657527|P3|End of Study (Population at Day 90)|Physician Decision|1
1621172|NCT01989156|5657528|P2|End of Study (Population at Day 90)|Physician Decision|0
1621173|NCT01989156|5657529|P1|End of Study (Population at Day 90)|Physician Decision|1
1621174|NCT01989156|5657527|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
1621175|NCT01989156|5657528|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
1621176|NCT01989156|5657529|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
1621177|NCT01989156|5657527|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
1621178|NCT01989156|5657528|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
1621179|NCT01989156|5657529|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
1621180|NCT01989156|5657527|P3|Confinement Period (Population at Day 5)|Adverse Event|1
1621181|NCT01989156|5657528|P2|Confinement Period (Population at Day 5)|Adverse Event|0
1621182|NCT01989156|5657529|P1|Confinement Period (Population at Day 5)|Adverse Event|0
1621183|NCT01989156|5657527|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
1621184|NCT01989156|5657528|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
1621185|NCT01989156|5657529|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
1621186|NCT01989156|5657527|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
1621187|NCT01989156|5657528|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1621188|NCT01989156|5657529|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
1621189|NCT01988779|5657589|P2|Overall Study|Protocol Violation|0
1621190|NCT01988779|5657590|P1|Overall Study|Protocol Violation|1
1621191|NCT01988779|5657589|P2|Overall Study|Withdrawal by Subject|2
1621192|NCT01988779|5657590|P1|Overall Study|Withdrawal by Subject|2
1621193|NCT01988662|5657598|P2|Overall Study|Adverse Event|1
1621194|NCT01988662|5657599|P1|Overall Study|Adverse Event|3
1621195|NCT01988662|5657598|P2|Overall Study|Subject/guardian decision|1
1621196|NCT01988662|5657599|P1|Overall Study|Subject/guardian decision|1
1621197|NCT01988493|5657621|P5|Overall Study|Ongoing|0
1621198|NCT01988493|5657622|P4|Overall Study|Ongoing|2
1621199|NCT01988493|5657623|P3|Overall Study|Ongoing|0
1621200|NCT01988493|5657624|P2|Overall Study|Ongoing|0
1621201|NCT01988493|5657625|P1|Overall Study|Ongoing|0
1621202|NCT01988493|5657621|P5|Overall Study|Randomized but not treated|1
1621203|NCT01988493|5657622|P4|Overall Study|Randomized but not treated|0
1621204|NCT01988493|5657623|P3|Overall Study|Randomized but not treated|0
1621205|NCT01988493|5657624|P2|Overall Study|Randomized but not treated|0
1621206|NCT01988493|5657625|P1|Overall Study|Randomized but not treated|0
1621207|NCT01988402|5657704|P2|Overall Study|Withdrawal by Subject|0
1621208|NCT01988402|5657705|P1|Overall Study|Withdrawal by Subject|1
1621209|NCT01988402|5657704|P2|Overall Study|Adverse Event|2
1621210|NCT01988402|5657705|P1|Overall Study|Adverse Event|1
1621211|NCT01988090|5657758|P2|Complete Study After Start|Protocol Violation|1
1621212|NCT01988090|5657759|P1|Complete Study After Start|Protocol Violation|1
1621213|NCT01988090|5657758|P2|Complete Study After Start|Withdrawal by Subject|0
1621214|NCT01988090|5657759|P1|Complete Study After Start|Withdrawal by Subject|2
1621215|NCT01988090|5657758|P2|Start Treament After Randomization|Protocol Violation|1
1621216|NCT01988090|5657759|P1|Start Treament After Randomization|Protocol Violation|0
1621217|NCT01988090|5657758|P2|Start Treament After Randomization|Withdrawal by Subject|3
1621218|NCT01988090|5657759|P1|Start Treament After Randomization|Withdrawal by Subject|2
1621219|NCT01988012|5657769|P1|Overall Study|Protocol Violation|1
1621220|NCT01988012|5657769|P1|Overall Study|Physician Decision|1
1621221|NCT01988012|5657769|P1|Overall Study|Lost to Follow-up|1
1621222|NCT01988012|5657769|P1|Overall Study|Patient Withdrawal of Consent|4
1621223|NCT01988012|5657769|P1|Overall Study|Insufficient Therapeutic Response|3
1621224|NCT01988012|5657769|P1|Overall Study|Adverse Event|5
1621225|NCT01987986|5657795|P4|Overall Study|Adverse Event|0
1621226|NCT01987986|5657796|P3|Overall Study|Adverse Event|2
1621227|NCT01987986|5657797|P2|Overall Study|Adverse Event|0
1621228|NCT01987986|5657798|P1|Overall Study|Adverse Event|1
1621229|NCT01987986|5657795|P4|Overall Study|Lost to Follow-up|0
1621230|NCT01987986|5657796|P3|Overall Study|Lost to Follow-up|0
1621231|NCT01987986|5657797|P2|Overall Study|Lost to Follow-up|0
1621232|NCT01987986|5657798|P1|Overall Study|Lost to Follow-up|1
1621233|NCT01987960|5657838|P4|Period 3|Administrative or other reason|43
1621234|NCT01987960|5657839|P3|Period 3|Administrative or other reason|0
1621235|NCT01987960|5657840|P2|Period 3|Administrative or other reason|0
1621236|NCT01987960|5657841|P1|Period 3|Administrative or other reason|0
1621237|NCT01987960|5657838|P4|Period 3|Lost to Follow-up|5
1621238|NCT01987960|5657839|P3|Period 3|Lost to Follow-up|0
1621239|NCT01987960|5657840|P2|Period 3|Lost to Follow-up|0
1621240|NCT01987960|5657841|P1|Period 3|Lost to Follow-up|0
1621241|NCT01987960|5657838|P4|Period 3|Withdrawal by Subject|9
1621242|NCT01987960|5657839|P3|Period 3|Withdrawal by Subject|0
1621243|NCT01987960|5657840|P2|Period 3|Withdrawal by Subject|0
1621244|NCT01987960|5657841|P1|Period 3|Withdrawal by Subject|0
1621245|NCT01987960|5657838|P4|Period 3|Protocol Violation|6
1621246|NCT01987960|5657839|P3|Period 3|Protocol Violation|0
1621247|NCT01987960|5657840|P2|Period 3|Protocol Violation|0
1621248|NCT01987960|5657841|P1|Period 3|Protocol Violation|0
1621249|NCT01987960|5657838|P4|Period 3|Non-compliance with IMP|1
1621250|NCT01987960|5657839|P3|Period 3|Non-compliance with IMP|0
1621251|NCT01987960|5657840|P2|Period 3|Non-compliance with IMP|0
1621252|NCT01987960|5657841|P1|Period 3|Non-compliance with IMP|0
1621253|NCT01987960|5657838|P4|Period 3|Adverse Event|7
1621254|NCT01987960|5657839|P3|Period 3|Adverse Event|0
1621255|NCT01987960|5657840|P2|Period 3|Adverse Event|0
1621256|NCT01987960|5657841|P1|Period 3|Adverse Event|0
1621257|NCT01987960|5657838|P4|Period 2|Administrative or other reason|0
1621258|NCT01987960|5657839|P3|Period 2|Administrative or other reason|7
1621259|NCT01987960|5657840|P2|Period 2|Administrative or other reason|5
1621260|NCT01987960|5657841|P1|Period 2|Administrative or other reason|0
1621261|NCT01987960|5657838|P4|Period 2|Withdrawal by Subject|0
1621262|NCT01987960|5657839|P3|Period 2|Withdrawal by Subject|1
1621263|NCT01987960|5657840|P2|Period 2|Withdrawal by Subject|0
1621264|NCT01987960|5657841|P1|Period 2|Withdrawal by Subject|0
1621265|NCT01987960|5657838|P4|Period 2|Adverse Event|0
1621266|NCT01987960|5657839|P3|Period 2|Adverse Event|1
1621267|NCT01987960|5657840|P2|Period 2|Adverse Event|0
1621268|NCT01987960|5657841|P1|Period 2|Adverse Event|0
1621269|NCT01987960|5657838|P4|Period 1|Withdrawal of consent before treatment|0
1621270|NCT01987960|5657839|P3|Period 1|Withdrawal of consent before treatment|0
1621271|NCT01987960|5657840|P2|Period 1|Withdrawal of consent before treatment|0
1621272|NCT01987960|5657841|P1|Period 1|Withdrawal of consent before treatment|4
1621273|NCT01987960|5657838|P4|Period 1|administrative or other reason|0
1621274|NCT01987960|5657839|P3|Period 1|administrative or other reason|0
1621275|NCT01987960|5657840|P2|Period 1|administrative or other reason|0
1621276|NCT01987960|5657841|P1|Period 1|administrative or other reason|75
1621277|NCT01987960|5657838|P4|Period 1|Lost to Follow-up|0
1621278|NCT01987960|5657839|P3|Period 1|Lost to Follow-up|0
1621279|NCT01987960|5657840|P2|Period 1|Lost to Follow-up|0
1621280|NCT01987960|5657841|P1|Period 1|Lost to Follow-up|40
1621281|NCT01987960|5657838|P4|Period 1|Withdrawal by Subject|0
1621282|NCT01987960|5657839|P3|Period 1|Withdrawal by Subject|0
1621283|NCT01987960|5657840|P2|Period 1|Withdrawal by Subject|0
1621284|NCT01987960|5657841|P1|Period 1|Withdrawal by Subject|21
1621285|NCT01987960|5657838|P4|Period 1|Protocol Violation|0
1621286|NCT01987960|5657839|P3|Period 1|Protocol Violation|0
1621287|NCT01987960|5657840|P2|Period 1|Protocol Violation|0
1621288|NCT01987960|5657841|P1|Period 1|Protocol Violation|12
1621289|NCT01987960|5657838|P4|Period 1|Non-compliance with IMP|0
1621290|NCT01987960|5657839|P3|Period 1|Non-compliance with IMP|0
1621291|NCT01987960|5657840|P2|Period 1|Non-compliance with IMP|0
1621292|NCT01987960|5657841|P1|Period 1|Non-compliance with IMP|6
1621293|NCT01987960|5657838|P4|Period 1|Lack of Efficacy|0
1621294|NCT01987960|5657839|P3|Period 1|Lack of Efficacy|0
1621295|NCT01987960|5657840|P2|Period 1|Lack of Efficacy|0
1621296|NCT01987960|5657841|P1|Period 1|Lack of Efficacy|4
1621297|NCT01987960|5657838|P4|Period 1|Adverse Event|0
1621298|NCT01987960|5657839|P3|Period 1|Adverse Event|0
1621299|NCT01987960|5657840|P2|Period 1|Adverse Event|0
1621300|NCT01987960|5657841|P1|Period 1|Adverse Event|24
1621301|NCT01987908|5657853|P3|Post-Treatment Observation Period|Other: Bad Veins|0
1621302|NCT01987908|5657854|P2|Post-Treatment Observation Period|Other: Bad Veins|1
1621303|NCT01987908|5657855|P1|Post-Treatment Observation Period|Other: Bad Veins|0
1621304|NCT01987908|5657853|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1621305|NCT01987908|5657854|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
1621306|NCT01987908|5657855|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
1621307|NCT01987908|5657853|P3|Treatment Period|Adverse Event|1
1621308|NCT01987908|5657854|P2|Treatment Period|Adverse Event|1
1621309|NCT01987908|5657855|P1|Treatment Period|Adverse Event|0
1621310|NCT01987908|5657853|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1621311|NCT01987908|5657854|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
1621312|NCT01987908|5657855|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
1621313|NCT01987908|5657853|P3|Placebo Lead-in Period|Withdrawal by Subject|0
1621314|NCT01987908|5657854|P2|Placebo Lead-in Period|Withdrawal by Subject|0
1621315|NCT01987908|5657855|P1|Placebo Lead-in Period|Withdrawal by Subject|1
1621316|NCT01987908|5657853|P3|Placebo Lead-in Period|Physician Decision|0
1621317|NCT01987908|5657854|P2|Placebo Lead-in Period|Physician Decision|0
1621318|NCT01987908|5657855|P1|Placebo Lead-in Period|Physician Decision|2
1621319|NCT01987908|5657853|P3|Placebo Lead-in Period|Adverse Event|0
1621320|NCT01987908|5657854|P2|Placebo Lead-in Period|Adverse Event|0
1621321|NCT01987908|5657855|P1|Placebo Lead-in Period|Adverse Event|2
1621322|NCT01987895|5657938|P2|Overall Study|randomized before giving IC|1
1621323|NCT01987895|5657939|P1|Overall Study|randomized before giving IC|0
1621324|NCT01987895|5657938|P2|Overall Study|Lost to Follow-up|5
1621325|NCT01987895|5657939|P1|Overall Study|Lost to Follow-up|3
1621326|NCT01987895|5657938|P2|Overall Study|Death|7
1621327|NCT01987895|5657939|P1|Overall Study|Death|7
1621328|NCT01987895|5657938|P2|Overall Study|Physician Decision|10
1621329|NCT01987895|5657939|P1|Overall Study|Physician Decision|8
1621330|NCT01987895|5657938|P2|Overall Study|Withdrawal by Subject|7
1621331|NCT01987895|5657939|P1|Overall Study|Withdrawal by Subject|12
1621332|NCT01987765|5657963|P1|Overall Study|Lost to Follow-up|37
1621333|NCT01987765|5657963|P1|Overall Study|Protocol Violation|65
1621334|NCT01987609|5657973|P1|Overall Study|Adverse Event|1
1621335|NCT01987557|5658018|P3|Overall Study|Adverse Event|0
1621336|NCT01987557|5658019|P2|Overall Study|Adverse Event|2
1621337|NCT01987557|5658020|P1|Overall Study|Adverse Event|0
1621338|NCT01987557|5658018|P3|Overall Study|Withdrawal by Subject|2
1621339|NCT01987557|5658019|P2|Overall Study|Withdrawal by Subject|1
1621340|NCT01987557|5658020|P1|Overall Study|Withdrawal by Subject|2
1621341|NCT01987557|5658018|P3|Overall Study|Protocol Violation|1
1621342|NCT01987557|5658019|P2|Overall Study|Protocol Violation|0
1621343|NCT01987557|5658020|P1|Overall Study|Protocol Violation|1
1621344|NCT01987505|5658030|P1|Overall Study|Death|4
1621345|NCT01987505|5658030|P1|Overall Study|Investigator Decision|2
1621346|NCT01987505|5658030|P1|Overall Study|Lost to Follow-up|15
1621347|NCT01987505|5658030|P1|Overall Study|Other Reason|2
1621348|NCT01987505|5658030|P1|Overall Study|Withdrawal by Subject|2
1621349|NCT01987505|5658030|P1|Overall Study|Other|9
1621350|NCT01987479|5658060|P1|Overall Study|Adverse Event|7
1621351|NCT01987479|5658060|P1|Overall Study|Lost to Follow-up|1
1621352|NCT01987479|5658060|P1|Overall Study|Other|5
1621353|NCT01987479|5658060|P1|Overall Study|Participant/legal guardian decision|1
1621354|NCT01987479|5658060|P1|Overall Study|Physician Decision|2
1621355|NCT01987479|5658060|P1|Overall Study|Protocol Violation|1
1621356|NCT01987453|5658088|P3|Overall Study|Lack of Efficacy|0
1621357|NCT01987453|5658089|P2|Overall Study|Lack of Efficacy|12
1621358|NCT01987453|5658090|P1|Overall Study|Lack of Efficacy|1
1621359|NCT01987453|5658088|P3|Overall Study|Death|1
1621360|NCT01987453|5658089|P2|Overall Study|Death|0
1621361|NCT01987453|5658090|P1|Overall Study|Death|0
1621362|NCT01987427|5658116|P3|Overall Study|Other|0
1621363|NCT01987427|5658117|P2|Overall Study|Other|1
1621364|NCT01987427|5658118|P1|Overall Study|Other|1
1621365|NCT01987427|5658116|P3|Overall Study|Lack of Efficacy|0
1621366|NCT01987427|5658117|P2|Overall Study|Lack of Efficacy|0
1621367|NCT01987427|5658118|P1|Overall Study|Lack of Efficacy|1
1621368|NCT01987427|5658116|P3|Overall Study|Withdrawal by Subject|3
1621369|NCT01987427|5658117|P2|Overall Study|Withdrawal by Subject|1
1621370|NCT01987427|5658118|P1|Overall Study|Withdrawal by Subject|2
1621371|NCT01987427|5658116|P3|Overall Study|Lost to Follow-up|9
1621372|NCT01987427|5658117|P2|Overall Study|Lost to Follow-up|6
1621373|NCT01987427|5658118|P1|Overall Study|Lost to Follow-up|6
1621374|NCT01987427|5658116|P3|Overall Study|Adverse Event|8
1621375|NCT01987427|5658117|P2|Overall Study|Adverse Event|2
1621376|NCT01987427|5658118|P1|Overall Study|Adverse Event|4
1621377|NCT01987232|5658255|P5|Overall Study|Ongoing in Study|0
1621378|NCT01987232|5658256|P4|Overall Study|Ongoing in Study|1
1621379|NCT01987232|5658257|P3|Overall Study|Ongoing in Study|0
1621380|NCT01987232|5658258|P2|Overall Study|Ongoing in Study|0
1621381|NCT01987232|5658259|P1|Overall Study|Ongoing in Study|0
1621382|NCT01987102|5658348|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
1621383|NCT01987102|5658349|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
1621384|NCT01987102|5658348|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
1621385|NCT01987102|5658349|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
1621386|NCT01987102|5658348|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
1621387|NCT01987102|5658349|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
1621388|NCT01987102|5658348|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
1621389|NCT01987102|5658349|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
1621390|NCT01987102|5658348|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
1621391|NCT01987102|5658349|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
1621392|NCT01987102|5658348|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
1621393|NCT01987102|5658349|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
1621394|NCT01986985|5658381|P1|Overall Study|Scan not completed due to malfunction|3
1621395|NCT01986985|5658381|P1|Overall Study|Withdrawal by Subject|4
1621396|NCT01986920|5658418|P4|Placebo|Withdrawal by Subject|1
1621397|NCT01986920|5658419|P3|Placebo|Withdrawal by Subject|0
1621398|NCT01986920|5658420|P2|Placebo|Withdrawal by Subject|0
1621399|NCT01986920|5658421|P1|Placebo|Withdrawal by Subject|0
1621400|NCT01986920|5658418|P4|A-101 40%|Withdrawal by Subject|0
1621401|NCT01986920|5658419|P3|A-101 40%|Withdrawal by Subject|1
1621402|NCT01986920|5658420|P2|A-101 40%|Withdrawal by Subject|0
1621403|NCT01986920|5658421|P1|A-101 40%|Withdrawal by Subject|0
1621404|NCT01986920|5658418|P4|A-101 32.5%|Withdrawal by Subject|0
1621405|NCT01986920|5658419|P3|A-101 32.5%|Withdrawal by Subject|0
1621406|NCT01986920|5658420|P2|A-101 32.5%|Withdrawal by Subject|1
1621407|NCT01986920|5658421|P1|A-101 32.5%|Withdrawal by Subject|0
1621408|NCT01986920|5658418|P4|A- 101 25%|Withdrawal by Subject|0
1621409|NCT01986920|5658419|P3|A- 101 25%|Withdrawal by Subject|0
1621410|NCT01986920|5658420|P2|A- 101 25%|Withdrawal by Subject|0
1621411|NCT01986920|5658421|P1|A- 101 25%|Withdrawal by Subject|1
1621412|NCT01986907|5658435|P1|Overall Study|Death|9
1621413|NCT01986907|5658435|P1|Overall Study|Lost to Follow-up|38
1621414|NCT01986907|5658435|P1|Overall Study|Withdrawal by Subject|76
1621415|NCT01986907|5658435|P1|Overall Study|Protocol Violation|4
1621416|NCT01986907|5658435|P1|Overall Study|Unsatisfactory therapeutic effect|24
1621417|NCT01986907|5658435|P1|Overall Study|Adverse Event|11
1621418|NCT01986855|5658448|P3|Overall Study|Withdrawal by Subject|5
1621419|NCT01986855|5658449|P2|Overall Study|Withdrawal by Subject|8
1621420|NCT01986855|5658450|P1|Overall Study|Withdrawal by Subject|7
1621421|NCT01986855|5658448|P3|Overall Study|Participant Moved|2
1621422|NCT01986855|5658449|P2|Overall Study|Participant Moved|0
1621423|NCT01986855|5658450|P1|Overall Study|Participant Moved|0
1621424|NCT01986855|5658448|P3|Overall Study|Screen Failure|0
1621425|NCT01986855|5658449|P2|Overall Study|Screen Failure|1
1621426|NCT01986855|5658450|P1|Overall Study|Screen Failure|0
1621427|NCT01986855|5658448|P3|Overall Study|Lost to Follow-up|0
1621428|NCT01986855|5658449|P2|Overall Study|Lost to Follow-up|1
1621429|NCT01986855|5658450|P1|Overall Study|Lost to Follow-up|2
1621430|NCT01986855|5658448|P3|Overall Study|Death|4
1621431|NCT01986855|5658449|P2|Overall Study|Death|4
1621432|NCT01986855|5658450|P1|Overall Study|Death|3
1621433|NCT01986855|5658448|P3|Overall Study|Adverse Event|0
1621434|NCT01986855|5658449|P2|Overall Study|Adverse Event|0
1621435|NCT01986855|5658450|P1|Overall Study|Adverse Event|1
1621436|NCT01986829|5658479|P1|Overall Study|Death|1
1621437|NCT01986751|5658527|P2|Overall Study|improperly consented|2
1621438|NCT01986751|5658528|P1|Overall Study|improperly consented|10
1621439|NCT01986647|5658561|P4|Overall Study|Health|4
1621440|NCT01986647|5658562|P3|Overall Study|Health|6
1621441|NCT01986647|5658563|P2|Overall Study|Health|3
1621442|NCT01986647|5658564|P1|Overall Study|Health|5
1621443|NCT01986647|5658561|P4|Overall Study|Withdrawal by Subject|3
1621444|NCT01986647|5658562|P3|Overall Study|Withdrawal by Subject|2
1621445|NCT01986647|5658563|P2|Overall Study|Withdrawal by Subject|3
1621446|NCT01986647|5658564|P1|Overall Study|Withdrawal by Subject|1
1621447|NCT01986647|5658561|P4|Overall Study|Lost to Follow-up|4
1621448|NCT01986647|5658562|P3|Overall Study|Lost to Follow-up|4
1621449|NCT01986647|5658563|P2|Overall Study|Lost to Follow-up|1
1621450|NCT01986647|5658564|P1|Overall Study|Lost to Follow-up|4
1621451|NCT01986231|5658659|P1|Overall Study|Adverse Event|1
1621452|NCT01986140|5658666|P2|Overall Study|progression disease|1
1621453|NCT01986140|5658667|P1|Overall Study|progression disease|0
1621454|NCT01986140|5658666|P2|Overall Study|Adverse Event|1
1621455|NCT01986140|5658667|P1|Overall Study|Adverse Event|0
1621456|NCT01986140|5658666|P2|Overall Study|found not eligible|0
1621457|NCT01986140|5658667|P1|Overall Study|found not eligible|3
1621458|NCT01986140|5658666|P2|Overall Study|alternative treatment|1
1621459|NCT01986140|5658667|P1|Overall Study|alternative treatment|1
1621460|NCT01986140|5658666|P2|Overall Study|Withdrawal by Subject|25
1621461|NCT01986140|5658667|P1|Overall Study|Withdrawal by Subject|31
1621462|NCT01986114|5658673|P1|Overall Study|Other reason|7
1621463|NCT01986114|5658673|P1|Overall Study|Lost to Follow-up|5
1621464|NCT01986114|5658673|P1|Overall Study|Protocol Violation|1
1621465|NCT01986114|5658673|P1|Overall Study|Noncompliance|3
1621466|NCT01986114|5658673|P1|Overall Study|Withdrawal by Subject|58
1621467|NCT01986114|5658673|P1|Overall Study|Lack of Efficacy|23
1621468|NCT01986114|5658673|P1|Overall Study|Adverse Event|59
1621469|NCT01986062|5658712|P2|Overall Study|Lost to Follow-up|1
1621470|NCT01986062|5658713|P1|Overall Study|Lost to Follow-up|1
1621471|NCT01985334|5658817|P8|Overall Study|Lost to Follow-up|3
1621472|NCT01985334|5658818|P7|Overall Study|Lost to Follow-up|0
1621473|NCT01985334|5658819|P6|Overall Study|Lost to Follow-up|4
1621474|NCT01985334|5658820|P5|Overall Study|Lost to Follow-up|1
1621475|NCT01985334|5658821|P4|Overall Study|Lost to Follow-up|3
1621476|NCT01985334|5658822|P3|Overall Study|Lost to Follow-up|0
1621477|NCT01985334|5658823|P2|Overall Study|Lost to Follow-up|2
1621478|NCT01985334|5658824|P1|Overall Study|Lost to Follow-up|0
1621479|NCT01985334|5658817|P8|Overall Study|Investigator decision|4
1621480|NCT01985334|5658818|P7|Overall Study|Investigator decision|0
1621481|NCT01985334|5658819|P6|Overall Study|Investigator decision|1
1621482|NCT01985334|5658820|P5|Overall Study|Investigator decision|1
1621483|NCT01985334|5658821|P4|Overall Study|Investigator decision|7
1621484|NCT01985334|5658822|P3|Overall Study|Investigator decision|0
1621485|NCT01985334|5658823|P2|Overall Study|Investigator decision|3
1621486|NCT01985334|5658824|P1|Overall Study|Investigator decision|0
1621487|NCT01985334|5658817|P8|Overall Study|Use of prohibited treatment|0
1621488|NCT01985334|5658818|P7|Overall Study|Use of prohibited treatment|2
1621489|NCT01985334|5658819|P6|Overall Study|Use of prohibited treatment|6
1621490|NCT01985334|5658820|P5|Overall Study|Use of prohibited treatment|1
1621491|NCT01985334|5658821|P4|Overall Study|Use of prohibited treatment|2
1621492|NCT01985334|5658822|P3|Overall Study|Use of prohibited treatment|1
1621493|NCT01985334|5658823|P2|Overall Study|Use of prohibited treatment|4
1621494|NCT01985334|5658824|P1|Overall Study|Use of prohibited treatment|1
1621495|NCT01985334|5658817|P8|Overall Study|Medication non-compliance|3
1621496|NCT01985334|5658818|P7|Overall Study|Medication non-compliance|1
1621497|NCT01985334|5658819|P6|Overall Study|Medication non-compliance|3
1621498|NCT01985334|5658820|P5|Overall Study|Medication non-compliance|2
1621499|NCT01985334|5658821|P4|Overall Study|Medication non-compliance|6
1621500|NCT01985334|5658822|P3|Overall Study|Medication non-compliance|1
1621501|NCT01985334|5658823|P2|Overall Study|Medication non-compliance|4
1621502|NCT01985334|5658824|P1|Overall Study|Medication non-compliance|0
1621503|NCT01985334|5658817|P8|Overall Study|Other|2
1621504|NCT01985334|5658818|P7|Overall Study|Other|2
1621505|NCT01985334|5658819|P6|Overall Study|Other|6
1621506|NCT01985334|5658820|P5|Overall Study|Other|1
1621507|NCT01985334|5658821|P4|Overall Study|Other|10
1621508|NCT01985334|5658822|P3|Overall Study|Other|3
1621509|NCT01985334|5658823|P2|Overall Study|Other|2
1621510|NCT01985334|5658824|P1|Overall Study|Other|4
1621511|NCT01985334|5658817|P8|Overall Study|Adverse Event|15
1621512|NCT01985334|5658818|P7|Overall Study|Adverse Event|3
1621513|NCT01985334|5658819|P6|Overall Study|Adverse Event|18
1621514|NCT01985334|5658820|P5|Overall Study|Adverse Event|3
1621515|NCT01985334|5658821|P4|Overall Study|Adverse Event|26
1621516|NCT01985334|5658822|P3|Overall Study|Adverse Event|2
1621517|NCT01985334|5658823|P2|Overall Study|Adverse Event|8
1621518|NCT01985334|5658824|P1|Overall Study|Adverse Event|0
1621519|NCT01985334|5658817|P8|Overall Study|Subject withdrawal of consent|20
1621520|NCT01985334|5658818|P7|Overall Study|Subject withdrawal of consent|0
1621521|NCT01985334|5658819|P6|Overall Study|Subject withdrawal of consent|19
1621522|NCT01985334|5658820|P5|Overall Study|Subject withdrawal of consent|4
1621523|NCT01985334|5658821|P4|Overall Study|Subject withdrawal of consent|28
1621524|NCT01985334|5658822|P3|Overall Study|Subject withdrawal of consent|2
1621525|NCT01985334|5658823|P2|Overall Study|Subject withdrawal of consent|6
1621526|NCT01985334|5658824|P1|Overall Study|Subject withdrawal of consent|3
1621527|NCT01985334|5658817|P8|Overall Study|Moderate / severe COPD exacerbation|19
1621528|NCT01985334|5658818|P7|Overall Study|Moderate / severe COPD exacerbation|8
1621529|NCT01985334|5658819|P6|Overall Study|Moderate / severe COPD exacerbation|40
1621530|NCT01985334|5658820|P5|Overall Study|Moderate / severe COPD exacerbation|6
1621531|NCT01985334|5658821|P4|Overall Study|Moderate / severe COPD exacerbation|40
1621532|NCT01985334|5658822|P3|Overall Study|Moderate / severe COPD exacerbation|12
1621533|NCT01985334|5658823|P2|Overall Study|Moderate / severe COPD exacerbation|14
1621534|NCT01985334|5658824|P1|Overall Study|Moderate / severe COPD exacerbation|5
1621535|NCT01985334|5658817|P8|Overall Study|Protocol deviation|42
1621536|NCT01985334|5658818|P7|Overall Study|Protocol deviation|15
1621537|NCT01985334|5658819|P6|Overall Study|Protocol deviation|47
1621538|NCT01985334|5658820|P5|Overall Study|Protocol deviation|17
1621539|NCT01985334|5658821|P4|Overall Study|Protocol deviation|84
1621540|NCT01985334|5658822|P3|Overall Study|Protocol deviation|25
1621541|NCT01985334|5658823|P2|Overall Study|Protocol deviation|31
1621542|NCT01985334|5658824|P1|Overall Study|Protocol deviation|6
1621543|NCT01985334|5658817|P8|Overall Study|Other|7
1621544|NCT01985334|5658818|P7|Overall Study|Other|4
1621545|NCT01985334|5658819|P6|Overall Study|Other|8
1621546|NCT01985334|5658820|P5|Overall Study|Other|4
1621547|NCT01985334|5658821|P4|Overall Study|Other|17
1621548|NCT01985334|5658822|P3|Overall Study|Other|7
1621549|NCT01985334|5658823|P2|Overall Study|Other|9
1621550|NCT01985334|5658824|P1|Overall Study|Other|2
1621551|NCT01985334|5658817|P8|Overall Study|Worsening of disease|1
1621552|NCT01985334|5658818|P7|Overall Study|Worsening of disease|0
1621553|NCT01985334|5658819|P6|Overall Study|Worsening of disease|3
1621554|NCT01985334|5658820|P5|Overall Study|Worsening of disease|0
1621555|NCT01985334|5658821|P4|Overall Study|Worsening of disease|1
1621556|NCT01985334|5658822|P3|Overall Study|Worsening of disease|0
1621557|NCT01985334|5658823|P2|Overall Study|Worsening of disease|0
1621558|NCT01985334|5658824|P1|Overall Study|Worsening of disease|0
1621559|NCT01985334|5658817|P8|Overall Study|Death|2
1621560|NCT01985334|5658818|P7|Overall Study|Death|1
1621561|NCT01985334|5658819|P6|Overall Study|Death|0
1621562|NCT01985334|5658820|P5|Overall Study|Death|0
1621563|NCT01985334|5658821|P4|Overall Study|Death|3
1621564|NCT01985334|5658822|P3|Overall Study|Death|0
1621565|NCT01985334|5658823|P2|Overall Study|Death|0
1621566|NCT01985334|5658824|P1|Overall Study|Death|1
1621567|NCT01985334|5658817|P8|Overall Study|Administrative problems|3
1621568|NCT01985334|5658818|P7|Overall Study|Administrative problems|1
1621569|NCT01985334|5658819|P6|Overall Study|Administrative problems|1
1621570|NCT01985334|5658820|P5|Overall Study|Administrative problems|0
1621571|NCT01985334|5658821|P4|Overall Study|Administrative problems|2
1621572|NCT01985334|5658822|P3|Overall Study|Administrative problems|0
1621573|NCT01985334|5658823|P2|Overall Study|Administrative problems|1
1621574|NCT01985334|5658824|P1|Overall Study|Administrative problems|1
1621575|NCT01985321|5658892|P2|Overall Study|Subject treated wrong type of sore|0
1621576|NCT01985321|5658893|P1|Overall Study|Subject treated wrong type of sore|1
1621577|NCT01985321|5658892|P2|Overall Study|Lost to Follow-up|2
1621578|NCT01985321|5658893|P1|Overall Study|Lost to Follow-up|5
1621579|NCT01985321|5658892|P2|Overall Study|Withdrawal by Subject|0
1621580|NCT01985321|5658893|P1|Overall Study|Withdrawal by Subject|1
1621581|NCT01985321|5658892|P2|Overall Study|Protocol Violation|3
1621582|NCT01985321|5658893|P1|Overall Study|Protocol Violation|4
1621583|NCT01985126|5658903|P2|Overall Study|Withdrawal by Subject|7
1621584|NCT01985126|5658904|P1|Overall Study|Withdrawal by Subject|2
1621585|NCT01985126|5658903|P2|Overall Study|Study Terminated By Sponsor|22
1621586|NCT01985126|5658904|P1|Overall Study|Study Terminated By Sponsor|1
1621587|NCT01985126|5658903|P2|Overall Study|Lost to Follow-up|8
1621588|NCT01985126|5658904|P1|Overall Study|Lost to Follow-up|0
1621589|NCT01985126|5658903|P2|Overall Study|Death|69
1621590|NCT01985126|5658904|P1|Overall Study|Death|15
1621591|NCT01984892|5658922|P1|Overall Study|Progressive disease|7
1621592|NCT01984697|5658933|P5|Overall Study|Pregnancy|1
1621593|NCT01984697|5658934|P4|Overall Study|Pregnancy|0
1621594|NCT01984697|5658935|P3|Overall Study|Pregnancy|1
1621595|NCT01984697|5658936|P2|Overall Study|Pregnancy|0
1621596|NCT01984697|5658937|P1|Overall Study|Pregnancy|2
1621597|NCT01984697|5658933|P5|Overall Study|Death|0
1621598|NCT01984697|5658934|P4|Overall Study|Death|1
1621599|NCT01984697|5658935|P3|Overall Study|Death|0
1621600|NCT01984697|5658936|P2|Overall Study|Death|0
1621601|NCT01984697|5658937|P1|Overall Study|Death|0
1621602|NCT01984697|5658933|P5|Overall Study|Missed last follow-up visit|0
1621603|NCT01984697|5658934|P4|Overall Study|Missed last follow-up visit|0
1621604|NCT01984697|5658935|P3|Overall Study|Missed last follow-up visit|0
1621605|NCT01984697|5658936|P2|Overall Study|Missed last follow-up visit|0
1621606|NCT01984697|5658937|P1|Overall Study|Missed last follow-up visit|1
1621607|NCT01984697|5658933|P5|Overall Study|Withdrawal by Subject|13
1621608|NCT01984697|5658934|P4|Overall Study|Withdrawal by Subject|11
1621609|NCT01984697|5658935|P3|Overall Study|Withdrawal by Subject|13
1621610|NCT01984697|5658936|P2|Overall Study|Withdrawal by Subject|21
1621611|NCT01984697|5658937|P1|Overall Study|Withdrawal by Subject|15
1621612|NCT01984697|5658933|P5|Overall Study|Protocol Violation|0
1621613|NCT01984697|5658934|P4|Overall Study|Protocol Violation|2
1621614|NCT01984697|5658935|P3|Overall Study|Protocol Violation|3
1621615|NCT01984697|5658936|P2|Overall Study|Protocol Violation|5
1621616|NCT01984697|5658937|P1|Overall Study|Protocol Violation|8
1621617|NCT01984697|5658933|P5|Overall Study|Physician Decision|0
1621618|NCT01984697|5658934|P4|Overall Study|Physician Decision|1
1621619|NCT01984697|5658935|P3|Overall Study|Physician Decision|0
1621620|NCT01984697|5658936|P2|Overall Study|Physician Decision|0
1621621|NCT01984697|5658937|P1|Overall Study|Physician Decision|3
1621622|NCT01984697|5658933|P5|Overall Study|Lost to Follow-up|21
1621623|NCT01984697|5658934|P4|Overall Study|Lost to Follow-up|6
1621624|NCT01984697|5658935|P3|Overall Study|Lost to Follow-up|10
1621625|NCT01984697|5658936|P2|Overall Study|Lost to Follow-up|5
1621626|NCT01984697|5658937|P1|Overall Study|Lost to Follow-up|14
1621627|NCT01984697|5658933|P5|Overall Study|Adverse Event|0
1621628|NCT01984697|5658934|P4|Overall Study|Adverse Event|0
1621629|NCT01984697|5658935|P3|Overall Study|Adverse Event|2
1621630|NCT01984697|5658936|P2|Overall Study|Adverse Event|0
1621631|NCT01984697|5658937|P1|Overall Study|Adverse Event|0
1621632|NCT01984684|5659056|P2|Overall Study|Subject had inadequate IV access|1
1621633|NCT01984684|5659057|P1|Overall Study|Subject had inadequate IV access|0
1621634|NCT01984684|5659056|P2|Overall Study|Study drug not available at site|1
1621635|NCT01984684|5659057|P1|Overall Study|Study drug not available at site|1
1621636|NCT01984684|5659056|P2|Overall Study|Subject incarcerated|0
1621637|NCT01984684|5659057|P1|Overall Study|Subject incarcerated|1
1621638|NCT01984684|5659056|P2|Overall Study|Noncompliance with study drug|1
1621639|NCT01984684|5659057|P1|Overall Study|Noncompliance with study drug|2
1621640|NCT01984684|5659056|P2|Overall Study|Death|1
1621641|NCT01984684|5659057|P1|Overall Study|Death|0
1621642|NCT01984684|5659056|P2|Overall Study|Protocol Violation|2
1621643|NCT01984684|5659057|P1|Overall Study|Protocol Violation|4
1621644|NCT01984684|5659056|P2|Overall Study|Physician Decision|2
1621645|NCT01984684|5659057|P1|Overall Study|Physician Decision|4
1621646|NCT01984684|5659056|P2|Overall Study|Lack of Efficacy|6
1621647|NCT01984684|5659057|P1|Overall Study|Lack of Efficacy|3
1621648|NCT01984684|5659056|P2|Overall Study|Withdrawal by Subject|9
1621649|NCT01984684|5659057|P1|Overall Study|Withdrawal by Subject|9
1621650|NCT01984684|5659056|P2|Overall Study|Adverse Event|12
1621651|NCT01984684|5659057|P1|Overall Study|Adverse Event|8
1621652|NCT01984684|5659056|P2|Overall Study|Lost to Follow-up|24
1621653|NCT01984684|5659057|P1|Overall Study|Lost to Follow-up|25
1621654|NCT01984424|5659075|P2|Overall Study|Lost to Follow-up|1
1621655|NCT01984424|5659076|P1|Overall Study|Lost to Follow-up|0
1621656|NCT01984424|5659075|P2|Overall Study|Sponsor Decision|1
1621657|NCT01984424|5659076|P1|Overall Study|Sponsor Decision|0
1621658|NCT01984424|5659075|P2|Overall Study|Withdrawal by Subject|5
1621659|NCT01984424|5659076|P1|Overall Study|Withdrawal by Subject|3
1621660|NCT01984294|5659146|P3|Overall Study|Adverse Event|0
1621661|NCT01984294|5659147|P2|Overall Study|Adverse Event|1
1621662|NCT01984294|5659148|P1|Overall Study|Adverse Event|0
1621663|NCT01984294|5659146|P3|Overall Study|Lack of Efficacy|6
1621664|NCT01984294|5659147|P2|Overall Study|Lack of Efficacy|2
1621665|NCT01984294|5659148|P1|Overall Study|Lack of Efficacy|4
1621666|NCT01984294|5659146|P3|Overall Study|Randomized but Never Treated|1
1621667|NCT01984294|5659147|P2|Overall Study|Randomized but Never Treated|0
1621668|NCT01984294|5659148|P1|Overall Study|Randomized but Never Treated|0
1621669|NCT01984242|5659171|P3|Overall Study|Disease Progression|1
1621670|NCT01984242|5659172|P2|Overall Study|Disease Progression|0
1621671|NCT01984242|5659173|P1|Overall Study|Disease Progression|0
1621672|NCT01984242|5659171|P3|Overall Study|Study terminated by Sponsor|34
1621673|NCT01984242|5659172|P2|Overall Study|Study terminated by Sponsor|50
1621674|NCT01984242|5659173|P1|Overall Study|Study terminated by Sponsor|38
1621675|NCT01984242|5659171|P3|Overall Study|Non-Compliance|0
1621676|NCT01984242|5659172|P2|Overall Study|Non-Compliance|0
1621677|NCT01984242|5659173|P1|Overall Study|Non-Compliance|1
1621678|NCT01984242|5659171|P3|Overall Study|Sponsor Decision|0
1621679|NCT01984242|5659172|P2|Overall Study|Sponsor Decision|0
1621680|NCT01984242|5659173|P1|Overall Study|Sponsor Decision|1
1621681|NCT01984242|5659171|P3|Overall Study|Lost to Follow-up|3
1621682|NCT01984242|5659172|P2|Overall Study|Lost to Follow-up|0
1621683|NCT01984242|5659173|P1|Overall Study|Lost to Follow-up|4
1621684|NCT01984242|5659171|P3|Overall Study|Physician Decision|1
1621685|NCT01984242|5659172|P2|Overall Study|Physician Decision|0
1621686|NCT01984242|5659173|P1|Overall Study|Physician Decision|0
1621687|NCT01984242|5659171|P3|Overall Study|Withdrawal by Subject|10
1621688|NCT01984242|5659172|P2|Overall Study|Withdrawal by Subject|3
1621689|NCT01984242|5659173|P1|Overall Study|Withdrawal by Subject|5
1621690|NCT01984242|5659171|P3|Overall Study|Death|52
1621691|NCT01984242|5659172|P2|Overall Study|Death|50
1621692|NCT01984242|5659173|P1|Overall Study|Death|52
1621693|NCT01984229|5659323|P2|Safety Follow-up Period|Lost to Follow-up|0
1621694|NCT01984229|5659324|P1|Safety Follow-up Period|Lost to Follow-up|1
1621695|NCT01984229|5659323|P2|Safety Follow-up Period|Adverse Event|1
1621696|NCT01984229|5659324|P1|Safety Follow-up Period|Adverse Event|1
1621697|NCT01983969|5659377|P3|Overall Study|Disease Progression|0
1621698|NCT01983969|5659378|P2|Overall Study|Disease Progression|1
1621699|NCT01983969|5659379|P1|Overall Study|Disease Progression|0
1621700|NCT01983930|5659393|P2|Overall Study|Adverse Event|1
1621701|NCT01983930|5659394|P1|Overall Study|Adverse Event|0
1621702|NCT01983930|5659393|P2|Overall Study|Withdrawal by Subject|8
1621703|NCT01983930|5659394|P1|Overall Study|Withdrawal by Subject|9
1621704|NCT01983683|5659468|P2|Overall Study|Sponsor Decision|1
1621705|NCT01983683|5659469|P1|Overall Study|Sponsor Decision|1
1621706|NCT01983683|5659468|P2|Overall Study|Lost to Follow-up|8
1621707|NCT01983683|5659469|P1|Overall Study|Lost to Follow-up|4
1621708|NCT01983683|5659468|P2|Overall Study|Physician Decision|9
1621709|NCT01983683|5659469|P1|Overall Study|Physician Decision|8
1621710|NCT01983683|5659468|P2|Overall Study|Death|15
1621711|NCT01983683|5659469|P1|Overall Study|Death|11
1621712|NCT01983683|5659468|P2|Overall Study|Withdrawal by Subject|18
1621713|NCT01983683|5659469|P1|Overall Study|Withdrawal by Subject|14
1621714|NCT01983293|5659556|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
1621715|NCT01983293|5659557|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
1621716|NCT01983293|5659556|P2|Overall Study|Missing 12-month visit|3
1621717|NCT01983293|5659557|P1|Overall Study|Missing 12-month visit|3
1621718|NCT01983293|5659556|P2|Overall Study|Withdrawal by Subject|15
1621719|NCT01983293|5659557|P1|Overall Study|Withdrawal by Subject|29
1621720|NCT01983254|5659565|P2|Overall Study|too ill|8
1621721|NCT01983254|5659566|P1|Overall Study|too ill|11
1621722|NCT01983254|5659565|P2|Overall Study|Lost to Follow-up|16
1621723|NCT01983254|5659566|P1|Overall Study|Lost to Follow-up|17
1621724|NCT01983254|5659565|P2|Overall Study|Death|6
1621725|NCT01983254|5659566|P1|Overall Study|Death|6
1621726|NCT01983111|5659578|P2|Overall Study|Protocol Violation|1
1621727|NCT01983111|5659579|P1|Overall Study|Protocol Violation|0
1621728|NCT01983111|5659578|P2|Overall Study|Adverse Event|0
1621729|NCT01983111|5659579|P1|Overall Study|Adverse Event|4
1621730|NCT01983111|5659578|P2|Overall Study|Withdrawal by Subject|6
1621731|NCT01983111|5659579|P1|Overall Study|Withdrawal by Subject|8
1621732|NCT01982812|5659614|P2|Overall Study|Adverse Event|5
1621733|NCT01982812|5659615|P1|Overall Study|Adverse Event|0
1621734|NCT01982812|5659614|P2|Overall Study|Death|5
1621735|NCT01982812|5659615|P1|Overall Study|Death|1
1621736|NCT01982773|5659629|P2|Overall Study|Lost to Follow-up|1
1621737|NCT01982773|5659630|P1|Overall Study|Lost to Follow-up|7
1621738|NCT01982773|5659629|P2|Overall Study|Withdrawal by Subject|3
1621739|NCT01982773|5659630|P1|Overall Study|Withdrawal by Subject|1
1621740|NCT01982682|5659651|P1|Overall Study|Physician Decision|1
1621741|NCT01982435|5659665|P2|Overall Study|Adverse Event|0
1621742|NCT01982435|5659666|P1|Overall Study|Adverse Event|1
1621743|NCT01982331|5659705|P2|Completed Study (Day 112)|Withdrawal by Subject|0
1621744|NCT01982331|5659706|P1|Completed Study (Day 112)|Withdrawal by Subject|2
1621745|NCT01982331|5659705|P2|Received Vaccination 2|Withdrawal by Subject|1
1621746|NCT01982331|5659706|P1|Received Vaccination 2|Withdrawal by Subject|0
1621747|NCT01982331|5659705|P2|Received Vaccination 2|Adverse Event|2
1621748|NCT01982331|5659706|P1|Received Vaccination 2|Adverse Event|1
1621749|NCT01982292|5659742|P2|Overall Study|Technical Problems|0
1621750|NCT01982292|5659743|P1|Overall Study|Technical Problems|2
1621751|NCT01982292|5659742|P2|Overall Study|Patient/Guardian Decision|1
1621752|NCT01982292|5659743|P1|Overall Study|Patient/Guardian Decision|3
1621753|NCT01982292|5659742|P2|Overall Study|Protocol Deviation|0
1621754|NCT01982292|5659743|P1|Overall Study|Protocol Deviation|1
1621755|NCT01982292|5659742|P2|Overall Study|Non-Compliance With Study Treatment|0
1621756|NCT01982292|5659743|P1|Overall Study|Non-Compliance With Study Treatment|1
1621757|NCT01982292|5659742|P2|Overall Study|Lost to Follow-up|0
1621758|NCT01982292|5659743|P1|Overall Study|Lost to Follow-up|2
1621759|NCT01982292|5659742|P2|Overall Study|Death|0
1621760|NCT01982292|5659743|P1|Overall Study|Death|1
1621761|NCT01982292|5659742|P2|Overall Study|Adverse Event|0
1621762|NCT01982292|5659743|P1|Overall Study|Adverse Event|2
1621763|NCT01982253|5659764|P3|Overall Study|Study terminated by sponsor|4
1621764|NCT01982253|5659765|P2|Overall Study|Study terminated by sponsor|4
1621765|NCT01982253|5659766|P1|Overall Study|Study terminated by sponsor|1
1621766|NCT01982253|5659764|P3|Overall Study|Withdrawal by Subject|0
1621767|NCT01982253|5659765|P2|Overall Study|Withdrawal by Subject|0
1621768|NCT01982253|5659766|P1|Overall Study|Withdrawal by Subject|1
1621769|NCT01981954|5659820|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
1621770|NCT01981954|5659820|P1|Titration Period|Protocol Deviation|1
1621771|NCT01981616|5659893|P2|Overall Study|Protocol Violation|0
1621772|NCT01981616|5659894|P1|Overall Study|Protocol Violation|1
1621773|NCT01981616|5659893|P2|Overall Study|Adverse Event|1
1621774|NCT01981616|5659894|P1|Overall Study|Adverse Event|0
1621775|NCT01981551|5659917|P1|Overall Study|Adverse Event|1
1621776|NCT01981551|5659917|P1|Overall Study|Refused further treatment|8
1621777|NCT01981473|5659927|P3|Overall Study|Received treatment for >24 months|6
1621778|NCT01981473|5659928|P2|Overall Study|Received treatment for >24 months|0
1621779|NCT01981473|5659929|P1|Overall Study|Received treatment for >24 months|2
1621780|NCT01981473|5659927|P3|Overall Study|Received treatment for < 6 months|1
1621781|NCT01981473|5659928|P2|Overall Study|Received treatment for < 6 months|0
1621782|NCT01981473|5659929|P1|Overall Study|Received treatment for < 6 months|0
1621783|NCT01981473|5659927|P3|Overall Study|Incorrect diagnosis of RA|1
1621784|NCT01981473|5659928|P2|Overall Study|Incorrect diagnosis of RA|0
1621785|NCT01981473|5659929|P1|Overall Study|Incorrect diagnosis of RA|0
1621786|NCT01981356|5659970|P2|Overall Study|Protocol Violation|0
1621787|NCT01981356|5659971|P1|Overall Study|Protocol Violation|2
1621788|NCT01981356|5659970|P2|Overall Study|Withdrawal by Subject|1
1621789|NCT01981356|5659971|P1|Overall Study|Withdrawal by Subject|1
1621790|NCT01981356|5659970|P2|Overall Study|Lost to Follow-up|1
1621791|NCT01981356|5659971|P1|Overall Study|Lost to Follow-up|4
1621792|NCT01981122|5659998|P2|Overall Study|Death|15
1621793|NCT01981122|5659999|P1|Overall Study|Death|14
1621794|NCT01981122|5659998|P2|Overall Study|Investigator Or Dendreon Discretion|1
1621795|NCT01981122|5659999|P1|Overall Study|Investigator Or Dendreon Discretion|0
1621796|NCT01981122|5659998|P2|Overall Study|Lost to Follow-up|1
1621797|NCT01981122|5659999|P1|Overall Study|Lost to Follow-up|0
1621798|NCT01981122|5659998|P2|Overall Study|Protocol Violation|1
1621799|NCT01981122|5659999|P1|Overall Study|Protocol Violation|0
1621800|NCT01981122|5659998|P2|Overall Study|Withdrawal by Subject|2
1621801|NCT01981122|5659999|P1|Overall Study|Withdrawal by Subject|0
1621802|NCT01981109|5660005|P1|Overall Study|No data available|2
1621803|NCT01981109|5660005|P1|Overall Study|Study Termination|100
1621804|NCT01981109|5660005|P1|Overall Study|No Discontinuation Documentation|37
1621805|NCT01981109|5660005|P1|Overall Study|Lost to Follow-up|9
1621806|NCT01981109|5660005|P1|Overall Study|Withdrawal by Subject|40
1621807|NCT01981109|5660005|P1|Overall Study|Death|36
1621808|NCT01981096|5660012|P2|Overall Study|Lost to Follow-up|0
1621809|NCT01981096|5660013|P1|Overall Study|Lost to Follow-up|2
1621810|NCT01981096|5660012|P2|Overall Study|Withdrawal by Subject|1
1621811|NCT01981096|5660013|P1|Overall Study|Withdrawal by Subject|0
1621812|NCT01981096|5660012|P2|Overall Study|Parent illness|0
1621813|NCT01981096|5660013|P1|Overall Study|Parent illness|1
1621814|NCT01980992|5660034|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
1621815|NCT01980992|5660035|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
1621816|NCT01980992|5660034|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
1621817|NCT01980992|5660035|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
1621818|NCT01980992|5660034|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
1621819|NCT01980992|5660035|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
1621820|NCT01980992|5660034|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
1621821|NCT01980992|5660035|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
1621822|NCT01980992|5660034|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1621823|NCT01980992|5660035|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
1621824|NCT01980992|5660034|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
1621825|NCT01980992|5660035|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
1621826|NCT01980940|5660060|P8|Overall Study|Protocol Violation|0
1621827|NCT01980940|5660061|P7|Overall Study|Protocol Violation|0
1621828|NCT01980940|5660062|P6|Overall Study|Protocol Violation|2
1621829|NCT01980940|5660063|P5|Overall Study|Protocol Violation|0
1621830|NCT01980940|5660064|P4|Overall Study|Protocol Violation|0
1621831|NCT01980940|5660065|P3|Overall Study|Protocol Violation|0
1621832|NCT01980940|5660066|P2|Overall Study|Protocol Violation|0
1621833|NCT01980940|5660067|P1|Overall Study|Protocol Violation|0
1621834|NCT01980888|5660121|P2|Overall Study|Non-Compliance with Study Drug|2
1621835|NCT01980888|5660122|P1|Overall Study|Non-Compliance with Study Drug|3
1621836|NCT01980888|5660121|P2|Overall Study|Investigator's Discretion|3
1621837|NCT01980888|5660122|P1|Overall Study|Investigator's Discretion|8
1621838|NCT01980888|5660121|P2|Overall Study|Withdrew Consent|6
1621839|NCT01980888|5660122|P1|Overall Study|Withdrew Consent|17
1621840|NCT01980888|5660121|P2|Overall Study|Study Terminated by Sponsor|122
1621841|NCT01980888|5660122|P1|Overall Study|Study Terminated by Sponsor|116
1621842|NCT01980875|5660141|P3|Overall Study|Lost to Follow-up|1
1621843|NCT01980875|5660142|P2|Overall Study|Lost to Follow-up|0
1621844|NCT01980875|5660143|P1|Overall Study|Lost to Follow-up|0
1621845|NCT01980875|5660141|P3|Overall Study|Study Terminated by Sponsor|22
1621846|NCT01980875|5660142|P2|Overall Study|Study Terminated by Sponsor|24
1621847|NCT01980875|5660143|P1|Overall Study|Study Terminated by Sponsor|7
1621848|NCT01980875|5660141|P3|Overall Study|Withdrew Consent|1
1621849|NCT01980875|5660142|P2|Overall Study|Withdrew Consent|1
1621850|NCT01980875|5660143|P1|Overall Study|Withdrew Consent|1
1621851|NCT01980706|5660178|P3|Overall Study|miscellaneous|3
1621852|NCT01980706|5660179|P2|Overall Study|miscellaneous|5
1621853|NCT01980706|5660180|P1|Overall Study|miscellaneous|4
1621854|NCT01980706|5660178|P3|Overall Study|Lost to Follow-up|3
1621855|NCT01980706|5660179|P2|Overall Study|Lost to Follow-up|4
1621856|NCT01980706|5660180|P1|Overall Study|Lost to Follow-up|3
1621857|NCT01980706|5660178|P3|Overall Study|Adverse Event|5
1621858|NCT01980706|5660179|P2|Overall Study|Adverse Event|2
1621859|NCT01980706|5660180|P1|Overall Study|Adverse Event|1
1621860|NCT01980706|5660178|P3|Overall Study|Withdrawal by Subject|2
1621861|NCT01980706|5660179|P2|Overall Study|Withdrawal by Subject|6
1621862|NCT01980706|5660180|P1|Overall Study|Withdrawal by Subject|9
1621863|NCT01980628|5660220|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
1621864|NCT01980628|5660220|P1|Overall Study|Withdrawal by Subject|4
1621865|NCT01980628|5660220|P1|Overall Study|Physician Decision|5
1621866|NCT01980628|5660220|P1|Overall Study|Adverse Event|12
1621867|NCT01980095|5660279|P2|Overall Study|Randomized by mistake|0
1621868|NCT01980095|5660280|P1|Overall Study|Randomized by mistake|1
1621869|NCT01980095|5660279|P2|Overall Study|Study drug discontinued|0
1621870|NCT01980095|5660280|P1|Overall Study|Study drug discontinued|1
1621871|NCT01980095|5660279|P2|Overall Study|Safety issue|1
1621872|NCT01980095|5660280|P1|Overall Study|Safety issue|0
1621873|NCT01980095|5660279|P2|Overall Study|Poor compliance|0
1621874|NCT01980095|5660280|P1|Overall Study|Poor compliance|5
1621875|NCT01980095|5660279|P2|Overall Study|Withdrawal by Subject|3
1621876|NCT01980095|5660280|P1|Overall Study|Withdrawal by Subject|2
1621877|NCT01980095|5660279|P2|Overall Study|Lost to Follow-up|7
1621878|NCT01980095|5660280|P1|Overall Study|Lost to Follow-up|6
1621879|NCT01980056|5660291|P3|Overall Study|Death|0
1621880|NCT01980056|5660292|P2|Overall Study|Death|1
1621881|NCT01980056|5660293|P1|Overall Study|Death|1
1621882|NCT01979952|5660307|P2|Overall Study|Other than specified above|0
1621883|NCT01979952|5660308|P1|Overall Study|Other than specified above|1
1621884|NCT01979952|5660307|P2|Overall Study|Withdrawal by Subject|1
1621885|NCT01979952|5660308|P1|Overall Study|Withdrawal by Subject|2
1621886|NCT01979952|5660307|P2|Overall Study|Protocol Violation|0
1621887|NCT01979952|5660308|P1|Overall Study|Protocol Violation|1
1621888|NCT01979952|5660307|P2|Overall Study|Adverse Event|5
1621889|NCT01979952|5660308|P1|Overall Study|Adverse Event|4
1621890|NCT01979614|5660338|P2|Overall Study|Adverse Event|1
1621891|NCT01979614|5660339|P1|Overall Study|Adverse Event|1
1621894|NCT01979185|5660422|P2|Period 2|Other|1
1621895|NCT01979185|5660423|P1|Period 2|Other|0
1621896|NCT01978938|5660471|P2|Overall Study|Previously scheduled procedure|1
1621897|NCT01978938|5660472|P1|Overall Study|Previously scheduled procedure|0
1621898|NCT01978938|5660471|P2|Overall Study|Did not meet inclusion criteria|1
1621899|NCT01978938|5660472|P1|Overall Study|Did not meet inclusion criteria|0
1621900|NCT01978938|5660471|P2|Overall Study|Participant noncompliance|1
1621901|NCT01978938|5660472|P1|Overall Study|Participant noncompliance|1
1621902|NCT01978938|5660471|P2|Overall Study|Adverse Event, non-fatal|1
1621903|NCT01978938|5660472|P1|Overall Study|Adverse Event, non-fatal|2
1621904|NCT01978938|5660471|P2|Overall Study|Withdrawal by Subject|4
1621905|NCT01978938|5660472|P1|Overall Study|Withdrawal by Subject|8
1621906|NCT01978938|5660471|P2|Overall Study|Lost to Follow-up|6
1621907|NCT01978938|5660472|P1|Overall Study|Lost to Follow-up|12
1621908|NCT01978912|5660486|P4|Overall Study|Intradiscal Steroid Injection|0
1621909|NCT01978912|5660487|P3|Overall Study|Intradiscal Steroid Injection|0
1621910|NCT01978912|5660488|P2|Overall Study|Intradiscal Steroid Injection|1
1621911|NCT01978912|5660489|P1|Overall Study|Intradiscal Steroid Injection|0
1621912|NCT01978912|5660486|P4|Overall Study|Lumbar Surgery|0
1621913|NCT01978912|5660487|P3|Overall Study|Lumbar Surgery|1
1621914|NCT01978912|5660488|P2|Overall Study|Lumbar Surgery|0
1621915|NCT01978912|5660489|P1|Overall Study|Lumbar Surgery|1
1621916|NCT01978912|5660486|P4|Overall Study|Withdrawal by Subject|2
1621917|NCT01978912|5660487|P3|Overall Study|Withdrawal by Subject|2
1621918|NCT01978912|5660488|P2|Overall Study|Withdrawal by Subject|0
1621919|NCT01978912|5660489|P1|Overall Study|Withdrawal by Subject|1
1621920|NCT01978912|5660486|P4|Overall Study|Lost to Follow-up|1
1621921|NCT01978912|5660487|P3|Overall Study|Lost to Follow-up|0
1621922|NCT01978912|5660488|P2|Overall Study|Lost to Follow-up|1
1621923|NCT01978912|5660489|P1|Overall Study|Lost to Follow-up|1
1621924|NCT01978912|5660486|P4|Overall Study|Adverse Event|0
1621925|NCT01978912|5660487|P3|Overall Study|Adverse Event|0
1621926|NCT01978912|5660488|P2|Overall Study|Adverse Event|1
1621927|NCT01978912|5660489|P1|Overall Study|Adverse Event|0
1621928|NCT01978262|5660660|P1|Overall Study|Lost to Follow-up|2
1621929|NCT01978262|5660660|P1|Overall Study|Withdrawal by Subject|9
1621930|NCT01978236|5660665|P1|Overall Study|Discontinued due to study close|2
1621931|NCT01978184|5660686|P2|Overall Study|Withdrew- toxicities or physical decline|8
1621932|NCT01978184|5660687|P1|Overall Study|Withdrew- toxicities or physical decline|4
1621933|NCT01978184|5660686|P2|Overall Study|Death|0
1621934|NCT01978184|5660687|P1|Overall Study|Death|1
1621935|NCT01978184|5660686|P2|Overall Study|Noncompliance|2
1621936|NCT01978184|5660687|P1|Overall Study|Noncompliance|1
1621937|NCT01978184|5660686|P2|Overall Study|Physician Decision|3
1621938|NCT01978184|5660687|P1|Overall Study|Physician Decision|0
1621939|NCT01978184|5660686|P2|Overall Study|Other than PDA|2
1621940|NCT01978184|5660687|P1|Overall Study|Other than PDA|2
1621941|NCT01978184|5660686|P2|Overall Study|Progressive disease|5
1621942|NCT01978184|5660687|P1|Overall Study|Progressive disease|5
1621943|NCT01978145|5660713|P2|Treatment Period 2|Par. reached defined stopping criteria|5
1621944|NCT01978145|5660714|P1|Treatment Period 2|Par. reached defined stopping criteria|8
1621945|NCT01978145|5660713|P2|Treatment Period 2|Withdrawal by Subject|4
1621946|NCT01978145|5660714|P1|Treatment Period 2|Withdrawal by Subject|7
1621947|NCT01978145|5660713|P2|Treatment Period 2|Lost to Follow-up|1
1621948|NCT01978145|5660714|P1|Treatment Period 2|Lost to Follow-up|1
1621949|NCT01978145|5660713|P2|Treatment Period 2|Protocol Violation|1
1621950|NCT01978145|5660714|P1|Treatment Period 2|Protocol Violation|0
1621951|NCT01978145|5660713|P2|Treatment Period 2|Adverse Event|3
1621952|NCT01978145|5660714|P1|Treatment Period 2|Adverse Event|3
1621953|NCT01978145|5660713|P2|Washout Period 1|Par. reached defined stopping criteria|1
1621954|NCT01978145|5660714|P1|Washout Period 1|Par. reached defined stopping criteria|0
1621955|NCT01978145|5660713|P2|Washout Period 1|Withdrawal by Subject|1
1621956|NCT01978145|5660714|P1|Washout Period 1|Withdrawal by Subject|1
1621957|NCT01978145|5660713|P2|Washout Period 1|Adverse Event|1
1621958|NCT01978145|5660714|P1|Washout Period 1|Adverse Event|0
1621959|NCT01978145|5660713|P2|Treatment Period 1|Par. reached defined stopping criteria|3
1621960|NCT01978145|5660714|P1|Treatment Period 1|Par. reached defined stopping criteria|2
1621961|NCT01978145|5660713|P2|Treatment Period 1|Withdrawal by Subject|4
1621962|NCT01978145|5660714|P1|Treatment Period 1|Withdrawal by Subject|5
1621963|NCT01978145|5660713|P2|Treatment Period 1|Physician Decision|0
1621964|NCT01978145|5660714|P1|Treatment Period 1|Physician Decision|1
1621965|NCT01978145|5660713|P2|Treatment Period 1|Adverse Event|9
1621966|NCT01978145|5660714|P1|Treatment Period 1|Adverse Event|1
1621967|NCT01978119|5660730|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
1621968|NCT01978119|5660731|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1621969|NCT01978119|5660730|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1621970|NCT01978119|5660731|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1621971|NCT01978119|5660730|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
1621972|NCT01978119|5660731|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
1621973|NCT01978093|5660757|P2|Overall Study|N/A for vaccine administration|1
1621974|NCT01978093|5660758|P1|Overall Study|N/A for vaccine administration|0
1621975|NCT01978093|5660757|P2|Overall Study|Child was in care of grandmother|1
1621976|NCT01978093|5660758|P1|Overall Study|Child was in care of grandmother|0
1621977|NCT01978093|5660757|P2|Overall Study|Mother lost custody of child|1
1621978|NCT01978093|5660758|P1|Overall Study|Mother lost custody of child|0
1621979|NCT01978093|5660757|P2|Overall Study|Lost kaiser health plan unable to contac|0
1621980|NCT01978093|5660758|P1|Overall Study|Lost kaiser health plan unable to contac|1
1621981|NCT01978093|5660757|P2|Overall Study|Loss of kaiser coverage|10
1621982|NCT01978093|5660758|P1|Overall Study|Loss of kaiser coverage|4
1621983|NCT01978093|5660757|P2|Overall Study|Migrated/moved from study area|13
1621984|NCT01978093|5660758|P1|Overall Study|Migrated/moved from study area|11
1621985|NCT01978093|5660757|P2|Overall Study|Lost to Follow-up|15
1621986|NCT01978093|5660758|P1|Overall Study|Lost to Follow-up|11
1621987|NCT01978093|5660757|P2|Overall Study|Withdrawal by Subject|25
1621988|NCT01978093|5660758|P1|Overall Study|Withdrawal by Subject|29
1621989|NCT01978093|5660757|P2|Overall Study|Protocol Violation|2
1621990|NCT01978093|5660758|P1|Overall Study|Protocol Violation|8
1621991|NCT01978093|5660757|P2|Overall Study|Adverse Event|5
1621992|NCT01978093|5660758|P1|Overall Study|Adverse Event|0
1621993|NCT01978093|5660757|P2|Overall Study|Death|0
1621994|NCT01978093|5660758|P1|Overall Study|Death|1
1621995|NCT01977937|5660802|P2|Overall Study|Physician Decision|1
1621996|NCT01977937|5660803|P1|Overall Study|Physician Decision|0
1621997|NCT01977937|5660802|P2|Overall Study|Adverse Event|0
1621998|NCT01977937|5660803|P1|Overall Study|Adverse Event|1
1621999|NCT01977937|5660802|P2|Overall Study|Withdrawal by Subject|1
1622000|NCT01977937|5660803|P1|Overall Study|Withdrawal by Subject|2
1622001|NCT01977846|5660813|P2|Total Study - Prospective|Protocol Violation|1
1622002|NCT01977846|5660814|P1|Total Study - Prospective|Protocol Violation|0
1622003|NCT01977846|5660813|P2|Total Study - Prospective|No show|1
1622004|NCT01977846|5660814|P1|Total Study - Prospective|No show|0
1622005|NCT01977846|5660813|P2|Total Study - Prospective|Not available at time of visit|5
1622006|NCT01977846|5660814|P1|Total Study - Prospective|Not available at time of visit|0
1622007|NCT01977846|5660813|P2|Total Study - Prospective|Withdrawal by Subject|13
1622008|NCT01977846|5660814|P1|Total Study - Prospective|Withdrawal by Subject|0
1622009|NCT01977846|5660813|P2|Total Study - Prospective|Lost to Follow-up|8
1622010|NCT01977846|5660814|P1|Total Study - Prospective|Lost to Follow-up|0
1622011|NCT01977846|5660813|P2|Total Study - Prospective|Death|1
1622012|NCT01977846|5660814|P1|Total Study - Prospective|Death|0
1622013|NCT01977820|5660832|P2|Overall Study|Sponsor terminated the study|1
1622014|NCT01977820|5660833|P1|Overall Study|Sponsor terminated the study|1
1622015|NCT01977794|5660841|P2|Overall Study|Other|1
1622016|NCT01977794|5660842|P1|Overall Study|Other|0
1622017|NCT01977794|5660841|P2|Overall Study|Withdrew consent|1
1622018|NCT01977794|5660842|P1|Overall Study|Withdrew consent|2
1622019|NCT01977794|5660841|P2|Overall Study|Death|1
1622020|NCT01977794|5660842|P1|Overall Study|Death|1
1622021|NCT01977794|5660841|P2|Overall Study|Protocol Violation|0
1622022|NCT01977794|5660842|P1|Overall Study|Protocol Violation|1
1622023|NCT01977794|5660841|P2|Overall Study|Lost to Follow-up|1
1622024|NCT01977794|5660842|P1|Overall Study|Lost to Follow-up|2
1622025|NCT01977794|5660841|P2|Overall Study|Adverse Event|2
1622026|NCT01977794|5660842|P1|Overall Study|Adverse Event|2
1622027|NCT01977729|5660877|P1|Overall Study|Study terminated|1
1622028|NCT01977690|5660889|P2|Overall Study|Withdrawal by Subject|4
1622029|NCT01977690|5660890|P1|Overall Study|Withdrawal by Subject|0
1622030|NCT01977677|5660899|P3|Overall Study|Unrelated Adverse Event|1
1622031|NCT01977677|5660900|P2|Overall Study|Unrelated Adverse Event|0
1622032|NCT01977677|5660901|P1|Overall Study|Unrelated Adverse Event|0
1622033|NCT01977625|5660912|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1622034|NCT01977625|5660913|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1622035|NCT01977625|5660912|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
1622036|NCT01977625|5660913|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
1622037|NCT01977612|5660923|P2|Overall Study|Lost to Follow-up|1
1622038|NCT01977612|5660924|P1|Overall Study|Lost to Follow-up|1
1622039|NCT01977573|5660946|P4|Overall Study|Withdrawal by Subject|1
1622040|NCT01977573|5660947|P3|Overall Study|Withdrawal by Subject|1
1622041|NCT01977573|5660948|P2|Overall Study|Withdrawal by Subject|1
1622042|NCT01977573|5660949|P1|Overall Study|Withdrawal by Subject|6
1622043|NCT01977573|5660946|P4|Overall Study|Reached Defined Stopping Criteria|0
1622044|NCT01977573|5660947|P3|Overall Study|Reached Defined Stopping Criteria|1
1622045|NCT01977573|5660948|P2|Overall Study|Reached Defined Stopping Criteria|1
1622046|NCT01977573|5660949|P1|Overall Study|Reached Defined Stopping Criteria|2
1622047|NCT01977573|5660946|P4|Overall Study|Protocol Violation|0
1622048|NCT01977573|5660947|P3|Overall Study|Protocol Violation|0
1622049|NCT01977573|5660948|P2|Overall Study|Protocol Violation|1
1622050|NCT01977573|5660949|P1|Overall Study|Protocol Violation|3
1622051|NCT01977573|5660946|P4|Overall Study|Physician Decision|0
1622052|NCT01977573|5660947|P3|Overall Study|Physician Decision|0
1622053|NCT01977573|5660948|P2|Overall Study|Physician Decision|0
1622054|NCT01977573|5660949|P1|Overall Study|Physician Decision|1
1622055|NCT01977573|5660946|P4|Overall Study|Lost to Follow-up|1
1622056|NCT01977573|5660947|P3|Overall Study|Lost to Follow-up|0
1622057|NCT01977573|5660948|P2|Overall Study|Lost to Follow-up|0
1622058|NCT01977573|5660949|P1|Overall Study|Lost to Follow-up|1
1622059|NCT01977573|5660946|P4|Overall Study|Adverse Event|1
1622060|NCT01977573|5660947|P3|Overall Study|Adverse Event|2
1622061|NCT01977573|5660948|P2|Overall Study|Adverse Event|0
1622062|NCT01977573|5660949|P1|Overall Study|Adverse Event|7
1622063|NCT01977482|5661063|P6|Overall Study|Withdrawal by Subject|5
1622064|NCT01977482|5661064|P5|Overall Study|Withdrawal by Subject|1
1622065|NCT01977482|5661065|P4|Overall Study|Withdrawal by Subject|3
1622066|NCT01977482|5661066|P3|Overall Study|Withdrawal by Subject|1
1622067|NCT01977482|5661067|P2|Overall Study|Withdrawal by Subject|4
1622068|NCT01977482|5661068|P1|Overall Study|Withdrawal by Subject|2
1622069|NCT01977482|5661063|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
1622070|NCT01977482|5661064|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
1622071|NCT01977482|5661065|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
1622072|NCT01977482|5661066|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
1622073|NCT01977482|5661067|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
1622074|NCT01977482|5661068|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
1622075|NCT01977482|5661063|P6|Overall Study|Protocol Violation|0
1622076|NCT01977482|5661064|P5|Overall Study|Protocol Violation|0
1622077|NCT01977482|5661065|P4|Overall Study|Protocol Violation|0
1622078|NCT01977482|5661066|P3|Overall Study|Protocol Violation|1
1622079|NCT01977482|5661067|P2|Overall Study|Protocol Violation|0
1622080|NCT01977482|5661068|P1|Overall Study|Protocol Violation|0
1622081|NCT01977482|5661063|P6|Overall Study|Physician Decision|0
1622082|NCT01977482|5661064|P5|Overall Study|Physician Decision|0
1622083|NCT01977482|5661065|P4|Overall Study|Physician Decision|0
1622084|NCT01977482|5661066|P3|Overall Study|Physician Decision|0
1622085|NCT01977482|5661067|P2|Overall Study|Physician Decision|1
1622086|NCT01977482|5661068|P1|Overall Study|Physician Decision|0
1622087|NCT01977482|5661063|P6|Overall Study|Lost to Follow-up|0
1622088|NCT01977482|5661064|P5|Overall Study|Lost to Follow-up|0
1622089|NCT01977482|5661065|P4|Overall Study|Lost to Follow-up|0
1622090|NCT01977482|5661066|P3|Overall Study|Lost to Follow-up|0
1622091|NCT01977482|5661067|P2|Overall Study|Lost to Follow-up|0
1622092|NCT01977482|5661068|P1|Overall Study|Lost to Follow-up|1
1622093|NCT01977482|5661063|P6|Overall Study|Adverse Event|0
1622094|NCT01977482|5661064|P5|Overall Study|Adverse Event|2
1622095|NCT01977482|5661065|P4|Overall Study|Adverse Event|0
1622096|NCT01977482|5661066|P3|Overall Study|Adverse Event|1
1622097|NCT01977482|5661067|P2|Overall Study|Adverse Event|1
1622098|NCT01977482|5661068|P1|Overall Study|Adverse Event|0
1622099|NCT01977456|5661183|P1|Overall Study|Death|5
1622100|NCT01977352|5661192|P2|Overall Study|Lost to Follow-up|2
1622101|NCT01977352|5661193|P1|Overall Study|Lost to Follow-up|1
1622102|NCT01977222|5661211|P1|Overall Study|Withdrawal by Subject|1
1622103|NCT01977092|5661224|P2|Overall Study|In prison|11
1622104|NCT01977092|5661225|P1|Overall Study|In prison|3
1622105|NCT01977092|5661224|P2|Overall Study|Withdrawal by Subject|1
1622106|NCT01977092|5661225|P1|Overall Study|Withdrawal by Subject|2
1622107|NCT01977092|5661224|P2|Overall Study|Lost to Follow-up|14
1622108|NCT01977092|5661225|P1|Overall Study|Lost to Follow-up|23
1622109|NCT01977092|5661224|P2|Overall Study|Death|4
1622110|NCT01977092|5661225|P1|Overall Study|Death|3
1622111|NCT01977040|5661235|P1|Overall Study|Vasa previa not confirmed|2
1622112|NCT01976845|5661289|P3|Overall Study|Physician Decision|3
1622113|NCT01976845|5661290|P2|Overall Study|Physician Decision|8
1622114|NCT01976845|5661291|P1|Overall Study|Physician Decision|8
1622115|NCT01976806|5661316|P2|Overall Study|Withdrawal by Subject|1
1622116|NCT01976806|5661317|P1|Overall Study|Withdrawal by Subject|1
1622117|NCT01976806|5661316|P2|Overall Study|Adverse Event|1
1622118|NCT01976806|5661317|P1|Overall Study|Adverse Event|1
1622119|NCT01976806|5661316|P2|Overall Study|Lost to Follow-up|4
1622120|NCT01976806|5661317|P1|Overall Study|Lost to Follow-up|1
1622121|NCT01976663|5661345|P1|Overall Study|Lost to Follow-up|3
1622122|NCT01976663|5661345|P1|Overall Study|Adverse Event|2
1622123|NCT01976663|5661345|P1|Overall Study|Screen Failure|3
1622124|NCT01976663|5661345|P1|Overall Study|Withdrawal by Subject|4
1622125|NCT01976663|5661345|P1|Overall Study|Personal Reasons|6
1622126|NCT01976663|5661345|P1|Overall Study|Completed 18 mos but no repeat treatment|24
1622127|NCT01976624|5661364|P1|Overall Study|Participants age less than 19 years|12
1622128|NCT01976624|5661364|P1|Overall Study|Participants contraindicated|2
1622129|NCT01976507|5661392|P1|Overall Study|ablation not done, drug not given|1
1622130|NCT01976507|5661392|P1|Overall Study|Adverse Event|6
1622131|NCT01976338|5661425|P2|Overall Study|Adverse Event|1
1622132|NCT01976338|5661426|P1|Overall Study|Adverse Event|5
1622133|NCT01976338|5661425|P2|Overall Study|Withdrawal by Subject|2
1622134|NCT01976338|5661426|P1|Overall Study|Withdrawal by Subject|5
1622135|NCT01976338|5661425|P2|Overall Study|Lost to Follow-up|0
1622136|NCT01976338|5661426|P1|Overall Study|Lost to Follow-up|3
1622137|NCT01976338|5661425|P2|Overall Study|Physician Decision|1
1622138|NCT01976338|5661426|P1|Overall Study|Physician Decision|0
1622139|NCT01976312|5661453|P2|Overall Study|Protocol Violation|0
1622140|NCT01976312|5661454|P1|Overall Study|Protocol Violation|2
1622141|NCT01976312|5661453|P2|Overall Study|Adverse Event|6
1622142|NCT01976312|5661454|P1|Overall Study|Adverse Event|6
1622143|NCT01976312|5661453|P2|Overall Study|Withdrawal by Subject|2
1622144|NCT01976312|5661454|P1|Overall Study|Withdrawal by Subject|7
1622145|NCT01976312|5661453|P2|Overall Study|Lost to Follow-up|0
1622146|NCT01976312|5661454|P1|Overall Study|Lost to Follow-up|2
1622147|NCT01976312|5661453|P2|Overall Study|Pregnancy|1
1622148|NCT01976312|5661454|P1|Overall Study|Pregnancy|0
1622149|NCT01976299|5661475|P2|Overall Study|See clarification above in comments|2
1622150|NCT01976299|5661476|P1|Overall Study|See clarification above in comments|9
1622151|NCT01976299|5661475|P2|Overall Study|Lost to Follow-up|1
1622152|NCT01976299|5661476|P1|Overall Study|Lost to Follow-up|7
1622153|NCT01976299|5661475|P2|Overall Study|Death|2
1622154|NCT01976299|5661476|P1|Overall Study|Death|4
1622155|NCT01976299|5661475|P2|Overall Study|Withdrawal by Subject|1
1622156|NCT01976299|5661476|P1|Overall Study|Withdrawal by Subject|3
1622157|NCT01976104|5661503|P4|Overall Study|Other|0
1622158|NCT01976104|5661504|P3|Overall Study|Other|0
1622159|NCT01976104|5661505|P2|Overall Study|Other|1
1622160|NCT01976104|5661506|P1|Overall Study|Other|0
1622161|NCT01976104|5661503|P4|Overall Study|Withdrawal by Subject|1
1622162|NCT01976104|5661504|P3|Overall Study|Withdrawal by Subject|0
1622163|NCT01976104|5661505|P2|Overall Study|Withdrawal by Subject|0
1622164|NCT01976104|5661506|P1|Overall Study|Withdrawal by Subject|3
1622165|NCT01976104|5661503|P4|Overall Study|Subject Choice|1
1622166|NCT01976104|5661504|P3|Overall Study|Subject Choice|0
1622167|NCT01976104|5661505|P2|Overall Study|Subject Choice|1
1622168|NCT01976104|5661506|P1|Overall Study|Subject Choice|0
1622169|NCT01976104|5661503|P4|Overall Study|Lost to Follow-up|1
1622170|NCT01976104|5661504|P3|Overall Study|Lost to Follow-up|1
1622171|NCT01976104|5661505|P2|Overall Study|Lost to Follow-up|0
1622172|NCT01976104|5661506|P1|Overall Study|Lost to Follow-up|3
1622173|NCT01976104|5661503|P4|Overall Study|Adverse Event|0
1622174|NCT01976104|5661504|P3|Overall Study|Adverse Event|1
1622175|NCT01976104|5661505|P2|Overall Study|Adverse Event|0
1622176|NCT01976104|5661506|P1|Overall Study|Adverse Event|0
1622177|NCT01975948|5661540|P4|Overall Study|Withdrawal by Subject|6
1622178|NCT01975948|5661541|P3|Overall Study|Withdrawal by Subject|7
1622179|NCT01975948|5661542|P2|Overall Study|Withdrawal by Subject|21
1622180|NCT01975948|5661543|P1|Overall Study|Withdrawal by Subject|17
1622181|NCT01975701|5661610|P1|Overall Study|Physician Decision|1
1622182|NCT01975701|5661610|P1|Overall Study|Death|23
1622183|NCT01975701|5661610|P1|Overall Study|Lost to Follow-up|1
1622184|NCT01975675|5661621|P4|Overall Study|Death|0
1622185|NCT01975675|5661622|P3|Overall Study|Death|0
1622186|NCT01975675|5661623|P2|Overall Study|Death|1
1622187|NCT01975675|5661624|P1|Overall Study|Death|0
1622188|NCT01975389|5661657|P2|Overall Study|Randomized, not treated|5
1622189|NCT01975389|5661658|P1|Overall Study|Randomized, not treated|4
1622190|NCT01975389|5661657|P2|Overall Study|Other|9
1622191|NCT01975389|5661658|P1|Overall Study|Other|6
1622192|NCT01975389|5661657|P2|Overall Study|Withdrawal by Subject|76
1622193|NCT01975389|5661658|P1|Overall Study|Withdrawal by Subject|90
1622194|NCT01975389|5661657|P2|Overall Study|Lost to Follow-up|86
1622195|NCT01975389|5661658|P1|Overall Study|Lost to Follow-up|81
1622196|NCT01975389|5661657|P2|Overall Study|Death|54
1622197|NCT01975389|5661658|P1|Overall Study|Death|61
1622198|NCT01975389|5661657|P2|Overall Study|Adverse Event|6
1622199|NCT01975389|5661658|P1|Overall Study|Adverse Event|10
1622200|NCT01975376|5661718|P2|Overall Study|Randomized, Not Treated|8
1622201|NCT01975376|5661719|P1|Overall Study|Randomized, Not Treated|16
1622202|NCT01975376|5661718|P2|Overall Study|Other|4
1622203|NCT01975376|5661719|P1|Overall Study|Other|2
1622204|NCT01975376|5661718|P2|Overall Study|Withdrew consent|62
1622205|NCT01975376|5661719|P1|Overall Study|Withdrew consent|68
1622206|NCT01975376|5661718|P2|Overall Study|Lost to Follow-up|66
1622207|NCT01975376|5661719|P1|Overall Study|Lost to Follow-up|70
1622208|NCT01975376|5661718|P2|Overall Study|Death|72
1622209|NCT01975376|5661719|P1|Overall Study|Death|65
1622210|NCT01975376|5661718|P2|Overall Study|Adverse Event|5
1622211|NCT01975376|5661719|P1|Overall Study|Adverse Event|5
1622212|NCT01975285|5661779|P2|Overall Study|Failed Block and follow up|2
1622213|NCT01975285|5661780|P1|Overall Study|Failed Block and follow up|2
1622214|NCT01975246|5661796|P2|Overall Study|Other than stated|1
1622215|NCT01975246|5661797|P1|Overall Study|Other than stated|0
1622216|NCT01975246|5661796|P2|Overall Study|Protocol Violation|0
1622217|NCT01975246|5661797|P1|Overall Study|Protocol Violation|1
1622218|NCT01975246|5661796|P2|Overall Study|Lack of Efficacy|0
1622219|NCT01975246|5661797|P1|Overall Study|Lack of Efficacy|1
1622220|NCT01975246|5661796|P2|Overall Study|Adverse Event|1
1622221|NCT01975246|5661797|P1|Overall Study|Adverse Event|2
1622222|NCT01975220|5661810|P6|Test Period 1|Not treated|0
1622223|NCT01975220|5661811|P5|Test Period 1|Not treated|0
1622224|NCT01975220|5661812|P4|Test Period 1|Not treated|0
1622225|NCT01975220|5661813|P3|Test Period 1|Not treated|0
1622226|NCT01975220|5661814|P2|Test Period 1|Not treated|1
1622227|NCT01975220|5661815|P1|Test Period 1|Not treated|0
1622228|NCT01974895|5661871|P2|Overall Study|Other (Reason unknown)|8
1622229|NCT01974895|5661872|P1|Overall Study|Other (Reason unknown)|9
1622230|NCT01974895|5661871|P2|Overall Study|Other (Missed Visit)|0
1622231|NCT01974895|5661872|P1|Overall Study|Other (Missed Visit)|1
1622232|NCT01974895|5661871|P2|Overall Study|Withdrawal by Subject|1
1622233|NCT01974895|5661872|P1|Overall Study|Withdrawal by Subject|0
1622234|NCT01974895|5661871|P2|Overall Study|Lost to Follow-up|6
1622235|NCT01974895|5661872|P1|Overall Study|Lost to Follow-up|4
1622236|NCT01974895|5661871|P2|Overall Study|Protocol Violation|0
1622237|NCT01974895|5661872|P1|Overall Study|Protocol Violation|1
1622238|NCT01974817|5661902|P1|Overall Study|Protocol Violation|2
1622239|NCT01974817|5661902|P1|Overall Study|Lost to Follow-up|2
1622240|NCT01974817|5661902|P1|Overall Study|Death|4
1622241|NCT01974752|5661908|P2|Overall Study|Other Eligibility Criteria|1
1622242|NCT01974752|5661909|P1|Overall Study|Other Eligibility Criteria|0
1622243|NCT01974752|5661908|P2|Overall Study|Withdrawal by Subject|3
1622244|NCT01974752|5661909|P1|Overall Study|Withdrawal by Subject|2
1622245|NCT01974752|5661908|P2|Overall Study|Lost to Follow-up|0
1622246|NCT01974752|5661909|P1|Overall Study|Lost to Follow-up|2
1622247|NCT01974752|5661908|P2|Overall Study|Death|11
1622248|NCT01974752|5661909|P1|Overall Study|Death|33
1622249|NCT01974323|5662337|P2|Overall Study|Adverse Event|2
1622250|NCT01974323|5662338|P1|Overall Study|Adverse Event|2
1622251|NCT01974323|5662337|P2|Overall Study|Lack of Efficacy|1
1622252|NCT01974323|5662338|P1|Overall Study|Lack of Efficacy|1
1622253|NCT01974323|5662337|P2|Overall Study|Pregnancy|1
1622254|NCT01974323|5662338|P1|Overall Study|Pregnancy|2
1622255|NCT01974323|5662337|P2|Overall Study|Lost to Follow-up|40
1622256|NCT01974323|5662338|P1|Overall Study|Lost to Follow-up|45
1622257|NCT01974323|5662337|P2|Overall Study|Personal Reasons|19
1622258|NCT01974323|5662338|P1|Overall Study|Personal Reasons|15
1622259|NCT01974323|5662337|P2|Overall Study|Protocol Violation|2
1622260|NCT01974323|5662338|P1|Overall Study|Protocol Violation|2
1622261|NCT01974323|5662337|P2|Overall Study|Other Reasons|28
1622262|NCT01974323|5662338|P1|Overall Study|Other Reasons|25
1622263|NCT01974141|5662378|P2|Overall Study|Adverse Event|5
1622264|NCT01974141|5662379|P1|Overall Study|Adverse Event|4
1622265|NCT01974141|5662378|P2|Overall Study|Lack of Efficacy|1
1622266|NCT01974141|5662379|P1|Overall Study|Lack of Efficacy|0
1622267|NCT01974141|5662378|P2|Overall Study|Pregnancy|3
1622268|NCT01974141|5662379|P1|Overall Study|Pregnancy|3
1622269|NCT01974141|5662378|P2|Overall Study|Lost to Follow-up|29
1622270|NCT01974141|5662379|P1|Overall Study|Lost to Follow-up|38
1622271|NCT01974141|5662378|P2|Overall Study|Personal Reasons|20
1622272|NCT01974141|5662379|P1|Overall Study|Personal Reasons|21
1622273|NCT01974141|5662378|P2|Overall Study|Protocol Violation|6
1622274|NCT01974141|5662379|P1|Overall Study|Protocol Violation|2
1622275|NCT01974141|5662378|P2|Overall Study|Other Reasons|18
1622276|NCT01974141|5662379|P1|Overall Study|Other Reasons|28
1622277|NCT01973595|5662473|P4|Washout|Withdrawal by Subject|0
1622278|NCT01973595|5662474|P3|Washout|Withdrawal by Subject|1
1622279|NCT01973595|5662475|P2|Washout|Withdrawal by Subject|0
1622280|NCT01973595|5662476|P1|Washout|Withdrawal by Subject|1
1622281|NCT01973569|5662493|P3|Overall Study|Did not receive study drug|3
1622282|NCT01973569|5662494|P2|Overall Study|Did not receive study drug|3
1622283|NCT01973569|5662495|P1|Overall Study|Did not receive study drug|6
1622284|NCT01973569|5662493|P3|Overall Study|Other|0
1622285|NCT01973569|5662494|P2|Overall Study|Other|1
1622286|NCT01973569|5662495|P1|Overall Study|Other|1
1622287|NCT01973569|5662493|P3|Overall Study|Disease progression|0
1622288|NCT01973569|5662494|P2|Overall Study|Disease progression|3
1622289|NCT01973569|5662495|P1|Overall Study|Disease progression|0
1622290|NCT01973569|5662493|P3|Overall Study|Prohibited concomitant d|0
1622291|NCT01973569|5662494|P2|Overall Study|Prohibited concomitant d|5
1622292|NCT01973569|5662495|P1|Overall Study|Prohibited concomitant d|1
1622293|NCT01973569|5662493|P3|Overall Study|Invasive dental treatment|6
1622294|NCT01973569|5662494|P2|Overall Study|Invasive dental treatment|5
1622295|NCT01973569|5662495|P1|Overall Study|Invasive dental treatment|3
1622296|NCT01973569|5662493|P3|Overall Study|Withdrawal by Subject|2
1622297|NCT01973569|5662494|P2|Overall Study|Withdrawal by Subject|5
1622298|NCT01973569|5662495|P1|Overall Study|Withdrawal by Subject|7
1622299|NCT01973569|5662493|P3|Overall Study|Protocol Violation|3
1622300|NCT01973569|5662494|P2|Overall Study|Protocol Violation|1
1622301|NCT01973569|5662495|P1|Overall Study|Protocol Violation|2
1622302|NCT01973569|5662493|P3|Overall Study|Adverse Event|4
1622303|NCT01973569|5662494|P2|Overall Study|Adverse Event|2
1622304|NCT01973569|5662495|P1|Overall Study|Adverse Event|9
1622305|NCT01973491|5662521|P1|Treatment Period (16 Weeks)|Adverse Event|1
1622306|NCT01973491|5662521|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
1622307|NCT01973491|5662521|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
1622308|NCT01973439|5662537|P1|Overall Study|PK curve incomplete|2
1622309|NCT01973439|5662537|P1|Overall Study|Vomiting after commencing once daily|1
1622310|NCT01973439|5662537|P1|Overall Study|Lost samples from one PK Day|2
1622311|NCT01973387|5662559|P2|Overall Study|Randomized, not treated|2
1622312|NCT01973387|5662560|P1|Overall Study|Randomized, not treated|2
1622313|NCT01973387|5662559|P2|Overall Study|Death|3
1622314|NCT01973387|5662560|P1|Overall Study|Death|4
1622315|NCT01973387|5662559|P2|Overall Study|Progressive disease or relapse|5
1622316|NCT01973387|5662560|P1|Overall Study|Progressive disease or relapse|16
1622317|NCT01973387|5662559|P2|Overall Study|Study terminated by sponsor|0
1622318|NCT01973387|5662560|P1|Overall Study|Study terminated by sponsor|63
1622319|NCT01973387|5662559|P2|Overall Study|Withdrawal by Subject|4
1622320|NCT01973387|5662560|P1|Overall Study|Withdrawal by Subject|7
1622321|NCT01973387|5662559|P2|Overall Study|Adverse Event|4
1622322|NCT01973387|5662560|P1|Overall Study|Adverse Event|14
1622323|NCT01973231|5662642|P2|Overall Study|Withdrawal by Subject|9
1622324|NCT01973231|5662643|P1|Overall Study|Withdrawal by Subject|7
1622325|NCT01973231|5662642|P2|Overall Study|unclassified|1
1622326|NCT01973231|5662643|P1|Overall Study|unclassified|2
1622327|NCT01973231|5662642|P2|Overall Study|Lost to Follow-up|1
1622328|NCT01973231|5662643|P1|Overall Study|Lost to Follow-up|1
1622329|NCT01973231|5662642|P2|Overall Study|Protocol Violation|1
1622330|NCT01973231|5662643|P1|Overall Study|Protocol Violation|1
1622331|NCT01973218|5662663|P2|Overall Study|Withdrawal by Subject|0
1622332|NCT01973218|5662664|P1|Overall Study|Withdrawal by Subject|1
1622333|NCT01973218|5662663|P2|Overall Study|Adverse Event|0
1622334|NCT01973218|5662664|P1|Overall Study|Adverse Event|1
1622335|NCT01972841|5662757|P6|Overall Study|Did not have end of treatment page|0
1622336|NCT01972841|5662758|P5|Overall Study|Did not have end of treatment page|1
1622337|NCT01972841|5662759|P4|Overall Study|Did not have end of treatment page|0
1622338|NCT01972841|5662760|P3|Overall Study|Did not have end of treatment page|0
1622339|NCT01972841|5662761|P2|Overall Study|Did not have end of treatment page|0
1622340|NCT01972841|5662762|P1|Overall Study|Did not have end of treatment page|0
1622341|NCT01972841|5662757|P6|Overall Study|Miscellaneous|4
1622342|NCT01972841|5662758|P5|Overall Study|Miscellaneous|0
1622343|NCT01972841|5662759|P4|Overall Study|Miscellaneous|1
1622344|NCT01972841|5662760|P3|Overall Study|Miscellaneous|4
1622345|NCT01972841|5662761|P2|Overall Study|Miscellaneous|0
1622346|NCT01972841|5662762|P1|Overall Study|Miscellaneous|0
1622347|NCT01972841|5662757|P6|Overall Study|Withdrawal by participants|34
1622348|NCT01972841|5662758|P5|Overall Study|Withdrawal by participants|33
1622349|NCT01972841|5662759|P4|Overall Study|Withdrawal by participants|16
1622350|NCT01972841|5662760|P3|Overall Study|Withdrawal by participants|23
1622351|NCT01972841|5662761|P2|Overall Study|Withdrawal by participants|27
1622352|NCT01972841|5662762|P1|Overall Study|Withdrawal by participants|21
1622353|NCT01972841|5662757|P6|Overall Study|Protocol Violation|4
1622354|NCT01972841|5662758|P5|Overall Study|Protocol Violation|9
1622355|NCT01972841|5662759|P4|Overall Study|Protocol Violation|5
1622356|NCT01972841|5662760|P3|Overall Study|Protocol Violation|3
1622357|NCT01972841|5662761|P2|Overall Study|Protocol Violation|2
1622358|NCT01972841|5662762|P1|Overall Study|Protocol Violation|2
1622359|NCT01972841|5662757|P6|Overall Study|Lost to Follow-up|3
1622360|NCT01972841|5662758|P5|Overall Study|Lost to Follow-up|9
1622361|NCT01972841|5662759|P4|Overall Study|Lost to Follow-up|2
1622362|NCT01972841|5662760|P3|Overall Study|Lost to Follow-up|4
1622363|NCT01972841|5662761|P2|Overall Study|Lost to Follow-up|2
1622364|NCT01972841|5662762|P1|Overall Study|Lost to Follow-up|4
1622365|NCT01972841|5662757|P6|Overall Study|Lack of Efficacy|1
1622366|NCT01972841|5662758|P5|Overall Study|Lack of Efficacy|4
1622367|NCT01972841|5662759|P4|Overall Study|Lack of Efficacy|2
1622368|NCT01972841|5662760|P3|Overall Study|Lack of Efficacy|0
1622369|NCT01972841|5662761|P2|Overall Study|Lack of Efficacy|0
1622370|NCT01972841|5662762|P1|Overall Study|Lack of Efficacy|1
1622371|NCT01972841|5662757|P6|Overall Study|Adverse Event|26
1622372|NCT01972841|5662758|P5|Overall Study|Adverse Event|21
1622373|NCT01972841|5662759|P4|Overall Study|Adverse Event|9
1622374|NCT01972841|5662760|P3|Overall Study|Adverse Event|12
1622375|NCT01972841|5662761|P2|Overall Study|Adverse Event|8
1622376|NCT01972841|5662762|P1|Overall Study|Adverse Event|13
1622377|NCT01972841|5662757|P6|Overall Study|Randomized but Never Received Treatment|13
1622378|NCT01972841|5662758|P5|Overall Study|Randomized but Never Received Treatment|6
1622379|NCT01972841|5662759|P4|Overall Study|Randomized but Never Received Treatment|2
1622380|NCT01972841|5662760|P3|Overall Study|Randomized but Never Received Treatment|4
1622381|NCT01972841|5662761|P2|Overall Study|Randomized but Never Received Treatment|5
1622382|NCT01972841|5662762|P1|Overall Study|Randomized but Never Received Treatment|2
1622383|NCT01972789|5663192|P2|Overall Study|Physician Decision|2
1622384|NCT01972789|5663193|P1|Overall Study|Physician Decision|3
1622385|NCT01972789|5663192|P2|Overall Study|Protocol deviation|0
1622386|NCT01972789|5663193|P1|Overall Study|Protocol deviation|1
1622387|NCT01972789|5663192|P2|Overall Study|Death|5
1622388|NCT01972789|5663193|P1|Overall Study|Death|7
1622389|NCT01972789|5663192|P2|Overall Study|Lost to Follow-up|7
1622390|NCT01972789|5663193|P1|Overall Study|Lost to Follow-up|4
1622391|NCT01972789|5663192|P2|Overall Study|Subject withdrew consent|12
1622392|NCT01972789|5663193|P1|Overall Study|Subject withdrew consent|14
1622393|NCT01972789|5663192|P2|Overall Study|Adverse Event|4
1622394|NCT01972789|5663193|P1|Overall Study|Adverse Event|11
1622395|NCT01972776|5663227|P6|Part 2|Administrative problems|7
1622396|NCT01972776|5663228|P5|Part 2|Administrative problems|10
1622397|NCT01972776|5663229|P4|Part 2|Administrative problems|0
1622398|NCT01972776|5663230|P3|Part 2|Administrative problems|0
1622399|NCT01972776|5663231|P2|Part 2|Administrative problems|0
1622400|NCT01972776|5663232|P1|Part 2|Administrative problems|0
1622401|NCT01972776|5663227|P6|Part 2|Adverse Event|0
1622402|NCT01972776|5663228|P5|Part 2|Adverse Event|3
1622403|NCT01972776|5663229|P4|Part 2|Adverse Event|0
1622404|NCT01972776|5663230|P3|Part 2|Adverse Event|0
1622405|NCT01972776|5663231|P2|Part 2|Adverse Event|0
1622406|NCT01972776|5663232|P1|Part 2|Adverse Event|0
1622407|NCT01972776|5663227|P6|Part 1|Adverse Event|0
1622408|NCT01972776|5663228|P5|Part 1|Adverse Event|0
1622409|NCT01972776|5663229|P4|Part 1|Adverse Event|1
1622410|NCT01972776|5663230|P3|Part 1|Adverse Event|1
1622411|NCT01972776|5663231|P2|Part 1|Adverse Event|0
1622412|NCT01972776|5663232|P1|Part 1|Adverse Event|0
1622413|NCT01972776|5663227|P6|Part 1|Withdrawal by Subject|0
1622414|NCT01972776|5663228|P5|Part 1|Withdrawal by Subject|0
1622415|NCT01972776|5663229|P4|Part 1|Withdrawal by Subject|0
1622416|NCT01972776|5663230|P3|Part 1|Withdrawal by Subject|1
1622417|NCT01972776|5663231|P2|Part 1|Withdrawal by Subject|0
1622418|NCT01972776|5663232|P1|Part 1|Withdrawal by Subject|0
1622419|NCT01972724|5663303|P3|Open-Label|Significant Protocol Deviation|2
1622420|NCT01972724|5663304|P2|Open-Label|Significant Protocol Deviation|0
1622421|NCT01972724|5663305|P1|Open-Label|Significant Protocol Deviation|0
1622422|NCT01972724|5663303|P3|Open-Label|Withdrew Consent|3
1622423|NCT01972724|5663304|P2|Open-Label|Withdrew Consent|0
1622424|NCT01972724|5663305|P1|Open-Label|Withdrew Consent|0
1622425|NCT01972724|5663303|P3|Double-Blind|Significant Protocol Deviation|0
1622426|NCT01972724|5663304|P2|Double-Blind|Significant Protocol Deviation|8
1622427|NCT01972724|5663305|P1|Double-Blind|Significant Protocol Deviation|5
1622428|NCT01972724|5663303|P3|Double-Blind|Withdrawal of Consent|0
1622429|NCT01972724|5663304|P2|Double-Blind|Withdrawal of Consent|1
1622430|NCT01972724|5663305|P1|Double-Blind|Withdrawal of Consent|2
1622431|NCT01972724|5663303|P3|Double-Blind|Adverse Event|0
1622432|NCT01972724|5663304|P2|Double-Blind|Adverse Event|0
1622433|NCT01972724|5663305|P1|Double-Blind|Adverse Event|1
1622434|NCT01972724|5663303|P3|Double-Blind|Rescue Criteria Met|0
1622435|NCT01972724|5663304|P2|Double-Blind|Rescue Criteria Met|0
1622436|NCT01972724|5663305|P1|Double-Blind|Rescue Criteria Met|1
1622437|NCT01972659|5663318|P2|Overall Study|problems realted to acceleromyograph|1
1622438|NCT01972659|5663319|P1|Overall Study|problems realted to acceleromyograph|2
1622439|NCT01972659|5663318|P2|Overall Study|Protocol Violation|2
1622440|NCT01972659|5663319|P1|Overall Study|Protocol Violation|2
1622441|NCT01972568|5663328|P3|Overall Study|Adverse Event|5
1622442|NCT01972568|5663329|P2|Overall Study|Adverse Event|6
1622443|NCT01972568|5663330|P1|Overall Study|Adverse Event|5
1622444|NCT01972568|5663328|P3|Overall Study|Lost to Follow-up|0
1622445|NCT01972568|5663329|P2|Overall Study|Lost to Follow-up|0
1622446|NCT01972568|5663330|P1|Overall Study|Lost to Follow-up|1
1622447|NCT01972568|5663328|P3|Overall Study|Withdrawal by Subject|7
1622448|NCT01972568|5663329|P2|Overall Study|Withdrawal by Subject|3
1622449|NCT01972568|5663330|P1|Overall Study|Withdrawal by Subject|6
1622450|NCT01972568|5663328|P3|Overall Study|Protocol Violation|2
1622451|NCT01972568|5663329|P2|Overall Study|Protocol Violation|2
1622452|NCT01972568|5663330|P1|Overall Study|Protocol Violation|1
1622453|NCT01972568|5663328|P3|Overall Study|Lack of Efficacy|2
1622454|NCT01972568|5663329|P2|Overall Study|Lack of Efficacy|1
1622455|NCT01972568|5663330|P1|Overall Study|Lack of Efficacy|0
1622456|NCT01972568|5663328|P3|Overall Study|Other events|0
1622457|NCT01972568|5663329|P2|Overall Study|Other events|0
1622458|NCT01972568|5663330|P1|Overall Study|Other events|3
1622459|NCT01972529|5663369|P4|Overall Study|Not treated|1
1622460|NCT01972529|5663370|P3|Overall Study|Not treated|2
1622461|NCT01972529|5663371|P2|Overall Study|Not treated|1
1622462|NCT01972529|5663372|P1|Overall Study|Not treated|0
1622463|NCT01972529|5663369|P4|Overall Study|Other|2
1622464|NCT01972529|5663370|P3|Overall Study|Other|0
1622465|NCT01972529|5663371|P2|Overall Study|Other|0
1622466|NCT01972529|5663372|P1|Overall Study|Other|0
1622467|NCT01972529|5663369|P4|Overall Study|Withdrawl of Consent|1
1622468|NCT01972529|5663370|P3|Overall Study|Withdrawl of Consent|0
1622469|NCT01972529|5663371|P2|Overall Study|Withdrawl of Consent|2
1622470|NCT01972529|5663372|P1|Overall Study|Withdrawl of Consent|1
1622471|NCT01972529|5663369|P4|Overall Study|Participant Choice|0
1622472|NCT01972529|5663370|P3|Overall Study|Participant Choice|0
1622473|NCT01972529|5663371|P2|Overall Study|Participant Choice|1
1622474|NCT01972529|5663372|P1|Overall Study|Participant Choice|0
1622475|NCT01972529|5663369|P4|Overall Study|Lost to Follow-up|0
1622476|NCT01972529|5663370|P3|Overall Study|Lost to Follow-up|0
1622477|NCT01972529|5663371|P2|Overall Study|Lost to Follow-up|0
1622478|NCT01972529|5663372|P1|Overall Study|Lost to Follow-up|1
1622479|NCT01972529|5663369|P4|Overall Study|Adverse Event|0
1622480|NCT01972529|5663370|P3|Overall Study|Adverse Event|0
1622481|NCT01972529|5663371|P2|Overall Study|Adverse Event|1
1622482|NCT01972529|5663372|P1|Overall Study|Adverse Event|0
1622483|NCT01972464|5663417|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1622484|NCT01972464|5663418|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
1622485|NCT01972464|5663417|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
1622486|NCT01972464|5663418|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
1622487|NCT01972464|5663417|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
1622488|NCT01972464|5663418|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
1622489|NCT01972464|5663417|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
1622490|NCT01972464|5663418|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
1622491|NCT01972438|5663434|P2|Post Month 12 Study Period|Early Study Closure|4
1622492|NCT01972438|5663435|P1|Post Month 12 Study Period|Early Study Closure|3
1622493|NCT01972438|5663434|P2|Months 6-12 Study Period|Early Study Closure|2
1622494|NCT01972438|5663435|P1|Months 6-12 Study Period|Early Study Closure|2
1622495|NCT01972438|5663434|P2|Months 6-12 Study Period|Death|0
1622496|NCT01972438|5663435|P1|Months 6-12 Study Period|Death|1
1622497|NCT01972438|5663434|P2|Months 3-6 Crossover Period|Early Study Closure|1
1622498|NCT01972438|5663435|P1|Months 3-6 Crossover Period|Early Study Closure|0
1622499|NCT01972438|5663434|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
1622500|NCT01972438|5663435|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
1622501|NCT01972438|5663434|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
1622502|NCT01972438|5663435|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
1622503|NCT01972438|5663434|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
1622504|NCT01972438|5663435|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
1622505|NCT01972438|5663434|P2|Baseline-Month 3 Crossover Period|Death|0
1622506|NCT01972438|5663435|P1|Baseline-Month 3 Crossover Period|Death|1
1622507|NCT01972308|5663489|P2|Overall Study|Death|1
1622508|NCT01972308|5663490|P1|Overall Study|Death|4
1622509|NCT01972308|5663489|P2|Overall Study|Lost to Follow-up|6
1622510|NCT01972308|5663490|P1|Overall Study|Lost to Follow-up|4
1622511|NCT01972308|5663489|P2|Overall Study|Withdrawal by Subject|1
1622512|NCT01972308|5663490|P1|Overall Study|Withdrawal by Subject|0
1622513|NCT01972217|5663516|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
1622514|NCT01972217|5663517|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1622515|NCT01972217|5663518|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1622516|NCT01972217|5663519|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
1622517|NCT01972217|5663516|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
1622518|NCT01972217|5663517|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
1622519|NCT01972217|5663518|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
1622520|NCT01972217|5663519|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
1622521|NCT01972217|5663516|P4|Part B Double-blind, Randomised Period|Screen failure|1
1622522|NCT01972217|5663517|P3|Part B Double-blind, Randomised Period|Screen failure|0
1622523|NCT01972217|5663518|P2|Part B Double-blind, Randomised Period|Screen failure|0
1622524|NCT01972217|5663519|P1|Part B Double-blind, Randomised Period|Screen failure|0
1622525|NCT01972217|5663516|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
1622526|NCT01972217|5663517|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
1622527|NCT01972217|5663518|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
1622528|NCT01972217|5663519|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
1622529|NCT01972217|5663516|P4|Part B Double-blind, Randomised Period|Death|44
1622530|NCT01972217|5663517|P3|Part B Double-blind, Randomised Period|Death|43
1622531|NCT01972217|5663518|P2|Part B Double-blind, Randomised Period|Death|0
1622532|NCT01972217|5663519|P1|Part B Double-blind, Randomised Period|Death|0
1622533|NCT01972217|5663516|P4|Part A: Open-label Safety Run-in Period|Death|0
1622534|NCT01972217|5663517|P3|Part A: Open-label Safety Run-in Period|Death|0
1622535|NCT01972217|5663518|P2|Part A: Open-label Safety Run-in Period|Death|1
1622536|NCT01972217|5663519|P1|Part A: Open-label Safety Run-in Period|Death|0
1622537|NCT01972217|5663516|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
1622538|NCT01972217|5663517|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
1622539|NCT01972217|5663518|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
1622540|NCT01972217|5663519|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
1622541|NCT01972217|5663516|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1622542|NCT01972217|5663517|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
1622543|NCT01972217|5663518|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
1622544|NCT01972217|5663519|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
1622545|NCT01972217|5663516|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1622546|NCT01972217|5663517|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1622547|NCT01972217|5663518|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
1622548|NCT01972217|5663519|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
1622549|NCT01972152|5663580|P6|Second Treatment Visit|Protocol Violation|0
1622550|NCT01972152|5663581|P5|Second Treatment Visit|Protocol Violation|0
1622551|NCT01972152|5663582|P4|Second Treatment Visit|Protocol Violation|0
1622552|NCT01972152|5663583|P3|Second Treatment Visit|Protocol Violation|0
1622553|NCT01972152|5663584|P2|Second Treatment Visit|Protocol Violation|1
1622554|NCT01972152|5663585|P1|Second Treatment Visit|Protocol Violation|0
1622555|NCT01972152|5663580|P6|First Treatment Visit|Lost to Follow-up|0
1622556|NCT01972152|5663581|P5|First Treatment Visit|Lost to Follow-up|0
1622557|NCT01972152|5663582|P4|First Treatment Visit|Lost to Follow-up|0
1622558|NCT01972152|5663583|P3|First Treatment Visit|Lost to Follow-up|0
1622559|NCT01972152|5663584|P2|First Treatment Visit|Lost to Follow-up|1
1622560|NCT01972152|5663585|P1|First Treatment Visit|Lost to Follow-up|0
1622561|NCT01972074|5663623|P3|Overall Study|Scanner Unavailable|1
1622562|NCT01972074|5663624|P2|Overall Study|Scanner Unavailable|0
1622563|NCT01972074|5663625|P1|Overall Study|Scanner Unavailable|0
1622564|NCT01972074|5663623|P3|Overall Study|Withdrawal by Subject|1
1622565|NCT01972074|5663624|P2|Overall Study|Withdrawal by Subject|1
1622566|NCT01972074|5663625|P1|Overall Study|Withdrawal by Subject|1
1622567|NCT01972074|5663623|P3|Overall Study|Lost to Follow-up|1
1622568|NCT01972074|5663624|P2|Overall Study|Lost to Follow-up|1
1622569|NCT01972074|5663625|P1|Overall Study|Lost to Follow-up|0
1622570|NCT01972074|5663623|P3|Overall Study|Lack of Efficacy|0
1622571|NCT01972074|5663624|P2|Overall Study|Lack of Efficacy|1
1622572|NCT01972074|5663625|P1|Overall Study|Lack of Efficacy|1
1622573|NCT01972074|5663623|P3|Overall Study|Adverse Event|0
1622574|NCT01972074|5663624|P2|Overall Study|Adverse Event|1
1622575|NCT01972074|5663625|P1|Overall Study|Adverse Event|4
1622576|NCT01971723|5663634|P2|Overall Study|Protocol Violation|2
1622577|NCT01971723|5663635|P1|Overall Study|Protocol Violation|1
1622578|NCT01971723|5663634|P2|Overall Study|Withdrawal by Subject|1
1622579|NCT01971723|5663635|P1|Overall Study|Withdrawal by Subject|1
1622580|NCT01971645|5663668|P3|Overall Study|Protocol Violation|1
1622581|NCT01971645|5663669|P2|Overall Study|Protocol Violation|0
1622582|NCT01971645|5663670|P1|Overall Study|Protocol Violation|0
1622583|NCT01971645|5663668|P3|Overall Study|Lost to Follow-up|1
1622584|NCT01971645|5663669|P2|Overall Study|Lost to Follow-up|0
1622585|NCT01971645|5663670|P1|Overall Study|Lost to Follow-up|1
1622586|NCT01971645|5663668|P3|Overall Study|Adverse Event|0
1622587|NCT01971645|5663669|P2|Overall Study|Adverse Event|0
1622588|NCT01971645|5663670|P1|Overall Study|Adverse Event|1
1622589|NCT01971567|5663704|P2|Overall Study|Lost to Follow-up|0
1622590|NCT01971567|5663705|P1|Overall Study|Lost to Follow-up|1
1622591|NCT01971567|5663704|P2|Overall Study|Withdrawal by Subject|2
1622592|NCT01971567|5663705|P1|Overall Study|Withdrawal by Subject|3
1622593|NCT01971554|5663731|P4|Overall Study|Lost to Follow-up|0
1622594|NCT01971554|5663732|P3|Overall Study|Lost to Follow-up|0
1622595|NCT01971554|5663733|P2|Overall Study|Lost to Follow-up|0
1622596|NCT01971554|5663734|P1|Overall Study|Lost to Follow-up|1
1622597|NCT01971476|5663771|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
1622598|NCT01971476|5663772|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
1622599|NCT01971476|5663773|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
1622600|NCT01971476|5663771|P3|Cohort 2: 12 to <18 Years|Other not defined|0
1622601|NCT01971476|5663772|P2|Cohort 2: 12 to <18 Years|Other not defined|3
1622602|NCT01971476|5663773|P1|Cohort 2: 12 to <18 Years|Other not defined|6
1622603|NCT01971476|5663771|P3|Cohort 1: 2 to <12 Years|Other not defined|6
1622604|NCT01971476|5663772|P2|Cohort 1: 2 to <12 Years|Other not defined|3
1622605|NCT01971476|5663773|P1|Cohort 1: 2 to <12 Years|Other not defined|3
1622606|NCT01971346|5663867|P1|Overall Study|Physician Decision|1
1622607|NCT01971346|5663867|P1|Overall Study|Withdrawal by Subject|2
1622608|NCT01971346|5663867|P1|Overall Study|Lost to Follow-up|2
1622609|NCT01971346|5663867|P1|Overall Study|Protocol Violation|3
1622610|NCT01971203|5663900|P2|Overall Study|Adverse Event|0
1622611|NCT01971203|5663901|P1|Overall Study|Adverse Event|1
1622612|NCT01971203|5663900|P2|Overall Study|Withdrawal by Subject|6
1622613|NCT01971203|5663901|P1|Overall Study|Withdrawal by Subject|5
1622614|NCT01971203|5663900|P2|Overall Study|Protocol Violation|2
1622615|NCT01971203|5663901|P1|Overall Study|Protocol Violation|3
1622616|NCT01970995|5663928|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
1622617|NCT01970995|5663929|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
1622618|NCT01970995|5663930|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
1622619|NCT01970995|5663928|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1622620|NCT01970995|5663929|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1622621|NCT01970995|5663930|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
1622622|NCT01970982|5663953|P3|Overall Study|Withdrawal by Subject|2
1622623|NCT01970982|5663954|P2|Overall Study|Withdrawal by Subject|0
1622624|NCT01970982|5663955|P1|Overall Study|Withdrawal by Subject|0
1622625|NCT01970878|5663990|P4|Overall Study|No Completion Status|0
1622626|NCT01970878|5663991|P3|Overall Study|No Completion Status|0
1622627|NCT01970878|5663992|P2|Overall Study|No Completion Status|1
1622628|NCT01970878|5663993|P1|Overall Study|No Completion Status|0
1622629|NCT01970878|5663990|P4|Overall Study|Physician Decision|0
1622630|NCT01970878|5663991|P3|Overall Study|Physician Decision|1
1622631|NCT01970878|5663992|P2|Overall Study|Physician Decision|1
1622632|NCT01970878|5663993|P1|Overall Study|Physician Decision|0
1622633|NCT01970878|5663990|P4|Overall Study|Protocol Specified Criteria|6
1622634|NCT01970878|5663991|P3|Overall Study|Protocol Specified Criteria|3
1622635|NCT01970878|5663992|P2|Overall Study|Protocol Specified Criteria|4
1622636|NCT01970878|5663993|P1|Overall Study|Protocol Specified Criteria|10
1622637|NCT01970878|5663990|P4|Overall Study|Adverse Event|3
1622638|NCT01970878|5663991|P3|Overall Study|Adverse Event|4
1622639|NCT01970878|5663992|P2|Overall Study|Adverse Event|7
1622640|NCT01970878|5663993|P1|Overall Study|Adverse Event|12
1622641|NCT01970878|5663990|P4|Overall Study|Lack of Efficacy|0
1622642|NCT01970878|5663991|P3|Overall Study|Lack of Efficacy|2
1622643|NCT01970878|5663992|P2|Overall Study|Lack of Efficacy|1
1622644|NCT01970878|5663993|P1|Overall Study|Lack of Efficacy|2
1622645|NCT01970878|5663990|P4|Overall Study|Administrative Reasons|4
1622646|NCT01970878|5663991|P3|Overall Study|Administrative Reasons|0
1622647|NCT01970878|5663992|P2|Overall Study|Administrative Reasons|0
1622648|NCT01970878|5663993|P1|Overall Study|Administrative Reasons|1
1622649|NCT01970878|5663990|P4|Overall Study|Lost to Follow-up|4
1622650|NCT01970878|5663991|P3|Overall Study|Lost to Follow-up|2
1622651|NCT01970878|5663992|P2|Overall Study|Lost to Follow-up|3
1622652|NCT01970878|5663993|P1|Overall Study|Lost to Follow-up|1
1622653|NCT01970878|5663990|P4|Overall Study|Withdrawal by Subject|7
1622654|NCT01970878|5663991|P3|Overall Study|Withdrawal by Subject|14
1622655|NCT01970878|5663992|P2|Overall Study|Withdrawal by Subject|10
1622656|NCT01970878|5663993|P1|Overall Study|Withdrawal by Subject|11
1622657|NCT01970865|5664036|P17|Overall Study|Study ongoing|2
1622658|NCT01970865|5664037|P16|Overall Study|Study ongoing|29
1622659|NCT01970865|5664038|P15|Overall Study|Study ongoing|29
1622660|NCT01970865|5664039|P14|Overall Study|Study ongoing|41
1622661|NCT01970865|5664040|P13|Overall Study|Study ongoing|43
1622662|NCT01970865|5664041|P12|Overall Study|Study ongoing|22
1622663|NCT01970865|5664042|P11|Overall Study|Study ongoing|29
1622664|NCT01970865|5664043|P10|Overall Study|Study ongoing|3
1622665|NCT01970865|5664044|P9|Overall Study|Study ongoing|1
1622666|NCT01970865|5664045|P8|Overall Study|Study ongoing|0
1622667|NCT01970865|5664046|P7|Overall Study|Study ongoing|2
1622668|NCT01970865|5664047|P6|Overall Study|Study ongoing|0
1622669|NCT01970865|5664048|P5|Overall Study|Study ongoing|8
1622670|NCT01970865|5664049|P4|Overall Study|Study ongoing|6
1622671|NCT01970865|5664050|P3|Overall Study|Study ongoing|0
1622672|NCT01970865|5664051|P2|Overall Study|Study ongoing|2
1622673|NCT01970865|5664052|P1|Overall Study|Study ongoing|0
1622674|NCT01970865|5664036|P17|Overall Study|Other|0
1622675|NCT01970865|5664037|P16|Overall Study|Other|1
1622676|NCT01970865|5664038|P15|Overall Study|Other|0
1622677|NCT01970865|5664039|P14|Overall Study|Other|1
1622678|NCT01970865|5664040|P13|Overall Study|Other|0
1622679|NCT01970865|5664041|P12|Overall Study|Other|0
1622680|NCT01970865|5664042|P11|Overall Study|Other|0
1622681|NCT01970865|5664043|P10|Overall Study|Other|0
1622682|NCT01970865|5664044|P9|Overall Study|Other|0
1622683|NCT01970865|5664045|P8|Overall Study|Other|0
1622684|NCT01970865|5664046|P7|Overall Study|Other|0
1622685|NCT01970865|5664047|P6|Overall Study|Other|0
1622686|NCT01970865|5664048|P5|Overall Study|Other|0
1622687|NCT01970865|5664049|P4|Overall Study|Other|1
1622688|NCT01970865|5664050|P3|Overall Study|Other|0
1622689|NCT01970865|5664051|P2|Overall Study|Other|0
1622690|NCT01970865|5664052|P1|Overall Study|Other|0
1622691|NCT01970865|5664036|P17|Overall Study|Withdrawal by Subject|0
1622692|NCT01970865|5664037|P16|Overall Study|Withdrawal by Subject|7
1622693|NCT01970865|5664038|P15|Overall Study|Withdrawal by Subject|2
1622694|NCT01970865|5664039|P14|Overall Study|Withdrawal by Subject|5
1622695|NCT01970865|5664040|P13|Overall Study|Withdrawal by Subject|2
1622696|NCT01970865|5664041|P12|Overall Study|Withdrawal by Subject|1
1622697|NCT01970865|5664042|P11|Overall Study|Withdrawal by Subject|0
1622698|NCT01970865|5664043|P10|Overall Study|Withdrawal by Subject|0
1622699|NCT01970865|5664044|P9|Overall Study|Withdrawal by Subject|0
1622700|NCT01970865|5664045|P8|Overall Study|Withdrawal by Subject|0
1622701|NCT01970865|5664046|P7|Overall Study|Withdrawal by Subject|0
1622702|NCT01970865|5664047|P6|Overall Study|Withdrawal by Subject|0
1622703|NCT01970865|5664048|P5|Overall Study|Withdrawal by Subject|2
1622704|NCT01970865|5664049|P4|Overall Study|Withdrawal by Subject|1
1622705|NCT01970865|5664050|P3|Overall Study|Withdrawal by Subject|0
1622706|NCT01970865|5664051|P2|Overall Study|Withdrawal by Subject|0
1622707|NCT01970865|5664052|P1|Overall Study|Withdrawal by Subject|0
1622708|NCT01970865|5664036|P17|Overall Study|Lost to Follow-up|0
1622709|NCT01970865|5664037|P16|Overall Study|Lost to Follow-up|0
1622710|NCT01970865|5664038|P15|Overall Study|Lost to Follow-up|0
1622711|NCT01970865|5664039|P14|Overall Study|Lost to Follow-up|0
1622712|NCT01970865|5664040|P13|Overall Study|Lost to Follow-up|1
1622713|NCT01970865|5664041|P12|Overall Study|Lost to Follow-up|0
1622714|NCT01970865|5664042|P11|Overall Study|Lost to Follow-up|0
1622715|NCT01970865|5664043|P10|Overall Study|Lost to Follow-up|0
1622716|NCT01970865|5664044|P9|Overall Study|Lost to Follow-up|0
1622717|NCT01970865|5664045|P8|Overall Study|Lost to Follow-up|0
1622718|NCT01970865|5664046|P7|Overall Study|Lost to Follow-up|0
1622719|NCT01970865|5664047|P6|Overall Study|Lost to Follow-up|0
1622720|NCT01970865|5664048|P5|Overall Study|Lost to Follow-up|1
1622721|NCT01970865|5664049|P4|Overall Study|Lost to Follow-up|1
1622722|NCT01970865|5664050|P3|Overall Study|Lost to Follow-up|0
1622723|NCT01970865|5664051|P2|Overall Study|Lost to Follow-up|0
1622724|NCT01970865|5664052|P1|Overall Study|Lost to Follow-up|0
1622725|NCT01970865|5664036|P17|Overall Study|Death|1
1622726|NCT01970865|5664037|P16|Overall Study|Death|10
1622727|NCT01970865|5664038|P15|Overall Study|Death|15
1622728|NCT01970865|5664039|P14|Overall Study|Death|19
1622729|NCT01970865|5664040|P13|Overall Study|Death|14
1622730|NCT01970865|5664041|P12|Overall Study|Death|4
1622731|NCT01970865|5664042|P11|Overall Study|Death|1
1622732|NCT01970865|5664043|P10|Overall Study|Death|1
1622733|NCT01970865|5664044|P9|Overall Study|Death|2
1622734|NCT01970865|5664045|P8|Overall Study|Death|3
1622735|NCT01970865|5664046|P7|Overall Study|Death|1
1622736|NCT01970865|5664047|P6|Overall Study|Death|3
1622737|NCT01970865|5664048|P5|Overall Study|Death|6
1622738|NCT01970865|5664049|P4|Overall Study|Death|4
1622739|NCT01970865|5664050|P3|Overall Study|Death|3
1622740|NCT01970865|5664051|P2|Overall Study|Death|1
1622741|NCT01970865|5664052|P1|Overall Study|Death|3
1622742|NCT01970527|5664486|P2|Follow-up Clinic Visit|Lost to Follow-up|1
1622743|NCT01970527|5664487|P1|Follow-up Clinic Visit|Lost to Follow-up|0
1622744|NCT01970527|5664486|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
1622745|NCT01970527|5664487|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
1622746|NCT01970527|5664486|P2|Follow-up Clinic Visit|Disease progression|1
1622747|NCT01970527|5664487|P1|Follow-up Clinic Visit|Disease progression|1
1622748|NCT01970527|5664486|P2|Treatment|Death|1
1622749|NCT01970527|5664487|P1|Treatment|Death|0
1622750|NCT01970527|5664486|P2|Treatment|Participant did not tolerate Ipilimumab|1
1622751|NCT01970527|5664487|P1|Treatment|Participant did not tolerate Ipilimumab|0
1622752|NCT01970527|5664486|P2|Treatment|Disease progression|1
1622753|NCT01970527|5664487|P1|Treatment|Disease progression|0
1622754|NCT01970527|5664486|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
1622755|NCT01970527|5664487|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
1622756|NCT01970488|5664500|P5|Part 2: Post Week 16|Lost to Follow-up|2
1622757|NCT01970488|5664501|P4|Part 2: Post Week 16|Lost to Follow-up|1
1622758|NCT01970488|5664502|P3|Part 2: Post Week 16|Lost to Follow-up|1
1622759|NCT01970488|5664503|P2|Part 2: Post Week 16|Lost to Follow-up|0
1622760|NCT01970488|5664504|P1|Part 2: Post Week 16|Lost to Follow-up|0
1622761|NCT01970488|5664500|P5|Part 2: Post Week 16|Withdrawal by Subject|3
1622762|NCT01970488|5664501|P4|Part 2: Post Week 16|Withdrawal by Subject|3
1622763|NCT01970488|5664502|P3|Part 2: Post Week 16|Withdrawal by Subject|8
1622764|NCT01970488|5664503|P2|Part 2: Post Week 16|Withdrawal by Subject|0
1622765|NCT01970488|5664504|P1|Part 2: Post Week 16|Withdrawal by Subject|0
1622766|NCT01970488|5664500|P5|Part 2: Post Week 16|Adverse Event|1
1622767|NCT01970488|5664501|P4|Part 2: Post Week 16|Adverse Event|1
1622768|NCT01970488|5664502|P3|Part 2: Post Week 16|Adverse Event|5
1622769|NCT01970488|5664503|P2|Part 2: Post Week 16|Adverse Event|0
1622770|NCT01970488|5664504|P1|Part 2: Post Week 16|Adverse Event|0
1622771|NCT01970488|5664500|P5|Part 2: Post Week 16|Lack of Efficacy|1
1622772|NCT01970488|5664501|P4|Part 2: Post Week 16|Lack of Efficacy|3
1622773|NCT01970488|5664502|P3|Part 2: Post Week 16|Lack of Efficacy|2
1622774|NCT01970488|5664503|P2|Part 2: Post Week 16|Lack of Efficacy|0
1622775|NCT01970488|5664504|P1|Part 2: Post Week 16|Lack of Efficacy|0
1622776|NCT01970488|5664500|P5|Part 2: Post Week 16|Non-compliance|0
1622777|NCT01970488|5664501|P4|Part 2: Post Week 16|Non-compliance|0
1622778|NCT01970488|5664502|P3|Part 2: Post Week 16|Non-compliance|1
1622779|NCT01970488|5664503|P2|Part 2: Post Week 16|Non-compliance|0
1622780|NCT01970488|5664504|P1|Part 2: Post Week 16|Non-compliance|0
1622781|NCT01970488|5664500|P5|Part 2: Post Week 16|Physician Decision|1
1622782|NCT01970488|5664501|P4|Part 2: Post Week 16|Physician Decision|0
1622783|NCT01970488|5664502|P3|Part 2: Post Week 16|Physician Decision|0
1622784|NCT01970488|5664503|P2|Part 2: Post Week 16|Physician Decision|0
1622785|NCT01970488|5664504|P1|Part 2: Post Week 16|Physician Decision|0
1622786|NCT01970488|5664500|P5|Part 1: Through Week 16|Lost to Follow-up|0
1622787|NCT01970488|5664501|P4|Part 1: Through Week 16|Lost to Follow-up|0
1622788|NCT01970488|5664502|P3|Part 1: Through Week 16|Lost to Follow-up|0
1622789|NCT01970488|5664503|P2|Part 1: Through Week 16|Lost to Follow-up|2
1622790|NCT01970488|5664504|P1|Part 1: Through Week 16|Lost to Follow-up|0
1622791|NCT01970488|5664500|P5|Part 1: Through Week 16|Withdrawal by Subject|0
1622792|NCT01970488|5664501|P4|Part 1: Through Week 16|Withdrawal by Subject|0
1622793|NCT01970488|5664502|P3|Part 1: Through Week 16|Withdrawal by Subject|0
1622794|NCT01970488|5664503|P2|Part 1: Through Week 16|Withdrawal by Subject|2
1622795|NCT01970488|5664504|P1|Part 1: Through Week 16|Withdrawal by Subject|3
1622796|NCT01970488|5664500|P5|Part 1: Through Week 16|Adverse Event|0
1622797|NCT01970488|5664501|P4|Part 1: Through Week 16|Adverse Event|0
1622798|NCT01970488|5664502|P3|Part 1: Through Week 16|Adverse Event|0
1622799|NCT01970488|5664503|P2|Part 1: Through Week 16|Adverse Event|5
1622800|NCT01970488|5664504|P1|Part 1: Through Week 16|Adverse Event|6
1622801|NCT01970488|5664500|P5|Part 1: Through Week 16|Protocol Violation|0
1622802|NCT01970488|5664501|P4|Part 1: Through Week 16|Protocol Violation|0
1622803|NCT01970488|5664502|P3|Part 1: Through Week 16|Protocol Violation|0
1622804|NCT01970488|5664503|P2|Part 1: Through Week 16|Protocol Violation|2
1622805|NCT01970488|5664504|P1|Part 1: Through Week 16|Protocol Violation|1
1622806|NCT01970488|5664500|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
1622807|NCT01970488|5664501|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
1622808|NCT01970488|5664502|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
1622809|NCT01970488|5664503|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
1622810|NCT01970488|5664504|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
1622811|NCT01970475|5664571|P2|Overall Study|Protocol Violation|0
1622812|NCT01970475|5664572|P1|Overall Study|Protocol Violation|1
1622813|NCT01970475|5664571|P2|Overall Study|Lost to Follow-up|2
1622814|NCT01970475|5664572|P1|Overall Study|Lost to Follow-up|2
1622815|NCT01970475|5664571|P2|Overall Study|Adverse Event|3
1622816|NCT01970475|5664572|P1|Overall Study|Adverse Event|7
1622817|NCT01970475|5664571|P2|Overall Study|Withdrawal by Subject|6
1622818|NCT01970475|5664572|P1|Overall Study|Withdrawal by Subject|11
1622819|NCT01970462|5664592|P2|Overall Study|Lost to Follow-up|2
1622820|NCT01970462|5664593|P1|Overall Study|Lost to Follow-up|0
1622821|NCT01970397|5664607|P2|Overall Study|Protocol Violation|1
1622822|NCT01970397|5664608|P1|Overall Study|Protocol Violation|1
1622823|NCT01970397|5664607|P2|Overall Study|Personal Reasons|2
1622824|NCT01970397|5664608|P1|Overall Study|Personal Reasons|1
1622825|NCT01970397|5664607|P2|Overall Study|Lost to Follow-up|1
1622826|NCT01970397|5664608|P1|Overall Study|Lost to Follow-up|0
1622827|NCT01970397|5664607|P2|Overall Study|Adverse Event|1
1622828|NCT01970397|5664608|P1|Overall Study|Adverse Event|0
1622829|NCT01970371|5664621|P3|Overall Study|Lost to Follow-up|1
1622830|NCT01970371|5664622|P2|Overall Study|Lost to Follow-up|0
1622831|NCT01970371|5664623|P1|Overall Study|Lost to Follow-up|0
1622832|NCT01970371|5664621|P3|Overall Study|Death|12
1622833|NCT01970371|5664622|P2|Overall Study|Death|13
1622834|NCT01970371|5664623|P1|Overall Study|Death|8
1622835|NCT01970241|5664648|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
1622836|NCT01970241|5664649|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
1622837|NCT01970241|5664648|P2|Overall Study|Withdrawal by Subject|0
1622838|NCT01970241|5664649|P1|Overall Study|Withdrawal by Subject|2
1622839|NCT01969851|5664696|P3|Overall Study|Sponsor decision|1
1622840|NCT01969851|5664697|P2|Overall Study|Sponsor decision|0
1622841|NCT01969851|5664698|P1|Overall Study|Sponsor decision|0
1622842|NCT01969851|5664696|P3|Overall Study|No effective dose in Titration period|1
1622843|NCT01969851|5664697|P2|Overall Study|No effective dose in Titration period|0
1622844|NCT01969851|5664698|P1|Overall Study|No effective dose in Titration period|0
1622845|NCT01969851|5664696|P3|Overall Study|Withdrawal by Subject|1
1622846|NCT01969851|5664697|P2|Overall Study|Withdrawal by Subject|0
1622847|NCT01969851|5664698|P1|Overall Study|Withdrawal by Subject|1
1622848|NCT01969851|5664696|P3|Overall Study|Lack of Efficacy|1
1622849|NCT01969851|5664697|P2|Overall Study|Lack of Efficacy|3
1622850|NCT01969851|5664698|P1|Overall Study|Lack of Efficacy|0
1622851|NCT01969851|5664696|P3|Overall Study|Adverse Event|3
1622852|NCT01969851|5664697|P2|Overall Study|Adverse Event|0
1622853|NCT01969851|5664698|P1|Overall Study|Adverse Event|0
1622854|NCT01969799|5664720|P2|Overall Study|Physician Decision|0
1622855|NCT01969799|5664721|P1|Overall Study|Physician Decision|1
1622856|NCT01969799|5664720|P2|Overall Study|Lost to Follow-up|2
1622857|NCT01969799|5664721|P1|Overall Study|Lost to Follow-up|0
1622858|NCT01969799|5664720|P2|Overall Study|Death|11
1622859|NCT01969799|5664721|P1|Overall Study|Death|16
1622860|NCT01969799|5664720|P2|Overall Study|Adverse Event|1
1622861|NCT01969799|5664721|P1|Overall Study|Adverse Event|0
1622862|NCT01969721|5664758|P4|Overall Study|Discontinued during washout periods.|2
1622863|NCT01969721|5664759|P3|Overall Study|Discontinued during washout periods.|1
1622864|NCT01969721|5664760|P2|Overall Study|Discontinued during washout periods.|1
1622865|NCT01969721|5664761|P1|Overall Study|Discontinued during washout periods.|0
1622866|NCT01969721|5664758|P4|Overall Study|Other not defined above|0
1622867|NCT01969721|5664759|P3|Overall Study|Other not defined above|0
1622868|NCT01969721|5664760|P2|Overall Study|Other not defined above|2
1622869|NCT01969721|5664761|P1|Overall Study|Other not defined above|0
1622870|NCT01969721|5664758|P4|Overall Study|Non compliant with protocol|2
1622871|NCT01969721|5664759|P3|Overall Study|Non compliant with protocol|0
1622872|NCT01969721|5664760|P2|Overall Study|Non compliant with protocol|1
1622873|NCT01969721|5664761|P1|Overall Study|Non compliant with protocol|1
1622874|NCT01969721|5664758|P4|Overall Study|Lack of Efficacy|0
1622875|NCT01969721|5664759|P3|Overall Study|Lack of Efficacy|1
1622876|NCT01969721|5664760|P2|Overall Study|Lack of Efficacy|0
1622877|NCT01969721|5664761|P1|Overall Study|Lack of Efficacy|0
1622878|NCT01969721|5664758|P4|Overall Study|Adverse Event|2
1622879|NCT01969721|5664759|P3|Overall Study|Adverse Event|3
1622880|NCT01969721|5664760|P2|Overall Study|Adverse Event|8
1622881|NCT01969721|5664761|P1|Overall Study|Adverse Event|3
1622882|NCT01969565|5664806|P1|Overall Study|Withdrawal by Subject|1
1622883|NCT01969500|5664820|P2|Overall Study|extended hospitalization|1
1622884|NCT01969500|5664821|P1|Overall Study|extended hospitalization|1
1622885|NCT01969500|5664820|P2|Overall Study|Death|1
1622886|NCT01969500|5664821|P1|Overall Study|Death|0
1622887|NCT01969084|5664925|P2|Overall Study|Adverse Event|1
1622888|NCT01969084|5664926|P1|Overall Study|Adverse Event|0
1622889|NCT01969058|5664942|P2|Overall Study|Adverse Event|0
1622890|NCT01969058|5664943|P1|Overall Study|Adverse Event|1
1622891|NCT01969058|5664942|P2|Overall Study|Withdrawal by Subject|0
1622892|NCT01969058|5664943|P1|Overall Study|Withdrawal by Subject|2
1622893|NCT01968980|5664987|P2|Overall Study|Other unspecified|2
1622894|NCT01968980|5664988|P1|Overall Study|Other unspecified|1
1622895|NCT01968980|5664987|P2|Overall Study|Withdrawal by Subject|5
1622896|NCT01968980|5664988|P1|Overall Study|Withdrawal by Subject|13
1622897|NCT01968980|5664987|P2|Overall Study|Does not meet entry criteria|3
1622898|NCT01968980|5664988|P1|Overall Study|Does not meet entry criteria|1
1622899|NCT01968980|5664987|P2|Overall Study|Adverse Event|3
1622900|NCT01968980|5664988|P1|Overall Study|Adverse Event|1
1622901|NCT01968980|5664987|P2|Overall Study|Death|1
1622902|NCT01968980|5664988|P1|Overall Study|Death|0
1622903|NCT01968967|5665050|P5|Extension Period|Withdrew Consent|5
1622904|NCT01968967|5665051|P4|Extension Period|Withdrew Consent|0
1622905|NCT01968967|5665052|P3|Extension Period|Withdrew Consent|2
1622906|NCT01968967|5665053|P2|Extension Period|Withdrew Consent|0
1622907|NCT01968967|5665054|P1|Extension Period|Withdrew Consent|0
1622908|NCT01968967|5665050|P5|Treatment Period|Randomized Not Treated|0
1622909|NCT01968967|5665051|P4|Treatment Period|Randomized Not Treated|0
1622910|NCT01968967|5665052|P3|Treatment Period|Randomized Not Treated|0
1622911|NCT01968967|5665053|P2|Treatment Period|Randomized Not Treated|5
1622912|NCT01968967|5665054|P1|Treatment Period|Randomized Not Treated|6
1622913|NCT01968967|5665050|P5|Treatment Period|Death|0
1622914|NCT01968967|5665051|P4|Treatment Period|Death|0
1622915|NCT01968967|5665052|P3|Treatment Period|Death|0
1622916|NCT01968967|5665053|P2|Treatment Period|Death|2
1622917|NCT01968967|5665054|P1|Treatment Period|Death|9
1622918|NCT01968967|5665050|P5|Treatment Period|Adverse Event|0
1622919|NCT01968967|5665051|P4|Treatment Period|Adverse Event|0
1622920|NCT01968967|5665052|P3|Treatment Period|Adverse Event|0
1622921|NCT01968967|5665053|P2|Treatment Period|Adverse Event|8
1622922|NCT01968967|5665054|P1|Treatment Period|Adverse Event|9
1622923|NCT01968967|5665050|P5|Treatment Period|Protocol Violation|0
1622924|NCT01968967|5665051|P4|Treatment Period|Protocol Violation|0
1622925|NCT01968967|5665052|P3|Treatment Period|Protocol Violation|0
1622926|NCT01968967|5665053|P2|Treatment Period|Protocol Violation|2
1622927|NCT01968967|5665054|P1|Treatment Period|Protocol Violation|1
1622928|NCT01968967|5665050|P5|Treatment Period|Lost to Follow-up|0
1622929|NCT01968967|5665051|P4|Treatment Period|Lost to Follow-up|0
1622930|NCT01968967|5665052|P3|Treatment Period|Lost to Follow-up|0
1622931|NCT01968967|5665053|P2|Treatment Period|Lost to Follow-up|31
1622932|NCT01968967|5665054|P1|Treatment Period|Lost to Follow-up|26
1622933|NCT01968967|5665050|P5|Treatment Period|Did Not Meet Entrance Criteria|0
1622934|NCT01968967|5665051|P4|Treatment Period|Did Not Meet Entrance Criteria|0
1622935|NCT01968967|5665052|P3|Treatment Period|Did Not Meet Entrance Criteria|0
1622936|NCT01968967|5665053|P2|Treatment Period|Did Not Meet Entrance Criteria|3
1622937|NCT01968967|5665054|P1|Treatment Period|Did Not Meet Entrance Criteria|2
1622938|NCT01968967|5665050|P5|Treatment Period|Withdrawal by Subject|0
1622939|NCT01968967|5665051|P4|Treatment Period|Withdrawal by Subject|0
1622940|NCT01968967|5665052|P3|Treatment Period|Withdrawal by Subject|0
1622941|NCT01968967|5665053|P2|Treatment Period|Withdrawal by Subject|61
1622942|NCT01968967|5665054|P1|Treatment Period|Withdrawal by Subject|71
1622943|NCT01968967|5665050|P5|Treatment Period|Other|0
1622944|NCT01968967|5665051|P4|Treatment Period|Other|0
1622945|NCT01968967|5665052|P3|Treatment Period|Other|0
1622946|NCT01968967|5665053|P2|Treatment Period|Other|22
1622947|NCT01968967|5665054|P1|Treatment Period|Other|22
1622948|NCT01968954|5665123|P2|Overall Study|Did not met inclusion criteria|2
1622949|NCT01968954|5665124|P1|Overall Study|Did not met inclusion criteria|0
1622950|NCT01968954|5665123|P2|Overall Study|Protocol Violation|1
1622951|NCT01968954|5665124|P1|Overall Study|Protocol Violation|0
1622952|NCT01968954|5665123|P2|Overall Study|Other|8
1622953|NCT01968954|5665124|P1|Overall Study|Other|7
1622954|NCT01968954|5665123|P2|Overall Study|Withdrawal by Subject|23
1622955|NCT01968954|5665124|P1|Overall Study|Withdrawal by Subject|20
1622956|NCT01968954|5665123|P2|Overall Study|Lost to Follow-up|4
1622957|NCT01968954|5665124|P1|Overall Study|Lost to Follow-up|6
1622958|NCT01968954|5665123|P2|Overall Study|Death|2
1622959|NCT01968954|5665124|P1|Overall Study|Death|1
1622960|NCT01968954|5665123|P2|Overall Study|Adverse Event|3
1622961|NCT01968954|5665124|P1|Overall Study|Adverse Event|6
1622962|NCT01968811|5665188|P1|Overall Study|post op.ref. of subject to other hospita|1
1622963|NCT01968811|5665188|P1|Overall Study|Protocol Violation|4
1622964|NCT01968694|5665195|P2|Washout (1 Month)|Lost to Follow-up|1
1622965|NCT01968694|5665196|P1|Washout (1 Month)|Lost to Follow-up|0
1622966|NCT01968551|5665213|P3|Extension Phase|Lost to Follow-up|1
1622967|NCT01968551|5665214|P2|Extension Phase|Lost to Follow-up|0
1622968|NCT01968551|5665215|P1|Extension Phase|Lost to Follow-up|1
1622969|NCT01968551|5665213|P3|Extension Phase|Withdrew Consent|1
1622970|NCT01968551|5665214|P2|Extension Phase|Withdrew Consent|0
1622971|NCT01968551|5665215|P1|Extension Phase|Withdrew Consent|0
1622972|NCT01968551|5665213|P3|Extension Phase|Death|0
1622973|NCT01968551|5665214|P2|Extension Phase|Death|1
1622974|NCT01968551|5665215|P1|Extension Phase|Death|0
1622975|NCT01968551|5665213|P3|Extension Phase|Adverse Event|2
1622976|NCT01968551|5665214|P2|Extension Phase|Adverse Event|0
1622977|NCT01968551|5665215|P1|Extension Phase|Adverse Event|0
1622978|NCT01968551|5665213|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
1622979|NCT01968551|5665214|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1622980|NCT01968551|5665215|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
1622981|NCT01968551|5665213|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
1622982|NCT01968551|5665214|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
1622983|NCT01968551|5665215|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
1622984|NCT01968551|5665213|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
1622985|NCT01968551|5665214|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
1622986|NCT01968551|5665215|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
1622987|NCT01968551|5665213|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
1622988|NCT01968551|5665214|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1622989|NCT01968551|5665215|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
1622990|NCT01968434|5665231|P2|Overall Study|Lost to Follow-up|6
1622991|NCT01968434|5665232|P1|Overall Study|Lost to Follow-up|3
1622992|NCT01968226|5665291|P1|Overall Study|[F-18] RDG-K5 was not available|2
1622995|NCT01968070|5665340|P18|Period 2|Withdrawal by Subject|0
1622996|NCT01968070|5665341|P17|Period 2|Withdrawal by Subject|0
1622997|NCT01968070|5665342|P16|Period 2|Withdrawal by Subject|0
1622998|NCT01968070|5665343|P15|Period 2|Withdrawal by Subject|0
1622999|NCT01968070|5665344|P14|Period 2|Withdrawal by Subject|0
1623000|NCT01968070|5665345|P13|Period 2|Withdrawal by Subject|0
1623001|NCT01968070|5665346|P12|Period 2|Withdrawal by Subject|0
1623002|NCT01968070|5665347|P11|Period 2|Withdrawal by Subject|0
1623003|NCT01968070|5665348|P10|Period 2|Withdrawal by Subject|0
1623004|NCT01968070|5665349|P9|Period 2|Withdrawal by Subject|0
1623005|NCT01968070|5665350|P8|Period 2|Withdrawal by Subject|0
1623006|NCT01968070|5665351|P7|Period 2|Withdrawal by Subject|0
1623007|NCT01968070|5665352|P6|Period 2|Withdrawal by Subject|0
1623008|NCT01968070|5665353|P5|Period 2|Withdrawal by Subject|1
1623009|NCT01968070|5665354|P4|Period 2|Withdrawal by Subject|0
1623010|NCT01968070|5665355|P3|Period 2|Withdrawal by Subject|0
1623011|NCT01968070|5665356|P2|Period 2|Withdrawal by Subject|0
1623012|NCT01968070|5665357|P1|Period 2|Withdrawal by Subject|0
1623013|NCT01968070|5665340|P18|Period 1|Physician Decision|0
1623014|NCT01968070|5665341|P17|Period 1|Physician Decision|0
1623015|NCT01968070|5665342|P16|Period 1|Physician Decision|0
1623016|NCT01968070|5665343|P15|Period 1|Physician Decision|0
1623017|NCT01968070|5665344|P14|Period 1|Physician Decision|0
1623018|NCT01968070|5665345|P13|Period 1|Physician Decision|0
1623019|NCT01968070|5665346|P12|Period 1|Physician Decision|1
1623020|NCT01968070|5665347|P11|Period 1|Physician Decision|0
1623021|NCT01968070|5665348|P10|Period 1|Physician Decision|0
1623022|NCT01968070|5665349|P9|Period 1|Physician Decision|0
1623023|NCT01968070|5665350|P8|Period 1|Physician Decision|0
1623024|NCT01968070|5665351|P7|Period 1|Physician Decision|0
1623025|NCT01968070|5665352|P6|Period 1|Physician Decision|0
1623026|NCT01968070|5665353|P5|Period 1|Physician Decision|0
1623027|NCT01968070|5665354|P4|Period 1|Physician Decision|0
1623028|NCT01968070|5665355|P3|Period 1|Physician Decision|0
1623029|NCT01968070|5665356|P2|Period 1|Physician Decision|0
1623030|NCT01968070|5665357|P1|Period 1|Physician Decision|0
1623031|NCT01968070|5665340|P18|Period 1|Adverse Event|0
1623032|NCT01968070|5665341|P17|Period 1|Adverse Event|0
1623033|NCT01968070|5665342|P16|Period 1|Adverse Event|0
1623034|NCT01968070|5665343|P15|Period 1|Adverse Event|0
1623035|NCT01968070|5665344|P14|Period 1|Adverse Event|0
1623036|NCT01968070|5665345|P13|Period 1|Adverse Event|0
1623037|NCT01968070|5665346|P12|Period 1|Adverse Event|0
1623038|NCT01968070|5665347|P11|Period 1|Adverse Event|0
1623039|NCT01968070|5665348|P10|Period 1|Adverse Event|0
1623040|NCT01968070|5665349|P9|Period 1|Adverse Event|0
1623041|NCT01968070|5665350|P8|Period 1|Adverse Event|0
1623042|NCT01968070|5665351|P7|Period 1|Adverse Event|1
1623043|NCT01968070|5665352|P6|Period 1|Adverse Event|0
1623044|NCT01968070|5665353|P5|Period 1|Adverse Event|0
1623045|NCT01968070|5665354|P4|Period 1|Adverse Event|0
1623046|NCT01968070|5665355|P3|Period 1|Adverse Event|0
1623047|NCT01968070|5665356|P2|Period 1|Adverse Event|0
1623048|NCT01968070|5665357|P1|Period 1|Adverse Event|0
1623049|NCT01968070|5665340|P18|Period 1|Lost to Follow-up|0
1623050|NCT01968070|5665341|P17|Period 1|Lost to Follow-up|0
1623051|NCT01968070|5665342|P16|Period 1|Lost to Follow-up|0
1623052|NCT01968070|5665343|P15|Period 1|Lost to Follow-up|0
1623053|NCT01968070|5665344|P14|Period 1|Lost to Follow-up|0
1623054|NCT01968070|5665345|P13|Period 1|Lost to Follow-up|0
1623055|NCT01968070|5665346|P12|Period 1|Lost to Follow-up|0
1623056|NCT01968070|5665347|P11|Period 1|Lost to Follow-up|0
1623057|NCT01968070|5665348|P10|Period 1|Lost to Follow-up|0
1623058|NCT01968070|5665349|P9|Period 1|Lost to Follow-up|0
1623059|NCT01968070|5665350|P8|Period 1|Lost to Follow-up|0
1623060|NCT01968070|5665351|P7|Period 1|Lost to Follow-up|0
1623061|NCT01968070|5665352|P6|Period 1|Lost to Follow-up|0
1623062|NCT01968070|5665353|P5|Period 1|Lost to Follow-up|0
1623063|NCT01968070|5665354|P4|Period 1|Lost to Follow-up|1
1623064|NCT01968070|5665355|P3|Period 1|Lost to Follow-up|0
1623065|NCT01968070|5665356|P2|Period 1|Lost to Follow-up|0
1623066|NCT01968070|5665357|P1|Period 1|Lost to Follow-up|0
1623067|NCT01968070|5665340|P18|Period 1|Protocol Violation|0
1623068|NCT01968070|5665341|P17|Period 1|Protocol Violation|0
1623069|NCT01968070|5665342|P16|Period 1|Protocol Violation|0
1623070|NCT01968070|5665343|P15|Period 1|Protocol Violation|0
1623071|NCT01968070|5665344|P14|Period 1|Protocol Violation|0
1623072|NCT01968070|5665345|P13|Period 1|Protocol Violation|0
1623073|NCT01968070|5665346|P12|Period 1|Protocol Violation|0
1623074|NCT01968070|5665347|P11|Period 1|Protocol Violation|0
1623075|NCT01968070|5665348|P10|Period 1|Protocol Violation|0
1623076|NCT01968070|5665349|P9|Period 1|Protocol Violation|0
1623077|NCT01968070|5665350|P8|Period 1|Protocol Violation|0
1623078|NCT01968070|5665351|P7|Period 1|Protocol Violation|0
1623079|NCT01968070|5665352|P6|Period 1|Protocol Violation|0
1623080|NCT01968070|5665353|P5|Period 1|Protocol Violation|1
1623081|NCT01968070|5665354|P4|Period 1|Protocol Violation|1
1623082|NCT01968070|5665355|P3|Period 1|Protocol Violation|0
1623083|NCT01968070|5665356|P2|Period 1|Protocol Violation|0
1623084|NCT01968070|5665357|P1|Period 1|Protocol Violation|0
1623085|NCT01968070|5665340|P18|Period 1|Withdrawal by Subject|0
1623086|NCT01968070|5665341|P17|Period 1|Withdrawal by Subject|0
1623087|NCT01968070|5665342|P16|Period 1|Withdrawal by Subject|1
1623088|NCT01968070|5665343|P15|Period 1|Withdrawal by Subject|0
1623089|NCT01968070|5665344|P14|Period 1|Withdrawal by Subject|0
1623090|NCT01968070|5665345|P13|Period 1|Withdrawal by Subject|0
1623091|NCT01968070|5665346|P12|Period 1|Withdrawal by Subject|0
1623092|NCT01968070|5665347|P11|Period 1|Withdrawal by Subject|0
1623093|NCT01968070|5665348|P10|Period 1|Withdrawal by Subject|0
1623094|NCT01968070|5665349|P9|Period 1|Withdrawal by Subject|0
1623095|NCT01968070|5665350|P8|Period 1|Withdrawal by Subject|0
1623096|NCT01968070|5665351|P7|Period 1|Withdrawal by Subject|1
1623097|NCT01968070|5665352|P6|Period 1|Withdrawal by Subject|0
1623098|NCT01968070|5665353|P5|Period 1|Withdrawal by Subject|0
1623099|NCT01968070|5665354|P4|Period 1|Withdrawal by Subject|0
1623100|NCT01968070|5665355|P3|Period 1|Withdrawal by Subject|0
1623101|NCT01968070|5665356|P2|Period 1|Withdrawal by Subject|1
1623102|NCT01968070|5665357|P1|Period 1|Withdrawal by Subject|0
1623103|NCT01967940|5665428|P4|Part 2|Unknown Reason|1
1623104|NCT01967940|5665429|P3|Part 2|Unknown Reason|0
1623105|NCT01967940|5665430|P2|Part 2|Unknown Reason|0
1623106|NCT01967940|5665431|P1|Part 2|Unknown Reason|0
1623107|NCT01967940|5665428|P4|Part 2|Adverse Event|1
1623108|NCT01967940|5665429|P3|Part 2|Adverse Event|0
1623109|NCT01967940|5665430|P2|Part 2|Adverse Event|0
1623110|NCT01967940|5665431|P1|Part 2|Adverse Event|0
1623111|NCT01967940|5665428|P4|Part 2|Enrolled in Part 2 and Never Treated|1
1623112|NCT01967940|5665429|P3|Part 2|Enrolled in Part 2 and Never Treated|0
1623113|NCT01967940|5665430|P2|Part 2|Enrolled in Part 2 and Never Treated|0
1623114|NCT01967940|5665431|P1|Part 2|Enrolled in Part 2 and Never Treated|0
1623115|NCT01967888|5665459|P2|Overall Study|Subject Unable To Comply With Final Day|1
1623116|NCT01967888|5665460|P1|Overall Study|Subject Unable To Comply With Final Day|0
1623117|NCT01967888|5665459|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
1623118|NCT01967888|5665460|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
1623119|NCT01967888|5665459|P2|Overall Study|Subject excluded after randomization|0
1623120|NCT01967888|5665460|P1|Overall Study|Subject excluded after randomization|1
1623121|NCT01967888|5665459|P2|Overall Study|Research visit not done, data recorded|0
1623122|NCT01967888|5665460|P1|Overall Study|Research visit not done, data recorded|1
1623123|NCT01967888|5665459|P2|Overall Study|Did Not Have Transplant|0
1623124|NCT01967888|5665460|P1|Overall Study|Did Not Have Transplant|1
1623125|NCT01967888|5665459|P2|Overall Study|Withdrawal by Subject|1
1623126|NCT01967888|5665460|P1|Overall Study|Withdrawal by Subject|1
1623127|NCT01967888|5665459|P2|Overall Study|Lost to Follow-up|4
1623128|NCT01967888|5665460|P1|Overall Study|Lost to Follow-up|6
1623129|NCT01967732|5665544|P4|First Intervention (Day 1)|Poor venous access|0
1623130|NCT01967732|5665545|P3|First Intervention (Day 1)|Poor venous access|0
1623131|NCT01967732|5665546|P2|First Intervention (Day 1)|Poor venous access|1
1623132|NCT01967732|5665547|P1|First Intervention (Day 1)|Poor venous access|0
1623133|NCT01967732|5665544|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1623134|NCT01967732|5665545|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1623135|NCT01967732|5665546|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
1623136|NCT01967732|5665547|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
1623137|NCT01967719|5665561|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
1623138|NCT01967719|5665562|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
1623139|NCT01967719|5665563|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
1623140|NCT01967719|5665564|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
1623141|NCT01967719|5665561|P4|First Intervention (Day 1)|Withdrawal by Subject|1
1623142|NCT01967719|5665562|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1623143|NCT01967719|5665563|P2|First Intervention (Day 1)|Withdrawal by Subject|1
1623144|NCT01967719|5665564|P1|First Intervention (Day 1)|Withdrawal by Subject|0
1623145|NCT01967706|5665579|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1623146|NCT01967706|5665580|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1623147|NCT01967706|5665581|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1623148|NCT01967706|5665582|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1623149|NCT01967628|5665603|P2|Overall Study|Low protein concentration in sample|25
1623150|NCT01967628|5665604|P1|Overall Study|Low protein concentration in sample|20
1623151|NCT01967628|5665603|P2|Overall Study|Lost to Follow-up|0
1623152|NCT01967628|5665604|P1|Overall Study|Lost to Follow-up|1
1623153|NCT01967628|5665603|P2|Overall Study|Unable to complete bronchoscopy|6
1623154|NCT01967628|5665604|P1|Overall Study|Unable to complete bronchoscopy|4
1623155|NCT01967628|5665603|P2|Overall Study|Withdrawal by Subject|0
1623156|NCT01967628|5665604|P1|Overall Study|Withdrawal by Subject|2
1623157|NCT01967550|5665612|P2|Overall Study|Non Compliance|1
1623158|NCT01967550|5665613|P1|Overall Study|Non Compliance|0
1623159|NCT01967550|5665612|P2|Overall Study|Protocol Violation|1
1623160|NCT01967550|5665613|P1|Overall Study|Protocol Violation|2
1623161|NCT01967550|5665612|P2|Overall Study|Adverse Event|0
1623162|NCT01967550|5665613|P1|Overall Study|Adverse Event|2
1623163|NCT01967550|5665612|P2|Overall Study|Withdrawal by Subject|0
1623164|NCT01967550|5665613|P1|Overall Study|Withdrawal by Subject|1
1623165|NCT01967537|5665619|P1|Overall Study|Lost to Follow-up|6
1623166|NCT01967537|5665619|P1|Overall Study|Refuse treatment|2
1623167|NCT01967537|5665619|P1|Overall Study|Withdrawal by Subject|52
1623168|NCT01967277|5665652|P2|Overall Study|Unrelated illness|1
1623169|NCT01967277|5665653|P1|Overall Study|Unrelated illness|0
1623170|NCT01967277|5665652|P2|Overall Study|Lost to Follow-up|2
1623171|NCT01967277|5665653|P1|Overall Study|Lost to Follow-up|1
1623172|NCT01967225|5665665|P2|Overall Study|Protocol Violation|0
1623173|NCT01967225|5665666|P1|Overall Study|Protocol Violation|2
1623174|NCT01967225|5665665|P2|Overall Study|Logistical difficulties|0
1623175|NCT01967225|5665666|P1|Overall Study|Logistical difficulties|1
1623176|NCT01967225|5665665|P2|Overall Study|Protocol driven decision point|0
1623177|NCT01967225|5665666|P1|Overall Study|Protocol driven decision point|1
1623178|NCT01967225|5665665|P2|Overall Study|Switching to other therapy|0
1623179|NCT01967225|5665666|P1|Overall Study|Switching to other therapy|2
1623180|NCT01967225|5665665|P2|Overall Study|Lack of Efficacy|1
1623181|NCT01967225|5665666|P1|Overall Study|Lack of Efficacy|1
1623182|NCT01967225|5665665|P2|Overall Study|Withdrawal by Subject|1
1623183|NCT01967225|5665666|P1|Overall Study|Withdrawal by Subject|2
1623184|NCT01967225|5665665|P2|Overall Study|Adverse Event|1
1623185|NCT01967225|5665666|P1|Overall Study|Adverse Event|3
1623186|NCT01967173|5665698|P8|Overall Study|Withdrawal by Subject|12
1623187|NCT01967173|5665699|P7|Overall Study|Withdrawal by Subject|10
1623188|NCT01967173|5665700|P6|Overall Study|Withdrawal by Subject|9
1623189|NCT01967173|5665701|P5|Overall Study|Withdrawal by Subject|8
1623190|NCT01967173|5665702|P4|Overall Study|Withdrawal by Subject|7
1623191|NCT01967173|5665703|P3|Overall Study|Withdrawal by Subject|10
1623192|NCT01967173|5665704|P2|Overall Study|Withdrawal by Subject|14
1623193|NCT01967173|5665705|P1|Overall Study|Withdrawal by Subject|15
1623194|NCT01967173|5665698|P8|Overall Study|Adverse Event|1
1623195|NCT01967173|5665699|P7|Overall Study|Adverse Event|0
1623196|NCT01967173|5665700|P6|Overall Study|Adverse Event|0
1623197|NCT01967173|5665701|P5|Overall Study|Adverse Event|0
1623198|NCT01967173|5665702|P4|Overall Study|Adverse Event|0
1623199|NCT01967173|5665703|P3|Overall Study|Adverse Event|0
1623200|NCT01967173|5665704|P2|Overall Study|Adverse Event|0
1623201|NCT01967173|5665705|P1|Overall Study|Adverse Event|0
1623202|NCT01967173|5665698|P8|Overall Study|Pregnancy|1
1623203|NCT01967173|5665699|P7|Overall Study|Pregnancy|1
1623204|NCT01967173|5665700|P6|Overall Study|Pregnancy|0
1623205|NCT01967173|5665701|P5|Overall Study|Pregnancy|0
1623206|NCT01967173|5665702|P4|Overall Study|Pregnancy|0
1623207|NCT01967173|5665703|P3|Overall Study|Pregnancy|0
1623208|NCT01967173|5665704|P2|Overall Study|Pregnancy|0
1623209|NCT01967173|5665705|P1|Overall Study|Pregnancy|0
1623210|NCT01967173|5665698|P8|Overall Study|Lack of Efficacy|2
1623211|NCT01967173|5665699|P7|Overall Study|Lack of Efficacy|0
1623212|NCT01967173|5665700|P6|Overall Study|Lack of Efficacy|1
1623213|NCT01967173|5665701|P5|Overall Study|Lack of Efficacy|0
1623214|NCT01967173|5665702|P4|Overall Study|Lack of Efficacy|2
1623215|NCT01967173|5665703|P3|Overall Study|Lack of Efficacy|2
1623216|NCT01967173|5665704|P2|Overall Study|Lack of Efficacy|0
1623217|NCT01967173|5665705|P1|Overall Study|Lack of Efficacy|2
1623218|NCT01967173|5665698|P8|Overall Study|Physician Decision|0
1623219|NCT01967173|5665699|P7|Overall Study|Physician Decision|1
1623220|NCT01967173|5665700|P6|Overall Study|Physician Decision|1
1623221|NCT01967173|5665701|P5|Overall Study|Physician Decision|1
1623222|NCT01967173|5665702|P4|Overall Study|Physician Decision|1
1623223|NCT01967173|5665703|P3|Overall Study|Physician Decision|2
1623224|NCT01967173|5665704|P2|Overall Study|Physician Decision|0
1623225|NCT01967173|5665705|P1|Overall Study|Physician Decision|2
1623226|NCT01967173|5665698|P8|Overall Study|Lost to Follow-up|8
1623227|NCT01967173|5665699|P7|Overall Study|Lost to Follow-up|6
1623228|NCT01967173|5665700|P6|Overall Study|Lost to Follow-up|12
1623229|NCT01967173|5665701|P5|Overall Study|Lost to Follow-up|8
1623230|NCT01967173|5665702|P4|Overall Study|Lost to Follow-up|4
1623231|NCT01967173|5665703|P3|Overall Study|Lost to Follow-up|2
1623232|NCT01967173|5665704|P2|Overall Study|Lost to Follow-up|3
1623233|NCT01967173|5665705|P1|Overall Study|Lost to Follow-up|5
1623234|NCT01967147|5665719|P2|Overall Study|Other|5
1623235|NCT01967147|5665720|P1|Overall Study|Other|4
1623236|NCT01967147|5665719|P2|Overall Study|Non-compliance with Study Drug|3
1623237|NCT01967147|5665720|P1|Overall Study|Non-compliance with Study Drug|0
1623238|NCT01967147|5665719|P2|Overall Study|Withdrawal by Subject|4
1623239|NCT01967147|5665720|P1|Overall Study|Withdrawal by Subject|2
1623240|NCT01967147|5665719|P2|Overall Study|Lost to Follow-up|2
1623241|NCT01967147|5665720|P1|Overall Study|Lost to Follow-up|1
1623242|NCT01967147|5665719|P2|Overall Study|Lack of Efficacy|4
1623243|NCT01967147|5665720|P1|Overall Study|Lack of Efficacy|1
1623244|NCT01967147|5665719|P2|Overall Study|Adverse Event|2
1623245|NCT01967147|5665720|P1|Overall Study|Adverse Event|5
1623246|NCT01967134|5665738|P3|Overall Study|Lost to Follow-up|0
1623247|NCT01967134|5665739|P2|Overall Study|Lost to Follow-up|1
1623248|NCT01967134|5665740|P1|Overall Study|Lost to Follow-up|0
1623249|NCT01967069|5665775|P2|Overall Study|Lack of Efficacy|1
1623250|NCT01967069|5665776|P1|Overall Study|Lack of Efficacy|0
1623251|NCT01967069|5665775|P2|Overall Study|Withdrawal by Subject|3
1623252|NCT01967069|5665776|P1|Overall Study|Withdrawal by Subject|1
1623253|NCT01967069|5665775|P2|Overall Study|Lost to Follow-up|2
1623254|NCT01967069|5665776|P1|Overall Study|Lost to Follow-up|5
1623255|NCT01967069|5665775|P2|Overall Study|Adverse Event|2
1623256|NCT01967069|5665776|P1|Overall Study|Adverse Event|2
1623257|NCT01966445|5665979|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
1623258|NCT01966445|5665980|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1623259|NCT01966445|5665981|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1623260|NCT01966445|5665982|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1623261|NCT01966445|5665983|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1623262|NCT01966445|5665984|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1623263|NCT01966445|5665985|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
1623264|NCT01966445|5665979|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
1623265|NCT01966445|5665980|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1623266|NCT01966445|5665981|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1623267|NCT01966445|5665982|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1623268|NCT01966445|5665983|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1623269|NCT01966445|5665984|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1623270|NCT01966445|5665985|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
1623271|NCT01966445|5665979|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1623272|NCT01966445|5665980|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1623273|NCT01966445|5665981|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
1623274|NCT01966445|5665982|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1623275|NCT01966445|5665983|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
1623276|NCT01966445|5665984|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
1623277|NCT01966445|5665985|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
1623278|NCT01966445|5665979|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1623279|NCT01966445|5665980|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1623280|NCT01966445|5665981|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
1623281|NCT01966445|5665982|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
1623282|NCT01966445|5665983|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1623283|NCT01966445|5665984|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
1623284|NCT01966445|5665985|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
1623285|NCT01966445|5665979|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1623286|NCT01966445|5665980|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
1623287|NCT01966445|5665981|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1623288|NCT01966445|5665982|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
1623289|NCT01966445|5665983|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1623290|NCT01966445|5665984|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1623291|NCT01966445|5665985|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
1623292|NCT01966432|5666095|P3|Overall Study|SBIRT program ended|20
1623293|NCT01966432|5666096|P2|Overall Study|SBIRT program ended|8
1623294|NCT01966432|5666097|P1|Overall Study|SBIRT program ended|1
1623295|NCT01966432|5666095|P3|Overall Study|Subject Incarcerated|1
1623296|NCT01966432|5666096|P2|Overall Study|Subject Incarcerated|0
1623297|NCT01966432|5666097|P1|Overall Study|Subject Incarcerated|0
1623298|NCT01966432|5666095|P3|Overall Study|Withdrawal by Subject|0
1623299|NCT01966432|5666096|P2|Overall Study|Withdrawal by Subject|3
1623300|NCT01966432|5666097|P1|Overall Study|Withdrawal by Subject|1
1623301|NCT01966432|5666095|P3|Overall Study|Lost to Follow-up|5
1623302|NCT01966432|5666096|P2|Overall Study|Lost to Follow-up|2
1623303|NCT01966432|5666097|P1|Overall Study|Lost to Follow-up|3
1623304|NCT01966120|5666167|P2|Overall Study|Lost to Follow-up|1
1623305|NCT01966120|5666168|P1|Overall Study|Lost to Follow-up|1
1623306|NCT01966120|5666167|P2|Overall Study|Withdrawal by Subject|5
1623307|NCT01966120|5666168|P1|Overall Study|Withdrawal by Subject|0
1623308|NCT01966107|5666192|P2|Overall Study|withdrew from the study|303
1623309|NCT01966107|5666193|P1|Overall Study|withdrew from the study|272
1623310|NCT01966107|5666192|P2|Overall Study|due to study closure|186
1623311|NCT01966107|5666193|P1|Overall Study|due to study closure|164
1623312|NCT01966107|5666192|P2|Overall Study|discontinued treatment|372
1623313|NCT01966107|5666193|P1|Overall Study|discontinued treatment|345
1623314|NCT01966107|5666192|P2|Overall Study|excluded from FAS|20
1623315|NCT01966107|5666193|P1|Overall Study|excluded from FAS|21
1623316|NCT01966068|5666207|P1|Overall Study|Lost to Follow-up|81
1623317|NCT01966068|5666207|P1|Overall Study|Withdrawal by Subject|57
1623318|NCT01966042|5666212|P1|Overall Study|Death|2
1623319|NCT01966003|5666221|P2|Overall Study|Other|1
1623320|NCT01966003|5666222|P1|Overall Study|Other|1
1623321|NCT01966003|5666221|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
1623322|NCT01966003|5666222|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
1623323|NCT01966003|5666221|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
1623324|NCT01966003|5666222|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
1623325|NCT01966003|5666221|P2|Overall Study|Withdrawal by Subject|19
1623326|NCT01966003|5666222|P1|Overall Study|Withdrawal by Subject|29
1623327|NCT01966003|5666221|P2|Overall Study|Physician Decision|13
1623328|NCT01966003|5666222|P1|Overall Study|Physician Decision|12
1623329|NCT01966003|5666221|P2|Overall Study|Lost to Follow-up|3
1623330|NCT01966003|5666222|P1|Overall Study|Lost to Follow-up|4
1623331|NCT01966003|5666221|P2|Overall Study|Protocol Violation|4
1623332|NCT01966003|5666222|P1|Overall Study|Protocol Violation|6
1623333|NCT01966003|5666221|P2|Overall Study|Death|36
1623334|NCT01966003|5666222|P1|Overall Study|Death|43
1623335|NCT01965938|5666240|P2|Overall Study|Withdrawal by Subject|0
1623336|NCT01965938|5666241|P1|Overall Study|Withdrawal by Subject|1
1623337|NCT01965834|5666272|P1|Overall Study|Lack of Efficacy|4
1623338|NCT01965652|5666313|P2|Overall Study|Pregnancy|1
1623339|NCT01965652|5666314|P1|Overall Study|Pregnancy|0
1623340|NCT01965652|5666313|P2|Overall Study|Other - Miscellaneous|21
1623341|NCT01965652|5666314|P1|Overall Study|Other - Miscellaneous|18
1623342|NCT01965652|5666313|P2|Overall Study|Death|4
1623343|NCT01965652|5666314|P1|Overall Study|Death|3
1623344|NCT01965652|5666313|P2|Overall Study|Protocol Violation|38
1623345|NCT01965652|5666314|P1|Overall Study|Protocol Violation|34
1623346|NCT01965652|5666313|P2|Overall Study|Lost to Follow-up|40
1623347|NCT01965652|5666314|P1|Overall Study|Lost to Follow-up|53
1623348|NCT01965652|5666313|P2|Overall Study|Withdrawal by Subject|69
1623349|NCT01965652|5666314|P1|Overall Study|Withdrawal by Subject|62
1623350|NCT01965652|5666313|P2|Overall Study|Adverse Event|37
1623351|NCT01965652|5666314|P1|Overall Study|Adverse Event|40
1623352|NCT01965600|5666344|P4|Second Intervention|Study terminated by Sponsor|2
1623353|NCT01965600|5666345|P3|Second Intervention|Study terminated by Sponsor|2
1623354|NCT01965600|5666346|P2|Second Intervention|Study terminated by Sponsor|0
1623355|NCT01965600|5666347|P1|Second Intervention|Study terminated by Sponsor|0
1623356|NCT01965600|5666344|P4|Washout Period of Approximately 15 Days|Adverse Event|1
1623357|NCT01965600|5666345|P3|Washout Period of Approximately 15 Days|Adverse Event|0
1623358|NCT01965600|5666346|P2|Washout Period of Approximately 15 Days|Adverse Event|0
1623359|NCT01965600|5666347|P1|Washout Period of Approximately 15 Days|Adverse Event|0
1623360|NCT01965600|5666344|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1623361|NCT01965600|5666345|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1623362|NCT01965600|5666346|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
1623363|NCT01965600|5666347|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
1623364|NCT01965600|5666344|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1623365|NCT01965600|5666345|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1623366|NCT01965600|5666346|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
1623367|NCT01965600|5666347|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
1623368|NCT01965600|5666344|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1623369|NCT01965600|5666345|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
1623370|NCT01965600|5666346|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
1623371|NCT01965600|5666347|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
1623372|NCT01965535|5666404|P2|Overall Study|Lack of Efficacy|1
1623373|NCT01965535|5666405|P1|Overall Study|Lack of Efficacy|2
1623374|NCT01965431|5666419|P6|Overall Study|Other than stated above|6
1623375|NCT01965431|5666420|P5|Overall Study|Other than stated above|6
1623376|NCT01965431|5666421|P4|Overall Study|Other than stated above|6
1623377|NCT01965431|5666422|P3|Overall Study|Other than stated above|6
1623378|NCT01965431|5666423|P2|Overall Study|Other than stated above|5
1623379|NCT01965431|5666424|P1|Overall Study|Other than stated above|6
1623380|NCT01965431|5666419|P6|Overall Study|Adverse Event|0
1623381|NCT01965431|5666420|P5|Overall Study|Adverse Event|0
1623382|NCT01965431|5666421|P4|Overall Study|Adverse Event|0
1623383|NCT01965431|5666422|P3|Overall Study|Adverse Event|0
1623384|NCT01965431|5666423|P2|Overall Study|Adverse Event|1
1623385|NCT01965431|5666424|P1|Overall Study|Adverse Event|0
1623386|NCT01965327|5666448|P1|Overall Study|Physician Decision|2
1623387|NCT01965262|5666662|P2|Second Intervention (7 Days)|Poor visual acuity|0
1623388|NCT01965262|5666663|P1|Second Intervention (7 Days)|Poor visual acuity|1
1623389|NCT01965262|5666662|P2|Second Intervention (7 Days)|Poor lens fit|9
1623390|NCT01965262|5666663|P1|Second Intervention (7 Days)|Poor lens fit|0
1623391|NCT01965262|5666662|P2|Second Intervention (7 Days)|Discontinued|1
1623392|NCT01965262|5666663|P1|Second Intervention (7 Days)|Discontinued|0
1623393|NCT01965158|5666727|P2|Overall Study|Other - Miscellaneous|0
1623394|NCT01965158|5666728|P1|Overall Study|Other - Miscellaneous|3
1623395|NCT01965158|5666727|P2|Overall Study|Protocol Violation|1
1623396|NCT01965158|5666728|P1|Overall Study|Protocol Violation|1
1623397|NCT01965158|5666727|P2|Overall Study|Lost to Follow-up|5
1623398|NCT01965158|5666728|P1|Overall Study|Lost to Follow-up|7
1623399|NCT01965158|5666727|P2|Overall Study|Withdrawal by Subject|24
1623400|NCT01965158|5666728|P1|Overall Study|Withdrawal by Subject|16
1623401|NCT01965158|5666727|P2|Overall Study|Adverse Event|5
1623402|NCT01965158|5666728|P1|Overall Study|Adverse Event|14
1623403|NCT01964976|5666769|P1|Overall Study|Protocol Violation|31
1623404|NCT01964963|5666781|P1|Overall Study|Data Reliability was not Assured|5
1623405|NCT01964963|5666781|P1|Overall Study|Protocol Deviation|50
1623406|NCT01964963|5666781|P1|Overall Study|Case Report Forms Uncollected|888
1623407|NCT01964950|5666789|P1|Overall Study|Protocol Violation|25
1623408|NCT01964924|5666801|P2|Trametinib Monotherapy|Progression|0
1623409|NCT01964924|5666802|P1|Trametinib Monotherapy|Progression|19
1623410|NCT01964898|5666826|P2|Overall Study|Withdrawal by Subject|0
1623411|NCT01964898|5666827|P1|Overall Study|Withdrawal by Subject|1
1623412|NCT01964898|5666826|P2|Overall Study|Lost to Follow-up|5
1623413|NCT01964898|5666827|P1|Overall Study|Lost to Follow-up|3
1623414|NCT01964898|5666826|P2|Overall Study|did not receive the allocated interventi|1
1623415|NCT01964898|5666827|P1|Overall Study|did not receive the allocated interventi|2
1623416|NCT01964898|5666826|P2|Overall Study|ineligible post-randomization|1
1623417|NCT01964898|5666827|P1|Overall Study|ineligible post-randomization|1
1623418|NCT01964755|5666847|P1|Overall Study|Death|2
1623419|NCT01964716|5666862|P2|Overall Study|Death|0
1623420|NCT01964716|5666863|P1|Overall Study|Death|1
1623421|NCT01964716|5666862|P2|Overall Study|No longer met eligibility criteria|1
1623422|NCT01964716|5666863|P1|Overall Study|No longer met eligibility criteria|1
1623423|NCT01964716|5666862|P2|Overall Study|Lost to Follow-up|2
1623424|NCT01964716|5666863|P1|Overall Study|Lost to Follow-up|1
1623425|NCT01964716|5666862|P2|Overall Study|Withdrawal by Subject|3
1623426|NCT01964716|5666863|P1|Overall Study|Withdrawal by Subject|2
1623427|NCT01964547|5666901|P2|Overall Study|Withdrawal by Investigator|1
1623428|NCT01964547|5666902|P1|Overall Study|Withdrawal by Investigator|0
1623429|NCT01964547|5666901|P2|Overall Study|Lost to Follow-up|1
1623430|NCT01964547|5666902|P1|Overall Study|Lost to Follow-up|0
1623431|NCT01964547|5666901|P2|Overall Study|Withdrawal by Subject|7
1623432|NCT01964547|5666902|P1|Overall Study|Withdrawal by Subject|4
1623433|NCT01964547|5666901|P2|Overall Study|Adverse Event|2
1623434|NCT01964547|5666902|P1|Overall Study|Adverse Event|8
1623435|NCT01964521|5666926|P1|Overall Study|Lost to Follow-up|4
1623436|NCT01964430|5666933|P2|Overall Study|Randomized but not Treated|11
1623437|NCT01964430|5666934|P1|Overall Study|Randomized but not Treated|3
1623438|NCT01964430|5666933|P2|Overall Study|Miscellaneous|3
1623439|NCT01964430|5666934|P1|Overall Study|Miscellaneous|1
1623440|NCT01964430|5666933|P2|Overall Study|Disease Relapse|38
1623441|NCT01964430|5666934|P1|Overall Study|Disease Relapse|28
1623442|NCT01964430|5666933|P2|Overall Study|Physician Decision|4
1623443|NCT01964430|5666934|P1|Overall Study|Physician Decision|5
1623444|NCT01964430|5666933|P2|Overall Study|Protocol Deviation|1
1623445|NCT01964430|5666934|P1|Overall Study|Protocol Deviation|0
1623446|NCT01964430|5666933|P2|Overall Study|Death|3
1623447|NCT01964430|5666934|P1|Overall Study|Death|1
1623448|NCT01964430|5666933|P2|Overall Study|Withdrawal by Subject|27
1623449|NCT01964430|5666934|P1|Overall Study|Withdrawal by Subject|36
1623450|NCT01964430|5666933|P2|Overall Study|Adverse Event|37
1623451|NCT01964430|5666934|P1|Overall Study|Adverse Event|71
1623472|NCT01964352|5666983|P4|Overall Study|Other than stated above|2
1623473|NCT01964352|5666984|P3|Overall Study|Other than stated above|1
1623474|NCT01964352|5666985|P2|Overall Study|Other than stated above|2
1623475|NCT01964352|5666986|P1|Overall Study|Other than stated above|0
1623476|NCT01964352|5666983|P4|Overall Study|Withdrawal by Subject|0
1623477|NCT01964352|5666984|P3|Overall Study|Withdrawal by Subject|1
1623478|NCT01964352|5666985|P2|Overall Study|Withdrawal by Subject|2
1623479|NCT01964352|5666986|P1|Overall Study|Withdrawal by Subject|4
1623480|NCT01964352|5666983|P4|Overall Study|Lost to Follow-up|1
1623481|NCT01964352|5666984|P3|Overall Study|Lost to Follow-up|0
1623482|NCT01964352|5666985|P2|Overall Study|Lost to Follow-up|0
1623483|NCT01964352|5666986|P1|Overall Study|Lost to Follow-up|1
1623484|NCT01964352|5666983|P4|Overall Study|Protocol Violation|2
1623485|NCT01964352|5666984|P3|Overall Study|Protocol Violation|0
1623486|NCT01964352|5666985|P2|Overall Study|Protocol Violation|4
1623487|NCT01964352|5666986|P1|Overall Study|Protocol Violation|2
1623488|NCT01964352|5666983|P4|Overall Study|Lack of Efficacy|0
1623489|NCT01964352|5666984|P3|Overall Study|Lack of Efficacy|0
1623490|NCT01964352|5666985|P2|Overall Study|Lack of Efficacy|0
1623491|NCT01964352|5666986|P1|Overall Study|Lack of Efficacy|6
1623492|NCT01964352|5666983|P4|Overall Study|Adverse Event|3
1623493|NCT01964352|5666984|P3|Overall Study|Adverse Event|4
1623494|NCT01964352|5666985|P2|Overall Study|Adverse Event|3
1623495|NCT01964352|5666986|P1|Overall Study|Adverse Event|13
1623496|NCT01964326|5667016|P1|Overall Study|Did not meet eligibility criteria|1
1623497|NCT01964326|5667016|P1|Overall Study|Other|9
1623498|NCT01964326|5667016|P1|Overall Study|Investigator Discretion|1
1623499|NCT01964326|5667016|P1|Overall Study|Physician Decision|55
1623500|NCT01964326|5667016|P1|Overall Study|No Longer Meets Eligibility Criteria|1
1623501|NCT01964326|5667016|P1|Overall Study|Pregnancy|1
1623502|NCT01964326|5667016|P1|Overall Study|Withdrawal by Subject|87
1623503|NCT01964326|5667016|P1|Overall Study|Lost to Follow-up|88
1623504|NCT01964326|5667016|P1|Overall Study|Protocol Violation|4
1623505|NCT01964326|5667016|P1|Overall Study|Death|2
1623506|NCT01964326|5667016|P1|Overall Study|Adverse Event|48
1623521|NCT01964222|5667040|P2|Overall Study|Screening Failure|0
1623522|NCT01964222|5667041|P1|Overall Study|Screening Failure|2
1623523|NCT01964222|5667040|P2|Overall Study|Withdrawal by Subject|6
1623524|NCT01964222|5667041|P1|Overall Study|Withdrawal by Subject|6
1623525|NCT01964222|5667040|P2|Overall Study|Lost to Follow-up|5
1623526|NCT01964222|5667041|P1|Overall Study|Lost to Follow-up|7
1623527|NCT01964105|5667058|P3|Overall Study|Lost to Follow-up|0
1623528|NCT01964105|5667059|P2|Overall Study|Lost to Follow-up|13
1623529|NCT01964105|5667060|P1|Overall Study|Lost to Follow-up|2
1623530|NCT01963767|5667087|P2|Overall Study|Adverse Event|0
1623531|NCT01963767|5667088|P1|Overall Study|Adverse Event|2
1623532|NCT01963767|5667087|P2|Overall Study|Withdrawal by Subject|2
1623533|NCT01963767|5667088|P1|Overall Study|Withdrawal by Subject|4
1623534|NCT01963676|5667098|P2|Overall Study|Withdrawal by Subject|0
1623535|NCT01963676|5667099|P1|Overall Study|Withdrawal by Subject|1
1623536|NCT01963611|5667112|P5|Overall Study|Other|45
1623537|NCT01963611|5667113|P4|Overall Study|Other|45
1623538|NCT01963611|5667114|P3|Overall Study|Other|48
1623539|NCT01963611|5667115|P2|Overall Study|Other|46
1623540|NCT01963611|5667116|P1|Overall Study|Other|47
1623541|NCT01963611|5667112|P5|Overall Study|Withdrawal by Subject|3
1623542|NCT01963611|5667113|P4|Overall Study|Withdrawal by Subject|1
1623543|NCT01963611|5667114|P3|Overall Study|Withdrawal by Subject|1
1623544|NCT01963611|5667115|P2|Overall Study|Withdrawal by Subject|2
1623545|NCT01963611|5667116|P1|Overall Study|Withdrawal by Subject|3
1623546|NCT01963611|5667112|P5|Overall Study|Lack of Efficacy|0
1623547|NCT01963611|5667113|P4|Overall Study|Lack of Efficacy|1
1623548|NCT01963611|5667114|P3|Overall Study|Lack of Efficacy|0
1623549|NCT01963611|5667115|P2|Overall Study|Lack of Efficacy|0
1623550|NCT01963611|5667116|P1|Overall Study|Lack of Efficacy|0
1623551|NCT01963611|5667112|P5|Overall Study|Protocol Violation|0
1623552|NCT01963611|5667113|P4|Overall Study|Protocol Violation|1
1623553|NCT01963611|5667114|P3|Overall Study|Protocol Violation|0
1623554|NCT01963611|5667115|P2|Overall Study|Protocol Violation|0
1623555|NCT01963611|5667116|P1|Overall Study|Protocol Violation|0
1623556|NCT01963611|5667112|P5|Overall Study|Adverse Event|3
1623557|NCT01963611|5667113|P4|Overall Study|Adverse Event|4
1623558|NCT01963611|5667114|P3|Overall Study|Adverse Event|3
1623559|NCT01963611|5667115|P2|Overall Study|Adverse Event|1
1623560|NCT01963611|5667116|P1|Overall Study|Adverse Event|1
1623561|NCT01963403|5667175|P2|Overall Study|Implant removal|1
1623562|NCT01963403|5667176|P1|Overall Study|Implant removal|0
1623563|NCT01963403|5667175|P2|Overall Study|Lost to Follow-up|3
1623564|NCT01963403|5667176|P1|Overall Study|Lost to Follow-up|2
1623565|NCT01963260|5667198|P10|Overall Study|Withdrawal by Subject|0
1623566|NCT01963260|5667199|P9|Overall Study|Withdrawal by Subject|0
1623567|NCT01963260|5667200|P8|Overall Study|Withdrawal by Subject|0
1623568|NCT01963260|5667201|P7|Overall Study|Withdrawal by Subject|0
1623569|NCT01963260|5667202|P6|Overall Study|Withdrawal by Subject|0
1623570|NCT01963260|5667203|P5|Overall Study|Withdrawal by Subject|2
1623571|NCT01963260|5667204|P4|Overall Study|Withdrawal by Subject|1
1623572|NCT01963260|5667205|P3|Overall Study|Withdrawal by Subject|0
1623573|NCT01963260|5667206|P2|Overall Study|Withdrawal by Subject|0
1623574|NCT01963260|5667207|P1|Overall Study|Withdrawal by Subject|2
1623575|NCT01962974|5667351|P1|Overall Study|Study termination|7
1623576|NCT01962922|5667378|P2|Extendion Portion (up to Month 6)|Physician Decision|0
1623577|NCT01962922|5667379|P1|Extendion Portion (up to Month 6)|Physician Decision|1
1623578|NCT01962922|5667378|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
1623579|NCT01962922|5667379|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
1623580|NCT01962922|5667378|P2|PK Portion Day 7|non-compliance|0
1623581|NCT01962922|5667379|P1|PK Portion Day 7|non-compliance|1
1623582|NCT01962922|5667378|P2|PK Portion Day 7|Withdrawal by Subject|0
1623583|NCT01962922|5667379|P1|PK Portion Day 7|Withdrawal by Subject|3
1623584|NCT01962896|5667401|P1|Overall Study|Lack of Efficacy|4
1623585|NCT01962493|5667512|P2|Overall Study|Withdrawal by Subject|2
1623586|NCT01962493|5667513|P1|Overall Study|Withdrawal by Subject|4
1623587|NCT01962493|5667512|P2|Overall Study|Protocol Violation|1
1623588|NCT01962493|5667513|P1|Overall Study|Protocol Violation|0
1623589|NCT01962493|5667512|P2|Overall Study|Adverse Event|2
1623590|NCT01962493|5667513|P1|Overall Study|Adverse Event|1
1623591|NCT01962441|5667536|P3|Retreatment Substudy|Lost to Follow-up|0
1623592|NCT01962441|5667537|P2|Retreatment Substudy|Lost to Follow-up|0
1623593|NCT01962441|5667538|P1|Retreatment Substudy|Lost to Follow-up|1
1623594|NCT01962441|5667536|P3|Retreatment Substudy|Lack of Efficacy|0
1623595|NCT01962441|5667537|P2|Retreatment Substudy|Lack of Efficacy|0
1623596|NCT01962441|5667538|P1|Retreatment Substudy|Lack of Efficacy|1
1623597|NCT01962441|5667536|P3|Randomized Period|Protocol Violation|0
1623598|NCT01962441|5667537|P2|Randomized Period|Protocol Violation|1
1623599|NCT01962441|5667538|P1|Randomized Period|Protocol Violation|0
1623600|NCT01962441|5667536|P3|Randomized Period|Death|2
1623601|NCT01962441|5667537|P2|Randomized Period|Death|0
1623602|NCT01962441|5667538|P1|Randomized Period|Death|0
1623603|NCT01962441|5667536|P3|Randomized Period|Adverse Event|0
1623604|NCT01962441|5667537|P2|Randomized Period|Adverse Event|1
1623605|NCT01962441|5667538|P1|Randomized Period|Adverse Event|1
1623606|NCT01962441|5667536|P3|Randomized Period|Withdrew Consent|2
1623607|NCT01962441|5667537|P2|Randomized Period|Withdrew Consent|3
1623608|NCT01962441|5667538|P1|Randomized Period|Withdrew Consent|3
1623609|NCT01962441|5667536|P3|Randomized Period|Lost to Follow-up|4
1623610|NCT01962441|5667537|P2|Randomized Period|Lost to Follow-up|4
1623611|NCT01962441|5667538|P1|Randomized Period|Lost to Follow-up|2
1623612|NCT01962441|5667536|P3|Randomized Period|Randomized but Never Treated|3
1623613|NCT01962441|5667537|P2|Randomized Period|Randomized but Never Treated|2
1623614|NCT01962441|5667538|P1|Randomized Period|Randomized but Never Treated|4
1623615|NCT01962298|5667582|P5|Overall Study|Physician Decision|1
1623616|NCT01962298|5667583|P4|Overall Study|Physician Decision|0
1623617|NCT01962298|5667584|P3|Overall Study|Physician Decision|0
1623618|NCT01962298|5667585|P2|Overall Study|Physician Decision|1
1623619|NCT01962298|5667586|P1|Overall Study|Physician Decision|0
1623620|NCT01962298|5667582|P5|Overall Study|Incorrect data recorded|0
1623621|NCT01962298|5667583|P4|Overall Study|Incorrect data recorded|0
1623622|NCT01962298|5667584|P3|Overall Study|Incorrect data recorded|0
1623623|NCT01962298|5667585|P2|Overall Study|Incorrect data recorded|1
1623624|NCT01962298|5667586|P1|Overall Study|Incorrect data recorded|0
1623625|NCT01962298|5667582|P5|Overall Study|Insufficient data|1
1623626|NCT01962298|5667583|P4|Overall Study|Insufficient data|0
1623627|NCT01962298|5667584|P3|Overall Study|Insufficient data|1
1623628|NCT01962298|5667585|P2|Overall Study|Insufficient data|2
1623629|NCT01962298|5667586|P1|Overall Study|Insufficient data|0
1623630|NCT01962298|5667582|P5|Overall Study|Data quality insufficient|4
1623631|NCT01962298|5667583|P4|Overall Study|Data quality insufficient|1
1623632|NCT01962298|5667584|P3|Overall Study|Data quality insufficient|3
1623633|NCT01962298|5667585|P2|Overall Study|Data quality insufficient|0
1623634|NCT01962298|5667586|P1|Overall Study|Data quality insufficient|2
1623635|NCT01962298|5667582|P5|Overall Study|Protocol Violation|0
1623636|NCT01962298|5667583|P4|Overall Study|Protocol Violation|1
1623637|NCT01962298|5667584|P3|Overall Study|Protocol Violation|1
1623638|NCT01962298|5667585|P2|Overall Study|Protocol Violation|0
1623639|NCT01962298|5667586|P1|Overall Study|Protocol Violation|1
1623640|NCT01962207|5667607|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
1623641|NCT01962207|5667608|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
1623642|NCT01962207|5667609|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
1623643|NCT01962207|5667610|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
1623644|NCT01962207|5667607|P4|Persistence Phase (5 Years)|Adverse Event|0
1623645|NCT01962207|5667608|P3|Persistence Phase (5 Years)|Adverse Event|1
1623646|NCT01962207|5667609|P2|Persistence Phase (5 Years)|Adverse Event|0
1623647|NCT01962207|5667610|P1|Persistence Phase (5 Years)|Adverse Event|0
1623648|NCT01962207|5667607|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
1623649|NCT01962207|5667608|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
1623650|NCT01962207|5667609|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
1623651|NCT01962207|5667610|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
1623652|NCT01962207|5667607|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
1623653|NCT01962207|5667608|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
1623654|NCT01962207|5667609|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
1623655|NCT01962207|5667610|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
1623656|NCT01962207|5667607|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
1623657|NCT01962207|5667608|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
1623658|NCT01962207|5667609|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
1623659|NCT01962207|5667610|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
1623660|NCT01962207|5667607|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
1623661|NCT01962207|5667608|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
1623662|NCT01962207|5667609|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
1623663|NCT01962207|5667610|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
1623664|NCT01962103|5667721|P9|Phase 2|Symptomatic Deterioration|0
1623665|NCT01962103|5667722|P8|Phase 2|Symptomatic Deterioration|2
1623666|NCT01962103|5667723|P7|Phase 2|Symptomatic Deterioration|2
1623667|NCT01962103|5667724|P6|Phase 2|Symptomatic Deterioration|0
1623668|NCT01962103|5667725|P5|Phase 2|Symptomatic Deterioration|0
1623669|NCT01962103|5667726|P4|Phase 2|Symptomatic Deterioration|0
1623670|NCT01962103|5667727|P3|Phase 2|Symptomatic Deterioration|0
1623671|NCT01962103|5667728|P2|Phase 2|Symptomatic Deterioration|0
1623672|NCT01962103|5667729|P1|Phase 2|Symptomatic Deterioration|0
1623673|NCT01962103|5667721|P9|Phase 2|Progressive Disease|11
1623674|NCT01962103|5667722|P8|Phase 2|Progressive Disease|12
1623675|NCT01962103|5667723|P7|Phase 2|Progressive Disease|11
1623676|NCT01962103|5667724|P6|Phase 2|Progressive Disease|0
1623677|NCT01962103|5667725|P5|Phase 2|Progressive Disease|0
1623678|NCT01962103|5667726|P4|Phase 2|Progressive Disease|0
1623679|NCT01962103|5667727|P3|Phase 2|Progressive Disease|0
1623680|NCT01962103|5667728|P2|Phase 2|Progressive Disease|0
1623681|NCT01962103|5667729|P1|Phase 2|Progressive Disease|0
1623682|NCT01962103|5667721|P9|Phase 2|Adverse Event|3
1623683|NCT01962103|5667722|P8|Phase 2|Adverse Event|0
1623684|NCT01962103|5667723|P7|Phase 2|Adverse Event|1
1623685|NCT01962103|5667724|P6|Phase 2|Adverse Event|0
1623686|NCT01962103|5667725|P5|Phase 2|Adverse Event|0
1623687|NCT01962103|5667726|P4|Phase 2|Adverse Event|0
1623688|NCT01962103|5667727|P3|Phase 2|Adverse Event|0
1623689|NCT01962103|5667728|P2|Phase 2|Adverse Event|0
1623690|NCT01962103|5667729|P1|Phase 2|Adverse Event|0
1623691|NCT01962103|5667721|P9|Phase 1|Miscellaneous|0
1623692|NCT01962103|5667722|P8|Phase 1|Miscellaneous|0
1623693|NCT01962103|5667723|P7|Phase 1|Miscellaneous|0
1623694|NCT01962103|5667724|P6|Phase 1|Miscellaneous|0
1623695|NCT01962103|5667725|P5|Phase 1|Miscellaneous|0
1623696|NCT01962103|5667726|P4|Phase 1|Miscellaneous|0
1623697|NCT01962103|5667727|P3|Phase 1|Miscellaneous|0
1623698|NCT01962103|5667728|P2|Phase 1|Miscellaneous|0
1623699|NCT01962103|5667729|P1|Phase 1|Miscellaneous|1
1623700|NCT01962103|5667721|P9|Phase 1|Symptomatic Deterioration|0
1623701|NCT01962103|5667722|P8|Phase 1|Symptomatic Deterioration|0
1623702|NCT01962103|5667723|P7|Phase 1|Symptomatic Deterioration|0
1623703|NCT01962103|5667724|P6|Phase 1|Symptomatic Deterioration|1
1623704|NCT01962103|5667725|P5|Phase 1|Symptomatic Deterioration|1
1623705|NCT01962103|5667726|P4|Phase 1|Symptomatic Deterioration|2
1623706|NCT01962103|5667727|P3|Phase 1|Symptomatic Deterioration|2
1623707|NCT01962103|5667728|P2|Phase 1|Symptomatic Deterioration|2
1623708|NCT01962103|5667729|P1|Phase 1|Symptomatic Deterioration|3
1623709|NCT01962103|5667721|P9|Phase 1|Physician Decision|0
1623710|NCT01962103|5667722|P8|Phase 1|Physician Decision|0
1623711|NCT01962103|5667723|P7|Phase 1|Physician Decision|0
1623712|NCT01962103|5667724|P6|Phase 1|Physician Decision|0
1623713|NCT01962103|5667725|P5|Phase 1|Physician Decision|0
1623714|NCT01962103|5667726|P4|Phase 1|Physician Decision|1
1623715|NCT01962103|5667727|P3|Phase 1|Physician Decision|0
1623716|NCT01962103|5667728|P2|Phase 1|Physician Decision|0
1623717|NCT01962103|5667729|P1|Phase 1|Physician Decision|0
1623718|NCT01962103|5667721|P9|Phase 1|Withdrawal by Parent/Guardian|0
1623719|NCT01962103|5667722|P8|Phase 1|Withdrawal by Parent/Guardian|0
1623720|NCT01962103|5667723|P7|Phase 1|Withdrawal by Parent/Guardian|0
1623721|NCT01962103|5667724|P6|Phase 1|Withdrawal by Parent/Guardian|0
1623722|NCT01962103|5667725|P5|Phase 1|Withdrawal by Parent/Guardian|0
1623723|NCT01962103|5667726|P4|Phase 1|Withdrawal by Parent/Guardian|1
1623724|NCT01962103|5667727|P3|Phase 1|Withdrawal by Parent/Guardian|2
1623725|NCT01962103|5667728|P2|Phase 1|Withdrawal by Parent/Guardian|0
1623726|NCT01962103|5667729|P1|Phase 1|Withdrawal by Parent/Guardian|0
1623727|NCT01962103|5667721|P9|Phase 1|Withdrawal by Subject|0
1623728|NCT01962103|5667722|P8|Phase 1|Withdrawal by Subject|0
1623729|NCT01962103|5667723|P7|Phase 1|Withdrawal by Subject|0
1623730|NCT01962103|5667724|P6|Phase 1|Withdrawal by Subject|0
1623731|NCT01962103|5667725|P5|Phase 1|Withdrawal by Subject|0
1623732|NCT01962103|5667726|P4|Phase 1|Withdrawal by Subject|2
1623733|NCT01962103|5667727|P3|Phase 1|Withdrawal by Subject|0
1623734|NCT01962103|5667728|P2|Phase 1|Withdrawal by Subject|0
1623735|NCT01962103|5667729|P1|Phase 1|Withdrawal by Subject|0
1623736|NCT01962103|5667721|P9|Phase 1|Progressive Disease|0
1623737|NCT01962103|5667722|P8|Phase 1|Progressive Disease|0
1623738|NCT01962103|5667723|P7|Phase 1|Progressive Disease|0
1623739|NCT01962103|5667724|P6|Phase 1|Progressive Disease|4
1623740|NCT01962103|5667725|P5|Phase 1|Progressive Disease|5
1623741|NCT01962103|5667726|P4|Phase 1|Progressive Disease|4
1623742|NCT01962103|5667727|P3|Phase 1|Progressive Disease|8
1623743|NCT01962103|5667728|P2|Phase 1|Progressive Disease|6
1623744|NCT01962103|5667729|P1|Phase 1|Progressive Disease|8
1623745|NCT01962103|5667721|P9|Phase 1|Adverse Event|0
1623746|NCT01962103|5667722|P8|Phase 1|Adverse Event|0
1623747|NCT01962103|5667723|P7|Phase 1|Adverse Event|0
1623748|NCT01962103|5667724|P6|Phase 1|Adverse Event|2
1623749|NCT01962103|5667725|P5|Phase 1|Adverse Event|2
1623750|NCT01962103|5667726|P4|Phase 1|Adverse Event|1
1623751|NCT01962103|5667727|P3|Phase 1|Adverse Event|2
1623752|NCT01962103|5667728|P2|Phase 1|Adverse Event|0
1623753|NCT01962103|5667729|P1|Phase 1|Adverse Event|4
1623754|NCT01961609|5667841|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
1623755|NCT01961609|5667842|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
1623756|NCT01961609|5667843|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
1623757|NCT01961609|5667844|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
1623758|NCT01961609|5667841|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
1623759|NCT01961609|5667842|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
1623760|NCT01961609|5667843|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
1623761|NCT01961609|5667844|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
1623762|NCT01961609|5667841|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
1623763|NCT01961609|5667842|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
1623764|NCT01961609|5667843|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
1623765|NCT01961609|5667844|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
1623766|NCT01961609|5667841|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
1623767|NCT01961609|5667842|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
1623768|NCT01961609|5667843|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
1623769|NCT01961609|5667844|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
1623770|NCT01961609|5667841|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
1623771|NCT01961609|5667842|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
1623772|NCT01961609|5667843|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
1623773|NCT01961609|5667844|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
1623774|NCT01961609|5667841|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
1623775|NCT01961609|5667842|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
1623776|NCT01961609|5667843|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
1623777|NCT01961609|5667844|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
1623778|NCT01961609|5667841|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
1623779|NCT01961609|5667842|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
1623780|NCT01961609|5667843|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
1623781|NCT01961609|5667844|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
1623782|NCT01961609|5667841|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
1623783|NCT01961609|5667842|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
1623784|NCT01961609|5667843|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
1623785|NCT01961609|5667844|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
1623786|NCT01961609|5667841|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
1623787|NCT01961609|5667842|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
1623788|NCT01961609|5667843|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
1623789|NCT01961609|5667844|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
1623790|NCT01961609|5667841|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
1623791|NCT01961609|5667842|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
1623792|NCT01961609|5667843|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
1623793|NCT01961609|5667844|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
1623794|NCT01961609|5667841|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
1623795|NCT01961609|5667842|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
1623796|NCT01961609|5667843|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
1623797|NCT01961609|5667844|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
1623798|NCT01961609|5667841|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
1623799|NCT01961609|5667842|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
1623800|NCT01961609|5667843|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
1623801|NCT01961609|5667844|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
1623802|NCT01961609|5667841|P4|Initiation|Randomized but not treated|0
1623803|NCT01961609|5667842|P3|Initiation|Randomized but not treated|0
1623804|NCT01961609|5667843|P2|Initiation|Randomized but not treated|1
1623805|NCT01961609|5667844|P1|Initiation|Randomized but not treated|1
1623806|NCT01961609|5667841|P4|Initiation|Adverse Event|0
1623807|NCT01961609|5667842|P3|Initiation|Adverse Event|0
1623808|NCT01961609|5667843|P2|Initiation|Adverse Event|5
1623809|NCT01961609|5667844|P1|Initiation|Adverse Event|3
1623810|NCT01961609|5667841|P4|Initiation|Abnormal lab values|0
1623811|NCT01961609|5667842|P3|Initiation|Abnormal lab values|0
1623812|NCT01961609|5667843|P2|Initiation|Abnormal lab values|1
1623813|NCT01961609|5667844|P1|Initiation|Abnormal lab values|0
1623814|NCT01961609|5667841|P4|Initiation|Lack of Efficacy|0
1623815|NCT01961609|5667842|P3|Initiation|Lack of Efficacy|0
1623816|NCT01961609|5667843|P2|Initiation|Lack of Efficacy|1
1623817|NCT01961609|5667844|P1|Initiation|Lack of Efficacy|2
1623818|NCT01961609|5667841|P4|Initiation|Withdrawal by Subject|0
1623819|NCT01961609|5667842|P3|Initiation|Withdrawal by Subject|0
1623820|NCT01961609|5667843|P2|Initiation|Withdrawal by Subject|2
1623821|NCT01961609|5667844|P1|Initiation|Withdrawal by Subject|1
1623822|NCT01961609|5667841|P4|Initiation|Administrative problems|0
1623823|NCT01961609|5667842|P3|Initiation|Administrative problems|0
1623824|NCT01961609|5667843|P2|Initiation|Administrative problems|0
1623825|NCT01961609|5667844|P1|Initiation|Administrative problems|1
1623826|NCT01961609|5667841|P4|Initiation|Death|0
1623827|NCT01961609|5667842|P3|Initiation|Death|0
1623828|NCT01961609|5667843|P2|Initiation|Death|1
1623829|NCT01961609|5667844|P1|Initiation|Death|0
1623830|NCT01961609|5667841|P4|Initiation|Protocol deviation|0
1623831|NCT01961609|5667842|P3|Initiation|Protocol deviation|0
1623832|NCT01961609|5667843|P2|Initiation|Protocol deviation|0
1623833|NCT01961609|5667844|P1|Initiation|Protocol deviation|1
1623834|NCT01961609|5667841|P4|Initiation|Missing|0
1623835|NCT01961609|5667842|P3|Initiation|Missing|0
1623836|NCT01961609|5667843|P2|Initiation|Missing|2
1623837|NCT01961609|5667844|P1|Initiation|Missing|3
1623838|NCT01961544|5667896|P1|Overall Study|Aggravation of Steral Pain|1
1623839|NCT01961544|5667896|P1|Overall Study|Poor Tolerance|1
1623840|NCT01961544|5667896|P1|Overall Study|Physician Decision|2
1623841|NCT01961544|5667896|P1|Overall Study|Adverse Event|1
1623842|NCT01961544|5667896|P1|Overall Study|Withdrawal by Subject|7
1623843|NCT01961544|5667896|P1|Overall Study|Protocol Violation|1
1623844|NCT01961349|5667910|P3|Overall Study|registration error, personal reason etc|1
1623845|NCT01961349|5667911|P2|Overall Study|registration error, personal reason etc|2
1623846|NCT01961349|5667912|P1|Overall Study|registration error, personal reason etc|2
1623847|NCT01961349|5667910|P3|Overall Study|Adverse Event|1
1623848|NCT01961349|5667911|P2|Overall Study|Adverse Event|0
1623849|NCT01961349|5667912|P1|Overall Study|Adverse Event|0
1623850|NCT01961349|5667910|P3|Overall Study|Withdrawal by Subject|0
1623851|NCT01961349|5667911|P2|Overall Study|Withdrawal by Subject|4
1623852|NCT01961349|5667912|P1|Overall Study|Withdrawal by Subject|1
1623853|NCT01961323|5667923|P1|Overall Study|screen failure|34
1623854|NCT01961323|5667923|P1|Overall Study|Lost to Follow-up|8
1623855|NCT01961323|5667923|P1|Overall Study|Withdrawal by Subject|7
1623856|NCT01961297|5667931|P2|Overall Study|unconfirmed diagnosis of SD|1
1623857|NCT01961297|5667932|P1|Overall Study|unconfirmed diagnosis of SD|2
1623858|NCT01961115|5667996|P3|Overall Study|Adverse Event|1
1623859|NCT01961115|5667997|P2|Overall Study|Adverse Event|0
1623860|NCT01961115|5667998|P1|Overall Study|Adverse Event|1
1623861|NCT01961115|5667996|P3|Overall Study|Disease Progression|3
1623862|NCT01961115|5667997|P2|Overall Study|Disease Progression|0
1623863|NCT01961115|5667998|P1|Overall Study|Disease Progression|1
1623864|NCT01960907|5668041|P2|Overall Study|Withdrawal by Subject|42
1623865|NCT01960907|5668042|P1|Overall Study|Withdrawal by Subject|32
1623866|NCT01960907|5668041|P2|Overall Study|Death|3
1623867|NCT01960907|5668042|P1|Overall Study|Death|4
1623868|NCT01960855|5668057|P5|Overall Study|Lost to Follow-up|2
1623869|NCT01960855|5668058|P4|Overall Study|Lost to Follow-up|0
1623870|NCT01960855|5668059|P3|Overall Study|Lost to Follow-up|0
1623871|NCT01960855|5668060|P2|Overall Study|Lost to Follow-up|1
1623872|NCT01960855|5668061|P1|Overall Study|Lost to Follow-up|2
1623873|NCT01960855|5668057|P5|Overall Study|Consent withdrawn by subject|1
1623874|NCT01960855|5668058|P4|Overall Study|Consent withdrawn by subject|1
1623875|NCT01960855|5668059|P3|Overall Study|Consent withdrawn by subject|2
1623876|NCT01960855|5668060|P2|Overall Study|Consent withdrawn by subject|1
1623877|NCT01960855|5668061|P1|Overall Study|Consent withdrawn by subject|3
1623878|NCT01960855|5668057|P5|Overall Study|Other|0
1623879|NCT01960855|5668058|P4|Overall Study|Other|1
1623880|NCT01960855|5668059|P3|Overall Study|Other|1
1623881|NCT01960855|5668060|P2|Overall Study|Other|1
1623882|NCT01960855|5668061|P1|Overall Study|Other|2
1623883|NCT01960855|5668057|P5|Overall Study|Lack of Efficacy|0
1623884|NCT01960855|5668058|P4|Overall Study|Lack of Efficacy|0
1623885|NCT01960855|5668059|P3|Overall Study|Lack of Efficacy|0
1623886|NCT01960855|5668060|P2|Overall Study|Lack of Efficacy|1
1623887|NCT01960855|5668061|P1|Overall Study|Lack of Efficacy|1
1623888|NCT01960855|5668057|P5|Overall Study|Adverse Event|2
1623889|NCT01960855|5668058|P4|Overall Study|Adverse Event|2
1623890|NCT01960855|5668059|P3|Overall Study|Adverse Event|6
1623891|NCT01960855|5668060|P2|Overall Study|Adverse Event|0
1623892|NCT01960855|5668061|P1|Overall Study|Adverse Event|2
1623893|NCT01960855|5668057|P5|Overall Study|Subject noncompliant|0
1623894|NCT01960855|5668058|P4|Overall Study|Subject noncompliant|0
1623895|NCT01960855|5668059|P3|Overall Study|Subject noncompliant|0
1623896|NCT01960855|5668060|P2|Overall Study|Subject noncompliant|0
1623897|NCT01960855|5668061|P1|Overall Study|Subject noncompliant|1
1623898|NCT01960842|5668093|P1|Overall Study|Withdrawal by Subject|2
1623899|NCT01960842|5668093|P1|Overall Study|Adverse Event|1
1623900|NCT01960816|5668116|P1|Overall Study|Lost to Follow-up|1
1623901|NCT01960790|5668122|P1|Overall Study|Unevaluable for safety|1
1623902|NCT01960790|5668122|P1|Overall Study|Transferred to another hospital|4
1623903|NCT01960790|5668122|P1|Overall Study|Treat with Humira outside survey period|3
1623904|NCT01960790|5668122|P1|Overall Study|Survey forms could not be recovered|3
1623905|NCT01960725|5668134|P2|Overall Study|unable to obtain blood sample|2
1623906|NCT01960725|5668135|P1|Overall Study|unable to obtain blood sample|1
1623907|NCT01960725|5668134|P2|Overall Study|Withdrawal by Subject|0
1623908|NCT01960725|5668135|P1|Overall Study|Withdrawal by Subject|1
1623909|NCT01960725|5668134|P2|Overall Study|Lost to Follow-up|3
1623910|NCT01960725|5668135|P1|Overall Study|Lost to Follow-up|4
1623911|NCT01960413|5668192|P2|Overall Study|Lost to Follow-up|0
1623912|NCT01960413|5668193|P1|Overall Study|Lost to Follow-up|2
1623913|NCT01960413|5668192|P2|Overall Study|Physician Decision|0
1623914|NCT01960413|5668193|P1|Overall Study|Physician Decision|1
1623915|NCT01960413|5668192|P2|Overall Study|Withdrawal by Subject|1
1623916|NCT01960413|5668193|P1|Overall Study|Withdrawal by Subject|1
1623917|NCT01960348|5668223|P2|Overall Study|Protocol Violation|0
1623918|NCT01960348|5668224|P1|Overall Study|Protocol Violation|1
1623919|NCT01960348|5668223|P2|Overall Study|Physician Decision|1
1623920|NCT01960348|5668224|P1|Overall Study|Physician Decision|0
1623921|NCT01960348|5668223|P2|Overall Study|Withdrawal by Subject|11
1623922|NCT01960348|5668224|P1|Overall Study|Withdrawal by Subject|1
1623923|NCT01960348|5668223|P2|Overall Study|Adverse event, serious non-fatal|3
1623924|NCT01960348|5668224|P1|Overall Study|Adverse event, serious non-fatal|0
1623925|NCT01960348|5668223|P2|Overall Study|Adverse event, serious fatal|5
1623926|NCT01960348|5668224|P1|Overall Study|Adverse event, serious fatal|6
1623927|NCT01960348|5668223|P2|Overall Study|Adverse event, not serious|2
1623928|NCT01960348|5668224|P1|Overall Study|Adverse event, not serious|2
1623929|NCT01960296|5668244|P2|Overall Study|Received different procedure|3
1623930|NCT01960296|5668245|P1|Overall Study|Received different procedure|1
1623931|NCT01960296|5668244|P2|Overall Study|Postponed surgery|0
1623932|NCT01960296|5668245|P1|Overall Study|Postponed surgery|1
1623933|NCT01960140|5668265|P1|Period 2 (Days 3-18)|Adverse Event|2
1623934|NCT01960114|5668276|P2|Overall Study|Could not swallow study medication|1
1623935|NCT01960114|5668277|P1|Overall Study|Could not swallow study medication|0
1623936|NCT01960114|5668276|P2|Overall Study|Adverse Event|0
1623937|NCT01960114|5668277|P1|Overall Study|Adverse Event|1
1623938|NCT01959932|5668323|P3|Overall Study|Withdrawal by Subject|0
1623939|NCT01959932|5668324|P2|Overall Study|Withdrawal by Subject|0
1623940|NCT01959932|5668325|P1|Overall Study|Withdrawal by Subject|1
1623941|NCT01959919|5668343|P1|Overall Study|Did not meet the eligibility criteria|2
1623942|NCT01959880|5668357|P4|Overall Study|Study completed early-FDA approved|152
1623943|NCT01959880|5668358|P3|Overall Study|Study completed early-FDA approved|179
1623944|NCT01959880|5668359|P2|Overall Study|Study completed early-FDA approved|311
1623945|NCT01959880|5668360|P1|Overall Study|Study completed early-FDA approved|1003
1623946|NCT01959880|5668357|P4|Overall Study|Explantation w/o study device reimplant.|12
1623947|NCT01959880|5668358|P3|Overall Study|Explantation w/o study device reimplant.|5
1623948|NCT01959880|5668359|P2|Overall Study|Explantation w/o study device reimplant.|17
1623949|NCT01959880|5668360|P1|Overall Study|Explantation w/o study device reimplant.|22
1623950|NCT01959880|5668357|P4|Overall Study|Lost to Follow-up|8
1623951|NCT01959880|5668358|P3|Overall Study|Lost to Follow-up|15
1623952|NCT01959880|5668359|P2|Overall Study|Lost to Follow-up|18
1623953|NCT01959880|5668360|P1|Overall Study|Lost to Follow-up|95
1623954|NCT01959880|5668357|P4|Overall Study|Death|2
1623955|NCT01959880|5668358|P3|Overall Study|Death|1
1623956|NCT01959880|5668359|P2|Overall Study|Death|10
1623957|NCT01959880|5668360|P1|Overall Study|Death|1
1623958|NCT01959880|5668357|P4|Overall Study|Withdrawal by Subject|7
1623959|NCT01959880|5668358|P3|Overall Study|Withdrawal by Subject|8
1623960|NCT01959880|5668359|P2|Overall Study|Withdrawal by Subject|13
1623961|NCT01959880|5668360|P1|Overall Study|Withdrawal by Subject|11
1623962|NCT01959841|5668385|P3|Overall Study|Platelet count below on day1 or 4|11
1623963|NCT01959841|5668386|P2|Overall Study|Platelet count below on day1 or 4|15
1623964|NCT01959841|5668387|P1|Overall Study|Platelet count below on day1 or 4|11
1623965|NCT01959841|5668385|P3|Overall Study|Clinical laboratory value|6
1623966|NCT01959841|5668386|P2|Overall Study|Clinical laboratory value|6
1623967|NCT01959841|5668387|P1|Overall Study|Clinical laboratory value|2
1623968|NCT01959841|5668385|P3|Overall Study|Withdrawal by Subject|5
1623969|NCT01959841|5668386|P2|Overall Study|Withdrawal by Subject|7
1623970|NCT01959841|5668387|P1|Overall Study|Withdrawal by Subject|7
1623971|NCT01959841|5668385|P3|Overall Study|Protocol Violation|16
1623972|NCT01959841|5668386|P2|Overall Study|Protocol Violation|23
1623973|NCT01959841|5668387|P1|Overall Study|Protocol Violation|16
1623974|NCT01959841|5668385|P3|Overall Study|Physician Decision|3
1623975|NCT01959841|5668386|P2|Overall Study|Physician Decision|2
1623976|NCT01959841|5668387|P1|Overall Study|Physician Decision|0
1623977|NCT01959841|5668385|P3|Overall Study|Lost to Follow-up|0
1623978|NCT01959841|5668386|P2|Overall Study|Lost to Follow-up|1
1623979|NCT01959841|5668387|P1|Overall Study|Lost to Follow-up|1
1623980|NCT01959841|5668385|P3|Overall Study|Lack of Efficacy|0
1623981|NCT01959841|5668386|P2|Overall Study|Lack of Efficacy|0
1623982|NCT01959841|5668387|P1|Overall Study|Lack of Efficacy|5
1623983|NCT01959841|5668385|P3|Overall Study|Adverse Event|2
1623984|NCT01959841|5668386|P2|Overall Study|Adverse Event|3
1623985|NCT01959841|5668387|P1|Overall Study|Adverse Event|1
1623986|NCT01959672|5668415|P1|Overall Study|Death|1
1623987|NCT01959607|5668421|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1623988|NCT01959607|5668422|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1623989|NCT01959607|5668423|P2|First Intervention (Day 1)|Withdrawal by Subject|1
1623990|NCT01959607|5668424|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1623991|NCT01959581|5668437|P1|Overall Study|Lost to Follow-up|5
1623992|NCT01959529|5668443|P2|Overall Study|Lack of glycaemic control|1
1623993|NCT01959529|5668444|P1|Overall Study|Lack of glycaemic control|1
1623994|NCT01959529|5668443|P2|Overall Study|Hypoglycaemia|1
1623995|NCT01959529|5668444|P1|Overall Study|Hypoglycaemia|1
1623996|NCT01959529|5668443|P2|Overall Study|Other|68
1623997|NCT01959529|5668444|P1|Overall Study|Other|70
1623998|NCT01959529|5668443|P2|Overall Study|Lost to Follow-up|1
1623999|NCT01959529|5668444|P1|Overall Study|Lost to Follow-up|4
1624000|NCT01959529|5668443|P2|Overall Study|Adverse event (not hypoglycaemia)|1
1624001|NCT01959529|5668444|P1|Overall Study|Adverse event (not hypoglycaemia)|0
1624002|NCT01959516|5668456|P2|Epoch 2|Moderate or severe COPD exacerbation|1
1624003|NCT01959516|5668457|P1|Epoch 2|Moderate or severe COPD exacerbation|0
1624004|NCT01959516|5668456|P2|Epoch 2|Subject withdrew consent|0
1624005|NCT01959516|5668457|P1|Epoch 2|Subject withdrew consent|1
1624006|NCT01959516|5668456|P2|Epoch 2|unsatisfactory therapeutic effect|0
1624007|NCT01959516|5668457|P1|Epoch 2|unsatisfactory therapeutic effect|1
1624008|NCT01959516|5668456|P2|Epoch 1|Protocol deviation|1
1624009|NCT01959516|5668457|P1|Epoch 1|Protocol deviation|0
1624010|NCT01959516|5668456|P2|Epoch 1|Moderate or severe COPD exacerbation|1
1624011|NCT01959516|5668457|P1|Epoch 1|Moderate or severe COPD exacerbation|0
1624012|NCT01959516|5668456|P2|Epoch 1|Use of prohibited treatment|0
1624013|NCT01959516|5668457|P1|Epoch 1|Use of prohibited treatment|1
1624014|NCT01959516|5668456|P2|Epoch 1|Administrative problems|0
1624015|NCT01959516|5668457|P1|Epoch 1|Administrative problems|1
1624016|NCT01959516|5668456|P2|Epoch 1|Subject withdrew consent|2
1624017|NCT01959516|5668457|P1|Epoch 1|Subject withdrew consent|3
1624018|NCT01959516|5668456|P2|Epoch 1|unsatisfactory therapeutic effect|0
1624019|NCT01959516|5668457|P1|Epoch 1|unsatisfactory therapeutic effect|1
1624020|NCT01959516|5668456|P2|Epoch 1|Adverse Event|1
1624021|NCT01959516|5668457|P1|Epoch 1|Adverse Event|4
1624022|NCT01959503|5668467|P2|Overall Study|Randomized but not treated|1
1624023|NCT01959503|5668468|P1|Overall Study|Randomized but not treated|1
1624024|NCT01959503|5668467|P2|Overall Study|Death|1
1624025|NCT01959503|5668468|P1|Overall Study|Death|2
1624026|NCT01959412|5668519|P6|Overall Study|Adverse Event|0
1624027|NCT01959412|5668520|P5|Overall Study|Adverse Event|0
1624028|NCT01959412|5668521|P4|Overall Study|Adverse Event|1
1624029|NCT01959412|5668522|P3|Overall Study|Adverse Event|0
1624030|NCT01959412|5668523|P2|Overall Study|Adverse Event|0
1624031|NCT01959412|5668524|P1|Overall Study|Adverse Event|0
1624032|NCT01959412|5668519|P6|Overall Study|Protocol deviation|0
1624033|NCT01959412|5668520|P5|Overall Study|Protocol deviation|3
1624034|NCT01959412|5668521|P4|Overall Study|Protocol deviation|1
1624035|NCT01959412|5668522|P3|Overall Study|Protocol deviation|0
1624036|NCT01959412|5668523|P2|Overall Study|Protocol deviation|1
1624037|NCT01959412|5668524|P1|Overall Study|Protocol deviation|1
1624038|NCT01959334|5668564|P2|Third Dose|Adverse Event|1
1624039|NCT01959334|5668565|P1|Third Dose|Adverse Event|0
1624040|NCT01959334|5668564|P2|Second Dose|Adverse Event|0
1624041|NCT01959334|5668565|P1|Second Dose|Adverse Event|1
1624042|NCT01959243|5668577|P2|Overall Study|Lost to Follow-up|1
1624043|NCT01959243|5668578|P1|Overall Study|Lost to Follow-up|3
1624044|NCT01959243|5668577|P2|Overall Study|Administrative reasons|1
1624045|NCT01959243|5668578|P1|Overall Study|Administrative reasons|2
1624046|NCT01959243|5668577|P2|Overall Study|Adverse Event|2
1624047|NCT01959243|5668578|P1|Overall Study|Adverse Event|5
1624048|NCT01959243|5668577|P2|Overall Study|Investigator Decision|0
1624049|NCT01959243|5668578|P1|Overall Study|Investigator Decision|3
1624050|NCT01959230|5668590|P2|Overall Study|Withdrawal by Subject|0
1624051|NCT01959230|5668591|P1|Overall Study|Withdrawal by Subject|2
1624052|NCT01959230|5668590|P2|Overall Study|Administrative reasons|0
1624053|NCT01959230|5668591|P1|Overall Study|Administrative reasons|2
1624054|NCT01959230|5668590|P2|Overall Study|Failure to follow study procedures|1
1624055|NCT01959230|5668591|P1|Overall Study|Failure to follow study procedures|0
1624056|NCT01959165|5668605|P4|Overall Study|Welfare recipient|0
1624057|NCT01959165|5668606|P3|Overall Study|Welfare recipient|0
1624058|NCT01959165|5668607|P2|Overall Study|Welfare recipient|1
1624059|NCT01959165|5668608|P1|Overall Study|Welfare recipient|0
1624060|NCT01959165|5668605|P4|Overall Study|overdose|1
1624061|NCT01959165|5668606|P3|Overall Study|overdose|0
1624062|NCT01959165|5668607|P2|Overall Study|overdose|0
1624063|NCT01959165|5668608|P1|Overall Study|overdose|0
1624064|NCT01959165|5668605|P4|Overall Study|Lack of Efficacy|0
1624065|NCT01959165|5668606|P3|Overall Study|Lack of Efficacy|0
1624066|NCT01959165|5668607|P2|Overall Study|Lack of Efficacy|0
1624067|NCT01959165|5668608|P1|Overall Study|Lack of Efficacy|1
1624068|NCT01959165|5668605|P4|Overall Study|Adverse Event|1
1624069|NCT01959165|5668606|P3|Overall Study|Adverse Event|0
1624070|NCT01959165|5668607|P2|Overall Study|Adverse Event|0
1624071|NCT01959165|5668608|P1|Overall Study|Adverse Event|0
1624072|NCT01959139|5668634|P4|Phase II|On treatment|0
1624073|NCT01959139|5668635|P3|Phase II|On treatment|4
1624074|NCT01959139|5668636|P2|Phase II|On treatment|0
1624075|NCT01959139|5668637|P1|Phase II|On treatment|0
1624076|NCT01959139|5668634|P4|Phase II|Other/Unknown|5
1624077|NCT01959139|5668635|P3|Phase II|Other/Unknown|8
1624078|NCT01959139|5668636|P2|Phase II|Other/Unknown|0
1624079|NCT01959139|5668637|P1|Phase II|Other/Unknown|0
1624080|NCT01959139|5668634|P4|Phase II|Death|1
1624081|NCT01959139|5668635|P3|Phase II|Death|3
1624082|NCT01959139|5668636|P2|Phase II|Death|0
1624083|NCT01959139|5668637|P1|Phase II|Death|0
1624084|NCT01959139|5668634|P4|Phase II|Patient Refusal|4
1624085|NCT01959139|5668635|P3|Phase II|Patient Refusal|5
1624086|NCT01959139|5668636|P2|Phase II|Patient Refusal|0
1624087|NCT01959139|5668637|P1|Phase II|Patient Refusal|0
1624088|NCT01959139|5668634|P4|Phase II|Adverse Event|11
1624089|NCT01959139|5668635|P3|Phase II|Adverse Event|10
1624090|NCT01959139|5668636|P2|Phase II|Adverse Event|0
1624091|NCT01959139|5668637|P1|Phase II|Adverse Event|0
1624092|NCT01959139|5668634|P4|Phase II|Disease progression|34
1624093|NCT01959139|5668635|P3|Phase II|Disease progression|26
1624094|NCT01959139|5668636|P2|Phase II|Disease progression|0
1624095|NCT01959139|5668637|P1|Phase II|Disease progression|0
1624096|NCT01959035|5668664|P1|Overall Study|Other (no primary reason given)|1
1624097|NCT01959035|5668664|P1|Overall Study|Lost to Follow-up|1
1624098|NCT01959035|5668664|P1|Overall Study|Withdrawal by Subject|4
1624099|NCT01959035|5668664|P1|Overall Study|Adverse Event|5
1624100|NCT01958918|5668692|P2|Overall Study|administrative problems|2
1624101|NCT01958918|5668693|P1|Overall Study|administrative problems|0
1624102|NCT01958918|5668692|P2|Overall Study|Adverse Event|12
1624103|NCT01958918|5668693|P1|Overall Study|Adverse Event|12
1624104|NCT01958918|5668692|P2|Overall Study|Lack of Efficacy|10
1624105|NCT01958918|5668693|P1|Overall Study|Lack of Efficacy|13
1624106|NCT01958918|5668692|P2|Overall Study|Withdrawal by Subject|8
1624107|NCT01958918|5668693|P1|Overall Study|Withdrawal by Subject|13
1624108|NCT01958918|5668692|P2|Overall Study|Lost to Follow-up|7
1624109|NCT01958918|5668693|P1|Overall Study|Lost to Follow-up|4
1624110|NCT01958918|5668692|P2|Overall Study|Death|3
1624111|NCT01958918|5668693|P1|Overall Study|Death|1
1624112|NCT01958827|5668707|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
1624113|NCT01958827|5668707|P1|Overall Study|Lack of Efficacy|6
1624114|NCT01958827|5668707|P1|Overall Study|Adverse Event|3
1624115|NCT01958671|5668738|P3|Overall Study|Withdrawal by Subject|13
1624116|NCT01958671|5668739|P2|Overall Study|Withdrawal by Subject|10
1624117|NCT01958671|5668740|P1|Overall Study|Withdrawal by Subject|8
1624118|NCT01958671|5668738|P3|Overall Study|Participant moved|1
1624119|NCT01958671|5668739|P2|Overall Study|Participant moved|0
1624120|NCT01958671|5668740|P1|Overall Study|Participant moved|0
1624121|NCT01958671|5668738|P3|Overall Study|Study site terminated by sponsor|1
1624122|NCT01958671|5668739|P2|Overall Study|Study site terminated by sponsor|0
1624123|NCT01958671|5668740|P1|Overall Study|Study site terminated by sponsor|1
1624124|NCT01958671|5668738|P3|Overall Study|Protocol Violation|0
1624125|NCT01958671|5668739|P2|Overall Study|Protocol Violation|1
1624126|NCT01958671|5668740|P1|Overall Study|Protocol Violation|0
1624127|NCT01958671|5668738|P3|Overall Study|Pregnancy|1
1624128|NCT01958671|5668739|P2|Overall Study|Pregnancy|0
1624129|NCT01958671|5668740|P1|Overall Study|Pregnancy|0
1624130|NCT01958671|5668738|P3|Overall Study|Non-compliance with study drug|1
1624131|NCT01958671|5668739|P2|Overall Study|Non-compliance with study drug|1
1624132|NCT01958671|5668740|P1|Overall Study|Non-compliance with study drug|1
1624133|NCT01958671|5668738|P3|Overall Study|Lost to Follow-up|7
1624134|NCT01958671|5668739|P2|Overall Study|Lost to Follow-up|11
1624135|NCT01958671|5668740|P1|Overall Study|Lost to Follow-up|7
1624136|NCT01958671|5668738|P3|Overall Study|Hyperglycemia|2
1624137|NCT01958671|5668739|P2|Overall Study|Hyperglycemia|0
1624138|NCT01958671|5668740|P1|Overall Study|Hyperglycemia|0
1624139|NCT01958671|5668738|P3|Overall Study|Excluded medication|1
1624140|NCT01958671|5668739|P2|Overall Study|Excluded medication|0
1624141|NCT01958671|5668740|P1|Overall Study|Excluded medication|0
1624142|NCT01958671|5668738|P3|Overall Study|Death|0
1624143|NCT01958671|5668739|P2|Overall Study|Death|0
1624144|NCT01958671|5668740|P1|Overall Study|Death|1
1624145|NCT01958671|5668738|P3|Overall Study|Adverse Event|5
1624146|NCT01958671|5668739|P2|Overall Study|Adverse Event|1
1624147|NCT01958671|5668740|P1|Overall Study|Adverse Event|1
1624148|NCT01958619|5668814|P4|Overall Study|Protocol Violation|0
1624149|NCT01958619|5668815|P3|Overall Study|Protocol Violation|1
1624150|NCT01958619|5668816|P2|Overall Study|Protocol Violation|0
1624151|NCT01958619|5668817|P1|Overall Study|Protocol Violation|2
1624152|NCT01958489|5668878|P2|Period 2|Adverse Event|1
1624153|NCT01958489|5668879|P1|Period 2|Adverse Event|0
1624154|NCT01958476|5668895|P2|Overall Study|Parent requested exclusion from analysis|0
1624155|NCT01958476|5668896|P1|Overall Study|Parent requested exclusion from analysis|1
1624156|NCT01958437|5668926|P4|Overall Study|Incidental MRI findings|1
1624157|NCT01958437|5668927|P3|Overall Study|Incidental MRI findings|1
1624158|NCT01958437|5668928|P2|Overall Study|Incidental MRI findings|0
1624159|NCT01958437|5668929|P1|Overall Study|Incidental MRI findings|0
1624160|NCT01958294|5668993|P1|Overall Study|Clinical Circumstances|2
1624161|NCT01958281|5669002|P3|Overall Study|Withdrew Consent|0
1624162|NCT01958281|5669003|P2|Overall Study|Withdrew Consent|0
1624163|NCT01958281|5669004|P1|Overall Study|Withdrew Consent|1
1624164|NCT01958281|5669002|P3|Overall Study|Adverse Event|0
1624165|NCT01958281|5669003|P2|Overall Study|Adverse Event|2
1624166|NCT01958281|5669004|P1|Overall Study|Adverse Event|0
1624167|NCT01958281|5669002|P3|Overall Study|Lack of Efficacy|0
1624168|NCT01958281|5669003|P2|Overall Study|Lack of Efficacy|2
1624169|NCT01958281|5669004|P1|Overall Study|Lack of Efficacy|5
1624170|NCT01958164|5669080|P2|Overall Study|Lost to Follow-up|3
1624171|NCT01958164|5669081|P1|Overall Study|Lost to Follow-up|2
1624172|NCT01958164|5669080|P2|Overall Study|Adverse Event|2
1624173|NCT01958164|5669081|P1|Overall Study|Adverse Event|0
1624174|NCT01958125|5669096|P2|Overall Study|No headache attacks|2
1624175|NCT01958125|5669097|P1|Overall Study|No headache attacks|0
1624176|NCT01958125|5669096|P2|Overall Study|Missing diary data|6
1624177|NCT01958125|5669097|P1|Overall Study|Missing diary data|2
1624178|NCT01958060|5669125|P6|Overall Study|Not treated|0
1624179|NCT01958060|5669126|P5|Overall Study|Not treated|1
1624180|NCT01958060|5669127|P4|Overall Study|Not treated|0
1624181|NCT01958060|5669128|P3|Overall Study|Not treated|0
1624182|NCT01958060|5669129|P2|Overall Study|Not treated|0
1624183|NCT01958060|5669130|P1|Overall Study|Not treated|2
1624184|NCT01958021|5669155|P2|Overall Study|Death|0
1624185|NCT01958021|5669156|P1|Overall Study|Death|2
1624186|NCT01958021|5669155|P2|Overall Study|Protocol Violation|1
1624187|NCT01958021|5669156|P1|Overall Study|Protocol Violation|3
1624188|NCT01958021|5669155|P2|Overall Study|Physician Decision|13
1624189|NCT01958021|5669156|P1|Overall Study|Physician Decision|10
1624190|NCT01958021|5669155|P2|Overall Study|Subject/guardian decision|13
1624191|NCT01958021|5669156|P1|Overall Study|Subject/guardian decision|12
1624192|NCT01958021|5669155|P2|Overall Study|Adverse Event|7
1624193|NCT01958021|5669156|P1|Overall Study|Adverse Event|25
1624194|NCT01958021|5669155|P2|Overall Study|Progressive disease|146
1624195|NCT01958021|5669156|P1|Overall Study|Progressive disease|87
1624196|NCT01958008|5669168|P4|Overall Study|Other adverse event|0
1624197|NCT01958008|5669169|P3|Overall Study|Other adverse event|0
1624198|NCT01958008|5669170|P2|Overall Study|Other adverse event|0
1624199|NCT01958008|5669171|P1|Overall Study|Other adverse event|1
1624200|NCT01958008|5669168|P4|Overall Study|Worsening of disease under study|0
1624201|NCT01958008|5669169|P3|Overall Study|Worsening of disease under study|1
1624202|NCT01958008|5669170|P2|Overall Study|Worsening of disease under study|0
1624203|NCT01958008|5669171|P1|Overall Study|Worsening of disease under study|0
1624204|NCT01957865|5669211|P3|Overall Study|Lost to Follow-up|2
1624205|NCT01957865|5669212|P2|Overall Study|Lost to Follow-up|2
1624206|NCT01957865|5669213|P1|Overall Study|Lost to Follow-up|0
1624207|NCT01957865|5669211|P3|Overall Study|Found HIV negative|1
1624208|NCT01957865|5669212|P2|Overall Study|Found HIV negative|0
1624209|NCT01957865|5669213|P1|Overall Study|Found HIV negative|0
1624210|NCT01957787|5669224|P1|Overall Study|Local therapy, not cryoablation|6
1624211|NCT01957787|5669224|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
1624212|NCT01957787|5669224|P1|Overall Study|Index Tumor(s) Resected|2
1624213|NCT01957787|5669224|P1|Overall Study|Entered Hospice or Similar Program|2
1624214|NCT01957787|5669224|P1|Overall Study|Withdrawal by Subject|3
1624215|NCT01957787|5669224|P1|Overall Study|Lost to Follow-up|3
1624216|NCT01957787|5669224|P1|Overall Study|Death|18
1624217|NCT01957709|5669243|P1|Overall Study|Patient refused to complete post-tx bx|1
1624218|NCT01957644|5669268|P5|Overall Study|Protocol Violation|0
1624219|NCT01957644|5669269|P4|Overall Study|Protocol Violation|0
1624220|NCT01957644|5669270|P3|Overall Study|Protocol Violation|0
1624221|NCT01957644|5669271|P2|Overall Study|Protocol Violation|1
1624222|NCT01957644|5669272|P1|Overall Study|Protocol Violation|0
1624223|NCT01957644|5669268|P5|Overall Study|Withdrawal by Subject|0
1624224|NCT01957644|5669269|P4|Overall Study|Withdrawal by Subject|0
1624225|NCT01957644|5669270|P3|Overall Study|Withdrawal by Subject|0
1624226|NCT01957644|5669271|P2|Overall Study|Withdrawal by Subject|0
1624227|NCT01957644|5669272|P1|Overall Study|Withdrawal by Subject|1
1624228|NCT01957644|5669268|P5|Overall Study|Other reason|0
1624229|NCT01957644|5669269|P4|Overall Study|Other reason|1
1624230|NCT01957644|5669270|P3|Overall Study|Other reason|1
1624231|NCT01957644|5669271|P2|Overall Study|Other reason|2
1624232|NCT01957644|5669272|P1|Overall Study|Other reason|1
1624233|NCT01957644|5669268|P5|Overall Study|Progressive disease / relapse|0
1624234|NCT01957644|5669269|P4|Overall Study|Progressive disease / relapse|1
1624235|NCT01957644|5669270|P3|Overall Study|Progressive disease / relapse|0
1624236|NCT01957644|5669271|P2|Overall Study|Progressive disease / relapse|1
1624237|NCT01957644|5669272|P1|Overall Study|Progressive disease / relapse|0
1624238|NCT01957644|5669268|P5|Overall Study|Adverse Event|1
1624239|NCT01957644|5669269|P4|Overall Study|Adverse Event|0
1624240|NCT01957644|5669270|P3|Overall Study|Adverse Event|0
1624241|NCT01957644|5669271|P2|Overall Study|Adverse Event|2
1624242|NCT01957644|5669272|P1|Overall Study|Adverse Event|4
1624243|NCT01957579|5669296|P4|Overall Study|Death|0
1624244|NCT01957579|5669297|P3|Overall Study|Death|2
1624245|NCT01957579|5669298|P2|Overall Study|Death|0
1624246|NCT01957579|5669299|P1|Overall Study|Death|0
1624247|NCT01957579|5669296|P4|Overall Study|Withdrawal of concent|0
1624248|NCT01957579|5669297|P3|Overall Study|Withdrawal of concent|0
1624249|NCT01957579|5669298|P2|Overall Study|Withdrawal of concent|1
1624250|NCT01957579|5669299|P1|Overall Study|Withdrawal of concent|0
1624251|NCT01957553|5669366|P2|Test Period 2 (21 +- 1 Days)|Other|0
1624252|NCT01957553|5669367|P1|Test Period 2 (21 +- 1 Days)|Other|1
1624253|NCT01957553|5669366|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
1624254|NCT01957553|5669367|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
1624255|NCT01957553|5669366|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
1624256|NCT01957553|5669367|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
1624257|NCT01957553|5669366|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
1624258|NCT01957553|5669367|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
1624259|NCT01957553|5669366|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
1624260|NCT01957553|5669367|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
1624261|NCT01957553|5669366|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
1624262|NCT01957553|5669367|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
1624263|NCT01957553|5669366|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
1624264|NCT01957553|5669367|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
1624265|NCT01957553|5669366|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
1624266|NCT01957553|5669367|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
1624267|NCT01957553|5669366|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
1624268|NCT01957553|5669367|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
1624269|NCT01957488|5669373|P6|Test Period 3|Lack of Efficacy|0
1624270|NCT01957488|5669374|P5|Test Period 3|Lack of Efficacy|0
1624271|NCT01957488|5669375|P4|Test Period 3|Lack of Efficacy|0
1624272|NCT01957488|5669376|P3|Test Period 3|Lack of Efficacy|0
1624273|NCT01957488|5669377|P2|Test Period 3|Lack of Efficacy|1
1624274|NCT01957488|5669378|P1|Test Period 3|Lack of Efficacy|0
1624275|NCT01957488|5669373|P6|Test Period 3|Withdrawal by Subject|0
1624276|NCT01957488|5669374|P5|Test Period 3|Withdrawal by Subject|0
1624277|NCT01957488|5669375|P4|Test Period 3|Withdrawal by Subject|0
1624278|NCT01957488|5669376|P3|Test Period 3|Withdrawal by Subject|0
1624279|NCT01957488|5669377|P2|Test Period 3|Withdrawal by Subject|0
1624280|NCT01957488|5669378|P1|Test Period 3|Withdrawal by Subject|1
1624281|NCT01957488|5669373|P6|Test Period 2|Discontinue due to personal problems|1
1624282|NCT01957488|5669374|P5|Test Period 2|Discontinue due to personal problems|0
1624283|NCT01957488|5669375|P4|Test Period 2|Discontinue due to personal problems|0
1624284|NCT01957488|5669376|P3|Test Period 2|Discontinue due to personal problems|0
1624285|NCT01957488|5669377|P2|Test Period 2|Discontinue due to personal problems|0
1624286|NCT01957488|5669378|P1|Test Period 2|Discontinue due to personal problems|0
1624287|NCT01957488|5669373|P6|Test Period 2|Adverse Event|0
1624288|NCT01957488|5669374|P5|Test Period 2|Adverse Event|2
1624289|NCT01957488|5669375|P4|Test Period 2|Adverse Event|0
1624290|NCT01957488|5669376|P3|Test Period 2|Adverse Event|0
1624291|NCT01957488|5669377|P2|Test Period 2|Adverse Event|0
1624292|NCT01957488|5669378|P1|Test Period 2|Adverse Event|0
1624293|NCT01957488|5669373|P6|Test Period 2|Withdrawal by Subject|0
1624294|NCT01957488|5669374|P5|Test Period 2|Withdrawal by Subject|0
1624295|NCT01957488|5669375|P4|Test Period 2|Withdrawal by Subject|0
1624296|NCT01957488|5669376|P3|Test Period 2|Withdrawal by Subject|0
1624297|NCT01957488|5669377|P2|Test Period 2|Withdrawal by Subject|1
1624298|NCT01957488|5669378|P1|Test Period 2|Withdrawal by Subject|0
1624299|NCT01957488|5669373|P6|Test Period 2|Other|0
1624300|NCT01957488|5669374|P5|Test Period 2|Other|0
1624301|NCT01957488|5669375|P4|Test Period 2|Other|0
1624302|NCT01957488|5669376|P3|Test Period 2|Other|0
1624303|NCT01957488|5669377|P2|Test Period 2|Other|0
1624304|NCT01957488|5669378|P1|Test Period 2|Other|1
1624305|NCT01957488|5669373|P6|Test Period 2|Protocol Violation|0
1624306|NCT01957488|5669374|P5|Test Period 2|Protocol Violation|0
1624307|NCT01957488|5669375|P4|Test Period 2|Protocol Violation|1
1624308|NCT01957488|5669376|P3|Test Period 2|Protocol Violation|1
1624309|NCT01957488|5669377|P2|Test Period 2|Protocol Violation|0
1624310|NCT01957488|5669378|P1|Test Period 2|Protocol Violation|2
1624311|NCT01957488|5669373|P6|Test Period 1|screen failure|1
1624312|NCT01957488|5669374|P5|Test Period 1|screen failure|0
1624313|NCT01957488|5669375|P4|Test Period 1|screen failure|0
1624314|NCT01957488|5669376|P3|Test Period 1|screen failure|0
1624315|NCT01957488|5669377|P2|Test Period 1|screen failure|0
1624316|NCT01957488|5669378|P1|Test Period 1|screen failure|0
1624317|NCT01957488|5669373|P6|Test Period 1|subject did not want to wait for cut bag|0
1624318|NCT01957488|5669374|P5|Test Period 1|subject did not want to wait for cut bag|1
1624319|NCT01957488|5669375|P4|Test Period 1|subject did not want to wait for cut bag|0
1624320|NCT01957488|5669376|P3|Test Period 1|subject did not want to wait for cut bag|0
1624321|NCT01957488|5669377|P2|Test Period 1|subject did not want to wait for cut bag|0
1624322|NCT01957488|5669378|P1|Test Period 1|subject did not want to wait for cut bag|0
1624323|NCT01957488|5669373|P6|Test Period 1|Withdrawal by Subject|2
1624324|NCT01957488|5669374|P5|Test Period 1|Withdrawal by Subject|1
1624325|NCT01957488|5669375|P4|Test Period 1|Withdrawal by Subject|1
1624326|NCT01957488|5669376|P3|Test Period 1|Withdrawal by Subject|0
1624327|NCT01957488|5669377|P2|Test Period 1|Withdrawal by Subject|0
1624328|NCT01957488|5669378|P1|Test Period 1|Withdrawal by Subject|0
1624329|NCT01957488|5669373|P6|Test Period 1|Adverse Event|0
1624330|NCT01957488|5669374|P5|Test Period 1|Adverse Event|1
1624331|NCT01957488|5669375|P4|Test Period 1|Adverse Event|0
1624332|NCT01957488|5669376|P3|Test Period 1|Adverse Event|1
1624333|NCT01957488|5669377|P2|Test Period 1|Adverse Event|1
1624334|NCT01957488|5669378|P1|Test Period 1|Adverse Event|0
1624335|NCT01957488|5669373|P6|Test Period 1|Protocol Violation|3
1624336|NCT01957488|5669374|P5|Test Period 1|Protocol Violation|0
1624337|NCT01957488|5669375|P4|Test Period 1|Protocol Violation|1
1624338|NCT01957488|5669376|P3|Test Period 1|Protocol Violation|2
1624339|NCT01957488|5669377|P2|Test Period 1|Protocol Violation|2
1624340|NCT01957488|5669378|P1|Test Period 1|Protocol Violation|1
1624341|NCT01957488|5669373|P6|Test Period 1|Lost to Follow-up|0
1624342|NCT01957488|5669374|P5|Test Period 1|Lost to Follow-up|0
1624343|NCT01957488|5669375|P4|Test Period 1|Lost to Follow-up|1
1624344|NCT01957488|5669376|P3|Test Period 1|Lost to Follow-up|1
1624345|NCT01957488|5669377|P2|Test Period 1|Lost to Follow-up|0
1624346|NCT01957488|5669378|P1|Test Period 1|Lost to Follow-up|2
1624347|NCT01957475|5669386|P2|Test Period 2|Adverse Event|0
1624348|NCT01957475|5669387|P1|Test Period 2|Adverse Event|1
1624349|NCT01957475|5669386|P2|Test Period 1|Lack of Efficacy|1
1624350|NCT01957475|5669387|P1|Test Period 1|Lack of Efficacy|0
1624351|NCT01957475|5669386|P2|Test Period 1|Other|0
1624352|NCT01957475|5669387|P1|Test Period 1|Other|1
1624353|NCT01957475|5669386|P2|Test Period 1|Withdrawal by Subject|0
1624354|NCT01957475|5669387|P1|Test Period 1|Withdrawal by Subject|1
1624355|NCT01957462|5669393|P2|Test Period 1|Adverse Event|0
1624356|NCT01957462|5669394|P1|Test Period 1|Adverse Event|1
1624357|NCT01957462|5669393|P2|Test Period 1|Withdrawal by Subject|0
1624358|NCT01957462|5669394|P1|Test Period 1|Withdrawal by Subject|1
1624359|NCT01957397|5669405|P2|Test Period 3|the adhesive did not work|0
1624360|NCT01957397|5669406|P1|Test Period 3|the adhesive did not work|1
1624361|NCT01957397|5669405|P2|Test Period 3|Adverse Event|2
1624362|NCT01957397|5669406|P1|Test Period 3|Adverse Event|1
1624363|NCT01957397|5669405|P2|Test Period 2|Adverse Event|1
1624364|NCT01957397|5669406|P1|Test Period 2|Adverse Event|0
1624365|NCT01957397|5669405|P2|Test Period 1|Withdrawal by Subject|0
1624366|NCT01957397|5669406|P1|Test Period 1|Withdrawal by Subject|1
1624367|NCT01957397|5669405|P2|Test Period 1|sudden leakage/small bag|1
1624368|NCT01957397|5669406|P1|Test Period 1|sudden leakage/small bag|1
1624369|NCT01957215|5669431|P2|Overall Study|Withdrawal by Subject|5
1624370|NCT01957215|5669432|P1|Overall Study|Withdrawal by Subject|7
1624371|NCT01957215|5669431|P2|Overall Study|Protocol Violation|2
1624372|NCT01957215|5669432|P1|Overall Study|Protocol Violation|1
1624373|NCT01957215|5669431|P2|Overall Study|Lost to Follow-up|3
1624374|NCT01957215|5669432|P1|Overall Study|Lost to Follow-up|3
1624375|NCT01957215|5669431|P2|Overall Study|Adverse Event|2
1624376|NCT01957215|5669432|P1|Overall Study|Adverse Event|2
1624377|NCT01957202|5669460|P18|Treatment Period 3 (8 Days)|Adverse Event|0
1624378|NCT01957202|5669461|P17|Treatment Period 3 (8 Days)|Adverse Event|1
1624379|NCT01957202|5669462|P16|Treatment Period 3 (8 Days)|Adverse Event|0
1624380|NCT01957202|5669463|P15|Treatment Period 3 (8 Days)|Adverse Event|0
1624381|NCT01957202|5669464|P14|Treatment Period 3 (8 Days)|Adverse Event|0
1624382|NCT01957202|5669465|P13|Treatment Period 3 (8 Days)|Adverse Event|0
1624383|NCT01957202|5669466|P12|Treatment Period 3 (8 Days)|Adverse Event|0
1624384|NCT01957202|5669467|P11|Treatment Period 3 (8 Days)|Adverse Event|0
1624385|NCT01957202|5669468|P10|Treatment Period 3 (8 Days)|Adverse Event|0
1624386|NCT01957202|5669469|P9|Treatment Period 3 (8 Days)|Adverse Event|0
1624387|NCT01957202|5669470|P8|Treatment Period 3 (8 Days)|Adverse Event|0
1624388|NCT01957202|5669471|P7|Treatment Period 3 (8 Days)|Adverse Event|0
1624389|NCT01957202|5669472|P6|Treatment Period 3 (8 Days)|Adverse Event|0
1624390|NCT01957202|5669473|P5|Treatment Period 3 (8 Days)|Adverse Event|0
1624391|NCT01957202|5669474|P4|Treatment Period 3 (8 Days)|Adverse Event|0
1624392|NCT01957202|5669475|P3|Treatment Period 3 (8 Days)|Adverse Event|0
1624393|NCT01957202|5669476|P2|Treatment Period 3 (8 Days)|Adverse Event|0
1624394|NCT01957202|5669477|P1|Treatment Period 3 (8 Days)|Adverse Event|0
1624395|NCT01957202|5669460|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624396|NCT01957202|5669461|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1624397|NCT01957202|5669462|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624398|NCT01957202|5669463|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624399|NCT01957202|5669464|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624400|NCT01957202|5669465|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624401|NCT01957202|5669466|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624402|NCT01957202|5669467|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624403|NCT01957202|5669468|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624404|NCT01957202|5669469|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624405|NCT01957202|5669470|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624406|NCT01957202|5669471|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624407|NCT01957202|5669472|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624408|NCT01957202|5669473|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624409|NCT01957202|5669474|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624410|NCT01957202|5669475|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624411|NCT01957202|5669476|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
1624412|NCT01957202|5669477|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
1624413|NCT01957163|5669502|P3|Overall Study|Withdrawal by Subject|4
1624414|NCT01957163|5669503|P2|Overall Study|Withdrawal by Subject|2
1624415|NCT01957163|5669504|P1|Overall Study|Withdrawal by Subject|4
1624416|NCT01957163|5669502|P3|Overall Study|Lost to Follow-up|0
1624417|NCT01957163|5669503|P2|Overall Study|Lost to Follow-up|1
1624418|NCT01957163|5669504|P1|Overall Study|Lost to Follow-up|0
1624419|NCT01957163|5669502|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
1624420|NCT01957163|5669503|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
1624421|NCT01957163|5669504|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
1624422|NCT01957163|5669502|P3|Overall Study|Protocol Violation|0
1624423|NCT01957163|5669503|P2|Overall Study|Protocol Violation|2
1624424|NCT01957163|5669504|P1|Overall Study|Protocol Violation|1
1624425|NCT01957163|5669502|P3|Overall Study|Lack of Efficacy|9
1624426|NCT01957163|5669503|P2|Overall Study|Lack of Efficacy|4
1624427|NCT01957163|5669504|P1|Overall Study|Lack of Efficacy|5
1624428|NCT01957163|5669502|P3|Overall Study|Adverse Event|4
1624429|NCT01957163|5669503|P2|Overall Study|Adverse Event|2
1624430|NCT01957163|5669504|P1|Overall Study|Adverse Event|5
1624431|NCT01957150|5669517|P2|Overall Study|Lack of Efficacy|11
1624432|NCT01957150|5669518|P1|Overall Study|Lack of Efficacy|11
1624433|NCT01957150|5669517|P2|Overall Study|Protocol Violation|0
1624434|NCT01957150|5669518|P1|Overall Study|Protocol Violation|1
1624435|NCT01957150|5669517|P2|Overall Study|Lost to Follow-up|4
1624436|NCT01957150|5669518|P1|Overall Study|Lost to Follow-up|4
1624437|NCT01957150|5669517|P2|Overall Study|Physician Decision|6
1624438|NCT01957150|5669518|P1|Overall Study|Physician Decision|3
1624439|NCT01957150|5669517|P2|Overall Study|Withdrawal by Subject|17
1624440|NCT01957150|5669518|P1|Overall Study|Withdrawal by Subject|13
1624441|NCT01957150|5669517|P2|Overall Study|Adverse Event|20
1624442|NCT01957150|5669518|P1|Overall Study|Adverse Event|23
1624443|NCT01957137|5669534|P1|Randomized Portion|Withdrawal by Subject|1
1624444|NCT01957137|5669534|P1|Randomized Portion|Adverse Event|1
1624445|NCT01957111|5669564|P2|Overall Study|Withdrawal by Subject|1
1624446|NCT01957111|5669565|P1|Overall Study|Withdrawal by Subject|1
1624447|NCT01956773|5669575|P2|Overall Study|Lost to Follow-up|1
1624448|NCT01956773|5669576|P1|Overall Study|Lost to Follow-up|628
1624449|NCT01956240|5669597|P2|Overall Study|Adverse Event|4
1624450|NCT01956240|5669598|P1|Overall Study|Adverse Event|17
1624451|NCT01956240|5669597|P2|Overall Study|Lost to Follow-up|20
1624452|NCT01956240|5669598|P1|Overall Study|Lost to Follow-up|6
1624453|NCT01956123|5669608|P4|COS Cycle 3|Withdrawal by Subject|1
1624454|NCT01956123|5669609|P3|COS Cycle 3|Withdrawal by Subject|0
1624455|NCT01956123|5669610|P2|COS Cycle 3|Withdrawal by Subject|0
1624456|NCT01956123|5669611|P1|COS Cycle 3|Withdrawal by Subject|0
1624457|NCT01956123|5669608|P4|COS Cycle 3|Personal Reasons|0
1624458|NCT01956123|5669609|P3|COS Cycle 3|Personal Reasons|1
1624459|NCT01956123|5669610|P2|COS Cycle 3|Personal Reasons|0
1624460|NCT01956123|5669611|P1|COS Cycle 3|Personal Reasons|0
1624461|NCT01956123|5669608|P4|COS Cycle 3|Adverse Event|0
1624462|NCT01956123|5669609|P3|COS Cycle 3|Adverse Event|3
1624463|NCT01956123|5669610|P2|COS Cycle 3|Adverse Event|0
1624464|NCT01956123|5669611|P1|COS Cycle 3|Adverse Event|0
1624465|NCT01956123|5669608|P4|COS Cycle 3|Protocol Violation|1
1624466|NCT01956123|5669609|P3|COS Cycle 3|Protocol Violation|2
1624467|NCT01956123|5669610|P2|COS Cycle 3|Protocol Violation|0
1624468|NCT01956123|5669611|P1|COS Cycle 3|Protocol Violation|0
1624469|NCT01956123|5669608|P4|COS Cycle 2|Withdrawal by Subject|0
1624470|NCT01956123|5669609|P3|COS Cycle 2|Withdrawal by Subject|0
1624471|NCT01956123|5669610|P2|COS Cycle 2|Withdrawal by Subject|0
1624472|NCT01956123|5669611|P1|COS Cycle 2|Withdrawal by Subject|1
1624473|NCT01956123|5669608|P4|COS Cycle 2|Personal Reasons|0
1624474|NCT01956123|5669609|P3|COS Cycle 2|Personal Reasons|0
1624475|NCT01956123|5669610|P2|COS Cycle 2|Personal Reasons|0
1624476|NCT01956123|5669611|P1|COS Cycle 2|Personal Reasons|2
1624477|NCT01956123|5669608|P4|COS Cycle 2|Adverse Event|0
1624478|NCT01956123|5669609|P3|COS Cycle 2|Adverse Event|0
1624479|NCT01956123|5669610|P2|COS Cycle 2|Adverse Event|4
1624480|NCT01956123|5669611|P1|COS Cycle 2|Adverse Event|3
1624481|NCT01956123|5669608|P4|COS Cycle 2|Protocol Violation|0
1624482|NCT01956123|5669609|P3|COS Cycle 2|Protocol Violation|0
1624483|NCT01956123|5669610|P2|COS Cycle 2|Protocol Violation|3
1624484|NCT01956123|5669611|P1|COS Cycle 2|Protocol Violation|8
1624485|NCT01956110|5669663|P2|Overall Study|Personal reasons|1
1624486|NCT01956110|5669664|P1|Overall Study|Personal reasons|1
1624487|NCT01956110|5669663|P2|Overall Study|Adverse Event|10
1624488|NCT01956110|5669664|P1|Overall Study|Adverse Event|9
1624489|NCT01956110|5669663|P2|Overall Study|Protocol Violation|11
1624490|NCT01956110|5669664|P1|Overall Study|Protocol Violation|25
1624491|NCT01955733|5669799|P3|Period 2|Other not defined above|2
1624492|NCT01955733|5669800|P2|Period 2|Other not defined above|2
1624493|NCT01955733|5669801|P1|Period 2|Other not defined above|0
1624494|NCT01955733|5669799|P3|Period 2|Lost to Follow-up|0
1624495|NCT01955733|5669800|P2|Period 2|Lost to Follow-up|0
1624496|NCT01955733|5669801|P1|Period 2|Lost to Follow-up|2
1624497|NCT01955733|5669799|P3|Period 2|Study terminated by sponsor|16
1624498|NCT01955733|5669800|P2|Period 2|Study terminated by sponsor|14
1624499|NCT01955733|5669801|P1|Period 2|Study terminated by sponsor|8
1624500|NCT01955733|5669799|P3|Period 2|Withdrawal by Subject|2
1624501|NCT01955733|5669800|P2|Period 2|Withdrawal by Subject|3
1624502|NCT01955733|5669801|P1|Period 2|Withdrawal by Subject|1
1624503|NCT01955733|5669799|P3|Period 2|Physician Decision|1
1624504|NCT01955733|5669800|P2|Period 2|Physician Decision|0
1624505|NCT01955733|5669801|P1|Period 2|Physician Decision|0
1624506|NCT01955733|5669799|P3|Period 2|Adverse Event|0
1624507|NCT01955733|5669800|P2|Period 2|Adverse Event|0
1624508|NCT01955733|5669801|P1|Period 2|Adverse Event|1
1624509|NCT01955733|5669799|P3|Period 1|Lost to Follow-up|0
1624510|NCT01955733|5669800|P2|Period 1|Lost to Follow-up|0
1624511|NCT01955733|5669801|P1|Period 1|Lost to Follow-up|1
1624512|NCT01955707|5669894|P2|Overall Study|Other|2
1624513|NCT01955707|5669895|P1|Overall Study|Other|4
1624514|NCT01955707|5669894|P2|Overall Study|Death|14
1624515|NCT01955707|5669895|P1|Overall Study|Death|13
1624516|NCT01955707|5669894|P2|Overall Study|Withdrawal by Subject|3
1624517|NCT01955707|5669895|P1|Overall Study|Withdrawal by Subject|0
1624518|NCT01955707|5669894|P2|Overall Study|Lost to Follow-up|1
1624519|NCT01955707|5669895|P1|Overall Study|Lost to Follow-up|2
1624520|NCT01955707|5669894|P2|Overall Study|Adverse Event|2
1624521|NCT01955707|5669895|P1|Overall Study|Adverse Event|1
1624522|NCT01955161|5670163|P3|Overall Study|Other reason: patient's will|1
1624523|NCT01955161|5670164|P2|Overall Study|Other reason: patient's will|0
1624524|NCT01955161|5670165|P1|Overall Study|Other reason: patient's will|0
1624525|NCT01955161|5670163|P3|Overall Study|Other reason: primary biliary cirrhosis|0
1624526|NCT01955161|5670164|P2|Overall Study|Other reason: primary biliary cirrhosis|0
1624527|NCT01955161|5670165|P1|Overall Study|Other reason: primary biliary cirrhosis|1
1624528|NCT01955161|5670163|P3|Overall Study|Other reason: insufficient compliance|1
1624529|NCT01955161|5670164|P2|Overall Study|Other reason: insufficient compliance|0
1624530|NCT01955161|5670165|P1|Overall Study|Other reason: insufficient compliance|0
1624531|NCT01955161|5670163|P3|Overall Study|Other reason: moved to nursing home|0
1624532|NCT01955161|5670164|P2|Overall Study|Other reason: moved to nursing home|1
1624533|NCT01955161|5670165|P1|Overall Study|Other reason: moved to nursing home|0
1624534|NCT01955161|5670163|P3|Overall Study|Other reason: caregiver unavailable|0
1624535|NCT01955161|5670164|P2|Overall Study|Other reason: caregiver unavailable|0
1624536|NCT01955161|5670165|P1|Overall Study|Other reason: caregiver unavailable|1
1624537|NCT01955161|5670163|P3|Overall Study|Other reason: disallowed medication|1
1624538|NCT01955161|5670164|P2|Overall Study|Other reason: disallowed medication|0
1624539|NCT01955161|5670165|P1|Overall Study|Other reason: disallowed medication|1
1624540|NCT01955161|5670163|P3|Overall Study|Other reason: physician decision|1
1624541|NCT01955161|5670164|P2|Overall Study|Other reason: physician decision|1
1624542|NCT01955161|5670165|P1|Overall Study|Other reason: physician decision|0
1624543|NCT01955161|5670163|P3|Overall Study|Protocol Violation|0
1624544|NCT01955161|5670164|P2|Overall Study|Protocol Violation|0
1624545|NCT01955161|5670165|P1|Overall Study|Protocol Violation|2
1624546|NCT01955161|5670163|P3|Overall Study|Withdrawal by Subject|12
1624547|NCT01955161|5670164|P2|Overall Study|Withdrawal by Subject|8
1624548|NCT01955161|5670165|P1|Overall Study|Withdrawal by Subject|9
1624549|NCT01955161|5670163|P3|Overall Study|Death|3
1624550|NCT01955161|5670164|P2|Overall Study|Death|1
1624551|NCT01955161|5670165|P1|Overall Study|Death|1
1624552|NCT01955161|5670163|P3|Overall Study|Adverse Event|15
1624553|NCT01955161|5670164|P2|Overall Study|Adverse Event|14
1624554|NCT01955161|5670165|P1|Overall Study|Adverse Event|10
1624555|NCT01955161|5670163|P3|Overall Study|Withdrawal before treatment|1
1624556|NCT01955161|5670164|P2|Overall Study|Withdrawal before treatment|0
1624557|NCT01955161|5670165|P1|Overall Study|Withdrawal before treatment|2
1624558|NCT01955122|5670205|P2|Overall Study|Physician Decision|5
1624559|NCT01955122|5670206|P1|Overall Study|Physician Decision|5
1624560|NCT01955083|5670226|P2|Overall Study|Lost to Follow-up|1
1624561|NCT01955083|5670227|P1|Overall Study|Lost to Follow-up|1
1624562|NCT01955044|5670260|P3|Overall Study|Death|0
1624563|NCT01955044|5670261|P2|Overall Study|Death|1
1624564|NCT01955044|5670262|P1|Overall Study|Death|1
1624565|NCT01955005|5670275|P2|Overall Study|Withdrawal by Subject|5
1624566|NCT01955005|5670276|P1|Overall Study|Withdrawal by Subject|3
1624567|NCT01954927|5670288|P2|Overall Study|Withdrawal by Subject|1
1624568|NCT01954927|5670289|P1|Overall Study|Withdrawal by Subject|3
1624569|NCT01954771|5670310|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
1624570|NCT01954771|5670311|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
1624571|NCT01954771|5670312|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
1624572|NCT01954771|5670310|P3|Overall Study|Missing CGMS of end-point|0
1624573|NCT01954771|5670311|P2|Overall Study|Missing CGMS of end-point|1
1624574|NCT01954771|5670312|P1|Overall Study|Missing CGMS of end-point|1
1624575|NCT01954771|5670310|P3|Overall Study|Missing HbA1c of end-point|0
1624576|NCT01954771|5670311|P2|Overall Study|Missing HbA1c of end-point|1
1624577|NCT01954771|5670312|P1|Overall Study|Missing HbA1c of end-point|1
1624578|NCT01954745|5670329|P1|Overall Study|Death|1
1624579|NCT01954745|5670329|P1|Overall Study|Adverse Event|2
1624580|NCT01954745|5670329|P1|Overall Study|Clinical Progression|5
1624581|NCT01954745|5670329|P1|Overall Study|Radiological Progression|11
1624582|NCT01954394|5670360|P2|Overall Study|Other than specified above|21
1624583|NCT01954394|5670361|P1|Overall Study|Other than specified above|10
1624584|NCT01954394|5670360|P2|Overall Study|Related to Study Drug administration|2
1624585|NCT01954394|5670361|P1|Overall Study|Related to Study Drug administration|2
1624586|NCT01954394|5670360|P2|Overall Study|Participant Moved|4
1624587|NCT01954394|5670361|P1|Overall Study|Participant Moved|0
1624588|NCT01954394|5670360|P2|Overall Study|Poor compliance to protocol|7
1624589|NCT01954394|5670361|P1|Overall Study|Poor compliance to protocol|7
1624590|NCT01954394|5670360|P2|Overall Study|Adverse Event|23
1624591|NCT01954394|5670361|P1|Overall Study|Adverse Event|10
1624592|NCT01954394|5670360|P2|Overall Study|Enrolled but not treated|0
1624593|NCT01954394|5670361|P1|Overall Study|Enrolled but not treated|1
1624594|NCT01954251|5670463|P2|Overall Study|Withdrawal by Subject|6
1624595|NCT01954251|5670464|P1|Overall Study|Withdrawal by Subject|2
1624596|NCT01954251|5670463|P2|Overall Study|Lost to Follow-up|6
1624597|NCT01954251|5670464|P1|Overall Study|Lost to Follow-up|6
1624598|NCT01954251|5670463|P2|Overall Study|Adverse Event|7
1624599|NCT01954251|5670464|P1|Overall Study|Adverse Event|5
1624600|NCT01954121|5670561|P2|Overall Study|Subject did not follow instructions|2
1624601|NCT01954121|5670562|P1|Overall Study|Subject did not follow instructions|0
1624602|NCT01954121|5670561|P2|Overall Study|Non-compliant patient|1
1624603|NCT01954121|5670562|P1|Overall Study|Non-compliant patient|1
1624604|NCT01954121|5670561|P2|Overall Study|Non-compliant with study procedures|0
1624605|NCT01954121|5670562|P1|Overall Study|Non-compliant with study procedures|1
1624606|NCT01954121|5670561|P2|Overall Study|SAE, non-fatal|4
1624607|NCT01954121|5670562|P1|Overall Study|SAE, non-fatal|1
1624608|NCT01954121|5670561|P2|Overall Study|AE, non-serious non-fatal|22
1624609|NCT01954121|5670562|P1|Overall Study|AE, non-serious non-fatal|5
1624610|NCT01954121|5670561|P2|Overall Study|AE, serious fatal|0
1624611|NCT01954121|5670562|P1|Overall Study|AE, serious fatal|1
1624612|NCT01954121|5670561|P2|Overall Study|Pregnancy|1
1624613|NCT01954121|5670562|P1|Overall Study|Pregnancy|1
1624614|NCT01954121|5670561|P2|Overall Study|Withdrawal by Subject|12
1624615|NCT01954121|5670562|P1|Overall Study|Withdrawal by Subject|18
1624616|NCT01954121|5670561|P2|Overall Study|Lost to Follow-up|6
1624617|NCT01954121|5670562|P1|Overall Study|Lost to Follow-up|5
1624618|NCT01954121|5670561|P2|Overall Study|Protocol Violation|2
1624619|NCT01954121|5670562|P1|Overall Study|Protocol Violation|0
1624620|NCT01954121|5670561|P2|Overall Study|Lack of Efficacy|41
1624621|NCT01954121|5670562|P1|Overall Study|Lack of Efficacy|94
1624622|NCT01954082|5670578|P2|Overall Study|Randomized not Treated|2
1624623|NCT01954082|5670579|P1|Overall Study|Randomized not Treated|4
1624624|NCT01954082|5670578|P2|Overall Study|Infant Moved|1
1624625|NCT01954082|5670579|P1|Overall Study|Infant Moved|0
1624626|NCT01954082|5670578|P2|Overall Study|Comfort Care|1
1624627|NCT01954082|5670579|P1|Overall Study|Comfort Care|0
1624628|NCT01954082|5670578|P2|Overall Study|Miscalculation of Final Dose Day|3
1624629|NCT01954082|5670579|P1|Overall Study|Miscalculation of Final Dose Day|0
1624630|NCT01954082|5670578|P2|Overall Study|Redirection of Care|2
1624631|NCT01954082|5670579|P1|Overall Study|Redirection of Care|0
1624632|NCT01954082|5670578|P2|Overall Study|Discontinued Early Prior to Transfer|2
1624633|NCT01954082|5670579|P1|Overall Study|Discontinued Early Prior to Transfer|3
1624634|NCT01954082|5670578|P2|Overall Study|Withdrawal by Subject|1
1624635|NCT01954082|5670579|P1|Overall Study|Withdrawal by Subject|0
1624636|NCT01954082|5670578|P2|Overall Study|Parent Decision|0
1624637|NCT01954082|5670579|P1|Overall Study|Parent Decision|1
1624638|NCT01954082|5670578|P2|Overall Study|Physician Decision|0
1624639|NCT01954082|5670579|P1|Overall Study|Physician Decision|2
1624640|NCT01954082|5670578|P2|Overall Study|Non-compliance|4
1624641|NCT01954082|5670579|P1|Overall Study|Non-compliance|6
1624642|NCT01954082|5670578|P2|Overall Study|Intolerance|1
1624643|NCT01954082|5670579|P1|Overall Study|Intolerance|0
1624644|NCT01954082|5670578|P2|Overall Study|Adverse Event|4
1624645|NCT01954082|5670579|P1|Overall Study|Adverse Event|10
1624646|NCT01954082|5670578|P2|Overall Study|Study Suspension|36
1624647|NCT01954082|5670579|P1|Overall Study|Study Suspension|42
1624648|NCT01954056|5670599|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
1624649|NCT01954056|5670600|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
1624650|NCT01953913|5670642|P1|Overall Study|Not Treated|1
1624651|NCT01953913|5670642|P1|Overall Study|Other than listed|108
1624652|NCT01953913|5670642|P1|Overall Study|Withdrawal by Subject|32
1624653|NCT01953913|5670642|P1|Overall Study|Lost to Follow-up|4
1624654|NCT01953913|5670642|P1|Overall Study|Protocol Violation|6
1624655|NCT01953913|5670642|P1|Overall Study|Adverse Event|20
1624656|NCT01953913|5670642|P1|Overall Study|Worsening of underlying cancer|22
1624657|NCT01953913|5670642|P1|Overall Study|Disease Progression|349
1624658|NCT01953601|5670697|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
1624659|NCT01953601|5670698|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
1624660|NCT01953601|5670699|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
1624661|NCT01953601|5670697|P3|Part 2 (Extension Study)|Subject moved|1
1624662|NCT01953601|5670698|P2|Part 2 (Extension Study)|Subject moved|0
1624663|NCT01953601|5670699|P1|Part 2 (Extension Study)|Subject moved|0
1624664|NCT01953601|5670697|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
1624665|NCT01953601|5670698|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
1624666|NCT01953601|5670699|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
1624667|NCT01953601|5670697|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
1624668|NCT01953601|5670698|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
1624669|NCT01953601|5670699|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
1624670|NCT01953601|5670697|P3|Part 2 (Extension Study)|Site discontinued study participation|1
1624671|NCT01953601|5670698|P2|Part 2 (Extension Study)|Site discontinued study participation|1
1624672|NCT01953601|5670699|P1|Part 2 (Extension Study)|Site discontinued study participation|0
1624673|NCT01953601|5670697|P3|Part 2 (Extension Study)|Physician Decision|2
1624674|NCT01953601|5670698|P2|Part 2 (Extension Study)|Physician Decision|0
1624675|NCT01953601|5670699|P1|Part 2 (Extension Study)|Physician Decision|2
1624676|NCT01953601|5670697|P3|Part 2 (Extension Study)|Lost to Follow-up|1
1624677|NCT01953601|5670698|P2|Part 2 (Extension Study)|Lost to Follow-up|1
1624678|NCT01953601|5670699|P1|Part 2 (Extension Study)|Lost to Follow-up|2
1624679|NCT01953601|5670697|P3|Part 2 (Extension Study)|Lack of Efficacy|0
1624680|NCT01953601|5670698|P2|Part 2 (Extension Study)|Lack of Efficacy|0
1624681|NCT01953601|5670699|P1|Part 2 (Extension Study)|Lack of Efficacy|2
1624682|NCT01953601|5670697|P3|Part 2 (Extension Study)|Death|0
1624683|NCT01953601|5670698|P2|Part 2 (Extension Study)|Death|3
1624684|NCT01953601|5670699|P1|Part 2 (Extension Study)|Death|0
1624685|NCT01953601|5670697|P3|Part 2 (Extension Study)|Adverse Event|10
1624686|NCT01953601|5670698|P2|Part 2 (Extension Study)|Adverse Event|1
1624687|NCT01953601|5670699|P1|Part 2 (Extension Study)|Adverse Event|1
1624688|NCT01953601|5670697|P3|Part 1 (Base Study)|Withdrawal by Subject|22
1624689|NCT01953601|5670698|P2|Part 1 (Base Study)|Withdrawal by Subject|23
1624690|NCT01953601|5670699|P1|Part 1 (Base Study)|Withdrawal by Subject|32
1624691|NCT01953601|5670697|P3|Part 1 (Base Study)|Subject moved|1
1624692|NCT01953601|5670698|P2|Part 1 (Base Study)|Subject moved|2
1624693|NCT01953601|5670699|P1|Part 1 (Base Study)|Subject moved|2
1624694|NCT01953601|5670697|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
1624695|NCT01953601|5670698|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
1624696|NCT01953601|5670699|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
1624697|NCT01953601|5670697|P3|Part 1 (Base Study)|Study terminated by sponsor|179
1624698|NCT01953601|5670698|P2|Part 1 (Base Study)|Study terminated by sponsor|169
1624699|NCT01953601|5670699|P1|Part 1 (Base Study)|Study terminated by sponsor|174
1624700|NCT01953601|5670697|P3|Part 1 (Base Study)|Site discontinued study participation|0
1624701|NCT01953601|5670698|P2|Part 1 (Base Study)|Site discontinued study participation|0
1624702|NCT01953601|5670699|P1|Part 1 (Base Study)|Site discontinued study participation|2
1624703|NCT01953601|5670697|P3|Part 1 (Base Study)|Screen failure|1
1624704|NCT01953601|5670698|P2|Part 1 (Base Study)|Screen failure|0
1624705|NCT01953601|5670699|P1|Part 1 (Base Study)|Screen failure|1
1624706|NCT01953601|5670697|P3|Part 1 (Base Study)|Physician Decision|4
1624707|NCT01953601|5670698|P2|Part 1 (Base Study)|Physician Decision|7
1624708|NCT01953601|5670699|P1|Part 1 (Base Study)|Physician Decision|3
1624709|NCT01953601|5670697|P3|Part 1 (Base Study)|Non-compliance with study drug|1
1624710|NCT01953601|5670698|P2|Part 1 (Base Study)|Non-compliance with study drug|3
1624711|NCT01953601|5670699|P1|Part 1 (Base Study)|Non-compliance with study drug|0
1624712|NCT01953601|5670697|P3|Part 1 (Base Study)|Lost to Follow-up|6
1624713|NCT01953601|5670698|P2|Part 1 (Base Study)|Lost to Follow-up|3
1624714|NCT01953601|5670699|P1|Part 1 (Base Study)|Lost to Follow-up|1
1624715|NCT01953601|5670697|P3|Part 1 (Base Study)|Lack of Efficacy|4
1624716|NCT01953601|5670698|P2|Part 1 (Base Study)|Lack of Efficacy|1
1624717|NCT01953601|5670699|P1|Part 1 (Base Study)|Lack of Efficacy|3
1624718|NCT01953601|5670697|P3|Part 1 (Base Study)|Death|3
1624719|NCT01953601|5670698|P2|Part 1 (Base Study)|Death|0
1624720|NCT01953601|5670699|P1|Part 1 (Base Study)|Death|2
1624721|NCT01953601|5670697|P3|Part 1 (Base Study)|Adverse Event|15
1624722|NCT01953601|5670698|P2|Part 1 (Base Study)|Adverse Event|37
1624723|NCT01953601|5670699|P1|Part 1 (Base Study)|Adverse Event|24
1624724|NCT01953354|5670757|P2|Overall Study|Disease Exacerbation|0
1624725|NCT01953354|5670758|P1|Overall Study|Disease Exacerbation|1
1624726|NCT01953354|5670757|P2|Overall Study|Decision of Sponsor|1
1624727|NCT01953354|5670758|P1|Overall Study|Decision of Sponsor|0
1624728|NCT01953354|5670757|P2|Overall Study|Withdrawal by Subject|1
1624729|NCT01953354|5670758|P1|Overall Study|Withdrawal by Subject|0
1624730|NCT01953328|5670786|P8|Overall Study|Lost to Follow-up|0
1624731|NCT01953328|5670787|P7|Overall Study|Lost to Follow-up|0
1624732|NCT01953328|5670788|P6|Overall Study|Lost to Follow-up|0
1624733|NCT01953328|5670789|P5|Overall Study|Lost to Follow-up|1
1624734|NCT01953328|5670790|P4|Overall Study|Lost to Follow-up|0
1624735|NCT01953328|5670791|P3|Overall Study|Lost to Follow-up|0
1624736|NCT01953328|5670792|P2|Overall Study|Lost to Follow-up|0
1624737|NCT01953328|5670793|P1|Overall Study|Lost to Follow-up|0
1624738|NCT01953328|5670786|P8|Overall Study|Withdrawal by Subject|0
1624739|NCT01953328|5670787|P7|Overall Study|Withdrawal by Subject|0
1624740|NCT01953328|5670788|P6|Overall Study|Withdrawal by Subject|0
1624741|NCT01953328|5670789|P5|Overall Study|Withdrawal by Subject|1
1624742|NCT01953328|5670790|P4|Overall Study|Withdrawal by Subject|0
1624743|NCT01953328|5670791|P3|Overall Study|Withdrawal by Subject|0
1624744|NCT01953328|5670792|P2|Overall Study|Withdrawal by Subject|0
1624745|NCT01953328|5670793|P1|Overall Study|Withdrawal by Subject|0
1624746|NCT01953224|5671006|P2|Overall Study|Withdrawal by Subject|2
1624747|NCT01953224|5671007|P1|Overall Study|Withdrawal by Subject|1
1624748|NCT01953224|5671006|P2|Overall Study|Lost to Follow-up|1
1624749|NCT01953224|5671007|P1|Overall Study|Lost to Follow-up|1
1624750|NCT01953003|5671056|P2|Overall Study|Withdrawal by Subject|4
1624751|NCT01953003|5671057|P1|Overall Study|Withdrawal by Subject|14
1624752|NCT01953003|5671056|P2|Overall Study|Protocol Violation|1
1624753|NCT01953003|5671057|P1|Overall Study|Protocol Violation|0
1624754|NCT01953003|5671056|P2|Overall Study|Non-related adverse events|2
1624755|NCT01953003|5671057|P1|Overall Study|Non-related adverse events|0
1624756|NCT01953003|5671056|P2|Overall Study|Related Adverse events|2
1624757|NCT01953003|5671057|P1|Overall Study|Related Adverse events|7
1624758|NCT01953003|5671056|P2|Overall Study|Progressive disease|45
1624759|NCT01953003|5671057|P1|Overall Study|Progressive disease|35
1624760|NCT01953003|5671056|P2|Overall Study|Not treated|1
1624761|NCT01953003|5671057|P1|Overall Study|Not treated|0
1624762|NCT01952834|5671063|P1|Overall Study|Adverse Event|1
1624763|NCT01952691|5671070|P1|Overall Study|Lost to Follow-up|2
1624764|NCT01952665|5671097|P2|Overall Study|Protocol Violation|1
1624765|NCT01952665|5671098|P1|Overall Study|Protocol Violation|0
1624766|NCT01952665|5671097|P2|Overall Study|Adverse Event|1
1624767|NCT01952665|5671098|P1|Overall Study|Adverse Event|2
1624768|NCT01952665|5671097|P2|Overall Study|Lost to Follow-up|2
1624769|NCT01952665|5671098|P1|Overall Study|Lost to Follow-up|1
1624770|NCT01952665|5671097|P2|Overall Study|Physician Decision|2
1624771|NCT01952665|5671098|P1|Overall Study|Physician Decision|3
1624772|NCT01952574|5671253|P4|Overall Study|Lost to Follow-up|0
1624773|NCT01952574|5671254|P3|Overall Study|Lost to Follow-up|1
1624774|NCT01952574|5671255|P2|Overall Study|Lost to Follow-up|0
1624775|NCT01952574|5671256|P1|Overall Study|Lost to Follow-up|2
1624776|NCT01952574|5671253|P4|Overall Study|Sponsor Decision|2
1624777|NCT01952574|5671254|P3|Overall Study|Sponsor Decision|5
1624778|NCT01952574|5671255|P2|Overall Study|Sponsor Decision|0
1624779|NCT01952574|5671256|P1|Overall Study|Sponsor Decision|6
1624780|NCT01952574|5671253|P4|Overall Study|Withdrawal by Subject|4
1624781|NCT01952574|5671254|P3|Overall Study|Withdrawal by Subject|3
1624782|NCT01952574|5671255|P2|Overall Study|Withdrawal by Subject|3
1624783|NCT01952574|5671256|P1|Overall Study|Withdrawal by Subject|9
1624784|NCT01952366|5671355|P1|Overall Study|Withdrawal by Subject|9
1624785|NCT01952366|5671355|P1|Overall Study|Death|22
1624786|NCT01952145|5671370|P2|Overall Study|Unclassified|1
1624787|NCT01952145|5671371|P1|Overall Study|Unclassified|1
1624788|NCT01952145|5671370|P2|Overall Study|Withdrawal Criteria|11
1624789|NCT01952145|5671371|P1|Overall Study|Withdrawal Criteria|16
1624790|NCT01952145|5671370|P2|Overall Study|Adverse Event|0
1624791|NCT01952145|5671371|P1|Overall Study|Adverse Event|9
1624792|NCT01952145|5671370|P2|Overall Study|Death|1
1624793|NCT01952145|5671371|P1|Overall Study|Death|0
1624794|NCT01952145|5671370|P2|Overall Study|Protocol Violation|1
1624795|NCT01952145|5671371|P1|Overall Study|Protocol Violation|2
1624796|NCT01952080|5671385|P4|Overall Study|Protocol Non-compliance|0
1624797|NCT01952080|5671386|P3|Overall Study|Protocol Non-compliance|0
1624798|NCT01952080|5671387|P2|Overall Study|Protocol Non-compliance|1
1624799|NCT01952080|5671388|P1|Overall Study|Protocol Non-compliance|0
1624800|NCT01952080|5671385|P4|Overall Study|Withdrawal by Subject|1
1624801|NCT01952080|5671386|P3|Overall Study|Withdrawal by Subject|0
1624802|NCT01952080|5671387|P2|Overall Study|Withdrawal by Subject|0
1624803|NCT01952080|5671388|P1|Overall Study|Withdrawal by Subject|0
1624804|NCT01952054|5671434|P1|Overall Study|Physician Decision|1
1624805|NCT01952041|5671442|P2|Overall Study|Death|0
1624806|NCT01952041|5671443|P1|Overall Study|Death|1
1624807|NCT01952041|5671442|P2|Overall Study|Withdrawal by Subject|5
1624808|NCT01952041|5671443|P1|Overall Study|Withdrawal by Subject|7
1624809|NCT01952041|5671442|P2|Overall Study|Lost to Follow-up|16
1624810|NCT01952041|5671443|P1|Overall Study|Lost to Follow-up|9
1624811|NCT01952015|5671457|P1|Treatment Period 3|Physician Decision|9
1624812|NCT01952015|5671457|P1|Maintenance|Adverse Event|2
1624813|NCT01952015|5671457|P1|Induction|Protocol Violation|1
1624814|NCT01951703|5671524|P2|Second Intervention|Unsatisfactory Lens fitting|1
1624815|NCT01951703|5671525|P1|Second Intervention|Unsatisfactory Lens fitting|0
1624816|NCT01951703|5671524|P2|Second Intervention|Protocol Violation|1
1624817|NCT01951703|5671525|P1|Second Intervention|Protocol Violation|0
1624818|NCT01951703|5671524|P2|First Intervention|Physician Decision|0
1624819|NCT01951703|5671525|P1|First Intervention|Physician Decision|1
1624820|NCT01951703|5671524|P2|First Intervention|Subject was not compliant|1
1624821|NCT01951703|5671525|P1|First Intervention|Subject was not compliant|1
1624822|NCT01951703|5671524|P2|First Intervention|Withdrawal by Subject|0
1624823|NCT01951703|5671525|P1|First Intervention|Withdrawal by Subject|1
1624824|NCT01951586|5671550|P2|Overall Study|Sponsor Decision|10
1624825|NCT01951586|5671551|P1|Overall Study|Sponsor Decision|9
1624826|NCT01951586|5671550|P2|Overall Study|Lost to Follow-up|1
1624827|NCT01951586|5671551|P1|Overall Study|Lost to Follow-up|0
1624828|NCT01951586|5671550|P2|Overall Study|Withdrawal by Subject|17
1624829|NCT01951586|5671551|P1|Overall Study|Withdrawal by Subject|8
1624830|NCT01951586|5671550|P2|Overall Study|Death|120
1624831|NCT01951586|5671551|P1|Overall Study|Death|61
1624832|NCT01951573|5671575|P2|Washout Period|Adverse Event|1
1624833|NCT01951573|5671576|P1|Washout Period|Adverse Event|0
1624834|NCT01951417|5671586|P1|Overall Study|Lost to Follow-up|6
1624835|NCT01951417|5671586|P1|Overall Study|Protocol Violation|2
1624836|NCT01951417|5671586|P1|Overall Study|Withdrawal by Subject|1
1624837|NCT01951170|5671652|P1|Overall Study|Investigator decision|1
1624838|NCT01951157|5671678|P3|Overall Study|Treatment-related death|0
1624839|NCT01951157|5671679|P2|Overall Study|Treatment-related death|2
1624840|NCT01951157|5671680|P1|Overall Study|Treatment-related death|0
1624841|NCT01951157|5671678|P3|Overall Study|Consent withdrawn by subject|3
1624842|NCT01951157|5671679|P2|Overall Study|Consent withdrawn by subject|1
1624843|NCT01951157|5671680|P1|Overall Study|Consent withdrawn by subject|0
1624844|NCT01951157|5671678|P3|Overall Study|Treatment-related AE|4
1624845|NCT01951157|5671679|P2|Overall Study|Treatment-related AE|0
1624846|NCT01951157|5671680|P1|Overall Study|Treatment-related AE|2
1624847|NCT01951157|5671678|P3|Overall Study|No treated|0
1624848|NCT01951157|5671679|P2|Overall Study|No treated|1
1624849|NCT01951157|5671680|P1|Overall Study|No treated|0
1624850|NCT01951157|5671678|P3|Overall Study|Non-treatmentrelated death|2
1624851|NCT01951157|5671679|P2|Overall Study|Non-treatmentrelated death|2
1624852|NCT01951157|5671680|P1|Overall Study|Non-treatmentrelated death|2
1624853|NCT01951157|5671678|P3|Overall Study|Physician Decision|2
1624854|NCT01951157|5671679|P2|Overall Study|Physician Decision|3
1624855|NCT01951157|5671680|P1|Overall Study|Physician Decision|5
1624856|NCT01951157|5671678|P3|Overall Study|Study Termination|1
1624857|NCT01951157|5671679|P2|Overall Study|Study Termination|0
1624858|NCT01951157|5671680|P1|Overall Study|Study Termination|0
1624859|NCT01951157|5671678|P3|Overall Study|Treatment-unrelated AE|3
1624860|NCT01951157|5671679|P2|Overall Study|Treatment-unrelated AE|0
1624861|NCT01951157|5671680|P1|Overall Study|Treatment-unrelated AE|1
1624862|NCT01951157|5671678|P3|Overall Study|Progressive Disease|10
1624863|NCT01951157|5671679|P2|Overall Study|Progressive Disease|13
1624864|NCT01951157|5671680|P1|Overall Study|Progressive Disease|12
1624865|NCT01951105|5671712|P3|Overall Study|Withdrawal by Subject|1
1624866|NCT01951105|5671713|P2|Overall Study|Withdrawal by Subject|3
1624867|NCT01951105|5671714|P1|Overall Study|Withdrawal by Subject|0
1624868|NCT01951105|5671712|P3|Overall Study|Protocol Violation|1
1624869|NCT01951105|5671713|P2|Overall Study|Protocol Violation|1
1624870|NCT01951105|5671714|P1|Overall Study|Protocol Violation|1
1624871|NCT01951105|5671712|P3|Overall Study|Lost to Follow-up|0
1624872|NCT01951105|5671713|P2|Overall Study|Lost to Follow-up|1
1624873|NCT01951105|5671714|P1|Overall Study|Lost to Follow-up|0
1624874|NCT01951105|5671712|P3|Overall Study|Adverse Event|0
1624875|NCT01951105|5671713|P2|Overall Study|Adverse Event|5
1624876|NCT01951105|5671714|P1|Overall Study|Adverse Event|0
1624877|NCT01951092|5671728|P1|Overall Study|Transfer of Care|1
1624878|NCT01951092|5671728|P1|Overall Study|Incarceration|1
1624879|NCT01951092|5671728|P1|Overall Study|Lost to Follow-up|10
1624880|NCT01950819|5671741|P2|Overall Study|Lost to Follow-up|17
1624881|NCT01950819|5671742|P1|Overall Study|Lost to Follow-up|9
1624882|NCT01950819|5671741|P2|Overall Study|Pregnancy|2
1624883|NCT01950819|5671742|P1|Overall Study|Pregnancy|0
1624884|NCT01950819|5671741|P2|Overall Study|technical problems|0
1624885|NCT01950819|5671742|P1|Overall Study|technical problems|2
1624886|NCT01950819|5671741|P2|Overall Study|Subject / Gardian decision|51
1624887|NCT01950819|5671742|P1|Overall Study|Subject / Gardian decision|54
1624888|NCT01950819|5671741|P2|Overall Study|Death|34
1624889|NCT01950819|5671742|P1|Overall Study|Death|29
1624890|NCT01950819|5671741|P2|Overall Study|Graft Loss|30
1624891|NCT01950819|5671742|P1|Overall Study|Graft Loss|35
1624892|NCT01950741|5671795|P1|Overall Study|Withdrawal by Subject|1
1624893|NCT01950741|5671795|P1|Overall Study|Death|1
1624894|NCT01950741|5671795|P1|Overall Study|Lost to Follow-up|1
1624895|NCT01950364|5671810|P2|Overall Study|Protocol Violation|1
1624896|NCT01950364|5671811|P1|Overall Study|Protocol Violation|0
1624897|NCT01950364|5671810|P2|Overall Study|Withdrawal by Subject|1
1624898|NCT01950364|5671811|P1|Overall Study|Withdrawal by Subject|0
1624899|NCT01950364|5671810|P2|Overall Study|Disease Progression|2
1624900|NCT01950364|5671811|P1|Overall Study|Disease Progression|5
1624901|NCT01950364|5671810|P2|Overall Study|Stem Cell Transplant|6
1624902|NCT01950364|5671811|P1|Overall Study|Stem Cell Transplant|2
1624903|NCT01950364|5671810|P2|Overall Study|Adverse Event|0
1624904|NCT01950364|5671811|P1|Overall Study|Adverse Event|3
1624905|NCT01950273|5671933|P2|Overall Study|Other not defined above|0
1624906|NCT01950273|5671934|P1|Overall Study|Other not defined above|1
1624907|NCT01950273|5671933|P2|Overall Study|Withdrawal by Subject|0
1624908|NCT01950273|5671934|P1|Overall Study|Withdrawal by Subject|2
1624909|NCT01950273|5671933|P2|Overall Study|Protocol Violation|0
1624910|NCT01950273|5671934|P1|Overall Study|Protocol Violation|1
1624911|NCT01950013|5671981|P3|Overall Study|Withdrawal by Subject|0
1624912|NCT01950013|5671982|P2|Overall Study|Withdrawal by Subject|2
1624913|NCT01950013|5671983|P1|Overall Study|Withdrawal by Subject|0
1624914|NCT01949870|5671994|P1|Overall Study|Eligibility requirements not fulfilled|2
1624915|NCT01949870|5671994|P1|Overall Study|Study termination|1
1624916|NCT01949870|5671994|P1|Overall Study|Adverse Event|1
1624917|NCT01949870|5671994|P1|Overall Study|Lack of Efficacy|2
1624918|NCT01949532|5672163|P2|Overall Study|On-study at the Data Cut-off Date|3
1624919|NCT01949532|5672164|P1|Overall Study|On-study at the Data Cut-off Date|3
1624920|NCT01949480|5672234|P2|Overall Study|Physician Decision|8
1624921|NCT01949480|5672235|P1|Overall Study|Physician Decision|5
1624922|NCT01949155|5672270|P2|Overall Study|Protocol Violation|0
1624923|NCT01949155|5672271|P1|Overall Study|Protocol Violation|1
1624924|NCT01949155|5672270|P2|Overall Study|Lost to Follow-up|0
1624925|NCT01949155|5672271|P1|Overall Study|Lost to Follow-up|1
1624926|NCT01949142|5672283|P2|Overall Study|Parent changed their mind|0
1624927|NCT01949142|5672284|P1|Overall Study|Parent changed their mind|1
1624928|NCT01949142|5672283|P2|Overall Study|Lost to Follow-up|1
1624929|NCT01949142|5672284|P1|Overall Study|Lost to Follow-up|1
1624930|NCT01949142|5672283|P2|Overall Study|Withdrawal of consent|0
1624931|NCT01949142|5672284|P1|Overall Study|Withdrawal of consent|1
1624932|NCT01949116|5672296|P2|Overall Study|Withdrawal by Subject|3
1624933|NCT01949116|5672297|P1|Overall Study|Withdrawal by Subject|5
1624934|NCT01949116|5672296|P2|Overall Study|Lost to Follow-up|3
1624935|NCT01949116|5672297|P1|Overall Study|Lost to Follow-up|1
1624936|NCT01949116|5672296|P2|Overall Study|Death|0
1624937|NCT01949116|5672297|P1|Overall Study|Death|2
1624938|NCT01949090|5672334|P5|Overall Study|Lost to Follow-up|1
1624939|NCT01949090|5672335|P4|Overall Study|Lost to Follow-up|1
1624940|NCT01949090|5672336|P3|Overall Study|Lost to Follow-up|0
1624941|NCT01949090|5672337|P2|Overall Study|Lost to Follow-up|1
1624942|NCT01949090|5672338|P1|Overall Study|Lost to Follow-up|2
1624943|NCT01949090|5672334|P5|Overall Study|Protocol non-compliance|1
1624944|NCT01949090|5672335|P4|Overall Study|Protocol non-compliance|0
1624945|NCT01949090|5672336|P3|Overall Study|Protocol non-compliance|0
1624946|NCT01949090|5672337|P2|Overall Study|Protocol non-compliance|0
1624947|NCT01949090|5672338|P1|Overall Study|Protocol non-compliance|0
1624948|NCT01949090|5672334|P5|Overall Study|Withdrawal by Subject|1
1624949|NCT01949090|5672335|P4|Overall Study|Withdrawal by Subject|0
1624950|NCT01949090|5672336|P3|Overall Study|Withdrawal by Subject|0
1624951|NCT01949090|5672337|P2|Overall Study|Withdrawal by Subject|0
1624952|NCT01949090|5672338|P1|Overall Study|Withdrawal by Subject|2
1624953|NCT01949090|5672334|P5|Overall Study|Serious Adverse Event|1
1624954|NCT01949090|5672335|P4|Overall Study|Serious Adverse Event|0
1624955|NCT01949090|5672336|P3|Overall Study|Serious Adverse Event|2
1624956|NCT01949090|5672337|P2|Overall Study|Serious Adverse Event|1
1624957|NCT01949090|5672338|P1|Overall Study|Serious Adverse Event|0
1624958|NCT01949051|5672515|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1624959|NCT01949051|5672516|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1624960|NCT01949051|5672517|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1624961|NCT01949051|5672518|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
1624962|NCT01949051|5672519|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1624963|NCT01949051|5672520|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
1624964|NCT01949051|5672515|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1624965|NCT01949051|5672516|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1624966|NCT01949051|5672517|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1624967|NCT01949051|5672518|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1624968|NCT01949051|5672519|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
1624969|NCT01949051|5672520|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
1624970|NCT01949051|5672515|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
1624971|NCT01949051|5672516|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
1624972|NCT01949051|5672517|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
1624973|NCT01949051|5672518|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
1624974|NCT01949051|5672519|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
1624975|NCT01949051|5672520|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
1624976|NCT01949051|5672515|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1624977|NCT01949051|5672516|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1624978|NCT01949051|5672517|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1624979|NCT01949051|5672518|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1624980|NCT01949051|5672519|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1624981|NCT01949051|5672520|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
1624982|NCT01949051|5672515|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
1624983|NCT01949051|5672516|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
1624984|NCT01949051|5672517|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
1624985|NCT01949051|5672518|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
1624986|NCT01949051|5672519|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
1624987|NCT01949051|5672520|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
1624988|NCT01948908|5672715|P3|Overall Study|Protocol Violation|2
1624989|NCT01948908|5672716|P2|Overall Study|Protocol Violation|0
1624990|NCT01948908|5672717|P1|Overall Study|Protocol Violation|1
1624991|NCT01948830|5672733|P2|Overall Study|Death|4
1624992|NCT01948830|5672734|P1|Overall Study|Death|3
1624993|NCT01948830|5672733|P2|Overall Study|Adverse Event|2
1624994|NCT01948830|5672734|P1|Overall Study|Adverse Event|9
1624995|NCT01948830|5672733|P2|Overall Study|Withdrawal by Subject|17
1624996|NCT01948830|5672734|P1|Overall Study|Withdrawal by Subject|14
1624997|NCT01948830|5672733|P2|Overall Study|Lost to Follow-up|4
1624998|NCT01948830|5672734|P1|Overall Study|Lost to Follow-up|5
1624999|NCT01948830|5672733|P2|Overall Study|Protocol deviation|2
1625000|NCT01948830|5672734|P1|Overall Study|Protocol deviation|1
1625001|NCT01948830|5672733|P2|Overall Study|Physician Decision|3
1625002|NCT01948830|5672734|P1|Overall Study|Physician Decision|1
1625003|NCT01948791|5672766|P1|Overall Study|Screening failure|35
1625004|NCT01948791|5672766|P1|Overall Study|Others|7
1625005|NCT01948791|5672766|P1|Overall Study|Management issues|1
1625006|NCT01948791|5672766|P1|Overall Study|Lost to Follow-up|6
1625007|NCT01948791|5672766|P1|Overall Study|Withdrawal by Subject|5
1625008|NCT01948791|5672766|P1|Overall Study|Protocol Violation|2
1625009|NCT01948791|5672766|P1|Overall Study|Lack of Efficacy|3
1625010|NCT01948791|5672766|P1|Overall Study|Adverse Event|12
1625011|NCT01948258|5672826|P1|Overall Study|Removed from statistical analysis|2
1625012|NCT01948258|5672826|P1|Overall Study|Health Care Professional|43
1625013|NCT01948258|5672826|P1|Overall Study|Withdrawal by Subject|6
1625014|NCT01948258|5672826|P1|Overall Study|Withdrawal by SPD|8
1625015|NCT01948258|5672826|P1|Overall Study|Lost to Follow-up|27
1625016|NCT01948258|5672826|P1|Overall Study|Did not complete by cut-off date|35
1625017|NCT01948258|5672826|P1|Overall Study|Pregnancy|41
1625018|NCT01948193|5672832|P1|Overall Study|Lost to Follow-up|7
1625019|NCT01948193|5672832|P1|Overall Study|Serious event|2
1625020|NCT01948076|5672854|P2|Overall Study|Withdrawal by Subject|1
1625021|NCT01948076|5672855|P1|Overall Study|Withdrawal by Subject|0
1625022|NCT01948063|5672865|P2|Overall Study|Blood samples were accidentally thawed|0
1625023|NCT01948063|5672866|P1|Overall Study|Blood samples were accidentally thawed|1
1625024|NCT01948063|5672865|P2|Overall Study|Discovered an enrollment in other study|1
1625025|NCT01948063|5672866|P1|Overall Study|Discovered an enrollment in other study|0
1625026|NCT01948063|5672865|P2|Overall Study|Boston MCI halted research protocol|1
1625027|NCT01948063|5672866|P1|Overall Study|Boston MCI halted research protocol|0
1625028|NCT01948050|5672874|P2|Overall Study|Withdrawal by Subject|1
1625029|NCT01948050|5672875|P1|Overall Study|Withdrawal by Subject|0
1625030|NCT01947894|5672943|P3|Overall Study|Switched to other growth hormone brand|23
1625031|NCT01947894|5672944|P2|Overall Study|Switched to other growth hormone brand|8
1625032|NCT01947894|5672945|P1|Overall Study|Switched to other growth hormone brand|53
1625033|NCT01947894|5672943|P3|Overall Study|Adverse Event|0
1625034|NCT01947894|5672944|P2|Overall Study|Adverse Event|1
1625035|NCT01947894|5672945|P1|Overall Study|Adverse Event|5
1625036|NCT01947894|5672943|P3|Overall Study|Physician Decision|0
1625037|NCT01947894|5672944|P2|Overall Study|Physician Decision|0
1625038|NCT01947894|5672945|P1|Overall Study|Physician Decision|2
1625039|NCT01947894|5672943|P3|Overall Study|Death|0
1625040|NCT01947894|5672944|P2|Overall Study|Death|1
1625041|NCT01947894|5672945|P1|Overall Study|Death|12
1625042|NCT01947894|5672943|P3|Overall Study|Withdrawal by Subject|1
1625043|NCT01947894|5672944|P2|Overall Study|Withdrawal by Subject|4
1625044|NCT01947894|5672945|P1|Overall Study|Withdrawal by Subject|12
1625045|NCT01947894|5672943|P3|Overall Study|Other|3
1625046|NCT01947894|5672944|P2|Overall Study|Other|4
1625047|NCT01947894|5672945|P1|Overall Study|Other|3
1625048|NCT01947855|5673010|P3|Overall Study|Withdrawal by Subject|0
1625049|NCT01947855|5673011|P2|Overall Study|Withdrawal by Subject|0
1625050|NCT01947855|5673012|P1|Overall Study|Withdrawal by Subject|1
1625051|NCT01947582|5673047|P1|Overall Study|Withdrawal by Subject|1
1625052|NCT01947517|5673056|P2|Overall Study|Withdrawal by Subject|1
1625053|NCT01947517|5673057|P1|Overall Study|Withdrawal by Subject|1
1625054|NCT01947491|5673075|P4|Overall Study|Adverse Event|2
1625055|NCT01947491|5673076|P3|Overall Study|Adverse Event|0
1625056|NCT01947491|5673077|P2|Overall Study|Adverse Event|1
1625057|NCT01947491|5673078|P1|Overall Study|Adverse Event|0
1625058|NCT01947491|5673075|P4|Overall Study|Worsening of condition|0
1625059|NCT01947491|5673076|P3|Overall Study|Worsening of condition|0
1625060|NCT01947491|5673077|P2|Overall Study|Worsening of condition|1
1625061|NCT01947491|5673078|P1|Overall Study|Worsening of condition|0
1625062|NCT01947491|5673075|P4|Overall Study|Withdrawal by Subject|0
1625063|NCT01947491|5673076|P3|Overall Study|Withdrawal by Subject|1
1625064|NCT01947491|5673077|P2|Overall Study|Withdrawal by Subject|1
1625065|NCT01947491|5673078|P1|Overall Study|Withdrawal by Subject|1
1625066|NCT01947491|5673075|P4|Overall Study|Protocol Violation|0
1625067|NCT01947491|5673076|P3|Overall Study|Protocol Violation|0
1625068|NCT01947491|5673077|P2|Overall Study|Protocol Violation|0
1625069|NCT01947491|5673078|P1|Overall Study|Protocol Violation|1
1625070|NCT01947491|5673075|P4|Overall Study|Lack of Efficacy|1
1625071|NCT01947491|5673076|P3|Overall Study|Lack of Efficacy|0
1625072|NCT01947491|5673077|P2|Overall Study|Lack of Efficacy|0
1625073|NCT01947491|5673078|P1|Overall Study|Lack of Efficacy|1
1625074|NCT01947491|5673075|P4|Overall Study|Lost to Follow-up|2
1625075|NCT01947491|5673076|P3|Overall Study|Lost to Follow-up|1
1625076|NCT01947491|5673077|P2|Overall Study|Lost to Follow-up|3
1625077|NCT01947491|5673078|P1|Overall Study|Lost to Follow-up|5
1625078|NCT01947283|5673108|P7|Overall Study|No patients were enrolled in study|1
1625079|NCT01947283|5673109|P6|Overall Study|No patients were enrolled in study|3
1625080|NCT01947283|5673110|P5|Overall Study|No patients were enrolled in study|0
1625081|NCT01947283|5673111|P4|Overall Study|No patients were enrolled in study|0
1625082|NCT01947283|5673112|P3|Overall Study|No patients were enrolled in study|0
1625083|NCT01947283|5673113|P2|Overall Study|No patients were enrolled in study|0
1625084|NCT01947283|5673114|P1|Overall Study|No patients were enrolled in study|0
1625085|NCT01947283|5673108|P7|Overall Study|Missing Follow-up Assessment|0
1625086|NCT01947283|5673109|P6|Overall Study|Missing Follow-up Assessment|2
1625087|NCT01947283|5673110|P5|Overall Study|Missing Follow-up Assessment|0
1625088|NCT01947283|5673111|P4|Overall Study|Missing Follow-up Assessment|0
1625089|NCT01947283|5673112|P3|Overall Study|Missing Follow-up Assessment|3
1625090|NCT01947283|5673113|P2|Overall Study|Missing Follow-up Assessment|2
1625091|NCT01947283|5673114|P1|Overall Study|Missing Follow-up Assessment|2
1625092|NCT01947283|5673108|P7|Overall Study|Non-coding Clinical Recording language|0
1625093|NCT01947283|5673109|P6|Overall Study|Non-coding Clinical Recording language|0
1625094|NCT01947283|5673110|P5|Overall Study|Non-coding Clinical Recording language|0
1625095|NCT01947283|5673111|P4|Overall Study|Non-coding Clinical Recording language|1
1625096|NCT01947283|5673112|P3|Overall Study|Non-coding Clinical Recording language|0
1625097|NCT01947283|5673113|P2|Overall Study|Non-coding Clinical Recording language|0
1625098|NCT01947283|5673114|P1|Overall Study|Non-coding Clinical Recording language|0
1625099|NCT01947283|5673108|P7|Overall Study|No Clinical Recording|0
1625100|NCT01947283|5673109|P6|Overall Study|No Clinical Recording|0
1625101|NCT01947283|5673110|P5|Overall Study|No Clinical Recording|0
1625102|NCT01947283|5673111|P4|Overall Study|No Clinical Recording|10
1625103|NCT01947283|5673112|P3|Overall Study|No Clinical Recording|8
1625104|NCT01947283|5673113|P2|Overall Study|No Clinical Recording|6
1625105|NCT01947283|5673114|P1|Overall Study|No Clinical Recording|12
1625106|NCT01947283|5673108|P7|Overall Study|Withdrawal by Subject|2
1625107|NCT01947283|5673109|P6|Overall Study|Withdrawal by Subject|0
1625108|NCT01947283|5673110|P5|Overall Study|Withdrawal by Subject|0
1625109|NCT01947283|5673111|P4|Overall Study|Withdrawal by Subject|1
1625110|NCT01947283|5673112|P3|Overall Study|Withdrawal by Subject|4
1625111|NCT01947283|5673113|P2|Overall Study|Withdrawal by Subject|8
1625112|NCT01947283|5673114|P1|Overall Study|Withdrawal by Subject|10
1625113|NCT01947283|5673108|P7|Overall Study|Lost to Follow-up|5
1625114|NCT01947283|5673109|P6|Overall Study|Lost to Follow-up|2
1625115|NCT01947283|5673110|P5|Overall Study|Lost to Follow-up|0
1625116|NCT01947283|5673111|P4|Overall Study|Lost to Follow-up|5
1625117|NCT01947283|5673112|P3|Overall Study|Lost to Follow-up|5
1625118|NCT01947283|5673113|P2|Overall Study|Lost to Follow-up|6
1625119|NCT01947283|5673114|P1|Overall Study|Lost to Follow-up|4
1625120|NCT01947283|5673108|P7|Overall Study|Death|0
1625121|NCT01947283|5673109|P6|Overall Study|Death|0
1625122|NCT01947283|5673110|P5|Overall Study|Death|0
1625123|NCT01947283|5673111|P4|Overall Study|Death|0
1625124|NCT01947283|5673112|P3|Overall Study|Death|1
1625125|NCT01947283|5673113|P2|Overall Study|Death|1
1625126|NCT01947283|5673114|P1|Overall Study|Death|1
1625127|NCT01947127|5673186|P2|Overall Study|Data loss|4
1625128|NCT01947127|5673187|P1|Overall Study|Data loss|4
1625129|NCT01947127|5673186|P2|Overall Study|Withdrawal by Subject|1
1625130|NCT01947127|5673187|P1|Overall Study|Withdrawal by Subject|1
1625131|NCT01947127|5673186|P2|Overall Study|Protocol Violation|38
1625132|NCT01947127|5673187|P1|Overall Study|Protocol Violation|18
1625133|NCT01946529|5673211|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
1625134|NCT01946529|5673212|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
1625135|NCT01946529|5673213|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
1625136|NCT01946529|5673211|P3|End of Window Therapy (2 Courses)|Physician Decision|0
1625137|NCT01946529|5673212|P2|End of Window Therapy (2 Courses)|Physician Decision|1
1625138|NCT01946529|5673213|P1|End of Window Therapy (2 Courses)|Physician Decision|0
1625139|NCT01946438|5673224|P4|Overall Study|Withdrawal by Subject|0
1625140|NCT01946438|5673225|P3|Overall Study|Withdrawal by Subject|0
1625141|NCT01946438|5673226|P2|Overall Study|Withdrawal by Subject|0
1625142|NCT01946438|5673227|P1|Overall Study|Withdrawal by Subject|1
1625143|NCT01946438|5673224|P4|Overall Study|Protocol Violation|0
1625144|NCT01946438|5673225|P3|Overall Study|Protocol Violation|1
1625145|NCT01946438|5673226|P2|Overall Study|Protocol Violation|0
1625146|NCT01946438|5673227|P1|Overall Study|Protocol Violation|0
1625147|NCT01946438|5673224|P4|Overall Study|Serious Adverse event|0
1625148|NCT01946438|5673225|P3|Overall Study|Serious Adverse event|0
1625149|NCT01946438|5673226|P2|Overall Study|Serious Adverse event|0
1625150|NCT01946438|5673227|P1|Overall Study|Serious Adverse event|1
1625151|NCT01946438|5673224|P4|Overall Study|Adverse Event|1
1625152|NCT01946438|5673225|P3|Overall Study|Adverse Event|0
1625153|NCT01946438|5673226|P2|Overall Study|Adverse Event|0
1625154|NCT01946438|5673227|P1|Overall Study|Adverse Event|0
1625155|NCT01946425|5673255|P2|Overall Study|Withdrawal by Subject|0
1625156|NCT01946425|5673256|P1|Overall Study|Withdrawal by Subject|1
1625157|NCT01946425|5673255|P2|Overall Study|Protocol Violation|0
1625158|NCT01946425|5673256|P1|Overall Study|Protocol Violation|1
1625159|NCT01946412|5673270|P1|Overall Study|Difficulty in swallowing|1
1625160|NCT01946412|5673270|P1|Overall Study|Continued with commercial Kalydeco|2
1625161|NCT01946412|5673270|P1|Overall Study|Non-Compliance|1
1625162|NCT01946412|5673270|P1|Overall Study|Adverse Event|1
1625163|NCT01946204|5673315|P2|Overall Study|Other|3
1625164|NCT01946204|5673316|P1|Overall Study|Other|7
1625165|NCT01946204|5673315|P2|Overall Study|Ongoing|687
1625166|NCT01946204|5673316|P1|Overall Study|Ongoing|316
1625167|NCT01946204|5673315|P2|Overall Study|Lost to Follow-up|7
1625168|NCT01946204|5673316|P1|Overall Study|Lost to Follow-up|3
1625169|NCT01946204|5673315|P2|Overall Study|Withdrawal by Subject|50
1625170|NCT01946204|5673316|P1|Overall Study|Withdrawal by Subject|37
1625171|NCT01946204|5673315|P2|Overall Study|Death|59
1625172|NCT01946204|5673316|P1|Overall Study|Death|38
1625173|NCT01946178|5673332|P1|Overall Study|Lost to Follow-up|1
1625174|NCT01946178|5673332|P1|Overall Study|Pregnancy|1
1625175|NCT01946165|5673342|P2|Overall Study|Withdrawal by Subject|2
1625176|NCT01946165|5673343|P1|Overall Study|Withdrawal by Subject|0
1625177|NCT01946165|5673342|P2|Overall Study|Physician Decision|0
1625178|NCT01946165|5673343|P1|Overall Study|Physician Decision|2
1625179|NCT01945996|5673370|P2|Overall Study|Lost to Follow-up|5
1625180|NCT01945996|5673371|P1|Overall Study|Lost to Follow-up|3
1625181|NCT01945944|5673447|P2|Overall Study|Withdrawal by Subject|1
1625182|NCT01945944|5673448|P1|Overall Study|Withdrawal by Subject|0
1625183|NCT01945944|5673447|P2|Overall Study|Physician Decision|0
1625184|NCT01945944|5673448|P1|Overall Study|Physician Decision|1
1625185|NCT01945944|5673447|P2|Overall Study|Adverse Event|2
1625186|NCT01945944|5673448|P1|Overall Study|Adverse Event|0
1625187|NCT01945866|5673472|P2|Overall Study|Eyes did not complete or were dropped|0
1625188|NCT01945866|5673473|P1|Overall Study|Eyes did not complete or were dropped|2
1625189|NCT01945775|5673494|P2|Overall Study|Lost to Follow-up|6
1625190|NCT01945775|5673495|P1|Overall Study|Lost to Follow-up|7
1625191|NCT01945775|5673494|P2|Overall Study|Withdrawal by Subject|20
1625192|NCT01945775|5673495|P1|Overall Study|Withdrawal by Subject|7
1625193|NCT01945775|5673494|P2|Overall Study|Death|53
1625194|NCT01945775|5673495|P1|Overall Study|Death|107
1625195|NCT01945775|5673494|P2|Overall Study|On going|65
1625196|NCT01945775|5673495|P1|Overall Study|On going|166
1625197|NCT01945710|5673531|P7|Overall Study|Withdrawal by Subject|0
1625198|NCT01945710|5673532|P6|Overall Study|Withdrawal by Subject|0
1625199|NCT01945710|5673533|P5|Overall Study|Withdrawal by Subject|1
1625200|NCT01945710|5673534|P4|Overall Study|Withdrawal by Subject|0
1625201|NCT01945710|5673535|P3|Overall Study|Withdrawal by Subject|1
1625202|NCT01945710|5673536|P2|Overall Study|Withdrawal by Subject|1
1625203|NCT01945710|5673537|P1|Overall Study|Withdrawal by Subject|0
1625204|NCT01945710|5673531|P7|Overall Study|Other|4
1625205|NCT01945710|5673532|P6|Overall Study|Other|0
1625206|NCT01945710|5673533|P5|Overall Study|Other|1
1625207|NCT01945710|5673534|P4|Overall Study|Other|1
1625208|NCT01945710|5673535|P3|Overall Study|Other|3
1625209|NCT01945710|5673536|P2|Overall Study|Other|0
1625210|NCT01945710|5673537|P1|Overall Study|Other|2
1625211|NCT01945710|5673531|P7|Overall Study|Adverse Event|0
1625212|NCT01945710|5673532|P6|Overall Study|Adverse Event|0
1625213|NCT01945710|5673533|P5|Overall Study|Adverse Event|0
1625214|NCT01945710|5673534|P4|Overall Study|Adverse Event|0
1625215|NCT01945710|5673535|P3|Overall Study|Adverse Event|0
1625216|NCT01945710|5673536|P2|Overall Study|Adverse Event|1
1625217|NCT01945710|5673537|P1|Overall Study|Adverse Event|0
1625218|NCT01945710|5673531|P7|Overall Study|Progressive Disease|19
1625219|NCT01945710|5673532|P6|Overall Study|Progressive Disease|3
1625220|NCT01945710|5673533|P5|Overall Study|Progressive Disease|7
1625221|NCT01945710|5673534|P4|Overall Study|Progressive Disease|2
1625222|NCT01945710|5673535|P3|Overall Study|Progressive Disease|3
1625223|NCT01945710|5673536|P2|Overall Study|Progressive Disease|4
1625224|NCT01945710|5673537|P1|Overall Study|Progressive Disease|5
1625225|NCT01945593|5673656|P4|Overall Study|Other: Screen Failure|0
1625226|NCT01945593|5673657|P3|Overall Study|Other: Screen Failure|0
1625227|NCT01945593|5673658|P2|Overall Study|Other: Screen Failure|2
1625228|NCT01945593|5673659|P1|Overall Study|Other: Screen Failure|0
1625229|NCT01945593|5673656|P4|Overall Study|Other: Surgical Procedure|6
1625230|NCT01945593|5673657|P3|Overall Study|Other: Surgical Procedure|0
1625231|NCT01945593|5673658|P2|Overall Study|Other: Surgical Procedure|2
1625232|NCT01945593|5673659|P1|Overall Study|Other: Surgical Procedure|0
1625233|NCT01945593|5673656|P4|Overall Study|Other: Terminated|1
1625234|NCT01945593|5673657|P3|Overall Study|Other: Terminated|0
1625235|NCT01945593|5673658|P2|Overall Study|Other: Terminated|0
1625236|NCT01945593|5673659|P1|Overall Study|Other: Terminated|0
1625237|NCT01945593|5673656|P4|Overall Study|Death|0
1625238|NCT01945593|5673657|P3|Overall Study|Death|1
1625239|NCT01945593|5673658|P2|Overall Study|Death|0
1625240|NCT01945593|5673659|P1|Overall Study|Death|0
1625241|NCT01945593|5673656|P4|Overall Study|Protocol Violation|3
1625242|NCT01945593|5673657|P3|Overall Study|Protocol Violation|1
1625243|NCT01945593|5673658|P2|Overall Study|Protocol Violation|2
1625244|NCT01945593|5673659|P1|Overall Study|Protocol Violation|0
1625245|NCT01945593|5673656|P4|Overall Study|Withdrawal by Subject|4
1625246|NCT01945593|5673657|P3|Overall Study|Withdrawal by Subject|0
1625247|NCT01945593|5673658|P2|Overall Study|Withdrawal by Subject|2
1625248|NCT01945593|5673659|P1|Overall Study|Withdrawal by Subject|0
1625249|NCT01945593|5673656|P4|Overall Study|Physician Decision|1
1625250|NCT01945593|5673657|P3|Overall Study|Physician Decision|1
1625251|NCT01945593|5673658|P2|Overall Study|Physician Decision|0
1625252|NCT01945593|5673659|P1|Overall Study|Physician Decision|0
1625253|NCT01945593|5673656|P4|Overall Study|Adverse Event|5
1625254|NCT01945593|5673657|P3|Overall Study|Adverse Event|0
1625255|NCT01945593|5673658|P2|Overall Study|Adverse Event|0
1625256|NCT01945593|5673659|P1|Overall Study|Adverse Event|0
1625257|NCT01945489|5673741|P2|Cycle 2|Lost to Follow-up|1
1625258|NCT01945489|5673742|P1|Cycle 2|Lost to Follow-up|0
1625259|NCT01945489|5673741|P2|Cycle 2|Adverse Event|0
1625260|NCT01945489|5673742|P1|Cycle 2|Adverse Event|1
1625261|NCT01945489|5673741|P2|Cycle 1|Other Miscellaneous Reasons|1
1625262|NCT01945489|5673742|P1|Cycle 1|Other Miscellaneous Reasons|3
1625263|NCT01945489|5673741|P2|Cycle 1|Protocol Violation|1
1625264|NCT01945489|5673742|P1|Cycle 1|Protocol Violation|0
1625265|NCT01945489|5673741|P2|Cycle 1|Personal Reasons|2
1625266|NCT01945489|5673742|P1|Cycle 1|Personal Reasons|4
1625267|NCT01945489|5673741|P2|Cycle 1|Lost to Follow-up|0
1625268|NCT01945489|5673742|P1|Cycle 1|Lost to Follow-up|4
1625269|NCT01945489|5673741|P2|Cycle 1|Adverse Event|0
1625270|NCT01945489|5673742|P1|Cycle 1|Adverse Event|2
1625271|NCT01945281|5673796|P2|Overall Study|Technical Problems|0
1625272|NCT01945281|5673797|P1|Overall Study|Technical Problems|1
1625273|NCT01945281|5673796|P2|Overall Study|Physician Decision|1
1625274|NCT01945281|5673797|P1|Overall Study|Physician Decision|1
1625275|NCT01945281|5673796|P2|Overall Study|Death|3
1625276|NCT01945281|5673797|P1|Overall Study|Death|3
1625277|NCT01945281|5673796|P2|Overall Study|Adverse Event|0
1625278|NCT01945281|5673797|P1|Overall Study|Adverse Event|1
1625279|NCT01945242|5673809|P2|Overall Study|Physician Decision|3
1625280|NCT01945242|5673810|P1|Overall Study|Physician Decision|3
1625281|NCT01945216|5673825|P1|Overall Study|CRF not assured by investigators|5
1625282|NCT01945216|5673825|P1|Overall Study|Protocol Violation|42
1625283|NCT01945216|5673825|P1|Overall Study|Case report forms (CRF) uncollected|52
1625284|NCT01945086|5673883|P3|Overall Study|Adverse Event|1
1625285|NCT01945086|5673884|P2|Overall Study|Adverse Event|0
1625286|NCT01945086|5673885|P1|Overall Study|Adverse Event|0
1625287|NCT01945086|5673883|P3|Overall Study|Withdrawal by Subject|1
1625288|NCT01945086|5673884|P2|Overall Study|Withdrawal by Subject|0
1625289|NCT01945086|5673885|P1|Overall Study|Withdrawal by Subject|1
1625290|NCT01945034|5673929|P3|Overall Study|Protocol Violation|1
1625291|NCT01945034|5673930|P2|Overall Study|Protocol Violation|0
1625292|NCT01945034|5673931|P1|Overall Study|Protocol Violation|1
1625293|NCT01945034|5673929|P3|Overall Study|Lost to Follow-up|2
1625294|NCT01945034|5673930|P2|Overall Study|Lost to Follow-up|0
1625295|NCT01945034|5673931|P1|Overall Study|Lost to Follow-up|0
1625296|NCT01945034|5673929|P3|Overall Study|Other|3
1625297|NCT01945034|5673930|P2|Overall Study|Other|1
1625298|NCT01945034|5673931|P1|Overall Study|Other|0
1625299|NCT01945034|5673929|P3|Overall Study|Withdrawal by Subject|1
1625300|NCT01945034|5673930|P2|Overall Study|Withdrawal by Subject|3
1625301|NCT01945034|5673931|P1|Overall Study|Withdrawal by Subject|0
1625302|NCT01945034|5673929|P3|Overall Study|Medication Error|0
1625303|NCT01945034|5673930|P2|Overall Study|Medication Error|1
1625304|NCT01945034|5673931|P1|Overall Study|Medication Error|0
1625305|NCT01945021|5673981|P1|Overall Study|Non-RECIST disease progression|1
1625306|NCT01945021|5673981|P1|Overall Study|Withdrawal of consent|3
1625307|NCT01945021|5673981|P1|Overall Study|Withdrawal by Subject|2
1625308|NCT01945021|5673981|P1|Overall Study|Global deterioration of health-related s|1
1625309|NCT01945021|5673981|P1|Overall Study|Disease progression by RECIST v1.1|30
1625310|NCT01945021|5673981|P1|Overall Study|Pregnancy|1
1625311|NCT01945021|5673981|P1|Overall Study|Death|1
1625312|NCT01945021|5673981|P1|Overall Study|Adverse Event|8
1625313|NCT01944969|5673995|P1|Overall Study|Administrative or other reasons|23
1625314|NCT01944969|5673995|P1|Overall Study|Non-compliance with IMP|1
1625315|NCT01944969|5673995|P1|Overall Study|Lack of Efficacy|1
1625316|NCT01944969|5673995|P1|Overall Study|Adverse Event|1
1625317|NCT01944839|5674019|P2|Overall Study|Subject non-compliance|3
1625318|NCT01944839|5674020|P1|Overall Study|Subject non-compliance|0
1625319|NCT01944839|5674019|P2|Overall Study|Lost to Follow-up|0
1625320|NCT01944839|5674020|P1|Overall Study|Lost to Follow-up|1
1625321|NCT01944839|5674019|P2|Overall Study|Withdrawal by Subject|17
1625322|NCT01944839|5674020|P1|Overall Study|Withdrawal by Subject|9
1625323|NCT01944839|5674019|P2|Overall Study|Adverse Event|5
1625324|NCT01944839|5674020|P1|Overall Study|Adverse Event|10
1625325|NCT01944839|5674019|P2|Overall Study|Protocol Violation|1
1625326|NCT01944839|5674020|P1|Overall Study|Protocol Violation|0
1625327|NCT01944839|5674019|P2|Overall Study|Physician Decision|2
1625328|NCT01944839|5674020|P1|Overall Study|Physician Decision|2
1625329|NCT01944774|5674029|P3|Overall Study|Lost to Follow-up|0
1625330|NCT01944774|5674030|P2|Overall Study|Lost to Follow-up|1
1625331|NCT01944774|5674031|P1|Overall Study|Lost to Follow-up|0
1625332|NCT01944774|5674029|P3|Overall Study|Lack of Efficacy|2
1625333|NCT01944774|5674030|P2|Overall Study|Lack of Efficacy|2
1625334|NCT01944774|5674031|P1|Overall Study|Lack of Efficacy|1
1625335|NCT01944774|5674029|P3|Overall Study|Adverse Event|3
1625336|NCT01944774|5674030|P2|Overall Study|Adverse Event|2
1625337|NCT01944774|5674031|P1|Overall Study|Adverse Event|3
1625338|NCT01944774|5674029|P3|Overall Study|Withdrawal by Subject|3
1625339|NCT01944774|5674030|P2|Overall Study|Withdrawal by Subject|3
1625340|NCT01944774|5674031|P1|Overall Study|Withdrawal by Subject|2
1625341|NCT01944722|5674074|P1|Overall Study|>ASCUS Cytology|1122
1625342|NCT01944722|5674074|P1|Overall Study|Unsatisfactory Cytology Result|63
1625343|NCT01944722|5674074|P1|Overall Study|NILM Subjects <30 years old|8106
1625344|NCT01944722|5674074|P1|Overall Study|Withdrawal by Subject|8
1625345|NCT01944722|5674074|P1|Overall Study|Specimens Mislabeled|2
1625346|NCT01944722|5674074|P1|Overall Study|Missing Specimens|3
1625347|NCT01944722|5674074|P1|Overall Study|Insufficient Volume for Test|1
1625348|NCT01944722|5674074|P1|Overall Study|Improper Storage/Transport|5
1625349|NCT01944722|5674074|P1|Overall Study|Specimen Shipping Issues|34
1625350|NCT01944722|5674074|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
1625351|NCT01944670|5674108|P1|Overall Study|Lost to Follow-up|2
1625352|NCT01944631|5674130|P2|Overall Study|Withdrawal by Subject|1
1625353|NCT01944631|5674131|P1|Overall Study|Withdrawal by Subject|0
1625354|NCT01944631|5674130|P2|Overall Study|Lost to Follow-up|1
1625355|NCT01944631|5674131|P1|Overall Study|Lost to Follow-up|3
1625356|NCT01944631|5674130|P2|Overall Study|Adverse Event|0
1625357|NCT01944631|5674131|P1|Overall Study|Adverse Event|1
1625358|NCT01944462|5674147|P1|PPPP Educational Program|Lost to Follow-up|60
1625359|NCT01944098|5674188|P2|Overall Study|Physician Decision|0
1625360|NCT01944098|5674189|P1|Overall Study|Physician Decision|1
1625361|NCT01944059|5674201|P1|Overall Study|Adverse Event|2
1625362|NCT01944059|5674201|P1|Overall Study|Withdrawal by Subject|1
1625363|NCT01944059|5674201|P1|Overall Study|Physician Decision|3
1625364|NCT01944059|5674201|P1|Overall Study|Lost to Follow-up|1
1625365|NCT01943825|5674242|P4|Overall Study|Other than specified above|1
1625366|NCT01943825|5674243|P3|Overall Study|Other than specified above|0
1625367|NCT01943825|5674244|P2|Overall Study|Other than specified above|1
1625368|NCT01943825|5674245|P1|Overall Study|Other than specified above|0
1625369|NCT01943825|5674242|P4|Overall Study|Withdrawal by Subject|2
1625370|NCT01943825|5674243|P3|Overall Study|Withdrawal by Subject|3
1625371|NCT01943825|5674244|P2|Overall Study|Withdrawal by Subject|0
1625372|NCT01943825|5674245|P1|Overall Study|Withdrawal by Subject|1
1625373|NCT01943825|5674242|P4|Overall Study|Lost to Follow-up|8
1625374|NCT01943825|5674243|P3|Overall Study|Lost to Follow-up|12
1625375|NCT01943825|5674244|P2|Overall Study|Lost to Follow-up|3
1625376|NCT01943825|5674245|P1|Overall Study|Lost to Follow-up|9
1625377|NCT01943799|5674287|P4|Overall Study|Withdrawal by Subject|0
1625378|NCT01943799|5674288|P3|Overall Study|Withdrawal by Subject|1
1625379|NCT01943799|5674289|P2|Overall Study|Withdrawal by Subject|2
1625380|NCT01943799|5674290|P1|Overall Study|Withdrawal by Subject|4
1625381|NCT01943799|5674287|P4|Overall Study|Protocol Violation|0
1625382|NCT01943799|5674288|P3|Overall Study|Protocol Violation|0
1625383|NCT01943799|5674289|P2|Overall Study|Protocol Violation|0
1625384|NCT01943799|5674290|P1|Overall Study|Protocol Violation|1
1625385|NCT01943799|5674287|P4|Overall Study|Lost to Follow-up|0
1625386|NCT01943799|5674288|P3|Overall Study|Lost to Follow-up|1
1625387|NCT01943799|5674289|P2|Overall Study|Lost to Follow-up|1
1625388|NCT01943799|5674290|P1|Overall Study|Lost to Follow-up|0
1625389|NCT01943591|5674330|P2|Overall Study|Death|7
1625390|NCT01943591|5674331|P1|Overall Study|Death|2
1625391|NCT01943591|5674330|P2|Overall Study|Lost to Follow-up|4
1625392|NCT01943591|5674331|P1|Overall Study|Lost to Follow-up|3
1625393|NCT01943552|5674389|P2|Overall Study|Other Reasons|17
1625394|NCT01943552|5674390|P1|Overall Study|Other Reasons|16
1625395|NCT01943552|5674389|P2|Overall Study|Withdrawal by Subject|6
1625396|NCT01943552|5674390|P1|Overall Study|Withdrawal by Subject|6
1625397|NCT01943552|5674389|P2|Overall Study|Adverse Event|2
1625398|NCT01943552|5674390|P1|Overall Study|Adverse Event|3
1625399|NCT01943539|5674406|P2|Overall Study|Non-compliance with at-home intervention|0
1625400|NCT01943539|5674407|P1|Overall Study|Non-compliance with at-home intervention|4
1625401|NCT01943435|5674443|P3|6 Month Follow up|Lost to Follow-up|15
1625402|NCT01943435|5674444|P2|6 Month Follow up|Lost to Follow-up|7
1625403|NCT01943435|5674445|P1|6 Month Follow up|Lost to Follow-up|12
1625404|NCT01943435|5674443|P3|2 Month Follow up|Lost to Follow-up|0
1625405|NCT01943435|5674444|P2|2 Month Follow up|Lost to Follow-up|3
1625406|NCT01943435|5674445|P1|2 Month Follow up|Lost to Follow-up|2
1625407|NCT01943435|5674443|P3|Intervention Period|Withdrawal by Subject|4
1625408|NCT01943435|5674444|P2|Intervention Period|Withdrawal by Subject|3
1625409|NCT01943435|5674445|P1|Intervention Period|Withdrawal by Subject|3
1625410|NCT01943435|5674443|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
1625411|NCT01943435|5674444|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
1625412|NCT01943435|5674445|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
1625413|NCT01943292|5674468|P3|Overall Study|Withdrawal by Subject|0
1625414|NCT01943292|5674469|P2|Overall Study|Withdrawal by Subject|0
1625415|NCT01943292|5674470|P1|Overall Study|Withdrawal by Subject|1
1625416|NCT01942785|5674506|P1|Overall Study|Protocol Violation|1
1625417|NCT01942785|5674506|P1|Overall Study|Withdrawal by Subject|1
1625418|NCT01942785|5674506|P1|Overall Study|Adverse Event|2
1625419|NCT01942733|5674535|P1|Overall Study|Administrative|1
1625420|NCT01942733|5674535|P1|Overall Study|Non-compliance with IMP|1
1625421|NCT01942733|5674535|P1|Overall Study|Lost to Follow-up|1
1625422|NCT01942590|5675653|P2|Overall Study|Adverse Event|0
1625423|NCT01942590|5675654|P1|Overall Study|Adverse Event|1
1625424|NCT01942590|5675653|P2|Overall Study|Withdrawal by Subject|1
1625425|NCT01942590|5675654|P1|Overall Study|Withdrawal by Subject|0
1625426|NCT01942161|5675687|P3|Overall Study|Withdrawal by Subject|1
1625427|NCT01942161|5675688|P2|Overall Study|Withdrawal by Subject|3
1625428|NCT01942161|5675689|P1|Overall Study|Withdrawal by Subject|3
1625429|NCT01942161|5675687|P3|Overall Study|Protocol Violation|0
1625430|NCT01942161|5675688|P2|Overall Study|Protocol Violation|0
1625431|NCT01942161|5675689|P1|Overall Study|Protocol Violation|1
1625432|NCT01942161|5675687|P3|Overall Study|Physician Decision|0
1625433|NCT01942161|5675688|P2|Overall Study|Physician Decision|1
1625434|NCT01942161|5675689|P1|Overall Study|Physician Decision|3
1625435|NCT01942161|5675687|P3|Overall Study|Adverse Event|5
1625436|NCT01942161|5675688|P2|Overall Study|Adverse Event|2
1625437|NCT01942161|5675689|P1|Overall Study|Adverse Event|1
1625438|NCT01942148|5675709|P1|Overall Study|Use of the prohibition medicine|1
1625439|NCT01942148|5675709|P1|Overall Study|Withdrawal by Subject|8
1625440|NCT01942148|5675709|P1|Overall Study|Protocol Violation|1
1625441|NCT01942148|5675709|P1|Overall Study|Physician Decision|11
1625442|NCT01942148|5675709|P1|Overall Study|Lack of Efficacy|2
1625443|NCT01942148|5675709|P1|Overall Study|Adverse Event|4
1625444|NCT01942135|5675717|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
1625445|NCT01942135|5675718|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
1625446|NCT01942135|5675717|P2|Overall Study|Withdrawal by Subject|2
1625447|NCT01942135|5675718|P1|Overall Study|Withdrawal by Subject|4
1625448|NCT01942135|5675717|P2|Overall Study|Participant Refused toContinue Treatment|1
1625449|NCT01942135|5675718|P1|Overall Study|Participant Refused toContinue Treatment|1
1625450|NCT01942135|5675717|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
1625451|NCT01942135|5675718|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
1625452|NCT01942135|5675717|P2|Overall Study|Death|1
1625453|NCT01942135|5675718|P1|Overall Study|Death|0
1625454|NCT01942135|5675717|P2|Overall Study|Randomized Not Treated|2
1625455|NCT01942135|5675718|P1|Overall Study|Randomized Not Treated|2
1625456|NCT01942135|5675717|P2|Overall Study|Global deterioration of health status|3
1625457|NCT01942135|5675718|P1|Overall Study|Global deterioration of health status|8
1625458|NCT01942135|5675717|P2|Overall Study|Adverse Event|3
1625459|NCT01942135|5675718|P1|Overall Study|Adverse Event|9
1625460|NCT01941940|5675755|P1|Overall Study|Other|1
1625461|NCT01941940|5675755|P1|Overall Study|Other|1
1625462|NCT01941940|5675755|P1|Overall Study|Death|1
1625463|NCT01941940|5675755|P1|Overall Study|Withdrawal by Subject|15
1625464|NCT01941940|5675755|P1|Overall Study|Physician Decision|2
1625465|NCT01941940|5675755|P1|Overall Study|Lost to Follow-up|2
1625466|NCT01941940|5675755|P1|Overall Study|Adverse Event|11
1625467|NCT01941537|5675863|P2|Overall Study|Withdrawal by Subject|1
1625468|NCT01941537|5675864|P1|Overall Study|Withdrawal by Subject|0
1625469|NCT01941537|5675863|P2|Overall Study|Adverse Event|0
1625470|NCT01941537|5675864|P1|Overall Study|Adverse Event|1
1625471|NCT01941537|5675863|P2|Overall Study|Pregnancy|0
1625472|NCT01941537|5675864|P1|Overall Study|Pregnancy|1
1625473|NCT01941537|5675863|P2|Overall Study|Lost to Follow-up|0
1625474|NCT01941537|5675864|P1|Overall Study|Lost to Follow-up|1
1625475|NCT01941537|5675863|P2|Overall Study|Lack of Efficacy|2
1625476|NCT01941537|5675864|P1|Overall Study|Lack of Efficacy|1
1625477|NCT01941498|5675876|P1|Overall Study|Relocated out of state|1
1625478|NCT01941186|5675994|P2|Follow-up|Lost to Follow-up|0
1625479|NCT01941186|5675995|P1|Follow-up|Lost to Follow-up|1
1625480|NCT01941095|5676021|P1|Overall Study|Lost to Follow-up|10
1625481|NCT01941095|5676021|P1|Overall Study|Withdrawal by Subject|17
1625482|NCT01941095|5676021|P1|Overall Study|Physician Decision|3
1625483|NCT01941095|5676021|P1|Overall Study|Adverse Event|11
1625484|NCT01941095|5676021|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
1625485|NCT01941095|5676021|P1|Overall Study|Insufficient therapeutic response|13
1625486|NCT01941030|5676046|P2|Overall Study|Withdrawal by Subject|6
1625487|NCT01941030|5676047|P1|Overall Study|Withdrawal by Subject|4
1625488|NCT01941030|5676046|P2|Overall Study|Lost to Follow-up|5
1625489|NCT01941030|5676047|P1|Overall Study|Lost to Follow-up|6
1625490|NCT01941030|5676046|P2|Overall Study|Death|2
1625491|NCT01941030|5676047|P1|Overall Study|Death|3
1625492|NCT01940939|5676069|P2|Overall Study|Withdrawal by Subject|8
1625493|NCT01940939|5676070|P1|Overall Study|Withdrawal by Subject|2
1625494|NCT01940900|5676082|P2|Overall Study|other|0
1625495|NCT01940900|5676083|P1|Overall Study|other|1
1625496|NCT01940900|5676082|P2|Overall Study|subject non-compliance|1
1625497|NCT01940900|5676083|P1|Overall Study|subject non-compliance|1
1625498|NCT01940900|5676082|P2|Overall Study|Sponsor Decision|0
1625499|NCT01940900|5676083|P1|Overall Study|Sponsor Decision|1
1625500|NCT01940900|5676082|P2|Overall Study|Lost to Follow-up|0
1625501|NCT01940900|5676083|P1|Overall Study|Lost to Follow-up|1
1625502|NCT01940900|5676082|P2|Overall Study|Withdrawal by Subject|15
1625503|NCT01940900|5676083|P1|Overall Study|Withdrawal by Subject|11
1625504|NCT01940900|5676082|P2|Overall Study|Adverse Event|15
1625505|NCT01940900|5676083|P1|Overall Study|Adverse Event|10
1625506|NCT01940900|5676082|P2|Overall Study|Physician Decision|0
1625507|NCT01940900|5676083|P1|Overall Study|Physician Decision|4
1625508|NCT01940705|5676093|P4|Overall Study|Withdrawal by team - hearing aid change|0
1625509|NCT01940705|5676094|P3|Overall Study|Withdrawal by team - hearing aid change|0
1625510|NCT01940705|5676095|P2|Overall Study|Withdrawal by team - hearing aid change|0
1625511|NCT01940705|5676096|P1|Overall Study|Withdrawal by team - hearing aid change|1
1625512|NCT01940705|5676093|P4|Overall Study|Intervention not given|0
1625513|NCT01940705|5676094|P3|Overall Study|Intervention not given|3
1625514|NCT01940705|5676095|P2|Overall Study|Intervention not given|3
1625515|NCT01940705|5676096|P1|Overall Study|Intervention not given|0
1625516|NCT01940705|5676093|P4|Overall Study|Withdrawal by Subject|2
1625517|NCT01940705|5676094|P3|Overall Study|Withdrawal by Subject|3
1625518|NCT01940705|5676095|P2|Overall Study|Withdrawal by Subject|2
1625519|NCT01940705|5676096|P1|Overall Study|Withdrawal by Subject|2
1625520|NCT01940705|5676093|P4|Overall Study|Lost to Follow-up|2
1625521|NCT01940705|5676094|P3|Overall Study|Lost to Follow-up|2
1625522|NCT01940705|5676095|P2|Overall Study|Lost to Follow-up|3
1625523|NCT01940705|5676096|P1|Overall Study|Lost to Follow-up|1
1625524|NCT01940497|5676160|P2|Overall Study|Ongoing at data cut-off|117
1625525|NCT01940497|5676161|P1|Overall Study|Ongoing at data cut-off|116
1625526|NCT01940497|5676160|P2|Overall Study|Withdrawal by Subject|0
1625527|NCT01940497|5676161|P1|Overall Study|Withdrawal by Subject|2
1625528|NCT01940497|5676160|P2|Overall Study|Protocol Violation|0
1625529|NCT01940497|5676161|P1|Overall Study|Protocol Violation|1
1625530|NCT01940497|5676160|P2|Overall Study|Failure to return|1
1625531|NCT01940497|5676161|P1|Overall Study|Failure to return|0
1625532|NCT01940497|5676160|P2|Overall Study|Adverse event/Intercurrent illness|0
1625533|NCT01940497|5676161|P1|Overall Study|Adverse event/Intercurrent illness|1
1625534|NCT01940484|5676200|P1|Overall Study|Adverse Event|1
1625535|NCT01940484|5676200|P1|Overall Study|Death|2
1625536|NCT01940484|5676200|P1|Overall Study|Underwent transplantation|4
1625537|NCT01940484|5676200|P1|Overall Study|Withdrawal by Subject|3
1625538|NCT01940471|5676220|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
1625539|NCT01940471|5676221|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
1625540|NCT01940471|5676220|P2|Double-Blind Phase|Still in Double-Blind Phase|270
1625541|NCT01940471|5676221|P1|Double-Blind Phase|Still in Double-Blind Phase|539
1625542|NCT01940471|5676220|P2|Double-Blind Phase|Protocol Violation|1
1625543|NCT01940471|5676221|P1|Double-Blind Phase|Protocol Violation|0
1625544|NCT01940471|5676220|P2|Double-Blind Phase|Lack of Efficacy|0
1625545|NCT01940471|5676221|P1|Double-Blind Phase|Lack of Efficacy|1
1625546|NCT01940471|5676220|P2|Double-Blind Phase|Death|0
1625547|NCT01940471|5676221|P1|Double-Blind Phase|Death|1
1625548|NCT01940471|5676220|P2|Double-Blind Phase|Protocol-Specified Criteria|0
1625549|NCT01940471|5676221|P1|Double-Blind Phase|Protocol-Specified Criteria|1
1625550|NCT01940471|5676220|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
1625551|NCT01940471|5676221|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
1625552|NCT01940471|5676220|P2|Double-Blind Phase|Investigator's Discretion|0
1625553|NCT01940471|5676221|P1|Double-Blind Phase|Investigator's Discretion|5
1625554|NCT01940471|5676220|P2|Double-Blind Phase|Pregnancy|1
1625555|NCT01940471|5676221|P1|Double-Blind Phase|Pregnancy|2
1625556|NCT01940471|5676220|P2|Double-Blind Phase|Lost to Follow-up|2
1625557|NCT01940471|5676221|P1|Double-Blind Phase|Lost to Follow-up|3
1625558|NCT01940471|5676220|P2|Double-Blind Phase|Adverse Event|2
1625559|NCT01940471|5676221|P1|Double-Blind Phase|Adverse Event|1
1625560|NCT01940471|5676220|P2|Double-Blind Phase|Withdrew Consent|7
1625561|NCT01940471|5676221|P1|Double-Blind Phase|Withdrew Consent|13
1625562|NCT01940471|5676220|P2|Double-Blind Phase|Randomized but Never Treated|1
1625563|NCT01940471|5676221|P1|Double-Blind Phase|Randomized but Never Treated|1
1625564|NCT01940354|5676239|P2|Overall Study|Withdrawal by Subject|2
1625565|NCT01940354|5676240|P1|Overall Study|Withdrawal by Subject|4
1625566|NCT01940341|5676252|P2|Open-label Extension Phase|Still on Study|1
1625567|NCT01940341|5676253|P1|Open-label Extension Phase|Still on Study|4
1625568|NCT01940341|5676252|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
1625569|NCT01940341|5676253|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
1625570|NCT01940341|5676252|P2|Double-Blind Phase|Protocol Specified Criteria|0
1625571|NCT01940341|5676253|P1|Double-Blind Phase|Protocol Specified Criteria|1
1625572|NCT01940341|5676252|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
1625573|NCT01940341|5676253|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
1625574|NCT01940341|5676252|P2|Double-Blind Phase|Investigator's Discretion|0
1625575|NCT01940341|5676253|P1|Double-Blind Phase|Investigator's Discretion|1
1625576|NCT01940341|5676252|P2|Double-Blind Phase|Pregnancy|1
1625577|NCT01940341|5676253|P1|Double-Blind Phase|Pregnancy|0
1625578|NCT01940341|5676252|P2|Double-Blind Phase|Lost to Follow-up|1
1625579|NCT01940341|5676253|P1|Double-Blind Phase|Lost to Follow-up|4
1625580|NCT01940341|5676252|P2|Double-Blind Phase|Withdrew Consent|2
1625581|NCT01940341|5676253|P1|Double-Blind Phase|Withdrew Consent|3
1625582|NCT01940341|5676252|P2|Double-Blind Phase|Adverse Event|2
1625583|NCT01940341|5676253|P1|Double-Blind Phase|Adverse Event|3
1625584|NCT01940341|5676252|P2|Double-Blind Phase|Randomized but Never Treated|1
1625585|NCT01940341|5676253|P1|Double-Blind Phase|Randomized but Never Treated|0
1625586|NCT01940120|5676284|P1|Overall Study|Withdrawal by Subject|8
1625587|NCT01940120|5676284|P1|Overall Study|Death|40
1625588|NCT01939977|5676440|P2|Overall Study|Did not receive study medication|1
1625589|NCT01939977|5676441|P1|Overall Study|Did not receive study medication|0
1625590|NCT01939977|5676440|P2|Overall Study|Did not meet inclusion criteria|0
1625591|NCT01939977|5676441|P1|Overall Study|Did not meet inclusion criteria|1
1625592|NCT01939977|5676440|P2|Overall Study|Withdrawal by Subject|2
1625593|NCT01939977|5676441|P1|Overall Study|Withdrawal by Subject|0
1625594|NCT01939977|5676440|P2|Overall Study|Physician Decision|1
1625595|NCT01939977|5676441|P1|Overall Study|Physician Decision|1
1625596|NCT01939977|5676440|P2|Overall Study|Lack of Efficacy|0
1625597|NCT01939977|5676441|P1|Overall Study|Lack of Efficacy|3
1625598|NCT01939977|5676440|P2|Overall Study|Adverse Event|3
1625599|NCT01939977|5676441|P1|Overall Study|Adverse Event|4
1625600|NCT01939899|5676488|P5|Phase 2|Disease Progression|1
1625601|NCT01939899|5676489|P4|Phase 2|Disease Progression|9
1625602|NCT01939899|5676490|P3|Phase 2|Disease Progression|0
1625603|NCT01939899|5676491|P2|Phase 2|Disease Progression|0
1625604|NCT01939899|5676492|P1|Phase 2|Disease Progression|0
1625605|NCT01939899|5676488|P5|Phase 2|Withdrawal by Subject|0
1625606|NCT01939899|5676489|P4|Phase 2|Withdrawal by Subject|2
1625607|NCT01939899|5676490|P3|Phase 2|Withdrawal by Subject|0
1625608|NCT01939899|5676491|P2|Phase 2|Withdrawal by Subject|0
1625609|NCT01939899|5676492|P1|Phase 2|Withdrawal by Subject|0
1625610|NCT01939899|5676488|P5|Lead-in Dose Finding Phase|Other|0
1625611|NCT01939899|5676489|P4|Lead-in Dose Finding Phase|Other|0
1625612|NCT01939899|5676490|P3|Lead-in Dose Finding Phase|Other|1
1625613|NCT01939899|5676491|P2|Lead-in Dose Finding Phase|Other|0
1625614|NCT01939899|5676492|P1|Lead-in Dose Finding Phase|Other|0
1625615|NCT01939899|5676488|P5|Lead-in Dose Finding Phase|Disease Progression|0
1625616|NCT01939899|5676489|P4|Lead-in Dose Finding Phase|Disease Progression|0
1625617|NCT01939899|5676490|P3|Lead-in Dose Finding Phase|Disease Progression|3
1625618|NCT01939899|5676491|P2|Lead-in Dose Finding Phase|Disease Progression|4
1625619|NCT01939899|5676492|P1|Lead-in Dose Finding Phase|Disease Progression|2
1625620|NCT01939899|5676488|P5|Lead-in Dose Finding Phase|Death|0
1625621|NCT01939899|5676489|P4|Lead-in Dose Finding Phase|Death|0
1625622|NCT01939899|5676490|P3|Lead-in Dose Finding Phase|Death|1
1625623|NCT01939899|5676491|P2|Lead-in Dose Finding Phase|Death|3
1625624|NCT01939899|5676492|P1|Lead-in Dose Finding Phase|Death|0
1625625|NCT01939548|5676539|P3|Overall Study|Did not complete follow-up|0
1625626|NCT01939548|5676540|P2|Overall Study|Did not complete follow-up|1
1625627|NCT01939548|5676541|P1|Overall Study|Did not complete follow-up|0
1625628|NCT01939548|5676539|P3|Overall Study|Participant withdrew consent|0
1625629|NCT01939548|5676540|P2|Overall Study|Participant withdrew consent|2
1625630|NCT01939548|5676541|P1|Overall Study|Participant withdrew consent|0
1625631|NCT01939548|5676539|P3|Overall Study|Participant unwilling to continue|0
1625632|NCT01939548|5676540|P2|Overall Study|Participant unwilling to continue|1
1625633|NCT01939548|5676541|P1|Overall Study|Participant unwilling to continue|0
1625634|NCT01939548|5676539|P3|Overall Study|Participant dropped|1
1625635|NCT01939548|5676540|P2|Overall Study|Participant dropped|0
1625636|NCT01939548|5676541|P1|Overall Study|Participant dropped|0
1625637|NCT01939548|5676539|P3|Overall Study|Death|1
1625638|NCT01939548|5676540|P2|Overall Study|Death|0
1625639|NCT01939548|5676541|P1|Overall Study|Death|0
1625640|NCT01939548|5676539|P3|Overall Study|Adverse Event|7
1625641|NCT01939548|5676540|P2|Overall Study|Adverse Event|9
1625642|NCT01939548|5676541|P1|Overall Study|Adverse Event|2
1625643|NCT01939548|5676539|P3|Overall Study|Lost to Follow-up|3
1625644|NCT01939548|5676540|P2|Overall Study|Lost to Follow-up|5
1625645|NCT01939548|5676541|P1|Overall Study|Lost to Follow-up|5
1625646|NCT01939548|5676539|P3|Overall Study|Protocol Violation|5
1625647|NCT01939548|5676540|P2|Overall Study|Protocol Violation|6
1625648|NCT01939548|5676541|P1|Overall Study|Protocol Violation|7
1625649|NCT01939548|5676539|P3|Overall Study|Withdrawal by Subject|1
1625650|NCT01939548|5676540|P2|Overall Study|Withdrawal by Subject|4
1625651|NCT01939548|5676541|P1|Overall Study|Withdrawal by Subject|4
1625652|NCT01939548|5676539|P3|Overall Study|Did Not Meet Entrance Criteria|0
1625653|NCT01939548|5676540|P2|Overall Study|Did Not Meet Entrance Criteria|0
1625654|NCT01939548|5676541|P1|Overall Study|Did Not Meet Entrance Criteria|1
1625655|NCT01939548|5676539|P3|Overall Study|Insufficient Clinical Response|0
1625656|NCT01939548|5676540|P2|Overall Study|Insufficient Clinical Response|0
1625657|NCT01939548|5676541|P1|Overall Study|Insufficient Clinical Response|1
1625658|NCT01939548|5676539|P3|Overall Study|Study Terminated by Sponsor|12
1625659|NCT01939548|5676540|P2|Overall Study|Study Terminated by Sponsor|19
1625660|NCT01939548|5676541|P1|Overall Study|Study Terminated by Sponsor|17
1625661|NCT01939548|5676539|P3|Overall Study|Non compliance|0
1625662|NCT01939548|5676540|P2|Overall Study|Non compliance|2
1625663|NCT01939548|5676541|P1|Overall Study|Non compliance|0
1625664|NCT01939496|5676615|P3|Overall Study|Other|1
1625665|NCT01939496|5676616|P2|Overall Study|Other|0
1625666|NCT01939496|5676617|P1|Overall Study|Other|2
1625667|NCT01939496|5676615|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
1625668|NCT01939496|5676616|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
1625669|NCT01939496|5676617|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
1625670|NCT01939496|5676615|P3|Overall Study|Withdrawal by Subject|1
1625671|NCT01939496|5676616|P2|Overall Study|Withdrawal by Subject|1
1625672|NCT01939496|5676617|P1|Overall Study|Withdrawal by Subject|0
1625673|NCT01939496|5676615|P3|Overall Study|Protocol Violation|0
1625674|NCT01939496|5676616|P2|Overall Study|Protocol Violation|0
1625675|NCT01939496|5676617|P1|Overall Study|Protocol Violation|3
1625676|NCT01939496|5676615|P3|Overall Study|Physician Decision|0
1625677|NCT01939496|5676616|P2|Overall Study|Physician Decision|0
1625678|NCT01939496|5676617|P1|Overall Study|Physician Decision|1
1625679|NCT01939496|5676615|P3|Overall Study|Lost to Follow-up|0
1625680|NCT01939496|5676616|P2|Overall Study|Lost to Follow-up|1
1625681|NCT01939496|5676617|P1|Overall Study|Lost to Follow-up|1
1625682|NCT01939496|5676615|P3|Overall Study|Adverse Event|0
1625683|NCT01939496|5676616|P2|Overall Study|Adverse Event|0
1625684|NCT01939496|5676617|P1|Overall Study|Adverse Event|2
1625685|NCT01939366|5676687|P5|Overall Study|GCP non-compliance at site|3
1625686|NCT01939366|5676688|P4|Overall Study|GCP non-compliance at site|3
1625687|NCT01939366|5676689|P3|Overall Study|GCP non-compliance at site|2
1625688|NCT01939366|5676690|P2|Overall Study|GCP non-compliance at site|3
1625689|NCT01939366|5676691|P1|Overall Study|GCP non-compliance at site|2
1625690|NCT01939366|5676687|P5|Overall Study|Sponsor decision|2
1625691|NCT01939366|5676688|P4|Overall Study|Sponsor decision|0
1625692|NCT01939366|5676689|P3|Overall Study|Sponsor decision|0
1625693|NCT01939366|5676690|P2|Overall Study|Sponsor decision|0
1625694|NCT01939366|5676691|P1|Overall Study|Sponsor decision|0
1625695|NCT01939366|5676687|P5|Overall Study|Protocol Violation|0
1625696|NCT01939366|5676688|P4|Overall Study|Protocol Violation|1
1625697|NCT01939366|5676689|P3|Overall Study|Protocol Violation|0
1625698|NCT01939366|5676690|P2|Overall Study|Protocol Violation|0
1625699|NCT01939366|5676691|P1|Overall Study|Protocol Violation|0
1625700|NCT01939366|5676687|P5|Overall Study|Other|1
1625701|NCT01939366|5676688|P4|Overall Study|Other|2
1625702|NCT01939366|5676689|P3|Overall Study|Other|2
1625703|NCT01939366|5676690|P2|Overall Study|Other|0
1625704|NCT01939366|5676691|P1|Overall Study|Other|0
1625705|NCT01939366|5676687|P5|Overall Study|Inclusion criteria not met|1
1625706|NCT01939366|5676688|P4|Overall Study|Inclusion criteria not met|0
1625707|NCT01939366|5676689|P3|Overall Study|Inclusion criteria not met|1
1625708|NCT01939366|5676690|P2|Overall Study|Inclusion criteria not met|1
1625709|NCT01939366|5676691|P1|Overall Study|Inclusion criteria not met|0
1625710|NCT01939366|5676687|P5|Overall Study|Withdrawal by Subject|3
1625711|NCT01939366|5676688|P4|Overall Study|Withdrawal by Subject|2
1625712|NCT01939366|5676689|P3|Overall Study|Withdrawal by Subject|2
1625713|NCT01939366|5676690|P2|Overall Study|Withdrawal by Subject|0
1625714|NCT01939366|5676691|P1|Overall Study|Withdrawal by Subject|1
1625715|NCT01939366|5676687|P5|Overall Study|Lost to Follow-up|0
1625716|NCT01939366|5676688|P4|Overall Study|Lost to Follow-up|0
1625717|NCT01939366|5676689|P3|Overall Study|Lost to Follow-up|0
1625718|NCT01939366|5676690|P2|Overall Study|Lost to Follow-up|1
1625719|NCT01939366|5676691|P1|Overall Study|Lost to Follow-up|1
1625720|NCT01939366|5676687|P5|Overall Study|Lack of Efficacy|3
1625721|NCT01939366|5676688|P4|Overall Study|Lack of Efficacy|1
1625722|NCT01939366|5676689|P3|Overall Study|Lack of Efficacy|1
1625723|NCT01939366|5676690|P2|Overall Study|Lack of Efficacy|1
1625724|NCT01939366|5676691|P1|Overall Study|Lack of Efficacy|2
1625725|NCT01939366|5676687|P5|Overall Study|Adverse Event|5
1625726|NCT01939366|5676688|P4|Overall Study|Adverse Event|8
1625727|NCT01939366|5676689|P3|Overall Study|Adverse Event|30
1625728|NCT01939366|5676690|P2|Overall Study|Adverse Event|17
1625729|NCT01939366|5676691|P1|Overall Study|Adverse Event|8
1625730|NCT01939314|5676705|P2|Overall Study|Lost to Follow-up|6
1625731|NCT01939314|5676706|P1|Overall Study|Lost to Follow-up|5
1625732|NCT01939314|5676705|P2|Overall Study|Pregnancy|1
1625733|NCT01939314|5676706|P1|Overall Study|Pregnancy|0
1625734|NCT01939314|5676705|P2|Overall Study|Protocol Violation|0
1625735|NCT01939314|5676706|P1|Overall Study|Protocol Violation|1
1625736|NCT01939314|5676705|P2|Overall Study|Withdrawal by Subject|1
1625737|NCT01939314|5676706|P1|Overall Study|Withdrawal by Subject|3
1625738|NCT01939223|5676740|P2|Overall Study|Withdrawal by Subject|0
1625739|NCT01939223|5676741|P1|Overall Study|Withdrawal by Subject|6
1625740|NCT01939223|5676740|P2|Overall Study|Study stopped by Sponsor|7
1625741|NCT01939223|5676741|P1|Overall Study|Study stopped by Sponsor|5
1625742|NCT01939223|5676740|P2|Overall Study|Disease recurrence (radiological)|3
1625743|NCT01939223|5676741|P1|Overall Study|Disease recurrence (radiological)|1
1625744|NCT01939223|5676740|P2|Overall Study|AE not assoc. with disease recurrence|1
1625745|NCT01939223|5676741|P1|Overall Study|AE not assoc. with disease recurrence|1
1625746|NCT01939197|5676756|P7|Overall Study|Lost to Follow-up|2
1625747|NCT01939197|5676757|P6|Overall Study|Lost to Follow-up|1
1625748|NCT01939197|5676758|P5|Overall Study|Lost to Follow-up|3
1625749|NCT01939197|5676759|P4|Overall Study|Lost to Follow-up|1
1625750|NCT01939197|5676760|P3|Overall Study|Lost to Follow-up|0
1625751|NCT01939197|5676761|P2|Overall Study|Lost to Follow-up|1
1625752|NCT01939197|5676762|P1|Overall Study|Lost to Follow-up|0
1625753|NCT01939197|5676756|P7|Overall Study|Withdrawal by Subject|0
1625754|NCT01939197|5676757|P6|Overall Study|Withdrawal by Subject|0
1625755|NCT01939197|5676758|P5|Overall Study|Withdrawal by Subject|1
1625756|NCT01939197|5676759|P4|Overall Study|Withdrawal by Subject|0
1625757|NCT01939197|5676760|P3|Overall Study|Withdrawal by Subject|0
1625758|NCT01939197|5676761|P2|Overall Study|Withdrawal by Subject|0
1625759|NCT01939197|5676762|P1|Overall Study|Withdrawal by Subject|1
1625760|NCT01939002|5676833|P2|Overall Study|Other|2
1625761|NCT01939002|5676834|P1|Overall Study|Other|1
1625762|NCT01939002|5676833|P2|Overall Study|Withdrawal by Subject|3
1625763|NCT01939002|5676834|P1|Overall Study|Withdrawal by Subject|5
1625764|NCT01939002|5676833|P2|Overall Study|Adverse Event|13
1625765|NCT01939002|5676834|P1|Overall Study|Adverse Event|13
1625766|NCT01938846|5676910|P3|Overall Study|Other than listed|4
1625767|NCT01938846|5676911|P2|Overall Study|Other than listed|1
1625768|NCT01938846|5676912|P1|Overall Study|Other than listed|5
1625769|NCT01938846|5676910|P3|Overall Study|Withdrawal by Subject|1
1625770|NCT01938846|5676911|P2|Overall Study|Withdrawal by Subject|2
1625771|NCT01938846|5676912|P1|Overall Study|Withdrawal by Subject|2
1625772|NCT01938846|5676910|P3|Overall Study|Adverse Event|3
1625773|NCT01938846|5676911|P2|Overall Study|Adverse Event|4
1625774|NCT01938846|5676912|P1|Overall Study|Adverse Event|8
1625775|NCT01938846|5676910|P3|Overall Study|Progressive disease|16
1625776|NCT01938846|5676911|P2|Overall Study|Progressive disease|18
1625777|NCT01938846|5676912|P1|Overall Study|Progressive disease|26
1625778|NCT01938625|5677127|P2|Overall Study|Adverse Event|1
1625779|NCT01938625|5677128|P1|Overall Study|Adverse Event|0
1625780|NCT01938625|5677127|P2|Overall Study|Withdrawal by Subject|1
1625781|NCT01938625|5677128|P1|Overall Study|Withdrawal by Subject|0
1625782|NCT01938573|5677148|P2|Overall Study|Operation at other hospital|0
1625783|NCT01938573|5677149|P1|Overall Study|Operation at other hospital|1
1625784|NCT01938573|5677148|P2|Overall Study|Lack of Efficacy|0
1625785|NCT01938573|5677149|P1|Overall Study|Lack of Efficacy|1
1625786|NCT01938430|5677169|P14|Overall Study|Withdrew Consent|0
1625787|NCT01938430|5677170|P13|Overall Study|Withdrew Consent|0
1625788|NCT01938430|5677171|P12|Overall Study|Withdrew Consent|0
1625789|NCT01938430|5677172|P11|Overall Study|Withdrew Consent|0
1625790|NCT01938430|5677173|P10|Overall Study|Withdrew Consent|0
1625791|NCT01938430|5677174|P9|Overall Study|Withdrew Consent|1
1625792|NCT01938430|5677175|P8|Overall Study|Withdrew Consent|0
1625793|NCT01938430|5677176|P7|Overall Study|Withdrew Consent|0
1625794|NCT01938430|5677177|P6|Overall Study|Withdrew Consent|0
1625795|NCT01938430|5677178|P5|Overall Study|Withdrew Consent|0
1625796|NCT01938430|5677179|P4|Overall Study|Withdrew Consent|0
1625797|NCT01938430|5677180|P3|Overall Study|Withdrew Consent|0
1625798|NCT01938430|5677181|P2|Overall Study|Withdrew Consent|0
1625799|NCT01938430|5677182|P1|Overall Study|Withdrew Consent|0
1625800|NCT01938430|5677169|P14|Overall Study|Lost to Follow-up|0
1625801|NCT01938430|5677170|P13|Overall Study|Lost to Follow-up|0
1625802|NCT01938430|5677171|P12|Overall Study|Lost to Follow-up|0
1625803|NCT01938430|5677172|P11|Overall Study|Lost to Follow-up|0
1625804|NCT01938430|5677173|P10|Overall Study|Lost to Follow-up|0
1625805|NCT01938430|5677174|P9|Overall Study|Lost to Follow-up|0
1625806|NCT01938430|5677175|P8|Overall Study|Lost to Follow-up|0
1625807|NCT01938430|5677176|P7|Overall Study|Lost to Follow-up|0
1625808|NCT01938430|5677177|P6|Overall Study|Lost to Follow-up|1
1625809|NCT01938430|5677178|P5|Overall Study|Lost to Follow-up|0
1625810|NCT01938430|5677179|P4|Overall Study|Lost to Follow-up|0
1625811|NCT01938430|5677180|P3|Overall Study|Lost to Follow-up|1
1625812|NCT01938430|5677181|P2|Overall Study|Lost to Follow-up|0
1625813|NCT01938430|5677182|P1|Overall Study|Lost to Follow-up|0
1625814|NCT01938430|5677169|P14|Overall Study|Lack of Efficacy|0
1625815|NCT01938430|5677170|P13|Overall Study|Lack of Efficacy|0
1625816|NCT01938430|5677171|P12|Overall Study|Lack of Efficacy|1
1625817|NCT01938430|5677172|P11|Overall Study|Lack of Efficacy|2
1625818|NCT01938430|5677173|P10|Overall Study|Lack of Efficacy|0
1625819|NCT01938430|5677174|P9|Overall Study|Lack of Efficacy|1
1625820|NCT01938430|5677175|P8|Overall Study|Lack of Efficacy|0
1625821|NCT01938430|5677176|P7|Overall Study|Lack of Efficacy|0
1625822|NCT01938430|5677177|P6|Overall Study|Lack of Efficacy|0
1625823|NCT01938430|5677178|P5|Overall Study|Lack of Efficacy|0
1625824|NCT01938430|5677179|P4|Overall Study|Lack of Efficacy|1
1625825|NCT01938430|5677180|P3|Overall Study|Lack of Efficacy|1
1625826|NCT01938430|5677181|P2|Overall Study|Lack of Efficacy|1
1625827|NCT01938430|5677182|P1|Overall Study|Lack of Efficacy|3
1625828|NCT01938430|5677169|P14|Overall Study|Investigator's Discretion|0
1625829|NCT01938430|5677170|P13|Overall Study|Investigator's Discretion|0
1625830|NCT01938430|5677171|P12|Overall Study|Investigator's Discretion|0
1625831|NCT01938430|5677172|P11|Overall Study|Investigator's Discretion|0
1625832|NCT01938430|5677173|P10|Overall Study|Investigator's Discretion|0
1625833|NCT01938430|5677174|P9|Overall Study|Investigator's Discretion|0
1625834|NCT01938430|5677175|P8|Overall Study|Investigator's Discretion|0
1625835|NCT01938430|5677176|P7|Overall Study|Investigator's Discretion|0
1625836|NCT01938430|5677177|P6|Overall Study|Investigator's Discretion|0
1625837|NCT01938430|5677178|P5|Overall Study|Investigator's Discretion|0
1625838|NCT01938430|5677179|P4|Overall Study|Investigator's Discretion|0
1625839|NCT01938430|5677180|P3|Overall Study|Investigator's Discretion|1
1625840|NCT01938430|5677181|P2|Overall Study|Investigator's Discretion|0
1625841|NCT01938430|5677182|P1|Overall Study|Investigator's Discretion|0
1625842|NCT01938430|5677169|P14|Overall Study|Death|0
1625843|NCT01938430|5677170|P13|Overall Study|Death|0
1625844|NCT01938430|5677171|P12|Overall Study|Death|0
1625845|NCT01938430|5677172|P11|Overall Study|Death|0
1625846|NCT01938430|5677173|P10|Overall Study|Death|3
1625847|NCT01938430|5677174|P9|Overall Study|Death|2
1625848|NCT01938430|5677175|P8|Overall Study|Death|1
1625849|NCT01938430|5677176|P7|Overall Study|Death|1
1625850|NCT01938430|5677177|P6|Overall Study|Death|0
1625851|NCT01938430|5677178|P5|Overall Study|Death|0
1625852|NCT01938430|5677179|P4|Overall Study|Death|1
1625853|NCT01938430|5677180|P3|Overall Study|Death|2
1625854|NCT01938430|5677181|P2|Overall Study|Death|2
1625855|NCT01938430|5677182|P1|Overall Study|Death|1
1625856|NCT01938430|5677169|P14|Overall Study|Adverse Event|0
1625857|NCT01938430|5677170|P13|Overall Study|Adverse Event|0
1625858|NCT01938430|5677171|P12|Overall Study|Adverse Event|0
1625859|NCT01938430|5677172|P11|Overall Study|Adverse Event|0
1625860|NCT01938430|5677173|P10|Overall Study|Adverse Event|0
1625861|NCT01938430|5677174|P9|Overall Study|Adverse Event|0
1625862|NCT01938430|5677175|P8|Overall Study|Adverse Event|0
1625863|NCT01938430|5677176|P7|Overall Study|Adverse Event|1
1625864|NCT01938430|5677177|P6|Overall Study|Adverse Event|0
1625865|NCT01938430|5677178|P5|Overall Study|Adverse Event|0
1625866|NCT01938430|5677179|P4|Overall Study|Adverse Event|0
1625867|NCT01938430|5677180|P3|Overall Study|Adverse Event|0
1625868|NCT01938430|5677181|P2|Overall Study|Adverse Event|0
1625869|NCT01938430|5677182|P1|Overall Study|Adverse Event|0
1625870|NCT01938430|5677169|P14|Overall Study|Randomized but Not Treated|1
1625871|NCT01938430|5677170|P13|Overall Study|Randomized but Not Treated|0
1625872|NCT01938430|5677171|P12|Overall Study|Randomized but Not Treated|0
1625873|NCT01938430|5677172|P11|Overall Study|Randomized but Not Treated|1
1625874|NCT01938430|5677173|P10|Overall Study|Randomized but Not Treated|0
1625875|NCT01938430|5677174|P9|Overall Study|Randomized but Not Treated|0
1625876|NCT01938430|5677175|P8|Overall Study|Randomized but Not Treated|0
1625877|NCT01938430|5677176|P7|Overall Study|Randomized but Not Treated|0
1625878|NCT01938430|5677177|P6|Overall Study|Randomized but Not Treated|0
1625879|NCT01938430|5677178|P5|Overall Study|Randomized but Not Treated|0
1625880|NCT01938430|5677179|P4|Overall Study|Randomized but Not Treated|0
1625881|NCT01938430|5677180|P3|Overall Study|Randomized but Not Treated|0
1625882|NCT01938430|5677181|P2|Overall Study|Randomized but Not Treated|0
1625883|NCT01938430|5677182|P1|Overall Study|Randomized but Not Treated|0
1625884|NCT01938391|5677507|P1|12 Month Follow up|Withdrawal by Subject|1
1625885|NCT01938391|5677507|P1|12 Month Follow up|Physician Decision|1
1625886|NCT01938391|5677507|P1|6 Month Follow up|Withdrawal by Subject|1
1625887|NCT01938001|5677573|P2|Overall Study|Death|26
1625888|NCT01938001|5677574|P1|Overall Study|Death|16
1625889|NCT01938001|5677573|P2|Overall Study|Lost to Follow-up|3
1625890|NCT01938001|5677574|P1|Overall Study|Lost to Follow-up|1
1625891|NCT01938001|5677573|P2|Overall Study|Participant Moved|1
1625892|NCT01938001|5677574|P1|Overall Study|Participant Moved|0
1625893|NCT01938001|5677573|P2|Overall Study|Non-compliant|0
1625894|NCT01938001|5677574|P1|Overall Study|Non-compliant|1
1625895|NCT01938001|5677573|P2|Overall Study|Withdrawal by Subject|17
1625896|NCT01938001|5677574|P1|Overall Study|Withdrawal by Subject|25
1625897|NCT01937871|5677653|P3|Overall Study|Entry Criteria Not Met|1
1625898|NCT01937871|5677654|P2|Overall Study|Entry Criteria Not Met|2
1625899|NCT01937871|5677655|P1|Overall Study|Entry Criteria Not Met|1
1625900|NCT01937871|5677653|P3|Overall Study|Physician Decision|0
1625901|NCT01937871|5677654|P2|Overall Study|Physician Decision|1
1625902|NCT01937871|5677655|P1|Overall Study|Physician Decision|0
1625903|NCT01937871|5677653|P3|Overall Study|Withdrawal by Subject|4
1625904|NCT01937871|5677654|P2|Overall Study|Withdrawal by Subject|6
1625905|NCT01937871|5677655|P1|Overall Study|Withdrawal by Subject|9
1625906|NCT01937871|5677653|P3|Overall Study|Lost to Follow-up|4
1625907|NCT01937871|5677654|P2|Overall Study|Lost to Follow-up|2
1625908|NCT01937871|5677655|P1|Overall Study|Lost to Follow-up|8
1625909|NCT01937871|5677653|P3|Overall Study|Adverse Event|2
1625910|NCT01937871|5677654|P2|Overall Study|Adverse Event|6
1625911|NCT01937871|5677655|P1|Overall Study|Adverse Event|6
1625912|NCT01937715|5677731|P5|Overall Study|Other|0
1625913|NCT01937715|5677732|P4|Overall Study|Other|3
1625914|NCT01937715|5677733|P3|Overall Study|Other|0
1625915|NCT01937715|5677734|P2|Overall Study|Other|0
1625916|NCT01937715|5677735|P1|Overall Study|Other|0
1625917|NCT01937715|5677731|P5|Overall Study|Withdrawal by Subject|2
1625918|NCT01937715|5677732|P4|Overall Study|Withdrawal by Subject|0
1625919|NCT01937715|5677733|P3|Overall Study|Withdrawal by Subject|0
1625920|NCT01937715|5677734|P2|Overall Study|Withdrawal by Subject|1
1625921|NCT01937715|5677735|P1|Overall Study|Withdrawal by Subject|0
1625922|NCT01937715|5677731|P5|Overall Study|Death|0
1625923|NCT01937715|5677732|P4|Overall Study|Death|1
1625924|NCT01937715|5677733|P3|Overall Study|Death|0
1625925|NCT01937715|5677734|P2|Overall Study|Death|0
1625926|NCT01937715|5677735|P1|Overall Study|Death|0
1625927|NCT01937390|5677930|P1|Overall Study|Fail to return|21
1625928|NCT01937390|5677930|P1|Overall Study|Withdrawal by Subject|5
1625929|NCT01937390|5677930|P1|Overall Study|Lost to Follow-up|7
1625930|NCT01937390|5677930|P1|Overall Study|Death|2
1625931|NCT01937364|5677940|P2|Overall Study|Adverse Event|1
1625932|NCT01937364|5677941|P1|Overall Study|Adverse Event|2
1625933|NCT01937351|5677953|P2|Overall Study|Not treated w device, per protocol fail|0
1625934|NCT01937351|5677954|P1|Overall Study|Not treated w device, per protocol fail|4
1625935|NCT01937351|5677953|P2|Overall Study|Death|0
1625936|NCT01937351|5677954|P1|Overall Study|Death|1
1625937|NCT01937351|5677953|P2|Overall Study|Withdrawal by Subject|2
1625938|NCT01937351|5677954|P1|Overall Study|Withdrawal by Subject|4
1625939|NCT01937312|5677962|P2|Overall Study|Withdrawal of subject prior to treatment|1
1625940|NCT01937312|5677963|P1|Overall Study|Withdrawal of subject prior to treatment|1
1625941|NCT01937312|5677962|P2|Overall Study|Lack of Efficacy|1
1625942|NCT01937312|5677963|P1|Overall Study|Lack of Efficacy|0
1625943|NCT01937312|5677962|P2|Overall Study|Adverse Event|1
1625944|NCT01937312|5677963|P1|Overall Study|Adverse Event|10
1625945|NCT01937299|5677978|P2|Overall Study|Withdrawal by Subject|0
1625946|NCT01937299|5677979|P1|Overall Study|Withdrawal by Subject|1
1625947|NCT01937299|5677978|P2|Overall Study|Lack of Efficacy|4
1625948|NCT01937299|5677979|P1|Overall Study|Lack of Efficacy|0
1625949|NCT01937299|5677978|P2|Overall Study|Adverse Event|0
1625950|NCT01937299|5677979|P1|Overall Study|Adverse Event|13
1625951|NCT01937130|5678014|P4|Overall Study|Patient lost to FU due to death|0
1625952|NCT01937130|5678015|P3|Overall Study|Patient lost to FU due to death|0
1625953|NCT01937130|5678016|P2|Overall Study|Patient lost to FU due to death|0
1625954|NCT01937130|5678017|P1|Overall Study|Patient lost to FU due to death|2
1625955|NCT01937130|5678014|P4|Overall Study|Patients unable to swallow|0
1625956|NCT01937130|5678015|P3|Overall Study|Patients unable to swallow|0
1625957|NCT01937130|5678016|P2|Overall Study|Patients unable to swallow|1
1625958|NCT01937130|5678017|P1|Overall Study|Patients unable to swallow|0
1625959|NCT01937130|5678014|P4|Overall Study|Physician Decision|0
1625960|NCT01937130|5678015|P3|Overall Study|Physician Decision|0
1625961|NCT01937130|5678016|P2|Overall Study|Physician Decision|1
1625962|NCT01937130|5678017|P1|Overall Study|Physician Decision|0
1625963|NCT01937130|5678014|P4|Overall Study|Lost to Follow-up|0
1625964|NCT01937130|5678015|P3|Overall Study|Lost to Follow-up|2
1625965|NCT01937130|5678016|P2|Overall Study|Lost to Follow-up|0
1625966|NCT01937130|5678017|P1|Overall Study|Lost to Follow-up|2
1625967|NCT01937130|5678014|P4|Overall Study|Death|0
1625968|NCT01937130|5678015|P3|Overall Study|Death|1
1625969|NCT01937130|5678016|P2|Overall Study|Death|1
1625970|NCT01937130|5678017|P1|Overall Study|Death|1
1625971|NCT01937130|5678014|P4|Overall Study|Adverse Event|1
1625972|NCT01937130|5678015|P3|Overall Study|Adverse Event|0
1625973|NCT01937130|5678016|P2|Overall Study|Adverse Event|1
1625974|NCT01937130|5678017|P1|Overall Study|Adverse Event|0
1625975|NCT01937130|5678014|P4|Overall Study|Withdrawal by Subject|1
1625976|NCT01937130|5678015|P3|Overall Study|Withdrawal by Subject|0
1625977|NCT01937130|5678016|P2|Overall Study|Withdrawal by Subject|0
1625978|NCT01937130|5678017|P1|Overall Study|Withdrawal by Subject|0
1625979|NCT01937117|5678044|P1|Overall Study|Adverse Event|2
1625980|NCT01937117|5678044|P1|Overall Study|Physician Decision|4
1625981|NCT01937117|5678044|P1|Overall Study|Disease Progression|7
1625982|NCT01936974|5678059|P2|Overall Study|Physician Decision|5
1625983|NCT01936974|5678060|P1|Overall Study|Physician Decision|2
1625984|NCT01936870|5678090|P1|Overall Study|No Drug Administration|1
1625985|NCT01936870|5678090|P1|Overall Study|Protocol Violation|12
1625986|NCT01936870|5678090|P1|Overall Study|No Visit After Treatment|176
1625987|NCT01936649|5678127|P1|Overall Study|Other than specified above|5
1625988|NCT01936649|5678127|P1|Overall Study|Protocol Violation|2
1625989|NCT01936649|5678127|P1|Overall Study|Physician Decision|2
1625990|NCT01936649|5678127|P1|Overall Study|Withdrawal by Subject|4
1625991|NCT01936623|5678134|P2|Overall Study|Lost to Follow-up|5
1625992|NCT01936623|5678135|P1|Overall Study|Lost to Follow-up|0
1625993|NCT01936181|5678243|P4|Transition-extension|Withdrawal by Subject|1
1625994|NCT01936181|5678244|P3|Transition-extension|Withdrawal by Subject|2
1625995|NCT01936181|5678245|P2|Transition-extension|Withdrawal by Subject|0
1625996|NCT01936181|5678246|P1|Transition-extension|Withdrawal by Subject|7
1625997|NCT01936181|5678243|P4|Transition-extension|Physician Decision|1
1625998|NCT01936181|5678244|P3|Transition-extension|Physician Decision|0
1625999|NCT01936181|5678245|P2|Transition-extension|Physician Decision|0
1626000|NCT01936181|5678246|P1|Transition-extension|Physician Decision|2
1626001|NCT01936181|5678243|P4|Transition-extension|Lost to Follow-up|2
1626002|NCT01936181|5678244|P3|Transition-extension|Lost to Follow-up|1
1626003|NCT01936181|5678245|P2|Transition-extension|Lost to Follow-up|0
1626004|NCT01936181|5678246|P1|Transition-extension|Lost to Follow-up|3
1626005|NCT01936181|5678243|P4|Transition-extension|Adverse Event|1
1626006|NCT01936181|5678244|P3|Transition-extension|Adverse Event|3
1626007|NCT01936181|5678245|P2|Transition-extension|Adverse Event|0
1626008|NCT01936181|5678246|P1|Transition-extension|Adverse Event|3
1626009|NCT01936181|5678243|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1626010|NCT01936181|5678244|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
1626011|NCT01936181|5678245|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1626012|NCT01936181|5678246|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
1626013|NCT01936181|5678243|P4|Randomised, Double-blind|Withdrawal by Subject|0
1626014|NCT01936181|5678244|P3|Randomised, Double-blind|Withdrawal by Subject|0
1626015|NCT01936181|5678245|P2|Randomised, Double-blind|Withdrawal by Subject|26
1626016|NCT01936181|5678246|P1|Randomised, Double-blind|Withdrawal by Subject|23
1626017|NCT01936181|5678243|P4|Randomised, Double-blind|Physician Decision|0
1626018|NCT01936181|5678244|P3|Randomised, Double-blind|Physician Decision|0
1626019|NCT01936181|5678245|P2|Randomised, Double-blind|Physician Decision|4
1626020|NCT01936181|5678246|P1|Randomised, Double-blind|Physician Decision|4
1626021|NCT01936181|5678243|P4|Randomised, Double-blind|Pregnancy|0
1626022|NCT01936181|5678244|P3|Randomised, Double-blind|Pregnancy|0
1626023|NCT01936181|5678245|P2|Randomised, Double-blind|Pregnancy|1
1626024|NCT01936181|5678246|P1|Randomised, Double-blind|Pregnancy|0
1626025|NCT01936181|5678243|P4|Randomised, Double-blind|Lost to Follow-up|0
1626026|NCT01936181|5678244|P3|Randomised, Double-blind|Lost to Follow-up|0
1626027|NCT01936181|5678245|P2|Randomised, Double-blind|Lost to Follow-up|1
1626028|NCT01936181|5678246|P1|Randomised, Double-blind|Lost to Follow-up|0
1626029|NCT01936181|5678243|P4|Randomised, Double-blind|Lack of Efficacy|0
1626030|NCT01936181|5678244|P3|Randomised, Double-blind|Lack of Efficacy|0
1626031|NCT01936181|5678245|P2|Randomised, Double-blind|Lack of Efficacy|6
1626032|NCT01936181|5678246|P1|Randomised, Double-blind|Lack of Efficacy|5
1626033|NCT01936181|5678243|P4|Randomised, Double-blind|Protocol Violation|0
1626034|NCT01936181|5678244|P3|Randomised, Double-blind|Protocol Violation|0
1626035|NCT01936181|5678245|P2|Randomised, Double-blind|Protocol Violation|5
1626036|NCT01936181|5678246|P1|Randomised, Double-blind|Protocol Violation|1
1626037|NCT01936181|5678243|P4|Randomised, Double-blind|Adverse Event|0
1626038|NCT01936181|5678244|P3|Randomised, Double-blind|Adverse Event|0
1626039|NCT01936181|5678245|P2|Randomised, Double-blind|Adverse Event|21
1626040|NCT01936181|5678246|P1|Randomised, Double-blind|Adverse Event|27
1626041|NCT01935947|5678260|P3|Overall Study|Death|0
1626042|NCT01935947|5678261|P2|Overall Study|Death|0
1626043|NCT01935947|5678262|P1|Overall Study|Death|1
1626044|NCT01935947|5678260|P3|Overall Study|Diease Progression|2
1626045|NCT01935947|5678261|P2|Overall Study|Diease Progression|2
1626046|NCT01935947|5678262|P1|Overall Study|Diease Progression|2
1626047|NCT01935947|5678260|P3|Overall Study|Adverse Event|0
1626048|NCT01935947|5678261|P2|Overall Study|Adverse Event|2
1626049|NCT01935947|5678262|P1|Overall Study|Adverse Event|0
1626050|NCT01934894|5678321|P2|Overall Study|Progressive Disease|2
1626051|NCT01934894|5678322|P1|Overall Study|Progressive Disease|3
1626052|NCT01934894|5678321|P2|Overall Study|Withdrawal by Subject|1
1626053|NCT01934894|5678322|P1|Overall Study|Withdrawal by Subject|0
1626054|NCT01934894|5678321|P2|Overall Study|Death|0
1626055|NCT01934894|5678322|P1|Overall Study|Death|2
1626056|NCT01934894|5678321|P2|Overall Study|Adverse Event|2
1626057|NCT01934894|5678322|P1|Overall Study|Adverse Event|1
1626058|NCT01934790|5678337|P1|Active Follow up|Other reason|1
1626059|NCT01934790|5678337|P1|Active Follow up|Progressive disease|1
1626060|NCT01934790|5678337|P1|Active Follow up|Physician Decision|2
1626061|NCT01934790|5678337|P1|Active Follow up|Death|20
1626062|NCT01934790|5678337|P1|Treatment|Study drug never administered|1
1626063|NCT01934790|5678337|P1|Treatment|Withdrawal by Subject|2
1626064|NCT01934790|5678337|P1|Treatment|Radiological progression|4
1626065|NCT01934790|5678337|P1|Treatment|Clinical progression|6
1626066|NCT01934790|5678337|P1|Treatment|Adverse Event|3
1626067|NCT01934504|5678404|P4|Overall Study|Study Terminated by Sponsor|5
1626068|NCT01934504|5678405|P3|Overall Study|Study Terminated by Sponsor|5
1626069|NCT01934504|5678406|P2|Overall Study|Study Terminated by Sponsor|0
1626070|NCT01934504|5678407|P1|Overall Study|Study Terminated by Sponsor|1
1626071|NCT01934504|5678404|P4|Overall Study|Protocol Deviation|2
1626072|NCT01934504|5678405|P3|Overall Study|Protocol Deviation|0
1626073|NCT01934504|5678406|P2|Overall Study|Protocol Deviation|0
1626074|NCT01934504|5678407|P1|Overall Study|Protocol Deviation|0
1626075|NCT01934218|5678440|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
1626076|NCT01934218|5678441|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
1626077|NCT01934218|5678440|P2|Open-Label Phase|Noncompliance with Study Protocol|2
1626078|NCT01934218|5678441|P1|Open-Label Phase|Noncompliance with Study Protocol|4
1626079|NCT01934218|5678440|P2|Open-Label Phase|Withdrawal by Subject|11
1626080|NCT01934218|5678441|P1|Open-Label Phase|Withdrawal by Subject|13
1626081|NCT01934218|5678440|P2|Open-Label Phase|Protocol Violation|0
1626082|NCT01934218|5678441|P1|Open-Label Phase|Protocol Violation|1
1626083|NCT01934218|5678440|P2|Open-Label Phase|Physician Decision|0
1626084|NCT01934218|5678441|P1|Open-Label Phase|Physician Decision|1
1626085|NCT01934218|5678440|P2|Open-Label Phase|Lost to Follow-up|2
1626086|NCT01934218|5678441|P1|Open-Label Phase|Lost to Follow-up|4
1626087|NCT01934218|5678440|P2|Open-Label Phase|Lack of Efficacy|4
1626088|NCT01934218|5678441|P1|Open-Label Phase|Lack of Efficacy|1
1626089|NCT01934218|5678440|P2|Open-Label Phase|Adverse Event|4
1626090|NCT01934218|5678441|P1|Open-Label Phase|Adverse Event|2
1626091|NCT01934218|5678440|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
1626173|NCT01933880|5678744|P1|Overall Study|Lack of Efficacy|1
1626092|NCT01934218|5678441|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
1626093|NCT01934218|5678440|P2|Double-blind Phase|Noncompliance with Study Protocol|8
1626094|NCT01934218|5678441|P1|Double-blind Phase|Noncompliance with Study Protocol|5
1626095|NCT01934218|5678440|P2|Double-blind Phase|Withdrawal by Subject|13
1626096|NCT01934218|5678441|P1|Double-blind Phase|Withdrawal by Subject|16
1626097|NCT01934218|5678440|P2|Double-blind Phase|Protocol Violation|0
1626098|NCT01934218|5678441|P1|Double-blind Phase|Protocol Violation|4
1626099|NCT01934218|5678440|P2|Double-blind Phase|Physician Decision|2
1626100|NCT01934218|5678441|P1|Double-blind Phase|Physician Decision|1
1626101|NCT01934218|5678440|P2|Double-blind Phase|Lost to Follow-up|14
1626102|NCT01934218|5678441|P1|Double-blind Phase|Lost to Follow-up|7
1626103|NCT01934218|5678440|P2|Double-blind Phase|Lack of Efficacy|7
1626104|NCT01934218|5678441|P1|Double-blind Phase|Lack of Efficacy|6
1626105|NCT01934218|5678440|P2|Double-blind Phase|Adverse Event|8
1626106|NCT01934218|5678441|P1|Double-blind Phase|Adverse Event|8
1626107|NCT01934192|5678452|P4|Overall Study|Physician Decision|0
1626108|NCT01934192|5678453|P3|Overall Study|Physician Decision|0
1626109|NCT01934192|5678454|P2|Overall Study|Physician Decision|2
1626110|NCT01934192|5678455|P1|Overall Study|Physician Decision|3
1626111|NCT01934192|5678452|P4|Overall Study|Other: reached stopping criteria|0
1626112|NCT01934192|5678453|P3|Overall Study|Other: reached stopping criteria|1
1626113|NCT01934192|5678454|P2|Overall Study|Other: reached stopping criteria|5
1626114|NCT01934192|5678455|P1|Overall Study|Other: reached stopping criteria|6
1626115|NCT01934192|5678452|P4|Overall Study|Protocol Violation|1
1626116|NCT01934192|5678453|P3|Overall Study|Protocol Violation|0
1626117|NCT01934192|5678454|P2|Overall Study|Protocol Violation|0
1626118|NCT01934192|5678455|P1|Overall Study|Protocol Violation|0
1626119|NCT01934140|5678591|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
1626120|NCT01934140|5678592|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
1626121|NCT01934140|5678591|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
1626122|NCT01934140|5678592|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
1626123|NCT01934140|5678591|P2|Booster Phase (6 Months)|Lost to Follow-up|0
1626124|NCT01934140|5678592|P1|Booster Phase (6 Months)|Lost to Follow-up|1
1626125|NCT01934140|5678591|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
1626126|NCT01934140|5678592|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
1626127|NCT01934140|5678591|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
1626128|NCT01934140|5678592|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
1626129|NCT01934140|5678591|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
1626130|NCT01934140|5678592|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
1626131|NCT01934140|5678591|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
1626132|NCT01934140|5678592|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
1626133|NCT01934140|5678591|P2|Persistence Phase (Year 6-10)|Other|6
1626134|NCT01934140|5678592|P1|Persistence Phase (Year 6-10)|Other|24
1626135|NCT01934010|5678643|P3|Overall Study|Lost to Follow-up|0
1626136|NCT01934010|5678644|P2|Overall Study|Lost to Follow-up|4
1626137|NCT01934010|5678645|P1|Overall Study|Lost to Follow-up|7
1626138|NCT01934010|5678643|P3|Overall Study|Withdrawal by Subject|2
1626139|NCT01934010|5678644|P2|Overall Study|Withdrawal by Subject|6
1626140|NCT01934010|5678645|P1|Overall Study|Withdrawal by Subject|15
1626141|NCT01934010|5678643|P3|Overall Study|Adverse Event|0
1626142|NCT01934010|5678644|P2|Overall Study|Adverse Event|1
1626143|NCT01934010|5678645|P1|Overall Study|Adverse Event|1
1626144|NCT01933932|5678687|P2|Overall Study|Eligibility criteria not fulfilled|1
1626145|NCT01933932|5678688|P1|Overall Study|Eligibility criteria not fulfilled|0
1626146|NCT01933932|5678687|P2|Overall Study|Withdrawal by Subject|14
1626147|NCT01933932|5678688|P1|Overall Study|Withdrawal by Subject|11
1626148|NCT01933932|5678687|P2|Overall Study|Death|163
1626149|NCT01933932|5678688|P1|Overall Study|Death|173
1626150|NCT01933919|5678706|P2|Open-label Long-term Phase|Other|2
1626151|NCT01933919|5678707|P1|Open-label Long-term Phase|Other|1
1626152|NCT01933919|5678706|P2|Open-label Long-term Phase|Lost to Follow-up|0
1626153|NCT01933919|5678707|P1|Open-label Long-term Phase|Lost to Follow-up|1
1626154|NCT01933919|5678706|P2|Open-label Long-term Phase|Withdrawal by Subject|4
1626155|NCT01933919|5678707|P1|Open-label Long-term Phase|Withdrawal by Subject|3
1626156|NCT01933919|5678706|P2|Open-label Long-term Phase|Adverse Event|0
1626157|NCT01933919|5678707|P1|Open-label Long-term Phase|Adverse Event|2
1626158|NCT01933919|5678706|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
1626159|NCT01933919|5678707|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
1626160|NCT01933919|5678706|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
1626161|NCT01933919|5678707|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
1626162|NCT01933919|5678706|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
1626163|NCT01933919|5678707|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
1626164|NCT01933880|5678743|P2|Overall Study|Protocol Violation|0
1626165|NCT01933880|5678744|P1|Overall Study|Protocol Violation|1
1626166|NCT01933880|5678743|P2|Overall Study|Other|0
1626167|NCT01933880|5678744|P1|Overall Study|Other|4
1626168|NCT01933880|5678743|P2|Overall Study|Followup exceeded 4 days to visit window|0
1626169|NCT01933880|5678744|P1|Overall Study|Followup exceeded 4 days to visit window|19
1626170|NCT01933880|5678743|P2|Overall Study|Concomitant medication Interference|1
1626171|NCT01933880|5678744|P1|Overall Study|Concomitant medication Interference|0
1626172|NCT01933880|5678743|P2|Overall Study|Lack of Efficacy|0
1626174|NCT01933880|5678743|P2|Overall Study|Withdrawal by Subject|0
1626175|NCT01933880|5678744|P1|Overall Study|Withdrawal by Subject|5
1626176|NCT01933789|5678818|P9|Overall Study|Became Ineligible|0
1626177|NCT01933789|5678819|P8|Overall Study|Became Ineligible|6
1626178|NCT01933789|5678820|P7|Overall Study|Became Ineligible|13
1626179|NCT01933789|5678821|P6|Overall Study|Became Ineligible|10
1626180|NCT01933789|5678822|P5|Overall Study|Became Ineligible|13
1626181|NCT01933789|5678823|P4|Overall Study|Became Ineligible|0
1626182|NCT01933789|5678824|P3|Overall Study|Became Ineligible|0
1626183|NCT01933789|5678825|P2|Overall Study|Became Ineligible|0
1626184|NCT01933789|5678826|P1|Overall Study|Became Ineligible|4
1626185|NCT01933789|5678818|P9|Overall Study|Withdrawal by Subject|0
1626186|NCT01933789|5678819|P8|Overall Study|Withdrawal by Subject|4
1626187|NCT01933789|5678820|P7|Overall Study|Withdrawal by Subject|1
1626188|NCT01933789|5678821|P6|Overall Study|Withdrawal by Subject|16
1626189|NCT01933789|5678822|P5|Overall Study|Withdrawal by Subject|17
1626190|NCT01933789|5678823|P4|Overall Study|Withdrawal by Subject|0
1626191|NCT01933789|5678824|P3|Overall Study|Withdrawal by Subject|0
1626192|NCT01933789|5678825|P2|Overall Study|Withdrawal by Subject|1
1626193|NCT01933789|5678826|P1|Overall Study|Withdrawal by Subject|2
1626194|NCT01933789|5678818|P9|Overall Study|Lost to Follow-up|0
1626195|NCT01933789|5678819|P8|Overall Study|Lost to Follow-up|4
1626196|NCT01933789|5678820|P7|Overall Study|Lost to Follow-up|1
1626197|NCT01933789|5678821|P6|Overall Study|Lost to Follow-up|9
1626198|NCT01933789|5678822|P5|Overall Study|Lost to Follow-up|8
1626199|NCT01933789|5678823|P4|Overall Study|Lost to Follow-up|1
1626200|NCT01933789|5678824|P3|Overall Study|Lost to Follow-up|0
1626201|NCT01933789|5678825|P2|Overall Study|Lost to Follow-up|0
1626202|NCT01933789|5678826|P1|Overall Study|Lost to Follow-up|0
1626203|NCT01933789|5678818|P9|Overall Study|Death|0
1626204|NCT01933789|5678819|P8|Overall Study|Death|0
1626205|NCT01933789|5678820|P7|Overall Study|Death|0
1626206|NCT01933789|5678821|P6|Overall Study|Death|32
1626207|NCT01933789|5678822|P5|Overall Study|Death|21
1626208|NCT01933789|5678823|P4|Overall Study|Death|0
1626209|NCT01933789|5678824|P3|Overall Study|Death|0
1626210|NCT01933789|5678825|P2|Overall Study|Death|0
1626211|NCT01933789|5678826|P1|Overall Study|Death|0
1626212|NCT01933672|5679136|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1626213|NCT01933672|5679137|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1626214|NCT01933672|5679138|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1626215|NCT01933672|5679139|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1626216|NCT01933672|5679140|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1626217|NCT01933672|5679141|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
1626218|NCT01933672|5679142|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
1626219|NCT01933672|5679136|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1626220|NCT01933672|5679137|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1626221|NCT01933672|5679138|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1626222|NCT01933672|5679139|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
1626223|NCT01933672|5679140|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1626224|NCT01933672|5679141|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1626225|NCT01933672|5679142|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
1626226|NCT01933672|5679136|P7|Second Intervention Period (12-16 Days)|Other|0
1626227|NCT01933672|5679137|P6|Second Intervention Period (12-16 Days)|Other|0
1626228|NCT01933672|5679138|P5|Second Intervention Period (12-16 Days)|Other|0
1626229|NCT01933672|5679139|P4|Second Intervention Period (12-16 Days)|Other|0
1626230|NCT01933672|5679140|P3|Second Intervention Period (12-16 Days)|Other|1
1626231|NCT01933672|5679141|P2|Second Intervention Period (12-16 Days)|Other|1
1626232|NCT01933672|5679142|P1|Second Intervention Period (12-16 Days)|Other|0
1626233|NCT01933672|5679136|P7|First Intervention Period (12-16 Days)|Other|0
1626234|NCT01933672|5679137|P6|First Intervention Period (12-16 Days)|Other|1
1626235|NCT01933672|5679138|P5|First Intervention Period (12-16 Days)|Other|0
1626236|NCT01933672|5679139|P4|First Intervention Period (12-16 Days)|Other|0
1626237|NCT01933672|5679140|P3|First Intervention Period (12-16 Days)|Other|1
1626238|NCT01933672|5679141|P2|First Intervention Period (12-16 Days)|Other|0
1626239|NCT01933672|5679142|P1|First Intervention Period (12-16 Days)|Other|0
1626240|NCT01933672|5679136|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1626241|NCT01933672|5679137|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1626242|NCT01933672|5679138|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
1626243|NCT01933672|5679139|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1626244|NCT01933672|5679140|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1626245|NCT01933672|5679141|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1626246|NCT01933672|5679142|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
1626247|NCT01933672|5679136|P7|Metformin Run-in Period|Other|0
1626248|NCT01933672|5679137|P6|Metformin Run-in Period|Other|0
1626249|NCT01933672|5679138|P5|Metformin Run-in Period|Other|0
1626250|NCT01933672|5679139|P4|Metformin Run-in Period|Other|0
1626251|NCT01933672|5679140|P3|Metformin Run-in Period|Other|0
1626252|NCT01933672|5679141|P2|Metformin Run-in Period|Other|0
1626253|NCT01933672|5679142|P1|Metformin Run-in Period|Other|5
1626254|NCT01933672|5679136|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
1626255|NCT01933672|5679137|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
1626256|NCT01933672|5679138|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
1626257|NCT01933672|5679139|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
1626258|NCT01933672|5679140|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
1626259|NCT01933672|5679141|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
1626260|NCT01933672|5679142|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
1626261|NCT01933672|5679136|P7|Metformin Run-in Period|Adverse Event|0
1626262|NCT01933672|5679137|P6|Metformin Run-in Period|Adverse Event|0
1626263|NCT01933672|5679138|P5|Metformin Run-in Period|Adverse Event|0
1626264|NCT01933672|5679139|P4|Metformin Run-in Period|Adverse Event|0
1626265|NCT01933672|5679140|P3|Metformin Run-in Period|Adverse Event|0
1626266|NCT01933672|5679141|P2|Metformin Run-in Period|Adverse Event|0
1626267|NCT01933672|5679142|P1|Metformin Run-in Period|Adverse Event|1
1626268|NCT01933594|5679194|P6|Overall Study|Ineligible for subsequent study step|0
1626269|NCT01933594|5679195|P5|Overall Study|Ineligible for subsequent study step|1
1626270|NCT01933594|5679196|P4|Overall Study|Ineligible for subsequent study step|0
1626271|NCT01933594|5679197|P3|Overall Study|Ineligible for subsequent study step|0
1626272|NCT01933594|5679198|P2|Overall Study|Ineligible for subsequent study step|0
1626273|NCT01933594|5679199|P1|Overall Study|Ineligible for subsequent study step|0
1626274|NCT01933594|5679194|P6|Overall Study|Lost to Follow-up|0
1626275|NCT01933594|5679195|P5|Overall Study|Lost to Follow-up|1
1626276|NCT01933594|5679196|P4|Overall Study|Lost to Follow-up|0
1626277|NCT01933594|5679197|P3|Overall Study|Lost to Follow-up|0
1626278|NCT01933594|5679198|P2|Overall Study|Lost to Follow-up|0
1626279|NCT01933594|5679199|P1|Overall Study|Lost to Follow-up|1
1626280|NCT01933334|5679333|P2|Overall Study|Withdrawal by Subject|1
1626281|NCT01933334|5679334|P1|Overall Study|Withdrawal by Subject|0
1626282|NCT01933334|5679333|P2|Overall Study|Adverse Event|1
1626283|NCT01933334|5679334|P1|Overall Study|Adverse Event|5
1626284|NCT01933113|5679361|P1|Overall Study|Fractured nonfunctioning lead.|1
1626285|NCT01933048|5679367|P2|Overall Study|unknown reasons|1
1626286|NCT01933048|5679368|P1|Overall Study|unknown reasons|1
1626287|NCT01933048|5679367|P2|Overall Study|Physician Decision|0
1626288|NCT01933048|5679368|P1|Overall Study|Physician Decision|1
1626289|NCT01933048|5679367|P2|Overall Study|Protocol Violation|8
1626290|NCT01933048|5679368|P1|Overall Study|Protocol Violation|7
1626291|NCT01933048|5679367|P2|Overall Study|personal reasons|1
1626292|NCT01933048|5679368|P1|Overall Study|personal reasons|1
1626293|NCT01933048|5679367|P2|Overall Study|Lost to Follow-up|18
1626294|NCT01933048|5679368|P1|Overall Study|Lost to Follow-up|15
1626295|NCT01932970|5679381|P1|Overall Study|Protocol Specified Criteria|10
1626296|NCT01932970|5679381|P1|Overall Study|Lost to Follow-up|2
1626297|NCT01932970|5679381|P1|Overall Study|Death|1
1626298|NCT01932970|5679381|P1|Overall Study|Withdrawal by Subject|5
1626299|NCT01932788|5679391|P2|Overall Study|Withdrawal by Subject|5
1626300|NCT01932788|5679392|P1|Overall Study|Withdrawal by Subject|0
1626301|NCT01932788|5679391|P2|Overall Study|Lack of Efficacy|0
1626302|NCT01932788|5679392|P1|Overall Study|Lack of Efficacy|2
1626303|NCT01932788|5679391|P2|Overall Study|Lost to Follow-up|46
1626304|NCT01932788|5679392|P1|Overall Study|Lost to Follow-up|18
1626305|NCT01932788|5679391|P2|Overall Study|Protocol Violation|0
1626306|NCT01932788|5679392|P1|Overall Study|Protocol Violation|18
1626307|NCT01932762|5679402|P4|Overall Study|Physician Decision|0
1626308|NCT01932762|5679403|P3|Overall Study|Physician Decision|0
1626309|NCT01932762|5679404|P2|Overall Study|Physician Decision|0
1626310|NCT01932762|5679405|P1|Overall Study|Physician Decision|1
1626311|NCT01932762|5679402|P4|Overall Study|Lost to Follow-up|1
1626312|NCT01932762|5679403|P3|Overall Study|Lost to Follow-up|0
1626313|NCT01932762|5679404|P2|Overall Study|Lost to Follow-up|0
1626314|NCT01932762|5679405|P1|Overall Study|Lost to Follow-up|4
1626315|NCT01932762|5679402|P4|Overall Study|Withdrawal by Subject|0
1626316|NCT01932762|5679403|P3|Overall Study|Withdrawal by Subject|0
1626317|NCT01932762|5679404|P2|Overall Study|Withdrawal by Subject|2
1626318|NCT01932762|5679405|P1|Overall Study|Withdrawal by Subject|1
1626319|NCT01932697|5679441|P2|Overall Study|Ineligible|0
1626320|NCT01932697|5679442|P1|Overall Study|Ineligible|1
1626321|NCT01932697|5679441|P2|Overall Study|Received a different amount of tx|0
1626322|NCT01932697|5679442|P1|Overall Study|Received a different amount of tx|1
1626323|NCT01932437|5679509|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
1626324|NCT01932437|5679510|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1626325|NCT01932437|5679511|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1626326|NCT01932437|5679512|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1626327|NCT01932437|5679513|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1626328|NCT01932437|5679514|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
1626329|NCT01932294|5679564|P1|Overall Study|Transferred to other hospitals|12
1626330|NCT01932294|5679564|P1|Overall Study|Heart Transplantation|16
1626331|NCT01932294|5679564|P1|Overall Study|VAD Implantation|20
1626332|NCT01932294|5679564|P1|Overall Study|Lost to Follow-up|8
1626333|NCT01932294|5679564|P1|Overall Study|Death|43
1626334|NCT01931956|5679641|P4|Overall Study|Not due|0
1626335|NCT01931956|5679642|P3|Overall Study|Not due|21
1626336|NCT01931956|5679643|P2|Overall Study|Not due|0
1626337|NCT01931956|5679644|P1|Overall Study|Not due|0
1626338|NCT01931956|5679641|P4|Overall Study|Expected|0
1626339|NCT01931956|5679642|P3|Overall Study|Expected|6
1626340|NCT01931956|5679643|P2|Overall Study|Expected|0
1626341|NCT01931956|5679644|P1|Overall Study|Expected|2
1626342|NCT01931956|5679641|P4|Overall Study|Lost to Follow-up|7
1626343|NCT01931956|5679642|P3|Overall Study|Lost to Follow-up|11
1626344|NCT01931956|5679643|P2|Overall Study|Lost to Follow-up|0
1626345|NCT01931956|5679644|P1|Overall Study|Lost to Follow-up|2
1626346|NCT01931956|5679641|P4|Overall Study|Withdrawal by Subject|30
1626347|NCT01931956|5679642|P3|Overall Study|Withdrawal by Subject|70
1626348|NCT01931956|5679643|P2|Overall Study|Withdrawal by Subject|0
1626349|NCT01931956|5679644|P1|Overall Study|Withdrawal by Subject|5
1626350|NCT01931956|5679641|P4|Overall Study|Death|96
1626351|NCT01931956|5679642|P3|Overall Study|Death|379
1626352|NCT01931956|5679643|P2|Overall Study|Death|7
1626353|NCT01931956|5679644|P1|Overall Study|Death|42
1626354|NCT01931865|5680011|P1|Overall Study|Withdrawal by Subject|2
1626355|NCT01931865|5680011|P1|Overall Study|Lost to Follow-up|2
1626356|NCT01931839|5680024|P7|Overall Study|Other|0
1626357|NCT01931839|5680025|P6|Overall Study|Other|0
1626358|NCT01931839|5680026|P5|Overall Study|Other|0
1626359|NCT01931839|5680027|P4|Overall Study|Other|0
1626360|NCT01931839|5680028|P3|Overall Study|Other|6
1626361|NCT01931839|5680029|P2|Overall Study|Other|2
1626362|NCT01931839|5680030|P1|Overall Study|Other|4
1626363|NCT01931839|5680024|P7|Overall Study|Lost to Follow-up|0
1626364|NCT01931839|5680025|P6|Overall Study|Lost to Follow-up|0
1626365|NCT01931839|5680026|P5|Overall Study|Lost to Follow-up|0
1626366|NCT01931839|5680027|P4|Overall Study|Lost to Follow-up|5
1626367|NCT01931839|5680028|P3|Overall Study|Lost to Follow-up|4
1626368|NCT01931839|5680029|P2|Overall Study|Lost to Follow-up|2
1626369|NCT01931839|5680030|P1|Overall Study|Lost to Follow-up|1
1626370|NCT01931839|5680024|P7|Overall Study|Other non-compliance|0
1626371|NCT01931839|5680025|P6|Overall Study|Other non-compliance|3
1626372|NCT01931839|5680026|P5|Overall Study|Other non-compliance|0
1626373|NCT01931839|5680027|P4|Overall Study|Other non-compliance|3
1626374|NCT01931839|5680028|P3|Overall Study|Other non-compliance|12
1626375|NCT01931839|5680029|P2|Overall Study|Other non-compliance|9
1626376|NCT01931839|5680030|P1|Overall Study|Other non-compliance|15
1626377|NCT01931839|5680024|P7|Overall Study|Withdrawal of consent (not due to AE)|2
1626378|NCT01931839|5680025|P6|Overall Study|Withdrawal of consent (not due to AE)|2
1626379|NCT01931839|5680026|P5|Overall Study|Withdrawal of consent (not due to AE)|0
1626380|NCT01931839|5680027|P4|Overall Study|Withdrawal of consent (not due to AE)|3
1626381|NCT01931839|5680028|P3|Overall Study|Withdrawal of consent (not due to AE)|13
1626382|NCT01931839|5680029|P2|Overall Study|Withdrawal of consent (not due to AE)|8
1626383|NCT01931839|5680030|P1|Overall Study|Withdrawal of consent (not due to AE)|11
1626384|NCT01931839|5680024|P7|Overall Study|Adverse Event|1
1626385|NCT01931839|5680025|P6|Overall Study|Adverse Event|0
1626386|NCT01931839|5680026|P5|Overall Study|Adverse Event|0
1626387|NCT01931839|5680027|P4|Overall Study|Adverse Event|3
1626388|NCT01931839|5680028|P3|Overall Study|Adverse Event|1
1626389|NCT01931839|5680029|P2|Overall Study|Adverse Event|4
1626390|NCT01931839|5680030|P1|Overall Study|Adverse Event|9
1626391|NCT01931839|5680024|P7|Overall Study|Withdrawal of consent|0
1626392|NCT01931839|5680025|P6|Overall Study|Withdrawal of consent|0
1626393|NCT01931839|5680026|P5|Overall Study|Withdrawal of consent|1
1626394|NCT01931839|5680027|P4|Overall Study|Withdrawal of consent|0
1626395|NCT01931839|5680028|P3|Overall Study|Withdrawal of consent|0
1626396|NCT01931839|5680029|P2|Overall Study|Withdrawal of consent|0
1626397|NCT01931839|5680030|P1|Overall Study|Withdrawal of consent|0
1626398|NCT01931839|5680024|P7|Overall Study|Physician Decision|1
1626399|NCT01931839|5680025|P6|Overall Study|Physician Decision|0
1626400|NCT01931839|5680026|P5|Overall Study|Physician Decision|0
1626401|NCT01931839|5680027|P4|Overall Study|Physician Decision|0
1626402|NCT01931839|5680028|P3|Overall Study|Physician Decision|1
1626403|NCT01931839|5680029|P2|Overall Study|Physician Decision|0
1626404|NCT01931839|5680030|P1|Overall Study|Physician Decision|1
1626405|NCT01931839|5680024|P7|Overall Study|Death|0
1626406|NCT01931839|5680025|P6|Overall Study|Death|0
1626407|NCT01931839|5680026|P5|Overall Study|Death|0
1626408|NCT01931839|5680027|P4|Overall Study|Death|0
1626409|NCT01931839|5680028|P3|Overall Study|Death|2
1626410|NCT01931839|5680029|P2|Overall Study|Death|1
1626411|NCT01931839|5680030|P1|Overall Study|Death|0
1626412|NCT01931735|5680102|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
1626413|NCT01931735|5680103|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
1626414|NCT01931735|5680104|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
1626415|NCT01931735|5680105|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
1626416|NCT01931735|5680102|P4|Observational Non-Randomized Phase|Adverse Event|1
1626417|NCT01931735|5680103|P3|Observational Non-Randomized Phase|Adverse Event|0
1626418|NCT01931735|5680104|P2|Observational Non-Randomized Phase|Adverse Event|0
1626419|NCT01931735|5680105|P1|Observational Non-Randomized Phase|Adverse Event|0
1626420|NCT01931735|5680102|P4|Randomized Phase|Lost to Follow-up|0
1626421|NCT01931735|5680103|P3|Randomized Phase|Lost to Follow-up|5
1626422|NCT01931735|5680104|P2|Randomized Phase|Lost to Follow-up|2
1626423|NCT01931735|5680105|P1|Randomized Phase|Lost to Follow-up|2
1626424|NCT01931670|5680152|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
1626425|NCT01931670|5680153|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
1626426|NCT01931670|5680154|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
1626427|NCT01931670|5680152|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
1626428|NCT01931670|5680153|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
1626429|NCT01931670|5680154|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
1626430|NCT01931670|5680152|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
1626431|NCT01931670|5680153|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
1626432|NCT01931670|5680154|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
1626433|NCT01931670|5680152|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
1626434|NCT01931670|5680153|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
1626435|NCT01931670|5680154|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
1626436|NCT01931670|5680152|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
1626437|NCT01931670|5680153|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
1626438|NCT01931670|5680154|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
1626439|NCT01931670|5680152|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
1626440|NCT01931670|5680153|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
1626441|NCT01931670|5680154|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
1626442|NCT01931670|5680152|P3|Treatment Period|Lost to Follow-up|7
1626443|NCT01931670|5680153|P2|Treatment Period|Lost to Follow-up|5
1626444|NCT01931670|5680154|P1|Treatment Period|Lost to Follow-up|19
1626445|NCT01931670|5680152|P3|Treatment Period|Consent Withdrawn by Subject|7
1626446|NCT01931670|5680153|P2|Treatment Period|Consent Withdrawn by Subject|12
1626447|NCT01931670|5680154|P1|Treatment Period|Consent Withdrawn by Subject|17
1626448|NCT01931670|5680152|P3|Treatment Period|Other|2
1626449|NCT01931670|5680153|P2|Treatment Period|Other|7
1626450|NCT01931670|5680154|P1|Treatment Period|Other|8
1626451|NCT01931670|5680152|P3|Treatment Period|Pregnancy|0
1626452|NCT01931670|5680153|P2|Treatment Period|Pregnancy|2
1626453|NCT01931670|5680154|P1|Treatment Period|Pregnancy|7
1626454|NCT01931670|5680152|P3|Treatment Period|Lack of Efficacy|2
1626455|NCT01931670|5680153|P2|Treatment Period|Lack of Efficacy|2
1626456|NCT01931670|5680154|P1|Treatment Period|Lack of Efficacy|11
1626457|NCT01931670|5680152|P3|Treatment Period|Adverse Event|21
1626458|NCT01931670|5680153|P2|Treatment Period|Adverse Event|8
1626459|NCT01931670|5680154|P1|Treatment Period|Adverse Event|19
1626460|NCT01931670|5680152|P3|Treatment Period|Subject Noncompliant|5
1626461|NCT01931670|5680153|P2|Treatment Period|Subject Noncompliant|9
1626462|NCT01931670|5680154|P1|Treatment Period|Subject Noncompliant|4
1626463|NCT01931670|5680152|P3|Treatment Period|Surgery/Invasive Intervention|0
1626464|NCT01931670|5680153|P2|Treatment Period|Surgery/Invasive Intervention|2
1626465|NCT01931670|5680154|P1|Treatment Period|Surgery/Invasive Intervention|4
1626466|NCT01931670|5680152|P3|Treatment Period|Exclusionary Medication Received|1
1626467|NCT01931670|5680153|P2|Treatment Period|Exclusionary Medication Received|1
1626468|NCT01931670|5680154|P1|Treatment Period|Exclusionary Medication Received|1
1626469|NCT01931566|5680255|P3|Overall Study|Missing|1
1626470|NCT01931566|5680256|P2|Overall Study|Missing|0
1626471|NCT01931566|5680257|P1|Overall Study|Missing|0
1626472|NCT01931566|5680255|P3|Overall Study|Reason Not Specified|53
1626473|NCT01931566|5680256|P2|Overall Study|Reason Not Specified|47
1626474|NCT01931566|5680257|P1|Overall Study|Reason Not Specified|11
1626475|NCT01931566|5680255|P3|Overall Study|Study Termination|1037
1626476|NCT01931566|5680256|P2|Overall Study|Study Termination|968
1626477|NCT01931566|5680257|P1|Overall Study|Study Termination|289
1626478|NCT01931566|5680255|P3|Overall Study|Voluntary Withdrawal|225
1626479|NCT01931566|5680256|P2|Overall Study|Voluntary Withdrawal|245
1626480|NCT01931566|5680257|P1|Overall Study|Voluntary Withdrawal|78
1626481|NCT01931566|5680255|P3|Overall Study|Lost to Follow-up|23
1626482|NCT01931566|5680256|P2|Overall Study|Lost to Follow-up|26
1626483|NCT01931566|5680257|P1|Overall Study|Lost to Follow-up|3
1626484|NCT01931566|5680255|P3|Overall Study|Major Protocol Deviation|21
1626485|NCT01931566|5680256|P2|Overall Study|Major Protocol Deviation|14
1626486|NCT01931566|5680257|P1|Overall Study|Major Protocol Deviation|5
1626487|NCT01931566|5680255|P3|Overall Study|Adverse Event|132
1626488|NCT01931566|5680256|P2|Overall Study|Adverse Event|167
1626489|NCT01931566|5680257|P1|Overall Study|Adverse Event|37
1626490|NCT01931566|5680255|P3|Overall Study|Randomized But Not Treated|14
1626491|NCT01931566|5680256|P2|Overall Study|Randomized But Not Treated|9
1626492|NCT01931566|5680257|P1|Overall Study|Randomized But Not Treated|6
1626493|NCT01931475|5680295|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1626494|NCT01931475|5680296|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
1626495|NCT01931475|5680295|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
1626496|NCT01931475|5680296|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
1626497|NCT01931475|5680295|P2|Period 2: Extension Treatment Phase|Physician Decision|1
1626498|NCT01931475|5680296|P1|Period 2: Extension Treatment Phase|Physician Decision|1
1626499|NCT01931475|5680295|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
1626500|NCT01931475|5680296|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
1626501|NCT01931475|5680295|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
1626502|NCT01931475|5680296|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
1626503|NCT01931475|5680295|P2|Period 2: Extension Treatment Phase|Adverse Event|8
1626504|NCT01931475|5680296|P1|Period 2: Extension Treatment Phase|Adverse Event|0
1626505|NCT01931475|5680295|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
1626506|NCT01931475|5680296|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
1626674|NCT01929044|5681017|P1|Overall Study|Not Treated|1
1626507|NCT01931475|5680295|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
1626508|NCT01931475|5680296|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
1626509|NCT01931475|5680295|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
1626510|NCT01931475|5680296|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
1626511|NCT01931475|5680295|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
1626512|NCT01931475|5680296|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
1626513|NCT01931475|5680295|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
1626514|NCT01931475|5680296|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
1626515|NCT01931462|5680323|P1|Overall Study|Withdrawal by Subject|1
1626516|NCT01931397|5680334|P1|Overall Study|moved out of state|1
1626517|NCT01931397|5680334|P1|Overall Study|Withdrawal by Subject|8
1626518|NCT01931397|5680334|P1|Overall Study|Physician Decision|2
1626519|NCT01931150|5680345|P2|Overall Study|Withdrawal by Subject|2
1626520|NCT01931150|5680346|P1|Overall Study|Withdrawal by Subject|1
1626521|NCT01931059|5680354|P2|Day3|Lost to Follow-up|0
1626522|NCT01931059|5680355|P1|Day3|Lost to Follow-up|1
1626523|NCT01931059|5680354|P2|Day 1|Pregnancy|1
1626524|NCT01931059|5680355|P1|Day 1|Pregnancy|0
1626525|NCT01930890|5680371|P4|Overall Study|Adverse Event|0
1626526|NCT01930890|5680372|P3|Overall Study|Adverse Event|0
1626527|NCT01930890|5680373|P2|Overall Study|Adverse Event|1
1626528|NCT01930890|5680374|P1|Overall Study|Adverse Event|0
1626529|NCT01930890|5680371|P4|Overall Study|Consent Withdrawn|1
1626530|NCT01930890|5680372|P3|Overall Study|Consent Withdrawn|0
1626531|NCT01930890|5680373|P2|Overall Study|Consent Withdrawn|3
1626532|NCT01930890|5680374|P1|Overall Study|Consent Withdrawn|0
1626533|NCT01930890|5680371|P4|Overall Study|Investigator Decision|0
1626534|NCT01930890|5680372|P3|Overall Study|Investigator Decision|0
1626535|NCT01930890|5680373|P2|Overall Study|Investigator Decision|1
1626536|NCT01930890|5680374|P1|Overall Study|Investigator Decision|0
1626537|NCT01930890|5680371|P4|Overall Study|Death|1
1626538|NCT01930890|5680372|P3|Overall Study|Death|0
1626539|NCT01930890|5680373|P2|Overall Study|Death|0
1626540|NCT01930890|5680374|P1|Overall Study|Death|0
1626541|NCT01930890|5680371|P4|Overall Study|Study Termination|25
1626542|NCT01930890|5680372|P3|Overall Study|Study Termination|13
1626543|NCT01930890|5680373|P2|Overall Study|Study Termination|28
1626544|NCT01930890|5680374|P1|Overall Study|Study Termination|14
1626545|NCT01930799|5680388|P1|Overall Study|Lost to Follow-up|5
1626546|NCT01930799|5680388|P1|Overall Study|Withdrawal by Subject|3
1626547|NCT01930214|5680527|P3|Overall Study|Physician Decision|0
1626548|NCT01930214|5680528|P2|Overall Study|Physician Decision|0
1626549|NCT01930214|5680529|P1|Overall Study|Physician Decision|2
1626550|NCT01930214|5680527|P3|Overall Study|Voluntary withdrawal of infomed consent|2
1626551|NCT01930214|5680528|P2|Overall Study|Voluntary withdrawal of infomed consent|4
1626552|NCT01930214|5680529|P1|Overall Study|Voluntary withdrawal of infomed consent|2
1626553|NCT01930214|5680527|P3|Overall Study|Lost to Follow-up|12
1626554|NCT01930214|5680528|P2|Overall Study|Lost to Follow-up|13
1626555|NCT01930214|5680529|P1|Overall Study|Lost to Follow-up|12
1626556|NCT01930214|5680527|P3|Overall Study|Death|11
1626557|NCT01930214|5680528|P2|Overall Study|Death|4
1626558|NCT01930214|5680529|P1|Overall Study|Death|4
1626559|NCT01930188|5680549|P3|Overall Study|Withdrawal by Subject|8
1626560|NCT01930188|5680550|P2|Overall Study|Withdrawal by Subject|11
1626561|NCT01930188|5680551|P1|Overall Study|Withdrawal by Subject|9
1626562|NCT01930188|5680549|P3|Overall Study|Death|3
1626563|NCT01930188|5680550|P2|Overall Study|Death|1
1626564|NCT01930188|5680551|P1|Overall Study|Death|2
1626565|NCT01930188|5680549|P3|Overall Study|Lost to Follow-up|2
1626566|NCT01930188|5680550|P2|Overall Study|Lost to Follow-up|2
1626567|NCT01930188|5680551|P1|Overall Study|Lost to Follow-up|5
1626568|NCT01930188|5680549|P3|Overall Study|Missing follow-up information|3
1626569|NCT01930188|5680550|P2|Overall Study|Missing follow-up information|2
1626570|NCT01930188|5680551|P1|Overall Study|Missing follow-up information|2
1626571|NCT01930188|5680549|P3|Overall Study|unclassified|3
1626572|NCT01930188|5680550|P2|Overall Study|unclassified|5
1626573|NCT01930188|5680551|P1|Overall Study|unclassified|4
1626574|NCT01930162|5680575|P1|Overall Study|Death|1
1626575|NCT01930162|5680575|P1|Overall Study|Abnormal test procedure result(s)|4
1626576|NCT01930045|5680611|P6|Pause (up to 37 Days)|Protocol Violation|1
1626577|NCT01930045|5680612|P5|Pause (up to 37 Days)|Protocol Violation|0
1626578|NCT01930045|5680613|P4|Pause (up to 37 Days)|Protocol Violation|0
1626579|NCT01930045|5680614|P3|Pause (up to 37 Days)|Protocol Violation|0
1626580|NCT01930045|5680615|P2|Pause (up to 37 Days)|Protocol Violation|0
1626581|NCT01930045|5680616|P1|Pause (up to 37 Days)|Protocol Violation|0
1626582|NCT01930045|5680611|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
1626583|NCT01930045|5680612|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
1626584|NCT01930045|5680613|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
1626585|NCT01930045|5680614|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
1626586|NCT01930045|5680615|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
1626587|NCT01930045|5680616|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
1626588|NCT01929993|5680643|P2|Overall Study|Absent CIN, invasion present or artifact|22
1626589|NCT01929993|5680644|P1|Overall Study|Absent CIN, invasion present or artifact|26
1626590|NCT01929993|5680643|P2|Overall Study|Protocol Violation|6
1626591|NCT01929993|5680644|P1|Overall Study|Protocol Violation|4
1626592|NCT01929980|5680650|P1|Overall Study|Physician Decision|1
1626593|NCT01929876|5680658|P1|Period 2|Non-Compliance|1
1626594|NCT01929863|5680671|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
1626595|NCT01929863|5680672|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
1626596|NCT01929863|5680671|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
1626597|NCT01929863|5680672|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
1626598|NCT01929863|5680671|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
1626599|NCT01929863|5680672|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
1626600|NCT01929707|5680727|P8|Intervention Period 2|Withdrawal by Subject|0
1626601|NCT01929707|5680728|P7|Intervention Period 2|Withdrawal by Subject|0
1626602|NCT01929707|5680729|P6|Intervention Period 2|Withdrawal by Subject|2
1626603|NCT01929707|5680730|P5|Intervention Period 2|Withdrawal by Subject|0
1626604|NCT01929707|5680731|P4|Intervention Period 2|Withdrawal by Subject|0
1626605|NCT01929707|5680732|P3|Intervention Period 2|Withdrawal by Subject|0
1626606|NCT01929707|5680733|P2|Intervention Period 2|Withdrawal by Subject|0
1626607|NCT01929707|5680734|P1|Intervention Period 2|Withdrawal by Subject|0
1626608|NCT01929707|5680727|P8|Intervention Period 1|Withdrawal by Subject|0
1626609|NCT01929707|5680728|P7|Intervention Period 1|Withdrawal by Subject|0
1626610|NCT01929707|5680729|P6|Intervention Period 1|Withdrawal by Subject|0
1626611|NCT01929707|5680730|P5|Intervention Period 1|Withdrawal by Subject|0
1626612|NCT01929707|5680731|P4|Intervention Period 1|Withdrawal by Subject|2
1626613|NCT01929707|5680732|P3|Intervention Period 1|Withdrawal by Subject|0
1626614|NCT01929707|5680733|P2|Intervention Period 1|Withdrawal by Subject|0
1626615|NCT01929707|5680734|P1|Intervention Period 1|Withdrawal by Subject|0
1626616|NCT01929707|5680727|P8|Intervention Period 1|Lost to Follow-up|0
1626617|NCT01929707|5680728|P7|Intervention Period 1|Lost to Follow-up|0
1626618|NCT01929707|5680729|P6|Intervention Period 1|Lost to Follow-up|0
1626619|NCT01929707|5680730|P5|Intervention Period 1|Lost to Follow-up|0
1626620|NCT01929707|5680731|P4|Intervention Period 1|Lost to Follow-up|1
1626621|NCT01929707|5680732|P3|Intervention Period 1|Lost to Follow-up|0
1626622|NCT01929707|5680733|P2|Intervention Period 1|Lost to Follow-up|0
1626623|NCT01929707|5680734|P1|Intervention Period 1|Lost to Follow-up|0
1626624|NCT01929681|5680766|P2|Overall Study|Physician Decision|1
1626625|NCT01929681|5680767|P1|Overall Study|Physician Decision|1
1626626|NCT01929681|5680766|P2|Overall Study|Withdrawal by Subject|0
1626627|NCT01929681|5680767|P1|Overall Study|Withdrawal by Subject|1
1626628|NCT01929408|5680810|P1|Overall Study|received HCT as initial treatment|8
1626629|NCT01929395|5680818|P3|Overall Study|Screen Fail|1
1626630|NCT01929395|5680819|P2|Overall Study|Screen Fail|0
1626631|NCT01929395|5680820|P1|Overall Study|Screen Fail|0
1626632|NCT01929395|5680818|P3|Overall Study|Withdrawal by Subject|0
1626633|NCT01929395|5680819|P2|Overall Study|Withdrawal by Subject|1
1626634|NCT01929395|5680820|P1|Overall Study|Withdrawal by Subject|0
1626635|NCT01929395|5680818|P3|Overall Study|Did not complete - non-related toxicity|0
1626636|NCT01929395|5680819|P2|Overall Study|Did not complete - non-related toxicity|0
1626637|NCT01929395|5680820|P1|Overall Study|Did not complete - non-related toxicity|1
1626638|NCT01929317|5680832|P2|Long-term Phase|Study Closed/Terminated|3
1626639|NCT01929317|5680833|P1|Long-term Phase|Study Closed/Terminated|5
1626640|NCT01929317|5680832|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
1626641|NCT01929317|5680833|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
1626642|NCT01929317|5680832|P2|Long-term Phase|Protocol Violation|0
1626643|NCT01929317|5680833|P1|Long-term Phase|Protocol Violation|1
1626644|NCT01929317|5680832|P2|Long-term Phase|Withdrawal by Subject|0
1626645|NCT01929317|5680833|P1|Long-term Phase|Withdrawal by Subject|4
1626646|NCT01929317|5680832|P2|Long-term Phase|Physician Decision|0
1626647|NCT01929317|5680833|P1|Long-term Phase|Physician Decision|3
1626648|NCT01929317|5680832|P2|Long-term Phase|Adverse Event|1
1626649|NCT01929317|5680833|P1|Long-term Phase|Adverse Event|5
1626650|NCT01929317|5680832|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
1626651|NCT01929317|5680833|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
1626652|NCT01929317|5680832|P2|Dose Increase Effect Verification Phase|Physician Decision|0
1626653|NCT01929317|5680833|P1|Dose Increase Effect Verification Phase|Physician Decision|1
1626654|NCT01929317|5680832|P2|Dose Increase Effect Verification Phase|Adverse Event|1
1626655|NCT01929317|5680833|P1|Dose Increase Effect Verification Phase|Adverse Event|5
1626656|NCT01929226|5680908|P2|Overall Study|Withdrawal by Subject|1
1626657|NCT01929226|5680909|P1|Overall Study|Withdrawal by Subject|1
1626658|NCT01929226|5680908|P2|Overall Study|Lost to Follow-up|0
1626659|NCT01929226|5680909|P1|Overall Study|Lost to Follow-up|4
1626660|NCT01929135|5680935|P2|Overall Study|Lost to Follow-up|1
1626661|NCT01929135|5680936|P1|Overall Study|Lost to Follow-up|1
1626662|NCT01929109|5680955|P5|Period 1 (All Groups)|Deviation from protocol|0
1626663|NCT01929109|5680956|P4|Period 1 (All Groups)|Deviation from protocol|0
1626664|NCT01929109|5680957|P3|Period 1 (All Groups)|Deviation from protocol|1
1626665|NCT01929109|5680958|P2|Period 1 (All Groups)|Deviation from protocol|0
1626666|NCT01929109|5680959|P1|Period 1 (All Groups)|Deviation from protocol|0
1626667|NCT01929083|5680978|P2|Intervention 2|Adverse Event|1
1626668|NCT01929083|5680979|P1|Intervention 2|Adverse Event|0
1626669|NCT01929083|5680978|P2|Intervention 1|Nonadherent to study medications|0
1626670|NCT01929083|5680979|P1|Intervention 1|Nonadherent to study medications|1
1626671|NCT01929083|5680978|P2|Intervention 1|Lost to Follow-up|0
1626672|NCT01929083|5680979|P1|Intervention 1|Lost to Follow-up|2
1626673|NCT01929044|5681016|P2|Overall Study|Not Treated|3
1626675|NCT01929044|5681016|P2|Overall Study|Protocol Violation|14
1626676|NCT01929044|5681017|P1|Overall Study|Protocol Violation|9
1626677|NCT01929044|5681016|P2|Overall Study|Adverse Event|0
1626678|NCT01929044|5681017|P1|Overall Study|Adverse Event|1
1626679|NCT01929031|5681039|P6|Overall Study|Reason other than specified above|0
1626680|NCT01929031|5681040|P5|Overall Study|Reason other than specified above|1
1626681|NCT01929031|5681041|P4|Overall Study|Reason other than specified above|0
1626682|NCT01929031|5681042|P3|Overall Study|Reason other than specified above|0
1626683|NCT01929031|5681043|P2|Overall Study|Reason other than specified above|1
1626684|NCT01929031|5681044|P1|Overall Study|Reason other than specified above|0
1626685|NCT01929031|5681039|P6|Overall Study|Protocol Violation|1
1626686|NCT01929031|5681040|P5|Overall Study|Protocol Violation|0
1626687|NCT01929031|5681041|P4|Overall Study|Protocol Violation|0
1626688|NCT01929031|5681042|P3|Overall Study|Protocol Violation|0
1626689|NCT01929031|5681043|P2|Overall Study|Protocol Violation|0
1626690|NCT01929031|5681044|P1|Overall Study|Protocol Violation|1
1626691|NCT01929031|5681039|P6|Overall Study|Adverse Event|0
1626692|NCT01929031|5681040|P5|Overall Study|Adverse Event|0
1626693|NCT01929031|5681041|P4|Overall Study|Adverse Event|0
1626694|NCT01929031|5681042|P3|Overall Study|Adverse Event|1
1626695|NCT01929031|5681043|P2|Overall Study|Adverse Event|1
1626696|NCT01929031|5681044|P1|Overall Study|Adverse Event|3
1626697|NCT01929018|5681068|P2|Overall Study|Hospitalization|1
1626698|NCT01929018|5681069|P1|Overall Study|Hospitalization|0
1626699|NCT01929018|5681068|P2|Overall Study|Lost to Follow-up|0
1626700|NCT01929018|5681069|P1|Overall Study|Lost to Follow-up|1
1626701|NCT01928940|5681093|P2|Overall Study|Adverse Event|1
1626702|NCT01928940|5681094|P1|Overall Study|Adverse Event|0
1626703|NCT01928927|5681137|P2|Overall Study|Withdrawal by Subject|1
1626704|NCT01928927|5681138|P1|Overall Study|Withdrawal by Subject|1
1626705|NCT01928927|5681137|P2|Overall Study|Lost to Follow-up|0
1626706|NCT01928927|5681138|P1|Overall Study|Lost to Follow-up|1
1626707|NCT01928862|5681265|P5|Overall Study|Lost to Follow-up|1
1626708|NCT01928862|5681266|P4|Overall Study|Lost to Follow-up|0
1626709|NCT01928862|5681267|P3|Overall Study|Lost to Follow-up|0
1626710|NCT01928862|5681268|P2|Overall Study|Lost to Follow-up|0
1626711|NCT01928862|5681269|P1|Overall Study|Lost to Follow-up|1
1626712|NCT01928771|5681343|P3|Overall Study|Severe Non-Compliance to Protocol|2
1626713|NCT01928771|5681344|P2|Overall Study|Severe Non-Compliance to Protocol|2
1626714|NCT01928771|5681345|P1|Overall Study|Severe Non-Compliance to Protocol|4
1626715|NCT01928771|5681343|P3|Overall Study|Other Reasons|14
1626716|NCT01928771|5681344|P2|Overall Study|Other Reasons|9
1626717|NCT01928771|5681345|P1|Overall Study|Other Reasons|9
1626718|NCT01928771|5681343|P3|Overall Study|Study-Specific Withdrawal Criteria|1
1626719|NCT01928771|5681344|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1626720|NCT01928771|5681345|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1626721|NCT01928771|5681343|P3|Overall Study|Withdrawal by Subject|17
1626722|NCT01928771|5681344|P2|Overall Study|Withdrawal by Subject|15
1626723|NCT01928771|5681345|P1|Overall Study|Withdrawal by Subject|20
1626724|NCT01928771|5681343|P3|Overall Study|Lost to Follow-up|3
1626725|NCT01928771|5681344|P2|Overall Study|Lost to Follow-up|6
1626726|NCT01928771|5681345|P1|Overall Study|Lost to Follow-up|5
1626727|NCT01928771|5681343|P3|Overall Study|Death|2
1626728|NCT01928771|5681344|P2|Overall Study|Death|2
1626729|NCT01928771|5681345|P1|Overall Study|Death|2
1626730|NCT01928771|5681343|P3|Overall Study|Adverse Event|1
1626731|NCT01928771|5681344|P2|Overall Study|Adverse Event|5
1626732|NCT01928771|5681345|P1|Overall Study|Adverse Event|6
1626733|NCT01928758|5681424|P2|Overall Study|Protocol Violation|4
1626734|NCT01928758|5681425|P1|Overall Study|Protocol Violation|3
1626735|NCT01928758|5681424|P2|Overall Study|Adverse Event|5
1626736|NCT01928758|5681425|P1|Overall Study|Adverse Event|3
1626737|NCT01928758|5681424|P2|Overall Study|Withdrawal by Subject|2
1626738|NCT01928758|5681425|P1|Overall Study|Withdrawal by Subject|5
1626739|NCT01928758|5681424|P2|Overall Study|Lost to Follow-up|9
1626740|NCT01928758|5681425|P1|Overall Study|Lost to Follow-up|14
1626741|NCT01928719|5681443|P2|Overall Study|Adverse Event|0
1626742|NCT01928719|5681444|P1|Overall Study|Adverse Event|1
1626743|NCT01928719|5681443|P2|Overall Study|Protocol Violation|1
1626744|NCT01928719|5681444|P1|Overall Study|Protocol Violation|3
1626745|NCT01928719|5681443|P2|Overall Study|Withdrawal by Subject|7
1626746|NCT01928719|5681444|P1|Overall Study|Withdrawal by Subject|22
1626747|NCT01928719|5681443|P2|Overall Study|Lost to Follow-up|11
1626748|NCT01928719|5681444|P1|Overall Study|Lost to Follow-up|26
1626749|NCT01928615|5681496|P1|Overall Study|Study Terminated by Sponsor|2
1626750|NCT01928472|5681515|P4|Overall Study|Unclassified|0
1626751|NCT01928472|5681516|P3|Overall Study|Unclassified|1
1626752|NCT01928472|5681517|P2|Overall Study|Unclassified|0
1626753|NCT01928472|5681518|P1|Overall Study|Unclassified|0
1626754|NCT01928472|5681515|P4|Overall Study|Administrative Reason|0
1626755|NCT01928472|5681516|P3|Overall Study|Administrative Reason|0
1626756|NCT01928472|5681517|P2|Overall Study|Administrative Reason|1
1626757|NCT01928472|5681518|P1|Overall Study|Administrative Reason|2
1626758|NCT01928472|5681515|P4|Overall Study|Lost to Follow-up|0
1626759|NCT01928472|5681516|P3|Overall Study|Lost to Follow-up|4
1626760|NCT01928472|5681517|P2|Overall Study|Lost to Follow-up|3
1626761|NCT01928472|5681518|P1|Overall Study|Lost to Follow-up|2
1626762|NCT01928472|5681515|P4|Overall Study|Withdrawal by Subject|2
1626763|NCT01928472|5681516|P3|Overall Study|Withdrawal by Subject|1
1626764|NCT01928472|5681517|P2|Overall Study|Withdrawal by Subject|4
1626765|NCT01928472|5681518|P1|Overall Study|Withdrawal by Subject|4
1626766|NCT01928472|5681515|P4|Overall Study|Death|0
1626767|NCT01928472|5681516|P3|Overall Study|Death|1
1626768|NCT01928472|5681517|P2|Overall Study|Death|0
1626769|NCT01928472|5681518|P1|Overall Study|Death|0
1626770|NCT01928433|5681588|P3|Overall Study|Other reasons|4
1626771|NCT01928433|5681589|P2|Overall Study|Other reasons|3
1626772|NCT01928433|5681590|P1|Overall Study|Other reasons|3
1626773|NCT01928433|5681588|P3|Overall Study|Lost to Follow-up|3
1626774|NCT01928433|5681589|P2|Overall Study|Lost to Follow-up|2
1626775|NCT01928433|5681590|P1|Overall Study|Lost to Follow-up|0
1626776|NCT01928433|5681588|P3|Overall Study|Negative screening urine culture|10
1626777|NCT01928433|5681589|P2|Overall Study|Negative screening urine culture|6
1626778|NCT01928433|5681590|P1|Overall Study|Negative screening urine culture|7
1626779|NCT01928433|5681588|P3|Overall Study|Withdrawal by Subject|0
1626780|NCT01928433|5681589|P2|Overall Study|Withdrawal by Subject|4
1626781|NCT01928433|5681590|P1|Overall Study|Withdrawal by Subject|0
1626782|NCT01928433|5681588|P3|Overall Study|Lack of Efficacy|4
1626783|NCT01928433|5681589|P2|Overall Study|Lack of Efficacy|4
1626784|NCT01928433|5681590|P1|Overall Study|Lack of Efficacy|5
1626785|NCT01928433|5681588|P3|Overall Study|Protocol Violation|2
1626786|NCT01928433|5681589|P2|Overall Study|Protocol Violation|0
1626787|NCT01928433|5681590|P1|Overall Study|Protocol Violation|0
1626788|NCT01928433|5681588|P3|Overall Study|Adverse Event|5
1626789|NCT01928433|5681589|P2|Overall Study|Adverse Event|2
1626790|NCT01928433|5681590|P1|Overall Study|Adverse Event|5
1626791|NCT01928381|5681613|P7|Part 2 - Post Third Intervention|Protocol Violation|0
1626792|NCT01928381|5681614|P6|Part 2 - Post Third Intervention|Protocol Violation|0
1626793|NCT01928381|5681615|P5|Part 2 - Post Third Intervention|Protocol Violation|0
1626794|NCT01928381|5681616|P4|Part 2 - Post Third Intervention|Protocol Violation|0
1626795|NCT01928381|5681617|P3|Part 2 - Post Third Intervention|Protocol Violation|1
1626796|NCT01928381|5681618|P2|Part 2 - Post Third Intervention|Protocol Violation|0
1626797|NCT01928381|5681619|P1|Part 2 - Post Third Intervention|Protocol Violation|0
1626798|NCT01928381|5681613|P7|Part 2 - Second Intervention|Lost to Follow-up|0
1626799|NCT01928381|5681614|P6|Part 2 - Second Intervention|Lost to Follow-up|0
1626800|NCT01928381|5681615|P5|Part 2 - Second Intervention|Lost to Follow-up|0
1626801|NCT01928381|5681616|P4|Part 2 - Second Intervention|Lost to Follow-up|1
1626802|NCT01928381|5681617|P3|Part 2 - Second Intervention|Lost to Follow-up|0
1626803|NCT01928381|5681618|P2|Part 2 - Second Intervention|Lost to Follow-up|1
1626804|NCT01928381|5681619|P1|Part 2 - Second Intervention|Lost to Follow-up|0
1626805|NCT01928381|5681613|P7|Washout First Intervention|Protocol Violation|0
1626806|NCT01928381|5681614|P6|Washout First Intervention|Protocol Violation|0
1626807|NCT01928381|5681615|P5|Washout First Intervention|Protocol Violation|1
1626808|NCT01928381|5681616|P4|Washout First Intervention|Protocol Violation|0
1626809|NCT01928381|5681617|P3|Washout First Intervention|Protocol Violation|0
1626810|NCT01928381|5681618|P2|Washout First Intervention|Protocol Violation|0
1626811|NCT01928381|5681619|P1|Washout First Intervention|Protocol Violation|0
1626812|NCT01928381|5681613|P7|Part 2 - First Intervention|Lost to Follow-up|0
1626813|NCT01928381|5681614|P6|Part 2 - First Intervention|Lost to Follow-up|0
1626814|NCT01928381|5681615|P5|Part 2 - First Intervention|Lost to Follow-up|0
1626815|NCT01928381|5681616|P4|Part 2 - First Intervention|Lost to Follow-up|1
1626816|NCT01928381|5681617|P3|Part 2 - First Intervention|Lost to Follow-up|0
1626817|NCT01928381|5681618|P2|Part 2 - First Intervention|Lost to Follow-up|0
1626818|NCT01928381|5681619|P1|Part 2 - First Intervention|Lost to Follow-up|0
1626819|NCT01928381|5681613|P7|Part 2 - First Intervention|Eligibility criterion not met|1
1626820|NCT01928381|5681614|P6|Part 2 - First Intervention|Eligibility criterion not met|1
1626821|NCT01928381|5681615|P5|Part 2 - First Intervention|Eligibility criterion not met|0
1626822|NCT01928381|5681616|P4|Part 2 - First Intervention|Eligibility criterion not met|0
1626823|NCT01928381|5681617|P3|Part 2 - First Intervention|Eligibility criterion not met|0
1626824|NCT01928381|5681618|P2|Part 2 - First Intervention|Eligibility criterion not met|0
1626825|NCT01928381|5681619|P1|Part 2 - First Intervention|Eligibility criterion not met|0
1626826|NCT01928381|5681613|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
1626827|NCT01928381|5681614|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
1626828|NCT01928381|5681615|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
1626829|NCT01928381|5681616|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
1626830|NCT01928381|5681617|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
1626831|NCT01928381|5681618|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
1626832|NCT01928381|5681619|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
1626833|NCT01928381|5681613|P7|Part 2 - First Intervention|Withdrawal by Subject|0
1626834|NCT01928381|5681614|P6|Part 2 - First Intervention|Withdrawal by Subject|0
1626835|NCT01928381|5681615|P5|Part 2 - First Intervention|Withdrawal by Subject|0
1626836|NCT01928381|5681616|P4|Part 2 - First Intervention|Withdrawal by Subject|0
1626837|NCT01928381|5681617|P3|Part 2 - First Intervention|Withdrawal by Subject|1
1626838|NCT01928381|5681618|P2|Part 2 - First Intervention|Withdrawal by Subject|0
1626839|NCT01928381|5681619|P1|Part 2 - First Intervention|Withdrawal by Subject|0
1626840|NCT01928381|5681613|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1626841|NCT01928381|5681614|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1626842|NCT01928381|5681615|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1626843|NCT01928381|5681616|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1626844|NCT01928381|5681617|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1626845|NCT01928381|5681618|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
1626846|NCT01928381|5681619|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
1626847|NCT01928381|5681613|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1626848|NCT01928381|5681614|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1626849|NCT01928381|5681615|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1626850|NCT01928381|5681616|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1626851|NCT01928381|5681617|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1626852|NCT01928381|5681618|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
1626853|NCT01928381|5681619|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
1626854|NCT01928381|5681613|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1626855|NCT01928381|5681614|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1626856|NCT01928381|5681615|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1626857|NCT01928381|5681616|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1626858|NCT01928381|5681617|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1626859|NCT01928381|5681618|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
1626860|NCT01928381|5681619|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
1626861|NCT01928381|5681613|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1626862|NCT01928381|5681614|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1626863|NCT01928381|5681615|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1626864|NCT01928381|5681616|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1626865|NCT01928381|5681617|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1626866|NCT01928381|5681618|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
1626867|NCT01928381|5681619|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
1626868|NCT01928381|5681613|P7|Part 1 - Pain Training|Protocol Violation|0
1626869|NCT01928381|5681614|P6|Part 1 - Pain Training|Protocol Violation|0
1626870|NCT01928381|5681615|P5|Part 1 - Pain Training|Protocol Violation|0
1626871|NCT01928381|5681616|P4|Part 1 - Pain Training|Protocol Violation|0
1626872|NCT01928381|5681617|P3|Part 1 - Pain Training|Protocol Violation|0
1626873|NCT01928381|5681618|P2|Part 1 - Pain Training|Protocol Violation|0
1626874|NCT01928381|5681619|P1|Part 1 - Pain Training|Protocol Violation|1
1626875|NCT01928381|5681613|P7|Part 1 - Pain Training|Lost to Follow-up|0
1626876|NCT01928381|5681614|P6|Part 1 - Pain Training|Lost to Follow-up|0
1626877|NCT01928381|5681615|P5|Part 1 - Pain Training|Lost to Follow-up|0
1626878|NCT01928381|5681616|P4|Part 1 - Pain Training|Lost to Follow-up|0
1626879|NCT01928381|5681617|P3|Part 1 - Pain Training|Lost to Follow-up|0
1626880|NCT01928381|5681618|P2|Part 1 - Pain Training|Lost to Follow-up|0
1626881|NCT01928381|5681619|P1|Part 1 - Pain Training|Lost to Follow-up|4
1626882|NCT01928381|5681613|P7|Part 1 - Pain Training|Withdrawal by Subject|0
1626883|NCT01928381|5681614|P6|Part 1 - Pain Training|Withdrawal by Subject|0
1626884|NCT01928381|5681615|P5|Part 1 - Pain Training|Withdrawal by Subject|0
1626885|NCT01928381|5681616|P4|Part 1 - Pain Training|Withdrawal by Subject|0
1626886|NCT01928381|5681617|P3|Part 1 - Pain Training|Withdrawal by Subject|0
1626887|NCT01928381|5681618|P2|Part 1 - Pain Training|Withdrawal by Subject|0
1626888|NCT01928381|5681619|P1|Part 1 - Pain Training|Withdrawal by Subject|1
1626889|NCT01928381|5681613|P7|Part 1 - Pain Training|Pain training criteria not met|0
1626890|NCT01928381|5681614|P6|Part 1 - Pain Training|Pain training criteria not met|0
1626891|NCT01928381|5681615|P5|Part 1 - Pain Training|Pain training criteria not met|0
1626892|NCT01928381|5681616|P4|Part 1 - Pain Training|Pain training criteria not met|0
1626893|NCT01928381|5681617|P3|Part 1 - Pain Training|Pain training criteria not met|0
1626894|NCT01928381|5681618|P2|Part 1 - Pain Training|Pain training criteria not met|0
1626895|NCT01928381|5681619|P1|Part 1 - Pain Training|Pain training criteria not met|29
1626896|NCT01928381|5681613|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1626897|NCT01928381|5681614|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1626898|NCT01928381|5681615|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1626899|NCT01928381|5681616|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1626900|NCT01928381|5681617|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1626901|NCT01928381|5681618|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
1626902|NCT01928381|5681619|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
1626903|NCT01928329|5681634|P2|Overall Study|Physician Decision|1
1626904|NCT01928329|5681635|P1|Overall Study|Physician Decision|1
1626905|NCT01928329|5681634|P2|Overall Study|Withdrawal by Subject|5
1626906|NCT01928329|5681635|P1|Overall Study|Withdrawal by Subject|1
1626907|NCT01928329|5681634|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
1626908|NCT01928329|5681635|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
1626909|NCT01928329|5681634|P2|Overall Study|Adverse Event|3
1626910|NCT01928329|5681635|P1|Overall Study|Adverse Event|5
1626911|NCT01928329|5681634|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
1626912|NCT01928329|5681635|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
1626913|NCT01928329|5681634|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
1626914|NCT01928329|5681635|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
1626915|NCT01928082|5681674|P1|Overall Study|Study terminated.|1
1626916|NCT01927861|5681708|P2|Extension Phase (104 Weeks)|Unclassified|1
1626917|NCT01927861|5681709|P1|Extension Phase (104 Weeks)|Unclassified|0
1626918|NCT01927861|5681708|P2|Extension Phase (104 Weeks)|Adverse Event|2
1626919|NCT01927861|5681709|P1|Extension Phase (104 Weeks)|Adverse Event|0
1626920|NCT01927757|5681847|P1|Overall Study|Ethical Reasons|4
1626921|NCT01927757|5681847|P1|Overall Study|Other|1
1626922|NCT01927757|5681847|P1|Overall Study|Decision by Sponsor|2
1626923|NCT01927757|5681847|P1|Overall Study|Lost to Follow-up|2
1626924|NCT01927757|5681847|P1|Overall Study|Withdrawal by Subject|14
1626925|NCT01927627|5681869|P1|Overall Study|Financial Concerns|1
1626926|NCT01927627|5681869|P1|Overall Study|Lack of Efficacy|1
1626927|NCT01927627|5681869|P1|Overall Study|Adverse Event|3
1626928|NCT01927419|5681884|P2|Overall Study|Not reported|0
1626929|NCT01927419|5681885|P1|Overall Study|Not reported|1
1626930|NCT01927419|5681884|P2|Overall Study|Other|1
1626931|NCT01927419|5681885|P1|Overall Study|Other|2
1626932|NCT01927419|5681884|P2|Overall Study|Withdrawal by Subject|1
1626933|NCT01927419|5681885|P1|Overall Study|Withdrawal by Subject|3
1626934|NCT01927419|5681884|P2|Overall Study|Adverse event unrelated to study drug|1
1626935|NCT01927419|5681885|P1|Overall Study|Adverse event unrelated to study drug|6
1626936|NCT01927419|5681884|P2|Overall Study|Death|1
1626937|NCT01927419|5681885|P1|Overall Study|Death|0
1626938|NCT01927419|5681884|P2|Overall Study|Study drug toxicity|7
1626939|NCT01927419|5681885|P1|Overall Study|Study drug toxicity|43
1626940|NCT01927419|5681884|P2|Overall Study|Disease progression|17
1626941|NCT01927419|5681885|P1|Overall Study|Disease progression|15
1626942|NCT01927055|5681919|P3|Double-Blind|Extended Vacation|0
1626943|NCT01927055|5681920|P2|Double-Blind|Extended Vacation|1
1626944|NCT01927055|5681921|P1|Double-Blind|Extended Vacation|0
1626945|NCT01927055|5681919|P3|Double-Blind|Supine Hypertension|1
1626946|NCT01927055|5681920|P2|Double-Blind|Supine Hypertension|0
1626947|NCT01927055|5681921|P1|Double-Blind|Supine Hypertension|0
1626948|NCT01927055|5681919|P3|Double-Blind|Study Stopped|7
1626949|NCT01927055|5681920|P2|Double-Blind|Study Stopped|7
1626950|NCT01927055|5681921|P1|Double-Blind|Study Stopped|0
1626951|NCT01927055|5681919|P3|Double-Blind|Withdrawal by Subject|3
1626952|NCT01927055|5681920|P2|Double-Blind|Withdrawal by Subject|2
1626953|NCT01927055|5681921|P1|Double-Blind|Withdrawal by Subject|0
1626954|NCT01927055|5681919|P3|Double-Blind|Protocol Violation|1
1626955|NCT01927055|5681920|P2|Double-Blind|Protocol Violation|0
1626956|NCT01927055|5681921|P1|Double-Blind|Protocol Violation|0
1626957|NCT01927055|5681919|P3|Double-Blind|Adverse Event|1
1626958|NCT01927055|5681920|P2|Double-Blind|Adverse Event|1
1626959|NCT01927055|5681921|P1|Double-Blind|Adverse Event|0
1626960|NCT01927055|5681919|P3|Open-label|Difficulty attending study visits|0
1626961|NCT01927055|5681920|P2|Open-label|Difficulty attending study visits|0
1626962|NCT01927055|5681921|P1|Open-label|Difficulty attending study visits|1
1626963|NCT01927055|5681919|P3|Open-label|Supine Hypertension|0
1626964|NCT01927055|5681920|P2|Open-label|Supine Hypertension|0
1626965|NCT01927055|5681921|P1|Open-label|Supine Hypertension|4
1626966|NCT01927055|5681919|P3|Open-label|Study Stopped|0
1626967|NCT01927055|5681920|P2|Open-label|Study Stopped|0
1626968|NCT01927055|5681921|P1|Open-label|Study Stopped|4
1626969|NCT01927055|5681919|P3|Open-label|Withdrawal by Subject|0
1626970|NCT01927055|5681920|P2|Open-label|Withdrawal by Subject|0
1626971|NCT01927055|5681921|P1|Open-label|Withdrawal by Subject|1
1626972|NCT01927055|5681919|P3|Open-label|Adverse Event|0
1626973|NCT01927055|5681920|P2|Open-label|Adverse Event|0
1626974|NCT01927055|5681921|P1|Open-label|Adverse Event|6
1626975|NCT01926886|5681939|P2|Overall Study|Did not cooperate|0
1626976|NCT01926886|5681940|P1|Overall Study|Did not cooperate|1
1626977|NCT01926886|5681939|P2|Overall Study|Death|0
1626978|NCT01926886|5681940|P1|Overall Study|Death|1
1626979|NCT01926886|5681939|P2|Overall Study|Progression of disease|0
1626980|NCT01926886|5681940|P1|Overall Study|Progression of disease|2
1626981|NCT01926886|5681939|P2|Overall Study|Recurrence of disease|0
1626982|NCT01926886|5681940|P1|Overall Study|Recurrence of disease|1
1626983|NCT01926886|5681939|P2|Overall Study|Failure to return|0
1626984|NCT01926886|5681940|P1|Overall Study|Failure to return|3
1626985|NCT01926886|5681939|P2|Overall Study|Withdrawal by Subject|0
1626986|NCT01926886|5681940|P1|Overall Study|Withdrawal by Subject|15
1626987|NCT01926886|5681939|P2|Overall Study|Disease progression/recurrence|0
1626988|NCT01926886|5681940|P1|Overall Study|Disease progression/recurrence|4
1626989|NCT01926886|5681939|P2|Overall Study|Adverse event/intercurrent illness|0
1626990|NCT01926886|5681940|P1|Overall Study|Adverse event/intercurrent illness|4
1626991|NCT01926886|5681939|P2|Overall Study|Administrative/other|0
1626992|NCT01926886|5681940|P1|Overall Study|Administrative/other|1
1626993|NCT01926782|5681959|P6|Overall Study|Related to study drug administration|2
1626994|NCT01926782|5681960|P5|Overall Study|Related to study drug administration|0
1626995|NCT01926782|5681961|P4|Overall Study|Related to study drug administration|0
1626996|NCT01926782|5681962|P3|Overall Study|Related to study drug administration|0
1626997|NCT01926782|5681963|P2|Overall Study|Related to study drug administration|0
1626998|NCT01926782|5681964|P1|Overall Study|Related to study drug administration|0
1626999|NCT01926782|5681959|P6|Overall Study|Withdrawal by Subject|5
1627000|NCT01926782|5681960|P5|Overall Study|Withdrawal by Subject|0
1627001|NCT01926782|5681961|P4|Overall Study|Withdrawal by Subject|1
1627002|NCT01926782|5681962|P3|Overall Study|Withdrawal by Subject|8
1627003|NCT01926782|5681963|P2|Overall Study|Withdrawal by Subject|1
1627004|NCT01926782|5681964|P1|Overall Study|Withdrawal by Subject|6
1627005|NCT01926782|5681959|P6|Overall Study|Randomized and not treated|0
1627006|NCT01926782|5681960|P5|Overall Study|Randomized and not treated|0
1627007|NCT01926782|5681961|P4|Overall Study|Randomized and not treated|1
1627008|NCT01926782|5681962|P3|Overall Study|Randomized and not treated|0
1627009|NCT01926782|5681963|P2|Overall Study|Randomized and not treated|0
1627010|NCT01926782|5681964|P1|Overall Study|Randomized and not treated|0
1627011|NCT01926782|5681959|P6|Overall Study|Poor compliance to protocol|6
1627012|NCT01926782|5681960|P5|Overall Study|Poor compliance to protocol|1
1627013|NCT01926782|5681961|P4|Overall Study|Poor compliance to protocol|0
1627014|NCT01926782|5681962|P3|Overall Study|Poor compliance to protocol|8
1627015|NCT01926782|5681963|P2|Overall Study|Poor compliance to protocol|3
1627016|NCT01926782|5681964|P1|Overall Study|Poor compliance to protocol|5
1627017|NCT01926782|5681959|P6|Overall Study|Adverse Event|14
1627018|NCT01926782|5681960|P5|Overall Study|Adverse Event|3
1627019|NCT01926782|5681961|P4|Overall Study|Adverse Event|4
1627020|NCT01926782|5681962|P3|Overall Study|Adverse Event|17
1627021|NCT01926782|5681963|P2|Overall Study|Adverse Event|4
1627022|NCT01926782|5681964|P1|Overall Study|Adverse Event|13
1627023|NCT01926782|5681959|P6|Overall Study|Other than specified|11
1627024|NCT01926782|5681960|P5|Overall Study|Other than specified|4
1627025|NCT01926782|5681961|P4|Overall Study|Other than specified|12
1627026|NCT01926782|5681962|P3|Overall Study|Other than specified|5
1627027|NCT01926782|5681963|P2|Overall Study|Other than specified|3
1627028|NCT01926782|5681964|P1|Overall Study|Other than specified|2
1627029|NCT01926782|5681959|P6|Overall Study|Physician Decision|0
1627030|NCT01926782|5681960|P5|Overall Study|Physician Decision|0
1627031|NCT01926782|5681961|P4|Overall Study|Physician Decision|1
1627032|NCT01926782|5681962|P3|Overall Study|Physician Decision|1
1627033|NCT01926782|5681963|P2|Overall Study|Physician Decision|2
1627034|NCT01926782|5681964|P1|Overall Study|Physician Decision|0
1627035|NCT01926782|5681959|P6|Overall Study|Participant moved|3
1627036|NCT01926782|5681960|P5|Overall Study|Participant moved|0
1627037|NCT01926782|5681961|P4|Overall Study|Participant moved|1
1627038|NCT01926782|5681962|P3|Overall Study|Participant moved|1
1627039|NCT01926782|5681963|P2|Overall Study|Participant moved|0
1627040|NCT01926782|5681964|P1|Overall Study|Participant moved|2
1627041|NCT01926626|5682113|P1|Overall Study|Lost to Follow-up|7
1627042|NCT01926626|5682113|P1|Overall Study|Withdrawal by Subject|15
1627043|NCT01926509|5682127|P4|Overall Study|vital sign met discontinuation criteria|0
1627044|NCT01926509|5682128|P3|Overall Study|vital sign met discontinuation criteria|0
1627045|NCT01926509|5682129|P2|Overall Study|vital sign met discontinuation criteria|0
1627046|NCT01926509|5682130|P1|Overall Study|vital sign met discontinuation criteria|1
1627047|NCT01926444|5682151|P4|Overall Study|Colonoscopy not performed|2
1627048|NCT01926444|5682152|P3|Overall Study|Colonoscopy not performed|4
1627049|NCT01926444|5682153|P2|Overall Study|Colonoscopy not performed|0
1627050|NCT01926444|5682154|P1|Overall Study|Colonoscopy not performed|0
1627051|NCT01926119|5682196|P1|Overall Study|Withdrawal by Subject|1
1627052|NCT01926028|5682209|P3|Overall Study|Non compliance or other reasons|0
1627053|NCT01926028|5682210|P2|Overall Study|Non compliance or other reasons|2
1627054|NCT01926028|5682211|P1|Overall Study|Non compliance or other reasons|4
1627055|NCT01926028|5682209|P3|Overall Study|Withdrawal by Subject|2
1627056|NCT01926028|5682210|P2|Overall Study|Withdrawal by Subject|9
1627057|NCT01926028|5682211|P1|Overall Study|Withdrawal by Subject|9
1627058|NCT01926028|5682209|P3|Overall Study|Physician Decision|0
1627059|NCT01926028|5682210|P2|Overall Study|Physician Decision|5
1627060|NCT01926028|5682211|P1|Overall Study|Physician Decision|1
1627061|NCT01926028|5682209|P3|Overall Study|Lost to Follow-up|0
1627062|NCT01926028|5682210|P2|Overall Study|Lost to Follow-up|6
1627063|NCT01926028|5682211|P1|Overall Study|Lost to Follow-up|7
1627064|NCT01926015|5682247|P2|Overall Study|Randomized not treated|0
1627065|NCT01926015|5682248|P1|Overall Study|Randomized not treated|2
1627066|NCT01926015|5682247|P2|Overall Study|Withdrawal by parent/guardian|1
1627067|NCT01926015|5682248|P1|Overall Study|Withdrawal by parent/guardian|0
1627068|NCT01925989|5682280|P3|Period 1|Withdrawal by Subject|0
1627069|NCT01925989|5682281|P2|Period 1|Withdrawal by Subject|1
1627070|NCT01925989|5682282|P1|Period 1|Withdrawal by Subject|0
1627071|NCT01925989|5682280|P3|Period 1|Sponsor Decision|0
1627072|NCT01925989|5682281|P2|Period 1|Sponsor Decision|1
1627073|NCT01925989|5682282|P1|Period 1|Sponsor Decision|1
1627074|NCT01925950|5682302|P2|Part 2|Withdrawal by Subject|0
1627075|NCT01925950|5682303|P1|Part 2|Withdrawal by Subject|1
1627076|NCT01925768|5682322|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
1627077|NCT01925768|5682323|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
1627078|NCT01925768|5682322|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
1627079|NCT01925768|5682323|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
1627080|NCT01925768|5682322|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
1627081|NCT01925768|5682323|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
1627082|NCT01925768|5682322|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
1627083|NCT01925768|5682323|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
1627084|NCT01925768|5682322|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
1627085|NCT01925768|5682323|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
1627086|NCT01925768|5682322|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
1627087|NCT01925768|5682323|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
1627088|NCT01925768|5682322|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1627089|NCT01925768|5682323|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
1627090|NCT01925768|5682322|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
1627091|NCT01925768|5682323|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1627092|NCT01925768|5682322|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
1627093|NCT01925768|5682323|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
1627094|NCT01925768|5682322|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
1627095|NCT01925768|5682323|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1627096|NCT01925768|5682322|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1627097|NCT01925768|5682323|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1627098|NCT01925703|5682371|P1|Overall Study|Discharge prior to full iron repletion|1
1627099|NCT01925703|5682371|P1|Overall Study|Lost to Follow-up|2
1627100|NCT01925703|5682371|P1|Overall Study|Physician Decision|1
1627101|NCT01925612|5682389|P5|Overall Study|Adverse Event|2
1627102|NCT01925612|5682390|P4|Overall Study|Adverse Event|1
1627103|NCT01925612|5682391|P3|Overall Study|Adverse Event|0
1627104|NCT01925612|5682392|P2|Overall Study|Adverse Event|3
1627105|NCT01925612|5682393|P1|Overall Study|Adverse Event|3
1627106|NCT01925612|5682389|P5|Overall Study|Progressive Disease|0
1627107|NCT01925612|5682390|P4|Overall Study|Progressive Disease|0
1627108|NCT01925612|5682391|P3|Overall Study|Progressive Disease|1
1627109|NCT01925612|5682392|P2|Overall Study|Progressive Disease|1
1627110|NCT01925612|5682393|P1|Overall Study|Progressive Disease|1
1627111|NCT01925417|5682443|P1|Overall Study|Death|1
1627112|NCT01925417|5682443|P1|Overall Study|Withdrawal by Subject|2
1627113|NCT01925339|5682474|P2|Overall Study|Adverse Event|0
1627114|NCT01925339|5682475|P1|Overall Study|Adverse Event|2
1627115|NCT01925274|5682486|P3|Overall Study|Protocol amendment|6
1627116|NCT01925274|5682487|P2|Overall Study|Protocol amendment|3
1627117|NCT01925274|5682488|P1|Overall Study|Protocol amendment|1
1627118|NCT01925274|5682486|P3|Overall Study|Study terminated by sponsor|0
1627119|NCT01925274|5682487|P2|Overall Study|Study terminated by sponsor|0
1627120|NCT01925274|5682488|P1|Overall Study|Study terminated by sponsor|4
1627121|NCT01925274|5682486|P3|Overall Study|Withdrawal by Subject|0
1627122|NCT01925274|5682487|P2|Overall Study|Withdrawal by Subject|2
1627123|NCT01925274|5682488|P1|Overall Study|Withdrawal by Subject|1
1627124|NCT01925274|5682486|P3|Overall Study|Lost to Follow-up|0
1627125|NCT01925274|5682487|P2|Overall Study|Lost to Follow-up|1
1627126|NCT01925274|5682488|P1|Overall Study|Lost to Follow-up|0
1627127|NCT01925274|5682486|P3|Overall Study|Death|0
1627128|NCT01925274|5682487|P2|Overall Study|Death|0
1627129|NCT01925274|5682488|P1|Overall Study|Death|1
1627130|NCT01925209|5682569|P4|Follow-up|Withdrawal by Subject|2
1627131|NCT01925209|5682570|P3|Follow-up|Withdrawal by Subject|0
1627132|NCT01925209|5682571|P2|Follow-up|Withdrawal by Subject|2
1627133|NCT01925209|5682572|P1|Follow-up|Withdrawal by Subject|0
1627134|NCT01925209|5682569|P4|Follow-up|Non-compliance with study treatment|1
1627135|NCT01925209|5682570|P3|Follow-up|Non-compliance with study treatment|0
1627136|NCT01925209|5682571|P2|Follow-up|Non-compliance with study treatment|0
1627137|NCT01925209|5682572|P1|Follow-up|Non-compliance with study treatment|0
1627138|NCT01925209|5682569|P4|Follow-up|Physician Decision|0
1627139|NCT01925209|5682570|P3|Follow-up|Physician Decision|1
1627140|NCT01925209|5682571|P2|Follow-up|Physician Decision|0
1627141|NCT01925209|5682572|P1|Follow-up|Physician Decision|0
1627142|NCT01925209|5682569|P4|Follow-up|Adverse Event|1
1627143|NCT01925209|5682570|P3|Follow-up|Adverse Event|0
1627144|NCT01925209|5682571|P2|Follow-up|Adverse Event|4
1627145|NCT01925209|5682572|P1|Follow-up|Adverse Event|1
1627146|NCT01925209|5682569|P4|Maintenance Treatment Epoch|Adverse Event|0
1627147|NCT01925209|5682570|P3|Maintenance Treatment Epoch|Adverse Event|1
1627148|NCT01925209|5682571|P2|Maintenance Treatment Epoch|Adverse Event|0
1627149|NCT01925209|5682572|P1|Maintenance Treatment Epoch|Adverse Event|0
1627150|NCT01925209|5682569|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
1627151|NCT01925209|5682570|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
1627152|NCT01925209|5682571|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
1627153|NCT01925209|5682572|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
1627154|NCT01925209|5682569|P4|Treatment Epoch|Adverse Event|1
1627155|NCT01925209|5682570|P3|Treatment Epoch|Adverse Event|3
1627156|NCT01925209|5682571|P2|Treatment Epoch|Adverse Event|5
1627157|NCT01925209|5682572|P1|Treatment Epoch|Adverse Event|3
1627158|NCT01925209|5682569|P4|Treatment Epoch|Withdrawal by Subject|2
1627159|NCT01925209|5682570|P3|Treatment Epoch|Withdrawal by Subject|3
1627160|NCT01925209|5682571|P2|Treatment Epoch|Withdrawal by Subject|3
1627161|NCT01925209|5682572|P1|Treatment Epoch|Withdrawal by Subject|4
1627162|NCT01925209|5682569|P4|Treatment Epoch|Protocol deviation|1
1627163|NCT01925209|5682570|P3|Treatment Epoch|Protocol deviation|1
1627164|NCT01925209|5682571|P2|Treatment Epoch|Protocol deviation|0
1627165|NCT01925209|5682572|P1|Treatment Epoch|Protocol deviation|0
1627166|NCT01925209|5682569|P4|Treatment Epoch|Death|0
1627167|NCT01925209|5682570|P3|Treatment Epoch|Death|0
1627168|NCT01925209|5682571|P2|Treatment Epoch|Death|0
1627169|NCT01925209|5682572|P1|Treatment Epoch|Death|1
1627170|NCT01925209|5682569|P4|Treatment Epoch|Non-compliance with study treatment|1
1627171|NCT01925209|5682570|P3|Treatment Epoch|Non-compliance with study treatment|0
1627172|NCT01925209|5682571|P2|Treatment Epoch|Non-compliance with study treatment|0
1627173|NCT01925209|5682572|P1|Treatment Epoch|Non-compliance with study treatment|0
1627174|NCT01925209|5682569|P4|Treatment Epoch|Physician Decision|0
1627175|NCT01925209|5682570|P3|Treatment Epoch|Physician Decision|0
1627176|NCT01925209|5682571|P2|Treatment Epoch|Physician Decision|0
1627177|NCT01925209|5682572|P1|Treatment Epoch|Physician Decision|1
1627178|NCT01925183|5682604|P2|Overall Study|Adverse Event|0
1627179|NCT01925183|5682605|P1|Overall Study|Adverse Event|1
1627180|NCT01925170|5682613|P1|Overall Study|Unverified cancer status|53
1627181|NCT01925014|5682644|P2|Overall Study|Withdrawal by Subject|13
1627182|NCT01925014|5682645|P1|Overall Study|Withdrawal by Subject|5
1627183|NCT01925014|5682644|P2|Overall Study|Inappropriate enrollment|6
1627184|NCT01925014|5682645|P1|Overall Study|Inappropriate enrollment|4
1627185|NCT01924845|5682720|P1|Overall Study|Protocol Violation|1
1627186|NCT01924845|5682720|P1|Overall Study|Withdrawal by Subject|2
1627187|NCT01924845|5682720|P1|Overall Study|Adverse Event|3
1627188|NCT01924767|5682733|P5|Overall Study|Adverse Event|0
1627189|NCT01924767|5682734|P4|Overall Study|Adverse Event|0
1627190|NCT01924767|5682735|P3|Overall Study|Adverse Event|1
1627191|NCT01924767|5682736|P2|Overall Study|Adverse Event|0
1627192|NCT01924767|5682737|P1|Overall Study|Adverse Event|1
1627193|NCT01924689|5682843|P6|Overall Study|Other|0
1627194|NCT01924689|5682844|P5|Overall Study|Other|1
1627195|NCT01924689|5682845|P4|Overall Study|Other|0
1627196|NCT01924689|5682846|P3|Overall Study|Other|0
1627197|NCT01924689|5682847|P2|Overall Study|Other|0
1627198|NCT01924689|5682848|P1|Overall Study|Other|0
1627199|NCT01924689|5682843|P6|Overall Study|Withdrawal of consent|0
1627200|NCT01924689|5682844|P5|Overall Study|Withdrawal of consent|0
1627201|NCT01924689|5682845|P4|Overall Study|Withdrawal of consent|1
1627202|NCT01924689|5682846|P3|Overall Study|Withdrawal of consent|1
1627203|NCT01924689|5682847|P2|Overall Study|Withdrawal of consent|0
1627204|NCT01924689|5682848|P1|Overall Study|Withdrawal of consent|0
1627205|NCT01924689|5682843|P6|Overall Study|New therapy or study|0
1627206|NCT01924689|5682844|P5|Overall Study|New therapy or study|2
1627207|NCT01924689|5682845|P4|Overall Study|New therapy or study|4
1627208|NCT01924689|5682846|P3|Overall Study|New therapy or study|1
1627209|NCT01924689|5682847|P2|Overall Study|New therapy or study|2
1627210|NCT01924689|5682848|P1|Overall Study|New therapy or study|3
1627211|NCT01924689|5682843|P6|Overall Study|Disease progression|2
1627212|NCT01924689|5682844|P5|Overall Study|Disease progression|3
1627213|NCT01924689|5682845|P4|Overall Study|Disease progression|0
1627214|NCT01924689|5682846|P3|Overall Study|Disease progression|2
1627215|NCT01924689|5682847|P2|Overall Study|Disease progression|0
1627216|NCT01924689|5682848|P1|Overall Study|Disease progression|0
1627217|NCT01924689|5682843|P6|Overall Study|Death|0
1627218|NCT01924689|5682844|P5|Overall Study|Death|0
1627219|NCT01924689|5682845|P4|Overall Study|Death|1
1627220|NCT01924689|5682846|P3|Overall Study|Death|0
1627221|NCT01924689|5682847|P2|Overall Study|Death|1
1627222|NCT01924689|5682848|P1|Overall Study|Death|0
1627223|NCT01924533|5682922|P2|Overall Study|Other Eligibility criteria|1
1627224|NCT01924533|5682923|P1|Overall Study|Other Eligibility criteria|1
1627225|NCT01924533|5682922|P2|Overall Study|Withdrawal by Subject|3
1627226|NCT01924533|5682923|P1|Overall Study|Withdrawal by Subject|7
1627227|NCT01924533|5682922|P2|Overall Study|Lost to Follow-up|1
1627228|NCT01924533|5682923|P1|Overall Study|Lost to Follow-up|0
1627229|NCT01924533|5682922|P2|Overall Study|Death|200
1627230|NCT01924533|5682923|P1|Overall Study|Death|181
1627231|NCT01924429|5682964|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
1627232|NCT01924429|5682965|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
1627233|NCT01924364|5683008|P1|Overall Study|Physician Decision|3
1627234|NCT01924299|5683025|P2|Period 2|Adverse Event|1
1627235|NCT01924299|5683026|P1|Period 2|Adverse Event|0
1627236|NCT01924299|5683025|P2|Period 2|Withdrawal by Subject|0
1627237|NCT01924299|5683026|P1|Period 2|Withdrawal by Subject|1
1627238|NCT01924182|5683048|P2|Overall Study|Withdrawal by Subject|0
1627239|NCT01924182|5683049|P1|Overall Study|Withdrawal by Subject|1
1627240|NCT01923896|5683090|P2|Overall Study|Adverse Event|0
1627241|NCT01923896|5683091|P1|Overall Study|Adverse Event|1
1627242|NCT01923740|5683114|P2|Overall Study|Withdrawal by Subject|0
1627243|NCT01923740|5683115|P1|Overall Study|Withdrawal by Subject|2
1627244|NCT01923740|5683114|P2|Overall Study|Lost to Follow-up|9
1627245|NCT01923740|5683115|P1|Overall Study|Lost to Follow-up|4
1627246|NCT01923467|5683540|P1|Overall Study|Subject non-interest|479
1627247|NCT01923467|5683540|P1|Overall Study|Lost to Follow-up|62
1627248|NCT01923428|5683548|P4|Overall Study|Lack of Efficacy|1
1627249|NCT01923428|5683549|P3|Overall Study|Lack of Efficacy|1
1627250|NCT01923428|5683550|P2|Overall Study|Lack of Efficacy|0
1627251|NCT01923428|5683551|P1|Overall Study|Lack of Efficacy|0
1627252|NCT01923428|5683548|P4|Overall Study|Non Compliance to treatment|1
1627253|NCT01923428|5683549|P3|Overall Study|Non Compliance to treatment|0
1627254|NCT01923428|5683550|P2|Overall Study|Non Compliance to treatment|2
1627255|NCT01923428|5683551|P1|Overall Study|Non Compliance to treatment|1
1627256|NCT01923428|5683548|P4|Overall Study|Protocol Violation|1
1627257|NCT01923428|5683549|P3|Overall Study|Protocol Violation|2
1627258|NCT01923428|5683550|P2|Overall Study|Protocol Violation|0
1627259|NCT01923428|5683551|P1|Overall Study|Protocol Violation|3
1627260|NCT01923428|5683548|P4|Overall Study|Lost to Follow-up|0
1627261|NCT01923428|5683549|P3|Overall Study|Lost to Follow-up|5
1627262|NCT01923428|5683550|P2|Overall Study|Lost to Follow-up|1
1627263|NCT01923428|5683551|P1|Overall Study|Lost to Follow-up|2
1627264|NCT01923428|5683548|P4|Overall Study|Withdrawal by Subject|4
1627265|NCT01923428|5683549|P3|Overall Study|Withdrawal by Subject|0
1627266|NCT01923428|5683550|P2|Overall Study|Withdrawal by Subject|3
1627267|NCT01923428|5683551|P1|Overall Study|Withdrawal by Subject|5
1627268|NCT01923428|5683548|P4|Overall Study|Adverse Event|3
1627269|NCT01923428|5683549|P3|Overall Study|Adverse Event|3
1627270|NCT01923428|5683550|P2|Overall Study|Adverse Event|6
1627271|NCT01923428|5683551|P1|Overall Study|Adverse Event|8
1627272|NCT01923389|5683563|P2|Overall Study|Protocol Violation|0
1627273|NCT01923389|5683564|P1|Overall Study|Protocol Violation|1
1627274|NCT01923363|5683586|P1|Overall Study|Protocol Violation|1
1627275|NCT01923311|5683595|P2|Overall Study|Study Terminated by Sponsor|0
1627276|NCT01923311|5683596|P1|Overall Study|Study Terminated by Sponsor|12
1627277|NCT01923311|5683595|P2|Overall Study|Withdrew Consent|0
1627278|NCT01923311|5683596|P1|Overall Study|Withdrew Consent|1
1627279|NCT01923311|5683595|P2|Overall Study|Non-Compliance with Study Drug|1
1627280|NCT01923311|5683596|P1|Overall Study|Non-Compliance with Study Drug|2
1627281|NCT01923311|5683595|P2|Overall Study|Investigator's Discretion|0
1627282|NCT01923311|5683596|P1|Overall Study|Investigator's Discretion|1
1627283|NCT01923311|5683595|P2|Overall Study|Pregnancy|0
1627284|NCT01923311|5683596|P1|Overall Study|Pregnancy|1
1627321|NCT01923168|5683734|P3|Overall Study|Death|1
1627322|NCT01923168|5683735|P2|Overall Study|Death|0
1627323|NCT01923168|5683736|P1|Overall Study|Death|0
1627324|NCT01923168|5683734|P3|Overall Study|Progressive disease|7
1627325|NCT01923168|5683735|P2|Overall Study|Progressive disease|3
1627326|NCT01923168|5683736|P1|Overall Study|Progressive disease|4
1627327|NCT01923168|5683734|P3|Overall Study|Physician Decision|5
1627328|NCT01923168|5683735|P2|Overall Study|Physician Decision|9
1627329|NCT01923168|5683736|P1|Overall Study|Physician Decision|6
1627330|NCT01923168|5683734|P3|Overall Study|Adverse Event|0
1627331|NCT01923168|5683735|P2|Overall Study|Adverse Event|12
1627332|NCT01923168|5683736|P1|Overall Study|Adverse Event|12
1627333|NCT01923168|5683734|P3|Overall Study|Subject/guardian decision|4
1627334|NCT01923168|5683735|P2|Overall Study|Subject/guardian decision|14
1627335|NCT01923168|5683736|P1|Overall Study|Subject/guardian decision|14
1627336|NCT01923168|5683734|P3|Overall Study|Protocol Violation|0
1627337|NCT01923168|5683735|P2|Overall Study|Protocol Violation|1
1627338|NCT01923168|5683736|P1|Overall Study|Protocol Violation|1
1627339|NCT01922934|5683819|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
1627340|NCT01922934|5683820|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
1627341|NCT01922934|5683819|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
1627342|NCT01922934|5683820|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
1627343|NCT01922934|5683819|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
1627344|NCT01922934|5683820|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
1627345|NCT01922934|5683819|P2|Eligible Patients|Did not meet inclusion criteria|81
1627346|NCT01922934|5683820|P1|Eligible Patients|Did not meet inclusion criteria|36
1627347|NCT01922934|5683819|P2|Eligible Patients|Physician Decision|0
1627348|NCT01922934|5683820|P1|Eligible Patients|Physician Decision|17
1627349|NCT01922934|5683819|P2|Eligible Patients|Death|7
1627350|NCT01922934|5683820|P1|Eligible Patients|Death|0
1627351|NCT01922739|5683832|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
1627352|NCT01922739|5683832|P1|Open-label Treatment Period|Physician Decision|1
1627353|NCT01922739|5683832|P1|Open-label Treatment Period|Lost to Follow-up|2
1627354|NCT01922739|5683832|P1|Open-label Treatment Period|Noncompliance to study procedures|1
1627355|NCT01922739|5683832|P1|Open-label Treatment Period|Pregnancy|1
1627356|NCT01922739|5683832|P1|Open-label Treatment Period|Protocol Violation|5
1627357|NCT01922739|5683832|P1|Open-label Treatment Period|Noncompliance to study medication|3
1627358|NCT01922739|5683832|P1|Open-label Treatment Period|Withdrawal by Subject|14
1627359|NCT01922739|5683832|P1|Open-label Treatment Period|Adverse Event|6
1627360|NCT01922739|5683832|P1|Titration/Adjustment Period|Lack of Efficacy|3
1627361|NCT01922739|5683832|P1|Titration/Adjustment Period|Lost to Follow-up|1
1627362|NCT01922739|5683832|P1|Titration/Adjustment Period|Withdrawal by Subject|5
1627363|NCT01922739|5683832|P1|Titration/Adjustment Period|Adverse Event|3
1627364|NCT01922349|5683861|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
1627365|NCT01922349|5683862|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
1627366|NCT01922349|5683863|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
1627367|NCT01922349|5683864|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
1627368|NCT01922271|5683993|P2|WASHOUT Period|Withdrawal by Subject|0
1627369|NCT01922271|5683994|P1|WASHOUT Period|Withdrawal by Subject|1
1627370|NCT01922102|5684036|P3|Overall Study|Administrative problems|0
1627371|NCT01922102|5684037|P2|Overall Study|Administrative problems|2
1627372|NCT01922102|5684038|P1|Overall Study|Administrative problems|0
1627373|NCT01922102|5684036|P3|Overall Study|Lost to Follow-up|0
1627374|NCT01922102|5684037|P2|Overall Study|Lost to Follow-up|0
1627375|NCT01922102|5684038|P1|Overall Study|Lost to Follow-up|1
1627376|NCT01922102|5684036|P3|Overall Study|Adverse Event|0
1627377|NCT01922102|5684037|P2|Overall Study|Adverse Event|2
1627378|NCT01922102|5684038|P1|Overall Study|Adverse Event|1
1627379|NCT01922102|5684036|P3|Overall Study|Physician Decision|1
1627380|NCT01922102|5684037|P2|Overall Study|Physician Decision|2
1627381|NCT01922102|5684038|P1|Overall Study|Physician Decision|0
1627382|NCT01922102|5684036|P3|Overall Study|Withdrawal by Subject|7
1627383|NCT01922102|5684037|P2|Overall Study|Withdrawal by Subject|3
1627384|NCT01922102|5684038|P1|Overall Study|Withdrawal by Subject|7
1627385|NCT01922089|5684074|P2|Overall Study|Lost to Follow-up|1
1627386|NCT01922089|5684075|P1|Overall Study|Lost to Follow-up|0
1627387|NCT01922089|5684074|P2|Overall Study|Death|1
1627388|NCT01922089|5684075|P1|Overall Study|Death|2
1627389|NCT01922089|5684074|P2|Overall Study|Physician Decision|3
1627390|NCT01922089|5684075|P1|Overall Study|Physician Decision|2
1627391|NCT01922089|5684074|P2|Overall Study|administrative problems|1
1627392|NCT01922089|5684075|P1|Overall Study|administrative problems|4
1627393|NCT01922089|5684074|P2|Overall Study|Withdrawal by Subject|4
1627394|NCT01922089|5684075|P1|Overall Study|Withdrawal by Subject|3
1627395|NCT01922089|5684074|P2|Overall Study|Protocol Deviation|7
1627396|NCT01922089|5684075|P1|Overall Study|Protocol Deviation|10
1627397|NCT01922089|5684074|P2|Overall Study|Adverse Event|13
1627398|NCT01922089|5684075|P1|Overall Study|Adverse Event|18
1627399|NCT01922037|5684152|P2|Overall Study|Other unspecified|66
1627400|NCT01922037|5684153|P1|Overall Study|Other unspecified|2
1627401|NCT01922037|5684152|P2|Overall Study|Investigator/Sponsor decision|4
1627402|NCT01922037|5684153|P1|Overall Study|Investigator/Sponsor decision|1
1627403|NCT01922037|5684152|P2|Overall Study|Participant non-compliance|46
1627404|NCT01922037|5684153|P1|Overall Study|Participant non-compliance|4
1627405|NCT01922037|5684152|P2|Overall Study|Pregnancy|2
1627406|NCT01922037|5684153|P1|Overall Study|Pregnancy|0
1627407|NCT01922037|5684152|P2|Overall Study|Death|5
1627408|NCT01922037|5684153|P1|Overall Study|Death|0
1627409|NCT01922037|5684152|P2|Overall Study|Adverse Event|7
1627410|NCT01922037|5684153|P1|Overall Study|Adverse Event|1
1627411|NCT01922037|5684152|P2|Overall Study|Withdrawal by Subject|44
1627412|NCT01922037|5684153|P1|Overall Study|Withdrawal by Subject|2
1627413|NCT01922011|5684256|P2|Overall Study|Randomized in error|0
1627414|NCT01922011|5684257|P1|Overall Study|Randomized in error|1
1627415|NCT01922011|5684256|P2|Overall Study|Lack of willing home health agency|0
1627416|NCT01922011|5684257|P1|Overall Study|Lack of willing home health agency|1
1627417|NCT01922011|5684256|P2|Overall Study|Not Treated|0
1627418|NCT01922011|5684257|P1|Overall Study|Not Treated|1
1627419|NCT01922011|5684256|P2|Overall Study|Missed Test-of-Cure Visit|2
1627420|NCT01922011|5684257|P1|Overall Study|Missed Test-of-Cure Visit|0
1627421|NCT01922011|5684256|P2|Overall Study|Lost to Follow-up|1
1627422|NCT01922011|5684257|P1|Overall Study|Lost to Follow-up|0
1627423|NCT01922011|5684256|P2|Overall Study|Parent/Guardian Decision|0
1627424|NCT01922011|5684257|P1|Overall Study|Parent/Guardian Decision|3
1627425|NCT01922011|5684256|P2|Overall Study|Physician Decision|1
1627426|NCT01922011|5684257|P1|Overall Study|Physician Decision|0
1627427|NCT01922011|5684256|P2|Overall Study|Protocol Violation|1
1627428|NCT01922011|5684257|P1|Overall Study|Protocol Violation|0
1627429|NCT01921829|5684324|P2|Overall Study|Withdrawal by Subject|1
1627430|NCT01921829|5684325|P1|Overall Study|Withdrawal by Subject|0
1627431|NCT01921517|5684396|P2|Overall Study|Subject missed final imaging|4
1627432|NCT01921517|5684397|P1|Overall Study|Subject missed final imaging|1
1627433|NCT01921517|5684396|P2|Overall Study|Withdrawal by Subject|3
1627434|NCT01921517|5684397|P1|Overall Study|Withdrawal by Subject|7
1627435|NCT01921517|5684396|P2|Overall Study|Physician Decision|2
1627436|NCT01921517|5684397|P1|Overall Study|Physician Decision|0
1627437|NCT01921517|5684396|P2|Overall Study|Newly diagnosed health concern|0
1627438|NCT01921517|5684397|P1|Overall Study|Newly diagnosed health concern|2
1627439|NCT01921517|5684396|P2|Overall Study|Lost to Follow-up|0
1627440|NCT01921517|5684397|P1|Overall Study|Lost to Follow-up|5
1627441|NCT01921387|5684408|P1|Overall Study|Adverse Event|1
1627442|NCT01921348|5684417|P2|Overall Study|Lost to Follow-up|2
1627443|NCT01921348|5684418|P1|Overall Study|Lost to Follow-up|0
1627444|NCT01921348|5684417|P2|Overall Study|Withdrawal by Subject|0
1627445|NCT01921348|5684418|P1|Overall Study|Withdrawal by Subject|1
1627446|NCT01921270|5684447|P1|Overall Study|Withdrawal by Subject|1
1627447|NCT01921257|5684463|P1|Overall Study|Withdrawal by Subject|1
1627448|NCT01921257|5684463|P1|Overall Study|Protocol Violation|1
1627449|NCT01921257|5684463|P1|Overall Study|Adverse Event|1
1627450|NCT01921205|5684470|P2|Overall Study|Non Compliance Of Child|1
1627451|NCT01921205|5684471|P1|Overall Study|Non Compliance Of Child|0
1627452|NCT01921205|5684470|P2|Overall Study|Non Compliance Of The Parent|1
1627453|NCT01921205|5684471|P1|Overall Study|Non Compliance Of The Parent|0
1627454|NCT01921205|5684470|P2|Overall Study|The Excessive Use Of Rescue Medication|1
1627455|NCT01921205|5684471|P1|Overall Study|The Excessive Use Of Rescue Medication|0
1627456|NCT01921205|5684470|P2|Overall Study|Use Of Prohibited Medication|1
1627457|NCT01921205|5684471|P1|Overall Study|Use Of Prohibited Medication|0
1627458|NCT01921205|5684470|P2|Overall Study|Withdrawal by Subject|5
1627459|NCT01921205|5684471|P1|Overall Study|Withdrawal by Subject|6
1627460|NCT01921205|5684470|P2|Overall Study|Lost to Follow-up|1
1627461|NCT01921205|5684471|P1|Overall Study|Lost to Follow-up|1
1627462|NCT01921205|5684470|P2|Overall Study|Protocol Violation|3
1627463|NCT01921205|5684471|P1|Overall Study|Protocol Violation|1
1627464|NCT01921205|5684470|P2|Overall Study|Lack of Efficacy|0
1627465|NCT01921205|5684471|P1|Overall Study|Lack of Efficacy|1
1627466|NCT01921205|5684470|P2|Overall Study|Adverse Event|7
1627467|NCT01921205|5684471|P1|Overall Study|Adverse Event|12
1627472|NCT01921101|5684539|P2|Overall Study|Death|6
1627473|NCT01921101|5684540|P1|Overall Study|Death|16
1627474|NCT01920958|5684548|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
1627475|NCT01920893|5684566|P2|Overall Study|Lack of Efficacy|0
1627476|NCT01920893|5684567|P1|Overall Study|Lack of Efficacy|2
1627477|NCT01920893|5684566|P2|Overall Study|Adverse Event|2
1627478|NCT01920893|5684567|P1|Overall Study|Adverse Event|5
1627479|NCT01920854|5684600|P7|Overall Study|Withdrawal by Subject|1
1627480|NCT01920854|5684601|P6|Overall Study|Withdrawal by Subject|0
1627481|NCT01920854|5684602|P5|Overall Study|Withdrawal by Subject|1
1627482|NCT01920854|5684603|P4|Overall Study|Withdrawal by Subject|0
1627483|NCT01920854|5684604|P3|Overall Study|Withdrawal by Subject|0
1627484|NCT01920854|5684605|P2|Overall Study|Withdrawal by Subject|0
1627485|NCT01920854|5684606|P1|Overall Study|Withdrawal by Subject|1
1627486|NCT01920594|5684766|P2|Overall Study|Investigator discretion|1
1627487|NCT01920594|5684767|P1|Overall Study|Investigator discretion|0
1627488|NCT01920594|5684766|P2|Overall Study|Recovery|0
1627489|NCT01920594|5684767|P1|Overall Study|Recovery|2
1627490|NCT01920594|5684766|P2|Overall Study|Lost to Follow-up|0
1627491|NCT01920594|5684767|P1|Overall Study|Lost to Follow-up|1
1627492|NCT01920594|5684766|P2|Overall Study|Adverse Event|2
1627493|NCT01920594|5684767|P1|Overall Study|Adverse Event|4
1627494|NCT01920568|5684817|P2|Overall Study|Death due to disease progression|12
1627495|NCT01920568|5684818|P1|Overall Study|Death due to disease progression|25
1627496|NCT01920568|5684817|P2|Overall Study|Withdrawal by Subject|55
1627497|NCT01920568|5684818|P1|Overall Study|Withdrawal by Subject|79
1627498|NCT01920568|5684817|P2|Overall Study|Physician Decision|4
1627499|NCT01920568|5684818|P1|Overall Study|Physician Decision|13
1627500|NCT01920568|5684817|P2|Overall Study|Lost to Follow-up|2
1627501|NCT01920568|5684818|P1|Overall Study|Lost to Follow-up|2
1627502|NCT01920568|5684817|P2|Overall Study|Protocol Violation|3
1627503|NCT01920568|5684818|P1|Overall Study|Protocol Violation|5
1627504|NCT01920568|5684817|P2|Overall Study|Adverse Event|8
1627505|NCT01920568|5684818|P1|Overall Study|Adverse Event|27
1627506|NCT01920555|5684844|P5|Overall Study|Lost to Follow-up|0
1627507|NCT01920555|5684845|P4|Overall Study|Lost to Follow-up|1
1627508|NCT01920555|5684846|P3|Overall Study|Lost to Follow-up|0
1627509|NCT01920555|5684847|P2|Overall Study|Lost to Follow-up|1
1627510|NCT01920555|5684848|P1|Overall Study|Lost to Follow-up|0
1627511|NCT01920555|5684844|P5|Overall Study|Travel Difficulties|1
1627512|NCT01920555|5684845|P4|Overall Study|Travel Difficulties|0
1627513|NCT01920555|5684846|P3|Overall Study|Travel Difficulties|0
1627514|NCT01920555|5684847|P2|Overall Study|Travel Difficulties|1
1627515|NCT01920555|5684848|P1|Overall Study|Travel Difficulties|1
1627516|NCT01920555|5684844|P5|Overall Study|Lack of Efficacy|0
1627517|NCT01920555|5684845|P4|Overall Study|Lack of Efficacy|0
1627518|NCT01920555|5684846|P3|Overall Study|Lack of Efficacy|0
1627519|NCT01920555|5684847|P2|Overall Study|Lack of Efficacy|0
1627520|NCT01920555|5684848|P1|Overall Study|Lack of Efficacy|2
1627521|NCT01920555|5684844|P5|Overall Study|Physician Decision|0
1627522|NCT01920555|5684845|P4|Overall Study|Physician Decision|2
1627523|NCT01920555|5684846|P3|Overall Study|Physician Decision|1
1627524|NCT01920555|5684847|P2|Overall Study|Physician Decision|2
1627525|NCT01920555|5684848|P1|Overall Study|Physician Decision|1
1627526|NCT01920477|5684907|P2|Overall Study|Withdrawal by Subject|1
1627527|NCT01920477|5684908|P1|Overall Study|Withdrawal by Subject|0
1627528|NCT01920477|5684907|P2|Overall Study|Study closed/terminated|15
1627529|NCT01920477|5684908|P1|Overall Study|Study closed/terminated|14
1627530|NCT01920477|5684907|P2|Overall Study|Lack of Efficacy|0
1627531|NCT01920477|5684908|P1|Overall Study|Lack of Efficacy|1
1627532|NCT01920477|5684907|P2|Overall Study|Adverse Event|1
1627533|NCT01920477|5684908|P1|Overall Study|Adverse Event|0
1627534|NCT01920178|5684957|P2|Overall Study|Lost to Follow-up|1
1627535|NCT01920178|5684958|P1|Overall Study|Lost to Follow-up|2
1627536|NCT01919970|5684976|P2|Overall Study|Withdrawal by Subject|0
1627537|NCT01919970|5684977|P1|Overall Study|Withdrawal by Subject|3
1627538|NCT01919814|5684985|P2|Overall Study|Withdrawal by Subject|0
1627539|NCT01919814|5684986|P1|Overall Study|Withdrawal by Subject|1
1627540|NCT01919814|5684985|P2|Overall Study|Protocol Violation|0
1627541|NCT01919814|5684986|P1|Overall Study|Protocol Violation|1
1627542|NCT01919814|5684985|P2|Overall Study|Adverse Event|0
1627543|NCT01919814|5684986|P1|Overall Study|Adverse Event|1
1627544|NCT01919801|5684998|P2|Overall Study|Other|1
1627545|NCT01919801|5684999|P1|Overall Study|Other|0
1627546|NCT01919801|5684998|P2|Overall Study|Lost to Follow-up|1
1627547|NCT01919801|5684999|P1|Overall Study|Lost to Follow-up|0
1627548|NCT01919801|5684998|P2|Overall Study|Physician Decision|1
1627549|NCT01919801|5684999|P1|Overall Study|Physician Decision|0
1627550|NCT01919801|5684998|P2|Overall Study|Withdrawal by Subject|0
1627551|NCT01919801|5684999|P1|Overall Study|Withdrawal by Subject|1
1627552|NCT01919723|5685024|P2|Overall Study|Blood Samples Hemolyzed|2
1627553|NCT01919723|5685025|P1|Overall Study|Blood Samples Hemolyzed|2
1627560|NCT01919398|5685118|P3|Overall Study|Progressive Disease|4
1627561|NCT01919398|5685119|P2|Overall Study|Progressive Disease|0
1627562|NCT01919398|5685120|P1|Overall Study|Progressive Disease|0
1627563|NCT01919307|5685140|P1|Overall Study|Withdrawal by Subject|9
1627564|NCT01919229|5685150|P3|Overall Study|Subject/guardian decision|1
1627565|NCT01919229|5685151|P2|Overall Study|Subject/guardian decision|0
1627566|NCT01919229|5685152|P1|Overall Study|Subject/guardian decision|0
1627567|NCT01918774|5685215|P1|Overall Study|Lost to Follow-up|1
1627568|NCT01918774|5685215|P1|Overall Study|Lost prior to first CBTw session|4
1627569|NCT01918371|5685239|P2|Overall Study|Missing Data|1
1627570|NCT01918371|5685240|P1|Overall Study|Missing Data|1
1627571|NCT01918332|5685318|P4|Overall Study|lipid result by central lab did not meet|0
1627572|NCT01918332|5685319|P3|Overall Study|lipid result by central lab did not meet|1
1627573|NCT01918332|5685320|P2|Overall Study|lipid result by central lab did not meet|0
1627574|NCT01918332|5685321|P1|Overall Study|lipid result by central lab did not meet|0
1627575|NCT01918332|5685318|P4|Overall Study|Protocol Violation|3
1627576|NCT01918332|5685319|P3|Overall Study|Protocol Violation|6
1627577|NCT01918332|5685320|P2|Overall Study|Protocol Violation|2
1627578|NCT01918332|5685321|P1|Overall Study|Protocol Violation|6
1627579|NCT01918332|5685318|P4|Overall Study|Withdrawal by Subject|3
1627580|NCT01918332|5685319|P3|Overall Study|Withdrawal by Subject|2
1627581|NCT01918332|5685320|P2|Overall Study|Withdrawal by Subject|3
1627582|NCT01918332|5685321|P1|Overall Study|Withdrawal by Subject|2
1627583|NCT01918332|5685318|P4|Overall Study|Adverse Event|1
1627584|NCT01918332|5685319|P3|Overall Study|Adverse Event|0
1627585|NCT01918332|5685320|P2|Overall Study|Adverse Event|0
1627586|NCT01918332|5685321|P1|Overall Study|Adverse Event|0
1627587|NCT01918306|5685333|P4|Overall Study|progress disease, crossover|0
1627588|NCT01918306|5685334|P3|Overall Study|progress disease, crossover|1
1627589|NCT01918306|5685335|P2|Overall Study|progress disease, crossover|0
1627590|NCT01918306|5685336|P1|Overall Study|progress disease, crossover|0
1627591|NCT01918306|5685333|P4|Overall Study|Lack of Efficacy|0
1627592|NCT01918306|5685334|P3|Overall Study|Lack of Efficacy|0
1627593|NCT01918306|5685335|P2|Overall Study|Lack of Efficacy|0
1627594|NCT01918306|5685336|P1|Overall Study|Lack of Efficacy|1
1627595|NCT01918306|5685333|P4|Overall Study|neutropenia|0
1627596|NCT01918306|5685334|P3|Overall Study|neutropenia|0
1627597|NCT01918306|5685335|P2|Overall Study|neutropenia|0
1627598|NCT01918306|5685336|P1|Overall Study|neutropenia|1
1627599|NCT01918306|5685333|P4|Overall Study|Withdrawal by Subject|2
1627600|NCT01918306|5685334|P3|Overall Study|Withdrawal by Subject|0
1627601|NCT01918306|5685335|P2|Overall Study|Withdrawal by Subject|0
1627602|NCT01918306|5685336|P1|Overall Study|Withdrawal by Subject|0
1627603|NCT01918306|5685333|P4|Overall Study|progresive disease|1
1627604|NCT01918306|5685334|P3|Overall Study|progresive disease|1
1627605|NCT01918306|5685335|P2|Overall Study|progresive disease|0
1627606|NCT01918306|5685336|P1|Overall Study|progresive disease|4
1627607|NCT01918085|5685367|P2|Test Period 1: Strata Strip|Adverse Event|1
1627608|NCT01918085|5685368|P1|Test Period 1: Strata Strip|Adverse Event|0
1627609|NCT01918033|5685392|P3|Overall Study|Withdrawal by Subject|0
1627610|NCT01918033|5685393|P2|Overall Study|Withdrawal by Subject|1
1627611|NCT01918033|5685394|P1|Overall Study|Withdrawal by Subject|2
1627612|NCT01918033|5685392|P3|Overall Study|Protocol Violation|1
1627613|NCT01918033|5685393|P2|Overall Study|Protocol Violation|0
1627614|NCT01918033|5685394|P1|Overall Study|Protocol Violation|2
1627615|NCT01918033|5685392|P3|Overall Study|Lost to Follow-up|0
1627616|NCT01918033|5685393|P2|Overall Study|Lost to Follow-up|1
1627617|NCT01918033|5685394|P1|Overall Study|Lost to Follow-up|0
1627618|NCT01918033|5685392|P3|Overall Study|Adverse Event|2
1627619|NCT01918033|5685393|P2|Overall Study|Adverse Event|0
1627620|NCT01918033|5685394|P1|Overall Study|Adverse Event|1
1627621|NCT01917747|5685465|P2|Overall Study|Withdrawal by Subject|0
1627622|NCT01917747|5685466|P1|Overall Study|Withdrawal by Subject|1
1627623|NCT01917656|5685474|P2|Overall Study|Lost to Follow-up|4
1627624|NCT01917656|5685475|P1|Overall Study|Lost to Follow-up|3
1627625|NCT01917656|5685474|P2|Overall Study|Withdrawal by Subject|3
1627626|NCT01917656|5685475|P1|Overall Study|Withdrawal by Subject|4
1627627|NCT01917656|5685474|P2|Overall Study|Unclassified|3
1627628|NCT01917656|5685475|P1|Overall Study|Unclassified|0
1627629|NCT01917656|5685474|P2|Overall Study|Withdrawal criteria|14
1627630|NCT01917656|5685475|P1|Overall Study|Withdrawal criteria|8
1627631|NCT01917656|5685474|P2|Overall Study|Adverse Event|0
1627632|NCT01917656|5685475|P1|Overall Study|Adverse Event|11
1627633|NCT01917526|5685501|P2|Overall Study|Protocol Violation|1
1627634|NCT01917526|5685502|P1|Overall Study|Protocol Violation|1
1627635|NCT01917344|5685519|P1|Overall Study|Withdrawal by Subject|1
1627636|NCT01917318|5685525|P2|First Treatment|Withdrawal by Subject|1
1627637|NCT01917318|5685526|P1|First Treatment|Withdrawal by Subject|0
1627638|NCT01917006|5685579|P8|Open-label Period|Lost to Follow-up|1
1627639|NCT01917006|5685580|P7|Open-label Period|Lost to Follow-up|0
1627640|NCT01917006|5685581|P6|Open-label Period|Lost to Follow-up|0
1627641|NCT01917006|5685582|P5|Open-label Period|Lost to Follow-up|0
1627642|NCT01917006|5685583|P4|Open-label Period|Lost to Follow-up|0
1627643|NCT01917006|5685584|P3|Open-label Period|Lost to Follow-up|0
1627644|NCT01917006|5685585|P2|Open-label Period|Lost to Follow-up|0
1627645|NCT01917006|5685586|P1|Open-label Period|Lost to Follow-up|0
1627646|NCT01917006|5685579|P8|Open-label Period|Adverse Event|1
1627647|NCT01917006|5685580|P7|Open-label Period|Adverse Event|0
1627648|NCT01917006|5685581|P6|Open-label Period|Adverse Event|0
1627649|NCT01917006|5685582|P5|Open-label Period|Adverse Event|0
1627650|NCT01917006|5685583|P4|Open-label Period|Adverse Event|0
1627651|NCT01917006|5685584|P3|Open-label Period|Adverse Event|0
1627652|NCT01917006|5685585|P2|Open-label Period|Adverse Event|0
1627653|NCT01917006|5685586|P1|Open-label Period|Adverse Event|0
1627654|NCT01917006|5685579|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
1627655|NCT01917006|5685580|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
1627656|NCT01917006|5685581|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
1627657|NCT01917006|5685582|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
1627658|NCT01917006|5685583|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
1627659|NCT01917006|5685584|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
1627660|NCT01917006|5685585|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
1627661|NCT01917006|5685586|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
1627662|NCT01917006|5685579|P8|Randomized-treatment Period|Protocol Violation|0
1627663|NCT01917006|5685580|P7|Randomized-treatment Period|Protocol Violation|0
1627664|NCT01917006|5685581|P6|Randomized-treatment Period|Protocol Violation|0
1627665|NCT01917006|5685582|P5|Randomized-treatment Period|Protocol Violation|0
1627666|NCT01917006|5685583|P4|Randomized-treatment Period|Protocol Violation|0
1627667|NCT01917006|5685584|P3|Randomized-treatment Period|Protocol Violation|0
1627668|NCT01917006|5685585|P2|Randomized-treatment Period|Protocol Violation|0
1627669|NCT01917006|5685586|P1|Randomized-treatment Period|Protocol Violation|1
1627670|NCT01917006|5685579|P8|Randomized-treatment Period|Personal Reasons|0
1627671|NCT01917006|5685580|P7|Randomized-treatment Period|Personal Reasons|0
1627672|NCT01917006|5685581|P6|Randomized-treatment Period|Personal Reasons|1
1627673|NCT01917006|5685582|P5|Randomized-treatment Period|Personal Reasons|0
1627674|NCT01917006|5685583|P4|Randomized-treatment Period|Personal Reasons|0
1627675|NCT01917006|5685584|P3|Randomized-treatment Period|Personal Reasons|0
1627676|NCT01917006|5685585|P2|Randomized-treatment Period|Personal Reasons|0
1627677|NCT01917006|5685586|P1|Randomized-treatment Period|Personal Reasons|0
1627678|NCT01917006|5685579|P8|Randomized-treatment Period|Lost to Follow-up|0
1627679|NCT01917006|5685580|P7|Randomized-treatment Period|Lost to Follow-up|0
1627680|NCT01917006|5685581|P6|Randomized-treatment Period|Lost to Follow-up|0
1627681|NCT01917006|5685582|P5|Randomized-treatment Period|Lost to Follow-up|0
1627682|NCT01917006|5685583|P4|Randomized-treatment Period|Lost to Follow-up|1
1627683|NCT01917006|5685584|P3|Randomized-treatment Period|Lost to Follow-up|0
1627684|NCT01917006|5685585|P2|Randomized-treatment Period|Lost to Follow-up|0
1627685|NCT01917006|5685586|P1|Randomized-treatment Period|Lost to Follow-up|1
1627686|NCT01916980|5685619|P2|Overall Study|Withdrawal by Subject|0
1627687|NCT01916980|5685620|P1|Overall Study|Withdrawal by Subject|1
1627688|NCT01916980|5685619|P2|Overall Study|Lack of Efficacy|2
1627689|NCT01916980|5685620|P1|Overall Study|Lack of Efficacy|2
1627690|NCT01916980|5685619|P2|Overall Study|Adverse Event|2
1627691|NCT01916980|5685620|P1|Overall Study|Adverse Event|4
1627692|NCT01916967|5685639|P3|Overall Study|Protocol Violation|0
1627693|NCT01916967|5685640|P2|Overall Study|Protocol Violation|1
1627694|NCT01916967|5685641|P1|Overall Study|Protocol Violation|0
1627695|NCT01916967|5685639|P3|Overall Study|Physician Decision|1
1627696|NCT01916967|5685640|P2|Overall Study|Physician Decision|0
1627697|NCT01916967|5685641|P1|Overall Study|Physician Decision|0
1627698|NCT01916967|5685639|P3|Overall Study|Lack of Efficacy|6
1627699|NCT01916967|5685640|P2|Overall Study|Lack of Efficacy|0
1627700|NCT01916967|5685641|P1|Overall Study|Lack of Efficacy|0
1627701|NCT01916967|5685639|P3|Overall Study|Adverse Event|2
1627702|NCT01916967|5685640|P2|Overall Study|Adverse Event|0
1627703|NCT01916967|5685641|P1|Overall Study|Adverse Event|0
1627704|NCT01916824|5685697|P2|Overall Study|Withdrawal by Subject|3
1627705|NCT01916824|5685698|P1|Overall Study|Withdrawal by Subject|2
1627706|NCT01916824|5685697|P2|Overall Study|Physician Decision|0
1627707|NCT01916824|5685698|P1|Overall Study|Physician Decision|2
1627708|NCT01916824|5685697|P2|Overall Study|Lost to Follow-up|6
1627709|NCT01916824|5685698|P1|Overall Study|Lost to Follow-up|3
1627710|NCT01916304|5685780|P1|Overall Study|Screening failure|17
1627711|NCT01916226|5685792|P4|Overall Study|Physician Decision|1
1627712|NCT01916226|5685793|P3|Overall Study|Physician Decision|0
1627713|NCT01916226|5685794|P2|Overall Study|Physician Decision|0
1627714|NCT01916226|5685795|P1|Overall Study|Physician Decision|0
1627715|NCT01916226|5685792|P4|Overall Study|Protocol Violation|1
1627716|NCT01916226|5685793|P3|Overall Study|Protocol Violation|0
1627717|NCT01916226|5685794|P2|Overall Study|Protocol Violation|1
1627718|NCT01916226|5685795|P1|Overall Study|Protocol Violation|0
1627719|NCT01916226|5685792|P4|Overall Study|Lack of Efficacy|1
1627720|NCT01916226|5685793|P3|Overall Study|Lack of Efficacy|2
1627721|NCT01916226|5685794|P2|Overall Study|Lack of Efficacy|0
1627722|NCT01916226|5685795|P1|Overall Study|Lack of Efficacy|0
1627723|NCT01916226|5685792|P4|Overall Study|Adverse Event|1
1627724|NCT01916226|5685793|P3|Overall Study|Adverse Event|1
1627725|NCT01916226|5685794|P2|Overall Study|Adverse Event|0
1627726|NCT01916226|5685795|P1|Overall Study|Adverse Event|1
1627727|NCT01916109|5685829|P1|Overall Study|Withdrawal by Subject|1
1627728|NCT01915940|5685835|P3|Treatment Period|Other Miscellaneous Reasons|0
1627729|NCT01915940|5685836|P2|Treatment Period|Other Miscellaneous Reasons|1
1627730|NCT01915940|5685837|P1|Treatment Period|Other Miscellaneous Reasons|0
1627731|NCT01915940|5685835|P3|Treatment Period|Adverse Event|1
1627732|NCT01915940|5685836|P2|Treatment Period|Adverse Event|9
1627733|NCT01915940|5685837|P1|Treatment Period|Adverse Event|0
1627734|NCT01915940|5685835|P3|Treatment Period|Decision of Participant|3
1627735|NCT01915940|5685836|P2|Treatment Period|Decision of Participant|1
1627736|NCT01915940|5685837|P1|Treatment Period|Decision of Participant|0
1627737|NCT01915940|5685835|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
1627738|NCT01915940|5685836|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
1627739|NCT01915940|5685837|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
1627740|NCT01915914|5685853|P4|Follow-up Phase|Physician Decision|1
1627741|NCT01915914|5685854|P3|Follow-up Phase|Physician Decision|0
1627742|NCT01915914|5685855|P2|Follow-up Phase|Physician Decision|0
1627743|NCT01915914|5685856|P1|Follow-up Phase|Physician Decision|0
1627744|NCT01915914|5685853|P4|Follow-up Phase|Withdrawal by Subject|1
1627745|NCT01915914|5685854|P3|Follow-up Phase|Withdrawal by Subject|0
1627746|NCT01915914|5685855|P2|Follow-up Phase|Withdrawal by Subject|0
1627747|NCT01915914|5685856|P1|Follow-up Phase|Withdrawal by Subject|0
1627748|NCT01915914|5685853|P4|Maintenance Phase|Missing|0
1627749|NCT01915914|5685854|P3|Maintenance Phase|Missing|0
1627750|NCT01915914|5685855|P2|Maintenance Phase|Missing|1
1627751|NCT01915914|5685856|P1|Maintenance Phase|Missing|0
1627752|NCT01915914|5685853|P4|Maintenance Phase|Lost to Follow-up|0
1627753|NCT01915914|5685854|P3|Maintenance Phase|Lost to Follow-up|1
1627754|NCT01915914|5685855|P2|Maintenance Phase|Lost to Follow-up|4
1627755|NCT01915914|5685856|P1|Maintenance Phase|Lost to Follow-up|0
1627756|NCT01915914|5685853|P4|Maintenance Phase|Withdrawal by Subject|0
1627757|NCT01915914|5685854|P3|Maintenance Phase|Withdrawal by Subject|1
1627758|NCT01915914|5685855|P2|Maintenance Phase|Withdrawal by Subject|1
1627759|NCT01915914|5685856|P1|Maintenance Phase|Withdrawal by Subject|0
1627760|NCT01915914|5685853|P4|Acute Phase|Missing|0
1627761|NCT01915914|5685854|P3|Acute Phase|Missing|0
1627762|NCT01915914|5685855|P2|Acute Phase|Missing|0
1627763|NCT01915914|5685856|P1|Acute Phase|Missing|1
1627764|NCT01915914|5685853|P4|Acute Phase|"Not Achieved treatment success"|0
1627765|NCT01915914|5685854|P3|Acute Phase|"Not Achieved treatment success"|0
1627766|NCT01915914|5685855|P2|Acute Phase|"Not Achieved treatment success"|0
1627767|NCT01915914|5685856|P1|Acute Phase|"Not Achieved treatment success"|1
1627768|NCT01915914|5685853|P4|Acute Phase|Accepted Other Topic Therapies|0
1627769|NCT01915914|5685854|P3|Acute Phase|Accepted Other Topic Therapies|0
1627770|NCT01915914|5685855|P2|Acute Phase|Accepted Other Topic Therapies|0
1627771|NCT01915914|5685856|P1|Acute Phase|Accepted Other Topic Therapies|1
1627772|NCT01915914|5685853|P4|Acute Phase|Physician Decision|0
1627773|NCT01915914|5685854|P3|Acute Phase|Physician Decision|0
1627774|NCT01915914|5685855|P2|Acute Phase|Physician Decision|0
1627775|NCT01915914|5685856|P1|Acute Phase|Physician Decision|1
1627776|NCT01915914|5685853|P4|Acute Phase|Lost to Follow-up|0
1627777|NCT01915914|5685854|P3|Acute Phase|Lost to Follow-up|0
1627778|NCT01915914|5685855|P2|Acute Phase|Lost to Follow-up|0
1627779|NCT01915914|5685856|P1|Acute Phase|Lost to Follow-up|4
1627780|NCT01915914|5685853|P4|Acute Phase|Withdrawal by Subject|0
1627781|NCT01915914|5685854|P3|Acute Phase|Withdrawal by Subject|0
1627782|NCT01915914|5685855|P2|Acute Phase|Withdrawal by Subject|0
1627783|NCT01915914|5685856|P1|Acute Phase|Withdrawal by Subject|4
1627784|NCT01915849|5685888|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1627785|NCT01915849|5685889|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1627786|NCT01915849|5685890|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1627787|NCT01915849|5685891|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1627788|NCT01915849|5685888|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
1627789|NCT01915849|5685889|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
1627790|NCT01915849|5685890|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
1627791|NCT01915849|5685891|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
1627792|NCT01915732|5685916|P2|Overall Study|Poor Conscious Effect|1
1627793|NCT01915732|5685917|P1|Overall Study|Poor Conscious Effect|0
1627794|NCT01915732|5685916|P2|Overall Study|Improper Facial Procedure|1
1627795|NCT01915732|5685917|P1|Overall Study|Improper Facial Procedure|0
1627796|NCT01915732|5685916|P2|Overall Study|Job Transfer|1
1627797|NCT01915732|5685917|P1|Overall Study|Job Transfer|0
1627798|NCT01915732|5685916|P2|Overall Study|Par. Refused to Hospital Visits|1
1627799|NCT01915732|5685917|P1|Overall Study|Par. Refused to Hospital Visits|0
1627800|NCT01915732|5685916|P2|Overall Study|Par. not Willing to Continue Treatment|1
1627801|NCT01915732|5685917|P1|Overall Study|Par. not Willing to Continue Treatment|0
1627802|NCT01915732|5685916|P2|Overall Study|Got Well|1
1627803|NCT01915732|5685917|P1|Overall Study|Got Well|0
1627804|NCT01915732|5685916|P2|Overall Study|Par. Unable to Come to the Hospital|1
1627805|NCT01915732|5685917|P1|Overall Study|Par. Unable to Come to the Hospital|0
1627806|NCT01915732|5685916|P2|Overall Study|Poor Perceived Efficacy|0
1627807|NCT01915732|5685917|P1|Overall Study|Poor Perceived Efficacy|1
1627808|NCT01915732|5685916|P2|Overall Study|Pregnancy|0
1627809|NCT01915732|5685917|P1|Overall Study|Pregnancy|1
1627810|NCT01915732|5685916|P2|Overall Study|Recovered|0
1627811|NCT01915732|5685917|P1|Overall Study|Recovered|1
1627812|NCT01915732|5685916|P2|Overall Study|Drug Release Error|0
1627813|NCT01915732|5685917|P1|Overall Study|Drug Release Error|1
1627814|NCT01915732|5685916|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
1627815|NCT01915732|5685917|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
1627816|NCT01915732|5685916|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
1627817|NCT01915732|5685917|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
1627818|NCT01915732|5685916|P2|Overall Study|Lost to Follow-up|26
1627819|NCT01915732|5685917|P1|Overall Study|Lost to Follow-up|22
1627820|NCT01915732|5685916|P2|Overall Study|Lack of Efficacy|11
1627821|NCT01915732|5685917|P1|Overall Study|Lack of Efficacy|6
1627822|NCT01915732|5685916|P2|Overall Study|Protocol Violation|5
1627823|NCT01915732|5685917|P1|Overall Study|Protocol Violation|5
1627824|NCT01915732|5685916|P2|Overall Study|Adverse Event|4
1627825|NCT01915732|5685917|P1|Overall Study|Adverse Event|12
1627826|NCT01915732|5685916|P2|Overall Study|Failure to Meet Randomization Criteria|0
1627827|NCT01915732|5685917|P1|Overall Study|Failure to Meet Randomization Criteria|1
1627828|NCT01915732|5685916|P2|Overall Study|Withdrawal by Subject|18
1627829|NCT01915732|5685917|P1|Overall Study|Withdrawal by Subject|18
1627830|NCT01914926|5685996|P2|Overall Study|uncooperative, agitated and removed|1
1627831|NCT01914926|5685997|P1|Overall Study|uncooperative, agitated and removed|0
1627832|NCT01914926|5685996|P2|Overall Study|Adverse Event|0
1627833|NCT01914926|5685997|P1|Overall Study|Adverse Event|1
1627834|NCT01914757|5686006|P3|Overall Study|Other reasons|4
1627835|NCT01914757|5686007|P2|Overall Study|Other reasons|9
1627836|NCT01914757|5686008|P1|Overall Study|Other reasons|5
1627837|NCT01914757|5686006|P3|Overall Study|Eligibility criteria not fulfilled|2
1627838|NCT01914757|5686007|P2|Overall Study|Eligibility criteria not fulfilled|0
1627839|NCT01914757|5686008|P1|Overall Study|Eligibility criteria not fulfilled|2
1627840|NCT01914757|5686006|P3|Overall Study|Study specific withdrawal criteria|0
1627841|NCT01914757|5686007|P2|Overall Study|Study specific withdrawal criteria|1
1627842|NCT01914757|5686008|P1|Overall Study|Study specific withdrawal criteria|0
1627843|NCT01914757|5686006|P3|Overall Study|Adverse Event|4
1627844|NCT01914757|5686007|P2|Overall Study|Adverse Event|3
1627845|NCT01914757|5686008|P1|Overall Study|Adverse Event|4
1627846|NCT01914757|5686006|P3|Overall Study|Death|1
1627847|NCT01914757|5686007|P2|Overall Study|Death|2
1627848|NCT01914757|5686008|P1|Overall Study|Death|2
1627849|NCT01914757|5686006|P3|Overall Study|Withdrawal by Subject|19
1627850|NCT01914757|5686007|P2|Overall Study|Withdrawal by Subject|27
1627851|NCT01914757|5686008|P1|Overall Study|Withdrawal by Subject|15
1627852|NCT01914757|5686006|P3|Overall Study|Lost to Follow-up|6
1627853|NCT01914757|5686007|P2|Overall Study|Lost to Follow-up|8
1627854|NCT01914757|5686008|P1|Overall Study|Lost to Follow-up|5
1627855|NCT01914757|5686006|P3|Overall Study|Severe non-compliance to protocol|2
1627856|NCT01914757|5686007|P2|Overall Study|Severe non-compliance to protocol|1
1627857|NCT01914757|5686008|P1|Overall Study|Severe non-compliance to protocol|3
1627858|NCT01914679|5686082|P1|Overall Study|Sponsor terminated study|4
1627859|NCT01914679|5686082|P1|Overall Study|Lack of Efficacy|1
1627860|NCT01914666|5686089|P3|Treatment Period|Physician Decision|2
1627861|NCT01914666|5686090|P2|Treatment Period|Physician Decision|0
1627862|NCT01914666|5686091|P1|Treatment Period|Physician Decision|0
1627863|NCT01914666|5686089|P3|Treatment Period|Withdrawal by Subject|2
1627864|NCT01914666|5686090|P2|Treatment Period|Withdrawal by Subject|2
1627865|NCT01914666|5686091|P1|Treatment Period|Withdrawal by Subject|3
1627866|NCT01914666|5686089|P3|Treatment Period|Adverse Event|2
1627867|NCT01914666|5686090|P2|Treatment Period|Adverse Event|4
1627868|NCT01914666|5686091|P1|Treatment Period|Adverse Event|10
1627869|NCT01914666|5686089|P3|Treatment Period|Lack of Efficacy|2
1627870|NCT01914666|5686090|P2|Treatment Period|Lack of Efficacy|0
1627871|NCT01914666|5686091|P1|Treatment Period|Lack of Efficacy|0
1627872|NCT01914393|5686134|P3|Overall Study|subject never dosed|1
1627873|NCT01914393|5686135|P2|Overall Study|subject never dosed|0
1627874|NCT01914393|5686136|P1|Overall Study|subject never dosed|0
1627875|NCT01914393|5686134|P3|Overall Study|Lost to Follow-up|19
1627876|NCT01914393|5686135|P2|Overall Study|Lost to Follow-up|6
1627877|NCT01914393|5686136|P1|Overall Study|Lost to Follow-up|12
1627878|NCT01914393|5686134|P3|Overall Study|Withdrawal by Subject|47
1627879|NCT01914393|5686135|P2|Overall Study|Withdrawal by Subject|20
1627880|NCT01914393|5686136|P1|Overall Study|Withdrawal by Subject|38
1627881|NCT01914393|5686134|P3|Overall Study|Adverse Event|31
1627882|NCT01914393|5686135|P2|Overall Study|Adverse Event|18
1627883|NCT01914393|5686136|P1|Overall Study|Adverse Event|29
1627884|NCT01914393|5686134|P3|Overall Study|no reason given|16
1627885|NCT01914393|5686135|P2|Overall Study|no reason given|8
1627886|NCT01914393|5686136|P1|Overall Study|no reason given|14
1627887|NCT01914393|5686134|P3|Overall Study|Lack of Efficacy|5
1627888|NCT01914393|5686135|P2|Overall Study|Lack of Efficacy|16
1627889|NCT01914393|5686136|P1|Overall Study|Lack of Efficacy|11
1627890|NCT01914393|5686134|P3|Overall Study|Protocol Violation|19
1627891|NCT01914393|5686135|P2|Overall Study|Protocol Violation|3
1627892|NCT01914393|5686136|P1|Overall Study|Protocol Violation|11
1627893|NCT01913483|5686263|P2|Overall Study|Death|17
1627894|NCT01913483|5686264|P1|Overall Study|Death|14
1627895|NCT01913483|5686263|P2|Overall Study|Lost to Follow-up|3
1627896|NCT01913483|5686264|P1|Overall Study|Lost to Follow-up|6
1627897|NCT01913483|5686263|P2|Overall Study|Withdrawal by Subject|2
1627898|NCT01913483|5686264|P1|Overall Study|Withdrawal by Subject|1
1627899|NCT01913470|5686276|P2|Overall Study|Withdrawal by Subject|1
1627900|NCT01913470|5686277|P1|Overall Study|Withdrawal by Subject|0
1627901|NCT01913470|5686276|P2|Overall Study|Physician Decision|1
1627902|NCT01913470|5686277|P1|Overall Study|Physician Decision|0
1627903|NCT01913470|5686276|P2|Overall Study|Lost to Follow-up|1
1627904|NCT01913470|5686277|P1|Overall Study|Lost to Follow-up|0
1627905|NCT01913405|5686295|P1|Overall Study|Adverse Event|1
1627906|NCT01913405|5686295|P1|Overall Study|Withdrawal by Subject|1
1627907|NCT01913353|5686351|P2|Overall Study|multiple reasons|7
1627908|NCT01913353|5686352|P1|Overall Study|multiple reasons|10
1627909|NCT01913353|5686351|P2|Overall Study|Withdrawal by Subject|6
1627910|NCT01913353|5686352|P1|Overall Study|Withdrawal by Subject|20
1627911|NCT01913353|5686351|P2|Overall Study|Physician Decision|2
1627912|NCT01913353|5686352|P1|Overall Study|Physician Decision|0
1627913|NCT01913353|5686351|P2|Overall Study|Adverse Event|0
1627914|NCT01913353|5686352|P1|Overall Study|Adverse Event|2
1627915|NCT01913041|5686433|P1|Overall Study|Physician Decision|1
1627916|NCT01913041|5686433|P1|Overall Study|Withdrawal by Subject|3
1627917|NCT01913041|5686433|P1|Overall Study|Protocol Violation|35
1627918|NCT01912963|5686440|P3|Overall Study|Sought treatment locally|0
1627919|NCT01912963|5686441|P2|Overall Study|Sought treatment locally|1
1627920|NCT01912963|5686442|P1|Overall Study|Sought treatment locally|0
1627921|NCT01912963|5686440|P3|Overall Study|Withdrawal by Subject|0
1627922|NCT01912963|5686441|P2|Overall Study|Withdrawal by Subject|1
1627923|NCT01912963|5686442|P1|Overall Study|Withdrawal by Subject|0
1627924|NCT01912963|5686440|P3|Overall Study|Adverse Event|1
1627925|NCT01912963|5686441|P2|Overall Study|Adverse Event|1
1627926|NCT01912963|5686442|P1|Overall Study|Adverse Event|0
1627927|NCT01912963|5686440|P3|Overall Study|Disease Progression (not RECIST1.1)|1
1627928|NCT01912963|5686441|P2|Overall Study|Disease Progression (not RECIST1.1)|7
1627929|NCT01912963|5686442|P1|Overall Study|Disease Progression (not RECIST1.1)|0
1627930|NCT01912963|5686440|P3|Overall Study|Disease Progression (RECIST1.1)|5
1627931|NCT01912963|5686441|P2|Overall Study|Disease Progression (RECIST1.1)|9
1627932|NCT01912963|5686442|P1|Overall Study|Disease Progression (RECIST1.1)|6
1627933|NCT01912872|5686465|P4|Overall Study|Missing|1
1627934|NCT01912872|5686466|P3|Overall Study|Missing|0
1627935|NCT01912872|5686467|P2|Overall Study|Missing|0
1627936|NCT01912872|5686468|P1|Overall Study|Missing|0
1627937|NCT01912872|5686465|P4|Overall Study|Withdrawal of study medication|2
1627938|NCT01912872|5686466|P3|Overall Study|Withdrawal of study medication|0
1627939|NCT01912872|5686467|P2|Overall Study|Withdrawal of study medication|0
1627940|NCT01912872|5686468|P1|Overall Study|Withdrawal of study medication|0
1627941|NCT01912872|5686465|P4|Overall Study|Unsatisfactory therapeutic effect|2
1627942|NCT01912872|5686466|P3|Overall Study|Unsatisfactory therapeutic effect|0
1627943|NCT01912872|5686467|P2|Overall Study|Unsatisfactory therapeutic effect|0
1627944|NCT01912872|5686468|P1|Overall Study|Unsatisfactory therapeutic effect|0
1627945|NCT01912872|5686465|P4|Overall Study|Protocol Violation|0
1627946|NCT01912872|5686466|P3|Overall Study|Protocol Violation|1
1627947|NCT01912872|5686467|P2|Overall Study|Protocol Violation|0
1627948|NCT01912872|5686468|P1|Overall Study|Protocol Violation|0
1627949|NCT01912872|5686465|P4|Overall Study|Non-compliance with lab inc/exclusion|1
1627950|NCT01912872|5686466|P3|Overall Study|Non-compliance with lab inc/exclusion|0
1627951|NCT01912872|5686467|P2|Overall Study|Non-compliance with lab inc/exclusion|0
1627952|NCT01912872|5686468|P1|Overall Study|Non-compliance with lab inc/exclusion|0
1627953|NCT01912872|5686465|P4|Overall Study|Informed consent withdrawn|1
1627954|NCT01912872|5686466|P3|Overall Study|Informed consent withdrawn|1
1627955|NCT01912872|5686467|P2|Overall Study|Informed consent withdrawn|0
1627956|NCT01912872|5686468|P1|Overall Study|Informed consent withdrawn|0
1627957|NCT01912872|5686465|P4|Overall Study|Other unspecified|0
1627958|NCT01912872|5686466|P3|Overall Study|Other unspecified|3
1627959|NCT01912872|5686467|P2|Overall Study|Other unspecified|1
1627960|NCT01912872|5686468|P1|Overall Study|Other unspecified|3
1627961|NCT01912872|5686465|P4|Overall Study|Lost to Follow-up|5
1627962|NCT01912872|5686466|P3|Overall Study|Lost to Follow-up|5
1627963|NCT01912872|5686467|P2|Overall Study|Lost to Follow-up|3
1627964|NCT01912872|5686468|P1|Overall Study|Lost to Follow-up|2
1627965|NCT01912781|5686512|P2|Overall Study|Withdrawal by Subject|0
1627966|NCT01912781|5686513|P1|Overall Study|Withdrawal by Subject|2
1627967|NCT01912768|5686544|P2|Overall Study|Randomized in error|0
1627968|NCT01912768|5686545|P1|Overall Study|Randomized in error|1
1627969|NCT01912768|5686544|P2|Overall Study|Withdrawal by Subject|3
1627970|NCT01912768|5686545|P1|Overall Study|Withdrawal by Subject|5
1627971|NCT01912768|5686544|P2|Overall Study|Lost to Follow-up|1
1627972|NCT01912768|5686545|P1|Overall Study|Lost to Follow-up|2
1627973|NCT01912768|5686544|P2|Overall Study|Adverse Event|0
1627974|NCT01912768|5686545|P1|Overall Study|Adverse Event|2
1627975|NCT01912729|5686576|P2|Overall Study|Withdrawal by Subject|1
1627976|NCT01912729|5686577|P1|Overall Study|Withdrawal by Subject|0
1627977|NCT01912599|5686600|P2|Overall Study|Withdrawal by Subject|1
1627978|NCT01912599|5686601|P1|Overall Study|Withdrawal by Subject|0
1627979|NCT01912404|5686626|P2|Overall Study|Due to personal reasons|0
1627980|NCT01912404|5686627|P1|Overall Study|Due to personal reasons|1
1628020|NCT01912222|5686659|P3|Part B: Treatment Period|Withdrawal by Subject|2
1628021|NCT01912222|5686660|P2|Part B: Treatment Period|Withdrawal by Subject|1
1628022|NCT01912222|5686661|P1|Part B: Treatment Period|Withdrawal by Subject|2
1628023|NCT01912222|5686659|P3|Part B: Treatment Period|Adverse Event|3
1628024|NCT01912222|5686660|P2|Part B: Treatment Period|Adverse Event|2
1628025|NCT01912222|5686661|P1|Part B: Treatment Period|Adverse Event|1
1628026|NCT01912222|5686659|P3|Part B: Treatment Period|Progressive disease|15
1628027|NCT01912222|5686660|P2|Part B: Treatment Period|Progressive disease|12
1628028|NCT01912222|5686661|P1|Part B: Treatment Period|Progressive disease|10
1628029|NCT01912222|5686659|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1628030|NCT01912222|5686660|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
1628031|NCT01912222|5686661|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
1628032|NCT01911845|5686684|P1|Overall Study|Other (not specified)|3
1628033|NCT01911845|5686684|P1|Overall Study|Lost to Follow-up|1
1628034|NCT01911845|5686684|P1|Overall Study|Adverse Event|2
1628035|NCT01911819|5686701|P3|Overall Study|Withdrawal by Subject|0
1628036|NCT01911819|5686702|P2|Overall Study|Withdrawal by Subject|1
1628037|NCT01911819|5686703|P1|Overall Study|Withdrawal by Subject|1
1628038|NCT01911819|5686701|P3|Overall Study|Adverse Event|0
1628039|NCT01911819|5686702|P2|Overall Study|Adverse Event|1
1628040|NCT01911819|5686703|P1|Overall Study|Adverse Event|0
1628041|NCT01911793|5686716|P2|Overall Study|Physician Decision|5
1628042|NCT01911793|5686717|P1|Overall Study|Physician Decision|1
1628043|NCT01911780|5686741|P2|Extension Period (52 Weeks)|Personal reason|1
1628044|NCT01911780|5686742|P1|Extension Period (52 Weeks)|Personal reason|1
1628045|NCT01911780|5686741|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
1628046|NCT01911780|5686742|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
1628047|NCT01911780|5686741|P2|Extension Period (52 Weeks)|Adverse Event|0
1628048|NCT01911780|5686742|P1|Extension Period (52 Weeks)|Adverse Event|3
1628049|NCT01911780|5686741|P2|Double-blind Period (8 Weeks)|Personal reason|0
1628050|NCT01911780|5686742|P1|Double-blind Period (8 Weeks)|Personal reason|1
1628051|NCT01911780|5686741|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1628052|NCT01911780|5686742|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
1628053|NCT01911780|5686741|P2|Double-blind Period (8 Weeks)|Adverse Event|2
1628054|NCT01911780|5686742|P1|Double-blind Period (8 Weeks)|Adverse Event|1
1628055|NCT01911546|5686776|P1|Overall Study|Everolimus was discontinued|5
1628056|NCT01911546|5686776|P1|Overall Study|Lost to Follow-up|1
1628057|NCT01911442|5686786|P3|Overall Study|Mother's Work Schedule|0
1628058|NCT01911442|5686787|P2|Overall Study|Mother's Work Schedule|1
1628059|NCT01911442|5686788|P1|Overall Study|Mother's Work Schedule|0
1628060|NCT01911442|5686786|P3|Overall Study|Withdrawal by Subject|6
1628061|NCT01911442|5686787|P2|Overall Study|Withdrawal by Subject|0
1628062|NCT01911442|5686788|P1|Overall Study|Withdrawal by Subject|1
1628063|NCT01911442|5686786|P3|Overall Study|Lost to Follow-up|1
1628064|NCT01911442|5686787|P2|Overall Study|Lost to Follow-up|0
1628065|NCT01911442|5686788|P1|Overall Study|Lost to Follow-up|2
1628066|NCT01911442|5686786|P3|Overall Study|Lack of Efficacy|1
1628067|NCT01911442|5686787|P2|Overall Study|Lack of Efficacy|1
1628068|NCT01911442|5686788|P1|Overall Study|Lack of Efficacy|1
1628069|NCT01911442|5686786|P3|Overall Study|Adverse Event|4
1628070|NCT01911442|5686787|P2|Overall Study|Adverse Event|2
1628071|NCT01911442|5686788|P1|Overall Study|Adverse Event|2
1628072|NCT01911429|5686817|P3|Overall Study|subject left study|0
1628073|NCT01911429|5686818|P2|Overall Study|subject left study|0
1628074|NCT01911429|5686819|P1|Overall Study|subject left study|1
1628075|NCT01911429|5686817|P3|Overall Study|Accidental randomization|1
1628076|NCT01911429|5686818|P2|Overall Study|Accidental randomization|0
1628077|NCT01911429|5686819|P1|Overall Study|Accidental randomization|0
1628078|NCT01911429|5686817|P3|Overall Study|Withdrawal by Subject|4
1628079|NCT01911429|5686818|P2|Overall Study|Withdrawal by Subject|5
1628080|NCT01911429|5686819|P1|Overall Study|Withdrawal by Subject|5
1628081|NCT01911429|5686817|P3|Overall Study|Protocol Violation|1
1628082|NCT01911429|5686818|P2|Overall Study|Protocol Violation|0
1628083|NCT01911429|5686819|P1|Overall Study|Protocol Violation|0
1628084|NCT01911429|5686817|P3|Overall Study|Lost to Follow-up|1
1628085|NCT01911429|5686818|P2|Overall Study|Lost to Follow-up|0
1628086|NCT01911429|5686819|P1|Overall Study|Lost to Follow-up|0
1628087|NCT01911429|5686817|P3|Overall Study|Lack of Efficacy|4
1628088|NCT01911429|5686818|P2|Overall Study|Lack of Efficacy|2
1628089|NCT01911429|5686819|P1|Overall Study|Lack of Efficacy|1
1628090|NCT01911429|5686817|P3|Overall Study|Adverse Event|9
1628091|NCT01911429|5686818|P2|Overall Study|Adverse Event|3
1628092|NCT01911429|5686819|P1|Overall Study|Adverse Event|5
1628093|NCT01911273|5686911|P2|Overall Study|Withdrawal by Subject|2
1628094|NCT01911273|5686912|P1|Overall Study|Withdrawal by Subject|0
1628095|NCT01911273|5686911|P2|Overall Study|Progression of Disease|0
1628096|NCT01911273|5686912|P1|Overall Study|Progression of Disease|1
1628097|NCT01911260|5686946|P4|Follow-up Period|transference or evasion of school|12
1628098|NCT01911260|5686947|P3|Follow-up Period|transference or evasion of school|15
1628099|NCT01911260|5686948|P2|Follow-up Period|transference or evasion of school|20
1628100|NCT01911260|5686949|P1|Follow-up Period|transference or evasion of school|13
1628101|NCT01911260|5686946|P4|Supplementation Period|less than 12 weeks supplementation|2
1628102|NCT01911260|5686947|P3|Supplementation Period|less than 12 weeks supplementation|1
1628103|NCT01911260|5686948|P2|Supplementation Period|less than 12 weeks supplementation|3
1628104|NCT01911260|5686949|P1|Supplementation Period|less than 12 weeks supplementation|0
1628105|NCT01911260|5686946|P4|Supplementation Period|refused to receive supplement|0
1628106|NCT01911260|5686947|P3|Supplementation Period|refused to receive supplement|1
1628107|NCT01911260|5686948|P2|Supplementation Period|refused to receive supplement|0
1628108|NCT01911260|5686949|P1|Supplementation Period|refused to receive supplement|1
1628109|NCT01911260|5686946|P4|Supplementation Period|Adverse Event|0
1628110|NCT01911260|5686947|P3|Supplementation Period|Adverse Event|1
1628111|NCT01911260|5686948|P2|Supplementation Period|Adverse Event|0
1628112|NCT01911260|5686949|P1|Supplementation Period|Adverse Event|2
1628113|NCT01911260|5686946|P4|Supplementation Period|transference or evasion of school|6
1628114|NCT01911260|5686947|P3|Supplementation Period|transference or evasion of school|7
1628115|NCT01911260|5686948|P2|Supplementation Period|transference or evasion of school|9
1628116|NCT01911260|5686949|P1|Supplementation Period|transference or evasion of school|7
1628117|NCT01910519|5687035|P2|Overall Study|Adverse Event|0
1628118|NCT01910519|5687036|P1|Overall Study|Adverse Event|2
1628119|NCT01910519|5687035|P2|Overall Study|Withdrawal by Subject|0
1628120|NCT01910519|5687036|P1|Overall Study|Withdrawal by Subject|2
1628121|NCT01910441|5687062|P2|Overall Study|Physician Decision|1
1628122|NCT01910441|5687063|P1|Overall Study|Physician Decision|0
1628123|NCT01910441|5687062|P2|Overall Study|Adverse Event|0
1628124|NCT01910441|5687063|P1|Overall Study|Adverse Event|1
1628125|NCT01910441|5687062|P2|Overall Study|Non-compliance|1
1628126|NCT01910441|5687063|P1|Overall Study|Non-compliance|0
1628127|NCT01910441|5687062|P2|Overall Study|Withdrawal by Subject|1
1628128|NCT01910441|5687063|P1|Overall Study|Withdrawal by Subject|0
1628129|NCT01910441|5687062|P2|Overall Study|Lost to Follow-up|5
1628130|NCT01910441|5687063|P1|Overall Study|Lost to Follow-up|6
1628131|NCT01910441|5687062|P2|Overall Study|Sponsor decision|2
1628132|NCT01910441|5687063|P1|Overall Study|Sponsor decision|0
1628133|NCT01910402|5687071|P2|Continuation Phase|Withdrawal by Subject|0
1628134|NCT01910402|5687072|P1|Continuation Phase|Withdrawal by Subject|2
1628135|NCT01910402|5687071|P2|Continuation Phase|Protocol Violation|0
1628136|NCT01910402|5687072|P1|Continuation Phase|Protocol Violation|3
1628137|NCT01910402|5687071|P2|Continuation Phase|Adverse Event|0
1628138|NCT01910402|5687072|P1|Continuation Phase|Adverse Event|1
1628139|NCT01910402|5687071|P2|Continuation Phase|Ongoing|0
1628140|NCT01910402|5687072|P1|Continuation Phase|Ongoing|84
1628141|NCT01910402|5687071|P2|Randomized Phase|Withdrawal by Subject|7
1628142|NCT01910402|5687072|P1|Randomized Phase|Withdrawal by Subject|5
1628143|NCT01910402|5687071|P2|Randomized Phase|Protocol Violation|13
1628144|NCT01910402|5687072|P1|Randomized Phase|Protocol Violation|10
1628145|NCT01910402|5687071|P2|Randomized Phase|Lost to Follow-up|13
1628146|NCT01910402|5687072|P1|Randomized Phase|Lost to Follow-up|11
1628147|NCT01910402|5687071|P2|Randomized Phase|Lack of Efficacy|4
1628148|NCT01910402|5687072|P1|Randomized Phase|Lack of Efficacy|5
1628149|NCT01910402|5687071|P2|Randomized Phase|Physician Decision|0
1628150|NCT01910402|5687072|P1|Randomized Phase|Physician Decision|1
1628151|NCT01910402|5687071|P2|Randomized Phase|Adverse Event|18
1628152|NCT01910402|5687072|P1|Randomized Phase|Adverse Event|10
1628153|NCT01910389|5687142|P2|Overall Study|Study Closed|8
1628154|NCT01910389|5687143|P1|Overall Study|Study Closed|13
1628155|NCT01910389|5687142|P2|Overall Study|Withdrawal by Subject|0
1628156|NCT01910389|5687143|P1|Overall Study|Withdrawal by Subject|2
1628157|NCT01910298|5687186|P2|Overall Study|Other Miscellaneous Reasons|2
1628158|NCT01910298|5687187|P1|Overall Study|Other Miscellaneous Reasons|0
1628159|NCT01910298|5687186|P2|Overall Study|Study Terminated by Sponsor|17
1628160|NCT01910298|5687187|P1|Overall Study|Study Terminated by Sponsor|1
1628161|NCT01910298|5687186|P2|Overall Study|Lost to Follow-up|1
1628162|NCT01910298|5687187|P1|Overall Study|Lost to Follow-up|1
1628163|NCT01910298|5687186|P2|Overall Study|Protocol Deviation|5
1628164|NCT01910298|5687187|P1|Overall Study|Protocol Deviation|0
1628165|NCT01910298|5687186|P2|Overall Study|Withdrawal by Subject|7
1628166|NCT01910298|5687187|P1|Overall Study|Withdrawal by Subject|2
1628167|NCT01910298|5687186|P2|Overall Study|Adverse Event|0
1628168|NCT01910298|5687187|P1|Overall Study|Adverse Event|1
1628169|NCT01910181|5687205|P1|Overall Study|Study Terminated by Sponsor|6
1628170|NCT01910181|5687205|P1|Overall Study|Lost to Follow-up|3
1628171|NCT01910181|5687205|P1|Overall Study|Death|37
1628172|NCT01910129|5687232|P3|Randomized Phase 3|Withdrawal by Subject|0
1628173|NCT01910129|5687233|P2|Randomized Phase 3|Withdrawal by Subject|1
1628174|NCT01910129|5687234|P1|Randomized Phase 3|Withdrawal by Subject|0
1628175|NCT01910129|5687232|P3|Randomized Phase 2|Withdrawal by Subject|0
1628176|NCT01910129|5687233|P2|Randomized Phase 2|Withdrawal by Subject|1
1628177|NCT01910129|5687234|P1|Randomized Phase 2|Withdrawal by Subject|2
1628178|NCT01910116|5687258|P2|Overall Study|incomplete data|1
1628179|NCT01910116|5687259|P1|Overall Study|incomplete data|0
1628180|NCT01910116|5687258|P2|Overall Study|uncertain allocation|3
1628181|NCT01910116|5687259|P1|Overall Study|uncertain allocation|1
1628182|NCT01910116|5687258|P2|Overall Study|Withdrawal by Subject|3
1628183|NCT01910116|5687259|P1|Overall Study|Withdrawal by Subject|8
1628184|NCT01910116|5687258|P2|Overall Study|Protocol Violation|2
1628185|NCT01910116|5687259|P1|Overall Study|Protocol Violation|1
1628186|NCT01910116|5687258|P2|Overall Study|Lost to Follow-up|0
1628187|NCT01910116|5687259|P1|Overall Study|Lost to Follow-up|1
1628188|NCT01910116|5687258|P2|Overall Study|Lack of Efficacy|4
1628189|NCT01910116|5687259|P1|Overall Study|Lack of Efficacy|3
1628190|NCT01910116|5687258|P2|Overall Study|Adverse Event|3
1628191|NCT01910116|5687259|P1|Overall Study|Adverse Event|0
1628192|NCT01909973|5687346|P2|Overall Study|Lost to Follow-up|0
1628193|NCT01909973|5687347|P1|Overall Study|Lost to Follow-up|1
1628194|NCT01909804|5687367|P12|Overall Study|Protocol Violation|1
1628195|NCT01909804|5687368|P11|Overall Study|Protocol Violation|0
1628196|NCT01909804|5687369|P10|Overall Study|Protocol Violation|0
1628197|NCT01909804|5687370|P9|Overall Study|Protocol Violation|0
1628198|NCT01909804|5687371|P8|Overall Study|Protocol Violation|0
1628199|NCT01909804|5687372|P7|Overall Study|Protocol Violation|0
1628200|NCT01909804|5687373|P6|Overall Study|Protocol Violation|0
1628201|NCT01909804|5687374|P5|Overall Study|Protocol Violation|0
1628202|NCT01909804|5687375|P4|Overall Study|Protocol Violation|0
1628203|NCT01909804|5687376|P3|Overall Study|Protocol Violation|0
1628204|NCT01909804|5687377|P2|Overall Study|Protocol Violation|0
1628205|NCT01909804|5687378|P1|Overall Study|Protocol Violation|0
1628206|NCT01909804|5687367|P12|Overall Study|Withdrew Consent|0
1628207|NCT01909804|5687368|P11|Overall Study|Withdrew Consent|0
1628208|NCT01909804|5687369|P10|Overall Study|Withdrew Consent|0
1628209|NCT01909804|5687370|P9|Overall Study|Withdrew Consent|0
1628210|NCT01909804|5687371|P8|Overall Study|Withdrew Consent|0
1628211|NCT01909804|5687372|P7|Overall Study|Withdrew Consent|0
1628212|NCT01909804|5687373|P6|Overall Study|Withdrew Consent|1
1628213|NCT01909804|5687374|P5|Overall Study|Withdrew Consent|1
1628214|NCT01909804|5687375|P4|Overall Study|Withdrew Consent|0
1628215|NCT01909804|5687376|P3|Overall Study|Withdrew Consent|0
1628216|NCT01909804|5687377|P2|Overall Study|Withdrew Consent|0
1628217|NCT01909804|5687378|P1|Overall Study|Withdrew Consent|0
1628218|NCT01909804|5687367|P12|Overall Study|Lack of Efficacy|1
1628219|NCT01909804|5687368|P11|Overall Study|Lack of Efficacy|0
1628220|NCT01909804|5687369|P10|Overall Study|Lack of Efficacy|1
1628221|NCT01909804|5687370|P9|Overall Study|Lack of Efficacy|0
1628222|NCT01909804|5687371|P8|Overall Study|Lack of Efficacy|1
1628223|NCT01909804|5687372|P7|Overall Study|Lack of Efficacy|1
1628224|NCT01909804|5687373|P6|Overall Study|Lack of Efficacy|3
1628225|NCT01909804|5687374|P5|Overall Study|Lack of Efficacy|7
1628226|NCT01909804|5687375|P4|Overall Study|Lack of Efficacy|0
1628227|NCT01909804|5687376|P3|Overall Study|Lack of Efficacy|0
1628228|NCT01909804|5687377|P2|Overall Study|Lack of Efficacy|1
1628229|NCT01909804|5687378|P1|Overall Study|Lack of Efficacy|4
1628230|NCT01909804|5687367|P12|Overall Study|Death|0
1628231|NCT01909804|5687368|P11|Overall Study|Death|1
1628232|NCT01909804|5687369|P10|Overall Study|Death|0
1628233|NCT01909804|5687370|P9|Overall Study|Death|0
1628234|NCT01909804|5687371|P8|Overall Study|Death|0
1628235|NCT01909804|5687372|P7|Overall Study|Death|0
1628236|NCT01909804|5687373|P6|Overall Study|Death|0
1628237|NCT01909804|5687374|P5|Overall Study|Death|0
1628238|NCT01909804|5687375|P4|Overall Study|Death|0
1628239|NCT01909804|5687376|P3|Overall Study|Death|0
1628240|NCT01909804|5687377|P2|Overall Study|Death|0
1628241|NCT01909804|5687378|P1|Overall Study|Death|0
1628242|NCT01909804|5687367|P12|Overall Study|Randomized but Never Treated|1
1628243|NCT01909804|5687368|P11|Overall Study|Randomized but Never Treated|0
1628244|NCT01909804|5687369|P10|Overall Study|Randomized but Never Treated|0
1628245|NCT01909804|5687370|P9|Overall Study|Randomized but Never Treated|0
1628246|NCT01909804|5687371|P8|Overall Study|Randomized but Never Treated|0
1628247|NCT01909804|5687372|P7|Overall Study|Randomized but Never Treated|1
1628248|NCT01909804|5687373|P6|Overall Study|Randomized but Never Treated|0
1628249|NCT01909804|5687374|P5|Overall Study|Randomized but Never Treated|0
1628250|NCT01909804|5687375|P4|Overall Study|Randomized but Never Treated|0
1628251|NCT01909804|5687376|P3|Overall Study|Randomized but Never Treated|0
1628252|NCT01909804|5687377|P2|Overall Study|Randomized but Never Treated|0
1628253|NCT01909804|5687378|P1|Overall Study|Randomized but Never Treated|0
1628254|NCT01909791|5687427|P3|Overall Study|Missed Visit|1
1628255|NCT01909791|5687428|P2|Overall Study|Missed Visit|0
1628256|NCT01909791|5687429|P1|Overall Study|Missed Visit|2
1628257|NCT01909791|5687427|P3|Overall Study|Lost to Follow-up|10
1628258|NCT01909791|5687428|P2|Overall Study|Lost to Follow-up|11
1628259|NCT01909791|5687429|P1|Overall Study|Lost to Follow-up|5
1628260|NCT01909791|5687427|P3|Overall Study|Withdrawal by Subject|13
1628261|NCT01909791|5687428|P2|Overall Study|Withdrawal by Subject|9
1628262|NCT01909791|5687429|P1|Overall Study|Withdrawal by Subject|5
1628263|NCT01909791|5687427|P3|Overall Study|Death|4
1628264|NCT01909791|5687428|P2|Overall Study|Death|8
1628265|NCT01909791|5687429|P1|Overall Study|Death|9
1628266|NCT01909778|5687487|P1|Overall Study|failed screening|1
1628267|NCT01909674|5687566|P2|Overall Study|Withdrawal by Subject|2
1628268|NCT01909674|5687567|P1|Overall Study|Withdrawal by Subject|5
1628269|NCT01909466|5687586|P2|Overall Study|Lack of Efficacy|0
1628270|NCT01909466|5687587|P1|Overall Study|Lack of Efficacy|1
1628271|NCT01909466|5687586|P2|Overall Study|Withdrawal by Subject|9
1628272|NCT01909466|5687587|P1|Overall Study|Withdrawal by Subject|11
1628273|NCT01909466|5687586|P2|Overall Study|Physician Decision|0
1628274|NCT01909466|5687587|P1|Overall Study|Physician Decision|2
1628275|NCT01909466|5687586|P2|Overall Study|Met Withdrawal Criteria|3
1628276|NCT01909466|5687587|P1|Overall Study|Met Withdrawal Criteria|0
1628277|NCT01909466|5687586|P2|Overall Study|Adverse Event|4
1628278|NCT01909466|5687587|P1|Overall Study|Adverse Event|3
1628279|NCT01909466|5687586|P2|Overall Study|Lost to Follow-up|7
1628280|NCT01909466|5687587|P1|Overall Study|Lost to Follow-up|5
1628281|NCT01909336|5687610|P3|Overall Study|Physician Decision|1
1628282|NCT01909336|5687611|P2|Overall Study|Physician Decision|1
1628283|NCT01909336|5687612|P1|Overall Study|Physician Decision|0
1628284|NCT01909336|5687610|P3|Overall Study|Lost to Follow-up|2
1628285|NCT01909336|5687611|P2|Overall Study|Lost to Follow-up|2
1628286|NCT01909336|5687612|P1|Overall Study|Lost to Follow-up|4
1628287|NCT01908907|5687710|P2|Overall Study|Protocol Violation|0
1628288|NCT01908907|5687711|P1|Overall Study|Protocol Violation|1
1628289|NCT01908907|5687710|P2|Overall Study|Physician Decision|0
1628290|NCT01908907|5687711|P1|Overall Study|Physician Decision|1
1628291|NCT01908829|5687755|P3|Overall Study|Withdrawal by Subject|22
1628292|NCT01908829|5687756|P2|Overall Study|Withdrawal by Subject|29
1628293|NCT01908829|5687757|P1|Overall Study|Withdrawal by Subject|26
1628294|NCT01908829|5687755|P3|Overall Study|Lack of Efficacy|2
1628295|NCT01908829|5687756|P2|Overall Study|Lack of Efficacy|3
1628296|NCT01908829|5687757|P1|Overall Study|Lack of Efficacy|1
1628297|NCT01908829|5687755|P3|Overall Study|Protocol Violation|0
1628298|NCT01908829|5687756|P2|Overall Study|Protocol Violation|2
1628299|NCT01908829|5687757|P1|Overall Study|Protocol Violation|2
1628300|NCT01908829|5687755|P3|Overall Study|Miscellaneous|0
1628301|NCT01908829|5687756|P2|Overall Study|Miscellaneous|2
1628302|NCT01908829|5687757|P1|Overall Study|Miscellaneous|0
1628303|NCT01908829|5687755|P3|Overall Study|Discontinued (no EoT page)|0
1628304|NCT01908829|5687756|P2|Overall Study|Discontinued (no EoT page)|0
1628305|NCT01908829|5687757|P1|Overall Study|Discontinued (no EoT page)|2
1628306|NCT01908829|5687755|P3|Overall Study|Randomized no double-blind drug received|1
1628307|NCT01908829|5687756|P2|Overall Study|Randomized no double-blind drug received|0
1628308|NCT01908829|5687757|P1|Overall Study|Randomized no double-blind drug received|1
1628309|NCT01908829|5687755|P3|Overall Study|Lost to Follow-up|1
1628310|NCT01908829|5687756|P2|Overall Study|Lost to Follow-up|2
1628311|NCT01908829|5687757|P1|Overall Study|Lost to Follow-up|4
1628312|NCT01908829|5687755|P3|Overall Study|Adverse Event|13
1628313|NCT01908829|5687756|P2|Overall Study|Adverse Event|11
1628314|NCT01908829|5687757|P1|Overall Study|Adverse Event|13
1628315|NCT01908816|5687874|P4|Overall Study|Early termination|28
1628316|NCT01908816|5687875|P3|Overall Study|Early termination|43
1628317|NCT01908816|5687876|P2|Overall Study|Early termination|60
1628318|NCT01908816|5687877|P1|Overall Study|Early termination|87
1628319|NCT01908816|5687874|P4|Overall Study|Unsatisfactory therapeutic effect|0
1628320|NCT01908816|5687875|P3|Overall Study|Unsatisfactory therapeutic effect|1
1628321|NCT01908816|5687876|P2|Overall Study|Unsatisfactory therapeutic effect|13
1628322|NCT01908816|5687877|P1|Overall Study|Unsatisfactory therapeutic effect|1
1628323|NCT01908816|5687874|P4|Overall Study|Death|1
1628324|NCT01908816|5687875|P3|Overall Study|Death|7
1628325|NCT01908816|5687876|P2|Overall Study|Death|0
1628326|NCT01908816|5687877|P1|Overall Study|Death|1
1628327|NCT01908816|5687874|P4|Overall Study|Lost to Follow-up|2
1628328|NCT01908816|5687875|P3|Overall Study|Lost to Follow-up|4
1628329|NCT01908816|5687876|P2|Overall Study|Lost to Follow-up|5
1628330|NCT01908816|5687877|P1|Overall Study|Lost to Follow-up|3
1628331|NCT01908816|5687874|P4|Overall Study|Withdrawal by Subject|2
1628332|NCT01908816|5687875|P3|Overall Study|Withdrawal by Subject|2
1628333|NCT01908816|5687876|P2|Overall Study|Withdrawal by Subject|4
1628334|NCT01908816|5687877|P1|Overall Study|Withdrawal by Subject|0
1628335|NCT01908816|5687874|P4|Overall Study|Protocol deviation|1
1628336|NCT01908816|5687875|P3|Overall Study|Protocol deviation|1
1628337|NCT01908816|5687876|P2|Overall Study|Protocol deviation|2
1628338|NCT01908816|5687877|P1|Overall Study|Protocol deviation|1
1628339|NCT01908816|5687874|P4|Overall Study|Subject's no longer requires study drug|1
1628340|NCT01908816|5687875|P3|Overall Study|Subject's no longer requires study drug|0
1628341|NCT01908816|5687876|P2|Overall Study|Subject's no longer requires study drug|0
1628342|NCT01908816|5687877|P1|Overall Study|Subject's no longer requires study drug|0
1628343|NCT01908803|5687902|P2|Overall Study|Adverse Event (pre-treatment)|0
1628344|NCT01908803|5687903|P1|Overall Study|Adverse Event (pre-treatment)|1
1628345|NCT01908803|5687902|P2|Overall Study|Randomization Error|0
1628346|NCT01908803|5687903|P1|Overall Study|Randomization Error|1
1628347|NCT01908803|5687902|P2|Overall Study|Withdrawal by Subject|0
1628348|NCT01908803|5687903|P1|Overall Study|Withdrawal by Subject|1
1628349|NCT01908803|5687902|P2|Overall Study|Physician Decision|1
1628350|NCT01908803|5687903|P1|Overall Study|Physician Decision|0
1628351|NCT01908803|5687902|P2|Overall Study|Adverse Event|0
1628352|NCT01908803|5687903|P1|Overall Study|Adverse Event|1
1628353|NCT01908582|5687914|P1|Period 2|Withdrawal by Subject|1
1628354|NCT01908582|5687914|P1|Period 2|Physician Decision|1
1628355|NCT01908426|5687958|P2|Overall Study|No Study Treatment Given|0
1628356|NCT01908426|5687959|P1|Overall Study|No Study Treatment Given|3
1628357|NCT01908426|5687958|P2|Overall Study|Protocol Violation|0
1628358|NCT01908426|5687959|P1|Overall Study|Protocol Violation|1
1628359|NCT01908426|5687958|P2|Overall Study|Progressive Disease|152
1628360|NCT01908426|5687959|P1|Overall Study|Progressive Disease|206
1628361|NCT01908426|5687958|P2|Overall Study|Withdrawal by Subject|6
1628362|NCT01908426|5687959|P1|Overall Study|Withdrawal by Subject|11
1628363|NCT01908426|5687958|P2|Overall Study|Physician Decision|3
1628364|NCT01908426|5687959|P1|Overall Study|Physician Decision|3
1628365|NCT01908426|5687958|P2|Overall Study|Lost to Follow-up|1
1628366|NCT01908426|5687959|P1|Overall Study|Lost to Follow-up|0
1628367|NCT01908426|5687958|P2|Overall Study|Lack of Efficacy|0
1628368|NCT01908426|5687959|P1|Overall Study|Lack of Efficacy|3
1628369|NCT01908426|5687958|P2|Overall Study|Clinical Deterioration|38
1628370|NCT01908426|5687959|P1|Overall Study|Clinical Deterioration|72
1628371|NCT01908426|5687958|P2|Overall Study|Adverse Event|11
1628372|NCT01908426|5687959|P1|Overall Study|Adverse Event|98
1628373|NCT01908140|5687971|P2|Overall Study|Adverse Event|23
1628374|NCT01908140|5687972|P1|Overall Study|Adverse Event|22
1628375|NCT01908140|5687971|P2|Overall Study|Protocol Violation|9
1628376|NCT01908140|5687972|P1|Overall Study|Protocol Violation|8
1628377|NCT01908140|5687971|P2|Overall Study|Lost to Follow-up|6
1628378|NCT01908140|5687972|P1|Overall Study|Lost to Follow-up|1
1628379|NCT01908140|5687971|P2|Overall Study|Withdrawal by Subject|24
1628380|NCT01908140|5687972|P1|Overall Study|Withdrawal by Subject|23
1628381|NCT01908140|5687971|P2|Overall Study|Lack of Efficacy|5
1628382|NCT01908140|5687972|P1|Overall Study|Lack of Efficacy|7
1628383|NCT01908140|5687971|P2|Overall Study|Other or Progressive Disease|12
1628384|NCT01908140|5687972|P1|Overall Study|Other or Progressive Disease|5
1628385|NCT01907906|5688021|P2|Overall Study|Physician Decision|1
1628386|NCT01907906|5688022|P1|Overall Study|Physician Decision|3
1628387|NCT01907906|5688021|P2|Overall Study|Withdrawal by Subject|0
1628388|NCT01907906|5688022|P1|Overall Study|Withdrawal by Subject|1
1628389|NCT01907854|5688102|P2|Overall Study|Unclassified|3
1628390|NCT01907854|5688103|P1|Overall Study|Unclassified|4
1628391|NCT01907854|5688102|P2|Overall Study|Lost to Follow-up|2
1628392|NCT01907854|5688103|P1|Overall Study|Lost to Follow-up|2
1628393|NCT01907854|5688102|P2|Overall Study|Withdrawal by Subject|7
1628394|NCT01907854|5688103|P1|Overall Study|Withdrawal by Subject|9
1628395|NCT01907854|5688102|P2|Overall Study|Protocol Violation|1
1628396|NCT01907854|5688103|P1|Overall Study|Protocol Violation|1
1628397|NCT01907815|5688123|P2|Overall Study|Withdrawal by Subject|0
1628398|NCT01907815|5688124|P1|Overall Study|Withdrawal by Subject|1
1628399|NCT01907737|5688138|P1|Overall Study|Withdrawal by Subject|1
1628400|NCT01907516|5688150|P2|First Intervention (3 Weeks)|Developed DKA during study|0
1628401|NCT01907516|5688151|P1|First Intervention (3 Weeks)|Developed DKA during study|1
1628402|NCT01907516|5688150|P2|First Intervention (3 Weeks)|Delivered before second arm|4
1628403|NCT01907516|5688151|P1|First Intervention (3 Weeks)|Delivered before second arm|3
1628404|NCT01907516|5688150|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
1628405|NCT01907516|5688151|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
1628406|NCT01907516|5688150|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
1628407|NCT01907516|5688151|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
1628408|NCT01907217|5688192|P2|Overall Study|Withdrawal by Subject|2
1628409|NCT01907217|5688193|P1|Overall Study|Withdrawal by Subject|0
1628410|NCT01907100|5688305|P4|Overall Study|Worsening/AE underlying cancer disease|8
1628411|NCT01907100|5688306|P3|Overall Study|Worsening/AE underlying cancer disease|8
1628412|NCT01907100|5688307|P2|Overall Study|Worsening/AE underlying cancer disease|0
1628413|NCT01907100|5688308|P1|Overall Study|Worsening/AE underlying cancer disease|0
1628414|NCT01907100|5688305|P4|Overall Study|Adverse event (AE)|23
1628415|NCT01907100|5688306|P3|Overall Study|Adverse event (AE)|22
1628416|NCT01907100|5688307|P2|Overall Study|Adverse event (AE)|3
1628417|NCT01907100|5688308|P1|Overall Study|Adverse event (AE)|6
1628418|NCT01907100|5688305|P4|Overall Study|Other than reasons specified|6
1628419|NCT01907100|5688306|P3|Overall Study|Other than reasons specified|10
1628420|NCT01907100|5688307|P2|Overall Study|Other than reasons specified|0
1628421|NCT01907100|5688308|P1|Overall Study|Other than reasons specified|1
1628422|NCT01907100|5688305|P4|Overall Study|Not treated|2
1628423|NCT01907100|5688306|P3|Overall Study|Not treated|1
1628424|NCT01907100|5688307|P2|Overall Study|Not treated|0
1628425|NCT01907100|5688308|P1|Overall Study|Not treated|2
1628426|NCT01907100|5688305|P4|Overall Study|Lost to Follow-up|1
1628427|NCT01907100|5688306|P3|Overall Study|Lost to Follow-up|0
1628428|NCT01907100|5688307|P2|Overall Study|Lost to Follow-up|0
1628429|NCT01907100|5688308|P1|Overall Study|Lost to Follow-up|0
1628430|NCT01907100|5688305|P4|Overall Study|Protocol Violation|1
1628431|NCT01907100|5688306|P3|Overall Study|Protocol Violation|1
1628432|NCT01907100|5688307|P2|Overall Study|Protocol Violation|0
1628433|NCT01907100|5688308|P1|Overall Study|Protocol Violation|0
1628434|NCT01907100|5688305|P4|Overall Study|Withdrawal by Subject|13
1628435|NCT01907100|5688306|P3|Overall Study|Withdrawal by Subject|10
1628436|NCT01907100|5688307|P2|Overall Study|Withdrawal by Subject|5
1628437|NCT01907100|5688308|P1|Overall Study|Withdrawal by Subject|2
1628438|NCT01907100|5688305|P4|Overall Study|PD based on modified RECIST criteria|92
1628439|NCT01907100|5688306|P3|Overall Study|PD based on modified RECIST criteria|95
1628440|NCT01907100|5688307|P2|Overall Study|PD based on modified RECIST criteria|32
1628441|NCT01907100|5688308|P1|Overall Study|PD based on modified RECIST criteria|31
1628442|NCT01907087|5688322|P1|Overall Study|Withdrawal by Subject|1
1628443|NCT01906372|5688383|P1|Overall Study|Withdrawal by Subject|2
1628444|NCT01906346|5688388|P1|Overall Study|AEs|1
1628445|NCT01905943|5688419|P1|Overall Study|Other|12
1628446|NCT01905943|5688419|P1|Overall Study|Adverse Event|3
1628447|NCT01905943|5688419|P1|Overall Study|Death|186
1628448|NCT01905943|5688419|P1|Overall Study|Investigator discretion|7
1628449|NCT01905943|5688419|P1|Overall Study|Lost to Follow-up|16
1628450|NCT01905943|5688419|P1|Overall Study|Withdrawal of consent|90
1628451|NCT01905683|5688536|P1|Overall Study|Lost to Follow-up|4
1628452|NCT01905683|5688536|P1|Overall Study|Adverse Event|4
1628453|NCT01905683|5688536|P1|Overall Study|Withdrawal by Subject|20
1628454|NCT01905683|5688536|P1|Overall Study|Lack of Efficacy|8
1628455|NCT01905683|5688536|P1|Overall Study|Physician Decision|1
1628456|NCT01905683|5688536|P1|Overall Study|Re-injection criteria not met; others|13
1628457|NCT01905683|5688536|P1|Overall Study|Protocol Violation|1
1628458|NCT01905657|5688552|P3|Overall Study|Excluded from Efficacy Analysis|0
1628459|NCT01905657|5688553|P2|Overall Study|Excluded from Efficacy Analysis|0
1628460|NCT01905657|5688554|P1|Overall Study|Excluded from Efficacy Analysis|1
1628461|NCT01905657|5688552|P3|Overall Study|Continuing in Study|11
1628462|NCT01905657|5688553|P2|Overall Study|Continuing in Study|74
1628463|NCT01905657|5688554|P1|Overall Study|Continuing in Study|74
1628464|NCT01905657|5688552|P3|Overall Study|Withdrawal by Subject|45
1628465|NCT01905657|5688553|P2|Overall Study|Withdrawal by Subject|10
1628466|NCT01905657|5688554|P1|Overall Study|Withdrawal by Subject|5
1628467|NCT01905657|5688552|P3|Overall Study|Protocol Violation|1
1628468|NCT01905657|5688553|P2|Overall Study|Protocol Violation|1
1628469|NCT01905657|5688554|P1|Overall Study|Protocol Violation|2
1628470|NCT01905657|5688552|P3|Overall Study|Progressive Disease|89
1628471|NCT01905657|5688553|P2|Overall Study|Progressive Disease|126
1628472|NCT01905657|5688554|P1|Overall Study|Progressive Disease|124
1628473|NCT01905657|5688552|P3|Overall Study|Physician Decision|113
1628474|NCT01905657|5688553|P2|Overall Study|Physician Decision|74
1628475|NCT01905657|5688554|P1|Overall Study|Physician Decision|82
1628476|NCT01905657|5688552|P3|Overall Study|Other|1
1628477|NCT01905657|5688553|P2|Overall Study|Other|7
1628478|NCT01905657|5688554|P1|Overall Study|Other|3
1628479|NCT01905657|5688552|P3|Overall Study|Death|21
1628480|NCT01905657|5688553|P2|Overall Study|Death|21
1628481|NCT01905657|5688554|P1|Overall Study|Death|21
1628482|NCT01905657|5688552|P3|Overall Study|Adverse Event|47
1628483|NCT01905657|5688553|P2|Overall Study|Adverse Event|32
1628484|NCT01905657|5688554|P1|Overall Study|Adverse Event|33
1628485|NCT01905657|5688552|P3|Overall Study|Not Treated|0
1628486|NCT01905657|5688553|P2|Overall Study|Not Treated|1
1628487|NCT01905657|5688554|P1|Overall Study|Not Treated|0
1628488|NCT01905553|5688579|P2|Period 2|Adverse Event|0
1628489|NCT01905553|5688580|P1|Period 2|Adverse Event|1
1628490|NCT01905540|5688594|P4|Period 3|Other|1
1628491|NCT01905540|5688595|P3|Period 3|Other|1
1628492|NCT01905540|5688596|P2|Period 3|Other|0
1628493|NCT01905540|5688597|P1|Period 3|Other|1
1628494|NCT01905267|5688632|P2|Overall Study|Physician Decision|2
1628495|NCT01905267|5688633|P1|Overall Study|Physician Decision|2
1628496|NCT01904773|5688654|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628497|NCT01904773|5688655|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628498|NCT01904773|5688656|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628499|NCT01904773|5688657|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628500|NCT01904773|5688658|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628501|NCT01904773|5688659|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628502|NCT01904773|5688660|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628503|NCT01904773|5688661|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
1628504|NCT01904773|5688662|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
1628505|NCT01904773|5688654|P9|Fifth Intervention|Adverse Event|0
1628506|NCT01904773|5688655|P8|Fifth Intervention|Adverse Event|1
1628507|NCT01904773|5688656|P7|Fifth Intervention|Adverse Event|0
1628508|NCT01904773|5688657|P6|Fifth Intervention|Adverse Event|0
1628509|NCT01904773|5688658|P5|Fifth Intervention|Adverse Event|0
1628510|NCT01904773|5688659|P4|Fifth Intervention|Adverse Event|0
1628511|NCT01904773|5688660|P3|Fifth Intervention|Adverse Event|0
1628512|NCT01904773|5688661|P2|Fifth Intervention|Adverse Event|0
1628513|NCT01904773|5688662|P1|Fifth Intervention|Adverse Event|0
1628514|NCT01904773|5688654|P9|Placebo Washout First Intervention|Condition worsened|0
1628515|NCT01904773|5688655|P8|Placebo Washout First Intervention|Condition worsened|0
1628516|NCT01904773|5688656|P7|Placebo Washout First Intervention|Condition worsened|0
1628517|NCT01904773|5688657|P6|Placebo Washout First Intervention|Condition worsened|0
1628518|NCT01904773|5688658|P5|Placebo Washout First Intervention|Condition worsened|0
1628519|NCT01904773|5688659|P4|Placebo Washout First Intervention|Condition worsened|0
1628520|NCT01904773|5688660|P3|Placebo Washout First Intervention|Condition worsened|0
1628521|NCT01904773|5688661|P2|Placebo Washout First Intervention|Condition worsened|1
1628522|NCT01904773|5688662|P1|Placebo Washout First Intervention|Condition worsened|0
1628523|NCT01904773|5688654|P9|First Intervention|Adverse Event|0
1628524|NCT01904773|5688655|P8|First Intervention|Adverse Event|0
1628525|NCT01904773|5688656|P7|First Intervention|Adverse Event|1
1628526|NCT01904773|5688657|P6|First Intervention|Adverse Event|0
1628527|NCT01904773|5688658|P5|First Intervention|Adverse Event|0
1628528|NCT01904773|5688659|P4|First Intervention|Adverse Event|0
1628529|NCT01904773|5688660|P3|First Intervention|Adverse Event|0
1628530|NCT01904773|5688661|P2|First Intervention|Adverse Event|0
1628531|NCT01904773|5688662|P1|First Intervention|Adverse Event|0
1628532|NCT01904773|5688654|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628533|NCT01904773|5688655|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628534|NCT01904773|5688656|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628535|NCT01904773|5688657|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628536|NCT01904773|5688658|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628537|NCT01904773|5688659|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628538|NCT01904773|5688660|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628539|NCT01904773|5688661|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
1628540|NCT01904773|5688662|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
1628541|NCT01904773|5688654|P9|Screen|Withdrawal by Subject|0
1628542|NCT01904773|5688655|P8|Screen|Withdrawal by Subject|0
1628543|NCT01904773|5688656|P7|Screen|Withdrawal by Subject|0
1628544|NCT01904773|5688657|P6|Screen|Withdrawal by Subject|0
1628545|NCT01904773|5688658|P5|Screen|Withdrawal by Subject|0
1628546|NCT01904773|5688659|P4|Screen|Withdrawal by Subject|0
1628547|NCT01904773|5688660|P3|Screen|Withdrawal by Subject|0
1628548|NCT01904773|5688661|P2|Screen|Withdrawal by Subject|0
1628549|NCT01904773|5688662|P1|Screen|Withdrawal by Subject|1
1628550|NCT01904773|5688654|P9|Screen|Screen failure|0
1628551|NCT01904773|5688655|P8|Screen|Screen failure|0
1628552|NCT01904773|5688656|P7|Screen|Screen failure|0
1628553|NCT01904773|5688657|P6|Screen|Screen failure|0
1628554|NCT01904773|5688658|P5|Screen|Screen failure|0
1628555|NCT01904773|5688659|P4|Screen|Screen failure|0
1628556|NCT01904773|5688660|P3|Screen|Screen failure|0
1628557|NCT01904773|5688661|P2|Screen|Screen failure|0
1628558|NCT01904773|5688662|P1|Screen|Screen failure|3
1628559|NCT01904760|5688679|P2|Overall Study|Protocol Violation|0
1628560|NCT01904760|5688680|P1|Overall Study|Protocol Violation|1
1628561|NCT01904721|5688695|P7|Overall Study|Adverse Event|0
1628562|NCT01904721|5688696|P6|Overall Study|Adverse Event|1
1628563|NCT01904721|5688697|P5|Overall Study|Adverse Event|3
1628564|NCT01904721|5688698|P4|Overall Study|Adverse Event|0
1628565|NCT01904721|5688699|P3|Overall Study|Adverse Event|0
1628566|NCT01904721|5688700|P2|Overall Study|Adverse Event|0
1628567|NCT01904721|5688701|P1|Overall Study|Adverse Event|0
1628568|NCT01904721|5688695|P7|Overall Study|Lack of Efficacy|1
1628569|NCT01904721|5688696|P6|Overall Study|Lack of Efficacy|0
1628570|NCT01904721|5688697|P5|Overall Study|Lack of Efficacy|0
1628571|NCT01904721|5688698|P4|Overall Study|Lack of Efficacy|0
1628572|NCT01904721|5688699|P3|Overall Study|Lack of Efficacy|0
1628573|NCT01904721|5688700|P2|Overall Study|Lack of Efficacy|0
1628574|NCT01904721|5688701|P1|Overall Study|Lack of Efficacy|0
1628575|NCT01904721|5688695|P7|Overall Study|Lost to Follow-up|1
1628576|NCT01904721|5688696|P6|Overall Study|Lost to Follow-up|3
1628577|NCT01904721|5688697|P5|Overall Study|Lost to Follow-up|1
1628578|NCT01904721|5688698|P4|Overall Study|Lost to Follow-up|0
1628579|NCT01904721|5688699|P3|Overall Study|Lost to Follow-up|0
1628580|NCT01904721|5688700|P2|Overall Study|Lost to Follow-up|0
1628581|NCT01904721|5688701|P1|Overall Study|Lost to Follow-up|0
1628582|NCT01904721|5688695|P7|Overall Study|Personal Reasons|3
1628583|NCT01904721|5688696|P6|Overall Study|Personal Reasons|3
1628584|NCT01904721|5688697|P5|Overall Study|Personal Reasons|2
1628585|NCT01904721|5688698|P4|Overall Study|Personal Reasons|0
1628586|NCT01904721|5688699|P3|Overall Study|Personal Reasons|0
1628587|NCT01904721|5688700|P2|Overall Study|Personal Reasons|0
1628588|NCT01904721|5688701|P1|Overall Study|Personal Reasons|0
1628589|NCT01904721|5688695|P7|Overall Study|Other Reasons|2
1628590|NCT01904721|5688696|P6|Overall Study|Other Reasons|2
1628591|NCT01904721|5688697|P5|Overall Study|Other Reasons|2
1628592|NCT01904721|5688698|P4|Overall Study|Other Reasons|1
1628593|NCT01904721|5688699|P3|Overall Study|Other Reasons|1
1628594|NCT01904721|5688700|P2|Overall Study|Other Reasons|0
1628595|NCT01904721|5688701|P1|Overall Study|Other Reasons|0
1628596|NCT01904604|5688731|P3|Overall Study|Lost to Follow-up|1
1628597|NCT01904604|5688732|P2|Overall Study|Lost to Follow-up|0
1628598|NCT01904604|5688733|P1|Overall Study|Lost to Follow-up|0
1628599|NCT01904604|5688731|P3|Overall Study|Participant Relocated|1
1628600|NCT01904604|5688732|P2|Overall Study|Participant Relocated|1
1628601|NCT01904604|5688733|P1|Overall Study|Participant Relocated|1
1628602|NCT01904604|5688731|P3|Overall Study|Withdrawal by Subject|0
1628603|NCT01904604|5688732|P2|Overall Study|Withdrawal by Subject|2
1628604|NCT01904604|5688733|P1|Overall Study|Withdrawal by Subject|1
1628605|NCT01904604|5688731|P3|Overall Study|Passed Week 52 OFC|0
1628606|NCT01904604|5688732|P2|Overall Study|Passed Week 52 OFC|0
1628607|NCT01904604|5688733|P1|Overall Study|Passed Week 52 OFC|1
1628608|NCT01904604|5688731|P3|Overall Study|Unrelated illness|0
1628609|NCT01904604|5688732|P2|Overall Study|Unrelated illness|1
1628610|NCT01904604|5688733|P1|Overall Study|Unrelated illness|0
1628611|NCT01904604|5688731|P3|Overall Study|Increased syncope|0
1628612|NCT01904604|5688732|P2|Overall Study|Increased syncope|1
1628613|NCT01904604|5688733|P1|Overall Study|Increased syncope|0
1628614|NCT01904604|5688731|P3|Overall Study|Patch site reactions|0
1628615|NCT01904604|5688732|P2|Overall Study|Patch site reactions|1
1628616|NCT01904604|5688733|P1|Overall Study|Patch site reactions|1
1628617|NCT01904604|5688731|P3|Overall Study|Anxiety about OFC/Refused OFC|0
1628618|NCT01904604|5688732|P2|Overall Study|Anxiety about OFC/Refused OFC|0
1628619|NCT01904604|5688733|P1|Overall Study|Anxiety about OFC/Refused OFC|2
1628620|NCT01904604|5688731|P3|Overall Study|Non-compliance|0
1628621|NCT01904604|5688732|P2|Overall Study|Non-compliance|0
1628622|NCT01904604|5688733|P1|Overall Study|Non-compliance|1
1628623|NCT01904604|5688731|P3|Overall Study|Withdrew before receiving dosing|0
1628624|NCT01904604|5688732|P2|Overall Study|Withdrew before receiving dosing|1
1628625|NCT01904604|5688733|P1|Overall Study|Withdrew before receiving dosing|0
1628626|NCT01904383|5688798|P1|Overall Study|No patient visit after entry|54
1628627|NCT01904383|5688798|P1|Overall Study|Adverse Event|271
1628628|NCT01904383|5688798|P1|Overall Study|Improvement|141
1628629|NCT01904383|5688798|P1|Overall Study|Lack of Efficacy|370
1628630|NCT01904383|5688798|P1|Overall Study|Lost to Follow-up|674
1628631|NCT01904383|5688798|P1|Overall Study|Reason not listed|147
1628632|NCT01904383|5688798|P1|Overall Study|CRF not collected|117
1628633|NCT01904279|5688805|P2|Overall Study|Withdrawal by Subject|0
1628634|NCT01904279|5688806|P1|Overall Study|Withdrawal by Subject|1
1628635|NCT01904279|5688805|P2|Overall Study|Lack of Efficacy|3
1628636|NCT01904279|5688806|P1|Overall Study|Lack of Efficacy|2
1628637|NCT01904149|5688832|P6|Overall Study|non compliance with study drug|0
1628638|NCT01904149|5688833|P5|Overall Study|non compliance with study drug|0
1628639|NCT01904149|5688834|P4|Overall Study|non compliance with study drug|0
1628640|NCT01904149|5688835|P3|Overall Study|non compliance with study drug|0
1628641|NCT01904149|5688836|P2|Overall Study|non compliance with study drug|0
1628642|NCT01904149|5688837|P1|Overall Study|non compliance with study drug|1
1628643|NCT01904149|5688832|P6|Overall Study|Protocol Violation|0
1628644|NCT01904149|5688833|P5|Overall Study|Protocol Violation|0
1628645|NCT01904149|5688834|P4|Overall Study|Protocol Violation|0
1628646|NCT01904149|5688835|P3|Overall Study|Protocol Violation|0
1628647|NCT01904149|5688836|P2|Overall Study|Protocol Violation|1
1628648|NCT01904149|5688837|P1|Overall Study|Protocol Violation|0
1628649|NCT01904149|5688832|P6|Overall Study|Withdrawal by Subject|0
1628650|NCT01904149|5688833|P5|Overall Study|Withdrawal by Subject|1
1628651|NCT01904149|5688834|P4|Overall Study|Withdrawal by Subject|0
1628652|NCT01904149|5688835|P3|Overall Study|Withdrawal by Subject|1
1628653|NCT01904149|5688836|P2|Overall Study|Withdrawal by Subject|3
1628654|NCT01904149|5688837|P1|Overall Study|Withdrawal by Subject|1
1628655|NCT01904149|5688832|P6|Overall Study|Lack of Efficacy|1
1628656|NCT01904149|5688833|P5|Overall Study|Lack of Efficacy|3
1628657|NCT01904149|5688834|P4|Overall Study|Lack of Efficacy|3
1628658|NCT01904149|5688835|P3|Overall Study|Lack of Efficacy|1
1628659|NCT01904149|5688836|P2|Overall Study|Lack of Efficacy|3
1628660|NCT01904149|5688837|P1|Overall Study|Lack of Efficacy|0
1628661|NCT01904149|5688832|P6|Overall Study|Adverse Event|2
1628662|NCT01904149|5688833|P5|Overall Study|Adverse Event|1
1628663|NCT01904149|5688834|P4|Overall Study|Adverse Event|1
1628664|NCT01904149|5688835|P3|Overall Study|Adverse Event|0
1628665|NCT01904149|5688836|P2|Overall Study|Adverse Event|4
1628666|NCT01904149|5688837|P1|Overall Study|Adverse Event|3
1628667|NCT01904058|5688888|P4|Overall Study|Pregnancy|1
1628668|NCT01904058|5688889|P3|Overall Study|Pregnancy|0
1628669|NCT01904058|5688890|P2|Overall Study|Pregnancy|0
1628670|NCT01904058|5688891|P1|Overall Study|Pregnancy|0
1628671|NCT01904058|5688888|P4|Overall Study|Withdrawal by Subject|0
1628672|NCT01904058|5688889|P3|Overall Study|Withdrawal by Subject|1
1628673|NCT01904058|5688890|P2|Overall Study|Withdrawal by Subject|0
1628674|NCT01904058|5688891|P1|Overall Study|Withdrawal by Subject|1
1628675|NCT01904058|5688888|P4|Overall Study|Adverse Event|0
1628676|NCT01904058|5688889|P3|Overall Study|Adverse Event|0
1628677|NCT01904058|5688890|P2|Overall Study|Adverse Event|0
1628678|NCT01904058|5688891|P1|Overall Study|Adverse Event|2
1628679|NCT01903993|5688931|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
1628680|NCT01903993|5688932|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
1628681|NCT01903993|5688931|P2|Overall Study|Study Terminated by Sponsor|14
1628682|NCT01903993|5688932|P1|Overall Study|Study Terminated by Sponsor|8
1628683|NCT01903993|5688931|P2|Overall Study|Lost to Follow-up|3
1628684|NCT01903993|5688932|P1|Overall Study|Lost to Follow-up|2
1628685|NCT01903993|5688931|P2|Overall Study|Withdrawal by Subject|4
1628686|NCT01903993|5688932|P1|Overall Study|Withdrawal by Subject|15
1628687|NCT01903993|5688931|P2|Overall Study|Death|121
1628688|NCT01903993|5688932|P1|Overall Study|Death|118
1628689|NCT01903876|5688949|P2|Six-Month Follow-up Period|Lost to Follow-up|145
1628690|NCT01903876|5688950|P1|Six-Month Follow-up Period|Lost to Follow-up|91
1628691|NCT01903876|5688949|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
1628692|NCT01903876|5688950|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
1628693|NCT01903863|5688960|P2|Overall Study|Physician Decision|0
1628694|NCT01903863|5688961|P1|Overall Study|Physician Decision|2
1628695|NCT01903811|5688983|P2|Overall Study|Withdrawal by Subject|1
1628696|NCT01903811|5688984|P1|Overall Study|Withdrawal by Subject|0
1628697|NCT01903811|5688983|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
1628698|NCT01903811|5688984|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
1628699|NCT01903811|5688983|P2|Overall Study|Incomplete/discontinued prior therapy|1
1628700|NCT01903811|5688984|P1|Overall Study|Incomplete/discontinued prior therapy|1
1628701|NCT01903811|5688983|P2|Overall Study|No measurable disease|1
1628702|NCT01903811|5688984|P1|Overall Study|No measurable disease|1
1628703|NCT01903720|5689018|P1|Overall Study|Treatment with alternative drug|1
1628704|NCT01903720|5689018|P1|Overall Study|Lost to Follow-up|2
1628705|NCT01903720|5689018|P1|Overall Study|Rescinding of informed consent|2
1628706|NCT01903720|5689018|P1|Overall Study|Adverse Event|1
1628707|NCT01903720|5689018|P1|Overall Study|Inclusion / exclusion criteria not met|6
1628708|NCT01903460|5689056|P4|Overall Study|Adverse Event|1
1628709|NCT01903460|5689057|P3|Overall Study|Adverse Event|0
1628710|NCT01903460|5689058|P2|Overall Study|Adverse Event|0
1628711|NCT01903460|5689059|P1|Overall Study|Adverse Event|0
1628712|NCT01903434|5689076|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
1628713|NCT01903434|5689077|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
1628714|NCT01903434|5689076|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
1628715|NCT01903434|5689077|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
1628716|NCT01903356|5689085|P1|Overall Study|Violated the dosage and administration|3
1628717|NCT01903356|5689085|P1|Overall Study|Violated inclusion/exclusion criteria|5
1628718|NCT01903356|5689085|P1|Overall Study|Lost to Follow-up|7
1628719|NCT01903252|5689112|P6|Maintenance, Open-Label|Other|2
1628720|NCT01903252|5689113|P5|Maintenance, Open-Label|Other|6
1628721|NCT01903252|5689114|P4|Maintenance, Open-Label|Other|2
1628722|NCT01903252|5689115|P3|Maintenance, Open-Label|Other|0
1628723|NCT01903252|5689116|P2|Maintenance, Open-Label|Other|0
1628724|NCT01903252|5689117|P1|Maintenance, Open-Label|Other|0
1628725|NCT01903252|5689112|P6|Maintenance, Open-Label|Withdrawal by Subject|2
1628726|NCT01903252|5689113|P5|Maintenance, Open-Label|Withdrawal by Subject|6
1628727|NCT01903252|5689114|P4|Maintenance, Open-Label|Withdrawal by Subject|1
1628728|NCT01903252|5689115|P3|Maintenance, Open-Label|Withdrawal by Subject|0
1628729|NCT01903252|5689116|P2|Maintenance, Open-Label|Withdrawal by Subject|0
1628730|NCT01903252|5689117|P1|Maintenance, Open-Label|Withdrawal by Subject|0
1628731|NCT01903252|5689112|P6|Maintenance, Open-Label|Adverse Event|14
1628732|NCT01903252|5689113|P5|Maintenance, Open-Label|Adverse Event|9
1628733|NCT01903252|5689114|P4|Maintenance, Open-Label|Adverse Event|3
1628734|NCT01903252|5689115|P3|Maintenance, Open-Label|Adverse Event|0
1628735|NCT01903252|5689116|P2|Maintenance, Open-Label|Adverse Event|0
1628736|NCT01903252|5689117|P1|Maintenance, Open-Label|Adverse Event|0
1628737|NCT01903252|5689112|P6|Extended Induction, Open-Label|Physician Decision|0
1628738|NCT01903252|5689113|P5|Extended Induction, Open-Label|Physician Decision|0
1628739|NCT01903252|5689114|P4|Extended Induction, Open-Label|Physician Decision|0
1628740|NCT01903252|5689115|P3|Extended Induction, Open-Label|Physician Decision|1
1628741|NCT01903252|5689116|P2|Extended Induction, Open-Label|Physician Decision|0
1628742|NCT01903252|5689117|P1|Extended Induction, Open-Label|Physician Decision|0
1628743|NCT01903252|5689112|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
1628744|NCT01903252|5689113|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
1628745|NCT01903252|5689114|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
1628746|NCT01903252|5689115|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
1628747|NCT01903252|5689116|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
1628748|NCT01903252|5689117|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
1628749|NCT01903252|5689112|P6|Extended Induction, Open-Label|Adverse Event|0
1628750|NCT01903252|5689113|P5|Extended Induction, Open-Label|Adverse Event|0
1628751|NCT01903252|5689114|P4|Extended Induction, Open-Label|Adverse Event|0
1628752|NCT01903252|5689115|P3|Extended Induction, Open-Label|Adverse Event|17
1628753|NCT01903252|5689116|P2|Extended Induction, Open-Label|Adverse Event|0
1628754|NCT01903252|5689117|P1|Extended Induction, Open-Label|Adverse Event|0
1628755|NCT01903252|5689112|P6|Double-Blind Induction|non-compliance,|0
1628756|NCT01903252|5689113|P5|Double-Blind Induction|non-compliance,|0
1628757|NCT01903252|5689114|P4|Double-Blind Induction|non-compliance,|0
1628758|NCT01903252|5689115|P3|Double-Blind Induction|non-compliance,|0
1628759|NCT01903252|5689116|P2|Double-Blind Induction|non-compliance,|7
1628760|NCT01903252|5689117|P1|Double-Blind Induction|non-compliance,|7
1628761|NCT01903252|5689112|P6|Double-Blind Induction|Physician Decision|0
1628762|NCT01903252|5689113|P5|Double-Blind Induction|Physician Decision|0
1628763|NCT01903252|5689114|P4|Double-Blind Induction|Physician Decision|0
1628764|NCT01903252|5689115|P3|Double-Blind Induction|Physician Decision|0
1628765|NCT01903252|5689116|P2|Double-Blind Induction|Physician Decision|3
1628766|NCT01903252|5689117|P1|Double-Blind Induction|Physician Decision|2
1628767|NCT01903252|5689112|P6|Double-Blind Induction|Withdrawal by Subject|0
1628768|NCT01903252|5689113|P5|Double-Blind Induction|Withdrawal by Subject|0
1628769|NCT01903252|5689114|P4|Double-Blind Induction|Withdrawal by Subject|0
1628770|NCT01903252|5689115|P3|Double-Blind Induction|Withdrawal by Subject|0
1628771|NCT01903252|5689116|P2|Double-Blind Induction|Withdrawal by Subject|13
1628772|NCT01903252|5689117|P1|Double-Blind Induction|Withdrawal by Subject|10
1628773|NCT01903252|5689112|P6|Double-Blind Induction|Adverse Event|0
1628774|NCT01903252|5689113|P5|Double-Blind Induction|Adverse Event|0
1628775|NCT01903252|5689114|P4|Double-Blind Induction|Adverse Event|0
1628776|NCT01903252|5689115|P3|Double-Blind Induction|Adverse Event|0
1628777|NCT01903252|5689116|P2|Double-Blind Induction|Adverse Event|18
1628778|NCT01903252|5689117|P1|Double-Blind Induction|Adverse Event|20
1628779|NCT01903031|5689230|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
1628780|NCT01903031|5689231|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
1628781|NCT01903031|5689232|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
1628782|NCT01903031|5689230|P3|Overall Study|Lost to Follow-up|1
1628783|NCT01903031|5689231|P2|Overall Study|Lost to Follow-up|0
1628784|NCT01903031|5689232|P1|Overall Study|Lost to Follow-up|0
1628785|NCT01903031|5689230|P3|Overall Study|Protocol Violation|2
1628786|NCT01903031|5689231|P2|Overall Study|Protocol Violation|0
1628787|NCT01903031|5689232|P1|Overall Study|Protocol Violation|0
1628788|NCT01903031|5689230|P3|Overall Study|Withdrawal by Subject|1
1628789|NCT01903031|5689231|P2|Overall Study|Withdrawal by Subject|1
1628790|NCT01903031|5689232|P1|Overall Study|Withdrawal by Subject|0
1628791|NCT01903031|5689230|P3|Overall Study|Adverse Event|0
1628792|NCT01903031|5689231|P2|Overall Study|Adverse Event|1
1628793|NCT01903031|5689232|P1|Overall Study|Adverse Event|0
1628794|NCT01903031|5689230|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1628795|NCT01903031|5689231|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
1628796|NCT01903031|5689232|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
1628797|NCT01903031|5689230|P3|Overall Study|Not Able to Attend Clinic|0
1628798|NCT01903031|5689231|P2|Overall Study|Not Able to Attend Clinic|1
1628799|NCT01903031|5689232|P1|Overall Study|Not Able to Attend Clinic|1
1628800|NCT01902888|5689301|P1|Overall Study|Study Terminated|3
1628801|NCT01902628|5689315|P1|Overall Study|Lost to Follow-up|35
1628802|NCT01902628|5689315|P1|Overall Study|Adverse Event|41
1628803|NCT01902628|5689315|P1|Overall Study|Withdrawal of participant's consent|7
1628804|NCT01902303|5689343|P2|Overall Study|Did not develop a cold sore|19
1628805|NCT01902303|5689344|P1|Overall Study|Did not develop a cold sore|21
1628806|NCT01902303|5689343|P2|Overall Study|subject lost investigational product|1
1628807|NCT01902303|5689344|P1|Overall Study|subject lost investigational product|0
1628808|NCT01902303|5689343|P2|Overall Study|Protocol Violation|2
1628809|NCT01902303|5689344|P1|Overall Study|Protocol Violation|2
1628810|NCT01902303|5689343|P2|Overall Study|Lost to Follow-up|1
1628811|NCT01902303|5689344|P1|Overall Study|Lost to Follow-up|0
1628812|NCT01902303|5689343|P2|Overall Study|Adverse Event|1
1628813|NCT01902303|5689344|P1|Overall Study|Adverse Event|0
1628814|NCT01902134|5689358|P6|Overall Study|Other|0
1628815|NCT01902134|5689359|P5|Overall Study|Other|1
1628816|NCT01902134|5689360|P4|Overall Study|Other|0
1628817|NCT01902134|5689361|P3|Overall Study|Other|2
1628818|NCT01902134|5689362|P2|Overall Study|Other|1
1628819|NCT01902134|5689363|P1|Overall Study|Other|0
1628820|NCT01902134|5689358|P6|Overall Study|no compliance|0
1628821|NCT01902134|5689359|P5|Overall Study|no compliance|0
1628822|NCT01902134|5689360|P4|Overall Study|no compliance|0
1628823|NCT01902134|5689361|P3|Overall Study|no compliance|0
1628824|NCT01902134|5689362|P2|Overall Study|no compliance|0
1628825|NCT01902134|5689363|P1|Overall Study|no compliance|1
1628826|NCT01902134|5689358|P6|Overall Study|Withdrawal by Subject|4
1628827|NCT01902134|5689359|P5|Overall Study|Withdrawal by Subject|5
1628828|NCT01902134|5689360|P4|Overall Study|Withdrawal by Subject|1
1628829|NCT01902134|5689361|P3|Overall Study|Withdrawal by Subject|9
1628830|NCT01902134|5689362|P2|Overall Study|Withdrawal by Subject|8
1628831|NCT01902134|5689363|P1|Overall Study|Withdrawal by Subject|4
1628832|NCT01902134|5689358|P6|Overall Study|Protocol Violation|1
1628833|NCT01902134|5689359|P5|Overall Study|Protocol Violation|0
1628834|NCT01902134|5689360|P4|Overall Study|Protocol Violation|0
1628835|NCT01902134|5689361|P3|Overall Study|Protocol Violation|0
1628836|NCT01902134|5689362|P2|Overall Study|Protocol Violation|0
1628837|NCT01902134|5689363|P1|Overall Study|Protocol Violation|0
1628838|NCT01902134|5689358|P6|Overall Study|Physician Decision|0
1628839|NCT01902134|5689359|P5|Overall Study|Physician Decision|0
1628840|NCT01902134|5689360|P4|Overall Study|Physician Decision|0
1628841|NCT01902134|5689361|P3|Overall Study|Physician Decision|0
1628842|NCT01902134|5689362|P2|Overall Study|Physician Decision|1
1628843|NCT01902134|5689363|P1|Overall Study|Physician Decision|0
1628844|NCT01902134|5689358|P6|Overall Study|Lack of Efficacy|1
1628845|NCT01902134|5689359|P5|Overall Study|Lack of Efficacy|0
1628846|NCT01902134|5689360|P4|Overall Study|Lack of Efficacy|0
1628847|NCT01902134|5689361|P3|Overall Study|Lack of Efficacy|2
1628848|NCT01902134|5689362|P2|Overall Study|Lack of Efficacy|0
1628849|NCT01902134|5689363|P1|Overall Study|Lack of Efficacy|0
1628850|NCT01902134|5689358|P6|Overall Study|Adverse Event|3
1628851|NCT01902134|5689359|P5|Overall Study|Adverse Event|1
1628852|NCT01902134|5689360|P4|Overall Study|Adverse Event|1
1628853|NCT01902134|5689361|P3|Overall Study|Adverse Event|2
1628854|NCT01902134|5689362|P2|Overall Study|Adverse Event|1
1628855|NCT01902134|5689363|P1|Overall Study|Adverse Event|3
1628856|NCT01901874|5689400|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
1628857|NCT01901874|5689400|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
1628858|NCT01901874|5689400|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
1628859|NCT01901874|5689400|P1|1-Year (365-Day) MAE Evaluation|Death|7
1628860|NCT01901874|5689400|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
1628861|NCT01901874|5689400|P1|Screening Committee Retrospective Review|Protocol Violation|47
1628862|NCT01901848|5689415|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
1628863|NCT01901848|5689416|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
1628864|NCT01901848|5689415|P2|Randomized and Treated|Lost to Follow-up|6
1628865|NCT01901848|5689416|P1|Randomized and Treated|Lost to Follow-up|3
1628866|NCT01901653|5689458|P13|Overall Study|Alive at Study Termination by Sponsor|1
1628867|NCT01901653|5689459|P12|Overall Study|Alive at Study Termination by Sponsor|1
1628868|NCT01901653|5689460|P11|Overall Study|Alive at Study Termination by Sponsor|0
1628869|NCT01901653|5689461|P10|Overall Study|Alive at Study Termination by Sponsor|2
1628870|NCT01901653|5689462|P9|Overall Study|Alive at Study Termination by Sponsor|0
1628871|NCT01901653|5689463|P8|Overall Study|Alive at Study Termination by Sponsor|0
1628872|NCT01901653|5689464|P7|Overall Study|Alive at Study Termination by Sponsor|0
1628873|NCT01901653|5689465|P6|Overall Study|Alive at Study Termination by Sponsor|0
1628874|NCT01901653|5689466|P5|Overall Study|Alive at Study Termination by Sponsor|0
1628875|NCT01901653|5689467|P4|Overall Study|Alive at Study Termination by Sponsor|0
1628876|NCT01901653|5689468|P3|Overall Study|Alive at Study Termination by Sponsor|1
1628877|NCT01901653|5689469|P2|Overall Study|Alive at Study Termination by Sponsor|0
1628878|NCT01901653|5689470|P1|Overall Study|Alive at Study Termination by Sponsor|0
1628879|NCT01901653|5689458|P13|Overall Study|Withdrawal by Subject|0
1628880|NCT01901653|5689459|P12|Overall Study|Withdrawal by Subject|0
1628881|NCT01901653|5689460|P11|Overall Study|Withdrawal by Subject|0
1628882|NCT01901653|5689461|P10|Overall Study|Withdrawal by Subject|0
1628883|NCT01901653|5689462|P9|Overall Study|Withdrawal by Subject|0
1628884|NCT01901653|5689463|P8|Overall Study|Withdrawal by Subject|0
1628885|NCT01901653|5689464|P7|Overall Study|Withdrawal by Subject|1
1628886|NCT01901653|5689465|P6|Overall Study|Withdrawal by Subject|0
1628887|NCT01901653|5689466|P5|Overall Study|Withdrawal by Subject|0
1628888|NCT01901653|5689467|P4|Overall Study|Withdrawal by Subject|0
1628889|NCT01901653|5689468|P3|Overall Study|Withdrawal by Subject|0
1628890|NCT01901653|5689469|P2|Overall Study|Withdrawal by Subject|0
1628891|NCT01901653|5689470|P1|Overall Study|Withdrawal by Subject|0
1628892|NCT01901653|5689458|P13|Overall Study|Lost to Follow-up|0
1628893|NCT01901653|5689459|P12|Overall Study|Lost to Follow-up|0
1628894|NCT01901653|5689460|P11|Overall Study|Lost to Follow-up|0
1628895|NCT01901653|5689461|P10|Overall Study|Lost to Follow-up|0
1628896|NCT01901653|5689462|P9|Overall Study|Lost to Follow-up|0
1628897|NCT01901653|5689463|P8|Overall Study|Lost to Follow-up|1
1628898|NCT01901653|5689464|P7|Overall Study|Lost to Follow-up|0
1628899|NCT01901653|5689465|P6|Overall Study|Lost to Follow-up|1
1628900|NCT01901653|5689466|P5|Overall Study|Lost to Follow-up|0
1628901|NCT01901653|5689467|P4|Overall Study|Lost to Follow-up|0
1628902|NCT01901653|5689468|P3|Overall Study|Lost to Follow-up|2
1628903|NCT01901653|5689469|P2|Overall Study|Lost to Follow-up|0
1628904|NCT01901653|5689470|P1|Overall Study|Lost to Follow-up|1
1628905|NCT01901653|5689458|P13|Overall Study|Death|4
1628906|NCT01901653|5689459|P12|Overall Study|Death|15
1628907|NCT01901653|5689460|P11|Overall Study|Death|2
1628908|NCT01901653|5689461|P10|Overall Study|Death|16
1628909|NCT01901653|5689462|P9|Overall Study|Death|1
1628910|NCT01901653|5689463|P8|Overall Study|Death|9
1628911|NCT01901653|5689464|P7|Overall Study|Death|6
1628912|NCT01901653|5689465|P6|Overall Study|Death|2
1628913|NCT01901653|5689466|P5|Overall Study|Death|2
1628914|NCT01901653|5689467|P4|Overall Study|Death|3
1628915|NCT01901653|5689468|P3|Overall Study|Death|8
1628916|NCT01901653|5689469|P2|Overall Study|Death|1
1628917|NCT01901653|5689470|P1|Overall Study|Death|2
1628918|NCT01901614|5689514|P2|Overall Study|Screen Fail|0
1628919|NCT01901614|5689515|P1|Overall Study|Screen Fail|1
1628920|NCT01901614|5689514|P2|Overall Study|Lost to Follow-up|0
1628921|NCT01901614|5689515|P1|Overall Study|Lost to Follow-up|1
1628922|NCT01901614|5689514|P2|Overall Study|Adverse Event|1
1628923|NCT01901614|5689515|P1|Overall Study|Adverse Event|0
1628924|NCT01901432|5689550|P5|Overall Study|Patient decision to stop study drug|1
1628925|NCT01901432|5689551|P4|Overall Study|Patient decision to stop study drug|0
1628926|NCT01901432|5689552|P3|Overall Study|Patient decision to stop study drug|0
1628927|NCT01901432|5689553|P2|Overall Study|Patient decision to stop study drug|0
1628928|NCT01901432|5689554|P1|Overall Study|Patient decision to stop study drug|0
1628929|NCT01901432|5689550|P5|Overall Study|Physician Decision|2
1628930|NCT01901432|5689551|P4|Overall Study|Physician Decision|0
1628931|NCT01901432|5689552|P3|Overall Study|Physician Decision|0
1628932|NCT01901432|5689553|P2|Overall Study|Physician Decision|0
1628933|NCT01901432|5689554|P1|Overall Study|Physician Decision|0
1628934|NCT01901432|5689550|P5|Overall Study|Withdrawal by Subject|5
1628935|NCT01901432|5689551|P4|Overall Study|Withdrawal by Subject|0
1628936|NCT01901432|5689552|P3|Overall Study|Withdrawal by Subject|1
1628937|NCT01901432|5689553|P2|Overall Study|Withdrawal by Subject|0
1628938|NCT01901432|5689554|P1|Overall Study|Withdrawal by Subject|0
1628939|NCT01901432|5689550|P5|Overall Study|Adverse Event|1
1628940|NCT01901432|5689551|P4|Overall Study|Adverse Event|0
1628941|NCT01901432|5689552|P3|Overall Study|Adverse Event|1
1628942|NCT01901432|5689553|P2|Overall Study|Adverse Event|1
1628943|NCT01901432|5689554|P1|Overall Study|Adverse Event|0
1628944|NCT01901393|5689606|P2|Overall Study|Adverse Event|0
1628945|NCT01901393|5689607|P1|Overall Study|Adverse Event|1
1628946|NCT01901341|5689625|P2|Overall Study|Withdrawal by Subject|1
1628947|NCT01901341|5689626|P1|Overall Study|Withdrawal by Subject|1
1628948|NCT01901341|5689625|P2|Overall Study|Study Terminated by Sponsor|15
1628949|NCT01901341|5689626|P1|Overall Study|Study Terminated by Sponsor|13
1628950|NCT01901341|5689625|P2|Overall Study|Protocol Violation|0
1628951|NCT01901341|5689626|P1|Overall Study|Protocol Violation|2
1628952|NCT01901341|5689625|P2|Overall Study|Lost to Follow-up|1
1628953|NCT01901341|5689626|P1|Overall Study|Lost to Follow-up|0
1628954|NCT01901341|5689625|P2|Overall Study|Lack of Efficacy|2
1628955|NCT01901341|5689626|P1|Overall Study|Lack of Efficacy|0
1628956|NCT01901341|5689625|P2|Overall Study|Adverse Event|2
1628957|NCT01901341|5689626|P1|Overall Study|Adverse Event|4
1628958|NCT01901328|5689640|P2|Overall Study|Lack of Efficacy|1
1628959|NCT01901328|5689641|P1|Overall Study|Lack of Efficacy|0
1628960|NCT01901328|5689640|P2|Overall Study|Withdrawal by Subject|2
1628961|NCT01901328|5689641|P1|Overall Study|Withdrawal by Subject|1
1628962|NCT01901328|5689640|P2|Overall Study|Study Terminated by Sponsor|16
1628963|NCT01901328|5689641|P1|Overall Study|Study Terminated by Sponsor|19
1628964|NCT01901328|5689640|P2|Overall Study|Protocol Violation|1
1628965|NCT01901328|5689641|P1|Overall Study|Protocol Violation|1
1628966|NCT01901328|5689640|P2|Overall Study|Physician Decision|1
1628967|NCT01901328|5689641|P1|Overall Study|Physician Decision|0
1628968|NCT01901328|5689640|P2|Overall Study|Lost to Follow-up|0
1628969|NCT01901328|5689641|P1|Overall Study|Lost to Follow-up|1
1628970|NCT01901302|5689655|P2|Overall Study|Withdrawal by Subject|0
1628971|NCT01901302|5689656|P1|Overall Study|Withdrawal by Subject|2
1628972|NCT01901302|5689655|P2|Overall Study|Study Terminated by Sponsor|20
1628973|NCT01901302|5689656|P1|Overall Study|Study Terminated by Sponsor|23
1628974|NCT01901302|5689655|P2|Overall Study|Lack of Efficacy|2
1628975|NCT01901302|5689656|P1|Overall Study|Lack of Efficacy|0
1628976|NCT01901302|5689655|P2|Overall Study|Adverse Event|1
1628977|NCT01901302|5689656|P1|Overall Study|Adverse Event|2
1628978|NCT01901224|5689681|P1|Overall Study|study was not funded and terminated|2
1628979|NCT01901185|5689716|P1|Overall Study|Withdrawal by Subject|2
1628980|NCT01901146|5689725|P5|Adjuvant Phase|Withdrawal by Subject|4
1628981|NCT01901146|5689726|P4|Adjuvant Phase|Withdrawal by Subject|1
1628982|NCT01901146|5689727|P3|Adjuvant Phase|Withdrawal by Subject|4
1628983|NCT01901146|5689728|P2|Adjuvant Phase|Withdrawal by Subject|0
1628984|NCT01901146|5689729|P1|Adjuvant Phase|Withdrawal by Subject|0
1628985|NCT01901146|5689725|P5|Adjuvant Phase|Physician Decision|4
1628986|NCT01901146|5689726|P4|Adjuvant Phase|Physician Decision|2
1628987|NCT01901146|5689727|P3|Adjuvant Phase|Physician Decision|9
1628988|NCT01901146|5689728|P2|Adjuvant Phase|Physician Decision|0
1628989|NCT01901146|5689729|P1|Adjuvant Phase|Physician Decision|0
1628990|NCT01901146|5689725|P5|Adjuvant Phase|Disease Progression or Recurrence|3
1628991|NCT01901146|5689726|P4|Adjuvant Phase|Disease Progression or Recurrence|4
1628992|NCT01901146|5689727|P3|Adjuvant Phase|Disease Progression or Recurrence|12
1628993|NCT01901146|5689728|P2|Adjuvant Phase|Disease Progression or Recurrence|0
1628994|NCT01901146|5689729|P1|Adjuvant Phase|Disease Progression or Recurrence|0
1628995|NCT01901146|5689725|P5|Adjuvant Phase|Death|3
1628996|NCT01901146|5689726|P4|Adjuvant Phase|Death|0
1628997|NCT01901146|5689727|P3|Adjuvant Phase|Death|0
1628998|NCT01901146|5689728|P2|Adjuvant Phase|Death|0
1628999|NCT01901146|5689729|P1|Adjuvant Phase|Death|0
1629000|NCT01901146|5689725|P5|Adjuvant Phase|Other|0
1629001|NCT01901146|5689726|P4|Adjuvant Phase|Other|0
1629002|NCT01901146|5689727|P3|Adjuvant Phase|Other|1
1629003|NCT01901146|5689728|P2|Adjuvant Phase|Other|0
1629004|NCT01901146|5689729|P1|Adjuvant Phase|Other|0
1629005|NCT01901146|5689725|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1629006|NCT01901146|5689726|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1629007|NCT01901146|5689727|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1629008|NCT01901146|5689728|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
1629009|NCT01901146|5689729|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
1629010|NCT01901146|5689725|P5|Neoadjuvant Phase|Withdrawal by Subject|0
1629011|NCT01901146|5689726|P4|Neoadjuvant Phase|Withdrawal by Subject|0
1629012|NCT01901146|5689727|P3|Neoadjuvant Phase|Withdrawal by Subject|0
1629013|NCT01901146|5689728|P2|Neoadjuvant Phase|Withdrawal by Subject|5
1629014|NCT01901146|5689729|P1|Neoadjuvant Phase|Withdrawal by Subject|2
1629015|NCT01901146|5689725|P5|Neoadjuvant Phase|Physician Decision|0
1629016|NCT01901146|5689726|P4|Neoadjuvant Phase|Physician Decision|0
1629017|NCT01901146|5689727|P3|Neoadjuvant Phase|Physician Decision|0
1629018|NCT01901146|5689728|P2|Neoadjuvant Phase|Physician Decision|2
1629019|NCT01901146|5689729|P1|Neoadjuvant Phase|Physician Decision|1
1629020|NCT01901146|5689725|P5|Neoadjuvant Phase|Lost to Follow-up|0
1629021|NCT01901146|5689726|P4|Neoadjuvant Phase|Lost to Follow-up|0
1629022|NCT01901146|5689727|P3|Neoadjuvant Phase|Lost to Follow-up|0
1629023|NCT01901146|5689728|P2|Neoadjuvant Phase|Lost to Follow-up|1
1629024|NCT01901146|5689729|P1|Neoadjuvant Phase|Lost to Follow-up|0
1629025|NCT01901146|5689725|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
1629026|NCT01901146|5689726|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
1629027|NCT01901146|5689727|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
1629028|NCT01901146|5689728|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
1629029|NCT01901146|5689729|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
1629030|NCT01901146|5689725|P5|Neoadjuvant Phase|Death|0
1629031|NCT01901146|5689726|P4|Neoadjuvant Phase|Death|0
1629032|NCT01901146|5689727|P3|Neoadjuvant Phase|Death|0
1629033|NCT01901146|5689728|P2|Neoadjuvant Phase|Death|2
1629034|NCT01901146|5689729|P1|Neoadjuvant Phase|Death|1
1629035|NCT01900899|5689744|P2|Overall Study|Migrated from study area|0
1629036|NCT01900899|5689745|P1|Overall Study|Migrated from study area|2
1629037|NCT01900899|5689744|P2|Overall Study|Withdrawal by Subject|1
1629038|NCT01900899|5689745|P1|Overall Study|Withdrawal by Subject|7
1629043|NCT01900665|5689780|P2|Open Label Period|Withdrawal by Subject|28
1629044|NCT01900665|5689781|P1|Open Label Period|Withdrawal by Subject|20
1629045|NCT01900665|5689780|P2|Open Label Period|Sponsor Decision|765
1629046|NCT01900665|5689781|P1|Open Label Period|Sponsor Decision|802
1629047|NCT01900665|5689780|P2|Open Label Period|Protocol Violation|1
1629048|NCT01900665|5689781|P1|Open Label Period|Protocol Violation|0
1629049|NCT01900665|5689780|P2|Open Label Period|Physician Decision|4
1629050|NCT01900665|5689781|P1|Open Label Period|Physician Decision|4
1629051|NCT01900665|5689780|P2|Open Label Period|Parent/Caregiver Decision|34
1629052|NCT01900665|5689781|P1|Open Label Period|Parent/Caregiver Decision|33
1629053|NCT01900665|5689780|P2|Open Label Period|Lost to Follow-up|1
1629054|NCT01900665|5689781|P1|Open Label Period|Lost to Follow-up|1
1629055|NCT01900665|5689780|P2|Open Label Period|Death|6
1629056|NCT01900665|5689781|P1|Open Label Period|Death|5
1629057|NCT01900665|5689780|P2|Open Label Period|Adverse Event|20
1629058|NCT01900665|5689781|P1|Open Label Period|Adverse Event|16
1629059|NCT01900665|5689780|P2|Placebo Controlled Period|Entry Criteria Not Met|9
1629060|NCT01900665|5689781|P1|Placebo Controlled Period|Entry Criteria Not Met|5
1629061|NCT01900665|5689780|P2|Placebo Controlled Period|Caregiver Decision|41
1629062|NCT01900665|5689781|P1|Placebo Controlled Period|Caregiver Decision|33
1629063|NCT01900665|5689780|P2|Placebo Controlled Period|Lost to Follow-up|0
1629064|NCT01900665|5689781|P1|Placebo Controlled Period|Lost to Follow-up|3
1629065|NCT01900665|5689780|P2|Placebo Controlled Period|Physician Decision|7
1629066|NCT01900665|5689781|P1|Placebo Controlled Period|Physician Decision|11
1629067|NCT01900665|5689780|P2|Placebo Controlled Period|Withdrawal by Subject|45
1629068|NCT01900665|5689781|P1|Placebo Controlled Period|Withdrawal by Subject|33
1629069|NCT01900665|5689780|P2|Placebo Controlled Period|Protocol Violation|7
1629070|NCT01900665|5689781|P1|Placebo Controlled Period|Protocol Violation|1
1629071|NCT01900665|5689780|P2|Placebo Controlled Period|Adverse Event|39
1629072|NCT01900665|5689781|P1|Placebo Controlled Period|Adverse Event|48
1629073|NCT01900665|5689780|P2|Placebo Controlled Period|Death|16
1629074|NCT01900665|5689781|P1|Placebo Controlled Period|Death|9
1629075|NCT01900652|5689824|P2|Overall Study|Physician Decision|1
1629076|NCT01900652|5689825|P1|Overall Study|Physician Decision|1
1629077|NCT01900652|5689824|P2|Overall Study|Adverse Event|1
1629078|NCT01900652|5689825|P1|Overall Study|Adverse Event|2
1629079|NCT01900652|5689824|P2|Overall Study|Death|0
1629080|NCT01900652|5689825|P1|Overall Study|Death|3
1629081|NCT01900652|5689824|P2|Overall Study|Consent withdrawn by subject|1
1629082|NCT01900652|5689825|P1|Overall Study|Consent withdrawn by subject|1
1629083|NCT01900652|5689824|P2|Overall Study|Progressive Disease|0
1629084|NCT01900652|5689825|P1|Overall Study|Progressive Disease|1
1629085|NCT01900626|5689861|P2|Overall Study|study was closed due to low enrollment|1
1629086|NCT01900626|5689862|P1|Overall Study|study was closed due to low enrollment|1
1629087|NCT01900444|5689941|P1|Overall Study|Lost to Follow-up|1
1629088|NCT01900444|5689941|P1|Overall Study|Protocol Violation|2
1629089|NCT01900431|5689954|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
1629090|NCT01900431|5689955|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1629091|NCT01900431|5689956|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
1629092|NCT01900431|5689954|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
1629093|NCT01900431|5689955|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1629094|NCT01900431|5689956|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
1629095|NCT01900431|5689954|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
1629096|NCT01900431|5689955|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
1629097|NCT01900431|5689956|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
1629098|NCT01900431|5689954|P3|Extended Treatment Period (Part B)|Other than specified above|0
1629099|NCT01900431|5689955|P2|Extended Treatment Period (Part B)|Other than specified above|1
1629100|NCT01900431|5689956|P1|Extended Treatment Period (Part B)|Other than specified above|0
1629101|NCT01900431|5689954|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
1629102|NCT01900431|5689955|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
1629103|NCT01900431|5689956|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
1629104|NCT01900431|5689954|P3|Extended Treatment Period (Part B)|Adverse Event|0
1629105|NCT01900431|5689955|P2|Extended Treatment Period (Part B)|Adverse Event|2
1629106|NCT01900431|5689956|P1|Extended Treatment Period (Part B)|Adverse Event|0
1629107|NCT01900431|5689954|P3|Principal Treatment Period (Part A)|Other than specified above|0
1629108|NCT01900431|5689955|P2|Principal Treatment Period (Part A)|Other than specified above|1
1629109|NCT01900431|5689956|P1|Principal Treatment Period (Part A)|Other than specified above|0
1629110|NCT01900431|5689954|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
1629111|NCT01900431|5689955|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
1629112|NCT01900431|5689956|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
1629113|NCT01900431|5689954|P3|Principal Treatment Period (Part A)|Adverse Event|0
1629114|NCT01900431|5689955|P2|Principal Treatment Period (Part A)|Adverse Event|3
1629115|NCT01900431|5689956|P1|Principal Treatment Period (Part A)|Adverse Event|1
1629116|NCT01900314|5689998|P2|Overall Study|Withdrawal by Subject|3
1629117|NCT01900314|5689999|P1|Overall Study|Withdrawal by Subject|3
1629118|NCT01900314|5689998|P2|Overall Study|Protocol Violation|1
1629119|NCT01900314|5689999|P1|Overall Study|Protocol Violation|0
1629120|NCT01900314|5689998|P2|Overall Study|Lost to Follow-up|0
1629121|NCT01900314|5689999|P1|Overall Study|Lost to Follow-up|1
1629122|NCT01900054|5690029|P1|Overall Study|Withdrawal by Subject|1
1629123|NCT01900054|5690029|P1|Overall Study|Physician Decision|1
1629124|NCT01899768|5690038|P1|Part B|Withdrawal by Subject|1
1629125|NCT01899768|5690038|P1|Part B|Adverse Event|1
1629126|NCT01899768|5690038|P1|Part A|Withdrawal by Subject|1
1629127|NCT01899768|5690038|P1|Part A|Adverse Event|2
1629128|NCT01899742|5690112|P2|Overall Study|Withdrawal by Subject|5
1629129|NCT01899742|5690113|P1|Overall Study|Withdrawal by Subject|9
1629130|NCT01899742|5690112|P2|Overall Study|Protocol Violation|2
1629131|NCT01899742|5690113|P1|Overall Study|Protocol Violation|2
1629132|NCT01899742|5690112|P2|Overall Study|Lack of Efficacy|5
1629133|NCT01899742|5690113|P1|Overall Study|Lack of Efficacy|1
1629134|NCT01899742|5690112|P2|Overall Study|Adverse Event|4
1629135|NCT01899742|5690113|P1|Overall Study|Adverse Event|5
1629136|NCT01899729|5690126|P5|Overall Study|Lack of Efficacy|1
1629137|NCT01899729|5690127|P4|Overall Study|Lack of Efficacy|0
1629138|NCT01899729|5690128|P3|Overall Study|Lack of Efficacy|2
1629139|NCT01899729|5690129|P2|Overall Study|Lack of Efficacy|0
1629140|NCT01899729|5690130|P1|Overall Study|Lack of Efficacy|0
1629141|NCT01899729|5690126|P5|Overall Study|Withdrawal by Subject|0
1629142|NCT01899729|5690127|P4|Overall Study|Withdrawal by Subject|0
1629143|NCT01899729|5690128|P3|Overall Study|Withdrawal by Subject|0
1629144|NCT01899729|5690129|P2|Overall Study|Withdrawal by Subject|2
1629145|NCT01899729|5690130|P1|Overall Study|Withdrawal by Subject|1
1629146|NCT01899729|5690126|P5|Overall Study|Adverse Event|1
1629147|NCT01899729|5690127|P4|Overall Study|Adverse Event|0
1629148|NCT01899729|5690128|P3|Overall Study|Adverse Event|0
1629149|NCT01899729|5690129|P2|Overall Study|Adverse Event|0
1629150|NCT01899729|5690130|P1|Overall Study|Adverse Event|1
1629151|NCT01899144|5690177|P1|Treatment Period 5|Other|1
1629152|NCT01899144|5690177|P1|Treatment Period 3|Other|2
1629153|NCT01899144|5690177|P1|Treatment Period 2|Other|1
1629154|NCT01899053|5690213|P14|Overall Study|Symptomatic Deterioration|0
1629155|NCT01899053|5690214|P13|Overall Study|Symptomatic Deterioration|2
1629156|NCT01899053|5690215|P12|Overall Study|Symptomatic Deterioration|1
1629157|NCT01899053|5690216|P11|Overall Study|Symptomatic Deterioration|0
1629158|NCT01899053|5690217|P10|Overall Study|Symptomatic Deterioration|0
1629159|NCT01899053|5690218|P9|Overall Study|Symptomatic Deterioration|0
1629160|NCT01899053|5690219|P8|Overall Study|Symptomatic Deterioration|1
1629161|NCT01899053|5690220|P7|Overall Study|Symptomatic Deterioration|0
1629162|NCT01899053|5690221|P6|Overall Study|Symptomatic Deterioration|1
1629163|NCT01899053|5690222|P5|Overall Study|Symptomatic Deterioration|0
1629164|NCT01899053|5690223|P4|Overall Study|Symptomatic Deterioration|0
1629165|NCT01899053|5690224|P3|Overall Study|Symptomatic Deterioration|0
1629166|NCT01899053|5690225|P2|Overall Study|Symptomatic Deterioration|0
1629167|NCT01899053|5690226|P1|Overall Study|Symptomatic Deterioration|0
1629168|NCT01899053|5690213|P14|Overall Study|Unsatisfactory Therapeutic Response|0
1629169|NCT01899053|5690214|P13|Overall Study|Unsatisfactory Therapeutic Response|0
1629170|NCT01899053|5690215|P12|Overall Study|Unsatisfactory Therapeutic Response|0
1629171|NCT01899053|5690216|P11|Overall Study|Unsatisfactory Therapeutic Response|1
1629172|NCT01899053|5690217|P10|Overall Study|Unsatisfactory Therapeutic Response|0
1629173|NCT01899053|5690218|P9|Overall Study|Unsatisfactory Therapeutic Response|0
1629174|NCT01899053|5690219|P8|Overall Study|Unsatisfactory Therapeutic Response|0
1629175|NCT01899053|5690220|P7|Overall Study|Unsatisfactory Therapeutic Response|0
1629176|NCT01899053|5690221|P6|Overall Study|Unsatisfactory Therapeutic Response|0
1629177|NCT01899053|5690222|P5|Overall Study|Unsatisfactory Therapeutic Response|0
1629178|NCT01899053|5690223|P4|Overall Study|Unsatisfactory Therapeutic Response|0
1629179|NCT01899053|5690224|P3|Overall Study|Unsatisfactory Therapeutic Response|0
1629180|NCT01899053|5690225|P2|Overall Study|Unsatisfactory Therapeutic Response|1
1629181|NCT01899053|5690226|P1|Overall Study|Unsatisfactory Therapeutic Response|1
1629182|NCT01899053|5690213|P14|Overall Study|Protocol Violation|0
1629183|NCT01899053|5690214|P13|Overall Study|Protocol Violation|0
1629184|NCT01899053|5690215|P12|Overall Study|Protocol Violation|0
1629185|NCT01899053|5690216|P11|Overall Study|Protocol Violation|0
1629186|NCT01899053|5690217|P10|Overall Study|Protocol Violation|0
1629187|NCT01899053|5690218|P9|Overall Study|Protocol Violation|0
1629188|NCT01899053|5690219|P8|Overall Study|Protocol Violation|0
1629189|NCT01899053|5690220|P7|Overall Study|Protocol Violation|0
1629190|NCT01899053|5690221|P6|Overall Study|Protocol Violation|0
1629191|NCT01899053|5690222|P5|Overall Study|Protocol Violation|0
1629192|NCT01899053|5690223|P4|Overall Study|Protocol Violation|0
1629193|NCT01899053|5690224|P3|Overall Study|Protocol Violation|1
1629194|NCT01899053|5690225|P2|Overall Study|Protocol Violation|0
1629195|NCT01899053|5690226|P1|Overall Study|Protocol Violation|0
1629196|NCT01899053|5690213|P14|Overall Study|Withdrawal by Subject|1
1629197|NCT01899053|5690214|P13|Overall Study|Withdrawal by Subject|1
1629198|NCT01899053|5690215|P12|Overall Study|Withdrawal by Subject|0
1629199|NCT01899053|5690216|P11|Overall Study|Withdrawal by Subject|0
1629200|NCT01899053|5690217|P10|Overall Study|Withdrawal by Subject|0
1629201|NCT01899053|5690218|P9|Overall Study|Withdrawal by Subject|0
1629202|NCT01899053|5690219|P8|Overall Study|Withdrawal by Subject|1
1629203|NCT01899053|5690220|P7|Overall Study|Withdrawal by Subject|0
1629204|NCT01899053|5690221|P6|Overall Study|Withdrawal by Subject|0
1629205|NCT01899053|5690222|P5|Overall Study|Withdrawal by Subject|2
1629206|NCT01899053|5690223|P4|Overall Study|Withdrawal by Subject|0
1629207|NCT01899053|5690224|P3|Overall Study|Withdrawal by Subject|2
1629208|NCT01899053|5690225|P2|Overall Study|Withdrawal by Subject|1
1629209|NCT01899053|5690226|P1|Overall Study|Withdrawal by Subject|1
1629210|NCT01899053|5690213|P14|Overall Study|Reason Not Specified|0
1629211|NCT01899053|5690214|P13|Overall Study|Reason Not Specified|1
1629212|NCT01899053|5690215|P12|Overall Study|Reason Not Specified|0
1629213|NCT01899053|5690216|P11|Overall Study|Reason Not Specified|0
1629214|NCT01899053|5690217|P10|Overall Study|Reason Not Specified|0
1629215|NCT01899053|5690218|P9|Overall Study|Reason Not Specified|0
1629216|NCT01899053|5690219|P8|Overall Study|Reason Not Specified|0
1629217|NCT01899053|5690220|P7|Overall Study|Reason Not Specified|1
1629218|NCT01899053|5690221|P6|Overall Study|Reason Not Specified|0
1629219|NCT01899053|5690222|P5|Overall Study|Reason Not Specified|0
1629220|NCT01899053|5690223|P4|Overall Study|Reason Not Specified|0
1629221|NCT01899053|5690224|P3|Overall Study|Reason Not Specified|0
1629222|NCT01899053|5690225|P2|Overall Study|Reason Not Specified|0
1629223|NCT01899053|5690226|P1|Overall Study|Reason Not Specified|0
1629224|NCT01899053|5690213|P14|Overall Study|Adverse Event|2
1629225|NCT01899053|5690214|P13|Overall Study|Adverse Event|2
1629226|NCT01899053|5690215|P12|Overall Study|Adverse Event|1
1629227|NCT01899053|5690216|P11|Overall Study|Adverse Event|3
1629228|NCT01899053|5690217|P10|Overall Study|Adverse Event|0
1629229|NCT01899053|5690218|P9|Overall Study|Adverse Event|2
1629230|NCT01899053|5690219|P8|Overall Study|Adverse Event|0
1629231|NCT01899053|5690220|P7|Overall Study|Adverse Event|1
1629232|NCT01899053|5690221|P6|Overall Study|Adverse Event|1
1629233|NCT01899053|5690222|P5|Overall Study|Adverse Event|1
1629234|NCT01899053|5690223|P4|Overall Study|Adverse Event|3
1629235|NCT01899053|5690224|P3|Overall Study|Adverse Event|1
1629236|NCT01899053|5690225|P2|Overall Study|Adverse Event|1
1629237|NCT01899053|5690226|P1|Overall Study|Adverse Event|1
1629238|NCT01899053|5690213|P14|Overall Study|Progressive Disease|17
1629239|NCT01899053|5690214|P13|Overall Study|Progressive Disease|8
1629240|NCT01899053|5690215|P12|Overall Study|Progressive Disease|5
1629241|NCT01899053|5690216|P11|Overall Study|Progressive Disease|12
1629242|NCT01899053|5690217|P10|Overall Study|Progressive Disease|3
1629243|NCT01899053|5690218|P9|Overall Study|Progressive Disease|4
1629244|NCT01899053|5690219|P8|Overall Study|Progressive Disease|1
1629245|NCT01899053|5690220|P7|Overall Study|Progressive Disease|1
1629246|NCT01899053|5690221|P6|Overall Study|Progressive Disease|1
1629247|NCT01899053|5690222|P5|Overall Study|Progressive Disease|3
1629248|NCT01899053|5690223|P4|Overall Study|Progressive Disease|0
1629249|NCT01899053|5690224|P3|Overall Study|Progressive Disease|3
1629250|NCT01899053|5690225|P2|Overall Study|Progressive Disease|0
1629251|NCT01899053|5690226|P1|Overall Study|Progressive Disease|4
1629252|NCT01898884|5690483|P9|Multiple Dose Period|Randomized Not Treated|1
1629253|NCT01898884|5690484|P8|Multiple Dose Period|Randomized Not Treated|0
1629254|NCT01898884|5690485|P7|Multiple Dose Period|Randomized Not Treated|0
1629255|NCT01898884|5690486|P6|Multiple Dose Period|Randomized Not Treated|0
1629256|NCT01898884|5690487|P5|Multiple Dose Period|Randomized Not Treated|0
1629257|NCT01898884|5690488|P4|Multiple Dose Period|Randomized Not Treated|0
1629258|NCT01898884|5690489|P3|Multiple Dose Period|Randomized Not Treated|0
1629259|NCT01898884|5690490|P2|Multiple Dose Period|Randomized Not Treated|0
1629260|NCT01898884|5690491|P1|Multiple Dose Period|Randomized Not Treated|0
1629261|NCT01898884|5690483|P9|Multiple Dose Period|Adverse Event|0
1629262|NCT01898884|5690484|P8|Multiple Dose Period|Adverse Event|0
1629263|NCT01898884|5690485|P7|Multiple Dose Period|Adverse Event|1
1629264|NCT01898884|5690486|P6|Multiple Dose Period|Adverse Event|0
1629265|NCT01898884|5690487|P5|Multiple Dose Period|Adverse Event|0
1629266|NCT01898884|5690488|P4|Multiple Dose Period|Adverse Event|0
1629267|NCT01898884|5690489|P3|Multiple Dose Period|Adverse Event|0
1629268|NCT01898884|5690490|P2|Multiple Dose Period|Adverse Event|0
1629269|NCT01898884|5690491|P1|Multiple Dose Period|Adverse Event|0
1629270|NCT01898806|5690641|P1|Overall Study|Physician Decision|1
1629271|NCT01898806|5690641|P1|Overall Study|Withdrawal by Subject|2
1629272|NCT01898598|5690671|P2|Overall Study|Other|1
1629273|NCT01898598|5690672|P1|Overall Study|Other|0
1629274|NCT01898598|5690671|P2|Overall Study|Lost to Follow-up|1
1629275|NCT01898598|5690672|P1|Overall Study|Lost to Follow-up|0
1629276|NCT01898598|5690671|P2|Overall Study|Withdrawal by Subject|0
1629277|NCT01898598|5690672|P1|Overall Study|Withdrawal by Subject|3
1629278|NCT01898598|5690671|P2|Overall Study|Adverse Event|0
1629279|NCT01898598|5690672|P1|Overall Study|Adverse Event|1
1629280|NCT01898442|5690691|P3|Overall Study|Patient vomited pills|1
1629281|NCT01898442|5690692|P2|Overall Study|Patient vomited pills|0
1629282|NCT01898442|5690693|P1|Overall Study|Patient vomited pills|0
1629283|NCT01898442|5690691|P3|Overall Study|Hemolysis/technical problems|2
1629284|NCT01898442|5690692|P2|Overall Study|Hemolysis/technical problems|2
1629285|NCT01898442|5690693|P1|Overall Study|Hemolysis/technical problems|1
1629286|NCT01898286|5690728|P1|Overall Study|Lost to Follow-up|1
1629287|NCT01898286|5690728|P1|Overall Study|Protocol Violation|1
1629288|NCT01898286|5690728|P1|Overall Study|Withdrawal by Subject|1
1629289|NCT01898208|5690738|P3|Overall Study|Lost to Follow-up|1
1629290|NCT01898208|5690739|P2|Overall Study|Lost to Follow-up|1
1629291|NCT01898208|5690740|P1|Overall Study|Lost to Follow-up|3
1629292|NCT01898208|5690738|P3|Overall Study|System/Technical Error|3
1629293|NCT01898208|5690739|P2|Overall Study|System/Technical Error|2
1629294|NCT01898208|5690740|P1|Overall Study|System/Technical Error|1
1629295|NCT01898208|5690738|P3|Overall Study|Non-Blood Specimens in Bottles|4
1629296|NCT01898208|5690739|P2|Overall Study|Non-Blood Specimens in Bottles|5
1629297|NCT01898208|5690740|P1|Overall Study|Non-Blood Specimens in Bottles|3
1629298|NCT01898208|5690738|P3|Overall Study|Negative Gram Stain|6
1629299|NCT01898208|5690739|P2|Overall Study|Negative Gram Stain|9
1629300|NCT01898208|5690740|P1|Overall Study|Negative Gram Stain|6
1629301|NCT01898208|5690738|P3|Overall Study|Death/comfort care within 24 hours|8
1629302|NCT01898208|5690739|P2|Overall Study|Death/comfort care within 24 hours|9
1629303|NCT01898208|5690740|P1|Overall Study|Death/comfort care within 24 hours|10
1629304|NCT01898208|5690738|P3|Overall Study|Positive blood culture|15
1629305|NCT01898208|5690739|P2|Overall Study|Positive blood culture|23
1629306|NCT01898208|5690740|P1|Overall Study|Positive blood culture|17
1629307|NCT01898195|5690787|P3|Smoking Abstinence|Did not have good measurements|36
1629308|NCT01898195|5690788|P2|Smoking Abstinence|Did not have good measurements|38
1629309|NCT01898195|5690789|P1|Smoking Abstinence|Did not have good measurements|35
1629310|NCT01898130|5690800|P1|Follow up Until PD or Death|Lost to Follow-up|1
1629311|NCT01898130|5690800|P1|Treatment|Progressive Disease|4
1629312|NCT01898130|5690800|P1|Treatment|Withdrawal by Subject|2
1629313|NCT01898091|5690815|P2|Overall Study|Withdrawal by Subject|5
1629314|NCT01898091|5690816|P1|Overall Study|Withdrawal by Subject|1
1629315|NCT01898091|5690815|P2|Overall Study|Lost to Follow-up|1
1629316|NCT01898091|5690816|P1|Overall Study|Lost to Follow-up|1
1629317|NCT01898078|5690824|P2|Overall Study|Reason not Specified|1
1629318|NCT01898078|5690825|P1|Overall Study|Reason not Specified|0
1629319|NCT01898078|5690824|P2|Overall Study|Symptomatic Deterioration|0
1629320|NCT01898078|5690825|P1|Overall Study|Symptomatic Deterioration|2
1629321|NCT01898078|5690824|P2|Overall Study|Withdrawal by Subject|1
1629322|NCT01898078|5690825|P1|Overall Study|Withdrawal by Subject|1
1629323|NCT01898078|5690824|P2|Overall Study|Adverse Event|1
1629324|NCT01898078|5690825|P1|Overall Study|Adverse Event|2
1629325|NCT01898078|5690824|P2|Overall Study|Progressive Disease|5
1629326|NCT01898078|5690825|P1|Overall Study|Progressive Disease|1
1629327|NCT01897896|5690862|P2|Overall Study|Other than specified|1
1629328|NCT01897896|5690863|P1|Overall Study|Other than specified|2
1629329|NCT01897896|5690862|P2|Overall Study|Caregiver can no longer participate|2
1629330|NCT01897896|5690863|P1|Overall Study|Caregiver can no longer participate|0
1629331|NCT01897896|5690862|P2|Overall Study|Withdrawal per Investigator’s judgement|1
1629332|NCT01897896|5690863|P1|Overall Study|Withdrawal per Investigator’s judgement|1
1629333|NCT01897896|5690862|P2|Overall Study|Protocol Violation|1
1629334|NCT01897896|5690863|P1|Overall Study|Protocol Violation|1
1629335|NCT01897896|5690862|P2|Overall Study|Require drug that interfere with study|4
1629336|NCT01897896|5690863|P1|Overall Study|Require drug that interfere with study|1
1629337|NCT01897896|5690862|P2|Overall Study|Withdrawal by Subject|1
1629338|NCT01897896|5690863|P1|Overall Study|Withdrawal by Subject|7
1629339|NCT01897896|5690862|P2|Overall Study|Non-compliance with study drug dosing|1
1629340|NCT01897896|5690863|P1|Overall Study|Non-compliance with study drug dosing|1
1629341|NCT01897896|5690862|P2|Overall Study|Lost to Follow-up|0
1629342|NCT01897896|5690863|P1|Overall Study|Lost to Follow-up|1
1629343|NCT01897896|5690862|P2|Overall Study|Adverse Event|1
1629344|NCT01897896|5690863|P1|Overall Study|Adverse Event|11
1629345|NCT01897896|5690862|P2|Overall Study|Death|0
1629346|NCT01897896|5690863|P1|Overall Study|Death|1
1629347|NCT01897727|5690995|P2|Overall Study|Exclusion: central sleep apnea|1
1629348|NCT01897727|5690996|P1|Overall Study|Exclusion: central sleep apnea|0
1629349|NCT01897532|5691004|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
1629350|NCT01897532|5691005|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
1629351|NCT01897532|5691004|P2|Discontinuation From Trial|Not Treated|5
1629352|NCT01897532|5691005|P1|Discontinuation From Trial|Not Treated|7
1629353|NCT01897532|5691004|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
1629354|NCT01897532|5691005|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
1629355|NCT01897532|5691004|P2|Discontinuation From Treatment|Non compliance|15
1629356|NCT01897532|5691005|P1|Discontinuation From Treatment|Non compliance|24
1629357|NCT01897532|5691004|P2|Discontinuation From Treatment|Withdrawal by Subject|281
1629358|NCT01897532|5691005|P1|Discontinuation From Treatment|Withdrawal by Subject|333
1629359|NCT01897532|5691004|P2|Discontinuation From Treatment|Other reason than specified|176
1629360|NCT01897532|5691005|P1|Discontinuation From Treatment|Other reason than specified|196
1629361|NCT01897532|5691004|P2|Discontinuation From Treatment|Not Treated|5
1629362|NCT01897532|5691005|P1|Discontinuation From Treatment|Not Treated|7
1629363|NCT01897493|5691013|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
1629364|NCT01897233|5691049|P1|Part B (24 Weeks)|Physician Decision|1
1629365|NCT01897233|5691049|P1|Part B (24 Weeks)|Withdrawal by Subject|2
1629366|NCT01897233|5691049|P1|Part B (24 Weeks)|Adverse Event|1
1629367|NCT01896986|5691101|P2|Overall Study|samples lost|23
1629368|NCT01896986|5691102|P1|Overall Study|samples lost|14
1629369|NCT01896934|5691108|P1|Overall Study|Withdrawal by Subject|1
1629370|NCT01896934|5691108|P1|Overall Study|Adverse Event|1
1629371|NCT01896895|5691121|P4|Double-blind MP|Lost to Follow-up|0
1629372|NCT01896895|5691122|P3|Double-blind MP|Lost to Follow-up|1
1629373|NCT01896895|5691123|P2|Double-blind MP|Lost to Follow-up|0
1629374|NCT01896895|5691124|P1|Double-blind MP|Lost to Follow-up|1
1629375|NCT01896895|5691121|P4|Double-blind MP|Withdrawal by Subject|0
1629376|NCT01896895|5691122|P3|Double-blind MP|Withdrawal by Subject|1
1629377|NCT01896895|5691123|P2|Double-blind MP|Withdrawal by Subject|2
1629378|NCT01896895|5691124|P1|Double-blind MP|Withdrawal by Subject|0
1629379|NCT01896895|5691121|P4|Double-blind MP|Physician Decision|0
1629380|NCT01896895|5691122|P3|Double-blind MP|Physician Decision|1
1629381|NCT01896895|5691123|P2|Double-blind MP|Physician Decision|0
1629382|NCT01896895|5691124|P1|Double-blind MP|Physician Decision|0
1629383|NCT01896726|5691139|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
1629384|NCT01896726|5691139|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
1629385|NCT01896700|5691154|P2|Overall Study|Withdrawal by Subject|1
1629386|NCT01896700|5691155|P1|Overall Study|Withdrawal by Subject|0
1629387|NCT01896700|5691154|P2|Overall Study|Adverse Event|5
1629388|NCT01896700|5691155|P1|Overall Study|Adverse Event|4
1629389|NCT01896557|5691186|P2|Clopidogrel + GI Protector|Reading error|3
1629390|NCT01896557|5691187|P1|Clopidogrel + GI Protector|Reading error|1
1629391|NCT01896557|5691186|P2|Clopidogrel + GI Protector|low adherence|1
1629392|NCT01896557|5691187|P1|Clopidogrel + GI Protector|low adherence|1
1629393|NCT01896557|5691186|P2|Clopidogrel Alone|Adverse Event|0
1629394|NCT01896557|5691187|P1|Clopidogrel Alone|Adverse Event|1
1629395|NCT01896297|5691224|P1|Overall Study|Died in post treatment phase|1
1629396|NCT01896232|5691231|P2|Overall Study|Lost to Follow-up|12
1629397|NCT01896232|5691232|P1|Overall Study|Lost to Follow-up|9
1629398|NCT01896232|5691231|P2|Overall Study|Sponsor Decision|0
1629399|NCT01896232|5691232|P1|Overall Study|Sponsor Decision|2
1629400|NCT01896232|5691231|P2|Overall Study|Withdrawal by Subject|31
1629401|NCT01896232|5691232|P1|Overall Study|Withdrawal by Subject|32
1629402|NCT01896232|5691231|P2|Overall Study|Death|10
1629403|NCT01896232|5691232|P1|Overall Study|Death|6
1629404|NCT01896193|5691260|P2|Overall Study|Withdrew Consent|0
1629405|NCT01896193|5691261|P1|Overall Study|Withdrew Consent|1
1629406|NCT01896193|5691260|P2|Overall Study|Protocol Violation|1
1629407|NCT01896193|5691261|P1|Overall Study|Protocol Violation|0
1629408|NCT01896193|5691260|P2|Overall Study|Lack of Efficacy|11
1629409|NCT01896193|5691261|P1|Overall Study|Lack of Efficacy|20
1629410|NCT01896128|5691287|P2|Overall Study|Withdrawal by Subject|3
1629411|NCT01896128|5691288|P1|Overall Study|Withdrawal by Subject|3
1629412|NCT01896050|5691330|P2|Overall Study|Death|0
1629413|NCT01896050|5691331|P1|Overall Study|Death|1
1629414|NCT01896050|5691330|P2|Overall Study|Adverse Event|2
1629415|NCT01896050|5691331|P1|Overall Study|Adverse Event|37
1629416|NCT01895608|5691398|P4|Overall Study|Withdrawal by Subject|0
1629417|NCT01895608|5691399|P3|Overall Study|Withdrawal by Subject|2
1629418|NCT01895608|5691400|P2|Overall Study|Withdrawal by Subject|0
1629419|NCT01895608|5691401|P1|Overall Study|Withdrawal by Subject|0
1629420|NCT01895608|5691398|P4|Overall Study|change in health status|0
1629421|NCT01895608|5691399|P3|Overall Study|change in health status|1
1629422|NCT01895608|5691400|P2|Overall Study|change in health status|1
1629423|NCT01895608|5691401|P1|Overall Study|change in health status|0
1629424|NCT01895543|5691431|P1|Overall Study|Other (Not fulfilling above criteria)|24
1629425|NCT01895543|5691431|P1|Overall Study|Physician Decision|2
1629426|NCT01895543|5691431|P1|Overall Study|Protocol Violation|1
1629427|NCT01895543|5691431|P1|Overall Study|Subject's substantial non-compliance|6
1629428|NCT01895543|5691431|P1|Overall Study|Adverse Event|28
1629429|NCT01895543|5691431|P1|Overall Study|Lost to Follow-up|25
1629430|NCT01895543|5691431|P1|Overall Study|Withdrawal by Subject|43
1629431|NCT01895452|5691447|P2|Overall Study|Noncompliance with study drug|1
1629432|NCT01895452|5691448|P1|Overall Study|Noncompliance with study drug|0
1629433|NCT01895452|5691447|P2|Overall Study|Underlying disease|3
1629434|NCT01895452|5691448|P1|Overall Study|Underlying disease|0
1629435|NCT01895452|5691447|P2|Overall Study|Withdrawal by Subject|14
1629436|NCT01895452|5691448|P1|Overall Study|Withdrawal by Subject|2
1629437|NCT01895452|5691447|P2|Overall Study|Pregnancy|1
1629438|NCT01895452|5691448|P1|Overall Study|Pregnancy|0
1629439|NCT01895452|5691447|P2|Overall Study|Lost to Follow-up|5
1629440|NCT01895452|5691448|P1|Overall Study|Lost to Follow-up|1
1629441|NCT01895452|5691447|P2|Overall Study|Adverse Event|4
1629442|NCT01895452|5691448|P1|Overall Study|Adverse Event|1
1629443|NCT01895361|5691461|P3|Overall Study|Reasons different from categories above|4
1629444|NCT01895361|5691462|P2|Overall Study|Reasons different from categories above|3
1629445|NCT01895361|5691463|P1|Overall Study|Reasons different from categories above|7
1629446|NCT01895361|5691461|P3|Overall Study|Lack of Efficacy|0
1629447|NCT01895361|5691462|P2|Overall Study|Lack of Efficacy|1
1629448|NCT01895361|5691463|P1|Overall Study|Lack of Efficacy|0
1629449|NCT01895361|5691461|P3|Overall Study|Withdrawal by Subject|6
1629450|NCT01895361|5691462|P2|Overall Study|Withdrawal by Subject|6
1629451|NCT01895361|5691463|P1|Overall Study|Withdrawal by Subject|7
1629452|NCT01895361|5691461|P3|Overall Study|Physician Decision|2
1629453|NCT01895361|5691462|P2|Overall Study|Physician Decision|2
1629454|NCT01895361|5691463|P1|Overall Study|Physician Decision|2
1629455|NCT01895361|5691461|P3|Overall Study|Non-compliance with study|1
1629456|NCT01895361|5691462|P2|Overall Study|Non-compliance with study|3
1629457|NCT01895361|5691463|P1|Overall Study|Non-compliance with study|1
1629458|NCT01895361|5691461|P3|Overall Study|Lost to Follow-up|6
1629459|NCT01895361|5691462|P2|Overall Study|Lost to Follow-up|4
1629460|NCT01895361|5691463|P1|Overall Study|Lost to Follow-up|4
1629461|NCT01895361|5691461|P3|Overall Study|Death|2
1629462|NCT01895361|5691462|P2|Overall Study|Death|1
1629463|NCT01895361|5691463|P1|Overall Study|Death|2
1629464|NCT01895361|5691461|P3|Overall Study|Adverse Event|3
1629465|NCT01895361|5691462|P2|Overall Study|Adverse Event|1
1629466|NCT01895361|5691463|P1|Overall Study|Adverse Event|1
1629467|NCT01895335|5691492|P1|Overall Study|Other than Specified Above|44
1629468|NCT01895335|5691492|P1|Overall Study|Included But Not treated|1
1629469|NCT01895335|5691492|P1|Overall Study|Poor Compliance to Protocol|11
1629470|NCT01895335|5691492|P1|Overall Study|Lack of Efficacy|53
1629471|NCT01895335|5691492|P1|Overall Study|Adverse Event|106
1629472|NCT01895322|5691509|P1|Overall Study|Protocol Violation|10
1629473|NCT01895322|5691509|P1|Overall Study|Withdrawal by Subject|2
1629474|NCT01895322|5691509|P1|Overall Study|Adverse Event|1
1629475|NCT01895309|5691518|P2|Overall Study|Withdrawal by Subject|18
1629476|NCT01895309|5691519|P1|Overall Study|Withdrawal by Subject|9
1629477|NCT01895309|5691518|P2|Overall Study|Physician Decision|10
1629478|NCT01895309|5691519|P1|Overall Study|Physician Decision|15
1629479|NCT01895309|5691518|P2|Overall Study|Lost to Follow-up|3
1629480|NCT01895309|5691519|P1|Overall Study|Lost to Follow-up|1
1629481|NCT01895309|5691518|P2|Overall Study|Lack of Efficacy|3
1629482|NCT01895309|5691519|P1|Overall Study|Lack of Efficacy|1
1629483|NCT01895309|5691518|P2|Overall Study|Protocol Violation|0
1629484|NCT01895309|5691519|P1|Overall Study|Protocol Violation|1
1629485|NCT01895309|5691518|P2|Overall Study|Adverse Event|17
1629486|NCT01895309|5691519|P1|Overall Study|Adverse Event|13
1629487|NCT01895270|5691533|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
1629488|NCT01895270|5691534|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
1629489|NCT01895270|5691533|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
1629490|NCT01895270|5691534|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
1629491|NCT01895270|5691533|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
1629492|NCT01895270|5691534|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
1629493|NCT01895270|5691533|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
1629494|NCT01895270|5691534|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
1629495|NCT01895270|5691533|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
1629496|NCT01895270|5691534|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
1629497|NCT01895270|5691533|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
1629498|NCT01895270|5691534|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
1629499|NCT01895270|5691533|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
1629500|NCT01895270|5691534|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
1629501|NCT01895101|5691553|P3|Overall Study|coagulation disorder|0
1629502|NCT01895101|5691554|P2|Overall Study|coagulation disorder|1
1629503|NCT01895101|5691555|P1|Overall Study|coagulation disorder|0
1629504|NCT01895101|5691553|P3|Overall Study|Death|0
1629505|NCT01895101|5691554|P2|Overall Study|Death|1
1629506|NCT01895101|5691555|P1|Overall Study|Death|0
1629507|NCT01895101|5691553|P3|Overall Study|another study, enrolled in other study|0
1629508|NCT01895101|5691554|P2|Overall Study|another study, enrolled in other study|1
1629509|NCT01895101|5691555|P1|Overall Study|another study, enrolled in other study|0
1629510|NCT01895101|5691553|P3|Overall Study|Withdrawal by Subject|2
1629511|NCT01895101|5691554|P2|Overall Study|Withdrawal by Subject|1
1629512|NCT01895101|5691555|P1|Overall Study|Withdrawal by Subject|0
1629513|NCT01895101|5691553|P3|Overall Study|OPCAB procedure|3
1629514|NCT01895101|5691554|P2|Overall Study|OPCAB procedure|1
1629515|NCT01895101|5691555|P1|Overall Study|OPCAB procedure|1
1629516|NCT01894984|5691590|P2|Overall Study|Other|175
1629517|NCT01894984|5691591|P1|Overall Study|Other|314
1629518|NCT01894919|5691620|P13|Overall Study|Lost to Follow-up|0
1629519|NCT01894919|5691621|P12|Overall Study|Lost to Follow-up|0
1629520|NCT01894919|5691622|P11|Overall Study|Lost to Follow-up|0
1629521|NCT01894919|5691623|P10|Overall Study|Lost to Follow-up|0
1629522|NCT01894919|5691624|P9|Overall Study|Lost to Follow-up|0
1629523|NCT01894919|5691625|P8|Overall Study|Lost to Follow-up|0
1629524|NCT01894919|5691626|P7|Overall Study|Lost to Follow-up|0
1629525|NCT01894919|5691627|P6|Overall Study|Lost to Follow-up|0
1629526|NCT01894919|5691628|P5|Overall Study|Lost to Follow-up|2
1629527|NCT01894919|5691629|P4|Overall Study|Lost to Follow-up|0
1629528|NCT01894919|5691630|P3|Overall Study|Lost to Follow-up|0
1629529|NCT01894919|5691631|P2|Overall Study|Lost to Follow-up|0
1629530|NCT01894919|5691632|P1|Overall Study|Lost to Follow-up|0
1629531|NCT01894919|5691620|P13|Overall Study|Other-Unspecified|0
1629532|NCT01894919|5691621|P12|Overall Study|Other-Unspecified|0
1629533|NCT01894919|5691622|P11|Overall Study|Other-Unspecified|0
1629534|NCT01894919|5691623|P10|Overall Study|Other-Unspecified|0
1629535|NCT01894919|5691624|P9|Overall Study|Other-Unspecified|0
1629536|NCT01894919|5691625|P8|Overall Study|Other-Unspecified|0
1629537|NCT01894919|5691626|P7|Overall Study|Other-Unspecified|0
1629538|NCT01894919|5691627|P6|Overall Study|Other-Unspecified|0
1629539|NCT01894919|5691628|P5|Overall Study|Other-Unspecified|0
1629540|NCT01894919|5691629|P4|Overall Study|Other-Unspecified|0
1629541|NCT01894919|5691630|P3|Overall Study|Other-Unspecified|0
1629542|NCT01894919|5691631|P2|Overall Study|Other-Unspecified|0
1629543|NCT01894919|5691632|P1|Overall Study|Other-Unspecified|1
1629544|NCT01894919|5691620|P13|Overall Study|Adverse Event|0
1629545|NCT01894919|5691621|P12|Overall Study|Adverse Event|0
1629546|NCT01894919|5691622|P11|Overall Study|Adverse Event|1
1629547|NCT01894919|5691623|P10|Overall Study|Adverse Event|0
1629548|NCT01894919|5691624|P9|Overall Study|Adverse Event|0
1629549|NCT01894919|5691625|P8|Overall Study|Adverse Event|0
1629550|NCT01894919|5691626|P7|Overall Study|Adverse Event|0
1629551|NCT01894919|5691627|P6|Overall Study|Adverse Event|0
1629552|NCT01894919|5691628|P5|Overall Study|Adverse Event|0
1629553|NCT01894919|5691629|P4|Overall Study|Adverse Event|0
1629554|NCT01894919|5691630|P3|Overall Study|Adverse Event|0
1629555|NCT01894919|5691631|P2|Overall Study|Adverse Event|0
1629556|NCT01894919|5691632|P1|Overall Study|Adverse Event|0
1629557|NCT01894919|5691620|P13|Overall Study|Withdrawal by Subject|0
1629558|NCT01894919|5691621|P12|Overall Study|Withdrawal by Subject|0
1629559|NCT01894919|5691622|P11|Overall Study|Withdrawal by Subject|1
1629560|NCT01894919|5691623|P10|Overall Study|Withdrawal by Subject|1
1629561|NCT01894919|5691624|P9|Overall Study|Withdrawal by Subject|0
1629562|NCT01894919|5691625|P8|Overall Study|Withdrawal by Subject|0
1629563|NCT01894919|5691626|P7|Overall Study|Withdrawal by Subject|0
1629564|NCT01894919|5691627|P6|Overall Study|Withdrawal by Subject|0
1629565|NCT01894919|5691628|P5|Overall Study|Withdrawal by Subject|1
1629566|NCT01894919|5691629|P4|Overall Study|Withdrawal by Subject|0
1629567|NCT01894919|5691630|P3|Overall Study|Withdrawal by Subject|0
1629568|NCT01894919|5691631|P2|Overall Study|Withdrawal by Subject|0
1629569|NCT01894919|5691632|P1|Overall Study|Withdrawal by Subject|1
1629570|NCT01894841|5691787|P2|Overall Study|Lost to Follow-up|3
1629571|NCT01894841|5691788|P1|Overall Study|Lost to Follow-up|7
1629572|NCT01894841|5691787|P2|Overall Study|Withdrawn by investigator|2
1629573|NCT01894841|5691788|P1|Overall Study|Withdrawn by investigator|2
1629574|NCT01894841|5691787|P2|Overall Study|Withdrawal by Subject|4
1629575|NCT01894841|5691788|P1|Overall Study|Withdrawal by Subject|9
1629576|NCT01894620|5691812|P2|Overall Study|Withdrawal by Subject|1
1629577|NCT01894620|5691813|P1|Overall Study|Withdrawal by Subject|0
1629578|NCT01894607|5691821|P1|Overall Study|Ineligible|1
1629579|NCT01894581|5691828|P2|Overall Study|Screen Failure|4
1629580|NCT01894581|5691829|P1|Overall Study|Screen Failure|3
1629581|NCT01894581|5691828|P2|Overall Study|Withdrawal by Subject|3
1629582|NCT01894581|5691829|P1|Overall Study|Withdrawal by Subject|2
1629583|NCT01894568|5691837|P2|Overall Study|Lost to Follow-up|1
1629584|NCT01894568|5691838|P1|Overall Study|Lost to Follow-up|0
1629585|NCT01894568|5691837|P2|Overall Study|Physician Decision|0
1629586|NCT01894568|5691838|P1|Overall Study|Physician Decision|1
1629587|NCT01894568|5691837|P2|Overall Study|Withdrawal by Subject|5
1629588|NCT01894568|5691838|P1|Overall Study|Withdrawal by Subject|5
1629589|NCT01894568|5691837|P2|Overall Study|Protocol required discontinuation|1
1629590|NCT01894568|5691838|P1|Overall Study|Protocol required discontinuation|2
1629591|NCT01894568|5691837|P2|Overall Study|Adverse Event|3
1629592|NCT01894568|5691838|P1|Overall Study|Adverse Event|2
1629593|NCT01894477|5691889|P2|Overall Study|protocol changed due SC changed to cord|1
1629594|NCT01894477|5691890|P1|Overall Study|protocol changed due SC changed to cord|0
1629595|NCT01894477|5691889|P2|Overall Study|Protocol Violation|1
1629596|NCT01894477|5691890|P1|Overall Study|Protocol Violation|0
1629597|NCT01894256|5691901|P3|Part B|Lack of Efficacy|13
1629598|NCT01894256|5691902|P2|Part B|Lack of Efficacy|12
1629599|NCT01894256|5691903|P1|Part B|Lack of Efficacy|15
1629600|NCT01894256|5691901|P3|Part B|Withdrawal by Subject|0
1629601|NCT01894256|5691902|P2|Part B|Withdrawal by Subject|1
1629602|NCT01894256|5691903|P1|Part B|Withdrawal by Subject|0
1629603|NCT01894256|5691901|P3|Part B|Death|1
1629604|NCT01894256|5691902|P2|Part B|Death|1
1629605|NCT01894256|5691903|P1|Part B|Death|0
1629606|NCT01894256|5691901|P3|Part A|Adverse Event|0
1629607|NCT01894256|5691902|P2|Part A|Adverse Event|1
1629608|NCT01894256|5691903|P1|Part A|Adverse Event|0
1629609|NCT01894243|5691950|P3|Overall Study|Other|0
1629610|NCT01894243|5691951|P2|Overall Study|Other|0
1629611|NCT01894243|5691952|P1|Overall Study|Other|1
1629612|NCT01894243|5691950|P3|Overall Study|Subject decision|0
1629613|NCT01894243|5691951|P2|Overall Study|Subject decision|0
1629614|NCT01894243|5691952|P1|Overall Study|Subject decision|1
1629615|NCT01894243|5691950|P3|Overall Study|Condition under investigation worsened|2
1629616|NCT01894243|5691951|P2|Overall Study|Condition under investigation worsened|6
1629617|NCT01894243|5691952|P1|Overall Study|Condition under investigation worsened|8
1629618|NCT01894243|5691950|P3|Overall Study|Lack of Efficacy|1
1629619|NCT01894243|5691951|P2|Overall Study|Lack of Efficacy|3
1629620|NCT01894243|5691952|P1|Overall Study|Lack of Efficacy|3
1629621|NCT01894243|5691950|P3|Overall Study|Death|3
1629622|NCT01894243|5691951|P2|Overall Study|Death|0
1629623|NCT01894243|5691952|P1|Overall Study|Death|0
1629624|NCT01894243|5691950|P3|Overall Study|Adverse Event|2
1629625|NCT01894243|5691951|P2|Overall Study|Adverse Event|1
1629626|NCT01894243|5691952|P1|Overall Study|Adverse Event|0
1629627|NCT01894230|5691991|P2|Overall Study|Death|0
1629628|NCT01894230|5691992|P1|Overall Study|Death|1
1629629|NCT01894230|5691991|P2|Overall Study|Non-adherent|1
1629630|NCT01894230|5691992|P1|Overall Study|Non-adherent|0
1629631|NCT01894230|5691991|P2|Overall Study|Withdrawal by Subject|4
1629632|NCT01894230|5691992|P1|Overall Study|Withdrawal by Subject|4
1629633|NCT01894230|5691991|P2|Overall Study|Lost to Follow-up|2
1629634|NCT01894230|5691992|P1|Overall Study|Lost to Follow-up|2
1629635|NCT01894152|5692027|P1|Overall Study|No DMR or due to stent thrombosis|143
1629636|NCT01894100|5692076|P2|Overall Study|Withdrawal by Subject|0
1629637|NCT01894100|5692077|P1|Overall Study|Withdrawal by Subject|3
1629638|NCT01894100|5692076|P2|Overall Study|Lost to Follow-up|1
1629639|NCT01894100|5692077|P1|Overall Study|Lost to Follow-up|0
1629640|NCT01894022|5692102|P2|Overall Study|Study Closed/terminated|10
1629641|NCT01894022|5692103|P1|Overall Study|Study Closed/terminated|7
1629642|NCT01894022|5692102|P2|Overall Study|Adverse Event, non-fatal|0
1629643|NCT01894022|5692103|P1|Overall Study|Adverse Event, non-fatal|1
1629644|NCT01894022|5692102|P2|Overall Study|Death|0
1629645|NCT01894022|5692103|P1|Overall Study|Death|1
1629646|NCT01893905|5692172|P2|Overall Study|Other reason|3
1629647|NCT01893905|5692173|P1|Overall Study|Other reason|1
1629648|NCT01893905|5692172|P2|Overall Study|Lack of adherence to treatment|0
1629649|NCT01893905|5692173|P1|Overall Study|Lack of adherence to treatment|2
1629650|NCT01893905|5692172|P2|Overall Study|Protocol Violation|1
1629651|NCT01893905|5692173|P1|Overall Study|Protocol Violation|6
1629652|NCT01893905|5692172|P2|Overall Study|Lost to Follow-up|0
1629653|NCT01893905|5692173|P1|Overall Study|Lost to Follow-up|1
1629654|NCT01893905|5692172|P2|Overall Study|Lack of Efficacy|7
1629655|NCT01893905|5692173|P1|Overall Study|Lack of Efficacy|5
1629656|NCT01893905|5692172|P2|Overall Study|Adverse Event|3
1629657|NCT01893905|5692173|P1|Overall Study|Adverse Event|9
1629658|NCT01893905|5692172|P2|Overall Study|Withdrawal by Subject|0
1629659|NCT01893905|5692173|P1|Overall Study|Withdrawal by Subject|1
1629660|NCT01893411|5692212|P3|Overall Study|Lost to Follow-up|1
1629661|NCT01893411|5692213|P2|Overall Study|Lost to Follow-up|0
1629662|NCT01893411|5692214|P1|Overall Study|Lost to Follow-up|2
1629663|NCT01893411|5692212|P3|Overall Study|Withdrawal by Subject|3
1629664|NCT01893411|5692213|P2|Overall Study|Withdrawal by Subject|4
1629665|NCT01893411|5692214|P1|Overall Study|Withdrawal by Subject|7
1629666|NCT01893411|5692212|P3|Overall Study|Adverse Event|0
1629667|NCT01893411|5692213|P2|Overall Study|Adverse Event|0
1629668|NCT01893411|5692214|P1|Overall Study|Adverse Event|1
1629669|NCT01893411|5692212|P3|Overall Study|Other|3
1629670|NCT01893411|5692213|P2|Overall Study|Other|1
1629671|NCT01893411|5692214|P1|Overall Study|Other|3
1629672|NCT01893411|5692212|P3|Overall Study|Lack of Efficacy|0
1629673|NCT01893411|5692213|P2|Overall Study|Lack of Efficacy|1
1629674|NCT01893411|5692214|P1|Overall Study|Lack of Efficacy|2
1629675|NCT01893411|5692212|P3|Overall Study|Physician Decision|2
1629676|NCT01893411|5692213|P2|Overall Study|Physician Decision|1
1629677|NCT01893411|5692214|P1|Overall Study|Physician Decision|1
1629678|NCT01893411|5692212|P3|Overall Study|Protocol Violation|0
1629679|NCT01893411|5692213|P2|Overall Study|Protocol Violation|0
1629680|NCT01893411|5692214|P1|Overall Study|Protocol Violation|1
1629681|NCT01893346|5692311|P4|Overall Study|Withdrawal by Subject|0
1629682|NCT01893346|5692312|P3|Overall Study|Withdrawal by Subject|0
1629683|NCT01893346|5692313|P2|Overall Study|Withdrawal by Subject|0
1629684|NCT01893346|5692314|P1|Overall Study|Withdrawal by Subject|2
1629685|NCT01893346|5692311|P4|Overall Study|Protocol Violation|0
1629686|NCT01893346|5692312|P3|Overall Study|Protocol Violation|0
1629687|NCT01893346|5692313|P2|Overall Study|Protocol Violation|0
1629688|NCT01893346|5692314|P1|Overall Study|Protocol Violation|1
1629689|NCT01893346|5692311|P4|Overall Study|Lost to Follow-up|0
1629690|NCT01893346|5692312|P3|Overall Study|Lost to Follow-up|0
1629691|NCT01893346|5692313|P2|Overall Study|Lost to Follow-up|1
1629692|NCT01893346|5692314|P1|Overall Study|Lost to Follow-up|0
1629693|NCT01893281|5692328|P1|Overall Study|Withdrawal by Subject|1
1629694|NCT01893281|5692328|P1|Overall Study|Protocol Violation|1
1629695|NCT01893281|5692328|P1|Overall Study|Adverse Event|1
1629696|NCT01893203|5692335|P1|Overall Study|Withdrawal by Subject|1
1629697|NCT01892722|5692359|P2|Overall Study|Withdrawal by Subject|5
1629698|NCT01892722|5692360|P1|Overall Study|Withdrawal by Subject|3
1629699|NCT01892722|5692359|P2|Overall Study|Lack of Efficacy|7
1629700|NCT01892722|5692360|P1|Overall Study|Lack of Efficacy|0
1629701|NCT01892722|5692359|P2|Overall Study|Adverse Event|2
1629702|NCT01892722|5692360|P1|Overall Study|Adverse Event|3
1629703|NCT01892722|5692359|P2|Overall Study|Physician Decision|2
1629704|NCT01892722|5692360|P1|Overall Study|Physician Decision|1
1629705|NCT01892722|5692359|P2|Overall Study|Patient/guardian decision|2
1629706|NCT01892722|5692360|P1|Overall Study|Patient/guardian decision|0
1629707|NCT01892722|5692359|P2|Overall Study|Administrative problems|1
1629708|NCT01892722|5692360|P1|Overall Study|Administrative problems|0
1629709|NCT01892722|5692359|P2|Overall Study|Protocol deviation|1
1629710|NCT01892722|5692360|P1|Overall Study|Protocol deviation|0
1629711|NCT01892657|5692376|P1|Overall Study|Protocol Violation|12
1629712|NCT01892657|5692376|P1|Overall Study|Withdrawal by Subject|6
1629719|NCT01892436|5692418|P4|Overall Study|Adverse Event|3
1629720|NCT01892436|5692419|P3|Overall Study|Adverse Event|2
1629721|NCT01892436|5692420|P2|Overall Study|Adverse Event|6
1629722|NCT01892436|5692421|P1|Overall Study|Adverse Event|7
1629723|NCT01892436|5692418|P4|Overall Study|non-compliance with treatment|0
1629724|NCT01892436|5692419|P3|Overall Study|non-compliance with treatment|0
1629725|NCT01892436|5692420|P2|Overall Study|non-compliance with treatment|0
1629726|NCT01892436|5692421|P1|Overall Study|non-compliance with treatment|1
1629727|NCT01892436|5692418|P4|Overall Study|Lost to Follow-up|3
1629728|NCT01892436|5692419|P3|Overall Study|Lost to Follow-up|1
1629729|NCT01892436|5692420|P2|Overall Study|Lost to Follow-up|1
1629730|NCT01892436|5692421|P1|Overall Study|Lost to Follow-up|1
1629731|NCT01892436|5692418|P4|Overall Study|Lack of Efficacy|2
1629732|NCT01892436|5692419|P3|Overall Study|Lack of Efficacy|2
1629733|NCT01892436|5692420|P2|Overall Study|Lack of Efficacy|2
1629734|NCT01892436|5692421|P1|Overall Study|Lack of Efficacy|1
1629735|NCT01892436|5692418|P4|Overall Study|Technical problems|1
1629736|NCT01892436|5692419|P3|Overall Study|Technical problems|1
1629737|NCT01892436|5692420|P2|Overall Study|Technical problems|1
1629738|NCT01892436|5692421|P1|Overall Study|Technical problems|2
1629739|NCT01892436|5692418|P4|Overall Study|Pregnancy|0
1629740|NCT01892436|5692419|P3|Overall Study|Pregnancy|1
1629741|NCT01892436|5692420|P2|Overall Study|Pregnancy|2
1629742|NCT01892436|5692421|P1|Overall Study|Pregnancy|0
1629743|NCT01892436|5692418|P4|Overall Study|Physician Decision|1
1629744|NCT01892436|5692419|P3|Overall Study|Physician Decision|0
1629745|NCT01892436|5692420|P2|Overall Study|Physician Decision|1
1629746|NCT01892436|5692421|P1|Overall Study|Physician Decision|2
1629747|NCT01892436|5692418|P4|Overall Study|Death|0
1629748|NCT01892436|5692419|P3|Overall Study|Death|0
1629749|NCT01892436|5692420|P2|Overall Study|Death|1
1629750|NCT01892436|5692421|P1|Overall Study|Death|1
1629751|NCT01892436|5692418|P4|Overall Study|Withdrawal by Subject|4
1629752|NCT01892436|5692419|P3|Overall Study|Withdrawal by Subject|4
1629753|NCT01892436|5692420|P2|Overall Study|Withdrawal by Subject|15
1629754|NCT01892436|5692421|P1|Overall Study|Withdrawal by Subject|8
1629755|NCT01892345|5692461|P2|Overall Study|Withdrawal by Subject|1
1629756|NCT01892345|5692462|P1|Overall Study|Withdrawal by Subject|12
1629757|NCT01892345|5692461|P2|Overall Study|Lost to Follow-up|0
1629758|NCT01892345|5692462|P1|Overall Study|Lost to Follow-up|3
1629759|NCT01892345|5692461|P2|Overall Study|Death|0
1629760|NCT01892345|5692462|P1|Overall Study|Death|1
1629761|NCT01892345|5692461|P2|Overall Study|Adverse Event|2
1629762|NCT01892345|5692462|P1|Overall Study|Adverse Event|0
1629763|NCT01892293|5692503|P1|Overall Study|Apheresed but not treated|4
1629764|NCT01892189|5692547|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629765|NCT01892189|5692548|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629766|NCT01892189|5692549|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629767|NCT01892189|5692550|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
1629768|NCT01892189|5692551|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629769|NCT01892189|5692552|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629770|NCT01892189|5692553|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629771|NCT01892189|5692554|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629772|NCT01892189|5692555|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
1629773|NCT01892189|5692547|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1629774|NCT01892189|5692548|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1629775|NCT01892189|5692549|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1629776|NCT01892189|5692550|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1629777|NCT01892189|5692551|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1629778|NCT01892189|5692552|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1629779|NCT01892189|5692553|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
1629780|NCT01892189|5692554|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1629781|NCT01892189|5692555|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1629782|NCT01892189|5692547|P9|Washout Period 1 (7 Days)|Adverse Event|1
1629783|NCT01892189|5692548|P8|Washout Period 1 (7 Days)|Adverse Event|0
1629784|NCT01892189|5692549|P7|Washout Period 1 (7 Days)|Adverse Event|0
1629785|NCT01892189|5692550|P6|Washout Period 1 (7 Days)|Adverse Event|0
1629786|NCT01892189|5692551|P5|Washout Period 1 (7 Days)|Adverse Event|0
1629787|NCT01892189|5692552|P4|Washout Period 1 (7 Days)|Adverse Event|0
1629788|NCT01892189|5692553|P3|Washout Period 1 (7 Days)|Adverse Event|0
1629789|NCT01892189|5692554|P2|Washout Period 1 (7 Days)|Adverse Event|0
1629790|NCT01892189|5692555|P1|Washout Period 1 (7 Days)|Adverse Event|0
1629791|NCT01892163|5692597|P2|Overall Study|Lost to Follow-up|0
1629792|NCT01892163|5692598|P1|Overall Study|Lost to Follow-up|1
1629793|NCT01892163|5692597|P2|Overall Study|Death|1
1629794|NCT01892163|5692598|P1|Overall Study|Death|1
1629795|NCT01892020|5692610|P2|Period 2|Protocol Violation|0
1629796|NCT01892020|5692611|P1|Period 2|Protocol Violation|1
1629797|NCT01892020|5692610|P2|Period 1|Unclassified|1
1629798|NCT01892020|5692611|P1|Period 1|Unclassified|0
1629799|NCT01892020|5692610|P2|Period 1|Protocol Violation|4
1629800|NCT01892020|5692611|P1|Period 1|Protocol Violation|2
1629801|NCT01892020|5692610|P2|Period 1|Adverse Event|1
1629802|NCT01892020|5692611|P1|Period 1|Adverse Event|1
1629803|NCT01891890|5692640|P3|Overall Study|Study ended before endpoint reached|6
1629804|NCT01891890|5692641|P2|Overall Study|Study ended before endpoint reached|3
1629805|NCT01891890|5692642|P1|Overall Study|Study ended before endpoint reached|7
1629806|NCT01891890|5692640|P3|Overall Study|Lost to Follow-up|1
1629807|NCT01891890|5692641|P2|Overall Study|Lost to Follow-up|0
1629808|NCT01891890|5692642|P1|Overall Study|Lost to Follow-up|0
1629809|NCT01891864|5692685|P6|Extension Period|Lost to Follow-up|0
1629810|NCT01891864|5692686|P5|Extension Period|Lost to Follow-up|0
1629811|NCT01891864|5692687|P4|Extension Period|Lost to Follow-up|0
1629812|NCT01891864|5692688|P3|Extension Period|Lost to Follow-up|2
1629813|NCT01891864|5692689|P2|Extension Period|Lost to Follow-up|0
1629814|NCT01891864|5692690|P1|Extension Period|Lost to Follow-up|0
1629815|NCT01891864|5692685|P6|Extension Period|Withdrawal by Subject|0
1629816|NCT01891864|5692686|P5|Extension Period|Withdrawal by Subject|4
1629817|NCT01891864|5692687|P4|Extension Period|Withdrawal by Subject|2
1629818|NCT01891864|5692688|P3|Extension Period|Withdrawal by Subject|1
1629819|NCT01891864|5692689|P2|Extension Period|Withdrawal by Subject|0
1629820|NCT01891864|5692690|P1|Extension Period|Withdrawal by Subject|0
1629821|NCT01891864|5692685|P6|Extension Period|Adverse Event|0
1629822|NCT01891864|5692686|P5|Extension Period|Adverse Event|2
1629823|NCT01891864|5692687|P4|Extension Period|Adverse Event|2
1629824|NCT01891864|5692688|P3|Extension Period|Adverse Event|4
1629825|NCT01891864|5692689|P2|Extension Period|Adverse Event|0
1629826|NCT01891864|5692690|P1|Extension Period|Adverse Event|0
1629827|NCT01891864|5692685|P6|Extension Period|Pregnancy|0
1629828|NCT01891864|5692686|P5|Extension Period|Pregnancy|0
1629829|NCT01891864|5692687|P4|Extension Period|Pregnancy|0
1629830|NCT01891864|5692688|P3|Extension Period|Pregnancy|1
1629831|NCT01891864|5692689|P2|Extension Period|Pregnancy|0
1629832|NCT01891864|5692690|P1|Extension Period|Pregnancy|0
1629833|NCT01891864|5692685|P6|Extension Period|Lack of Efficacy|0
1629834|NCT01891864|5692686|P5|Extension Period|Lack of Efficacy|1
1629835|NCT01891864|5692687|P4|Extension Period|Lack of Efficacy|1
1629836|NCT01891864|5692688|P3|Extension Period|Lack of Efficacy|0
1629837|NCT01891864|5692689|P2|Extension Period|Lack of Efficacy|0
1629838|NCT01891864|5692690|P1|Extension Period|Lack of Efficacy|0
1629839|NCT01891864|5692685|P6|Treatment Period 2|Withdrawal by Subject|1
1629840|NCT01891864|5692686|P5|Treatment Period 2|Withdrawal by Subject|1
1629841|NCT01891864|5692687|P4|Treatment Period 2|Withdrawal by Subject|4
1629842|NCT01891864|5692688|P3|Treatment Period 2|Withdrawal by Subject|3
1629843|NCT01891864|5692689|P2|Treatment Period 2|Withdrawal by Subject|0
1629844|NCT01891864|5692690|P1|Treatment Period 2|Withdrawal by Subject|0
1629845|NCT01891864|5692685|P6|Treatment Period 2|Termination of Site|0
1629846|NCT01891864|5692686|P5|Treatment Period 2|Termination of Site|2
1629847|NCT01891864|5692687|P4|Treatment Period 2|Termination of Site|0
1629848|NCT01891864|5692688|P3|Treatment Period 2|Termination of Site|0
1629849|NCT01891864|5692689|P2|Treatment Period 2|Termination of Site|0
1629850|NCT01891864|5692690|P1|Treatment Period 2|Termination of Site|0
1629851|NCT01891864|5692685|P6|Treatment Period 2|Adverse Event|4
1629852|NCT01891864|5692686|P5|Treatment Period 2|Adverse Event|0
1629853|NCT01891864|5692687|P4|Treatment Period 2|Adverse Event|2
1629854|NCT01891864|5692688|P3|Treatment Period 2|Adverse Event|1
1629855|NCT01891864|5692689|P2|Treatment Period 2|Adverse Event|0
1629856|NCT01891864|5692690|P1|Treatment Period 2|Adverse Event|0
1629857|NCT01891864|5692685|P6|Treatment Period 2|Lack of Efficacy|0
1629858|NCT01891864|5692686|P5|Treatment Period 2|Lack of Efficacy|1
1629859|NCT01891864|5692687|P4|Treatment Period 2|Lack of Efficacy|0
1629860|NCT01891864|5692688|P3|Treatment Period 2|Lack of Efficacy|1
1629861|NCT01891864|5692689|P2|Treatment Period 2|Lack of Efficacy|0
1629862|NCT01891864|5692690|P1|Treatment Period 2|Lack of Efficacy|0
1629863|NCT01891864|5692685|P6|Treatment Period 2|Site Termination|0
1629864|NCT01891864|5692686|P5|Treatment Period 2|Site Termination|0
1629865|NCT01891864|5692687|P4|Treatment Period 2|Site Termination|2
1629866|NCT01891864|5692688|P3|Treatment Period 2|Site Termination|1
1629867|NCT01891864|5692689|P2|Treatment Period 2|Site Termination|0
1629868|NCT01891864|5692690|P1|Treatment Period 2|Site Termination|0
1629869|NCT01891864|5692685|P6|Treatment Period 2|Physician Decision|0
1629870|NCT01891864|5692686|P5|Treatment Period 2|Physician Decision|0
1629871|NCT01891864|5692687|P4|Treatment Period 2|Physician Decision|0
1629872|NCT01891864|5692688|P3|Treatment Period 2|Physician Decision|1
1629873|NCT01891864|5692689|P2|Treatment Period 2|Physician Decision|0
1629874|NCT01891864|5692690|P1|Treatment Period 2|Physician Decision|0
1629875|NCT01891864|5692685|P6|Treatment Period 2|Protocol Violation|0
1629876|NCT01891864|5692686|P5|Treatment Period 2|Protocol Violation|0
1629877|NCT01891864|5692687|P4|Treatment Period 2|Protocol Violation|1
1629878|NCT01891864|5692688|P3|Treatment Period 2|Protocol Violation|0
1629879|NCT01891864|5692689|P2|Treatment Period 2|Protocol Violation|0
1629880|NCT01891864|5692690|P1|Treatment Period 2|Protocol Violation|0
1629881|NCT01891864|5692685|P6|Treatment Period 1|Lost to Follow-up|0
1629882|NCT01891864|5692686|P5|Treatment Period 1|Lost to Follow-up|0
1629883|NCT01891864|5692687|P4|Treatment Period 1|Lost to Follow-up|0
1629884|NCT01891864|5692688|P3|Treatment Period 1|Lost to Follow-up|0
1629885|NCT01891864|5692689|P2|Treatment Period 1|Lost to Follow-up|0
1629886|NCT01891864|5692690|P1|Treatment Period 1|Lost to Follow-up|1
1629887|NCT01891864|5692685|P6|Treatment Period 1|Withdrawal by Subject|0
1629888|NCT01891864|5692686|P5|Treatment Period 1|Withdrawal by Subject|0
1629889|NCT01891864|5692687|P4|Treatment Period 1|Withdrawal by Subject|0
1629890|NCT01891864|5692688|P3|Treatment Period 1|Withdrawal by Subject|0
1629891|NCT01891864|5692689|P2|Treatment Period 1|Withdrawal by Subject|5
1629892|NCT01891864|5692690|P1|Treatment Period 1|Withdrawal by Subject|2
1629893|NCT01891864|5692685|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1629894|NCT01891864|5692686|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1629895|NCT01891864|5692687|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1629896|NCT01891864|5692688|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
1629897|NCT01891864|5692689|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1629898|NCT01891864|5692690|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
1629899|NCT01891864|5692685|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
1629900|NCT01891864|5692686|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
1629901|NCT01891864|5692687|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
1629902|NCT01891864|5692688|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
1629903|NCT01891864|5692689|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
1629904|NCT01891864|5692690|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
1629905|NCT01891864|5692685|P6|Treatment Period 1|Physician Decision|0
1629906|NCT01891864|5692686|P5|Treatment Period 1|Physician Decision|0
1629907|NCT01891864|5692687|P4|Treatment Period 1|Physician Decision|0
1629908|NCT01891864|5692688|P3|Treatment Period 1|Physician Decision|0
1629909|NCT01891864|5692689|P2|Treatment Period 1|Physician Decision|1
1629910|NCT01891864|5692690|P1|Treatment Period 1|Physician Decision|0
1629911|NCT01891864|5692685|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1629912|NCT01891864|5692686|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1629913|NCT01891864|5692687|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1629914|NCT01891864|5692688|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
1629915|NCT01891864|5692689|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1629916|NCT01891864|5692690|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
1629917|NCT01891721|5692726|P3|Overall Study|Lost to Follow-up|1
1629918|NCT01891721|5692727|P2|Overall Study|Lost to Follow-up|5
1629919|NCT01891721|5692728|P1|Overall Study|Lost to Follow-up|10
1629920|NCT01891669|5692752|P10|Overall Study|Other|0
1629921|NCT01891669|5692753|P9|Overall Study|Other|0
1629922|NCT01891669|5692754|P8|Overall Study|Other|1
1629923|NCT01891669|5692755|P7|Overall Study|Other|0
1629924|NCT01891669|5692756|P6|Overall Study|Other|0
1629925|NCT01891669|5692757|P5|Overall Study|Other|0
1629926|NCT01891669|5692758|P4|Overall Study|Other|0
1629927|NCT01891669|5692759|P3|Overall Study|Other|0
1629928|NCT01891669|5692760|P2|Overall Study|Other|0
1629929|NCT01891669|5692761|P1|Overall Study|Other|1
1629930|NCT01891669|5692752|P10|Overall Study|Withdrawal by Subject|1
1629931|NCT01891669|5692753|P9|Overall Study|Withdrawal by Subject|1
1629932|NCT01891669|5692754|P8|Overall Study|Withdrawal by Subject|2
1629933|NCT01891669|5692755|P7|Overall Study|Withdrawal by Subject|1
1629934|NCT01891669|5692756|P6|Overall Study|Withdrawal by Subject|0
1629935|NCT01891669|5692757|P5|Overall Study|Withdrawal by Subject|0
1629936|NCT01891669|5692758|P4|Overall Study|Withdrawal by Subject|0
1629937|NCT01891669|5692759|P3|Overall Study|Withdrawal by Subject|0
1629938|NCT01891669|5692760|P2|Overall Study|Withdrawal by Subject|1
1629939|NCT01891669|5692761|P1|Overall Study|Withdrawal by Subject|1
1629940|NCT01891669|5692752|P10|Overall Study|Death|1
1629941|NCT01891669|5692753|P9|Overall Study|Death|0
1629942|NCT01891669|5692754|P8|Overall Study|Death|1
1629943|NCT01891669|5692755|P7|Overall Study|Death|0
1629944|NCT01891669|5692756|P6|Overall Study|Death|0
1629945|NCT01891669|5692757|P5|Overall Study|Death|0
1629946|NCT01891669|5692758|P4|Overall Study|Death|0
1629947|NCT01891669|5692759|P3|Overall Study|Death|0
1629948|NCT01891669|5692760|P2|Overall Study|Death|0
1629949|NCT01891669|5692761|P1|Overall Study|Death|0
1629950|NCT01891357|5692912|P1|Overall Study|Protocol Violation|3
1629951|NCT01890967|5692959|P6|Overall Study|Withdrawal by Subject|1
1629952|NCT01890967|5692960|P5|Overall Study|Withdrawal by Subject|3
1629953|NCT01890967|5692961|P4|Overall Study|Withdrawal by Subject|3
1629954|NCT01890967|5692962|P3|Overall Study|Withdrawal by Subject|2
1629955|NCT01890967|5692963|P2|Overall Study|Withdrawal by Subject|4
1629956|NCT01890967|5692964|P1|Overall Study|Withdrawal by Subject|3
1629957|NCT01890967|5692959|P6|Overall Study|Sponsor Decision|3
1629958|NCT01890967|5692960|P5|Overall Study|Sponsor Decision|2
1629959|NCT01890967|5692961|P4|Overall Study|Sponsor Decision|3
1629960|NCT01890967|5692962|P3|Overall Study|Sponsor Decision|1
1629961|NCT01890967|5692963|P2|Overall Study|Sponsor Decision|0
1629962|NCT01890967|5692964|P1|Overall Study|Sponsor Decision|2
1629963|NCT01890967|5692959|P6|Overall Study|Protocol Violation|1
1629964|NCT01890967|5692960|P5|Overall Study|Protocol Violation|4
1629965|NCT01890967|5692961|P4|Overall Study|Protocol Violation|2
1629966|NCT01890967|5692962|P3|Overall Study|Protocol Violation|3
1629967|NCT01890967|5692963|P2|Overall Study|Protocol Violation|3
1629968|NCT01890967|5692964|P1|Overall Study|Protocol Violation|0
1629969|NCT01890967|5692959|P6|Overall Study|Lost to Follow-up|1
1629970|NCT01890967|5692960|P5|Overall Study|Lost to Follow-up|0
1629971|NCT01890967|5692961|P4|Overall Study|Lost to Follow-up|1
1629972|NCT01890967|5692962|P3|Overall Study|Lost to Follow-up|1
1629973|NCT01890967|5692963|P2|Overall Study|Lost to Follow-up|1
1629974|NCT01890967|5692964|P1|Overall Study|Lost to Follow-up|1
1629975|NCT01890967|5692959|P6|Overall Study|Death|0
1629976|NCT01890967|5692960|P5|Overall Study|Death|0
1629977|NCT01890967|5692961|P4|Overall Study|Death|0
1629978|NCT01890967|5692962|P3|Overall Study|Death|0
1629979|NCT01890967|5692963|P2|Overall Study|Death|0
1629980|NCT01890967|5692964|P1|Overall Study|Death|1
1629981|NCT01890967|5692959|P6|Overall Study|Adverse Event|7
1629982|NCT01890967|5692960|P5|Overall Study|Adverse Event|1
1629983|NCT01890967|5692961|P4|Overall Study|Adverse Event|2
1629984|NCT01890967|5692962|P3|Overall Study|Adverse Event|3
1629985|NCT01890967|5692963|P2|Overall Study|Adverse Event|3
1629986|NCT01890967|5692964|P1|Overall Study|Adverse Event|3
1629987|NCT01890915|5693042|P2|Overall Study|Equipment Malfunction|1
1629988|NCT01890915|5693043|P1|Overall Study|Equipment Malfunction|0
1629989|NCT01890915|5693042|P2|Overall Study|Protocol Violation|0
1629990|NCT01890915|5693043|P1|Overall Study|Protocol Violation|2
1629991|NCT01890915|5693042|P2|Overall Study|Adverse Event|0
1629992|NCT01890915|5693043|P1|Overall Study|Adverse Event|1
1629993|NCT01890785|5693059|P6|Third Intervention|Withdrawal by Subject|0
1629994|NCT01890785|5693060|P5|Third Intervention|Withdrawal by Subject|0
1629995|NCT01890785|5693061|P4|Third Intervention|Withdrawal by Subject|0
1629996|NCT01890785|5693062|P3|Third Intervention|Withdrawal by Subject|0
1629997|NCT01890785|5693063|P2|Third Intervention|Withdrawal by Subject|1
1629998|NCT01890785|5693064|P1|Third Intervention|Withdrawal by Subject|0
1629999|NCT01890759|5693083|P2|Overall Study|Withdrawal by Subject|8
1630000|NCT01890759|5693084|P1|Overall Study|Withdrawal by Subject|2
1630001|NCT01890759|5693083|P2|Overall Study|Lost to Follow-up|2
1630002|NCT01890759|5693084|P1|Overall Study|Lost to Follow-up|0
1630003|NCT01890759|5693083|P2|Overall Study|Protocol Violation|2
1630004|NCT01890759|5693084|P1|Overall Study|Protocol Violation|0
1630005|NCT01890746|5693118|P2|Overall Study|Withdrawal by Subject|8
1630006|NCT01890746|5693119|P1|Overall Study|Withdrawal by Subject|5
1630007|NCT01890746|5693118|P2|Overall Study|Physician Decision|2
1630008|NCT01890746|5693119|P1|Overall Study|Physician Decision|3
1630009|NCT01890746|5693118|P2|Overall Study|Lost to Follow-up|1
1630010|NCT01890746|5693119|P1|Overall Study|Lost to Follow-up|4
1630011|NCT01890746|5693118|P2|Overall Study|Adverse Event|0
1630012|NCT01890746|5693119|P1|Overall Study|Adverse Event|1
1630013|NCT01890746|5693118|P2|Overall Study|Death|30
1630014|NCT01890746|5693119|P1|Overall Study|Death|39
1630015|NCT01890707|5693205|P2|Overall Study|Lost to Follow-up|1
1630016|NCT01890707|5693206|P1|Overall Study|Lost to Follow-up|1
1630017|NCT01890512|5693285|P1|Overall Study|Protocol Violation|1
1630018|NCT01890512|5693285|P1|Overall Study|Withdrawal by Subject|1
1630019|NCT01890512|5693285|P1|Overall Study|Physician Decision|1
1630020|NCT01890473|5693291|P2|Overall Study|Poor/non-compliance|0
1630021|NCT01890473|5693292|P1|Overall Study|Poor/non-compliance|1
1630022|NCT01890473|5693291|P2|Overall Study|Lost to Follow-up|0
1630023|NCT01890473|5693292|P1|Overall Study|Lost to Follow-up|1
1630024|NCT01890434|5693318|P1|Overall Study|Withdrawal by PI for ICA not performed|2
1630025|NCT01890434|5693318|P1|Overall Study|Unable to contact|1
1630026|NCT01890434|5693318|P1|Overall Study|Moved out of position|1
1630027|NCT01890434|5693318|P1|Overall Study|Uncontactable by phone|1
1630028|NCT01890434|5693318|P1|Overall Study|Participant didn't complete MRI|1
1630029|NCT01890434|5693318|P1|Overall Study|GSPECT at rest was not done|1
1630030|NCT01890434|5693318|P1|Overall Study|Decline to return for GSPECT|1
1630031|NCT01890434|5693318|P1|Overall Study|Could not get whole set of images|1
1630032|NCT01890434|5693318|P1|Overall Study|CRC didn't contact participant for FU|1
1630033|NCT01890434|5693318|P1|Overall Study|Assessment discrepancy|1
1630034|NCT01890434|5693318|P1|Overall Study|PCI at external hospital|1
1630035|NCT01890434|5693318|P1|Overall Study|Adverse Event|8
1630036|NCT01890421|5693348|P1|Overall Study|Other reason|10
1630037|NCT01890421|5693348|P1|Overall Study|Adverse Event|1
1630038|NCT01890148|5693402|P1|Overall Study|Adverse Event|1
1630039|NCT01890122|5693422|P4|Overall Study|Randomized but not Treated|0
1630040|NCT01890122|5693423|P3|Overall Study|Randomized but not Treated|0
1630041|NCT01890122|5693424|P2|Overall Study|Randomized but not Treated|1
1630042|NCT01890122|5693425|P1|Overall Study|Randomized but not Treated|1
1630043|NCT01890122|5693422|P4|Overall Study|Reason not Specified|2
1630044|NCT01890122|5693423|P3|Overall Study|Reason not Specified|1
1630045|NCT01890122|5693424|P2|Overall Study|Reason not Specified|1
1630046|NCT01890122|5693425|P1|Overall Study|Reason not Specified|0
1630047|NCT01890122|5693422|P4|Overall Study|Lack of Efficacy|41
1630048|NCT01890122|5693423|P3|Overall Study|Lack of Efficacy|7
1630049|NCT01890122|5693424|P2|Overall Study|Lack of Efficacy|24
1630050|NCT01890122|5693425|P1|Overall Study|Lack of Efficacy|14
1630051|NCT01890122|5693422|P4|Overall Study|Voluntary Withdrawal|11
1630052|NCT01890122|5693423|P3|Overall Study|Voluntary Withdrawal|2
1630053|NCT01890122|5693424|P2|Overall Study|Voluntary Withdrawal|8
1630054|NCT01890122|5693425|P1|Overall Study|Voluntary Withdrawal|8
1630055|NCT01890122|5693422|P4|Overall Study|Lost to Follow-up|2
1630056|NCT01890122|5693423|P3|Overall Study|Lost to Follow-up|2
1630057|NCT01890122|5693424|P2|Overall Study|Lost to Follow-up|1
1630058|NCT01890122|5693425|P1|Overall Study|Lost to Follow-up|0
1630059|NCT01890122|5693422|P4|Overall Study|Major Protocol Deviation|1
1630060|NCT01890122|5693423|P3|Overall Study|Major Protocol Deviation|0
1630061|NCT01890122|5693424|P2|Overall Study|Major Protocol Deviation|1
1630062|NCT01890122|5693425|P1|Overall Study|Major Protocol Deviation|3
1630063|NCT01890122|5693422|P4|Overall Study|Adverse Event|2
1630064|NCT01890122|5693423|P3|Overall Study|Adverse Event|1
1630065|NCT01890122|5693424|P2|Overall Study|Adverse Event|1
1630066|NCT01890122|5693425|P1|Overall Study|Adverse Event|1
1630067|NCT01890109|5693489|P2|Overall Study|Lost to Follow-up|2
1630068|NCT01890109|5693490|P1|Overall Study|Lost to Follow-up|1
1630069|NCT01890109|5693489|P2|Overall Study|Withdrawal by Subject|3
1630070|NCT01890109|5693490|P1|Overall Study|Withdrawal by Subject|0
1630071|NCT01889602|5693595|P3|Third Intervention|Withdrawal by Subject|0
1630072|NCT01889602|5693596|P2|Third Intervention|Withdrawal by Subject|2
1630073|NCT01889602|5693597|P1|Third Intervention|Withdrawal by Subject|2
1630074|NCT01889602|5693595|P3|Third Intervention|Protocol Violation|0
1630075|NCT01889602|5693596|P2|Third Intervention|Protocol Violation|0
1630076|NCT01889602|5693597|P1|Third Intervention|Protocol Violation|1
1630077|NCT01889602|5693595|P3|Second Intervention|Withdrawal by Subject|1
1630078|NCT01889602|5693596|P2|Second Intervention|Withdrawal by Subject|0
1630079|NCT01889602|5693597|P1|Second Intervention|Withdrawal by Subject|0
1630080|NCT01889602|5693595|P3|Second Intervention|Study ending|0
1630081|NCT01889602|5693596|P2|Second Intervention|Study ending|0
1630082|NCT01889602|5693597|P1|Second Intervention|Study ending|1
1630083|NCT01889602|5693595|P3|Second Intervention|Adverse Event|1
1630084|NCT01889602|5693596|P2|Second Intervention|Adverse Event|0
1630085|NCT01889602|5693597|P1|Second Intervention|Adverse Event|0
1630086|NCT01889602|5693595|P3|First Intervention|Study ending|0
1630087|NCT01889602|5693596|P2|First Intervention|Study ending|1
1630088|NCT01889602|5693597|P1|First Intervention|Study ending|0
1630089|NCT01889602|5693595|P3|First Intervention|Protocol Violation|1
1630090|NCT01889602|5693596|P2|First Intervention|Protocol Violation|1
1630091|NCT01889602|5693597|P1|First Intervention|Protocol Violation|0
1630092|NCT01889602|5693595|P3|First Intervention|Adverse Event|1
1630093|NCT01889602|5693596|P2|First Intervention|Adverse Event|1
1630094|NCT01889602|5693597|P1|First Intervention|Adverse Event|1
1630095|NCT01889251|5693645|P2|Overall Study|Adverse Event|0
1630096|NCT01889251|5693646|P1|Overall Study|Adverse Event|1
1630097|NCT01889238|5693652|P1|Overall Study|Treatment ongoing|9
1630098|NCT01888965|5693669|P1|Overall Study|Lack of Efficacy|4
1630099|NCT01888965|5693669|P1|Overall Study|Adverse Event|5
1630100|NCT01888900|5693681|P2|Overall Study|failed treatment|2
1630101|NCT01888900|5693682|P1|Overall Study|failed treatment|0
1630102|NCT01888640|5693705|P3|Overall Study|Researcher Termination of Participant|1
1630103|NCT01888640|5693706|P2|Overall Study|Researcher Termination of Participant|1
1630104|NCT01888640|5693707|P1|Overall Study|Researcher Termination of Participant|0
1630105|NCT01888640|5693705|P3|Overall Study|Excluded for prior TENS|0
1630106|NCT01888640|5693706|P2|Overall Study|Excluded for prior TENS|1
1630107|NCT01888640|5693707|P1|Overall Study|Excluded for prior TENS|0
1630108|NCT01888640|5693705|P3|Overall Study|Given wrong unit (placebo)|0
1630109|NCT01888640|5693706|P2|Overall Study|Given wrong unit (placebo)|0
1630110|NCT01888640|5693707|P1|Overall Study|Given wrong unit (placebo)|1
1630111|NCT01888640|5693705|P3|Overall Study|Minimum dose not met|0
1630112|NCT01888640|5693706|P2|Overall Study|Minimum dose not met|16
1630113|NCT01888640|5693707|P1|Overall Study|Minimum dose not met|10
1630114|NCT01888640|5693705|P3|Overall Study|Withdrawal by Subject|4
1630115|NCT01888640|5693706|P2|Overall Study|Withdrawal by Subject|11
1630116|NCT01888640|5693707|P1|Overall Study|Withdrawal by Subject|15
1630117|NCT01888640|5693705|P3|Overall Study|Lost to Follow-up|0
1630118|NCT01888640|5693706|P2|Overall Study|Lost to Follow-up|2
1630119|NCT01888640|5693707|P1|Overall Study|Lost to Follow-up|1
1630120|NCT01888432|5693763|P2|36-month Analysis (Extension)|Death|0
1630121|NCT01888432|5693764|P1|36-month Analysis (Extension)|Death|1
1630122|NCT01888432|5693763|P2|24-month Analysis (FAS)|Death|4
1630123|NCT01888432|5693764|P1|24-month Analysis (FAS)|Death|8
1630124|NCT01888432|5693763|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
1630125|NCT01888432|5693764|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
1630126|NCT01888432|5693763|P2|24-month Analysis (FAS)|Physician Decision|4
1630127|NCT01888432|5693764|P1|24-month Analysis (FAS)|Physician Decision|2
1630128|NCT01888432|5693763|P2|24-month Analysis (FAS)|Lost to Follow-up|2
1630129|NCT01888432|5693764|P1|24-month Analysis (FAS)|Lost to Follow-up|0
1630130|NCT01888432|5693763|P2|24-month Analysis (FAS)|Graft loss|1
1630131|NCT01888432|5693764|P1|24-month Analysis (FAS)|Graft loss|0
1630132|NCT01888432|5693763|P2|12-month Analysis (FAS)|Death|3
1630133|NCT01888432|5693764|P1|12-month Analysis (FAS)|Death|4
1630134|NCT01888432|5693763|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
1630135|NCT01888432|5693764|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
1630136|NCT01888432|5693763|P2|12-month Analysis (FAS)|Physician Decision|1
1630137|NCT01888432|5693764|P1|12-month Analysis (FAS)|Physician Decision|1
1630138|NCT01888432|5693763|P2|12-month Analysis (FAS)|Lost to Follow-up|2
1630139|NCT01888432|5693764|P1|12-month Analysis (FAS)|Lost to Follow-up|0
1630140|NCT01888367|5693805|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1630141|NCT01888367|5693806|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
1630142|NCT01888367|5693807|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
1630143|NCT01888367|5693805|P3|Overall Study|Protocol Violation|1
1630144|NCT01888367|5693806|P2|Overall Study|Protocol Violation|0
1630145|NCT01888367|5693807|P1|Overall Study|Protocol Violation|0
1630146|NCT01888367|5693805|P3|Overall Study|Lost to Follow-up|0
1630147|NCT01888367|5693806|P2|Overall Study|Lost to Follow-up|1
1630148|NCT01888367|5693807|P1|Overall Study|Lost to Follow-up|1
1630149|NCT01888367|5693805|P3|Overall Study|Withdrawal by Subject|1
1630150|NCT01888367|5693806|P2|Overall Study|Withdrawal by Subject|0
1630151|NCT01888367|5693807|P1|Overall Study|Withdrawal by Subject|1
1630152|NCT01888367|5693805|P3|Overall Study|Death|1
1630153|NCT01888367|5693806|P2|Overall Study|Death|0
1630154|NCT01888367|5693807|P1|Overall Study|Death|2
1630155|NCT01888367|5693805|P3|Overall Study|Physician Decision|2
1630156|NCT01888367|5693806|P2|Overall Study|Physician Decision|4
1630157|NCT01888367|5693807|P1|Overall Study|Physician Decision|3
1630158|NCT01888003|5693827|P3|Overall Study|Study Terminated|40
1630159|NCT01888003|5693828|P2|Overall Study|Study Terminated|6
1630160|NCT01888003|5693829|P1|Overall Study|Study Terminated|5
1630161|NCT01887912|5693869|P2|Overall Study|Other|58
1630162|NCT01887912|5693870|P1|Overall Study|Other|122
1630163|NCT01887912|5693869|P2|Overall Study|Withdrawal by Subject|349
1630164|NCT01887912|5693870|P1|Overall Study|Withdrawal by Subject|606
1630165|NCT01887912|5693869|P2|Overall Study|Lost to Follow-up|74
1630166|NCT01887912|5693870|P1|Overall Study|Lost to Follow-up|163
1630167|NCT01887912|5693869|P2|Overall Study|Protocol Violation|37
1630168|NCT01887912|5693870|P1|Overall Study|Protocol Violation|67
1630169|NCT01887912|5693869|P2|Overall Study|Other Adverse Event|15
1630170|NCT01887912|5693870|P1|Overall Study|Other Adverse Event|34
1630171|NCT01887912|5693869|P2|Overall Study|Serious adverse event|198
1630172|NCT01887912|5693870|P1|Overall Study|Serious adverse event|400
1630173|NCT01887717|5693898|P2|Overall Study|Administrative reasons|2
1630174|NCT01887717|5693899|P1|Overall Study|Administrative reasons|5
1630175|NCT01887717|5693898|P2|Overall Study|Physician Decision|2
1630176|NCT01887717|5693899|P1|Overall Study|Physician Decision|0
1630177|NCT01887717|5693898|P2|Overall Study|Withdrawal by Subject|7
1630178|NCT01887717|5693899|P1|Overall Study|Withdrawal by Subject|1
1630179|NCT01887678|5693921|P2|Overall Study|Specified|2
1630180|NCT01887678|5693922|P1|Overall Study|Specified|1
1630181|NCT01887678|5693921|P2|Overall Study|Non-compliance|3
1630182|NCT01887678|5693922|P1|Overall Study|Non-compliance|0
1630183|NCT01887678|5693921|P2|Overall Study|Lack of Efficacy|2
1630184|NCT01887678|5693922|P1|Overall Study|Lack of Efficacy|1
1630185|NCT01887678|5693921|P2|Overall Study|Deterioration of clinical condition|4
1630186|NCT01887678|5693922|P1|Overall Study|Deterioration of clinical condition|0
1630187|NCT01887678|5693921|P2|Overall Study|Lost to Follow-up|2
1630188|NCT01887678|5693922|P1|Overall Study|Lost to Follow-up|4
1630189|NCT01887678|5693921|P2|Overall Study|Withdrawal of consent|4
1630190|NCT01887678|5693922|P1|Overall Study|Withdrawal of consent|3
1630191|NCT01887678|5693921|P2|Overall Study|Exceeded rescue medication dosage|5
1630192|NCT01887678|5693922|P1|Overall Study|Exceeded rescue medication dosage|4
1630193|NCT01887678|5693921|P2|Overall Study|Adverse Event|6
1630194|NCT01887678|5693922|P1|Overall Study|Adverse Event|4
1630195|NCT01887418|5693995|P3|Overall Study|Travelling difficulties|1
1630196|NCT01887418|5693996|P2|Overall Study|Travelling difficulties|0
1630197|NCT01887418|5693997|P1|Overall Study|Travelling difficulties|0
1630198|NCT01887353|5694016|P2|Overall Study|Study stopped early|3
1630199|NCT01887353|5694017|P1|Overall Study|Study stopped early|4
1630200|NCT01887288|5694045|P1|Overall Study|The study was terminated and the PI has|16
1630201|NCT01887210|5694052|P2|Overall Study|Lost to Follow-up|1
1630202|NCT01887210|5694053|P1|Overall Study|Lost to Follow-up|0
1630203|NCT01887210|5694052|P2|Overall Study|Withdrawal by Subject|3
1630204|NCT01887210|5694053|P1|Overall Study|Withdrawal by Subject|1
1630208|NCT01886833|5694135|P1|Overall Study|IgA not available from both periods|204
1630209|NCT01886781|5694167|P2|Overall Study|Worsening of symptoms|1
1630210|NCT01886781|5694168|P1|Overall Study|Worsening of symptoms|1
1630211|NCT01886781|5694167|P2|Overall Study|Withdrawal by Subject|1
1630212|NCT01886781|5694168|P1|Overall Study|Withdrawal by Subject|2
1630213|NCT01886781|5694167|P2|Overall Study|Lost to Follow-up|0
1630214|NCT01886781|5694168|P1|Overall Study|Lost to Follow-up|5
1630215|NCT01886781|5694167|P2|Overall Study|Adverse Event|0
1630216|NCT01886781|5694168|P1|Overall Study|Adverse Event|1
1630217|NCT01886781|5694167|P2|Overall Study|Protocol Violation|0
1630218|NCT01886781|5694168|P1|Overall Study|Protocol Violation|5
1630219|NCT01886716|5694178|P4|Week 3|Lost to Follow-up|1
1630220|NCT01886716|5694179|P3|Week 3|Lost to Follow-up|0
1630221|NCT01886716|5694180|P2|Week 3|Lost to Follow-up|1
1630222|NCT01886716|5694181|P1|Week 3|Lost to Follow-up|1
1630223|NCT01886716|5694178|P4|Week 2|Lost to Follow-up|3
1630224|NCT01886716|5694179|P3|Week 2|Lost to Follow-up|1
1630225|NCT01886716|5694180|P2|Week 2|Lost to Follow-up|2
1630226|NCT01886716|5694181|P1|Week 2|Lost to Follow-up|3
1630227|NCT01886716|5694178|P4|Week 1|Lost to Follow-up|2
1630228|NCT01886716|5694179|P3|Week 1|Lost to Follow-up|2
1630229|NCT01886716|5694180|P2|Week 1|Lost to Follow-up|0
1630230|NCT01886716|5694181|P1|Week 1|Lost to Follow-up|0
1630231|NCT01886690|5694197|P2|Overall Study|Personal Reasons|1
1630232|NCT01886690|5694198|P1|Overall Study|Personal Reasons|0
1630233|NCT01886690|5694197|P2|Overall Study|Protocol Violation|1
1630234|NCT01886690|5694198|P1|Overall Study|Protocol Violation|0
1630235|NCT01886313|5694214|P2|Overall Study|Adverse Event|1
1630236|NCT01886313|5694215|P1|Overall Study|Adverse Event|1
1630237|NCT01886300|5694221|P1|Overall Study|Trial terminated by sponsor|16
1630238|NCT01886287|5694232|P1|Overall Study|Clinical progression due to disease|1
1630239|NCT01886287|5694232|P1|Overall Study|Radiographic disease progression|1
1630240|NCT01886105|5694248|P1|Overall Study|Lack of Efficacy|3
1630241|NCT01885936|5694255|P2|Overall Study|Withdrawal by Subject|0
1630242|NCT01885936|5694256|P1|Overall Study|Withdrawal by Subject|1
1630243|NCT01885559|5694290|P2|Overall Study|Protocol Violation|1
1630244|NCT01885559|5694291|P1|Overall Study|Protocol Violation|0
1630245|NCT01885559|5694290|P2|Overall Study|Less than full participation|19
1630246|NCT01885559|5694291|P1|Overall Study|Less than full participation|9
1630247|NCT01885559|5694290|P2|Overall Study|Lost to Follow-up|16
1630248|NCT01885559|5694291|P1|Overall Study|Lost to Follow-up|15
1630249|NCT01885208|5694313|P2|Overall Study|Unclassified|38
1630250|NCT01885208|5694314|P1|Overall Study|Unclassified|32
1630251|NCT01885182|5694332|P2|Overall Study|Lack of Efficacy|1
1630252|NCT01885182|5694333|P1|Overall Study|Lack of Efficacy|8
1630253|NCT01885182|5694332|P2|Overall Study|Lost to Follow-up|2
1630254|NCT01885182|5694333|P1|Overall Study|Lost to Follow-up|2
1630255|NCT01885182|5694332|P2|Overall Study|Withdrawal by Subject|6
1630256|NCT01885182|5694333|P1|Overall Study|Withdrawal by Subject|13
1630257|NCT01885182|5694332|P2|Overall Study|Adverse Event|13
1630258|NCT01885182|5694333|P1|Overall Study|Adverse Event|11
1630259|NCT01885104|5694380|P2|Overall Study|Physician Decision|0
1630260|NCT01885104|5694381|P1|Overall Study|Physician Decision|1
1630261|NCT01885104|5694380|P2|Overall Study|Lost to Follow-up|1
1630262|NCT01885104|5694381|P1|Overall Study|Lost to Follow-up|0
1630263|NCT01885104|5694380|P2|Overall Study|Withdrawal of Consent|0
1630264|NCT01885104|5694381|P1|Overall Study|Withdrawal of Consent|1
1630265|NCT01885000|5694391|P2|Overall Study|Protocol Violation|1
1630266|NCT01885000|5694392|P1|Overall Study|Protocol Violation|0
1630267|NCT01885000|5694391|P2|Overall Study|Withdrawal by Subject|1
1630268|NCT01885000|5694392|P1|Overall Study|Withdrawal by Subject|1
1630269|NCT01885000|5694391|P2|Overall Study|Adverse Event|0
1630270|NCT01885000|5694392|P1|Overall Study|Adverse Event|1
1630271|NCT01884688|5694413|P1|Overall Study|Screen Failure|2
1630272|NCT01884675|5694419|P2|Overall Study|Study closed/terminated|2
1630273|NCT01884675|5694420|P1|Overall Study|Study closed/terminated|3
1630274|NCT01884597|5694463|P3|Overall Study|Death|0
1630275|NCT01884597|5694464|P2|Overall Study|Death|1
1630276|NCT01884597|5694465|P1|Overall Study|Death|0
1630277|NCT01884597|5694463|P3|Overall Study|Lack of Efficacy|0
1630278|NCT01884597|5694464|P2|Overall Study|Lack of Efficacy|0
1630279|NCT01884597|5694465|P1|Overall Study|Lack of Efficacy|1
1630280|NCT01884597|5694463|P3|Overall Study|Adverse Event|1
1630281|NCT01884597|5694464|P2|Overall Study|Adverse Event|0
1630282|NCT01884597|5694465|P1|Overall Study|Adverse Event|0
1630283|NCT01884571|5694494|P1|Overall Study|Disease progression|3
1630284|NCT01884571|5694494|P1|Overall Study|Withdrawal by Subject|2
1630285|NCT01884571|5694494|P1|Overall Study|Death|2
1630286|NCT01884571|5694494|P1|Overall Study|Adverse Event|1
1630287|NCT01884545|5694509|P4|Overall Study|Non-adherence|0
1630288|NCT01884545|5694510|P3|Overall Study|Non-adherence|0
1630289|NCT01884545|5694511|P2|Overall Study|Non-adherence|2
1630290|NCT01884545|5694512|P1|Overall Study|Non-adherence|0
1630291|NCT01884545|5694509|P4|Overall Study|Patient withdrawn|5
1630292|NCT01884545|5694510|P3|Overall Study|Patient withdrawn|5
1630293|NCT01884545|5694511|P2|Overall Study|Patient withdrawn|12
1630294|NCT01884545|5694512|P1|Overall Study|Patient withdrawn|7
1630295|NCT01884545|5694509|P4|Overall Study|Lost to Follow-up|4
1630296|NCT01884545|5694510|P3|Overall Study|Lost to Follow-up|9
1630297|NCT01884545|5694511|P2|Overall Study|Lost to Follow-up|4
1630298|NCT01884545|5694512|P1|Overall Study|Lost to Follow-up|6
1630299|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
1630300|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
1630301|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
1630302|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
1630303|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
1630304|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
1630305|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
1630306|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
1630307|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
1630308|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
1630309|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
1630310|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
1630311|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
1630312|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
1630313|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
1630314|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
1630315|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
1630316|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
1630317|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
1630318|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
1630319|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
1630320|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
1630321|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
1630322|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
1630323|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
1630324|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
1630325|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
1630326|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
1630327|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
1630328|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
1630329|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
1630330|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
1630331|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
1630332|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
1630333|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
1630334|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
1630335|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
1630336|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
1630337|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
1630338|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
1630339|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
1630340|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
1630341|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
1630342|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
1630343|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
1630344|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
1630345|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
1630346|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
1630347|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
1630348|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
1630349|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
1630350|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
1630351|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
1630352|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
1630353|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
1630354|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
1630355|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
1630356|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
1630357|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
1630358|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
1630359|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
1630360|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
1630361|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
1630362|NCT01884350|5694665|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
1630363|NCT01884350|5694666|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
1630364|NCT01884350|5694667|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
1630365|NCT01884337|5694690|P2|Follow-up Period|Lost to Follow-up|1
1630366|NCT01884337|5694691|P1|Follow-up Period|Lost to Follow-up|1
1630367|NCT01884337|5694690|P2|Treatment|Subj. request to discont. treatment|0
1630368|NCT01884337|5694691|P1|Treatment|Subj. request to discont. treatment|2
1630369|NCT01884337|5694690|P2|Treatment|Adverse Event|2
1630370|NCT01884337|5694691|P1|Treatment|Adverse Event|2
1630371|NCT01884311|5694699|P1|Overall Study|Precautionary measure|1
1630372|NCT01884311|5694699|P1|Overall Study|withdrew consent due to AEs|1
1630373|NCT01884311|5694699|P1|Overall Study|Withdrawal by Subject|3
1630374|NCT01884077|5694709|P2|Overall Study|study closed|4
1630375|NCT01884077|5694710|P1|Overall Study|study closed|6
1630376|NCT01884077|5694709|P2|Overall Study|Lost to Follow-up|4
1630377|NCT01884077|5694710|P1|Overall Study|Lost to Follow-up|0
1630378|NCT01884077|5694709|P2|Overall Study|canceled surgery|0
1630379|NCT01884077|5694710|P1|Overall Study|canceled surgery|2
1630380|NCT01884077|5694709|P2|Overall Study|screen fail|2
1630381|NCT01884077|5694710|P1|Overall Study|screen fail|0
1630382|NCT01884025|5694731|P2|Overall Study|Lost to Follow-up|4
1630383|NCT01884025|5694732|P1|Overall Study|Lost to Follow-up|3
1630384|NCT01883895|5694792|P1|Overall Study|Lost to Follow-up|2
1630385|NCT01883635|5694806|P2|Overall Study|Withdrawal by Subject|0
1630386|NCT01883635|5694807|P1|Overall Study|Withdrawal by Subject|4
1630399|NCT01883453|5694854|P2|Overall Study|No episode of common cold|23
1630400|NCT01883453|5694855|P1|Overall Study|No episode of common cold|25
1630401|NCT01882985|5694890|P1|Overall Study|Withdrawal by Subject|1
1630402|NCT01882985|5694890|P1|Overall Study|Lost to Follow-up|1
1630403|NCT01882907|5694899|P2|Overall Study|Withdrawal by Subject|6
1630404|NCT01882907|5694900|P1|Overall Study|Withdrawal by Subject|0
1630405|NCT01882907|5694899|P2|Overall Study|Protocol Violation|14
1630406|NCT01882907|5694900|P1|Overall Study|Protocol Violation|10
1630407|NCT01882907|5694899|P2|Overall Study|Lost to Follow-up|4
1630408|NCT01882907|5694900|P1|Overall Study|Lost to Follow-up|1
1630409|NCT01882907|5694899|P2|Overall Study|Lack of Efficacy|3
1630410|NCT01882907|5694900|P1|Overall Study|Lack of Efficacy|0
1630411|NCT01882907|5694899|P2|Overall Study|Adverse Event|1
1630412|NCT01882907|5694900|P1|Overall Study|Adverse Event|3
1630413|NCT01882829|5694946|P1|Overall Study|Withdrawal by Subject|1
1630414|NCT01882829|5694946|P1|Overall Study|Protocol Violation|1
1630415|NCT01882829|5694946|P1|Overall Study|Adverse Event|4
1630416|NCT01882803|5694960|P1|Overall Study|Withdrawal by Subject|4
1630417|NCT01882803|5694960|P1|Overall Study|Protocol Violation|1
1630418|NCT01882803|5694960|P1|Overall Study|Physician Decision|7
1630419|NCT01882803|5694960|P1|Overall Study|Death|7
1630420|NCT01882803|5694960|P1|Overall Study|Adverse Event|22
1630421|NCT01882803|5694960|P1|Overall Study|Disease Progression|53
1630422|NCT01882647|5694987|P2|Overall Study|Withdrawal by Subject|4
1630423|NCT01882647|5694988|P1|Overall Study|Withdrawal by Subject|0
1630424|NCT01882647|5694987|P2|Overall Study|Lost to Follow-up|2
1630425|NCT01882647|5694988|P1|Overall Study|Lost to Follow-up|2
1630426|NCT01882465|5695028|P7|Period 2|Protocol Violation|0
1630427|NCT01882465|5695029|P6|Period 2|Protocol Violation|0
1630428|NCT01882465|5695030|P5|Period 2|Protocol Violation|1
1630429|NCT01882465|5695031|P4|Period 2|Protocol Violation|0
1630430|NCT01882465|5695032|P3|Period 2|Protocol Violation|0
1630431|NCT01882465|5695033|P2|Period 2|Protocol Violation|0
1630432|NCT01882465|5695034|P1|Period 2|Protocol Violation|0
1630433|NCT01882465|5695028|P7|Period 1|Withdrawal by Subject|1
1630434|NCT01882465|5695029|P6|Period 1|Withdrawal by Subject|0
1630435|NCT01882465|5695030|P5|Period 1|Withdrawal by Subject|0
1630436|NCT01882465|5695031|P4|Period 1|Withdrawal by Subject|0
1630437|NCT01882465|5695032|P3|Period 1|Withdrawal by Subject|0
1630438|NCT01882465|5695033|P2|Period 1|Withdrawal by Subject|0
1630439|NCT01882465|5695034|P1|Period 1|Withdrawal by Subject|0
1630440|NCT01882465|5695028|P7|Period 1|Lens Discomfort|0
1630441|NCT01882465|5695029|P6|Period 1|Lens Discomfort|0
1630442|NCT01882465|5695030|P5|Period 1|Lens Discomfort|0
1630443|NCT01882465|5695031|P4|Period 1|Lens Discomfort|1
1630444|NCT01882465|5695032|P3|Period 1|Lens Discomfort|0
1630445|NCT01882465|5695033|P2|Period 1|Lens Discomfort|0
1630446|NCT01882465|5695034|P1|Period 1|Lens Discomfort|0
1630447|NCT01882439|5695046|P4|Overall Study|Adverse event unrelated to study drug|1
1630448|NCT01882439|5695047|P3|Overall Study|Adverse event unrelated to study drug|1
1630449|NCT01882439|5695048|P2|Overall Study|Adverse event unrelated to study drug|2
1630450|NCT01882439|5695049|P1|Overall Study|Adverse event unrelated to study drug|2
1630451|NCT01882439|5695046|P4|Overall Study|Insufficient clinical response|2
1630452|NCT01882439|5695047|P3|Overall Study|Insufficient clinical response|4
1630453|NCT01882439|5695048|P2|Overall Study|Insufficient clinical response|4
1630454|NCT01882439|5695049|P1|Overall Study|Insufficient clinical response|1
1630455|NCT01882439|5695046|P4|Overall Study|Medication error with no associated AE|0
1630456|NCT01882439|5695047|P3|Overall Study|Medication error with no associated AE|2
1630457|NCT01882439|5695048|P2|Overall Study|Medication error with no associated AE|0
1630458|NCT01882439|5695049|P1|Overall Study|Medication error with no associated AE|0
1630459|NCT01882439|5695046|P4|Overall Study|No longer willing to participate|3
1630460|NCT01882439|5695047|P3|Overall Study|No longer willing to participate|2
1630461|NCT01882439|5695048|P2|Overall Study|No longer willing to participate|4
1630462|NCT01882439|5695049|P1|Overall Study|No longer willing to participate|1
1630463|NCT01882439|5695046|P4|Overall Study|Protocol Violation|1
1630464|NCT01882439|5695047|P3|Overall Study|Protocol Violation|0
1630465|NCT01882439|5695048|P2|Overall Study|Protocol Violation|2
1630466|NCT01882439|5695049|P1|Overall Study|Protocol Violation|2
1630467|NCT01882439|5695046|P4|Overall Study|Pregnancy|0
1630468|NCT01882439|5695047|P3|Overall Study|Pregnancy|0
1630469|NCT01882439|5695048|P2|Overall Study|Pregnancy|1
1630470|NCT01882439|5695049|P1|Overall Study|Pregnancy|0
1630471|NCT01882439|5695046|P4|Overall Study|Adverse event related to study drug|2
1630472|NCT01882439|5695047|P3|Overall Study|Adverse event related to study drug|1
1630473|NCT01882439|5695048|P2|Overall Study|Adverse event related to study drug|8
1630474|NCT01882439|5695049|P1|Overall Study|Adverse event related to study drug|3
1630475|NCT01882257|5695246|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
1630476|NCT01882257|5695247|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
1630477|NCT01882257|5695248|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
1630478|NCT01882257|5695246|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
1630479|NCT01882257|5695247|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
1630480|NCT01882257|5695248|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
1630481|NCT01882088|5695255|P1|Overall Study|inadequate pH-impedance tracings|2
1630482|NCT01882088|5695255|P1|Overall Study|Protocol Violation|1
1630483|NCT01882088|5695255|P1|Overall Study|no possibility to place the catheter|1
1630484|NCT01882088|5695255|P1|Overall Study|Intolerance of esophageal manometry|1
1630485|NCT01881776|5695337|P3|Overall Study|Protocol Violation|1
1630486|NCT01881776|5695338|P2|Overall Study|Protocol Violation|2
1630487|NCT01881776|5695339|P1|Overall Study|Protocol Violation|0
1630488|NCT01881776|5695337|P3|Overall Study|Lost to Follow-up|1
1630489|NCT01881776|5695338|P2|Overall Study|Lost to Follow-up|2
1630490|NCT01881776|5695339|P1|Overall Study|Lost to Follow-up|1
1630491|NCT01881750|5695367|P2|Overall Study|Lost to Follow-up|1
1630492|NCT01881750|5695368|P1|Overall Study|Lost to Follow-up|0
1630493|NCT01881750|5695367|P2|Overall Study|Changes in concomitant therapies|3
1630494|NCT01881750|5695368|P1|Overall Study|Changes in concomitant therapies|2
1630495|NCT01881737|5695386|P1|Overall Study|Worsening of baseline behavior|1
1630496|NCT01881737|5695386|P1|Overall Study|Withdrawal by Subject|1
1630497|NCT01881737|5695386|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1630498|NCT01881620|5695395|P1|Overall Study|Protocol Violation|4
1630499|NCT01881230|5695407|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
1630500|NCT01881230|5695408|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
1630501|NCT01881230|5695409|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
1630502|NCT01881230|5695407|P3|Overall Study|Untreated: Death|1
1630503|NCT01881230|5695408|P2|Overall Study|Untreated: Death|0
1630504|NCT01881230|5695409|P1|Overall Study|Untreated: Death|0
1630505|NCT01881230|5695407|P3|Overall Study|Untreated: Other|1
1630506|NCT01881230|5695408|P2|Overall Study|Untreated: Other|0
1630507|NCT01881230|5695409|P1|Overall Study|Untreated: Other|0
1630508|NCT01881230|5695407|P3|Overall Study|Miscellaneous|0
1630509|NCT01881230|5695408|P2|Overall Study|Miscellaneous|3
1630510|NCT01881230|5695409|P1|Overall Study|Miscellaneous|3
1630511|NCT01881230|5695407|P3|Overall Study|Protocol Violation|0
1630512|NCT01881230|5695408|P2|Overall Study|Protocol Violation|1
1630513|NCT01881230|5695409|P1|Overall Study|Protocol Violation|1
1630514|NCT01881230|5695407|P3|Overall Study|Given Commercially Available Drug|2
1630515|NCT01881230|5695408|P2|Overall Study|Given Commercially Available Drug|0
1630516|NCT01881230|5695409|P1|Overall Study|Given Commercially Available Drug|0
1630517|NCT01881230|5695407|P3|Overall Study|Non-Compliance with Study Drug|0
1630518|NCT01881230|5695408|P2|Overall Study|Non-Compliance with Study Drug|2
1630519|NCT01881230|5695409|P1|Overall Study|Non-Compliance with Study Drug|1
1630520|NCT01881230|5695407|P3|Overall Study|Physician Decision|6
1630521|NCT01881230|5695408|P2|Overall Study|Physician Decision|3
1630522|NCT01881230|5695409|P1|Overall Study|Physician Decision|4
1630523|NCT01881230|5695407|P3|Overall Study|Withdrawal by Subject|6
1630524|NCT01881230|5695408|P2|Overall Study|Withdrawal by Subject|4
1630525|NCT01881230|5695409|P1|Overall Study|Withdrawal by Subject|6
1630526|NCT01881230|5695407|P3|Overall Study|Symptomatic Deterioration|1
1630527|NCT01881230|5695408|P2|Overall Study|Symptomatic Deterioration|3
1630528|NCT01881230|5695409|P1|Overall Study|Symptomatic Deterioration|3
1630529|NCT01881230|5695407|P3|Overall Study|Progressive Disease|36
1630530|NCT01881230|5695408|P2|Overall Study|Progressive Disease|35
1630531|NCT01881230|5695409|P1|Overall Study|Progressive Disease|31
1630532|NCT01881230|5695407|P3|Overall Study|Adverse Event|12
1630533|NCT01881230|5695408|P2|Overall Study|Adverse Event|13
1630534|NCT01881230|5695409|P1|Overall Study|Adverse Event|9
1630535|NCT01881230|5695407|P3|Overall Study|Death|1
1630536|NCT01881230|5695408|P2|Overall Study|Death|0
1630537|NCT01881230|5695409|P1|Overall Study|Death|2
1630538|NCT01881126|5695437|P2|Overall Study|Adverse Event|1
1630539|NCT01881126|5695438|P1|Overall Study|Adverse Event|0
1630540|NCT01881126|5695437|P2|Overall Study|Non-compliance|1
1630541|NCT01881126|5695438|P1|Overall Study|Non-compliance|1
1630542|NCT01881009|5695519|P2|Summer Camp Session (6 Days)|Unable to wear device|1
1630543|NCT01881009|5695520|P1|Summer Camp Session (6 Days)|Unable to wear device|0
1630544|NCT01880736|5695542|P4|Overall Study|Withdrawal Criteria|5
1630545|NCT01880736|5695543|P3|Overall Study|Withdrawal Criteria|1
1630546|NCT01880736|5695544|P2|Overall Study|Withdrawal Criteria|2
1630547|NCT01880736|5695545|P1|Overall Study|Withdrawal Criteria|1
1630548|NCT01880736|5695542|P4|Overall Study|Adverse Event|1
1630549|NCT01880736|5695543|P3|Overall Study|Adverse Event|0
1630550|NCT01880736|5695544|P2|Overall Study|Adverse Event|0
1630551|NCT01880736|5695545|P1|Overall Study|Adverse Event|0
1630552|NCT01880593|5695629|P2|Overall Study|Withdrawal by Subject|1
1630553|NCT01880593|5695630|P1|Overall Study|Withdrawal by Subject|6
1630554|NCT01880593|5695629|P2|Overall Study|Lack of Efficacy|5
1630555|NCT01880593|5695630|P1|Overall Study|Lack of Efficacy|1
1630556|NCT01880593|5695629|P2|Overall Study|Adverse Event|0
1630557|NCT01880593|5695630|P1|Overall Study|Adverse Event|1
1630558|NCT01880528|5695650|P2|Overall Study|Other|1
1630559|NCT01880528|5695651|P1|Overall Study|Other|1
1630560|NCT01880515|5695667|P2|Overall Study|Disease Progression|7
1630561|NCT01880515|5695668|P1|Overall Study|Disease Progression|5
1630562|NCT01880515|5695667|P2|Overall Study|Lost to Follow-up|2
1630563|NCT01880515|5695668|P1|Overall Study|Lost to Follow-up|3
1630564|NCT01880437|5695679|P3|Overall Study|Study terminated by Sponsor|2
1630565|NCT01880437|5695680|P2|Overall Study|Study terminated by Sponsor|0
1630566|NCT01880437|5695681|P1|Overall Study|Study terminated by Sponsor|3
1630567|NCT01880437|5695679|P3|Overall Study|Death|17
1630568|NCT01880437|5695680|P2|Overall Study|Death|4
1630569|NCT01880437|5695681|P1|Overall Study|Death|12
1630570|NCT01880424|5695707|P2|Overall Study|Other|0
1630571|NCT01880424|5695708|P1|Overall Study|Other|1
1630572|NCT01880424|5695707|P2|Overall Study|Withdrawal by Subject|30
1630573|NCT01880424|5695708|P1|Overall Study|Withdrawal by Subject|10
1630574|NCT01880424|5695707|P2|Overall Study|Protocol Violation|13
1630575|NCT01880424|5695708|P1|Overall Study|Protocol Violation|11
1630576|NCT01880424|5695707|P2|Overall Study|Lost to Follow-up|2
1630577|NCT01880424|5695708|P1|Overall Study|Lost to Follow-up|3
1630578|NCT01880424|5695707|P2|Overall Study|Lack of Efficacy|4
1630579|NCT01880424|5695708|P1|Overall Study|Lack of Efficacy|1
1630580|NCT01880424|5695707|P2|Overall Study|Adverse Event|6
1630581|NCT01880424|5695708|P1|Overall Study|Adverse Event|7
1630582|NCT01880086|5695764|P2|Overall Study|Lost to Follow-up|1
1630583|NCT01880086|5695765|P1|Overall Study|Lost to Follow-up|1
1630584|NCT01879852|5695813|P2|Overall Study|Withdrawal by Subject|0
1630585|NCT01879852|5695814|P1|Overall Study|Withdrawal by Subject|2
1630586|NCT01879722|5695869|P10|Overall Study|Voluntary Withdrawal|0
1630587|NCT01879722|5695870|P9|Overall Study|Voluntary Withdrawal|1
1630588|NCT01879722|5695871|P8|Overall Study|Voluntary Withdrawal|0
1630589|NCT01879722|5695872|P7|Overall Study|Voluntary Withdrawal|0
1630590|NCT01879722|5695873|P6|Overall Study|Voluntary Withdrawal|0
1630591|NCT01879722|5695874|P5|Overall Study|Voluntary Withdrawal|0
1630592|NCT01879722|5695875|P4|Overall Study|Voluntary Withdrawal|0
1630593|NCT01879722|5695876|P3|Overall Study|Voluntary Withdrawal|0
1630594|NCT01879722|5695877|P2|Overall Study|Voluntary Withdrawal|0
1630595|NCT01879722|5695878|P1|Overall Study|Voluntary Withdrawal|0
1630596|NCT01879722|5695869|P10|Overall Study|Pretreatment Event/Adverse Event|0
1630597|NCT01879722|5695870|P9|Overall Study|Pretreatment Event/Adverse Event|1
1630598|NCT01879722|5695871|P8|Overall Study|Pretreatment Event/Adverse Event|1
1630599|NCT01879722|5695872|P7|Overall Study|Pretreatment Event/Adverse Event|0
1630600|NCT01879722|5695873|P6|Overall Study|Pretreatment Event/Adverse Event|0
1630601|NCT01879722|5695874|P5|Overall Study|Pretreatment Event/Adverse Event|1
1630773|NCT01877421|5696853|P7|Phase 2|Protocol Violation|0
1630602|NCT01879722|5695875|P4|Overall Study|Pretreatment Event/Adverse Event|1
1630603|NCT01879722|5695876|P3|Overall Study|Pretreatment Event/Adverse Event|0
1630604|NCT01879722|5695877|P2|Overall Study|Pretreatment Event/Adverse Event|1
1630605|NCT01879722|5695878|P1|Overall Study|Pretreatment Event/Adverse Event|0
1630606|NCT01879683|5696026|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
1630607|NCT01879618|5696033|P1|Overall Study|Adverse Event|5
1630608|NCT01879618|5696033|P1|Overall Study|Protocol Violation|6
1630609|NCT01879618|5696033|P1|Overall Study|Surgery;changed schedule; not available|8
1630610|NCT01879618|5696033|P1|Overall Study|Withdrawal by Subject|1
1630611|NCT01879618|5696033|P1|Overall Study|Does not meet entrance criteria|1
1630612|NCT01879579|5696040|P2|Overall Study|Discontinued insulin - possible allergy|1
1630613|NCT01879579|5696041|P1|Overall Study|Discontinued insulin - possible allergy|0
1630614|NCT01879579|5696040|P2|Overall Study|Phenotypic type 1 diabetes|1
1630615|NCT01879579|5696041|P1|Overall Study|Phenotypic type 1 diabetes|0
1630616|NCT01879579|5696040|P2|Overall Study|Did not initiate insulin treatment|0
1630617|NCT01879579|5696041|P1|Overall Study|Did not initiate insulin treatment|1
1630618|NCT01879579|5696040|P2|Overall Study|Did not enroll in texting platform|0
1630619|NCT01879579|5696041|P1|Overall Study|Did not enroll in texting platform|1
1630620|NCT01879579|5696040|P2|Overall Study|Phone incompatible with texting platform|0
1630621|NCT01879579|5696041|P1|Overall Study|Phone incompatible with texting platform|3
1630622|NCT01879553|5696071|P2|Overall Study|Withdrawal by Subject|0
1630623|NCT01879553|5696072|P1|Overall Study|Withdrawal by Subject|1
1630624|NCT01879410|5696106|P2|Overall Study|Randomised in Error|2
1630625|NCT01879410|5696107|P1|Overall Study|Randomised in Error|1
1630626|NCT01879410|5696106|P2|Overall Study|Withdrawal by Subject|8
1630627|NCT01879410|5696107|P1|Overall Study|Withdrawal by Subject|7
1630628|NCT01879410|5696106|P2|Overall Study|Lost to Follow-up|1
1630629|NCT01879410|5696107|P1|Overall Study|Lost to Follow-up|2
1630630|NCT01879410|5696106|P2|Overall Study|Protocol Violation|7
1630631|NCT01879410|5696107|P1|Overall Study|Protocol Violation|1
1630632|NCT01879410|5696106|P2|Overall Study|Lack of Efficacy|6
1630633|NCT01879410|5696107|P1|Overall Study|Lack of Efficacy|4
1630634|NCT01879410|5696106|P2|Overall Study|Adverse Event|14
1630635|NCT01879410|5696107|P1|Overall Study|Adverse Event|9
1630636|NCT01879319|5696174|P2|Overall Study|Lost to Follow-up|5
1630637|NCT01879319|5696175|P1|Overall Study|Lost to Follow-up|1
1630638|NCT01879319|5696174|P2|Overall Study|Withdrawal by Subject|0
1630639|NCT01879319|5696175|P1|Overall Study|Withdrawal by Subject|1
1630640|NCT01879072|5696192|P1|Overall Study|Not Transplanted|30
1630641|NCT01879072|5696192|P1|Overall Study|Withdrawal by Subject|121
1630642|NCT01878292|5696337|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
1630643|NCT01878292|5696338|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
1630644|NCT01878292|5696339|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
1630645|NCT01878292|5696337|P3|Double-blind Treatment Period|Adverse Event|8
1630646|NCT01878292|5696338|P2|Double-blind Treatment Period|Adverse Event|9
1630647|NCT01878292|5696339|P1|Double-blind Treatment Period|Adverse Event|4
1630648|NCT01878292|5696337|P3|Double-blind Treatment Period|Lack of Efficacy|0
1630649|NCT01878292|5696338|P2|Double-blind Treatment Period|Lack of Efficacy|3
1630650|NCT01878292|5696339|P1|Double-blind Treatment Period|Lack of Efficacy|5
1630651|NCT01878292|5696337|P3|Double-blind Treatment Period|Protocol Violation|2
1630652|NCT01878292|5696338|P2|Double-blind Treatment Period|Protocol Violation|4
1630653|NCT01878292|5696339|P1|Double-blind Treatment Period|Protocol Violation|3
1630654|NCT01878292|5696337|P3|Double-blind Treatment Period|Withdrawal by Subject|8
1630655|NCT01878292|5696338|P2|Double-blind Treatment Period|Withdrawal by Subject|7
1630656|NCT01878292|5696339|P1|Double-blind Treatment Period|Withdrawal by Subject|9
1630657|NCT01878292|5696337|P3|Double-blind Treatment Period|Lost to Follow-up|1
1630658|NCT01878292|5696338|P2|Double-blind Treatment Period|Lost to Follow-up|3
1630659|NCT01878292|5696339|P1|Double-blind Treatment Period|Lost to Follow-up|6
1630660|NCT01878292|5696337|P3|Double-blind Treatment Period|Other Reasons|0
1630661|NCT01878292|5696338|P2|Double-blind Treatment Period|Other Reasons|0
1630662|NCT01878292|5696339|P1|Double-blind Treatment Period|Other Reasons|2
1630663|NCT01878292|5696337|P3|Randomized|Adverse Event|0
1630664|NCT01878292|5696338|P2|Randomized|Adverse Event|0
1630665|NCT01878292|5696339|P1|Randomized|Adverse Event|1
1630666|NCT01878292|5696337|P3|Randomized|Lost to Follow-up|0
1630667|NCT01878292|5696338|P2|Randomized|Lost to Follow-up|0
1630668|NCT01878292|5696339|P1|Randomized|Lost to Follow-up|1
1630669|NCT01878292|5696337|P3|Randomized|Protocol Violation|0
1630670|NCT01878292|5696338|P2|Randomized|Protocol Violation|0
1630671|NCT01878292|5696339|P1|Randomized|Protocol Violation|1
1630672|NCT01878253|5696350|P1|Overall Study|Completed Study w/o Follow-up Data|2
1630673|NCT01878253|5696350|P1|Overall Study|Lost to Follow-up|2
1630674|NCT01878253|5696350|P1|Overall Study|Withdrawal by Subject|1
1630675|NCT01878253|5696350|P1|Overall Study|SIdus System Removal|3
1630676|NCT01878253|5696350|P1|Overall Study|Death|1
1630677|NCT01878214|5696361|P2|Overall Study|Lost to Follow-up|36
1630678|NCT01878214|5696362|P1|Overall Study|Lost to Follow-up|35
1630679|NCT01878214|5696361|P2|Overall Study|Death|1
1630680|NCT01878214|5696362|P1|Overall Study|Death|0
1630681|NCT01878214|5696361|P2|Overall Study|Withdrawal by Subject|7
1630682|NCT01878214|5696362|P1|Overall Study|Withdrawal by Subject|18
1630683|NCT01878175|5696376|P1|Overall Study|Developed contraindicated health problem|2
1630684|NCT01878149|5696395|P2|Overall Study|Did Not Meet Eligibility Criteria|2
1630685|NCT01878149|5696396|P1|Overall Study|Did Not Meet Eligibility Criteria|2
1630686|NCT01878097|5696404|P2|Implementation Year 4|Surveys not fully completed|3007
1630687|NCT01878097|5696405|P1|Implementation Year 4|Surveys not fully completed|3604
1630688|NCT01878097|5696404|P2|Implementation Year 3|Surveys not fully completed|2980
1630689|NCT01878097|5696405|P1|Implementation Year 3|Surveys not fully completed|3494
1630690|NCT01878097|5696404|P2|Implementation Year 2|Surveys not fully completed|2841
1630691|NCT01878097|5696405|P1|Implementation Year 2|Surveys not fully completed|3281
1630692|NCT01878097|5696404|P2|Implementation Year 1|Surveys not fully completed|2549
1630693|NCT01878097|5696405|P1|Implementation Year 1|Surveys not fully completed|3202
1630694|NCT01878097|5696404|P2|Baseline|Surveys not fully completed|1800
1630695|NCT01878097|5696405|P1|Baseline|Surveys not fully completed|2497
1630697|NCT01877915|5696447|P2|Overall Study|Other|4
1630698|NCT01877915|5696448|P1|Overall Study|Other|2
1630699|NCT01877915|5696447|P2|Overall Study|Withdrawal by Subject|55
1630700|NCT01877915|5696448|P1|Overall Study|Withdrawal by Subject|42
1630701|NCT01877915|5696447|P2|Overall Study|Lost to Follow-up|9
1630702|NCT01877915|5696448|P1|Overall Study|Lost to Follow-up|10
1630703|NCT01877720|5696470|P2|Overall Study|Adverse Event|0
1630704|NCT01877720|5696471|P1|Overall Study|Adverse Event|1
1630705|NCT01877668|5696500|P5|Overall Study|Adverse event unrelated to study drug|1
1630706|NCT01877668|5696501|P4|Overall Study|Adverse event unrelated to study drug|0
1630707|NCT01877668|5696502|P3|Overall Study|Adverse event unrelated to study drug|2
1630708|NCT01877668|5696503|P2|Overall Study|Adverse event unrelated to study drug|1
1630709|NCT01877668|5696504|P1|Overall Study|Adverse event unrelated to study drug|4
1630710|NCT01877668|5696500|P5|Overall Study|Adverse event related to study drug|1
1630711|NCT01877668|5696501|P4|Overall Study|Adverse event related to study drug|2
1630712|NCT01877668|5696502|P3|Overall Study|Adverse event related to study drug|2
1630713|NCT01877668|5696503|P2|Overall Study|Adverse event related to study drug|2
1630714|NCT01877668|5696504|P1|Overall Study|Adverse event related to study drug|2
1630715|NCT01877668|5696500|P5|Overall Study|Protocol Violation|3
1630716|NCT01877668|5696501|P4|Overall Study|Protocol Violation|0
1630717|NCT01877668|5696502|P3|Overall Study|Protocol Violation|0
1630718|NCT01877668|5696503|P2|Overall Study|Protocol Violation|1
1630719|NCT01877668|5696504|P1|Overall Study|Protocol Violation|1
1630720|NCT01877668|5696500|P5|Overall Study|Other|3
1630721|NCT01877668|5696501|P4|Overall Study|Other|1
1630722|NCT01877668|5696502|P3|Overall Study|Other|1
1630723|NCT01877668|5696503|P2|Overall Study|Other|1
1630724|NCT01877668|5696504|P1|Overall Study|Other|1
1630725|NCT01877668|5696500|P5|Overall Study|Withdrawal by Subject|2
1630726|NCT01877668|5696501|P4|Overall Study|Withdrawal by Subject|2
1630727|NCT01877668|5696502|P3|Overall Study|Withdrawal by Subject|3
1630728|NCT01877668|5696503|P2|Overall Study|Withdrawal by Subject|0
1630729|NCT01877668|5696504|P1|Overall Study|Withdrawal by Subject|2
1630730|NCT01877668|5696500|P5|Overall Study|Lost to Follow-up|0
1630731|NCT01877668|5696501|P4|Overall Study|Lost to Follow-up|0
1630732|NCT01877668|5696502|P3|Overall Study|Lost to Follow-up|1
1630733|NCT01877668|5696503|P2|Overall Study|Lost to Follow-up|2
1630734|NCT01877668|5696504|P1|Overall Study|Lost to Follow-up|0
1630735|NCT01877668|5696500|P5|Overall Study|Insufficient clinical response|0
1630736|NCT01877668|5696501|P4|Overall Study|Insufficient clinical response|2
1630737|NCT01877668|5696502|P3|Overall Study|Insufficient clinical response|2
1630738|NCT01877668|5696503|P2|Overall Study|Insufficient clinical response|1
1630739|NCT01877668|5696504|P1|Overall Study|Insufficient clinical response|0
1630740|NCT01877668|5696500|P5|Overall Study|No longer met study criteria|0
1630741|NCT01877668|5696501|P4|Overall Study|No longer met study criteria|0
1630742|NCT01877668|5696502|P3|Overall Study|No longer met study criteria|1
1630743|NCT01877668|5696503|P2|Overall Study|No longer met study criteria|0
1630744|NCT01877668|5696504|P1|Overall Study|No longer met study criteria|1
1630745|NCT01877668|5696500|P5|Overall Study|Death|0
1630746|NCT01877668|5696501|P4|Overall Study|Death|1
1630747|NCT01877668|5696502|P3|Overall Study|Death|0
1630748|NCT01877668|5696503|P2|Overall Study|Death|0
1630749|NCT01877668|5696504|P1|Overall Study|Death|0
1630750|NCT01877655|5696735|P2|Overall Study|Randomized but Never Received Drug|5
1630751|NCT01877655|5696736|P1|Overall Study|Randomized but Never Received Drug|8
1630752|NCT01877655|5696735|P2|Overall Study|Miscellaneous|4
1630753|NCT01877655|5696736|P1|Overall Study|Miscellaneous|4
1630754|NCT01877655|5696735|P2|Overall Study|Physician Decision|10
1630755|NCT01877655|5696736|P1|Overall Study|Physician Decision|11
1630756|NCT01877655|5696735|P2|Overall Study|Withdrawal by Subject|26
1630757|NCT01877655|5696736|P1|Overall Study|Withdrawal by Subject|18
1630758|NCT01877655|5696735|P2|Overall Study|Death|52
1630759|NCT01877655|5696736|P1|Overall Study|Death|57
1630760|NCT01877551|5696792|P2|Overall Study|Physician Decision|1
1630761|NCT01877551|5696793|P1|Overall Study|Physician Decision|0
1630762|NCT01877421|5696842|P18|Phase 2|Protocol Violation|0
1630763|NCT01877421|5696843|P17|Phase 2|Protocol Violation|0
1630764|NCT01877421|5696844|P16|Phase 2|Protocol Violation|0
1630765|NCT01877421|5696845|P15|Phase 2|Protocol Violation|0
1630766|NCT01877421|5696846|P14|Phase 2|Protocol Violation|0
1630767|NCT01877421|5696847|P13|Phase 2|Protocol Violation|0
1630768|NCT01877421|5696848|P12|Phase 2|Protocol Violation|0
1630769|NCT01877421|5696849|P11|Phase 2|Protocol Violation|1
1630770|NCT01877421|5696850|P10|Phase 2|Protocol Violation|0
1630771|NCT01877421|5696851|P9|Phase 2|Protocol Violation|0
1630772|NCT01877421|5696852|P8|Phase 2|Protocol Violation|0
1630774|NCT01877421|5696854|P6|Phase 2|Protocol Violation|0
1630775|NCT01877421|5696855|P5|Phase 2|Protocol Violation|0
1630776|NCT01877421|5696856|P4|Phase 2|Protocol Violation|0
1630777|NCT01877421|5696857|P3|Phase 2|Protocol Violation|0
1630778|NCT01877421|5696858|P2|Phase 2|Protocol Violation|0
1630779|NCT01877421|5696859|P1|Phase 2|Protocol Violation|0
1630780|NCT01877421|5696842|P18|Phase 2|Withdrawal by Subject|0
1630781|NCT01877421|5696843|P17|Phase 2|Withdrawal by Subject|0
1630782|NCT01877421|5696844|P16|Phase 2|Withdrawal by Subject|1
1630783|NCT01877421|5696845|P15|Phase 2|Withdrawal by Subject|0
1630784|NCT01877421|5696846|P14|Phase 2|Withdrawal by Subject|0
1630785|NCT01877421|5696847|P13|Phase 2|Withdrawal by Subject|1
1630786|NCT01877421|5696848|P12|Phase 2|Withdrawal by Subject|0
1630787|NCT01877421|5696849|P11|Phase 2|Withdrawal by Subject|1
1630788|NCT01877421|5696850|P10|Phase 2|Withdrawal by Subject|0
1630789|NCT01877421|5696851|P9|Phase 2|Withdrawal by Subject|1
1630790|NCT01877421|5696852|P8|Phase 2|Withdrawal by Subject|0
1630791|NCT01877421|5696853|P7|Phase 2|Withdrawal by Subject|0
1630792|NCT01877421|5696854|P6|Phase 2|Withdrawal by Subject|0
1630793|NCT01877421|5696855|P5|Phase 2|Withdrawal by Subject|0
1630794|NCT01877421|5696856|P4|Phase 2|Withdrawal by Subject|0
1630795|NCT01877421|5696857|P3|Phase 2|Withdrawal by Subject|0
1630796|NCT01877421|5696858|P2|Phase 2|Withdrawal by Subject|0
1630797|NCT01877421|5696859|P1|Phase 2|Withdrawal by Subject|0
1630798|NCT01877421|5696842|P18|Phase 2|Lost to Follow-up|0
1630799|NCT01877421|5696843|P17|Phase 2|Lost to Follow-up|0
1630800|NCT01877421|5696844|P16|Phase 2|Lost to Follow-up|0
1630801|NCT01877421|5696845|P15|Phase 2|Lost to Follow-up|0
1630802|NCT01877421|5696846|P14|Phase 2|Lost to Follow-up|0
1630803|NCT01877421|5696847|P13|Phase 2|Lost to Follow-up|0
1630804|NCT01877421|5696848|P12|Phase 2|Lost to Follow-up|0
1630805|NCT01877421|5696849|P11|Phase 2|Lost to Follow-up|0
1630806|NCT01877421|5696850|P10|Phase 2|Lost to Follow-up|0
1630807|NCT01877421|5696851|P9|Phase 2|Lost to Follow-up|0
1630808|NCT01877421|5696852|P8|Phase 2|Lost to Follow-up|0
1630809|NCT01877421|5696853|P7|Phase 2|Lost to Follow-up|1
1630810|NCT01877421|5696854|P6|Phase 2|Lost to Follow-up|0
1630811|NCT01877421|5696855|P5|Phase 2|Lost to Follow-up|0
1630812|NCT01877421|5696856|P4|Phase 2|Lost to Follow-up|0
1630813|NCT01877421|5696857|P3|Phase 2|Lost to Follow-up|0
1630814|NCT01877421|5696858|P2|Phase 2|Lost to Follow-up|0
1630815|NCT01877421|5696859|P1|Phase 2|Lost to Follow-up|0
1630816|NCT01877408|5696969|P2|Overall Study|Lost to Follow-up|2
1630817|NCT01877408|5696970|P1|Overall Study|Lost to Follow-up|0
1630818|NCT01877278|5697003|P2|Overall Study|Lost to Follow-up|3
1630819|NCT01877278|5697004|P1|Overall Study|Lost to Follow-up|3
1630820|NCT01877265|5697012|P6|Treatment Period 3|Lost to Follow-up|0
1630821|NCT01877265|5697013|P5|Treatment Period 3|Lost to Follow-up|0
1630822|NCT01877265|5697014|P4|Treatment Period 3|Lost to Follow-up|0
1630823|NCT01877265|5697015|P3|Treatment Period 3|Lost to Follow-up|0
1630824|NCT01877265|5697016|P2|Treatment Period 3|Lost to Follow-up|0
1630825|NCT01877265|5697017|P1|Treatment Period 3|Lost to Follow-up|1
1630826|NCT01877265|5697012|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
1630827|NCT01877265|5697013|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1630828|NCT01877265|5697014|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1630829|NCT01877265|5697015|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1630830|NCT01877265|5697016|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1630831|NCT01877265|5697017|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
1630832|NCT01877265|5697012|P6|Treatment Period 1|Sponsor Decision|0
1630833|NCT01877265|5697013|P5|Treatment Period 1|Sponsor Decision|0
1630834|NCT01877265|5697014|P4|Treatment Period 1|Sponsor Decision|0
1630835|NCT01877265|5697015|P3|Treatment Period 1|Sponsor Decision|1
1630836|NCT01877265|5697016|P2|Treatment Period 1|Sponsor Decision|0
1630837|NCT01877265|5697017|P1|Treatment Period 1|Sponsor Decision|0
1630838|NCT01877239|5697034|P1|Overall Study|Data not available|35
1630839|NCT01877239|5697034|P1|Overall Study|Lack of Efficacy|4
1630840|NCT01877239|5697034|P1|Overall Study|Other|2
1630841|NCT01877239|5697034|P1|Overall Study|Withdrawal by Subject|4
1630842|NCT01877239|5697034|P1|Overall Study|Disease Remission|1
1630843|NCT01877239|5697034|P1|Overall Study|Adverse Event|4
1630844|NCT01877083|5697063|P1|Extension Phase|Adverse Event|2
1630845|NCT01877083|5697063|P1|Extension Phase|Disease Progression|3
1630846|NCT01877083|5697063|P1|Treatment Phase|Lost to Follow-up|1
1630847|NCT01877083|5697063|P1|Treatment Phase|Withdrawal by Subject|2
1630848|NCT01877083|5697063|P1|Treatment Phase|Adverse Event|6
1630849|NCT01877083|5697063|P1|Treatment Phase|Clinical Progression|1
1630850|NCT01877083|5697063|P1|Treatment Phase|Disease Progression|10
1630851|NCT01876979|5697087|P2|Overall Study|Physician Decision|3
1630852|NCT01876979|5697088|P1|Overall Study|Physician Decision|2
1630853|NCT01876823|5697094|P1|Overall Study|Patients moved|2
1630854|NCT01876823|5697094|P1|Overall Study|Physician Decision|2
1630855|NCT01876823|5697094|P1|Overall Study|Withdrawal by Subject|5
1630856|NCT01876810|5697107|P2|Overall Study|Physician Decision|1
1630857|NCT01876810|5697108|P1|Overall Study|Physician Decision|0
1630858|NCT01876784|5697120|P2|Overall Study|Ongoing|40
1630859|NCT01876784|5697121|P1|Overall Study|Ongoing|41
1630860|NCT01876784|5697120|P2|Overall Study|Other than specified above|6
1630861|NCT01876784|5697121|P1|Overall Study|Other than specified above|5
1630862|NCT01876784|5697120|P2|Overall Study|Randomized but not treated|1
1630863|NCT01876784|5697121|P1|Overall Study|Randomized but not treated|2
1630864|NCT01876784|5697120|P2|Overall Study|Death|0
1630865|NCT01876784|5697121|P1|Overall Study|Death|1
1630866|NCT01876784|5697120|P2|Overall Study|Lost to Follow-up|1
1630867|NCT01876784|5697121|P1|Overall Study|Lost to Follow-up|0
1630868|NCT01876784|5697120|P2|Overall Study|Disease progression|67
1630869|NCT01876784|5697121|P1|Overall Study|Disease progression|37
1630870|NCT01876784|5697120|P2|Overall Study|Protocol Violation|0
1630871|NCT01876784|5697121|P1|Overall Study|Protocol Violation|1
1630872|NCT01876784|5697120|P2|Overall Study|Adverse Event|2
1630873|NCT01876784|5697121|P1|Overall Study|Adverse Event|15
1630874|NCT01876784|5697120|P2|Overall Study|Withdrawal by Subject|2
1630875|NCT01876784|5697121|P1|Overall Study|Withdrawal by Subject|17
1630876|NCT01876732|5697127|P1|Overall Study|MMA was not over 800mg/dL|75
1630877|NCT01876706|5697132|P1|Overall Study|Death|3
1630878|NCT01876706|5697132|P1|Overall Study|Withdrawals|6
1630879|NCT01876706|5697132|P1|Overall Study|Lost to Follow-up|7
1630880|NCT01876706|5697132|P1|Overall Study|BPH Intervention|9
1630881|NCT01876511|5697152|P3|Overall Study|Physician Decision|1
1630882|NCT01876511|5697153|P2|Overall Study|Physician Decision|0
1630883|NCT01876511|5697154|P1|Overall Study|Physician Decision|1
1630884|NCT01876511|5697152|P3|Overall Study|Patient Decision|6
1630885|NCT01876511|5697153|P2|Overall Study|Patient Decision|0
1630886|NCT01876511|5697154|P1|Overall Study|Patient Decision|3
1630887|NCT01876511|5697152|P3|Overall Study|Drug-related Toxicity|6
1630888|NCT01876511|5697153|P2|Overall Study|Drug-related Toxicity|1
1630889|NCT01876511|5697154|P1|Overall Study|Drug-related Toxicity|5
1630890|NCT01876511|5697152|P3|Overall Study|Death (unrelated)|2
1630891|NCT01876511|5697153|P2|Overall Study|Death (unrelated)|0
1630892|NCT01876511|5697154|P1|Overall Study|Death (unrelated)|3
1630893|NCT01876511|5697152|P3|Overall Study|Disease Progression-clinical/radiologic|16
1630894|NCT01876511|5697153|P2|Overall Study|Disease Progression-clinical/radiologic|24
1630895|NCT01876511|5697154|P1|Overall Study|Disease Progression-clinical/radiologic|11
1630896|NCT01876446|5697202|P2|Overall Study|Physician Decision|3
1630897|NCT01876446|5697203|P1|Overall Study|Physician Decision|1
1630898|NCT01876446|5697202|P2|Overall Study|Withdrawal by Subject|2
1630899|NCT01876446|5697203|P1|Overall Study|Withdrawal by Subject|1
1630900|NCT01876446|5697202|P2|Overall Study|Death|1
1630901|NCT01876446|5697203|P1|Overall Study|Death|0
1630902|NCT01876420|5697219|P1|Overall Study|Missed 30 day visit|1
1630903|NCT01876381|5697231|P1|Overall Study|Withdrawal by Subject|1
1630904|NCT01876381|5697231|P1|Overall Study|Physician Decision|1
1630905|NCT01876381|5697231|P1|Overall Study|Lack of Efficacy|5
1630906|NCT01876368|5697238|P2|Overall Study|Subject/guardian decision|1
1630907|NCT01876368|5697239|P1|Overall Study|Subject/guardian decision|3
1630908|NCT01876368|5697238|P2|Overall Study|Protocol deviation|3
1630909|NCT01876368|5697239|P1|Overall Study|Protocol deviation|3
1630910|NCT01876368|5697238|P2|Overall Study|Physician Decision|2
1630911|NCT01876368|5697239|P1|Overall Study|Physician Decision|0
1630912|NCT01876368|5697238|P2|Overall Study|Non-compliance with study treatment|1
1630913|NCT01876368|5697239|P1|Overall Study|Non-compliance with study treatment|0
1630914|NCT01876368|5697238|P2|Overall Study|Lost to Follow-up|1
1630915|NCT01876368|5697239|P1|Overall Study|Lost to Follow-up|0
1630916|NCT01876368|5697238|P2|Overall Study|Lack of Efficacy|0
1630917|NCT01876368|5697239|P1|Overall Study|Lack of Efficacy|1
1630918|NCT01876368|5697238|P2|Overall Study|Adverse Event|5
1630919|NCT01876368|5697239|P1|Overall Study|Adverse Event|2
1630920|NCT01876251|5697284|P3|Overall Study|Objective progression or relapse|8
1630921|NCT01876251|5697285|P2|Overall Study|Objective progression or relapse|3
1630922|NCT01876251|5697286|P1|Overall Study|Objective progression or relapse|10
1630923|NCT01876251|5697284|P3|Overall Study|Study terminated|0
1630924|NCT01876251|5697285|P2|Overall Study|Study terminated|0
1630925|NCT01876251|5697286|P1|Overall Study|Study terminated|1
1630926|NCT01876251|5697284|P3|Overall Study|Participant refused further follow-up|1
1630927|NCT01876251|5697285|P2|Overall Study|Participant refused further follow-up|0
1630928|NCT01876251|5697286|P1|Overall Study|Participant refused further follow-up|0
1630929|NCT01876251|5697284|P3|Overall Study|Participant started new treatment|1
1630930|NCT01876251|5697285|P2|Overall Study|Participant started new treatment|0
1630931|NCT01876251|5697286|P1|Overall Study|Participant started new treatment|1
1630932|NCT01876251|5697284|P3|Overall Study|Death|1
1630933|NCT01876251|5697285|P2|Overall Study|Death|0
1630934|NCT01876251|5697286|P1|Overall Study|Death|2
1630935|NCT01876251|5697284|P3|Overall Study|Clinical progression|0
1630936|NCT01876251|5697285|P2|Overall Study|Clinical progression|0
1630937|NCT01876251|5697286|P1|Overall Study|Clinical progression|1
1630938|NCT01876043|5697390|P1|Overall Study|Withdrawal by Subject|1
1630939|NCT01876043|5697390|P1|Overall Study|Death|1
1630940|NCT01875991|5697402|P2|Overall Study|Sponsor Decision|0
1630941|NCT01875991|5697403|P1|Overall Study|Sponsor Decision|1
1630942|NCT01875991|5697402|P2|Overall Study|Withdrawal by Subject|6
1630943|NCT01875991|5697403|P1|Overall Study|Withdrawal by Subject|6
1630944|NCT01875874|5697439|P1|Overall Study|Death|3
1630945|NCT01875848|5697459|P2|Overall Study|Withdrawal by Subject|0
1630946|NCT01875848|5697460|P1|Overall Study|Withdrawal by Subject|2
1630947|NCT01875731|5697477|P2|Overall Study|Fail to obtain lab sample|0
1630948|NCT01875731|5697478|P1|Overall Study|Fail to obtain lab sample|1
1630949|NCT01875471|5697497|P2|Overall Study|Unsatisfactory Lens Fitting|0
1630950|NCT01875471|5697498|P1|Overall Study|Unsatisfactory Lens Fitting|1
1630951|NCT01875471|5697497|P2|Overall Study|Adverse Event|1
1630952|NCT01875471|5697498|P1|Overall Study|Adverse Event|0
1630953|NCT01875445|5697506|P2|Overall Study|Withdrawal by Subject|0
1630954|NCT01875445|5697507|P1|Overall Study|Withdrawal by Subject|2
1630955|NCT01875445|5697506|P2|Overall Study|Lost to Follow-up|0
1630956|NCT01875445|5697507|P1|Overall Study|Lost to Follow-up|5
1630957|NCT01875237|5697517|P2|Overall Study|DLI cells could not be produced|0
1630958|NCT01875237|5697518|P1|Overall Study|DLI cells could not be produced|1
1630959|NCT01875237|5697517|P2|Overall Study|GVDH before DLI|0
1630960|NCT01875237|5697518|P1|Overall Study|GVDH before DLI|1
1630961|NCT01875185|5697544|P2|Overall Study|study was terminated|48
1630962|NCT01875185|5697545|P1|Overall Study|study was terminated|52
1630963|NCT01874665|5697630|P2|Overall Study|Other|0
1630964|NCT01874665|5697631|P1|Overall Study|Other|2
1630965|NCT01874665|5697630|P2|Overall Study|Documented Progressive Disease|7
1630966|NCT01874665|5697631|P1|Overall Study|Documented Progressive Disease|11
1630967|NCT01874665|5697630|P2|Overall Study|Study Terminated by Sponsor|2
1630968|NCT01874665|5697631|P1|Overall Study|Study Terminated by Sponsor|0
1630969|NCT01874665|5697630|P2|Overall Study|Clinical Progressive Disease|3
1630970|NCT01874665|5697631|P1|Overall Study|Clinical Progressive Disease|4
1630971|NCT01874665|5697630|P2|Overall Study|Physician Decision|0
1630972|NCT01874665|5697631|P1|Overall Study|Physician Decision|3
1630973|NCT01874665|5697630|P2|Overall Study|Withdrawal by Subject|1
1630974|NCT01874665|5697631|P1|Overall Study|Withdrawal by Subject|4
1630975|NCT01874665|5697630|P2|Overall Study|Adverse Event|2
1630976|NCT01874665|5697631|P1|Overall Study|Adverse Event|6
1630977|NCT01874535|5697659|P2|Overall Study|incomplete symptom resolution|35
1630978|NCT01874535|5697660|P1|Overall Study|incomplete symptom resolution|45
1630979|NCT01874535|5697659|P2|Overall Study|Lost to Follow-up|9
1630980|NCT01874535|5697660|P1|Overall Study|Lost to Follow-up|10
1630981|NCT01874353|5697668|P2|Overall Study|Withdrawal by Subject|9
1630982|NCT01874353|5697669|P1|Overall Study|Withdrawal by Subject|7
1630983|NCT01874353|5697668|P2|Overall Study|Death|27
1630984|NCT01874353|5697669|P1|Overall Study|Death|45
1630985|NCT01874353|5697668|P2|Overall Study|Lost to Follow-up|1
1630986|NCT01874353|5697669|P1|Overall Study|Lost to Follow-up|1
1630987|NCT01874353|5697668|P2|Overall Study|Other|0
1630988|NCT01874353|5697669|P1|Overall Study|Other|2
1630989|NCT01874340|5697696|P4|Overall Study|Withdrawal by Subject|1
1630990|NCT01874340|5697697|P3|Overall Study|Withdrawal by Subject|0
1630991|NCT01874340|5697698|P2|Overall Study|Withdrawal by Subject|0
1630992|NCT01874340|5697699|P1|Overall Study|Withdrawal by Subject|0
1630993|NCT01874340|5697696|P4|Overall Study|Study terminated by Sponsor|4
1630994|NCT01874340|5697697|P3|Overall Study|Study terminated by Sponsor|8
1630995|NCT01874340|5697698|P2|Overall Study|Study terminated by Sponsor|8
1630996|NCT01874340|5697699|P1|Overall Study|Study terminated by Sponsor|6
1630997|NCT01874275|5697727|P2|Overall Study|Lost to Follow-up|0
1630998|NCT01874275|5697728|P1|Overall Study|Lost to Follow-up|1
1630999|NCT01874145|5697751|P2|Extension Period|Lost to Follow-up|1
1631000|NCT01874145|5697752|P1|Extension Period|Lost to Follow-up|1
1631001|NCT01874145|5697751|P2|Extension Period|Withdrawal by Subject|1
1631002|NCT01874145|5697752|P1|Extension Period|Withdrawal by Subject|2
1631003|NCT01874145|5697751|P2|Extension Period|Adverse Event|2
1631004|NCT01874145|5697752|P1|Extension Period|Adverse Event|3
1631005|NCT01874145|5697751|P2|Core Period|Withdrawal by Subject|4
1631006|NCT01874145|5697752|P1|Core Period|Withdrawal by Subject|0
1631007|NCT01874145|5697751|P2|Core Period|Adverse Event|1
1631008|NCT01874145|5697752|P1|Core Period|Adverse Event|0
1631009|NCT01874145|5697751|P2|Core Period|Physician Decision|1
1631010|NCT01874145|5697752|P1|Core Period|Physician Decision|1
1631011|NCT01874145|5697751|P2|Core Period|Protocol Violation|1
1631012|NCT01874145|5697752|P1|Core Period|Protocol Violation|1
1631013|NCT01874145|5697751|P2|Core Period|Non-compliance|0
1631014|NCT01874145|5697752|P1|Core Period|Non-compliance|1
1631015|NCT01874054|5697811|P1|Overall Study|Death|5
1631016|NCT01874054|5697811|P1|Overall Study|Lost to Follow-up|5
1631017|NCT01874054|5697811|P1|Overall Study|Study Termination by Sponsor|42
1631018|NCT01874054|5697811|P1|Overall Study|Withdrawal by Subject|3
1631019|NCT01873950|5697833|P5|Period 5|Withdrawal by Subject|0
1631020|NCT01873950|5697834|P4|Period 5|Withdrawal by Subject|1
1631021|NCT01873950|5697835|P3|Period 5|Withdrawal by Subject|0
1631022|NCT01873950|5697836|P2|Period 5|Withdrawal by Subject|0
1631023|NCT01873950|5697837|P1|Period 5|Withdrawal by Subject|0
1631024|NCT01873859|5697874|P2|Overall Study|Withdrawal by Subject|4
1631025|NCT01873859|5697875|P1|Overall Study|Withdrawal by Subject|0
1631026|NCT01873729|5697891|P1|Overall Study|Withdrawal by Subject|1
1631027|NCT01873586|5697896|P1|Overall Study|Lost to Follow-up|3
1631028|NCT01873495|5697909|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
1631029|NCT01873495|5697909|P1|Overall Study|Removed for Transplantation|1
1631030|NCT01873495|5697909|P1|Overall Study|Adverse Event|1
1631031|NCT01873495|5697909|P1|Overall Study|Physician Decision|3
1631032|NCT01873495|5697909|P1|Overall Study|Withdrawal by Subject|1
1631033|NCT01873417|5697917|P1|Overall Study|Physician Decision|3
1631034|NCT01873417|5697917|P1|Overall Study|Withdrawal by Subject|2
1631035|NCT01873417|5697917|P1|Overall Study|Lost to Follow-up|2
1631036|NCT01873417|5697917|P1|Overall Study|Adverse Event|24
1631037|NCT01873417|5697917|P1|Overall Study|Did Not Receive Any Study Drug|4
1631038|NCT01872910|5697945|P6|Overall Study|Lost to Follow-up|0
1631039|NCT01872910|5697946|P5|Overall Study|Lost to Follow-up|0
1631040|NCT01872910|5697947|P4|Overall Study|Lost to Follow-up|0
1631041|NCT01872910|5697948|P3|Overall Study|Lost to Follow-up|2
1631042|NCT01872910|5697949|P2|Overall Study|Lost to Follow-up|0
1631043|NCT01872910|5697950|P1|Overall Study|Lost to Follow-up|2
1631044|NCT01872715|5697995|P1|Overall Study|Withdrawal by Subject|2
1631045|NCT01872715|5697995|P1|Overall Study|Protocol Violation|1
1631046|NCT01872715|5697995|P1|Overall Study|Adverse Event|1
1631047|NCT01872689|5698014|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1631048|NCT01872689|5698015|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
1631049|NCT01872689|5698016|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
1631050|NCT01872689|5698017|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
1631051|NCT01872689|5698014|P4|Open-Label Period (Only For Monotherapy)|Death|0
1631052|NCT01872689|5698015|P3|Open-Label Period (Only For Monotherapy)|Death|0
1631053|NCT01872689|5698016|P2|Open-Label Period (Only For Monotherapy)|Death|3
1631054|NCT01872689|5698017|P1|Open-Label Period (Only For Monotherapy)|Death|5
1631055|NCT01872689|5698014|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1631056|NCT01872689|5698015|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
1631057|NCT01872689|5698016|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
1631058|NCT01872689|5698017|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
1631059|NCT01872689|5698014|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1631060|NCT01872689|5698015|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1631061|NCT01872689|5698016|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
1631062|NCT01872689|5698017|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
1631063|NCT01872689|5698014|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1631064|NCT01872689|5698015|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
1631065|NCT01872689|5698016|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
1631066|NCT01872689|5698017|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
1631067|NCT01872689|5698014|P4|Open-Label Period (Only For Monotherapy)|Other|0
1631068|NCT01872689|5698015|P3|Open-Label Period (Only For Monotherapy)|Other|0
1631069|NCT01872689|5698016|P2|Open-Label Period (Only For Monotherapy)|Other|3
1631070|NCT01872689|5698017|P1|Open-Label Period (Only For Monotherapy)|Other|2
1631071|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
1631072|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
1631073|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
1631074|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
1631075|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Death|9
1631076|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Death|14
1631077|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Death|4
1631078|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Death|3
1631079|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1631080|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1631081|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
1631082|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
1631083|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
1631084|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1631085|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
1631086|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
1631087|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1631088|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
1631089|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1631090|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
1631091|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
1631092|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
1631093|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
1631094|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
1631095|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Other|3
1631096|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Other|6
1631097|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Other|1
1631098|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Other|1
1631099|NCT01872689|5698014|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1631100|NCT01872689|5698015|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1631101|NCT01872689|5698016|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
1631102|NCT01872689|5698017|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
1631103|NCT01872611|5698093|P2|Overall Study|Reason not provided|6
1631104|NCT01872611|5698094|P1|Overall Study|Reason not provided|6
1631105|NCT01872611|5698093|P2|Overall Study|Withdrawal by Subject|1
1631106|NCT01872611|5698094|P1|Overall Study|Withdrawal by Subject|6
1631107|NCT01872611|5698093|P2|Overall Study|Physician Decision|0
1631108|NCT01872611|5698094|P1|Overall Study|Physician Decision|1
1631109|NCT01872611|5698093|P2|Overall Study|Lost to Follow-up|1
1631110|NCT01872611|5698094|P1|Overall Study|Lost to Follow-up|8
1631111|NCT01872611|5698093|P2|Overall Study|Death, prior to treatment|1
1631112|NCT01872611|5698094|P1|Overall Study|Death, prior to treatment|0
1631113|NCT01872611|5698093|P2|Overall Study|Death|1
1631114|NCT01872611|5698094|P1|Overall Study|Death|0
1631115|NCT01872611|5698093|P2|Overall Study|Adverse Event, prior to treatment|1
1631116|NCT01872611|5698094|P1|Overall Study|Adverse Event, prior to treatment|0
1631117|NCT01872611|5698093|P2|Overall Study|Adverse Event|1
1631118|NCT01872611|5698094|P1|Overall Study|Adverse Event|3
1631119|NCT01872078|5698116|P4|Overall Study|Patient met exclusion criterion 16.|1
1631120|NCT01872078|5698117|P3|Overall Study|Patient met exclusion criterion 16.|0
1631121|NCT01872078|5698118|P2|Overall Study|Patient met exclusion criterion 16.|0
1631122|NCT01872078|5698119|P1|Overall Study|Patient met exclusion criterion 16.|0
1631123|NCT01872078|5698116|P4|Overall Study|Withdrawal by Subject|0
1631124|NCT01872078|5698117|P3|Overall Study|Withdrawal by Subject|1
1631125|NCT01872078|5698118|P2|Overall Study|Withdrawal by Subject|0
1631126|NCT01872078|5698119|P1|Overall Study|Withdrawal by Subject|0
1631127|NCT01872078|5698116|P4|Overall Study|Protocol Violation|0
1631128|NCT01872078|5698117|P3|Overall Study|Protocol Violation|1
1631129|NCT01872078|5698118|P2|Overall Study|Protocol Violation|0
1631130|NCT01872078|5698119|P1|Overall Study|Protocol Violation|0
1631131|NCT01872078|5698116|P4|Overall Study|Dose administration non-compliance|1
1631132|NCT01872078|5698117|P3|Overall Study|Dose administration non-compliance|0
1631133|NCT01872078|5698118|P2|Overall Study|Dose administration non-compliance|0
1631134|NCT01872078|5698119|P1|Overall Study|Dose administration non-compliance|0
1631135|NCT01872078|5698116|P4|Overall Study|Adverse Event|0
1631136|NCT01872078|5698117|P3|Overall Study|Adverse Event|1
1631137|NCT01872078|5698118|P2|Overall Study|Adverse Event|0
1631138|NCT01872078|5698119|P1|Overall Study|Adverse Event|0
1631139|NCT01871870|5698129|P1|Overall Study|hyperglycemia|2
1631140|NCT01871870|5698129|P1|Overall Study|Hardware issues|7
1631141|NCT01871805|5698140|P6|Phase II|Lost to Follow-up|13
1631142|NCT01871805|5698141|P5|Phase II|Lost to Follow-up|0
1631143|NCT01871805|5698142|P4|Phase II|Lost to Follow-up|0
1631144|NCT01871805|5698143|P3|Phase II|Lost to Follow-up|0
1631145|NCT01871805|5698144|P2|Phase II|Lost to Follow-up|0
1631146|NCT01871805|5698145|P1|Phase II|Lost to Follow-up|0
1631147|NCT01871805|5698140|P6|Phase II|Alive in Survival Follow-up|29
1631148|NCT01871805|5698141|P5|Phase II|Alive in Survival Follow-up|0
1631149|NCT01871805|5698142|P4|Phase II|Alive in Survival Follow-up|0
1631150|NCT01871805|5698143|P3|Phase II|Alive in Survival Follow-up|0
1631151|NCT01871805|5698144|P2|Phase II|Alive in Survival Follow-up|0
1631152|NCT01871805|5698145|P1|Phase II|Alive in Survival Follow-up|0
1631153|NCT01871805|5698140|P6|Phase II|Death|45
1631154|NCT01871805|5698141|P5|Phase II|Death|0
1631155|NCT01871805|5698142|P4|Phase II|Death|0
1631156|NCT01871805|5698143|P3|Phase II|Death|0
1631157|NCT01871805|5698144|P2|Phase II|Death|0
1631158|NCT01871805|5698145|P1|Phase II|Death|0
1631159|NCT01871805|5698140|P6|Phase I|Lost to Follow-up|0
1631160|NCT01871805|5698141|P5|Phase I|Lost to Follow-up|0
1631161|NCT01871805|5698142|P4|Phase I|Lost to Follow-up|0
1631162|NCT01871805|5698143|P3|Phase I|Lost to Follow-up|3
1631163|NCT01871805|5698144|P2|Phase I|Lost to Follow-up|1
1631164|NCT01871805|5698145|P1|Phase I|Lost to Follow-up|0
1631165|NCT01871805|5698140|P6|Phase I|Alive in Survival Follow-up|0
1631166|NCT01871805|5698141|P5|Phase I|Alive in Survival Follow-up|4
1631167|NCT01871805|5698142|P4|Phase I|Alive in Survival Follow-up|5
1631168|NCT01871805|5698143|P3|Phase I|Alive in Survival Follow-up|4
1631169|NCT01871805|5698144|P2|Phase I|Alive in Survival Follow-up|2
1631170|NCT01871805|5698145|P1|Phase I|Alive in Survival Follow-up|0
1631171|NCT01871805|5698140|P6|Phase I|Death|0
1631172|NCT01871805|5698141|P5|Phase I|Death|9
1631173|NCT01871805|5698142|P4|Phase I|Death|2
1631174|NCT01871805|5698143|P3|Phase I|Death|6
1631175|NCT01871805|5698144|P2|Phase I|Death|4
1631176|NCT01871805|5698145|P1|Phase I|Death|7
1631177|NCT01871558|5698217|P2|Overall Study|Withdrawal by Subject|0
1631178|NCT01871558|5698218|P1|Overall Study|Withdrawal by Subject|2
1631179|NCT01871558|5698217|P2|Overall Study|antidiabetic drug prematurely stopped|1
1631180|NCT01871558|5698218|P1|Overall Study|antidiabetic drug prematurely stopped|1
1631181|NCT01871558|5698217|P2|Overall Study|Other reason|1
1631182|NCT01871558|5698218|P1|Overall Study|Other reason|0
1631183|NCT01871532|5698238|P2|Overall Study|Withdrawal by Subject|2
1631184|NCT01871532|5698239|P1|Overall Study|Withdrawal by Subject|1
1631185|NCT01871519|5698273|P1|Overall Study|Withdrawal by Subject|49
1631186|NCT01871519|5698273|P1|Overall Study|Lost to Follow-up|15
1631187|NCT01871519|5698273|P1|Overall Study|Death|26
1631188|NCT01871402|5698330|P2|Overall Study|Non-compliance|1
1631189|NCT01871402|5698331|P1|Overall Study|Non-compliance|0
1631190|NCT01871402|5698330|P2|Overall Study|Withdrawal by Subject|2
1631191|NCT01871402|5698331|P1|Overall Study|Withdrawal by Subject|0
1631192|NCT01871402|5698330|P2|Overall Study|Lost to Follow-up|0
1631193|NCT01871402|5698331|P1|Overall Study|Lost to Follow-up|1
1631194|NCT01871285|5698349|P4|First Intervention (1 Day)|Lost to Follow-up|0
1631195|NCT01871285|5698350|P3|First Intervention (1 Day)|Lost to Follow-up|1
1631196|NCT01871285|5698351|P2|First Intervention (1 Day)|Lost to Follow-up|1
1631197|NCT01871285|5698352|P1|First Intervention (1 Day)|Lost to Follow-up|0
1631198|NCT01871285|5698349|P4|First Intervention (1 Day)|Adverse Event|0
1631199|NCT01871285|5698350|P3|First Intervention (1 Day)|Adverse Event|0
1631200|NCT01871285|5698351|P2|First Intervention (1 Day)|Adverse Event|0
1631201|NCT01871285|5698352|P1|First Intervention (1 Day)|Adverse Event|1
1631202|NCT01871142|5698378|P1|Overall Study|Adverse Event|1
1631203|NCT01871090|5698394|P2|Overall Study|Subject Non-Compliance|1
1631204|NCT01871090|5698395|P1|Overall Study|Subject Non-Compliance|0
1631205|NCT01871090|5698394|P2|Overall Study|Interrogation not completed correctly|0
1631206|NCT01871090|5698395|P1|Overall Study|Interrogation not completed correctly|1
1631207|NCT01871090|5698394|P2|Overall Study|Interrogation not done in Emergency Room|22
1631208|NCT01871090|5698395|P1|Overall Study|Interrogation not done in Emergency Room|1
1631209|NCT01870999|5698415|P3|Overall Study|Protocol Violation|1
1631210|NCT01870999|5698416|P2|Overall Study|Protocol Violation|0
1631211|NCT01870999|5698417|P1|Overall Study|Protocol Violation|0
1631212|NCT01870999|5698415|P3|Overall Study|Withdrawal by Subject|5
1631213|NCT01870999|5698416|P2|Overall Study|Withdrawal by Subject|2
1631214|NCT01870999|5698417|P1|Overall Study|Withdrawal by Subject|0
1631215|NCT01870999|5698415|P3|Overall Study|Subject withdrawn by Investigator|0
1631216|NCT01870999|5698416|P2|Overall Study|Subject withdrawn by Investigator|0
1631217|NCT01870999|5698417|P1|Overall Study|Subject withdrawn by Investigator|1
1631218|NCT01870999|5698415|P3|Overall Study|Subject met withdrawal criteria|0
1631219|NCT01870999|5698416|P2|Overall Study|Subject met withdrawal criteria|2
1631220|NCT01870999|5698417|P1|Overall Study|Subject met withdrawal criteria|3
1631221|NCT01870999|5698415|P3|Overall Study|Adverse Event|1
1631222|NCT01870999|5698416|P2|Overall Study|Adverse Event|4
1631223|NCT01870999|5698417|P1|Overall Study|Adverse Event|0
1631224|NCT01870973|5698475|P2|Overall Study|Lost to Follow-up|3
1631225|NCT01870973|5698476|P1|Overall Study|Lost to Follow-up|10
1631226|NCT01870921|5698482|P1|Overall Study|Other|1
1631227|NCT01870921|5698482|P1|Overall Study|Subject Lost to Follow up|2
1631228|NCT01870921|5698482|P1|Overall Study|Severe non-compliance to protocol|7
1631229|NCT01870921|5698482|P1|Overall Study|Subject decision|80
1631230|NCT01870843|5698501|P1|Overall Study|Withdrawal by Subject|18
1631231|NCT01870843|5698501|P1|Overall Study|Death|1
1631232|NCT01870843|5698501|P1|Overall Study|Lost to Follow-up|24
1631233|NCT01870843|5698501|P1|Overall Study|Adverse Event|10
1631234|NCT01870778|5698516|P2|Overall Study|Lost to Follow-up|2
1631235|NCT01870778|5698517|P1|Overall Study|Lost to Follow-up|0
1631236|NCT01870778|5698516|P2|Overall Study|Withdrawal by Subject|7
1631237|NCT01870778|5698517|P1|Overall Study|Withdrawal by Subject|8
1631238|NCT01870739|5698543|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
1631239|NCT01870739|5698544|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
1631240|NCT01870739|5698543|P2|Add-on Period (40 Weeks)|Protocol deviation|1
1631241|NCT01870739|5698544|P1|Add-on Period (40 Weeks)|Protocol deviation|1
1631242|NCT01870739|5698543|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
1631243|NCT01870739|5698544|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
1631244|NCT01870739|5698543|P2|Add-on Period (40 Weeks)|Adverse Event|1
1631245|NCT01870739|5698544|P1|Add-on Period (40 Weeks)|Adverse Event|0
1631246|NCT01870739|5698543|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
1631247|NCT01870739|5698544|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
1631248|NCT01870739|5698543|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
1631249|NCT01870739|5698544|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
1631250|NCT01870739|5698543|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
1631251|NCT01870739|5698544|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
1631252|NCT01870726|5698583|P7|Overall Study|Progressive disease|10
1631253|NCT01870726|5698584|P6|Overall Study|Progressive disease|4
1631254|NCT01870726|5698585|P5|Overall Study|Progressive disease|6
1631255|NCT01870726|5698586|P4|Overall Study|Progressive disease|5
1631256|NCT01870726|5698587|P3|Overall Study|Progressive disease|4
1631257|NCT01870726|5698588|P2|Overall Study|Progressive disease|5
1631258|NCT01870726|5698589|P1|Overall Study|Progressive disease|5
1631259|NCT01870726|5698583|P7|Overall Study|Adverse Event|0
1631260|NCT01870726|5698584|P6|Overall Study|Adverse Event|1
1631261|NCT01870726|5698585|P5|Overall Study|Adverse Event|1
1631262|NCT01870726|5698586|P4|Overall Study|Adverse Event|0
1631263|NCT01870726|5698587|P3|Overall Study|Adverse Event|0
1631264|NCT01870726|5698588|P2|Overall Study|Adverse Event|0
1631265|NCT01870726|5698589|P1|Overall Study|Adverse Event|0
1631266|NCT01870726|5698583|P7|Overall Study|Withdrawal by Subject|0
1631267|NCT01870726|5698584|P6|Overall Study|Withdrawal by Subject|0
1631268|NCT01870726|5698585|P5|Overall Study|Withdrawal by Subject|0
1631269|NCT01870726|5698586|P4|Overall Study|Withdrawal by Subject|0
1631270|NCT01870726|5698587|P3|Overall Study|Withdrawal by Subject|0
1631271|NCT01870726|5698588|P2|Overall Study|Withdrawal by Subject|1
1631272|NCT01870726|5698589|P1|Overall Study|Withdrawal by Subject|0
1631273|NCT01870726|5698583|P7|Overall Study|Withdrawal of informed consent|0
1631274|NCT01870726|5698584|P6|Overall Study|Withdrawal of informed consent|0
1631275|NCT01870726|5698585|P5|Overall Study|Withdrawal of informed consent|0
1631276|NCT01870726|5698586|P4|Overall Study|Withdrawal of informed consent|1
1631277|NCT01870726|5698587|P3|Overall Study|Withdrawal of informed consent|0
1631278|NCT01870726|5698588|P2|Overall Study|Withdrawal of informed consent|0
1631279|NCT01870726|5698589|P1|Overall Study|Withdrawal of informed consent|0
1631280|NCT01870583|5698684|P3|Overall Study|Lost to Follow-up|5
1631281|NCT01870583|5698685|P2|Overall Study|Lost to Follow-up|13
1631282|NCT01870583|5698686|P1|Overall Study|Lost to Follow-up|11
1631283|NCT01870583|5698684|P3|Overall Study|Protocol Violation|3
1631284|NCT01870583|5698685|P2|Overall Study|Protocol Violation|5
1631285|NCT01870583|5698686|P1|Overall Study|Protocol Violation|0
1631286|NCT01870297|5698712|P7|Overall Study|Sponsor Decision|1
1631287|NCT01870297|5698713|P6|Overall Study|Sponsor Decision|0
1631288|NCT01870297|5698714|P5|Overall Study|Sponsor Decision|0
1631289|NCT01870297|5698715|P4|Overall Study|Sponsor Decision|0
1631290|NCT01870297|5698716|P3|Overall Study|Sponsor Decision|0
1631291|NCT01870297|5698717|P2|Overall Study|Sponsor Decision|6
1631292|NCT01870297|5698718|P1|Overall Study|Sponsor Decision|0
1631293|NCT01870297|5698712|P7|Overall Study|Withdrawal by Subject|1
1631294|NCT01870297|5698713|P6|Overall Study|Withdrawal by Subject|1
1631295|NCT01870297|5698714|P5|Overall Study|Withdrawal by Subject|1
1631296|NCT01870297|5698715|P4|Overall Study|Withdrawal by Subject|0
1631297|NCT01870297|5698716|P3|Overall Study|Withdrawal by Subject|0
1631298|NCT01870297|5698717|P2|Overall Study|Withdrawal by Subject|0
1631299|NCT01870297|5698718|P1|Overall Study|Withdrawal by Subject|0
1631300|NCT01870297|5698712|P7|Overall Study|Lost to Follow-up|0
1631301|NCT01870297|5698713|P6|Overall Study|Lost to Follow-up|0
1631302|NCT01870297|5698714|P5|Overall Study|Lost to Follow-up|0
1631303|NCT01870297|5698715|P4|Overall Study|Lost to Follow-up|0
1631304|NCT01870297|5698716|P3|Overall Study|Lost to Follow-up|1
1631305|NCT01870297|5698717|P2|Overall Study|Lost to Follow-up|1
1631306|NCT01870297|5698718|P1|Overall Study|Lost to Follow-up|0
1631307|NCT01870297|5698712|P7|Overall Study|Adverse Event|0
1631308|NCT01870297|5698713|P6|Overall Study|Adverse Event|0
1631309|NCT01870297|5698714|P5|Overall Study|Adverse Event|2
1631310|NCT01870297|5698715|P4|Overall Study|Adverse Event|0
1631311|NCT01870297|5698716|P3|Overall Study|Adverse Event|0
1631312|NCT01870297|5698717|P2|Overall Study|Adverse Event|0
1631313|NCT01870297|5698718|P1|Overall Study|Adverse Event|0
1631314|NCT01870076|5698762|P4|Overall Study|Withdrawal by Subject|0
1631315|NCT01870076|5698763|P3|Overall Study|Withdrawal by Subject|1
1631316|NCT01870076|5698764|P2|Overall Study|Withdrawal by Subject|0
1631317|NCT01870076|5698765|P1|Overall Study|Withdrawal by Subject|1
1631318|NCT01869959|5698783|P5|Treatment Period|Withdrawal by Subject|0
1631319|NCT01869959|5698784|P4|Treatment Period|Withdrawal by Subject|0
1631320|NCT01869959|5698785|P3|Treatment Period|Withdrawal by Subject|0
1631321|NCT01869959|5698786|P2|Treatment Period|Withdrawal by Subject|1
1631322|NCT01869959|5698787|P1|Treatment Period|Withdrawal by Subject|0
1631323|NCT01869959|5698783|P5|Treatment Period|Sponsor decision|0
1631324|NCT01869959|5698784|P4|Treatment Period|Sponsor decision|1
1631325|NCT01869959|5698785|P3|Treatment Period|Sponsor decision|0
1631326|NCT01869959|5698786|P2|Treatment Period|Sponsor decision|1
1631327|NCT01869959|5698787|P1|Treatment Period|Sponsor decision|0
1631328|NCT01869959|5698783|P5|Treatment Period|Adverse Event|0
1631329|NCT01869959|5698784|P4|Treatment Period|Adverse Event|1
1631330|NCT01869959|5698785|P3|Treatment Period|Adverse Event|3
1631331|NCT01869959|5698786|P2|Treatment Period|Adverse Event|0
1631332|NCT01869959|5698787|P1|Treatment Period|Adverse Event|1
1631333|NCT01869959|5698783|P5|Randomization Period|Physician Decision|1
1631334|NCT01869959|5698784|P4|Randomization Period|Physician Decision|0
1631335|NCT01869959|5698785|P3|Randomization Period|Physician Decision|0
1631336|NCT01869959|5698786|P2|Randomization Period|Physician Decision|0
1631337|NCT01869959|5698787|P1|Randomization Period|Physician Decision|0
1631338|NCT01869764|5698857|P2|Overall Study|Withdrawal by Subject|2
1631339|NCT01869764|5698858|P1|Overall Study|Withdrawal by Subject|0
1631340|NCT01869699|5698876|P2|Overall Study|Withdrawal by Subject|0
1631341|NCT01869699|5698877|P1|Overall Study|Withdrawal by Subject|1
1631342|NCT01869348|5698940|P2|Overall Study|Withdrawal by Subject|1
1631343|NCT01869348|5698941|P1|Overall Study|Withdrawal by Subject|1
1631344|NCT01869192|5698949|P2|Postoperative Chemotherapy|Physician Decision|2
1631345|NCT01869192|5698950|P1|Postoperative Chemotherapy|Physician Decision|0
1631346|NCT01869192|5698949|P2|Preoperative Chemotherapy to Surgery|patient choice|1
1631347|NCT01869192|5698950|P1|Preoperative Chemotherapy to Surgery|patient choice|2
1631348|NCT01868997|5698985|P2|Overall Study|Other|1
1631349|NCT01868997|5698986|P1|Overall Study|Other|3
1631350|NCT01868997|5698985|P2|Overall Study|Lack of Efficacy|0
1631351|NCT01868997|5698986|P1|Overall Study|Lack of Efficacy|2
1631352|NCT01868997|5698985|P2|Overall Study|Adverse Event|5
1631353|NCT01868997|5698986|P1|Overall Study|Adverse Event|2
1631354|NCT01868893|5699002|P1|Overall Study|Neutropenia|1
1631355|NCT01868893|5699002|P1|Overall Study|Commercial availability of study drug|17
1631356|NCT01868893|5699002|P1|Overall Study|Adverse Event|2
1631357|NCT01868646|5699031|P2|Overall Study|Do not meet inclusion criteria|5
1631358|NCT01868646|5699032|P1|Overall Study|Do not meet inclusion criteria|3
1631359|NCT01868594|5699077|P2|Overall Study|Do not meet inclusion criteria|3
1631360|NCT01868594|5699078|P1|Overall Study|Do not meet inclusion criteria|4
1631361|NCT01868542|5699098|P2|Overall Study|Unclassified|1
1631362|NCT01868542|5699099|P1|Overall Study|Unclassified|0
1631363|NCT01868542|5699098|P2|Overall Study|Protocol Violation|1
1631364|NCT01868542|5699099|P1|Overall Study|Protocol Violation|0
1631365|NCT01868503|5699117|P1|Overall Study|Protocol Violation|1
1631366|NCT01868503|5699117|P1|Overall Study|Withdrawal by Subject|1
1631367|NCT01868477|5699127|P2|Overall Study|Withdrawal by Subject|0
1631368|NCT01868477|5699128|P1|Overall Study|Withdrawal by Subject|1
1631369|NCT01868477|5699127|P2|Overall Study|Disease progression|1
1631370|NCT01868477|5699128|P1|Overall Study|Disease progression|1
1631371|NCT01868477|5699127|P2|Overall Study|Adverse Event|4
1631372|NCT01868477|5699128|P1|Overall Study|Adverse Event|2
1631373|NCT01868243|5699199|P2|Overall Study|Death|1
1631374|NCT01868243|5699200|P1|Overall Study|Death|0
1631375|NCT01868165|5699208|P1|Overall Study|Death|4
1631376|NCT01868165|5699208|P1|Overall Study|Lost to Follow-up|3
1631377|NCT01868165|5699208|P1|Overall Study|Physician Decision|2
1631378|NCT01868165|5699208|P1|Overall Study|Withdrawal by Subject|36
1631379|NCT01868074|5699224|P2|Overall Study|Withdrawal by Subject|2
1631380|NCT01868074|5699225|P1|Overall Study|Withdrawal by Subject|4
1631381|NCT01868074|5699224|P2|Overall Study|Lost to Follow-up|2
1631382|NCT01868074|5699225|P1|Overall Study|Lost to Follow-up|3
1631383|NCT01868035|5699235|P1|Overall Study|Non-compliance|1
1631384|NCT01868035|5699235|P1|Overall Study|Progressive Disease|2
1631385|NCT01868035|5699235|P1|Overall Study|Withdrawal by Subject|1
1631386|NCT01868035|5699235|P1|Overall Study|Lost to Follow-up|3
1631387|NCT01868022|5699260|P9|Overall Study|Ongoing|0
1631388|NCT01868022|5699261|P8|Overall Study|Ongoing|3
1631389|NCT01868022|5699262|P7|Overall Study|Ongoing|0
1631390|NCT01868022|5699263|P6|Overall Study|Ongoing|0
1631391|NCT01868022|5699264|P5|Overall Study|Ongoing|0
1631392|NCT01868022|5699265|P4|Overall Study|Ongoing|0
1631393|NCT01868022|5699266|P3|Overall Study|Ongoing|0
1631394|NCT01868022|5699267|P2|Overall Study|Ongoing|0
1631395|NCT01868022|5699268|P1|Overall Study|Ongoing|0
1631396|NCT01868022|5699260|P9|Overall Study|Study closed/terminated|0
1631397|NCT01868022|5699261|P8|Overall Study|Study closed/terminated|1
1631398|NCT01868022|5699262|P7|Overall Study|Study closed/terminated|0
1631399|NCT01868022|5699263|P6|Overall Study|Study closed/terminated|0
1631400|NCT01868022|5699264|P5|Overall Study|Study closed/terminated|0
1631401|NCT01868022|5699265|P4|Overall Study|Study closed/terminated|0
1631402|NCT01868022|5699266|P3|Overall Study|Study closed/terminated|0
1631403|NCT01868022|5699267|P2|Overall Study|Study closed/terminated|0
1631404|NCT01868022|5699268|P1|Overall Study|Study closed/terminated|0
1631405|NCT01868022|5699260|P9|Overall Study|Physician Decision|0
1631406|NCT01868022|5699261|P8|Overall Study|Physician Decision|2
1631407|NCT01868022|5699262|P7|Overall Study|Physician Decision|0
1631408|NCT01868022|5699263|P6|Overall Study|Physician Decision|1
1631409|NCT01868022|5699264|P5|Overall Study|Physician Decision|0
1631410|NCT01868022|5699265|P4|Overall Study|Physician Decision|0
1631411|NCT01868022|5699266|P3|Overall Study|Physician Decision|0
1631412|NCT01868022|5699267|P2|Overall Study|Physician Decision|0
1631413|NCT01868022|5699268|P1|Overall Study|Physician Decision|0
1631414|NCT01868022|5699260|P9|Overall Study|Adverse Event|2
1631415|NCT01868022|5699261|P8|Overall Study|Adverse Event|2
1631416|NCT01868022|5699262|P7|Overall Study|Adverse Event|0
1631417|NCT01868022|5699263|P6|Overall Study|Adverse Event|0
1631418|NCT01868022|5699264|P5|Overall Study|Adverse Event|2
1631419|NCT01868022|5699265|P4|Overall Study|Adverse Event|0
1631420|NCT01868022|5699266|P3|Overall Study|Adverse Event|0
1631421|NCT01868022|5699267|P2|Overall Study|Adverse Event|0
1631422|NCT01868022|5699268|P1|Overall Study|Adverse Event|0
1631423|NCT01868022|5699260|P9|Overall Study|Withdrawal by Subject|0
1631424|NCT01868022|5699261|P8|Overall Study|Withdrawal by Subject|1
1631425|NCT01868022|5699262|P7|Overall Study|Withdrawal by Subject|0
1631426|NCT01868022|5699263|P6|Overall Study|Withdrawal by Subject|0
1631427|NCT01868022|5699264|P5|Overall Study|Withdrawal by Subject|0
1631428|NCT01868022|5699265|P4|Overall Study|Withdrawal by Subject|1
1631429|NCT01868022|5699266|P3|Overall Study|Withdrawal by Subject|1
1631430|NCT01868022|5699267|P2|Overall Study|Withdrawal by Subject|0
1631431|NCT01868022|5699268|P1|Overall Study|Withdrawal by Subject|0
1631432|NCT01868009|5699474|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
1631433|NCT01868009|5699475|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
1631434|NCT01868009|5699474|P2|Period 2 (5-9 Days)|Adverse Event|0
1631435|NCT01868009|5699475|P1|Period 2 (5-9 Days)|Adverse Event|1
1631436|NCT01868009|5699474|P2|Period 1 (5-9 Days)|Adverse Event|2
1631437|NCT01868009|5699475|P1|Period 1 (5-9 Days)|Adverse Event|0
1631438|NCT01867710|5699489|P4|Overall Study|Study medication no longer effective|0
1631439|NCT01867710|5699490|P3|Overall Study|Study medication no longer effective|0
1631440|NCT01867710|5699491|P2|Overall Study|Study medication no longer effective|1
1631441|NCT01867710|5699492|P1|Overall Study|Study medication no longer effective|0
1631442|NCT01867710|5699489|P4|Overall Study|PSA-progression|0
1631443|NCT01867710|5699490|P3|Overall Study|PSA-progression|0
1631444|NCT01867710|5699491|P2|Overall Study|PSA-progression|1
1631445|NCT01867710|5699492|P1|Overall Study|PSA-progression|0
1631446|NCT01867710|5699489|P4|Overall Study|Protocol Violation|1
1631447|NCT01867710|5699490|P3|Overall Study|Protocol Violation|0
1631448|NCT01867710|5699491|P2|Overall Study|Protocol Violation|0
1631449|NCT01867710|5699492|P1|Overall Study|Protocol Violation|0
1631450|NCT01867710|5699489|P4|Overall Study|Progressive disease|0
1631451|NCT01867710|5699490|P3|Overall Study|Progressive disease|0
1631452|NCT01867710|5699491|P2|Overall Study|Progressive disease|0
1631453|NCT01867710|5699492|P1|Overall Study|Progressive disease|1
1631454|NCT01867710|5699489|P4|Overall Study|Patient to follow subsequent treatment|0
1631455|NCT01867710|5699490|P3|Overall Study|Patient to follow subsequent treatment|0
1631456|NCT01867710|5699491|P2|Overall Study|Patient to follow subsequent treatment|1
1631457|NCT01867710|5699492|P1|Overall Study|Patient to follow subsequent treatment|0
1631458|NCT01867710|5699489|P4|Overall Study|Patient decision|1
1631459|NCT01867710|5699490|P3|Overall Study|Patient decision|0
1631460|NCT01867710|5699491|P2|Overall Study|Patient decision|0
1631461|NCT01867710|5699492|P1|Overall Study|Patient decision|0
1631462|NCT01867710|5699489|P4|Overall Study|Disease progression|0
1631463|NCT01867710|5699490|P3|Overall Study|Disease progression|0
1631464|NCT01867710|5699491|P2|Overall Study|Disease progression|0
1631465|NCT01867710|5699492|P1|Overall Study|Disease progression|1
1631466|NCT01867710|5699489|P4|Overall Study|Clinical progression|0
1631467|NCT01867710|5699490|P3|Overall Study|Clinical progression|1
1631468|NCT01867710|5699491|P2|Overall Study|Clinical progression|0
1631469|NCT01867710|5699492|P1|Overall Study|Clinical progression|0
1631470|NCT01867710|5699489|P4|Overall Study|Biochemical progression|0
1631471|NCT01867710|5699490|P3|Overall Study|Biochemical progression|0
1631472|NCT01867710|5699491|P2|Overall Study|Biochemical progression|1
1631473|NCT01867710|5699492|P1|Overall Study|Biochemical progression|0
1631474|NCT01867710|5699489|P4|Overall Study|Study Terminated by Sponsor|16
1631475|NCT01867710|5699490|P3|Overall Study|Study Terminated by Sponsor|8
1631476|NCT01867710|5699491|P2|Overall Study|Study Terminated by Sponsor|13
1631477|NCT01867710|5699492|P1|Overall Study|Study Terminated by Sponsor|9
1631478|NCT01867710|5699489|P4|Overall Study|Withdrawal of consent|2
1631479|NCT01867710|5699490|P3|Overall Study|Withdrawal of consent|1
1631480|NCT01867710|5699491|P2|Overall Study|Withdrawal of consent|5
1631481|NCT01867710|5699492|P1|Overall Study|Withdrawal of consent|2
1631482|NCT01867710|5699489|P4|Overall Study|Lost to Follow-up|2
1631483|NCT01867710|5699490|P3|Overall Study|Lost to Follow-up|3
1631484|NCT01867710|5699491|P2|Overall Study|Lost to Follow-up|4
1631485|NCT01867710|5699492|P1|Overall Study|Lost to Follow-up|3
1631486|NCT01867710|5699489|P4|Overall Study|Death|20
1631487|NCT01867710|5699490|P3|Overall Study|Death|27
1631488|NCT01867710|5699491|P2|Overall Study|Death|15
1631489|NCT01867710|5699492|P1|Overall Study|Death|25
1631490|NCT01867671|5699560|P2|Overall Study|Withdrawal by Subject|21
1631491|NCT01867671|5699561|P1|Overall Study|Withdrawal by Subject|21
1631492|NCT01867671|5699560|P2|Overall Study|Non-compliance with Study Drug|2
1631493|NCT01867671|5699561|P1|Overall Study|Non-compliance with Study Drug|1
1631494|NCT01867671|5699560|P2|Overall Study|Lost to Follow-up|1
1631495|NCT01867671|5699561|P1|Overall Study|Lost to Follow-up|0
1631496|NCT01867671|5699560|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
1631497|NCT01867671|5699561|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
1631498|NCT01867671|5699560|P2|Overall Study|Anaphylaxis|1
1631499|NCT01867671|5699561|P1|Overall Study|Anaphylaxis|0
1631500|NCT01867671|5699560|P2|Overall Study|Adverse Event|3
1631501|NCT01867671|5699561|P1|Overall Study|Adverse Event|5
1631502|NCT01867658|5699574|P1|Overall Study|Subject could not be contacted|1
1631503|NCT01867658|5699574|P1|Overall Study|Death|2
1631504|NCT01867658|5699574|P1|Overall Study|Withdrawal by Subject|6
1631505|NCT01867580|5699598|P2|Overall Study|Wound recurrence|1
1631506|NCT01867580|5699599|P1|Overall Study|Wound recurrence|0
1631507|NCT01867580|5699598|P2|Overall Study|Continuation of therapy|1
1631508|NCT01867580|5699599|P1|Overall Study|Continuation of therapy|0
1631509|NCT01867580|5699598|P2|Overall Study|Osteomyelitis|1
1631510|NCT01867580|5699599|P1|Overall Study|Osteomyelitis|0
1631511|NCT01867580|5699598|P2|Overall Study|Interruption to therapy|0
1631512|NCT01867580|5699599|P1|Overall Study|Interruption to therapy|3
1631513|NCT01867580|5699598|P2|Overall Study|Missed follow-up assessment|1
1631514|NCT01867580|5699599|P1|Overall Study|Missed follow-up assessment|2
1631515|NCT01867580|5699598|P2|Overall Study|Sponsor terminated study|0
1631516|NCT01867580|5699599|P1|Overall Study|Sponsor terminated study|1
1631517|NCT01867580|5699598|P2|Overall Study|Lost to Follow-up|5
1631518|NCT01867580|5699599|P1|Overall Study|Lost to Follow-up|3
1631519|NCT01867580|5699598|P2|Overall Study|Physician Decision|12
1631520|NCT01867580|5699599|P1|Overall Study|Physician Decision|17
1631521|NCT01867580|5699598|P2|Overall Study|Withdrawal by Subject|3
1631522|NCT01867580|5699599|P1|Overall Study|Withdrawal by Subject|2
1631523|NCT01867424|5699624|P2|Overall Study|Patient noncompliance|1
1631524|NCT01867424|5699625|P1|Overall Study|Patient noncompliance|2
1631525|NCT01867307|5699639|P2|Overall Study|Other Adverse Event|3
1631526|NCT01867307|5699640|P1|Overall Study|Other Adverse Event|1
1631527|NCT01867307|5699639|P2|Overall Study|Protocol Violation|0
1631528|NCT01867307|5699640|P1|Overall Study|Protocol Violation|2
1631529|NCT01867294|5699650|P4|Overall Study|Withdrawal by Subject|0
1631530|NCT01867294|5699651|P3|Overall Study|Withdrawal by Subject|0
1631531|NCT01867294|5699652|P2|Overall Study|Withdrawal by Subject|1
1631532|NCT01867294|5699653|P1|Overall Study|Withdrawal by Subject|1
1631533|NCT01867216|5699700|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
1631534|NCT01867216|5699701|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
1631535|NCT01867216|5699702|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
1631536|NCT01867216|5699703|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
1631537|NCT01867216|5699704|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
1631538|NCT01867216|5699705|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
1631539|NCT01867216|5699706|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
1631540|NCT01867216|5699700|P7|Overall Study|Physician Decision|0
1631541|NCT01867216|5699701|P6|Overall Study|Physician Decision|0
1631542|NCT01867216|5699702|P5|Overall Study|Physician Decision|0
1631543|NCT01867216|5699703|P4|Overall Study|Physician Decision|0
1631544|NCT01867216|5699704|P3|Overall Study|Physician Decision|0
1631545|NCT01867216|5699705|P2|Overall Study|Physician Decision|0
1631546|NCT01867216|5699706|P1|Overall Study|Physician Decision|1
1631547|NCT01867216|5699700|P7|Overall Study|Withdrawal by Subject|1
1631548|NCT01867216|5699701|P6|Overall Study|Withdrawal by Subject|0
1631549|NCT01867216|5699702|P5|Overall Study|Withdrawal by Subject|1
1631550|NCT01867216|5699703|P4|Overall Study|Withdrawal by Subject|0
1631551|NCT01867216|5699704|P3|Overall Study|Withdrawal by Subject|0
1631552|NCT01867216|5699705|P2|Overall Study|Withdrawal by Subject|0
1631553|NCT01867216|5699706|P1|Overall Study|Withdrawal by Subject|2
1631554|NCT01867086|5699778|P1|Overall Study|Disease Progression|1
1631555|NCT01867047|5699787|P2|Overall Study|surgery not indicated in protocol|2
1631556|NCT01867047|5699788|P1|Overall Study|surgery not indicated in protocol|1
1631557|NCT01867047|5699787|P2|Overall Study|Physician Decision|0
1631558|NCT01867047|5699788|P1|Overall Study|Physician Decision|2
1631559|NCT01867047|5699787|P2|Overall Study|Withdrawal by Subject|0
1631560|NCT01867047|5699788|P1|Overall Study|Withdrawal by Subject|2
1631561|NCT01867047|5699787|P2|Overall Study|Lost to Follow-up|3
1631562|NCT01867047|5699788|P1|Overall Study|Lost to Follow-up|3
1631563|NCT01867021|5699808|P2|Overall Study|Withdrawal by Subject|6
1631564|NCT01867021|5699809|P1|Overall Study|Withdrawal by Subject|1
1631565|NCT01867021|5699808|P2|Overall Study|Lost to Follow-up|2
1631566|NCT01867021|5699809|P1|Overall Study|Lost to Follow-up|0
1631567|NCT01867021|5699808|P2|Overall Study|Death|0
1631568|NCT01867021|5699809|P1|Overall Study|Death|1
1631569|NCT01867021|5699808|P2|Overall Study|Not Eligible|1
1631570|NCT01867021|5699809|P1|Overall Study|Not Eligible|0
1631571|NCT01867021|5699808|P2|Overall Study|Adverse Event|1
1631572|NCT01867021|5699809|P1|Overall Study|Adverse Event|0
1631579|NCT01866709|5699855|P2|Overall Study|Adverse Event|0
1631580|NCT01866709|5699856|P1|Overall Study|Adverse Event|1
1631581|NCT01866423|5699897|P1|Overall Study|Sponsor Decision|1
1631582|NCT01866423|5699897|P1|Overall Study|Lack of Efficacy|3
1631583|NCT01866319|5699925|P3|Overall Study|Remain on study|176
1631584|NCT01866319|5699926|P2|Overall Study|Remain on study|190
1631585|NCT01866319|5699927|P1|Overall Study|Remain on study|131
1631586|NCT01866319|5699925|P3|Overall Study|Withdrawal by Subject|6
1631587|NCT01866319|5699926|P2|Overall Study|Withdrawal by Subject|9
1631588|NCT01866319|5699927|P1|Overall Study|Withdrawal by Subject|31
1631589|NCT01866319|5699925|P3|Overall Study|Physician Decision|0
1631590|NCT01866319|5699926|P2|Overall Study|Physician Decision|0
1631591|NCT01866319|5699927|P1|Overall Study|Physician Decision|1
1631592|NCT01866319|5699925|P3|Overall Study|Lost to Follow-up|6
1631593|NCT01866319|5699926|P2|Overall Study|Lost to Follow-up|0
1631594|NCT01866319|5699927|P1|Overall Study|Lost to Follow-up|3
1631595|NCT01866319|5699925|P3|Overall Study|Death|77
1631596|NCT01866319|5699926|P2|Overall Study|Death|74
1631597|NCT01866319|5699927|P1|Overall Study|Death|97
1631598|NCT01866319|5699925|P3|Overall Study|Clinical progression|0
1631599|NCT01866319|5699926|P2|Overall Study|Clinical progression|0
1631600|NCT01866319|5699927|P1|Overall Study|Clinical progression|1
1631601|NCT01866319|5699925|P3|Overall Study|Adverse Event|12
1631602|NCT01866319|5699926|P2|Overall Study|Adverse Event|6
1631603|NCT01866319|5699927|P1|Overall Study|Adverse Event|13
1631604|NCT01866293|5700026|P1|Overall Study|Adverse Event|2
1631605|NCT01865812|5700068|P1|Overall Study|Adverse Event|2
1631606|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Other|1
1631607|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Other|0
1631608|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
1631609|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
1631610|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
1631611|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
1631612|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Physician Decision|2
1631613|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Physician Decision|4
1631614|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
1631615|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
1631616|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
1631617|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
1631618|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
1631619|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
1631620|NCT01865747|5700076|P2|Primary Intent to Treat (PITT)|Adverse Event|20
1631621|NCT01865747|5700077|P1|Primary Intent to Treat (PITT)|Adverse Event|21
1631622|NCT01865747|5700076|P2|Overall Study (ITT)|Reason Not Provided|1
1631623|NCT01865747|5700077|P1|Overall Study (ITT)|Reason Not Provided|0
1631624|NCT01865747|5700076|P2|Overall Study (ITT)|Progressive Disease|158
1631625|NCT01865747|5700077|P1|Overall Study (ITT)|Progressive Disease|122
1631626|NCT01865747|5700076|P2|Overall Study (ITT)|Sponsor Decision|1
1631627|NCT01865747|5700077|P1|Overall Study (ITT)|Sponsor Decision|0
1631628|NCT01865747|5700076|P2|Overall Study (ITT)|Withdrawal by Subject|11
1631629|NCT01865747|5700077|P1|Overall Study (ITT)|Withdrawal by Subject|6
1631630|NCT01865747|5700076|P2|Overall Study (ITT)|Physician Decision|2
1631631|NCT01865747|5700077|P1|Overall Study (ITT)|Physician Decision|5
1631632|NCT01865747|5700076|P2|Overall Study (ITT)|Protocol Violation|1
1631633|NCT01865747|5700077|P1|Overall Study (ITT)|Protocol Violation|1
1631634|NCT01865747|5700076|P2|Overall Study (ITT)|Lack of Efficacy|0
1631635|NCT01865747|5700077|P1|Overall Study (ITT)|Lack of Efficacy|3
1631636|NCT01865747|5700076|P2|Overall Study (ITT)|Clinical Deterioration|50
1631637|NCT01865747|5700077|P1|Overall Study (ITT)|Clinical Deterioration|29
1631638|NCT01865747|5700076|P2|Overall Study (ITT)|Adverse Event|31
1631639|NCT01865747|5700077|P1|Overall Study (ITT)|Adverse Event|32
1631640|NCT01865552|5700098|P6|Period 1|Other|0
1631641|NCT01865552|5700099|P5|Period 1|Other|1
1631642|NCT01865552|5700100|P4|Period 1|Other|0
1631643|NCT01865552|5700101|P3|Period 1|Other|0
1631644|NCT01865552|5700102|P2|Period 1|Other|0
1631645|NCT01865552|5700103|P1|Period 1|Other|0
1631646|NCT01865552|5700098|P6|Period 1|Pathological lab|0
1631647|NCT01865552|5700099|P5|Period 1|Pathological lab|1
1631648|NCT01865552|5700100|P4|Period 1|Pathological lab|0
1631649|NCT01865552|5700101|P3|Period 1|Pathological lab|0
1631650|NCT01865552|5700102|P2|Period 1|Pathological lab|0
1631651|NCT01865552|5700103|P1|Period 1|Pathological lab|0
1631652|NCT01865552|5700098|P6|Period 1|Adverse Event|1
1631653|NCT01865552|5700099|P5|Period 1|Adverse Event|1
1631654|NCT01865552|5700100|P4|Period 1|Adverse Event|1
1631655|NCT01865552|5700101|P3|Period 1|Adverse Event|0
1631656|NCT01865552|5700102|P2|Period 1|Adverse Event|0
1631657|NCT01865552|5700103|P1|Period 1|Adverse Event|1
1631658|NCT01865487|5700141|P10|Overall Study|Withdrawal by Subject|0
1631659|NCT01865487|5700142|P9|Overall Study|Withdrawal by Subject|0
1631660|NCT01865487|5700143|P8|Overall Study|Withdrawal by Subject|0
1631661|NCT01865487|5700144|P7|Overall Study|Withdrawal by Subject|0
1631662|NCT01865487|5700145|P6|Overall Study|Withdrawal by Subject|0
1631663|NCT01865487|5700146|P5|Overall Study|Withdrawal by Subject|1
1631664|NCT01865487|5700147|P4|Overall Study|Withdrawal by Subject|0
1631665|NCT01865487|5700148|P3|Overall Study|Withdrawal by Subject|0
1631666|NCT01865487|5700149|P2|Overall Study|Withdrawal by Subject|0
1631667|NCT01865487|5700150|P1|Overall Study|Withdrawal by Subject|0
1631668|NCT01865487|5700141|P10|Overall Study|Lost to Follow-up|0
1631669|NCT01865487|5700142|P9|Overall Study|Lost to Follow-up|0
1631670|NCT01865487|5700143|P8|Overall Study|Lost to Follow-up|0
1631671|NCT01865487|5700144|P7|Overall Study|Lost to Follow-up|1
1631672|NCT01865487|5700145|P6|Overall Study|Lost to Follow-up|0
1631673|NCT01865487|5700146|P5|Overall Study|Lost to Follow-up|0
1631674|NCT01865487|5700147|P4|Overall Study|Lost to Follow-up|1
1631675|NCT01865487|5700148|P3|Overall Study|Lost to Follow-up|0
1631676|NCT01865487|5700149|P2|Overall Study|Lost to Follow-up|0
1631677|NCT01865487|5700150|P1|Overall Study|Lost to Follow-up|0
1631678|NCT01865448|5700189|P2|Overall Study|dropout unrelated to study|1
1631679|NCT01865448|5700190|P1|Overall Study|dropout unrelated to study|1
1631680|NCT01865448|5700189|P2|Overall Study|Pregnancy|1
1631681|NCT01865448|5700190|P1|Overall Study|Pregnancy|0
1631682|NCT01865448|5700189|P2|Overall Study|Adverse Event|1
1631683|NCT01865448|5700190|P1|Overall Study|Adverse Event|1
1631684|NCT01865084|5700301|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1631685|NCT01865084|5700302|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
1631686|NCT01865084|5700303|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
1631687|NCT01865084|5700301|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
1631688|NCT01865084|5700302|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
1631689|NCT01865084|5700303|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
1631690|NCT01865084|5700301|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
1631691|NCT01865084|5700302|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
1631692|NCT01865084|5700303|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
1631693|NCT01865084|5700301|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
1631694|NCT01865084|5700302|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
1631695|NCT01865084|5700303|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
1631696|NCT01865084|5700301|P3|Open Label Extension (OLE) Period|Adverse Event|1
1631697|NCT01865084|5700302|P2|Open Label Extension (OLE) Period|Adverse Event|0
1631698|NCT01865084|5700303|P1|Open Label Extension (OLE) Period|Adverse Event|0
1631699|NCT01865084|5700301|P3|Double Blind Period (DB)|Withdrawal by Subject|0
1631700|NCT01865084|5700302|P2|Double Blind Period (DB)|Withdrawal by Subject|0
1631701|NCT01865084|5700303|P1|Double Blind Period (DB)|Withdrawal by Subject|1
1631702|NCT01865084|5700301|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
1631703|NCT01865084|5700302|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1631704|NCT01865084|5700303|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
1631705|NCT01865084|5700301|P3|Double Blind Period (DB)|Protocol Violation|1
1631706|NCT01865084|5700302|P2|Double Blind Period (DB)|Protocol Violation|0
1631707|NCT01865084|5700303|P1|Double Blind Period (DB)|Protocol Violation|0
1631708|NCT01865084|5700301|P3|Double Blind Period (DB)|Adverse Event|1
1631709|NCT01865084|5700302|P2|Double Blind Period (DB)|Adverse Event|2
1631710|NCT01865084|5700303|P1|Double Blind Period (DB)|Adverse Event|2
1631711|NCT01864525|5700335|P2|Overall Study|Adverse Event|0
1631712|NCT01864525|5700336|P1|Overall Study|Adverse Event|1
1631713|NCT01864200|5700359|P2|Overall Study|Protocol Violation|0
1631714|NCT01864200|5700360|P1|Overall Study|Protocol Violation|1
1631715|NCT01864200|5700359|P2|Overall Study|Lost to Follow-up|3
1631716|NCT01864200|5700360|P1|Overall Study|Lost to Follow-up|1
1631717|NCT01864174|5700368|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
1631718|NCT01864174|5700369|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
1631719|NCT01864174|5700368|P2|Off Treatment Follow-Up|Other|0
1631720|NCT01864174|5700369|P1|Off Treatment Follow-Up|Other|2
1631721|NCT01864174|5700368|P2|Double Blind - Compliant Randomized|Other|10
1631722|NCT01864174|5700369|P1|Double Blind - Compliant Randomized|Other|6
1631723|NCT01864174|5700368|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
1631724|NCT01864174|5700369|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
1631725|NCT01864174|5700368|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
1631726|NCT01864174|5700369|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
1631727|NCT01864174|5700368|P2|Double Blind - Compliant Randomized|Death|0
1631728|NCT01864174|5700369|P1|Double Blind - Compliant Randomized|Death|1
1631729|NCT01864174|5700368|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
1631730|NCT01864174|5700369|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
1631731|NCT01864174|5700368|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
1631732|NCT01864174|5700369|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
1631733|NCT01864174|5700368|P2|Double Blind - Compliant Randomized|Adverse Event|1
1631734|NCT01864174|5700369|P1|Double Blind - Compliant Randomized|Adverse Event|6
1631735|NCT01864174|5700368|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
1631736|NCT01864174|5700369|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
1631737|NCT01864148|5700388|P5|Overall Study|Not Dosed|0
1631738|NCT01864148|5700389|P4|Overall Study|Not Dosed|1
1631739|NCT01864148|5700390|P3|Overall Study|Not Dosed|0
1631740|NCT01864148|5700391|P2|Overall Study|Not Dosed|0
1631741|NCT01864148|5700392|P1|Overall Study|Not Dosed|0
1631742|NCT01864148|5700388|P5|Overall Study|Adverse Event|7
1631743|NCT01864148|5700389|P4|Overall Study|Adverse Event|7
1631744|NCT01864148|5700390|P3|Overall Study|Adverse Event|4
1631745|NCT01864148|5700391|P2|Overall Study|Adverse Event|2
1631746|NCT01864148|5700392|P1|Overall Study|Adverse Event|4
1631747|NCT01864148|5700388|P5|Overall Study|Lost to Follow-up|1
1631748|NCT01864148|5700389|P4|Overall Study|Lost to Follow-up|2
1631749|NCT01864148|5700390|P3|Overall Study|Lost to Follow-up|0
1631750|NCT01864148|5700391|P2|Overall Study|Lost to Follow-up|0
1631751|NCT01864148|5700392|P1|Overall Study|Lost to Follow-up|0
1631752|NCT01864148|5700388|P5|Overall Study|Withdrawal by Subject|8
1631753|NCT01864148|5700389|P4|Overall Study|Withdrawal by Subject|8
1631754|NCT01864148|5700390|P3|Overall Study|Withdrawal by Subject|6
1631755|NCT01864148|5700391|P2|Overall Study|Withdrawal by Subject|2
1631756|NCT01864148|5700392|P1|Overall Study|Withdrawal by Subject|9
1631757|NCT01864148|5700388|P5|Overall Study|Investigator Decision|6
1631758|NCT01864148|5700389|P4|Overall Study|Investigator Decision|4
1631759|NCT01864148|5700390|P3|Overall Study|Investigator Decision|0
1631760|NCT01864148|5700391|P2|Overall Study|Investigator Decision|0
1631761|NCT01864148|5700392|P1|Overall Study|Investigator Decision|5
1631762|NCT01864148|5700388|P5|Overall Study|Death|0
1631763|NCT01864148|5700389|P4|Overall Study|Death|1
1631764|NCT01864148|5700390|P3|Overall Study|Death|0
1631765|NCT01864148|5700391|P2|Overall Study|Death|0
1631766|NCT01864148|5700392|P1|Overall Study|Death|0
1631767|NCT01864148|5700388|P5|Overall Study|Other|1
1631768|NCT01864148|5700389|P4|Overall Study|Other|3
1631769|NCT01864148|5700390|P3|Overall Study|Other|1
1631770|NCT01864148|5700391|P2|Overall Study|Other|1
1631771|NCT01864148|5700392|P1|Overall Study|Other|2
1631772|NCT01864005|5700421|P2|Overall Study|Need GP IIb/IIIa|3
1631773|NCT01864005|5700422|P1|Overall Study|Need GP IIb/IIIa|1
1631774|NCT01864005|5700421|P2|Overall Study|Disease need|1
1631775|NCT01864005|5700422|P1|Overall Study|Disease need|1
1631776|NCT01864005|5700421|P2|Overall Study|Incorrect enrolment|0
1631777|NCT01864005|5700422|P1|Overall Study|Incorrect enrolment|1
1631778|NCT01864005|5700421|P2|Overall Study|Withdrawal by Subject|1
1631779|NCT01864005|5700422|P1|Overall Study|Withdrawal by Subject|0
1631780|NCT01864005|5700421|P2|Overall Study|Protocol Violation|1
1631781|NCT01864005|5700422|P1|Overall Study|Protocol Violation|0
1631782|NCT01863953|5700439|P3|Overall Study|Adverse Event|1
1631783|NCT01863953|5700440|P2|Overall Study|Adverse Event|0
1631784|NCT01863953|5700441|P1|Overall Study|Adverse Event|0
1631785|NCT01863771|5700455|P4|Maintenance Phase|Withdrawal by Subject|3
1631786|NCT01863771|5700456|P3|Maintenance Phase|Withdrawal by Subject|2
1631787|NCT01863771|5700457|P2|Maintenance Phase|Withdrawal by Subject|1
1631788|NCT01863771|5700458|P1|Maintenance Phase|Withdrawal by Subject|0
1631789|NCT01863771|5700455|P4|Maintenance Phase|Pregnancy|0
1631790|NCT01863771|5700456|P3|Maintenance Phase|Pregnancy|0
1631791|NCT01863771|5700457|P2|Maintenance Phase|Pregnancy|1
1631792|NCT01863771|5700458|P1|Maintenance Phase|Pregnancy|0
1631793|NCT01863771|5700455|P4|Maintenance Phase|Physician Decision|1
1631794|NCT01863771|5700456|P3|Maintenance Phase|Physician Decision|2
1631795|NCT01863771|5700457|P2|Maintenance Phase|Physician Decision|0
1631796|NCT01863771|5700458|P1|Maintenance Phase|Physician Decision|0
1631797|NCT01863771|5700455|P4|Maintenance Phase|Lack of Efficacy|38
1631798|NCT01863771|5700456|P3|Maintenance Phase|Lack of Efficacy|7
1631799|NCT01863771|5700457|P2|Maintenance Phase|Lack of Efficacy|3
1631800|NCT01863771|5700458|P1|Maintenance Phase|Lack of Efficacy|0
1631801|NCT01863771|5700455|P4|Maintenance Phase|Adverse Event|1
1631802|NCT01863771|5700456|P3|Maintenance Phase|Adverse Event|1
1631803|NCT01863771|5700457|P2|Maintenance Phase|Adverse Event|0
1631804|NCT01863771|5700458|P1|Maintenance Phase|Adverse Event|0
1631805|NCT01863771|5700455|P4|Induction Phase|Withdrawal by Subject|0
1631806|NCT01863771|5700456|P3|Induction Phase|Withdrawal by Subject|0
1631807|NCT01863771|5700457|P2|Induction Phase|Withdrawal by Subject|0
1631808|NCT01863771|5700458|P1|Induction Phase|Withdrawal by Subject|2
1631809|NCT01863771|5700455|P4|Induction Phase|Lack of Efficacy|0
1631810|NCT01863771|5700456|P3|Induction Phase|Lack of Efficacy|0
1631811|NCT01863771|5700457|P2|Induction Phase|Lack of Efficacy|0
1631812|NCT01863771|5700458|P1|Induction Phase|Lack of Efficacy|10
1631813|NCT01863771|5700455|P4|Induction Phase|Adverse Event|0
1631814|NCT01863771|5700456|P3|Induction Phase|Adverse Event|0
1631815|NCT01863771|5700457|P2|Induction Phase|Adverse Event|0
1631816|NCT01863771|5700458|P1|Induction Phase|Adverse Event|9
1631817|NCT01863758|5700470|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
1631818|NCT01863758|5700470|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
1631819|NCT01863732|5700482|P4|Overall Study|Death|1
1631820|NCT01863732|5700483|P3|Overall Study|Death|0
1631821|NCT01863732|5700484|P2|Overall Study|Death|0
1631822|NCT01863732|5700485|P1|Overall Study|Death|1
1631823|NCT01863732|5700482|P4|Overall Study|Subject/guardian decision|1
1631824|NCT01863732|5700483|P3|Overall Study|Subject/guardian decision|3
1631825|NCT01863732|5700484|P2|Overall Study|Subject/guardian decision|9
1631826|NCT01863732|5700485|P1|Overall Study|Subject/guardian decision|6
1631827|NCT01863732|5700482|P4|Overall Study|Technical problems|0
1631828|NCT01863732|5700483|P3|Overall Study|Technical problems|1
1631829|NCT01863732|5700484|P2|Overall Study|Technical problems|1
1631830|NCT01863732|5700485|P1|Overall Study|Technical problems|0
1631831|NCT01863732|5700482|P4|Overall Study|Pregnancy|1
1631832|NCT01863732|5700483|P3|Overall Study|Pregnancy|0
1631833|NCT01863732|5700484|P2|Overall Study|Pregnancy|0
1631834|NCT01863732|5700485|P1|Overall Study|Pregnancy|0
1631835|NCT01863732|5700482|P4|Overall Study|Physician Decision|0
1631836|NCT01863732|5700483|P3|Overall Study|Physician Decision|1
1631837|NCT01863732|5700484|P2|Overall Study|Physician Decision|0
1631838|NCT01863732|5700485|P1|Overall Study|Physician Decision|1
1631839|NCT01863732|5700482|P4|Overall Study|Lost to Follow-up|1
1631840|NCT01863732|5700483|P3|Overall Study|Lost to Follow-up|1
1631841|NCT01863732|5700484|P2|Overall Study|Lost to Follow-up|2
1631842|NCT01863732|5700485|P1|Overall Study|Lost to Follow-up|2
1631843|NCT01863732|5700482|P4|Overall Study|Lack of Efficacy|1
1631844|NCT01863732|5700483|P3|Overall Study|Lack of Efficacy|2
1631845|NCT01863732|5700484|P2|Overall Study|Lack of Efficacy|0
1631846|NCT01863732|5700485|P1|Overall Study|Lack of Efficacy|1
1631847|NCT01863732|5700482|P4|Overall Study|Adverse Event|3
1631848|NCT01863732|5700483|P3|Overall Study|Adverse Event|3
1631849|NCT01863732|5700484|P2|Overall Study|Adverse Event|0
1631850|NCT01863732|5700485|P1|Overall Study|Adverse Event|2
1631851|NCT01863680|5700498|P1|Overall Study|Other|6
1631852|NCT01863680|5700498|P1|Overall Study|Did not undergo IVF/ET|14
1631853|NCT01863680|5700498|P1|Overall Study|Withdrawal by Subject|1
1631854|NCT01863680|5700498|P1|Overall Study|Spontaneous pregnancy|2
1631855|NCT01863680|5700498|P1|Overall Study|Risk of OHSS|17
1631856|NCT01863680|5700498|P1|Overall Study|Adverse Event|17
1631857|NCT01863667|5700506|P2|Overall Study|Withdrawal by Subject|2
1631858|NCT01863667|5700507|P1|Overall Study|Withdrawal by Subject|2
1631859|NCT01863667|5700506|P2|Overall Study|Study terminated by Sponsor|30
1631860|NCT01863667|5700507|P1|Overall Study|Study terminated by Sponsor|30
1631861|NCT01863667|5700506|P2|Overall Study|Adverse Event|0
1631862|NCT01863667|5700507|P1|Overall Study|Adverse Event|1
1631863|NCT01863433|5700531|P1|Overall Study|Protocol Violation|1
1631864|NCT01863368|5700541|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
1631865|NCT01863368|5700542|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
1631866|NCT01863368|5700541|P2|Phase II, Day 35 to Day 90|Adverse Event|0
1631867|NCT01863368|5700542|P1|Phase II, Day 35 to Day 90|Adverse Event|1
1631868|NCT01863368|5700541|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
1631869|NCT01863368|5700542|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
1631870|NCT01863368|5700541|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
1631871|NCT01863368|5700542|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
1631872|NCT01863368|5700541|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
1631873|NCT01863368|5700542|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
1631874|NCT01863368|5700541|P2|Phase I, Day 0 to Day 35|Adverse Event|4
1631875|NCT01863368|5700542|P1|Phase I, Day 0 to Day 35|Adverse Event|2
1631876|NCT01862991|5700596|P3|Overall Study|Protocol Violation|0
1631877|NCT01862991|5700597|P2|Overall Study|Protocol Violation|0
1631878|NCT01862991|5700598|P1|Overall Study|Protocol Violation|1
1631879|NCT01862991|5700596|P3|Overall Study|Lost to Follow-up|1
1631880|NCT01862991|5700597|P2|Overall Study|Lost to Follow-up|1
1631881|NCT01862991|5700598|P1|Overall Study|Lost to Follow-up|2
1631882|NCT01862874|5700611|P2|Overall Study|Death|1
1631883|NCT01862874|5700612|P1|Overall Study|Death|0
1631884|NCT01862874|5700611|P2|Overall Study|Withdrawal by Subject|40
1631885|NCT01862874|5700612|P1|Overall Study|Withdrawal by Subject|46
1631886|NCT01862874|5700611|P2|Overall Study|Withdrawn by parent/guardian|1
1631887|NCT01862874|5700612|P1|Overall Study|Withdrawn by parent/guardian|1
1631888|NCT01862874|5700611|P2|Overall Study|Physician Decision|3
1631889|NCT01862874|5700612|P1|Overall Study|Physician Decision|5
1631890|NCT01862874|5700611|P2|Overall Study|Lost to Follow-up|29
1631891|NCT01862874|5700612|P1|Overall Study|Lost to Follow-up|26
1631892|NCT01862874|5700611|P2|Overall Study|Adverse Event|3
1631893|NCT01862874|5700612|P1|Overall Study|Adverse Event|0
1631894|NCT01862874|5700611|P2|Overall Study|Randomized not treated|0
1631895|NCT01862874|5700612|P1|Overall Study|Randomized not treated|1
1631896|NCT01862796|5700631|P3|Overall Study|Prohibited medications|1
1631897|NCT01862796|5700632|P2|Overall Study|Prohibited medications|0
1631898|NCT01862796|5700633|P1|Overall Study|Prohibited medications|0
1631899|NCT01862484|5700646|P2|Overall Study|Withdrawal by Subject|3
1631900|NCT01862484|5700647|P1|Overall Study|Withdrawal by Subject|0
1631901|NCT01862484|5700646|P2|Overall Study|Protocol Violation|2
1631902|NCT01862484|5700647|P1|Overall Study|Protocol Violation|0
1631903|NCT01862484|5700646|P2|Overall Study|Lost to Follow-up|2
1631904|NCT01862484|5700647|P1|Overall Study|Lost to Follow-up|1
1631905|NCT01862484|5700646|P2|Overall Study|Lack of Efficacy|1
1631906|NCT01862484|5700647|P1|Overall Study|Lack of Efficacy|1
1631907|NCT01862250|5700666|P1|Overall Study|Adverse Event|4
1631908|NCT01862029|5700687|P1|Overall Study|Physician Decision|1
1631909|NCT01861522|5700790|P2|Overall Study|Withdrawal by Subject|0
1631910|NCT01861522|5700791|P1|Overall Study|Withdrawal by Subject|2
1631911|NCT01861522|5700790|P2|Overall Study|Adverse Event|0
1631912|NCT01861522|5700791|P1|Overall Study|Adverse Event|1
1631913|NCT01860989|5700815|P1|Overall Study|Unsatisfactory therapeutic|5
1631914|NCT01860976|5700821|P2|Long Term Extension|Ongoing treatment at time of analysis|100
1631915|NCT01860976|5700822|P1|Long Term Extension|Ongoing treatment at time of analysis|106
1631916|NCT01860976|5700821|P2|Long Term Extension|Withdrawal by Subject|0
1631917|NCT01860976|5700822|P1|Long Term Extension|Withdrawal by Subject|1
1631918|NCT01860976|5700821|P2|Long Term Extension|Subject request to discontinue treatment|0
1631919|NCT01860976|5700822|P1|Long Term Extension|Subject request to discontinue treatment|2
1631920|NCT01860976|5700821|P2|Long Term Extension|Lack of Efficacy|7
1631921|NCT01860976|5700822|P1|Long Term Extension|Lack of Efficacy|3
1631922|NCT01860976|5700821|P2|Long Term Extension|Adverse Event|0
1631923|NCT01860976|5700822|P1|Long Term Extension|Adverse Event|1
1631924|NCT01860976|5700821|P2|Open-Label|Ongoing OL treatment at time of analysis|45
1631925|NCT01860976|5700822|P1|Open-Label|Ongoing OL treatment at time of analysis|46
1631926|NCT01860976|5700821|P2|Open-Label|Other Reasons|1
1631927|NCT01860976|5700822|P1|Open-Label|Other Reasons|1
1631928|NCT01860976|5700821|P2|Open-Label|Withdrawal by Subject|1
1631929|NCT01860976|5700822|P1|Open-Label|Withdrawal by Subject|4
1631930|NCT01860976|5700821|P2|Open-Label|Subject request discontinue treatment|3
1631931|NCT01860976|5700822|P1|Open-Label|Subject request discontinue treatment|4
1631932|NCT01860976|5700821|P2|Open-Label|Lost to Follow-up|2
1631933|NCT01860976|5700822|P1|Open-Label|Lost to Follow-up|1
1631934|NCT01860976|5700821|P2|Open-Label|Lack of Efficacy|8
1631935|NCT01860976|5700822|P1|Open-Label|Lack of Efficacy|16
1631936|NCT01860976|5700821|P2|Open-Label|Adverse Event|4
1631937|NCT01860976|5700822|P1|Open-Label|Adverse Event|2
1631938|NCT01860976|5700821|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
1631939|NCT01860976|5700822|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
1631940|NCT01860976|5700821|P2|Blinded Treatment|Entered Open-Label in error|1
1631941|NCT01860976|5700822|P1|Blinded Treatment|Entered Open-Label in error|0
1631942|NCT01860976|5700821|P2|Blinded Treatment|Subject no longer met criteria|0
1631943|NCT01860976|5700822|P1|Blinded Treatment|Subject no longer met criteria|1
1631944|NCT01860976|5700821|P2|Blinded Treatment|Withdrawal by Subject|5
1631945|NCT01860976|5700822|P1|Blinded Treatment|Withdrawal by Subject|3
1631946|NCT01860976|5700821|P2|Blinded Treatment|Subject request to discontinue treatment|3
1631947|NCT01860976|5700822|P1|Blinded Treatment|Subject request to discontinue treatment|2
1631948|NCT01860976|5700821|P2|Blinded Treatment|Lack of Efficacy|12
1631949|NCT01860976|5700822|P1|Blinded Treatment|Lack of Efficacy|5
1631950|NCT01860976|5700821|P2|Blinded Treatment|Adverse Event|3
1631951|NCT01860976|5700822|P1|Blinded Treatment|Adverse Event|1
1631952|NCT01860846|5700876|P1|Overall Study|Lost to Follow-up|33
1631953|NCT01860703|5700896|P4|Overall Study|Personal reason|0
1631954|NCT01860703|5700897|P3|Overall Study|Personal reason|1
1631955|NCT01860703|5700898|P2|Overall Study|Personal reason|0
1631956|NCT01860703|5700899|P1|Overall Study|Personal reason|1
1631957|NCT01860703|5700896|P4|Overall Study|Withdrawal by Subject|0
1631958|NCT01860703|5700897|P3|Overall Study|Withdrawal by Subject|0
1631959|NCT01860703|5700898|P2|Overall Study|Withdrawal by Subject|1
1631960|NCT01860703|5700899|P1|Overall Study|Withdrawal by Subject|0
1631961|NCT01860703|5700896|P4|Overall Study|Adverse Event|2
1631962|NCT01860703|5700897|P3|Overall Study|Adverse Event|0
1631963|NCT01860703|5700898|P2|Overall Study|Adverse Event|4
1631964|NCT01860703|5700899|P1|Overall Study|Adverse Event|1
1631965|NCT01860677|5700931|P2|Second Intervention (1 Day)|Lost to Follow-up|0
1631966|NCT01860677|5700932|P1|Second Intervention (1 Day)|Lost to Follow-up|7
1631967|NCT01860534|5700989|P2|ROP #2|discharged prior to ROP #2|0
1631968|NCT01860534|5700990|P1|ROP #2|discharged prior to ROP #2|1
1631969|NCT01860534|5700989|P2|ROP #1|Needed treatment for ROP|1
1631970|NCT01860534|5700990|P1|ROP #1|Needed treatment for ROP|0
1631971|NCT01860079|5701051|P2|Overall Study|Physician Decision|22
1631972|NCT01860079|5701052|P1|Overall Study|Physician Decision|14
1631973|NCT01860040|5701060|P2|Overall Study|Withdrawal by Subject|0
1631974|NCT01860040|5701061|P1|Overall Study|Withdrawal by Subject|1
1631975|NCT01859988|5701072|P6|Overall Study|Other than specified above|3
1631976|NCT01859988|5701073|P5|Overall Study|Other than specified above|5
1631977|NCT01859988|5701074|P4|Overall Study|Other than specified above|3
1631978|NCT01859988|5701075|P3|Overall Study|Other than specified above|11
1631979|NCT01859988|5701076|P2|Overall Study|Other than specified above|2
1631980|NCT01859988|5701077|P1|Overall Study|Other than specified above|0
1631981|NCT01859988|5701072|P6|Overall Study|Protocol Violation|0
1631982|NCT01859988|5701073|P5|Overall Study|Protocol Violation|0
1631983|NCT01859988|5701074|P4|Overall Study|Protocol Violation|0
1631984|NCT01859988|5701075|P3|Overall Study|Protocol Violation|1
1631985|NCT01859988|5701076|P2|Overall Study|Protocol Violation|0
1631986|NCT01859988|5701077|P1|Overall Study|Protocol Violation|0
1631987|NCT01859988|5701072|P6|Overall Study|Lost to Follow-up|2
1631988|NCT01859988|5701073|P5|Overall Study|Lost to Follow-up|3
1631989|NCT01859988|5701074|P4|Overall Study|Lost to Follow-up|0
1631990|NCT01859988|5701075|P3|Overall Study|Lost to Follow-up|3
1631991|NCT01859988|5701076|P2|Overall Study|Lost to Follow-up|2
1631992|NCT01859988|5701077|P1|Overall Study|Lost to Follow-up|1
1631993|NCT01859988|5701072|P6|Overall Study|Adverse Event|2
1631994|NCT01859988|5701073|P5|Overall Study|Adverse Event|2
1631995|NCT01859988|5701074|P4|Overall Study|Adverse Event|1
1631996|NCT01859988|5701075|P3|Overall Study|Adverse Event|3
1631997|NCT01859988|5701076|P2|Overall Study|Adverse Event|1
1631998|NCT01859988|5701077|P1|Overall Study|Adverse Event|2
1631999|NCT01859988|5701072|P6|Overall Study|Physician Decision|1
1632000|NCT01859988|5701073|P5|Overall Study|Physician Decision|4
1632001|NCT01859988|5701074|P4|Overall Study|Physician Decision|3
1632002|NCT01859988|5701075|P3|Overall Study|Physician Decision|1
1632003|NCT01859988|5701076|P2|Overall Study|Physician Decision|3
1632004|NCT01859988|5701077|P1|Overall Study|Physician Decision|1
1632005|NCT01859988|5701072|P6|Overall Study|Lack of Efficacy|9
1632006|NCT01859988|5701073|P5|Overall Study|Lack of Efficacy|7
1632007|NCT01859988|5701074|P4|Overall Study|Lack of Efficacy|0
1632008|NCT01859988|5701075|P3|Overall Study|Lack of Efficacy|5
1632009|NCT01859988|5701076|P2|Overall Study|Lack of Efficacy|1
1632010|NCT01859988|5701077|P1|Overall Study|Lack of Efficacy|1
1632011|NCT01859988|5701072|P6|Overall Study|Withdrawal by Subject|2
1632012|NCT01859988|5701073|P5|Overall Study|Withdrawal by Subject|2
1632013|NCT01859988|5701074|P4|Overall Study|Withdrawal by Subject|3
1632014|NCT01859988|5701075|P3|Overall Study|Withdrawal by Subject|4
1632015|NCT01859988|5701076|P2|Overall Study|Withdrawal by Subject|3
1632016|NCT01859988|5701077|P1|Overall Study|Withdrawal by Subject|6
1632017|NCT01859949|5701171|P2|Overall Study|Adverse Event|1
1632018|NCT01859949|5701172|P1|Overall Study|Adverse Event|0
1632019|NCT01859949|5701171|P2|Overall Study|Protocol Violation|1
1632020|NCT01859949|5701172|P1|Overall Study|Protocol Violation|1
1632021|NCT01859949|5701171|P2|Overall Study|Withdrawal by Subject|10
1632022|NCT01859949|5701172|P1|Overall Study|Withdrawal by Subject|11
1632023|NCT01859949|5701171|P2|Overall Study|Physician Decision|4
1632024|NCT01859949|5701172|P1|Overall Study|Physician Decision|2
1632025|NCT01859949|5701171|P2|Overall Study|Family Matters|1
1632026|NCT01859949|5701172|P1|Overall Study|Family Matters|0
1632027|NCT01859793|5701190|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
1632028|NCT01859793|5701191|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
1632029|NCT01859793|5701190|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
1632030|NCT01859793|5701191|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
1632031|NCT01859793|5701190|P2|First Intervention (8 Weeks)|Adverse Event|0
1632032|NCT01859793|5701191|P1|First Intervention (8 Weeks)|Adverse Event|1
1632033|NCT01859793|5701190|P2|First Intervention (8 Weeks)|Protocol Violation|0
1632034|NCT01859793|5701191|P1|First Intervention (8 Weeks)|Protocol Violation|2
1632035|NCT01859741|5701209|P8|Overall Study|Other|0
1632036|NCT01859741|5701210|P7|Overall Study|Other|2
1632037|NCT01859741|5701211|P6|Overall Study|Other|0
1632038|NCT01859741|5701212|P5|Overall Study|Other|0
1632039|NCT01859741|5701213|P4|Overall Study|Other|0
1632040|NCT01859741|5701214|P3|Overall Study|Other|0
1632041|NCT01859741|5701215|P2|Overall Study|Other|0
1632042|NCT01859741|5701216|P1|Overall Study|Other|0
1632043|NCT01859741|5701209|P8|Overall Study|Study Terminated by Sponsor|14
1632044|NCT01859741|5701210|P7|Overall Study|Study Terminated by Sponsor|16
1632045|NCT01859741|5701211|P6|Overall Study|Study Terminated by Sponsor|0
1632046|NCT01859741|5701212|P5|Overall Study|Study Terminated by Sponsor|1
1632047|NCT01859741|5701213|P4|Overall Study|Study Terminated by Sponsor|0
1632048|NCT01859741|5701214|P3|Overall Study|Study Terminated by Sponsor|0
1632049|NCT01859741|5701215|P2|Overall Study|Study Terminated by Sponsor|0
1632050|NCT01859741|5701216|P1|Overall Study|Study Terminated by Sponsor|0
1632051|NCT01859741|5701209|P8|Overall Study|Withdrawal by Subject|1
1632052|NCT01859741|5701210|P7|Overall Study|Withdrawal by Subject|1
1632053|NCT01859741|5701211|P6|Overall Study|Withdrawal by Subject|1
1632054|NCT01859741|5701212|P5|Overall Study|Withdrawal by Subject|0
1632055|NCT01859741|5701213|P4|Overall Study|Withdrawal by Subject|0
1632056|NCT01859741|5701214|P3|Overall Study|Withdrawal by Subject|2
1632057|NCT01859741|5701215|P2|Overall Study|Withdrawal by Subject|1
1632058|NCT01859741|5701216|P1|Overall Study|Withdrawal by Subject|0
1632059|NCT01859741|5701209|P8|Overall Study|Lost to Follow-up|4
1632060|NCT01859741|5701210|P7|Overall Study|Lost to Follow-up|0
1632061|NCT01859741|5701211|P6|Overall Study|Lost to Follow-up|1
1632062|NCT01859741|5701212|P5|Overall Study|Lost to Follow-up|0
1632063|NCT01859741|5701213|P4|Overall Study|Lost to Follow-up|0
1632064|NCT01859741|5701214|P3|Overall Study|Lost to Follow-up|0
1632065|NCT01859741|5701215|P2|Overall Study|Lost to Follow-up|0
1632066|NCT01859741|5701216|P1|Overall Study|Lost to Follow-up|0
1632067|NCT01859741|5701209|P8|Overall Study|Death|51
1632068|NCT01859741|5701210|P7|Overall Study|Death|51
1632069|NCT01859741|5701211|P6|Overall Study|Death|4
1632070|NCT01859741|5701212|P5|Overall Study|Death|5
1632071|NCT01859741|5701213|P4|Overall Study|Death|3
1632072|NCT01859741|5701214|P3|Overall Study|Death|4
1632073|NCT01859741|5701215|P2|Overall Study|Death|2
1632074|NCT01859741|5701216|P1|Overall Study|Death|3
1632075|NCT01859715|5701245|P3|Overall Study|No 2nd VAS|23
1632076|NCT01859715|5701246|P2|Overall Study|No 2nd VAS|8
1632077|NCT01859715|5701247|P1|Overall Study|No 2nd VAS|16
1632078|NCT01859702|5701258|P1|Overall Study|Adverse Event|2
1632079|NCT01859702|5701258|P1|Overall Study|Protocol deviation|3
1632080|NCT01859598|5701272|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
1632081|NCT01859507|5701280|P1|Overall Study|left the country|4
1632082|NCT01859494|5701285|P1|Overall Study|Adverse Event|1
1632083|NCT01859390|5701296|P2|Overall Study|Shipment Error|1
1632084|NCT01859390|5701297|P1|Overall Study|Shipment Error|0
1632085|NCT01859390|5701296|P2|Overall Study|Tube Cracked|2
1632086|NCT01859390|5701297|P1|Overall Study|Tube Cracked|0
1632087|NCT01859390|5701296|P2|Overall Study|Sample Missing Collection Date|1
1632088|NCT01859390|5701297|P1|Overall Study|Sample Missing Collection Date|0
1632089|NCT01859390|5701296|P2|Overall Study|Insufficient Sputum Collected|3
1632090|NCT01859390|5701297|P1|Overall Study|Insufficient Sputum Collected|1
1632091|NCT01859143|5701431|P2|Overall Study|Lost to Follow-up|0
1632092|NCT01859143|5701432|P1|Overall Study|Lost to Follow-up|2
1632093|NCT01858766|5701488|P19|Overall Study|Withdrew Consent|0
1632094|NCT01858766|5701489|P18|Overall Study|Withdrew Consent|0
1632095|NCT01858766|5701490|P17|Overall Study|Withdrew Consent|0
1632096|NCT01858766|5701491|P16|Overall Study|Withdrew Consent|0
1632097|NCT01858766|5701492|P15|Overall Study|Withdrew Consent|0
1632098|NCT01858766|5701493|P14|Overall Study|Withdrew Consent|0
1632099|NCT01858766|5701494|P13|Overall Study|Withdrew Consent|0
1632100|NCT01858766|5701495|P12|Overall Study|Withdrew Consent|1
1632101|NCT01858766|5701496|P11|Overall Study|Withdrew Consent|0
1632102|NCT01858766|5701497|P10|Overall Study|Withdrew Consent|0
1632103|NCT01858766|5701498|P9|Overall Study|Withdrew Consent|0
1632104|NCT01858766|5701499|P8|Overall Study|Withdrew Consent|0
1632105|NCT01858766|5701500|P7|Overall Study|Withdrew Consent|0
1632106|NCT01858766|5701501|P6|Overall Study|Withdrew Consent|0
1632107|NCT01858766|5701502|P5|Overall Study|Withdrew Consent|0
1632108|NCT01858766|5701503|P4|Overall Study|Withdrew Consent|0
1632109|NCT01858766|5701504|P3|Overall Study|Withdrew Consent|0
1632110|NCT01858766|5701505|P2|Overall Study|Withdrew Consent|0
1632111|NCT01858766|5701506|P1|Overall Study|Withdrew Consent|0
1632112|NCT01858766|5701488|P19|Overall Study|Lost to Follow-up|1
1632113|NCT01858766|5701489|P18|Overall Study|Lost to Follow-up|0
1632114|NCT01858766|5701490|P17|Overall Study|Lost to Follow-up|1
1632115|NCT01858766|5701491|P16|Overall Study|Lost to Follow-up|1
1632116|NCT01858766|5701492|P15|Overall Study|Lost to Follow-up|3
1632117|NCT01858766|5701493|P14|Overall Study|Lost to Follow-up|0
1632118|NCT01858766|5701494|P13|Overall Study|Lost to Follow-up|0
1632119|NCT01858766|5701495|P12|Overall Study|Lost to Follow-up|1
1632120|NCT01858766|5701496|P11|Overall Study|Lost to Follow-up|0
1632121|NCT01858766|5701497|P10|Overall Study|Lost to Follow-up|0
1632122|NCT01858766|5701498|P9|Overall Study|Lost to Follow-up|0
1632123|NCT01858766|5701499|P8|Overall Study|Lost to Follow-up|2
1632124|NCT01858766|5701500|P7|Overall Study|Lost to Follow-up|0
1632125|NCT01858766|5701501|P6|Overall Study|Lost to Follow-up|1
1632126|NCT01858766|5701502|P5|Overall Study|Lost to Follow-up|0
1632127|NCT01858766|5701503|P4|Overall Study|Lost to Follow-up|0
1632128|NCT01858766|5701504|P3|Overall Study|Lost to Follow-up|0
1632129|NCT01858766|5701505|P2|Overall Study|Lost to Follow-up|0
1632130|NCT01858766|5701506|P1|Overall Study|Lost to Follow-up|0
1632131|NCT01858766|5701488|P19|Overall Study|Lack of Efficacy|3
1632132|NCT01858766|5701489|P18|Overall Study|Lack of Efficacy|3
1632133|NCT01858766|5701490|P17|Overall Study|Lack of Efficacy|2
1632134|NCT01858766|5701491|P16|Overall Study|Lack of Efficacy|5
1632135|NCT01858766|5701492|P15|Overall Study|Lack of Efficacy|5
1632136|NCT01858766|5701493|P14|Overall Study|Lack of Efficacy|3
1632137|NCT01858766|5701494|P13|Overall Study|Lack of Efficacy|5
1632138|NCT01858766|5701495|P12|Overall Study|Lack of Efficacy|3
1632139|NCT01858766|5701496|P11|Overall Study|Lack of Efficacy|0
1632140|NCT01858766|5701497|P10|Overall Study|Lack of Efficacy|0
1632141|NCT01858766|5701498|P9|Overall Study|Lack of Efficacy|0
1632142|NCT01858766|5701499|P8|Overall Study|Lack of Efficacy|0
1632143|NCT01858766|5701500|P7|Overall Study|Lack of Efficacy|0
1632144|NCT01858766|5701501|P6|Overall Study|Lack of Efficacy|2
1632145|NCT01858766|5701502|P5|Overall Study|Lack of Efficacy|1
1632146|NCT01858766|5701503|P4|Overall Study|Lack of Efficacy|0
1632147|NCT01858766|5701504|P3|Overall Study|Lack of Efficacy|0
1632148|NCT01858766|5701505|P2|Overall Study|Lack of Efficacy|0
1632149|NCT01858766|5701506|P1|Overall Study|Lack of Efficacy|1
1632150|NCT01858766|5701488|P19|Overall Study|Death|0
1632151|NCT01858766|5701489|P18|Overall Study|Death|0
1632152|NCT01858766|5701490|P17|Overall Study|Death|0
1632153|NCT01858766|5701491|P16|Overall Study|Death|0
1632154|NCT01858766|5701492|P15|Overall Study|Death|0
1632155|NCT01858766|5701493|P14|Overall Study|Death|0
1632156|NCT01858766|5701494|P13|Overall Study|Death|0
1632157|NCT01858766|5701495|P12|Overall Study|Death|0
1632158|NCT01858766|5701496|P11|Overall Study|Death|0
1632159|NCT01858766|5701497|P10|Overall Study|Death|0
1632160|NCT01858766|5701498|P9|Overall Study|Death|0
1632161|NCT01858766|5701499|P8|Overall Study|Death|0
1632162|NCT01858766|5701500|P7|Overall Study|Death|0
1632163|NCT01858766|5701501|P6|Overall Study|Death|0
1632164|NCT01858766|5701502|P5|Overall Study|Death|0
1632165|NCT01858766|5701503|P4|Overall Study|Death|0
1632166|NCT01858766|5701504|P3|Overall Study|Death|1
1632167|NCT01858766|5701505|P2|Overall Study|Death|0
1632168|NCT01858766|5701506|P1|Overall Study|Death|0
1632169|NCT01858766|5701488|P19|Overall Study|Randomized but Never Treated|0
1632170|NCT01858766|5701489|P18|Overall Study|Randomized but Never Treated|1
1632171|NCT01858766|5701490|P17|Overall Study|Randomized but Never Treated|0
1632172|NCT01858766|5701491|P16|Overall Study|Randomized but Never Treated|0
1632173|NCT01858766|5701492|P15|Overall Study|Randomized but Never Treated|0
1632174|NCT01858766|5701493|P14|Overall Study|Randomized but Never Treated|0
1632175|NCT01858766|5701494|P13|Overall Study|Randomized but Never Treated|0
1632176|NCT01858766|5701495|P12|Overall Study|Randomized but Never Treated|0
1632177|NCT01858766|5701496|P11|Overall Study|Randomized but Never Treated|0
1632178|NCT01858766|5701497|P10|Overall Study|Randomized but Never Treated|0
1632179|NCT01858766|5701498|P9|Overall Study|Randomized but Never Treated|0
1632180|NCT01858766|5701499|P8|Overall Study|Randomized but Never Treated|0
1632181|NCT01858766|5701500|P7|Overall Study|Randomized but Never Treated|0
1632182|NCT01858766|5701501|P6|Overall Study|Randomized but Never Treated|1
1632183|NCT01858766|5701502|P5|Overall Study|Randomized but Never Treated|0
1632184|NCT01858766|5701503|P4|Overall Study|Randomized but Never Treated|0
1632185|NCT01858766|5701504|P3|Overall Study|Randomized but Never Treated|0
1632186|NCT01858766|5701505|P2|Overall Study|Randomized but Never Treated|0
1632187|NCT01858766|5701506|P1|Overall Study|Randomized but Never Treated|0
1632188|NCT01858701|5701577|P2|Period 2, Second 30 Days of Wear|Comfort|1
1632189|NCT01858701|5701578|P1|Period 2, Second 30 Days of Wear|Comfort|0
1632190|NCT01858701|5701577|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
1632191|NCT01858701|5701578|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
1632192|NCT01858701|5701577|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
1632193|NCT01858701|5701578|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
1632194|NCT01858701|5701577|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
1632195|NCT01858701|5701578|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
1632196|NCT01858636|5701584|P1|Overall Study|Withdrawal by Subject|1
1632197|NCT01858636|5701584|P1|Overall Study|Lost to Follow-up|1
1632198|NCT01858636|5701584|P1|Overall Study|Death|1
1632199|NCT01858636|5701584|P1|Overall Study|Physician Decision|1
1632200|NCT01858636|5701584|P1|Overall Study|No Device Deployment Attempted|24
1632201|NCT01858532|5701602|P4|Overall Study|Other, not specified|11
1632202|NCT01858532|5701603|P3|Overall Study|Other, not specified|13
1632203|NCT01858532|5701604|P2|Overall Study|Other, not specified|15
1632204|NCT01858532|5701605|P1|Overall Study|Other, not specified|29
1632205|NCT01858532|5701602|P4|Overall Study|Investigator request|6
1632206|NCT01858532|5701603|P3|Overall Study|Investigator request|2
1632207|NCT01858532|5701604|P2|Overall Study|Investigator request|4
1632208|NCT01858532|5701605|P1|Overall Study|Investigator request|3
1632209|NCT01858532|5701602|P4|Overall Study|Deterioration of medical status|7
1632210|NCT01858532|5701603|P3|Overall Study|Deterioration of medical status|3
1632211|NCT01858532|5701604|P2|Overall Study|Deterioration of medical status|4
1632212|NCT01858532|5701605|P1|Overall Study|Deterioration of medical status|3
1632213|NCT01858532|5701602|P4|Overall Study|Lost to Follow-up|14
1632214|NCT01858532|5701603|P3|Overall Study|Lost to Follow-up|11
1632215|NCT01858532|5701604|P2|Overall Study|Lost to Follow-up|26
1632216|NCT01858532|5701605|P1|Overall Study|Lost to Follow-up|17
1632217|NCT01858532|5701602|P4|Overall Study|Withdrew consent|27
1632218|NCT01858532|5701603|P3|Overall Study|Withdrew consent|46
1632219|NCT01858532|5701604|P2|Overall Study|Withdrew consent|93
1632220|NCT01858532|5701605|P1|Overall Study|Withdrew consent|71
1632221|NCT01858532|5701602|P4|Overall Study|Adverse Event|28
1632222|NCT01858532|5701603|P3|Overall Study|Adverse Event|23
1632223|NCT01858532|5701604|P2|Overall Study|Adverse Event|50
1632224|NCT01858532|5701605|P1|Overall Study|Adverse Event|58
1632225|NCT01858389|5701659|P2|Overall Study|Did not receive treatment|3
1632226|NCT01858389|5701660|P1|Overall Study|Did not receive treatment|0
1632227|NCT01858389|5701659|P2|Overall Study|Adverse Event|1
1632228|NCT01858389|5701660|P1|Overall Study|Adverse Event|3
1632229|NCT01858389|5701659|P2|Overall Study|Other|4
1632230|NCT01858389|5701660|P1|Overall Study|Other|2
1632231|NCT01858389|5701659|P2|Overall Study|Progressive disease|11
1632232|NCT01858389|5701660|P1|Overall Study|Progressive disease|10
1632233|NCT01858389|5701659|P2|Overall Study|Withdrawal by Subject|1
1632234|NCT01858389|5701660|P1|Overall Study|Withdrawal by Subject|0
1632235|NCT01858389|5701659|P2|Overall Study|Study terminated by sponsor|2
1632236|NCT01858389|5701660|P1|Overall Study|Study terminated by sponsor|0
1632237|NCT01858389|5701659|P2|Overall Study|Death|3
1632238|NCT01858389|5701660|P1|Overall Study|Death|1
1632239|NCT01858376|5701675|P1|Overall Study|Dropped d/t lab work not fitting criter|4
1632240|NCT01857973|5701695|P1|Overall Study|Physician Decision|1
1632241|NCT01857973|5701695|P1|Overall Study|drop out after 3 failed attempts|1
1632242|NCT01857973|5701695|P1|Overall Study|Subject did not meet required BG range|3
1632243|NCT01857869|5701725|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632244|NCT01857869|5701726|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632245|NCT01857869|5701727|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632246|NCT01857869|5701728|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632247|NCT01857869|5701729|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632248|NCT01857869|5701730|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632249|NCT01857869|5701731|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
1632250|NCT01857869|5701732|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632251|NCT01857869|5701733|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632252|NCT01857869|5701734|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
1632253|NCT01857869|5701725|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632254|NCT01857869|5701726|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632255|NCT01857869|5701727|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632256|NCT01857869|5701728|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632257|NCT01857869|5701729|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632258|NCT01857869|5701730|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632259|NCT01857869|5701731|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
1632260|NCT01857869|5701732|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632261|NCT01857869|5701733|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632262|NCT01857869|5701734|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
1632263|NCT01857869|5701725|P10|Primary/Challenge Phase|Other|0
1632264|NCT01857869|5701726|P9|Primary/Challenge Phase|Other|0
1632265|NCT01857869|5701727|P8|Primary/Challenge Phase|Other|0
1632266|NCT01857869|5701728|P7|Primary/Challenge Phase|Other|0
1632267|NCT01857869|5701729|P6|Primary/Challenge Phase|Other|0
1632268|NCT01857869|5701730|P5|Primary/Challenge Phase|Other|0
1632269|NCT01857869|5701731|P4|Primary/Challenge Phase|Other|0
1632270|NCT01857869|5701732|P3|Primary/Challenge Phase|Other|0
1632271|NCT01857869|5701733|P2|Primary/Challenge Phase|Other|1
1632272|NCT01857869|5701734|P1|Primary/Challenge Phase|Other|1
1632273|NCT01857869|5701725|P10|Primary/Challenge Phase|Protocol Violation|0
1632274|NCT01857869|5701726|P9|Primary/Challenge Phase|Protocol Violation|0
1632275|NCT01857869|5701727|P8|Primary/Challenge Phase|Protocol Violation|0
1632276|NCT01857869|5701728|P7|Primary/Challenge Phase|Protocol Violation|0
1632277|NCT01857869|5701729|P6|Primary/Challenge Phase|Protocol Violation|0
1632278|NCT01857869|5701730|P5|Primary/Challenge Phase|Protocol Violation|0
1632279|NCT01857869|5701731|P4|Primary/Challenge Phase|Protocol Violation|0
1632280|NCT01857869|5701732|P3|Primary/Challenge Phase|Protocol Violation|0
1632281|NCT01857869|5701733|P2|Primary/Challenge Phase|Protocol Violation|0
1632282|NCT01857869|5701734|P1|Primary/Challenge Phase|Protocol Violation|1
1632283|NCT01857869|5701725|P10|Primary/Challenge Phase|Pregnancy|0
1632284|NCT01857869|5701726|P9|Primary/Challenge Phase|Pregnancy|0
1632285|NCT01857869|5701727|P8|Primary/Challenge Phase|Pregnancy|0
1632286|NCT01857869|5701728|P7|Primary/Challenge Phase|Pregnancy|0
1632287|NCT01857869|5701729|P6|Primary/Challenge Phase|Pregnancy|0
1632288|NCT01857869|5701730|P5|Primary/Challenge Phase|Pregnancy|0
1632289|NCT01857869|5701731|P4|Primary/Challenge Phase|Pregnancy|0
1632290|NCT01857869|5701732|P3|Primary/Challenge Phase|Pregnancy|0
1632291|NCT01857869|5701733|P2|Primary/Challenge Phase|Pregnancy|0
1632292|NCT01857869|5701734|P1|Primary/Challenge Phase|Pregnancy|1
1632293|NCT01857869|5701725|P10|Primary/Challenge Phase|Lost to Follow-up|0
1632294|NCT01857869|5701726|P9|Primary/Challenge Phase|Lost to Follow-up|0
1632295|NCT01857869|5701727|P8|Primary/Challenge Phase|Lost to Follow-up|0
1632296|NCT01857869|5701728|P7|Primary/Challenge Phase|Lost to Follow-up|0
1632297|NCT01857869|5701729|P6|Primary/Challenge Phase|Lost to Follow-up|0
1632298|NCT01857869|5701730|P5|Primary/Challenge Phase|Lost to Follow-up|0
1632299|NCT01857869|5701731|P4|Primary/Challenge Phase|Lost to Follow-up|0
1632300|NCT01857869|5701732|P3|Primary/Challenge Phase|Lost to Follow-up|0
1632301|NCT01857869|5701733|P2|Primary/Challenge Phase|Lost to Follow-up|0
1632302|NCT01857869|5701734|P1|Primary/Challenge Phase|Lost to Follow-up|2
1632303|NCT01857622|5701824|P3|Overall Study|Withdrawal by Subject|0
1632304|NCT01857622|5701825|P2|Overall Study|Withdrawal by Subject|0
1632305|NCT01857622|5701826|P1|Overall Study|Withdrawal by Subject|1
1632306|NCT01857622|5701824|P3|Overall Study|Protocol Violation|0
1632307|NCT01857622|5701825|P2|Overall Study|Protocol Violation|1
1632308|NCT01857622|5701826|P1|Overall Study|Protocol Violation|4
1632309|NCT01857622|5701824|P3|Overall Study|Physician Decision|0
1632310|NCT01857622|5701825|P2|Overall Study|Physician Decision|0
1632311|NCT01857622|5701826|P1|Overall Study|Physician Decision|1
1632312|NCT01857622|5701824|P3|Overall Study|Adverse Event|2
1632313|NCT01857622|5701825|P2|Overall Study|Adverse Event|0
1632314|NCT01857622|5701826|P1|Overall Study|Adverse Event|5
1632315|NCT01857583|5701838|P4|Overall Study|Withdrawal by Subject|2
1632316|NCT01857583|5701839|P3|Overall Study|Withdrawal by Subject|1
1632317|NCT01857583|5701840|P2|Overall Study|Withdrawal by Subject|0
1632318|NCT01857583|5701841|P1|Overall Study|Withdrawal by Subject|1
1632319|NCT01857583|5701838|P4|Overall Study|Physician Decision|1
1632320|NCT01857583|5701839|P3|Overall Study|Physician Decision|0
1632321|NCT01857583|5701840|P2|Overall Study|Physician Decision|0
1632322|NCT01857583|5701841|P1|Overall Study|Physician Decision|0
1632323|NCT01857583|5701838|P4|Overall Study|Death|0
1632324|NCT01857583|5701839|P3|Overall Study|Death|1
1632325|NCT01857583|5701840|P2|Overall Study|Death|1
1632326|NCT01857583|5701841|P1|Overall Study|Death|0
1632327|NCT01857583|5701838|P4|Overall Study|Adverse Event|1
1632328|NCT01857583|5701839|P3|Overall Study|Adverse Event|1
1632329|NCT01857583|5701840|P2|Overall Study|Adverse Event|0
1632330|NCT01857583|5701841|P1|Overall Study|Adverse Event|0
1632331|NCT01857531|5701851|P1|Overall Study|Withdrawal by Subject|4
1632332|NCT01857323|5701869|P1|Overall Study|Did not complete 180 doses|48
1632333|NCT01857323|5701869|P1|Overall Study|Other|4
1632334|NCT01857323|5701869|P1|Overall Study|Lost to Follow-up|1
1632335|NCT01857323|5701869|P1|Overall Study|Protocol Violation|6
1632336|NCT01857323|5701869|P1|Overall Study|Non-compliance|1
1632337|NCT01857323|5701869|P1|Overall Study|Withdrawal by Subject|3
1632338|NCT01857323|5701869|P1|Overall Study|Adverse Event|1
1632339|NCT01857206|5701944|P2|Overall Study|Withdrawal by Subject|0
1632340|NCT01857206|5701945|P1|Overall Study|Withdrawal by Subject|1
1632341|NCT01857206|5701944|P2|Overall Study|Unclassified|3
1632342|NCT01857206|5701945|P1|Overall Study|Unclassified|3
1632343|NCT01857206|5701944|P2|Overall Study|Lost to Follow-up|6
1632344|NCT01857206|5701945|P1|Overall Study|Lost to Follow-up|9
1632345|NCT01857206|5701944|P2|Overall Study|ADMINISTRATIVE REASON|1
1632346|NCT01857206|5701945|P1|Overall Study|ADMINISTRATIVE REASON|0
1632347|NCT01857102|5701963|P2|Period 2|Unsatisfactory Lens Fit|0
1632348|NCT01857102|5701964|P1|Period 2|Unsatisfactory Lens Fit|1
1632349|NCT01857102|5701963|P2|Period 2|Lens Discomfort|0
1632350|NCT01857102|5701964|P1|Period 2|Lens Discomfort|1
1632351|NCT01857102|5701963|P2|Period 1|Physician Decision|0
1632352|NCT01857102|5701964|P1|Period 1|Physician Decision|1
1632353|NCT01857102|5701963|P2|Period 1|Unsatisfactory Visual Response|0
1632354|NCT01857102|5701964|P1|Period 1|Unsatisfactory Visual Response|1
1632355|NCT01857102|5701963|P2|Period 1|Unsatisfactory Lens Fit|0
1632356|NCT01857102|5701964|P1|Period 1|Unsatisfactory Lens Fit|1
1632357|NCT01857102|5701963|P2|Period 1|Lost to Follow-up|3
1632358|NCT01857102|5701964|P1|Period 1|Lost to Follow-up|0
1632359|NCT01857102|5701963|P2|Period 1|No longer meets Eligibility Criteria|2
1632360|NCT01857102|5701964|P1|Period 1|No longer meets Eligibility Criteria|0
1632361|NCT01857063|5701974|P2|Period 2 (7 Days)|Withdrawal by Subject|0
1632362|NCT01857063|5701975|P1|Period 2 (7 Days)|Withdrawal by Subject|1
1632363|NCT01857063|5701974|P2|Period 2 (7 Days)|Physician Decision|1
1632364|NCT01857063|5701975|P1|Period 2 (7 Days)|Physician Decision|1
1632365|NCT01857063|5701974|P2|Period 2 (7 Days)|Adverse Event|1
1632366|NCT01857063|5701975|P1|Period 2 (7 Days)|Adverse Event|2
1632367|NCT01857063|5701974|P2|Period 1 (7 Days)|Withdrawal by Subject|3
1632368|NCT01857063|5701975|P1|Period 1 (7 Days)|Withdrawal by Subject|1
1632369|NCT01857063|5701974|P2|Period 1 (7 Days)|Physician Decision|0
1632370|NCT01857063|5701975|P1|Period 1 (7 Days)|Physician Decision|1
1632371|NCT01857063|5701974|P2|Period 1 (7 Days)|Adverse Event|1
1632372|NCT01857063|5701975|P1|Period 1 (7 Days)|Adverse Event|0
1632373|NCT01856907|5702009|P3|Overall Study|Withdrawal by Subject|0
1632374|NCT01856907|5702010|P2|Overall Study|Withdrawal by Subject|1
1632375|NCT01856907|5702011|P1|Overall Study|Withdrawal by Subject|0
1632376|NCT01856907|5702009|P3|Overall Study|Pregnancy|0
1632377|NCT01856907|5702010|P2|Overall Study|Pregnancy|1
1632378|NCT01856907|5702011|P1|Overall Study|Pregnancy|0
1632379|NCT01856907|5702009|P3|Overall Study|Pregnancy|0
1632380|NCT01856907|5702010|P2|Overall Study|Pregnancy|1
1632381|NCT01856907|5702011|P1|Overall Study|Pregnancy|0
1632382|NCT01856790|5702049|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
1632383|NCT01856790|5702049|P1|Closed Loop Control|Withdrawal by Subject|2
1632384|NCT01856686|5702103|P2|Overall Study|Lost to Follow-up|11
1632385|NCT01856686|5702104|P1|Overall Study|Lost to Follow-up|5
1632386|NCT01856673|5702147|P3|Overall Study|Protocol Violation|1
1632387|NCT01856673|5702148|P2|Overall Study|Protocol Violation|0
1632388|NCT01856673|5702149|P1|Overall Study|Protocol Violation|1
1632389|NCT01856673|5702147|P3|Overall Study|Death|0
1632390|NCT01856673|5702148|P2|Overall Study|Death|1
1632391|NCT01856673|5702149|P1|Overall Study|Death|2
1632392|NCT01856673|5702147|P3|Overall Study|Paperwork errors|0
1632393|NCT01856673|5702148|P2|Overall Study|Paperwork errors|0
1632394|NCT01856673|5702149|P1|Overall Study|Paperwork errors|4
1632395|NCT01856673|5702147|P3|Overall Study|Psychologist decision|0
1632396|NCT01856673|5702148|P2|Overall Study|Psychologist decision|0
1632397|NCT01856673|5702149|P1|Overall Study|Psychologist decision|3
1632398|NCT01856673|5702147|P3|Overall Study|Unknown reasons|0
1632399|NCT01856673|5702148|P2|Overall Study|Unknown reasons|0
1632400|NCT01856673|5702149|P1|Overall Study|Unknown reasons|20
1632401|NCT01856673|5702147|P3|Overall Study|Lost to Follow-up|0
1632402|NCT01856673|5702148|P2|Overall Study|Lost to Follow-up|34
1632403|NCT01856673|5702149|P1|Overall Study|Lost to Follow-up|22
1632404|NCT01856673|5702147|P3|Overall Study|Withdrawal by Subject|33
1632405|NCT01856673|5702148|P2|Overall Study|Withdrawal by Subject|50
1632406|NCT01856673|5702149|P1|Overall Study|Withdrawal by Subject|46
1632407|NCT01856595|5702169|P9|Overall Study|Withdrawal by Subject|0
1632408|NCT01856595|5702170|P8|Overall Study|Withdrawal by Subject|0
1632409|NCT01856595|5702171|P7|Overall Study|Withdrawal by Subject|1
1632410|NCT01856595|5702172|P6|Overall Study|Withdrawal by Subject|0
1632411|NCT01856595|5702173|P5|Overall Study|Withdrawal by Subject|0
1632412|NCT01856595|5702174|P4|Overall Study|Withdrawal by Subject|0
1632413|NCT01856595|5702175|P3|Overall Study|Withdrawal by Subject|0
1632414|NCT01856595|5702176|P2|Overall Study|Withdrawal by Subject|1
1632415|NCT01856595|5702177|P1|Overall Study|Withdrawal by Subject|0
1632416|NCT01856582|5702410|P1|Overall Study|Died prior to Boost infusion|1
1632417|NCT01856569|5702414|P1|Overall Study|Did not met inclusion criteria|8
1632418|NCT01856569|5702414|P1|Overall Study|Lost to Follow-up|3
1632419|NCT01856569|5702414|P1|Overall Study|Changed Site/Structure|1
1632420|NCT01856569|5702414|P1|Overall Study|Other|1
1632421|NCT01856543|5702425|P2|Overall Study|Withdrawn before start|3
1632422|NCT01856543|5702426|P1|Overall Study|Withdrawn before start|7
1632423|NCT01856543|5702425|P2|Overall Study|Treatment discontinued|3
1632424|NCT01856543|5702426|P1|Overall Study|Treatment discontinued|6
1632425|NCT01856322|5702484|P3|Overall Study|off study due to lack of accrual|3
1632426|NCT01856322|5702485|P2|Overall Study|off study due to lack of accrual|0
1632427|NCT01856322|5702486|P1|Overall Study|off study due to lack of accrual|0
1632428|NCT01856309|5702497|P4|Overall Study|Noncompliance With Study Drug|1
1632429|NCT01856309|5702498|P3|Overall Study|Noncompliance With Study Drug|4
1632430|NCT01856309|5702499|P2|Overall Study|Noncompliance With Study Drug|1
1632431|NCT01856309|5702500|P1|Overall Study|Noncompliance With Study Drug|0
1632432|NCT01856309|5702497|P4|Overall Study|Physician Decision|8
1632433|NCT01856309|5702498|P3|Overall Study|Physician Decision|6
1632434|NCT01856309|5702499|P2|Overall Study|Physician Decision|1
1632435|NCT01856309|5702500|P1|Overall Study|Physician Decision|6
1632436|NCT01856309|5702497|P4|Overall Study|Pregnancy|1
1632437|NCT01856309|5702498|P3|Overall Study|Pregnancy|0
1632438|NCT01856309|5702499|P2|Overall Study|Pregnancy|0
1632439|NCT01856309|5702500|P1|Overall Study|Pregnancy|0
1632440|NCT01856309|5702497|P4|Overall Study|Adverse Event|65
1632441|NCT01856309|5702498|P3|Overall Study|Adverse Event|55
1632442|NCT01856309|5702499|P2|Overall Study|Adverse Event|31
1632443|NCT01856309|5702500|P1|Overall Study|Adverse Event|31
1632444|NCT01856309|5702497|P4|Overall Study|Lack of Efficacy|25
1632445|NCT01856309|5702498|P3|Overall Study|Lack of Efficacy|40
1632446|NCT01856309|5702499|P2|Overall Study|Lack of Efficacy|9
1632447|NCT01856309|5702500|P1|Overall Study|Lack of Efficacy|14
1632448|NCT01856309|5702497|P4|Overall Study|Other|469
1632449|NCT01856309|5702498|P3|Overall Study|Other|447
1632450|NCT01856309|5702499|P2|Overall Study|Other|225
1632451|NCT01856309|5702500|P1|Overall Study|Other|227
1632452|NCT01856309|5702497|P4|Overall Study|Withdrawal by Subject|26
1632453|NCT01856309|5702498|P3|Overall Study|Withdrawal by Subject|28
1632454|NCT01856309|5702499|P2|Overall Study|Withdrawal by Subject|13
1632455|NCT01856309|5702500|P1|Overall Study|Withdrawal by Subject|11
1632456|NCT01856309|5702497|P4|Overall Study|Lost to Follow-up|8
1632457|NCT01856309|5702498|P3|Overall Study|Lost to Follow-up|4
1632458|NCT01856309|5702499|P2|Overall Study|Lost to Follow-up|2
1632459|NCT01856309|5702500|P1|Overall Study|Lost to Follow-up|6
1632460|NCT01856309|5702497|P4|Overall Study|Death|6
1632461|NCT01856309|5702498|P3|Overall Study|Death|11
1632462|NCT01856309|5702499|P2|Overall Study|Death|6
1632463|NCT01856309|5702500|P1|Overall Study|Death|4
1632464|NCT01856257|5702624|P4|Overall Study|Donor complication|1
1632465|NCT01856257|5702625|P3|Overall Study|Donor complication|0
1632466|NCT01856257|5702626|P2|Overall Study|Donor complication|0
1632467|NCT01856257|5702627|P1|Overall Study|Donor complication|0
1632468|NCT01856257|5702624|P4|Overall Study|Withdrawal by Subject|0
1632469|NCT01856257|5702625|P3|Overall Study|Withdrawal by Subject|0
1632470|NCT01856257|5702626|P2|Overall Study|Withdrawal by Subject|1
1632471|NCT01856257|5702627|P1|Overall Study|Withdrawal by Subject|1
1632472|NCT01856257|5702624|P4|Overall Study|Physician Decision|1
1632473|NCT01856257|5702625|P3|Overall Study|Physician Decision|0
1632474|NCT01856257|5702626|P2|Overall Study|Physician Decision|0
1632475|NCT01856257|5702627|P1|Overall Study|Physician Decision|0
1632476|NCT01856257|5702624|P4|Overall Study|Death|0
1632477|NCT01856257|5702625|P3|Overall Study|Death|0
1632478|NCT01856257|5702626|P2|Overall Study|Death|0
1632479|NCT01856257|5702627|P1|Overall Study|Death|2
1632480|NCT01855958|5702795|P2|Overall Study|Withdrawal by Subject|0
1632481|NCT01855958|5702796|P1|Overall Study|Withdrawal by Subject|1
1632482|NCT01855945|5702826|P12|Overall Study|Withdrawal by Subject|1
1632483|NCT01855945|5702827|P11|Overall Study|Withdrawal by Subject|4
1632484|NCT01855945|5702828|P10|Overall Study|Withdrawal by Subject|2
1632485|NCT01855945|5702829|P9|Overall Study|Withdrawal by Subject|0
1632486|NCT01855945|5702830|P8|Overall Study|Withdrawal by Subject|0
1632487|NCT01855945|5702831|P7|Overall Study|Withdrawal by Subject|1
1632488|NCT01855945|5702832|P6|Overall Study|Withdrawal by Subject|0
1632489|NCT01855945|5702833|P5|Overall Study|Withdrawal by Subject|1
1632490|NCT01855945|5702834|P4|Overall Study|Withdrawal by Subject|1
1632491|NCT01855945|5702835|P3|Overall Study|Withdrawal by Subject|4
1632492|NCT01855945|5702836|P2|Overall Study|Withdrawal by Subject|0
1632493|NCT01855945|5702837|P1|Overall Study|Withdrawal by Subject|4
1632494|NCT01855945|5702826|P12|Overall Study|Other - Unclassified|0
1632495|NCT01855945|5702827|P11|Overall Study|Other - Unclassified|1
1632496|NCT01855945|5702828|P10|Overall Study|Other - Unclassified|0
1632497|NCT01855945|5702829|P9|Overall Study|Other - Unclassified|0
1632498|NCT01855945|5702830|P8|Overall Study|Other - Unclassified|1
1632499|NCT01855945|5702831|P7|Overall Study|Other - Unclassified|2
1632500|NCT01855945|5702832|P6|Overall Study|Other - Unclassified|0
1632501|NCT01855945|5702833|P5|Overall Study|Other - Unclassified|0
1632502|NCT01855945|5702834|P4|Overall Study|Other - Unclassified|0
1632503|NCT01855945|5702835|P3|Overall Study|Other - Unclassified|1
1632504|NCT01855945|5702836|P2|Overall Study|Other - Unclassified|1
1632505|NCT01855945|5702837|P1|Overall Study|Other - Unclassified|1
1632506|NCT01855945|5702826|P12|Overall Study|Lost to Follow-up|2
1632507|NCT01855945|5702827|P11|Overall Study|Lost to Follow-up|0
1632508|NCT01855945|5702828|P10|Overall Study|Lost to Follow-up|0
1632509|NCT01855945|5702829|P9|Overall Study|Lost to Follow-up|2
1632510|NCT01855945|5702830|P8|Overall Study|Lost to Follow-up|7
1632511|NCT01855945|5702831|P7|Overall Study|Lost to Follow-up|4
1632512|NCT01855945|5702832|P6|Overall Study|Lost to Follow-up|3
1632513|NCT01855945|5702833|P5|Overall Study|Lost to Follow-up|0
1632514|NCT01855945|5702834|P4|Overall Study|Lost to Follow-up|3
1632515|NCT01855945|5702835|P3|Overall Study|Lost to Follow-up|7
1632516|NCT01855945|5702836|P2|Overall Study|Lost to Follow-up|10
1632517|NCT01855945|5702837|P1|Overall Study|Lost to Follow-up|11
1632518|NCT01855945|5702826|P12|Overall Study|Death|0
1632519|NCT01855945|5702827|P11|Overall Study|Death|0
1632520|NCT01855945|5702828|P10|Overall Study|Death|0
1632521|NCT01855945|5702829|P9|Overall Study|Death|0
1632522|NCT01855945|5702830|P8|Overall Study|Death|0
1632523|NCT01855945|5702831|P7|Overall Study|Death|2
1632524|NCT01855945|5702832|P6|Overall Study|Death|0
1632525|NCT01855945|5702833|P5|Overall Study|Death|0
1632526|NCT01855945|5702834|P4|Overall Study|Death|0
1632527|NCT01855945|5702835|P3|Overall Study|Death|0
1632528|NCT01855945|5702836|P2|Overall Study|Death|0
1632529|NCT01855945|5702837|P1|Overall Study|Death|0
1632530|NCT01855945|5702826|P12|Overall Study|Adverse Event|0
1632531|NCT01855945|5702827|P11|Overall Study|Adverse Event|0
1632532|NCT01855945|5702828|P10|Overall Study|Adverse Event|0
1632533|NCT01855945|5702829|P9|Overall Study|Adverse Event|0
1632534|NCT01855945|5702830|P8|Overall Study|Adverse Event|0
1632535|NCT01855945|5702831|P7|Overall Study|Adverse Event|1
1632536|NCT01855945|5702832|P6|Overall Study|Adverse Event|0
1632537|NCT01855945|5702833|P5|Overall Study|Adverse Event|0
1632538|NCT01855945|5702834|P4|Overall Study|Adverse Event|0
1632539|NCT01855945|5702835|P3|Overall Study|Adverse Event|0
1632540|NCT01855945|5702836|P2|Overall Study|Adverse Event|0
1632541|NCT01855945|5702837|P1|Overall Study|Adverse Event|0
1632542|NCT01855919|5702973|P2|Overall Study|Protocol Violation|4
1632543|NCT01855919|5702974|P1|Overall Study|Protocol Violation|1
1632544|NCT01855919|5702973|P2|Overall Study|Entry Criteria Not Met|1
1632545|NCT01855919|5702974|P1|Overall Study|Entry Criteria Not Met|1
1632546|NCT01855919|5702973|P2|Overall Study|Withdrawal by Subject|10
1632547|NCT01855919|5702974|P1|Overall Study|Withdrawal by Subject|4
1632548|NCT01855919|5702973|P2|Overall Study|Lack of Efficacy|3
1632549|NCT01855919|5702974|P1|Overall Study|Lack of Efficacy|1
1632550|NCT01855919|5702973|P2|Overall Study|Adverse Event|8
1632551|NCT01855919|5702974|P1|Overall Study|Adverse Event|16
1632552|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Other|1
1632553|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Other|0
1632554|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Other|0
1632555|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Other|0
1632556|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Sponsor Decision|1
1632557|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Sponsor Decision|0
1632558|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Sponsor Decision|0
1632559|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Sponsor Decision|0
1632560|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
1632561|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
1632562|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
1632563|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
1632564|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Physician Decision|4
1632565|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Physician Decision|2
1632566|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Physician Decision|0
1632567|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Physician Decision|0
1632568|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
1632569|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
1632570|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
1632571|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
1632572|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Protocol Violation|1
1632573|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Protocol Violation|0
1632574|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Protocol Violation|0
1632575|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Protocol Violation|0
1632576|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
1632577|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
1632578|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
1632579|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
1632580|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
1632581|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
1632582|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
1632583|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
1632584|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
1632585|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1632586|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1632587|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
1632588|NCT01855789|5703006|P4|2) Week 24 up to End of Study|Adverse Event|21
1632589|NCT01855789|5703007|P3|2) Week 24 up to End of Study|Adverse Event|5
1632590|NCT01855789|5703008|P2|2) Week 24 up to End of Study|Adverse Event|4
1632591|NCT01855789|5703009|P1|2) Week 24 up to End of Study|Adverse Event|0
1632592|NCT01855789|5703006|P4|1) Baseline up to Week 24|Other|0
1632593|NCT01855789|5703007|P3|1) Baseline up to Week 24|Other|0
1632594|NCT01855789|5703008|P2|1) Baseline up to Week 24|Other|0
1632595|NCT01855789|5703009|P1|1) Baseline up to Week 24|Other|4
1632596|NCT01855789|5703006|P4|1) Baseline up to Week 24|Sponsor Decision|0
1632597|NCT01855789|5703007|P3|1) Baseline up to Week 24|Sponsor Decision|0
1632598|NCT01855789|5703008|P2|1) Baseline up to Week 24|Sponsor Decision|0
1632599|NCT01855789|5703009|P1|1) Baseline up to Week 24|Sponsor Decision|3
1632600|NCT01855789|5703006|P4|1) Baseline up to Week 24|Participant Non-compliance|0
1632601|NCT01855789|5703007|P3|1) Baseline up to Week 24|Participant Non-compliance|0
1632602|NCT01855789|5703008|P2|1) Baseline up to Week 24|Participant Non-compliance|0
1632603|NCT01855789|5703009|P1|1) Baseline up to Week 24|Participant Non-compliance|3
1632604|NCT01855789|5703006|P4|1) Baseline up to Week 24|Pregnancy|0
1632605|NCT01855789|5703007|P3|1) Baseline up to Week 24|Pregnancy|0
1632606|NCT01855789|5703008|P2|1) Baseline up to Week 24|Pregnancy|0
1632607|NCT01855789|5703009|P1|1) Baseline up to Week 24|Pregnancy|1
1632608|NCT01855789|5703006|P4|1) Baseline up to Week 24|Physician Decision|0
1632609|NCT01855789|5703007|P3|1) Baseline up to Week 24|Physician Decision|0
1632610|NCT01855789|5703008|P2|1) Baseline up to Week 24|Physician Decision|0
1632611|NCT01855789|5703009|P1|1) Baseline up to Week 24|Physician Decision|4
1632612|NCT01855789|5703006|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
1632613|NCT01855789|5703007|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
1632614|NCT01855789|5703008|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
1632615|NCT01855789|5703009|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
1632616|NCT01855789|5703006|P4|1) Baseline up to Week 24|Protocol Violation|0
1632617|NCT01855789|5703007|P3|1) Baseline up to Week 24|Protocol Violation|0
1632618|NCT01855789|5703008|P2|1) Baseline up to Week 24|Protocol Violation|0
1632619|NCT01855789|5703009|P1|1) Baseline up to Week 24|Protocol Violation|4
1632620|NCT01855789|5703006|P4|1) Baseline up to Week 24|Lost to Follow-up|0
1632621|NCT01855789|5703007|P3|1) Baseline up to Week 24|Lost to Follow-up|0
1632622|NCT01855789|5703008|P2|1) Baseline up to Week 24|Lost to Follow-up|0
1632623|NCT01855789|5703009|P1|1) Baseline up to Week 24|Lost to Follow-up|11
1632624|NCT01855789|5703006|P4|1) Baseline up to Week 24|Lack of Efficacy|0
1632625|NCT01855789|5703007|P3|1) Baseline up to Week 24|Lack of Efficacy|0
1632626|NCT01855789|5703008|P2|1) Baseline up to Week 24|Lack of Efficacy|0
1632627|NCT01855789|5703009|P1|1) Baseline up to Week 24|Lack of Efficacy|16
1632628|NCT01855789|5703006|P4|1) Baseline up to Week 24|Death|0
1632629|NCT01855789|5703007|P3|1) Baseline up to Week 24|Death|0
1632630|NCT01855789|5703008|P2|1) Baseline up to Week 24|Death|0
1632631|NCT01855789|5703009|P1|1) Baseline up to Week 24|Death|2
1632632|NCT01855789|5703006|P4|1) Baseline up to Week 24|Adverse Event|0
1632633|NCT01855789|5703007|P3|1) Baseline up to Week 24|Adverse Event|0
1632634|NCT01855789|5703008|P2|1) Baseline up to Week 24|Adverse Event|0
1632635|NCT01855789|5703009|P1|1) Baseline up to Week 24|Adverse Event|37
1632636|NCT01855750|5703033|P2|Overall Study|Withdrawal by Subject|25
1632637|NCT01855750|5703034|P1|Overall Study|Withdrawal by Subject|33
1632638|NCT01855750|5703033|P2|Overall Study|Physician Decision|1
1632639|NCT01855750|5703034|P1|Overall Study|Physician Decision|1
1632640|NCT01855750|5703033|P2|Overall Study|Lost to Follow-up|9
1632641|NCT01855750|5703034|P1|Overall Study|Lost to Follow-up|5
1632642|NCT01855750|5703033|P2|Overall Study|Death|71
1632643|NCT01855750|5703034|P1|Overall Study|Death|68
1632644|NCT01855425|5703050|P1|Overall Study|Physician Decision|20
1632645|NCT01855399|5703056|P2|12 Month|Lost to Follow-up|11
1632646|NCT01855399|5703057|P1|12 Month|Lost to Follow-up|7
1632647|NCT01855399|5703056|P2|6 Month|Withdrawal by Subject|6
1632648|NCT01855399|5703057|P1|6 Month|Withdrawal by Subject|8
1632649|NCT01855399|5703056|P2|6 Month|Lost to Follow-up|9
1632650|NCT01855399|5703057|P1|6 Month|Lost to Follow-up|12
1632651|NCT01855243|5703066|P3|Overall Study|develpoed diabetic ketoacidosis|0
1632652|NCT01855243|5703067|P2|Overall Study|develpoed diabetic ketoacidosis|0
1632653|NCT01855243|5703068|P1|Overall Study|develpoed diabetic ketoacidosis|1
1632654|NCT01855126|5703090|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
1632655|NCT01855126|5703091|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
1632656|NCT01855126|5703090|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
1632657|NCT01855126|5703091|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
1632658|NCT01855074|5703103|P1|Overall Study|Started but not treated|1
1632659|NCT01855074|5703103|P1|Overall Study|Withdrawal by Subject|8
1632660|NCT01855074|5703103|P1|Overall Study|Lost to Follow-up|4
1632661|NCT01855074|5703103|P1|Overall Study|Adverse Event|1
1632662|NCT01854944|5703115|P3|Overall Study|Withdrawal by Subject|1
1632663|NCT01854944|5703116|P2|Overall Study|Withdrawal by Subject|0
1632664|NCT01854944|5703117|P1|Overall Study|Withdrawal by Subject|0
1632665|NCT01854918|5703169|P2|All-IP Period (Years 2 and 3)|Death|16
1632666|NCT01854918|5703170|P1|All-IP Period (Years 2 and 3)|Death|5
1632667|NCT01854918|5703169|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
1632668|NCT01854918|5703170|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
1632669|NCT01854918|5703169|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
1632670|NCT01854918|5703170|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
1632671|NCT01854918|5703169|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
1632672|NCT01854918|5703170|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
1632673|NCT01854918|5703169|P2|SOC-controlled Period (Year 1)|Death|5
1632674|NCT01854918|5703170|P1|SOC-controlled Period (Year 1)|Death|5
1632675|NCT01854918|5703169|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
1632676|NCT01854918|5703170|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
1632677|NCT01854918|5703169|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
1632678|NCT01854918|5703170|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
1632679|NCT01854918|5703169|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
1632680|NCT01854918|5703170|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
1632681|NCT01854827|5703189|P1|Overall Study|Death|1
1632682|NCT01854710|5703201|P6|Overall Study|CRI procedural error|2
1632683|NCT01854710|5703202|P5|Overall Study|CRI procedural error|2
1632684|NCT01854710|5703203|P4|Overall Study|CRI procedural error|2
1632685|NCT01854710|5703204|P3|Overall Study|CRI procedural error|2
1632686|NCT01854710|5703205|P2|Overall Study|CRI procedural error|2
1632687|NCT01854710|5703206|P1|Overall Study|CRI procedural error|2
1632688|NCT01854710|5703201|P6|Overall Study|Withdrawal by Subject|0
1632689|NCT01854710|5703202|P5|Overall Study|Withdrawal by Subject|0
1632690|NCT01854710|5703203|P4|Overall Study|Withdrawal by Subject|0
1632691|NCT01854710|5703204|P3|Overall Study|Withdrawal by Subject|0
1632692|NCT01854710|5703205|P2|Overall Study|Withdrawal by Subject|1
1632693|NCT01854710|5703206|P1|Overall Study|Withdrawal by Subject|2
1632694|NCT01854697|5703227|P5|Overall Study|Other|0
1632695|NCT01854697|5703228|P4|Overall Study|Other|0
1632696|NCT01854697|5703229|P3|Overall Study|Other|1
1632697|NCT01854697|5703230|P2|Overall Study|Other|1
1632698|NCT01854697|5703231|P1|Overall Study|Other|0
1632699|NCT01854697|5703227|P5|Overall Study|Withdrew Consent|0
1632700|NCT01854697|5703228|P4|Overall Study|Withdrew Consent|1
1632701|NCT01854697|5703229|P3|Overall Study|Withdrew Consent|0
1632702|NCT01854697|5703230|P2|Overall Study|Withdrew Consent|1
1632703|NCT01854697|5703231|P1|Overall Study|Withdrew Consent|0
1632704|NCT01854697|5703227|P5|Overall Study|To enter another AbbVie study|1
1632705|NCT01854697|5703228|P4|Overall Study|To enter another AbbVie study|0
1632706|NCT01854697|5703229|P3|Overall Study|To enter another AbbVie study|0
1632707|NCT01854697|5703230|P2|Overall Study|To enter another AbbVie study|0
1632708|NCT01854697|5703231|P1|Overall Study|To enter another AbbVie study|1
1632709|NCT01854697|5703227|P5|Overall Study|Lost to Follow-up|0
1632710|NCT01854697|5703228|P4|Overall Study|Lost to Follow-up|2
1632711|NCT01854697|5703229|P3|Overall Study|Lost to Follow-up|1
1632712|NCT01854697|5703230|P2|Overall Study|Lost to Follow-up|1
1632713|NCT01854697|5703231|P1|Overall Study|Lost to Follow-up|4
1632714|NCT01854697|5703227|P5|Overall Study|Adverse Event|1
1632715|NCT01854697|5703228|P4|Overall Study|Adverse Event|0
1632716|NCT01854697|5703229|P3|Overall Study|Adverse Event|0
1632717|NCT01854697|5703230|P2|Overall Study|Adverse Event|0
1632718|NCT01854697|5703231|P1|Overall Study|Adverse Event|1
1632719|NCT01854658|5703275|P4|Overall Study|Administrative reasons|2
1632720|NCT01854658|5703276|P3|Overall Study|Administrative reasons|2
1632721|NCT01854658|5703277|P2|Overall Study|Administrative reasons|1
1632722|NCT01854658|5703278|P1|Overall Study|Administrative reasons|5
1632723|NCT01854658|5703275|P4|Overall Study|Adverse Event|19
1632724|NCT01854658|5703276|P3|Overall Study|Adverse Event|23
1632725|NCT01854658|5703277|P2|Overall Study|Adverse Event|14
1632726|NCT01854658|5703278|P1|Overall Study|Adverse Event|21
1632727|NCT01854658|5703275|P4|Overall Study|Lack of Efficacy|7
1632728|NCT01854658|5703276|P3|Overall Study|Lack of Efficacy|4
1632729|NCT01854658|5703277|P2|Overall Study|Lack of Efficacy|8
1632730|NCT01854658|5703278|P1|Overall Study|Lack of Efficacy|3
1632731|NCT01854658|5703275|P4|Overall Study|Protocol-specified criteria|7
1632732|NCT01854658|5703276|P3|Overall Study|Protocol-specified criteria|10
1632733|NCT01854658|5703277|P2|Overall Study|Protocol-specified criteria|15
1632734|NCT01854658|5703278|P1|Overall Study|Protocol-specified criteria|15
1632735|NCT01854658|5703275|P4|Overall Study|Withdrawal by Subject|15
1632736|NCT01854658|5703276|P3|Overall Study|Withdrawal by Subject|29
1632737|NCT01854658|5703277|P2|Overall Study|Withdrawal by Subject|21
1632738|NCT01854658|5703278|P1|Overall Study|Withdrawal by Subject|28
1632739|NCT01854658|5703275|P4|Overall Study|Lost to Follow-up|4
1632740|NCT01854658|5703276|P3|Overall Study|Lost to Follow-up|8
1632741|NCT01854658|5703277|P2|Overall Study|Lost to Follow-up|9
1632742|NCT01854658|5703278|P1|Overall Study|Lost to Follow-up|8
1632743|NCT01854658|5703275|P4|Overall Study|Physician Decision|4
1632744|NCT01854658|5703276|P3|Overall Study|Physician Decision|2
1632745|NCT01854658|5703277|P2|Overall Study|Physician Decision|5
1632746|NCT01854658|5703278|P1|Overall Study|Physician Decision|7
1632747|NCT01854658|5703275|P4|Overall Study|Protocol Violation|1
1632748|NCT01854658|5703276|P3|Overall Study|Protocol Violation|2
1632749|NCT01854658|5703277|P2|Overall Study|Protocol Violation|2
1632750|NCT01854658|5703278|P1|Overall Study|Protocol Violation|6
1632751|NCT01854645|5703313|P5|Overall Study|Adverse Event|11
1632752|NCT01854645|5703314|P4|Overall Study|Adverse Event|20
1632753|NCT01854645|5703315|P3|Overall Study|Adverse Event|19
1632754|NCT01854645|5703316|P2|Overall Study|Adverse Event|31
1632755|NCT01854645|5703317|P1|Overall Study|Adverse Event|33
1632756|NCT01854645|5703313|P5|Overall Study|Lack of Efficacy|9
1632757|NCT01854645|5703314|P4|Overall Study|Lack of Efficacy|3
1632758|NCT01854645|5703315|P3|Overall Study|Lack of Efficacy|9
1632759|NCT01854645|5703316|P2|Overall Study|Lack of Efficacy|12
1632760|NCT01854645|5703317|P1|Overall Study|Lack of Efficacy|7
1632761|NCT01854645|5703313|P5|Overall Study|Withdrawal by Subject|24
1632762|NCT01854645|5703314|P4|Overall Study|Withdrawal by Subject|21
1632763|NCT01854645|5703315|P3|Overall Study|Withdrawal by Subject|30
1632764|NCT01854645|5703316|P2|Overall Study|Withdrawal by Subject|41
1632765|NCT01854645|5703317|P1|Overall Study|Withdrawal by Subject|31
1632766|NCT01854645|5703313|P5|Overall Study|Physician Decision|7
1632767|NCT01854645|5703314|P4|Overall Study|Physician Decision|3
1632768|NCT01854645|5703315|P3|Overall Study|Physician Decision|3
1632769|NCT01854645|5703316|P2|Overall Study|Physician Decision|5
1632770|NCT01854645|5703317|P1|Overall Study|Physician Decision|1
1632771|NCT01854645|5703313|P5|Overall Study|Lost to Follow-up|0
1632772|NCT01854645|5703314|P4|Overall Study|Lost to Follow-up|5
1632773|NCT01854645|5703315|P3|Overall Study|Lost to Follow-up|8
1632774|NCT01854645|5703316|P2|Overall Study|Lost to Follow-up|7
1632775|NCT01854645|5703317|P1|Overall Study|Lost to Follow-up|10
1632776|NCT01854645|5703313|P5|Overall Study|Protocol Violation|1
1632777|NCT01854645|5703314|P4|Overall Study|Protocol Violation|4
1632778|NCT01854645|5703315|P3|Overall Study|Protocol Violation|5
1632779|NCT01854645|5703316|P2|Overall Study|Protocol Violation|0
1632780|NCT01854645|5703317|P1|Overall Study|Protocol Violation|3
1632781|NCT01854645|5703313|P5|Overall Study|Administrative Reasons / Missing|1
1632782|NCT01854645|5703314|P4|Overall Study|Administrative Reasons / Missing|1
1632783|NCT01854645|5703315|P3|Overall Study|Administrative Reasons / Missing|0
1632784|NCT01854645|5703316|P2|Overall Study|Administrative Reasons / Missing|0
1632785|NCT01854645|5703317|P1|Overall Study|Administrative Reasons / Missing|0
1632786|NCT01854645|5703313|P5|Overall Study|Protocol-Specified Criteria|7
1632787|NCT01854645|5703314|P4|Overall Study|Protocol-Specified Criteria|5
1632788|NCT01854645|5703315|P3|Overall Study|Protocol-Specified Criteria|8
1632789|NCT01854645|5703316|P2|Overall Study|Protocol-Specified Criteria|10
1632790|NCT01854645|5703317|P1|Overall Study|Protocol-Specified Criteria|13
1632791|NCT01854528|5703398|P2|Overall Study|Virologic Failure|9
1632792|NCT01854528|5703399|P1|Overall Study|Virologic Failure|0
1632793|NCT01854528|5703398|P2|Overall Study|Withdrawal by Subject|2
1632794|NCT01854528|5703399|P1|Overall Study|Withdrawal by Subject|0
1632795|NCT01854528|5703398|P2|Overall Study|Adverse Event|4
1632796|NCT01854528|5703399|P1|Overall Study|Adverse Event|0
1632797|NCT01854047|5703470|P5|Overall Study|Other than specified above|8
1632798|NCT01854047|5703471|P4|Overall Study|Other than specified above|5
1632799|NCT01854047|5703472|P3|Overall Study|Other than specified above|3
1632800|NCT01854047|5703473|P2|Overall Study|Other than specified above|3
1632801|NCT01854047|5703474|P1|Overall Study|Other than specified above|3
1632802|NCT01854047|5703470|P5|Overall Study|Randomized but not treated|4
1632803|NCT01854047|5703471|P4|Overall Study|Randomized but not treated|0
1632804|NCT01854047|5703472|P3|Overall Study|Randomized but not treated|2
1632805|NCT01854047|5703473|P2|Overall Study|Randomized but not treated|1
1632806|NCT01854047|5703474|P1|Overall Study|Randomized but not treated|0
1632807|NCT01854047|5703470|P5|Overall Study|Adverse Event|7
1632808|NCT01854047|5703471|P4|Overall Study|Adverse Event|10
1632809|NCT01854047|5703472|P3|Overall Study|Adverse Event|6
1632810|NCT01854047|5703473|P2|Overall Study|Adverse Event|4
1632811|NCT01854047|5703474|P1|Overall Study|Adverse Event|5
1632812|NCT01854047|5703470|P5|Overall Study|Poor compliance to protocol|0
1632813|NCT01854047|5703471|P4|Overall Study|Poor compliance to protocol|0
1632814|NCT01854047|5703472|P3|Overall Study|Poor compliance to protocol|2
1632815|NCT01854047|5703473|P2|Overall Study|Poor compliance to protocol|0
1632816|NCT01854047|5703474|P1|Overall Study|Poor compliance to protocol|3
1632817|NCT01854047|5703470|P5|Overall Study|Lack of Efficacy|0
1632818|NCT01854047|5703471|P4|Overall Study|Lack of Efficacy|0
1632819|NCT01854047|5703472|P3|Overall Study|Lack of Efficacy|0
1632820|NCT01854047|5703473|P2|Overall Study|Lack of Efficacy|0
1632821|NCT01854047|5703474|P1|Overall Study|Lack of Efficacy|1
1632822|NCT01853982|5703605|P2|Overall Study|Lost to Follow-up|1
1632823|NCT01853982|5703606|P1|Overall Study|Lost to Follow-up|0
1632824|NCT01853982|5703605|P2|Overall Study|Death|0
1632825|NCT01853982|5703606|P1|Overall Study|Death|1
1632826|NCT01853982|5703605|P2|Overall Study|Withdrawal by Subject|0
1632827|NCT01853982|5703606|P1|Overall Study|Withdrawal by Subject|1
1632828|NCT01853878|5703623|P2|Overall Study|Other|43
1632829|NCT01853878|5703624|P1|Overall Study|Other|55
1632830|NCT01853878|5703623|P2|Overall Study|Migrated/moved from the study area|0
1632831|NCT01853878|5703624|P1|Overall Study|Migrated/moved from the study area|1
1632832|NCT01853878|5703623|P2|Overall Study|Withdrawal by Subject|1
1632833|NCT01853878|5703624|P1|Overall Study|Withdrawal by Subject|3
1632834|NCT01853878|5703623|P2|Overall Study|Adverse Event|0
1632835|NCT01853878|5703624|P1|Overall Study|Adverse Event|2
1632836|NCT01853878|5703623|P2|Overall Study|Recurrence|0
1632837|NCT01853878|5703624|P1|Overall Study|Recurrence|2
1632838|NCT01853839|5703648|P1|Overall Study|Lost to follow-up or no valid BP measure|336
1632839|NCT01853839|5703648|P1|Overall Study|End of treatment visit too early|33
1632840|NCT01853839|5703648|P1|Overall Study|Not meet ITT population definition|58
1632841|NCT01853839|5703648|P1|Overall Study|Violated inclusion criteria|2
1632842|NCT01853696|5703681|P2|Overall Study|Lost to Follow-up|4
1632843|NCT01853696|5703682|P1|Overall Study|Lost to Follow-up|5
1632844|NCT01853696|5703681|P2|Overall Study|Withdrawal by Subject|1
1632845|NCT01853696|5703682|P1|Overall Study|Withdrawal by Subject|1
1632846|NCT01853618|5703695|P5|Overall Study|Refused further treatment|1
1632847|NCT01853618|5703696|P4|Overall Study|Refused further treatment|0
1632848|NCT01853618|5703697|P3|Overall Study|Refused further treatment|0
1632849|NCT01853618|5703698|P2|Overall Study|Refused further treatment|0
1632850|NCT01853618|5703699|P1|Overall Study|Refused further treatment|0
1632851|NCT01853618|5703695|P5|Overall Study|Physician Decision|0
1632852|NCT01853618|5703696|P4|Overall Study|Physician Decision|0
1632853|NCT01853618|5703697|P3|Overall Study|Physician Decision|1
1632854|NCT01853618|5703698|P2|Overall Study|Physician Decision|1
1632855|NCT01853618|5703699|P1|Overall Study|Physician Decision|0
1632856|NCT01853618|5703695|P5|Overall Study|Progressive disease|2
1632857|NCT01853618|5703696|P4|Overall Study|Progressive disease|1
1632858|NCT01853618|5703697|P3|Overall Study|Progressive disease|1
1632859|NCT01853618|5703698|P2|Overall Study|Progressive disease|1
1632860|NCT01853618|5703699|P1|Overall Study|Progressive disease|1
1632861|NCT01853618|5703695|P5|Overall Study|Bile duct stent blockage/progressive dis|0
1632862|NCT01853618|5703696|P4|Overall Study|Bile duct stent blockage/progressive dis|0
1632863|NCT01853618|5703697|P3|Overall Study|Bile duct stent blockage/progressive dis|0
1632864|NCT01853618|5703698|P2|Overall Study|Bile duct stent blockage/progressive dis|0
1632865|NCT01853618|5703699|P1|Overall Study|Bile duct stent blockage/progressive dis|1
1632866|NCT01853475|5703765|P3|Overall Study|Withdrawal by Subject|0
1632867|NCT01853475|5703766|P2|Overall Study|Withdrawal by Subject|1
1632868|NCT01853475|5703767|P1|Overall Study|Withdrawal by Subject|0
1632869|NCT01853462|5703786|P2|Overall Study|Withdrawal by Subject|1
1632870|NCT01853462|5703787|P1|Overall Study|Withdrawal by Subject|1
1632871|NCT01853397|5703857|P4|Overall Study|Subject Noncompliance|1
1632872|NCT01853397|5703858|P3|Overall Study|Subject Noncompliance|0
1632873|NCT01853397|5703859|P2|Overall Study|Subject Noncompliance|0
1632874|NCT01853397|5703860|P1|Overall Study|Subject Noncompliance|0
1632875|NCT01853397|5703857|P4|Overall Study|Withdrawal by Subject|1
1632876|NCT01853397|5703858|P3|Overall Study|Withdrawal by Subject|0
1632877|NCT01853397|5703859|P2|Overall Study|Withdrawal by Subject|0
1632878|NCT01853397|5703860|P1|Overall Study|Withdrawal by Subject|0
1632879|NCT01853384|5703888|P2|Completed Follow up Visit 2|Lost to Follow-up|1
1632880|NCT01853384|5703889|P1|Completed Follow up Visit 2|Lost to Follow-up|0
1632881|NCT01853384|5703888|P2|Completed Follow up Visit 2|Death|0
1632882|NCT01853384|5703889|P1|Completed Follow up Visit 2|Death|1
1632883|NCT01853384|5703888|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
1632884|NCT01853384|5703889|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
1632885|NCT01853384|5703888|P2|Completed Follow up Visit 2|Adverse Event|0
1632886|NCT01853384|5703889|P1|Completed Follow up Visit 2|Adverse Event|1
1632887|NCT01853384|5703888|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
1632888|NCT01853384|5703889|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
1632889|NCT01853384|5703888|P2|Completed Follow up Visit 1|Early Termination|9
1632890|NCT01853384|5703889|P1|Completed Follow up Visit 1|Early Termination|13
1632891|NCT01853384|5703888|P2|Randomized|Other|3
1632892|NCT01853384|5703889|P1|Randomized|Other|3
1632893|NCT01853384|5703888|P2|Randomized|Sponsor Decision|34
1632894|NCT01853384|5703889|P1|Randomized|Sponsor Decision|47
1632895|NCT01853384|5703888|P2|Randomized|Withdrawal by Subject|3
1632896|NCT01853384|5703889|P1|Randomized|Withdrawal by Subject|5
1632897|NCT01853384|5703888|P2|Randomized|Lost to Follow-up|1
1632898|NCT01853384|5703889|P1|Randomized|Lost to Follow-up|1
1632899|NCT01853384|5703888|P2|Randomized|Death|2
1632900|NCT01853384|5703889|P1|Randomized|Death|1
1632901|NCT01853384|5703888|P2|Randomized|Adverse Event|3
1632902|NCT01853384|5703889|P1|Randomized|Adverse Event|5
1632903|NCT01853280|5703929|P2|Overall Study|Ineligible|1
1632904|NCT01853280|5703930|P1|Overall Study|Ineligible|0
1632905|NCT01853280|5703929|P2|Overall Study|Withdrawal by Subject|1
1632906|NCT01853280|5703930|P1|Overall Study|Withdrawal by Subject|0
1632907|NCT01853280|5703929|P2|Overall Study|Physician Decision|1
1632908|NCT01853280|5703930|P1|Overall Study|Physician Decision|0
1632909|NCT01853280|5703929|P2|Overall Study|Lost to Follow-up|1
1632910|NCT01853280|5703930|P1|Overall Study|Lost to Follow-up|0
1632911|NCT01853280|5703929|P2|Overall Study|Lack of Efficacy|2
1632912|NCT01853280|5703930|P1|Overall Study|Lack of Efficacy|2
1632913|NCT01853254|5703936|P1|Overall Study|Administrative/Other|16
1632914|NCT01853254|5703936|P1|Overall Study|Withdrawal of Consent|16
1632915|NCT01853254|5703936|P1|Overall Study|Other Protocol Violation|1
1632916|NCT01853254|5703936|P1|Overall Study|Refusal of Treatment|1
1632917|NCT01853254|5703936|P1|Overall Study|Insufficient Therapeutic Response|22
1632918|NCT01853254|5703936|P1|Overall Study|Failure to Return|43
1632919|NCT01853254|5703936|P1|Overall Study|Death|1
1632920|NCT01853254|5703936|P1|Overall Study|Adverse Event/Intercurrent Illness|3
1632921|NCT01853254|5703936|P1|Overall Study|Abnormal Laboratory Test|1
1632922|NCT01853228|5703940|P2|Phase 2|Lack of Efficacy|4
1632923|NCT01853228|5703941|P1|Phase 2|Lack of Efficacy|0
1632924|NCT01853228|5703940|P2|Phase 2|Proceed To Transplant|3
1632925|NCT01853228|5703941|P1|Phase 2|Proceed To Transplant|0
1632926|NCT01853228|5703940|P2|Phase 2|Physician Decision|1
1632927|NCT01853228|5703941|P1|Phase 2|Physician Decision|0
1632928|NCT01853228|5703940|P2|Phase 1|Other|0
1632929|NCT01853228|5703941|P1|Phase 1|Other|1
1632930|NCT01853228|5703940|P2|Phase 1|Lack of Efficacy|0
1632931|NCT01853228|5703941|P1|Phase 1|Lack of Efficacy|8
1632932|NCT01853176|5703971|P2|Overall Study|Study terminated|0
1632933|NCT01853176|5703972|P1|Overall Study|Study terminated|4
1632934|NCT01853072|5703991|P2|Overall Study|Reason not specified|6
1632935|NCT01853072|5703992|P1|Overall Study|Reason not specified|9
1632936|NCT01853072|5703991|P2|Overall Study|Withdrawal by Subject|2
1632937|NCT01853072|5703992|P1|Overall Study|Withdrawal by Subject|1
1632938|NCT01853072|5703991|P2|Overall Study|Physician Decision|1
1632939|NCT01853072|5703992|P1|Overall Study|Physician Decision|1
1632940|NCT01853072|5703991|P2|Overall Study|Non-compliance with study drug|1
1632941|NCT01853072|5703992|P1|Overall Study|Non-compliance with study drug|0
1632942|NCT01853072|5703991|P2|Overall Study|Lost to Follow-up|3
1632943|NCT01853072|5703992|P1|Overall Study|Lost to Follow-up|0
1632944|NCT01853072|5703991|P2|Overall Study|Death|4
1632945|NCT01853072|5703992|P1|Overall Study|Death|1
1632946|NCT01853072|5703991|P2|Overall Study|Adverse Event|3
1632947|NCT01853072|5703992|P1|Overall Study|Adverse Event|0
1632948|NCT01853072|5703991|P2|Overall Study|Adverse event prior to treatment|1
1632949|NCT01853072|5703992|P1|Overall Study|Adverse event prior to treatment|0
1632950|NCT01853046|5704012|P2|Overall Study|Disease progression|3
1632951|NCT01853046|5704013|P1|Overall Study|Disease progression|13
1632952|NCT01853046|5704012|P2|Overall Study|Adverse Event|2
1632953|NCT01853046|5704013|P1|Overall Study|Adverse Event|4
1632954|NCT01853046|5704012|P2|Overall Study|Withdrawal by Subject|1
1632955|NCT01853046|5704013|P1|Overall Study|Withdrawal by Subject|1
1632956|NCT01852825|5704081|P3|Overall Study|Withdrawal by Subject|0
1632957|NCT01852825|5704082|P2|Overall Study|Withdrawal by Subject|0
1632958|NCT01852825|5704083|P1|Overall Study|Withdrawal by Subject|2
1632959|NCT01852812|5704109|P3|Overall Study|Non-compliance With Study Drug|0
1632960|NCT01852812|5704110|P2|Overall Study|Non-compliance With Study Drug|1
1632961|NCT01852812|5704111|P1|Overall Study|Non-compliance With Study Drug|0
1632962|NCT01852812|5704109|P3|Overall Study|Adverse Event|1
1632963|NCT01852812|5704110|P2|Overall Study|Adverse Event|0
1632964|NCT01852812|5704111|P1|Overall Study|Adverse Event|0
1632965|NCT01852591|5704149|P1|Overall Study|Not Evaluable at Time of Analysis|1
1632966|NCT01852591|5704149|P1|Overall Study|Withdrawal by Subject|2
1632967|NCT01852292|5704190|P2|Overall Study|Progressive disease|52
1632968|NCT01852292|5704191|P1|Overall Study|Progressive disease|42
1632969|NCT01852292|5704190|P2|Overall Study|Study terminated by Sponsor|1
1632970|NCT01852292|5704191|P1|Overall Study|Study terminated by Sponsor|0
1632971|NCT01852292|5704190|P2|Overall Study|Non-compliance with study treatment|0
1632972|NCT01852292|5704191|P1|Overall Study|Non-compliance with study treatment|1
1632973|NCT01852292|5704190|P2|Overall Study|Protocol Violation|0
1632974|NCT01852292|5704191|P1|Overall Study|Protocol Violation|2
1632975|NCT01852292|5704190|P2|Overall Study|Physician Decision|2
1632976|NCT01852292|5704191|P1|Overall Study|Physician Decision|6
1632977|NCT01852292|5704190|P2|Overall Study|Adverse Event|11
1632978|NCT01852292|5704191|P1|Overall Study|Adverse Event|8
1632979|NCT01852292|5704190|P2|Overall Study|Patient/guardian decision|4
1632980|NCT01852292|5704191|P1|Overall Study|Patient/guardian decision|8
1632981|NCT01852292|5704190|P2|Overall Study|Death|8
1632982|NCT01852292|5704191|P1|Overall Study|Death|9
1632983|NCT01852292|5704190|P2|Overall Study|Untreated - did not receive study drug|1
1632984|NCT01852292|5704191|P1|Overall Study|Untreated - did not receive study drug|3
1632985|NCT01852214|5704215|P2|Washout Period|Withdrawal by Subject|1
1632986|NCT01852214|5704216|P1|Washout Period|Withdrawal by Subject|0
1632987|NCT01852214|5704215|P2|Period 1|Withdrawal by Subject|1
1632988|NCT01852214|5704216|P1|Period 1|Withdrawal by Subject|0
1632989|NCT01852214|5704215|P2|Period 1|Adverse Event|2
1632990|NCT01852214|5704216|P1|Period 1|Adverse Event|1
1632991|NCT01852162|5704268|P2|Overall Study|Withdrawal by Subject|1
1632992|NCT01852162|5704269|P1|Overall Study|Withdrawal by Subject|3
1632993|NCT01852162|5704268|P2|Overall Study|Adverse Event|0
1632994|NCT01852162|5704269|P1|Overall Study|Adverse Event|1
1632995|NCT01852110|5704285|P6|Overall Study|Withdrawal by Subject|0
1632996|NCT01852110|5704286|P5|Overall Study|Withdrawal by Subject|0
1632997|NCT01852110|5704287|P4|Overall Study|Withdrawal by Subject|0
1632998|NCT01852110|5704288|P3|Overall Study|Withdrawal by Subject|0
1632999|NCT01852110|5704289|P2|Overall Study|Withdrawal by Subject|4
1633000|NCT01852110|5704290|P1|Overall Study|Withdrawal by Subject|4
1633001|NCT01852110|5704285|P6|Overall Study|Study Terminated by Sponsor|0
1633002|NCT01852110|5704286|P5|Overall Study|Study Terminated by Sponsor|0
1633003|NCT01852110|5704287|P4|Overall Study|Study Terminated by Sponsor|0
1633004|NCT01852110|5704288|P3|Overall Study|Study Terminated by Sponsor|0
1633005|NCT01852110|5704289|P2|Overall Study|Study Terminated by Sponsor|32
1633006|NCT01852110|5704290|P1|Overall Study|Study Terminated by Sponsor|30
1633007|NCT01852110|5704285|P6|Overall Study|Protocol Violation|0
1633008|NCT01852110|5704286|P5|Overall Study|Protocol Violation|0
1633009|NCT01852110|5704287|P4|Overall Study|Protocol Violation|0
1633010|NCT01852110|5704288|P3|Overall Study|Protocol Violation|0
1633011|NCT01852110|5704289|P2|Overall Study|Protocol Violation|1
1633012|NCT01852110|5704290|P1|Overall Study|Protocol Violation|0
1633013|NCT01852110|5704285|P6|Overall Study|Physician Decision|0
1633014|NCT01852110|5704286|P5|Overall Study|Physician Decision|0
1633015|NCT01852110|5704287|P4|Overall Study|Physician Decision|0
1633016|NCT01852110|5704288|P3|Overall Study|Physician Decision|0
1633017|NCT01852110|5704289|P2|Overall Study|Physician Decision|0
1633018|NCT01852110|5704290|P1|Overall Study|Physician Decision|1
1633019|NCT01852110|5704285|P6|Overall Study|Non-compliance with Study Drug|0
1633020|NCT01852110|5704286|P5|Overall Study|Non-compliance with Study Drug|0
1633021|NCT01852110|5704287|P4|Overall Study|Non-compliance with Study Drug|0
1633022|NCT01852110|5704288|P3|Overall Study|Non-compliance with Study Drug|0
1633023|NCT01852110|5704289|P2|Overall Study|Non-compliance with Study Drug|1
1633024|NCT01852110|5704290|P1|Overall Study|Non-compliance with Study Drug|2
1633025|NCT01852110|5704285|P6|Overall Study|Lost to Follow-up|0
1633026|NCT01852110|5704286|P5|Overall Study|Lost to Follow-up|0
1633027|NCT01852110|5704287|P4|Overall Study|Lost to Follow-up|0
1633028|NCT01852110|5704288|P3|Overall Study|Lost to Follow-up|0
1633029|NCT01852110|5704289|P2|Overall Study|Lost to Follow-up|3
1633030|NCT01852110|5704290|P1|Overall Study|Lost to Follow-up|1
1633031|NCT01852110|5704285|P6|Overall Study|Adverse Event|0
1633032|NCT01852110|5704286|P5|Overall Study|Adverse Event|0
1633033|NCT01852110|5704287|P4|Overall Study|Adverse Event|0
1633034|NCT01852110|5704288|P3|Overall Study|Adverse Event|0
1633035|NCT01852110|5704289|P2|Overall Study|Adverse Event|5
1633036|NCT01852110|5704290|P1|Overall Study|Adverse Event|12
1633037|NCT01852045|5704321|P3|Overall Study|Other Miscellaneous Reasons|2
1633038|NCT01852045|5704322|P2|Overall Study|Other Miscellaneous Reasons|3
1633039|NCT01852045|5704323|P1|Overall Study|Other Miscellaneous Reasons|1
1633040|NCT01852045|5704321|P3|Overall Study|Withdrawal by Subject|1
1633041|NCT01852045|5704322|P2|Overall Study|Withdrawal by Subject|0
1633042|NCT01852045|5704323|P1|Overall Study|Withdrawal by Subject|1
1633043|NCT01852045|5704321|P3|Overall Study|Lost to Follow-up|1
1633044|NCT01852045|5704322|P2|Overall Study|Lost to Follow-up|1
1633045|NCT01852045|5704323|P1|Overall Study|Lost to Follow-up|0
1633046|NCT01852045|5704321|P3|Overall Study|Lack of Efficacy|0
1633047|NCT01852045|5704322|P2|Overall Study|Lack of Efficacy|0
1633048|NCT01852045|5704323|P1|Overall Study|Lack of Efficacy|3
1633049|NCT01852045|5704321|P3|Overall Study|Adverse Event|0
1633050|NCT01852045|5704322|P2|Overall Study|Adverse Event|0
1633051|NCT01852045|5704323|P1|Overall Study|Adverse Event|1
1633052|NCT01851863|5704407|P4|Overall Study|Lost to Follow-up|3
1633053|NCT01851863|5704408|P3|Overall Study|Lost to Follow-up|2
1633054|NCT01851863|5704409|P2|Overall Study|Lost to Follow-up|4
1633055|NCT01851863|5704410|P1|Overall Study|Lost to Follow-up|3
1633056|NCT01851863|5704407|P4|Overall Study|Did not receive study medication|0
1633057|NCT01851863|5704408|P3|Overall Study|Did not receive study medication|3
1633058|NCT01851863|5704409|P2|Overall Study|Did not receive study medication|5
1633059|NCT01851863|5704410|P1|Overall Study|Did not receive study medication|2
1633060|NCT01851720|5704439|P2|Overall Study|Lost to Follow-up|1
1633061|NCT01851720|5704440|P1|Overall Study|Lost to Follow-up|0
1633062|NCT01851590|5704470|P3|Overall Study|Lack of Efficacy|0
1633063|NCT01851590|5704471|P2|Overall Study|Lack of Efficacy|1
1633064|NCT01851590|5704472|P1|Overall Study|Lack of Efficacy|0
1633065|NCT01851590|5704470|P3|Overall Study|Adverse Event|2
1633066|NCT01851590|5704471|P2|Overall Study|Adverse Event|0
1633067|NCT01851590|5704472|P1|Overall Study|Adverse Event|0
1633068|NCT01851590|5704470|P3|Overall Study|Withdrawal by Subject|1
1633069|NCT01851590|5704471|P2|Overall Study|Withdrawal by Subject|0
1633070|NCT01851590|5704472|P1|Overall Study|Withdrawal by Subject|0
1633071|NCT01851330|5704495|P3|Overall Study|Investigator’s Discretion|1
1633072|NCT01851330|5704496|P2|Overall Study|Investigator’s Discretion|0
1633073|NCT01851330|5704497|P1|Overall Study|Investigator’s Discretion|0
1633074|NCT01851330|5704495|P3|Overall Study|Withdrew Consent|0
1633075|NCT01851330|5704496|P2|Overall Study|Withdrew Consent|1
1633076|NCT01851330|5704497|P1|Overall Study|Withdrew Consent|2
1633077|NCT01851330|5704495|P3|Overall Study|Lost to Follow-up|9
1633078|NCT01851330|5704496|P2|Overall Study|Lost to Follow-up|6
1633079|NCT01851330|5704497|P1|Overall Study|Lost to Follow-up|1
1633080|NCT01851330|5704495|P3|Overall Study|Lack of Efficacy|2
1633081|NCT01851330|5704496|P2|Overall Study|Lack of Efficacy|9
1633082|NCT01851330|5704497|P1|Overall Study|Lack of Efficacy|10
1633083|NCT01850641|5704550|P1|Overall Study|Increase in serum ferritin|1
1633084|NCT01850641|5704550|P1|Overall Study|Decrease in serum calcium|2
1633085|NCT01850641|5704550|P1|Overall Study|Decrease in serum phosphorus|1
1633086|NCT01850641|5704550|P1|Overall Study|Physician Decision|1
1633087|NCT01850615|5704564|P2|Overall Study|Unclassified|1
1633088|NCT01850615|5704565|P1|Overall Study|Unclassified|0
1633089|NCT01850615|5704564|P2|Overall Study|Lost to Follow-up|1
1633090|NCT01850615|5704565|P1|Overall Study|Lost to Follow-up|0
1633091|NCT01850615|5704564|P2|Overall Study|Withdrawal by Subject|1
1633092|NCT01850615|5704565|P1|Overall Study|Withdrawal by Subject|3
1633093|NCT01850615|5704564|P2|Overall Study|Adverse Event|1
1633094|NCT01850615|5704565|P1|Overall Study|Adverse Event|2
1633095|NCT01850615|5704564|P2|Overall Study|Protocol Violation|1
1633096|NCT01850615|5704565|P1|Overall Study|Protocol Violation|4
1633097|NCT01850602|5704583|P2|Overall Study|Increase in serum ferritin|0
1633098|NCT01850602|5704584|P1|Overall Study|Increase in serum ferritin|1
1633099|NCT01850602|5704583|P2|Overall Study|Decrease in serum calcium|3
1633100|NCT01850602|5704584|P1|Overall Study|Decrease in serum calcium|2
1633101|NCT01850602|5704583|P2|Overall Study|Withdrawal by Subject|4
1633102|NCT01850602|5704584|P1|Overall Study|Withdrawal by Subject|2
1633103|NCT01850602|5704583|P2|Overall Study|Physician Decision|1
1633104|NCT01850602|5704584|P1|Overall Study|Physician Decision|2
1633105|NCT01850602|5704583|P2|Overall Study|Adverse Event|10
1633106|NCT01850602|5704584|P1|Overall Study|Adverse Event|7
1633107|NCT01850589|5704598|P2|Overall Study|Withdrawal by Subject|0
1633108|NCT01850589|5704599|P1|Overall Study|Withdrawal by Subject|8
1633109|NCT01850030|5704664|P2|Overall Study|pregnancy not confirmed at visit 4|249
1633110|NCT01850030|5704665|P1|Overall Study|pregnancy not confirmed at visit 4|248
1633111|NCT01850030|5704664|P2|Overall Study|Protocol Violation|28
1633112|NCT01850030|5704665|P1|Overall Study|Protocol Violation|24
1633113|NCT01850030|5704664|P2|Overall Study|Withdrawal by Subject|4
1633114|NCT01850030|5704665|P1|Overall Study|Withdrawal by Subject|3
1633115|NCT01850030|5704664|P2|Overall Study|Lost to Follow-up|5
1633116|NCT01850030|5704665|P1|Overall Study|Lost to Follow-up|5
1633117|NCT01850030|5704664|P2|Overall Study|Lack of Efficacy|1
1633118|NCT01850030|5704665|P1|Overall Study|Lack of Efficacy|3
1633119|NCT01850030|5704664|P2|Overall Study|Adverse Event|82
1633120|NCT01850030|5704665|P1|Overall Study|Adverse Event|64
1633121|NCT01850004|5704677|P1|Overall Study|AE Unrelated to Study Drug|1
1633122|NCT01850004|5704677|P1|Overall Study|Subject Request to Discontinue Treatment|1
1633123|NCT01850004|5704677|P1|Overall Study|Subject Withdrew Consent|4
1633124|NCT01850004|5704677|P1|Overall Study|Poor/Non-compliance|1
1633125|NCT01850004|5704677|P1|Overall Study|Subject Moved|1
1633126|NCT01849848|5704684|P1|Overall Study|Progression of the primary disease|3
1633127|NCT01849848|5704684|P1|Overall Study|Physician Decision|1
1633128|NCT01849588|5704782|P1|Overall Study|Lack of Efficacy|3
1633129|NCT01849562|5704792|P3|Overall Study|Non-compliance with Study Drug|0
1633130|NCT01849562|5704793|P2|Overall Study|Non-compliance with Study Drug|0
1633131|NCT01849562|5704794|P1|Overall Study|Non-compliance with Study Drug|1
1633132|NCT01849562|5704792|P3|Overall Study|Lost to Follow-up|0
1633133|NCT01849562|5704793|P2|Overall Study|Lost to Follow-up|0
1633134|NCT01849562|5704794|P1|Overall Study|Lost to Follow-up|1
1633135|NCT01849497|5704807|P2|Overall Study|Lost to Follow-up|1
1633136|NCT01849497|5704808|P1|Overall Study|Lost to Follow-up|0
1633137|NCT01849497|5704807|P2|Overall Study|Sponsor Decision|1
1633138|NCT01849497|5704808|P1|Overall Study|Sponsor Decision|0
1633139|NCT01849497|5704807|P2|Overall Study|Withdrawal by Subject|2
1633140|NCT01849497|5704808|P1|Overall Study|Withdrawal by Subject|1
1633141|NCT01849458|5704816|P1|Overall Study|Lost to Follow-up|4
1633142|NCT01849289|5704855|P2|Overall Study|Unclassified|18
1633143|NCT01849289|5704856|P1|Overall Study|Unclassified|25
1633144|NCT01849289|5704855|P2|Overall Study|Withdrawal criteria|0
1633145|NCT01849289|5704856|P1|Overall Study|Withdrawal criteria|1
1633146|NCT01849289|5704855|P2|Overall Study|Protocol Violation|3
1633147|NCT01849289|5704856|P1|Overall Study|Protocol Violation|3
1633148|NCT01849289|5704855|P2|Overall Study|Adverse Event|3
1633149|NCT01849289|5704856|P1|Overall Study|Adverse Event|3
1633150|NCT01849276|5704872|P1|Followed for Survival for 5 Years|Early termination of the study|1
1633151|NCT01849276|5704872|P1|Followed for Survival for 5 Years|Death|1
1633152|NCT01849055|5704954|P6|Overall Study|Withdrawal by Subject|0
1633153|NCT01849055|5704955|P5|Overall Study|Withdrawal by Subject|0
1633154|NCT01849055|5704956|P4|Overall Study|Withdrawal by Subject|0
1633155|NCT01849055|5704957|P3|Overall Study|Withdrawal by Subject|1
1633156|NCT01849055|5704958|P2|Overall Study|Withdrawal by Subject|0
1633157|NCT01849055|5704959|P1|Overall Study|Withdrawal by Subject|0
1633158|NCT01848990|5704994|P3|Overall Study|Other|2
1633159|NCT01848990|5704995|P2|Overall Study|Other|4
1633160|NCT01848990|5704996|P1|Overall Study|Other|1
1633161|NCT01848990|5704994|P3|Overall Study|Death|1
1633162|NCT01848990|5704995|P2|Overall Study|Death|0
1633163|NCT01848990|5704996|P1|Overall Study|Death|1
1633164|NCT01848990|5704994|P3|Overall Study|Non Compliance|0
1633165|NCT01848990|5704995|P2|Overall Study|Non Compliance|0
1633166|NCT01848990|5704996|P1|Overall Study|Non Compliance|1
1633167|NCT01848990|5704994|P3|Overall Study|Physician Decision|0
1633168|NCT01848990|5704995|P2|Overall Study|Physician Decision|1
1633169|NCT01848990|5704996|P1|Overall Study|Physician Decision|1
1633170|NCT01848990|5704994|P3|Overall Study|Withdrawal by Subject|11
1633171|NCT01848990|5704995|P2|Overall Study|Withdrawal by Subject|10
1633172|NCT01848990|5704996|P1|Overall Study|Withdrawal by Subject|29
1633173|NCT01848990|5704994|P3|Overall Study|Protocol Violation|0
1633174|NCT01848990|5704995|P2|Overall Study|Protocol Violation|1
1633175|NCT01848990|5704996|P1|Overall Study|Protocol Violation|1
1633176|NCT01848990|5704994|P3|Overall Study|Lost to Follow-up|2
1633177|NCT01848990|5704995|P2|Overall Study|Lost to Follow-up|2
1633178|NCT01848990|5704996|P1|Overall Study|Lost to Follow-up|6
1633179|NCT01848990|5704994|P3|Overall Study|Adverse Event|0
1633180|NCT01848990|5704995|P2|Overall Study|Adverse Event|2
1633181|NCT01848990|5704996|P1|Overall Study|Adverse Event|6
1633182|NCT01848938|5705066|P2|Overall Study|Lost to Follow-up|1
1633183|NCT01848938|5705067|P1|Overall Study|Lost to Follow-up|1
1633184|NCT01848834|5705116|P5|Overall Study|Not Treated|0
1633185|NCT01848834|5705117|P4|Overall Study|Not Treated|0
1633186|NCT01848834|5705118|P3|Overall Study|Not Treated|0
1633187|NCT01848834|5705119|P2|Overall Study|Not Treated|1
1633188|NCT01848834|5705120|P1|Overall Study|Not Treated|0
1633189|NCT01848834|5705116|P5|Overall Study|Withdrawal by Subject|7
1633190|NCT01848834|5705117|P4|Overall Study|Withdrawal by Subject|0
1633191|NCT01848834|5705118|P3|Overall Study|Withdrawal by Subject|3
1633192|NCT01848834|5705119|P2|Overall Study|Withdrawal by Subject|2
1633193|NCT01848834|5705120|P1|Overall Study|Withdrawal by Subject|0
1633194|NCT01848834|5705116|P5|Overall Study|Protocol Violation|2
1633195|NCT01848834|5705117|P4|Overall Study|Protocol Violation|0
1633196|NCT01848834|5705118|P3|Overall Study|Protocol Violation|1
1633197|NCT01848834|5705119|P2|Overall Study|Protocol Violation|0
1633198|NCT01848834|5705120|P1|Overall Study|Protocol Violation|0
1633199|NCT01848834|5705116|P5|Overall Study|Progressive Disease|78
1633200|NCT01848834|5705117|P4|Overall Study|Progressive Disease|36
1633201|NCT01848834|5705118|P3|Overall Study|Progressive Disease|21
1633202|NCT01848834|5705119|P2|Overall Study|Progressive Disease|41
1633203|NCT01848834|5705120|P1|Overall Study|Progressive Disease|27
1633204|NCT01848834|5705116|P5|Overall Study|Death|3
1633205|NCT01848834|5705117|P4|Overall Study|Death|0
1633206|NCT01848834|5705118|P3|Overall Study|Death|0
1633207|NCT01848834|5705119|P2|Overall Study|Death|1
1633208|NCT01848834|5705120|P1|Overall Study|Death|0
1633209|NCT01848834|5705116|P5|Overall Study|Complete Response|0
1633210|NCT01848834|5705117|P4|Overall Study|Complete Response|0
1633211|NCT01848834|5705118|P3|Overall Study|Complete Response|0
1633212|NCT01848834|5705119|P2|Overall Study|Complete Response|1
1633213|NCT01848834|5705120|P1|Overall Study|Complete Response|0
1633214|NCT01848834|5705116|P5|Overall Study|Adverse Event|15
1633215|NCT01848834|5705117|P4|Overall Study|Adverse Event|1
1633216|NCT01848834|5705118|P3|Overall Study|Adverse Event|6
1633217|NCT01848834|5705119|P2|Overall Study|Adverse Event|8
1633218|NCT01848834|5705120|P1|Overall Study|Adverse Event|3
1633219|NCT01848834|5705116|P5|Overall Study|Physician Decision|1
1633220|NCT01848834|5705117|P4|Overall Study|Physician Decision|0
1633221|NCT01848834|5705118|P3|Overall Study|Physician Decision|0
1633222|NCT01848834|5705119|P2|Overall Study|Physician Decision|0
1633223|NCT01848834|5705120|P1|Overall Study|Physician Decision|0
1633224|NCT01848834|5705116|P5|Overall Study|Ongoing in Study|26
1633225|NCT01848834|5705117|P4|Overall Study|Ongoing in Study|0
1633226|NCT01848834|5705118|P3|Overall Study|Ongoing in Study|1
1633227|NCT01848834|5705119|P2|Overall Study|Ongoing in Study|6
1633228|NCT01848834|5705120|P1|Overall Study|Ongoing in Study|0
1633229|NCT01848756|5705168|P1|Overall Study|Enrolled in Error|1
1633230|NCT01848756|5705168|P1|Overall Study|Withdrawal by Subject|1
1633231|NCT01848756|5705168|P1|Overall Study|Adverse Event|1
1633232|NCT01848483|5705180|P2|Overall Study|Incarceration|2
1633233|NCT01848483|5705181|P1|Overall Study|Incarceration|2
1633234|NCT01848483|5705180|P2|Overall Study|Withdrawal by Subject|0
1633235|NCT01848483|5705181|P1|Overall Study|Withdrawal by Subject|1
1633236|NCT01848483|5705180|P2|Overall Study|Lost to Follow-up|8
1633237|NCT01848483|5705181|P1|Overall Study|Lost to Follow-up|6
1633238|NCT01848483|5705180|P2|Overall Study|Death|1
1633239|NCT01848483|5705181|P1|Overall Study|Death|2
1633240|NCT01848353|5705203|P4|Phase 3|Withdrawal by Subject|0
1633241|NCT01848353|5705204|P3|Phase 3|Withdrawal by Subject|0
1633242|NCT01848353|5705205|P2|Phase 3|Withdrawal by Subject|1
1633243|NCT01848353|5705206|P1|Phase 3|Withdrawal by Subject|1
1633244|NCT01848353|5705203|P4|Phase 2|Withdrawal by Subject|0
1633245|NCT01848353|5705204|P3|Phase 2|Withdrawal by Subject|0
1633246|NCT01848353|5705205|P2|Phase 2|Withdrawal by Subject|2
1633247|NCT01848353|5705206|P1|Phase 2|Withdrawal by Subject|3
1633248|NCT01848353|5705203|P4|Phase 1|Withdrawal by Subject|0
1633249|NCT01848353|5705204|P3|Phase 1|Withdrawal by Subject|0
1633250|NCT01848353|5705205|P2|Phase 1|Withdrawal by Subject|1
1633251|NCT01848353|5705206|P1|Phase 1|Withdrawal by Subject|3
1633252|NCT01848288|5705262|P1|Overall Study|Withdrawal by Subject|1
1633253|NCT01848288|5705262|P1|Overall Study|Protocol Violation|1
1633254|NCT01848288|5705262|P1|Overall Study|Death|1
1633255|NCT01848210|5705273|P2|Overall Study|Administrative|0
1633256|NCT01848210|5705274|P1|Overall Study|Administrative|1
1633257|NCT01848210|5705273|P2|Overall Study|Chronic Venous Insufficiency Course|2
1633258|NCT01848210|5705274|P1|Overall Study|Chronic Venous Insufficiency Course|1
1633259|NCT01848210|5705273|P2|Overall Study|Hepatic Function Alteration|0
1633260|NCT01848210|5705274|P1|Overall Study|Hepatic Function Alteration|4
1633261|NCT01848210|5705273|P2|Overall Study|Hypesensitivity|0
1633262|NCT01848210|5705274|P1|Overall Study|Hypesensitivity|1
1633263|NCT01848210|5705273|P2|Overall Study|Discontinuation Criterion|7
1633264|NCT01848210|5705274|P1|Overall Study|Discontinuation Criterion|5
1633265|NCT01848210|5705273|P2|Overall Study|Adverse Event|9
1633266|NCT01848210|5705274|P1|Overall Study|Adverse Event|7
1633267|NCT01848210|5705273|P2|Overall Study|Impedition Condition|9
1633268|NCT01848210|5705274|P1|Overall Study|Impedition Condition|5
1633269|NCT01848210|5705273|P2|Overall Study|Use of Forbidden Drugs|10
1633270|NCT01848210|5705274|P1|Overall Study|Use of Forbidden Drugs|9
1633271|NCT01848210|5705273|P2|Overall Study|Protocol Violation|5
1633272|NCT01848210|5705274|P1|Overall Study|Protocol Violation|3
1633273|NCT01848210|5705273|P2|Overall Study|Lost to Follow-up|12
1633274|NCT01848210|5705274|P1|Overall Study|Lost to Follow-up|24
1633275|NCT01848210|5705273|P2|Overall Study|Informed Consent Form Withdrawal|24
1633276|NCT01848210|5705274|P1|Overall Study|Informed Consent Form Withdrawal|28
1633277|NCT01848145|5705296|P1|Subsequent Infusions: Weeks 3-8|Death|1
1633278|NCT01848145|5705296|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
1633279|NCT01848145|5705296|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
1633280|NCT01848145|5705296|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
1633281|NCT01848145|5705296|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
1633282|NCT01848145|5705296|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
1633283|NCT01848145|5705296|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
1633284|NCT01847885|5705336|P3|Randomization|Screen Failure|0
1633285|NCT01847885|5705337|P2|Randomization|Screen Failure|3
1633286|NCT01847885|5705338|P1|Randomization|Screen Failure|0
1633287|NCT01847885|5705336|P3|Randomization|Withdrawal by Subject|2
1633288|NCT01847885|5705337|P2|Randomization|Withdrawal by Subject|0
1633289|NCT01847885|5705338|P1|Randomization|Withdrawal by Subject|0
1633290|NCT01847885|5705336|P3|Randomization|Protocol Violation|0
1633291|NCT01847885|5705337|P2|Randomization|Protocol Violation|1
1633292|NCT01847885|5705338|P1|Randomization|Protocol Violation|0
1633293|NCT01847885|5705336|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1633294|NCT01847885|5705337|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
1633295|NCT01847885|5705338|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
1633296|NCT01847885|5705336|P3|Initial Enrollment (Consented)|Screen failure|0
1633297|NCT01847885|5705337|P2|Initial Enrollment (Consented)|Screen failure|0
1633298|NCT01847885|5705338|P1|Initial Enrollment (Consented)|Screen failure|39
1633299|NCT01847885|5705336|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
1633300|NCT01847885|5705337|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
1633301|NCT01847885|5705338|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
1633302|NCT01847885|5705336|P3|Initial Enrollment (Consented)|Protocol Violation|0
1633303|NCT01847885|5705337|P2|Initial Enrollment (Consented)|Protocol Violation|0
1633304|NCT01847885|5705338|P1|Initial Enrollment (Consented)|Protocol Violation|1
1633305|NCT01847443|5705489|P4|Washout Period Before Study Period 4|Positive alcohol test|0
1633306|NCT01847443|5705490|P3|Washout Period Before Study Period 4|Positive alcohol test|0
1633307|NCT01847443|5705491|P2|Washout Period Before Study Period 4|Positive alcohol test|0
1633308|NCT01847443|5705492|P1|Washout Period Before Study Period 4|Positive alcohol test|1
1633309|NCT01847443|5705489|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
1633310|NCT01847443|5705490|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
1633311|NCT01847443|5705491|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
1633312|NCT01847443|5705492|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
1633313|NCT01847443|5705489|P4|Washout Period Before Study Period 3|Other reason|0
1633314|NCT01847443|5705490|P3|Washout Period Before Study Period 3|Other reason|0
1633315|NCT01847443|5705491|P2|Washout Period Before Study Period 3|Other reason|0
1633316|NCT01847443|5705492|P1|Washout Period Before Study Period 3|Other reason|1
1633317|NCT01847443|5705489|P4|Washout Period Before Study Period 2|Other reason|0
1633318|NCT01847443|5705490|P3|Washout Period Before Study Period 2|Other reason|0
1633319|NCT01847443|5705491|P2|Washout Period Before Study Period 2|Other reason|0
1633320|NCT01847443|5705492|P1|Washout Period Before Study Period 2|Other reason|1
1633321|NCT01847443|5705489|P4|Washout Period Before Study Period 2|Adverse Event|0
1633322|NCT01847443|5705490|P3|Washout Period Before Study Period 2|Adverse Event|0
1633323|NCT01847443|5705491|P2|Washout Period Before Study Period 2|Adverse Event|1
1633324|NCT01847443|5705492|P1|Washout Period Before Study Period 2|Adverse Event|1
1633325|NCT01847443|5705489|P4|Study Period 1|Withdrawal by Subject|0
1633326|NCT01847443|5705490|P3|Study Period 1|Withdrawal by Subject|0
1633327|NCT01847443|5705491|P2|Study Period 1|Withdrawal by Subject|1
1633328|NCT01847443|5705492|P1|Study Period 1|Withdrawal by Subject|0
1633329|NCT01847313|5705535|P2|Overall Study|Withdrawal by Subject|1
1633330|NCT01847313|5705536|P1|Overall Study|Withdrawal by Subject|0
1633331|NCT01847313|5705535|P2|Overall Study|Death|1
1633332|NCT01847313|5705536|P1|Overall Study|Death|0
1633333|NCT01847274|5705552|P4|Overall Study|Non Compliance|0
1633334|NCT01847274|5705553|P3|Overall Study|Non Compliance|2
1633335|NCT01847274|5705554|P2|Overall Study|Non Compliance|0
1633336|NCT01847274|5705555|P1|Overall Study|Non Compliance|0
1633337|NCT01847274|5705552|P4|Overall Study|Other Reasons|3
1633338|NCT01847274|5705553|P3|Overall Study|Other Reasons|11
1633339|NCT01847274|5705554|P2|Overall Study|Other Reasons|1
1633340|NCT01847274|5705555|P1|Overall Study|Other Reasons|3
1633341|NCT01847274|5705552|P4|Overall Study|Treatment Associated Risk|0
1633342|NCT01847274|5705553|P3|Overall Study|Treatment Associated Risk|2
1633343|NCT01847274|5705554|P2|Overall Study|Treatment Associated Risk|2
1633344|NCT01847274|5705555|P1|Overall Study|Treatment Associated Risk|0
1633345|NCT01847274|5705552|P4|Overall Study|Disease Progression|98
1633346|NCT01847274|5705553|P3|Overall Study|Disease Progression|129
1633347|NCT01847274|5705554|P2|Overall Study|Disease Progression|49
1633348|NCT01847274|5705555|P1|Overall Study|Disease Progression|63
1633349|NCT01847274|5705552|P4|Overall Study|Withdrawal by Subject|1
1633350|NCT01847274|5705553|P3|Overall Study|Withdrawal by Subject|11
1633351|NCT01847274|5705554|P2|Overall Study|Withdrawal by Subject|8
1633352|NCT01847274|5705555|P1|Overall Study|Withdrawal by Subject|8
1633353|NCT01847274|5705552|P4|Overall Study|Adverse Event|2
1633354|NCT01847274|5705553|P3|Overall Study|Adverse Event|33
1633355|NCT01847274|5705554|P2|Overall Study|Adverse Event|1
1633356|NCT01847274|5705555|P1|Overall Study|Adverse Event|17
1633357|NCT01847209|5705609|P1|Overall Study|No lung nodule found on intraop CT scan|1
1633358|NCT01847209|5705609|P1|Overall Study|Withdrawal by Subject|1
1633359|NCT01846741|5705676|P1|Baseline Visit|Subject did not meet entry criteria|2
1633360|NCT01846624|5705832|P1|Overall Study|Died during induction, no midostaurin|1
1633361|NCT01846611|5705842|P2|Overall Study|Other|18
1633362|NCT01846611|5705843|P1|Overall Study|Other|19
1633363|NCT01846611|5705842|P2|Overall Study|Withdrawal by Subject|19
1633364|NCT01846611|5705843|P1|Overall Study|Withdrawal by Subject|15
1633365|NCT01846611|5705842|P2|Overall Study|Lost to Follow-up|6
1633366|NCT01846611|5705843|P1|Overall Study|Lost to Follow-up|4
1633367|NCT01846507|5705853|P1|Overall Study|Missing data|2
1633368|NCT01846507|5705853|P1|Overall Study|Protocol Violation|1
1633369|NCT01846507|5705853|P1|Overall Study|Lost to Follow-up|4
1633370|NCT01846442|5705951|P4|Overall Study|Left the city/Lost medication|1
1633371|NCT01846442|5705952|P3|Overall Study|Left the city/Lost medication|1
1633372|NCT01846442|5705953|P2|Overall Study|Left the city/Lost medication|0
1633373|NCT01846442|5705954|P1|Overall Study|Left the city/Lost medication|1
1633374|NCT01846442|5705951|P4|Overall Study|Withdrawal by Subject|1
1633375|NCT01846442|5705952|P3|Overall Study|Withdrawal by Subject|0
1633376|NCT01846442|5705953|P2|Overall Study|Withdrawal by Subject|2
1633377|NCT01846442|5705954|P1|Overall Study|Withdrawal by Subject|3
1633378|NCT01846442|5705951|P4|Overall Study|Lost to Follow-up|0
1633379|NCT01846442|5705952|P3|Overall Study|Lost to Follow-up|1
1633380|NCT01846442|5705953|P2|Overall Study|Lost to Follow-up|0
1633381|NCT01846442|5705954|P1|Overall Study|Lost to Follow-up|0
1633382|NCT01846442|5705951|P4|Overall Study|Adverse Event|1
1633383|NCT01846442|5705952|P3|Overall Study|Adverse Event|2
1633384|NCT01846442|5705953|P2|Overall Study|Adverse Event|4
1633385|NCT01846442|5705954|P1|Overall Study|Adverse Event|2
1633386|NCT01846416|5705995|P3|Survival Follow-up|Other|1
1633387|NCT01846416|5705996|P2|Survival Follow-up|Other|1
1633388|NCT01846416|5705997|P1|Survival Follow-up|Other|3
1633389|NCT01846416|5705995|P3|Survival Follow-up|Study Terminated by Sponsor|0
1633390|NCT01846416|5705996|P2|Survival Follow-up|Study Terminated by Sponsor|8
1633391|NCT01846416|5705997|P1|Survival Follow-up|Study Terminated by Sponsor|2
1633392|NCT01846416|5705995|P3|Survival Follow-up|Withdrawal by Subject|0
1633393|NCT01846416|5705996|P2|Survival Follow-up|Withdrawal by Subject|7
1633394|NCT01846416|5705997|P1|Survival Follow-up|Withdrawal by Subject|2
1633395|NCT01846416|5705995|P3|Survival Follow-up|Lost to Follow-up|2
1633396|NCT01846416|5705996|P2|Survival Follow-up|Lost to Follow-up|2
1633397|NCT01846416|5705997|P1|Survival Follow-up|Lost to Follow-up|0
1633398|NCT01846416|5705995|P3|Survival Follow-up|Death|9
1633399|NCT01846416|5705996|P2|Survival Follow-up|Death|62
1633400|NCT01846416|5705997|P1|Survival Follow-up|Death|21
1633401|NCT01846416|5705995|P3|Treatment Phase|Progressive Disease|9
1633402|NCT01846416|5705996|P2|Treatment Phase|Progressive Disease|63
1633403|NCT01846416|5705997|P1|Treatment Phase|Progressive Disease|21
1633404|NCT01846416|5705995|P3|Treatment Phase|Study Terminated by Sponsor|0
1633405|NCT01846416|5705996|P2|Treatment Phase|Study Terminated by Sponsor|4
1633406|NCT01846416|5705997|P1|Treatment Phase|Study Terminated by Sponsor|1
1633407|NCT01846416|5705995|P3|Treatment Phase|Non-compliance|0
1633408|NCT01846416|5705996|P2|Treatment Phase|Non-compliance|2
1633409|NCT01846416|5705997|P1|Treatment Phase|Non-compliance|0
1633410|NCT01846416|5705995|P3|Treatment Phase|Adverse Event|0
1633411|NCT01846416|5705996|P2|Treatment Phase|Adverse Event|4
1633412|NCT01846416|5705997|P1|Treatment Phase|Adverse Event|3
1633413|NCT01846416|5705995|P3|Treatment Phase|Physician Decision|0
1633414|NCT01846416|5705996|P2|Treatment Phase|Physician Decision|2
1633415|NCT01846416|5705997|P1|Treatment Phase|Physician Decision|1
1633416|NCT01846416|5705995|P3|Treatment Phase|Other|1
1633417|NCT01846416|5705996|P2|Treatment Phase|Other|5
1633418|NCT01846416|5705997|P1|Treatment Phase|Other|1
1633419|NCT01846416|5705995|P3|Treatment Phase|Withdrawal by Subject|2
1633420|NCT01846416|5705996|P2|Treatment Phase|Withdrawal by Subject|4
1633421|NCT01846416|5705997|P1|Treatment Phase|Withdrawal by Subject|2
1633422|NCT01846416|5705995|P3|Treatment Phase|Death|1
1633423|NCT01846416|5705996|P2|Treatment Phase|Death|9
1633424|NCT01846416|5705997|P1|Treatment Phase|Death|2
1633425|NCT01846299|5706042|P2|Overall Study|Adverse Event|0
1633426|NCT01846299|5706043|P1|Overall Study|Adverse Event|2
1633427|NCT01846299|5706042|P2|Overall Study|Withdrawal by Subject|6
1633428|NCT01846299|5706043|P1|Overall Study|Withdrawal by Subject|1
1633429|NCT01846299|5706042|P2|Overall Study|Lost to Follow-up|0
1633430|NCT01846299|5706043|P1|Overall Study|Lost to Follow-up|3
1633431|NCT01846299|5706042|P2|Overall Study|Death|2
1633432|NCT01846299|5706043|P1|Overall Study|Death|1
1633433|NCT01846299|5706042|P2|Overall Study|Protocol deviation|0
1633434|NCT01846299|5706043|P1|Overall Study|Protocol deviation|1
1633435|NCT01846299|5706042|P2|Overall Study|Physician Decision|2
1633436|NCT01846299|5706043|P1|Overall Study|Physician Decision|4
1633437|NCT01846273|5706082|P3|Overall Study|Physician Decision|0
1633438|NCT01846273|5706083|P2|Overall Study|Physician Decision|2
1633439|NCT01846273|5706084|P1|Overall Study|Physician Decision|1
1633440|NCT01846273|5706082|P3|Overall Study|Protocol Deviation|0
1633441|NCT01846273|5706083|P2|Overall Study|Protocol Deviation|3
1633442|NCT01846273|5706084|P1|Overall Study|Protocol Deviation|2
1633443|NCT01846273|5706082|P3|Overall Study|Disease Progression|0
1633444|NCT01846273|5706083|P2|Overall Study|Disease Progression|4
1633445|NCT01846273|5706084|P1|Overall Study|Disease Progression|0
1633446|NCT01846273|5706082|P3|Overall Study|Death|0
1633447|NCT01846273|5706083|P2|Overall Study|Death|1
1633448|NCT01846273|5706084|P1|Overall Study|Death|2
1633449|NCT01846273|5706082|P3|Overall Study|Administrative problems|0
1633450|NCT01846273|5706083|P2|Overall Study|Administrative problems|0
1633451|NCT01846273|5706084|P1|Overall Study|Administrative problems|1
1633452|NCT01846273|5706082|P3|Overall Study|Lost to Follow-up|0
1633453|NCT01846273|5706083|P2|Overall Study|Lost to Follow-up|1
1633454|NCT01846273|5706084|P1|Overall Study|Lost to Follow-up|2
1633455|NCT01846273|5706082|P3|Overall Study|Subject withdrew consent|0
1633456|NCT01846273|5706083|P2|Overall Study|Subject withdrew consent|8
1633457|NCT01846273|5706084|P1|Overall Study|Subject withdrew consent|5
1633458|NCT01846273|5706082|P3|Overall Study|Adverse Event|0
1633459|NCT01846273|5706083|P2|Overall Study|Adverse Event|7
1633460|NCT01846273|5706084|P1|Overall Study|Adverse Event|9
1633461|NCT01846221|5706140|P2|Overall Study|Age Exclusion|0
1633462|NCT01846221|5706141|P1|Overall Study|Age Exclusion|1
1633463|NCT01846221|5706140|P2|Overall Study|Catheter Failure|0
1633464|NCT01846221|5706141|P1|Overall Study|Catheter Failure|2
1633465|NCT01846208|5706158|P3|Overall Study|Refused SU OFC|1
1633466|NCT01846208|5706159|P2|Overall Study|Refused SU OFC|0
1633467|NCT01846208|5706160|P1|Overall Study|Refused SU OFC|0
1633468|NCT01846208|5706158|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
1633469|NCT01846208|5706159|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
1633470|NCT01846208|5706160|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
1633471|NCT01846208|5706158|P3|Overall Study|Non-compliance|0
1633472|NCT01846208|5706159|P2|Overall Study|Non-compliance|1
1633473|NCT01846208|5706160|P1|Overall Study|Non-compliance|1
1633474|NCT01846208|5706158|P3|Overall Study|Withdrawal by Subject|0
1633475|NCT01846208|5706159|P2|Overall Study|Withdrawal by Subject|0
1633476|NCT01846208|5706160|P1|Overall Study|Withdrawal by Subject|5
1633477|NCT01846208|5706158|P3|Overall Study|Dosing Symptoms|6
1633478|NCT01846208|5706159|P2|Overall Study|Dosing Symptoms|2
1633479|NCT01846208|5706160|P1|Overall Study|Dosing Symptoms|1
1633480|NCT01846208|5706158|P3|Overall Study|Withdrew prior to treatment|1
1633481|NCT01846208|5706159|P2|Overall Study|Withdrew prior to treatment|1
1633482|NCT01846208|5706160|P1|Overall Study|Withdrew prior to treatment|1
1633483|NCT01846104|5706180|P1|Overall Study|Withdrawal by Subject|1
1633484|NCT01846039|5706186|P1|Overall Study|Subject Withdrew Consent|1
1633485|NCT01846039|5706186|P1|Overall Study|Protocol Violation|1
1633486|NCT01845974|5706198|P2|Overall Study|screen failure|0
1633487|NCT01845974|5706199|P1|Overall Study|screen failure|1
1633488|NCT01845831|5706207|P5|Inpatient Phase|Withdrawal by Subject|0
1633489|NCT01845831|5706208|P4|Inpatient Phase|Withdrawal by Subject|0
1633490|NCT01845831|5706209|P3|Inpatient Phase|Withdrawal by Subject|0
1633491|NCT01845831|5706210|P2|Inpatient Phase|Withdrawal by Subject|1
1633492|NCT01845831|5706211|P1|Inpatient Phase|Withdrawal by Subject|1
1633493|NCT01845818|5706240|P2|Overall Study|No Follow-Up Data Available|1
1633494|NCT01845818|5706241|P1|Overall Study|No Follow-Up Data Available|4
1633495|NCT01845818|5706240|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
1633496|NCT01845818|5706241|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
1633497|NCT01845818|5706240|P2|Overall Study|Other|8
1633498|NCT01845818|5706241|P1|Overall Study|Other|25
1633499|NCT01845818|5706240|P2|Overall Study|Serious Adverse Event|1
1633500|NCT01845818|5706241|P1|Overall Study|Serious Adverse Event|1
1633501|NCT01845818|5706240|P2|Overall Study|Administrative Reasons|1
1633502|NCT01845818|5706241|P1|Overall Study|Administrative Reasons|3
1633503|NCT01845818|5706240|P2|Overall Study|Lost to Follow-up|5
1633504|NCT01845818|5706241|P1|Overall Study|Lost to Follow-up|7
1633505|NCT01845818|5706240|P2|Overall Study|Withdrawal by Subject|1
1633506|NCT01845818|5706241|P1|Overall Study|Withdrawal by Subject|0
1633507|NCT01845077|5706325|P6|Washout Period|Protocol Violation|0
1633508|NCT01845077|5706326|P5|Washout Period|Protocol Violation|1
1633509|NCT01845077|5706327|P4|Washout Period|Protocol Violation|1
1633510|NCT01845077|5706328|P3|Washout Period|Protocol Violation|0
1633511|NCT01845077|5706329|P2|Washout Period|Protocol Violation|0
1633512|NCT01845077|5706330|P1|Washout Period|Protocol Violation|0
1633513|NCT01845077|5706325|P6|Washout Period|elevated lab values (not clinic. sign.)|0
1633514|NCT01845077|5706326|P5|Washout Period|elevated lab values (not clinic. sign.)|0
1633515|NCT01845077|5706327|P4|Washout Period|elevated lab values (not clinic. sign.)|0
1633516|NCT01845077|5706328|P3|Washout Period|elevated lab values (not clinic. sign.)|1
1633517|NCT01845077|5706329|P2|Washout Period|elevated lab values (not clinic. sign.)|0
1633518|NCT01845077|5706330|P1|Washout Period|elevated lab values (not clinic. sign.)|0
1633519|NCT01845077|5706325|P6|Washout Period|Adverse Event|0
1633520|NCT01845077|5706326|P5|Washout Period|Adverse Event|0
1633521|NCT01845077|5706327|P4|Washout Period|Adverse Event|0
1633522|NCT01845077|5706328|P3|Washout Period|Adverse Event|0
1633523|NCT01845077|5706329|P2|Washout Period|Adverse Event|0
1633524|NCT01845077|5706330|P1|Washout Period|Adverse Event|1
1633525|NCT01845077|5706325|P6|Washout Period|Lost to Follow-up|1
1633526|NCT01845077|5706326|P5|Washout Period|Lost to Follow-up|0
1633527|NCT01845077|5706327|P4|Washout Period|Lost to Follow-up|1
1633528|NCT01845077|5706328|P3|Washout Period|Lost to Follow-up|0
1633529|NCT01845077|5706329|P2|Washout Period|Lost to Follow-up|1
1633530|NCT01845077|5706330|P1|Washout Period|Lost to Follow-up|0
1633531|NCT01845025|5706376|P2|Overall Study|Missing|1
1633532|NCT01845025|5706377|P1|Overall Study|Missing|1
1633533|NCT01845025|5706376|P2|Overall Study|Protocol deviation|6
1633534|NCT01845025|5706377|P1|Overall Study|Protocol deviation|3
1633535|NCT01845025|5706376|P2|Overall Study|Death|0
1633536|NCT01845025|5706377|P1|Overall Study|Death|2
1633537|NCT01845025|5706376|P2|Overall Study|Administrative problems|8
1633538|NCT01845025|5706377|P1|Overall Study|Administrative problems|8
1633539|NCT01845025|5706376|P2|Overall Study|Lost to Follow-up|13
1633540|NCT01845025|5706377|P1|Overall Study|Lost to Follow-up|13
1633541|NCT01845025|5706376|P2|Overall Study|Withdrawal by Subject|44
1633542|NCT01845025|5706377|P1|Overall Study|Withdrawal by Subject|48
1633543|NCT01845025|5706376|P2|Overall Study|Unsatisfactory therapeutic effect|2
1633544|NCT01845025|5706377|P1|Overall Study|Unsatisfactory therapeutic effect|4
1633545|NCT01845025|5706376|P2|Overall Study|Adverse Event|3
1633546|NCT01845025|5706377|P1|Overall Study|Adverse Event|6
1633547|NCT01844986|5706401|P2|Overall Study|Death|26
1633548|NCT01844986|5706402|P1|Overall Study|Death|55
1633549|NCT01844986|5706401|P2|Overall Study|Withdrawal by Subject|14
1633550|NCT01844986|5706402|P1|Overall Study|Withdrawal by Subject|21
1633551|NCT01844986|5706401|P2|Overall Study|Severe non-compliance to protocol|0
1633552|NCT01844986|5706402|P1|Overall Study|Severe non-compliance to protocol|1
1633553|NCT01844895|5706424|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
1633554|NCT01844895|5706424|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
1633555|NCT01844895|5706424|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
1633556|NCT01844895|5706424|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
1633557|NCT01844895|5706424|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
1633558|NCT01844895|5706424|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
1633559|NCT01844895|5706424|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
1633560|NCT01844856|5706442|P2|Overall Study|Randomized but was a Screen Failure|1
1633561|NCT01844856|5706443|P1|Overall Study|Randomized but was a Screen Failure|0
1633562|NCT01844856|5706442|P2|Overall Study|Inadvertently Not Scheduled|0
1633563|NCT01844856|5706443|P1|Overall Study|Inadvertently Not Scheduled|1
1633564|NCT01844856|5706442|P2|Overall Study|Enterococcus Resistant|1
1633565|NCT01844856|5706443|P1|Overall Study|Enterococcus Resistant|0
1633566|NCT01844856|5706442|P2|Overall Study|Noncompliance|3
1633567|NCT01844856|5706443|P1|Overall Study|Noncompliance|2
1633568|NCT01844856|5706442|P2|Overall Study|Withdrawal by Subject|2
1633569|NCT01844856|5706443|P1|Overall Study|Withdrawal by Subject|3
1633570|NCT01844856|5706442|P2|Overall Study|Adverse Event|6
1633571|NCT01844856|5706443|P1|Overall Study|Adverse Event|3
1633572|NCT01844856|5706442|P2|Overall Study|Lost to Follow-up|3
1633573|NCT01844856|5706443|P1|Overall Study|Lost to Follow-up|15
1633574|NCT01844830|5706455|P2|Overall Study|Withdrawal by Subject|0
1633575|NCT01844830|5706456|P1|Overall Study|Withdrawal by Subject|1
1633576|NCT01844817|5706486|P2|Treatment|Other|3
1633577|NCT01844817|5706487|P1|Treatment|Other|0
1633578|NCT01844817|5706486|P2|Treatment|Lost to Follow-up|1
1633579|NCT01844817|5706487|P1|Treatment|Lost to Follow-up|0
1633580|NCT01844817|5706486|P2|Treatment|Death|8
1633581|NCT01844817|5706487|P1|Treatment|Death|10
1633582|NCT01844817|5706486|P2|Treatment|Withdrawal by Subject|6
1633583|NCT01844817|5706487|P1|Treatment|Withdrawal by Subject|10
1633584|NCT01844817|5706486|P2|Treatment|Adverse Event|9
1633585|NCT01844817|5706487|P1|Treatment|Adverse Event|17
1633586|NCT01844817|5706486|P2|Treatment|Progressive Disease|36
1633587|NCT01844817|5706487|P1|Treatment|Progressive Disease|27
1633588|NCT01844817|5706486|P2|Enrolled and Randomized|Withdrawal by Subject|3
1633589|NCT01844817|5706487|P1|Enrolled and Randomized|Withdrawal by Subject|2
1633590|NCT01844778|5706500|P3|Overall Study|Adverse Event|2
1633591|NCT01844778|5706501|P2|Overall Study|Adverse Event|2
1633592|NCT01844778|5706502|P1|Overall Study|Adverse Event|0
1633593|NCT01844778|5706500|P3|Overall Study|Withdrawal by Subject|0
1633594|NCT01844778|5706501|P2|Overall Study|Withdrawal by Subject|0
1633595|NCT01844778|5706502|P1|Overall Study|Withdrawal by Subject|2
1633596|NCT01844778|5706500|P3|Overall Study|Protocol deviation|2
1633597|NCT01844778|5706501|P2|Overall Study|Protocol deviation|1
1633598|NCT01844778|5706502|P1|Overall Study|Protocol deviation|0
1633599|NCT01844765|5706528|P2|Overall Study|Untreated|0
1633600|NCT01844765|5706529|P1|Overall Study|Untreated|1
1633601|NCT01844765|5706528|P2|Overall Study|Protocol Violation|0
1633602|NCT01844765|5706529|P1|Overall Study|Protocol Violation|1
1633603|NCT01844765|5706528|P2|Overall Study|Disease progression|0
1633604|NCT01844765|5706529|P1|Overall Study|Disease progression|1
1633605|NCT01844765|5706528|P2|Overall Study|Administrative problems|1
1633606|NCT01844765|5706529|P1|Overall Study|Administrative problems|1
1633607|NCT01844765|5706528|P2|Overall Study|Withdrawal by Subject|1
1633608|NCT01844765|5706529|P1|Overall Study|Withdrawal by Subject|0
1633609|NCT01844765|5706528|P2|Overall Study|Adverse Event|4
1633610|NCT01844765|5706529|P1|Overall Study|Adverse Event|5
1633611|NCT01844700|5706549|P2|Overall Study|stopped taking meds|1
1633612|NCT01844700|5706550|P1|Overall Study|stopped taking meds|0
1633613|NCT01844700|5706549|P2|Overall Study|Withdrawal by Subject|0
1633614|NCT01844700|5706550|P1|Overall Study|Withdrawal by Subject|1
1633615|NCT01844700|5706549|P2|Overall Study|refused medication switch|0
1633616|NCT01844700|5706550|P1|Overall Study|refused medication switch|1
1633617|NCT01844700|5706549|P2|Overall Study|Lack of Efficacy|0
1633618|NCT01844700|5706550|P1|Overall Study|Lack of Efficacy|1
1633619|NCT01844687|5706562|P1|Visit 4|Withdrawal by Subject|2
1633620|NCT01844687|5706562|P1|Visit 4|Lost to Follow-up|1
1633621|NCT01844687|5706562|P1|Visit 4|Pregnancy|1
1633622|NCT01844687|5706562|P1|Visit 3|child care problems|1
1633623|NCT01844687|5706562|P1|Visit 3|Withdrawal by Subject|3
1633624|NCT01844687|5706562|P1|Visit 3|Lost to Follow-up|1
1633625|NCT01844687|5706562|P1|Visit 2|Protocol Violation|1
1633626|NCT01844687|5706562|P1|Visit 2|Withdrawal by Subject|1
1633627|NCT01844687|5706562|P1|Visit 1|Lost to Follow-up|5
1633628|NCT01844687|5706562|P1|Visit 1|Protocol Violation|3
1633629|NCT01844583|5706623|P2|Overall Study|Didn’t complete dosing;PK/ECG assessment|10
1633630|NCT01844583|5706624|P1|Overall Study|Didn’t complete dosing;PK/ECG assessment|8
1633631|NCT01844531|5706656|P4|Overall Study|Withdrawal by Subject|0
1633632|NCT01844531|5706657|P3|Overall Study|Withdrawal by Subject|0
1633633|NCT01844531|5706658|P2|Overall Study|Withdrawal by Subject|1
1633634|NCT01844531|5706659|P1|Overall Study|Withdrawal by Subject|0
1633635|NCT01844518|5706689|P1|Long-Term Extension|Still in On-Going Study|149
1633636|NCT01844518|5706689|P1|Long-Term Extension|No Longer Met Study Criteria|1
1633637|NCT01844518|5706689|P1|Long-Term Extension|Adverse Event|1
1633638|NCT01844518|5706689|P1|Long-Term Extension|Lack of Efficacy|6
1633639|NCT01844518|5706689|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
1633640|NCT01844518|5706689|P1|Short-Term (ST) Period|Withdrawal of Consent|2
1633641|NCT01844518|5706689|P1|Short-Term (ST) Period|Lack of Efficacy|3
1633642|NCT01844518|5706689|P1|Short-Term (ST) Period|Adverse Event|3
1633643|NCT01844505|5706706|P3|Overall Study|Not Reported|1
1633644|NCT01844505|5706707|P2|Overall Study|Not Reported|0
1633645|NCT01844505|5706708|P1|Overall Study|Not Reported|0
1633646|NCT01844505|5706706|P3|Overall Study|Other Reasons|2
1633647|NCT01844505|5706707|P2|Overall Study|Other Reasons|2
1633648|NCT01844505|5706708|P1|Overall Study|Other Reasons|4
1633649|NCT01844505|5706706|P3|Overall Study|Subject no longer meets criteria|0
1633650|NCT01844505|5706707|P2|Overall Study|Subject no longer meets criteria|1
1633651|NCT01844505|5706708|P1|Overall Study|Subject no longer meets criteria|0
1633652|NCT01844505|5706706|P3|Overall Study|Poor/non-compliance|1
1633653|NCT01844505|5706707|P2|Overall Study|Poor/non-compliance|1
1633654|NCT01844505|5706708|P1|Overall Study|Poor/non-compliance|1
1633655|NCT01844505|5706706|P3|Overall Study|Maximum clinical benefit|2
1633656|NCT01844505|5706707|P2|Overall Study|Maximum clinical benefit|11
1633657|NCT01844505|5706708|P1|Overall Study|Maximum clinical benefit|8
1633658|NCT01844505|5706706|P3|Overall Study|Lost to Follow-up|0
1633659|NCT01844505|5706707|P2|Overall Study|Lost to Follow-up|0
1633660|NCT01844505|5706708|P1|Overall Study|Lost to Follow-up|1
1633661|NCT01844505|5706706|P3|Overall Study|Withdrawal by Subject|0
1633662|NCT01844505|5706707|P2|Overall Study|Withdrawal by Subject|3
1633663|NCT01844505|5706708|P1|Overall Study|Withdrawal by Subject|0
1633664|NCT01844505|5706706|P3|Overall Study|Subject request discontinue treatment|8
1633665|NCT01844505|5706707|P2|Overall Study|Subject request discontinue treatment|14
1633666|NCT01844505|5706708|P1|Overall Study|Subject request discontinue treatment|17
1633667|NCT01844505|5706706|P3|Overall Study|Adverse event unrelated to study drug|6
1633668|NCT01844505|5706707|P2|Overall Study|Adverse event unrelated to study drug|15
1633669|NCT01844505|5706708|P1|Overall Study|Adverse event unrelated to study drug|7
1633670|NCT01844505|5706706|P3|Overall Study|Death|1
1633671|NCT01844505|5706707|P2|Overall Study|Death|3
1633672|NCT01844505|5706708|P1|Overall Study|Death|1
1633673|NCT01844505|5706706|P3|Overall Study|Study drug toxicity|50
1633674|NCT01844505|5706707|P2|Overall Study|Study drug toxicity|131
1633675|NCT01844505|5706708|P1|Overall Study|Study drug toxicity|40
1633676|NCT01844505|5706706|P3|Overall Study|Disease progression|224
1633677|NCT01844505|5706707|P2|Overall Study|Disease progression|88
1633678|NCT01844505|5706708|P1|Overall Study|Disease progression|170
1633679|NCT01844375|5706802|P2|Overall Study|Protocol Violation|1
1633680|NCT01844375|5706803|P1|Overall Study|Protocol Violation|1
1633681|NCT01844284|5706815|P2|Overall Study|Lost to Follow-up|7
1633682|NCT01844284|5706816|P1|Overall Study|Lost to Follow-up|12
1633683|NCT01844115|5707035|P2|Overall Study|Pregnancy|1
1633684|NCT01844115|5707036|P1|Overall Study|Pregnancy|0
1633685|NCT01844115|5707035|P2|Overall Study|Lost to Follow-up|10
1633686|NCT01844115|5707036|P1|Overall Study|Lost to Follow-up|11
1633687|NCT01844115|5707035|P2|Overall Study|Withdrawal by Subject|11
1633688|NCT01844115|5707036|P1|Overall Study|Withdrawal by Subject|11
1633689|NCT01844115|5707035|P2|Overall Study|Protocol Violation|10
1633690|NCT01844115|5707036|P1|Overall Study|Protocol Violation|12
1633691|NCT01844115|5707035|P2|Overall Study|Lack of Efficacy|4
1633692|NCT01844115|5707036|P1|Overall Study|Lack of Efficacy|1
1633693|NCT01844115|5707035|P2|Overall Study|Adverse Event|22
1633694|NCT01844115|5707036|P1|Overall Study|Adverse Event|4
1633695|NCT01843972|5707054|P10|Overall Study|Withdrawal by Subject|0
1633696|NCT01843972|5707055|P9|Overall Study|Withdrawal by Subject|0
1633697|NCT01843972|5707056|P8|Overall Study|Withdrawal by Subject|0
1633698|NCT01843972|5707057|P7|Overall Study|Withdrawal by Subject|0
1633699|NCT01843972|5707058|P6|Overall Study|Withdrawal by Subject|0
1633700|NCT01843972|5707059|P5|Overall Study|Withdrawal by Subject|1
1633701|NCT01843972|5707060|P4|Overall Study|Withdrawal by Subject|0
1633702|NCT01843972|5707061|P3|Overall Study|Withdrawal by Subject|0
1633703|NCT01843972|5707062|P2|Overall Study|Withdrawal by Subject|0
1633704|NCT01843972|5707063|P1|Overall Study|Withdrawal by Subject|0
1633705|NCT01843933|5707133|P2|Overall Study|Data lost|4
1633706|NCT01843933|5707134|P1|Overall Study|Data lost|6
1633707|NCT01843842|5707153|P2|Overall Study|Do not meet inclusion criteria|1
1633708|NCT01843842|5707154|P1|Overall Study|Do not meet inclusion criteria|1
1633709|NCT01843803|5707176|P2|Overall Study|not a Veteran, did not see provider|3
1633710|NCT01843803|5707177|P1|Overall Study|not a Veteran, did not see provider|1
1633711|NCT01843777|5707191|P2|Overall Study|Withdrawal by Subject|0
1633712|NCT01843777|5707192|P1|Overall Study|Withdrawal by Subject|1
1633713|NCT01843673|5707217|P1|Overall Study|Withdrawal by Subject|4
1633714|NCT01843673|5707217|P1|Overall Study|Lack of Efficacy|2
1633715|NCT01843660|5707229|P1|Overall Study|Other|30
1633716|NCT01843374|5707270|P2|Overall Study|Withdrawing due to Other reason|46
1633717|NCT01843374|5707271|P1|Overall Study|Withdrawing due to Other reason|20
1633718|NCT01843374|5707270|P2|Overall Study|Withdrawal by Subject|20
1633719|NCT01843374|5707271|P1|Overall Study|Withdrawal by Subject|14
1633720|NCT01843374|5707270|P2|Overall Study|Death|313
1633721|NCT01843374|5707271|P1|Overall Study|Death|155
1633722|NCT01843348|5707298|P3|Overall Study|Various reasons|6
1633723|NCT01843348|5707299|P2|Overall Study|Various reasons|9
1633724|NCT01843348|5707300|P1|Overall Study|Various reasons|4
1633725|NCT01843348|5707298|P3|Overall Study|Graft loss/retransplantation|11
1633726|NCT01843348|5707299|P2|Overall Study|Graft loss/retransplantation|8
1633727|NCT01843348|5707300|P1|Overall Study|Graft loss/retransplantation|5
1633728|NCT01843348|5707298|P3|Overall Study|Death|4
1633729|NCT01843348|5707299|P2|Overall Study|Death|3
1633730|NCT01843348|5707300|P1|Overall Study|Death|5
1633731|NCT01843348|5707298|P3|Overall Study|Lost to Follow-up|2
1633732|NCT01843348|5707299|P2|Overall Study|Lost to Follow-up|4
1633733|NCT01843348|5707300|P1|Overall Study|Lost to Follow-up|5
1633734|NCT01843348|5707298|P3|Overall Study|Withdrawal by Subject|18
1633735|NCT01843348|5707299|P2|Overall Study|Withdrawal by Subject|16
1633736|NCT01843348|5707300|P1|Overall Study|Withdrawal by Subject|4
1633737|NCT01843205|5707340|P2|First Treatment (11 Days)|Withdrawal by Subject|0
1633738|NCT01843205|5707341|P1|First Treatment (11 Days)|Withdrawal by Subject|1
1633739|NCT01843192|5707402|P3|Overall Study|Intra-operative exclusions per protocol|2
1633740|NCT01843192|5707403|P2|Overall Study|Intra-operative exclusions per protocol|6
1633741|NCT01843192|5707404|P1|Overall Study|Intra-operative exclusions per protocol|2
1633742|NCT01843062|5707435|P2|Overall Study|Lost to Follow-up|4
1633743|NCT01843062|5707436|P1|Overall Study|Lost to Follow-up|2
1633744|NCT01843062|5707435|P2|Overall Study|Death|2
1633745|NCT01843062|5707436|P1|Overall Study|Death|1
1633746|NCT01843062|5707435|P2|Overall Study|Withdrawal by Subject|3
1633747|NCT01843062|5707436|P1|Overall Study|Withdrawal by Subject|12
1633748|NCT01843062|5707435|P2|Overall Study|Incorrect randomisation|0
1633749|NCT01843062|5707436|P1|Overall Study|Incorrect randomisation|1
1633750|NCT01843062|5707435|P2|Overall Study|Adverse Event|0
1633751|NCT01843062|5707436|P1|Overall Study|Adverse Event|2
1633752|NCT01843062|5707435|P2|Overall Study|Pregnancy|0
1633753|NCT01843062|5707436|P1|Overall Study|Pregnancy|1
1633754|NCT01843062|5707435|P2|Overall Study|New treatment following progression|0
1633755|NCT01843062|5707436|P1|Overall Study|New treatment following progression|2
1633756|NCT01843062|5707435|P2|Overall Study|Protocol Violation|0
1633757|NCT01843062|5707436|P1|Overall Study|Protocol Violation|1
1633758|NCT01842958|5707450|P2|Overall Study|Lost to Follow-up|1
1633759|NCT01842958|5707451|P1|Overall Study|Lost to Follow-up|1
1633760|NCT01842633|5707526|P3|Overall Study|Technical issues|0
1633761|NCT01842633|5707527|P2|Overall Study|Technical issues|0
1633762|NCT01842633|5707528|P1|Overall Study|Technical issues|1
1633763|NCT01842633|5707526|P3|Overall Study|Withdrawal by Subject|0
1633764|NCT01842633|5707527|P2|Overall Study|Withdrawal by Subject|1
1633765|NCT01842633|5707528|P1|Overall Study|Withdrawal by Subject|0
1633766|NCT01842633|5707526|P3|Overall Study|Adverse Event|0
1633767|NCT01842633|5707527|P2|Overall Study|Adverse Event|1
1633768|NCT01842633|5707528|P1|Overall Study|Adverse Event|1
1633769|NCT01842633|5707526|P3|Overall Study|Screen Failure|0
1633770|NCT01842633|5707527|P2|Overall Study|Screen Failure|0
1633771|NCT01842633|5707528|P1|Overall Study|Screen Failure|1
1633772|NCT01842620|5707575|P2|Period 1|Withdrawal by Subject|0
1633773|NCT01842620|5707576|P1|Period 1|Withdrawal by Subject|1
1633774|NCT01842607|5707592|P1|Overall Study|Withdrawal by Subject|14
1633775|NCT01842607|5707592|P1|Overall Study|Physician Decision|9
1633776|NCT01842607|5707592|P1|Overall Study|Lost to Follow-up|3
1633777|NCT01842607|5707592|P1|Overall Study|Protocol defined stopping criteria|2
1633778|NCT01842607|5707592|P1|Overall Study|Protocol Violation|8
1633779|NCT01842607|5707592|P1|Overall Study|Lack of Efficacy|19
1633780|NCT01842607|5707592|P1|Overall Study|Adverse Event|11
1633781|NCT01842581|5707618|P2|Overall Study|Other than specified|1
1633782|NCT01842581|5707619|P1|Overall Study|Other than specified|3
1633783|NCT01842581|5707618|P2|Overall Study|Withdrawal by Subject|7
1633784|NCT01842581|5707619|P1|Overall Study|Withdrawal by Subject|5
1633785|NCT01842581|5707618|P2|Overall Study|Lost to Follow-up|5
1633786|NCT01842581|5707619|P1|Overall Study|Lost to Follow-up|2
1633787|NCT01842581|5707618|P2|Overall Study|Liver transplant|0
1633788|NCT01842581|5707619|P1|Overall Study|Liver transplant|2
1633789|NCT01842581|5707618|P2|Overall Study|HE breakthrough|13
1633790|NCT01842581|5707619|P1|Overall Study|HE breakthrough|26
1633791|NCT01842581|5707618|P2|Overall Study|Adverse Event|4
1633792|NCT01842581|5707619|P1|Overall Study|Adverse Event|6
1633793|NCT01842438|5707643|P2|T2: 6month Follow-up|Death|1
1633794|NCT01842438|5707644|P1|T2: 6month Follow-up|Death|0
1633795|NCT01842438|5707643|P2|T2: 6month Follow-up|Withdrawal by Subject|3
1633796|NCT01842438|5707644|P1|T2: 6month Follow-up|Withdrawal by Subject|4
1633797|NCT01842438|5707643|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
1633798|NCT01842438|5707644|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
1633799|NCT01842334|5707658|P2|Overall Study|Moved away mid-study|1
1633800|NCT01842334|5707659|P1|Overall Study|Moved away mid-study|0
1633801|NCT01842334|5707658|P2|Overall Study|Withdrawal by Subject|3
1633802|NCT01842334|5707659|P1|Overall Study|Withdrawal by Subject|3
1633803|NCT01841970|5707665|P1|Overall Study|Lost to Follow-up|8
1633804|NCT01841970|5707665|P1|Overall Study|Physician Decision|2
1633805|NCT01841970|5707665|P1|Overall Study|Withdrawal by Subject|1
1633806|NCT01841762|5707689|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
1633807|NCT01841762|5707689|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
1633808|NCT01841762|5707689|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
1633809|NCT01841762|5707689|P1|Post-Treatment Safety Follow-Up Period|Death|1
1633810|NCT01841762|5707689|P1|Treatment Period|Other, including non-compliance|5
1633811|NCT01841762|5707689|P1|Treatment Period|Physician Decision|2
1633812|NCT01841762|5707689|P1|Treatment Period|Lost to Follow-up|1
1633813|NCT01841762|5707689|P1|Treatment Period|Withdrawal by Subject|7
1633814|NCT01841762|5707689|P1|Treatment Period|Death|1
1633815|NCT01841762|5707689|P1|Treatment Period|Adverse Event|16
1633816|NCT01841762|5707689|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
1633817|NCT01841697|5707699|P2|Overall Study|Withdrawal by Subject|16
1633818|NCT01841697|5707700|P1|Overall Study|Withdrawal by Subject|16
1633819|NCT01841697|5707699|P2|Overall Study|Lost to Follow-up|1
1633820|NCT01841697|5707700|P1|Overall Study|Lost to Follow-up|4
1633821|NCT01841697|5707699|P2|Overall Study|Death|1
1633822|NCT01841697|5707700|P1|Overall Study|Death|0
1633823|NCT01841593|5707740|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
1633824|NCT01841593|5707741|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
1633825|NCT01841593|5707740|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
1633826|NCT01841593|5707741|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
1633827|NCT01841567|5707757|P1|Overall Study|Adverse Event|3
1633828|NCT01841073|5707775|P2|Overall Study|Lost to Follow-up|2
1633829|NCT01841073|5707776|P1|Overall Study|Lost to Follow-up|0
1633830|NCT01841073|5707775|P2|Overall Study|Physician Decision|0
1633831|NCT01841073|5707776|P1|Overall Study|Physician Decision|1
1633832|NCT01841073|5707775|P2|Overall Study|Adverse Event|1
1633833|NCT01841073|5707776|P1|Overall Study|Adverse Event|1
1633834|NCT01840943|5707798|P2|Overall Study|Lost to Follow-up|4
1633835|NCT01840943|5707799|P1|Overall Study|Lost to Follow-up|4
1633836|NCT01840943|5707798|P2|Overall Study|Physician Decision|2
1633837|NCT01840943|5707799|P1|Overall Study|Physician Decision|4
1633838|NCT01840943|5707798|P2|Overall Study|Withdrawal by Subject|6
1633839|NCT01840943|5707799|P1|Overall Study|Withdrawal by Subject|5
1633840|NCT01840605|5707848|P2|Overall Study|Physician Decision|1
1633841|NCT01840605|5707849|P1|Overall Study|Physician Decision|2
1633842|NCT01840605|5707848|P2|Overall Study|Adverse Event|1
1633843|NCT01840605|5707849|P1|Overall Study|Adverse Event|0
1633844|NCT01840410|5707863|P2|Overall Study|Adverse Event|1
1633845|NCT01840410|5707864|P1|Overall Study|Adverse Event|1
1633846|NCT01840410|5707863|P2|Overall Study|Withdrawal by Subject|1
1633847|NCT01840410|5707864|P1|Overall Study|Withdrawal by Subject|2
1633848|NCT01840410|5707863|P2|Overall Study|Lost to Follow-up|0
1633849|NCT01840410|5707864|P1|Overall Study|Lost to Follow-up|1
1633850|NCT01840410|5707863|P2|Overall Study|Protocol deviation|0
1633851|NCT01840410|5707864|P1|Overall Study|Protocol deviation|1
1633852|NCT01840410|5707863|P2|Overall Study|Pregnancy|0
1633853|NCT01840410|5707864|P1|Overall Study|Pregnancy|1
1633854|NCT01840410|5707863|P2|Overall Study|Physician Decision|2
1633855|NCT01840410|5707864|P1|Overall Study|Physician Decision|1
1633856|NCT01840228|5707913|P2|Overall Study|Lost to Follow-up|1
1633857|NCT01840228|5707914|P1|Overall Study|Lost to Follow-up|1
1633858|NCT01840163|5707942|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
1633859|NCT01840163|5707943|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
1633860|NCT01840163|5707942|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
1633861|NCT01840163|5707943|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
1633862|NCT01840163|5707942|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
1633863|NCT01840163|5707943|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
1633864|NCT01839916|5707988|P1|Overall Study|Graft Failure|1
1633865|NCT01839916|5707988|P1|Overall Study|GVHD|2
1633866|NCT01839916|5707988|P1|Overall Study|Relapse|12
1633867|NCT01839916|5707988|P1|Overall Study|Physician Decision|17
1633868|NCT01839916|5707988|P1|Overall Study|Death|9
1633869|NCT01839656|5708039|P2|Overall Study|Adverse Event|0
1633870|NCT01839656|5708040|P1|Overall Study|Adverse Event|1
1633871|NCT01839656|5708039|P2|Overall Study|Early study closure|11
1633872|NCT01839656|5708040|P1|Overall Study|Early study closure|0
1633873|NCT01839656|5708039|P2|Overall Study|Adverse event, serious fatal|4
1633874|NCT01839656|5708040|P1|Overall Study|Adverse event, serious fatal|1
1633875|NCT01839656|5708039|P2|Overall Study|Withdrawal by Subject|1
1633876|NCT01839656|5708040|P1|Overall Study|Withdrawal by Subject|1
1633877|NCT01839279|5708128|P3|Overall Study|Classified as 'Other'|0
1633878|NCT01839279|5708129|P2|Overall Study|Classified as 'Other'|0
1633879|NCT01839279|5708130|P1|Overall Study|Classified as 'Other'|5
1633880|NCT01839279|5708128|P3|Overall Study|Withdrawal by Subject|1
1633881|NCT01839279|5708129|P2|Overall Study|Withdrawal by Subject|1
1633882|NCT01839279|5708130|P1|Overall Study|Withdrawal by Subject|4
1633883|NCT01839279|5708128|P3|Overall Study|Adverse Event|1
1633884|NCT01839279|5708129|P2|Overall Study|Adverse Event|1
1633885|NCT01839279|5708130|P1|Overall Study|Adverse Event|4
1633886|NCT01839188|5708149|P1|Overall Study|Withdrawal by Subject|1
1633887|NCT01838941|5708221|P1|Overall Study|Withdrawal by Subject|1
1633888|NCT01838941|5708221|P1|Overall Study|Adverse Event|1
1633889|NCT01838876|5708226|P1|Overall Study|Did not meet eligibility criteria|78
1633890|NCT01838876|5708226|P1|Overall Study|Reason not Specified|7
1633891|NCT01838876|5708226|P1|Overall Study|Study or Site Terminated by Sponsor|1
1633892|NCT01838876|5708226|P1|Overall Study|Lost to Follow-up|21
1633893|NCT01838876|5708226|P1|Overall Study|Withdrawal of Consent|33
1633894|NCT01838876|5708226|P1|Overall Study|Protocol Violation|34
1633895|NCT01838876|5708226|P1|Overall Study|Insufficient Therapeutic Response|10
1633896|NCT01838876|5708226|P1|Overall Study|Adverse Event|49
1633897|NCT01838694|5708335|P2|Overall Study|Adverse Event|1
1633898|NCT01838694|5708336|P1|Overall Study|Adverse Event|0
1633899|NCT01838681|5708345|P4|Period B/A+|Administrative or other reasons|28
1633900|NCT01838681|5708346|P3|Period B/A+|Administrative or other reasons|10
1633901|NCT01838681|5708347|P2|Period B/A+|Administrative or other reasons|6
1633902|NCT01838681|5708348|P1|Period B/A+|Administrative or other reasons|0
1633903|NCT01838681|5708345|P4|Period B/A+|Withdrawal before treatment|0
1633904|NCT01838681|5708346|P3|Period B/A+|Withdrawal before treatment|0
1633905|NCT01838681|5708347|P2|Period B/A+|Withdrawal before treatment|1
1633906|NCT01838681|5708348|P1|Period B/A+|Withdrawal before treatment|0
1633907|NCT01838681|5708345|P4|Period B/A+|Lost to Follow-up|11
1633908|NCT01838681|5708346|P3|Period B/A+|Lost to Follow-up|5
1633909|NCT01838681|5708347|P2|Period B/A+|Lost to Follow-up|2
1633910|NCT01838681|5708348|P1|Period B/A+|Lost to Follow-up|0
1633911|NCT01838681|5708345|P4|Period B/A+|Non-compliance with IMP|3
1633912|NCT01838681|5708346|P3|Period B/A+|Non-compliance with IMP|3
1633913|NCT01838681|5708347|P2|Period B/A+|Non-compliance with IMP|2
1633914|NCT01838681|5708348|P1|Period B/A+|Non-compliance with IMP|0
1633915|NCT01838681|5708345|P4|Period B/A+|Protocol Violation|6
1633916|NCT01838681|5708346|P3|Period B/A+|Protocol Violation|4
1633917|NCT01838681|5708347|P2|Period B/A+|Protocol Violation|1
1633918|NCT01838681|5708348|P1|Period B/A+|Protocol Violation|0
1633919|NCT01838681|5708345|P4|Period B/A+|Withdrawal by Subject|47
1633920|NCT01838681|5708346|P3|Period B/A+|Withdrawal by Subject|35
1633921|NCT01838681|5708347|P2|Period B/A+|Withdrawal by Subject|28
1633922|NCT01838681|5708348|P1|Period B/A+|Withdrawal by Subject|0
1633923|NCT01838681|5708345|P4|Period B/A+|Lack of Efficacy|6
1633924|NCT01838681|5708346|P3|Period B/A+|Lack of Efficacy|11
1633925|NCT01838681|5708347|P2|Period B/A+|Lack of Efficacy|9
1633926|NCT01838681|5708348|P1|Period B/A+|Lack of Efficacy|0
1633927|NCT01838681|5708345|P4|Period B/A+|Adverse Event|16
1633928|NCT01838681|5708346|P3|Period B/A+|Adverse Event|27
1633929|NCT01838681|5708347|P2|Period B/A+|Adverse Event|13
1633930|NCT01838681|5708348|P1|Period B/A+|Adverse Event|0
1633931|NCT01838681|5708345|P4|Period A|Administrative or other reasons|0
1633932|NCT01838681|5708346|P3|Period A|Administrative or other reasons|0
1633933|NCT01838681|5708347|P2|Period A|Administrative or other reasons|0
1633934|NCT01838681|5708348|P1|Period A|Administrative or other reasons|17
1633935|NCT01838681|5708345|P4|Period A|Withdrawal before treatment|0
1633936|NCT01838681|5708346|P3|Period A|Withdrawal before treatment|0
1633937|NCT01838681|5708347|P2|Period A|Withdrawal before treatment|0
1633938|NCT01838681|5708348|P1|Period A|Withdrawal before treatment|4
1633939|NCT01838681|5708345|P4|Period A|Lost to Follow-up|0
1633940|NCT01838681|5708346|P3|Period A|Lost to Follow-up|0
1633941|NCT01838681|5708347|P2|Period A|Lost to Follow-up|0
1633942|NCT01838681|5708348|P1|Period A|Lost to Follow-up|4
1633943|NCT01838681|5708345|P4|Period A|Non-compliance with IMP|0
1633944|NCT01838681|5708346|P3|Period A|Non-compliance with IMP|0
1633945|NCT01838681|5708347|P2|Period A|Non-compliance with IMP|0
1633946|NCT01838681|5708348|P1|Period A|Non-compliance with IMP|6
1633947|NCT01838681|5708345|P4|Period A|Protocol Violation|0
1633948|NCT01838681|5708346|P3|Period A|Protocol Violation|0
1633949|NCT01838681|5708347|P2|Period A|Protocol Violation|0
1633950|NCT01838681|5708348|P1|Period A|Protocol Violation|16
1633951|NCT01838681|5708345|P4|Period A|Withdrawal by Subject|0
1633952|NCT01838681|5708346|P3|Period A|Withdrawal by Subject|0
1633953|NCT01838681|5708347|P2|Period A|Withdrawal by Subject|0
1633954|NCT01838681|5708348|P1|Period A|Withdrawal by Subject|70
1633955|NCT01838681|5708345|P4|Period A|Early response|0
1633956|NCT01838681|5708346|P3|Period A|Early response|0
1633957|NCT01838681|5708347|P2|Period A|Early response|0
1633958|NCT01838681|5708348|P1|Period A|Early response|148
1633959|NCT01838681|5708345|P4|Period A|Lack of Efficacy|0
1633960|NCT01838681|5708346|P3|Period A|Lack of Efficacy|0
1633961|NCT01838681|5708347|P2|Period A|Lack of Efficacy|0
1633962|NCT01838681|5708348|P1|Period A|Lack of Efficacy|21
1633963|NCT01838681|5708345|P4|Period A|Adverse Event|0
1633964|NCT01838681|5708346|P3|Period A|Adverse Event|0
1633965|NCT01838681|5708347|P2|Period A|Adverse Event|0
1633966|NCT01838681|5708348|P1|Period A|Adverse Event|39
1633967|NCT01838642|5708456|P1|Overall Study|Died on study|1
1633968|NCT01838616|5708469|P2|Pick-up Arm|Technical problems|0
1633969|NCT01838616|5708470|P1|Pick-up Arm|Technical problems|1
1633970|NCT01838616|5708469|P2|Pick-up Arm|Withdrawal by Subject|0
1633971|NCT01838616|5708470|P1|Pick-up Arm|Withdrawal by Subject|1
1633972|NCT01838616|5708469|P2|Pick-up Arm|Adverse Event|0
1633973|NCT01838616|5708470|P1|Pick-up Arm|Adverse Event|9
1633974|NCT01838616|5708469|P2|Pick-up Arm|Lack of Efficacy|0
1633975|NCT01838616|5708470|P1|Pick-up Arm|Lack of Efficacy|4
1633976|NCT01838616|5708469|P2|Continuation Period|Technical problems|1
1633977|NCT01838616|5708470|P1|Continuation Period|Technical problems|0
1633978|NCT01838616|5708469|P2|Continuation Period|Withdrawal by Subject|4
1633979|NCT01838616|5708470|P1|Continuation Period|Withdrawal by Subject|0
1633980|NCT01838616|5708469|P2|Continuation Period|Lost to Follow-up|0
1633981|NCT01838616|5708470|P1|Continuation Period|Lost to Follow-up|1
1633982|NCT01838616|5708469|P2|Continuation Period|Protocol Violation|0
1633983|NCT01838616|5708470|P1|Continuation Period|Protocol Violation|2
1633984|NCT01838616|5708469|P2|Continuation Period|Adverse Event|4
1633985|NCT01838616|5708470|P1|Continuation Period|Adverse Event|8
1633986|NCT01838616|5708469|P2|Continuation Period|Lack of Efficacy|5
1633987|NCT01838616|5708470|P1|Continuation Period|Lack of Efficacy|3
1633988|NCT01838616|5708469|P2|Titration Period|Protocol Violation|1
1633989|NCT01838616|5708470|P1|Titration Period|Protocol Violation|0
1633990|NCT01838616|5708469|P2|Titration Period|Other|0
1633991|NCT01838616|5708470|P1|Titration Period|Other|1
1633992|NCT01838616|5708469|P2|Titration Period|Technical problems|0
1633993|NCT01838616|5708470|P1|Titration Period|Technical problems|1
1633994|NCT01838616|5708469|P2|Titration Period|Withdrawal by Subject|5
1633995|NCT01838616|5708470|P1|Titration Period|Withdrawal by Subject|5
1633996|NCT01838616|5708469|P2|Titration Period|Lack of Efficacy|12
1633997|NCT01838616|5708470|P1|Titration Period|Lack of Efficacy|5
1633998|NCT01838616|5708469|P2|Titration Period|Adverse Event|48
1633999|NCT01838616|5708470|P1|Titration Period|Adverse Event|18
1634000|NCT01838590|5708541|P2|Overall Study|Lost to Follow-up|1
1634001|NCT01838590|5708542|P1|Overall Study|Lost to Follow-up|0
1634002|NCT01838590|5708541|P2|Overall Study|Lack of Efficacy|4
1634003|NCT01838590|5708542|P1|Overall Study|Lack of Efficacy|12
1634004|NCT01838499|5708566|P2|Overall Study|Withdrawal by Subject|9
1634005|NCT01838499|5708567|P1|Overall Study|Withdrawal by Subject|19
1634006|NCT01838499|5708566|P2|Overall Study|Adverse Event|1
1634007|NCT01838499|5708567|P1|Overall Study|Adverse Event|2
1634008|NCT01838499|5708566|P2|Overall Study|Lack of Efficacy|2
1634009|NCT01838499|5708567|P1|Overall Study|Lack of Efficacy|1
1634010|NCT01838499|5708566|P2|Overall Study|Lost to Follow-up|4
1634011|NCT01838499|5708567|P1|Overall Study|Lost to Follow-up|2
1634012|NCT01838499|5708566|P2|Overall Study|Protocol Violation|1
1634013|NCT01838499|5708567|P1|Overall Study|Protocol Violation|0
1634014|NCT01838447|5708579|P2|Overall Study|Withdrawal by Subject|1
1634015|NCT01838447|5708580|P1|Overall Study|Withdrawal by Subject|1
1634016|NCT01838447|5708579|P2|Overall Study|Change in surgical plan|2
1634017|NCT01838447|5708580|P1|Overall Study|Change in surgical plan|1
1634018|NCT01838213|5708615|P2|Overall Study|Ineligible|191
1634019|NCT01838213|5708616|P1|Overall Study|Ineligible|166
1634020|NCT01838200|5708624|P2|Overall Study|Progressive disease|0
1634021|NCT01838200|5708625|P1|Overall Study|Progressive disease|3
1634022|NCT01838200|5708624|P2|Overall Study|Adverse Event|2
1634023|NCT01838200|5708625|P1|Overall Study|Adverse Event|0
1634024|NCT01838044|5708637|P2|Overall Study|Lost to Follow-up|2
1634025|NCT01838044|5708638|P1|Overall Study|Lost to Follow-up|0
1634026|NCT01838044|5708637|P2|Overall Study|Medication error without associated AE|1
1634027|NCT01838044|5708638|P1|Overall Study|Medication error without associated AE|0
1634028|NCT01838044|5708637|P2|Overall Study|Insufficient clinical response|2
1634029|NCT01838044|5708638|P1|Overall Study|Insufficient clinical response|1
1634030|NCT01838044|5708637|P2|Overall Study|Withdrawal by Subject|2
1634031|NCT01838044|5708638|P1|Overall Study|Withdrawal by Subject|0
1634032|NCT01838044|5708637|P2|Overall Study|Protocol Violation|3
1634033|NCT01838044|5708638|P1|Overall Study|Protocol Violation|3
1634034|NCT01838044|5708637|P2|Overall Study|Adverse Event|6
1634035|NCT01838044|5708638|P1|Overall Study|Adverse Event|4
1634036|NCT01837966|5708671|P2|Overall Study|Withdrawal by Subject|1
1634037|NCT01837966|5708672|P1|Overall Study|Withdrawal by Subject|2
1634038|NCT01837823|5708678|P1|Overall Study|Lost to Follow-up|6
1634039|NCT01837797|5708709|P5|Period 3|Other|2
1634040|NCT01837797|5708710|P4|Period 3|Other|0
1634041|NCT01837797|5708711|P3|Period 3|Other|0
1634042|NCT01837797|5708712|P2|Period 3|Other|0
1634043|NCT01837797|5708713|P1|Period 3|Other|0
1634044|NCT01837797|5708709|P5|Period 3|Administrative reasons|20
1634045|NCT01837797|5708710|P4|Period 3|Administrative reasons|0
1634046|NCT01837797|5708711|P3|Period 3|Administrative reasons|0
1634047|NCT01837797|5708712|P2|Period 3|Administrative reasons|0
1634048|NCT01837797|5708713|P1|Period 3|Administrative reasons|0
1634049|NCT01837797|5708709|P5|Period 3|Adverse Event|1
1634050|NCT01837797|5708710|P4|Period 3|Adverse Event|0
1634051|NCT01837797|5708711|P3|Period 3|Adverse Event|0
1634052|NCT01837797|5708712|P2|Period 3|Adverse Event|0
1634053|NCT01837797|5708713|P1|Period 3|Adverse Event|0
1634054|NCT01837797|5708709|P5|Period 2|Adverse Event|0
1634055|NCT01837797|5708710|P4|Period 2|Adverse Event|1
1634056|NCT01837797|5708711|P3|Period 2|Adverse Event|0
1634057|NCT01837797|5708712|P2|Period 2|Adverse Event|0
1634058|NCT01837797|5708713|P1|Period 2|Adverse Event|0
1634059|NCT01837797|5708709|P5|Period 2|Administrative or other reasons|0
1634060|NCT01837797|5708710|P4|Period 2|Administrative or other reasons|4
1634061|NCT01837797|5708711|P3|Period 2|Administrative or other reasons|2
1634062|NCT01837797|5708712|P2|Period 2|Administrative or other reasons|5
1634063|NCT01837797|5708713|P1|Period 2|Administrative or other reasons|0
1634064|NCT01837797|5708709|P5|Period 1|Other|0
1634065|NCT01837797|5708710|P4|Period 1|Other|0
1634066|NCT01837797|5708711|P3|Period 1|Other|0
1634067|NCT01837797|5708712|P2|Period 1|Other|0
1634068|NCT01837797|5708713|P1|Period 1|Other|10
1634069|NCT01837797|5708709|P5|Period 1|Withdrawal of consent before treatment|0
1634070|NCT01837797|5708710|P4|Period 1|Withdrawal of consent before treatment|0
1634071|NCT01837797|5708711|P3|Period 1|Withdrawal of consent before treatment|0
1634072|NCT01837797|5708712|P2|Period 1|Withdrawal of consent before treatment|0
1634073|NCT01837797|5708713|P1|Period 1|Withdrawal of consent before treatment|1
1634074|NCT01837797|5708709|P5|Period 1|Administrative reasons|0
1634075|NCT01837797|5708710|P4|Period 1|Administrative reasons|0
1634076|NCT01837797|5708711|P3|Period 1|Administrative reasons|0
1634077|NCT01837797|5708712|P2|Period 1|Administrative reasons|0
1634078|NCT01837797|5708713|P1|Period 1|Administrative reasons|76
1634079|NCT01837797|5708709|P5|Period 1|Withdrawal by Subject|0
1634080|NCT01837797|5708710|P4|Period 1|Withdrawal by Subject|0
1634081|NCT01837797|5708711|P3|Period 1|Withdrawal by Subject|0
1634082|NCT01837797|5708712|P2|Period 1|Withdrawal by Subject|0
1634083|NCT01837797|5708713|P1|Period 1|Withdrawal by Subject|6
1634084|NCT01837797|5708709|P5|Period 1|Adverse Event|0
1634085|NCT01837797|5708710|P4|Period 1|Adverse Event|0
1634086|NCT01837797|5708711|P3|Period 1|Adverse Event|0
1634087|NCT01837797|5708712|P2|Period 1|Adverse Event|0
1634088|NCT01837797|5708713|P1|Period 1|Adverse Event|9
1634089|NCT01837719|5708748|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
1634090|NCT01837719|5708748|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
1634091|NCT01837680|5708817|P2|Overall Study|switched to oral hypoglycemic or diet|4
1634092|NCT01837680|5708818|P1|Overall Study|switched to oral hypoglycemic or diet|2
1634093|NCT01837680|5708817|P2|Overall Study|allergic reaction|0
1634094|NCT01837680|5708818|P1|Overall Study|allergic reaction|6
1634095|NCT01837680|5708817|P2|Overall Study|lack of insurance|2
1634096|NCT01837680|5708818|P1|Overall Study|lack of insurance|0
1634097|NCT01837680|5708817|P2|Overall Study|Lost to Follow-up|2
1634098|NCT01837680|5708818|P1|Overall Study|Lost to Follow-up|2
1634099|NCT01836549|5708937|P7|Overall Study|Patient inevaluable to start therapy|1
1634100|NCT01836549|5708938|P6|Overall Study|Patient inevaluable to start therapy|0
1634101|NCT01836549|5708939|P5|Overall Study|Patient inevaluable to start therapy|0
1634102|NCT01836549|5708940|P4|Overall Study|Patient inevaluable to start therapy|0
1634103|NCT01836549|5708941|P3|Overall Study|Patient inevaluable to start therapy|0
1634104|NCT01836549|5708942|P2|Overall Study|Patient inevaluable to start therapy|0
1634105|NCT01836549|5708943|P1|Overall Study|Patient inevaluable to start therapy|0
1634106|NCT01836549|5708937|P7|Overall Study|Patient declared ineligible|0
1634107|NCT01836549|5708938|P6|Overall Study|Patient declared ineligible|0
1634108|NCT01836549|5708939|P5|Overall Study|Patient declared ineligible|0
1634109|NCT01836549|5708940|P4|Overall Study|Patient declared ineligible|1
1634110|NCT01836549|5708941|P3|Overall Study|Patient declared ineligible|0
1634111|NCT01836549|5708942|P2|Overall Study|Patient declared ineligible|0
1634112|NCT01836549|5708943|P1|Overall Study|Patient declared ineligible|0
1634113|NCT01836549|5708937|P7|Overall Study|Did not receive study drug|0
1634114|NCT01836549|5708938|P6|Overall Study|Did not receive study drug|0
1634115|NCT01836549|5708939|P5|Overall Study|Did not receive study drug|0
1634116|NCT01836549|5708940|P4|Overall Study|Did not receive study drug|0
1634117|NCT01836549|5708941|P3|Overall Study|Did not receive study drug|1
1634118|NCT01836549|5708942|P2|Overall Study|Did not receive study drug|0
1634119|NCT01836549|5708943|P1|Overall Study|Did not receive study drug|0
1634120|NCT01836523|5708967|P4|Overall Study|Unclassified|29
1634121|NCT01836523|5708968|P3|Overall Study|Unclassified|19
1634122|NCT01836523|5708969|P2|Overall Study|Unclassified|28
1634123|NCT01836523|5708970|P1|Overall Study|Unclassified|17
1634124|NCT01836523|5708967|P4|Overall Study|Met Withdrawal Criteria|27
1634125|NCT01836523|5708968|P3|Overall Study|Met Withdrawal Criteria|21
1634126|NCT01836523|5708969|P2|Overall Study|Met Withdrawal Criteria|13
1634127|NCT01836523|5708970|P1|Overall Study|Met Withdrawal Criteria|13
1634128|NCT01836523|5708967|P4|Overall Study|Protocol Violation|4
1634129|NCT01836523|5708968|P3|Overall Study|Protocol Violation|2
1634130|NCT01836523|5708969|P2|Overall Study|Protocol Violation|3
1634131|NCT01836523|5708970|P1|Overall Study|Protocol Violation|6
1634132|NCT01836523|5708967|P4|Overall Study|Adverse Event|14
1634133|NCT01836523|5708968|P3|Overall Study|Adverse Event|49
1634134|NCT01836523|5708969|P2|Overall Study|Adverse Event|41
1634135|NCT01836523|5708970|P1|Overall Study|Adverse Event|15
1634136|NCT01836471|5708997|P5|Overall Study|Non compliance with tx|0
1634137|NCT01836471|5708998|P4|Overall Study|Non compliance with tx|0
1634138|NCT01836471|5708999|P3|Overall Study|Non compliance with tx|0
1634139|NCT01836471|5709000|P2|Overall Study|Non compliance with tx|1
1634140|NCT01836471|5709001|P1|Overall Study|Non compliance with tx|1
1634141|NCT01836471|5708997|P5|Overall Study|Adverse Event|2
1634142|NCT01836471|5708998|P4|Overall Study|Adverse Event|1
1634143|NCT01836471|5708999|P3|Overall Study|Adverse Event|1
1634144|NCT01836471|5709000|P2|Overall Study|Adverse Event|3
1634145|NCT01836471|5709001|P1|Overall Study|Adverse Event|6
1634146|NCT01836471|5708997|P5|Overall Study|Lost to Follow-up|1
1634147|NCT01836471|5708998|P4|Overall Study|Lost to Follow-up|1
1634148|NCT01836471|5708999|P3|Overall Study|Lost to Follow-up|0
1634149|NCT01836471|5709000|P2|Overall Study|Lost to Follow-up|0
1634150|NCT01836471|5709001|P1|Overall Study|Lost to Follow-up|0
1634151|NCT01836471|5708997|P5|Overall Study|Physician Decision|0
1634152|NCT01836471|5708998|P4|Overall Study|Physician Decision|0
1634153|NCT01836471|5708999|P3|Overall Study|Physician Decision|0
1634154|NCT01836471|5709000|P2|Overall Study|Physician Decision|1
1634155|NCT01836471|5709001|P1|Overall Study|Physician Decision|0
1634156|NCT01836471|5708997|P5|Overall Study|Withdrawal by Subject|2
1634157|NCT01836471|5708998|P4|Overall Study|Withdrawal by Subject|0
1634158|NCT01836471|5708999|P3|Overall Study|Withdrawal by Subject|1
1634159|NCT01836471|5709000|P2|Overall Study|Withdrawal by Subject|4
1634160|NCT01836471|5709001|P1|Overall Study|Withdrawal by Subject|3
1634161|NCT01836471|5708997|P5|Overall Study|Pregnancy|0
1634162|NCT01836471|5708998|P4|Overall Study|Pregnancy|0
1634163|NCT01836471|5708999|P3|Overall Study|Pregnancy|0
1634164|NCT01836471|5709000|P2|Overall Study|Pregnancy|0
1634165|NCT01836471|5709001|P1|Overall Study|Pregnancy|1
1634166|NCT01836458|5709030|P4|Overall Study|Unsatisfactory therapeutic effect|6
1634167|NCT01836458|5709031|P3|Overall Study|Unsatisfactory therapeutic effect|5
1634168|NCT01836458|5709032|P2|Overall Study|Unsatisfactory therapeutic effect|2
1634169|NCT01836458|5709033|P1|Overall Study|Unsatisfactory therapeutic effect|3
1634170|NCT01836276|5709118|P2|Overall Study|Lost to Follow-up|51
1634171|NCT01836276|5709119|P1|Overall Study|Lost to Follow-up|28
1634172|NCT01836198|5709127|P3|Part A, Period 2|Protocol Violation|0
1634173|NCT01836198|5709128|P2|Part A, Period 2|Protocol Violation|1
1634174|NCT01836198|5709129|P1|Part A, Period 2|Protocol Violation|0
1634175|NCT01835899|5709231|P3|Overall Study|Other than stated above|0
1634176|NCT01835899|5709232|P2|Overall Study|Other than stated above|1
1634177|NCT01835899|5709233|P1|Overall Study|Other than stated above|0
1634178|NCT01835899|5709231|P3|Overall Study|Adverse Event|1
1634179|NCT01835899|5709232|P2|Overall Study|Adverse Event|0
1634180|NCT01835899|5709233|P1|Overall Study|Adverse Event|0
1634181|NCT01835587|5709279|P4|Overall Study|Miscellaneous|0
1634182|NCT01835587|5709280|P3|Overall Study|Miscellaneous|0
1634183|NCT01835587|5709281|P2|Overall Study|Miscellaneous|1
1634184|NCT01835587|5709282|P1|Overall Study|Miscellaneous|0
1634185|NCT01835587|5709279|P4|Overall Study|Death|1
1634186|NCT01835587|5709280|P3|Overall Study|Death|0
1634187|NCT01835587|5709281|P2|Overall Study|Death|0
1634188|NCT01835587|5709282|P1|Overall Study|Death|0
1634189|NCT01835587|5709279|P4|Overall Study|Adverse Event|2
1634190|NCT01835587|5709280|P3|Overall Study|Adverse Event|2
1634191|NCT01835587|5709281|P2|Overall Study|Adverse Event|0
1634192|NCT01835587|5709282|P1|Overall Study|Adverse Event|0
1634193|NCT01835587|5709279|P4|Overall Study|Withdrawal by Subject|3
1634194|NCT01835587|5709280|P3|Overall Study|Withdrawal by Subject|0
1634195|NCT01835587|5709281|P2|Overall Study|Withdrawal by Subject|0
1634196|NCT01835587|5709282|P1|Overall Study|Withdrawal by Subject|2
1634197|NCT01835587|5709279|P4|Overall Study|Disease Recurrence or Relapse|3
1634198|NCT01835587|5709280|P3|Overall Study|Disease Recurrence or Relapse|0
1634199|NCT01835587|5709281|P2|Overall Study|Disease Recurrence or Relapse|3
1634200|NCT01835587|5709282|P1|Overall Study|Disease Recurrence or Relapse|0
1634201|NCT01835548|5709343|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
1634202|NCT01835548|5709344|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1634203|NCT01835548|5709345|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1634204|NCT01835548|5709343|P3|Double-Blind Treatment Period|Adverse Event|0
1634205|NCT01835548|5709344|P2|Double-Blind Treatment Period|Adverse Event|1
1634206|NCT01835548|5709345|P1|Double-Blind Treatment Period|Adverse Event|0
1634207|NCT01835548|5709343|P3|Dose Optimization Period|Withdrawal by Subject|1
1634208|NCT01835548|5709344|P2|Dose Optimization Period|Withdrawal by Subject|0
1634209|NCT01835548|5709345|P1|Dose Optimization Period|Withdrawal by Subject|0
1634210|NCT01835548|5709343|P3|Dose Optimization Period|Adverse Event|1
1634211|NCT01835548|5709344|P2|Dose Optimization Period|Adverse Event|0
1634212|NCT01835548|5709345|P1|Dose Optimization Period|Adverse Event|0
1634213|NCT01835470|5709374|P1|Long Term Treatment Period|Lack of Efficacy|3
1634214|NCT01835470|5709374|P1|Long Term Treatment Period|Subject Request to Discontinue|1
1634215|NCT01835431|5709386|P2|Overall Study|Protocol Violation|0
1634216|NCT01835431|5709387|P1|Overall Study|Protocol Violation|1
1634217|NCT01835431|5709386|P2|Overall Study|Withdrawal by Subject|10
1634218|NCT01835431|5709387|P1|Overall Study|Withdrawal by Subject|6
1634219|NCT01835431|5709386|P2|Overall Study|other|2
1634220|NCT01835431|5709387|P1|Overall Study|other|0
1634221|NCT01835431|5709386|P2|Overall Study|Adverse Event|0
1634222|NCT01835431|5709387|P1|Overall Study|Adverse Event|1
1634223|NCT01835158|5709427|P2|Overall Study|Withdrawal by Subject|6
1634224|NCT01835158|5709428|P1|Overall Study|Withdrawal by Subject|1
1634225|NCT01835145|5709440|P2|Overall Study|Ineligible prior to treatment|0
1634226|NCT01835145|5709441|P1|Overall Study|Ineligible prior to treatment|1
1634227|NCT01835132|5709456|P1|Initial Phase|Insufficient Therapeutic Response|2
1634228|NCT01835015|5709501|P5|Overall Study|Adverse Event|0
1634229|NCT01835015|5709502|P4|Overall Study|Adverse Event|0
1634230|NCT01835015|5709503|P3|Overall Study|Adverse Event|1
1634231|NCT01835015|5709504|P2|Overall Study|Adverse Event|0
1634232|NCT01835015|5709505|P1|Overall Study|Adverse Event|0
1634233|NCT01834729|5709582|P4|Overall Study|Adverse Event|2
1634234|NCT01834729|5709583|P3|Overall Study|Adverse Event|0
1634235|NCT01834729|5709584|P2|Overall Study|Adverse Event|0
1634236|NCT01834729|5709585|P1|Overall Study|Adverse Event|0
1634237|NCT01834729|5709582|P4|Overall Study|Withdrawal by Subject|0
1634238|NCT01834729|5709583|P3|Overall Study|Withdrawal by Subject|0
1634239|NCT01834729|5709584|P2|Overall Study|Withdrawal by Subject|1
1634240|NCT01834729|5709585|P1|Overall Study|Withdrawal by Subject|1
1634241|NCT01834729|5709582|P4|Overall Study|Did not return bowel diaries|0
1634242|NCT01834729|5709583|P3|Overall Study|Did not return bowel diaries|3
1634243|NCT01834729|5709584|P2|Overall Study|Did not return bowel diaries|0
1634244|NCT01834729|5709585|P1|Overall Study|Did not return bowel diaries|0
1634245|NCT01834586|5709618|P1|Overall Study|Adverse Event|1
1634246|NCT01834274|5709658|P2|Overall Study|Other|1
1634247|NCT01834274|5709659|P1|Overall Study|Other|2
1634248|NCT01834274|5709658|P2|Overall Study|Lost to Follow-up|1
1634249|NCT01834274|5709659|P1|Overall Study|Lost to Follow-up|3
1634250|NCT01834274|5709658|P2|Overall Study|Withdrawal by Subject|1
1634251|NCT01834274|5709659|P1|Overall Study|Withdrawal by Subject|1
1634252|NCT01834274|5709658|P2|Overall Study|Study Termination|38
1634253|NCT01834274|5709659|P1|Overall Study|Study Termination|41
1634254|NCT01834222|5709682|P1|Overall Study|Not meet inclusion/exclusion criteria|1
1634255|NCT01833897|5709777|P1|Overall Study|Lack of Efficacy|1
1634256|NCT01833832|5709789|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
1634257|NCT01833533|5709944|P2|Overall Study|Other|7
1634258|NCT01833533|5709945|P1|Overall Study|Other|2
1634259|NCT01833533|5709944|P2|Overall Study|To Enter an Extension Study|4
1634260|NCT01833533|5709945|P1|Overall Study|To Enter an Extension Study|0
1634261|NCT01833533|5709944|P2|Overall Study|Lost to Follow-up|9
1634262|NCT01833533|5709945|P1|Overall Study|Lost to Follow-up|4
1634263|NCT01833533|5709944|P2|Overall Study|Adverse Event|1
1634264|NCT01833533|5709945|P1|Overall Study|Adverse Event|0
1634265|NCT01833494|5709959|P1|Overall Study|Increase in serum ferritin|1
1634266|NCT01833494|5709959|P1|Overall Study|Decrease in serum calcium|4
1634267|NCT01833494|5709959|P1|Overall Study|Decrease in serum phosphorus|4
1634268|NCT01833494|5709959|P1|Overall Study|Withdrawal by Subject|6
1634269|NCT01833494|5709959|P1|Overall Study|Physician Decision|6
1634270|NCT01833494|5709959|P1|Overall Study|Adverse Event|24
1634271|NCT01833455|5709987|P2|Overall Study|Withdrawal by Subject|0
1634272|NCT01833455|5709988|P1|Overall Study|Withdrawal by Subject|1
1634273|NCT01833169|5710017|P1|Overall Study|Physician Decision|2
1634274|NCT01833169|5710017|P1|Overall Study|Death|3
1634275|NCT01833169|5710017|P1|Overall Study|Withdrawal by Subject|9
1634276|NCT01833169|5710017|P1|Overall Study|Adverse Event|33
1634277|NCT01833169|5710017|P1|Overall Study|Disease Progression|99
1634278|NCT01833065|5710086|P5|Overall Study|Others|4
1634279|NCT01833065|5710087|P4|Overall Study|Others|1
1634280|NCT01833065|5710088|P3|Overall Study|Others|1
1634281|NCT01833065|5710089|P2|Overall Study|Others|1
1634282|NCT01833065|5710090|P1|Overall Study|Others|2
1634283|NCT01833065|5710086|P5|Overall Study|Trial terminated by sponsor|13
1634284|NCT01833065|5710087|P4|Overall Study|Trial terminated by sponsor|3
1634285|NCT01833065|5710088|P3|Overall Study|Trial terminated by sponsor|7
1634286|NCT01833065|5710089|P2|Overall Study|Trial terminated by sponsor|8
1634287|NCT01833065|5710090|P1|Overall Study|Trial terminated by sponsor|8
1634288|NCT01833065|5710086|P5|Overall Study|Subject's substantial non-compliance|0
1634289|NCT01833065|5710087|P4|Overall Study|Subject's substantial non-compliance|0
1634290|NCT01833065|5710088|P3|Overall Study|Subject's substantial non-compliance|0
1634291|NCT01833065|5710089|P2|Overall Study|Subject's substantial non-compliance|1
1634292|NCT01833065|5710090|P1|Overall Study|Subject's substantial non-compliance|0
1634293|NCT01833065|5710086|P5|Overall Study|Withdrawal by Subject|11
1634294|NCT01833065|5710087|P4|Overall Study|Withdrawal by Subject|3
1634295|NCT01833065|5710088|P3|Overall Study|Withdrawal by Subject|4
1634296|NCT01833065|5710089|P2|Overall Study|Withdrawal by Subject|2
1634297|NCT01833065|5710090|P1|Overall Study|Withdrawal by Subject|6
1634298|NCT01833065|5710086|P5|Overall Study|Lost to Follow-up|3
1634299|NCT01833065|5710087|P4|Overall Study|Lost to Follow-up|0
1634300|NCT01833065|5710088|P3|Overall Study|Lost to Follow-up|0
1634301|NCT01833065|5710089|P2|Overall Study|Lost to Follow-up|0
1634302|NCT01833065|5710090|P1|Overall Study|Lost to Follow-up|1
1634303|NCT01833065|5710086|P5|Overall Study|Protocol Violation|2
1634304|NCT01833065|5710087|P4|Overall Study|Protocol Violation|0
1634305|NCT01833065|5710088|P3|Overall Study|Protocol Violation|0
1634306|NCT01833065|5710089|P2|Overall Study|Protocol Violation|0
1634307|NCT01833065|5710090|P1|Overall Study|Protocol Violation|1
1634308|NCT01833065|5710086|P5|Overall Study|Adverse Event|3
1634309|NCT01833065|5710087|P4|Overall Study|Adverse Event|2
1634310|NCT01833065|5710088|P3|Overall Study|Adverse Event|0
1634311|NCT01833065|5710089|P2|Overall Study|Adverse Event|1
1634312|NCT01833065|5710090|P1|Overall Study|Adverse Event|6
1634313|NCT01832818|5710130|P1|Overall Study|Lost to Follow-up|6
1634314|NCT01832766|5710139|P2|Washout|Lost to Follow-up|1
1634315|NCT01832766|5710140|P1|Washout|Lost to Follow-up|0
1634316|NCT01832493|5710234|P1|Overall Study|Unable to place LV lead|2
1634317|NCT01832493|5710234|P1|Overall Study|Protocol Violation|4
1634318|NCT01832493|5710234|P1|Overall Study|Physician Decision|2
1634319|NCT01832480|5710243|P2|Overall Study|post randomization ineligible|10
1634320|NCT01832480|5710244|P1|Overall Study|post randomization ineligible|8
1634321|NCT01832480|5710243|P2|Overall Study|Withdrawal by Subject|2
1634322|NCT01832480|5710244|P1|Overall Study|Withdrawal by Subject|0
1634323|NCT01832480|5710243|P2|Overall Study|Lost to Follow-up|30
1634324|NCT01832480|5710244|P1|Overall Study|Lost to Follow-up|33
1634325|NCT01832155|5710265|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
1634326|NCT01832155|5710266|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
1634327|NCT01832155|5710265|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
1634328|NCT01832155|5710266|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
1634329|NCT01831856|5710369|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
1634330|NCT01831856|5710370|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
1634331|NCT01831856|5710369|P2|Overall Study|Lack of Efficacy|11
1634332|NCT01831856|5710370|P1|Overall Study|Lack of Efficacy|13
1634333|NCT01831856|5710369|P2|Overall Study|Adverse Event|8
1634334|NCT01831856|5710370|P1|Overall Study|Adverse Event|5
1634335|NCT01831817|5710380|P4|Overall Study|Withdrawl of Consent|0
1634336|NCT01831817|5710381|P3|Overall Study|Withdrawl of Consent|0
1634337|NCT01831817|5710382|P2|Overall Study|Withdrawl of Consent|0
1634338|NCT01831817|5710383|P1|Overall Study|Withdrawl of Consent|3
1634339|NCT01831817|5710380|P4|Overall Study|Lost to Follow-up|0
1634340|NCT01831817|5710381|P3|Overall Study|Lost to Follow-up|0
1634341|NCT01831817|5710382|P2|Overall Study|Lost to Follow-up|0
1634342|NCT01831817|5710383|P1|Overall Study|Lost to Follow-up|1
1634343|NCT01831804|5710430|P9|Overall Study|Withdrew Consent|0
1634344|NCT01831804|5710431|P8|Overall Study|Withdrew Consent|2
1634345|NCT01831804|5710432|P7|Overall Study|Withdrew Consent|0
1634346|NCT01831804|5710433|P6|Overall Study|Withdrew Consent|0
1634347|NCT01831804|5710434|P5|Overall Study|Withdrew Consent|0
1634348|NCT01831804|5710435|P4|Overall Study|Withdrew Consent|0
1634349|NCT01831804|5710436|P3|Overall Study|Withdrew Consent|0
1634350|NCT01831804|5710437|P2|Overall Study|Withdrew Consent|1
1634351|NCT01831804|5710438|P1|Overall Study|Withdrew Consent|0
1634352|NCT01831804|5710430|P9|Overall Study|Investigator discretion|0
1634353|NCT01831804|5710431|P8|Overall Study|Investigator discretion|1
1634354|NCT01831804|5710432|P7|Overall Study|Investigator discretion|0
1634355|NCT01831804|5710433|P6|Overall Study|Investigator discretion|0
1634356|NCT01831804|5710434|P5|Overall Study|Investigator discretion|1
1634357|NCT01831804|5710435|P4|Overall Study|Investigator discretion|0
1634358|NCT01831804|5710436|P3|Overall Study|Investigator discretion|0
1634359|NCT01831804|5710437|P2|Overall Study|Investigator discretion|0
1634360|NCT01831804|5710438|P1|Overall Study|Investigator discretion|0
1634361|NCT01831804|5710430|P9|Overall Study|Lost to Follow-up|1
1634362|NCT01831804|5710431|P8|Overall Study|Lost to Follow-up|0
1634363|NCT01831804|5710432|P7|Overall Study|Lost to Follow-up|0
1634364|NCT01831804|5710433|P6|Overall Study|Lost to Follow-up|0
1634365|NCT01831804|5710434|P5|Overall Study|Lost to Follow-up|0
1634366|NCT01831804|5710435|P4|Overall Study|Lost to Follow-up|0
1634367|NCT01831804|5710436|P3|Overall Study|Lost to Follow-up|1
1634368|NCT01831804|5710437|P2|Overall Study|Lost to Follow-up|0
1634369|NCT01831804|5710438|P1|Overall Study|Lost to Follow-up|0
1634370|NCT01831804|5710430|P9|Overall Study|Protocol defined stopping criteria|0
1634371|NCT01831804|5710431|P8|Overall Study|Protocol defined stopping criteria|0
1634372|NCT01831804|5710432|P7|Overall Study|Protocol defined stopping criteria|0
1634373|NCT01831804|5710433|P6|Overall Study|Protocol defined stopping criteria|0
1634374|NCT01831804|5710434|P5|Overall Study|Protocol defined stopping criteria|1
1634375|NCT01831804|5710435|P4|Overall Study|Protocol defined stopping criteria|0
1634376|NCT01831804|5710436|P3|Overall Study|Protocol defined stopping criteria|3
1634377|NCT01831804|5710437|P2|Overall Study|Protocol defined stopping criteria|1
1634378|NCT01831804|5710438|P1|Overall Study|Protocol defined stopping criteria|1
1634379|NCT01831804|5710430|P9|Overall Study|Protocol Violation|0
1634380|NCT01831804|5710431|P8|Overall Study|Protocol Violation|0
1634381|NCT01831804|5710432|P7|Overall Study|Protocol Violation|0
1634382|NCT01831804|5710433|P6|Overall Study|Protocol Violation|0
1634383|NCT01831804|5710434|P5|Overall Study|Protocol Violation|0
1634384|NCT01831804|5710435|P4|Overall Study|Protocol Violation|0
1634385|NCT01831804|5710436|P3|Overall Study|Protocol Violation|2
1634386|NCT01831804|5710437|P2|Overall Study|Protocol Violation|0
1634387|NCT01831804|5710438|P1|Overall Study|Protocol Violation|0
1634388|NCT01831804|5710430|P9|Overall Study|Adverse Event|1
1634389|NCT01831804|5710431|P8|Overall Study|Adverse Event|0
1634390|NCT01831804|5710432|P7|Overall Study|Adverse Event|1
1634391|NCT01831804|5710433|P6|Overall Study|Adverse Event|0
1634392|NCT01831804|5710434|P5|Overall Study|Adverse Event|0
1634393|NCT01831804|5710435|P4|Overall Study|Adverse Event|0
1634394|NCT01831804|5710436|P3|Overall Study|Adverse Event|0
1634395|NCT01831804|5710437|P2|Overall Study|Adverse Event|0
1634396|NCT01831804|5710438|P1|Overall Study|Adverse Event|0
1634397|NCT01831791|5710533|P1|Overall Study|Withdrawal by Subject|10
1634398|NCT01831765|5710562|P3|Overall Study|Lost to Follow-up|3
1634399|NCT01831765|5710563|P2|Overall Study|Lost to Follow-up|3
1634400|NCT01831765|5710564|P1|Overall Study|Lost to Follow-up|2
1634401|NCT01831765|5710562|P3|Overall Study|Withdrawal criteria|16
1634402|NCT01831765|5710563|P2|Overall Study|Withdrawal criteria|10
1634403|NCT01831765|5710564|P1|Overall Study|Withdrawal criteria|12
1634404|NCT01831765|5710562|P3|Overall Study|Withdrawal by Subject|17
1634405|NCT01831765|5710563|P2|Overall Study|Withdrawal by Subject|7
1634406|NCT01831765|5710564|P1|Overall Study|Withdrawal by Subject|22
1634407|NCT01831765|5710562|P3|Overall Study|Adverse Event|3
1634408|NCT01831765|5710563|P2|Overall Study|Adverse Event|3
1634409|NCT01831765|5710564|P1|Overall Study|Adverse Event|5
1634410|NCT01831765|5710562|P3|Overall Study|Other, site closed|0
1634411|NCT01831765|5710563|P2|Overall Study|Other, site closed|1
1634412|NCT01831765|5710564|P1|Overall Study|Other, site closed|1
1634413|NCT01831765|5710562|P3|Overall Study|Death|1
1634414|NCT01831765|5710563|P2|Overall Study|Death|1
1634415|NCT01831765|5710564|P1|Overall Study|Death|0
1634416|NCT01831765|5710562|P3|Overall Study|Pregnancy|2
1634417|NCT01831765|5710563|P2|Overall Study|Pregnancy|1
1634418|NCT01831765|5710564|P1|Overall Study|Pregnancy|1
1634419|NCT01831765|5710562|P3|Overall Study|Other, sponsor withdrew subject|0
1634420|NCT01831765|5710563|P2|Overall Study|Other, sponsor withdrew subject|1
1634421|NCT01831765|5710564|P1|Overall Study|Other, sponsor withdrew subject|0
1634422|NCT01831765|5710562|P3|Overall Study|Lack of Efficacy|0
1634423|NCT01831765|5710563|P2|Overall Study|Lack of Efficacy|0
1634424|NCT01831765|5710564|P1|Overall Study|Lack of Efficacy|1
1634425|NCT01831726|5710590|P1|Overall Study|Subject/guardian decision|7
1634426|NCT01831726|5710590|P1|Overall Study|Physician Decision|1
1634427|NCT01831726|5710590|P1|Overall Study|Disease Progression|49
1634428|NCT01831726|5710590|P1|Overall Study|Death|7
1634429|NCT01831726|5710590|P1|Overall Study|Adverse Event|16
1634430|NCT01831466|5710609|P12|Overall Study|Adverse Event|2
1634431|NCT01831466|5710610|P11|Overall Study|Adverse Event|0
1634432|NCT01831466|5710611|P10|Overall Study|Adverse Event|1
1634433|NCT01831466|5710612|P9|Overall Study|Adverse Event|1
1634434|NCT01831466|5710613|P8|Overall Study|Adverse Event|1
1634435|NCT01831466|5710614|P7|Overall Study|Adverse Event|0
1634436|NCT01831466|5710615|P6|Overall Study|Adverse Event|7
1634437|NCT01831466|5710616|P5|Overall Study|Adverse Event|3
1634438|NCT01831466|5710617|P4|Overall Study|Adverse Event|6
1634439|NCT01831466|5710618|P3|Overall Study|Adverse Event|4
1634440|NCT01831466|5710619|P2|Overall Study|Adverse Event|0
1634441|NCT01831466|5710620|P1|Overall Study|Adverse Event|0
1634442|NCT01831466|5710609|P12|Overall Study|Lack of Efficacy|0
1634443|NCT01831466|5710610|P11|Overall Study|Lack of Efficacy|2
1634444|NCT01831466|5710611|P10|Overall Study|Lack of Efficacy|2
1634445|NCT01831466|5710612|P9|Overall Study|Lack of Efficacy|2
1634446|NCT01831466|5710613|P8|Overall Study|Lack of Efficacy|1
1634447|NCT01831466|5710614|P7|Overall Study|Lack of Efficacy|1
1634448|NCT01831466|5710615|P6|Overall Study|Lack of Efficacy|8
1634449|NCT01831466|5710616|P5|Overall Study|Lack of Efficacy|9
1634450|NCT01831466|5710617|P4|Overall Study|Lack of Efficacy|6
1634451|NCT01831466|5710618|P3|Overall Study|Lack of Efficacy|7
1634452|NCT01831466|5710619|P2|Overall Study|Lack of Efficacy|8
1634453|NCT01831466|5710620|P1|Overall Study|Lack of Efficacy|5
1634454|NCT01831466|5710609|P12|Overall Study|Lost to Follow-up|1
1634455|NCT01831466|5710610|P11|Overall Study|Lost to Follow-up|0
1634456|NCT01831466|5710611|P10|Overall Study|Lost to Follow-up|1
1634457|NCT01831466|5710612|P9|Overall Study|Lost to Follow-up|0
1634458|NCT01831466|5710613|P8|Overall Study|Lost to Follow-up|0
1634459|NCT01831466|5710614|P7|Overall Study|Lost to Follow-up|0
1634460|NCT01831466|5710615|P6|Overall Study|Lost to Follow-up|3
1634461|NCT01831466|5710616|P5|Overall Study|Lost to Follow-up|0
1634462|NCT01831466|5710617|P4|Overall Study|Lost to Follow-up|2
1634463|NCT01831466|5710618|P3|Overall Study|Lost to Follow-up|4
1634464|NCT01831466|5710619|P2|Overall Study|Lost to Follow-up|1
1634465|NCT01831466|5710620|P1|Overall Study|Lost to Follow-up|0
1634466|NCT01831466|5710609|P12|Overall Study|Withdrawal by Subject|1
1634467|NCT01831466|5710610|P11|Overall Study|Withdrawal by Subject|0
1634468|NCT01831466|5710611|P10|Overall Study|Withdrawal by Subject|1
1634469|NCT01831466|5710612|P9|Overall Study|Withdrawal by Subject|0
1634470|NCT01831466|5710613|P8|Overall Study|Withdrawal by Subject|0
1634471|NCT01831466|5710614|P7|Overall Study|Withdrawal by Subject|0
1634472|NCT01831466|5710615|P6|Overall Study|Withdrawal by Subject|5
1634473|NCT01831466|5710616|P5|Overall Study|Withdrawal by Subject|3
1634474|NCT01831466|5710617|P4|Overall Study|Withdrawal by Subject|3
1634475|NCT01831466|5710618|P3|Overall Study|Withdrawal by Subject|3
1634476|NCT01831466|5710619|P2|Overall Study|Withdrawal by Subject|3
1634477|NCT01831466|5710620|P1|Overall Study|Withdrawal by Subject|6
1634478|NCT01831466|5710609|P12|Overall Study|Death|0
1634479|NCT01831466|5710610|P11|Overall Study|Death|0
1634480|NCT01831466|5710611|P10|Overall Study|Death|0
1634481|NCT01831466|5710612|P9|Overall Study|Death|0
1634482|NCT01831466|5710613|P8|Overall Study|Death|0
1634483|NCT01831466|5710614|P7|Overall Study|Death|0
1634484|NCT01831466|5710615|P6|Overall Study|Death|0
1634485|NCT01831466|5710616|P5|Overall Study|Death|0
1634486|NCT01831466|5710617|P4|Overall Study|Death|0
1634487|NCT01831466|5710618|P3|Overall Study|Death|0
1634488|NCT01831466|5710619|P2|Overall Study|Death|1
1634489|NCT01831466|5710620|P1|Overall Study|Death|0
1634490|NCT01831466|5710609|P12|Overall Study|Non-compliance with study treatment|0
1634491|NCT01831466|5710610|P11|Overall Study|Non-compliance with study treatment|0
1634492|NCT01831466|5710611|P10|Overall Study|Non-compliance with study treatment|0
1634493|NCT01831466|5710612|P9|Overall Study|Non-compliance with study treatment|0
1634494|NCT01831466|5710613|P8|Overall Study|Non-compliance with study treatment|0
1634495|NCT01831466|5710614|P7|Overall Study|Non-compliance with study treatment|0
1634496|NCT01831466|5710615|P6|Overall Study|Non-compliance with study treatment|1
1634497|NCT01831466|5710616|P5|Overall Study|Non-compliance with study treatment|0
1634498|NCT01831466|5710617|P4|Overall Study|Non-compliance with study treatment|0
1634499|NCT01831466|5710618|P3|Overall Study|Non-compliance with study treatment|1
1634500|NCT01831466|5710619|P2|Overall Study|Non-compliance with study treatment|1
1634501|NCT01831466|5710620|P1|Overall Study|Non-compliance with study treatment|2
1634502|NCT01831466|5710609|P12|Overall Study|Other|0
1634503|NCT01831466|5710610|P11|Overall Study|Other|0
1634504|NCT01831466|5710611|P10|Overall Study|Other|0
1634505|NCT01831466|5710612|P9|Overall Study|Other|0
1634506|NCT01831466|5710613|P8|Overall Study|Other|0
1634507|NCT01831466|5710614|P7|Overall Study|Other|0
1634508|NCT01831466|5710615|P6|Overall Study|Other|1
1634509|NCT01831466|5710616|P5|Overall Study|Other|2
1634510|NCT01831466|5710617|P4|Overall Study|Other|2
1634511|NCT01831466|5710618|P3|Overall Study|Other|2
1634512|NCT01831466|5710619|P2|Overall Study|Other|3
1634513|NCT01831466|5710620|P1|Overall Study|Other|2
1634514|NCT01831466|5710609|P12|Overall Study|Protocol Violation|0
1634515|NCT01831466|5710610|P11|Overall Study|Protocol Violation|0
1634516|NCT01831466|5710611|P10|Overall Study|Protocol Violation|0
1634517|NCT01831466|5710612|P9|Overall Study|Protocol Violation|0
1634518|NCT01831466|5710613|P8|Overall Study|Protocol Violation|0
1634519|NCT01831466|5710614|P7|Overall Study|Protocol Violation|0
1634520|NCT01831466|5710615|P6|Overall Study|Protocol Violation|1
1634521|NCT01831466|5710616|P5|Overall Study|Protocol Violation|0
1634522|NCT01831466|5710617|P4|Overall Study|Protocol Violation|0
1634523|NCT01831466|5710618|P3|Overall Study|Protocol Violation|2
1634524|NCT01831466|5710619|P2|Overall Study|Protocol Violation|1
1634525|NCT01831466|5710620|P1|Overall Study|Protocol Violation|1
1634526|NCT01831258|5710742|P2|Overall Study|Lost to Follow-up|2
1634527|NCT01831258|5710743|P1|Overall Study|Lost to Follow-up|3
1634528|NCT01831258|5710742|P2|Overall Study|Withdrawal by Subject|1
1634529|NCT01831258|5710743|P1|Overall Study|Withdrawal by Subject|2
1634530|NCT01830972|5710838|P2|Part IV|Non-Compliance|0
1634531|NCT01830972|5710839|P1|Part IV|Non-Compliance|1
1634532|NCT01830972|5710838|P2|Part IV|Withdrawal by Subject|1
1634533|NCT01830972|5710839|P1|Part IV|Withdrawal by Subject|2
1634534|NCT01830972|5710838|P2|Part III|Noncompliance|0
1634535|NCT01830972|5710839|P1|Part III|Noncompliance|1
1634536|NCT01830972|5710838|P2|Part III|Withdrawal by Subject|0
1634537|NCT01830972|5710839|P1|Part III|Withdrawal by Subject|1
1634538|NCT01830972|5710838|P2|Part II|Withdrawal by Subject|2
1634539|NCT01830972|5710839|P1|Part II|Withdrawal by Subject|2
1634540|NCT01830920|5710883|P5|Overall Study|Other|3
1634541|NCT01830920|5710884|P4|Overall Study|Other|5
1634542|NCT01830920|5710885|P3|Overall Study|Other|1
1634543|NCT01830920|5710886|P2|Overall Study|Other|1
1634544|NCT01830920|5710887|P1|Overall Study|Other|15
1634545|NCT01830920|5710883|P5|Overall Study|Death|4
1634546|NCT01830920|5710884|P4|Overall Study|Death|4
1634547|NCT01830920|5710885|P3|Overall Study|Death|5
1634548|NCT01830920|5710886|P2|Overall Study|Death|3
1634549|NCT01830920|5710887|P1|Overall Study|Death|3
1634550|NCT01830920|5710883|P5|Overall Study|Withdrawal by Subject|1
1634551|NCT01830920|5710884|P4|Overall Study|Withdrawal by Subject|7
1634552|NCT01830920|5710885|P3|Overall Study|Withdrawal by Subject|1
1634553|NCT01830920|5710886|P2|Overall Study|Withdrawal by Subject|2
1634554|NCT01830920|5710887|P1|Overall Study|Withdrawal by Subject|2
1634555|NCT01830920|5710883|P5|Overall Study|Adverse Event|0
1634556|NCT01830920|5710884|P4|Overall Study|Adverse Event|0
1634557|NCT01830920|5710885|P3|Overall Study|Adverse Event|1
1634558|NCT01830920|5710886|P2|Overall Study|Adverse Event|0
1634559|NCT01830920|5710887|P1|Overall Study|Adverse Event|1
1634560|NCT01830881|5710926|P2|Overall Study|Changed decision to have an abortion|1
1634561|NCT01830881|5710927|P1|Overall Study|Changed decision to have an abortion|0
1634562|NCT01830855|5710975|P4|Overall Study|Lost to Follow-up|33
1634563|NCT01830855|5710976|P3|Overall Study|Lost to Follow-up|23
1634564|NCT01830855|5710977|P2|Overall Study|Lost to Follow-up|20
1634565|NCT01830855|5710978|P1|Overall Study|Lost to Follow-up|47
1634566|NCT01830855|5710975|P4|Overall Study|No longer willing to participate|17
1634567|NCT01830855|5710976|P3|Overall Study|No longer willing to participate|12
1634568|NCT01830855|5710977|P2|Overall Study|No longer willing to participate|13
1634569|NCT01830855|5710978|P1|Overall Study|No longer willing to participate|32
1634570|NCT01830855|5710975|P4|Overall Study|Withdrawal by Subject|12
1634571|NCT01830855|5710976|P3|Overall Study|Withdrawal by Subject|10
1634572|NCT01830855|5710977|P2|Overall Study|Withdrawal by Subject|14
1634573|NCT01830855|5710978|P1|Overall Study|Withdrawal by Subject|33
1634574|NCT01830855|5710975|P4|Overall Study|Protocol deviation|6
1634575|NCT01830855|5710976|P3|Overall Study|Protocol deviation|6
1634576|NCT01830855|5710977|P2|Overall Study|Protocol deviation|5
1634577|NCT01830855|5710978|P1|Overall Study|Protocol deviation|10
1634578|NCT01830855|5710975|P4|Overall Study|Adverse Event|3
1634579|NCT01830855|5710976|P3|Overall Study|Adverse Event|6
1634580|NCT01830855|5710977|P2|Overall Study|Adverse Event|5
1634581|NCT01830855|5710978|P1|Overall Study|Adverse Event|11
1634582|NCT01830855|5710975|P4|Overall Study|No longer meets eligibility criteria|5
1634583|NCT01830855|5710976|P3|Overall Study|No longer meets eligibility criteria|3
1634584|NCT01830855|5710977|P2|Overall Study|No longer meets eligibility criteria|2
1634585|NCT01830855|5710978|P1|Overall Study|No longer meets eligibility criteria|11
1634586|NCT01830855|5710975|P4|Overall Study|Pregnancy|1
1634587|NCT01830855|5710976|P3|Overall Study|Pregnancy|2
1634588|NCT01830855|5710977|P2|Overall Study|Pregnancy|1
1634589|NCT01830855|5710978|P1|Overall Study|Pregnancy|3
1634590|NCT01830855|5710975|P4|Overall Study|Medication error without associated AE|1
1634591|NCT01830855|5710976|P3|Overall Study|Medication error without associated AE|0
1634592|NCT01830855|5710977|P2|Overall Study|Medication error without associated AE|0
1634593|NCT01830855|5710978|P1|Overall Study|Medication error without associated AE|1
1634594|NCT01830855|5710975|P4|Overall Study|Other|4
1634595|NCT01830855|5710976|P3|Overall Study|Other|4
1634596|NCT01830855|5710977|P2|Overall Study|Other|1
1634597|NCT01830855|5710978|P1|Overall Study|Other|7
1634598|NCT01830816|5711094|P3|Overall Study|Reason not Specified|0
1634599|NCT01830816|5711095|P2|Overall Study|Reason not Specified|0
1634600|NCT01830816|5711096|P1|Overall Study|Reason not Specified|2
1634601|NCT01830816|5711094|P3|Overall Study|Symptomatic Deterioration|0
1634602|NCT01830816|5711095|P2|Overall Study|Symptomatic Deterioration|0
1634603|NCT01830816|5711096|P1|Overall Study|Symptomatic Deterioration|1
1634604|NCT01830816|5711094|P3|Overall Study|Lost to Follow-up|0
1634605|NCT01830816|5711095|P2|Overall Study|Lost to Follow-up|1
1634606|NCT01830816|5711096|P1|Overall Study|Lost to Follow-up|0
1634607|NCT01830816|5711094|P3|Overall Study|Withdrawal by Subject|0
1634608|NCT01830816|5711095|P2|Overall Study|Withdrawal by Subject|1
1634609|NCT01830816|5711096|P1|Overall Study|Withdrawal by Subject|1
1634610|NCT01830816|5711094|P3|Overall Study|Study Terminated by Sponsor|0
1634611|NCT01830816|5711095|P2|Overall Study|Study Terminated by Sponsor|1
1634612|NCT01830816|5711096|P1|Overall Study|Study Terminated by Sponsor|1
1634613|NCT01830816|5711094|P3|Overall Study|Adverse Event|0
1634614|NCT01830816|5711095|P2|Overall Study|Adverse Event|4
1634615|NCT01830816|5711096|P1|Overall Study|Adverse Event|3
1634616|NCT01830816|5711094|P3|Overall Study|Progressive Disease|7
1634617|NCT01830816|5711095|P2|Overall Study|Progressive Disease|7
1634618|NCT01830816|5711096|P1|Overall Study|Progressive Disease|12
1634619|NCT01830595|5711160|P2|Washout|Withdrawal by Subject|2
1634620|NCT01830595|5711161|P1|Washout|Withdrawal by Subject|2
1634621|NCT01830595|5711160|P2|First Period|Withdrawal by Subject|3
1634622|NCT01830595|5711161|P1|First Period|Withdrawal by Subject|1
1634623|NCT01830543|5711178|P3|Overall Study|Other|37
1634624|NCT01830543|5711179|P2|Overall Study|Other|17
1634625|NCT01830543|5711180|P1|Overall Study|Other|12
1634626|NCT01830543|5711178|P3|Overall Study|Withdrawal by consent|3
1634627|NCT01830543|5711179|P2|Overall Study|Withdrawal by consent|3
1634628|NCT01830543|5711180|P1|Overall Study|Withdrawal by consent|3
1634629|NCT01830543|5711178|P3|Overall Study|Physician Decision|12
1634630|NCT01830543|5711179|P2|Overall Study|Physician Decision|5
1634631|NCT01830543|5711180|P1|Overall Study|Physician Decision|11
1634632|NCT01830543|5711178|P3|Overall Study|Protocol Violation|7
1634633|NCT01830543|5711179|P2|Overall Study|Protocol Violation|7
1634634|NCT01830543|5711180|P1|Overall Study|Protocol Violation|3
1634635|NCT01830543|5711178|P3|Overall Study|Death|22
1634636|NCT01830543|5711179|P2|Overall Study|Death|22
1634637|NCT01830543|5711180|P1|Overall Study|Death|20
1634638|NCT01830543|5711178|P3|Overall Study|Adverse Event|76
1634639|NCT01830543|5711179|P2|Overall Study|Adverse Event|77
1634640|NCT01830543|5711180|P1|Overall Study|Adverse Event|91
1634641|NCT01830543|5711178|P3|Overall Study|Subject Decision|57
1634642|NCT01830543|5711179|P2|Overall Study|Subject Decision|21
1634643|NCT01830543|5711180|P1|Overall Study|Subject Decision|19
1634644|NCT01830127|5711312|P2|Overall Study|Other reason not defined above|2
1634645|NCT01830127|5711313|P1|Overall Study|Other reason not defined above|0
1634646|NCT01830127|5711312|P2|Overall Study|Withdrawal by Subject|1
1634647|NCT01830127|5711313|P1|Overall Study|Withdrawal by Subject|1
1634648|NCT01830127|5711312|P2|Overall Study|Lack of Efficacy|0
1634649|NCT01830127|5711313|P1|Overall Study|Lack of Efficacy|3
1634650|NCT01830127|5711312|P2|Overall Study|Adverse Event|6
1634651|NCT01830127|5711313|P1|Overall Study|Adverse Event|1
1634652|NCT01829711|5711346|P1|Overall Study|Still in Follow Up|50
1634653|NCT01829711|5711346|P1|Overall Study|Death|3
1634654|NCT01829711|5711346|P1|Overall Study|Withdrawal by Subject|2
1634655|NCT01829711|5711346|P1|Overall Study|Lost to Follow-up|1
1634656|NCT01829711|5711346|P1|Overall Study|Other|24
1634657|NCT01829477|5711402|P2|Overall Study|Withdrawal by Subject|0
1634658|NCT01829477|5711403|P1|Overall Study|Withdrawal by Subject|1
1634659|NCT01829477|5711402|P2|Overall Study|Study Terminated by Sponsor|15
1634660|NCT01829477|5711403|P1|Overall Study|Study Terminated by Sponsor|15
1634661|NCT01829464|5711416|P3|Overall Study|Lack of Efficacy|0
1634662|NCT01829464|5711417|P2|Overall Study|Lack of Efficacy|1
1634663|NCT01829464|5711418|P1|Overall Study|Lack of Efficacy|0
1634664|NCT01829464|5711416|P3|Overall Study|Study terminated by sponsor|25
1634665|NCT01829464|5711417|P2|Overall Study|Study terminated by sponsor|28
1634666|NCT01829464|5711418|P1|Overall Study|Study terminated by sponsor|25
1634667|NCT01829464|5711416|P3|Overall Study|Withdrawal by Subject|0
1634668|NCT01829464|5711417|P2|Overall Study|Withdrawal by Subject|0
1634669|NCT01829464|5711418|P1|Overall Study|Withdrawal by Subject|2
1634670|NCT01829464|5711416|P3|Overall Study|Lost to Follow-up|1
1634671|NCT01829464|5711417|P2|Overall Study|Lost to Follow-up|0
1634672|NCT01829464|5711418|P1|Overall Study|Lost to Follow-up|0
1634673|NCT01829464|5711416|P3|Overall Study|Adverse Event|0
1634674|NCT01829464|5711417|P2|Overall Study|Adverse Event|0
1634675|NCT01829464|5711418|P1|Overall Study|Adverse Event|1
1634676|NCT01829425|5711434|P2|Overall Study|Lost to Follow-up|1
1634677|NCT01829425|5711435|P1|Overall Study|Lost to Follow-up|2
1634678|NCT01829425|5711434|P2|Overall Study|Withdrawal by Subject|3
1634679|NCT01829425|5711435|P1|Overall Study|Withdrawal by Subject|4
1634680|NCT01829360|5711478|P4|Overall Study|Protocol Violation|0
1634681|NCT01829360|5711479|P3|Overall Study|Protocol Violation|1
1634682|NCT01829360|5711480|P2|Overall Study|Protocol Violation|0
1634683|NCT01829360|5711481|P1|Overall Study|Protocol Violation|0
1634684|NCT01829347|5711501|P2|VTI-210E|Study terminated prematurely|5
1634685|NCT01829347|5711502|P1|VTI-210E|Study terminated prematurely|1
1634686|NCT01829347|5711501|P2|VTI-210E|Death|1
1634687|NCT01829347|5711502|P1|VTI-210E|Death|2
1634688|NCT01829347|5711501|P2|VTI-210|Withdrawal by Subject|0
1634689|NCT01829347|5711502|P1|VTI-210|Withdrawal by Subject|1
1634690|NCT01829347|5711501|P2|VTI-210|Death|3
1634691|NCT01829347|5711502|P1|VTI-210|Death|5
1634692|NCT01829295|5711512|P4|6-12 Months|Withdrawal by Subject|0
1634693|NCT01829295|5711513|P3|6-12 Months|Withdrawal by Subject|0
1634694|NCT01829295|5711514|P2|6-12 Months|Withdrawal by Subject|2
1634695|NCT01829295|5711515|P1|6-12 Months|Withdrawal by Subject|2
1634696|NCT01829295|5711512|P4|6-12 Months|Lost to Follow-up|0
1634697|NCT01829295|5711513|P3|6-12 Months|Lost to Follow-up|0
1634698|NCT01829295|5711514|P2|6-12 Months|Lost to Follow-up|0
1634699|NCT01829295|5711515|P1|6-12 Months|Lost to Follow-up|2
1634700|NCT01829295|5711512|P4|6-12 Months|Adverse Event|2
1634701|NCT01829295|5711513|P3|6-12 Months|Adverse Event|3
1634702|NCT01829295|5711514|P2|6-12 Months|Adverse Event|0
1634703|NCT01829295|5711515|P1|6-12 Months|Adverse Event|0
1634704|NCT01829295|5711512|P4|6-12 Months|Did not want to switch antimetabolites|11
1634705|NCT01829295|5711513|P3|6-12 Months|Did not want to switch antimetabolites|9
1634706|NCT01829295|5711514|P2|6-12 Months|Did not want to switch antimetabolites|0
1634707|NCT01829295|5711515|P1|6-12 Months|Did not want to switch antimetabolites|0
1634708|NCT01829243|5711525|P2|First Intervention|Screen Failure|2
1634709|NCT01829243|5711526|P1|First Intervention|Screen Failure|4
1634710|NCT01829230|5711540|P2|Overall Study|Lost to Follow-up|1
1634711|NCT01829230|5711541|P1|Overall Study|Lost to Follow-up|1
1634712|NCT01829230|5711540|P2|Overall Study|Withdrawal by Subject|1
1634713|NCT01829230|5711541|P1|Overall Study|Withdrawal by Subject|0
1634714|NCT01829230|5711540|P2|Overall Study|Protocol Violation|2
1634715|NCT01829230|5711541|P1|Overall Study|Protocol Violation|0
1634716|NCT01829191|5711555|P2|Overall Study|Subject was fit for ortho - k|1
1634717|NCT01829191|5711556|P1|Overall Study|Subject was fit for ortho - k|0
1634718|NCT01829191|5711555|P2|Overall Study|Lost to Follow-up|1
1634719|NCT01829191|5711556|P1|Overall Study|Lost to Follow-up|0
1634720|NCT01829191|5711555|P2|Overall Study|Withdrawal by Subject|3
1634721|NCT01829191|5711556|P1|Overall Study|Withdrawal by Subject|2
1634722|NCT01829191|5711555|P2|Overall Study|Protocol Violation|1
1634723|NCT01829191|5711556|P1|Overall Study|Protocol Violation|4
1634724|NCT01829191|5711555|P2|Overall Study|Lens handling difficulty|4
1634725|NCT01829191|5711556|P1|Overall Study|Lens handling difficulty|1
1634726|NCT01829191|5711555|P2|Overall Study|Lens discomfort|3
1634727|NCT01829191|5711556|P1|Overall Study|Lens discomfort|0
1634728|NCT01829191|5711555|P2|Overall Study|Relocation|1
1634729|NCT01829191|5711556|P1|Overall Study|Relocation|0
1634730|NCT01829165|5711565|P2|Overall Study|Did not complete intervention|0
1634731|NCT01829165|5711566|P1|Overall Study|Did not complete intervention|2
1634732|NCT01829113|5711574|P2|Overall Study|Physician Decision|1
1634733|NCT01829113|5711575|P1|Overall Study|Physician Decision|1
1634734|NCT01829113|5711574|P2|Overall Study|No Study Treatment Received|2
1634735|NCT01829113|5711575|P1|Overall Study|No Study Treatment Received|3
1634736|NCT01829113|5711574|P2|Overall Study|Sponsor Decision|1
1634737|NCT01829113|5711575|P1|Overall Study|Sponsor Decision|1
1634738|NCT01829113|5711574|P2|Overall Study|Death|6
1634739|NCT01829113|5711575|P1|Overall Study|Death|4
1634740|NCT01829113|5711574|P2|Overall Study|Withdrawal by Subject|10
1634741|NCT01829113|5711575|P1|Overall Study|Withdrawal by Subject|17
1634742|NCT01829113|5711574|P2|Overall Study|Adverse Event|10
1634743|NCT01829113|5711575|P1|Overall Study|Adverse Event|14
1634744|NCT01829113|5711574|P2|Overall Study|Disease Progression|48
1634745|NCT01829113|5711575|P1|Overall Study|Disease Progression|37
1634746|NCT01829048|5711592|P5|Overall Study|Withdrawal by Subject|0
1634747|NCT01829048|5711593|P4|Overall Study|Withdrawal by Subject|2
1634748|NCT01829048|5711594|P3|Overall Study|Withdrawal by Subject|0
1634749|NCT01829048|5711595|P2|Overall Study|Withdrawal by Subject|0
1634750|NCT01829048|5711596|P1|Overall Study|Withdrawal by Subject|0
1634751|NCT01828567|5711709|P2|Overall Study|Excluded - did not meet criteria|1
1634752|NCT01828567|5711710|P1|Overall Study|Excluded - did not meet criteria|4
1634753|NCT01828567|5711709|P2|Overall Study|Lost to Follow-up|9
1634754|NCT01828567|5711710|P1|Overall Study|Lost to Follow-up|27
1634755|NCT01828281|5711765|P2|Overall Study|Withdrawal by Subject|0
1634756|NCT01828281|5711766|P1|Overall Study|Withdrawal by Subject|1
1634757|NCT01828112|5711799|P2|Overall Study|Subject/guardian decision|8
1634758|NCT01828112|5711800|P1|Overall Study|Subject/guardian decision|6
1634759|NCT01828112|5711799|P2|Overall Study|Progressive disease|82
1634760|NCT01828112|5711800|P1|Overall Study|Progressive disease|56
1634761|NCT01828112|5711799|P2|Overall Study|Physician Decision|5
1634762|NCT01828112|5711800|P1|Overall Study|Physician Decision|5
1634763|NCT01828112|5711799|P2|Overall Study|Death|5
1634764|NCT01828112|5711800|P1|Overall Study|Death|9
1634765|NCT01828112|5711799|P2|Overall Study|Adverse Event|8
1634766|NCT01828112|5711800|P1|Overall Study|Adverse Event|6
1634767|NCT01828099|5711808|P2|Overall Study|Subject/guardian decision|23
1634768|NCT01828099|5711809|P1|Overall Study|Subject/guardian decision|7
1634769|NCT01828099|5711808|P2|Overall Study|Protocol Violation|0
1634770|NCT01828099|5711809|P1|Overall Study|Protocol Violation|1
1634771|NCT01828099|5711808|P2|Overall Study|Progressive disease|94
1634772|NCT01828099|5711809|P1|Overall Study|Progressive disease|51
1634773|NCT01828099|5711808|P2|Overall Study|Physician Decision|11
1634774|NCT01828099|5711809|P1|Overall Study|Physician Decision|7
1634775|NCT01828099|5711808|P2|Overall Study|Non-compliance with study treatment|0
1634776|NCT01828099|5711809|P1|Overall Study|Non-compliance with study treatment|2
1634777|NCT01828099|5711808|P2|Overall Study|Lost to Follow-up|0
1634778|NCT01828099|5711809|P1|Overall Study|Lost to Follow-up|2
1634779|NCT01828099|5711808|P2|Overall Study|Death|11
1634780|NCT01828099|5711809|P1|Overall Study|Death|9
1634781|NCT01828099|5711808|P2|Overall Study|Adverse Event|18
1634782|NCT01828099|5711809|P1|Overall Study|Adverse Event|15
1634785|NCT01827839|5711838|P1|Overall Study|Consent Withdrawal|2
1634786|NCT01827839|5711838|P1|Overall Study|Adverse Event|1
1634787|NCT01827670|5711883|P2|Overall Study|Lost to Follow-up|1
1634788|NCT01827670|5711884|P1|Overall Study|Lost to Follow-up|0
1634789|NCT01827670|5711883|P2|Overall Study|Withdrawal of Consent|2
1634790|NCT01827670|5711884|P1|Overall Study|Withdrawal of Consent|3
1634791|NCT01827592|5711903|P3|Overall Study|Others|3
1634792|NCT01827592|5711904|P2|Overall Study|Others|1
1634793|NCT01827592|5711905|P1|Overall Study|Others|0
1634794|NCT01827592|5711903|P3|Overall Study|Trial terminated by Sponsor|51
1634795|NCT01827592|5711904|P2|Overall Study|Trial terminated by Sponsor|53
1634796|NCT01827592|5711905|P1|Overall Study|Trial terminated by Sponsor|47
1634797|NCT01827592|5711903|P3|Overall Study|Patient's substantial non-compliance|6
1634798|NCT01827592|5711904|P2|Overall Study|Patient's substantial non-compliance|1
1634799|NCT01827592|5711905|P1|Overall Study|Patient's substantial non-compliance|1
1634800|NCT01827592|5711903|P3|Overall Study|Withdrawal by Subject|11
1634801|NCT01827592|5711904|P2|Overall Study|Withdrawal by Subject|11
1634802|NCT01827592|5711905|P1|Overall Study|Withdrawal by Subject|12
1634803|NCT01827592|5711903|P3|Overall Study|Lost to Follow-up|2
1634804|NCT01827592|5711904|P2|Overall Study|Lost to Follow-up|2
1634805|NCT01827592|5711905|P1|Overall Study|Lost to Follow-up|1
1634806|NCT01827592|5711903|P3|Overall Study|Protocol Violation|0
1634807|NCT01827592|5711904|P2|Overall Study|Protocol Violation|1
1634808|NCT01827592|5711905|P1|Overall Study|Protocol Violation|2
1634809|NCT01827592|5711903|P3|Overall Study|Physician Decision|1
1634810|NCT01827592|5711904|P2|Overall Study|Physician Decision|2
1634811|NCT01827592|5711905|P1|Overall Study|Physician Decision|0
1634812|NCT01827592|5711903|P3|Overall Study|Adverse Event|2
1634813|NCT01827592|5711904|P2|Overall Study|Adverse Event|9
1634814|NCT01827592|5711905|P1|Overall Study|Adverse Event|11
1634815|NCT01827371|5711970|P4|Overall Study|Temporary study halt to vaccinations|13
1634816|NCT01827371|5711971|P3|Overall Study|Temporary study halt to vaccinations|5
1634817|NCT01827371|5711972|P2|Overall Study|Temporary study halt to vaccinations|2
1634818|NCT01827371|5711973|P1|Overall Study|Temporary study halt to vaccinations|11
1634819|NCT01827371|5711970|P4|Overall Study|Physician Decision|1
1634820|NCT01827371|5711971|P3|Overall Study|Physician Decision|0
1634821|NCT01827371|5711972|P2|Overall Study|Physician Decision|1
1634822|NCT01827371|5711973|P1|Overall Study|Physician Decision|0
1634823|NCT01827371|5711970|P4|Overall Study|Withdrawal by Subject|3
1634824|NCT01827371|5711971|P3|Overall Study|Withdrawal by Subject|2
1634825|NCT01827371|5711972|P2|Overall Study|Withdrawal by Subject|2
1634826|NCT01827371|5711973|P1|Overall Study|Withdrawal by Subject|1
1634827|NCT01827371|5711970|P4|Overall Study|Protocol Violation|0
1634828|NCT01827371|5711971|P3|Overall Study|Protocol Violation|0
1634829|NCT01827371|5711972|P2|Overall Study|Protocol Violation|0
1634830|NCT01827371|5711973|P1|Overall Study|Protocol Violation|1
1634831|NCT01827371|5711970|P4|Overall Study|Lost to Follow-up|4
1634832|NCT01827371|5711971|P3|Overall Study|Lost to Follow-up|0
1634833|NCT01827371|5711972|P2|Overall Study|Lost to Follow-up|2
1634834|NCT01827371|5711973|P1|Overall Study|Lost to Follow-up|0
1634835|NCT01827371|5711970|P4|Overall Study|Adverse Event|2
1634836|NCT01827371|5711971|P3|Overall Study|Adverse Event|4
1634837|NCT01827371|5711972|P2|Overall Study|Adverse Event|0
1634838|NCT01827371|5711973|P1|Overall Study|Adverse Event|0
1634839|NCT01827332|5712032|P2|Overall Study|Lost to Follow-up|1
1634840|NCT01827332|5712033|P1|Overall Study|Lost to Follow-up|2
1634841|NCT01827319|5712041|P1|Overall Study|Lost to Follow-up|3
1634842|NCT01827267|5712064|P2|Overall Study|Still on study|2
1634843|NCT01827267|5712065|P1|Overall Study|Still on study|0
1634844|NCT01827267|5712064|P2|Overall Study|Sponsor Discontinued Study|8
1634845|NCT01827267|5712065|P1|Overall Study|Sponsor Discontinued Study|2
1634846|NCT01827267|5712064|P2|Overall Study|Disease Progression|1
1634847|NCT01827267|5712065|P1|Overall Study|Disease Progression|1
1634848|NCT01827267|5712064|P2|Overall Study|Physician Decision|0
1634849|NCT01827267|5712065|P1|Overall Study|Physician Decision|1
1634850|NCT01827267|5712064|P2|Overall Study|Did not receive study drug|1
1634851|NCT01827267|5712065|P1|Overall Study|Did not receive study drug|1
1634852|NCT01827254|5712080|P1|Overall Study|Intolerance to treatment|4
1634853|NCT01827254|5712080|P1|Overall Study|Disease progression|36
1634854|NCT01827254|5712080|P1|Overall Study|Did not complete re-challenge|1
1634855|NCT01827254|5712080|P1|Overall Study|Discontinued prior initiation: sunitinib|1
1634856|NCT01827254|5712080|P1|Overall Study|Invalidated centre|3
1634857|NCT01827254|5712080|P1|Overall Study|Case report form not completed|4
1634858|NCT01827254|5712080|P1|Overall Study|Death|10
1634859|NCT01827163|5712090|P1|Overall Study|Adverse Event|9
1634860|NCT01827163|5712090|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
1634861|NCT01827046|5712097|P2|Overall Study|Withdrawal by Subject|4
1634862|NCT01827046|5712098|P1|Overall Study|Withdrawal by Subject|0
1634863|NCT01827046|5712097|P2|Overall Study|Lost to Follow-up|5
1634864|NCT01827046|5712098|P1|Overall Study|Lost to Follow-up|1
1634865|NCT01826981|5712153|P15|Overall Study|Enrolled/Randomized but Not Treated|0
1634866|NCT01826981|5712154|P14|Overall Study|Enrolled/Randomized but Not Treated|0
1634867|NCT01826981|5712155|P13|Overall Study|Enrolled/Randomized but Not Treated|0
1634868|NCT01826981|5712156|P12|Overall Study|Enrolled/Randomized but Not Treated|0
1634869|NCT01826981|5712157|P11|Overall Study|Enrolled/Randomized but Not Treated|0
1634870|NCT01826981|5712158|P10|Overall Study|Enrolled/Randomized but Not Treated|0
1634871|NCT01826981|5712159|P9|Overall Study|Enrolled/Randomized but Not Treated|0
1634872|NCT01826981|5712160|P8|Overall Study|Enrolled/Randomized but Not Treated|1
1634873|NCT01826981|5712161|P7|Overall Study|Enrolled/Randomized but Not Treated|0
1634874|NCT01826981|5712162|P6|Overall Study|Enrolled/Randomized but Not Treated|0
1634875|NCT01826981|5712163|P5|Overall Study|Enrolled/Randomized but Not Treated|0
1634876|NCT01826981|5712164|P4|Overall Study|Enrolled/Randomized but Not Treated|0
1634877|NCT01826981|5712165|P3|Overall Study|Enrolled/Randomized but Not Treated|0
1634878|NCT01826981|5712166|P2|Overall Study|Enrolled/Randomized but Not Treated|0
1634879|NCT01826981|5712167|P1|Overall Study|Enrolled/Randomized but Not Treated|0
1634880|NCT01826981|5712153|P15|Overall Study|Upper G-I Haemorrhage|0
1634881|NCT01826981|5712154|P14|Overall Study|Upper G-I Haemorrhage|1
1634882|NCT01826981|5712155|P13|Overall Study|Upper G-I Haemorrhage|0
1634883|NCT01826981|5712156|P12|Overall Study|Upper G-I Haemorrhage|0
1634884|NCT01826981|5712157|P11|Overall Study|Upper G-I Haemorrhage|0
1634885|NCT01826981|5712158|P10|Overall Study|Upper G-I Haemorrhage|0
1634886|NCT01826981|5712159|P9|Overall Study|Upper G-I Haemorrhage|0
1634887|NCT01826981|5712160|P8|Overall Study|Upper G-I Haemorrhage|0
1634888|NCT01826981|5712161|P7|Overall Study|Upper G-I Haemorrhage|0
1634889|NCT01826981|5712162|P6|Overall Study|Upper G-I Haemorrhage|0
1634890|NCT01826981|5712163|P5|Overall Study|Upper G-I Haemorrhage|0
1634891|NCT01826981|5712164|P4|Overall Study|Upper G-I Haemorrhage|0
1634892|NCT01826981|5712165|P3|Overall Study|Upper G-I Haemorrhage|0
1634893|NCT01826981|5712166|P2|Overall Study|Upper G-I Haemorrhage|0
1634894|NCT01826981|5712167|P1|Overall Study|Upper G-I Haemorrhage|0
1634895|NCT01826981|5712153|P15|Overall Study|Adverse Event|0
1634896|NCT01826981|5712154|P14|Overall Study|Adverse Event|0
1634897|NCT01826981|5712155|P13|Overall Study|Adverse Event|0
1634898|NCT01826981|5712156|P12|Overall Study|Adverse Event|0
1634899|NCT01826981|5712157|P11|Overall Study|Adverse Event|0
1634900|NCT01826981|5712158|P10|Overall Study|Adverse Event|0
1634901|NCT01826981|5712159|P9|Overall Study|Adverse Event|0
1634902|NCT01826981|5712160|P8|Overall Study|Adverse Event|0
1634903|NCT01826981|5712161|P7|Overall Study|Adverse Event|0
1634904|NCT01826981|5712162|P6|Overall Study|Adverse Event|0
1634905|NCT01826981|5712163|P5|Overall Study|Adverse Event|1
1634906|NCT01826981|5712164|P4|Overall Study|Adverse Event|0
1634907|NCT01826981|5712165|P3|Overall Study|Adverse Event|0
1634908|NCT01826981|5712166|P2|Overall Study|Adverse Event|0
1634909|NCT01826981|5712167|P1|Overall Study|Adverse Event|0
1634910|NCT01826981|5712153|P15|Overall Study|Withdrew Consent|0
1634911|NCT01826981|5712154|P14|Overall Study|Withdrew Consent|1
1634912|NCT01826981|5712155|P13|Overall Study|Withdrew Consent|0
1634913|NCT01826981|5712156|P12|Overall Study|Withdrew Consent|1
1634914|NCT01826981|5712157|P11|Overall Study|Withdrew Consent|0
1634915|NCT01826981|5712158|P10|Overall Study|Withdrew Consent|0
1634916|NCT01826981|5712159|P9|Overall Study|Withdrew Consent|0
1634917|NCT01826981|5712160|P8|Overall Study|Withdrew Consent|1
1634918|NCT01826981|5712161|P7|Overall Study|Withdrew Consent|1
1634919|NCT01826981|5712162|P6|Overall Study|Withdrew Consent|0
1634920|NCT01826981|5712163|P5|Overall Study|Withdrew Consent|0
1634921|NCT01826981|5712164|P4|Overall Study|Withdrew Consent|0
1634922|NCT01826981|5712165|P3|Overall Study|Withdrew Consent|0
1634923|NCT01826981|5712166|P2|Overall Study|Withdrew Consent|0
1634924|NCT01826981|5712167|P1|Overall Study|Withdrew Consent|0
1634925|NCT01826981|5712153|P15|Overall Study|Lost to Follow-up|0
1634926|NCT01826981|5712154|P14|Overall Study|Lost to Follow-up|0
1634927|NCT01826981|5712155|P13|Overall Study|Lost to Follow-up|1
1634928|NCT01826981|5712156|P12|Overall Study|Lost to Follow-up|1
1634929|NCT01826981|5712157|P11|Overall Study|Lost to Follow-up|1
1634930|NCT01826981|5712158|P10|Overall Study|Lost to Follow-up|1
1634931|NCT01826981|5712159|P9|Overall Study|Lost to Follow-up|0
1634932|NCT01826981|5712160|P8|Overall Study|Lost to Follow-up|1
1634933|NCT01826981|5712161|P7|Overall Study|Lost to Follow-up|0
1634934|NCT01826981|5712162|P6|Overall Study|Lost to Follow-up|1
1634935|NCT01826981|5712163|P5|Overall Study|Lost to Follow-up|1
1634936|NCT01826981|5712164|P4|Overall Study|Lost to Follow-up|0
1634937|NCT01826981|5712165|P3|Overall Study|Lost to Follow-up|0
1634938|NCT01826981|5712166|P2|Overall Study|Lost to Follow-up|0
1634939|NCT01826981|5712167|P1|Overall Study|Lost to Follow-up|0
1634940|NCT01826981|5712153|P15|Overall Study|Lack of Efficacy|0
1634941|NCT01826981|5712154|P14|Overall Study|Lack of Efficacy|3
1634942|NCT01826981|5712155|P13|Overall Study|Lack of Efficacy|0
1634943|NCT01826981|5712156|P12|Overall Study|Lack of Efficacy|0
1634944|NCT01826981|5712157|P11|Overall Study|Lack of Efficacy|1
1634945|NCT01826981|5712158|P10|Overall Study|Lack of Efficacy|0
1634946|NCT01826981|5712159|P9|Overall Study|Lack of Efficacy|7
1634947|NCT01826981|5712160|P8|Overall Study|Lack of Efficacy|8
1634948|NCT01826981|5712161|P7|Overall Study|Lack of Efficacy|0
1634949|NCT01826981|5712162|P6|Overall Study|Lack of Efficacy|0
1634950|NCT01826981|5712163|P5|Overall Study|Lack of Efficacy|5
1634951|NCT01826981|5712164|P4|Overall Study|Lack of Efficacy|0
1634952|NCT01826981|5712165|P3|Overall Study|Lack of Efficacy|0
1634953|NCT01826981|5712166|P2|Overall Study|Lack of Efficacy|1
1634954|NCT01826981|5712167|P1|Overall Study|Lack of Efficacy|0
1634955|NCT01826604|5712353|P2|Overall Study|Lost to Follow-up|9
1634956|NCT01826604|5712354|P1|Overall Study|Lost to Follow-up|8
1634957|NCT01826422|5712398|P2|Overall Study|Withdrawal by Subject|3
1634958|NCT01826422|5712399|P1|Overall Study|Withdrawal by Subject|1
1634959|NCT01826370|5712443|P1|Overall Study|Other reason not defined above|2
1634960|NCT01826370|5712443|P1|Overall Study|Lost to Follow-up|12
1634961|NCT01826370|5712443|P1|Overall Study|Protocol Violation|6
1634962|NCT01826214|5712455|P2|Overall Study|Subject/guardian decision|3
1634963|NCT01826214|5712456|P1|Overall Study|Subject/guardian decision|2
1634964|NCT01826214|5712455|P2|Overall Study|Study terminated by Sponsor|1
1634965|NCT01826214|5712456|P1|Overall Study|Study terminated by Sponsor|0
1634966|NCT01826214|5712455|P2|Overall Study|Progressive disease|21
1634967|NCT01826214|5712456|P1|Overall Study|Progressive disease|22
1634968|NCT01826214|5712455|P2|Overall Study|Physician Decision|2
1634969|NCT01826214|5712456|P1|Overall Study|Physician Decision|0
1634970|NCT01826214|5712455|P2|Overall Study|Lost to Follow-up|0
1634971|NCT01826214|5712456|P1|Overall Study|Lost to Follow-up|1
1634972|NCT01826214|5712455|P2|Overall Study|Death|1
1634973|NCT01826214|5712456|P1|Overall Study|Death|3
1634974|NCT01826214|5712455|P2|Overall Study|Adverse Event|6
1634975|NCT01826214|5712456|P1|Overall Study|Adverse Event|7
1634976|NCT01826201|5712474|P1|Overall Study|Non compliance with protocol|4
1634977|NCT01825941|5712482|P2|Overall Study|Lost to Follow-up|1
1634978|NCT01825941|5712483|P1|Overall Study|Lost to Follow-up|4
1634979|NCT01825876|5712502|P2|Period 2|Withdrawal by Subject|1
1634980|NCT01825876|5712503|P1|Period 2|Withdrawal by Subject|0
1634981|NCT01825837|5712524|P4|PART II|reason unspecified|0
1634982|NCT01825837|5712525|P3|PART II|reason unspecified|2
1634983|NCT01825837|5712526|P2|PART II|reason unspecified|2
1634984|NCT01825837|5712527|P1|PART II|reason unspecified|2
1634985|NCT01825837|5712524|P4|PART II|Treatment failure|0
1634986|NCT01825837|5712525|P3|PART II|Treatment failure|5
1634987|NCT01825837|5712526|P2|PART II|Treatment failure|4
1634988|NCT01825837|5712527|P1|PART II|Treatment failure|6
1634989|NCT01825837|5712524|P4|PART II|Adverse Event|0
1634990|NCT01825837|5712525|P3|PART II|Adverse Event|1
1634991|NCT01825837|5712526|P2|PART II|Adverse Event|3
1634992|NCT01825837|5712527|P1|PART II|Adverse Event|3
1634993|NCT01825837|5712524|P4|PART II|Patient non-compliance|0
1634994|NCT01825837|5712525|P3|PART II|Patient non-compliance|4
1634995|NCT01825837|5712526|P2|PART II|Patient non-compliance|2
1634996|NCT01825837|5712527|P1|PART II|Patient non-compliance|5
1634997|NCT01825837|5712524|P4|PART II|Withdrawal by Subject|0
1634998|NCT01825837|5712525|P3|PART II|Withdrawal by Subject|7
1634999|NCT01825837|5712526|P2|PART II|Withdrawal by Subject|3
1635000|NCT01825837|5712527|P1|PART II|Withdrawal by Subject|3
1635001|NCT01825837|5712524|P4|PART I|reason unspecified|3
1635002|NCT01825837|5712525|P3|PART I|reason unspecified|0
1635003|NCT01825837|5712526|P2|PART I|reason unspecified|0
1635004|NCT01825837|5712527|P1|PART I|reason unspecified|0
1635005|NCT01825837|5712524|P4|PART I|Treatment failure|7
1635006|NCT01825837|5712525|P3|PART I|Treatment failure|0
1635007|NCT01825837|5712526|P2|PART I|Treatment failure|0
1635008|NCT01825837|5712527|P1|PART I|Treatment failure|0
1635009|NCT01825837|5712524|P4|PART I|Patient non-compliance|1
1635010|NCT01825837|5712525|P3|PART I|Patient non-compliance|0
1635011|NCT01825837|5712526|P2|PART I|Patient non-compliance|0
1635012|NCT01825837|5712527|P1|PART I|Patient non-compliance|0
1635013|NCT01825837|5712524|P4|PART I|Withdrawal by Subject|6
1635014|NCT01825837|5712525|P3|PART I|Withdrawal by Subject|0
1635015|NCT01825837|5712526|P2|PART I|Withdrawal by Subject|0
1635016|NCT01825837|5712527|P1|PART I|Withdrawal by Subject|0
1635017|NCT01825798|5712537|P2|Overall Study|Lost to Follow-up|0
1635018|NCT01825798|5712538|P1|Overall Study|Lost to Follow-up|1
1635019|NCT01825798|5712537|P2|Overall Study|Adverse Event|5
1635020|NCT01825798|5712538|P1|Overall Study|Adverse Event|1
1635021|NCT01825785|5712573|P7|Overall Study|Withdrawal by Subject|0
1635022|NCT01825785|5712574|P6|Overall Study|Withdrawal by Subject|1
1635023|NCT01825785|5712575|P5|Overall Study|Withdrawal by Subject|1
1635024|NCT01825785|5712576|P4|Overall Study|Withdrawal by Subject|0
1635025|NCT01825785|5712577|P3|Overall Study|Withdrawal by Subject|0
1635026|NCT01825785|5712578|P2|Overall Study|Withdrawal by Subject|0
1635027|NCT01825785|5712579|P1|Overall Study|Withdrawal by Subject|0
1635028|NCT01825785|5712573|P7|Overall Study|Adverse Event|0
1635029|NCT01825785|5712574|P6|Overall Study|Adverse Event|0
1635030|NCT01825785|5712575|P5|Overall Study|Adverse Event|1
1635031|NCT01825785|5712576|P4|Overall Study|Adverse Event|0
1635032|NCT01825785|5712577|P3|Overall Study|Adverse Event|0
1635033|NCT01825785|5712578|P2|Overall Study|Adverse Event|0
1635034|NCT01825785|5712579|P1|Overall Study|Adverse Event|0
1635035|NCT01825577|5712732|P1|Overall Study|Lack of Efficacy|3
1635036|NCT01825577|5712732|P1|Overall Study|Withdrawn by family members|2
1635037|NCT01825577|5712732|P1|Overall Study|Withdrawal by Subject|1
1635038|NCT01825577|5712732|P1|Overall Study|Physician Decision|2
1635039|NCT01825200|5712756|P2|Overall Study|Withdrawal by Subject|1
1635040|NCT01825200|5712757|P1|Overall Study|Withdrawal by Subject|0
1635041|NCT01825200|5712756|P2|Overall Study|Lost to Follow-up|6
1635042|NCT01825200|5712757|P1|Overall Study|Lost to Follow-up|5
1635043|NCT01824979|5712780|P2|Overall Study|Protocol Violation|13
1635044|NCT01824979|5712781|P1|Overall Study|Protocol Violation|6
1635045|NCT01824979|5712780|P2|Overall Study|Physician Decision|0
1635046|NCT01824979|5712781|P1|Overall Study|Physician Decision|2
1635047|NCT01824979|5712780|P2|Overall Study|Withdrawal by Subject|0
1635048|NCT01824979|5712781|P1|Overall Study|Withdrawal by Subject|5
1635049|NCT01824823|5712798|P2|Overall Study|Off-treatment reason not submitted|0
1635050|NCT01824823|5712799|P1|Overall Study|Off-treatment reason not submitted|1
1635051|NCT01824823|5712798|P2|Overall Study|Lack of Efficacy|1
1635052|NCT01824823|5712799|P1|Overall Study|Lack of Efficacy|1
1635053|NCT01824693|5712808|P3|Overall Study|No Transplant Planned|10
1635054|NCT01824693|5712809|P2|Overall Study|No Transplant Planned|0
1635055|NCT01824693|5712810|P1|Overall Study|No Transplant Planned|0
1635056|NCT01824693|5712808|P3|Overall Study|Ineligible|3
1635057|NCT01824693|5712809|P2|Overall Study|Ineligible|0
1635058|NCT01824693|5712810|P1|Overall Study|Ineligible|0
1635059|NCT01824693|5712808|P3|Overall Study|Progressive Disease|0
1635060|NCT01824693|5712809|P2|Overall Study|Progressive Disease|5
1635061|NCT01824693|5712810|P1|Overall Study|Progressive Disease|0
1635062|NCT01824693|5712808|P3|Overall Study|Withdrawal by Subject|1
1635063|NCT01824693|5712809|P2|Overall Study|Withdrawal by Subject|0
1635064|NCT01824693|5712810|P1|Overall Study|Withdrawal by Subject|0
1635065|NCT01824693|5712808|P3|Overall Study|Physician Decision|1
1635066|NCT01824693|5712809|P2|Overall Study|Physician Decision|1
1635067|NCT01824693|5712810|P1|Overall Study|Physician Decision|1
1635068|NCT01824693|5712808|P3|Overall Study|Death|0
1635069|NCT01824693|5712809|P2|Overall Study|Death|1
1635070|NCT01824693|5712810|P1|Overall Study|Death|0
1635071|NCT01824602|5712827|P4|Overall Study|Treatment failure|1
1635072|NCT01824602|5712828|P3|Overall Study|Treatment failure|0
1635073|NCT01824602|5712829|P2|Overall Study|Treatment failure|0
1635074|NCT01824602|5712830|P1|Overall Study|Treatment failure|0
1635075|NCT01824602|5712827|P4|Overall Study|Adverse Event|2
1635076|NCT01824602|5712828|P3|Overall Study|Adverse Event|2
1635077|NCT01824602|5712829|P2|Overall Study|Adverse Event|0
1635078|NCT01824602|5712830|P1|Overall Study|Adverse Event|1
1635079|NCT01824602|5712827|P4|Overall Study|Patient non-compliance|0
1635080|NCT01824602|5712828|P3|Overall Study|Patient non-compliance|1
1635081|NCT01824602|5712829|P2|Overall Study|Patient non-compliance|0
1635082|NCT01824602|5712830|P1|Overall Study|Patient non-compliance|0
1635083|NCT01824602|5712827|P4|Overall Study|Withdrawal by Subject|2
1635084|NCT01824602|5712828|P3|Overall Study|Withdrawal by Subject|1
1635085|NCT01824602|5712829|P2|Overall Study|Withdrawal by Subject|0
1635086|NCT01824602|5712830|P1|Overall Study|Withdrawal by Subject|0
1635087|NCT01824576|5712869|P1|Overall Study|Device deficiency|2
1635088|NCT01824498|5712887|P6|Washout (8 Weeks)|Withdrawal by Subject|0
1635089|NCT01824498|5712888|P5|Washout (8 Weeks)|Withdrawal by Subject|1
1635090|NCT01824498|5712889|P4|Washout (8 Weeks)|Withdrawal by Subject|1
1635091|NCT01824498|5712890|P3|Washout (8 Weeks)|Withdrawal by Subject|2
1635092|NCT01824498|5712891|P2|Washout (8 Weeks)|Withdrawal by Subject|0
1635093|NCT01824498|5712892|P1|Washout (8 Weeks)|Withdrawal by Subject|2
1635094|NCT01824394|5712926|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
1635095|NCT01824394|5712927|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
1635096|NCT01824394|5712928|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
1635097|NCT01824394|5712926|P3|Overall Study|Discontinued Subjects|2
1635098|NCT01824394|5712927|P2|Overall Study|Discontinued Subjects|1
1635099|NCT01824394|5712928|P1|Overall Study|Discontinued Subjects|1
1635100|NCT01824394|5712926|P3|Overall Study|Death|4
1635101|NCT01824394|5712927|P2|Overall Study|Death|2
1635102|NCT01824394|5712928|P1|Overall Study|Death|3
1635103|NCT01824394|5712926|P3|Overall Study|Lost to Follow-up|3
1635104|NCT01824394|5712927|P2|Overall Study|Lost to Follow-up|9
1635105|NCT01824394|5712928|P1|Overall Study|Lost to Follow-up|0
1635106|NCT01824394|5712926|P3|Overall Study|Withdrawn due to Study Termination|41
1635107|NCT01824394|5712927|P2|Overall Study|Withdrawn due to Study Termination|83
1635108|NCT01824394|5712928|P1|Overall Study|Withdrawn due to Study Termination|91
1635109|NCT01824394|5712926|P3|Overall Study|Early Termination|3
1635110|NCT01824394|5712927|P2|Overall Study|Early Termination|1
1635111|NCT01824394|5712928|P1|Overall Study|Early Termination|1
1635112|NCT01824355|5712938|P1|Overall Study|unevaluable reference method results per|1
1635113|NCT01824355|5712938|P1|Overall Study|Adverse Event|2
1635114|NCT01824342|5712949|P2|Overall Study|Death|0
1635115|NCT01824342|5712950|P1|Overall Study|Death|2
1635116|NCT01824342|5712949|P2|Overall Study|Physician Decision|0
1635117|NCT01824342|5712950|P1|Overall Study|Physician Decision|5
1635118|NCT01824342|5712949|P2|Overall Study|Disease Progression|1
1635119|NCT01824342|5712950|P1|Overall Study|Disease Progression|1
1635120|NCT01824342|5712949|P2|Overall Study|Adverse Event|1
1635121|NCT01824342|5712950|P1|Overall Study|Adverse Event|1
1635122|NCT01824342|5712949|P2|Overall Study|Withdrawal by Subject|3
1635123|NCT01824342|5712950|P1|Overall Study|Withdrawal by Subject|0
1635124|NCT01824303|5712964|P2|Randomized Study|Other Miscellaneous Reasons|0
1635125|NCT01824303|5712965|P1|Randomized Study|Other Miscellaneous Reasons|1
1635126|NCT01824303|5712964|P2|Randomized Study|Withdrawal by Subject|1
1635127|NCT01824303|5712965|P1|Randomized Study|Withdrawal by Subject|1
1635128|NCT01823991|5712995|P2|Overall Study|Withdrawal by Subject|5
1635129|NCT01823991|5712996|P1|Overall Study|Withdrawal by Subject|8
1635130|NCT01823679|5713028|P1|Overall Study|Death|1
1635131|NCT01823536|5713081|P6|Overall Study|Subject moved out of the state|0
1635132|NCT01823536|5713082|P5|Overall Study|Subject moved out of the state|1
1635133|NCT01823536|5713083|P4|Overall Study|Subject moved out of the state|0
1635134|NCT01823536|5713084|P3|Overall Study|Subject moved out of the state|0
1635135|NCT01823536|5713085|P2|Overall Study|Subject moved out of the state|0
1635136|NCT01823536|5713086|P1|Overall Study|Subject moved out of the state|0
1635137|NCT01823536|5713081|P6|Overall Study|Met exclusion criterion No 6|0
1635138|NCT01823536|5713082|P5|Overall Study|Met exclusion criterion No 6|0
1635139|NCT01823536|5713083|P4|Overall Study|Met exclusion criterion No 6|1
1635140|NCT01823536|5713084|P3|Overall Study|Met exclusion criterion No 6|0
1635141|NCT01823536|5713085|P2|Overall Study|Met exclusion criterion No 6|0
1635142|NCT01823536|5713086|P1|Overall Study|Met exclusion criterion No 6|0
1635143|NCT01823536|5713081|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
1635144|NCT01823536|5713082|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
1635145|NCT01823536|5713083|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
1635146|NCT01823536|5713084|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
1635147|NCT01823536|5713085|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
1635148|NCT01823536|5713086|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
1635149|NCT01823536|5713081|P6|Overall Study|Withdrawal by Subject|0
1635150|NCT01823536|5713082|P5|Overall Study|Withdrawal by Subject|0
1635151|NCT01823536|5713083|P4|Overall Study|Withdrawal by Subject|0
1635152|NCT01823536|5713084|P3|Overall Study|Withdrawal by Subject|0
1635153|NCT01823536|5713085|P2|Overall Study|Withdrawal by Subject|1
1635154|NCT01823536|5713086|P1|Overall Study|Withdrawal by Subject|1
1635155|NCT01823536|5713081|P6|Overall Study|Protocol Violation|0
1635156|NCT01823536|5713082|P5|Overall Study|Protocol Violation|0
1635157|NCT01823536|5713083|P4|Overall Study|Protocol Violation|0
1635158|NCT01823536|5713084|P3|Overall Study|Protocol Violation|0
1635159|NCT01823536|5713085|P2|Overall Study|Protocol Violation|1
1635160|NCT01823536|5713086|P1|Overall Study|Protocol Violation|0
1635161|NCT01823536|5713081|P6|Overall Study|Lost to Follow-up|0
1635162|NCT01823536|5713082|P5|Overall Study|Lost to Follow-up|1
1635163|NCT01823536|5713083|P4|Overall Study|Lost to Follow-up|1
1635164|NCT01823536|5713084|P3|Overall Study|Lost to Follow-up|0
1635165|NCT01823536|5713085|P2|Overall Study|Lost to Follow-up|0
1635166|NCT01823536|5713086|P1|Overall Study|Lost to Follow-up|1
1635167|NCT01823341|5713137|P1|Overall Study|Adverse Event|1
1635168|NCT01823341|5713137|P1|Overall Study|Withdrawal by Subject|7
1635169|NCT01823341|5713137|P1|Overall Study|Failed run-in|7
1635170|NCT01823328|5713182|P2|Overall Study|Withdrawal by Subject|6
1635171|NCT01823328|5713183|P1|Overall Study|Withdrawal by Subject|8
1635172|NCT01823289|5713203|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
1635173|NCT01823289|5713203|P1|Overall Study|Drug affected efficacy and safety|1
1635174|NCT01823289|5713203|P1|Overall Study|Transaminase increased more than 3 times|1
1635175|NCT01823289|5713203|P1|Overall Study|Administered contraindicated medicine|1
1635176|NCT01823289|5713203|P1|Overall Study|Physician Decision|9
1635177|NCT01823289|5713203|P1|Overall Study|Lack of Efficacy|1
1635178|NCT01823289|5713203|P1|Overall Study|Adverse Event|5
1635179|NCT01823289|5713203|P1|Overall Study|Lost to Follow-up|5
1635180|NCT01823224|5713211|P2|Overall Study|Withdrawal by Subject|1
1635181|NCT01823224|5713212|P1|Overall Study|Withdrawal by Subject|0
1635182|NCT01823224|5713211|P2|Overall Study|missed med dose|1
1635183|NCT01823224|5713212|P1|Overall Study|missed med dose|0
1635184|NCT01823224|5713211|P2|Overall Study|pharmacy error|1
1635185|NCT01823224|5713212|P1|Overall Study|pharmacy error|0
1635186|NCT01823224|5713211|P2|Overall Study|didn't qualify|2
1635187|NCT01823224|5713212|P1|Overall Study|didn't qualify|1
1635188|NCT01823224|5713211|P2|Overall Study|Lost to Follow-up|6
1635189|NCT01823224|5713212|P1|Overall Study|Lost to Follow-up|5
1635190|NCT01823146|5713222|P2|Overall Study|Lost to Follow-up|1
1635191|NCT01823146|5713223|P1|Overall Study|Lost to Follow-up|2
1635192|NCT01823146|5713222|P2|Overall Study|Withdrawal by Subject|1
1635193|NCT01823146|5713223|P1|Overall Study|Withdrawal by Subject|0
1635194|NCT01823107|5713233|P1|Overall Study|Withdrawal by Subject|1
1635195|NCT01822899|5713241|P2|Overall Study|Withdrawal by Subject|7
1635196|NCT01822899|5713242|P1|Overall Study|Withdrawal by Subject|5
1635197|NCT01822899|5713241|P2|Overall Study|Lost to Follow-up|0
1635198|NCT01822899|5713242|P1|Overall Study|Lost to Follow-up|1
1635199|NCT01822899|5713241|P2|Overall Study|Protocol Violation|3
1635200|NCT01822899|5713242|P1|Overall Study|Protocol Violation|6
1635201|NCT01822899|5713241|P2|Overall Study|Lack of Efficacy|3
1635202|NCT01822899|5713242|P1|Overall Study|Lack of Efficacy|6
1635203|NCT01822899|5713241|P2|Overall Study|Adverse Event|5
1635204|NCT01822899|5713242|P1|Overall Study|Adverse Event|6
1635205|NCT01822821|5713260|P2|Overall Study|Other reasons|0
1635206|NCT01822821|5713261|P1|Overall Study|Other reasons|1
1635207|NCT01822821|5713260|P2|Overall Study|Eligible surgery cancelled|1
1635208|NCT01822821|5713261|P1|Overall Study|Eligible surgery cancelled|1
1635209|NCT01822756|5713290|P5|Overall Study|disease progression & patient preference|0
1635210|NCT01822756|5713291|P4|Overall Study|disease progression & patient preference|0
1635211|NCT01822756|5713292|P3|Overall Study|disease progression & patient preference|1
1635212|NCT01822756|5713293|P2|Overall Study|disease progression & patient preference|0
1635213|NCT01822756|5713294|P1|Overall Study|disease progression & patient preference|2
1635214|NCT01822756|5713290|P5|Overall Study|Physician Decision|0
1635215|NCT01822756|5713291|P4|Overall Study|Physician Decision|0
1635216|NCT01822756|5713292|P3|Overall Study|Physician Decision|0
1635217|NCT01822756|5713293|P2|Overall Study|Physician Decision|1
1635218|NCT01822756|5713294|P1|Overall Study|Physician Decision|0
1635219|NCT01822756|5713290|P5|Overall Study|Lost to Follow-up|1
1635220|NCT01822756|5713291|P4|Overall Study|Lost to Follow-up|0
1635221|NCT01822756|5713292|P3|Overall Study|Lost to Follow-up|1
1635222|NCT01822756|5713293|P2|Overall Study|Lost to Follow-up|0
1635223|NCT01822756|5713294|P1|Overall Study|Lost to Follow-up|1
1635224|NCT01822756|5713290|P5|Overall Study|Death|0
1635225|NCT01822756|5713291|P4|Overall Study|Death|0
1635226|NCT01822756|5713292|P3|Overall Study|Death|1
1635227|NCT01822756|5713293|P2|Overall Study|Death|2
1635228|NCT01822756|5713294|P1|Overall Study|Death|2
1635229|NCT01822756|5713290|P5|Overall Study|Disease progression|6
1635230|NCT01822756|5713291|P4|Overall Study|Disease progression|2
1635231|NCT01822756|5713292|P3|Overall Study|Disease progression|7
1635232|NCT01822756|5713293|P2|Overall Study|Disease progression|1
1635233|NCT01822756|5713294|P1|Overall Study|Disease progression|11
1635234|NCT01822756|5713290|P5|Overall Study|Adverse Event|0
1635235|NCT01822756|5713291|P4|Overall Study|Adverse Event|2
1635236|NCT01822756|5713292|P3|Overall Study|Adverse Event|0
1635237|NCT01822756|5713293|P2|Overall Study|Adverse Event|0
1635238|NCT01822756|5713294|P1|Overall Study|Adverse Event|0
1635239|NCT01822691|5713336|P1|Overall Study|Withdrawal by Subject|2
1635240|NCT01822678|5713347|P3|Overall Study|Lost to Follow-up|1
1635241|NCT01822678|5713348|P2|Overall Study|Lost to Follow-up|2
1635242|NCT01822678|5713349|P1|Overall Study|Lost to Follow-up|0
1635243|NCT01822678|5713347|P3|Overall Study|Lack of Efficacy|5
1635244|NCT01822678|5713348|P2|Overall Study|Lack of Efficacy|6
1635245|NCT01822678|5713349|P1|Overall Study|Lack of Efficacy|3
1635246|NCT01822678|5713347|P3|Overall Study|Adverse Event|1
1635247|NCT01822678|5713348|P2|Overall Study|Adverse Event|3
1635248|NCT01822678|5713349|P1|Overall Study|Adverse Event|4
1635249|NCT01822678|5713347|P3|Overall Study|Withdrawal by Subject|4
1635250|NCT01822678|5713348|P2|Overall Study|Withdrawal by Subject|4
1635251|NCT01822678|5713349|P1|Overall Study|Withdrawal by Subject|5
1635252|NCT01822665|5713357|P1|Overall Study|Other Reason|5
1635253|NCT01822665|5713357|P1|Overall Study|Adverse Event|3
1635254|NCT01822587|5713384|P3|Overall Study|Physician Decision|6
1635255|NCT01822587|5713385|P2|Overall Study|Physician Decision|6
1635256|NCT01822587|5713386|P1|Overall Study|Physician Decision|9
1635257|NCT01822587|5713384|P3|Overall Study|Lost to Follow-up|12
1635258|NCT01822587|5713385|P2|Overall Study|Lost to Follow-up|9
1635259|NCT01822587|5713386|P1|Overall Study|Lost to Follow-up|7
1635260|NCT01822561|5713425|P1|Overall Study|Withdrawal by Subject|2
1635261|NCT01822535|5713446|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
1635262|NCT01822535|5713447|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
1635263|NCT01822535|5713446|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
1635264|NCT01822535|5713447|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
1635265|NCT01822535|5713446|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
1635266|NCT01822535|5713447|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
1635267|NCT01822496|5713463|P4|Overall Study|Withdrawal by Subject|3
1635268|NCT01822496|5713464|P3|Overall Study|Withdrawal by Subject|0
1635269|NCT01822496|5713465|P2|Overall Study|Withdrawal by Subject|0
1635270|NCT01822496|5713466|P1|Overall Study|Withdrawal by Subject|0
1635271|NCT01822496|5713463|P4|Overall Study|Protocol Violation|1
1635272|NCT01822496|5713464|P3|Overall Study|Protocol Violation|0
1635273|NCT01822496|5713465|P2|Overall Study|Protocol Violation|2
1635274|NCT01822496|5713466|P1|Overall Study|Protocol Violation|2
1635275|NCT01822366|5713519|P4|Overall Study|Partial Intervention Completion|15
1635276|NCT01822366|5713520|P3|Overall Study|Partial Intervention Completion|0
1635277|NCT01822366|5713521|P2|Overall Study|Partial Intervention Completion|15
1635278|NCT01822366|5713522|P1|Overall Study|Partial Intervention Completion|0
1635279|NCT01822366|5713519|P4|Overall Study|Withdrawal by Subject|6
1635280|NCT01822366|5713520|P3|Overall Study|Withdrawal by Subject|0
1635281|NCT01822366|5713521|P2|Overall Study|Withdrawal by Subject|6
1635282|NCT01822366|5713522|P1|Overall Study|Withdrawal by Subject|0
1635283|NCT01822366|5713519|P4|Overall Study|Lost to Follow-up|1
1635284|NCT01822366|5713520|P3|Overall Study|Lost to Follow-up|5
1635285|NCT01822366|5713521|P2|Overall Study|Lost to Follow-up|1
1635286|NCT01822366|5713522|P1|Overall Study|Lost to Follow-up|5
1635287|NCT01822353|5713553|P3|Overall Study|Withdrawal by Subject|0
1635288|NCT01822353|5713554|P2|Overall Study|Withdrawal by Subject|1
1635289|NCT01822353|5713555|P1|Overall Study|Withdrawal by Subject|3
1635290|NCT01822353|5713553|P3|Overall Study|Pregnancy|0
1635291|NCT01822353|5713554|P2|Overall Study|Pregnancy|1
1635292|NCT01822353|5713555|P1|Overall Study|Pregnancy|0
1635293|NCT01822353|5713553|P3|Overall Study|Adverse Event|1
1635294|NCT01822353|5713554|P2|Overall Study|Adverse Event|3
1635295|NCT01822353|5713555|P1|Overall Study|Adverse Event|1
1635296|NCT01822223|5713575|P2|Overall Study|Death|1
1635297|NCT01822223|5713576|P1|Overall Study|Death|0
1635298|NCT01822132|5713600|P2|Overall Study|Lost to Follow-up|2
1635299|NCT01822132|5713601|P1|Overall Study|Lost to Follow-up|4
1635300|NCT01821963|5713638|P1|Overall Study|Adverse Event|1
1635301|NCT01821937|5713644|P2|Overall Study|Adverse Event|3
1635302|NCT01821937|5713645|P1|Overall Study|Adverse Event|0
1635303|NCT01821807|5713669|P2|Overall Study|Lost to Follow-up|1
1635304|NCT01821807|5713670|P1|Overall Study|Lost to Follow-up|3
1635305|NCT01821729|5713678|P1|Overall Study|Withdrawal by Subject|1
1635306|NCT01821625|5713683|P1|Overall Study|Medical contraindication|1
1635307|NCT01821625|5713683|P1|Overall Study|Adverse Event|1
1635308|NCT01821625|5713683|P1|Overall Study|Lack of Efficacy|2
1635309|NCT01821625|5713683|P1|Overall Study|Withdrawal by Subject|2
1635310|NCT01821560|5713689|P2|Overall Study|Protocol Violation|1
1635311|NCT01821560|5713690|P1|Overall Study|Protocol Violation|0
1635312|NCT01821560|5713689|P2|Overall Study|Withdrawal by Subject|1
1635313|NCT01821560|5713690|P1|Overall Study|Withdrawal by Subject|1
1635314|NCT01821560|5713689|P2|Overall Study|Lost to Follow-up|5
1635315|NCT01821560|5713690|P1|Overall Study|Lost to Follow-up|5
1635316|NCT01821118|5713811|P2|Overall Study|Death|1
1635317|NCT01821118|5713812|P1|Overall Study|Death|0
1635318|NCT01820637|5713859|P1|Overall Study|Withdrawal by Subject|1
1635319|NCT01820637|5713859|P1|Overall Study|Death|2
1635320|NCT01820585|5713868|P4|Overall Study|Pregnancy|0
1635321|NCT01820585|5713869|P3|Overall Study|Pregnancy|0
1635322|NCT01820585|5713870|P2|Overall Study|Pregnancy|1
1635323|NCT01820585|5713871|P1|Overall Study|Pregnancy|0
1635324|NCT01820585|5713868|P4|Overall Study|at sponsor request|0
1635325|NCT01820585|5713869|P3|Overall Study|at sponsor request|1
1635326|NCT01820585|5713870|P2|Overall Study|at sponsor request|0
1635327|NCT01820585|5713871|P1|Overall Study|at sponsor request|0
1635328|NCT01820585|5713868|P4|Overall Study|Subject non-compliance|2
1635329|NCT01820585|5713869|P3|Overall Study|Subject non-compliance|1
1635330|NCT01820585|5713870|P2|Overall Study|Subject non-compliance|0
1635331|NCT01820585|5713871|P1|Overall Study|Subject non-compliance|0
1635332|NCT01820585|5713868|P4|Overall Study|Protocol Violation|1
1635333|NCT01820585|5713869|P3|Overall Study|Protocol Violation|1
1635334|NCT01820585|5713870|P2|Overall Study|Protocol Violation|1
1635335|NCT01820585|5713871|P1|Overall Study|Protocol Violation|3
1635336|NCT01820585|5713868|P4|Overall Study|Lost to Follow-up|3
1635337|NCT01820585|5713869|P3|Overall Study|Lost to Follow-up|0
1635338|NCT01820585|5713870|P2|Overall Study|Lost to Follow-up|3
1635339|NCT01820585|5713871|P1|Overall Study|Lost to Follow-up|3
1635340|NCT01820585|5713868|P4|Overall Study|Withdrawal by Subject|8
1635341|NCT01820585|5713869|P3|Overall Study|Withdrawal by Subject|3
1635342|NCT01820585|5713870|P2|Overall Study|Withdrawal by Subject|7
1635343|NCT01820585|5713871|P1|Overall Study|Withdrawal by Subject|3
1635344|NCT01820585|5713868|P4|Overall Study|Lack of Efficacy|1
1635345|NCT01820585|5713869|P3|Overall Study|Lack of Efficacy|5
1635346|NCT01820585|5713870|P2|Overall Study|Lack of Efficacy|7
1635347|NCT01820585|5713871|P1|Overall Study|Lack of Efficacy|9
1635348|NCT01820585|5713868|P4|Overall Study|Adverse Event|34
1635349|NCT01820585|5713869|P3|Overall Study|Adverse Event|23
1635350|NCT01820585|5713870|P2|Overall Study|Adverse Event|13
1635351|NCT01820585|5713871|P1|Overall Study|Adverse Event|9
1635352|NCT01820559|5713884|P3|Overall Study|Lack of Efficacy|3
1635353|NCT01820559|5713885|P2|Overall Study|Lack of Efficacy|2
1635354|NCT01820559|5713886|P1|Overall Study|Lack of Efficacy|3
1635355|NCT01820559|5713884|P3|Overall Study|At sponsor request|1
1635356|NCT01820559|5713885|P2|Overall Study|At sponsor request|0
1635357|NCT01820559|5713886|P1|Overall Study|At sponsor request|0
1635358|NCT01820559|5713884|P3|Overall Study|Lost to Follow-up|2
1635359|NCT01820559|5713885|P2|Overall Study|Lost to Follow-up|2
1635360|NCT01820559|5713886|P1|Overall Study|Lost to Follow-up|3
1635361|NCT01820559|5713884|P3|Overall Study|Subject's non-compliance|2
1635362|NCT01820559|5713885|P2|Overall Study|Subject's non-compliance|0
1635363|NCT01820559|5713886|P1|Overall Study|Subject's non-compliance|1
1635364|NCT01820559|5713884|P3|Overall Study|Protocol Violation|3
1635365|NCT01820559|5713885|P2|Overall Study|Protocol Violation|1
1635366|NCT01820559|5713886|P1|Overall Study|Protocol Violation|2
1635367|NCT01820559|5713884|P3|Overall Study|Withdrawal by Subject|5
1635368|NCT01820559|5713885|P2|Overall Study|Withdrawal by Subject|2
1635369|NCT01820559|5713886|P1|Overall Study|Withdrawal by Subject|1
1635370|NCT01820559|5713884|P3|Overall Study|Adverse Event|13
1635371|NCT01820559|5713885|P2|Overall Study|Adverse Event|6
1635372|NCT01820559|5713886|P1|Overall Study|Adverse Event|4
1635373|NCT01820364|5713907|P2|Part II: LGX818 + MEK162|Study Termination|1
1635374|NCT01820364|5713908|P1|Part II: LGX818 + MEK162|Study Termination|0
1635375|NCT01820364|5713907|P2|Part I: LGX818|Disease Progression|0
1635376|NCT01820364|5713908|P1|Part I: LGX818|Disease Progression|4
1635377|NCT01820364|5713907|P2|Part I: LGX818|Adverse Event|0
1635378|NCT01820364|5713908|P1|Part I: LGX818|Adverse Event|6
1635379|NCT01820364|5713907|P2|Part I: LGX818|Administrative Problems|0
1635380|NCT01820364|5713908|P1|Part I: LGX818|Administrative Problems|3
1635381|NCT01820364|5713907|P2|Part I: LGX818|Death|0
1635382|NCT01820364|5713908|P1|Part I: LGX818|Death|1
1635383|NCT01819727|5714052|P2|Overall Study|Quit due to lack of health benifits|1
1635384|NCT01819727|5714053|P1|Overall Study|Quit due to lack of health benifits|0
1635385|NCT01819727|5714052|P2|Overall Study|Unable to demostrate ability self-inject|1
1635386|NCT01819727|5714053|P1|Overall Study|Unable to demostrate ability self-inject|0
1635387|NCT01819727|5714052|P2|Overall Study|Withdrawal by Subject|11
1635388|NCT01819727|5714053|P1|Overall Study|Withdrawal by Subject|6
1635389|NCT01819727|5714052|P2|Overall Study|Study Terminated by Sponsor|1
1635390|NCT01819727|5714053|P1|Overall Study|Study Terminated by Sponsor|0
1635391|NCT01819727|5714052|P2|Overall Study|Protocol Violation|2
1635392|NCT01819727|5714053|P1|Overall Study|Protocol Violation|0
1635393|NCT01819727|5714052|P2|Overall Study|Pregnancy|0
1635394|NCT01819727|5714053|P1|Overall Study|Pregnancy|1
1635395|NCT01819727|5714052|P2|Overall Study|Physician Decision|2
1635396|NCT01819727|5714053|P1|Overall Study|Physician Decision|3
1635397|NCT01819727|5714052|P2|Overall Study|Lost to Follow-up|1
1635398|NCT01819727|5714053|P1|Overall Study|Lost to Follow-up|1
1635399|NCT01819727|5714052|P2|Overall Study|Death|0
1635400|NCT01819727|5714053|P1|Overall Study|Death|1
1635401|NCT01819727|5714052|P2|Overall Study|Adverse Event|9
1635402|NCT01819727|5714053|P1|Overall Study|Adverse Event|8
1635403|NCT01819506|5714075|P2|Overall Study|Withdrawal by Subject|3
1635404|NCT01819506|5714076|P1|Overall Study|Withdrawal by Subject|3
1635405|NCT01819506|5714075|P2|Overall Study|Physician Decision|2
1635406|NCT01819506|5714076|P1|Overall Study|Physician Decision|5
1635407|NCT01819272|5714128|P6|Overall Study|Loss of Glucose Control|0
1635408|NCT01819272|5714129|P5|Overall Study|Loss of Glucose Control|2
1635409|NCT01819272|5714130|P4|Overall Study|Loss of Glucose Control|1
1635410|NCT01819272|5714131|P3|Overall Study|Loss of Glucose Control|0
1635411|NCT01819272|5714132|P2|Overall Study|Loss of Glucose Control|1
1635412|NCT01819272|5714133|P1|Overall Study|Loss of Glucose Control|2
1635413|NCT01819272|5714128|P6|Overall Study|Withdrawal of Consent|1
1635414|NCT01819272|5714129|P5|Overall Study|Withdrawal of Consent|0
1635415|NCT01819272|5714130|P4|Overall Study|Withdrawal of Consent|1
1635416|NCT01819272|5714131|P3|Overall Study|Withdrawal of Consent|2
1635417|NCT01819272|5714132|P2|Overall Study|Withdrawal of Consent|1
1635418|NCT01819272|5714133|P1|Overall Study|Withdrawal of Consent|0
1635419|NCT01819272|5714128|P6|Overall Study|Physician Decision|0
1635420|NCT01819272|5714129|P5|Overall Study|Physician Decision|0
1635421|NCT01819272|5714130|P4|Overall Study|Physician Decision|0
1635422|NCT01819272|5714131|P3|Overall Study|Physician Decision|0
1635423|NCT01819272|5714132|P2|Overall Study|Physician Decision|1
1635424|NCT01819272|5714133|P1|Overall Study|Physician Decision|0
1635425|NCT01819272|5714128|P6|Overall Study|Protocol Violation|3
1635426|NCT01819272|5714129|P5|Overall Study|Protocol Violation|2
1635427|NCT01819272|5714130|P4|Overall Study|Protocol Violation|1
1635428|NCT01819272|5714131|P3|Overall Study|Protocol Violation|0
1635429|NCT01819272|5714132|P2|Overall Study|Protocol Violation|0
1635430|NCT01819272|5714133|P1|Overall Study|Protocol Violation|0
1635431|NCT01819272|5714128|P6|Overall Study|Lost to Follow-up|3
1635432|NCT01819272|5714129|P5|Overall Study|Lost to Follow-up|0
1635433|NCT01819272|5714130|P4|Overall Study|Lost to Follow-up|0
1635434|NCT01819272|5714131|P3|Overall Study|Lost to Follow-up|1
1635435|NCT01819272|5714132|P2|Overall Study|Lost to Follow-up|0
1635436|NCT01819272|5714133|P1|Overall Study|Lost to Follow-up|3
1635437|NCT01819272|5714128|P6|Overall Study|Adverse Event|0
1635438|NCT01819272|5714129|P5|Overall Study|Adverse Event|0
1635439|NCT01819272|5714130|P4|Overall Study|Adverse Event|2
1635440|NCT01819272|5714131|P3|Overall Study|Adverse Event|0
1635441|NCT01819272|5714132|P2|Overall Study|Adverse Event|0
1635442|NCT01819272|5714133|P1|Overall Study|Adverse Event|1
1635443|NCT01819194|5714171|P1|Overall Study|Loss of study articles|2
1635444|NCT01819129|5714178|P2|Overall Study|Withdrawal Criteria|15
1635445|NCT01819129|5714179|P1|Overall Study|Withdrawal Criteria|20
1635446|NCT01819129|5714178|P2|Overall Study|Death|1
1635447|NCT01819129|5714179|P1|Overall Study|Death|1
1635448|NCT01819129|5714178|P2|Overall Study|Adverse Event|4
1635449|NCT01819129|5714179|P1|Overall Study|Adverse Event|1
1635450|NCT01819129|5714178|P2|Overall Study|Lack of Efficacy|1
1635451|NCT01819129|5714179|P1|Overall Study|Lack of Efficacy|0
1635452|NCT01819129|5714178|P2|Overall Study|Lost to Follow-up|2
1635453|NCT01819129|5714179|P1|Overall Study|Lost to Follow-up|5
1635454|NCT01819129|5714178|P2|Overall Study|Withdrawal by Subject|15
1635455|NCT01819129|5714179|P1|Overall Study|Withdrawal by Subject|15
1635456|NCT01819129|5714178|P2|Overall Study|Other, Subject moved out of the country|1
1635457|NCT01819129|5714179|P1|Overall Study|Other, Subject moved out of the country|0
1635458|NCT01819129|5714178|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
1635459|NCT01819129|5714179|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
1635460|NCT01819129|5714178|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
1635461|NCT01819129|5714179|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
1635462|NCT01818765|5714191|P1|Overall Study|Death|2
1635463|NCT01818752|5714204|P2|Overall Study|Randomized but not Dosed|4
1635464|NCT01818752|5714205|P1|Overall Study|Randomized but not Dosed|7
1635465|NCT01818752|5714204|P2|Overall Study|Continuing Treatment|4
1635466|NCT01818752|5714205|P1|Overall Study|Continuing Treatment|1
1635467|NCT01818752|5714204|P2|Overall Study|Other|8
1635468|NCT01818752|5714205|P1|Overall Study|Other|7
1635469|NCT01818752|5714204|P2|Overall Study|Disease Progression|48
1635470|NCT01818752|5714205|P1|Overall Study|Disease Progression|54
1635471|NCT01818752|5714204|P2|Overall Study|Physician Decision|8
1635472|NCT01818752|5714205|P1|Overall Study|Physician Decision|9
1635473|NCT01818752|5714204|P2|Overall Study|Withdrawal by Subject|14
1635474|NCT01818752|5714205|P1|Overall Study|Withdrawal by Subject|15
1635475|NCT01818752|5714204|P2|Overall Study|Non-compliance|20
1635476|NCT01818752|5714205|P1|Overall Study|Non-compliance|16
1635477|NCT01818752|5714204|P2|Overall Study|Death|18
1635478|NCT01818752|5714205|P1|Overall Study|Death|14
1635479|NCT01818752|5714204|P2|Overall Study|Adverse Event|74
1635480|NCT01818752|5714205|P1|Overall Study|Adverse Event|64
1635481|NCT01818726|5714225|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
1635482|NCT01818726|5714226|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
1635483|NCT01818726|5714225|P2|Overall Study|Withdrawal by Subject|1
1635484|NCT01818726|5714226|P1|Overall Study|Withdrawal by Subject|0
1635485|NCT01818726|5714225|P2|Overall Study|Administrative reasons|1
1635486|NCT01818726|5714226|P1|Overall Study|Administrative reasons|5
1635487|NCT01818700|5714236|P1|Overall Study|Other|1
1635488|NCT01818700|5714236|P1|Overall Study|Protocol Violation|2
1635489|NCT01818700|5714236|P1|Overall Study|Withdrawal by Subject|27
1635490|NCT01818700|5714236|P1|Overall Study|Lost to Follow-up|5
1635491|NCT01818700|5714236|P1|Overall Study|Lack of Efficacy|2
1635492|NCT01818700|5714236|P1|Overall Study|Adverse Event|67
1635493|NCT01818596|5714247|P2|Overall Study|Lost to Follow-up|0
1635494|NCT01818596|5714248|P1|Overall Study|Lost to Follow-up|7
1635495|NCT01818596|5714247|P2|Overall Study|Withdrew Consent|0
1635496|NCT01818596|5714248|P1|Overall Study|Withdrew Consent|5
1635497|NCT01818596|5714247|P2|Overall Study|Protocol Violation|0
1635498|NCT01818596|5714248|P1|Overall Study|Protocol Violation|1
1635499|NCT01818596|5714247|P2|Overall Study|Investigator's Discretion|0
1635500|NCT01818596|5714248|P1|Overall Study|Investigator's Discretion|4
1635501|NCT01818596|5714247|P2|Overall Study|Death|0
1635502|NCT01818596|5714248|P1|Overall Study|Death|3
1635503|NCT01818596|5714247|P2|Overall Study|Adverse Event|0
1635504|NCT01818596|5714248|P1|Overall Study|Adverse Event|7
1635505|NCT01818596|5714247|P2|Overall Study|Enrolled but Not Treated|0
1635506|NCT01818596|5714248|P1|Overall Study|Enrolled but Not Treated|4
1635507|NCT01818531|5714287|P2|Overall Study|Withdrawn for failure to place block|1
1635508|NCT01818531|5714288|P1|Overall Study|Withdrawn for failure to place block|0
1635509|NCT01818531|5714287|P2|Overall Study|Withdrawn for long-acting opioid patch|1
1635510|NCT01818531|5714288|P1|Overall Study|Withdrawn for long-acting opioid patch|0
1635511|NCT01818531|5714287|P2|Overall Study|Withdrawn for case delay after block|0
1635512|NCT01818531|5714288|P1|Overall Study|Withdrawn for case delay after block|1
1635513|NCT01818336|5714361|P2|Overall Study|Lost to Follow-up|1
1635514|NCT01818336|5714362|P1|Overall Study|Lost to Follow-up|0
1635515|NCT01818336|5714361|P2|Overall Study|Declined retest visit|11
1635516|NCT01818336|5714362|P1|Overall Study|Declined retest visit|0
1635517|NCT01818297|5714370|P2|Open Label Phase (3-12 Months)|Early study closure|10
1635518|NCT01818297|5714371|P1|Open Label Phase (3-12 Months)|Early study closure|17
1635519|NCT01818297|5714370|P2|Open Label Phase (3-12 Months)|Physician Decision|0
1635520|NCT01818297|5714371|P1|Open Label Phase (3-12 Months)|Physician Decision|1
1635521|NCT01818297|5714370|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
1635522|NCT01818297|5714371|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
1635523|NCT01818284|5714389|P2|Overall Study|Death|2
1635524|NCT01818284|5714390|P1|Overall Study|Death|0
1635525|NCT01818284|5714389|P2|Overall Study|Not eligible due to White Blood Counts|4
1635526|NCT01818284|5714390|P1|Overall Study|Not eligible due to White Blood Counts|4
1635527|NCT01818141|5714423|P2|Overall Study|Lost to Follow-up|2
1635528|NCT01818141|5714424|P1|Overall Study|Lost to Follow-up|0
1635529|NCT01818141|5714423|P2|Overall Study|No baseline C.diff colonies|1
1635530|NCT01818141|5714424|P1|Overall Study|No baseline C.diff colonies|1
1635531|NCT01818141|5714423|P2|Overall Study|Withdrawal by Subject|0
1635532|NCT01818141|5714424|P1|Overall Study|Withdrawal by Subject|2
1635541|NCT01817790|5714540|P2|Overall Study|Other: Could not attend appointment|1
1635542|NCT01817790|5714541|P1|Overall Study|Other: Could not attend appointment|1
1635543|NCT01817790|5714540|P2|Overall Study|Withdrawal by Subject|3
1635544|NCT01817790|5714541|P1|Overall Study|Withdrawal by Subject|1
1635545|NCT01817790|5714540|P2|Overall Study|Protocol Violation|1
1635546|NCT01817790|5714541|P1|Overall Study|Protocol Violation|2
1635547|NCT01817790|5714540|P2|Overall Study|Lost to Follow-up|1
1635548|NCT01817790|5714541|P1|Overall Study|Lost to Follow-up|0
1635549|NCT01817790|5714540|P2|Overall Study|Adverse Event|2
1635550|NCT01817790|5714541|P1|Overall Study|Adverse Event|0
1635551|NCT01817777|5714585|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
1635552|NCT01817777|5714586|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
1635553|NCT01817777|5714587|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
1635554|NCT01817777|5714585|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
1635555|NCT01817777|5714586|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
1635556|NCT01817777|5714587|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
1635557|NCT01817777|5714585|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1635558|NCT01817777|5714586|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
1635559|NCT01817777|5714587|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
1635560|NCT01817777|5714585|P3|Observational Phase (8 Weeks)|Early Study Termination|0
1635561|NCT01817777|5714586|P2|Observational Phase (8 Weeks)|Early Study Termination|0
1635562|NCT01817777|5714587|P1|Observational Phase (8 Weeks)|Early Study Termination|2
1635563|NCT01817777|5714585|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
1635564|NCT01817777|5714586|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
1635565|NCT01817777|5714587|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
1635566|NCT01817764|5714611|P2|Overall Study|Withdrawal by Subject|12
1635567|NCT01817764|5714612|P1|Overall Study|Withdrawal by Subject|10
1635568|NCT01817764|5714611|P2|Overall Study|Lost to Follow-up|4
1635569|NCT01817764|5714612|P1|Overall Study|Lost to Follow-up|1
1635570|NCT01817764|5714611|P2|Overall Study|Protocol Violation|5
1635571|NCT01817764|5714612|P1|Overall Study|Protocol Violation|7
1635572|NCT01817764|5714611|P2|Overall Study|Lack of Efficacy|7
1635573|NCT01817764|5714612|P1|Overall Study|Lack of Efficacy|9
1635574|NCT01817764|5714611|P2|Overall Study|Adverse Event|10
1635575|NCT01817764|5714612|P1|Overall Study|Adverse Event|7
1635576|NCT01817725|5714620|P1|Overall Study|Withdrawal by Subject|1
1635577|NCT01817582|5714641|P3|Overall Study|Randomized but exclusion criteria met|0
1635578|NCT01817582|5714642|P2|Overall Study|Randomized but exclusion criteria met|0
1635579|NCT01817582|5714643|P1|Overall Study|Randomized but exclusion criteria met|1
1635580|NCT01817582|5714641|P3|Overall Study|Participant revealed masked treatment|0
1635581|NCT01817582|5714642|P2|Overall Study|Participant revealed masked treatment|0
1635582|NCT01817582|5714643|P1|Overall Study|Participant revealed masked treatment|1
1635583|NCT01817582|5714641|P3|Overall Study|Withdrawal by Subject|0
1635584|NCT01817582|5714642|P2|Overall Study|Withdrawal by Subject|1
1635585|NCT01817582|5714643|P1|Overall Study|Withdrawal by Subject|0
1635586|NCT01816906|5714768|P2|12 Months|Lost to Follow-up|1
1635587|NCT01816906|5714769|P1|12 Months|Lost to Follow-up|2
1635588|NCT01816906|5714768|P2|12 Months|Death|2
1635589|NCT01816906|5714769|P1|12 Months|Death|0
1635590|NCT01816906|5714768|P2|12 Months|Adverse Event|2
1635591|NCT01816906|5714769|P1|12 Months|Adverse Event|2
1635592|NCT01816906|5714768|P2|Six Months|Lost to Follow-up|16
1635593|NCT01816906|5714769|P1|Six Months|Lost to Follow-up|14
1635594|NCT01816906|5714768|P2|Six Months|Did Not Show Up for Baseline Measurement|6
1635595|NCT01816906|5714769|P1|Six Months|Did Not Show Up for Baseline Measurement|7
1635596|NCT01816893|5714787|P2|Washout Period|Withdrawal by Subject|0
1635597|NCT01816893|5714788|P1|Washout Period|Withdrawal by Subject|2
1635598|NCT01816763|5714824|P3|Overall Study|The main reason for an incomplete survey|11
1635599|NCT01816763|5714825|P2|Overall Study|The main reason for an incomplete survey|15
1635600|NCT01816763|5714826|P1|Overall Study|The main reason for an incomplete survey|4
1635601|NCT01816685|5714842|P2|Overall Study|Surgery Cancelled|2
1635602|NCT01816685|5714843|P1|Overall Study|Surgery Cancelled|3
1635603|NCT01816685|5714842|P2|Overall Study|Lost to Follow-up|9
1635604|NCT01816685|5714843|P1|Overall Study|Lost to Follow-up|7
1635605|NCT01816594|5714853|P2|Overall Study|Physician Decision|0
1635606|NCT01816594|5714854|P1|Overall Study|Physician Decision|1
1635607|NCT01816594|5714853|P2|Overall Study|Withdrawal by Subject|0
1635608|NCT01816594|5714854|P1|Overall Study|Withdrawal by Subject|1
1635609|NCT01816594|5714853|P2|Overall Study|Adverse Event|0
1635610|NCT01816594|5714854|P1|Overall Study|Adverse Event|9
1635611|NCT01816594|5714853|P2|Overall Study|Local Progress|2
1635612|NCT01816594|5714854|P1|Overall Study|Local Progress|0
1635613|NCT01816477|5714892|P2|Overall Study|Unable to tolerate catheter placement|0
1635614|NCT01816477|5714893|P1|Overall Study|Unable to tolerate catheter placement|3
1635615|NCT01816477|5714892|P2|Overall Study|Withdrawal by Subject|1
1635616|NCT01816477|5714893|P1|Overall Study|Withdrawal by Subject|13
1635617|NCT01816295|5714947|P2|OLE Phase|Lack of Efficacy|7
1635618|NCT01816295|5714948|P1|OLE Phase|Lack of Efficacy|3
1635619|NCT01816295|5714947|P2|OLE Phase|Withdrawal by Subject|10
1635620|NCT01816295|5714948|P1|OLE Phase|Withdrawal by Subject|10
1635621|NCT01816295|5714947|P2|OLE Phase|Sponsor Decision|9
1635622|NCT01816295|5714948|P1|OLE Phase|Sponsor Decision|7
1635623|NCT01816295|5714947|P2|OLE Phase|Protocol Violation|4
1635624|NCT01816295|5714948|P1|OLE Phase|Protocol Violation|4
1635625|NCT01816295|5714947|P2|OLE Phase|Physician Decision|1
1635626|NCT01816295|5714948|P1|OLE Phase|Physician Decision|3
1635627|NCT01816295|5714947|P2|OLE Phase|Lost to Follow-up|5
1635628|NCT01816295|5714948|P1|OLE Phase|Lost to Follow-up|5
1635629|NCT01816295|5714947|P2|OLE Phase|Entry Criteria Not Met|5
1635630|NCT01816295|5714948|P1|OLE Phase|Entry Criteria Not Met|3
1635631|NCT01816295|5714947|P2|OLE Phase|Death|0
1635632|NCT01816295|5714948|P1|OLE Phase|Death|1
1635633|NCT01816295|5714947|P2|OLE Phase|Adverse Event|15
1635634|NCT01816295|5714948|P1|OLE Phase|Adverse Event|17
1635635|NCT01816295|5714947|P2|Double Blind Phase|Withdrawal by Subject|20
1635636|NCT01816295|5714948|P1|Double Blind Phase|Withdrawal by Subject|22
1635637|NCT01816295|5714947|P2|Double Blind Phase|Sponsor Decision|8
1635638|NCT01816295|5714948|P1|Double Blind Phase|Sponsor Decision|8
1635639|NCT01816295|5714947|P2|Double Blind Phase|Protocol Violation|11
1635640|NCT01816295|5714948|P1|Double Blind Phase|Protocol Violation|17
1635641|NCT01816295|5714947|P2|Double Blind Phase|Physician Decision|2
1635642|NCT01816295|5714948|P1|Double Blind Phase|Physician Decision|2
1635643|NCT01816295|5714947|P2|Double Blind Phase|Lost to Follow-up|5
1635644|NCT01816295|5714948|P1|Double Blind Phase|Lost to Follow-up|3
1635645|NCT01816295|5714947|P2|Double Blind Phase|Entry Criteria Not Met|2
1635646|NCT01816295|5714948|P1|Double Blind Phase|Entry Criteria Not Met|0
1635647|NCT01816295|5714947|P2|Double Blind Phase|Adverse Event|8
1635648|NCT01816295|5714948|P1|Double Blind Phase|Adverse Event|11
1635649|NCT01816243|5714963|P1|Overall Study|Amputation|3
1635650|NCT01816243|5714963|P1|Overall Study|Not eligible for the study|1
1635651|NCT01816243|5714963|P1|Overall Study|Lack of Efficacy|1
1635652|NCT01816243|5714963|P1|Overall Study|Lost to Follow-up|1
1635653|NCT01816243|5714963|P1|Overall Study|Adverse Event|6
1635654|NCT01816074|5714974|P4|Phase 2|Withdrawal by Subject|0
1635655|NCT01816074|5714975|P3|Phase 2|Withdrawal by Subject|0
1635656|NCT01816074|5714976|P2|Phase 2|Withdrawal by Subject|0
1635657|NCT01816074|5714977|P1|Phase 2|Withdrawal by Subject|1
1635658|NCT01816074|5714974|P4|Phase 2|Physician Decision|1
1635659|NCT01816074|5714975|P3|Phase 2|Physician Decision|0
1635660|NCT01816074|5714976|P2|Phase 2|Physician Decision|0
1635661|NCT01816074|5714977|P1|Phase 2|Physician Decision|0
1635662|NCT01816074|5714974|P4|Phase 2|Unsatisfied with Randomization assignmen|0
1635663|NCT01816074|5714975|P3|Phase 2|Unsatisfied with Randomization assignmen|0
1635664|NCT01816074|5714976|P2|Phase 2|Unsatisfied with Randomization assignmen|0
1635665|NCT01816074|5714977|P1|Phase 2|Unsatisfied with Randomization assignmen|1
1635666|NCT01816074|5714974|P4|Phase 2|Time commitment Issues|0
1635667|NCT01816074|5714975|P3|Phase 2|Time commitment Issues|0
1635668|NCT01816074|5714976|P2|Phase 2|Time commitment Issues|2
1635669|NCT01816074|5714977|P1|Phase 2|Time commitment Issues|0
1635670|NCT01816074|5714974|P4|Phase 1|Time commitment issues|0
1635671|NCT01816074|5714975|P3|Phase 1|Time commitment issues|1
1635672|NCT01816074|5714976|P2|Phase 1|Time commitment issues|0
1635673|NCT01816074|5714977|P1|Phase 1|Time commitment issues|0
1635674|NCT01816061|5715007|P2|Overall Study|Lost to Follow-up|24
1635675|NCT01816061|5715008|P1|Overall Study|Lost to Follow-up|13
1635676|NCT01816048|5715016|P1|Overall Study|Disease Progression|3
1635677|NCT01816048|5715016|P1|Overall Study|Withdrawal by Subject|1
1635678|NCT01816048|5715016|P1|Overall Study|Death|1
1635679|NCT01816048|5715016|P1|Overall Study|Adverse Event|1
1635680|NCT01815918|5715031|P2|Overall Study|Lack of Efficacy|15
1635681|NCT01815918|5715032|P1|Overall Study|Lack of Efficacy|15
1635682|NCT01815918|5715031|P2|Overall Study|Patient samples not analyzable|4
1635683|NCT01815918|5715032|P1|Overall Study|Patient samples not analyzable|3
1635684|NCT01815840|5715048|P2|Overall Study|Sponsor Termination Treatment|0
1635685|NCT01815840|5715049|P1|Overall Study|Sponsor Termination Treatment|1
1635686|NCT01815840|5715048|P2|Overall Study|Refused Treatment|1
1635687|NCT01815840|5715049|P1|Overall Study|Refused Treatment|5
1635688|NCT01815840|5715048|P2|Overall Study|Lost to Follow-up|6
1635689|NCT01815840|5715049|P1|Overall Study|Lost to Follow-up|3
1635690|NCT01815840|5715048|P2|Overall Study|Investigators Decision|3
1635691|NCT01815840|5715049|P1|Overall Study|Investigators Decision|2
1635692|NCT01815840|5715048|P2|Overall Study|Disease progression|2
1635693|NCT01815840|5715049|P1|Overall Study|Disease progression|3
1635694|NCT01815840|5715048|P2|Overall Study|Death|2
1635695|NCT01815840|5715049|P1|Overall Study|Death|2
1635696|NCT01815840|5715048|P2|Overall Study|Adverse Event|16
1635697|NCT01815840|5715049|P1|Overall Study|Adverse Event|10
1635698|NCT01815840|5715048|P2|Overall Study|Administrative/Other|3
1635699|NCT01815840|5715049|P1|Overall Study|Administrative/Other|1
1635700|NCT01815840|5715048|P2|Overall Study|Withdrew Consent|30
1635701|NCT01815840|5715049|P1|Overall Study|Withdrew Consent|31
1635702|NCT01815840|5715048|P2|Overall Study|Missing|0
1635703|NCT01815840|5715049|P1|Overall Study|Missing|1
1635704|NCT01815736|5715079|P2|Overall Study|Still on Study|449
1635705|NCT01815736|5715080|P1|Overall Study|Still on Study|929
1635706|NCT01815736|5715079|P2|Overall Study|Lost to Follow-up|7
1635707|NCT01815736|5715080|P1|Overall Study|Lost to Follow-up|6
1635708|NCT01815736|5715079|P2|Overall Study|Withdrew Consent|15
1635709|NCT01815736|5715080|P1|Overall Study|Withdrew Consent|7
1635710|NCT01815736|5715079|P2|Overall Study|Investigator's Discretion|0
1635711|NCT01815736|5715080|P1|Overall Study|Investigator's Discretion|4
1635712|NCT01815736|5715079|P2|Overall Study|Death|0
1635713|NCT01815736|5715080|P1|Overall Study|Death|4
1635714|NCT01815736|5715079|P2|Overall Study|Adverse Event|4
1635715|NCT01815736|5715080|P1|Overall Study|Adverse Event|7
1635716|NCT01815736|5715079|P2|Overall Study|Randomized but Not Treated|3
1635717|NCT01815736|5715080|P1|Overall Study|Randomized but Not Treated|4
1635718|NCT01815424|5715149|P5|Week 16 to 52|Withdrawal by Subject|0
1635719|NCT01815424|5715150|P4|Week 16 to 52|Withdrawal by Subject|0
1635720|NCT01815424|5715151|P3|Week 16 to 52|Withdrawal by Subject|0
1635721|NCT01815424|5715152|P2|Week 16 to 52|Withdrawal by Subject|2
1635722|NCT01815424|5715153|P1|Week 16 to 52|Withdrawal by Subject|1
1635723|NCT01815424|5715149|P5|Week 16 to 52|Lost to Follow-up|1
1635724|NCT01815424|5715150|P4|Week 16 to 52|Lost to Follow-up|2
1635725|NCT01815424|5715151|P3|Week 16 to 52|Lost to Follow-up|0
1635726|NCT01815424|5715152|P2|Week 16 to 52|Lost to Follow-up|2
1635727|NCT01815424|5715153|P1|Week 16 to 52|Lost to Follow-up|0
1635728|NCT01815424|5715149|P5|Week 16 to 52|Insufficient Clinical Response|1
1635729|NCT01815424|5715150|P4|Week 16 to 52|Insufficient Clinical Response|1
1635730|NCT01815424|5715151|P3|Week 16 to 52|Insufficient Clinical Response|0
1635731|NCT01815424|5715152|P2|Week 16 to 52|Insufficient Clinical Response|0
1635732|NCT01815424|5715153|P1|Week 16 to 52|Insufficient Clinical Response|1
1635733|NCT01815424|5715149|P5|Week 16 to 52|Adverse Event|1
1635734|NCT01815424|5715150|P4|Week 16 to 52|Adverse Event|0
1635735|NCT01815424|5715151|P3|Week 16 to 52|Adverse Event|0
1635736|NCT01815424|5715152|P2|Week 16 to 52|Adverse Event|0
1635737|NCT01815424|5715153|P1|Week 16 to 52|Adverse Event|0
1635738|NCT01815424|5715149|P5|Week 16 to 52|Other|0
1635739|NCT01815424|5715150|P4|Week 16 to 52|Other|0
1635740|NCT01815424|5715151|P3|Week 16 to 52|Other|0
1635741|NCT01815424|5715152|P2|Week 16 to 52|Other|1
1635742|NCT01815424|5715153|P1|Week 16 to 52|Other|0
1635743|NCT01815424|5715149|P5|Week 0 to 16|Insufficient Clinical Response|0
1635744|NCT01815424|5715150|P4|Week 0 to 16|Insufficient Clinical Response|0
1635745|NCT01815424|5715151|P3|Week 0 to 16|Insufficient Clinical Response|4
1635746|NCT01815424|5715152|P2|Week 0 to 16|Insufficient Clinical Response|0
1635747|NCT01815424|5715153|P1|Week 0 to 16|Insufficient Clinical Response|2
1635748|NCT01815424|5715149|P5|Week 0 to 16|Protocol Violation|0
1635749|NCT01815424|5715150|P4|Week 0 to 16|Protocol Violation|0
1635750|NCT01815424|5715151|P3|Week 0 to 16|Protocol Violation|0
1635751|NCT01815424|5715152|P2|Week 0 to 16|Protocol Violation|0
1635752|NCT01815424|5715153|P1|Week 0 to 16|Protocol Violation|1
1635753|NCT01815424|5715149|P5|Week 0 to 16|Other|0
1635754|NCT01815424|5715150|P4|Week 0 to 16|Other|0
1635755|NCT01815424|5715151|P3|Week 0 to 16|Other|3
1635756|NCT01815424|5715152|P2|Week 0 to 16|Other|0
1635757|NCT01815424|5715153|P1|Week 0 to 16|Other|1
1635758|NCT01815424|5715149|P5|Week 0 to 16|Withdrawal by Subject|0
1635759|NCT01815424|5715150|P4|Week 0 to 16|Withdrawal by Subject|0
1635760|NCT01815424|5715151|P3|Week 0 to 16|Withdrawal by Subject|1
1635761|NCT01815424|5715152|P2|Week 0 to 16|Withdrawal by Subject|0
1635762|NCT01815424|5715153|P1|Week 0 to 16|Withdrawal by Subject|0
1635763|NCT01815424|5715149|P5|Week 0 to 16|Lost to Follow-up|0
1635764|NCT01815424|5715150|P4|Week 0 to 16|Lost to Follow-up|0
1635765|NCT01815424|5715151|P3|Week 0 to 16|Lost to Follow-up|0
1635766|NCT01815424|5715152|P2|Week 0 to 16|Lost to Follow-up|1
1635767|NCT01815424|5715153|P1|Week 0 to 16|Lost to Follow-up|0
1635768|NCT01815424|5715149|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
1635769|NCT01815424|5715150|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
1635770|NCT01815424|5715151|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
1635771|NCT01815424|5715152|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
1635772|NCT01815424|5715153|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
1635773|NCT01815424|5715149|P5|Week 0 to 16|Adverse Event|0
1635774|NCT01815424|5715150|P4|Week 0 to 16|Adverse Event|0
1635775|NCT01815424|5715151|P3|Week 0 to 16|Adverse Event|3
1635776|NCT01815424|5715152|P2|Week 0 to 16|Adverse Event|3
1635777|NCT01815424|5715153|P1|Week 0 to 16|Adverse Event|1
1635778|NCT01815138|5715365|P2|Overall Study|Physician Decision|5
1635779|NCT01815138|5715366|P1|Overall Study|Physician Decision|8
1635780|NCT01815138|5715365|P2|Overall Study|Withdrawal by Subject|1
1635781|NCT01815138|5715366|P1|Overall Study|Withdrawal by Subject|0
1635782|NCT01815099|5715378|P1|Overall Study|unable to attend study visits|1
1635783|NCT01815099|5715378|P1|Overall Study|Lack of Efficacy|1
1635784|NCT01814878|5715392|P2|Overall Study|Other|0
1635785|NCT01814878|5715393|P1|Overall Study|Other|2
1635786|NCT01814878|5715392|P2|Overall Study|Screening failure (drop-out)|3
1635787|NCT01814878|5715393|P1|Overall Study|Screening failure (drop-out)|0
1635788|NCT01814878|5715392|P2|Overall Study|Physician Decision|1
1635789|NCT01814878|5715393|P1|Overall Study|Physician Decision|3
1635790|NCT01814878|5715392|P2|Overall Study|Protocol Violation|5
1635791|NCT01814878|5715393|P1|Overall Study|Protocol Violation|5
1635792|NCT01814878|5715392|P2|Overall Study|Withdrawal by Subject|16
1635793|NCT01814878|5715393|P1|Overall Study|Withdrawal by Subject|20
1635794|NCT01814878|5715392|P2|Overall Study|Adverse Event|5
1635795|NCT01814878|5715393|P1|Overall Study|Adverse Event|16
1635796|NCT01814800|5715432|P1|Overall Study|Subject relocation|1
1635797|NCT01814800|5715432|P1|Overall Study|Sponsor decision|1
1635798|NCT01814800|5715432|P1|Overall Study|Pregnancy|1
1635799|NCT01814800|5715432|P1|Overall Study|Adverse Event|2
1635800|NCT01814761|5715492|P2|Overall Study|Lost to Follow-up|5
1635801|NCT01814761|5715493|P1|Overall Study|Lost to Follow-up|1
1635802|NCT01814761|5715492|P2|Overall Study|Ocular Adverse Event|15
1635803|NCT01814761|5715493|P1|Overall Study|Ocular Adverse Event|6
1635804|NCT01814761|5715492|P2|Overall Study|Other Reasons|10
1635805|NCT01814761|5715493|P1|Overall Study|Other Reasons|1
1635806|NCT01814748|5715507|P2|Overall Study|Withdrawal by Subject|4
1635807|NCT01814748|5715508|P1|Overall Study|Withdrawal by Subject|6
1635808|NCT01814748|5715507|P2|Overall Study|Study site terminated by sponsor|1
1635809|NCT01814748|5715508|P1|Overall Study|Study site terminated by sponsor|1
1635810|NCT01814748|5715507|P2|Overall Study|Lost to Follow-up|2
1635811|NCT01814748|5715508|P1|Overall Study|Lost to Follow-up|1
1635812|NCT01814696|5715552|P2|Overall Study|Randomized to wrong group|0
1635813|NCT01814696|5715553|P1|Overall Study|Randomized to wrong group|1
1635814|NCT01814696|5715552|P2|Overall Study|Withdrawal by Subject|0
1635815|NCT01814696|5715553|P1|Overall Study|Withdrawal by Subject|1
1635816|NCT01814670|5715571|P1|Overall Study|Protocol Violation|12
1635817|NCT01814553|5715581|P2|Overall Study|Other than stated|8
1635818|NCT01814553|5715582|P1|Overall Study|Other than stated|7
1635819|NCT01814553|5715581|P2|Overall Study|Withdrawal by Subject|1
1635820|NCT01814553|5715582|P1|Overall Study|Withdrawal by Subject|1
1635821|NCT01814553|5715581|P2|Overall Study|Other Adverse Event|5
1635822|NCT01814553|5715582|P1|Overall Study|Other Adverse Event|4
1635823|NCT01814553|5715581|P2|Overall Study|PD per clinical progression|8
1635824|NCT01814553|5715582|P1|Overall Study|PD per clinical progression|6
1635825|NCT01814397|5715596|P1|Overall Study|Withdrawal by Subject|7
1635826|NCT01814397|5715596|P1|Overall Study|Adverse Event|7
1635827|NCT01814371|5715605|P2|Overall Study|Lost to Follow-up|27
1635828|NCT01814371|5715606|P1|Overall Study|Lost to Follow-up|30
1635829|NCT01814332|5715641|P2|Overall Study|Lost to Follow-up|1
1635830|NCT01814332|5715642|P1|Overall Study|Lost to Follow-up|5
1635831|NCT01814332|5715641|P2|Overall Study|Protocol Violation|4
1635832|NCT01814332|5715642|P1|Overall Study|Protocol Violation|0
1635833|NCT01814332|5715641|P2|Overall Study|Withdrawal by Subject|8
1635834|NCT01814332|5715642|P1|Overall Study|Withdrawal by Subject|3
1635835|NCT01814332|5715641|P2|Overall Study|Adverse Event|3
1635836|NCT01814332|5715642|P1|Overall Study|Adverse Event|8
1635837|NCT01814137|5715664|P2|Overall Study|Unclassified|1
1635838|NCT01814137|5715665|P1|Overall Study|Unclassified|2
1635839|NCT01814137|5715664|P2|Overall Study|Physician Decision|1
1635840|NCT01814137|5715665|P1|Overall Study|Physician Decision|1
1635841|NCT01814137|5715664|P2|Overall Study|Withdrawal by Subject|2
1635842|NCT01814137|5715665|P1|Overall Study|Withdrawal by Subject|2
1635843|NCT01814137|5715664|P2|Overall Study|Adverse Event|1
1635844|NCT01814137|5715665|P1|Overall Study|Adverse Event|0
1635845|NCT01814046|5715681|P3|Drug Administration|Death due to complications of RSV|0
1635846|NCT01814046|5715682|P2|Drug Administration|Death due to complications of RSV|0
1635847|NCT01814046|5715683|P1|Drug Administration|Death due to complications of RSV|1
1635848|NCT01813890|5715697|P3|Overall Study|Lack of Efficacy|2
1635849|NCT01813890|5715698|P2|Overall Study|Lack of Efficacy|1
1635850|NCT01813890|5715699|P1|Overall Study|Lack of Efficacy|9
1635851|NCT01813890|5715697|P3|Overall Study|Adverse Event|4
1635852|NCT01813890|5715698|P2|Overall Study|Adverse Event|3
1635853|NCT01813890|5715699|P1|Overall Study|Adverse Event|0
1635854|NCT01813721|5715736|P1|Overall Study|Withdrawal by Subject|1
1635855|NCT01813721|5715736|P1|Overall Study|Ineligibility determined|63
1635856|NCT01813474|5715791|P3|Overall Study|Death|1
1635857|NCT01813474|5715792|P2|Overall Study|Death|0
1635858|NCT01813474|5715793|P1|Overall Study|Death|0
1635859|NCT01813474|5715791|P3|Overall Study|Lack of Efficacy|9
1635860|NCT01813474|5715792|P2|Overall Study|Lack of Efficacy|6
1635861|NCT01813474|5715793|P1|Overall Study|Lack of Efficacy|2
1635862|NCT01813474|5715791|P3|Overall Study|Adverse Event|0
1635863|NCT01813474|5715792|P2|Overall Study|Adverse Event|1
1635864|NCT01813474|5715793|P1|Overall Study|Adverse Event|1
1635865|NCT01813474|5715791|P3|Overall Study|Withdrawal by Subject|1
1635866|NCT01813474|5715792|P2|Overall Study|Withdrawal by Subject|0
1635867|NCT01813474|5715793|P1|Overall Study|Withdrawal by Subject|0
1635868|NCT01813435|5715817|P2|Overall Study|Lost to Follow-up|237
1635869|NCT01813435|5715818|P1|Overall Study|Lost to Follow-up|268
1635870|NCT01813435|5715817|P2|Overall Study|did not finish experimental regimen|770
1635871|NCT01813435|5715818|P1|Overall Study|did not finish experimental regimen|1902
1635872|NCT01813422|5715842|P2|Overall Study|Lost to Follow-up|4
1635873|NCT01813422|5715843|P1|Overall Study|Lost to Follow-up|2
1635874|NCT01813422|5715842|P2|Overall Study|Sponsor Decision|1
1635875|NCT01813422|5715843|P1|Overall Study|Sponsor Decision|2
1635876|NCT01813422|5715842|P2|Overall Study|Death|3
1635877|NCT01813422|5715843|P1|Overall Study|Death|2
1635878|NCT01813422|5715842|P2|Overall Study|Withdrawal by Subject|8
1635879|NCT01813422|5715843|P1|Overall Study|Withdrawal by Subject|14
1635880|NCT01813071|5715888|P9|Overall Study|Met inc/exc criteria|1
1635881|NCT01813071|5715889|P8|Overall Study|Met inc/exc criteria|1
1635882|NCT01813071|5715890|P7|Overall Study|Met inc/exc criteria|0
1635883|NCT01813071|5715891|P6|Overall Study|Met inc/exc criteria|1
1635884|NCT01813071|5715892|P5|Overall Study|Met inc/exc criteria|0
1635885|NCT01813071|5715893|P4|Overall Study|Met inc/exc criteria|0
1635886|NCT01813071|5715894|P3|Overall Study|Met inc/exc criteria|0
1635887|NCT01813071|5715895|P2|Overall Study|Met inc/exc criteria|0
1635888|NCT01813071|5715896|P1|Overall Study|Met inc/exc criteria|0
1635889|NCT01813071|5715888|P9|Overall Study|Physician Decision|0
1635890|NCT01813071|5715889|P8|Overall Study|Physician Decision|0
1635891|NCT01813071|5715890|P7|Overall Study|Physician Decision|1
1635892|NCT01813071|5715891|P6|Overall Study|Physician Decision|0
1635893|NCT01813071|5715892|P5|Overall Study|Physician Decision|0
1635894|NCT01813071|5715893|P4|Overall Study|Physician Decision|0
1635895|NCT01813071|5715894|P3|Overall Study|Physician Decision|0
1635896|NCT01813071|5715895|P2|Overall Study|Physician Decision|0
1635897|NCT01813071|5715896|P1|Overall Study|Physician Decision|0
1635898|NCT01813071|5715888|P9|Overall Study|Adverse Event|0
1635899|NCT01813071|5715889|P8|Overall Study|Adverse Event|0
1635900|NCT01813071|5715890|P7|Overall Study|Adverse Event|0
1635901|NCT01813071|5715891|P6|Overall Study|Adverse Event|1
1635902|NCT01813071|5715892|P5|Overall Study|Adverse Event|0
1635903|NCT01813071|5715893|P4|Overall Study|Adverse Event|0
1635904|NCT01813071|5715894|P3|Overall Study|Adverse Event|0
1635905|NCT01813071|5715895|P2|Overall Study|Adverse Event|0
1635906|NCT01813071|5715896|P1|Overall Study|Adverse Event|0
1635907|NCT01813071|5715888|P9|Overall Study|Withdrawal by Subject|0
1635908|NCT01813071|5715889|P8|Overall Study|Withdrawal by Subject|0
1635909|NCT01813071|5715890|P7|Overall Study|Withdrawal by Subject|0
1635910|NCT01813071|5715891|P6|Overall Study|Withdrawal by Subject|1
1635911|NCT01813071|5715892|P5|Overall Study|Withdrawal by Subject|0
1635912|NCT01813071|5715893|P4|Overall Study|Withdrawal by Subject|0
1635913|NCT01813071|5715894|P3|Overall Study|Withdrawal by Subject|0
1635914|NCT01813071|5715895|P2|Overall Study|Withdrawal by Subject|0
1635915|NCT01813071|5715896|P1|Overall Study|Withdrawal by Subject|0
1635916|NCT01813071|5715888|P9|Overall Study|Protocol Violation|2
1635917|NCT01813071|5715889|P8|Overall Study|Protocol Violation|4
1635918|NCT01813071|5715890|P7|Overall Study|Protocol Violation|2
1635919|NCT01813071|5715891|P6|Overall Study|Protocol Violation|4
1635920|NCT01813071|5715892|P5|Overall Study|Protocol Violation|1
1635921|NCT01813071|5715893|P4|Overall Study|Protocol Violation|0
1635922|NCT01813071|5715894|P3|Overall Study|Protocol Violation|0
1635923|NCT01813071|5715895|P2|Overall Study|Protocol Violation|0
1635924|NCT01813071|5715896|P1|Overall Study|Protocol Violation|0
1635925|NCT01813058|5716363|P2|Overall Study|Withdrawal by Subject|4
1635926|NCT01813058|5716364|P1|Overall Study|Withdrawal by Subject|5
1635927|NCT01813019|5716372|P2|Overall Study|Protocol Deviation|1
1635928|NCT01813019|5716373|P1|Overall Study|Protocol Deviation|2
1635929|NCT01813019|5716372|P2|Overall Study|administrative problems|0
1635930|NCT01813019|5716373|P1|Overall Study|administrative problems|2
1635931|NCT01813019|5716372|P2|Overall Study|Withdrawal by Subject|2
1635932|NCT01813019|5716373|P1|Overall Study|Withdrawal by Subject|3
1635933|NCT01813019|5716372|P2|Overall Study|Adverse Event|3
1635934|NCT01813019|5716373|P1|Overall Study|Adverse Event|0
1635935|NCT01812837|5716384|P3|Overall Study|Protocol Violation|0
1635936|NCT01812837|5716385|P2|Overall Study|Protocol Violation|0
1635937|NCT01812837|5716386|P1|Overall Study|Protocol Violation|1
1635938|NCT01812837|5716384|P3|Overall Study|Lost to Follow-up|0
1635939|NCT01812837|5716385|P2|Overall Study|Lost to Follow-up|1
1635940|NCT01812837|5716386|P1|Overall Study|Lost to Follow-up|1
1635941|NCT01812707|5716398|P4|Overall Study|Consent withdrawn by participant|0
1635942|NCT01812707|5716399|P3|Overall Study|Consent withdrawn by participant|0
1635943|NCT01812707|5716400|P2|Overall Study|Consent withdrawn by participant|0
1635944|NCT01812707|5716401|P1|Overall Study|Consent withdrawn by participant|1
1635945|NCT01812707|5716398|P4|Overall Study|Poor compliance to protocol|0
1635946|NCT01812707|5716399|P3|Overall Study|Poor compliance to protocol|0
1635947|NCT01812707|5716400|P2|Overall Study|Poor compliance to protocol|0
1635948|NCT01812707|5716401|P1|Overall Study|Poor compliance to protocol|1
1635949|NCT01812707|5716398|P4|Overall Study|Adverse Event|2
1635950|NCT01812707|5716399|P3|Overall Study|Adverse Event|0
1635951|NCT01812707|5716400|P2|Overall Study|Adverse Event|0
1635952|NCT01812707|5716401|P1|Overall Study|Adverse Event|0
1635953|NCT01812655|5716449|P3|Overall Study|Protocol Violation|0
1635954|NCT01812655|5716450|P2|Overall Study|Protocol Violation|1
1635955|NCT01812655|5716451|P1|Overall Study|Protocol Violation|1
1635956|NCT01812057|5716476|P2|Overall Study|Physician Decision|0
1635957|NCT01812057|5716477|P1|Overall Study|Physician Decision|1
1635958|NCT01812057|5716476|P2|Overall Study|Protocol Violation|0
1635959|NCT01812057|5716477|P1|Overall Study|Protocol Violation|1
1635960|NCT01811953|5716580|P6|Overall Study|Protocol Violation|0
1635961|NCT01811953|5716581|P5|Overall Study|Protocol Violation|1
1635962|NCT01811953|5716582|P4|Overall Study|Protocol Violation|0
1635963|NCT01811953|5716583|P3|Overall Study|Protocol Violation|0
1635964|NCT01811953|5716584|P2|Overall Study|Protocol Violation|0
1635965|NCT01811953|5716585|P1|Overall Study|Protocol Violation|0
1635966|NCT01811953|5716580|P6|Overall Study|Adverse Event|1
1635967|NCT01811953|5716581|P5|Overall Study|Adverse Event|0
1635968|NCT01811953|5716582|P4|Overall Study|Adverse Event|1
1635969|NCT01811953|5716583|P3|Overall Study|Adverse Event|0
1635970|NCT01811953|5716584|P2|Overall Study|Adverse Event|0
1635971|NCT01811953|5716585|P1|Overall Study|Adverse Event|0
1635972|NCT01811732|5716642|P2|Overall Study|Correct study drug not available on site|0
1635973|NCT01811732|5716643|P1|Overall Study|Correct study drug not available on site|1
1635974|NCT01811732|5716642|P2|Overall Study|Admitted to another facility|0
1635975|NCT01811732|5716643|P1|Overall Study|Admitted to another facility|1
1635976|NCT01811732|5716642|P2|Overall Study|Subject incarcerated|2
1635977|NCT01811732|5716643|P1|Overall Study|Subject incarcerated|1
1635978|NCT01811732|5716642|P2|Overall Study|Protocol Violation|1
1635979|NCT01811732|5716643|P1|Overall Study|Protocol Violation|0
1635980|NCT01811732|5716642|P2|Overall Study|Insufficient venous access|1
1635981|NCT01811732|5716643|P1|Overall Study|Insufficient venous access|0
1635982|NCT01811732|5716642|P2|Overall Study|Death|1
1635983|NCT01811732|5716643|P1|Overall Study|Death|1
1635984|NCT01811732|5716642|P2|Overall Study|Physician Decision|0
1635985|NCT01811732|5716643|P1|Overall Study|Physician Decision|2
1635986|NCT01811732|5716642|P2|Overall Study|Non-compliance with study drug/procedure|3
1635987|NCT01811732|5716643|P1|Overall Study|Non-compliance with study drug/procedure|3
1635988|NCT01811732|5716642|P2|Overall Study|Lack of Efficacy|1
1635989|NCT01811732|5716643|P1|Overall Study|Lack of Efficacy|3
1635990|NCT01811732|5716642|P2|Overall Study|Adverse Event|9
1635991|NCT01811732|5716643|P1|Overall Study|Adverse Event|3
1635992|NCT01811732|5716642|P2|Overall Study|Withdrawal by Subject|10
1635993|NCT01811732|5716643|P1|Overall Study|Withdrawal by Subject|16
1635994|NCT01811732|5716642|P2|Overall Study|Lost to Follow-up|30
1635995|NCT01811732|5716643|P1|Overall Study|Lost to Follow-up|24
1635996|NCT01811706|5716653|P2|First Intervention ( 4 Weeks)|Adverse Event|0
1635997|NCT01811706|5716654|P1|First Intervention ( 4 Weeks)|Adverse Event|1
1635998|NCT01811563|5716682|P2|Overall Study|Incorrect Randomization procedure|1
1635999|NCT01811563|5716683|P1|Overall Study|Incorrect Randomization procedure|0
1636000|NCT01811563|5716682|P2|Overall Study|Lost to Follow-up|2
1636001|NCT01811563|5716683|P1|Overall Study|Lost to Follow-up|5
1636002|NCT01811485|5716712|P3|Overall Study|Protocol Deviation|0
1636003|NCT01811485|5716713|P2|Overall Study|Protocol Deviation|1
1636004|NCT01811485|5716714|P1|Overall Study|Protocol Deviation|0
1636005|NCT01811485|5716712|P3|Overall Study|Administrative problems|0
1636006|NCT01811485|5716713|P2|Overall Study|Administrative problems|0
1636007|NCT01811485|5716714|P1|Overall Study|Administrative problems|1
1636008|NCT01811485|5716712|P3|Overall Study|Unsatisfactory therapeutic effect|3
1636009|NCT01811485|5716713|P2|Overall Study|Unsatisfactory therapeutic effect|0
1636010|NCT01811485|5716714|P1|Overall Study|Unsatisfactory therapeutic effect|0
1636011|NCT01811485|5716712|P3|Overall Study|Adverse Event|2
1636012|NCT01811485|5716713|P2|Overall Study|Adverse Event|3
1636013|NCT01811485|5716714|P1|Overall Study|Adverse Event|1
1636014|NCT01811472|5716734|P3|Overall Study|Subject/guardian decision|0
1636015|NCT01811472|5716735|P2|Overall Study|Subject/guardian decision|0
1636016|NCT01811472|5716736|P1|Overall Study|Subject/guardian decision|1
1636017|NCT01811472|5716734|P3|Overall Study|Lost to Follow-up|1
1636018|NCT01811472|5716735|P2|Overall Study|Lost to Follow-up|0
1636019|NCT01811472|5716736|P1|Overall Study|Lost to Follow-up|0
1636020|NCT01811472|5716734|P3|Overall Study|Adverse Event|4
1636021|NCT01811472|5716735|P2|Overall Study|Adverse Event|0
1636022|NCT01811472|5716736|P1|Overall Study|Adverse Event|1
1636023|NCT01811238|5716823|P1|Overall Study|subject refused study medication|6
1636024|NCT01811238|5716823|P1|Overall Study|Lack of Efficacy|4
1636025|NCT01811238|5716823|P1|Overall Study|Protocol Violation|4
1636026|NCT01811238|5716823|P1|Overall Study|Adverse Event|25
1636027|NCT01811238|5716823|P1|Overall Study|Withdrawal by Subject|42
1636028|NCT01811186|5716847|P2|Overall Study|Lost to Follow-up|2
1636029|NCT01811186|5716848|P1|Overall Study|Lost to Follow-up|4
1636030|NCT01811186|5716847|P2|Overall Study|Lack of Efficacy|6
1636031|NCT01811186|5716848|P1|Overall Study|Lack of Efficacy|3
1636032|NCT01811186|5716847|P2|Overall Study|Withdrawal by Subject|10
1636033|NCT01811186|5716848|P1|Overall Study|Withdrawal by Subject|5
1636034|NCT01811186|5716847|P2|Overall Study|Protocol Violation|6
1636035|NCT01811186|5716848|P1|Overall Study|Protocol Violation|5
1636036|NCT01811186|5716847|P2|Overall Study|Adverse Event|38
1636037|NCT01811186|5716848|P1|Overall Study|Adverse Event|54
1636038|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1636039|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
1636040|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
1636041|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
1636042|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
1636043|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
1636044|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
1636045|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
1636046|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
1636047|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
1636048|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
1636049|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
1636050|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1636051|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
1636052|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
1636053|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
1636054|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1636055|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
1636056|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Death|1
1636057|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Death|0
1636058|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Death|0
1636059|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1636060|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
1636061|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
1636062|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1636063|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
1636064|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
1636065|NCT01810939|5716902|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1636066|NCT01810939|5716903|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
1636067|NCT01810939|5716904|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
1636068|NCT01810939|5716902|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
1636069|NCT01810939|5716903|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
1636070|NCT01810939|5716904|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
1636071|NCT01810939|5716902|P3|Part A Treatment Period|Protocol-specified (High K+)|0
1636072|NCT01810939|5716903|P2|Part A Treatment Period|Protocol-specified (High K+)|0
1636073|NCT01810939|5716904|P1|Part A Treatment Period|Protocol-specified (High K+)|3
1636074|NCT01810939|5716902|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
1636075|NCT01810939|5716903|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
1636076|NCT01810939|5716904|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
1636077|NCT01810939|5716902|P3|Part A Treatment Period|Withdrawal by Subject|0
1636078|NCT01810939|5716903|P2|Part A Treatment Period|Withdrawal by Subject|0
1636079|NCT01810939|5716904|P1|Part A Treatment Period|Withdrawal by Subject|5
1636080|NCT01810939|5716902|P3|Part A Treatment Period|Adverse Event|0
1636081|NCT01810939|5716903|P2|Part A Treatment Period|Adverse Event|0
1636082|NCT01810939|5716904|P1|Part A Treatment Period|Adverse Event|10
1636083|NCT01810939|5716902|P3|Part A Treatment Period|Protocol Violation|0
1636084|NCT01810939|5716903|P2|Part A Treatment Period|Protocol Violation|0
1636085|NCT01810939|5716904|P1|Part A Treatment Period|Protocol Violation|2
1636086|NCT01810939|5716902|P3|Part A Treatment Period|Non-compliance with Study Drug|0
1636087|NCT01810939|5716903|P2|Part A Treatment Period|Non-compliance with Study Drug|0
1636088|NCT01810939|5716904|P1|Part A Treatment Period|Non-compliance with Study Drug|1
1636089|NCT01810783|5716917|P1|Overall Study|Enrolled, not treated|1
1636090|NCT01810783|5716917|P1|Overall Study|Adminstrative or other reason(s)|23
1636091|NCT01810783|5716917|P1|Overall Study|Non-compliance with IMP|4
1636092|NCT01810783|5716917|P1|Overall Study|Protocol Violation|5
1636093|NCT01810783|5716917|P1|Overall Study|Lost to Follow-up|10
1636094|NCT01810783|5716917|P1|Overall Study|Lack of Efficacy|12
1636095|NCT01810783|5716917|P1|Overall Study|Withdrawal by Subject|22
1636096|NCT01810783|5716917|P1|Overall Study|Adverse Event|32
1636097|NCT01810432|5716942|P2|Period 2|Lost to Follow-up|1
1636098|NCT01810432|5716943|P1|Period 2|Lost to Follow-up|1
1636099|NCT01810432|5716942|P2|Period 2|Physician Decision|0
1636100|NCT01810432|5716943|P1|Period 2|Physician Decision|1
1636101|NCT01810432|5716942|P2|Period 2|Withdrawal by Subject|1
1636102|NCT01810432|5716943|P1|Period 2|Withdrawal by Subject|2
1636103|NCT01810432|5716942|P2|Washout|Adverse Event|0
1636104|NCT01810432|5716943|P1|Washout|Adverse Event|1
1636105|NCT01810432|5716942|P2|Washout|Protocol Violation|1
1636106|NCT01810432|5716943|P1|Washout|Protocol Violation|0
1636107|NCT01810380|5716956|P3|Overall Study|Administrative or other reasons|9
1636108|NCT01810380|5716957|P2|Overall Study|Administrative or other reasons|13
1636109|NCT01810380|5716958|P1|Overall Study|Administrative or other reasons|11
1636110|NCT01810380|5716956|P3|Overall Study|Withdrawal by Subject|6
1636111|NCT01810380|5716957|P2|Overall Study|Withdrawal by Subject|0
1636112|NCT01810380|5716958|P1|Overall Study|Withdrawal by Subject|6
1636113|NCT01810380|5716956|P3|Overall Study|Protocol Violation|1
1636114|NCT01810380|5716957|P2|Overall Study|Protocol Violation|0
1636115|NCT01810380|5716958|P1|Overall Study|Protocol Violation|1
1636116|NCT01810380|5716956|P3|Overall Study|Lack of Efficacy|11
1636117|NCT01810380|5716957|P2|Overall Study|Lack of Efficacy|10
1636118|NCT01810380|5716958|P1|Overall Study|Lack of Efficacy|24
1636119|NCT01810380|5716956|P3|Overall Study|Adverse Event|4
1636120|NCT01810380|5716957|P2|Overall Study|Adverse Event|14
1636121|NCT01810380|5716958|P1|Overall Study|Adverse Event|11
1636122|NCT01810380|5716956|P3|Overall Study|Randomised not treated|1
1636123|NCT01810380|5716957|P2|Overall Study|Randomised not treated|1
1636124|NCT01810380|5716958|P1|Overall Study|Randomised not treated|2
1636125|NCT01810302|5717019|P2|Overall Study|Physician Decision|1
1636126|NCT01810302|5717020|P1|Overall Study|Physician Decision|0
1636127|NCT01810302|5717019|P2|Overall Study|Death|0
1636128|NCT01810302|5717020|P1|Overall Study|Death|1
1636129|NCT01810263|5717047|P2|Overall Study|Lost to Follow-up|7
1636130|NCT01810263|5717048|P1|Overall Study|Lost to Follow-up|8
1636131|NCT01810042|5717054|P1|Overall Study|Lost to Follow-up|10
1636132|NCT01810016|5717064|P3|Overall Study|Death|1
1636133|NCT01810016|5717065|P2|Overall Study|Death|0
1636134|NCT01810016|5717066|P1|Overall Study|Death|0
1636135|NCT01810016|5717064|P3|Overall Study|Progressive disease|0
1636136|NCT01810016|5717065|P2|Overall Study|Progressive disease|1
1636137|NCT01810016|5717066|P1|Overall Study|Progressive disease|1
1636138|NCT01809327|5717136|P5|Overall Study|Other|9
1636139|NCT01809327|5717137|P4|Overall Study|Other|4
1636140|NCT01809327|5717138|P3|Overall Study|Other|7
1636141|NCT01809327|5717139|P2|Overall Study|Other|15
1636142|NCT01809327|5717140|P1|Overall Study|Other|14
1636143|NCT01809327|5717136|P5|Overall Study|Pregnancy|0
1636144|NCT01809327|5717137|P4|Overall Study|Pregnancy|0
1636145|NCT01809327|5717138|P3|Overall Study|Pregnancy|0
1636146|NCT01809327|5717139|P2|Overall Study|Pregnancy|0
1636147|NCT01809327|5717140|P1|Overall Study|Pregnancy|1
1636148|NCT01809327|5717136|P5|Overall Study|Physician Decision|0
1636149|NCT01809327|5717137|P4|Overall Study|Physician Decision|0
1636150|NCT01809327|5717138|P3|Overall Study|Physician Decision|0
1636151|NCT01809327|5717139|P2|Overall Study|Physician Decision|1
1636152|NCT01809327|5717140|P1|Overall Study|Physician Decision|1
1636153|NCT01809327|5717136|P5|Overall Study|Protocol Violation|0
1636154|NCT01809327|5717137|P4|Overall Study|Protocol Violation|0
1636155|NCT01809327|5717138|P3|Overall Study|Protocol Violation|0
1636156|NCT01809327|5717139|P2|Overall Study|Protocol Violation|1
1636157|NCT01809327|5717140|P1|Overall Study|Protocol Violation|0
1636158|NCT01809327|5717136|P5|Overall Study|Death|0
1636159|NCT01809327|5717137|P4|Overall Study|Death|0
1636160|NCT01809327|5717138|P3|Overall Study|Death|0
1636161|NCT01809327|5717139|P2|Overall Study|Death|0
1636162|NCT01809327|5717140|P1|Overall Study|Death|1
1636163|NCT01809327|5717136|P5|Overall Study|Adverse Event|8
1636164|NCT01809327|5717137|P4|Overall Study|Adverse Event|4
1636165|NCT01809327|5717138|P3|Overall Study|Adverse Event|7
1636166|NCT01809327|5717139|P2|Overall Study|Adverse Event|3
1636167|NCT01809327|5717140|P1|Overall Study|Adverse Event|4
1636168|NCT01809327|5717136|P5|Overall Study|Withdrawal by Subject|5
1636169|NCT01809327|5717137|P4|Overall Study|Withdrawal by Subject|2
1636170|NCT01809327|5717138|P3|Overall Study|Withdrawal by Subject|4
1636171|NCT01809327|5717139|P2|Overall Study|Withdrawal by Subject|4
1636172|NCT01809327|5717140|P1|Overall Study|Withdrawal by Subject|6
1636173|NCT01809327|5717136|P5|Overall Study|Lost to Follow-up|3
1636174|NCT01809327|5717137|P4|Overall Study|Lost to Follow-up|2
1636175|NCT01809327|5717138|P3|Overall Study|Lost to Follow-up|4
1636176|NCT01809327|5717139|P2|Overall Study|Lost to Follow-up|2
1636177|NCT01809327|5717140|P1|Overall Study|Lost to Follow-up|5
1636178|NCT01809314|5717182|P1|Overall Study|Lost to Follow-up|724
1636179|NCT01809314|5717182|P1|Overall Study|Insufficient Therapeutic Response|14
1636180|NCT01809314|5717182|P1|Overall Study|Adverse Event|6
1636181|NCT01809314|5717182|P1|Overall Study|Withdrawal Prior to Treatment|1
1636182|NCT01809262|5717188|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
1636183|NCT01809262|5717189|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
1636184|NCT01809262|5717190|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
1636185|NCT01809262|5717191|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
1636186|NCT01809262|5717192|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
1636187|NCT01809262|5717193|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
1636188|NCT01809262|5717194|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
1636189|NCT01809262|5717195|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
1636190|NCT01809262|5717196|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
1636191|NCT01809262|5717197|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
1636192|NCT01809262|5717188|P10|Period 1 (First Dose + Washout)|Adverse Event|0
1636193|NCT01809262|5717189|P9|Period 1 (First Dose + Washout)|Adverse Event|0
1636194|NCT01809262|5717190|P8|Period 1 (First Dose + Washout)|Adverse Event|0
1636195|NCT01809262|5717191|P7|Period 1 (First Dose + Washout)|Adverse Event|0
1636196|NCT01809262|5717192|P6|Period 1 (First Dose + Washout)|Adverse Event|0
1636197|NCT01809262|5717193|P5|Period 1 (First Dose + Washout)|Adverse Event|1
1636198|NCT01809262|5717194|P4|Period 1 (First Dose + Washout)|Adverse Event|0
1636199|NCT01809262|5717195|P3|Period 1 (First Dose + Washout)|Adverse Event|0
1636200|NCT01809262|5717196|P2|Period 1 (First Dose + Washout)|Adverse Event|0
1636201|NCT01809262|5717197|P1|Period 1 (First Dose + Washout)|Adverse Event|0
1636202|NCT01809210|5717271|P7|Overall Study|Death|1
1636203|NCT01809210|5717272|P6|Overall Study|Death|3
1636204|NCT01809210|5717273|P5|Overall Study|Death|1
1636205|NCT01809210|5717274|P4|Overall Study|Death|0
1636206|NCT01809210|5717275|P3|Overall Study|Death|2
1636207|NCT01809210|5717276|P2|Overall Study|Death|1
1636208|NCT01809210|5717277|P1|Overall Study|Death|1
1636209|NCT01809210|5717271|P7|Overall Study|Withdrawal by Subject|4
1636210|NCT01809210|5717272|P6|Overall Study|Withdrawal by Subject|0
1636211|NCT01809210|5717273|P5|Overall Study|Withdrawal by Subject|1
1636212|NCT01809210|5717274|P4|Overall Study|Withdrawal by Subject|1
1636213|NCT01809210|5717275|P3|Overall Study|Withdrawal by Subject|1
1636214|NCT01809210|5717276|P2|Overall Study|Withdrawal by Subject|0
1636215|NCT01809210|5717277|P1|Overall Study|Withdrawal by Subject|0
1636216|NCT01809197|5717351|P2|Overall Study|Product not available|1
1636217|NCT01809197|5717352|P1|Overall Study|Product not available|0
1636218|NCT01809197|5717351|P2|Overall Study|Withdrawal by Subject|1
1636219|NCT01809197|5717352|P1|Overall Study|Withdrawal by Subject|1
1636220|NCT01809197|5717351|P2|Overall Study|Decision Unrelated to an Adverse Event|0
1636221|NCT01809197|5717352|P1|Overall Study|Decision Unrelated to an Adverse Event|1
1636222|NCT01809197|5717351|P2|Overall Study|Non-Compliance|1
1636223|NCT01809197|5717352|P1|Overall Study|Non-Compliance|1
1636224|NCT01809197|5717351|P2|Overall Study|Failed slit lamp exam|0
1636225|NCT01809197|5717352|P1|Overall Study|Failed slit lamp exam|1
1636226|NCT01809197|5717351|P2|Overall Study|Adverse Event|3
1636227|NCT01809197|5717352|P1|Overall Study|Adverse Event|2
1636228|NCT01809197|5717351|P2|Overall Study|Lost to Follow-up|2
1636229|NCT01809197|5717352|P1|Overall Study|Lost to Follow-up|4
1636230|NCT01808690|5717433|P2|Overall Study|Withdrawal by Subject|2
1636231|NCT01808690|5717434|P1|Overall Study|Withdrawal by Subject|1
1636232|NCT01808651|5717453|P3|Study Period 1|Participant Decision|3
1636233|NCT01808651|5717454|P2|Study Period 1|Participant Decision|7
1636234|NCT01808651|5717455|P1|Study Period 1|Participant Decision|9
1636235|NCT01808651|5717453|P3|Study Period 1|Adverse Event|1
1636236|NCT01808651|5717454|P2|Study Period 1|Adverse Event|4
1636237|NCT01808651|5717455|P1|Study Period 1|Adverse Event|10
1636238|NCT01808651|5717453|P3|Study Period 1|Lack of Efficacy|0
1636239|NCT01808651|5717454|P2|Study Period 1|Lack of Efficacy|1
1636240|NCT01808651|5717455|P1|Study Period 1|Lack of Efficacy|2
1636241|NCT01808651|5717453|P3|Study Period 1|Physician Decision|0
1636242|NCT01808651|5717454|P2|Study Period 1|Physician Decision|2
1636243|NCT01808651|5717455|P1|Study Period 1|Physician Decision|3
1636244|NCT01808651|5717453|P3|Study Period 1|Protocol Violation|1
1636245|NCT01808651|5717454|P2|Study Period 1|Protocol Violation|0
1636246|NCT01808651|5717455|P1|Study Period 1|Protocol Violation|1
1636247|NCT01808651|5717453|P3|Study Period 1|Lost to Follow-up|0
1636248|NCT01808651|5717454|P2|Study Period 1|Lost to Follow-up|3
1636249|NCT01808651|5717455|P1|Study Period 1|Lost to Follow-up|1
1636250|NCT01808612|5717490|P3|Discontinuation Period|Lost to Follow-up|0
1636251|NCT01808612|5717491|P2|Discontinuation Period|Lost to Follow-up|1
1636252|NCT01808612|5717492|P1|Discontinuation Period|Lost to Follow-up|0
1636253|NCT01808612|5717490|P3|Discontinuation Period|Physician Decision|0
1636254|NCT01808612|5717491|P2|Discontinuation Period|Physician Decision|0
1636255|NCT01808612|5717492|P1|Discontinuation Period|Physician Decision|1
1636256|NCT01808612|5717490|P3|Discontinuation Period|Adverse Event|0
1636257|NCT01808612|5717491|P2|Discontinuation Period|Adverse Event|0
1636258|NCT01808612|5717492|P1|Discontinuation Period|Adverse Event|1
1636259|NCT01808612|5717490|P3|Treatment Period|Lack of Efficacy|2
1636260|NCT01808612|5717491|P2|Treatment Period|Lack of Efficacy|1
1636261|NCT01808612|5717492|P1|Treatment Period|Lack of Efficacy|1
1636262|NCT01808612|5717490|P3|Treatment Period|Sponsor Decision|0
1636263|NCT01808612|5717491|P2|Treatment Period|Sponsor Decision|0
1636264|NCT01808612|5717492|P1|Treatment Period|Sponsor Decision|1
1636265|NCT01808612|5717490|P3|Treatment Period|Physician Decision|4
1636266|NCT01808612|5717491|P2|Treatment Period|Physician Decision|0
1636267|NCT01808612|5717492|P1|Treatment Period|Physician Decision|1
1636268|NCT01808612|5717490|P3|Treatment Period|Withdrawal by Subject|4
1636269|NCT01808612|5717491|P2|Treatment Period|Withdrawal by Subject|0
1636270|NCT01808612|5717492|P1|Treatment Period|Withdrawal by Subject|1
1636271|NCT01808612|5717490|P3|Treatment Period|Protocol Violation|0
1636272|NCT01808612|5717491|P2|Treatment Period|Protocol Violation|0
1636273|NCT01808612|5717492|P1|Treatment Period|Protocol Violation|1
1636274|NCT01808612|5717490|P3|Treatment Period|Lost to Follow-up|1
1636275|NCT01808612|5717491|P2|Treatment Period|Lost to Follow-up|2
1636276|NCT01808612|5717492|P1|Treatment Period|Lost to Follow-up|2
1636277|NCT01808612|5717490|P3|Treatment Period|Adverse Event|3
1636278|NCT01808612|5717491|P2|Treatment Period|Adverse Event|4
1636279|NCT01808612|5717492|P1|Treatment Period|Adverse Event|8
1636280|NCT01808573|5717523|P2|Overall Study|Ongoing|91
1636281|NCT01808573|5717524|P1|Overall Study|Ongoing|109
1636282|NCT01808573|5717523|P2|Overall Study|Randomized in Error|0
1636283|NCT01808573|5717524|P1|Overall Study|Randomized in Error|1
1636284|NCT01808573|5717523|P2|Overall Study|Lost to Follow-up|0
1636285|NCT01808573|5717524|P1|Overall Study|Lost to Follow-up|2
1636286|NCT01808573|5717523|P2|Overall Study|Withdrawal by Subject|8
1636287|NCT01808573|5717524|P1|Overall Study|Withdrawal by Subject|10
1636288|NCT01808534|5717579|P1|Overall Study|Physician Decision|1
1636289|NCT01808534|5717579|P1|Overall Study|Disease progression|3
1636290|NCT01808508|5717590|P3|Overall Study|Lost to Follow-up|0
1636291|NCT01808508|5717591|P2|Overall Study|Lost to Follow-up|0
1636292|NCT01808508|5717592|P1|Overall Study|Lost to Follow-up|1
1636293|NCT01808339|5717609|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636294|NCT01808339|5717610|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636295|NCT01808339|5717611|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636296|NCT01808339|5717612|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
1636297|NCT01808339|5717613|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636298|NCT01808339|5717614|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636299|NCT01808339|5717609|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1636300|NCT01808339|5717610|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1636301|NCT01808339|5717611|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1636302|NCT01808339|5717612|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1636303|NCT01808339|5717613|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1636304|NCT01808339|5717614|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1636305|NCT01808339|5717609|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1636306|NCT01808339|5717610|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
1636307|NCT01808339|5717611|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
1636308|NCT01808339|5717612|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636309|NCT01808339|5717613|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636310|NCT01808339|5717614|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
1636311|NCT01808313|5717658|P1|Overall Study|Physician Decision|1
1636312|NCT01808313|5717658|P1|Overall Study|Lost to Follow-up|1
1636313|NCT01808313|5717658|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1636314|NCT01808313|5717658|P1|Overall Study|Protocol Violation|2
1636315|NCT01808313|5717658|P1|Overall Study|Adverse Event|5
1636316|NCT01808261|5717688|P2|Overall Study|Lost to Follow-up|1
1636317|NCT01808261|5717689|P1|Overall Study|Lost to Follow-up|3
1636318|NCT01808261|5717688|P2|Overall Study|Consent withdrawn by subject|7
1636319|NCT01808261|5717689|P1|Overall Study|Consent withdrawn by subject|6
1636320|NCT01808261|5717688|P2|Overall Study|Adverse event, non-fatal|0
1636321|NCT01808261|5717689|P1|Overall Study|Adverse event, non-fatal|2
1636322|NCT01808261|5717688|P2|Overall Study|Study Closed/Terminated|23
1636323|NCT01808261|5717689|P1|Overall Study|Study Closed/Terminated|25
1636324|NCT01808261|5717688|P2|Overall Study|Physician Decision|2
1636325|NCT01808261|5717689|P1|Overall Study|Physician Decision|0
1636326|NCT01808248|5717745|P1|Overall Study|Lost to Follow-up|1
1636327|NCT01808248|5717745|P1|Overall Study|Withdrawal by Subject|1
1636328|NCT01808248|5717745|P1|Overall Study|Lack of Efficacy|3
1636329|NCT01808222|5717757|P1|Overall Study|mpMR scan was not performed|1
1636330|NCT01808209|5717764|P2|Overall Study|Lost to Follow-up|1
1636331|NCT01808209|5717765|P1|Overall Study|Lost to Follow-up|0
1636332|NCT01808144|5717809|P2|Overall Study|Adverse Event|15
1636333|NCT01808144|5717810|P1|Overall Study|Adverse Event|11
1636334|NCT01808144|5717809|P2|Overall Study|Gout flare|1
1636335|NCT01808144|5717810|P1|Overall Study|Gout flare|0
1636336|NCT01808144|5717809|P2|Overall Study|Protocol Violation|6
1636337|NCT01808144|5717810|P1|Overall Study|Protocol Violation|6
1636338|NCT01808144|5717809|P2|Overall Study|Lost to Follow-up|3
1636339|NCT01808144|5717810|P1|Overall Study|Lost to Follow-up|6
1636340|NCT01808144|5717809|P2|Overall Study|Withdrawal by Subject|23
1636341|NCT01808144|5717810|P1|Overall Study|Withdrawal by Subject|16
1636342|NCT01808144|5717809|P2|Overall Study|Death|0
1636343|NCT01808144|5717810|P1|Overall Study|Death|1
1636344|NCT01808118|5717818|P3|Period 2|Switched to other therapy|0
1636345|NCT01808118|5717819|P2|Period 2|Switched to other therapy|1
1636346|NCT01808118|5717820|P1|Period 2|Switched to other therapy|0
1636347|NCT01808118|5717818|P3|Period 2|Investigator no longer conducting trials|0
1636348|NCT01808118|5717819|P2|Period 2|Investigator no longer conducting trials|1
1636349|NCT01808118|5717820|P1|Period 2|Investigator no longer conducting trials|0
1636350|NCT01808118|5717818|P3|Period 2|Lost to Follow-up|2
1636351|NCT01808118|5717819|P2|Period 2|Lost to Follow-up|0
1636352|NCT01808118|5717820|P1|Period 2|Lost to Follow-up|0
1636353|NCT01808118|5717818|P3|Period 2|Withdrew consent|6
1636354|NCT01808118|5717819|P2|Period 2|Withdrew consent|7
1636355|NCT01808118|5717820|P1|Period 2|Withdrew consent|0
1636356|NCT01808118|5717818|P3|Period 2|Adverse Event|0
1636357|NCT01808118|5717819|P2|Period 2|Adverse Event|4
1636358|NCT01808118|5717820|P1|Period 2|Adverse Event|0
1636359|NCT01808118|5717818|P3|Period 1|Lack of Efficacy|0
1636360|NCT01808118|5717819|P2|Period 1|Lack of Efficacy|0
1636361|NCT01808118|5717820|P1|Period 1|Lack of Efficacy|1
1636362|NCT01808118|5717818|P3|Period 1|Non-compliance per sponsor|0
1636363|NCT01808118|5717819|P2|Period 1|Non-compliance per sponsor|0
1636364|NCT01808118|5717820|P1|Period 1|Non-compliance per sponsor|1
1636365|NCT01808118|5717818|P3|Period 1|Investigator decision: site closure|0
1636366|NCT01808118|5717819|P2|Period 1|Investigator decision: site closure|0
1636367|NCT01808118|5717820|P1|Period 1|Investigator decision: site closure|2
1636368|NCT01808118|5717818|P3|Period 1|Non-conformance with inclusion criteria|0
1636369|NCT01808118|5717819|P2|Period 1|Non-conformance with inclusion criteria|0
1636370|NCT01808118|5717820|P1|Period 1|Non-conformance with inclusion criteria|3
1636371|NCT01808118|5717818|P3|Period 1|Did not meet inclusion criteria|0
1636372|NCT01808118|5717819|P2|Period 1|Did not meet inclusion criteria|0
1636373|NCT01808118|5717820|P1|Period 1|Did not meet inclusion criteria|3
1636374|NCT01808118|5717818|P3|Period 1|Enrolled in error|0
1636375|NCT01808118|5717819|P2|Period 1|Enrolled in error|0
1636376|NCT01808118|5717820|P1|Period 1|Enrolled in error|7
1636377|NCT01808118|5717818|P3|Period 1|Did not meet criteria for remission|0
1636378|NCT01808118|5717819|P2|Period 1|Did not meet criteria for remission|0
1636379|NCT01808118|5717820|P1|Period 1|Did not meet criteria for remission|303
1636380|NCT01808118|5717818|P3|Period 1|Lost to Follow-up|0
1636381|NCT01808118|5717819|P2|Period 1|Lost to Follow-up|0
1636382|NCT01808118|5717820|P1|Period 1|Lost to Follow-up|9
1636383|NCT01808118|5717818|P3|Period 1|Withdrew consent|0
1636384|NCT01808118|5717819|P2|Period 1|Withdrew consent|0
1636385|NCT01808118|5717820|P1|Period 1|Withdrew consent|24
1636386|NCT01808118|5717818|P3|Period 1|Adverse Event|0
1636387|NCT01808118|5717819|P2|Period 1|Adverse Event|0
1636388|NCT01808118|5717820|P1|Period 1|Adverse Event|15
1636389|NCT01808092|5717883|P2|Overall Study|Other Eligibility criteria|5
1636390|NCT01808092|5717884|P1|Overall Study|Other Eligibility criteria|3
1636391|NCT01808092|5717883|P2|Overall Study|Withdrawal by Subject|4
1636392|NCT01808092|5717884|P1|Overall Study|Withdrawal by Subject|9
1636393|NCT01808092|5717883|P2|Overall Study|Lost to Follow-up|7
1636394|NCT01808092|5717884|P1|Overall Study|Lost to Follow-up|3
1636395|NCT01808092|5717883|P2|Overall Study|Death|29
1636396|NCT01808092|5717884|P1|Overall Study|Death|39
1636397|NCT01808066|5717986|P1|Overall Study|Withdrawal by Subject|15
1636398|NCT01807949|5717997|P3|Overall Study|Randomized But Not Treated|2
1636399|NCT01807949|5717998|P2|Overall Study|Randomized But Not Treated|2
1636400|NCT01807949|5717999|P1|Overall Study|Randomized But Not Treated|0
1636401|NCT01807949|5717997|P3|Overall Study|Undefined|2
1636402|NCT01807949|5717998|P2|Overall Study|Undefined|1
1636403|NCT01807949|5717999|P1|Overall Study|Undefined|0
1636404|NCT01807949|5717997|P3|Overall Study|Non-Compliance|1
1636405|NCT01807949|5717998|P2|Overall Study|Non-Compliance|0
1636406|NCT01807949|5717999|P1|Overall Study|Non-Compliance|0
1636407|NCT01807949|5717997|P3|Overall Study|Withdrawal by Subject|2
1636408|NCT01807949|5717998|P2|Overall Study|Withdrawal by Subject|2
1636409|NCT01807949|5717999|P1|Overall Study|Withdrawal by Subject|1
1636410|NCT01807949|5717997|P3|Overall Study|Adverse Event|2
1636411|NCT01807949|5717998|P2|Overall Study|Adverse Event|2
1636412|NCT01807949|5717999|P1|Overall Study|Adverse Event|1
1636413|NCT01807923|5718051|P3|Overall Study|Randomized But Not Treated|5
1636414|NCT01807923|5718052|P2|Overall Study|Randomized But Not Treated|2
1636415|NCT01807923|5718053|P1|Overall Study|Randomized But Not Treated|3
1636416|NCT01807923|5718051|P3|Overall Study|Not Eligible (Genotype)|1
1636417|NCT01807923|5718052|P2|Overall Study|Not Eligible (Genotype)|0
1636418|NCT01807923|5718053|P1|Overall Study|Not Eligible (Genotype)|0
1636419|NCT01807923|5718051|P3|Overall Study|Physician Decision|1
1636420|NCT01807923|5718052|P2|Overall Study|Physician Decision|0
1636421|NCT01807923|5718053|P1|Overall Study|Physician Decision|0
1636422|NCT01807923|5718051|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
1636423|NCT01807923|5718052|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
1636424|NCT01807923|5718053|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
1636425|NCT01807923|5718051|P3|Overall Study|Adverse Event|2
1636426|NCT01807923|5718052|P2|Overall Study|Adverse Event|1
1636427|NCT01807923|5718053|P1|Overall Study|Adverse Event|2
1636428|NCT01807650|5718115|P1|Overall Study|Other|2
1636429|NCT01807650|5718115|P1|Overall Study|Adverse Event|5
1636430|NCT01807650|5718115|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
1636431|NCT01807598|5718201|P1|Overall Study|Other Physician Decision|1
1636432|NCT01807598|5718201|P1|Overall Study|Adverse Event|1
1636433|NCT01807598|5718201|P1|Overall Study|Withdrawal by Subject|4
1636434|NCT01807520|5718233|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
1636435|NCT01807520|5718234|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
1636436|NCT01807520|5718235|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1636437|NCT01807520|5718236|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1636438|NCT01807520|5718237|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1636439|NCT01807520|5718238|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1636440|NCT01807520|5718239|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
1636441|NCT01807520|5718233|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
1636442|NCT01807520|5718234|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
1636443|NCT01807520|5718235|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
1636444|NCT01807520|5718236|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
1636445|NCT01807520|5718237|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
1636446|NCT01807520|5718238|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
1636447|NCT01807520|5718239|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
1636448|NCT01807520|5718233|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1636449|NCT01807520|5718234|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
1636450|NCT01807520|5718235|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1636451|NCT01807520|5718236|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1636452|NCT01807520|5718237|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1636453|NCT01807520|5718238|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1636454|NCT01807520|5718239|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
1636455|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1636456|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1636457|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1636458|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
1636459|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
1636460|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
1636461|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
1636462|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1636463|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1636464|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1636465|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1636466|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
1636467|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1636468|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
1636469|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1636470|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1636471|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
1636472|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1636473|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
1636474|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
1636475|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
1636476|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1636477|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1636478|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1636479|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
1636480|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1636481|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
1636482|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
1636483|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1636484|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1636485|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1636486|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1636487|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1636488|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
1636489|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
1636490|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1636491|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1636492|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1636493|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1636494|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1636495|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
1636496|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
1636497|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1636498|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1636499|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1636500|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
1636501|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1636502|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1636503|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
1636504|NCT01807520|5718233|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1636505|NCT01807520|5718234|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1636506|NCT01807520|5718235|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
1636507|NCT01807520|5718236|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1636508|NCT01807520|5718237|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
1636509|NCT01807520|5718238|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
1636510|NCT01807520|5718239|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
1636511|NCT01807520|5718233|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1636512|NCT01807520|5718234|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1636513|NCT01807520|5718235|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1636514|NCT01807520|5718236|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1636515|NCT01807520|5718237|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1636516|NCT01807520|5718238|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
1636517|NCT01807520|5718239|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
1636518|NCT01807520|5718233|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1636519|NCT01807520|5718234|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1636520|NCT01807520|5718235|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1636521|NCT01807520|5718236|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1636522|NCT01807520|5718237|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
1636523|NCT01807520|5718238|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1636524|NCT01807520|5718239|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
1636525|NCT01807520|5718233|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1636526|NCT01807520|5718234|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1636527|NCT01807520|5718235|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1636528|NCT01807520|5718236|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1636529|NCT01807520|5718237|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1636530|NCT01807520|5718238|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
1636531|NCT01807520|5718239|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
1636532|NCT01807520|5718233|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1636533|NCT01807520|5718234|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1636534|NCT01807520|5718235|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1636535|NCT01807520|5718236|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1636536|NCT01807520|5718237|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
1636537|NCT01807520|5718238|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1636538|NCT01807520|5718239|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
1636539|NCT01807520|5718233|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1636540|NCT01807520|5718234|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1636541|NCT01807520|5718235|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1636542|NCT01807520|5718236|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1636543|NCT01807520|5718237|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1636544|NCT01807520|5718238|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
1636545|NCT01807520|5718239|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
1636546|NCT01807520|5718233|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1636547|NCT01807520|5718234|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1636548|NCT01807520|5718235|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1636549|NCT01807520|5718236|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1636550|NCT01807520|5718237|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
1636551|NCT01807520|5718238|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
1636552|NCT01807520|5718239|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
1636553|NCT01807234|5718272|P6|Overall Study|Lack of Efficacy|1
1636554|NCT01807234|5718273|P5|Overall Study|Lack of Efficacy|1
1636555|NCT01807234|5718274|P4|Overall Study|Lack of Efficacy|0
1636556|NCT01807234|5718275|P3|Overall Study|Lack of Efficacy|0
1636557|NCT01807234|5718276|P2|Overall Study|Lack of Efficacy|0
1636558|NCT01807234|5718277|P1|Overall Study|Lack of Efficacy|0
1636559|NCT01807234|5718272|P6|Overall Study|Withdrawal by Subject|1
1636560|NCT01807234|5718273|P5|Overall Study|Withdrawal by Subject|2
1636561|NCT01807234|5718274|P4|Overall Study|Withdrawal by Subject|1
1636562|NCT01807234|5718275|P3|Overall Study|Withdrawal by Subject|1
1636563|NCT01807234|5718276|P2|Overall Study|Withdrawal by Subject|1
1636564|NCT01807234|5718277|P1|Overall Study|Withdrawal by Subject|3
1636565|NCT01807234|5718272|P6|Overall Study|Lost to Follow-up|2
1636566|NCT01807234|5718273|P5|Overall Study|Lost to Follow-up|1
1636567|NCT01807234|5718274|P4|Overall Study|Lost to Follow-up|1
1636568|NCT01807234|5718275|P3|Overall Study|Lost to Follow-up|1
1636569|NCT01807234|5718276|P2|Overall Study|Lost to Follow-up|5
1636570|NCT01807234|5718277|P1|Overall Study|Lost to Follow-up|2
1636571|NCT01807156|5718312|P1|Overall Study|Physician Decision|1
1636572|NCT01806961|5718384|P1|Overall Study|sponsor decision|16
1636573|NCT01806896|5718390|P2|Overall Study|Other|0
1636574|NCT01806896|5718391|P1|Overall Study|Other|1
1636575|NCT01806896|5718390|P2|Overall Study|Adverse Event|0
1636576|NCT01806896|5718391|P1|Overall Study|Adverse Event|2
1636577|NCT01806779|5718458|P3|Overall Study|Withdrawal by Subject|22
1636578|NCT01806779|5718459|P2|Overall Study|Withdrawal by Subject|23
1636579|NCT01806779|5718460|P1|Overall Study|Withdrawal by Subject|20
1636580|NCT01806779|5718458|P3|Overall Study|Lost to Follow-up|0
1636581|NCT01806779|5718459|P2|Overall Study|Lost to Follow-up|20
1636582|NCT01806779|5718460|P1|Overall Study|Lost to Follow-up|19
1636583|NCT01806779|5718458|P3|Overall Study|Lack of Efficacy|0
1636584|NCT01806779|5718459|P2|Overall Study|Lack of Efficacy|1
1636585|NCT01806779|5718460|P1|Overall Study|Lack of Efficacy|1
1636586|NCT01806779|5718458|P3|Overall Study|Physician Decision|1
1636587|NCT01806779|5718459|P2|Overall Study|Physician Decision|0
1636588|NCT01806779|5718460|P1|Overall Study|Physician Decision|2
1636589|NCT01806740|5718473|P1|Overall Study|Patient’s refusal of treatment|1
1636590|NCT01806740|5718473|P1|Overall Study|Physician Decision|1
1636591|NCT01806740|5718473|P1|Overall Study|Withdrawal by Subject|4
1636592|NCT01806714|5718484|P2|Overall Study|No functioning phone number|170
1636593|NCT01806714|5718485|P1|Overall Study|No functioning phone number|200
1636594|NCT01806662|5718520|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
1636595|NCT01806662|5718521|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
1636596|NCT01806662|5718520|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
1636597|NCT01806662|5718521|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
1636598|NCT01806662|5718520|P2|First Intervention (Weeks 0-16)|Adverse Event|1
1636599|NCT01806662|5718521|P1|First Intervention (Weeks 0-16)|Adverse Event|0
1636600|NCT01806662|5718520|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
1636601|NCT01806662|5718521|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
1636602|NCT01806623|5718527|P1|Overall Study|Did not meet the inclusion criteria|56
1636603|NCT01806623|5718527|P1|Overall Study|Adverse Event|1
1636604|NCT01806623|5718527|P1|Overall Study|Withdrawal by Subject|1
1636605|NCT01806597|5718547|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
1636606|NCT01806597|5718548|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1636607|NCT01806597|5718549|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1636608|NCT01806597|5718550|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1636609|NCT01806597|5718551|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1636610|NCT01806597|5718552|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
1636611|NCT01806597|5718547|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
1636612|NCT01806597|5718548|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1636613|NCT01806597|5718549|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1636614|NCT01806597|5718550|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1636615|NCT01806597|5718551|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1636616|NCT01806597|5718552|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
1636617|NCT01806597|5718547|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
1636618|NCT01806597|5718548|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1636619|NCT01806597|5718549|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1636620|NCT01806597|5718550|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1636621|NCT01806597|5718551|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1636622|NCT01806597|5718552|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
1636623|NCT01806597|5718547|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
1636624|NCT01806597|5718548|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1636625|NCT01806597|5718549|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1636626|NCT01806597|5718550|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1636627|NCT01806597|5718551|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1636628|NCT01806597|5718552|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
1636629|NCT01806597|5718547|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
1636630|NCT01806597|5718548|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1636631|NCT01806597|5718549|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1636632|NCT01806597|5718550|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1636633|NCT01806597|5718551|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1636634|NCT01806597|5718552|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
1636635|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
1636636|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
1636637|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
1636638|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
1636639|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
1636640|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
1636641|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1636642|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
1636643|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1636644|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
1636645|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1636646|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
1636647|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1636648|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
1636649|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1636650|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
1636651|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
1636652|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
1636653|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1636654|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1636655|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1636656|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1636657|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
1636658|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
1636659|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1636660|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1636661|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1636662|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1636663|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
1636664|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
1636665|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1636666|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1636667|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1636668|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
1636669|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1636670|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
1636671|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1636672|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1636673|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1636674|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1636675|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
1636676|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
1636677|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1636678|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
1636679|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
1636680|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
1636681|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
1636682|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
1636683|NCT01806597|5718547|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
1636684|NCT01806597|5718548|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
1636685|NCT01806597|5718549|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
1636686|NCT01806597|5718550|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
1636687|NCT01806597|5718551|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
1636688|NCT01806597|5718552|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
1636689|NCT01806597|5718547|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
1636690|NCT01806597|5718548|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
1636691|NCT01806597|5718549|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
1636692|NCT01806597|5718550|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
1636693|NCT01806597|5718551|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
1636694|NCT01806597|5718552|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
1636695|NCT01806597|5718547|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1636696|NCT01806597|5718548|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1636697|NCT01806597|5718549|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1636698|NCT01806597|5718550|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
1636699|NCT01806597|5718551|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
1636700|NCT01806597|5718552|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
1636701|NCT01806597|5718547|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
1636702|NCT01806597|5718548|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
1636703|NCT01806597|5718549|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
1636704|NCT01806597|5718550|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
1636705|NCT01806597|5718551|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
1636706|NCT01806597|5718552|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
1636707|NCT01806597|5718547|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1636708|NCT01806597|5718548|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1636709|NCT01806597|5718549|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1636710|NCT01806597|5718550|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1636711|NCT01806597|5718551|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
1636712|NCT01806597|5718552|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
1636713|NCT01806597|5718547|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
1636714|NCT01806597|5718548|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
1636715|NCT01806597|5718549|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
1636716|NCT01806597|5718550|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
1636717|NCT01806597|5718551|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
1636718|NCT01806597|5718552|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
1636719|NCT01806584|5718588|P2|Overall Study|Other unspecified|0
1636720|NCT01806584|5718589|P1|Overall Study|Other unspecified|1
1636721|NCT01806584|5718588|P2|Overall Study|Withdrawal by Subject|1
1636722|NCT01806584|5718589|P1|Overall Study|Withdrawal by Subject|1
1636723|NCT01806584|5718588|P2|Overall Study|Study terminated by sponsor|14
1636724|NCT01806584|5718589|P1|Overall Study|Study terminated by sponsor|9
1636725|NCT01806584|5718588|P2|Overall Study|Lost to Follow-up|2
1636726|NCT01806584|5718589|P1|Overall Study|Lost to Follow-up|0
1636727|NCT01806584|5718588|P2|Overall Study|Death|0
1636728|NCT01806584|5718589|P1|Overall Study|Death|1
1636729|NCT01806584|5718588|P2|Overall Study|Adverse Event|1
1636730|NCT01806584|5718589|P1|Overall Study|Adverse Event|2
1636731|NCT01806545|5718611|P2|Overall Study|Withdrawal by Subject|2
1636732|NCT01806545|5718612|P1|Overall Study|Withdrawal by Subject|3
1636733|NCT01806545|5718611|P2|Overall Study|Lost to Follow-up|0
1636734|NCT01806545|5718612|P1|Overall Study|Lost to Follow-up|1
1636735|NCT01806545|5718611|P2|Overall Study|Adverse Event|3
1636736|NCT01806545|5718612|P1|Overall Study|Adverse Event|2
1636737|NCT01806506|5718636|P2|Overall Study|Lost to Follow-up|1
1636738|NCT01806506|5718637|P1|Overall Study|Lost to Follow-up|2
1636739|NCT01806389|5718643|P1|Overall Study|Withdrawal by Subject|4
1636740|NCT01806298|5718657|P1|Overall Study|Other|5
1636741|NCT01806298|5718657|P1|Overall Study|Withdrawal by Subject|1
1636742|NCT01806298|5718657|P1|Overall Study|Protocol Non-compliance|1
1636743|NCT01806298|5718657|P1|Overall Study|Adverse Event|3
1636744|NCT01806051|5718678|P1|Overall Study|Withdrawal by Subject|6
1636745|NCT01805180|5718795|P3|Lead-in Donor Phase|screen failure|0
1636746|NCT01805180|5718796|P2|Lead-in Donor Phase|screen failure|0
1636747|NCT01805180|5718797|P1|Lead-in Donor Phase|screen failure|1
1636748|NCT01804946|5718872|P2|Overall Study|Do not meet inclusion criteria|2
1636749|NCT01804946|5718873|P1|Overall Study|Do not meet inclusion criteria|1
1636750|NCT01804946|5718872|P2|Overall Study|Insufficient data available|1
1636751|NCT01804946|5718873|P1|Overall Study|Insufficient data available|0
1636752|NCT01804946|5718872|P2|Overall Study|Adverse Event|1
1636753|NCT01804946|5718873|P1|Overall Study|Adverse Event|0
1636754|NCT01804946|5718872|P2|Overall Study|Protocol Violation|0
1636755|NCT01804946|5718873|P1|Overall Study|Protocol Violation|1
1636756|NCT01804842|5718911|P3|Overall Study|Personal Reason|1
1636757|NCT01804842|5718912|P2|Overall Study|Personal Reason|0
1636758|NCT01804842|5718913|P1|Overall Study|Personal Reason|0
1636759|NCT01804842|5718911|P3|Overall Study|Non-Compliance|0
1636760|NCT01804842|5718912|P2|Overall Study|Non-Compliance|1
1636761|NCT01804842|5718913|P1|Overall Study|Non-Compliance|1
1636762|NCT01804842|5718911|P3|Overall Study|Lost to Follow-up|0
1636763|NCT01804842|5718912|P2|Overall Study|Lost to Follow-up|0
1636764|NCT01804842|5718913|P1|Overall Study|Lost to Follow-up|1
1636765|NCT01804842|5718911|P3|Overall Study|Adverse Event|0
1636766|NCT01804842|5718912|P2|Overall Study|Adverse Event|1
1636767|NCT01804842|5718913|P1|Overall Study|Adverse Event|1
1636768|NCT01804816|5718930|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
1636769|NCT01804816|5718930|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
1636770|NCT01804673|5718942|P1|Overall Study|Other|4
1636771|NCT01804673|5718942|P1|Overall Study|Use of Prohibited Medication|1
1636772|NCT01804673|5718942|P1|Overall Study|No Further Therapy Required|84
1636773|NCT01804673|5718942|P1|Overall Study|Change to Oral Therapy|37
1636774|NCT01804673|5718942|P1|Overall Study|Lack of Efficacy|9
1636775|NCT01804673|5718942|P1|Overall Study|Withdrawal by Subject|1
1636776|NCT01804673|5718942|P1|Overall Study|Adverse Event|4
1636777|NCT01804582|5718960|P2|Overall Study|Physician Decision|0
1636778|NCT01804582|5718961|P1|Overall Study|Physician Decision|2
1636779|NCT01804582|5718960|P2|Overall Study|Lost to Follow-up|56
1636780|NCT01804582|5718961|P1|Overall Study|Lost to Follow-up|47
1636781|NCT01804140|5718981|P1|Overall Study|No sampling or biopsy procedures done|114
1636782|NCT01804049|5719015|P2|Overall Study|Enrollment in dual studies|1
1636783|NCT01804049|5719016|P1|Overall Study|Enrollment in dual studies|0
1636784|NCT01804049|5719015|P2|Overall Study|other MD recommended|1
1636785|NCT01804049|5719016|P1|Overall Study|other MD recommended|1
1636786|NCT01804049|5719015|P2|Overall Study|Moved out of area|7
1636787|NCT01804049|5719016|P1|Overall Study|Moved out of area|0
1636788|NCT01804049|5719015|P2|Overall Study|Other health concerns|7
1636789|NCT01804049|5719016|P1|Overall Study|Other health concerns|2
1636790|NCT01804049|5719015|P2|Overall Study|Decreased interest/personal|5
1636791|NCT01804049|5719016|P1|Overall Study|Decreased interest/personal|4
1636792|NCT01804049|5719015|P2|Overall Study|Lost to Follow-up|1
1636793|NCT01804049|5719016|P1|Overall Study|Lost to Follow-up|2
1636794|NCT01804049|5719015|P2|Overall Study|Adverse Event|10
1636795|NCT01804049|5719016|P1|Overall Study|Adverse Event|2
1636796|NCT01803880|5719064|P3|Overall Study|Incomplete data entry by sites|0
1636797|NCT01803880|5719065|P2|Overall Study|Incomplete data entry by sites|0
1636798|NCT01803880|5719066|P1|Overall Study|Incomplete data entry by sites|2
1636799|NCT01803880|5719064|P3|Overall Study|Early study termination|5
1636800|NCT01803880|5719065|P2|Overall Study|Early study termination|6
1636801|NCT01803880|5719066|P1|Overall Study|Early study termination|0
1636802|NCT01803880|5719064|P3|Overall Study|Protocol Violation|0
1636803|NCT01803880|5719065|P2|Overall Study|Protocol Violation|0
1636804|NCT01803880|5719066|P1|Overall Study|Protocol Violation|1
1636805|NCT01803880|5719064|P3|Overall Study|Lost to Follow-up|3
1636806|NCT01803880|5719065|P2|Overall Study|Lost to Follow-up|2
1636807|NCT01803880|5719066|P1|Overall Study|Lost to Follow-up|1
1636808|NCT01803880|5719064|P3|Overall Study|Unable to return for follow-up visits|2
1636809|NCT01803880|5719065|P2|Overall Study|Unable to return for follow-up visits|1
1636810|NCT01803880|5719066|P1|Overall Study|Unable to return for follow-up visits|0
1636811|NCT01803880|5719064|P3|Overall Study|Physician Decision|1
1636812|NCT01803880|5719065|P2|Overall Study|Physician Decision|0
1636813|NCT01803880|5719066|P1|Overall Study|Physician Decision|0
1636814|NCT01803880|5719064|P3|Overall Study|Withdrawal by Subject|4
1636815|NCT01803880|5719065|P2|Overall Study|Withdrawal by Subject|1
1636816|NCT01803880|5719066|P1|Overall Study|Withdrawal by Subject|1
1636817|NCT01803880|5719064|P3|Overall Study|Adverse Event|0
1636818|NCT01803880|5719065|P2|Overall Study|Adverse Event|0
1636819|NCT01803880|5719066|P1|Overall Study|Adverse Event|1
1636820|NCT01803737|5719102|P2|Overall Study|Lost to Follow-up|2
1636821|NCT01803737|5719103|P1|Overall Study|Lost to Follow-up|0
1636822|NCT01803737|5719102|P2|Overall Study|Medical Reason|1
1636823|NCT01803737|5719103|P1|Overall Study|Medical Reason|0
1636824|NCT01803737|5719102|P2|Overall Study|Lack of Time|0
1636825|NCT01803737|5719103|P1|Overall Study|Lack of Time|1
1636826|NCT01803711|5719127|P2|Overall Study|Adverse Event|1
1636827|NCT01803711|5719128|P1|Overall Study|Adverse Event|1
1636828|NCT01803646|5719146|P2|Overall Study|Lost to Follow-up|1
1636829|NCT01803646|5719147|P1|Overall Study|Lost to Follow-up|5
1636830|NCT01803646|5719146|P2|Overall Study|Randomization error|2
1636831|NCT01803646|5719147|P1|Overall Study|Randomization error|1
1636832|NCT01803646|5719146|P2|Overall Study|Withdrawal by Subject|6
1636833|NCT01803646|5719147|P1|Overall Study|Withdrawal by Subject|9
1636834|NCT01803646|5719146|P2|Overall Study|Adverse Event|1
1636835|NCT01803646|5719147|P1|Overall Study|Adverse Event|1
1636836|NCT01803646|5719146|P2|Overall Study|Protocol Violation|0
1636837|NCT01803646|5719147|P1|Overall Study|Protocol Violation|1
1636838|NCT01803607|5719159|P2|Overall Study|Withdrawal by Subject|5
1636839|NCT01803607|5719160|P1|Overall Study|Withdrawal by Subject|6
1636840|NCT01803607|5719159|P2|Overall Study|Study terminated by sponsor|56
1636841|NCT01803607|5719160|P1|Overall Study|Study terminated by sponsor|54
1636842|NCT01803607|5719159|P2|Overall Study|Protocol Violation|2
1636843|NCT01803607|5719160|P1|Overall Study|Protocol Violation|3
1636844|NCT01803607|5719159|P2|Overall Study|Lack of Efficacy|1
1636845|NCT01803607|5719160|P1|Overall Study|Lack of Efficacy|0
1636846|NCT01803607|5719159|P2|Overall Study|Adverse Event|3
1636847|NCT01803607|5719160|P1|Overall Study|Adverse Event|5
1636848|NCT01803464|5719184|P4|Overall Study|Withdrawal by Subject|0
1636849|NCT01803464|5719185|P3|Overall Study|Withdrawal by Subject|0
1636850|NCT01803464|5719186|P2|Overall Study|Withdrawal by Subject|0
1636851|NCT01803464|5719187|P1|Overall Study|Withdrawal by Subject|1
1636852|NCT01803464|5719184|P4|Overall Study|Incomplete data|0
1636853|NCT01803464|5719185|P3|Overall Study|Incomplete data|4
1636854|NCT01803464|5719186|P2|Overall Study|Incomplete data|0
1636855|NCT01803464|5719187|P1|Overall Study|Incomplete data|0
1636856|NCT01802879|5719499|P1|Overall Study|Disease progression|6
1636857|NCT01802879|5719499|P1|Overall Study|Administrative problems|2
1636858|NCT01802775|5719506|P2|Overall Study|Lost to Follow-up|2
1636859|NCT01802775|5719507|P1|Overall Study|Lost to Follow-up|1
1636860|NCT01802775|5719506|P2|Overall Study|Withdrawal by Subject|5
1636861|NCT01802775|5719507|P1|Overall Study|Withdrawal by Subject|3
1636862|NCT01802775|5719506|P2|Overall Study|Adverse Event|1
1636863|NCT01802775|5719507|P1|Overall Study|Adverse Event|1
1636864|NCT01802775|5719506|P2|Overall Study|Physician Decision|0
1636865|NCT01802775|5719507|P1|Overall Study|Physician Decision|1
1636866|NCT01802775|5719506|P2|Overall Study|Reason not provided|1
1636867|NCT01802775|5719507|P1|Overall Study|Reason not provided|0
1636868|NCT01802775|5719506|P2|Overall Study|Death|3
1636869|NCT01802775|5719507|P1|Overall Study|Death|0
1636870|NCT01802632|5719542|P6|Overall Study|Other (not specified)|1
1636871|NCT01802632|5719543|P5|Overall Study|Other (not specified)|0
1636872|NCT01802632|5719544|P4|Overall Study|Other (not specified)|1
1636873|NCT01802632|5719545|P3|Overall Study|Other (not specified)|7
1636874|NCT01802632|5719546|P2|Overall Study|Other (not specified)|0
1636875|NCT01802632|5719547|P1|Overall Study|Other (not specified)|0
1636876|NCT01802632|5719542|P6|Overall Study|Ongoing Study at Data Cut-off|22
1636877|NCT01802632|5719543|P5|Overall Study|Ongoing Study at Data Cut-off|6
1636878|NCT01802632|5719544|P4|Overall Study|Ongoing Study at Data Cut-off|50
1636879|NCT01802632|5719545|P3|Overall Study|Ongoing Study at Data Cut-off|115
1636880|NCT01802632|5719546|P2|Overall Study|Ongoing Study at Data Cut-off|16
1636881|NCT01802632|5719547|P1|Overall Study|Ongoing Study at Data Cut-off|168
1636882|NCT01802632|5719542|P6|Overall Study|Objective Disease Progression|4
1636883|NCT01802632|5719543|P5|Overall Study|Objective Disease Progression|4
1636884|NCT01802632|5719544|P4|Overall Study|Objective Disease Progression|6
1636885|NCT01802632|5719545|P3|Overall Study|Objective Disease Progression|104
1636886|NCT01802632|5719546|P2|Overall Study|Objective Disease Progression|12
1636887|NCT01802632|5719547|P1|Overall Study|Objective Disease Progression|1
1636888|NCT01802632|5719542|P6|Overall Study|Withdrawal by Subject|1
1636889|NCT01802632|5719543|P5|Overall Study|Withdrawal by Subject|0
1636890|NCT01802632|5719544|P4|Overall Study|Withdrawal by Subject|3
1636891|NCT01802632|5719545|P3|Overall Study|Withdrawal by Subject|7
1636892|NCT01802632|5719546|P2|Overall Study|Withdrawal by Subject|2
1636893|NCT01802632|5719547|P1|Overall Study|Withdrawal by Subject|4
1636894|NCT01802632|5719542|P6|Overall Study|Death|0
1636895|NCT01802632|5719543|P5|Overall Study|Death|2
1636896|NCT01802632|5719544|P4|Overall Study|Death|0
1636897|NCT01802632|5719545|P3|Overall Study|Death|38
1636898|NCT01802632|5719546|P2|Overall Study|Death|1
1636899|NCT01802632|5719547|P1|Overall Study|Death|28
1636900|NCT01802580|5719563|P2|Overall Study|Lack of Efficacy|2
1636901|NCT01802580|5719564|P1|Overall Study|Lack of Efficacy|0
1636902|NCT01802580|5719563|P2|Overall Study|Other|3
1636903|NCT01802580|5719564|P1|Overall Study|Other|1
1636904|NCT01802580|5719563|P2|Overall Study|Withdrawal by Subject|6
1636905|NCT01802580|5719564|P1|Overall Study|Withdrawal by Subject|5
1636906|NCT01802580|5719563|P2|Overall Study|Protocol Violation|0
1636907|NCT01802580|5719564|P1|Overall Study|Protocol Violation|2
1636908|NCT01802580|5719563|P2|Overall Study|Physician Decision|0
1636909|NCT01802580|5719564|P1|Overall Study|Physician Decision|1
1636910|NCT01802515|5719595|P3|Overall Study|Withdrawal by Subject|0
1636911|NCT01802515|5719596|P2|Overall Study|Withdrawal by Subject|0
1636912|NCT01802515|5719597|P1|Overall Study|Withdrawal by Subject|3
1636913|NCT01802437|5719610|P2|Overall Study|Withdrawal by Subject|4
1636914|NCT01802437|5719611|P1|Overall Study|Withdrawal by Subject|3
1636915|NCT01802437|5719610|P2|Overall Study|Lost to Follow-up|0
1636916|NCT01802437|5719611|P1|Overall Study|Lost to Follow-up|1
1636917|NCT01802385|5719623|P2|Overall Study|Death|120
1636918|NCT01802385|5719624|P1|Overall Study|Death|106
1636919|NCT01802333|5719647|P3|Overall Study|Did not start treatment|5
1636920|NCT01802333|5719648|P2|Overall Study|Did not start treatment|2
1636921|NCT01802333|5719649|P1|Overall Study|Did not start treatment|0
1636922|NCT01802333|5719647|P3|Overall Study|Other - not protocol specified|24
1636923|NCT01802333|5719648|P2|Overall Study|Other - not protocol specified|22
1636924|NCT01802333|5719649|P1|Overall Study|Other - not protocol specified|32
1636925|NCT01802333|5719647|P3|Overall Study|Death|13
1636926|NCT01802333|5719648|P2|Overall Study|Death|14
1636927|NCT01802333|5719649|P1|Overall Study|Death|7
1636928|NCT01802333|5719647|P3|Overall Study|Progression/relapse|0
1636929|NCT01802333|5719648|P2|Overall Study|Progression/relapse|3
1636930|NCT01802333|5719649|P1|Overall Study|Progression/relapse|1
1636931|NCT01802333|5719647|P3|Overall Study|Withdrawal by Subject|5
1636932|NCT01802333|5719648|P2|Overall Study|Withdrawal by Subject|6
1636933|NCT01802333|5719649|P1|Overall Study|Withdrawal by Subject|6
1636934|NCT01802333|5719647|P3|Overall Study|Adverse Event|8
1636935|NCT01802333|5719648|P2|Overall Study|Adverse Event|8
1636936|NCT01802333|5719649|P1|Overall Study|Adverse Event|1
1636937|NCT01802333|5719647|P3|Overall Study|Ineligible|8
1636938|NCT01802333|5719648|P2|Overall Study|Ineligible|6
1636939|NCT01802333|5719649|P1|Overall Study|Ineligible|2
1636940|NCT01802320|5719676|P1|Overall Study|Withdrawal by Subject|1
1636941|NCT01802320|5719676|P1|Overall Study|Death|1
1636942|NCT01802216|5719686|P2|12 Month Visit|Participant did not show to visit|4
1636943|NCT01802216|5719687|P1|12 Month Visit|Participant did not show to visit|3
1636944|NCT01802216|5719686|P2|8 Month Visit|Participant did not show to visit|5
1636945|NCT01802216|5719687|P1|8 Month Visit|Participant did not show to visit|3
1636946|NCT01802216|5719686|P2|4 Month Visit|Participant did not show to visit|4
1636947|NCT01802216|5719687|P1|4 Month Visit|Participant did not show to visit|3
1636948|NCT01802073|5719766|P2|Overall Study|Physician Decision|7
1636949|NCT01802073|5719767|P1|Overall Study|Physician Decision|0
1636950|NCT01802073|5719766|P2|Overall Study|Withdrawal by Subject|1
1636951|NCT01802073|5719767|P1|Overall Study|Withdrawal by Subject|1
1636952|NCT01802073|5719766|P2|Overall Study|Non-compliant|2
1636953|NCT01802073|5719767|P1|Overall Study|Non-compliant|4
1636954|NCT01802073|5719766|P2|Overall Study|Lost to Follow-up|1
1636955|NCT01802073|5719767|P1|Overall Study|Lost to Follow-up|0
1636956|NCT01801982|5719783|P1|Overall Study|Lost to Follow-up|1
1636957|NCT01801917|5719797|P4|Period 1 - Randomized|Adverse Event|0
1636958|NCT01801917|5719798|P3|Period 1 - Randomized|Adverse Event|1
1636959|NCT01801917|5719799|P2|Period 1 - Randomized|Adverse Event|0
1636960|NCT01801917|5719800|P1|Period 1 - Randomized|Adverse Event|1
1636961|NCT01801735|5719820|P1|Overall Study|Other, including site closure|19
1636962|NCT01801735|5719820|P1|Overall Study|Death|1
1636963|NCT01801735|5719820|P1|Overall Study|Physician Decision|3
1636964|NCT01801735|5719820|P1|Overall Study|Non-compliance with Trial Drug|13
1636965|NCT01801735|5719820|P1|Overall Study|Lost to Follow-up|15
1636966|NCT01801735|5719820|P1|Overall Study|Protocol Violation|25
1636967|NCT01801735|5719820|P1|Overall Study|Withdrawal by Subject|27
1636968|NCT01801735|5719820|P1|Overall Study|Lack of Efficacy|28
1636969|NCT01801735|5719820|P1|Overall Study|Adverse Event|79
1636970|NCT01801475|5719827|P5|Overall Study|Withdrawal by Subject|1
1636971|NCT01801475|5719828|P4|Overall Study|Withdrawal by Subject|0
1636972|NCT01801475|5719829|P3|Overall Study|Withdrawal by Subject|0
1636973|NCT01801475|5719830|P2|Overall Study|Withdrawal by Subject|0
1636974|NCT01801475|5719831|P1|Overall Study|Withdrawal by Subject|0
1636975|NCT01801436|5719856|P1|Overall Study|Progressive disease|4
1636976|NCT01801436|5719856|P1|Overall Study|Adverse Event|2
1636977|NCT01801436|5719856|P1|Overall Study|Withdrawal by Subject|3
1636978|NCT01801358|5719894|P6|Overall Study|Withdrawal by Subject|2
1636979|NCT01801358|5719895|P5|Overall Study|Withdrawal by Subject|0
1636980|NCT01801358|5719896|P4|Overall Study|Withdrawal by Subject|1
1636981|NCT01801358|5719897|P3|Overall Study|Withdrawal by Subject|0
1636982|NCT01801358|5719898|P2|Overall Study|Withdrawal by Subject|0
1636983|NCT01801358|5719899|P1|Overall Study|Withdrawal by Subject|0
1636984|NCT01801358|5719894|P6|Overall Study|Progressive Disease|5
1636985|NCT01801358|5719895|P5|Overall Study|Progressive Disease|6
1636986|NCT01801358|5719896|P4|Overall Study|Progressive Disease|5
1636987|NCT01801358|5719897|P3|Overall Study|Progressive Disease|4
1636988|NCT01801358|5719898|P2|Overall Study|Progressive Disease|4
1636989|NCT01801358|5719899|P1|Overall Study|Progressive Disease|6
1636990|NCT01801358|5719894|P6|Overall Study|Physician Decision|0
1636991|NCT01801358|5719895|P5|Overall Study|Physician Decision|0
1636992|NCT01801358|5719896|P4|Overall Study|Physician Decision|0
1636993|NCT01801358|5719897|P3|Overall Study|Physician Decision|1
1636994|NCT01801358|5719898|P2|Overall Study|Physician Decision|0
1636995|NCT01801358|5719899|P1|Overall Study|Physician Decision|0
1636996|NCT01801358|5719894|P6|Overall Study|Adverse Event|1
1636997|NCT01801358|5719895|P5|Overall Study|Adverse Event|0
1636998|NCT01801358|5719896|P4|Overall Study|Adverse Event|0
1636999|NCT01801358|5719897|P3|Overall Study|Adverse Event|1
1637000|NCT01801358|5719898|P2|Overall Study|Adverse Event|2
1637001|NCT01801358|5719899|P1|Overall Study|Adverse Event|0
1637002|NCT01801280|5720021|P4|Period 4|Protocol Violation|0
1637003|NCT01801280|5720022|P3|Period 4|Protocol Violation|1
1637004|NCT01801280|5720023|P2|Period 4|Protocol Violation|0
1637005|NCT01801280|5720024|P1|Period 4|Protocol Violation|0
1637006|NCT01801280|5720021|P4|Period 2|Withdrawal by Subject|0
1637007|NCT01801280|5720022|P3|Period 2|Withdrawal by Subject|0
1637008|NCT01801280|5720023|P2|Period 2|Withdrawal by Subject|0
1637009|NCT01801280|5720024|P1|Period 2|Withdrawal by Subject|1
1637010|NCT01801280|5720021|P4|Period 1|Withdrawal by Subject|0
1637011|NCT01801280|5720022|P3|Period 1|Withdrawal by Subject|0
1637012|NCT01801280|5720023|P2|Period 1|Withdrawal by Subject|1
1637013|NCT01801280|5720024|P1|Period 1|Withdrawal by Subject|0
1637014|NCT01801111|5720039|P1|Overall Study|Progressive Disease|81
1637015|NCT01801111|5720039|P1|Overall Study|Study Terminated by Sponsor|27
1637016|NCT01801111|5720039|P1|Overall Study|Withdrawal by Subject|4
1637017|NCT01801111|5720039|P1|Overall Study|Other|1
1637018|NCT01801111|5720039|P1|Overall Study|Physician Decision|5
1637019|NCT01801111|5720039|P1|Overall Study|Death|8
1637020|NCT01801111|5720039|P1|Overall Study|Adverse Event|12
1637021|NCT01800968|5720080|P2|Overall Study|Physician Decision|0
1637022|NCT01800968|5720081|P1|Overall Study|Physician Decision|1
1637023|NCT01800968|5720080|P2|Overall Study|Withdrawal by Subject|9
1637024|NCT01800968|5720081|P1|Overall Study|Withdrawal by Subject|7
1637025|NCT01800968|5720080|P2|Overall Study|Lost to Follow-up|7
1637026|NCT01800968|5720081|P1|Overall Study|Lost to Follow-up|5
1637027|NCT01800968|5720080|P2|Overall Study|Death|16
1637028|NCT01800968|5720081|P1|Overall Study|Death|23
1637029|NCT01800916|5720123|P9|Test Period 1 (1 Week)|Adverse Event|0
1637030|NCT01800916|5720124|P8|Test Period 1 (1 Week)|Adverse Event|0
1637031|NCT01800916|5720125|P7|Test Period 1 (1 Week)|Adverse Event|0
1637032|NCT01800916|5720126|P6|Test Period 1 (1 Week)|Adverse Event|0
1637033|NCT01800916|5720127|P5|Test Period 1 (1 Week)|Adverse Event|1
1637034|NCT01800916|5720128|P4|Test Period 1 (1 Week)|Adverse Event|0
1637035|NCT01800916|5720129|P3|Test Period 1 (1 Week)|Adverse Event|0
1637036|NCT01800916|5720130|P2|Test Period 1 (1 Week)|Adverse Event|0
1637037|NCT01800916|5720131|P1|Test Period 1 (1 Week)|Adverse Event|0
1637038|NCT01800916|5720123|P9|Test Period 1 (1 Week)|Convex product user|0
1637039|NCT01800916|5720124|P8|Test Period 1 (1 Week)|Convex product user|0
1637040|NCT01800916|5720125|P7|Test Period 1 (1 Week)|Convex product user|0
1637041|NCT01800916|5720126|P6|Test Period 1 (1 Week)|Convex product user|0
1637042|NCT01800916|5720127|P5|Test Period 1 (1 Week)|Convex product user|0
1637043|NCT01800916|5720128|P4|Test Period 1 (1 Week)|Convex product user|1
1637044|NCT01800916|5720129|P3|Test Period 1 (1 Week)|Convex product user|0
1637045|NCT01800916|5720130|P2|Test Period 1 (1 Week)|Convex product user|0
1637046|NCT01800916|5720131|P1|Test Period 1 (1 Week)|Convex product user|0
1637047|NCT01800903|5720141|P6|Second Test Period|unable to catheterise|0
1637048|NCT01800903|5720142|P5|Second Test Period|unable to catheterise|0
1637049|NCT01800903|5720143|P4|Second Test Period|unable to catheterise|0
1637050|NCT01800903|5720144|P3|Second Test Period|unable to catheterise|0
1637051|NCT01800903|5720145|P2|Second Test Period|unable to catheterise|0
1637052|NCT01800903|5720146|P1|Second Test Period|unable to catheterise|1
1637053|NCT01800201|5720235|P2|Overall Study|PI withdrawal, cognitive concerns|1
1637054|NCT01800201|5720236|P1|Overall Study|PI withdrawal, cognitive concerns|0
1637055|NCT01800201|5720235|P2|Overall Study|did not want to use device|1
1637056|NCT01800201|5720236|P1|Overall Study|did not want to use device|0
1637057|NCT01800201|5720235|P2|Overall Study|patient privacy concerns|1
1637058|NCT01800201|5720236|P1|Overall Study|patient privacy concerns|1
1637059|NCT01800201|5720235|P2|Overall Study|Withdrawal by Subject|0
1637060|NCT01800201|5720236|P1|Overall Study|Withdrawal by Subject|2
1637061|NCT01799993|5720279|P2|Overall Study|Subject didn't return for follow-up|1
1637062|NCT01799993|5720280|P1|Overall Study|Subject didn't return for follow-up|0
1637063|NCT01799993|5720279|P2|Overall Study|Other|0
1637064|NCT01799993|5720280|P1|Overall Study|Other|1
1637065|NCT01799993|5720279|P2|Overall Study|Withdrawal by parent/guardian|1
1637066|NCT01799993|5720280|P1|Overall Study|Withdrawal by parent/guardian|0
1637067|NCT01799993|5720279|P2|Overall Study|Non-compliance with medical device|0
1637068|NCT01799993|5720280|P1|Overall Study|Non-compliance with medical device|1
1637069|NCT01799993|5720279|P2|Overall Study|Protocol deviation|0
1637070|NCT01799993|5720280|P1|Overall Study|Protocol deviation|1
1637071|NCT01799993|5720279|P2|Overall Study|Logistical difficulties|0
1637072|NCT01799993|5720280|P1|Overall Study|Logistical difficulties|1
1637073|NCT01799993|5720279|P2|Overall Study|Recovery|1
1637074|NCT01799993|5720280|P1|Overall Study|Recovery|0
1637075|NCT01799993|5720279|P2|Overall Study|Lack of Efficacy|0
1637076|NCT01799993|5720280|P1|Overall Study|Lack of Efficacy|1
1637077|NCT01799993|5720279|P2|Overall Study|Adverse Event|0
1637078|NCT01799993|5720280|P1|Overall Study|Adverse Event|1
1637079|NCT01799993|5720279|P2|Overall Study|Screen failure|1
1637080|NCT01799993|5720280|P1|Overall Study|Screen failure|0
1637081|NCT01799993|5720279|P2|Overall Study|Deterioration of general conditions|0
1637082|NCT01799993|5720280|P1|Overall Study|Deterioration of general conditions|2
1637083|NCT01799993|5720279|P2|Overall Study|Protocol Violation|1
1637084|NCT01799993|5720280|P1|Overall Study|Protocol Violation|1
1637085|NCT01799993|5720279|P2|Overall Study|Protocol driven decision point|3
1637086|NCT01799993|5720280|P1|Overall Study|Protocol driven decision point|0
1637087|NCT01799993|5720279|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
1637088|NCT01799993|5720280|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
1637089|NCT01799993|5720279|P2|Overall Study|Lost to Follow-up|8
1637090|NCT01799993|5720280|P1|Overall Study|Lost to Follow-up|5
1637091|NCT01799993|5720279|P2|Overall Study|Withdrawal by Subject|24
1637092|NCT01799993|5720280|P1|Overall Study|Withdrawal by Subject|23
1637093|NCT01799993|5720279|P2|Overall Study|Death|45
1637094|NCT01799993|5720280|P1|Overall Study|Death|61
1637095|NCT01799993|5720279|P2|Overall Study|"Didn't complete CRF page End of FU"|40
1637096|NCT01799993|5720280|P1|Overall Study|"Didn't complete CRF page End of FU"|30
1637097|NCT01799941|5720312|P1|Overall Study|Other|15
1637098|NCT01799941|5720312|P1|Overall Study|Lost to Follow-up|17
1637099|NCT01799941|5720312|P1|Overall Study|Lack of Efficacy|3
1637100|NCT01799941|5720312|P1|Overall Study|Investigator Decision|4
1637101|NCT01799941|5720312|P1|Overall Study|Death|2
1637102|NCT01799941|5720312|P1|Overall Study|Withdrawal by Subject|21
1637103|NCT01799941|5720312|P1|Overall Study|Adverse Event|34
1637104|NCT01799720|5720369|P3|Overall Study|Pregnancy|1
1637105|NCT01799720|5720370|P2|Overall Study|Pregnancy|0
1637106|NCT01799720|5720371|P1|Overall Study|Pregnancy|0
1637107|NCT01799720|5720369|P3|Overall Study|Protocol Violation|0
1637108|NCT01799720|5720370|P2|Overall Study|Protocol Violation|1
1637109|NCT01799720|5720371|P1|Overall Study|Protocol Violation|0
1637110|NCT01799720|5720369|P3|Overall Study|Withdrawal by Subject|0
1637111|NCT01799720|5720370|P2|Overall Study|Withdrawal by Subject|0
1637112|NCT01799720|5720371|P1|Overall Study|Withdrawal by Subject|3
1637113|NCT01799590|5720409|P3|Overall Study|Other|1
1637114|NCT01799590|5720410|P2|Overall Study|Other|0
1637115|NCT01799590|5720411|P1|Overall Study|Other|3
1637116|NCT01799590|5720409|P3|Overall Study|Use of prohibited concomitant drugs|0
1637117|NCT01799590|5720410|P2|Overall Study|Use of prohibited concomitant drugs|0
1637118|NCT01799590|5720411|P1|Overall Study|Use of prohibited concomitant drugs|1
1637119|NCT01799590|5720409|P3|Overall Study|Using drugs with restricted days of use|2
1637120|NCT01799590|5720410|P2|Overall Study|Using drugs with restricted days of use|3
1637121|NCT01799590|5720411|P1|Overall Study|Using drugs with restricted days of use|0
1637122|NCT01799590|5720409|P3|Overall Study|Aggravation of complications|1
1637123|NCT01799590|5720410|P2|Overall Study|Aggravation of complications|1
1637124|NCT01799590|5720411|P1|Overall Study|Aggravation of complications|0
1637125|NCT01799590|5720409|P3|Overall Study|Participants convenience|2
1637126|NCT01799590|5720410|P2|Overall Study|Participants convenience|4
1637127|NCT01799590|5720411|P1|Overall Study|Participants convenience|4
1637128|NCT01799590|5720409|P3|Overall Study|Lack of Efficacy|3
1637129|NCT01799590|5720410|P2|Overall Study|Lack of Efficacy|1
1637130|NCT01799590|5720411|P1|Overall Study|Lack of Efficacy|3
1637131|NCT01799590|5720409|P3|Overall Study|Pregnancy|0
1637132|NCT01799590|5720410|P2|Overall Study|Pregnancy|0
1637133|NCT01799590|5720411|P1|Overall Study|Pregnancy|2
1637134|NCT01799590|5720409|P3|Overall Study|Adverse Event|5
1637135|NCT01799590|5720410|P2|Overall Study|Adverse Event|7
1637136|NCT01799590|5720411|P1|Overall Study|Adverse Event|13
1637137|NCT01799239|5720454|P2|Period 2 (7 Days)|Protocol Violation|0
1637138|NCT01799239|5720455|P1|Period 2 (7 Days)|Protocol Violation|1
1637139|NCT01799239|5720454|P2|Period 2 (7 Days)|Withdrawal by Subject|1
1637140|NCT01799239|5720455|P1|Period 2 (7 Days)|Withdrawal by Subject|1
1637141|NCT01799239|5720454|P2|Period 1 (7 Days)|Protocol Violation|1
1637142|NCT01799239|5720455|P1|Period 1 (7 Days)|Protocol Violation|0
1637143|NCT01799239|5720454|P2|Period 1 (7 Days)|Withdrawal by Subject|0
1637144|NCT01799239|5720455|P1|Period 1 (7 Days)|Withdrawal by Subject|2
1637145|NCT01799239|5720454|P2|Period 1 (7 Days)|Lack of Efficacy|0
1637146|NCT01799239|5720455|P1|Period 1 (7 Days)|Lack of Efficacy|1
1637147|NCT01799226|5720463|P2|Overall Study|Disqualified at Day 14|0
1637148|NCT01799226|5720464|P1|Overall Study|Disqualified at Day 14|1
1637149|NCT01799226|5720463|P2|Overall Study|Withdrawal by Subject|0
1637150|NCT01799226|5720464|P1|Overall Study|Withdrawal by Subject|1
1637151|NCT01798992|5720495|P4|Overall Study|Insufficient biopsy tissue|0
1637152|NCT01798992|5720496|P3|Overall Study|Insufficient biopsy tissue|1
1637153|NCT01798992|5720497|P2|Overall Study|Insufficient biopsy tissue|0
1637154|NCT01798992|5720498|P1|Overall Study|Insufficient biopsy tissue|0
1637155|NCT01798992|5720495|P4|Overall Study|Lost to Follow-up|0
1637156|NCT01798992|5720496|P3|Overall Study|Lost to Follow-up|1
1637157|NCT01798992|5720497|P2|Overall Study|Lost to Follow-up|1
1637158|NCT01798992|5720498|P1|Overall Study|Lost to Follow-up|0
1637159|NCT01798992|5720495|P4|Overall Study|Administrative withdrawal|1
1637160|NCT01798992|5720496|P3|Overall Study|Administrative withdrawal|0
1637161|NCT01798992|5720497|P2|Overall Study|Administrative withdrawal|1
1637162|NCT01798992|5720498|P1|Overall Study|Administrative withdrawal|0
1637163|NCT01798927|5720518|P1|Overall Study|Withdrawal by Subject|1
1637164|NCT01798849|5720527|P3|Overall Study|Physician Decision|1
1637165|NCT01798849|5720528|P2|Overall Study|Physician Decision|0
1637166|NCT01798849|5720529|P1|Overall Study|Physician Decision|0
1637167|NCT01798706|5720719|P2|Overall Study|Other than specified above|9
1637168|NCT01798706|5720720|P1|Overall Study|Other than specified above|5
1637169|NCT01798706|5720719|P2|Overall Study|Poor compliance to protocol|0
1637170|NCT01798706|5720720|P1|Overall Study|Poor compliance to protocol|1
1637171|NCT01798706|5720719|P2|Overall Study|Lack of Efficacy|2
1637172|NCT01798706|5720720|P1|Overall Study|Lack of Efficacy|0
1637173|NCT01798706|5720719|P2|Overall Study|Adverse Event|10
1637174|NCT01798706|5720720|P1|Overall Study|Adverse Event|15
1637175|NCT01798485|5720782|P2|Overall Study|Clinical Progression|24
1637176|NCT01798485|5720783|P1|Overall Study|Clinical Progression|35
1637177|NCT01798485|5720782|P2|Overall Study|Sponsor Decision|54
1637178|NCT01798485|5720783|P1|Overall Study|Sponsor Decision|61
1637179|NCT01798485|5720782|P2|Overall Study|Death|22
1637180|NCT01798485|5720783|P1|Overall Study|Death|25
1637181|NCT01798485|5720782|P2|Overall Study|Objective Disease Progression|106
1637182|NCT01798485|5720783|P1|Overall Study|Objective Disease Progression|152
1637183|NCT01798485|5720782|P2|Overall Study|Physician Decision|10
1637184|NCT01798485|5720783|P1|Overall Study|Physician Decision|14
1637185|NCT01798485|5720782|P2|Overall Study|Lost to Follow-up|3
1637186|NCT01798485|5720783|P1|Overall Study|Lost to Follow-up|0
1637187|NCT01798485|5720782|P2|Overall Study|Withdrawal by Subject|31
1637188|NCT01798485|5720783|P1|Overall Study|Withdrawal by Subject|27
1637189|NCT01798485|5720782|P2|Overall Study|Adverse Event|40
1637190|NCT01798485|5720783|P1|Overall Study|Adverse Event|32
1637191|NCT01798134|5720920|P1|Overall Study|Liver transplant/surgery|4
1637192|NCT01798134|5720920|P1|Overall Study|Physician Decision|3
1637193|NCT01798134|5720920|P1|Overall Study|Adverse Event|3
1637194|NCT01798134|5720920|P1|Overall Study|Death|2
1637195|NCT01798134|5720920|P1|Overall Study|Withdrawal by Subject|3
1637196|NCT01798134|5720920|P1|Overall Study|Lost to Follow-up|1
1637197|NCT01798056|5720929|P2|Overall Study|Other|2
1637198|NCT01798056|5720930|P1|Overall Study|Other|0
1637199|NCT01798056|5720929|P2|Overall Study|Lost to Follow-up|1
1637200|NCT01798056|5720930|P1|Overall Study|Lost to Follow-up|1
1637201|NCT01798056|5720929|P2|Overall Study|Migrated/moved from study area|1
1637202|NCT01798056|5720930|P1|Overall Study|Migrated/moved from study area|1
1637203|NCT01798056|5720929|P2|Overall Study|Withdrawal by Subject|9
1637204|NCT01798056|5720930|P1|Overall Study|Withdrawal by Subject|12
1637205|NCT01798056|5720929|P2|Overall Study|Serious Adverse Event|12
1637206|NCT01798056|5720930|P1|Overall Study|Serious Adverse Event|13
1637207|NCT01798004|5720964|P1|Overall Study|Enrollment another COG therapeutic trial|32
1637208|NCT01798004|5720964|P1|Overall Study|Initiation of other non-protocol therapy|5
1637209|NCT01798004|5720964|P1|Overall Study|Patient/parent refusal|7
1637210|NCT01798004|5720964|P1|Overall Study|Ineligible|4
1637211|NCT01798004|5720964|P1|Overall Study|Withdrawal by Subject|4
1637212|NCT01798004|5720964|P1|Overall Study|Physician Decision|25
1637213|NCT01798004|5720964|P1|Overall Study|Lack of Efficacy|8
1637214|NCT01798004|5720964|P1|Overall Study|Death|2
1637215|NCT01797965|5720972|P4|Overall Study|Reason Not Specified|15
1637216|NCT01797965|5720973|P3|Overall Study|Reason Not Specified|0
1637217|NCT01797965|5720974|P2|Overall Study|Reason Not Specified|295
1637218|NCT01797965|5720975|P1|Overall Study|Reason Not Specified|280
1637219|NCT01797965|5720972|P4|Overall Study|Disease progression, defined by protocol|0
1637220|NCT01797965|5720973|P3|Overall Study|Disease progression, defined by protocol|0
1637221|NCT01797965|5720974|P2|Overall Study|Disease progression, defined by protocol|1
1637222|NCT01797965|5720975|P1|Overall Study|Disease progression, defined by protocol|3
1637223|NCT01797965|5720972|P4|Overall Study|Death|0
1637224|NCT01797965|5720973|P3|Overall Study|Death|0
1637225|NCT01797965|5720974|P2|Overall Study|Death|4
1637226|NCT01797965|5720975|P1|Overall Study|Death|2
1637227|NCT01797965|5720972|P4|Overall Study|Investigator decision|0
1637228|NCT01797965|5720973|P3|Overall Study|Investigator decision|0
1637229|NCT01797965|5720974|P2|Overall Study|Investigator decision|15
1637230|NCT01797965|5720975|P1|Overall Study|Investigator decision|21
1637231|NCT01797965|5720972|P4|Overall Study|Consent withdrawn|35
1637232|NCT01797965|5720973|P3|Overall Study|Consent withdrawn|3
1637233|NCT01797965|5720974|P2|Overall Study|Consent withdrawn|117
1637234|NCT01797965|5720975|P1|Overall Study|Consent withdrawn|130
1637235|NCT01797965|5720972|P4|Overall Study|Lost to Follow-up|2
1637236|NCT01797965|5720973|P3|Overall Study|Lost to Follow-up|1
1637237|NCT01797965|5720974|P2|Overall Study|Lost to Follow-up|8
1637238|NCT01797965|5720975|P1|Overall Study|Lost to Follow-up|9
1637239|NCT01797965|5720972|P4|Overall Study|Adverse Event|21
1637240|NCT01797965|5720973|P3|Overall Study|Adverse Event|4
1637241|NCT01797965|5720974|P2|Overall Study|Adverse Event|129
1637242|NCT01797965|5720975|P1|Overall Study|Adverse Event|104
1637243|NCT01797835|5721109|P2|Overall Study|Lost to Follow-up|27
1637244|NCT01797835|5721110|P1|Overall Study|Lost to Follow-up|31
1637245|NCT01797783|5721126|P2|Overall Study|Withdrawal by Subject|0
1637246|NCT01797783|5721127|P1|Overall Study|Withdrawal by Subject|1
1637247|NCT01797783|5721126|P2|Overall Study|Adverse Event|1
1637248|NCT01797783|5721127|P1|Overall Study|Adverse Event|1
1637249|NCT01797731|5721151|P2|Overall Study|Didn't have proper radiographs required|3
1637250|NCT01797731|5721152|P1|Overall Study|Didn't have proper radiographs required|3
1637251|NCT01797705|5721160|P1|Overall Study|Withdrawal by Subject|1
1637252|NCT01797705|5721160|P1|Overall Study|Equipment anomalies during sleep studies|4
1637253|NCT01797536|5721225|P4|Overall Study|Adverse Event|0
1637254|NCT01797536|5721226|P3|Overall Study|Adverse Event|0
1637255|NCT01797536|5721227|P2|Overall Study|Adverse Event|1
1637256|NCT01797536|5721228|P1|Overall Study|Adverse Event|0
1637257|NCT01797445|5721300|P2|Open-Label Extension Phase|Investigator's Discretion|0
1637258|NCT01797445|5721301|P1|Open-Label Extension Phase|Investigator's Discretion|1
1637259|NCT01797445|5721300|P2|Double-Blind Phase|Lost to Follow-up|26
1637260|NCT01797445|5721301|P1|Double-Blind Phase|Lost to Follow-up|34
1637261|NCT01797445|5721300|P2|Double-Blind Phase|Withdrew Consent|35
1637262|NCT01797445|5721301|P1|Double-Blind Phase|Withdrew Consent|20
1637263|NCT01797445|5721300|P2|Double-Blind Phase|Protocol Violation|1
1637264|NCT01797445|5721301|P1|Double-Blind Phase|Protocol Violation|0
1637265|NCT01797445|5721300|P2|Double-Blind Phase|Noncompliance with Study Drug|1
1637266|NCT01797445|5721301|P1|Double-Blind Phase|Noncompliance with Study Drug|5
1637267|NCT01797445|5721300|P2|Double-Blind Phase|Investigator's Discretion|17
1637268|NCT01797445|5721301|P1|Double-Blind Phase|Investigator's Discretion|15
1637269|NCT01797445|5721300|P2|Double-Blind Phase|Lack of Efficacy|2
1637270|NCT01797445|5721301|P1|Double-Blind Phase|Lack of Efficacy|1
1637271|NCT01797445|5721300|P2|Double-Blind Phase|Pregnancy|1
1637272|NCT01797445|5721301|P1|Double-Blind Phase|Pregnancy|0
1637273|NCT01797445|5721300|P2|Double-Blind Phase|Death|4
1637274|NCT01797445|5721301|P1|Double-Blind Phase|Death|5
1637275|NCT01797445|5721300|P2|Double-Blind Phase|Adverse Event|0
1637276|NCT01797445|5721301|P1|Double-Blind Phase|Adverse Event|3
1637277|NCT01797445|5721300|P2|Double-Blind Phase|Randomized but Not Treated|2
1637278|NCT01797445|5721301|P1|Double-Blind Phase|Randomized but Not Treated|4
1637285|NCT01797185|5721397|P3|Overall Study|Protocol Violation|0
1637286|NCT01797185|5721398|P2|Overall Study|Protocol Violation|1
1637287|NCT01797185|5721399|P1|Overall Study|Protocol Violation|1
1637288|NCT01797185|5721397|P3|Overall Study|Physician Decision|0
1637289|NCT01797185|5721398|P2|Overall Study|Physician Decision|3
1637290|NCT01797185|5721399|P1|Overall Study|Physician Decision|1
1637291|NCT01797185|5721397|P3|Overall Study|Withdrawn per sponsor|0
1637292|NCT01797185|5721398|P2|Overall Study|Withdrawn per sponsor|0
1637293|NCT01797185|5721399|P1|Overall Study|Withdrawn per sponsor|5
1637294|NCT01797185|5721397|P3|Overall Study|Lost to Follow-up|1
1637295|NCT01797185|5721398|P2|Overall Study|Lost to Follow-up|6
1637296|NCT01797185|5721399|P1|Overall Study|Lost to Follow-up|2
1637297|NCT01797185|5721397|P3|Overall Study|Site terminated|0
1637298|NCT01797185|5721398|P2|Overall Study|Site terminated|4
1637299|NCT01797185|5721399|P1|Overall Study|Site terminated|8
1637300|NCT01797185|5721397|P3|Overall Study|Withdrawal by Subject|5
1637301|NCT01797185|5721398|P2|Overall Study|Withdrawal by Subject|9
1637302|NCT01797185|5721399|P1|Overall Study|Withdrawal by Subject|6
1637303|NCT01797185|5721397|P3|Overall Study|Adverse Event|6
1637304|NCT01797185|5721398|P2|Overall Study|Adverse Event|15
1637305|NCT01797185|5721399|P1|Overall Study|Adverse Event|5
1637306|NCT01797120|5721409|P2|Overall Study|never start protocol therapy|0
1637307|NCT01797120|5721410|P1|Overall Study|never start protocol therapy|2
1637308|NCT01797120|5721409|P2|Overall Study|still on treatment|4
1637309|NCT01797120|5721410|P1|Overall Study|still on treatment|2
1637310|NCT01797120|5721409|P2|Overall Study|Physician Decision|0
1637311|NCT01797120|5721410|P1|Overall Study|Physician Decision|3
1637312|NCT01797120|5721409|P2|Overall Study|Non-compliance|0
1637313|NCT01797120|5721410|P1|Overall Study|Non-compliance|1
1637314|NCT01797120|5721409|P2|Overall Study|Symptomatic progression|1
1637315|NCT01797120|5721410|P1|Overall Study|Symptomatic progression|2
1637316|NCT01797120|5721409|P2|Overall Study|Withdrawal by Subject|6
1637317|NCT01797120|5721410|P1|Overall Study|Withdrawal by Subject|6
1637318|NCT01797120|5721409|P2|Overall Study|Adverse Event|5
1637319|NCT01797120|5721410|P1|Overall Study|Adverse Event|13
1637320|NCT01797120|5721409|P2|Overall Study|Disesae progression|49
1637321|NCT01797120|5721410|P1|Overall Study|Disesae progression|37
1637322|NCT01797094|5721424|P2|Overall Study|Other Miscellaneous Reasons|0
1637323|NCT01797094|5721425|P1|Overall Study|Other Miscellaneous Reasons|1
1637324|NCT01797094|5721424|P2|Overall Study|Protocol Violation|1
1637325|NCT01797094|5721425|P1|Overall Study|Protocol Violation|0
1637326|NCT01797094|5721424|P2|Overall Study|Personal Reasons|0
1637327|NCT01797094|5721425|P1|Overall Study|Personal Reasons|4
1637328|NCT01797094|5721424|P2|Overall Study|Adverse Event|1
1637329|NCT01797094|5721425|P1|Overall Study|Adverse Event|1
1637330|NCT01797081|5721447|P4|Overall Study|Protocol Violation|1
1637331|NCT01797081|5721448|P3|Overall Study|Protocol Violation|0
1637332|NCT01797081|5721449|P2|Overall Study|Protocol Violation|0
1637333|NCT01797081|5721450|P1|Overall Study|Protocol Violation|0
1637334|NCT01797081|5721447|P4|Overall Study|Personal Reasons|8
1637335|NCT01797081|5721448|P3|Overall Study|Personal Reasons|4
1637336|NCT01797081|5721449|P2|Overall Study|Personal Reasons|4
1637337|NCT01797081|5721450|P1|Overall Study|Personal Reasons|12
1637338|NCT01797081|5721447|P4|Overall Study|Pregnancy|0
1637339|NCT01797081|5721448|P3|Overall Study|Pregnancy|0
1637340|NCT01797081|5721449|P2|Overall Study|Pregnancy|0
1637341|NCT01797081|5721450|P1|Overall Study|Pregnancy|1
1637342|NCT01797081|5721447|P4|Overall Study|Adverse Event|0
1637343|NCT01797081|5721448|P3|Overall Study|Adverse Event|1
1637344|NCT01797081|5721449|P2|Overall Study|Adverse Event|0
1637345|NCT01797081|5721450|P1|Overall Study|Adverse Event|1
1637346|NCT01796964|5721491|P2|Overall Study|Withdrawal by Subject|1
1637347|NCT01796964|5721492|P1|Overall Study|Withdrawal by Subject|1
1637348|NCT01796964|5721491|P2|Overall Study|Protocol Violation|1
1637349|NCT01796964|5721492|P1|Overall Study|Protocol Violation|0
1637350|NCT01796964|5721491|P2|Overall Study|Death|0
1637351|NCT01796964|5721492|P1|Overall Study|Death|1
1637352|NCT01796964|5721491|P2|Overall Study|Adverse Event|1
1637353|NCT01796964|5721492|P1|Overall Study|Adverse Event|1
1637354|NCT01796860|5721533|P1|Overall Study|Withdrawal by Subject|3
1637355|NCT01796548|5721539|P1|Overall Study|Other|2
1637356|NCT01796548|5721539|P1|Overall Study|Lost to Follow-up|1
1637357|NCT01796392|5721553|P2|Overall Study|Lost to Follow-up|0
1637358|NCT01796392|5721554|P1|Overall Study|Lost to Follow-up|1
1637359|NCT01796392|5721553|P2|Overall Study|Excluded for medical reasons|2
1637360|NCT01796392|5721554|P1|Overall Study|Excluded for medical reasons|1
1637361|NCT01796392|5721553|P2|Overall Study|Death|1
1637362|NCT01796392|5721554|P1|Overall Study|Death|5
1637363|NCT01796392|5721553|P2|Overall Study|Withdrawal by Subject|0
1637364|NCT01796392|5721554|P1|Overall Study|Withdrawal by Subject|2
1637365|NCT01796301|5721568|P2|Overall Study|Decision by Sponsor|1
1637366|NCT01796301|5721569|P1|Overall Study|Decision by Sponsor|0
1637367|NCT01796301|5721568|P2|Overall Study|Death|1
1637368|NCT01796301|5721569|P1|Overall Study|Death|0
1637369|NCT01796301|5721568|P2|Overall Study|Lost to Follow-up|3
1637370|NCT01796301|5721569|P1|Overall Study|Lost to Follow-up|3
1637371|NCT01796301|5721568|P2|Overall Study|Withdrawal by Subject|15
1637372|NCT01796301|5721569|P1|Overall Study|Withdrawal by Subject|15
1637373|NCT01795937|5721655|P3|Overall Study|Physician Decision|0
1637374|NCT01795937|5721656|P2|Overall Study|Physician Decision|1
1637375|NCT01795937|5721657|P1|Overall Study|Physician Decision|0
1637376|NCT01795937|5721655|P3|Overall Study|Withdrawal by Subject|0
1637377|NCT01795937|5721656|P2|Overall Study|Withdrawal by Subject|0
1637378|NCT01795937|5721657|P1|Overall Study|Withdrawal by Subject|1
1637379|NCT01795898|5721686|P1|Overall Study|Physician Decision|1
1637380|NCT01795898|5721686|P1|Overall Study|Withdrew consent & had adverse events|3
1637381|NCT01795898|5721686|P1|Overall Study|Death|1
1637382|NCT01795898|5721686|P1|Overall Study|No pain|1
1637383|NCT01795898|5721686|P1|Overall Study|Diagnosed with metastasis|1
1637384|NCT01795898|5721686|P1|Overall Study|Withdrawal of consent|6
1637385|NCT01795898|5721686|P1|Overall Study|Lost to Follow-up|20
1637386|NCT01795898|5721686|P1|Overall Study|Adverse Event|27
1637387|NCT01795547|5721745|P2|Overall Study|Not stated|1
1637388|NCT01795547|5721746|P1|Overall Study|Not stated|0
1637389|NCT01795547|5721745|P2|Overall Study|Others|1
1637390|NCT01795547|5721746|P1|Overall Study|Others|4
1637391|NCT01795547|5721745|P2|Overall Study|Non-compliance with IMP|1
1637392|NCT01795547|5721746|P1|Overall Study|Non-compliance with IMP|1
1637393|NCT01795547|5721745|P2|Overall Study|Not Treated|10
1637394|NCT01795547|5721746|P1|Overall Study|Not Treated|4
1637395|NCT01795547|5721745|P2|Overall Study|Withdrawal of consent|12
1637396|NCT01795547|5721746|P1|Overall Study|Withdrawal of consent|7
1637397|NCT01795547|5721745|P2|Overall Study|Lost to Follow-up|5
1637398|NCT01795547|5721746|P1|Overall Study|Lost to Follow-up|2
1637399|NCT01795547|5721745|P2|Overall Study|Protocol Violation|4
1637400|NCT01795547|5721746|P1|Overall Study|Protocol Violation|6
1637401|NCT01795547|5721745|P2|Overall Study|Lack of Efficacy|3
1637402|NCT01795547|5721746|P1|Overall Study|Lack of Efficacy|8
1637403|NCT01795547|5721745|P2|Overall Study|Adverse Event|27
1637404|NCT01795547|5721746|P1|Overall Study|Adverse Event|16
1637405|NCT01795495|5721778|P3|Overall Study|Physician Decision|1
1637406|NCT01795495|5721779|P2|Overall Study|Physician Decision|0
1637407|NCT01795495|5721780|P1|Overall Study|Physician Decision|0
1637408|NCT01795495|5721778|P3|Overall Study|Protocol Violation|1
1637409|NCT01795495|5721779|P2|Overall Study|Protocol Violation|0
1637410|NCT01795495|5721780|P1|Overall Study|Protocol Violation|1
1637411|NCT01794949|5721800|P2|Overall Study|Lost to Follow-up|0
1637412|NCT01794949|5721801|P1|Overall Study|Lost to Follow-up|1
1637413|NCT01794845|5721812|P1|Overall Study|Withdrawal by Subject|1
1637414|NCT01794780|5721840|P8|Overall Study|Other|1
1637415|NCT01794780|5721841|P7|Overall Study|Other|4
1637416|NCT01794780|5721842|P6|Overall Study|Other|24
1637417|NCT01794780|5721843|P5|Overall Study|Other|1
1637418|NCT01794780|5721844|P4|Overall Study|Other|20
1637419|NCT01794780|5721845|P3|Overall Study|Other|25
1637420|NCT01794780|5721846|P2|Overall Study|Other|12
1637421|NCT01794780|5721847|P1|Overall Study|Other|0
1637422|NCT01794780|5721840|P8|Overall Study|Withdrew informed consent|3
1637423|NCT01794780|5721841|P7|Overall Study|Withdrew informed consent|4
1637424|NCT01794780|5721842|P6|Overall Study|Withdrew informed consent|48
1637425|NCT01794780|5721843|P5|Overall Study|Withdrew informed consent|0
1637426|NCT01794780|5721844|P4|Overall Study|Withdrew informed consent|9
1637427|NCT01794780|5721845|P3|Overall Study|Withdrew informed consent|36
1637428|NCT01794780|5721846|P2|Overall Study|Withdrew informed consent|17
1637429|NCT01794780|5721847|P1|Overall Study|Withdrew informed consent|7
1637430|NCT01794780|5721840|P8|Overall Study|Lost to Follow-up|5
1637431|NCT01794780|5721841|P7|Overall Study|Lost to Follow-up|30
1637432|NCT01794780|5721842|P6|Overall Study|Lost to Follow-up|99
1637433|NCT01794780|5721843|P5|Overall Study|Lost to Follow-up|2
1637434|NCT01794780|5721844|P4|Overall Study|Lost to Follow-up|53
1637435|NCT01794780|5721845|P3|Overall Study|Lost to Follow-up|165
1637436|NCT01794780|5721846|P2|Overall Study|Lost to Follow-up|64
1637437|NCT01794780|5721847|P1|Overall Study|Lost to Follow-up|10
1637438|NCT01794780|5721840|P8|Overall Study|Death|0
1637439|NCT01794780|5721841|P7|Overall Study|Death|4
1637440|NCT01794780|5721842|P6|Overall Study|Death|9
1637441|NCT01794780|5721843|P5|Overall Study|Death|0
1637442|NCT01794780|5721844|P4|Overall Study|Death|1
1637443|NCT01794780|5721845|P3|Overall Study|Death|14
1637444|NCT01794780|5721846|P2|Overall Study|Death|2
1637445|NCT01794780|5721847|P1|Overall Study|Death|0
1637446|NCT01794780|5721840|P8|Overall Study|Adverse Event|0
1637447|NCT01794780|5721841|P7|Overall Study|Adverse Event|0
1637448|NCT01794780|5721842|P6|Overall Study|Adverse Event|0
1637449|NCT01794780|5721843|P5|Overall Study|Adverse Event|0
1637450|NCT01794780|5721844|P4|Overall Study|Adverse Event|0
1637451|NCT01794780|5721845|P3|Overall Study|Adverse Event|2
1637452|NCT01794780|5721846|P2|Overall Study|Adverse Event|1
1637453|NCT01794780|5721847|P1|Overall Study|Adverse Event|0
1637454|NCT01794689|5721923|P4|Intervention 1 (2 Nights)|Adverse Event|0
1637455|NCT01794689|5721924|P3|Intervention 1 (2 Nights)|Adverse Event|0
1637456|NCT01794689|5721925|P2|Intervention 1 (2 Nights)|Adverse Event|1
1637457|NCT01794689|5721926|P1|Intervention 1 (2 Nights)|Adverse Event|0
1637458|NCT01794689|5721923|P4|Intervention 1 (2 Nights)|Physician Decision|0
1637459|NCT01794689|5721924|P3|Intervention 1 (2 Nights)|Physician Decision|0
1637460|NCT01794689|5721925|P2|Intervention 1 (2 Nights)|Physician Decision|1
1637461|NCT01794689|5721926|P1|Intervention 1 (2 Nights)|Physician Decision|1
1637462|NCT01794689|5721923|P4|Intervention 1 (2 Nights)|Protocol Violation|0
1637463|NCT01794689|5721924|P3|Intervention 1 (2 Nights)|Protocol Violation|1
1637464|NCT01794689|5721925|P2|Intervention 1 (2 Nights)|Protocol Violation|0
1637465|NCT01794689|5721926|P1|Intervention 1 (2 Nights)|Protocol Violation|1
1637466|NCT01794689|5721923|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
1637467|NCT01794689|5721924|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
1637468|NCT01794689|5721925|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
1637469|NCT01794689|5721926|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
1637470|NCT01794000|5721995|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
1637471|NCT01794000|5721996|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
1637472|NCT01794000|5721995|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
1637473|NCT01794000|5721996|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
1637474|NCT01794000|5721995|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
1637475|NCT01794000|5721996|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
1637476|NCT01794000|5721995|P2|Double-Blind Phase (DBP)|Physician Decision|0
1637477|NCT01794000|5721996|P1|Double-Blind Phase (DBP)|Physician Decision|2
1637478|NCT01794000|5721995|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
1637479|NCT01794000|5721996|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
1637480|NCT01794000|5721995|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
1637481|NCT01794000|5721996|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
1637482|NCT01794000|5721995|P2|Double-Blind Phase (DBP)|Death|2
1637483|NCT01794000|5721996|P1|Double-Blind Phase (DBP)|Death|1
1637484|NCT01794000|5721995|P2|Double-Blind Phase (DBP)|Adverse Event|2
1637485|NCT01794000|5721996|P1|Double-Blind Phase (DBP)|Adverse Event|5
1637486|NCT01793935|5722029|P2|Overall Study|Lost to Follow-up|1
1637487|NCT01793935|5722030|P1|Overall Study|Lost to Follow-up|0
1637488|NCT01793935|5722029|P2|Overall Study|Patient did not take study medication|1
1637489|NCT01793935|5722030|P1|Overall Study|Patient did not take study medication|1
1637490|NCT01793935|5722029|P2|Overall Study|Adverse Event|0
1637491|NCT01793935|5722030|P1|Overall Study|Adverse Event|2
1637492|NCT01793935|5722029|P2|Overall Study|Protocol Violation|1
1637493|NCT01793935|5722030|P1|Overall Study|Protocol Violation|2
1637494|NCT01793935|5722029|P2|Overall Study|Pregnancy|0
1637495|NCT01793935|5722030|P1|Overall Study|Pregnancy|1
1637496|NCT01793883|5722076|P3|Overall Study|Respiratory distress during spirometry|1
1637497|NCT01793883|5722077|P2|Overall Study|Respiratory distress during spirometry|0
1637498|NCT01793883|5722078|P1|Overall Study|Respiratory distress during spirometry|0
1637499|NCT01793883|5722076|P3|Overall Study|Dosing error|0
1637500|NCT01793883|5722077|P2|Overall Study|Dosing error|1
1637501|NCT01793883|5722078|P1|Overall Study|Dosing error|0
1637502|NCT01793883|5722076|P3|Overall Study|Met exclusion criteria|0
1637503|NCT01793883|5722077|P2|Overall Study|Met exclusion criteria|0
1637504|NCT01793883|5722078|P1|Overall Study|Met exclusion criteria|1
1637505|NCT01793883|5722076|P3|Overall Study|Unable to complete measurements|0
1637506|NCT01793883|5722077|P2|Overall Study|Unable to complete measurements|0
1637507|NCT01793883|5722078|P1|Overall Study|Unable to complete measurements|1
1637508|NCT01793883|5722076|P3|Overall Study|Unable to complete spriometry|0
1637509|NCT01793883|5722077|P2|Overall Study|Unable to complete spriometry|0
1637510|NCT01793883|5722078|P1|Overall Study|Unable to complete spriometry|1
1637511|NCT01793883|5722076|P3|Overall Study|Randomized in error|0
1637512|NCT01793883|5722077|P2|Overall Study|Randomized in error|0
1637513|NCT01793883|5722078|P1|Overall Study|Randomized in error|1
1637514|NCT01793883|5722076|P3|Overall Study|Lost to Follow-up|3
1637515|NCT01793883|5722077|P2|Overall Study|Lost to Follow-up|1
1637516|NCT01793883|5722078|P1|Overall Study|Lost to Follow-up|5
1637517|NCT01793883|5722076|P3|Overall Study|Subject noncompliance|1
1637518|NCT01793883|5722077|P2|Overall Study|Subject noncompliance|1
1637519|NCT01793883|5722078|P1|Overall Study|Subject noncompliance|0
1637520|NCT01793883|5722076|P3|Overall Study|Withdrawal by Subject|3
1637521|NCT01793883|5722077|P2|Overall Study|Withdrawal by Subject|7
1637522|NCT01793883|5722078|P1|Overall Study|Withdrawal by Subject|3
1637523|NCT01793792|5722086|P1|Overall Study|Device Not Implanted|1
1637524|NCT01793792|5722086|P1|Overall Study|Withdrawal by Subject|1
1637525|NCT01793792|5722086|P1|Overall Study|Lost to Follow-up|5
1637526|NCT01793792|5722086|P1|Overall Study|Death|5
1637527|NCT01793688|5722091|P1|Overall Study|Protocol Violation|2
1637528|NCT01793142|5722118|P1|Overall Study|Randomized not treated|7
1637529|NCT01792830|5722148|P11|Overall Study|Adverse Event|0
1637530|NCT01792830|5722149|P10|Overall Study|Adverse Event|0
1637531|NCT01792830|5722150|P9|Overall Study|Adverse Event|1
1637532|NCT01792830|5722151|P8|Overall Study|Adverse Event|0
1637533|NCT01792830|5722152|P7|Overall Study|Adverse Event|0
1637534|NCT01792830|5722153|P6|Overall Study|Adverse Event|0
1637535|NCT01792830|5722154|P5|Overall Study|Adverse Event|0
1637536|NCT01792830|5722155|P4|Overall Study|Adverse Event|0
1637537|NCT01792830|5722156|P3|Overall Study|Adverse Event|0
1637538|NCT01792830|5722157|P2|Overall Study|Adverse Event|0
1637539|NCT01792830|5722158|P1|Overall Study|Adverse Event|0
1637540|NCT01792830|5722148|P11|Overall Study|Death|1
1637541|NCT01792830|5722149|P10|Overall Study|Death|0
1637542|NCT01792830|5722150|P9|Overall Study|Death|1
1637543|NCT01792830|5722151|P8|Overall Study|Death|0
1637544|NCT01792830|5722152|P7|Overall Study|Death|1
1637545|NCT01792830|5722153|P6|Overall Study|Death|0
1637546|NCT01792830|5722154|P5|Overall Study|Death|0
1637547|NCT01792830|5722155|P4|Overall Study|Death|1
1637548|NCT01792830|5722156|P3|Overall Study|Death|0
1637549|NCT01792830|5722157|P2|Overall Study|Death|0
1637550|NCT01792830|5722158|P1|Overall Study|Death|3
1637551|NCT01792830|5722148|P11|Overall Study|Withdrawal by Subject|2
1637552|NCT01792830|5722149|P10|Overall Study|Withdrawal by Subject|0
1637553|NCT01792830|5722150|P9|Overall Study|Withdrawal by Subject|7
1637554|NCT01792830|5722151|P8|Overall Study|Withdrawal by Subject|1
1637555|NCT01792830|5722152|P7|Overall Study|Withdrawal by Subject|1
1637556|NCT01792830|5722153|P6|Overall Study|Withdrawal by Subject|1
1637557|NCT01792830|5722154|P5|Overall Study|Withdrawal by Subject|1
1637558|NCT01792830|5722155|P4|Overall Study|Withdrawal by Subject|2
1637559|NCT01792830|5722156|P3|Overall Study|Withdrawal by Subject|0
1637560|NCT01792830|5722157|P2|Overall Study|Withdrawal by Subject|0
1637561|NCT01792830|5722158|P1|Overall Study|Withdrawal by Subject|22
1637562|NCT01792635|5722245|P3|Part B|Study terminated|3
1637563|NCT01792635|5722246|P2|Part B|Study terminated|4
1637564|NCT01792635|5722247|P1|Part B|Study terminated|0
1637565|NCT01792635|5722245|P3|Part B|Adverse Event|1
1637566|NCT01792635|5722246|P2|Part B|Adverse Event|0
1637567|NCT01792635|5722247|P1|Part B|Adverse Event|0
1637568|NCT01792518|5722275|P2|Overall Study|Other Reason|1
1637569|NCT01792518|5722276|P1|Overall Study|Other Reason|0
1637570|NCT01792518|5722275|P2|Overall Study|Withdrawal by Subject|0
1637571|NCT01792518|5722276|P1|Overall Study|Withdrawal by Subject|2
1637572|NCT01792518|5722275|P2|Overall Study|Lost to Follow-up|1
1637573|NCT01792518|5722276|P1|Overall Study|Lost to Follow-up|3
1637574|NCT01792518|5722275|P2|Overall Study|Protocol Violation|1
1637575|NCT01792518|5722276|P1|Overall Study|Protocol Violation|0
1637576|NCT01792518|5722275|P2|Overall Study|Adverse Event|4
1637577|NCT01792518|5722276|P1|Overall Study|Adverse Event|3
1637578|NCT01792284|5722286|P3|Randomization Period 2|Withdrawal by Subject|0
1637579|NCT01792284|5722287|P2|Randomization Period 2|Withdrawal by Subject|2
1637580|NCT01792284|5722288|P1|Randomization Period 2|Withdrawal by Subject|0
1637581|NCT01792284|5722286|P3|Randomization Period 2|Protocol Violation|0
1637582|NCT01792284|5722287|P2|Randomization Period 2|Protocol Violation|1
1637583|NCT01792284|5722288|P1|Randomization Period 2|Protocol Violation|0
1637584|NCT01792284|5722286|P3|Randomization Period 1|Lost to Follow-up|1
1637585|NCT01792284|5722287|P2|Randomization Period 1|Lost to Follow-up|0
1637586|NCT01792284|5722288|P1|Randomization Period 1|Lost to Follow-up|0
1637587|NCT01792284|5722286|P3|Randomization Period 1|Adverse Event|2
1637588|NCT01792284|5722287|P2|Randomization Period 1|Adverse Event|0
1637589|NCT01792284|5722288|P1|Randomization Period 1|Adverse Event|0
1637590|NCT01792284|5722286|P3|Randomization Period 1|Physician Decision|1
1637591|NCT01792284|5722287|P2|Randomization Period 1|Physician Decision|1
1637592|NCT01792284|5722288|P1|Randomization Period 1|Physician Decision|0
1637593|NCT01792284|5722286|P3|Randomization Period 1|Withdrawal by Subject|1
1637594|NCT01792284|5722287|P2|Randomization Period 1|Withdrawal by Subject|1
1637595|NCT01792284|5722288|P1|Randomization Period 1|Withdrawal by Subject|0
1637596|NCT01792284|5722286|P3|Lead-in Period|Protocol Required Discontinuation|0
1637597|NCT01792284|5722287|P2|Lead-in Period|Protocol Required Discontinuation|0
1637598|NCT01792284|5722288|P1|Lead-in Period|Protocol Required Discontinuation|1
1637599|NCT01792284|5722286|P3|Lead-in Period|Physician Decision|0
1637600|NCT01792284|5722287|P2|Lead-in Period|Physician Decision|0
1637601|NCT01792284|5722288|P1|Lead-in Period|Physician Decision|1
1637602|NCT01792284|5722286|P3|Lead-in Period|Withdrawal by Subject|0
1637603|NCT01792284|5722287|P2|Lead-in Period|Withdrawal by Subject|0
1637604|NCT01792284|5722288|P1|Lead-in Period|Withdrawal by Subject|10
1637605|NCT01792284|5722286|P3|Lead-in Period|Protocol Violation|0
1637606|NCT01792284|5722287|P2|Lead-in Period|Protocol Violation|0
1637607|NCT01792284|5722288|P1|Lead-in Period|Protocol Violation|1
1637608|NCT01792284|5722286|P3|Lead-in Period|Lost to Follow-up|0
1637609|NCT01792284|5722287|P2|Lead-in Period|Lost to Follow-up|0
1637610|NCT01792284|5722288|P1|Lead-in Period|Lost to Follow-up|2
1637611|NCT01792284|5722286|P3|Lead-in Period|Adverse Event|0
1637612|NCT01792284|5722287|P2|Lead-in Period|Adverse Event|0
1637613|NCT01792284|5722288|P1|Lead-in Period|Adverse Event|15
1637614|NCT01791894|5722347|P1|Overall Study|Adverse Event|1
1637615|NCT01791803|5722358|P4|Overall Study|Death|2
1637616|NCT01791803|5722359|P3|Overall Study|Death|2
1637617|NCT01791803|5722360|P2|Overall Study|Death|0
1637618|NCT01791803|5722361|P1|Overall Study|Death|0
1637619|NCT01791803|5722358|P4|Overall Study|Physician Decision|1
1637620|NCT01791803|5722359|P3|Overall Study|Physician Decision|0
1637621|NCT01791803|5722360|P2|Overall Study|Physician Decision|2
1637622|NCT01791803|5722361|P1|Overall Study|Physician Decision|0
1637623|NCT01791803|5722358|P4|Overall Study|Withdrawal by Subject|2
1637624|NCT01791803|5722359|P3|Overall Study|Withdrawal by Subject|0
1637625|NCT01791803|5722360|P2|Overall Study|Withdrawal by Subject|0
1637626|NCT01791803|5722361|P1|Overall Study|Withdrawal by Subject|0
1637627|NCT01791725|5722379|P3|Overall Study|Withdrawal by Subject|0
1637628|NCT01791725|5722380|P2|Overall Study|Withdrawal by Subject|1
1637629|NCT01791725|5722381|P1|Overall Study|Withdrawal by Subject|0
1637630|NCT01791517|5722404|P12|Phase II|Pre-Existing Ocular Issue|1
1637631|NCT01791517|5722405|P11|Phase II|Pre-Existing Ocular Issue|0
1637632|NCT01791517|5722406|P10|Phase II|Pre-Existing Ocular Issue|0
1637633|NCT01791517|5722407|P9|Phase II|Pre-Existing Ocular Issue|0
1637634|NCT01791517|5722408|P8|Phase II|Pre-Existing Ocular Issue|0
1637635|NCT01791517|5722409|P7|Phase II|Pre-Existing Ocular Issue|0
1637636|NCT01791517|5722410|P6|Phase II|Pre-Existing Ocular Issue|0
1637637|NCT01791517|5722411|P5|Phase II|Pre-Existing Ocular Issue|0
1637638|NCT01791517|5722412|P4|Phase II|Pre-Existing Ocular Issue|0
1637639|NCT01791517|5722413|P3|Phase II|Pre-Existing Ocular Issue|0
1637640|NCT01791517|5722414|P2|Phase II|Pre-Existing Ocular Issue|0
1637641|NCT01791517|5722415|P1|Phase II|Pre-Existing Ocular Issue|0
1637642|NCT01791517|5722404|P12|Phase II|Unsatisfactory Lens Fitting|0
1637643|NCT01791517|5722405|P11|Phase II|Unsatisfactory Lens Fitting|0
1637644|NCT01791517|5722406|P10|Phase II|Unsatisfactory Lens Fitting|1
1637645|NCT01791517|5722407|P9|Phase II|Unsatisfactory Lens Fitting|0
1637646|NCT01791517|5722408|P8|Phase II|Unsatisfactory Lens Fitting|0
1637647|NCT01791517|5722409|P7|Phase II|Unsatisfactory Lens Fitting|0
1637648|NCT01791517|5722410|P6|Phase II|Unsatisfactory Lens Fitting|0
1637649|NCT01791517|5722411|P5|Phase II|Unsatisfactory Lens Fitting|0
1637650|NCT01791517|5722412|P4|Phase II|Unsatisfactory Lens Fitting|0
1637651|NCT01791517|5722413|P3|Phase II|Unsatisfactory Lens Fitting|0
1637652|NCT01791517|5722414|P2|Phase II|Unsatisfactory Lens Fitting|0
1637653|NCT01791517|5722415|P1|Phase II|Unsatisfactory Lens Fitting|0
1637654|NCT01791517|5722404|P12|Phase II|Lens Handling Difficulties|0
1637655|NCT01791517|5722405|P11|Phase II|Lens Handling Difficulties|0
1637656|NCT01791517|5722406|P10|Phase II|Lens Handling Difficulties|0
1637657|NCT01791517|5722407|P9|Phase II|Lens Handling Difficulties|1
1637658|NCT01791517|5722408|P8|Phase II|Lens Handling Difficulties|0
1637659|NCT01791517|5722409|P7|Phase II|Lens Handling Difficulties|0
1637660|NCT01791517|5722410|P6|Phase II|Lens Handling Difficulties|0
1637661|NCT01791517|5722411|P5|Phase II|Lens Handling Difficulties|0
1637662|NCT01791517|5722412|P4|Phase II|Lens Handling Difficulties|0
1637663|NCT01791517|5722413|P3|Phase II|Lens Handling Difficulties|0
1637664|NCT01791517|5722414|P2|Phase II|Lens Handling Difficulties|0
1637665|NCT01791517|5722415|P1|Phase II|Lens Handling Difficulties|0
1637666|NCT01791517|5722404|P12|Phase II|Adverse Event|0
1637667|NCT01791517|5722405|P11|Phase II|Adverse Event|0
1637668|NCT01791517|5722406|P10|Phase II|Adverse Event|1
1637669|NCT01791517|5722407|P9|Phase II|Adverse Event|0
1637670|NCT01791517|5722408|P8|Phase II|Adverse Event|1
1637671|NCT01791517|5722409|P7|Phase II|Adverse Event|2
1637672|NCT01791517|5722410|P6|Phase II|Adverse Event|0
1637673|NCT01791517|5722411|P5|Phase II|Adverse Event|0
1637674|NCT01791517|5722412|P4|Phase II|Adverse Event|0
1637675|NCT01791517|5722413|P3|Phase II|Adverse Event|0
1637676|NCT01791517|5722414|P2|Phase II|Adverse Event|0
1637677|NCT01791517|5722415|P1|Phase II|Adverse Event|0
1637678|NCT01791517|5722404|P12|Phase II|Lack of Efficacy|0
1637679|NCT01791517|5722405|P11|Phase II|Lack of Efficacy|0
1637680|NCT01791517|5722406|P10|Phase II|Lack of Efficacy|0
1637681|NCT01791517|5722407|P9|Phase II|Lack of Efficacy|0
1637682|NCT01791517|5722408|P8|Phase II|Lack of Efficacy|0
1637683|NCT01791517|5722409|P7|Phase II|Lack of Efficacy|0
1637684|NCT01791517|5722410|P6|Phase II|Lack of Efficacy|0
1637685|NCT01791517|5722411|P5|Phase II|Lack of Efficacy|1
1637686|NCT01791517|5722412|P4|Phase II|Lack of Efficacy|0
1637687|NCT01791517|5722413|P3|Phase II|Lack of Efficacy|0
1637688|NCT01791517|5722414|P2|Phase II|Lack of Efficacy|0
1637689|NCT01791517|5722415|P1|Phase II|Lack of Efficacy|0
1637690|NCT01791517|5722404|P12|Phase II|Withdrawal by Subject|0
1637691|NCT01791517|5722405|P11|Phase II|Withdrawal by Subject|1
1637692|NCT01791517|5722406|P10|Phase II|Withdrawal by Subject|0
1637693|NCT01791517|5722407|P9|Phase II|Withdrawal by Subject|0
1637694|NCT01791517|5722408|P8|Phase II|Withdrawal by Subject|1
1637695|NCT01791517|5722409|P7|Phase II|Withdrawal by Subject|0
1637696|NCT01791517|5722410|P6|Phase II|Withdrawal by Subject|2
1637697|NCT01791517|5722411|P5|Phase II|Withdrawal by Subject|0
1637698|NCT01791517|5722412|P4|Phase II|Withdrawal by Subject|0
1637699|NCT01791517|5722413|P3|Phase II|Withdrawal by Subject|0
1637700|NCT01791517|5722414|P2|Phase II|Withdrawal by Subject|0
1637701|NCT01791517|5722415|P1|Phase II|Withdrawal by Subject|1
1637702|NCT01791517|5722404|P12|Phase II|Lost to Follow-up|0
1637703|NCT01791517|5722405|P11|Phase II|Lost to Follow-up|0
1637704|NCT01791517|5722406|P10|Phase II|Lost to Follow-up|1
1637705|NCT01791517|5722407|P9|Phase II|Lost to Follow-up|1
1637706|NCT01791517|5722408|P8|Phase II|Lost to Follow-up|1
1637707|NCT01791517|5722409|P7|Phase II|Lost to Follow-up|0
1637708|NCT01791517|5722410|P6|Phase II|Lost to Follow-up|2
1637709|NCT01791517|5722411|P5|Phase II|Lost to Follow-up|1
1637710|NCT01791517|5722412|P4|Phase II|Lost to Follow-up|0
1637711|NCT01791517|5722413|P3|Phase II|Lost to Follow-up|1
1637712|NCT01791517|5722414|P2|Phase II|Lost to Follow-up|0
1637713|NCT01791517|5722415|P1|Phase II|Lost to Follow-up|1
1637714|NCT01791517|5722404|P12|Phase I: Period 3|Adverse Event|0
1637715|NCT01791517|5722405|P11|Phase I: Period 3|Adverse Event|0
1637716|NCT01791517|5722406|P10|Phase I: Period 3|Adverse Event|0
1637717|NCT01791517|5722407|P9|Phase I: Period 3|Adverse Event|0
1637718|NCT01791517|5722408|P8|Phase I: Period 3|Adverse Event|0
1637719|NCT01791517|5722409|P7|Phase I: Period 3|Adverse Event|0
1637720|NCT01791517|5722410|P6|Phase I: Period 3|Adverse Event|0
1637721|NCT01791517|5722411|P5|Phase I: Period 3|Adverse Event|0
1637722|NCT01791517|5722412|P4|Phase I: Period 3|Adverse Event|1
1637723|NCT01791517|5722413|P3|Phase I: Period 3|Adverse Event|0
1637724|NCT01791517|5722414|P2|Phase I: Period 3|Adverse Event|0
1637725|NCT01791517|5722415|P1|Phase I: Period 3|Adverse Event|0
1637726|NCT01791517|5722404|P12|Phase I: Period 3|Lost to Follow-up|0
1637727|NCT01791517|5722405|P11|Phase I: Period 3|Lost to Follow-up|0
1637728|NCT01791517|5722406|P10|Phase I: Period 3|Lost to Follow-up|0
1637729|NCT01791517|5722407|P9|Phase I: Period 3|Lost to Follow-up|0
1637730|NCT01791517|5722408|P8|Phase I: Period 3|Lost to Follow-up|0
1637731|NCT01791517|5722409|P7|Phase I: Period 3|Lost to Follow-up|0
1637732|NCT01791517|5722410|P6|Phase I: Period 3|Lost to Follow-up|0
1637733|NCT01791517|5722411|P5|Phase I: Period 3|Lost to Follow-up|1
1637734|NCT01791517|5722412|P4|Phase I: Period 3|Lost to Follow-up|0
1637735|NCT01791517|5722413|P3|Phase I: Period 3|Lost to Follow-up|0
1637736|NCT01791517|5722414|P2|Phase I: Period 3|Lost to Follow-up|1
1637737|NCT01791517|5722415|P1|Phase I: Period 3|Lost to Follow-up|0
1637738|NCT01791517|5722404|P12|Phase I: Period 3|Lens Discomfort|1
1637739|NCT01791517|5722405|P11|Phase I: Period 3|Lens Discomfort|0
1637740|NCT01791517|5722406|P10|Phase I: Period 3|Lens Discomfort|0
1637741|NCT01791517|5722407|P9|Phase I: Period 3|Lens Discomfort|0
1637742|NCT01791517|5722408|P8|Phase I: Period 3|Lens Discomfort|0
1637743|NCT01791517|5722409|P7|Phase I: Period 3|Lens Discomfort|0
1637744|NCT01791517|5722410|P6|Phase I: Period 3|Lens Discomfort|0
1637745|NCT01791517|5722411|P5|Phase I: Period 3|Lens Discomfort|0
1637746|NCT01791517|5722412|P4|Phase I: Period 3|Lens Discomfort|0
1637747|NCT01791517|5722413|P3|Phase I: Period 3|Lens Discomfort|0
1637748|NCT01791517|5722414|P2|Phase I: Period 3|Lens Discomfort|0
1637749|NCT01791517|5722415|P1|Phase I: Period 3|Lens Discomfort|0
1637750|NCT01791517|5722404|P12|Phase I: Period 2|Lost to Follow-up|0
1637751|NCT01791517|5722405|P11|Phase I: Period 2|Lost to Follow-up|0
1637752|NCT01791517|5722406|P10|Phase I: Period 2|Lost to Follow-up|0
1637753|NCT01791517|5722407|P9|Phase I: Period 2|Lost to Follow-up|0
1637754|NCT01791517|5722408|P8|Phase I: Period 2|Lost to Follow-up|0
1637755|NCT01791517|5722409|P7|Phase I: Period 2|Lost to Follow-up|0
1637756|NCT01791517|5722410|P6|Phase I: Period 2|Lost to Follow-up|0
1637757|NCT01791517|5722411|P5|Phase I: Period 2|Lost to Follow-up|0
1637758|NCT01791517|5722412|P4|Phase I: Period 2|Lost to Follow-up|0
1637759|NCT01791517|5722413|P3|Phase I: Period 2|Lost to Follow-up|2
1637760|NCT01791517|5722414|P2|Phase I: Period 2|Lost to Follow-up|3
1637761|NCT01791517|5722415|P1|Phase I: Period 2|Lost to Follow-up|0
1637762|NCT01791517|5722404|P12|Phase I: Period 2|Lens Discomfort|0
1637763|NCT01791517|5722405|P11|Phase I: Period 2|Lens Discomfort|0
1637764|NCT01791517|5722406|P10|Phase I: Period 2|Lens Discomfort|0
1637765|NCT01791517|5722407|P9|Phase I: Period 2|Lens Discomfort|0
1637766|NCT01791517|5722408|P8|Phase I: Period 2|Lens Discomfort|0
1637767|NCT01791517|5722409|P7|Phase I: Period 2|Lens Discomfort|0
1637768|NCT01791517|5722410|P6|Phase I: Period 2|Lens Discomfort|1
1637769|NCT01791517|5722411|P5|Phase I: Period 2|Lens Discomfort|0
1637770|NCT01791517|5722412|P4|Phase I: Period 2|Lens Discomfort|0
1637771|NCT01791517|5722413|P3|Phase I: Period 2|Lens Discomfort|0
1637772|NCT01791517|5722414|P2|Phase I: Period 2|Lens Discomfort|0
1637773|NCT01791517|5722415|P1|Phase I: Period 2|Lens Discomfort|0
1637774|NCT01791517|5722404|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
1637775|NCT01791517|5722405|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
1637776|NCT01791517|5722406|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
1637777|NCT01791517|5722407|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
1637778|NCT01791517|5722408|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
1637779|NCT01791517|5722409|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
1637780|NCT01791517|5722410|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
1637781|NCT01791517|5722411|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
1637782|NCT01791517|5722412|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
1637783|NCT01791517|5722413|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
1637784|NCT01791517|5722414|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
1637785|NCT01791517|5722415|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
1637786|NCT01791517|5722404|P12|Phase I: Period 2|Withdrawal by Subject|0
1637787|NCT01791517|5722405|P11|Phase I: Period 2|Withdrawal by Subject|1
1637788|NCT01791517|5722406|P10|Phase I: Period 2|Withdrawal by Subject|1
1637789|NCT01791517|5722407|P9|Phase I: Period 2|Withdrawal by Subject|0
1637790|NCT01791517|5722408|P8|Phase I: Period 2|Withdrawal by Subject|0
1637791|NCT01791517|5722409|P7|Phase I: Period 2|Withdrawal by Subject|0
1637792|NCT01791517|5722410|P6|Phase I: Period 2|Withdrawal by Subject|0
1637793|NCT01791517|5722411|P5|Phase I: Period 2|Withdrawal by Subject|0
1637794|NCT01791517|5722412|P4|Phase I: Period 2|Withdrawal by Subject|0
1637795|NCT01791517|5722413|P3|Phase I: Period 2|Withdrawal by Subject|0
1637796|NCT01791517|5722414|P2|Phase I: Period 2|Withdrawal by Subject|0
1637797|NCT01791517|5722415|P1|Phase I: Period 2|Withdrawal by Subject|0
1637798|NCT01791517|5722404|P12|Phase I: Period 2|Protocol Violation|0
1637799|NCT01791517|5722405|P11|Phase I: Period 2|Protocol Violation|0
1637800|NCT01791517|5722406|P10|Phase I: Period 2|Protocol Violation|0
1637801|NCT01791517|5722407|P9|Phase I: Period 2|Protocol Violation|0
1637802|NCT01791517|5722408|P8|Phase I: Period 2|Protocol Violation|0
1637803|NCT01791517|5722409|P7|Phase I: Period 2|Protocol Violation|0
1637804|NCT01791517|5722410|P6|Phase I: Period 2|Protocol Violation|0
1637805|NCT01791517|5722411|P5|Phase I: Period 2|Protocol Violation|0
1637806|NCT01791517|5722412|P4|Phase I: Period 2|Protocol Violation|1
1637807|NCT01791517|5722413|P3|Phase I: Period 2|Protocol Violation|0
1637808|NCT01791517|5722414|P2|Phase I: Period 2|Protocol Violation|0
1637809|NCT01791517|5722415|P1|Phase I: Period 2|Protocol Violation|0
1637810|NCT01791517|5722404|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637811|NCT01791517|5722405|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637812|NCT01791517|5722406|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637813|NCT01791517|5722407|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637814|NCT01791517|5722408|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637815|NCT01791517|5722409|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637816|NCT01791517|5722410|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637817|NCT01791517|5722411|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637818|NCT01791517|5722412|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637819|NCT01791517|5722413|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637820|NCT01791517|5722414|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
1637821|NCT01791517|5722415|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
1637822|NCT01791517|5722404|P12|Phase I: Period 1|Lens Handling DIfficulties|1
1637823|NCT01791517|5722405|P11|Phase I: Period 1|Lens Handling DIfficulties|0
1637824|NCT01791517|5722406|P10|Phase I: Period 1|Lens Handling DIfficulties|0
1637825|NCT01791517|5722407|P9|Phase I: Period 1|Lens Handling DIfficulties|0
1637826|NCT01791517|5722408|P8|Phase I: Period 1|Lens Handling DIfficulties|0
1637827|NCT01791517|5722409|P7|Phase I: Period 1|Lens Handling DIfficulties|0
1637828|NCT01791517|5722410|P6|Phase I: Period 1|Lens Handling DIfficulties|0
1637829|NCT01791517|5722411|P5|Phase I: Period 1|Lens Handling DIfficulties|0
1637830|NCT01791517|5722412|P4|Phase I: Period 1|Lens Handling DIfficulties|0
1637831|NCT01791517|5722413|P3|Phase I: Period 1|Lens Handling DIfficulties|0
1637832|NCT01791517|5722414|P2|Phase I: Period 1|Lens Handling DIfficulties|0
1637833|NCT01791517|5722415|P1|Phase I: Period 1|Lens Handling DIfficulties|0
1637834|NCT01791517|5722404|P12|Phase I: Period 1|Lost to Follow-up|0
1637835|NCT01791517|5722405|P11|Phase I: Period 1|Lost to Follow-up|0
1637836|NCT01791517|5722406|P10|Phase I: Period 1|Lost to Follow-up|1
1637837|NCT01791517|5722407|P9|Phase I: Period 1|Lost to Follow-up|1
1637838|NCT01791517|5722408|P8|Phase I: Period 1|Lost to Follow-up|0
1637839|NCT01791517|5722409|P7|Phase I: Period 1|Lost to Follow-up|1
1637840|NCT01791517|5722410|P6|Phase I: Period 1|Lost to Follow-up|0
1637841|NCT01791517|5722411|P5|Phase I: Period 1|Lost to Follow-up|0
1637842|NCT01791517|5722412|P4|Phase I: Period 1|Lost to Follow-up|1
1637843|NCT01791517|5722413|P3|Phase I: Period 1|Lost to Follow-up|0
1637844|NCT01791517|5722414|P2|Phase I: Period 1|Lost to Follow-up|0
1637845|NCT01791517|5722415|P1|Phase I: Period 1|Lost to Follow-up|0
1637846|NCT01791517|5722404|P12|Phase I: Period 1|Protocol Violation|0
1637847|NCT01791517|5722405|P11|Phase I: Period 1|Protocol Violation|0
1637848|NCT01791517|5722406|P10|Phase I: Period 1|Protocol Violation|0
1637849|NCT01791517|5722407|P9|Phase I: Period 1|Protocol Violation|0
1637850|NCT01791517|5722408|P8|Phase I: Period 1|Protocol Violation|0
1637851|NCT01791517|5722409|P7|Phase I: Period 1|Protocol Violation|0
1637852|NCT01791517|5722410|P6|Phase I: Period 1|Protocol Violation|0
1637853|NCT01791517|5722411|P5|Phase I: Period 1|Protocol Violation|0
1637854|NCT01791517|5722412|P4|Phase I: Period 1|Protocol Violation|0
1637855|NCT01791517|5722413|P3|Phase I: Period 1|Protocol Violation|0
1637856|NCT01791517|5722414|P2|Phase I: Period 1|Protocol Violation|1
1637857|NCT01791517|5722415|P1|Phase I: Period 1|Protocol Violation|0
1637858|NCT01791517|5722404|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637859|NCT01791517|5722405|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637860|NCT01791517|5722406|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637861|NCT01791517|5722407|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637862|NCT01791517|5722408|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637863|NCT01791517|5722409|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637864|NCT01791517|5722410|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637865|NCT01791517|5722411|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637866|NCT01791517|5722412|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637867|NCT01791517|5722413|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637868|NCT01791517|5722414|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
1637869|NCT01791517|5722415|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
1637870|NCT01791517|5722404|P12|Phase I: Period 1|Adverse Event|0
1637871|NCT01791517|5722405|P11|Phase I: Period 1|Adverse Event|0
1637872|NCT01791517|5722406|P10|Phase I: Period 1|Adverse Event|0
1637873|NCT01791517|5722407|P9|Phase I: Period 1|Adverse Event|0
1637874|NCT01791517|5722408|P8|Phase I: Period 1|Adverse Event|0
1637875|NCT01791517|5722409|P7|Phase I: Period 1|Adverse Event|0
1637876|NCT01791517|5722410|P6|Phase I: Period 1|Adverse Event|0
1637877|NCT01791517|5722411|P5|Phase I: Period 1|Adverse Event|0
1637878|NCT01791517|5722412|P4|Phase I: Period 1|Adverse Event|1
1637879|NCT01791517|5722413|P3|Phase I: Period 1|Adverse Event|1
1637880|NCT01791517|5722414|P2|Phase I: Period 1|Adverse Event|0
1637881|NCT01791517|5722415|P1|Phase I: Period 1|Adverse Event|0
1637882|NCT01791517|5722404|P12|Phase I: Period 1|Withdrawal by Subject|0
1637883|NCT01791517|5722405|P11|Phase I: Period 1|Withdrawal by Subject|0
1637884|NCT01791517|5722406|P10|Phase I: Period 1|Withdrawal by Subject|0
1637885|NCT01791517|5722407|P9|Phase I: Period 1|Withdrawal by Subject|0
1637886|NCT01791517|5722408|P8|Phase I: Period 1|Withdrawal by Subject|0
1637887|NCT01791517|5722409|P7|Phase I: Period 1|Withdrawal by Subject|0
1637888|NCT01791517|5722410|P6|Phase I: Period 1|Withdrawal by Subject|1
1637889|NCT01791517|5722411|P5|Phase I: Period 1|Withdrawal by Subject|1
1637890|NCT01791517|5722412|P4|Phase I: Period 1|Withdrawal by Subject|0
1637891|NCT01791517|5722413|P3|Phase I: Period 1|Withdrawal by Subject|1
1637892|NCT01791517|5722414|P2|Phase I: Period 1|Withdrawal by Subject|1
1637893|NCT01791517|5722415|P1|Phase I: Period 1|Withdrawal by Subject|0
1637894|NCT01791413|5722479|P2|Overall Study|Lost to Follow-up|1
1637895|NCT01791413|5722480|P1|Overall Study|Lost to Follow-up|5
1637896|NCT01791244|5722489|P2|Overall Study|Laboratory Abnormality|1
1637897|NCT01791244|5722490|P1|Overall Study|Laboratory Abnormality|0
1637898|NCT01791244|5722489|P2|Overall Study|Insufficient clinical response|10
1637899|NCT01791244|5722490|P1|Overall Study|Insufficient clinical response|10
1637900|NCT01791244|5722489|P2|Overall Study|Adverse Event|7
1637901|NCT01791244|5722490|P1|Overall Study|Adverse Event|5
1637902|NCT01791205|5722526|P2|Phase II|Physician’s decision|0
1637903|NCT01791205|5722527|P1|Phase II|Physician’s decision|1
1637904|NCT01791205|5722526|P2|Phase II|Remission of disease|0
1637905|NCT01791205|5722527|P1|Phase II|Remission of disease|1
1637906|NCT01791205|5722526|P2|Phase II|Lost to Follow-up|0
1637907|NCT01791205|5722527|P1|Phase II|Lost to Follow-up|1
1637908|NCT01791205|5722526|P2|Phase II|Safety|0
1637909|NCT01791205|5722527|P1|Phase II|Safety|1
1637910|NCT01791205|5722526|P2|Phase II|Adverse Event|0
1637911|NCT01791205|5722527|P1|Phase II|Adverse Event|2
1637912|NCT01791205|5722526|P2|Phase II|Lack of Efficacy|0
1637913|NCT01791205|5722527|P1|Phase II|Lack of Efficacy|6
1637914|NCT01791153|5722611|P8|Part 2: Open-label Period|Physician Decision|0
1637915|NCT01791153|5722612|P7|Part 2: Open-label Period|Physician Decision|0
1637916|NCT01791153|5722613|P6|Part 2: Open-label Period|Physician Decision|1
1637917|NCT01791153|5722614|P5|Part 2: Open-label Period|Physician Decision|1
1637918|NCT01791153|5722615|P4|Part 2: Open-label Period|Physician Decision|0
1637919|NCT01791153|5722616|P3|Part 2: Open-label Period|Physician Decision|0
1637920|NCT01791153|5722617|P2|Part 2: Open-label Period|Physician Decision|0
1637921|NCT01791153|5722618|P1|Part 2: Open-label Period|Physician Decision|0
1637922|NCT01791153|5722611|P8|Part 2: Open-label Period|Withdrawal by Subject|2
1637923|NCT01791153|5722612|P7|Part 2: Open-label Period|Withdrawal by Subject|3
1637924|NCT01791153|5722613|P6|Part 2: Open-label Period|Withdrawal by Subject|1
1637925|NCT01791153|5722614|P5|Part 2: Open-label Period|Withdrawal by Subject|1
1637926|NCT01791153|5722615|P4|Part 2: Open-label Period|Withdrawal by Subject|0
1637927|NCT01791153|5722616|P3|Part 2: Open-label Period|Withdrawal by Subject|0
1637928|NCT01791153|5722617|P2|Part 2: Open-label Period|Withdrawal by Subject|0
1637929|NCT01791153|5722618|P1|Part 2: Open-label Period|Withdrawal by Subject|0
1637930|NCT01791153|5722611|P8|Part 2: Open-label Period|Lack of Efficacy|1
1637931|NCT01791153|5722612|P7|Part 2: Open-label Period|Lack of Efficacy|0
1637932|NCT01791153|5722613|P6|Part 2: Open-label Period|Lack of Efficacy|0
1637933|NCT01791153|5722614|P5|Part 2: Open-label Period|Lack of Efficacy|0
1637934|NCT01791153|5722615|P4|Part 2: Open-label Period|Lack of Efficacy|0
1637935|NCT01791153|5722616|P3|Part 2: Open-label Period|Lack of Efficacy|0
1637936|NCT01791153|5722617|P2|Part 2: Open-label Period|Lack of Efficacy|0
1637937|NCT01791153|5722618|P1|Part 2: Open-label Period|Lack of Efficacy|0
1637938|NCT01791153|5722611|P8|Part 2: Open-label Period|Lost to Follow-up|0
1637939|NCT01791153|5722612|P7|Part 2: Open-label Period|Lost to Follow-up|1
1637940|NCT01791153|5722613|P6|Part 2: Open-label Period|Lost to Follow-up|0
1637941|NCT01791153|5722614|P5|Part 2: Open-label Period|Lost to Follow-up|0
1637942|NCT01791153|5722615|P4|Part 2: Open-label Period|Lost to Follow-up|0
1637943|NCT01791153|5722616|P3|Part 2: Open-label Period|Lost to Follow-up|0
1637944|NCT01791153|5722617|P2|Part 2: Open-label Period|Lost to Follow-up|0
1637945|NCT01791153|5722618|P1|Part 2: Open-label Period|Lost to Follow-up|0
1637946|NCT01791153|5722611|P8|Part 2: Open-label Period|Death|1
1637947|NCT01791153|5722612|P7|Part 2: Open-label Period|Death|1
1637948|NCT01791153|5722613|P6|Part 2: Open-label Period|Death|1
1637949|NCT01791153|5722614|P5|Part 2: Open-label Period|Death|0
1637950|NCT01791153|5722615|P4|Part 2: Open-label Period|Death|0
1637951|NCT01791153|5722616|P3|Part 2: Open-label Period|Death|0
1637952|NCT01791153|5722617|P2|Part 2: Open-label Period|Death|0
1637953|NCT01791153|5722618|P1|Part 2: Open-label Period|Death|0
1637954|NCT01791153|5722611|P8|Part 2: Open-label Period|Adverse Event|2
1637955|NCT01791153|5722612|P7|Part 2: Open-label Period|Adverse Event|1
1637956|NCT01791153|5722613|P6|Part 2: Open-label Period|Adverse Event|1
1637957|NCT01791153|5722614|P5|Part 2: Open-label Period|Adverse Event|0
1637958|NCT01791153|5722615|P4|Part 2: Open-label Period|Adverse Event|0
1637959|NCT01791153|5722616|P3|Part 2: Open-label Period|Adverse Event|0
1637960|NCT01791153|5722617|P2|Part 2: Open-label Period|Adverse Event|0
1637961|NCT01791153|5722618|P1|Part 2: Open-label Period|Adverse Event|0
1637962|NCT01791153|5722611|P8|Part 1: Blinded Period|Withdrawal by Subject|0
1637963|NCT01791153|5722612|P7|Part 1: Blinded Period|Withdrawal by Subject|0
1637964|NCT01791153|5722613|P6|Part 1: Blinded Period|Withdrawal by Subject|0
1637965|NCT01791153|5722614|P5|Part 1: Blinded Period|Withdrawal by Subject|0
1637966|NCT01791153|5722615|P4|Part 1: Blinded Period|Withdrawal by Subject|1
1637967|NCT01791153|5722616|P3|Part 1: Blinded Period|Withdrawal by Subject|2
1637968|NCT01791153|5722617|P2|Part 1: Blinded Period|Withdrawal by Subject|2
1637969|NCT01791153|5722618|P1|Part 1: Blinded Period|Withdrawal by Subject|6
1637970|NCT01791153|5722611|P8|Part 1: Blinded Period|Protocol Violation|0
1637971|NCT01791153|5722612|P7|Part 1: Blinded Period|Protocol Violation|0
1637972|NCT01791153|5722613|P6|Part 1: Blinded Period|Protocol Violation|0
1637973|NCT01791153|5722614|P5|Part 1: Blinded Period|Protocol Violation|0
1637974|NCT01791153|5722615|P4|Part 1: Blinded Period|Protocol Violation|1
1637975|NCT01791153|5722616|P3|Part 1: Blinded Period|Protocol Violation|0
1637976|NCT01791153|5722617|P2|Part 1: Blinded Period|Protocol Violation|0
1637977|NCT01791153|5722618|P1|Part 1: Blinded Period|Protocol Violation|0
1637978|NCT01791153|5722611|P8|Part 1: Blinded Period|Physician Decision|0
1637979|NCT01791153|5722612|P7|Part 1: Blinded Period|Physician Decision|0
1637980|NCT01791153|5722613|P6|Part 1: Blinded Period|Physician Decision|0
1637981|NCT01791153|5722614|P5|Part 1: Blinded Period|Physician Decision|0
1637982|NCT01791153|5722615|P4|Part 1: Blinded Period|Physician Decision|1
1637983|NCT01791153|5722616|P3|Part 1: Blinded Period|Physician Decision|0
1637984|NCT01791153|5722617|P2|Part 1: Blinded Period|Physician Decision|0
1637985|NCT01791153|5722618|P1|Part 1: Blinded Period|Physician Decision|0
1637986|NCT01791153|5722611|P8|Part 1: Blinded Period|Non-Compliance|0
1637987|NCT01791153|5722612|P7|Part 1: Blinded Period|Non-Compliance|0
1637988|NCT01791153|5722613|P6|Part 1: Blinded Period|Non-Compliance|0
1637989|NCT01791153|5722614|P5|Part 1: Blinded Period|Non-Compliance|0
1637990|NCT01791153|5722615|P4|Part 1: Blinded Period|Non-Compliance|0
1637991|NCT01791153|5722616|P3|Part 1: Blinded Period|Non-Compliance|0
1637992|NCT01791153|5722617|P2|Part 1: Blinded Period|Non-Compliance|0
1637993|NCT01791153|5722618|P1|Part 1: Blinded Period|Non-Compliance|1
1637994|NCT01791153|5722611|P8|Part 1: Blinded Period|Lack of Efficacy|0
1637995|NCT01791153|5722612|P7|Part 1: Blinded Period|Lack of Efficacy|0
1637996|NCT01791153|5722613|P6|Part 1: Blinded Period|Lack of Efficacy|0
1637997|NCT01791153|5722614|P5|Part 1: Blinded Period|Lack of Efficacy|0
1637998|NCT01791153|5722615|P4|Part 1: Blinded Period|Lack of Efficacy|2
1637999|NCT01791153|5722616|P3|Part 1: Blinded Period|Lack of Efficacy|2
1638000|NCT01791153|5722617|P2|Part 1: Blinded Period|Lack of Efficacy|3
1638001|NCT01791153|5722618|P1|Part 1: Blinded Period|Lack of Efficacy|1
1638002|NCT01791153|5722611|P8|Part 1: Blinded Period|Adverse Event|0
1638003|NCT01791153|5722612|P7|Part 1: Blinded Period|Adverse Event|0
1638004|NCT01791153|5722613|P6|Part 1: Blinded Period|Adverse Event|0
1638005|NCT01791153|5722614|P5|Part 1: Blinded Period|Adverse Event|0
1638006|NCT01791153|5722615|P4|Part 1: Blinded Period|Adverse Event|0
1638007|NCT01791153|5722616|P3|Part 1: Blinded Period|Adverse Event|2
1638008|NCT01791153|5722617|P2|Part 1: Blinded Period|Adverse Event|3
1638009|NCT01791153|5722618|P1|Part 1: Blinded Period|Adverse Event|7
1638010|NCT01790932|5722678|P1|Overall Study|Withdrawal by Subject|1
1638011|NCT01790932|5722678|P1|Overall Study|Physician Decision|1
1638012|NCT01790932|5722678|P1|Overall Study|Adverse Event|7
1638013|NCT01790932|5722678|P1|Overall Study|Disease Progression|41
1638014|NCT01790828|5722684|P1|Overall Study|Other|34
1638015|NCT01790633|5722742|P2|Overall Study|RT failure and no follow-up ELISA|3
1638016|NCT01790633|5722743|P1|Overall Study|RT failure and no follow-up ELISA|0
1638017|NCT01790633|5722742|P2|Overall Study|Did not have serology performed|0
1638018|NCT01790633|5722743|P1|Overall Study|Did not have serology performed|47
1638019|NCT01790633|5722742|P2|Overall Study|Protocol Violation|2
1638020|NCT01790633|5722743|P1|Overall Study|Protocol Violation|1
1638021|NCT01790594|5722756|P3|Overall Study|Terminated prior to week 76|0
1638022|NCT01790594|5722757|P2|Overall Study|Terminated prior to week 76|2
1638023|NCT01790594|5722758|P1|Overall Study|Terminated prior to week 76|0
1638024|NCT01790594|5722756|P3|Overall Study|Transplant was not done|3
1638025|NCT01790594|5722757|P2|Overall Study|Transplant was not done|0
1638026|NCT01790594|5722758|P1|Overall Study|Transplant was not done|0
1638027|NCT01790594|5722756|P3|Overall Study|Withdrawal by Subject|0
1638028|NCT01790594|5722757|P2|Overall Study|Withdrawal by Subject|0
1638029|NCT01790594|5722758|P1|Overall Study|Withdrawal by Subject|2
1638030|NCT01790594|5722756|P3|Overall Study|Physician Decision|0
1638031|NCT01790594|5722757|P2|Overall Study|Physician Decision|1
1638032|NCT01790594|5722758|P1|Overall Study|Physician Decision|2
1638033|NCT01790594|5722756|P3|Overall Study|Death|0
1638034|NCT01790594|5722757|P2|Overall Study|Death|0
1638035|NCT01790594|5722758|P1|Overall Study|Death|1
1638036|NCT01790568|5722835|P2|Overall Study|Progression prior to transplant|1
1638037|NCT01790568|5722836|P1|Overall Study|Progression prior to transplant|0
1638038|NCT01790516|5722844|P2|Overall Study|Physician Decision|0
1638039|NCT01790516|5722845|P1|Overall Study|Physician Decision|1
1638040|NCT01790503|5722862|P11|Overall Study|Other|0
1638041|NCT01790503|5722863|P10|Overall Study|Other|2
1638042|NCT01790503|5722864|P9|Overall Study|Other|1
1638043|NCT01790503|5722865|P8|Overall Study|Other|0
1638044|NCT01790503|5722866|P7|Overall Study|Other|0
1638045|NCT01790503|5722867|P6|Overall Study|Other|0
1638046|NCT01790503|5722868|P5|Overall Study|Other|1
1638047|NCT01790503|5722869|P4|Overall Study|Other|0
1638048|NCT01790503|5722870|P3|Overall Study|Other|0
1638049|NCT01790503|5722871|P2|Overall Study|Other|0
1638050|NCT01790503|5722872|P1|Overall Study|Other|0
1638051|NCT01790503|5722862|P11|Overall Study|Non Compliance|0
1638052|NCT01790503|5722863|P10|Overall Study|Non Compliance|0
1638053|NCT01790503|5722864|P9|Overall Study|Non Compliance|0
1638054|NCT01790503|5722865|P8|Overall Study|Non Compliance|0
1638055|NCT01790503|5722866|P7|Overall Study|Non Compliance|0
1638056|NCT01790503|5722867|P6|Overall Study|Non Compliance|0
1638057|NCT01790503|5722868|P5|Overall Study|Non Compliance|1
1638058|NCT01790503|5722869|P4|Overall Study|Non Compliance|0
1638059|NCT01790503|5722870|P3|Overall Study|Non Compliance|0
1638060|NCT01790503|5722871|P2|Overall Study|Non Compliance|0
1638061|NCT01790503|5722872|P1|Overall Study|Non Compliance|0
1638062|NCT01790503|5722862|P11|Overall Study|Death|0
1638063|NCT01790503|5722863|P10|Overall Study|Death|1
1638064|NCT01790503|5722864|P9|Overall Study|Death|0
1638065|NCT01790503|5722865|P8|Overall Study|Death|0
1638066|NCT01790503|5722866|P7|Overall Study|Death|0
1638067|NCT01790503|5722867|P6|Overall Study|Death|0
1638068|NCT01790503|5722868|P5|Overall Study|Death|0
1638069|NCT01790503|5722869|P4|Overall Study|Death|0
1638070|NCT01790503|5722870|P3|Overall Study|Death|0
1638071|NCT01790503|5722871|P2|Overall Study|Death|0
1638072|NCT01790503|5722872|P1|Overall Study|Death|0
1638073|NCT01790503|5722862|P11|Overall Study|Physician Decision|1
1638074|NCT01790503|5722863|P10|Overall Study|Physician Decision|1
1638075|NCT01790503|5722864|P9|Overall Study|Physician Decision|0
1638076|NCT01790503|5722865|P8|Overall Study|Physician Decision|0
1638077|NCT01790503|5722866|P7|Overall Study|Physician Decision|0
1638078|NCT01790503|5722867|P6|Overall Study|Physician Decision|0
1638079|NCT01790503|5722868|P5|Overall Study|Physician Decision|0
1638080|NCT01790503|5722869|P4|Overall Study|Physician Decision|0
1638081|NCT01790503|5722870|P3|Overall Study|Physician Decision|0
1638082|NCT01790503|5722871|P2|Overall Study|Physician Decision|0
1638083|NCT01790503|5722872|P1|Overall Study|Physician Decision|0
1638084|NCT01790503|5722862|P11|Overall Study|Protocol Violation|0
1638085|NCT01790503|5722863|P10|Overall Study|Protocol Violation|1
1638086|NCT01790503|5722864|P9|Overall Study|Protocol Violation|0
1638087|NCT01790503|5722865|P8|Overall Study|Protocol Violation|0
1638088|NCT01790503|5722866|P7|Overall Study|Protocol Violation|0
1638089|NCT01790503|5722867|P6|Overall Study|Protocol Violation|0
1638090|NCT01790503|5722868|P5|Overall Study|Protocol Violation|0
1638091|NCT01790503|5722869|P4|Overall Study|Protocol Violation|0
1638092|NCT01790503|5722870|P3|Overall Study|Protocol Violation|0
1638093|NCT01790503|5722871|P2|Overall Study|Protocol Violation|0
1638094|NCT01790503|5722872|P1|Overall Study|Protocol Violation|0
1638095|NCT01790503|5722862|P11|Overall Study|Disease progression|7
1638096|NCT01790503|5722863|P10|Overall Study|Disease progression|17
1638097|NCT01790503|5722864|P9|Overall Study|Disease progression|0
1638098|NCT01790503|5722865|P8|Overall Study|Disease progression|1
1638099|NCT01790503|5722866|P7|Overall Study|Disease progression|0
1638100|NCT01790503|5722867|P6|Overall Study|Disease progression|1
1638101|NCT01790503|5722868|P5|Overall Study|Disease progression|2
1638102|NCT01790503|5722869|P4|Overall Study|Disease progression|1
1638103|NCT01790503|5722870|P3|Overall Study|Disease progression|0
1638104|NCT01790503|5722871|P2|Overall Study|Disease progression|1
1638105|NCT01790503|5722872|P1|Overall Study|Disease progression|2
1638106|NCT01790503|5722862|P11|Overall Study|Withdrawal by Subject|1
1638107|NCT01790503|5722863|P10|Overall Study|Withdrawal by Subject|0
1638108|NCT01790503|5722864|P9|Overall Study|Withdrawal by Subject|0
1638109|NCT01790503|5722865|P8|Overall Study|Withdrawal by Subject|0
1638110|NCT01790503|5722866|P7|Overall Study|Withdrawal by Subject|1
1638111|NCT01790503|5722867|P6|Overall Study|Withdrawal by Subject|2
1638112|NCT01790503|5722868|P5|Overall Study|Withdrawal by Subject|1
1638113|NCT01790503|5722869|P4|Overall Study|Withdrawal by Subject|1
1638114|NCT01790503|5722870|P3|Overall Study|Withdrawal by Subject|1
1638115|NCT01790503|5722871|P2|Overall Study|Withdrawal by Subject|0
1638116|NCT01790503|5722872|P1|Overall Study|Withdrawal by Subject|0
1638117|NCT01790503|5722862|P11|Overall Study|Adverse Event|7
1638118|NCT01790503|5722863|P10|Overall Study|Adverse Event|4
1638119|NCT01790503|5722864|P9|Overall Study|Adverse Event|2
1638120|NCT01790503|5722865|P8|Overall Study|Adverse Event|0
1638121|NCT01790503|5722866|P7|Overall Study|Adverse Event|0
1638122|NCT01790503|5722867|P6|Overall Study|Adverse Event|2
1638123|NCT01790503|5722868|P5|Overall Study|Adverse Event|0
1638124|NCT01790503|5722869|P4|Overall Study|Adverse Event|0
1638125|NCT01790503|5722870|P3|Overall Study|Adverse Event|0
1638126|NCT01790503|5722871|P2|Overall Study|Adverse Event|0
1638127|NCT01790503|5722872|P1|Overall Study|Adverse Event|1
1638128|NCT01790438|5722942|P2|Overall Study|Protocol Required Discontinuation|1
1638129|NCT01790438|5722943|P1|Overall Study|Protocol Required Discontinuation|7
1638130|NCT01790438|5722942|P2|Overall Study|Sponsor Decision|3
1638131|NCT01790438|5722943|P1|Overall Study|Sponsor Decision|0
1638132|NCT01790438|5722942|P2|Overall Study|Physician Decision|1
1638133|NCT01790438|5722943|P1|Overall Study|Physician Decision|3
1638134|NCT01790438|5722942|P2|Overall Study|Withdrawal by Subject|2
1638135|NCT01790438|5722943|P1|Overall Study|Withdrawal by Subject|13
1638136|NCT01790438|5722942|P2|Overall Study|Lost to Follow-up|2
1638137|NCT01790438|5722943|P1|Overall Study|Lost to Follow-up|5
1638138|NCT01790438|5722942|P2|Overall Study|Death|0
1638139|NCT01790438|5722943|P1|Overall Study|Death|4
1638140|NCT01790438|5722942|P2|Overall Study|Adverse Event|2
1638141|NCT01790438|5722943|P1|Overall Study|Adverse Event|3
1638142|NCT01790295|5722993|P1|Overall Study|Study closure|4
1638143|NCT01790295|5722993|P1|Overall Study|Lack of Efficacy|2
1638144|NCT01790295|5722993|P1|Overall Study|Death|4
1638145|NCT01790295|5722993|P1|Overall Study|Adverse Event|1
1638146|NCT01790048|5723035|P2|Overall Study|Measurement error|0
1638147|NCT01790048|5723036|P1|Overall Study|Measurement error|1
1638148|NCT01790048|5723035|P2|Overall Study|SAM at Enrollment|0
1638149|NCT01790048|5723036|P1|Overall Study|SAM at Enrollment|2
1638150|NCT01790048|5723035|P2|Overall Study|Other|2
1638151|NCT01790048|5723036|P1|Overall Study|Other|0
1638152|NCT01790048|5723035|P2|Overall Study|data entry error|1
1638153|NCT01790048|5723036|P1|Overall Study|data entry error|0
1638154|NCT01790048|5723035|P2|Overall Study|Incorrect Age|14
1638155|NCT01790048|5723036|P1|Overall Study|Incorrect Age|9
1638156|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1638157|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
1638158|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
1638159|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Other|3
1638160|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Other|1
1638161|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Other|0
1638162|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1638163|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
1638164|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
1638165|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
1638166|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
1638167|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
1638168|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
1638169|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
1638170|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
1638171|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1638172|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
1638173|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
1638174|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
1638175|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
1638176|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
1638177|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
1638178|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
1638179|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1638180|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
1638181|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
1638182|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1638183|NCT01789970|5723054|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
1638184|NCT01789970|5723055|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
1638185|NCT01789970|5723056|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
1638186|NCT01789970|5723054|P3|Open-label Titration Period|Dropped out prior to dosing|0
1638187|NCT01789970|5723055|P2|Open-label Titration Period|Dropped out prior to dosing|0
1638188|NCT01789970|5723056|P1|Open-label Titration Period|Dropped out prior to dosing|2
1638189|NCT01789970|5723054|P3|Open-label Titration Period|Other|0
1638190|NCT01789970|5723055|P2|Open-label Titration Period|Other|0
1638191|NCT01789970|5723056|P1|Open-label Titration Period|Other|76
1638192|NCT01789970|5723054|P3|Open-label Titration Period|Pregnancy|0
1638193|NCT01789970|5723055|P2|Open-label Titration Period|Pregnancy|0
1638194|NCT01789970|5723056|P1|Open-label Titration Period|Pregnancy|2
1638195|NCT01789970|5723054|P3|Open-label Titration Period|Noncompliance with study procedures|0
1638196|NCT01789970|5723055|P2|Open-label Titration Period|Noncompliance with study procedures|0
1638197|NCT01789970|5723056|P1|Open-label Titration Period|Noncompliance with study procedures|8
1638198|NCT01789970|5723054|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
1638199|NCT01789970|5723055|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
1638200|NCT01789970|5723056|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
1638201|NCT01789970|5723054|P3|Open-label Titration Period|Noncompliance to study drug admin|0
1638202|NCT01789970|5723055|P2|Open-label Titration Period|Noncompliance to study drug admin|0
1638203|NCT01789970|5723056|P1|Open-label Titration Period|Noncompliance to study drug admin|11
1638204|NCT01789970|5723054|P3|Open-label Titration Period|Lost to Follow-up|0
1638205|NCT01789970|5723055|P2|Open-label Titration Period|Lost to Follow-up|0
1638206|NCT01789970|5723056|P1|Open-label Titration Period|Lost to Follow-up|5
1638207|NCT01789970|5723054|P3|Open-label Titration Period|Protocol Violation|0
1638208|NCT01789970|5723055|P2|Open-label Titration Period|Protocol Violation|0
1638209|NCT01789970|5723056|P1|Open-label Titration Period|Protocol Violation|18
1638210|NCT01789970|5723054|P3|Open-label Titration Period|Withdrawal by Subject|0
1638211|NCT01789970|5723055|P2|Open-label Titration Period|Withdrawal by Subject|0
1638212|NCT01789970|5723056|P1|Open-label Titration Period|Withdrawal by Subject|31
1638213|NCT01789970|5723054|P3|Open-label Titration Period|Lack of Efficacy|0
1638214|NCT01789970|5723055|P2|Open-label Titration Period|Lack of Efficacy|0
1638215|NCT01789970|5723056|P1|Open-label Titration Period|Lack of Efficacy|31
1638216|NCT01789970|5723054|P3|Open-label Titration Period|Adverse Event|0
1638217|NCT01789970|5723055|P2|Open-label Titration Period|Adverse Event|0
1638218|NCT01789970|5723056|P1|Open-label Titration Period|Adverse Event|68
1638219|NCT01789606|5723114|P2|Overall Study|Ineligible or not Willing to Continue|348
1638220|NCT01789606|5723115|P1|Overall Study|Ineligible or not Willing to Continue|0
1638221|NCT01789606|5723114|P2|Overall Study|Lost to Follow-up|14
1638222|NCT01789606|5723115|P1|Overall Study|Lost to Follow-up|0
1638223|NCT01789606|5723114|P2|Overall Study|Adverse Event|3
1638224|NCT01789606|5723115|P1|Overall Study|Adverse Event|0
1638225|NCT01789606|5723114|P2|Overall Study|Protocol Violation|55
1638226|NCT01789606|5723115|P1|Overall Study|Protocol Violation|0
1638227|NCT01789606|5723114|P2|Overall Study|No Study Medication Taken|1
1638228|NCT01789606|5723115|P1|Overall Study|No Study Medication Taken|0
1638229|NCT01789606|5723114|P2|Overall Study|Administrative Reasons|6
1638230|NCT01789606|5723115|P1|Overall Study|Administrative Reasons|17
1638231|NCT01789606|5723114|P2|Overall Study|Ineligible|2
1638232|NCT01789606|5723115|P1|Overall Study|Ineligible|6
1638233|NCT01789606|5723114|P2|Overall Study|Withdrawal by Subject|1
1638234|NCT01789606|5723115|P1|Overall Study|Withdrawal by Subject|0
1638235|NCT01789606|5723114|P2|Overall Study|Participant not Purchased the Product|20
1638236|NCT01789606|5723115|P1|Overall Study|Participant not Purchased the Product|0
1638237|NCT01789567|5723133|P1|Overall Study|Death|6
1638238|NCT01789476|5723142|P2|Overall Study|Unable to get IV access|0
1638239|NCT01789476|5723143|P1|Overall Study|Unable to get IV access|1
1638240|NCT01789476|5723142|P2|Overall Study|Adverse Event|0
1638241|NCT01789476|5723143|P1|Overall Study|Adverse Event|1
1638242|NCT01789476|5723142|P2|Overall Study|Lack of Efficacy|2
1638243|NCT01789476|5723143|P1|Overall Study|Lack of Efficacy|6
1638244|NCT01789203|5723165|P2|Overall Study|patient non-adherent|0
1638245|NCT01789203|5723166|P1|Overall Study|patient non-adherent|2
1638246|NCT01789203|5723165|P2|Overall Study|Other|1
1638247|NCT01789203|5723166|P1|Overall Study|Other|1
1638248|NCT01789203|5723165|P2|Overall Study|Protocol Violation|1
1638249|NCT01789203|5723166|P1|Overall Study|Protocol Violation|2
1638250|NCT01789203|5723165|P2|Overall Study|Death|0
1638251|NCT01789203|5723166|P1|Overall Study|Death|1
1638252|NCT01789203|5723165|P2|Overall Study|Withdrawal by Subject|0
1638253|NCT01789203|5723166|P1|Overall Study|Withdrawal by Subject|1
1638254|NCT01789203|5723165|P2|Overall Study|Adverse Event|2
1638255|NCT01789203|5723166|P1|Overall Study|Adverse Event|2
1638256|NCT01789047|5723207|P2|Overall Study|Withdrawal by Subject|2
1638257|NCT01789047|5723208|P1|Overall Study|Withdrawal by Subject|1
1638258|NCT01789047|5723207|P2|Overall Study|Adverse Event|2
1638259|NCT01789047|5723208|P1|Overall Study|Adverse Event|3
1638260|NCT01788943|5723216|P2|Overall Study|Withdrawal by Subject|0
1638261|NCT01788943|5723217|P1|Overall Study|Withdrawal by Subject|1
1638262|NCT01788566|5723246|P1|Overall Study|Clinical Progressive Disease|3
1638263|NCT01788566|5723246|P1|Overall Study|Adverse Event|1
1638264|NCT01788566|5723246|P1|Overall Study|Death|4
1638265|NCT01788423|5723284|P3|Overall Study|See Comments in Completed (above)|5
1638266|NCT01788423|5723285|P2|Overall Study|See Comments in Completed (above)|4
1638267|NCT01788423|5723286|P1|Overall Study|See Comments in Completed (above)|0
1638268|NCT01788358|5723297|P1|Overall Study|Adverse Event|51
1638269|NCT01788358|5723297|P1|Overall Study|Lack of Efficacy|1
1638270|NCT01788358|5723297|P1|Overall Study|Withdrawal by Subject|26
1638271|NCT01788358|5723297|P1|Overall Study|Protocol Violation|3
1638272|NCT01788358|5723297|P1|Overall Study|Lost to Follow-up|5
1638273|NCT01788358|5723297|P1|Overall Study|Logistical difficulties|1
1638274|NCT01788358|5723297|P1|Overall Study|Other|11
1638275|NCT01788228|5723311|P2|Overall Study|Migrated/moved from study area|0
1638276|NCT01788228|5723312|P1|Overall Study|Migrated/moved from study area|1
1638277|NCT01788215|5723331|P2|Overall Study|Lost to Follow-up|0
1638278|NCT01788215|5723332|P1|Overall Study|Lost to Follow-up|2
1638279|NCT01788215|5723331|P2|Overall Study|Withdrawal by Subject|1
1638280|NCT01788215|5723332|P1|Overall Study|Withdrawal by Subject|0
1638281|NCT01788163|5723361|P9|Overall Study|Withdrawal by Subject|1
1638282|NCT01788163|5723362|P8|Overall Study|Withdrawal by Subject|0
1638283|NCT01788163|5723363|P7|Overall Study|Withdrawal by Subject|0
1638284|NCT01788163|5723364|P6|Overall Study|Withdrawal by Subject|0
1638285|NCT01788163|5723365|P5|Overall Study|Withdrawal by Subject|0
1638286|NCT01788163|5723366|P4|Overall Study|Withdrawal by Subject|0
1638287|NCT01788163|5723367|P3|Overall Study|Withdrawal by Subject|0
1638288|NCT01788163|5723368|P2|Overall Study|Withdrawal by Subject|0
1638289|NCT01788163|5723369|P1|Overall Study|Withdrawal by Subject|2
1638290|NCT01788163|5723361|P9|Overall Study|Other|15
1638291|NCT01788163|5723362|P8|Overall Study|Other|48
1638292|NCT01788163|5723363|P7|Overall Study|Other|1
1638293|NCT01788163|5723364|P6|Overall Study|Other|7
1638294|NCT01788163|5723365|P5|Overall Study|Other|0
1638295|NCT01788163|5723366|P4|Overall Study|Other|0
1638296|NCT01788163|5723367|P3|Overall Study|Other|0
1638297|NCT01788163|5723368|P2|Overall Study|Other|0
1638298|NCT01788163|5723369|P1|Overall Study|Other|53
1638299|NCT01788046|5723532|P2|Overall Study|Protocol Specified Criteria|1
1638300|NCT01788046|5723533|P1|Overall Study|Protocol Specified Criteria|25
1638301|NCT01788046|5723532|P2|Overall Study|Death|5
1638302|NCT01788046|5723533|P1|Overall Study|Death|7
1638303|NCT01788046|5723532|P2|Overall Study|Lost to Follow-up|19
1638304|NCT01788046|5723533|P1|Overall Study|Lost to Follow-up|12
1638305|NCT01788046|5723532|P2|Overall Study|Withdrawal by Subject|12
1638306|NCT01788046|5723533|P1|Overall Study|Withdrawal by Subject|12
1638307|NCT01787838|5723556|P1|Overall Study|refused|1413
1638308|NCT01787825|5723560|P2|Overall Study|Data Not Analyzable|1
1638309|NCT01787825|5723561|P1|Overall Study|Data Not Analyzable|5
1638310|NCT01787825|5723560|P2|Overall Study|Subject Did Not Ingest Capsules|0
1638395|NCT01787188|5723744|P2|Overall Study|Adverse Event|4
1638311|NCT01787825|5723561|P1|Overall Study|Subject Did Not Ingest Capsules|1
1638312|NCT01787760|5723579|P3|Overall Study|Near vision blur|0
1638313|NCT01787760|5723580|P2|Overall Study|Near vision blur|0
1638314|NCT01787760|5723581|P1|Overall Study|Near vision blur|1
1638315|NCT01787760|5723579|P3|Overall Study|Unsatisfactory visual response|0
1638316|NCT01787760|5723580|P2|Overall Study|Unsatisfactory visual response|1
1638317|NCT01787760|5723581|P1|Overall Study|Unsatisfactory visual response|1
1638318|NCT01787760|5723579|P3|Overall Study|Unsatisfactory physiological response|0
1638319|NCT01787760|5723580|P2|Overall Study|Unsatisfactory physiological response|4
1638320|NCT01787760|5723581|P1|Overall Study|Unsatisfactory physiological response|2
1638321|NCT01787760|5723579|P3|Overall Study|Unsatisfactory lens fitting performance|0
1638322|NCT01787760|5723580|P2|Overall Study|Unsatisfactory lens fitting performance|6
1638323|NCT01787760|5723581|P1|Overall Study|Unsatisfactory lens fitting performance|3
1638324|NCT01787760|5723579|P3|Overall Study|Stroke|0
1638325|NCT01787760|5723580|P2|Overall Study|Stroke|0
1638326|NCT01787760|5723581|P1|Overall Study|Stroke|1
1638327|NCT01787760|5723579|P3|Overall Study|Lost to Follow-up|1
1638328|NCT01787760|5723580|P2|Overall Study|Lost to Follow-up|0
1638329|NCT01787760|5723581|P1|Overall Study|Lost to Follow-up|1
1638330|NCT01787760|5723579|P3|Overall Study|Withdrawal by Subject|2
1638331|NCT01787760|5723580|P2|Overall Study|Withdrawal by Subject|1
1638332|NCT01787760|5723581|P1|Overall Study|Withdrawal by Subject|5
1638333|NCT01787760|5723579|P3|Overall Study|Protocol Violation|1
1638334|NCT01787760|5723580|P2|Overall Study|Protocol Violation|0
1638335|NCT01787760|5723581|P1|Overall Study|Protocol Violation|6
1638336|NCT01787760|5723579|P3|Overall Study|Lens handling difficulty|0
1638337|NCT01787760|5723580|P2|Overall Study|Lens handling difficulty|2
1638338|NCT01787760|5723581|P1|Overall Study|Lens handling difficulty|1
1638339|NCT01787760|5723579|P3|Overall Study|Lens discomfort|0
1638340|NCT01787760|5723580|P2|Overall Study|Lens discomfort|0
1638341|NCT01787760|5723581|P1|Overall Study|Lens discomfort|3
1638342|NCT01787760|5723579|P3|Overall Study|Relocation|0
1638343|NCT01787760|5723580|P2|Overall Study|Relocation|1
1638344|NCT01787760|5723581|P1|Overall Study|Relocation|1
1638345|NCT01787760|5723579|P3|Overall Study|Dryness|0
1638346|NCT01787760|5723580|P2|Overall Study|Dryness|1
1638347|NCT01787760|5723581|P1|Overall Study|Dryness|0
1638348|NCT01787760|5723579|P3|Overall Study|Decompensated on left exotropia|1
1638349|NCT01787760|5723580|P2|Overall Study|Decompensated on left exotropia|0
1638350|NCT01787760|5723581|P1|Overall Study|Decompensated on left exotropia|0
1638351|NCT01787760|5723579|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
1638352|NCT01787760|5723580|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
1638353|NCT01787760|5723581|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
1638354|NCT01787591|5723606|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
1638355|NCT01787591|5723607|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1638356|NCT01787591|5723608|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1638357|NCT01787591|5723609|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
1638358|NCT01787461|5723637|P2|Overall Study|Protocol Violation|0
1638359|NCT01787461|5723638|P1|Overall Study|Protocol Violation|3
1638360|NCT01787461|5723637|P2|Overall Study|Withdrawal by Subject|4
1638361|NCT01787461|5723638|P1|Overall Study|Withdrawal by Subject|3
1638362|NCT01787461|5723637|P2|Overall Study|No longer met eligibility criteria|0
1638363|NCT01787461|5723638|P1|Overall Study|No longer met eligibility criteria|1
1638364|NCT01787461|5723637|P2|Overall Study|Lost to Follow-up|2
1638365|NCT01787461|5723638|P1|Overall Study|Lost to Follow-up|3
1638366|NCT01787461|5723637|P2|Overall Study|Adverse Event|3
1638367|NCT01787461|5723638|P1|Overall Study|Adverse Event|4
1638368|NCT01787331|5723687|P1|Overall Study|Withdrawal by Subject|1
1638369|NCT01787331|5723687|P1|Overall Study|Physician Decision|1
1638374|NCT01787279|5723717|P1|Overall Study|Lack of Efficacy|1
1638375|NCT01787279|5723717|P1|Overall Study|Lost to Follow-up|2
1638376|NCT01787188|5723743|P3|Overall Study|Other, including patient moved|0
1638377|NCT01787188|5723744|P2|Overall Study|Other, including patient moved|3
1638378|NCT01787188|5723745|P1|Overall Study|Other, including patient moved|0
1638379|NCT01787188|5723743|P3|Overall Study|Lost to Follow-up|2
1638380|NCT01787188|5723744|P2|Overall Study|Lost to Follow-up|2
1638381|NCT01787188|5723745|P1|Overall Study|Lost to Follow-up|1
1638382|NCT01787188|5723743|P3|Overall Study|Protocol Violation|3
1638383|NCT01787188|5723744|P2|Overall Study|Protocol Violation|2
1638384|NCT01787188|5723745|P1|Overall Study|Protocol Violation|3
1638385|NCT01787188|5723743|P3|Overall Study|Withdrawal by Subject|2
1638386|NCT01787188|5723744|P2|Overall Study|Withdrawal by Subject|3
1638387|NCT01787188|5723745|P1|Overall Study|Withdrawal by Subject|4
1638388|NCT01787188|5723743|P3|Overall Study|Non-compliance with Study Drug|0
1638389|NCT01787188|5723744|P2|Overall Study|Non-compliance with Study Drug|1
1638390|NCT01787188|5723745|P1|Overall Study|Non-compliance with Study Drug|0
1638391|NCT01787188|5723743|P3|Overall Study|Lack of Efficacy|5
1638392|NCT01787188|5723744|P2|Overall Study|Lack of Efficacy|3
1638393|NCT01787188|5723745|P1|Overall Study|Lack of Efficacy|7
1638394|NCT01787188|5723743|P3|Overall Study|Adverse Event|6
1638396|NCT01787188|5723745|P1|Overall Study|Adverse Event|2
1638397|NCT01787032|5723817|P6|Overall Study|Protocol Violation|1
1638398|NCT01787032|5723818|P5|Overall Study|Protocol Violation|1
1638399|NCT01787032|5723819|P4|Overall Study|Protocol Violation|0
1638400|NCT01787032|5723820|P3|Overall Study|Protocol Violation|0
1638401|NCT01787032|5723821|P2|Overall Study|Protocol Violation|0
1638402|NCT01787032|5723822|P1|Overall Study|Protocol Violation|0
1638403|NCT01786993|5723846|P2|Overall Study|Hospice Admission|0
1638404|NCT01786993|5723847|P1|Overall Study|Hospice Admission|1
1638405|NCT01786993|5723846|P2|Overall Study|System Explant|0
1638406|NCT01786993|5723847|P1|Overall Study|System Explant|1
1638407|NCT01786993|5723846|P2|Overall Study|Subject Non-Compliance|0
1638408|NCT01786993|5723847|P1|Overall Study|Subject Non-Compliance|1
1638409|NCT01786993|5723846|P2|Overall Study|Lost to Follow-up|1
1638410|NCT01786993|5723847|P1|Overall Study|Lost to Follow-up|0
1638411|NCT01786993|5723846|P2|Overall Study|Withdrawal by Subject|2
1638412|NCT01786993|5723847|P1|Overall Study|Withdrawal by Subject|3
1638413|NCT01786993|5723846|P2|Overall Study|Death|7
1638414|NCT01786993|5723847|P1|Overall Study|Death|6
1638415|NCT01786707|5723906|P2|Overall Study|Lost to Follow-up|1
1638416|NCT01786707|5723907|P1|Overall Study|Lost to Follow-up|1
1638417|NCT01786668|5723919|P4|Overall Study|Lost to Follow-up|0
1638418|NCT01786668|5723920|P3|Overall Study|Lost to Follow-up|1
1638419|NCT01786668|5723921|P2|Overall Study|Lost to Follow-up|0
1638420|NCT01786668|5723922|P1|Overall Study|Lost to Follow-up|1
1638421|NCT01786668|5723919|P4|Overall Study|Pregnancy|1
1638422|NCT01786668|5723920|P3|Overall Study|Pregnancy|0
1638423|NCT01786668|5723921|P2|Overall Study|Pregnancy|0
1638424|NCT01786668|5723922|P1|Overall Study|Pregnancy|0
1638425|NCT01786668|5723919|P4|Overall Study|Withdrawal by Subject|1
1638426|NCT01786668|5723920|P3|Overall Study|Withdrawal by Subject|3
1638427|NCT01786668|5723921|P2|Overall Study|Withdrawal by Subject|0
1638428|NCT01786668|5723922|P1|Overall Study|Withdrawal by Subject|0
1638429|NCT01786668|5723919|P4|Overall Study|Adverse Event|2
1638430|NCT01786668|5723920|P3|Overall Study|Adverse Event|1
1638431|NCT01786668|5723921|P2|Overall Study|Adverse Event|1
1638432|NCT01786668|5723922|P1|Overall Study|Adverse Event|0
1638433|NCT01786629|5724022|P2|Overall Study|Adverse Event|1
1638434|NCT01786629|5724023|P1|Overall Study|Adverse Event|0
1638435|NCT01786629|5724022|P2|Overall Study|Lack of Efficacy|4
1638436|NCT01786629|5724023|P1|Overall Study|Lack of Efficacy|0
1638437|NCT01786603|5724031|P2|Overall Study|Lost to Follow-up|2
1638438|NCT01786603|5724032|P1|Overall Study|Lost to Follow-up|1
1638439|NCT01786603|5724031|P2|Overall Study|Physician decision to withdraw|7
1638440|NCT01786603|5724032|P1|Overall Study|Physician decision to withdraw|6
1638441|NCT01786603|5724031|P2|Overall Study|Adverse Event|2
1638442|NCT01786603|5724032|P1|Overall Study|Adverse Event|6
1638443|NCT01786603|5724031|P2|Overall Study|Death|1
1638444|NCT01786603|5724032|P1|Overall Study|Death|5
1638445|NCT01786551|5724050|P1|Overall Study|Participant withdrew consent|2
1638446|NCT01786330|5724058|P2|Overall Study|Protocol Violation|0
1638447|NCT01786330|5724059|P1|Overall Study|Protocol Violation|1
1638448|NCT01786330|5724058|P2|Overall Study|Excluded intraoperatively|1
1638449|NCT01786330|5724059|P1|Overall Study|Excluded intraoperatively|0
1638450|NCT01786330|5724058|P2|Overall Study|Lost to Follow-up|1
1638451|NCT01786330|5724059|P1|Overall Study|Lost to Follow-up|0
1638452|NCT01786330|5724058|P2|Overall Study|Withdrawal by Subject|1
1638453|NCT01786330|5724059|P1|Overall Study|Withdrawal by Subject|0
1638454|NCT01786174|5724111|P2|Overall Study|Discontinued Study Drug|0
1638455|NCT01786174|5724112|P1|Overall Study|Discontinued Study Drug|2
1638456|NCT01786148|5724141|P2|Overall Study|Incarceration|1
1638457|NCT01786148|5724142|P1|Overall Study|Incarceration|1
1638458|NCT01786148|5724141|P2|Overall Study|Withdrawal by Subject|7
1638459|NCT01786148|5724142|P1|Overall Study|Withdrawal by Subject|0
1638460|NCT01786148|5724141|P2|Overall Study|Death|1
1638461|NCT01786148|5724142|P1|Overall Study|Death|0
1638462|NCT01786148|5724141|P2|Overall Study|Lost to Follow-up|13
1638463|NCT01786148|5724142|P1|Overall Study|Lost to Follow-up|21
1638464|NCT01786109|5724157|P3|Overall Study|adverse effects colon preparation|1
1638465|NCT01786109|5724158|P2|Overall Study|adverse effects colon preparation|0
1638466|NCT01786109|5724159|P1|Overall Study|adverse effects colon preparation|0
1638467|NCT01786109|5724157|P3|Overall Study|unrelated illness|1
1638468|NCT01786109|5724158|P2|Overall Study|unrelated illness|0
1638469|NCT01786109|5724159|P1|Overall Study|unrelated illness|0
1638470|NCT01786109|5724157|P3|Overall Study|fail manometry barostat tube placement|0
1638471|NCT01786109|5724158|P2|Overall Study|fail manometry barostat tube placement|0
1638472|NCT01786109|5724159|P1|Overall Study|fail manometry barostat tube placement|1
1638473|NCT01785875|5724188|P3|Overall Study|Missing|3
1638474|NCT01785875|5724189|P2|Overall Study|Missing|1
1638475|NCT01785875|5724190|P1|Overall Study|Missing|0
1638476|NCT01785875|5724188|P3|Overall Study|Protocol Specified Criteria|55
1638477|NCT01785875|5724189|P2|Overall Study|Protocol Specified Criteria|214
1638478|NCT01785875|5724190|P1|Overall Study|Protocol Specified Criteria|207
1638479|NCT01785875|5724188|P3|Overall Study|Sponsor Decision|0
1638480|NCT01785875|5724189|P2|Overall Study|Sponsor Decision|2
1638481|NCT01785875|5724190|P1|Overall Study|Sponsor Decision|0
1638482|NCT01785875|5724188|P3|Overall Study|Death|7
1638483|NCT01785875|5724189|P2|Overall Study|Death|16
1638484|NCT01785875|5724190|P1|Overall Study|Death|27
1638485|NCT01785875|5724188|P3|Overall Study|Lost to Follow-up|6
1638486|NCT01785875|5724189|P2|Overall Study|Lost to Follow-up|22
1638487|NCT01785875|5724190|P1|Overall Study|Lost to Follow-up|19
1638488|NCT01785875|5724188|P3|Overall Study|Withdrawal by Subject|36
1638489|NCT01785875|5724189|P2|Overall Study|Withdrawal by Subject|34
1638490|NCT01785875|5724190|P1|Overall Study|Withdrawal by Subject|41
1638491|NCT01785849|5724259|P2|Overall Study|Lost to Follow-up|11
1638492|NCT01785849|5724260|P1|Overall Study|Lost to Follow-up|10
1638493|NCT01785849|5724259|P2|Overall Study|Sponsor Decision|1
1638494|NCT01785849|5724260|P1|Overall Study|Sponsor Decision|0
1638495|NCT01785849|5724259|P2|Overall Study|Withdrawal by Subject|12
1638496|NCT01785849|5724260|P1|Overall Study|Withdrawal by Subject|15
1638497|NCT01785849|5724259|P2|Overall Study|Protocol Specified Criteria|1
1638498|NCT01785849|5724260|P1|Overall Study|Protocol Specified Criteria|29
1638499|NCT01785849|5724259|P2|Overall Study|Death|9
1638500|NCT01785849|5724260|P1|Overall Study|Death|7
1638501|NCT01785628|5724278|P2|Overall Study|Lost to Follow-up|3
1638502|NCT01785628|5724279|P1|Overall Study|Lost to Follow-up|2
1638503|NCT01785615|5724302|P4|Dietary Phase|Lost to Follow-up|24
1638504|NCT01785615|5724303|P3|Dietary Phase|Lost to Follow-up|0
1638505|NCT01785615|5724304|P2|Dietary Phase|Lost to Follow-up|0
1638506|NCT01785615|5724305|P1|Dietary Phase|Lost to Follow-up|0
1638507|NCT01785602|5724377|P2|Overall Study|Administrative problems|3
1638508|NCT01785602|5724378|P1|Overall Study|Administrative problems|7
1638509|NCT01785602|5724377|P2|Overall Study|Adverse Event|5
1638510|NCT01785602|5724378|P1|Overall Study|Adverse Event|3
1638511|NCT01785602|5724377|P2|Overall Study|Lost to Follow-up|1
1638512|NCT01785602|5724378|P1|Overall Study|Lost to Follow-up|1
1638513|NCT01785602|5724377|P2|Overall Study|Withdrawal by Subject|0
1638514|NCT01785602|5724378|P1|Overall Study|Withdrawal by Subject|2
1638515|NCT01785524|5724388|P2|Overall Study|Withdrawal by Subject|2
1638516|NCT01785524|5724389|P1|Overall Study|Withdrawal by Subject|2
1638517|NCT01785472|5724408|P3|Overall Study|Technical problems|1
1638518|NCT01785472|5724409|P2|Overall Study|Technical problems|0
1638519|NCT01785472|5724410|P1|Overall Study|Technical problems|0
1638520|NCT01785472|5724408|P3|Overall Study|Subject/guardian decision|11
1638521|NCT01785472|5724409|P2|Overall Study|Subject/guardian decision|10
1638522|NCT01785472|5724410|P1|Overall Study|Subject/guardian decision|15
1638523|NCT01785472|5724408|P3|Overall Study|Protocol deviation|2
1638524|NCT01785472|5724409|P2|Overall Study|Protocol deviation|2
1638525|NCT01785472|5724410|P1|Overall Study|Protocol deviation|0
1638526|NCT01785472|5724408|P3|Overall Study|Physician Decision|1
1638527|NCT01785472|5724409|P2|Overall Study|Physician Decision|1
1638528|NCT01785472|5724410|P1|Overall Study|Physician Decision|1
1638529|NCT01785472|5724408|P3|Overall Study|Lost to Follow-up|0
1638530|NCT01785472|5724409|P2|Overall Study|Lost to Follow-up|2
1638531|NCT01785472|5724410|P1|Overall Study|Lost to Follow-up|1
1638532|NCT01785472|5724408|P3|Overall Study|Lack of Efficacy|1
1638533|NCT01785472|5724409|P2|Overall Study|Lack of Efficacy|0
1638534|NCT01785472|5724410|P1|Overall Study|Lack of Efficacy|2
1638535|NCT01785472|5724408|P3|Overall Study|Adverse Event|6
1638536|NCT01785472|5724409|P2|Overall Study|Adverse Event|4
1638537|NCT01785472|5724410|P1|Overall Study|Adverse Event|5
1638538|NCT01785160|5724496|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
1638539|NCT01785160|5724496|P1|Treatment Period 1: Raltegravir|Not treated|1
1638540|NCT01784965|5724531|P2|Overall Study|Adverse Event|8
1638541|NCT01784965|5724532|P1|Overall Study|Adverse Event|0
1638542|NCT01784965|5724531|P2|Overall Study|Withdrawal by Subject|3
1638543|NCT01784965|5724532|P1|Overall Study|Withdrawal by Subject|6
1638544|NCT01784211|5724655|P6|Part A (Days 1-15)|Withdrawal by Subject|0
1638545|NCT01784211|5724656|P5|Part A (Days 1-15)|Withdrawal by Subject|0
1638546|NCT01784211|5724657|P4|Part A (Days 1-15)|Withdrawal by Subject|0
1638547|NCT01784211|5724658|P3|Part A (Days 1-15)|Withdrawal by Subject|0
1638548|NCT01784211|5724659|P2|Part A (Days 1-15)|Withdrawal by Subject|1
1638549|NCT01784211|5724660|P1|Part A (Days 1-15)|Withdrawal by Subject|2
1638550|NCT01784211|5724655|P6|Part A (Days 1-15)|Adverse Event|0
1638551|NCT01784211|5724656|P5|Part A (Days 1-15)|Adverse Event|0
1638552|NCT01784211|5724657|P4|Part A (Days 1-15)|Adverse Event|0
1638553|NCT01784211|5724658|P3|Part A (Days 1-15)|Adverse Event|0
1638554|NCT01784211|5724659|P2|Part A (Days 1-15)|Adverse Event|1
1638555|NCT01784211|5724660|P1|Part A (Days 1-15)|Adverse Event|1
1638556|NCT01784029|5724685|P3|Overall Study|Lost to Follow-up|22
1638557|NCT01784029|5724686|P2|Overall Study|Lost to Follow-up|20
1638558|NCT01784029|5724687|P1|Overall Study|Lost to Follow-up|19
1638559|NCT01783938|5724697|P2|Overall Study|Other|0
1638560|NCT01783938|5724698|P1|Overall Study|Other|1
1638561|NCT01783938|5724697|P2|Overall Study|Withdrew Consent|0
1638562|NCT01783938|5724698|P1|Overall Study|Withdrew Consent|3
1638563|NCT01783938|5724697|P2|Overall Study|Request to Discontinue Study Treatment|2
1638564|NCT01783938|5724698|P1|Overall Study|Request to Discontinue Study Treatment|1
1638565|NCT01783938|5724697|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
1638566|NCT01783938|5724698|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
1638567|NCT01783938|5724697|P2|Overall Study|Study Drug Toxicity|10
1638568|NCT01783938|5724698|P1|Overall Study|Study Drug Toxicity|22
1638569|NCT01783938|5724697|P2|Overall Study|Disease Progression|39
1638570|NCT01783938|5724698|P1|Overall Study|Disease Progression|18
1638571|NCT01783886|5724726|P3|Overall Study|Adverse Event|4
1638572|NCT01783886|5724727|P2|Overall Study|Adverse Event|5
1638573|NCT01783886|5724728|P1|Overall Study|Adverse Event|4
1638574|NCT01783886|5724726|P3|Overall Study|Withdrawal of consent by participant|4
1638575|NCT01783886|5724727|P2|Overall Study|Withdrawal of consent by participant|3
1638576|NCT01783886|5724728|P1|Overall Study|Withdrawal of consent by participant|1
1638577|NCT01783886|5724726|P3|Overall Study|Protocol deviation|2
1638578|NCT01783886|5724727|P2|Overall Study|Protocol deviation|0
1638579|NCT01783886|5724728|P1|Overall Study|Protocol deviation|0
1638580|NCT01783886|5724726|P3|Overall Study|Lost to Follow-up|0
1638581|NCT01783886|5724727|P2|Overall Study|Lost to Follow-up|3
1638582|NCT01783886|5724728|P1|Overall Study|Lost to Follow-up|0
1638583|NCT01783821|5724791|P2|Overall Study|Screen Failure|1
1638584|NCT01783821|5724792|P1|Overall Study|Screen Failure|1
1638585|NCT01783743|5724810|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
1638586|NCT01783743|5724811|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
1638587|NCT01783743|5724810|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
1638588|NCT01783743|5724811|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
1638589|NCT01783743|5724810|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
1638590|NCT01783743|5724811|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
1638591|NCT01783730|5724825|P1|Overall Study|Failed to meet inclusion criteria|6
1638592|NCT01783678|5724850|P6|Overall Study|Withdrew Consent|0
1638593|NCT01783678|5724851|P5|Overall Study|Withdrew Consent|0
1638594|NCT01783678|5724852|P4|Overall Study|Withdrew Consent|2
1638595|NCT01783678|5724853|P3|Overall Study|Withdrew Consent|0
1638596|NCT01783678|5724854|P2|Overall Study|Withdrew Consent|1
1638597|NCT01783678|5724855|P1|Overall Study|Withdrew Consent|1
1638598|NCT01783678|5724850|P6|Overall Study|Lost to Follow-up|0
1638599|NCT01783678|5724851|P5|Overall Study|Lost to Follow-up|1
1638600|NCT01783678|5724852|P4|Overall Study|Lost to Follow-up|2
1638601|NCT01783678|5724853|P3|Overall Study|Lost to Follow-up|0
1638602|NCT01783678|5724854|P2|Overall Study|Lost to Follow-up|4
1638603|NCT01783678|5724855|P1|Overall Study|Lost to Follow-up|0
1638604|NCT01783678|5724850|P6|Overall Study|Lack of Efficacy|5
1638605|NCT01783678|5724851|P5|Overall Study|Lack of Efficacy|6
1638606|NCT01783678|5724852|P4|Overall Study|Lack of Efficacy|3
1638607|NCT01783678|5724853|P3|Overall Study|Lack of Efficacy|1
1638608|NCT01783678|5724854|P2|Overall Study|Lack of Efficacy|13
1638609|NCT01783678|5724855|P1|Overall Study|Lack of Efficacy|1
1638610|NCT01783678|5724850|P6|Overall Study|Randomized but Not Treated|0
1638611|NCT01783678|5724851|P5|Overall Study|Randomized but Not Treated|0
1638612|NCT01783678|5724852|P4|Overall Study|Randomized but Not Treated|1
1638613|NCT01783678|5724853|P3|Overall Study|Randomized but Not Treated|0
1638614|NCT01783678|5724854|P2|Overall Study|Randomized but Not Treated|0
1638615|NCT01783678|5724855|P1|Overall Study|Randomized but Not Treated|0
1638616|NCT01783548|5724959|P2|Overall Study|Lack of Efficacy|1
1638617|NCT01783548|5724960|P1|Overall Study|Lack of Efficacy|1
1638618|NCT01783548|5724959|P2|Overall Study|Lost to Follow-up|3
1638619|NCT01783548|5724960|P1|Overall Study|Lost to Follow-up|8
1638620|NCT01783548|5724959|P2|Overall Study|Protocol Violation|2
1638621|NCT01783548|5724960|P1|Overall Study|Protocol Violation|2
1638622|NCT01783548|5724959|P2|Overall Study|Non-compliance|0
1638623|NCT01783548|5724960|P1|Overall Study|Non-compliance|4
1638624|NCT01783548|5724959|P2|Overall Study|Withdrawal by Subject|8
1638625|NCT01783548|5724960|P1|Overall Study|Withdrawal by Subject|11
1638626|NCT01783548|5724959|P2|Overall Study|Adverse Event|4
1638627|NCT01783548|5724960|P1|Overall Study|Adverse Event|8
1638628|NCT01783496|5724993|P6|Overall Study|Withdrawal by Subject|0
1638629|NCT01783496|5724994|P5|Overall Study|Withdrawal by Subject|0
1638630|NCT01783496|5724995|P4|Overall Study|Withdrawal by Subject|0
1638631|NCT01783496|5724996|P3|Overall Study|Withdrawal by Subject|0
1638632|NCT01783496|5724997|P2|Overall Study|Withdrawal by Subject|0
1638633|NCT01783496|5724998|P1|Overall Study|Withdrawal by Subject|1
1638634|NCT01783496|5724993|P6|Overall Study|Lost to Follow-up|1
1638635|NCT01783496|5724994|P5|Overall Study|Lost to Follow-up|0
1638636|NCT01783496|5724995|P4|Overall Study|Lost to Follow-up|2
1638637|NCT01783496|5724996|P3|Overall Study|Lost to Follow-up|0
1638638|NCT01783496|5724997|P2|Overall Study|Lost to Follow-up|0
1638639|NCT01783496|5724998|P1|Overall Study|Lost to Follow-up|0
1638640|NCT01783483|5725026|P2|Overall Study|Physician Decision|1
1638641|NCT01783483|5725027|P1|Overall Study|Physician Decision|1
1638642|NCT01783483|5725026|P2|Overall Study|Withdrawal by Subject|1
1638643|NCT01783483|5725027|P1|Overall Study|Withdrawal by Subject|2
1638644|NCT01783483|5725026|P2|Overall Study|Lost to Follow-up|10
1638645|NCT01783483|5725027|P1|Overall Study|Lost to Follow-up|14
1638646|NCT01783483|5725026|P2|Overall Study|Death|3
1638647|NCT01783483|5725027|P1|Overall Study|Death|3
1638648|NCT01783418|5725065|P2|Overall Study|Withdrawal by Subject|0
1638649|NCT01783418|5725066|P1|Overall Study|Withdrawal by Subject|1
1638650|NCT01783015|5725119|P3|Open Label Treatment|Study Terminated by Sponsor|6
1638651|NCT01783015|5725120|P2|Open Label Treatment|Study Terminated by Sponsor|0
1638652|NCT01783015|5725121|P1|Open Label Treatment|Study Terminated by Sponsor|0
1638653|NCT01783015|5725119|P3|Blinded Treatment|Study Terminated by Sponsor|0
1638654|NCT01783015|5725120|P2|Blinded Treatment|Study Terminated by Sponsor|0
1638655|NCT01783015|5725121|P1|Blinded Treatment|Study Terminated by Sponsor|2
1638656|NCT01783015|5725119|P3|Blinded Treatment|Withdrawal by Subject|0
1638657|NCT01783015|5725120|P2|Blinded Treatment|Withdrawal by Subject|1
1638658|NCT01783015|5725121|P1|Blinded Treatment|Withdrawal by Subject|0
1638659|NCT01783015|5725119|P3|Blinded Treatment|Protocol Violation|0
1638660|NCT01783015|5725120|P2|Blinded Treatment|Protocol Violation|1
1638661|NCT01783015|5725121|P1|Blinded Treatment|Protocol Violation|0
1638662|NCT01783015|5725119|P3|Blinded Treatment|Adverse Event|0
1638663|NCT01783015|5725120|P2|Blinded Treatment|Adverse Event|1
1638664|NCT01783015|5725121|P1|Blinded Treatment|Adverse Event|0
1638665|NCT01782885|5725234|P2|Overall Study|Lost to Follow-up|6
1638666|NCT01782885|5725235|P1|Overall Study|Lost to Follow-up|4
1638667|NCT01782872|5725261|P4|Overall Study|Withdrawal by Subject|0
1638668|NCT01782872|5725262|P3|Overall Study|Withdrawal by Subject|0
1638669|NCT01782872|5725263|P2|Overall Study|Withdrawal by Subject|1
1638670|NCT01782872|5725264|P1|Overall Study|Withdrawal by Subject|0
1638671|NCT01782872|5725261|P4|Overall Study|Protocol Violation|1
1638672|NCT01782872|5725262|P3|Overall Study|Protocol Violation|0
1638673|NCT01782872|5725263|P2|Overall Study|Protocol Violation|0
1638674|NCT01782872|5725264|P1|Overall Study|Protocol Violation|0
1638675|NCT01782859|5725288|P2|Overall Study|Withdrawal by Subject|1
1638676|NCT01782859|5725289|P1|Overall Study|Withdrawal by Subject|0
1638677|NCT01782859|5725288|P2|Overall Study|Protocol Violation|6
1638678|NCT01782859|5725289|P1|Overall Study|Protocol Violation|6
1638679|NCT01782742|5725311|P2|Double-blind Treatment Phase|Adverse Event|0
1638680|NCT01782742|5725312|P1|Double-blind Treatment Phase|Adverse Event|1
1638681|NCT01782690|5725345|P1|Overall Study|Study completion unknown|7
1638682|NCT01782690|5725345|P1|Overall Study|Death|133
1638683|NCT01782690|5725345|P1|Overall Study|Tumor progression|74
1638684|NCT01782690|5725345|P1|Overall Study|Patient's wish|21
1638685|NCT01782690|5725345|P1|Overall Study|Physician Decision|13
1638686|NCT01782690|5725345|P1|Overall Study|Absent rash|9
1638687|NCT01782690|5725345|P1|Overall Study|Withdrawal of informed consent|2
1638688|NCT01782690|5725345|P1|Overall Study|Lost to Follow-up|31
1638689|NCT01782690|5725345|P1|Overall Study|Toxicity of erlotinib|1
1638690|NCT01782690|5725345|P1|Overall Study|Toxicity of gemcitabine|1
1638691|NCT01782690|5725345|P1|Overall Study|Not reported|7
1638692|NCT01782664|5725367|P6|Overall Study|Withdrawal by Subject|0
1638693|NCT01782664|5725368|P5|Overall Study|Withdrawal by Subject|0
1638694|NCT01782664|5725369|P4|Overall Study|Withdrawal by Subject|0
1638695|NCT01782664|5725370|P3|Overall Study|Withdrawal by Subject|0
1638696|NCT01782664|5725371|P2|Overall Study|Withdrawal by Subject|2
1638697|NCT01782664|5725372|P1|Overall Study|Withdrawal by Subject|2
1638698|NCT01782664|5725367|P6|Overall Study|Protocol Violation|0
1638699|NCT01782664|5725368|P5|Overall Study|Protocol Violation|0
1638700|NCT01782664|5725369|P4|Overall Study|Protocol Violation|1
1638701|NCT01782664|5725370|P3|Overall Study|Protocol Violation|0
1638702|NCT01782664|5725371|P2|Overall Study|Protocol Violation|1
1638703|NCT01782664|5725372|P1|Overall Study|Protocol Violation|0
1638704|NCT01782664|5725367|P6|Overall Study|Lack of Efficacy|0
1638705|NCT01782664|5725368|P5|Overall Study|Lack of Efficacy|0
1638706|NCT01782664|5725369|P4|Overall Study|Lack of Efficacy|2
1638707|NCT01782664|5725370|P3|Overall Study|Lack of Efficacy|2
1638708|NCT01782664|5725371|P2|Overall Study|Lack of Efficacy|0
1638709|NCT01782664|5725372|P1|Overall Study|Lack of Efficacy|2
1638710|NCT01782664|5725367|P6|Overall Study|Adverse Event|0
1638711|NCT01782664|5725368|P5|Overall Study|Adverse Event|0
1638712|NCT01782664|5725369|P4|Overall Study|Adverse Event|2
1638713|NCT01782664|5725370|P3|Overall Study|Adverse Event|2
1638714|NCT01782664|5725371|P2|Overall Study|Adverse Event|2
1638715|NCT01782664|5725372|P1|Overall Study|Adverse Event|2
1638716|NCT01782495|5725529|P11|Overall Study|Withdrew Consent|0
1638717|NCT01782495|5725530|P10|Overall Study|Withdrew Consent|0
1638718|NCT01782495|5725531|P9|Overall Study|Withdrew Consent|0
1638719|NCT01782495|5725532|P8|Overall Study|Withdrew Consent|1
1638720|NCT01782495|5725533|P7|Overall Study|Withdrew Consent|0
1638721|NCT01782495|5725534|P6|Overall Study|Withdrew Consent|0
1638722|NCT01782495|5725535|P5|Overall Study|Withdrew Consent|0
1638723|NCT01782495|5725536|P4|Overall Study|Withdrew Consent|0
1638724|NCT01782495|5725537|P3|Overall Study|Withdrew Consent|0
1638725|NCT01782495|5725538|P2|Overall Study|Withdrew Consent|1
1638726|NCT01782495|5725539|P1|Overall Study|Withdrew Consent|0
1638727|NCT01782495|5725529|P11|Overall Study|Adverse Event|0
1638728|NCT01782495|5725530|P10|Overall Study|Adverse Event|0
1638729|NCT01782495|5725531|P9|Overall Study|Adverse Event|0
1638730|NCT01782495|5725532|P8|Overall Study|Adverse Event|2
1638731|NCT01782495|5725533|P7|Overall Study|Adverse Event|0
1638732|NCT01782495|5725534|P6|Overall Study|Adverse Event|0
1638733|NCT01782495|5725535|P5|Overall Study|Adverse Event|0
1638734|NCT01782495|5725536|P4|Overall Study|Adverse Event|0
1638735|NCT01782495|5725537|P3|Overall Study|Adverse Event|0
1638736|NCT01782495|5725538|P2|Overall Study|Adverse Event|0
1638737|NCT01782495|5725539|P1|Overall Study|Adverse Event|0
1638738|NCT01782482|5725598|P2|Overall Study|Habitually wearing toric lens OS|1
1638739|NCT01782482|5725599|P1|Overall Study|Habitually wearing toric lens OS|0
1638740|NCT01782482|5725598|P2|Overall Study|Randomized in Error|2
1638741|NCT01782482|5725599|P1|Overall Study|Randomized in Error|2
1638742|NCT01782482|5725598|P2|Overall Study|Withdrawal by Subject|3
1638743|NCT01782482|5725599|P1|Overall Study|Withdrawal by Subject|2
1638744|NCT01782482|5725598|P2|Overall Study|Protocol Violation|0
1638745|NCT01782482|5725599|P1|Overall Study|Protocol Violation|1
1638746|NCT01782482|5725598|P2|Overall Study|Physician Decision|0
1638747|NCT01782482|5725599|P1|Overall Study|Physician Decision|1
1638748|NCT01782482|5725598|P2|Overall Study|Lost to Follow-up|3
1638749|NCT01782482|5725599|P1|Overall Study|Lost to Follow-up|2
1638750|NCT01782482|5725598|P2|Overall Study|Adverse Event|1
1638751|NCT01782482|5725599|P1|Overall Study|Adverse Event|2
1638752|NCT01782469|5725607|P1|Overall Study|Lost to Follow-up|1
1638753|NCT01782378|5725617|P2|Second Series|Did not choose to complete S2 Optional|0
1638754|NCT01782378|5725618|P1|Second Series|Did not choose to complete S2 Optional|18
1638755|NCT01782378|5725617|P2|Second Series|Lost to Follow-up|7
1638756|NCT01782378|5725618|P1|Second Series|Lost to Follow-up|8
1638757|NCT01782378|5725617|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
1638758|NCT01782378|5725618|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
1638759|NCT01782378|5725617|P2|First Series|Lost to Follow-up|8
1638760|NCT01782378|5725618|P1|First Series|Lost to Follow-up|7
1638761|NCT01782326|5725684|P2|Double-blind Treatment|Technical problems|5
1638762|NCT01782326|5725685|P1|Double-blind Treatment|Technical problems|0
1638763|NCT01782326|5725684|P2|Double-blind Treatment|Protocol deviation|7
1638764|NCT01782326|5725685|P1|Double-blind Treatment|Protocol deviation|8
1638765|NCT01782326|5725684|P2|Double-blind Treatment|Physician Decision|16
1638766|NCT01782326|5725685|P1|Double-blind Treatment|Physician Decision|13
1638767|NCT01782326|5725684|P2|Double-blind Treatment|Lack of Efficacy|22
1638768|NCT01782326|5725685|P1|Double-blind Treatment|Lack of Efficacy|17
1638769|NCT01782326|5725684|P2|Double-blind Treatment|Subject/guardian decision|125
1638770|NCT01782326|5725685|P1|Double-blind Treatment|Subject/guardian decision|111
1638771|NCT01782326|5725684|P2|Double-blind Treatment|Adverse Event|145
1638772|NCT01782326|5725685|P1|Double-blind Treatment|Adverse Event|129
1638773|NCT01782326|5725684|P2|Planned Treatment Epoch|Technical problems|4
1638774|NCT01782326|5725685|P1|Planned Treatment Epoch|Technical problems|0
1638775|NCT01782326|5725684|P2|Planned Treatment Epoch|Lost to Follow-up|4
1638776|NCT01782326|5725685|P1|Planned Treatment Epoch|Lost to Follow-up|4
1638777|NCT01782326|5725684|P2|Planned Treatment Epoch|Protocol deviation|3
1638778|NCT01782326|5725685|P1|Planned Treatment Epoch|Protocol deviation|2
1638779|NCT01782326|5725684|P2|Planned Treatment Epoch|Physician Decision|16
1638780|NCT01782326|5725685|P1|Planned Treatment Epoch|Physician Decision|18
1638781|NCT01782326|5725684|P2|Planned Treatment Epoch|Death|30
1638782|NCT01782326|5725685|P1|Planned Treatment Epoch|Death|29
1638783|NCT01782326|5725684|P2|Planned Treatment Epoch|Subject/guardian decision|151
1638784|NCT01782326|5725685|P1|Planned Treatment Epoch|Subject/guardian decision|149
1638785|NCT01782313|5725745|P1|Survival Follow up|Lost to Follow-up|1
1638786|NCT01782313|5725745|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
1638787|NCT01782313|5725745|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
1638788|NCT01782313|5725745|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
1638789|NCT01782313|5725745|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
1638790|NCT01782313|5725745|P1|Treated Cycle 3|Progressive Disease|21
1638791|NCT01782313|5725745|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
1638792|NCT01782313|5725745|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
1638793|NCT01782222|5725759|P3|Overall Study|Moved to other state|0
1638794|NCT01782222|5725760|P2|Overall Study|Moved to other state|1
1638795|NCT01782222|5725761|P1|Overall Study|Moved to other state|0
1638796|NCT01782222|5725759|P3|Overall Study|Withdrawal by Subject|1
1638797|NCT01782222|5725760|P2|Overall Study|Withdrawal by Subject|4
1638798|NCT01782222|5725761|P1|Overall Study|Withdrawal by Subject|1
1638799|NCT01782222|5725759|P3|Overall Study|Protocol Violation|0
1638800|NCT01782222|5725760|P2|Overall Study|Protocol Violation|0
1638801|NCT01782222|5725761|P1|Overall Study|Protocol Violation|1
1638802|NCT01782222|5725759|P3|Overall Study|Lack of Efficacy|0
1638803|NCT01782222|5725760|P2|Overall Study|Lack of Efficacy|1
1638804|NCT01782222|5725761|P1|Overall Study|Lack of Efficacy|2
1638805|NCT01782222|5725759|P3|Overall Study|Adverse Event|3
1638806|NCT01782222|5725760|P2|Overall Study|Adverse Event|5
1638807|NCT01782222|5725761|P1|Overall Study|Adverse Event|4
1638808|NCT01781975|5725795|P2|Overall Study|Withdrawal by Subject|1
1638809|NCT01781975|5725796|P1|Overall Study|Withdrawal by Subject|1
1638810|NCT01781975|5725795|P2|Overall Study|Death|0
1638811|NCT01781975|5725796|P1|Overall Study|Death|1
1638812|NCT01781962|5725812|P1|Overall Study|Other Miscellaneous Reasons|5
1638813|NCT01781832|5725818|P1|Overall Study|Withdrawal by Subject|1
1638814|NCT01781637|5725838|P2|Overall Study|Withdrawal by Subject|0
1638815|NCT01781637|5725839|P1|Overall Study|Withdrawal by Subject|1
1638816|NCT01781637|5725838|P2|Overall Study|Lack of Efficacy|6
1638817|NCT01781637|5725839|P1|Overall Study|Lack of Efficacy|2
1638818|NCT01781637|5725838|P2|Overall Study|Adverse Event|0
1638819|NCT01781637|5725839|P1|Overall Study|Adverse Event|1
1638820|NCT01781299|5725926|P2|Overall Study|Withdrawal by Subject|1
1638821|NCT01781299|5725927|P1|Overall Study|Withdrawal by Subject|0
1638822|NCT01781286|5725935|P6|Overall Study|Noncompliance|0
1638823|NCT01781286|5725936|P5|Overall Study|Noncompliance|0
1638824|NCT01781286|5725937|P4|Overall Study|Noncompliance|1
1638825|NCT01781286|5725938|P3|Overall Study|Noncompliance|0
1638826|NCT01781286|5725939|P2|Overall Study|Noncompliance|0
1638827|NCT01781286|5725940|P1|Overall Study|Noncompliance|0
1638828|NCT01781286|5725935|P6|Overall Study|Time Constraints|0
1638829|NCT01781286|5725936|P5|Overall Study|Time Constraints|0
1638830|NCT01781286|5725937|P4|Overall Study|Time Constraints|0
1638831|NCT01781286|5725938|P3|Overall Study|Time Constraints|2
1638832|NCT01781286|5725939|P2|Overall Study|Time Constraints|0
1638833|NCT01781286|5725940|P1|Overall Study|Time Constraints|2
1638834|NCT01781286|5725935|P6|Overall Study|Lost to Follow-up|1
1638835|NCT01781286|5725936|P5|Overall Study|Lost to Follow-up|0
1638836|NCT01781286|5725937|P4|Overall Study|Lost to Follow-up|0
1638837|NCT01781286|5725938|P3|Overall Study|Lost to Follow-up|0
1638838|NCT01781286|5725939|P2|Overall Study|Lost to Follow-up|0
1638839|NCT01781286|5725940|P1|Overall Study|Lost to Follow-up|0
1638840|NCT01781234|5725965|P2|Overall Study|Withdrawal by Subject|3
1638841|NCT01781234|5725966|P1|Overall Study|Withdrawal by Subject|4
1638842|NCT01781234|5725965|P2|Overall Study|Protocol Violation|0
1638843|NCT01781234|5725966|P1|Overall Study|Protocol Violation|3
1638844|NCT01781234|5725965|P2|Overall Study|Adverse Event|0
1638845|NCT01781234|5725966|P1|Overall Study|Adverse Event|2
1638846|NCT01781026|5726004|P1|Overall Study|Lack of Efficacy|2
1638847|NCT01780987|5726010|P2|Overall Study|Not Receiving any Study Medication|1
1638848|NCT01780987|5726011|P1|Overall Study|Not Receiving any Study Medication|0
1638849|NCT01780987|5726010|P2|Overall Study|Changing Residence|0
1638850|NCT01780987|5726011|P1|Overall Study|Changing Residence|1
1638851|NCT01780987|5726010|P2|Overall Study|Request of Changing Hospital|1
1638852|NCT01780987|5726011|P1|Overall Study|Request of Changing Hospital|0
1638853|NCT01780987|5726010|P2|Overall Study|Withdrawal by Subject|0
1638854|NCT01780987|5726011|P1|Overall Study|Withdrawal by Subject|2
1638855|NCT01780987|5726010|P2|Overall Study|Adverse Event|4
1638856|NCT01780987|5726011|P1|Overall Study|Adverse Event|0
1638857|NCT01780974|5726029|P2|Overall Study|Adverse Event|3
1638858|NCT01780974|5726030|P1|Overall Study|Adverse Event|1
1638859|NCT01780974|5726029|P2|Overall Study|Death|0
1638860|NCT01780974|5726030|P1|Overall Study|Death|1
1638861|NCT01780935|5726040|P2|Overall Study|Patient withdrew consent|9
1638862|NCT01780935|5726041|P1|Overall Study|Patient withdrew consent|8
1638863|NCT01780935|5726040|P2|Overall Study|Protocol deviation|1
1638864|NCT01780935|5726041|P1|Overall Study|Protocol deviation|0
1638865|NCT01780935|5726040|P2|Overall Study|Physician Decision|1
1638866|NCT01780935|5726041|P1|Overall Study|Physician Decision|1
1638867|NCT01780935|5726040|P2|Overall Study|Lost to Follow-up|6
1638868|NCT01780935|5726041|P1|Overall Study|Lost to Follow-up|2
1638869|NCT01780935|5726040|P2|Overall Study|Death|6
1638870|NCT01780935|5726041|P1|Overall Study|Death|1
1638871|NCT01780935|5726040|P2|Overall Study|Adverse Event|4
1638872|NCT01780935|5726041|P1|Overall Study|Adverse Event|2
1638873|NCT01780935|5726040|P2|Overall Study|Admin problems due to early termination|309
1638874|NCT01780935|5726041|P1|Overall Study|Admin problems due to early termination|321
1638875|NCT01780662|5726145|P3|Overall Study|Ineligible|1
1638876|NCT01780662|5726146|P2|Overall Study|Ineligible|0
1638877|NCT01780662|5726147|P1|Overall Study|Ineligible|0
1638878|NCT01780662|5726145|P3|Overall Study|Protocol Violation|0
1638879|NCT01780662|5726146|P2|Overall Study|Protocol Violation|1
1638880|NCT01780662|5726147|P1|Overall Study|Protocol Violation|0
1638881|NCT01780662|5726145|P3|Overall Study|Physician Decision|7
1638882|NCT01780662|5726146|P2|Overall Study|Physician Decision|5
1638883|NCT01780662|5726147|P1|Overall Study|Physician Decision|0
1638884|NCT01780662|5726145|P3|Overall Study|Adverse Event|2
1638885|NCT01780662|5726146|P2|Overall Study|Adverse Event|0
1638886|NCT01780662|5726147|P1|Overall Study|Adverse Event|1
1638887|NCT01780584|5726164|P3|Overall Study|Protocol Violation|1
1638888|NCT01780584|5726165|P2|Overall Study|Protocol Violation|0
1638889|NCT01780584|5726166|P1|Overall Study|Protocol Violation|0
1638890|NCT01780584|5726164|P3|Overall Study|Adverse Event|0
1638891|NCT01780584|5726165|P2|Overall Study|Adverse Event|1
1638892|NCT01780584|5726166|P1|Overall Study|Adverse Event|0
1638893|NCT01780584|5726164|P3|Overall Study|Death|1
1638894|NCT01780584|5726165|P2|Overall Study|Death|0
1638895|NCT01780584|5726166|P1|Overall Study|Death|1
1638896|NCT01780545|5726188|P2|Overall Study|Lost to Follow-up|1
1638897|NCT01780545|5726189|P1|Overall Study|Lost to Follow-up|1
1638898|NCT01780545|5726188|P2|Overall Study|Withdrawal by Subject|1
1638899|NCT01780545|5726189|P1|Overall Study|Withdrawal by Subject|3
1638900|NCT01780506|5726207|P2|Open-Label Extension Phase|Enrolled but not Treated|1
1638901|NCT01780506|5726208|P1|Open-Label Extension Phase|Enrolled but not Treated|0
1638902|NCT01780506|5726207|P2|Double-Blind Phase|Lost to Follow-up|26
1638903|NCT01780506|5726208|P1|Double-Blind Phase|Lost to Follow-up|23
1638904|NCT01780506|5726207|P2|Double-Blind Phase|Withdrew Consent|24
1638905|NCT01780506|5726208|P1|Double-Blind Phase|Withdrew Consent|23
1638906|NCT01780506|5726207|P2|Double-Blind Phase|Protocol Violation|3
1638907|NCT01780506|5726208|P1|Double-Blind Phase|Protocol Violation|4
1638908|NCT01780506|5726207|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
1638909|NCT01780506|5726208|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
1638910|NCT01780506|5726207|P2|Double-Blind Phase|Investigator's Discretion|2
1638911|NCT01780506|5726208|P1|Double-Blind Phase|Investigator's Discretion|5
1638912|NCT01780506|5726207|P2|Double-Blind Phase|Lack of Efficacy|1
1638913|NCT01780506|5726208|P1|Double-Blind Phase|Lack of Efficacy|1
1638914|NCT01780506|5726207|P2|Double-Blind Phase|Pregnancy|1
1638915|NCT01780506|5726208|P1|Double-Blind Phase|Pregnancy|2
1638916|NCT01780506|5726207|P2|Double-Blind Phase|Death|2
1638917|NCT01780506|5726208|P1|Double-Blind Phase|Death|1
1638918|NCT01780506|5726207|P2|Double-Blind Phase|Adverse Event|14
1638919|NCT01780506|5726208|P1|Double-Blind Phase|Adverse Event|4
1638920|NCT01780506|5726207|P2|Double-Blind Phase|Randomized but not Treated|2
1638921|NCT01780506|5726208|P1|Double-Blind Phase|Randomized but not Treated|3
1638922|NCT01780389|5726262|P1|Overall Study|Adverse Event|1
1638923|NCT01779869|5726300|P1|Overall Study|Physician Decision|2
1638924|NCT01779700|5726306|P2|Overall Study|Withdrawal by Subject|2
1638925|NCT01779700|5726307|P1|Overall Study|Withdrawal by Subject|0
1638926|NCT01779700|5726306|P2|Overall Study|Adverse Event|3
1638927|NCT01779700|5726307|P1|Overall Study|Adverse Event|4
1638928|NCT01779648|5726347|P2|Overall Study|Protocol Violation|0
1638929|NCT01779648|5726348|P1|Overall Study|Protocol Violation|1
1638930|NCT01779440|5726378|P2|Overall Study|Withdrawal by Subject|5
1638931|NCT01779440|5726379|P1|Overall Study|Withdrawal by Subject|3
1638932|NCT01778985|5726444|P2|Overall Study|Protocol Violation|1
1638933|NCT01778985|5726445|P1|Overall Study|Protocol Violation|4
1638934|NCT01778985|5726444|P2|Overall Study|Physician Decision|2
1638935|NCT01778985|5726445|P1|Overall Study|Physician Decision|2
1638936|NCT01778985|5726444|P2|Overall Study|Lost to Follow-up|0
1638937|NCT01778985|5726445|P1|Overall Study|Lost to Follow-up|1
1638938|NCT01778855|5726491|P2|Overall Study|Death|1
1638939|NCT01778855|5726492|P1|Overall Study|Death|0
1638940|NCT01778751|5726500|P2|Overall Study|Transfered care|0
1638941|NCT01778751|5726501|P1|Overall Study|Transfered care|1
1638942|NCT01778751|5726500|P2|Overall Study|Withdrawal by Subject|2
1638943|NCT01778751|5726501|P1|Overall Study|Withdrawal by Subject|0
1638944|NCT01778751|5726500|P2|Overall Study|Lost to Follow-up|0
1638945|NCT01778751|5726501|P1|Overall Study|Lost to Follow-up|1
1638946|NCT01778556|5726554|P2|Long-term Follow-up|noncompliance with metreleptin|0
1638947|NCT01778556|5726555|P1|Long-term Follow-up|noncompliance with metreleptin|1
1638948|NCT01778556|5726554|P2|Intervention 2 (14 Days)|Protocol Violation|0
1638949|NCT01778556|5726555|P1|Intervention 2 (14 Days)|Protocol Violation|1
1638950|NCT01778556|5726554|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
1638951|NCT01778556|5726555|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
1638952|NCT01778556|5726554|P2|Intervention 1 (5 Days)|Protocol Violation|1
1638953|NCT01778556|5726555|P1|Intervention 1 (5 Days)|Protocol Violation|0
1638954|NCT01778530|5726568|P1|Overall Study|Adverse event/side effect|1
1638955|NCT01778530|5726568|P1|Overall Study|Progression on study|1
1638956|NCT01778127|5726599|P3|Overall Study|Withdrawal by Subject|4
1638957|NCT01778127|5726600|P2|Overall Study|Withdrawal by Subject|1
1638958|NCT01778127|5726601|P1|Overall Study|Withdrawal by Subject|3
1638959|NCT01778127|5726599|P3|Overall Study|Lost to Follow-up|2
1638960|NCT01778127|5726600|P2|Overall Study|Lost to Follow-up|1
1638961|NCT01778127|5726601|P1|Overall Study|Lost to Follow-up|5
1638962|NCT01778062|5726644|P2|Overall Study|major protocol deviation|3
1638963|NCT01778062|5726645|P1|Overall Study|major protocol deviation|4
1638964|NCT01778062|5726644|P2|Overall Study|Consent Withdrawal|5
1638965|NCT01778062|5726645|P1|Overall Study|Consent Withdrawal|1
1638966|NCT01778062|5726644|P2|Overall Study|Adverse Event|3
1638967|NCT01778062|5726645|P1|Overall Study|Adverse Event|1
1638968|NCT01778049|5726659|P6|Double Blind Treatment Period|Other reason not defined above|1
1638969|NCT01778049|5726660|P5|Double Blind Treatment Period|Other reason not defined above|2
1638970|NCT01778049|5726661|P4|Double Blind Treatment Period|Other reason not defined above|2
1638971|NCT01778049|5726662|P3|Double Blind Treatment Period|Other reason not defined above|4
1638972|NCT01778049|5726663|P2|Double Blind Treatment Period|Other reason not defined above|0
1638973|NCT01778049|5726664|P1|Double Blind Treatment Period|Other reason not defined above|0
1638974|NCT01778049|5726659|P6|Double Blind Treatment Period|Not treated|0
1638975|NCT01778049|5726660|P5|Double Blind Treatment Period|Not treated|2
1638976|NCT01778049|5726661|P4|Double Blind Treatment Period|Not treated|2
1638977|NCT01778049|5726662|P3|Double Blind Treatment Period|Not treated|0
1638978|NCT01778049|5726663|P2|Double Blind Treatment Period|Not treated|0
1638979|NCT01778049|5726664|P1|Double Blind Treatment Period|Not treated|0
1638980|NCT01778049|5726659|P6|Double Blind Treatment Period|Withdrawal by Subject|1
1638981|NCT01778049|5726660|P5|Double Blind Treatment Period|Withdrawal by Subject|0
1638982|NCT01778049|5726661|P4|Double Blind Treatment Period|Withdrawal by Subject|2
1638983|NCT01778049|5726662|P3|Double Blind Treatment Period|Withdrawal by Subject|1
1638984|NCT01778049|5726663|P2|Double Blind Treatment Period|Withdrawal by Subject|0
1638985|NCT01778049|5726664|P1|Double Blind Treatment Period|Withdrawal by Subject|0
1638986|NCT01778049|5726659|P6|Double Blind Treatment Period|Lost to Follow-up|2
1638987|NCT01778049|5726660|P5|Double Blind Treatment Period|Lost to Follow-up|5
1638988|NCT01778049|5726661|P4|Double Blind Treatment Period|Lost to Follow-up|1
1638989|NCT01778049|5726662|P3|Double Blind Treatment Period|Lost to Follow-up|4
1638990|NCT01778049|5726663|P2|Double Blind Treatment Period|Lost to Follow-up|0
1638991|NCT01778049|5726664|P1|Double Blind Treatment Period|Lost to Follow-up|0
1638992|NCT01778049|5726659|P6|Double Blind Treatment Period|Protocol Violation|0
1638993|NCT01778049|5726660|P5|Double Blind Treatment Period|Protocol Violation|0
1638994|NCT01778049|5726661|P4|Double Blind Treatment Period|Protocol Violation|0
1638995|NCT01778049|5726662|P3|Double Blind Treatment Period|Protocol Violation|2
1638996|NCT01778049|5726663|P2|Double Blind Treatment Period|Protocol Violation|0
1638997|NCT01778049|5726664|P1|Double Blind Treatment Period|Protocol Violation|0
1638998|NCT01778049|5726659|P6|Double Blind Treatment Period|Lack of Efficacy|1
1638999|NCT01778049|5726660|P5|Double Blind Treatment Period|Lack of Efficacy|0
1639000|NCT01778049|5726661|P4|Double Blind Treatment Period|Lack of Efficacy|0
1639001|NCT01778049|5726662|P3|Double Blind Treatment Period|Lack of Efficacy|0
1639002|NCT01778049|5726663|P2|Double Blind Treatment Period|Lack of Efficacy|0
1639003|NCT01778049|5726664|P1|Double Blind Treatment Period|Lack of Efficacy|0
1639004|NCT01778049|5726659|P6|Double Blind Treatment Period|Adverse Event|2
1639005|NCT01778049|5726660|P5|Double Blind Treatment Period|Adverse Event|3
1639006|NCT01778049|5726661|P4|Double Blind Treatment Period|Adverse Event|5
1639007|NCT01778049|5726662|P3|Double Blind Treatment Period|Adverse Event|4
1639008|NCT01778049|5726663|P2|Double Blind Treatment Period|Adverse Event|0
1639009|NCT01778049|5726664|P1|Double Blind Treatment Period|Adverse Event|0
1639010|NCT01778049|5726659|P6|Open Label Treatment Period|Other reason not defined above|0
1639011|NCT01778049|5726660|P5|Open Label Treatment Period|Other reason not defined above|0
1639012|NCT01778049|5726661|P4|Open Label Treatment Period|Other reason not defined above|0
1639013|NCT01778049|5726662|P3|Open Label Treatment Period|Other reason not defined above|0
1639014|NCT01778049|5726663|P2|Open Label Treatment Period|Other reason not defined above|94
1639015|NCT01778049|5726664|P1|Open Label Treatment Period|Other reason not defined above|77
1639016|NCT01778049|5726659|P6|Open Label Treatment Period|Not treated|0
1639017|NCT01778049|5726660|P5|Open Label Treatment Period|Not treated|0
1639018|NCT01778049|5726661|P4|Open Label Treatment Period|Not treated|0
1639019|NCT01778049|5726662|P3|Open Label Treatment Period|Not treated|0
1639020|NCT01778049|5726663|P2|Open Label Treatment Period|Not treated|1
1639021|NCT01778049|5726664|P1|Open Label Treatment Period|Not treated|2
1639022|NCT01778049|5726659|P6|Open Label Treatment Period|Withdrawal by Subject|0
1639023|NCT01778049|5726660|P5|Open Label Treatment Period|Withdrawal by Subject|0
1639024|NCT01778049|5726661|P4|Open Label Treatment Period|Withdrawal by Subject|0
1639025|NCT01778049|5726662|P3|Open Label Treatment Period|Withdrawal by Subject|0
1639026|NCT01778049|5726663|P2|Open Label Treatment Period|Withdrawal by Subject|10
1639027|NCT01778049|5726664|P1|Open Label Treatment Period|Withdrawal by Subject|4
1639028|NCT01778049|5726659|P6|Open Label Treatment Period|Lost to Follow-up|0
1639029|NCT01778049|5726660|P5|Open Label Treatment Period|Lost to Follow-up|0
1639030|NCT01778049|5726661|P4|Open Label Treatment Period|Lost to Follow-up|0
1639031|NCT01778049|5726662|P3|Open Label Treatment Period|Lost to Follow-up|0
1639032|NCT01778049|5726663|P2|Open Label Treatment Period|Lost to Follow-up|3
1639033|NCT01778049|5726664|P1|Open Label Treatment Period|Lost to Follow-up|4
1639034|NCT01778049|5726659|P6|Open Label Treatment Period|Protocol Violation|0
1639035|NCT01778049|5726660|P5|Open Label Treatment Period|Protocol Violation|0
1639036|NCT01778049|5726661|P4|Open Label Treatment Period|Protocol Violation|0
1639037|NCT01778049|5726662|P3|Open Label Treatment Period|Protocol Violation|0
1639038|NCT01778049|5726663|P2|Open Label Treatment Period|Protocol Violation|5
1639039|NCT01778049|5726664|P1|Open Label Treatment Period|Protocol Violation|5
1639040|NCT01778049|5726659|P6|Open Label Treatment Period|Lack of Efficacy|0
1639041|NCT01778049|5726660|P5|Open Label Treatment Period|Lack of Efficacy|0
1639042|NCT01778049|5726661|P4|Open Label Treatment Period|Lack of Efficacy|0
1639043|NCT01778049|5726662|P3|Open Label Treatment Period|Lack of Efficacy|0
1639044|NCT01778049|5726663|P2|Open Label Treatment Period|Lack of Efficacy|1
1639045|NCT01778049|5726664|P1|Open Label Treatment Period|Lack of Efficacy|1
1639046|NCT01778049|5726659|P6|Open Label Treatment Period|Adverse Event|0
1639047|NCT01778049|5726660|P5|Open Label Treatment Period|Adverse Event|0
1639048|NCT01778049|5726661|P4|Open Label Treatment Period|Adverse Event|0
1639049|NCT01778049|5726662|P3|Open Label Treatment Period|Adverse Event|0
1639050|NCT01778049|5726663|P2|Open Label Treatment Period|Adverse Event|15
1639051|NCT01778049|5726664|P1|Open Label Treatment Period|Adverse Event|5
1639052|NCT01778023|5726682|P2|Overall Study|Withdrawal by Subject|3
1639053|NCT01778023|5726683|P1|Overall Study|Withdrawal by Subject|0
1639054|NCT01778010|5726700|P1|Overall Study|rash while on placebo|1
1639055|NCT01778010|5726700|P1|Overall Study|Arrested|1
1639056|NCT01778010|5726700|P1|Overall Study|abnormal ECG before meds|1
1639057|NCT01778010|5726700|P1|Overall Study|Withdrawal by Subject|2
1639058|NCT01777997|5726741|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
1639059|NCT01777997|5726741|P1|Weeks 48 to 72/96 on ART|Death|1
1639060|NCT01777997|5726741|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
1639061|NCT01777997|5726741|P1|12 Week lead-in of no ART|Severe debilitation|2
1639062|NCT01777932|5726763|P1|Overall Study|Patient refused further treatment|10
1639063|NCT01777932|5726763|P1|Overall Study|Reimbursement limit|9
1639064|NCT01777932|5726763|P1|Overall Study|Investigator decision|10
1639065|NCT01777932|5726763|P1|Overall Study|Lost to Follow-up|3
1639066|NCT01777932|5726763|P1|Overall Study|Adverse Event|34
1639067|NCT01777932|5726763|P1|Overall Study|Death|3
1639068|NCT01777932|5726763|P1|Overall Study|Disease progression|136
1639069|NCT01777854|5726777|P2|Overall Study|Physician Decision|3
1639070|NCT01777854|5726778|P1|Overall Study|Physician Decision|3
1639071|NCT01777776|5726786|P4|Overall Study|Withdrawal by Subject|1
1639072|NCT01777776|5726787|P3|Overall Study|Withdrawal by Subject|0
1639073|NCT01777776|5726788|P2|Overall Study|Withdrawal by Subject|0
1639074|NCT01777776|5726789|P1|Overall Study|Withdrawal by Subject|0
1639075|NCT01777776|5726786|P4|Overall Study|Disease Progression|3
1639076|NCT01777776|5726787|P3|Overall Study|Disease Progression|6
1639077|NCT01777776|5726788|P2|Overall Study|Disease Progression|8
1639078|NCT01777776|5726789|P1|Overall Study|Disease Progression|4
1639079|NCT01777776|5726786|P4|Overall Study|Adverse Event|0
1639080|NCT01777776|5726787|P3|Overall Study|Adverse Event|0
1639081|NCT01777776|5726788|P2|Overall Study|Adverse Event|4
1639082|NCT01777776|5726789|P1|Overall Study|Adverse Event|2
1639083|NCT01777763|5726848|P2|Overall Study|Treatment Failure|6
1639084|NCT01777763|5726849|P1|Overall Study|Treatment Failure|1
1639085|NCT01777763|5726848|P2|Overall Study|Withdrawal by Subject|2
1639086|NCT01777763|5726849|P1|Overall Study|Withdrawal by Subject|0
1639087|NCT01777763|5726848|P2|Overall Study|Protocol Violation|7
1639088|NCT01777763|5726849|P1|Overall Study|Protocol Violation|1
1639089|NCT01777763|5726848|P2|Overall Study|Adverse Event|32
1639090|NCT01777763|5726849|P1|Overall Study|Adverse Event|2
1639091|NCT01777620|5726873|P2|Overall Study|Subject Withdrawal|0
1639092|NCT01777620|5726874|P1|Overall Study|Subject Withdrawal|1
1639093|NCT01777581|5726900|P2|Overall Study|Lack of Efficacy|1
1639094|NCT01777581|5726901|P1|Overall Study|Lack of Efficacy|0
1639095|NCT01777581|5726900|P2|Overall Study|Adverse Event|0
1639096|NCT01777581|5726901|P1|Overall Study|Adverse Event|2
1639097|NCT01777581|5726900|P2|Overall Study|Lost to Follow-up|1
1639098|NCT01777581|5726901|P1|Overall Study|Lost to Follow-up|1
1639099|NCT01777542|5726930|P2|Second Intervention (20 Weeks)|Adverse Event|1
1639100|NCT01777542|5726931|P1|Second Intervention (20 Weeks)|Adverse Event|0
1639101|NCT01777490|5726974|P4|Overall Study|Dyad withdrew with data use prohibition|1
1639102|NCT01777490|5726975|P3|Overall Study|Dyad withdrew with data use prohibition|1
1639103|NCT01777490|5726976|P2|Overall Study|Dyad withdrew with data use prohibition|0
1639104|NCT01777490|5726977|P1|Overall Study|Dyad withdrew with data use prohibition|0
1639105|NCT01777334|5727022|P2|Overall Study|Withdrawal by Subject|11
1639106|NCT01777334|5727023|P1|Overall Study|Withdrawal by Subject|14
1639107|NCT01777334|5727022|P2|Overall Study|Lost to Follow-up|2
1639108|NCT01777334|5727023|P1|Overall Study|Lost to Follow-up|3
1639109|NCT01777334|5727022|P2|Overall Study|Protocol Violation|7
1639110|NCT01777334|5727023|P1|Overall Study|Protocol Violation|3
1639111|NCT01777334|5727022|P2|Overall Study|Lack of Efficacy|29
1639112|NCT01777334|5727023|P1|Overall Study|Lack of Efficacy|15
1639113|NCT01777334|5727022|P2|Overall Study|Adverse Event|14
1639114|NCT01777334|5727023|P1|Overall Study|Adverse Event|18
1639115|NCT01777321|5727033|P2|Overall Study|Withdrawal by Subject|1
1639116|NCT01777321|5727034|P1|Overall Study|Withdrawal by Subject|0
1639117|NCT01777308|5727072|P2|Overall Study|Blood draw refusal at Visit 3|0
1639118|NCT01777308|5727073|P1|Overall Study|Blood draw refusal at Visit 3|1
1639119|NCT01777308|5727072|P2|Overall Study|Lost to Follow-up|2
1639120|NCT01777308|5727073|P1|Overall Study|Lost to Follow-up|7
1639121|NCT01777308|5727072|P2|Overall Study|Migrated/moved from study area|0
1639122|NCT01777308|5727073|P1|Overall Study|Migrated/moved from study area|1
1639123|NCT01777308|5727072|P2|Overall Study|Withdrawal by Subject|1
1639124|NCT01777308|5727073|P1|Overall Study|Withdrawal by Subject|5
1639125|NCT01777295|5727105|P2|Overall Study|Investigator call for AEs check|0
1639126|NCT01777295|5727106|P1|Overall Study|Investigator call for AEs check|1
1639127|NCT01777295|5727105|P2|Overall Study|Personal problem|0
1639128|NCT01777295|5727106|P1|Overall Study|Personal problem|1
1639129|NCT01777295|5727105|P2|Overall Study|Pregnancy|1
1639130|NCT01777295|5727106|P1|Overall Study|Pregnancy|0
1639131|NCT01777295|5727105|P2|Overall Study|Withdrawal by Subject|2
1639132|NCT01777295|5727106|P1|Overall Study|Withdrawal by Subject|2
1639133|NCT01777282|5727313|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
1639134|NCT01777282|5727314|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
1639135|NCT01777282|5727315|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
1639136|NCT01777282|5727316|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
1639137|NCT01777282|5727317|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
1639138|NCT01777282|5727313|P5|Overall Study|Protocol Violation|2
1639139|NCT01777282|5727314|P4|Overall Study|Protocol Violation|0
1639140|NCT01777282|5727315|P3|Overall Study|Protocol Violation|1
1639141|NCT01777282|5727316|P2|Overall Study|Protocol Violation|0
1639142|NCT01777282|5727317|P1|Overall Study|Protocol Violation|2
1639143|NCT01777282|5727313|P5|Overall Study|Withdrawal by Subject|2
1639144|NCT01777282|5727314|P4|Overall Study|Withdrawal by Subject|1
1639145|NCT01777282|5727315|P3|Overall Study|Withdrawal by Subject|0
1639146|NCT01777282|5727316|P2|Overall Study|Withdrawal by Subject|0
1639147|NCT01777282|5727317|P1|Overall Study|Withdrawal by Subject|4
1639148|NCT01777282|5727313|P5|Overall Study|Adverse Event|3
1639149|NCT01777282|5727314|P4|Overall Study|Adverse Event|1
1639150|NCT01777282|5727315|P3|Overall Study|Adverse Event|2
1639151|NCT01777282|5727316|P2|Overall Study|Adverse Event|4
1639152|NCT01777282|5727317|P1|Overall Study|Adverse Event|4
1639153|NCT01777282|5727313|P5|Overall Study|New Antidiabetic Medication|0
1639154|NCT01777282|5727314|P4|Overall Study|New Antidiabetic Medication|0
1639155|NCT01777282|5727315|P3|Overall Study|New Antidiabetic Medication|1
1639156|NCT01777282|5727316|P2|Overall Study|New Antidiabetic Medication|0
1639157|NCT01777282|5727317|P1|Overall Study|New Antidiabetic Medication|0
1639158|NCT01777282|5727313|P5|Overall Study|Persistent Hyperglycemia|0
1639159|NCT01777282|5727314|P4|Overall Study|Persistent Hyperglycemia|0
1639160|NCT01777282|5727315|P3|Overall Study|Persistent Hyperglycemia|1
1639161|NCT01777282|5727316|P2|Overall Study|Persistent Hyperglycemia|0
1639162|NCT01777282|5727317|P1|Overall Study|Persistent Hyperglycemia|0
1639163|NCT01777269|5727361|P2|Overall Study|Withdrawal by Subject|9
1639164|NCT01777269|5727362|P1|Overall Study|Withdrawal by Subject|9
1639165|NCT01777269|5727361|P2|Overall Study|Physician Decision|2
1639166|NCT01777269|5727362|P1|Overall Study|Physician Decision|5
1639167|NCT01777269|5727361|P2|Overall Study|Lost to Follow-up|0
1639168|NCT01777269|5727362|P1|Overall Study|Lost to Follow-up|4
1639169|NCT01777269|5727361|P2|Overall Study|Participants reached stopping criteria|1
1639170|NCT01777269|5727362|P1|Overall Study|Participants reached stopping criteria|1
1639171|NCT01777269|5727361|P2|Overall Study|Protocol Violation|4
1639172|NCT01777269|5727362|P1|Overall Study|Protocol Violation|4
1639173|NCT01777269|5727361|P2|Overall Study|Lack of Efficacy|10
1639174|NCT01777269|5727362|P1|Overall Study|Lack of Efficacy|8
1639175|NCT01777269|5727361|P2|Overall Study|Adverse Event|33
1639176|NCT01777269|5727362|P1|Overall Study|Adverse Event|24
1639177|NCT01777191|5727399|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
1639178|NCT01777191|5727400|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
1639179|NCT01777191|5727399|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
1639180|NCT01777191|5727400|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
1639181|NCT01777191|5727399|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1639182|NCT01777191|5727400|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
1639183|NCT01777191|5727399|P2|Safety Extension Per (Week 12-Week 48)|Death|1
1639184|NCT01777191|5727400|P1|Safety Extension Per (Week 12-Week 48)|Death|0
1639185|NCT01777191|5727399|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1639186|NCT01777191|5727400|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
1639187|NCT01777191|5727399|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
1639188|NCT01777191|5727400|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
1639189|NCT01777191|5727399|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1639190|NCT01777191|5727400|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
1639191|NCT01777191|5727399|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
1639192|NCT01777191|5727400|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
1639193|NCT01777191|5727399|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
1639194|NCT01777191|5727400|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
1639195|NCT01777191|5727399|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1639196|NCT01777191|5727400|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
1639197|NCT01777191|5727399|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
1639198|NCT01777191|5727400|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
1639199|NCT01777152|5727430|P2|Overall Study|Change of diagnosis|0
1639200|NCT01777152|5727431|P1|Overall Study|Change of diagnosis|1
1639201|NCT01777152|5727430|P2|Overall Study|Not eligible, no study drug received|0
1639202|NCT01777152|5727431|P1|Overall Study|Not eligible, no study drug received|1
1639203|NCT01777152|5727430|P2|Overall Study|Death|73
1639204|NCT01777152|5727431|P1|Overall Study|Death|51
1639205|NCT01777152|5727430|P2|Overall Study|Lost to Follow-up|4
1639206|NCT01777152|5727431|P1|Overall Study|Lost to Follow-up|0
1639207|NCT01777152|5727430|P2|Overall Study|Withdrawal by Subject|10
1639208|NCT01777152|5727431|P1|Overall Study|Withdrawal by Subject|16
1639209|NCT01777152|5727430|P2|Overall Study|In Follow Up|139
1639210|NCT01777152|5727431|P1|Overall Study|In Follow Up|157
1639211|NCT01777139|5727447|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
1639212|NCT01777139|5727448|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
1639213|NCT01777139|5727447|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
1639214|NCT01777139|5727448|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
1639215|NCT01777139|5727447|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
1639216|NCT01777139|5727448|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
1639217|NCT01777139|5727447|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
1639218|NCT01777139|5727448|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
1639219|NCT01777139|5727447|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
1639220|NCT01777139|5727448|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
1639221|NCT01777139|5727447|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
1639222|NCT01777139|5727448|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
1639223|NCT01777139|5727447|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
1639224|NCT01777139|5727448|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
1639225|NCT01777139|5727447|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
1639226|NCT01777139|5727448|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
1639227|NCT01776554|5727537|P2|Overall Study|Unclassified|1
1639228|NCT01776554|5727538|P1|Overall Study|Unclassified|4
1639229|NCT01776554|5727537|P2|Overall Study|Protocol Violation|0
1639230|NCT01776554|5727538|P1|Overall Study|Protocol Violation|1
1639231|NCT01776554|5727537|P2|Overall Study|Administrative Reason|5
1639232|NCT01776554|5727538|P1|Overall Study|Administrative Reason|2
1639233|NCT01776554|5727537|P2|Overall Study|Lost to Follow-up|9
1639234|NCT01776554|5727538|P1|Overall Study|Lost to Follow-up|6
1639235|NCT01776554|5727537|P2|Overall Study|Withdrawal by Subject|8
1639236|NCT01776554|5727538|P1|Overall Study|Withdrawal by Subject|3
1639237|NCT01776554|5727537|P2|Overall Study|Adverse Event|0
1639238|NCT01776554|5727538|P1|Overall Study|Adverse Event|1
1639239|NCT01776541|5727581|P2|Overall Study|Withdrawal by Subject|20
1639240|NCT01776541|5727582|P1|Overall Study|Withdrawal by Subject|12
1639241|NCT01776541|5727581|P2|Overall Study|Protocol Violation|1
1639242|NCT01776541|5727582|P1|Overall Study|Protocol Violation|2
1639243|NCT01776541|5727581|P2|Overall Study|Unclassified|4
1639244|NCT01776541|5727582|P1|Overall Study|Unclassified|5
1639245|NCT01776541|5727581|P2|Overall Study|Lost to Follow-up|48
1639246|NCT01776541|5727582|P1|Overall Study|Lost to Follow-up|27
1639247|NCT01776541|5727581|P2|Overall Study|Death|0
1639248|NCT01776541|5727582|P1|Overall Study|Death|4
1639249|NCT01776541|5727581|P2|Overall Study|Administrative Reason|2
1639250|NCT01776541|5727582|P1|Overall Study|Administrative Reason|6
1639251|NCT01776424|5727604|P3|Overall Study|Withdrawal by Subject|15
1639252|NCT01776424|5727605|P2|Overall Study|Withdrawal by Subject|11
1639253|NCT01776424|5727606|P1|Overall Study|Withdrawal by Subject|10
1639254|NCT01776424|5727604|P3|Overall Study|Lost to Follow-up|9
1639255|NCT01776424|5727605|P2|Overall Study|Lost to Follow-up|8
1639256|NCT01776424|5727606|P1|Overall Study|Lost to Follow-up|10
1639257|NCT01776008|5727637|P1|Overall Study|ineligible|2
1639258|NCT01775995|5727651|P2|Overall Study|Lost to Follow-up|1
1639259|NCT01775995|5727652|P1|Overall Study|Lost to Follow-up|1
1639260|NCT01775904|5727712|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
1639261|NCT01775904|5727712|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
1639262|NCT01775787|5727778|P2|Second 7-10 Days|concerns with using IV|1
1639263|NCT01775787|5727779|P1|Second 7-10 Days|concerns with using IV|0
1639264|NCT01775787|5727778|P2|Second 7-10 Days|time commitment|1
1639265|NCT01775787|5727779|P1|Second 7-10 Days|time commitment|0
1639266|NCT01775787|5727778|P2|First 7-10 Days|concerns with using IV|2
1639267|NCT01775787|5727779|P1|First 7-10 Days|concerns with using IV|1
1639268|NCT01775787|5727778|P2|First 7-10 Days|time commitment|2
1639269|NCT01775787|5727779|P1|First 7-10 Days|time commitment|0
1639270|NCT01775787|5727778|P2|First 7-10 Days|family emergency|1
1639271|NCT01775787|5727779|P1|First 7-10 Days|family emergency|0
1639272|NCT01775787|5727778|P2|First 7-10 Days|Adverse Event|1
1639273|NCT01775787|5727779|P1|First 7-10 Days|Adverse Event|0
1639274|NCT01775670|5727835|P2|Overall Study|Lost to Follow-up|1
1639275|NCT01775670|5727836|P1|Overall Study|Lost to Follow-up|1
1639276|NCT01775553|5727862|P1|Overall Study|Disease Progression|12
1639277|NCT01775553|5727862|P1|Overall Study|Adverse Event|1
1639278|NCT01775189|5727870|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
1639279|NCT01775189|5727871|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
1639280|NCT01775189|5727872|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
1639281|NCT01775189|5727873|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
1639282|NCT01775189|5727874|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
1639283|NCT01775189|5727875|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
1639284|NCT01775189|5727876|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
1639285|NCT01775189|5727870|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
1639286|NCT01775189|5727871|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
1639287|NCT01775189|5727872|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
1639288|NCT01775189|5727873|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
1639289|NCT01775189|5727874|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
1639290|NCT01775189|5727875|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
1639291|NCT01775189|5727876|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
1639292|NCT01775189|5727870|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
1639293|NCT01775189|5727871|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
1639294|NCT01775189|5727872|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
1639295|NCT01775189|5727873|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
1639296|NCT01775189|5727874|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
1639297|NCT01775189|5727875|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
1639298|NCT01775189|5727876|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
1639299|NCT01775189|5727870|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1639300|NCT01775189|5727871|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1639301|NCT01775189|5727872|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1639302|NCT01775189|5727873|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1639303|NCT01775189|5727874|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
1639304|NCT01775189|5727875|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
1639305|NCT01775189|5727876|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
1639306|NCT01775189|5727870|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
1639307|NCT01775189|5727871|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
1639308|NCT01775189|5727872|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
1639309|NCT01775189|5727873|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
1639310|NCT01775189|5727874|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
1639311|NCT01775189|5727875|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
1639312|NCT01775189|5727876|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
1639313|NCT01775189|5727870|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
1639314|NCT01775189|5727871|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
1639315|NCT01775189|5727872|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
1639316|NCT01775189|5727873|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
1639317|NCT01775189|5727874|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
1639318|NCT01775189|5727875|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
1639319|NCT01775189|5727876|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
1639320|NCT01775137|5728095|P1|Overall Study|Withdrawal by participants|5
1639321|NCT01775137|5728095|P1|Overall Study|Adverse Event|1
1639322|NCT01775137|5728095|P1|Overall Study|Unsatisfactory therapeutic effect|2
1639323|NCT01775137|5728095|P1|Overall Study|Protocol deviation|2
1639324|NCT01775137|5728095|P1|Overall Study|Death|1
1639325|NCT01775124|5728122|P2|Extension Period|Withdrawal by Subject|12
1639326|NCT01775124|5728123|P1|Extension Period|Withdrawal by Subject|9
1639327|NCT01775124|5728122|P2|Extension Period|Lost to Follow-up|1
1639328|NCT01775124|5728123|P1|Extension Period|Lost to Follow-up|0
1639329|NCT01775124|5728122|P2|Extension Period|Administrative problems|1
1639330|NCT01775124|5728123|P1|Extension Period|Administrative problems|0
1639331|NCT01775124|5728122|P2|Extension Period|Physician Decision|2
1639332|NCT01775124|5728123|P1|Extension Period|Physician Decision|0
1639333|NCT01775124|5728122|P2|Extension Period|Adverse Event|2
1639334|NCT01775124|5728123|P1|Extension Period|Adverse Event|3
1639335|NCT01775124|5728122|P2|Core Period|Adverse Event|5
1639336|NCT01775124|5728123|P1|Core Period|Adverse Event|5
1639337|NCT01775124|5728122|P2|Core Period|Withdrawal by Subject|2
1639338|NCT01775124|5728123|P1|Core Period|Withdrawal by Subject|4
1639339|NCT01775124|5728122|P2|Core Period|Administrative problems|0
1639340|NCT01775124|5728123|P1|Core Period|Administrative problems|1
1639341|NCT01775124|5728122|P2|Core Period|Death|1
1639342|NCT01775124|5728123|P1|Core Period|Death|0
1639343|NCT01775124|5728122|P2|Core Period|Physician Decision|1
1639344|NCT01775124|5728123|P1|Core Period|Physician Decision|1
1639345|NCT01775124|5728122|P2|Core Period|Disease Progression|1
1639346|NCT01775124|5728123|P1|Core Period|Disease Progression|0
1639347|NCT01774981|5728158|P8|Overall Study|Death|0
1639348|NCT01774981|5728159|P7|Overall Study|Death|0
1639349|NCT01774981|5728160|P6|Overall Study|Death|0
1639350|NCT01774981|5728161|P5|Overall Study|Death|1
1639351|NCT01774981|5728162|P4|Overall Study|Death|0
1639352|NCT01774981|5728163|P3|Overall Study|Death|0
1639353|NCT01774981|5728164|P2|Overall Study|Death|0
1639354|NCT01774981|5728165|P1|Overall Study|Death|0
1639355|NCT01774981|5728158|P8|Overall Study|Withdrawal by Subject|1
1639356|NCT01774981|5728159|P7|Overall Study|Withdrawal by Subject|0
1639357|NCT01774981|5728160|P6|Overall Study|Withdrawal by Subject|0
1639358|NCT01774981|5728161|P5|Overall Study|Withdrawal by Subject|0
1639359|NCT01774981|5728162|P4|Overall Study|Withdrawal by Subject|0
1639360|NCT01774981|5728163|P3|Overall Study|Withdrawal by Subject|0
1639361|NCT01774981|5728164|P2|Overall Study|Withdrawal by Subject|0
1639362|NCT01774981|5728165|P1|Overall Study|Withdrawal by Subject|0
1639363|NCT01774981|5728158|P8|Overall Study|Adverse Event|0
1639364|NCT01774981|5728159|P7|Overall Study|Adverse Event|0
1639365|NCT01774981|5728160|P6|Overall Study|Adverse Event|1
1639366|NCT01774981|5728161|P5|Overall Study|Adverse Event|0
1639367|NCT01774981|5728162|P4|Overall Study|Adverse Event|0
1639368|NCT01774981|5728163|P3|Overall Study|Adverse Event|0
1639369|NCT01774981|5728164|P2|Overall Study|Adverse Event|0
1639370|NCT01774981|5728165|P1|Overall Study|Adverse Event|0
1639371|NCT01774968|5728197|P2|Overall Study|Withdrawal by Subject|11
1639372|NCT01774968|5728198|P1|Overall Study|Withdrawal by Subject|6
1639373|NCT01774968|5728197|P2|Overall Study|Sponsor Decision|2
1639374|NCT01774968|5728198|P1|Overall Study|Sponsor Decision|0
1639375|NCT01774968|5728197|P2|Overall Study|Protocol Violation|13
1639376|NCT01774968|5728198|P1|Overall Study|Protocol Violation|14
1639377|NCT01774968|5728197|P2|Overall Study|Physician Decision|1
1639378|NCT01774968|5728198|P1|Overall Study|Physician Decision|5
1639379|NCT01774968|5728197|P2|Overall Study|Lost to Follow-up|3
1639380|NCT01774968|5728198|P1|Overall Study|Lost to Follow-up|1
1639381|NCT01774968|5728197|P2|Overall Study|Death|1
1639382|NCT01774968|5728198|P1|Overall Study|Death|0
1639383|NCT01774968|5728197|P2|Overall Study|Adverse Event|4
1639384|NCT01774968|5728198|P1|Overall Study|Adverse Event|4
1639385|NCT01774929|5728232|P1|Overall Study|Adverse Event|3
1639386|NCT01774903|5728238|P1|Overall Study|Ineligible to continue the trial|1
1639387|NCT01774903|5728238|P1|Overall Study|Lack of Efficacy|1
1639388|NCT01774903|5728238|P1|Overall Study|Withdrawal by Subject|2
1639389|NCT01774903|5728238|P1|Overall Study|Adverse Event|7
1639390|NCT01774799|5728258|P4|Overall Study|Lost to Follow-up|0
1639391|NCT01774799|5728259|P3|Overall Study|Lost to Follow-up|0
1639392|NCT01774799|5728260|P2|Overall Study|Lost to Follow-up|1
1639393|NCT01774799|5728261|P1|Overall Study|Lost to Follow-up|1
1639394|NCT01774786|5728277|P2|Overall Study|Ineligible for Study|3
1639395|NCT01774786|5728278|P1|Overall Study|Ineligible for Study|1
1639396|NCT01774786|5728277|P2|Overall Study|Physician Decision|0
1639397|NCT01774786|5728278|P1|Overall Study|Physician Decision|1
1639398|NCT01774786|5728277|P2|Overall Study|Withdrawal by Subject|12
1639399|NCT01774786|5728278|P1|Overall Study|Withdrawal by Subject|15
1639400|NCT01774786|5728277|P2|Overall Study|Lost to Follow-up|4
1639401|NCT01774786|5728278|P1|Overall Study|Lost to Follow-up|3
1639402|NCT01774786|5728277|P2|Overall Study|Death|262
1639403|NCT01774786|5728278|P1|Overall Study|Death|242
1639404|NCT01774786|5728277|P2|Overall Study|In Follow-up|62
1639405|NCT01774786|5728278|P1|Overall Study|In Follow-up|65
1639406|NCT01774786|5728277|P2|Overall Study|Between Treatment and Follow-up|2
1639407|NCT01774786|5728278|P1|Overall Study|Between Treatment and Follow-up|6
1639408|NCT01774786|5728277|P2|Overall Study|On Treatment|47
1639409|NCT01774786|5728278|P1|Overall Study|On Treatment|55
1639410|NCT01774721|5728312|P2|Overall Study|Ongoing in study|120
1639411|NCT01774721|5728313|P1|Overall Study|Ongoing in study|136
1639412|NCT01774721|5728312|P2|Overall Study|Did not meet eligibility criteria|3
1639413|NCT01774721|5728313|P1|Overall Study|Did not meet eligibility criteria|0
1639414|NCT01774721|5728312|P2|Overall Study|Lost to Follow-up|1
1639415|NCT01774721|5728313|P1|Overall Study|Lost to Follow-up|1
1639416|NCT01774721|5728312|P2|Overall Study|Withdrawal by Subject|10
1639417|NCT01774721|5728313|P1|Overall Study|Withdrawal by Subject|14
1639418|NCT01774721|5728312|P2|Overall Study|Death|91
1639419|NCT01774721|5728313|P1|Overall Study|Death|76
1639420|NCT01774591|5728378|P2|Overall Study|Adverse Event|2
1639421|NCT01774591|5728379|P1|Overall Study|Adverse Event|0
1639422|NCT01774591|5728378|P2|Overall Study|Withdrawal by Subject|1
1639423|NCT01774591|5728379|P1|Overall Study|Withdrawal by Subject|0
1639424|NCT01774591|5728378|P2|Overall Study|Physician Decision|1
1639425|NCT01774591|5728379|P1|Overall Study|Physician Decision|1
1639426|NCT01774370|5728389|P1|Overall Study|Follow-up failure|34
1639427|NCT01774370|5728389|P1|Overall Study|Violated inclusion/exclusion criteria|53
1639428|NCT01774370|5728389|P1|Overall Study|Subjects of contraindications|34
1639429|NCT01774370|5728389|P1|Overall Study|Administered prior to the contract date|4
1639430|NCT01774370|5728389|P1|Overall Study|Never taken the PRADAXA during the study|4
1639431|NCT01774344|5728397|P2|Overall Study|Non-compliance with study drug|2
1639432|NCT01774344|5728398|P1|Overall Study|Non-compliance with study drug|0
1639433|NCT01774344|5728397|P2|Overall Study|Physician Decision|1
1639434|NCT01774344|5728398|P1|Overall Study|Physician Decision|0
1639435|NCT01774344|5728397|P2|Overall Study|Adverse event (AE)|1
1639436|NCT01774344|5728398|P1|Overall Study|Adverse event (AE)|0
1639437|NCT01774344|5728397|P2|Overall Study|AE not related to disease progression|47
1639438|NCT01774344|5728398|P1|Overall Study|AE not related to disease progression|12
1639439|NCT01774344|5728397|P2|Overall Study|Ongoing with treatment|65
1639440|NCT01774344|5728398|P1|Overall Study|Ongoing with treatment|10
1639441|NCT01774344|5728397|P2|Overall Study|Other|0
1639442|NCT01774344|5728398|P1|Overall Study|Other|1
1639443|NCT01774344|5728397|P2|Overall Study|Study drug never administered|5
1639444|NCT01774344|5728398|P1|Overall Study|Study drug never administered|1
1639445|NCT01774344|5728397|P2|Overall Study|Withdrawal by Subject|26
1639446|NCT01774344|5728398|P1|Overall Study|Withdrawal by Subject|5
1639447|NCT01774344|5728397|P2|Overall Study|Protocol Violation|1
1639448|NCT01774344|5728398|P1|Overall Study|Protocol Violation|3
1639449|NCT01774305|5728414|P2|Overall Study|Physician Decision|0
1639450|NCT01774305|5728415|P1|Overall Study|Physician Decision|1
1639451|NCT01774253|5728423|P1|Overall Study|Death|1
1639452|NCT01774253|5728423|P1|Overall Study|Withdrawal by Subject|2
1639453|NCT01774253|5728423|P1|Overall Study|Physician Decision|2
1639454|NCT01774253|5728423|P1|Overall Study|Lack of Efficacy|4
1639455|NCT01774110|5728442|P1|Overall Study|Lost to Follow-up|7
1639456|NCT01774097|5728450|P2|Overall Study|Adverse Event|1
1639457|NCT01774097|5728451|P1|Overall Study|Adverse Event|1
1639458|NCT01774097|5728450|P2|Overall Study|Withdrawal by Subject|1
1639459|NCT01774097|5728451|P1|Overall Study|Withdrawal by Subject|1
1639460|NCT01774084|5728481|P2|Overall Study|Personal reasons|0
1639461|NCT01774084|5728482|P1|Overall Study|Personal reasons|1
1639462|NCT01773993|5728507|P1|Overall Study|No Visit After Treatment|35
1639463|NCT01773967|5728526|P2|Overall Study|Lost to Follow-up|13
1639464|NCT01773967|5728527|P1|Overall Study|Lost to Follow-up|15
1639465|NCT01773889|5728542|P1|Overall Study|lack of funding|2
1639466|NCT01773473|5728548|P2|Overall Study|Lost to Follow-up|0
1639467|NCT01773473|5728549|P1|Overall Study|Lost to Follow-up|2
1639468|NCT01773473|5728548|P2|Overall Study|Withdrawal by Subject|3
1639469|NCT01773473|5728549|P1|Overall Study|Withdrawal by Subject|5
1639470|NCT01773473|5728548|P2|Overall Study|Non-Compliance with study drug|4
1639471|NCT01773473|5728549|P1|Overall Study|Non-Compliance with study drug|1
1639472|NCT01773473|5728548|P2|Overall Study|Lack of Efficacy|1
1639473|NCT01773473|5728549|P1|Overall Study|Lack of Efficacy|0
1639474|NCT01773473|5728548|P2|Overall Study|Sponsor Decision|0
1639475|NCT01773473|5728549|P1|Overall Study|Sponsor Decision|2
1639476|NCT01773473|5728548|P2|Overall Study|Physician Decision|5
1639477|NCT01773473|5728549|P1|Overall Study|Physician Decision|3
1639478|NCT01773473|5728548|P2|Overall Study|Protocol Violation|4
1639479|NCT01773473|5728549|P1|Overall Study|Protocol Violation|0
1639480|NCT01773473|5728548|P2|Overall Study|Adverse Event|2
1639481|NCT01773473|5728549|P1|Overall Study|Adverse Event|3
1639482|NCT01773421|5728571|P7|Extension Phase|Adverse Event|0
1639483|NCT01773421|5728572|P6|Extension Phase|Adverse Event|0
1639484|NCT01773421|5728573|P5|Extension Phase|Adverse Event|2
1639485|NCT01773421|5728574|P4|Extension Phase|Adverse Event|0
1639486|NCT01773421|5728575|P3|Extension Phase|Adverse Event|0
1639487|NCT01773421|5728576|P2|Extension Phase|Adverse Event|0
1639488|NCT01773421|5728577|P1|Extension Phase|Adverse Event|0
1639489|NCT01773421|5728571|P7|Extension Phase|Other|0
1639490|NCT01773421|5728572|P6|Extension Phase|Other|2
1639491|NCT01773421|5728573|P5|Extension Phase|Other|1
1639492|NCT01773421|5728574|P4|Extension Phase|Other|0
1639493|NCT01773421|5728575|P3|Extension Phase|Other|0
1639494|NCT01773421|5728576|P2|Extension Phase|Other|0
1639495|NCT01773421|5728577|P1|Extension Phase|Other|0
1639496|NCT01773421|5728571|P7|Treatment Phase|Withdrawal by Subject|0
1639497|NCT01773421|5728572|P6|Treatment Phase|Withdrawal by Subject|0
1639498|NCT01773421|5728573|P5|Treatment Phase|Withdrawal by Subject|0
1639499|NCT01773421|5728574|P4|Treatment Phase|Withdrawal by Subject|1
1639500|NCT01773421|5728575|P3|Treatment Phase|Withdrawal by Subject|1
1639501|NCT01773421|5728576|P2|Treatment Phase|Withdrawal by Subject|0
1639502|NCT01773421|5728577|P1|Treatment Phase|Withdrawal by Subject|0
1639503|NCT01773421|5728571|P7|Treatment Phase|Adverse Event|0
1639504|NCT01773421|5728572|P6|Treatment Phase|Adverse Event|0
1639505|NCT01773421|5728573|P5|Treatment Phase|Adverse Event|0
1639506|NCT01773421|5728574|P4|Treatment Phase|Adverse Event|1
1639507|NCT01773421|5728575|P3|Treatment Phase|Adverse Event|3
1639508|NCT01773421|5728576|P2|Treatment Phase|Adverse Event|0
1639509|NCT01773421|5728577|P1|Treatment Phase|Adverse Event|0
1639510|NCT01773421|5728571|P7|Treatment Phase|Other|0
1639511|NCT01773421|5728572|P6|Treatment Phase|Other|0
1639512|NCT01773421|5728573|P5|Treatment Phase|Other|0
1639513|NCT01773421|5728574|P4|Treatment Phase|Other|0
1639514|NCT01773421|5728575|P3|Treatment Phase|Other|2
1639515|NCT01773421|5728576|P2|Treatment Phase|Other|0
1639516|NCT01773421|5728577|P1|Treatment Phase|Other|0
1639517|NCT01773291|5728608|P3|Overall Study|Withdrawal by Subject|1
1639518|NCT01773291|5728609|P2|Overall Study|Withdrawal by Subject|0
1639519|NCT01773291|5728610|P1|Overall Study|Withdrawal by Subject|0
1639520|NCT01773291|5728608|P3|Overall Study|Protocol Violation|0
1639521|NCT01773291|5728609|P2|Overall Study|Protocol Violation|0
1639522|NCT01773291|5728610|P1|Overall Study|Protocol Violation|1
1639523|NCT01773226|5728621|P1|Overall Study|Withdrawal by Subject|1
1639524|NCT01773122|5728640|P4|Overall Study|Due to amended age eligibility criteria|1
1639525|NCT01773122|5728641|P3|Overall Study|Due to amended age eligibility criteria|0
1639526|NCT01773122|5728642|P2|Overall Study|Due to amended age eligibility criteria|1
1639527|NCT01773122|5728643|P1|Overall Study|Due to amended age eligibility criteria|3
1639528|NCT01773070|5728657|P1|Overall Study|Death (unrelated to study procedures)|3
1639529|NCT01773070|5728657|P1|Overall Study|Other|15
1639530|NCT01773070|5728657|P1|Overall Study|Lost to Follow-up|39
1639531|NCT01773070|5728657|P1|Overall Study|Withdrawal by Subject|24
1639532|NCT01772823|5728667|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
1639533|NCT01772823|5728668|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
1639534|NCT01772823|5728667|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1639535|NCT01772823|5728668|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
1639536|NCT01772823|5728667|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
1639537|NCT01772823|5728668|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
1639538|NCT01772823|5728667|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
1639539|NCT01772823|5728668|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
1639540|NCT01772823|5728667|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1639541|NCT01772823|5728668|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
1639542|NCT01772823|5728667|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
1639543|NCT01772823|5728668|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
1639544|NCT01772823|5728667|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
1639545|NCT01772823|5728668|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
1639546|NCT01772823|5728667|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
1639547|NCT01772823|5728668|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
1639548|NCT01772823|5728667|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
1639549|NCT01772823|5728668|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
1639550|NCT01772823|5728667|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
1639551|NCT01772823|5728668|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
1639552|NCT01772823|5728667|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
1639553|NCT01772823|5728668|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
1639554|NCT01772823|5728667|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
1639555|NCT01772823|5728668|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
1639556|NCT01772823|5728667|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
1639557|NCT01772823|5728668|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
1639558|NCT01772823|5728667|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
1639559|NCT01772823|5728668|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
1639560|NCT01772823|5728667|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1639561|NCT01772823|5728668|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
1639562|NCT01772823|5728667|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
1639563|NCT01772823|5728668|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
1639564|NCT01772719|5728781|P1|Overall Study|Lost to Follow-up|1
1639565|NCT01772719|5728781|P1|Overall Study|Protocol Violation|1
1639566|NCT01772719|5728781|P1|Overall Study|Adverse Event|2
1639567|NCT01772719|5728781|P1|Overall Study|Withdrawal by Subject|3
1639568|NCT01772576|5728801|P1|Overall Study|Withdrawal by Subject|6
1639569|NCT01772576|5728801|P1|Overall Study|Adverse Event|6
1639570|NCT01772576|5728801|P1|Overall Study|Study device not used|3
1639571|NCT01772576|5728801|P1|Overall Study|Lost to Follow-up|3
1639572|NCT01772576|5728801|P1|Overall Study|Protocol Violation|1
1639573|NCT01772576|5728801|P1|Overall Study|Death|15
1639574|NCT01772550|5728813|P3|Overall Study|Adverse Event|1
1639575|NCT01772550|5728814|P2|Overall Study|Adverse Event|0
1639576|NCT01772550|5728815|P1|Overall Study|Adverse Event|0
1639577|NCT01772550|5728813|P3|Overall Study|Unable to insert IV in antecubital vein|5
1639578|NCT01772550|5728814|P2|Overall Study|Unable to insert IV in antecubital vein|1
1639579|NCT01772550|5728815|P1|Overall Study|Unable to insert IV in antecubital vein|1
1639580|NCT01772537|5728856|P3|Overall Study|unsuccessful lumbar drain placement|0
1639581|NCT01772537|5728857|P2|Overall Study|unsuccessful lumbar drain placement|0
1639582|NCT01772537|5728858|P1|Overall Study|unsuccessful lumbar drain placement|1
1639583|NCT01772472|5728874|P2|Overall Study|Ongoing|635
1639584|NCT01772472|5728875|P1|Overall Study|Ongoing|597
1639585|NCT01772472|5728874|P2|Overall Study|Withdrawal by Subject|50
1639586|NCT01772472|5728875|P1|Overall Study|Withdrawal by Subject|72
1639587|NCT01772472|5728874|P2|Overall Study|Lost to Follow-up|8
1639588|NCT01772472|5728875|P1|Overall Study|Lost to Follow-up|12
1639589|NCT01772472|5728874|P2|Overall Study|Other|5
1639590|NCT01772472|5728875|P1|Overall Study|Other|5
1639591|NCT01772472|5728874|P2|Overall Study|Physician Decision|3
1639592|NCT01772472|5728875|P1|Overall Study|Physician Decision|1
1639593|NCT01772472|5728874|P2|Overall Study|Death|42
1639594|NCT01772472|5728875|P1|Overall Study|Death|56
1639595|NCT01772368|5728887|P1|Overall Study|Other|1
1639596|NCT01772368|5728887|P1|Overall Study|Protocol Violation|2
1639597|NCT01772368|5728887|P1|Overall Study|Withdrawal by Subject|3
1639598|NCT01772368|5728887|P1|Overall Study|Adverse Event|1
1639599|NCT01772316|5728933|P1|Overall Study|Withdrawn by sponsor decision|5
1639600|NCT01772316|5728933|P1|Overall Study|Inform consent withdrawn|1
1639601|NCT01772316|5728933|P1|Overall Study|Serious adverse event|1
1639602|NCT01772147|5728954|P3|Overall Study|Lack of Efficacy|6
1639603|NCT01772147|5728955|P2|Overall Study|Lack of Efficacy|6
1639604|NCT01772147|5728956|P1|Overall Study|Lack of Efficacy|8
1639605|NCT01772147|5728954|P3|Overall Study|Protocol Deviation|1
1639606|NCT01772147|5728955|P2|Overall Study|Protocol Deviation|1
1639607|NCT01772147|5728956|P1|Overall Study|Protocol Deviation|2
1639608|NCT01772147|5728954|P3|Overall Study|Lost to Follow-up|1
1639609|NCT01772147|5728955|P2|Overall Study|Lost to Follow-up|0
1639610|NCT01772147|5728956|P1|Overall Study|Lost to Follow-up|1
1639611|NCT01772147|5728954|P3|Overall Study|Withdrew Consent|4
1639612|NCT01772147|5728955|P2|Overall Study|Withdrew Consent|8
1639613|NCT01772147|5728956|P1|Overall Study|Withdrew Consent|7
1639614|NCT01772147|5728954|P3|Overall Study|Adverse Event|6
1639615|NCT01772147|5728955|P2|Overall Study|Adverse Event|10
1639616|NCT01772147|5728956|P1|Overall Study|Adverse Event|13
1639617|NCT01772134|5728976|P3|Overall Study|Randomized Study Medication Not Received|1
1639618|NCT01772134|5728977|P2|Overall Study|Randomized Study Medication Not Received|0
1639619|NCT01772134|5728978|P1|Overall Study|Randomized Study Medication Not Received|2
1639620|NCT01772134|5728976|P3|Overall Study|Protocol-defined Stopping Criteria|0
1639621|NCT01772134|5728977|P2|Overall Study|Protocol-defined Stopping Criteria|0
1639622|NCT01772134|5728978|P1|Overall Study|Protocol-defined Stopping Criteria|1
1639623|NCT01772134|5728976|P3|Overall Study|Lack of Efficacy|3
1639624|NCT01772134|5728977|P2|Overall Study|Lack of Efficacy|5
1639625|NCT01772134|5728978|P1|Overall Study|Lack of Efficacy|11
1639626|NCT01772134|5728976|P3|Overall Study|Protocol Deviation|3
1639627|NCT01772134|5728977|P2|Overall Study|Protocol Deviation|3
1639628|NCT01772134|5728978|P1|Overall Study|Protocol Deviation|4
1639629|NCT01772134|5728976|P3|Overall Study|Lost to Follow-up|0
1639630|NCT01772134|5728977|P2|Overall Study|Lost to Follow-up|0
1639631|NCT01772134|5728978|P1|Overall Study|Lost to Follow-up|2
1639632|NCT01772134|5728976|P3|Overall Study|Withdrew Consent|5
1639633|NCT01772134|5728977|P2|Overall Study|Withdrew Consent|1
1639634|NCT01772134|5728978|P1|Overall Study|Withdrew Consent|3
1639635|NCT01772134|5728976|P3|Overall Study|Adverse Event|10
1639636|NCT01772134|5728977|P2|Overall Study|Adverse Event|5
1639637|NCT01772134|5728978|P1|Overall Study|Adverse Event|6
1639638|NCT01771913|5729021|P2|Overall Study|Withdrawal by Subject|0
1639639|NCT01771913|5729022|P1|Overall Study|Withdrawal by Subject|1
1639640|NCT01771809|5729034|P2|Overall Study|Other (other)|5
1639641|NCT01771809|5729035|P1|Overall Study|Other (other)|9
1639642|NCT01771809|5729034|P2|Overall Study|Death|0
1639643|NCT01771809|5729035|P1|Overall Study|Death|1
1639644|NCT01771809|5729034|P2|Overall Study|Other (Insufficient clinical response)|20
1639645|NCT01771809|5729035|P1|Overall Study|Other (Insufficient clinical response)|22
1639646|NCT01771809|5729034|P2|Overall Study|Lost to Follow-up|3
1639647|NCT01771809|5729035|P1|Overall Study|Lost to Follow-up|1
1639648|NCT01771809|5729034|P2|Overall Study|Withdrawal by Subject|42
1639649|NCT01771809|5729035|P1|Overall Study|Withdrawal by Subject|34
1639650|NCT01771809|5729034|P2|Overall Study|Protocol Violation|1
1639651|NCT01771809|5729035|P1|Overall Study|Protocol Violation|0
1639652|NCT01771809|5729034|P2|Overall Study|Adverse Event|12
1639653|NCT01771809|5729035|P1|Overall Study|Adverse Event|4
1639654|NCT01771250|5729054|P2|Period 1|Met exclusion criteria|0
1639655|NCT01771250|5729055|P1|Period 1|Met exclusion criteria|1
1639656|NCT01770860|5729071|P1|Overall Study|Administrative decision made by the PI|1
1639657|NCT01770860|5729071|P1|Overall Study|Lost to Follow-up|1
1639658|NCT01770860|5729071|P1|Overall Study|Withdrawal by Subject|4
1639659|NCT01770743|5729119|P5|Overall Study|Moving Out of State|0
1639660|NCT01770743|5729120|P4|Overall Study|Moving Out of State|0
1639661|NCT01770743|5729121|P3|Overall Study|Moving Out of State|0
1639662|NCT01770743|5729122|P2|Overall Study|Moving Out of State|1
1639663|NCT01770743|5729123|P1|Overall Study|Moving Out of State|0
1639664|NCT01770743|5729119|P5|Overall Study|Sponsor Terminated Subject|0
1639665|NCT01770743|5729120|P4|Overall Study|Sponsor Terminated Subject|1
1639666|NCT01770743|5729121|P3|Overall Study|Sponsor Terminated Subject|0
1639667|NCT01770743|5729122|P2|Overall Study|Sponsor Terminated Subject|0
1639668|NCT01770743|5729123|P1|Overall Study|Sponsor Terminated Subject|1
1639669|NCT01770743|5729119|P5|Overall Study|Lost to Follow-up|1
1639670|NCT01770743|5729120|P4|Overall Study|Lost to Follow-up|0
1639671|NCT01770743|5729121|P3|Overall Study|Lost to Follow-up|0
1639672|NCT01770743|5729122|P2|Overall Study|Lost to Follow-up|2
1639673|NCT01770743|5729123|P1|Overall Study|Lost to Follow-up|0
1639674|NCT01770743|5729119|P5|Overall Study|Withdrawal by Subject|1
1639675|NCT01770743|5729120|P4|Overall Study|Withdrawal by Subject|1
1639676|NCT01770743|5729121|P3|Overall Study|Withdrawal by Subject|1
1639677|NCT01770743|5729122|P2|Overall Study|Withdrawal by Subject|0
1639678|NCT01770743|5729123|P1|Overall Study|Withdrawal by Subject|0
1639679|NCT01770743|5729119|P5|Overall Study|Adverse Event|0
1639680|NCT01770743|5729120|P4|Overall Study|Adverse Event|0
1639681|NCT01770743|5729121|P3|Overall Study|Adverse Event|0
1639682|NCT01770743|5729122|P2|Overall Study|Adverse Event|0
1639683|NCT01770743|5729123|P1|Overall Study|Adverse Event|1
1639684|NCT01770509|5729225|P2|Overall Study|Lost to Follow-up|2
1639685|NCT01770509|5729226|P1|Overall Study|Lost to Follow-up|1
1639686|NCT01770509|5729225|P2|Overall Study|Injury|1
1639687|NCT01770509|5729226|P1|Overall Study|Injury|0
1639688|NCT01770392|5729262|P1|Washout Period of at Least 14 Days|Adverse Event|1
1639689|NCT01770379|5729277|P3|Overall Study|Adverse Event|2
1639690|NCT01770379|5729278|P2|Overall Study|Adverse Event|3
1639691|NCT01770379|5729279|P1|Overall Study|Adverse Event|1
1639692|NCT01770379|5729277|P3|Overall Study|Lack of Efficacy|6
1639693|NCT01770379|5729278|P2|Overall Study|Lack of Efficacy|6
1639694|NCT01770379|5729279|P1|Overall Study|Lack of Efficacy|8
1639695|NCT01770379|5729277|P3|Overall Study|Lost to Follow-up|2
1639696|NCT01770379|5729278|P2|Overall Study|Lost to Follow-up|0
1639697|NCT01770379|5729279|P1|Overall Study|Lost to Follow-up|0
1639698|NCT01770379|5729277|P3|Overall Study|Physician Decision|2
1639699|NCT01770379|5729278|P2|Overall Study|Physician Decision|1
1639700|NCT01770379|5729279|P1|Overall Study|Physician Decision|0
1639701|NCT01770379|5729277|P3|Overall Study|Protocol Violation|1
1639702|NCT01770379|5729278|P2|Overall Study|Protocol Violation|1
1639703|NCT01770379|5729279|P1|Overall Study|Protocol Violation|0
1639704|NCT01770379|5729277|P3|Overall Study|study terminated by sponsor|22
1639705|NCT01770379|5729278|P2|Overall Study|study terminated by sponsor|23
1639706|NCT01770379|5729279|P1|Overall Study|study terminated by sponsor|22
1639707|NCT01770379|5729277|P3|Overall Study|Withdrawal by Subject|7
1639708|NCT01770379|5729278|P2|Overall Study|Withdrawal by Subject|10
1639709|NCT01770379|5729279|P1|Overall Study|Withdrawal by Subject|7
1639710|NCT01770379|5729277|P3|Overall Study|Technical issues|0
1639711|NCT01770379|5729278|P2|Overall Study|Technical issues|0
1639712|NCT01770379|5729279|P1|Overall Study|Technical issues|1
1639713|NCT01770353|5729307|P2|Overall Study|Toxicity related diarrhoea + progression|1
1639714|NCT01770353|5729308|P1|Overall Study|Toxicity related diarrhoea + progression|0
1639715|NCT01770353|5729307|P2|Overall Study|Clinical deterioration|6
1639716|NCT01770353|5729308|P1|Overall Study|Clinical deterioration|3
1639717|NCT01770353|5729307|P2|Overall Study|Physician Decision|3
1639718|NCT01770353|5729308|P1|Overall Study|Physician Decision|0
1639719|NCT01770353|5729307|P2|Overall Study|Protocol Violation|0
1639720|NCT01770353|5729308|P1|Overall Study|Protocol Violation|1
1639721|NCT01770353|5729307|P2|Overall Study|Adverse Event|1
1639722|NCT01770353|5729308|P1|Overall Study|Adverse Event|0
1639723|NCT01770353|5729307|P2|Overall Study|Progressive disease|1
1639724|NCT01770353|5729308|P1|Overall Study|Progressive disease|2
1639725|NCT01770145|5729367|P1|Treatment|Withdrawal by Subject|1
1639726|NCT01770145|5729367|P1|Treatment|Adverse Event|3
1639727|NCT01770145|5729367|P1|Baseline|Unable to define optimal dose|4
1639728|NCT01770145|5729367|P1|Baseline|Lost to Follow-up|1
1639729|NCT01770145|5729367|P1|Baseline|Withdrawal by Subject|1
1639730|NCT01770145|5729367|P1|Baseline|Adverse Event|20
1639731|NCT01769508|5729423|P1|Overall Study|Lost to Follow-up|1
1639732|NCT01769508|5729423|P1|Overall Study|Adverse Event|1
1639733|NCT01769508|5729423|P1|Overall Study|Withdrawal by Subject|1
1639734|NCT01769508|5729423|P1|Overall Study|Death|3
1639735|NCT01769469|5729432|P1|Overall Study|Subject Confirmed HIV Positive|3
1639736|NCT01769469|5729432|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
1639737|NCT01769469|5729432|P1|Overall Study|Lost to Follow-up|17
1639738|NCT01769469|5729432|P1|Overall Study|Moved Out Of Area|3
1639739|NCT01769469|5729432|P1|Overall Study|Consent Withdrawn|5
1639740|NCT01769456|5729592|P1|Overall Study|Parental request to youth to withdraw|1
1639741|NCT01769456|5729592|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
1639742|NCT01769456|5729592|P1|Overall Study|Moved out of the area|3
1639743|NCT01769456|5729592|P1|Overall Study|Did not receive PCC intervention|6
1639744|NCT01769456|5729592|P1|Overall Study|Withdrawal by Subject|3
1639745|NCT01769456|5729592|P1|Overall Study|Lost to Follow-up|19
1639746|NCT01769443|5729613|P2|Overall Study|Study closure|0
1639747|NCT01769443|5729614|P1|Overall Study|Study closure|1
1639748|NCT01769404|5729656|P2|Treatment Period 2|Sponsor decision|0
1639749|NCT01769404|5729657|P1|Treatment Period 2|Sponsor decision|7
1639750|NCT01769404|5729656|P2|Treatment Period 1|Sponsor decision|0
1639751|NCT01769404|5729657|P1|Treatment Period 1|Sponsor decision|1
1639752|NCT01769404|5729656|P2|Treatment Period 1|Withdrawal by Subject|0
1639753|NCT01769404|5729657|P1|Treatment Period 1|Withdrawal by Subject|3
1639754|NCT01769404|5729656|P2|Treatment Period 1|Did not meet eligibility criteria|0
1639755|NCT01769404|5729657|P1|Treatment Period 1|Did not meet eligibility criteria|1
1639756|NCT01769391|5729679|P2|Overall Study|Investigator Decision|0
1639757|NCT01769391|5729680|P1|Overall Study|Investigator Decision|2
1639758|NCT01769391|5729679|P2|Overall Study|Withdrawal by Subject|3
1639759|NCT01769391|5729680|P1|Overall Study|Withdrawal by Subject|4
1639760|NCT01769391|5729679|P2|Overall Study|Progressive Disease|2
1639761|NCT01769391|5729680|P1|Overall Study|Progressive Disease|1
1639762|NCT01769391|5729679|P2|Overall Study|Adverse Event|3
1639763|NCT01769391|5729680|P1|Overall Study|Adverse Event|0
1639764|NCT01769391|5729679|P2|Overall Study|Death|1
1639765|NCT01769391|5729680|P1|Overall Study|Death|10
1639766|NCT01769378|5729699|P2|Overall Study|Lost to Follow-up|0
1639767|NCT01769378|5729700|P1|Overall Study|Lost to Follow-up|2
1639768|NCT01769378|5729699|P2|Overall Study|Sponsor Decision|0
1639769|NCT01769378|5729700|P1|Overall Study|Sponsor Decision|1
1639770|NCT01769378|5729699|P2|Overall Study|Withdrawal by Subject|3
1639771|NCT01769378|5729700|P1|Overall Study|Withdrawal by Subject|10
1639772|NCT01769378|5729699|P2|Overall Study|Protocol Violation|1
1639773|NCT01769378|5729700|P1|Overall Study|Protocol Violation|1
1639774|NCT01769378|5729699|P2|Overall Study|Entry criteria not met|0
1639775|NCT01769378|5729700|P1|Overall Study|Entry criteria not met|1
1639776|NCT01769378|5729699|P2|Overall Study|Adverse Event|0
1639777|NCT01769378|5729700|P1|Overall Study|Adverse Event|10
1639778|NCT01769339|5729780|P1|Overall Study|Adverse Event|1
1639779|NCT01769339|5729780|P1|Overall Study|Lost to Follow-up|42
1639780|NCT01769326|5729791|P4|Overall Study|Got sick and could not complete study|0
1639781|NCT01769326|5729792|P3|Overall Study|Got sick and could not complete study|1
1639782|NCT01769326|5729793|P2|Overall Study|Got sick and could not complete study|0
1639783|NCT01769326|5729794|P1|Overall Study|Got sick and could not complete study|0
1639784|NCT01769326|5729791|P4|Overall Study|got a job|0
1639785|NCT01769326|5729792|P3|Overall Study|got a job|0
1639786|NCT01769326|5729793|P2|Overall Study|got a job|1
1639787|NCT01769326|5729794|P1|Overall Study|got a job|0
1639788|NCT01769326|5729791|P4|Overall Study|unrelated injry|0
1639789|NCT01769326|5729792|P3|Overall Study|unrelated injry|0
1639790|NCT01769326|5729793|P2|Overall Study|unrelated injry|1
1639791|NCT01769326|5729794|P1|Overall Study|unrelated injry|1
1639792|NCT01769326|5729791|P4|Overall Study|Lost to Follow-up|0
1639793|NCT01769326|5729792|P3|Overall Study|Lost to Follow-up|0
1639794|NCT01769326|5729793|P2|Overall Study|Lost to Follow-up|2
1639795|NCT01769326|5729794|P1|Overall Study|Lost to Follow-up|1
1639796|NCT01769196|5729939|P2|Overall Study|Withdrew consent|40
1639797|NCT01769196|5729940|P1|Overall Study|Withdrew consent|36
1639798|NCT01769196|5729939|P2|Overall Study|Participant never dosed with study drug|0
1639799|NCT01769196|5729940|P1|Overall Study|Participant never dosed with study drug|1
1639800|NCT01769196|5729939|P2|Overall Study|Study terminated by sponsor|161
1639801|NCT01769196|5729940|P1|Overall Study|Study terminated by sponsor|160
1639802|NCT01769196|5729939|P2|Overall Study|Protocol Violation|3
1639803|NCT01769196|5729940|P1|Overall Study|Protocol Violation|0
1639804|NCT01769196|5729939|P2|Overall Study|Protocol defined criteria for withdrawal|11
1639805|NCT01769196|5729940|P1|Overall Study|Protocol defined criteria for withdrawal|9
1639806|NCT01769196|5729939|P2|Overall Study|Progressive disease|6
1639807|NCT01769196|5729940|P1|Overall Study|Progressive disease|11
1639808|NCT01769196|5729939|P2|Overall Study|Lack of Efficacy|2
1639809|NCT01769196|5729940|P1|Overall Study|Lack of Efficacy|3
1639810|NCT01769196|5729939|P2|Overall Study|Investigator Discretion|3
1639811|NCT01769196|5729940|P1|Overall Study|Investigator Discretion|7
1639812|NCT01769196|5729939|P2|Overall Study|Death|26
1639813|NCT01769196|5729940|P1|Overall Study|Death|21
1639814|NCT01769196|5729939|P2|Overall Study|Adverse Event|20
1639815|NCT01769196|5729940|P1|Overall Study|Adverse Event|24
1639816|NCT01769105|5729970|P2|Cross-over|Lost to Follow-up|0
1639817|NCT01769105|5729971|P1|Cross-over|Lost to Follow-up|5
1639818|NCT01769105|5729970|P2|First Intervention|Protocol Violation|2
1639819|NCT01769105|5729971|P1|First Intervention|Protocol Violation|2
1639820|NCT01768858|5729990|P1|Overall Study|Withdrawal by Subject|1
1639821|NCT01768858|5729990|P1|Overall Study|Exanthema|1
1639822|NCT01768858|5729990|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
1639823|NCT01768858|5729990|P1|Overall Study|Participant moved to Germany|1
1639824|NCT01768858|5729990|P1|Overall Study|Serious Adverse Event|1
1639825|NCT01768858|5729990|P1|Overall Study|Lack of Efficacy|8
1639826|NCT01768858|5729990|P1|Overall Study|Lost to Follow-up|9
1639827|NCT01768676|5730041|P2|Overall Study|Withdrawal by Subject|10
1639828|NCT01768676|5730042|P1|Overall Study|Withdrawal by Subject|3
1639829|NCT01768676|5730041|P2|Overall Study|Physician Decision|1
1639830|NCT01768676|5730042|P1|Overall Study|Physician Decision|4
1639831|NCT01768676|5730041|P2|Overall Study|Protocol Violation|1
1639832|NCT01768676|5730042|P1|Overall Study|Protocol Violation|1
1639833|NCT01768676|5730041|P2|Overall Study|Lost to Follow-up|16
1639834|NCT01768676|5730042|P1|Overall Study|Lost to Follow-up|13
1639835|NCT01768676|5730041|P2|Overall Study|Adverse Event|3
1639836|NCT01768676|5730042|P1|Overall Study|Adverse Event|3
1639837|NCT01768637|5730058|P2|Overall Study|Difficult blood draw|0
1639838|NCT01768637|5730059|P1|Overall Study|Difficult blood draw|1
1639839|NCT01768637|5730058|P2|Overall Study|Lost to Follow-up|7
1639840|NCT01768637|5730059|P1|Overall Study|Lost to Follow-up|2
1639841|NCT01768572|5730072|P3|Overall Study|Other, Not due to an adverse event|1
1639842|NCT01768572|5730073|P2|Overall Study|Other, Not due to an adverse event|1
1639843|NCT01768572|5730074|P1|Overall Study|Other, Not due to an adverse event|1
1639844|NCT01768572|5730072|P3|Overall Study|Lack of Efficacy|1
1639845|NCT01768572|5730073|P2|Overall Study|Lack of Efficacy|3
1639846|NCT01768572|5730074|P1|Overall Study|Lack of Efficacy|1
1639847|NCT01768572|5730072|P3|Overall Study|Adverse Event|4
1639848|NCT01768572|5730073|P2|Overall Study|Adverse Event|8
1639849|NCT01768572|5730074|P1|Overall Study|Adverse Event|7
1639850|NCT01768559|5730085|P3|Overall Study|Other than specified|5
1639851|NCT01768559|5730086|P2|Overall Study|Other than specified|8
1639852|NCT01768559|5730087|P1|Overall Study|Other than specified|9
1639853|NCT01768559|5730085|P3|Overall Study|Poor compliance to protocol|2
1639854|NCT01768559|5730086|P2|Overall Study|Poor compliance to protocol|3
1639855|NCT01768559|5730087|P1|Overall Study|Poor compliance to protocol|0
1639856|NCT01768559|5730085|P3|Overall Study|Lack of Efficacy|0
1639857|NCT01768559|5730086|P2|Overall Study|Lack of Efficacy|4
1639858|NCT01768559|5730087|P1|Overall Study|Lack of Efficacy|6
1639859|NCT01768559|5730085|P3|Overall Study|Adverse Event|5
1639860|NCT01768559|5730086|P2|Overall Study|Adverse Event|2
1639861|NCT01768559|5730087|P1|Overall Study|Adverse Event|15
1639862|NCT01768559|5730085|P3|Overall Study|Randomized but not treated|1
1639863|NCT01768559|5730086|P2|Overall Study|Randomized but not treated|0
1639864|NCT01768559|5730087|P1|Overall Study|Randomized but not treated|0
1639865|NCT01768286|5730168|P4|Overall Study|Withdrew Consent|0
1639866|NCT01768286|5730169|P3|Overall Study|Withdrew Consent|1
1639867|NCT01768286|5730170|P2|Overall Study|Withdrew Consent|0
1639868|NCT01768286|5730171|P1|Overall Study|Withdrew Consent|0
1639869|NCT01768286|5730168|P4|Overall Study|Lack of Efficacy|1
1639870|NCT01768286|5730169|P3|Overall Study|Lack of Efficacy|0
1639871|NCT01768286|5730170|P2|Overall Study|Lack of Efficacy|4
1639872|NCT01768286|5730171|P1|Overall Study|Lack of Efficacy|7
1639873|NCT01768286|5730168|P4|Overall Study|Randomized But Not Treated|0
1639874|NCT01768286|5730169|P3|Overall Study|Randomized But Not Treated|1
1639875|NCT01768286|5730170|P2|Overall Study|Randomized But Not Treated|0
1639876|NCT01768286|5730171|P1|Overall Study|Randomized But Not Treated|0
1639877|NCT01768117|5730233|P1|Overall Study|Protocol Violation|3
1639878|NCT01768117|5730233|P1|Overall Study|Withdrawal by Subject|2
1639879|NCT01768117|5730233|P1|Overall Study|Lost to Follow-up|1
1639880|NCT01767987|5730297|P2|Overall Study|Physician Decision|1
1639881|NCT01767987|5730298|P1|Overall Study|Physician Decision|4
1639882|NCT01767597|5730364|P2|Overall Study|Withdrawal by Subject|0
1639883|NCT01767597|5730365|P1|Overall Study|Withdrawal by Subject|1
1639884|NCT01767597|5730364|P2|Overall Study|Incomplete intervention|1
1639885|NCT01767597|5730365|P1|Overall Study|Incomplete intervention|3
1639886|NCT01767519|5730374|P3|Overall Study|Adverse Event|1
1639887|NCT01767519|5730375|P2|Overall Study|Adverse Event|5
1639888|NCT01767519|5730376|P1|Overall Study|Adverse Event|5
1639889|NCT01767519|5730374|P3|Overall Study|Lack of Efficacy|0
1639890|NCT01767519|5730375|P2|Overall Study|Lack of Efficacy|0
1639891|NCT01767519|5730376|P1|Overall Study|Lack of Efficacy|1
1639892|NCT01767519|5730374|P3|Overall Study|Lost to Follow-up|2
1639893|NCT01767519|5730375|P2|Overall Study|Lost to Follow-up|1
1639894|NCT01767519|5730376|P1|Overall Study|Lost to Follow-up|3
1639895|NCT01767519|5730374|P3|Overall Study|Personal Reasons|0
1639896|NCT01767519|5730375|P2|Overall Study|Personal Reasons|0
1639897|NCT01767519|5730376|P1|Overall Study|Personal Reasons|1
1639898|NCT01767519|5730374|P3|Overall Study|Protocol Violation|0
1639899|NCT01767519|5730375|P2|Overall Study|Protocol Violation|3
1639900|NCT01767519|5730376|P1|Overall Study|Protocol Violation|0
1639901|NCT01767519|5730374|P3|Overall Study|Other Reasons|2
1639902|NCT01767519|5730375|P2|Overall Study|Other Reasons|4
1639903|NCT01767519|5730376|P1|Overall Study|Other Reasons|4
1639904|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
1639905|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
1639906|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Physician Decision|0
1639907|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Physician Decision|1
1639908|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
1639909|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
1639910|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
1639911|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
1639912|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
1639913|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
1639914|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
1639915|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
1639916|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
1639917|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
1639918|NCT01767467|5730417|P2|End of Study Phase (up to Month 13)|Adverse Event|39
1639919|NCT01767467|5730418|P1|End of Study Phase (up to Month 13)|Adverse Event|29
1639920|NCT01767467|5730417|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
1639921|NCT01767467|5730418|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
1639922|NCT01767467|5730417|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
1639923|NCT01767467|5730418|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
1639924|NCT01767467|5730417|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
1639925|NCT01767467|5730418|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
1639926|NCT01767467|5730417|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
1639927|NCT01767467|5730418|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
1639928|NCT01767467|5730417|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
1639929|NCT01767467|5730418|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
1639930|NCT01767467|5730417|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
1639931|NCT01767467|5730418|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
1639932|NCT01767376|5730474|P3|Overall Study|Withdrawal by Subject|0
1639933|NCT01767376|5730475|P2|Overall Study|Withdrawal by Subject|1
1639934|NCT01767376|5730476|P1|Overall Study|Withdrawal by Subject|1
1639935|NCT01767376|5730474|P3|Overall Study|Lost to Follow-up|0
1639936|NCT01767376|5730475|P2|Overall Study|Lost to Follow-up|2
1639937|NCT01767376|5730476|P1|Overall Study|Lost to Follow-up|3
1639938|NCT01767194|5730542|P2|Overall Study|Criteria not met on time for next cycle|1
1639939|NCT01767194|5730543|P1|Overall Study|Criteria not met on time for next cycle|0
1639940|NCT01767194|5730542|P2|Overall Study|Refusal by patient/parent|4
1639941|NCT01767194|5730543|P1|Overall Study|Refusal by patient/parent|2
1639942|NCT01767194|5730542|P2|Overall Study|Ineligible|1
1639943|NCT01767194|5730543|P1|Overall Study|Ineligible|1
1639944|NCT01767194|5730542|P2|Overall Study|Withdrawal by Subject|1
1639945|NCT01767194|5730543|P1|Overall Study|Withdrawal by Subject|0
1639946|NCT01767194|5730542|P2|Overall Study|Physician Decision|23
1639947|NCT01767194|5730543|P1|Overall Study|Physician Decision|2
1639948|NCT01767194|5730542|P2|Overall Study|Lack of Efficacy|11
1639949|NCT01767194|5730543|P1|Overall Study|Lack of Efficacy|12
1639950|NCT01767194|5730542|P2|Overall Study|Death|1
1639951|NCT01767194|5730543|P1|Overall Study|Death|0
1639952|NCT01767194|5730542|P2|Overall Study|Adverse Event|1
1639953|NCT01767194|5730543|P1|Overall Study|Adverse Event|1
1639954|NCT01767116|5730567|P2|Overall Study|Lost to Follow-up|2
1639955|NCT01767116|5730568|P1|Overall Study|Lost to Follow-up|2
1639956|NCT01766921|5730626|P2|Overall Study|Withdrawal by Subject|5
1639957|NCT01766921|5730627|P1|Overall Study|Withdrawal by Subject|14
1639958|NCT01766921|5730626|P2|Overall Study|Protocol Violation|1
1639959|NCT01766921|5730627|P1|Overall Study|Protocol Violation|1
1639960|NCT01766921|5730626|P2|Overall Study|Unclassified|2
1639961|NCT01766921|5730627|P1|Overall Study|Unclassified|2
1639962|NCT01766921|5730626|P2|Overall Study|Lost to Follow-up|3
1639963|NCT01766921|5730627|P1|Overall Study|Lost to Follow-up|1
1639964|NCT01766921|5730626|P2|Overall Study|Death|1
1639965|NCT01766921|5730627|P1|Overall Study|Death|1
1639966|NCT01766921|5730626|P2|Overall Study|Administrative Reason|5
1639967|NCT01766921|5730627|P1|Overall Study|Administrative Reason|5
1639968|NCT01766817|5730649|P3|Overall Study|Other|0
1639969|NCT01766817|5730650|P2|Overall Study|Other|0
1639970|NCT01766817|5730651|P1|Overall Study|Other|1
1639971|NCT01766817|5730649|P3|Overall Study|Physician Decision|4
1639972|NCT01766817|5730650|P2|Overall Study|Physician Decision|3
1639973|NCT01766817|5730651|P1|Overall Study|Physician Decision|3
1639974|NCT01766817|5730649|P3|Overall Study|Subject non-compliance|2
1639975|NCT01766817|5730650|P2|Overall Study|Subject non-compliance|1
1639976|NCT01766817|5730651|P1|Overall Study|Subject non-compliance|0
1639977|NCT01766817|5730649|P3|Overall Study|Withdrawal by Subject|3
1639978|NCT01766817|5730650|P2|Overall Study|Withdrawal by Subject|0
1639979|NCT01766817|5730651|P1|Overall Study|Withdrawal by Subject|2
1639980|NCT01766817|5730649|P3|Overall Study|Unable to take study drug|0
1639981|NCT01766817|5730650|P2|Overall Study|Unable to take study drug|1
1639982|NCT01766817|5730651|P1|Overall Study|Unable to take study drug|0
1639983|NCT01766817|5730649|P3|Overall Study|Death|0
1639984|NCT01766817|5730650|P2|Overall Study|Death|1
1639985|NCT01766817|5730651|P1|Overall Study|Death|1
1639986|NCT01766817|5730649|P3|Overall Study|Drug-unrelated adverse event|3
1639987|NCT01766817|5730650|P2|Overall Study|Drug-unrelated adverse event|3
1639988|NCT01766817|5730651|P1|Overall Study|Drug-unrelated adverse event|3
1639989|NCT01766817|5730649|P3|Overall Study|Drug-related adverse event|1
1639990|NCT01766817|5730650|P2|Overall Study|Drug-related adverse event|2
1639991|NCT01766817|5730651|P1|Overall Study|Drug-related adverse event|1
1639992|NCT01766778|5730702|P2|Overall Study|Withdrawal by Subject|0
1639993|NCT01766778|5730703|P1|Overall Study|Withdrawal by Subject|1
1639994|NCT01766778|5730702|P2|Overall Study|Adverse Event|4
1639995|NCT01766778|5730703|P1|Overall Study|Adverse Event|4
1639996|NCT01766401|5730757|P2|Overall Study|Pregnancy|1
1639997|NCT01766401|5730758|P1|Overall Study|Pregnancy|1
1639998|NCT01766401|5730757|P2|Overall Study|Lost to Follow-up|11
1639999|NCT01766401|5730758|P1|Overall Study|Lost to Follow-up|10
1640000|NCT01766401|5730757|P2|Overall Study|Withdrawal by Subject|12
1640001|NCT01766401|5730758|P1|Overall Study|Withdrawal by Subject|15
1640002|NCT01766401|5730757|P2|Overall Study|Protocol Violation|8
1640003|NCT01766401|5730758|P1|Overall Study|Protocol Violation|3
1640004|NCT01766401|5730757|P2|Overall Study|Lack of Efficacy|2
1640005|NCT01766401|5730758|P1|Overall Study|Lack of Efficacy|1
1640006|NCT01766401|5730757|P2|Overall Study|Adverse Event|22
1640007|NCT01766401|5730758|P1|Overall Study|Adverse Event|7
1640008|NCT01766336|5730768|P2|Overall Study|Withdrawal by Subject|15
1640009|NCT01766336|5730769|P1|Overall Study|Withdrawal by Subject|18
1640010|NCT01766336|5730768|P2|Overall Study|Sponsor Decision|43
1640011|NCT01766336|5730769|P1|Overall Study|Sponsor Decision|52
1640012|NCT01766336|5730768|P2|Overall Study|Protocol Violation|1
1640013|NCT01766336|5730769|P1|Overall Study|Protocol Violation|0
1640014|NCT01766336|5730768|P2|Overall Study|Physician Decision|2
1640015|NCT01766336|5730769|P1|Overall Study|Physician Decision|4
1640016|NCT01766336|5730768|P2|Overall Study|Lost to Follow-up|3
1640017|NCT01766336|5730769|P1|Overall Study|Lost to Follow-up|1
1640018|NCT01766336|5730768|P2|Overall Study|Death|3
1640019|NCT01766336|5730769|P1|Overall Study|Death|4
1640020|NCT01766336|5730768|P2|Overall Study|Adverse Event|8
1640021|NCT01766336|5730769|P1|Overall Study|Adverse Event|11
1640022|NCT01766310|5730777|P2|Overall Study|Lost to Follow-up|3
1640023|NCT01766310|5730778|P1|Overall Study|Lost to Follow-up|1
1640024|NCT01766206|5730808|P1|Overall Study|Withdrawal and inappropriate enrollment|1
1640025|NCT01766206|5730808|P1|Overall Study|Inappropriate enrollment|18
1640026|NCT01766206|5730808|P1|Overall Study|Lost to Follow-up|10
1640027|NCT01766206|5730808|P1|Overall Study|Withdrawal by Subject|22
1640028|NCT01766050|5730835|P1|Overall Study|Withdrawal by Subject|2
1640029|NCT01766050|5730835|P1|Overall Study|Lost to Follow-up|1
1640030|NCT01766050|5730835|P1|Overall Study|Adverse Event|1
1640031|NCT01766037|5730970|P2|Overall Study|nausea / discomfort|0
1640032|NCT01766037|5730971|P1|Overall Study|nausea / discomfort|3
1640033|NCT01766037|5730970|P2|Overall Study|medical - unrelated|2
1640034|NCT01766037|5730971|P1|Overall Study|medical - unrelated|1
1640035|NCT01766037|5730970|P2|Overall Study|Moved from area|0
1640036|NCT01766037|5730971|P1|Overall Study|Moved from area|5
1640037|NCT01766037|5730970|P2|Overall Study|Withdrawal by Subject|16
1640038|NCT01766037|5730971|P1|Overall Study|Withdrawal by Subject|18
1640039|NCT01766037|5730970|P2|Overall Study|Physician Decision|1
1640040|NCT01766037|5730971|P1|Overall Study|Physician Decision|0
1640041|NCT01766037|5730970|P2|Overall Study|Lost to Follow-up|10
1640042|NCT01766037|5730971|P1|Overall Study|Lost to Follow-up|0
1640043|NCT01766037|5730970|P2|Overall Study|Lack of Efficacy|0
1640044|NCT01766037|5730971|P1|Overall Study|Lack of Efficacy|1
1640045|NCT01766037|5730970|P2|Overall Study|Adverse Event|0
1640046|NCT01766037|5730971|P1|Overall Study|Adverse Event|1
1640047|NCT01765764|5731040|P3|Treatment Period|Other Miscellaneous Reasons|2
1640048|NCT01765764|5731041|P2|Treatment Period|Other Miscellaneous Reasons|2
1640049|NCT01765764|5731042|P1|Treatment Period|Other Miscellaneous Reasons|1
1640050|NCT01765764|5731040|P3|Treatment Period|Personal Reasons|1
1640051|NCT01765764|5731041|P2|Treatment Period|Personal Reasons|2
1640052|NCT01765764|5731042|P1|Treatment Period|Personal Reasons|1
1640053|NCT01765764|5731040|P3|Treatment Period|Lost to Follow-up|2
1640054|NCT01765764|5731041|P2|Treatment Period|Lost to Follow-up|3
1640055|NCT01765764|5731042|P1|Treatment Period|Lost to Follow-up|0
1640056|NCT01765764|5731040|P3|Treatment Period|Adverse Event|1
1640057|NCT01765764|5731041|P2|Treatment Period|Adverse Event|2
1640058|NCT01765764|5731042|P1|Treatment Period|Adverse Event|1
1640059|NCT01765751|5731062|P3|Overall Study|Lost to Follow-up|1
1640060|NCT01765751|5731063|P2|Overall Study|Lost to Follow-up|2
1640061|NCT01765751|5731064|P1|Overall Study|Lost to Follow-up|0
1640062|NCT01765673|5731096|P1|Overall Study|No transportation for 2nd/3rd visits|1
1640063|NCT01765582|5731129|P3|Overall Study|Withdrawal of Consent|10
1640064|NCT01765582|5731130|P2|Overall Study|Withdrawal of Consent|6
1640065|NCT01765582|5731131|P1|Overall Study|Withdrawal of Consent|11
1640066|NCT01765582|5731129|P3|Overall Study|Sponsor Decision|42
1640067|NCT01765582|5731130|P2|Overall Study|Sponsor Decision|42
1640068|NCT01765582|5731131|P1|Overall Study|Sponsor Decision|46
1640069|NCT01765582|5731129|P3|Overall Study|Death|33
1640070|NCT01765582|5731130|P2|Overall Study|Death|36
1640071|NCT01765582|5731131|P1|Overall Study|Death|31
1640072|NCT01765582|5731129|P3|Overall Study|Lost to Follow-up|1
1640073|NCT01765582|5731130|P2|Overall Study|Lost to Follow-up|2
1640074|NCT01765582|5731131|P1|Overall Study|Lost to Follow-up|2
1640075|NCT01765582|5731129|P3|Overall Study|Other|9
1640076|NCT01765582|5731130|P2|Overall Study|Other|6
1640077|NCT01765582|5731131|P1|Overall Study|Other|3
1640078|NCT01765569|5731164|P1|Period C|Death|1
1640079|NCT01765569|5731164|P1|Period B|Withdrawal by Subject|1
1640080|NCT01765543|5731185|P1|Overall Study|Withdrawal by Subject|2
1640081|NCT01765543|5731185|P1|Overall Study|Death|1
1640082|NCT01765426|5731237|P4|Overall Study|Lost to Follow-up|0
1640083|NCT01765426|5731238|P3|Overall Study|Lost to Follow-up|0
1640084|NCT01765426|5731239|P2|Overall Study|Lost to Follow-up|1
1640085|NCT01765426|5731240|P1|Overall Study|Lost to Follow-up|0
1640086|NCT01765270|5731296|P2|Overall Study|Withdrawal by Subject|1
1640087|NCT01765270|5731297|P1|Overall Study|Withdrawal by Subject|0
1640088|NCT01765270|5731296|P2|Overall Study|Physician Decision|0
1640089|NCT01765270|5731297|P1|Overall Study|Physician Decision|1
1640090|NCT01765192|5731319|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
1640091|NCT01765192|5731320|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
1640092|NCT01765192|5731319|P2|Treatment Period 2|Reason not specified|2
1640093|NCT01765192|5731320|P1|Treatment Period 2|Reason not specified|0
1640094|NCT01765192|5731319|P2|Washout Period|Reason not specified|0
1640095|NCT01765192|5731320|P1|Washout Period|Reason not specified|1
1640096|NCT01765192|5731319|P2|Washout Period|Voluntary Withdrawal|1
1640097|NCT01765192|5731320|P1|Washout Period|Voluntary Withdrawal|1
1640098|NCT01765192|5731319|P2|Treatment Period 1|Adverse Event|1
1640099|NCT01765192|5731320|P1|Treatment Period 1|Adverse Event|0
1640100|NCT01765179|5731338|P1|Overall Study|Ca elevated 10.6|1
1640101|NCT01765179|5731338|P1|Overall Study|work conflict|1
1640102|NCT01765179|5731338|P1|Overall Study|lack of venous access|1
1640103|NCT01765179|5731338|P1|Overall Study|Out of country unable to finish study|1
1640104|NCT01765179|5731338|P1|Overall Study|prohibited med|1
1640105|NCT01765179|5731338|P1|Overall Study|Hematocrit >54%|3
1640106|NCT01765179|5731338|P1|Overall Study|Withdrawal by Subject|8
1640107|NCT01765179|5731338|P1|Overall Study|Protocol Violation|1
1640108|NCT01765179|5731338|P1|Overall Study|Non-compliance with study drug|2
1640109|NCT01765179|5731338|P1|Overall Study|Lost to Follow-up|5
1640110|NCT01765179|5731338|P1|Overall Study|Adverse Event|3
1640111|NCT01765153|5731345|P2|Rest Phase 2|Lost to Follow-up|1
1640112|NCT01765153|5731346|P1|Rest Phase 2|Lost to Follow-up|2
1640113|NCT01765153|5731345|P2|Training Phase 2|Withdrawal by Subject|1
1640114|NCT01765153|5731346|P1|Training Phase 2|Withdrawal by Subject|0
1640115|NCT01765153|5731345|P2|Rest Phase 1|Withdrawal by Subject|1
1640116|NCT01765153|5731346|P1|Rest Phase 1|Withdrawal by Subject|0
1640117|NCT01765153|5731345|P2|Training Phase 1|Poor participation in intervention|1
1640118|NCT01765153|5731346|P1|Training Phase 1|Poor participation in intervention|0
1640119|NCT01765153|5731345|P2|Training Phase 1|Format of intervention differed|0
1640120|NCT01765153|5731346|P1|Training Phase 1|Format of intervention differed|1
1640121|NCT01764997|5731453|P5|Study Drug Treatment Period|Other than specified above|10
1640122|NCT01764997|5731454|P4|Study Drug Treatment Period|Other than specified above|0
1640123|NCT01764997|5731455|P3|Study Drug Treatment Period|Other than specified above|0
1640124|NCT01764997|5731456|P2|Study Drug Treatment Period|Other than specified above|0
1640125|NCT01764997|5731457|P1|Study Drug Treatment Period|Other than specified above|0
1640126|NCT01764997|5731453|P5|Study Drug Treatment Period|Lack of Efficacy|2
1640127|NCT01764997|5731454|P4|Study Drug Treatment Period|Lack of Efficacy|0
1640128|NCT01764997|5731455|P3|Study Drug Treatment Period|Lack of Efficacy|0
1640129|NCT01764997|5731456|P2|Study Drug Treatment Period|Lack of Efficacy|0
1640130|NCT01764997|5731457|P1|Study Drug Treatment Period|Lack of Efficacy|0
1640131|NCT01764997|5731453|P5|Study Drug Treatment Period|Adverse Event|24
1640132|NCT01764997|5731454|P4|Study Drug Treatment Period|Adverse Event|0
1640133|NCT01764997|5731455|P3|Study Drug Treatment Period|Adverse Event|0
1640134|NCT01764997|5731456|P2|Study Drug Treatment Period|Adverse Event|1
1640135|NCT01764997|5731457|P1|Study Drug Treatment Period|Adverse Event|0
1640136|NCT01764997|5731453|P5|Run-in Period|Other than specified above|0
1640137|NCT01764997|5731454|P4|Run-in Period|Other than specified above|0
1640138|NCT01764997|5731455|P3|Run-in Period|Other than specified above|0
1640139|NCT01764997|5731456|P2|Run-in Period|Other than specified above|0
1640140|NCT01764997|5731457|P1|Run-in Period|Other than specified above|17
1640141|NCT01764997|5731453|P5|Run-in Period|Poor compliance to protocol|0
1640142|NCT01764997|5731454|P4|Run-in Period|Poor compliance to protocol|0
1640143|NCT01764997|5731455|P3|Run-in Period|Poor compliance to protocol|0
1640144|NCT01764997|5731456|P2|Run-in Period|Poor compliance to protocol|0
1640145|NCT01764997|5731457|P1|Run-in Period|Poor compliance to protocol|1
1640146|NCT01764997|5731453|P5|Run-in Period|Lack of Efficacy|0
1640147|NCT01764997|5731454|P4|Run-in Period|Lack of Efficacy|0
1640148|NCT01764997|5731455|P3|Run-in Period|Lack of Efficacy|0
1640149|NCT01764997|5731456|P2|Run-in Period|Lack of Efficacy|0
1640150|NCT01764997|5731457|P1|Run-in Period|Lack of Efficacy|5
1640151|NCT01764997|5731453|P5|Run-in Period|Adverse Event|0
1640152|NCT01764997|5731454|P4|Run-in Period|Adverse Event|0
1640153|NCT01764997|5731455|P3|Run-in Period|Adverse Event|0
1640154|NCT01764997|5731456|P2|Run-in Period|Adverse Event|0
1640155|NCT01764997|5731457|P1|Run-in Period|Adverse Event|15
1640156|NCT01764945|5731484|P8|Overall Study|Adverse Event|0
1640157|NCT01764945|5731485|P7|Overall Study|Adverse Event|1
1640158|NCT01764945|5731486|P6|Overall Study|Adverse Event|0
1640159|NCT01764945|5731487|P5|Overall Study|Adverse Event|0
1640160|NCT01764945|5731488|P4|Overall Study|Adverse Event|0
1640161|NCT01764945|5731489|P3|Overall Study|Adverse Event|0
1640162|NCT01764945|5731490|P2|Overall Study|Adverse Event|1
1640163|NCT01764945|5731491|P1|Overall Study|Adverse Event|0
1640164|NCT01764841|5731537|P4|Overall Study|Lost to Follow-up|0
1640165|NCT01764841|5731538|P3|Overall Study|Lost to Follow-up|1
1640166|NCT01764841|5731539|P2|Overall Study|Lost to Follow-up|0
1640167|NCT01764841|5731540|P1|Overall Study|Lost to Follow-up|3
1640168|NCT01764841|5731537|P4|Overall Study|Withdrawal by Subject|15
1640169|NCT01764841|5731538|P3|Overall Study|Withdrawal by Subject|11
1640170|NCT01764841|5731539|P2|Overall Study|Withdrawal by Subject|24
1640171|NCT01764841|5731540|P1|Overall Study|Withdrawal by Subject|16
1640172|NCT01764841|5731537|P4|Overall Study|Protocol Violation|0
1640173|NCT01764841|5731538|P3|Overall Study|Protocol Violation|0
1640174|NCT01764841|5731539|P2|Overall Study|Protocol Violation|1
1640175|NCT01764841|5731540|P1|Overall Study|Protocol Violation|0
1640176|NCT01764841|5731537|P4|Overall Study|No Follow Up|0
1640177|NCT01764841|5731538|P3|Overall Study|No Follow Up|1
1640178|NCT01764841|5731539|P2|Overall Study|No Follow Up|0
1640179|NCT01764841|5731540|P1|Overall Study|No Follow Up|1
1640180|NCT01764841|5731537|P4|Overall Study|Death|4
1640181|NCT01764841|5731538|P3|Overall Study|Death|1
1640182|NCT01764841|5731539|P2|Overall Study|Death|0
1640183|NCT01764841|5731540|P1|Overall Study|Death|3
1640184|NCT01764841|5731537|P4|Overall Study|Logistical Difficulties|0
1640185|NCT01764841|5731538|P3|Overall Study|Logistical Difficulties|0
1640186|NCT01764841|5731539|P2|Overall Study|Logistical Difficulties|1
1640187|NCT01764841|5731540|P1|Overall Study|Logistical Difficulties|0
1640188|NCT01764633|5731583|P2|Overall Study|Lost to Follow-up|5
1640189|NCT01764633|5731584|P1|Overall Study|Lost to Follow-up|13
1640190|NCT01764633|5731583|P2|Overall Study|Withdrawal by Subject|88
1640191|NCT01764633|5731584|P1|Overall Study|Withdrawal by Subject|105
1640192|NCT01764464|5731613|P2|Second Intervention (Cross-over)|Adverse Event|0
1640193|NCT01764464|5731614|P1|Second Intervention (Cross-over)|Adverse Event|2
1640194|NCT01764464|5731613|P2|First Intervention|did not receive study drug|1
1640195|NCT01764464|5731614|P1|First Intervention|did not receive study drug|0
1640196|NCT01764464|5731613|P2|First Intervention|Adverse Event|2
1640197|NCT01764464|5731614|P1|First Intervention|Adverse Event|0
1640198|NCT01764464|5731613|P2|First Intervention|Lost to Follow-up|0
1640199|NCT01764464|5731614|P1|First Intervention|Lost to Follow-up|1
1640200|NCT01764464|5731613|P2|First Intervention|Withdrawal by Subject|0
1640201|NCT01764464|5731614|P1|First Intervention|Withdrawal by Subject|1
1640202|NCT01764386|5731632|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1640203|NCT01764386|5731633|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
1640204|NCT01764386|5731632|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1640205|NCT01764386|5731633|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
1640206|NCT01764386|5731632|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
1640207|NCT01764386|5731633|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
1640208|NCT01764386|5731632|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
1640209|NCT01764386|5731633|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
1640210|NCT01764386|5731632|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
1640211|NCT01764386|5731633|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
1640212|NCT01764386|5731632|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
1640213|NCT01764386|5731633|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
1640214|NCT01764386|5731632|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
1640215|NCT01764386|5731633|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
1640216|NCT01764386|5731632|P2|Controlled Treatment Period (CTP)|Adverse Event|0
1640217|NCT01764386|5731633|P1|Controlled Treatment Period (CTP)|Adverse Event|35
1640218|NCT01764256|5731678|P4|Completed Study|Lost to Follow-up|1
1640219|NCT01764256|5731679|P3|Completed Study|Lost to Follow-up|0
1640220|NCT01764256|5731680|P2|Completed Study|Lost to Follow-up|0
1640221|NCT01764256|5731681|P1|Completed Study|Lost to Follow-up|0
1640222|NCT01764256|5731678|P4|Received All Vaccinations|Lost to Follow-up|0
1640223|NCT01764256|5731679|P3|Received All Vaccinations|Lost to Follow-up|0
1640224|NCT01764256|5731680|P2|Received All Vaccinations|Lost to Follow-up|0
1640225|NCT01764256|5731681|P1|Received All Vaccinations|Lost to Follow-up|1
1640226|NCT01764256|5731678|P4|Received All Vaccinations|Did not meet inclusion criteria|0
1640227|NCT01764256|5731679|P3|Received All Vaccinations|Did not meet inclusion criteria|1
1640228|NCT01764256|5731680|P2|Received All Vaccinations|Did not meet inclusion criteria|0
1640229|NCT01764256|5731681|P1|Received All Vaccinations|Did not meet inclusion criteria|0
1640230|NCT01764256|5731678|P4|Received All Vaccinations|Adverse Event|0
1640231|NCT01764256|5731679|P3|Received All Vaccinations|Adverse Event|0
1640232|NCT01764256|5731680|P2|Received All Vaccinations|Adverse Event|1
1640233|NCT01764256|5731681|P1|Received All Vaccinations|Adverse Event|1
1640234|NCT01764022|5731724|P2|Overall Study|Protocol Violation|0
1640235|NCT01764022|5731725|P1|Overall Study|Protocol Violation|1
1640236|NCT01764022|5731724|P2|Overall Study|Lost to Follow-up|0
1640237|NCT01764022|5731725|P1|Overall Study|Lost to Follow-up|2
1640238|NCT01764022|5731724|P2|Overall Study|Physician Decision|2
1640239|NCT01764022|5731725|P1|Overall Study|Physician Decision|0
1640240|NCT01764022|5731724|P2|Overall Study|Lack of Efficacy|1
1640241|NCT01764022|5731725|P1|Overall Study|Lack of Efficacy|0
1640242|NCT01764022|5731724|P2|Overall Study|Withdrawal by Subject|6
1640243|NCT01764022|5731725|P1|Overall Study|Withdrawal by Subject|2
1640244|NCT01764022|5731724|P2|Overall Study|Death|5
1640245|NCT01764022|5731725|P1|Overall Study|Death|3
1640246|NCT01763996|5731757|P2|Treatment Period 2|Adverse Event|1
1640247|NCT01763996|5731758|P1|Treatment Period 2|Adverse Event|0
1640248|NCT01763918|5731799|P4|Overall Study|Sponsor Decision|0
1640249|NCT01763918|5731800|P3|Overall Study|Sponsor Decision|9
1640250|NCT01763918|5731801|P2|Overall Study|Sponsor Decision|0
1640251|NCT01763918|5731802|P1|Overall Study|Sponsor Decision|4
1640252|NCT01763918|5731799|P4|Overall Study|Withdrawal by Subject|2
1640253|NCT01763918|5731800|P3|Overall Study|Withdrawal by Subject|1
1640254|NCT01763918|5731801|P2|Overall Study|Withdrawal by Subject|1
1640255|NCT01763918|5731802|P1|Overall Study|Withdrawal by Subject|2
1640256|NCT01763905|5731900|P4|Overall Study|Lost to Follow-up|0
1640257|NCT01763905|5731901|P3|Overall Study|Lost to Follow-up|1
1640258|NCT01763905|5731902|P2|Overall Study|Lost to Follow-up|0
1640259|NCT01763905|5731903|P1|Overall Study|Lost to Follow-up|0
1640260|NCT01763905|5731900|P4|Overall Study|Decision by sponsor|0
1640261|NCT01763905|5731901|P3|Overall Study|Decision by sponsor|8
1640262|NCT01763905|5731902|P2|Overall Study|Decision by sponsor|0
1640263|NCT01763905|5731903|P1|Overall Study|Decision by sponsor|5
1640264|NCT01763905|5731900|P4|Overall Study|Withdrawal by Subject|1
1640265|NCT01763905|5731901|P3|Overall Study|Withdrawal by Subject|0
1640266|NCT01763905|5731902|P2|Overall Study|Withdrawal by Subject|1
1640267|NCT01763905|5731903|P1|Overall Study|Withdrawal by Subject|1
1640268|NCT01763866|5732021|P24|Overall Study|Death|0
1640269|NCT01763866|5732022|P23|Overall Study|Death|0
1640270|NCT01763866|5732023|P22|Overall Study|Death|0
1640271|NCT01763866|5732024|P21|Overall Study|Death|0
1640272|NCT01763866|5732025|P20|Overall Study|Death|0
1640273|NCT01763866|5732026|P19|Overall Study|Death|0
1640274|NCT01763866|5732027|P18|Overall Study|Death|0
1640275|NCT01763866|5732028|P17|Overall Study|Death|1
1640276|NCT01763866|5732029|P16|Overall Study|Death|0
1640277|NCT01763866|5732030|P15|Overall Study|Death|0
1640278|NCT01763866|5732031|P14|Overall Study|Death|0
1640279|NCT01763866|5732032|P13|Overall Study|Death|0
1640280|NCT01763866|5732033|P12|Overall Study|Death|0
1640281|NCT01763866|5732034|P11|Overall Study|Death|0
1640282|NCT01763866|5732035|P10|Overall Study|Death|0
1640283|NCT01763866|5732036|P9|Overall Study|Death|0
1640284|NCT01763866|5732037|P8|Overall Study|Death|0
1640285|NCT01763866|5732038|P7|Overall Study|Death|0
1640286|NCT01763866|5732039|P6|Overall Study|Death|0
1640287|NCT01763866|5732040|P5|Overall Study|Death|0
1640288|NCT01763866|5732041|P4|Overall Study|Death|0
1640289|NCT01763866|5732042|P3|Overall Study|Death|0
1640290|NCT01763866|5732043|P2|Overall Study|Death|0
1640291|NCT01763866|5732044|P1|Overall Study|Death|0
1640292|NCT01763866|5732021|P24|Overall Study|Lost to Follow-up|1
1640293|NCT01763866|5732022|P23|Overall Study|Lost to Follow-up|0
1640294|NCT01763866|5732023|P22|Overall Study|Lost to Follow-up|0
1640295|NCT01763866|5732024|P21|Overall Study|Lost to Follow-up|0
1640296|NCT01763866|5732025|P20|Overall Study|Lost to Follow-up|1
1640297|NCT01763866|5732026|P19|Overall Study|Lost to Follow-up|1
1640298|NCT01763866|5732027|P18|Overall Study|Lost to Follow-up|0
1640299|NCT01763866|5732028|P17|Overall Study|Lost to Follow-up|0
1640300|NCT01763866|5732029|P16|Overall Study|Lost to Follow-up|0
1640301|NCT01763866|5732030|P15|Overall Study|Lost to Follow-up|1
1640302|NCT01763866|5732031|P14|Overall Study|Lost to Follow-up|0
1640303|NCT01763866|5732032|P13|Overall Study|Lost to Follow-up|1
1640304|NCT01763866|5732033|P12|Overall Study|Lost to Follow-up|0
1640305|NCT01763866|5732034|P11|Overall Study|Lost to Follow-up|0
1640306|NCT01763866|5732035|P10|Overall Study|Lost to Follow-up|0
1640307|NCT01763866|5732036|P9|Overall Study|Lost to Follow-up|0
1640308|NCT01763866|5732037|P8|Overall Study|Lost to Follow-up|0
1640309|NCT01763866|5732038|P7|Overall Study|Lost to Follow-up|1
1640310|NCT01763866|5732039|P6|Overall Study|Lost to Follow-up|0
1640311|NCT01763866|5732040|P5|Overall Study|Lost to Follow-up|0
1640312|NCT01763866|5732041|P4|Overall Study|Lost to Follow-up|0
1640313|NCT01763866|5732042|P3|Overall Study|Lost to Follow-up|0
1640314|NCT01763866|5732043|P2|Overall Study|Lost to Follow-up|0
1640315|NCT01763866|5732044|P1|Overall Study|Lost to Follow-up|0
1640316|NCT01763866|5732021|P24|Overall Study|Decision by sponsor|0
1640317|NCT01763866|5732022|P23|Overall Study|Decision by sponsor|1
1640318|NCT01763866|5732023|P22|Overall Study|Decision by sponsor|0
1640319|NCT01763866|5732024|P21|Overall Study|Decision by sponsor|2
1640320|NCT01763866|5732025|P20|Overall Study|Decision by sponsor|0
1640321|NCT01763866|5732026|P19|Overall Study|Decision by sponsor|4
1640322|NCT01763866|5732027|P18|Overall Study|Decision by sponsor|0
1640323|NCT01763866|5732028|P17|Overall Study|Decision by sponsor|0
1640324|NCT01763866|5732029|P16|Overall Study|Decision by sponsor|0
1640325|NCT01763866|5732030|P15|Overall Study|Decision by sponsor|5
1640326|NCT01763866|5732031|P14|Overall Study|Decision by sponsor|0
1640327|NCT01763866|5732032|P13|Overall Study|Decision by sponsor|1
1640328|NCT01763866|5732033|P12|Overall Study|Decision by sponsor|0
1640329|NCT01763866|5732034|P11|Overall Study|Decision by sponsor|6
1640330|NCT01763866|5732035|P10|Overall Study|Decision by sponsor|0
1640331|NCT01763866|5732036|P9|Overall Study|Decision by sponsor|2
1640332|NCT01763866|5732037|P8|Overall Study|Decision by sponsor|0
1640333|NCT01763866|5732038|P7|Overall Study|Decision by sponsor|2
1640334|NCT01763866|5732039|P6|Overall Study|Decision by sponsor|0
1640335|NCT01763866|5732040|P5|Overall Study|Decision by sponsor|2
1640336|NCT01763866|5732041|P4|Overall Study|Decision by sponsor|0
1640337|NCT01763866|5732042|P3|Overall Study|Decision by sponsor|1
1640338|NCT01763866|5732043|P2|Overall Study|Decision by sponsor|0
1640339|NCT01763866|5732044|P1|Overall Study|Decision by sponsor|0
1640340|NCT01763866|5732021|P24|Overall Study|Withdrawal by Subject|1
1640341|NCT01763866|5732022|P23|Overall Study|Withdrawal by Subject|2
1640342|NCT01763866|5732023|P22|Overall Study|Withdrawal by Subject|1
1640343|NCT01763866|5732024|P21|Overall Study|Withdrawal by Subject|2
1640344|NCT01763866|5732025|P20|Overall Study|Withdrawal by Subject|1
1640345|NCT01763866|5732026|P19|Overall Study|Withdrawal by Subject|1
1640346|NCT01763866|5732027|P18|Overall Study|Withdrawal by Subject|1
1640347|NCT01763866|5732028|P17|Overall Study|Withdrawal by Subject|0
1640348|NCT01763866|5732029|P16|Overall Study|Withdrawal by Subject|3
1640349|NCT01763866|5732030|P15|Overall Study|Withdrawal by Subject|6
1640350|NCT01763866|5732031|P14|Overall Study|Withdrawal by Subject|0
1640351|NCT01763866|5732032|P13|Overall Study|Withdrawal by Subject|2
1640352|NCT01763866|5732033|P12|Overall Study|Withdrawal by Subject|2
1640353|NCT01763866|5732034|P11|Overall Study|Withdrawal by Subject|2
1640354|NCT01763866|5732035|P10|Overall Study|Withdrawal by Subject|1
1640355|NCT01763866|5732036|P9|Overall Study|Withdrawal by Subject|1
1640356|NCT01763866|5732037|P8|Overall Study|Withdrawal by Subject|0
1640357|NCT01763866|5732038|P7|Overall Study|Withdrawal by Subject|4
1640358|NCT01763866|5732039|P6|Overall Study|Withdrawal by Subject|3
1640359|NCT01763866|5732040|P5|Overall Study|Withdrawal by Subject|0
1640360|NCT01763866|5732041|P4|Overall Study|Withdrawal by Subject|0
1640361|NCT01763866|5732042|P3|Overall Study|Withdrawal by Subject|4
1640362|NCT01763866|5732043|P2|Overall Study|Withdrawal by Subject|1
1640363|NCT01763866|5732044|P1|Overall Study|Withdrawal by Subject|2
1640364|NCT01763827|5732604|P6|Overall Study|Lost to Follow-up|1
1640365|NCT01763827|5732605|P5|Overall Study|Lost to Follow-up|2
1640366|NCT01763827|5732606|P4|Overall Study|Lost to Follow-up|1
1640367|NCT01763827|5732607|P3|Overall Study|Lost to Follow-up|1
1640368|NCT01763827|5732608|P2|Overall Study|Lost to Follow-up|1
1640369|NCT01763827|5732609|P1|Overall Study|Lost to Follow-up|0
1640370|NCT01763827|5732604|P6|Overall Study|Decision by sponsor|1
1640371|NCT01763827|5732605|P5|Overall Study|Decision by sponsor|2
1640372|NCT01763827|5732606|P4|Overall Study|Decision by sponsor|0
1640373|NCT01763827|5732607|P3|Overall Study|Decision by sponsor|3
1640374|NCT01763827|5732608|P2|Overall Study|Decision by sponsor|0
1640375|NCT01763827|5732609|P1|Overall Study|Decision by sponsor|2
1640376|NCT01763827|5732604|P6|Overall Study|Withdrawal by Subject|0
1640377|NCT01763827|5732605|P5|Overall Study|Withdrawal by Subject|2
1640378|NCT01763827|5732606|P4|Overall Study|Withdrawal by Subject|0
1640379|NCT01763827|5732607|P3|Overall Study|Withdrawal by Subject|0
1640380|NCT01763827|5732608|P2|Overall Study|Withdrawal by Subject|0
1640381|NCT01763827|5732609|P1|Overall Study|Withdrawal by Subject|1
1640382|NCT01763788|5732753|P4|Overall Study|Lost to Follow-up|0
1640383|NCT01763788|5732754|P3|Overall Study|Lost to Follow-up|1
1640384|NCT01763788|5732755|P2|Overall Study|Lost to Follow-up|0
1640385|NCT01763788|5732756|P1|Overall Study|Lost to Follow-up|0
1640386|NCT01763203|5732965|P2|Overall Study|Physician Decision|1
1640387|NCT01763203|5732966|P1|Overall Study|Physician Decision|2
1640388|NCT01763203|5732965|P2|Overall Study|Moved out of study region|10
1640389|NCT01763203|5732966|P1|Overall Study|Moved out of study region|7
1640390|NCT01763203|5732965|P2|Overall Study|Withdrawal by Subject|12
1640391|NCT01763203|5732966|P1|Overall Study|Withdrawal by Subject|8
1640392|NCT01763203|5732965|P2|Overall Study|Lost to Follow-up|12
1640393|NCT01763203|5732966|P1|Overall Study|Lost to Follow-up|12
1640394|NCT01763203|5732965|P2|Overall Study|Death|7
1640395|NCT01763203|5732966|P1|Overall Study|Death|4
1640396|NCT01763047|5733012|P2|Period 2|Unsatisfactory lens Fitting|1
1640397|NCT01763047|5733013|P1|Period 2|Unsatisfactory lens Fitting|0
1640398|NCT01763047|5733012|P2|Period 2|Protocol Violation|2
1640399|NCT01763047|5733013|P1|Period 2|Protocol Violation|0
1640400|NCT01763047|5733012|P2|Period 2|Unsatisfactory Visual Response|1
1640401|NCT01763047|5733013|P1|Period 2|Unsatisfactory Visual Response|1
1640402|NCT01763047|5733012|P2|Period 2|Study Site office Closed|1
1640403|NCT01763047|5733013|P1|Period 2|Study Site office Closed|1
1640404|NCT01763047|5733012|P2|Period 2|No longer meets Eligibility Criteria|0
1640405|NCT01763047|5733013|P1|Period 2|No longer meets Eligibility Criteria|1
1640406|NCT01763047|5733012|P2|Period 2|Lens Discomfort|0
1640407|NCT01763047|5733013|P1|Period 2|Lens Discomfort|1
1640408|NCT01763047|5733012|P2|Period 1|Study Site office Closed|1
1640409|NCT01763047|5733013|P1|Period 1|Study Site office Closed|0
1640410|NCT01763047|5733012|P2|Period 1|Lens Power Not Available|1
1640411|NCT01763047|5733013|P1|Period 1|Lens Power Not Available|0
1640412|NCT01763047|5733012|P2|Period 1|Unsatisfactory Visual Response|3
1640413|NCT01763047|5733013|P1|Period 1|Unsatisfactory Visual Response|0
1640414|NCT01763047|5733012|P2|Period 1|Adverse Event|1
1640415|NCT01763047|5733013|P1|Period 1|Adverse Event|0
1640416|NCT01763047|5733012|P2|Period 1|No Longer Meets Eligibility criteria|0
1640417|NCT01763047|5733013|P1|Period 1|No Longer Meets Eligibility criteria|1
1640418|NCT01763047|5733012|P2|Period 1|Protocol Violation|4
1640419|NCT01763047|5733013|P1|Period 1|Protocol Violation|4
1640420|NCT01763047|5733012|P2|Period 1|Test Article Not Available|1
1640421|NCT01763047|5733013|P1|Period 1|Test Article Not Available|4
1640422|NCT01762943|5733052|P2|Overall Study|Withdrawal by Subject|1
1640423|NCT01762943|5733053|P1|Overall Study|Withdrawal by Subject|2
1640424|NCT01762943|5733052|P2|Overall Study|Protocol Violation|0
1640425|NCT01762943|5733053|P1|Overall Study|Protocol Violation|1
1640426|NCT01762943|5733052|P2|Overall Study|Physician Decision|1
1640427|NCT01762943|5733053|P1|Overall Study|Physician Decision|1
1640428|NCT01762800|5733070|P2|Overall Study|Withdrawal by Subject|4
1640429|NCT01762800|5733071|P1|Overall Study|Withdrawal by Subject|7
1640430|NCT01762800|5733070|P2|Overall Study|Physician Decision|1
1640431|NCT01762800|5733071|P1|Overall Study|Physician Decision|1
1640432|NCT01762800|5733070|P2|Overall Study|Study Closed/Terminated|1
1640433|NCT01762800|5733071|P1|Overall Study|Study Closed/Terminated|0
1640434|NCT01762800|5733070|P2|Overall Study|Lack of Efficacy|2
1640435|NCT01762800|5733071|P1|Overall Study|Lack of Efficacy|3
1640436|NCT01762800|5733070|P2|Overall Study|Adverse Event|13
1640437|NCT01762800|5733071|P1|Overall Study|Adverse Event|8
1640438|NCT01762761|5733145|P2|Overall Study|Withdrawal by Subject|8
1640439|NCT01762761|5733146|P1|Overall Study|Withdrawal by Subject|7
1640440|NCT01762761|5733145|P2|Overall Study|Physician Decision|6
1640441|NCT01762761|5733146|P1|Overall Study|Physician Decision|4
1640442|NCT01762761|5733145|P2|Overall Study|Lost to Follow-up|6
1640443|NCT01762761|5733146|P1|Overall Study|Lost to Follow-up|3
1640444|NCT01762761|5733145|P2|Overall Study|Study closed/terminated|2
1640445|NCT01762761|5733146|P1|Overall Study|Study closed/terminated|0
1640446|NCT01762761|5733145|P2|Overall Study|Protocol Violation|1
1640447|NCT01762761|5733146|P1|Overall Study|Protocol Violation|1
1640448|NCT01762761|5733145|P2|Overall Study|Lack of Efficacy|25
1640449|NCT01762761|5733146|P1|Overall Study|Lack of Efficacy|9
1640450|NCT01762761|5733145|P2|Overall Study|Adverse Event|17
1640451|NCT01762761|5733146|P1|Overall Study|Adverse Event|15
1640452|NCT01762345|5733245|P1|Overall Study|Protocol Violation|2
1640453|NCT01762345|5733245|P1|Overall Study|Adverse Event|5
1640454|NCT01761565|5733293|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
1640455|NCT01761266|5733317|P2|Overall Study|Ongoing as of data-cut off|107
1640456|NCT01761266|5733318|P1|Overall Study|Ongoing as of data-cut off|109
1640457|NCT01761266|5733317|P2|Overall Study|Withdrawal by Subject|8
1640458|NCT01761266|5733318|P1|Overall Study|Withdrawal by Subject|13
1640459|NCT01761266|5733317|P2|Overall Study|Lost to Follow-up|11
1640460|NCT01761266|5733318|P1|Overall Study|Lost to Follow-up|5
1640461|NCT01761266|5733317|P2|Overall Study|Death|350
1640462|NCT01761266|5733318|P1|Overall Study|Death|351
1640463|NCT01761162|5733375|P1|Overall Study|Withdrawal by Subject|3
1640464|NCT01760954|5733464|P4|Post-treatment Follow-up (12 Months)|Other|6
1640465|NCT01760954|5733465|P3|Post-treatment Follow-up (12 Months)|Other|9
1640466|NCT01760954|5733466|P2|Post-treatment Follow-up (12 Months)|Other|8
1640467|NCT01760954|5733467|P1|Post-treatment Follow-up (12 Months)|Other|13
1640468|NCT01760954|5733464|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1640469|NCT01760954|5733465|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
1640470|NCT01760954|5733466|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1640471|NCT01760954|5733467|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
1640472|NCT01760954|5733464|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
1640473|NCT01760954|5733465|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
1640474|NCT01760954|5733466|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
1640475|NCT01760954|5733467|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
1640476|NCT01760954|5733464|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
1640477|NCT01760954|5733465|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
1640478|NCT01760954|5733466|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
1640479|NCT01760954|5733467|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
1640480|NCT01760954|5733464|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
1640481|NCT01760954|5733465|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
1640482|NCT01760954|5733466|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
1640483|NCT01760954|5733467|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
1640484|NCT01760954|5733464|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
1640485|NCT01760954|5733465|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
1640486|NCT01760954|5733466|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1640487|NCT01760954|5733467|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
1640488|NCT01760954|5733464|P4|Treatment Period (6 Months)|Exclusionary Medication|0
1640489|NCT01760954|5733465|P3|Treatment Period (6 Months)|Exclusionary Medication|0
1640490|NCT01760954|5733466|P2|Treatment Period (6 Months)|Exclusionary Medication|0
1640491|NCT01760954|5733467|P1|Treatment Period (6 Months)|Exclusionary Medication|1
1640492|NCT01760954|5733464|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
1640493|NCT01760954|5733465|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
1640494|NCT01760954|5733466|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
1640495|NCT01760954|5733467|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
1640496|NCT01760954|5733464|P4|Treatment Period (6 Months)|Other|1
1640497|NCT01760954|5733465|P3|Treatment Period (6 Months)|Other|3
1640498|NCT01760954|5733466|P2|Treatment Period (6 Months)|Other|3
1640499|NCT01760954|5733467|P1|Treatment Period (6 Months)|Other|0
1640500|NCT01760954|5733464|P4|Treatment Period (6 Months)|Non-compliance|3
1640501|NCT01760954|5733465|P3|Treatment Period (6 Months)|Non-compliance|0
1640502|NCT01760954|5733466|P2|Treatment Period (6 Months)|Non-compliance|4
1640503|NCT01760954|5733467|P1|Treatment Period (6 Months)|Non-compliance|1
1640504|NCT01760954|5733464|P4|Treatment Period (6 Months)|Pregnancy|2
1640505|NCT01760954|5733465|P3|Treatment Period (6 Months)|Pregnancy|3
1640506|NCT01760954|5733466|P2|Treatment Period (6 Months)|Pregnancy|0
1640507|NCT01760954|5733467|P1|Treatment Period (6 Months)|Pregnancy|5
1640508|NCT01760954|5733464|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
1640509|NCT01760954|5733465|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1640510|NCT01760954|5733466|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1640511|NCT01760954|5733467|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
1640512|NCT01760954|5733464|P4|Treatment Period (6 Months)|Lost to Follow-up|3
1640513|NCT01760954|5733465|P3|Treatment Period (6 Months)|Lost to Follow-up|4
1640514|NCT01760954|5733466|P2|Treatment Period (6 Months)|Lost to Follow-up|1
1640515|NCT01760954|5733467|P1|Treatment Period (6 Months)|Lost to Follow-up|9
1640516|NCT01760954|5733464|P4|Treatment Period (6 Months)|Adverse Event|10
1640517|NCT01760954|5733465|P3|Treatment Period (6 Months)|Adverse Event|4
1640518|NCT01760954|5733466|P2|Treatment Period (6 Months)|Adverse Event|3
1640519|NCT01760954|5733467|P1|Treatment Period (6 Months)|Adverse Event|5
1640520|NCT01760954|5733464|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
1640521|NCT01760954|5733465|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
1640522|NCT01760954|5733466|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
1640523|NCT01760954|5733467|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
1640524|NCT01760876|5733604|P1|Overall Study|Very poor baseline OCT quality|2
1640525|NCT01760876|5733604|P1|Overall Study|Major depression|1
1640526|NCT01760876|5733604|P1|Overall Study|Impaired renal function|1
1640527|NCT01760876|5733604|P1|Overall Study|Carcinoma of prostate|1
1640528|NCT01760876|5733604|P1|Overall Study|Non-cardiac death (head injury)|1
1640529|NCT01759862|5733910|P2|Overall Study|Adverse Event|1
1640530|NCT01759862|5733911|P1|Overall Study|Adverse Event|0
1640531|NCT01759862|5733910|P2|Overall Study|Physician Decision|1
1640532|NCT01759862|5733911|P1|Overall Study|Physician Decision|3
1640533|NCT01759511|5733929|P1|Overall Study|Withdrawal by Subject|3
1640534|NCT01759511|5733929|P1|Overall Study|Study Terminated by Sponsor|13
1640535|NCT01759511|5733929|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
1640536|NCT01759511|5733929|P1|Overall Study|Progressive Disease|5
1640537|NCT01759511|5733929|P1|Overall Study|Physician Decision|1
1640538|NCT01759511|5733929|P1|Overall Study|Lack of Efficacy|2
1640539|NCT01759511|5733929|P1|Overall Study|Death|2
1640540|NCT01759511|5733929|P1|Overall Study|Adverse Event|4
1640541|NCT01759446|5733942|P5|Overall Study|Withdrawal by Subject|0
1640542|NCT01759446|5733943|P4|Overall Study|Withdrawal by Subject|1
1640543|NCT01759446|5733944|P3|Overall Study|Withdrawal by Subject|0
1640544|NCT01759446|5733945|P2|Overall Study|Withdrawal by Subject|1
1640545|NCT01759446|5733946|P1|Overall Study|Withdrawal by Subject|0
1640546|NCT01759446|5733942|P5|Overall Study|Protocol Violation|0
1640547|NCT01759446|5733943|P4|Overall Study|Protocol Violation|0
1640548|NCT01759446|5733944|P3|Overall Study|Protocol Violation|1
1640549|NCT01759446|5733945|P2|Overall Study|Protocol Violation|0
1640550|NCT01759446|5733946|P1|Overall Study|Protocol Violation|1
1640551|NCT01759420|5733958|P1|Overall Study|Inaccurate EKG machine readings|1
1640552|NCT01759420|5733958|P1|Overall Study|Screen failure|5
1640553|NCT01759407|5733965|P2|Overall Study|Protocol Violation|2
1640554|NCT01759407|5733966|P1|Overall Study|Protocol Violation|0
1640555|NCT01759381|5733978|P2|Overall Study|Death|0
1640556|NCT01759381|5733979|P1|Overall Study|Death|1
1640557|NCT01759368|5733987|P2|Overall Study|Lost to Follow-up|0
1640558|NCT01759368|5733988|P1|Overall Study|Lost to Follow-up|1
1640559|NCT01759290|5734006|P1|Overall Study|Unknown reason|4
1640560|NCT01759290|5734006|P1|Overall Study|Lost to Follow-up|53
1640561|NCT01759290|5734006|P1|Overall Study|Death|17
1640562|NCT01759290|5734006|P1|Overall Study|Physician Decision|2
1640563|NCT01759290|5734006|P1|Overall Study|Subjects withdrawn consent|5
1640564|NCT01759264|5734075|P1|Overall Study|Discontinued Humira Due to Business Trip|1
1640565|NCT01759264|5734075|P1|Overall Study|Withdrawal by Subject|3
1640566|NCT01759264|5734075|P1|Overall Study|Lost to Follow-up|2
1640567|NCT01759264|5734075|P1|Overall Study|Other|2
1640568|NCT01759264|5734075|P1|Overall Study|Adverse Event|1
1640569|NCT01759264|5734075|P1|Overall Study|Serious Adverse Events (SAEs)|1
1640570|NCT01758900|5734103|P2|Overall Study|difficulty for further intubation|8
1640571|NCT01758900|5734104|P1|Overall Study|difficulty for further intubation|7
1640572|NCT01758731|5734122|P1|Overall Study|Physician Decision|1
1640573|NCT01758523|5734141|P2|Overall Study|Withdrawal by Subject|7
1640574|NCT01758523|5734142|P1|Overall Study|Withdrawal by Subject|12
1640575|NCT01758523|5734141|P2|Overall Study|Lost to Follow-up|4
1640576|NCT01758523|5734142|P1|Overall Study|Lost to Follow-up|3
1640577|NCT01758523|5734141|P2|Overall Study|Lack of Efficacy|2
1640578|NCT01758523|5734142|P1|Overall Study|Lack of Efficacy|4
1640579|NCT01758523|5734141|P2|Overall Study|Adverse Event|1
1640580|NCT01758523|5734142|P1|Overall Study|Adverse Event|2
1640581|NCT01758289|5734245|P1|Overall Study|Adverse Event|9
1640582|NCT01758289|5734245|P1|Overall Study|Premature Study Termination|44
1640583|NCT01757847|5734271|P2|Overall Study|Withdrawal by Subject|4
1640584|NCT01757847|5734272|P1|Overall Study|Withdrawal by Subject|3
1640585|NCT01757821|5734280|P1|Overall Study|Adverse Event|1
1640586|NCT01757704|5734295|P2|Overall Study|Protocol Violation|3
1640587|NCT01757704|5734296|P1|Overall Study|Protocol Violation|1
1640588|NCT01757691|5734314|P2|Overall Study|Administrative problems|0
1640589|NCT01757691|5734315|P1|Overall Study|Administrative problems|2
1640590|NCT01757665|5734342|P2|Overall Study|Not Implanted with Device|1
1640591|NCT01757665|5734343|P1|Overall Study|Not Implanted with Device|5
1640592|NCT01757665|5734342|P2|Overall Study|Lost to Follow-up|1
1640593|NCT01757665|5734343|P1|Overall Study|Lost to Follow-up|1
1640594|NCT01757665|5734342|P2|Overall Study|Withdrawal by Subject|0
1640595|NCT01757665|5734343|P1|Overall Study|Withdrawal by Subject|10
1640596|NCT01757665|5734342|P2|Overall Study|Explant|2
1640597|NCT01757665|5734343|P1|Overall Study|Explant|1
1640598|NCT01757665|5734342|P2|Overall Study|Death|8
1640599|NCT01757665|5734343|P1|Overall Study|Death|25
1640600|NCT01757665|5734342|P2|Overall Study|Still on Study - Missed Visit|1
1640601|NCT01757665|5734343|P1|Overall Study|Still on Study - Missed Visit|14
1640602|NCT01757665|5734342|P2|Overall Study|Still on Study - Visit Pending|40
1640603|NCT01757665|5734343|P1|Overall Study|Still on Study - Visit Pending|398
1640604|NCT01757665|5734342|P2|Overall Study|Still on Study - Visit Completed|30
1640605|NCT01757665|5734343|P1|Overall Study|Still on Study - Visit Completed|240
1640606|NCT01757405|5734515|P2|Overall Study|Withdrawal by Subject|1
1640607|NCT01757405|5734516|P1|Overall Study|Withdrawal by Subject|0
1640608|NCT01757405|5734515|P2|Overall Study|Lost to Follow-up|1
1640609|NCT01757405|5734516|P1|Overall Study|Lost to Follow-up|1
1640610|NCT01757275|5734551|P2|Overall Study|Not treated|4
1640611|NCT01757275|5734552|P1|Overall Study|Not treated|3
1640612|NCT01757275|5734551|P2|Overall Study|Withdrawal by Subject|4
1640613|NCT01757275|5734552|P1|Overall Study|Withdrawal by Subject|2
1640614|NCT01757275|5734551|P2|Overall Study|Adverse Event|3
1640615|NCT01757275|5734552|P1|Overall Study|Adverse Event|3
1640616|NCT01757275|5734551|P2|Overall Study|Lost to Follow-up|2
1640617|NCT01757275|5734552|P1|Overall Study|Lost to Follow-up|1
1640618|NCT01757197|5734574|P1|Overall Study|Death|2
1640619|NCT01757184|5734583|P4|Open-label Period|Discontinued by Sponsor|2
1640620|NCT01757184|5734584|P3|Open-label Period|Discontinued by Sponsor|1
1640621|NCT01757184|5734585|P2|Open-label Period|Discontinued by Sponsor|0
1640622|NCT01757184|5734586|P1|Open-label Period|Discontinued by Sponsor|0
1640623|NCT01757184|5734583|P4|Open-label Period|Withdrawal by Subject|1
1640624|NCT01757184|5734584|P3|Open-label Period|Withdrawal by Subject|1
1640625|NCT01757184|5734585|P2|Open-label Period|Withdrawal by Subject|0
1640626|NCT01757184|5734586|P1|Open-label Period|Withdrawal by Subject|0
1640627|NCT01757184|5734583|P4|Open-label Period|Lost to Follow-up|0
1640628|NCT01757184|5734584|P3|Open-label Period|Lost to Follow-up|2
1640629|NCT01757184|5734585|P2|Open-label Period|Lost to Follow-up|0
1640630|NCT01757184|5734586|P1|Open-label Period|Lost to Follow-up|0
1640631|NCT01757184|5734583|P4|Double-blind Period|Adverse Event|0
1640632|NCT01757184|5734584|P3|Double-blind Period|Adverse Event|0
1640633|NCT01757184|5734585|P2|Double-blind Period|Adverse Event|0
1640634|NCT01757184|5734586|P1|Double-blind Period|Adverse Event|1
1640635|NCT01757171|5734630|P2|Overall Study|ECOG decline|0
1640636|NCT01757171|5734631|P1|Overall Study|ECOG decline|1
1640637|NCT01757171|5734630|P2|Overall Study|Hospitalization|0
1640638|NCT01757171|5734631|P1|Overall Study|Hospitalization|1
1640639|NCT01757171|5734630|P2|Overall Study|Disease Progression|0
1640640|NCT01757171|5734631|P1|Overall Study|Disease Progression|1
1640641|NCT01757171|5734630|P2|Overall Study|Adverse Event|1
1640642|NCT01757171|5734631|P1|Overall Study|Adverse Event|5
1640643|NCT01756846|5734667|P2|Overall Study|Withdrawal by Subject|2
1640644|NCT01756846|5734668|P1|Overall Study|Withdrawal by Subject|1
1640645|NCT01756846|5734667|P2|Overall Study|Lost to Follow-up|10
1640646|NCT01756846|5734668|P1|Overall Study|Lost to Follow-up|5
1640647|NCT01756456|5734713|P6|Follow Up Period Phase I/II|Other causes|5
1640648|NCT01756456|5734714|P5|Follow Up Period Phase I/II|Other causes|3
1640649|NCT01756456|5734715|P4|Follow Up Period Phase I/II|Other causes|1
1640650|NCT01756456|5734716|P3|Follow Up Period Phase I/II|Other causes|0
1640651|NCT01756456|5734717|P2|Follow Up Period Phase I/II|Other causes|0
1640652|NCT01756456|5734718|P1|Follow Up Period Phase I/II|Other causes|0
1640653|NCT01756456|5734713|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
1640654|NCT01756456|5734714|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
1640655|NCT01756456|5734715|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
1640656|NCT01756456|5734716|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
1640657|NCT01756456|5734717|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
1640658|NCT01756456|5734718|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
1640659|NCT01756456|5734713|P6|Follow Up Period Phase I/II|Adverse Event|1
1640660|NCT01756456|5734714|P5|Follow Up Period Phase I/II|Adverse Event|0
1640661|NCT01756456|5734715|P4|Follow Up Period Phase I/II|Adverse Event|5
1640662|NCT01756456|5734716|P3|Follow Up Period Phase I/II|Adverse Event|0
1640663|NCT01756456|5734717|P2|Follow Up Period Phase I/II|Adverse Event|0
1640664|NCT01756456|5734718|P1|Follow Up Period Phase I/II|Adverse Event|1
1640665|NCT01756456|5734713|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
1640666|NCT01756456|5734714|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
1640667|NCT01756456|5734715|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
1640668|NCT01756456|5734716|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
1640669|NCT01756456|5734717|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
1640670|NCT01756456|5734718|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
1640671|NCT01756456|5734713|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1640672|NCT01756456|5734714|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1640673|NCT01756456|5734715|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1640674|NCT01756456|5734716|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1640675|NCT01756456|5734717|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
1640676|NCT01756456|5734718|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
1640677|NCT01756456|5734713|P6|Follow Up Period Phase I/II|still in study after week 20|25
1640678|NCT01756456|5734714|P5|Follow Up Period Phase I/II|still in study after week 20|23
1640679|NCT01756456|5734715|P4|Follow Up Period Phase I/II|still in study after week 20|25
1640680|NCT01756456|5734716|P3|Follow Up Period Phase I/II|still in study after week 20|0
1640681|NCT01756456|5734717|P2|Follow Up Period Phase I/II|still in study after week 20|0
1640682|NCT01756456|5734718|P1|Follow Up Period Phase I/II|still in study after week 20|0
1640683|NCT01756456|5734713|P6|Treatment Period: Phase I/II|Other causes|2
1640684|NCT01756456|5734714|P5|Treatment Period: Phase I/II|Other causes|2
1640685|NCT01756456|5734715|P4|Treatment Period: Phase I/II|Other causes|1
1640686|NCT01756456|5734716|P3|Treatment Period: Phase I/II|Other causes|0
1640687|NCT01756456|5734717|P2|Treatment Period: Phase I/II|Other causes|0
1640688|NCT01756456|5734718|P1|Treatment Period: Phase I/II|Other causes|0
1640689|NCT01756456|5734713|P6|Treatment Period: Phase I/II|Adverse Event|1
1640690|NCT01756456|5734714|P5|Treatment Period: Phase I/II|Adverse Event|9
1640691|NCT01756456|5734715|P4|Treatment Period: Phase I/II|Adverse Event|3
1640692|NCT01756456|5734716|P3|Treatment Period: Phase I/II|Adverse Event|2
1640693|NCT01756456|5734717|P2|Treatment Period: Phase I/II|Adverse Event|0
1640694|NCT01756456|5734718|P1|Treatment Period: Phase I/II|Adverse Event|1
1640695|NCT01756456|5734713|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
1640696|NCT01756456|5734714|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
1640697|NCT01756456|5734715|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
1640698|NCT01756456|5734716|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
1640699|NCT01756456|5734717|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
1640700|NCT01756456|5734718|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
1640701|NCT01756456|5734713|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
1640702|NCT01756456|5734714|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
1640703|NCT01756456|5734715|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
1640704|NCT01756456|5734716|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
1640705|NCT01756456|5734717|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
1640706|NCT01756456|5734718|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
1640707|NCT01756456|5734713|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
1640708|NCT01756456|5734714|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
1640709|NCT01756456|5734715|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
1640710|NCT01756456|5734716|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
1640711|NCT01756456|5734717|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
1640712|NCT01756456|5734718|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
1640713|NCT01756352|5734820|P1|Overall Study|moved away and lost to followup|1
1640714|NCT01756300|5734825|P1|Overall Study|Withdrawal by Subject|1
1640715|NCT01756300|5734825|P1|Overall Study|Death|1
1640716|NCT01756274|5734847|P1|Overall Study|Laboratory error|1
1640717|NCT01756274|5734847|P1|Overall Study|Protocol Violation|2
1640718|NCT01756235|5734854|P1|Overall Study|Adalimumab Treatment was not Documented|2
1640719|NCT01756157|5734875|P2|First Intervention Period|Lost to Follow-up|2
1640720|NCT01756157|5734876|P1|First Intervention Period|Lost to Follow-up|0
1640721|NCT01756157|5734875|P2|First Intervention Period|Withdrawal by Subject|0
1640722|NCT01756157|5734876|P1|First Intervention Period|Withdrawal by Subject|1
1640723|NCT01756079|5734890|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
1640724|NCT01756079|5734890|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
1640725|NCT01756079|5734890|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
1640726|NCT01756079|5734890|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
1640727|NCT01756079|5734890|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
1640728|NCT01756053|5734896|P2|Period 2 (10 Days)|Protocol Violation|2
1640729|NCT01756053|5734897|P1|Period 2 (10 Days)|Protocol Violation|0
1640730|NCT01756053|5734896|P2|Period 1 (10 Days)|Protocol Violation|1
1640731|NCT01756053|5734897|P1|Period 1 (10 Days)|Protocol Violation|1
1640732|NCT01755702|5734954|P1|Washout Period II|Other Reason|5
1640733|NCT01755702|5734954|P1|Wash Out Period I|Other Reason|3
1640734|NCT01755689|5735001|P5|Overall Study|Pregnancy|2
1640735|NCT01755689|5735002|P4|Overall Study|Pregnancy|4
1640736|NCT01755689|5735003|P3|Overall Study|Pregnancy|2
1640737|NCT01755689|5735004|P2|Overall Study|Pregnancy|1
1640738|NCT01755689|5735005|P1|Overall Study|Pregnancy|1
1640739|NCT01755689|5735001|P5|Overall Study|Lost to Follow-up|2
1640740|NCT01755689|5735002|P4|Overall Study|Lost to Follow-up|0
1640741|NCT01755689|5735003|P3|Overall Study|Lost to Follow-up|1
1640742|NCT01755689|5735004|P2|Overall Study|Lost to Follow-up|0
1640743|NCT01755689|5735005|P1|Overall Study|Lost to Follow-up|1
1640744|NCT01755689|5735001|P5|Overall Study|Migrated/moved from study area|1
1640745|NCT01755689|5735002|P4|Overall Study|Migrated/moved from study area|1
1640746|NCT01755689|5735003|P3|Overall Study|Migrated/moved from study area|1
1640747|NCT01755689|5735004|P2|Overall Study|Migrated/moved from study area|1
1640748|NCT01755689|5735005|P1|Overall Study|Migrated/moved from study area|0
1640749|NCT01755689|5735001|P5|Overall Study|Withdrawal by Subject|1
1640750|NCT01755689|5735002|P4|Overall Study|Withdrawal by Subject|1
1640751|NCT01755689|5735003|P3|Overall Study|Withdrawal by Subject|2
1640752|NCT01755689|5735004|P2|Overall Study|Withdrawal by Subject|3
1640753|NCT01755689|5735005|P1|Overall Study|Withdrawal by Subject|1
1640754|NCT01755637|5735080|P2|Period 1|Adverse Event|1
1640755|NCT01755637|5735081|P1|Period 1|Adverse Event|0
1640756|NCT01755598|5735101|P2|Overall Study|Adverse Event|28
1640757|NCT01755598|5735102|P1|Overall Study|Adverse Event|19
1640758|NCT01755598|5735101|P2|Overall Study|Protocol Violation|7
1640759|NCT01755598|5735102|P1|Overall Study|Protocol Violation|7
1640760|NCT01755598|5735101|P2|Overall Study|Withdrawal by Subject|31
1640761|NCT01755598|5735102|P1|Overall Study|Withdrawal by Subject|22
1640762|NCT01755598|5735101|P2|Overall Study|Migrated/moved from study area|65
1640763|NCT01755598|5735102|P1|Overall Study|Migrated/moved from study area|76
1640764|NCT01755598|5735101|P2|Overall Study|Lost to Follow-up|43
1640765|NCT01755598|5735102|P1|Overall Study|Lost to Follow-up|32
1640766|NCT01755598|5735101|P2|Overall Study|Other|109
1640767|NCT01755598|5735102|P1|Overall Study|Other|109
1640768|NCT01755546|5735136|P1|Long Term Treatment|other and ongoing|41
1640769|NCT01755546|5735136|P1|Long Term Treatment|Lost to Follow-up|17
1640770|NCT01755546|5735136|P1|Long Term Treatment|Withdrawal by Subject|35
1640771|NCT01755546|5735136|P1|Long Term Treatment|Protocol Violation|10
1640772|NCT01755546|5735136|P1|Long Term Treatment|Lack of Efficacy|6
1640773|NCT01755546|5735136|P1|Long Term Treatment|Adverse Event|12
1640774|NCT01755546|5735136|P1|Titration Phase|Withdrawal by Subject|8
1640775|NCT01755546|5735136|P1|Titration Phase|Other and Continuing|22
1640776|NCT01755546|5735136|P1|Titration Phase|Lost to Follow-up|2
1640777|NCT01755546|5735136|P1|Titration Phase|Protocol Violation|9
1640778|NCT01755546|5735136|P1|Titration Phase|Lack of Efficacy|18
1640779|NCT01755546|5735136|P1|Titration Phase|Adverse Event|11
1640780|NCT01755546|5735136|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
1640781|NCT01755546|5735136|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
1640869|NCT01754194|5735579|P1|Overall Study|Withdrawal by Subject|4
1640782|NCT01755546|5735136|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
1640783|NCT01755546|5735136|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
1640784|NCT01755416|5735153|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
1640785|NCT01755416|5735154|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
1640786|NCT01755234|5735162|P2|Overall Study|unblinded|0
1640787|NCT01755234|5735163|P1|Overall Study|unblinded|1
1640788|NCT01755234|5735162|P2|Overall Study|Withdrawal by Subject|1
1640789|NCT01755234|5735163|P1|Overall Study|Withdrawal by Subject|0
1640790|NCT01755234|5735162|P2|Overall Study|case cancelled|0
1640791|NCT01755234|5735163|P1|Overall Study|case cancelled|1
1640792|NCT01755234|5735162|P2|Overall Study|Change in surgical case|1
1640793|NCT01755234|5735163|P1|Overall Study|Change in surgical case|2
1640794|NCT01755234|5735162|P2|Overall Study|Lost to Follow-up|6
1640795|NCT01755234|5735163|P1|Overall Study|Lost to Follow-up|11
1640796|NCT01755156|5735194|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
1640797|NCT01755156|5735195|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
1640798|NCT01755156|5735194|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
1640799|NCT01755156|5735195|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
1640800|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1640801|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
1640802|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
1640803|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
1640804|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
1640805|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
1640806|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Protocol Violation|1
1640807|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Protocol Violation|1
1640808|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Physician Decision|1
1640809|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Physician Decision|0
1640810|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
1640811|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
1640812|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
1640813|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
1640814|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
1640815|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
1640816|NCT01755156|5735194|P2|Phase A (Weeks 0-24)|Adverse Event|3
1640817|NCT01755156|5735195|P1|Phase A (Weeks 0-24)|Adverse Event|2
1640818|NCT01755091|5735259|P3|Overall Study|Physician Decision|2
1640819|NCT01755091|5735260|P2|Overall Study|Physician Decision|1
1640820|NCT01755091|5735261|P1|Overall Study|Physician Decision|1
1640821|NCT01755091|5735259|P3|Overall Study|Lost to Follow-up|1
1640822|NCT01755091|5735260|P2|Overall Study|Lost to Follow-up|0
1640823|NCT01755091|5735261|P1|Overall Study|Lost to Follow-up|1
1640824|NCT01755091|5735259|P3|Overall Study|Adverse Event|1
1640825|NCT01755091|5735260|P2|Overall Study|Adverse Event|1
1640826|NCT01755091|5735261|P1|Overall Study|Adverse Event|1
1640827|NCT01755091|5735259|P3|Overall Study|Withdrawal by Subject|3
1640828|NCT01755091|5735260|P2|Overall Study|Withdrawal by Subject|1
1640829|NCT01755091|5735261|P1|Overall Study|Withdrawal by Subject|6
1640830|NCT01755026|5735286|P2|Overall Study|Withdrawal by Subject|1
1640831|NCT01755026|5735287|P1|Overall Study|Withdrawal by Subject|1
1640832|NCT01755026|5735286|P2|Overall Study|Adverse Event|0
1640833|NCT01755026|5735287|P1|Overall Study|Adverse Event|1
1640834|NCT01754922|5735310|P2|Overall Study|Adverse Event|1
1640835|NCT01754922|5735311|P1|Overall Study|Adverse Event|0
1640836|NCT01754766|5735337|P3|Overall Study|Personal reasons|0
1640837|NCT01754766|5735338|P2|Overall Study|Personal reasons|1
1640838|NCT01754766|5735339|P1|Overall Study|Personal reasons|1
1640839|NCT01754727|5735353|P1|Overall Study|Adalimumab Treatment was not Documented|2
1640840|NCT01754493|5735485|P1|Overall Study|Scheduling conflict|1
1640841|NCT01754493|5735485|P1|Overall Study|Moved out of town|1
1640842|NCT01754493|5735485|P1|Overall Study|Withdrawal by Subject|1
1640843|NCT01754493|5735485|P1|Overall Study|Lost to Follow-up|3
1640844|NCT01754493|5735485|P1|Overall Study|Adverse Event|1
1640845|NCT01754467|5735510|P1|Overall Study|Lost to Follow-up|1
1640846|NCT01754402|5735520|P3|Overall Study|Lack of Efficacy|1
1640847|NCT01754402|5735521|P2|Overall Study|Lack of Efficacy|0
1640848|NCT01754402|5735522|P1|Overall Study|Lack of Efficacy|0
1640849|NCT01754402|5735520|P3|Overall Study|Withdrawal by Subject|1
1640850|NCT01754402|5735521|P2|Overall Study|Withdrawal by Subject|0
1640851|NCT01754402|5735522|P1|Overall Study|Withdrawal by Subject|0
1640852|NCT01754402|5735520|P3|Overall Study|Adverse Event|1
1640853|NCT01754402|5735521|P2|Overall Study|Adverse Event|2
1640854|NCT01754402|5735522|P1|Overall Study|Adverse Event|2
1640855|NCT01754402|5735520|P3|Overall Study|Death|1
1640856|NCT01754402|5735521|P2|Overall Study|Death|0
1640857|NCT01754402|5735522|P1|Overall Study|Death|0
1640858|NCT01754376|5735556|P1|Overall Study|Lack of Efficacy|2
1640859|NCT01754376|5735556|P1|Overall Study|Adverse Event|1
1640860|NCT01754259|5735567|P2|Overall Study|Lost to Follow-up|1
1640861|NCT01754259|5735568|P1|Overall Study|Lost to Follow-up|0
1640862|NCT01754259|5735567|P2|Overall Study|Adverse Event|1
1640863|NCT01754259|5735568|P1|Overall Study|Adverse Event|3
1640864|NCT01754259|5735567|P2|Overall Study|Withdrawal by Subject|4
1640865|NCT01754259|5735568|P1|Overall Study|Withdrawal by Subject|2
1640866|NCT01754194|5735578|P2|Overall Study|Other|8
1640867|NCT01754194|5735579|P1|Overall Study|Other|9
1640868|NCT01754194|5735578|P2|Overall Study|Withdrawal by Subject|5
1640870|NCT01754194|5735578|P2|Overall Study|Lost to Follow-up|14
1640871|NCT01754194|5735579|P1|Overall Study|Lost to Follow-up|39
1640872|NCT01754129|5735599|P1|Overall Study|Inclusion/exclusion criteria violation|3
1640873|NCT01754129|5735599|P1|Overall Study|Withdrew consent|1
1640874|NCT01754129|5735599|P1|Overall Study|Lost to Follow-up|7
1640875|NCT01754129|5735599|P1|Overall Study|Duodopa discontinuation|9
1640876|NCT01754129|5735599|P1|Overall Study|Death|13
1640877|NCT01753999|5735622|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
1640878|NCT01753999|5735623|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
1640879|NCT01753999|5735622|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
1640880|NCT01753999|5735623|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
1640881|NCT01753999|5735622|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
1640882|NCT01753999|5735623|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
1640883|NCT01753999|5735622|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
1640884|NCT01753999|5735623|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
1640885|NCT01753999|5735622|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
1640886|NCT01753999|5735623|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
1640887|NCT01753999|5735622|P2|Period 1 - Initial Assignment|Physician Decision|3
1640888|NCT01753999|5735623|P1|Period 1 - Initial Assignment|Physician Decision|2
1640889|NCT01753856|5735637|P2|Overall Study|Sponsor Decision|0
1640890|NCT01753856|5735638|P1|Overall Study|Sponsor Decision|2
1640891|NCT01753856|5735637|P2|Overall Study|Withdrawal by Subject|2
1640892|NCT01753856|5735638|P1|Overall Study|Withdrawal by Subject|0
1640893|NCT01753856|5735637|P2|Overall Study|Adverse Event|0
1640894|NCT01753856|5735638|P1|Overall Study|Adverse Event|1
1640895|NCT01753570|5735710|P3|Overall Study|Withdrawal by Subject|0
1640896|NCT01753570|5735711|P2|Overall Study|Withdrawal by Subject|4
1640897|NCT01753570|5735712|P1|Overall Study|Withdrawal by Subject|1
1640898|NCT01753570|5735710|P3|Overall Study|Physician Decision|0
1640899|NCT01753570|5735711|P2|Overall Study|Physician Decision|1
1640900|NCT01753570|5735712|P1|Overall Study|Physician Decision|0
1640901|NCT01753570|5735710|P3|Overall Study|Adverse Event|1
1640902|NCT01753570|5735711|P2|Overall Study|Adverse Event|0
1640903|NCT01753570|5735712|P1|Overall Study|Adverse Event|1
1640904|NCT01753518|5735755|P2|Postpartum Follow-up|Lost to Follow-up|15
1640905|NCT01753518|5735756|P1|Postpartum Follow-up|Lost to Follow-up|22
1640906|NCT01753518|5735755|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
1640907|NCT01753518|5735756|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
1640908|NCT01753518|5735755|P2|Intention-to-Treat Analysis|Multifetal gestation|3
1640909|NCT01753518|5735756|P1|Intention-to-Treat Analysis|Multifetal gestation|2
1640910|NCT01753518|5735755|P2|Intention-to-Treat Analysis|Missing consent form|3
1640911|NCT01753518|5735756|P1|Intention-to-Treat Analysis|Missing consent form|5
1640912|NCT01753336|5735789|P1|Overall Study|Withdrawal by Subject|1
1640913|NCT01753336|5735789|P1|Overall Study|Sponsor's decision|2
1640914|NCT01753336|5735789|P1|Overall Study|Physician Decision|2
1640915|NCT01753336|5735789|P1|Overall Study|Lost to Follow-up|3
1640916|NCT01753336|5735789|P1|Overall Study|Patient decision|12
1640917|NCT01753323|5735801|P3|Overall Study|Adverse Event|1
1640918|NCT01753323|5735802|P2|Overall Study|Adverse Event|0
1640919|NCT01753323|5735803|P1|Overall Study|Adverse Event|0
1640920|NCT01753323|5735801|P3|Overall Study|Protocol deviation|0
1640921|NCT01753323|5735802|P2|Overall Study|Protocol deviation|0
1640922|NCT01753323|5735803|P1|Overall Study|Protocol deviation|1
1640923|NCT01753323|5735801|P3|Overall Study|Lack of Efficacy|8
1640924|NCT01753323|5735802|P2|Overall Study|Lack of Efficacy|0
1640925|NCT01753323|5735803|P1|Overall Study|Lack of Efficacy|0
1640926|NCT01753310|5735841|P2|Overall Study|Withdrawal by Subject|0
1640927|NCT01753310|5735842|P1|Overall Study|Withdrawal by Subject|1
1640928|NCT01753310|5735841|P2|Overall Study|Sponsor decision|0
1640929|NCT01753310|5735842|P1|Overall Study|Sponsor decision|1
1640930|NCT01753310|5735841|P2|Overall Study|Subject decision|2
1640931|NCT01753310|5735842|P1|Overall Study|Subject decision|2
1640932|NCT01753310|5735841|P2|Overall Study|Lost to Follow-up|0
1640933|NCT01753310|5735842|P1|Overall Study|Lost to Follow-up|2
1640934|NCT01753310|5735841|P2|Overall Study|Adverse Event|0
1640935|NCT01753310|5735842|P1|Overall Study|Adverse Event|1
1640936|NCT01753310|5735841|P2|Overall Study|Entered into open label extension study|22
1640937|NCT01753310|5735842|P1|Overall Study|Entered into open label extension study|25
1640938|NCT01753193|5735862|P1|Overall Study|Other|16
1640939|NCT01753193|5735862|P1|Overall Study|Death|1
1640940|NCT01753193|5735862|P1|Overall Study|Lost to Follow-up|6
1640941|NCT01753193|5735862|P1|Overall Study|Withdrawal by Subject|23
1640942|NCT01753115|5735877|P3|Overall Study|Used excluded drug|0
1640943|NCT01753115|5735878|P2|Overall Study|Used excluded drug|1
1640944|NCT01753115|5735879|P1|Overall Study|Used excluded drug|0
1640945|NCT01753115|5735877|P3|Overall Study|Subject non-compliant|0
1640946|NCT01753115|5735878|P2|Overall Study|Subject non-compliant|3
1640947|NCT01753115|5735879|P1|Overall Study|Subject non-compliant|3
1640948|NCT01753115|5735877|P3|Overall Study|Withdrawal by Subject|6
1640949|NCT01753115|5735878|P2|Overall Study|Withdrawal by Subject|5
1640950|NCT01753115|5735879|P1|Overall Study|Withdrawal by Subject|6
1640951|NCT01753115|5735877|P3|Overall Study|Lost to Follow-up|8
1640952|NCT01753115|5735878|P2|Overall Study|Lost to Follow-up|6
1640953|NCT01753115|5735879|P1|Overall Study|Lost to Follow-up|3
1640954|NCT01753076|5735889|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
1640955|NCT01753076|5735890|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
1640956|NCT01753076|5735889|P2|Overall Study|Withdrawal by Subject|24
1640957|NCT01753076|5735890|P1|Overall Study|Withdrawal by Subject|14
1640958|NCT01753076|5735889|P2|Overall Study|Physician Decision|2
1640959|NCT01753076|5735890|P1|Overall Study|Physician Decision|4
1640960|NCT01753076|5735889|P2|Overall Study|Lost to Follow-up|1
1640961|NCT01753076|5735890|P1|Overall Study|Lost to Follow-up|2
1640962|NCT01753076|5735889|P2|Overall Study|Lack of Efficacy|1
1640963|NCT01753076|5735890|P1|Overall Study|Lack of Efficacy|3
1640964|NCT01753076|5735889|P2|Overall Study|Adverse Event|18
1640965|NCT01753076|5735890|P1|Overall Study|Adverse Event|17
1640966|NCT01752985|5735917|P3|Treatment Period|Lost to Follow-up|1
1640967|NCT01752985|5735918|P2|Treatment Period|Lost to Follow-up|0
1640968|NCT01752985|5735919|P1|Treatment Period|Lost to Follow-up|0
1640969|NCT01752985|5735917|P3|Treatment Period|Withdrawal by Subject|0
1640970|NCT01752985|5735918|P2|Treatment Period|Withdrawal by Subject|1
1640971|NCT01752985|5735919|P1|Treatment Period|Withdrawal by Subject|1
1640972|NCT01752985|5735917|P3|Treatment Period|Adverse Event|2
1640973|NCT01752985|5735918|P2|Treatment Period|Adverse Event|1
1640974|NCT01752985|5735919|P1|Treatment Period|Adverse Event|2
1640975|NCT01752985|5735917|P3|Treatment Period|Subject no longer meets study criteria|1
1640976|NCT01752985|5735918|P2|Treatment Period|Subject no longer meets study criteria|1
1640977|NCT01752985|5735919|P1|Treatment Period|Subject no longer meets study criteria|0
1640978|NCT01752985|5735917|P3|Treatment Period|Subject request to discontinue treatment|1
1640979|NCT01752985|5735918|P2|Treatment Period|Subject request to discontinue treatment|0
1640980|NCT01752985|5735919|P1|Treatment Period|Subject request to discontinue treatment|1
1640981|NCT01752933|5735947|P2|Overall Study and Follow-up|Lost to Follow-up|2
1640982|NCT01752933|5735948|P1|Overall Study and Follow-up|Lost to Follow-up|0
1640983|NCT01752933|5735947|P2|Overall Study and Follow-up|Withdrawal by Subject|3
1640984|NCT01752933|5735948|P1|Overall Study and Follow-up|Withdrawal by Subject|0
1640985|NCT01752933|5735947|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
1640986|NCT01752933|5735948|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
1640987|NCT01752933|5735947|P2|Overall Study and Follow-up|Death|34
1640988|NCT01752933|5735948|P1|Overall Study and Follow-up|Death|4
1640989|NCT01752933|5735947|P2|Treatment|Patient unable to travel to appointments|1
1640990|NCT01752933|5735948|P1|Treatment|Patient unable to travel to appointments|0
1640991|NCT01752933|5735947|P2|Treatment|Patient noncompliant|1
1640992|NCT01752933|5735948|P1|Treatment|Patient noncompliant|0
1640993|NCT01752933|5735947|P2|Treatment|Hepatocellular carcinoma not confirmed|1
1640994|NCT01752933|5735948|P1|Treatment|Hepatocellular carcinoma not confirmed|0
1640995|NCT01752933|5735947|P2|Treatment|Death|2
1640996|NCT01752933|5735948|P1|Treatment|Death|0
1640997|NCT01752933|5735947|P2|Treatment|Physician Decision|3
1640998|NCT01752933|5735948|P1|Treatment|Physician Decision|0
1640999|NCT01752933|5735947|P2|Treatment|Adverse Event|4
1641000|NCT01752933|5735948|P1|Treatment|Adverse Event|1
1641001|NCT01752933|5735947|P2|Treatment|Withdrawal by Subject|5
1641002|NCT01752933|5735948|P1|Treatment|Withdrawal by Subject|0
1641003|NCT01752933|5735947|P2|Treatment|Disease Progression|29
1641004|NCT01752933|5735948|P1|Treatment|Disease Progression|3
1641005|NCT01752907|5735966|P2|Overall Study|Decision by Sponsor|9
1641006|NCT01752907|5735967|P1|Overall Study|Decision by Sponsor|6
1641007|NCT01752907|5735966|P2|Overall Study|Lost to Follow-up|1
1641008|NCT01752907|5735967|P1|Overall Study|Lost to Follow-up|2
1641009|NCT01752907|5735966|P2|Overall Study|Withdrawal by Subject|10
1641010|NCT01752907|5735967|P1|Overall Study|Withdrawal by Subject|4
1641011|NCT01752855|5735987|P2|Overall Study|Lack of Efficacy|2
1641012|NCT01752855|5735988|P1|Overall Study|Lack of Efficacy|0
1641013|NCT01752855|5735987|P2|Overall Study|Withdrew Consent|2
1641014|NCT01752855|5735988|P1|Overall Study|Withdrew Consent|0
1641015|NCT01752855|5735987|P2|Overall Study|Adverse Event|0
1641016|NCT01752855|5735988|P1|Overall Study|Adverse Event|1
1641017|NCT01752842|5736004|P2|Overall Study|Withdrawal by Subject|2
1641018|NCT01752842|5736005|P1|Overall Study|Withdrawal by Subject|0
1641019|NCT01752842|5736004|P2|Overall Study|Adverse Event|0
1641020|NCT01752842|5736005|P1|Overall Study|Adverse Event|3
1641021|NCT01752023|5736052|P2|Overall Study|Physician Decision|1
1641022|NCT01752023|5736053|P1|Overall Study|Physician Decision|2
1641023|NCT01751906|5736089|P2|Overall Study|Other|0
1641024|NCT01751906|5736090|P1|Overall Study|Other|1
1641025|NCT01751906|5736089|P2|Overall Study|Death|22
1641026|NCT01751906|5736090|P1|Overall Study|Death|38
1641027|NCT01751906|5736089|P2|Overall Study|Physician Decision|1
1641028|NCT01751906|5736090|P1|Overall Study|Physician Decision|3
1641029|NCT01751906|5736089|P2|Overall Study|Withdrawal by Subject|6
1641030|NCT01751906|5736090|P1|Overall Study|Withdrawal by Subject|14
1641031|NCT01751906|5736089|P2|Overall Study|Lost to Follow-up|18
1641032|NCT01751906|5736090|P1|Overall Study|Lost to Follow-up|28
1641033|NCT01751867|5736294|P2|Overall Study|Randomized but not treated.|1
1641034|NCT01751867|5736295|P1|Overall Study|Randomized but not treated.|2
1641035|NCT01751867|5736294|P2|Overall Study|Other|37
1641036|NCT01751867|5736295|P1|Overall Study|Other|11
1641037|NCT01751867|5736294|P2|Overall Study|Death|5
1641038|NCT01751867|5736295|P1|Overall Study|Death|0
1641039|NCT01751867|5736294|P2|Overall Study|Protocol Violation|2
1641040|NCT01751867|5736295|P1|Overall Study|Protocol Violation|0
1641041|NCT01751867|5736294|P2|Overall Study|Physician Decision|7
1641042|NCT01751867|5736295|P1|Overall Study|Physician Decision|4
1641043|NCT01751867|5736294|P2|Overall Study|Withdrawal by Subject|1
1641044|NCT01751867|5736295|P1|Overall Study|Withdrawal by Subject|3
1641045|NCT01751867|5736294|P2|Overall Study|Poor Compliance|5
1641046|NCT01751867|5736295|P1|Overall Study|Poor Compliance|0
1641047|NCT01751867|5736294|P2|Overall Study|Adverse Event|15
1641048|NCT01751867|5736295|P1|Overall Study|Adverse Event|8
1641049|NCT01751867|5736294|P2|Overall Study|Diease Progression|18
1641050|NCT01751867|5736295|P1|Overall Study|Diease Progression|4
1641051|NCT01751867|5736294|P2|Overall Study|Completed treatment,dropped in follow-up|8
1641052|NCT01751867|5736295|P1|Overall Study|Completed treatment,dropped in follow-up|4
1641053|NCT01751802|5736315|P2|Overall Study|Adverse Event|2
1641054|NCT01751802|5736316|P1|Overall Study|Adverse Event|4
1641055|NCT01751724|5736330|P2|Overall Study|withdrawn by parent|2
1641056|NCT01751724|5736331|P1|Overall Study|withdrawn by parent|0
1641057|NCT01751724|5736330|P2|Overall Study|extubated bef.start assigned treatment|0
1641058|NCT01751724|5736331|P1|Overall Study|extubated bef.start assigned treatment|1
1641059|NCT01751646|5736359|P2|Overall Study|Childcare issues|1
1641060|NCT01751646|5736360|P1|Overall Study|Childcare issues|1
1641061|NCT01751646|5736359|P2|Overall Study|Fails to comply with study requirements|1
1641062|NCT01751646|5736360|P1|Overall Study|Fails to comply with study requirements|0
1641063|NCT01751646|5736359|P2|Overall Study|Off study due to multiple obligations|1
1641064|NCT01751646|5736360|P1|Overall Study|Off study due to multiple obligations|0
1641065|NCT01751646|5736359|P2|Overall Study|Inability to attend required visits|1
1641066|NCT01751646|5736360|P1|Overall Study|Inability to attend required visits|0
1641067|NCT01751646|5736359|P2|Overall Study|Moved out of the area|5
1641068|NCT01751646|5736360|P1|Overall Study|Moved out of the area|1
1641069|NCT01751646|5736359|P2|Overall Study|Inadvertent enrollment|1
1641070|NCT01751646|5736360|P1|Overall Study|Inadvertent enrollment|1
1641071|NCT01751646|5736359|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
1641072|NCT01751646|5736360|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
1641073|NCT01751646|5736359|P2|Overall Study|Starting hormone therapy|0
1641074|NCT01751646|5736360|P1|Overall Study|Starting hormone therapy|1
1641075|NCT01751646|5736359|P2|Overall Study|Withdrawal by Subject|4
1641076|NCT01751646|5736360|P1|Overall Study|Withdrawal by Subject|0
1641077|NCT01751646|5736359|P2|Overall Study|Lost to Follow-up|1
1641078|NCT01751646|5736360|P1|Overall Study|Lost to Follow-up|5
1641079|NCT01751412|5736508|P1|Overall Study|Disease Progression Before Treatment|1
1641080|NCT01751178|5736618|P3|Overall Study|Other Reason (unknown)|2
1641081|NCT01751178|5736619|P2|Overall Study|Other Reason (unknown)|0
1641082|NCT01751178|5736620|P1|Overall Study|Other Reason (unknown)|1
1641083|NCT01751178|5736618|P3|Overall Study|Adverse Event|0
1641084|NCT01751178|5736619|P2|Overall Study|Adverse Event|0
1641085|NCT01751178|5736620|P1|Overall Study|Adverse Event|2
1641086|NCT01751165|5736640|P3|Overall Study|Lost to Follow-up|1
1641087|NCT01751165|5736641|P2|Overall Study|Lost to Follow-up|1
1641088|NCT01751165|5736642|P1|Overall Study|Lost to Follow-up|1
1641089|NCT01751165|5736640|P3|Overall Study|Serious adverse event|0
1641090|NCT01751165|5736641|P2|Overall Study|Serious adverse event|2
1641091|NCT01751165|5736642|P1|Overall Study|Serious adverse event|0
1641092|NCT01751165|5736640|P3|Overall Study|Withdrawal by Subject|1
1641093|NCT01751165|5736641|P2|Overall Study|Withdrawal by Subject|0
1641094|NCT01751165|5736642|P1|Overall Study|Withdrawal by Subject|0
1641095|NCT01751165|5736640|P3|Overall Study|Adverse event, serious fatal|1
1641096|NCT01751165|5736641|P2|Overall Study|Adverse event, serious fatal|0
1641097|NCT01751165|5736642|P1|Overall Study|Adverse event, serious fatal|1
1641098|NCT01751113|5736682|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
1641099|NCT01751113|5736683|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
1641100|NCT01751113|5736684|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
1641101|NCT01751113|5736685|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
1641102|NCT01751113|5736686|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
1641103|NCT01751113|5736687|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
1641104|NCT01751113|5736682|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
1641105|NCT01751113|5736683|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
1641106|NCT01751113|5736684|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
1641107|NCT01751113|5736685|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
1641108|NCT01751113|5736686|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
1641109|NCT01751113|5736687|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
1641110|NCT01751087|5736728|P3|Overall Study|Physician Decision|1
1641111|NCT01751087|5736729|P2|Overall Study|Physician Decision|0
1641112|NCT01751087|5736730|P1|Overall Study|Physician Decision|0
1641113|NCT01751087|5736728|P3|Overall Study|Withdrawal by Subject|0
1641114|NCT01751087|5736729|P2|Overall Study|Withdrawal by Subject|0
1641115|NCT01751087|5736730|P1|Overall Study|Withdrawal by Subject|1
1641116|NCT01751061|5736764|P2|Overall Study|Physician Decision|0
1641117|NCT01751061|5736765|P1|Overall Study|Physician Decision|2
1641118|NCT01751061|5736764|P2|Overall Study|Withdrawal by Subject|1
1641119|NCT01751061|5736765|P1|Overall Study|Withdrawal by Subject|4
1641120|NCT01751061|5736764|P2|Overall Study|patient regained decisional capacity|8
1641121|NCT01751061|5736765|P1|Overall Study|patient regained decisional capacity|4
1641122|NCT01751061|5736764|P2|Overall Study|Lost to Follow-up|25
1641123|NCT01751061|5736765|P1|Overall Study|Lost to Follow-up|40
1641124|NCT01751061|5736764|P2|Overall Study|patient death|0
1641125|NCT01751061|5736765|P1|Overall Study|patient death|5
1641126|NCT01751061|5736764|P2|Overall Study|Death|0
1641127|NCT01751061|5736765|P1|Overall Study|Death|1
1641128|NCT01750840|5736839|P1|Overall Study|Lost to Follow-up|4
1641129|NCT01750697|5736844|P1|Overall Study|Withdrawal by Subject|1
1641130|NCT01750697|5736844|P1|Overall Study|Physician Decision|1
1641131|NCT01750697|5736844|P1|Overall Study|Transferred to Adult Services|5
1641132|NCT01750697|5736844|P1|Overall Study|Physician and Family Decision|1
1641133|NCT01750697|5736844|P1|Overall Study|Transferred Back to Local Hospital|1
1641134|NCT01750684|5736856|P2|Overall Study|Protocol Violation|0
1641135|NCT01750684|5736857|P1|Overall Study|Protocol Violation|1
1641136|NCT01750684|5736856|P2|Overall Study|Withdrawn by Sponsor|1
1641137|NCT01750684|5736857|P1|Overall Study|Withdrawn by Sponsor|0
1641138|NCT01750684|5736856|P2|Overall Study|Non-compliance with Study Drug|1
1641139|NCT01750684|5736857|P1|Overall Study|Non-compliance with Study Drug|0
1641140|NCT01750684|5736856|P2|Overall Study|Death|0
1641141|NCT01750684|5736857|P1|Overall Study|Death|1
1641142|NCT01750346|5736894|P3|Overall Study|Adverse Event|0
1641143|NCT01750346|5736895|P2|Overall Study|Adverse Event|0
1641144|NCT01750346|5736896|P1|Overall Study|Adverse Event|1
1641145|NCT01750294|5736922|P1|Overall Study|Safety Endpoint|1
1641146|NCT01750294|5736922|P1|Overall Study|Withdrawal by Subject|1
1641147|NCT01750281|5736929|P3|Overall Study|Did not receive treatment|0
1641148|NCT01750281|5736930|P2|Overall Study|Did not receive treatment|1
1641149|NCT01750281|5736931|P1|Overall Study|Did not receive treatment|0
1641150|NCT01750281|5736929|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
1641151|NCT01750281|5736930|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
1641152|NCT01750281|5736931|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
1641153|NCT01750281|5736929|P3|Overall Study|Discontinued Selumetinib/Placebo|75
1641154|NCT01750281|5736930|P2|Overall Study|Discontinued Selumetinib/Placebo|77
1641155|NCT01750281|5736931|P1|Overall Study|Discontinued Selumetinib/Placebo|37
1641156|NCT01750242|5736961|P1|Overall Study|Unreadable Images|3
1641157|NCT01750229|5736966|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
1641158|NCT01750229|5736966|P1|Long-term Follow-up Phase|Adverse Event|2
1641159|NCT01750229|5736966|P1|Randomized Crossover Phase|Withdrawal by Subject|1
1641160|NCT01750229|5736966|P1|Randomized Crossover Phase|Adverse Event|1
1641161|NCT01749982|5736993|P4|Overall Study|Withdrawal by Subject|1
1641162|NCT01749982|5736994|P3|Overall Study|Withdrawal by Subject|0
1641163|NCT01749982|5736995|P2|Overall Study|Withdrawal by Subject|0
1641164|NCT01749982|5736996|P1|Overall Study|Withdrawal by Subject|0
1641165|NCT01749982|5736993|P4|Overall Study|Lost to Follow-up|1
1641166|NCT01749982|5736994|P3|Overall Study|Lost to Follow-up|0
1641167|NCT01749982|5736995|P2|Overall Study|Lost to Follow-up|0
1641168|NCT01749982|5736996|P1|Overall Study|Lost to Follow-up|0
1641169|NCT01749982|5736993|P4|Overall Study|Physician Decision|1
1641170|NCT01749982|5736994|P3|Overall Study|Physician Decision|0
1641171|NCT01749982|5736995|P2|Overall Study|Physician Decision|0
1641172|NCT01749982|5736996|P1|Overall Study|Physician Decision|0
1641173|NCT01749826|5737060|P2|Overall Study|Study Terminated|0
1641174|NCT01749826|5737061|P1|Overall Study|Study Terminated|20
1641175|NCT01749800|5737076|P3|Overall Study|Withdrawal by Subject|0
1641176|NCT01749800|5737077|P2|Overall Study|Withdrawal by Subject|1
1641177|NCT01749800|5737078|P1|Overall Study|Withdrawal by Subject|0
1641178|NCT01749800|5737076|P3|Overall Study|not meeting inclusion criteria|0
1641179|NCT01749800|5737077|P2|Overall Study|not meeting inclusion criteria|0
1641180|NCT01749800|5737078|P1|Overall Study|not meeting inclusion criteria|3
1641181|NCT01749735|5737088|P2|Overall Study|Withdrawal by Subject|0
1641182|NCT01749735|5737089|P1|Overall Study|Withdrawal by Subject|1
1641183|NCT01749033|5737140|P3|Overall Study|Lost to Follow-up|1
1641184|NCT01749033|5737141|P2|Overall Study|Lost to Follow-up|2
1641185|NCT01749033|5737142|P1|Overall Study|Lost to Follow-up|0
1641186|NCT01749033|5737140|P3|Overall Study|Did not receive allocated intervention|0
1641187|NCT01749033|5737141|P2|Overall Study|Did not receive allocated intervention|3
1641188|NCT01749033|5737142|P1|Overall Study|Did not receive allocated intervention|3
1641189|NCT01748890|5737212|P1|Overall Study|Insufficient recruitment for analysis|4
1641190|NCT01748760|5737267|P2|Overall Study|Lost to Follow-up|1
1641191|NCT01748760|5737268|P1|Overall Study|Lost to Follow-up|5
1641192|NCT01748760|5737267|P2|Overall Study|Withdrawal by Subject|1
1641193|NCT01748760|5737268|P1|Overall Study|Withdrawal by Subject|1
1641194|NCT01748552|5737314|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
1641195|NCT01748552|5737315|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
1641196|NCT01748552|5737316|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
1641197|NCT01748552|5737317|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
1641198|NCT01748552|5737318|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
1641199|NCT01748552|5737319|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
1641200|NCT01748552|5737320|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
1641201|NCT01748552|5737321|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
1641202|NCT01748552|5737322|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
1641203|NCT01748552|5737323|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
1641204|NCT01748552|5737324|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
1641205|NCT01748552|5737325|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
1641206|NCT01748552|5737314|P12|Intervention Period 2 and Washout|Physician Decision|0
1641207|NCT01748552|5737315|P11|Intervention Period 2 and Washout|Physician Decision|0
1641208|NCT01748552|5737316|P10|Intervention Period 2 and Washout|Physician Decision|0
1641209|NCT01748552|5737317|P9|Intervention Period 2 and Washout|Physician Decision|0
1641210|NCT01748552|5737318|P8|Intervention Period 2 and Washout|Physician Decision|0
1641211|NCT01748552|5737319|P7|Intervention Period 2 and Washout|Physician Decision|0
1641212|NCT01748552|5737320|P6|Intervention Period 2 and Washout|Physician Decision|0
1641213|NCT01748552|5737321|P5|Intervention Period 2 and Washout|Physician Decision|0
1641214|NCT01748552|5737322|P4|Intervention Period 2 and Washout|Physician Decision|0
1641215|NCT01748552|5737323|P3|Intervention Period 2 and Washout|Physician Decision|1
1641216|NCT01748552|5737324|P2|Intervention Period 2 and Washout|Physician Decision|0
1641217|NCT01748552|5737325|P1|Intervention Period 2 and Washout|Physician Decision|0
1641218|NCT01748292|5737395|P2|Overall Study|Withdrawal by Subject|2
1641219|NCT01748292|5737396|P1|Overall Study|Withdrawal by Subject|0
1641220|NCT01748292|5737395|P2|Overall Study|Death|3
1641221|NCT01748292|5737396|P1|Overall Study|Death|0
1641222|NCT01748292|5737395|P2|Overall Study|Lost to Follow-up|3
1641223|NCT01748292|5737396|P1|Overall Study|Lost to Follow-up|0
1641224|NCT01748292|5737395|P2|Overall Study|Adverse Event|4
1641225|NCT01748292|5737396|P1|Overall Study|Adverse Event|2
1641226|NCT01748162|5737430|P2|Overall Study|reasons not available|2
1641227|NCT01748162|5737431|P1|Overall Study|reasons not available|3
1641228|NCT01748162|5737430|P2|Overall Study|participant consented but did not begin|1
1641229|NCT01748162|5737431|P1|Overall Study|participant consented but did not begin|0
1641230|NCT01748162|5737430|P2|Overall Study|no additional croup episodes to evaluate|2
1641231|NCT01748162|5737431|P1|Overall Study|no additional croup episodes to evaluate|2
1641232|NCT01748071|5737442|P3|Overall Study|Adverse Event|0
1641233|NCT01748071|5737443|P2|Overall Study|Adverse Event|2
1641234|NCT01748071|5737444|P1|Overall Study|Adverse Event|2
1641235|NCT01747915|5737707|P3|Overall Study|Pregnancy|1
1641236|NCT01747915|5737708|P2|Overall Study|Pregnancy|0
1641237|NCT01747915|5737709|P1|Overall Study|Pregnancy|0
1641238|NCT01747915|5737707|P3|Overall Study|Protocol Violation|0
1641239|NCT01747915|5737708|P2|Overall Study|Protocol Violation|0
1641240|NCT01747915|5737709|P1|Overall Study|Protocol Violation|1
1641241|NCT01747915|5737707|P3|Overall Study|Withdrawal by Subject|1
1641242|NCT01747915|5737708|P2|Overall Study|Withdrawal by Subject|4
1641243|NCT01747915|5737709|P1|Overall Study|Withdrawal by Subject|4
1641244|NCT01747915|5737707|P3|Overall Study|Lost to Follow-up|0
1641245|NCT01747915|5737708|P2|Overall Study|Lost to Follow-up|0
1641246|NCT01747915|5737709|P1|Overall Study|Lost to Follow-up|1
1641247|NCT01747915|5737707|P3|Overall Study|Lack of Efficacy|0
1641248|NCT01747915|5737708|P2|Overall Study|Lack of Efficacy|1
1641249|NCT01747915|5737709|P1|Overall Study|Lack of Efficacy|0
1641250|NCT01747915|5737707|P3|Overall Study|Death|1
1641251|NCT01747915|5737708|P2|Overall Study|Death|0
1641252|NCT01747915|5737709|P1|Overall Study|Death|0
1641253|NCT01747915|5737707|P3|Overall Study|Adverse Event|2
1641254|NCT01747915|5737708|P2|Overall Study|Adverse Event|5
1641255|NCT01747915|5737709|P1|Overall Study|Adverse Event|8
1641256|NCT01747915|5737707|P3|Overall Study|Other|1
1641257|NCT01747915|5737708|P2|Overall Study|Other|1
1641258|NCT01747915|5737709|P1|Overall Study|Other|1
1641259|NCT01747876|5737723|P3|Overall Study|Trtment duration compl. as per protocol|1
1641260|NCT01747876|5737724|P2|Overall Study|Trtment duration compl. as per protocol|1
1641261|NCT01747876|5737725|P1|Overall Study|Trtment duration compl. as per protocol|0
1641262|NCT01747876|5737723|P3|Overall Study|Disease progression|8
1641263|NCT01747876|5737724|P2|Overall Study|Disease progression|13
1641264|NCT01747876|5737725|P1|Overall Study|Disease progression|4
1641265|NCT01747876|5737723|P3|Overall Study|Withdrawal by Subject|1
1641266|NCT01747876|5737724|P2|Overall Study|Withdrawal by Subject|1
1641267|NCT01747876|5737725|P1|Overall Study|Withdrawal by Subject|0
1641268|NCT01747876|5737723|P3|Overall Study|Adverse Event|2
1641269|NCT01747876|5737724|P2|Overall Study|Adverse Event|0
1641270|NCT01747876|5737725|P1|Overall Study|Adverse Event|1
1641271|NCT01747837|5737778|P2|Overall Study|Death|4
1641272|NCT01747837|5737779|P1|Overall Study|Death|4
1641273|NCT01747837|5737778|P2|Overall Study|Lost to Follow-up|2
1641274|NCT01747837|5737779|P1|Overall Study|Lost to Follow-up|5
1641275|NCT01747811|5737809|P2|Overall Study|Lack of Efficacy|4
1641276|NCT01747811|5737810|P1|Overall Study|Lack of Efficacy|2
1641277|NCT01747772|5737826|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
1641278|NCT01747655|5737834|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
1641279|NCT01747655|5737835|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
1641280|NCT01747655|5737834|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
1641281|NCT01747655|5737835|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
1641282|NCT01747655|5737834|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
1641283|NCT01747655|5737835|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
1641284|NCT01747629|5737865|P2|Overall Study|Other|1
1641285|NCT01747629|5737866|P1|Overall Study|Other|2
1641286|NCT01747629|5737865|P2|Overall Study|Not treated|0
1641287|NCT01747629|5737866|P1|Overall Study|Not treated|1
1641288|NCT01747629|5737865|P2|Overall Study|Inclusion criteria not met|0
1641289|NCT01747629|5737866|P1|Overall Study|Inclusion criteria not met|1
1641290|NCT01747629|5737865|P2|Overall Study|Noncompliance|1
1641291|NCT01747629|5737866|P1|Overall Study|Noncompliance|1
1641292|NCT01747629|5737865|P2|Overall Study|Withdrawal by Subject|2
1641293|NCT01747629|5737866|P1|Overall Study|Withdrawal by Subject|2
1641294|NCT01747629|5737865|P2|Overall Study|Adverse Event|2
1641295|NCT01747629|5737866|P1|Overall Study|Adverse Event|1
1641296|NCT01747551|5737900|P2|Overall Study|Other|0
1641297|NCT01747551|5737901|P1|Overall Study|Other|2
1641298|NCT01747551|5737900|P2|Overall Study|Physician Decision|1
1641299|NCT01747551|5737901|P1|Overall Study|Physician Decision|2
1641300|NCT01747551|5737900|P2|Overall Study|Withdrawal by Subject|1
1641301|NCT01747551|5737901|P1|Overall Study|Withdrawal by Subject|3
1641302|NCT01747551|5737900|P2|Overall Study|Prolonged Treatment Delay|0
1641303|NCT01747551|5737901|P1|Overall Study|Prolonged Treatment Delay|2
1641304|NCT01747551|5737900|P2|Overall Study|Adverse Event|1
1641305|NCT01747551|5737901|P1|Overall Study|Adverse Event|7
1641306|NCT01747551|5737900|P2|Overall Study|Death|1
1641307|NCT01747551|5737901|P1|Overall Study|Death|3
1641308|NCT01747551|5737900|P2|Overall Study|Progressive Disease|17
1641309|NCT01747551|5737901|P1|Overall Study|Progressive Disease|24
1641310|NCT01747499|5737918|P5|Overall Study|Determined not to be eligible|1
1641311|NCT01747499|5737919|P4|Overall Study|Determined not to be eligible|0
1641312|NCT01747499|5737920|P3|Overall Study|Determined not to be eligible|0
1641313|NCT01747499|5737921|P2|Overall Study|Determined not to be eligible|0
1641314|NCT01747499|5737922|P1|Overall Study|Determined not to be eligible|0
1641315|NCT01747499|5737918|P5|Overall Study|Developed AML and death|1
1641316|NCT01747499|5737919|P4|Overall Study|Developed AML and death|0
1641317|NCT01747499|5737920|P3|Overall Study|Developed AML and death|0
1641318|NCT01747499|5737921|P2|Overall Study|Developed AML and death|0
1641319|NCT01747499|5737922|P1|Overall Study|Developed AML and death|0
1641320|NCT01747499|5737918|P5|Overall Study|Withdrawal by Subject|6
1641321|NCT01747499|5737919|P4|Overall Study|Withdrawal by Subject|0
1641322|NCT01747499|5737920|P3|Overall Study|Withdrawal by Subject|0
1641323|NCT01747499|5737921|P2|Overall Study|Withdrawal by Subject|0
1641324|NCT01747499|5737922|P1|Overall Study|Withdrawal by Subject|0
1641325|NCT01747499|5737918|P5|Overall Study|Death|1
1641326|NCT01747499|5737919|P4|Overall Study|Death|1
1641327|NCT01747499|5737920|P3|Overall Study|Death|0
1641328|NCT01747499|5737921|P2|Overall Study|Death|0
1641329|NCT01747499|5737922|P1|Overall Study|Death|0
1641330|NCT01747499|5737918|P5|Overall Study|Physician Decision|2
1641331|NCT01747499|5737919|P4|Overall Study|Physician Decision|0
1641332|NCT01747499|5737920|P3|Overall Study|Physician Decision|0
1641333|NCT01747499|5737921|P2|Overall Study|Physician Decision|1
1641334|NCT01747499|5737922|P1|Overall Study|Physician Decision|0
1641335|NCT01747499|5737918|P5|Overall Study|Steroid refractory aGvHD|4
1641336|NCT01747499|5737919|P4|Overall Study|Steroid refractory aGvHD|1
1641337|NCT01747499|5737920|P3|Overall Study|Steroid refractory aGvHD|0
1641338|NCT01747499|5737921|P2|Overall Study|Steroid refractory aGvHD|0
1641339|NCT01747499|5737922|P1|Overall Study|Steroid refractory aGvHD|1
1641340|NCT01747486|5737958|P2|Stage 2|Disease Progression|0
1641341|NCT01747486|5737959|P1|Stage 2|Disease Progression|3
1641342|NCT01747486|5737958|P2|Stage 2|New Cancer Therapy|0
1641343|NCT01747486|5737959|P1|Stage 2|New Cancer Therapy|3
1641344|NCT01747486|5737958|P2|Stage 2|Withdrawal by Subject|0
1641345|NCT01747486|5737959|P1|Stage 2|Withdrawal by Subject|1
1641346|NCT01747486|5737958|P2|Stage 2|Physician Decision|0
1641347|NCT01747486|5737959|P1|Stage 2|Physician Decision|2
1641348|NCT01747486|5737958|P2|Stage 1|Death|1
1641349|NCT01747486|5737959|P1|Stage 1|Death|1
1641350|NCT01747486|5737958|P2|Stage 1|Disease progression|9
1641351|NCT01747486|5737959|P1|Stage 1|Disease progression|4
1641352|NCT01747486|5737958|P2|Stage 1|Withdrawal by Subject|3
1641353|NCT01747486|5737959|P1|Stage 1|Withdrawal by Subject|4
1641354|NCT01747486|5737958|P2|Stage 1|Physician Decision|0
1641355|NCT01747486|5737959|P1|Stage 1|Physician Decision|3
1641356|NCT01746901|5738009|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
1641357|NCT01746901|5738010|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
1641358|NCT01746901|5738011|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
1641359|NCT01746901|5738012|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
1641360|NCT01746901|5738013|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
1641361|NCT01746901|5738014|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
1641362|NCT01746901|5738015|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
1641363|NCT01746901|5738016|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
1641364|NCT01746901|5738017|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
1641365|NCT01746901|5738009|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
1641366|NCT01746901|5738010|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
1641367|NCT01746901|5738011|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
1641368|NCT01746901|5738012|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
1641369|NCT01746901|5738013|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
1641370|NCT01746901|5738014|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
1641371|NCT01746901|5738015|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
1641372|NCT01746901|5738016|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
1641373|NCT01746901|5738017|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
1641374|NCT01746901|5738009|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641375|NCT01746901|5738010|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641376|NCT01746901|5738011|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641377|NCT01746901|5738012|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641378|NCT01746901|5738013|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641379|NCT01746901|5738014|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
1641380|NCT01746901|5738015|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641381|NCT01746901|5738016|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641382|NCT01746901|5738017|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
1641383|NCT01746901|5738009|P9|Treatment Phase: Third Intervention|Protocol Violation|0
1641384|NCT01746901|5738010|P8|Treatment Phase: Third Intervention|Protocol Violation|0
1641385|NCT01746901|5738011|P7|Treatment Phase: Third Intervention|Protocol Violation|1
1641386|NCT01746901|5738012|P6|Treatment Phase: Third Intervention|Protocol Violation|1
1641387|NCT01746901|5738013|P5|Treatment Phase: Third Intervention|Protocol Violation|0
1641388|NCT01746901|5738014|P4|Treatment Phase: Third Intervention|Protocol Violation|0
1641389|NCT01746901|5738015|P3|Treatment Phase: Third Intervention|Protocol Violation|0
1641390|NCT01746901|5738016|P2|Treatment Phase: Third Intervention|Protocol Violation|0
1641391|NCT01746901|5738017|P1|Treatment Phase: Third Intervention|Protocol Violation|0
1641392|NCT01746901|5738009|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641393|NCT01746901|5738010|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
1641394|NCT01746901|5738011|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641395|NCT01746901|5738012|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641396|NCT01746901|5738013|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641397|NCT01746901|5738014|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641398|NCT01746901|5738015|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641399|NCT01746901|5738016|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641400|NCT01746901|5738017|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
1641401|NCT01746901|5738009|P9|Treatment Phase: First Intervention|Protocol Violation|0
1641402|NCT01746901|5738010|P8|Treatment Phase: First Intervention|Protocol Violation|0
1641403|NCT01746901|5738011|P7|Treatment Phase: First Intervention|Protocol Violation|1
1641404|NCT01746901|5738012|P6|Treatment Phase: First Intervention|Protocol Violation|0
1641405|NCT01746901|5738013|P5|Treatment Phase: First Intervention|Protocol Violation|0
1641406|NCT01746901|5738014|P4|Treatment Phase: First Intervention|Protocol Violation|0
1641407|NCT01746901|5738015|P3|Treatment Phase: First Intervention|Protocol Violation|0
1641408|NCT01746901|5738016|P2|Treatment Phase: First Intervention|Protocol Violation|0
1641409|NCT01746901|5738017|P1|Treatment Phase: First Intervention|Protocol Violation|0
1641410|NCT01746901|5738009|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
1641411|NCT01746901|5738010|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
1641412|NCT01746901|5738011|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
1641413|NCT01746901|5738012|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
1641414|NCT01746901|5738013|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
1641415|NCT01746901|5738014|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
1641416|NCT01746901|5738015|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
1641417|NCT01746901|5738016|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
1641418|NCT01746901|5738017|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
1641419|NCT01746901|5738009|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1641420|NCT01746901|5738010|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1641421|NCT01746901|5738011|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1641422|NCT01746901|5738012|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1641423|NCT01746901|5738013|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1641424|NCT01746901|5738014|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1641425|NCT01746901|5738015|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
1641426|NCT01746901|5738016|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
1641427|NCT01746901|5738017|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
1641428|NCT01746901|5738009|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
1641429|NCT01746901|5738010|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
1641430|NCT01746901|5738011|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
1641431|NCT01746901|5738012|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
1641432|NCT01746901|5738013|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
1641433|NCT01746901|5738014|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
1641434|NCT01746901|5738015|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
1641435|NCT01746901|5738016|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
1641436|NCT01746901|5738017|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
1641437|NCT01746901|5738009|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
1641438|NCT01746901|5738010|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
1641439|NCT01746901|5738011|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
1641440|NCT01746901|5738012|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
1641441|NCT01746901|5738013|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
1641442|NCT01746901|5738014|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
1641443|NCT01746901|5738015|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
1641444|NCT01746901|5738016|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
1641445|NCT01746901|5738017|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
1641446|NCT01746901|5738009|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641447|NCT01746901|5738010|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641448|NCT01746901|5738011|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641449|NCT01746901|5738012|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641450|NCT01746901|5738013|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641451|NCT01746901|5738014|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641452|NCT01746901|5738015|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641453|NCT01746901|5738016|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
1641454|NCT01746901|5738017|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
1641455|NCT01746901|5738009|P9|Naloxone Challenge Phase|Adverse Event|0
1641456|NCT01746901|5738010|P8|Naloxone Challenge Phase|Adverse Event|0
1641457|NCT01746901|5738011|P7|Naloxone Challenge Phase|Adverse Event|0
1641458|NCT01746901|5738012|P6|Naloxone Challenge Phase|Adverse Event|0
1641459|NCT01746901|5738013|P5|Naloxone Challenge Phase|Adverse Event|0
1641460|NCT01746901|5738014|P4|Naloxone Challenge Phase|Adverse Event|0
1641461|NCT01746901|5738015|P3|Naloxone Challenge Phase|Adverse Event|0
1641462|NCT01746901|5738016|P2|Naloxone Challenge Phase|Adverse Event|0
1641463|NCT01746901|5738017|P1|Naloxone Challenge Phase|Adverse Event|2
1641464|NCT01746862|5738340|P2|Overall Study|Entered puberty during the study|0
1641465|NCT01746862|5738341|P1|Overall Study|Entered puberty during the study|1
1641466|NCT01746862|5738340|P2|Overall Study|Consent withdrawal by parent’s guardian|2
1641467|NCT01746862|5738341|P1|Overall Study|Consent withdrawal by parent’s guardian|5
1641468|NCT01746862|5738340|P2|Overall Study|Protocol Violation|0
1641469|NCT01746862|5738341|P1|Overall Study|Protocol Violation|1
1641470|NCT01746862|5738340|P2|Overall Study|Withdrawal by Subject|1
1641471|NCT01746862|5738341|P1|Overall Study|Withdrawal by Subject|1
1641472|NCT01746732|5738405|P3|Period 2|Lost to Follow-up|1
1641473|NCT01746732|5738406|P2|Period 2|Lost to Follow-up|0
1641474|NCT01746732|5738407|P1|Period 2|Lost to Follow-up|0
1641475|NCT01746732|5738405|P3|Period 2|Adverse Event|1
1641476|NCT01746732|5738406|P2|Period 2|Adverse Event|0
1641477|NCT01746732|5738407|P1|Period 2|Adverse Event|0
1641478|NCT01746732|5738405|P3|Period 2|Withdrawal by Subject|2
1641479|NCT01746732|5738406|P2|Period 2|Withdrawal by Subject|0
1641480|NCT01746732|5738407|P1|Period 2|Withdrawal by Subject|0
1641481|NCT01746732|5738405|P3|Period 1|Physician Decision|0
1641482|NCT01746732|5738406|P2|Period 1|Physician Decision|1
1641483|NCT01746732|5738407|P1|Period 1|Physician Decision|0
1641484|NCT01746732|5738405|P3|Lead-In Period|Withdrawal by Subject|0
1641485|NCT01746732|5738406|P2|Lead-In Period|Withdrawal by Subject|0
1641486|NCT01746732|5738407|P1|Lead-In Period|Withdrawal by Subject|1
1641487|NCT01746368|5738488|P2|Overall Study|Withdrawal by Subject|1
1641488|NCT01746368|5738489|P1|Overall Study|Withdrawal by Subject|0
1641489|NCT01746368|5738488|P2|Overall Study|Lost to Follow-up|0
1641490|NCT01746368|5738489|P1|Overall Study|Lost to Follow-up|2
1641491|NCT01746173|5738516|P1|Overall Study|Disease Progression|2
1641492|NCT01746108|5738524|P3|Overall Study|Lost to Follow-up|0
1641493|NCT01746108|5738525|P2|Overall Study|Lost to Follow-up|1
1641494|NCT01746108|5738526|P1|Overall Study|Lost to Follow-up|0
1641495|NCT01746108|5738524|P3|Overall Study|Withdrawal by Subject|0
1641496|NCT01746108|5738525|P2|Overall Study|Withdrawal by Subject|1
1641497|NCT01746108|5738526|P1|Overall Study|Withdrawal by Subject|0
1641498|NCT01746108|5738524|P3|Overall Study|Adverse event, non-fatal|0
1641499|NCT01746108|5738525|P2|Overall Study|Adverse event, non-fatal|1
1641500|NCT01746108|5738526|P1|Overall Study|Adverse event, non-fatal|0
1641501|NCT01746108|5738524|P3|Overall Study|Migrated /moved from study area|0
1641502|NCT01746108|5738525|P2|Overall Study|Migrated /moved from study area|1
1641503|NCT01746108|5738526|P1|Overall Study|Migrated /moved from study area|0
1641504|NCT01746017|5738643|P11|Period 3|Withdrawal by Subject|0
1641505|NCT01746017|5738644|P10|Period 3|Withdrawal by Subject|0
1641506|NCT01746017|5738645|P9|Period 3|Withdrawal by Subject|0
1641507|NCT01746017|5738646|P8|Period 3|Withdrawal by Subject|0
1641508|NCT01746017|5738647|P7|Period 3|Withdrawal by Subject|0
1641509|NCT01746017|5738648|P6|Period 3|Withdrawal by Subject|1
1641510|NCT01746017|5738649|P5|Period 3|Withdrawal by Subject|0
1641511|NCT01746017|5738650|P4|Period 3|Withdrawal by Subject|0
1641512|NCT01746017|5738651|P3|Period 3|Withdrawal by Subject|0
1641513|NCT01746017|5738652|P2|Period 3|Withdrawal by Subject|0
1641514|NCT01746017|5738653|P1|Period 3|Withdrawal by Subject|0
1641515|NCT01746017|5738643|P11|Period 1|Withdrawal by Subject|0
1641516|NCT01746017|5738644|P10|Period 1|Withdrawal by Subject|0
1641517|NCT01746017|5738645|P9|Period 1|Withdrawal by Subject|0
1641518|NCT01746017|5738646|P8|Period 1|Withdrawal by Subject|0
1641519|NCT01746017|5738647|P7|Period 1|Withdrawal by Subject|1
1641520|NCT01746017|5738648|P6|Period 1|Withdrawal by Subject|0
1641521|NCT01746017|5738649|P5|Period 1|Withdrawal by Subject|0
1641522|NCT01746017|5738650|P4|Period 1|Withdrawal by Subject|0
1641523|NCT01746017|5738651|P3|Period 1|Withdrawal by Subject|0
1641524|NCT01746017|5738652|P2|Period 1|Withdrawal by Subject|0
1641525|NCT01746017|5738653|P1|Period 1|Withdrawal by Subject|0
1641526|NCT01745848|5738774|P1|Overall Study|Adverse Event|6
1641527|NCT01745393|5738781|P2|12-month Follow-up|Lost to Follow-up|5
1641528|NCT01745393|5738782|P1|12-month Follow-up|Lost to Follow-up|6
1641529|NCT01745393|5738781|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
1641530|NCT01745393|5738782|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
1641531|NCT01745393|5738781|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
1641532|NCT01745393|5738782|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
1641533|NCT01745380|5738794|P2|Overall Study|Lack of Efficacy|1
1641534|NCT01745380|5738795|P1|Overall Study|Lack of Efficacy|0
1641535|NCT01745380|5738794|P2|Overall Study|Lost to Follow-up|0
1641536|NCT01745380|5738795|P1|Overall Study|Lost to Follow-up|1
1641537|NCT01745146|5738833|P2|Overall Study|Lost to Follow-up|0
1641538|NCT01745146|5738834|P1|Overall Study|Lost to Follow-up|2
1641539|NCT01745146|5738833|P2|Overall Study|Withdrawal by Subject|3
1641540|NCT01745146|5738834|P1|Overall Study|Withdrawal by Subject|1
1641541|NCT01745120|5738856|P2|Overall Study|Investigator decision|0
1641542|NCT01745120|5738857|P1|Overall Study|Investigator decision|1
1641543|NCT01745094|5738915|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
1641544|NCT01745094|5738916|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
1641545|NCT01745094|5738917|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
1641546|NCT01745094|5738918|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
1641547|NCT01745094|5738915|P4|Overall Study|Show no Stable Solifenacin Intake|0
1641548|NCT01745094|5738916|P3|Overall Study|Show no Stable Solifenacin Intake|1
1641549|NCT01745094|5738917|P2|Overall Study|Show no Stable Solifenacin Intake|0
1641550|NCT01745094|5738918|P1|Overall Study|Show no Stable Solifenacin Intake|0
1641551|NCT01745094|5738915|P4|Overall Study|Need Further Examinations Due to Biopsy|0
1641552|NCT01745094|5738916|P3|Overall Study|Need Further Examinations Due to Biopsy|1
1641553|NCT01745094|5738917|P2|Overall Study|Need Further Examinations Due to Biopsy|0
1641554|NCT01745094|5738918|P1|Overall Study|Need Further Examinations Due to Biopsy|0
1641555|NCT01745094|5738915|P4|Overall Study|Protocol Violation|1
1641556|NCT01745094|5738916|P3|Overall Study|Protocol Violation|3
1641557|NCT01745094|5738917|P2|Overall Study|Protocol Violation|0
1641558|NCT01745094|5738918|P1|Overall Study|Protocol Violation|1
1641559|NCT01745094|5738915|P4|Overall Study|Withdrawal by Subject|2
1641560|NCT01745094|5738916|P3|Overall Study|Withdrawal by Subject|1
1641561|NCT01745094|5738917|P2|Overall Study|Withdrawal by Subject|0
1641562|NCT01745094|5738918|P1|Overall Study|Withdrawal by Subject|2
1641563|NCT01745094|5738915|P4|Overall Study|Adverse Event|0
1641564|NCT01745094|5738916|P3|Overall Study|Adverse Event|3
1641565|NCT01745094|5738917|P2|Overall Study|Adverse Event|0
1641566|NCT01745094|5738918|P1|Overall Study|Adverse Event|0
1641567|NCT01745094|5738915|P4|Overall Study|Not Meeting the Eligibility Criteria|0
1641568|NCT01745094|5738916|P3|Overall Study|Not Meeting the Eligibility Criteria|3
1641569|NCT01745094|5738917|P2|Overall Study|Not Meeting the Eligibility Criteria|0
1641570|NCT01745094|5738918|P1|Overall Study|Not Meeting the Eligibility Criteria|1
1641571|NCT01744977|5739019|P2|Overall Study|No longer meets inclusion|0
1641572|NCT01744977|5739020|P1|Overall Study|No longer meets inclusion|6
1641573|NCT01744977|5739019|P2|Overall Study|Lost to Follow-up|0
1641574|NCT01744977|5739020|P1|Overall Study|Lost to Follow-up|2
1641575|NCT01744977|5739019|P2|Overall Study|Death|3
1641576|NCT01744977|5739020|P1|Overall Study|Death|2
1641577|NCT01744977|5739019|P2|Overall Study|Withdrawal by Subject|2
1641578|NCT01744977|5739020|P1|Overall Study|Withdrawal by Subject|1
1641579|NCT01744782|5739091|P1|Overall Study|Death|1
1641580|NCT01744691|5739252|P1|Overall Study|Physician Decision|4
1641581|NCT01744691|5739252|P1|Overall Study|Withdrawal of consent for treatment|3
1641582|NCT01744691|5739252|P1|Overall Study|Unacceptable toxicity, AE or death|18
1641583|NCT01744691|5739252|P1|Overall Study|Progressive Disease|18
1641584|NCT01744496|5739300|P2|Maintenance Period|Subject left town|0
1641585|NCT01744496|5739301|P1|Maintenance Period|Subject left town|1
1641586|NCT01744496|5739300|P2|Maintenance Period|Withdrawal by Subject|1
1641587|NCT01744496|5739301|P1|Maintenance Period|Withdrawal by Subject|1
1641588|NCT01744496|5739300|P2|Maintenance Period|Protocol Violation|0
1641589|NCT01744496|5739301|P1|Maintenance Period|Protocol Violation|1
1641590|NCT01744496|5739300|P2|Maintenance Period|Adverse Event|3
1641591|NCT01744496|5739301|P1|Maintenance Period|Adverse Event|1
1641592|NCT01744496|5739300|P2|Titration Period|Personal reasons|1
1641593|NCT01744496|5739301|P1|Titration Period|Personal reasons|0
1641594|NCT01744496|5739300|P2|Titration Period|Adverse Event|1
1641595|NCT01744496|5739301|P1|Titration Period|Adverse Event|2
1641596|NCT01744483|5739322|P3|Overall Study|Routed to OSH|1
1641597|NCT01744483|5739323|P2|Overall Study|Routed to OSH|0
1641598|NCT01744483|5739324|P1|Overall Study|Routed to OSH|2
1641599|NCT01744483|5739322|P3|Overall Study|No ICU Admit|2
1641600|NCT01744483|5739323|P2|Overall Study|No ICU Admit|1
1641601|NCT01744483|5739324|P1|Overall Study|No ICU Admit|5
1641602|NCT01744483|5739322|P3|Overall Study|Withdrawal by Subject|2
1641603|NCT01744483|5739323|P2|Overall Study|Withdrawal by Subject|6
1641604|NCT01744483|5739324|P1|Overall Study|Withdrawal by Subject|4
1641605|NCT01744483|5739322|P3|Overall Study|Protocol Violation|1
1641606|NCT01744483|5739323|P2|Overall Study|Protocol Violation|2
1641607|NCT01744483|5739324|P1|Overall Study|Protocol Violation|1
1641608|NCT01744483|5739322|P3|Overall Study|Lost to Follow-up|11
1641609|NCT01744483|5739323|P2|Overall Study|Lost to Follow-up|9
1641610|NCT01744483|5739324|P1|Overall Study|Lost to Follow-up|8
1641611|NCT01744483|5739322|P3|Overall Study|Death|11
1641612|NCT01744483|5739323|P2|Overall Study|Death|4
1641613|NCT01744483|5739324|P1|Overall Study|Death|9
1641614|NCT01744392|5739332|P1|Overall Study|Physician Decision|1
1641615|NCT01744197|5739372|P2|Overall Study|No patch received|2
1641616|NCT01744197|5739373|P1|Overall Study|No patch received|2
1641617|NCT01744197|5739372|P2|Overall Study|Received 1 patch|1
1641618|NCT01744197|5739373|P1|Overall Study|Received 1 patch|2
1641619|NCT01743560|5739424|P1|Overall Study|>1 dose of study drug|3
1641620|NCT01743560|5739424|P1|Overall Study|Protocol Violation|1
1641621|NCT01743560|5739424|P1|Overall Study|Withdrawal by Subject|2
1641622|NCT01743560|5739424|P1|Overall Study|Death|3
1641623|NCT01743560|5739424|P1|Overall Study|Adverse Event|8
1641624|NCT01743560|5739424|P1|Overall Study|Disease progression|26
1641625|NCT01743469|5739508|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1641626|NCT01743469|5739509|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
1641627|NCT01743469|5739510|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1641628|NCT01743469|5739511|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
1641629|NCT01743469|5739508|P4|Follow-up Period - Post-Treatment|Death|16
1641630|NCT01743469|5739509|P3|Follow-up Period - Post-Treatment|Death|22
1641631|NCT01743469|5739510|P2|Follow-up Period - Post-Treatment|Death|47
1641632|NCT01743469|5739511|P1|Follow-up Period - Post-Treatment|Death|43
1641633|NCT01743469|5739508|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1641634|NCT01743469|5739509|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1641635|NCT01743469|5739510|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
1641636|NCT01743469|5739511|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
1641637|NCT01743469|5739508|P4|Active Treatment Phase|Missing|0
1641638|NCT01743469|5739509|P3|Active Treatment Phase|Missing|0
1641639|NCT01743469|5739510|P2|Active Treatment Phase|Missing|0
1641640|NCT01743469|5739511|P1|Active Treatment Phase|Missing|1
1641641|NCT01743469|5739508|P4|Active Treatment Phase|Withdrawal by Subject|0
1641642|NCT01743469|5739509|P3|Active Treatment Phase|Withdrawal by Subject|0
1641643|NCT01743469|5739510|P2|Active Treatment Phase|Withdrawal by Subject|3
1641644|NCT01743469|5739511|P1|Active Treatment Phase|Withdrawal by Subject|2
1641645|NCT01743469|5739508|P4|Active Treatment Phase|Disease Progression|20
1641646|NCT01743469|5739509|P3|Active Treatment Phase|Disease Progression|30
1641647|NCT01743469|5739510|P2|Active Treatment Phase|Disease Progression|47
1641648|NCT01743469|5739511|P1|Active Treatment Phase|Disease Progression|40
1641649|NCT01743469|5739508|P4|Active Treatment Phase|Adverse Event|1
1641650|NCT01743469|5739509|P3|Active Treatment Phase|Adverse Event|8
1641651|NCT01743469|5739510|P2|Active Treatment Phase|Adverse Event|5
1641652|NCT01743469|5739511|P1|Active Treatment Phase|Adverse Event|10
1641653|NCT01743092|5739551|P2|Overall Study|Lost to Follow-up|15
1641654|NCT01743092|5739552|P1|Overall Study|Lost to Follow-up|14
1641655|NCT01743027|5739564|P4|Overall Study|Withdrawal by Subject|1
1641656|NCT01743027|5739565|P3|Overall Study|Withdrawal by Subject|3
1641657|NCT01743027|5739566|P2|Overall Study|Withdrawal by Subject|0
1641658|NCT01743027|5739567|P1|Overall Study|Withdrawal by Subject|1
1641659|NCT01743027|5739564|P4|Overall Study|Protocol Violation|0
1641660|NCT01743027|5739565|P3|Overall Study|Protocol Violation|1
1641661|NCT01743027|5739566|P2|Overall Study|Protocol Violation|1
1641662|NCT01743027|5739567|P1|Overall Study|Protocol Violation|1
1641663|NCT01743027|5739564|P4|Overall Study|Progressive Disease|0
1641664|NCT01743027|5739565|P3|Overall Study|Progressive Disease|3
1641665|NCT01743027|5739566|P2|Overall Study|Progressive Disease|4
1641666|NCT01743027|5739567|P1|Overall Study|Progressive Disease|1
1641667|NCT01743027|5739564|P4|Overall Study|Lost to Follow-up|0
1641668|NCT01743027|5739565|P3|Overall Study|Lost to Follow-up|2
1641669|NCT01743027|5739566|P2|Overall Study|Lost to Follow-up|0
1641670|NCT01743027|5739567|P1|Overall Study|Lost to Follow-up|0
1641671|NCT01743027|5739564|P4|Overall Study|Adverse Event|0
1641672|NCT01743027|5739565|P3|Overall Study|Adverse Event|0
1641673|NCT01743027|5739566|P2|Overall Study|Adverse Event|0
1641674|NCT01743027|5739567|P1|Overall Study|Adverse Event|2
1641675|NCT01743001|5739607|P2|Overall Study|Death|0
1641676|NCT01743001|5739608|P1|Overall Study|Death|1
1641677|NCT01743001|5739607|P2|Overall Study|Pregnancy|0
1641678|NCT01743001|5739608|P1|Overall Study|Pregnancy|1
1641679|NCT01743001|5739607|P2|Overall Study|Physician Decision|0
1641680|NCT01743001|5739608|P1|Overall Study|Physician Decision|1
1641681|NCT01742897|5739651|P1|Overall Study|Other|1
1641682|NCT01742897|5739651|P1|Overall Study|Withdrawal by Subject|1
1641683|NCT01742897|5739651|P1|Overall Study|Adverse Event|3
1641684|NCT01742091|5739732|P6|Overall Study|Lost to Follow-up|1
1641685|NCT01742091|5739733|P5|Overall Study|Lost to Follow-up|0
1641686|NCT01742091|5739734|P4|Overall Study|Lost to Follow-up|0
1641687|NCT01742091|5739735|P3|Overall Study|Lost to Follow-up|0
1641688|NCT01742091|5739736|P2|Overall Study|Lost to Follow-up|0
1641689|NCT01742091|5739737|P1|Overall Study|Lost to Follow-up|0
1641690|NCT01742091|5739732|P6|Overall Study|Withdrawal by Subject|0
1641691|NCT01742091|5739733|P5|Overall Study|Withdrawal by Subject|0
1641692|NCT01742091|5739734|P4|Overall Study|Withdrawal by Subject|1
1641693|NCT01742091|5739735|P3|Overall Study|Withdrawal by Subject|0
1641694|NCT01742091|5739736|P2|Overall Study|Withdrawal by Subject|0
1641695|NCT01742091|5739737|P1|Overall Study|Withdrawal by Subject|0
1641696|NCT01742091|5739732|P6|Overall Study|Physician Decision|1
1641697|NCT01742091|5739733|P5|Overall Study|Physician Decision|0
1641698|NCT01742091|5739734|P4|Overall Study|Physician Decision|0
1641699|NCT01742091|5739735|P3|Overall Study|Physician Decision|0
1641700|NCT01742091|5739736|P2|Overall Study|Physician Decision|0
1641701|NCT01742091|5739737|P1|Overall Study|Physician Decision|0
1641702|NCT01742091|5739732|P6|Overall Study|Adverse Event|0
1641703|NCT01742091|5739733|P5|Overall Study|Adverse Event|1
1641704|NCT01742091|5739734|P4|Overall Study|Adverse Event|0
1641705|NCT01742091|5739735|P3|Overall Study|Adverse Event|0
1641706|NCT01742091|5739736|P2|Overall Study|Adverse Event|0
1641707|NCT01742091|5739737|P1|Overall Study|Adverse Event|0
1641708|NCT01742078|5739783|P9|Overall Study|Withdrawal by Subject|0
1641709|NCT01742078|5739784|P8|Overall Study|Withdrawal by Subject|0
1641710|NCT01742078|5739785|P7|Overall Study|Withdrawal by Subject|0
1641711|NCT01742078|5739786|P6|Overall Study|Withdrawal by Subject|0
1641712|NCT01742078|5739787|P5|Overall Study|Withdrawal by Subject|0
1641713|NCT01742078|5739788|P4|Overall Study|Withdrawal by Subject|1
1641714|NCT01742078|5739789|P3|Overall Study|Withdrawal by Subject|0
1641715|NCT01742078|5739790|P2|Overall Study|Withdrawal by Subject|0
1641716|NCT01742078|5739791|P1|Overall Study|Withdrawal by Subject|0
1641717|NCT01741792|5739860|P3|Overall Study|Death|12
1641718|NCT01741792|5739861|P2|Overall Study|Death|1
1641719|NCT01741792|5739862|P1|Overall Study|Death|6
1641720|NCT01741701|5739929|P2|Overall Study|Withdrawal by Subject|1
1641721|NCT01741701|5739930|P1|Overall Study|Withdrawal by Subject|0
1641722|NCT01741701|5739929|P2|Overall Study|Adverse Event|1
1641723|NCT01741701|5739930|P1|Overall Study|Adverse Event|5
1641724|NCT01741688|5739946|P1|Overall Study|Withdrawal by Subject|1
1641725|NCT01741688|5739946|P1|Overall Study|Lack of insurance coverage|2
1641726|NCT01741545|5739965|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
1641727|NCT01741545|5739966|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
1641728|NCT01741545|5739965|P2|Follow-up Period (24 Weeks)|Other than specified|1
1641729|NCT01741545|5739966|P1|Follow-up Period (24 Weeks)|Other than specified|0
1641730|NCT01741545|5739965|P2|Treatment Period|Adverse event, non-fatal|3
1641731|NCT01741545|5739966|P1|Treatment Period|Adverse event, non-fatal|1
1641732|NCT01741545|5739965|P2|Treatment Period|Lack of Efficacy|1
1641733|NCT01741545|5739966|P1|Treatment Period|Lack of Efficacy|0
1641734|NCT01741532|5739990|P2|Overall Study|Medical event|0
1641735|NCT01741532|5739991|P1|Overall Study|Medical event|1
1641736|NCT01741532|5739990|P2|Overall Study|Sponsor decision|0
1641737|NCT01741532|5739991|P1|Overall Study|Sponsor decision|1
1641738|NCT01741532|5739990|P2|Overall Study|Worsening of the disease|1
1641739|NCT01741532|5739991|P1|Overall Study|Worsening of the disease|3
1641740|NCT01741532|5739990|P2|Overall Study|Protocol Violation|1
1641741|NCT01741532|5739991|P1|Overall Study|Protocol Violation|0
1641742|NCT01741532|5739990|P2|Overall Study|Withdrawal by Subject|1
1641743|NCT01741532|5739991|P1|Overall Study|Withdrawal by Subject|1
1641744|NCT01741532|5739990|P2|Overall Study|Adverse Event|0
1641745|NCT01741532|5739991|P1|Overall Study|Adverse Event|4
1641746|NCT01741259|5740205|P2|Overall Study|Withdrawal by Subject|2
1641747|NCT01741259|5740206|P1|Overall Study|Withdrawal by Subject|0
1641748|NCT01741259|5740205|P2|Overall Study|Protocol Violation|4
1641749|NCT01741259|5740206|P1|Overall Study|Protocol Violation|6
1641750|NCT01741012|5740260|P1|Overall Study|Withdrawal by Subject|2
1641751|NCT01741012|5740260|P1|Overall Study|Lost to Follow-up|1
1641752|NCT01740440|5740332|P1|Overall Study|Lost to Follow-up|3
1641773|NCT01740401|5740393|P1|Overall Study|Did not reach primary endpoint|2
1641774|NCT01740401|5740393|P1|Overall Study|Adverse Event|2
1641775|NCT01740401|5740393|P1|Overall Study|Progression of disease|6
1641776|NCT01740388|5740402|P2|Overall Study|Subjects missing data, completed|36
1641777|NCT01740388|5740403|P1|Overall Study|Subjects missing data, completed|41
1641778|NCT01740388|5740402|P2|Overall Study|Physician Decision|6
1641779|NCT01740388|5740403|P1|Overall Study|Physician Decision|2
1641780|NCT01740388|5740402|P2|Overall Study|Lost to Follow-up|0
1641781|NCT01740388|5740403|P1|Overall Study|Lost to Follow-up|2
1641782|NCT01740388|5740402|P2|Overall Study|Withdrawal by Subject|2
1641783|NCT01740388|5740403|P1|Overall Study|Withdrawal by Subject|1
1641784|NCT01740323|5740454|P2|Overall Study|Randomized but did not take study drug|0
1641785|NCT01740323|5740455|P1|Overall Study|Randomized but did not take study drug|1
1641786|NCT01740323|5740454|P2|Overall Study|Adverse Event|0
1641787|NCT01740323|5740455|P1|Overall Study|Adverse Event|1
1641788|NCT01740297|5740476|P3|Overall Study|Sponsor Decision|0
1641789|NCT01740297|5740477|P2|Overall Study|Sponsor Decision|1
1641790|NCT01740297|5740478|P1|Overall Study|Sponsor Decision|0
1641791|NCT01740297|5740476|P3|Overall Study|Death|19
1641792|NCT01740297|5740477|P2|Overall Study|Death|23
1641793|NCT01740297|5740478|P1|Overall Study|Death|8
1641794|NCT01740297|5740476|P3|Overall Study|Withdrawal by Subject|11
1641795|NCT01740297|5740477|P2|Overall Study|Withdrawal by Subject|9
1641796|NCT01740297|5740478|P1|Overall Study|Withdrawal by Subject|1
1641797|NCT01740297|5740476|P3|Overall Study|Continuing Study|68
1641798|NCT01740297|5740477|P2|Overall Study|Continuing Study|67
1641799|NCT01740297|5740478|P1|Overall Study|Continuing Study|10
1641800|NCT01740154|5740527|P1|Overall Study|Adverse Event|1
1641801|NCT01740128|5740535|P2|Overall Study|Insufficient protocol compliance|2
1641802|NCT01740128|5740536|P1|Overall Study|Insufficient protocol compliance|2
1641803|NCT01740128|5740535|P2|Overall Study|Withdrawal by Subject|0
1641804|NCT01740128|5740536|P1|Overall Study|Withdrawal by Subject|1
1641805|NCT01740128|5740535|P2|Overall Study|Lost to Follow-up|2
1641806|NCT01740128|5740536|P1|Overall Study|Lost to Follow-up|2
1641807|NCT01740128|5740535|P2|Overall Study|Protocol Violation|2
1641808|NCT01740128|5740536|P1|Overall Study|Protocol Violation|1
1641809|NCT01740128|5740535|P2|Overall Study|Pregnancy|1
1641810|NCT01740128|5740536|P1|Overall Study|Pregnancy|0
1641811|NCT01740089|5740565|P3|After 12 Weeks|Withdrawal by Subject|1
1641812|NCT01740089|5740566|P2|After 12 Weeks|Withdrawal by Subject|1
1641813|NCT01740089|5740567|P1|After 12 Weeks|Withdrawal by Subject|1
1641814|NCT01740089|5740565|P3|After 12 Weeks|Protocol Violation|1
1641815|NCT01740089|5740566|P2|After 12 Weeks|Protocol Violation|1
1641816|NCT01740089|5740567|P1|After 12 Weeks|Protocol Violation|1
1641817|NCT01740089|5740565|P3|After 12 Weeks|Adverse Event|5
1641818|NCT01740089|5740566|P2|After 12 Weeks|Adverse Event|0
1641819|NCT01740089|5740567|P1|After 12 Weeks|Adverse Event|2
1641820|NCT01740089|5740565|P3|After 12 Weeks|Lack of Efficacy|4
1641821|NCT01740089|5740566|P2|After 12 Weeks|Lack of Efficacy|1
1641822|NCT01740089|5740567|P1|After 12 Weeks|Lack of Efficacy|3
1641823|NCT01740089|5740565|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
1641824|NCT01740089|5740566|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
1641825|NCT01740089|5740567|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
1641826|NCT01740089|5740565|P3|First 12 Weeks of Treatment|Adverse Event|2
1641827|NCT01740089|5740566|P2|First 12 Weeks of Treatment|Adverse Event|1
1641828|NCT01740089|5740567|P1|First 12 Weeks of Treatment|Adverse Event|0
1641829|NCT01739803|5740585|P2|Overall Study|Lost to Follow-up|6
1641830|NCT01739803|5740586|P1|Overall Study|Lost to Follow-up|9
1641831|NCT01739790|5740598|P2|Overall Study|Early Trial Termination|4
1641832|NCT01739790|5740599|P1|Overall Study|Early Trial Termination|2
1641833|NCT01739595|5740608|P3|Overall Study|Drug discrepancy|0
1641834|NCT01739595|5740609|P2|Overall Study|Drug discrepancy|0
1641835|NCT01739595|5740610|P1|Overall Study|Drug discrepancy|1
1641836|NCT01739595|5740608|P3|Overall Study|Lab assessment|0
1641837|NCT01739595|5740609|P2|Overall Study|Lab assessment|0
1641838|NCT01739595|5740610|P1|Overall Study|Lab assessment|1
1641839|NCT01739595|5740608|P3|Overall Study|Protocol Violation|0
1641840|NCT01739595|5740609|P2|Overall Study|Protocol Violation|0
1641841|NCT01739595|5740610|P1|Overall Study|Protocol Violation|1
1641842|NCT01739595|5740608|P3|Overall Study|Eligibility issue|0
1641843|NCT01739595|5740609|P2|Overall Study|Eligibility issue|0
1641844|NCT01739595|5740610|P1|Overall Study|Eligibility issue|3
1641845|NCT01739595|5740608|P3|Overall Study|Withdrawal by Subject|2
1641846|NCT01739595|5740609|P2|Overall Study|Withdrawal by Subject|1
1641847|NCT01739595|5740610|P1|Overall Study|Withdrawal by Subject|2
1641848|NCT01739595|5740608|P3|Overall Study|Lost to Follow-up|0
1641849|NCT01739595|5740609|P2|Overall Study|Lost to Follow-up|0
1641850|NCT01739595|5740610|P1|Overall Study|Lost to Follow-up|2
1641851|NCT01739595|5740608|P3|Overall Study|Adverse Event|0
1641852|NCT01739595|5740609|P2|Overall Study|Adverse Event|0
1641853|NCT01739595|5740610|P1|Overall Study|Adverse Event|3
1641854|NCT01739400|5740620|P2|Overall Study|Withdrawal by Subject|7
1641855|NCT01739400|5740621|P1|Overall Study|Withdrawal by Subject|7
1641856|NCT01739400|5740620|P2|Overall Study|Death|2
1641857|NCT01739400|5740621|P1|Overall Study|Death|5
1641858|NCT01739400|5740620|P2|Overall Study|Lost to Follow-up|0
1641859|NCT01739400|5740621|P1|Overall Study|Lost to Follow-up|2
1641860|NCT01739400|5740620|P2|Overall Study|Physician Decision|0
1641861|NCT01739400|5740621|P1|Overall Study|Physician Decision|3
1641862|NCT01739348|5740649|P4|Part II (Extension Study)|Withdrawal by Subject|7
1641863|NCT01739348|5740650|P3|Part II (Extension Study)|Withdrawal by Subject|4
1641864|NCT01739348|5740651|P2|Part II (Extension Study)|Withdrawal by Subject|2
1641865|NCT01739348|5740652|P1|Part II (Extension Study)|Withdrawal by Subject|5
1641866|NCT01739348|5740649|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
1641867|NCT01739348|5740650|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
1641868|NCT01739348|5740651|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
1641869|NCT01739348|5740652|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
1641870|NCT01739348|5740649|P4|Part II (Extension Study)|Participant Moved|3
1641871|NCT01739348|5740650|P3|Part II (Extension Study)|Participant Moved|0
1641872|NCT01739348|5740651|P2|Part II (Extension Study)|Participant Moved|3
1641873|NCT01739348|5740652|P1|Part II (Extension Study)|Participant Moved|3
1641874|NCT01739348|5740649|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
1641875|NCT01739348|5740650|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
1641876|NCT01739348|5740651|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
1641877|NCT01739348|5740652|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
1641878|NCT01739348|5740649|P4|Part II (Extension Study)|Physician Decision|12
1641879|NCT01739348|5740650|P3|Part II (Extension Study)|Physician Decision|6
1641880|NCT01739348|5740651|P2|Part II (Extension Study)|Physician Decision|11
1641881|NCT01739348|5740652|P1|Part II (Extension Study)|Physician Decision|7
1641882|NCT01739348|5740649|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
1641883|NCT01739348|5740650|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
1641884|NCT01739348|5740651|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
1641885|NCT01739348|5740652|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
1641886|NCT01739348|5740649|P4|Part II (Extension Study)|Lost to Follow-up|1
1641887|NCT01739348|5740650|P3|Part II (Extension Study)|Lost to Follow-up|0
1641888|NCT01739348|5740651|P2|Part II (Extension Study)|Lost to Follow-up|4
1641889|NCT01739348|5740652|P1|Part II (Extension Study)|Lost to Follow-up|3
1641890|NCT01739348|5740649|P4|Part II (Extension Study)|Lack of Efficacy|1
1641891|NCT01739348|5740650|P3|Part II (Extension Study)|Lack of Efficacy|0
1641892|NCT01739348|5740651|P2|Part II (Extension Study)|Lack of Efficacy|5
1641893|NCT01739348|5740652|P1|Part II (Extension Study)|Lack of Efficacy|1
1641894|NCT01739348|5740649|P4|Part II (Extension Study)|Death|6
1641895|NCT01739348|5740650|P3|Part II (Extension Study)|Death|2
1641896|NCT01739348|5740651|P2|Part II (Extension Study)|Death|3
1641897|NCT01739348|5740652|P1|Part II (Extension Study)|Death|3
1641898|NCT01739348|5740649|P4|Part II (Extension Study)|Adverse Event|26
1641899|NCT01739348|5740650|P3|Part II (Extension Study)|Adverse Event|7
1641900|NCT01739348|5740651|P2|Part II (Extension Study)|Adverse Event|11
1641901|NCT01739348|5740652|P1|Part II (Extension Study)|Adverse Event|10
1641902|NCT01739348|5740649|P4|Part I (Base Study)|Withdrawal by Subject|20
1641903|NCT01739348|5740650|P3|Part I (Base Study)|Withdrawal by Subject|7
1641904|NCT01739348|5740651|P2|Part I (Base Study)|Withdrawal by Subject|21
1641905|NCT01739348|5740652|P1|Part I (Base Study)|Withdrawal by Subject|23
1641906|NCT01739348|5740649|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
1641907|NCT01739348|5740650|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
1641908|NCT01739348|5740651|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
1641909|NCT01739348|5740652|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
1641910|NCT01739348|5740649|P4|Part I (Base Study)|Participant Moved|7
1641911|NCT01739348|5740650|P3|Part I (Base Study)|Participant Moved|1
1641912|NCT01739348|5740651|P2|Part I (Base Study)|Participant Moved|3
1641913|NCT01739348|5740652|P1|Part I (Base Study)|Participant Moved|4
1641914|NCT01739348|5740649|P4|Part I (Base Study)|Study Terminated by Sponsor|86
1641915|NCT01739348|5740650|P3|Part I (Base Study)|Study Terminated by Sponsor|0
1641916|NCT01739348|5740651|P2|Part I (Base Study)|Study Terminated by Sponsor|73
1641917|NCT01739348|5740652|P1|Part I (Base Study)|Study Terminated by Sponsor|72
1641918|NCT01739348|5740649|P4|Part I (Base Study)|Site Discontinued Study Participation|0
1641919|NCT01739348|5740650|P3|Part I (Base Study)|Site Discontinued Study Participation|0
1641920|NCT01739348|5740651|P2|Part I (Base Study)|Site Discontinued Study Participation|3
1641921|NCT01739348|5740652|P1|Part I (Base Study)|Site Discontinued Study Participation|1
1641922|NCT01739348|5740649|P4|Part I (Base Study)|Screen Failure|0
1641923|NCT01739348|5740650|P3|Part I (Base Study)|Screen Failure|0
1641924|NCT01739348|5740651|P2|Part I (Base Study)|Screen Failure|0
1641925|NCT01739348|5740652|P1|Part I (Base Study)|Screen Failure|2
1641926|NCT01739348|5740649|P4|Part I (Base Study)|Protocol Violation|2
1641927|NCT01739348|5740650|P3|Part I (Base Study)|Protocol Violation|1
1641928|NCT01739348|5740651|P2|Part I (Base Study)|Protocol Violation|0
1641929|NCT01739348|5740652|P1|Part I (Base Study)|Protocol Violation|2
1641930|NCT01739348|5740649|P4|Part I (Base Study)|Physician Decision|4
1641931|NCT01739348|5740650|P3|Part I (Base Study)|Physician Decision|1
1641932|NCT01739348|5740651|P2|Part I (Base Study)|Physician Decision|7
1641933|NCT01739348|5740652|P1|Part I (Base Study)|Physician Decision|10
1641934|NCT01739348|5740649|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
1641935|NCT01739348|5740650|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
1641936|NCT01739348|5740651|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
1641937|NCT01739348|5740652|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
1641938|NCT01739348|5740649|P4|Part I (Base Study)|Lost to Follow-up|4
1641939|NCT01739348|5740650|P3|Part I (Base Study)|Lost to Follow-up|4
1641940|NCT01739348|5740651|P2|Part I (Base Study)|Lost to Follow-up|2
1641941|NCT01739348|5740652|P1|Part I (Base Study)|Lost to Follow-up|4
1641942|NCT01739348|5740649|P4|Part I (Base Study)|Lack of Efficacy|7
1641943|NCT01739348|5740650|P3|Part I (Base Study)|Lack of Efficacy|0
1641944|NCT01739348|5740651|P2|Part I (Base Study)|Lack of Efficacy|8
1641945|NCT01739348|5740652|P1|Part I (Base Study)|Lack of Efficacy|3
1641946|NCT01739348|5740649|P4|Part I (Base Study)|Death|8
1641947|NCT01739348|5740650|P3|Part I (Base Study)|Death|2
1641948|NCT01739348|5740651|P2|Part I (Base Study)|Death|7
1641949|NCT01739348|5740652|P1|Part I (Base Study)|Death|10
1641950|NCT01739348|5740649|P4|Part I (Base Study)|Adverse Event|33
1641951|NCT01739348|5740650|P3|Part I (Base Study)|Adverse Event|8
1641952|NCT01739348|5740651|P2|Part I (Base Study)|Adverse Event|52
1641953|NCT01739348|5740652|P1|Part I (Base Study)|Adverse Event|41
1641954|NCT01739335|5740724|P2|Overall Study|Ineligible patient randomized|1
1641955|NCT01739335|5740725|P1|Overall Study|Ineligible patient randomized|0
1641956|NCT01739335|5740724|P2|Overall Study|Lost to Follow-up|4
1641957|NCT01739335|5740725|P1|Overall Study|Lost to Follow-up|7
1641958|NCT01739309|5740757|P1|Overall Study|On study treatment|3
1641959|NCT01738984|5740952|P2|Overall Study|Lost to Follow-up|39
1641960|NCT01738984|5740953|P1|Overall Study|Lost to Follow-up|59
1641961|NCT01738984|5740952|P2|Overall Study|Withdrawal by Subject|0
1641962|NCT01738984|5740953|P1|Overall Study|Withdrawal by Subject|1
1641963|NCT01738984|5740952|P2|Overall Study|Pregnancy|0
1641964|NCT01738984|5740953|P1|Overall Study|Pregnancy|4
1641965|NCT01738971|5740966|P3|Overall Study|Lost to Follow-up|17
1641966|NCT01738971|5740967|P2|Overall Study|Lost to Follow-up|30
1641967|NCT01738971|5740968|P1|Overall Study|Lost to Follow-up|19
1641968|NCT01738919|5740984|P2|Overall Study|Not treated in accordance to guidelines|1
1641969|NCT01738919|5740985|P1|Overall Study|Not treated in accordance to guidelines|0
1641970|NCT01738919|5740984|P2|Overall Study|Withdrawal by Subject|1
1641971|NCT01738919|5740985|P1|Overall Study|Withdrawal by Subject|0
1641972|NCT01738919|5740984|P2|Overall Study|Immigrated|1
1641973|NCT01738919|5740985|P1|Overall Study|Immigrated|0
1641974|NCT01738919|5740984|P2|Overall Study|Lost to Follow-up|0
1641975|NCT01738919|5740985|P1|Overall Study|Lost to Follow-up|1
1641976|NCT01738646|5741135|P1|Overall Study|Still Receiving Treatment|2
1641977|NCT01738594|5741146|P8|Follow up for 1 Year|Other|0
1641978|NCT01738594|5741147|P7|Follow up for 1 Year|Other|0
1641979|NCT01738594|5741148|P6|Follow up for 1 Year|Other|2
1641980|NCT01738594|5741149|P5|Follow up for 1 Year|Other|0
1641981|NCT01738594|5741150|P4|Follow up for 1 Year|Other|0
1641982|NCT01738594|5741151|P3|Follow up for 1 Year|Other|0
1641983|NCT01738594|5741152|P2|Follow up for 1 Year|Other|0
1641984|NCT01738594|5741153|P1|Follow up for 1 Year|Other|0
1641985|NCT01738594|5741146|P8|Follow up for 1 Year|Death|0
1641986|NCT01738594|5741147|P7|Follow up for 1 Year|Death|0
1641987|NCT01738594|5741148|P6|Follow up for 1 Year|Death|1
1641988|NCT01738594|5741149|P5|Follow up for 1 Year|Death|0
1641989|NCT01738594|5741150|P4|Follow up for 1 Year|Death|0
1641990|NCT01738594|5741151|P3|Follow up for 1 Year|Death|0
1641991|NCT01738594|5741152|P2|Follow up for 1 Year|Death|0
1641992|NCT01738594|5741153|P1|Follow up for 1 Year|Death|0
1641993|NCT01738594|5741146|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1641994|NCT01738594|5741147|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1641995|NCT01738594|5741148|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1641996|NCT01738594|5741149|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
1641997|NCT01738594|5741150|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1641998|NCT01738594|5741151|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1641999|NCT01738594|5741152|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1642000|NCT01738594|5741153|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
1642001|NCT01738594|5741146|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1642002|NCT01738594|5741147|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1642003|NCT01738594|5741148|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
1642004|NCT01738594|5741149|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1642005|NCT01738594|5741150|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1642006|NCT01738594|5741151|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1642007|NCT01738594|5741152|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1642008|NCT01738594|5741153|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
1642009|NCT01738594|5741146|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
1642010|NCT01738594|5741147|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
1642011|NCT01738594|5741148|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
1642012|NCT01738594|5741149|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
1642013|NCT01738594|5741150|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
1642014|NCT01738594|5741151|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
1642015|NCT01738594|5741152|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
1642016|NCT01738594|5741153|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
1642017|NCT01738594|5741146|P8|Completed 4 Cycles of Treatment|Progressive disease|0
1642018|NCT01738594|5741147|P7|Completed 4 Cycles of Treatment|Progressive disease|0
1642019|NCT01738594|5741148|P6|Completed 4 Cycles of Treatment|Progressive disease|0
1642020|NCT01738594|5741149|P5|Completed 4 Cycles of Treatment|Progressive disease|0
1642021|NCT01738594|5741150|P4|Completed 4 Cycles of Treatment|Progressive disease|0
1642022|NCT01738594|5741151|P3|Completed 4 Cycles of Treatment|Progressive disease|0
1642023|NCT01738594|5741152|P2|Completed 4 Cycles of Treatment|Progressive disease|2
1642024|NCT01738594|5741153|P1|Completed 4 Cycles of Treatment|Progressive disease|0
1642025|NCT01738594|5741146|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1642026|NCT01738594|5741147|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1642027|NCT01738594|5741148|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
1642028|NCT01738594|5741149|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1642029|NCT01738594|5741150|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1642030|NCT01738594|5741151|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1642031|NCT01738594|5741152|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1642032|NCT01738594|5741153|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
1642033|NCT01738594|5741146|P8|Registration and Treatment Start|Adverse Event|0
1642034|NCT01738594|5741147|P7|Registration and Treatment Start|Adverse Event|0
1642035|NCT01738594|5741148|P6|Registration and Treatment Start|Adverse Event|0
1642036|NCT01738594|5741149|P5|Registration and Treatment Start|Adverse Event|0
1642037|NCT01738594|5741150|P4|Registration and Treatment Start|Adverse Event|0
1642038|NCT01738594|5741151|P3|Registration and Treatment Start|Adverse Event|0
1642039|NCT01738594|5741152|P2|Registration and Treatment Start|Adverse Event|1
1642040|NCT01738594|5741153|P1|Registration and Treatment Start|Adverse Event|0
1642041|NCT01738581|5741171|P2|Overall Study|Lost to Follow-up|0
1642042|NCT01738581|5741172|P1|Overall Study|Lost to Follow-up|1
1642043|NCT01738503|5741196|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1642044|NCT01738503|5741197|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
1642045|NCT01738503|5741198|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1642046|NCT01738503|5741199|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1642047|NCT01738503|5741200|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1642048|NCT01738503|5741201|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1642049|NCT01738503|5741202|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
1642050|NCT01738503|5741196|P7|PET Imaging Sub-study|Adverse Event|0
1642051|NCT01738503|5741197|P6|PET Imaging Sub-study|Adverse Event|1
1642052|NCT01738503|5741198|P5|PET Imaging Sub-study|Adverse Event|0
1642053|NCT01738503|5741199|P4|PET Imaging Sub-study|Adverse Event|0
1642054|NCT01738503|5741200|P3|PET Imaging Sub-study|Adverse Event|0
1642055|NCT01738503|5741201|P2|PET Imaging Sub-study|Adverse Event|0
1642056|NCT01738503|5741202|P1|PET Imaging Sub-study|Adverse Event|0
1642057|NCT01738503|5741196|P7|Treatment Period|Other|0
1642058|NCT01738503|5741197|P6|Treatment Period|Other|0
1642059|NCT01738503|5741198|P5|Treatment Period|Other|0
1642060|NCT01738503|5741199|P4|Treatment Period|Other|0
1642061|NCT01738503|5741200|P3|Treatment Period|Other|1
1642062|NCT01738503|5741201|P2|Treatment Period|Other|0
1642063|NCT01738503|5741202|P1|Treatment Period|Other|0
1642064|NCT01738503|5741196|P7|Treatment Period|Protocol Violation|0
1642065|NCT01738503|5741197|P6|Treatment Period|Protocol Violation|2
1642066|NCT01738503|5741198|P5|Treatment Period|Protocol Violation|4
1642067|NCT01738503|5741199|P4|Treatment Period|Protocol Violation|0
1642068|NCT01738503|5741200|P3|Treatment Period|Protocol Violation|1
1642069|NCT01738503|5741201|P2|Treatment Period|Protocol Violation|3
1642070|NCT01738503|5741202|P1|Treatment Period|Protocol Violation|0
1642071|NCT01738503|5741196|P7|Treatment Period|Withdrawal by Subject|1
1642072|NCT01738503|5741197|P6|Treatment Period|Withdrawal by Subject|1
1642073|NCT01738503|5741198|P5|Treatment Period|Withdrawal by Subject|1
1642074|NCT01738503|5741199|P4|Treatment Period|Withdrawal by Subject|1
1642075|NCT01738503|5741200|P3|Treatment Period|Withdrawal by Subject|0
1642076|NCT01738503|5741201|P2|Treatment Period|Withdrawal by Subject|1
1642077|NCT01738503|5741202|P1|Treatment Period|Withdrawal by Subject|0
1642078|NCT01738503|5741196|P7|Treatment Period|Lost to Follow-up|5
1642079|NCT01738503|5741197|P6|Treatment Period|Lost to Follow-up|1
1642080|NCT01738503|5741198|P5|Treatment Period|Lost to Follow-up|1
1642081|NCT01738503|5741199|P4|Treatment Period|Lost to Follow-up|4
1642082|NCT01738503|5741200|P3|Treatment Period|Lost to Follow-up|3
1642083|NCT01738503|5741201|P2|Treatment Period|Lost to Follow-up|0
1642084|NCT01738503|5741202|P1|Treatment Period|Lost to Follow-up|0
1642085|NCT01738503|5741196|P7|Treatment Period|Adverse Event|2
1642086|NCT01738503|5741197|P6|Treatment Period|Adverse Event|2
1642087|NCT01738503|5741198|P5|Treatment Period|Adverse Event|2
1642088|NCT01738503|5741199|P4|Treatment Period|Adverse Event|1
1642089|NCT01738503|5741200|P3|Treatment Period|Adverse Event|0
1642090|NCT01738503|5741201|P2|Treatment Period|Adverse Event|1
1642091|NCT01738503|5741202|P1|Treatment Period|Adverse Event|0
1642092|NCT01738503|5741196|P7|Induction/Stabilization (Days -14 to -1)|Other|0
1642093|NCT01738503|5741197|P6|Induction/Stabilization (Days -14 to -1)|Other|0
1642094|NCT01738503|5741198|P5|Induction/Stabilization (Days -14 to -1)|Other|0
1642095|NCT01738503|5741199|P4|Induction/Stabilization (Days -14 to -1)|Other|0
1642096|NCT01738503|5741200|P3|Induction/Stabilization (Days -14 to -1)|Other|0
1642097|NCT01738503|5741201|P2|Induction/Stabilization (Days -14 to -1)|Other|0
1642098|NCT01738503|5741202|P1|Induction/Stabilization (Days -14 to -1)|Other|35
1642099|NCT01738477|5741400|P2|Overall Study|Lost to Follow-up|4
1642100|NCT01738477|5741401|P1|Overall Study|Lost to Follow-up|1
1642101|NCT01738438|5741429|P1|Overall Study|Adverse Event|3
1642102|NCT01738438|5741429|P1|Overall Study|Disease Progression|32
1642103|NCT01738191|5741446|P2|Overall Study|Withdrawal by Subject|1
1642104|NCT01738191|5741447|P1|Overall Study|Withdrawal by Subject|4
1642105|NCT01737996|5741470|P3|Overall Study|Withdrawal by Subject|1
1642106|NCT01737996|5741471|P2|Overall Study|Withdrawal by Subject|0
1642107|NCT01737996|5741472|P1|Overall Study|Withdrawal by Subject|0
1642108|NCT01737996|5741470|P3|Overall Study|Adverse Event|1
1642109|NCT01737996|5741471|P2|Overall Study|Adverse Event|1
1642110|NCT01737996|5741472|P1|Overall Study|Adverse Event|0
1642111|NCT01737931|5741534|P3|Overall Study|Physician Decision|0
1642112|NCT01737931|5741535|P2|Overall Study|Physician Decision|1
1642113|NCT01737931|5741536|P1|Overall Study|Physician Decision|0
1642114|NCT01737931|5741534|P3|Overall Study|Withdrawal by Subject|1
1642115|NCT01737931|5741535|P2|Overall Study|Withdrawal by Subject|1
1642116|NCT01737931|5741536|P1|Overall Study|Withdrawal by Subject|0
1642117|NCT01737879|5741551|P1|Overall Study|Sponsor decision|40
1642118|NCT01737879|5741551|P1|Overall Study|Death|1
1642119|NCT01737840|5741560|P2|Overall Study|Diagnosed with an other pathology|2
1642120|NCT01737840|5741561|P1|Overall Study|Diagnosed with an other pathology|2
1642121|NCT01737762|5741571|P2|Overall Study|Trial termination|9
1642122|NCT01737762|5741572|P1|Overall Study|Trial termination|11
1642123|NCT01737762|5741571|P2|Overall Study|Moved from area|1
1642124|NCT01737762|5741572|P1|Overall Study|Moved from area|2
1642125|NCT01737762|5741571|P2|Overall Study|Physician Decision|1
1642126|NCT01737762|5741572|P1|Overall Study|Physician Decision|1
1642127|NCT01737762|5741571|P2|Overall Study|Progressive disease|2
1642128|NCT01737762|5741572|P1|Overall Study|Progressive disease|1
1642129|NCT01737762|5741571|P2|Overall Study|Withdrawal by Subject|2
1642130|NCT01737762|5741572|P1|Overall Study|Withdrawal by Subject|2
1642131|NCT01737762|5741571|P2|Overall Study|Lost to Follow-up|0
1642132|NCT01737762|5741572|P1|Overall Study|Lost to Follow-up|1
1642133|NCT01737762|5741571|P2|Overall Study|Adverse Event|2
1642134|NCT01737762|5741572|P1|Overall Study|Adverse Event|2
1642135|NCT01737710|5741585|P5|Overall Study|Vaccinated in Error/Ineligible|0
1642136|NCT01737710|5741586|P4|Overall Study|Vaccinated in Error/Ineligible|0
1642137|NCT01737710|5741587|P3|Overall Study|Vaccinated in Error/Ineligible|0
1642138|NCT01737710|5741588|P2|Overall Study|Vaccinated in Error/Ineligible|1
1642139|NCT01737710|5741589|P1|Overall Study|Vaccinated in Error/Ineligible|1
1642140|NCT01737710|5741585|P5|Overall Study|Withdrawal by Subject|0
1642141|NCT01737710|5741586|P4|Overall Study|Withdrawal by Subject|0
1642142|NCT01737710|5741587|P3|Overall Study|Withdrawal by Subject|1
1642143|NCT01737710|5741588|P2|Overall Study|Withdrawal by Subject|1
1642144|NCT01737710|5741589|P1|Overall Study|Withdrawal by Subject|1
1642145|NCT01737710|5741585|P5|Overall Study|Lost to Follow-up|0
1642146|NCT01737710|5741586|P4|Overall Study|Lost to Follow-up|0
1642147|NCT01737710|5741587|P3|Overall Study|Lost to Follow-up|2
1642148|NCT01737710|5741588|P2|Overall Study|Lost to Follow-up|2
1642149|NCT01737710|5741589|P1|Overall Study|Lost to Follow-up|0
1642150|NCT01737697|5741631|P15|Subacute Phase|Death|0
1642151|NCT01737697|5741632|P14|Subacute Phase|Death|0
1642152|NCT01737697|5741633|P13|Subacute Phase|Death|0
1642153|NCT01737697|5741634|P12|Subacute Phase|Death|0
1642154|NCT01737697|5741635|P11|Subacute Phase|Death|1
1642155|NCT01737697|5741636|P10|Subacute Phase|Death|0
1642156|NCT01737697|5741637|P9|Subacute Phase|Death|0
1642157|NCT01737697|5741638|P8|Subacute Phase|Death|0
1642158|NCT01737697|5741639|P7|Subacute Phase|Death|0
1642159|NCT01737697|5741640|P6|Subacute Phase|Death|0
1642160|NCT01737697|5741641|P5|Subacute Phase|Death|0
1642161|NCT01737697|5741642|P4|Subacute Phase|Death|0
1642162|NCT01737697|5741643|P3|Subacute Phase|Death|0
1642163|NCT01737697|5741644|P2|Subacute Phase|Death|0
1642164|NCT01737697|5741645|P1|Subacute Phase|Death|0
1642165|NCT01737697|5741631|P15|Subacute Phase|Physician Decision|0
1642166|NCT01737697|5741632|P14|Subacute Phase|Physician Decision|0
1642167|NCT01737697|5741633|P13|Subacute Phase|Physician Decision|0
1642168|NCT01737697|5741634|P12|Subacute Phase|Physician Decision|0
1642169|NCT01737697|5741635|P11|Subacute Phase|Physician Decision|0
1642170|NCT01737697|5741636|P10|Subacute Phase|Physician Decision|0
1642171|NCT01737697|5741637|P9|Subacute Phase|Physician Decision|1
1642172|NCT01737697|5741638|P8|Subacute Phase|Physician Decision|0
1642173|NCT01737697|5741639|P7|Subacute Phase|Physician Decision|0
1642174|NCT01737697|5741640|P6|Subacute Phase|Physician Decision|0
1642175|NCT01737697|5741641|P5|Subacute Phase|Physician Decision|0
1642176|NCT01737697|5741642|P4|Subacute Phase|Physician Decision|0
1642177|NCT01737697|5741643|P3|Subacute Phase|Physician Decision|0
1642178|NCT01737697|5741644|P2|Subacute Phase|Physician Decision|0
1642179|NCT01737697|5741645|P1|Subacute Phase|Physician Decision|0
1642180|NCT01737697|5741631|P15|Subacute Phase|Protocol Violation|0
1642181|NCT01737697|5741632|P14|Subacute Phase|Protocol Violation|0
1642182|NCT01737697|5741633|P13|Subacute Phase|Protocol Violation|0
1642183|NCT01737697|5741634|P12|Subacute Phase|Protocol Violation|0
1642184|NCT01737697|5741635|P11|Subacute Phase|Protocol Violation|1
1642185|NCT01737697|5741636|P10|Subacute Phase|Protocol Violation|0
1642186|NCT01737697|5741637|P9|Subacute Phase|Protocol Violation|0
1642187|NCT01737697|5741638|P8|Subacute Phase|Protocol Violation|0
1642188|NCT01737697|5741639|P7|Subacute Phase|Protocol Violation|0
1642189|NCT01737697|5741640|P6|Subacute Phase|Protocol Violation|1
1642190|NCT01737697|5741641|P5|Subacute Phase|Protocol Violation|0
1642191|NCT01737697|5741642|P4|Subacute Phase|Protocol Violation|0
1642192|NCT01737697|5741643|P3|Subacute Phase|Protocol Violation|0
1642193|NCT01737697|5741644|P2|Subacute Phase|Protocol Violation|0
1642194|NCT01737697|5741645|P1|Subacute Phase|Protocol Violation|0
1642195|NCT01737697|5741631|P15|Subacute Phase|Hypo-or hyperkalemia|0
1642196|NCT01737697|5741632|P14|Subacute Phase|Hypo-or hyperkalemia|1
1642197|NCT01737697|5741633|P13|Subacute Phase|Hypo-or hyperkalemia|0
1642198|NCT01737697|5741634|P12|Subacute Phase|Hypo-or hyperkalemia|1
1642199|NCT01737697|5741635|P11|Subacute Phase|Hypo-or hyperkalemia|0
1642200|NCT01737697|5741636|P10|Subacute Phase|Hypo-or hyperkalemia|0
1642201|NCT01737697|5741637|P9|Subacute Phase|Hypo-or hyperkalemia|0
1642202|NCT01737697|5741638|P8|Subacute Phase|Hypo-or hyperkalemia|0
1642203|NCT01737697|5741639|P7|Subacute Phase|Hypo-or hyperkalemia|0
1642204|NCT01737697|5741640|P6|Subacute Phase|Hypo-or hyperkalemia|0
1642205|NCT01737697|5741641|P5|Subacute Phase|Hypo-or hyperkalemia|0
1642206|NCT01737697|5741642|P4|Subacute Phase|Hypo-or hyperkalemia|0
1642207|NCT01737697|5741643|P3|Subacute Phase|Hypo-or hyperkalemia|0
1642208|NCT01737697|5741644|P2|Subacute Phase|Hypo-or hyperkalemia|0
1642209|NCT01737697|5741645|P1|Subacute Phase|Hypo-or hyperkalemia|0
1642210|NCT01737697|5741631|P15|Subacute Phase|Lost to Follow-up|1
1642211|NCT01737697|5741632|P14|Subacute Phase|Lost to Follow-up|0
1642212|NCT01737697|5741633|P13|Subacute Phase|Lost to Follow-up|0
1642213|NCT01737697|5741634|P12|Subacute Phase|Lost to Follow-up|0
1642214|NCT01737697|5741635|P11|Subacute Phase|Lost to Follow-up|0
1642215|NCT01737697|5741636|P10|Subacute Phase|Lost to Follow-up|0
1642216|NCT01737697|5741637|P9|Subacute Phase|Lost to Follow-up|0
1642217|NCT01737697|5741638|P8|Subacute Phase|Lost to Follow-up|0
1642218|NCT01737697|5741639|P7|Subacute Phase|Lost to Follow-up|0
1642219|NCT01737697|5741640|P6|Subacute Phase|Lost to Follow-up|0
1642220|NCT01737697|5741641|P5|Subacute Phase|Lost to Follow-up|0
1642221|NCT01737697|5741642|P4|Subacute Phase|Lost to Follow-up|0
1642222|NCT01737697|5741643|P3|Subacute Phase|Lost to Follow-up|0
1642223|NCT01737697|5741644|P2|Subacute Phase|Lost to Follow-up|0
1642224|NCT01737697|5741645|P1|Subacute Phase|Lost to Follow-up|0
1642225|NCT01737697|5741631|P15|Subacute Phase|Withdrawal by Subject|0
1642226|NCT01737697|5741632|P14|Subacute Phase|Withdrawal by Subject|1
1642227|NCT01737697|5741633|P13|Subacute Phase|Withdrawal by Subject|1
1642228|NCT01737697|5741634|P12|Subacute Phase|Withdrawal by Subject|1
1642229|NCT01737697|5741635|P11|Subacute Phase|Withdrawal by Subject|0
1642230|NCT01737697|5741636|P10|Subacute Phase|Withdrawal by Subject|1
1642231|NCT01737697|5741637|P9|Subacute Phase|Withdrawal by Subject|0
1642232|NCT01737697|5741638|P8|Subacute Phase|Withdrawal by Subject|2
1642233|NCT01737697|5741639|P7|Subacute Phase|Withdrawal by Subject|0
1642234|NCT01737697|5741640|P6|Subacute Phase|Withdrawal by Subject|1
1642235|NCT01737697|5741641|P5|Subacute Phase|Withdrawal by Subject|0
1642236|NCT01737697|5741642|P4|Subacute Phase|Withdrawal by Subject|0
1642237|NCT01737697|5741643|P3|Subacute Phase|Withdrawal by Subject|0
1642238|NCT01737697|5741644|P2|Subacute Phase|Withdrawal by Subject|0
1642239|NCT01737697|5741645|P1|Subacute Phase|Withdrawal by Subject|0
1642240|NCT01737697|5741631|P15|Subacute Phase|Adverse Event|0
1642241|NCT01737697|5741632|P14|Subacute Phase|Adverse Event|0
1642242|NCT01737697|5741633|P13|Subacute Phase|Adverse Event|1
1642243|NCT01737697|5741634|P12|Subacute Phase|Adverse Event|1
1642244|NCT01737697|5741635|P11|Subacute Phase|Adverse Event|4
1642245|NCT01737697|5741636|P10|Subacute Phase|Adverse Event|1
1642246|NCT01737697|5741637|P9|Subacute Phase|Adverse Event|1
1642247|NCT01737697|5741638|P8|Subacute Phase|Adverse Event|1
1642248|NCT01737697|5741639|P7|Subacute Phase|Adverse Event|1
1642249|NCT01737697|5741640|P6|Subacute Phase|Adverse Event|1
1642250|NCT01737697|5741641|P5|Subacute Phase|Adverse Event|0
1642251|NCT01737697|5741642|P4|Subacute Phase|Adverse Event|0
1642252|NCT01737697|5741643|P3|Subacute Phase|Adverse Event|0
1642253|NCT01737697|5741644|P2|Subacute Phase|Adverse Event|0
1642254|NCT01737697|5741645|P1|Subacute Phase|Adverse Event|0
1642255|NCT01737697|5741631|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642256|NCT01737697|5741632|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642257|NCT01737697|5741633|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642258|NCT01737697|5741634|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642259|NCT01737697|5741635|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642260|NCT01737697|5741636|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642261|NCT01737697|5741637|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642262|NCT01737697|5741638|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642263|NCT01737697|5741639|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642264|NCT01737697|5741640|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642265|NCT01737697|5741641|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1642266|NCT01737697|5741642|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
1642267|NCT01737697|5741643|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1642268|NCT01737697|5741644|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
1642269|NCT01737697|5741645|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
1642270|NCT01737697|5741631|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642271|NCT01737697|5741632|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642272|NCT01737697|5741633|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642273|NCT01737697|5741634|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642274|NCT01737697|5741635|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642275|NCT01737697|5741636|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642276|NCT01737697|5741637|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642277|NCT01737697|5741638|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642278|NCT01737697|5741639|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642279|NCT01737697|5741640|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642280|NCT01737697|5741641|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
1642281|NCT01737697|5741642|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642282|NCT01737697|5741643|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642283|NCT01737697|5741644|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642284|NCT01737697|5741645|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
1642285|NCT01737697|5741631|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642286|NCT01737697|5741632|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642287|NCT01737697|5741633|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642288|NCT01737697|5741634|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642289|NCT01737697|5741635|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642290|NCT01737697|5741636|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642291|NCT01737697|5741637|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642292|NCT01737697|5741638|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642293|NCT01737697|5741639|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642294|NCT01737697|5741640|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642295|NCT01737697|5741641|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642296|NCT01737697|5741642|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642297|NCT01737697|5741643|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642298|NCT01737697|5741644|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
1642299|NCT01737697|5741645|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
1642300|NCT01737697|5741631|P15|Acute Phase-Initial 48 Hours|Family emergency|0
1642301|NCT01737697|5741632|P14|Acute Phase-Initial 48 Hours|Family emergency|0
1642302|NCT01737697|5741633|P13|Acute Phase-Initial 48 Hours|Family emergency|0
1642303|NCT01737697|5741634|P12|Acute Phase-Initial 48 Hours|Family emergency|0
1642304|NCT01737697|5741635|P11|Acute Phase-Initial 48 Hours|Family emergency|0
1642305|NCT01737697|5741636|P10|Acute Phase-Initial 48 Hours|Family emergency|0
1642306|NCT01737697|5741637|P9|Acute Phase-Initial 48 Hours|Family emergency|0
1642307|NCT01737697|5741638|P8|Acute Phase-Initial 48 Hours|Family emergency|0
1642308|NCT01737697|5741639|P7|Acute Phase-Initial 48 Hours|Family emergency|0
1642309|NCT01737697|5741640|P6|Acute Phase-Initial 48 Hours|Family emergency|0
1642310|NCT01737697|5741641|P5|Acute Phase-Initial 48 Hours|Family emergency|0
1642311|NCT01737697|5741642|P4|Acute Phase-Initial 48 Hours|Family emergency|1
1642312|NCT01737697|5741643|P3|Acute Phase-Initial 48 Hours|Family emergency|0
1642313|NCT01737697|5741644|P2|Acute Phase-Initial 48 Hours|Family emergency|0
1642314|NCT01737697|5741645|P1|Acute Phase-Initial 48 Hours|Family emergency|0
1642315|NCT01737697|5741631|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642316|NCT01737697|5741632|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642317|NCT01737697|5741633|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642318|NCT01737697|5741634|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642319|NCT01737697|5741635|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642320|NCT01737697|5741636|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642321|NCT01737697|5741637|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642322|NCT01737697|5741638|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642323|NCT01737697|5741639|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642324|NCT01737697|5741640|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642325|NCT01737697|5741641|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642326|NCT01737697|5741642|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
1642327|NCT01737697|5741643|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
1642328|NCT01737697|5741644|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
1642329|NCT01737697|5741645|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
1642330|NCT01737697|5741631|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
1642331|NCT01737697|5741632|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
1642332|NCT01737697|5741633|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
1642333|NCT01737697|5741634|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
1642334|NCT01737697|5741635|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
1642335|NCT01737697|5741636|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
1642336|NCT01737697|5741637|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
1642337|NCT01737697|5741638|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
1642338|NCT01737697|5741639|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
1642339|NCT01737697|5741640|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
1642340|NCT01737697|5741641|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
1642341|NCT01737697|5741642|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
1642342|NCT01737697|5741643|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
1642343|NCT01737697|5741644|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
1642344|NCT01737697|5741645|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
1642345|NCT01737398|5741788|P2|Overall Study|Sponsor's decision|0
1642346|NCT01737398|5741789|P1|Overall Study|Sponsor's decision|2
1642347|NCT01737398|5741788|P2|Overall Study|Disease progression|3
1642348|NCT01737398|5741789|P1|Overall Study|Disease progression|2
1642349|NCT01737398|5741788|P2|Overall Study|Liver transplant|0
1642350|NCT01737398|5741789|P1|Overall Study|Liver transplant|1
1642351|NCT01737398|5741788|P2|Overall Study|Ineligibility|0
1642352|NCT01737398|5741789|P1|Overall Study|Ineligibility|1
1642353|NCT01737398|5741788|P2|Overall Study|Voluntary withdrawal|3
1642354|NCT01737398|5741789|P1|Overall Study|Voluntary withdrawal|2
1642355|NCT01737398|5741788|P2|Overall Study|Stopping rule met|1
1642356|NCT01737398|5741789|P1|Overall Study|Stopping rule met|2
1642357|NCT01737398|5741788|P2|Overall Study|Adverse event or SAE|1
1642358|NCT01737398|5741789|P1|Overall Study|Adverse event or SAE|16
1642359|NCT01737268|5741842|P1|Overall Study|In consideration of the patient’s safety|1
1642360|NCT01737268|5741842|P1|Overall Study|Worsening of Target Disease|2
1642361|NCT01737268|5741842|P1|Overall Study|Adverse Event|6
1642362|NCT01737021|5741856|P2|Overall Study|Lost to Follow-up|3
1642363|NCT01737021|5741857|P1|Overall Study|Lost to Follow-up|5
1642364|NCT01736917|5741903|P1|Overall Study|Protocol Violation|10
1642365|NCT01736917|5741903|P1|Overall Study|Adverse Event|1
1642366|NCT01736696|5741932|P7|Overall Study|Withdrawal by Subject|0
1642367|NCT01736696|5741933|P6|Overall Study|Withdrawal by Subject|0
1642368|NCT01736696|5741934|P5|Overall Study|Withdrawal by Subject|0
1642369|NCT01736696|5741935|P4|Overall Study|Withdrawal by Subject|0
1642370|NCT01736696|5741936|P3|Overall Study|Withdrawal by Subject|1
1642371|NCT01736696|5741937|P2|Overall Study|Withdrawal by Subject|0
1642372|NCT01736696|5741938|P1|Overall Study|Withdrawal by Subject|0
1642373|NCT01736683|5742260|P5|Overall Study|Other|1
1642374|NCT01736683|5742261|P4|Overall Study|Other|9
1642375|NCT01736683|5742262|P3|Overall Study|Other|1
1642376|NCT01736683|5742263|P2|Overall Study|Other|0
1642377|NCT01736683|5742264|P1|Overall Study|Other|0
1642378|NCT01736683|5742260|P5|Overall Study|Progressive Disease|0
1642379|NCT01736683|5742261|P4|Overall Study|Progressive Disease|1
1642380|NCT01736683|5742262|P3|Overall Study|Progressive Disease|0
1642381|NCT01736683|5742263|P2|Overall Study|Progressive Disease|0
1642382|NCT01736683|5742264|P1|Overall Study|Progressive Disease|0
1642383|NCT01736683|5742260|P5|Overall Study|Lack of Therapeutic Effect|1
1642384|NCT01736683|5742261|P4|Overall Study|Lack of Therapeutic Effect|20
1642385|NCT01736683|5742262|P3|Overall Study|Lack of Therapeutic Effect|13
1642386|NCT01736683|5742263|P2|Overall Study|Lack of Therapeutic Effect|4
1642387|NCT01736683|5742264|P1|Overall Study|Lack of Therapeutic Effect|7
1642388|NCT01736683|5742260|P5|Overall Study|Withdrawal by Subject|1
1642389|NCT01736683|5742261|P4|Overall Study|Withdrawal by Subject|1
1642390|NCT01736683|5742262|P3|Overall Study|Withdrawal by Subject|3
1642391|NCT01736683|5742263|P2|Overall Study|Withdrawal by Subject|0
1642392|NCT01736683|5742264|P1|Overall Study|Withdrawal by Subject|0
1642393|NCT01736683|5742260|P5|Overall Study|Adverse Event|2
1642394|NCT01736683|5742261|P4|Overall Study|Adverse Event|3
1642395|NCT01736683|5742262|P3|Overall Study|Adverse Event|2
1642396|NCT01736683|5742263|P2|Overall Study|Adverse Event|2
1642397|NCT01736683|5742264|P1|Overall Study|Adverse Event|0
1642398|NCT01736683|5742260|P5|Overall Study|Disease Relapse|0
1642399|NCT01736683|5742261|P4|Overall Study|Disease Relapse|1
1642400|NCT01736683|5742262|P3|Overall Study|Disease Relapse|2
1642401|NCT01736683|5742263|P2|Overall Study|Disease Relapse|0
1642402|NCT01736683|5742264|P1|Overall Study|Disease Relapse|0
1642403|NCT01736657|5742326|P1|Overall Study|insufficient vascular access|1
1642404|NCT01736579|5742335|P2|Overall Study|Termination of Study by Sponsor|2
1642405|NCT01736579|5742336|P1|Overall Study|Termination of Study by Sponsor|2
1642406|NCT01736566|5742375|P5|Long Term Follow-up|Still collecting data|1
1642407|NCT01736566|5742376|P4|Long Term Follow-up|Still collecting data|0
1642408|NCT01736566|5742377|P3|Long Term Follow-up|Still collecting data|49
1642409|NCT01736566|5742378|P2|Long Term Follow-up|Still collecting data|0
1642410|NCT01736566|5742379|P1|Long Term Follow-up|Still collecting data|42
1642411|NCT01736553|5742464|P2|Overall Study|Lost to Follow-up|2
1642412|NCT01736553|5742465|P1|Overall Study|Lost to Follow-up|2
1642413|NCT01736553|5742464|P2|Overall Study|Withdrawal by Subject|2
1642414|NCT01736553|5742465|P1|Overall Study|Withdrawal by Subject|5
1642415|NCT01736553|5742464|P2|Overall Study|Death|0
1642416|NCT01736553|5742465|P1|Overall Study|Death|12
1642417|NCT01736540|5742516|P1|Overall Study|Unable to make MRI appointment|3
1642418|NCT01736540|5742516|P1|Overall Study|No show for MRI appointment|1
1642419|NCT01736540|5742516|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
1642420|NCT01736540|5742516|P1|Overall Study|Protocol Violation|1
1642421|NCT01736540|5742516|P1|Overall Study|Withdrawal by Subject|5
1642422|NCT01736540|5742516|P1|Overall Study|Abnormal test procedure|1
1642423|NCT01736540|5742516|P1|Overall Study|Death|1
1642424|NCT01736540|5742516|P1|Overall Study|Did not complete scan within 45 days|2
1642425|NCT01736475|5742582|P2|Overall Study|Other - Surgical procedure|0
1642426|NCT01736475|5742583|P1|Overall Study|Other - Surgical procedure|1
1642427|NCT01736475|5742582|P2|Overall Study|Other - Screen failure|0
1642428|NCT01736475|5742583|P1|Overall Study|Other - Screen failure|1
1642429|NCT01736475|5742582|P2|Overall Study|Protocol Violation|0
1642430|NCT01736475|5742583|P1|Overall Study|Protocol Violation|4
1642431|NCT01736475|5742582|P2|Overall Study|Withdrawal by Subject|0
1642432|NCT01736475|5742583|P1|Overall Study|Withdrawal by Subject|2
1642433|NCT01736475|5742582|P2|Overall Study|Adverse Event|0
1642434|NCT01736475|5742583|P1|Overall Study|Adverse Event|4
1642435|NCT01736397|5742638|P2|Overall Study|Not stated|4
1642436|NCT01736397|5742639|P1|Overall Study|Not stated|1
1642437|NCT01736397|5742638|P2|Overall Study|Adverse Event|3
1642438|NCT01736397|5742639|P1|Overall Study|Adverse Event|6
1642439|NCT01736397|5742638|P2|Overall Study|Lost to Follow-up|1
1642440|NCT01736397|5742639|P1|Overall Study|Lost to Follow-up|0
1642441|NCT01736397|5742638|P2|Overall Study|Withdrawal by Subject|5
1642442|NCT01736397|5742639|P1|Overall Study|Withdrawal by Subject|6
1642443|NCT01736397|5742638|P2|Overall Study|Lack of Efficacy|11
1642444|NCT01736397|5742639|P1|Overall Study|Lack of Efficacy|1
1642445|NCT01736254|5742668|P1|Period 3 (Days 13 to 23)|Adverse Event|1
1642446|NCT01736254|5742668|P1|Period 2 (Days 2 to 12)|Adverse Event|3
1642447|NCT01736215|5742733|P1|Overall Study|Insufficient data to perform analysis|8
1642448|NCT01736215|5742733|P1|Overall Study|Progressive disease stop chemotherapy|1
1642449|NCT01736215|5742733|P1|Overall Study|Adverse Event|4
1642450|NCT01736215|5742733|P1|Overall Study|Early termination of erythropoietin use|1
1642451|NCT01736189|5742745|P1|Overall Study|Criteria and protocol violations|1
1642452|NCT01736189|5742745|P1|Overall Study|Protocol Violation|4
1642453|NCT01736189|5742745|P1|Overall Study|Violation of registration criteria|41
1642454|NCT01736176|5742754|P1|Overall Study|Unable to Complete PEG Placement|1
1642455|NCT01736176|5742754|P1|Overall Study|Lack of Efficacy|3
1642456|NCT01736176|5742754|P1|Overall Study|Withdrawal by Subject|4
1642457|NCT01736176|5742754|P1|Overall Study|Adverse Event|3
1642458|NCT01735994|5742825|P2|Overall Study|Lost to Follow-up|62
1642459|NCT01735994|5742826|P1|Overall Study|Lost to Follow-up|50
1642460|NCT01735994|5742825|P2|Overall Study|Kicked off team|0
1642461|NCT01735994|5742826|P1|Overall Study|Kicked off team|5
1642462|NCT01735994|5742825|P2|Overall Study|Injury|0
1642463|NCT01735994|5742826|P1|Overall Study|Injury|2
1642464|NCT01735994|5742825|P2|Overall Study|Withdrawal by Subject|4
1642465|NCT01735994|5742826|P1|Overall Study|Withdrawal by Subject|6
1642466|NCT01735916|5742841|P3|Overall Study|Withdrawal by Subject|0
1642467|NCT01735916|5742842|P2|Overall Study|Withdrawal by Subject|0
1642468|NCT01735916|5742843|P1|Overall Study|Withdrawal by Subject|3
1642469|NCT01735916|5742841|P3|Overall Study|Early termination of study by sponsor|7
1642470|NCT01735916|5742842|P2|Overall Study|Early termination of study by sponsor|19
1642471|NCT01735916|5742843|P1|Overall Study|Early termination of study by sponsor|4
1642472|NCT01735916|5742841|P3|Overall Study|Subject not eligible to be randomized|0
1642473|NCT01735916|5742842|P2|Overall Study|Subject not eligible to be randomized|0
1642474|NCT01735916|5742843|P1|Overall Study|Subject not eligible to be randomized|11
1642475|NCT01735630|5742881|P2|Overall Study|Withdrawal by Subject|9
1642476|NCT01735630|5742882|P1|Overall Study|Withdrawal by Subject|7
1642477|NCT01735630|5742881|P2|Overall Study|Sponsor Decision|1
1642478|NCT01735630|5742882|P1|Overall Study|Sponsor Decision|2
1642479|NCT01735630|5742881|P2|Overall Study|Physician Decision|1
1642480|NCT01735630|5742882|P1|Overall Study|Physician Decision|0
1642481|NCT01735630|5742881|P2|Overall Study|Lost to Follow-up|0
1642482|NCT01735630|5742882|P1|Overall Study|Lost to Follow-up|1
1642483|NCT01735630|5742881|P2|Overall Study|Adverse Event|7
1642484|NCT01735630|5742882|P1|Overall Study|Adverse Event|8
1642485|NCT01735396|5742909|P1|Overall Study|not evaluable|1
1642486|NCT01735201|5742938|P8|Overall Study|Other Miscellaneous Reasons|1
1642487|NCT01735201|5742939|P7|Overall Study|Other Miscellaneous Reasons|1
1642488|NCT01735201|5742940|P6|Overall Study|Other Miscellaneous Reasons|2
1642489|NCT01735201|5742941|P5|Overall Study|Other Miscellaneous Reasons|0
1642490|NCT01735201|5742942|P4|Overall Study|Other Miscellaneous Reasons|1
1642491|NCT01735201|5742943|P3|Overall Study|Other Miscellaneous Reasons|0
1642492|NCT01735201|5742944|P2|Overall Study|Other Miscellaneous Reasons|0
1642493|NCT01735201|5742945|P1|Overall Study|Other Miscellaneous Reasons|0
1642494|NCT01735201|5742938|P8|Overall Study|Protocol Violation|0
1642495|NCT01735201|5742939|P7|Overall Study|Protocol Violation|0
1642496|NCT01735201|5742940|P6|Overall Study|Protocol Violation|0
1642497|NCT01735201|5742941|P5|Overall Study|Protocol Violation|0
1642498|NCT01735201|5742942|P4|Overall Study|Protocol Violation|0
1642499|NCT01735201|5742943|P3|Overall Study|Protocol Violation|0
1642500|NCT01735201|5742944|P2|Overall Study|Protocol Violation|0
1642501|NCT01735201|5742945|P1|Overall Study|Protocol Violation|1
1642502|NCT01735201|5742938|P8|Overall Study|Personal Reasons|0
1642503|NCT01735201|5742939|P7|Overall Study|Personal Reasons|0
1642504|NCT01735201|5742940|P6|Overall Study|Personal Reasons|0
1642505|NCT01735201|5742941|P5|Overall Study|Personal Reasons|0
1642506|NCT01735201|5742942|P4|Overall Study|Personal Reasons|0
1642507|NCT01735201|5742943|P3|Overall Study|Personal Reasons|0
1642508|NCT01735201|5742944|P2|Overall Study|Personal Reasons|0
1642509|NCT01735201|5742945|P1|Overall Study|Personal Reasons|1
1642510|NCT01735201|5742938|P8|Overall Study|Adverse Event|1
1642511|NCT01735201|5742939|P7|Overall Study|Adverse Event|2
1642512|NCT01735201|5742940|P6|Overall Study|Adverse Event|3
1642513|NCT01735201|5742941|P5|Overall Study|Adverse Event|1
1642514|NCT01735201|5742942|P4|Overall Study|Adverse Event|1
1642515|NCT01735201|5742943|P3|Overall Study|Adverse Event|0
1642516|NCT01735201|5742944|P2|Overall Study|Adverse Event|1
1642517|NCT01735201|5742945|P1|Overall Study|Adverse Event|1
1642518|NCT01735175|5742981|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
1642519|NCT01735175|5742982|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
1642520|NCT01735175|5742981|P2|Overall Study|Death|2
1642521|NCT01735175|5742982|P1|Overall Study|Death|3
1642522|NCT01735175|5742981|P2|Overall Study|Lost to Follow-up|2
1642523|NCT01735175|5742982|P1|Overall Study|Lost to Follow-up|4
1642524|NCT01735175|5742981|P2|Overall Study|Withdrawal by Subject|2
1642525|NCT01735175|5742982|P1|Overall Study|Withdrawal by Subject|9
1642526|NCT01734993|5743002|P1|Overall Study|Lack of Efficacy|1
1642527|NCT01734993|5743002|P1|Overall Study|Adverse Event|1
1642528|NCT01734902|5743030|P2|Overall Study|Other than listed|2
1642529|NCT01734902|5743031|P1|Overall Study|Other than listed|0
1642530|NCT01734785|5743052|P4|Double−Blind Period|Not treated|0
1642531|NCT01734785|5743053|P3|Double−Blind Period|Not treated|0
1642532|NCT01734785|5743054|P2|Double−Blind Period|Not treated|0
1642533|NCT01734785|5743055|P1|Double−Blind Period|Not treated|1
1642534|NCT01734785|5743052|P4|Double−Blind Period|Withdrawal by Subject|0
1642535|NCT01734785|5743053|P3|Double−Blind Period|Withdrawal by Subject|0
1642536|NCT01734785|5743054|P2|Double−Blind Period|Withdrawal by Subject|0
1642537|NCT01734785|5743055|P1|Double−Blind Period|Withdrawal by Subject|2
1642538|NCT01734785|5743052|P4|Double−Blind Period|Lost to Follow-up|0
1642539|NCT01734785|5743053|P3|Double−Blind Period|Lost to Follow-up|2
1642540|NCT01734785|5743054|P2|Double−Blind Period|Lost to Follow-up|4
1642541|NCT01734785|5743055|P1|Double−Blind Period|Lost to Follow-up|2
1642542|NCT01734785|5743052|P4|Double−Blind Period|Protocol Violation|0
1642543|NCT01734785|5743053|P3|Double−Blind Period|Protocol Violation|1
1642544|NCT01734785|5743054|P2|Double−Blind Period|Protocol Violation|1
1642545|NCT01734785|5743055|P1|Double−Blind Period|Protocol Violation|0
1642546|NCT01734785|5743052|P4|Double−Blind Period|Lack of Efficacy|0
1642547|NCT01734785|5743053|P3|Double−Blind Period|Lack of Efficacy|0
1642548|NCT01734785|5743054|P2|Double−Blind Period|Lack of Efficacy|1
1642549|NCT01734785|5743055|P1|Double−Blind Period|Lack of Efficacy|0
1642550|NCT01734785|5743052|P4|Double−Blind Period|Adverse Event|0
1642551|NCT01734785|5743053|P3|Double−Blind Period|Adverse Event|2
1642552|NCT01734785|5743054|P2|Double−Blind Period|Adverse Event|3
1642553|NCT01734785|5743055|P1|Double−Blind Period|Adverse Event|0
1642554|NCT01734785|5743052|P4|Open−Label Period|Other Reasons|224
1642555|NCT01734785|5743053|P3|Open−Label Period|Other Reasons|0
1642556|NCT01734785|5743054|P2|Open−Label Period|Other Reasons|0
1642557|NCT01734785|5743055|P1|Open−Label Period|Other Reasons|0
1642558|NCT01734785|5743052|P4|Open−Label Period|Withdrawal by Subject|12
1642559|NCT01734785|5743053|P3|Open−Label Period|Withdrawal by Subject|0
1642560|NCT01734785|5743054|P2|Open−Label Period|Withdrawal by Subject|0
1642561|NCT01734785|5743055|P1|Open−Label Period|Withdrawal by Subject|0
1642562|NCT01734785|5743052|P4|Open−Label Period|Lost to Follow-up|14
1642563|NCT01734785|5743053|P3|Open−Label Period|Lost to Follow-up|0
1642564|NCT01734785|5743054|P2|Open−Label Period|Lost to Follow-up|0
1642565|NCT01734785|5743055|P1|Open−Label Period|Lost to Follow-up|0
1642566|NCT01734785|5743052|P4|Open−Label Period|Protocol Violation|13
1642567|NCT01734785|5743053|P3|Open−Label Period|Protocol Violation|0
1642568|NCT01734785|5743054|P2|Open−Label Period|Protocol Violation|0
1642569|NCT01734785|5743055|P1|Open−Label Period|Protocol Violation|0
1642570|NCT01734785|5743052|P4|Open−Label Period|Lack of Efficacy|1
1642571|NCT01734785|5743053|P3|Open−Label Period|Lack of Efficacy|0
1642572|NCT01734785|5743054|P2|Open−Label Period|Lack of Efficacy|0
1642573|NCT01734785|5743055|P1|Open−Label Period|Lack of Efficacy|0
1642574|NCT01734785|5743052|P4|Open−Label Period|Adverse Event|9
1642575|NCT01734785|5743053|P3|Open−Label Period|Adverse Event|0
1642576|NCT01734785|5743054|P2|Open−Label Period|Adverse Event|0
1642577|NCT01734785|5743055|P1|Open−Label Period|Adverse Event|0
1642578|NCT01734772|5743072|P2|Overall Study|Withdrawal by Subject|1
1642579|NCT01734772|5743073|P1|Overall Study|Withdrawal by Subject|0
1642580|NCT01734772|5743072|P2|Overall Study|Adverse Event|2
1642581|NCT01734772|5743073|P1|Overall Study|Adverse Event|1
1642582|NCT01734434|5743128|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
1642583|NCT01734434|5743129|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
1642584|NCT01734434|5743130|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
1642585|NCT01734434|5743131|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
1642586|NCT01734434|5743128|P4|Overall Study|Wrong Version of Consent Form Signed|0
1642587|NCT01734434|5743129|P3|Overall Study|Wrong Version of Consent Form Signed|1
1642588|NCT01734434|5743130|P2|Overall Study|Wrong Version of Consent Form Signed|0
1642589|NCT01734434|5743131|P1|Overall Study|Wrong Version of Consent Form Signed|0
1642590|NCT01734434|5743128|P4|Overall Study|Treatment Defaulter|0
1642591|NCT01734434|5743129|P3|Overall Study|Treatment Defaulter|1
1642592|NCT01734434|5743130|P2|Overall Study|Treatment Defaulter|0
1642593|NCT01734434|5743131|P1|Overall Study|Treatment Defaulter|0
1642594|NCT01734434|5743128|P4|Overall Study|Subject Not Reachable|0
1642595|NCT01734434|5743129|P3|Overall Study|Subject Not Reachable|1
1642596|NCT01734434|5743130|P2|Overall Study|Subject Not Reachable|0
1642597|NCT01734434|5743131|P1|Overall Study|Subject Not Reachable|0
1642598|NCT01734434|5743128|P4|Overall Study|Signed Adult Version of Consent Form|0
1642599|NCT01734434|5743129|P3|Overall Study|Signed Adult Version of Consent Form|1
1642600|NCT01734434|5743130|P2|Overall Study|Signed Adult Version of Consent Form|0
1642601|NCT01734434|5743131|P1|Overall Study|Signed Adult Version of Consent Form|0
1642602|NCT01734434|5743128|P4|Overall Study|Withdrawal by Subject|1
1642603|NCT01734434|5743129|P3|Overall Study|Withdrawal by Subject|8
1642604|NCT01734434|5743130|P2|Overall Study|Withdrawal by Subject|0
1642605|NCT01734434|5743131|P1|Overall Study|Withdrawal by Subject|4
1642606|NCT01734434|5743128|P4|Overall Study|No Live Birth|6
1642607|NCT01734434|5743129|P3|Overall Study|No Live Birth|32
1642608|NCT01734434|5743130|P2|Overall Study|No Live Birth|2
1642609|NCT01734434|5743131|P1|Overall Study|No Live Birth|1
1642610|NCT01734434|5743128|P4|Overall Study|Lost to Follow-up|11
1642611|NCT01734434|5743129|P3|Overall Study|Lost to Follow-up|67
1642612|NCT01734434|5743130|P2|Overall Study|Lost to Follow-up|9
1642613|NCT01734434|5743131|P1|Overall Study|Lost to Follow-up|2
1642614|NCT01734434|5743128|P4|Overall Study|Death Infant|5
1642615|NCT01734434|5743129|P3|Overall Study|Death Infant|17
1642616|NCT01734434|5743130|P2|Overall Study|Death Infant|1
1642617|NCT01734434|5743131|P1|Overall Study|Death Infant|3
1642618|NCT01734395|5743153|P1|Overall Study|Missing the reasons for not completed|3
1642619|NCT01734395|5743153|P1|Overall Study|Withdrawal by Subject|10
1642620|NCT01734395|5743153|P1|Overall Study|Adverse Event|40
1642621|NCT01734395|5743153|P1|Overall Study|Lack of Efficacy|5
1642622|NCT01734395|5743153|P1|Overall Study|Lost to Follow-up|287
1642623|NCT01734395|5743153|P1|Overall Study|Other|65
1642624|NCT01733758|5743211|P4|Overall Study|Inv Decision, HbA1c not controlled|1
1642625|NCT01733758|5743212|P3|Overall Study|Inv Decision, HbA1c not controlled|0
1642626|NCT01733758|5743213|P2|Overall Study|Inv Decision, HbA1c not controlled|1
1642627|NCT01733758|5743214|P1|Overall Study|Inv Decision, HbA1c not controlled|1
1642628|NCT01733758|5743211|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
1642629|NCT01733758|5743212|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
1642630|NCT01733758|5743213|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
1642631|NCT01733758|5743214|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
1642632|NCT01733758|5743211|P4|Overall Study|Non-compliance|0
1642633|NCT01733758|5743212|P3|Overall Study|Non-compliance|0
1642634|NCT01733758|5743213|P2|Overall Study|Non-compliance|0
1642635|NCT01733758|5743214|P1|Overall Study|Non-compliance|1
1642636|NCT01733758|5743211|P4|Overall Study|Protocol Violation|2
1642637|NCT01733758|5743212|P3|Overall Study|Protocol Violation|2
1642638|NCT01733758|5743213|P2|Overall Study|Protocol Violation|1
1642639|NCT01733758|5743214|P1|Overall Study|Protocol Violation|0
1642640|NCT01733758|5743211|P4|Overall Study|Persistent Hyperglycemia|0
1642641|NCT01733758|5743212|P3|Overall Study|Persistent Hyperglycemia|0
1642642|NCT01733758|5743213|P2|Overall Study|Persistent Hyperglycemia|2
1642643|NCT01733758|5743214|P1|Overall Study|Persistent Hyperglycemia|3
1642644|NCT01733758|5743211|P4|Overall Study|Withdrawal by Subject|3
1642645|NCT01733758|5743212|P3|Overall Study|Withdrawal by Subject|5
1642646|NCT01733758|5743213|P2|Overall Study|Withdrawal by Subject|1
1642647|NCT01733758|5743214|P1|Overall Study|Withdrawal by Subject|1
1642648|NCT01733758|5743211|P4|Overall Study|Adverse Event|1
1642649|NCT01733758|5743212|P3|Overall Study|Adverse Event|8
1642650|NCT01733758|5743213|P2|Overall Study|Adverse Event|7
1642651|NCT01733758|5743214|P1|Overall Study|Adverse Event|5
1642652|NCT01733732|5743280|P2|Overall Study|Did not attend all study visits|0
1642653|NCT01733732|5743281|P1|Overall Study|Did not attend all study visits|1
1642654|NCT01733732|5743280|P2|Overall Study|Adverse Event|0
1642655|NCT01733732|5743281|P1|Overall Study|Adverse Event|1
1642656|NCT01733680|5743317|P2|Overall Study|Withdrawal by Subject|1
1642657|NCT01733680|5743318|P1|Overall Study|Withdrawal by Subject|0
1642658|NCT01733329|5743377|P2|Overall Study|Uterine artery injury|0
1642659|NCT01733329|5743378|P1|Overall Study|Uterine artery injury|1
1642660|NCT01733329|5743377|P2|Overall Study|Protocol Violation|1
1642661|NCT01733329|5743378|P1|Overall Study|Protocol Violation|1
1642662|NCT01733316|5743390|P1|Long Term Extension Phase|Sponsor Decision|2
1642663|NCT01733316|5743390|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
1642664|NCT01733316|5743390|P1|Long Term Extension Phase|Adverse Event|1
1642665|NCT01733316|5743390|P1|RP103 Phase|Non-compliance|1
1642666|NCT01733121|5743428|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1642667|NCT01733121|5743429|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1642668|NCT01733121|5743428|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
1642669|NCT01733121|5743429|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1642670|NCT01733121|5743428|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1642671|NCT01733121|5743429|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1642672|NCT01733121|5743428|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1642673|NCT01733121|5743429|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
1642674|NCT01732926|5743471|P2|Overall Study|Blind Broken by Subject or Study Site|1
1642675|NCT01732926|5743472|P1|Overall Study|Blind Broken by Subject or Study Site|1
1642676|NCT01732926|5743471|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
1642677|NCT01732926|5743472|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
1642678|NCT01732926|5743471|P2|Overall Study|Other Reason|4
1642679|NCT01732926|5743472|P1|Overall Study|Other Reason|21
1642680|NCT01732926|5743471|P2|Overall Study|Physician Decision|11
1642681|NCT01732926|5743472|P1|Overall Study|Physician Decision|24
1642682|NCT01732926|5743471|P2|Overall Study|Withdrawal by Subject|8
1642683|NCT01732926|5743472|P1|Overall Study|Withdrawal by Subject|46
1642684|NCT01732926|5743471|P2|Overall Study|Study Terminated by Sponsor|80
1642685|NCT01732926|5743472|P1|Overall Study|Study Terminated by Sponsor|168
1642686|NCT01732913|5743488|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
1642687|NCT01732913|5743489|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
1642688|NCT01732913|5743488|P2|Overall Study|Other|1
1642689|NCT01732913|5743489|P1|Overall Study|Other|7
1642690|NCT01732913|5743488|P2|Overall Study|Physician Decision|7
1642691|NCT01732913|5743489|P1|Overall Study|Physician Decision|14
1642692|NCT01732913|5743488|P2|Overall Study|Withdrawal by Subject|4
1642693|NCT01732913|5743489|P1|Overall Study|Withdrawal by Subject|27
1642694|NCT01732913|5743488|P2|Overall Study|Study Terminated by Sponsor|55
1642695|NCT01732913|5743489|P1|Overall Study|Study Terminated by Sponsor|105
1642696|NCT01732835|5743503|P1|2-year Extended Follow-up|Death|1
1642697|NCT01732835|5743503|P1|2-year Extended Follow-up|Adverse Event|3
1642698|NCT01732835|5743503|P1|2-year Extended Follow-up|Withdrawal by Subject|1
1642699|NCT01732835|5743503|P1|6-month Primary Endpoint|Adverse Event|3
1642700|NCT01732835|5743503|P1|6-month Primary Endpoint|Withdrawal by Subject|2
1642701|NCT01732835|5743503|P1|6-month Primary Endpoint|Did not receive device|19
1642702|NCT01732822|5743536|P2|Overall Study|Withdrawal by Subject|113
1642703|NCT01732822|5743537|P1|Overall Study|Withdrawal by Subject|123
1642704|NCT01732796|5743610|P3|Overall Study|Other reason not defined above|2
1642705|NCT01732796|5743611|P2|Overall Study|Other reason not defined above|0
1642706|NCT01732796|5743612|P1|Overall Study|Other reason not defined above|1
1642707|NCT01732796|5743610|P3|Overall Study|Withdrawal by Subject|2
1642708|NCT01732796|5743611|P2|Overall Study|Withdrawal by Subject|8
1642709|NCT01732796|5743612|P1|Overall Study|Withdrawal by Subject|6
1642710|NCT01732796|5743610|P3|Overall Study|Lost to Follow-up|0
1642711|NCT01732796|5743611|P2|Overall Study|Lost to Follow-up|0
1642712|NCT01732796|5743612|P1|Overall Study|Lost to Follow-up|2
1642713|NCT01732796|5743610|P3|Overall Study|Lack of Efficacy|5
1642714|NCT01732796|5743611|P2|Overall Study|Lack of Efficacy|18
1642715|NCT01732796|5743612|P1|Overall Study|Lack of Efficacy|21
1642716|NCT01732796|5743610|P3|Overall Study|Adverse Event|4
1642717|NCT01732796|5743611|P2|Overall Study|Adverse Event|16
1642718|NCT01732796|5743612|P1|Overall Study|Adverse Event|16
1642719|NCT01732783|5743631|P3|Overall Study|Withdrawal by Subject|0
1642720|NCT01732783|5743632|P2|Overall Study|Withdrawal by Subject|0
1642721|NCT01732783|5743633|P1|Overall Study|Withdrawal by Subject|1
1642722|NCT01732783|5743631|P3|Overall Study|Administrative Decision|1
1642723|NCT01732783|5743632|P2|Overall Study|Administrative Decision|2
1642724|NCT01732783|5743633|P1|Overall Study|Administrative Decision|8
1642725|NCT01732783|5743631|P3|Overall Study|Lost to Follow-up|1
1642726|NCT01732783|5743632|P2|Overall Study|Lost to Follow-up|1
1642727|NCT01732783|5743633|P1|Overall Study|Lost to Follow-up|7
1642728|NCT01732783|5743631|P3|Overall Study|Death|1
1642729|NCT01732783|5743632|P2|Overall Study|Death|4
1642730|NCT01732783|5743633|P1|Overall Study|Death|13
1642731|NCT01732783|5743631|P3|Overall Study|Discontinued Panitumumab Treatment|7
1642732|NCT01732783|5743632|P2|Overall Study|Discontinued Panitumumab Treatment|25
1642733|NCT01732783|5743633|P1|Overall Study|Discontinued Panitumumab Treatment|106
1642734|NCT01732770|5743697|P2|Overall Study|Death|0
1642735|NCT01732770|5743698|P1|Overall Study|Death|1
1642736|NCT01732770|5743697|P2|Overall Study|Decision by Sponsor|2
1642737|NCT01732770|5743698|P1|Overall Study|Decision by Sponsor|2
1642738|NCT01732770|5743697|P2|Overall Study|Withdrawal by Subject|3
1642739|NCT01732770|5743698|P1|Overall Study|Withdrawal by Subject|5
1642740|NCT01732770|5743697|P2|Overall Study|Lost to Follow-up|3
1642741|NCT01732770|5743698|P1|Overall Study|Lost to Follow-up|2
1642742|NCT01732757|5743713|P3|Overall Study|Lost to Follow-up|0
1642743|NCT01732757|5743714|P2|Overall Study|Lost to Follow-up|0
1642744|NCT01732757|5743715|P1|Overall Study|Lost to Follow-up|1
1642745|NCT01732692|5743792|P2|Overall Study|Adverse Event|1
1642746|NCT01732692|5743793|P1|Overall Study|Adverse Event|0
1642747|NCT01732640|5743807|P2|Overall Study|Death|1
1642748|NCT01732640|5743808|P1|Overall Study|Death|0
1642749|NCT01732640|5743807|P2|Overall Study|Adverse Event|1
1642750|NCT01732640|5743808|P1|Overall Study|Adverse Event|0
1642751|NCT01732588|5743826|P3|First Intervention (7 Days)|Adverse Event|0
1642752|NCT01732588|5743827|P2|First Intervention (7 Days)|Adverse Event|1
1642753|NCT01732588|5743828|P1|First Intervention (7 Days)|Adverse Event|0
1642754|NCT01732549|5743844|P2|Overall Study|Other|14
1642755|NCT01732549|5743845|P1|Overall Study|Other|8
1642756|NCT01732549|5743844|P2|Overall Study|Disease progression|50
1642757|NCT01732549|5743845|P1|Overall Study|Disease progression|37
1642758|NCT01732549|5743844|P2|Overall Study|Consent withdrawn|6
1642759|NCT01732549|5743845|P1|Overall Study|Consent withdrawn|13
1642760|NCT01732549|5743844|P2|Overall Study|Adverse Event|3
1642761|NCT01732549|5743845|P1|Overall Study|Adverse Event|13
1642762|NCT01732536|5743867|P2|Overall Study|Withdrawal by Subject|1
1642763|NCT01732536|5743868|P1|Overall Study|Withdrawal by Subject|1
1642764|NCT01732510|5743891|P7|Overall Study|Study Terminated By Sponsor|6
1642765|NCT01732510|5743892|P6|Overall Study|Study Terminated By Sponsor|12
1642766|NCT01732510|5743893|P5|Overall Study|Study Terminated By Sponsor|0
1642767|NCT01732510|5743894|P4|Overall Study|Study Terminated By Sponsor|1
1642768|NCT01732510|5743895|P3|Overall Study|Study Terminated By Sponsor|0
1642769|NCT01732510|5743896|P2|Overall Study|Study Terminated By Sponsor|0
1642770|NCT01732510|5743897|P1|Overall Study|Study Terminated By Sponsor|0
1642771|NCT01732510|5743891|P7|Overall Study|Pregnancy|0
1642772|NCT01732510|5743892|P6|Overall Study|Pregnancy|0
1642773|NCT01732510|5743893|P5|Overall Study|Pregnancy|0
1642774|NCT01732510|5743894|P4|Overall Study|Pregnancy|1
1642775|NCT01732510|5743895|P3|Overall Study|Pregnancy|0
1642776|NCT01732510|5743896|P2|Overall Study|Pregnancy|0
1642777|NCT01732510|5743897|P1|Overall Study|Pregnancy|0
1642778|NCT01732510|5743891|P7|Overall Study|Physician Decision|0
1642779|NCT01732510|5743892|P6|Overall Study|Physician Decision|0
1642780|NCT01732510|5743893|P5|Overall Study|Physician Decision|0
1642781|NCT01732510|5743894|P4|Overall Study|Physician Decision|0
1642782|NCT01732510|5743895|P3|Overall Study|Physician Decision|0
1642783|NCT01732510|5743896|P2|Overall Study|Physician Decision|1
1642784|NCT01732510|5743897|P1|Overall Study|Physician Decision|0
1642785|NCT01732510|5743891|P7|Overall Study|Lost to Follow-up|0
1642786|NCT01732510|5743892|P6|Overall Study|Lost to Follow-up|1
1642787|NCT01732510|5743893|P5|Overall Study|Lost to Follow-up|0
1642788|NCT01732510|5743894|P4|Overall Study|Lost to Follow-up|1
1642789|NCT01732510|5743895|P3|Overall Study|Lost to Follow-up|1
1642790|NCT01732510|5743896|P2|Overall Study|Lost to Follow-up|0
1642791|NCT01732510|5743897|P1|Overall Study|Lost to Follow-up|0
1642792|NCT01732510|5743891|P7|Overall Study|Withdrawal by Subject|1
1642793|NCT01732510|5743892|P6|Overall Study|Withdrawal by Subject|0
1642794|NCT01732510|5743893|P5|Overall Study|Withdrawal by Subject|5
1642795|NCT01732510|5743894|P4|Overall Study|Withdrawal by Subject|1
1642796|NCT01732510|5743895|P3|Overall Study|Withdrawal by Subject|2
1642797|NCT01732510|5743896|P2|Overall Study|Withdrawal by Subject|3
1642798|NCT01732510|5743897|P1|Overall Study|Withdrawal by Subject|1
1642799|NCT01732510|5743891|P7|Overall Study|Protocol Violation|0
1642800|NCT01732510|5743892|P6|Overall Study|Protocol Violation|0
1642801|NCT01732510|5743893|P5|Overall Study|Protocol Violation|0
1642802|NCT01732510|5743894|P4|Overall Study|Protocol Violation|1
1642803|NCT01732510|5743895|P3|Overall Study|Protocol Violation|0
1642804|NCT01732510|5743896|P2|Overall Study|Protocol Violation|0
1642805|NCT01732510|5743897|P1|Overall Study|Protocol Violation|0
1642806|NCT01732510|5743891|P7|Overall Study|Adverse Event|1
1642807|NCT01732510|5743892|P6|Overall Study|Adverse Event|0
1642808|NCT01732510|5743893|P5|Overall Study|Adverse Event|0
1642809|NCT01732510|5743894|P4|Overall Study|Adverse Event|0
1642810|NCT01732510|5743895|P3|Overall Study|Adverse Event|1
1642811|NCT01732510|5743896|P2|Overall Study|Adverse Event|1
1642812|NCT01732510|5743897|P1|Overall Study|Adverse Event|0
1642813|NCT01732484|5743976|P1|Overall Study|chronical illness|5
1642814|NCT01732484|5743976|P1|Overall Study|Lost to Follow-up|14
1642815|NCT01732484|5743976|P1|Overall Study|Death|7
1642816|NCT01732471|5743984|P1|Overall Study|Withdrawal by Subject|1
1642817|NCT01732458|5743995|P4|Overall Study|Screen Failure|0
1642818|NCT01732458|5743996|P3|Overall Study|Screen Failure|0
1642819|NCT01732458|5743997|P2|Overall Study|Screen Failure|1
1642820|NCT01732458|5743998|P1|Overall Study|Screen Failure|0
1642821|NCT01732458|5743995|P4|Overall Study|Protocol Violation|2
1642822|NCT01732458|5743996|P3|Overall Study|Protocol Violation|0
1642823|NCT01732458|5743997|P2|Overall Study|Protocol Violation|0
1642824|NCT01732458|5743998|P1|Overall Study|Protocol Violation|2
1642825|NCT01732458|5743995|P4|Overall Study|Physician Decision|0
1642826|NCT01732458|5743996|P3|Overall Study|Physician Decision|2
1642827|NCT01732458|5743997|P2|Overall Study|Physician Decision|2
1642828|NCT01732458|5743998|P1|Overall Study|Physician Decision|1
1642829|NCT01732458|5743995|P4|Overall Study|Non-Compliance With Study Drug|0
1642830|NCT01732458|5743996|P3|Overall Study|Non-Compliance With Study Drug|1
1642831|NCT01732458|5743997|P2|Overall Study|Non-Compliance With Study Drug|0
1642832|NCT01732458|5743998|P1|Overall Study|Non-Compliance With Study Drug|0
1642833|NCT01732458|5743995|P4|Overall Study|Lost to Follow-up|0
1642834|NCT01732458|5743996|P3|Overall Study|Lost to Follow-up|0
1642835|NCT01732458|5743997|P2|Overall Study|Lost to Follow-up|2
1642836|NCT01732458|5743998|P1|Overall Study|Lost to Follow-up|0
1642837|NCT01732107|5744160|P1|Overall Study|Withdrawal by Subject|2
1642838|NCT01732107|5744160|P1|Overall Study|Physician Decision|1
1642839|NCT01732107|5744160|P1|Overall Study|Disease Progression|8
1642840|NCT01732107|5744160|P1|Overall Study|Adverse Event|2
1642841|NCT01731990|5744177|P2|Overall Study|Death|0
1642842|NCT01731990|5744178|P1|Overall Study|Death|1
1642843|NCT01731990|5744177|P2|Overall Study|Protocol deviation|2
1642844|NCT01731990|5744178|P1|Overall Study|Protocol deviation|1
1642845|NCT01731990|5744177|P2|Overall Study|Withdrawal by Subject|1
1642846|NCT01731990|5744178|P1|Overall Study|Withdrawal by Subject|1
1642847|NCT01731990|5744177|P2|Overall Study|Adverse Event|5
1642848|NCT01731990|5744178|P1|Overall Study|Adverse Event|1
1642849|NCT01731938|5744194|P2|Primary Part II|Missed Week 6 visit|3
1642850|NCT01731938|5744195|P1|Primary Part II|Missed Week 6 visit|2
1642851|NCT01731938|5744194|P2|Primary Part II|Death|1
1642852|NCT01731938|5744195|P1|Primary Part II|Death|2
1642853|NCT01731938|5744194|P2|Primary Part II|Lost to Follow-up|5
1642854|NCT01731938|5744195|P1|Primary Part II|Lost to Follow-up|4
1642855|NCT01731938|5744194|P2|Primary Part II|Withdrawal by Subject|4
1642856|NCT01731938|5744195|P1|Primary Part II|Withdrawal by Subject|5
1642857|NCT01731938|5744194|P2|Preliminary Part I|Missed Week 6 visit|3
1642858|NCT01731938|5744195|P1|Preliminary Part I|Missed Week 6 visit|0
1642859|NCT01731938|5744194|P2|Preliminary Part I|Lost to Follow-up|3
1642860|NCT01731938|5744195|P1|Preliminary Part I|Lost to Follow-up|0
1642861|NCT01731938|5744194|P2|Preliminary Part I|Physician Decision|0
1642862|NCT01731938|5744195|P1|Preliminary Part I|Physician Decision|1
1642863|NCT01731938|5744194|P2|Preliminary Part I|Withdrawal by Subject|2
1642864|NCT01731938|5744195|P1|Preliminary Part I|Withdrawal by Subject|2
1642865|NCT01731912|5744207|P1|Overall Study|noncompliance|2
1642866|NCT01731886|5744214|P2|Overall Study|Non-compliant|0
1642867|NCT01731886|5744215|P1|Overall Study|Non-compliant|1
1642868|NCT01731886|5744214|P2|Overall Study|Never started treatment|1
1642869|NCT01731886|5744215|P1|Overall Study|Never started treatment|0
1642870|NCT01731886|5744214|P2|Overall Study|Death|0
1642871|NCT01731886|5744215|P1|Overall Study|Death|1
1642872|NCT01731678|5744229|P1|Overall Study|RMT too high, making TMS difficult|3
1642873|NCT01731678|5744229|P1|Overall Study|Did not meet inclusion criteria|1
1642874|NCT01731678|5744229|P1|Overall Study|Withdrawal by Subject|3
1642875|NCT01731600|5744235|P2|Overall Study|Other reasons|0
1642876|NCT01731600|5744236|P1|Overall Study|Other reasons|3
1642877|NCT01731600|5744235|P2|Overall Study|Withdrawal criteria|0
1642878|NCT01731600|5744236|P1|Overall Study|Withdrawal criteria|1
1642879|NCT01731600|5744235|P2|Overall Study|Adverse Event|0
1642880|NCT01731600|5744236|P1|Overall Study|Adverse Event|2
1642881|NCT01731470|5744290|P1|Overall Study|Did not meet study criteria|1
1642882|NCT01731470|5744290|P1|Overall Study|Withdrawal by Subject|1
1642883|NCT01731171|5744297|P2|Overall Study|Terminated for Safety Reasons|1
1642884|NCT01731171|5744298|P1|Overall Study|Terminated for Safety Reasons|0
1642885|NCT01731171|5744297|P2|Overall Study|Terminated for Lack of Adherence|1
1642886|NCT01731171|5744298|P1|Overall Study|Terminated for Lack of Adherence|0
1642887|NCT01731171|5744297|P2|Overall Study|Moved out of Area|2
1642888|NCT01731171|5744298|P1|Overall Study|Moved out of Area|0
1642889|NCT01731171|5744297|P2|Overall Study|Lost to Follow-up|2
1642890|NCT01731171|5744298|P1|Overall Study|Lost to Follow-up|3
1642891|NCT01731171|5744297|P2|Overall Study|Withdrawal by Subject|1
1642892|NCT01731171|5744298|P1|Overall Study|Withdrawal by Subject|4
1642893|NCT01731002|5744332|P3|Overall Study|Inappropriate use of study medications|1
1642894|NCT01731002|5744333|P2|Overall Study|Inappropriate use of study medications|0
1642895|NCT01731002|5744334|P1|Overall Study|Inappropriate use of study medications|0
1642896|NCT01731002|5744332|P3|Overall Study|Elevated IOP|0
1642897|NCT01731002|5744333|P2|Overall Study|Elevated IOP|0
1642898|NCT01731002|5744334|P1|Overall Study|Elevated IOP|1
1642899|NCT01731002|5744332|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1642900|NCT01731002|5744333|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
1642901|NCT01731002|5744334|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
1642902|NCT01731002|5744332|P3|Overall Study|Test Agent Discontinuation|0
1642903|NCT01731002|5744333|P2|Overall Study|Test Agent Discontinuation|1
1642904|NCT01731002|5744334|P1|Overall Study|Test Agent Discontinuation|0
1642905|NCT01731002|5744332|P3|Overall Study|Lost to Follow-up|0
1642906|NCT01731002|5744333|P2|Overall Study|Lost to Follow-up|0
1642907|NCT01731002|5744334|P1|Overall Study|Lost to Follow-up|1
1642908|NCT01731002|5744332|P3|Overall Study|Non-Compliant|0
1642909|NCT01731002|5744333|P2|Overall Study|Non-Compliant|1
1642910|NCT01731002|5744334|P1|Overall Study|Non-Compliant|0
1642911|NCT01731002|5744332|P3|Overall Study|Adverse Event|2
1642912|NCT01731002|5744333|P2|Overall Study|Adverse Event|2
1642913|NCT01731002|5744334|P1|Overall Study|Adverse Event|0
1642914|NCT01730729|5744377|P1|Overall Study|Progressive Disease|12
1642915|NCT01730729|5744377|P1|Overall Study|Death|1
1642916|NCT01730729|5744377|P1|Overall Study|Adverse Event|1
1642917|NCT01730586|5744391|P1|Overall Study|Hospice|1
1642918|NCT01730586|5744391|P1|Overall Study|Adverse Event|2
1642919|NCT01730586|5744391|P1|Overall Study|Inadequate Trial|8
1642920|NCT01730586|5744391|P1|Overall Study|Progressive Disease|2
1642921|NCT01730534|5744400|P2|Overall Study|Lost to Follow-up|18
1642922|NCT01730534|5744401|P1|Overall Study|Lost to Follow-up|12
1642923|NCT01730534|5744400|P2|Overall Study|Withdrawal by Subject|127
1642924|NCT01730534|5744401|P1|Overall Study|Withdrawal by Subject|97
1642925|NCT01730378|5744415|P2|Overall Study|Lost to Follow-up|0
1642926|NCT01730378|5744416|P1|Overall Study|Lost to Follow-up|1
1642927|NCT01730339|5744447|P2|Overall Study|Un-specified|0
1642928|NCT01730339|5744448|P1|Overall Study|Un-specified|1
1642929|NCT01730339|5744447|P2|Overall Study|Lost to Follow-up|1
1642930|NCT01730339|5744448|P1|Overall Study|Lost to Follow-up|1
1642931|NCT01730339|5744447|P2|Overall Study|Withdrawal by Subject|2
1642932|NCT01730339|5744448|P1|Overall Study|Withdrawal by Subject|3
1642933|NCT01730053|5744488|P6|Overall Study|Other than specified|9
1642934|NCT01730053|5744489|P5|Overall Study|Other than specified|7
1642935|NCT01730053|5744490|P4|Overall Study|Other than specified|4
1642936|NCT01730053|5744491|P3|Overall Study|Other than specified|5
1642937|NCT01730053|5744492|P2|Overall Study|Other than specified|6
1642938|NCT01730053|5744493|P1|Overall Study|Other than specified|2
1642939|NCT01730053|5744488|P6|Overall Study|Poor compliance to protocol|2
1642940|NCT01730053|5744489|P5|Overall Study|Poor compliance to protocol|0
1642941|NCT01730053|5744490|P4|Overall Study|Poor compliance to protocol|0
1642942|NCT01730053|5744491|P3|Overall Study|Poor compliance to protocol|2
1642943|NCT01730053|5744492|P2|Overall Study|Poor compliance to protocol|2
1642944|NCT01730053|5744493|P1|Overall Study|Poor compliance to protocol|1
1642945|NCT01730053|5744488|P6|Overall Study|Adverse Event|2
1642946|NCT01730053|5744489|P5|Overall Study|Adverse Event|2
1642947|NCT01730053|5744490|P4|Overall Study|Adverse Event|3
1642948|NCT01730053|5744491|P3|Overall Study|Adverse Event|3
1642949|NCT01730053|5744492|P2|Overall Study|Adverse Event|6
1642950|NCT01730053|5744493|P1|Overall Study|Adverse Event|2
1642951|NCT01730053|5744488|P6|Overall Study|Physician Decision|0
1642952|NCT01730053|5744489|P5|Overall Study|Physician Decision|0
1642953|NCT01730053|5744490|P4|Overall Study|Physician Decision|1
1642954|NCT01730053|5744491|P3|Overall Study|Physician Decision|0
1642955|NCT01730053|5744492|P2|Overall Study|Physician Decision|0
1642956|NCT01730053|5744493|P1|Overall Study|Physician Decision|0
1642957|NCT01730053|5744488|P6|Overall Study|Participant moved|0
1642958|NCT01730053|5744489|P5|Overall Study|Participant moved|0
1642959|NCT01730053|5744490|P4|Overall Study|Participant moved|0
1642960|NCT01730053|5744491|P3|Overall Study|Participant moved|1
1642961|NCT01730053|5744492|P2|Overall Study|Participant moved|0
1642962|NCT01730053|5744493|P1|Overall Study|Participant moved|0
1642963|NCT01730040|5744652|P7|Overall Study|Poor compliance to protocol|1
1642964|NCT01730040|5744653|P6|Overall Study|Poor compliance to protocol|0
1642965|NCT01730040|5744654|P5|Overall Study|Poor compliance to protocol|0
1642966|NCT01730040|5744655|P4|Overall Study|Poor compliance to protocol|0
1642967|NCT01730040|5744656|P3|Overall Study|Poor compliance to protocol|0
1642968|NCT01730040|5744657|P2|Overall Study|Poor compliance to protocol|4
1642969|NCT01730040|5744658|P1|Overall Study|Poor compliance to protocol|2
1642970|NCT01730040|5744652|P7|Overall Study|Adverse Event|2
1642971|NCT01730040|5744653|P6|Overall Study|Adverse Event|1
1642972|NCT01730040|5744654|P5|Overall Study|Adverse Event|1
1642973|NCT01730040|5744655|P4|Overall Study|Adverse Event|3
1642974|NCT01730040|5744656|P3|Overall Study|Adverse Event|5
1642975|NCT01730040|5744657|P2|Overall Study|Adverse Event|3
1642976|NCT01730040|5744658|P1|Overall Study|Adverse Event|4
1642977|NCT01730040|5744652|P7|Overall Study|Other than specified|4
1642978|NCT01730040|5744653|P6|Overall Study|Other than specified|4
1642979|NCT01730040|5744654|P5|Overall Study|Other than specified|5
1642980|NCT01730040|5744655|P4|Overall Study|Other than specified|5
1642981|NCT01730040|5744656|P3|Overall Study|Other than specified|5
1642982|NCT01730040|5744657|P2|Overall Study|Other than specified|8
1642983|NCT01730040|5744658|P1|Overall Study|Other than specified|7
1642984|NCT01730040|5744652|P7|Overall Study|Physician Decision|1
1642985|NCT01730040|5744653|P6|Overall Study|Physician Decision|1
1642986|NCT01730040|5744654|P5|Overall Study|Physician Decision|0
1642987|NCT01730040|5744655|P4|Overall Study|Physician Decision|0
1642988|NCT01730040|5744656|P3|Overall Study|Physician Decision|0
1642989|NCT01730040|5744657|P2|Overall Study|Physician Decision|0
1642990|NCT01730040|5744658|P1|Overall Study|Physician Decision|0
1642991|NCT01730040|5744652|P7|Overall Study|Subject moved|1
1642992|NCT01730040|5744653|P6|Overall Study|Subject moved|0
1642993|NCT01730040|5744654|P5|Overall Study|Subject moved|0
1642994|NCT01730040|5744655|P4|Overall Study|Subject moved|0
1642995|NCT01730040|5744656|P3|Overall Study|Subject moved|1
1642996|NCT01730040|5744657|P2|Overall Study|Subject moved|0
1642997|NCT01730040|5744658|P1|Overall Study|Subject moved|0
1642998|NCT01730040|5744652|P7|Overall Study|Randomized but not treated|0
1642999|NCT01730040|5744653|P6|Overall Study|Randomized but not treated|1
1643000|NCT01730040|5744654|P5|Overall Study|Randomized but not treated|0
1643001|NCT01730040|5744655|P4|Overall Study|Randomized but not treated|0
1643002|NCT01730040|5744656|P3|Overall Study|Randomized but not treated|0
1643003|NCT01730040|5744657|P2|Overall Study|Randomized but not treated|0
1643004|NCT01730040|5744658|P1|Overall Study|Randomized but not treated|0
1643005|NCT01729871|5744847|P2|Overall Study|Other|9
1643006|NCT01729871|5744848|P1|Overall Study|Other|4
1643007|NCT01729871|5744847|P2|Overall Study|Withdrawal by Subject|3
1643008|NCT01729871|5744848|P1|Overall Study|Withdrawal by Subject|0
1643009|NCT01729871|5744847|P2|Overall Study|Protocol Violation|0
1643010|NCT01729871|5744848|P1|Overall Study|Protocol Violation|1
1643011|NCT01729871|5744847|P2|Overall Study|Physician Decision|2
1643012|NCT01729871|5744848|P1|Overall Study|Physician Decision|0
1643013|NCT01729871|5744847|P2|Overall Study|Lack of Efficacy|1
1643014|NCT01729871|5744848|P1|Overall Study|Lack of Efficacy|0
1643015|NCT01729871|5744847|P2|Overall Study|Death|1
1643016|NCT01729871|5744848|P1|Overall Study|Death|0
1643017|NCT01729871|5744847|P2|Overall Study|Adverse Event|7
1643018|NCT01729871|5744848|P1|Overall Study|Adverse Event|7
1643019|NCT01729819|5744882|P2|Overall Study|Withdrawal by Subject|2
1643020|NCT01729819|5744883|P1|Overall Study|Withdrawal by Subject|0
1643021|NCT01729819|5744882|P2|Overall Study|Protocol Violation|1
1643022|NCT01729819|5744883|P1|Overall Study|Protocol Violation|0
1643023|NCT01729819|5744882|P2|Overall Study|Other reason|0
1643024|NCT01729819|5744883|P1|Overall Study|Other reason|1
1643025|NCT01729819|5744882|P2|Overall Study|Lost to Follow-up|0
1643026|NCT01729819|5744883|P1|Overall Study|Lost to Follow-up|2
1643027|NCT01729819|5744882|P2|Overall Study|Lack of Efficacy|0
1643028|NCT01729819|5744883|P1|Overall Study|Lack of Efficacy|1
1643029|NCT01729819|5744882|P2|Overall Study|Adverse Event|4
1643030|NCT01729819|5744883|P1|Overall Study|Adverse Event|2
1643031|NCT01729754|5744902|P10|Part 3|Other Protocol Specified Criteria|0
1643032|NCT01729754|5744903|P9|Part 3|Other Protocol Specified Criteria|0
1643033|NCT01729754|5744904|P8|Part 3|Other Protocol Specified Criteria|1
1643034|NCT01729754|5744905|P7|Part 3|Other Protocol Specified Criteria|0
1643035|NCT01729754|5744906|P6|Part 3|Other Protocol Specified Criteria|2
1643036|NCT01729754|5744907|P5|Part 3|Other Protocol Specified Criteria|0
1643037|NCT01729754|5744908|P4|Part 3|Other Protocol Specified Criteria|0
1643038|NCT01729754|5744909|P3|Part 3|Other Protocol Specified Criteria|0
1643039|NCT01729754|5744910|P2|Part 3|Other Protocol Specified Criteria|0
1643040|NCT01729754|5744911|P1|Part 3|Other Protocol Specified Criteria|0
1643041|NCT01729754|5744902|P10|Part 3|Withdrawal by Subject|0
1643042|NCT01729754|5744903|P9|Part 3|Withdrawal by Subject|0
1643043|NCT01729754|5744904|P8|Part 3|Withdrawal by Subject|2
1643044|NCT01729754|5744905|P7|Part 3|Withdrawal by Subject|0
1643045|NCT01729754|5744906|P6|Part 3|Withdrawal by Subject|1
1643046|NCT01729754|5744907|P5|Part 3|Withdrawal by Subject|2
1643047|NCT01729754|5744908|P4|Part 3|Withdrawal by Subject|0
1643048|NCT01729754|5744909|P3|Part 3|Withdrawal by Subject|1
1643049|NCT01729754|5744910|P2|Part 3|Withdrawal by Subject|4
1643050|NCT01729754|5744911|P1|Part 3|Withdrawal by Subject|0
1643051|NCT01729754|5744902|P10|Part 3|Physician Decision|0
1643052|NCT01729754|5744903|P9|Part 3|Physician Decision|0
1643053|NCT01729754|5744904|P8|Part 3|Physician Decision|0
1643054|NCT01729754|5744905|P7|Part 3|Physician Decision|0
1643055|NCT01729754|5744906|P6|Part 3|Physician Decision|0
1643056|NCT01729754|5744907|P5|Part 3|Physician Decision|0
1643057|NCT01729754|5744908|P4|Part 3|Physician Decision|0
1643058|NCT01729754|5744909|P3|Part 3|Physician Decision|1
1643059|NCT01729754|5744910|P2|Part 3|Physician Decision|0
1643060|NCT01729754|5744911|P1|Part 3|Physician Decision|0
1643061|NCT01729754|5744902|P10|Part 3|Lost to Follow-up|0
1643062|NCT01729754|5744903|P9|Part 3|Lost to Follow-up|1
1643063|NCT01729754|5744904|P8|Part 3|Lost to Follow-up|0
1643064|NCT01729754|5744905|P7|Part 3|Lost to Follow-up|0
1643065|NCT01729754|5744906|P6|Part 3|Lost to Follow-up|3
1643066|NCT01729754|5744907|P5|Part 3|Lost to Follow-up|0
1643067|NCT01729754|5744908|P4|Part 3|Lost to Follow-up|0
1643068|NCT01729754|5744909|P3|Part 3|Lost to Follow-up|2
1643069|NCT01729754|5744910|P2|Part 3|Lost to Follow-up|1
1643070|NCT01729754|5744911|P1|Part 3|Lost to Follow-up|0
1643071|NCT01729754|5744902|P10|Part 3|Lack of Efficacy|4
1643072|NCT01729754|5744903|P9|Part 3|Lack of Efficacy|0
1643073|NCT01729754|5744904|P8|Part 3|Lack of Efficacy|0
1643074|NCT01729754|5744905|P7|Part 3|Lack of Efficacy|0
1643075|NCT01729754|5744906|P6|Part 3|Lack of Efficacy|0
1643076|NCT01729754|5744907|P5|Part 3|Lack of Efficacy|2
1643077|NCT01729754|5744908|P4|Part 3|Lack of Efficacy|0
1643078|NCT01729754|5744909|P3|Part 3|Lack of Efficacy|0
1643079|NCT01729754|5744910|P2|Part 3|Lack of Efficacy|0
1643080|NCT01729754|5744911|P1|Part 3|Lack of Efficacy|0
1643081|NCT01729754|5744902|P10|Part 3|Death|0
1643082|NCT01729754|5744903|P9|Part 3|Death|0
1643083|NCT01729754|5744904|P8|Part 3|Death|0
1643084|NCT01729754|5744905|P7|Part 3|Death|0
1643085|NCT01729754|5744906|P6|Part 3|Death|2
1643086|NCT01729754|5744907|P5|Part 3|Death|0
1643087|NCT01729754|5744908|P4|Part 3|Death|0
1643088|NCT01729754|5744909|P3|Part 3|Death|0
1643089|NCT01729754|5744910|P2|Part 3|Death|0
1643090|NCT01729754|5744911|P1|Part 3|Death|0
1643091|NCT01729754|5744902|P10|Part 3|Adverse Event|3
1643092|NCT01729754|5744903|P9|Part 3|Adverse Event|0
1643093|NCT01729754|5744904|P8|Part 3|Adverse Event|0
1643094|NCT01729754|5744905|P7|Part 3|Adverse Event|0
1643095|NCT01729754|5744906|P6|Part 3|Adverse Event|5
1643096|NCT01729754|5744907|P5|Part 3|Adverse Event|0
1643097|NCT01729754|5744908|P4|Part 3|Adverse Event|0
1643098|NCT01729754|5744909|P3|Part 3|Adverse Event|1
1643099|NCT01729754|5744910|P2|Part 3|Adverse Event|0
1643100|NCT01729754|5744911|P1|Part 3|Adverse Event|0
1643101|NCT01729754|5744902|P10|Part 2|Other Protocol Specified Criteria|0
1643102|NCT01729754|5744903|P9|Part 2|Other Protocol Specified Criteria|0
1643103|NCT01729754|5744904|P8|Part 2|Other Protocol Specified Criteria|1
1643104|NCT01729754|5744905|P7|Part 2|Other Protocol Specified Criteria|0
1643105|NCT01729754|5744906|P6|Part 2|Other Protocol Specified Criteria|0
1643106|NCT01729754|5744907|P5|Part 2|Other Protocol Specified Criteria|0
1643107|NCT01729754|5744908|P4|Part 2|Other Protocol Specified Criteria|0
1643108|NCT01729754|5744909|P3|Part 2|Other Protocol Specified Criteria|0
1643109|NCT01729754|5744910|P2|Part 2|Other Protocol Specified Criteria|0
1643110|NCT01729754|5744911|P1|Part 2|Other Protocol Specified Criteria|1
1643111|NCT01729754|5744902|P10|Part 2|Withdrawal by Subject|4
1643112|NCT01729754|5744903|P9|Part 2|Withdrawal by Subject|1
1643113|NCT01729754|5744904|P8|Part 2|Withdrawal by Subject|1
1643114|NCT01729754|5744905|P7|Part 2|Withdrawal by Subject|0
1643115|NCT01729754|5744906|P6|Part 2|Withdrawal by Subject|0
1643116|NCT01729754|5744907|P5|Part 2|Withdrawal by Subject|0
1643117|NCT01729754|5744908|P4|Part 2|Withdrawal by Subject|2
1643118|NCT01729754|5744909|P3|Part 2|Withdrawal by Subject|0
1643119|NCT01729754|5744910|P2|Part 2|Withdrawal by Subject|0
1643120|NCT01729754|5744911|P1|Part 2|Withdrawal by Subject|3
1643121|NCT01729754|5744902|P10|Part 2|Pregnancy|1
1643122|NCT01729754|5744903|P9|Part 2|Pregnancy|0
1643123|NCT01729754|5744904|P8|Part 2|Pregnancy|0
1643124|NCT01729754|5744905|P7|Part 2|Pregnancy|0
1643125|NCT01729754|5744906|P6|Part 2|Pregnancy|0
1643126|NCT01729754|5744907|P5|Part 2|Pregnancy|0
1643127|NCT01729754|5744908|P4|Part 2|Pregnancy|1
1643128|NCT01729754|5744909|P3|Part 2|Pregnancy|0
1643129|NCT01729754|5744910|P2|Part 2|Pregnancy|0
1643130|NCT01729754|5744911|P1|Part 2|Pregnancy|0
1643131|NCT01729754|5744902|P10|Part 2|Non-Compliance with Study Drug|1
1643132|NCT01729754|5744903|P9|Part 2|Non-Compliance with Study Drug|0
1643133|NCT01729754|5744904|P8|Part 2|Non-Compliance with Study Drug|0
1643134|NCT01729754|5744905|P7|Part 2|Non-Compliance with Study Drug|0
1643135|NCT01729754|5744906|P6|Part 2|Non-Compliance with Study Drug|0
1643136|NCT01729754|5744907|P5|Part 2|Non-Compliance with Study Drug|0
1643137|NCT01729754|5744908|P4|Part 2|Non-Compliance with Study Drug|0
1643138|NCT01729754|5744909|P3|Part 2|Non-Compliance with Study Drug|0
1643139|NCT01729754|5744910|P2|Part 2|Non-Compliance with Study Drug|0
1643140|NCT01729754|5744911|P1|Part 2|Non-Compliance with Study Drug|0
1643141|NCT01729754|5744902|P10|Part 2|Lost to Follow-up|2
1643142|NCT01729754|5744903|P9|Part 2|Lost to Follow-up|0
1643143|NCT01729754|5744904|P8|Part 2|Lost to Follow-up|1
1643144|NCT01729754|5744905|P7|Part 2|Lost to Follow-up|0
1643145|NCT01729754|5744906|P6|Part 2|Lost to Follow-up|0
1643146|NCT01729754|5744907|P5|Part 2|Lost to Follow-up|0
1643147|NCT01729754|5744908|P4|Part 2|Lost to Follow-up|2
1643148|NCT01729754|5744909|P3|Part 2|Lost to Follow-up|0
1643149|NCT01729754|5744910|P2|Part 2|Lost to Follow-up|0
1643150|NCT01729754|5744911|P1|Part 2|Lost to Follow-up|0
1643151|NCT01729754|5744902|P10|Part 2|Lack of Efficacy|2
1643152|NCT01729754|5744903|P9|Part 2|Lack of Efficacy|2
1643153|NCT01729754|5744904|P8|Part 2|Lack of Efficacy|0
1643154|NCT01729754|5744905|P7|Part 2|Lack of Efficacy|0
1643155|NCT01729754|5744906|P6|Part 2|Lack of Efficacy|0
1643156|NCT01729754|5744907|P5|Part 2|Lack of Efficacy|0
1643157|NCT01729754|5744908|P4|Part 2|Lack of Efficacy|0
1643158|NCT01729754|5744909|P3|Part 2|Lack of Efficacy|0
1643159|NCT01729754|5744910|P2|Part 2|Lack of Efficacy|0
1643160|NCT01729754|5744911|P1|Part 2|Lack of Efficacy|0
1643161|NCT01729754|5744902|P10|Part 2|Adverse Event|2
1643162|NCT01729754|5744903|P9|Part 2|Adverse Event|1
1643163|NCT01729754|5744904|P8|Part 2|Adverse Event|0
1643164|NCT01729754|5744905|P7|Part 2|Adverse Event|0
1643165|NCT01729754|5744906|P6|Part 2|Adverse Event|0
1643166|NCT01729754|5744907|P5|Part 2|Adverse Event|0
1643167|NCT01729754|5744908|P4|Part 2|Adverse Event|0
1643168|NCT01729754|5744909|P3|Part 2|Adverse Event|0
1643169|NCT01729754|5744910|P2|Part 2|Adverse Event|0
1643170|NCT01729754|5744911|P1|Part 2|Adverse Event|2
1643171|NCT01729754|5744902|P10|Part 1|Other Protocol Specified Criteria|4
1643172|NCT01729754|5744903|P9|Part 1|Other Protocol Specified Criteria|0
1643173|NCT01729754|5744904|P8|Part 1|Other Protocol Specified Criteria|0
1643174|NCT01729754|5744905|P7|Part 1|Other Protocol Specified Criteria|1
1643175|NCT01729754|5744906|P6|Part 1|Other Protocol Specified Criteria|0
1643176|NCT01729754|5744907|P5|Part 1|Other Protocol Specified Criteria|0
1643177|NCT01729754|5744908|P4|Part 1|Other Protocol Specified Criteria|0
1643178|NCT01729754|5744909|P3|Part 1|Other Protocol Specified Criteria|0
1643179|NCT01729754|5744910|P2|Part 1|Other Protocol Specified Criteria|0
1643180|NCT01729754|5744911|P1|Part 1|Other Protocol Specified Criteria|2
1643181|NCT01729754|5744902|P10|Part 1|Withdrawal by Subject|6
1643182|NCT01729754|5744903|P9|Part 1|Withdrawal by Subject|0
1643183|NCT01729754|5744904|P8|Part 1|Withdrawal by Subject|0
1643184|NCT01729754|5744905|P7|Part 1|Withdrawal by Subject|5
1643185|NCT01729754|5744906|P6|Part 1|Withdrawal by Subject|0
1643186|NCT01729754|5744907|P5|Part 1|Withdrawal by Subject|0
1643187|NCT01729754|5744908|P4|Part 1|Withdrawal by Subject|7
1643188|NCT01729754|5744909|P3|Part 1|Withdrawal by Subject|0
1643189|NCT01729754|5744910|P2|Part 1|Withdrawal by Subject|0
1643190|NCT01729754|5744911|P1|Part 1|Withdrawal by Subject|5
1643191|NCT01729754|5744902|P10|Part 1|Protocol Violation|0
1643192|NCT01729754|5744903|P9|Part 1|Protocol Violation|0
1643193|NCT01729754|5744904|P8|Part 1|Protocol Violation|0
1643194|NCT01729754|5744905|P7|Part 1|Protocol Violation|1
1643195|NCT01729754|5744906|P6|Part 1|Protocol Violation|0
1643196|NCT01729754|5744907|P5|Part 1|Protocol Violation|0
1643197|NCT01729754|5744908|P4|Part 1|Protocol Violation|1
1643198|NCT01729754|5744909|P3|Part 1|Protocol Violation|0
1643199|NCT01729754|5744910|P2|Part 1|Protocol Violation|0
1643200|NCT01729754|5744911|P1|Part 1|Protocol Violation|2
1643201|NCT01729754|5744902|P10|Part 1|Progressive Disease|1
1643202|NCT01729754|5744903|P9|Part 1|Progressive Disease|0
1643203|NCT01729754|5744904|P8|Part 1|Progressive Disease|0
1643204|NCT01729754|5744905|P7|Part 1|Progressive Disease|0
1643205|NCT01729754|5744906|P6|Part 1|Progressive Disease|0
1643206|NCT01729754|5744907|P5|Part 1|Progressive Disease|0
1643207|NCT01729754|5744908|P4|Part 1|Progressive Disease|0
1643208|NCT01729754|5744909|P3|Part 1|Progressive Disease|0
1643209|NCT01729754|5744910|P2|Part 1|Progressive Disease|0
1643210|NCT01729754|5744911|P1|Part 1|Progressive Disease|0
1643211|NCT01729754|5744902|P10|Part 1|Pregnancy|1
1643212|NCT01729754|5744903|P9|Part 1|Pregnancy|0
1643213|NCT01729754|5744904|P8|Part 1|Pregnancy|0
1643214|NCT01729754|5744905|P7|Part 1|Pregnancy|0
1643215|NCT01729754|5744906|P6|Part 1|Pregnancy|0
1643216|NCT01729754|5744907|P5|Part 1|Pregnancy|0
1643217|NCT01729754|5744908|P4|Part 1|Pregnancy|1
1643218|NCT01729754|5744909|P3|Part 1|Pregnancy|0
1643219|NCT01729754|5744910|P2|Part 1|Pregnancy|0
1643220|NCT01729754|5744911|P1|Part 1|Pregnancy|0
1643221|NCT01729754|5744902|P10|Part 1|Physician Decision|4
1643222|NCT01729754|5744903|P9|Part 1|Physician Decision|0
1643223|NCT01729754|5744904|P8|Part 1|Physician Decision|0
1643224|NCT01729754|5744905|P7|Part 1|Physician Decision|0
1643225|NCT01729754|5744906|P6|Part 1|Physician Decision|0
1643226|NCT01729754|5744907|P5|Part 1|Physician Decision|0
1643227|NCT01729754|5744908|P4|Part 1|Physician Decision|0
1643228|NCT01729754|5744909|P3|Part 1|Physician Decision|0
1643229|NCT01729754|5744910|P2|Part 1|Physician Decision|0
1643230|NCT01729754|5744911|P1|Part 1|Physician Decision|0
1643231|NCT01729754|5744902|P10|Part 1|Non-compliance with Study Drug|0
1643232|NCT01729754|5744903|P9|Part 1|Non-compliance with Study Drug|0
1643233|NCT01729754|5744904|P8|Part 1|Non-compliance with Study Drug|0
1643234|NCT01729754|5744905|P7|Part 1|Non-compliance with Study Drug|0
1643235|NCT01729754|5744906|P6|Part 1|Non-compliance with Study Drug|0
1643236|NCT01729754|5744907|P5|Part 1|Non-compliance with Study Drug|0
1643237|NCT01729754|5744908|P4|Part 1|Non-compliance with Study Drug|0
1643238|NCT01729754|5744909|P3|Part 1|Non-compliance with Study Drug|0
1643239|NCT01729754|5744910|P2|Part 1|Non-compliance with Study Drug|0
1643240|NCT01729754|5744911|P1|Part 1|Non-compliance with Study Drug|1
1643241|NCT01729754|5744902|P10|Part 1|Lost to Follow-up|3
1643242|NCT01729754|5744903|P9|Part 1|Lost to Follow-up|0
1643243|NCT01729754|5744904|P8|Part 1|Lost to Follow-up|0
1643244|NCT01729754|5744905|P7|Part 1|Lost to Follow-up|3
1643245|NCT01729754|5744906|P6|Part 1|Lost to Follow-up|0
1643246|NCT01729754|5744907|P5|Part 1|Lost to Follow-up|0
1643247|NCT01729754|5744908|P4|Part 1|Lost to Follow-up|2
1643248|NCT01729754|5744909|P3|Part 1|Lost to Follow-up|0
1643249|NCT01729754|5744910|P2|Part 1|Lost to Follow-up|0
1643250|NCT01729754|5744911|P1|Part 1|Lost to Follow-up|1
1643251|NCT01729754|5744902|P10|Part 1|Lack of Efficacy|0
1643252|NCT01729754|5744903|P9|Part 1|Lack of Efficacy|0
1643253|NCT01729754|5744904|P8|Part 1|Lack of Efficacy|0
1643254|NCT01729754|5744905|P7|Part 1|Lack of Efficacy|2
1643255|NCT01729754|5744906|P6|Part 1|Lack of Efficacy|0
1643256|NCT01729754|5744907|P5|Part 1|Lack of Efficacy|0
1643257|NCT01729754|5744908|P4|Part 1|Lack of Efficacy|0
1643258|NCT01729754|5744909|P3|Part 1|Lack of Efficacy|0
1643259|NCT01729754|5744910|P2|Part 1|Lack of Efficacy|0
1643260|NCT01729754|5744911|P1|Part 1|Lack of Efficacy|1
1643261|NCT01729754|5744902|P10|Part 1|Adverse Event|5
1643262|NCT01729754|5744903|P9|Part 1|Adverse Event|0
1643263|NCT01729754|5744904|P8|Part 1|Adverse Event|0
1643264|NCT01729754|5744905|P7|Part 1|Adverse Event|2
1643265|NCT01729754|5744906|P6|Part 1|Adverse Event|0
1643266|NCT01729754|5744907|P5|Part 1|Adverse Event|0
1643267|NCT01729754|5744908|P4|Part 1|Adverse Event|1
1643268|NCT01729754|5744909|P3|Part 1|Adverse Event|0
1643269|NCT01729754|5744910|P2|Part 1|Adverse Event|0
1643270|NCT01729754|5744911|P1|Part 1|Adverse Event|2
1643271|NCT01729728|5745118|P3|Overall Study|Protocol Violation|1
1643272|NCT01729728|5745119|P2|Overall Study|Protocol Violation|0
1643273|NCT01729728|5745120|P1|Overall Study|Protocol Violation|1
1643274|NCT01729728|5745118|P3|Overall Study|Adverse Event|0
1643275|NCT01729728|5745119|P2|Overall Study|Adverse Event|6
1643276|NCT01729728|5745120|P1|Overall Study|Adverse Event|0
1643277|NCT01729559|5745270|P2|Overall Study|Protocol Violation|28
1643278|NCT01729559|5745271|P1|Overall Study|Protocol Violation|31
1643291|NCT01729156|5745348|P3|Overall Study|Withdrawal by Subject|0
1643292|NCT01729156|5745349|P2|Overall Study|Withdrawal by Subject|0
1643293|NCT01729156|5745350|P1|Overall Study|Withdrawal by Subject|1
1643294|NCT01729039|5745378|P2|Overall Study|Withdrawal by Subject|7
1643295|NCT01729039|5745379|P1|Overall Study|Withdrawal by Subject|8
1643296|NCT01729039|5745378|P2|Overall Study|disqualified|5
1643297|NCT01729039|5745379|P1|Overall Study|disqualified|2
1643298|NCT01729026|5745395|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
1643299|NCT01729026|5745396|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
1643300|NCT01729026|5745395|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
1643301|NCT01729026|5745396|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
1643302|NCT01728792|5745424|P5|Overall Study|Lost to Follow-up|0
1643303|NCT01728792|5745425|P4|Overall Study|Lost to Follow-up|2
1643304|NCT01728792|5745426|P3|Overall Study|Lost to Follow-up|4
1643305|NCT01728792|5745427|P2|Overall Study|Lost to Follow-up|1
1643306|NCT01728792|5745428|P1|Overall Study|Lost to Follow-up|2
1643307|NCT01728792|5745424|P5|Overall Study|Withdrawal of Consent|0
1643308|NCT01728792|5745425|P4|Overall Study|Withdrawal of Consent|1
1643309|NCT01728792|5745426|P3|Overall Study|Withdrawal of Consent|0
1643310|NCT01728792|5745427|P2|Overall Study|Withdrawal of Consent|1
1643311|NCT01728792|5745428|P1|Overall Study|Withdrawal of Consent|1
1643312|NCT01728584|5745479|P4|Overall Study|Other reason (not specified)|1
1643313|NCT01728584|5745480|P3|Overall Study|Other reason (not specified)|0
1643314|NCT01728584|5745481|P2|Overall Study|Other reason (not specified)|0
1643315|NCT01728584|5745482|P1|Overall Study|Other reason (not specified)|1
1643316|NCT01728584|5745479|P4|Overall Study|Screen failure|0
1643317|NCT01728584|5745480|P3|Overall Study|Screen failure|0
1643318|NCT01728584|5745481|P2|Overall Study|Screen failure|0
1643319|NCT01728584|5745482|P1|Overall Study|Screen failure|1
1643320|NCT01728584|5745479|P4|Overall Study|Withdrawal by Subject|0
1643321|NCT01728584|5745480|P3|Overall Study|Withdrawal by Subject|0
1643322|NCT01728584|5745481|P2|Overall Study|Withdrawal by Subject|0
1643323|NCT01728584|5745482|P1|Overall Study|Withdrawal by Subject|1
1643324|NCT01728584|5745479|P4|Overall Study|Physician Decision|0
1643325|NCT01728584|5745480|P3|Overall Study|Physician Decision|1
1643326|NCT01728584|5745481|P2|Overall Study|Physician Decision|0
1643327|NCT01728584|5745482|P1|Overall Study|Physician Decision|4
1643328|NCT01728584|5745479|P4|Overall Study|Adverse Event|0
1643329|NCT01728584|5745480|P3|Overall Study|Adverse Event|0
1643330|NCT01728584|5745481|P2|Overall Study|Adverse Event|0
1643331|NCT01728584|5745482|P1|Overall Study|Adverse Event|1
1643332|NCT01728454|5745537|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
1643333|NCT01728454|5745538|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
1643334|NCT01728454|5745539|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
1643335|NCT01728454|5745537|P3|Stage 3|Lost to Follow-up|1
1643336|NCT01728454|5745538|P2|Stage 3|Lost to Follow-up|3
1643337|NCT01728454|5745539|P1|Stage 3|Lost to Follow-up|0
1643338|NCT01728454|5745537|P3|Stage 3|Non-compliance with Protocol|1
1643339|NCT01728454|5745538|P2|Stage 3|Non-compliance with Protocol|0
1643340|NCT01728454|5745539|P1|Stage 3|Non-compliance with Protocol|0
1643341|NCT01728454|5745537|P3|Stage 3|Withdrew Consent|1
1643342|NCT01728454|5745538|P2|Stage 3|Withdrew Consent|0
1643343|NCT01728454|5745539|P1|Stage 3|Withdrew Consent|1
1643344|NCT01728454|5745537|P3|Stage 3|Pregnancy|0
1643345|NCT01728454|5745538|P2|Stage 3|Pregnancy|0
1643346|NCT01728454|5745539|P1|Stage 3|Pregnancy|1
1643347|NCT01728454|5745537|P3|Stage 3|Subject Required Other Treatment|0
1643348|NCT01728454|5745538|P2|Stage 3|Subject Required Other Treatment|1
1643349|NCT01728454|5745539|P1|Stage 3|Subject Required Other Treatment|0
1643350|NCT01728454|5745537|P3|Stage 3|Reason Missing|1
1643351|NCT01728454|5745538|P2|Stage 3|Reason Missing|0
1643352|NCT01728454|5745539|P1|Stage 3|Reason Missing|0
1643353|NCT01728454|5745537|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
1643354|NCT01728454|5745538|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
1643355|NCT01728454|5745539|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
1643356|NCT01728454|5745537|P3|Stage 1 and 2|Lost to Follow-up|0
1643357|NCT01728454|5745538|P2|Stage 1 and 2|Lost to Follow-up|1
1643358|NCT01728454|5745539|P1|Stage 1 and 2|Lost to Follow-up|1
1643359|NCT01728454|5745537|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
1643360|NCT01728454|5745538|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
1643361|NCT01728454|5745539|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
1643362|NCT01728454|5745537|P3|Stage 1 and 2|Non-compliance with Protocol|1
1643363|NCT01728454|5745538|P2|Stage 1 and 2|Non-compliance with Protocol|0
1643364|NCT01728454|5745539|P1|Stage 1 and 2|Non-compliance with Protocol|0
1643365|NCT01728454|5745537|P3|Stage 1 and 2|Pregnancy|0
1643366|NCT01728454|5745538|P2|Stage 1 and 2|Pregnancy|0
1643367|NCT01728454|5745539|P1|Stage 1 and 2|Pregnancy|1
1643368|NCT01728376|5745589|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
1643369|NCT01728376|5745590|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
1643370|NCT01728376|5745591|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
1643371|NCT01728376|5745592|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
1643372|NCT01728376|5745593|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
1643373|NCT01728376|5745594|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
1643374|NCT01728376|5745589|P6|Overall Study|Did not receive treatment|0
1643375|NCT01728376|5745590|P5|Overall Study|Did not receive treatment|0
1643376|NCT01728376|5745591|P4|Overall Study|Did not receive treatment|0
1643377|NCT01728376|5745592|P3|Overall Study|Did not receive treatment|0
1643378|NCT01728376|5745593|P2|Overall Study|Did not receive treatment|1
1643379|NCT01728376|5745594|P1|Overall Study|Did not receive treatment|0
1643380|NCT01728376|5745589|P6|Overall Study|No relevant bacteria|1
1643381|NCT01728376|5745590|P5|Overall Study|No relevant bacteria|1
1643382|NCT01728376|5745591|P4|Overall Study|No relevant bacteria|0
1643383|NCT01728376|5745592|P3|Overall Study|No relevant bacteria|0
1643384|NCT01728376|5745593|P2|Overall Study|No relevant bacteria|0
1643385|NCT01728376|5745594|P1|Overall Study|No relevant bacteria|2
1643386|NCT01728376|5745589|P6|Overall Study|Persistent Positive Blood Cultures|0
1643387|NCT01728376|5745590|P5|Overall Study|Persistent Positive Blood Cultures|0
1643388|NCT01728376|5745591|P4|Overall Study|Persistent Positive Blood Cultures|0
1643389|NCT01728376|5745592|P3|Overall Study|Persistent Positive Blood Cultures|1
1643390|NCT01728376|5745593|P2|Overall Study|Persistent Positive Blood Cultures|0
1643391|NCT01728376|5745594|P1|Overall Study|Persistent Positive Blood Cultures|1
1643392|NCT01728376|5745589|P6|Overall Study|Adverse Event|0
1643393|NCT01728376|5745590|P5|Overall Study|Adverse Event|1
1643394|NCT01728376|5745591|P4|Overall Study|Adverse Event|1
1643395|NCT01728376|5745592|P3|Overall Study|Adverse Event|1
1643396|NCT01728376|5745593|P2|Overall Study|Adverse Event|1
1643397|NCT01728376|5745594|P1|Overall Study|Adverse Event|1
1643398|NCT01728324|5745667|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
1643399|NCT01728324|5745668|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
1643400|NCT01728324|5745669|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
1643401|NCT01728324|5745667|P3|Termination of RBV|Adverse Event (Placebo Period)|0
1643402|NCT01728324|5745668|P2|Termination of RBV|Adverse Event (Placebo Period)|1
1643403|NCT01728324|5745669|P1|Termination of RBV|Adverse Event (Placebo Period)|0
1643404|NCT01728324|5745667|P3|Termination of RBV|Other than stated|1
1643405|NCT01728324|5745668|P2|Termination of RBV|Other than stated|3
1643406|NCT01728324|5745669|P1|Termination of RBV|Other than stated|1
1643407|NCT01728324|5745667|P3|Termination of RBV|Withdrawal by Subject|2
1643408|NCT01728324|5745668|P2|Termination of RBV|Withdrawal by Subject|5
1643409|NCT01728324|5745669|P1|Termination of RBV|Withdrawal by Subject|9
1643410|NCT01728324|5745667|P3|Termination of RBV|Lack of Efficacy|7
1643411|NCT01728324|5745668|P2|Termination of RBV|Lack of Efficacy|11
1643412|NCT01728324|5745669|P1|Termination of RBV|Lack of Efficacy|14
1643413|NCT01728324|5745667|P3|Termination of RBV|Adverse Event|5
1643414|NCT01728324|5745668|P2|Termination of RBV|Adverse Event|16
1643415|NCT01728324|5745669|P1|Termination of RBV|Adverse Event|15
1643416|NCT01728324|5745667|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
1643417|NCT01728324|5745668|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
1643418|NCT01728324|5745669|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
1643419|NCT01728324|5745667|P3|Termination of FDV|Adverse Event (Placebo Period)|0
1643420|NCT01728324|5745668|P2|Termination of FDV|Adverse Event (Placebo Period)|1
1643421|NCT01728324|5745669|P1|Termination of FDV|Adverse Event (Placebo Period)|0
1643422|NCT01728324|5745667|P3|Termination of FDV|Other than stated|0
1643423|NCT01728324|5745668|P2|Termination of FDV|Other than stated|3
1643424|NCT01728324|5745669|P1|Termination of FDV|Other than stated|1
1643425|NCT01728324|5745667|P3|Termination of FDV|Withdrawal by Subject|2
1643426|NCT01728324|5745668|P2|Termination of FDV|Withdrawal by Subject|6
1643427|NCT01728324|5745669|P1|Termination of FDV|Withdrawal by Subject|9
1643428|NCT01728324|5745667|P3|Termination of FDV|Lack of Efficacy|8
1643429|NCT01728324|5745668|P2|Termination of FDV|Lack of Efficacy|12
1643430|NCT01728324|5745669|P1|Termination of FDV|Lack of Efficacy|14
1643431|NCT01728324|5745667|P3|Termination of FDV|Adverse Event|4
1643432|NCT01728324|5745668|P2|Termination of FDV|Adverse Event|13
1643433|NCT01728324|5745669|P1|Termination of FDV|Adverse Event|14
1643434|NCT01728324|5745667|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
1643435|NCT01728324|5745668|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
1643436|NCT01728324|5745669|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
1643437|NCT01728324|5745667|P3|Termination of DBV|Adverse Event (Placebo Period)|0
1643526|NCT01727297|5745912|P2|Overall Study|Death|0
1643438|NCT01728324|5745668|P2|Termination of DBV|Adverse Event (Placebo Period)|1
1643439|NCT01728324|5745669|P1|Termination of DBV|Adverse Event (Placebo Period)|0
1643440|NCT01728324|5745667|P3|Termination of DBV|Other than stated|0
1643441|NCT01728324|5745668|P2|Termination of DBV|Other than stated|3
1643442|NCT01728324|5745669|P1|Termination of DBV|Other than stated|1
1643443|NCT01728324|5745667|P3|Termination of DBV|Withdrawal by Subject|2
1643444|NCT01728324|5745668|P2|Termination of DBV|Withdrawal by Subject|6
1643445|NCT01728324|5745669|P1|Termination of DBV|Withdrawal by Subject|9
1643446|NCT01728324|5745667|P3|Termination of DBV|Lack of Efficacy|8
1643447|NCT01728324|5745668|P2|Termination of DBV|Lack of Efficacy|12
1643448|NCT01728324|5745669|P1|Termination of DBV|Lack of Efficacy|14
1643449|NCT01728324|5745667|P3|Termination of DBV|Adverse Event|4
1643450|NCT01728324|5745668|P2|Termination of DBV|Adverse Event|13
1643451|NCT01728324|5745669|P1|Termination of DBV|Adverse Event|14
1643452|NCT01728246|5745690|P2|Overall Study|Adverse Event|5
1643453|NCT01728246|5745691|P1|Overall Study|Adverse Event|8
1643454|NCT01728246|5745690|P2|Overall Study|Lack of Efficacy|1
1643455|NCT01728246|5745691|P1|Overall Study|Lack of Efficacy|1
1643456|NCT01728246|5745690|P2|Overall Study|Lost to Follow-up|22
1643457|NCT01728246|5745691|P1|Overall Study|Lost to Follow-up|23
1643458|NCT01728246|5745690|P2|Overall Study|Withdrawal by Subject|3
1643459|NCT01728246|5745691|P1|Overall Study|Withdrawal by Subject|2
1643460|NCT01728246|5745690|P2|Overall Study|Protocol Violation|0
1643461|NCT01728246|5745691|P1|Overall Study|Protocol Violation|1
1643462|NCT01728246|5745690|P2|Overall Study|Participant needed rescue medication|5
1643463|NCT01728246|5745691|P1|Overall Study|Participant needed rescue medication|1
1643464|NCT01728116|5745709|P2|Overall Study|various not noted previously|0
1643465|NCT01728116|5745710|P1|Overall Study|various not noted previously|5
1643466|NCT01728116|5745709|P2|Overall Study|Incorrectly enrolled in Study|1
1643467|NCT01728116|5745710|P1|Overall Study|Incorrectly enrolled in Study|0
1643468|NCT01728116|5745709|P2|Overall Study|Inter-current finding at procedure|0
1643469|NCT01728116|5745710|P1|Overall Study|Inter-current finding at procedure|1
1643470|NCT01728116|5745709|P2|Overall Study|Subject Non-Compliance|0
1643471|NCT01728116|5745710|P1|Overall Study|Subject Non-Compliance|2
1643472|NCT01728116|5745709|P2|Overall Study|Physician Decision|0
1643473|NCT01728116|5745710|P1|Overall Study|Physician Decision|2
1643474|NCT01728116|5745709|P2|Overall Study|Lost to Follow-up|2
1643475|NCT01728116|5745710|P1|Overall Study|Lost to Follow-up|9
1643476|NCT01728116|5745709|P2|Overall Study|Procedure/device failure|0
1643477|NCT01728116|5745710|P1|Overall Study|Procedure/device failure|7
1643478|NCT01728116|5745709|P2|Overall Study|Adverse Event|0
1643479|NCT01728116|5745710|P1|Overall Study|Adverse Event|13
1643480|NCT01728116|5745709|P2|Overall Study|Withdrawal by Subject|9
1643481|NCT01728116|5745710|P1|Overall Study|Withdrawal by Subject|16
1643482|NCT01728116|5745709|P2|Overall Study|Sponsor Terminated Study|35
1643483|NCT01728116|5745710|P1|Overall Study|Sponsor Terminated Study|106
1643484|NCT01728077|5745735|P2|Overall Study|Non compliance|0
1643485|NCT01728077|5745736|P1|Overall Study|Non compliance|1
1643486|NCT01728077|5745735|P2|Overall Study|Patient moving|0
1643487|NCT01728077|5745736|P1|Overall Study|Patient moving|1
1643488|NCT01728077|5745735|P2|Overall Study|Death|1
1643489|NCT01728077|5745736|P1|Overall Study|Death|0
1643490|NCT01728077|5745735|P2|Overall Study|Subject choice|3
1643491|NCT01728077|5745736|P1|Overall Study|Subject choice|2
1643492|NCT01728077|5745735|P2|Overall Study|Lost to Follow-up|0
1643493|NCT01728077|5745736|P1|Overall Study|Lost to Follow-up|1
1643494|NCT01728077|5745735|P2|Overall Study|Lack of Efficacy|1
1643495|NCT01728077|5745736|P1|Overall Study|Lack of Efficacy|3
1643496|NCT01727713|5745834|P1|Overall Study|Protocol Deviation|2
1643497|NCT01727713|5745834|P1|Overall Study|Withdrawal by Subject|13
1643498|NCT01727713|5745834|P1|Overall Study|Participant Met Withdrawal Criteria|5
1643499|NCT01727713|5745834|P1|Overall Study|Adverse Event|10
1643500|NCT01727713|5745834|P1|Overall Study|Lost to Follow-up|5
1643501|NCT01727700|5745861|P3|Overall Study|Protocol Violation|0
1643502|NCT01727700|5745862|P2|Overall Study|Protocol Violation|0
1643503|NCT01727700|5745863|P1|Overall Study|Protocol Violation|2
1643504|NCT01727700|5745861|P3|Overall Study|Particpant withdrew consent|1
1643505|NCT01727700|5745862|P2|Overall Study|Particpant withdrew consent|3
1643506|NCT01727700|5745863|P1|Overall Study|Particpant withdrew consent|0
1643507|NCT01727700|5745861|P3|Overall Study|Adverse Event|1
1643508|NCT01727700|5745862|P2|Overall Study|Adverse Event|7
1643509|NCT01727700|5745863|P1|Overall Study|Adverse Event|0
1643510|NCT01727505|5745886|P2|Second 24 Hours|Missing data|1
1643511|NCT01727505|5745887|P1|Second 24 Hours|Missing data|0
1643512|NCT01727505|5745886|P2|First 24 Hours|Adverse Event|1
1643513|NCT01727505|5745887|P1|First 24 Hours|Adverse Event|0
1643514|NCT01727297|5745912|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
1643515|NCT01727297|5745913|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
1643516|NCT01727297|5745912|P2|Overall Study|Physician Decision|5
1643517|NCT01727297|5745913|P1|Overall Study|Physician Decision|19
1643518|NCT01727297|5745912|P2|Overall Study|Withdrawal by Subject|27
1643519|NCT01727297|5745913|P1|Overall Study|Withdrawal by Subject|26
1643520|NCT01727297|5745912|P2|Overall Study|Lost to Follow-up|0
1643521|NCT01727297|5745913|P1|Overall Study|Lost to Follow-up|11
1643522|NCT01727297|5745912|P2|Overall Study|Adverse Event|1
1643523|NCT01727297|5745913|P1|Overall Study|Adverse Event|3
1643524|NCT01727297|5745912|P2|Overall Study|Protocol Violation|10
1643525|NCT01727297|5745913|P1|Overall Study|Protocol Violation|1
1643527|NCT01727297|5745913|P1|Overall Study|Death|13
1643528|NCT01727258|5745929|P3|Overall Study|Lost to Follow-up|0
1643529|NCT01727258|5745930|P2|Overall Study|Lost to Follow-up|0
1643530|NCT01727258|5745931|P1|Overall Study|Lost to Follow-up|1
1643531|NCT01727258|5745929|P3|Overall Study|Withdrawal by Subject|0
1643532|NCT01727258|5745930|P2|Overall Study|Withdrawal by Subject|1
1643533|NCT01727258|5745931|P1|Overall Study|Withdrawal by Subject|1
1643534|NCT01727258|5745929|P3|Overall Study|Noncompliance with Study Drug|1
1643535|NCT01727258|5745930|P2|Overall Study|Noncompliance with Study Drug|0
1643536|NCT01727258|5745931|P1|Overall Study|Noncompliance with Study Drug|0
1643537|NCT01727258|5745929|P3|Overall Study|Adverse Event|0
1643538|NCT01727258|5745930|P2|Overall Study|Adverse Event|2
1643539|NCT01727258|5745931|P1|Overall Study|Adverse Event|0
1643540|NCT01727154|5745969|P1|Overall Study|No Discontinuation Documentation|4
1643541|NCT01727154|5745969|P1|Overall Study|Study Terminated|6
1643542|NCT01727154|5745969|P1|Overall Study|Subject Withdrew Consent|18
1643543|NCT01727154|5745969|P1|Overall Study|Withdrawal by Subject|14
1643544|NCT01727154|5745969|P1|Overall Study|Death|17
1643545|NCT01727141|5745977|P4|Overall Study|Withdrawal by Subject|11
1643546|NCT01727141|5745978|P3|Overall Study|Withdrawal by Subject|2
1643547|NCT01727141|5745979|P2|Overall Study|Withdrawal by Subject|4
1643548|NCT01727141|5745980|P1|Overall Study|Withdrawal by Subject|4
1643549|NCT01727141|5745977|P4|Overall Study|Protocol deviation|1
1643550|NCT01727141|5745978|P3|Overall Study|Protocol deviation|0
1643551|NCT01727141|5745979|P2|Overall Study|Protocol deviation|1
1643552|NCT01727141|5745980|P1|Overall Study|Protocol deviation|1
1643553|NCT01727141|5745977|P4|Overall Study|Death|1
1643554|NCT01727141|5745978|P3|Overall Study|Death|1
1643555|NCT01727141|5745979|P2|Overall Study|Death|1
1643556|NCT01727141|5745980|P1|Overall Study|Death|0
1643557|NCT01727141|5745977|P4|Overall Study|Lost to Follow-up|0
1643558|NCT01727141|5745978|P3|Overall Study|Lost to Follow-up|0
1643559|NCT01727141|5745979|P2|Overall Study|Lost to Follow-up|2
1643560|NCT01727141|5745980|P1|Overall Study|Lost to Follow-up|0
1643561|NCT01727141|5745977|P4|Overall Study|Physician Decision|2
1643562|NCT01727141|5745978|P3|Overall Study|Physician Decision|0
1643563|NCT01727141|5745979|P2|Overall Study|Physician Decision|1
1643564|NCT01727141|5745980|P1|Overall Study|Physician Decision|0
1643565|NCT01727024|5746045|P2|Period 1|Withdrawal by Subject|3
1643566|NCT01727024|5746046|P1|Period 1|Withdrawal by Subject|2
1643567|NCT01727024|5746045|P2|Period 1|Lost to Follow-up|1
1643568|NCT01727024|5746046|P1|Period 1|Lost to Follow-up|1
1643569|NCT01726803|5746061|P2|Overall Study|Withdrawal by Subject|0
1643570|NCT01726803|5746062|P1|Overall Study|Withdrawal by Subject|1
1643571|NCT01726803|5746061|P2|Overall Study|Lost to Follow-up|1
1643572|NCT01726803|5746062|P1|Overall Study|Lost to Follow-up|6
1643573|NCT01726517|5746104|P5|Overall Study|Withdrawal by Subject|0
1643574|NCT01726517|5746105|P4|Overall Study|Withdrawal by Subject|0
1643575|NCT01726517|5746106|P3|Overall Study|Withdrawal by Subject|1
1643576|NCT01726517|5746107|P2|Overall Study|Withdrawal by Subject|0
1643577|NCT01726517|5746108|P1|Overall Study|Withdrawal by Subject|0
1643578|NCT01726335|5746164|P1|Overall Study|Exacerbation of psychotic symptoms|1
1643579|NCT01726335|5746164|P1|Overall Study|Lost to Follow-up|2
1643580|NCT01726335|5746164|P1|Overall Study|Adverse Event|4
1643581|NCT01726335|5746164|P1|Overall Study|Withdrawal by Subject|15
1643582|NCT01726335|5746164|P1|Overall Study|Lost to Follow-up|2
1643583|NCT01726049|5746182|P2|Overall Study|refused second HC|2
1643584|NCT01726049|5746183|P1|Overall Study|refused second HC|0
1643585|NCT01726049|5746182|P2|Overall Study|Adverse Event|1
1643586|NCT01726049|5746183|P1|Overall Study|Adverse Event|4
1643587|NCT01726049|5746182|P2|Overall Study|Death|1
1643588|NCT01726049|5746183|P1|Overall Study|Death|1
1643589|NCT01726023|5746208|P2|Overall Study|Withdrawal by Subject|8
1643590|NCT01726023|5746209|P1|Overall Study|Withdrawal by Subject|16
1643591|NCT01726023|5746208|P2|Overall Study|Other Eligibility criteria|7
1643592|NCT01726023|5746209|P1|Overall Study|Other Eligibility criteria|7
1643593|NCT01726023|5746208|P2|Overall Study|Lost to Follow-up|10
1643594|NCT01726023|5746209|P1|Overall Study|Lost to Follow-up|5
1643595|NCT01726023|5746208|P2|Overall Study|Death|1
1643596|NCT01726023|5746209|P1|Overall Study|Death|1
1643597|NCT01725750|5746343|P2|Overall Study|Withdrawal by Subject|9
1643598|NCT01725750|5746344|P1|Overall Study|Withdrawal by Subject|0
1643599|NCT01725750|5746343|P2|Overall Study|Lost to Follow-up|1
1643600|NCT01725750|5746344|P1|Overall Study|Lost to Follow-up|1
1643601|NCT01725750|5746343|P2|Overall Study|Adverse Event|0
1643602|NCT01725750|5746344|P1|Overall Study|Adverse Event|1
1643603|NCT01725529|5746377|P3|Overall Study|Withdrawal by Subject|8
1643604|NCT01725529|5746378|P2|Overall Study|Withdrawal by Subject|14
1643605|NCT01725529|5746379|P1|Overall Study|Withdrawal by Subject|12
1643606|NCT01725529|5746377|P3|Overall Study|Protocol Violation|1
1643607|NCT01725529|5746378|P2|Overall Study|Protocol Violation|1
1643608|NCT01725529|5746379|P1|Overall Study|Protocol Violation|0
1643609|NCT01725529|5746377|P3|Overall Study|Lost to Follow-up|1
1643610|NCT01725529|5746378|P2|Overall Study|Lost to Follow-up|1
1643611|NCT01725529|5746379|P1|Overall Study|Lost to Follow-up|2
1643612|NCT01725529|5746377|P3|Overall Study|Adverse Event|0
1643613|NCT01725529|5746378|P2|Overall Study|Adverse Event|0
1643614|NCT01725529|5746379|P1|Overall Study|Adverse Event|1
1643615|NCT01725451|5746405|P4|Period 4|Adverse Event|0
1643616|NCT01725451|5746406|P3|Period 4|Adverse Event|1
1643617|NCT01725451|5746407|P2|Period 4|Adverse Event|0
1643618|NCT01725451|5746408|P1|Period 4|Adverse Event|0
1643619|NCT01725451|5746405|P4|Washout From Period 3|Adverse Event|0
1643620|NCT01725451|5746406|P3|Washout From Period 3|Adverse Event|0
1643621|NCT01725451|5746407|P2|Washout From Period 3|Adverse Event|1
1643622|NCT01725451|5746408|P1|Washout From Period 3|Adverse Event|0
1643623|NCT01725451|5746405|P4|Washout From Period 3|Protocol Violation|0
1643624|NCT01725451|5746406|P3|Washout From Period 3|Protocol Violation|1
1643625|NCT01725451|5746407|P2|Washout From Period 3|Protocol Violation|0
1643626|NCT01725451|5746408|P1|Washout From Period 3|Protocol Violation|0
1643627|NCT01725451|5746405|P4|Period 1|Withdrawal by Subject|0
1643628|NCT01725451|5746406|P3|Period 1|Withdrawal by Subject|0
1643629|NCT01725451|5746407|P2|Period 1|Withdrawal by Subject|0
1643630|NCT01725451|5746408|P1|Period 1|Withdrawal by Subject|1
1643631|NCT01725386|5746430|P2|Overall Study|Withdrawal by Subject|0
1643632|NCT01725386|5746431|P1|Overall Study|Withdrawal by Subject|10
1643633|NCT01725386|5746430|P2|Overall Study|Lost to Follow-up|6
1643634|NCT01725386|5746431|P1|Overall Study|Lost to Follow-up|81
1643635|NCT01725386|5746430|P2|Overall Study|Death|40
1643636|NCT01725386|5746431|P1|Overall Study|Death|84
1643637|NCT01725308|5746450|P3|Treatment Period II|Miscellaneous|7
1643638|NCT01725308|5746451|P2|Treatment Period II|Miscellaneous|3
1643639|NCT01725308|5746452|P1|Treatment Period II|Miscellaneous|5
1643640|NCT01725308|5746450|P3|Treatment Period II|Protocol Deviations|1
1643641|NCT01725308|5746451|P2|Treatment Period II|Protocol Deviations|0
1643642|NCT01725308|5746452|P1|Treatment Period II|Protocol Deviations|0
1643643|NCT01725308|5746450|P3|Treatment Period II|Lost to Follow-up|3
1643644|NCT01725308|5746451|P2|Treatment Period II|Lost to Follow-up|5
1643645|NCT01725308|5746452|P1|Treatment Period II|Lost to Follow-up|1
1643646|NCT01725308|5746450|P3|Treatment Period II|Withdrawal of Consent|16
1643647|NCT01725308|5746451|P2|Treatment Period II|Withdrawal of Consent|2
1643648|NCT01725308|5746452|P1|Treatment Period II|Withdrawal of Consent|28
1643649|NCT01725308|5746450|P3|Treatment Period II|Changes in the Episodes|5
1643650|NCT01725308|5746451|P2|Treatment Period II|Changes in the Episodes|0
1643651|NCT01725308|5746452|P1|Treatment Period II|Changes in the Episodes|1
1643652|NCT01725308|5746450|P3|Treatment Period II|Worsening of the Target Disease|2
1643653|NCT01725308|5746451|P2|Treatment Period II|Worsening of the Target Disease|4
1643654|NCT01725308|5746452|P1|Treatment Period II|Worsening of the Target Disease|1
1643655|NCT01725308|5746450|P3|Treatment Period II|Insufficient Response|6
1643656|NCT01725308|5746451|P2|Treatment Period II|Insufficient Response|4
1643657|NCT01725308|5746452|P1|Treatment Period II|Insufficient Response|2
1643658|NCT01725308|5746450|P3|Treatment Period II|Adverse Event|20
1643659|NCT01725308|5746451|P2|Treatment Period II|Adverse Event|8
1643660|NCT01725308|5746452|P1|Treatment Period II|Adverse Event|13
1643661|NCT01725308|5746450|P3|Treatment Period II|Did Not Receive Drug|0
1643662|NCT01725308|5746451|P2|Treatment Period II|Did Not Receive Drug|0
1643663|NCT01725308|5746452|P1|Treatment Period II|Did Not Receive Drug|4
1643664|NCT01725308|5746450|P3|Treatment Period II|Did Not Meet Transition Criteria|4
1643665|NCT01725308|5746451|P2|Treatment Period II|Did Not Meet Transition Criteria|3
1643666|NCT01725308|5746452|P1|Treatment Period II|Did Not Meet Transition Criteria|0
1643667|NCT01725308|5746450|P3|Treatment Period I|Miscellaneous|3
1643668|NCT01725308|5746451|P2|Treatment Period I|Miscellaneous|0
1643669|NCT01725308|5746452|P1|Treatment Period I|Miscellaneous|2
1643670|NCT01725308|5746450|P3|Treatment Period I|Protocol Deviations|1
1643671|NCT01725308|5746451|P2|Treatment Period I|Protocol Deviations|1
1643672|NCT01725308|5746452|P1|Treatment Period I|Protocol Deviations|3
1643673|NCT01725308|5746450|P3|Treatment Period I|Lost to Follow-up|2
1643674|NCT01725308|5746451|P2|Treatment Period I|Lost to Follow-up|2
1643675|NCT01725308|5746452|P1|Treatment Period I|Lost to Follow-up|3
1643676|NCT01725308|5746450|P3|Treatment Period I|Withdrawal of Consent|5
1643677|NCT01725308|5746451|P2|Treatment Period I|Withdrawal of Consent|7
1643678|NCT01725308|5746452|P1|Treatment Period I|Withdrawal of Consent|12
1643679|NCT01725308|5746450|P3|Treatment Period I|Changes in the Episodes|2
1643680|NCT01725308|5746451|P2|Treatment Period I|Changes in the Episodes|0
1643681|NCT01725308|5746452|P1|Treatment Period I|Changes in the Episodes|3
1643682|NCT01725308|5746450|P3|Treatment Period I|Worsening of the Target Disease|2
1643683|NCT01725308|5746451|P2|Treatment Period I|Worsening of the Target Disease|0
1643684|NCT01725308|5746452|P1|Treatment Period I|Worsening of the Target Disease|8
1643685|NCT01725308|5746450|P3|Treatment Period I|Insufficient Response|5
1643686|NCT01725308|5746451|P2|Treatment Period I|Insufficient Response|0
1643687|NCT01725308|5746452|P1|Treatment Period I|Insufficient Response|7
1643688|NCT01725308|5746450|P3|Treatment Period I|Adverse Event|21
1643689|NCT01725308|5746451|P2|Treatment Period I|Adverse Event|4
1643690|NCT01725308|5746452|P1|Treatment Period I|Adverse Event|5
1643691|NCT01725308|5746450|P3|Treatment Period I|Did Not Receive Drug|0
1643692|NCT01725308|5746451|P2|Treatment Period I|Did Not Receive Drug|0
1643693|NCT01725308|5746452|P1|Treatment Period I|Did Not Receive Drug|1
1643694|NCT01725282|5746599|P4|Overall Study|Lack of Efficacy|1
1643695|NCT01725282|5746600|P3|Overall Study|Lack of Efficacy|0
1643696|NCT01725282|5746601|P2|Overall Study|Lack of Efficacy|1
1643697|NCT01725282|5746602|P1|Overall Study|Lack of Efficacy|0
1643698|NCT01725282|5746599|P4|Overall Study|Withdrawal by Subject|1
1643699|NCT01725282|5746600|P3|Overall Study|Withdrawal by Subject|1
1643700|NCT01725282|5746601|P2|Overall Study|Withdrawal by Subject|0
1643701|NCT01725282|5746602|P1|Overall Study|Withdrawal by Subject|0
1643702|NCT01725282|5746599|P4|Overall Study|Study Site Withdrawal|0
1643703|NCT01725282|5746600|P3|Overall Study|Study Site Withdrawal|0
1643704|NCT01725282|5746601|P2|Overall Study|Study Site Withdrawal|1
1643705|NCT01725282|5746602|P1|Overall Study|Study Site Withdrawal|0
1643706|NCT01725282|5746599|P4|Overall Study|Met Exclusion Criteria|0
1643707|NCT01725282|5746600|P3|Overall Study|Met Exclusion Criteria|1
1643708|NCT01725282|5746601|P2|Overall Study|Met Exclusion Criteria|0
1643709|NCT01725282|5746602|P1|Overall Study|Met Exclusion Criteria|0
1643710|NCT01725282|5746599|P4|Overall Study|Exacerbation of Target Disease|1
1643711|NCT01725282|5746600|P3|Overall Study|Exacerbation of Target Disease|0
1643712|NCT01725282|5746601|P2|Overall Study|Exacerbation of Target Disease|0
1643713|NCT01725282|5746602|P1|Overall Study|Exacerbation of Target Disease|1
1643714|NCT01725282|5746599|P4|Overall Study|Adverse Event|4
1643715|NCT01725282|5746600|P3|Overall Study|Adverse Event|6
1643716|NCT01725282|5746601|P2|Overall Study|Adverse Event|3
1643717|NCT01725282|5746602|P1|Overall Study|Adverse Event|1
1643718|NCT01725217|5746635|P3|Overall Study|Withdrawal by Subject|0
1643719|NCT01725217|5746636|P2|Overall Study|Withdrawal by Subject|0
1643720|NCT01725217|5746637|P1|Overall Study|Withdrawal by Subject|1
1643721|NCT01725126|5746671|P6|Overall Study|Withdrawal by Subject|0
1643722|NCT01725126|5746672|P5|Overall Study|Withdrawal by Subject|0
1643723|NCT01725126|5746673|P4|Overall Study|Withdrawal by Subject|1
1643724|NCT01725126|5746674|P3|Overall Study|Withdrawal by Subject|0
1643725|NCT01725126|5746675|P2|Overall Study|Withdrawal by Subject|0
1643726|NCT01725126|5746676|P1|Overall Study|Withdrawal by Subject|0
1643727|NCT01725126|5746671|P6|Overall Study|Protocol Violation|0
1643728|NCT01725126|5746672|P5|Overall Study|Protocol Violation|0
1643729|NCT01725126|5746673|P4|Overall Study|Protocol Violation|0
1643730|NCT01725126|5746674|P3|Overall Study|Protocol Violation|0
1643731|NCT01725126|5746675|P2|Overall Study|Protocol Violation|1
1643732|NCT01725126|5746676|P1|Overall Study|Protocol Violation|0
1643733|NCT01724528|5746874|P2|Overall Study|Patient refused to attend last visit|0
1643734|NCT01724528|5746875|P1|Overall Study|Patient refused to attend last visit|1
1643735|NCT01724528|5746874|P2|Overall Study|Protocol Violation|1
1643736|NCT01724528|5746875|P1|Overall Study|Protocol Violation|0
1643737|NCT01724528|5746874|P2|Overall Study|Withdrawal by Subject|2
1643738|NCT01724528|5746875|P1|Overall Study|Withdrawal by Subject|0
1643739|NCT01724528|5746874|P2|Overall Study|Death|0
1643740|NCT01724528|5746875|P1|Overall Study|Death|3
1643741|NCT01724489|5746891|P2|Overall Study|Withdrawal by Subject|6
1643742|NCT01724489|5746892|P1|Overall Study|Withdrawal by Subject|6
1643743|NCT01724489|5746891|P2|Overall Study|Lost to Follow-up|2
1643744|NCT01724489|5746892|P1|Overall Study|Lost to Follow-up|1
1643745|NCT01724489|5746891|P2|Overall Study|Surgery, medication|1
1643746|NCT01724489|5746892|P1|Overall Study|Surgery, medication|1
1643747|NCT01724489|5746891|P2|Overall Study|Adverse Event|3
1643748|NCT01724489|5746892|P1|Overall Study|Adverse Event|8
1643749|NCT01724359|5746898|P1|Overall Study|Other|20
1643750|NCT01724359|5746898|P1|Overall Study|Death|1
1643751|NCT01724359|5746898|P1|Overall Study|Adverse Event|10
1643752|NCT01724216|5746911|P1|Overall Study|Scan was not completed|1
1643753|NCT01724177|5746915|P1|Overall Study|Serious Adverse Event Related|1
1643754|NCT01724177|5746915|P1|Overall Study|Nervous participant|1
1643755|NCT01724177|5746915|P1|Overall Study|Progressive disease or Relapsed Disease|16
1643756|NCT01724177|5746915|P1|Overall Study|Adverse Event|8
1643757|NCT01724021|5746928|P2|Overall Study|Missing|1
1643758|NCT01724021|5746929|P1|Overall Study|Missing|1
1643759|NCT01724021|5746928|P2|Overall Study|Reason Not Specified|39
1643760|NCT01724021|5746929|P1|Overall Study|Reason Not Specified|36
1643761|NCT01724021|5746928|P2|Overall Study|Lost to Follow-up|15
1643762|NCT01724021|5746929|P1|Overall Study|Lost to Follow-up|15
1643763|NCT01724021|5746928|P2|Overall Study|Participant request/ Withdrew consent|14
1643764|NCT01724021|5746929|P1|Overall Study|Participant request/ Withdrew consent|18
1643765|NCT01724021|5746928|P2|Overall Study|Death|58
1643766|NCT01724021|5746929|P1|Overall Study|Death|46
1643767|NCT01724021|5746928|P2|Overall Study|Adverse Event|6
1643768|NCT01724021|5746929|P1|Overall Study|Adverse Event|11
1643769|NCT01723904|5746961|P1|Overall Study|Unable to follow protocol/ judged by inv|3
1643770|NCT01723904|5746961|P1|Overall Study|Adverse Event|5
1643771|NCT01723904|5746961|P1|Overall Study|Noncompliant|3
1643808|NCT01723397|5747123|P2|Study Period 2|Protocol Violation|1
1643809|NCT01723397|5747124|P1|Study Period 2|Protocol Violation|0
1643810|NCT01723397|5747123|P2|Study Period 1|Protocol Violation|1
1643811|NCT01723397|5747124|P1|Study Period 1|Protocol Violation|0
1643812|NCT01723254|5747151|P8|Overall Study|Withdrawal by Subject|2
1643813|NCT01723254|5747152|P7|Overall Study|Withdrawal by Subject|1
1643814|NCT01723254|5747153|P6|Overall Study|Withdrawal by Subject|1
1643815|NCT01723254|5747154|P5|Overall Study|Withdrawal by Subject|1
1643816|NCT01723254|5747155|P4|Overall Study|Withdrawal by Subject|0
1643817|NCT01723254|5747156|P3|Overall Study|Withdrawal by Subject|1
1643818|NCT01723254|5747157|P2|Overall Study|Withdrawal by Subject|2
1643819|NCT01723254|5747158|P1|Overall Study|Withdrawal by Subject|1
1643820|NCT01723254|5747151|P8|Overall Study|Protocol Violation|0
1643821|NCT01723254|5747152|P7|Overall Study|Protocol Violation|0
1643822|NCT01723254|5747153|P6|Overall Study|Protocol Violation|0
1643823|NCT01723254|5747154|P5|Overall Study|Protocol Violation|0
1643824|NCT01723254|5747155|P4|Overall Study|Protocol Violation|0
1643825|NCT01723254|5747156|P3|Overall Study|Protocol Violation|0
1643826|NCT01723254|5747157|P2|Overall Study|Protocol Violation|1
1643827|NCT01723254|5747158|P1|Overall Study|Protocol Violation|0
1643828|NCT01723254|5747151|P8|Overall Study|Move/Left to another country/city|0
1643829|NCT01723254|5747152|P7|Overall Study|Move/Left to another country/city|0
1643830|NCT01723254|5747153|P6|Overall Study|Move/Left to another country/city|0
1643831|NCT01723254|5747154|P5|Overall Study|Move/Left to another country/city|1
1643832|NCT01723254|5747155|P4|Overall Study|Move/Left to another country/city|1
1643833|NCT01723254|5747156|P3|Overall Study|Move/Left to another country/city|2
1643834|NCT01723254|5747157|P2|Overall Study|Move/Left to another country/city|0
1643835|NCT01723254|5747158|P1|Overall Study|Move/Left to another country/city|0
1643836|NCT01723254|5747151|P8|Overall Study|No longer have time to participate|0
1643837|NCT01723254|5747152|P7|Overall Study|No longer have time to participate|0
1643838|NCT01723254|5747153|P6|Overall Study|No longer have time to participate|0
1643839|NCT01723254|5747154|P5|Overall Study|No longer have time to participate|0
1643840|NCT01723254|5747155|P4|Overall Study|No longer have time to participate|1
1643841|NCT01723254|5747156|P3|Overall Study|No longer have time to participate|0
1643842|NCT01723254|5747157|P2|Overall Study|No longer have time to participate|0
1643843|NCT01723254|5747158|P1|Overall Study|No longer have time to participate|0
1643844|NCT01723254|5747151|P8|Overall Study|Personal issues|0
1643845|NCT01723254|5747152|P7|Overall Study|Personal issues|0
1643846|NCT01723254|5747153|P6|Overall Study|Personal issues|1
1643847|NCT01723254|5747154|P5|Overall Study|Personal issues|0
1643848|NCT01723254|5747155|P4|Overall Study|Personal issues|0
1643849|NCT01723254|5747156|P3|Overall Study|Personal issues|0
1643850|NCT01723254|5747157|P2|Overall Study|Personal issues|0
1643851|NCT01723254|5747158|P1|Overall Study|Personal issues|0
1643852|NCT01723254|5747151|P8|Overall Study|Conflict with work schedule|1
1643853|NCT01723254|5747152|P7|Overall Study|Conflict with work schedule|0
1643854|NCT01723254|5747153|P6|Overall Study|Conflict with work schedule|0
1643855|NCT01723254|5747154|P5|Overall Study|Conflict with work schedule|0
1643856|NCT01723254|5747155|P4|Overall Study|Conflict with work schedule|0
1643857|NCT01723254|5747156|P3|Overall Study|Conflict with work schedule|0
1643858|NCT01723254|5747157|P2|Overall Study|Conflict with work schedule|0
1643859|NCT01723254|5747158|P1|Overall Study|Conflict with work schedule|0
1643860|NCT01723228|5747210|P2|Overall Study|Other|1
1643861|NCT01723228|5747211|P1|Overall Study|Other|2
1643862|NCT01723228|5747210|P2|Overall Study|Lost to Follow-up|1
1643863|NCT01723228|5747211|P1|Overall Study|Lost to Follow-up|2
1643864|NCT01723228|5747210|P2|Overall Study|Protocol Violation|2
1643865|NCT01723228|5747211|P1|Overall Study|Protocol Violation|0
1643866|NCT01723228|5747210|P2|Overall Study|Withdrawal by Subject|1
1643867|NCT01723228|5747211|P1|Overall Study|Withdrawal by Subject|2
1643868|NCT01723228|5747210|P2|Overall Study|Adverse Event|6
1643869|NCT01723228|5747211|P1|Overall Study|Adverse Event|2
1643870|NCT01723163|5747229|P2|12-Month Follow-up|Unable to Contact|28
1643871|NCT01723163|5747230|P1|12-Month Follow-up|Unable to Contact|23
1643872|NCT01723163|5747229|P2|12-Month Follow-up|Death|0
1643873|NCT01723163|5747230|P1|12-Month Follow-up|Death|1
1643874|NCT01723163|5747229|P2|6-Month Follow-up|Unable to Contact|15
1643875|NCT01723163|5747230|P1|6-Month Follow-up|Unable to Contact|17
1643876|NCT01723163|5747229|P2|6-Month Follow-up|Death|0
1643877|NCT01723163|5747230|P1|6-Month Follow-up|Death|1
1643878|NCT01723163|5747229|P2|3-Month Follow-up|Unable to Contact|19
1643879|NCT01723163|5747230|P1|3-Month Follow-up|Unable to Contact|12
1643880|NCT01723163|5747229|P2|3-Month Follow-up|Withdrawal by Subject|0
1643881|NCT01723163|5747230|P1|3-Month Follow-up|Withdrawal by Subject|1
1643882|NCT01723163|5747229|P2|Treatment Phase|Withdrawal by PI|1
1643883|NCT01723163|5747230|P1|Treatment Phase|Withdrawal by PI|5
1643884|NCT01723163|5747229|P2|Treatment Phase|Withdrawal by Subject|6
1643885|NCT01723163|5747230|P1|Treatment Phase|Withdrawal by Subject|14
1643886|NCT01722994|5747238|P2|Overall Study|Missing data|17
1643887|NCT01722994|5747239|P1|Overall Study|Missing data|25
1643888|NCT01722877|5747258|P1|Overall Study|Lost to Follow-up|1
1643889|NCT01722877|5747258|P1|Overall Study|Death|1
1643890|NCT01722331|5747329|P7|Part 3|Other Protocol Specified Criteria|0
1643891|NCT01722331|5747330|P6|Part 3|Other Protocol Specified Criteria|0
1643892|NCT01722331|5747331|P5|Part 3|Other Protocol Specified Criteria|0
1643893|NCT01722331|5747332|P4|Part 3|Other Protocol Specified Criteria|0
1643894|NCT01722331|5747333|P3|Part 3|Other Protocol Specified Criteria|0
1643895|NCT01722331|5747334|P2|Part 3|Other Protocol Specified Criteria|1
1643896|NCT01722331|5747335|P1|Part 3|Other Protocol Specified Criteria|1
1643897|NCT01722331|5747329|P7|Part 3|Withdrawal by Subject|1
1643898|NCT01722331|5747330|P6|Part 3|Withdrawal by Subject|2
1643899|NCT01722331|5747331|P5|Part 3|Withdrawal by Subject|0
1643900|NCT01722331|5747332|P4|Part 3|Withdrawal by Subject|0
1643901|NCT01722331|5747333|P3|Part 3|Withdrawal by Subject|0
1643902|NCT01722331|5747334|P2|Part 3|Withdrawal by Subject|7
1643903|NCT01722331|5747335|P1|Part 3|Withdrawal by Subject|4
1643904|NCT01722331|5747329|P7|Part 3|Protocol Violation|0
1643905|NCT01722331|5747330|P6|Part 3|Protocol Violation|0
1643906|NCT01722331|5747331|P5|Part 3|Protocol Violation|0
1643907|NCT01722331|5747332|P4|Part 3|Protocol Violation|0
1643908|NCT01722331|5747333|P3|Part 3|Protocol Violation|0
1643909|NCT01722331|5747334|P2|Part 3|Protocol Violation|1
1643910|NCT01722331|5747335|P1|Part 3|Protocol Violation|2
1643911|NCT01722331|5747329|P7|Part 3|Physician Decision|1
1643912|NCT01722331|5747330|P6|Part 3|Physician Decision|0
1643913|NCT01722331|5747331|P5|Part 3|Physician Decision|0
1643914|NCT01722331|5747332|P4|Part 3|Physician Decision|0
1643915|NCT01722331|5747333|P3|Part 3|Physician Decision|0
1643916|NCT01722331|5747334|P2|Part 3|Physician Decision|1
1643917|NCT01722331|5747335|P1|Part 3|Physician Decision|1
1643918|NCT01722331|5747329|P7|Part 3|Non-Compliance with Study Drug|0
1643919|NCT01722331|5747330|P6|Part 3|Non-Compliance with Study Drug|0
1643920|NCT01722331|5747331|P5|Part 3|Non-Compliance with Study Drug|0
1643921|NCT01722331|5747332|P4|Part 3|Non-Compliance with Study Drug|0
1643922|NCT01722331|5747333|P3|Part 3|Non-Compliance with Study Drug|0
1643923|NCT01722331|5747334|P2|Part 3|Non-Compliance with Study Drug|1
1643924|NCT01722331|5747335|P1|Part 3|Non-Compliance with Study Drug|0
1643925|NCT01722331|5747329|P7|Part 3|Lost to Follow-up|0
1643926|NCT01722331|5747330|P6|Part 3|Lost to Follow-up|1
1643927|NCT01722331|5747331|P5|Part 3|Lost to Follow-up|0
1643928|NCT01722331|5747332|P4|Part 3|Lost to Follow-up|0
1643929|NCT01722331|5747333|P3|Part 3|Lost to Follow-up|0
1643930|NCT01722331|5747334|P2|Part 3|Lost to Follow-up|4
1643931|NCT01722331|5747335|P1|Part 3|Lost to Follow-up|3
1643932|NCT01722331|5747329|P7|Part 3|Lack of Efficacy|0
1643933|NCT01722331|5747330|P6|Part 3|Lack of Efficacy|0
1643934|NCT01722331|5747331|P5|Part 3|Lack of Efficacy|0
1643935|NCT01722331|5747332|P4|Part 3|Lack of Efficacy|0
1643936|NCT01722331|5747333|P3|Part 3|Lack of Efficacy|0
1643937|NCT01722331|5747334|P2|Part 3|Lack of Efficacy|0
1643938|NCT01722331|5747335|P1|Part 3|Lack of Efficacy|1
1643939|NCT01722331|5747329|P7|Part 3|Death|0
1643940|NCT01722331|5747330|P6|Part 3|Death|0
1643941|NCT01722331|5747331|P5|Part 3|Death|0
1643942|NCT01722331|5747332|P4|Part 3|Death|0
1643943|NCT01722331|5747333|P3|Part 3|Death|0
1643944|NCT01722331|5747334|P2|Part 3|Death|0
1643945|NCT01722331|5747335|P1|Part 3|Death|1
1643946|NCT01722331|5747329|P7|Part 3|Adverse Event|0
1643947|NCT01722331|5747330|P6|Part 3|Adverse Event|0
1643948|NCT01722331|5747331|P5|Part 3|Adverse Event|0
1643949|NCT01722331|5747332|P4|Part 3|Adverse Event|1
1643950|NCT01722331|5747333|P3|Part 3|Adverse Event|0
1643951|NCT01722331|5747334|P2|Part 3|Adverse Event|2
1643952|NCT01722331|5747335|P1|Part 3|Adverse Event|2
1643953|NCT01722331|5747329|P7|Part 2|Other Protocol Specified Criteria|1
1643954|NCT01722331|5747330|P6|Part 2|Other Protocol Specified Criteria|2
1643955|NCT01722331|5747331|P5|Part 2|Other Protocol Specified Criteria|0
1643956|NCT01722331|5747332|P4|Part 2|Other Protocol Specified Criteria|0
1643957|NCT01722331|5747333|P3|Part 2|Other Protocol Specified Criteria|10
1643958|NCT01722331|5747334|P2|Part 2|Other Protocol Specified Criteria|0
1643959|NCT01722331|5747335|P1|Part 2|Other Protocol Specified Criteria|6
1643960|NCT01722331|5747329|P7|Part 2|Withdrawal by Subject|2
1643961|NCT01722331|5747330|P6|Part 2|Withdrawal by Subject|2
1643962|NCT01722331|5747331|P5|Part 2|Withdrawal by Subject|0
1643963|NCT01722331|5747332|P4|Part 2|Withdrawal by Subject|0
1643964|NCT01722331|5747333|P3|Part 2|Withdrawal by Subject|3
1643965|NCT01722331|5747334|P2|Part 2|Withdrawal by Subject|0
1643966|NCT01722331|5747335|P1|Part 2|Withdrawal by Subject|5
1643967|NCT01722331|5747329|P7|Part 2|Protocol Violation|0
1643968|NCT01722331|5747330|P6|Part 2|Protocol Violation|0
1643969|NCT01722331|5747331|P5|Part 2|Protocol Violation|0
1643970|NCT01722331|5747332|P4|Part 2|Protocol Violation|0
1643971|NCT01722331|5747333|P3|Part 2|Protocol Violation|0
1643972|NCT01722331|5747334|P2|Part 2|Protocol Violation|0
1643973|NCT01722331|5747335|P1|Part 2|Protocol Violation|1
1643974|NCT01722331|5747329|P7|Part 2|Progressive Disease|0
1643975|NCT01722331|5747330|P6|Part 2|Progressive Disease|0
1643976|NCT01722331|5747331|P5|Part 2|Progressive Disease|0
1643977|NCT01722331|5747332|P4|Part 2|Progressive Disease|0
1643978|NCT01722331|5747333|P3|Part 2|Progressive Disease|1
1643979|NCT01722331|5747334|P2|Part 2|Progressive Disease|0
1643980|NCT01722331|5747335|P1|Part 2|Progressive Disease|0
1643981|NCT01722331|5747329|P7|Part 2|Pregnancy|0
1643982|NCT01722331|5747330|P6|Part 2|Pregnancy|1
1643983|NCT01722331|5747331|P5|Part 2|Pregnancy|0
1643984|NCT01722331|5747332|P4|Part 2|Pregnancy|0
1643985|NCT01722331|5747333|P3|Part 2|Pregnancy|0
1643986|NCT01722331|5747334|P2|Part 2|Pregnancy|0
1643987|NCT01722331|5747335|P1|Part 2|Pregnancy|0
1643988|NCT01722331|5747329|P7|Part 2|Physician Decision|0
1643989|NCT01722331|5747330|P6|Part 2|Physician Decision|0
1643990|NCT01722331|5747331|P5|Part 2|Physician Decision|0
1643991|NCT01722331|5747332|P4|Part 2|Physician Decision|0
1643992|NCT01722331|5747333|P3|Part 2|Physician Decision|2
1643993|NCT01722331|5747334|P2|Part 2|Physician Decision|0
1643994|NCT01722331|5747335|P1|Part 2|Physician Decision|0
1643995|NCT01722331|5747329|P7|Part 2|Non-Compliance with Study Drug|0
1643996|NCT01722331|5747330|P6|Part 2|Non-Compliance with Study Drug|0
1643997|NCT01722331|5747331|P5|Part 2|Non-Compliance with Study Drug|0
1643998|NCT01722331|5747332|P4|Part 2|Non-Compliance with Study Drug|0
1643999|NCT01722331|5747333|P3|Part 2|Non-Compliance with Study Drug|1
1644000|NCT01722331|5747334|P2|Part 2|Non-Compliance with Study Drug|0
1644001|NCT01722331|5747335|P1|Part 2|Non-Compliance with Study Drug|1
1644002|NCT01722331|5747329|P7|Part 2|Lost to Follow-up|1
1644003|NCT01722331|5747330|P6|Part 2|Lost to Follow-up|1
1644004|NCT01722331|5747331|P5|Part 2|Lost to Follow-up|0
1644005|NCT01722331|5747332|P4|Part 2|Lost to Follow-up|0
1644006|NCT01722331|5747333|P3|Part 2|Lost to Follow-up|3
1644007|NCT01722331|5747334|P2|Part 2|Lost to Follow-up|0
1644008|NCT01722331|5747335|P1|Part 2|Lost to Follow-up|0
1644009|NCT01722331|5747329|P7|Part 2|Lack of Efficacy|3
1644010|NCT01722331|5747330|P6|Part 2|Lack of Efficacy|3
1644011|NCT01722331|5747331|P5|Part 2|Lack of Efficacy|0
1644012|NCT01722331|5747332|P4|Part 2|Lack of Efficacy|0
1644013|NCT01722331|5747333|P3|Part 2|Lack of Efficacy|11
1644014|NCT01722331|5747334|P2|Part 2|Lack of Efficacy|0
1644015|NCT01722331|5747335|P1|Part 2|Lack of Efficacy|3
1644016|NCT01722331|5747329|P7|Part 2|Adverse Event|0
1644017|NCT01722331|5747330|P6|Part 2|Adverse Event|1
1644018|NCT01722331|5747331|P5|Part 2|Adverse Event|0
1644019|NCT01722331|5747332|P4|Part 2|Adverse Event|0
1644020|NCT01722331|5747333|P3|Part 2|Adverse Event|0
1644021|NCT01722331|5747334|P2|Part 2|Adverse Event|0
1644022|NCT01722331|5747335|P1|Part 2|Adverse Event|3
1644023|NCT01722331|5747329|P7|Part 1|Withdrawal by Subject|0
1644024|NCT01722331|5747330|P6|Part 1|Withdrawal by Subject|0
1644025|NCT01722331|5747331|P5|Part 1|Withdrawal by Subject|3
1644026|NCT01722331|5747332|P4|Part 1|Withdrawal by Subject|0
1644027|NCT01722331|5747333|P3|Part 1|Withdrawal by Subject|3
1644028|NCT01722331|5747334|P2|Part 1|Withdrawal by Subject|0
1644029|NCT01722331|5747335|P1|Part 1|Withdrawal by Subject|2
1644030|NCT01722331|5747329|P7|Part 1|Protocol Violation|0
1644031|NCT01722331|5747330|P6|Part 1|Protocol Violation|0
1644032|NCT01722331|5747331|P5|Part 1|Protocol Violation|1
1644033|NCT01722331|5747332|P4|Part 1|Protocol Violation|0
1644034|NCT01722331|5747333|P3|Part 1|Protocol Violation|0
1644035|NCT01722331|5747334|P2|Part 1|Protocol Violation|0
1644036|NCT01722331|5747335|P1|Part 1|Protocol Violation|1
1644037|NCT01722331|5747329|P7|Part 1|Progressive Disease|0
1644038|NCT01722331|5747330|P6|Part 1|Progressive Disease|0
1644039|NCT01722331|5747331|P5|Part 1|Progressive Disease|1
1644040|NCT01722331|5747332|P4|Part 1|Progressive Disease|0
1644041|NCT01722331|5747333|P3|Part 1|Progressive Disease|0
1644042|NCT01722331|5747334|P2|Part 1|Progressive Disease|0
1644043|NCT01722331|5747335|P1|Part 1|Progressive Disease|0
1644044|NCT01722331|5747329|P7|Part 1|Pregnancy|0
1644045|NCT01722331|5747330|P6|Part 1|Pregnancy|0
1644046|NCT01722331|5747331|P5|Part 1|Pregnancy|0
1644047|NCT01722331|5747332|P4|Part 1|Pregnancy|0
1644048|NCT01722331|5747333|P3|Part 1|Pregnancy|0
1644049|NCT01722331|5747334|P2|Part 1|Pregnancy|0
1644050|NCT01722331|5747335|P1|Part 1|Pregnancy|1
1644051|NCT01722331|5747329|P7|Part 1|Physician Decision|0
1644052|NCT01722331|5747330|P6|Part 1|Physician Decision|0
1644053|NCT01722331|5747331|P5|Part 1|Physician Decision|1
1644054|NCT01722331|5747332|P4|Part 1|Physician Decision|0
1644055|NCT01722331|5747333|P3|Part 1|Physician Decision|3
1644056|NCT01722331|5747334|P2|Part 1|Physician Decision|0
1644057|NCT01722331|5747335|P1|Part 1|Physician Decision|0
1644058|NCT01722331|5747329|P7|Part 1|Lost to Follow-up|0
1644059|NCT01722331|5747330|P6|Part 1|Lost to Follow-up|0
1644060|NCT01722331|5747331|P5|Part 1|Lost to Follow-up|1
1644061|NCT01722331|5747332|P4|Part 1|Lost to Follow-up|0
1644062|NCT01722331|5747333|P3|Part 1|Lost to Follow-up|2
1644063|NCT01722331|5747334|P2|Part 1|Lost to Follow-up|0
1644064|NCT01722331|5747335|P1|Part 1|Lost to Follow-up|1
1644065|NCT01722331|5747329|P7|Part 1|Lack of Efficacy|0
1644066|NCT01722331|5747330|P6|Part 1|Lack of Efficacy|0
1644067|NCT01722331|5747331|P5|Part 1|Lack of Efficacy|2
1644068|NCT01722331|5747332|P4|Part 1|Lack of Efficacy|0
1644069|NCT01722331|5747333|P3|Part 1|Lack of Efficacy|1
1644070|NCT01722331|5747334|P2|Part 1|Lack of Efficacy|0
1644071|NCT01722331|5747335|P1|Part 1|Lack of Efficacy|0
1644072|NCT01722331|5747329|P7|Part 1|Adverse Event|0
1644073|NCT01722331|5747330|P6|Part 1|Adverse Event|0
1644074|NCT01722331|5747331|P5|Part 1|Adverse Event|0
1644075|NCT01722331|5747332|P4|Part 1|Adverse Event|0
1644076|NCT01722331|5747333|P3|Part 1|Adverse Event|0
1644077|NCT01722331|5747334|P2|Part 1|Adverse Event|0
1644078|NCT01722331|5747335|P1|Part 1|Adverse Event|5
1644079|NCT01722266|5747451|P4|Overall Study|Dropped out due to Nausea|0
1644080|NCT01722266|5747452|P3|Overall Study|Dropped out due to Nausea|2
1644081|NCT01722266|5747453|P2|Overall Study|Dropped out due to Nausea|0
1644082|NCT01722266|5747454|P1|Overall Study|Dropped out due to Nausea|0
1644083|NCT01722266|5747451|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
1644084|NCT01722266|5747452|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
1644085|NCT01722266|5747453|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
1644086|NCT01722266|5747454|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
1644087|NCT01722266|5747451|P4|Overall Study|Withdrawal by Subject|0
1644088|NCT01722266|5747452|P3|Overall Study|Withdrawal by Subject|0
1644089|NCT01722266|5747453|P2|Overall Study|Withdrawal by Subject|2
1644090|NCT01722266|5747454|P1|Overall Study|Withdrawal by Subject|1
1644091|NCT01722162|5747482|P2|Overall Study|Noncompliance|1
1644092|NCT01722162|5747483|P1|Overall Study|Noncompliance|0
1644093|NCT01722162|5747482|P2|Overall Study|Insurance denial post enrollment|1
1644094|NCT01722162|5747483|P1|Overall Study|Insurance denial post enrollment|0
1644095|NCT01722162|5747482|P2|Overall Study|Adverse Event|1
1644096|NCT01722162|5747483|P1|Overall Study|Adverse Event|1
1644097|NCT01722162|5747482|P2|Overall Study|Unrelated to study adverse event|2
1644098|NCT01722162|5747483|P1|Overall Study|Unrelated to study adverse event|2
1644099|NCT01722162|5747482|P2|Overall Study|Found ineligible|0
1644100|NCT01722162|5747483|P1|Overall Study|Found ineligible|1
1644101|NCT01722162|5747482|P2|Overall Study|Withdrawal by Subject|1
1644102|NCT01722162|5747483|P1|Overall Study|Withdrawal by Subject|1
1644103|NCT01722097|5747493|P2|Overall Study|Patient sheets not returned|5
1644104|NCT01722097|5747494|P1|Overall Study|Patient sheets not returned|6
1644105|NCT01722071|5747502|P2|Overall Study|Protocol Violation|0
1644106|NCT01722071|5747503|P1|Overall Study|Protocol Violation|1
1644107|NCT01722045|5747509|P1|Overall Study|Relocation (did not wish to transfer)|1
1644108|NCT01722045|5747509|P1|Overall Study|Physician Decision|3
1644109|NCT01722045|5747509|P1|Overall Study|Protocol Deviation|1
1644110|NCT01722045|5747509|P1|Overall Study|Lost to Follow-up|4
1644111|NCT01722045|5747509|P1|Overall Study|Withdrawal by Subject|8
1644112|NCT01722045|5747509|P1|Overall Study|Death|3
1644113|NCT01722045|5747509|P1|Overall Study|Adverse Event|8
1644114|NCT01721954|5747530|P2|Overall Study|Lost to Follow-up|1
1644115|NCT01721954|5747531|P1|Overall Study|Lost to Follow-up|2
1644116|NCT01721954|5747530|P2|Overall Study|Adverse Event|0
1644117|NCT01721954|5747531|P1|Overall Study|Adverse Event|2
1644118|NCT01721954|5747530|P2|Overall Study|Withdrawal by Subject|4
1644119|NCT01721954|5747531|P1|Overall Study|Withdrawal by Subject|8
1644120|NCT01721954|5747530|P2|Overall Study|Death|64
1644121|NCT01721954|5747531|P1|Overall Study|Death|58
1644122|NCT01721772|5747545|P2|Overall Study|Other|1
1644123|NCT01721772|5747546|P1|Overall Study|Other|0
1644124|NCT01721772|5747545|P2|Overall Study|Maximum clinical benefit|1
1644125|NCT01721772|5747546|P1|Overall Study|Maximum clinical benefit|1
1644126|NCT01721772|5747545|P2|Overall Study|Withdrawal by Subject|5
1644127|NCT01721772|5747546|P1|Overall Study|Withdrawal by Subject|7
1644128|NCT01721772|5747545|P2|Overall Study|Unrelated adverse event|3
1644129|NCT01721772|5747546|P1|Overall Study|Unrelated adverse event|2
1644130|NCT01721772|5747545|P2|Overall Study|Study drug toxicity|7
1644131|NCT01721772|5747546|P1|Overall Study|Study drug toxicity|5
1644132|NCT01721772|5747545|P2|Overall Study|Disease progression|175
1644133|NCT01721772|5747546|P1|Overall Study|Disease progression|96
1644134|NCT01721759|5747566|P1|Overall Study|Withdrawal by Subject|1
1644135|NCT01721759|5747566|P1|Overall Study|Adverse event unrelated to study drug|9
1644136|NCT01721759|5747566|P1|Overall Study|Study drug toxicity|14
1644137|NCT01721759|5747566|P1|Overall Study|Disease progression|78
1644138|NCT01721746|5747574|P3|Treatment Period|Other|1
1644139|NCT01721746|5747575|P2|Treatment Period|Other|1
1644140|NCT01721746|5747576|P1|Treatment Period|Other|2
1644141|NCT01721746|5747574|P3|Treatment Period|Subject No Longer Met Study Criteria|0
1644142|NCT01721746|5747575|P2|Treatment Period|Subject No Longer Met Study Criteria|0
1644143|NCT01721746|5747576|P1|Treatment Period|Subject No Longer Met Study Criteria|4
1644144|NCT01721746|5747574|P3|Treatment Period|Poor/Non-compliance|0
1644145|NCT01721746|5747575|P2|Treatment Period|Poor/Non-compliance|0
1644146|NCT01721746|5747576|P1|Treatment Period|Poor/Non-compliance|1
1644147|NCT01721746|5747574|P3|Treatment Period|Maximum Clinical Benefit|3
1644148|NCT01721746|5747575|P2|Treatment Period|Maximum Clinical Benefit|0
1644149|NCT01721746|5747576|P1|Treatment Period|Maximum Clinical Benefit|1
1644150|NCT01721746|5747574|P3|Treatment Period|Subject Withdrew Consent|2
1644151|NCT01721746|5747575|P2|Treatment Period|Subject Withdrew Consent|0
1644152|NCT01721746|5747576|P1|Treatment Period|Subject Withdrew Consent|3
1644153|NCT01721746|5747574|P3|Treatment Period|Subject Request to Discontinue Treatment|6
1644154|NCT01721746|5747575|P2|Treatment Period|Subject Request to Discontinue Treatment|1
1644155|NCT01721746|5747576|P1|Treatment Period|Subject Request to Discontinue Treatment|19
1644156|NCT01721746|5747574|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
1644157|NCT01721746|5747575|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
1644158|NCT01721746|5747576|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
1644159|NCT01721746|5747574|P3|Treatment Period|Study Drug Toxicity|9
1644160|NCT01721746|5747575|P2|Treatment Period|Study Drug Toxicity|2
1644161|NCT01721746|5747576|P1|Treatment Period|Study Drug Toxicity|15
1644162|NCT01721746|5747574|P3|Treatment Period|Disease Progression|34
1644163|NCT01721746|5747575|P2|Treatment Period|Disease Progression|40
1644164|NCT01721746|5747576|P1|Treatment Period|Disease Progression|182
1644165|NCT01721486|5747616|P2|Overall Study|Physician Decision|1
1644166|NCT01721486|5747617|P1|Overall Study|Physician Decision|0
1644167|NCT01721486|5747616|P2|Overall Study|Protocol Violation|0
1644168|NCT01721486|5747617|P1|Overall Study|Protocol Violation|1
1644169|NCT01721408|5747665|P2|Overall Study|Does not meet entrance criteria|0
1644170|NCT01721408|5747666|P1|Overall Study|Does not meet entrance criteria|1
1644171|NCT01721408|5747665|P2|Overall Study|Lost to Follow-up|2
1644172|NCT01721408|5747666|P1|Overall Study|Lost to Follow-up|1
1644173|NCT01721408|5747665|P2|Overall Study|Other|3
1644174|NCT01721408|5747666|P1|Overall Study|Other|3
1644175|NCT01721408|5747665|P2|Overall Study|Protocol Violation|2
1644176|NCT01721408|5747666|P1|Overall Study|Protocol Violation|0
1644177|NCT01721408|5747665|P2|Overall Study|No longer willing to participate study|10
1644178|NCT01721408|5747666|P1|Overall Study|No longer willing to participate study|9
1644179|NCT01721408|5747665|P2|Overall Study|Insufficient clinical response|6
1644180|NCT01721408|5747666|P1|Overall Study|Insufficient clinical response|15
1644181|NCT01721408|5747665|P2|Overall Study|Death|0
1644182|NCT01721408|5747666|P1|Overall Study|Death|1
1644183|NCT01721408|5747665|P2|Overall Study|Adverse Event|1
1644184|NCT01721408|5747666|P1|Overall Study|Adverse Event|6
1644185|NCT01721330|5747682|P2|Overall Study|Withdrawal by Subject|1
1644186|NCT01721330|5747683|P1|Overall Study|Withdrawal by Subject|0
1644187|NCT01721317|5747691|P2|Overall Study|Withdrawal by Subject|1
1644188|NCT01721317|5747692|P1|Overall Study|Withdrawal by Subject|0
1644189|NCT01721317|5747691|P2|Overall Study|Physician Decision|1
1644190|NCT01721317|5747692|P1|Overall Study|Physician Decision|0
1644191|NCT01721317|5747691|P2|Overall Study|Study Closed / Terminated|2
1644192|NCT01721317|5747692|P1|Overall Study|Study Closed / Terminated|2
1644193|NCT01721200|5747771|P2|Overall Study|Lost to Follow-up|5
1644194|NCT01721200|5747772|P1|Overall Study|Lost to Follow-up|3
1644195|NCT01721161|5747797|P2|Overall Study|Other|1
1644196|NCT01721161|5747798|P1|Overall Study|Other|0
1644197|NCT01721161|5747797|P2|Overall Study|Withdrawal by Subject|1
1644198|NCT01721161|5747798|P1|Overall Study|Withdrawal by Subject|1
1644199|NCT01721161|5747797|P2|Overall Study|Lost to Follow-up|2
1644200|NCT01721161|5747798|P1|Overall Study|Lost to Follow-up|1
1644201|NCT01721161|5747797|P2|Overall Study|Adverse Event|3
1644202|NCT01721161|5747798|P1|Overall Study|Adverse Event|2
1644203|NCT01721109|5747821|P1|Overall Study|Lost to Follow-up|2
1644204|NCT01721109|5747821|P1|Overall Study|Withdrew Consent|1
1644205|NCT01721109|5747821|P1|Overall Study|Non- Compliance with Study Drug|3
1644206|NCT01721109|5747821|P1|Overall Study|Lack of Efficacy|1
1644207|NCT01721070|5748016|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
1644208|NCT01721057|5748027|P7|Rescue Period|Lack of Efficacy|0
1644209|NCT01721057|5748028|P6|Rescue Period|Lack of Efficacy|0
1644210|NCT01721057|5748029|P5|Rescue Period|Lack of Efficacy|0
1644211|NCT01721057|5748030|P4|Rescue Period|Lack of Efficacy|2
1644212|NCT01721057|5748031|P3|Rescue Period|Lack of Efficacy|0
1644213|NCT01721057|5748032|P2|Rescue Period|Lack of Efficacy|0
1644214|NCT01721057|5748033|P1|Rescue Period|Lack of Efficacy|0
1644215|NCT01721057|5748027|P7|Rescue Period|Adverse Event|0
1644216|NCT01721057|5748028|P6|Rescue Period|Adverse Event|0
1644217|NCT01721057|5748029|P5|Rescue Period|Adverse Event|0
1644218|NCT01721057|5748030|P4|Rescue Period|Adverse Event|1
1644219|NCT01721057|5748031|P3|Rescue Period|Adverse Event|0
1644220|NCT01721057|5748032|P2|Rescue Period|Adverse Event|0
1644221|NCT01721057|5748033|P1|Rescue Period|Adverse Event|0
1644222|NCT01721057|5748027|P7|Treatment Period|Death|0
1644223|NCT01721057|5748028|P6|Treatment Period|Death|0
1644224|NCT01721057|5748029|P5|Treatment Period|Death|0
1644225|NCT01721057|5748030|P4|Treatment Period|Death|0
1644226|NCT01721057|5748031|P3|Treatment Period|Death|0
1644227|NCT01721057|5748032|P2|Treatment Period|Death|0
1644228|NCT01721057|5748033|P1|Treatment Period|Death|2
1644229|NCT01721057|5748027|P7|Treatment Period|Physician Decision|0
1644230|NCT01721057|5748028|P6|Treatment Period|Physician Decision|0
1644231|NCT01721057|5748029|P5|Treatment Period|Physician Decision|0
1644232|NCT01721057|5748030|P4|Treatment Period|Physician Decision|0
1644233|NCT01721057|5748031|P3|Treatment Period|Physician Decision|3
1644234|NCT01721057|5748032|P2|Treatment Period|Physician Decision|1
1644235|NCT01721057|5748033|P1|Treatment Period|Physician Decision|0
1644236|NCT01721057|5748027|P7|Treatment Period|Lost to Follow-up|0
1644237|NCT01721057|5748028|P6|Treatment Period|Lost to Follow-up|0
1644238|NCT01721057|5748029|P5|Treatment Period|Lost to Follow-up|0
1644239|NCT01721057|5748030|P4|Treatment Period|Lost to Follow-up|0
1644240|NCT01721057|5748031|P3|Treatment Period|Lost to Follow-up|0
1644241|NCT01721057|5748032|P2|Treatment Period|Lost to Follow-up|0
1644242|NCT01721057|5748033|P1|Treatment Period|Lost to Follow-up|1
1644243|NCT01721057|5748027|P7|Treatment Period|Lack of Efficacy|0
1644244|NCT01721057|5748028|P6|Treatment Period|Lack of Efficacy|0
1644245|NCT01721057|5748029|P5|Treatment Period|Lack of Efficacy|0
1644246|NCT01721057|5748030|P4|Treatment Period|Lack of Efficacy|0
1644247|NCT01721057|5748031|P3|Treatment Period|Lack of Efficacy|0
1644248|NCT01721057|5748032|P2|Treatment Period|Lack of Efficacy|3
1644249|NCT01721057|5748033|P1|Treatment Period|Lack of Efficacy|7
1644250|NCT01721057|5748027|P7|Treatment Period|Adverse Event|0
1644251|NCT01721057|5748028|P6|Treatment Period|Adverse Event|0
1644252|NCT01721057|5748029|P5|Treatment Period|Adverse Event|0
1644253|NCT01721057|5748030|P4|Treatment Period|Adverse Event|0
1644254|NCT01721057|5748031|P3|Treatment Period|Adverse Event|12
1644255|NCT01721057|5748032|P2|Treatment Period|Adverse Event|10
1644256|NCT01721057|5748033|P1|Treatment Period|Adverse Event|7
1644257|NCT01721057|5748027|P7|Treatment Period|Withdrawal by Subject|0
1644258|NCT01721057|5748028|P6|Treatment Period|Withdrawal by Subject|0
1644259|NCT01721057|5748029|P5|Treatment Period|Withdrawal by Subject|0
1644260|NCT01721057|5748030|P4|Treatment Period|Withdrawal by Subject|0
1644261|NCT01721057|5748031|P3|Treatment Period|Withdrawal by Subject|8
1644262|NCT01721057|5748032|P2|Treatment Period|Withdrawal by Subject|5
1644263|NCT01721057|5748033|P1|Treatment Period|Withdrawal by Subject|11
1644264|NCT01721044|5748106|P3|Treatment Period|Withdrawal by Subject|1
1644265|NCT01721044|5748107|P2|Treatment Period|Withdrawal by Subject|6
1644266|NCT01721044|5748108|P1|Treatment Period|Withdrawal by Subject|7
1644267|NCT01721044|5748106|P3|Treatment Period|Protocol Violation|0
1644268|NCT01721044|5748107|P2|Treatment Period|Protocol Violation|0
1644269|NCT01721044|5748108|P1|Treatment Period|Protocol Violation|1
1644270|NCT01721044|5748106|P3|Treatment Period|Physician Decision|2
1644271|NCT01721044|5748107|P2|Treatment Period|Physician Decision|0
1644272|NCT01721044|5748108|P1|Treatment Period|Physician Decision|1
1644273|NCT01721044|5748106|P3|Treatment Period|Lost to Follow-up|1
1644274|NCT01721044|5748107|P2|Treatment Period|Lost to Follow-up|0
1644275|NCT01721044|5748108|P1|Treatment Period|Lost to Follow-up|0
1644276|NCT01721044|5748106|P3|Treatment Period|Lack of Efficacy|4
1644277|NCT01721044|5748107|P2|Treatment Period|Lack of Efficacy|4
1644278|NCT01721044|5748108|P1|Treatment Period|Lack of Efficacy|16
1644279|NCT01721044|5748106|P3|Treatment Period|Death|1
1644280|NCT01721044|5748107|P2|Treatment Period|Death|0
1644281|NCT01721044|5748108|P1|Treatment Period|Death|0
1644282|NCT01721044|5748106|P3|Treatment Period|Adverse Event|10
1644283|NCT01721044|5748107|P2|Treatment Period|Adverse Event|7
1644284|NCT01721044|5748108|P1|Treatment Period|Adverse Event|7
1644285|NCT01720797|5748181|P2|Overall Study|Withdrawal by Subject|0
1644286|NCT01720797|5748182|P1|Overall Study|Withdrawal by Subject|3
1644287|NCT01720667|5748190|P2|Overall Study|Withdrawal by Subject|0
1644288|NCT01720667|5748191|P1|Overall Study|Withdrawal by Subject|3
1644289|NCT01720667|5748190|P2|Overall Study|Adverse Event|1
1644290|NCT01720667|5748191|P1|Overall Study|Adverse Event|1
1644291|NCT01720602|5748205|P1|Overall Study|Progressive disease on therapy|2
1644292|NCT01720602|5748205|P1|Overall Study|Adverse Event|3
1644293|NCT01720446|5748217|P4|Overall Study|Withdrawal by Subject|4
1644294|NCT01720446|5748218|P3|Overall Study|Withdrawal by Subject|4
1644295|NCT01720446|5748219|P2|Overall Study|Withdrawal by Subject|5
1644296|NCT01720446|5748220|P1|Overall Study|Withdrawal by Subject|2
1644297|NCT01720446|5748217|P4|Overall Study|Lost to Follow-up|16
1644298|NCT01720446|5748218|P3|Overall Study|Lost to Follow-up|16
1644299|NCT01720446|5748219|P2|Overall Study|Lost to Follow-up|6
1644300|NCT01720446|5748220|P1|Overall Study|Lost to Follow-up|12
1644301|NCT01720264|5748341|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
1644302|NCT01720264|5748341|P1|Post-transplant (Day 16) to 1 Year|Death|8
1644303|NCT01720264|5748341|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
1644304|NCT01720043|5748369|P1|Overall Study|Withdrawal by Subject|1
1644305|NCT01719861|5748398|P1|Cycle 2|Death|1
1644306|NCT01719861|5748398|P1|Cycle 1|Death|4
1644307|NCT01719783|5748408|P2|Dose 2|Physician Decision|0
1644308|NCT01719783|5748409|P1|Dose 2|Physician Decision|1
1644309|NCT01719757|5748495|P1|Overall Study|well controlled pain|27
1644310|NCT01719757|5748495|P1|Overall Study|Protocol Violation|1
1644311|NCT01719757|5748495|P1|Overall Study|Lost to Follow-up|20
1644312|NCT01719757|5748495|P1|Overall Study|Withdrawal by Subject|15
1644313|NCT01719757|5748495|P1|Overall Study|Adverse Event|38
1644314|NCT01719224|5748549|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
1644315|NCT01719224|5748550|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
1644316|NCT01719172|5748559|P1|Overall Study|Death|1
1644317|NCT01719172|5748559|P1|Overall Study|Lost to Follow-up|1
1644318|NCT01719003|5748573|P9|Overall Study|Lack of Efficacy|0
1644319|NCT01719003|5748574|P8|Overall Study|Lack of Efficacy|0
1644320|NCT01719003|5748575|P7|Overall Study|Lack of Efficacy|1
1644321|NCT01719003|5748576|P6|Overall Study|Lack of Efficacy|0
1644322|NCT01719003|5748577|P5|Overall Study|Lack of Efficacy|0
1644323|NCT01719003|5748578|P4|Overall Study|Lack of Efficacy|0
1644324|NCT01719003|5748579|P3|Overall Study|Lack of Efficacy|0
1644325|NCT01719003|5748580|P2|Overall Study|Lack of Efficacy|0
1644326|NCT01719003|5748581|P1|Overall Study|Lack of Efficacy|0
1644327|NCT01719003|5748573|P9|Overall Study|Reason other than those specified|1
1644328|NCT01719003|5748574|P8|Overall Study|Reason other than those specified|3
1644329|NCT01719003|5748575|P7|Overall Study|Reason other than those specified|0
1644330|NCT01719003|5748576|P6|Overall Study|Reason other than those specified|1
1644331|NCT01719003|5748577|P5|Overall Study|Reason other than those specified|4
1644332|NCT01719003|5748578|P4|Overall Study|Reason other than those specified|3
1644333|NCT01719003|5748579|P3|Overall Study|Reason other than those specified|2
1644334|NCT01719003|5748580|P2|Overall Study|Reason other than those specified|0
1644335|NCT01719003|5748581|P1|Overall Study|Reason other than those specified|0
1644336|NCT01719003|5748573|P9|Overall Study|Refusal to continue, not due to AE|1
1644337|NCT01719003|5748574|P8|Overall Study|Refusal to continue, not due to AE|7
1644338|NCT01719003|5748575|P7|Overall Study|Refusal to continue, not due to AE|8
1644339|NCT01719003|5748576|P6|Overall Study|Refusal to continue, not due to AE|3
1644340|NCT01719003|5748577|P5|Overall Study|Refusal to continue, not due to AE|4
1644341|NCT01719003|5748578|P4|Overall Study|Refusal to continue, not due to AE|4
1644342|NCT01719003|5748579|P3|Overall Study|Refusal to continue, not due to AE|4
1644343|NCT01719003|5748580|P2|Overall Study|Refusal to continue, not due to AE|5
1644344|NCT01719003|5748581|P1|Overall Study|Refusal to continue, not due to AE|2
1644345|NCT01719003|5748573|P9|Overall Study|Lost to Follow-up|2
1644346|NCT01719003|5748574|P8|Overall Study|Lost to Follow-up|2
1644347|NCT01719003|5748575|P7|Overall Study|Lost to Follow-up|3
1644348|NCT01719003|5748576|P6|Overall Study|Lost to Follow-up|4
1644349|NCT01719003|5748577|P5|Overall Study|Lost to Follow-up|3
1644350|NCT01719003|5748578|P4|Overall Study|Lost to Follow-up|2
1644351|NCT01719003|5748579|P3|Overall Study|Lost to Follow-up|7
1644352|NCT01719003|5748580|P2|Overall Study|Lost to Follow-up|6
1644353|NCT01719003|5748581|P1|Overall Study|Lost to Follow-up|0
1644354|NCT01719003|5748573|P9|Overall Study|Adverse Event|0
1644355|NCT01719003|5748574|P8|Overall Study|Adverse Event|5
1644356|NCT01719003|5748575|P7|Overall Study|Adverse Event|6
1644357|NCT01719003|5748576|P6|Overall Study|Adverse Event|3
1644358|NCT01719003|5748577|P5|Overall Study|Adverse Event|4
1644359|NCT01719003|5748578|P4|Overall Study|Adverse Event|3
1644360|NCT01719003|5748579|P3|Overall Study|Adverse Event|4
1644361|NCT01719003|5748580|P2|Overall Study|Adverse Event|5
1644362|NCT01719003|5748581|P1|Overall Study|Adverse Event|6
1644363|NCT01719003|5748573|P9|Overall Study|Non compliant with protocol|0
1644364|NCT01719003|5748574|P8|Overall Study|Non compliant with protocol|3
1644365|NCT01719003|5748575|P7|Overall Study|Non compliant with protocol|2
1644366|NCT01719003|5748576|P6|Overall Study|Non compliant with protocol|1
1644367|NCT01719003|5748577|P5|Overall Study|Non compliant with protocol|2
1644368|NCT01719003|5748578|P4|Overall Study|Non compliant with protocol|1
1644369|NCT01719003|5748579|P3|Overall Study|Non compliant with protocol|0
1644370|NCT01719003|5748580|P2|Overall Study|Non compliant with protocol|1
1644371|NCT01719003|5748581|P1|Overall Study|Non compliant with protocol|1
1644372|NCT01718535|5748662|P10|Overall Study|Bidirectional Sequencing not possible|0
1644373|NCT01718535|5748663|P9|Overall Study|Bidirectional Sequencing not possible|0
1644374|NCT01718535|5748664|P8|Overall Study|Bidirectional Sequencing not possible|0
1644375|NCT01718535|5748665|P7|Overall Study|Bidirectional Sequencing not possible|0
1644376|NCT01718535|5748666|P6|Overall Study|Bidirectional Sequencing not possible|0
1644377|NCT01718535|5748667|P5|Overall Study|Bidirectional Sequencing not possible|0
1644378|NCT01718535|5748668|P4|Overall Study|Bidirectional Sequencing not possible|1
1644379|NCT01718535|5748669|P3|Overall Study|Bidirectional Sequencing not possible|0
1644380|NCT01718535|5748670|P2|Overall Study|Bidirectional Sequencing not possible|0
1644381|NCT01718535|5748671|P1|Overall Study|Bidirectional Sequencing not possible|1
1644382|NCT01718509|5748709|P2|Overall Study|Lack of Efficacy|0
1644383|NCT01718509|5748710|P1|Overall Study|Lack of Efficacy|1
1644384|NCT01718509|5748709|P2|Overall Study|Protocol Violation|2
1644385|NCT01718509|5748710|P1|Overall Study|Protocol Violation|4
1644386|NCT01718509|5748709|P2|Overall Study|Other|11
1644387|NCT01718509|5748710|P1|Overall Study|Other|13
1644388|NCT01718509|5748709|P2|Overall Study|Adverse Event|7
1644389|NCT01718509|5748710|P1|Overall Study|Adverse Event|5
1644390|NCT01718509|5748709|P2|Overall Study|Withdrawal by Subject|13
1644391|NCT01718509|5748710|P1|Overall Study|Withdrawal by Subject|7
1644392|NCT01718509|5748709|P2|Overall Study|Lost to Follow-up|15
1644393|NCT01718509|5748710|P1|Overall Study|Lost to Follow-up|18
1644394|NCT01718483|5748756|P2|Overall Study|Lack of Efficacy|0
1644395|NCT01718483|5748757|P1|Overall Study|Lack of Efficacy|1
1644396|NCT01718483|5748756|P2|Overall Study|Pregnancy|1
1644397|NCT01718483|5748757|P1|Overall Study|Pregnancy|1
1644398|NCT01718483|5748756|P2|Overall Study|Other|4
1644399|NCT01718483|5748757|P1|Overall Study|Other|1
1644400|NCT01718483|5748756|P2|Overall Study|Protocol Violation|2
1644401|NCT01718483|5748757|P1|Overall Study|Protocol Violation|4
1644402|NCT01718483|5748756|P2|Overall Study|Lost to Follow-up|3
1644403|NCT01718483|5748757|P1|Overall Study|Lost to Follow-up|8
1644404|NCT01718483|5748756|P2|Overall Study|Adverse Event|12
1644405|NCT01718483|5748757|P1|Overall Study|Adverse Event|5
1644406|NCT01718483|5748756|P2|Overall Study|Withdrawal by Subject|12
1644407|NCT01718483|5748757|P1|Overall Study|Withdrawal by Subject|14
1644408|NCT01718353|5748803|P2|Overall Study|Randomized but not treated|0
1644409|NCT01718353|5748804|P1|Overall Study|Randomized but not treated|2
1644410|NCT01718353|5748803|P2|Overall Study|Principal Investigator's Decision|4
1644411|NCT01718353|5748804|P1|Overall Study|Principal Investigator's Decision|10
1644412|NCT01718353|5748803|P2|Overall Study|Lost to Follow-up|1
1644413|NCT01718353|5748804|P1|Overall Study|Lost to Follow-up|0
1644414|NCT01717989|5748835|P1|Overall Study|Other|40
1644415|NCT01717989|5748835|P1|Overall Study|Protocol-specified criteria|551
1644416|NCT01717989|5748835|P1|Overall Study|Death|439
1644417|NCT01717989|5748835|P1|Overall Study|Lost to Follow-up|11
1644418|NCT01717989|5748835|P1|Overall Study|Physician Decision|2
1644419|NCT01717989|5748835|P1|Overall Study|Withdrawal by Subject|11
1644420|NCT01717989|5748835|P1|Overall Study|Protocol deviation|6
1644421|NCT01717989|5748835|P1|Overall Study|Ineligibility determined|6
1644422|NCT01717976|5748903|P2|Overall Study|Protocol Violation|1
1644423|NCT01717976|5748904|P1|Overall Study|Protocol Violation|0
1644424|NCT01717859|5748959|P1|Overall Study|Withdrawal by Subject|2
1644425|NCT01717859|5748959|P1|Overall Study|Lost to Follow-up|1
1644426|NCT01717859|5748959|P1|Overall Study|Patient concerned about mental health|1
1644427|NCT01717859|5748959|P1|Overall Study|Moved out of state|1
1644428|NCT01717859|5748959|P1|Overall Study|Adverse Event|5
1644429|NCT01717768|5748980|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644430|NCT01717768|5748981|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644431|NCT01717768|5748982|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
1644432|NCT01717768|5748983|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644433|NCT01717768|5748984|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644434|NCT01717768|5748985|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644435|NCT01717768|5748986|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644436|NCT01717768|5748987|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644437|NCT01717768|5748988|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644438|NCT01717768|5748989|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644439|NCT01717768|5748990|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644440|NCT01717768|5748991|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
1644441|NCT01717768|5748980|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644442|NCT01717768|5748981|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644443|NCT01717768|5748982|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644444|NCT01717768|5748983|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644445|NCT01717768|5748984|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
1644446|NCT01717768|5748985|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644447|NCT01717768|5748986|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644448|NCT01717768|5748987|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644449|NCT01717768|5748988|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644450|NCT01717768|5748989|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644451|NCT01717768|5748990|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644452|NCT01717768|5748991|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
1644453|NCT01717768|5748980|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
1644454|NCT01717768|5748981|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644455|NCT01717768|5748982|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644456|NCT01717768|5748983|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644457|NCT01717768|5748984|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644458|NCT01717768|5748985|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644459|NCT01717768|5748986|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644460|NCT01717768|5748987|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644461|NCT01717768|5748988|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644462|NCT01717768|5748989|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644463|NCT01717768|5748990|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644464|NCT01717768|5748991|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
1644465|NCT01717768|5748980|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644466|NCT01717768|5748981|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644467|NCT01717768|5748982|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644468|NCT01717768|5748983|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644469|NCT01717768|5748984|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644470|NCT01717768|5748985|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644471|NCT01717768|5748986|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644472|NCT01717768|5748987|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644473|NCT01717768|5748988|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644474|NCT01717768|5748989|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644475|NCT01717768|5748990|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
1644476|NCT01717768|5748991|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
1644477|NCT01717638|5749042|P13|Overall Study|Withdrawal by Subject|18
1644478|NCT01717638|5749043|P12|Overall Study|Withdrawal by Subject|0
1644479|NCT01717638|5749044|P11|Overall Study|Withdrawal by Subject|0
1644480|NCT01717638|5749045|P10|Overall Study|Withdrawal by Subject|1
1644481|NCT01717638|5749046|P9|Overall Study|Withdrawal by Subject|2
1644482|NCT01717638|5749047|P8|Overall Study|Withdrawal by Subject|1
1644483|NCT01717638|5749048|P7|Overall Study|Withdrawal by Subject|2
1644484|NCT01717638|5749049|P6|Overall Study|Withdrawal by Subject|0
1644485|NCT01717638|5749050|P5|Overall Study|Withdrawal by Subject|1
1644486|NCT01717638|5749051|P4|Overall Study|Withdrawal by Subject|0
1644487|NCT01717638|5749052|P3|Overall Study|Withdrawal by Subject|1
1644488|NCT01717638|5749053|P2|Overall Study|Withdrawal by Subject|1
1644489|NCT01717638|5749054|P1|Overall Study|Withdrawal by Subject|0
1644490|NCT01717638|5749042|P13|Overall Study|Father in hospital|1
1644491|NCT01717638|5749043|P12|Overall Study|Father in hospital|0
1644492|NCT01717638|5749044|P11|Overall Study|Father in hospital|0
1644493|NCT01717638|5749045|P10|Overall Study|Father in hospital|0
1644494|NCT01717638|5749046|P9|Overall Study|Father in hospital|0
1644495|NCT01717638|5749047|P8|Overall Study|Father in hospital|0
1644496|NCT01717638|5749048|P7|Overall Study|Father in hospital|0
1644497|NCT01717638|5749049|P6|Overall Study|Father in hospital|0
1644498|NCT01717638|5749050|P5|Overall Study|Father in hospital|0
1644499|NCT01717638|5749051|P4|Overall Study|Father in hospital|0
1644500|NCT01717638|5749052|P3|Overall Study|Father in hospital|0
1644501|NCT01717638|5749053|P2|Overall Study|Father in hospital|0
1644502|NCT01717638|5749054|P1|Overall Study|Father in hospital|0
1644503|NCT01717638|5749042|P13|Overall Study|Lost to Follow-up|0
1644504|NCT01717638|5749043|P12|Overall Study|Lost to Follow-up|0
1644505|NCT01717638|5749044|P11|Overall Study|Lost to Follow-up|0
1644506|NCT01717638|5749045|P10|Overall Study|Lost to Follow-up|0
1644507|NCT01717638|5749046|P9|Overall Study|Lost to Follow-up|0
1644508|NCT01717638|5749047|P8|Overall Study|Lost to Follow-up|0
1644509|NCT01717638|5749048|P7|Overall Study|Lost to Follow-up|0
1644510|NCT01717638|5749049|P6|Overall Study|Lost to Follow-up|1
1644511|NCT01717638|5749050|P5|Overall Study|Lost to Follow-up|0
1644512|NCT01717638|5749051|P4|Overall Study|Lost to Follow-up|0
1644513|NCT01717638|5749052|P3|Overall Study|Lost to Follow-up|0
1644514|NCT01717638|5749053|P2|Overall Study|Lost to Follow-up|0
1644515|NCT01717638|5749054|P1|Overall Study|Lost to Follow-up|0
1644516|NCT01717456|5749224|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1644517|NCT01717456|5749225|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
1644518|NCT01717456|5749224|P2|End of Treatment|Lost to Follow-up|1
1644519|NCT01717456|5749225|P1|End of Treatment|Lost to Follow-up|0
1644520|NCT01717456|5749224|P2|End of Treatment|Physician Decision|1
1644521|NCT01717456|5749225|P1|End of Treatment|Physician Decision|0
1644522|NCT01717391|5749293|P1|Overall Study|FLT technical failure|3
1644523|NCT01717391|5749293|P1|Overall Study|Physician Decision|1
1644524|NCT01717391|5749293|P1|Overall Study|Withdrawal by Subject|5
1644525|NCT01717326|5749322|P20|Overall Study|Withdrawal by Subject|3
1644526|NCT01717326|5749323|P19|Overall Study|Withdrawal by Subject|2
1644527|NCT01717326|5749324|P18|Overall Study|Withdrawal by Subject|0
1644528|NCT01717326|5749325|P17|Overall Study|Withdrawal by Subject|0
1644529|NCT01717326|5749326|P16|Overall Study|Withdrawal by Subject|1
1644530|NCT01717326|5749327|P15|Overall Study|Withdrawal by Subject|0
1644531|NCT01717326|5749328|P14|Overall Study|Withdrawal by Subject|0
1644532|NCT01717326|5749329|P13|Overall Study|Withdrawal by Subject|1
1644533|NCT01717326|5749330|P12|Overall Study|Withdrawal by Subject|0
1644534|NCT01717326|5749331|P11|Overall Study|Withdrawal by Subject|0
1644535|NCT01717326|5749332|P10|Overall Study|Withdrawal by Subject|1
1644536|NCT01717326|5749333|P9|Overall Study|Withdrawal by Subject|0
1644537|NCT01717326|5749334|P8|Overall Study|Withdrawal by Subject|0
1644538|NCT01717326|5749335|P7|Overall Study|Withdrawal by Subject|0
1644539|NCT01717326|5749336|P6|Overall Study|Withdrawal by Subject|0
1644540|NCT01717326|5749337|P5|Overall Study|Withdrawal by Subject|0
1644541|NCT01717326|5749338|P4|Overall Study|Withdrawal by Subject|0
1644542|NCT01717326|5749339|P3|Overall Study|Withdrawal by Subject|0
1644543|NCT01717326|5749340|P2|Overall Study|Withdrawal by Subject|1
1644544|NCT01717326|5749341|P1|Overall Study|Withdrawal by Subject|0
1644545|NCT01717326|5749322|P20|Overall Study|Protocol Violation|0
1644546|NCT01717326|5749323|P19|Overall Study|Protocol Violation|0
1644547|NCT01717326|5749324|P18|Overall Study|Protocol Violation|0
1644548|NCT01717326|5749325|P17|Overall Study|Protocol Violation|0
1644549|NCT01717326|5749326|P16|Overall Study|Protocol Violation|0
1644550|NCT01717326|5749327|P15|Overall Study|Protocol Violation|0
1644551|NCT01717326|5749328|P14|Overall Study|Protocol Violation|0
1644552|NCT01717326|5749329|P13|Overall Study|Protocol Violation|0
1644553|NCT01717326|5749330|P12|Overall Study|Protocol Violation|0
1644554|NCT01717326|5749331|P11|Overall Study|Protocol Violation|0
1644555|NCT01717326|5749332|P10|Overall Study|Protocol Violation|0
1644556|NCT01717326|5749333|P9|Overall Study|Protocol Violation|0
1644557|NCT01717326|5749334|P8|Overall Study|Protocol Violation|0
1644558|NCT01717326|5749335|P7|Overall Study|Protocol Violation|0
1644559|NCT01717326|5749336|P6|Overall Study|Protocol Violation|0
1644560|NCT01717326|5749337|P5|Overall Study|Protocol Violation|1
1644561|NCT01717326|5749338|P4|Overall Study|Protocol Violation|0
1644562|NCT01717326|5749339|P3|Overall Study|Protocol Violation|0
1644563|NCT01717326|5749340|P2|Overall Study|Protocol Violation|0
1644564|NCT01717326|5749341|P1|Overall Study|Protocol Violation|0
1644565|NCT01717326|5749322|P20|Overall Study|Physician Decision|0
1644566|NCT01717326|5749323|P19|Overall Study|Physician Decision|0
1644567|NCT01717326|5749324|P18|Overall Study|Physician Decision|0
1644568|NCT01717326|5749325|P17|Overall Study|Physician Decision|0
1644569|NCT01717326|5749326|P16|Overall Study|Physician Decision|0
1644570|NCT01717326|5749327|P15|Overall Study|Physician Decision|0
1644571|NCT01717326|5749328|P14|Overall Study|Physician Decision|0
1644572|NCT01717326|5749329|P13|Overall Study|Physician Decision|0
1644573|NCT01717326|5749330|P12|Overall Study|Physician Decision|0
1644574|NCT01717326|5749331|P11|Overall Study|Physician Decision|0
1644575|NCT01717326|5749332|P10|Overall Study|Physician Decision|1
1644576|NCT01717326|5749333|P9|Overall Study|Physician Decision|0
1644577|NCT01717326|5749334|P8|Overall Study|Physician Decision|0
1644578|NCT01717326|5749335|P7|Overall Study|Physician Decision|0
1644579|NCT01717326|5749336|P6|Overall Study|Physician Decision|0
1644580|NCT01717326|5749337|P5|Overall Study|Physician Decision|0
1644581|NCT01717326|5749338|P4|Overall Study|Physician Decision|0
1644582|NCT01717326|5749339|P3|Overall Study|Physician Decision|0
1644583|NCT01717326|5749340|P2|Overall Study|Physician Decision|0
1644584|NCT01717326|5749341|P1|Overall Study|Physician Decision|0
1644585|NCT01717326|5749322|P20|Overall Study|Lost to Follow-up|3
1644586|NCT01717326|5749323|P19|Overall Study|Lost to Follow-up|2
1644587|NCT01717326|5749324|P18|Overall Study|Lost to Follow-up|0
1644588|NCT01717326|5749325|P17|Overall Study|Lost to Follow-up|1
1644589|NCT01717326|5749326|P16|Overall Study|Lost to Follow-up|2
1644590|NCT01717326|5749327|P15|Overall Study|Lost to Follow-up|0
1644591|NCT01717326|5749328|P14|Overall Study|Lost to Follow-up|0
1644592|NCT01717326|5749329|P13|Overall Study|Lost to Follow-up|0
1644593|NCT01717326|5749330|P12|Overall Study|Lost to Follow-up|0
1644594|NCT01717326|5749331|P11|Overall Study|Lost to Follow-up|1
1644595|NCT01717326|5749332|P10|Overall Study|Lost to Follow-up|0
1644596|NCT01717326|5749333|P9|Overall Study|Lost to Follow-up|0
1644597|NCT01717326|5749334|P8|Overall Study|Lost to Follow-up|0
1644598|NCT01717326|5749335|P7|Overall Study|Lost to Follow-up|1
1644599|NCT01717326|5749336|P6|Overall Study|Lost to Follow-up|0
1644600|NCT01717326|5749337|P5|Overall Study|Lost to Follow-up|1
1644601|NCT01717326|5749338|P4|Overall Study|Lost to Follow-up|2
1644602|NCT01717326|5749339|P3|Overall Study|Lost to Follow-up|0
1644603|NCT01717326|5749340|P2|Overall Study|Lost to Follow-up|0
1644604|NCT01717326|5749341|P1|Overall Study|Lost to Follow-up|3
1644605|NCT01717326|5749322|P20|Overall Study|Death|0
1644606|NCT01717326|5749323|P19|Overall Study|Death|0
1644607|NCT01717326|5749324|P18|Overall Study|Death|0
1644608|NCT01717326|5749325|P17|Overall Study|Death|0
1644609|NCT01717326|5749326|P16|Overall Study|Death|0
1644610|NCT01717326|5749327|P15|Overall Study|Death|0
1644611|NCT01717326|5749328|P14|Overall Study|Death|0
1644612|NCT01717326|5749329|P13|Overall Study|Death|0
1644613|NCT01717326|5749330|P12|Overall Study|Death|0
1644614|NCT01717326|5749331|P11|Overall Study|Death|1
1644615|NCT01717326|5749332|P10|Overall Study|Death|0
1644616|NCT01717326|5749333|P9|Overall Study|Death|0
1644617|NCT01717326|5749334|P8|Overall Study|Death|0
1644618|NCT01717326|5749335|P7|Overall Study|Death|0
1644619|NCT01717326|5749336|P6|Overall Study|Death|0
1644620|NCT01717326|5749337|P5|Overall Study|Death|0
1644621|NCT01717326|5749338|P4|Overall Study|Death|0
1644622|NCT01717326|5749339|P3|Overall Study|Death|0
1644623|NCT01717326|5749340|P2|Overall Study|Death|0
1644624|NCT01717326|5749341|P1|Overall Study|Death|0
1644625|NCT01717313|5749605|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
1644626|NCT01717313|5749606|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
1644627|NCT01717313|5749605|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
1644628|NCT01717313|5749606|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
1644629|NCT01717313|5749605|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1644630|NCT01717313|5749606|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
1644631|NCT01717313|5749605|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
1644632|NCT01717313|5749606|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
1644633|NCT01717313|5749605|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1644634|NCT01717313|5749606|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
1644635|NCT01717313|5749605|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
1644636|NCT01717313|5749606|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
1644637|NCT01717313|5749605|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
1644638|NCT01717313|5749606|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
1644639|NCT01717313|5749605|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
1644640|NCT01717313|5749606|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
1644641|NCT01717313|5749605|P2|Phase A (Weeks 0 to 24)|Death|1
1644642|NCT01717313|5749606|P1|Phase A (Weeks 0 to 24)|Death|0
1644643|NCT01717287|5749644|P2|Overall Study|Protocol Violation|1
1644644|NCT01717287|5749645|P1|Overall Study|Protocol Violation|0
1644645|NCT01717287|5749644|P2|Overall Study|Lost to Follow-up|2
1644646|NCT01717287|5749645|P1|Overall Study|Lost to Follow-up|0
1644647|NCT01717040|5749685|P2|Overall Study|New Substance Use Disorder|0
1644648|NCT01717040|5749686|P1|Overall Study|New Substance Use Disorder|1
1644649|NCT01717040|5749685|P2|Overall Study|Required Medication Change|1
1644650|NCT01717040|5749686|P1|Overall Study|Required Medication Change|0
1644651|NCT01717040|5749685|P2|Overall Study|Adverse Event|0
1644652|NCT01717040|5749686|P1|Overall Study|Adverse Event|1
1644653|NCT01717040|5749685|P2|Overall Study|Lack of Efficacy|1
1644654|NCT01717040|5749686|P1|Overall Study|Lack of Efficacy|1
1644655|NCT01717040|5749685|P2|Overall Study|Lost to Follow-up|3
1644656|NCT01717040|5749686|P1|Overall Study|Lost to Follow-up|2
1644657|NCT01716754|5749704|P4|Overall Study|Withdrawal by Subject|3
1644658|NCT01716754|5749705|P3|Overall Study|Withdrawal by Subject|4
1644659|NCT01716754|5749706|P2|Overall Study|Withdrawal by Subject|0
1644660|NCT01716754|5749707|P1|Overall Study|Withdrawal by Subject|5
1644661|NCT01716754|5749704|P4|Overall Study|Adverse Event|1
1644662|NCT01716754|5749705|P3|Overall Study|Adverse Event|2
1644663|NCT01716754|5749706|P2|Overall Study|Adverse Event|2
1644664|NCT01716754|5749707|P1|Overall Study|Adverse Event|4
1644665|NCT01716754|5749704|P4|Overall Study|Lost to Follow-up|1
1644666|NCT01716754|5749705|P3|Overall Study|Lost to Follow-up|0
1644667|NCT01716754|5749706|P2|Overall Study|Lost to Follow-up|0
1644668|NCT01716754|5749707|P1|Overall Study|Lost to Follow-up|1
1644669|NCT01716754|5749704|P4|Overall Study|Physician Decision|0
1644670|NCT01716754|5749705|P3|Overall Study|Physician Decision|0
1644671|NCT01716754|5749706|P2|Overall Study|Physician Decision|0
1644672|NCT01716754|5749707|P1|Overall Study|Physician Decision|1
1644673|NCT01716754|5749704|P4|Overall Study|Non-compliance with study treatment|0
1644674|NCT01716754|5749705|P3|Overall Study|Non-compliance with study treatment|1
1644675|NCT01716754|5749706|P2|Overall Study|Non-compliance with study treatment|0
1644676|NCT01716754|5749707|P1|Overall Study|Non-compliance with study treatment|0
1644677|NCT01716754|5749704|P4|Overall Study|Protocol deviation|2
1644678|NCT01716754|5749705|P3|Overall Study|Protocol deviation|7
1644679|NCT01716754|5749706|P2|Overall Study|Protocol deviation|2
1644680|NCT01716754|5749707|P1|Overall Study|Protocol deviation|0
1644681|NCT01716754|5749704|P4|Overall Study|Death|1
1644682|NCT01716754|5749705|P3|Overall Study|Death|0
1644683|NCT01716754|5749706|P2|Overall Study|Death|0
1644684|NCT01716754|5749707|P1|Overall Study|Death|0
1644685|NCT01716663|5749728|P1|Overall Study|Treated with non-study catheter|2
1644686|NCT01716663|5749728|P1|Overall Study|Withdrawn prior to procedure|4
1644687|NCT01716585|5749738|P2|Open-label Treatment|Withdrawal by Subject|3
1644688|NCT01716585|5749739|P1|Open-label Treatment|Withdrawal by Subject|0
1644689|NCT01716585|5749738|P2|Open-label Treatment|Virologic Failure|2
1644690|NCT01716585|5749739|P1|Open-label Treatment|Virologic Failure|0
1644691|NCT01716585|5749738|P2|Open-label Treatment|Adverse Event|2
1644692|NCT01716585|5749739|P1|Open-label Treatment|Adverse Event|0
1644693|NCT01716585|5749738|P2|Double-blind Treatment|Other|0
1644694|NCT01716585|5749739|P1|Double-blind Treatment|Other|1
1644695|NCT01716585|5749738|P2|Double-blind Treatment|Subject Noncompliant|0
1644696|NCT01716585|5749739|P1|Double-blind Treatment|Subject Noncompliant|1
1644697|NCT01716585|5749738|P2|Double-blind Treatment|Lost to Follow-up|0
1644698|NCT01716585|5749739|P1|Double-blind Treatment|Lost to Follow-up|2
1644699|NCT01716585|5749738|P2|Double-blind Treatment|Withdrawal by Subject|0
1644700|NCT01716585|5749739|P1|Double-blind Treatment|Withdrawal by Subject|3
1644701|NCT01716585|5749738|P2|Double-blind Treatment|Adverse Event|1
1644702|NCT01716585|5749739|P1|Double-blind Treatment|Adverse Event|2
1644703|NCT01716585|5749738|P2|Double-blind Treatment|Did Not Receive Study Drug|1
1644704|NCT01716585|5749739|P1|Double-blind Treatment|Did Not Receive Study Drug|4
1644705|NCT01716559|5749751|P1|Overall Study|Other withdrawal reason|75
1644706|NCT01716559|5749751|P1|Overall Study|Withdrawal by Subject|4
1644707|NCT01716559|5749751|P1|Overall Study|Death|21
1644708|NCT01716559|5749751|P1|Overall Study|Adverse Event|11
1644709|NCT01716533|5749763|P4|Overall Study|Immunosuppressants>14days past 6months|1
1644710|NCT01716533|5749764|P3|Overall Study|Immunosuppressants>14days past 6months|0
1644711|NCT01716533|5749765|P2|Overall Study|Immunosuppressants>14days past 6months|0
1644712|NCT01716533|5749766|P1|Overall Study|Immunosuppressants>14days past 6months|0
1644713|NCT01716533|5749763|P4|Overall Study|Death|2
1644714|NCT01716533|5749764|P3|Overall Study|Death|0
1644715|NCT01716533|5749765|P2|Overall Study|Death|0
1644716|NCT01716533|5749766|P1|Overall Study|Death|0
1644717|NCT01716533|5749763|P4|Overall Study|Withdrawal by Subject|5
1644718|NCT01716533|5749764|P3|Overall Study|Withdrawal by Subject|0
1644719|NCT01716533|5749765|P2|Overall Study|Withdrawal by Subject|0
1644720|NCT01716533|5749766|P1|Overall Study|Withdrawal by Subject|0
1644721|NCT01716533|5749763|P4|Overall Study|Failure of antibiotic treatment to treat|0
1644722|NCT01716533|5749764|P3|Overall Study|Failure of antibiotic treatment to treat|5
1644723|NCT01716533|5749765|P2|Overall Study|Failure of antibiotic treatment to treat|0
1644724|NCT01716533|5749766|P1|Overall Study|Failure of antibiotic treatment to treat|0
1644725|NCT01716520|5749820|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1644726|NCT01716520|5749821|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1644727|NCT01716520|5749822|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1644728|NCT01716520|5749823|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
1644729|NCT01716520|5749824|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1644730|NCT01716520|5749825|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
1644731|NCT01716520|5749820|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
1644732|NCT01716520|5749821|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1644733|NCT01716520|5749822|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1644734|NCT01716520|5749823|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1644735|NCT01716520|5749824|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1644736|NCT01716520|5749825|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
1644737|NCT01716520|5749820|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1644738|NCT01716520|5749821|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1644739|NCT01716520|5749822|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1644740|NCT01716520|5749823|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1644741|NCT01716520|5749824|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
1644742|NCT01716520|5749825|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
1644743|NCT01716520|5749820|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
1644744|NCT01716520|5749821|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1644745|NCT01716520|5749822|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1644746|NCT01716520|5749823|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1644747|NCT01716520|5749824|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1644748|NCT01716520|5749825|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
1644749|NCT01716520|5749820|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1644750|NCT01716520|5749821|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1644751|NCT01716520|5749822|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1644752|NCT01716520|5749823|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1644753|NCT01716520|5749824|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
1644754|NCT01716520|5749825|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
1644755|NCT01716520|5749820|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1644756|NCT01716520|5749821|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1644757|NCT01716520|5749822|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1644758|NCT01716520|5749823|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1644759|NCT01716520|5749824|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
1644760|NCT01716520|5749825|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
1644761|NCT01716520|5749820|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1644762|NCT01716520|5749821|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1644763|NCT01716520|5749822|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
1644764|NCT01716520|5749823|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1644765|NCT01716520|5749824|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1644766|NCT01716520|5749825|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
1644767|NCT01716520|5749820|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
1644768|NCT01716520|5749821|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
1644769|NCT01716520|5749822|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
1644770|NCT01716520|5749823|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
1644771|NCT01716520|5749824|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
1644772|NCT01716520|5749825|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
1644773|NCT01716520|5749820|P6|Treatment Period 2 (14 Days)|Adverse Event|0
1644774|NCT01716520|5749821|P5|Treatment Period 2 (14 Days)|Adverse Event|1
1644775|NCT01716520|5749822|P4|Treatment Period 2 (14 Days)|Adverse Event|0
1644776|NCT01716520|5749823|P3|Treatment Period 2 (14 Days)|Adverse Event|0
1644777|NCT01716520|5749824|P2|Treatment Period 2 (14 Days)|Adverse Event|0
1644778|NCT01716520|5749825|P1|Treatment Period 2 (14 Days)|Adverse Event|0
1644779|NCT01716520|5749820|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1644780|NCT01716520|5749821|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1644781|NCT01716520|5749822|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1644782|NCT01716520|5749823|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
1644783|NCT01716520|5749824|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1644784|NCT01716520|5749825|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
1644785|NCT01716520|5749820|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
1644786|NCT01716520|5749821|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1644787|NCT01716520|5749822|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1644788|NCT01716520|5749823|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1644789|NCT01716520|5749824|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1644790|NCT01716520|5749825|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
1644791|NCT01716520|5749820|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1644792|NCT01716520|5749821|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1644793|NCT01716520|5749822|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1644794|NCT01716520|5749823|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1644795|NCT01716520|5749824|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
1644796|NCT01716520|5749825|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
1644797|NCT01716520|5749820|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1644798|NCT01716520|5749821|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1644799|NCT01716520|5749822|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1644800|NCT01716520|5749823|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1644801|NCT01716520|5749824|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1644802|NCT01716520|5749825|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1644803|NCT01716520|5749820|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1644804|NCT01716520|5749821|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1644805|NCT01716520|5749822|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1644806|NCT01716520|5749823|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
1644807|NCT01716520|5749824|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
1644808|NCT01716520|5749825|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
1644809|NCT01716520|5749820|P6|Treatment Period 1 (14 Days)|Adverse Event|0
1644810|NCT01716520|5749821|P5|Treatment Period 1 (14 Days)|Adverse Event|0
1644811|NCT01716520|5749822|P4|Treatment Period 1 (14 Days)|Adverse Event|0
1644812|NCT01716520|5749823|P3|Treatment Period 1 (14 Days)|Adverse Event|0
1644813|NCT01716520|5749824|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1644814|NCT01716520|5749825|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1644815|NCT01716234|5749880|P7|Overall Study|Withdrawal by Subject|0
1644816|NCT01716234|5749881|P6|Overall Study|Withdrawal by Subject|3
1644817|NCT01716234|5749882|P5|Overall Study|Withdrawal by Subject|1
1644818|NCT01716234|5749883|P4|Overall Study|Withdrawal by Subject|2
1644819|NCT01716234|5749884|P3|Overall Study|Withdrawal by Subject|2
1644820|NCT01716234|5749885|P2|Overall Study|Withdrawal by Subject|0
1644821|NCT01716234|5749886|P1|Overall Study|Withdrawal by Subject|3
1644822|NCT01716234|5749880|P7|Overall Study|Adverse Event|0
1644823|NCT01716234|5749881|P6|Overall Study|Adverse Event|6
1644824|NCT01716234|5749882|P5|Overall Study|Adverse Event|3
1644825|NCT01716234|5749883|P4|Overall Study|Adverse Event|8
1644826|NCT01716234|5749884|P3|Overall Study|Adverse Event|2
1644827|NCT01716234|5749885|P2|Overall Study|Adverse Event|10
1644828|NCT01716234|5749886|P1|Overall Study|Adverse Event|7
1644829|NCT01716234|5749880|P7|Overall Study|Did not meet protocol eligibility|0
1644830|NCT01716234|5749881|P6|Overall Study|Did not meet protocol eligibility|4
1644831|NCT01716234|5749882|P5|Overall Study|Did not meet protocol eligibility|0
1644832|NCT01716234|5749883|P4|Overall Study|Did not meet protocol eligibility|0
1644833|NCT01716234|5749884|P3|Overall Study|Did not meet protocol eligibility|1
1644834|NCT01716234|5749885|P2|Overall Study|Did not meet protocol eligibility|0
1644835|NCT01716234|5749886|P1|Overall Study|Did not meet protocol eligibility|0
1644836|NCT01716234|5749880|P7|Overall Study|Lack of Efficacy|0
1644837|NCT01716234|5749881|P6|Overall Study|Lack of Efficacy|0
1644838|NCT01716234|5749882|P5|Overall Study|Lack of Efficacy|0
1644839|NCT01716234|5749883|P4|Overall Study|Lack of Efficacy|1
1644840|NCT01716234|5749884|P3|Overall Study|Lack of Efficacy|0
1644841|NCT01716234|5749885|P2|Overall Study|Lack of Efficacy|0
1644842|NCT01716234|5749886|P1|Overall Study|Lack of Efficacy|0
1644843|NCT01716234|5749880|P7|Overall Study|Protocol Violation|0
1644844|NCT01716234|5749881|P6|Overall Study|Protocol Violation|1
1644845|NCT01716234|5749882|P5|Overall Study|Protocol Violation|1
1644846|NCT01716234|5749883|P4|Overall Study|Protocol Violation|1
1644847|NCT01716234|5749884|P3|Overall Study|Protocol Violation|0
1644848|NCT01716234|5749885|P2|Overall Study|Protocol Violation|0
1644849|NCT01716234|5749886|P1|Overall Study|Protocol Violation|0
1644850|NCT01716169|5749949|P1|Overall Study|inconsistent dressing application|1
1644851|NCT01716169|5749949|P1|Overall Study|Withdrawal by Subject|1
1644852|NCT01716169|5749949|P1|Overall Study|Lost to Follow-up|1
1644853|NCT01716169|5749949|P1|Overall Study|Adverse Event|1
1644854|NCT01716156|5749958|P3|Overall Study|Lost to Follow-up|0
1644855|NCT01716156|5749959|P2|Overall Study|Lost to Follow-up|0
1644856|NCT01716156|5749960|P1|Overall Study|Lost to Follow-up|1
1644857|NCT01716156|5749958|P3|Overall Study|Withdrawal by Subject|2
1644858|NCT01716156|5749959|P2|Overall Study|Withdrawal by Subject|1
1644859|NCT01716156|5749960|P1|Overall Study|Withdrawal by Subject|0
1644860|NCT01716156|5749958|P3|Overall Study|Protocol Violation|0
1644861|NCT01716156|5749959|P2|Overall Study|Protocol Violation|0
1644862|NCT01716156|5749960|P1|Overall Study|Protocol Violation|1
1644863|NCT01716117|5749986|P2|Overall Study|Withdrawal by Subject|0
1644864|NCT01716117|5749987|P1|Overall Study|Withdrawal by Subject|2
1644865|NCT01716117|5749986|P2|Overall Study|Death|2
1644866|NCT01716117|5749987|P1|Overall Study|Death|5
1644867|NCT01716104|5750006|P2|Overall Study|Do not meet inclusion criteria|7
1644868|NCT01716104|5750007|P1|Overall Study|Do not meet inclusion criteria|6
1644869|NCT01716052|5750033|P2|Overall Study|Withdrawal of funding|1
1644870|NCT01716052|5750034|P1|Overall Study|Withdrawal of funding|1
1644871|NCT01715896|5750076|P2|Overall Study|Other|5
1644872|NCT01715896|5750077|P1|Overall Study|Other|2
1644873|NCT01715896|5750076|P2|Overall Study|Withdrawal by Subject|4
1644874|NCT01715896|5750077|P1|Overall Study|Withdrawal by Subject|1
1644875|NCT01715896|5750076|P2|Overall Study|Lost to Follow-up|2
1644876|NCT01715896|5750077|P1|Overall Study|Lost to Follow-up|0
1644877|NCT01715857|5750150|P1|Overall Study|Did Not Meet Eligibility Criteria|96
1644878|NCT01715831|5750160|P1|Overall Study|Adverse Event|1
1644879|NCT01715805|5750176|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
1644880|NCT01715805|5750177|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
1644881|NCT01715805|5750178|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
1644882|NCT01715805|5750179|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
1644883|NCT01715805|5750176|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
1644884|NCT01715805|5750177|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
1644885|NCT01715805|5750178|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
1644886|NCT01715805|5750179|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
1644887|NCT01715805|5750176|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
1644888|NCT01715805|5750177|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
1644889|NCT01715805|5750178|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
1644890|NCT01715805|5750179|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
1644891|NCT01715805|5750176|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
1644892|NCT01715805|5750177|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
1644893|NCT01715805|5750178|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
1644894|NCT01715805|5750179|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
1644895|NCT01715805|5750176|P4|Double-Blind or Continued Treatment|Protocol Violation|19
1644896|NCT01715805|5750177|P3|Double-Blind or Continued Treatment|Protocol Violation|12
1644897|NCT01715805|5750178|P2|Double-Blind or Continued Treatment|Protocol Violation|14
1644898|NCT01715805|5750179|P1|Double-Blind or Continued Treatment|Protocol Violation|0
1644899|NCT01715805|5750176|P4|Double-Blind or Continued Treatment|Adverse Event|2
1644900|NCT01715805|5750177|P3|Double-Blind or Continued Treatment|Adverse Event|23
1644901|NCT01715805|5750178|P2|Double-Blind or Continued Treatment|Adverse Event|3
1644902|NCT01715805|5750179|P1|Double-Blind or Continued Treatment|Adverse Event|0
1644903|NCT01715805|5750176|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
1644904|NCT01715805|5750177|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
1644905|NCT01715805|5750178|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
1644906|NCT01715805|5750179|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
1644907|NCT01715805|5750176|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
1644908|NCT01715805|5750177|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
1644909|NCT01715805|5750178|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
1644910|NCT01715805|5750179|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
1644911|NCT01715805|5750176|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
1644912|NCT01715805|5750177|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
1644913|NCT01715805|5750178|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
1644914|NCT01715805|5750179|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
1644915|NCT01715805|5750176|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
1644916|NCT01715805|5750177|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
1644917|NCT01715805|5750178|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
1644918|NCT01715805|5750179|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
1644919|NCT01715805|5750176|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
1644920|NCT01715805|5750177|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
1644921|NCT01715805|5750178|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
1644922|NCT01715805|5750179|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
1644923|NCT01715805|5750176|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
1644924|NCT01715805|5750177|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
1644925|NCT01715805|5750178|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
1644926|NCT01715805|5750179|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
1644927|NCT01715805|5750176|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
1644928|NCT01715805|5750177|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
1644929|NCT01715805|5750178|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
1644930|NCT01715805|5750179|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
1644931|NCT01715805|5750176|P4|Placebo + ADT Lead-in Period|Adverse Event|0
1644932|NCT01715805|5750177|P3|Placebo + ADT Lead-in Period|Adverse Event|0
1644933|NCT01715805|5750178|P2|Placebo + ADT Lead-in Period|Adverse Event|0
1644934|NCT01715805|5750179|P1|Placebo + ADT Lead-in Period|Adverse Event|41
1644935|NCT01715415|5750193|P2|Open-label Treatment|Subject Noncompliant|1
1644936|NCT01715415|5750194|P1|Open-label Treatment|Subject Noncompliant|0
1644937|NCT01715415|5750193|P2|Open-label Treatment|Adverse Event|1
1644938|NCT01715415|5750194|P1|Open-label Treatment|Adverse Event|0
1644939|NCT01715415|5750193|P2|Double-blind Treatment|Other|0
1644940|NCT01715415|5750194|P1|Double-blind Treatment|Other|1
1644941|NCT01715415|5750193|P2|Double-blind Treatment|Withdrawal by Subject|1
1644942|NCT01715415|5750194|P1|Double-blind Treatment|Withdrawal by Subject|1
1644943|NCT01715415|5750193|P2|Double-blind Treatment|Adverse Event|0
1644944|NCT01715415|5750194|P1|Double-blind Treatment|Adverse Event|3
1644945|NCT01715415|5750193|P2|Double-blind Treatment|Did Not Receive Study Drug|1
1644946|NCT01715415|5750194|P1|Double-blind Treatment|Did Not Receive Study Drug|0
1644947|NCT01715298|5750208|P2|Overall Study|Patient/guardian decision|9
1644948|NCT01715298|5750209|P1|Overall Study|Patient/guardian decision|7
1644949|NCT01715298|5750208|P2|Overall Study|Lost to Follow-up|2
1644950|NCT01715298|5750209|P1|Overall Study|Lost to Follow-up|0
1644951|NCT01715285|5750247|P3|Open-label (OL) Extension Phase|Ongoing|72
1644952|NCT01715285|5750248|P2|Open-label (OL) Extension Phase|Ongoing|0
1644953|NCT01715285|5750249|P1|Open-label (OL) Extension Phase|Ongoing|157
1644954|NCT01715285|5750247|P3|Treatment Period|Placebo Cross-over|0
1644955|NCT01715285|5750248|P2|Treatment Period|Placebo Cross-over|72
1644956|NCT01715285|5750249|P1|Treatment Period|Placebo Cross-over|0
1644957|NCT01715285|5750247|P3|Treatment Period|Other|0
1644958|NCT01715285|5750248|P2|Treatment Period|Other|12
1644959|NCT01715285|5750249|P1|Treatment Period|Other|10
1644960|NCT01715285|5750247|P3|Treatment Period|Ongoing|0
1644961|NCT01715285|5750248|P2|Treatment Period|Ongoing|0
1644962|NCT01715285|5750249|P1|Treatment Period|Ongoing|157
1644963|NCT01715285|5750247|P3|Treatment Period|Physician Decision|0
1644964|NCT01715285|5750248|P2|Treatment Period|Physician Decision|23
1644965|NCT01715285|5750249|P1|Treatment Period|Physician Decision|21
1644966|NCT01715285|5750247|P3|Treatment Period|Withdrawal Of Consent|0
1644967|NCT01715285|5750248|P2|Treatment Period|Withdrawal Of Consent|47
1644968|NCT01715285|5750249|P1|Treatment Period|Withdrawal Of Consent|52
1644969|NCT01715285|5750247|P3|Treatment Period|Progressive Disease|0
1644970|NCT01715285|5750248|P2|Treatment Period|Progressive Disease|388
1644971|NCT01715285|5750249|P1|Treatment Period|Progressive Disease|254
1644972|NCT01715285|5750247|P3|Treatment Period|Noncompliance With Study Drug|0
1644973|NCT01715285|5750248|P2|Treatment Period|Noncompliance With Study Drug|2
1644974|NCT01715285|5750249|P1|Treatment Period|Noncompliance With Study Drug|4
1644975|NCT01715285|5750247|P3|Treatment Period|Death|0
1644976|NCT01715285|5750248|P2|Treatment Period|Death|23
1644977|NCT01715285|5750249|P1|Treatment Period|Death|36
1644978|NCT01715285|5750247|P3|Treatment Period|Lost to Follow-up|0
1644979|NCT01715285|5750248|P2|Treatment Period|Lost to Follow-up|2
1644980|NCT01715285|5750249|P1|Treatment Period|Lost to Follow-up|3
1644981|NCT01715285|5750247|P3|Treatment Period|Adverse Event|0
1644982|NCT01715285|5750248|P2|Treatment Period|Adverse Event|33
1644983|NCT01715285|5750249|P1|Treatment Period|Adverse Event|60
1644984|NCT01715129|5750285|P1|Overall Study|Other|1
1644985|NCT01715129|5750285|P1|Overall Study|Lost to Follow-up|1
1644986|NCT01715129|5750285|P1|Overall Study|Consent Withdrawn|2
1644987|NCT01715129|5750285|P1|Overall Study|Protocol Violation|1
1644988|NCT01715129|5750285|P1|Overall Study|Lack of Efficacy|3
1644989|NCT01715129|5750285|P1|Overall Study|Adverse Event, fatal|1
1644990|NCT01714947|5750311|P1|Part B|Progressive Disease|3
1644991|NCT01714817|5750352|P2|Overall Study|Hypersensitivity to the medication|1
1644992|NCT01714817|5750353|P1|Overall Study|Hypersensitivity to the medication|0
1644993|NCT01714817|5750352|P2|Overall Study|Antiproteinuric changed/dose increased|1
1644994|NCT01714817|5750353|P1|Overall Study|Antiproteinuric changed/dose increased|0
1644995|NCT01714817|5750352|P2|Overall Study|Need of use of Prohibited Medications|0
1644996|NCT01714817|5750353|P1|Overall Study|Need of use of Prohibited Medications|1
1644997|NCT01714817|5750352|P2|Overall Study|Change in Concomitant Medication|1
1644998|NCT01714817|5750353|P1|Overall Study|Change in Concomitant Medication|0
1644999|NCT01714817|5750352|P2|Overall Study|Not treated- received ACE inhibition|0
1645000|NCT01714817|5750353|P1|Overall Study|Not treated- received ACE inhibition|1
1645001|NCT01714817|5750352|P2|Overall Study|Participant no longer meets criteria|2
1645002|NCT01714817|5750353|P1|Overall Study|Participant no longer meets criteria|6
1645003|NCT01714817|5750352|P2|Overall Study|Pregnancy|0
1645004|NCT01714817|5750353|P1|Overall Study|Pregnancy|2
1645005|NCT01714817|5750352|P2|Overall Study|Poor / non-compliance|1
1645006|NCT01714817|5750353|P1|Overall Study|Poor / non-compliance|0
1645007|NCT01714817|5750352|P2|Overall Study|Lost to Follow-up|2
1645008|NCT01714817|5750353|P1|Overall Study|Lost to Follow-up|0
1645009|NCT01714817|5750352|P2|Overall Study|Death|1
1645010|NCT01714817|5750353|P1|Overall Study|Death|1
1645011|NCT01714817|5750352|P2|Overall Study|Withdrawal by Subject|7
1645012|NCT01714817|5750353|P1|Overall Study|Withdrawal by Subject|6
1645013|NCT01714817|5750352|P2|Overall Study|Adverse Event|17
1645014|NCT01714817|5750353|P1|Overall Study|Adverse Event|20
1645015|NCT01714817|5750352|P2|Overall Study|Lack of Efficacy|9
1645016|NCT01714817|5750353|P1|Overall Study|Lack of Efficacy|11
1645017|NCT01714726|5750385|P4|Open-Label Period|Lost to Follow-up|4
1645018|NCT01714726|5750386|P3|Open-Label Period|Lost to Follow-up|3
1645019|NCT01714726|5750387|P2|Open-Label Period|Lost to Follow-up|0
1645020|NCT01714726|5750388|P1|Open-Label Period|Lost to Follow-up|0
1645021|NCT01714726|5750385|P4|Open-Label Period|Developed specific withdrawal criteria|2
1645022|NCT01714726|5750386|P3|Open-Label Period|Developed specific withdrawal criteria|5
1645023|NCT01714726|5750387|P2|Open-Label Period|Developed specific withdrawal criteria|0
1645024|NCT01714726|5750388|P1|Open-Label Period|Developed specific withdrawal criteria|0
1645025|NCT01714726|5750385|P4|Open-Label Period|Withdrawal by Subject|19
1645026|NCT01714726|5750386|P3|Open-Label Period|Withdrawal by Subject|9
1645027|NCT01714726|5750387|P2|Open-Label Period|Withdrawal by Subject|0
1645028|NCT01714726|5750388|P1|Open-Label Period|Withdrawal by Subject|0
1645029|NCT01714726|5750385|P4|Open-Label Period|Adverse Event|0
1645030|NCT01714726|5750386|P3|Open-Label Period|Adverse Event|1
1645031|NCT01714726|5750387|P2|Open-Label Period|Adverse Event|0
1645032|NCT01714726|5750388|P1|Open-Label Period|Adverse Event|0
1645033|NCT01714726|5750385|P4|Open-Label Period|Other|3
1645034|NCT01714726|5750386|P3|Open-Label Period|Other|1
1645035|NCT01714726|5750387|P2|Open-Label Period|Other|0
1645036|NCT01714726|5750388|P1|Open-Label Period|Other|0
1645037|NCT01714726|5750385|P4|Double-Blinded Induction Period|Lost to Follow-up|0
1645038|NCT01714726|5750386|P3|Double-Blinded Induction Period|Lost to Follow-up|0
1645039|NCT01714726|5750387|P2|Double-Blinded Induction Period|Lost to Follow-up|2
1645040|NCT01714726|5750388|P1|Double-Blinded Induction Period|Lost to Follow-up|0
1645041|NCT01714726|5750385|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
1645042|NCT01714726|5750386|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
1645043|NCT01714726|5750387|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
1645044|NCT01714726|5750388|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
1645045|NCT01714726|5750385|P4|Double-Blinded Induction Period|Adverse Event|0
1645046|NCT01714726|5750386|P3|Double-Blinded Induction Period|Adverse Event|0
1645047|NCT01714726|5750387|P2|Double-Blinded Induction Period|Adverse Event|1
1645048|NCT01714726|5750388|P1|Double-Blinded Induction Period|Adverse Event|0
1645049|NCT01714726|5750385|P4|Double-Blinded Induction Period|Subject not in open label period|0
1645050|NCT01714726|5750386|P3|Double-Blinded Induction Period|Subject not in open label period|0
1645051|NCT01714726|5750387|P2|Double-Blinded Induction Period|Subject not in open label period|1
1645052|NCT01714726|5750388|P1|Double-Blinded Induction Period|Subject not in open label period|3
1645053|NCT01714687|5750468|P2|Overall Study|Lost to Follow-up|4
1645054|NCT01714687|5750469|P1|Overall Study|Lost to Follow-up|2
1645055|NCT01714687|5750468|P2|Overall Study|Withdrawal by Subject|0
1645056|NCT01714687|5750469|P1|Overall Study|Withdrawal by Subject|1
1645057|NCT01714635|5750493|P3|Overall Study|Missed 6-month exam|0
1645058|NCT01714635|5750494|P2|Overall Study|Missed 6-month exam|0
1645059|NCT01714635|5750495|P1|Overall Study|Missed 6-month exam|1
1645060|NCT01714635|5750493|P3|Overall Study|Discontinued|2
1645061|NCT01714635|5750494|P2|Overall Study|Discontinued|0
1645062|NCT01714635|5750495|P1|Overall Study|Discontinued|1
1645063|NCT01714609|5750511|P2|Overall Study|Protocol Violation|0
1645064|NCT01714609|5750512|P1|Overall Study|Protocol Violation|1
1645065|NCT01714544|5750518|P1|Overall Study|Withdrawal by Subject|1
1645066|NCT01714544|5750518|P1|Overall Study|Physician Decision|1
1645067|NCT01714544|5750518|P1|Overall Study|Lost to Follow-up|1
1645068|NCT01714310|5750589|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
1645069|NCT01714310|5750590|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
1645070|NCT01714310|5750591|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
1645071|NCT01714310|5750589|P3|Double Blind Adjunctive Treatment|Adverse Event|0
1645072|NCT01714310|5750590|P2|Double Blind Adjunctive Treatment|Adverse Event|1
1645073|NCT01714310|5750591|P1|Double Blind Adjunctive Treatment|Adverse Event|1
1645074|NCT01714310|5750589|P3|Open Lisdexamfetamine Titration|Adverse Event|3
1645075|NCT01714310|5750590|P2|Open Lisdexamfetamine Titration|Adverse Event|0
1645076|NCT01714310|5750591|P1|Open Lisdexamfetamine Titration|Adverse Event|0
1645077|NCT01714310|5750589|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
1645078|NCT01714310|5750590|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
1645079|NCT01714310|5750591|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
1645080|NCT01714063|5750644|P1|Overall Study|Equipment malfunction|2
1645081|NCT01713998|5750681|P3|Overall Study|Withdrawal by Subject|0
1645082|NCT01713998|5750682|P2|Overall Study|Withdrawal by Subject|0
1645083|NCT01713998|5750683|P1|Overall Study|Withdrawal by Subject|1
1645084|NCT01713998|5750681|P3|Overall Study|Lost to Follow-up|2
1645085|NCT01713998|5750682|P2|Overall Study|Lost to Follow-up|0
1645086|NCT01713998|5750683|P1|Overall Study|Lost to Follow-up|2
1645087|NCT01713946|5750704|P3|Overall Study|Patients never switched to everolimus|5
1645088|NCT01713946|5750705|P2|Overall Study|Patients never switched to everolimus|0
1645089|NCT01713946|5750706|P1|Overall Study|Patients never switched to everolimus|0
1645090|NCT01713946|5750704|P3|Overall Study|Did not continue in Post-Ext. Phase|0
1645091|NCT01713946|5750705|P2|Overall Study|Did not continue in Post-Ext. Phase|2
1645092|NCT01713946|5750706|P1|Overall Study|Did not continue in Post-Ext. Phase|1
1645093|NCT01713946|5750704|P3|Overall Study|Did not continue in Ext|0
1645094|NCT01713946|5750705|P2|Overall Study|Did not continue in Ext|3
1645095|NCT01713946|5750706|P1|Overall Study|Did not continue in Ext|0
1645096|NCT01713946|5750704|P3|Overall Study|Administrative problems|0
1645097|NCT01713946|5750705|P2|Overall Study|Administrative problems|0
1645098|NCT01713946|5750706|P1|Overall Study|Administrative problems|1
1645099|NCT01713946|5750704|P3|Overall Study|Lost to Follow-up|1
1645100|NCT01713946|5750705|P2|Overall Study|Lost to Follow-up|0
1645101|NCT01713946|5750706|P1|Overall Study|Lost to Follow-up|0
1645102|NCT01713946|5750704|P3|Overall Study|Protocol Violation|1
1645103|NCT01713946|5750705|P2|Overall Study|Protocol Violation|4
1645104|NCT01713946|5750706|P1|Overall Study|Protocol Violation|2
1645105|NCT01713946|5750704|P3|Overall Study|Lack of Efficacy|14
1645106|NCT01713946|5750705|P2|Overall Study|Lack of Efficacy|8
1645107|NCT01713946|5750706|P1|Overall Study|Lack of Efficacy|8
1645108|NCT01713946|5750704|P3|Overall Study|Withdrawal by Subject|8
1645109|NCT01713946|5750705|P2|Overall Study|Withdrawal by Subject|12
1645110|NCT01713946|5750706|P1|Overall Study|Withdrawal by Subject|12
1645111|NCT01713946|5750704|P3|Overall Study|Adverse Event|13
1645112|NCT01713946|5750705|P2|Overall Study|Adverse Event|14
1645113|NCT01713946|5750706|P1|Overall Study|Adverse Event|19
1645114|NCT01713946|5750704|P3|Overall Study|Death|2
1645115|NCT01713946|5750705|P2|Overall Study|Death|2
1645116|NCT01713946|5750706|P1|Overall Study|Death|0
1645117|NCT01713933|5750797|P1|Overall Study|Excluded from analysis as a BMI outlier|1
1645118|NCT01713933|5750797|P1|Overall Study|Withdrawal by Subject|3
1645119|NCT01713933|5750797|P1|Overall Study|Lost to Follow-up|2
1645120|NCT01713686|5750846|P1|Overall Study|Withdrawal by Subject|6
1645121|NCT01713686|5750846|P1|Overall Study|Lost to Follow-up|9
1645122|NCT01713582|5750916|P21|Overall Study|Disease progression and adverse event|0
1645123|NCT01713582|5750917|P20|Overall Study|Disease progression and adverse event|0
1645124|NCT01713582|5750918|P19|Overall Study|Disease progression and adverse event|0
1645125|NCT01713582|5750919|P18|Overall Study|Disease progression and adverse event|0
1645126|NCT01713582|5750920|P17|Overall Study|Disease progression and adverse event|1
1645127|NCT01713582|5750921|P16|Overall Study|Disease progression and adverse event|0
1645128|NCT01713582|5750922|P15|Overall Study|Disease progression and adverse event|0
1645129|NCT01713582|5750923|P14|Overall Study|Disease progression and adverse event|0
1645130|NCT01713582|5750924|P13|Overall Study|Disease progression and adverse event|0
1645131|NCT01713582|5750925|P12|Overall Study|Disease progression and adverse event|0
1645132|NCT01713582|5750926|P11|Overall Study|Disease progression and adverse event|0
1645133|NCT01713582|5750927|P10|Overall Study|Disease progression and adverse event|0
1645134|NCT01713582|5750928|P9|Overall Study|Disease progression and adverse event|0
1645135|NCT01713582|5750929|P8|Overall Study|Disease progression and adverse event|0
1645136|NCT01713582|5750930|P7|Overall Study|Disease progression and adverse event|0
1645137|NCT01713582|5750931|P6|Overall Study|Disease progression and adverse event|0
1645138|NCT01713582|5750932|P5|Overall Study|Disease progression and adverse event|0
1645139|NCT01713582|5750933|P4|Overall Study|Disease progression and adverse event|0
1645140|NCT01713582|5750934|P3|Overall Study|Disease progression and adverse event|0
1645141|NCT01713582|5750935|P2|Overall Study|Disease progression and adverse event|0
1645142|NCT01713582|5750936|P1|Overall Study|Disease progression and adverse event|0
1645143|NCT01713582|5750916|P21|Overall Study|Stopped to receive bone marrow graft|0
1645144|NCT01713582|5750917|P20|Overall Study|Stopped to receive bone marrow graft|0
1645145|NCT01713582|5750918|P19|Overall Study|Stopped to receive bone marrow graft|0
1645146|NCT01713582|5750919|P18|Overall Study|Stopped to receive bone marrow graft|0
1645147|NCT01713582|5750920|P17|Overall Study|Stopped to receive bone marrow graft|1
1645233|NCT01713582|5750922|P15|Overall Study|Adverse event-unrelated|1
1645148|NCT01713582|5750921|P16|Overall Study|Stopped to receive bone marrow graft|0
1645149|NCT01713582|5750922|P15|Overall Study|Stopped to receive bone marrow graft|0
1645150|NCT01713582|5750923|P14|Overall Study|Stopped to receive bone marrow graft|0
1645151|NCT01713582|5750924|P13|Overall Study|Stopped to receive bone marrow graft|0
1645152|NCT01713582|5750925|P12|Overall Study|Stopped to receive bone marrow graft|0
1645153|NCT01713582|5750926|P11|Overall Study|Stopped to receive bone marrow graft|0
1645154|NCT01713582|5750927|P10|Overall Study|Stopped to receive bone marrow graft|0
1645155|NCT01713582|5750928|P9|Overall Study|Stopped to receive bone marrow graft|0
1645156|NCT01713582|5750929|P8|Overall Study|Stopped to receive bone marrow graft|0
1645157|NCT01713582|5750930|P7|Overall Study|Stopped to receive bone marrow graft|0
1645158|NCT01713582|5750931|P6|Overall Study|Stopped to receive bone marrow graft|0
1645159|NCT01713582|5750932|P5|Overall Study|Stopped to receive bone marrow graft|0
1645160|NCT01713582|5750933|P4|Overall Study|Stopped to receive bone marrow graft|0
1645161|NCT01713582|5750934|P3|Overall Study|Stopped to receive bone marrow graft|0
1645162|NCT01713582|5750935|P2|Overall Study|Stopped to receive bone marrow graft|0
1645163|NCT01713582|5750936|P1|Overall Study|Stopped to receive bone marrow graft|0
1645164|NCT01713582|5750916|P21|Overall Study|Withdrawal by Subject|0
1645165|NCT01713582|5750917|P20|Overall Study|Withdrawal by Subject|0
1645166|NCT01713582|5750918|P19|Overall Study|Withdrawal by Subject|0
1645167|NCT01713582|5750919|P18|Overall Study|Withdrawal by Subject|1
1645168|NCT01713582|5750920|P17|Overall Study|Withdrawal by Subject|0
1645169|NCT01713582|5750921|P16|Overall Study|Withdrawal by Subject|0
1645170|NCT01713582|5750922|P15|Overall Study|Withdrawal by Subject|0
1645171|NCT01713582|5750923|P14|Overall Study|Withdrawal by Subject|0
1645172|NCT01713582|5750924|P13|Overall Study|Withdrawal by Subject|0
1645173|NCT01713582|5750925|P12|Overall Study|Withdrawal by Subject|0
1645174|NCT01713582|5750926|P11|Overall Study|Withdrawal by Subject|0
1645175|NCT01713582|5750927|P10|Overall Study|Withdrawal by Subject|0
1645176|NCT01713582|5750928|P9|Overall Study|Withdrawal by Subject|0
1645177|NCT01713582|5750929|P8|Overall Study|Withdrawal by Subject|0
1645178|NCT01713582|5750930|P7|Overall Study|Withdrawal by Subject|0
1645179|NCT01713582|5750931|P6|Overall Study|Withdrawal by Subject|0
1645180|NCT01713582|5750932|P5|Overall Study|Withdrawal by Subject|0
1645181|NCT01713582|5750933|P4|Overall Study|Withdrawal by Subject|0
1645182|NCT01713582|5750934|P3|Overall Study|Withdrawal by Subject|0
1645183|NCT01713582|5750935|P2|Overall Study|Withdrawal by Subject|0
1645184|NCT01713582|5750936|P1|Overall Study|Withdrawal by Subject|0
1645185|NCT01713582|5750916|P21|Overall Study|Lack of Efficacy|0
1645186|NCT01713582|5750917|P20|Overall Study|Lack of Efficacy|0
1645187|NCT01713582|5750918|P19|Overall Study|Lack of Efficacy|0
1645188|NCT01713582|5750919|P18|Overall Study|Lack of Efficacy|0
1645189|NCT01713582|5750920|P17|Overall Study|Lack of Efficacy|0
1645190|NCT01713582|5750921|P16|Overall Study|Lack of Efficacy|0
1645191|NCT01713582|5750922|P15|Overall Study|Lack of Efficacy|0
1645192|NCT01713582|5750923|P14|Overall Study|Lack of Efficacy|0
1645193|NCT01713582|5750924|P13|Overall Study|Lack of Efficacy|0
1645194|NCT01713582|5750925|P12|Overall Study|Lack of Efficacy|0
1645195|NCT01713582|5750926|P11|Overall Study|Lack of Efficacy|2
1645196|NCT01713582|5750927|P10|Overall Study|Lack of Efficacy|1
1645197|NCT01713582|5750928|P9|Overall Study|Lack of Efficacy|0
1645198|NCT01713582|5750929|P8|Overall Study|Lack of Efficacy|0
1645199|NCT01713582|5750930|P7|Overall Study|Lack of Efficacy|0
1645200|NCT01713582|5750931|P6|Overall Study|Lack of Efficacy|0
1645201|NCT01713582|5750932|P5|Overall Study|Lack of Efficacy|0
1645202|NCT01713582|5750933|P4|Overall Study|Lack of Efficacy|0
1645203|NCT01713582|5750934|P3|Overall Study|Lack of Efficacy|0
1645204|NCT01713582|5750935|P2|Overall Study|Lack of Efficacy|0
1645205|NCT01713582|5750936|P1|Overall Study|Lack of Efficacy|0
1645206|NCT01713582|5750916|P21|Overall Study|Withdrawal of consent|0
1645207|NCT01713582|5750917|P20|Overall Study|Withdrawal of consent|0
1645208|NCT01713582|5750918|P19|Overall Study|Withdrawal of consent|1
1645209|NCT01713582|5750919|P18|Overall Study|Withdrawal of consent|0
1645210|NCT01713582|5750920|P17|Overall Study|Withdrawal of consent|0
1645211|NCT01713582|5750921|P16|Overall Study|Withdrawal of consent|0
1645212|NCT01713582|5750922|P15|Overall Study|Withdrawal of consent|0
1645213|NCT01713582|5750923|P14|Overall Study|Withdrawal of consent|0
1645214|NCT01713582|5750924|P13|Overall Study|Withdrawal of consent|0
1645215|NCT01713582|5750925|P12|Overall Study|Withdrawal of consent|0
1645216|NCT01713582|5750926|P11|Overall Study|Withdrawal of consent|0
1645217|NCT01713582|5750927|P10|Overall Study|Withdrawal of consent|1
1645218|NCT01713582|5750928|P9|Overall Study|Withdrawal of consent|0
1645219|NCT01713582|5750929|P8|Overall Study|Withdrawal of consent|0
1645220|NCT01713582|5750930|P7|Overall Study|Withdrawal of consent|0
1645221|NCT01713582|5750931|P6|Overall Study|Withdrawal of consent|1
1645222|NCT01713582|5750932|P5|Overall Study|Withdrawal of consent|0
1645223|NCT01713582|5750933|P4|Overall Study|Withdrawal of consent|0
1645224|NCT01713582|5750934|P3|Overall Study|Withdrawal of consent|1
1645225|NCT01713582|5750935|P2|Overall Study|Withdrawal of consent|0
1645226|NCT01713582|5750936|P1|Overall Study|Withdrawal of consent|0
1645227|NCT01713582|5750916|P21|Overall Study|Adverse event-unrelated|0
1645228|NCT01713582|5750917|P20|Overall Study|Adverse event-unrelated|0
1645229|NCT01713582|5750918|P19|Overall Study|Adverse event-unrelated|0
1645230|NCT01713582|5750919|P18|Overall Study|Adverse event-unrelated|0
1645231|NCT01713582|5750920|P17|Overall Study|Adverse event-unrelated|0
1645232|NCT01713582|5750921|P16|Overall Study|Adverse event-unrelated|0
1645234|NCT01713582|5750923|P14|Overall Study|Adverse event-unrelated|1
1645235|NCT01713582|5750924|P13|Overall Study|Adverse event-unrelated|0
1645236|NCT01713582|5750925|P12|Overall Study|Adverse event-unrelated|0
1645237|NCT01713582|5750926|P11|Overall Study|Adverse event-unrelated|0
1645238|NCT01713582|5750927|P10|Overall Study|Adverse event-unrelated|0
1645239|NCT01713582|5750928|P9|Overall Study|Adverse event-unrelated|0
1645240|NCT01713582|5750929|P8|Overall Study|Adverse event-unrelated|1
1645241|NCT01713582|5750930|P7|Overall Study|Adverse event-unrelated|1
1645242|NCT01713582|5750931|P6|Overall Study|Adverse event-unrelated|1
1645243|NCT01713582|5750932|P5|Overall Study|Adverse event-unrelated|0
1645244|NCT01713582|5750933|P4|Overall Study|Adverse event-unrelated|0
1645245|NCT01713582|5750934|P3|Overall Study|Adverse event-unrelated|0
1645246|NCT01713582|5750935|P2|Overall Study|Adverse event-unrelated|0
1645247|NCT01713582|5750936|P1|Overall Study|Adverse event-unrelated|0
1645248|NCT01713582|5750916|P21|Overall Study|Adverse event-related|0
1645249|NCT01713582|5750917|P20|Overall Study|Adverse event-related|0
1645250|NCT01713582|5750918|P19|Overall Study|Adverse event-related|1
1645251|NCT01713582|5750919|P18|Overall Study|Adverse event-related|0
1645252|NCT01713582|5750920|P17|Overall Study|Adverse event-related|0
1645253|NCT01713582|5750921|P16|Overall Study|Adverse event-related|0
1645254|NCT01713582|5750922|P15|Overall Study|Adverse event-related|0
1645255|NCT01713582|5750923|P14|Overall Study|Adverse event-related|0
1645256|NCT01713582|5750924|P13|Overall Study|Adverse event-related|0
1645257|NCT01713582|5750925|P12|Overall Study|Adverse event-related|0
1645258|NCT01713582|5750926|P11|Overall Study|Adverse event-related|1
1645259|NCT01713582|5750927|P10|Overall Study|Adverse event-related|1
1645260|NCT01713582|5750928|P9|Overall Study|Adverse event-related|0
1645261|NCT01713582|5750929|P8|Overall Study|Adverse event-related|0
1645262|NCT01713582|5750930|P7|Overall Study|Adverse event-related|0
1645263|NCT01713582|5750931|P6|Overall Study|Adverse event-related|0
1645264|NCT01713582|5750932|P5|Overall Study|Adverse event-related|0
1645265|NCT01713582|5750933|P4|Overall Study|Adverse event-related|0
1645266|NCT01713582|5750934|P3|Overall Study|Adverse event-related|0
1645267|NCT01713582|5750935|P2|Overall Study|Adverse event-related|0
1645268|NCT01713582|5750936|P1|Overall Study|Adverse event-related|0
1645269|NCT01713582|5750916|P21|Overall Study|Death|0
1645270|NCT01713582|5750917|P20|Overall Study|Death|0
1645271|NCT01713582|5750918|P19|Overall Study|Death|0
1645272|NCT01713582|5750919|P18|Overall Study|Death|0
1645273|NCT01713582|5750920|P17|Overall Study|Death|0
1645274|NCT01713582|5750921|P16|Overall Study|Death|0
1645275|NCT01713582|5750922|P15|Overall Study|Death|0
1645276|NCT01713582|5750923|P14|Overall Study|Death|0
1645277|NCT01713582|5750924|P13|Overall Study|Death|0
1645278|NCT01713582|5750925|P12|Overall Study|Death|0
1645279|NCT01713582|5750926|P11|Overall Study|Death|3
1645280|NCT01713582|5750927|P10|Overall Study|Death|4
1645281|NCT01713582|5750928|P9|Overall Study|Death|3
1645282|NCT01713582|5750929|P8|Overall Study|Death|2
1645283|NCT01713582|5750930|P7|Overall Study|Death|3
1645284|NCT01713582|5750931|P6|Overall Study|Death|3
1645285|NCT01713582|5750932|P5|Overall Study|Death|1
1645286|NCT01713582|5750933|P4|Overall Study|Death|1
1645287|NCT01713582|5750934|P3|Overall Study|Death|0
1645288|NCT01713582|5750935|P2|Overall Study|Death|0
1645289|NCT01713582|5750936|P1|Overall Study|Death|0
1645290|NCT01713582|5750916|P21|Overall Study|Disease progression|15
1645291|NCT01713582|5750917|P20|Overall Study|Disease progression|5
1645292|NCT01713582|5750918|P19|Overall Study|Disease progression|3
1645293|NCT01713582|5750919|P18|Overall Study|Disease progression|2
1645294|NCT01713582|5750920|P17|Overall Study|Disease progression|5
1645295|NCT01713582|5750921|P16|Overall Study|Disease progression|6
1645296|NCT01713582|5750922|P15|Overall Study|Disease progression|6
1645297|NCT01713582|5750923|P14|Overall Study|Disease progression|3
1645298|NCT01713582|5750924|P13|Overall Study|Disease progression|3
1645299|NCT01713582|5750925|P12|Overall Study|Disease progression|5
1645300|NCT01713582|5750926|P11|Overall Study|Disease progression|10
1645301|NCT01713582|5750927|P10|Overall Study|Disease progression|11
1645302|NCT01713582|5750928|P9|Overall Study|Disease progression|3
1645303|NCT01713582|5750929|P8|Overall Study|Disease progression|3
1645304|NCT01713582|5750930|P7|Overall Study|Disease progression|3
1645305|NCT01713582|5750931|P6|Overall Study|Disease progression|3
1645306|NCT01713582|5750932|P5|Overall Study|Disease progression|3
1645307|NCT01713582|5750933|P4|Overall Study|Disease progression|2
1645308|NCT01713582|5750934|P3|Overall Study|Disease progression|3
1645309|NCT01713582|5750935|P2|Overall Study|Disease progression|3
1645310|NCT01713582|5750936|P1|Overall Study|Disease progression|3
1645311|NCT01713530|5751099|P2|Overall Study|Unclassified|2
1645312|NCT01713530|5751100|P1|Overall Study|Unclassified|4
1645313|NCT01713530|5751099|P2|Overall Study|Withdrawal criteria|12
1645314|NCT01713530|5751100|P1|Overall Study|Withdrawal criteria|21
1645315|NCT01713530|5751099|P2|Overall Study|Adverse Event|5
1645316|NCT01713530|5751100|P1|Overall Study|Adverse Event|0
1645317|NCT01713348|5751131|P4|Overall Study|Lost to Follow-up|0
1645318|NCT01713348|5751132|P3|Overall Study|Lost to Follow-up|0
1645319|NCT01713348|5751133|P2|Overall Study|Lost to Follow-up|0
1645320|NCT01713348|5751134|P1|Overall Study|Lost to Follow-up|1
1645321|NCT01713348|5751131|P4|Overall Study|Withdrawal by Subject|0
1645322|NCT01713348|5751132|P3|Overall Study|Withdrawal by Subject|2
1645323|NCT01713348|5751133|P2|Overall Study|Withdrawal by Subject|2
1645324|NCT01713348|5751134|P1|Overall Study|Withdrawal by Subject|3
1645325|NCT01713283|5751164|P2|Overall Study|Lost to Follow-up|1
1645326|NCT01713283|5751165|P1|Overall Study|Lost to Follow-up|1
1645327|NCT01713283|5751164|P2|Overall Study|Lack of Efficacy|2
1645328|NCT01713283|5751165|P1|Overall Study|Lack of Efficacy|10
1645329|NCT01713036|5751187|P1|Overall Study|Death|1
1645330|NCT01712984|5751227|P3|Overall Study|Withdrawal by Subject|7
1645331|NCT01712984|5751228|P2|Overall Study|Withdrawal by Subject|6
1645332|NCT01712984|5751229|P1|Overall Study|Withdrawal by Subject|6
1645333|NCT01712984|5751227|P3|Overall Study|Lost to Follow-up|1
1645334|NCT01712984|5751228|P2|Overall Study|Lost to Follow-up|10
1645335|NCT01712984|5751229|P1|Overall Study|Lost to Follow-up|8
1645336|NCT01712984|5751227|P3|Overall Study|Protocol Violation|1
1645337|NCT01712984|5751228|P2|Overall Study|Protocol Violation|0
1645338|NCT01712984|5751229|P1|Overall Study|Protocol Violation|2
1645339|NCT01712984|5751227|P3|Overall Study|Adverse Event|1
1645340|NCT01712984|5751228|P2|Overall Study|Adverse Event|0
1645341|NCT01712984|5751229|P1|Overall Study|Adverse Event|0
1645342|NCT01712854|5751249|P1|Overall Study|Physician Decision|1
1645343|NCT01712685|5751272|P1|Overall Study|pt declined to participate before trmt|1
1645344|NCT01712516|5751288|P4|Overall Study|Withdrawal by Subject|9
1645345|NCT01712516|5751289|P3|Overall Study|Withdrawal by Subject|3
1645346|NCT01712516|5751290|P2|Overall Study|Withdrawal by Subject|9
1645347|NCT01712516|5751291|P1|Overall Study|Withdrawal by Subject|3
1645348|NCT01712516|5751288|P4|Overall Study|Physician Decision|1
1645349|NCT01712516|5751289|P3|Overall Study|Physician Decision|0
1645350|NCT01712516|5751290|P2|Overall Study|Physician Decision|0
1645351|NCT01712516|5751291|P1|Overall Study|Physician Decision|2
1645352|NCT01712516|5751288|P4|Overall Study|Protocol deviation|0
1645353|NCT01712516|5751289|P3|Overall Study|Protocol deviation|1
1645354|NCT01712516|5751290|P2|Overall Study|Protocol deviation|0
1645355|NCT01712516|5751291|P1|Overall Study|Protocol deviation|1
1645356|NCT01712516|5751288|P4|Overall Study|Death|0
1645357|NCT01712516|5751289|P3|Overall Study|Death|0
1645358|NCT01712516|5751290|P2|Overall Study|Death|1
1645359|NCT01712516|5751291|P1|Overall Study|Death|0
1645360|NCT01712516|5751288|P4|Overall Study|Lost to Follow-up|1
1645361|NCT01712516|5751289|P3|Overall Study|Lost to Follow-up|2
1645362|NCT01712516|5751290|P2|Overall Study|Lost to Follow-up|0
1645363|NCT01712516|5751291|P1|Overall Study|Lost to Follow-up|0
1645364|NCT01712516|5751288|P4|Overall Study|Technical problems|2
1645365|NCT01712516|5751289|P3|Overall Study|Technical problems|0
1645366|NCT01712516|5751290|P2|Overall Study|Technical problems|0
1645367|NCT01712516|5751291|P1|Overall Study|Technical problems|0
1645368|NCT01712490|5751343|P2|Overall Study|Lost to Follow-up|29
1645369|NCT01712490|5751344|P1|Overall Study|Lost to Follow-up|16
1645370|NCT01712490|5751343|P2|Overall Study|Withdrawal by Subject|44
1645371|NCT01712490|5751344|P1|Overall Study|Withdrawal by Subject|36
1645372|NCT01712490|5751343|P2|Overall Study|Other|11
1645373|NCT01712490|5751344|P1|Overall Study|Other|11
1645374|NCT01712490|5751343|P2|Overall Study|Ongoing|586
1645375|NCT01712490|5751344|P1|Overall Study|Ongoing|601
1645376|NCT01712438|5751381|P1|Overall Study|Prematurely Discontinued|25
1645377|NCT01712438|5751381|P1|Overall Study|Violated inclusion & exclusion criteria|4
1645378|NCT01712438|5751381|P1|Overall Study|Ongoing ITI treatment|6
1645379|NCT01712438|5751381|P1|Overall Study|Not treated with Human-cl rhFVIII|2
1645380|NCT01712399|5751391|P1|Overall Study|Study closure|345
1645381|NCT01712399|5751391|P1|Overall Study|Adverse Event|11
1645382|NCT01712399|5751391|P1|Overall Study|Death|1
1645383|NCT01712399|5751391|P1|Overall Study|Withdrawal by Subject|39
1645384|NCT01712399|5751391|P1|Overall Study|Lost to Follow-up|1
1645385|NCT01712334|5751437|P2|Treatment Period 1|Randomized in Error|2
1645386|NCT01712334|5751438|P1|Treatment Period 1|Randomized in Error|0
1645387|NCT01712256|5751446|P1|Overall Study|Lost to Follow-up|1
1645388|NCT01712204|5751476|P2|Overall Study|Protocol Violation|1
1645389|NCT01712204|5751477|P1|Overall Study|Protocol Violation|1
1645390|NCT01712204|5751476|P2|Overall Study|Lost to Follow-up|0
1645391|NCT01712204|5751477|P1|Overall Study|Lost to Follow-up|1
1645392|NCT01712204|5751476|P2|Overall Study|Withdrawal by Subject|3
1645393|NCT01712204|5751477|P1|Overall Study|Withdrawal by Subject|3
1645394|NCT01712204|5751476|P2|Overall Study|Adverse Event|1
1645395|NCT01712204|5751477|P1|Overall Study|Adverse Event|3
1645396|NCT01712178|5751485|P2|Overall Study|Lost to Follow-up|1
1645397|NCT01712178|5751486|P1|Overall Study|Lost to Follow-up|0
1645398|NCT01712178|5751485|P2|Overall Study|Serious adverse event/withdrew consent|1
1645399|NCT01712178|5751486|P1|Overall Study|Serious adverse event/withdrew consent|0
1645400|NCT01712178|5751485|P2|Overall Study|Withdrew consent due to an adverse event|1
1645401|NCT01712178|5751486|P1|Overall Study|Withdrew consent due to an adverse event|1
1645402|NCT01712074|5751511|P3|Double Blind Period|No longer met eligibility criteria|0
1645403|NCT01712074|5751512|P2|Double Blind Period|No longer met eligibility criteria|3
1645404|NCT01712074|5751513|P1|Double Blind Period|No longer met eligibility criteria|0
1645405|NCT01712074|5751511|P3|Double Blind Period|Protocol Violation|1
1645406|NCT01712074|5751512|P2|Double Blind Period|Protocol Violation|0
1645407|NCT01712074|5751513|P1|Double Blind Period|Protocol Violation|0
1645408|NCT01712074|5751511|P3|Double Blind Period|Other|1
1645409|NCT01712074|5751512|P2|Double Blind Period|Other|4
1645410|NCT01712074|5751513|P1|Double Blind Period|Other|0
1645411|NCT01712074|5751511|P3|Double Blind Period|Lost to Follow-up|1
1645412|NCT01712074|5751512|P2|Double Blind Period|Lost to Follow-up|2
1645413|NCT01712074|5751513|P1|Double Blind Period|Lost to Follow-up|0
1645414|NCT01712074|5751511|P3|Double Blind Period|Death|0
1645415|NCT01712074|5751512|P2|Double Blind Period|Death|1
1645416|NCT01712074|5751513|P1|Double Blind Period|Death|0
1645417|NCT01712074|5751511|P3|Double Blind Period|No longer willing to participate|4
1645418|NCT01712074|5751512|P2|Double Blind Period|No longer willing to participate|2
1645419|NCT01712074|5751513|P1|Double Blind Period|No longer willing to participate|0
1645420|NCT01712074|5751511|P3|Double Blind Period|Adverse Event|1
1645421|NCT01712074|5751512|P2|Double Blind Period|Adverse Event|2
1645422|NCT01712074|5751513|P1|Double Blind Period|Adverse Event|0
1645423|NCT01712074|5751511|P3|Placebo Run-in Period|No longer willing to participate|0
1645424|NCT01712074|5751512|P2|Placebo Run-in Period|No longer willing to participate|0
1645425|NCT01712074|5751513|P1|Placebo Run-in Period|No longer willing to participate|1
1645426|NCT01712074|5751511|P3|Placebo Run-in Period|Other|0
1645427|NCT01712074|5751512|P2|Placebo Run-in Period|Other|0
1645428|NCT01712074|5751513|P1|Placebo Run-in Period|Other|1
1645429|NCT01712074|5751511|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
1645430|NCT01712074|5751512|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
1645431|NCT01712074|5751513|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
1645432|NCT01712074|5751511|P3|Placebo Run-in Period|Lost to Follow-up|0
1645433|NCT01712074|5751512|P2|Placebo Run-in Period|Lost to Follow-up|0
1645434|NCT01712074|5751513|P1|Placebo Run-in Period|Lost to Follow-up|1
1645435|NCT01712074|5751511|P3|Placebo Run-in Period|Adverse Event|0
1645436|NCT01712074|5751512|P2|Placebo Run-in Period|Adverse Event|0
1645437|NCT01712074|5751513|P1|Placebo Run-in Period|Adverse Event|2
1645438|NCT01712061|5751569|P3|Overall Study|Other|0
1645439|NCT01712061|5751570|P2|Overall Study|Other|3
1645440|NCT01712061|5751571|P1|Overall Study|Other|0
1645441|NCT01712061|5751569|P3|Overall Study|Withdrawal by Subject|1
1645442|NCT01712061|5751570|P2|Overall Study|Withdrawal by Subject|7
1645443|NCT01712061|5751571|P1|Overall Study|Withdrawal by Subject|1
1645444|NCT01712061|5751569|P3|Overall Study|Medication Error Without Associated AE|0
1645445|NCT01712061|5751570|P2|Overall Study|Medication Error Without Associated AE|1
1645446|NCT01712061|5751571|P1|Overall Study|Medication Error Without Associated AE|0
1645447|NCT01712061|5751569|P3|Overall Study|Did Not Meet Entrance Criteria|3
1645448|NCT01712061|5751570|P2|Overall Study|Did Not Meet Entrance Criteria|6
1645449|NCT01712061|5751571|P1|Overall Study|Did Not Meet Entrance Criteria|4
1645450|NCT01712061|5751569|P3|Overall Study|Lost to Follow-up|1
1645451|NCT01712061|5751570|P2|Overall Study|Lost to Follow-up|0
1645452|NCT01712061|5751571|P1|Overall Study|Lost to Follow-up|1
1645453|NCT01712061|5751569|P3|Overall Study|Death|1
1645454|NCT01712061|5751570|P2|Overall Study|Death|0
1645455|NCT01712061|5751571|P1|Overall Study|Death|0
1645456|NCT01712061|5751569|P3|Overall Study|Adverse Event|5
1645457|NCT01712061|5751570|P2|Overall Study|Adverse Event|9
1645458|NCT01712061|5751571|P1|Overall Study|Adverse Event|4
1645459|NCT01712009|5751611|P3|Overall Study|Decision by Sponsor|12
1645460|NCT01712009|5751612|P2|Overall Study|Decision by Sponsor|14
1645461|NCT01712009|5751613|P1|Overall Study|Decision by Sponsor|12
1645462|NCT01712009|5751611|P3|Overall Study|Lost to Follow-up|1
1645463|NCT01712009|5751612|P2|Overall Study|Lost to Follow-up|0
1645464|NCT01712009|5751613|P1|Overall Study|Lost to Follow-up|2
1645465|NCT01712009|5751611|P3|Overall Study|Withdrawal by Subject|8
1645466|NCT01712009|5751612|P2|Overall Study|Withdrawal by Subject|15
1645467|NCT01712009|5751613|P1|Overall Study|Withdrawal by Subject|24
1645468|NCT01711866|5751647|P1|Overall Study|Adverse Event|2
1645469|NCT01711866|5751647|P1|Overall Study|Withdrawal by Subject|3
1645470|NCT01711866|5751647|P1|Overall Study|Noncompliant|3
1645471|NCT01711853|5751652|P1|Overall Study|Not treated|3
1645472|NCT01711736|5751659|P2|Overall Study|Migrated/moved from study area|1
1645473|NCT01711736|5751660|P1|Overall Study|Migrated/moved from study area|2
1645474|NCT01711736|5751659|P2|Overall Study|Withdrawal by Subject|6
1645475|NCT01711736|5751660|P1|Overall Study|Withdrawal by Subject|6
1645476|NCT01711736|5751659|P2|Overall Study|Lost to Follow-up|1
1645477|NCT01711736|5751660|P1|Overall Study|Lost to Follow-up|4
1645478|NCT01711645|5751688|P1|Overall Study|Physician Decision|5
1645479|NCT01711645|5751688|P1|Overall Study|Lost to Follow-up|6
1645480|NCT01711645|5751688|P1|Overall Study|Withdrawal by Subject|8
1645481|NCT01711619|5751725|P2|Overall Study|Lost to Follow-up|0
1645482|NCT01711619|5751726|P1|Overall Study|Lost to Follow-up|1
1645483|NCT01711619|5751725|P2|Overall Study|Adverse Event|0
1645484|NCT01711619|5751726|P1|Overall Study|Adverse Event|2
1645485|NCT01711619|5751725|P2|Overall Study|Protocol Violation|3
1645486|NCT01711619|5751726|P1|Overall Study|Protocol Violation|2
1645487|NCT01711619|5751725|P2|Overall Study|Withdrawal by Subject|7
1645488|NCT01711619|5751726|P1|Overall Study|Withdrawal by Subject|3
1645489|NCT01711619|5751725|P2|Overall Study|Early study termination|14
1645490|NCT01711619|5751726|P1|Overall Study|Early study termination|10
1645491|NCT01711541|5751743|P5|Overall Study|Ineligible|0
1645492|NCT01711541|5751744|P4|Overall Study|Ineligible|0
1645493|NCT01711541|5751745|P3|Overall Study|Ineligible|0
1645494|NCT01711541|5751746|P2|Overall Study|Ineligible|1
1645495|NCT01711541|5751747|P1|Overall Study|Ineligible|0
1645496|NCT01711541|5751743|P5|Overall Study|Cancel prior to treatment|0
1645497|NCT01711541|5751744|P4|Overall Study|Cancel prior to treatment|1
1645498|NCT01711541|5751745|P3|Overall Study|Cancel prior to treatment|0
1645499|NCT01711541|5751746|P2|Overall Study|Cancel prior to treatment|0
1645500|NCT01711541|5751747|P1|Overall Study|Cancel prior to treatment|0
1645501|NCT01711359|5751796|P3|Treatment Period|Randomized, Not Treated|0
1645502|NCT01711359|5751797|P2|Treatment Period|Randomized, Not Treated|1
1645503|NCT01711359|5751798|P1|Treatment Period|Randomized, Not Treated|3
1645504|NCT01711359|5751796|P3|Treatment Period|Lost to Follow-up|1
1645505|NCT01711359|5751797|P2|Treatment Period|Lost to Follow-up|1
1645506|NCT01711359|5751798|P1|Treatment Period|Lost to Follow-up|1
1645507|NCT01711359|5751796|P3|Treatment Period|Sponsor Decision|0
1645508|NCT01711359|5751797|P2|Treatment Period|Sponsor Decision|0
1645509|NCT01711359|5751798|P1|Treatment Period|Sponsor Decision|1
1645510|NCT01711359|5751796|P3|Treatment Period|Entry Criteria Not Met|0
1645511|NCT01711359|5751797|P2|Treatment Period|Entry Criteria Not Met|0
1645512|NCT01711359|5751798|P1|Treatment Period|Entry Criteria Not Met|1
1645513|NCT01711359|5751796|P3|Treatment Period|Death|0
1645514|NCT01711359|5751797|P2|Treatment Period|Death|0
1645515|NCT01711359|5751798|P1|Treatment Period|Death|3
1645516|NCT01711359|5751796|P3|Treatment Period|Physician Decision|2
1645517|NCT01711359|5751797|P2|Treatment Period|Physician Decision|3
1645518|NCT01711359|5751798|P1|Treatment Period|Physician Decision|4
1645519|NCT01711359|5751796|P3|Treatment Period|Adverse Event|24
1645520|NCT01711359|5751797|P2|Treatment Period|Adverse Event|10
1645521|NCT01711359|5751798|P1|Treatment Period|Adverse Event|8
1645522|NCT01711359|5751796|P3|Treatment Period|Lack of Efficacy|2
1645523|NCT01711359|5751797|P2|Treatment Period|Lack of Efficacy|2
1645524|NCT01711359|5751798|P1|Treatment Period|Lack of Efficacy|13
1645525|NCT01711359|5751796|P3|Treatment Period|Withdrawal by Subject|13
1645526|NCT01711359|5751797|P2|Treatment Period|Withdrawal by Subject|7
1645527|NCT01711359|5751798|P1|Treatment Period|Withdrawal by Subject|18
1645528|NCT01711216|5751869|P1|Overall Study|no reason specified|22
1645529|NCT01711216|5751869|P1|Overall Study|variety of other minor reasons|83
1645530|NCT01711216|5751869|P1|Overall Study|Lost to Follow-up|46
1645531|NCT01711216|5751869|P1|Overall Study|Withdrawal by Subject|6
1645532|NCT01711216|5751869|P1|Overall Study|Pregnancy|56
1645533|NCT01711216|5751869|P1|Overall Study|Adverse Event|4
1645534|NCT01710800|5751947|P1|Overall Study|Protocol Violation|1
1645535|NCT01710800|5751947|P1|Overall Study|Withdrawal by Subject|21
1645536|NCT01710709|5752011|P1|Overall Study|Lack of Efficacy|3
1645537|NCT01710709|5752011|P1|Overall Study|Protocol Violation|5
1645538|NCT01710709|5752011|P1|Overall Study|Withdrawal by Subject|53
1645539|NCT01710709|5752011|P1|Overall Study|Participant withdrawn by investigator|2
1645540|NCT01710709|5752011|P1|Overall Study|Participant met withdrawal criteria|33
1645541|NCT01710709|5752011|P1|Overall Study|Adverse Event|48
1645542|NCT01710709|5752011|P1|Overall Study|Lost to Follow-up|29
1645543|NCT01710657|5752026|P3|Overall Study|Lack of Efficacy|1
1645544|NCT01710657|5752027|P2|Overall Study|Lack of Efficacy|1
1645545|NCT01710657|5752028|P1|Overall Study|Lack of Efficacy|0
1645546|NCT01710657|5752026|P3|Overall Study|Withdrawal by Subject|2
1645547|NCT01710657|5752027|P2|Overall Study|Withdrawal by Subject|1
1645548|NCT01710657|5752028|P1|Overall Study|Withdrawal by Subject|0
1645549|NCT01710657|5752026|P3|Overall Study|Adverse Event|28
1645550|NCT01710657|5752027|P2|Overall Study|Adverse Event|8
1645551|NCT01710657|5752028|P1|Overall Study|Adverse Event|14
1645552|NCT01710657|5752026|P3|Overall Study|Protocol Violation|0
1645553|NCT01710657|5752027|P2|Overall Study|Protocol Violation|2
1645554|NCT01710657|5752028|P1|Overall Study|Protocol Violation|2
1645555|NCT01710657|5752026|P3|Overall Study|Lost to Follow-up|1
1645556|NCT01710657|5752027|P2|Overall Study|Lost to Follow-up|0
1645557|NCT01710657|5752028|P1|Overall Study|Lost to Follow-up|2
1645558|NCT01710527|5752045|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
1645559|NCT01710527|5752046|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
1645560|NCT01710514|5752072|P2|Overall Study|Withdrawal by Subject|0
1645561|NCT01710514|5752073|P1|Overall Study|Withdrawal by Subject|1
1645562|NCT01710514|5752072|P2|Overall Study|Adverse Event|7
1645563|NCT01710514|5752073|P1|Overall Study|Adverse Event|6
1645564|NCT01710501|5752094|P3|Overall Study|Lost to Follow-up|0
1645565|NCT01710501|5752095|P2|Overall Study|Lost to Follow-up|0
1645566|NCT01710501|5752096|P1|Overall Study|Lost to Follow-up|2
1645567|NCT01710358|5752128|P3|Rescue Period|Withdrawal by Subject|0
1645568|NCT01710358|5752129|P2|Rescue Period|Withdrawal by Subject|8
1645569|NCT01710358|5752130|P1|Rescue Period|Withdrawal by Subject|0
1645570|NCT01710358|5752128|P3|Rescue Period|Lack of Efficacy|0
1645571|NCT01710358|5752129|P2|Rescue Period|Lack of Efficacy|7
1645572|NCT01710358|5752130|P1|Rescue Period|Lack of Efficacy|0
1645573|NCT01710358|5752128|P3|Rescue Period|Death|0
1645574|NCT01710358|5752129|P2|Rescue Period|Death|1
1645575|NCT01710358|5752130|P1|Rescue Period|Death|0
1645576|NCT01710358|5752128|P3|Rescue Period|Adverse Event|0
1645577|NCT01710358|5752129|P2|Rescue Period|Adverse Event|15
1645578|NCT01710358|5752130|P1|Rescue Period|Adverse Event|0
1645579|NCT01710358|5752128|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
1645580|NCT01710358|5752129|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
1645581|NCT01710358|5752130|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
1645582|NCT01710358|5752128|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
1645583|NCT01710358|5752129|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
1645584|NCT01710358|5752130|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
1645585|NCT01710358|5752128|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1645586|NCT01710358|5752129|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
1645587|NCT01710358|5752130|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
1645588|NCT01710358|5752128|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
1645589|NCT01710358|5752129|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1645590|NCT01710358|5752130|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
1645591|NCT01710358|5752128|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
1645592|NCT01710358|5752129|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1645593|NCT01710358|5752130|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
1645594|NCT01710358|5752128|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
1645595|NCT01710358|5752129|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
1645596|NCT01710358|5752130|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
1645597|NCT01710358|5752128|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
1645598|NCT01710358|5752129|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
1645599|NCT01710358|5752130|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
1645600|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
1645601|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1645602|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
1645603|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
1645604|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
1645605|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
1645606|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1645607|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
1645608|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
1645609|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1645610|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
1645611|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
1645612|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1645613|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
1645614|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
1645615|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
1645616|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
1645617|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
1645618|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1645619|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
1645620|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
1645621|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
1645622|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
1645623|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
1645624|NCT01710358|5752128|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
1645625|NCT01710358|5752129|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
1645626|NCT01710358|5752130|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
1645627|NCT01710345|5752201|P3|Overall Study|Drug Dosing Error|0
1645628|NCT01710345|5752202|P2|Overall Study|Drug Dosing Error|0
1645629|NCT01710345|5752203|P1|Overall Study|Drug Dosing Error|1
1645630|NCT01710345|5752201|P3|Overall Study|Lack of Efficacy|1
1645631|NCT01710345|5752202|P2|Overall Study|Lack of Efficacy|3
1645632|NCT01710345|5752203|P1|Overall Study|Lack of Efficacy|2
1645633|NCT01710345|5752201|P3|Overall Study|Adverse Event|0
1645634|NCT01710345|5752202|P2|Overall Study|Adverse Event|2
1645635|NCT01710345|5752203|P1|Overall Study|Adverse Event|0
1645636|NCT01710046|5752262|P2|Overall Study|Lost to Follow-up|0
1645637|NCT01710046|5752263|P1|Overall Study|Lost to Follow-up|1
1645638|NCT01710033|5752303|P5|Stage 2|Adverse Event|1
1645639|NCT01710033|5752304|P4|Stage 2|Adverse Event|0
1645640|NCT01710033|5752305|P3|Stage 2|Adverse Event|0
1645641|NCT01710033|5752306|P2|Stage 2|Adverse Event|0
1645642|NCT01710033|5752307|P1|Stage 2|Adverse Event|0
1645643|NCT01710020|5752388|P1|Period 1|Protocol Violation|1
1645644|NCT01709903|5752407|P2|Overall Study|Adverse Event|18
1645645|NCT01709903|5752408|P1|Overall Study|Adverse Event|11
1645646|NCT01709903|5752407|P2|Overall Study|Withdrawal by Subject|6
1645647|NCT01709903|5752408|P1|Overall Study|Withdrawal by Subject|6
1645648|NCT01709903|5752407|P2|Overall Study|Lack of Efficacy|3
1645649|NCT01709903|5752408|P1|Overall Study|Lack of Efficacy|3
1645650|NCT01709903|5752407|P2|Overall Study|Protocol Violation|2
1645651|NCT01709903|5752408|P1|Overall Study|Protocol Violation|3
1645652|NCT01709903|5752407|P2|Overall Study|Death|0
1645653|NCT01709903|5752408|P1|Overall Study|Death|2
1645654|NCT01709903|5752407|P2|Overall Study|Lost to Follow-up|2
1645655|NCT01709903|5752408|P1|Overall Study|Lost to Follow-up|0
1645656|NCT01709903|5752407|P2|Overall Study|no longer needed study drug|1
1645657|NCT01709903|5752408|P1|Overall Study|no longer needed study drug|0
1645658|NCT01709903|5752407|P2|Overall Study|In ability to use device|1
1645659|NCT01709903|5752408|P1|Overall Study|In ability to use device|1
1645660|NCT01709903|5752407|P2|Overall Study|Abnormal test procedure results|0
1645661|NCT01709903|5752408|P1|Overall Study|Abnormal test procedure results|1
1645662|NCT01709903|5752407|P2|Overall Study|administrative problems|6
1645663|NCT01709903|5752408|P1|Overall Study|administrative problems|2
1645664|NCT01709864|5752432|P2|Overall Study|Death|1
1645665|NCT01709864|5752433|P1|Overall Study|Death|0
1645666|NCT01709864|5752432|P2|Overall Study|Adverse Event|2
1645667|NCT01709864|5752433|P1|Overall Study|Adverse Event|0
1645668|NCT01709864|5752432|P2|Overall Study|non-compliance with study treatment|1
1645669|NCT01709864|5752433|P1|Overall Study|non-compliance with study treatment|1
1645670|NCT01709864|5752432|P2|Overall Study|Lost to Follow-up|0
1645671|NCT01709864|5752433|P1|Overall Study|Lost to Follow-up|1
1645672|NCT01709864|5752432|P2|Overall Study|subject/guardian decision|6
1645673|NCT01709864|5752433|P1|Overall Study|subject/guardian decision|5
1645674|NCT01709864|5752432|P2|Overall Study|Physician Decision|1
1645675|NCT01709864|5752433|P1|Overall Study|Physician Decision|0
1645676|NCT01709838|5752467|P1|Overall Study|Protocol Violation|1
1645677|NCT01709838|5752467|P1|Overall Study|Death|3
1645678|NCT01709838|5752467|P1|Overall Study|Physician Decision|4
1645679|NCT01709838|5752467|P1|Overall Study|Adverse Event|4
1645680|NCT01709838|5752467|P1|Overall Study|Subject/guardian decision|8
1645681|NCT01709838|5752467|P1|Overall Study|Pregnancy|10
1645682|NCT01709838|5752467|P1|Overall Study|Lost to Follow-up|16
1645683|NCT01709838|5752467|P1|Overall Study|Withdrawal by Subject|21
1645684|NCT01709708|5752524|P2|Overall Study|Protocol Violation|2
1645685|NCT01709708|5752525|P1|Overall Study|Protocol Violation|1
1645686|NCT01709695|5752549|P2|Overall Study|Withdrawal by Subject|1
1645687|NCT01709695|5752550|P1|Overall Study|Withdrawal by Subject|1
1645688|NCT01709578|5752575|P3|Overall Study|Other, not related to safety or efficacy|5
1645689|NCT01709578|5752576|P2|Overall Study|Other, not related to safety or efficacy|7
1645690|NCT01709578|5752577|P1|Overall Study|Other, not related to safety or efficacy|2
1645691|NCT01709578|5752575|P3|Overall Study|Poor compliance to protocol|1
1645692|NCT01709578|5752576|P2|Overall Study|Poor compliance to protocol|2
1645693|NCT01709578|5752577|P1|Overall Study|Poor compliance to protocol|1
1645694|NCT01709578|5752575|P3|Overall Study|Lack of Efficacy|2
1645695|NCT01709578|5752576|P2|Overall Study|Lack of Efficacy|4
1645696|NCT01709578|5752577|P1|Overall Study|Lack of Efficacy|5
1645697|NCT01709578|5752575|P3|Overall Study|Adverse Event|17
1645698|NCT01709578|5752576|P2|Overall Study|Adverse Event|18
1645699|NCT01709578|5752577|P1|Overall Study|Adverse Event|9
1645700|NCT01709578|5752575|P3|Overall Study|Rescued and entered in long term safety|26
1645701|NCT01709578|5752576|P2|Overall Study|Rescued and entered in long term safety|25
1645702|NCT01709578|5752577|P1|Overall Study|Rescued and entered in long term safety|63
1645703|NCT01709513|5752708|P3|Overall Study|Other|7
1645704|NCT01709513|5752709|P2|Overall Study|Other|11
1645705|NCT01709513|5752710|P1|Overall Study|Other|3
1645706|NCT01709513|5752708|P3|Overall Study|Poor compliance to protocol|0
1645707|NCT01709513|5752709|P2|Overall Study|Poor compliance to protocol|0
1645708|NCT01709513|5752710|P1|Overall Study|Poor compliance to protocol|2
1645709|NCT01709513|5752708|P3|Overall Study|Adverse Event|23
1645710|NCT01709513|5752709|P2|Overall Study|Adverse Event|31
1645711|NCT01709513|5752710|P1|Overall Study|Adverse Event|16
1645712|NCT01709513|5752708|P3|Overall Study|Randomized but not treated|0
1645713|NCT01709513|5752709|P2|Overall Study|Randomized but not treated|1
1645714|NCT01709513|5752710|P1|Overall Study|Randomized but not treated|0
1645715|NCT01709500|5752771|P2|Overall Study|Treatment ongoing|78
1645716|NCT01709500|5752772|P1|Overall Study|Treatment ongoing|156
1645717|NCT01709500|5752771|P2|Overall Study|Related to IMP administration|0
1645718|NCT01709500|5752772|P1|Overall Study|Related to IMP administration|1
1645719|NCT01709500|5752771|P2|Overall Study|Other|1
1645720|NCT01709500|5752772|P1|Overall Study|Other|3
1645721|NCT01709500|5752771|P2|Overall Study|Poor compliance to protocol|1
1645722|NCT01709500|5752772|P1|Overall Study|Poor compliance to protocol|2
1645723|NCT01709500|5752771|P2|Overall Study|Adverse Event|1
1645724|NCT01709500|5752772|P1|Overall Study|Adverse Event|5
1645725|NCT01709500|5752771|P2|Overall Study|Randomized but not treated|1
1645726|NCT01709500|5752772|P1|Overall Study|Randomized but not treated|0
1645727|NCT01709409|5752850|P2|Overall Study|Protocol Violation|0
1645728|NCT01709409|5752851|P1|Overall Study|Protocol Violation|1
1645729|NCT01709383|5752859|P2|Overall Study|Lost to Follow-up|0
1645730|NCT01709383|5752860|P1|Overall Study|Lost to Follow-up|1
1645731|NCT01709331|5752878|P1|Overall Study|Adverse Event|1
1645732|NCT01709318|5752891|P7|Overall Study|Other Protocol Specified Criteria|0
1645733|NCT01709318|5752892|P6|Overall Study|Other Protocol Specified Criteria|0
1645734|NCT01709318|5752893|P5|Overall Study|Other Protocol Specified Criteria|0
1645735|NCT01709318|5752894|P4|Overall Study|Other Protocol Specified Criteria|0
1645736|NCT01709318|5752895|P3|Overall Study|Other Protocol Specified Criteria|0
1645737|NCT01709318|5752896|P2|Overall Study|Other Protocol Specified Criteria|1
1645738|NCT01709318|5752897|P1|Overall Study|Other Protocol Specified Criteria|0
1645739|NCT01709318|5752891|P7|Overall Study|Withdrawal by Subject|4
1645740|NCT01709318|5752892|P6|Overall Study|Withdrawal by Subject|2
1645741|NCT01709318|5752893|P5|Overall Study|Withdrawal by Subject|0
1645742|NCT01709318|5752894|P4|Overall Study|Withdrawal by Subject|3
1645743|NCT01709318|5752895|P3|Overall Study|Withdrawal by Subject|3
1645744|NCT01709318|5752896|P2|Overall Study|Withdrawal by Subject|0
1645745|NCT01709318|5752897|P1|Overall Study|Withdrawal by Subject|3
1645746|NCT01709318|5752891|P7|Overall Study|Technical Problems|0
1645747|NCT01709318|5752892|P6|Overall Study|Technical Problems|0
1645748|NCT01709318|5752893|P5|Overall Study|Technical Problems|0
1645749|NCT01709318|5752894|P4|Overall Study|Technical Problems|0
1645750|NCT01709318|5752895|P3|Overall Study|Technical Problems|0
1645751|NCT01709318|5752896|P2|Overall Study|Technical Problems|0
1645752|NCT01709318|5752897|P1|Overall Study|Technical Problems|1
1645753|NCT01709318|5752891|P7|Overall Study|Protocol Violation|1
1645754|NCT01709318|5752892|P6|Overall Study|Protocol Violation|0
1645755|NCT01709318|5752893|P5|Overall Study|Protocol Violation|2
1645756|NCT01709318|5752894|P4|Overall Study|Protocol Violation|0
1645757|NCT01709318|5752895|P3|Overall Study|Protocol Violation|0
1645758|NCT01709318|5752896|P2|Overall Study|Protocol Violation|0
1645759|NCT01709318|5752897|P1|Overall Study|Protocol Violation|0
1645760|NCT01709318|5752891|P7|Overall Study|Pregnancy|0
1645761|NCT01709318|5752892|P6|Overall Study|Pregnancy|0
1645762|NCT01709318|5752893|P5|Overall Study|Pregnancy|1
1645763|NCT01709318|5752894|P4|Overall Study|Pregnancy|0
1645764|NCT01709318|5752895|P3|Overall Study|Pregnancy|0
1645765|NCT01709318|5752896|P2|Overall Study|Pregnancy|0
1645766|NCT01709318|5752897|P1|Overall Study|Pregnancy|0
1645767|NCT01709318|5752891|P7|Overall Study|Physician Decision|1
1645768|NCT01709318|5752892|P6|Overall Study|Physician Decision|0
1645769|NCT01709318|5752893|P5|Overall Study|Physician Decision|0
1645770|NCT01709318|5752894|P4|Overall Study|Physician Decision|0
1645771|NCT01709318|5752895|P3|Overall Study|Physician Decision|0
1645772|NCT01709318|5752896|P2|Overall Study|Physician Decision|0
1645773|NCT01709318|5752897|P1|Overall Study|Physician Decision|0
1645774|NCT01709318|5752891|P7|Overall Study|Non-compliance with Study Drug|2
1645775|NCT01709318|5752892|P6|Overall Study|Non-compliance with Study Drug|0
1645776|NCT01709318|5752893|P5|Overall Study|Non-compliance with Study Drug|0
1645777|NCT01709318|5752894|P4|Overall Study|Non-compliance with Study Drug|1
1645778|NCT01709318|5752895|P3|Overall Study|Non-compliance with Study Drug|1
1645779|NCT01709318|5752896|P2|Overall Study|Non-compliance with Study Drug|2
1645780|NCT01709318|5752897|P1|Overall Study|Non-compliance with Study Drug|0
1645781|NCT01709318|5752891|P7|Overall Study|Lost to Follow-up|1
1645782|NCT01709318|5752892|P6|Overall Study|Lost to Follow-up|1
1645783|NCT01709318|5752893|P5|Overall Study|Lost to Follow-up|1
1645784|NCT01709318|5752894|P4|Overall Study|Lost to Follow-up|0
1645785|NCT01709318|5752895|P3|Overall Study|Lost to Follow-up|0
1645786|NCT01709318|5752896|P2|Overall Study|Lost to Follow-up|0
1645787|NCT01709318|5752897|P1|Overall Study|Lost to Follow-up|2
1645788|NCT01709318|5752891|P7|Overall Study|Adverse Event|2
1645789|NCT01709318|5752892|P6|Overall Study|Adverse Event|1
1645790|NCT01709318|5752893|P5|Overall Study|Adverse Event|0
1645791|NCT01709318|5752894|P4|Overall Study|Adverse Event|2
1645792|NCT01709318|5752895|P3|Overall Study|Adverse Event|2
1645793|NCT01709318|5752896|P2|Overall Study|Adverse Event|4
1645794|NCT01709318|5752897|P1|Overall Study|Adverse Event|3
1645795|NCT01709305|5752990|P5|Phase 2|Withdrawal by Subject|12
1645796|NCT01709305|5752991|P4|Phase 2|Withdrawal by Subject|15
1645797|NCT01709305|5752992|P3|Phase 2|Withdrawal by Subject|6
1645798|NCT01709305|5752993|P2|Phase 2|Withdrawal by Subject|8
1645799|NCT01709305|5752994|P1|Phase 2|Withdrawal by Subject|0
1645800|NCT01709305|5752990|P5|Phase 2|Protocol Violation|9
1645801|NCT01709305|5752991|P4|Phase 2|Protocol Violation|13
1645802|NCT01709305|5752992|P3|Phase 2|Protocol Violation|19
1645803|NCT01709305|5752993|P2|Phase 2|Protocol Violation|19
1645804|NCT01709305|5752994|P1|Phase 2|Protocol Violation|0
1645805|NCT01709305|5752990|P5|Phase 2|Physician Decision|2
1645806|NCT01709305|5752991|P4|Phase 2|Physician Decision|1
1645807|NCT01709305|5752992|P3|Phase 2|Physician Decision|0
1645808|NCT01709305|5752993|P2|Phase 2|Physician Decision|2
1645809|NCT01709305|5752994|P1|Phase 2|Physician Decision|0
1645810|NCT01709305|5752990|P5|Phase 2|Travel, moving, etc.|5
1645811|NCT01709305|5752991|P4|Phase 2|Travel, moving, etc.|3
1645812|NCT01709305|5752992|P3|Phase 2|Travel, moving, etc.|3
1645813|NCT01709305|5752993|P2|Phase 2|Travel, moving, etc.|2
1645814|NCT01709305|5752994|P1|Phase 2|Travel, moving, etc.|0
1645815|NCT01709305|5752990|P5|Phase 2|Lost to Follow-up|5
1645816|NCT01709305|5752991|P4|Phase 2|Lost to Follow-up|9
1645817|NCT01709305|5752992|P3|Phase 2|Lost to Follow-up|6
1645818|NCT01709305|5752993|P2|Phase 2|Lost to Follow-up|10
1645819|NCT01709305|5752994|P1|Phase 2|Lost to Follow-up|0
1645820|NCT01709305|5752990|P5|Phase 2|Laboratory Adverse Event|1
1645821|NCT01709305|5752991|P4|Phase 2|Laboratory Adverse Event|1
1645822|NCT01709305|5752992|P3|Phase 2|Laboratory Adverse Event|0
1645823|NCT01709305|5752993|P2|Phase 2|Laboratory Adverse Event|1
1645824|NCT01709305|5752994|P1|Phase 2|Laboratory Adverse Event|0
1645825|NCT01709305|5752990|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
1645826|NCT01709305|5752991|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
1645827|NCT01709305|5752992|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
1645828|NCT01709305|5752993|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
1645829|NCT01709305|5752994|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
1645830|NCT01709305|5752990|P5|Phase 2|Death|0
1645831|NCT01709305|5752991|P4|Phase 2|Death|0
1645832|NCT01709305|5752992|P3|Phase 2|Death|1
1645833|NCT01709305|5752993|P2|Phase 2|Death|0
1645834|NCT01709305|5752994|P1|Phase 2|Death|0
1645835|NCT01709305|5752990|P5|Phase 2|Clinical Adverse Event|11
1645836|NCT01709305|5752991|P4|Phase 2|Clinical Adverse Event|6
1645837|NCT01709305|5752992|P3|Phase 2|Clinical Adverse Event|10
1645838|NCT01709305|5752993|P2|Phase 2|Clinical Adverse Event|10
1645839|NCT01709305|5752994|P1|Phase 2|Clinical Adverse Event|0
1645840|NCT01709305|5752990|P5|Phase 1|Withdrawal by Subject|0
1645841|NCT01709305|5752991|P4|Phase 1|Withdrawal by Subject|0
1645842|NCT01709305|5752992|P3|Phase 1|Withdrawal by Subject|0
1645843|NCT01709305|5752993|P2|Phase 1|Withdrawal by Subject|0
1645844|NCT01709305|5752994|P1|Phase 1|Withdrawal by Subject|218
1645845|NCT01709305|5752990|P5|Phase 1|Protocol Violation|0
1645846|NCT01709305|5752991|P4|Phase 1|Protocol Violation|0
1645847|NCT01709305|5752992|P3|Phase 1|Protocol Violation|0
1645848|NCT01709305|5752993|P2|Phase 1|Protocol Violation|0
1645849|NCT01709305|5752994|P1|Phase 1|Protocol Violation|118
1645850|NCT01709305|5752990|P5|Phase 1|Physician Decision|0
1645851|NCT01709305|5752991|P4|Phase 1|Physician Decision|0
1645852|NCT01709305|5752992|P3|Phase 1|Physician Decision|0
1645853|NCT01709305|5752993|P2|Phase 1|Physician Decision|0
1645854|NCT01709305|5752994|P1|Phase 1|Physician Decision|13
1645855|NCT01709305|5752990|P5|Phase 1|Travel, moving, etc.|0
1645856|NCT01709305|5752991|P4|Phase 1|Travel, moving, etc.|0
1645857|NCT01709305|5752992|P3|Phase 1|Travel, moving, etc.|0
1645858|NCT01709305|5752993|P2|Phase 1|Travel, moving, etc.|0
1645859|NCT01709305|5752994|P1|Phase 1|Travel, moving, etc.|30
1645860|NCT01709305|5752990|P5|Phase 1|Lost to Follow-up|0
1645861|NCT01709305|5752991|P4|Phase 1|Lost to Follow-up|0
1645862|NCT01709305|5752992|P3|Phase 1|Lost to Follow-up|0
1645863|NCT01709305|5752993|P2|Phase 1|Lost to Follow-up|0
1645864|NCT01709305|5752994|P1|Phase 1|Lost to Follow-up|147
1645865|NCT01709305|5752990|P5|Phase 1|Laboratory Adverse Event|0
1645866|NCT01709305|5752991|P4|Phase 1|Laboratory Adverse Event|0
1645867|NCT01709305|5752992|P3|Phase 1|Laboratory Adverse Event|0
1645868|NCT01709305|5752993|P2|Phase 1|Laboratory Adverse Event|0
1645869|NCT01709305|5752994|P1|Phase 1|Laboratory Adverse Event|16
1645870|NCT01709305|5752990|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
1645871|NCT01709305|5752991|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
1645872|NCT01709305|5752992|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
1645873|NCT01709305|5752993|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
1645874|NCT01709305|5752994|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
1645875|NCT01709305|5752990|P5|Phase 1|Death|0
1645876|NCT01709305|5752991|P4|Phase 1|Death|0
1645877|NCT01709305|5752992|P3|Phase 1|Death|0
1645878|NCT01709305|5752993|P2|Phase 1|Death|0
1645879|NCT01709305|5752994|P1|Phase 1|Death|2
1645880|NCT01709305|5752990|P5|Phase 1|Clinical Adverse Event|0
1645881|NCT01709305|5752991|P4|Phase 1|Clinical Adverse Event|0
1645882|NCT01709305|5752992|P3|Phase 1|Clinical Adverse Event|0
1645883|NCT01709305|5752993|P2|Phase 1|Clinical Adverse Event|0
1645884|NCT01709305|5752994|P1|Phase 1|Clinical Adverse Event|80
1645885|NCT01709227|5753031|P2|Overall Study|Pleural Peritoneal communication|9
1645886|NCT01709227|5753032|P1|Overall Study|Pleural Peritoneal communication|0
1645887|NCT01709227|5753031|P2|Overall Study|Physician Decision|0
1645888|NCT01709227|5753032|P1|Overall Study|Physician Decision|1
1645889|NCT01709162|5753058|P2|Overall Study|Withdrawal by Subject|1
1645890|NCT01709162|5753059|P1|Overall Study|Withdrawal by Subject|0
1645891|NCT01709162|5753058|P2|Overall Study|Other|0
1645892|NCT01709162|5753059|P1|Overall Study|Other|1
1645893|NCT01709162|5753058|P2|Overall Study|Administrative reason by sponsor|1
1645894|NCT01709162|5753059|P1|Overall Study|Administrative reason by sponsor|0
1645895|NCT01709162|5753058|P2|Overall Study|Study drug toxicity|0
1645896|NCT01709162|5753059|P1|Overall Study|Study drug toxicity|2
1645897|NCT01709162|5753058|P2|Overall Study|Disease progression|3
1645898|NCT01709162|5753059|P1|Overall Study|Disease progression|3
1645899|NCT01709110|5753080|P2|Overall Study|Caregiver Decision|1
1645900|NCT01709110|5753081|P1|Overall Study|Caregiver Decision|1
1645901|NCT01709110|5753080|P2|Overall Study|Lack of Efficacy|1
1645902|NCT01709110|5753081|P1|Overall Study|Lack of Efficacy|1
1645903|NCT01709110|5753080|P2|Overall Study|Sponsor Decision|2
1645904|NCT01709110|5753081|P1|Overall Study|Sponsor Decision|2
1645905|NCT01709110|5753080|P2|Overall Study|Physician Decision|10
1645906|NCT01709110|5753081|P1|Overall Study|Physician Decision|4
1645907|NCT01709110|5753080|P2|Overall Study|Withdrawal by Subject|89
1645908|NCT01709110|5753081|P1|Overall Study|Withdrawal by Subject|96
1645909|NCT01709110|5753080|P2|Overall Study|Protocol Violation|6
1645910|NCT01709110|5753081|P1|Overall Study|Protocol Violation|4
1645911|NCT01709110|5753080|P2|Overall Study|Lost to Follow-up|5
1645912|NCT01709110|5753081|P1|Overall Study|Lost to Follow-up|7
1645913|NCT01709110|5753080|P2|Overall Study|Death|6
1645914|NCT01709110|5753081|P1|Overall Study|Death|14
1645915|NCT01709110|5753080|P2|Overall Study|Adverse Event|48
1645916|NCT01709110|5753081|P1|Overall Study|Adverse Event|56
1645917|NCT01709084|5753111|P2|Overall Study|Not Treated|2
1645918|NCT01709084|5753112|P1|Overall Study|Not Treated|0
1645919|NCT01709084|5753111|P2|Overall Study|Participant Reached a Virologic Endpoint|1
1645920|NCT01709084|5753112|P1|Overall Study|Participant Reached a Virologic Endpoint|0
1645921|NCT01709084|5753111|P2|Overall Study|Other|3
1645922|NCT01709084|5753112|P1|Overall Study|Other|5
1645923|NCT01709084|5753111|P2|Overall Study|Adverse Event|0
1645924|NCT01709084|5753112|P1|Overall Study|Adverse Event|5
1645925|NCT01709084|5753111|P2|Overall Study|Withdrawal by Subject|2
1645926|NCT01709084|5753112|P1|Overall Study|Withdrawal by Subject|2
1645927|NCT01709084|5753111|P2|Overall Study|Lost to Follow-up|7
1645928|NCT01709084|5753112|P1|Overall Study|Lost to Follow-up|4
1645929|NCT01708954|5753145|P3|Step 2|Withdrawal by Subject|0
1645930|NCT01708954|5753146|P2|Step 2|Withdrawal by Subject|1
1645931|NCT01708954|5753147|P1|Step 2|Withdrawal by Subject|1
1645932|NCT01708954|5753145|P3|Step 2|Adverse Event|0
1645933|NCT01708954|5753146|P2|Step 2|Adverse Event|2
1645934|NCT01708954|5753147|P1|Step 2|Adverse Event|3
1645935|NCT01708954|5753145|P3|Step 2|Disease progression|0
1645936|NCT01708954|5753146|P2|Step 2|Disease progression|4
1645937|NCT01708954|5753147|P1|Step 2|Disease progression|9
1645938|NCT01708954|5753145|P3|Step 1|Ineligible or never received treatment|8
1645939|NCT01708954|5753146|P2|Step 1|Ineligible or never received treatment|2
1645940|NCT01708954|5753147|P1|Step 1|Ineligible or never received treatment|4
1645941|NCT01708954|5753145|P3|Step 1|Off-treatment reason not submitted|1
1645942|NCT01708954|5753146|P2|Step 1|Off-treatment reason not submitted|1
1645943|NCT01708954|5753147|P1|Step 1|Off-treatment reason not submitted|1
1645944|NCT01708954|5753145|P3|Step 1|Symptomatic deterioration|1
1645945|NCT01708954|5753146|P2|Step 1|Symptomatic deterioration|0
1645946|NCT01708954|5753147|P1|Step 1|Symptomatic deterioration|1
1645947|NCT01708954|5753145|P3|Step 1|Crossed over to Step 2|0
1645948|NCT01708954|5753146|P2|Step 1|Crossed over to Step 2|0
1645949|NCT01708954|5753147|P1|Step 1|Crossed over to Step 2|2
1645950|NCT01708954|5753145|P3|Step 1|Other complicating disease|0
1645951|NCT01708954|5753146|P2|Step 1|Other complicating disease|2
1645952|NCT01708954|5753147|P1|Step 1|Other complicating disease|0
1645953|NCT01708954|5753145|P3|Step 1|Withdrawal by Subject|3
1645954|NCT01708954|5753146|P2|Step 1|Withdrawal by Subject|5
1645955|NCT01708954|5753147|P1|Step 1|Withdrawal by Subject|2
1645956|NCT01708954|5753145|P3|Step 1|Death|3
1645957|NCT01708954|5753146|P2|Step 1|Death|2
1645958|NCT01708954|5753147|P1|Step 1|Death|3
1645959|NCT01708954|5753145|P3|Step 1|Adverse Event|13
1645960|NCT01708954|5753146|P2|Step 1|Adverse Event|11
1645961|NCT01708954|5753147|P1|Step 1|Adverse Event|3
1645962|NCT01708954|5753145|P3|Step 1|Disease progression|14
1645963|NCT01708954|5753146|P2|Step 1|Disease progression|17
1645964|NCT01708954|5753147|P1|Step 1|Disease progression|26
1645965|NCT01708941|5753172|P4|Overall Study|Ineligible|0
1645966|NCT01708941|5753173|P3|Overall Study|Ineligible|2
1645967|NCT01708941|5753174|P2|Overall Study|Ineligible|0
1645968|NCT01708941|5753175|P1|Overall Study|Ineligible|0
1645969|NCT01708941|5753172|P4|Overall Study|Never started treatment|0
1645970|NCT01708941|5753173|P3|Overall Study|Never started treatment|0
1645971|NCT01708941|5753174|P2|Overall Study|Never started treatment|1
1645972|NCT01708941|5753175|P1|Overall Study|Never started treatment|2
1645973|NCT01708941|5753172|P4|Overall Study|Ineligible and never started treatment|0
1645974|NCT01708941|5753173|P3|Overall Study|Ineligible and never started treatment|1
1645975|NCT01708941|5753174|P2|Overall Study|Ineligible and never started treatment|0
1645976|NCT01708941|5753175|P1|Overall Study|Ineligible and never started treatment|1
1645977|NCT01708941|5753172|P4|Overall Study|Alternative therapy|0
1645978|NCT01708941|5753173|P3|Overall Study|Alternative therapy|2
1645979|NCT01708941|5753174|P2|Overall Study|Alternative therapy|0
1645980|NCT01708941|5753175|P1|Overall Study|Alternative therapy|0
1645981|NCT01708941|5753172|P4|Overall Study|Disease progression|0
1645982|NCT01708941|5753173|P3|Overall Study|Disease progression|8
1645983|NCT01708941|5753174|P2|Overall Study|Disease progression|10
1645984|NCT01708941|5753175|P1|Overall Study|Disease progression|9
1645985|NCT01708941|5753172|P4|Overall Study|Withdrawal by Subject|4
1645986|NCT01708941|5753173|P3|Overall Study|Withdrawal by Subject|3
1645987|NCT01708941|5753174|P2|Overall Study|Withdrawal by Subject|0
1645988|NCT01708941|5753175|P1|Overall Study|Withdrawal by Subject|1
1645989|NCT01708941|5753172|P4|Overall Study|Death|14
1645990|NCT01708941|5753173|P3|Overall Study|Death|2
1645991|NCT01708941|5753174|P2|Overall Study|Death|1
1645992|NCT01708941|5753175|P1|Overall Study|Death|1
1645993|NCT01708941|5753172|P4|Overall Study|Adverse Event|0
1645994|NCT01708941|5753173|P3|Overall Study|Adverse Event|1
1645995|NCT01708941|5753174|P2|Overall Study|Adverse Event|6
1645996|NCT01708941|5753175|P1|Overall Study|Adverse Event|4
1645997|NCT01708915|5753193|P4|Overall Study|Other reasons than stated above|2
1645998|NCT01708915|5753194|P3|Overall Study|Other reasons than stated above|0
1645999|NCT01708915|5753195|P2|Overall Study|Other reasons than stated above|1
1646000|NCT01708915|5753196|P1|Overall Study|Other reasons than stated above|1
1646001|NCT01708915|5753193|P4|Overall Study|Withdrawal by Subject|2
1646002|NCT01708915|5753194|P3|Overall Study|Withdrawal by Subject|2
1646003|NCT01708915|5753195|P2|Overall Study|Withdrawal by Subject|1
1646004|NCT01708915|5753196|P1|Overall Study|Withdrawal by Subject|0
1646005|NCT01708915|5753193|P4|Overall Study|Protocol Violation|1
1646006|NCT01708915|5753194|P3|Overall Study|Protocol Violation|0
1646007|NCT01708915|5753195|P2|Overall Study|Protocol Violation|0
1646008|NCT01708915|5753196|P1|Overall Study|Protocol Violation|0
1646009|NCT01708915|5753193|P4|Overall Study|Lack of Efficacy|15
1646010|NCT01708915|5753194|P3|Overall Study|Lack of Efficacy|35
1646011|NCT01708915|5753195|P2|Overall Study|Lack of Efficacy|60
1646012|NCT01708915|5753196|P1|Overall Study|Lack of Efficacy|84
1646013|NCT01708915|5753193|P4|Overall Study|Adverse Event|13
1646014|NCT01708915|5753194|P3|Overall Study|Adverse Event|9
1646015|NCT01708915|5753195|P2|Overall Study|Adverse Event|0
1646016|NCT01708915|5753196|P1|Overall Study|Adverse Event|1
1646017|NCT01708902|5753225|P7|Overall Study|Other Reason|0
1646018|NCT01708902|5753226|P6|Overall Study|Other Reason|2
1646019|NCT01708902|5753227|P5|Overall Study|Other Reason|1
1646020|NCT01708902|5753228|P4|Overall Study|Other Reason|1
1646021|NCT01708902|5753229|P3|Overall Study|Other Reason|1
1646022|NCT01708902|5753230|P2|Overall Study|Other Reason|0
1646023|NCT01708902|5753231|P1|Overall Study|Other Reason|1
1646024|NCT01708902|5753225|P7|Overall Study|Refused to continue trial medication|1
1646025|NCT01708902|5753226|P6|Overall Study|Refused to continue trial medication|1
1646026|NCT01708902|5753227|P5|Overall Study|Refused to continue trial medication|8
1646027|NCT01708902|5753228|P4|Overall Study|Refused to continue trial medication|2
1646028|NCT01708902|5753229|P3|Overall Study|Refused to continue trial medication|4
1646029|NCT01708902|5753230|P2|Overall Study|Refused to continue trial medication|0
1646030|NCT01708902|5753231|P1|Overall Study|Refused to continue trial medication|8
1646031|NCT01708902|5753225|P7|Overall Study|Lost to Follow-up|1
1646032|NCT01708902|5753226|P6|Overall Study|Lost to Follow-up|0
1646033|NCT01708902|5753227|P5|Overall Study|Lost to Follow-up|0
1646034|NCT01708902|5753228|P4|Overall Study|Lost to Follow-up|2
1646035|NCT01708902|5753229|P3|Overall Study|Lost to Follow-up|2
1646036|NCT01708902|5753230|P2|Overall Study|Lost to Follow-up|1
1646037|NCT01708902|5753231|P1|Overall Study|Lost to Follow-up|2
1646038|NCT01708902|5753225|P7|Overall Study|Non compliance with protocol|0
1646039|NCT01708902|5753226|P6|Overall Study|Non compliance with protocol|0
1646040|NCT01708902|5753227|P5|Overall Study|Non compliance with protocol|0
1646041|NCT01708902|5753228|P4|Overall Study|Non compliance with protocol|3
1646042|NCT01708902|5753229|P3|Overall Study|Non compliance with protocol|1
1646043|NCT01708902|5753230|P2|Overall Study|Non compliance with protocol|2
1646044|NCT01708902|5753231|P1|Overall Study|Non compliance with protocol|0
1646045|NCT01708902|5753225|P7|Overall Study|Lack of Efficacy|0
1646046|NCT01708902|5753226|P6|Overall Study|Lack of Efficacy|1
1646047|NCT01708902|5753227|P5|Overall Study|Lack of Efficacy|0
1646048|NCT01708902|5753228|P4|Overall Study|Lack of Efficacy|0
1646049|NCT01708902|5753229|P3|Overall Study|Lack of Efficacy|0
1646050|NCT01708902|5753230|P2|Overall Study|Lack of Efficacy|1
1646051|NCT01708902|5753231|P1|Overall Study|Lack of Efficacy|3
1646052|NCT01708902|5753225|P7|Overall Study|Adverse Event|5
1646053|NCT01708902|5753226|P6|Overall Study|Adverse Event|3
1646054|NCT01708902|5753227|P5|Overall Study|Adverse Event|7
1646055|NCT01708902|5753228|P4|Overall Study|Adverse Event|2
1646056|NCT01708902|5753229|P3|Overall Study|Adverse Event|9
1646057|NCT01708902|5753230|P2|Overall Study|Adverse Event|4
1646058|NCT01708902|5753231|P1|Overall Study|Adverse Event|3
1646059|NCT01708291|5753373|P2|Overall Study|fighting|1
1646060|NCT01708291|5753374|P1|Overall Study|fighting|2
1646061|NCT01708187|5753413|P2|Overall Study|Lost to Follow-up|1
1646062|NCT01708187|5753414|P1|Overall Study|Lost to Follow-up|0
1646063|NCT01708174|5753423|P3|Treatment Period|Adverse Event|0
1646064|NCT01708174|5753424|P2|Treatment Period|Adverse Event|1
1646065|NCT01708174|5753425|P1|Treatment Period|Adverse Event|0
1646066|NCT01708174|5753423|P3|Treatment Period|Death|1
1646067|NCT01708174|5753424|P2|Treatment Period|Death|0
1646068|NCT01708174|5753425|P1|Treatment Period|Death|0
1646069|NCT01708174|5753423|P3|Treatment Period|Progressive disease|0
1646070|NCT01708174|5753424|P2|Treatment Period|Progressive disease|1
1646071|NCT01708174|5753425|P1|Treatment Period|Progressive disease|0
1646072|NCT01708174|5753423|P3|Treatment Period|Withdrawal by Subject|0
1646073|NCT01708174|5753424|P2|Treatment Period|Withdrawal by Subject|0
1646074|NCT01708174|5753425|P1|Treatment Period|Withdrawal by Subject|1
1646075|NCT01708161|5753457|P6|Overall Study|Disease progression|0
1646076|NCT01708161|5753458|P5|Overall Study|Disease progression|3
1646077|NCT01708161|5753459|P4|Overall Study|Disease progression|13
1646078|NCT01708161|5753460|P3|Overall Study|Disease progression|5
1646079|NCT01708161|5753461|P2|Overall Study|Disease progression|5
1646080|NCT01708161|5753462|P1|Overall Study|Disease progression|3
1646081|NCT01708161|5753457|P6|Overall Study|Administrative problems|0
1646082|NCT01708161|5753458|P5|Overall Study|Administrative problems|0
1646083|NCT01708161|5753459|P4|Overall Study|Administrative problems|0
1646084|NCT01708161|5753460|P3|Overall Study|Administrative problems|0
1646085|NCT01708161|5753461|P2|Overall Study|Administrative problems|1
1646086|NCT01708161|5753462|P1|Overall Study|Administrative problems|0
1646087|NCT01708161|5753457|P6|Overall Study|Withdrawal by Subject|0
1646088|NCT01708161|5753458|P5|Overall Study|Withdrawal by Subject|0
1646089|NCT01708161|5753459|P4|Overall Study|Withdrawal by Subject|0
1646090|NCT01708161|5753460|P3|Overall Study|Withdrawal by Subject|1
1646091|NCT01708161|5753461|P2|Overall Study|Withdrawal by Subject|1
1646092|NCT01708161|5753462|P1|Overall Study|Withdrawal by Subject|0
1646093|NCT01708161|5753457|P6|Overall Study|Death|1
1646094|NCT01708161|5753458|P5|Overall Study|Death|0
1646095|NCT01708161|5753459|P4|Overall Study|Death|1
1646096|NCT01708161|5753460|P3|Overall Study|Death|0
1646097|NCT01708161|5753461|P2|Overall Study|Death|0
1646098|NCT01708161|5753462|P1|Overall Study|Death|0
1646099|NCT01708161|5753457|P6|Overall Study|Adverse Event|0
1646100|NCT01708161|5753458|P5|Overall Study|Adverse Event|3
1646101|NCT01708161|5753459|P4|Overall Study|Adverse Event|2
1646102|NCT01708161|5753460|P3|Overall Study|Adverse Event|4
1646103|NCT01708161|5753461|P2|Overall Study|Adverse Event|3
1646104|NCT01708161|5753462|P1|Overall Study|Adverse Event|1
1646105|NCT01708057|5753513|P3|Overall Study|Withdrawal due to study termination.|1
1646106|NCT01708057|5753514|P2|Overall Study|Withdrawal due to study termination.|1
1646107|NCT01708057|5753515|P1|Overall Study|Withdrawal due to study termination.|1
1646108|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1646109|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
1646110|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1646111|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1646112|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1646113|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
1646114|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
1646115|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
1646116|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
1646117|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
1646118|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
1646119|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
1646120|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Noncompliance|2
1646121|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Noncompliance|4
1646122|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Noncompliance|0
1646123|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Noncompliance|0
1646124|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Noncompliance|0
1646125|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Noncompliance|0
1646126|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Other than specified|2
1646127|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Other than specified|5
1646128|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Other than specified|1
1646129|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Other than specified|0
1646130|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Other than specified|0
1646131|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Other than specified|0
1646132|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Death|0
1646133|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Death|0
1646134|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Death|2
1646135|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Death|0
1646136|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Death|0
1646137|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Death|0
1646138|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
1646139|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
1646140|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
1646141|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
1646142|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
1646143|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
1646144|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Pregnancy|2
1646145|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Pregnancy|5
1646146|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Pregnancy|2
1646147|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Pregnancy|0
1646148|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Pregnancy|0
1646149|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Pregnancy|0
1646150|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
1646151|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
1646152|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
1646153|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
1646154|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
1646155|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
1646156|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
1646157|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
1646158|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
1646159|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
1646160|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
1646161|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
1646162|NCT01707992|5753574|P6|Active Treatment Phase (24 Months)|Adverse Event|0
1646163|NCT01707992|5753575|P5|Active Treatment Phase (24 Months)|Adverse Event|1
1646164|NCT01707992|5753576|P4|Active Treatment Phase (24 Months)|Adverse Event|4
1646165|NCT01707992|5753577|P3|Active Treatment Phase (24 Months)|Adverse Event|0
1646166|NCT01707992|5753578|P2|Active Treatment Phase (24 Months)|Adverse Event|0
1646167|NCT01707992|5753579|P1|Active Treatment Phase (24 Months)|Adverse Event|0
1646168|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
1646169|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
1646170|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
1646171|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
1646172|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
1646173|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
1646174|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
1646175|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
1646176|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
1646177|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
1646178|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
1646179|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
1646180|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Death|0
1646181|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Death|0
1646182|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Death|0
1646183|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Death|1
1646184|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Death|1
1646185|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Death|2
1646186|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
1646187|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
1646188|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
1646189|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
1646190|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
1646191|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
1646192|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
1646193|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
1646194|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
1646195|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
1646196|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
1646197|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
1646198|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1646199|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1646200|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1646201|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1646202|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
1646203|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
1646204|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
1646205|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
1646206|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
1646207|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
1646208|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
1646209|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
1646210|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
1646211|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
1646212|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
1646213|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
1646214|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
1646215|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
1646216|NCT01707992|5753574|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
1646217|NCT01707992|5753575|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
1646218|NCT01707992|5753576|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
1646219|NCT01707992|5753577|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
1646220|NCT01707992|5753578|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
1646221|NCT01707992|5753579|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
1646222|NCT01707693|5753631|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
1646223|NCT01707693|5753632|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
1646224|NCT01707693|5753631|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
1646225|NCT01707693|5753632|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
1646226|NCT01707693|5753631|P2|Overall Study Allocation|Protocol Violation|3
1646227|NCT01707693|5753632|P1|Overall Study Allocation|Protocol Violation|4
1646228|NCT01707693|5753631|P2|Overall Study Allocation|Withdrawal by Subject|5
1646229|NCT01707693|5753632|P1|Overall Study Allocation|Withdrawal by Subject|9
1646230|NCT01707667|5753646|P2|Period 1|expulsion of colonic sensor catheter|0
1646231|NCT01707667|5753647|P1|Period 1|expulsion of colonic sensor catheter|1
1646232|NCT01707290|5753717|P2|Overall Study|Other unspecified|0
1646233|NCT01707290|5753718|P1|Overall Study|Other unspecified|17
1646234|NCT01707290|5753717|P2|Overall Study|Commercial drug available|1
1646235|NCT01707290|5753718|P1|Overall Study|Commercial drug available|60
1646236|NCT01707290|5753717|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
1646237|NCT01707290|5753718|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
1646238|NCT01707290|5753717|P2|Overall Study|Lost to Follow-up|0
1646239|NCT01707290|5753718|P1|Overall Study|Lost to Follow-up|3
1646240|NCT01707290|5753717|P2|Overall Study|Physician Decision|0
1646241|NCT01707290|5753718|P1|Overall Study|Physician Decision|1
1646242|NCT01707290|5753717|P2|Overall Study|Adverse event (AE)|0
1646243|NCT01707290|5753718|P1|Overall Study|Adverse event (AE)|1
1646244|NCT01707147|5753763|P1|Overall Study|Violated inclusion/exclusion criteria|77
1646245|NCT01707147|5753763|P1|Overall Study|Follow-up failure|17
1646246|NCT01707147|5753763|P1|Overall Study|Patients who have not taken Trajenta|1
1646247|NCT01707147|5753763|P1|Overall Study|Administered Trajenta prior to contract|5
1646248|NCT01707030|5753795|P2|Overall Study|Lost to Follow-up|13
1646249|NCT01707030|5753796|P1|Overall Study|Lost to Follow-up|8
1646250|NCT01707030|5753795|P2|Overall Study|Withdrawal by Subject|3
1646251|NCT01707030|5753796|P1|Overall Study|Withdrawal by Subject|2
1646252|NCT01707030|5753795|P2|Overall Study|Death|1
1646253|NCT01707030|5753796|P1|Overall Study|Death|1
1646254|NCT01707004|5753812|P1|Overall Study|Physician Decision|3
1646255|NCT01706926|5753851|P4|Overall Study|Other|3
1646256|NCT01706926|5753852|P3|Overall Study|Other|4
1646257|NCT01706926|5753853|P2|Overall Study|Other|4
1646258|NCT01706926|5753854|P1|Overall Study|Other|4
1646259|NCT01706926|5753851|P4|Overall Study|Withdrawal by Subject|2
1646260|NCT01706926|5753852|P3|Overall Study|Withdrawal by Subject|1
1646261|NCT01706926|5753853|P2|Overall Study|Withdrawal by Subject|0
1646262|NCT01706926|5753854|P1|Overall Study|Withdrawal by Subject|2
1646263|NCT01706926|5753851|P4|Overall Study|Lost to Follow-up|0
1646264|NCT01706926|5753852|P3|Overall Study|Lost to Follow-up|1
1646265|NCT01706926|5753853|P2|Overall Study|Lost to Follow-up|0
1646266|NCT01706926|5753854|P1|Overall Study|Lost to Follow-up|0
1646267|NCT01706770|5753973|P2|Overall Study|Physician Decision|0
1646268|NCT01706770|5753974|P1|Overall Study|Physician Decision|1
1646269|NCT01706770|5753973|P2|Overall Study|Lost to Follow-up|0
1646270|NCT01706770|5753974|P1|Overall Study|Lost to Follow-up|1
1646271|NCT01706575|5754022|P1|Overall Study|Started but not Treated|6
1646272|NCT01706575|5754022|P1|Overall Study|Lost to Follow-up|2
1646273|NCT01706575|5754022|P1|Overall Study|Participant Withdrew Consent|4
1646274|NCT01706536|5754043|P5|Overall Study|non compliance|0
1646275|NCT01706536|5754044|P4|Overall Study|non compliance|0
1646276|NCT01706536|5754045|P3|Overall Study|non compliance|0
1646277|NCT01706536|5754046|P2|Overall Study|non compliance|1
1646278|NCT01706536|5754047|P1|Overall Study|non compliance|0
1646279|NCT01706536|5754043|P5|Overall Study|Lack of Efficacy|0
1646280|NCT01706536|5754044|P4|Overall Study|Lack of Efficacy|1
1646281|NCT01706536|5754045|P3|Overall Study|Lack of Efficacy|0
1646282|NCT01706536|5754046|P2|Overall Study|Lack of Efficacy|0
1646283|NCT01706536|5754047|P1|Overall Study|Lack of Efficacy|1
1646284|NCT01706536|5754043|P5|Overall Study|Adverse Event|2
1646285|NCT01706536|5754044|P4|Overall Study|Adverse Event|3
1646286|NCT01706536|5754045|P3|Overall Study|Adverse Event|4
1646287|NCT01706536|5754046|P2|Overall Study|Adverse Event|3
1646288|NCT01706536|5754047|P1|Overall Study|Adverse Event|2
1646289|NCT01706536|5754043|P5|Overall Study|Withdrawal by Subject|0
1646290|NCT01706536|5754044|P4|Overall Study|Withdrawal by Subject|0
1646291|NCT01706536|5754045|P3|Overall Study|Withdrawal by Subject|1
1646292|NCT01706536|5754046|P2|Overall Study|Withdrawal by Subject|0
1646293|NCT01706536|5754047|P1|Overall Study|Withdrawal by Subject|1
1646294|NCT01706458|5754114|P2|Overall Study|Physician Decision|4
1646295|NCT01706458|5754115|P1|Overall Study|Physician Decision|3
1646296|NCT01706328|5754139|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
1646297|NCT01706328|5754140|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
1646298|NCT01706328|5754141|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
1646299|NCT01706328|5754139|P3|12-week Double-blind Treatment Period|Physician Decision|2
1646300|NCT01706328|5754140|P2|12-week Double-blind Treatment Period|Physician Decision|2
1646301|NCT01706328|5754141|P1|12-week Double-blind Treatment Period|Physician Decision|0
1646302|NCT01706328|5754139|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
1646303|NCT01706328|5754140|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
1646304|NCT01706328|5754141|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
1646305|NCT01706328|5754139|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
1646306|NCT01706328|5754140|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
1646307|NCT01706328|5754141|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
1646308|NCT01706328|5754139|P3|12-week Double-blind Treatment Period|Protocol Violation|2
1646309|NCT01706328|5754140|P2|12-week Double-blind Treatment Period|Protocol Violation|4
1646310|NCT01706328|5754141|P1|12-week Double-blind Treatment Period|Protocol Violation|0
1646311|NCT01706328|5754139|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
1646312|NCT01706328|5754140|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
1646313|NCT01706328|5754141|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
1646314|NCT01706328|5754139|P3|12-week Double-blind Treatment Period|Adverse Event|16
1646315|NCT01706328|5754140|P2|12-week Double-blind Treatment Period|Adverse Event|14
1646316|NCT01706328|5754141|P1|12-week Double-blind Treatment Period|Adverse Event|0
1646317|NCT01706328|5754139|P3|2-week Run-in Period|Lost to Follow-up|0
1646318|NCT01706328|5754140|P2|2-week Run-in Period|Lost to Follow-up|0
1646319|NCT01706328|5754141|P1|2-week Run-in Period|Lost to Follow-up|2
1646320|NCT01706328|5754139|P3|2-week Run-in Period|Adverse Event|0
1646321|NCT01706328|5754140|P2|2-week Run-in Period|Adverse Event|0
1646322|NCT01706328|5754141|P1|2-week Run-in Period|Adverse Event|4
1646323|NCT01706328|5754139|P3|2-week Run-in Period|Physician Decision|0
1646324|NCT01706328|5754140|P2|2-week Run-in Period|Physician Decision|0
1646325|NCT01706328|5754141|P1|2-week Run-in Period|Physician Decision|4
1646326|NCT01706328|5754139|P3|2-week Run-in Period|Withdrawal by Subject|0
1646327|NCT01706328|5754140|P2|2-week Run-in Period|Withdrawal by Subject|0
1646328|NCT01706328|5754141|P1|2-week Run-in Period|Withdrawal by Subject|15
1646329|NCT01706328|5754139|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1646330|NCT01706328|5754140|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1646331|NCT01706328|5754141|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
1646332|NCT01706250|5754160|P1|Overall Study|Lost to Follow-up|2
1646333|NCT01706198|5754191|P2|Overall Study|Withdrawal by Subject|31
1646334|NCT01706198|5754192|P1|Overall Study|Withdrawal by Subject|23
1646335|NCT01706198|5754191|P2|Overall Study|Physician Decision|37
1646336|NCT01706198|5754192|P1|Overall Study|Physician Decision|23
1646337|NCT01706198|5754191|P2|Overall Study|Lost to Follow-up|93
1646338|NCT01706198|5754192|P1|Overall Study|Lost to Follow-up|97
1646339|NCT01706198|5754191|P2|Overall Study|Other: Subject reached stopping criteria|13
1646340|NCT01706198|5754192|P1|Overall Study|Other: Subject reached stopping criteria|11
1646341|NCT01706198|5754191|P2|Overall Study|Protocol Violation|5
1646342|NCT01706198|5754192|P1|Overall Study|Protocol Violation|7
1646343|NCT01706198|5754191|P2|Overall Study|Adverse Event|15
1646344|NCT01706198|5754192|P1|Overall Study|Adverse Event|12
1646345|NCT01706159|5754244|P2|Overall Study|Unclassified|1
1646346|NCT01706159|5754245|P1|Overall Study|Unclassified|6
1646347|NCT01706159|5754244|P2|Overall Study|Withdrawal Criteria|1
1646348|NCT01706159|5754245|P1|Overall Study|Withdrawal Criteria|2
1646349|NCT01706146|5754259|P1|Overall Study|Developed AF and need for antiplatelets|2
1646350|NCT01706146|5754259|P1|Overall Study|Adverse Event|3
1646351|NCT01706146|5754259|P1|Overall Study|Withdrawal by Subject|1
1646352|NCT01706003|5754279|P2|Overall Study|Lost to Follow-up|4
1646353|NCT01706003|5754280|P1|Overall Study|Lost to Follow-up|6
1646354|NCT01706003|5754279|P2|Overall Study|Not scheduled|0
1646355|NCT01706003|5754280|P1|Overall Study|Not scheduled|3
1646356|NCT01706003|5754279|P2|Overall Study|Withdrawal by Subject|0
1646357|NCT01706003|5754280|P1|Overall Study|Withdrawal by Subject|2
1646358|NCT01705977|5754288|P2|Overall Study|Missing study conclusion form|2
1646359|NCT01705977|5754289|P1|Overall Study|Missing study conclusion form|2
1646360|NCT01705977|5754288|P2|Overall Study|Physician Decision|38
1646361|NCT01705977|5754289|P1|Overall Study|Physician Decision|48
1646362|NCT01705977|5754288|P2|Overall Study|Lost to Follow-up|37
1646363|NCT01705977|5754289|P1|Overall Study|Lost to Follow-up|33
1646364|NCT01705977|5754288|P2|Overall Study|Site closure|2
1646365|NCT01705977|5754289|P1|Overall Study|Site closure|3
1646366|NCT01705977|5754288|P2|Overall Study|Protocol Violation|4
1646367|NCT01705977|5754289|P1|Overall Study|Protocol Violation|2
1646368|NCT01705977|5754288|P2|Overall Study|Adverse Event|49
1646369|NCT01705977|5754289|P1|Overall Study|Adverse Event|57
1646370|NCT01705977|5754288|P2|Overall Study|Withdrawal by Subject|128
1646371|NCT01705977|5754289|P1|Overall Study|Withdrawal by Subject|128
1646372|NCT01705730|5754307|P1|Overall Study|Reason not Specified|4
1646373|NCT01705730|5754307|P1|Overall Study|Lost to Follow-up|1
1646374|NCT01705730|5754307|P1|Overall Study|Adverse Event|3
1646375|NCT01705730|5754307|P1|Overall Study|Lack of Efficacy|1
1646376|NCT01705717|5754347|P2|Overall Study|Other|2
1646377|NCT01705717|5754348|P1|Overall Study|Other|0
1646378|NCT01705717|5754347|P2|Overall Study|Lack of Efficacy|1
1646379|NCT01705717|5754348|P1|Overall Study|Lack of Efficacy|0
1646380|NCT01705717|5754347|P2|Overall Study|Adverse Event|2
1646381|NCT01705717|5754348|P1|Overall Study|Adverse Event|2
1646382|NCT01705691|5754365|P2|Overall Study|Other|1
1646383|NCT01705691|5754366|P1|Overall Study|Other|0
1646384|NCT01705691|5754365|P2|Overall Study|Lost to Follow-up|1
1646385|NCT01705691|5754366|P1|Overall Study|Lost to Follow-up|1
1646386|NCT01705691|5754365|P2|Overall Study|Withdrawal by Subject|2
1646387|NCT01705691|5754366|P1|Overall Study|Withdrawal by Subject|1
1646388|NCT01705691|5754365|P2|Overall Study|Death|2
1646389|NCT01705691|5754366|P1|Overall Study|Death|1
1646390|NCT01705652|5754386|P2|Overall Study|non-compliance|1
1646391|NCT01705652|5754387|P1|Overall Study|non-compliance|1
1646392|NCT01705652|5754386|P2|Overall Study|Withdrawal by Subject|2
1646393|NCT01705652|5754387|P1|Overall Study|Withdrawal by Subject|1
1646394|NCT01705652|5754386|P2|Overall Study|Adverse Event|0
1646395|NCT01705652|5754387|P1|Overall Study|Adverse Event|1
1646396|NCT01705587|5754395|P2|Overall Study|Withdrawal by Subject|1
1646397|NCT01705587|5754396|P1|Overall Study|Withdrawal by Subject|0
1646398|NCT01705574|5754414|P4|Open-Label Extension Phase|Pregnancy|1
1646399|NCT01705574|5754415|P3|Open-Label Extension Phase|Pregnancy|1
1646400|NCT01705574|5754416|P2|Open-Label Extension Phase|Pregnancy|0
1646401|NCT01705574|5754417|P1|Open-Label Extension Phase|Pregnancy|0
1646402|NCT01705574|5754414|P4|Open-Label Extension Phase|Physician Decision|0
1646403|NCT01705574|5754415|P3|Open-Label Extension Phase|Physician Decision|2
1646404|NCT01705574|5754416|P2|Open-Label Extension Phase|Physician Decision|0
1646405|NCT01705574|5754417|P1|Open-Label Extension Phase|Physician Decision|0
1646406|NCT01705574|5754414|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
1646407|NCT01705574|5754415|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
1646408|NCT01705574|5754416|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
1646409|NCT01705574|5754417|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
1646410|NCT01705574|5754414|P4|Open-Label Extension Phase|Death|0
1646411|NCT01705574|5754415|P3|Open-Label Extension Phase|Death|1
1646412|NCT01705574|5754416|P2|Open-Label Extension Phase|Death|0
1646413|NCT01705574|5754417|P1|Open-Label Extension Phase|Death|2
1646414|NCT01705574|5754414|P4|Open-Label Extension Phase|Adverse Event|1
1646415|NCT01705574|5754415|P3|Open-Label Extension Phase|Adverse Event|0
1646416|NCT01705574|5754416|P2|Open-Label Extension Phase|Adverse Event|0
1646417|NCT01705574|5754417|P1|Open-Label Extension Phase|Adverse Event|3
1646418|NCT01705574|5754414|P4|Open-Label Extension Phase|Withdrew Consent|1
1646419|NCT01705574|5754415|P3|Open-Label Extension Phase|Withdrew Consent|4
1646420|NCT01705574|5754416|P2|Open-Label Extension Phase|Withdrew Consent|0
1646421|NCT01705574|5754417|P1|Open-Label Extension Phase|Withdrew Consent|4
1646422|NCT01705574|5754414|P4|Open-Label Extension Phase|Lost to Follow-up|2
1646423|NCT01705574|5754415|P3|Open-Label Extension Phase|Lost to Follow-up|2
1646424|NCT01705574|5754416|P2|Open-Label Extension Phase|Lost to Follow-up|0
1646425|NCT01705574|5754417|P1|Open-Label Extension Phase|Lost to Follow-up|6
1646426|NCT01705574|5754414|P4|Double-Blind Phase|Randomized but Not Treated|0
1646427|NCT01705574|5754415|P3|Double-Blind Phase|Randomized but Not Treated|0
1646428|NCT01705574|5754416|P2|Double-Blind Phase|Randomized but Not Treated|4
1646429|NCT01705574|5754417|P1|Double-Blind Phase|Randomized but Not Treated|4
1646430|NCT01705574|5754414|P4|Double-Blind Phase|Protocol Violation|0
1646431|NCT01705574|5754415|P3|Double-Blind Phase|Protocol Violation|0
1646432|NCT01705574|5754416|P2|Double-Blind Phase|Protocol Violation|0
1646433|NCT01705574|5754417|P1|Double-Blind Phase|Protocol Violation|1
1646434|NCT01705574|5754414|P4|Double-Blind Phase|Pregnancy|0
1646435|NCT01705574|5754415|P3|Double-Blind Phase|Pregnancy|0
1646436|NCT01705574|5754416|P2|Double-Blind Phase|Pregnancy|1
1646437|NCT01705574|5754417|P1|Double-Blind Phase|Pregnancy|1
1646438|NCT01705574|5754414|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
1646439|NCT01705574|5754415|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
1646440|NCT01705574|5754416|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
1646441|NCT01705574|5754417|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
1646442|NCT01705574|5754414|P4|Double-Blind Phase|Withdrew Consent|0
1646443|NCT01705574|5754415|P3|Double-Blind Phase|Withdrew Consent|0
1646444|NCT01705574|5754416|P2|Double-Blind Phase|Withdrew Consent|5
1646445|NCT01705574|5754417|P1|Double-Blind Phase|Withdrew Consent|8
1646446|NCT01705574|5754414|P4|Double-Blind Phase|Adverse Event|0
1646447|NCT01705574|5754415|P3|Double-Blind Phase|Adverse Event|0
1646448|NCT01705574|5754416|P2|Double-Blind Phase|Adverse Event|10
1646449|NCT01705574|5754417|P1|Double-Blind Phase|Adverse Event|3
1646450|NCT01705574|5754414|P4|Double-Blind Phase|Lost to Follow-up|0
1646451|NCT01705574|5754415|P3|Double-Blind Phase|Lost to Follow-up|0
1646452|NCT01705574|5754416|P2|Double-Blind Phase|Lost to Follow-up|16
1646453|NCT01705574|5754417|P1|Double-Blind Phase|Lost to Follow-up|12
1646457|NCT01705145|5754461|P1|Part B|Adverse Event|1
1646458|NCT01705080|5754501|P4|Overall Study|Missed 6M Visit|0
1646459|NCT01705080|5754502|P3|Overall Study|Missed 6M Visit|1
1646460|NCT01705080|5754503|P2|Overall Study|Missed 6M Visit|1
1646461|NCT01705080|5754504|P1|Overall Study|Missed 6M Visit|3
1646462|NCT01705080|5754501|P4|Overall Study|Protocol Violation|0
1646463|NCT01705080|5754502|P3|Overall Study|Protocol Violation|0
1646464|NCT01705080|5754503|P2|Overall Study|Protocol Violation|0
1646465|NCT01705080|5754504|P1|Overall Study|Protocol Violation|2
1646466|NCT01705080|5754501|P4|Overall Study|Lost to Follow-up|2
1646467|NCT01705080|5754502|P3|Overall Study|Lost to Follow-up|0
1646468|NCT01705080|5754503|P2|Overall Study|Lost to Follow-up|0
1646469|NCT01705080|5754504|P1|Overall Study|Lost to Follow-up|0
1646470|NCT01705080|5754501|P4|Overall Study|Physician Decision|8
1646471|NCT01705080|5754502|P3|Overall Study|Physician Decision|1
1646472|NCT01705080|5754503|P2|Overall Study|Physician Decision|2
1646473|NCT01705080|5754504|P1|Overall Study|Physician Decision|1
1646474|NCT01705080|5754501|P4|Overall Study|Withdrawal by Subject|12
1646475|NCT01705080|5754502|P3|Overall Study|Withdrawal by Subject|0
1646476|NCT01705080|5754503|P2|Overall Study|Withdrawal by Subject|1
1646477|NCT01705080|5754504|P1|Overall Study|Withdrawal by Subject|1
1646478|NCT01705080|5754501|P4|Overall Study|Death|0
1646479|NCT01705080|5754502|P3|Overall Study|Death|0
1646480|NCT01705080|5754503|P2|Overall Study|Death|1
1646481|NCT01705080|5754504|P1|Overall Study|Death|0
1646482|NCT01705080|5754501|P4|Overall Study|Failed Procedure|0
1646483|NCT01705080|5754502|P3|Overall Study|Failed Procedure|0
1646484|NCT01705080|5754503|P2|Overall Study|Failed Procedure|2
1646485|NCT01705080|5754504|P1|Overall Study|Failed Procedure|0
1646486|NCT01705080|5754501|P4|Overall Study|Screen Failure Post Consent|20
1646487|NCT01705080|5754502|P3|Overall Study|Screen Failure Post Consent|3
1646488|NCT01705080|5754503|P2|Overall Study|Screen Failure Post Consent|9
1646489|NCT01705080|5754504|P1|Overall Study|Screen Failure Post Consent|8
1646490|NCT01704846|5754533|P2|Treatment Period 2|Withdrawal by Subject|1
1646491|NCT01704846|5754534|P1|Treatment Period 2|Withdrawal by Subject|0
1646492|NCT01704755|5754589|P2|Overall Study|Withdrew consent and personal issues|0
1646493|NCT01704755|5754590|P1|Overall Study|Withdrew consent and personal issues|1
1646494|NCT01704755|5754589|P2|Overall Study|Other (not specified)|1
1646495|NCT01704755|5754590|P1|Overall Study|Other (not specified)|3
1646496|NCT01704755|5754589|P2|Overall Study|Withdrew consent|1
1646497|NCT01704755|5754590|P1|Overall Study|Withdrew consent|1
1646498|NCT01704755|5754589|P2|Overall Study|Lost to Follow-up|4
1646499|NCT01704755|5754590|P1|Overall Study|Lost to Follow-up|3
1646500|NCT01704755|5754589|P2|Overall Study|Adverse Event|1
1646501|NCT01704755|5754590|P1|Overall Study|Adverse Event|4
1646502|NCT01704651|5754604|P2|Overall Study|Post-op did not have laparotomy|1
1646503|NCT01704651|5754605|P1|Overall Study|Post-op did not have laparotomy|2
1646504|NCT01704651|5754604|P2|Overall Study|Nasogastric tube placement in surgery|1
1646505|NCT01704651|5754605|P1|Overall Study|Nasogastric tube placement in surgery|1
1646506|NCT01704651|5754604|P2|Overall Study|Pre-op change in treatment plan|4
1646507|NCT01704651|5754605|P1|Overall Study|Pre-op change in treatment plan|1
1646508|NCT01704651|5754604|P2|Overall Study|Pre-op withdrawal by subject|1
1646509|NCT01704651|5754605|P1|Overall Study|Pre-op withdrawal by subject|1
1646510|NCT01704599|5754613|P1|Overall Study|Adverse Event|1
1646511|NCT01704495|5754653|P4|Optional Safety Extension|Withdrawal by Subject|2
1646512|NCT01704495|5754654|P3|Optional Safety Extension|Withdrawal by Subject|1
1646513|NCT01704495|5754655|P2|Optional Safety Extension|Withdrawal by Subject|0
1646514|NCT01704495|5754656|P1|Optional Safety Extension|Withdrawal by Subject|2
1646515|NCT01704495|5754653|P4|Optional Safety Extension|Other reason|28
1646516|NCT01704495|5754654|P3|Optional Safety Extension|Other reason|30
1646517|NCT01704495|5754655|P2|Optional Safety Extension|Other reason|29
1646518|NCT01704495|5754656|P1|Optional Safety Extension|Other reason|27
1646519|NCT01704495|5754653|P4|Optional Safety Extension|Adverse Event|1
1646520|NCT01704495|5754654|P3|Optional Safety Extension|Adverse Event|0
1646521|NCT01704495|5754655|P2|Optional Safety Extension|Adverse Event|4
1646522|NCT01704495|5754656|P1|Optional Safety Extension|Adverse Event|0
1646523|NCT01704495|5754653|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
1646524|NCT01704495|5754654|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
1646525|NCT01704495|5754655|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
1646526|NCT01704495|5754656|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
1646527|NCT01704495|5754653|P4|Subjects Randomized|Protocol Violation|0
1646528|NCT01704495|5754654|P3|Subjects Randomized|Protocol Violation|2
1646529|NCT01704495|5754655|P2|Subjects Randomized|Protocol Violation|1
1646530|NCT01704495|5754656|P1|Subjects Randomized|Protocol Violation|1
1646531|NCT01704495|5754653|P4|Subjects Randomized|Withdrawal by Subject|5
1646532|NCT01704495|5754654|P3|Subjects Randomized|Withdrawal by Subject|5
1646533|NCT01704495|5754655|P2|Subjects Randomized|Withdrawal by Subject|5
1646534|NCT01704495|5754656|P1|Subjects Randomized|Withdrawal by Subject|5
1646535|NCT01704495|5754653|P4|Subjects Randomized|Adverse Event|7
1646536|NCT01704495|5754654|P3|Subjects Randomized|Adverse Event|0
1646537|NCT01704495|5754655|P2|Subjects Randomized|Adverse Event|2
1646538|NCT01704495|5754656|P1|Subjects Randomized|Adverse Event|8
1646539|NCT01704495|5754653|P4|Subjects Randomized|Discontinuation criteria met|0
1646540|NCT01704495|5754654|P3|Subjects Randomized|Discontinuation criteria met|2
1646541|NCT01704495|5754655|P2|Subjects Randomized|Discontinuation criteria met|2
1646542|NCT01704495|5754656|P1|Subjects Randomized|Discontinuation criteria met|4
1646543|NCT01704495|5754653|P4|Subjects Randomized|Other Reason|2
1646544|NCT01704495|5754654|P3|Subjects Randomized|Other Reason|3
1646545|NCT01704495|5754655|P2|Subjects Randomized|Other Reason|2
1646546|NCT01704495|5754656|P1|Subjects Randomized|Other Reason|3
1646547|NCT01704287|5754872|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1646548|NCT01704287|5754873|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
1646549|NCT01704287|5754874|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1646550|NCT01704287|5754875|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1646551|NCT01704287|5754876|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
1646552|NCT01704287|5754872|P5|Switch to Pembrolizumab Treatment Period|Death|37
1646553|NCT01704287|5754873|P4|Switch to Pembrolizumab Treatment Period|Death|35
1646554|NCT01704287|5754874|P3|Switch to Pembrolizumab Treatment Period|Death|0
1646555|NCT01704287|5754875|P2|Switch to Pembrolizumab Treatment Period|Death|0
1646556|NCT01704287|5754876|P1|Switch to Pembrolizumab Treatment Period|Death|0
1646557|NCT01704287|5754872|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
1646558|NCT01704287|5754873|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
1646559|NCT01704287|5754874|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1646560|NCT01704287|5754875|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1646561|NCT01704287|5754876|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
1646562|NCT01704287|5754872|P5|Initial Treatment Period|Switched to Pembrolizumab|0
1646563|NCT01704287|5754873|P4|Initial Treatment Period|Switched to Pembrolizumab|0
1646564|NCT01704287|5754874|P3|Initial Treatment Period|Switched to Pembrolizumab|98
1646565|NCT01704287|5754875|P2|Initial Treatment Period|Switched to Pembrolizumab|0
1646566|NCT01704287|5754876|P1|Initial Treatment Period|Switched to Pembrolizumab|0
1646567|NCT01704287|5754872|P5|Initial Treatment Period|Lost to Follow-up|0
1646568|NCT01704287|5754873|P4|Initial Treatment Period|Lost to Follow-up|0
1646569|NCT01704287|5754874|P3|Initial Treatment Period|Lost to Follow-up|0
1646570|NCT01704287|5754875|P2|Initial Treatment Period|Lost to Follow-up|3
1646571|NCT01704287|5754876|P1|Initial Treatment Period|Lost to Follow-up|5
1646572|NCT01704287|5754872|P5|Initial Treatment Period|Withdrawal by Subject|0
1646573|NCT01704287|5754873|P4|Initial Treatment Period|Withdrawal by Subject|0
1646574|NCT01704287|5754874|P3|Initial Treatment Period|Withdrawal by Subject|4
1646575|NCT01704287|5754875|P2|Initial Treatment Period|Withdrawal by Subject|2
1646576|NCT01704287|5754876|P1|Initial Treatment Period|Withdrawal by Subject|3
1646577|NCT01704287|5754872|P5|Initial Treatment Period|Death|0
1646578|NCT01704287|5754873|P4|Initial Treatment Period|Death|0
1646579|NCT01704287|5754874|P3|Initial Treatment Period|Death|71
1646580|NCT01704287|5754875|P2|Initial Treatment Period|Death|129
1646581|NCT01704287|5754876|P1|Initial Treatment Period|Death|139
1646582|NCT01704261|5754924|P2|Overall Study|Lost to Follow-up|0
1646583|NCT01704261|5754925|P1|Overall Study|Lost to Follow-up|1
1646584|NCT01704261|5754924|P2|Overall Study|Withdrawal by Subject|15
1646585|NCT01704261|5754925|P1|Overall Study|Withdrawal by Subject|12
1646586|NCT01704079|5754952|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
1646587|NCT01704079|5754953|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
1646588|NCT01704079|5754952|P2|Overall Study|Subject noncompliance|3
1646589|NCT01704079|5754953|P1|Overall Study|Subject noncompliance|2
1646590|NCT01704079|5754952|P2|Overall Study|Protocol Violation|0
1646591|NCT01704079|5754953|P1|Overall Study|Protocol Violation|1
1646592|NCT01704079|5754952|P2|Overall Study|Adverse Event|7
1646593|NCT01704079|5754953|P1|Overall Study|Adverse Event|4
1646594|NCT01704079|5754952|P2|Overall Study|Lost to Follow-up|5
1646595|NCT01704079|5754953|P1|Overall Study|Lost to Follow-up|2
1646596|NCT01704079|5754952|P2|Overall Study|Withdrawal by Subject|7
1646597|NCT01704079|5754953|P1|Overall Study|Withdrawal by Subject|5
1646598|NCT01703988|5754969|P4|Overall Study|Investigator Judgment|1
1646599|NCT01703988|5754970|P3|Overall Study|Investigator Judgment|0
1646600|NCT01703988|5754971|P2|Overall Study|Investigator Judgment|0
1646601|NCT01703988|5754972|P1|Overall Study|Investigator Judgment|0
1646602|NCT01703858|5755002|P3|Overall Study|Withdrawal by Subject|0
1646603|NCT01703858|5755003|P2|Overall Study|Withdrawal by Subject|1
1646604|NCT01703858|5755004|P1|Overall Study|Withdrawal by Subject|0
1646605|NCT01703845|5755029|P2|Overall Study|other than stated above|0
1646606|NCT01703845|5755030|P1|Overall Study|other than stated above|1
1646607|NCT01703845|5755029|P2|Overall Study|Protocol Violation|0
1646608|NCT01703845|5755030|P1|Overall Study|Protocol Violation|1
1646609|NCT01703845|5755029|P2|Overall Study|Adverse Event|0
1646610|NCT01703845|5755030|P1|Overall Study|Adverse Event|1
1646611|NCT01703832|5755067|P2|Overall Study|Withdrawal by Subject|0
1646612|NCT01703832|5755068|P1|Overall Study|Withdrawal by Subject|1
1646613|NCT01703819|5755100|P2|Overall Study|Withdrawal by Subject|1
1646614|NCT01703819|5755101|P1|Overall Study|Withdrawal by Subject|0
1646615|NCT01703819|5755100|P2|Overall Study|Adverse Event|1
1646616|NCT01703819|5755101|P1|Overall Study|Adverse Event|0
1646617|NCT01703741|5755131|P1|Overall Study|Subject started testosterone injections|1
1646618|NCT01703741|5755131|P1|Overall Study|Subject cannot comply with study visits|1
1646619|NCT01703741|5755131|P1|Overall Study|Subject did not want to continue|2
1646620|NCT01703741|5755131|P1|Overall Study|Lost to Follow-up|3
1646621|NCT01703741|5755131|P1|Overall Study|Protocol Violation|1
1646622|NCT01703741|5755131|P1|Overall Study|Physician Decision|2
1646623|NCT01703741|5755131|P1|Overall Study|Adverse Event|2
1646624|NCT01703741|5755131|P1|Overall Study|Withdrawal by Subject|6
1646625|NCT01703286|5755197|P6|Period 2 Including Washout|Adverse Event|0
1646626|NCT01703286|5755198|P5|Period 2 Including Washout|Adverse Event|0
1646627|NCT01703286|5755199|P4|Period 2 Including Washout|Adverse Event|1
1646628|NCT01703286|5755200|P3|Period 2 Including Washout|Adverse Event|0
1646629|NCT01703286|5755201|P2|Period 2 Including Washout|Adverse Event|0
1646630|NCT01703286|5755202|P1|Period 2 Including Washout|Adverse Event|0
1646631|NCT01703286|5755197|P6|Period 1 Including Washout|Withdrawal by Subject|1
1646632|NCT01703286|5755198|P5|Period 1 Including Washout|Withdrawal by Subject|0
1646633|NCT01703286|5755199|P4|Period 1 Including Washout|Withdrawal by Subject|1
1646634|NCT01703286|5755200|P3|Period 1 Including Washout|Withdrawal by Subject|0
1646635|NCT01703286|5755201|P2|Period 1 Including Washout|Withdrawal by Subject|0
1646636|NCT01703286|5755202|P1|Period 1 Including Washout|Withdrawal by Subject|0
1646637|NCT01703260|5755225|P3|Overall Study|Study Termination|0
1646638|NCT01703260|5755226|P2|Overall Study|Study Termination|2
1646639|NCT01703260|5755227|P1|Overall Study|Study Termination|1
1646640|NCT01703260|5755225|P3|Overall Study|Withdrawal by Subject|1
1646641|NCT01703260|5755226|P2|Overall Study|Withdrawal by Subject|0
1646642|NCT01703260|5755227|P1|Overall Study|Withdrawal by Subject|0
1646643|NCT01703260|5755225|P3|Overall Study|Lost to Follow-up|0
1646644|NCT01703260|5755226|P2|Overall Study|Lost to Follow-up|0
1646645|NCT01703260|5755227|P1|Overall Study|Lost to Follow-up|1
1646646|NCT01703260|5755225|P3|Overall Study|Adverse Event|2
1646647|NCT01703260|5755226|P2|Overall Study|Adverse Event|2
1646648|NCT01703260|5755227|P1|Overall Study|Adverse Event|1
1646649|NCT01703221|5755253|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
1646650|NCT01703221|5755254|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
1646651|NCT01703221|5755255|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
1646652|NCT01703221|5755253|P3|Phase B - (Week 25 to 52)|Adverse Event|2
1646653|NCT01703221|5755254|P2|Phase B - (Week 25 to 52)|Adverse Event|3
1646654|NCT01703221|5755255|P1|Phase B - (Week 25 to 52)|Adverse Event|2
1646655|NCT01703221|5755253|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
1646656|NCT01703221|5755254|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
1646657|NCT01703221|5755255|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
1646658|NCT01703221|5755253|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
1646659|NCT01703221|5755254|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
1646660|NCT01703221|5755255|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
1646661|NCT01703221|5755253|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1646662|NCT01703221|5755254|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1646663|NCT01703221|5755255|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
1646664|NCT01703221|5755253|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
1646665|NCT01703221|5755254|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
1646666|NCT01703221|5755255|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
1646667|NCT01703221|5755253|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
1646668|NCT01703221|5755254|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
1646669|NCT01703221|5755255|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
1646670|NCT01703221|5755253|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
1646671|NCT01703221|5755254|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
1646672|NCT01703221|5755255|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
1646673|NCT01703208|5755286|P2|Overall Study|Protocol Deviation|0
1646674|NCT01703208|5755287|P1|Overall Study|Protocol Deviation|2
1646675|NCT01703208|5755286|P2|Overall Study|Technical Problems|1
1646676|NCT01703208|5755287|P1|Overall Study|Technical Problems|0
1646677|NCT01703208|5755286|P2|Overall Study|Adverse Event|19
1646678|NCT01703208|5755287|P1|Overall Study|Adverse Event|14
1646679|NCT01703208|5755286|P2|Overall Study|Withdrawal by Subject|209
1646680|NCT01703208|5755287|P1|Overall Study|Withdrawal by Subject|205
1646681|NCT01703208|5755286|P2|Overall Study|Study Terminated by Sponsor|1716
1646682|NCT01703208|5755287|P1|Overall Study|Study Terminated by Sponsor|1710
1646683|NCT01703208|5755286|P2|Overall Study|Protocol Violation|1
1646684|NCT01703208|5755287|P1|Overall Study|Protocol Violation|1
1646685|NCT01703208|5755286|P2|Overall Study|Progressive disease|2
1646686|NCT01703208|5755287|P1|Overall Study|Progressive disease|2
1646687|NCT01703208|5755286|P2|Overall Study|Physician Decision|13
1646688|NCT01703208|5755287|P1|Overall Study|Physician Decision|11
1646689|NCT01703208|5755286|P2|Overall Study|Site Discontinued Study Participation|27
1646690|NCT01703208|5755287|P1|Overall Study|Site Discontinued Study Participation|23
1646691|NCT01703208|5755286|P2|Overall Study|Excluded Medication|2
1646692|NCT01703208|5755287|P1|Overall Study|Excluded Medication|1
1646693|NCT01703208|5755286|P2|Overall Study|Non-Compliance with Study Drug|0
1646694|NCT01703208|5755287|P1|Overall Study|Non-Compliance with Study Drug|1
1646695|NCT01703208|5755286|P2|Overall Study|Lost to Follow-up|62
1646696|NCT01703208|5755287|P1|Overall Study|Lost to Follow-up|68
1646697|NCT01703208|5755286|P2|Overall Study|Lack of Efficacy|2
1646698|NCT01703208|5755287|P1|Overall Study|Lack of Efficacy|1
1646699|NCT01703208|5755286|P2|Overall Study|Death|48
1646700|NCT01703208|5755287|P1|Overall Study|Death|61
1646701|NCT01703091|5755351|P2|Overall Study|Sponsor Decision|0
1646702|NCT01703091|5755352|P1|Overall Study|Sponsor Decision|1
1646703|NCT01703091|5755351|P2|Overall Study|Withdrawal by Subject|0
1646704|NCT01703091|5755352|P1|Overall Study|Withdrawal by Subject|1
1646705|NCT01703091|5755351|P2|Overall Study|Physician Decision|1
1646706|NCT01703091|5755352|P1|Overall Study|Physician Decision|2
1646707|NCT01703091|5755351|P2|Overall Study|Adverse Event|3
1646708|NCT01703091|5755352|P1|Overall Study|Adverse Event|5
1646709|NCT01703065|5755370|P2|Overall Study|Lack of Efficacy|0
1646710|NCT01703065|5755371|P1|Overall Study|Lack of Efficacy|1
1646711|NCT01703000|5755401|P1|Overall Study|Death|1
1646712|NCT01702987|5755434|P2|Overall Study|Withdrawal by Subject|0
1646713|NCT01702987|5755435|P1|Overall Study|Withdrawal by Subject|1
1646714|NCT01702961|5755441|P1|Overall Study|Ongoing|11
1646715|NCT01702961|5755441|P1|Overall Study|Lost to Follow-up|2
1646716|NCT01702961|5755441|P1|Overall Study|Death|6
1646717|NCT01702961|5755441|P1|Overall Study|Relapse|20
1646718|NCT01702961|5755441|P1|Overall Study|Progressive disease|5
1646719|NCT01702961|5755441|P1|Overall Study|Additional treatment|3
1646720|NCT01702558|5755464|P5|Overall Study|Other|17
1646721|NCT01702558|5755465|P4|Overall Study|Other|16
1646722|NCT01702558|5755466|P3|Overall Study|Other|0
1646723|NCT01702558|5755467|P2|Overall Study|Other|0
1646724|NCT01702558|5755468|P1|Overall Study|Other|0
1646725|NCT01702558|5755464|P5|Overall Study|Study Terminated by Sponsor|1
1646726|NCT01702558|5755465|P4|Overall Study|Study Terminated by Sponsor|0
1646727|NCT01702558|5755466|P3|Overall Study|Study Terminated by Sponsor|0
1646728|NCT01702558|5755467|P2|Overall Study|Study Terminated by Sponsor|1
1646729|NCT01702558|5755468|P1|Overall Study|Study Terminated by Sponsor|0
1646730|NCT01702558|5755464|P5|Overall Study|Safety Follow-Up less than 3 Months|0
1646731|NCT01702558|5755465|P4|Overall Study|Safety Follow-Up less than 3 Months|0
1646732|NCT01702558|5755466|P3|Overall Study|Safety Follow-Up less than 3 Months|2
1646733|NCT01702558|5755467|P2|Overall Study|Safety Follow-Up less than 3 Months|0
1646734|NCT01702558|5755468|P1|Overall Study|Safety Follow-Up less than 3 Months|0
1646735|NCT01702558|5755464|P5|Overall Study|Death|20
1646736|NCT01702558|5755465|P4|Overall Study|Death|16
1646737|NCT01702558|5755466|P3|Overall Study|Death|3
1646738|NCT01702558|5755467|P2|Overall Study|Death|3
1646739|NCT01702558|5755468|P1|Overall Study|Death|4
1646740|NCT01702558|5755464|P5|Overall Study|Lost to Follow-up|0
1646741|NCT01702558|5755465|P4|Overall Study|Lost to Follow-up|3
1646742|NCT01702558|5755466|P3|Overall Study|Lost to Follow-up|0
1646743|NCT01702558|5755467|P2|Overall Study|Lost to Follow-up|0
1646744|NCT01702558|5755468|P1|Overall Study|Lost to Follow-up|0
1646745|NCT01702558|5755464|P5|Overall Study|Withdrawal by Subject|4
1646746|NCT01702558|5755465|P4|Overall Study|Withdrawal by Subject|12
1646747|NCT01702558|5755466|P3|Overall Study|Withdrawal by Subject|0
1646748|NCT01702558|5755467|P2|Overall Study|Withdrawal by Subject|0
1646749|NCT01702558|5755468|P1|Overall Study|Withdrawal by Subject|0
1646750|NCT01702532|5755533|P2|Overall Study|Adverse Event|1
1646751|NCT01702532|5755534|P1|Overall Study|Adverse Event|0
1646752|NCT01702519|5755544|P2|Washout Period|Withdrawal by Subject|2
1646753|NCT01702519|5755545|P1|Washout Period|Withdrawal by Subject|0
1646754|NCT01702519|5755544|P2|Washout Period|Lost to Follow-up|0
1646755|NCT01702519|5755545|P1|Washout Period|Lost to Follow-up|1
1646756|NCT01702454|5755563|P2|Overall Study|Lost to Follow-up|6
1646757|NCT01702454|5755564|P1|Overall Study|Lost to Follow-up|3
1646758|NCT01702454|5755563|P2|Overall Study|Migrated/moved from study area|1
1646759|NCT01702454|5755564|P1|Overall Study|Migrated/moved from study area|0
1646760|NCT01702454|5755563|P2|Overall Study|Consent withdrawal|1
1646761|NCT01702454|5755564|P1|Overall Study|Consent withdrawal|0
1646762|NCT01702428|5755646|P4|Overall Study|Withdrawal by Subject|10
1646763|NCT01702428|5755647|P3|Overall Study|Withdrawal by Subject|14
1646764|NCT01702428|5755648|P2|Overall Study|Withdrawal by Subject|23
1646765|NCT01702428|5755649|P1|Overall Study|Withdrawal by Subject|21
1646766|NCT01702428|5755646|P4|Overall Study|Protocol Violation|0
1646767|NCT01702428|5755647|P3|Overall Study|Protocol Violation|1
1646768|NCT01702428|5755648|P2|Overall Study|Protocol Violation|0
1646769|NCT01702428|5755649|P1|Overall Study|Protocol Violation|3
1646770|NCT01702428|5755646|P4|Overall Study|Parents too busy|0
1646771|NCT01702428|5755647|P3|Overall Study|Parents too busy|0
1646772|NCT01702428|5755648|P2|Overall Study|Parents too busy|0
1646773|NCT01702428|5755649|P1|Overall Study|Parents too busy|1
1646774|NCT01702428|5755646|P4|Overall Study|Mother transferred care|0
1646775|NCT01702428|5755647|P3|Overall Study|Mother transferred care|0
1646776|NCT01702428|5755648|P2|Overall Study|Mother transferred care|1
1646777|NCT01702428|5755649|P1|Overall Study|Mother transferred care|0
1646778|NCT01702428|5755646|P4|Overall Study|Lost Health Plan|2
1646779|NCT01702428|5755647|P3|Overall Study|Lost Health Plan|0
1646780|NCT01702428|5755648|P2|Overall Study|Lost Health Plan|5
1646781|NCT01702428|5755649|P1|Overall Study|Lost Health Plan|3
1646782|NCT01702428|5755646|P4|Overall Study|Lost Coverage|1
1646783|NCT01702428|5755647|P3|Overall Study|Lost Coverage|0
1646784|NCT01702428|5755648|P2|Overall Study|Lost Coverage|0
1646785|NCT01702428|5755649|P1|Overall Study|Lost Coverage|0
1646786|NCT01702428|5755646|P4|Overall Study|Parents cannot assist to site|0
1646787|NCT01702428|5755647|P3|Overall Study|Parents cannot assist to site|1
1646788|NCT01702428|5755648|P2|Overall Study|Parents cannot assist to site|0
1646789|NCT01702428|5755649|P1|Overall Study|Parents cannot assist to site|1
1646790|NCT01702428|5755646|P4|Overall Study|Lost to Follow-up|44
1646791|NCT01702428|5755647|P3|Overall Study|Lost to Follow-up|37
1646792|NCT01702428|5755648|P2|Overall Study|Lost to Follow-up|41
1646793|NCT01702428|5755649|P1|Overall Study|Lost to Follow-up|33
1646794|NCT01702428|5755646|P4|Overall Study|Adverse Event|0
1646795|NCT01702428|5755647|P3|Overall Study|Adverse Event|0
1646796|NCT01702428|5755648|P2|Overall Study|Adverse Event|0
1646797|NCT01702428|5755649|P1|Overall Study|Adverse Event|2
1646798|NCT01702363|5755736|P1|Overall Study|Withdrawal by Subject|2
1646799|NCT01702363|5755736|P1|Overall Study|Lack of Efficacy|4
1646800|NCT01702363|5755736|P1|Overall Study|Adverse Event|14
1646801|NCT01702311|5755753|P2|Overall Study|Physician Decision|4
1646802|NCT01702311|5755754|P1|Overall Study|Physician Decision|3
1646803|NCT01702311|5755753|P2|Overall Study|Discharge less than 24 hours|7
1646804|NCT01702311|5755754|P1|Overall Study|Discharge less than 24 hours|10
1646805|NCT01702311|5755753|P2|Overall Study|Withdrawal by Subject|2
1646806|NCT01702311|5755754|P1|Overall Study|Withdrawal by Subject|3
1646807|NCT01702298|5755784|P1|Overall Study|Withdrawal by Subject|1
1646808|NCT01702246|5755812|P1|Overall Study|Physician Decision|1
1646809|NCT01702246|5755812|P1|Overall Study|Withdrawal by Subject|2
1646810|NCT01702246|5755812|P1|Overall Study|Lost to Follow-up|2
1646811|NCT01702025|5755866|P4|Overall Study|Adverse Event|0
1646812|NCT01702025|5755867|P3|Overall Study|Adverse Event|1
1646813|NCT01702025|5755868|P2|Overall Study|Adverse Event|1
1646814|NCT01702025|5755869|P1|Overall Study|Adverse Event|1
1646815|NCT01702025|5755866|P4|Overall Study|Equipment failure|0
1646816|NCT01702025|5755867|P3|Overall Study|Equipment failure|0
1646817|NCT01702025|5755868|P2|Overall Study|Equipment failure|0
1646818|NCT01702025|5755869|P1|Overall Study|Equipment failure|1
1646819|NCT01701973|5755898|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
1646820|NCT01701973|5755899|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
1646821|NCT01701973|5755900|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
1646822|NCT01701973|5755901|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
1646823|NCT01701973|5755902|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
1646824|NCT01701973|5755903|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
1646825|NCT01701973|5755904|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
1646826|NCT01701973|5755905|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
1646827|NCT01701674|5755952|P1|Overall Study|Unable to safely complete treatment|1
1646828|NCT01701401|5756038|P4|Overall Study|Protocol Violation|0
1646829|NCT01701401|5756039|P3|Overall Study|Protocol Violation|1
1646830|NCT01701401|5756040|P2|Overall Study|Protocol Violation|0
1646831|NCT01701401|5756041|P1|Overall Study|Protocol Violation|0
1646832|NCT01701401|5756038|P4|Overall Study|Adverse Event|0
1646833|NCT01701401|5756039|P3|Overall Study|Adverse Event|0
1646834|NCT01701401|5756040|P2|Overall Study|Adverse Event|0
1646835|NCT01701401|5756041|P1|Overall Study|Adverse Event|1
1646836|NCT01701401|5756038|P4|Overall Study|Lack of Efficacy|0
1646837|NCT01701401|5756039|P3|Overall Study|Lack of Efficacy|2
1646838|NCT01701401|5756040|P2|Overall Study|Lack of Efficacy|0
1646839|NCT01701401|5756041|P1|Overall Study|Lack of Efficacy|1
1646840|NCT01701401|5756038|P4|Overall Study|Withdrew Consent|2
1646841|NCT01701401|5756039|P3|Overall Study|Withdrew Consent|1
1646842|NCT01701401|5756040|P2|Overall Study|Withdrew Consent|3
1646843|NCT01701401|5756041|P1|Overall Study|Withdrew Consent|0
1646844|NCT01701401|5756038|P4|Overall Study|Lost to Follow-up|3
1646845|NCT01701401|5756039|P3|Overall Study|Lost to Follow-up|1
1646846|NCT01701401|5756040|P2|Overall Study|Lost to Follow-up|5
1646847|NCT01701401|5756041|P1|Overall Study|Lost to Follow-up|5
1646848|NCT01701401|5756038|P4|Overall Study|Randomized But Not Treated|1
1646849|NCT01701401|5756039|P3|Overall Study|Randomized But Not Treated|0
1646850|NCT01701401|5756040|P2|Overall Study|Randomized But Not Treated|1
1646851|NCT01701401|5756041|P1|Overall Study|Randomized But Not Treated|3
1646852|NCT01701362|5756093|P2|Overall Study|Reasons other than those mentioned above|5
1646853|NCT01701362|5756094|P1|Overall Study|Reasons other than those mentioned above|3
1646854|NCT01701362|5756093|P2|Overall Study|Randomized but not treated|2
1646855|NCT01701362|5756094|P1|Overall Study|Randomized but not treated|1
1646856|NCT01701362|5756093|P2|Overall Study|Death|1
1646857|NCT01701362|5756094|P1|Overall Study|Death|0
1646858|NCT01701362|5756093|P2|Overall Study|Insufficient clinical response|6
1646859|NCT01701362|5756094|P1|Overall Study|Insufficient clinical response|6
1646860|NCT01701362|5756093|P2|Overall Study|Lost to Follow-up|9
1646861|NCT01701362|5756094|P1|Overall Study|Lost to Follow-up|6
1646862|NCT01701362|5756093|P2|Overall Study|No longer willing to participate|14
1646863|NCT01701362|5756094|P1|Overall Study|No longer willing to participate|8
1646864|NCT01701362|5756093|P2|Overall Study|Protocol Violation|3
1646865|NCT01701362|5756094|P1|Overall Study|Protocol Violation|5
1646866|NCT01701362|5756093|P2|Overall Study|Adverse events related to study drug|10
1646867|NCT01701362|5756094|P1|Overall Study|Adverse events related to study drug|12
1646868|NCT01701362|5756093|P2|Overall Study|Adverse events not related to study drug|6
1646869|NCT01701362|5756094|P1|Overall Study|Adverse events not related to study drug|1
1646870|NCT01701258|5756132|P13|Assessment and Scheduling|Investigator Terminated|0
1646871|NCT01701258|5756133|P12|Assessment and Scheduling|Investigator Terminated|0
1646872|NCT01701258|5756134|P11|Assessment and Scheduling|Investigator Terminated|0
1646873|NCT01701258|5756135|P10|Assessment and Scheduling|Investigator Terminated|0
1646874|NCT01701258|5756136|P9|Assessment and Scheduling|Investigator Terminated|0
1646875|NCT01701258|5756137|P8|Assessment and Scheduling|Investigator Terminated|0
1646876|NCT01701258|5756138|P7|Assessment and Scheduling|Investigator Terminated|0
1646877|NCT01701258|5756139|P6|Assessment and Scheduling|Investigator Terminated|0
1646878|NCT01701258|5756140|P5|Assessment and Scheduling|Investigator Terminated|0
1646879|NCT01701258|5756141|P4|Assessment and Scheduling|Investigator Terminated|0
1646880|NCT01701258|5756142|P3|Assessment and Scheduling|Investigator Terminated|0
1646881|NCT01701258|5756143|P2|Assessment and Scheduling|Investigator Terminated|0
1646882|NCT01701258|5756144|P1|Assessment and Scheduling|Investigator Terminated|2
1646883|NCT01701258|5756132|P13|Assessment and Scheduling|Withdrawal by Subject|0
1646884|NCT01701258|5756133|P12|Assessment and Scheduling|Withdrawal by Subject|0
1646885|NCT01701258|5756134|P11|Assessment and Scheduling|Withdrawal by Subject|0
1646886|NCT01701258|5756135|P10|Assessment and Scheduling|Withdrawal by Subject|0
1646887|NCT01701258|5756136|P9|Assessment and Scheduling|Withdrawal by Subject|0
1646888|NCT01701258|5756137|P8|Assessment and Scheduling|Withdrawal by Subject|0
1646889|NCT01701258|5756138|P7|Assessment and Scheduling|Withdrawal by Subject|0
1646890|NCT01701258|5756139|P6|Assessment and Scheduling|Withdrawal by Subject|0
1646891|NCT01701258|5756140|P5|Assessment and Scheduling|Withdrawal by Subject|0
1646892|NCT01701258|5756141|P4|Assessment and Scheduling|Withdrawal by Subject|0
1646893|NCT01701258|5756142|P3|Assessment and Scheduling|Withdrawal by Subject|0
1646894|NCT01701258|5756143|P2|Assessment and Scheduling|Withdrawal by Subject|0
1646895|NCT01701258|5756144|P1|Assessment and Scheduling|Withdrawal by Subject|14
1646896|NCT01701258|5756132|P13|Assessment and Scheduling|Lost to Follow-up|0
1646897|NCT01701258|5756133|P12|Assessment and Scheduling|Lost to Follow-up|0
1646898|NCT01701258|5756134|P11|Assessment and Scheduling|Lost to Follow-up|0
1646899|NCT01701258|5756135|P10|Assessment and Scheduling|Lost to Follow-up|0
1646900|NCT01701258|5756136|P9|Assessment and Scheduling|Lost to Follow-up|0
1646901|NCT01701258|5756137|P8|Assessment and Scheduling|Lost to Follow-up|0
1646902|NCT01701258|5756138|P7|Assessment and Scheduling|Lost to Follow-up|0
1646903|NCT01701258|5756139|P6|Assessment and Scheduling|Lost to Follow-up|0
1646904|NCT01701258|5756140|P5|Assessment and Scheduling|Lost to Follow-up|0
1646905|NCT01701258|5756141|P4|Assessment and Scheduling|Lost to Follow-up|0
1646906|NCT01701258|5756142|P3|Assessment and Scheduling|Lost to Follow-up|0
1646907|NCT01701258|5756143|P2|Assessment and Scheduling|Lost to Follow-up|0
1646908|NCT01701258|5756144|P1|Assessment and Scheduling|Lost to Follow-up|10
1646909|NCT01701258|5756132|P13|Assessment and Scheduling|Found to be Ineligible|0
1646910|NCT01701258|5756133|P12|Assessment and Scheduling|Found to be Ineligible|0
1646911|NCT01701258|5756134|P11|Assessment and Scheduling|Found to be Ineligible|0
1646912|NCT01701258|5756135|P10|Assessment and Scheduling|Found to be Ineligible|0
1646913|NCT01701258|5756136|P9|Assessment and Scheduling|Found to be Ineligible|0
1646914|NCT01701258|5756137|P8|Assessment and Scheduling|Found to be Ineligible|0
1646915|NCT01701258|5756138|P7|Assessment and Scheduling|Found to be Ineligible|0
1646916|NCT01701258|5756139|P6|Assessment and Scheduling|Found to be Ineligible|0
1646917|NCT01701258|5756140|P5|Assessment and Scheduling|Found to be Ineligible|0
1646918|NCT01701258|5756141|P4|Assessment and Scheduling|Found to be Ineligible|0
1646919|NCT01701258|5756142|P3|Assessment and Scheduling|Found to be Ineligible|0
1646920|NCT01701258|5756143|P2|Assessment and Scheduling|Found to be Ineligible|0
1646921|NCT01701258|5756144|P1|Assessment and Scheduling|Found to be Ineligible|57
1646922|NCT01701245|5756198|P2|Overall Study|Did not complete the open label period|12
1646923|NCT01701245|5756199|P1|Overall Study|Did not complete the open label period|11
1646924|NCT01701245|5756198|P2|Overall Study|Protocol Violation|3
1646925|NCT01701245|5756199|P1|Overall Study|Protocol Violation|1
1646926|NCT01701063|5756246|P3|Overall Study|Other|1
1646927|NCT01701063|5756247|P2|Overall Study|Other|0
1646928|NCT01701063|5756248|P1|Overall Study|Other|0
1646929|NCT01701063|5756246|P3|Overall Study|Withdrawal by Subject|1
1646930|NCT01701063|5756247|P2|Overall Study|Withdrawal by Subject|0
1646931|NCT01701063|5756248|P1|Overall Study|Withdrawal by Subject|0
1646932|NCT01701063|5756246|P3|Overall Study|Lost to Follow-up|0
1646933|NCT01701063|5756247|P2|Overall Study|Lost to Follow-up|1
1646934|NCT01701063|5756248|P1|Overall Study|Lost to Follow-up|0
1646935|NCT01700985|5756332|P2|Overall Study|Incarcerated|1
1646936|NCT01700985|5756333|P1|Overall Study|Incarcerated|0
1646937|NCT01700959|5756355|P6|Overall Study|Side effects|1
1646938|NCT01700959|5756356|P5|Overall Study|Side effects|4
1646939|NCT01700959|5756357|P4|Overall Study|Side effects|4
1646940|NCT01700959|5756358|P3|Overall Study|Side effects|8
1646941|NCT01700959|5756359|P2|Overall Study|Side effects|4
1646942|NCT01700959|5756360|P1|Overall Study|Side effects|1
1646943|NCT01700959|5756355|P6|Overall Study|Noncompliant|9
1646944|NCT01700959|5756356|P5|Overall Study|Noncompliant|15
1646945|NCT01700959|5756357|P4|Overall Study|Noncompliant|18
1646946|NCT01700959|5756358|P3|Overall Study|Noncompliant|17
1646947|NCT01700959|5756359|P2|Overall Study|Noncompliant|9
1646948|NCT01700959|5756360|P1|Overall Study|Noncompliant|9
1646949|NCT01700959|5756355|P6|Overall Study|Ineligible|1
1646950|NCT01700959|5756356|P5|Overall Study|Ineligible|0
1646951|NCT01700959|5756357|P4|Overall Study|Ineligible|0
1646952|NCT01700959|5756358|P3|Overall Study|Ineligible|2
1646953|NCT01700959|5756359|P2|Overall Study|Ineligible|1
1646954|NCT01700959|5756360|P1|Overall Study|Ineligible|2
1646955|NCT01700959|5756355|P6|Overall Study|Withdrawal by Subject|12
1646956|NCT01700959|5756356|P5|Overall Study|Withdrawal by Subject|8
1646957|NCT01700959|5756357|P4|Overall Study|Withdrawal by Subject|11
1646958|NCT01700959|5756358|P3|Overall Study|Withdrawal by Subject|12
1646959|NCT01700959|5756359|P2|Overall Study|Withdrawal by Subject|9
1646960|NCT01700959|5756360|P1|Overall Study|Withdrawal by Subject|15
1646961|NCT01700959|5756355|P6|Overall Study|Adverse Event|2
1646962|NCT01700959|5756356|P5|Overall Study|Adverse Event|0
1646963|NCT01700959|5756357|P4|Overall Study|Adverse Event|2
1646964|NCT01700959|5756358|P3|Overall Study|Adverse Event|1
1646965|NCT01700959|5756359|P2|Overall Study|Adverse Event|1
1646966|NCT01700959|5756360|P1|Overall Study|Adverse Event|0
1646967|NCT01700621|5756449|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
1646968|NCT01700621|5756450|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
1646969|NCT01700621|5756449|P2|Analyzed for Immunogenicity|Protocol Violation|1
1646970|NCT01700621|5756450|P1|Analyzed for Immunogenicity|Protocol Violation|5
1646971|NCT01700621|5756449|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
1646972|NCT01700621|5756450|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
1646973|NCT01700530|5756488|P3|Overall Study|Withdrawal by Subject|1
1646974|NCT01700530|5756489|P2|Overall Study|Withdrawal by Subject|3
1646975|NCT01700530|5756490|P1|Overall Study|Withdrawal by Subject|0
1646976|NCT01700387|5756539|P2|Overall Study|Lost to Follow-up|1
1646977|NCT01700387|5756540|P1|Overall Study|Lost to Follow-up|2
1646978|NCT01700387|5756539|P2|Overall Study|Adverse Event|1
1646979|NCT01700387|5756540|P1|Overall Study|Adverse Event|1
1646980|NCT01700387|5756539|P2|Overall Study|Withdrawal by Subject|2
1646981|NCT01700387|5756540|P1|Overall Study|Withdrawal by Subject|1
1646982|NCT01700348|5756550|P1|Overall Study|Lost to Follow-up|1
1646983|NCT01700348|5756550|P1|Overall Study|Withdrawal by Subject|22
1646984|NCT01700205|5756573|P2|Overall Study|Protocol Violation|2
1646985|NCT01700205|5756574|P1|Overall Study|Protocol Violation|2
1646986|NCT01700205|5756573|P2|Overall Study|Withdrawal by Subject|13
1646987|NCT01700205|5756574|P1|Overall Study|Withdrawal by Subject|13
1646988|NCT01700192|5756596|P2|Overall Study|Never received study drug|0
1646989|NCT01700192|5756597|P1|Overall Study|Never received study drug|1
1646990|NCT01700192|5756596|P2|Overall Study|Withdrawal by Subject|64
1646991|NCT01700192|5756597|P1|Overall Study|Withdrawal by Subject|56
1646992|NCT01700192|5756596|P2|Overall Study|Technical problems|1
1646993|NCT01700192|5756597|P1|Overall Study|Technical problems|0
1646994|NCT01700192|5756596|P2|Overall Study|Protocol Violation|4
1646995|NCT01700192|5756597|P1|Overall Study|Protocol Violation|3
1646996|NCT01700192|5756596|P2|Overall Study|Progressive disease|0
1646997|NCT01700192|5756597|P1|Overall Study|Progressive disease|1
1646998|NCT01700192|5756596|P2|Overall Study|Pregnancy|4
1646999|NCT01700192|5756597|P1|Overall Study|Pregnancy|1
1647000|NCT01700192|5756596|P2|Overall Study|Physician Decision|3
1647001|NCT01700192|5756597|P1|Overall Study|Physician Decision|2
1647002|NCT01700192|5756596|P2|Overall Study|Noncompliance with study drug|5
1647003|NCT01700192|5756597|P1|Overall Study|Noncompliance with study drug|0
1647004|NCT01700192|5756596|P2|Overall Study|Lost to Follow-up|29
1647005|NCT01700192|5756597|P1|Overall Study|Lost to Follow-up|42
1647006|NCT01700192|5756596|P2|Overall Study|Lack of Efficacy|0
1647007|NCT01700192|5756597|P1|Overall Study|Lack of Efficacy|1
1647008|NCT01700192|5756596|P2|Overall Study|Adverse Event|18
1647009|NCT01700192|5756597|P1|Overall Study|Adverse Event|73
1647010|NCT01700179|5756615|P1|Overall Study|Physician Decision|2
1647011|NCT01700140|5756622|P3|Overall Study|Inclusion/exclusion criteria deviation|0
1647012|NCT01700140|5756623|P2|Overall Study|Inclusion/exclusion criteria deviation|4
1647013|NCT01700140|5756624|P1|Overall Study|Inclusion/exclusion criteria deviation|1
1647014|NCT01700140|5756622|P3|Overall Study|Adverse Event|0
1647015|NCT01700140|5756623|P2|Overall Study|Adverse Event|1
1647016|NCT01700140|5756624|P1|Overall Study|Adverse Event|0
1647017|NCT01700140|5756622|P3|Overall Study|Aggravation of symptoms|0
1647018|NCT01700140|5756623|P2|Overall Study|Aggravation of symptoms|0
1647019|NCT01700140|5756624|P1|Overall Study|Aggravation of symptoms|1
1647020|NCT01700140|5756622|P3|Overall Study|Use of chemotherapy or surgical therapy|0
1647021|NCT01700140|5756623|P2|Overall Study|Use of chemotherapy or surgical therapy|1
1647022|NCT01700140|5756624|P1|Overall Study|Use of chemotherapy or surgical therapy|0
1647023|NCT01700140|5756622|P3|Overall Study|Discontinuation of radiotherapy|0
1647024|NCT01700140|5756623|P2|Overall Study|Discontinuation of radiotherapy|0
1647025|NCT01700140|5756624|P1|Overall Study|Discontinuation of radiotherapy|1
1647026|NCT01700140|5756622|P3|Overall Study|Use of rescue drugs|1
1647027|NCT01700140|5756623|P2|Overall Study|Use of rescue drugs|3
1647028|NCT01700140|5756624|P1|Overall Study|Use of rescue drugs|3
1647029|NCT01700049|5756656|P1|Overall Study|Withdrawal by Subject|1
1647030|NCT01699867|5756671|P1|Overall Study|Screening Failure|3
1647031|NCT01699815|5756678|P2|Overall Study|Adverse Event|1
1647032|NCT01699815|5756679|P1|Overall Study|Adverse Event|0
1647033|NCT01699815|5756678|P2|Overall Study|record could not be located|0
1647034|NCT01699815|5756679|P1|Overall Study|record could not be located|1
1647035|NCT01699815|5756678|P2|Overall Study|Protocol Violation|7
1647036|NCT01699815|5756679|P1|Overall Study|Protocol Violation|4
1647037|NCT01699789|5756691|P2|Overall Study|Lost to Follow-up|101
1647038|NCT01699789|5756692|P1|Overall Study|Lost to Follow-up|83
1647039|NCT01699789|5756691|P2|Overall Study|Death|2
1647040|NCT01699789|5756692|P1|Overall Study|Death|1
1647041|NCT01699789|5756691|P2|Overall Study|Withdrawal by Subject|23
1647042|NCT01699789|5756692|P1|Overall Study|Withdrawal by Subject|18
1647043|NCT01699750|5756762|P2|Overall Study|Other|2
1647044|NCT01699750|5756763|P1|Overall Study|Other|0
1647045|NCT01699750|5756762|P2|Overall Study|Withdrew Consent|1
1647046|NCT01699750|5756763|P1|Overall Study|Withdrew Consent|0
1647047|NCT01699685|5756798|P2|Period 2|Lost to Follow-up|0
1647048|NCT01699685|5756799|P1|Period 2|Lost to Follow-up|1
1647049|NCT01699685|5756798|P2|Period 1|Patient request|1
1647050|NCT01699685|5756799|P1|Period 1|Patient request|0
1647051|NCT01699685|5756798|P2|Period 1|Other|1
1647052|NCT01699685|5756799|P1|Period 1|Other|0
1647053|NCT01699685|5756798|P2|Period 1|Medical or ethical, noncompliance|0
1647054|NCT01699685|5756799|P1|Period 1|Medical or ethical, noncompliance|2
1647055|NCT01699685|5756798|P2|Period 1|Adverse Event|1
1647056|NCT01699685|5756799|P1|Period 1|Adverse Event|1
1647057|NCT01699503|5756825|P2|Overall Study|Excluded due to quality|791
1647058|NCT01699503|5756826|P1|Overall Study|Excluded due to quality|783
1647059|NCT01699503|5756825|P2|Overall Study|Lost to Follow-up|117
1647060|NCT01699503|5756826|P1|Overall Study|Lost to Follow-up|121
1647061|NCT01699503|5756825|P2|Overall Study|Withdrawal by Subject|57
1647062|NCT01699503|5756826|P1|Overall Study|Withdrawal by Subject|65
1647063|NCT01699503|5756825|P2|Overall Study|Death|40
1647064|NCT01699503|5756826|P1|Overall Study|Death|31
1647065|NCT01699178|5756851|P2|Overall Study|ineligible/noncompliant/ subject reason|4
1647066|NCT01699178|5756852|P1|Overall Study|ineligible/noncompliant/ subject reason|4
1647067|NCT01699178|5756851|P2|Overall Study|PSA increase of >1.4 ng/mL|3
1647068|NCT01699178|5756852|P1|Overall Study|PSA increase of >1.4 ng/mL|4
1647069|NCT01699178|5756851|P2|Overall Study|Hematocrit >54%|1
1647070|NCT01699178|5756852|P1|Overall Study|Hematocrit >54%|1
1647071|NCT01699178|5756851|P2|Overall Study|Withdrawal by Subject|12
1647072|NCT01699178|5756852|P1|Overall Study|Withdrawal by Subject|4
1647073|NCT01699178|5756851|P2|Overall Study|Physician Decision|0
1647074|NCT01699178|5756852|P1|Overall Study|Physician Decision|1
1647075|NCT01699178|5756851|P2|Overall Study|Non-compliance with Study Drug|1
1647076|NCT01699178|5756852|P1|Overall Study|Non-compliance with Study Drug|3
1647077|NCT01699178|5756851|P2|Overall Study|Lost to Follow-up|6
1647078|NCT01699178|5756852|P1|Overall Study|Lost to Follow-up|1
1647079|NCT01699178|5756851|P2|Overall Study|Adverse Event|5
1647080|NCT01699178|5756852|P1|Overall Study|Adverse Event|1
1647081|NCT01699087|5756868|P1|Overall Study|Unable to make future visits|2
1647082|NCT01699087|5756868|P1|Overall Study|Screen failure (prior to treatment)|15
1647083|NCT01699087|5756868|P1|Overall Study|Lost to Follow-up|7
1647084|NCT01699022|5756882|P1|Overall Study|Early discontinuation from the study|3
1647085|NCT01698814|5756897|P2|Overall Study|Randomized in error|0
1647086|NCT01698814|5756898|P1|Overall Study|Randomized in error|1
1647087|NCT01698814|5756897|P2|Overall Study|Pregnancy|0
1647088|NCT01698814|5756898|P1|Overall Study|Pregnancy|1
1647089|NCT01698814|5756897|P2|Overall Study|Lost to Follow-up|1
1647090|NCT01698814|5756898|P1|Overall Study|Lost to Follow-up|0
1647091|NCT01698814|5756897|P2|Overall Study|Adverse Event|2
1647092|NCT01698814|5756898|P1|Overall Study|Adverse Event|0
1647093|NCT01698801|5756904|P1|Follow Up Phase|Death|4
1647094|NCT01698801|5756904|P1|Follow Up Phase|Withdrawal by Subject|1
1647095|NCT01698801|5756904|P1|Treatment Phase|Disease progression|1
1647096|NCT01698801|5756904|P1|Treatment Phase|Withdrawal by Subject|1
1647097|NCT01698801|5756904|P1|Treatment Phase|Other|4
1647098|NCT01698801|5756904|P1|Treatment Phase|Protocol Violation|1
1647099|NCT01698801|5756904|P1|Treatment Phase|Adverse Event|4
1647100|NCT01698775|5756915|P2|Phase B|Withdrawal by Subject|2
1647101|NCT01698775|5756916|P1|Phase B|Withdrawal by Subject|6
1647102|NCT01698775|5756915|P2|Phase B|Protocol Violation|1
1647103|NCT01698775|5756916|P1|Phase B|Protocol Violation|1
1647104|NCT01698775|5756915|P2|Phase B|Physician Decision|1
1647105|NCT01698775|5756916|P1|Phase B|Physician Decision|1
1647106|NCT01698775|5756915|P2|Phase B|Lost to Follow-up|1
1647107|NCT01698775|5756916|P1|Phase B|Lost to Follow-up|0
1647108|NCT01698775|5756915|P2|Phase B|Lack of Efficacy|1
1647109|NCT01698775|5756916|P1|Phase B|Lack of Efficacy|0
1647110|NCT01698775|5756915|P2|Phase B|Death|1
1647111|NCT01698775|5756916|P1|Phase B|Death|0
1647112|NCT01698775|5756915|P2|Phase B|Adverse Event|3
1647113|NCT01698775|5756916|P1|Phase B|Adverse Event|6
1647114|NCT01698775|5756915|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
1647115|NCT01698775|5756916|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
1647116|NCT01698775|5756915|P2|Phase A|Kidney [transplant]|1
1647117|NCT01698775|5756916|P1|Phase A|Kidney [transplant]|0
1647118|NCT01698775|5756915|P2|Phase A|Withdrawal by Subject|4
1647119|NCT01698775|5756916|P1|Phase A|Withdrawal by Subject|3
1647120|NCT01698775|5756915|P2|Phase A|Protocol Violation|0
1647121|NCT01698775|5756916|P1|Phase A|Protocol Violation|1
1647122|NCT01698775|5756915|P2|Phase A|Lost to Follow-up|2
1647123|NCT01698775|5756916|P1|Phase A|Lost to Follow-up|1
1647124|NCT01698775|5756915|P2|Phase A|Lack of Efficacy|0
1647125|NCT01698775|5756916|P1|Phase A|Lack of Efficacy|1
1647126|NCT01698775|5756915|P2|Phase A|Death|1
1647127|NCT01698775|5756916|P1|Phase A|Death|1
1647128|NCT01698775|5756915|P2|Phase A|Adverse Event|1
1647129|NCT01698775|5756916|P1|Phase A|Adverse Event|2
1647130|NCT01698554|5756965|P4|Overall Study|Other Miscellaneous Reasons|0
1647131|NCT01698554|5756966|P3|Overall Study|Other Miscellaneous Reasons|0
1647132|NCT01698554|5756967|P2|Overall Study|Other Miscellaneous Reasons|0
1647133|NCT01698554|5756968|P1|Overall Study|Other Miscellaneous Reasons|1
1647134|NCT01698554|5756965|P4|Overall Study|Protocol Violation|0
1647135|NCT01698554|5756966|P3|Overall Study|Protocol Violation|1
1647136|NCT01698554|5756967|P2|Overall Study|Protocol Violation|0
1647137|NCT01698554|5756968|P1|Overall Study|Protocol Violation|2
1647138|NCT01698554|5756965|P4|Overall Study|Personal Reasons|1
1647139|NCT01698554|5756966|P3|Overall Study|Personal Reasons|1
1647140|NCT01698554|5756967|P2|Overall Study|Personal Reasons|5
1647141|NCT01698554|5756968|P1|Overall Study|Personal Reasons|0
1647142|NCT01698554|5756965|P4|Overall Study|Lost to Follow-up|0
1647143|NCT01698554|5756966|P3|Overall Study|Lost to Follow-up|0
1647144|NCT01698554|5756967|P2|Overall Study|Lost to Follow-up|0
1647145|NCT01698554|5756968|P1|Overall Study|Lost to Follow-up|1
1647146|NCT01698554|5756965|P4|Overall Study|Adverse Event|1
1647147|NCT01698554|5756966|P3|Overall Study|Adverse Event|0
1647148|NCT01698554|5756967|P2|Overall Study|Adverse Event|5
1647149|NCT01698554|5756968|P1|Overall Study|Adverse Event|2
1647150|NCT01698320|5757038|P3|40-Week Open-Label Period|Lost to Follow-up|0
1647151|NCT01698320|5757039|P2|40-Week Open-Label Period|Lost to Follow-up|2
1647152|NCT01698320|5757040|P1|40-Week Open-Label Period|Lost to Follow-up|0
1647153|NCT01698320|5757038|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1647154|NCT01698320|5757039|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
1647155|NCT01698320|5757040|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
1647156|NCT01698320|5757038|P3|40-Week Open-Label Period|Pregnancy|1
1647157|NCT01698320|5757039|P2|40-Week Open-Label Period|Pregnancy|2
1647158|NCT01698320|5757040|P1|40-Week Open-Label Period|Pregnancy|0
1647159|NCT01698320|5757038|P3|40-Week Open-Label Period|Withdrawal by Subject|7
1647160|NCT01698320|5757039|P2|40-Week Open-Label Period|Withdrawal by Subject|11
1647161|NCT01698320|5757040|P1|40-Week Open-Label Period|Withdrawal by Subject|0
1647162|NCT01698320|5757038|P3|40-Week Open-Label Period|Adverse Event|2
1647163|NCT01698320|5757039|P2|40-Week Open-Label Period|Adverse Event|3
1647164|NCT01698320|5757040|P1|40-Week Open-Label Period|Adverse Event|0
1647165|NCT01698320|5757038|P3|12-Week Double-Blind Period|Lost to Follow-up|4
1647166|NCT01698320|5757039|P2|12-Week Double-Blind Period|Lost to Follow-up|0
1647167|NCT01698320|5757040|P1|12-Week Double-Blind Period|Lost to Follow-up|0
1647168|NCT01698320|5757038|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
1647169|NCT01698320|5757039|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1647170|NCT01698320|5757040|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
1647171|NCT01698320|5757038|P3|12-Week Double-Blind Period|Pregnancy|1
1647172|NCT01698320|5757039|P2|12-Week Double-Blind Period|Pregnancy|1
1647173|NCT01698320|5757040|P1|12-Week Double-Blind Period|Pregnancy|0
1647174|NCT01698320|5757038|P3|12-Week Double-Blind Period|Protocol Violation|2
1647175|NCT01698320|5757039|P2|12-Week Double-Blind Period|Protocol Violation|0
1647176|NCT01698320|5757040|P1|12-Week Double-Blind Period|Protocol Violation|0
1647177|NCT01698320|5757038|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
1647178|NCT01698320|5757039|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
1647179|NCT01698320|5757040|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
1647180|NCT01698320|5757038|P3|12-Week Double-Blind Period|Adverse Event|1
1647181|NCT01698320|5757039|P2|12-Week Double-Blind Period|Adverse Event|1
1647182|NCT01698320|5757040|P1|12-Week Double-Blind Period|Adverse Event|0
1647183|NCT01698320|5757038|P3|Run-In Period (Week -1 to Day 0)|Other|0
1647184|NCT01698320|5757039|P2|Run-In Period (Week -1 to Day 0)|Other|0
1647185|NCT01698320|5757040|P1|Run-In Period (Week -1 to Day 0)|Other|1
1647186|NCT01698320|5757038|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1647187|NCT01698320|5757039|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
1647188|NCT01698320|5757040|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
1647189|NCT01698320|5757038|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1647190|NCT01698320|5757039|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
1647191|NCT01698320|5757040|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
1647192|NCT01698320|5757038|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1647193|NCT01698320|5757039|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
1647194|NCT01698320|5757040|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
1647195|NCT01698268|5757060|P2|Overall Study|Physician Decision|1
1647196|NCT01698268|5757061|P1|Overall Study|Physician Decision|2
1647197|NCT01698008|5757069|P2|Overall Study|Withdrawal by Subject|2
1647198|NCT01698008|5757070|P1|Overall Study|Withdrawal by Subject|1
1647199|NCT01697969|5757076|P1|Overall Study|Did not meet inc/exc criteria|3
1647200|NCT01697956|5757083|P2|Overall Study|Protocol Violation|1
1647201|NCT01697956|5757084|P1|Overall Study|Protocol Violation|1
1647202|NCT01697748|5757114|P2|Overall Study|Lost to Follow-up|65
1647203|NCT01697748|5757115|P1|Overall Study|Lost to Follow-up|53
1647204|NCT01697748|5757114|P2|Overall Study|ineligible uterine incision|1
1647205|NCT01697748|5757115|P1|Overall Study|ineligible uterine incision|4
1647206|NCT01697748|5757114|P2|Overall Study|ineligible skin incision|2
1647207|NCT01697748|5757115|P1|Overall Study|ineligible skin incision|1
1647208|NCT01697696|5757144|P2|Overall Study|Subject/guardian decision|35
1647209|NCT01697696|5757145|P1|Overall Study|Subject/guardian decision|31
1647210|NCT01697696|5757144|P2|Overall Study|Lost to Follow-up|7
1647211|NCT01697696|5757145|P1|Overall Study|Lost to Follow-up|10
1647212|NCT01697696|5757144|P2|Overall Study|Death|2
1647213|NCT01697696|5757145|P1|Overall Study|Death|4
1647214|NCT01697696|5757144|P2|Overall Study|Physician Decision|0
1647215|NCT01697696|5757145|P1|Overall Study|Physician Decision|1
1647216|NCT01697696|5757144|P2|Overall Study|Protocol deviation|0
1647217|NCT01697696|5757145|P1|Overall Study|Protocol deviation|1
1647218|NCT01697696|5757144|P2|Overall Study|Study terminated by sponsor|3
1647219|NCT01697696|5757145|P1|Overall Study|Study terminated by sponsor|0
1647220|NCT01697592|5757177|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
1647221|NCT01697592|5757178|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
1647222|NCT01697592|5757179|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
1647223|NCT01697592|5757180|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
1647224|NCT01697592|5757181|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
1647225|NCT01697592|5757182|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
1647226|NCT01697592|5757183|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
1647227|NCT01697592|5757184|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
1647228|NCT01697592|5757185|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
1647229|NCT01697592|5757186|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
1647230|NCT01697592|5757177|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1647231|NCT01697592|5757178|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1647232|NCT01697592|5757179|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1647233|NCT01697592|5757180|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1647234|NCT01697592|5757181|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
1647235|NCT01697592|5757182|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1647236|NCT01697592|5757183|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1647237|NCT01697592|5757184|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1647238|NCT01697592|5757185|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
1647239|NCT01697592|5757186|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
1647240|NCT01697592|5757177|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
1647241|NCT01697592|5757178|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
1647242|NCT01697592|5757179|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
1647243|NCT01697592|5757180|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
1647244|NCT01697592|5757181|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
1647245|NCT01697592|5757182|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
1647246|NCT01697592|5757183|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
1647247|NCT01697592|5757184|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
1647248|NCT01697592|5757185|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
1647249|NCT01697592|5757186|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
1647250|NCT01697592|5757177|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
1647251|NCT01697592|5757178|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
1647252|NCT01697592|5757179|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
1647253|NCT01697592|5757180|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
1647254|NCT01697592|5757181|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
1647255|NCT01697592|5757182|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
1647256|NCT01697592|5757183|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
1647257|NCT01697592|5757184|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
1647258|NCT01697592|5757185|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
1647259|NCT01697592|5757186|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
1647260|NCT01697592|5757177|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1647261|NCT01697592|5757178|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1647262|NCT01697592|5757179|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1647263|NCT01697592|5757180|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1647264|NCT01697592|5757181|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1647265|NCT01697592|5757182|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1647266|NCT01697592|5757183|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1647267|NCT01697592|5757184|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
1647268|NCT01697592|5757185|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1647269|NCT01697592|5757186|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
1647270|NCT01697592|5757177|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647271|NCT01697592|5757178|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647272|NCT01697592|5757179|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647273|NCT01697592|5757180|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647274|NCT01697592|5757181|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647275|NCT01697592|5757182|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647276|NCT01697592|5757183|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647277|NCT01697592|5757184|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647278|NCT01697592|5757185|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
1647279|NCT01697592|5757186|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
1647280|NCT01697592|5757177|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
1647281|NCT01697592|5757178|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
1647282|NCT01697592|5757179|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
1647283|NCT01697592|5757180|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
1647284|NCT01697592|5757181|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
1647285|NCT01697592|5757182|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
1647286|NCT01697592|5757183|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
1647287|NCT01697592|5757184|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
1647288|NCT01697592|5757185|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
1647289|NCT01697592|5757186|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
1647290|NCT01697592|5757177|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647291|NCT01697592|5757178|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647292|NCT01697592|5757179|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647293|NCT01697592|5757180|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647294|NCT01697592|5757181|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647295|NCT01697592|5757182|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647296|NCT01697592|5757183|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647297|NCT01697592|5757184|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647298|NCT01697592|5757185|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
1647299|NCT01697592|5757186|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
1647300|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
1647301|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1647302|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1647303|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1647304|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1647305|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1647306|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
1647307|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
1647308|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
1647309|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1647310|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1647311|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1647312|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1647313|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
1647314|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Participant Moved|2
1647315|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Participant Moved|0
1647316|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Participant Moved|0
1647317|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Participant Moved|0
1647318|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Participant Moved|0
1647319|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Participant Moved|0
1647320|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Participant Moved|0
1647321|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Technical Problems|1
1647322|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Technical Problems|0
1647323|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Technical Problems|0
1647324|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Technical Problems|0
1647325|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Technical Problems|0
1647326|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Technical Problems|0
1647327|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Technical Problems|0
1647328|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
1647329|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1647330|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1647331|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1647332|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1647333|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1647334|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
1647335|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
1647336|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
1647337|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1647338|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1647339|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1647340|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1647341|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
1647342|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
1647343|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
1647344|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1647345|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1647346|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1647347|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1647348|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
1647349|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1647350|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
1647351|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1647352|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1647353|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1647354|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1647355|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
1647356|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
1647357|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
1647358|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
1647359|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
1647360|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
1647361|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
1647362|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
1647363|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
1647364|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
1647365|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
1647366|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
1647367|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
1647368|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
1647369|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
1647370|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Physician Decision|11
1647371|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Physician Decision|7
1647372|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Physician Decision|0
1647373|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Physician Decision|0
1647374|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Physician Decision|0
1647375|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Physician Decision|0
1647376|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Physician Decision|0
1647377|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
1647378|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
1647379|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1647380|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1647381|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1647382|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1647383|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
1647384|NCT01697579|5757255|P7|Optional Extension-Cycles 2-6|Death|2
1647385|NCT01697579|5757256|P6|Optional Extension-Cycles 2-6|Death|0
1647386|NCT01697579|5757257|P5|Optional Extension-Cycles 2-6|Death|0
1647387|NCT01697579|5757258|P4|Optional Extension-Cycles 2-6|Death|0
1647388|NCT01697579|5757259|P3|Optional Extension-Cycles 2-6|Death|0
1647389|NCT01697579|5757260|P2|Optional Extension-Cycles 2-6|Death|0
1647390|NCT01697579|5757261|P1|Optional Extension-Cycles 2-6|Death|0
1647391|NCT01697579|5757255|P7|Base Study-Cycle 1|Technical Problems|0
1647392|NCT01697579|5757256|P6|Base Study-Cycle 1|Technical Problems|0
1647393|NCT01697579|5757257|P5|Base Study-Cycle 1|Technical Problems|0
1647394|NCT01697579|5757258|P4|Base Study-Cycle 1|Technical Problems|1
1647395|NCT01697579|5757259|P3|Base Study-Cycle 1|Technical Problems|1
1647396|NCT01697579|5757260|P2|Base Study-Cycle 1|Technical Problems|0
1647397|NCT01697579|5757261|P1|Base Study-Cycle 1|Technical Problems|0
1647398|NCT01697579|5757255|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1647399|NCT01697579|5757256|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1647400|NCT01697579|5757257|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1647401|NCT01697579|5757258|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1647402|NCT01697579|5757259|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1647403|NCT01697579|5757260|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
1647404|NCT01697579|5757261|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
1647405|NCT01697579|5757255|P7|Base Study-Cycle 1|Protocol Violation|0
1647406|NCT01697579|5757256|P6|Base Study-Cycle 1|Protocol Violation|0
1647407|NCT01697579|5757257|P5|Base Study-Cycle 1|Protocol Violation|3
1647408|NCT01697579|5757258|P4|Base Study-Cycle 1|Protocol Violation|0
1647409|NCT01697579|5757259|P3|Base Study-Cycle 1|Protocol Violation|0
1647410|NCT01697579|5757260|P2|Base Study-Cycle 1|Protocol Violation|0
1647411|NCT01697579|5757261|P1|Base Study-Cycle 1|Protocol Violation|0
1647412|NCT01697579|5757255|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1647413|NCT01697579|5757256|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1647414|NCT01697579|5757257|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1647415|NCT01697579|5757258|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1647416|NCT01697579|5757259|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1647417|NCT01697579|5757260|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
1647418|NCT01697579|5757261|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
1647419|NCT01697579|5757255|P7|Base Study-Cycle 1|Adverse Event|0
1647420|NCT01697579|5757256|P6|Base Study-Cycle 1|Adverse Event|0
1647421|NCT01697579|5757257|P5|Base Study-Cycle 1|Adverse Event|0
1647422|NCT01697579|5757258|P4|Base Study-Cycle 1|Adverse Event|0
1647423|NCT01697579|5757259|P3|Base Study-Cycle 1|Adverse Event|0
1647424|NCT01697579|5757260|P2|Base Study-Cycle 1|Adverse Event|0
1647425|NCT01697579|5757261|P1|Base Study-Cycle 1|Adverse Event|1
1647426|NCT01697501|5757373|P1|Overall Study|Protocol Violation|2
1647427|NCT01697462|5757416|P1|Overall Study|Missing|5
1647428|NCT01697462|5757416|P1|Overall Study|Other|10
1647429|NCT01697462|5757416|P1|Overall Study|Death|1
1647430|NCT01697462|5757416|P1|Overall Study|Investigator Decision|21
1647431|NCT01697462|5757416|P1|Overall Study|Withdrawal by Subject|12
1647432|NCT01697462|5757416|P1|Overall Study|Lost to Follow-up|21
1647433|NCT01697462|5757416|P1|Overall Study|Adverse Event|6
1647434|NCT01697462|5757416|P1|Overall Study|Disease Progression|1
1647435|NCT01697449|5757423|P1|Overall Study|Missing|25
1647436|NCT01697449|5757423|P1|Overall Study|Other|1
1647437|NCT01697449|5757423|P1|Overall Study|Death|2
1647438|NCT01697449|5757423|P1|Overall Study|Physician Decision|1
1647439|NCT01697449|5757423|P1|Overall Study|Withdrawal by Subject|2
1647440|NCT01697449|5757423|P1|Overall Study|Lost to Follow-up|5
1647441|NCT01697449|5757423|P1|Overall Study|Adverse Event|7
1647442|NCT01697449|5757423|P1|Overall Study|Disease progression|47
1647443|NCT01697358|5757434|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
1647444|NCT01697358|5757435|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
1647445|NCT01697358|5757434|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
1647446|NCT01697358|5757435|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
1647447|NCT01697358|5757434|P2|Period II: 6-24M Long-term Follow-up|Death|1
1647448|NCT01697358|5757435|P1|Period II: 6-24M Long-term Follow-up|Death|1
1647449|NCT01697358|5757434|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1647450|NCT01697358|5757435|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
1647451|NCT01697358|5757434|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
1647452|NCT01697358|5757435|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
1647453|NCT01697358|5757434|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
1647454|NCT01697358|5757435|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
1647455|NCT01697358|5757434|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
1647456|NCT01697358|5757435|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
1647457|NCT01697358|5757434|P2|Period I: Randomization to 6 Months|Adverse Event|1
1647458|NCT01697358|5757435|P1|Period I: Randomization to 6 Months|Adverse Event|1
1647459|NCT01697358|5757434|P2|Period I: Randomization to 6 Months|Physician Decision|0
1647460|NCT01697358|5757435|P1|Period I: Randomization to 6 Months|Physician Decision|4
1647461|NCT01697358|5757434|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
1647462|NCT01697358|5757435|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
1647463|NCT01697345|5757451|P1|Overall Study|Withdrawal by Subject|1
1647464|NCT01697319|5757476|P1|Extension Phase|Terminated by Sponsor|15
1647465|NCT01697319|5757476|P1|Primary Phase|Withdrawal by Subject|1
1647466|NCT01696994|5757485|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
1647467|NCT01696994|5757486|P1|Overall Study|Refused Screen (Ovarian Screening)|0
1647468|NCT01696994|5757485|P2|Overall Study|Refused ASU (Control)|0
1647469|NCT01696994|5757486|P1|Overall Study|Refused ASU (Control)|311
1647470|NCT01696994|5757485|P2|Overall Study|No Ovaries at Baseline|4851
1647471|NCT01696994|5757486|P1|Overall Study|No Ovaries at Baseline|4807
1647472|NCT01696994|5757485|P2|Overall Study|Died Before ASU (Control)|0
1647473|NCT01696994|5757486|P1|Overall Study|Died Before ASU (Control)|73
1647474|NCT01696994|5757485|P2|Overall Study|Died Before Randomization|2
1647475|NCT01696994|5757486|P1|Overall Study|Died Before Randomization|1
1647476|NCT01696994|5757485|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
1647477|NCT01696994|5757486|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
1647478|NCT01696981|5757514|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
1647479|NCT01696981|5757515|P1|Overall Study|Refused Screen (Colorectal Screening)|0
1647480|NCT01696981|5757514|P2|Overall Study|Refused ASU (Control)|0
1647481|NCT01696981|5757515|P1|Overall Study|Refused ASU (Control)|920
1647482|NCT01696981|5757514|P2|Overall Study|Died Before ASU (Control)|0
1647483|NCT01696981|5757515|P1|Overall Study|Died Before ASU (Control)|278
1647484|NCT01696981|5757514|P2|Overall Study|Died Before Randomization|8
1647485|NCT01696981|5757515|P1|Overall Study|Died Before Randomization|3
1647486|NCT01696981|5757514|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
1647487|NCT01696981|5757515|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
1647488|NCT01696968|5757535|P2|Overall Study|Refused Screen (Lung Screening)|6796
1647489|NCT01696968|5757536|P1|Overall Study|Refused Screen (Lung Screening)|0
1647490|NCT01696968|5757535|P2|Overall Study|Refused ASU (Control)|0
1647491|NCT01696968|5757536|P1|Overall Study|Refused ASU (Control)|920
1647492|NCT01696968|5757535|P2|Overall Study|Died Before ASU (Control)|0
1647493|NCT01696968|5757536|P1|Overall Study|Died Before ASU (Control)|278
1647494|NCT01696968|5757535|P2|Overall Study|Died Before Randomization|8
1647495|NCT01696968|5757536|P1|Overall Study|Died Before Randomization|3
1647496|NCT01696968|5757535|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
1647497|NCT01696968|5757536|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
1647498|NCT01696955|5757558|P2|Main Study|Withdrawal by Subject|1
1647499|NCT01696955|5757559|P1|Main Study|Withdrawal by Subject|1
1647500|NCT01696955|5757558|P2|Main Study|Protocol Violation|0
1647501|NCT01696955|5757559|P1|Main Study|Protocol Violation|1
1647502|NCT01696942|5757584|P2|Overall Study|screen failure|1
1647503|NCT01696942|5757585|P1|Overall Study|screen failure|0
1647504|NCT01696942|5757584|P2|Overall Study|Protocol Violation|2
1647505|NCT01696942|5757585|P1|Overall Study|Protocol Violation|1
1647506|NCT01696942|5757584|P2|Overall Study|Withdrawal by Subject|0
1647507|NCT01696942|5757585|P1|Overall Study|Withdrawal by Subject|1
1647508|NCT01696929|5757593|P1|Overall Study|Physician Decision|1
1647509|NCT01696877|5757600|P2|Overall Study|Adverse Event|1
1647510|NCT01696877|5757601|P1|Overall Study|Adverse Event|0
1647511|NCT01696773|5757623|P2|Days 15-27, Washout|Adverse Event|0
1647512|NCT01696773|5757624|P1|Days 15-27, Washout|Adverse Event|1
1647513|NCT01696695|5757651|P1|Overall Study|Major Protocol Violation|192
1647514|NCT01696695|5757651|P1|Overall Study|Other|74
1647515|NCT01696695|5757651|P1|Overall Study|Lost to Follow-up|48
1647516|NCT01696695|5757651|P1|Overall Study|Withdrawal by Subject|92
1647517|NCT01696695|5757651|P1|Overall Study|Adverse Event|74
1647518|NCT01696695|5757651|P1|Overall Study|Death|29
1647519|NCT01696695|5757651|P1|Overall Study|Disease progression|373
1647520|NCT01696643|5757663|P2|Overall Study|Participant Did Not Receive Study Drug|2
1647521|NCT01696643|5757664|P1|Overall Study|Participant Did Not Receive Study Drug|2
1647522|NCT01696643|5757663|P2|Overall Study|Medical Monitor Decision|2
1647523|NCT01696643|5757664|P1|Overall Study|Medical Monitor Decision|0
1647524|NCT01696643|5757663|P2|Overall Study|Participant Incarcerated|1
1647525|NCT01696643|5757664|P1|Overall Study|Participant Incarcerated|0
1647526|NCT01696643|5757663|P2|Overall Study|Site Error|1
1647527|NCT01696643|5757664|P1|Overall Study|Site Error|2
1647528|NCT01696643|5757663|P2|Overall Study|Participant on Restricted Bed Rest|0
1647529|NCT01696643|5757664|P1|Overall Study|Participant on Restricted Bed Rest|1
1647530|NCT01696643|5757663|P2|Overall Study|Withdrawal by Subject|149
1647531|NCT01696643|5757664|P1|Overall Study|Withdrawal by Subject|142
1647532|NCT01696643|5757663|P2|Overall Study|Study Terminated by Sponsor|294
1647533|NCT01696643|5757664|P1|Overall Study|Study Terminated by Sponsor|286
1647534|NCT01696643|5757663|P2|Overall Study|Protocol Violation|7
1647535|NCT01696643|5757664|P1|Overall Study|Protocol Violation|7
1647536|NCT01696643|5757663|P2|Overall Study|Pregnancy|1
1647537|NCT01696643|5757664|P1|Overall Study|Pregnancy|0
1647538|NCT01696643|5757663|P2|Overall Study|Physician Decision|2
1647539|NCT01696643|5757664|P1|Overall Study|Physician Decision|3
1647540|NCT01696643|5757663|P2|Overall Study|Lost to Follow-up|67
1647541|NCT01696643|5757664|P1|Overall Study|Lost to Follow-up|67
1647542|NCT01696643|5757663|P2|Overall Study|Lack of Efficacy|0
1647543|NCT01696643|5757664|P1|Overall Study|Lack of Efficacy|3
1647544|NCT01696643|5757663|P2|Overall Study|Death|2
1647545|NCT01696643|5757664|P1|Overall Study|Death|1
1647546|NCT01696643|5757663|P2|Overall Study|Adverse Event|7
1647547|NCT01696643|5757664|P1|Overall Study|Adverse Event|15
1647548|NCT01696396|5757683|P4|Overall Study|Death|0
1647549|NCT01696396|5757684|P3|Overall Study|Death|1
1647550|NCT01696396|5757685|P2|Overall Study|Death|0
1647551|NCT01696396|5757686|P1|Overall Study|Death|0
1647552|NCT01696396|5757683|P4|Overall Study|Lost to Follow-up|1
1647553|NCT01696396|5757684|P3|Overall Study|Lost to Follow-up|4
1647554|NCT01696396|5757685|P2|Overall Study|Lost to Follow-up|1
1647555|NCT01696396|5757686|P1|Overall Study|Lost to Follow-up|9
1647556|NCT01696396|5757683|P4|Overall Study|Decision by Sponsor|2
1647557|NCT01696396|5757684|P3|Overall Study|Decision by Sponsor|2
1647558|NCT01696396|5757685|P2|Overall Study|Decision by Sponsor|1
1647559|NCT01696396|5757686|P1|Overall Study|Decision by Sponsor|3
1647560|NCT01696396|5757683|P4|Overall Study|Withdrawal by Subject|11
1647561|NCT01696396|5757684|P3|Overall Study|Withdrawal by Subject|19
1647562|NCT01696396|5757685|P2|Overall Study|Withdrawal by Subject|5
1647563|NCT01696396|5757686|P1|Overall Study|Withdrawal by Subject|19
1647564|NCT01696279|5757737|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
1647565|NCT01696279|5757738|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
1647566|NCT01696279|5757739|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
1647567|NCT01696279|5757740|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
1647568|NCT01696279|5757737|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
1647569|NCT01696279|5757738|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
1647570|NCT01696279|5757739|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
1647571|NCT01696279|5757740|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
1647572|NCT01696279|5757737|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
1647573|NCT01696279|5757738|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
1647574|NCT01696279|5757739|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
1647575|NCT01696279|5757740|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
1647576|NCT01696279|5757737|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
1647577|NCT01696279|5757738|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
1647578|NCT01696279|5757739|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
1647579|NCT01696279|5757740|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
1647580|NCT01696279|5757737|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
1647581|NCT01696279|5757738|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
1647582|NCT01696279|5757739|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
1647583|NCT01696279|5757740|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
1647584|NCT01696279|5757737|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
1647585|NCT01696279|5757738|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
1647586|NCT01696279|5757739|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
1647587|NCT01696279|5757740|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
1647588|NCT01696279|5757737|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
1647589|NCT01696279|5757738|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
1647590|NCT01696279|5757739|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
1647591|NCT01696279|5757740|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
1647592|NCT01696279|5757737|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
1647593|NCT01696279|5757738|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
1647594|NCT01696279|5757739|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
1647595|NCT01696279|5757740|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
1647596|NCT01696279|5757737|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
1647597|NCT01696279|5757738|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
1647598|NCT01696279|5757739|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
1647599|NCT01696279|5757740|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
1647600|NCT01696279|5757737|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
1647601|NCT01696279|5757738|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
1647602|NCT01696279|5757739|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
1647603|NCT01696279|5757740|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
1647604|NCT01696279|5757737|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
1647605|NCT01696279|5757738|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
1647606|NCT01696279|5757739|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
1647607|NCT01696279|5757740|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
1647608|NCT01696214|5757778|P4|Overall Study|Lost to Follow-up|0
1647609|NCT01696214|5757779|P3|Overall Study|Lost to Follow-up|0
1647610|NCT01696214|5757780|P2|Overall Study|Lost to Follow-up|0
1647611|NCT01696214|5757781|P1|Overall Study|Lost to Follow-up|1
1647612|NCT01696188|5757801|P2|Overall Study|Protocol Violation|1
1647613|NCT01696188|5757802|P1|Overall Study|Protocol Violation|1
1647614|NCT01696071|5757833|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
1647615|NCT01696071|5757834|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
1647616|NCT01696058|5757862|P2|Overall Study|Other reason prematurely discontinued|3
1647617|NCT01696058|5757863|P1|Overall Study|Other reason prematurely discontinued|5
1647618|NCT01696058|5757862|P2|Overall Study|Withdrawal by Subject|6
1647619|NCT01696058|5757863|P1|Overall Study|Withdrawal by Subject|4
1647620|NCT01696058|5757862|P2|Overall Study|Lost to Follow-up|5
1647621|NCT01696058|5757863|P1|Overall Study|Lost to Follow-up|2
1647622|NCT01696058|5757862|P2|Overall Study|Protocol Violation|3
1647623|NCT01696058|5757863|P1|Overall Study|Protocol Violation|9
1647624|NCT01696058|5757862|P2|Overall Study|Lack of Efficacy|3
1647625|NCT01696058|5757863|P1|Overall Study|Lack of Efficacy|2
1647626|NCT01696058|5757862|P2|Overall Study|Adverse Event|11
1647627|NCT01696058|5757863|P1|Overall Study|Adverse Event|21
1647628|NCT01696045|5757891|P2|Overall Study|Disease progression|2
1647629|NCT01696045|5757892|P1|Overall Study|Disease progression|2
1647630|NCT01696045|5757891|P2|Overall Study|Study drug toxicity|5
1647631|NCT01696045|5757892|P1|Overall Study|Study drug toxicity|1
1647632|NCT01695993|5757911|P3|Overall Study|Changed Medical Facility|1
1647633|NCT01695993|5757912|P2|Overall Study|Changed Medical Facility|0
1647634|NCT01695993|5757913|P1|Overall Study|Changed Medical Facility|0
1647635|NCT01695993|5757911|P3|Overall Study|To ill to continue|0
1647636|NCT01695993|5757912|P2|Overall Study|To ill to continue|2
1647637|NCT01695993|5757913|P1|Overall Study|To ill to continue|1
1647638|NCT01695993|5757911|P3|Overall Study|Withdrawal by Subject|2
1647639|NCT01695993|5757912|P2|Overall Study|Withdrawal by Subject|2
1647640|NCT01695993|5757913|P1|Overall Study|Withdrawal by Subject|2
1647641|NCT01695993|5757911|P3|Overall Study|Lost to Follow-up|3
1647642|NCT01695993|5757912|P2|Overall Study|Lost to Follow-up|1
1647643|NCT01695993|5757913|P1|Overall Study|Lost to Follow-up|2
1647644|NCT01695772|5757921|P1|Overall Study|Unspecified Reason|1
1647645|NCT01695772|5757921|P1|Overall Study|Protocol Violation|2
1647646|NCT01695772|5757921|P1|Overall Study|Lost to Follow-up|4
1647647|NCT01695772|5757921|P1|Overall Study|Investigator Decision|5
1647648|NCT01695772|5757921|P1|Overall Study|Progressive Disease|8
1647649|NCT01695772|5757921|P1|Overall Study|Withdrawal by Subject|18
1647650|NCT01695746|5757933|P1|Overall Study|Participant not willing to participate|3
1647651|NCT01695746|5757933|P1|Overall Study|Protocol Violation|5
1647652|NCT01695746|5757933|P1|Overall Study|Non-compliance by the participant|3
1647653|NCT01695746|5757933|P1|Overall Study|Adverse Event|1
1647654|NCT01695239|5757993|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
1647655|NCT01695239|5757994|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
1647656|NCT01695239|5757995|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
1647657|NCT01695239|5757996|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
1647658|NCT01695239|5757997|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
1647659|NCT01695239|5757998|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
1647660|NCT01695239|5757999|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
1647661|NCT01695239|5758000|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
1647662|NCT01695239|5758001|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
1647663|NCT01695239|5758002|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
1647664|NCT01695239|5758003|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
1647665|NCT01695239|5758004|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
1647666|NCT01695239|5758005|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
1647667|NCT01695239|5758006|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
1647668|NCT01695239|5757993|P14|Post-Treatment Follow-Up Period|Physician Decision|0
1647669|NCT01695239|5757994|P13|Post-Treatment Follow-Up Period|Physician Decision|2
1647670|NCT01695239|5757995|P12|Post-Treatment Follow-Up Period|Physician Decision|0
1647671|NCT01695239|5757996|P11|Post-Treatment Follow-Up Period|Physician Decision|0
1647672|NCT01695239|5757997|P10|Post-Treatment Follow-Up Period|Physician Decision|0
1647673|NCT01695239|5757998|P9|Post-Treatment Follow-Up Period|Physician Decision|0
1647674|NCT01695239|5757999|P8|Post-Treatment Follow-Up Period|Physician Decision|0
1647675|NCT01695239|5758000|P7|Post-Treatment Follow-Up Period|Physician Decision|0
1647676|NCT01695239|5758001|P6|Post-Treatment Follow-Up Period|Physician Decision|0
1647677|NCT01695239|5758002|P5|Post-Treatment Follow-Up Period|Physician Decision|0
1647678|NCT01695239|5758003|P4|Post-Treatment Follow-Up Period|Physician Decision|0
1647679|NCT01695239|5758004|P3|Post-Treatment Follow-Up Period|Physician Decision|0
1647680|NCT01695239|5758005|P2|Post-Treatment Follow-Up Period|Physician Decision|0
1647681|NCT01695239|5758006|P1|Post-Treatment Follow-Up Period|Physician Decision|0
1647682|NCT01695239|5757993|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
1647683|NCT01695239|5757994|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
1647684|NCT01695239|5757995|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647685|NCT01695239|5757996|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647686|NCT01695239|5757997|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647687|NCT01695239|5757998|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647688|NCT01695239|5757999|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647689|NCT01695239|5758000|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647690|NCT01695239|5758001|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647691|NCT01695239|5758002|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647692|NCT01695239|5758003|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647693|NCT01695239|5758004|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647694|NCT01695239|5758005|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647695|NCT01695239|5758006|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
1647696|NCT01695239|5757993|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1647697|NCT01695239|5757994|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
1647698|NCT01695239|5757995|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
1647699|NCT01695239|5757996|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647700|NCT01695239|5757997|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647701|NCT01695239|5757998|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647702|NCT01695239|5757999|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647703|NCT01695239|5758000|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647704|NCT01695239|5758001|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647705|NCT01695239|5758002|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647706|NCT01695239|5758003|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647707|NCT01695239|5758004|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647708|NCT01695239|5758005|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647709|NCT01695239|5758006|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
1647710|NCT01695239|5757993|P14|Extension Long-Term Extension Periods|Death|0
1647711|NCT01695239|5757994|P13|Extension Long-Term Extension Periods|Death|0
1647712|NCT01695239|5757995|P12|Extension Long-Term Extension Periods|Death|0
1647713|NCT01695239|5757996|P11|Extension Long-Term Extension Periods|Death|0
1647714|NCT01695239|5757997|P10|Extension Long-Term Extension Periods|Death|0
1647715|NCT01695239|5757998|P9|Extension Long-Term Extension Periods|Death|1
1647716|NCT01695239|5757999|P8|Extension Long-Term Extension Periods|Death|0
1647717|NCT01695239|5758000|P7|Extension Long-Term Extension Periods|Death|0
1647718|NCT01695239|5758001|P6|Extension Long-Term Extension Periods|Death|0
1647719|NCT01695239|5758002|P5|Extension Long-Term Extension Periods|Death|0
1647720|NCT01695239|5758003|P4|Extension Long-Term Extension Periods|Death|0
1647721|NCT01695239|5758004|P3|Extension Long-Term Extension Periods|Death|0
1647722|NCT01695239|5758005|P2|Extension Long-Term Extension Periods|Death|0
1647723|NCT01695239|5758006|P1|Extension Long-Term Extension Periods|Death|0
1647724|NCT01695239|5757993|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
1647725|NCT01695239|5757994|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
1647726|NCT01695239|5757995|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
1647727|NCT01695239|5757996|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
1647728|NCT01695239|5757997|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
1647729|NCT01695239|5757998|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
1647730|NCT01695239|5757999|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
1647731|NCT01695239|5758000|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
1647732|NCT01695239|5758001|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
1647733|NCT01695239|5758002|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
1647734|NCT01695239|5758003|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
1647735|NCT01695239|5758004|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
1647736|NCT01695239|5758005|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
1647737|NCT01695239|5758006|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
1647738|NCT01695239|5757993|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647739|NCT01695239|5757994|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647740|NCT01695239|5757995|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647741|NCT01695239|5757996|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647742|NCT01695239|5757997|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
1647743|NCT01695239|5757998|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
1647744|NCT01695239|5757999|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647745|NCT01695239|5758000|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647746|NCT01695239|5758001|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647747|NCT01695239|5758002|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647748|NCT01695239|5758003|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647749|NCT01695239|5758004|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647750|NCT01695239|5758005|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647751|NCT01695239|5758006|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
1647752|NCT01695239|5757993|P14|Extension Long-Term Extension Periods|Physician Decision|0
1647753|NCT01695239|5757994|P13|Extension Long-Term Extension Periods|Physician Decision|0
1647754|NCT01695239|5757995|P12|Extension Long-Term Extension Periods|Physician Decision|0
1647755|NCT01695239|5757996|P11|Extension Long-Term Extension Periods|Physician Decision|0
1647756|NCT01695239|5757997|P10|Extension Long-Term Extension Periods|Physician Decision|0
1647757|NCT01695239|5757998|P9|Extension Long-Term Extension Periods|Physician Decision|3
1647758|NCT01695239|5757999|P8|Extension Long-Term Extension Periods|Physician Decision|0
1647759|NCT01695239|5758000|P7|Extension Long-Term Extension Periods|Physician Decision|0
1647760|NCT01695239|5758001|P6|Extension Long-Term Extension Periods|Physician Decision|0
1647761|NCT01695239|5758002|P5|Extension Long-Term Extension Periods|Physician Decision|0
1647762|NCT01695239|5758003|P4|Extension Long-Term Extension Periods|Physician Decision|0
1647763|NCT01695239|5758004|P3|Extension Long-Term Extension Periods|Physician Decision|0
1647764|NCT01695239|5758005|P2|Extension Long-Term Extension Periods|Physician Decision|0
1647765|NCT01695239|5758006|P1|Extension Long-Term Extension Periods|Physician Decision|0
1647766|NCT01695239|5757993|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647767|NCT01695239|5757994|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647768|NCT01695239|5757995|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647769|NCT01695239|5757996|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647770|NCT01695239|5757997|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
1647771|NCT01695239|5757998|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
1647772|NCT01695239|5757999|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647773|NCT01695239|5758000|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647774|NCT01695239|5758001|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647775|NCT01695239|5758002|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647776|NCT01695239|5758003|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647777|NCT01695239|5758004|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647778|NCT01695239|5758005|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647779|NCT01695239|5758006|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
1647780|NCT01695239|5757993|P14|Extension Long-Term Extension Periods|Adverse Event|0
1647781|NCT01695239|5757994|P13|Extension Long-Term Extension Periods|Adverse Event|0
1647782|NCT01695239|5757995|P12|Extension Long-Term Extension Periods|Adverse Event|0
1647783|NCT01695239|5757996|P11|Extension Long-Term Extension Periods|Adverse Event|0
1647784|NCT01695239|5757997|P10|Extension Long-Term Extension Periods|Adverse Event|21
1647785|NCT01695239|5757998|P9|Extension Long-Term Extension Periods|Adverse Event|15
1647786|NCT01695239|5757999|P8|Extension Long-Term Extension Periods|Adverse Event|0
1647787|NCT01695239|5758000|P7|Extension Long-Term Extension Periods|Adverse Event|0
1647788|NCT01695239|5758001|P6|Extension Long-Term Extension Periods|Adverse Event|0
1647789|NCT01695239|5758002|P5|Extension Long-Term Extension Periods|Adverse Event|0
1647790|NCT01695239|5758003|P4|Extension Long-Term Extension Periods|Adverse Event|0
1647791|NCT01695239|5758004|P3|Extension Long-Term Extension Periods|Adverse Event|0
1647792|NCT01695239|5758005|P2|Extension Long-Term Extension Periods|Adverse Event|0
1647793|NCT01695239|5758006|P1|Extension Long-Term Extension Periods|Adverse Event|0
1647794|NCT01695239|5757993|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647795|NCT01695239|5757994|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647796|NCT01695239|5757995|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647797|NCT01695239|5757996|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647798|NCT01695239|5757997|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
1647799|NCT01695239|5757998|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
1647800|NCT01695239|5757999|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647801|NCT01695239|5758000|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647802|NCT01695239|5758001|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647803|NCT01695239|5758002|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647804|NCT01695239|5758003|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647805|NCT01695239|5758004|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647806|NCT01695239|5758005|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647807|NCT01695239|5758006|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
1647808|NCT01695239|5757993|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647809|NCT01695239|5757994|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647810|NCT01695239|5757995|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647811|NCT01695239|5757996|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647812|NCT01695239|5757997|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647813|NCT01695239|5757998|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647814|NCT01695239|5757999|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
1647815|NCT01695239|5758000|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647816|NCT01695239|5758001|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647817|NCT01695239|5758002|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647818|NCT01695239|5758003|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647819|NCT01695239|5758004|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647820|NCT01695239|5758005|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647821|NCT01695239|5758006|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
1647822|NCT01695239|5757993|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647823|NCT01695239|5757994|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647824|NCT01695239|5757995|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647825|NCT01695239|5757996|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647826|NCT01695239|5757997|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647827|NCT01695239|5757998|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647828|NCT01695239|5757999|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
1647829|NCT01695239|5758000|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647830|NCT01695239|5758001|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647831|NCT01695239|5758002|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647832|NCT01695239|5758003|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647833|NCT01695239|5758004|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647834|NCT01695239|5758005|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647835|NCT01695239|5758006|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
1647836|NCT01695239|5757993|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647837|NCT01695239|5757994|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647838|NCT01695239|5757995|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647839|NCT01695239|5757996|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647840|NCT01695239|5757997|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647841|NCT01695239|5757998|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647842|NCT01695239|5757999|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
1647843|NCT01695239|5758000|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647844|NCT01695239|5758001|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647845|NCT01695239|5758002|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647846|NCT01695239|5758003|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647847|NCT01695239|5758004|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647848|NCT01695239|5758005|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647849|NCT01695239|5758006|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
1647850|NCT01695239|5757993|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647851|NCT01695239|5757994|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647852|NCT01695239|5757995|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647853|NCT01695239|5757996|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647854|NCT01695239|5757997|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647855|NCT01695239|5757998|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647856|NCT01695239|5757999|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647857|NCT01695239|5758000|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647858|NCT01695239|5758001|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647859|NCT01695239|5758002|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647860|NCT01695239|5758003|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647861|NCT01695239|5758004|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647862|NCT01695239|5758005|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
1647863|NCT01695239|5758006|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
1647864|NCT01695239|5757993|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647865|NCT01695239|5757994|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647866|NCT01695239|5757995|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647867|NCT01695239|5757996|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647868|NCT01695239|5757997|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647869|NCT01695239|5757998|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647870|NCT01695239|5757999|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647871|NCT01695239|5758000|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647872|NCT01695239|5758001|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647873|NCT01695239|5758002|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647874|NCT01695239|5758003|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647875|NCT01695239|5758004|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1647876|NCT01695239|5758005|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1647877|NCT01695239|5758006|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1647878|NCT01695239|5757993|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647879|NCT01695239|5757994|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647880|NCT01695239|5757995|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647881|NCT01695239|5757996|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647882|NCT01695239|5757997|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647883|NCT01695239|5757998|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647884|NCT01695239|5757999|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647885|NCT01695239|5758000|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647886|NCT01695239|5758001|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647887|NCT01695239|5758002|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647888|NCT01695239|5758003|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647889|NCT01695239|5758004|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
1647890|NCT01695239|5758005|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
1647891|NCT01695239|5758006|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
1647892|NCT01695239|5757993|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647893|NCT01695239|5757994|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647894|NCT01695239|5757995|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647895|NCT01695239|5757996|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647896|NCT01695239|5757997|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647897|NCT01695239|5757998|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647898|NCT01695239|5757999|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647899|NCT01695239|5758000|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647900|NCT01695239|5758001|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647901|NCT01695239|5758002|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647902|NCT01695239|5758003|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1647903|NCT01695239|5758004|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
1647904|NCT01695239|5758005|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
1647905|NCT01695239|5758006|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
1647906|NCT01695239|5757993|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647907|NCT01695239|5757994|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647908|NCT01695239|5757995|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647909|NCT01695239|5757996|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647910|NCT01695239|5757997|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647911|NCT01695239|5757998|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647912|NCT01695239|5757999|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647913|NCT01695239|5758000|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647914|NCT01695239|5758001|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647915|NCT01695239|5758002|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647916|NCT01695239|5758003|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647917|NCT01695239|5758004|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
1647918|NCT01695239|5758005|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1647919|NCT01695239|5758006|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
1647920|NCT01695239|5757993|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
1647921|NCT01695239|5757994|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
1647922|NCT01695239|5757995|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
1647923|NCT01695239|5757996|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
1647924|NCT01695239|5757997|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
1647925|NCT01695239|5757998|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
1647926|NCT01695239|5757999|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
1647927|NCT01695239|5758000|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
1647928|NCT01695239|5758001|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
1647929|NCT01695239|5758002|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
1647930|NCT01695239|5758003|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
1647931|NCT01695239|5758004|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
1647932|NCT01695239|5758005|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
1647933|NCT01695239|5758006|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
1647934|NCT01695239|5757993|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647935|NCT01695239|5757994|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647936|NCT01695239|5757995|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647937|NCT01695239|5757996|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647938|NCT01695239|5757997|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647939|NCT01695239|5757998|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647940|NCT01695239|5757999|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647941|NCT01695239|5758000|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647942|NCT01695239|5758001|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647943|NCT01695239|5758002|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
1647944|NCT01695239|5758003|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
1647945|NCT01695239|5758004|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
1647946|NCT01695239|5758005|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
1647947|NCT01695239|5758006|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
1647948|NCT01695135|5758147|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
1647949|NCT01695135|5758148|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
1647950|NCT01695135|5758149|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
1647951|NCT01695135|5758150|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
1647952|NCT01695135|5758147|P4|Open Label Extension Treatment Phase|Death|7
1647953|NCT01695135|5758148|P3|Open Label Extension Treatment Phase|Death|2
1647954|NCT01695135|5758149|P2|Open Label Extension Treatment Phase|Death|0
1647955|NCT01695135|5758150|P1|Open Label Extension Treatment Phase|Death|0
1647956|NCT01695135|5758147|P4|Open Label Extension Treatment Phase|Physician Decision|1
1647957|NCT01695135|5758148|P3|Open Label Extension Treatment Phase|Physician Decision|4
1647958|NCT01695135|5758149|P2|Open Label Extension Treatment Phase|Physician Decision|0
1647959|NCT01695135|5758150|P1|Open Label Extension Treatment Phase|Physician Decision|0
1647960|NCT01695135|5758147|P4|Open Label Extension Treatment Phase|Other|7
1647961|NCT01695135|5758148|P3|Open Label Extension Treatment Phase|Other|4
1647962|NCT01695135|5758149|P2|Open Label Extension Treatment Phase|Other|0
1647963|NCT01695135|5758150|P1|Open Label Extension Treatment Phase|Other|0
1647964|NCT01695135|5758147|P4|Open Label Extension Treatment Phase|Adverse Event|16
1647965|NCT01695135|5758148|P3|Open Label Extension Treatment Phase|Adverse Event|11
1647966|NCT01695135|5758149|P2|Open Label Extension Treatment Phase|Adverse Event|0
1647967|NCT01695135|5758150|P1|Open Label Extension Treatment Phase|Adverse Event|0
1647968|NCT01695135|5758147|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
1647969|NCT01695135|5758148|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
1647970|NCT01695135|5758149|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
1647971|NCT01695135|5758150|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
1647972|NCT01695135|5758147|P4|Open Label Extension Treatment Phase|Progressive disease|22
1647973|NCT01695135|5758148|P3|Open Label Extension Treatment Phase|Progressive disease|13
1647974|NCT01695135|5758149|P2|Open Label Extension Treatment Phase|Progressive disease|0
1647975|NCT01695135|5758150|P1|Open Label Extension Treatment Phase|Progressive disease|0
1647976|NCT01695135|5758147|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
1647977|NCT01695135|5758148|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
1647978|NCT01695135|5758149|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
1647979|NCT01695135|5758150|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
1647980|NCT01695135|5758147|P4|Double-blind Treatment Phase|Death|0
1647981|NCT01695135|5758148|P3|Double-blind Treatment Phase|Death|0
1647982|NCT01695135|5758149|P2|Double-blind Treatment Phase|Death|1
1647983|NCT01695135|5758150|P1|Double-blind Treatment Phase|Death|1
1647984|NCT01695135|5758147|P4|Double-blind Treatment Phase|Physician Decision|0
1647985|NCT01695135|5758148|P3|Double-blind Treatment Phase|Physician Decision|0
1647986|NCT01695135|5758149|P2|Double-blind Treatment Phase|Physician Decision|3
1647987|NCT01695135|5758150|P1|Double-blind Treatment Phase|Physician Decision|6
1647988|NCT01695135|5758147|P4|Double-blind Treatment Phase|Other|0
1647989|NCT01695135|5758148|P3|Double-blind Treatment Phase|Other|0
1647990|NCT01695135|5758149|P2|Double-blind Treatment Phase|Other|3
1647991|NCT01695135|5758150|P1|Double-blind Treatment Phase|Other|1
1647992|NCT01695135|5758147|P4|Double-blind Treatment Phase|Adverse Event|0
1647993|NCT01695135|5758148|P3|Double-blind Treatment Phase|Adverse Event|0
1647994|NCT01695135|5758149|P2|Double-blind Treatment Phase|Adverse Event|7
1647995|NCT01695135|5758150|P1|Double-blind Treatment Phase|Adverse Event|7
1647996|NCT01695135|5758147|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
1647997|NCT01695135|5758148|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
1647998|NCT01695135|5758149|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
1647999|NCT01695135|5758150|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
1648000|NCT01695135|5758147|P4|Double-blind Treatment Phase|Progressive disease|0
1648001|NCT01695135|5758148|P3|Double-blind Treatment Phase|Progressive disease|0
1648002|NCT01695135|5758149|P2|Double-blind Treatment Phase|Progressive disease|110
1648003|NCT01695135|5758150|P1|Double-blind Treatment Phase|Progressive disease|50
1648004|NCT01694771|5758199|P2|Overall Study|Other reasons|6
1648005|NCT01694771|5758200|P1|Overall Study|Other reasons|5
1648006|NCT01694771|5758199|P2|Overall Study|Consent withdrawn|9
1648007|NCT01694771|5758200|P1|Overall Study|Consent withdrawn|7
1648008|NCT01694771|5758199|P2|Overall Study|Lost to Follow-up|3
1648009|NCT01694771|5758200|P1|Overall Study|Lost to Follow-up|2
1648010|NCT01694771|5758199|P2|Overall Study|Non compliance protocol|6
1648011|NCT01694771|5758200|P1|Overall Study|Non compliance protocol|7
1648012|NCT01694771|5758199|P2|Overall Study|Lack of Efficacy|0
1648013|NCT01694771|5758200|P1|Overall Study|Lack of Efficacy|1
1648014|NCT01694771|5758199|P2|Overall Study|Adverse Event|16
1648015|NCT01694771|5758200|P1|Overall Study|Adverse Event|18
1648016|NCT01694706|5758224|P3|Overall Study|other reason not defined above|0
1648017|NCT01694706|5758225|P2|Overall Study|other reason not defined above|0
1648018|NCT01694706|5758226|P1|Overall Study|other reason not defined above|1
1648019|NCT01694706|5758224|P3|Overall Study|Adverse Event|0
1648020|NCT01694706|5758225|P2|Overall Study|Adverse Event|1
1648021|NCT01694706|5758226|P1|Overall Study|Adverse Event|0
1648022|NCT01694485|5758283|P5|Overall Study|Death|0
1648023|NCT01694485|5758284|P4|Overall Study|Death|1
1648024|NCT01694485|5758285|P3|Overall Study|Death|0
1648025|NCT01694485|5758286|P2|Overall Study|Death|0
1648026|NCT01694485|5758287|P1|Overall Study|Death|1
1648027|NCT01694485|5758283|P5|Overall Study|Lost to Follow-up|7
1648028|NCT01694485|5758284|P4|Overall Study|Lost to Follow-up|10
1648029|NCT01694485|5758285|P3|Overall Study|Lost to Follow-up|6
1648030|NCT01694485|5758286|P2|Overall Study|Lost to Follow-up|1
1648031|NCT01694485|5758287|P1|Overall Study|Lost to Follow-up|9
1648032|NCT01694485|5758283|P5|Overall Study|Sponsor Decision|0
1648033|NCT01694485|5758284|P4|Overall Study|Sponsor Decision|2
1648034|NCT01694485|5758285|P3|Overall Study|Sponsor Decision|0
1648035|NCT01694485|5758286|P2|Overall Study|Sponsor Decision|0
1648036|NCT01694485|5758287|P1|Overall Study|Sponsor Decision|3
1648037|NCT01694485|5758283|P5|Overall Study|Withdrawal by Subject|18
1648038|NCT01694485|5758284|P4|Overall Study|Withdrawal by Subject|25
1648039|NCT01694485|5758285|P3|Overall Study|Withdrawal by Subject|7
1648040|NCT01694485|5758286|P2|Overall Study|Withdrawal by Subject|6
1648041|NCT01694485|5758287|P1|Overall Study|Withdrawal by Subject|20
1648042|NCT01694433|5758321|P2|Overall Study|Withdrawal by Subject|4
1648043|NCT01694433|5758322|P1|Overall Study|Withdrawal by Subject|3
1648044|NCT01694433|5758321|P2|Overall Study|Physician Decision|0
1648045|NCT01694433|5758322|P1|Overall Study|Physician Decision|1
1648046|NCT01694433|5758321|P2|Overall Study|Adverse Event|0
1648047|NCT01694433|5758322|P1|Overall Study|Adverse Event|7
1648048|NCT01694420|5758330|P1|Overall Study|Lost to Follow-up|3
1648049|NCT01694121|5758358|P2|Overall Study|Participant used false ID, was withdrawn|0
1648050|NCT01694121|5758359|P1|Overall Study|Participant used false ID, was withdrawn|1
1648051|NCT01693614|5758473|P3|Overall Study|Withdrawal by Subject|5
1648052|NCT01693614|5758474|P2|Overall Study|Withdrawal by Subject|0
1648053|NCT01693614|5758475|P1|Overall Study|Withdrawal by Subject|1
1648054|NCT01693614|5758473|P3|Overall Study|Withdrawal by subject/guardian|2
1648055|NCT01693614|5758474|P2|Overall Study|Withdrawal by subject/guardian|0
1648056|NCT01693614|5758475|P1|Overall Study|Withdrawal by subject/guardian|0
1648057|NCT01693614|5758473|P3|Overall Study|Physician Decision|4
1648058|NCT01693614|5758474|P2|Overall Study|Physician Decision|1
1648059|NCT01693614|5758475|P1|Overall Study|Physician Decision|1
1648060|NCT01693614|5758473|P3|Overall Study|Death|0
1648061|NCT01693614|5758474|P2|Overall Study|Death|0
1648062|NCT01693614|5758475|P1|Overall Study|Death|1
1648063|NCT01693614|5758473|P3|Overall Study|Protocol Violation|1
1648064|NCT01693614|5758474|P2|Overall Study|Protocol Violation|2
1648065|NCT01693614|5758475|P1|Overall Study|Protocol Violation|5
1648066|NCT01693614|5758473|P3|Overall Study|Disease progression|7
1648067|NCT01693614|5758474|P2|Overall Study|Disease progression|8
1648068|NCT01693614|5758475|P1|Overall Study|Disease progression|11
1648069|NCT01693614|5758473|P3|Overall Study|Adverse Event|5
1648070|NCT01693614|5758474|P2|Overall Study|Adverse Event|11
1648071|NCT01693614|5758475|P1|Overall Study|Adverse Event|7
1648093|NCT01693367|5758518|P2|Overall Study|Physician Decision|1
1648094|NCT01693367|5758519|P1|Overall Study|Physician Decision|0
1648095|NCT01693367|5758518|P2|Overall Study|Withdrawal by Subject|1
1648096|NCT01693367|5758519|P1|Overall Study|Withdrawal by Subject|1
1648097|NCT01693250|5758537|P2|Overall Study|Lost to Follow-up|2
1648098|NCT01693250|5758538|P1|Overall Study|Lost to Follow-up|2
1648099|NCT01693185|5758548|P2|Overall Study|diagnostic procedure after colonoscopy|6
1648100|NCT01693185|5758549|P1|Overall Study|diagnostic procedure after colonoscopy|0
1648101|NCT01693120|5758565|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
1648102|NCT01693120|5758565|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
1648103|NCT01693120|5758565|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
1648104|NCT01693120|5758565|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
1648105|NCT01693120|5758565|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
1648106|NCT01693120|5758565|P1|Enrollment|Other|1
1648107|NCT01693120|5758565|P1|Enrollment|Study closed|8
1648108|NCT01693120|5758565|P1|Enrollment|Adverse Event|1
1648109|NCT01693120|5758565|P1|Enrollment|Physician Decision|3
1648110|NCT01693120|5758565|P1|Enrollment|Protocol Violation|46
1648111|NCT01693120|5758565|P1|Enrollment|Withdrawal by Subject|10
1648112|NCT01693120|5758565|P1|Enrollment|Lost to Follow-up|1
1648113|NCT01693068|5758574|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
1648114|NCT01693068|5758575|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1648115|NCT01693068|5758576|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
1648116|NCT01693068|5758574|P3|Randomization Period|On-study|0
1648117|NCT01693068|5758575|P2|Randomization Period|On-study|5
1648118|NCT01693068|5758576|P1|Randomization Period|On-study|2
1648119|NCT01693029|5758608|P2|Overall Study|Non-compliance|1
1648120|NCT01693029|5758609|P1|Overall Study|Non-compliance|2
1648121|NCT01693029|5758608|P2|Overall Study|Death|8
1648122|NCT01693029|5758609|P1|Overall Study|Death|5
1648123|NCT01693029|5758608|P2|Overall Study|Adverse Event|6
1648124|NCT01693029|5758609|P1|Overall Study|Adverse Event|1
1648125|NCT01693029|5758608|P2|Overall Study|Lost to Follow-up|1
1648126|NCT01693029|5758609|P1|Overall Study|Lost to Follow-up|0
1648127|NCT01693029|5758608|P2|Overall Study|Physician Decision|2
1648128|NCT01693029|5758609|P1|Overall Study|Physician Decision|0
1648129|NCT01693029|5758608|P2|Overall Study|Change in dialysis modality|1
1648130|NCT01693029|5758609|P1|Overall Study|Change in dialysis modality|2
1648131|NCT01693029|5758608|P2|Overall Study|Protocol Violation|7
1648132|NCT01693029|5758609|P1|Overall Study|Protocol Violation|6
1648133|NCT01693029|5758608|P2|Overall Study|Bindinging anti-EPO antibodies|2
1648134|NCT01693029|5758609|P1|Overall Study|Bindinging anti-EPO antibodies|6
1648135|NCT01693029|5758608|P2|Overall Study|Kidney transplantation|7
1648136|NCT01693029|5758609|P1|Overall Study|Kidney transplantation|7
1648137|NCT01693029|5758608|P2|Overall Study|Withdrawal by Subject|22
1648138|NCT01693029|5758609|P1|Overall Study|Withdrawal by Subject|15
1648139|NCT01692938|5758640|P2|Overall Study|Study completed prior to site completion|3
1648140|NCT01692938|5758641|P1|Overall Study|Study completed prior to site completion|3
1648141|NCT01692938|5758640|P2|Overall Study|Protocol Deviation|1
1648142|NCT01692938|5758641|P1|Overall Study|Protocol Deviation|1
1648143|NCT01692782|5758652|P3|Overall Study|Withdrawal by Subject|3
1648144|NCT01692782|5758653|P2|Overall Study|Withdrawal by Subject|10
1648145|NCT01692782|5758654|P1|Overall Study|Withdrawal by Subject|3
1648146|NCT01692782|5758652|P3|Overall Study|SAE not related to study drug|0
1648147|NCT01692782|5758653|P2|Overall Study|SAE not related to study drug|1
1648148|NCT01692782|5758654|P1|Overall Study|SAE not related to study drug|0
1648149|NCT01692782|5758652|P3|Overall Study|Non-compliant with study visits|1
1648150|NCT01692782|5758653|P2|Overall Study|Non-compliant with study visits|0
1648151|NCT01692782|5758654|P1|Overall Study|Non-compliant with study visits|0
1648152|NCT01692782|5758652|P3|Overall Study|Non-complance with study drug|1
1648153|NCT01692782|5758653|P2|Overall Study|Non-complance with study drug|4
1648154|NCT01692782|5758654|P1|Overall Study|Non-complance with study drug|0
1648155|NCT01692782|5758652|P3|Overall Study|Protocol Violation|2
1648156|NCT01692782|5758653|P2|Overall Study|Protocol Violation|0
1648157|NCT01692782|5758654|P1|Overall Study|Protocol Violation|1
1648158|NCT01692782|5758652|P3|Overall Study|Pregnancy|0
1648159|NCT01692782|5758653|P2|Overall Study|Pregnancy|0
1648160|NCT01692782|5758654|P1|Overall Study|Pregnancy|1
1648161|NCT01692782|5758652|P3|Overall Study|Lost to Follow-up|1
1648162|NCT01692782|5758653|P2|Overall Study|Lost to Follow-up|7
1648163|NCT01692782|5758654|P1|Overall Study|Lost to Follow-up|2
1648164|NCT01692782|5758652|P3|Overall Study|Lack of Efficacy|0
1648165|NCT01692782|5758653|P2|Overall Study|Lack of Efficacy|2
1648166|NCT01692782|5758654|P1|Overall Study|Lack of Efficacy|1
1648167|NCT01692782|5758652|P3|Overall Study|Adverse Event|2
1648168|NCT01692782|5758653|P2|Overall Study|Adverse Event|32
1648169|NCT01692782|5758654|P1|Overall Study|Adverse Event|12
1648170|NCT01692730|5758763|P2|Overall Study|Lost to Follow-up|227
1648171|NCT01692730|5758764|P1|Overall Study|Lost to Follow-up|225
1648172|NCT01692626|5758778|P2|Overall Study|Withdrawal by Subject|0
1648173|NCT01692626|5758779|P1|Overall Study|Withdrawal by Subject|1
1648174|NCT01692626|5758778|P2|Overall Study|Protocol Violation|2
1648175|NCT01692626|5758779|P1|Overall Study|Protocol Violation|1
1648176|NCT01692626|5758778|P2|Overall Study|Adverse Event|3
1648177|NCT01692626|5758779|P1|Overall Study|Adverse Event|2
1648178|NCT01692626|5758778|P2|Overall Study|Death|1
1648179|NCT01692626|5758779|P1|Overall Study|Death|0
1648180|NCT01692301|5758804|P2|Overall Study|Lost to Follow-up|1
1648181|NCT01692301|5758805|P1|Overall Study|Lost to Follow-up|1
1648182|NCT01692301|5758804|P2|Overall Study|Physician Decision|2
1648183|NCT01692301|5758805|P1|Overall Study|Physician Decision|2
1648184|NCT01692301|5758804|P2|Overall Study|Technical problems|1
1648185|NCT01692301|5758805|P1|Overall Study|Technical problems|0
1648186|NCT01692301|5758804|P2|Overall Study|Patient/guardian decision|15
1648187|NCT01692301|5758805|P1|Overall Study|Patient/guardian decision|16
1648188|NCT01692301|5758804|P2|Overall Study|Protocol deviation|2
1648189|NCT01692301|5758805|P1|Overall Study|Protocol deviation|9
1648190|NCT01692301|5758804|P2|Overall Study|Non-compliance with study treatment|2
1648191|NCT01692301|5758805|P1|Overall Study|Non-compliance with study treatment|1
1648192|NCT01692301|5758804|P2|Overall Study|Lack of Efficacy|5
1648193|NCT01692301|5758805|P1|Overall Study|Lack of Efficacy|0
1648194|NCT01692301|5758804|P2|Overall Study|Death|2
1648195|NCT01692301|5758805|P1|Overall Study|Death|1
1648196|NCT01692301|5758804|P2|Overall Study|Adverse Event|12
1648197|NCT01692301|5758805|P1|Overall Study|Adverse Event|15
1648198|NCT01692275|5758837|P2|Overall Study|Withdrawal by Subject|11
1648199|NCT01692275|5758838|P1|Overall Study|Withdrawal by Subject|9
1648200|NCT01692275|5758837|P2|Overall Study|Lost to Follow-up|48
1648201|NCT01692275|5758838|P1|Overall Study|Lost to Follow-up|57
1648202|NCT01692197|5758898|P1|Overall Study|Failed Screening|3
1648239|NCT01691885|5759079|P2|Washout Period (7-9 Days)|Adverse Event|1
1648240|NCT01691885|5759080|P1|Washout Period (7-9 Days)|Adverse Event|0
1648241|NCT01691885|5759079|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
1648242|NCT01691885|5759080|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
1648243|NCT01691859|5759086|P1|Overall Study|Withdrawal by Subject|31
1648244|NCT01691859|5759086|P1|Overall Study|Physician Decision|6
1648245|NCT01691859|5759086|P1|Overall Study|Lost to Follow-up|5
1648246|NCT01691859|5759086|P1|Overall Study|Study closed/terminated|50
1648247|NCT01691859|5759086|P1|Overall Study|Product commercially available|221
1648248|NCT01691859|5759086|P1|Overall Study|Protocol Violation|4
1648249|NCT01691859|5759086|P1|Overall Study|Lack of Efficacy|11
1648250|NCT01691859|5759086|P1|Overall Study|Adverse Event|19
1648251|NCT01691820|5759133|P3|Overall Study|Other (unspecified)|1
1648252|NCT01691820|5759134|P2|Overall Study|Other (unspecified)|0
1648253|NCT01691820|5759135|P1|Overall Study|Other (unspecified)|5
1648254|NCT01691820|5759133|P3|Overall Study|Lost to Follow-up|0
1648255|NCT01691820|5759134|P2|Overall Study|Lost to Follow-up|15
1648256|NCT01691820|5759135|P1|Overall Study|Lost to Follow-up|8
1648257|NCT01691820|5759133|P3|Overall Study|Migrated/moved from study area|0
1648258|NCT01691820|5759134|P2|Overall Study|Migrated/moved from study area|4
1648259|NCT01691820|5759135|P1|Overall Study|Migrated/moved from study area|7
1648260|NCT01691820|5759133|P3|Overall Study|Consent withdrawal (not due to an AE)|0
1648261|NCT01691820|5759134|P2|Overall Study|Consent withdrawal (not due to an AE)|15
1648262|NCT01691820|5759135|P1|Overall Study|Consent withdrawal (not due to an AE)|9
1648263|NCT01691794|5759173|P3|Overall Study|Did not complete first 24 weeks of study|3
1648264|NCT01691794|5759174|P2|Overall Study|Did not complete first 24 weeks of study|3
1648265|NCT01691794|5759175|P1|Overall Study|Did not complete first 24 weeks of study|0
1648266|NCT01691794|5759173|P3|Overall Study|Completed Only first 24 weeks of study|3
1648267|NCT01691794|5759174|P2|Overall Study|Completed Only first 24 weeks of study|2
1648268|NCT01691794|5759175|P1|Overall Study|Completed Only first 24 weeks of study|0
1648269|NCT01691794|5759173|P3|Overall Study|Adverse Event|1
1648270|NCT01691794|5759174|P2|Overall Study|Adverse Event|1
1648271|NCT01691794|5759175|P1|Overall Study|Adverse Event|0
1648272|NCT01691794|5759173|P3|Overall Study|Participant request to discontinue|0
1648273|NCT01691794|5759174|P2|Overall Study|Participant request to discontinue|1
1648274|NCT01691794|5759175|P1|Overall Study|Participant request to discontinue|0
1648275|NCT01691794|5759173|P3|Overall Study|Lack of Efficacy|1
1648276|NCT01691794|5759174|P2|Overall Study|Lack of Efficacy|7
1648277|NCT01691794|5759175|P1|Overall Study|Lack of Efficacy|0
1648278|NCT01691794|5759173|P3|Overall Study|Death|1
1648279|NCT01691794|5759174|P2|Overall Study|Death|0
1648280|NCT01691794|5759175|P1|Overall Study|Death|0
1648281|NCT01691794|5759173|P3|Overall Study|Poor/Non-Compliance|1
1648282|NCT01691794|5759174|P2|Overall Study|Poor/Non-Compliance|4
1648283|NCT01691794|5759175|P1|Overall Study|Poor/Non-Compliance|1
1648284|NCT01691781|5759191|P2|Overall Study|Adverse Event|1
1648285|NCT01691781|5759192|P1|Overall Study|Adverse Event|0
1648286|NCT01691781|5759191|P2|Overall Study|Protocol Violation|2
1648287|NCT01691781|5759192|P1|Overall Study|Protocol Violation|2
1648288|NCT01691781|5759191|P2|Overall Study|Physician Decision|1
1648289|NCT01691781|5759192|P1|Overall Study|Physician Decision|1
1648290|NCT01691781|5759191|P2|Overall Study|Withdrawal by Subject|3
1648291|NCT01691781|5759192|P1|Overall Study|Withdrawal by Subject|4
1648292|NCT01691768|5759204|P2|Overall Study|Investigator decision|1
1648293|NCT01691768|5759205|P1|Overall Study|Investigator decision|1
1648294|NCT01691768|5759204|P2|Overall Study|Relocated|1
1648295|NCT01691768|5759205|P1|Overall Study|Relocated|0
1648296|NCT01691768|5759204|P2|Overall Study|Withdrawal by Subject|9
1648297|NCT01691768|5759205|P1|Overall Study|Withdrawal by Subject|10
1648298|NCT01691768|5759204|P2|Overall Study|Lost to Follow-up|3
1648299|NCT01691768|5759205|P1|Overall Study|Lost to Follow-up|4
1648300|NCT01691768|5759204|P2|Overall Study|Death|2
1648301|NCT01691768|5759205|P1|Overall Study|Death|0
1648302|NCT01691612|5759240|P1|Overall Study|Adverse Event|1
1648303|NCT01691612|5759240|P1|Overall Study|deemed ineligible after 1st visit|6
1648304|NCT01691521|5759351|P3|Overall Study|Withdrawal by Subject|4
1648305|NCT01691521|5759352|P2|Overall Study|Withdrawal by Subject|9
1648306|NCT01691521|5759353|P1|Overall Study|Withdrawal by Subject|5
1648307|NCT01691521|5759351|P3|Overall Study|Physician Decision|0
1648308|NCT01691521|5759352|P2|Overall Study|Physician Decision|1
1648309|NCT01691521|5759353|P1|Overall Study|Physician Decision|2
1648310|NCT01691521|5759351|P3|Overall Study|Lost to Follow-up|2
1648311|NCT01691521|5759352|P2|Overall Study|Lost to Follow-up|2
1648312|NCT01691521|5759353|P1|Overall Study|Lost to Follow-up|0
1648313|NCT01691521|5759351|P3|Overall Study|Protocol Violation|0
1648314|NCT01691521|5759352|P2|Overall Study|Protocol Violation|3
1648315|NCT01691521|5759353|P1|Overall Study|Protocol Violation|0
1648316|NCT01691521|5759351|P3|Overall Study|Lack of Efficacy|2
1648317|NCT01691521|5759352|P2|Overall Study|Lack of Efficacy|1
1648318|NCT01691521|5759353|P1|Overall Study|Lack of Efficacy|1
1648319|NCT01691521|5759351|P3|Overall Study|Adverse Event|1
1648320|NCT01691521|5759352|P2|Overall Study|Adverse Event|0
1648321|NCT01691521|5759353|P1|Overall Study|Adverse Event|4
1648322|NCT01691508|5759375|P2|Overall Study|Withdrawal by Subject|0
1648323|NCT01691508|5759376|P1|Overall Study|Withdrawal by Subject|1
1648324|NCT01691508|5759375|P2|Overall Study|Adverse Event|3
1648325|NCT01691508|5759376|P1|Overall Study|Adverse Event|3
1648326|NCT01691482|5759390|P2|Treatment Period 2|Protocol Violation|1
1648327|NCT01691482|5759391|P1|Treatment Period 2|Protocol Violation|1
1648328|NCT01691482|5759390|P2|Treatment Period 2|Adverse Event|1
1648329|NCT01691482|5759391|P1|Treatment Period 2|Adverse Event|0
1648330|NCT01691430|5759409|P2|Overall Study|Lost to Follow-up|3
1648331|NCT01691430|5759410|P1|Overall Study|Lost to Follow-up|0
1648332|NCT01691430|5759409|P2|Overall Study|Withdrawal by Subject|1
1648333|NCT01691430|5759410|P1|Overall Study|Withdrawal by Subject|5
1648334|NCT01691430|5759409|P2|Overall Study|Death|16
1648335|NCT01691430|5759410|P1|Overall Study|Death|17
1648336|NCT01691378|5759436|P2|Overall Study|Lost to Follow-up|2
1648337|NCT01691378|5759437|P1|Overall Study|Lost to Follow-up|5
1648338|NCT01691378|5759436|P2|Overall Study|Withdrawal by Subject|0
1648339|NCT01691378|5759437|P1|Overall Study|Withdrawal by Subject|2
1648340|NCT01691248|5759520|P2|Overall Study|Not Treated|7
1648341|NCT01691248|5759521|P1|Overall Study|Not Treated|4
1648342|NCT01691248|5759520|P2|Overall Study|Reason not provided|4
1648343|NCT01691248|5759521|P1|Overall Study|Reason not provided|4
1648344|NCT01691248|5759520|P2|Overall Study|Lost to Follow-up|5
1648345|NCT01691248|5759521|P1|Overall Study|Lost to Follow-up|2
1648346|NCT01691248|5759520|P2|Overall Study|Confirmed CDAD|31
1648347|NCT01691248|5759521|P1|Overall Study|Confirmed CDAD|14
1648348|NCT01691248|5759520|P2|Overall Study|Withdrawal by Subject|18
1648349|NCT01691248|5759521|P1|Overall Study|Withdrawal by Subject|20
1648350|NCT01691248|5759520|P2|Overall Study|Adverse Event|22
1648351|NCT01691248|5759521|P1|Overall Study|Adverse Event|24
1648352|NCT01691248|5759520|P2|Overall Study|Protocol Violation|27
1648353|NCT01691248|5759521|P1|Overall Study|Protocol Violation|43
1648354|NCT01691105|5759533|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
1648355|NCT01691105|5759534|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
1648356|NCT01691105|5759533|P2|12 Month Biochemical Verification|Lost to Follow-up|71
1648357|NCT01691105|5759534|P1|12 Month Biochemical Verification|Lost to Follow-up|50
1648358|NCT01691105|5759533|P2|12 Month Biochemical Verification|Death|30
1648359|NCT01691105|5759534|P1|12 Month Biochemical Verification|Death|22
1648360|NCT01691105|5759533|P2|12 Month Follow-up|Death|30
1648361|NCT01691105|5759534|P1|12 Month Follow-up|Death|22
1648362|NCT01691105|5759533|P2|12 Month Follow-up|Lost to Follow-up|71
1648363|NCT01691105|5759534|P1|12 Month Follow-up|Lost to Follow-up|50
1648364|NCT01691105|5759533|P2|6 Month Follow-up|Death|13
1648365|NCT01691105|5759534|P1|6 Month Follow-up|Death|13
1648366|NCT01691105|5759533|P2|6 Month Follow-up|Lost to Follow-up|58
1648367|NCT01691105|5759534|P1|6 Month Follow-up|Lost to Follow-up|39
1648368|NCT01691105|5759533|P2|1 Month Follow-up|Death|3
1648369|NCT01691105|5759534|P1|1 Month Follow-up|Death|2
1648370|NCT01691105|5759533|P2|1 Month Follow-up|Lost to Follow-up|38
1648371|NCT01691105|5759534|P1|1 Month Follow-up|Lost to Follow-up|41
1648372|NCT01691092|5759554|P1|Overall Study|screen fail|19
1648373|NCT01691092|5759554|P1|Overall Study|used for different study|2
1648374|NCT01691092|5759554|P1|Overall Study|non-compliance|3
1648375|NCT01691092|5759554|P1|Overall Study|Withdrawal by Subject|3
1648376|NCT01691092|5759554|P1|Overall Study|Physician Decision|4
1648377|NCT01691092|5759554|P1|Overall Study|Lost to Follow-up|10
1648378|NCT01691014|5759567|P4|Overall Study|Lack of Efficacy|0
1648379|NCT01691014|5759568|P3|Overall Study|Lack of Efficacy|7
1648380|NCT01691014|5759569|P2|Overall Study|Lack of Efficacy|3
1648381|NCT01691014|5759570|P1|Overall Study|Lack of Efficacy|2
1648382|NCT01691014|5759567|P4|Overall Study|Adverse Event|1
1648383|NCT01691014|5759568|P3|Overall Study|Adverse Event|1
1648384|NCT01691014|5759569|P2|Overall Study|Adverse Event|5
1648385|NCT01691014|5759570|P1|Overall Study|Adverse Event|0
1648386|NCT01691014|5759567|P4|Overall Study|Withdrawal by Subject|1
1648387|NCT01691014|5759568|P3|Overall Study|Withdrawal by Subject|1
1648388|NCT01691014|5759569|P2|Overall Study|Withdrawal by Subject|1
1648389|NCT01691014|5759570|P1|Overall Study|Withdrawal by Subject|0
1648390|NCT01691014|5759567|P4|Overall Study|Other|0
1648391|NCT01691014|5759568|P3|Overall Study|Other|2
1648392|NCT01691014|5759569|P2|Overall Study|Other|0
1648393|NCT01691014|5759570|P1|Overall Study|Other|0
1648394|NCT01691014|5759567|P4|Overall Study|Premature Termination|3
1648395|NCT01691014|5759568|P3|Overall Study|Premature Termination|0
1648396|NCT01691014|5759569|P2|Overall Study|Premature Termination|6
1648397|NCT01691014|5759570|P1|Overall Study|Premature Termination|1
1648398|NCT01690988|5759615|P3|Overall Study|Sedated|2
1648399|NCT01690988|5759616|P2|Overall Study|Sedated|1
1648400|NCT01690988|5759617|P1|Overall Study|Sedated|1
1648401|NCT01690988|5759615|P3|Overall Study|Death|1
1648402|NCT01690988|5759616|P2|Overall Study|Death|1
1648403|NCT01690988|5759617|P1|Overall Study|Death|1
1648404|NCT01690988|5759615|P3|Overall Study|Determined ineligible|0
1648405|NCT01690988|5759616|P2|Overall Study|Determined ineligible|0
1648406|NCT01690988|5759617|P1|Overall Study|Determined ineligible|1
1648407|NCT01690988|5759615|P3|Overall Study|Operation Cancelled|0
1648408|NCT01690988|5759616|P2|Overall Study|Operation Cancelled|1
1648409|NCT01690988|5759617|P1|Overall Study|Operation Cancelled|1
1648410|NCT01690988|5759615|P3|Overall Study|Physician Decision|1
1648411|NCT01690988|5759616|P2|Overall Study|Physician Decision|0
1648412|NCT01690988|5759617|P1|Overall Study|Physician Decision|0
1648413|NCT01690988|5759615|P3|Overall Study|Withdrawal by Subject|3
1648414|NCT01690988|5759616|P2|Overall Study|Withdrawal by Subject|2
1648415|NCT01690988|5759617|P1|Overall Study|Withdrawal by Subject|2
1648416|NCT01690299|5759685|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
1648417|NCT01690299|5759686|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1648418|NCT01690299|5759687|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1648419|NCT01690299|5759688|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1648420|NCT01690299|5759689|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1648421|NCT01690299|5759690|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
1648422|NCT01690299|5759685|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1648423|NCT01690299|5759686|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
1648424|NCT01690299|5759687|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
1648425|NCT01690299|5759688|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1648426|NCT01690299|5759689|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1648427|NCT01690299|5759690|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
1648428|NCT01690299|5759685|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
1648429|NCT01690299|5759686|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
1648430|NCT01690299|5759687|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
1648431|NCT01690299|5759688|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1648432|NCT01690299|5759689|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1648433|NCT01690299|5759690|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
1648434|NCT01690299|5759685|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1648435|NCT01690299|5759686|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
1648436|NCT01690299|5759687|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1648437|NCT01690299|5759688|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1648438|NCT01690299|5759689|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1648439|NCT01690299|5759690|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
1648440|NCT01690299|5759685|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
1648441|NCT01690299|5759686|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
1648442|NCT01690299|5759687|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
1648443|NCT01690299|5759688|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1648444|NCT01690299|5759689|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1648445|NCT01690299|5759690|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
1648446|NCT01690299|5759685|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1648447|NCT01690299|5759686|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
1648448|NCT01690299|5759687|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
1648449|NCT01690299|5759688|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1648450|NCT01690299|5759689|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1648451|NCT01690299|5759690|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
1648452|NCT01690299|5759685|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
1648453|NCT01690299|5759686|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
1648454|NCT01690299|5759687|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
1648455|NCT01690299|5759688|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
1648456|NCT01690299|5759689|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
1648457|NCT01690299|5759690|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
1648458|NCT01690299|5759685|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1648459|NCT01690299|5759686|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1648460|NCT01690299|5759687|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1648461|NCT01690299|5759688|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1648462|NCT01690299|5759689|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
1648463|NCT01690299|5759690|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
1648464|NCT01690299|5759685|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1648465|NCT01690299|5759686|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1648466|NCT01690299|5759687|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1648467|NCT01690299|5759688|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1648468|NCT01690299|5759689|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1648469|NCT01690299|5759690|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
1648470|NCT01690299|5759685|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1648471|NCT01690299|5759686|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1648472|NCT01690299|5759687|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
1648473|NCT01690299|5759688|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
1648474|NCT01690299|5759689|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1648475|NCT01690299|5759690|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
1648476|NCT01690143|5759787|P1|Overall Study|Withdrawal by Subject|1
1648477|NCT01690130|5759797|P2|Overall Study|Subject have cancelled visit.|0
1648478|NCT01690130|5759798|P1|Overall Study|Subject have cancelled visit.|1
1648479|NCT01690052|5759845|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
1648480|NCT01690052|5759846|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
1648481|NCT01689974|5759863|P2|Overall Study|Termination of Study|5
1648482|NCT01689974|5759864|P1|Overall Study|Termination of Study|5
1648483|NCT01689857|5759895|P2|Overall Study|Lost to Follow-up|2
1648484|NCT01689857|5759896|P1|Overall Study|Lost to Follow-up|5
1648485|NCT01689649|5759944|P1|Overall Study|Lost to Follow-up|5
1648486|NCT01689649|5759944|P1|Overall Study|Protocol Violation|3
1648487|NCT01689649|5759944|P1|Overall Study|Non-compliance|11
1648488|NCT01689649|5759944|P1|Overall Study|Lack of Efficacy|3
1648489|NCT01689532|5759956|P2|Overall Study|Physician Decision|0
1648490|NCT01689532|5759957|P1|Overall Study|Physician Decision|2
1648491|NCT01689532|5759956|P2|Overall Study|Withdrawal by Subject|2
1648492|NCT01689532|5759957|P1|Overall Study|Withdrawal by Subject|1
1648493|NCT01689532|5759956|P2|Overall Study|Lack of Efficacy|2
1648494|NCT01689532|5759957|P1|Overall Study|Lack of Efficacy|2
1648495|NCT01689532|5759956|P2|Overall Study|Adverse Event|5
1648496|NCT01689532|5759957|P1|Overall Study|Adverse Event|9
1648497|NCT01689519|5760021|P2|Overall Study|Physician Decision|3
1648498|NCT01689519|5760022|P1|Overall Study|Physician Decision|0
1648499|NCT01689519|5760021|P2|Overall Study|Withdrawal by Subject|17
1648500|NCT01689519|5760022|P1|Overall Study|Withdrawal by Subject|17
1648501|NCT01689519|5760021|P2|Overall Study|Lost to Follow-up|2
1648502|NCT01689519|5760022|P1|Overall Study|Lost to Follow-up|6
1648503|NCT01689519|5760021|P2|Overall Study|Death|116
1648504|NCT01689519|5760022|P1|Overall Study|Death|143
1648505|NCT01689363|5760049|P8|Overall Study|Protocol Violation|0
1648506|NCT01689363|5760050|P7|Overall Study|Protocol Violation|0
1648507|NCT01689363|5760051|P6|Overall Study|Protocol Violation|0
1648508|NCT01689363|5760052|P5|Overall Study|Protocol Violation|0
1648509|NCT01689363|5760053|P4|Overall Study|Protocol Violation|0
1648510|NCT01689363|5760054|P3|Overall Study|Protocol Violation|0
1648511|NCT01689363|5760055|P2|Overall Study|Protocol Violation|1
1648512|NCT01689363|5760056|P1|Overall Study|Protocol Violation|0
1648513|NCT01689337|5760111|P1|Overall Study|Study Discontinuation|1
1648514|NCT01689207|5760150|P11|Overall Study|Adverse Event|0
1648515|NCT01689207|5760151|P10|Overall Study|Adverse Event|0
1648516|NCT01689207|5760152|P9|Overall Study|Adverse Event|1
1648517|NCT01689207|5760153|P8|Overall Study|Adverse Event|0
1648518|NCT01689207|5760154|P7|Overall Study|Adverse Event|0
1648519|NCT01689207|5760155|P6|Overall Study|Adverse Event|1
1648520|NCT01689207|5760156|P5|Overall Study|Adverse Event|2
1648521|NCT01689207|5760157|P4|Overall Study|Adverse Event|0
1648522|NCT01689207|5760158|P3|Overall Study|Adverse Event|0
1648523|NCT01689207|5760159|P2|Overall Study|Adverse Event|1
1648524|NCT01689207|5760160|P1|Overall Study|Adverse Event|0
1648525|NCT01688973|5760267|P2|Overall Study|Ineligible|3
1648526|NCT01688973|5760268|P1|Overall Study|Ineligible|2
1648527|NCT01688921|5760282|P2|Overall Study|informed consent|0
1648528|NCT01688921|5760283|P1|Overall Study|informed consent|3
1648529|NCT01688921|5760282|P2|Overall Study|Protocol Violation|1
1648530|NCT01688921|5760283|P1|Overall Study|Protocol Violation|0
1648531|NCT01688921|5760282|P2|Overall Study|Physician Decision|1
1648532|NCT01688921|5760283|P1|Overall Study|Physician Decision|6
1648533|NCT01688921|5760282|P2|Overall Study|Lost to Follow-up|13
1648534|NCT01688921|5760283|P1|Overall Study|Lost to Follow-up|7
1648535|NCT01688882|5760308|P2|Overall Study|Administrative problems|0
1648536|NCT01688882|5760309|P1|Overall Study|Administrative problems|1
1648537|NCT01688882|5760308|P2|Overall Study|Unsatisfactory therapeutic effect|1
1648538|NCT01688882|5760309|P1|Overall Study|Unsatisfactory therapeutic effect|1
1648539|NCT01688882|5760308|P2|Overall Study|Adverse Event|0
1648540|NCT01688882|5760309|P1|Overall Study|Adverse Event|1
1648541|NCT01688830|5760379|P21|Overall Study|Lost to Follow-up|0
1648542|NCT01688830|5760380|P20|Overall Study|Lost to Follow-up|0
1648543|NCT01688830|5760381|P19|Overall Study|Lost to Follow-up|0
1648544|NCT01688830|5760382|P18|Overall Study|Lost to Follow-up|0
1648545|NCT01688830|5760383|P17|Overall Study|Lost to Follow-up|0
1648546|NCT01688830|5760384|P16|Overall Study|Lost to Follow-up|0
1648547|NCT01688830|5760385|P15|Overall Study|Lost to Follow-up|0
1648548|NCT01688830|5760386|P14|Overall Study|Lost to Follow-up|0
1648549|NCT01688830|5760387|P13|Overall Study|Lost to Follow-up|0
1648550|NCT01688830|5760388|P12|Overall Study|Lost to Follow-up|0
1648551|NCT01688830|5760389|P11|Overall Study|Lost to Follow-up|1
1648552|NCT01688830|5760390|P10|Overall Study|Lost to Follow-up|0
1648553|NCT01688830|5760391|P9|Overall Study|Lost to Follow-up|0
1648554|NCT01688830|5760392|P8|Overall Study|Lost to Follow-up|0
1648555|NCT01688830|5760393|P7|Overall Study|Lost to Follow-up|0
1648556|NCT01688830|5760394|P6|Overall Study|Lost to Follow-up|0
1648557|NCT01688830|5760395|P5|Overall Study|Lost to Follow-up|0
1648558|NCT01688830|5760396|P4|Overall Study|Lost to Follow-up|0
1648559|NCT01688830|5760397|P3|Overall Study|Lost to Follow-up|0
1648560|NCT01688830|5760398|P2|Overall Study|Lost to Follow-up|0
1648561|NCT01688830|5760399|P1|Overall Study|Lost to Follow-up|0
1648562|NCT01688739|5760553|P10|Overall Study|Administrative Decision|0
1648563|NCT01688739|5760554|P9|Overall Study|Administrative Decision|0
1648564|NCT01688739|5760555|P8|Overall Study|Administrative Decision|0
1648565|NCT01688739|5760556|P7|Overall Study|Administrative Decision|0
1648566|NCT01688739|5760557|P6|Overall Study|Administrative Decision|0
1648567|NCT01688739|5760558|P5|Overall Study|Administrative Decision|0
1648568|NCT01688739|5760559|P4|Overall Study|Administrative Decision|0
1648569|NCT01688739|5760560|P3|Overall Study|Administrative Decision|0
1648570|NCT01688739|5760561|P2|Overall Study|Administrative Decision|0
1648571|NCT01688739|5760562|P1|Overall Study|Administrative Decision|1
1648572|NCT01688726|5760638|P2|Overall Study|Relocated abroad|1
1648573|NCT01688726|5760639|P1|Overall Study|Relocated abroad|0
1648574|NCT01688726|5760638|P2|Overall Study|Adverse Event|0
1648575|NCT01688726|5760639|P1|Overall Study|Adverse Event|1
1648576|NCT01688635|5760651|P2|Washout 3|Withdrawal by Subject|0
1648577|NCT01688635|5760652|P1|Washout 3|Withdrawal by Subject|1
1648578|NCT01688635|5760651|P2|Washout 2|Sponsor Decision|2
1648579|NCT01688635|5760652|P1|Washout 2|Sponsor Decision|1
1648580|NCT01688635|5760651|P2|Washout 2|Withdrawal by Subject|0
1648581|NCT01688635|5760652|P1|Washout 2|Withdrawal by Subject|1
1648582|NCT01688635|5760651|P2|Washout 2|Physician Decision|0
1648583|NCT01688635|5760652|P1|Washout 2|Physician Decision|1
1648584|NCT01688635|5760651|P2|Washout 1|Physician Decision|1
1648585|NCT01688635|5760652|P1|Washout 1|Physician Decision|0
1648586|NCT01688635|5760651|P2|Washout 1|Adverse Event|1
1648587|NCT01688635|5760652|P1|Washout 1|Adverse Event|0
1648588|NCT01688635|5760651|P2|Washout 1|Withdrawal by Subject|0
1648589|NCT01688635|5760652|P1|Washout 1|Withdrawal by Subject|1
1648590|NCT01688466|5760699|P2|Overall Study|Not evaluable|1
1648591|NCT01688466|5760700|P1|Overall Study|Not evaluable|0
1648592|NCT01688466|5760699|P2|Overall Study|Adverse Event|4
1648593|NCT01688466|5760700|P1|Overall Study|Adverse Event|0
1648594|NCT01688466|5760699|P2|Overall Study|Death|1
1648595|NCT01688466|5760700|P1|Overall Study|Death|0
1648596|NCT01688466|5760699|P2|Overall Study|Withdrawal by Subject|1
1648597|NCT01688466|5760700|P1|Overall Study|Withdrawal by Subject|2
1648598|NCT01688050|5760770|P1|Overall Study|Still be eligible for follow-up|37
1648599|NCT01688050|5760770|P1|Overall Study|Withdrawal by Subject|2
1648600|NCT01688050|5760770|P1|Overall Study|Lost to Follow-up|5
1648601|NCT01688050|5760770|P1|Overall Study|Conversion to open repair|1
1648602|NCT01688050|5760770|P1|Overall Study|Death|5
1648603|NCT01688037|5760779|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1648604|NCT01688037|5760780|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
1648605|NCT01688037|5760781|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
1648606|NCT01688037|5760779|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
1648607|NCT01688037|5760780|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1648608|NCT01688037|5760781|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
1648609|NCT01688037|5760779|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
1648610|NCT01688037|5760780|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
1648611|NCT01688037|5760781|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
1648612|NCT01688037|5760779|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
1648613|NCT01688037|5760780|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
1648614|NCT01688037|5760781|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
1648615|NCT01688037|5760779|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
1648616|NCT01688037|5760780|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
1648617|NCT01688037|5760781|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
1648618|NCT01688037|5760779|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1648619|NCT01688037|5760780|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
1648620|NCT01688037|5760781|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
1648621|NCT01688037|5760779|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1648622|NCT01688037|5760780|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
1648623|NCT01688037|5760781|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
1648624|NCT01688037|5760779|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
1648625|NCT01688037|5760780|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
1648626|NCT01688037|5760781|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
1648627|NCT01688037|5760779|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
1648628|NCT01688037|5760780|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
1648629|NCT01688037|5760781|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
1648630|NCT01688037|5760779|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1648631|NCT01688037|5760780|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
1648632|NCT01688037|5760781|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
1648633|NCT01687998|5760797|P2|Overall Study|Lost to Follow-up|7
1648634|NCT01687998|5760798|P1|Overall Study|Lost to Follow-up|9
1648635|NCT01687998|5760797|P2|Overall Study|Known to be Alive at Study End|62
1648636|NCT01687998|5760798|P1|Overall Study|Known to be Alive at Study End|54
1648637|NCT01687998|5760797|P2|Overall Study|Withdrawal by Subject|51
1648638|NCT01687998|5760798|P1|Overall Study|Withdrawal by Subject|49
1648639|NCT01687712|5760834|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
1648640|NCT01687712|5760835|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
1648641|NCT01687712|5760834|P2|Cycle 3|Ectopic Pregnancy|0
1648642|NCT01687712|5760835|P1|Cycle 3|Ectopic Pregnancy|1
1648643|NCT01687712|5760834|P2|Cycle 3|Early Pregnancy Loss|2
1648644|NCT01687712|5760835|P1|Cycle 3|Early Pregnancy Loss|1
1648645|NCT01687712|5760834|P2|Cycle 3|Not Biochemically Pregnant|22
1648646|NCT01687712|5760835|P1|Cycle 3|Not Biochemically Pregnant|21
1648647|NCT01687712|5760834|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
1648648|NCT01687712|5760835|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
1648649|NCT01687712|5760834|P2|Cycle 2|Still Birth|0
1648650|NCT01687712|5760835|P1|Cycle 2|Still Birth|1
1648651|NCT01687712|5760834|P2|Cycle 2|Ectopic Pregnancy|1
1648652|NCT01687712|5760835|P1|Cycle 2|Ectopic Pregnancy|0
1648653|NCT01687712|5760834|P2|Cycle 2|Early Pregnancy Loss|16
1648654|NCT01687712|5760835|P1|Cycle 2|Early Pregnancy Loss|18
1648655|NCT01687712|5760834|P2|Cycle 2|Not Biochemically Pregnant|77
1648656|NCT01687712|5760835|P1|Cycle 2|Not Biochemically Pregnant|74
1648657|NCT01687712|5760834|P2|Cycle 1|Lost to Follow-up|1
1648658|NCT01687712|5760835|P1|Cycle 1|Lost to Follow-up|1
1648659|NCT01687712|5760834|P2|Cycle 1|Intrauterine Fetal Death|1
1648660|NCT01687712|5760835|P1|Cycle 1|Intrauterine Fetal Death|0
1648661|NCT01687712|5760834|P2|Cycle 1|Abortion|0
1648662|NCT01687712|5760835|P1|Cycle 1|Abortion|3
1648663|NCT01687712|5760834|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
1648664|NCT01687712|5760835|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
1648665|NCT01687712|5760834|P2|Cycle 1|Heterotropic Pregnancy|0
1648666|NCT01687712|5760835|P1|Cycle 1|Heterotropic Pregnancy|1
1648667|NCT01687712|5760834|P2|Cycle 1|Ectopic Pregnancy|5
1648668|NCT01687712|5760835|P1|Cycle 1|Ectopic Pregnancy|5
1648669|NCT01687712|5760834|P2|Cycle 1|Early Pregnancy Loss|60
1648670|NCT01687712|5760835|P1|Cycle 1|Early Pregnancy Loss|43
1648671|NCT01687712|5760834|P2|Cycle 1|Not Biochemically Pregnant|348
1648672|NCT01687712|5760835|P1|Cycle 1|Not Biochemically Pregnant|386
1648673|NCT01687478|5760875|P2|Overall Study|Entry Criteria Not Met|2
1648674|NCT01687478|5760876|P1|Overall Study|Entry Criteria Not Met|6
1648675|NCT01687478|5760875|P2|Overall Study|Physician Decision|3
1648676|NCT01687478|5760876|P1|Overall Study|Physician Decision|1
1648677|NCT01687478|5760875|P2|Overall Study|Withdrawal by Subject|19
1648678|NCT01687478|5760876|P1|Overall Study|Withdrawal by Subject|21
1648679|NCT01687478|5760875|P2|Overall Study|Protocol Violation|2
1648680|NCT01687478|5760876|P1|Overall Study|Protocol Violation|0
1648681|NCT01687478|5760875|P2|Overall Study|Lost to Follow-up|3
1648682|NCT01687478|5760876|P1|Overall Study|Lost to Follow-up|1
1648683|NCT01687478|5760875|P2|Overall Study|Adverse Event|10
1648684|NCT01687478|5760876|P1|Overall Study|Adverse Event|3
1648685|NCT01687296|5760927|P2|Overall Study|Withdrawal by Subject|3
1648686|NCT01687296|5760928|P1|Overall Study|Withdrawal by Subject|6
1648687|NCT01687296|5760927|P2|Overall Study|Protocol Violation|1
1648688|NCT01687296|5760928|P1|Overall Study|Protocol Violation|0
1648689|NCT01687296|5760927|P2|Overall Study|Lack of Efficacy|1
1648690|NCT01687296|5760928|P1|Overall Study|Lack of Efficacy|1
1648691|NCT01687283|5760950|P2|Overall Study|Withdrawal by Subject|8
1648692|NCT01687283|5760951|P1|Overall Study|Withdrawal by Subject|9
1648693|NCT01687283|5760950|P2|Overall Study|Investigator discretion|0
1648694|NCT01687283|5760951|P1|Overall Study|Investigator discretion|2
1648695|NCT01687283|5760950|P2|Overall Study|Lost to Follow-up|1
1648696|NCT01687283|5760951|P1|Overall Study|Lost to Follow-up|1
1648697|NCT01687283|5760950|P2|Overall Study|protocol defined stopping criteria|10
1648698|NCT01687283|5760951|P1|Overall Study|protocol defined stopping criteria|8
1648699|NCT01687283|5760950|P2|Overall Study|Protocol Violation|3
1648700|NCT01687283|5760951|P1|Overall Study|Protocol Violation|1
1648701|NCT01687283|5760950|P2|Overall Study|Lack of Efficacy|1
1648702|NCT01687283|5760951|P1|Overall Study|Lack of Efficacy|3
1648703|NCT01687283|5760950|P2|Overall Study|Adverse Event|4
1648704|NCT01687283|5760951|P1|Overall Study|Adverse Event|11
1648705|NCT01687270|5760974|P1|Overall Study|Lost to Follow-up|1
1648706|NCT01687270|5760974|P1|Overall Study|Lack of Efficacy|11
1648707|NCT01687257|5760985|P3|Overall Study|Investigator's Discretion|0
1648708|NCT01687257|5760986|P2|Overall Study|Investigator's Discretion|3
1648709|NCT01687257|5760987|P1|Overall Study|Investigator's Discretion|0
1648710|NCT01687257|5760985|P3|Overall Study|Adverse Event|0
1648711|NCT01687257|5760986|P2|Overall Study|Adverse Event|0
1648712|NCT01687257|5760987|P1|Overall Study|Adverse Event|1
1648713|NCT01687257|5760985|P3|Overall Study|Subject Withdrew Consent|1
1648714|NCT01687257|5760986|P2|Overall Study|Subject Withdrew Consent|1
1648715|NCT01687257|5760987|P1|Overall Study|Subject Withdrew Consent|1
1648716|NCT01687257|5760985|P3|Overall Study|Efficacy Failure|5
1648717|NCT01687257|5760986|P2|Overall Study|Efficacy Failure|0
1648718|NCT01687257|5760987|P1|Overall Study|Efficacy Failure|6
1648719|NCT01687218|5761052|P6|Overall Study|Relocated, no follow-up planned|0
1648720|NCT01687218|5761053|P5|Overall Study|Relocated, no follow-up planned|0
1648721|NCT01687218|5761054|P4|Overall Study|Relocated, no follow-up planned|1
1648722|NCT01687218|5761055|P3|Overall Study|Relocated, no follow-up planned|1
1648723|NCT01687218|5761056|P2|Overall Study|Relocated, no follow-up planned|0
1648724|NCT01687218|5761057|P1|Overall Study|Relocated, no follow-up planned|1
1648725|NCT01687218|5761052|P6|Overall Study|Withdrawal by Subject|0
1648726|NCT01687218|5761053|P5|Overall Study|Withdrawal by Subject|1
1648727|NCT01687218|5761054|P4|Overall Study|Withdrawal by Subject|1
1648728|NCT01687218|5761055|P3|Overall Study|Withdrawal by Subject|0
1648729|NCT01687218|5761056|P2|Overall Study|Withdrawal by Subject|3
1648730|NCT01687218|5761057|P1|Overall Study|Withdrawal by Subject|2
1648731|NCT01687166|5761088|P4|Overall Study|Insurance|1
1648732|NCT01687166|5761089|P3|Overall Study|Insurance|1
1648733|NCT01687166|5761090|P2|Overall Study|Insurance|0
1648734|NCT01687166|5761091|P1|Overall Study|Insurance|0
1648735|NCT01687166|5761088|P4|Overall Study|Physician choice to use different device|0
1648736|NCT01687166|5761089|P3|Overall Study|Physician choice to use different device|4
1648737|NCT01687166|5761090|P2|Overall Study|Physician choice to use different device|2
1648738|NCT01687166|5761091|P1|Overall Study|Physician choice to use different device|1
1648739|NCT01687166|5761088|P4|Overall Study|Patient unable to be compliant|0
1648740|NCT01687166|5761089|P3|Overall Study|Patient unable to be compliant|0
1648741|NCT01687166|5761090|P2|Overall Study|Patient unable to be compliant|0
1648742|NCT01687166|5761091|P1|Overall Study|Patient unable to be compliant|1
1648743|NCT01687166|5761088|P4|Overall Study|Subject moved out of state|0
1648744|NCT01687166|5761089|P3|Overall Study|Subject moved out of state|0
1648745|NCT01687166|5761090|P2|Overall Study|Subject moved out of state|1
1648746|NCT01687166|5761091|P1|Overall Study|Subject moved out of state|0
1648747|NCT01687166|5761088|P4|Overall Study|Protocol Violation|0
1648748|NCT01687166|5761089|P3|Overall Study|Protocol Violation|1
1648749|NCT01687166|5761090|P2|Overall Study|Protocol Violation|1
1648750|NCT01687166|5761091|P1|Overall Study|Protocol Violation|1
1648751|NCT01687166|5761088|P4|Overall Study|Death|0
1648752|NCT01687166|5761089|P3|Overall Study|Death|0
1648753|NCT01687166|5761090|P2|Overall Study|Death|1
1648754|NCT01687166|5761091|P1|Overall Study|Death|1
1648755|NCT01687166|5761088|P4|Overall Study|Equipment/Device Availability|0
1648756|NCT01687166|5761089|P3|Overall Study|Equipment/Device Availability|0
1648757|NCT01687166|5761090|P2|Overall Study|Equipment/Device Availability|1
1648758|NCT01687166|5761091|P1|Overall Study|Equipment/Device Availability|0
1648759|NCT01687166|5761088|P4|Overall Study|Lost to Follow-up|0
1648760|NCT01687166|5761089|P3|Overall Study|Lost to Follow-up|1
1648761|NCT01687166|5761090|P2|Overall Study|Lost to Follow-up|5
1648762|NCT01687166|5761091|P1|Overall Study|Lost to Follow-up|2
1648763|NCT01687166|5761088|P4|Overall Study|Withdrawal by Subject|0
1648764|NCT01687166|5761089|P3|Overall Study|Withdrawal by Subject|3
1648765|NCT01687166|5761090|P2|Overall Study|Withdrawal by Subject|4
1648766|NCT01687166|5761091|P1|Overall Study|Withdrawal by Subject|11
1648767|NCT01687166|5761088|P4|Overall Study|Physician Decision|0
1648768|NCT01687166|5761089|P3|Overall Study|Physician Decision|1
1648769|NCT01687166|5761090|P2|Overall Study|Physician Decision|2
1648770|NCT01687166|5761091|P1|Overall Study|Physician Decision|3
1648771|NCT01687166|5761088|P4|Overall Study|Adverse Event|0
1648772|NCT01687166|5761089|P3|Overall Study|Adverse Event|0
1648773|NCT01687166|5761090|P2|Overall Study|Adverse Event|1
1648774|NCT01687166|5761091|P1|Overall Study|Adverse Event|2
1648775|NCT01687166|5761088|P4|Overall Study|Did not meet eligibility criteria|1
1648776|NCT01687166|5761089|P3|Overall Study|Did not meet eligibility criteria|1
1648777|NCT01687166|5761090|P2|Overall Study|Did not meet eligibility criteria|6
1648778|NCT01687166|5761091|P1|Overall Study|Did not meet eligibility criteria|4
1648779|NCT01687166|5761088|P4|Overall Study|Attempt subject|0
1648780|NCT01687166|5761089|P3|Overall Study|Attempt subject|2
1648781|NCT01687166|5761090|P2|Overall Study|Attempt subject|3
1648782|NCT01687166|5761091|P1|Overall Study|Attempt subject|2
1648783|NCT01687101|5761107|P1|Overall Study|Lost to Follow-up|7
1648784|NCT01686958|5761132|P1|Overall Study|Withdrawal by Subject|1
1648785|NCT01686932|5761145|P2|Period 1|Adverse Event|1
1648786|NCT01686932|5761146|P1|Period 1|Adverse Event|1
1648787|NCT01686828|5761176|P4|Overall Study|Weight Loss|0
1648788|NCT01686828|5761177|P3|Overall Study|Weight Loss|1
1648789|NCT01686828|5761178|P2|Overall Study|Weight Loss|0
1648790|NCT01686828|5761179|P1|Overall Study|Weight Loss|0
1648791|NCT01686828|5761176|P4|Overall Study|New Job|0
1648792|NCT01686828|5761177|P3|Overall Study|New Job|0
1648793|NCT01686828|5761178|P2|Overall Study|New Job|1
1648794|NCT01686828|5761179|P1|Overall Study|New Job|0
1648795|NCT01686828|5761176|P4|Overall Study|Physician Decision|0
1648796|NCT01686828|5761177|P3|Overall Study|Physician Decision|0
1648797|NCT01686828|5761178|P2|Overall Study|Physician Decision|0
1648798|NCT01686828|5761179|P1|Overall Study|Physician Decision|1
1648799|NCT01686633|5761292|P3|Overall Study|Lost to Follow-up|1
1648800|NCT01686633|5761293|P2|Overall Study|Lost to Follow-up|1
1648801|NCT01686633|5761294|P1|Overall Study|Lost to Follow-up|0
1648802|NCT01686633|5761292|P3|Overall Study|Protocol-defined Stopping Criteria|1
1648803|NCT01686633|5761293|P2|Overall Study|Protocol-defined Stopping Criteria|0
1648804|NCT01686633|5761294|P1|Overall Study|Protocol-defined Stopping Criteria|1
1648805|NCT01686633|5761292|P3|Overall Study|Protocol Violation|0
1648806|NCT01686633|5761293|P2|Overall Study|Protocol Violation|3
1648807|NCT01686633|5761294|P1|Overall Study|Protocol Violation|2
1648808|NCT01686633|5761292|P3|Overall Study|Adverse Event|3
1648809|NCT01686633|5761293|P2|Overall Study|Adverse Event|3
1648810|NCT01686633|5761294|P1|Overall Study|Adverse Event|4
1648811|NCT01686633|5761292|P3|Overall Study|Physician Decision|4
1648812|NCT01686633|5761293|P2|Overall Study|Physician Decision|4
1648813|NCT01686633|5761294|P1|Overall Study|Physician Decision|3
1648814|NCT01686633|5761292|P3|Overall Study|Withdrawal by Subject|5
1648815|NCT01686633|5761293|P2|Overall Study|Withdrawal by Subject|8
1648816|NCT01686633|5761294|P1|Overall Study|Withdrawal by Subject|8
1648817|NCT01686633|5761292|P3|Overall Study|Lack of Efficacy|11
1648818|NCT01686633|5761293|P2|Overall Study|Lack of Efficacy|13
1648819|NCT01686633|5761294|P1|Overall Study|Lack of Efficacy|33
1648820|NCT01686581|5761317|P1|Overall Study|Reason Missing|1
1648821|NCT01686581|5761317|P1|Overall Study|Other Miscellaneous Reasons|36
1648822|NCT01686581|5761317|P1|Overall Study|Thinks it is Inconvenient|17
1648823|NCT01686581|5761317|P1|Overall Study|Trying to get Pregnant or Nursing|2
1648824|NCT01686581|5761317|P1|Overall Study|Thinks Injections Take Too Much Time|2
1648825|NCT01686581|5761317|P1|Overall Study|Thinks Injections Too Painful|8
1648826|NCT01686581|5761317|P1|Overall Study|Participant Concerned about Risks|6
1648827|NCT01686581|5761317|P1|Overall Study|Lack of Efficacy|90
1648828|NCT01686581|5761317|P1|Overall Study|Side-effects or Health Problems|15
1648829|NCT01686568|5761330|P2|Sub-Study|Not consented for sub-study|2
1648830|NCT01686568|5761331|P1|Sub-Study|Not consented for sub-study|2
1648831|NCT01686568|5761330|P2|Main Study|Liver enzymes above range of exclusion|0
1648832|NCT01686568|5761331|P1|Main Study|Liver enzymes above range of exclusion|1
1648833|NCT01686568|5761330|P2|Main Study|Noncompliance with protocol|1
1648834|NCT01686568|5761331|P1|Main Study|Noncompliance with protocol|0
1648835|NCT01686568|5761330|P2|Main Study|Withdrawal by Subject|3
1648836|NCT01686568|5761331|P1|Main Study|Withdrawal by Subject|1
1648837|NCT01686438|5761408|P3|Overall Study|Withdrawal by Subject|1
1648838|NCT01686438|5761409|P2|Overall Study|Withdrawal by Subject|0
1648839|NCT01686438|5761410|P1|Overall Study|Withdrawal by Subject|0
1648840|NCT01686438|5761408|P3|Overall Study|Protocol Violation|1
1648841|NCT01686438|5761409|P2|Overall Study|Protocol Violation|0
1648842|NCT01686438|5761410|P1|Overall Study|Protocol Violation|0
1648843|NCT01686438|5761408|P3|Overall Study|Adverse Event|1
1648844|NCT01686438|5761409|P2|Overall Study|Adverse Event|0
1648845|NCT01686438|5761410|P1|Overall Study|Adverse Event|0
1648846|NCT01686438|5761408|P3|Overall Study|Lost to Follow-up|10
1648847|NCT01686438|5761409|P2|Overall Study|Lost to Follow-up|9
1648848|NCT01686438|5761410|P1|Overall Study|Lost to Follow-up|8
1648849|NCT01686373|5761458|P2|Overall Study|Adverse Event|1
1648850|NCT01686373|5761459|P1|Overall Study|Adverse Event|0
1648851|NCT01686373|5761458|P2|Overall Study|Withdrawal by Subject|1
1648852|NCT01686373|5761459|P1|Overall Study|Withdrawal by Subject|0
1648853|NCT01686373|5761458|P2|Overall Study|Lost to Follow-up|0
1648854|NCT01686373|5761459|P1|Overall Study|Lost to Follow-up|3
1648855|NCT01685983|5761483|P1|Overall Study|Noncompliance with Study Drug|1
1648856|NCT01685983|5761483|P1|Overall Study|Progressive Disease|32
1648857|NCT01685983|5761483|P1|Overall Study|Other|7
1648858|NCT01685983|5761483|P1|Overall Study|Physician Decision|13
1648859|NCT01685983|5761483|P1|Overall Study|Protocol Violation|2
1648860|NCT01685983|5761483|P1|Overall Study|Withdrawal by Subject|19
1648861|NCT01685983|5761483|P1|Overall Study|Death|1
1648862|NCT01685983|5761483|P1|Overall Study|Adverse Event|7
1648863|NCT01685840|5761495|P2|Overall Study|Had VAD, Dialysis or Transplant|17
1648864|NCT01685840|5761496|P1|Overall Study|Had VAD, Dialysis or Transplant|11
1648865|NCT01685840|5761495|P2|Overall Study|Futility|200
1648866|NCT01685840|5761496|P1|Overall Study|Futility|197
1648867|NCT01685840|5761495|P2|Overall Study|Withdrawal by Subject|17
1648868|NCT01685840|5761496|P1|Overall Study|Withdrawal by Subject|14
1648869|NCT01685840|5761495|P2|Overall Study|Physician Decision|7
1648870|NCT01685840|5761496|P1|Overall Study|Physician Decision|3
1648871|NCT01685840|5761495|P2|Overall Study|Lost to Follow-up|25
1648872|NCT01685840|5761496|P1|Overall Study|Lost to Follow-up|27
1648873|NCT01685840|5761495|P2|Overall Study|Death|66
1648874|NCT01685840|5761496|P1|Overall Study|Death|77
1648875|NCT01685801|5761540|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1648876|NCT01685801|5761541|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1648877|NCT01685801|5761542|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
1648878|NCT01685801|5761543|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
1648879|NCT01685801|5761540|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
1648880|NCT01685801|5761541|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1648881|NCT01685801|5761542|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1648882|NCT01685801|5761543|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
1648883|NCT01685697|5761565|P2|Overall Study|Protocol Violation|3
1648884|NCT01685697|5761566|P1|Overall Study|Protocol Violation|3
1648885|NCT01685606|5761600|P1|Overall Study|Withdrawal by Subject|1
1648886|NCT01685437|5761628|P1|Overall Study|Unable to make visits due to work|1
1648887|NCT01685437|5761628|P1|Overall Study|Protocol Violation|4
1648888|NCT01685437|5761628|P1|Overall Study|Adverse Event|1
1648889|NCT01685437|5761628|P1|Overall Study|Lost to Follow-up|3
1648890|NCT01685437|5761628|P1|Overall Study|Withdrawal by Subject|22
1648891|NCT01685372|5761642|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
1648892|NCT01685372|5761643|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
1648893|NCT01685229|5761733|P2|Overall Study|Death|0
1648894|NCT01685229|5761734|P1|Overall Study|Death|1
1648895|NCT01685229|5761733|P2|Overall Study|Withdrawal by Subject|5
1648896|NCT01685229|5761734|P1|Overall Study|Withdrawal by Subject|6
1648897|NCT01685229|5761733|P2|Overall Study|Lost to Follow-up|10
1648898|NCT01685229|5761734|P1|Overall Study|Lost to Follow-up|16
1648899|NCT01685229|5761733|P2|Overall Study|Subjects missing Study Exit form|1
1648900|NCT01685229|5761734|P1|Overall Study|Subjects missing Study Exit form|3
1648901|NCT01685216|5761760|P1|Overall Study|Did not receive study drug|1
1648902|NCT01685203|5761777|P7|Overall Study|Patient's decision|0
1648903|NCT01685203|5761778|P6|Overall Study|Patient's decision|1
1648904|NCT01685203|5761779|P5|Overall Study|Patient's decision|0
1648905|NCT01685203|5761780|P4|Overall Study|Patient's decision|0
1648906|NCT01685203|5761781|P3|Overall Study|Patient's decision|0
1648907|NCT01685203|5761782|P2|Overall Study|Patient's decision|0
1648908|NCT01685203|5761783|P1|Overall Study|Patient's decision|0
1648909|NCT01685203|5761777|P7|Overall Study|Adverse event and withdrew consent|0
1648910|NCT01685203|5761778|P6|Overall Study|Adverse event and withdrew consent|0
1648911|NCT01685203|5761779|P5|Overall Study|Adverse event and withdrew consent|0
1648912|NCT01685203|5761780|P4|Overall Study|Adverse event and withdrew consent|0
1648913|NCT01685203|5761781|P3|Overall Study|Adverse event and withdrew consent|0
1648914|NCT01685203|5761782|P2|Overall Study|Adverse event and withdrew consent|0
1648915|NCT01685203|5761783|P1|Overall Study|Adverse event and withdrew consent|1
1648916|NCT01685203|5761777|P7|Overall Study|Adverse Event|0
1648917|NCT01685203|5761778|P6|Overall Study|Adverse Event|2
1648918|NCT01685203|5761779|P5|Overall Study|Adverse Event|0
1648919|NCT01685203|5761780|P4|Overall Study|Adverse Event|0
1648920|NCT01685203|5761781|P3|Overall Study|Adverse Event|0
1648921|NCT01685203|5761782|P2|Overall Study|Adverse Event|0
1648922|NCT01685203|5761783|P1|Overall Study|Adverse Event|0
1648923|NCT01685203|5761777|P7|Overall Study|Lost to Follow-up|0
1648924|NCT01685203|5761778|P6|Overall Study|Lost to Follow-up|0
1648925|NCT01685203|5761779|P5|Overall Study|Lost to Follow-up|0
1648926|NCT01685203|5761780|P4|Overall Study|Lost to Follow-up|1
1648927|NCT01685203|5761781|P3|Overall Study|Lost to Follow-up|0
1648928|NCT01685203|5761782|P2|Overall Study|Lost to Follow-up|3
1648929|NCT01685203|5761783|P1|Overall Study|Lost to Follow-up|3
1648930|NCT01685138|5761827|P1|Overall Study|Progressive disease|53
1648931|NCT01685138|5761827|P1|Overall Study|Adverse Event|18
1648932|NCT01685138|5761827|P1|Overall Study|Death|10
1648933|NCT01685138|5761827|P1|Overall Study|Physician Decision|6
1648934|NCT01685138|5761827|P1|Overall Study|Subject/guardian decision|2
1648935|NCT01685138|5761827|P1|Overall Study|No longer requires treatment|1
1648936|NCT01685138|5761827|P1|Overall Study|Protocol Violation|1
1648937|NCT01685138|5761827|P1|Overall Study|Lost to Follow-up|1
1648938|NCT01685073|5761843|P2|Overall Study|Withdrawal by Subject|24
1648939|NCT01685073|5761844|P1|Overall Study|Withdrawal by Subject|24
1648940|NCT01685073|5761843|P2|Overall Study|Lost to Follow-up|8
1648941|NCT01685073|5761844|P1|Overall Study|Lost to Follow-up|6
1648942|NCT01685060|5761852|P1|Overall Study|Death|8
1648943|NCT01685060|5761852|P1|Overall Study|Lost to Follow-up|1
1648944|NCT01685060|5761852|P1|Overall Study|Subject/guardian decision|20
1648945|NCT01685060|5761852|P1|Overall Study|Physician Decision|14
1648946|NCT01685060|5761852|P1|Overall Study|Progressive disease|69
1648947|NCT01685060|5761852|P1|Overall Study|Adverse Event|12
1648948|NCT01685060|5761852|P1|Overall Study|Rollover patients|16
1648949|NCT01685047|5761867|P1|Overall Study|patient withdrawn by sponsor|1
1648950|NCT01685047|5761867|P1|Overall Study|Adverse Event|5
1648951|NCT01685047|5761867|P1|Overall Study|Physician Decision|25
1648952|NCT01685047|5761867|P1|Overall Study|Lost to Follow-up|8
1648953|NCT01685047|5761867|P1|Overall Study|Death|26
1648954|NCT01685047|5761867|P1|Overall Study|Withdrawal by Subject|20
1648955|NCT01684943|5761883|P3|Overall Study|Planning Pregnancy|0
1648956|NCT01684943|5761884|P2|Overall Study|Planning Pregnancy|0
1648957|NCT01684943|5761885|P1|Overall Study|Planning Pregnancy|1
1648958|NCT01684943|5761883|P3|Overall Study|Lost to Follow-up|0
1648959|NCT01684943|5761884|P2|Overall Study|Lost to Follow-up|0
1648960|NCT01684943|5761885|P1|Overall Study|Lost to Follow-up|3
1648961|NCT01684943|5761883|P3|Overall Study|Excluded from Analysis|1
1648962|NCT01684943|5761884|P2|Overall Study|Excluded from Analysis|1
1648963|NCT01684943|5761885|P1|Overall Study|Excluded from Analysis|1
1648964|NCT01684943|5761883|P3|Overall Study|Principal Investigator Determination|0
1648965|NCT01684943|5761884|P2|Overall Study|Principal Investigator Determination|0
1648966|NCT01684943|5761885|P1|Overall Study|Principal Investigator Determination|1
1648967|NCT01684943|5761883|P3|Overall Study|Inadequate Venous Access|0
1648968|NCT01684943|5761884|P2|Overall Study|Inadequate Venous Access|0
1648969|NCT01684943|5761885|P1|Overall Study|Inadequate Venous Access|3
1648970|NCT01684930|5761904|P2|Overall Study|Withdrawal by Subject|1
1648971|NCT01684930|5761905|P1|Overall Study|Withdrawal by Subject|3
1648972|NCT01684878|5761962|P4|Part 2: Randomized Phase|Participant noncompliance|1
1648973|NCT01684878|5761963|P3|Part 2: Randomized Phase|Participant noncompliance|0
1648974|NCT01684878|5761964|P2|Part 2: Randomized Phase|Participant noncompliance|0
1648975|NCT01684878|5761965|P1|Part 2: Randomized Phase|Participant noncompliance|0
1648976|NCT01684878|5761962|P4|Part 2: Randomized Phase|Alive at data-cut|7
1648977|NCT01684878|5761963|P3|Part 2: Randomized Phase|Alive at data-cut|13
1648978|NCT01684878|5761964|P2|Part 2: Randomized Phase|Alive at data-cut|0
1648979|NCT01684878|5761965|P1|Part 2: Randomized Phase|Alive at data-cut|0
1648980|NCT01684878|5761962|P4|Part 2: Randomized Phase|Death|68
1648981|NCT01684878|5761963|P3|Part 2: Randomized Phase|Death|62
1648982|NCT01684878|5761964|P2|Part 2: Randomized Phase|Death|0
1648983|NCT01684878|5761965|P1|Part 2: Randomized Phase|Death|0
1648984|NCT01684878|5761962|P4|Part 2: Randomized Phase|Lost to Follow-up|0
1648985|NCT01684878|5761963|P3|Part 2: Randomized Phase|Lost to Follow-up|2
1648986|NCT01684878|5761964|P2|Part 2: Randomized Phase|Lost to Follow-up|0
1648987|NCT01684878|5761965|P1|Part 2: Randomized Phase|Lost to Follow-up|0
1648988|NCT01684878|5761962|P4|Part 2: Randomized Phase|Participant withdrew consent|2
1648989|NCT01684878|5761963|P3|Part 2: Randomized Phase|Participant withdrew consent|1
1648990|NCT01684878|5761964|P2|Part 2: Randomized Phase|Participant withdrew consent|0
1648991|NCT01684878|5761965|P1|Part 2: Randomized Phase|Participant withdrew consent|0
1648992|NCT01684878|5761962|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
1648993|NCT01684878|5761963|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
1648994|NCT01684878|5761964|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
1648995|NCT01684878|5761965|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
1648996|NCT01684878|5761962|P4|Part 1: Safety Run in Phase|Death|0
1648997|NCT01684878|5761963|P3|Part 1: Safety Run in Phase|Death|0
1648998|NCT01684878|5761964|P2|Part 1: Safety Run in Phase|Death|20
1648999|NCT01684878|5761965|P1|Part 1: Safety Run in Phase|Death|15
1649000|NCT01684878|5761962|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1649001|NCT01684878|5761963|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
1649002|NCT01684878|5761964|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1649003|NCT01684878|5761965|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
1649004|NCT01684423|5762069|P5|Overall Study|Withdrawal by Subject|0
1649005|NCT01684423|5762070|P4|Overall Study|Withdrawal by Subject|0
1649006|NCT01684423|5762071|P3|Overall Study|Withdrawal by Subject|1
1649007|NCT01684423|5762072|P2|Overall Study|Withdrawal by Subject|0
1649008|NCT01684423|5762073|P1|Overall Study|Withdrawal by Subject|0
1649009|NCT01684215|5762130|P4|Phase 2|Lost to Follow-up|4
1649010|NCT01684215|5762131|P3|Phase 2|Lost to Follow-up|0
1649011|NCT01684215|5762132|P2|Phase 2|Lost to Follow-up|0
1649012|NCT01684215|5762133|P1|Phase 2|Lost to Follow-up|0
1649013|NCT01684215|5762130|P4|Phase 2|Enrolled but not treated|1
1649014|NCT01684215|5762131|P3|Phase 2|Enrolled but not treated|0
1649015|NCT01684215|5762132|P2|Phase 2|Enrolled but not treated|0
1649016|NCT01684215|5762133|P1|Phase 2|Enrolled but not treated|0
1649017|NCT01684215|5762130|P4|Phase 2|Study terminated by sponsor|30
1649018|NCT01684215|5762131|P3|Phase 2|Study terminated by sponsor|0
1649019|NCT01684215|5762132|P2|Phase 2|Study terminated by sponsor|0
1649020|NCT01684215|5762133|P1|Phase 2|Study terminated by sponsor|0
1649021|NCT01684215|5762130|P4|Phase 2|Death|8
1649022|NCT01684215|5762131|P3|Phase 2|Death|0
1649023|NCT01684215|5762132|P2|Phase 2|Death|0
1649024|NCT01684215|5762133|P1|Phase 2|Death|0
1649025|NCT01684215|5762130|P4|Phase 1, Part 2|Withdrawal by Subject|0
1649026|NCT01684215|5762131|P3|Phase 1, Part 2|Withdrawal by Subject|1
1649027|NCT01684215|5762132|P2|Phase 1, Part 2|Withdrawal by Subject|0
1649028|NCT01684215|5762133|P1|Phase 1, Part 2|Withdrawal by Subject|0
1649029|NCT01684215|5762130|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
1649030|NCT01684215|5762131|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
1649031|NCT01684215|5762132|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
1649032|NCT01684215|5762133|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
1649033|NCT01684215|5762130|P4|Phase 1, Part 2|Adverse Event|0
1649034|NCT01684215|5762131|P3|Phase 1, Part 2|Adverse Event|1
1649035|NCT01684215|5762132|P2|Phase 1, Part 2|Adverse Event|0
1649036|NCT01684215|5762133|P1|Phase 1, Part 2|Adverse Event|0
1649037|NCT01684215|5762130|P4|Phase 1, Part 1|Objective progression or relapse|0
1649038|NCT01684215|5762131|P3|Phase 1, Part 1|Objective progression or relapse|0
1649039|NCT01684215|5762132|P2|Phase 1, Part 1|Objective progression or relapse|6
1649040|NCT01684215|5762133|P1|Phase 1, Part 1|Objective progression or relapse|5
1649041|NCT01684215|5762130|P4|Phase 1, Part 1|Adverse Event|0
1649042|NCT01684215|5762131|P3|Phase 1, Part 1|Adverse Event|0
1649043|NCT01684215|5762132|P2|Phase 1, Part 1|Adverse Event|0
1649044|NCT01684215|5762133|P1|Phase 1, Part 1|Adverse Event|1
1649045|NCT01684046|5762207|P2|Period 1, First 30 Days|Adverse Event|2
1649046|NCT01684046|5762208|P1|Period 1, First 30 Days|Adverse Event|0
1649047|NCT01684033|5762214|P2|Period 2, Second 30 Days|Adverse Event|0
1649048|NCT01684033|5762215|P1|Period 2, Second 30 Days|Adverse Event|1
1649049|NCT01684033|5762214|P2|Period 1, First 30 Days|Lost to Follow-up|0
1649050|NCT01684033|5762215|P1|Period 1, First 30 Days|Lost to Follow-up|1
1649051|NCT01684033|5762214|P2|Period 1, First 30 Days|Withdrawal by Subject|0
1649052|NCT01684033|5762215|P1|Period 1, First 30 Days|Withdrawal by Subject|1
1649053|NCT01684033|5762214|P2|Period 1, First 30 Days|Noncompliance|0
1649054|NCT01684033|5762215|P1|Period 1, First 30 Days|Noncompliance|1
1649055|NCT01684033|5762214|P2|Period 1, First 30 Days|Adverse Event|1
1649056|NCT01684033|5762215|P1|Period 1, First 30 Days|Adverse Event|1
1649057|NCT01683994|5762239|P5|Overall Study|Intercurrent illness|1
1649058|NCT01683994|5762240|P4|Overall Study|Intercurrent illness|2
1649059|NCT01683994|5762241|P3|Overall Study|Intercurrent illness|0
1649060|NCT01683994|5762242|P2|Overall Study|Intercurrent illness|0
1649061|NCT01683994|5762243|P1|Overall Study|Intercurrent illness|0
1649062|NCT01683994|5762239|P5|Overall Study|Withdrawal by Subject|0
1649063|NCT01683994|5762240|P4|Overall Study|Withdrawal by Subject|1
1649064|NCT01683994|5762241|P3|Overall Study|Withdrawal by Subject|0
1649065|NCT01683994|5762242|P2|Overall Study|Withdrawal by Subject|0
1649066|NCT01683994|5762243|P1|Overall Study|Withdrawal by Subject|1
1649067|NCT01683838|5762284|P2|Overall Study|Other|3
1649068|NCT01683838|5762285|P1|Overall Study|Other|4
1649069|NCT01683838|5762284|P2|Overall Study|Lost to Follow-up|1
1649070|NCT01683838|5762285|P1|Overall Study|Lost to Follow-up|1
1649071|NCT01683838|5762284|P2|Overall Study|Withdrawal by Subject|5
1649072|NCT01683838|5762285|P1|Overall Study|Withdrawal by Subject|6
1649073|NCT01683838|5762284|P2|Overall Study|Protocol Violation|1
1649074|NCT01683838|5762285|P1|Overall Study|Protocol Violation|3
1649075|NCT01683838|5762284|P2|Overall Study|Adverse Event|2
1649076|NCT01683838|5762285|P1|Overall Study|Adverse Event|12
1649077|NCT01683604|5762325|P1|Overall Study|Other|2
1649078|NCT01683604|5762325|P1|Overall Study|Lack of Efficacy|1
1649079|NCT01683604|5762325|P1|Overall Study|Adverse Event|2
1649080|NCT01683565|5762490|P2|Overall Study|Discontinued Intervention|1
1649081|NCT01683565|5762491|P1|Overall Study|Discontinued Intervention|1
1649082|NCT01683565|5762490|P2|Overall Study|Lost to Follow-up|0
1649083|NCT01683565|5762491|P1|Overall Study|Lost to Follow-up|2
1649084|NCT01683409|5762525|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1649085|NCT01683409|5762526|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1649086|NCT01683409|5762527|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
1649087|NCT01683409|5762528|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1649088|NCT01683409|5762529|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
1649089|NCT01683409|5762525|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
1649090|NCT01683409|5762526|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1649091|NCT01683409|5762527|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1649092|NCT01683409|5762528|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1649093|NCT01683409|5762529|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
1649094|NCT01683409|5762525|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
1649095|NCT01683409|5762526|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
1649096|NCT01683409|5762527|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1649097|NCT01683409|5762528|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
1649098|NCT01683409|5762529|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
1649099|NCT01683409|5762525|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1649100|NCT01683409|5762526|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1649101|NCT01683409|5762527|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1649102|NCT01683409|5762528|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
1649103|NCT01683409|5762529|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
1649104|NCT01683409|5762525|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1649105|NCT01683409|5762526|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1649106|NCT01683409|5762527|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1649107|NCT01683409|5762528|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
1649108|NCT01683409|5762529|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
1649109|NCT01683409|5762525|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1649110|NCT01683409|5762526|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1649111|NCT01683409|5762527|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1649112|NCT01683409|5762528|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
1649113|NCT01683409|5762529|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
1649114|NCT01683409|5762525|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1649115|NCT01683409|5762526|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1649116|NCT01683409|5762527|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
1649117|NCT01683409|5762528|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1649118|NCT01683409|5762529|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
1649119|NCT01683409|5762525|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1649120|NCT01683409|5762526|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
1649121|NCT01683409|5762527|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1649122|NCT01683409|5762528|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1649123|NCT01683409|5762529|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
1649124|NCT01683409|5762525|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1649125|NCT01683409|5762526|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1649126|NCT01683409|5762527|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1649127|NCT01683409|5762528|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
1649128|NCT01683409|5762529|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
1649129|NCT01683409|5762525|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
1649130|NCT01683409|5762526|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
1649131|NCT01683409|5762527|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
1649132|NCT01683409|5762528|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
1649133|NCT01683409|5762529|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
1649134|NCT01683409|5762525|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1649135|NCT01683409|5762526|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1649136|NCT01683409|5762527|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
1649137|NCT01683409|5762528|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1649138|NCT01683409|5762529|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
1649139|NCT01683383|5762572|P2|Overall Study|Infant was not transported|0
1649140|NCT01683383|5762573|P1|Overall Study|Infant was not transported|1
1649141|NCT01683266|5762600|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
1649142|NCT01683266|5762601|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
1649143|NCT01683266|5762600|P2|Overall Study|Possibly Hypoglycemia|0
1649144|NCT01683266|5762601|P1|Overall Study|Possibly Hypoglycemia|1
1649145|NCT01683266|5762600|P2|Overall Study|Perceived Lack of Efficacy|1
1649146|NCT01683266|5762601|P1|Overall Study|Perceived Lack of Efficacy|1
1649147|NCT01683266|5762600|P2|Overall Study|Nonserious Hypoglycemia|3
1649148|NCT01683266|5762601|P1|Overall Study|Nonserious Hypoglycemia|0
1649149|NCT01683266|5762600|P2|Overall Study|Site Closure / Site Withdrawal|3
1649150|NCT01683266|5762601|P1|Overall Study|Site Closure / Site Withdrawal|1
1649151|NCT01683266|5762600|P2|Overall Study|Lost to Follow-up|0
1649152|NCT01683266|5762601|P1|Overall Study|Lost to Follow-up|5
1649153|NCT01683266|5762600|P2|Overall Study|Selection Criterion / Protocol Violation|5
1649154|NCT01683266|5762601|P1|Overall Study|Selection Criterion / Protocol Violation|7
1649155|NCT01683266|5762600|P2|Overall Study|Personal Reason|25
1649156|NCT01683266|5762601|P1|Overall Study|Personal Reason|17
1649157|NCT01683266|5762600|P2|Overall Study|Protocol Violation|6
1649158|NCT01683266|5762601|P1|Overall Study|Protocol Violation|13
1649159|NCT01683266|5762600|P2|Overall Study|Lack of Efficacy|2
1649160|NCT01683266|5762601|P1|Overall Study|Lack of Efficacy|5
1649161|NCT01683266|5762600|P2|Overall Study|Adverse Event|4
1649162|NCT01683266|5762601|P1|Overall Study|Adverse Event|5
1649163|NCT01683058|5762629|P1|Overall Study|Lack of Efficacy|2
1649164|NCT01683058|5762629|P1|Overall Study|Withdrawal by Subject|7
1649165|NCT01683058|5762629|P1|Overall Study|Subject Met Withdrawal Criteria|5
1649166|NCT01683058|5762629|P1|Overall Study|Adverse Event|6
1649167|NCT01683058|5762629|P1|Overall Study|Lost to Follow-up|9
1649168|NCT01683019|5762660|P3|Overall Study|Withdrawal by Subject|4
1649169|NCT01683019|5762661|P2|Overall Study|Withdrawal by Subject|1
1649170|NCT01683019|5762662|P1|Overall Study|Withdrawal by Subject|2
1649171|NCT01682876|5762685|P4|Overall Study|Other|1
1649172|NCT01682876|5762686|P3|Overall Study|Other|1
1649173|NCT01682876|5762687|P2|Overall Study|Other|0
1649174|NCT01682876|5762688|P1|Overall Study|Other|1
1649175|NCT01682876|5762685|P4|Overall Study|Withdrawal by Subject|2
1649176|NCT01682876|5762686|P3|Overall Study|Withdrawal by Subject|0
1649177|NCT01682876|5762687|P2|Overall Study|Withdrawal by Subject|0
1649178|NCT01682876|5762688|P1|Overall Study|Withdrawal by Subject|4
1649179|NCT01682876|5762685|P4|Overall Study|Protocol Violation|1
1649180|NCT01682876|5762686|P3|Overall Study|Protocol Violation|1
1649181|NCT01682876|5762687|P2|Overall Study|Protocol Violation|1
1649182|NCT01682876|5762688|P1|Overall Study|Protocol Violation|1
1649183|NCT01682876|5762685|P4|Overall Study|Lost to Follow-up|11
1649184|NCT01682876|5762686|P3|Overall Study|Lost to Follow-up|9
1649185|NCT01682876|5762687|P2|Overall Study|Lost to Follow-up|15
1649186|NCT01682876|5762688|P1|Overall Study|Lost to Follow-up|11
1649187|NCT01682876|5762685|P4|Overall Study|Adverse Event|1
1649188|NCT01682876|5762686|P3|Overall Study|Adverse Event|0
1649189|NCT01682876|5762687|P2|Overall Study|Adverse Event|0
1649190|NCT01682876|5762688|P1|Overall Study|Adverse Event|0
1649191|NCT01682876|5762685|P4|Overall Study|Administrative reason|3
1649192|NCT01682876|5762686|P3|Overall Study|Administrative reason|0
1649193|NCT01682876|5762687|P2|Overall Study|Administrative reason|4
1649194|NCT01682876|5762688|P1|Overall Study|Administrative reason|4
1649195|NCT01682863|5762734|P3|Overall Study|Physician Decision|1
1649196|NCT01682863|5762735|P2|Overall Study|Physician Decision|0
1649197|NCT01682863|5762736|P1|Overall Study|Physician Decision|0
1649198|NCT01682863|5762734|P3|Overall Study|Adverse Event|2
1649199|NCT01682863|5762735|P2|Overall Study|Adverse Event|1
1649200|NCT01682863|5762736|P1|Overall Study|Adverse Event|0
1649201|NCT01682863|5762734|P3|Overall Study|Technical problems|0
1649202|NCT01682863|5762735|P2|Overall Study|Technical problems|0
1649203|NCT01682863|5762736|P1|Overall Study|Technical problems|1
1649204|NCT01682863|5762734|P3|Overall Study|Protocol deviation|1
1649205|NCT01682863|5762735|P2|Overall Study|Protocol deviation|0
1649206|NCT01682863|5762736|P1|Overall Study|Protocol deviation|1
1649207|NCT01682863|5762734|P3|Overall Study|Death|4
1649208|NCT01682863|5762735|P2|Overall Study|Death|3
1649209|NCT01682863|5762736|P1|Overall Study|Death|1
1649210|NCT01682863|5762734|P3|Overall Study|Lost to Follow-up|6
1649211|NCT01682863|5762735|P2|Overall Study|Lost to Follow-up|1
1649212|NCT01682863|5762736|P1|Overall Study|Lost to Follow-up|5
1649213|NCT01682863|5762734|P3|Overall Study|Subject/guardian decision|10
1649214|NCT01682863|5762735|P2|Overall Study|Subject/guardian decision|12
1649215|NCT01682863|5762736|P1|Overall Study|Subject/guardian decision|19
1649216|NCT01682837|5762765|P1|Baseline|Withdrawal by Subject|5
1649217|NCT01682759|5762809|P2|Overall Study|Withdrawal by Subject|55
1649218|NCT01682759|5762810|P1|Overall Study|Withdrawal by Subject|56
1649219|NCT01682759|5762809|P2|Overall Study|Physician Decision|1
1649220|NCT01682759|5762810|P1|Overall Study|Physician Decision|1
1649221|NCT01682759|5762809|P2|Overall Study|Lost to Follow-up|13
1649222|NCT01682759|5762810|P1|Overall Study|Lost to Follow-up|10
1649223|NCT01682759|5762809|P2|Overall Study|Death|1
1649224|NCT01682759|5762810|P1|Overall Study|Death|2
1649225|NCT01682720|5762834|P4|Overall Study|Adverse Event|1
1649226|NCT01682720|5762835|P3|Overall Study|Adverse Event|1
1649227|NCT01682720|5762836|P2|Overall Study|Adverse Event|0
1649228|NCT01682720|5762837|P1|Overall Study|Adverse Event|1
1649229|NCT01682720|5762834|P4|Overall Study|Subject Withdrew Consent|2
1649230|NCT01682720|5762835|P3|Overall Study|Subject Withdrew Consent|2
1649231|NCT01682720|5762836|P2|Overall Study|Subject Withdrew Consent|0
1649232|NCT01682720|5762837|P1|Overall Study|Subject Withdrew Consent|0
1649233|NCT01682720|5762834|P4|Overall Study|Lost to Follow-up|6
1649234|NCT01682720|5762835|P3|Overall Study|Lost to Follow-up|0
1649235|NCT01682720|5762836|P2|Overall Study|Lost to Follow-up|1
1649236|NCT01682720|5762837|P1|Overall Study|Lost to Follow-up|1
1649237|NCT01682720|5762834|P4|Overall Study|Efficacy Failure|30
1649238|NCT01682720|5762835|P3|Overall Study|Efficacy Failure|3
1649239|NCT01682720|5762836|P2|Overall Study|Efficacy Failure|3
1649240|NCT01682720|5762837|P1|Overall Study|Efficacy Failure|0
1649241|NCT01682720|5762834|P4|Overall Study|Terminated by Sponsor|0
1649242|NCT01682720|5762835|P3|Overall Study|Terminated by Sponsor|0
1649243|NCT01682720|5762836|P2|Overall Study|Terminated by Sponsor|0
1649244|NCT01682720|5762837|P1|Overall Study|Terminated by Sponsor|83
1649245|NCT01682720|5762834|P4|Overall Study|Randomized but Not Treated|0
1649246|NCT01682720|5762835|P3|Overall Study|Randomized but Not Treated|1
1649247|NCT01682720|5762836|P2|Overall Study|Randomized but Not Treated|1
1649248|NCT01682720|5762837|P1|Overall Study|Randomized but Not Treated|0
1649249|NCT01682681|5762854|P1|Overall Study|Low compliance|13
1649250|NCT01682681|5762854|P1|Overall Study|Other|21
1649251|NCT01682681|5762854|P1|Overall Study|tapering of topiramate|5
1649252|NCT01682681|5762854|P1|Overall Study|Adverse Event|46
1649253|NCT01682681|5762854|P1|Overall Study|Lost to Follow-up|174
1649254|NCT01682681|5762854|P1|Overall Study|Moved to other hospital|10
1649255|NCT01682681|5762854|P1|Overall Study|Withdrawal by Subject|1
1649256|NCT01682681|5762854|P1|Overall Study|Lack of Efficacy|62
1649257|NCT01682603|5762883|P1|Overall Study|Lost to Follow-up|3
1649258|NCT01682512|5762928|P3|Overall Study|Other than stated above|2
1649259|NCT01682512|5762929|P2|Overall Study|Other than stated above|4
1649260|NCT01682512|5762930|P1|Overall Study|Other than stated above|2
1649261|NCT01682512|5762928|P3|Overall Study|Secondary lack of efficacy|0
1649262|NCT01682512|5762929|P2|Overall Study|Secondary lack of efficacy|1
1649263|NCT01682512|5762930|P1|Overall Study|Secondary lack of efficacy|1
1649264|NCT01682512|5762928|P3|Overall Study|Primary lack of efficacy|7
1649265|NCT01682512|5762929|P2|Overall Study|Primary lack of efficacy|7
1649266|NCT01682512|5762930|P1|Overall Study|Primary lack of efficacy|10
1649267|NCT01682512|5762928|P3|Overall Study|Protocol Violation|2
1649268|NCT01682512|5762929|P2|Overall Study|Protocol Violation|3
1649269|NCT01682512|5762930|P1|Overall Study|Protocol Violation|2
1649270|NCT01682512|5762928|P3|Overall Study|Lost to Follow-up|2
1649271|NCT01682512|5762929|P2|Overall Study|Lost to Follow-up|0
1649272|NCT01682512|5762930|P1|Overall Study|Lost to Follow-up|3
1649273|NCT01682512|5762928|P3|Overall Study|Study terminated by sponsor|0
1649274|NCT01682512|5762929|P2|Overall Study|Study terminated by sponsor|43
1649275|NCT01682512|5762930|P1|Overall Study|Study terminated by sponsor|46
1649276|NCT01682512|5762928|P3|Overall Study|Physician Decision|0
1649277|NCT01682512|5762929|P2|Overall Study|Physician Decision|2
1649278|NCT01682512|5762930|P1|Overall Study|Physician Decision|0
1649279|NCT01682512|5762928|P3|Overall Study|Withdrawal by Subject|3
1649280|NCT01682512|5762929|P2|Overall Study|Withdrawal by Subject|6
1649281|NCT01682512|5762930|P1|Overall Study|Withdrawal by Subject|2
1649282|NCT01682512|5762928|P3|Overall Study|Adverse Event|2
1649283|NCT01682512|5762929|P2|Overall Study|Adverse Event|5
1649284|NCT01682512|5762930|P1|Overall Study|Adverse Event|6
1649285|NCT01682460|5762955|P1|Overall Study|Did not meet inclusion criteria|2
1649286|NCT01682460|5762955|P1|Overall Study|Withdrawal by Subject|2
1649287|NCT01682148|5762972|P2|Overall Study|Protocol Violation|1
1649288|NCT01682148|5762973|P1|Overall Study|Protocol Violation|1
1649289|NCT01682148|5762972|P2|Overall Study|Lost to Follow-up|2
1649290|NCT01682148|5762973|P1|Overall Study|Lost to Follow-up|1
1649291|NCT01682148|5762972|P2|Overall Study|Withdrawal by Subject|0
1649292|NCT01682148|5762973|P1|Overall Study|Withdrawal by Subject|2
1649293|NCT01682083|5763033|P2|Overall Study|Physician Decision|4
1649294|NCT01682083|5763034|P1|Overall Study|Physician Decision|5
1649295|NCT01682083|5763033|P2|Overall Study|Death|93
1649296|NCT01682083|5763034|P1|Overall Study|Death|60
1649297|NCT01682083|5763033|P2|Overall Study|Withdrawal by Subject|40
1649298|NCT01682083|5763034|P1|Overall Study|Withdrawal by Subject|31
1649299|NCT01682083|5763033|P2|Overall Study|Lost to Follow-up|18
1649300|NCT01682083|5763034|P1|Overall Study|Lost to Follow-up|11
1649301|NCT01682044|5763046|P1|Overall Study|Progression|3
1649302|NCT01682044|5763046|P1|Overall Study|Death|1
1649303|NCT01682031|5763058|P2|Overall Study|Patient stopped selenium on his own|1
1649304|NCT01682031|5763059|P1|Overall Study|Patient stopped selenium on his own|0
1649305|NCT01682031|5763058|P2|Overall Study|Patient could not swallow tablets|0
1649306|NCT01682031|5763059|P1|Overall Study|Patient could not swallow tablets|1
1649307|NCT01682031|5763058|P2|Overall Study|MRI results indicate increased nodul|1
1649308|NCT01682031|5763059|P1|Overall Study|MRI results indicate increased nodul|0
1649309|NCT01682031|5763058|P2|Overall Study|Adverse Event|2
1649310|NCT01682031|5763059|P1|Overall Study|Adverse Event|0
1649311|NCT01682031|5763058|P2|Overall Study|Withdrawal by Subject|1
1649312|NCT01682031|5763059|P1|Overall Study|Withdrawal by Subject|0
1649313|NCT01681992|5763082|P3|Overall Study|Withdrawal by Subject|25
1649314|NCT01681992|5763083|P2|Overall Study|Withdrawal by Subject|30
1649315|NCT01681992|5763084|P1|Overall Study|Withdrawal by Subject|27
1649316|NCT01681992|5763082|P3|Overall Study|Protocol Violation|1
1649317|NCT01681992|5763083|P2|Overall Study|Protocol Violation|0
1649318|NCT01681992|5763084|P1|Overall Study|Protocol Violation|0
1649319|NCT01681992|5763082|P3|Overall Study|As Per Sponsor Decision|1
1649320|NCT01681992|5763083|P2|Overall Study|As Per Sponsor Decision|0
1649321|NCT01681992|5763084|P1|Overall Study|As Per Sponsor Decision|0
1649322|NCT01681992|5763082|P3|Overall Study|Lost to Follow-up|53
1649323|NCT01681992|5763083|P2|Overall Study|Lost to Follow-up|38
1649324|NCT01681992|5763084|P1|Overall Study|Lost to Follow-up|36
1649325|NCT01681992|5763082|P3|Overall Study|Adverse Event|3
1649326|NCT01681992|5763083|P2|Overall Study|Adverse Event|2
1649327|NCT01681992|5763084|P1|Overall Study|Adverse Event|3
1649328|NCT01681849|5763173|P3|Overall Study|Lost to Follow-up|6
1649329|NCT01681849|5763174|P2|Overall Study|Lost to Follow-up|2
1649330|NCT01681849|5763175|P1|Overall Study|Lost to Follow-up|3
1649331|NCT01681849|5763173|P3|Overall Study|Withdrawal by Subject|33
1649332|NCT01681849|5763174|P2|Overall Study|Withdrawal by Subject|5
1649333|NCT01681849|5763175|P1|Overall Study|Withdrawal by Subject|3
1649334|NCT01681849|5763173|P3|Overall Study|Protocol Violation|0
1649335|NCT01681849|5763174|P2|Overall Study|Protocol Violation|0
1649336|NCT01681849|5763175|P1|Overall Study|Protocol Violation|2
1649337|NCT01681836|5763184|P2|Second Intervention|Withdrawal by Subject|1
1649338|NCT01681836|5763185|P1|Second Intervention|Withdrawal by Subject|0
1649339|NCT01681771|5763219|P2|Overall Study|Lost to Follow-up|2
1649340|NCT01681771|5763220|P1|Overall Study|Lost to Follow-up|4
1649341|NCT01681628|5763228|P2|19 Months Follow-up|Lost to Follow-up|43
1649342|NCT01681628|5763229|P1|19 Months Follow-up|Lost to Follow-up|61
1649343|NCT01681628|5763228|P2|19 Months Follow-up|Death|0
1649344|NCT01681628|5763229|P1|19 Months Follow-up|Death|1
1649345|NCT01681628|5763228|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
1649346|NCT01681628|5763229|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
1649347|NCT01681628|5763228|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
1649348|NCT01681628|5763229|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
1649349|NCT01681576|5763242|P2|Period 2|Non-compliance with study treatment|0
1649350|NCT01681576|5763243|P1|Period 2|Non-compliance with study treatment|1
1649351|NCT01681576|5763242|P2|Period 2|subject/guardian decision|1
1649352|NCT01681576|5763243|P1|Period 2|subject/guardian decision|3
1649353|NCT01681576|5763242|P2|Period 1|Protocol Deviation|0
1649354|NCT01681576|5763243|P1|Period 1|Protocol Deviation|1
1649355|NCT01681576|5763242|P2|Period 1|Adverse Event|0
1649356|NCT01681576|5763243|P1|Period 1|Adverse Event|1
1649357|NCT01681511|5763259|P2|Overall Study|No post-catheter sample collected|4
1649358|NCT01681511|5763260|P1|Overall Study|No post-catheter sample collected|11
1649359|NCT01681511|5763259|P2|Overall Study|No Daily Urine Sample Collected|1
1649360|NCT01681511|5763260|P1|Overall Study|No Daily Urine Sample Collected|0
1649361|NCT01681511|5763259|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
1649362|NCT01681511|5763260|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
1649363|NCT01681511|5763259|P2|Overall Study|Failed Inclusion/Exclusion|0
1649364|NCT01681511|5763260|P1|Overall Study|Failed Inclusion/Exclusion|3
1649365|NCT01681511|5763259|P2|Overall Study|No Treatment Received|3
1649366|NCT01681511|5763260|P1|Overall Study|No Treatment Received|1
1649367|NCT01681472|5763278|P4|Overall Study|Adverse Event|0
1649368|NCT01681472|5763279|P3|Overall Study|Adverse Event|0
1649369|NCT01681472|5763280|P2|Overall Study|Adverse Event|1
1649370|NCT01681472|5763281|P1|Overall Study|Adverse Event|0
1649371|NCT01681433|5763461|P2|Overall Study|Lost to Follow-up|1
1649372|NCT01681433|5763462|P1|Overall Study|Lost to Follow-up|0
1649373|NCT01681433|5763461|P2|Overall Study|Adverse Event|4
1649374|NCT01681433|5763462|P1|Overall Study|Adverse Event|2
1649375|NCT01681433|5763461|P2|Overall Study|Protocol Violation|0
1649376|NCT01681433|5763462|P1|Overall Study|Protocol Violation|2
1649377|NCT01681433|5763461|P2|Overall Study|Withdrawal by Subject|5
1649378|NCT01681433|5763462|P1|Overall Study|Withdrawal by Subject|5
1649379|NCT01681433|5763461|P2|Overall Study|Lack of Efficacy|23
1649380|NCT01681433|5763462|P1|Overall Study|Lack of Efficacy|23
1649381|NCT01681368|5763480|P1|Overall Study|Refused further follow up|1
1649382|NCT01681368|5763480|P1|Overall Study|Refused further treatment|1
1649383|NCT01681277|5763497|P5|Overall Study|Adverse Event|0
1649384|NCT01681277|5763498|P4|Overall Study|Adverse Event|0
1649385|NCT01681277|5763499|P3|Overall Study|Adverse Event|0
1649386|NCT01681277|5763500|P2|Overall Study|Adverse Event|0
1649387|NCT01681277|5763501|P1|Overall Study|Adverse Event|1
1649388|NCT01681212|5763542|P1|Overall Study|Administrative reason by sponsor|1
1649389|NCT01681212|5763542|P1|Overall Study|No longer met study criteria|5
1649390|NCT01681186|5763556|P8|Fourth Intervention|Protocol Violation|1
1649391|NCT01681186|5763557|P7|Fourth Intervention|Protocol Violation|0
1649392|NCT01681186|5763558|P6|Fourth Intervention|Protocol Violation|0
1649393|NCT01681186|5763559|P5|Fourth Intervention|Protocol Violation|0
1649394|NCT01681186|5763560|P4|Fourth Intervention|Protocol Violation|0
1649395|NCT01681186|5763561|P3|Fourth Intervention|Protocol Violation|0
1649396|NCT01681186|5763562|P2|Fourth Intervention|Protocol Violation|0
1649397|NCT01681186|5763563|P1|Fourth Intervention|Protocol Violation|0
1649398|NCT01681186|5763556|P8|Washout Period From Third Intervention|Lost to Follow-up|0
1649399|NCT01681186|5763557|P7|Washout Period From Third Intervention|Lost to Follow-up|1
1649400|NCT01681186|5763558|P6|Washout Period From Third Intervention|Lost to Follow-up|0
1649401|NCT01681186|5763559|P5|Washout Period From Third Intervention|Lost to Follow-up|0
1649402|NCT01681186|5763560|P4|Washout Period From Third Intervention|Lost to Follow-up|0
1649486|NCT01680016|5764064|P3|Overall Study|Adverse Event|1
1649403|NCT01681186|5763561|P3|Washout Period From Third Intervention|Lost to Follow-up|0
1649404|NCT01681186|5763562|P2|Washout Period From Third Intervention|Lost to Follow-up|0
1649405|NCT01681186|5763563|P1|Washout Period From Third Intervention|Lost to Follow-up|0
1649406|NCT01681186|5763556|P8|Washout Period From Second Intervention|Protocol Violation|1
1649407|NCT01681186|5763557|P7|Washout Period From Second Intervention|Protocol Violation|0
1649408|NCT01681186|5763558|P6|Washout Period From Second Intervention|Protocol Violation|0
1649409|NCT01681186|5763559|P5|Washout Period From Second Intervention|Protocol Violation|0
1649410|NCT01681186|5763560|P4|Washout Period From Second Intervention|Protocol Violation|0
1649411|NCT01681186|5763561|P3|Washout Period From Second Intervention|Protocol Violation|0
1649412|NCT01681186|5763562|P2|Washout Period From Second Intervention|Protocol Violation|0
1649413|NCT01681186|5763563|P1|Washout Period From Second Intervention|Protocol Violation|0
1649414|NCT01681186|5763556|P8|Washout Period From Second Intervention|Adverse Event|0
1649415|NCT01681186|5763557|P7|Washout Period From Second Intervention|Adverse Event|1
1649416|NCT01681186|5763558|P6|Washout Period From Second Intervention|Adverse Event|0
1649417|NCT01681186|5763559|P5|Washout Period From Second Intervention|Adverse Event|0
1649418|NCT01681186|5763560|P4|Washout Period From Second Intervention|Adverse Event|0
1649419|NCT01681186|5763561|P3|Washout Period From Second Intervention|Adverse Event|0
1649420|NCT01681186|5763562|P2|Washout Period From Second Intervention|Adverse Event|0
1649421|NCT01681186|5763563|P1|Washout Period From Second Intervention|Adverse Event|0
1649422|NCT01681069|5763666|P2|Overall Study|Adverse Event|1
1649423|NCT01681069|5763667|P1|Overall Study|Adverse Event|0
1649424|NCT01681069|5763666|P2|Overall Study|Protocol Violation|1
1649425|NCT01681069|5763667|P1|Overall Study|Protocol Violation|1
1649426|NCT01681069|5763666|P2|Overall Study|Withdrawal by Subject|5
1649427|NCT01681069|5763667|P1|Overall Study|Withdrawal by Subject|4
1649428|NCT01681004|5763704|P2|Study Completion|Death|1
1649429|NCT01681004|5763705|P1|Study Completion|Death|1
1649430|NCT01681004|5763704|P2|Study Completion|Site Termination|1
1649431|NCT01681004|5763705|P1|Study Completion|Site Termination|2
1649432|NCT01681004|5763704|P2|Study Completion|Physician Decision|3
1649433|NCT01681004|5763705|P1|Study Completion|Physician Decision|1
1649434|NCT01681004|5763704|P2|Study Completion|Lost to Follow-up|3
1649435|NCT01681004|5763705|P1|Study Completion|Lost to Follow-up|8
1649436|NCT01681004|5763704|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
1649437|NCT01681004|5763705|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
1649438|NCT01680991|5763762|P3|Overall Study|PD confirmed in other hospital|0
1649439|NCT01680991|5763763|P2|Overall Study|PD confirmed in other hospital|0
1649440|NCT01680991|5763764|P1|Overall Study|PD confirmed in other hospital|1
1649441|NCT01680991|5763762|P3|Overall Study|Bad physical condition|1
1649442|NCT01680991|5763763|P2|Overall Study|Bad physical condition|0
1649443|NCT01680991|5763764|P1|Overall Study|Bad physical condition|0
1649444|NCT01680991|5763762|P3|Overall Study|Physician Decision|2
1649445|NCT01680991|5763763|P2|Overall Study|Physician Decision|7
1649446|NCT01680991|5763764|P1|Overall Study|Physician Decision|0
1649447|NCT01680991|5763762|P3|Overall Study|Progressive disease (PD)|0
1649448|NCT01680991|5763763|P2|Overall Study|Progressive disease (PD)|10
1649449|NCT01680991|5763764|P1|Overall Study|Progressive disease (PD)|0
1649450|NCT01680991|5763762|P3|Overall Study|Withdrawal by Subject|0
1649451|NCT01680991|5763763|P2|Overall Study|Withdrawal by Subject|1
1649452|NCT01680991|5763764|P1|Overall Study|Withdrawal by Subject|5
1649453|NCT01680991|5763762|P3|Overall Study|Protocol Violation|0
1649454|NCT01680991|5763763|P2|Overall Study|Protocol Violation|1
1649455|NCT01680991|5763764|P1|Overall Study|Protocol Violation|0
1649456|NCT01680991|5763762|P3|Overall Study|Death|1
1649457|NCT01680991|5763763|P2|Overall Study|Death|0
1649458|NCT01680991|5763764|P1|Overall Study|Death|1
1649459|NCT01680991|5763762|P3|Overall Study|Adverse Event|0
1649460|NCT01680991|5763763|P2|Overall Study|Adverse Event|0
1649461|NCT01680991|5763764|P1|Overall Study|Adverse Event|1
1649462|NCT01680861|5763855|P2|Early Post-transplant Period|Protocol Violation|1
1649463|NCT01680861|5763856|P1|Early Post-transplant Period|Protocol Violation|1
1649464|NCT01680497|5763943|P1|Overall Study|Lost to Follow-up|2
1649465|NCT01680458|5763953|P1|Overall Study|Protocol Violation|3
1649466|NCT01680341|5763964|P2|Overall Study|Unclassified|15
1649467|NCT01680341|5763965|P1|Overall Study|Unclassified|18
1649468|NCT01680341|5763964|P2|Overall Study|Adverse Event|2
1649469|NCT01680341|5763965|P1|Overall Study|Adverse Event|3
1649470|NCT01680159|5764036|P1|Increased Dose Period|Withdrawal by Subject|2
1649471|NCT01680159|5764036|P1|Increased Dose Period|Adverse Event|6
1649472|NCT01680159|5764036|P1|Screening Period|Not meet criteria for dose-up period|7
1649473|NCT01680016|5764063|P4|Overall Study|Withdrawal by Subject|1
1649474|NCT01680016|5764064|P3|Overall Study|Withdrawal by Subject|1
1649475|NCT01680016|5764065|P2|Overall Study|Withdrawal by Subject|7
1649476|NCT01680016|5764066|P1|Overall Study|Withdrawal by Subject|5
1649477|NCT01680016|5764063|P4|Overall Study|Protocol Violation|0
1649478|NCT01680016|5764064|P3|Overall Study|Protocol Violation|0
1649479|NCT01680016|5764065|P2|Overall Study|Protocol Violation|1
1649480|NCT01680016|5764066|P1|Overall Study|Protocol Violation|0
1649481|NCT01680016|5764063|P4|Overall Study|The Subject went out of The Trial|0
1649482|NCT01680016|5764064|P3|Overall Study|The Subject went out of The Trial|3
1649483|NCT01680016|5764065|P2|Overall Study|The Subject went out of The Trial|0
1649484|NCT01680016|5764066|P1|Overall Study|The Subject went out of The Trial|1
1649485|NCT01680016|5764063|P4|Overall Study|Adverse Event|4
1649487|NCT01680016|5764065|P2|Overall Study|Adverse Event|0
1649488|NCT01680016|5764066|P1|Overall Study|Adverse Event|0
1649489|NCT01679613|5764128|P4|Overall Study|other than stated above|2
1649490|NCT01679613|5764129|P3|Overall Study|other than stated above|2
1649491|NCT01679613|5764130|P2|Overall Study|other than stated above|1
1649492|NCT01679613|5764131|P1|Overall Study|other than stated above|0
1649493|NCT01679405|5764153|P2|Overall Study|Death|5
1649494|NCT01679405|5764154|P1|Overall Study|Death|2
1649495|NCT01679301|5764189|P3|Screening Period|screen failure|0
1649496|NCT01679301|5764190|P2|Screening Period|screen failure|0
1649497|NCT01679301|5764191|P1|Screening Period|screen failure|3
1649498|NCT01679236|5764199|P2|Overall Study|Lost to Follow-up|15
1649499|NCT01679236|5764200|P1|Overall Study|Lost to Follow-up|15
1649500|NCT01679002|5764247|P3|Overall Study|Adverse Event|0
1649501|NCT01679002|5764248|P2|Overall Study|Adverse Event|1
1649502|NCT01679002|5764249|P1|Overall Study|Adverse Event|1
1649503|NCT01678924|5764280|P4|Overall Study|Unable to attend scheduled visits|1
1649504|NCT01678924|5764281|P3|Overall Study|Unable to attend scheduled visits|0
1649505|NCT01678924|5764282|P2|Overall Study|Unable to attend scheduled visits|0
1649506|NCT01678924|5764283|P1|Overall Study|Unable to attend scheduled visits|0
1649507|NCT01678924|5764280|P4|Overall Study|Withdrawal by Subject|2
1649508|NCT01678924|5764281|P3|Overall Study|Withdrawal by Subject|0
1649509|NCT01678924|5764282|P2|Overall Study|Withdrawal by Subject|3
1649510|NCT01678924|5764283|P1|Overall Study|Withdrawal by Subject|0
1649511|NCT01678924|5764280|P4|Overall Study|Personal Reasons|7
1649512|NCT01678924|5764281|P3|Overall Study|Personal Reasons|2
1649513|NCT01678924|5764282|P2|Overall Study|Personal Reasons|2
1649514|NCT01678924|5764283|P1|Overall Study|Personal Reasons|2
1649515|NCT01678924|5764280|P4|Overall Study|Lost to Follow-up|2
1649516|NCT01678924|5764281|P3|Overall Study|Lost to Follow-up|0
1649517|NCT01678924|5764282|P2|Overall Study|Lost to Follow-up|4
1649518|NCT01678924|5764283|P1|Overall Study|Lost to Follow-up|0
1649519|NCT01678924|5764280|P4|Overall Study|Lack of Efficacy|5
1649520|NCT01678924|5764281|P3|Overall Study|Lack of Efficacy|0
1649521|NCT01678924|5764282|P2|Overall Study|Lack of Efficacy|2
1649522|NCT01678924|5764283|P1|Overall Study|Lack of Efficacy|7
1649523|NCT01678924|5764280|P4|Overall Study|Adverse Event|1
1649524|NCT01678924|5764281|P3|Overall Study|Adverse Event|0
1649525|NCT01678924|5764282|P2|Overall Study|Adverse Event|1
1649526|NCT01678924|5764283|P1|Overall Study|Adverse Event|1
1649527|NCT01678911|5764414|P2|Second Intervention|Lost to Follow-up|0
1649528|NCT01678911|5764415|P1|Second Intervention|Lost to Follow-up|2
1649529|NCT01678898|5764432|P3|PB-102-F01|Physician Decision|0
1649530|NCT01678898|5764433|P2|PB-102-F01|Physician Decision|1
1649531|NCT01678898|5764434|P1|PB-102-F01|Physician Decision|0
1649532|NCT01678898|5764432|P3|PB-102-F01|Adverse Event|0
1649533|NCT01678898|5764433|P2|PB-102-F01|Adverse Event|1
1649534|NCT01678898|5764434|P1|PB-102-F01|Adverse Event|0
1649535|NCT01678820|5764544|P3|Overall Study|Not treated with double-blind study drug|2
1649536|NCT01678820|5764545|P2|Overall Study|Not treated with double-blind study drug|2
1649537|NCT01678820|5764546|P1|Overall Study|Not treated with double-blind study drug|0
1649538|NCT01678820|5764544|P3|Overall Study|Protocol Violation|4
1649539|NCT01678820|5764545|P2|Overall Study|Protocol Violation|5
1649540|NCT01678820|5764546|P1|Overall Study|Protocol Violation|4
1649541|NCT01678820|5764544|P3|Overall Study|Physician Decision|1
1649542|NCT01678820|5764545|P2|Overall Study|Physician Decision|0
1649543|NCT01678820|5764546|P1|Overall Study|Physician Decision|0
1649544|NCT01678820|5764544|P3|Overall Study|Non-compliance with study drug|0
1649545|NCT01678820|5764545|P2|Overall Study|Non-compliance with study drug|1
1649546|NCT01678820|5764546|P1|Overall Study|Non-compliance with study drug|0
1649547|NCT01678820|5764544|P3|Overall Study|Lost to Follow-up|2
1649548|NCT01678820|5764545|P2|Overall Study|Lost to Follow-up|2
1649549|NCT01678820|5764546|P1|Overall Study|Lost to Follow-up|7
1649550|NCT01678820|5764544|P3|Overall Study|Adverse Event|2
1649551|NCT01678820|5764545|P2|Overall Study|Adverse Event|2
1649552|NCT01678820|5764546|P1|Overall Study|Adverse Event|2
1649553|NCT01678820|5764544|P3|Overall Study|Protocol Specified Criteria|1
1649554|NCT01678820|5764545|P2|Overall Study|Protocol Specified Criteria|3
1649555|NCT01678820|5764546|P1|Overall Study|Protocol Specified Criteria|2
1649556|NCT01678820|5764544|P3|Overall Study|Withdrawal by Subject|2
1649557|NCT01678820|5764545|P2|Overall Study|Withdrawal by Subject|5
1649558|NCT01678820|5764546|P1|Overall Study|Withdrawal by Subject|2
1649559|NCT01678820|5764544|P3|Overall Study|Study Terminated by Sponsor|43
1649560|NCT01678820|5764545|P2|Overall Study|Study Terminated by Sponsor|43
1649561|NCT01678820|5764546|P1|Overall Study|Study Terminated by Sponsor|45
1649562|NCT01678807|5764591|P3|Overall Study|Withdrawn by Parent/Guardian|0
1649563|NCT01678807|5764592|P2|Overall Study|Withdrawn by Parent/Guardian|1
1649564|NCT01678807|5764593|P1|Overall Study|Withdrawn by Parent/Guardian|0
1649565|NCT01678807|5764591|P3|Overall Study|Adverse Event|0
1649566|NCT01678807|5764592|P2|Overall Study|Adverse Event|4
1649567|NCT01678807|5764593|P1|Overall Study|Adverse Event|4
1649568|NCT01678560|5764606|P2|Overall Study|Withdrawal by Subject|1
1649569|NCT01678560|5764607|P1|Overall Study|Withdrawal by Subject|0
1649570|NCT01678560|5764606|P2|Overall Study|Death|1
1649571|NCT01678560|5764607|P1|Overall Study|Death|0
1649572|NCT01678560|5764606|P2|Overall Study|Physician Decision|4
1649573|NCT01678560|5764607|P1|Overall Study|Physician Decision|4
1649574|NCT01678313|5764628|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
1649575|NCT01678313|5764629|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
1649576|NCT01678313|5764628|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
1649577|NCT01678313|5764629|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
1649578|NCT01678313|5764628|P2|Completed the 3-month Therapy|Physician Decision|4
1649579|NCT01678313|5764629|P1|Completed the 3-month Therapy|Physician Decision|3
1649580|NCT01678313|5764628|P2|Completed the 3-month Therapy|Lost to Follow-up|8
1649581|NCT01678313|5764629|P1|Completed the 3-month Therapy|Lost to Follow-up|3
1649582|NCT01678144|5764660|P1|Stage 1: MAR Classic|Adverse Event|1
1649583|NCT01678131|5764679|P3|Overall Study|Withdrawal by Subject|2
1649584|NCT01678131|5764680|P2|Overall Study|Withdrawal by Subject|0
1649585|NCT01678131|5764681|P1|Overall Study|Withdrawal by Subject|0
1649586|NCT01678131|5764679|P3|Overall Study|Adverse Event|0
1649587|NCT01678131|5764680|P2|Overall Study|Adverse Event|1
1649588|NCT01678131|5764681|P1|Overall Study|Adverse Event|0
1649589|NCT01677988|5764689|P1|Overall Study|Lack of Efficacy|2
1649590|NCT01677936|5764702|P2|Overall Study|Protocol Violation|4
1649591|NCT01677936|5764703|P1|Overall Study|Protocol Violation|0
1649592|NCT01677936|5764702|P2|Overall Study|Lost to Follow-up|0
1649593|NCT01677936|5764703|P1|Overall Study|Lost to Follow-up|1
1649594|NCT01677936|5764702|P2|Overall Study|Adverse Event|0
1649595|NCT01677936|5764703|P1|Overall Study|Adverse Event|1
1649596|NCT01677936|5764702|P2|Overall Study|Protocol Violation|0
1649597|NCT01677936|5764703|P1|Overall Study|Protocol Violation|3
1649598|NCT01677936|5764702|P2|Overall Study|Lost to Follow-up|1
1649599|NCT01677936|5764703|P1|Overall Study|Lost to Follow-up|4
1649600|NCT01677910|5764714|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
1649601|NCT01677910|5764715|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1649602|NCT01677910|5764716|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1649603|NCT01677910|5764717|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
1649604|NCT01677910|5764714|P4|Open-Label Extension Period (OLE)|Adverse Event|15
1649605|NCT01677910|5764715|P3|Open-Label Extension Period (OLE)|Adverse Event|0
1649606|NCT01677910|5764716|P2|Open-Label Extension Period (OLE)|Adverse Event|0
1649607|NCT01677910|5764717|P1|Open-Label Extension Period (OLE)|Adverse Event|0
1649608|NCT01677910|5764714|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
1649609|NCT01677910|5764715|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1649610|NCT01677910|5764716|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1649611|NCT01677910|5764717|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
1649612|NCT01677910|5764714|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
1649613|NCT01677910|5764715|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1649614|NCT01677910|5764716|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1649615|NCT01677910|5764717|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
1649616|NCT01677910|5764714|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
1649617|NCT01677910|5764715|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
1649618|NCT01677910|5764716|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
1649619|NCT01677910|5764717|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
1649620|NCT01677910|5764714|P4|Open-Label Extension Period (OLE)|Physician Decision|4
1649621|NCT01677910|5764715|P3|Open-Label Extension Period (OLE)|Physician Decision|0
1649622|NCT01677910|5764716|P2|Open-Label Extension Period (OLE)|Physician Decision|0
1649623|NCT01677910|5764717|P1|Open-Label Extension Period (OLE)|Physician Decision|0
1649624|NCT01677910|5764714|P4|Double-Blind Treatment Period|Reason Not Specified|0
1649625|NCT01677910|5764715|P3|Double-Blind Treatment Period|Reason Not Specified|0
1649626|NCT01677910|5764716|P2|Double-Blind Treatment Period|Reason Not Specified|1
1649627|NCT01677910|5764717|P1|Double-Blind Treatment Period|Reason Not Specified|0
1649628|NCT01677910|5764714|P4|Double-Blind Treatment Period|Withdrawal of consent|0
1649629|NCT01677910|5764715|P3|Double-Blind Treatment Period|Withdrawal of consent|3
1649630|NCT01677910|5764716|P2|Double-Blind Treatment Period|Withdrawal of consent|0
1649631|NCT01677910|5764717|P1|Double-Blind Treatment Period|Withdrawal of consent|1
1649632|NCT01677910|5764714|P4|Double-Blind Treatment Period|Physician Decision|0
1649633|NCT01677910|5764715|P3|Double-Blind Treatment Period|Physician Decision|1
1649634|NCT01677910|5764716|P2|Double-Blind Treatment Period|Physician Decision|0
1649635|NCT01677910|5764717|P1|Double-Blind Treatment Period|Physician Decision|0
1649636|NCT01677910|5764714|P4|Double-Blind Treatment Period|Adverse Event|0
1649637|NCT01677910|5764715|P3|Double-Blind Treatment Period|Adverse Event|3
1649638|NCT01677910|5764716|P2|Double-Blind Treatment Period|Adverse Event|2
1649639|NCT01677910|5764717|P1|Double-Blind Treatment Period|Adverse Event|6
1649640|NCT01677858|5764744|P5|Overall Study|Lost to Follow-up|1
1649641|NCT01677858|5764745|P4|Overall Study|Lost to Follow-up|0
1649642|NCT01677858|5764746|P3|Overall Study|Lost to Follow-up|0
1649643|NCT01677858|5764747|P2|Overall Study|Lost to Follow-up|0
1649644|NCT01677858|5764748|P1|Overall Study|Lost to Follow-up|0
1649645|NCT01677858|5764744|P5|Overall Study|Withdrawal by Subject|15
1649646|NCT01677858|5764745|P4|Overall Study|Withdrawal by Subject|0
1649647|NCT01677858|5764746|P3|Overall Study|Withdrawal by Subject|1
1649648|NCT01677858|5764747|P2|Overall Study|Withdrawal by Subject|1
1649649|NCT01677858|5764748|P1|Overall Study|Withdrawal by Subject|0
1649650|NCT01677858|5764744|P5|Overall Study|Progressive Disease|43
1649651|NCT01677858|5764745|P4|Overall Study|Progressive Disease|3
1649652|NCT01677858|5764746|P3|Overall Study|Progressive Disease|9
1649653|NCT01677858|5764747|P2|Overall Study|Progressive Disease|1
1649654|NCT01677858|5764748|P1|Overall Study|Progressive Disease|2
1649655|NCT01677858|5764744|P5|Overall Study|Physician Decision|12
1649656|NCT01677858|5764745|P4|Overall Study|Physician Decision|0
1649657|NCT01677858|5764746|P3|Overall Study|Physician Decision|2
1649658|NCT01677858|5764747|P2|Overall Study|Physician Decision|0
1649659|NCT01677858|5764748|P1|Overall Study|Physician Decision|1
1649660|NCT01677858|5764744|P5|Overall Study|Death|1
1649661|NCT01677858|5764745|P4|Overall Study|Death|0
1649662|NCT01677858|5764746|P3|Overall Study|Death|0
1649663|NCT01677858|5764747|P2|Overall Study|Death|0
1649664|NCT01677858|5764748|P1|Overall Study|Death|0
1649665|NCT01677858|5764744|P5|Overall Study|Adverse Event|13
1649666|NCT01677858|5764745|P4|Overall Study|Adverse Event|3
1649667|NCT01677858|5764746|P3|Overall Study|Adverse Event|2
1649668|NCT01677858|5764747|P2|Overall Study|Adverse Event|0
1649669|NCT01677858|5764748|P1|Overall Study|Adverse Event|0
1649670|NCT01677767|5764821|P1|Overall Study|Non-compliance by the participants|3
1649671|NCT01677767|5764821|P1|Overall Study|Withdrawal by Subject|10
1649672|NCT01677767|5764821|P1|Overall Study|Protocol Violation|4
1649673|NCT01677767|5764821|P1|Overall Study|Death|4
1649674|NCT01677767|5764821|P1|Overall Study|Adverse Event|1
1649675|NCT01677624|5764835|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
1649676|NCT01677507|5764840|P2|Second Assigment|Adverse Event|3
1649677|NCT01677507|5764841|P1|Second Assigment|Adverse Event|1
1649678|NCT01677507|5764840|P2|Second Assigment|Withdrawal by Subject|2
1649679|NCT01677507|5764841|P1|Second Assigment|Withdrawal by Subject|2
1649680|NCT01677507|5764840|P2|Initial Assignment|Protocol Violation|1
1649681|NCT01677507|5764841|P1|Initial Assignment|Protocol Violation|0
1649682|NCT01677507|5764840|P2|Initial Assignment|Adverse Event|1
1649683|NCT01677507|5764841|P1|Initial Assignment|Adverse Event|0
1649684|NCT01677377|5764854|P3|Overall Study|Pregnancy|1
1649685|NCT01677377|5764855|P2|Overall Study|Pregnancy|0
1649686|NCT01677377|5764856|P1|Overall Study|Pregnancy|0
1649687|NCT01677377|5764854|P3|Overall Study|Lack of Efficacy|1
1649688|NCT01677377|5764855|P2|Overall Study|Lack of Efficacy|0
1649689|NCT01677377|5764856|P1|Overall Study|Lack of Efficacy|0
1649690|NCT01677377|5764854|P3|Overall Study|Withdrawal by Subject|3
1649691|NCT01677377|5764855|P2|Overall Study|Withdrawal by Subject|0
1649692|NCT01677377|5764856|P1|Overall Study|Withdrawal by Subject|0
1649693|NCT01677377|5764854|P3|Overall Study|Lost to Follow-up|1
1649694|NCT01677377|5764855|P2|Overall Study|Lost to Follow-up|1
1649695|NCT01677377|5764856|P1|Overall Study|Lost to Follow-up|0
1649696|NCT01677377|5764854|P3|Overall Study|Protocol Violation|0
1649697|NCT01677377|5764855|P2|Overall Study|Protocol Violation|0
1649698|NCT01677377|5764856|P1|Overall Study|Protocol Violation|1
1649699|NCT01677299|5765057|P4|Overall Study|Withdrawal by Subject|1
1649700|NCT01677299|5765058|P3|Overall Study|Withdrawal by Subject|0
1649701|NCT01677299|5765059|P2|Overall Study|Withdrawal by Subject|1
1649702|NCT01677299|5765060|P1|Overall Study|Withdrawal by Subject|0
1649703|NCT01677299|5765057|P4|Overall Study|Adverse Event|0
1649704|NCT01677299|5765058|P3|Overall Study|Adverse Event|1
1649705|NCT01677299|5765059|P2|Overall Study|Adverse Event|2
1649706|NCT01677299|5765060|P1|Overall Study|Adverse Event|0
1649707|NCT01677195|5765092|P3|Overall Study|Protocol Violation|4
1649708|NCT01677195|5765093|P2|Overall Study|Protocol Violation|3
1649709|NCT01677195|5765094|P1|Overall Study|Protocol Violation|7
1649710|NCT01677195|5765092|P3|Overall Study|Pregnancy|0
1649711|NCT01677195|5765093|P2|Overall Study|Pregnancy|1
1649712|NCT01677195|5765094|P1|Overall Study|Pregnancy|0
1649713|NCT01677195|5765092|P3|Overall Study|Physician Decision|2
1649714|NCT01677195|5765093|P2|Overall Study|Physician Decision|2
1649715|NCT01677195|5765094|P1|Overall Study|Physician Decision|1
1649716|NCT01677195|5765092|P3|Overall Study|Adverse Event|1
1649717|NCT01677195|5765093|P2|Overall Study|Adverse Event|4
1649718|NCT01677195|5765094|P1|Overall Study|Adverse Event|6
1649719|NCT01677195|5765092|P3|Overall Study|Withdrawal by Subject|1
1649720|NCT01677195|5765093|P2|Overall Study|Withdrawal by Subject|0
1649721|NCT01677195|5765094|P1|Overall Study|Withdrawal by Subject|1
1649722|NCT01677195|5765092|P3|Overall Study|Lost to Follow-up|22
1649723|NCT01677195|5765093|P2|Overall Study|Lost to Follow-up|22
1649724|NCT01677195|5765094|P1|Overall Study|Lost to Follow-up|14
1649725|NCT01677182|5765105|P3|Overall Study|Other reasons|2
1649726|NCT01677182|5765106|P2|Overall Study|Other reasons|5
1649727|NCT01677182|5765107|P1|Overall Study|Other reasons|1
1649728|NCT01677182|5765105|P3|Overall Study|Lack of Efficacy|1
1649729|NCT01677182|5765106|P2|Overall Study|Lack of Efficacy|0
1649730|NCT01677182|5765107|P1|Overall Study|Lack of Efficacy|3
1649731|NCT01677182|5765105|P3|Overall Study|Study termination|11
1649732|NCT01677182|5765106|P2|Overall Study|Study termination|9
1649733|NCT01677182|5765107|P1|Overall Study|Study termination|12
1649734|NCT01677182|5765105|P3|Overall Study|Withdrawal by Subject|10
1649735|NCT01677182|5765106|P2|Overall Study|Withdrawal by Subject|12
1649736|NCT01677182|5765107|P1|Overall Study|Withdrawal by Subject|7
1649737|NCT01677182|5765105|P3|Overall Study|Lost to Follow-up|3
1649738|NCT01677182|5765106|P2|Overall Study|Lost to Follow-up|0
1649739|NCT01677182|5765107|P1|Overall Study|Lost to Follow-up|4
1649740|NCT01677182|5765105|P3|Overall Study|Protocol Violation|4
1649741|NCT01677182|5765106|P2|Overall Study|Protocol Violation|1
1649742|NCT01677182|5765107|P1|Overall Study|Protocol Violation|5
1649743|NCT01677182|5765105|P3|Overall Study|Adverse Event|8
1649744|NCT01677182|5765106|P2|Overall Study|Adverse Event|1
1649745|NCT01677182|5765107|P1|Overall Study|Adverse Event|2
1649746|NCT01676961|5765139|P1|Overall Study|Withdrawal by Subject|1
1649747|NCT01676961|5765139|P1|Overall Study|Lost to Follow-up|1
1649748|NCT01676961|5765139|P1|Overall Study|Death|3
1649749|NCT01676909|5765146|P2|Overall Study|Lost to Follow-up|9
1649750|NCT01676909|5765147|P1|Overall Study|Lost to Follow-up|15
1649751|NCT01676909|5765146|P2|Overall Study|Withdrawal by Subject|5
1649752|NCT01676909|5765147|P1|Overall Study|Withdrawal by Subject|3
1649753|NCT01676896|5765212|P3|Overall Study|Withdrawal by Subject|19
1649754|NCT01676896|5765213|P2|Overall Study|Withdrawal by Subject|7
1649755|NCT01676896|5765214|P1|Overall Study|Withdrawal by Subject|12
1649756|NCT01676727|5765322|P1|Overall Study|Valve explanted|1
1649757|NCT01676727|5765322|P1|Overall Study|Not willing to attend 1-year visit|2
1649758|NCT01676727|5765322|P1|Overall Study|Screening failure|5
1649759|NCT01676727|5765322|P1|Overall Study|Withdrawal by Subject|6
1649760|NCT01676727|5765322|P1|Overall Study|Death|18
1649761|NCT01676701|5765336|P2|Overall Study|Sponsor Decision|4
1649762|NCT01676701|5765337|P1|Overall Study|Sponsor Decision|3
1649763|NCT01676701|5765336|P2|Overall Study|Protocol Violation|0
1649764|NCT01676701|5765337|P1|Overall Study|Protocol Violation|1
1649765|NCT01676220|5765439|P2|Overall Study|No More Need of Insulin|0
1649766|NCT01676220|5765440|P1|Overall Study|No More Need of Insulin|1
1649767|NCT01676220|5765439|P2|Overall Study|Non Serious Hypoglycemia|0
1649768|NCT01676220|5765440|P1|Overall Study|Non Serious Hypoglycemia|2
1649769|NCT01676220|5765439|P2|Overall Study|Perceived Lack of Efficacy|1
1649770|NCT01676220|5765440|P1|Overall Study|Perceived Lack of Efficacy|3
1649771|NCT01676220|5765439|P2|Overall Study|Site Closure/Site Withdrawal|4
1649772|NCT01676220|5765440|P1|Overall Study|Site Closure/Site Withdrawal|1
1649773|NCT01676220|5765439|P2|Overall Study|Selection Criterion/Protocol Violation|9
1649774|NCT01676220|5765440|P1|Overall Study|Selection Criterion/Protocol Violation|9
1649775|NCT01676220|5765439|P2|Overall Study|Lost to Follow-up|18
1649776|NCT01676220|5765440|P1|Overall Study|Lost to Follow-up|11
1649777|NCT01676220|5765439|P2|Overall Study|Personal Reason|45
1649778|NCT01676220|5765440|P1|Overall Study|Personal Reason|34
1649779|NCT01676220|5765439|P2|Overall Study|Received Rescue Therapy|22
1649780|NCT01676220|5765440|P1|Overall Study|Received Rescue Therapy|14
1649781|NCT01676220|5765439|P2|Overall Study|Protocol Violation|12
1649782|NCT01676220|5765440|P1|Overall Study|Protocol Violation|11
1649783|NCT01676220|5765439|P2|Overall Study|Lack of Efficacy|5
1649784|NCT01676220|5765440|P1|Overall Study|Lack of Efficacy|2
1649785|NCT01676220|5765439|P2|Overall Study|Adverse Event|8
1649786|NCT01676220|5765440|P1|Overall Study|Adverse Event|10
1649787|NCT01676220|5765439|P2|Overall Study|Randomized But Not Treated|1
1649788|NCT01676220|5765440|P1|Overall Study|Randomized But Not Treated|4
1649789|NCT01676116|5765472|P2|Overall Study|Protocol Violation|3
1649790|NCT01676116|5765473|P1|Overall Study|Protocol Violation|9
1649791|NCT01676116|5765472|P2|Overall Study|Unclassified|10
1649792|NCT01676116|5765473|P1|Overall Study|Unclassified|4
1649793|NCT01676116|5765472|P2|Overall Study|Adverse Event|2
1649794|NCT01676116|5765473|P1|Overall Study|Adverse Event|1
1649795|NCT01676116|5765472|P2|Overall Study|Withdrawal criteria|14
1649796|NCT01676116|5765473|P1|Overall Study|Withdrawal criteria|2
1649797|NCT01676012|5765495|P1|Overall Study|incomplete set of videos|1
1649798|NCT01676012|5765495|P1|Overall Study|Adverse Event|2
1649799|NCT01675661|5765517|P2|Overall Study|Other reason|2
1649800|NCT01675661|5765518|P1|Overall Study|Other reason|1
1649801|NCT01675661|5765517|P2|Overall Study|Death|1
1649802|NCT01675661|5765518|P1|Overall Study|Death|0
1649803|NCT01675661|5765517|P2|Overall Study|Physician Decision|2
1649804|NCT01675661|5765518|P1|Overall Study|Physician Decision|0
1649805|NCT01675661|5765517|P2|Overall Study|Withdrawal by Subject|7
1649806|NCT01675661|5765518|P1|Overall Study|Withdrawal by Subject|3
1649807|NCT01675661|5765517|P2|Overall Study|Moved away|6
1649808|NCT01675661|5765518|P1|Overall Study|Moved away|5
1649809|NCT01675661|5765517|P2|Overall Study|Practical problems|5
1649810|NCT01675661|5765518|P1|Overall Study|Practical problems|9
1649811|NCT01675661|5765517|P2|Overall Study|Lost to Follow-up|23
1649812|NCT01675661|5765518|P1|Overall Study|Lost to Follow-up|22
1649813|NCT01675622|5765547|P2|Overall Study|Other|4
1649814|NCT01675622|5765548|P1|Overall Study|Other|5
1649815|NCT01675622|5765547|P2|Overall Study|Lost to Follow-up|3
1649816|NCT01675622|5765548|P1|Overall Study|Lost to Follow-up|1
1649817|NCT01675622|5765547|P2|Overall Study|Lack of Efficacy|4
1649818|NCT01675622|5765548|P1|Overall Study|Lack of Efficacy|2
1649819|NCT01675622|5765547|P2|Overall Study|Protocol Violation|1
1649820|NCT01675622|5765548|P1|Overall Study|Protocol Violation|4
1649821|NCT01675622|5765547|P2|Overall Study|Adverse Event|10
1649822|NCT01675622|5765548|P1|Overall Study|Adverse Event|12
1649823|NCT01675622|5765547|P2|Overall Study|Withdrawal by Subject|2
1649824|NCT01675622|5765548|P1|Overall Study|Withdrawal by Subject|2
1649825|NCT01675596|5765572|P1|Overall Study|Missed Visit|1
1649826|NCT01675596|5765572|P1|Overall Study|Exit with other reason|1
1649827|NCT01675596|5765572|P1|Overall Study|Death|6
1649828|NCT01675544|5765578|P1|Overall Study|Withdrawal by Subject|2
1649829|NCT01675531|5765583|P1|Overall Study|Protocol Violation|8
1649830|NCT01675531|5765583|P1|Overall Study|Lack of Efficacy|1
1649831|NCT01675531|5765583|P1|Overall Study|Withdrawal by Subject|7
1649832|NCT01675531|5765583|P1|Overall Study|Adverse Event|9
1649833|NCT01675492|5765590|P1|Overall Study|study completed early - product approval|42
1649834|NCT01675479|5765595|P1|Overall Study|Lost to Follow-up|11
1649835|NCT01675427|5765609|P1|Overall Study|Other|2
1649836|NCT01675427|5765609|P1|Overall Study|Lost to Follow-up|5
1649837|NCT01675427|5765609|P1|Overall Study|Sample not Collected by Mistake|2
1649838|NCT01675427|5765609|P1|Overall Study|Participant Refused Sample Collection|18
1649839|NCT01675427|5765609|P1|Overall Study|Withdrawal by Subject|7
1649840|NCT01675167|5765909|P3|Double-blind Treatment Phase|Other|5
1649841|NCT01675167|5765910|P2|Double-blind Treatment Phase|Other|7
1649842|NCT01675167|5765911|P1|Double-blind Treatment Phase|Other|0
1649843|NCT01675167|5765909|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
1649844|NCT01675167|5765910|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1649845|NCT01675167|5765911|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1649846|NCT01675167|5765909|P3|Double-blind Treatment Phase|Lost to Follow-up|5
1649847|NCT01675167|5765910|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1649848|NCT01675167|5765911|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1649849|NCT01675167|5765909|P3|Double-blind Treatment Phase|Protocol Violation|11
1649850|NCT01675167|5765910|P2|Double-blind Treatment Phase|Protocol Violation|4
1649851|NCT01675167|5765911|P1|Double-blind Treatment Phase|Protocol Violation|0
1649852|NCT01675167|5765909|P3|Double-blind Treatment Phase|Adverse Event|13
1649853|NCT01675167|5765910|P2|Double-blind Treatment Phase|Adverse Event|5
1649854|NCT01675167|5765911|P1|Double-blind Treatment Phase|Adverse Event|0
1649855|NCT01675167|5765909|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
1649856|NCT01675167|5765910|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
1649857|NCT01675167|5765911|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1649858|NCT01675167|5765909|P3|Double-blind Treatment Phase|Lack of Efficacy|61
1649859|NCT01675167|5765910|P2|Double-blind Treatment Phase|Lack of Efficacy|19
1649860|NCT01675167|5765911|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1649861|NCT01675167|5765909|P3|Open-label Titration Phase|Other|0
1649862|NCT01675167|5765910|P2|Open-label Titration Phase|Other|0
1649863|NCT01675167|5765911|P1|Open-label Titration Phase|Other|55
1649864|NCT01675167|5765909|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1649865|NCT01675167|5765910|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
1649866|NCT01675167|5765911|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
1649867|NCT01675167|5765909|P3|Open-label Titration Phase|Lost to Follow-up|0
1649868|NCT01675167|5765910|P2|Open-label Titration Phase|Lost to Follow-up|0
1649869|NCT01675167|5765911|P1|Open-label Titration Phase|Lost to Follow-up|15
1649870|NCT01675167|5765909|P3|Open-label Titration Phase|Protocol Violation|0
1649871|NCT01675167|5765910|P2|Open-label Titration Phase|Protocol Violation|0
1649872|NCT01675167|5765911|P1|Open-label Titration Phase|Protocol Violation|43
1649873|NCT01675167|5765909|P3|Open-label Titration Phase|Withdrawal by Subject|0
1649874|NCT01675167|5765910|P2|Open-label Titration Phase|Withdrawal by Subject|0
1649875|NCT01675167|5765911|P1|Open-label Titration Phase|Withdrawal by Subject|46
1649876|NCT01675167|5765909|P3|Open-label Titration Phase|Lack of Efficacy|0
1649877|NCT01675167|5765910|P2|Open-label Titration Phase|Lack of Efficacy|0
1649878|NCT01675167|5765911|P1|Open-label Titration Phase|Lack of Efficacy|63
1649879|NCT01675167|5765909|P3|Open-label Titration Phase|Adverse Event|0
1649880|NCT01675167|5765910|P2|Open-label Titration Phase|Adverse Event|0
1649881|NCT01675167|5765911|P1|Open-label Titration Phase|Adverse Event|81
1649882|NCT01675141|5765933|P1|Overall Study|No treatment, per protocol|1
1649883|NCT01675141|5765933|P1|Overall Study|Physician Decision|4
1649884|NCT01675141|5765933|P1|Overall Study|Withdrawal by Subject|3
1649885|NCT01675141|5765933|P1|Overall Study|Lenalidomide outside NIH|3
1649886|NCT01675128|5765946|P3|Overall Study|Pulmonary complication; off study|0
1649887|NCT01675128|5765947|P2|Overall Study|Pulmonary complication; off study|1
1649888|NCT01675128|5765948|P1|Overall Study|Pulmonary complication; off study|0
1649889|NCT01675128|5765946|P3|Overall Study|Refused further treatment|0
1649890|NCT01675128|5765947|P2|Overall Study|Refused further treatment|0
1649891|NCT01675128|5765948|P1|Overall Study|Refused further treatment|1
1649892|NCT01675128|5765946|P3|Overall Study|Disease progression on study|1
1649893|NCT01675128|5765947|P2|Overall Study|Disease progression on study|1
1649894|NCT01675128|5765948|P1|Overall Study|Disease progression on study|1
1649895|NCT01675050|5765976|P2|Period One Treatment|Withdrawal by Subject|0
1649896|NCT01675050|5765977|P1|Period One Treatment|Withdrawal by Subject|1
1649897|NCT01675011|5765987|P2|Overall Study|Trial terminated by Sponsor|1
1649898|NCT01675011|5765988|P1|Overall Study|Trial terminated by Sponsor|3
1649899|NCT01674725|5765996|P2|Overall Study|Lost to Follow-up|1
1649900|NCT01674725|5765997|P1|Overall Study|Lost to Follow-up|0
1649901|NCT01674725|5765996|P2|Overall Study|Withdrawal by Subject|0
1649902|NCT01674725|5765997|P1|Overall Study|Withdrawal by Subject|1
1649903|NCT01674725|5765996|P2|Overall Study|Did not receive study drug|0
1649904|NCT01674725|5765997|P1|Overall Study|Did not receive study drug|1
1649905|NCT01674725|5765996|P2|Overall Study|Adverse Event|0
1649906|NCT01674725|5765997|P1|Overall Study|Adverse Event|1
1649907|NCT01674712|5766016|P5|Overall Study|Lack of Efficacy|1
1649908|NCT01674712|5766017|P4|Overall Study|Lack of Efficacy|0
1649909|NCT01674712|5766018|P3|Overall Study|Lack of Efficacy|1
1649910|NCT01674712|5766019|P2|Overall Study|Lack of Efficacy|0
1649911|NCT01674712|5766020|P1|Overall Study|Lack of Efficacy|0
1649912|NCT01674712|5766016|P5|Overall Study|Administrative|1
1649913|NCT01674712|5766017|P4|Overall Study|Administrative|0
1649914|NCT01674712|5766018|P3|Overall Study|Administrative|0
1649915|NCT01674712|5766019|P2|Overall Study|Administrative|1
1649916|NCT01674712|5766020|P1|Overall Study|Administrative|0
1649917|NCT01674712|5766016|P5|Overall Study|Withdrawal by Subject|3
1649918|NCT01674712|5766017|P4|Overall Study|Withdrawal by Subject|4
1649919|NCT01674712|5766018|P3|Overall Study|Withdrawal by Subject|5
1649920|NCT01674712|5766019|P2|Overall Study|Withdrawal by Subject|2
1649921|NCT01674712|5766020|P1|Overall Study|Withdrawal by Subject|2
1649922|NCT01674712|5766016|P5|Overall Study|Protocol Violation|0
1649923|NCT01674712|5766017|P4|Overall Study|Protocol Violation|0
1649924|NCT01674712|5766018|P3|Overall Study|Protocol Violation|0
1649925|NCT01674712|5766019|P2|Overall Study|Protocol Violation|0
1649926|NCT01674712|5766020|P1|Overall Study|Protocol Violation|2
1649927|NCT01674712|5766016|P5|Overall Study|Lost to Follow-up|0
1649928|NCT01674712|5766017|P4|Overall Study|Lost to Follow-up|0
1649929|NCT01674712|5766018|P3|Overall Study|Lost to Follow-up|0
1649930|NCT01674712|5766019|P2|Overall Study|Lost to Follow-up|0
1649931|NCT01674712|5766020|P1|Overall Study|Lost to Follow-up|1
1649932|NCT01674712|5766016|P5|Overall Study|Adverse Event|6
1649933|NCT01674712|5766017|P4|Overall Study|Adverse Event|4
1649934|NCT01674712|5766018|P3|Overall Study|Adverse Event|3
1649935|NCT01674712|5766019|P2|Overall Study|Adverse Event|6
1649936|NCT01674712|5766020|P1|Overall Study|Adverse Event|5
1649937|NCT01674647|5766044|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
1649938|NCT01674647|5766045|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
1649939|NCT01674647|5766044|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
1649940|NCT01674647|5766045|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
1649941|NCT01674647|5766044|P2|30-day Safety Follow-up Period|Logistical difficulties|3
1649942|NCT01674647|5766045|P1|30-day Safety Follow-up Period|Logistical difficulties|1
1649943|NCT01674647|5766044|P2|30-day Safety Follow-up Period|Protocol Violation|22
1649944|NCT01674647|5766045|P1|30-day Safety Follow-up Period|Protocol Violation|39
1649945|NCT01674647|5766044|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
1649946|NCT01674647|5766045|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
1649947|NCT01674647|5766044|P2|30-day Safety Follow-up Period|Death|2
1649948|NCT01674647|5766045|P1|30-day Safety Follow-up Period|Death|3
1649949|NCT01674647|5766044|P2|Treatment Period|Protocol Violation|36
1649950|NCT01674647|5766045|P1|Treatment Period|Protocol Violation|56
1649951|NCT01674647|5766044|P2|Treatment Period|Treatment failure|14
1649952|NCT01674647|5766045|P1|Treatment Period|Treatment failure|0
1649953|NCT01674647|5766044|P2|Treatment Period|Logistical difficulties|8
1649954|NCT01674647|5766045|P1|Treatment Period|Logistical difficulties|5
1649955|NCT01674647|5766044|P2|Treatment Period|Switching to other therapy|2
1649956|NCT01674647|5766045|P1|Treatment Period|Switching to other therapy|5
1649957|NCT01674647|5766044|P2|Treatment Period|Withdrawal by Subject|16
1649958|NCT01674647|5766045|P1|Treatment Period|Withdrawal by Subject|19
1649959|NCT01674647|5766044|P2|Treatment Period|Lost to Follow-up|1
1649960|NCT01674647|5766045|P1|Treatment Period|Lost to Follow-up|1
1649961|NCT01674647|5766044|P2|Treatment Period|Non-compliance with study drug|0
1649962|NCT01674647|5766045|P1|Treatment Period|Non-compliance with study drug|3
1649963|NCT01674647|5766044|P2|Treatment Period|Adverse Event|22
1649964|NCT01674647|5766045|P1|Treatment Period|Adverse Event|60
1649965|NCT01674647|5766044|P2|Treatment Period|Physician Decision|1
1649966|NCT01674647|5766045|P1|Treatment Period|Physician Decision|3
1649967|NCT01674647|5766044|P2|Treatment Period|Efficacy outcome reached|1
1649968|NCT01674647|5766045|P1|Treatment Period|Efficacy outcome reached|0
1649969|NCT01674647|5766044|P2|Treatment Period|Death|1
1649970|NCT01674647|5766045|P1|Treatment Period|Death|4
1649971|NCT01674634|5766071|P1|Overall Study|Lost to Follow-up|3
1649972|NCT01674634|5766071|P1|Overall Study|Withdrawal by Subject|3
1649973|NCT01674569|5766117|P6|Overall Study|Withdrawal by Subject|0
1649974|NCT01674569|5766118|P5|Overall Study|Withdrawal by Subject|0
1649975|NCT01674569|5766119|P4|Overall Study|Withdrawal by Subject|0
1649976|NCT01674569|5766120|P3|Overall Study|Withdrawal by Subject|1
1649977|NCT01674569|5766121|P2|Overall Study|Withdrawal by Subject|0
1649978|NCT01674569|5766122|P1|Overall Study|Withdrawal by Subject|0
1649979|NCT01674569|5766117|P6|Overall Study|Protocol Violation|0
1649980|NCT01674569|5766118|P5|Overall Study|Protocol Violation|0
1649981|NCT01674569|5766119|P4|Overall Study|Protocol Violation|0
1649982|NCT01674569|5766120|P3|Overall Study|Protocol Violation|1
1649983|NCT01674569|5766121|P2|Overall Study|Protocol Violation|1
1649984|NCT01674569|5766122|P1|Overall Study|Protocol Violation|0
1649985|NCT01674569|5766117|P6|Overall Study|Adverse Event|2
1649986|NCT01674569|5766118|P5|Overall Study|Adverse Event|2
1649987|NCT01674569|5766119|P4|Overall Study|Adverse Event|1
1649988|NCT01674569|5766120|P3|Overall Study|Adverse Event|0
1649989|NCT01674569|5766121|P2|Overall Study|Adverse Event|2
1649990|NCT01674569|5766122|P1|Overall Study|Adverse Event|0
1649991|NCT01674062|5766143|P2|Overall Study|Programming Error|0
1649992|NCT01674062|5766144|P1|Overall Study|Programming Error|1
1649993|NCT01674062|5766143|P2|Overall Study|Death|1
1649994|NCT01674062|5766144|P1|Overall Study|Death|0
1649995|NCT01674062|5766143|P2|Overall Study|Adverse Event|1
1649996|NCT01674062|5766144|P1|Overall Study|Adverse Event|1
1649997|NCT01674062|5766143|P2|Overall Study|Other|1
1649998|NCT01674062|5766144|P1|Overall Study|Other|8
1649999|NCT01674062|5766143|P2|Overall Study|Insufficient Therapeutic Response|26
1650000|NCT01674062|5766144|P1|Overall Study|Insufficient Therapeutic Response|56
1650001|NCT01674010|5766159|P3|Randomization Phase 2|Withdrawal by Subject|7
1650002|NCT01674010|5766160|P2|Randomization Phase 2|Withdrawal by Subject|8
1650003|NCT01674010|5766161|P1|Randomization Phase 2|Withdrawal by Subject|0
1650004|NCT01674010|5766159|P3|Randomization Phase 2|Sponsor Decision|45
1650005|NCT01674010|5766160|P2|Randomization Phase 2|Sponsor Decision|42
1650006|NCT01674010|5766161|P1|Randomization Phase 2|Sponsor Decision|0
1650007|NCT01674010|5766159|P3|Randomization Phase 2|Protocol Violation|1
1650008|NCT01674010|5766160|P2|Randomization Phase 2|Protocol Violation|1
1650009|NCT01674010|5766161|P1|Randomization Phase 2|Protocol Violation|0
1650010|NCT01674010|5766159|P3|Randomization Phase 2|Pregnancy|1
1650011|NCT01674010|5766160|P2|Randomization Phase 2|Pregnancy|1
1650012|NCT01674010|5766161|P1|Randomization Phase 2|Pregnancy|0
1650013|NCT01674010|5766159|P3|Randomization Phase 2|Physician Decision|2
1650014|NCT01674010|5766160|P2|Randomization Phase 2|Physician Decision|0
1650015|NCT01674010|5766161|P1|Randomization Phase 2|Physician Decision|0
1650016|NCT01674010|5766159|P3|Randomization Phase 2|Mood episode recurrence|2
1650017|NCT01674010|5766160|P2|Randomization Phase 2|Mood episode recurrence|8
1650018|NCT01674010|5766161|P1|Randomization Phase 2|Mood episode recurrence|0
1650019|NCT01674010|5766159|P3|Randomization Phase 2|Lost to Follow-up|2
1650020|NCT01674010|5766160|P2|Randomization Phase 2|Lost to Follow-up|1
1650021|NCT01674010|5766161|P1|Randomization Phase 2|Lost to Follow-up|0
1650022|NCT01674010|5766159|P3|Randomization Phase 2|Adverse Event|1
1650023|NCT01674010|5766160|P2|Randomization Phase 2|Adverse Event|1
1650024|NCT01674010|5766161|P1|Randomization Phase 2|Adverse Event|0
1650025|NCT01674010|5766159|P3|Open Treatment Phase 1|Withdrawal by Subject|0
1650026|NCT01674010|5766160|P2|Open Treatment Phase 1|Withdrawal by Subject|0
1650027|NCT01674010|5766161|P1|Open Treatment Phase 1|Withdrawal by Subject|25
1650028|NCT01674010|5766159|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
1650029|NCT01674010|5766160|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
1650030|NCT01674010|5766161|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
1650031|NCT01674010|5766159|P3|Open Treatment Phase 1|Sponsor Decision|0
1650032|NCT01674010|5766160|P2|Open Treatment Phase 1|Sponsor Decision|0
1650033|NCT01674010|5766161|P1|Open Treatment Phase 1|Sponsor Decision|79
1650034|NCT01674010|5766159|P3|Open Treatment Phase 1|Protocol Violation|0
1650035|NCT01674010|5766160|P2|Open Treatment Phase 1|Protocol Violation|0
1650036|NCT01674010|5766161|P1|Open Treatment Phase 1|Protocol Violation|7
1650037|NCT01674010|5766159|P3|Open Treatment Phase 1|Physician Decision|0
1650038|NCT01674010|5766160|P2|Open Treatment Phase 1|Physician Decision|0
1650039|NCT01674010|5766161|P1|Open Treatment Phase 1|Physician Decision|9
1650040|NCT01674010|5766159|P3|Open Treatment Phase 1|Lost to Follow-up|0
1650041|NCT01674010|5766160|P2|Open Treatment Phase 1|Lost to Follow-up|0
1650042|NCT01674010|5766161|P1|Open Treatment Phase 1|Lost to Follow-up|19
1650043|NCT01674010|5766159|P3|Open Treatment Phase 1|Death|0
1650044|NCT01674010|5766160|P2|Open Treatment Phase 1|Death|0
1650045|NCT01674010|5766161|P1|Open Treatment Phase 1|Death|1
1650046|NCT01674010|5766159|P3|Open Treatment Phase 1|Adverse Event|0
1650047|NCT01674010|5766160|P2|Open Treatment Phase 1|Adverse Event|0
1650048|NCT01674010|5766161|P1|Open Treatment Phase 1|Adverse Event|10
1650049|NCT01673984|5766180|P2|Overall Study|Study termination|6
1650050|NCT01673984|5766181|P1|Overall Study|Study termination|9
1650051|NCT01673984|5766180|P2|Overall Study|Adverse Event|0
1650052|NCT01673984|5766181|P1|Overall Study|Adverse Event|1
1650053|NCT01673867|5766231|P2|Treatment|Physician Decision|1
1650054|NCT01673867|5766232|P1|Treatment|Physician Decision|0
1650055|NCT01673867|5766231|P2|Treatment|Symptomatic deterioration|1
1650056|NCT01673867|5766232|P1|Treatment|Symptomatic deterioration|0
1650057|NCT01673867|5766231|P2|Treatment|Required prolonged hospitalization|1
1650058|NCT01673867|5766232|P1|Treatment|Required prolonged hospitalization|0
1650059|NCT01673867|5766231|P2|Treatment|Health status not improved|0
1650060|NCT01673867|5766232|P1|Treatment|Health status not improved|1
1650061|NCT01673867|5766231|P2|Treatment|Required steroid therapy|0
1650062|NCT01673867|5766232|P1|Treatment|Required steroid therapy|1
1650063|NCT01673867|5766231|P2|Treatment|No longer meets criteria|0
1650064|NCT01673867|5766232|P1|Treatment|No longer meets criteria|2
1650065|NCT01673867|5766231|P2|Treatment|Maximum clinical benefit|10
1650066|NCT01673867|5766232|P1|Treatment|Maximum clinical benefit|0
1650067|NCT01673867|5766231|P2|Treatment|Withdrawal by Subject|6
1650068|NCT01673867|5766232|P1|Treatment|Withdrawal by Subject|4
1650069|NCT01673867|5766231|P2|Treatment|Requested treatment discontinuation|16
1650070|NCT01673867|5766232|P1|Treatment|Requested treatment discontinuation|5
1650071|NCT01673867|5766231|P2|Treatment|AE unrelated to study drug|11
1650072|NCT01673867|5766232|P1|Treatment|AE unrelated to study drug|19
1650073|NCT01673867|5766231|P2|Treatment|Death|1
1650074|NCT01673867|5766232|P1|Treatment|Death|1
1650075|NCT01673867|5766231|P2|Treatment|Study Drug Toxicity|42
1650076|NCT01673867|5766232|P1|Treatment|Study Drug Toxicity|17
1650077|NCT01673867|5766231|P2|Treatment|Disease Progression|179
1650078|NCT01673867|5766232|P1|Treatment|Disease Progression|194
1650079|NCT01673867|5766231|P2|Randomization|No longer meets criteria|5
1650080|NCT01673867|5766232|P1|Randomization|No longer meets criteria|4
1650081|NCT01673867|5766231|P2|Randomization|Lost to Follow-up|1
1650082|NCT01673867|5766232|P1|Randomization|Lost to Follow-up|0
1650083|NCT01673867|5766231|P2|Randomization|Withdrawal by Subject|12
1650084|NCT01673867|5766232|P1|Randomization|Withdrawal by Subject|0
1650085|NCT01673867|5766231|P2|Randomization|Requested treatment discontinuation|4
1650086|NCT01673867|5766232|P1|Randomization|Requested treatment discontinuation|0
1650087|NCT01673867|5766231|P2|Randomization|AE unrelated to study drug|0
1650088|NCT01673867|5766232|P1|Randomization|AE unrelated to study drug|1
1650089|NCT01673854|5766258|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
1650090|NCT01673854|5766258|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
1650091|NCT01673854|5766258|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
1650092|NCT01673854|5766258|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
1650093|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
1650094|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
1650095|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
1650096|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
1650097|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
1650098|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
1650099|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
1650100|NCT01673854|5766258|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
1650101|NCT01673698|5766281|P2|Overall Study|Lost to Follow-up|13
1650102|NCT01673698|5766282|P1|Overall Study|Lost to Follow-up|51
1650103|NCT01673646|5766293|P3|Overall Study|Completed Core/did not enter Ext.|1
1650104|NCT01673646|5766294|P2|Overall Study|Completed Core/did not enter Ext.|1
1650105|NCT01673646|5766295|P1|Overall Study|Completed Core/did not enter Ext.|2
1650106|NCT01673646|5766293|P3|Overall Study|Withdrawal by Subject|2
1650107|NCT01673646|5766294|P2|Overall Study|Withdrawal by Subject|2
1650108|NCT01673646|5766295|P1|Overall Study|Withdrawal by Subject|0
1650109|NCT01673646|5766293|P3|Overall Study|Condition no longer requires study drug|0
1650110|NCT01673646|5766294|P2|Overall Study|Condition no longer requires study drug|1
1650111|NCT01673646|5766295|P1|Overall Study|Condition no longer requires study drug|0
1650112|NCT01673646|5766293|P3|Overall Study|Unsatisfactory therapeutic effect|0
1650113|NCT01673646|5766294|P2|Overall Study|Unsatisfactory therapeutic effect|2
1650114|NCT01673646|5766295|P1|Overall Study|Unsatisfactory therapeutic effect|0
1650115|NCT01673646|5766293|P3|Overall Study|Adverse Event|1
1650116|NCT01673646|5766294|P2|Overall Study|Adverse Event|1
1650117|NCT01673646|5766295|P1|Overall Study|Adverse Event|2
1650118|NCT01673620|5766334|P2|Overall Study|Adverse Event|0
1650119|NCT01673620|5766335|P1|Overall Study|Adverse Event|1
1650120|NCT01673594|5766345|P2|Overall Study|Withdrawal by Subject|1
1650121|NCT01673594|5766346|P1|Overall Study|Withdrawal by Subject|0
1650122|NCT01673594|5766345|P2|Overall Study|Physician Decision|4
1650123|NCT01673594|5766346|P1|Overall Study|Physician Decision|2
1650124|NCT01673594|5766345|P2|Overall Study|Lost to Follow-up|0
1650125|NCT01673594|5766346|P1|Overall Study|Lost to Follow-up|1
1650126|NCT01673594|5766345|P2|Overall Study|Adverse Event|1
1650127|NCT01673594|5766346|P1|Overall Study|Adverse Event|3
1650128|NCT01673490|5766365|P1|Overall Study|Withdrawal by Subject|3
1650129|NCT01673490|5766365|P1|Overall Study|Adverse Event|3
1650130|NCT01673490|5766365|P1|Overall Study|Lost to Follow-up|1
1650131|NCT01673373|5766382|P1|Overall Study|Death|2
1650132|NCT01673347|5766398|P1|Overall Study|failure of allograft|7
1650133|NCT01673282|5766407|P2|Overall Study|Other|6
1650134|NCT01673282|5766408|P1|Overall Study|Other|1
1650135|NCT01673282|5766407|P2|Overall Study|Withdrawal by Subject|3
1650136|NCT01673282|5766408|P1|Overall Study|Withdrawal by Subject|3
1650137|NCT01673282|5766407|P2|Overall Study|Lost to Follow-up|10
1650138|NCT01673282|5766408|P1|Overall Study|Lost to Follow-up|11
1650139|NCT01673282|5766407|P2|Overall Study|Lack of Efficacy|2
1650140|NCT01673282|5766408|P1|Overall Study|Lack of Efficacy|9
1650141|NCT01673282|5766407|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
1650142|NCT01673282|5766408|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
1650143|NCT01673178|5766444|P5|Overall Study|Other|0
1650144|NCT01673178|5766445|P4|Overall Study|Other|1
1650145|NCT01673178|5766446|P3|Overall Study|Other|2
1650146|NCT01673178|5766447|P2|Overall Study|Other|0
1650147|NCT01673178|5766448|P1|Overall Study|Other|1
1650148|NCT01673178|5766444|P5|Overall Study|Adverse Event|0
1650149|NCT01673178|5766445|P4|Overall Study|Adverse Event|2
1650150|NCT01673178|5766446|P3|Overall Study|Adverse Event|0
1650151|NCT01673178|5766447|P2|Overall Study|Adverse Event|0
1650152|NCT01673178|5766448|P1|Overall Study|Adverse Event|1
1650153|NCT01673178|5766444|P5|Overall Study|Protocol Violation|0
1650154|NCT01673178|5766445|P4|Overall Study|Protocol Violation|1
1650155|NCT01673178|5766446|P3|Overall Study|Protocol Violation|0
1650156|NCT01673178|5766447|P2|Overall Study|Protocol Violation|1
1650157|NCT01673178|5766448|P1|Overall Study|Protocol Violation|1
1650158|NCT01673178|5766444|P5|Overall Study|Withdrawal by Subject|2
1650159|NCT01673178|5766445|P4|Overall Study|Withdrawal by Subject|4
1650160|NCT01673178|5766446|P3|Overall Study|Withdrawal by Subject|1
1650161|NCT01673178|5766447|P2|Overall Study|Withdrawal by Subject|0
1650162|NCT01673178|5766448|P1|Overall Study|Withdrawal by Subject|0
1650163|NCT01673178|5766444|P5|Overall Study|Lost to Follow-up|0
1650164|NCT01673178|5766445|P4|Overall Study|Lost to Follow-up|0
1650165|NCT01673178|5766446|P3|Overall Study|Lost to Follow-up|0
1650166|NCT01673178|5766447|P2|Overall Study|Lost to Follow-up|1
1650167|NCT01673178|5766448|P1|Overall Study|Lost to Follow-up|0
1650168|NCT01673126|5766687|P2|Overall Study|change of diagnosis|3
1650169|NCT01673126|5766688|P1|Overall Study|change of diagnosis|4
1650170|NCT01673009|5766708|P1|Overall Study|Withdrawal by Subject|8
1650171|NCT01673009|5766708|P1|Overall Study|Physician Decision|5
1650172|NCT01672970|5766793|P1|Overall Study|Enrolled but not treated|1
1650173|NCT01672970|5766793|P1|Overall Study|Other|9
1650174|NCT01672970|5766793|P1|Overall Study|Lost to Follow-up|5
1650175|NCT01672970|5766793|P1|Overall Study|Withdrawal by Subject|2
1650176|NCT01672970|5766793|P1|Overall Study|Adverse Event|18
1650177|NCT01672970|5766793|P1|Overall Study|Lack of Efficacy|12
1650178|NCT01672957|5766829|P1|Overall Study|ICF Signed After Transplantation|5
1650179|NCT01672957|5766829|P1|Overall Study|Death|2
1650180|NCT01672957|5766829|P1|Overall Study|Protocol Violation|48
1650181|NCT01672892|5766844|P2|Overall Study|Protocol Violation|3
1650182|NCT01672892|5766845|P1|Overall Study|Protocol Violation|8
1650183|NCT01672879|5766864|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
1650184|NCT01672879|5766865|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
1650185|NCT01672879|5766866|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
1650186|NCT01672879|5766864|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
1650187|NCT01672879|5766865|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
1650188|NCT01672879|5766866|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
1650189|NCT01672879|5766864|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
1650190|NCT01672879|5766865|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
1650191|NCT01672879|5766866|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
1650192|NCT01672879|5766864|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
1650193|NCT01672879|5766865|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
1650194|NCT01672879|5766866|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
1650195|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
1650196|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
1650197|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
1650198|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
1650199|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
1650200|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
1650201|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
1650202|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
1650203|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
1650204|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Death|0
1650205|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Death|2
1650206|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Death|0
1650207|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
1650208|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
1650209|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
1650210|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
1650211|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
1650212|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
1650213|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
1650214|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
1650215|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
1650216|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
1650217|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
1650218|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
1650219|NCT01672879|5766864|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
1650220|NCT01672879|5766865|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
1650221|NCT01672879|5766866|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
1650222|NCT01672866|5766881|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
1650223|NCT01672866|5766882|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
1650224|NCT01672866|5766883|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
1650225|NCT01672866|5766881|P3|Open-Label Phase (up to 240 Weeks)|Death|0
1650226|NCT01672866|5766882|P2|Open-Label Phase (up to 240 Weeks)|Death|0
1650227|NCT01672866|5766883|P1|Open-Label Phase (up to 240 Weeks)|Death|1
1650228|NCT01672866|5766881|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
1650229|NCT01672866|5766882|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
1650230|NCT01672866|5766883|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
1650231|NCT01672866|5766881|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
1650232|NCT01672866|5766882|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
1650233|NCT01672866|5766883|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
1650234|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
1650235|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
1650236|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
1650237|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
1650238|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
1650239|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
1650240|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Death|1
1650241|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Death|0
1650242|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Death|0
1650243|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
1650244|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
1650245|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
1650246|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
1650247|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
1650248|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
1650249|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
1650250|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
1650251|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
1650252|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
1650253|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
1650254|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
1650255|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
1650256|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
1650257|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
1650258|NCT01672866|5766881|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
1650259|NCT01672866|5766882|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
1650260|NCT01672866|5766883|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
1650261|NCT01672853|5766898|P3|Overall Study|Randomized but Never Treated|1
1650262|NCT01672853|5766899|P2|Overall Study|Randomized but Never Treated|0
1650263|NCT01672853|5766900|P1|Overall Study|Randomized but Never Treated|0
1650264|NCT01672853|5766898|P3|Overall Study|Lost to Follow-up|0
1650265|NCT01672853|5766899|P2|Overall Study|Lost to Follow-up|1
1650266|NCT01672853|5766900|P1|Overall Study|Lost to Follow-up|0
1650267|NCT01672853|5766898|P3|Overall Study|Adverse Event|8
1650268|NCT01672853|5766899|P2|Overall Study|Adverse Event|6
1650269|NCT01672853|5766900|P1|Overall Study|Adverse Event|4
1650270|NCT01672853|5766898|P3|Overall Study|Withdrew Consent|5
1650271|NCT01672853|5766899|P2|Overall Study|Withdrew Consent|5
1650272|NCT01672853|5766900|P1|Overall Study|Withdrew Consent|5
1650273|NCT01672853|5766898|P3|Overall Study|Investigator's Discretion|0
1650274|NCT01672853|5766899|P2|Overall Study|Investigator's Discretion|0
1650275|NCT01672853|5766900|P1|Overall Study|Investigator's Discretion|1
1650276|NCT01672853|5766898|P3|Overall Study|Pregnancy|0
1650277|NCT01672853|5766899|P2|Overall Study|Pregnancy|1
1650278|NCT01672853|5766900|P1|Overall Study|Pregnancy|0
1650279|NCT01672853|5766898|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
1650280|NCT01672853|5766899|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
1650281|NCT01672853|5766900|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
1650282|NCT01672788|5766923|P4|Washout Period 2 (7 Days)|Adverse Event|1
1650283|NCT01672788|5766924|P3|Washout Period 2 (7 Days)|Adverse Event|0
1650284|NCT01672788|5766925|P2|Washout Period 2 (7 Days)|Adverse Event|0
1650285|NCT01672788|5766926|P1|Washout Period 2 (7 Days)|Adverse Event|0
1650286|NCT01672736|5766956|P1|Overall Study|Available drug expired on 31 May 16|3
1650287|NCT01672723|5766960|P2|First Intervention|Adverse Event|0
1650288|NCT01672723|5766961|P1|First Intervention|Adverse Event|3
1650289|NCT01672710|5766973|P2|3 Month Follow up|follow up due after termination date|1
1650290|NCT01672710|5766974|P1|3 Month Follow up|follow up due after termination date|4
1650291|NCT01672710|5766973|P2|3 Month Follow up|Lost to Follow-up|3
1650292|NCT01672710|5766974|P1|3 Month Follow up|Lost to Follow-up|2
1650293|NCT01672710|5766973|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
1650294|NCT01672710|5766974|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
1650295|NCT01672294|5767011|P4|Overall Study|Lost to Follow-up|9
1650296|NCT01672294|5767012|P3|Overall Study|Lost to Follow-up|7
1650297|NCT01672294|5767013|P2|Overall Study|Lost to Follow-up|16
1650298|NCT01672294|5767014|P1|Overall Study|Lost to Follow-up|1
1650299|NCT01672294|5767011|P4|Overall Study|Excluded by study|0
1650300|NCT01672294|5767012|P3|Overall Study|Excluded by study|0
1650301|NCT01672294|5767013|P2|Overall Study|Excluded by study|1
1650302|NCT01672294|5767014|P1|Overall Study|Excluded by study|1
1650303|NCT01672294|5767011|P4|Overall Study|Withdrawal by Subject|4
1650304|NCT01672294|5767012|P3|Overall Study|Withdrawal by Subject|4
1650305|NCT01672294|5767013|P2|Overall Study|Withdrawal by Subject|4
1650306|NCT01672294|5767014|P1|Overall Study|Withdrawal by Subject|4
1650307|NCT01671748|5767059|P2|4 Week run-in Phase|Not eligible|0
1650308|NCT01671748|5767060|P1|4 Week run-in Phase|Not eligible|9
1650309|NCT01671748|5767059|P2|4 Week run-in Phase|Adverse Event|0
1650310|NCT01671748|5767060|P1|4 Week run-in Phase|Adverse Event|1
1650311|NCT01671748|5767059|P2|4 Week run-in Phase|Withdrawal by Subject|0
1650312|NCT01671748|5767060|P1|4 Week run-in Phase|Withdrawal by Subject|1
1650314|NCT01671345|5767095|P2|Overall Study|visit with non-participating physician|3
1650315|NCT01671345|5767096|P1|Overall Study|visit with non-participating physician|3
1650316|NCT01671345|5767095|P2|Overall Study|Lost to Follow-up|6
1650317|NCT01671345|5767096|P1|Overall Study|Lost to Follow-up|10
1650318|NCT01671319|5767108|P1|Overall Study|Withdrawal by Subject|1
1650319|NCT01671280|5767123|P1|Overall Study|Withdrawal by Subject|2
1650320|NCT01671111|5767134|P1|Overall Study|Other|24
1650321|NCT01671111|5767134|P1|Overall Study|Physician Decision|1
1650322|NCT01671111|5767134|P1|Overall Study|Withdrawal by Subject|2
1650323|NCT01671111|5767134|P1|Overall Study|Lack of Efficacy|1
1650324|NCT01671111|5767134|P1|Overall Study|Adverse Event|2
1650325|NCT01671085|5767146|P2|Overall Study|Withdrawal by Subject|0
1650326|NCT01671085|5767147|P1|Overall Study|Withdrawal by Subject|1
1650327|NCT01671059|5767158|P1|Overall Study|Lack of Efficacy|1
1650328|NCT01671059|5767158|P1|Overall Study|Adverse Event|4
1650329|NCT01670721|5767250|P1|Overall Study|Other than specified above|38
1650330|NCT01670721|5767250|P1|Overall Study|Participant's decision|15
1650331|NCT01670656|5767262|P5|Overall Study|Subject moved|0
1650332|NCT01670656|5767263|P4|Overall Study|Subject moved|1
1650333|NCT01670656|5767264|P3|Overall Study|Subject moved|0
1650334|NCT01670656|5767265|P2|Overall Study|Subject moved|0
1650335|NCT01670656|5767266|P1|Overall Study|Subject moved|0
1650336|NCT01670656|5767262|P5|Overall Study|Lost to Follow-up|3
1650337|NCT01670656|5767263|P4|Overall Study|Lost to Follow-up|0
1650338|NCT01670656|5767264|P3|Overall Study|Lost to Follow-up|0
1650339|NCT01670656|5767265|P2|Overall Study|Lost to Follow-up|0
1650340|NCT01670656|5767266|P1|Overall Study|Lost to Follow-up|0
1650341|NCT01670656|5767262|P5|Overall Study|Subject withdrew consent|1
1650342|NCT01670656|5767263|P4|Overall Study|Subject withdrew consent|1
1650343|NCT01670656|5767264|P3|Overall Study|Subject withdrew consent|2
1650344|NCT01670656|5767265|P2|Overall Study|Subject withdrew consent|1
1650345|NCT01670656|5767266|P1|Overall Study|Subject withdrew consent|0
1650346|NCT01670656|5767262|P5|Overall Study|Adverse Event|3
1650347|NCT01670656|5767263|P4|Overall Study|Adverse Event|3
1650348|NCT01670656|5767264|P3|Overall Study|Adverse Event|2
1650349|NCT01670656|5767265|P2|Overall Study|Adverse Event|2
1650350|NCT01670656|5767266|P1|Overall Study|Adverse Event|2
1650351|NCT01670656|5767262|P5|Overall Study|Non-compliance with protocol|2
1650352|NCT01670656|5767263|P4|Overall Study|Non-compliance with protocol|1
1650353|NCT01670656|5767264|P3|Overall Study|Non-compliance with protocol|1
1650354|NCT01670656|5767265|P2|Overall Study|Non-compliance with protocol|3
1650355|NCT01670656|5767266|P1|Overall Study|Non-compliance with protocol|0
1650356|NCT01670656|5767262|P5|Overall Study|Withdrawal by Subject|0
1650357|NCT01670656|5767263|P4|Overall Study|Withdrawal by Subject|0
1650358|NCT01670656|5767264|P3|Overall Study|Withdrawal by Subject|0
1650359|NCT01670656|5767265|P2|Overall Study|Withdrawal by Subject|1
1650360|NCT01670656|5767266|P1|Overall Study|Withdrawal by Subject|1
1650361|NCT01670656|5767262|P5|Overall Study|Pregnancy|1
1650362|NCT01670656|5767263|P4|Overall Study|Pregnancy|0
1650363|NCT01670656|5767264|P3|Overall Study|Pregnancy|0
1650364|NCT01670656|5767265|P2|Overall Study|Pregnancy|0
1650365|NCT01670656|5767266|P1|Overall Study|Pregnancy|0
1650366|NCT01670656|5767262|P5|Overall Study|Non-compliance with study drug|1
1650367|NCT01670656|5767263|P4|Overall Study|Non-compliance with study drug|0
1650368|NCT01670656|5767264|P3|Overall Study|Non-compliance with study drug|3
1650369|NCT01670656|5767265|P2|Overall Study|Non-compliance with study drug|0
1650370|NCT01670656|5767266|P1|Overall Study|Non-compliance with study drug|0
1650371|NCT01670526|5767295|P2|Overall Study|Lost to Follow-up|5
1650372|NCT01670526|5767296|P1|Overall Study|Lost to Follow-up|9
1650373|NCT01670526|5767295|P2|Overall Study|Withdrawal by Subject|1
1650374|NCT01670526|5767296|P1|Overall Study|Withdrawal by Subject|3
1650375|NCT01670292|5767317|P1|Overall Study|Lost to Follow-up|14
1650376|NCT01670279|5767358|P4|Overall Study|Participant met withdrawal criteria|1
1650377|NCT01670279|5767359|P3|Overall Study|Participant met withdrawal criteria|0
1650378|NCT01670279|5767360|P2|Overall Study|Participant met withdrawal criteria|0
1650379|NCT01670279|5767361|P1|Overall Study|Participant met withdrawal criteria|0
1650380|NCT01670279|5767358|P4|Overall Study|Physician Decision|0
1650381|NCT01670279|5767359|P3|Overall Study|Physician Decision|0
1650382|NCT01670279|5767360|P2|Overall Study|Physician Decision|1
1650383|NCT01670279|5767361|P1|Overall Study|Physician Decision|0
1650384|NCT01670279|5767358|P4|Overall Study|Adverse Event|0
1650385|NCT01670279|5767359|P3|Overall Study|Adverse Event|0
1650386|NCT01670279|5767360|P2|Overall Study|Adverse Event|1
1650387|NCT01670279|5767361|P1|Overall Study|Adverse Event|0
1650388|NCT01670188|5767403|P2|Overall Study|Death|1
1650389|NCT01670188|5767404|P1|Overall Study|Death|0
1650390|NCT01670045|5767410|P1|Overall Study|Lost to Follow-up|11
1650391|NCT01670045|5767410|P1|Overall Study|Death|1
1650392|NCT01670045|5767410|P1|Overall Study|Adverse Event|1
1650393|NCT01670045|5767410|P1|Overall Study|Withdrawal by Subject|3
1650394|NCT01670019|5767428|P2|Overall Study|Withdrawal by Subject|0
1650395|NCT01670019|5767429|P1|Overall Study|Withdrawal by Subject|6
1650396|NCT01670019|5767428|P2|Overall Study|Adverse Event|0
1650397|NCT01670019|5767429|P1|Overall Study|Adverse Event|3
1650398|NCT01669902|5767443|P1|Overall Study|Other|8
1650399|NCT01669902|5767443|P1|Overall Study|Lack of Efficacy|10
1650400|NCT01669902|5767443|P1|Overall Study|Adverse Event|11
1650401|NCT01669811|5767478|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
1650402|NCT01669811|5767479|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1650403|NCT01669811|5767478|P2|Overall Study|Adverse Event|6
1650404|NCT01669811|5767479|P1|Overall Study|Adverse Event|2
1650405|NCT01669811|5767478|P2|Overall Study|Withdrawal by Subject|2
1650406|NCT01669811|5767479|P1|Overall Study|Withdrawal by Subject|1
1650407|NCT01669811|5767478|P2|Overall Study|Investigator decision|1
1650408|NCT01669811|5767479|P1|Overall Study|Investigator decision|0
1650409|NCT01669798|5767497|P1|Overall Study|Physician Decision|5
1650410|NCT01669629|5767603|P2|Period 1|protocol deviation|2
1650411|NCT01669629|5767604|P1|Period 1|protocol deviation|1
1650412|NCT01669577|5767627|P1|Overall Study|Physician Decision|34
1650413|NCT01669577|5767627|P1|Overall Study|Lost to Follow-up|78
1650414|NCT01669577|5767627|P1|Overall Study|Death|22
1650415|NCT01669421|5767665|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
1650416|NCT01669421|5767665|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
1650417|NCT01669174|5767684|P2|Overall Study|Administrative problems|2
1650418|NCT01669174|5767685|P1|Overall Study|Administrative problems|1
1650419|NCT01669174|5767684|P2|Overall Study|Adverse Event|2
1650420|NCT01669174|5767685|P1|Overall Study|Adverse Event|2
1650421|NCT01669174|5767684|P2|Overall Study|Lost to Follow-up|0
1650422|NCT01669174|5767685|P1|Overall Study|Lost to Follow-up|1
1650423|NCT01669174|5767684|P2|Overall Study|Subject withdrew consent|2
1650424|NCT01669174|5767685|P1|Overall Study|Subject withdrew consent|2
1650425|NCT01669122|5767701|P1|Washout Period II|Protocol Violation|2
1650426|NCT01669122|5767701|P1|Period I|Lost to Follow-up|1
1650427|NCT01668966|5767768|P1|Overall Study|Not treated|2
1650428|NCT01668966|5767768|P1|Overall Study|Death|1
1650429|NCT01668966|5767768|P1|Overall Study|Withdrawal by Subject|1
1650430|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
1650431|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
1650432|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1650433|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
1650434|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
1650435|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
1650436|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1650437|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
1650438|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
1650439|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
1650440|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1650441|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
1650442|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
1650443|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
1650444|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1650445|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
1650446|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1650447|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
1650448|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1650449|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
1650450|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
1650451|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
1650452|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1650453|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
1650454|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
1650455|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
1650456|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1650457|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
1650458|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1650459|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
1650460|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1650461|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
1650462|NCT01668797|5767864|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
1650463|NCT01668797|5767865|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
1650464|NCT01668797|5767866|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1650465|NCT01668797|5767867|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
1650466|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1650467|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1650468|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
1650469|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
1650470|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1650471|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1650472|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
1650473|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
1650474|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
1650475|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
1650476|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
1650477|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
1650478|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Protocol Violation|0
1650479|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Protocol Violation|0
1650480|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Protocol Violation|3
1650481|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Protocol Violation|0
1650482|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1650483|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1650484|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
1650485|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
1650486|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Physician Decision|0
1650487|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Physician Decision|0
1650488|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Physician Decision|11
1650489|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Physician Decision|0
1650490|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1650491|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1650492|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
1650493|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
1650494|NCT01668797|5767864|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
1650495|NCT01668797|5767865|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
1650496|NCT01668797|5767866|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
1650497|NCT01668797|5767867|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
1650498|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1650499|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1650500|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
1650501|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
1650502|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1650503|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1650504|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
1650505|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
1650506|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
1650507|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
1650508|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
1650509|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
1650510|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Protocol Violation|0
1650511|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Protocol Violation|0
1650512|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Protocol Violation|0
1650513|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Protocol Violation|2
1650514|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
1650515|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
1650516|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
1650517|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
1650518|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Physician Decision|0
1650519|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Physician Decision|0
1650520|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Physician Decision|0
1650521|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Physician Decision|2
1650522|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1650523|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1650524|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
1650525|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
1650526|NCT01668797|5767864|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
1650527|NCT01668797|5767865|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
1650528|NCT01668797|5767866|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
1650529|NCT01668797|5767867|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
1650530|NCT01668784|5767932|P2|Treated (Overall)|Other|4
1650531|NCT01668784|5767933|P1|Treated (Overall)|Other|0
1650532|NCT01668784|5767932|P2|Treated (Overall)|Maximal Clinical Benefit|3
1650533|NCT01668784|5767933|P1|Treated (Overall)|Maximal Clinical Benefit|2
1650534|NCT01668784|5767932|P2|Treated (Overall)|Withdrawal by Subject|3
1650535|NCT01668784|5767933|P1|Treated (Overall)|Withdrawal by Subject|2
1650536|NCT01668784|5767932|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
1650537|NCT01668784|5767933|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
1650538|NCT01668784|5767932|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
1650539|NCT01668784|5767933|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
1650540|NCT01668784|5767932|P2|Treated (Overall)|Death|1
1650541|NCT01668784|5767933|P1|Treated (Overall)|Death|1
1650542|NCT01668784|5767932|P2|Treated (Overall)|Study Drug Toxicity|53
1650543|NCT01668784|5767933|P1|Treated (Overall)|Study Drug Toxicity|35
1650544|NCT01668784|5767932|P2|Treated (Overall)|Disease Progression|273
1650545|NCT01668784|5767933|P1|Treated (Overall)|Disease Progression|285
1650546|NCT01668784|5767932|P2|Randomized (Pre-treatment)|Other|1
1650547|NCT01668784|5767933|P1|Randomized (Pre-treatment)|Other|0
1650548|NCT01668784|5767932|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
1650549|NCT01668784|5767933|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
1650550|NCT01668784|5767932|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
1650551|NCT01668784|5767933|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
1650552|NCT01668784|5767932|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
1650553|NCT01668784|5767933|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
1650554|NCT01668784|5767932|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
1650555|NCT01668784|5767933|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
1650556|NCT01668784|5767932|P2|Randomized (Pre-treatment)|Disease Progression|1
1650557|NCT01668784|5767933|P1|Randomized (Pre-treatment)|Disease Progression|0
1650558|NCT01668667|5767961|P4|Overall Study|Withdrawal by Subject|5
1650559|NCT01668667|5767962|P3|Overall Study|Withdrawal by Subject|5
1650560|NCT01668667|5767963|P2|Overall Study|Withdrawal by Subject|4
1650561|NCT01668667|5767964|P1|Overall Study|Withdrawal by Subject|7
1650562|NCT01668667|5767961|P4|Overall Study|Physician Decision|0
1650563|NCT01668667|5767962|P3|Overall Study|Physician Decision|1
1650564|NCT01668667|5767963|P2|Overall Study|Physician Decision|0
1650565|NCT01668667|5767964|P1|Overall Study|Physician Decision|3
1650566|NCT01668667|5767961|P4|Overall Study|Lost to Follow-up|6
1650567|NCT01668667|5767962|P3|Overall Study|Lost to Follow-up|7
1650568|NCT01668667|5767963|P2|Overall Study|Lost to Follow-up|4
1650569|NCT01668667|5767964|P1|Overall Study|Lost to Follow-up|9
1650570|NCT01668667|5767961|P4|Overall Study|Protocol Violation|5
1650571|NCT01668667|5767962|P3|Overall Study|Protocol Violation|12
1650572|NCT01668667|5767963|P2|Overall Study|Protocol Violation|10
1650573|NCT01668667|5767964|P1|Overall Study|Protocol Violation|6
1650574|NCT01668667|5767961|P4|Overall Study|Lack of Efficacy|3
1650575|NCT01668667|5767962|P3|Overall Study|Lack of Efficacy|2
1650576|NCT01668667|5767963|P2|Overall Study|Lack of Efficacy|2
1650577|NCT01668667|5767964|P1|Overall Study|Lack of Efficacy|3
1650578|NCT01668667|5767961|P4|Overall Study|Adverse Event|4
1650579|NCT01668667|5767962|P3|Overall Study|Adverse Event|4
1650580|NCT01668667|5767963|P2|Overall Study|Adverse Event|6
1650581|NCT01668667|5767964|P1|Overall Study|Adverse Event|3
1650582|NCT01668654|5767986|P1|Overall Study|Withdrawal by Subject|1
1650583|NCT01668654|5767986|P1|Overall Study|Study Closed/Terminated|3
1650584|NCT01668589|5768047|P4|Overall Study|Other|15
1650585|NCT01668589|5768048|P3|Overall Study|Other|7
1650586|NCT01668589|5768049|P2|Overall Study|Other|10
1650587|NCT01668589|5768050|P1|Overall Study|Other|44
1650588|NCT01668589|5768047|P4|Overall Study|Death|11
1650589|NCT01668589|5768048|P3|Overall Study|Death|2
1650590|NCT01668589|5768049|P2|Overall Study|Death|3
1650591|NCT01668589|5768050|P1|Overall Study|Death|12
1650592|NCT01668589|5768047|P4|Overall Study|Full Consent/Agreement Withdrawn|4
1650593|NCT01668589|5768048|P3|Overall Study|Full Consent/Agreement Withdrawn|11
1650594|NCT01668589|5768049|P2|Overall Study|Full Consent/Agreement Withdrawn|8
1650595|NCT01668589|5768050|P1|Overall Study|Full Consent/Agreement Withdrawn|54
1650596|NCT01668589|5768047|P4|Overall Study|Lost to Follow-up|5
1650597|NCT01668589|5768048|P3|Overall Study|Lost to Follow-up|15
1650598|NCT01668589|5768049|P2|Overall Study|Lost to Follow-up|37
1650599|NCT01668589|5768050|P1|Overall Study|Lost to Follow-up|29
1650600|NCT01668173|5768088|P1|Overall Study|Trial suspension|4
1650601|NCT01668173|5768088|P1|Overall Study|Adverse Event|3
1650602|NCT01668147|5768092|P1|Overall Study|Withdrawal by Subject|6
1650603|NCT01668004|5768222|P1|Overall Study|Non-compliance with treatment|2
1650604|NCT01668004|5768222|P1|Overall Study|Lack of Efficacy|9
1650605|NCT01668004|5768222|P1|Overall Study|Lost to Follow-up|5
1650606|NCT01668004|5768222|P1|Overall Study|Withdrawal by Subject|2
1650607|NCT01668004|5768222|P1|Overall Study|Adverse Event|7
1650608|NCT01667926|5768244|P3|Overall Study|Side effects|0
1650609|NCT01667926|5768245|P2|Overall Study|Side effects|0
1650610|NCT01667926|5768246|P1|Overall Study|Side effects|3
1650611|NCT01667926|5768244|P3|Overall Study|Lost to Follow-up|1
1650612|NCT01667926|5768245|P2|Overall Study|Lost to Follow-up|2
1650613|NCT01667926|5768246|P1|Overall Study|Lost to Follow-up|1
1650614|NCT01667926|5768244|P3|Overall Study|Inclusion/Exclusion Criteria|5
1650615|NCT01667926|5768245|P2|Overall Study|Inclusion/Exclusion Criteria|0
1650616|NCT01667926|5768246|P1|Overall Study|Inclusion/Exclusion Criteria|0
1650617|NCT01667926|5768244|P3|Overall Study|Time committment|2
1650618|NCT01667926|5768245|P2|Overall Study|Time committment|0
1650619|NCT01667926|5768246|P1|Overall Study|Time committment|0
1650620|NCT01667926|5768244|P3|Overall Study|Physician Decision|1
1650621|NCT01667926|5768245|P2|Overall Study|Physician Decision|0
1650622|NCT01667926|5768246|P1|Overall Study|Physician Decision|0
1650623|NCT01667926|5768244|P3|Overall Study|Withdrawal by Subject|2
1650624|NCT01667926|5768245|P2|Overall Study|Withdrawal by Subject|2
1650625|NCT01667926|5768246|P1|Overall Study|Withdrawal by Subject|1
1650626|NCT01667900|5768259|P20|Part B|Death|0
1650627|NCT01667900|5768260|P19|Part B|Death|0
1650628|NCT01667900|5768261|P18|Part B|Death|0
1650629|NCT01667900|5768262|P17|Part B|Death|1
1650630|NCT01667900|5768263|P16|Part B|Death|0
1650631|NCT01667900|5768264|P15|Part B|Death|0
1650632|NCT01667900|5768265|P14|Part B|Death|0
1650633|NCT01667900|5768266|P13|Part B|Death|0
1650634|NCT01667900|5768267|P12|Part B|Death|0
1650635|NCT01667900|5768268|P11|Part B|Death|0
1650636|NCT01667900|5768269|P10|Part B|Death|0
1650637|NCT01667900|5768270|P9|Part B|Death|0
1650638|NCT01667900|5768271|P8|Part B|Death|0
1650639|NCT01667900|5768272|P7|Part B|Death|0
1650640|NCT01667900|5768273|P6|Part B|Death|0
1650641|NCT01667900|5768274|P5|Part B|Death|0
1650642|NCT01667900|5768275|P4|Part B|Death|0
1650643|NCT01667900|5768276|P3|Part B|Death|0
1650644|NCT01667900|5768277|P2|Part B|Death|0
1650645|NCT01667900|5768278|P1|Part B|Death|0
1650646|NCT01667731|5768348|P5|Overall Study|Death|0
1650647|NCT01667731|5768349|P4|Overall Study|Death|0
1650648|NCT01667731|5768350|P3|Overall Study|Death|0
1650649|NCT01667731|5768351|P2|Overall Study|Death|1
1650650|NCT01667731|5768352|P1|Overall Study|Death|0
1650651|NCT01667731|5768348|P5|Overall Study|Subject Withdrew Consent|1
1650652|NCT01667731|5768349|P4|Overall Study|Subject Withdrew Consent|0
1650653|NCT01667731|5768350|P3|Overall Study|Subject Withdrew Consent|1
1650654|NCT01667731|5768351|P2|Overall Study|Subject Withdrew Consent|0
1650655|NCT01667731|5768352|P1|Overall Study|Subject Withdrew Consent|2
1650656|NCT01667731|5768348|P5|Overall Study|Lost to Follow-up|2
1650657|NCT01667731|5768349|P4|Overall Study|Lost to Follow-up|1
1650658|NCT01667731|5768350|P3|Overall Study|Lost to Follow-up|1
1650659|NCT01667731|5768351|P2|Overall Study|Lost to Follow-up|3
1650660|NCT01667731|5768352|P1|Overall Study|Lost to Follow-up|2
1650661|NCT01667731|5768348|P5|Overall Study|Efficacy Failure|24
1650662|NCT01667731|5768349|P4|Overall Study|Efficacy Failure|1
1650663|NCT01667731|5768350|P3|Overall Study|Efficacy Failure|0
1650664|NCT01667731|5768351|P2|Overall Study|Efficacy Failure|12
1650665|NCT01667731|5768352|P1|Overall Study|Efficacy Failure|1
1650666|NCT01667731|5768348|P5|Overall Study|Enrolled but not treated|1
1650667|NCT01667731|5768349|P4|Overall Study|Enrolled but not treated|0
1650668|NCT01667731|5768350|P3|Overall Study|Enrolled but not treated|0
1650669|NCT01667731|5768351|P2|Overall Study|Enrolled but not treated|0
1650670|NCT01667731|5768352|P1|Overall Study|Enrolled but not treated|0
1650671|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
1650672|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
1650673|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
1650674|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
1650675|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
1650676|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
1650677|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
1650678|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
1650679|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
1650680|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
1650681|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
1650682|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
1650683|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
1650684|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
1650685|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
1650686|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
1650687|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
1650688|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
1650689|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
1650690|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
1650691|NCT01667679|5768407|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
1650692|NCT01667679|5768408|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
1650693|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
1650694|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
1650695|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
1650696|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
1650697|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
1650698|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
1650699|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
1650700|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
1650701|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1650702|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
1650703|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
1650704|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
1650705|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
1650706|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
1650707|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
1650708|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
1650709|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
1650710|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
1650711|NCT01667679|5768407|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
1650712|NCT01667679|5768408|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
1650713|NCT01667562|5768466|P2|Erlotinib Phase|Switch to Commercial Drug|1
1650714|NCT01667562|5768467|P1|Erlotinib Phase|Switch to Commercial Drug|0
1650715|NCT01667562|5768466|P2|Erlotinib Phase|Adverse Event|1
1650716|NCT01667562|5768467|P1|Erlotinib Phase|Adverse Event|0
1650717|NCT01667562|5768466|P2|Erlotinib Phase|Lost to Follow-up|1
1650718|NCT01667562|5768467|P1|Erlotinib Phase|Lost to Follow-up|0
1650719|NCT01667562|5768466|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
1650720|NCT01667562|5768467|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
1650721|NCT01667549|5768481|P5|Overall Study|Withdrawal by Subject|1
1650722|NCT01667549|5768482|P4|Overall Study|Withdrawal by Subject|6
1650723|NCT01667549|5768483|P3|Overall Study|Withdrawal by Subject|7
1650724|NCT01667549|5768484|P2|Overall Study|Withdrawal by Subject|5
1650725|NCT01667549|5768485|P1|Overall Study|Withdrawal by Subject|3
1650726|NCT01667432|5768544|P1|Overall Study|Missing Information|4
1650727|NCT01667432|5768544|P1|Overall Study|Reason Not Specified|2
1650728|NCT01667432|5768544|P1|Overall Study|Principal Investigator Decision|1
1650729|NCT01667432|5768544|P1|Overall Study|Protocol Deviation|2
1650730|NCT01667432|5768544|P1|Overall Study|Adverse Event|1
1650731|NCT01667432|5768544|P1|Overall Study|Insufficient Therapeutic Response|4
1650732|NCT01667432|5768544|P1|Overall Study|Refused Treatment/Withdrew Consent|1
1650733|NCT01667432|5768544|P1|Overall Study|Lost to Follow-up|3
1650734|NCT01667432|5768544|P1|Overall Study|Moved to Another Center|3
1650735|NCT01667432|5768544|P1|Overall Study|Failure to Return|10
1650736|NCT01667432|5768544|P1|Overall Study|Premature Study Termination|26
1650737|NCT01667419|5768553|P4|Overall Study|Death|26
1650738|NCT01667419|5768554|P3|Overall Study|Death|25
1650739|NCT01667419|5768555|P2|Overall Study|Death|33
1650740|NCT01667419|5768556|P1|Overall Study|Death|18
1650741|NCT01667419|5768553|P4|Overall Study|Lost to Follow-up|4
1650742|NCT01667419|5768554|P3|Overall Study|Lost to Follow-up|2
1650743|NCT01667419|5768555|P2|Overall Study|Lost to Follow-up|6
1650744|NCT01667419|5768556|P1|Overall Study|Lost to Follow-up|7
1650745|NCT01667419|5768553|P4|Overall Study|Protocol Violation|0
1650746|NCT01667419|5768554|P3|Overall Study|Protocol Violation|0
1650747|NCT01667419|5768555|P2|Overall Study|Protocol Violation|0
1650748|NCT01667419|5768556|P1|Overall Study|Protocol Violation|1
1650749|NCT01667419|5768553|P4|Overall Study|Non-compliance|1
1650750|NCT01667419|5768554|P3|Overall Study|Non-compliance|0
1650751|NCT01667419|5768555|P2|Overall Study|Non-compliance|0
1650752|NCT01667419|5768556|P1|Overall Study|Non-compliance|0
1650753|NCT01667419|5768553|P4|Overall Study|Withdrawal by Subject|8
1650754|NCT01667419|5768554|P3|Overall Study|Withdrawal by Subject|9
1650755|NCT01667419|5768555|P2|Overall Study|Withdrawal by Subject|8
1650756|NCT01667419|5768556|P1|Overall Study|Withdrawal by Subject|16
1650757|NCT01667419|5768553|P4|Overall Study|Reason Not Specified|0
1650758|NCT01667419|5768554|P3|Overall Study|Reason Not Specified|0
1650759|NCT01667419|5768555|P2|Overall Study|Reason Not Specified|0
1650760|NCT01667419|5768556|P1|Overall Study|Reason Not Specified|1
1650761|NCT01667224|5768604|P2|Overall Study|Protocol Violation|1
1650762|NCT01667224|5768605|P1|Overall Study|Protocol Violation|1
1650763|NCT01667224|5768604|P2|Overall Study|Withdrawal by Subject|1
1650764|NCT01667224|5768605|P1|Overall Study|Withdrawal by Subject|3
1650765|NCT01667107|5768619|P2|Overall Study|Lack of Efficacy|1
1650766|NCT01667107|5768620|P1|Overall Study|Lack of Efficacy|0
1650767|NCT01667107|5768619|P2|Overall Study|Protocol Violation|1
1650768|NCT01667107|5768620|P1|Overall Study|Protocol Violation|0
1650769|NCT01667107|5768619|P2|Overall Study|Tolerability issues|2
1650770|NCT01667107|5768620|P1|Overall Study|Tolerability issues|0
1650771|NCT01667107|5768619|P2|Overall Study|Adverse Event|3
1650772|NCT01667107|5768620|P1|Overall Study|Adverse Event|4
1650773|NCT01666951|5768679|P2|Overall Study|Not dosed|1
1650774|NCT01666951|5768680|P1|Overall Study|Not dosed|1
1650775|NCT01666782|5768731|P2|Overall Study|Enrolled both years; year 1 data used|0
1650776|NCT01666782|5768732|P1|Overall Study|Enrolled both years; year 1 data used|4
1650777|NCT01666782|5768731|P2|Overall Study|Received 2 doses of vaccine|1
1650778|NCT01666782|5768732|P1|Overall Study|Received 2 doses of vaccine|0
1650779|NCT01666652|5768753|P5|Overall Study|Lost to Follow-up|0
1650780|NCT01666652|5768754|P4|Overall Study|Lost to Follow-up|1
1650781|NCT01666652|5768755|P3|Overall Study|Lost to Follow-up|1
1650782|NCT01666652|5768756|P2|Overall Study|Lost to Follow-up|1
1650783|NCT01666652|5768757|P1|Overall Study|Lost to Follow-up|1
1650784|NCT01666652|5768753|P5|Overall Study|Moved from study area|0
1650785|NCT01666652|5768754|P4|Overall Study|Moved from study area|2
1650786|NCT01666652|5768755|P3|Overall Study|Moved from study area|0
1650787|NCT01666652|5768756|P2|Overall Study|Moved from study area|0
1650788|NCT01666652|5768757|P1|Overall Study|Moved from study area|1
1650789|NCT01666652|5768753|P5|Overall Study|Withdrawal by Subject|1
1650790|NCT01666652|5768754|P4|Overall Study|Withdrawal by Subject|0
1650791|NCT01666652|5768755|P3|Overall Study|Withdrawal by Subject|0
1650792|NCT01666652|5768756|P2|Overall Study|Withdrawal by Subject|0
1650793|NCT01666652|5768757|P1|Overall Study|Withdrawal by Subject|0
1650794|NCT01666652|5768753|P5|Overall Study|Serious Adverse Event|0
1650795|NCT01666652|5768754|P4|Overall Study|Serious Adverse Event|1
1650796|NCT01666652|5768755|P3|Overall Study|Serious Adverse Event|0
1650797|NCT01666652|5768756|P2|Overall Study|Serious Adverse Event|0
1650798|NCT01666652|5768757|P1|Overall Study|Serious Adverse Event|0
1650799|NCT01666444|5768806|P2|Overall Study|Did not initiate treatment|1
1650800|NCT01666444|5768807|P1|Overall Study|Did not initiate treatment|2
1650801|NCT01666314|5768825|P4|Overall Study|Reason not Specified|5
1650802|NCT01666314|5768826|P3|Overall Study|Reason not Specified|5
1650803|NCT01666314|5768827|P2|Overall Study|Reason not Specified|7
1650804|NCT01666314|5768828|P1|Overall Study|Reason not Specified|10
1650805|NCT01666314|5768825|P4|Overall Study|Withdrawal by Subject|3
1650806|NCT01666314|5768826|P3|Overall Study|Withdrawal by Subject|2
1650807|NCT01666314|5768827|P2|Overall Study|Withdrawal by Subject|1
1650808|NCT01666314|5768828|P1|Overall Study|Withdrawal by Subject|1
1650809|NCT01666314|5768825|P4|Overall Study|Unsatisfactory Therapeutic Response|1
1650810|NCT01666314|5768826|P3|Overall Study|Unsatisfactory Therapeutic Response|1
1650811|NCT01666314|5768827|P2|Overall Study|Unsatisfactory Therapeutic Response|2
1650812|NCT01666314|5768828|P1|Overall Study|Unsatisfactory Therapeutic Response|7
1650813|NCT01666314|5768825|P4|Overall Study|Symptomatic Deterioration|0
1650814|NCT01666314|5768826|P3|Overall Study|Symptomatic Deterioration|2
1650815|NCT01666314|5768827|P2|Overall Study|Symptomatic Deterioration|0
1650816|NCT01666314|5768828|P1|Overall Study|Symptomatic Deterioration|1
1650817|NCT01666314|5768825|P4|Overall Study|Progressive Disease|20
1650818|NCT01666314|5768826|P3|Overall Study|Progressive Disease|19
1650819|NCT01666314|5768827|P2|Overall Study|Progressive Disease|9
1650820|NCT01666314|5768828|P1|Overall Study|Progressive Disease|11
1650821|NCT01666314|5768825|P4|Overall Study|Adverse Event|7
1650822|NCT01666314|5768826|P3|Overall Study|Adverse Event|7
1650823|NCT01666314|5768827|P2|Overall Study|Adverse Event|13
1650824|NCT01666314|5768828|P1|Overall Study|Adverse Event|3
1650825|NCT01666119|5768964|P1|Overall Study|Subject experiencing withdrawal symptoms|5
1650826|NCT01666119|5768964|P1|Overall Study|non compliance with study medication, pa|18
1650827|NCT01666119|5768964|P1|Overall Study|Lost to Follow-up|7
1650828|NCT01666119|5768964|P1|Overall Study|Withdrawal by Subject|16
1650829|NCT01666119|5768964|P1|Overall Study|Adverse Event|6
1650830|NCT01666002|5768971|P2|Overall Study|Lost to Follow-up|0
1650831|NCT01666002|5768972|P1|Overall Study|Lost to Follow-up|5
1650832|NCT01665911|5768993|P1|Overall Study|Adverse Event|1
1650833|NCT01665911|5768993|P1|Overall Study|Withdrawal by Subject|1
1650834|NCT01665911|5768993|P1|Overall Study|Protocol Violation|4
1650835|NCT01665807|5769019|P3|Overall Study|Withdrawal by Subject|1
1650836|NCT01665807|5769020|P2|Overall Study|Withdrawal by Subject|0
1650837|NCT01665807|5769021|P1|Overall Study|Withdrawal by Subject|2
1650841|NCT01665599|5769037|P1|Overall Study|Could Not Continue Due to Time Constrain|1
1650842|NCT01665599|5769037|P1|Overall Study|Participant Left for More Than 3 Months|1
1650843|NCT01665599|5769037|P1|Overall Study|Lost to Follow-up|2
1650844|NCT01665599|5769037|P1|Overall Study|Death|1
1650845|NCT01665599|5769037|P1|Overall Study|Investigator/Sponsor decision|1
1650846|NCT01665599|5769037|P1|Overall Study|Consent Withdrawn|1
1650847|NCT01665599|5769037|P1|Overall Study|Adverse Event|1
1650848|NCT01665430|5769073|P1|Overall Study|Other Unspecified|2
1650849|NCT01665430|5769073|P1|Overall Study|Withdrawal by Subject|6
1650850|NCT01665430|5769073|P1|Overall Study|Adverse Event|1
1650873|NCT01664949|5769252|P2|Overall Study|Other Miscellaneous Reasons|1
1650874|NCT01664949|5769253|P1|Overall Study|Other Miscellaneous Reasons|3
1650875|NCT01664949|5769252|P2|Overall Study|Protocol Violation|5
1650876|NCT01664949|5769253|P1|Overall Study|Protocol Violation|5
1650877|NCT01664949|5769252|P2|Overall Study|Personal Reasons|4
1650878|NCT01664949|5769253|P1|Overall Study|Personal Reasons|3
1650879|NCT01664949|5769252|P2|Overall Study|Lost to Follow-up|2
1650880|NCT01664949|5769253|P1|Overall Study|Lost to Follow-up|1
1650881|NCT01664949|5769252|P2|Overall Study|Lack of Efficacy|1
1650882|NCT01664949|5769253|P1|Overall Study|Lack of Efficacy|1
1650883|NCT01664949|5769252|P2|Overall Study|Adverse Event|12
1650884|NCT01664949|5769253|P1|Overall Study|Adverse Event|11
1650885|NCT01664923|5769269|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
1650886|NCT01664923|5769270|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
1650887|NCT01664923|5769269|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
1650888|NCT01664923|5769270|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
1650889|NCT01664923|5769269|P2|Period 2: Open-label Phase-36 Months|Other|1
1650890|NCT01664923|5769270|P1|Period 2: Open-label Phase-36 Months|Other|3
1650891|NCT01664923|5769269|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
1650892|NCT01664923|5769270|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
1650893|NCT01664923|5769269|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
1650894|NCT01664923|5769270|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
1650895|NCT01664923|5769269|P2|Period 2: Open-label Phase-36 Months|Death|1
1650896|NCT01664923|5769270|P1|Period 2: Open-label Phase-36 Months|Death|3
1650897|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
1650898|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
1650899|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Other|4
1650900|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Other|3
1650901|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
1650902|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
1650903|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
1650904|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
1650905|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
1650906|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
1650907|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
1650908|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
1650909|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
1650910|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
1650911|NCT01664923|5769269|P2|Period1:Double Blind Phase-29 Months|Death|6
1650912|NCT01664923|5769270|P1|Period1:Double Blind Phase-29 Months|Death|8
1650913|NCT01664624|5769361|P4|Overall Study|Adverse Event|0
1650914|NCT01664624|5769362|P3|Overall Study|Adverse Event|0
1650915|NCT01664624|5769363|P2|Overall Study|Adverse Event|1
1650916|NCT01664624|5769364|P1|Overall Study|Adverse Event|0
1650917|NCT01664533|5769411|P1|Overall Study|Protocol Violation|3
1650918|NCT01664533|5769411|P1|Overall Study|Study termination|9
1650919|NCT01664533|5769411|P1|Overall Study|Lost to Follow-up|3
1650920|NCT01664533|5769411|P1|Overall Study|Death|42
1650921|NCT01664494|5769419|P1|Overall Study|Lost to Follow-up|99
1650922|NCT01664494|5769419|P1|Overall Study|Other|49
1650923|NCT01664494|5769419|P1|Overall Study|Death|18
1650924|NCT01664494|5769419|P1|Overall Study|Withdrawal by Subject|27
1650925|NCT01664247|5769426|P2|Overall Study|Unclassified|29
1650926|NCT01664247|5769427|P1|Overall Study|Unclassified|5
1650927|NCT01664247|5769426|P2|Overall Study|Withdrawal Criteria|4
1650928|NCT01664247|5769427|P1|Overall Study|Withdrawal Criteria|1
1650929|NCT01664247|5769426|P2|Overall Study|Protocol Violation|5
1650930|NCT01664247|5769427|P1|Overall Study|Protocol Violation|3
1650931|NCT01664247|5769426|P2|Overall Study|Adverse Event|3
1650932|NCT01664247|5769427|P1|Overall Study|Adverse Event|5
1650933|NCT01664130|5769449|P1|Overall Study|competing secondary disease|2
1650934|NCT01664104|5769527|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
1650935|NCT01664104|5769527|P1|Overall Study|Other|1
1650936|NCT01664104|5769527|P1|Overall Study|Lost to Follow-up|4
1650937|NCT01664104|5769527|P1|Overall Study|Withdrawal by Subject|1
1650938|NCT01664104|5769527|P1|Overall Study|Lack of Efficacy|2
1650939|NCT01664104|5769527|P1|Overall Study|Adverse Event|6
1650940|NCT01664091|5769594|P1|Overall Study|Withdrawal by Subject|1
1650941|NCT01664091|5769594|P1|Overall Study|Lost to Follow-up|2
1650942|NCT01664091|5769594|P1|Overall Study|Disease Progression|2
1650943|NCT01664091|5769594|P1|Overall Study|Death|1
1650944|NCT01664052|5769604|P2|Phase 2|No device placement|4
1650945|NCT01664052|5769605|P1|Phase 2|No device placement|0
1650946|NCT01664052|5769604|P2|Phase 1|No HSG 1 hr post placement|0
1650947|NCT01664052|5769605|P1|Phase 1|No HSG 1 hr post placement|1
1650948|NCT01664052|5769604|P2|Phase 1|No device placement|0
1650949|NCT01664052|5769605|P1|Phase 1|No device placement|6
1650950|NCT01664039|5769623|P2|Overall Study|Noncompliance|1
1650951|NCT01664039|5769624|P1|Overall Study|Noncompliance|1
1650952|NCT01664039|5769623|P2|Overall Study|Withdrawal by Subject|3
1650953|NCT01664039|5769624|P1|Overall Study|Withdrawal by Subject|1
1650954|NCT01664039|5769623|P2|Overall Study|Lost to Follow-up|1
1650955|NCT01664039|5769624|P1|Overall Study|Lost to Follow-up|1
1650956|NCT01664039|5769623|P2|Overall Study|Adverse Event|4
1650957|NCT01664039|5769624|P1|Overall Study|Adverse Event|3
1650958|NCT01663987|5769646|P2|Overall Study|Other reason not defined above|0
1650959|NCT01663987|5769647|P1|Overall Study|Other reason not defined above|3
1650960|NCT01663987|5769646|P2|Overall Study|Withdrawal by Subject|3
1650961|NCT01663987|5769647|P1|Overall Study|Withdrawal by Subject|2
1650962|NCT01663987|5769646|P2|Overall Study|Lost to Follow-up|1
1650963|NCT01663987|5769647|P1|Overall Study|Lost to Follow-up|1
1650964|NCT01663987|5769646|P2|Overall Study|Adverse Event|2
1650965|NCT01663987|5769647|P1|Overall Study|Adverse Event|7
1650966|NCT01663857|5769690|P4|Overall Study|Lost to Follow-up|1
1650967|NCT01663857|5769691|P3|Overall Study|Lost to Follow-up|3
1650968|NCT01663857|5769692|P2|Overall Study|Lost to Follow-up|0
1650969|NCT01663857|5769693|P1|Overall Study|Lost to Follow-up|0
1650970|NCT01663857|5769690|P4|Overall Study|Withdrew Consent to Study Participation|3
1650971|NCT01663857|5769691|P3|Overall Study|Withdrew Consent to Study Participation|7
1650972|NCT01663857|5769692|P2|Overall Study|Withdrew Consent to Study Participation|1
1650973|NCT01663857|5769693|P1|Overall Study|Withdrew Consent to Study Participation|0
1650974|NCT01663740|5769721|P2|Overall Study|No end of study status|0
1650975|NCT01663740|5769722|P1|Overall Study|No end of study status|3
1650976|NCT01663740|5769721|P2|Overall Study|Withdrawal by Subject|1
1650977|NCT01663740|5769722|P1|Overall Study|Withdrawal by Subject|2
1650978|NCT01663740|5769721|P2|Overall Study|Death|1
1650979|NCT01663740|5769722|P1|Overall Study|Death|0
1650980|NCT01663740|5769721|P2|Overall Study|Inclusion/Exclusion not met|0
1650981|NCT01663740|5769722|P1|Overall Study|Inclusion/Exclusion not met|1
1650982|NCT01663740|5769721|P2|Overall Study|Other|2
1650983|NCT01663740|5769722|P1|Overall Study|Other|9
1650984|NCT01663740|5769721|P2|Overall Study|Lost to Follow-up|4
1650985|NCT01663740|5769722|P1|Overall Study|Lost to Follow-up|1
1650986|NCT01663727|5769782|P2|Overall Study|Withdrawal prior to dosing.|0
1650987|NCT01663727|5769783|P1|Overall Study|Withdrawal prior to dosing.|1
1650988|NCT01663727|5769782|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
1650989|NCT01663727|5769783|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
1650990|NCT01663727|5769782|P2|Overall Study|Study Terminated|50
1650991|NCT01663727|5769783|P1|Overall Study|Study Terminated|51
1650992|NCT01663727|5769782|P2|Overall Study|Withdrawal by Subject|25
1650993|NCT01663727|5769783|P1|Overall Study|Withdrawal by Subject|18
1650994|NCT01663727|5769782|P2|Overall Study|Lost to Follow-up|8
1650995|NCT01663727|5769783|P1|Overall Study|Lost to Follow-up|10
1650996|NCT01663727|5769782|P2|Overall Study|Death|155
1650997|NCT01663727|5769783|P1|Overall Study|Death|161
1650998|NCT01663714|5769815|P1|Long-Term Follow-Up|Non-compliance|1
1650999|NCT01663714|5769815|P1|Long-Term Follow-Up|Death|4
1651000|NCT01663714|5769815|P1|Long-Term Follow-Up|Lost to Follow-up|1
1651001|NCT01663714|5769815|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
1651002|NCT01663714|5769815|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
1651003|NCT01663714|5769815|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
1651004|NCT01663636|5769844|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
1651005|NCT01663636|5769845|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
1651006|NCT01663623|5769853|P2|Overall Study|Withdrawal by Subject|1
1651007|NCT01663623|5769854|P1|Overall Study|Withdrawal by Subject|2
1651008|NCT01663623|5769853|P2|Overall Study|Physician Decision|4
1651009|NCT01663623|5769854|P1|Overall Study|Physician Decision|1
1651010|NCT01663623|5769853|P2|Overall Study|Other-Study closed/terminated|1
1651011|NCT01663623|5769854|P1|Overall Study|Other-Study closed/terminated|1
1651012|NCT01663623|5769853|P2|Overall Study|Protocol Violation|1
1651013|NCT01663623|5769854|P1|Overall Study|Protocol Violation|0
1651014|NCT01663623|5769853|P2|Overall Study|Lack of Efficacy|6
1651015|NCT01663623|5769854|P1|Overall Study|Lack of Efficacy|5
1651016|NCT01663623|5769853|P2|Overall Study|Adverse Event|7
1651017|NCT01663623|5769854|P1|Overall Study|Adverse Event|3
1651018|NCT01663532|5769864|P2|Overall Study|Lack of Efficacy|60
1651019|NCT01663532|5769865|P1|Overall Study|Lack of Efficacy|15
1651020|NCT01663532|5769864|P2|Overall Study|Withdrawal by Subject|17
1651021|NCT01663532|5769865|P1|Overall Study|Withdrawal by Subject|35
1651022|NCT01663532|5769864|P2|Overall Study|Physician Decision|1
1651023|NCT01663532|5769865|P1|Overall Study|Physician Decision|1
1651024|NCT01663532|5769864|P2|Overall Study|Met Withdrawal Criteria|6
1651025|NCT01663532|5769865|P1|Overall Study|Met Withdrawal Criteria|7
1651026|NCT01663532|5769864|P2|Overall Study|Adverse Event|13
1651027|NCT01663532|5769865|P1|Overall Study|Adverse Event|7
1651028|NCT01663532|5769864|P2|Overall Study|Lost to Follow-up|10
1651029|NCT01663532|5769865|P1|Overall Study|Lost to Follow-up|9
1651030|NCT01663506|5769883|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
1651031|NCT01663506|5769883|P1|Overall Study|Adverse Event|1
1651032|NCT01663506|5769883|P1|Overall Study|Lost to Follow-up|1
1651033|NCT01663506|5769883|P1|Overall Study|Consent Withdrawal by Subject|1
1651034|NCT01663506|5769883|P1|Overall Study|Lack of Efficacy|3
1651035|NCT01663402|5769914|P2|Overall Study|Other than specified above|147
1651036|NCT01663402|5769915|P1|Overall Study|Other than specified above|172
1651037|NCT01663402|5769914|P2|Overall Study|Lost to Follow-up|15
1651038|NCT01663402|5769915|P1|Overall Study|Lost to Follow-up|17
1651039|NCT01663402|5769914|P2|Overall Study|Related to study drug administration|105
1651040|NCT01663402|5769915|P1|Overall Study|Related to study drug administration|96
1651041|NCT01663402|5769914|P2|Overall Study|Withdrawal by Subject|91
1651042|NCT01663402|5769915|P1|Overall Study|Withdrawal by Subject|118
1651043|NCT01663402|5769914|P2|Overall Study|Participant moved|104
1651044|NCT01663402|5769915|P1|Overall Study|Participant moved|139
1651045|NCT01663402|5769914|P2|Overall Study|Site terminated by sponsor|3
1651046|NCT01663402|5769915|P1|Overall Study|Site terminated by sponsor|1
1651047|NCT01663402|5769914|P2|Overall Study|Physician Decision|62
1651048|NCT01663402|5769915|P1|Overall Study|Physician Decision|77
1651049|NCT01663402|5769914|P2|Overall Study|Poor compliance to protocol|454
1651050|NCT01663402|5769915|P1|Overall Study|Poor compliance to protocol|529
1651051|NCT01663402|5769914|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
1651052|NCT01663402|5769915|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
1651053|NCT01663402|5769914|P2|Overall Study|Adverse Event|362
1651054|NCT01663402|5769915|P1|Overall Study|Adverse Event|347
1651055|NCT01663402|5769914|P2|Overall Study|Randomized but not treated|11
1651056|NCT01663402|5769915|P1|Overall Study|Randomized but not treated|19
1651057|NCT01663233|5769969|P2|Overall Study|Lost to Follow-up|1
1651058|NCT01663233|5769970|P1|Overall Study|Lost to Follow-up|0
1651059|NCT01663233|5769969|P2|Overall Study|Protocol Deviation|4
1651060|NCT01663233|5769970|P1|Overall Study|Protocol Deviation|1
1651061|NCT01663233|5769969|P2|Overall Study|Withdrawal by Subject|2
1651062|NCT01663233|5769970|P1|Overall Study|Withdrawal by Subject|3
1651063|NCT01663103|5769994|P2|Overall Study|dog bite|0
1651064|NCT01663103|5769995|P1|Overall Study|dog bite|1
1651065|NCT01663103|5769994|P2|Overall Study|Adverse Event|0
1651066|NCT01663103|5769995|P1|Overall Study|Adverse Event|1
1651067|NCT01663103|5769994|P2|Overall Study|Withdrawal by Subject|2
1651068|NCT01663103|5769995|P1|Overall Study|Withdrawal by Subject|1
1651069|NCT01662999|5770023|P6|Period 3|Withdrawal by Subject|0
1651070|NCT01662999|5770024|P5|Period 3|Withdrawal by Subject|0
1651071|NCT01662999|5770025|P4|Period 3|Withdrawal by Subject|0
1651072|NCT01662999|5770026|P3|Period 3|Withdrawal by Subject|0
1651073|NCT01662999|5770027|P2|Period 3|Withdrawal by Subject|1
1651074|NCT01662999|5770028|P1|Period 3|Withdrawal by Subject|0
1651075|NCT01662986|5770099|P2|Overall Study|Other than stated above|0
1651076|NCT01662986|5770100|P1|Overall Study|Other than stated above|3
1651077|NCT01662986|5770099|P2|Overall Study|Not Treated|0
1651078|NCT01662986|5770100|P1|Overall Study|Not Treated|1
1651079|NCT01662986|5770099|P2|Overall Study|Withdrawal by Subject|2
1651080|NCT01662986|5770100|P1|Overall Study|Withdrawal by Subject|2
1651081|NCT01662986|5770099|P2|Overall Study|Lost to Follow-up|4
1651082|NCT01662986|5770100|P1|Overall Study|Lost to Follow-up|5
1651083|NCT01662986|5770099|P2|Overall Study|Protocol Violation|3
1651084|NCT01662986|5770100|P1|Overall Study|Protocol Violation|2
1651085|NCT01662986|5770099|P2|Overall Study|Adverse Event|4
1651086|NCT01662986|5770100|P1|Overall Study|Adverse Event|5
1651087|NCT01662895|5770188|P2|Overall Study|Lost to Follow-up|1
1651088|NCT01662895|5770189|P1|Overall Study|Lost to Follow-up|0
1651089|NCT01662648|5770313|P2|Overall Study|LOE and Participant non-compliant|1
1651090|NCT01662648|5770314|P1|Overall Study|LOE and Participant non-compliant|0
1651091|NCT01662648|5770313|P2|Overall Study|LOE and other reason unspecified|0
1651092|NCT01662648|5770314|P1|Overall Study|LOE and other reason unspecified|1
1651093|NCT01662648|5770313|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
1651094|NCT01662648|5770314|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
1651095|NCT01662648|5770313|P2|Overall Study|Other|11
1651096|NCT01662648|5770314|P1|Overall Study|Other|8
1651097|NCT01662648|5770313|P2|Overall Study|Participant non-compliant|20
1651098|NCT01662648|5770314|P1|Overall Study|Participant non-compliant|16
1651099|NCT01662648|5770313|P2|Overall Study|Withdrawal by Subject|53
1651100|NCT01662648|5770314|P1|Overall Study|Withdrawal by Subject|36
1651101|NCT01662648|5770313|P2|Overall Study|Lost to Follow-up|36
1651102|NCT01662648|5770314|P1|Overall Study|Lost to Follow-up|24
1651103|NCT01662648|5770313|P2|Overall Study|Participant ineligible to continue trial|1
1651104|NCT01662648|5770314|P1|Overall Study|Participant ineligible to continue trial|1
1651105|NCT01662648|5770313|P2|Overall Study|Lack of Efficacy|16
1651106|NCT01662648|5770314|P1|Overall Study|Lack of Efficacy|17
1651107|NCT01662648|5770313|P2|Overall Study|Adverse Event|37
1651108|NCT01662648|5770314|P1|Overall Study|Adverse Event|40
1651109|NCT01662648|5770313|P2|Overall Study|Death|3
1651110|NCT01662648|5770314|P1|Overall Study|Death|1
1651111|NCT01662635|5770336|P1|Overall Study|scarce samples for evaluation|30
1651112|NCT01662505|5770387|P3|Overall Study|Not specified above|2
1651113|NCT01662505|5770388|P2|Overall Study|Not specified above|3
1651114|NCT01662505|5770389|P1|Overall Study|Not specified above|1
1651115|NCT01662505|5770387|P3|Overall Study|Refused cont. medication|1
1651116|NCT01662505|5770388|P2|Overall Study|Refused cont. medication|0
1651117|NCT01662505|5770389|P1|Overall Study|Refused cont. medication|0
1651118|NCT01662505|5770387|P3|Overall Study|Progressive disease|5
1651119|NCT01662505|5770388|P2|Overall Study|Progressive disease|1
1651120|NCT01662505|5770389|P1|Overall Study|Progressive disease|6
1651121|NCT01662492|5770413|P3|Overall Study|Lack of Efficacy|2
1651122|NCT01662492|5770414|P2|Overall Study|Lack of Efficacy|1
1651123|NCT01662492|5770415|P1|Overall Study|Lack of Efficacy|1
1651124|NCT01662492|5770413|P3|Overall Study|Lost to Follow-up|2
1651125|NCT01662492|5770414|P2|Overall Study|Lost to Follow-up|0
1651126|NCT01662492|5770415|P1|Overall Study|Lost to Follow-up|0
1651127|NCT01662492|5770413|P3|Overall Study|Protocol Violation|0
1651128|NCT01662492|5770414|P2|Overall Study|Protocol Violation|0
1651129|NCT01662492|5770415|P1|Overall Study|Protocol Violation|1
1651130|NCT01662492|5770413|P3|Overall Study|Withdrawal by Subject|1
1651131|NCT01662492|5770414|P2|Overall Study|Withdrawal by Subject|0
1651132|NCT01662492|5770415|P1|Overall Study|Withdrawal by Subject|0
1651133|NCT01662492|5770413|P3|Overall Study|Other miscellaneous reasons.|1
1651134|NCT01662492|5770414|P2|Overall Study|Other miscellaneous reasons.|0
1651135|NCT01662492|5770415|P1|Overall Study|Other miscellaneous reasons.|1
1651136|NCT01662440|5770439|P4|Overall Study|Withdrawal by Subject|2
1651137|NCT01662440|5770440|P3|Overall Study|Withdrawal by Subject|2
1651138|NCT01662440|5770441|P2|Overall Study|Withdrawal by Subject|2
1651139|NCT01662440|5770442|P1|Overall Study|Withdrawal by Subject|5
1651140|NCT01662440|5770439|P4|Overall Study|Protocol Violation|0
1651141|NCT01662440|5770440|P3|Overall Study|Protocol Violation|0
1651142|NCT01662440|5770441|P2|Overall Study|Protocol Violation|0
1651143|NCT01662440|5770442|P1|Overall Study|Protocol Violation|1
1651144|NCT01662440|5770439|P4|Overall Study|Subject moved to another country.|0
1651145|NCT01662440|5770440|P3|Overall Study|Subject moved to another country.|0
1651146|NCT01662440|5770441|P2|Overall Study|Subject moved to another country.|1
1651147|NCT01662440|5770442|P1|Overall Study|Subject moved to another country.|0
1651148|NCT01662440|5770439|P4|Overall Study|Lost to Follow-up|1
1651149|NCT01662440|5770440|P3|Overall Study|Lost to Follow-up|4
1651150|NCT01662440|5770441|P2|Overall Study|Lost to Follow-up|2
1651151|NCT01662440|5770442|P1|Overall Study|Lost to Follow-up|2
1651152|NCT01662440|5770439|P4|Overall Study|Death|0
1651153|NCT01662440|5770440|P3|Overall Study|Death|0
1651154|NCT01662440|5770441|P2|Overall Study|Death|1
1651155|NCT01662440|5770442|P1|Overall Study|Death|0
1651156|NCT01662440|5770439|P4|Overall Study|Adverse Event|1
1651157|NCT01662440|5770440|P3|Overall Study|Adverse Event|0
1651158|NCT01662440|5770441|P2|Overall Study|Adverse Event|0
1651159|NCT01662440|5770442|P1|Overall Study|Adverse Event|1
1651160|NCT01662362|5770490|P1|Overall Study|Lost to Follow-up|38
1651161|NCT01662336|5770495|P1|Overall Study|Withdrawal by Subject|6
1651162|NCT01662336|5770495|P1|Overall Study|Other|29
1651163|NCT01662336|5770495|P1|Overall Study|No longer on LPV/r|30
1651164|NCT01662336|5770495|P1|Overall Study|Adverse Event|1
1651165|NCT01662310|5770521|P5|Open-Label Extension Phase|Withdrawal by Subject|7
1651166|NCT01662310|5770522|P4|Open-Label Extension Phase|Withdrawal by Subject|2
1651167|NCT01662310|5770523|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1651168|NCT01662310|5770524|P2|Open-Label Extension Phase|Withdrawal by Subject|0
1651169|NCT01662310|5770525|P1|Open-Label Extension Phase|Withdrawal by Subject|0
1651170|NCT01662310|5770521|P5|Open-Label Extension Phase|Pregnancy|0
1651171|NCT01662310|5770522|P4|Open-Label Extension Phase|Pregnancy|1
1651172|NCT01662310|5770523|P3|Open-Label Extension Phase|Pregnancy|0
1651173|NCT01662310|5770524|P2|Open-Label Extension Phase|Pregnancy|0
1651174|NCT01662310|5770525|P1|Open-Label Extension Phase|Pregnancy|0
1651175|NCT01662310|5770521|P5|Open-Label Extension Phase|Lost to Follow-up|1
1651176|NCT01662310|5770522|P4|Open-Label Extension Phase|Lost to Follow-up|2
1651177|NCT01662310|5770523|P3|Open-Label Extension Phase|Lost to Follow-up|0
1651178|NCT01662310|5770524|P2|Open-Label Extension Phase|Lost to Follow-up|0
1651179|NCT01662310|5770525|P1|Open-Label Extension Phase|Lost to Follow-up|0
1651180|NCT01662310|5770521|P5|Open-Label Extension Phase|Lack of Efficacy|2
1651181|NCT01662310|5770522|P4|Open-Label Extension Phase|Lack of Efficacy|2
1651182|NCT01662310|5770523|P3|Open-Label Extension Phase|Lack of Efficacy|0
1651183|NCT01662310|5770524|P2|Open-Label Extension Phase|Lack of Efficacy|0
1651184|NCT01662310|5770525|P1|Open-Label Extension Phase|Lack of Efficacy|0
1651185|NCT01662310|5770521|P5|Open-Label Extension Phase|Death|0
1651186|NCT01662310|5770522|P4|Open-Label Extension Phase|Death|1
1651187|NCT01662310|5770523|P3|Open-Label Extension Phase|Death|0
1651188|NCT01662310|5770524|P2|Open-Label Extension Phase|Death|0
1651189|NCT01662310|5770525|P1|Open-Label Extension Phase|Death|0
1651190|NCT01662310|5770521|P5|Open-Label Extension Phase|Adverse Event|0
1651191|NCT01662310|5770522|P4|Open-Label Extension Phase|Adverse Event|3
1651192|NCT01662310|5770523|P3|Open-Label Extension Phase|Adverse Event|0
1651193|NCT01662310|5770524|P2|Open-Label Extension Phase|Adverse Event|0
1651194|NCT01662310|5770525|P1|Open-Label Extension Phase|Adverse Event|0
1651195|NCT01662310|5770521|P5|Double-Blind Phase|Randomized but not treated|0
1651196|NCT01662310|5770522|P4|Double-Blind Phase|Randomized but not treated|0
1651197|NCT01662310|5770523|P3|Double-Blind Phase|Randomized but not treated|0
1651198|NCT01662310|5770524|P2|Double-Blind Phase|Randomized but not treated|1
1651199|NCT01662310|5770525|P1|Double-Blind Phase|Randomized but not treated|0
1651200|NCT01662310|5770521|P5|Double-Blind Phase|Other|0
1651201|NCT01662310|5770522|P4|Double-Blind Phase|Other|0
1651202|NCT01662310|5770523|P3|Double-Blind Phase|Other|1
1651203|NCT01662310|5770524|P2|Double-Blind Phase|Other|0
1651204|NCT01662310|5770525|P1|Double-Blind Phase|Other|0
1651205|NCT01662310|5770521|P5|Double-Blind Phase|Withdrawal by Subject|0
1651206|NCT01662310|5770522|P4|Double-Blind Phase|Withdrawal by Subject|0
1651207|NCT01662310|5770523|P3|Double-Blind Phase|Withdrawal by Subject|3
1651208|NCT01662310|5770524|P2|Double-Blind Phase|Withdrawal by Subject|9
1651209|NCT01662310|5770525|P1|Double-Blind Phase|Withdrawal by Subject|0
1651210|NCT01662310|5770521|P5|Double-Blind Phase|Pregnancy|0
1651211|NCT01662310|5770522|P4|Double-Blind Phase|Pregnancy|0
1651212|NCT01662310|5770523|P3|Double-Blind Phase|Pregnancy|0
1651213|NCT01662310|5770524|P2|Double-Blind Phase|Pregnancy|2
1651214|NCT01662310|5770525|P1|Double-Blind Phase|Pregnancy|0
1651215|NCT01662310|5770521|P5|Double-Blind Phase|Lost to Follow-up|0
1651216|NCT01662310|5770522|P4|Double-Blind Phase|Lost to Follow-up|0
1651217|NCT01662310|5770523|P3|Double-Blind Phase|Lost to Follow-up|0
1651218|NCT01662310|5770524|P2|Double-Blind Phase|Lost to Follow-up|3
1651219|NCT01662310|5770525|P1|Double-Blind Phase|Lost to Follow-up|0
1651220|NCT01662310|5770521|P5|Double-Blind Phase|Adverse Event|0
1651221|NCT01662310|5770522|P4|Double-Blind Phase|Adverse Event|0
1651222|NCT01662310|5770523|P3|Double-Blind Phase|Adverse Event|1
1651223|NCT01662310|5770524|P2|Double-Blind Phase|Adverse Event|0
1651224|NCT01662310|5770525|P1|Double-Blind Phase|Adverse Event|0
1651225|NCT01662310|5770521|P5|Run-In or Stabilization Phase|Other|0
1651226|NCT01662310|5770522|P4|Run-In or Stabilization Phase|Other|0
1651227|NCT01662310|5770523|P3|Run-In or Stabilization Phase|Other|0
1651228|NCT01662310|5770524|P2|Run-In or Stabilization Phase|Other|0
1651229|NCT01662310|5770525|P1|Run-In or Stabilization Phase|Other|1
1651230|NCT01662310|5770521|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
1651231|NCT01662310|5770522|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
1651232|NCT01662310|5770523|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
1651233|NCT01662310|5770524|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
1651234|NCT01662310|5770525|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
1651235|NCT01662310|5770521|P5|Run-In or Stabilization Phase|Protocol Violation|0
1651236|NCT01662310|5770522|P4|Run-In or Stabilization Phase|Protocol Violation|0
1651237|NCT01662310|5770523|P3|Run-In or Stabilization Phase|Protocol Violation|0
1651238|NCT01662310|5770524|P2|Run-In or Stabilization Phase|Protocol Violation|0
1651239|NCT01662310|5770525|P1|Run-In or Stabilization Phase|Protocol Violation|15
1651240|NCT01662310|5770521|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
1651241|NCT01662310|5770522|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
1651242|NCT01662310|5770523|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
1651243|NCT01662310|5770524|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
1651244|NCT01662310|5770525|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
1651245|NCT01662310|5770521|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
1651246|NCT01662310|5770522|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
1651247|NCT01662310|5770523|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
1651248|NCT01662310|5770524|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
1651249|NCT01662310|5770525|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
1651250|NCT01662310|5770521|P5|Run-In or Stabilization Phase|Adverse Event|0
1651251|NCT01662310|5770522|P4|Run-In or Stabilization Phase|Adverse Event|0
1651252|NCT01662310|5770523|P3|Run-In or Stabilization Phase|Adverse Event|0
1651253|NCT01662310|5770524|P2|Run-In or Stabilization Phase|Adverse Event|0
1651254|NCT01662310|5770525|P1|Run-In or Stabilization Phase|Adverse Event|11
1651255|NCT01662102|5770606|P2|Overall Study|Sponsor's decision|0
1651256|NCT01662102|5770607|P1|Overall Study|Sponsor's decision|1
1651257|NCT01662063|5770615|P3|Overall Study|Other|0
1651258|NCT01662063|5770616|P2|Overall Study|Other|1
1651259|NCT01662063|5770617|P1|Overall Study|Other|0
1651260|NCT01662063|5770615|P3|Overall Study|Physician Decision|0
1651261|NCT01662063|5770616|P2|Overall Study|Physician Decision|2
1651262|NCT01662063|5770617|P1|Overall Study|Physician Decision|0
1651263|NCT01662063|5770615|P3|Overall Study|Withdrawal by Subject|1
1651264|NCT01662063|5770616|P2|Overall Study|Withdrawal by Subject|4
1651265|NCT01662063|5770617|P1|Overall Study|Withdrawal by Subject|2
1651266|NCT01662063|5770615|P3|Overall Study|Protocol Violation|0
1651267|NCT01662063|5770616|P2|Overall Study|Protocol Violation|0
1651268|NCT01662063|5770617|P1|Overall Study|Protocol Violation|1
1651269|NCT01662063|5770615|P3|Overall Study|Lost to Follow-up|0
1651270|NCT01662063|5770616|P2|Overall Study|Lost to Follow-up|4
1651271|NCT01662063|5770617|P1|Overall Study|Lost to Follow-up|0
1651272|NCT01662063|5770615|P3|Overall Study|Lack of Efficacy|0
1651273|NCT01662063|5770616|P2|Overall Study|Lack of Efficacy|6
1651274|NCT01662063|5770617|P1|Overall Study|Lack of Efficacy|1
1651275|NCT01662063|5770615|P3|Overall Study|Adverse Event or Intercurrent Illness|0
1651276|NCT01662063|5770616|P2|Overall Study|Adverse Event or Intercurrent Illness|12
1651277|NCT01662063|5770617|P1|Overall Study|Adverse Event or Intercurrent Illness|1
1651278|NCT01662024|5770696|P1|Overall Study|Withdrawal by Subject|3
1651279|NCT01662024|5770696|P1|Overall Study|Pregnancy|2
1651280|NCT01661972|5770708|P2|Overall Study|Withdrawal by Subject|1
1651281|NCT01661972|5770709|P1|Overall Study|Withdrawal by Subject|0
1651282|NCT01661972|5770708|P2|Overall Study|Death during Treatment period|1
1651283|NCT01661972|5770709|P1|Overall Study|Death during Treatment period|1
1651284|NCT01661972|5770708|P2|Overall Study|Adverse Event|2
1651285|NCT01661972|5770709|P1|Overall Study|Adverse Event|1
1651286|NCT01661933|5770728|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
1651287|NCT01661933|5770728|P1|Low-dose Gluten Challenge|Physician Decision|2
1651288|NCT01661881|5770735|P1|Overall Study|Disease Progression|1
1651289|NCT01661790|5770743|P2|Overall Study|Lost to Follow-up|2
1651290|NCT01661790|5770744|P1|Overall Study|Lost to Follow-up|0
1651291|NCT01661686|5770844|P2|Overall Study|did not receive allocated intervention|1
1651292|NCT01661686|5770845|P1|Overall Study|did not receive allocated intervention|0
1651293|NCT01661686|5770844|P2|Overall Study|Lost to Follow-up|1
1651294|NCT01661686|5770845|P1|Overall Study|Lost to Follow-up|2
1651295|NCT01661595|5770886|P4|Phase 2: Week 5-8.|Protocol Violation|0
1651296|NCT01661595|5770887|P3|Phase 2: Week 5-8.|Protocol Violation|1
1651297|NCT01661595|5770888|P2|Phase 2: Week 5-8.|Protocol Violation|0
1651298|NCT01661595|5770889|P1|Phase 2: Week 5-8.|Protocol Violation|0
1651299|NCT01661595|5770886|P4|Phase 1: Week 0-4|Adverse Event|0
1651300|NCT01661595|5770887|P3|Phase 1: Week 0-4|Adverse Event|0
1651301|NCT01661595|5770888|P2|Phase 1: Week 0-4|Adverse Event|0
1651302|NCT01661595|5770889|P1|Phase 1: Week 0-4|Adverse Event|1
1651303|NCT01661205|5771017|P1|Overall Study|Physician Decision|2
1651304|NCT01661179|5771028|P1|Overall Study|Other Eligibility criteria|4
1651305|NCT01661179|5771028|P1|Overall Study|Withdrawal by Subject|1
1651306|NCT01661179|5771028|P1|Overall Study|Death|1
1651307|NCT01661140|5771032|P3|Double-Blind Period|Administrative/Other|6
1651308|NCT01661140|5771033|P2|Double-Blind Period|Administrative/Other|7
1651309|NCT01661140|5771034|P1|Double-Blind Period|Administrative/Other|0
1651310|NCT01661140|5771032|P3|Double-Blind Period|Sponsor Termination|17
1651311|NCT01661140|5771033|P2|Double-Blind Period|Sponsor Termination|14
1651312|NCT01661140|5771034|P1|Double-Blind Period|Sponsor Termination|0
1651313|NCT01661140|5771032|P3|Double-Blind Period|Investigator's Decision|2
1651314|NCT01661140|5771033|P2|Double-Blind Period|Investigator's Decision|1
1651315|NCT01661140|5771034|P1|Double-Blind Period|Investigator's Decision|0
1651316|NCT01661140|5771032|P3|Double-Blind Period|Withdrawal by Subject|3
1651317|NCT01661140|5771033|P2|Double-Blind Period|Withdrawal by Subject|1
1651318|NCT01661140|5771034|P1|Double-Blind Period|Withdrawal by Subject|0
1651319|NCT01661140|5771032|P3|Double-Blind Period|Protocol Violation|3
1651320|NCT01661140|5771033|P2|Double-Blind Period|Protocol Violation|2
1651321|NCT01661140|5771034|P1|Double-Blind Period|Protocol Violation|0
1651322|NCT01661140|5771032|P3|Double-Blind Period|Adverse Event|18
1651323|NCT01661140|5771033|P2|Double-Blind Period|Adverse Event|16
1651324|NCT01661140|5771034|P1|Double-Blind Period|Adverse Event|0
1651325|NCT01661140|5771032|P3|Double-Blind Period|Refused Treatment|1
1651326|NCT01661140|5771033|P2|Double-Blind Period|Refused Treatment|0
1651327|NCT01661140|5771034|P1|Double-Blind Period|Refused Treatment|0
1651328|NCT01661140|5771032|P3|Open-Label Period|Lost to Follow-up|0
1651329|NCT01661140|5771033|P2|Open-Label Period|Lost to Follow-up|0
1651330|NCT01661140|5771034|P1|Open-Label Period|Lost to Follow-up|2
1651331|NCT01661140|5771032|P3|Open-Label Period|Did not meet EULAR criteria|0
1651332|NCT01661140|5771033|P2|Open-Label Period|Did not meet EULAR criteria|0
1651333|NCT01661140|5771034|P1|Open-Label Period|Did not meet EULAR criteria|1
1651334|NCT01661140|5771032|P3|Open-Label Period|Sponsor termination|0
1651335|NCT01661140|5771033|P2|Open-Label Period|Sponsor termination|0
1651336|NCT01661140|5771034|P1|Open-Label Period|Sponsor termination|16
1651337|NCT01661140|5771032|P3|Open-Label Period|Administrative/Other|0
1651338|NCT01661140|5771033|P2|Open-Label Period|Administrative/Other|0
1651339|NCT01661140|5771034|P1|Open-Label Period|Administrative/Other|1
1651340|NCT01661140|5771032|P3|Open-Label Period|Death|0
1651341|NCT01661140|5771033|P2|Open-Label Period|Death|0
1651342|NCT01661140|5771034|P1|Open-Label Period|Death|1
1651343|NCT01661140|5771032|P3|Open-Label Period|Investigator Decision|0
1651344|NCT01661140|5771033|P2|Open-Label Period|Investigator Decision|0
1651345|NCT01661140|5771034|P1|Open-Label Period|Investigator Decision|3
1651346|NCT01661140|5771032|P3|Open-Label Period|Withdrawal by Subject|0
1651347|NCT01661140|5771033|P2|Open-Label Period|Withdrawal by Subject|0
1651348|NCT01661140|5771034|P1|Open-Label Period|Withdrawal by Subject|5
1651349|NCT01661140|5771032|P3|Open-Label Period|Protocol Violation|0
1651350|NCT01661140|5771033|P2|Open-Label Period|Protocol Violation|0
1651351|NCT01661140|5771034|P1|Open-Label Period|Protocol Violation|3
1651352|NCT01661140|5771032|P3|Open-Label Period|Adverse Event|0
1651353|NCT01661140|5771033|P2|Open-Label Period|Adverse Event|0
1651354|NCT01661140|5771034|P1|Open-Label Period|Adverse Event|44
1651355|NCT01661062|5771086|P1|Overall Study|Withdrawal by Subject|2
1651356|NCT01661062|5771086|P1|Overall Study|Completed Treatment Off Study|3
1651357|NCT01660906|5771091|P1|Overall Study|Discontinued due to study drug toxicity|3
1651358|NCT01660763|5771174|P2|Overall Study|Patient ready for early discharge|4
1651359|NCT01660763|5771175|P1|Overall Study|Patient ready for early discharge|28
1651360|NCT01660763|5771174|P2|Overall Study|Withdrawal by Subject|0
1651361|NCT01660763|5771175|P1|Overall Study|Withdrawal by Subject|4
1651362|NCT01660763|5771174|P2|Overall Study|Protocol Violation|0
1651363|NCT01660763|5771175|P1|Overall Study|Protocol Violation|1
1651364|NCT01660763|5771174|P2|Overall Study|Adverse Event|7
1651365|NCT01660763|5771175|P1|Overall Study|Adverse Event|22
1651366|NCT01660763|5771174|P2|Overall Study|Lack of Efficacy|50
1651367|NCT01660763|5771175|P1|Overall Study|Lack of Efficacy|45
1651368|NCT01660451|5771223|P3|Overall Study|Ongoing with treatment|46
1651369|NCT01660451|5771224|P2|Overall Study|Ongoing with treatment|3
1651370|NCT01660451|5771225|P1|Overall Study|Ongoing with treatment|3
1651371|NCT01660451|5771223|P3|Overall Study|Withdrawal by Subject|16
1651372|NCT01660451|5771224|P2|Overall Study|Withdrawal by Subject|0
1651373|NCT01660451|5771225|P1|Overall Study|Withdrawal by Subject|1
1651374|NCT01660451|5771223|P3|Overall Study|Physician Decision|5
1651375|NCT01660451|5771224|P2|Overall Study|Physician Decision|2
1651376|NCT01660451|5771225|P1|Overall Study|Physician Decision|1
1651377|NCT01660451|5771223|P3|Overall Study|Protocol Deviation|1
1651378|NCT01660451|5771224|P2|Overall Study|Protocol Deviation|0
1651379|NCT01660451|5771225|P1|Overall Study|Protocol Deviation|0
1651380|NCT01660451|5771223|P3|Overall Study|Sponsor Decision|1
1651381|NCT01660451|5771224|P2|Overall Study|Sponsor Decision|0
1651382|NCT01660451|5771225|P1|Overall Study|Sponsor Decision|0
1651383|NCT01660451|5771223|P3|Overall Study|AE with Clinical PD|9
1651384|NCT01660451|5771224|P2|Overall Study|AE with Clinical PD|3
1651385|NCT01660451|5771225|P1|Overall Study|AE with Clinical PD|1
1651386|NCT01660451|5771223|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
1651387|NCT01660451|5771224|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
1651388|NCT01660451|5771225|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
1651389|NCT01660451|5771223|P3|Overall Study|Protocol Violation|1
1651390|NCT01660451|5771224|P2|Overall Study|Protocol Violation|1
1651391|NCT01660451|5771225|P1|Overall Study|Protocol Violation|0
1651392|NCT01660412|5771253|P2|Overall Study|Protocol Violation|3
1651393|NCT01660412|5771254|P1|Overall Study|Protocol Violation|0
1651394|NCT01660334|5771260|P1|Overall Study|Lost to Follow-up|1
1651395|NCT01660022|5771503|P6|First Sequence (7 Days)|Protocol Violation|1
1651396|NCT01660022|5771504|P5|First Sequence (7 Days)|Protocol Violation|0
1651397|NCT01660022|5771505|P4|First Sequence (7 Days)|Protocol Violation|0
1651398|NCT01660022|5771506|P3|First Sequence (7 Days)|Protocol Violation|0
1651399|NCT01660022|5771507|P2|First Sequence (7 Days)|Protocol Violation|0
1651400|NCT01660022|5771508|P1|First Sequence (7 Days)|Protocol Violation|0
1651401|NCT01660022|5771503|P6|First Sequence (7 Days)|Adverse Event|3
1651402|NCT01660022|5771504|P5|First Sequence (7 Days)|Adverse Event|1
1651403|NCT01660022|5771505|P4|First Sequence (7 Days)|Adverse Event|0
1651404|NCT01660022|5771506|P3|First Sequence (7 Days)|Adverse Event|0
1651405|NCT01660022|5771507|P2|First Sequence (7 Days)|Adverse Event|0
1651406|NCT01660022|5771508|P1|First Sequence (7 Days)|Adverse Event|0
1651407|NCT01660022|5771503|P6|First Sequence (7 Days)|Withdrawal by Subject|0
1651408|NCT01660022|5771504|P5|First Sequence (7 Days)|Withdrawal by Subject|0
1651409|NCT01660022|5771505|P4|First Sequence (7 Days)|Withdrawal by Subject|1
1651410|NCT01660022|5771506|P3|First Sequence (7 Days)|Withdrawal by Subject|0
1651411|NCT01660022|5771507|P2|First Sequence (7 Days)|Withdrawal by Subject|1
1651412|NCT01660022|5771508|P1|First Sequence (7 Days)|Withdrawal by Subject|0
1651413|NCT01659996|5771567|P3|Overall Study|Withdrawal by Subject|5
1651414|NCT01659996|5771568|P2|Overall Study|Withdrawal by Subject|1
1651415|NCT01659996|5771569|P1|Overall Study|Withdrawal by Subject|4
1651416|NCT01659996|5771567|P3|Overall Study|Adverse Event|1
1651417|NCT01659996|5771568|P2|Overall Study|Adverse Event|0
1651418|NCT01659996|5771569|P1|Overall Study|Adverse Event|0
1651419|NCT01659996|5771567|P3|Overall Study|Lost to Follow-up|2
1651420|NCT01659996|5771568|P2|Overall Study|Lost to Follow-up|3
1651421|NCT01659996|5771569|P1|Overall Study|Lost to Follow-up|1
1651422|NCT01659996|5771567|P3|Overall Study|Protocol Violation|3
1651423|NCT01659996|5771568|P2|Overall Study|Protocol Violation|3
1651424|NCT01659996|5771569|P1|Overall Study|Protocol Violation|3
1651425|NCT01659853|5771610|P2|Washout , 3 to 7 Days|Protocol Violation|0
1651426|NCT01659853|5771611|P1|Washout , 3 to 7 Days|Protocol Violation|1
1651427|NCT01659853|5771610|P2|Washout , 3 to 7 Days|Adverse Event|0
1651428|NCT01659853|5771611|P1|Washout , 3 to 7 Days|Adverse Event|1
1651429|NCT01659736|5771621|P2|3-month Follow-up|Lost to Follow-up|1
1651430|NCT01659736|5771622|P1|3-month Follow-up|Lost to Follow-up|0
1651431|NCT01659736|5771621|P2|Treatment Period|Withdrawal by Subject|0
1651432|NCT01659736|5771622|P1|Treatment Period|Withdrawal by Subject|1
1651433|NCT01659736|5771621|P2|Treatment Period|Protocol Violation|1
1651434|NCT01659736|5771622|P1|Treatment Period|Protocol Violation|3
1651435|NCT01659736|5771621|P2|Treatment Period|Adverse Event|1
1651436|NCT01659736|5771622|P1|Treatment Period|Adverse Event|1
1651437|NCT01659567|5771636|P1|Overall Study|Other|13
1651438|NCT01659567|5771636|P1|Overall Study|Progression of the main disease|1
1651439|NCT01659567|5771636|P1|Overall Study|Withdrawal by Subject|64
1651440|NCT01659567|5771636|P1|Overall Study|Good result at early stage of treatment|5
1651441|NCT01659567|5771636|P1|Overall Study|Adverse Event|12
1651442|NCT01659567|5771636|P1|Overall Study|Switched to Pegferon|6
1651443|NCT01659567|5771636|P1|Overall Study|Lack of Efficacy|22
1651444|NCT01659554|5771653|P1|Overall Study|Study Termination|4
1651445|NCT01659320|5771660|P1|Overall Study|Physician Decision|1
1651446|NCT01659320|5771660|P1|Overall Study|Withdrawal by Subject|2
1651447|NCT01659125|5771679|P1|Overall Study|Failed to Start Treatment|2
1651448|NCT01659125|5771679|P1|Overall Study|Time Constraints|2
1651449|NCT01659125|5771679|P1|Overall Study|Technical Problem|1
1651450|NCT01659125|5771679|P1|Overall Study|Lost to Follow-up|7
1651451|NCT01659125|5771679|P1|Overall Study|Withdrawal by Subject|2
1651452|NCT01659021|5771686|P2|Long-Term Follow Up|Withdrawal by Subject|1
1651453|NCT01659021|5771687|P1|Long-Term Follow Up|Withdrawal by Subject|2
1651454|NCT01659021|5771686|P2|Long-Term Follow Up|Lost to Follow-up|3
1651455|NCT01659021|5771687|P1|Long-Term Follow Up|Lost to Follow-up|3
1651456|NCT01659021|5771686|P2|Main Study|Study Terminated by Sponsor|1
1651457|NCT01659021|5771687|P1|Main Study|Study Terminated by Sponsor|16
1651458|NCT01659021|5771686|P2|Main Study|Withdrawal by Subject|16
1651459|NCT01659021|5771687|P1|Main Study|Withdrawal by Subject|19
1651460|NCT01659021|5771686|P2|Main Study|Physician Decision|16
1651461|NCT01659021|5771687|P1|Main Study|Physician Decision|34
1651462|NCT01659021|5771686|P2|Main Study|Unknown Reasons|1
1651463|NCT01659021|5771687|P1|Main Study|Unknown Reasons|2
1651464|NCT01659021|5771686|P2|Main Study|Lost to Follow-up|0
1651465|NCT01659021|5771687|P1|Main Study|Lost to Follow-up|1
1651466|NCT01659021|5771686|P2|Main Study|Adverse Event|3
1651467|NCT01659021|5771687|P1|Main Study|Adverse Event|2
1651468|NCT01658943|5771705|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
1651469|NCT01658943|5771706|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
1651470|NCT01658943|5771705|P2|Overall Study|Not eligible|9
1651471|NCT01658943|5771706|P1|Overall Study|Not eligible|7
1651472|NCT01658943|5771705|P2|Overall Study|not protocol specified|1
1651473|NCT01658943|5771706|P1|Overall Study|not protocol specified|4
1651474|NCT01658943|5771705|P2|Overall Study|Death|2
1651475|NCT01658943|5771706|P1|Overall Study|Death|4
1651476|NCT01658943|5771705|P2|Overall Study|Progression/Relapse|40
1651477|NCT01658943|5771706|P1|Overall Study|Progression/Relapse|39
1651478|NCT01658943|5771705|P2|Overall Study|Withdrawal by Subject|2
1651479|NCT01658943|5771706|P1|Overall Study|Withdrawal by Subject|9
1651480|NCT01658943|5771705|P2|Overall Study|Adverse Event|13
1651481|NCT01658943|5771706|P1|Overall Study|Adverse Event|6
1651482|NCT01658904|5771721|P3|Overall Study|Principal Investigator discretion|0
1651483|NCT01658904|5771722|P2|Overall Study|Principal Investigator discretion|0
1651484|NCT01658904|5771723|P1|Overall Study|Principal Investigator discretion|2
1651485|NCT01658813|5771749|P1|Overall Study|Disease progression|3
1651486|NCT01658735|5771760|P3|Overall Study|Withdrawal by Subject|3
1651487|NCT01658735|5771761|P2|Overall Study|Withdrawal by Subject|5
1651488|NCT01658735|5771762|P1|Overall Study|Withdrawal by Subject|3
1651489|NCT01658735|5771760|P3|Overall Study|Protocol Violation|0
1651490|NCT01658735|5771761|P2|Overall Study|Protocol Violation|1
1651491|NCT01658735|5771762|P1|Overall Study|Protocol Violation|0
1651492|NCT01658735|5771760|P3|Overall Study|Lost to Follow-up|0
1651493|NCT01658735|5771761|P2|Overall Study|Lost to Follow-up|1
1651494|NCT01658735|5771762|P1|Overall Study|Lost to Follow-up|1
1651495|NCT01658735|5771760|P3|Overall Study|Lack of Efficacy|1
1651496|NCT01658735|5771761|P2|Overall Study|Lack of Efficacy|0
1651497|NCT01658735|5771762|P1|Overall Study|Lack of Efficacy|1
1651498|NCT01658579|5771804|P4|Treatment Period B|Other|1
1651499|NCT01658579|5771805|P3|Treatment Period B|Other|0
1651500|NCT01658579|5771806|P2|Treatment Period B|Other|0
1651501|NCT01658579|5771807|P1|Treatment Period B|Other|0
1651502|NCT01658579|5771804|P4|Treatment Period A|Adverse Event|0
1651503|NCT01658579|5771805|P3|Treatment Period A|Adverse Event|0
1651504|NCT01658579|5771806|P2|Treatment Period A|Adverse Event|0
1651505|NCT01658579|5771807|P1|Treatment Period A|Adverse Event|1
1651506|NCT01658579|5771804|P4|Treatment Period A|Other|1
1651507|NCT01658579|5771805|P3|Treatment Period A|Other|1
1651508|NCT01658579|5771806|P2|Treatment Period A|Other|0
1651509|NCT01658579|5771807|P1|Treatment Period A|Other|0
1651510|NCT01658514|5771835|P3|Overall Study|Protocol Violation|2
1651511|NCT01658514|5771836|P2|Overall Study|Protocol Violation|0
1651512|NCT01658514|5771837|P1|Overall Study|Protocol Violation|1
1651513|NCT01658436|5771848|P2|Overall Study|Death|0
1651514|NCT01658436|5771849|P1|Overall Study|Death|1
1651515|NCT01658436|5771848|P2|Overall Study|Subject/guardian decision|1
1651516|NCT01658436|5771849|P1|Overall Study|Subject/guardian decision|0
1651517|NCT01658436|5771848|P2|Overall Study|Study terminated by sponsor|1
1651518|NCT01658436|5771849|P1|Overall Study|Study terminated by sponsor|0
1651519|NCT01658436|5771848|P2|Overall Study|Progressive disease|4
1651520|NCT01658436|5771849|P1|Overall Study|Progressive disease|12
1651521|NCT01658436|5771848|P2|Overall Study|Physician Decision|0
1651522|NCT01658436|5771849|P1|Overall Study|Physician Decision|1
1651523|NCT01658436|5771848|P2|Overall Study|Adverse Event|5
1651524|NCT01658436|5771849|P1|Overall Study|Adverse Event|6
1651525|NCT01658150|5771869|P1|Overall Study|Withdrawal by Subject|1
1651526|NCT01658072|5771891|P2|Overall Study|Protocol Violation|2
1651527|NCT01658072|5771892|P1|Overall Study|Protocol Violation|4
1651528|NCT01658020|5771907|P2|Overall Study|Protocol Violation|1
1651529|NCT01658020|5771908|P1|Overall Study|Protocol Violation|0
1651530|NCT01658020|5771907|P2|Overall Study|Withdrawal by Subject|5
1651531|NCT01658020|5771908|P1|Overall Study|Withdrawal by Subject|4
1651532|NCT01658020|5771907|P2|Overall Study|Lost to Follow-up|0
1651533|NCT01658020|5771908|P1|Overall Study|Lost to Follow-up|1
1651534|NCT01658020|5771907|P2|Overall Study|Adverse Event|3
1651535|NCT01658020|5771908|P1|Overall Study|Adverse Event|3
1651536|NCT01657903|5771924|P1|Overall Study|Withdrawal by Subject|1
1651537|NCT01657903|5771924|P1|Overall Study|Lost to Follow-up|1
1651538|NCT01657877|5771946|P1|Overall Study|Other Reason|2
1651539|NCT01657877|5771946|P1|Overall Study|Adverse Event|2
1651540|NCT01657877|5771946|P1|Overall Study|Protocol Violation|6
1651541|NCT01657877|5771946|P1|Overall Study|Withdrawal by Subject|4
1651542|NCT01657799|5771966|P3|Overall Study|Other|49
1651543|NCT01657799|5771967|P2|Overall Study|Other|62
1651544|NCT01657799|5771968|P1|Overall Study|Other|52
1651545|NCT01657799|5771966|P3|Overall Study|Radiographic & Clinical Progression|15
1651546|NCT01657799|5771967|P2|Overall Study|Radiographic & Clinical Progression|11
1651547|NCT01657799|5771968|P1|Overall Study|Radiographic & Clinical Progression|16
1651548|NCT01657799|5771966|P3|Overall Study|Progressive Disease Clinical|7
1651549|NCT01657799|5771967|P2|Overall Study|Progressive Disease Clinical|4
1651550|NCT01657799|5771968|P1|Overall Study|Progressive Disease Clinical|7
1651551|NCT01657799|5771966|P3|Overall Study|Disease Progression|4
1651552|NCT01657799|5771967|P2|Overall Study|Disease Progression|4
1651553|NCT01657799|5771968|P1|Overall Study|Disease Progression|2
1651554|NCT01657799|5771966|P3|Overall Study|Lost to Follow-up|1
1651555|NCT01657799|5771967|P2|Overall Study|Lost to Follow-up|0
1651556|NCT01657799|5771968|P1|Overall Study|Lost to Follow-up|1
1651557|NCT01657799|5771966|P3|Overall Study|Withdrawal by Subject|10
1651558|NCT01657799|5771967|P2|Overall Study|Withdrawal by Subject|10
1651559|NCT01657799|5771968|P1|Overall Study|Withdrawal by Subject|13
1651560|NCT01657799|5771966|P3|Overall Study|Adverse Event Not Related to Progression|4
1651561|NCT01657799|5771967|P2|Overall Study|Adverse Event Not Related to Progression|4
1651562|NCT01657799|5771968|P1|Overall Study|Adverse Event Not Related to Progression|5
1651563|NCT01657799|5771966|P3|Overall Study|Adverse Event Related to progression|12
1651564|NCT01657799|5771967|P2|Overall Study|Adverse Event Related to progression|8
1651565|NCT01657799|5771968|P1|Overall Study|Adverse Event Related to progression|6
1651566|NCT01657760|5771987|P4|Overall Study|Physician Decision|2
1651567|NCT01657760|5771988|P3|Overall Study|Physician Decision|1
1651568|NCT01657760|5771989|P2|Overall Study|Physician Decision|1
1651569|NCT01657760|5771990|P1|Overall Study|Physician Decision|1
1651570|NCT01657760|5771987|P4|Overall Study|Withdrawal by Subject|1
1651571|NCT01657760|5771988|P3|Overall Study|Withdrawal by Subject|0
1651572|NCT01657760|5771989|P2|Overall Study|Withdrawal by Subject|0
1651573|NCT01657760|5771990|P1|Overall Study|Withdrawal by Subject|0
1651574|NCT01657461|5772009|P2|Overall Study|Withdrawal by Subject|3
1651575|NCT01657461|5772010|P1|Overall Study|Withdrawal by Subject|1
1651576|NCT01657461|5772009|P2|Overall Study|Physician Decision|2
1651577|NCT01657461|5772010|P1|Overall Study|Physician Decision|0
1651578|NCT01657461|5772009|P2|Overall Study|Lost to Follow-up|3
1651579|NCT01657461|5772010|P1|Overall Study|Lost to Follow-up|0
1651580|NCT01657461|5772009|P2|Overall Study|Death|12
1651581|NCT01657461|5772010|P1|Overall Study|Death|9
1651582|NCT01657370|5772040|P6|Overall Study|Lost to Follow-up|1
1651583|NCT01657370|5772041|P5|Overall Study|Lost to Follow-up|0
1651584|NCT01657370|5772042|P4|Overall Study|Lost to Follow-up|0
1651585|NCT01657370|5772043|P3|Overall Study|Lost to Follow-up|1
1651586|NCT01657370|5772044|P2|Overall Study|Lost to Follow-up|0
1651587|NCT01657370|5772045|P1|Overall Study|Lost to Follow-up|2
1651588|NCT01657370|5772040|P6|Overall Study|Protocol Violation|0
1651589|NCT01657370|5772041|P5|Overall Study|Protocol Violation|0
1651590|NCT01657370|5772042|P4|Overall Study|Protocol Violation|1
1651591|NCT01657370|5772043|P3|Overall Study|Protocol Violation|1
1651592|NCT01657370|5772044|P2|Overall Study|Protocol Violation|1
1651593|NCT01657370|5772045|P1|Overall Study|Protocol Violation|1
1651594|NCT01657370|5772040|P6|Overall Study|Adverse Event|0
1651595|NCT01657370|5772041|P5|Overall Study|Adverse Event|1
1651596|NCT01657370|5772042|P4|Overall Study|Adverse Event|0
1651597|NCT01657370|5772043|P3|Overall Study|Adverse Event|0
1651598|NCT01657370|5772044|P2|Overall Study|Adverse Event|0
1651599|NCT01657370|5772045|P1|Overall Study|Adverse Event|0
1651600|NCT01657370|5772040|P6|Overall Study|Lack of Qualifying Event|2
1651601|NCT01657370|5772041|P5|Overall Study|Lack of Qualifying Event|1
1651602|NCT01657370|5772042|P4|Overall Study|Lack of Qualifying Event|2
1651603|NCT01657370|5772043|P3|Overall Study|Lack of Qualifying Event|3
1651604|NCT01657370|5772044|P2|Overall Study|Lack of Qualifying Event|0
1651605|NCT01657370|5772045|P1|Overall Study|Lack of Qualifying Event|1
1651606|NCT01657370|5772040|P6|Overall Study|Physician Decision|0
1651607|NCT01657370|5772041|P5|Overall Study|Physician Decision|5
1651608|NCT01657370|5772042|P4|Overall Study|Physician Decision|2
1651609|NCT01657370|5772043|P3|Overall Study|Physician Decision|1
1651610|NCT01657370|5772044|P2|Overall Study|Physician Decision|3
1651611|NCT01657370|5772045|P1|Overall Study|Physician Decision|2
1651612|NCT01657370|5772040|P6|Overall Study|Withdrawal by Subject|1
1651613|NCT01657370|5772041|P5|Overall Study|Withdrawal by Subject|0
1651614|NCT01657370|5772042|P4|Overall Study|Withdrawal by Subject|0
1651615|NCT01657370|5772043|P3|Overall Study|Withdrawal by Subject|1
1651616|NCT01657370|5772044|P2|Overall Study|Withdrawal by Subject|0
1651617|NCT01657370|5772045|P1|Overall Study|Withdrawal by Subject|0
1651618|NCT01657305|5772143|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
1651619|NCT01657305|5772143|P1|Overall Study|Lost to Follow-up|1
1651620|NCT01657305|5772143|P1|Overall Study|Adverse Event|1
1651621|NCT01657305|5772143|P1|Overall Study|Withdrawal by Subject|4
1651622|NCT01657305|5772143|P1|Overall Study|Lack of Wound Closure at Day 28|15
1651623|NCT01657292|5772193|P1|Overall Study|Change of therapy|1
1651624|NCT01657292|5772193|P1|Overall Study|Violation of eligibility criteria|1
1651625|NCT01657292|5772193|P1|Overall Study|Withdrawal by Subject|2
1651626|NCT01657292|5772193|P1|Overall Study|Adverse Event|6
1651627|NCT01657266|5772202|P2|Overall Study|Adverse Event|3
1651628|NCT01657266|5772203|P1|Overall Study|Adverse Event|2
1651629|NCT01657266|5772202|P2|Overall Study|Lost to Follow-up|2
1651630|NCT01657266|5772203|P1|Overall Study|Lost to Follow-up|2
1651631|NCT01657253|5772225|P2|Overall Study|Adverse Event|1
1651632|NCT01657253|5772226|P1|Overall Study|Adverse Event|0
1651633|NCT01657253|5772225|P2|Overall Study|Withdrawal by Subject|12
1651634|NCT01657253|5772226|P1|Overall Study|Withdrawal by Subject|11
1651635|NCT01657253|5772225|P2|Overall Study|Lost to Follow-up|5
1651636|NCT01657253|5772226|P1|Overall Study|Lost to Follow-up|6
1651637|NCT01657032|5772238|P2|Overall Study|Lost to Follow-up|7
1651638|NCT01657032|5772239|P1|Overall Study|Lost to Follow-up|0
1651639|NCT01657019|5772265|P1|Overall Study|Other|58
1651640|NCT01657019|5772265|P1|Overall Study|Lack of Efficacy|3
1651641|NCT01657019|5772265|P1|Overall Study|Protocol Violation|6
1651642|NCT01657019|5772265|P1|Overall Study|Lost to Follow-up|48
1651643|NCT01657019|5772265|P1|Overall Study|Adverse Event|55
1651644|NCT01657019|5772265|P1|Overall Study|Withdrawal by Subject|65
1651645|NCT01656967|5772279|P2|Overall Study|unsuccessful ETT insertion|2
1651646|NCT01656967|5772280|P1|Overall Study|unsuccessful ETT insertion|3
1651647|NCT01656967|5772279|P2|Overall Study|faulty monitor|0
1651648|NCT01656967|5772280|P1|Overall Study|faulty monitor|1
1651649|NCT01656889|5772306|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
1651650|NCT01656889|5772307|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
1651651|NCT01656889|5772306|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
1651652|NCT01656889|5772307|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
1651653|NCT01656889|5772306|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
1651654|NCT01656889|5772307|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
1651655|NCT01656889|5772306|P2|Post Treatment Follow-Up, 3 Months|Death|5
1651656|NCT01656889|5772307|P1|Post Treatment Follow-Up, 3 Months|Death|1
1651657|NCT01656889|5772306|P2|Treatment Period, 12 Weeks|Moved out of the area|2
1651658|NCT01656889|5772307|P1|Treatment Period, 12 Weeks|Moved out of the area|0
1651659|NCT01656889|5772306|P2|Treatment Period, 12 Weeks|Protocol Violation|1
1651660|NCT01656889|5772307|P1|Treatment Period, 12 Weeks|Protocol Violation|0
1651661|NCT01656889|5772306|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
1651662|NCT01656889|5772307|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
1651663|NCT01656889|5772306|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
1651664|NCT01656889|5772307|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
1651665|NCT01656889|5772306|P2|Treatment Period, 12 Weeks|Death|1
1651666|NCT01656889|5772307|P1|Treatment Period, 12 Weeks|Death|0
1651667|NCT01656889|5772306|P2|Treatment Period, 12 Weeks|Adverse Event|4
1651668|NCT01656889|5772307|P1|Treatment Period, 12 Weeks|Adverse Event|10
1651669|NCT01656850|5772327|P2|First Intervention (3 Months)|Withdrawal by Subject|4
1651670|NCT01656850|5772328|P1|First Intervention (3 Months)|Withdrawal by Subject|3
1651671|NCT01656759|5772419|P2|Overall Study|Protocol Violation|3
1651672|NCT01656759|5772420|P1|Overall Study|Protocol Violation|2
1651673|NCT01656733|5772434|P2|Overall Study|Spontaneous abortion|1
1651674|NCT01656733|5772435|P1|Overall Study|Spontaneous abortion|0
1651675|NCT01656733|5772434|P2|Overall Study|Delivery at another hospital|2
1651676|NCT01656733|5772435|P1|Overall Study|Delivery at another hospital|0
1651677|NCT01656733|5772434|P2|Overall Study|No permission to collect birth outcomes|1
1651678|NCT01656733|5772435|P1|Overall Study|No permission to collect birth outcomes|0
1651679|NCT01656434|5772479|P2|Overall Study|Withdrawal by Subject|7
1651680|NCT01656434|5772480|P1|Overall Study|Withdrawal by Subject|64
1651681|NCT01656434|5772479|P2|Overall Study|Participant withdrew consent|9
1651682|NCT01656434|5772480|P1|Overall Study|Participant withdrew consent|28
1651683|NCT01656434|5772479|P2|Overall Study|Participant moved|12
1651684|NCT01656434|5772480|P1|Overall Study|Participant moved|40
1651685|NCT01656434|5772479|P2|Overall Study|Non-compliance with protocol|15
1651686|NCT01656434|5772480|P1|Overall Study|Non-compliance with protocol|39
1651687|NCT01656434|5772479|P2|Overall Study|Part. discontinued; unrelated to drug|10
1651688|NCT01656434|5772480|P1|Overall Study|Part. discontinued; unrelated to drug|55
1651689|NCT01656434|5772479|P2|Overall Study|Participant discontinued; drug related|4
1651690|NCT01656434|5772480|P1|Overall Study|Participant discontinued; drug related|13
1651691|NCT01656434|5772479|P2|Overall Study|Study terminated by sponsor|348
1651692|NCT01656434|5772480|P1|Overall Study|Study terminated by sponsor|1501
1651693|NCT01656434|5772479|P2|Overall Study|Non-compliance with study drug|9
1651694|NCT01656434|5772480|P1|Overall Study|Non-compliance with study drug|48
1651695|NCT01656434|5772479|P2|Overall Study|Physician Decision|2
1651696|NCT01656434|5772480|P1|Overall Study|Physician Decision|7
1651697|NCT01656434|5772479|P2|Overall Study|Pregnancy|10
1651698|NCT01656434|5772480|P1|Overall Study|Pregnancy|45
1651699|NCT01656434|5772479|P2|Overall Study|Pregnancy wish|6
1651700|NCT01656434|5772480|P1|Overall Study|Pregnancy wish|18
1651701|NCT01656434|5772479|P2|Overall Study|Protocol Violation|0
1651702|NCT01656434|5772480|P1|Overall Study|Protocol Violation|7
1651703|NCT01656434|5772479|P2|Overall Study|Screen failure|0
1651704|NCT01656434|5772480|P1|Overall Study|Screen failure|2
1651705|NCT01656434|5772479|P2|Overall Study|Site discontinued study participation|9
1651706|NCT01656434|5772480|P1|Overall Study|Site discontinued study participation|24
1651707|NCT01656434|5772479|P2|Overall Study|Lost to Follow-up|76
1651708|NCT01656434|5772480|P1|Overall Study|Lost to Follow-up|309
1651709|NCT01656434|5772479|P2|Overall Study|Enrollment terminated at trial site|0
1651710|NCT01656434|5772480|P1|Overall Study|Enrollment terminated at trial site|2
1651711|NCT01656434|5772479|P2|Overall Study|Adverse Event|63
1651712|NCT01656434|5772480|P1|Overall Study|Adverse Event|199
1651713|NCT01656408|5772506|P10|Overall Study|Physician Decision|3
1651714|NCT01656408|5772507|P9|Overall Study|Physician Decision|1
1651715|NCT01656408|5772508|P8|Overall Study|Physician Decision|1
1651716|NCT01656408|5772509|P7|Overall Study|Physician Decision|0
1651717|NCT01656408|5772510|P6|Overall Study|Physician Decision|1
1651718|NCT01656408|5772511|P5|Overall Study|Physician Decision|1
1651719|NCT01656408|5772512|P4|Overall Study|Physician Decision|0
1651720|NCT01656408|5772513|P3|Overall Study|Physician Decision|1
1651721|NCT01656408|5772514|P2|Overall Study|Physician Decision|0
1651722|NCT01656408|5772515|P1|Overall Study|Physician Decision|1
1651723|NCT01656408|5772506|P10|Overall Study|Adverse Event|0
1651724|NCT01656408|5772507|P9|Overall Study|Adverse Event|1
1651725|NCT01656408|5772508|P8|Overall Study|Adverse Event|0
1651726|NCT01656408|5772509|P7|Overall Study|Adverse Event|1
1651727|NCT01656408|5772510|P6|Overall Study|Adverse Event|1
1651728|NCT01656408|5772511|P5|Overall Study|Adverse Event|0
1651729|NCT01656408|5772512|P4|Overall Study|Adverse Event|0
1651730|NCT01656408|5772513|P3|Overall Study|Adverse Event|1
1651731|NCT01656408|5772514|P2|Overall Study|Adverse Event|0
1651732|NCT01656408|5772515|P1|Overall Study|Adverse Event|0
1651733|NCT01656395|5772710|P8|Overall Study|Withdrawal by Subject|0
1651734|NCT01656395|5772711|P7|Overall Study|Withdrawal by Subject|0
1651735|NCT01656395|5772712|P6|Overall Study|Withdrawal by Subject|3
1651736|NCT01656395|5772713|P5|Overall Study|Withdrawal by Subject|0
1651737|NCT01656395|5772714|P4|Overall Study|Withdrawal by Subject|2
1651738|NCT01656395|5772715|P3|Overall Study|Withdrawal by Subject|4
1651739|NCT01656395|5772716|P2|Overall Study|Withdrawal by Subject|1
1651740|NCT01656395|5772717|P1|Overall Study|Withdrawal by Subject|3
1651741|NCT01656395|5772710|P8|Overall Study|Screen Failure|0
1651742|NCT01656395|5772711|P7|Overall Study|Screen Failure|0
1651743|NCT01656395|5772712|P6|Overall Study|Screen Failure|8
1651744|NCT01656395|5772713|P5|Overall Study|Screen Failure|0
1651745|NCT01656395|5772714|P4|Overall Study|Screen Failure|1
1651746|NCT01656395|5772715|P3|Overall Study|Screen Failure|7
1651747|NCT01656395|5772716|P2|Overall Study|Screen Failure|1
1651748|NCT01656395|5772717|P1|Overall Study|Screen Failure|2
1651749|NCT01656395|5772710|P8|Overall Study|Protocol Violation|0
1651750|NCT01656395|5772711|P7|Overall Study|Protocol Violation|0
1651751|NCT01656395|5772712|P6|Overall Study|Protocol Violation|10
1651752|NCT01656395|5772713|P5|Overall Study|Protocol Violation|4
1651753|NCT01656395|5772714|P4|Overall Study|Protocol Violation|2
1651754|NCT01656395|5772715|P3|Overall Study|Protocol Violation|9
1651755|NCT01656395|5772716|P2|Overall Study|Protocol Violation|6
1651756|NCT01656395|5772717|P1|Overall Study|Protocol Violation|6
1651757|NCT01656395|5772710|P8|Overall Study|Progressive Disease|0
1651758|NCT01656395|5772711|P7|Overall Study|Progressive Disease|0
1651759|NCT01656395|5772712|P6|Overall Study|Progressive Disease|1
1651760|NCT01656395|5772713|P5|Overall Study|Progressive Disease|0
1651761|NCT01656395|5772714|P4|Overall Study|Progressive Disease|0
1651762|NCT01656395|5772715|P3|Overall Study|Progressive Disease|0
1651763|NCT01656395|5772716|P2|Overall Study|Progressive Disease|0
1651764|NCT01656395|5772717|P1|Overall Study|Progressive Disease|0
1651765|NCT01656395|5772710|P8|Overall Study|Pregnancy|0
1651766|NCT01656395|5772711|P7|Overall Study|Pregnancy|0
1651767|NCT01656395|5772712|P6|Overall Study|Pregnancy|0
1651768|NCT01656395|5772713|P5|Overall Study|Pregnancy|0
1651769|NCT01656395|5772714|P4|Overall Study|Pregnancy|0
1651770|NCT01656395|5772715|P3|Overall Study|Pregnancy|1
1651771|NCT01656395|5772716|P2|Overall Study|Pregnancy|0
1651772|NCT01656395|5772717|P1|Overall Study|Pregnancy|0
1651773|NCT01656395|5772710|P8|Overall Study|Physician Decision|0
1651774|NCT01656395|5772711|P7|Overall Study|Physician Decision|0
1651775|NCT01656395|5772712|P6|Overall Study|Physician Decision|3
1651776|NCT01656395|5772713|P5|Overall Study|Physician Decision|3
1651777|NCT01656395|5772714|P4|Overall Study|Physician Decision|2
1651778|NCT01656395|5772715|P3|Overall Study|Physician Decision|3
1651779|NCT01656395|5772716|P2|Overall Study|Physician Decision|3
1651780|NCT01656395|5772717|P1|Overall Study|Physician Decision|2
1651781|NCT01656395|5772710|P8|Overall Study|Other|0
1651782|NCT01656395|5772711|P7|Overall Study|Other|0
1651783|NCT01656395|5772712|P6|Overall Study|Other|1
1651784|NCT01656395|5772713|P5|Overall Study|Other|0
1651785|NCT01656395|5772714|P4|Overall Study|Other|0
1651786|NCT01656395|5772715|P3|Overall Study|Other|1
1651787|NCT01656395|5772716|P2|Overall Study|Other|0
1651788|NCT01656395|5772717|P1|Overall Study|Other|0
1651789|NCT01656395|5772710|P8|Overall Study|Non-Compliance with Study Drug|0
1651790|NCT01656395|5772711|P7|Overall Study|Non-Compliance with Study Drug|0
1651791|NCT01656395|5772712|P6|Overall Study|Non-Compliance with Study Drug|1
1651792|NCT01656395|5772713|P5|Overall Study|Non-Compliance with Study Drug|1
1651793|NCT01656395|5772714|P4|Overall Study|Non-Compliance with Study Drug|0
1651794|NCT01656395|5772715|P3|Overall Study|Non-Compliance with Study Drug|0
1651795|NCT01656395|5772716|P2|Overall Study|Non-Compliance with Study Drug|1
1651796|NCT01656395|5772717|P1|Overall Study|Non-Compliance with Study Drug|1
1651797|NCT01656395|5772710|P8|Overall Study|Lost to Follow-up|0
1651798|NCT01656395|5772711|P7|Overall Study|Lost to Follow-up|0
1651799|NCT01656395|5772712|P6|Overall Study|Lost to Follow-up|0
1651800|NCT01656395|5772713|P5|Overall Study|Lost to Follow-up|0
1651801|NCT01656395|5772714|P4|Overall Study|Lost to Follow-up|0
1651802|NCT01656395|5772715|P3|Overall Study|Lost to Follow-up|0
1651803|NCT01656395|5772716|P2|Overall Study|Lost to Follow-up|0
1651804|NCT01656395|5772717|P1|Overall Study|Lost to Follow-up|1
1651805|NCT01656395|5772710|P8|Overall Study|Lack of Efficacy|0
1651806|NCT01656395|5772711|P7|Overall Study|Lack of Efficacy|0
1651807|NCT01656395|5772712|P6|Overall Study|Lack of Efficacy|6
1651808|NCT01656395|5772713|P5|Overall Study|Lack of Efficacy|1
1651809|NCT01656395|5772714|P4|Overall Study|Lack of Efficacy|1
1651810|NCT01656395|5772715|P3|Overall Study|Lack of Efficacy|6
1651811|NCT01656395|5772716|P2|Overall Study|Lack of Efficacy|8
1651812|NCT01656395|5772717|P1|Overall Study|Lack of Efficacy|1
1651813|NCT01656395|5772710|P8|Overall Study|Adverse Event|0
1651814|NCT01656395|5772711|P7|Overall Study|Adverse Event|0
1651815|NCT01656395|5772712|P6|Overall Study|Adverse Event|7
1651816|NCT01656395|5772713|P5|Overall Study|Adverse Event|5
1651817|NCT01656395|5772714|P4|Overall Study|Adverse Event|4
1651818|NCT01656395|5772715|P3|Overall Study|Adverse Event|5
1651819|NCT01656395|5772716|P2|Overall Study|Adverse Event|14
1651820|NCT01656395|5772717|P1|Overall Study|Adverse Event|1
1651821|NCT01656304|5772803|P1|Overall Study|Ineligible, uncontrolled hypertension|1
1651822|NCT01656200|5772844|P1|Overall Study|Withdrawal by Subject|1
1651823|NCT01656161|5772859|P1|Overall Study|Withdrawal by Subject|1
1651824|NCT01656161|5772859|P1|Overall Study|Protocol Violation|1
1651825|NCT01656161|5772859|P1|Overall Study|Adverse Event|2
1651826|NCT01656161|5772859|P1|Overall Study|Death|3
1651827|NCT01655901|5772877|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
1651828|NCT01655901|5772878|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
1651829|NCT01655901|5772879|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
1651830|NCT01655901|5772880|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
1651831|NCT01655901|5772881|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
1651832|NCT01655901|5772882|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
1651833|NCT01655823|5772896|P5|Overall Study|Withdrawal by Subject|0
1651834|NCT01655823|5772897|P4|Overall Study|Withdrawal by Subject|1
1651835|NCT01655823|5772898|P3|Overall Study|Withdrawal by Subject|0
1651836|NCT01655823|5772899|P2|Overall Study|Withdrawal by Subject|1
1651837|NCT01655823|5772900|P1|Overall Study|Withdrawal by Subject|0
1651838|NCT01655823|5772896|P5|Overall Study|Lost to Follow-up|1
1651839|NCT01655823|5772897|P4|Overall Study|Lost to Follow-up|0
1651840|NCT01655823|5772898|P3|Overall Study|Lost to Follow-up|0
1651841|NCT01655823|5772899|P2|Overall Study|Lost to Follow-up|1
1651842|NCT01655823|5772900|P1|Overall Study|Lost to Follow-up|0
1651843|NCT01655498|5772931|P1|Overall Study|Withdrawal by Subject|1
1651844|NCT01655498|5772931|P1|Overall Study|Protocol Violation|2
1651845|NCT01655498|5772931|P1|Overall Study|Unrelated health issue|2
1651846|NCT01655381|5772938|P1|Overall Study|Insufficient Treatment Response|1
1651847|NCT01655381|5772938|P1|Overall Study|Moved to Another City|1
1651848|NCT01655381|5772938|P1|Overall Study|Investigator Decision|1
1651849|NCT01655069|5772978|P4|Overall Study|Withdrawal by Subject|0
1651850|NCT01655069|5772979|P3|Overall Study|Withdrawal by Subject|0
1651851|NCT01655069|5772980|P2|Overall Study|Withdrawal by Subject|3
1651852|NCT01655069|5772981|P1|Overall Study|Withdrawal by Subject|2
1651853|NCT01655069|5772978|P4|Overall Study|No Treatment Needed|0
1651854|NCT01655069|5772979|P3|Overall Study|No Treatment Needed|0
1651855|NCT01655069|5772980|P2|Overall Study|No Treatment Needed|1
1651856|NCT01655069|5772981|P1|Overall Study|No Treatment Needed|0
1651857|NCT01655069|5772978|P4|Overall Study|Lack of Efficacy|0
1651858|NCT01655069|5772979|P3|Overall Study|Lack of Efficacy|0
1651859|NCT01655069|5772980|P2|Overall Study|Lack of Efficacy|1
1651860|NCT01655069|5772981|P1|Overall Study|Lack of Efficacy|0
1651861|NCT01655069|5772978|P4|Overall Study|Adverse Event|3
1651862|NCT01655069|5772979|P3|Overall Study|Adverse Event|2
1651863|NCT01655069|5772980|P2|Overall Study|Adverse Event|7
1651864|NCT01655069|5772981|P1|Overall Study|Adverse Event|6
1651865|NCT01655069|5772978|P4|Overall Study|Physician Decision|1
1651866|NCT01655069|5772979|P3|Overall Study|Physician Decision|0
1651867|NCT01655069|5772980|P2|Overall Study|Physician Decision|0
1651868|NCT01655069|5772981|P1|Overall Study|Physician Decision|0
1651869|NCT01654666|5773041|P3|Overall Study|Withdrawal by Subject|1
1651870|NCT01654666|5773042|P2|Overall Study|Withdrawal by Subject|4
1651871|NCT01654666|5773043|P1|Overall Study|Withdrawal by Subject|4
1651872|NCT01654666|5773041|P3|Overall Study|Lost to Follow-up|5
1651873|NCT01654666|5773042|P2|Overall Study|Lost to Follow-up|5
1651874|NCT01654666|5773043|P1|Overall Study|Lost to Follow-up|4
1651875|NCT01654666|5773041|P3|Overall Study|Protocol Violation|8
1651876|NCT01654666|5773042|P2|Overall Study|Protocol Violation|4
1651877|NCT01654666|5773043|P1|Overall Study|Protocol Violation|7
1651878|NCT01654601|5773068|P2|2nd Administration|Protocol Violation|1
1651879|NCT01654601|5773069|P1|2nd Administration|Protocol Violation|0
1651880|NCT01654601|5773068|P2|2nd Administration|Adverse Event|0
1651881|NCT01654601|5773069|P1|2nd Administration|Adverse Event|1
1651882|NCT01654601|5773068|P2|1st Administration|Protocol Violation|2
1651883|NCT01654601|5773069|P1|1st Administration|Protocol Violation|0
1651884|NCT01654601|5773068|P2|1st Administration|Withdrawal by Subject|0
1651885|NCT01654601|5773069|P1|1st Administration|Withdrawal by Subject|2
1651886|NCT01654549|5773083|P2|Overall Study|H.pylori eradication not successful|1
1651887|NCT01654549|5773084|P1|Overall Study|H.pylori eradication not successful|0
1651888|NCT01654536|5773096|P2|Overall Study|Withdrawal by Subject|25
1651889|NCT01654536|5773097|P1|Overall Study|Withdrawal by Subject|27
1651890|NCT01654536|5773096|P2|Overall Study|Physician Decision|8
1651891|NCT01654536|5773097|P1|Overall Study|Physician Decision|12
1651892|NCT01654536|5773096|P2|Overall Study|Lost to Follow-up|5
1651893|NCT01654536|5773097|P1|Overall Study|Lost to Follow-up|5
1651894|NCT01654523|5773133|P1|Overall Study|Withdrawal by Subject|1
1651895|NCT01654380|5773139|P4|Part B, Period 1|Physician Decision|0
1651896|NCT01654380|5773140|P3|Part B, Period 1|Physician Decision|1
1651897|NCT01654380|5773141|P2|Part B, Period 1|Physician Decision|0
1651898|NCT01654380|5773142|P1|Part B, Period 1|Physician Decision|0
1651899|NCT01654302|5773185|P2|Second Intervention (Day 7)|Lost to Follow-up|1
1651900|NCT01654302|5773186|P1|Second Intervention (Day 7)|Lost to Follow-up|1
1651901|NCT01654289|5773195|P3|Overall Study|Withdrew from intervention only|0
1651902|NCT01654289|5773196|P2|Overall Study|Withdrew from intervention only|20
1651903|NCT01654289|5773197|P1|Overall Study|Withdrew from intervention only|17
1651904|NCT01654289|5773195|P3|Overall Study|Withdrawal by Subject|5
1651905|NCT01654289|5773196|P2|Overall Study|Withdrawal by Subject|8
1651906|NCT01654289|5773197|P1|Overall Study|Withdrawal by Subject|10
1651907|NCT01654276|5773235|P1|Overall Study|Withdrawal by Subject|1
1651908|NCT01654276|5773235|P1|Overall Study|Lost to Follow-up|4
1651909|NCT01654276|5773235|P1|Overall Study|Lack of Efficacy|1
1651910|NCT01654250|5773289|P2|Overall Study|Lost to Follow-up|0
1651911|NCT01654250|5773290|P1|Overall Study|Lost to Follow-up|1
1651912|NCT01654224|5773307|P2|Overall Study|Insufficient blood sample|2
1651913|NCT01654224|5773308|P1|Overall Study|Insufficient blood sample|3
1651914|NCT01654224|5773307|P2|Overall Study|Did not receive allocation|8
1651915|NCT01654224|5773308|P1|Overall Study|Did not receive allocation|1
1651916|NCT01654224|5773307|P2|Overall Study|Lost to Follow-up|2
1651917|NCT01654224|5773308|P1|Overall Study|Lost to Follow-up|2
1651918|NCT01653912|5773339|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
1651919|NCT01653912|5773340|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1651920|NCT01653912|5773341|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1651921|NCT01653912|5773342|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1651922|NCT01653912|5773343|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1651923|NCT01653912|5773344|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
1651924|NCT01653912|5773339|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
1651925|NCT01653912|5773340|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1651926|NCT01653912|5773341|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1651927|NCT01653912|5773342|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1651928|NCT01653912|5773343|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1651929|NCT01653912|5773344|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
1651930|NCT01653912|5773339|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
1651931|NCT01653912|5773340|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
1651932|NCT01653912|5773341|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
1651933|NCT01653912|5773342|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
1651934|NCT01653912|5773343|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
1651935|NCT01653912|5773344|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
1651936|NCT01653912|5773339|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1651937|NCT01653912|5773340|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1651938|NCT01653912|5773341|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
1651939|NCT01653912|5773342|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1651940|NCT01653912|5773343|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1652028|NCT01652872|5773871|P1|Overall Study|Death|36
1651941|NCT01653912|5773344|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
1651942|NCT01653912|5773339|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1651943|NCT01653912|5773340|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1651944|NCT01653912|5773341|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
1651945|NCT01653912|5773342|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1651946|NCT01653912|5773343|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1651947|NCT01653912|5773344|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
1651948|NCT01653912|5773339|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1651949|NCT01653912|5773340|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1651950|NCT01653912|5773341|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1651951|NCT01653912|5773342|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
1651952|NCT01653912|5773343|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1651953|NCT01653912|5773344|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
1651954|NCT01653912|5773339|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1651955|NCT01653912|5773340|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1651956|NCT01653912|5773341|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1651957|NCT01653912|5773342|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1651958|NCT01653912|5773343|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
1651959|NCT01653912|5773344|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
1651960|NCT01653782|5773362|P3|Overall Study|Lost to Follow-up|2
1651961|NCT01653782|5773363|P2|Overall Study|Lost to Follow-up|3
1651962|NCT01653782|5773364|P1|Overall Study|Lost to Follow-up|7
1651963|NCT01653782|5773362|P3|Overall Study|Withdrawal by Subject|4
1651964|NCT01653782|5773363|P2|Overall Study|Withdrawal by Subject|15
1651965|NCT01653782|5773364|P1|Overall Study|Withdrawal by Subject|9
1651966|NCT01653743|5773374|P2|Overall Study|Investigator discretion|0
1651967|NCT01653743|5773375|P1|Overall Study|Investigator discretion|3
1651968|NCT01653743|5773374|P2|Overall Study|Withdrawal by Subject|0
1651969|NCT01653743|5773375|P1|Overall Study|Withdrawal by Subject|1
1651970|NCT01653704|5773391|P2|Overall Study|Performance not reflective of training|0
1651971|NCT01653704|5773392|P1|Overall Study|Performance not reflective of training|1
1651972|NCT01653704|5773391|P2|Overall Study|Technical failure during recording|1
1651973|NCT01653704|5773392|P1|Overall Study|Technical failure during recording|1
1651974|NCT01653327|5773461|P1|Overall Study|Withdrawal by Subject|1
1651975|NCT01653262|5773486|P1|Overall Study|AE, non-serious non-fatal|1
1651976|NCT01653262|5773486|P1|Overall Study|SAE, non-fatal|1
1651977|NCT01653262|5773486|P1|Overall Study|Lack of Efficacy|1
1651978|NCT01653158|5773499|P8|Overall Study|Withdrawal by Subject|0
1651979|NCT01653158|5773500|P7|Overall Study|Withdrawal by Subject|0
1651980|NCT01653158|5773501|P6|Overall Study|Withdrawal by Subject|0
1651981|NCT01653158|5773502|P5|Overall Study|Withdrawal by Subject|0
1651982|NCT01653158|5773503|P4|Overall Study|Withdrawal by Subject|0
1651983|NCT01653158|5773504|P3|Overall Study|Withdrawal by Subject|0
1651984|NCT01653158|5773505|P2|Overall Study|Withdrawal by Subject|0
1651985|NCT01653158|5773506|P1|Overall Study|Withdrawal by Subject|1
1651986|NCT01653158|5773499|P8|Overall Study|Progressive disease|9
1651987|NCT01653158|5773500|P7|Overall Study|Progressive disease|2
1651988|NCT01653158|5773501|P6|Overall Study|Progressive disease|1
1651989|NCT01653158|5773502|P5|Overall Study|Progressive disease|1
1651990|NCT01653158|5773503|P4|Overall Study|Progressive disease|0
1651991|NCT01653158|5773504|P3|Overall Study|Progressive disease|0
1651992|NCT01653158|5773505|P2|Overall Study|Progressive disease|0
1651993|NCT01653158|5773506|P1|Overall Study|Progressive disease|0
1651994|NCT01653158|5773499|P8|Overall Study|Other|1
1651995|NCT01653158|5773500|P7|Overall Study|Other|0
1651996|NCT01653158|5773501|P6|Overall Study|Other|0
1651997|NCT01653158|5773502|P5|Overall Study|Other|0
1651998|NCT01653158|5773503|P4|Overall Study|Other|0
1651999|NCT01653158|5773504|P3|Overall Study|Other|0
1652000|NCT01653158|5773505|P2|Overall Study|Other|0
1652001|NCT01653158|5773506|P1|Overall Study|Other|0
1652002|NCT01653158|5773499|P8|Overall Study|Adverse Event|3
1652003|NCT01653158|5773500|P7|Overall Study|Adverse Event|0
1652004|NCT01653158|5773501|P6|Overall Study|Adverse Event|0
1652005|NCT01653158|5773502|P5|Overall Study|Adverse Event|0
1652006|NCT01653158|5773503|P4|Overall Study|Adverse Event|1
1652007|NCT01653158|5773504|P3|Overall Study|Adverse Event|0
1652008|NCT01653158|5773505|P2|Overall Study|Adverse Event|0
1652009|NCT01653158|5773506|P1|Overall Study|Adverse Event|0
1652010|NCT01653158|5773499|P8|Overall Study|Death|2
1652011|NCT01653158|5773500|P7|Overall Study|Death|0
1652012|NCT01653158|5773501|P6|Overall Study|Death|0
1652013|NCT01653158|5773502|P5|Overall Study|Death|0
1652014|NCT01653158|5773503|P4|Overall Study|Death|1
1652015|NCT01653158|5773504|P3|Overall Study|Death|0
1652016|NCT01653158|5773505|P2|Overall Study|Death|0
1652017|NCT01653158|5773506|P1|Overall Study|Death|0
1652018|NCT01653132|5773778|P2|First Intervention|Protocol Violation|0
1652019|NCT01653132|5773779|P1|First Intervention|Protocol Violation|1
1652020|NCT01652885|5773843|P1|Overall Study|Adverse Event|1
1652021|NCT01652872|5773870|P2|Overall Study|Withdrawal by Subject|84
1652022|NCT01652872|5773871|P1|Overall Study|Withdrawal by Subject|76
1652023|NCT01652872|5773870|P2|Overall Study|Decision by sponsor|7
1652024|NCT01652872|5773871|P1|Overall Study|Decision by sponsor|5
1652025|NCT01652872|5773870|P2|Overall Study|Lost to Follow-up|23
1652026|NCT01652872|5773871|P1|Overall Study|Lost to Follow-up|28
1652027|NCT01652872|5773870|P2|Overall Study|Death|39
1652029|NCT01652729|5773888|P3|Overall Study|Administrative|0
1652030|NCT01652729|5773889|P2|Overall Study|Administrative|0
1652031|NCT01652729|5773890|P1|Overall Study|Administrative|1
1652032|NCT01652729|5773888|P3|Overall Study|Lost to Follow-up|3
1652033|NCT01652729|5773889|P2|Overall Study|Lost to Follow-up|6
1652034|NCT01652729|5773890|P1|Overall Study|Lost to Follow-up|6
1652035|NCT01652729|5773888|P3|Overall Study|Protocol Violation|0
1652036|NCT01652729|5773889|P2|Overall Study|Protocol Violation|0
1652037|NCT01652729|5773890|P1|Overall Study|Protocol Violation|1
1652038|NCT01652729|5773888|P3|Overall Study|Physician Decision|1
1652039|NCT01652729|5773889|P2|Overall Study|Physician Decision|0
1652040|NCT01652729|5773890|P1|Overall Study|Physician Decision|1
1652041|NCT01652729|5773888|P3|Overall Study|Adverse Event|3
1652042|NCT01652729|5773889|P2|Overall Study|Adverse Event|0
1652043|NCT01652729|5773890|P1|Overall Study|Adverse Event|4
1652044|NCT01652729|5773888|P3|Overall Study|Withdrawal by Subject|7
1652045|NCT01652729|5773889|P2|Overall Study|Withdrawal by Subject|7
1652046|NCT01652729|5773890|P1|Overall Study|Withdrawal by Subject|14
1652047|NCT01652716|5773912|P2|Overall Study|Withdrawal by Subject|18
1652048|NCT01652716|5773913|P1|Overall Study|Withdrawal by Subject|33
1652049|NCT01652716|5773912|P2|Overall Study|Adverse Event|10
1652050|NCT01652716|5773913|P1|Overall Study|Adverse Event|7
1652051|NCT01652716|5773912|P2|Overall Study|Protocol Violation|1
1652052|NCT01652716|5773913|P1|Overall Study|Protocol Violation|2
1652053|NCT01652716|5773912|P2|Overall Study|Lost to Follow-up|11
1652054|NCT01652716|5773913|P1|Overall Study|Lost to Follow-up|12
1652055|NCT01652716|5773912|P2|Overall Study|Investigator decision|4
1652056|NCT01652716|5773913|P1|Overall Study|Investigator decision|1
1652057|NCT01652716|5773912|P2|Overall Study|Administrative|2
1652058|NCT01652716|5773913|P1|Overall Study|Administrative|0
1652059|NCT01652716|5773912|P2|Overall Study|Loss of glucose control|0
1652060|NCT01652716|5773913|P1|Overall Study|Loss of glucose control|1
1652061|NCT01652703|5773933|P6|Overall Study|Other|1
1652062|NCT01652703|5773934|P5|Overall Study|Other|1
1652063|NCT01652703|5773935|P4|Overall Study|Other|1
1652064|NCT01652703|5773936|P3|Overall Study|Other|0
1652065|NCT01652703|5773937|P2|Overall Study|Other|0
1652066|NCT01652703|5773938|P1|Overall Study|Other|0
1652067|NCT01652703|5773933|P6|Overall Study|Withdrawal by Subject|1
1652068|NCT01652703|5773934|P5|Overall Study|Withdrawal by Subject|0
1652069|NCT01652703|5773935|P4|Overall Study|Withdrawal by Subject|1
1652070|NCT01652703|5773936|P3|Overall Study|Withdrawal by Subject|3
1652071|NCT01652703|5773937|P2|Overall Study|Withdrawal by Subject|1
1652072|NCT01652703|5773938|P1|Overall Study|Withdrawal by Subject|0
1652073|NCT01652690|5773996|P2|Overall Study|Death|2
1652074|NCT01652690|5773997|P1|Overall Study|Death|5
1652075|NCT01652690|5773996|P2|Overall Study|Lost to Follow-up|6
1652076|NCT01652690|5773997|P1|Overall Study|Lost to Follow-up|6
1652077|NCT01652690|5773996|P2|Overall Study|Other|9
1652078|NCT01652690|5773997|P1|Overall Study|Other|8
1652079|NCT01652690|5773996|P2|Overall Study|Withdrawal by Subject|4
1652080|NCT01652690|5773997|P1|Overall Study|Withdrawal by Subject|16
1652081|NCT01652664|5774031|P2|Overall Study|Inadequate IOP control|0
1652082|NCT01652664|5774032|P1|Overall Study|Inadequate IOP control|1
1652083|NCT01652664|5774031|P2|Overall Study|Treatment Failure|1
1652084|NCT01652664|5774032|P1|Overall Study|Treatment Failure|5
1652085|NCT01652573|5774041|P2|Overall Study|Adverse Event|1
1652086|NCT01652573|5774042|P1|Overall Study|Adverse Event|0
1652087|NCT01652534|5774084|P2|Overall Study|Lack of Efficacy|0
1652088|NCT01652534|5774085|P1|Overall Study|Lack of Efficacy|1
1652089|NCT01652469|5774126|P2|Overall Study|Lost to Follow-up|2
1652090|NCT01652469|5774127|P1|Overall Study|Lost to Follow-up|0
1652091|NCT01652469|5774126|P2|Overall Study|Withdrawal by Subject|4
1652092|NCT01652469|5774127|P1|Overall Study|Withdrawal by Subject|1
1652093|NCT01652287|5774143|P2|Overall Study|Withdrawal by Subject|0
1652094|NCT01652287|5774144|P1|Overall Study|Withdrawal by Subject|2
1652095|NCT01651949|5774175|P3|Overall Study|Withdrawal by Subject|9
1652096|NCT01651949|5774176|P2|Overall Study|Withdrawal by Subject|18
1652097|NCT01651949|5774177|P1|Overall Study|Withdrawal by Subject|17
1652098|NCT01651949|5774175|P3|Overall Study|Screen failure|0
1652099|NCT01651949|5774176|P2|Overall Study|Screen failure|2
1652100|NCT01651949|5774177|P1|Overall Study|Screen failure|2
1652101|NCT01651949|5774175|P3|Overall Study|Adverse Event|1
1652102|NCT01651949|5774176|P2|Overall Study|Adverse Event|2
1652103|NCT01651949|5774177|P1|Overall Study|Adverse Event|0
1652104|NCT01651949|5774175|P3|Overall Study|Physician Decision|0
1652105|NCT01651949|5774176|P2|Overall Study|Physician Decision|2
1652106|NCT01651949|5774177|P1|Overall Study|Physician Decision|0
1652107|NCT01651949|5774175|P3|Overall Study|Protocol Violation|1
1652108|NCT01651949|5774176|P2|Overall Study|Protocol Violation|2
1652109|NCT01651949|5774177|P1|Overall Study|Protocol Violation|0
1652110|NCT01651949|5774175|P3|Overall Study|Lost to Follow-up|20
1652111|NCT01651949|5774176|P2|Overall Study|Lost to Follow-up|56
1652112|NCT01651949|5774177|P1|Overall Study|Lost to Follow-up|30
1652113|NCT01651949|5774175|P3|Overall Study|Unknown status|0
1652114|NCT01651949|5774176|P2|Overall Study|Unknown status|4
1652115|NCT01651949|5774177|P1|Overall Study|Unknown status|4
1652116|NCT01651936|5774197|P3|Extension Study|Study terminated by sponsor|13
1652117|NCT01651936|5774198|P2|Extension Study|Study terminated by sponsor|0
1652118|NCT01651936|5774199|P1|Extension Study|Study terminated by sponsor|0
1652119|NCT01651936|5774197|P3|Extension Study|Lack of Efficacy|1
1652120|NCT01651936|5774198|P2|Extension Study|Lack of Efficacy|0
1652121|NCT01651936|5774199|P1|Extension Study|Lack of Efficacy|0
1652122|NCT01651936|5774197|P3|Base Study|Study terminated by sponsor|0
1652123|NCT01651936|5774198|P2|Base Study|Study terminated by sponsor|16
1652124|NCT01651936|5774199|P1|Base Study|Study terminated by sponsor|21
1652125|NCT01651936|5774197|P3|Base Study|Early Escape|0
1652126|NCT01651936|5774198|P2|Base Study|Early Escape|8
1652127|NCT01651936|5774199|P1|Base Study|Early Escape|2
1652128|NCT01651936|5774197|P3|Base Study|Withdrawal by Subject|0
1652129|NCT01651936|5774198|P2|Base Study|Withdrawal by Subject|1
1652130|NCT01651936|5774199|P1|Base Study|Withdrawal by Subject|1
1652131|NCT01651936|5774197|P3|Base Study|Adverse Event|0
1652132|NCT01651936|5774198|P2|Base Study|Adverse Event|0
1652133|NCT01651936|5774199|P1|Base Study|Adverse Event|3
1652134|NCT01651780|5774269|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
1652135|NCT01651780|5774270|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
1652136|NCT01651780|5774269|P2|Overall Study|Lost to Follow-up|2
1652137|NCT01651780|5774270|P1|Overall Study|Lost to Follow-up|1
1652138|NCT01651780|5774269|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1652139|NCT01651780|5774270|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
1652140|NCT01651780|5774269|P2|Overall Study|Withdrawal by Subject|0
1652141|NCT01651780|5774270|P1|Overall Study|Withdrawal by Subject|2
1652142|NCT01651780|5774269|P2|Overall Study|Reason Not Specified: No 30-day visit|2
1652143|NCT01651780|5774270|P1|Overall Study|Reason Not Specified: No 30-day visit|2
1652144|NCT01651780|5774269|P2|Overall Study|Physician decision: No 30-day visit|1
1652145|NCT01651780|5774270|P1|Overall Study|Physician decision: No 30-day visit|2
1652146|NCT01651403|5774321|P2|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|2
1652147|NCT01651403|5774322|P1|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|0
1652148|NCT01651403|5774321|P2|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|0
1652149|NCT01651403|5774322|P1|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|1
1652150|NCT01651403|5774321|P2|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|20
1652151|NCT01651403|5774322|P1|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|46
1652152|NCT01651403|5774321|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
1652153|NCT01651403|5774322|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
1652154|NCT01651403|5774321|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
1652155|NCT01651403|5774322|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
1652156|NCT01651403|5774321|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
1652157|NCT01651403|5774322|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
1652158|NCT01651260|5774370|P1|Overall Study|unable to apply product|3
1652159|NCT01651208|5774377|P2|Overall Study|Lost to Follow-up|16
1652160|NCT01651208|5774378|P1|Overall Study|Lost to Follow-up|14
1652161|NCT01651117|5774390|P4|Overall Study|Death|2
1652162|NCT01651117|5774391|P3|Overall Study|Death|2
1652163|NCT01651117|5774392|P2|Overall Study|Death|3
1652164|NCT01651117|5774393|P1|Overall Study|Death|2
1652165|NCT01651052|5774473|P1|Overall Study|Lost to Follow-up|3
1652166|NCT01651052|5774473|P1|Overall Study|Withdrawal by Subject|1
1652167|NCT01651052|5774473|P1|Overall Study|Explant|1
1652168|NCT01651052|5774473|P1|Overall Study|Death|21
1652169|NCT01651039|5774493|P1|Overall Study|Progressive Disease|22
1652170|NCT01651039|5774493|P1|Overall Study|Withdrawal by Subject|1
1652171|NCT01651039|5774493|P1|Overall Study|Physician Decision|2
1652172|NCT01651039|5774493|P1|Overall Study|Non-evaluables|5
1652173|NCT01651000|5774506|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
1652174|NCT01651000|5774507|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
1652175|NCT01651000|5774506|P2|Overall Study|Administrative reason|0
1652176|NCT01651000|5774507|P1|Overall Study|Administrative reason|1
1652177|NCT01651000|5774506|P2|Overall Study|Physician Decision|0
1652178|NCT01651000|5774507|P1|Overall Study|Physician Decision|1
1652179|NCT01651000|5774506|P2|Overall Study|Lack of Efficacy|1
1652180|NCT01651000|5774507|P1|Overall Study|Lack of Efficacy|1
1652181|NCT01651000|5774506|P2|Overall Study|Subject noncompliance|3
1652182|NCT01651000|5774507|P1|Overall Study|Subject noncompliance|0
1652183|NCT01651000|5774506|P2|Overall Study|Withdrawal by Subject|10
1652184|NCT01651000|5774507|P1|Overall Study|Withdrawal by Subject|2
1652185|NCT01651000|5774506|P2|Overall Study|Protocol Violation|3
1652186|NCT01651000|5774507|P1|Overall Study|Protocol Violation|0
1652187|NCT01651000|5774506|P2|Overall Study|Lost to Follow-up|2
1652188|NCT01651000|5774507|P1|Overall Study|Lost to Follow-up|3
1652189|NCT01651000|5774506|P2|Overall Study|Adverse Event|8
1652190|NCT01651000|5774507|P1|Overall Study|Adverse Event|2
1652191|NCT01650831|5774528|P1|Overall Study|Screen failure|1
1652192|NCT01650805|5774538|P2|Overall Study|Withdrawal by Subject|0
1652193|NCT01650805|5774539|P1|Overall Study|Withdrawal by Subject|1
1652194|NCT01650779|5774549|P1|Overall Study|Withdrawal by Subject|1
1652195|NCT01650636|5774558|P2|Washout up to 9 Months|Lost to Follow-up|1
1652196|NCT01650636|5774559|P1|Washout up to 9 Months|Lost to Follow-up|2
1652197|NCT01650636|5774558|P2|Washout up to 9 Months|Withdrawal by Subject|2
1652198|NCT01650636|5774559|P1|Washout up to 9 Months|Withdrawal by Subject|4
1652199|NCT01650636|5774558|P2|Washout up to 5 Months|Lost to Follow-up|8
1652200|NCT01650636|5774559|P1|Washout up to 5 Months|Lost to Follow-up|2
1652201|NCT01650636|5774558|P2|Washout up to 5 Months|Death|0
1652202|NCT01650636|5774559|P1|Washout up to 5 Months|Death|1
1652203|NCT01650636|5774558|P2|Washout up to 5 Months|Physician Decision|2
1652204|NCT01650636|5774559|P1|Washout up to 5 Months|Physician Decision|2
1652205|NCT01650636|5774558|P2|Washout up to 5 Months|Withdrawal by Subject|8
1652206|NCT01650636|5774559|P1|Washout up to 5 Months|Withdrawal by Subject|4
1652207|NCT01650519|5774592|P2|Overall Study|Withdrawal by Subject|0
1652208|NCT01650519|5774593|P1|Overall Study|Withdrawal by Subject|1
1652209|NCT01650285|5774655|P1|Overall Study|Adverse Event|1
1652210|NCT01650259|5774662|P2|Overall Study|Other than listed|146
1652211|NCT01650259|5774663|P1|Overall Study|Other than listed|64
1652212|NCT01650259|5774662|P2|Overall Study|Not treated|7
1652213|NCT01650259|5774663|P1|Overall Study|Not treated|1
1652214|NCT01650259|5774662|P2|Overall Study|CRF not collected|82
1652215|NCT01650259|5774663|P1|Overall Study|CRF not collected|98
1652216|NCT01650259|5774662|P2|Overall Study|Patients had no visit after entry|0
1652217|NCT01650259|5774663|P1|Overall Study|Patients had no visit after entry|70
1652218|NCT01650259|5774662|P2|Overall Study|Lost to Follow-up|0
1652219|NCT01650259|5774663|P1|Overall Study|Lost to Follow-up|435
1652220|NCT01650259|5774662|P2|Overall Study|Lack of Efficacy|0
1652221|NCT01650259|5774663|P1|Overall Study|Lack of Efficacy|143
1652222|NCT01650259|5774662|P2|Overall Study|Adverse Event|0
1652223|NCT01650259|5774663|P1|Overall Study|Adverse Event|127
1652224|NCT01650259|5774662|P2|Overall Study|Improvement|0
1652225|NCT01650259|5774663|P1|Overall Study|Improvement|105
1652226|NCT01650246|5774668|P1|Overall Study|Lack of Efficacy|30
1652227|NCT01650246|5774668|P1|Overall Study|Death|1
1652228|NCT01650246|5774668|P1|Overall Study|Withdrawal by Subject|26
1652229|NCT01650246|5774668|P1|Overall Study|Lost to Follow-up|5
1652230|NCT01650246|5774668|P1|Overall Study|Sponsor terminated study|53
1652231|NCT01650246|5774668|P1|Overall Study|Protocol Violation|5
1652232|NCT01650246|5774668|P1|Overall Study|Adverse Event|23
1652233|NCT01650194|5774673|P1|Overall Study|Miscellaneous|10
1652234|NCT01650194|5774673|P1|Overall Study|Withdrawal by Subject|2
1652235|NCT01650194|5774673|P1|Overall Study|Progressive Disease (PD)|35
1652236|NCT01649856|5774709|P2|Overall Study|Other|5
1652237|NCT01649856|5774710|P1|Overall Study|Other|20
1652238|NCT01649856|5774709|P2|Overall Study|Lack of Compliance|1
1652239|NCT01649856|5774710|P1|Overall Study|Lack of Compliance|6
1652240|NCT01649856|5774709|P2|Overall Study|Lost to Follow-up|16
1652241|NCT01649856|5774710|P1|Overall Study|Lost to Follow-up|20
1652242|NCT01649856|5774709|P2|Overall Study|Stable or Progressed Disease|3
1652243|NCT01649856|5774710|P1|Overall Study|Stable or Progressed Disease|5
1652244|NCT01649856|5774709|P2|Overall Study|Death|34
1652245|NCT01649856|5774710|P1|Overall Study|Death|69
1652246|NCT01649856|5774709|P2|Overall Study|Treatment Failure|1
1652247|NCT01649856|5774710|P1|Overall Study|Treatment Failure|1
1652248|NCT01649856|5774709|P2|Overall Study|Protocol Violation|4
1652249|NCT01649856|5774710|P1|Overall Study|Protocol Violation|4
1652250|NCT01649856|5774709|P2|Overall Study|Withdrawal by Subject|14
1652251|NCT01649856|5774710|P1|Overall Study|Withdrawal by Subject|14
1652252|NCT01649804|5774742|P1|Overall Study|Administrative/Other|8
1652253|NCT01649791|5774754|P1|Overall Study|Adverse Event|1
1652254|NCT01649791|5774754|P1|Overall Study|Disease Progression|2
1652265|NCT01649557|5774815|P3|Overall Study|Lack of Efficacy|0
1652266|NCT01649557|5774816|P2|Overall Study|Lack of Efficacy|0
1652267|NCT01649557|5774817|P1|Overall Study|Lack of Efficacy|5
1652268|NCT01649557|5774815|P3|Overall Study|Protocol deviation|0
1652269|NCT01649557|5774816|P2|Overall Study|Protocol deviation|2
1652270|NCT01649557|5774817|P1|Overall Study|Protocol deviation|0
1652271|NCT01649557|5774815|P3|Overall Study|Withdrawal by Subject|4
1652272|NCT01649557|5774816|P2|Overall Study|Withdrawal by Subject|5
1652273|NCT01649557|5774817|P1|Overall Study|Withdrawal by Subject|15
1652274|NCT01649557|5774815|P3|Overall Study|Physician Decision|1
1652275|NCT01649557|5774816|P2|Overall Study|Physician Decision|2
1652276|NCT01649557|5774817|P1|Overall Study|Physician Decision|8
1652277|NCT01649557|5774815|P3|Overall Study|Met withdrawal criteria|0
1652278|NCT01649557|5774816|P2|Overall Study|Met withdrawal criteria|0
1652279|NCT01649557|5774817|P1|Overall Study|Met withdrawal criteria|4
1652280|NCT01649557|5774815|P3|Overall Study|Adverse Event|1
1652281|NCT01649557|5774816|P2|Overall Study|Adverse Event|5
1652282|NCT01649557|5774817|P1|Overall Study|Adverse Event|7
1652283|NCT01649557|5774815|P3|Overall Study|Lost to Follow-up|3
1652284|NCT01649557|5774816|P2|Overall Study|Lost to Follow-up|0
1652285|NCT01649557|5774817|P1|Overall Study|Lost to Follow-up|5
1652286|NCT01649427|5774863|P2|Overall Study|Surgical problems during nephrectomy|2
1652287|NCT01649427|5774864|P1|Overall Study|Surgical problems during nephrectomy|2
1652288|NCT01649427|5774863|P2|Overall Study|Graft loss|1
1652289|NCT01649427|5774864|P1|Overall Study|Graft loss|0
1652290|NCT01649427|5774863|P2|Overall Study|Lost to Follow-up|1
1652291|NCT01649427|5774864|P1|Overall Study|Lost to Follow-up|0
1652292|NCT01649427|5774863|P2|Overall Study|Withdrawal by Subject|7
1652293|NCT01649427|5774864|P1|Overall Study|Withdrawal by Subject|8
1652294|NCT01649427|5774863|P2|Overall Study|Adverse Event|1
1652295|NCT01649427|5774864|P1|Overall Study|Adverse Event|1
1652296|NCT01649375|5774883|P5|Week 16 up to Week 260|Adverse Event|2
1652297|NCT01649375|5774884|P4|Week 16 up to Week 260|Adverse Event|3
1652298|NCT01649375|5774885|P3|Week 16 up to Week 260|Adverse Event|0
1652299|NCT01649375|5774886|P2|Week 16 up to Week 260|Adverse Event|2
1652300|NCT01649375|5774887|P1|Week 16 up to Week 260|Adverse Event|5
1652301|NCT01649375|5774883|P5|Week 16 up to Week 260|Death|0
1652302|NCT01649375|5774884|P4|Week 16 up to Week 260|Death|0
1652303|NCT01649375|5774885|P3|Week 16 up to Week 260|Death|0
1652304|NCT01649375|5774886|P2|Week 16 up to Week 260|Death|1
1652305|NCT01649375|5774887|P1|Week 16 up to Week 260|Death|1
1652306|NCT01649375|5774883|P5|Week 16 up to Week 260|Withdrawal by Subject|1
1652307|NCT01649375|5774884|P4|Week 16 up to Week 260|Withdrawal by Subject|3
1652308|NCT01649375|5774885|P3|Week 16 up to Week 260|Withdrawal by Subject|0
1652309|NCT01649375|5774886|P2|Week 16 up to Week 260|Withdrawal by Subject|2
1652310|NCT01649375|5774887|P1|Week 16 up to Week 260|Withdrawal by Subject|7
1652311|NCT01649375|5774883|P5|Week 16 up to Week 260|Technical issues|0
1652312|NCT01649375|5774884|P4|Week 16 up to Week 260|Technical issues|1
1652313|NCT01649375|5774885|P3|Week 16 up to Week 260|Technical issues|0
1652314|NCT01649375|5774886|P2|Week 16 up to Week 260|Technical issues|1
1652315|NCT01649375|5774887|P1|Week 16 up to Week 260|Technical issues|0
1652316|NCT01649375|5774883|P5|Week 16 up to Week 260|Physician Decision|0
1652317|NCT01649375|5774884|P4|Week 16 up to Week 260|Physician Decision|0
1652318|NCT01649375|5774885|P3|Week 16 up to Week 260|Physician Decision|0
1652319|NCT01649375|5774886|P2|Week 16 up to Week 260|Physician Decision|2
1652320|NCT01649375|5774887|P1|Week 16 up to Week 260|Physician Decision|0
1652321|NCT01649375|5774883|P5|Week 16 up to Week 260|Non-compliance|0
1652322|NCT01649375|5774884|P4|Week 16 up to Week 260|Non-compliance|1
1652323|NCT01649375|5774885|P3|Week 16 up to Week 260|Non-compliance|0
1652324|NCT01649375|5774886|P2|Week 16 up to Week 260|Non-compliance|1
1652325|NCT01649375|5774887|P1|Week 16 up to Week 260|Non-compliance|0
1652326|NCT01649375|5774883|P5|Week 16 up to Week 260|Lack of Efficacy|2
1652327|NCT01649375|5774884|P4|Week 16 up to Week 260|Lack of Efficacy|4
1652328|NCT01649375|5774885|P3|Week 16 up to Week 260|Lack of Efficacy|0
1652329|NCT01649375|5774886|P2|Week 16 up to Week 260|Lack of Efficacy|4
1652330|NCT01649375|5774887|P1|Week 16 up to Week 260|Lack of Efficacy|7
1652331|NCT01649375|5774883|P5|Up to Week 16|Death|0
1652332|NCT01649375|5774884|P4|Up to Week 16|Death|0
1652333|NCT01649375|5774885|P3|Up to Week 16|Death|0
1652334|NCT01649375|5774886|P2|Up to Week 16|Death|0
1652335|NCT01649375|5774887|P1|Up to Week 16|Death|1
1652336|NCT01649375|5774883|P5|Up to Week 16|Withdrawal by Subject|0
1652337|NCT01649375|5774884|P4|Up to Week 16|Withdrawal by Subject|0
1652338|NCT01649375|5774885|P3|Up to Week 16|Withdrawal by Subject|2
1652339|NCT01649375|5774886|P2|Up to Week 16|Withdrawal by Subject|1
1652340|NCT01649375|5774887|P1|Up to Week 16|Withdrawal by Subject|2
1652341|NCT01649375|5774883|P5|Up to Week 16|Physician Decision|0
1652342|NCT01649375|5774884|P4|Up to Week 16|Physician Decision|0
1652343|NCT01649375|5774885|P3|Up to Week 16|Physician Decision|1
1652344|NCT01649375|5774886|P2|Up to Week 16|Physician Decision|0
1652345|NCT01649375|5774887|P1|Up to Week 16|Physician Decision|0
1652346|NCT01649375|5774883|P5|Up to Week 16|Lack of Efficacy|0
1652347|NCT01649375|5774884|P4|Up to Week 16|Lack of Efficacy|0
1652348|NCT01649375|5774885|P3|Up to Week 16|Lack of Efficacy|1
1652349|NCT01649375|5774886|P2|Up to Week 16|Lack of Efficacy|0
1652350|NCT01649375|5774887|P1|Up to Week 16|Lack of Efficacy|0
1652351|NCT01649375|5774883|P5|Up to Week 16|Adverse Event|0
1652352|NCT01649375|5774884|P4|Up to Week 16|Adverse Event|0
1652353|NCT01649375|5774885|P3|Up to Week 16|Adverse Event|4
1652354|NCT01649375|5774886|P2|Up to Week 16|Adverse Event|5
1652355|NCT01649375|5774887|P1|Up to Week 16|Adverse Event|2
1652356|NCT01649297|5774934|P5|Overall Study|For other reason|0
1652357|NCT01649297|5774935|P4|Overall Study|For other reason|0
1652358|NCT01649297|5774936|P3|Overall Study|For other reason|2
1652359|NCT01649297|5774937|P2|Overall Study|For other reason|1
1652360|NCT01649297|5774938|P1|Overall Study|For other reason|4
1652361|NCT01649297|5774934|P5|Overall Study|Patient withdrawal (not due to AE)|1
1652362|NCT01649297|5774935|P4|Overall Study|Patient withdrawal (not due to AE)|1
1652363|NCT01649297|5774936|P3|Overall Study|Patient withdrawal (not due to AE)|4
1652364|NCT01649297|5774937|P2|Overall Study|Patient withdrawal (not due to AE)|6
1652365|NCT01649297|5774938|P1|Overall Study|Patient withdrawal (not due to AE)|3
1652366|NCT01649297|5774934|P5|Overall Study|Lost to Follow-up|0
1652367|NCT01649297|5774935|P4|Overall Study|Lost to Follow-up|3
1652368|NCT01649297|5774936|P3|Overall Study|Lost to Follow-up|4
1652369|NCT01649297|5774937|P2|Overall Study|Lost to Follow-up|1
1652370|NCT01649297|5774938|P1|Overall Study|Lost to Follow-up|1
1652371|NCT01649297|5774934|P5|Overall Study|Non compliant with Protocol|1
1652372|NCT01649297|5774935|P4|Overall Study|Non compliant with Protocol|2
1652373|NCT01649297|5774936|P3|Overall Study|Non compliant with Protocol|3
1652374|NCT01649297|5774937|P2|Overall Study|Non compliant with Protocol|0
1652375|NCT01649297|5774938|P1|Overall Study|Non compliant with Protocol|1
1652376|NCT01649297|5774934|P5|Overall Study|Lack of Efficacy|1
1652377|NCT01649297|5774935|P4|Overall Study|Lack of Efficacy|0
1652378|NCT01649297|5774936|P3|Overall Study|Lack of Efficacy|0
1652379|NCT01649297|5774937|P2|Overall Study|Lack of Efficacy|0
1652380|NCT01649297|5774938|P1|Overall Study|Lack of Efficacy|0
1652381|NCT01649297|5774934|P5|Overall Study|Adverse Event|1
1652382|NCT01649297|5774935|P4|Overall Study|Adverse Event|13
1652383|NCT01649297|5774936|P3|Overall Study|Adverse Event|4
1652384|NCT01649297|5774937|P2|Overall Study|Adverse Event|5
1652385|NCT01649297|5774938|P1|Overall Study|Adverse Event|5
1652386|NCT01649271|5774957|P2|Overall Study|Other than stated above|0
1652387|NCT01649271|5774958|P1|Overall Study|Other than stated above|1
1652388|NCT01649271|5774957|P2|Overall Study|Withdrawal by Subject|0
1652389|NCT01649271|5774958|P1|Overall Study|Withdrawal by Subject|1
1652390|NCT01649271|5774957|P2|Overall Study|Other Adverse Event|2
1652391|NCT01649271|5774958|P1|Overall Study|Other Adverse Event|0
1652392|NCT01649271|5774957|P2|Overall Study|Progressive disease|5
1652393|NCT01649271|5774958|P1|Overall Study|Progressive disease|4
1652394|NCT01649232|5774973|P2|Overall Study|Physician Decision|0
1652395|NCT01649232|5774974|P1|Overall Study|Physician Decision|2
1652396|NCT01648790|5775026|P5|Treatment 3|Withdrawal by Subject|0
1652397|NCT01648790|5775027|P4|Treatment 3|Withdrawal by Subject|1
1652398|NCT01648790|5775028|P3|Treatment 3|Withdrawal by Subject|0
1652399|NCT01648790|5775029|P2|Treatment 3|Withdrawal by Subject|0
1652400|NCT01648790|5775030|P1|Treatment 3|Withdrawal by Subject|0
1652401|NCT01648764|5775065|P14|Overall Study|Investigator Decision|0
1652402|NCT01648764|5775066|P13|Overall Study|Investigator Decision|0
1652403|NCT01648764|5775067|P12|Overall Study|Investigator Decision|1
1652404|NCT01648764|5775068|P11|Overall Study|Investigator Decision|0
1652405|NCT01648764|5775069|P10|Overall Study|Investigator Decision|0
1652406|NCT01648764|5775070|P9|Overall Study|Investigator Decision|0
1652407|NCT01648764|5775071|P8|Overall Study|Investigator Decision|0
1652408|NCT01648764|5775072|P7|Overall Study|Investigator Decision|1
1652409|NCT01648764|5775073|P6|Overall Study|Investigator Decision|0
1652410|NCT01648764|5775074|P5|Overall Study|Investigator Decision|0
1652411|NCT01648764|5775075|P4|Overall Study|Investigator Decision|0
1652412|NCT01648764|5775076|P3|Overall Study|Investigator Decision|0
1652413|NCT01648764|5775077|P2|Overall Study|Investigator Decision|0
1652414|NCT01648764|5775078|P1|Overall Study|Investigator Decision|0
1652415|NCT01648764|5775065|P14|Overall Study|Withdrawal by Subject|0
1652416|NCT01648764|5775066|P13|Overall Study|Withdrawal by Subject|1
1652417|NCT01648764|5775067|P12|Overall Study|Withdrawal by Subject|0
1652418|NCT01648764|5775068|P11|Overall Study|Withdrawal by Subject|0
1652419|NCT01648764|5775069|P10|Overall Study|Withdrawal by Subject|0
1652420|NCT01648764|5775070|P9|Overall Study|Withdrawal by Subject|0
1652421|NCT01648764|5775071|P8|Overall Study|Withdrawal by Subject|0
1652422|NCT01648764|5775072|P7|Overall Study|Withdrawal by Subject|2
1652423|NCT01648764|5775073|P6|Overall Study|Withdrawal by Subject|0
1652424|NCT01648764|5775074|P5|Overall Study|Withdrawal by Subject|0
1652425|NCT01648764|5775075|P4|Overall Study|Withdrawal by Subject|0
1652426|NCT01648764|5775076|P3|Overall Study|Withdrawal by Subject|0
1652427|NCT01648764|5775077|P2|Overall Study|Withdrawal by Subject|0
1652428|NCT01648764|5775078|P1|Overall Study|Withdrawal by Subject|0
1652429|NCT01648764|5775065|P14|Overall Study|Death|1
1652430|NCT01648764|5775066|P13|Overall Study|Death|0
1652431|NCT01648764|5775067|P12|Overall Study|Death|0
1652432|NCT01648764|5775068|P11|Overall Study|Death|0
1652433|NCT01648764|5775069|P10|Overall Study|Death|0
1652434|NCT01648764|5775070|P9|Overall Study|Death|0
1652435|NCT01648764|5775071|P8|Overall Study|Death|0
1652436|NCT01648764|5775072|P7|Overall Study|Death|1
1652437|NCT01648764|5775073|P6|Overall Study|Death|0
1652438|NCT01648764|5775074|P5|Overall Study|Death|0
1652439|NCT01648764|5775075|P4|Overall Study|Death|0
1652440|NCT01648764|5775076|P3|Overall Study|Death|0
1652441|NCT01648764|5775077|P2|Overall Study|Death|0
1652442|NCT01648764|5775078|P1|Overall Study|Death|0
1652443|NCT01648764|5775065|P14|Overall Study|Adverse Event|1
1652444|NCT01648764|5775066|P13|Overall Study|Adverse Event|1
1652445|NCT01648764|5775067|P12|Overall Study|Adverse Event|3
1652446|NCT01648764|5775068|P11|Overall Study|Adverse Event|0
1652447|NCT01648764|5775069|P10|Overall Study|Adverse Event|1
1652448|NCT01648764|5775070|P9|Overall Study|Adverse Event|0
1652449|NCT01648764|5775071|P8|Overall Study|Adverse Event|0
1652450|NCT01648764|5775072|P7|Overall Study|Adverse Event|0
1652451|NCT01648764|5775073|P6|Overall Study|Adverse Event|1
1652452|NCT01648764|5775074|P5|Overall Study|Adverse Event|0
1652453|NCT01648764|5775075|P4|Overall Study|Adverse Event|0
1652454|NCT01648764|5775076|P3|Overall Study|Adverse Event|0
1652455|NCT01648764|5775077|P2|Overall Study|Adverse Event|0
1652456|NCT01648764|5775078|P1|Overall Study|Adverse Event|0
1652457|NCT01648764|5775065|P14|Overall Study|Progressive Disease|1
1652458|NCT01648764|5775066|P13|Overall Study|Progressive Disease|2
1652459|NCT01648764|5775067|P12|Overall Study|Progressive Disease|1
1652460|NCT01648764|5775068|P11|Overall Study|Progressive Disease|0
1652461|NCT01648764|5775069|P10|Overall Study|Progressive Disease|2
1652462|NCT01648764|5775070|P9|Overall Study|Progressive Disease|0
1652463|NCT01648764|5775071|P8|Overall Study|Progressive Disease|0
1652464|NCT01648764|5775072|P7|Overall Study|Progressive Disease|1
1652465|NCT01648764|5775073|P6|Overall Study|Progressive Disease|1
1652466|NCT01648764|5775074|P5|Overall Study|Progressive Disease|0
1652467|NCT01648764|5775075|P4|Overall Study|Progressive Disease|0
1652468|NCT01648764|5775076|P3|Overall Study|Progressive Disease|0
1652469|NCT01648764|5775077|P2|Overall Study|Progressive Disease|1
1652470|NCT01648764|5775078|P1|Overall Study|Progressive Disease|0
1652471|NCT01648699|5775230|P1|Overall Study|Unspecified/unable to complete 4 visits|2
1652472|NCT01648699|5775230|P1|Overall Study|Lost to Follow-up|2
1652473|NCT01648699|5775230|P1|Overall Study|Death|1
1652474|NCT01648582|5775259|P3|Overall Study|Sponsor Decision|1
1652475|NCT01648582|5775260|P2|Overall Study|Sponsor Decision|1
1652476|NCT01648582|5775261|P1|Overall Study|Sponsor Decision|0
1652477|NCT01648582|5775259|P3|Overall Study|Death|0
1652478|NCT01648582|5775260|P2|Overall Study|Death|0
1652479|NCT01648582|5775261|P1|Overall Study|Death|1
1652480|NCT01648582|5775259|P3|Overall Study|Physician Decision|3
1652481|NCT01648582|5775260|P2|Overall Study|Physician Decision|1
1652482|NCT01648582|5775261|P1|Overall Study|Physician Decision|0
1652483|NCT01648582|5775259|P3|Overall Study|Withdrawal by Subject|17
1652484|NCT01648582|5775260|P2|Overall Study|Withdrawal by Subject|17
1652485|NCT01648582|5775261|P1|Overall Study|Withdrawal by Subject|15
1652486|NCT01648582|5775259|P3|Overall Study|Protocol Violation|1
1652487|NCT01648582|5775260|P2|Overall Study|Protocol Violation|2
1652488|NCT01648582|5775261|P1|Overall Study|Protocol Violation|1
1652489|NCT01648582|5775259|P3|Overall Study|Lost to Follow-up|8
1652490|NCT01648582|5775260|P2|Overall Study|Lost to Follow-up|6
1652491|NCT01648582|5775261|P1|Overall Study|Lost to Follow-up|9
1652492|NCT01648582|5775259|P3|Overall Study|Adverse Event|2
1652493|NCT01648582|5775260|P2|Overall Study|Adverse Event|11
1652494|NCT01648582|5775261|P1|Overall Study|Adverse Event|6
1652495|NCT01648348|5775364|P6|Overall Study|Replaced for MTD analysis|0
1652496|NCT01648348|5775365|P5|Overall Study|Replaced for MTD analysis|0
1652497|NCT01648348|5775366|P4|Overall Study|Replaced for MTD analysis|0
1652498|NCT01648348|5775367|P3|Overall Study|Replaced for MTD analysis|1
1652499|NCT01648348|5775368|P2|Overall Study|Replaced for MTD analysis|0
1652500|NCT01648348|5775369|P1|Overall Study|Replaced for MTD analysis|1
1652501|NCT01648348|5775364|P6|Overall Study|Cancel|6
1652502|NCT01648348|5775365|P5|Overall Study|Cancel|3
1652503|NCT01648348|5775366|P4|Overall Study|Cancel|0
1652504|NCT01648348|5775367|P3|Overall Study|Cancel|0
1652505|NCT01648348|5775368|P2|Overall Study|Cancel|0
1652506|NCT01648348|5775369|P1|Overall Study|Cancel|1
1652507|NCT01648283|5775456|P1|Overall Study|Withdrawal by Subject|14
1652508|NCT01648270|5775462|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
1652509|NCT01648166|5775474|P2|Overall Study|inadequate toenail samples|100
1652510|NCT01648166|5775475|P1|Overall Study|inadequate toenail samples|53
1652511|NCT01648140|5775485|P4|Overall Study|Lost to Follow-up|0
1652512|NCT01648140|5775486|P3|Overall Study|Lost to Follow-up|2
1652513|NCT01648140|5775487|P2|Overall Study|Lost to Follow-up|1
1652514|NCT01648140|5775488|P1|Overall Study|Lost to Follow-up|2
1652515|NCT01648140|5775485|P4|Overall Study|Withdrawal by Subject|2
1652516|NCT01648140|5775486|P3|Overall Study|Withdrawal by Subject|3
1652517|NCT01648140|5775487|P2|Overall Study|Withdrawal by Subject|3
1652518|NCT01648140|5775488|P1|Overall Study|Withdrawal by Subject|2
1652519|NCT01648140|5775485|P4|Overall Study|Adverse Event|0
1652520|NCT01648140|5775486|P3|Overall Study|Adverse Event|2
1652521|NCT01648140|5775487|P2|Overall Study|Adverse Event|1
1652522|NCT01648140|5775488|P1|Overall Study|Adverse Event|3
1652523|NCT01648140|5775485|P4|Overall Study|Lack of Efficacy|0
1652524|NCT01648140|5775486|P3|Overall Study|Lack of Efficacy|1
1652525|NCT01648140|5775487|P2|Overall Study|Lack of Efficacy|7
1652526|NCT01648140|5775488|P1|Overall Study|Lack of Efficacy|4
1652527|NCT01648140|5775485|P4|Overall Study|Physician Decision|0
1652528|NCT01648140|5775486|P3|Overall Study|Physician Decision|0
1652529|NCT01648140|5775487|P2|Overall Study|Physician Decision|0
1652530|NCT01648140|5775488|P1|Overall Study|Physician Decision|1
1652531|NCT01648101|5775653|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1652532|NCT01648101|5775654|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
1652533|NCT01648101|5775655|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
1652534|NCT01648101|5775653|P3|Transition Phase (4 Weeks)|Study Terminated|0
1652535|NCT01648101|5775654|P2|Transition Phase (4 Weeks)|Study Terminated|0
1652536|NCT01648101|5775655|P1|Transition Phase (4 Weeks)|Study Terminated|1
1652537|NCT01648101|5775653|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
1652538|NCT01648101|5775654|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1652539|NCT01648101|5775655|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
1652540|NCT01648101|5775653|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
1652541|NCT01648101|5775654|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
1652542|NCT01648101|5775655|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
1652543|NCT01648101|5775653|P3|Transition Phase (4 Weeks)|Adverse Event|2
1652544|NCT01648101|5775654|P2|Transition Phase (4 Weeks)|Adverse Event|3
1652545|NCT01648101|5775655|P1|Transition Phase (4 Weeks)|Adverse Event|4
1652546|NCT01648101|5775653|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
1652547|NCT01648101|5775654|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
1652548|NCT01648101|5775655|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
1652549|NCT01648101|5775653|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1652550|NCT01648101|5775654|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
1652551|NCT01648101|5775655|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
1652552|NCT01648101|5775653|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1652553|NCT01648101|5775654|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
1652554|NCT01648101|5775655|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
1652555|NCT01648101|5775653|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
1652556|NCT01648101|5775654|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1652557|NCT01648101|5775655|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
1652558|NCT01648101|5775653|P3|Titration Phase (4 Weeks)|Adverse Event|3
1652559|NCT01648101|5775654|P2|Titration Phase (4 Weeks)|Adverse Event|2
1652560|NCT01648101|5775655|P1|Titration Phase (4 Weeks)|Adverse Event|0
1652561|NCT01648101|5775653|P3|Titration Phase (4 Weeks)|Protocol Violation|2
1652562|NCT01648101|5775654|P2|Titration Phase (4 Weeks)|Protocol Violation|1
1652563|NCT01648101|5775655|P1|Titration Phase (4 Weeks)|Protocol Violation|2
1652564|NCT01647711|5775742|P5|Overall Study|Other reason not defined|0
1652565|NCT01647711|5775743|P4|Overall Study|Other reason not defined|1
1652566|NCT01647711|5775744|P3|Overall Study|Other reason not defined|1
1652567|NCT01647711|5775745|P2|Overall Study|Other reason not defined|1
1652568|NCT01647711|5775746|P1|Overall Study|Other reason not defined|0
1652569|NCT01647711|5775742|P5|Overall Study|Refused to continue taking medication|1
1652570|NCT01647711|5775743|P4|Overall Study|Refused to continue taking medication|2
1652571|NCT01647711|5775744|P3|Overall Study|Refused to continue taking medication|0
1652572|NCT01647711|5775745|P2|Overall Study|Refused to continue taking medication|0
1652573|NCT01647711|5775746|P1|Overall Study|Refused to continue taking medication|0
1652574|NCT01647711|5775742|P5|Overall Study|Protocol Violation|1
1652575|NCT01647711|5775743|P4|Overall Study|Protocol Violation|0
1652576|NCT01647711|5775744|P3|Overall Study|Protocol Violation|0
1652577|NCT01647711|5775745|P2|Overall Study|Protocol Violation|0
1652578|NCT01647711|5775746|P1|Overall Study|Protocol Violation|0
1652579|NCT01647711|5775742|P5|Overall Study|Other adverse event|2
1652580|NCT01647711|5775743|P4|Overall Study|Other adverse event|0
1652581|NCT01647711|5775744|P3|Overall Study|Other adverse event|2
1652582|NCT01647711|5775745|P2|Overall Study|Other adverse event|0
1652583|NCT01647711|5775746|P1|Overall Study|Other adverse event|0
1652584|NCT01647711|5775742|P5|Overall Study|Progressive disease|2
1652585|NCT01647711|5775743|P4|Overall Study|Progressive disease|8
1652586|NCT01647711|5775744|P3|Overall Study|Progressive disease|6
1652587|NCT01647711|5775745|P2|Overall Study|Progressive disease|2
1652588|NCT01647711|5775746|P1|Overall Study|Progressive disease|6
1652589|NCT01647542|5775783|P3|Overall Study|Death|1
1652590|NCT01647542|5775784|P2|Overall Study|Death|0
1652591|NCT01647542|5775785|P1|Overall Study|Death|0
1652592|NCT01647542|5775783|P3|Overall Study|Lack of Efficacy|0
1652593|NCT01647542|5775784|P2|Overall Study|Lack of Efficacy|1
1652594|NCT01647542|5775785|P1|Overall Study|Lack of Efficacy|1
1652595|NCT01647542|5775783|P3|Overall Study|Study Termination|65
1652596|NCT01647542|5775784|P2|Overall Study|Study Termination|61
1652597|NCT01647542|5775785|P1|Overall Study|Study Termination|64
1652598|NCT01647542|5775783|P3|Overall Study|Withdrawal by Subject|0
1652599|NCT01647542|5775784|P2|Overall Study|Withdrawal by Subject|4
1652600|NCT01647542|5775785|P1|Overall Study|Withdrawal by Subject|6
1652601|NCT01647542|5775783|P3|Overall Study|Lost to Follow-up|2
1652602|NCT01647542|5775784|P2|Overall Study|Lost to Follow-up|2
1652603|NCT01647542|5775785|P1|Overall Study|Lost to Follow-up|0
1652604|NCT01647542|5775783|P3|Overall Study|Adverse Event|4
1652605|NCT01647542|5775784|P2|Overall Study|Adverse Event|5
1652606|NCT01647542|5775785|P1|Overall Study|Adverse Event|4
1652607|NCT01647542|5775783|P3|Overall Study|Major Protocol Deviation|0
1652608|NCT01647542|5775784|P2|Overall Study|Major Protocol Deviation|0
1652609|NCT01647542|5775785|P1|Overall Study|Major Protocol Deviation|1
1652610|NCT01647282|5775819|P2|Overall Study|Physician Decision|5
1652611|NCT01647282|5775820|P1|Overall Study|Physician Decision|7
1652612|NCT01646827|5775841|P2|Overall Study|Withdrawal by Subject|0
1652613|NCT01646827|5775842|P1|Overall Study|Withdrawal by Subject|1
1652614|NCT01646827|5775841|P2|Overall Study|Physician Decision|2
1652615|NCT01646827|5775842|P1|Overall Study|Physician Decision|1
1652616|NCT01646827|5775841|P2|Overall Study|Lost to Follow-up|3
1652617|NCT01646827|5775842|P1|Overall Study|Lost to Follow-up|0
1652618|NCT01646398|5775929|P2|Overall Study|Withdrawal by Subject|0
1652619|NCT01646398|5775930|P1|Overall Study|Withdrawal by Subject|1
1652620|NCT01646385|5775946|P2|Overall Study|Switched to alternate biologic|649
1652621|NCT01646385|5775947|P1|Overall Study|Switched to alternate biologic|636
1652622|NCT01646385|5775946|P2|Overall Study|Death|222
1652623|NCT01646385|5775947|P1|Overall Study|Death|202
1652624|NCT01646320|5775990|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
1652625|NCT01646320|5775991|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
1652626|NCT01646320|5775990|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
1652627|NCT01646320|5775991|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
1652628|NCT01646320|5775990|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
1652629|NCT01646320|5775991|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
1652630|NCT01646320|5775990|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
1652631|NCT01646320|5775991|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
1652632|NCT01646320|5775990|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
1652633|NCT01646320|5775991|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
1652634|NCT01646320|5775990|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
1652635|NCT01646320|5775991|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
1652636|NCT01646320|5775990|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1652637|NCT01646320|5775991|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1652638|NCT01646320|5775990|P2|Short-term Period (Day 1 to Week 24)|Other|0
1652639|NCT01646320|5775991|P1|Short-term Period (Day 1 to Week 24)|Other|1
1652640|NCT01646320|5775990|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
1652641|NCT01646320|5775991|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
1652642|NCT01646320|5775990|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
1652643|NCT01646320|5775991|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
1652644|NCT01646320|5775990|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
1652645|NCT01646320|5775991|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
1652646|NCT01646268|5776007|P2|Overall Study|Other|0
1652647|NCT01646268|5776008|P1|Overall Study|Other|2
1652648|NCT01646268|5776007|P2|Overall Study|Withdrawal by Subject|5
1652649|NCT01646268|5776008|P1|Overall Study|Withdrawal by Subject|2
1652650|NCT01646268|5776007|P2|Overall Study|Protocol Violation|1
1652651|NCT01646268|5776008|P1|Overall Study|Protocol Violation|0
1652652|NCT01646268|5776007|P2|Overall Study|Lack of Efficacy|3
1652653|NCT01646268|5776008|P1|Overall Study|Lack of Efficacy|1
1652654|NCT01646268|5776007|P2|Overall Study|Adverse Event|7
1652655|NCT01646268|5776008|P1|Overall Study|Adverse Event|6
1652656|NCT01646255|5776022|P2|Overall Study|Inclusion Criteria Deviation|0
1652657|NCT01646255|5776023|P1|Overall Study|Inclusion Criteria Deviation|1
1652658|NCT01646255|5776022|P2|Overall Study|Compliance is not well|0
1652659|NCT01646255|5776023|P1|Overall Study|Compliance is not well|1
1652660|NCT01646255|5776022|P2|Overall Study|Withdrawal by Subject|6
1652661|NCT01646255|5776023|P1|Overall Study|Withdrawal by Subject|10
1652662|NCT01646255|5776022|P2|Overall Study|Lack of Efficacy|0
1652663|NCT01646255|5776023|P1|Overall Study|Lack of Efficacy|2
1652664|NCT01646255|5776022|P2|Overall Study|Adverse Event|8
1652665|NCT01646255|5776023|P1|Overall Study|Adverse Event|7
1652666|NCT01646216|5776055|P2|Overall Study|Investigator decision|1
1652667|NCT01646216|5776056|P1|Overall Study|Investigator decision|1
1652668|NCT01646216|5776055|P2|Overall Study|Did not complete training|2
1652669|NCT01646216|5776056|P1|Overall Study|Did not complete training|0
1652670|NCT01646216|5776055|P2|Overall Study|Baseline step length difference (<5cm)|10
1652671|NCT01646216|5776056|P1|Overall Study|Baseline step length difference (<5cm)|10
1652672|NCT01646203|5776078|P3|Overall Study|Physician's Decision|0
1652673|NCT01646203|5776079|P2|Overall Study|Physician's Decision|1
1652674|NCT01646203|5776080|P1|Overall Study|Physician's Decision|0
1652675|NCT01646203|5776078|P3|Overall Study|Withdrawal by Subject|0
1652676|NCT01646203|5776079|P2|Overall Study|Withdrawal by Subject|1
1652677|NCT01646203|5776080|P1|Overall Study|Withdrawal by Subject|0
1652678|NCT01646203|5776078|P3|Overall Study|Adverse Event|1
1652679|NCT01646203|5776079|P2|Overall Study|Adverse Event|0
1652680|NCT01646203|5776080|P1|Overall Study|Adverse Event|2
1652681|NCT01646177|5776109|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
1652682|NCT01646177|5776110|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1652683|NCT01646177|5776111|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
1652684|NCT01646177|5776112|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
1652685|NCT01646177|5776109|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
1652686|NCT01646177|5776110|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
1652687|NCT01646177|5776111|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1652688|NCT01646177|5776112|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
1652689|NCT01646177|5776109|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1652690|NCT01646177|5776110|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1652691|NCT01646177|5776111|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
1652692|NCT01646177|5776112|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
1652693|NCT01646177|5776109|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1652694|NCT01646177|5776110|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
1652695|NCT01646177|5776111|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
1652696|NCT01646177|5776112|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
1652697|NCT01646177|5776109|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
1652698|NCT01646177|5776110|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
1652699|NCT01646177|5776111|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
1652700|NCT01646177|5776112|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
1652701|NCT01646177|5776109|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
1652702|NCT01646177|5776110|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
1652703|NCT01646177|5776111|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
1652704|NCT01646177|5776112|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
1652705|NCT01646138|5776206|P5|Overall Study|Lost to Follow-up|2
1652706|NCT01646138|5776207|P4|Overall Study|Lost to Follow-up|0
1652707|NCT01646138|5776208|P3|Overall Study|Lost to Follow-up|0
1652708|NCT01646138|5776209|P2|Overall Study|Lost to Follow-up|0
1652709|NCT01646138|5776210|P1|Overall Study|Lost to Follow-up|0
1652710|NCT01646125|5776224|P2|Overall Study|Subject/Guardian decision|1
1652711|NCT01646125|5776225|P1|Overall Study|Subject/Guardian decision|1
1652712|NCT01646125|5776224|P2|Overall Study|Study terminated by sponsor|1
1652713|NCT01646125|5776225|P1|Overall Study|Study terminated by sponsor|2
1652714|NCT01646125|5776224|P2|Overall Study|Progressive disease|16
1652715|NCT01646125|5776225|P1|Overall Study|Progressive disease|22
1652716|NCT01646125|5776224|P2|Overall Study|Physician Decision|3
1652717|NCT01646125|5776225|P1|Overall Study|Physician Decision|1
1652718|NCT01646125|5776224|P2|Overall Study|Death|1
1652719|NCT01646125|5776225|P1|Overall Study|Death|1
1652720|NCT01646125|5776224|P2|Overall Study|Adverse Event|1
1652721|NCT01646125|5776225|P1|Overall Study|Adverse Event|2
1652722|NCT01646125|5776224|P2|Overall Study|Untreated|5
1652723|NCT01646125|5776225|P1|Overall Study|Untreated|2
1652724|NCT01646073|5776250|P2|Period B (12 Weeks)|Lost to Follow-up|1
1652725|NCT01646073|5776251|P1|Period B (12 Weeks)|Lost to Follow-up|0
1652726|NCT01646073|5776250|P2|Period B (12 Weeks)|Withdrawal by Subject|5
1652727|NCT01646073|5776251|P1|Period B (12 Weeks)|Withdrawal by Subject|1
1652728|NCT01646073|5776250|P2|Period B (12 Weeks)|Adverse Event|7
1652729|NCT01646073|5776251|P1|Period B (12 Weeks)|Adverse Event|0
1652730|NCT01646073|5776250|P2|Period A (12 Weeks)|Other|1
1652731|NCT01646073|5776251|P1|Period A (12 Weeks)|Other|0
1652732|NCT01646073|5776250|P2|Period A (12 Weeks)|Protocol Violation|1
1652733|NCT01646073|5776251|P1|Period A (12 Weeks)|Protocol Violation|0
1652734|NCT01646073|5776250|P2|Period A (12 Weeks)|Lack of Efficacy|0
1652735|NCT01646073|5776251|P1|Period A (12 Weeks)|Lack of Efficacy|1
1652736|NCT01646073|5776250|P2|Period A (12 Weeks)|Withdrawal by Subject|1
1652737|NCT01646073|5776251|P1|Period A (12 Weeks)|Withdrawal by Subject|1
1652738|NCT01646073|5776250|P2|Period A (12 Weeks)|Adverse Event|2
1652739|NCT01646073|5776251|P1|Period A (12 Weeks)|Adverse Event|0
1652740|NCT01646021|5776292|P2|Overall Study|Withdrawal by Subject|15
1652741|NCT01646021|5776293|P1|Overall Study|Withdrawal by Subject|10
1652742|NCT01646021|5776292|P2|Overall Study|Lost to Follow-up|2
1652743|NCT01646021|5776293|P1|Overall Study|Lost to Follow-up|2
1652744|NCT01646021|5776292|P2|Overall Study|Study Terminated by Sponsor|41
1652745|NCT01646021|5776293|P1|Overall Study|Study Terminated by Sponsor|50
1652746|NCT01646021|5776292|P2|Overall Study|Death|83
1652747|NCT01646021|5776293|P1|Overall Study|Death|77
1652748|NCT01645930|5776330|P1|Overall Study|Reason not Defined|1
1652749|NCT01645930|5776330|P1|Overall Study|Withdrawal by Participant|2
1652750|NCT01645930|5776330|P1|Overall Study|Unsatisfactory Therapeutic Response|2
1652751|NCT01645930|5776330|P1|Overall Study|Adverse Event|4
1652752|NCT01645930|5776330|P1|Overall Study|Progressive Disease|12
1652753|NCT01645930|5776330|P1|Overall Study|Participants Ongoing on Study Treatment|22
1652754|NCT01645735|5776347|P2|Overall Study|Adverse Event|1
1652755|NCT01645735|5776348|P1|Overall Study|Adverse Event|0
1652756|NCT01645735|5776347|P2|Overall Study|Protocol Violation|0
1652757|NCT01645735|5776348|P1|Overall Study|Protocol Violation|1
1652758|NCT01645735|5776347|P2|Overall Study|Withdrawal by Subject|0
1652759|NCT01645735|5776348|P1|Overall Study|Withdrawal by Subject|1
1652760|NCT01645735|5776347|P2|Overall Study|Physician Decision|0
1652761|NCT01645735|5776348|P1|Overall Study|Physician Decision|2
1652762|NCT01645280|5776390|P5|Overall Study|Treatment not completed/Completed f/u|2
1652763|NCT01645280|5776391|P4|Overall Study|Treatment not completed/Completed f/u|0
1652764|NCT01645280|5776392|P3|Overall Study|Treatment not completed/Completed f/u|2
1652765|NCT01645280|5776393|P2|Overall Study|Treatment not completed/Completed f/u|1
1652766|NCT01645280|5776394|P1|Overall Study|Treatment not completed/Completed f/u|1
1652767|NCT01645280|5776390|P5|Overall Study|Other|0
1652768|NCT01645280|5776391|P4|Overall Study|Other|0
1652769|NCT01645280|5776392|P3|Overall Study|Other|2
1652770|NCT01645280|5776393|P2|Overall Study|Other|1
1652771|NCT01645280|5776394|P1|Overall Study|Other|1
1652772|NCT01645280|5776390|P5|Overall Study|Lost to Follow-up|1
1652773|NCT01645280|5776391|P4|Overall Study|Lost to Follow-up|2
1652774|NCT01645280|5776392|P3|Overall Study|Lost to Follow-up|0
1652775|NCT01645280|5776393|P2|Overall Study|Lost to Follow-up|0
1652776|NCT01645280|5776394|P1|Overall Study|Lost to Follow-up|0
1652777|NCT01645280|5776390|P5|Overall Study|Withdrawal by Subject|5
1652778|NCT01645280|5776391|P4|Overall Study|Withdrawal by Subject|4
1652779|NCT01645280|5776392|P3|Overall Study|Withdrawal by Subject|2
1652780|NCT01645280|5776393|P2|Overall Study|Withdrawal by Subject|0
1652781|NCT01645280|5776394|P1|Overall Study|Withdrawal by Subject|4
1652782|NCT01645280|5776390|P5|Overall Study|Death|0
1652783|NCT01645280|5776391|P4|Overall Study|Death|0
1652784|NCT01645280|5776392|P3|Overall Study|Death|0
1652785|NCT01645280|5776393|P2|Overall Study|Death|1
1652786|NCT01645280|5776394|P1|Overall Study|Death|0
1652787|NCT01645176|5776422|P1|Overall Study|did not complete final MRI|1
1652788|NCT01645176|5776422|P1|Overall Study|Lack of Efficacy|4
1652789|NCT01645111|5776426|P1|Overall Study|Did not require Clevidipine|15
1652790|NCT01644890|5776467|P2|Overall Study|Other|9
1652791|NCT01644890|5776468|P1|Overall Study|Other|8
1652792|NCT01644890|5776467|P2|Overall Study|> 28 days since last dose of study drug|3
1652793|NCT01644890|5776468|P1|Overall Study|> 28 days since last dose of study drug|6
1652794|NCT01644890|5776467|P2|Overall Study|Clinical Progression|6
1652795|NCT01644890|5776468|P1|Overall Study|Clinical Progression|6
1652796|NCT01644890|5776467|P2|Overall Study|Progression Disease|131
1652797|NCT01644890|5776468|P1|Overall Study|Progression Disease|160
1652798|NCT01644890|5776467|P2|Overall Study|Withdrawal by Subject|27
1652799|NCT01644890|5776468|P1|Overall Study|Withdrawal by Subject|19
1652800|NCT01644890|5776467|P2|Overall Study|Protocol Violation|7
1652801|NCT01644890|5776468|P1|Overall Study|Protocol Violation|6
1652802|NCT01644890|5776467|P2|Overall Study|Physician Decision|9
1652803|NCT01644890|5776468|P1|Overall Study|Physician Decision|3
1652804|NCT01644890|5776467|P2|Overall Study|Death|3
1652805|NCT01644890|5776468|P1|Overall Study|Death|1
1652806|NCT01644890|5776467|P2|Overall Study|Adverse Event|20
1652807|NCT01644890|5776468|P1|Overall Study|Adverse Event|7
1652808|NCT01644734|5776478|P1|Overall Study|Missing documentation|238
1652809|NCT01644734|5776478|P1|Overall Study|Reasons other than stated above|7
1652810|NCT01644734|5776478|P1|Overall Study|Lost to Follow-up|17
1652811|NCT01644734|5776478|P1|Overall Study|Adverse Event|4
1652812|NCT01644643|5776492|P4|Overall Study|Other Eligibility criteria|2
1652813|NCT01644643|5776493|P3|Overall Study|Other Eligibility criteria|0
1652814|NCT01644643|5776494|P2|Overall Study|Other Eligibility criteria|0
1652815|NCT01644643|5776495|P1|Overall Study|Other Eligibility criteria|0
1652816|NCT01644643|5776492|P4|Overall Study|Withdrawal by Subject|1
1652817|NCT01644643|5776493|P3|Overall Study|Withdrawal by Subject|2
1652818|NCT01644643|5776494|P2|Overall Study|Withdrawal by Subject|0
1652819|NCT01644643|5776495|P1|Overall Study|Withdrawal by Subject|1
1652820|NCT01644643|5776492|P4|Overall Study|Lost to Follow-up|4
1652821|NCT01644643|5776493|P3|Overall Study|Lost to Follow-up|0
1652822|NCT01644643|5776494|P2|Overall Study|Lost to Follow-up|0
1652823|NCT01644643|5776495|P1|Overall Study|Lost to Follow-up|0
1652824|NCT01644643|5776492|P4|Overall Study|Death|3
1652825|NCT01644643|5776493|P3|Overall Study|Death|3
1652826|NCT01644643|5776494|P2|Overall Study|Death|0
1652827|NCT01644643|5776495|P1|Overall Study|Death|1
1652828|NCT01644617|5776660|P3|Overall Study|Adverse Event|6
1652829|NCT01644617|5776661|P2|Overall Study|Adverse Event|0
1652830|NCT01644617|5776662|P1|Overall Study|Adverse Event|3
1652831|NCT01644617|5776660|P3|Overall Study|Lost to Follow-up|0
1652832|NCT01644617|5776661|P2|Overall Study|Lost to Follow-up|1
1652833|NCT01644617|5776662|P1|Overall Study|Lost to Follow-up|0
1652834|NCT01644617|5776660|P3|Overall Study|Withdrawal by Subject|1
1652835|NCT01644617|5776661|P2|Overall Study|Withdrawal by Subject|4
1652836|NCT01644617|5776662|P1|Overall Study|Withdrawal by Subject|3
1652837|NCT01644565|5776712|P9|Overall Study|Relocation|1
1652838|NCT01644565|5776713|P8|Overall Study|Relocation|0
1652839|NCT01644565|5776714|P7|Overall Study|Relocation|0
1652840|NCT01644565|5776715|P6|Overall Study|Relocation|0
1652841|NCT01644565|5776716|P5|Overall Study|Relocation|0
1652842|NCT01644565|5776717|P4|Overall Study|Relocation|0
1652843|NCT01644565|5776718|P3|Overall Study|Relocation|0
1652844|NCT01644565|5776719|P2|Overall Study|Relocation|0
1652845|NCT01644565|5776720|P1|Overall Study|Relocation|0
1652846|NCT01644565|5776712|P9|Overall Study|Family emergency|0
1652847|NCT01644565|5776713|P8|Overall Study|Family emergency|0
1652848|NCT01644565|5776714|P7|Overall Study|Family emergency|0
1652849|NCT01644565|5776715|P6|Overall Study|Family emergency|0
1652850|NCT01644565|5776716|P5|Overall Study|Family emergency|1
1652851|NCT01644565|5776717|P4|Overall Study|Family emergency|0
1652852|NCT01644565|5776718|P3|Overall Study|Family emergency|0
1652853|NCT01644565|5776719|P2|Overall Study|Family emergency|0
1652854|NCT01644565|5776720|P1|Overall Study|Family emergency|0
1652855|NCT01644565|5776712|P9|Overall Study|Lost to Follow-up|0
1652856|NCT01644565|5776713|P8|Overall Study|Lost to Follow-up|2
1652857|NCT01644565|5776714|P7|Overall Study|Lost to Follow-up|0
1652858|NCT01644565|5776715|P6|Overall Study|Lost to Follow-up|0
1652859|NCT01644565|5776716|P5|Overall Study|Lost to Follow-up|0
1652860|NCT01644565|5776717|P4|Overall Study|Lost to Follow-up|1
1652861|NCT01644565|5776718|P3|Overall Study|Lost to Follow-up|0
1652862|NCT01644565|5776719|P2|Overall Study|Lost to Follow-up|0
1652863|NCT01644565|5776720|P1|Overall Study|Lost to Follow-up|0
1652864|NCT01644565|5776712|P9|Overall Study|Undisclosed Medical History|0
1652865|NCT01644565|5776713|P8|Overall Study|Undisclosed Medical History|0
1652866|NCT01644565|5776714|P7|Overall Study|Undisclosed Medical History|0
1652867|NCT01644565|5776715|P6|Overall Study|Undisclosed Medical History|0
1652868|NCT01644565|5776716|P5|Overall Study|Undisclosed Medical History|0
1652869|NCT01644565|5776717|P4|Overall Study|Undisclosed Medical History|0
1652870|NCT01644565|5776718|P3|Overall Study|Undisclosed Medical History|0
1652871|NCT01644565|5776719|P2|Overall Study|Undisclosed Medical History|0
1652872|NCT01644565|5776720|P1|Overall Study|Undisclosed Medical History|1
1652873|NCT01644500|5776761|P3|Overall Study|Physician Decision|1
1652874|NCT01644500|5776762|P2|Overall Study|Physician Decision|1
1652875|NCT01644500|5776763|P1|Overall Study|Physician Decision|1
1652876|NCT01644500|5776761|P3|Overall Study|Withdrawal by Subject|12
1652877|NCT01644500|5776762|P2|Overall Study|Withdrawal by Subject|12
1652878|NCT01644500|5776763|P1|Overall Study|Withdrawal by Subject|11
1652879|NCT01644500|5776761|P3|Overall Study|Protocol Violation|0
1652880|NCT01644500|5776762|P2|Overall Study|Protocol Violation|1
1652881|NCT01644500|5776763|P1|Overall Study|Protocol Violation|1
1652882|NCT01644500|5776761|P3|Overall Study|Lost to Follow-up|0
1652883|NCT01644500|5776762|P2|Overall Study|Lost to Follow-up|8
1652884|NCT01644500|5776763|P1|Overall Study|Lost to Follow-up|3
1652885|NCT01644500|5776761|P3|Overall Study|Death|0
1652886|NCT01644500|5776762|P2|Overall Study|Death|1
1652887|NCT01644500|5776763|P1|Overall Study|Death|0
1652888|NCT01644500|5776761|P3|Overall Study|Adverse Event|2
1652889|NCT01644500|5776762|P2|Overall Study|Adverse Event|1
1652890|NCT01644500|5776763|P1|Overall Study|Adverse Event|6
1652891|NCT01644474|5776833|P2|Overall Study|Protocol Violation|0
1652892|NCT01644474|5776834|P1|Overall Study|Protocol Violation|1
1652893|NCT01644474|5776833|P2|Overall Study|Site scheduling error|1
1652894|NCT01644474|5776834|P1|Overall Study|Site scheduling error|1
1652895|NCT01644474|5776833|P2|Overall Study|Adverse Event|5
1652896|NCT01644474|5776834|P1|Overall Study|Adverse Event|4
1652897|NCT01644474|5776833|P2|Overall Study|Participant moved|1
1652898|NCT01644474|5776834|P1|Overall Study|Participant moved|0
1652899|NCT01644474|5776833|P2|Overall Study|Consent withdrawn by participant|1
1652900|NCT01644474|5776834|P1|Overall Study|Consent withdrawn by participant|0
1652901|NCT01644474|5776833|P2|Overall Study|Poor compliance to protocol|0
1652902|NCT01644474|5776834|P1|Overall Study|Poor compliance to protocol|1
1652903|NCT01644188|5777018|P2|Overall Study|Other than specified above|7
1652904|NCT01644188|5777019|P1|Overall Study|Other than specified above|6
1652905|NCT01644188|5777018|P2|Overall Study|Site closure|1
1652906|NCT01644188|5777019|P1|Overall Study|Site closure|1
1652907|NCT01644188|5777018|P2|Overall Study|Last visit outside protocol visit window|16
1652908|NCT01644188|5777019|P1|Overall Study|Last visit outside protocol visit window|14
1652909|NCT01644188|5777018|P2|Overall Study|Death|3
1652910|NCT01644188|5777019|P1|Overall Study|Death|4
1652911|NCT01644188|5777018|P2|Overall Study|Lost to Follow-up|0
1652912|NCT01644188|5777019|P1|Overall Study|Lost to Follow-up|1
1652913|NCT01644188|5777018|P2|Overall Study|Selection criteria finally not met|0
1652914|NCT01644188|5777019|P1|Overall Study|Selection criteria finally not met|2
1652915|NCT01644188|5777018|P2|Overall Study|Consent withdrawn by participant|7
1652916|NCT01644188|5777019|P1|Overall Study|Consent withdrawn by participant|14
1652917|NCT01644188|5777018|P2|Overall Study|Related to auto-injector administration|2
1652918|NCT01644188|5777019|P1|Overall Study|Related to auto-injector administration|2
1652919|NCT01644188|5777018|P2|Overall Study|Participant moved|2
1652920|NCT01644188|5777019|P1|Overall Study|Participant moved|7
1652921|NCT01644188|5777018|P2|Overall Study|Physician Decision|3
1652922|NCT01644188|5777019|P1|Overall Study|Physician Decision|1
1652923|NCT01644188|5777018|P2|Overall Study|Poor compliance to protocol|14
1652924|NCT01644188|5777019|P1|Overall Study|Poor compliance to protocol|26
1652925|NCT01644188|5777018|P2|Overall Study|Adverse Event|20
1652926|NCT01644188|5777019|P1|Overall Study|Adverse Event|44
1652927|NCT01644175|5777077|P2|Overall Study|Other than specified above|3
1652928|NCT01644175|5777078|P1|Overall Study|Other than specified above|0
1652929|NCT01644175|5777077|P2|Overall Study|Lost to Follow-up|0
1652930|NCT01644175|5777078|P1|Overall Study|Lost to Follow-up|1
1652931|NCT01644175|5777077|P2|Overall Study|Site closure|2
1652932|NCT01644175|5777078|P1|Overall Study|Site closure|2
1652933|NCT01644175|5777077|P2|Overall Study|Selection criteria finally not met|1
1652934|NCT01644175|5777078|P1|Overall Study|Selection criteria finally not met|0
1652935|NCT01644175|5777077|P2|Overall Study|Last visit outside protocol visit window|11
1652936|NCT01644175|5777078|P1|Overall Study|Last visit outside protocol visit window|4
1652937|NCT01644175|5777077|P2|Overall Study|Related to Autoinjector Administration|1
1652938|NCT01644175|5777078|P1|Overall Study|Related to Autoinjector Administration|2
1652939|NCT01644175|5777077|P2|Overall Study|Consent withdrawn by participant|4
1652940|NCT01644175|5777078|P1|Overall Study|Consent withdrawn by participant|3
1652941|NCT01644175|5777077|P2|Overall Study|Participant Moved|2
1652942|NCT01644175|5777078|P1|Overall Study|Participant Moved|1
1652943|NCT01644175|5777077|P2|Overall Study|Physician Decision|2
1652944|NCT01644175|5777078|P1|Overall Study|Physician Decision|1
1652945|NCT01644175|5777077|P2|Overall Study|Poor compliance to protocol|10
1652946|NCT01644175|5777078|P1|Overall Study|Poor compliance to protocol|9
1652947|NCT01644175|5777077|P2|Overall Study|Death|2
1652948|NCT01644175|5777078|P1|Overall Study|Death|1
1652949|NCT01644175|5777077|P2|Overall Study|Adverse Event|13
1652950|NCT01644175|5777078|P1|Overall Study|Adverse Event|8
1652951|NCT01644175|5777077|P2|Overall Study|Randomized But Not Treated|2
1652952|NCT01644175|5777078|P1|Overall Study|Randomized But Not Treated|0
1652953|NCT01644149|5777130|P2|Overall Study|Lost to Follow-up|1
1652954|NCT01644149|5777131|P1|Overall Study|Lost to Follow-up|3
1652955|NCT01644149|5777130|P2|Overall Study|Withdrawal by Subject|0
1652956|NCT01644149|5777131|P1|Overall Study|Withdrawal by Subject|1
1652957|NCT01643928|5777151|P5|Overall Study|Adverse Event|2
1652958|NCT01643928|5777152|P4|Overall Study|Adverse Event|1
1652959|NCT01643928|5777153|P3|Overall Study|Adverse Event|0
1652960|NCT01643928|5777154|P2|Overall Study|Adverse Event|1
1652961|NCT01643928|5777155|P1|Overall Study|Adverse Event|2
1652962|NCT01643928|5777151|P5|Overall Study|Other|0
1652963|NCT01643928|5777152|P4|Overall Study|Other|0
1652964|NCT01643928|5777153|P3|Overall Study|Other|1
1652965|NCT01643928|5777154|P2|Overall Study|Other|1
1652966|NCT01643928|5777155|P1|Overall Study|Other|5
1652967|NCT01643928|5777151|P5|Overall Study|Pregnancy|0
1652968|NCT01643928|5777152|P4|Overall Study|Pregnancy|1
1652969|NCT01643928|5777153|P3|Overall Study|Pregnancy|0
1652970|NCT01643928|5777154|P2|Overall Study|Pregnancy|0
1652971|NCT01643928|5777155|P1|Overall Study|Pregnancy|0
1652972|NCT01643928|5777151|P5|Overall Study|Withdrawal by Subject|0
1652973|NCT01643928|5777152|P4|Overall Study|Withdrawal by Subject|1
1652974|NCT01643928|5777153|P3|Overall Study|Withdrawal by Subject|0
1652975|NCT01643928|5777154|P2|Overall Study|Withdrawal by Subject|0
1652976|NCT01643928|5777155|P1|Overall Study|Withdrawal by Subject|2
1652977|NCT01643928|5777151|P5|Overall Study|Lost to Follow-up|0
1652978|NCT01643928|5777152|P4|Overall Study|Lost to Follow-up|0
1652979|NCT01643928|5777153|P3|Overall Study|Lost to Follow-up|2
1652980|NCT01643928|5777154|P2|Overall Study|Lost to Follow-up|0
1652981|NCT01643928|5777155|P1|Overall Study|Lost to Follow-up|1
1652982|NCT01643798|5777450|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
1652983|NCT01643798|5777451|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
1652984|NCT01643772|5777466|P4|Overall Study|Adverse Event|1
1652985|NCT01643772|5777467|P3|Overall Study|Adverse Event|0
1652986|NCT01643772|5777468|P2|Overall Study|Adverse Event|0
1652987|NCT01643772|5777469|P1|Overall Study|Adverse Event|0
1652988|NCT01643772|5777466|P4|Overall Study|Protocol Violation|1
1652989|NCT01643772|5777467|P3|Overall Study|Protocol Violation|0
1652990|NCT01643772|5777468|P2|Overall Study|Protocol Violation|0
1652991|NCT01643772|5777469|P1|Overall Study|Protocol Violation|0
1652992|NCT01643668|5777509|P1|Overall Study|Death|1
1652993|NCT01643473|5777540|P2|Overall Study|Lost to Follow-up|0
1652994|NCT01643473|5777541|P1|Overall Study|Lost to Follow-up|1
1652995|NCT01643044|5777564|P2|Overall Study|Delivered outside of hospital|2
1652996|NCT01643044|5777565|P1|Overall Study|Delivered outside of hospital|1
1652997|NCT01643044|5777564|P2|Overall Study|Miscarried baby|2
1652998|NCT01643044|5777565|P1|Overall Study|Miscarried baby|2
1652999|NCT01643044|5777564|P2|Overall Study|Lost to Follow-up|1
1653000|NCT01643044|5777565|P1|Overall Study|Lost to Follow-up|1
1653001|NCT01642914|5777574|P3|Overall Study|Other Reason|0
1653002|NCT01642914|5777575|P2|Overall Study|Other Reason|0
1653003|NCT01642914|5777576|P1|Overall Study|Other Reason|1
1653004|NCT01642914|5777574|P3|Overall Study|Lost to Follow-up|7
1653005|NCT01642914|5777575|P2|Overall Study|Lost to Follow-up|3
1653006|NCT01642914|5777576|P1|Overall Study|Lost to Follow-up|5
1653007|NCT01642914|5777574|P3|Overall Study|Withdrawal by Subject|10
1653008|NCT01642914|5777575|P2|Overall Study|Withdrawal by Subject|5
1653009|NCT01642914|5777576|P1|Overall Study|Withdrawal by Subject|5
1653010|NCT01642914|5777574|P3|Overall Study|Protocol Violation|6
1653011|NCT01642914|5777575|P2|Overall Study|Protocol Violation|13
1653012|NCT01642914|5777576|P1|Overall Study|Protocol Violation|15
1653013|NCT01642914|5777574|P3|Overall Study|Lack of Efficacy|2
1653014|NCT01642914|5777575|P2|Overall Study|Lack of Efficacy|4
1653015|NCT01642914|5777576|P1|Overall Study|Lack of Efficacy|9
1653016|NCT01642914|5777574|P3|Overall Study|Adverse Event|15
1653017|NCT01642914|5777575|P2|Overall Study|Adverse Event|7
1653018|NCT01642914|5777576|P1|Overall Study|Adverse Event|11
1653019|NCT01642732|5777651|P1|Overall Study|Withdrawal by Subject|1
1653020|NCT01642615|5777656|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
1653021|NCT01642615|5777657|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1653022|NCT01642615|5777658|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
1653023|NCT01642615|5777656|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1653024|NCT01642615|5777657|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
1653025|NCT01642615|5777658|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
1653026|NCT01642615|5777656|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
1653027|NCT01642615|5777657|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
1653028|NCT01642615|5777658|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
1653029|NCT01642615|5777656|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
1653030|NCT01642615|5777657|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
1653031|NCT01642615|5777658|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
1653032|NCT01642615|5777656|P3|Open Label Maintenance Phase|Did not receive treatment|0
1653033|NCT01642615|5777657|P2|Open Label Maintenance Phase|Did not receive treatment|0
1653034|NCT01642615|5777658|P1|Open Label Maintenance Phase|Did not receive treatment|1
1653035|NCT01642615|5777656|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
1653036|NCT01642615|5777657|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
1653037|NCT01642615|5777658|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
1653038|NCT01642615|5777656|P3|Open Label Maintenance Phase|Lost to Follow-up|0
1653039|NCT01642615|5777657|P2|Open Label Maintenance Phase|Lost to Follow-up|0
1653040|NCT01642615|5777658|P1|Open Label Maintenance Phase|Lost to Follow-up|1
1653041|NCT01642615|5777656|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
1653042|NCT01642615|5777657|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
1653043|NCT01642615|5777658|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
1653044|NCT01642615|5777656|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1653045|NCT01642615|5777657|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
1653046|NCT01642615|5777658|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
1653047|NCT01642602|5777672|P1|Overall Study|Adverse Event|2
1653048|NCT01642589|5777679|P2|Overall Study|Withdrawal by Subject|1
1653049|NCT01642589|5777680|P1|Overall Study|Withdrawal by Subject|1
1653050|NCT01642407|5777719|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
1653051|NCT01642407|5777719|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
1653052|NCT01642407|5777719|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
1653053|NCT01642277|5777766|P2|Overall Study|Withdrawal by Subject|0
1653054|NCT01642277|5777767|P1|Overall Study|Withdrawal by Subject|11
1653055|NCT01642277|5777766|P2|Overall Study|Protocol Violation|0
1653056|NCT01642277|5777767|P1|Overall Study|Protocol Violation|1
1653057|NCT01642277|5777766|P2|Overall Study|Physician Decision|0
1653058|NCT01642277|5777767|P1|Overall Study|Physician Decision|2
1653059|NCT01642277|5777766|P2|Overall Study|Adverse Event|0
1653060|NCT01642277|5777767|P1|Overall Study|Adverse Event|10
1653061|NCT01642251|5777779|P4|Overall Study|Ineligible/never start protocol therapy|8
1653062|NCT01642251|5777780|P3|Overall Study|Ineligible/never start protocol therapy|11
1653063|NCT01642251|5777781|P2|Overall Study|Ineligible/never start protocol therapy|0
1653064|NCT01642251|5777782|P1|Overall Study|Ineligible/never start protocol therapy|0
1653065|NCT01642251|5777779|P4|Overall Study|Other complicating disease|0
1653066|NCT01642251|5777780|P3|Overall Study|Other complicating disease|1
1653067|NCT01642251|5777781|P2|Overall Study|Other complicating disease|0
1653068|NCT01642251|5777782|P1|Overall Study|Other complicating disease|0
1653069|NCT01642251|5777779|P4|Overall Study|Alternative therapy|2
1653070|NCT01642251|5777780|P3|Overall Study|Alternative therapy|0
1653071|NCT01642251|5777781|P2|Overall Study|Alternative therapy|0
1653072|NCT01642251|5777782|P1|Overall Study|Alternative therapy|0
1653073|NCT01642251|5777779|P4|Overall Study|Withdrawal by Subject|3
1653074|NCT01642251|5777780|P3|Overall Study|Withdrawal by Subject|1
1653075|NCT01642251|5777781|P2|Overall Study|Withdrawal by Subject|0
1653076|NCT01642251|5777782|P1|Overall Study|Withdrawal by Subject|0
1653077|NCT01642251|5777779|P4|Overall Study|Death|3
1653078|NCT01642251|5777780|P3|Overall Study|Death|1
1653079|NCT01642251|5777781|P2|Overall Study|Death|0
1653080|NCT01642251|5777782|P1|Overall Study|Death|0
1653081|NCT01642251|5777779|P4|Overall Study|Adverse Event|4
1653082|NCT01642251|5777780|P3|Overall Study|Adverse Event|5
1653083|NCT01642251|5777781|P2|Overall Study|Adverse Event|0
1653084|NCT01642251|5777782|P1|Overall Study|Adverse Event|0
1653085|NCT01642251|5777779|P4|Overall Study|Progressive disease|3
1653086|NCT01642251|5777780|P3|Overall Study|Progressive disease|3
1653087|NCT01642251|5777781|P2|Overall Study|Progressive disease|0
1653088|NCT01642251|5777782|P1|Overall Study|Progressive disease|0
1653089|NCT01642212|5777820|P5|Open-label Extension|Other|1
1653090|NCT01642212|5777821|P4|Open-label Extension|Other|0
1653091|NCT01642212|5777822|P3|Open-label Extension|Other|0
1653092|NCT01642212|5777823|P2|Open-label Extension|Other|0
1653093|NCT01642212|5777824|P1|Open-label Extension|Other|0
1653094|NCT01642212|5777820|P5|Open-label Extension|Lost to Follow-up|1
1653095|NCT01642212|5777821|P4|Open-label Extension|Lost to Follow-up|0
1653096|NCT01642212|5777822|P3|Open-label Extension|Lost to Follow-up|0
1653097|NCT01642212|5777823|P2|Open-label Extension|Lost to Follow-up|0
1653098|NCT01642212|5777824|P1|Open-label Extension|Lost to Follow-up|0
1653099|NCT01642212|5777820|P5|Open-label Extension|Consent Withdrawn|2
1653100|NCT01642212|5777821|P4|Open-label Extension|Consent Withdrawn|0
1653101|NCT01642212|5777822|P3|Open-label Extension|Consent Withdrawn|0
1653102|NCT01642212|5777823|P2|Open-label Extension|Consent Withdrawn|0
1653103|NCT01642212|5777824|P1|Open-label Extension|Consent Withdrawn|0
1653104|NCT01642212|5777820|P5|Open-label Extension|Sponsor Decision|4
1653105|NCT01642212|5777821|P4|Open-label Extension|Sponsor Decision|7
1653106|NCT01642212|5777822|P3|Open-label Extension|Sponsor Decision|0
1653107|NCT01642212|5777823|P2|Open-label Extension|Sponsor Decision|0
1653108|NCT01642212|5777824|P1|Open-label Extension|Sponsor Decision|0
1653109|NCT01642212|5777820|P5|Open-label Extension|Adverse Event|0
1653110|NCT01642212|5777821|P4|Open-label Extension|Adverse Event|3
1653111|NCT01642212|5777822|P3|Open-label Extension|Adverse Event|0
1653112|NCT01642212|5777823|P2|Open-label Extension|Adverse Event|0
1653113|NCT01642212|5777824|P1|Open-label Extension|Adverse Event|0
1653114|NCT01642212|5777820|P5|Double-blind Treatment|Adverse Event|0
1653115|NCT01642212|5777821|P4|Double-blind Treatment|Adverse Event|0
1653116|NCT01642212|5777822|P3|Double-blind Treatment|Adverse Event|1
1653117|NCT01642212|5777823|P2|Double-blind Treatment|Adverse Event|0
1653118|NCT01642212|5777824|P1|Double-blind Treatment|Adverse Event|0
1653119|NCT01642212|5777820|P5|Double-blind Treatment|Non-compliance|0
1653120|NCT01642212|5777821|P4|Double-blind Treatment|Non-compliance|0
1653121|NCT01642212|5777822|P3|Double-blind Treatment|Non-compliance|0
1653122|NCT01642212|5777823|P2|Double-blind Treatment|Non-compliance|1
1653123|NCT01642212|5777824|P1|Double-blind Treatment|Non-compliance|0
1653124|NCT01642212|5777820|P5|Double-blind Treatment|Other|0
1653125|NCT01642212|5777821|P4|Double-blind Treatment|Other|0
1653126|NCT01642212|5777822|P3|Double-blind Treatment|Other|1
1653127|NCT01642212|5777823|P2|Double-blind Treatment|Other|2
1653128|NCT01642212|5777824|P1|Double-blind Treatment|Other|0
1653129|NCT01642212|5777820|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1653130|NCT01642212|5777821|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1653131|NCT01642212|5777822|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1653132|NCT01642212|5777823|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
1653133|NCT01642212|5777824|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
1653134|NCT01642004|5777919|P2|Treatment|Missing from data|1
1653135|NCT01642004|5777920|P1|Treatment|Missing from data|0
1653136|NCT01642004|5777919|P2|Treatment|Other|2
1653137|NCT01642004|5777920|P1|Treatment|Other|1
1653138|NCT01642004|5777919|P2|Treatment|No longer meets study criteria|2
1653139|NCT01642004|5777920|P1|Treatment|No longer meets study criteria|1
1653140|NCT01642004|5777919|P2|Treatment|Poor/non-compliance|0
1653141|NCT01642004|5777920|P1|Treatment|Poor/non-compliance|1
1653142|NCT01642004|5777919|P2|Treatment|Maximum clinical benefit|7
1653143|NCT01642004|5777920|P1|Treatment|Maximum clinical benefit|2
1653144|NCT01642004|5777919|P2|Treatment|Withdrawal by Subject|9
1653145|NCT01642004|5777920|P1|Treatment|Withdrawal by Subject|5
1653146|NCT01642004|5777919|P2|Treatment|Adverse event unrelated to study drug|13
1653147|NCT01642004|5777920|P1|Treatment|Adverse event unrelated to study drug|6
1653148|NCT01642004|5777919|P2|Treatment|Death|0
1653149|NCT01642004|5777920|P1|Treatment|Death|1
1653150|NCT01642004|5777919|P2|Treatment|Study drug toxicity|13
1653151|NCT01642004|5777920|P1|Treatment|Study drug toxicity|5
1653152|NCT01642004|5777919|P2|Treatment|Disease progression|80
1653153|NCT01642004|5777920|P1|Treatment|Disease progression|88
1653154|NCT01642004|5777919|P2|Randomization|No longer meets study criteria|2
1653155|NCT01642004|5777920|P1|Randomization|No longer meets study criteria|2
1653156|NCT01642004|5777919|P2|Randomization|Withdrawal by Subject|6
1653157|NCT01642004|5777920|P1|Randomization|Withdrawal by Subject|1
1653158|NCT01642004|5777919|P2|Randomization|Adverse Event unrelated to study drug|0
1653159|NCT01642004|5777920|P1|Randomization|Adverse Event unrelated to study drug|1
1653160|NCT01641991|5777954|P4|Overall Study|no longer eligible|4
1653161|NCT01641991|5777955|P3|Overall Study|no longer eligible|0
1653162|NCT01641991|5777956|P2|Overall Study|no longer eligible|1
1653163|NCT01641991|5777957|P1|Overall Study|no longer eligible|2
1653164|NCT01641991|5777954|P4|Overall Study|Pregnancy|0
1653165|NCT01641991|5777955|P3|Overall Study|Pregnancy|1
1653166|NCT01641991|5777956|P2|Overall Study|Pregnancy|0
1653167|NCT01641991|5777957|P1|Overall Study|Pregnancy|0
1653168|NCT01641991|5777954|P4|Overall Study|Protocol Violation|0
1653169|NCT01641991|5777955|P3|Overall Study|Protocol Violation|3
1653170|NCT01641991|5777956|P2|Overall Study|Protocol Violation|1
1653171|NCT01641991|5777957|P1|Overall Study|Protocol Violation|1
1653172|NCT01641991|5777954|P4|Overall Study|Lost to Follow-up|1
1653173|NCT01641991|5777955|P3|Overall Study|Lost to Follow-up|3
1653174|NCT01641991|5777956|P2|Overall Study|Lost to Follow-up|2
1653175|NCT01641991|5777957|P1|Overall Study|Lost to Follow-up|0
1653176|NCT01641991|5777954|P4|Overall Study|Adverse Event|1
1653177|NCT01641991|5777955|P3|Overall Study|Adverse Event|2
1653178|NCT01641991|5777956|P2|Overall Study|Adverse Event|1
1653179|NCT01641991|5777957|P1|Overall Study|Adverse Event|2
1653180|NCT01641991|5777954|P4|Overall Study|Withdrawal by Subject|5
1653181|NCT01641991|5777955|P3|Overall Study|Withdrawal by Subject|1
1653182|NCT01641991|5777956|P2|Overall Study|Withdrawal by Subject|2
1653183|NCT01641991|5777957|P1|Overall Study|Withdrawal by Subject|4
1653184|NCT01641991|5777954|P4|Overall Study|Physician Decision|5
1653185|NCT01641991|5777955|P3|Overall Study|Physician Decision|7
1653186|NCT01641991|5777956|P2|Overall Study|Physician Decision|1
1653187|NCT01641991|5777957|P1|Overall Study|Physician Decision|0
1653188|NCT01641952|5778041|P1|Overall Study|Adverse Event|6
1653189|NCT01641952|5778041|P1|Overall Study|Lost to Follow-up|28
1653190|NCT01641939|5778057|P3|Overall Study|Study Terminated by Sponsor|3
1653191|NCT01641939|5778058|P2|Overall Study|Study Terminated by Sponsor|28
1653192|NCT01641939|5778059|P1|Overall Study|Study Terminated by Sponsor|10
1653193|NCT01641939|5778057|P3|Overall Study|Withdrawal by Subject|5
1653194|NCT01641939|5778058|P2|Overall Study|Withdrawal by Subject|11
1653195|NCT01641939|5778059|P1|Overall Study|Withdrawal by Subject|14
1653196|NCT01641939|5778057|P3|Overall Study|Lost to Follow-up|1
1653197|NCT01641939|5778058|P2|Overall Study|Lost to Follow-up|2
1653198|NCT01641939|5778059|P1|Overall Study|Lost to Follow-up|3
1653199|NCT01641939|5778057|P3|Overall Study|Death|61
1653200|NCT01641939|5778058|P2|Overall Study|Death|187
1653201|NCT01641939|5778059|P1|Overall Study|Death|90
1653202|NCT01641926|5778102|P4|Overall Study|Not Treated|0
1653203|NCT01641926|5778103|P3|Overall Study|Not Treated|1
1653204|NCT01641926|5778104|P2|Overall Study|Not Treated|1
1653205|NCT01641926|5778105|P1|Overall Study|Not Treated|1
1653206|NCT01641926|5778102|P4|Overall Study|Withdrawal by Subject|1
1653207|NCT01641926|5778103|P3|Overall Study|Withdrawal by Subject|6
1653208|NCT01641926|5778104|P2|Overall Study|Withdrawal by Subject|5
1653209|NCT01641926|5778105|P1|Overall Study|Withdrawal by Subject|13
1653210|NCT01641926|5778102|P4|Overall Study|Protocol Violation|1
1653211|NCT01641926|5778103|P3|Overall Study|Protocol Violation|0
1653212|NCT01641926|5778104|P2|Overall Study|Protocol Violation|0
1653213|NCT01641926|5778105|P1|Overall Study|Protocol Violation|1
1653214|NCT01641926|5778102|P4|Overall Study|Physician Decision|1
1653215|NCT01641926|5778103|P3|Overall Study|Physician Decision|0
1653216|NCT01641926|5778104|P2|Overall Study|Physician Decision|5
1653217|NCT01641926|5778105|P1|Overall Study|Physician Decision|6
1653218|NCT01641926|5778102|P4|Overall Study|Lost to Follow-up|0
1653219|NCT01641926|5778103|P3|Overall Study|Lost to Follow-up|1
1653220|NCT01641926|5778104|P2|Overall Study|Lost to Follow-up|2
1653221|NCT01641926|5778105|P1|Overall Study|Lost to Follow-up|2
1653222|NCT01641926|5778102|P4|Overall Study|Adverse Event|1
1653223|NCT01641926|5778103|P3|Overall Study|Adverse Event|3
1653224|NCT01641926|5778104|P2|Overall Study|Adverse Event|2
1653225|NCT01641926|5778105|P1|Overall Study|Adverse Event|5
1653226|NCT01641900|5778133|P2|Overall Study|Withdrawal by Subject|2
1653227|NCT01641900|5778134|P1|Overall Study|Withdrawal by Subject|2
1653228|NCT01641861|5778146|P2|Overall Study|Died due to drowning|1
1653229|NCT01641861|5778147|P1|Overall Study|Died due to drowning|0
1653230|NCT01641861|5778146|P2|Overall Study|Lost the tooth due to normal exfoliation|8
1653231|NCT01641861|5778147|P1|Overall Study|Lost the tooth due to normal exfoliation|14
1653232|NCT01641861|5778146|P2|Overall Study|Lost to Follow-up|16
1653233|NCT01641861|5778147|P1|Overall Study|Lost to Follow-up|21
1653234|NCT01641822|5778168|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
1653235|NCT01641822|5778169|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
1653236|NCT01641822|5778170|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
1653237|NCT01641822|5778168|P3|Comparative Phase|Withdrew consent|7
1653238|NCT01641822|5778169|P2|Comparative Phase|Withdrew consent|3
1653239|NCT01641822|5778170|P1|Comparative Phase|Withdrew consent|0
1653240|NCT01641822|5778168|P3|Comparative Phase|Adverse event, serious fatal|0
1653241|NCT01641822|5778169|P2|Comparative Phase|Adverse event, serious fatal|1
1653242|NCT01641822|5778170|P1|Comparative Phase|Adverse event, serious fatal|0
1653243|NCT01641822|5778168|P3|Comparative Phase|Pregnancy|1
1653244|NCT01641822|5778169|P2|Comparative Phase|Pregnancy|0
1653245|NCT01641822|5778170|P1|Comparative Phase|Pregnancy|0
1653246|NCT01641822|5778168|P3|Comparative Phase|Investigator's discretion|1
1653247|NCT01641822|5778169|P2|Comparative Phase|Investigator's discretion|0
1653248|NCT01641822|5778170|P1|Comparative Phase|Investigator's discretion|0
1653249|NCT01641822|5778168|P3|Comparative Phase|Noncompliance with study drug|0
1653250|NCT01641822|5778169|P2|Comparative Phase|Noncompliance with study drug|1
1653251|NCT01641822|5778170|P1|Comparative Phase|Noncompliance with study drug|0
1653252|NCT01641822|5778168|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
1653253|NCT01641822|5778169|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
1653254|NCT01641822|5778170|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
1653255|NCT01641822|5778168|P3|Run-in Phase|Withdrew consent|0
1653256|NCT01641822|5778169|P2|Run-in Phase|Withdrew consent|0
1653257|NCT01641822|5778170|P1|Run-in Phase|Withdrew consent|1
1653258|NCT01641822|5778168|P3|Run-in Phase|Adverse Event|0
1653259|NCT01641822|5778169|P2|Run-in Phase|Adverse Event|0
1653260|NCT01641822|5778170|P1|Run-in Phase|Adverse Event|3
1653261|NCT01641822|5778168|P3|Run-in Phase|Noncompliance with study drug|0
1653262|NCT01641822|5778169|P2|Run-in Phase|Noncompliance with study drug|0
1653263|NCT01641822|5778170|P1|Run-in Phase|Noncompliance with study drug|1
1653264|NCT01641809|5778191|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
1653265|NCT01641809|5778192|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
1653266|NCT01641809|5778193|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
1653267|NCT01641809|5778194|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
1653268|NCT01641809|5778191|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
1653269|NCT01641809|5778192|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
1653270|NCT01641809|5778193|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
1653271|NCT01641809|5778194|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
1653272|NCT01641809|5778191|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
1653273|NCT01641809|5778192|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
1653274|NCT01641809|5778193|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
1653275|NCT01641809|5778194|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
1653276|NCT01641809|5778191|P4|Open-label (Week 96 to Week 324)|Site closed|0
1653277|NCT01641809|5778192|P3|Open-label (Week 96 to Week 324)|Site closed|0
1653278|NCT01641809|5778193|P2|Open-label (Week 96 to Week 324)|Site closed|0
1653279|NCT01641809|5778194|P1|Open-label (Week 96 to Week 324)|Site closed|1
1653280|NCT01641809|5778191|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
1653281|NCT01641809|5778192|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
1653282|NCT01641809|5778193|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
1653283|NCT01641809|5778194|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
1653284|NCT01641809|5778191|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
1653285|NCT01641809|5778192|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
1653286|NCT01641809|5778193|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
1653287|NCT01641809|5778194|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
1653288|NCT01641809|5778191|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
1653289|NCT01641809|5778192|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
1653290|NCT01641809|5778193|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
1653291|NCT01641809|5778194|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
1653292|NCT01641809|5778191|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
1653293|NCT01641809|5778192|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
1653294|NCT01641809|5778193|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
1653295|NCT01641809|5778194|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
1653296|NCT01641809|5778191|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
1653297|NCT01641809|5778192|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
1653298|NCT01641809|5778193|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
1653299|NCT01641809|5778194|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
1653300|NCT01641809|5778191|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
1653301|NCT01641809|5778192|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
1653302|NCT01641809|5778193|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
1653303|NCT01641809|5778194|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
1653304|NCT01641809|5778191|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
1653305|NCT01641809|5778192|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
1653306|NCT01641809|5778193|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
1653307|NCT01641809|5778194|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
1653308|NCT01641809|5778191|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
1653309|NCT01641809|5778192|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
1653310|NCT01641809|5778193|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
1653311|NCT01641809|5778194|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
1653312|NCT01641809|5778191|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
1653313|NCT01641809|5778192|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
1653314|NCT01641809|5778193|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
1653315|NCT01641809|5778194|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
1653316|NCT01641809|5778191|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
1653317|NCT01641809|5778192|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
1653318|NCT01641809|5778193|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
1653319|NCT01641809|5778194|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
1653320|NCT01641809|5778191|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
1653321|NCT01641809|5778192|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
1653322|NCT01641809|5778193|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
1653323|NCT01641809|5778194|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
1653324|NCT01641809|5778191|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
1653325|NCT01641809|5778192|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
1653326|NCT01641809|5778193|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
1653327|NCT01641809|5778194|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
1653328|NCT01641809|5778191|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
1653329|NCT01641809|5778192|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
1653330|NCT01641809|5778193|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
1653331|NCT01641809|5778194|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
1653332|NCT01641809|5778191|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
1653333|NCT01641809|5778192|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
1653334|NCT01641809|5778193|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
1653335|NCT01641809|5778194|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
1653336|NCT01641692|5778378|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1653337|NCT01641692|5778379|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1653338|NCT01641692|5778380|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1653339|NCT01641692|5778381|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1653340|NCT01641692|5778382|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1653341|NCT01641692|5778383|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1653342|NCT01641692|5778384|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
1653343|NCT01641692|5778385|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
1653344|NCT01641692|5778378|P8|Washout Period 3 or Follow-up|Protocol Violation|0
1653345|NCT01641692|5778379|P7|Washout Period 3 or Follow-up|Protocol Violation|0
1653346|NCT01641692|5778380|P6|Washout Period 3 or Follow-up|Protocol Violation|1
1653347|NCT01641692|5778381|P5|Washout Period 3 or Follow-up|Protocol Violation|0
1653348|NCT01641692|5778382|P4|Washout Period 3 or Follow-up|Protocol Violation|0
1653349|NCT01641692|5778383|P3|Washout Period 3 or Follow-up|Protocol Violation|0
1653350|NCT01641692|5778384|P2|Washout Period 3 or Follow-up|Protocol Violation|0
1653351|NCT01641692|5778385|P1|Washout Period 3 or Follow-up|Protocol Violation|0
1653352|NCT01641692|5778378|P8|Treatment Period 3|Lost to Follow-up|0
1653353|NCT01641692|5778379|P7|Treatment Period 3|Lost to Follow-up|0
1653354|NCT01641692|5778380|P6|Treatment Period 3|Lost to Follow-up|0
1653355|NCT01641692|5778381|P5|Treatment Period 3|Lost to Follow-up|0
1653356|NCT01641692|5778382|P4|Treatment Period 3|Lost to Follow-up|0
1653357|NCT01641692|5778383|P3|Treatment Period 3|Lost to Follow-up|0
1653358|NCT01641692|5778384|P2|Treatment Period 3|Lost to Follow-up|1
1653359|NCT01641692|5778385|P1|Treatment Period 3|Lost to Follow-up|0
1653360|NCT01641692|5778378|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
1653361|NCT01641692|5778379|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
1653362|NCT01641692|5778380|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
1653363|NCT01641692|5778381|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
1653364|NCT01641692|5778382|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
1653365|NCT01641692|5778383|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
1653366|NCT01641692|5778384|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
1653367|NCT01641692|5778385|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
1653368|NCT01641692|5778378|P8|Treatment Period 3|Protocol Violation|0
1653369|NCT01641692|5778379|P7|Treatment Period 3|Protocol Violation|0
1653370|NCT01641692|5778380|P6|Treatment Period 3|Protocol Violation|0
1653371|NCT01641692|5778381|P5|Treatment Period 3|Protocol Violation|0
1653372|NCT01641692|5778382|P4|Treatment Period 3|Protocol Violation|0
1653373|NCT01641692|5778383|P3|Treatment Period 3|Protocol Violation|1
1653374|NCT01641692|5778384|P2|Treatment Period 3|Protocol Violation|0
1653375|NCT01641692|5778385|P1|Treatment Period 3|Protocol Violation|0
1653376|NCT01641692|5778378|P8|Treatment Period 3|Adverse Event|0
1653377|NCT01641692|5778379|P7|Treatment Period 3|Adverse Event|1
1653378|NCT01641692|5778380|P6|Treatment Period 3|Adverse Event|0
1653379|NCT01641692|5778381|P5|Treatment Period 3|Adverse Event|0
1653380|NCT01641692|5778382|P4|Treatment Period 3|Adverse Event|0
1653381|NCT01641692|5778383|P3|Treatment Period 3|Adverse Event|0
1653382|NCT01641692|5778384|P2|Treatment Period 3|Adverse Event|0
1653383|NCT01641692|5778385|P1|Treatment Period 3|Adverse Event|0
1653384|NCT01641692|5778378|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1653385|NCT01641692|5778379|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1653386|NCT01641692|5778380|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1653387|NCT01641692|5778381|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1653388|NCT01641692|5778382|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1653389|NCT01641692|5778383|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1653390|NCT01641692|5778384|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1653391|NCT01641692|5778385|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1653392|NCT01641692|5778378|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653393|NCT01641692|5778379|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
1653394|NCT01641692|5778380|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653395|NCT01641692|5778381|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
1653396|NCT01641692|5778382|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653397|NCT01641692|5778383|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653398|NCT01641692|5778384|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653399|NCT01641692|5778385|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653400|NCT01641692|5778378|P8|Treatment Period 2|Withdrawal by Subject|1
1653401|NCT01641692|5778379|P7|Treatment Period 2|Withdrawal by Subject|0
1653402|NCT01641692|5778380|P6|Treatment Period 2|Withdrawal by Subject|1
1653403|NCT01641692|5778381|P5|Treatment Period 2|Withdrawal by Subject|0
1653404|NCT01641692|5778382|P4|Treatment Period 2|Withdrawal by Subject|0
1653405|NCT01641692|5778383|P3|Treatment Period 2|Withdrawal by Subject|0
1653406|NCT01641692|5778384|P2|Treatment Period 2|Withdrawal by Subject|0
1653407|NCT01641692|5778385|P1|Treatment Period 2|Withdrawal by Subject|1
1653408|NCT01641692|5778378|P8|Treatment Period 2|Lost to Follow-up|0
1653409|NCT01641692|5778379|P7|Treatment Period 2|Lost to Follow-up|0
1653410|NCT01641692|5778380|P6|Treatment Period 2|Lost to Follow-up|1
1653411|NCT01641692|5778381|P5|Treatment Period 2|Lost to Follow-up|0
1653412|NCT01641692|5778382|P4|Treatment Period 2|Lost to Follow-up|0
1653413|NCT01641692|5778383|P3|Treatment Period 2|Lost to Follow-up|0
1653414|NCT01641692|5778384|P2|Treatment Period 2|Lost to Follow-up|0
1653415|NCT01641692|5778385|P1|Treatment Period 2|Lost to Follow-up|0
1653416|NCT01641692|5778378|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
1653417|NCT01641692|5778379|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
1653418|NCT01641692|5778380|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
1653419|NCT01641692|5778381|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
1653420|NCT01641692|5778382|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
1653421|NCT01641692|5778383|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
1653422|NCT01641692|5778384|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
1653423|NCT01641692|5778385|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
1653424|NCT01641692|5778378|P8|Treatment Period 2|Lack of Efficacy|0
1653425|NCT01641692|5778379|P7|Treatment Period 2|Lack of Efficacy|0
1653426|NCT01641692|5778380|P6|Treatment Period 2|Lack of Efficacy|0
1653427|NCT01641692|5778381|P5|Treatment Period 2|Lack of Efficacy|0
1653428|NCT01641692|5778382|P4|Treatment Period 2|Lack of Efficacy|0
1653429|NCT01641692|5778383|P3|Treatment Period 2|Lack of Efficacy|0
1653430|NCT01641692|5778384|P2|Treatment Period 2|Lack of Efficacy|0
1653431|NCT01641692|5778385|P1|Treatment Period 2|Lack of Efficacy|1
1653432|NCT01641692|5778378|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1653433|NCT01641692|5778379|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1653434|NCT01641692|5778380|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1653435|NCT01641692|5778381|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1653436|NCT01641692|5778382|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1653437|NCT01641692|5778383|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1653438|NCT01641692|5778384|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1653439|NCT01641692|5778385|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1653440|NCT01641692|5778378|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1653441|NCT01641692|5778379|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653442|NCT01641692|5778380|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653443|NCT01641692|5778381|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1653444|NCT01641692|5778382|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1653445|NCT01641692|5778383|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
1653446|NCT01641692|5778384|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
1653447|NCT01641692|5778385|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
1653448|NCT01641692|5778378|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
1653449|NCT01641692|5778379|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
1653450|NCT01641692|5778380|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
1653451|NCT01641692|5778381|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
1653452|NCT01641692|5778382|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
1653453|NCT01641692|5778383|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
1653454|NCT01641692|5778384|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
1653455|NCT01641692|5778385|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
1653456|NCT01641692|5778378|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
1653457|NCT01641692|5778379|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
1653458|NCT01641692|5778380|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
1653459|NCT01641692|5778381|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
1653460|NCT01641692|5778382|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
1653461|NCT01641692|5778383|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
1653462|NCT01641692|5778384|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
1653463|NCT01641692|5778385|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
1653464|NCT01641692|5778378|P8|Treatment Period 1|Withdrawal by Subject|1
1653465|NCT01641692|5778379|P7|Treatment Period 1|Withdrawal by Subject|0
1653466|NCT01641692|5778380|P6|Treatment Period 1|Withdrawal by Subject|2
1653467|NCT01641692|5778381|P5|Treatment Period 1|Withdrawal by Subject|0
1653468|NCT01641692|5778382|P4|Treatment Period 1|Withdrawal by Subject|0
1653469|NCT01641692|5778383|P3|Treatment Period 1|Withdrawal by Subject|0
1653470|NCT01641692|5778384|P2|Treatment Period 1|Withdrawal by Subject|0
1653471|NCT01641692|5778385|P1|Treatment Period 1|Withdrawal by Subject|0
1653472|NCT01641692|5778378|P8|Treatment Period 1|Physician Decision|0
1653473|NCT01641692|5778379|P7|Treatment Period 1|Physician Decision|0
1653474|NCT01641692|5778380|P6|Treatment Period 1|Physician Decision|0
1653475|NCT01641692|5778381|P5|Treatment Period 1|Physician Decision|1
1653476|NCT01641692|5778382|P4|Treatment Period 1|Physician Decision|0
1653477|NCT01641692|5778383|P3|Treatment Period 1|Physician Decision|0
1653478|NCT01641692|5778384|P2|Treatment Period 1|Physician Decision|0
1653479|NCT01641692|5778385|P1|Treatment Period 1|Physician Decision|0
1653480|NCT01641692|5778378|P8|Treatment Period 1|Lost to Follow-up|0
1653481|NCT01641692|5778379|P7|Treatment Period 1|Lost to Follow-up|0
1653482|NCT01641692|5778380|P6|Treatment Period 1|Lost to Follow-up|0
1653483|NCT01641692|5778381|P5|Treatment Period 1|Lost to Follow-up|0
1653484|NCT01641692|5778382|P4|Treatment Period 1|Lost to Follow-up|0
1653485|NCT01641692|5778383|P3|Treatment Period 1|Lost to Follow-up|1
1653486|NCT01641692|5778384|P2|Treatment Period 1|Lost to Follow-up|0
1653487|NCT01641692|5778385|P1|Treatment Period 1|Lost to Follow-up|0
1653488|NCT01641692|5778378|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
1653489|NCT01641692|5778379|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
1653490|NCT01641692|5778380|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
1653491|NCT01641692|5778381|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
1653492|NCT01641692|5778382|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
1653493|NCT01641692|5778383|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
1653494|NCT01641692|5778384|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
1653495|NCT01641692|5778385|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
1653496|NCT01641692|5778378|P8|Treatment Period 1|Protocol Violation|0
1653497|NCT01641692|5778379|P7|Treatment Period 1|Protocol Violation|0
1653498|NCT01641692|5778380|P6|Treatment Period 1|Protocol Violation|0
1653499|NCT01641692|5778381|P5|Treatment Period 1|Protocol Violation|2
1653500|NCT01641692|5778382|P4|Treatment Period 1|Protocol Violation|0
1653501|NCT01641692|5778383|P3|Treatment Period 1|Protocol Violation|0
1653502|NCT01641692|5778384|P2|Treatment Period 1|Protocol Violation|0
1653503|NCT01641692|5778385|P1|Treatment Period 1|Protocol Violation|1
1653504|NCT01641692|5778378|P8|Treatment Period 1|Lack of Efficacy|1
1653505|NCT01641692|5778379|P7|Treatment Period 1|Lack of Efficacy|0
1653506|NCT01641692|5778380|P6|Treatment Period 1|Lack of Efficacy|0
1653507|NCT01641692|5778381|P5|Treatment Period 1|Lack of Efficacy|0
1653508|NCT01641692|5778382|P4|Treatment Period 1|Lack of Efficacy|0
1653509|NCT01641692|5778383|P3|Treatment Period 1|Lack of Efficacy|0
1653510|NCT01641692|5778384|P2|Treatment Period 1|Lack of Efficacy|0
1653511|NCT01641692|5778385|P1|Treatment Period 1|Lack of Efficacy|0
1653512|NCT01641692|5778378|P8|Treatment Period 1|Adverse Event|0
1653513|NCT01641692|5778379|P7|Treatment Period 1|Adverse Event|0
1653514|NCT01641692|5778380|P6|Treatment Period 1|Adverse Event|0
1653515|NCT01641692|5778381|P5|Treatment Period 1|Adverse Event|0
1653516|NCT01641692|5778382|P4|Treatment Period 1|Adverse Event|0
1653517|NCT01641692|5778383|P3|Treatment Period 1|Adverse Event|0
1653518|NCT01641692|5778384|P2|Treatment Period 1|Adverse Event|0
1653519|NCT01641692|5778385|P1|Treatment Period 1|Adverse Event|1
1653520|NCT01641640|5778585|P1|Overall Study|Adverse Event|1
1653521|NCT01641640|5778585|P1|Overall Study|Withdrawal by Subject|2
1653522|NCT01641640|5778585|P1|Overall Study|Lost to Follow-up|3
1653523|NCT01641640|5778585|P1|Overall Study|Efficacy failure|29
1653524|NCT01641640|5778585|P1|Overall Study|Enrolled but not treated|1
1653525|NCT01641471|5778596|P2|Overall Study|Protocol Violation|4
1653526|NCT01641471|5778597|P1|Overall Study|Protocol Violation|2
1653527|NCT01641471|5778596|P2|Overall Study|Lost to Follow-up|4
1653528|NCT01641471|5778597|P1|Overall Study|Lost to Follow-up|2
1653529|NCT01641471|5778596|P2|Overall Study|Withdrawal by Subject|19
1653530|NCT01641471|5778597|P1|Overall Study|Withdrawal by Subject|19
1653531|NCT01641367|5778629|P8|Randomized Adherence Intervention|Lost to Follow-up|12
1653532|NCT01641367|5778630|P7|Randomized Adherence Intervention|Lost to Follow-up|8
1653533|NCT01641367|5778631|P6|Randomized Adherence Intervention|Lost to Follow-up|0
1653534|NCT01641367|5778632|P5|Randomized Adherence Intervention|Lost to Follow-up|0
1653535|NCT01641367|5778633|P4|Randomized Adherence Intervention|Lost to Follow-up|0
1653536|NCT01641367|5778634|P3|Randomized Adherence Intervention|Lost to Follow-up|0
1653537|NCT01641367|5778635|P2|Randomized Adherence Intervention|Lost to Follow-up|0
1653538|NCT01641367|5778636|P1|Randomized Adherence Intervention|Lost to Follow-up|0
1653539|NCT01641367|5778629|P8|Randomized Adherence Intervention|Death|12
1653540|NCT01641367|5778630|P7|Randomized Adherence Intervention|Death|11
1653541|NCT01641367|5778631|P6|Randomized Adherence Intervention|Death|0
1653542|NCT01641367|5778632|P5|Randomized Adherence Intervention|Death|0
1653543|NCT01641367|5778633|P4|Randomized Adherence Intervention|Death|0
1653544|NCT01641367|5778634|P3|Randomized Adherence Intervention|Death|0
1653545|NCT01641367|5778635|P2|Randomized Adherence Intervention|Death|0
1653546|NCT01641367|5778636|P1|Randomized Adherence Intervention|Death|0
1653547|NCT01641367|5778629|P8|Cohorts|Lost to Follow-up|0
1653548|NCT01641367|5778630|P7|Cohorts|Lost to Follow-up|0
1653549|NCT01641367|5778631|P6|Cohorts|Lost to Follow-up|0
1653550|NCT01641367|5778632|P5|Cohorts|Lost to Follow-up|2
1653551|NCT01641367|5778633|P4|Cohorts|Lost to Follow-up|0
1653552|NCT01641367|5778634|P3|Cohorts|Lost to Follow-up|2
1653553|NCT01641367|5778635|P2|Cohorts|Lost to Follow-up|0
1653554|NCT01641367|5778636|P1|Cohorts|Lost to Follow-up|16
1653555|NCT01641367|5778629|P8|Cohorts|Death|0
1653556|NCT01641367|5778630|P7|Cohorts|Death|0
1653557|NCT01641367|5778631|P6|Cohorts|Death|1
1653558|NCT01641367|5778632|P5|Cohorts|Death|1
1653559|NCT01641367|5778633|P4|Cohorts|Death|0
1653560|NCT01641367|5778634|P3|Cohorts|Death|2
1653561|NCT01641367|5778635|P2|Cohorts|Death|1
1653562|NCT01641367|5778636|P1|Cohorts|Death|18
1653563|NCT01641237|5778887|P4|Period III|Lost to Follow-up|0
1653564|NCT01641237|5778888|P3|Period III|Lost to Follow-up|0
1653565|NCT01641237|5778889|P2|Period III|Lost to Follow-up|0
1653566|NCT01641237|5778890|P1|Period III|Lost to Follow-up|1
1653567|NCT01641237|5778887|P4|Period II|Withdrawal by Subject|0
1653568|NCT01641237|5778888|P3|Period II|Withdrawal by Subject|0
1653569|NCT01641237|5778889|P2|Period II|Withdrawal by Subject|0
1653570|NCT01641237|5778890|P1|Period II|Withdrawal by Subject|1
1653571|NCT01641198|5778915|P3|At 15-20 Years of Function|Death|1
1653572|NCT01641198|5778916|P2|At 15-20 Years of Function|Death|0
1653573|NCT01641198|5778917|P1|At 15-20 Years of Function|Death|1
1653574|NCT01641198|5778915|P3|At 15-20 Years of Function|Lost to Follow-up|1
1653575|NCT01641198|5778916|P2|At 15-20 Years of Function|Lost to Follow-up|1
1653576|NCT01641198|5778917|P1|At 15-20 Years of Function|Lost to Follow-up|5
1653577|NCT01641198|5778915|P3|After 24 Months of Function|Lost to Follow-up|6
1653578|NCT01641198|5778916|P2|After 24 Months of Function|Lost to Follow-up|9
1653579|NCT01641198|5778917|P1|After 24 Months of Function|Lost to Follow-up|4
1653580|NCT01641198|5778915|P3|After 12 Months of Function|Adverse Event|0
1653581|NCT01641198|5778916|P2|After 12 Months of Function|Adverse Event|1
1653582|NCT01641198|5778917|P1|After 12 Months of Function|Adverse Event|0
1653583|NCT01641198|5778915|P3|After 12 Months of Function|Protocol Violation|0
1653584|NCT01641198|5778916|P2|After 12 Months of Function|Protocol Violation|0
1653585|NCT01641198|5778917|P1|After 12 Months of Function|Protocol Violation|1
1653586|NCT01641198|5778915|P3|After 12 Months of Function|Lost to Follow-up|2
1653587|NCT01641198|5778916|P2|After 12 Months of Function|Lost to Follow-up|2
1653588|NCT01641198|5778917|P1|After 12 Months of Function|Lost to Follow-up|3
1653589|NCT01641159|5778933|P2|Overall Study|Withdrawal by Subject|1
1653590|NCT01641159|5778934|P1|Overall Study|Withdrawal by Subject|0
1653591|NCT01641159|5778933|P2|Overall Study|Lost to Follow-up|1
1653592|NCT01641159|5778934|P1|Overall Study|Lost to Follow-up|2
1653593|NCT01641133|5778945|P3|Overall Study|Lost to Follow-up|2
1653594|NCT01641133|5778946|P2|Overall Study|Lost to Follow-up|2
1653595|NCT01641133|5778947|P1|Overall Study|Lost to Follow-up|0
1653596|NCT01641133|5778945|P3|Overall Study|Withdrawal by Subject|3
1653597|NCT01641133|5778946|P2|Overall Study|Withdrawal by Subject|3
1653598|NCT01641133|5778947|P1|Overall Study|Withdrawal by Subject|5
1653599|NCT01641133|5778945|P3|Overall Study|Adverse Event|1
1653600|NCT01641133|5778946|P2|Overall Study|Adverse Event|0
1653601|NCT01641133|5778947|P1|Overall Study|Adverse Event|0
1653602|NCT01641133|5778945|P3|Overall Study|Migrated/moved from study area|1
1653603|NCT01641133|5778946|P2|Overall Study|Migrated/moved from study area|3
1653604|NCT01641133|5778947|P1|Overall Study|Migrated/moved from study area|5
1653605|NCT01641133|5778945|P3|Overall Study|Protocol Violation|1
1653606|NCT01641133|5778946|P2|Overall Study|Protocol Violation|1
1653607|NCT01641133|5778947|P1|Overall Study|Protocol Violation|0
1653608|NCT01641081|5779000|P10|Period 5|Adverse Event|0
1653609|NCT01641081|5779001|P9|Period 5|Adverse Event|0
1653610|NCT01641081|5779002|P8|Period 5|Adverse Event|0
1653611|NCT01641081|5779003|P7|Period 5|Adverse Event|0
1653612|NCT01641081|5779004|P6|Period 5|Adverse Event|0
1653613|NCT01641081|5779005|P5|Period 5|Adverse Event|0
1653614|NCT01641081|5779006|P4|Period 5|Adverse Event|0
1653615|NCT01641081|5779007|P3|Period 5|Adverse Event|2
1653616|NCT01641081|5779008|P2|Period 5|Adverse Event|0
1653617|NCT01641081|5779009|P1|Period 5|Adverse Event|0
1653618|NCT01641081|5779000|P10|Period 4|Adverse Event|0
1653619|NCT01641081|5779001|P9|Period 4|Adverse Event|0
1653620|NCT01641081|5779002|P8|Period 4|Adverse Event|0
1653621|NCT01641081|5779003|P7|Period 4|Adverse Event|0
1653622|NCT01641081|5779004|P6|Period 4|Adverse Event|0
1653623|NCT01641081|5779005|P5|Period 4|Adverse Event|0
1653624|NCT01641081|5779006|P4|Period 4|Adverse Event|1
1653625|NCT01641081|5779007|P3|Period 4|Adverse Event|0
1653626|NCT01641081|5779008|P2|Period 4|Adverse Event|1
1653627|NCT01641081|5779009|P1|Period 4|Adverse Event|0
1653628|NCT01641081|5779000|P10|Period 3|Withdrawal by Subject|0
1653629|NCT01641081|5779001|P9|Period 3|Withdrawal by Subject|1
1653630|NCT01641081|5779002|P8|Period 3|Withdrawal by Subject|0
1653631|NCT01641081|5779003|P7|Period 3|Withdrawal by Subject|0
1653632|NCT01641081|5779004|P6|Period 3|Withdrawal by Subject|0
1653633|NCT01641081|5779005|P5|Period 3|Withdrawal by Subject|0
1653634|NCT01641081|5779006|P4|Period 3|Withdrawal by Subject|0
1653635|NCT01641081|5779007|P3|Period 3|Withdrawal by Subject|0
1653636|NCT01641081|5779008|P2|Period 3|Withdrawal by Subject|0
1653637|NCT01641081|5779009|P1|Period 3|Withdrawal by Subject|0
1653638|NCT01641081|5779000|P10|Period 3|Adverse Event|0
1653639|NCT01641081|5779001|P9|Period 3|Adverse Event|0
1653640|NCT01641081|5779002|P8|Period 3|Adverse Event|0
1653641|NCT01641081|5779003|P7|Period 3|Adverse Event|0
1653642|NCT01641081|5779004|P6|Period 3|Adverse Event|0
1653643|NCT01641081|5779005|P5|Period 3|Adverse Event|0
1653644|NCT01641081|5779006|P4|Period 3|Adverse Event|0
1653645|NCT01641081|5779007|P3|Period 3|Adverse Event|1
1653646|NCT01641081|5779008|P2|Period 3|Adverse Event|0
1653647|NCT01641081|5779009|P1|Period 3|Adverse Event|0
1653648|NCT01641081|5779000|P10|Period 2|Protocol Violation|0
1653649|NCT01641081|5779001|P9|Period 2|Protocol Violation|0
1653650|NCT01641081|5779002|P8|Period 2|Protocol Violation|0
1653651|NCT01641081|5779003|P7|Period 2|Protocol Violation|0
1653652|NCT01641081|5779004|P6|Period 2|Protocol Violation|0
1653653|NCT01641081|5779005|P5|Period 2|Protocol Violation|0
1653654|NCT01641081|5779006|P4|Period 2|Protocol Violation|0
1653655|NCT01641081|5779007|P3|Period 2|Protocol Violation|0
1653656|NCT01641081|5779008|P2|Period 2|Protocol Violation|0
1653657|NCT01641081|5779009|P1|Period 2|Protocol Violation|1
1653658|NCT01641081|5779000|P10|Period 2|Withdrawal by Subject|0
1653659|NCT01641081|5779001|P9|Period 2|Withdrawal by Subject|0
1653660|NCT01641081|5779002|P8|Period 2|Withdrawal by Subject|0
1653661|NCT01641081|5779003|P7|Period 2|Withdrawal by Subject|2
1653662|NCT01641081|5779004|P6|Period 2|Withdrawal by Subject|0
1653663|NCT01641081|5779005|P5|Period 2|Withdrawal by Subject|0
1653664|NCT01641081|5779006|P4|Period 2|Withdrawal by Subject|1
1653665|NCT01641081|5779007|P3|Period 2|Withdrawal by Subject|0
1653666|NCT01641081|5779008|P2|Period 2|Withdrawal by Subject|0
1653667|NCT01641081|5779009|P1|Period 2|Withdrawal by Subject|0
1653668|NCT01641081|5779000|P10|Period 2|Adverse Event|0
1653669|NCT01641081|5779001|P9|Period 2|Adverse Event|0
1653670|NCT01641081|5779002|P8|Period 2|Adverse Event|0
1653671|NCT01641081|5779003|P7|Period 2|Adverse Event|0
1653672|NCT01641081|5779004|P6|Period 2|Adverse Event|1
1653673|NCT01641081|5779005|P5|Period 2|Adverse Event|0
1653674|NCT01641081|5779006|P4|Period 2|Adverse Event|0
1653675|NCT01641081|5779007|P3|Period 2|Adverse Event|0
1653676|NCT01641081|5779008|P2|Period 2|Adverse Event|0
1653677|NCT01641081|5779009|P1|Period 2|Adverse Event|0
1653678|NCT01641081|5779000|P10|Period 1|Adverse Event|0
1653679|NCT01641081|5779001|P9|Period 1|Adverse Event|0
1653680|NCT01641081|5779002|P8|Period 1|Adverse Event|2
1653681|NCT01641081|5779003|P7|Period 1|Adverse Event|0
1653682|NCT01641081|5779004|P6|Period 1|Adverse Event|0
1653683|NCT01641081|5779005|P5|Period 1|Adverse Event|0
1653684|NCT01641081|5779006|P4|Period 1|Adverse Event|0
1653685|NCT01641081|5779007|P3|Period 1|Adverse Event|0
1653686|NCT01641081|5779008|P2|Period 1|Adverse Event|0
1653687|NCT01641081|5779009|P1|Period 1|Adverse Event|1
1653688|NCT01641081|5779000|P10|Period 1|Protocol Violation|0
1653689|NCT01641081|5779001|P9|Period 1|Protocol Violation|0
1653690|NCT01641081|5779002|P8|Period 1|Protocol Violation|1
1653691|NCT01641081|5779003|P7|Period 1|Protocol Violation|0
1653692|NCT01641081|5779004|P6|Period 1|Protocol Violation|0
1653693|NCT01641081|5779005|P5|Period 1|Protocol Violation|1
1653694|NCT01641081|5779006|P4|Period 1|Protocol Violation|0
1653695|NCT01641081|5779007|P3|Period 1|Protocol Violation|0
1653696|NCT01641081|5779008|P2|Period 1|Protocol Violation|0
1653697|NCT01641081|5779009|P1|Period 1|Protocol Violation|0
1653698|NCT01641081|5779000|P10|Period 1|Sponsor request (potential unblinding)|0
1653699|NCT01641081|5779001|P9|Period 1|Sponsor request (potential unblinding)|0
1653700|NCT01641081|5779002|P8|Period 1|Sponsor request (potential unblinding)|0
1653701|NCT01641081|5779003|P7|Period 1|Sponsor request (potential unblinding)|1
1653702|NCT01641081|5779004|P6|Period 1|Sponsor request (potential unblinding)|0
1653703|NCT01641081|5779005|P5|Period 1|Sponsor request (potential unblinding)|0
1653704|NCT01641081|5779006|P4|Period 1|Sponsor request (potential unblinding)|0
1653705|NCT01641081|5779007|P3|Period 1|Sponsor request (potential unblinding)|0
1653706|NCT01641081|5779008|P2|Period 1|Sponsor request (potential unblinding)|0
1653707|NCT01641081|5779009|P1|Period 1|Sponsor request (potential unblinding)|0
1653708|NCT01640964|5779078|P3|Overall Study|Protocol Deviation|2
1653709|NCT01640964|5779079|P2|Overall Study|Protocol Deviation|1
1653710|NCT01640964|5779080|P1|Overall Study|Protocol Deviation|1
1653711|NCT01640964|5779078|P3|Overall Study|Lost to Follow-up|1
1653712|NCT01640964|5779079|P2|Overall Study|Lost to Follow-up|0
1653713|NCT01640964|5779080|P1|Overall Study|Lost to Follow-up|0
1653714|NCT01640951|5779103|P8|Overall Study|Death|2
1653715|NCT01640951|5779104|P7|Overall Study|Death|0
1653716|NCT01640951|5779105|P6|Overall Study|Death|0
1653717|NCT01640951|5779106|P5|Overall Study|Death|0
1653718|NCT01640951|5779107|P4|Overall Study|Death|0
1653719|NCT01640951|5779108|P3|Overall Study|Death|1
1653720|NCT01640951|5779109|P2|Overall Study|Death|1
1653721|NCT01640951|5779110|P1|Overall Study|Death|0
1653722|NCT01640951|5779103|P8|Overall Study|Subject/Guardian decision|4
1653723|NCT01640951|5779104|P7|Overall Study|Subject/Guardian decision|5
1653724|NCT01640951|5779105|P6|Overall Study|Subject/Guardian decision|19
1653725|NCT01640951|5779106|P5|Overall Study|Subject/Guardian decision|7
1653726|NCT01640951|5779107|P4|Overall Study|Subject/Guardian decision|15
1653727|NCT01640951|5779108|P3|Overall Study|Subject/Guardian decision|13
1653728|NCT01640951|5779109|P2|Overall Study|Subject/Guardian decision|4
1653729|NCT01640951|5779110|P1|Overall Study|Subject/Guardian decision|12
1653730|NCT01640951|5779103|P8|Overall Study|Protocol Deviation|0
1653731|NCT01640951|5779104|P7|Overall Study|Protocol Deviation|0
1653732|NCT01640951|5779105|P6|Overall Study|Protocol Deviation|1
1653733|NCT01640951|5779106|P5|Overall Study|Protocol Deviation|0
1653734|NCT01640951|5779107|P4|Overall Study|Protocol Deviation|1
1653735|NCT01640951|5779108|P3|Overall Study|Protocol Deviation|2
1653736|NCT01640951|5779109|P2|Overall Study|Protocol Deviation|1
1653737|NCT01640951|5779110|P1|Overall Study|Protocol Deviation|0
1653738|NCT01640951|5779103|P8|Overall Study|Pregnancy|0
1653739|NCT01640951|5779104|P7|Overall Study|Pregnancy|2
1653740|NCT01640951|5779105|P6|Overall Study|Pregnancy|0
1653741|NCT01640951|5779106|P5|Overall Study|Pregnancy|0
1653742|NCT01640951|5779107|P4|Overall Study|Pregnancy|4
1653743|NCT01640951|5779108|P3|Overall Study|Pregnancy|0
1653744|NCT01640951|5779109|P2|Overall Study|Pregnancy|0
1653745|NCT01640951|5779110|P1|Overall Study|Pregnancy|3
1653746|NCT01640951|5779103|P8|Overall Study|Physician Decision|0
1653747|NCT01640951|5779104|P7|Overall Study|Physician Decision|3
1653748|NCT01640951|5779105|P6|Overall Study|Physician Decision|3
1653749|NCT01640951|5779106|P5|Overall Study|Physician Decision|2
1653750|NCT01640951|5779107|P4|Overall Study|Physician Decision|2
1653751|NCT01640951|5779108|P3|Overall Study|Physician Decision|2
1653752|NCT01640951|5779109|P2|Overall Study|Physician Decision|5
1653753|NCT01640951|5779110|P1|Overall Study|Physician Decision|2
1653754|NCT01640951|5779103|P8|Overall Study|Non-compliance with study treatment|0
1653755|NCT01640951|5779104|P7|Overall Study|Non-compliance with study treatment|1
1653756|NCT01640951|5779105|P6|Overall Study|Non-compliance with study treatment|4
1653757|NCT01640951|5779106|P5|Overall Study|Non-compliance with study treatment|1
1653758|NCT01640951|5779107|P4|Overall Study|Non-compliance with study treatment|1
1653759|NCT01640951|5779108|P3|Overall Study|Non-compliance with study treatment|1
1653760|NCT01640951|5779109|P2|Overall Study|Non-compliance with study treatment|0
1653761|NCT01640951|5779110|P1|Overall Study|Non-compliance with study treatment|0
1653762|NCT01640951|5779103|P8|Overall Study|Lost to Follow-up|1
1653763|NCT01640951|5779104|P7|Overall Study|Lost to Follow-up|1
1653764|NCT01640951|5779105|P6|Overall Study|Lost to Follow-up|3
1653765|NCT01640951|5779106|P5|Overall Study|Lost to Follow-up|2
1653766|NCT01640951|5779107|P4|Overall Study|Lost to Follow-up|2
1653767|NCT01640951|5779108|P3|Overall Study|Lost to Follow-up|6
1653768|NCT01640951|5779109|P2|Overall Study|Lost to Follow-up|0
1653769|NCT01640951|5779110|P1|Overall Study|Lost to Follow-up|1
1653770|NCT01640951|5779103|P8|Overall Study|Lack of Efficacy|6
1653771|NCT01640951|5779104|P7|Overall Study|Lack of Efficacy|5
1653772|NCT01640951|5779105|P6|Overall Study|Lack of Efficacy|6
1653773|NCT01640951|5779106|P5|Overall Study|Lack of Efficacy|0
1653774|NCT01640951|5779107|P4|Overall Study|Lack of Efficacy|14
1653775|NCT01640951|5779108|P3|Overall Study|Lack of Efficacy|7
1653776|NCT01640951|5779109|P2|Overall Study|Lack of Efficacy|1
1653777|NCT01640951|5779110|P1|Overall Study|Lack of Efficacy|20
1653778|NCT01640951|5779103|P8|Overall Study|Adverse Event|3
1653779|NCT01640951|5779104|P7|Overall Study|Adverse Event|1
1653780|NCT01640951|5779105|P6|Overall Study|Adverse Event|11
1653781|NCT01640951|5779106|P5|Overall Study|Adverse Event|1
1653782|NCT01640951|5779107|P4|Overall Study|Adverse Event|6
1653783|NCT01640951|5779108|P3|Overall Study|Adverse Event|10
1653784|NCT01640951|5779109|P2|Overall Study|Adverse Event|3
1653785|NCT01640951|5779110|P1|Overall Study|Adverse Event|8
1653786|NCT01640925|5779212|P2|Overall Study|Previously enrolled in this trial|11
1653787|NCT01640925|5779213|P1|Overall Study|Previously enrolled in this trial|13
1653788|NCT01640925|5779212|P2|Overall Study|Withdrawal by Subject|0
1653789|NCT01640925|5779213|P1|Overall Study|Withdrawal by Subject|1
1653790|NCT01640873|5779227|P2|Overall Study|Protocol Violation|1
1653791|NCT01640873|5779228|P1|Overall Study|Protocol Violation|2
1653792|NCT01640353|5779301|P1|Overall Study|Physician Decision|1
1653793|NCT01640353|5779301|P1|Overall Study|Lost to Follow-up|12
1653794|NCT01640353|5779301|P1|Overall Study|Early site termination|3
1653795|NCT01640353|5779301|P1|Overall Study|Death|2
1653796|NCT01640353|5779301|P1|Overall Study|Withdrawal by Subject|5
1653797|NCT01640353|5779301|P1|Overall Study|Withdrawn from analysis at term site|12
1653798|NCT01640353|5779301|P1|Overall Study|Withdrew prior to treatment|10
1653799|NCT01640314|5779349|P2|Overall Study|Protocol Violation|1
1653800|NCT01640314|5779350|P1|Overall Study|Protocol Violation|0
1653801|NCT01640249|5779371|P7|Period 1|Withdrawal by Subject|0
1653802|NCT01640249|5779372|P6|Period 1|Withdrawal by Subject|1
1653803|NCT01640249|5779373|P5|Period 1|Withdrawal by Subject|0
1653804|NCT01640249|5779374|P4|Period 1|Withdrawal by Subject|0
1653805|NCT01640249|5779375|P3|Period 1|Withdrawal by Subject|0
1653806|NCT01640249|5779376|P2|Period 1|Withdrawal by Subject|0
1653807|NCT01640249|5779377|P1|Period 1|Withdrawal by Subject|1
1653808|NCT01640184|5779425|P3|Overall Study|Protocol Violation|1
1653809|NCT01640184|5779426|P2|Overall Study|Protocol Violation|0
1653810|NCT01640184|5779427|P1|Overall Study|Protocol Violation|0
1653811|NCT01640184|5779425|P3|Overall Study|Withdrawal by Subject|1
1653812|NCT01640184|5779426|P2|Overall Study|Withdrawal by Subject|1
1653813|NCT01640184|5779427|P1|Overall Study|Withdrawal by Subject|0
1653814|NCT01640184|5779425|P3|Overall Study|Physician Decision|0
1653815|NCT01640184|5779426|P2|Overall Study|Physician Decision|0
1653816|NCT01640184|5779427|P1|Overall Study|Physician Decision|3
1653817|NCT01640184|5779425|P3|Overall Study|Lost to Follow-up|0
1653818|NCT01640184|5779426|P2|Overall Study|Lost to Follow-up|1
1653819|NCT01640184|5779427|P1|Overall Study|Lost to Follow-up|4
1653820|NCT01640184|5779425|P3|Overall Study|Death|0
1653821|NCT01640184|5779426|P2|Overall Study|Death|0
1653822|NCT01640184|5779427|P1|Overall Study|Death|1
1653823|NCT01640054|5779456|P1|Overall Study|Adverse Event|2
1653824|NCT01640054|5779456|P1|Overall Study|Lack of Efficacy|3
1653825|NCT01640054|5779456|P1|Overall Study|Study-specific disc criteria|1
1653826|NCT01639833|5779477|P2|Overall Study|Withdrawal by Subject|2
1653827|NCT01639833|5779478|P1|Overall Study|Withdrawal by Subject|2
1653828|NCT01639833|5779477|P2|Overall Study|Death|2
1653829|NCT01639833|5779478|P1|Overall Study|Death|4
1653830|NCT01639755|5779486|P1|Overall Study|Patient had device explantation|4
1653831|NCT01639755|5779486|P1|Overall Study|Study Ongoing|15
1653832|NCT01639742|5779494|P1|Overall Study|Lost to Follow-up|1
1653833|NCT01639742|5779494|P1|Overall Study|Study Ongoing|17
1653834|NCT01639729|5779502|P6|Overall Study|Withdrawal by Subject|0
1653835|NCT01639729|5779503|P5|Overall Study|Withdrawal by Subject|0
1653836|NCT01639729|5779504|P4|Overall Study|Withdrawal by Subject|1
1653837|NCT01639729|5779505|P3|Overall Study|Withdrawal by Subject|1
1653838|NCT01639729|5779506|P2|Overall Study|Withdrawal by Subject|0
1653839|NCT01639729|5779507|P1|Overall Study|Withdrawal by Subject|1
1653840|NCT01639703|5779529|P1|Overall Study|Other reason|7
1653841|NCT01639703|5779529|P1|Overall Study|Withdrawal by Subject|5
1653842|NCT01639560|5779572|P2|Overall Study|Adverse Event|2
1653843|NCT01639560|5779573|P1|Overall Study|Adverse Event|0
1653844|NCT01639560|5779572|P2|Overall Study|Lost to Follow-up|11
1653845|NCT01639560|5779573|P1|Overall Study|Lost to Follow-up|9
1653846|NCT01639560|5779572|P2|Overall Study|Lack of Efficacy|2
1653847|NCT01639560|5779573|P1|Overall Study|Lack of Efficacy|1
1653848|NCT01639560|5779572|P2|Overall Study|Withdrawal by Subject|14
1653849|NCT01639560|5779573|P1|Overall Study|Withdrawal by Subject|9
1653850|NCT01639495|5779585|P1|Overall Study|No radiofrequency energy applied|2
1653851|NCT01639495|5779585|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
1653852|NCT01639495|5779585|P1|Overall Study|Consented but didn’t have study catheter|4
1653853|NCT01639495|5779585|P1|Overall Study|Lost to Follow-up|6
1653854|NCT01639469|5779595|P2|Overall Study|Lost to Follow-up|1
1653855|NCT01639469|5779596|P1|Overall Study|Lost to Follow-up|1
1653856|NCT01639469|5779595|P2|Overall Study|Death|2
1653857|NCT01639469|5779596|P1|Overall Study|Death|4
1653858|NCT01639144|5779701|P2|Overall Study|Met postoperative exclusion criteria|3
1653859|NCT01639144|5779702|P1|Overall Study|Met postoperative exclusion criteria|4
1653860|NCT01639144|5779701|P2|Overall Study|Physician Decision|0
1653861|NCT01639144|5779702|P1|Overall Study|Physician Decision|2
1653862|NCT01639144|5779701|P2|Overall Study|Withdrawal by Subject|2
1653863|NCT01639144|5779702|P1|Overall Study|Withdrawal by Subject|4
1653864|NCT01639040|5779710|P2|Overall Study|Adverse Event|0
1653865|NCT01639040|5779711|P1|Overall Study|Adverse Event|1
1653866|NCT01639001|5779729|P2|Overall Study|Death|35
1653867|NCT01639001|5779730|P1|Overall Study|Death|35
1653868|NCT01639001|5779729|P2|Overall Study|Lost to Follow-up|0
1653869|NCT01639001|5779730|P1|Overall Study|Lost to Follow-up|1
1653870|NCT01639001|5779729|P2|Overall Study|Refused further follow-up|6
1653871|NCT01639001|5779730|P1|Overall Study|Refused further follow-up|3
1653872|NCT01639001|5779729|P2|Overall Study|Ongoing at date of cutoff|60
1653873|NCT01639001|5779730|P1|Overall Study|Ongoing at date of cutoff|65
1653874|NCT01639001|5779729|P2|Overall Study|Randomized but not treated|2
1653875|NCT01639001|5779730|P1|Overall Study|Randomized but not treated|0
1653876|NCT01638819|5779776|P2|Overall Study|Lost to Follow-up|0
1653877|NCT01638819|5779777|P1|Overall Study|Lost to Follow-up|1
1653878|NCT01638559|5779786|P1|Overall Study|Subject declined to travel for biopsy|1
1653879|NCT01638559|5779786|P1|Overall Study|Withdrawal by Subject|1
1653880|NCT01638559|5779786|P1|Overall Study|Lost to Follow-up|1
1653881|NCT01638546|5779804|P2|Overall Study|Adverse Event|3
1653882|NCT01638546|5779805|P1|Overall Study|Adverse Event|1
1653883|NCT01638429|5779844|P1|Overall Study|Withdrawal by Subject|1
1653884|NCT01638390|5779872|P1|Overall Study|screening failures|21
1653885|NCT01638000|5779895|P2|Overall Study|Miscellaneous|2
1653886|NCT01638000|5779896|P1|Overall Study|Miscellaneous|2
1653887|NCT01638000|5779895|P2|Overall Study|Withdrawal by Subject|24
1653888|NCT01638000|5779896|P1|Overall Study|Withdrawal by Subject|21
1653889|NCT01638000|5779895|P2|Overall Study|Protocol Violation|13
1653890|NCT01638000|5779896|P1|Overall Study|Protocol Violation|11
1653891|NCT01638000|5779895|P2|Overall Study|Lack of Efficacy|6
1653892|NCT01638000|5779896|P1|Overall Study|Lack of Efficacy|5
1653893|NCT01638000|5779895|P2|Overall Study|Adverse Event|16
1653894|NCT01638000|5779896|P1|Overall Study|Adverse Event|14
1653895|NCT01638000|5779895|P2|Overall Study|Randomized but Never Received Drug|10
1653896|NCT01638000|5779896|P1|Overall Study|Randomized but Never Received Drug|7
1653897|NCT01637961|5779994|P1|Overall Study|Ineligible: inadequate pathology|1
1653898|NCT01637961|5779994|P1|Overall Study|Ineligible: wrong primary|1
1653899|NCT01637922|5780026|P2|Overall Study|Lost to Follow-up|0
1653900|NCT01637922|5780027|P1|Overall Study|Lost to Follow-up|2
1653901|NCT01637922|5780026|P2|Overall Study|Withdrawal by Subject|3
1653902|NCT01637922|5780027|P1|Overall Study|Withdrawal by Subject|0
1653903|NCT01637922|5780026|P2|Overall Study|Protocol Violation|1
1653904|NCT01637922|5780027|P1|Overall Study|Protocol Violation|0
1653905|NCT01637922|5780026|P2|Overall Study|Adverse Event|1
1653906|NCT01637922|5780027|P1|Overall Study|Adverse Event|0
1653907|NCT01637584|5780056|P2|Overall Study|Withdrawal by Subject|3
1653908|NCT01637584|5780057|P1|Overall Study|Withdrawal by Subject|1
1653909|NCT01637272|5780064|P1|Overall Study|Protocol Violation|2
1653910|NCT01637272|5780064|P1|Overall Study|Administrative problems|1
1653911|NCT01637272|5780064|P1|Overall Study|completed core, did not enter ext. phase|4
1653912|NCT01637272|5780064|P1|Overall Study|Lost to Follow-up|2
1653913|NCT01637272|5780064|P1|Overall Study|Withdrawal by Subject|3
1653914|NCT01637272|5780064|P1|Overall Study|Unsatisfactory therapeutic effect|2
1653915|NCT01637272|5780064|P1|Overall Study|Adverse Event|6
1653916|NCT01637077|5780144|P2|Overall Study|No cycle 1 questionnaire data|0
1653917|NCT01637077|5780145|P1|Overall Study|No cycle 1 questionnaire data|2
1653918|NCT01637077|5780144|P2|Overall Study|Withdrawal by Subject|0
1653919|NCT01637077|5780145|P1|Overall Study|Withdrawal by Subject|1
1653920|NCT01637077|5780144|P2|Overall Study|Cancel|1
1653921|NCT01637077|5780145|P1|Overall Study|Cancel|1
1653922|NCT01636986|5780173|P2|Overall Study|Corneal Staining|1
1653923|NCT01636986|5780174|P1|Overall Study|Corneal Staining|0
1653924|NCT01636986|5780173|P2|Overall Study|Withdrawal by Subject|1
1653925|NCT01636986|5780174|P1|Overall Study|Withdrawal by Subject|0
1653926|NCT01636960|5780180|P1|Maintenance Phase|Progressive disease|1
1653927|NCT01636960|5780180|P1|Maintenance Phase|Adverse Event|3
1653928|NCT01636960|5780180|P1|Maintenance Phase|Continued drug after regulatory approval|3
1653929|NCT01636960|5780180|P1|Induction Phase|Adverse Event|2
1653930|NCT01636947|5780188|P2|Overall Study|Did Not Meet Eligibility Criteria|4
1653931|NCT01636947|5780189|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1653932|NCT01636947|5780188|P2|Overall Study|Adverse Event|1
1653933|NCT01636947|5780189|P1|Overall Study|Adverse Event|1
1653934|NCT01636947|5780188|P2|Overall Study|Withdrawal by Subject|3
1653935|NCT01636947|5780189|P1|Overall Study|Withdrawal by Subject|3
1653936|NCT01636947|5780188|P2|Overall Study|Protocol Violation|1
1653937|NCT01636947|5780189|P1|Overall Study|Protocol Violation|1
1653938|NCT01636947|5780188|P2|Overall Study|Lost to Follow-up|0
1653939|NCT01636947|5780189|P1|Overall Study|Lost to Follow-up|4
1653940|NCT01636947|5780188|P2|Overall Study|Not Treated|2
1653941|NCT01636947|5780189|P1|Overall Study|Not Treated|2
1653942|NCT01636778|5780213|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
1653943|NCT01636778|5780214|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
1653944|NCT01636778|5780215|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
1653945|NCT01636778|5780213|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
1653946|NCT01636778|5780214|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1653947|NCT01636778|5780215|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
1653948|NCT01636778|5780213|P3|Follow-up Period After Part 2|Other|1
1653949|NCT01636778|5780214|P2|Follow-up Period After Part 2|Other|0
1653950|NCT01636778|5780215|P1|Follow-up Period After Part 2|Other|0
1653951|NCT01636778|5780213|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
1653952|NCT01636778|5780214|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
1653953|NCT01636778|5780215|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
1653954|NCT01636778|5780213|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1653955|NCT01636778|5780214|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
1653956|NCT01636778|5780215|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
1653957|NCT01636778|5780213|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
1653958|NCT01636778|5780214|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
1653959|NCT01636778|5780215|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
1653960|NCT01636778|5780213|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1653961|NCT01636778|5780214|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
1653962|NCT01636778|5780215|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
1653963|NCT01636778|5780213|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1653964|NCT01636778|5780214|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
1653965|NCT01636778|5780215|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
1653966|NCT01636713|5780286|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
1653967|NCT01636713|5780287|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
1653968|NCT01636713|5780288|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
1653969|NCT01636713|5780286|P3|Overall Study|Withdrawal by Subject|8
1653970|NCT01636713|5780287|P2|Overall Study|Withdrawal by Subject|4
1653971|NCT01636713|5780288|P1|Overall Study|Withdrawal by Subject|5
1653972|NCT01636713|5780286|P3|Overall Study|Lost to Follow-up|1
1653973|NCT01636713|5780287|P2|Overall Study|Lost to Follow-up|0
1653974|NCT01636713|5780288|P1|Overall Study|Lost to Follow-up|0
1653975|NCT01636713|5780286|P3|Overall Study|Protocol Violation|1
1653976|NCT01636713|5780287|P2|Overall Study|Protocol Violation|0
1653977|NCT01636713|5780288|P1|Overall Study|Protocol Violation|3
1653978|NCT01636713|5780286|P3|Overall Study|Lack of Efficacy|2
1653979|NCT01636713|5780287|P2|Overall Study|Lack of Efficacy|6
1653980|NCT01636713|5780288|P1|Overall Study|Lack of Efficacy|6
1653981|NCT01636713|5780286|P3|Overall Study|Adverse Event|7
1653982|NCT01636713|5780287|P2|Overall Study|Adverse Event|16
1653983|NCT01636713|5780288|P1|Overall Study|Adverse Event|16
1653984|NCT01636687|5780305|P5|Follow-up Period|Withdrawal by Subject|1
1653985|NCT01636687|5780306|P4|Follow-up Period|Withdrawal by Subject|0
1653986|NCT01636687|5780307|P3|Follow-up Period|Withdrawal by Subject|0
1653987|NCT01636687|5780308|P2|Follow-up Period|Withdrawal by Subject|0
1653988|NCT01636687|5780309|P1|Follow-up Period|Withdrawal by Subject|1
1653989|NCT01636687|5780305|P5|Extension Period|Withdrawal by Subject|0
1653990|NCT01636687|5780306|P4|Extension Period|Withdrawal by Subject|1
1653991|NCT01636687|5780307|P3|Extension Period|Withdrawal by Subject|1
1653992|NCT01636687|5780308|P2|Extension Period|Withdrawal by Subject|0
1653993|NCT01636687|5780309|P1|Extension Period|Withdrawal by Subject|1
1653994|NCT01636687|5780305|P5|Extension Period|study terminated by sponsor|0
1653995|NCT01636687|5780306|P4|Extension Period|study terminated by sponsor|23
1653996|NCT01636687|5780307|P3|Extension Period|study terminated by sponsor|17
1653997|NCT01636687|5780308|P2|Extension Period|study terminated by sponsor|50
1653998|NCT01636687|5780309|P1|Extension Period|study terminated by sponsor|33
1653999|NCT01636687|5780305|P5|Extension Period|Physician Decision|0
1654000|NCT01636687|5780306|P4|Extension Period|Physician Decision|1
1654001|NCT01636687|5780307|P3|Extension Period|Physician Decision|0
1654002|NCT01636687|5780308|P2|Extension Period|Physician Decision|0
1654003|NCT01636687|5780309|P1|Extension Period|Physician Decision|1
1654004|NCT01636687|5780305|P5|Extension Period|Lost to Follow-up|0
1654005|NCT01636687|5780306|P4|Extension Period|Lost to Follow-up|0
1654006|NCT01636687|5780307|P3|Extension Period|Lost to Follow-up|1
1654007|NCT01636687|5780308|P2|Extension Period|Lost to Follow-up|0
1654008|NCT01636687|5780309|P1|Extension Period|Lost to Follow-up|1
1654009|NCT01636687|5780305|P5|Extension Period|Lack of Efficacy|0
1654010|NCT01636687|5780306|P4|Extension Period|Lack of Efficacy|1
1654011|NCT01636687|5780307|P3|Extension Period|Lack of Efficacy|2
1654012|NCT01636687|5780308|P2|Extension Period|Lack of Efficacy|0
1654013|NCT01636687|5780309|P1|Extension Period|Lack of Efficacy|7
1654014|NCT01636687|5780305|P5|Extension Period|Adverse Event|0
1654015|NCT01636687|5780306|P4|Extension Period|Adverse Event|1
1654016|NCT01636687|5780307|P3|Extension Period|Adverse Event|2
1654017|NCT01636687|5780308|P2|Extension Period|Adverse Event|3
1654018|NCT01636687|5780309|P1|Extension Period|Adverse Event|4
1654019|NCT01636687|5780305|P5|Extension Period|technical problems|0
1654020|NCT01636687|5780306|P4|Extension Period|technical problems|1
1654021|NCT01636687|5780307|P3|Extension Period|technical problems|2
1654022|NCT01636687|5780308|P2|Extension Period|technical problems|1
1654023|NCT01636687|5780309|P1|Extension Period|technical problems|0
1654024|NCT01636687|5780305|P5|Maintenance Period|Physician Decision|1
1654025|NCT01636687|5780306|P4|Maintenance Period|Physician Decision|0
1654026|NCT01636687|5780307|P3|Maintenance Period|Physician Decision|0
1654027|NCT01636687|5780308|P2|Maintenance Period|Physician Decision|0
1654028|NCT01636687|5780309|P1|Maintenance Period|Physician Decision|0
1654029|NCT01636687|5780305|P5|Maintenance Period|Lost to Follow-up|1
1654030|NCT01636687|5780306|P4|Maintenance Period|Lost to Follow-up|0
1654031|NCT01636687|5780307|P3|Maintenance Period|Lost to Follow-up|0
1654032|NCT01636687|5780308|P2|Maintenance Period|Lost to Follow-up|1
1654033|NCT01636687|5780309|P1|Maintenance Period|Lost to Follow-up|1
1654034|NCT01636687|5780305|P5|Maintenance Period|Lack of Efficacy|0
1654035|NCT01636687|5780306|P4|Maintenance Period|Lack of Efficacy|0
1654036|NCT01636687|5780307|P3|Maintenance Period|Lack of Efficacy|0
1654037|NCT01636687|5780308|P2|Maintenance Period|Lack of Efficacy|1
1654038|NCT01636687|5780309|P1|Maintenance Period|Lack of Efficacy|4
1654039|NCT01636687|5780305|P5|Maintenance Period|Adverse Event|0
1654040|NCT01636687|5780306|P4|Maintenance Period|Adverse Event|0
1654041|NCT01636687|5780307|P3|Maintenance Period|Adverse Event|0
1654042|NCT01636687|5780308|P2|Maintenance Period|Adverse Event|0
1654043|NCT01636687|5780309|P1|Maintenance Period|Adverse Event|1
1654044|NCT01636687|5780305|P5|Maintenance Period|Withdrawal by Subject|0
1654045|NCT01636687|5780306|P4|Maintenance Period|Withdrawal by Subject|0
1654046|NCT01636687|5780307|P3|Maintenance Period|Withdrawal by Subject|2
1654047|NCT01636687|5780308|P2|Maintenance Period|Withdrawal by Subject|0
1654048|NCT01636687|5780309|P1|Maintenance Period|Withdrawal by Subject|2
1654049|NCT01636687|5780305|P5|Induction Period|Physician Decision|0
1654050|NCT01636687|5780306|P4|Induction Period|Physician Decision|0
1654051|NCT01636687|5780307|P3|Induction Period|Physician Decision|0
1654052|NCT01636687|5780308|P2|Induction Period|Physician Decision|0
1654053|NCT01636687|5780309|P1|Induction Period|Physician Decision|1
1654054|NCT01636687|5780305|P5|Induction Period|Lack of Efficacy|1
1654055|NCT01636687|5780306|P4|Induction Period|Lack of Efficacy|0
1654056|NCT01636687|5780307|P3|Induction Period|Lack of Efficacy|0
1654057|NCT01636687|5780308|P2|Induction Period|Lack of Efficacy|0
1654058|NCT01636687|5780309|P1|Induction Period|Lack of Efficacy|0
1654059|NCT01636687|5780305|P5|Induction Period|Adverse Event|1
1654060|NCT01636687|5780306|P4|Induction Period|Adverse Event|0
1654061|NCT01636687|5780307|P3|Induction Period|Adverse Event|0
1654062|NCT01636687|5780308|P2|Induction Period|Adverse Event|0
1654063|NCT01636687|5780309|P1|Induction Period|Adverse Event|1
1654064|NCT01636687|5780305|P5|Induction Period|Withdrawal by Subject|0
1654065|NCT01636687|5780306|P4|Induction Period|Withdrawal by Subject|0
1654066|NCT01636687|5780307|P3|Induction Period|Withdrawal by Subject|0
1654067|NCT01636687|5780308|P2|Induction Period|Withdrawal by Subject|0
1654068|NCT01636687|5780309|P1|Induction Period|Withdrawal by Subject|1
1654069|NCT01636362|5780450|P1|Overall Study|Withdrawal by Subject|1
1654070|NCT01636362|5780450|P1|Overall Study|Subject healed, not returning|1
1654071|NCT01636362|5780450|P1|Overall Study|Physician Decision|6
1654072|NCT01636258|5780477|P2|Overall Study|Lost to Follow-up|0
1654073|NCT01636258|5780478|P1|Overall Study|Lost to Follow-up|1
1654074|NCT01636076|5780518|P2|Overall Study|Withdrawal by Subject|10
1654075|NCT01636076|5780519|P1|Overall Study|Withdrawal by Subject|7
1654076|NCT01636076|5780518|P2|Overall Study|Adverse Event|11
1654077|NCT01636076|5780519|P1|Overall Study|Adverse Event|6
1654078|NCT01636076|5780518|P2|Overall Study|Non-compliance with study treatment|1
1654079|NCT01636076|5780519|P1|Overall Study|Non-compliance with study treatment|1
1654080|NCT01636076|5780518|P2|Overall Study|Physician Decision|1
1654081|NCT01636076|5780519|P1|Overall Study|Physician Decision|1
1654082|NCT01636076|5780518|P2|Overall Study|Lost to Follow-up|0
1654083|NCT01636076|5780519|P1|Overall Study|Lost to Follow-up|1
1654084|NCT01636076|5780518|P2|Overall Study|Lack of Efficacy|1
1654085|NCT01636076|5780519|P1|Overall Study|Lack of Efficacy|0
1654086|NCT01636076|5780518|P2|Overall Study|Terminated by sponsor|1
1654087|NCT01636076|5780519|P1|Overall Study|Terminated by sponsor|1
1654088|NCT01635933|5780590|P2|Overall Study|No longer had transportation|1
1654089|NCT01635933|5780591|P1|Overall Study|No longer had transportation|0
1654090|NCT01635933|5780590|P2|Overall Study|Noncompliance|1
1654091|NCT01635933|5780591|P1|Overall Study|Noncompliance|0
1654092|NCT01635933|5780590|P2|Overall Study|Subject decision|1
1654093|NCT01635933|5780591|P1|Overall Study|Subject decision|1
1654094|NCT01635933|5780590|P2|Overall Study|Lost to Follow-up|5
1654095|NCT01635933|5780591|P1|Overall Study|Lost to Follow-up|0
1654096|NCT01635933|5780590|P2|Overall Study|Adverse Event|0
1654097|NCT01635933|5780591|P1|Overall Study|Adverse Event|1
1654098|NCT01635920|5780603|P2|Overall Study|Subject decision|0
1654099|NCT01635920|5780604|P1|Overall Study|Subject decision|2
1654100|NCT01635920|5780603|P2|Overall Study|Lost to Follow-up|1
1654101|NCT01635920|5780604|P1|Overall Study|Lost to Follow-up|0
1654102|NCT01635920|5780603|P2|Overall Study|Adverse Event|0
1654103|NCT01635920|5780604|P1|Overall Study|Adverse Event|1
1654104|NCT01635855|5780617|P1|Overall Study|Withdrawal by Subject|4
1654105|NCT01635764|5780626|P1|Overall Study|Other|28
1654106|NCT01635764|5780626|P1|Overall Study|Lost to Follow-up|53
1654107|NCT01635764|5780626|P1|Overall Study|Withdrew Consent|67
1654108|NCT01635764|5780626|P1|Overall Study|Protocol Deviation|1
1654109|NCT01635764|5780626|P1|Overall Study|Exceed Protocol-specified Interventions|2
1654110|NCT01635764|5780626|P1|Overall Study|Lack of Efficacy|76
1654111|NCT01635764|5780626|P1|Overall Study|Adverse Event|46
1654112|NCT01635218|5780692|P3|Overall Study|Lost to Follow-up|6
1654113|NCT01635218|5780693|P2|Overall Study|Lost to Follow-up|7
1654114|NCT01635218|5780694|P1|Overall Study|Lost to Follow-up|3
1654115|NCT01634854|5780757|P2|Overall Study|Cesarean delivery|7
1654116|NCT01634854|5780758|P1|Overall Study|Cesarean delivery|2
1654117|NCT01634659|5780778|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
1654118|NCT01634659|5780779|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
1654119|NCT01634659|5780778|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
1654120|NCT01634659|5780779|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
1654121|NCT01634555|5780809|P1|Overall Study|Physician Decision|1
1654122|NCT01634555|5780809|P1|Overall Study|Adverse Event|3
1654123|NCT01634360|5780820|P2|Overall Study|Study termination by sponsor|44
1654124|NCT01634360|5780821|P1|Overall Study|Study termination by sponsor|18
1654125|NCT01634360|5780820|P2|Overall Study|Other|20
1654126|NCT01634360|5780821|P1|Overall Study|Other|3
1654127|NCT01634360|5780820|P2|Overall Study|Lack of Efficacy|14
1654128|NCT01634360|5780821|P1|Overall Study|Lack of Efficacy|4
1654129|NCT01634360|5780820|P2|Overall Study|Protocol Violation|1
1654130|NCT01634360|5780821|P1|Overall Study|Protocol Violation|1
1654131|NCT01634360|5780820|P2|Overall Study|subject withdrew consent|23
1654132|NCT01634360|5780821|P1|Overall Study|subject withdrew consent|13
1654133|NCT01634360|5780820|P2|Overall Study|Adverse Event|34
1654134|NCT01634360|5780821|P1|Overall Study|Adverse Event|10
1654135|NCT01634243|5780895|P2|Overall Study|Lack of Efficacy|0
1654136|NCT01634243|5780896|P1|Overall Study|Lack of Efficacy|1
1654137|NCT01634243|5780895|P2|Overall Study|Adverse Event|5
1654138|NCT01634243|5780896|P1|Overall Study|Adverse Event|5
1654139|NCT01634165|5780922|P4|Period 2|Adverse Event|0
1654140|NCT01634165|5780923|P3|Period 2|Adverse Event|0
1654141|NCT01634165|5780924|P2|Period 2|Adverse Event|1
1654142|NCT01634165|5780925|P1|Period 2|Adverse Event|0
1654143|NCT01634152|5780958|P3|Overall Study|Other reason not defined above|1
1654144|NCT01634152|5780959|P2|Overall Study|Other reason not defined above|0
1654145|NCT01634152|5780960|P1|Overall Study|Other reason not defined above|1
1654146|NCT01634152|5780958|P3|Overall Study|Not treated|0
1654147|NCT01634152|5780959|P2|Overall Study|Not treated|1
1654148|NCT01634152|5780960|P1|Overall Study|Not treated|0
1654149|NCT01634152|5780958|P3|Overall Study|Consent withdrawn not due to AE|1
1654150|NCT01634152|5780959|P2|Overall Study|Consent withdrawn not due to AE|0
1654151|NCT01634152|5780960|P1|Overall Study|Consent withdrawn not due to AE|1
1654152|NCT01634152|5780958|P3|Overall Study|Adverse Event|2
1654153|NCT01634152|5780959|P2|Overall Study|Adverse Event|0
1654154|NCT01634152|5780960|P1|Overall Study|Adverse Event|2
1654155|NCT01634139|5781043|P3|Overall Study|Not treated|0
1654156|NCT01634139|5781044|P2|Overall Study|Not treated|1
1654157|NCT01634139|5781045|P1|Overall Study|Not treated|1
1654158|NCT01634139|5781043|P3|Overall Study|Lost to Follow-up|0
1654159|NCT01634139|5781044|P2|Overall Study|Lost to Follow-up|2
1654160|NCT01634139|5781045|P1|Overall Study|Lost to Follow-up|0
1654161|NCT01634139|5781043|P3|Overall Study|Other|3
1654162|NCT01634139|5781044|P2|Overall Study|Other|0
1654163|NCT01634139|5781045|P1|Overall Study|Other|4
1654164|NCT01634139|5781043|P3|Overall Study|Consent withdrawn not due to AE|2
1654165|NCT01634139|5781044|P2|Overall Study|Consent withdrawn not due to AE|3
1654166|NCT01634139|5781045|P1|Overall Study|Consent withdrawn not due to AE|4
1654167|NCT01634139|5781043|P3|Overall Study|Non compliant with protocol|0
1654168|NCT01634139|5781044|P2|Overall Study|Non compliant with protocol|0
1654169|NCT01634139|5781045|P1|Overall Study|Non compliant with protocol|1
1654170|NCT01634113|5781146|P3|Overall Study|Not treated|1
1654171|NCT01634113|5781147|P2|Overall Study|Not treated|0
1654172|NCT01634113|5781148|P1|Overall Study|Not treated|0
1654173|NCT01634100|5781192|P6|Overall Study|Withdrawal by Subject|0
1654174|NCT01634100|5781193|P5|Overall Study|Withdrawal by Subject|0
1654175|NCT01634100|5781194|P4|Overall Study|Withdrawal by Subject|0
1654176|NCT01634100|5781195|P3|Overall Study|Withdrawal by Subject|1
1654177|NCT01634100|5781196|P2|Overall Study|Withdrawal by Subject|0
1654178|NCT01634100|5781197|P1|Overall Study|Withdrawal by Subject|1
1654179|NCT01633944|5781213|P3|Double-blind Treatment Phase|Other|0
1654180|NCT01633944|5781214|P2|Double-blind Treatment Phase|Other|7
1654181|NCT01633944|5781215|P1|Double-blind Treatment Phase|Other|0
1654182|NCT01633944|5781213|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
1654183|NCT01633944|5781214|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
1654184|NCT01633944|5781215|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
1654185|NCT01633944|5781213|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
1654186|NCT01633944|5781214|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
1654187|NCT01633944|5781215|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
1654188|NCT01633944|5781213|P3|Double-blind Treatment Phase|Lost to Follow-up|9
1654189|NCT01633944|5781214|P2|Double-blind Treatment Phase|Lost to Follow-up|4
1654190|NCT01633944|5781215|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1654191|NCT01633944|5781213|P3|Double-blind Treatment Phase|Protocol Violation|10
1654192|NCT01633944|5781214|P2|Double-blind Treatment Phase|Protocol Violation|7
1654193|NCT01633944|5781215|P1|Double-blind Treatment Phase|Protocol Violation|0
1654194|NCT01633944|5781213|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
1654195|NCT01633944|5781214|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
1654196|NCT01633944|5781215|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1654197|NCT01633944|5781213|P3|Double-blind Treatment Phase|Lack of Efficacy|23
1654198|NCT01633944|5781214|P2|Double-blind Treatment Phase|Lack of Efficacy|8
1654199|NCT01633944|5781215|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1654200|NCT01633944|5781213|P3|Double-blind Treatment Phase|Adverse Event|7
1654201|NCT01633944|5781214|P2|Double-blind Treatment Phase|Adverse Event|13
1654202|NCT01633944|5781215|P1|Double-blind Treatment Phase|Adverse Event|0
1654203|NCT01633944|5781213|P3|Open-label Titration Phase|Other|0
1654204|NCT01633944|5781214|P2|Open-label Titration Phase|Other|0
1654205|NCT01633944|5781215|P1|Open-label Titration Phase|Other|68
1654206|NCT01633944|5781213|P3|Open-label Titration Phase|Lost to Follow-up|0
1654207|NCT01633944|5781214|P2|Open-label Titration Phase|Lost to Follow-up|0
1654208|NCT01633944|5781215|P1|Open-label Titration Phase|Lost to Follow-up|22
1654209|NCT01633944|5781213|P3|Open-label Titration Phase|Protocol Violation|0
1654210|NCT01633944|5781214|P2|Open-label Titration Phase|Protocol Violation|0
1654211|NCT01633944|5781215|P1|Open-label Titration Phase|Protocol Violation|24
1654212|NCT01633944|5781213|P3|Open-label Titration Phase|Withdrawal by Subject|0
1654213|NCT01633944|5781214|P2|Open-label Titration Phase|Withdrawal by Subject|0
1654214|NCT01633944|5781215|P1|Open-label Titration Phase|Withdrawal by Subject|34
1654215|NCT01633944|5781213|P3|Open-label Titration Phase|Lack of Efficacy|0
1654216|NCT01633944|5781214|P2|Open-label Titration Phase|Lack of Efficacy|0
1654217|NCT01633944|5781215|P1|Open-label Titration Phase|Lack of Efficacy|33
1654218|NCT01633944|5781213|P3|Open-label Titration Phase|Adverse Event|0
1654219|NCT01633944|5781214|P2|Open-label Titration Phase|Adverse Event|0
1654220|NCT01633944|5781215|P1|Open-label Titration Phase|Adverse Event|109
1654221|NCT01633788|5781283|P4|Overall Study|Other Reasons|7
1654222|NCT01633788|5781284|P3|Overall Study|Other Reasons|3
1654223|NCT01633788|5781285|P2|Overall Study|Other Reasons|2
1654224|NCT01633788|5781286|P1|Overall Study|Other Reasons|0
1654225|NCT01633788|5781283|P4|Overall Study|Protocol Violation|0
1654226|NCT01633788|5781284|P3|Overall Study|Protocol Violation|1
1654227|NCT01633788|5781285|P2|Overall Study|Protocol Violation|0
1654228|NCT01633788|5781286|P1|Overall Study|Protocol Violation|1
1654229|NCT01633788|5781283|P4|Overall Study|Personal Reasons|3
1654230|NCT01633788|5781284|P3|Overall Study|Personal Reasons|1
1654231|NCT01633788|5781285|P2|Overall Study|Personal Reasons|1
1654232|NCT01633788|5781286|P1|Overall Study|Personal Reasons|3
1654233|NCT01633788|5781283|P4|Overall Study|Lost to Follow-up|0
1654234|NCT01633788|5781284|P3|Overall Study|Lost to Follow-up|2
1654235|NCT01633788|5781285|P2|Overall Study|Lost to Follow-up|2
1654236|NCT01633788|5781286|P1|Overall Study|Lost to Follow-up|2
1654237|NCT01633788|5781283|P4|Overall Study|Adverse Event|3
1654238|NCT01633788|5781284|P3|Overall Study|Adverse Event|3
1654239|NCT01633788|5781285|P2|Overall Study|Adverse Event|3
1654240|NCT01633788|5781286|P1|Overall Study|Adverse Event|1
1654241|NCT01633112|5781318|P3|Overall Study|missing Study Completion CRF|4
1654242|NCT01633112|5781319|P2|Overall Study|missing Study Completion CRF|1
1654243|NCT01633112|5781320|P1|Overall Study|missing Study Completion CRF|1
1654244|NCT01633112|5781318|P3|Overall Study|Withdrawal by Subject|41
1654245|NCT01633112|5781319|P2|Overall Study|Withdrawal by Subject|12
1654246|NCT01633112|5781320|P1|Overall Study|Withdrawal by Subject|20
1654247|NCT01633112|5781318|P3|Overall Study|Subject no longer requires study drug|1
1654248|NCT01633112|5781319|P2|Overall Study|Subject no longer requires study drug|0
1654249|NCT01633112|5781320|P1|Overall Study|Subject no longer requires study drug|0
1654250|NCT01633112|5781318|P3|Overall Study|Protocol Violation|2
1654251|NCT01633112|5781319|P2|Overall Study|Protocol Violation|0
1654252|NCT01633112|5781320|P1|Overall Study|Protocol Violation|4
1654253|NCT01633112|5781318|P3|Overall Study|Lost to Follow-up|6
1654254|NCT01633112|5781319|P2|Overall Study|Lost to Follow-up|19
1654255|NCT01633112|5781320|P1|Overall Study|Lost to Follow-up|7
1654256|NCT01633112|5781318|P3|Overall Study|Adverse Event|20
1654257|NCT01633112|5781319|P2|Overall Study|Adverse Event|18
1654258|NCT01633112|5781320|P1|Overall Study|Adverse Event|16
1654259|NCT01633112|5781318|P3|Overall Study|Administrative problems|5
1654260|NCT01633112|5781319|P2|Overall Study|Administrative problems|2
1654261|NCT01633112|5781320|P1|Overall Study|Administrative problems|1
1654262|NCT01633112|5781318|P3|Overall Study|Abnormal test procedure result(s)|0
1654263|NCT01633112|5781319|P2|Overall Study|Abnormal test procedure result(s)|1
1654264|NCT01633112|5781320|P1|Overall Study|Abnormal test procedure result(s)|0
1654265|NCT01633112|5781318|P3|Overall Study|Abnormal laboratory value(s)|0
1654266|NCT01633112|5781319|P2|Overall Study|Abnormal laboratory value(s)|1
1654267|NCT01633112|5781320|P1|Overall Study|Abnormal laboratory value(s)|3
1654268|NCT01633112|5781318|P3|Overall Study|Lack of Efficacy|13
1654269|NCT01633112|5781319|P2|Overall Study|Lack of Efficacy|6
1654270|NCT01633112|5781320|P1|Overall Study|Lack of Efficacy|1
1654271|NCT01633060|5781355|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
1654272|NCT01633060|5781356|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
1654273|NCT01633060|5781355|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
1654274|NCT01633060|5781356|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
1654275|NCT01633060|5781355|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
1654276|NCT01633060|5781356|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
1654277|NCT01633060|5781355|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
1654278|NCT01633060|5781356|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
1654279|NCT01633060|5781355|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
1654280|NCT01633060|5781356|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
1654281|NCT01633060|5781355|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
1654282|NCT01633060|5781356|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
1654283|NCT01633060|5781355|P2|Treatment Phase|Death|3
1654284|NCT01633060|5781356|P1|Treatment Phase|Death|4
1654285|NCT01633060|5781355|P2|Treatment Phase|Subject/guardian decision|4
1654286|NCT01633060|5781356|P1|Treatment Phase|Subject/guardian decision|25
1654287|NCT01633060|5781355|P2|Treatment Phase|Study Terminated by sponsor|3
1654288|NCT01633060|5781356|P1|Treatment Phase|Study Terminated by sponsor|7
1654289|NCT01633060|5781355|P2|Treatment Phase|Protocol Deviation|0
1654290|NCT01633060|5781356|P1|Treatment Phase|Protocol Deviation|1
1654291|NCT01633060|5781355|P2|Treatment Phase|Progressive Disease|120
1654292|NCT01633060|5781356|P1|Treatment Phase|Progressive Disease|210
1654293|NCT01633060|5781355|P2|Treatment Phase|Physician Decision|7
1654294|NCT01633060|5781356|P1|Treatment Phase|Physician Decision|16
1654295|NCT01633060|5781355|P2|Treatment Phase|Lost to Follow-up|0
1654296|NCT01633060|5781356|P1|Treatment Phase|Lost to Follow-up|1
1654297|NCT01633060|5781355|P2|Treatment Phase|Adverse Event|3
1654298|NCT01633060|5781356|P1|Treatment Phase|Adverse Event|24
1654299|NCT01633060|5781355|P2|Randomization Phase|Technical problem|1
1654300|NCT01633060|5781356|P1|Randomization Phase|Technical problem|0
1654301|NCT01633060|5781355|P2|Randomization Phase|Protocol deviation|2
1654302|NCT01633060|5781356|P1|Randomization Phase|Protocol deviation|1
1654303|NCT01632904|5781396|P2|Overall Study|Reason for discontinuation not available|1
1654304|NCT01632904|5781397|P1|Overall Study|Reason for discontinuation not available|0
1654305|NCT01632904|5781396|P2|Overall Study|Disease Progression|1
1654306|NCT01632904|5781397|P1|Overall Study|Disease Progression|0
1654307|NCT01632904|5781396|P2|Overall Study|Subject decision|2
1654308|NCT01632904|5781397|P1|Overall Study|Subject decision|3
1654309|NCT01632904|5781396|P2|Overall Study|Physician Decision|1
1654310|NCT01632904|5781397|P1|Overall Study|Physician Decision|0
1654311|NCT01632904|5781396|P2|Overall Study|Adverse Event|1
1654312|NCT01632904|5781397|P1|Overall Study|Adverse Event|4
1654313|NCT01632891|5781408|P2|Overall Study|Withdrawal by Subject|0
1654314|NCT01632891|5781409|P1|Overall Study|Withdrawal by Subject|1
1654315|NCT01632891|5781408|P2|Overall Study|Lost to Follow-up|1
1654316|NCT01632891|5781409|P1|Overall Study|Lost to Follow-up|0
1654317|NCT01632878|5781433|P1|Treatment|no information on study completion|43
1654318|NCT01632878|5781433|P1|Treatment|missing information|4
1654319|NCT01632878|5781433|P1|Treatment|Physician Decision|34
1654320|NCT01632878|5781433|P1|Treatment|Withdrawal by Subject|36
1654321|NCT01632878|5781433|P1|Treatment|Lost to Follow-up|41
1654322|NCT01632878|5781433|P1|Screening|Physician Decision|268
1654323|NCT01632800|5781437|P1|Overall Study|Subject did not fit in apparatus|1
1654324|NCT01632579|5781504|P9|Period 2 (Second Intervention)|Adverse Event|0
1654325|NCT01632579|5781505|P8|Period 2 (Second Intervention)|Adverse Event|0
1654326|NCT01632579|5781506|P7|Period 2 (Second Intervention)|Adverse Event|0
1654327|NCT01632579|5781507|P6|Period 2 (Second Intervention)|Adverse Event|0
1654328|NCT01632579|5781508|P5|Period 2 (Second Intervention)|Adverse Event|0
1654329|NCT01632579|5781509|P4|Period 2 (Second Intervention)|Adverse Event|0
1654330|NCT01632579|5781510|P3|Period 2 (Second Intervention)|Adverse Event|0
1654331|NCT01632579|5781511|P2|Period 2 (Second Intervention)|Adverse Event|0
1654332|NCT01632579|5781512|P1|Period 2 (Second Intervention)|Adverse Event|1
1654333|NCT01632579|5781504|P9|Washout Period|Adverse Event|0
1654334|NCT01632579|5781505|P8|Washout Period|Adverse Event|0
1654335|NCT01632579|5781506|P7|Washout Period|Adverse Event|0
1654336|NCT01632579|5781507|P6|Washout Period|Adverse Event|0
1654337|NCT01632579|5781508|P5|Washout Period|Adverse Event|0
1654338|NCT01632579|5781509|P4|Washout Period|Adverse Event|0
1654339|NCT01632579|5781510|P3|Washout Period|Adverse Event|0
1654340|NCT01632579|5781511|P2|Washout Period|Adverse Event|0
1654341|NCT01632579|5781512|P1|Washout Period|Adverse Event|1
1654342|NCT01632566|5781579|P5|Overall Study|Sponsor Decision|2
1654343|NCT01632566|5781580|P4|Overall Study|Sponsor Decision|2
1654344|NCT01632566|5781581|P3|Overall Study|Sponsor Decision|9
1654345|NCT01632566|5781582|P2|Overall Study|Sponsor Decision|2
1654346|NCT01632566|5781583|P1|Overall Study|Sponsor Decision|0
1654347|NCT01632566|5781579|P5|Overall Study|Withdrawal by Subject|0
1654348|NCT01632566|5781580|P4|Overall Study|Withdrawal by Subject|0
1654349|NCT01632566|5781581|P3|Overall Study|Withdrawal by Subject|0
1654350|NCT01632566|5781582|P2|Overall Study|Withdrawal by Subject|1
1654351|NCT01632566|5781583|P1|Overall Study|Withdrawal by Subject|0
1654352|NCT01632345|5781634|P7|Treatment: Part II|Withdrawal by Subject|2
1654353|NCT01632345|5781635|P6|Treatment: Part II|Withdrawal by Subject|2
1654354|NCT01632345|5781636|P5|Treatment: Part II|Withdrawal by Subject|0
1654355|NCT01632345|5781637|P4|Treatment: Part II|Withdrawal by Subject|0
1654356|NCT01632345|5781638|P3|Treatment: Part II|Withdrawal by Subject|0
1654357|NCT01632345|5781639|P2|Treatment: Part II|Withdrawal by Subject|0
1654358|NCT01632345|5781640|P1|Treatment: Part II|Withdrawal by Subject|0
1654359|NCT01632345|5781634|P7|Treatment: Part II|Non-Compliance with Study Drug|0
1654360|NCT01632345|5781635|P6|Treatment: Part II|Non-Compliance with Study Drug|3
1654361|NCT01632345|5781636|P5|Treatment: Part II|Non-Compliance with Study Drug|0
1654362|NCT01632345|5781637|P4|Treatment: Part II|Non-Compliance with Study Drug|0
1654363|NCT01632345|5781638|P3|Treatment: Part II|Non-Compliance with Study Drug|0
1654364|NCT01632345|5781639|P2|Treatment: Part II|Non-Compliance with Study Drug|0
1654365|NCT01632345|5781640|P1|Treatment: Part II|Non-Compliance with Study Drug|0
1654366|NCT01632345|5781634|P7|Treatment: Part II|Lost to Follow-up|1
1654367|NCT01632345|5781635|P6|Treatment: Part II|Lost to Follow-up|3
1654368|NCT01632345|5781636|P5|Treatment: Part II|Lost to Follow-up|0
1654369|NCT01632345|5781637|P4|Treatment: Part II|Lost to Follow-up|0
1654370|NCT01632345|5781638|P3|Treatment: Part II|Lost to Follow-up|0
1654371|NCT01632345|5781639|P2|Treatment: Part II|Lost to Follow-up|0
1654372|NCT01632345|5781640|P1|Treatment: Part II|Lost to Follow-up|0
1654373|NCT01632345|5781634|P7|Treatment: Part II|Adverse Event|8
1654374|NCT01632345|5781635|P6|Treatment: Part II|Adverse Event|3
1654375|NCT01632345|5781636|P5|Treatment: Part II|Adverse Event|0
1654376|NCT01632345|5781637|P4|Treatment: Part II|Adverse Event|0
1654377|NCT01632345|5781638|P3|Treatment: Part II|Adverse Event|0
1654378|NCT01632345|5781639|P2|Treatment: Part II|Adverse Event|0
1654379|NCT01632345|5781640|P1|Treatment: Part II|Adverse Event|0
1654380|NCT01632345|5781634|P7|Treatment: Part I|Withdrawal by Subject|0
1654381|NCT01632345|5781635|P6|Treatment: Part I|Withdrawal by Subject|0
1654382|NCT01632345|5781636|P5|Treatment: Part I|Withdrawal by Subject|4
1654383|NCT01632345|5781637|P4|Treatment: Part I|Withdrawal by Subject|1
1654384|NCT01632345|5781638|P3|Treatment: Part I|Withdrawal by Subject|4
1654385|NCT01632345|5781639|P2|Treatment: Part I|Withdrawal by Subject|4
1654386|NCT01632345|5781640|P1|Treatment: Part I|Withdrawal by Subject|3
1654387|NCT01632345|5781634|P7|Treatment: Part I|Protocol Deviation|0
1654388|NCT01632345|5781635|P6|Treatment: Part I|Protocol Deviation|0
1654389|NCT01632345|5781636|P5|Treatment: Part I|Protocol Deviation|0
1654390|NCT01632345|5781637|P4|Treatment: Part I|Protocol Deviation|1
1654391|NCT01632345|5781638|P3|Treatment: Part I|Protocol Deviation|1
1654392|NCT01632345|5781639|P2|Treatment: Part I|Protocol Deviation|0
1654393|NCT01632345|5781640|P1|Treatment: Part I|Protocol Deviation|0
1654394|NCT01632345|5781634|P7|Treatment: Part I|Pregnancy|0
1654395|NCT01632345|5781635|P6|Treatment: Part I|Pregnancy|0
1654396|NCT01632345|5781636|P5|Treatment: Part I|Pregnancy|0
1654397|NCT01632345|5781637|P4|Treatment: Part I|Pregnancy|0
1654398|NCT01632345|5781638|P3|Treatment: Part I|Pregnancy|0
1654399|NCT01632345|5781639|P2|Treatment: Part I|Pregnancy|1
1654400|NCT01632345|5781640|P1|Treatment: Part I|Pregnancy|0
1654401|NCT01632345|5781634|P7|Treatment: Part I|Physician Decision|0
1654402|NCT01632345|5781635|P6|Treatment: Part I|Physician Decision|0
1654403|NCT01632345|5781636|P5|Treatment: Part I|Physician Decision|1
1654404|NCT01632345|5781637|P4|Treatment: Part I|Physician Decision|0
1654405|NCT01632345|5781638|P3|Treatment: Part I|Physician Decision|0
1654406|NCT01632345|5781639|P2|Treatment: Part I|Physician Decision|1
1654407|NCT01632345|5781640|P1|Treatment: Part I|Physician Decision|2
1654408|NCT01632345|5781634|P7|Treatment: Part I|Non-Compliance with Study Drug|0
1654409|NCT01632345|5781635|P6|Treatment: Part I|Non-Compliance with Study Drug|0
1654410|NCT01632345|5781636|P5|Treatment: Part I|Non-Compliance with Study Drug|0
1654411|NCT01632345|5781637|P4|Treatment: Part I|Non-Compliance with Study Drug|1
1654412|NCT01632345|5781638|P3|Treatment: Part I|Non-Compliance with Study Drug|2
1654413|NCT01632345|5781639|P2|Treatment: Part I|Non-Compliance with Study Drug|2
1654414|NCT01632345|5781640|P1|Treatment: Part I|Non-Compliance with Study Drug|3
1654415|NCT01632345|5781634|P7|Treatment: Part I|Lost to Follow-up|0
1654416|NCT01632345|5781635|P6|Treatment: Part I|Lost to Follow-up|0
1654417|NCT01632345|5781636|P5|Treatment: Part I|Lost to Follow-up|4
1654418|NCT01632345|5781637|P4|Treatment: Part I|Lost to Follow-up|3
1654419|NCT01632345|5781638|P3|Treatment: Part I|Lost to Follow-up|1
1654420|NCT01632345|5781639|P2|Treatment: Part I|Lost to Follow-up|2
1654421|NCT01632345|5781640|P1|Treatment: Part I|Lost to Follow-up|3
1654422|NCT01632345|5781634|P7|Treatment: Part I|Lack of Efficacy|0
1654423|NCT01632345|5781635|P6|Treatment: Part I|Lack of Efficacy|0
1654424|NCT01632345|5781636|P5|Treatment: Part I|Lack of Efficacy|1
1654425|NCT01632345|5781637|P4|Treatment: Part I|Lack of Efficacy|1
1654426|NCT01632345|5781638|P3|Treatment: Part I|Lack of Efficacy|0
1654427|NCT01632345|5781639|P2|Treatment: Part I|Lack of Efficacy|1
1654428|NCT01632345|5781640|P1|Treatment: Part I|Lack of Efficacy|0
1654429|NCT01632345|5781634|P7|Treatment: Part I|Adverse Event|0
1654430|NCT01632345|5781635|P6|Treatment: Part I|Adverse Event|0
1654431|NCT01632345|5781636|P5|Treatment: Part I|Adverse Event|3
1654432|NCT01632345|5781637|P4|Treatment: Part I|Adverse Event|1
1654433|NCT01632345|5781638|P3|Treatment: Part I|Adverse Event|2
1654434|NCT01632345|5781639|P2|Treatment: Part I|Adverse Event|4
1654435|NCT01632345|5781640|P1|Treatment: Part I|Adverse Event|1
1654436|NCT01632306|5781702|P3|Overall Study|Protocol Violation|0
1654437|NCT01632306|5781703|P2|Overall Study|Protocol Violation|0
1654438|NCT01632306|5781704|P1|Overall Study|Protocol Violation|1
1654439|NCT01632280|5781720|P2|Overall Study|Withdrawal by Subject|0
1654440|NCT01632280|5781721|P1|Overall Study|Withdrawal by Subject|1
1654441|NCT01632241|5781737|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
1654442|NCT01632241|5781738|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
1654443|NCT01632241|5781737|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
1654444|NCT01632241|5781738|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
1654445|NCT01632241|5781737|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
1654446|NCT01632241|5781738|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
1654447|NCT01632241|5781737|P2|Open-label (Week 52 to Week 76)|Site Closed|8
1654448|NCT01632241|5781738|P1|Open-label (Week 52 to Week 76)|Site Closed|2
1654449|NCT01632241|5781737|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
1654450|NCT01632241|5781738|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
1654451|NCT01632241|5781737|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
1654452|NCT01632241|5781738|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
1654453|NCT01632241|5781737|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
1654454|NCT01632241|5781738|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
1654455|NCT01632241|5781737|P2|Double-blinded (Up to Week 52)|Adverse Event|19
1654456|NCT01632241|5781738|P1|Double-blinded (Up to Week 52)|Adverse Event|10
1654457|NCT01632241|5781737|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
1654458|NCT01632241|5781738|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
1654459|NCT01632241|5781737|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
1654460|NCT01632241|5781738|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
1654461|NCT01632241|5781737|P2|Double-blinded (Up to Week 52)|Physician Decision|12
1654462|NCT01632241|5781738|P1|Double-blinded (Up to Week 52)|Physician Decision|9
1654463|NCT01632241|5781737|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
1654464|NCT01632241|5781738|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
1654465|NCT01632241|5781737|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
1654466|NCT01632241|5781738|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
1654467|NCT01632241|5781737|P2|Double-blinded (Up to Week 52)|Site Closed|5
1654468|NCT01632241|5781738|P1|Double-blinded (Up to Week 52)|Site Closed|3
1654469|NCT01632150|5781797|P1|Overall Study|Moved to compassionate program|2
1654470|NCT01632150|5781797|P1|Overall Study|Patient underwent autologous transplant|1
1654471|NCT01632150|5781797|P1|Overall Study|Withdrawal by Subject|2
1654472|NCT01632150|5781797|P1|Overall Study|Unrelated adverse event|7
1654473|NCT01632150|5781797|P1|Overall Study|Study drug toxicity|1
1654474|NCT01632150|5781797|P1|Overall Study|Disease progression|27
1654475|NCT01632020|5781806|P2|Overall Study|Adverse Event|0
1654476|NCT01632020|5781807|P1|Overall Study|Adverse Event|1
1654477|NCT01632020|5781806|P2|Overall Study|Withdrawal by Subject|0
1654478|NCT01632020|5781807|P1|Overall Study|Withdrawal by Subject|1
1654479|NCT01631864|5781826|P2|Overall Study|Adverse Event|3
1654480|NCT01631864|5781827|P1|Overall Study|Adverse Event|2
1654481|NCT01631864|5781826|P2|Overall Study|Withdrawal by Subject|1
1654482|NCT01631864|5781827|P1|Overall Study|Withdrawal by Subject|0
1654483|NCT01631825|5781839|P1|Overall Study|Physician Decision|2
1654484|NCT01631825|5781839|P1|Overall Study|Discontinuation criteria|1
1654485|NCT01631825|5781839|P1|Overall Study|Protocol Violation|4
1654486|NCT01631825|5781839|P1|Overall Study|Withdrawal by Subject|9
1654487|NCT01631825|5781839|P1|Overall Study|Lack of Efficacy|7
1654488|NCT01631825|5781839|P1|Overall Study|Adverse Event|42
1654489|NCT01631812|5781859|P1|Overall Study|Physician Decision|3
1654490|NCT01631812|5781859|P1|Overall Study|Withdrawal by Subject|4
1654491|NCT01631812|5781859|P1|Overall Study|Lack of Efficacy|5
1654492|NCT01631812|5781859|P1|Overall Study|Adverse Event|25
1654493|NCT01631747|5781869|P2|One Year Infant Outcomes|Patient Refused|9
1654494|NCT01631747|5781870|P1|One Year Infant Outcomes|Patient Refused|13
1654495|NCT01631747|5781869|P2|Live Birth|Stillbirth|1
1654496|NCT01631747|5781870|P1|Live Birth|Stillbirth|1
1654497|NCT01631747|5781869|P2|Live Birth|MIscarriage|0
1654498|NCT01631747|5781870|P1|Live Birth|MIscarriage|2
1654499|NCT01631747|5781869|P2|Live Birth|Pregnancy Termination|0
1654500|NCT01631747|5781870|P1|Live Birth|Pregnancy Termination|1
1654501|NCT01631747|5781869|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
1654502|NCT01631747|5781870|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
1654503|NCT01631435|5782047|P1|Overall Study|incomplete study procedure|5
1654504|NCT01631435|5782047|P1|Overall Study|Withdrawal by Subject|2
1654505|NCT01631435|5782047|P1|Overall Study|Adverse Event|2
1654506|NCT01631227|5782061|P2|Overall Study|administrative|1
1654507|NCT01631227|5782062|P1|Overall Study|administrative|2
1654508|NCT01631227|5782061|P2|Overall Study|Adverse Event|0
1654509|NCT01631227|5782062|P1|Overall Study|Adverse Event|1
1654510|NCT01631227|5782061|P2|Overall Study|withdrawn consent|21
1654511|NCT01631227|5782062|P1|Overall Study|withdrawn consent|27
1654512|NCT01631214|5782070|P2|Overall Study|Administrative Decision|0
1654513|NCT01631214|5782071|P1|Overall Study|Administrative Decision|1
1654514|NCT01631214|5782070|P2|Overall Study|Ineligibility determined|2
1654515|NCT01631214|5782071|P1|Overall Study|Ineligibility determined|5
1654516|NCT01631214|5782070|P2|Overall Study|Protocol Deviation|3
1654517|NCT01631214|5782071|P1|Overall Study|Protocol Deviation|4
1654518|NCT01631214|5782070|P2|Overall Study|Requirement for Alternative Therapy|3
1654519|NCT01631214|5782071|P1|Overall Study|Requirement for Alternative Therapy|8
1654520|NCT01631214|5782070|P2|Overall Study|Noncompliance|15
1654521|NCT01631214|5782071|P1|Overall Study|Noncompliance|16
1654522|NCT01631214|5782070|P2|Overall Study|Other|19
1654523|NCT01631214|5782071|P1|Overall Study|Other|22
1654524|NCT01631214|5782070|P2|Overall Study|Adverse Event|45
1654525|NCT01631214|5782071|P1|Overall Study|Adverse Event|45
1654526|NCT01631214|5782070|P2|Overall Study|Lost to Follow-up|40
1654527|NCT01631214|5782071|P1|Overall Study|Lost to Follow-up|54
1654528|NCT01631214|5782070|P2|Overall Study|Death|106
1654529|NCT01631214|5782071|P1|Overall Study|Death|113
1654530|NCT01631214|5782070|P2|Overall Study|Withdrawal by Subject|290
1654531|NCT01631214|5782071|P1|Overall Study|Withdrawal by Subject|276
1654532|NCT01630811|5782180|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
1654533|NCT01630811|5782181|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
1654534|NCT01630616|5782208|P6|Overall Study|Withdrawal by Subject|0
1654535|NCT01630616|5782209|P5|Overall Study|Withdrawal by Subject|0
1654536|NCT01630616|5782210|P4|Overall Study|Withdrawal by Subject|2
1654537|NCT01630616|5782211|P3|Overall Study|Withdrawal by Subject|0
1654538|NCT01630616|5782212|P2|Overall Study|Withdrawal by Subject|0
1654539|NCT01630616|5782213|P1|Overall Study|Withdrawal by Subject|0
1654540|NCT01630616|5782208|P6|Overall Study|Adverse Event|0
1654541|NCT01630616|5782209|P5|Overall Study|Adverse Event|0
1654542|NCT01630616|5782210|P4|Overall Study|Adverse Event|1
1654543|NCT01630616|5782211|P3|Overall Study|Adverse Event|0
1654544|NCT01630616|5782212|P2|Overall Study|Adverse Event|0
1654545|NCT01630616|5782213|P1|Overall Study|Adverse Event|0
1654546|NCT01630135|5782313|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
1654547|NCT01630135|5782314|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
1654548|NCT01629966|5782378|P3|Overall Study|Adverse Event|30
1654549|NCT01629966|5782379|P2|Overall Study|Adverse Event|18
1654550|NCT01629966|5782380|P1|Overall Study|Adverse Event|11
1654551|NCT01629966|5782378|P3|Overall Study|Lack of Efficacy|4
1654552|NCT01629966|5782379|P2|Overall Study|Lack of Efficacy|2
1654553|NCT01629966|5782380|P1|Overall Study|Lack of Efficacy|5
1654554|NCT01629966|5782378|P3|Overall Study|Protocol Violation|7
1654555|NCT01629966|5782379|P2|Overall Study|Protocol Violation|9
1654556|NCT01629966|5782380|P1|Overall Study|Protocol Violation|7
1654557|NCT01629966|5782378|P3|Overall Study|Withdrawal by Subject|16
1654558|NCT01629966|5782379|P2|Overall Study|Withdrawal by Subject|9
1654559|NCT01629966|5782380|P1|Overall Study|Withdrawal by Subject|8
1654560|NCT01629966|5782378|P3|Overall Study|Lost to Follow-up|9
1654561|NCT01629966|5782379|P2|Overall Study|Lost to Follow-up|13
1654562|NCT01629966|5782380|P1|Overall Study|Lost to Follow-up|10
1654563|NCT01629966|5782378|P3|Overall Study|Pregnancy|0
1654564|NCT01629966|5782379|P2|Overall Study|Pregnancy|1
1654565|NCT01629966|5782380|P1|Overall Study|Pregnancy|0
1654566|NCT01629953|5782393|P2|Overall Study|Lost to Follow-up|14
1654567|NCT01629953|5782394|P1|Overall Study|Lost to Follow-up|10
1654568|NCT01629953|5782393|P2|Overall Study|Death|1
1654569|NCT01629953|5782394|P1|Overall Study|Death|3
1654570|NCT01629823|5782414|P3|Washout Period|Protocol Violation|0
1654571|NCT01629823|5782415|P2|Washout Period|Protocol Violation|1
1654572|NCT01629823|5782416|P1|Washout Period|Protocol Violation|0
1654573|NCT01629823|5782414|P3|Washout Period|Pregnancy|0
1654574|NCT01629823|5782415|P2|Washout Period|Pregnancy|0
1654575|NCT01629823|5782416|P1|Washout Period|Pregnancy|1
1654576|NCT01629823|5782414|P3|Washout Period|Safety|0
1654577|NCT01629823|5782415|P2|Washout Period|Safety|5
1654578|NCT01629823|5782416|P1|Washout Period|Safety|2
1654579|NCT01629823|5782414|P3|Trial Period|Failed to hold medication|1
1654580|NCT01629823|5782415|P2|Trial Period|Failed to hold medication|0
1654581|NCT01629823|5782416|P1|Trial Period|Failed to hold medication|0
1654582|NCT01629823|5782414|P3|Trial Period|Out-of-window visit|0
1654583|NCT01629823|5782415|P2|Trial Period|Out-of-window visit|2
1654584|NCT01629823|5782416|P1|Trial Period|Out-of-window visit|0
1654585|NCT01629823|5782414|P3|Trial Period|Adverse Event|0
1654586|NCT01629823|5782415|P2|Trial Period|Adverse Event|1
1654587|NCT01629823|5782416|P1|Trial Period|Adverse Event|0
1654588|NCT01629823|5782414|P3|Trial Period|Pregnancy|0
1654589|NCT01629823|5782415|P2|Trial Period|Pregnancy|0
1654590|NCT01629823|5782416|P1|Trial Period|Pregnancy|1
1654591|NCT01629823|5782414|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1654592|NCT01629823|5782415|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1654593|NCT01629823|5782416|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
1654594|NCT01629823|5782414|P3|Trial Period|Missed visit|8
1654595|NCT01629823|5782415|P2|Trial Period|Missed visit|9
1654596|NCT01629823|5782416|P1|Trial Period|Missed visit|11
1654597|NCT01629706|5782451|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
1654598|NCT01629706|5782451|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
1654599|NCT01629706|5782451|P1|Phase 2 Habitual|Relocation prior to Dispense|1
1654600|NCT01629706|5782451|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
1654601|NCT01629706|5782451|P1|Phase 2 Habitual|Screen Failure|6
1654602|NCT01629706|5782451|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
1654603|NCT01629706|5782451|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
1654604|NCT01629706|5782451|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
1654605|NCT01629706|5782451|P1|Phase 1 PureVision|Screen Failure|4
1654606|NCT01629693|5782479|P2|Overall Study|Subject decision unrelated to AE|1
1654607|NCT01629693|5782480|P1|Overall Study|Subject decision unrelated to AE|0
1654608|NCT01629693|5782479|P2|Overall Study|Poor comfort of study lenses|2
1654609|NCT01629693|5782480|P1|Overall Study|Poor comfort of study lenses|0
1654610|NCT01629693|5782479|P2|Overall Study|Investigator decision|1
1654611|NCT01629693|5782480|P1|Overall Study|Investigator decision|0
1654612|NCT01629693|5782479|P2|Overall Study|Adverse Event|0
1654613|NCT01629693|5782480|P1|Overall Study|Adverse Event|1
1654614|NCT01629693|5782479|P2|Overall Study|Withdrawal by Subject|2
1654615|NCT01629693|5782480|P1|Overall Study|Withdrawal by Subject|2
1654616|NCT01629693|5782479|P2|Overall Study|Lost to Follow-up|4
1654617|NCT01629693|5782480|P1|Overall Study|Lost to Follow-up|2
1654618|NCT01629667|5782489|P3|Overall Study|Code break|0
1654619|NCT01629667|5782490|P2|Overall Study|Code break|0
1654620|NCT01629667|5782491|P1|Overall Study|Code break|1
1654621|NCT01629667|5782489|P3|Overall Study|Enrolled in another clinical study|0
1654622|NCT01629667|5782490|P2|Overall Study|Enrolled in another clinical study|1
1654623|NCT01629667|5782491|P1|Overall Study|Enrolled in another clinical study|0
1654624|NCT01629667|5782489|P3|Overall Study|Site error in safety follow-up|1
1654625|NCT01629667|5782490|P2|Overall Study|Site error in safety follow-up|0
1654626|NCT01629667|5782491|P1|Overall Study|Site error in safety follow-up|0
1654627|NCT01629667|5782489|P3|Overall Study|Started other medicine|1
1654628|NCT01629667|5782490|P2|Overall Study|Started other medicine|0
1654629|NCT01629667|5782491|P1|Overall Study|Started other medicine|1
1654630|NCT01629667|5782489|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
1654631|NCT01629667|5782490|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
1654632|NCT01629667|5782491|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
1654633|NCT01629667|5782489|P3|Overall Study|Requiring lung transplant|3
1654634|NCT01629667|5782490|P2|Overall Study|Requiring lung transplant|1
1654635|NCT01629667|5782491|P1|Overall Study|Requiring lung transplant|2
1654636|NCT01629667|5782489|P3|Overall Study|Ongoing AE worsening right heart failure|0
1654637|NCT01629667|5782490|P2|Overall Study|Ongoing AE worsening right heart failure|1
1654638|NCT01629667|5782491|P1|Overall Study|Ongoing AE worsening right heart failure|0
1654639|NCT01629667|5782489|P3|Overall Study|Randomized, not treated|0
1654640|NCT01629667|5782490|P2|Overall Study|Randomized, not treated|1
1654641|NCT01629667|5782491|P1|Overall Study|Randomized, not treated|2
1654642|NCT01629667|5782489|P3|Overall Study|Death|3
1654643|NCT01629667|5782490|P2|Overall Study|Death|5
1654644|NCT01629667|5782491|P1|Overall Study|Death|1
1654645|NCT01629667|5782489|P3|Overall Study|Withdrawal by Subject|28
1654646|NCT01629667|5782490|P2|Overall Study|Withdrawal by Subject|20
1654647|NCT01629667|5782491|P1|Overall Study|Withdrawal by Subject|31
1654648|NCT01629667|5782489|P3|Overall Study|Lost to Follow-up|1
1654649|NCT01629667|5782490|P2|Overall Study|Lost to Follow-up|1
1654650|NCT01629667|5782491|P1|Overall Study|Lost to Follow-up|0
1654651|NCT01629589|5782575|P2|Overall Study|Did not receive study vaccine|1
1654652|NCT01629589|5782576|P1|Overall Study|Did not receive study vaccine|0
1654653|NCT01629589|5782575|P2|Overall Study|Withdrawal by Subject|3
1654654|NCT01629589|5782576|P1|Overall Study|Withdrawal by Subject|2
1654655|NCT01629589|5782575|P2|Overall Study|Lost to Follow-up|1
1654656|NCT01629589|5782576|P1|Overall Study|Lost to Follow-up|2
1654657|NCT01629589|5782575|P2|Overall Study|Protocol Violation|2
1654658|NCT01629589|5782576|P1|Overall Study|Protocol Violation|4
1654659|NCT01629563|5782594|P2|Overall Study|Protocol Violation|1
1654660|NCT01629563|5782595|P1|Overall Study|Protocol Violation|0
1654661|NCT01629563|5782594|P2|Overall Study|Lack of return of menses|7
1654662|NCT01629563|5782595|P1|Overall Study|Lack of return of menses|12
1654663|NCT01629563|5782594|P2|Overall Study|surgery|3
1654664|NCT01629563|5782595|P1|Overall Study|surgery|0
1654665|NCT01629563|5782594|P2|Overall Study|Withdrawal by Subject|20
1654666|NCT01629563|5782595|P1|Overall Study|Withdrawal by Subject|27
1654667|NCT01629563|5782594|P2|Overall Study|Protocol Violation|1
1654668|NCT01629563|5782595|P1|Overall Study|Protocol Violation|0
1654669|NCT01629563|5782594|P2|Overall Study|Pregnancy|2
1654670|NCT01629563|5782595|P1|Overall Study|Pregnancy|1
1654671|NCT01629563|5782594|P2|Overall Study|Lost to Follow-up|0
1654672|NCT01629563|5782595|P1|Overall Study|Lost to Follow-up|1
1654673|NCT01629563|5782594|P2|Overall Study|Lack of Efficacy|3
1654674|NCT01629563|5782595|P1|Overall Study|Lack of Efficacy|2
1654675|NCT01629563|5782594|P2|Overall Study|Death|0
1654676|NCT01629563|5782595|P1|Overall Study|Death|2
1654677|NCT01629563|5782594|P2|Overall Study|Adverse Event|16
1654678|NCT01629563|5782595|P1|Overall Study|Adverse Event|16
1654679|NCT01628965|5782673|P1|Overall Study|Discontinuation criteria|8
1654680|NCT01628965|5782673|P1|Overall Study|Lost to Follow-up|1
1654681|NCT01628965|5782673|P1|Overall Study|Withdrawal by Subject|3
1654682|NCT01628965|5782673|P1|Overall Study|Lack of Efficacy|7
1654683|NCT01628965|5782673|P1|Overall Study|Adverse Event|30
1654684|NCT01628926|5782682|P3|Overall Study|Physician Decision|1
1654685|NCT01628926|5782683|P2|Overall Study|Physician Decision|2
1654686|NCT01628926|5782684|P1|Overall Study|Physician Decision|2
1654687|NCT01628926|5782682|P3|Overall Study|Discontinuation criteria|0
1654688|NCT01628926|5782683|P2|Overall Study|Discontinuation criteria|4
1654689|NCT01628926|5782684|P1|Overall Study|Discontinuation criteria|3
1654690|NCT01628926|5782682|P3|Overall Study|Protocol Violation|0
1654691|NCT01628926|5782683|P2|Overall Study|Protocol Violation|1
1654692|NCT01628926|5782684|P1|Overall Study|Protocol Violation|0
1654693|NCT01628926|5782682|P3|Overall Study|Withdrawal by Subject|2
1654694|NCT01628926|5782683|P2|Overall Study|Withdrawal by Subject|4
1654695|NCT01628926|5782684|P1|Overall Study|Withdrawal by Subject|6
1654696|NCT01628926|5782682|P3|Overall Study|Lack of Efficacy|5
1654697|NCT01628926|5782683|P2|Overall Study|Lack of Efficacy|1
1654698|NCT01628926|5782684|P1|Overall Study|Lack of Efficacy|2
1654699|NCT01628926|5782682|P3|Overall Study|Adverse Event|9
1654700|NCT01628926|5782683|P2|Overall Study|Adverse Event|11
1654701|NCT01628926|5782684|P1|Overall Study|Adverse Event|13
1654702|NCT01628913|5782733|P2|Overall Study|Physician Decision|3
1654703|NCT01628913|5782734|P1|Overall Study|Physician Decision|1
1654704|NCT01628913|5782733|P2|Overall Study|Withdrawal by Subject|0
1654705|NCT01628913|5782734|P1|Overall Study|Withdrawal by Subject|1
1654706|NCT01628913|5782733|P2|Overall Study|study terminated by Sponsor|9
1654707|NCT01628913|5782734|P1|Overall Study|study terminated by Sponsor|4
1654708|NCT01628913|5782733|P2|Overall Study|Death|0
1654709|NCT01628913|5782734|P1|Overall Study|Death|1
1654710|NCT01628913|5782733|P2|Overall Study|Protocol Violation|0
1654711|NCT01628913|5782734|P1|Overall Study|Protocol Violation|1
1654712|NCT01628913|5782733|P2|Overall Study|Disease Progression|14
1654713|NCT01628913|5782734|P1|Overall Study|Disease Progression|11
1654714|NCT01628913|5782733|P2|Overall Study|Adverse Event|5
1654715|NCT01628913|5782734|P1|Overall Study|Adverse Event|12
1654716|NCT01628874|5782748|P2|Overall Study|Age >4 months|2
1654717|NCT01628874|5782749|P1|Overall Study|Age >4 months|4
1654718|NCT01628874|5782748|P2|Overall Study|Physician Decision|1
1654719|NCT01628874|5782749|P1|Overall Study|Physician Decision|1
1654720|NCT01628848|5782765|P2|Overall Study|Physician Decision|1
1654721|NCT01628848|5782766|P1|Overall Study|Physician Decision|3
1654722|NCT01628848|5782765|P2|Overall Study|Withdrawal by Subject|2
1654723|NCT01628848|5782766|P1|Overall Study|Withdrawal by Subject|0
1654724|NCT01628848|5782765|P2|Overall Study|Lack of Efficacy|4
1654725|NCT01628848|5782766|P1|Overall Study|Lack of Efficacy|0
1654726|NCT01628848|5782765|P2|Overall Study|Adverse Event|7
1654727|NCT01628848|5782766|P1|Overall Study|Adverse Event|9
1654728|NCT01628692|5782800|P6|Overall Study|Completed 12 Week only|1
1654729|NCT01628692|5782801|P5|Overall Study|Completed 12 Week only|0
1654730|NCT01628692|5782802|P4|Overall Study|Completed 12 Week only|0
1654731|NCT01628692|5782803|P3|Overall Study|Completed 12 Week only|0
1654732|NCT01628692|5782804|P2|Overall Study|Completed 12 Week only|0
1654733|NCT01628692|5782805|P1|Overall Study|Completed 12 Week only|0
1654734|NCT01628692|5782800|P6|Overall Study|Administrative reason by sponsor|1
1654735|NCT01628692|5782801|P5|Overall Study|Administrative reason by sponsor|0
1654736|NCT01628692|5782802|P4|Overall Study|Administrative reason by sponsor|0
1654737|NCT01628692|5782803|P3|Overall Study|Administrative reason by sponsor|0
1654738|NCT01628692|5782804|P2|Overall Study|Administrative reason by sponsor|0
1654739|NCT01628692|5782805|P1|Overall Study|Administrative reason by sponsor|0
1654740|NCT01628692|5782800|P6|Overall Study|Poor compliance/noncompliance|0
1654741|NCT01628692|5782801|P5|Overall Study|Poor compliance/noncompliance|0
1654742|NCT01628692|5782802|P4|Overall Study|Poor compliance/noncompliance|0
1654743|NCT01628692|5782803|P3|Overall Study|Poor compliance/noncompliance|0
1654744|NCT01628692|5782804|P2|Overall Study|Poor compliance/noncompliance|0
1654745|NCT01628692|5782805|P1|Overall Study|Poor compliance/noncompliance|1
1654746|NCT01628692|5782800|P6|Overall Study|Death|0
1654747|NCT01628692|5782801|P5|Overall Study|Death|0
1654748|NCT01628692|5782802|P4|Overall Study|Death|0
1654749|NCT01628692|5782803|P3|Overall Study|Death|0
1654750|NCT01628692|5782804|P2|Overall Study|Death|1
1654751|NCT01628692|5782805|P1|Overall Study|Death|0
1654752|NCT01628692|5782800|P6|Overall Study|Withdrawal by Subject|0
1654753|NCT01628692|5782801|P5|Overall Study|Withdrawal by Subject|0
1654754|NCT01628692|5782802|P4|Overall Study|Withdrawal by Subject|0
1654755|NCT01628692|5782803|P3|Overall Study|Withdrawal by Subject|1
1654756|NCT01628692|5782804|P2|Overall Study|Withdrawal by Subject|1
1654757|NCT01628692|5782805|P1|Overall Study|Withdrawal by Subject|0
1654758|NCT01628692|5782800|P6|Overall Study|Adverse Event|0
1654759|NCT01628692|5782801|P5|Overall Study|Adverse Event|0
1654760|NCT01628692|5782802|P4|Overall Study|Adverse Event|0
1654761|NCT01628692|5782803|P3|Overall Study|Adverse Event|2
1654762|NCT01628692|5782804|P2|Overall Study|Adverse Event|0
1654763|NCT01628692|5782805|P1|Overall Study|Adverse Event|2
1654764|NCT01628692|5782800|P6|Overall Study|Lack of Efficacy|7
1654765|NCT01628692|5782801|P5|Overall Study|Lack of Efficacy|4
1654766|NCT01628692|5782802|P4|Overall Study|Lack of Efficacy|1
1654767|NCT01628692|5782803|P3|Overall Study|Lack of Efficacy|5
1654768|NCT01628692|5782804|P2|Overall Study|Lack of Efficacy|4
1654769|NCT01628692|5782805|P1|Overall Study|Lack of Efficacy|4
1654770|NCT01628549|5782875|P4|Overall Study|positive pregnancy test|1
1654771|NCT01628549|5782876|P3|Overall Study|positive pregnancy test|0
1654772|NCT01628549|5782877|P2|Overall Study|positive pregnancy test|0
1654773|NCT01628549|5782878|P1|Overall Study|positive pregnancy test|0
1654774|NCT01628549|5782875|P4|Overall Study|abnormal laboratory test results|0
1654775|NCT01628549|5782876|P3|Overall Study|abnormal laboratory test results|1
1654776|NCT01628549|5782877|P2|Overall Study|abnormal laboratory test results|0
1654777|NCT01628549|5782878|P1|Overall Study|abnormal laboratory test results|0
1654778|NCT01628549|5782875|P4|Overall Study|withdrawn for noncompliance|0
1654779|NCT01628549|5782876|P3|Overall Study|withdrawn for noncompliance|1
1654780|NCT01628549|5782877|P2|Overall Study|withdrawn for noncompliance|2
1654781|NCT01628549|5782878|P1|Overall Study|withdrawn for noncompliance|0
1654782|NCT01628549|5782875|P4|Overall Study|Protocol Violation|0
1654783|NCT01628549|5782876|P3|Overall Study|Protocol Violation|1
1654784|NCT01628549|5782877|P2|Overall Study|Protocol Violation|1
1654785|NCT01628549|5782878|P1|Overall Study|Protocol Violation|2
1654786|NCT01628549|5782875|P4|Overall Study|Withdrawal by Subject|1
1654787|NCT01628549|5782876|P3|Overall Study|Withdrawal by Subject|4
1654788|NCT01628549|5782877|P2|Overall Study|Withdrawal by Subject|4
1654789|NCT01628549|5782878|P1|Overall Study|Withdrawal by Subject|3
1654790|NCT01628549|5782875|P4|Overall Study|Lost to Follow-up|3
1654791|NCT01628549|5782876|P3|Overall Study|Lost to Follow-up|3
1654792|NCT01628549|5782877|P2|Overall Study|Lost to Follow-up|4
1654793|NCT01628549|5782878|P1|Overall Study|Lost to Follow-up|3
1654794|NCT01628549|5782875|P4|Overall Study|Adverse Event|4
1654795|NCT01628549|5782876|P3|Overall Study|Adverse Event|0
1654796|NCT01628549|5782877|P2|Overall Study|Adverse Event|1
1654797|NCT01628549|5782878|P1|Overall Study|Adverse Event|1
1654798|NCT01628510|5782914|P2|Overall Study|Death|1
1654799|NCT01628510|5782915|P1|Overall Study|Death|3
1654800|NCT01628510|5782914|P2|Overall Study|Withdrawal by Subject|4
1654801|NCT01628510|5782915|P1|Overall Study|Withdrawal by Subject|0
1654802|NCT01628367|5782925|P2|Overall Study|Adverse Event|0
1654803|NCT01628367|5782926|P1|Overall Study|Adverse Event|1
1654804|NCT01628198|5782945|P1|Overall Study|Screen failure|1
1654805|NCT01628198|5782945|P1|Overall Study|Withdrawal by Subject|10
1654806|NCT01628198|5782945|P1|Overall Study|Lost to Follow-up|7
1654807|NCT01628120|5782958|P1|Overall Study|Use of Standard of Care|1
1654808|NCT01628120|5782958|P1|Overall Study|Kidney Transplant|2
1654809|NCT01628120|5782958|P1|Overall Study|Moved or Relocated|5
1654810|NCT01628120|5782958|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
1654811|NCT01628120|5782958|P1|Overall Study|Switched Dialysis Method|2
1654812|NCT01628120|5782958|P1|Overall Study|Sponsor Decision|5
1654813|NCT01628120|5782958|P1|Overall Study|Not Treated|3
1654814|NCT01628120|5782958|P1|Overall Study|Non-compliant with Study Procedures|1
1654815|NCT01628120|5782958|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
1654816|NCT01628120|5782958|P1|Overall Study|Lost to Follow-up|1
1654817|NCT01628120|5782958|P1|Overall Study|Adverse Event|12
1654818|NCT01628120|5782958|P1|Overall Study|Withdrawal by Subject|7
1654819|NCT01628107|5782983|P1|Overall Study|Use of Standard of Care|9
1654820|NCT01628107|5782983|P1|Overall Study|Kidney Transplant|9
1654821|NCT01628107|5782983|P1|Overall Study|Relocated|8
1654822|NCT01628107|5782983|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
1654823|NCT01628107|5782983|P1|Overall Study|Sponsor Decision|11
1654824|NCT01628107|5782983|P1|Overall Study|Not Treated|8
1654825|NCT01628107|5782983|P1|Overall Study|Non-compliant with Study Procedures|10
1654826|NCT01628107|5782983|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
1654827|NCT01628107|5782983|P1|Overall Study|Physician Decision|2
1654828|NCT01628107|5782983|P1|Overall Study|Adverse Event|33
1654829|NCT01628107|5782983|P1|Overall Study|Lost to Follow-up|4
1654830|NCT01628107|5782983|P1|Overall Study|Withdrawal by Subject|17
1654831|NCT01627899|5783049|P1|Overall Study|Study terminated early by sponsor.|5
1654832|NCT01627860|5783059|P2|Overall Study|Protocol Violation|0
1654833|NCT01627860|5783060|P1|Overall Study|Protocol Violation|1
1654834|NCT01627860|5783059|P2|Overall Study|Seizure frequency doubled|1
1654835|NCT01627860|5783060|P1|Overall Study|Seizure frequency doubled|0
1654836|NCT01627860|5783059|P2|Overall Study|Withdrawal by Subject|1
1654837|NCT01627860|5783060|P1|Overall Study|Withdrawal by Subject|2
1654838|NCT01627860|5783059|P2|Overall Study|Adverse Event|4
1654839|NCT01627860|5783060|P1|Overall Study|Adverse Event|9
1654840|NCT01627782|5783074|P4|Overall Study|Randomized But Not Treated|0
1654841|NCT01627782|5783075|P3|Overall Study|Randomized But Not Treated|0
1654842|NCT01627782|5783076|P2|Overall Study|Randomized But Not Treated|0
1654843|NCT01627782|5783077|P1|Overall Study|Randomized But Not Treated|1
1654844|NCT01627782|5783074|P4|Overall Study|Other|3
1654845|NCT01627782|5783075|P3|Overall Study|Other|0
1654846|NCT01627782|5783076|P2|Overall Study|Other|2
1654847|NCT01627782|5783077|P1|Overall Study|Other|0
1654848|NCT01627782|5783074|P4|Overall Study|Withdrawal by Subject|0
1654849|NCT01627782|5783075|P3|Overall Study|Withdrawal by Subject|0
1654850|NCT01627782|5783076|P2|Overall Study|Withdrawal by Subject|1
1654851|NCT01627782|5783077|P1|Overall Study|Withdrawal by Subject|2
1654852|NCT01627782|5783074|P4|Overall Study|Protocol Violation|0
1654853|NCT01627782|5783075|P3|Overall Study|Protocol Violation|0
1654854|NCT01627782|5783076|P2|Overall Study|Protocol Violation|0
1654855|NCT01627782|5783077|P1|Overall Study|Protocol Violation|1
1654856|NCT01627782|5783074|P4|Overall Study|Lack of Efficacy|2
1654857|NCT01627782|5783075|P3|Overall Study|Lack of Efficacy|15
1654858|NCT01627782|5783076|P2|Overall Study|Lack of Efficacy|1
1654859|NCT01627782|5783077|P1|Overall Study|Lack of Efficacy|11
1654860|NCT01627782|5783074|P4|Overall Study|Adverse Event|1
1654861|NCT01627782|5783075|P3|Overall Study|Adverse Event|0
1654862|NCT01627782|5783076|P2|Overall Study|Adverse Event|2
1654863|NCT01627782|5783077|P1|Overall Study|Adverse Event|1
1654864|NCT01627691|5783133|P1|Overall Study|Missed the visit|3
1654865|NCT01627691|5783133|P1|Overall Study|Withdrawal by Subject|1
1654866|NCT01627691|5783133|P1|Overall Study|Lost to Follow-up|3
1654867|NCT01627691|5783133|P1|Overall Study|Death|11
1654868|NCT01627561|5783140|P2|Overall Study|Withdrawal by Subject|2
1654869|NCT01627561|5783141|P1|Overall Study|Withdrawal by Subject|0
1654870|NCT01627561|5783140|P2|Overall Study|Migrated/moved from study area|1
1654871|NCT01627561|5783141|P1|Overall Study|Migrated/moved from study area|0
1654872|NCT01627340|5783189|P2|Overall Study|Withdrawal by Subject|0
1654873|NCT01627340|5783190|P1|Overall Study|Withdrawal by Subject|2
1654874|NCT01627340|5783189|P2|Overall Study|Pregnancy|0
1654875|NCT01627340|5783190|P1|Overall Study|Pregnancy|1
1654876|NCT01627340|5783189|P2|Overall Study|Lost to Follow-up|4
1654877|NCT01627340|5783190|P1|Overall Study|Lost to Follow-up|8
1654878|NCT01627340|5783189|P2|Overall Study|Adverse Event|0
1654879|NCT01627340|5783190|P1|Overall Study|Adverse Event|1
1654880|NCT01627327|5783208|P2|Overall Study|Withdrawal by Subject|3
1654881|NCT01627327|5783209|P1|Overall Study|Withdrawal by Subject|3
1654882|NCT01627327|5783208|P2|Overall Study|Physician Decision|0
1654883|NCT01627327|5783209|P1|Overall Study|Physician Decision|1
1654884|NCT01627327|5783208|P2|Overall Study|Lost to Follow-up|3
1654885|NCT01627327|5783209|P1|Overall Study|Lost to Follow-up|1
1654886|NCT01627327|5783208|P2|Overall Study|Protocol Violation|10
1654887|NCT01627327|5783209|P1|Overall Study|Protocol Violation|4
1654888|NCT01627327|5783208|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
1654889|NCT01627327|5783209|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
1654890|NCT01627327|5783208|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
1654891|NCT01627327|5783209|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
1654892|NCT01627327|5783208|P2|Overall Study|Adverse Event|12
1654893|NCT01627327|5783209|P1|Overall Study|Adverse Event|6
1654894|NCT01627249|5783222|P3|Overall Study|Missed Visit|0
1654895|NCT01627249|5783223|P2|Overall Study|Missed Visit|1
1654896|NCT01627249|5783224|P1|Overall Study|Missed Visit|1
1654897|NCT01627249|5783222|P3|Overall Study|Withdrawal by Subject|9
1654898|NCT01627249|5783223|P2|Overall Study|Withdrawal by Subject|6
1654899|NCT01627249|5783224|P1|Overall Study|Withdrawal by Subject|12
1654900|NCT01627249|5783222|P3|Overall Study|Death|3
1654901|NCT01627249|5783223|P2|Overall Study|Death|5
1654902|NCT01627249|5783224|P1|Overall Study|Death|3
1654903|NCT01626989|5783320|P3|Screening Period|Withdrawal by Subject|0
1654904|NCT01626989|5783321|P2|Screening Period|Withdrawal by Subject|0
1654905|NCT01626989|5783322|P1|Screening Period|Withdrawal by Subject|2
1654906|NCT01626989|5783320|P3|Screening Period|Screen Failure|0
1654907|NCT01626989|5783321|P2|Screening Period|Screen Failure|0
1654908|NCT01626989|5783322|P1|Screening Period|Screen Failure|15
1654909|NCT01626690|5783394|P2|Overall Study|Adverse Event|0
1654910|NCT01626690|5783395|P1|Overall Study|Adverse Event|1
1654911|NCT01626690|5783394|P2|Overall Study|Protocol Violation|0
1654912|NCT01626690|5783395|P1|Overall Study|Protocol Violation|1
1654913|NCT01626456|5783434|P2|Overall Study|Incarceration|2
1654914|NCT01626456|5783435|P1|Overall Study|Incarceration|0
1654915|NCT01626456|5783434|P2|Overall Study|Site Closure|3
1654916|NCT01626456|5783435|P1|Overall Study|Site Closure|2
1654917|NCT01626456|5783434|P2|Overall Study|Protocol Violation|1
1654918|NCT01626456|5783435|P1|Overall Study|Protocol Violation|1
1654919|NCT01626456|5783434|P2|Overall Study|Physician Decision|4
1654920|NCT01626456|5783435|P1|Overall Study|Physician Decision|1
1654921|NCT01626456|5783434|P2|Overall Study|Lack of Efficacy|7
1654922|NCT01626456|5783435|P1|Overall Study|Lack of Efficacy|6
1654923|NCT01626456|5783434|P2|Overall Study|Lost to Follow-up|27
1654924|NCT01626456|5783435|P1|Overall Study|Lost to Follow-up|2
1654925|NCT01626456|5783434|P2|Overall Study|Adverse Event|27
1654926|NCT01626456|5783435|P1|Overall Study|Adverse Event|2
1654927|NCT01626456|5783434|P2|Overall Study|Withdrawal by Subject|46
1654928|NCT01626456|5783435|P1|Overall Study|Withdrawal by Subject|21
1654929|NCT01626391|5783465|P2|Overall Study|Withdrawal by Subject|0
1654930|NCT01626391|5783466|P1|Overall Study|Withdrawal by Subject|1
1654931|NCT01626391|5783465|P2|Overall Study|Physician Decision|0
1654932|NCT01626391|5783466|P1|Overall Study|Physician Decision|1
1654933|NCT01626352|5783472|P1|Overall Study|Never Treated|1
1654934|NCT01626352|5783472|P1|Overall Study|Non-Compliance|1
1654935|NCT01626352|5783472|P1|Overall Study|Withdrawal by Subject|1
1654936|NCT01626352|5783472|P1|Overall Study|Death|2
1654937|NCT01626352|5783472|P1|Overall Study|Intercurrent Illness|2
1654938|NCT01626352|5783472|P1|Overall Study|Disease Progression|3
1654939|NCT01626118|5783486|P4|Overall Study|Investigator Decision|0
1654940|NCT01626118|5783487|P3|Overall Study|Investigator Decision|0
1654941|NCT01626118|5783488|P2|Overall Study|Investigator Decision|1
1654942|NCT01626118|5783489|P1|Overall Study|Investigator Decision|0
1654943|NCT01626118|5783486|P4|Overall Study|Adverse Event|0
1654944|NCT01626118|5783487|P3|Overall Study|Adverse Event|1
1654945|NCT01626118|5783488|P2|Overall Study|Adverse Event|1
1654946|NCT01626118|5783489|P1|Overall Study|Adverse Event|0
1654947|NCT01626118|5783486|P4|Overall Study|Lost to Follow-up|0
1654948|NCT01626118|5783487|P3|Overall Study|Lost to Follow-up|0
1654949|NCT01626118|5783488|P2|Overall Study|Lost to Follow-up|0
1654950|NCT01626118|5783489|P1|Overall Study|Lost to Follow-up|1
1654951|NCT01626118|5783486|P4|Overall Study|Lack of Efficacy|3
1654952|NCT01626118|5783487|P3|Overall Study|Lack of Efficacy|1
1654953|NCT01626118|5783488|P2|Overall Study|Lack of Efficacy|0
1654954|NCT01626118|5783489|P1|Overall Study|Lack of Efficacy|1
1654955|NCT01625988|5783535|P2|Overall Study|Protocol Violation|2
1654956|NCT01625988|5783536|P1|Overall Study|Protocol Violation|0
1654957|NCT01625988|5783535|P2|Overall Study|Randomized Inappropriately|0
1654958|NCT01625988|5783536|P1|Overall Study|Randomized Inappropriately|1
1654959|NCT01625988|5783535|P2|Overall Study|Lack of Efficacy|1
1654960|NCT01625988|5783536|P1|Overall Study|Lack of Efficacy|0
1654961|NCT01625988|5783535|P2|Overall Study|Adverse Event|1
1654962|NCT01625988|5783536|P1|Overall Study|Adverse Event|0
1654963|NCT01625988|5783535|P2|Overall Study|Withdrawal by Subject|3
1654964|NCT01625988|5783536|P1|Overall Study|Withdrawal by Subject|8
1654965|NCT01625988|5783535|P2|Overall Study|Lost to Follow-up|6
1654966|NCT01625988|5783536|P1|Overall Study|Lost to Follow-up|5
1654967|NCT01625910|5783560|P2|Overall Study|Lost to Follow-up|4
1654968|NCT01625910|5783561|P1|Overall Study|Lost to Follow-up|3
1654969|NCT01625845|5783571|P2|Overall Study|Withdrawal by Subject|0
1654970|NCT01625845|5783572|P1|Overall Study|Withdrawal by Subject|2
1654971|NCT01625845|5783571|P2|Overall Study|Lost to Follow-up|1
1654972|NCT01625845|5783572|P1|Overall Study|Lost to Follow-up|2
1654973|NCT01625845|5783571|P2|Overall Study|Adverse Event|2
1654974|NCT01625845|5783572|P1|Overall Study|Adverse Event|1
1654975|NCT01625689|5783592|P2|Overall Study|Migration|1
1654976|NCT01625689|5783593|P1|Overall Study|Migration|2
1654977|NCT01625377|5783648|P2|Overall Study|Abnormal laboratory values|0
1654978|NCT01625377|5783649|P1|Overall Study|Abnormal laboratory values|1
1654979|NCT01625377|5783648|P2|Overall Study|Unsatisfactory therapeutic effect|1
1654980|NCT01625377|5783649|P1|Overall Study|Unsatisfactory therapeutic effect|0
1654981|NCT01625377|5783648|P2|Overall Study|Graft loss|0
1654982|NCT01625377|5783649|P1|Overall Study|Graft loss|1
1654983|NCT01625377|5783648|P2|Overall Study|Adverse Event|16
1654984|NCT01625377|5783649|P1|Overall Study|Adverse Event|3
1654985|NCT01625377|5783648|P2|Overall Study|Protocol Violation|3
1654986|NCT01625377|5783649|P1|Overall Study|Protocol Violation|0
1654987|NCT01625377|5783648|P2|Overall Study|Administrative Problem|1
1654988|NCT01625377|5783649|P1|Overall Study|Administrative Problem|1
1654989|NCT01625377|5783648|P2|Overall Study|Death|1
1654990|NCT01625377|5783649|P1|Overall Study|Death|1
1654991|NCT01625338|5783682|P3|Overall Study|Study Discontinued by Sponsor|1
1654992|NCT01625338|5783683|P2|Overall Study|Study Discontinued by Sponsor|0
1654993|NCT01625338|5783684|P1|Overall Study|Study Discontinued by Sponsor|0
1654994|NCT01625338|5783682|P3|Overall Study|Adverse Event|1
1654995|NCT01625338|5783683|P2|Overall Study|Adverse Event|0
1654996|NCT01625338|5783684|P1|Overall Study|Adverse Event|1
1654997|NCT01625338|5783682|P3|Overall Study|Subject Withdrew Consent|2
1654998|NCT01625338|5783683|P2|Overall Study|Subject Withdrew Consent|0
1654999|NCT01625338|5783684|P1|Overall Study|Subject Withdrew Consent|1
1655000|NCT01625338|5783682|P3|Overall Study|Investigator Decision|1
1655001|NCT01625338|5783683|P2|Overall Study|Investigator Decision|2
1655002|NCT01625338|5783684|P1|Overall Study|Investigator Decision|0
1655003|NCT01625338|5783682|P3|Overall Study|Lost to Follow-up|2
1655004|NCT01625338|5783683|P2|Overall Study|Lost to Follow-up|3
1655005|NCT01625338|5783684|P1|Overall Study|Lost to Follow-up|3
1655006|NCT01625338|5783682|P3|Overall Study|Efficacy Failure|31
1655007|NCT01625338|5783683|P2|Overall Study|Efficacy Failure|39
1655008|NCT01625338|5783684|P1|Overall Study|Efficacy Failure|27
1655009|NCT01625338|5783682|P3|Overall Study|Enrolled but not Treated|1
1655010|NCT01625338|5783683|P2|Overall Study|Enrolled but not Treated|0
1655011|NCT01625338|5783684|P1|Overall Study|Enrolled but not Treated|0
1655012|NCT01625286|5783711|P7|Overall Study|Ongoing on-treatment at DCO|6
1655013|NCT01625286|5783712|P6|Overall Study|Ongoing on-treatment at DCO|8
1655014|NCT01625286|5783713|P5|Overall Study|Ongoing on-treatment at DCO|0
1655015|NCT01625286|5783714|P4|Overall Study|Ongoing on-treatment at DCO|0
1655016|NCT01625286|5783715|P3|Overall Study|Ongoing on-treatment at DCO|0
1655017|NCT01625286|5783716|P2|Overall Study|Ongoing on-treatment at DCO|4
1655018|NCT01625286|5783717|P1|Overall Study|Ongoing on-treatment at DCO|6
1655019|NCT01625286|5783711|P7|Overall Study|Ongoing off-treatment at DCO|31
1655020|NCT01625286|5783712|P6|Overall Study|Ongoing off-treatment at DCO|32
1655021|NCT01625286|5783713|P5|Overall Study|Ongoing off-treatment at DCO|0
1655022|NCT01625286|5783714|P4|Overall Study|Ongoing off-treatment at DCO|0
1655023|NCT01625286|5783715|P3|Overall Study|Ongoing off-treatment at DCO|0
1655024|NCT01625286|5783716|P2|Overall Study|Ongoing off-treatment at DCO|0
1655025|NCT01625286|5783717|P1|Overall Study|Ongoing off-treatment at DCO|0
1655026|NCT01625286|5783711|P7|Overall Study|Lost to Follow-up|1
1655027|NCT01625286|5783712|P6|Overall Study|Lost to Follow-up|0
1655028|NCT01625286|5783713|P5|Overall Study|Lost to Follow-up|0
1655029|NCT01625286|5783714|P4|Overall Study|Lost to Follow-up|0
1655030|NCT01625286|5783715|P3|Overall Study|Lost to Follow-up|0
1655031|NCT01625286|5783716|P2|Overall Study|Lost to Follow-up|0
1655032|NCT01625286|5783717|P1|Overall Study|Lost to Follow-up|0
1655033|NCT01625286|5783711|P7|Overall Study|Progressive disease|0
1655034|NCT01625286|5783712|P6|Overall Study|Progressive disease|0
1655035|NCT01625286|5783713|P5|Overall Study|Progressive disease|5
1655036|NCT01625286|5783714|P4|Overall Study|Progressive disease|5
1655037|NCT01625286|5783715|P3|Overall Study|Progressive disease|4
1655038|NCT01625286|5783716|P2|Overall Study|Progressive disease|3
1655039|NCT01625286|5783717|P1|Overall Study|Progressive disease|6
1655040|NCT01625286|5783711|P7|Overall Study|Any reason not specifically recorded|0
1655041|NCT01625286|5783712|P6|Overall Study|Any reason not specifically recorded|1
1655042|NCT01625286|5783713|P5|Overall Study|Any reason not specifically recorded|0
1655043|NCT01625286|5783714|P4|Overall Study|Any reason not specifically recorded|0
1655044|NCT01625286|5783715|P3|Overall Study|Any reason not specifically recorded|0
1655045|NCT01625286|5783716|P2|Overall Study|Any reason not specifically recorded|0
1655046|NCT01625286|5783717|P1|Overall Study|Any reason not specifically recorded|0
1655047|NCT01625286|5783711|P7|Overall Study|Withdrawal by Subject|1
1655048|NCT01625286|5783712|P6|Overall Study|Withdrawal by Subject|0
1655049|NCT01625286|5783713|P5|Overall Study|Withdrawal by Subject|0
1655050|NCT01625286|5783714|P4|Overall Study|Withdrawal by Subject|1
1655051|NCT01625286|5783715|P3|Overall Study|Withdrawal by Subject|0
1655052|NCT01625286|5783716|P2|Overall Study|Withdrawal by Subject|1
1655053|NCT01625286|5783717|P1|Overall Study|Withdrawal by Subject|0
1655054|NCT01625286|5783711|P7|Overall Study|Death|16
1655055|NCT01625286|5783712|P6|Overall Study|Death|11
1655056|NCT01625286|5783713|P5|Overall Study|Death|0
1655057|NCT01625286|5783714|P4|Overall Study|Death|1
1655058|NCT01625286|5783715|P3|Overall Study|Death|1
1655059|NCT01625286|5783716|P2|Overall Study|Death|0
1655060|NCT01625286|5783717|P1|Overall Study|Death|0
1655061|NCT01625286|5783711|P7|Overall Study|Adverse Event|1
1655062|NCT01625286|5783712|P6|Overall Study|Adverse Event|2
1655063|NCT01625286|5783713|P5|Overall Study|Adverse Event|1
1655064|NCT01625286|5783714|P4|Overall Study|Adverse Event|0
1655065|NCT01625286|5783715|P3|Overall Study|Adverse Event|0
1655066|NCT01625286|5783716|P2|Overall Study|Adverse Event|0
1655067|NCT01625286|5783717|P1|Overall Study|Adverse Event|0
1655068|NCT01625182|5783803|P2|Overall Study|Lack of Efficacy|8
1655069|NCT01625182|5783804|P1|Overall Study|Lack of Efficacy|12
1655070|NCT01625182|5783803|P2|Overall Study|Withdrawal by Subject|1
1655071|NCT01625182|5783804|P1|Overall Study|Withdrawal by Subject|5
1655072|NCT01625182|5783803|P2|Overall Study|Adverse Event|0
1655073|NCT01625182|5783804|P1|Overall Study|Adverse Event|2
1655074|NCT01625182|5783803|P2|Overall Study|Protocol deviation|2
1655075|NCT01625182|5783804|P1|Overall Study|Protocol deviation|0
1655076|NCT01625182|5783803|P2|Overall Study|Administrative problems|0
1655077|NCT01625182|5783804|P1|Overall Study|Administrative problems|1
1655078|NCT01625091|5783841|P2|Post-intervention|Study termination|1
1655079|NCT01625091|5783842|P1|Post-intervention|Study termination|2
1655080|NCT01625091|5783841|P2|Post-intervention|Lost to Follow-up|0
1655081|NCT01625091|5783842|P1|Post-intervention|Lost to Follow-up|2
1655082|NCT01625091|5783841|P2|Post-intervention|Death|1
1655083|NCT01625091|5783842|P1|Post-intervention|Death|0
1655084|NCT01625091|5783841|P2|Intervention|Study termination|3
1655085|NCT01625091|5783842|P1|Intervention|Study termination|2
1655086|NCT01625091|5783841|P2|Intervention|Lost to Follow-up|4
1655087|NCT01625091|5783842|P1|Intervention|Lost to Follow-up|4
1655088|NCT01625091|5783841|P2|Intervention|Adverse Event|2
1655089|NCT01625091|5783842|P1|Intervention|Adverse Event|0
1655090|NCT01625091|5783841|P2|Intervention|Withdrawal by Subject|1
1655091|NCT01625091|5783842|P1|Intervention|Withdrawal by Subject|4
1655092|NCT01625091|5783841|P2|Intervention|Death|1
1655093|NCT01625091|5783842|P1|Intervention|Death|1
1655094|NCT01624974|5783856|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
1655095|NCT01624974|5783857|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
1655096|NCT01624974|5783856|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
1655097|NCT01624974|5783857|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
1655098|NCT01624974|5783856|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
1655099|NCT01624974|5783857|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
1655100|NCT01624974|5783856|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
1655101|NCT01624974|5783857|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
1655102|NCT01624974|5783856|P2|Period IV Washout (4 Weeks)|Adverse Event|0
1655103|NCT01624974|5783857|P1|Period IV Washout (4 Weeks)|Adverse Event|2
1655104|NCT01624974|5783856|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
1655105|NCT01624974|5783857|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
1655106|NCT01624974|5783856|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
1655107|NCT01624974|5783857|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
1655108|NCT01624974|5783856|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
1655109|NCT01624974|5783857|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
1655110|NCT01624974|5783856|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
1655111|NCT01624974|5783857|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
1655191|NCT01624142|5784183|P1|Overall Study|Study Closure|12
1655112|NCT01624974|5783856|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
1655113|NCT01624974|5783857|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
1655114|NCT01624974|5783856|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
1655115|NCT01624974|5783857|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
1655116|NCT01624974|5783856|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
1655117|NCT01624974|5783857|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
1655118|NCT01624870|5783898|P1|Overall Study|Lost to follow up|1
1655119|NCT01624870|5783898|P1|Overall Study|CoreValve not implanted|6
1655120|NCT01624870|5783898|P1|Overall Study|Withdrawal by Subject|1
1655121|NCT01624870|5783898|P1|Overall Study|Death|19
1655122|NCT01624662|5783918|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1655123|NCT01624662|5783919|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1655124|NCT01624662|5783920|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1655125|NCT01624662|5783921|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1655126|NCT01624662|5783918|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1655127|NCT01624662|5783919|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1655128|NCT01624662|5783920|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
1655129|NCT01624662|5783921|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1655130|NCT01624662|5783918|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1655131|NCT01624662|5783919|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1655132|NCT01624662|5783920|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1655133|NCT01624662|5783921|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1655134|NCT01624662|5783918|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1655135|NCT01624662|5783919|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
1655136|NCT01624662|5783920|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1655137|NCT01624662|5783921|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
1655138|NCT01624662|5783918|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1655139|NCT01624662|5783919|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1655140|NCT01624662|5783920|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
1655141|NCT01624662|5783921|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1655142|NCT01624662|5783918|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1655143|NCT01624662|5783919|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1655144|NCT01624662|5783920|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
1655145|NCT01624662|5783921|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
1655146|NCT01624662|5783918|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
1655147|NCT01624662|5783919|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1655148|NCT01624662|5783920|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1655149|NCT01624662|5783921|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
1655150|NCT01624467|5783992|P1|Overall Study|Subject Withdrew from Treatment|1
1655151|NCT01624467|5783992|P1|Overall Study|Per Sponsor Requirement|1
1655152|NCT01624467|5783992|P1|Overall Study|Progressive Disease|19
1655153|NCT01624467|5783992|P1|Overall Study|Adverse Event|7
1655154|NCT01624467|5783992|P1|Overall Study|Lost to Follow-up|1
1655155|NCT01624467|5783992|P1|Overall Study|Withdrawal by Subject|2
1655156|NCT01624259|5784031|P2|Overall Study|Abnormal laboratory measure|0
1655157|NCT01624259|5784032|P1|Overall Study|Abnormal laboratory measure|3
1655158|NCT01624259|5784031|P2|Overall Study|Lost to Follow-up|3
1655159|NCT01624259|5784032|P1|Overall Study|Lost to Follow-up|2
1655160|NCT01624259|5784031|P2|Overall Study|Physician Decision|1
1655161|NCT01624259|5784032|P1|Overall Study|Physician Decision|1
1655162|NCT01624259|5784031|P2|Overall Study|Withdrawal by Subject|7
1655163|NCT01624259|5784032|P1|Overall Study|Withdrawal by Subject|5
1655164|NCT01624259|5784031|P2|Overall Study|Protocol Violation|2
1655165|NCT01624259|5784032|P1|Overall Study|Protocol Violation|1
1655166|NCT01624259|5784031|P2|Overall Study|Adverse Event|18
1655167|NCT01624259|5784032|P1|Overall Study|Adverse Event|18
1655168|NCT01624233|5784081|P1|Period 6: Follow-up|Withdrawal by Subject|3
1655169|NCT01624233|5784081|P1|Period 6: Follow-up|Physician Decision|1
1655170|NCT01624233|5784081|P1|Period 6: Follow-up|Lack of Efficacy|2
1655171|NCT01624233|5784081|P1|Period 6: Follow-up|Adverse Event|3
1655172|NCT01624233|5784081|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
1655173|NCT01624233|5784081|P1|Period 5 - Retreatment Period|Physician Decision|1
1655174|NCT01624233|5784081|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
1655175|NCT01624233|5784081|P1|Period 5 - Retreatment Period|Adverse Event|5
1655176|NCT01624233|5784081|P1|Period 4 - Drug Free Period|Relapsed|61
1655177|NCT01624233|5784081|P1|Period 3 - Maintenance|Withdrawal by Subject|2
1655178|NCT01624233|5784081|P1|Period 3 - Maintenance|Physician Decision|2
1655179|NCT01624233|5784081|P1|Period 3 - Maintenance|Lack of Efficacy|1
1655180|NCT01624233|5784081|P1|Period 3 - Maintenance|Adverse Event|2
1655181|NCT01624233|5784081|P1|Period 2 - Induction|Adverse Event|1
1655182|NCT01624194|5784113|P2|Overall Study|Withdrawal by Subject|0
1655183|NCT01624194|5784114|P1|Overall Study|Withdrawal by Subject|1
1655184|NCT01624194|5784113|P2|Overall Study|Lost to Follow-up|0
1655185|NCT01624194|5784114|P1|Overall Study|Lost to Follow-up|1
1655186|NCT01624142|5784182|P2|Overall Study|Other|0
1655187|NCT01624142|5784183|P1|Overall Study|Other|1
1655188|NCT01624142|5784182|P2|Overall Study|Lost to Follow-up|0
1655189|NCT01624142|5784183|P1|Overall Study|Lost to Follow-up|2
1655190|NCT01624142|5784182|P2|Overall Study|Study Closure|6
1655192|NCT01624142|5784182|P2|Overall Study|Death|6
1655193|NCT01624142|5784183|P1|Overall Study|Death|3
1655194|NCT01624142|5784182|P2|Overall Study|Withdrawal by Subject|4
1655195|NCT01624142|5784183|P1|Overall Study|Withdrawal by Subject|14
1655196|NCT01624090|5784208|P4|Overall Study|Dose escalated|0
1655197|NCT01624090|5784209|P3|Overall Study|Dose escalated|3
1655198|NCT01624090|5784210|P2|Overall Study|Dose escalated|0
1655199|NCT01624090|5784211|P1|Overall Study|Dose escalated|0
1655200|NCT01624090|5784208|P4|Overall Study|Did not complete 1 crse of therapy|0
1655201|NCT01624090|5784209|P3|Overall Study|Did not complete 1 crse of therapy|2
1655202|NCT01624090|5784210|P2|Overall Study|Did not complete 1 crse of therapy|0
1655203|NCT01624090|5784211|P1|Overall Study|Did not complete 1 crse of therapy|0
1655204|NCT01624090|5784208|P4|Overall Study|Died on study|0
1655205|NCT01624090|5784209|P3|Overall Study|Died on study|2
1655206|NCT01624090|5784210|P2|Overall Study|Died on study|0
1655207|NCT01624090|5784211|P1|Overall Study|Died on study|0
1655208|NCT01624090|5784208|P4|Overall Study|Withdrew prior to treatment|0
1655209|NCT01624090|5784209|P3|Overall Study|Withdrew prior to treatment|0
1655210|NCT01624090|5784210|P2|Overall Study|Withdrew prior to treatment|1
1655211|NCT01624090|5784211|P1|Overall Study|Withdrew prior to treatment|0
1655212|NCT01624090|5784208|P4|Overall Study|DLT, taken off therapy|0
1655213|NCT01624090|5784209|P3|Overall Study|DLT, taken off therapy|0
1655214|NCT01624090|5784210|P2|Overall Study|DLT, taken off therapy|1
1655215|NCT01624090|5784211|P1|Overall Study|DLT, taken off therapy|0
1655216|NCT01623830|5784233|P2|Overall Study|Exclusion from Study|2
1655217|NCT01623830|5784234|P1|Overall Study|Exclusion from Study|1
1655218|NCT01623830|5784233|P2|Overall Study|Withdrawal by Subject|7
1655219|NCT01623830|5784234|P1|Overall Study|Withdrawal by Subject|6
1655220|NCT01623752|5784251|P3|Phase 2 (78 Weeks)|Adverse Event|0
1655221|NCT01623752|5784252|P2|Phase 2 (78 Weeks)|Adverse Event|4
1655222|NCT01623752|5784253|P1|Phase 2 (78 Weeks)|Adverse Event|4
1655223|NCT01623752|5784251|P3|Phase 2 (78 Weeks)|No Data|0
1655224|NCT01623752|5784252|P2|Phase 2 (78 Weeks)|No Data|11
1655225|NCT01623752|5784253|P1|Phase 2 (78 Weeks)|No Data|43
1655226|NCT01623752|5784251|P3|Phase 2 (78 Weeks)|Other|0
1655227|NCT01623752|5784252|P2|Phase 2 (78 Weeks)|Other|1
1655228|NCT01623752|5784253|P1|Phase 2 (78 Weeks)|Other|5
1655229|NCT01623752|5784251|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
1655230|NCT01623752|5784252|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
1655231|NCT01623752|5784253|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
1655232|NCT01623752|5784251|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
1655233|NCT01623752|5784252|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
1655234|NCT01623752|5784253|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
1655235|NCT01623752|5784251|P3|Phase 1 (78 Weeks)|Adverse Event|0
1655236|NCT01623752|5784252|P2|Phase 1 (78 Weeks)|Adverse Event|39
1655237|NCT01623752|5784253|P1|Phase 1 (78 Weeks)|Adverse Event|122
1655238|NCT01623752|5784251|P3|Phase 1 (78 Weeks)|Other|0
1655239|NCT01623752|5784252|P2|Phase 1 (78 Weeks)|Other|20
1655240|NCT01623752|5784253|P1|Phase 1 (78 Weeks)|Other|33
1655241|NCT01623752|5784251|P3|Phase 1 (78 Weeks)|No Data|2
1655242|NCT01623752|5784252|P2|Phase 1 (78 Weeks)|No Data|66
1655243|NCT01623752|5784253|P1|Phase 1 (78 Weeks)|No Data|249
1655244|NCT01623596|5784356|P2|Overall Study|Lack of Efficacy|3
1655245|NCT01623596|5784357|P1|Overall Study|Lack of Efficacy|5
1655246|NCT01623596|5784356|P2|Overall Study|Protocol Violation|6
1655247|NCT01623596|5784357|P1|Overall Study|Protocol Violation|0
1655248|NCT01623596|5784356|P2|Overall Study|Patient no longer requires study drug|0
1655249|NCT01623596|5784357|P1|Overall Study|Patient no longer requires study drug|1
1655250|NCT01623596|5784356|P2|Overall Study|Withdrawal by Subject|31
1655251|NCT01623596|5784357|P1|Overall Study|Withdrawal by Subject|13
1655252|NCT01623596|5784356|P2|Overall Study|Lost to Follow-up|16
1655253|NCT01623596|5784357|P1|Overall Study|Lost to Follow-up|12
1655254|NCT01623596|5784356|P2|Overall Study|Death|2
1655255|NCT01623596|5784357|P1|Overall Study|Death|0
1655256|NCT01623596|5784356|P2|Overall Study|Adverse Event|29
1655257|NCT01623596|5784357|P1|Overall Study|Adverse Event|20
1655258|NCT01623596|5784356|P2|Overall Study|Administrative problems|13
1655259|NCT01623596|5784357|P1|Overall Study|Administrative problems|9
1655260|NCT01623596|5784356|P2|Overall Study|Abnormal laboratory values|0
1655261|NCT01623596|5784357|P1|Overall Study|Abnormal laboratory values|2
1655262|NCT01623310|5784400|P1|Overall Study|Investigators Discretion-Noncompliant|1
1655263|NCT01623310|5784400|P1|Overall Study|Diagnoses of bilateral cateracts|1
1655264|NCT01623310|5784400|P1|Overall Study|Became potentially child-bearing|1
1655265|NCT01623310|5784400|P1|Overall Study|Withdrawal by Subject|25
1655266|NCT01623310|5784400|P1|Overall Study|Protocol Violation|6
1655267|NCT01623310|5784400|P1|Overall Study|Lack of Efficacy|6
1655268|NCT01623310|5784400|P1|Overall Study|Lost to Follow-up|18
1655269|NCT01623310|5784400|P1|Overall Study|Adverse Event|21
1655270|NCT01623271|5784409|P1|Overall Study|Withdrawal by Subject|2
1655271|NCT01623154|5784413|P1|Overall Study|Did not drink Pranactin Citric|4
1655272|NCT01623115|5784421|P2|Overall Study|Other than specified above|3
1655273|NCT01623115|5784422|P1|Overall Study|Other than specified above|0
1655274|NCT01623115|5784421|P2|Overall Study|Death|4
1655275|NCT01623115|5784422|P1|Overall Study|Death|0
1655276|NCT01623115|5784421|P2|Overall Study|Site closure|7
1655277|NCT01623115|5784422|P1|Overall Study|Site closure|1
1655278|NCT01623115|5784421|P2|Overall Study|Last visit outside protocol visit window|26
1655279|NCT01623115|5784422|P1|Overall Study|Last visit outside protocol visit window|14
1655280|NCT01623115|5784421|P2|Overall Study|Related to study drug administration|2
1655281|NCT01623115|5784422|P1|Overall Study|Related to study drug administration|0
1655282|NCT01623115|5784421|P2|Overall Study|Consent withdrawn by participant|6
1655283|NCT01623115|5784422|P1|Overall Study|Consent withdrawn by participant|2
1655284|NCT01623115|5784421|P2|Overall Study|Poor compliance to protocol|10
1655285|NCT01623115|5784422|P1|Overall Study|Poor compliance to protocol|4
1655286|NCT01623115|5784421|P2|Overall Study|Adverse Event|13
1655287|NCT01623115|5784422|P1|Overall Study|Adverse Event|10
1655288|NCT01623115|5784421|P2|Overall Study|Participants moved|5
1655289|NCT01623115|5784422|P1|Overall Study|Participants moved|1
1655290|NCT01623115|5784421|P2|Overall Study|Physician Decision|0
1655291|NCT01623115|5784422|P1|Overall Study|Physician Decision|1
1655292|NCT01623115|5784421|P2|Overall Study|Randomized but not treated|1
1655293|NCT01623115|5784422|P1|Overall Study|Randomized but not treated|0
1655294|NCT01623050|5784482|P1|Overall Study|Lost to Follow-up|9
1655295|NCT01622673|5784511|P6|Treatment Period 3|Protocol Violation|0
1655296|NCT01622673|5784512|P5|Treatment Period 3|Protocol Violation|0
1655297|NCT01622673|5784513|P4|Treatment Period 3|Protocol Violation|0
1655298|NCT01622673|5784514|P3|Treatment Period 3|Protocol Violation|0
1655299|NCT01622673|5784515|P2|Treatment Period 3|Protocol Violation|1
1655300|NCT01622673|5784516|P1|Treatment Period 3|Protocol Violation|0
1655301|NCT01622673|5784511|P6|Treatment Period 2|Withdrawal by Subject|0
1655302|NCT01622673|5784512|P5|Treatment Period 2|Withdrawal by Subject|0
1655303|NCT01622673|5784513|P4|Treatment Period 2|Withdrawal by Subject|1
1655304|NCT01622673|5784514|P3|Treatment Period 2|Withdrawal by Subject|0
1655305|NCT01622673|5784515|P2|Treatment Period 2|Withdrawal by Subject|0
1655306|NCT01622673|5784516|P1|Treatment Period 2|Withdrawal by Subject|0
1655307|NCT01622673|5784511|P6|Treatment Period 1|Protocol Violation|0
1655308|NCT01622673|5784512|P5|Treatment Period 1|Protocol Violation|0
1655309|NCT01622673|5784513|P4|Treatment Period 1|Protocol Violation|0
1655310|NCT01622673|5784514|P3|Treatment Period 1|Protocol Violation|0
1655311|NCT01622673|5784515|P2|Treatment Period 1|Protocol Violation|1
1655312|NCT01622673|5784516|P1|Treatment Period 1|Protocol Violation|0
1655313|NCT01622673|5784511|P6|Treatment Period 1|Withdrawal by Subject|0
1655314|NCT01622673|5784512|P5|Treatment Period 1|Withdrawal by Subject|0
1655315|NCT01622673|5784513|P4|Treatment Period 1|Withdrawal by Subject|1
1655316|NCT01622673|5784514|P3|Treatment Period 1|Withdrawal by Subject|0
1655317|NCT01622673|5784515|P2|Treatment Period 1|Withdrawal by Subject|0
1655318|NCT01622673|5784516|P1|Treatment Period 1|Withdrawal by Subject|0
1655319|NCT01622660|5784551|P1|Overall Study|Adverse Event|1
1655320|NCT01622569|5784559|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
1655321|NCT01622569|5784560|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1655322|NCT01622569|5784561|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1655323|NCT01622569|5784562|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
1655324|NCT01622569|5784559|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1655325|NCT01622569|5784560|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
1655326|NCT01622569|5784561|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
1655327|NCT01622569|5784562|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
1655328|NCT01622569|5784559|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1655329|NCT01622569|5784560|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
1655330|NCT01622569|5784561|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
1655331|NCT01622569|5784562|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
1655332|NCT01622569|5784559|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
1655333|NCT01622569|5784560|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1655334|NCT01622569|5784561|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1655335|NCT01622569|5784562|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
1655336|NCT01622569|5784559|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
1655337|NCT01622569|5784560|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1655338|NCT01622569|5784561|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
1655339|NCT01622569|5784562|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
1655340|NCT01622569|5784559|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
1655341|NCT01622569|5784560|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
1655342|NCT01622569|5784561|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
1655343|NCT01622569|5784562|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
1655344|NCT01622569|5784559|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1655345|NCT01622569|5784560|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
1655346|NCT01622569|5784561|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1655347|NCT01622569|5784562|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
1655348|NCT01622569|5784559|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
1655349|NCT01622569|5784560|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
1655350|NCT01622569|5784561|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
1655351|NCT01622569|5784562|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
1655352|NCT01622348|5784647|P3|Overall Study|Withdrawal by Subject|1
1655353|NCT01622348|5784648|P2|Overall Study|Withdrawal by Subject|0
1655354|NCT01622348|5784649|P1|Overall Study|Withdrawal by Subject|1
1655355|NCT01622231|5784688|P1|Overall Study|Withdrawal by Subject|1
1655356|NCT01622231|5784688|P1|Overall Study|Physician Decision|1
1655357|NCT01621880|5784718|P2|Overall Study|Withdrawal by Subject|4
1655358|NCT01621880|5784719|P1|Overall Study|Withdrawal by Subject|5
1655359|NCT01621880|5784718|P2|Overall Study|Adverse Event|1
1655360|NCT01621880|5784719|P1|Overall Study|Adverse Event|5
1655361|NCT01621802|5784733|P6|Overall Study|Lost to Follow-up|11
1655362|NCT01621802|5784734|P5|Overall Study|Lost to Follow-up|31
1655363|NCT01621802|5784735|P4|Overall Study|Lost to Follow-up|7
1655364|NCT01621802|5784736|P3|Overall Study|Lost to Follow-up|24
1655365|NCT01621802|5784737|P2|Overall Study|Lost to Follow-up|16
1655366|NCT01621802|5784738|P1|Overall Study|Lost to Follow-up|36
1655367|NCT01621802|5784733|P6|Overall Study|Others|0
1655368|NCT01621802|5784734|P5|Overall Study|Others|1
1655369|NCT01621802|5784735|P4|Overall Study|Others|2
1655370|NCT01621802|5784736|P3|Overall Study|Others|3
1655371|NCT01621802|5784737|P2|Overall Study|Others|3
1655372|NCT01621802|5784738|P1|Overall Study|Others|3
1655373|NCT01621802|5784733|P6|Overall Study|Migrated/moved from study area|0
1655374|NCT01621802|5784734|P5|Overall Study|Migrated/moved from study area|1
1655375|NCT01621802|5784735|P4|Overall Study|Migrated/moved from study area|0
1655376|NCT01621802|5784736|P3|Overall Study|Migrated/moved from study area|2
1655377|NCT01621802|5784737|P2|Overall Study|Migrated/moved from study area|0
1655378|NCT01621802|5784738|P1|Overall Study|Migrated/moved from study area|0
1655379|NCT01621802|5784733|P6|Overall Study|Withdrawal by Subject|0
1655380|NCT01621802|5784734|P5|Overall Study|Withdrawal by Subject|2
1655381|NCT01621802|5784735|P4|Overall Study|Withdrawal by Subject|2
1655382|NCT01621802|5784736|P3|Overall Study|Withdrawal by Subject|4
1655383|NCT01621802|5784737|P2|Overall Study|Withdrawal by Subject|4
1655384|NCT01621802|5784738|P1|Overall Study|Withdrawal by Subject|8
1655385|NCT01621802|5784733|P6|Overall Study|Protocol Violation|1
1655386|NCT01621802|5784734|P5|Overall Study|Protocol Violation|0
1655387|NCT01621802|5784735|P4|Overall Study|Protocol Violation|0
1655388|NCT01621802|5784736|P3|Overall Study|Protocol Violation|0
1655389|NCT01621802|5784737|P2|Overall Study|Protocol Violation|0
1655390|NCT01621802|5784738|P1|Overall Study|Protocol Violation|0
1655391|NCT01621542|5784923|P6|Overall Study|study stopped by sponsor|0
1655392|NCT01621542|5784924|P5|Overall Study|study stopped by sponsor|0
1655393|NCT01621542|5784925|P4|Overall Study|study stopped by sponsor|1
1655394|NCT01621542|5784926|P3|Overall Study|study stopped by sponsor|0
1655395|NCT01621542|5784927|P2|Overall Study|study stopped by sponsor|0
1655396|NCT01621542|5784928|P1|Overall Study|study stopped by sponsor|0
1655397|NCT01621542|5784923|P6|Overall Study|Protocol Violation|0
1655398|NCT01621542|5784924|P5|Overall Study|Protocol Violation|0
1655399|NCT01621542|5784925|P4|Overall Study|Protocol Violation|1
1655400|NCT01621542|5784926|P3|Overall Study|Protocol Violation|0
1655401|NCT01621542|5784927|P2|Overall Study|Protocol Violation|0
1655402|NCT01621542|5784928|P1|Overall Study|Protocol Violation|0
1655403|NCT01621542|5784923|P6|Overall Study|progression/treatment failure|5
1655404|NCT01621542|5784924|P5|Overall Study|progression/treatment failure|3
1655405|NCT01621542|5784925|P4|Overall Study|progression/treatment failure|7
1655406|NCT01621542|5784926|P3|Overall Study|progression/treatment failure|3
1655407|NCT01621542|5784927|P2|Overall Study|progression/treatment failure|4
1655408|NCT01621542|5784928|P1|Overall Study|progression/treatment failure|2
1655409|NCT01621542|5784923|P6|Overall Study|Withdrawal by Subject|3
1655410|NCT01621542|5784924|P5|Overall Study|Withdrawal by Subject|3
1655411|NCT01621542|5784925|P4|Overall Study|Withdrawal by Subject|3
1655412|NCT01621542|5784926|P3|Overall Study|Withdrawal by Subject|1
1655413|NCT01621542|5784927|P2|Overall Study|Withdrawal by Subject|0
1655414|NCT01621542|5784928|P1|Overall Study|Withdrawal by Subject|2
1655415|NCT01621542|5784923|P6|Overall Study|Physician Decision|1
1655416|NCT01621542|5784924|P5|Overall Study|Physician Decision|3
1655417|NCT01621542|5784925|P4|Overall Study|Physician Decision|13
1655418|NCT01621542|5784926|P3|Overall Study|Physician Decision|1
1655419|NCT01621542|5784927|P2|Overall Study|Physician Decision|0
1655420|NCT01621542|5784928|P1|Overall Study|Physician Decision|1
1655421|NCT01621542|5784923|P6|Overall Study|Death|0
1655422|NCT01621542|5784924|P5|Overall Study|Death|0
1655423|NCT01621542|5784925|P4|Overall Study|Death|0
1655424|NCT01621542|5784926|P3|Overall Study|Death|0
1655425|NCT01621542|5784927|P2|Overall Study|Death|1
1655426|NCT01621542|5784928|P1|Overall Study|Death|0
1655427|NCT01621542|5784923|P6|Overall Study|Adverse Event|0
1655428|NCT01621542|5784924|P5|Overall Study|Adverse Event|0
1655429|NCT01621542|5784925|P4|Overall Study|Adverse Event|3
1655430|NCT01621542|5784926|P3|Overall Study|Adverse Event|1
1655431|NCT01621542|5784927|P2|Overall Study|Adverse Event|0
1655432|NCT01621542|5784928|P1|Overall Study|Adverse Event|0
1655433|NCT01621490|5784969|P9|Overall Study|Patient delayed due to toxicity|0
1655434|NCT01621490|5784970|P8|Overall Study|Patient delayed due to toxicity|0
1655435|NCT01621490|5784971|P7|Overall Study|Patient delayed due to toxicity|0
1655436|NCT01621490|5784972|P6|Overall Study|Patient delayed due to toxicity|1
1655437|NCT01621490|5784973|P5|Overall Study|Patient delayed due to toxicity|0
1655438|NCT01621490|5784974|P4|Overall Study|Patient delayed due to toxicity|0
1655439|NCT01621490|5784975|P3|Overall Study|Patient delayed due to toxicity|0
1655440|NCT01621490|5784976|P2|Overall Study|Patient delayed due to toxicity|0
1655441|NCT01621490|5784977|P1|Overall Study|Patient delayed due to toxicity|0
1655442|NCT01621490|5784969|P9|Overall Study|Complete response|1
1655443|NCT01621490|5784970|P8|Overall Study|Complete response|0
1655444|NCT01621490|5784971|P7|Overall Study|Complete response|0
1655445|NCT01621490|5784972|P6|Overall Study|Complete response|0
1655446|NCT01621490|5784973|P5|Overall Study|Complete response|0
1655447|NCT01621490|5784974|P4|Overall Study|Complete response|0
1655448|NCT01621490|5784975|P3|Overall Study|Complete response|0
1655449|NCT01621490|5784976|P2|Overall Study|Complete response|0
1655450|NCT01621490|5784977|P1|Overall Study|Complete response|0
1655451|NCT01621490|5784969|P9|Overall Study|Clinical deterioration|0
1655452|NCT01621490|5784970|P8|Overall Study|Clinical deterioration|0
1655453|NCT01621490|5784971|P7|Overall Study|Clinical deterioration|0
1655454|NCT01621490|5784972|P6|Overall Study|Clinical deterioration|0
1655455|NCT01621490|5784973|P5|Overall Study|Clinical deterioration|0
1655456|NCT01621490|5784974|P4|Overall Study|Clinical deterioration|0
1655457|NCT01621490|5784975|P3|Overall Study|Clinical deterioration|0
1655458|NCT01621490|5784976|P2|Overall Study|Clinical deterioration|1
1655459|NCT01621490|5784977|P1|Overall Study|Clinical deterioration|0
1655460|NCT01621490|5784969|P9|Overall Study|Patient reached treatment 2 yr limit|0
1655461|NCT01621490|5784970|P8|Overall Study|Patient reached treatment 2 yr limit|0
1655462|NCT01621490|5784971|P7|Overall Study|Patient reached treatment 2 yr limit|0
1655463|NCT01621490|5784972|P6|Overall Study|Patient reached treatment 2 yr limit|0
1655464|NCT01621490|5784973|P5|Overall Study|Patient reached treatment 2 yr limit|0
1655465|NCT01621490|5784974|P4|Overall Study|Patient reached treatment 2 yr limit|0
1655466|NCT01621490|5784975|P3|Overall Study|Patient reached treatment 2 yr limit|0
1655467|NCT01621490|5784976|P2|Overall Study|Patient reached treatment 2 yr limit|1
1655468|NCT01621490|5784977|P1|Overall Study|Patient reached treatment 2 yr limit|0
1655469|NCT01621490|5784969|P9|Overall Study|Documented disease progression|0
1655470|NCT01621490|5784970|P8|Overall Study|Documented disease progression|0
1655471|NCT01621490|5784971|P7|Overall Study|Documented disease progression|0
1655472|NCT01621490|5784972|P6|Overall Study|Documented disease progression|0
1655473|NCT01621490|5784973|P5|Overall Study|Documented disease progression|0
1655474|NCT01621490|5784974|P4|Overall Study|Documented disease progression|0
1655475|NCT01621490|5784975|P3|Overall Study|Documented disease progression|1
1655476|NCT01621490|5784976|P2|Overall Study|Documented disease progression|0
1655477|NCT01621490|5784977|P1|Overall Study|Documented disease progression|0
1655478|NCT01621490|5784969|P9|Overall Study|Investigator decision|0
1655479|NCT01621490|5784970|P8|Overall Study|Investigator decision|0
1655480|NCT01621490|5784971|P7|Overall Study|Investigator decision|1
1655481|NCT01621490|5784972|P6|Overall Study|Investigator decision|0
1655482|NCT01621490|5784973|P5|Overall Study|Investigator decision|1
1655483|NCT01621490|5784974|P4|Overall Study|Investigator decision|0
1655484|NCT01621490|5784975|P3|Overall Study|Investigator decision|1
1655485|NCT01621490|5784976|P2|Overall Study|Investigator decision|0
1655486|NCT01621490|5784977|P1|Overall Study|Investigator decision|0
1655487|NCT01621490|5784969|P9|Overall Study|BMS informed of patient status|0
1655488|NCT01621490|5784970|P8|Overall Study|BMS informed of patient status|0
1655489|NCT01621490|5784971|P7|Overall Study|BMS informed of patient status|0
1655490|NCT01621490|5784972|P6|Overall Study|BMS informed of patient status|0
1655491|NCT01621490|5784973|P5|Overall Study|BMS informed of patient status|0
1655492|NCT01621490|5784974|P4|Overall Study|BMS informed of patient status|0
1655493|NCT01621490|5784975|P3|Overall Study|BMS informed of patient status|1
1655494|NCT01621490|5784976|P2|Overall Study|BMS informed of patient status|0
1655495|NCT01621490|5784977|P1|Overall Study|BMS informed of patient status|0
1655496|NCT01621490|5784969|P9|Overall Study|Grade 4 Lipase elevation|0
1655497|NCT01621490|5784970|P8|Overall Study|Grade 4 Lipase elevation|0
1655498|NCT01621490|5784971|P7|Overall Study|Grade 4 Lipase elevation|0
1655499|NCT01621490|5784972|P6|Overall Study|Grade 4 Lipase elevation|0
1655500|NCT01621490|5784973|P5|Overall Study|Grade 4 Lipase elevation|0
1655501|NCT01621490|5784974|P4|Overall Study|Grade 4 Lipase elevation|0
1655502|NCT01621490|5784975|P3|Overall Study|Grade 4 Lipase elevation|0
1655503|NCT01621490|5784976|P2|Overall Study|Grade 4 Lipase elevation|0
1655504|NCT01621490|5784977|P1|Overall Study|Grade 4 Lipase elevation|1
1655505|NCT01621490|5784969|P9|Overall Study|Death|0
1655506|NCT01621490|5784970|P8|Overall Study|Death|1
1655507|NCT01621490|5784971|P7|Overall Study|Death|0
1655508|NCT01621490|5784972|P6|Overall Study|Death|0
1655509|NCT01621490|5784973|P5|Overall Study|Death|0
1655510|NCT01621490|5784974|P4|Overall Study|Death|0
1655511|NCT01621490|5784975|P3|Overall Study|Death|0
1655512|NCT01621490|5784976|P2|Overall Study|Death|0
1655513|NCT01621490|5784977|P1|Overall Study|Death|0
1655514|NCT01621490|5784969|P9|Overall Study|Study drug toxicity|1
1655515|NCT01621490|5784970|P8|Overall Study|Study drug toxicity|4
1655516|NCT01621490|5784971|P7|Overall Study|Study drug toxicity|1
1655517|NCT01621490|5784972|P6|Overall Study|Study drug toxicity|10
1655518|NCT01621490|5784973|P5|Overall Study|Study drug toxicity|1
1655519|NCT01621490|5784974|P4|Overall Study|Study drug toxicity|3
1655520|NCT01621490|5784975|P3|Overall Study|Study drug toxicity|5
1655521|NCT01621490|5784976|P2|Overall Study|Study drug toxicity|4
1655522|NCT01621490|5784977|P1|Overall Study|Study drug toxicity|1
1655523|NCT01621490|5784969|P9|Overall Study|Disease progression|4
1655524|NCT01621490|5784970|P8|Overall Study|Disease progression|0
1655525|NCT01621490|5784971|P7|Overall Study|Disease progression|7
1655526|NCT01621490|5784972|P6|Overall Study|Disease progression|8
1655527|NCT01621490|5784973|P5|Overall Study|Disease progression|3
1655528|NCT01621490|5784974|P4|Overall Study|Disease progression|5
1655529|NCT01621490|5784975|P3|Overall Study|Disease progression|1
1655530|NCT01621490|5784976|P2|Overall Study|Disease progression|28
1655531|NCT01621490|5784977|P1|Overall Study|Disease progression|27
1655532|NCT01621490|5784969|P9|Overall Study|Adverse event unrelated to study drug|1
1655533|NCT01621490|5784970|P8|Overall Study|Adverse event unrelated to study drug|2
1655534|NCT01621490|5784971|P7|Overall Study|Adverse event unrelated to study drug|0
1655535|NCT01621490|5784972|P6|Overall Study|Adverse event unrelated to study drug|0
1655536|NCT01621490|5784973|P5|Overall Study|Adverse event unrelated to study drug|0
1655537|NCT01621490|5784974|P4|Overall Study|Adverse event unrelated to study drug|0
1655538|NCT01621490|5784975|P3|Overall Study|Adverse event unrelated to study drug|0
1655539|NCT01621490|5784976|P2|Overall Study|Adverse event unrelated to study drug|1
1655540|NCT01621490|5784977|P1|Overall Study|Adverse event unrelated to study drug|2
1655541|NCT01621490|5784969|P9|Overall Study|Subject request to discontinue study|1
1655542|NCT01621490|5784970|P8|Overall Study|Subject request to discontinue study|0
1655543|NCT01621490|5784971|P7|Overall Study|Subject request to discontinue study|1
1655544|NCT01621490|5784972|P6|Overall Study|Subject request to discontinue study|2
1655545|NCT01621490|5784973|P5|Overall Study|Subject request to discontinue study|0
1655546|NCT01621490|5784974|P4|Overall Study|Subject request to discontinue study|1
1655547|NCT01621490|5784975|P3|Overall Study|Subject request to discontinue study|1
1655548|NCT01621490|5784976|P2|Overall Study|Subject request to discontinue study|3
1655549|NCT01621490|5784977|P1|Overall Study|Subject request to discontinue study|1
1655550|NCT01621490|5784969|P9|Overall Study|Withdrawal by Subject|0
1655551|NCT01621490|5784970|P8|Overall Study|Withdrawal by Subject|0
1655552|NCT01621490|5784971|P7|Overall Study|Withdrawal by Subject|0
1655553|NCT01621490|5784972|P6|Overall Study|Withdrawal by Subject|3
1655554|NCT01621490|5784973|P5|Overall Study|Withdrawal by Subject|0
1655555|NCT01621490|5784974|P4|Overall Study|Withdrawal by Subject|0
1655556|NCT01621490|5784975|P3|Overall Study|Withdrawal by Subject|0
1655557|NCT01621490|5784976|P2|Overall Study|Withdrawal by Subject|0
1655558|NCT01621490|5784977|P1|Overall Study|Withdrawal by Subject|1
1655559|NCT01621490|5784969|P9|Overall Study|Maximum clinical benefit|0
1655560|NCT01621490|5784970|P8|Overall Study|Maximum clinical benefit|2
1655561|NCT01621490|5784971|P7|Overall Study|Maximum clinical benefit|1
1655562|NCT01621490|5784972|P6|Overall Study|Maximum clinical benefit|0
1655563|NCT01621490|5784973|P5|Overall Study|Maximum clinical benefit|0
1655564|NCT01621490|5784974|P4|Overall Study|Maximum clinical benefit|0
1655565|NCT01621490|5784975|P3|Overall Study|Maximum clinical benefit|0
1655566|NCT01621490|5784976|P2|Overall Study|Maximum clinical benefit|2
1655567|NCT01621490|5784977|P1|Overall Study|Maximum clinical benefit|3
1655568|NCT01621490|5784969|P9|Overall Study|Subject no longer meets study criteria|0
1655569|NCT01621490|5784970|P8|Overall Study|Subject no longer meets study criteria|0
1655570|NCT01621490|5784971|P7|Overall Study|Subject no longer meets study criteria|0
1655571|NCT01621490|5784972|P6|Overall Study|Subject no longer meets study criteria|0
1655572|NCT01621490|5784973|P5|Overall Study|Subject no longer meets study criteria|1
1655573|NCT01621490|5784974|P4|Overall Study|Subject no longer meets study criteria|0
1655574|NCT01621490|5784975|P3|Overall Study|Subject no longer meets study criteria|0
1655575|NCT01621490|5784976|P2|Overall Study|Subject no longer meets study criteria|0
1655576|NCT01621490|5784977|P1|Overall Study|Subject no longer meets study criteria|0
1655577|NCT01621490|5784969|P9|Overall Study|Patient could not travel|0
1655578|NCT01621490|5784970|P8|Overall Study|Patient could not travel|0
1655579|NCT01621490|5784971|P7|Overall Study|Patient could not travel|0
1655580|NCT01621490|5784972|P6|Overall Study|Patient could not travel|0
1655581|NCT01621490|5784973|P5|Overall Study|Patient could not travel|0
1655582|NCT01621490|5784974|P4|Overall Study|Patient could not travel|0
1655583|NCT01621490|5784975|P3|Overall Study|Patient could not travel|0
1655584|NCT01621490|5784976|P2|Overall Study|Patient could not travel|0
1655585|NCT01621490|5784977|P1|Overall Study|Patient could not travel|1
1655586|NCT01621490|5784969|P9|Overall Study|Participant completed treatment|0
1655587|NCT01621490|5784970|P8|Overall Study|Participant completed treatment|1
1655588|NCT01621490|5784971|P7|Overall Study|Participant completed treatment|0
1655589|NCT01621490|5784972|P6|Overall Study|Participant completed treatment|0
1655590|NCT01621490|5784973|P5|Overall Study|Participant completed treatment|0
1655591|NCT01621490|5784974|P4|Overall Study|Participant completed treatment|0
1655592|NCT01621490|5784975|P3|Overall Study|Participant completed treatment|1
1655593|NCT01621490|5784976|P2|Overall Study|Participant completed treatment|4
1655594|NCT01621490|5784977|P1|Overall Study|Participant completed treatment|4
1655595|NCT01621191|5785213|P1|Overall Study|Site Removed From Study|1
1655596|NCT01621191|5785213|P1|Overall Study|Lost to Follow-up|1
1655597|NCT01621191|5785213|P1|Overall Study|Lack of Efficacy|6
1655598|NCT01621191|5785213|P1|Overall Study|Withdrawal by Subject|8
1655599|NCT01621191|5785213|P1|Overall Study|Adverse Event|9
1655600|NCT01621178|5785227|P3|Overall Study|Physician Decision|7
1655601|NCT01621178|5785228|P2|Overall Study|Physician Decision|2
1655602|NCT01621178|5785229|P1|Overall Study|Physician Decision|5
1655603|NCT01621178|5785227|P3|Overall Study|Withdrawal by Subject|18
1655604|NCT01621178|5785228|P2|Overall Study|Withdrawal by Subject|17
1655605|NCT01621178|5785229|P1|Overall Study|Withdrawal by Subject|14
1655606|NCT01621178|5785227|P3|Overall Study|Lost to Follow-up|1
1655607|NCT01621178|5785228|P2|Overall Study|Lost to Follow-up|2
1655608|NCT01621178|5785229|P1|Overall Study|Lost to Follow-up|1
1655609|NCT01621178|5785227|P3|Overall Study|Death|2
1655610|NCT01621178|5785228|P2|Overall Study|Death|7
1655611|NCT01621178|5785229|P1|Overall Study|Death|6
1655612|NCT01621178|5785227|P3|Overall Study|Adverse Event|8
1655613|NCT01621178|5785228|P2|Overall Study|Adverse Event|2
1655614|NCT01621178|5785229|P1|Overall Study|Adverse Event|5
1655615|NCT01621126|5785321|P1|Overall Study|Physician Decision|6
1655616|NCT01620983|5785343|P3|Overall Study|Physician Decision|5
1655617|NCT01620983|5785344|P2|Overall Study|Physician Decision|10
1655618|NCT01620983|5785345|P1|Overall Study|Physician Decision|3
1655619|NCT01620983|5785343|P3|Overall Study|Death|0
1655620|NCT01620983|5785344|P2|Overall Study|Death|0
1655621|NCT01620983|5785345|P1|Overall Study|Death|2
1655622|NCT01620983|5785343|P3|Overall Study|Withdrawal by Subject|1
1655623|NCT01620983|5785344|P2|Overall Study|Withdrawal by Subject|8
1655624|NCT01620983|5785345|P1|Overall Study|Withdrawal by Subject|6
1655625|NCT01620983|5785343|P3|Overall Study|Lost to Follow-up|9
1655626|NCT01620983|5785344|P2|Overall Study|Lost to Follow-up|4
1655627|NCT01620983|5785345|P1|Overall Study|Lost to Follow-up|8
1655628|NCT01620762|5785374|P3|Overall Study|Use of prohibted therapies|1
1655629|NCT01620762|5785375|P2|Overall Study|Use of prohibted therapies|1
1655630|NCT01620762|5785376|P1|Overall Study|Use of prohibted therapies|0
1655631|NCT01620762|5785374|P3|Overall Study|Non-specified|5
1655632|NCT01620762|5785375|P2|Overall Study|Non-specified|6
1655633|NCT01620762|5785376|P1|Overall Study|Non-specified|3
1655634|NCT01620762|5785374|P3|Overall Study|Subject deterioration|1
1655635|NCT01620762|5785375|P2|Overall Study|Subject deterioration|1
1655636|NCT01620762|5785376|P1|Overall Study|Subject deterioration|0
1655637|NCT01620762|5785374|P3|Overall Study|Protocol deviation|6
1655638|NCT01620762|5785375|P2|Overall Study|Protocol deviation|1
1655639|NCT01620762|5785376|P1|Overall Study|Protocol deviation|1
1655640|NCT01620762|5785374|P3|Overall Study|Lost to Follow-up|10
1655641|NCT01620762|5785375|P2|Overall Study|Lost to Follow-up|17
1655642|NCT01620762|5785376|P1|Overall Study|Lost to Follow-up|11
1655643|NCT01620762|5785374|P3|Overall Study|Withdrawal by Subject|27
1655644|NCT01620762|5785375|P2|Overall Study|Withdrawal by Subject|26
1655645|NCT01620762|5785376|P1|Overall Study|Withdrawal by Subject|23
1655646|NCT01620762|5785374|P3|Overall Study|Adverse Event|2
1655647|NCT01620762|5785375|P2|Overall Study|Adverse Event|5
1655648|NCT01620762|5785376|P1|Overall Study|Adverse Event|9
1655649|NCT01620762|5785374|P3|Overall Study|Protocol Violation|1
1655650|NCT01620762|5785375|P2|Overall Study|Protocol Violation|1
1655651|NCT01620762|5785376|P1|Overall Study|Protocol Violation|1
1655652|NCT01620528|5785437|P3|Post-Treatment Follow-Up Period|Other|2
1655653|NCT01620528|5785438|P2|Post-Treatment Follow-Up Period|Other|4
1655654|NCT01620528|5785439|P1|Post-Treatment Follow-Up Period|Other|6
1655655|NCT01620528|5785437|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
1655656|NCT01620528|5785438|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
1655657|NCT01620528|5785439|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
1655658|NCT01620528|5785437|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
1655659|NCT01620528|5785438|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
1655660|NCT01620528|5785439|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
1655661|NCT01620528|5785437|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
1655662|NCT01620528|5785438|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
1655663|NCT01620528|5785439|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
1655664|NCT01620528|5785437|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1655665|NCT01620528|5785438|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
1655666|NCT01620528|5785439|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
1655667|NCT01620528|5785437|P3|Treatment Period|Exclusionary Medication Received|0
1655668|NCT01620528|5785438|P2|Treatment Period|Exclusionary Medication Received|1
1655669|NCT01620528|5785439|P1|Treatment Period|Exclusionary Medication Received|0
1655670|NCT01620528|5785437|P3|Treatment Period|Surgery/Invasive Intervention|3
1655671|NCT01620528|5785438|P2|Treatment Period|Surgery/Invasive Intervention|1
1655672|NCT01620528|5785439|P1|Treatment Period|Surgery/Invasive Intervention|5
1655673|NCT01620528|5785437|P3|Treatment Period|Pregnancy|2
1655674|NCT01620528|5785438|P2|Treatment Period|Pregnancy|2
1655675|NCT01620528|5785439|P1|Treatment Period|Pregnancy|7
1655676|NCT01620528|5785437|P3|Treatment Period|Subject Noncompliant|2
1655677|NCT01620528|5785438|P2|Treatment Period|Subject Noncompliant|2
1655678|NCT01620528|5785439|P1|Treatment Period|Subject Noncompliant|11
1655679|NCT01620528|5785437|P3|Treatment Period|Other|7
1655680|NCT01620528|5785438|P2|Treatment Period|Other|5
1655681|NCT01620528|5785439|P1|Treatment Period|Other|9
1655682|NCT01620528|5785437|P3|Treatment Period|Lost to Follow-up|14
1655683|NCT01620528|5785438|P2|Treatment Period|Lost to Follow-up|8
1655684|NCT01620528|5785439|P1|Treatment Period|Lost to Follow-up|16
1655685|NCT01620528|5785437|P3|Treatment Period|Adverse Event|21
1655686|NCT01620528|5785438|P2|Treatment Period|Adverse Event|13
1655687|NCT01620528|5785439|P1|Treatment Period|Adverse Event|17
1655688|NCT01620528|5785437|P3|Treatment Period|Withdrawal by Subject|16
1655689|NCT01620528|5785438|P2|Treatment Period|Withdrawal by Subject|21
1655690|NCT01620528|5785439|P1|Treatment Period|Withdrawal by Subject|35
1655691|NCT01620528|5785437|P3|Treatment Period|Did Not Receive Study Drug|1
1655692|NCT01620528|5785438|P2|Treatment Period|Did Not Receive Study Drug|0
1655693|NCT01620528|5785439|P1|Treatment Period|Did Not Receive Study Drug|0
1655694|NCT01620489|5785779|P2|Overall Study|Unclassified|2
1655695|NCT01620489|5785780|P1|Overall Study|Unclassified|1
1655696|NCT01620489|5785779|P2|Overall Study|Withdrawal Criteria|25
1655697|NCT01620489|5785780|P1|Overall Study|Withdrawal Criteria|17
1655698|NCT01620489|5785779|P2|Overall Study|Protocol Violation|3
1655699|NCT01620489|5785780|P1|Overall Study|Protocol Violation|0
1655700|NCT01620489|5785779|P2|Overall Study|Adverse Event|4
1655701|NCT01620489|5785780|P1|Overall Study|Adverse Event|17
1655702|NCT01620255|5785801|P5|Overall Study|Withdrawn at discretion of investigator|1
1655703|NCT01620255|5785802|P4|Overall Study|Withdrawn at discretion of investigator|0
1655704|NCT01620255|5785803|P3|Overall Study|Withdrawn at discretion of investigator|0
1655705|NCT01620255|5785804|P2|Overall Study|Withdrawn at discretion of investigator|0
1655706|NCT01620255|5785805|P1|Overall Study|Withdrawn at discretion of investigator|0
1655707|NCT01620255|5785801|P5|Overall Study|Adverse Event|1
1655708|NCT01620255|5785802|P4|Overall Study|Adverse Event|1
1655709|NCT01620255|5785803|P3|Overall Study|Adverse Event|0
1655710|NCT01620255|5785804|P2|Overall Study|Adverse Event|4
1655711|NCT01620255|5785805|P1|Overall Study|Adverse Event|0
1655712|NCT01620255|5785801|P5|Overall Study|Non-compliance|0
1655713|NCT01620255|5785802|P4|Overall Study|Non-compliance|0
1655714|NCT01620255|5785803|P3|Overall Study|Non-compliance|0
1655715|NCT01620255|5785804|P2|Overall Study|Non-compliance|1
1655716|NCT01620255|5785805|P1|Overall Study|Non-compliance|0
1655717|NCT01620255|5785801|P5|Overall Study|Participant underwent fecal transplant|0
1655718|NCT01620255|5785802|P4|Overall Study|Participant underwent fecal transplant|0
1655719|NCT01620255|5785803|P3|Overall Study|Participant underwent fecal transplant|1
1655720|NCT01620255|5785804|P2|Overall Study|Participant underwent fecal transplant|0
1655721|NCT01620255|5785805|P1|Overall Study|Participant underwent fecal transplant|0
1655722|NCT01620255|5785801|P5|Overall Study|Withdrawal by Subject|4
1655723|NCT01620255|5785802|P4|Overall Study|Withdrawal by Subject|2
1655724|NCT01620255|5785803|P3|Overall Study|Withdrawal by Subject|1
1655725|NCT01620255|5785804|P2|Overall Study|Withdrawal by Subject|1
1655726|NCT01620255|5785805|P1|Overall Study|Withdrawal by Subject|4
1655727|NCT01620177|5785882|P1|Overall Study|Randomized, Not Active due to Scheduling|1
1655728|NCT01620177|5785882|P1|Overall Study|Physician Decision|2
1655729|NCT01620177|5785882|P1|Overall Study|Lost to Follow-up|7
1655730|NCT01620177|5785882|P1|Overall Study|Withdrawal by Subject|26
1655731|NCT01620177|5785882|P1|Overall Study|Failure at Screening Visit|43
1655732|NCT01620138|5785907|P2|Overall Study|Adverse Event|0
1655733|NCT01620138|5785908|P1|Overall Study|Adverse Event|2
1655734|NCT01620138|5785907|P2|Overall Study|Lack of Efficacy|0
1655735|NCT01620138|5785908|P1|Overall Study|Lack of Efficacy|1
1655736|NCT01620138|5785907|P2|Overall Study|Withdrawal by Subject|0
1655737|NCT01620138|5785908|P1|Overall Study|Withdrawal by Subject|3
1655738|NCT01620086|5785916|P3|Overall Study|Physician Decision|0
1655739|NCT01620086|5785917|P2|Overall Study|Physician Decision|0
1655740|NCT01620086|5785918|P1|Overall Study|Physician Decision|1
1655741|NCT01620086|5785916|P3|Overall Study|failed study criteria|0
1655742|NCT01620086|5785917|P2|Overall Study|failed study criteria|4
1655743|NCT01620086|5785918|P1|Overall Study|failed study criteria|1
1655744|NCT01620086|5785916|P3|Overall Study|Withdrawal by Subject|0
1655745|NCT01620086|5785917|P2|Overall Study|Withdrawal by Subject|3
1655746|NCT01620086|5785918|P1|Overall Study|Withdrawal by Subject|3
1655747|NCT01620060|5785937|P1|Overall Study|Per Sponsor Decision|2
1655748|NCT01620060|5785937|P1|Overall Study|Family emergency|1
1655749|NCT01620060|5785937|P1|Overall Study|Did not comply with Study Produre|1
1655750|NCT01620060|5785937|P1|Overall Study|Withdrawal by Subject|1
1655751|NCT01620060|5785937|P1|Overall Study|Protocol Violation|1
1655752|NCT01620060|5785937|P1|Overall Study|Adverse Event|9
1655753|NCT01619878|5785975|P1|Follow-up at 12 Months of Age|Death|2
1655754|NCT01619878|5785975|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
1655755|NCT01619878|5785975|P1|6 Week Follow-up Phase|Adverse Event|1
1655756|NCT01619852|5785989|P2|3 Month Follow up|Lost to Follow-up|34
1655757|NCT01619852|5785990|P1|3 Month Follow up|Lost to Follow-up|31
1655758|NCT01619852|5785989|P2|24 Hour Assessment|Withdrawal by Subject|1
1655759|NCT01619852|5785990|P1|24 Hour Assessment|Withdrawal by Subject|1
1655760|NCT01619800|5786006|P2|Overall Study|study terminated|0
1655761|NCT01619800|5786007|P1|Overall Study|study terminated|2
1655762|NCT01619787|5786015|P1|Overall Study|Lost to Follow-up|5
1655763|NCT01619579|5786032|P2|Overall Study|Withdrawal by Subject|3
1655764|NCT01619579|5786033|P1|Overall Study|Withdrawal by Subject|0
1655765|NCT01619423|5786047|P4|Part 1 (Dose Escalation)|High basal Mn|0
1655766|NCT01619423|5786048|P3|Part 1 (Dose Escalation)|High basal Mn|0
1655767|NCT01619423|5786049|P2|Part 1 (Dose Escalation)|High basal Mn|2
1655768|NCT01619423|5786050|P1|Part 1 (Dose Escalation)|High basal Mn|0
1655769|NCT01619410|5786063|P2|Overall Study|Lost to Follow-up|4
1655770|NCT01619410|5786064|P1|Overall Study|Lost to Follow-up|7
1655778|NCT01619059|5786082|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
1655779|NCT01619059|5786083|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
1655780|NCT01619059|5786082|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1655781|NCT01619059|5786083|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
1655782|NCT01619059|5786082|P2|Long-Term (LT) Treatment Period|Death|0
1655783|NCT01619059|5786083|P1|Long-Term (LT) Treatment Period|Death|1
1655784|NCT01619059|5786082|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
1655785|NCT01619059|5786083|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
1655786|NCT01619059|5786082|P2|Long-Term (LT) Treatment Period|Adverse Event|3
1655787|NCT01619059|5786083|P1|Long-Term (LT) Treatment Period|Adverse Event|2
1655788|NCT01619059|5786082|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
1655789|NCT01619059|5786083|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
1655790|NCT01619059|5786082|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
1655791|NCT01619059|5786083|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
1655792|NCT01619059|5786082|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
1655793|NCT01619059|5786083|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
1655794|NCT01619059|5786082|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
1655795|NCT01619059|5786083|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
1655796|NCT01619059|5786082|P2|Short-Term (ST) Treatment Period|Adverse Event|0
1655797|NCT01619059|5786083|P1|Short-Term (ST) Treatment Period|Adverse Event|1
1655798|NCT01618968|5786099|P4|Overall Study|Death|1
1655799|NCT01618968|5786100|P3|Overall Study|Death|0
1655800|NCT01618968|5786101|P2|Overall Study|Death|0
1655801|NCT01618968|5786102|P1|Overall Study|Death|0
1655802|NCT01618968|5786099|P4|Overall Study|Adverse Event|0
1655803|NCT01618968|5786100|P3|Overall Study|Adverse Event|0
1655804|NCT01618968|5786101|P2|Overall Study|Adverse Event|0
1655805|NCT01618968|5786102|P1|Overall Study|Adverse Event|1
1655806|NCT01618916|5786175|P6|Overall Study|Lost to Follow-up|0
1655807|NCT01618916|5786176|P5|Overall Study|Lost to Follow-up|0
1655808|NCT01618916|5786177|P4|Overall Study|Lost to Follow-up|2
1655809|NCT01618916|5786178|P3|Overall Study|Lost to Follow-up|0
1655810|NCT01618916|5786179|P2|Overall Study|Lost to Follow-up|0
1655811|NCT01618916|5786180|P1|Overall Study|Lost to Follow-up|1
1655812|NCT01618916|5786175|P6|Overall Study|Withdrawal by Subject|0
1655813|NCT01618916|5786176|P5|Overall Study|Withdrawal by Subject|1
1655814|NCT01618916|5786177|P4|Overall Study|Withdrawal by Subject|0
1655815|NCT01618916|5786178|P3|Overall Study|Withdrawal by Subject|1
1655816|NCT01618916|5786179|P2|Overall Study|Withdrawal by Subject|1
1655817|NCT01618916|5786180|P1|Overall Study|Withdrawal by Subject|0
1655818|NCT01618916|5786175|P6|Overall Study|Adverse Event|0
1655819|NCT01618916|5786176|P5|Overall Study|Adverse Event|0
1655820|NCT01618916|5786177|P4|Overall Study|Adverse Event|0
1655821|NCT01618916|5786178|P3|Overall Study|Adverse Event|0
1655822|NCT01618916|5786179|P2|Overall Study|Adverse Event|0
1655823|NCT01618916|5786180|P1|Overall Study|Adverse Event|1
1655824|NCT01618864|5786210|P1|Overall Study|Lost to Follow-up|2
1655825|NCT01618864|5786210|P1|Overall Study|Withdrawal by Subject|2
1655826|NCT01618838|5786219|P1|Overall Study|slow accrual, trial closed prematurely.|4
1655827|NCT01618708|5786227|P2|Overall Study|Randomized but not treated|2
1655828|NCT01618708|5786228|P1|Overall Study|Randomized but not treated|3
1655829|NCT01618708|5786227|P2|Overall Study|Other than specified above|1
1655830|NCT01618708|5786228|P1|Overall Study|Other than specified above|1
1655831|NCT01618708|5786227|P2|Overall Study|Technical problems|0
1655832|NCT01618708|5786228|P1|Overall Study|Technical problems|2
1655833|NCT01618708|5786227|P2|Overall Study|Lack of Efficacy|8
1655834|NCT01618708|5786228|P1|Overall Study|Lack of Efficacy|8
1655835|NCT01618708|5786227|P2|Overall Study|Withdrawal by Subject|22
1655836|NCT01618708|5786228|P1|Overall Study|Withdrawal by Subject|17
1655837|NCT01618708|5786227|P2|Overall Study|Lost to Follow-up|3
1655838|NCT01618708|5786228|P1|Overall Study|Lost to Follow-up|3
1655839|NCT01618708|5786227|P2|Overall Study|Adverse Event|10
1655840|NCT01618708|5786228|P1|Overall Study|Adverse Event|10
1655841|NCT01618669|5786242|P2|Overall Study|Miscellaneous Reason|1
1655842|NCT01618669|5786243|P1|Overall Study|Miscellaneous Reason|0
1655843|NCT01618669|5786242|P2|Overall Study|Withdrawal by Subject|9
1655844|NCT01618669|5786243|P1|Overall Study|Withdrawal by Subject|9
1655845|NCT01618669|5786242|P2|Overall Study|Protocol Violation|3
1655846|NCT01618669|5786243|P1|Overall Study|Protocol Violation|5
1655847|NCT01618669|5786242|P2|Overall Study|Adverse Event|7
1655848|NCT01618669|5786243|P1|Overall Study|Adverse Event|16
1655849|NCT01618669|5786242|P2|Overall Study|Randomized but Never Received Study Drug|2
1655850|NCT01618669|5786243|P1|Overall Study|Randomized but Never Received Study Drug|3
1655851|NCT01618669|5786242|P2|Overall Study|Lost to Follow-up|1
1655852|NCT01618669|5786243|P1|Overall Study|Lost to Follow-up|1
1655853|NCT01618305|5786302|P2|Overall Study|Withdrawal by Subject|2
1655854|NCT01618305|5786303|P1|Overall Study|Withdrawal by Subject|3
1655855|NCT01618305|5786302|P2|Overall Study|Protocol Violation|0
1655856|NCT01618305|5786303|P1|Overall Study|Protocol Violation|1
1655857|NCT01618305|5786302|P2|Overall Study|Lost to Follow-up|7
1655858|NCT01618305|5786303|P1|Overall Study|Lost to Follow-up|11
1655859|NCT01618305|5786302|P2|Overall Study|Death|1
1655860|NCT01618305|5786303|P1|Overall Study|Death|0
1655861|NCT01618266|5786345|P1|Overall Study|Protocol Violation|43
1655862|NCT01618266|5786345|P1|Overall Study|Lack of Efficacy|23
1655863|NCT01618266|5786345|P1|Overall Study|Other reasons|11
1655864|NCT01618266|5786345|P1|Overall Study|Treatment satisfaction|10
1655865|NCT01618266|5786345|P1|Overall Study|Lost to Follow-up|9
1655866|NCT01618214|5786382|P2|Overall Study|Unclassified|5
1655867|NCT01618214|5786383|P1|Overall Study|Unclassified|4
1655868|NCT01618214|5786382|P2|Overall Study|Withdrawal Criteria|2
1655869|NCT01618214|5786383|P1|Overall Study|Withdrawal Criteria|1
1655870|NCT01618214|5786382|P2|Overall Study|Protocol Violation|4
1655871|NCT01618214|5786383|P1|Overall Study|Protocol Violation|1
1655872|NCT01618214|5786382|P2|Overall Study|Lack of Efficacy|1
1655873|NCT01618214|5786383|P1|Overall Study|Lack of Efficacy|1
1655874|NCT01618214|5786382|P2|Overall Study|Adverse Event|1
1655875|NCT01618214|5786383|P1|Overall Study|Adverse Event|3
1655876|NCT01618162|5786399|P2|Overall Study|Unclassified|13
1655877|NCT01618162|5786400|P1|Overall Study|Unclassified|14
1655878|NCT01618162|5786399|P2|Overall Study|Withdrawal Criteria|10
1655879|NCT01618162|5786400|P1|Overall Study|Withdrawal Criteria|2
1655880|NCT01618162|5786399|P2|Overall Study|Adverse Event|2
1655881|NCT01618162|5786400|P1|Overall Study|Adverse Event|9
1655882|NCT01618162|5786399|P2|Overall Study|Protocol Violation|10
1655883|NCT01618162|5786400|P1|Overall Study|Protocol Violation|13
1655884|NCT01618019|5786420|P2|Overall Study|Withdrawal by Subject|14
1655885|NCT01618019|5786421|P1|Overall Study|Withdrawal by Subject|14
1655886|NCT01617967|5786447|P6|Overall Study|Dosing Suspended by Sponsor|0
1655887|NCT01617967|5786448|P5|Overall Study|Dosing Suspended by Sponsor|0
1655888|NCT01617967|5786449|P4|Overall Study|Dosing Suspended by Sponsor|0
1655889|NCT01617967|5786450|P3|Overall Study|Dosing Suspended by Sponsor|0
1655890|NCT01617967|5786451|P2|Overall Study|Dosing Suspended by Sponsor|0
1655891|NCT01617967|5786452|P1|Overall Study|Dosing Suspended by Sponsor|1
1655892|NCT01617967|5786447|P6|Overall Study|Withdrawal by Subject|1
1655893|NCT01617967|5786448|P5|Overall Study|Withdrawal by Subject|0
1655894|NCT01617967|5786449|P4|Overall Study|Withdrawal by Subject|0
1655895|NCT01617967|5786450|P3|Overall Study|Withdrawal by Subject|0
1655896|NCT01617967|5786451|P2|Overall Study|Withdrawal by Subject|0
1655897|NCT01617967|5786452|P1|Overall Study|Withdrawal by Subject|0
1655898|NCT01617967|5786447|P6|Overall Study|Protocol Violation|0
1655899|NCT01617967|5786448|P5|Overall Study|Protocol Violation|0
1655900|NCT01617967|5786449|P4|Overall Study|Protocol Violation|1
1655901|NCT01617967|5786450|P3|Overall Study|Protocol Violation|0
1655902|NCT01617967|5786451|P2|Overall Study|Protocol Violation|0
1655903|NCT01617967|5786452|P1|Overall Study|Protocol Violation|0
1655904|NCT01617681|5786506|P5|Period 2 Open Label|Withdrawal by Subject|3
1655905|NCT01617681|5786507|P4|Period 2 Open Label|Withdrawal by Subject|0
1655906|NCT01617681|5786508|P3|Period 2 Open Label|Withdrawal by Subject|0
1655907|NCT01617681|5786509|P2|Period 2 Open Label|Withdrawal by Subject|0
1655908|NCT01617681|5786510|P1|Period 2 Open Label|Withdrawal by Subject|0
1655909|NCT01617681|5786506|P5|Period 2 Open Label|Adverse Event|3
1655910|NCT01617681|5786507|P4|Period 2 Open Label|Adverse Event|0
1655911|NCT01617681|5786508|P3|Period 2 Open Label|Adverse Event|0
1655912|NCT01617681|5786509|P2|Period 2 Open Label|Adverse Event|0
1655913|NCT01617681|5786510|P1|Period 2 Open Label|Adverse Event|0
1655914|NCT01617681|5786506|P5|Period 1 Double Blind|Withdrawal by Subject|0
1655915|NCT01617681|5786507|P4|Period 1 Double Blind|Withdrawal by Subject|0
1655916|NCT01617681|5786508|P3|Period 1 Double Blind|Withdrawal by Subject|1
1655917|NCT01617681|5786509|P2|Period 1 Double Blind|Withdrawal by Subject|1
1655918|NCT01617681|5786510|P1|Period 1 Double Blind|Withdrawal by Subject|1
1655919|NCT01617681|5786506|P5|Period 1 Double Blind|Adverse Event|0
1655920|NCT01617681|5786507|P4|Period 1 Double Blind|Adverse Event|2
1655921|NCT01617681|5786508|P3|Period 1 Double Blind|Adverse Event|0
1655922|NCT01617681|5786509|P2|Period 1 Double Blind|Adverse Event|0
1655923|NCT01617681|5786510|P1|Period 1 Double Blind|Adverse Event|2
1655924|NCT01617668|5786531|P4|Overall Study|Subject/guardian decision|1
1655925|NCT01617668|5786532|P3|Overall Study|Subject/guardian decision|2
1655926|NCT01617668|5786533|P2|Overall Study|Subject/guardian decision|3
1655927|NCT01617668|5786534|P1|Overall Study|Subject/guardian decision|1
1655928|NCT01617668|5786531|P4|Overall Study|Progressive Disease|9
1655929|NCT01617668|5786532|P3|Overall Study|Progressive Disease|6
1655930|NCT01617668|5786533|P2|Overall Study|Progressive Disease|4
1655931|NCT01617668|5786534|P1|Overall Study|Progressive Disease|4
1655932|NCT01617668|5786531|P4|Overall Study|Physician Decision|0
1655933|NCT01617668|5786532|P3|Overall Study|Physician Decision|3
1655934|NCT01617668|5786533|P2|Overall Study|Physician Decision|2
1655935|NCT01617668|5786534|P1|Overall Study|Physician Decision|1
1655936|NCT01617668|5786531|P4|Overall Study|Adverse Event|5
1655937|NCT01617668|5786532|P3|Overall Study|Adverse Event|12
1655938|NCT01617668|5786533|P2|Overall Study|Adverse Event|0
1655939|NCT01617668|5786534|P1|Overall Study|Adverse Event|7
1655940|NCT01617655|5786575|P2|Overall Study|Other than specified above|2
1655941|NCT01617655|5786576|P1|Overall Study|Other than specified above|1
1655942|NCT01617655|5786575|P2|Overall Study|Site closure|5
1655943|NCT01617655|5786576|P1|Overall Study|Site closure|3
1655944|NCT01617655|5786575|P2|Overall Study|Last visit outside protocol visit window|10
1655945|NCT01617655|5786576|P1|Overall Study|Last visit outside protocol visit window|1
1655946|NCT01617655|5786575|P2|Overall Study|Consent withdrawn by participant|1
1655947|NCT01617655|5786576|P1|Overall Study|Consent withdrawn by participant|1
1655948|NCT01617655|5786575|P2|Overall Study|Participants moved|4
1655949|NCT01617655|5786576|P1|Overall Study|Participants moved|0
1655950|NCT01617655|5786575|P2|Overall Study|Poor compliance to protocol|4
1655951|NCT01617655|5786576|P1|Overall Study|Poor compliance to protocol|1
1655952|NCT01617655|5786575|P2|Overall Study|Adverse Event|3
1655953|NCT01617655|5786576|P1|Overall Study|Adverse Event|2
1655954|NCT01617629|5786636|P1|Overall Study|Participant Withdrew Consent|2
1655955|NCT01617629|5786636|P1|Overall Study|Reason Not Specified|1
1655956|NCT01617629|5786636|P1|Overall Study|Investigator's Clinical Judgement|1
1655957|NCT01617629|5786636|P1|Overall Study|Death|2
1655958|NCT01617460|5786664|P1|Overall Study|Withdrawal by Subject|9
1655959|NCT01617460|5786664|P1|Overall Study|Protocol Violation|5
1655960|NCT01617460|5786664|P1|Overall Study|Physician Decision|16
1655961|NCT01617460|5786664|P1|Overall Study|Adverse Event|10
1655962|NCT01617447|5786670|P2|Overall Study|Physician Decision|2
1655963|NCT01617447|5786671|P1|Overall Study|Physician Decision|0
1655964|NCT01617447|5786670|P2|Overall Study|Adverse Event|1
1655965|NCT01617447|5786671|P1|Overall Study|Adverse Event|0
1655966|NCT01617434|5786679|P2|Overall Study|Unclassified|4
1655967|NCT01617434|5786680|P1|Overall Study|Unclassified|3
1655968|NCT01617434|5786679|P2|Overall Study|Withdrawal Criteria|37
1655969|NCT01617434|5786680|P1|Overall Study|Withdrawal Criteria|12
1655970|NCT01617434|5786679|P2|Overall Study|Protocol Violation|7
1655971|NCT01617434|5786680|P1|Overall Study|Protocol Violation|8
1655972|NCT01617434|5786679|P2|Overall Study|Adverse Event|3
1655973|NCT01617434|5786680|P1|Overall Study|Adverse Event|12
1655974|NCT01617187|5786719|P4|Treatment Through Study Completion|Protocol Violation|1
1655975|NCT01617187|5786720|P3|Treatment Through Study Completion|Protocol Violation|0
1655976|NCT01617187|5786721|P2|Treatment Through Study Completion|Protocol Violation|0
1655977|NCT01617187|5786722|P1|Treatment Through Study Completion|Protocol Violation|1
1655978|NCT01617187|5786719|P4|Treatment Through Study Completion|Withdrawal by Subject|6
1655979|NCT01617187|5786720|P3|Treatment Through Study Completion|Withdrawal by Subject|3
1655980|NCT01617187|5786721|P2|Treatment Through Study Completion|Withdrawal by Subject|8
1655981|NCT01617187|5786722|P1|Treatment Through Study Completion|Withdrawal by Subject|5
1655982|NCT01617187|5786719|P4|Treatment Through Study Completion|Lost to Follow-up|2
1655983|NCT01617187|5786720|P3|Treatment Through Study Completion|Lost to Follow-up|2
1655984|NCT01617187|5786721|P2|Treatment Through Study Completion|Lost to Follow-up|2
1655985|NCT01617187|5786722|P1|Treatment Through Study Completion|Lost to Follow-up|4
1655986|NCT01617187|5786719|P4|Treatment Through Study Completion|Adverse Event|1
1655987|NCT01617187|5786720|P3|Treatment Through Study Completion|Adverse Event|0
1655988|NCT01617187|5786721|P2|Treatment Through Study Completion|Adverse Event|1
1655989|NCT01617187|5786722|P1|Treatment Through Study Completion|Adverse Event|1
1655990|NCT01617187|5786719|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1655991|NCT01617187|5786720|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1655992|NCT01617187|5786721|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
1655993|NCT01617187|5786722|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
1655994|NCT01617187|5786719|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
1655995|NCT01617187|5786720|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1655996|NCT01617187|5786721|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1655997|NCT01617187|5786722|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
1655998|NCT01617187|5786719|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
1655999|NCT01617187|5786720|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1656000|NCT01617187|5786721|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1656001|NCT01617187|5786722|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
1656002|NCT01617070|5786819|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
1656003|NCT01617005|5786837|P1|Overall Study|Lack of motivation for treatment|1
1656004|NCT01617005|5786837|P1|Overall Study|Pregnancy|1
1656005|NCT01616953|5786846|P2|Overall Study|lack of bone and soft tissue|0
1656006|NCT01616953|5786847|P1|Overall Study|lack of bone and soft tissue|1
1656007|NCT01616953|5786846|P2|Overall Study|Lost to Follow-up|0
1656008|NCT01616953|5786847|P1|Overall Study|Lost to Follow-up|1
1656009|NCT01616771|5786855|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
1656010|NCT01616693|5786868|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
1656011|NCT01616693|5786869|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
1656012|NCT01616693|5786870|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
1656013|NCT01616693|5786871|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
1656014|NCT01616693|5786868|P4|Received Both Vaccines|Lost to Follow-up|4
1656015|NCT01616693|5786869|P3|Received Both Vaccines|Lost to Follow-up|4
1656016|NCT01616693|5786870|P2|Received Both Vaccines|Lost to Follow-up|3
1656017|NCT01616693|5786871|P1|Received Both Vaccines|Lost to Follow-up|4
1656018|NCT01616693|5786868|P4|Received Both Vaccines|Withdrawal by Subject|15
1656019|NCT01616693|5786869|P3|Received Both Vaccines|Withdrawal by Subject|8
1656020|NCT01616693|5786870|P2|Received Both Vaccines|Withdrawal by Subject|7
1656021|NCT01616693|5786871|P1|Received Both Vaccines|Withdrawal by Subject|7
1656022|NCT01616693|5786868|P4|Received Both Vaccines|Adverse Event|0
1656023|NCT01616693|5786869|P3|Received Both Vaccines|Adverse Event|0
1656024|NCT01616693|5786870|P2|Received Both Vaccines|Adverse Event|0
1656025|NCT01616693|5786871|P1|Received Both Vaccines|Adverse Event|2
1656026|NCT01616693|5786868|P4|Evaluated for Safety|Physician Decision|0
1656027|NCT01616693|5786869|P3|Evaluated for Safety|Physician Decision|1
1656028|NCT01616693|5786870|P2|Evaluated for Safety|Physician Decision|0
1656029|NCT01616693|5786871|P1|Evaluated for Safety|Physician Decision|1
1656030|NCT01616459|5786937|P4|Overall Study|Other reason|0
1656031|NCT01616459|5786938|P3|Overall Study|Other reason|1
1656032|NCT01616459|5786939|P2|Overall Study|Other reason|1
1656033|NCT01616459|5786940|P1|Overall Study|Other reason|0
1656034|NCT01616459|5786937|P4|Overall Study|Withdrawal by Subject|4
1656035|NCT01616459|5786938|P3|Overall Study|Withdrawal by Subject|4
1656036|NCT01616459|5786939|P2|Overall Study|Withdrawal by Subject|4
1656037|NCT01616459|5786940|P1|Overall Study|Withdrawal by Subject|2
1656038|NCT01616459|5786937|P4|Overall Study|Protocol Violation|2
1656039|NCT01616459|5786938|P3|Overall Study|Protocol Violation|0
1656040|NCT01616459|5786939|P2|Overall Study|Protocol Violation|0
1656041|NCT01616459|5786940|P1|Overall Study|Protocol Violation|0
1656042|NCT01616459|5786937|P4|Overall Study|Lost to Follow-up|2
1656043|NCT01616459|5786938|P3|Overall Study|Lost to Follow-up|3
1656044|NCT01616459|5786939|P2|Overall Study|Lost to Follow-up|11
1656045|NCT01616459|5786940|P1|Overall Study|Lost to Follow-up|1
1656046|NCT01616459|5786937|P4|Overall Study|Adverse Event|0
1656047|NCT01616459|5786938|P3|Overall Study|Adverse Event|2
1656048|NCT01616459|5786939|P2|Overall Study|Adverse Event|1
1656049|NCT01616459|5786940|P1|Overall Study|Adverse Event|1
1656050|NCT01616173|5787041|P3|Overall Study|Lost to Follow-up|0
1656051|NCT01616173|5787042|P2|Overall Study|Lost to Follow-up|2
1656052|NCT01616173|5787043|P1|Overall Study|Lost to Follow-up|0
1656053|NCT01615939|5787076|P2|Overall Study|Lost to Follow-up|0
1656054|NCT01615939|5787077|P1|Overall Study|Lost to Follow-up|5
1656055|NCT01615822|5787090|P3|Period 2|Lost to Follow-up|2
1656056|NCT01615822|5787091|P2|Period 2|Lost to Follow-up|1
1656057|NCT01615822|5787092|P1|Period 2|Lost to Follow-up|0
1656058|NCT01615822|5787090|P3|Period 1|Adverse Event|0
1656059|NCT01615822|5787091|P2|Period 1|Adverse Event|1
1656060|NCT01615822|5787092|P1|Period 1|Adverse Event|1
1656061|NCT01615822|5787090|P3|Period 1|Withdrawal by Subject|0
1656062|NCT01615822|5787091|P2|Period 1|Withdrawal by Subject|1
1656063|NCT01615822|5787092|P1|Period 1|Withdrawal by Subject|0
1656064|NCT01615328|5787180|P2|Overall Study|Lost to Follow-up|5
1656065|NCT01615328|5787181|P1|Overall Study|Lost to Follow-up|3
1656066|NCT01615263|5787193|P2|Overall Study|Post-randomization exclusion|2
1656067|NCT01615263|5787194|P1|Overall Study|Post-randomization exclusion|0
1656068|NCT01615198|5787208|P2|Overall Study|Adverse Event|5
1656069|NCT01615198|5787209|P1|Overall Study|Adverse Event|11
1656070|NCT01615198|5787208|P2|Overall Study|Lack of Efficacy|6
1656071|NCT01615198|5787209|P1|Overall Study|Lack of Efficacy|1
1656072|NCT01615198|5787208|P2|Overall Study|Lost to Follow-up|1
1656073|NCT01615198|5787209|P1|Overall Study|Lost to Follow-up|1
1656074|NCT01615198|5787208|P2|Overall Study|Physician Decision|1
1656075|NCT01615198|5787209|P1|Overall Study|Physician Decision|5
1656076|NCT01615198|5787208|P2|Overall Study|Protocol deviation|1
1656077|NCT01615198|5787209|P1|Overall Study|Protocol deviation|1
1656078|NCT01615198|5787208|P2|Overall Study|Withdrawal by Subject|5
1656079|NCT01615198|5787209|P1|Overall Study|Withdrawal by Subject|5
1656110|NCT01614886|5787314|P2|Overall Study|Protocol deviation|2
1656111|NCT01614886|5787315|P1|Overall Study|Protocol deviation|0
1656112|NCT01614886|5787314|P2|Overall Study|Death|0
1656113|NCT01614886|5787315|P1|Overall Study|Death|1
1656114|NCT01614886|5787314|P2|Overall Study|Withdrawal by Subject|4
1656115|NCT01614886|5787315|P1|Overall Study|Withdrawal by Subject|4
1656116|NCT01614886|5787314|P2|Overall Study|Adverse Event|20
1656117|NCT01614886|5787315|P1|Overall Study|Adverse Event|15
1656118|NCT01614795|5787342|P4|Overall Study|Ineligible|0
1656119|NCT01614795|5787343|P3|Overall Study|Ineligible|0
1656120|NCT01614795|5787344|P2|Overall Study|Ineligible|1
1656121|NCT01614795|5787345|P1|Overall Study|Ineligible|0
1656122|NCT01614795|5787342|P4|Overall Study|Withdrawal by Subject|2
1656123|NCT01614795|5787343|P3|Overall Study|Withdrawal by Subject|0
1656124|NCT01614795|5787344|P2|Overall Study|Withdrawal by Subject|1
1656125|NCT01614795|5787345|P1|Overall Study|Withdrawal by Subject|0
1656126|NCT01614795|5787342|P4|Overall Study|Physician Decision|1
1656127|NCT01614795|5787343|P3|Overall Study|Physician Decision|1
1656128|NCT01614795|5787344|P2|Overall Study|Physician Decision|0
1656129|NCT01614795|5787345|P1|Overall Study|Physician Decision|1
1656130|NCT01614795|5787342|P4|Overall Study|Lack of Efficacy|8
1656131|NCT01614795|5787343|P3|Overall Study|Lack of Efficacy|9
1656132|NCT01614795|5787344|P2|Overall Study|Lack of Efficacy|10
1656133|NCT01614795|5787345|P1|Overall Study|Lack of Efficacy|10
1656134|NCT01614795|5787342|P4|Overall Study|Adverse Event|1
1656135|NCT01614795|5787343|P3|Overall Study|Adverse Event|1
1656136|NCT01614795|5787344|P2|Overall Study|Adverse Event|0
1656137|NCT01614795|5787345|P1|Overall Study|Adverse Event|0
1656138|NCT01614769|5787365|P6|Period 3|Withdrawal by Subject|0
1656139|NCT01614769|5787366|P5|Period 3|Withdrawal by Subject|0
1656140|NCT01614769|5787367|P4|Period 3|Withdrawal by Subject|0
1656141|NCT01614769|5787368|P3|Period 3|Withdrawal by Subject|1
1656142|NCT01614769|5787369|P2|Period 3|Withdrawal by Subject|0
1656143|NCT01614769|5787370|P1|Period 3|Withdrawal by Subject|0
1656144|NCT01614769|5787365|P6|Period 1|Withdrawal by Subject|0
1656145|NCT01614769|5787366|P5|Period 1|Withdrawal by Subject|0
1656146|NCT01614769|5787367|P4|Period 1|Withdrawal by Subject|0
1656147|NCT01614769|5787368|P3|Period 1|Withdrawal by Subject|0
1656148|NCT01614769|5787369|P2|Period 1|Withdrawal by Subject|0
1656149|NCT01614769|5787370|P1|Period 1|Withdrawal by Subject|1
1656150|NCT01614769|5787365|P6|Period 1|Protocol Violation|0
1656151|NCT01614769|5787366|P5|Period 1|Protocol Violation|0
1656152|NCT01614769|5787367|P4|Period 1|Protocol Violation|1
1656153|NCT01614769|5787368|P3|Period 1|Protocol Violation|0
1656154|NCT01614769|5787369|P2|Period 1|Protocol Violation|0
1656155|NCT01614769|5787370|P1|Period 1|Protocol Violation|0
1656156|NCT01614769|5787365|P6|Period 1|Discontinued due to Hypoglycemia|1
1656157|NCT01614769|5787366|P5|Period 1|Discontinued due to Hypoglycemia|0
1656158|NCT01614769|5787367|P4|Period 1|Discontinued due to Hypoglycemia|1
1656159|NCT01614769|5787368|P3|Period 1|Discontinued due to Hypoglycemia|0
1656160|NCT01614769|5787369|P2|Period 1|Discontinued due to Hypoglycemia|0
1656161|NCT01614769|5787370|P1|Period 1|Discontinued due to Hypoglycemia|0
1656162|NCT01614600|5787392|P1|Overall Study|Protocol deviation|1
1656163|NCT01614600|5787392|P1|Overall Study|Unable to remove lens at the end of day|1
1656164|NCT01614600|5787392|P1|Overall Study|Discomfort|1
1656165|NCT01614600|5787392|P1|Overall Study|Unacceptable fit|1
1656166|NCT01614470|5787423|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
1656167|NCT01614470|5787424|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1656168|NCT01614470|5787425|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
1656169|NCT01614470|5787423|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1656170|NCT01614470|5787424|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
1656171|NCT01614470|5787425|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
1656172|NCT01614457|5787447|P2|Overall Study|Pregnancy (Self or Partner)|0
1656173|NCT01614457|5787448|P1|Overall Study|Pregnancy (Self or Partner)|1
1656174|NCT01614457|5787447|P2|Overall Study|Non-Compliance|0
1656175|NCT01614457|5787448|P1|Overall Study|Non-Compliance|1
1656176|NCT01614249|5787475|P2|Overall Study|Lost to Follow-up|23
1656177|NCT01614249|5787476|P1|Overall Study|Lost to Follow-up|11
1656178|NCT01614093|5787490|P1|Overall Study|Withdrawal by Subject|1
1656179|NCT01613716|5787503|P1|Overall Study|Lost to Follow-up|4
1656180|NCT01613716|5787503|P1|Overall Study|screen failures|3
1656181|NCT01613599|5787508|P1|Overall Study|Reason not specified|3
1656182|NCT01613599|5787508|P1|Overall Study|Withdrawal by Subject|8
1656183|NCT01613599|5787508|P1|Overall Study|Lost to Follow-up|5
1656184|NCT01613599|5787508|P1|Overall Study|Death|9
1656185|NCT01613417|5787523|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
1656186|NCT01613417|5787524|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
1656187|NCT01613378|5787561|P1|Overall Study|Other Reason|4
1656188|NCT01613378|5787561|P1|Overall Study|Lost to Follow-up|1
1656189|NCT01613378|5787561|P1|Overall Study|Death|2
1656190|NCT01613378|5787561|P1|Overall Study|Withdrawal by Subject|8
1656191|NCT01613378|5787561|P1|Overall Study|Adverse Event|11
1656192|NCT01613378|5787561|P1|Overall Study|Lack of Efficacy|13
1656193|NCT01613326|5787591|P2|Overall Study|Protocol Violation|1
1656194|NCT01613326|5787592|P1|Overall Study|Protocol Violation|0
1656195|NCT01613326|5787591|P2|Overall Study|Administrative|2
1656196|NCT01613326|5787592|P1|Overall Study|Administrative|0
1656197|NCT01613326|5787591|P2|Overall Study|Lost to Follow-up|1
1656198|NCT01613326|5787592|P1|Overall Study|Lost to Follow-up|0
1656199|NCT01613326|5787591|P2|Overall Study|Lack of Efficacy|1
1656200|NCT01613326|5787592|P1|Overall Study|Lack of Efficacy|0
1656201|NCT01613326|5787591|P2|Overall Study|inability to use device|0
1656202|NCT01613326|5787592|P1|Overall Study|inability to use device|1
1656203|NCT01613326|5787591|P2|Overall Study|Abnormal test procedure result(s)|0
1656204|NCT01613326|5787592|P1|Overall Study|Abnormal test procedure result(s)|2
1656205|NCT01613326|5787591|P2|Overall Study|Withdrawal by Subject|4
1656206|NCT01613326|5787592|P1|Overall Study|Withdrawal by Subject|3
1656207|NCT01613326|5787591|P2|Overall Study|Adverse Event|5
1656208|NCT01613326|5787592|P1|Overall Study|Adverse Event|7
1656209|NCT01613248|5787649|P6|Overall Study|Pregnancy|0
1656210|NCT01613248|5787650|P5|Overall Study|Pregnancy|0
1656211|NCT01613248|5787651|P4|Overall Study|Pregnancy|1
1656212|NCT01613248|5787652|P3|Overall Study|Pregnancy|0
1656213|NCT01613248|5787653|P2|Overall Study|Pregnancy|0
1656214|NCT01613248|5787654|P1|Overall Study|Pregnancy|0
1656215|NCT01613248|5787649|P6|Overall Study|Lack of Qualifying Event|18
1656216|NCT01613248|5787650|P5|Overall Study|Lack of Qualifying Event|15
1656217|NCT01613248|5787651|P4|Overall Study|Lack of Qualifying Event|11
1656218|NCT01613248|5787652|P3|Overall Study|Lack of Qualifying Event|10
1656219|NCT01613248|5787653|P2|Overall Study|Lack of Qualifying Event|11
1656220|NCT01613248|5787654|P1|Overall Study|Lack of Qualifying Event|9
1656221|NCT01613248|5787649|P6|Overall Study|Physician Decision|6
1656222|NCT01613248|5787650|P5|Overall Study|Physician Decision|7
1656223|NCT01613248|5787651|P4|Overall Study|Physician Decision|4
1656224|NCT01613248|5787652|P3|Overall Study|Physician Decision|9
1656225|NCT01613248|5787653|P2|Overall Study|Physician Decision|8
1656226|NCT01613248|5787654|P1|Overall Study|Physician Decision|8
1656227|NCT01613248|5787649|P6|Overall Study|Study Terminated by Sponsor|11
1656228|NCT01613248|5787650|P5|Overall Study|Study Terminated by Sponsor|9
1656229|NCT01613248|5787651|P4|Overall Study|Study Terminated by Sponsor|8
1656230|NCT01613248|5787652|P3|Overall Study|Study Terminated by Sponsor|8
1656231|NCT01613248|5787653|P2|Overall Study|Study Terminated by Sponsor|6
1656232|NCT01613248|5787654|P1|Overall Study|Study Terminated by Sponsor|4
1656233|NCT01613248|5787649|P6|Overall Study|Lost to Follow-up|2
1656234|NCT01613248|5787650|P5|Overall Study|Lost to Follow-up|4
1656235|NCT01613248|5787651|P4|Overall Study|Lost to Follow-up|8
1656236|NCT01613248|5787652|P3|Overall Study|Lost to Follow-up|4
1656237|NCT01613248|5787653|P2|Overall Study|Lost to Follow-up|7
1656238|NCT01613248|5787654|P1|Overall Study|Lost to Follow-up|5
1656239|NCT01613248|5787649|P6|Overall Study|Withdrawal by Subject|1
1656240|NCT01613248|5787650|P5|Overall Study|Withdrawal by Subject|0
1656241|NCT01613248|5787651|P4|Overall Study|Withdrawal by Subject|5
1656242|NCT01613248|5787652|P3|Overall Study|Withdrawal by Subject|2
1656243|NCT01613248|5787653|P2|Overall Study|Withdrawal by Subject|2
1656244|NCT01613248|5787654|P1|Overall Study|Withdrawal by Subject|3
1656245|NCT01613248|5787649|P6|Overall Study|Adverse Event|0
1656246|NCT01613248|5787650|P5|Overall Study|Adverse Event|0
1656247|NCT01613248|5787651|P4|Overall Study|Adverse Event|1
1656248|NCT01613248|5787652|P3|Overall Study|Adverse Event|0
1656249|NCT01613248|5787653|P2|Overall Study|Adverse Event|0
1656250|NCT01613248|5787654|P1|Overall Study|Adverse Event|0
1656251|NCT01613222|5787752|P1|Overall Study|Reused disposable sensors|10
1656252|NCT01613222|5787752|P1|Overall Study|Unable to place arterial line|1
1656253|NCT01613222|5787752|P1|Overall Study|Physician Decision|1
1656254|NCT01613131|5787767|P2|Overall Study|Withdrawal by Subject|5
1656255|NCT01613131|5787768|P1|Overall Study|Withdrawal by Subject|3
1656256|NCT01613027|5787796|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
1656257|NCT01613027|5787796|P1|Overall Study|Lack of Efficacy|1
1656258|NCT01613027|5787796|P1|Overall Study|Switched Physician|1
1656259|NCT01613027|5787796|P1|Overall Study|Lost to Follow-up|5
1656260|NCT01612858|5787839|P2|Overall Study|Withdrawal by Subject|1
1656261|NCT01612858|5787840|P1|Overall Study|Withdrawal by Subject|5
1656262|NCT01612702|5787913|P2|Overall Study|Protocol Violation|11
1656263|NCT01612702|5787914|P1|Overall Study|Protocol Violation|11
1656264|NCT01612676|5787928|P4|Overall Study|Protocol Violation|0
1656265|NCT01612676|5787929|P3|Overall Study|Protocol Violation|0
1656266|NCT01612676|5787930|P2|Overall Study|Protocol Violation|1
1656267|NCT01612676|5787931|P1|Overall Study|Protocol Violation|0
1656268|NCT01612676|5787928|P4|Overall Study|Adverse Event|3
1656269|NCT01612676|5787929|P3|Overall Study|Adverse Event|1
1656270|NCT01612676|5787930|P2|Overall Study|Adverse Event|3
1656271|NCT01612676|5787931|P1|Overall Study|Adverse Event|2
1656272|NCT01612156|5788029|P2|Overall Study|Protocol Violation|0
1656273|NCT01612156|5788030|P1|Overall Study|Protocol Violation|2
1656274|NCT01612000|5788042|P4|Overall Study|Withdrawal by Subject|2
1656275|NCT01612000|5788043|P3|Overall Study|Withdrawal by Subject|2
1656276|NCT01612000|5788044|P2|Overall Study|Withdrawal by Subject|1
1656277|NCT01612000|5788045|P1|Overall Study|Withdrawal by Subject|3
1656278|NCT01612000|5788042|P4|Overall Study|Physician Decision|0
1656279|NCT01612000|5788043|P3|Overall Study|Physician Decision|1
1656280|NCT01612000|5788044|P2|Overall Study|Physician Decision|0
1656281|NCT01612000|5788045|P1|Overall Study|Physician Decision|0
1656282|NCT01612000|5788042|P4|Overall Study|Lost to Follow-up|8
1656283|NCT01612000|5788043|P3|Overall Study|Lost to Follow-up|4
1656284|NCT01612000|5788044|P2|Overall Study|Lost to Follow-up|4
1656285|NCT01612000|5788045|P1|Overall Study|Lost to Follow-up|6
1656286|NCT01611974|5788070|P3|Overall Study|Withdrawal by Subject|4
1656287|NCT01611974|5788071|P2|Overall Study|Withdrawal by Subject|1
1656288|NCT01611974|5788072|P1|Overall Study|Withdrawal by Subject|0
1656289|NCT01611974|5788070|P3|Overall Study|Physician Decision|2
1656290|NCT01611974|5788071|P2|Overall Study|Physician Decision|1
1656291|NCT01611974|5788072|P1|Overall Study|Physician Decision|5
1656292|NCT01611974|5788070|P3|Overall Study|Lost to Follow-up|0
1656293|NCT01611974|5788071|P2|Overall Study|Lost to Follow-up|1
1656294|NCT01611974|5788072|P1|Overall Study|Lost to Follow-up|0
1656295|NCT01611974|5788070|P3|Overall Study|Death|10
1656296|NCT01611974|5788071|P2|Overall Study|Death|12
1656297|NCT01611974|5788072|P1|Overall Study|Death|10
1656298|NCT01611935|5788118|P2|Overall Study|Family Declined Participation|0
1656299|NCT01611935|5788119|P1|Overall Study|Family Declined Participation|1
1656300|NCT01611883|5788131|P2|Overall Study|Adverse Event|1
1656301|NCT01611883|5788132|P1|Overall Study|Adverse Event|1
1656302|NCT01611857|5788158|P2|Overall Study|Withdrawal by Subject|2
1656303|NCT01611857|5788159|P1|Overall Study|Withdrawal by Subject|0
1656304|NCT01611792|5788171|P2|Followup: at 6 Months|Lost to Follow-up|13
1656305|NCT01611792|5788172|P1|Followup: at 6 Months|Lost to Follow-up|6
1656306|NCT01611792|5788171|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
1656307|NCT01611792|5788172|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
1656308|NCT01611558|5788226|P1|Maintenance Phase|Study drug toxicity|1
1656309|NCT01611558|5788226|P1|Maintenance Phase|Withdrawal by Subject|1
1656310|NCT01611558|5788226|P1|Induction Phase|Death|1
1656311|NCT01611558|5788226|P1|Induction Phase|Adverse event unrelated to study drug|1
1656312|NCT01611558|5788226|P1|Induction Phase|Not reported|5
1656313|NCT01611558|5788226|P1|Induction Phase|Disease progression|14
1656314|NCT01611558|5788226|P1|Induction Phase|Study drug toxicity|17
1656315|NCT01611259|5788232|P1|Overall Study|Withdrawal by Subject|7
1656316|NCT01611259|5788232|P1|Overall Study|Adverse Event|4
1656317|NCT01611259|5788232|P1|Overall Study|Lack of Efficacy|2
1656318|NCT01611259|5788232|P1|Overall Study|Physician Decision|1
1656319|NCT01611194|5788238|P2|Overall Study|drug use|1
1656320|NCT01611194|5788239|P1|Overall Study|drug use|0
1656321|NCT01611194|5788238|P2|Overall Study|Withdrawal by Subject|1
1656322|NCT01611194|5788239|P1|Overall Study|Withdrawal by Subject|0
1656323|NCT01611194|5788238|P2|Overall Study|Lost to Follow-up|1
1656324|NCT01611194|5788239|P1|Overall Study|Lost to Follow-up|0
1656325|NCT01611155|5788277|P2|Overall Study|Ineligible patient|1
1656326|NCT01611155|5788278|P1|Overall Study|Ineligible patient|0
1656327|NCT01611155|5788277|P2|Overall Study|Alternative treatment|1
1656328|NCT01611155|5788278|P1|Overall Study|Alternative treatment|0
1656329|NCT01611155|5788277|P2|Overall Study|Withdrawal by Subject|0
1656330|NCT01611155|5788278|P1|Overall Study|Withdrawal by Subject|1
1656331|NCT01611155|5788277|P2|Overall Study|Disease progression|0
1656332|NCT01611155|5788278|P1|Overall Study|Disease progression|1
1656333|NCT01611155|5788277|P2|Overall Study|Refused further treatment|4
1656334|NCT01611155|5788278|P1|Overall Study|Refused further treatment|6
1656335|NCT01611155|5788277|P2|Overall Study|Adverse Event|1
1656336|NCT01611155|5788278|P1|Overall Study|Adverse Event|1
1656337|NCT01610791|5788286|P1|Overall Study|Not determined|5
1656338|NCT01610791|5788286|P1|Overall Study|Death|1
1656339|NCT01610791|5788286|P1|Overall Study|Adverse event and Investigator decision|1
1656340|NCT01610791|5788286|P1|Overall Study|Physician Decision|1
1656341|NCT01610791|5788286|P1|Overall Study|Adverse Event|6
1656342|NCT01610791|5788286|P1|Overall Study|Lost to Follow-up|7
1656343|NCT01610752|5788310|P3|Overall Study|Miscarriage/Pregnancy loss|4
1656344|NCT01610752|5788311|P2|Overall Study|Miscarriage/Pregnancy loss|0
1656345|NCT01610752|5788312|P1|Overall Study|Miscarriage/Pregnancy loss|0
1656346|NCT01610713|5788334|P2|Overall Study|Lost to Follow-up|1
1656347|NCT01610713|5788335|P1|Overall Study|Lost to Follow-up|0
1656348|NCT01610713|5788334|P2|Overall Study|adv. to use original dose/amitriptyline|0
1656349|NCT01610713|5788335|P1|Overall Study|adv. to use original dose/amitriptyline|1
1656350|NCT01610713|5788334|P2|Overall Study|low mood and poor motivation|0
1656351|NCT01610713|5788335|P1|Overall Study|low mood and poor motivation|1
1656352|NCT01610713|5788334|P2|Overall Study|Lack of Efficacy|0
1656353|NCT01610713|5788335|P1|Overall Study|Lack of Efficacy|1
1656354|NCT01610713|5788334|P2|Overall Study|Adverse Event|0
1656355|NCT01610713|5788335|P1|Overall Study|Adverse Event|3
1656356|NCT01610700|5788393|P2|Overall Study|subject took one dose of street cannabis|1
1656357|NCT01610700|5788394|P1|Overall Study|subject took one dose of street cannabis|0
1656358|NCT01610700|5788393|P2|Overall Study|Withdrawal by Subject|1
1656359|NCT01610700|5788394|P1|Overall Study|Withdrawal by Subject|0
1656360|NCT01610700|5788393|P2|Overall Study|Adverse Event|1
1656361|NCT01610700|5788394|P1|Overall Study|Adverse Event|3
1656362|NCT01610687|5788448|P1|Overall Study|Felt more alter without study medication|1
1656363|NCT01610687|5788448|P1|Overall Study|Cannabis affecting job|1
1656364|NCT01610687|5788448|P1|Overall Study|Death|1
1656365|NCT01610687|5788448|P1|Overall Study|Unable to make journey|1
1656366|NCT01610687|5788448|P1|Overall Study|Symptom control without study medication|2
1656367|NCT01610687|5788448|P1|Overall Study|Lost to Follow-up|4
1656368|NCT01610687|5788448|P1|Overall Study|Withdrawal by Subject|7
1656369|NCT01610687|5788448|P1|Overall Study|Moved out of area|6
1656370|NCT01610687|5788448|P1|Overall Study|Adverse Event|18
1656371|NCT01610687|5788448|P1|Overall Study|Lack of Efficacy|26
1656372|NCT01610596|5788461|P2|Overall Study|Lost to Follow-up|1
1656373|NCT01610596|5788462|P1|Overall Study|Lost to Follow-up|0
1656374|NCT01610557|5788520|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
1656375|NCT01610557|5788521|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
1656376|NCT01610557|5788522|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
1656377|NCT01610557|5788523|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
1656378|NCT01610557|5788524|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
1656379|NCT01610557|5788520|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1656380|NCT01610557|5788521|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1656381|NCT01610557|5788522|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1656382|NCT01610557|5788523|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
1656383|NCT01610557|5788524|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
1656384|NCT01610492|5788537|P1|Overall Study|Other:Treatment stopped due to remission|1
1656385|NCT01610492|5788537|P1|Overall Study|Other: Reached stopping criteria|1
1656386|NCT01610492|5788537|P1|Overall Study|Lack of Efficacy|3
1656387|NCT01610492|5788537|P1|Overall Study|Adverse Event|1
1656388|NCT01610414|5788588|P2|After Month 25|Study end not reached|53
1656389|NCT01610414|5788589|P1|After Month 25|Study end not reached|48
1656390|NCT01610414|5788588|P2|Month 13 - Month 25|Other reasons for withdrawal|7
1656391|NCT01610414|5788589|P1|Month 13 - Month 25|Other reasons for withdrawal|6
1656392|NCT01610414|5788588|P2|Month 13 - Month 25|Lost to Follow-up|9
1656393|NCT01610414|5788589|P1|Month 13 - Month 25|Lost to Follow-up|5
1656394|NCT01610414|5788588|P2|Month 13 - Month 25|Protocol Violation|2
1656395|NCT01610414|5788589|P1|Month 13 - Month 25|Protocol Violation|0
1656396|NCT01610414|5788588|P2|Month 13 - Month 25|Migrated/moved from study area|2
1656397|NCT01610414|5788589|P1|Month 13 - Month 25|Migrated/moved from study area|4
1656398|NCT01610414|5788588|P2|Month 13 - Month 25|Withdrawal by Subject|8
1656399|NCT01610414|5788589|P1|Month 13 - Month 25|Withdrawal by Subject|7
1656400|NCT01610414|5788588|P2|Month 13 - Month 25|Adverse Event|4
1656401|NCT01610414|5788589|P1|Month 13 - Month 25|Adverse Event|8
1656402|NCT01610414|5788588|P2|Month 13 - Month 25|Serious Adverse Event|38
1656403|NCT01610414|5788589|P1|Month 13 - Month 25|Serious Adverse Event|35
1656404|NCT01610414|5788588|P2|Study Start - Month 13|Other reasons for withdrawal|4
1656405|NCT01610414|5788589|P1|Study Start - Month 13|Other reasons for withdrawal|3
1656406|NCT01610414|5788588|P2|Study Start - Month 13|Suspected HZ episode|3
1656407|NCT01610414|5788589|P1|Study Start - Month 13|Suspected HZ episode|1
1656408|NCT01610414|5788588|P2|Study Start - Month 13|Lost to Follow-up|6
1656409|NCT01610414|5788589|P1|Study Start - Month 13|Lost to Follow-up|4
1656410|NCT01610414|5788588|P2|Study Start - Month 13|Migrated/moved from study area|4
1656411|NCT01610414|5788589|P1|Study Start - Month 13|Migrated/moved from study area|2
1656412|NCT01610414|5788588|P2|Study Start - Month 13|Withdrawal by Subject|30
1656413|NCT01610414|5788589|P1|Study Start - Month 13|Withdrawal by Subject|23
1656414|NCT01610414|5788588|P2|Study Start - Month 13|Protocol Violation|1
1656415|NCT01610414|5788589|P1|Study Start - Month 13|Protocol Violation|3
1656416|NCT01610414|5788588|P2|Study Start - Month 13|Adverse Event|14
1656417|NCT01610414|5788589|P1|Study Start - Month 13|Adverse Event|14
1656418|NCT01610414|5788588|P2|Study Start - Month 13|Serious Adverse Event|67
1656419|NCT01610414|5788589|P1|Study Start - Month 13|Serious Adverse Event|65
1656420|NCT01610297|5788618|P1|Overall Study|Lost to Follow-up|1
1656421|NCT01610271|5788628|P2|Overall Study|Prosthesis not implanted|3
1656422|NCT01610271|5788629|P1|Overall Study|Prosthesis not implanted|2
1656423|NCT01610271|5788628|P2|Overall Study|Surgery not complete|1
1656424|NCT01610271|5788629|P1|Overall Study|Surgery not complete|0
1656425|NCT01610167|5788644|P3|Overall Study|Scheduling conflict.|2
1656426|NCT01610167|5788645|P2|Overall Study|Scheduling conflict.|0
1656427|NCT01610167|5788646|P1|Overall Study|Scheduling conflict.|0
1656428|NCT01610076|5788683|P2|Overall Study|Lost to Follow-up|4
1656429|NCT01610076|5788684|P1|Overall Study|Lost to Follow-up|3
1656430|NCT01610076|5788683|P2|Overall Study|Technical issue with video|1
1656431|NCT01610076|5788684|P1|Overall Study|Technical issue with video|0
1656432|NCT01610063|5788695|P2|Overall Study|Lost to Follow-up|20
1656433|NCT01610063|5788696|P1|Overall Study|Lost to Follow-up|42
1656434|NCT01610037|5788719|P3|Treatment and Follow up Period|Lost to Follow-up|4
1656435|NCT01610037|5788720|P2|Treatment and Follow up Period|Lost to Follow-up|6
1656436|NCT01610037|5788721|P1|Treatment and Follow up Period|Lost to Follow-up|1
1656437|NCT01610037|5788719|P3|Treatment and Follow up Period|Administrative problems|2
1656438|NCT01610037|5788720|P2|Treatment and Follow up Period|Administrative problems|3
1656439|NCT01610037|5788721|P1|Treatment and Follow up Period|Administrative problems|1
1656440|NCT01610037|5788719|P3|Treatment and Follow up Period|Death|4
1656441|NCT01610037|5788720|P2|Treatment and Follow up Period|Death|5
1656442|NCT01610037|5788721|P1|Treatment and Follow up Period|Death|10
1656443|NCT01610037|5788719|P3|Treatment and Follow up Period|Subject withdrew consent|16
1656444|NCT01610037|5788720|P2|Treatment and Follow up Period|Subject withdrew consent|14
1656445|NCT01610037|5788721|P1|Treatment and Follow up Period|Subject withdrew consent|13
1656446|NCT01610037|5788719|P3|All Patients|Abnormal test procedure result(s)|3
1656447|NCT01610037|5788720|P2|All Patients|Abnormal test procedure result(s)|1
1656448|NCT01610037|5788721|P1|All Patients|Abnormal test procedure result(s)|0
1656449|NCT01610037|5788719|P3|All Patients|Lost to Follow-up|0
1656450|NCT01610037|5788720|P2|All Patients|Lost to Follow-up|0
1656451|NCT01610037|5788721|P1|All Patients|Lost to Follow-up|1
1656452|NCT01610037|5788719|P3|All Patients|Administrative problems|4
1656453|NCT01610037|5788720|P2|All Patients|Administrative problems|4
1656454|NCT01610037|5788721|P1|All Patients|Administrative problems|1
1656455|NCT01610037|5788719|P3|All Patients|Abnormal laboratory value|0
1656456|NCT01610037|5788720|P2|All Patients|Abnormal laboratory value|1
1656457|NCT01610037|5788721|P1|All Patients|Abnormal laboratory value|1
1656458|NCT01610037|5788719|P3|All Patients|Protocol deviation|3
1656459|NCT01610037|5788720|P2|All Patients|Protocol deviation|3
1656460|NCT01610037|5788721|P1|All Patients|Protocol deviation|4
1656461|NCT01610037|5788719|P3|All Patients|Death|1
1656462|NCT01610037|5788720|P2|All Patients|Death|2
1656463|NCT01610037|5788721|P1|All Patients|Death|4
1656464|NCT01610037|5788719|P3|All Patients|Unsatisfactory therapeutic effect|27
1656465|NCT01610037|5788720|P2|All Patients|Unsatisfactory therapeutic effect|8
1656466|NCT01610037|5788721|P1|All Patients|Unsatisfactory therapeutic effect|9
1656467|NCT01610037|5788719|P3|All Patients|Withdrawal by Subject|20
1656468|NCT01610037|5788720|P2|All Patients|Withdrawal by Subject|10
1656469|NCT01610037|5788721|P1|All Patients|Withdrawal by Subject|12
1656470|NCT01610037|5788719|P3|All Patients|Adverse Event|26
1656471|NCT01610037|5788720|P2|All Patients|Adverse Event|22
1656472|NCT01610037|5788721|P1|All Patients|Adverse Event|27
1656473|NCT01609933|5788771|P1|Overall Study|Withdrawal by Subject|3
1656474|NCT01609933|5788771|P1|Overall Study|Adverse Event|1
1656475|NCT01609842|5788782|P2|Concurrent Intervention Control|pharmacy data not available|0
1656476|NCT01609842|5788783|P1|Concurrent Intervention Control|pharmacy data not available|2
1656477|NCT01609790|5788810|P3|Overall Study|Protocol Violation|8
1656478|NCT01609790|5788811|P2|Overall Study|Protocol Violation|7
1656479|NCT01609790|5788812|P1|Overall Study|Protocol Violation|1
1656480|NCT01609582|5788831|P2|Overall Study|Randomized, but not treated|3
1656481|NCT01609582|5788832|P1|Overall Study|Randomized, but not treated|0
1656482|NCT01609582|5788831|P2|Overall Study|Other|10
1656483|NCT01609582|5788832|P1|Overall Study|Other|9
1656484|NCT01609582|5788831|P2|Overall Study|Study Terminated by Sponsor|1548
1656485|NCT01609582|5788832|P1|Overall Study|Study Terminated by Sponsor|1543
1656486|NCT01609582|5788831|P2|Overall Study|Withdrawal by Subject|15
1656487|NCT01609582|5788832|P1|Overall Study|Withdrawal by Subject|21
1656488|NCT01609582|5788831|P2|Overall Study|Lost to Follow-up|10
1656489|NCT01609582|5788832|P1|Overall Study|Lost to Follow-up|10
1656490|NCT01609582|5788831|P2|Overall Study|Adverse Event|18
1656491|NCT01609582|5788832|P1|Overall Study|Adverse Event|20
1656492|NCT01609543|5788840|P1|Overall Study|Death|7
1656493|NCT01609543|5788840|P1|Overall Study|Protocol Violation|1
1656494|NCT01609543|5788840|P1|Overall Study|Withdrawal by Subject|1
1656495|NCT01609543|5788840|P1|Overall Study|Adverse Event|5
1656496|NCT01609543|5788840|P1|Overall Study|Disease Progression|28
1656497|NCT01609478|5788849|P3|Overall Study|Withdrawal by Subject|2
1656498|NCT01609478|5788850|P2|Overall Study|Withdrawal by Subject|0
1656499|NCT01609478|5788851|P1|Overall Study|Withdrawal by Subject|2
1656500|NCT01609478|5788849|P3|Overall Study|Physician Decision|1
1656501|NCT01609478|5788850|P2|Overall Study|Physician Decision|0
1656502|NCT01609478|5788851|P1|Overall Study|Physician Decision|1
1656503|NCT01609478|5788849|P3|Overall Study|Non-Compliance with study treatment|0
1656504|NCT01609478|5788850|P2|Overall Study|Non-Compliance with study treatment|0
1656505|NCT01609478|5788851|P1|Overall Study|Non-Compliance with study treatment|1
1656506|NCT01609478|5788849|P3|Overall Study|Protocol Deviation|1
1656507|NCT01609478|5788850|P2|Overall Study|Protocol Deviation|1
1656508|NCT01609478|5788851|P1|Overall Study|Protocol Deviation|0
1656509|NCT01609478|5788849|P3|Overall Study|Adverse Event|5
1656510|NCT01609478|5788850|P2|Overall Study|Adverse Event|1
1656511|NCT01609478|5788851|P1|Overall Study|Adverse Event|3
1656512|NCT01609296|5788924|P1|Overall Study|Withdrawal by Subject|71
1656513|NCT01609296|5788924|P1|Overall Study|Death|49
1656514|NCT01609257|5788937|P2|Overall Study|Non-compliance/Protocol deviation|6
1656515|NCT01609257|5788938|P1|Overall Study|Non-compliance/Protocol deviation|4
1656516|NCT01609257|5788937|P2|Overall Study|Voluntary Withdrawal by Subject|1
1656517|NCT01609257|5788938|P1|Overall Study|Voluntary Withdrawal by Subject|0
1656518|NCT01609257|5788937|P2|Overall Study|Lost to Follow-up|1
1656519|NCT01609257|5788938|P1|Overall Study|Lost to Follow-up|2
1656520|NCT01609062|5789010|P2|Extension Phase|Anticipated surgery & transition to EAP|1
1656521|NCT01609062|5789011|P1|Extension Phase|Anticipated surgery & transition to EAP|0
1656522|NCT01609062|5789010|P2|Extension Phase|Discontinued drug and then was pregnant|0
1656523|NCT01609062|5789011|P1|Extension Phase|Discontinued drug and then was pregnant|1
1656524|NCT01609062|5789010|P2|Extension Phase|Terminated by Sponsor|9
1656525|NCT01609062|5789011|P1|Extension Phase|Terminated by Sponsor|14
1656526|NCT01609023|5789054|P1|Overall Study|Personal reasons|1
1656527|NCT01609023|5789054|P1|Overall Study|Death|2
1656528|NCT01609023|5789054|P1|Overall Study|Physician Decision|2
1656529|NCT01609023|5789054|P1|Overall Study|Disease progression|10
1656530|NCT01609023|5789054|P1|Overall Study|Toxicity|3
1656531|NCT01609023|5789054|P1|Overall Study|Lost to Follow-up|8
1656532|NCT01609023|5789054|P1|Overall Study|Withdrawal by Subject|4
1656533|NCT01609023|5789054|P1|Overall Study|Lack of Efficacy|3
1656534|NCT01609010|5789066|P2|Overall Study|Lost to Follow-up|1
1656535|NCT01609010|5789067|P1|Overall Study|Lost to Follow-up|1
1656536|NCT01609010|5789066|P2|Overall Study|New cancer|0
1656537|NCT01609010|5789067|P1|Overall Study|New cancer|1
1656538|NCT01609010|5789066|P2|Overall Study|Protocol Violation|1
1656539|NCT01609010|5789067|P1|Overall Study|Protocol Violation|1
1656540|NCT01609010|5789066|P2|Overall Study|Pathology review|1
1656541|NCT01609010|5789067|P1|Overall Study|Pathology review|2
1656542|NCT01609010|5789066|P2|Overall Study|Other malignancy|0
1656543|NCT01609010|5789067|P1|Overall Study|Other malignancy|1
1656544|NCT01609010|5789066|P2|Overall Study|Other|0
1656545|NCT01609010|5789067|P1|Overall Study|Other|2
1656546|NCT01609010|5789066|P2|Overall Study|Withdrawal by Subject|2
1656547|NCT01609010|5789067|P1|Overall Study|Withdrawal by Subject|2
1656548|NCT01609010|5789066|P2|Overall Study|Adverse Event|6
1656549|NCT01609010|5789067|P1|Overall Study|Adverse Event|3
1656550|NCT01609010|5789066|P2|Overall Study|Progressive disease (PD)|10
1656551|NCT01609010|5789067|P1|Overall Study|Progressive disease (PD)|8
1656552|NCT01609010|5789066|P2|Overall Study|Stable disease (SD)|16
1656553|NCT01609010|5789067|P1|Overall Study|Stable disease (SD)|22
1656554|NCT01608724|5789128|P1|Overall Study|Safety reasons|1
1656555|NCT01608724|5789128|P1|Overall Study|bood sugar too high, etc.|3
1656556|NCT01608724|5789128|P1|Overall Study|Protocol Violation|6
1656557|NCT01608724|5789128|P1|Overall Study|Adverse Event|29
1656558|NCT01608724|5789128|P1|Overall Study|Study-specific discontinuation criteria|32
1656559|NCT01608724|5789128|P1|Overall Study|Lost to Follow-up|41
1656560|NCT01608724|5789128|P1|Overall Study|Withdrawal by Subject|131
1656561|NCT01608321|5789160|P2|Overall Study|Withdrawal by Subject|0
1656562|NCT01608321|5789161|P1|Overall Study|Withdrawal by Subject|1
1656563|NCT01608308|5789169|P2|Overall Study|pretreatment medical and billing reasons|2
1656564|NCT01608308|5789170|P1|Overall Study|pretreatment medical and billing reasons|0
1656565|NCT01608087|5789233|P3|Overall Study|Other Reason|0
1656566|NCT01608087|5789234|P2|Overall Study|Other Reason|1
1656567|NCT01608087|5789235|P1|Overall Study|Other Reason|0
1656568|NCT01608087|5789233|P3|Overall Study|Lost to Follow-up|0
1656569|NCT01608087|5789234|P2|Overall Study|Lost to Follow-up|1
1656570|NCT01608087|5789235|P1|Overall Study|Lost to Follow-up|0
1656571|NCT01607957|5789251|P2|Overall Study|Participant refusal|0
1656572|NCT01607957|5789252|P1|Overall Study|Participant refusal|1
1656573|NCT01607957|5789251|P2|Overall Study|Lost to Follow-up|3
1656574|NCT01607957|5789252|P1|Overall Study|Lost to Follow-up|3
1656575|NCT01607957|5789251|P2|Overall Study|Death|211
1656576|NCT01607957|5789252|P1|Overall Study|Death|367
1656577|NCT01607957|5789251|P2|Overall Study|Not treated|1
1656578|NCT01607957|5789252|P1|Overall Study|Not treated|1
1656579|NCT01607593|5789431|P1|Overall Study|Other|4
1656580|NCT01607593|5789431|P1|Overall Study|Continuation|33
1656581|NCT01607593|5789431|P1|Overall Study|Lost to Follow-up|25
1656582|NCT01607593|5789431|P1|Overall Study|Lack of Efficacy|16
1656583|NCT01607593|5789431|P1|Overall Study|Adverse Event|15
1656584|NCT01607554|5789437|P1|Overall Study|Disease progression|2
1656585|NCT01607476|5789450|P3|Overall Study|Lost to Follow-up|2
1656586|NCT01607476|5789451|P2|Overall Study|Lost to Follow-up|0
1656587|NCT01607476|5789452|P1|Overall Study|Lost to Follow-up|0
1656588|NCT01607476|5789450|P3|Overall Study|Withdrawal by Subject|1
1656589|NCT01607476|5789451|P2|Overall Study|Withdrawal by Subject|0
1656590|NCT01607476|5789452|P1|Overall Study|Withdrawal by Subject|1
1656591|NCT01607398|5789546|P2|Overall Study|Severe COPD|0
1656592|NCT01607398|5789547|P1|Overall Study|Severe COPD|2
1656593|NCT01607398|5789546|P2|Overall Study|Adverse Event|2
1656594|NCT01607398|5789547|P1|Overall Study|Adverse Event|0
1656595|NCT01607346|5789591|P1|Overall Study|Adverse Event|3
1656596|NCT01606800|5789689|P2|Overall Study|Missing completion status|0
1656597|NCT01606800|5789690|P1|Overall Study|Missing completion status|2
1656598|NCT01606800|5789689|P2|Overall Study|Participant withdrew consent|1
1656599|NCT01606800|5789690|P1|Overall Study|Participant withdrew consent|0
1656600|NCT01606800|5789689|P2|Overall Study|Adverse Event|1
1656601|NCT01606800|5789690|P1|Overall Study|Adverse Event|3
1656602|NCT01606787|5789698|P2|Overall Study|Surgery canceled|2
1656603|NCT01606787|5789699|P1|Overall Study|Surgery canceled|0
1656604|NCT01606787|5789698|P2|Overall Study|Withdrawal by Subject|5
1656605|NCT01606787|5789699|P1|Overall Study|Withdrawal by Subject|4
1656606|NCT01606761|5789710|P5|Safety Follow-up Period (Week 52-68)|Other|3
1656607|NCT01606761|5789711|P4|Safety Follow-up Period (Week 52-68)|Other|1
1656608|NCT01606761|5789712|P3|Safety Follow-up Period (Week 52-68)|Other|9
1656609|NCT01606761|5789713|P2|Safety Follow-up Period (Week 52-68)|Other|3
1656610|NCT01606761|5789714|P1|Safety Follow-up Period (Week 52-68)|Other|0
1656611|NCT01606761|5789710|P5|Safety Follow-up Period (Week 52-68)|Death|1
1656612|NCT01606761|5789711|P4|Safety Follow-up Period (Week 52-68)|Death|0
1656613|NCT01606761|5789712|P3|Safety Follow-up Period (Week 52-68)|Death|0
1656614|NCT01606761|5789713|P2|Safety Follow-up Period (Week 52-68)|Death|0
1656615|NCT01606761|5789714|P1|Safety Follow-up Period (Week 52-68)|Death|0
1656616|NCT01606761|5789710|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
1656617|NCT01606761|5789711|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
1656618|NCT01606761|5789712|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1656619|NCT01606761|5789713|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
1656620|NCT01606761|5789714|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
1656621|NCT01606761|5789710|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1656622|NCT01606761|5789711|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1656623|NCT01606761|5789712|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
1656624|NCT01606761|5789713|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
1656625|NCT01606761|5789714|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
1656626|NCT01606761|5789710|P5|Week 24 to Week 52|Other|2
1656627|NCT01606761|5789711|P4|Week 24 to Week 52|Other|2
1656628|NCT01606761|5789712|P3|Week 24 to Week 52|Other|5
1656629|NCT01606761|5789713|P2|Week 24 to Week 52|Other|1
1656630|NCT01606761|5789714|P1|Week 24 to Week 52|Other|0
1656631|NCT01606761|5789710|P5|Week 24 to Week 52|Physician Decision|0
1656632|NCT01606761|5789711|P4|Week 24 to Week 52|Physician Decision|0
1656633|NCT01606761|5789712|P3|Week 24 to Week 52|Physician Decision|1
1656634|NCT01606761|5789713|P2|Week 24 to Week 52|Physician Decision|1
1656635|NCT01606761|5789714|P1|Week 24 to Week 52|Physician Decision|0
1656636|NCT01606761|5789710|P5|Week 24 to Week 52|Lack of Efficacy|3
1656637|NCT01606761|5789711|P4|Week 24 to Week 52|Lack of Efficacy|10
1656638|NCT01606761|5789712|P3|Week 24 to Week 52|Lack of Efficacy|7
1656639|NCT01606761|5789713|P2|Week 24 to Week 52|Lack of Efficacy|13
1656640|NCT01606761|5789714|P1|Week 24 to Week 52|Lack of Efficacy|0
1656641|NCT01606761|5789710|P5|Week 24 to Week 52|Death|0
1656642|NCT01606761|5789711|P4|Week 24 to Week 52|Death|1
1656643|NCT01606761|5789712|P3|Week 24 to Week 52|Death|2
1656644|NCT01606761|5789713|P2|Week 24 to Week 52|Death|0
1656645|NCT01606761|5789714|P1|Week 24 to Week 52|Death|0
1656646|NCT01606761|5789710|P5|Week 24 to Week 52|Adverse Event|15
1656647|NCT01606761|5789711|P4|Week 24 to Week 52|Adverse Event|3
1656648|NCT01606761|5789712|P3|Week 24 to Week 52|Adverse Event|14
1656649|NCT01606761|5789713|P2|Week 24 to Week 52|Adverse Event|11
1656650|NCT01606761|5789714|P1|Week 24 to Week 52|Adverse Event|0
1656651|NCT01606761|5789710|P5|Week 24 to Week 52|Withdrawal by Subject|0
1656652|NCT01606761|5789711|P4|Week 24 to Week 52|Withdrawal by Subject|0
1656653|NCT01606761|5789712|P3|Week 24 to Week 52|Withdrawal by Subject|3
1656654|NCT01606761|5789713|P2|Week 24 to Week 52|Withdrawal by Subject|6
1656655|NCT01606761|5789714|P1|Week 24 to Week 52|Withdrawal by Subject|0
1656656|NCT01606761|5789710|P5|Week 24 to Week 52|Lost to Follow-up|0
1656657|NCT01606761|5789711|P4|Week 24 to Week 52|Lost to Follow-up|1
1656658|NCT01606761|5789712|P3|Week 24 to Week 52|Lost to Follow-up|1
1656659|NCT01606761|5789713|P2|Week 24 to Week 52|Lost to Follow-up|1
1656660|NCT01606761|5789714|P1|Week 24 to Week 52|Lost to Follow-up|0
1656661|NCT01606761|5789710|P5|Prior to Week 24|Other|0
1656662|NCT01606761|5789711|P4|Prior to Week 24|Other|0
1656663|NCT01606761|5789712|P3|Prior to Week 24|Other|5
1656664|NCT01606761|5789713|P2|Prior to Week 24|Other|7
1656665|NCT01606761|5789714|P1|Prior to Week 24|Other|4
1656666|NCT01606761|5789710|P5|Prior to Week 24|Physician Decision|0
1656667|NCT01606761|5789711|P4|Prior to Week 24|Physician Decision|0
1656668|NCT01606761|5789712|P3|Prior to Week 24|Physician Decision|1
1656669|NCT01606761|5789713|P2|Prior to Week 24|Physician Decision|3
1656670|NCT01606761|5789714|P1|Prior to Week 24|Physician Decision|0
1656671|NCT01606761|5789710|P5|Prior to Week 24|Lack of Efficacy|0
1656672|NCT01606761|5789711|P4|Prior to Week 24|Lack of Efficacy|0
1656673|NCT01606761|5789712|P3|Prior to Week 24|Lack of Efficacy|8
1656674|NCT01606761|5789713|P2|Prior to Week 24|Lack of Efficacy|14
1656675|NCT01606761|5789714|P1|Prior to Week 24|Lack of Efficacy|15
1656676|NCT01606761|5789710|P5|Prior to Week 24|Adverse Event|0
1656677|NCT01606761|5789711|P4|Prior to Week 24|Adverse Event|0
1656678|NCT01606761|5789712|P3|Prior to Week 24|Adverse Event|22
1656679|NCT01606761|5789713|P2|Prior to Week 24|Adverse Event|18
1656680|NCT01606761|5789714|P1|Prior to Week 24|Adverse Event|11
1656681|NCT01606761|5789710|P5|Prior to Week 24|Withdrawal by Subject|0
1656682|NCT01606761|5789711|P4|Prior to Week 24|Withdrawal by Subject|0
1656683|NCT01606761|5789712|P3|Prior to Week 24|Withdrawal by Subject|9
1656684|NCT01606761|5789713|P2|Prior to Week 24|Withdrawal by Subject|10
1656685|NCT01606761|5789714|P1|Prior to Week 24|Withdrawal by Subject|12
1656686|NCT01606761|5789710|P5|Prior to Week 24|Lost to Follow-up|0
1656687|NCT01606761|5789711|P4|Prior to Week 24|Lost to Follow-up|0
1656688|NCT01606761|5789712|P3|Prior to Week 24|Lost to Follow-up|2
1656689|NCT01606761|5789713|P2|Prior to Week 24|Lost to Follow-up|3
1656690|NCT01606761|5789714|P1|Prior to Week 24|Lost to Follow-up|0
1656691|NCT01606748|5789740|P2|Overall Study|Withdrawal by Subject|0
1656692|NCT01606748|5789741|P1|Overall Study|Withdrawal by Subject|1
1656693|NCT01606748|5789740|P2|Overall Study|Progressive Disease|0
1656694|NCT01606748|5789741|P1|Overall Study|Progressive Disease|1
1656695|NCT01606748|5789740|P2|Overall Study|Adverse Event|0
1656696|NCT01606748|5789741|P1|Overall Study|Adverse Event|1
1656697|NCT01606670|5789793|P1|Overall Study|Other Reason|2
1656698|NCT01606670|5789793|P1|Overall Study|Withdrawal by Subject|3
1656699|NCT01606670|5789793|P1|Overall Study|Lost to Follow-up|3
1656700|NCT01606670|5789793|P1|Overall Study|Lack of Efficacy|2
1656701|NCT01606670|5789793|P1|Overall Study|Adverse Event|6
1656702|NCT01606319|5789803|P2|Overall Study|Adverse Event|4
1656703|NCT01606319|5789804|P1|Overall Study|Adverse Event|1
1656704|NCT01606319|5789803|P2|Overall Study|Lack of Efficacy|8
1656705|NCT01606319|5789804|P1|Overall Study|Lack of Efficacy|6
1656706|NCT01606319|5789803|P2|Overall Study|Physician Decision|2
1656707|NCT01606319|5789804|P1|Overall Study|Physician Decision|1
1656708|NCT01606319|5789803|P2|Overall Study|Withdrawal by Subject|12
1656709|NCT01606319|5789804|P1|Overall Study|Withdrawal by Subject|9
1656710|NCT01606319|5789803|P2|Overall Study|Lost to Follow-up|14
1656711|NCT01606319|5789804|P1|Overall Study|Lost to Follow-up|17
1656712|NCT01606306|5789822|P6|Overall Study|Physician Decision|0
1656713|NCT01606306|5789823|P5|Overall Study|Physician Decision|0
1656714|NCT01606306|5789824|P4|Overall Study|Physician Decision|0
1656715|NCT01606306|5789825|P3|Overall Study|Physician Decision|0
1656716|NCT01606306|5789826|P2|Overall Study|Physician Decision|2
1656717|NCT01606306|5789827|P1|Overall Study|Physician Decision|1
1656718|NCT01606306|5789822|P6|Overall Study|Withdrawal by Subject|4
1656719|NCT01606306|5789823|P5|Overall Study|Withdrawal by Subject|5
1656720|NCT01606306|5789824|P4|Overall Study|Withdrawal by Subject|4
1656721|NCT01606306|5789825|P3|Overall Study|Withdrawal by Subject|4
1656722|NCT01606306|5789826|P2|Overall Study|Withdrawal by Subject|3
1656723|NCT01606306|5789827|P1|Overall Study|Withdrawal by Subject|4
1656724|NCT01606306|5789822|P6|Overall Study|Lost to Follow-up|5
1656725|NCT01606306|5789823|P5|Overall Study|Lost to Follow-up|3
1656726|NCT01606306|5789824|P4|Overall Study|Lost to Follow-up|4
1656727|NCT01606306|5789825|P3|Overall Study|Lost to Follow-up|5
1656728|NCT01606306|5789826|P2|Overall Study|Lost to Follow-up|4
1656729|NCT01606306|5789827|P1|Overall Study|Lost to Follow-up|7
1656730|NCT01606306|5789822|P6|Overall Study|Adverse Event|0
1656731|NCT01606306|5789823|P5|Overall Study|Adverse Event|2
1656732|NCT01606306|5789824|P4|Overall Study|Adverse Event|1
1656733|NCT01606306|5789825|P3|Overall Study|Adverse Event|1
1656734|NCT01606306|5789826|P2|Overall Study|Adverse Event|0
1656735|NCT01606306|5789827|P1|Overall Study|Adverse Event|1
1656736|NCT01606306|5789822|P6|Overall Study|Lack of Efficacy|2
1656737|NCT01606306|5789823|P5|Overall Study|Lack of Efficacy|1
1656738|NCT01606306|5789824|P4|Overall Study|Lack of Efficacy|4
1656739|NCT01606306|5789825|P3|Overall Study|Lack of Efficacy|4
1656740|NCT01606306|5789826|P2|Overall Study|Lack of Efficacy|1
1656741|NCT01606306|5789827|P1|Overall Study|Lack of Efficacy|2
1656742|NCT01606254|5789837|P4|Overall Study|Adverse Event|1
1656743|NCT01606254|5789838|P3|Overall Study|Adverse Event|0
1656744|NCT01606254|5789839|P2|Overall Study|Adverse Event|1
1656745|NCT01606254|5789840|P1|Overall Study|Adverse Event|1
1656746|NCT01606254|5789837|P4|Overall Study|Withdrawal by Subject|2
1656747|NCT01606254|5789838|P3|Overall Study|Withdrawal by Subject|0
1656748|NCT01606254|5789839|P2|Overall Study|Withdrawal by Subject|3
1656749|NCT01606254|5789840|P1|Overall Study|Withdrawal by Subject|1
1656750|NCT01606228|5789922|P1|Overall Study|Adverse Event|1
1656751|NCT01606228|5789922|P1|Overall Study|Lack of Efficacy|2
1656752|NCT01606228|5789922|P1|Overall Study|Non-compliant|3
1656753|NCT01606228|5789922|P1|Overall Study|Withdrawal by Subject|3
1656754|NCT01606228|5789922|P1|Overall Study|Lost to Follow-up|20
1656755|NCT01606202|5789939|P2|Overall Study|Problems with administration|1
1656756|NCT01606202|5789940|P1|Overall Study|Problems with administration|0
1656757|NCT01606202|5789939|P2|Overall Study|Personal problems|1
1656758|NCT01606202|5789940|P1|Overall Study|Personal problems|0
1656759|NCT01606202|5789939|P2|Overall Study|Withdrawal by Subject|1
1656760|NCT01606202|5789940|P1|Overall Study|Withdrawal by Subject|2
1656761|NCT01606202|5789939|P2|Overall Study|Adverse Event|0
1656762|NCT01606202|5789940|P1|Overall Study|Adverse Event|5
1656763|NCT01606189|5789972|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
1656764|NCT01606189|5789973|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1656765|NCT01606189|5789974|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1656766|NCT01606189|5789975|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1656767|NCT01606189|5789976|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1656768|NCT01606189|5789977|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
1656769|NCT01606189|5789972|P6|Second Intenvention (14-20 Days)|Adverse Event|1
1656770|NCT01606189|5789973|P5|Second Intenvention (14-20 Days)|Adverse Event|0
1656771|NCT01606189|5789974|P4|Second Intenvention (14-20 Days)|Adverse Event|0
1656772|NCT01606189|5789975|P3|Second Intenvention (14-20 Days)|Adverse Event|0
1656773|NCT01606189|5789976|P2|Second Intenvention (14-20 Days)|Adverse Event|0
1656774|NCT01606189|5789977|P1|Second Intenvention (14-20 Days)|Adverse Event|0
1656775|NCT01606176|5790011|P2|Overall Study|Withdrawal by Subject|0
1656776|NCT01606176|5790012|P1|Overall Study|Withdrawal by Subject|1
1656777|NCT01606176|5790011|P2|Overall Study|Disease progression|0
1656778|NCT01606176|5790012|P1|Overall Study|Disease progression|1
1656779|NCT01606176|5790011|P2|Overall Study|Adverse Event|3
1656780|NCT01606176|5790012|P1|Overall Study|Adverse Event|2
1656781|NCT01606137|5790057|P1|Overall Study|Unable to collect consistent data|1
1656782|NCT01606137|5790057|P1|Overall Study|Patient moving|1
1656783|NCT01606137|5790057|P1|Overall Study|Unable to tolerate study med. taste|1
1656784|NCT01606137|5790057|P1|Overall Study|Personal reasons|1
1656785|NCT01606137|5790057|P1|Overall Study|Patient leaving country|1
1656786|NCT01606137|5790057|P1|Overall Study|Wanted to try another treatment|1
1656787|NCT01606137|5790057|P1|Overall Study|Not enough improvement|4
1656788|NCT01606137|5790057|P1|Overall Study|Spray causes nausea|1
1656789|NCT01606137|5790057|P1|Overall Study|Increased bilirubin|1
1656790|NCT01606137|5790057|P1|Overall Study|multiple sclerosis less stable|1
1656791|NCT01606137|5790057|P1|Overall Study|Issues with driving|4
1656792|NCT01606137|5790057|P1|Overall Study|Decreased/no pain|4
1656793|NCT01606137|5790057|P1|Overall Study|Death|1
1656794|NCT01606137|5790057|P1|Overall Study|Patient non-compliance|9
1656795|NCT01606137|5790057|P1|Overall Study|Protocol Violation|1
1656796|NCT01606137|5790057|P1|Overall Study|Lost to Follow-up|15
1656797|NCT01606137|5790057|P1|Overall Study|Lack of Efficacy|56
1656798|NCT01606137|5790057|P1|Overall Study|Withdrawal by Subject|74
1656799|NCT01606137|5790057|P1|Overall Study|Adverse Event|85
1656800|NCT01606007|5790091|P3|Overall Study|Poor/Non-compliance|0
1656801|NCT01606007|5790092|P2|Overall Study|Poor/Non-compliance|0
1656802|NCT01606007|5790093|P1|Overall Study|Poor/Non-compliance|1
1656803|NCT01606007|5790091|P3|Overall Study|Lost to Follow-up|5
1656804|NCT01606007|5790092|P2|Overall Study|Lost to Follow-up|8
1656805|NCT01606007|5790093|P1|Overall Study|Lost to Follow-up|6
1656806|NCT01606007|5790091|P3|Overall Study|discontinue study treatment|1
1656807|NCT01606007|5790092|P2|Overall Study|discontinue study treatment|2
1656808|NCT01606007|5790093|P1|Overall Study|discontinue study treatment|0
1656809|NCT01606007|5790091|P3|Overall Study|Adverse Event|1
1656810|NCT01606007|5790092|P2|Overall Study|Adverse Event|1
1656811|NCT01606007|5790093|P1|Overall Study|Adverse Event|0
1656812|NCT01606007|5790091|P3|Overall Study|Withdrawal by Subject|1
1656813|NCT01606007|5790092|P2|Overall Study|Withdrawal by Subject|6
1656814|NCT01606007|5790093|P1|Overall Study|Withdrawal by Subject|8
1656815|NCT01606007|5790091|P3|Overall Study|Pregnancy|1
1656816|NCT01606007|5790092|P2|Overall Study|Pregnancy|1
1656817|NCT01606007|5790093|P1|Overall Study|Pregnancy|0
1656818|NCT01606007|5790091|P3|Overall Study|Reason 'Other' in the protocol|1
1656819|NCT01606007|5790092|P2|Overall Study|Reason 'Other' in the protocol|1
1656820|NCT01606007|5790093|P1|Overall Study|Reason 'Other' in the protocol|0
1656821|NCT01605916|5790128|P5|Overall Study|Withdrawal by Subject|2
1656822|NCT01605916|5790129|P4|Overall Study|Withdrawal by Subject|0
1656823|NCT01605916|5790130|P3|Overall Study|Withdrawal by Subject|0
1656824|NCT01605916|5790131|P2|Overall Study|Withdrawal by Subject|1
1656825|NCT01605916|5790132|P1|Overall Study|Withdrawal by Subject|1
1656826|NCT01605916|5790128|P5|Overall Study|Lack of Efficacy|4
1656827|NCT01605916|5790129|P4|Overall Study|Lack of Efficacy|5
1656828|NCT01605916|5790130|P3|Overall Study|Lack of Efficacy|3
1656829|NCT01605916|5790131|P2|Overall Study|Lack of Efficacy|3
1656830|NCT01605916|5790132|P1|Overall Study|Lack of Efficacy|2
1656831|NCT01605916|5790128|P5|Overall Study|Adverse Event|0
1656832|NCT01605916|5790129|P4|Overall Study|Adverse Event|1
1656833|NCT01605916|5790130|P3|Overall Study|Adverse Event|0
1656834|NCT01605916|5790131|P2|Overall Study|Adverse Event|0
1656835|NCT01605916|5790132|P1|Overall Study|Adverse Event|1
1656836|NCT01605877|5790229|P1|Overall Study|Withdrawal by Subject|1
1656837|NCT01605825|5790293|P2|Overall Study|Non-Compliance with Protocol|0
1656838|NCT01605825|5790294|P1|Overall Study|Non-Compliance with Protocol|3
1656839|NCT01605825|5790293|P2|Overall Study|Non-Compliance -Investigational Drug|0
1656840|NCT01605825|5790294|P1|Overall Study|Non-Compliance -Investigational Drug|3
1656841|NCT01605825|5790293|P2|Overall Study|Withdrawal by Subject|1
1656842|NCT01605825|5790294|P1|Overall Study|Withdrawal by Subject|0
1656843|NCT01605825|5790293|P2|Overall Study|Adverse Event|2
1656844|NCT01605825|5790294|P1|Overall Study|Adverse Event|4
1656845|NCT01605799|5790302|P2|Overall Study|Withdrawal by Subject|1
1656846|NCT01605799|5790303|P1|Overall Study|Withdrawal by Subject|2
1656847|NCT01605617|5790318|P2|Washout Period of 4 Weeks|Study Terminated|1
1656848|NCT01605617|5790319|P1|Washout Period of 4 Weeks|Study Terminated|2
1656849|NCT01605617|5790318|P2|First Intervention|Adverse Event|1
1656850|NCT01605617|5790319|P1|First Intervention|Adverse Event|0
1656851|NCT01605461|5790378|P1|Overall Study|Withdrawal by Subject|1
1656852|NCT01605461|5790378|P1|Overall Study|Lost to Follow-up|3
1656853|NCT01605396|5790437|P2|Overall Study|Transfer Off Study|5
1656854|NCT01605396|5790438|P1|Overall Study|Transfer Off Study|4
1656855|NCT01605396|5790437|P2|Overall Study|Withdrawal by Subject|2
1656856|NCT01605396|5790438|P1|Overall Study|Withdrawal by Subject|4
1656857|NCT01605396|5790437|P2|Overall Study|Progressive Disease|27
1656858|NCT01605396|5790438|P1|Overall Study|Progressive Disease|23
1656859|NCT01605396|5790437|P2|Overall Study|Physician Decision|2
1656860|NCT01605396|5790438|P1|Overall Study|Physician Decision|2
1656861|NCT01605396|5790437|P2|Overall Study|Non-Compliance With Study Drug|1
1656862|NCT01605396|5790438|P1|Overall Study|Non-Compliance With Study Drug|1
1656863|NCT01605396|5790437|P2|Overall Study|Lost to Follow-up|0
1656864|NCT01605396|5790438|P1|Overall Study|Lost to Follow-up|1
1656865|NCT01605396|5790437|P2|Overall Study|Adverse Event|3
1656866|NCT01605396|5790438|P1|Overall Study|Adverse Event|5
1656867|NCT01605370|5790452|P2|Overall Study|Adverse Event|0
1656868|NCT01605370|5790453|P1|Overall Study|Adverse Event|1
1656869|NCT01605227|5790488|P2|Overall Study|Dose Held >6 weeks|1
1656870|NCT01605227|5790489|P1|Overall Study|Dose Held >6 weeks|0
1656871|NCT01605227|5790488|P2|Overall Study|Subject Decision|1
1656872|NCT01605227|5790489|P1|Overall Study|Subject Decision|0
1656873|NCT01605227|5790488|P2|Overall Study|Started New Therapy|0
1656874|NCT01605227|5790489|P1|Overall Study|Started New Therapy|1
1656875|NCT01605227|5790488|P2|Overall Study|Sponsor Decision|0
1656876|NCT01605227|5790489|P1|Overall Study|Sponsor Decision|2
1656877|NCT01605227|5790488|P2|Overall Study|Withdrawal by Subject|14
1656878|NCT01605227|5790489|P1|Overall Study|Withdrawal by Subject|18
1656879|NCT01605227|5790488|P2|Overall Study|Physician Decision|7
1656880|NCT01605227|5790489|P1|Overall Study|Physician Decision|9
1656881|NCT01605227|5790488|P2|Overall Study|Protocol Violation|0
1656882|NCT01605227|5790489|P1|Overall Study|Protocol Violation|1
1656883|NCT01605227|5790488|P2|Overall Study|Lost to Follow-up|0
1656884|NCT01605227|5790489|P1|Overall Study|Lost to Follow-up|1
1656885|NCT01605227|5790488|P2|Overall Study|Clinical Deterioration|133
1656886|NCT01605227|5790489|P1|Overall Study|Clinical Deterioration|227
1656887|NCT01605227|5790488|P2|Overall Study|Progressive Disease|128
1656888|NCT01605227|5790489|P1|Overall Study|Progressive Disease|132
1656889|NCT01605227|5790488|P2|Overall Study|Adverse Event|42
1656890|NCT01605227|5790489|P1|Overall Study|Adverse Event|228
1656891|NCT01605227|5790488|P2|Overall Study|Did not receive study treatment|3
1656892|NCT01605227|5790489|P1|Overall Study|Did not receive study treatment|2
1656893|NCT01605136|5790501|P2|Safety Follow-Up Period|Withdrawal by Subject|2
1656894|NCT01605136|5790502|P1|Safety Follow-Up Period|Withdrawal by Subject|1
1656895|NCT01605136|5790501|P2|Study Period|Lost to Follow-up|2
1656896|NCT01605136|5790502|P1|Study Period|Lost to Follow-up|0
1656897|NCT01605136|5790501|P2|Study Period|Physician Decision|1
1656898|NCT01605136|5790502|P1|Study Period|Physician Decision|1
1656899|NCT01605136|5790501|P2|Study Period|Withdrawal by Subject|0
1656900|NCT01605136|5790502|P1|Study Period|Withdrawal by Subject|2
1656901|NCT01605019|5790522|P2|Overall Study|pt did not meet transplant endpoint|0
1656902|NCT01605019|5790523|P1|Overall Study|pt did not meet transplant endpoint|3
1656903|NCT01604941|5790533|P6|Overall Study|Early Study Termination|0
1656904|NCT01604941|5790534|P5|Overall Study|Early Study Termination|0
1656905|NCT01604941|5790535|P4|Overall Study|Early Study Termination|3
1656906|NCT01604941|5790536|P3|Overall Study|Early Study Termination|3
1656907|NCT01604941|5790537|P2|Overall Study|Early Study Termination|2
1656908|NCT01604941|5790538|P1|Overall Study|Early Study Termination|9
1656909|NCT01604941|5790533|P6|Overall Study|Participant Decision|2
1656910|NCT01604941|5790534|P5|Overall Study|Participant Decision|0
1656911|NCT01604941|5790535|P4|Overall Study|Participant Decision|0
1656912|NCT01604941|5790536|P3|Overall Study|Participant Decision|0
1656913|NCT01604941|5790537|P2|Overall Study|Participant Decision|0
1656914|NCT01604941|5790538|P1|Overall Study|Participant Decision|0
1656915|NCT01604941|5790533|P6|Overall Study|Non-compliance|0
1656916|NCT01604941|5790534|P5|Overall Study|Non-compliance|0
1656917|NCT01604941|5790535|P4|Overall Study|Non-compliance|0
1656918|NCT01604941|5790536|P3|Overall Study|Non-compliance|0
1656919|NCT01604941|5790537|P2|Overall Study|Non-compliance|0
1656920|NCT01604941|5790538|P1|Overall Study|Non-compliance|1
1656921|NCT01604941|5790533|P6|Overall Study|Adverse Event|5
1656922|NCT01604941|5790534|P5|Overall Study|Adverse Event|1
1656923|NCT01604941|5790535|P4|Overall Study|Adverse Event|0
1656924|NCT01604941|5790536|P3|Overall Study|Adverse Event|0
1656925|NCT01604941|5790537|P2|Overall Study|Adverse Event|2
1656926|NCT01604941|5790538|P1|Overall Study|Adverse Event|1
1656927|NCT01604850|5790566|P2|Overall Study|Subject withdrew consent|0
1656928|NCT01604850|5790567|P1|Overall Study|Subject withdrew consent|1
1656929|NCT01604850|5790566|P2|Overall Study|Lost to Follow-up|0
1656930|NCT01604850|5790567|P1|Overall Study|Lost to Follow-up|1
1656931|NCT01604850|5790566|P2|Overall Study|Efficacy Failure|29
1656932|NCT01604850|5790567|P1|Overall Study|Efficacy Failure|50
1656933|NCT01604850|5790566|P2|Overall Study|Enrolled but never treated|1
1656934|NCT01604850|5790567|P1|Overall Study|Enrolled but never treated|0
1656935|NCT01604785|5790585|P2|Overall Study|Repeat Visits Not Included in Analysis|1
1656936|NCT01604785|5790586|P1|Overall Study|Repeat Visits Not Included in Analysis|7
1656937|NCT01604408|5790605|P2|Observation Period|Withdrawal by Subject|2
1656938|NCT01604408|5790606|P1|Observation Period|Withdrawal by Subject|0
1656939|NCT01604408|5790605|P2|Observation Period|Adverse Event|1
1656940|NCT01604408|5790606|P1|Observation Period|Adverse Event|1
1656941|NCT01604408|5790605|P2|Treatment Period 6|Sponsor decision|1
1656942|NCT01604408|5790606|P1|Treatment Period 6|Sponsor decision|0
1656943|NCT01604408|5790605|P2|Treatment Period 6|Adverse Event|0
1656944|NCT01604408|5790606|P1|Treatment Period 6|Adverse Event|2
1656945|NCT01604408|5790605|P2|Treatment Period 6|Lost to Follow-up|1
1656946|NCT01604408|5790606|P1|Treatment Period 6|Lost to Follow-up|0
1656947|NCT01604408|5790605|P2|Treatment Period 5|Adverse Event|0
1656948|NCT01604408|5790606|P1|Treatment Period 5|Adverse Event|4
1656949|NCT01604408|5790605|P2|Treatment Period 4|Adverse Event|1
1656950|NCT01604408|5790606|P1|Treatment Period 4|Adverse Event|0
1656951|NCT01604408|5790605|P2|Treatment Period 4|Withdrawal by Subject|1
1656952|NCT01604408|5790606|P1|Treatment Period 4|Withdrawal by Subject|2
1656953|NCT01604408|5790605|P2|Treatment Period 4|Death|0
1656954|NCT01604408|5790606|P1|Treatment Period 4|Death|1
1656955|NCT01604408|5790605|P2|Treatment Period 3|Sponsor Decision|0
1656956|NCT01604408|5790606|P1|Treatment Period 3|Sponsor Decision|1
1656957|NCT01604408|5790605|P2|Treatment Period 3|Withdrawal by Subject|1
1656958|NCT01604408|5790606|P1|Treatment Period 3|Withdrawal by Subject|3
1656959|NCT01604408|5790605|P2|Treatment Period 3|Adverse Event|3
1656960|NCT01604408|5790606|P1|Treatment Period 3|Adverse Event|0
1656961|NCT01604408|5790605|P2|Treatment Period 3|Protocol Violation|1
1656962|NCT01604408|5790606|P1|Treatment Period 3|Protocol Violation|1
1656963|NCT01604408|5790605|P2|Treatment Period 2|Adverse Event|1
1656964|NCT01604408|5790606|P1|Treatment Period 2|Adverse Event|0
1656965|NCT01604408|5790605|P2|Treatment Period 2|Protocol Violation|0
1656966|NCT01604408|5790606|P1|Treatment Period 2|Protocol Violation|1
1656967|NCT01604408|5790605|P2|Treatment Period 2|Withdrawal by Subject|1
1656968|NCT01604408|5790606|P1|Treatment Period 2|Withdrawal by Subject|1
1656969|NCT01604408|5790605|P2|Treatment Period 1|Protocol Violation|1
1656970|NCT01604408|5790606|P1|Treatment Period 1|Protocol Violation|0
1656971|NCT01604343|5790621|P5|Safety Follow-up Period (Week 104-120)|Other|14
1656972|NCT01604343|5790622|P4|Safety Follow-up Period (Week 104-120)|Other|6
1656973|NCT01604343|5790623|P3|Safety Follow-up Period (Week 104-120)|Other|20
1656974|NCT01604343|5790624|P2|Safety Follow-up Period (Week 104-120)|Other|2
1656975|NCT01604343|5790625|P1|Safety Follow-up Period (Week 104-120)|Other|15
1656976|NCT01604343|5790621|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
1656977|NCT01604343|5790622|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
1656978|NCT01604343|5790623|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
1656979|NCT01604343|5790624|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
1656980|NCT01604343|5790625|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
1656981|NCT01604343|5790621|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1656982|NCT01604343|5790622|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1656983|NCT01604343|5790623|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
1656984|NCT01604343|5790624|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
1656985|NCT01604343|5790625|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
1656986|NCT01604343|5790621|P5|Week 52 to Week 104|Other|3
1656987|NCT01604343|5790622|P4|Week 52 to Week 104|Other|6
1656988|NCT01604343|5790623|P3|Week 52 to Week 104|Other|11
1656989|NCT01604343|5790624|P2|Week 52 to Week 104|Other|11
1656990|NCT01604343|5790625|P1|Week 52 to Week 104|Other|0
1656991|NCT01604343|5790621|P5|Week 52 to Week 104|Pregnancy|1
1656992|NCT01604343|5790622|P4|Week 52 to Week 104|Pregnancy|2
1656993|NCT01604343|5790623|P3|Week 52 to Week 104|Pregnancy|1
1656994|NCT01604343|5790624|P2|Week 52 to Week 104|Pregnancy|0
1656995|NCT01604343|5790625|P1|Week 52 to Week 104|Pregnancy|0
1656996|NCT01604343|5790621|P5|Week 52 to Week 104|Physician Decision|2
1656997|NCT01604343|5790622|P4|Week 52 to Week 104|Physician Decision|0
1656998|NCT01604343|5790623|P3|Week 52 to Week 104|Physician Decision|0
1656999|NCT01604343|5790624|P2|Week 52 to Week 104|Physician Decision|1
1657000|NCT01604343|5790625|P1|Week 52 to Week 104|Physician Decision|0
1657001|NCT01604343|5790621|P5|Week 52 to Week 104|Lack of Efficacy|3
1657002|NCT01604343|5790622|P4|Week 52 to Week 104|Lack of Efficacy|2
1657003|NCT01604343|5790623|P3|Week 52 to Week 104|Lack of Efficacy|11
1657004|NCT01604343|5790624|P2|Week 52 to Week 104|Lack of Efficacy|6
1657005|NCT01604343|5790625|P1|Week 52 to Week 104|Lack of Efficacy|0
1657006|NCT01604343|5790621|P5|Week 52 to Week 104|Death|0
1657007|NCT01604343|5790622|P4|Week 52 to Week 104|Death|5
1657008|NCT01604343|5790623|P3|Week 52 to Week 104|Death|2
1657009|NCT01604343|5790624|P2|Week 52 to Week 104|Death|4
1657010|NCT01604343|5790625|P1|Week 52 to Week 104|Death|0
1657011|NCT01604343|5790621|P5|Week 52 to Week 104|Adverse Event|27
1657012|NCT01604343|5790622|P4|Week 52 to Week 104|Adverse Event|21
1657013|NCT01604343|5790623|P3|Week 52 to Week 104|Adverse Event|26
1657014|NCT01604343|5790624|P2|Week 52 to Week 104|Adverse Event|12
1657015|NCT01604343|5790625|P1|Week 52 to Week 104|Adverse Event|0
1657016|NCT01604343|5790621|P5|Week 52 to Week 104|Withdrawal by Subject|4
1657017|NCT01604343|5790622|P4|Week 52 to Week 104|Withdrawal by Subject|8
1657018|NCT01604343|5790623|P3|Week 52 to Week 104|Withdrawal by Subject|12
1657019|NCT01604343|5790624|P2|Week 52 to Week 104|Withdrawal by Subject|7
1657020|NCT01604343|5790625|P1|Week 52 to Week 104|Withdrawal by Subject|0
1657021|NCT01604343|5790621|P5|Week 52 to Week 104|Lost to Follow-up|1
1657022|NCT01604343|5790622|P4|Week 52 to Week 104|Lost to Follow-up|2
1657023|NCT01604343|5790623|P3|Week 52 to Week 104|Lost to Follow-up|4
1657024|NCT01604343|5790624|P2|Week 52 to Week 104|Lost to Follow-up|2
1657025|NCT01604343|5790625|P1|Week 52 to Week 104|Lost to Follow-up|0
1657026|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Other|6
1657027|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Other|0
1657028|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Other|10
1657029|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Other|0
1657030|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Other|15
1657031|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
1657032|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
1657033|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
1657034|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
1657035|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
1657036|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
1657037|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
1657038|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
1657039|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
1657040|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
1657041|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
1657042|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1657043|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
1657044|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
1657045|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
1657046|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Death|4
1657047|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Death|0
1657048|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Death|2
1657049|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Death|0
1657050|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Death|5
1657051|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
1657052|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
1657053|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
1657054|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
1657055|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
1657056|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
1657057|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1657058|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
1657059|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
1657060|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
1657061|NCT01604343|5790621|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
1657062|NCT01604343|5790622|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1657063|NCT01604343|5790623|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
1657064|NCT01604343|5790624|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
1657065|NCT01604343|5790625|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
1657066|NCT01604278|5790790|P2|Overall Study|Protocol Deviation|3
1657067|NCT01604278|5790791|P1|Overall Study|Protocol Deviation|5
1657068|NCT01604278|5790790|P2|Overall Study|Adverse Event|5
1657069|NCT01604278|5790791|P1|Overall Study|Adverse Event|3
1657070|NCT01604278|5790790|P2|Overall Study|Withdrawal by Subject|3
1657071|NCT01604278|5790791|P1|Overall Study|Withdrawal by Subject|3
1657072|NCT01604278|5790790|P2|Overall Study|Administrative problems|1
1657073|NCT01604278|5790791|P1|Overall Study|Administrative problems|2
1657074|NCT01604278|5790790|P2|Overall Study|Lost to Follow-up|0
1657075|NCT01604278|5790791|P1|Overall Study|Lost to Follow-up|1
1657076|NCT01604278|5790790|P2|Overall Study|Lack of Efficacy|1
1657077|NCT01604278|5790791|P1|Overall Study|Lack of Efficacy|0
1657078|NCT01604265|5790817|P2|Overall Study|Withdrawal by Subject|0
1657079|NCT01604265|5790818|P1|Overall Study|Withdrawal by Subject|1
1657080|NCT01604265|5790817|P2|Overall Study|Adverse Event|0
1657081|NCT01604265|5790818|P1|Overall Study|Adverse Event|1
1657082|NCT01603875|5790929|P3|Overall Study|Protocol Violation|0
1657083|NCT01603875|5790930|P2|Overall Study|Protocol Violation|1
1657084|NCT01603875|5790931|P1|Overall Study|Protocol Violation|0
1657085|NCT01603875|5790929|P3|Overall Study|Lost to Follow-up|6
1657086|NCT01603875|5790930|P2|Overall Study|Lost to Follow-up|3
1657087|NCT01603875|5790931|P1|Overall Study|Lost to Follow-up|4
1657088|NCT01603875|5790929|P3|Overall Study|Preexisting rabies antibody|3
1657089|NCT01603875|5790930|P2|Overall Study|Preexisting rabies antibody|4
1657090|NCT01603875|5790931|P1|Overall Study|Preexisting rabies antibody|3
1657091|NCT01603641|5790951|P1|Overall Study|Other Miscellaneous Reasons|6
1657092|NCT01603641|5790951|P1|Overall Study|Personal Reasons|18
1657093|NCT01603641|5790951|P1|Overall Study|Lost to Follow-up|6
1657094|NCT01603641|5790951|P1|Overall Study|Lack of Efficacy|1
1657095|NCT01603641|5790951|P1|Overall Study|Adverse Event|1
1657096|NCT01603641|5790951|P1|Overall Study|Did not Receive Treatment|3
1657097|NCT01603628|5790958|P3|Overall Study|Other Miscellaneous Reason|0
1657098|NCT01603628|5790959|P2|Overall Study|Other Miscellaneous Reason|0
1657099|NCT01603628|5790960|P1|Overall Study|Other Miscellaneous Reason|1
1657100|NCT01603628|5790958|P3|Overall Study|Lost to Follow-up|0
1657101|NCT01603628|5790959|P2|Overall Study|Lost to Follow-up|1
1657102|NCT01603628|5790960|P1|Overall Study|Lost to Follow-up|0
1657103|NCT01603628|5790958|P3|Overall Study|Protocol Violation|0
1657104|NCT01603628|5790959|P2|Overall Study|Protocol Violation|1
1657105|NCT01603628|5790960|P1|Overall Study|Protocol Violation|1
1657106|NCT01603628|5790958|P3|Overall Study|Personal Reasons|2
1657107|NCT01603628|5790959|P2|Overall Study|Personal Reasons|1
1657108|NCT01603628|5790960|P1|Overall Study|Personal Reasons|1
1657109|NCT01603615|5790977|P1|Overall Study|Other Miscellaneous|1
1657110|NCT01603615|5790977|P1|Overall Study|Personal Reasons|17
1657111|NCT01603615|5790977|P1|Overall Study|Lost to Follow-up|9
1657112|NCT01603615|5790977|P1|Overall Study|Did not Receive Treatment|7
1657113|NCT01603602|5790984|P3|Overall Study|Personal Reasons|1
1657114|NCT01603602|5790985|P2|Overall Study|Personal Reasons|0
1657115|NCT01603602|5790986|P1|Overall Study|Personal Reasons|1
1657116|NCT01603602|5790984|P3|Overall Study|Adverse Event|0
1657117|NCT01603602|5790985|P2|Overall Study|Adverse Event|0
1657118|NCT01603602|5790986|P1|Overall Study|Adverse Event|1
1657119|NCT01603459|5791006|P1|Overall Study|Administrative reason|1
1657120|NCT01603459|5791006|P1|Overall Study|Non-compliance|1
1657121|NCT01603459|5791006|P1|Overall Study|Predefined discontinuation criteria|3
1657122|NCT01603459|5791006|P1|Overall Study|Lost to Follow-up|3
1657123|NCT01603459|5791006|P1|Overall Study|Withdrawal by Subject|5
1657124|NCT01603459|5791006|P1|Overall Study|Adverse Event|5
1657125|NCT01603394|5791157|P1|Overall Study|Adverse Event|1
1657126|NCT01603355|5791172|P1|Overall Study|Lack of Efficacy|2
1657127|NCT01603277|5791178|P2|Overall Study|Non-Compliance|1
1657128|NCT01603277|5791179|P1|Overall Study|Non-Compliance|2
1657129|NCT01603277|5791178|P2|Overall Study|Withdrawal by Subject|4
1657130|NCT01603277|5791179|P1|Overall Study|Withdrawal by Subject|5
1657131|NCT01603277|5791178|P2|Overall Study|Protocol Violation|10
1657132|NCT01603277|5791179|P1|Overall Study|Protocol Violation|6
1657133|NCT01603277|5791178|P2|Overall Study|Physician Decision|1
1657134|NCT01603277|5791179|P1|Overall Study|Physician Decision|0
1657135|NCT01603277|5791178|P2|Overall Study|Adverse Event|2
1657136|NCT01603277|5791179|P1|Overall Study|Adverse Event|1
1657137|NCT01603121|5791185|P2|Second Intervention, 10 Hours|Adverse Event|0
1657138|NCT01603121|5791186|P1|Second Intervention, 10 Hours|Adverse Event|1
1657139|NCT01603082|5791198|P2|Overall Study|Failed inclusion criterion after dosed|0
1657140|NCT01603082|5791199|P1|Overall Study|Failed inclusion criterion after dosed|1
1657141|NCT01603082|5791198|P2|Overall Study|Withdrawal by Subject|0
1657142|NCT01603082|5791199|P1|Overall Study|Withdrawal by Subject|1
1657143|NCT01603082|5791198|P2|Overall Study|Adverse Event|1
1657144|NCT01603082|5791199|P1|Overall Study|Adverse Event|0
1657145|NCT01603043|5791240|P2|Overall Study|Study Futility|3
1657146|NCT01603043|5791241|P1|Overall Study|Study Futility|7
1657147|NCT01602965|5791253|P2|Overall Study|Lost to Follow-up|2
1657148|NCT01602965|5791254|P1|Overall Study|Lost to Follow-up|4
1657149|NCT01602744|5791262|P2|Overall Study|Lost to Follow-up|8
1657150|NCT01602744|5791263|P1|Overall Study|Lost to Follow-up|13
1657151|NCT01602744|5791262|P2|Overall Study|Death|15
1657152|NCT01602744|5791263|P1|Overall Study|Death|17
1657153|NCT01602562|5791300|P2|Overall Study|Withdrawal by Subject|1
1657154|NCT01602562|5791301|P1|Overall Study|Withdrawal by Subject|1
1657155|NCT01602562|5791300|P2|Overall Study|Physician Decision|1
1657156|NCT01602562|5791301|P1|Overall Study|Physician Decision|1
1657157|NCT01602562|5791300|P2|Overall Study|Adverse Event|1
1657158|NCT01602562|5791301|P1|Overall Study|Adverse Event|3
1657159|NCT01602549|5791337|P2|Overall Study|Withdrawal by Subject|0
1657160|NCT01602549|5791338|P1|Overall Study|Withdrawal by Subject|1
1657161|NCT01602549|5791337|P2|Overall Study|Protocol Violation|1
1657162|NCT01602549|5791338|P1|Overall Study|Protocol Violation|0
1657163|NCT01602510|5791417|P3|Randomized Phase|Withdrawal by Subject|7
1657164|NCT01602510|5791418|P2|Randomized Phase|Withdrawal by Subject|6
1657165|NCT01602510|5791419|P1|Randomized Phase|Withdrawal by Subject|0
1657166|NCT01602510|5791417|P3|Randomized Phase|Physician Decision|2
1657167|NCT01602510|5791418|P2|Randomized Phase|Physician Decision|0
1657168|NCT01602510|5791419|P1|Randomized Phase|Physician Decision|0
1657169|NCT01602510|5791417|P3|Randomized Phase|Lost to Follow-up|3
1657170|NCT01602510|5791418|P2|Randomized Phase|Lost to Follow-up|1
1657171|NCT01602510|5791419|P1|Randomized Phase|Lost to Follow-up|0
1657172|NCT01602510|5791417|P3|Randomized Phase|Met protocol-defined stopping criteria|48
1657173|NCT01602510|5791418|P2|Randomized Phase|Met protocol-defined stopping criteria|58
1657174|NCT01602510|5791419|P1|Randomized Phase|Met protocol-defined stopping criteria|0
1657175|NCT01602510|5791417|P3|Randomized Phase|Protocol Violation|3
1657176|NCT01602510|5791418|P2|Randomized Phase|Protocol Violation|3
1657177|NCT01602510|5791419|P1|Randomized Phase|Protocol Violation|0
1657178|NCT01602510|5791417|P3|Randomized Phase|Lack of Efficacy|4
1657179|NCT01602510|5791418|P2|Randomized Phase|Lack of Efficacy|4
1657180|NCT01602510|5791419|P1|Randomized Phase|Lack of Efficacy|0
1657181|NCT01602510|5791417|P3|Randomized Phase|Adverse Event|6
1657182|NCT01602510|5791418|P2|Randomized Phase|Adverse Event|2
1657183|NCT01602510|5791419|P1|Randomized Phase|Adverse Event|0
1657184|NCT01602510|5791417|P3|Open Label Phase|Withdrawal by Subject|0
1657185|NCT01602510|5791418|P2|Open Label Phase|Withdrawal by Subject|0
1657186|NCT01602510|5791419|P1|Open Label Phase|Withdrawal by Subject|57
1657187|NCT01602510|5791417|P3|Open Label Phase|Physician Decision|0
1657188|NCT01602510|5791418|P2|Open Label Phase|Physician Decision|0
1657189|NCT01602510|5791419|P1|Open Label Phase|Physician Decision|19
1657190|NCT01602510|5791417|P3|Open Label Phase|Lost to Follow-up|0
1657191|NCT01602510|5791418|P2|Open Label Phase|Lost to Follow-up|0
1657192|NCT01602510|5791419|P1|Open Label Phase|Lost to Follow-up|22
1657193|NCT01602510|5791417|P3|Open Label Phase|Met protocol-defined stopping criteria|0
1657194|NCT01602510|5791418|P2|Open Label Phase|Met protocol-defined stopping criteria|0
1657195|NCT01602510|5791419|P1|Open Label Phase|Met protocol-defined stopping criteria|122
1657196|NCT01602510|5791417|P3|Open Label Phase|Protocol Violation|0
1657197|NCT01602510|5791418|P2|Open Label Phase|Protocol Violation|0
1657198|NCT01602510|5791419|P1|Open Label Phase|Protocol Violation|15
1657199|NCT01602510|5791417|P3|Open Label Phase|Lack of Efficacy|0
1657200|NCT01602510|5791418|P2|Open Label Phase|Lack of Efficacy|0
1657201|NCT01602510|5791419|P1|Open Label Phase|Lack of Efficacy|22
1657202|NCT01602510|5791417|P3|Open Label Phase|Adverse Event|0
1657203|NCT01602510|5791418|P2|Open Label Phase|Adverse Event|0
1657204|NCT01602510|5791419|P1|Open Label Phase|Adverse Event|46
1657205|NCT01602484|5791445|P2|Overall Study|Airway issues unrelated to study|1
1657206|NCT01602484|5791446|P1|Overall Study|Airway issues unrelated to study|0
1657207|NCT01602419|5791462|P1|Overall Study|Lost to Follow-up|6
1657208|NCT01602419|5791462|P1|Overall Study|Withdrawal by Subject|5
1657209|NCT01602419|5791462|P1|Overall Study|Treatment centre closed|1
1657210|NCT01602419|5791462|P1|Overall Study|Changed treatment centre|1
1657211|NCT01602419|5791462|P1|Overall Study|Insurance issues|3
1657212|NCT01602419|5791462|P1|Overall Study|Adverse Drug Reaction|4
1657213|NCT01602419|5791462|P1|Overall Study|Not treated with Wilate|9
1657214|NCT01602380|5791517|P2|Overall Study|Eligibility criteria not fulfilled|3
1657215|NCT01602380|5791518|P1|Overall Study|Eligibility criteria not fulfilled|2
1657216|NCT01602380|5791517|P2|Overall Study|Lost to Follow-up|1
1657217|NCT01602380|5791518|P1|Overall Study|Lost to Follow-up|6
1657218|NCT01602380|5791517|P2|Overall Study|Withdrawal by Subject|29
1657219|NCT01602380|5791518|P1|Overall Study|Withdrawal by Subject|22
1657220|NCT01602380|5791517|P2|Overall Study|Death|68
1657221|NCT01602380|5791518|P1|Overall Study|Death|63
1657222|NCT01602341|5791542|P2|Overall Study|Adverse Event|1
1657223|NCT01602341|5791543|P1|Overall Study|Adverse Event|0
1657224|NCT01602315|5791584|P7|Overall Study|Cross-over patients to combo treatment|0
1657225|NCT01602315|5791585|P6|Overall Study|Cross-over patients to combo treatment|16
1657226|NCT01602315|5791586|P5|Overall Study|Cross-over patients to combo treatment|0
1657227|NCT01602315|5791587|P4|Overall Study|Cross-over patients to combo treatment|0
1657228|NCT01602315|5791588|P3|Overall Study|Cross-over patients to combo treatment|0
1657229|NCT01602315|5791589|P2|Overall Study|Cross-over patients to combo treatment|0
1657230|NCT01602315|5791590|P1|Overall Study|Cross-over patients to combo treatment|0
1657231|NCT01602315|5791584|P7|Overall Study|Subject/guardian decision|1
1657232|NCT01602315|5791585|P6|Overall Study|Subject/guardian decision|0
1657233|NCT01602315|5791586|P5|Overall Study|Subject/guardian decision|0
1657234|NCT01602315|5791587|P4|Overall Study|Subject/guardian decision|0
1657235|NCT01602315|5791588|P3|Overall Study|Subject/guardian decision|0
1657236|NCT01602315|5791589|P2|Overall Study|Subject/guardian decision|0
1657237|NCT01602315|5791590|P1|Overall Study|Subject/guardian decision|0
1657238|NCT01602315|5791584|P7|Overall Study|Adverse Event|9
1657239|NCT01602315|5791585|P6|Overall Study|Adverse Event|3
1657240|NCT01602315|5791586|P5|Overall Study|Adverse Event|15
1657241|NCT01602315|5791587|P4|Overall Study|Adverse Event|4
1657242|NCT01602315|5791588|P3|Overall Study|Adverse Event|5
1657243|NCT01602315|5791589|P2|Overall Study|Adverse Event|1
1657244|NCT01602315|5791590|P1|Overall Study|Adverse Event|5
1657245|NCT01602315|5791584|P7|Overall Study|Withdrawal by Subject|1
1657246|NCT01602315|5791585|P6|Overall Study|Withdrawal by Subject|0
1657247|NCT01602315|5791586|P5|Overall Study|Withdrawal by Subject|6
1657248|NCT01602315|5791587|P4|Overall Study|Withdrawal by Subject|0
1657249|NCT01602315|5791588|P3|Overall Study|Withdrawal by Subject|2
1657250|NCT01602315|5791589|P2|Overall Study|Withdrawal by Subject|0
1657251|NCT01602315|5791590|P1|Overall Study|Withdrawal by Subject|2
1657252|NCT01602315|5791584|P7|Overall Study|Death|2
1657253|NCT01602315|5791585|P6|Overall Study|Death|2
1657254|NCT01602315|5791586|P5|Overall Study|Death|7
1657255|NCT01602315|5791587|P4|Overall Study|Death|1
1657256|NCT01602315|5791588|P3|Overall Study|Death|1
1657257|NCT01602315|5791589|P2|Overall Study|Death|1
1657258|NCT01602315|5791590|P1|Overall Study|Death|1
1657259|NCT01602315|5791584|P7|Overall Study|Disease progression|15
1657260|NCT01602315|5791585|P6|Overall Study|Disease progression|12
1657261|NCT01602315|5791586|P5|Overall Study|Disease progression|41
1657262|NCT01602315|5791587|P4|Overall Study|Disease progression|1
1657263|NCT01602315|5791588|P3|Overall Study|Disease progression|10
1657264|NCT01602315|5791589|P2|Overall Study|Disease progression|3
1657265|NCT01602315|5791590|P1|Overall Study|Disease progression|6
1657266|NCT01602315|5791584|P7|Overall Study|Physician Decision|1
1657267|NCT01602315|5791585|P6|Overall Study|Physician Decision|1
1657268|NCT01602315|5791586|P5|Overall Study|Physician Decision|2
1657269|NCT01602315|5791587|P4|Overall Study|Physician Decision|0
1657270|NCT01602315|5791588|P3|Overall Study|Physician Decision|0
1657271|NCT01602315|5791589|P2|Overall Study|Physician Decision|0
1657272|NCT01602315|5791590|P1|Overall Study|Physician Decision|2
1657273|NCT01602315|5791584|P7|Overall Study|Protocol Violation|0
1657274|NCT01602315|5791585|P6|Overall Study|Protocol Violation|1
1657275|NCT01602315|5791586|P5|Overall Study|Protocol Violation|0
1657276|NCT01602315|5791587|P4|Overall Study|Protocol Violation|0
1657277|NCT01602315|5791588|P3|Overall Study|Protocol Violation|0
1657278|NCT01602315|5791589|P2|Overall Study|Protocol Violation|0
1657279|NCT01602315|5791590|P1|Overall Study|Protocol Violation|0
1657280|NCT01602224|5791679|P3|Overall Study|Withdrawal by Subject|3
1657281|NCT01602224|5791680|P2|Overall Study|Withdrawal by Subject|3
1657282|NCT01602224|5791681|P1|Overall Study|Withdrawal by Subject|5
1657283|NCT01602224|5791679|P3|Overall Study|Sponsor Decision|2
1657284|NCT01602224|5791680|P2|Overall Study|Sponsor Decision|3
1657285|NCT01602224|5791681|P1|Overall Study|Sponsor Decision|2
1657286|NCT01602224|5791679|P3|Overall Study|Protocol Violation|0
1657287|NCT01602224|5791680|P2|Overall Study|Protocol Violation|1
1657288|NCT01602224|5791681|P1|Overall Study|Protocol Violation|0
1657289|NCT01602224|5791679|P3|Overall Study|Lost to Follow-up|1
1657290|NCT01602224|5791680|P2|Overall Study|Lost to Follow-up|0
1657291|NCT01602224|5791681|P1|Overall Study|Lost to Follow-up|0
1657292|NCT01602224|5791679|P3|Overall Study|Investigator Decison|0
1657293|NCT01602224|5791680|P2|Overall Study|Investigator Decison|0
1657294|NCT01602224|5791681|P1|Overall Study|Investigator Decison|1
1657295|NCT01602224|5791679|P3|Overall Study|Adverse Event|0
1657296|NCT01602224|5791680|P2|Overall Study|Adverse Event|1
1657297|NCT01602224|5791681|P1|Overall Study|Adverse Event|0
1657298|NCT01602120|5791766|P4|Overall Study|Unspecified Reason|2
1657299|NCT01602120|5791767|P3|Overall Study|Unspecified Reason|0
1657300|NCT01602120|5791768|P2|Overall Study|Unspecified Reason|1
1657301|NCT01602120|5791769|P1|Overall Study|Unspecified Reason|3
1657302|NCT01602120|5791766|P4|Overall Study|Physician Decision|0
1657303|NCT01602120|5791767|P3|Overall Study|Physician Decision|0
1657304|NCT01602120|5791768|P2|Overall Study|Physician Decision|3
1657305|NCT01602120|5791769|P1|Overall Study|Physician Decision|2
1657306|NCT01602120|5791766|P4|Overall Study|Study Terminated by Sponsor|44
1657307|NCT01602120|5791767|P3|Overall Study|Study Terminated by Sponsor|17
1657308|NCT01602120|5791768|P2|Overall Study|Study Terminated by Sponsor|24
1657309|NCT01602120|5791769|P1|Overall Study|Study Terminated by Sponsor|12
1657310|NCT01602120|5791766|P4|Overall Study|Withdrawal by Subject|3
1657311|NCT01602120|5791767|P3|Overall Study|Withdrawal by Subject|0
1657312|NCT01602120|5791768|P2|Overall Study|Withdrawal by Subject|17
1657313|NCT01602120|5791769|P1|Overall Study|Withdrawal by Subject|8
1657314|NCT01602120|5791766|P4|Overall Study|Non-compliance|1
1657315|NCT01602120|5791767|P3|Overall Study|Non-compliance|0
1657316|NCT01602120|5791768|P2|Overall Study|Non-compliance|3
1657317|NCT01602120|5791769|P1|Overall Study|Non-compliance|0
1657318|NCT01602120|5791766|P4|Overall Study|Protocol Violation|0
1657319|NCT01602120|5791767|P3|Overall Study|Protocol Violation|0
1657320|NCT01602120|5791768|P2|Overall Study|Protocol Violation|1
1657321|NCT01602120|5791769|P1|Overall Study|Protocol Violation|1
1657322|NCT01602120|5791766|P4|Overall Study|Lost to Follow-up|1
1657323|NCT01602120|5791767|P3|Overall Study|Lost to Follow-up|0
1657324|NCT01602120|5791768|P2|Overall Study|Lost to Follow-up|1
1657325|NCT01602120|5791769|P1|Overall Study|Lost to Follow-up|0
1657326|NCT01602120|5791766|P4|Overall Study|Death|0
1657327|NCT01602120|5791767|P3|Overall Study|Death|0
1657328|NCT01602120|5791768|P2|Overall Study|Death|4
1657329|NCT01602120|5791769|P1|Overall Study|Death|0
1657330|NCT01602120|5791766|P4|Overall Study|Adverse Event|2
1657331|NCT01602120|5791767|P3|Overall Study|Adverse Event|0
1657332|NCT01602120|5791768|P2|Overall Study|Adverse Event|6
1657333|NCT01602120|5791769|P1|Overall Study|Adverse Event|3
1657334|NCT01601873|5791817|P2|Overall Study|Lost to Follow-up|3
1657335|NCT01601873|5791818|P1|Overall Study|Lost to Follow-up|2
1657336|NCT01601847|5791844|P2|Overall Study|Lost to Follow-up|3
1657337|NCT01601847|5791845|P1|Overall Study|Lost to Follow-up|1
1657338|NCT01601847|5791844|P2|Overall Study|Withdrawal by Subject|7
1657339|NCT01601847|5791845|P1|Overall Study|Withdrawal by Subject|11
1657340|NCT01601847|5791844|P2|Overall Study|Death|0
1657341|NCT01601847|5791845|P1|Overall Study|Death|1
1657342|NCT01601821|5791857|P2|Overall Study|Other|1
1657343|NCT01601821|5791858|P1|Overall Study|Other|5
1657344|NCT01601821|5791857|P2|Overall Study|Study Events|1
1657345|NCT01601821|5791858|P1|Overall Study|Study Events|7
1657346|NCT01601821|5791857|P2|Overall Study|Graft Loss|6
1657347|NCT01601821|5791858|P1|Overall Study|Graft Loss|6
1657348|NCT01601821|5791857|P2|Overall Study|Withdrawal by Subject|0
1657349|NCT01601821|5791858|P1|Overall Study|Withdrawal by Subject|1
1657350|NCT01601821|5791857|P2|Overall Study|Lost to Follow-up|14
1657351|NCT01601821|5791858|P1|Overall Study|Lost to Follow-up|6
1657352|NCT01601821|5791857|P2|Overall Study|Protocol Violation|2
1657353|NCT01601821|5791858|P1|Overall Study|Protocol Violation|2
1657354|NCT01601821|5791857|P2|Overall Study|Death|5
1657355|NCT01601821|5791858|P1|Overall Study|Death|2
1657356|NCT01601704|5791894|P2|Overall Study|Randomized but not dispensed study med|4
1657357|NCT01601704|5791895|P1|Overall Study|Randomized but not dispensed study med|1
1657358|NCT01601626|5791916|P3|Overall Study|Not Willing to Adhere to Requirements|0
1657359|NCT01601626|5791917|P2|Overall Study|Not Willing to Adhere to Requirements|0
1657360|NCT01601626|5791918|P1|Overall Study|Not Willing to Adhere to Requirements|1
1657361|NCT01601626|5791916|P3|Overall Study|Withdrawal by Subject|1
1657362|NCT01601626|5791917|P2|Overall Study|Withdrawal by Subject|1
1657363|NCT01601626|5791918|P1|Overall Study|Withdrawal by Subject|0
1657364|NCT01601626|5791916|P3|Overall Study|Unable to Get to Clinic|0
1657365|NCT01601626|5791917|P2|Overall Study|Unable to Get to Clinic|1
1657366|NCT01601626|5791918|P1|Overall Study|Unable to Get to Clinic|0
1657367|NCT01601626|5791916|P3|Overall Study|Lost to Follow-up|0
1657368|NCT01601626|5791917|P2|Overall Study|Lost to Follow-up|2
1657369|NCT01601626|5791918|P1|Overall Study|Lost to Follow-up|1
1657370|NCT01601626|5791916|P3|Overall Study|Death|1
1657371|NCT01601626|5791917|P2|Overall Study|Death|1
1657372|NCT01601626|5791918|P1|Overall Study|Death|1
1657373|NCT01601535|5792007|P6|Phase 2|Started Another Treatment|2
1657374|NCT01601535|5792008|P5|Phase 2|Started Another Treatment|1
1657375|NCT01601535|5792009|P4|Phase 2|Started Another Treatment|0
1657376|NCT01601535|5792010|P3|Phase 2|Started Another Treatment|0
1657377|NCT01601535|5792011|P2|Phase 2|Started Another Treatment|0
1657378|NCT01601535|5792012|P1|Phase 2|Started Another Treatment|0
1657379|NCT01601535|5792007|P6|Phase 2|Progressive Disease|7
1657380|NCT01601535|5792008|P5|Phase 2|Progressive Disease|5
1657381|NCT01601535|5792009|P4|Phase 2|Progressive Disease|0
1657382|NCT01601535|5792010|P3|Phase 2|Progressive Disease|0
1657383|NCT01601535|5792011|P2|Phase 2|Progressive Disease|0
1657384|NCT01601535|5792012|P1|Phase 2|Progressive Disease|0
1657385|NCT01601535|5792007|P6|Phase 2|Withdrawal by Subject|2
1657386|NCT01601535|5792008|P5|Phase 2|Withdrawal by Subject|8
1657387|NCT01601535|5792009|P4|Phase 2|Withdrawal by Subject|0
1657388|NCT01601535|5792010|P3|Phase 2|Withdrawal by Subject|0
1657389|NCT01601535|5792011|P2|Phase 2|Withdrawal by Subject|0
1657390|NCT01601535|5792012|P1|Phase 2|Withdrawal by Subject|0
1657391|NCT01601535|5792007|P6|Phase 2|Adverse Event|1
1657392|NCT01601535|5792008|P5|Phase 2|Adverse Event|5
1657393|NCT01601535|5792009|P4|Phase 2|Adverse Event|0
1657394|NCT01601535|5792010|P3|Phase 2|Adverse Event|0
1657395|NCT01601535|5792011|P2|Phase 2|Adverse Event|0
1657396|NCT01601535|5792012|P1|Phase 2|Adverse Event|0
1657397|NCT01601535|5792007|P6|Phase 1|Started Another Treatment|0
1657398|NCT01601535|5792008|P5|Phase 1|Started Another Treatment|0
1657399|NCT01601535|5792009|P4|Phase 1|Started Another Treatment|0
1657400|NCT01601535|5792010|P3|Phase 1|Started Another Treatment|0
1657401|NCT01601535|5792011|P2|Phase 1|Started Another Treatment|2
1657402|NCT01601535|5792012|P1|Phase 1|Started Another Treatment|1
1657403|NCT01601535|5792007|P6|Phase 1|Progressive Disease|0
1657404|NCT01601535|5792008|P5|Phase 1|Progressive Disease|0
1657405|NCT01601535|5792009|P4|Phase 1|Progressive Disease|1
1657406|NCT01601535|5792010|P3|Phase 1|Progressive Disease|2
1657407|NCT01601535|5792011|P2|Phase 1|Progressive Disease|3
1657408|NCT01601535|5792012|P1|Phase 1|Progressive Disease|2
1657409|NCT01601535|5792007|P6|Phase 1|Withdrawal by Subject|0
1657410|NCT01601535|5792008|P5|Phase 1|Withdrawal by Subject|0
1657411|NCT01601535|5792009|P4|Phase 1|Withdrawal by Subject|2
1657412|NCT01601535|5792010|P3|Phase 1|Withdrawal by Subject|1
1657413|NCT01601535|5792011|P2|Phase 1|Withdrawal by Subject|1
1657414|NCT01601535|5792012|P1|Phase 1|Withdrawal by Subject|2
1657415|NCT01601535|5792007|P6|Phase 1|Adverse Event|0
1657416|NCT01601535|5792008|P5|Phase 1|Adverse Event|0
1657417|NCT01601535|5792009|P4|Phase 1|Adverse Event|1
1657418|NCT01601535|5792010|P3|Phase 1|Adverse Event|2
1657419|NCT01601535|5792011|P2|Phase 1|Adverse Event|0
1657420|NCT01601535|5792012|P1|Phase 1|Adverse Event|1
1657421|NCT01601470|5792068|P1|Period 2 - LCZ696|Physician Decision|1
1657422|NCT01601132|5792139|P1|Overall Study|Protocol deviation|1
1657423|NCT01601132|5792139|P1|Overall Study|Patient withdrew consent|1
1657424|NCT01600885|5792184|P2|First Period|moved out of area|0
1657425|NCT01600885|5792185|P1|First Period|moved out of area|1
1657426|NCT01600885|5792184|P2|First Period|Adverse Event|1
1657427|NCT01600885|5792185|P1|First Period|Adverse Event|1
1657428|NCT01600716|5792202|P2|Overall Study|Adverse Event|1
1657429|NCT01600716|5792203|P1|Overall Study|Adverse Event|1
1657430|NCT01600716|5792202|P2|Overall Study|Lack of Efficacy|1
1657431|NCT01600716|5792203|P1|Overall Study|Lack of Efficacy|2
1657432|NCT01600716|5792202|P2|Overall Study|Pregnancy|0
1657433|NCT01600716|5792203|P1|Overall Study|Pregnancy|1
1657434|NCT01600716|5792202|P2|Overall Study|Lost to Follow-up|2
1657435|NCT01600716|5792203|P1|Overall Study|Lost to Follow-up|0
1657436|NCT01600716|5792202|P2|Overall Study|Personal Reasons|2
1657437|NCT01600716|5792203|P1|Overall Study|Personal Reasons|0
1657438|NCT01600716|5792202|P2|Overall Study|Other Reasons|1
1657439|NCT01600716|5792203|P1|Overall Study|Other Reasons|3
1657440|NCT01600586|5792243|P2|Overall Study|Physician Decision|3
1657441|NCT01600586|5792244|P1|Overall Study|Physician Decision|3
1657442|NCT01600326|5792296|P2|Overall Study|Lost to Follow-up|1
1657443|NCT01600326|5792297|P1|Overall Study|Lost to Follow-up|1
1657444|NCT01600105|5792373|P2|Sub Study V|Poor Image Quality|0
1657445|NCT01600105|5792374|P1|Sub Study V|Poor Image Quality|2
1657446|NCT01600105|5792373|P2|Sub Study III|Insufficient image quality|0
1657447|NCT01600105|5792374|P1|Sub Study III|Insufficient image quality|5
1657448|NCT01600105|5792373|P2|Sub Study II|Insufficient image quality|0
1657449|NCT01600105|5792374|P1|Sub Study II|Insufficient image quality|3
1657450|NCT01600105|5792373|P2|Sub Study II|No images in PACS|0
1657451|NCT01600105|5792374|P1|Sub Study II|No images in PACS|1
1657452|NCT01600105|5792373|P2|Sub Study II|Withdrawal by Subject|0
1657453|NCT01600105|5792374|P1|Sub Study II|Withdrawal by Subject|1
1657454|NCT01600105|5792373|P2|Sub Study I|Insufficient image quality|10
1657455|NCT01600105|5792374|P1|Sub Study I|Insufficient image quality|0
1657456|NCT01600105|5792373|P2|Total Participants|Insufficient image quality|10
1657457|NCT01600105|5792374|P1|Total Participants|Insufficient image quality|30
1657458|NCT01600105|5792373|P2|Total Participants|No images in PACS|0
1657459|NCT01600105|5792374|P1|Total Participants|No images in PACS|10
1657460|NCT01600105|5792373|P2|Total Participants|Withdrawal by Subject|0
1657461|NCT01600105|5792374|P1|Total Participants|Withdrawal by Subject|1
1657462|NCT01600092|5792402|P2|Overall Study|Randomized but not vaccinated|3
1657463|NCT01600092|5792403|P1|Overall Study|Randomized but not vaccinated|3
1657464|NCT01600092|5792402|P2|Overall Study|Physician Decision|1
1657465|NCT01600092|5792403|P1|Overall Study|Physician Decision|1
1657466|NCT01600092|5792402|P2|Overall Study|Withdrawal by parent/guardian|6
1657467|NCT01600092|5792403|P1|Overall Study|Withdrawal by parent/guardian|8
1657468|NCT01600092|5792402|P2|Overall Study|Lost to Follow-up|6
1657469|NCT01600092|5792403|P1|Overall Study|Lost to Follow-up|4
1657470|NCT01600092|5792402|P2|Overall Study|Adverse Event|0
1657471|NCT01600092|5792403|P1|Overall Study|Adverse Event|2
1657472|NCT01600053|5792417|P1|Overall Study|trial will not meet the interim endpoint|9
1657473|NCT01600053|5792417|P1|Overall Study|Adverse Event|2
1657474|NCT01600014|5792422|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
1657475|NCT01600014|5792423|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
1657476|NCT01600014|5792422|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
1657477|NCT01600014|5792423|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
1657478|NCT01600014|5792422|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
1657479|NCT01600014|5792423|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
1657480|NCT01600014|5792422|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
1657481|NCT01600014|5792423|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
1657482|NCT01600014|5792422|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1657483|NCT01600014|5792423|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
1657484|NCT01600014|5792422|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
1657485|NCT01600014|5792423|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
1657486|NCT01600014|5792422|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
1657487|NCT01600014|5792423|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
1657488|NCT01600014|5792422|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
1657489|NCT01600014|5792423|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
1657490|NCT01600014|5792422|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
1657491|NCT01600014|5792423|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
1657492|NCT01600014|5792422|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
1657493|NCT01600014|5792423|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
1657494|NCT01600014|5792422|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
1657495|NCT01600014|5792423|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
1657496|NCT01600014|5792422|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
1657497|NCT01600014|5792423|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
1657498|NCT01600014|5792422|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
1657499|NCT01600014|5792423|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
1657500|NCT01600014|5792422|P2|1. Cycle & Observation Period D1 to W52|Other|0
1657501|NCT01600014|5792423|P1|1. Cycle & Observation Period D1 to W52|Other|27
1657502|NCT01600014|5792422|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
1657503|NCT01600014|5792423|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
1657504|NCT01600014|5792422|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
1657505|NCT01600014|5792423|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
1657506|NCT01600014|5792422|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
1657507|NCT01600014|5792423|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
1657508|NCT01599806|5792451|P2|Overall Study|Other Eligibility criteria|9
1657509|NCT01599806|5792452|P1|Overall Study|Other Eligibility criteria|11
1657510|NCT01599806|5792451|P2|Overall Study|Withdrawal by Subject|12
1657511|NCT01599806|5792452|P1|Overall Study|Withdrawal by Subject|12
1657512|NCT01599806|5792451|P2|Overall Study|Lost to Follow-up|20
1657513|NCT01599806|5792452|P1|Overall Study|Lost to Follow-up|20
1657514|NCT01599754|5792578|P2|Overall Study|Study terminated by sponsor|285
1657515|NCT01599754|5792579|P1|Overall Study|Study terminated by sponsor|282
1657516|NCT01599754|5792578|P2|Overall Study|Withdrawal by Subject|25
1657517|NCT01599754|5792579|P1|Overall Study|Withdrawal by Subject|24
1657518|NCT01599754|5792578|P2|Overall Study|Investigator decision|3
1657519|NCT01599754|5792579|P1|Overall Study|Investigator decision|1
1657520|NCT01599754|5792578|P2|Overall Study|Adverse Event|2
1657521|NCT01599754|5792579|P1|Overall Study|Adverse Event|3
1657522|NCT01599754|5792578|P2|Overall Study|Death|33
1657523|NCT01599754|5792579|P1|Overall Study|Death|31
1657524|NCT01599754|5792578|P2|Overall Study|Lost to Follow-up|6
1657525|NCT01599754|5792579|P1|Overall Study|Lost to Follow-up|13
1657526|NCT01599754|5792578|P2|Overall Study|Participant noncompliance|4
1657527|NCT01599754|5792579|P1|Overall Study|Participant noncompliance|4
1657528|NCT01599754|5792578|P2|Overall Study|Anticancer therapy need not in protocol|2
1657529|NCT01599754|5792579|P1|Overall Study|Anticancer therapy need not in protocol|5
1657530|NCT01599650|5792610|P3|Overall Study|Adverse Event|4
1657531|NCT01599650|5792611|P2|Overall Study|Adverse Event|8
1657532|NCT01599650|5792612|P1|Overall Study|Adverse Event|3
1657533|NCT01599650|5792610|P3|Overall Study|Withdrawal by Subject|10
1657534|NCT01599650|5792611|P2|Overall Study|Withdrawal by Subject|11
1657535|NCT01599650|5792612|P1|Overall Study|Withdrawal by Subject|11
1657536|NCT01599650|5792610|P3|Overall Study|Lost to Follow-up|3
1657537|NCT01599650|5792611|P2|Overall Study|Lost to Follow-up|3
1657538|NCT01599650|5792612|P1|Overall Study|Lost to Follow-up|3
1657539|NCT01599650|5792610|P3|Overall Study|Death|2
1657540|NCT01599650|5792611|P2|Overall Study|Death|1
1657541|NCT01599650|5792612|P1|Overall Study|Death|2
1657542|NCT01599650|5792610|P3|Overall Study|Protocol Violation|0
1657543|NCT01599650|5792611|P2|Overall Study|Protocol Violation|3
1657544|NCT01599650|5792612|P1|Overall Study|Protocol Violation|0
1657545|NCT01599650|5792610|P3|Overall Study|Physician Decision|7
1657546|NCT01599650|5792611|P2|Overall Study|Physician Decision|0
1657547|NCT01599650|5792612|P1|Overall Study|Physician Decision|2
1657548|NCT01599650|5792610|P3|Overall Study|Administrative issue|1
1657549|NCT01599650|5792611|P2|Overall Study|Administrative issue|0
1657550|NCT01599650|5792612|P1|Overall Study|Administrative issue|1
1657551|NCT01599637|5792651|P3|Overall Study|Adverse Event|0
1657552|NCT01599637|5792652|P2|Overall Study|Adverse Event|0
1657553|NCT01599637|5792653|P1|Overall Study|Adverse Event|1
1657554|NCT01599637|5792651|P3|Overall Study|administrative problems|0
1657555|NCT01599637|5792652|P2|Overall Study|administrative problems|2
1657556|NCT01599637|5792653|P1|Overall Study|administrative problems|0
1657557|NCT01599585|5792700|P2|Overall Study|randomized did not start treatment|3
1657558|NCT01599585|5792701|P1|Overall Study|randomized did not start treatment|3
1657559|NCT01599585|5792700|P2|Overall Study|Lost to Follow-up|5
1657560|NCT01599585|5792701|P1|Overall Study|Lost to Follow-up|3
1657561|NCT01599585|5792700|P2|Overall Study|Withdrawal by Subject|9
1657562|NCT01599585|5792701|P1|Overall Study|Withdrawal by Subject|16
1657563|NCT01599325|5792739|P1|Extension Phase|Withdrawal by Subject|8
1657564|NCT01599325|5792739|P1|Extension Phase|Disease Progression|1
1657565|NCT01599325|5792739|P1|Extension Phase|Lack of Therapeutic Effect|4
1657566|NCT01599325|5792739|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
1657567|NCT01599325|5792739|P1|Extension Phase|Study Closure|1
1657568|NCT01599325|5792739|P1|Primary Parent Phase|Other|2
1657569|NCT01599325|5792739|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
1657570|NCT01599325|5792739|P1|Primary Parent Phase|Protocol Violation|1
1657571|NCT01599325|5792739|P1|Primary Parent Phase|Death|13
1657572|NCT01599325|5792739|P1|Primary Parent Phase|Withdrawal by Subject|20
1657573|NCT01599325|5792739|P1|Primary Parent Phase|Disease Progression|7
1657574|NCT01599325|5792739|P1|Primary Parent Phase|Adverse Event|5
1657575|NCT01599234|5792763|P2|Overall Study|Pregnancy|1
1657576|NCT01599234|5792764|P1|Overall Study|Pregnancy|0
1657577|NCT01599234|5792763|P2|Overall Study|Contra-indication discovered|1
1657578|NCT01599234|5792764|P1|Overall Study|Contra-indication discovered|0
1657579|NCT01599234|5792763|P2|Overall Study|Patient would not stop driving|0
1657580|NCT01599234|5792764|P1|Overall Study|Patient would not stop driving|1
1657581|NCT01599234|5792763|P2|Overall Study|Death|0
1657582|NCT01599234|5792764|P1|Overall Study|Death|1
1657583|NCT01599234|5792763|P2|Overall Study|Sponsor request as creatinine levels <50|1
1657584|NCT01599234|5792764|P1|Overall Study|Sponsor request as creatinine levels <50|0
1657585|NCT01599234|5792763|P2|Overall Study|Unable to operate spray|0
1657586|NCT01599234|5792764|P1|Overall Study|Unable to operate spray|1
1657587|NCT01599234|5792763|P2|Overall Study|Lack of Efficacy|4
1657588|NCT01599234|5792764|P1|Overall Study|Lack of Efficacy|2
1657589|NCT01599234|5792763|P2|Overall Study|Lost to Follow-up|2
1657590|NCT01599234|5792764|P1|Overall Study|Lost to Follow-up|1
1657591|NCT01599234|5792763|P2|Overall Study|Withdrawal by Subject|1
1657592|NCT01599234|5792764|P1|Overall Study|Withdrawal by Subject|2
1657593|NCT01599234|5792763|P2|Overall Study|Adverse Event|5
1657594|NCT01599234|5792764|P1|Overall Study|Adverse Event|9
1657595|NCT01599104|5792789|P3|Overall Study|Adverse Event|12
1657596|NCT01599104|5792790|P2|Overall Study|Adverse Event|6
1657597|NCT01599104|5792791|P1|Overall Study|Adverse Event|7
1657598|NCT01599104|5792789|P3|Overall Study|Lack of Efficacy|10
1657599|NCT01599104|5792790|P2|Overall Study|Lack of Efficacy|4
1657600|NCT01599104|5792791|P1|Overall Study|Lack of Efficacy|4
1657601|NCT01599104|5792789|P3|Overall Study|Non-compliance with study treatment|0
1657602|NCT01599104|5792790|P2|Overall Study|Non-compliance with study treatment|1
1657603|NCT01599104|5792791|P1|Overall Study|Non-compliance with study treatment|0
1657604|NCT01599104|5792789|P3|Overall Study|Physician Decision|2
1657605|NCT01599104|5792790|P2|Overall Study|Physician Decision|2
1657606|NCT01599104|5792791|P1|Overall Study|Physician Decision|3
1657607|NCT01599104|5792789|P3|Overall Study|Technical Problems|0
1657608|NCT01599104|5792790|P2|Overall Study|Technical Problems|0
1657609|NCT01599104|5792791|P1|Overall Study|Technical Problems|1
1657610|NCT01599104|5792789|P3|Overall Study|Withdrawal by Subject|2
1657611|NCT01599104|5792790|P2|Overall Study|Withdrawal by Subject|1
1657612|NCT01599104|5792791|P1|Overall Study|Withdrawal by Subject|1
1657613|NCT01598987|5792829|P1|Baseline to 24 Month|Lost to Follow-up|1
1657614|NCT01598987|5792829|P1|Baseline to 24 Month|Administrative problems|2
1657615|NCT01598987|5792829|P1|Baseline to 24 Month|Withdrawal by Subject|5
1657616|NCT01598987|5792829|P1|Baseline to Month 12|Withdrawal by Subject|4
1657617|NCT01598987|5792829|P1|Baseline to Month 12|Administrative problems|2
1657618|NCT01598896|5792865|P2|Overall Study|Lack of Efficacy|1
1657619|NCT01598896|5792866|P1|Overall Study|Lack of Efficacy|0
1657620|NCT01598896|5792865|P2|Overall Study|Withdrawal by Subject|1
1657621|NCT01598896|5792866|P1|Overall Study|Withdrawal by Subject|0
1657622|NCT01598753|5792886|P4|Overall Study|Withdrawal by Subject|1
1657623|NCT01598753|5792887|P3|Overall Study|Withdrawal by Subject|0
1657624|NCT01598753|5792888|P2|Overall Study|Withdrawal by Subject|2
1657625|NCT01598753|5792889|P1|Overall Study|Withdrawal by Subject|7
1657626|NCT01598753|5792886|P4|Overall Study|Physician Decision|2
1657627|NCT01598753|5792887|P3|Overall Study|Physician Decision|0
1657628|NCT01598753|5792888|P2|Overall Study|Physician Decision|1
1657629|NCT01598753|5792889|P1|Overall Study|Physician Decision|0
1657630|NCT01598753|5792886|P4|Overall Study|Lost to Follow-up|5
1657631|NCT01598753|5792887|P3|Overall Study|Lost to Follow-up|7
1657632|NCT01598753|5792888|P2|Overall Study|Lost to Follow-up|3
1657633|NCT01598753|5792889|P1|Overall Study|Lost to Follow-up|4
1657634|NCT01598753|5792886|P4|Overall Study|Adverse Event|7
1657635|NCT01598753|5792887|P3|Overall Study|Adverse Event|1
1657636|NCT01598753|5792888|P2|Overall Study|Adverse Event|9
1657637|NCT01598753|5792889|P1|Overall Study|Adverse Event|1
1657638|NCT01598662|5792929|P2|Overall Study|IUD expelled before month 6|2
1657639|NCT01598662|5792930|P1|Overall Study|IUD expelled before month 6|0
1657640|NCT01598662|5792929|P2|Overall Study|Physician Decision|2
1657641|NCT01598662|5792930|P1|Overall Study|Physician Decision|1
1657642|NCT01598662|5792929|P2|Overall Study|Lost to Follow-up|17
1657643|NCT01598662|5792930|P1|Overall Study|Lost to Follow-up|10
1657644|NCT01598610|5792936|P1|Overall Study|Adverse Event|1
1657645|NCT01598532|5792953|P1|Overall Study|Did not meet inclusion criteria|8
1657646|NCT01598532|5792953|P1|Overall Study|Lost to Follow-up|3
1657647|NCT01598506|5792962|P1|Overall Study|Withdrawal by Subject|2
1657648|NCT01598311|5792982|P2|Overall Study|Assigned to CB but received vancomycin|0
1657649|NCT01598311|5792983|P1|Overall Study|Assigned to CB but received vancomycin|1
1657650|NCT01598311|5792982|P2|Overall Study|Treated but no confirmed CDAD|8
1657651|NCT01598311|5792983|P1|Overall Study|Treated but no confirmed CDAD|9
1657652|NCT01598311|5792982|P2|Overall Study|Randomized but never treated|5
1657653|NCT01598311|5792983|P1|Overall Study|Randomized but never treated|8
1657654|NCT01598311|5792982|P2|Overall Study|No reason provided.|5
1657655|NCT01598311|5792983|P1|Overall Study|No reason provided.|0
1657656|NCT01598311|5792982|P2|Overall Study|Withdrawal by Subject|13
1657657|NCT01598311|5792983|P1|Overall Study|Withdrawal by Subject|9
1657658|NCT01598311|5792982|P2|Overall Study|Lost to Follow-up|12
1657659|NCT01598311|5792983|P1|Overall Study|Lost to Follow-up|7
1657660|NCT01598311|5792982|P2|Overall Study|Adverse Event|13
1657661|NCT01598311|5792983|P1|Overall Study|Adverse Event|9
1657662|NCT01598311|5792982|P2|Overall Study|Physician Decision|5
1657663|NCT01598311|5792983|P1|Overall Study|Physician Decision|4
1657664|NCT01598298|5792999|P2|Overall Study|Other reason (not protocol specified)|0
1657665|NCT01598298|5793000|P1|Overall Study|Other reason (not protocol specified)|4
1657666|NCT01598298|5792999|P2|Overall Study|Withdrawal by Subject|15
1657667|NCT01598298|5793000|P1|Overall Study|Withdrawal by Subject|10
1657668|NCT01598298|5792999|P2|Overall Study|Progression/relapse|2
1657669|NCT01598298|5793000|P1|Overall Study|Progression/relapse|0
1657670|NCT01598298|5792999|P2|Overall Study|Adverse Event|19
1657671|NCT01598298|5793000|P1|Overall Study|Adverse Event|21
1657672|NCT01598298|5792999|P2|Overall Study|Not eligible|5
1657673|NCT01598298|5793000|P1|Overall Study|Not eligible|5
1657674|NCT01598129|5793044|P1|Overall Study|Withdrawal by Subject|1
1657675|NCT01598129|5793044|P1|Overall Study|Deterioration of WHO status to WHO 4|2
1657676|NCT01598129|5793044|P1|Overall Study|Disease progression|6
1657677|NCT01598090|5793056|P3|Follow-up Period|Lost to Follow-up|12
1657678|NCT01598090|5793057|P2|Follow-up Period|Lost to Follow-up|10
1657679|NCT01598090|5793058|P1|Follow-up Period|Lost to Follow-up|2
1657680|NCT01598090|5793056|P3|Follow-up Period|Other reasons|8
1657681|NCT01598090|5793057|P2|Follow-up Period|Other reasons|8
1657682|NCT01598090|5793058|P1|Follow-up Period|Other reasons|2
1657683|NCT01598090|5793056|P3|Follow-up Period|Withdrawal by Subject|2
1657684|NCT01598090|5793057|P2|Follow-up Period|Withdrawal by Subject|3
1657685|NCT01598090|5793058|P1|Follow-up Period|Withdrawal by Subject|0
1657686|NCT01598090|5793056|P3|Follow-up Period|Not reported|4
1657687|NCT01598090|5793057|P2|Follow-up Period|Not reported|10
1657688|NCT01598090|5793058|P1|Follow-up Period|Not reported|0
1657689|NCT01598090|5793056|P3|Follow-up Period|No longer required per protocol|2
1657690|NCT01598090|5793057|P2|Follow-up Period|No longer required per protocol|3
1657691|NCT01598090|5793058|P1|Follow-up Period|No longer required per protocol|1
1657692|NCT01598090|5793056|P3|Follow-up Period|Death|0
1657693|NCT01598090|5793057|P2|Follow-up Period|Death|1
1657694|NCT01598090|5793058|P1|Follow-up Period|Death|0
1657695|NCT01598090|5793056|P3|Treatment Period|Lost to Follow-up|1
1657696|NCT01598090|5793057|P2|Treatment Period|Lost to Follow-up|5
1657697|NCT01598090|5793058|P1|Treatment Period|Lost to Follow-up|1
1657698|NCT01598090|5793056|P3|Treatment Period|Withdrawal by Subject|10
1657699|NCT01598090|5793057|P2|Treatment Period|Withdrawal by Subject|13
1657700|NCT01598090|5793058|P1|Treatment Period|Withdrawal by Subject|3
1657701|NCT01598090|5793056|P3|Treatment Period|Other reasons|1
1657702|NCT01598090|5793057|P2|Treatment Period|Other reasons|4
1657703|NCT01598090|5793058|P1|Treatment Period|Other reasons|0
1657704|NCT01598090|5793056|P3|Treatment Period|Adverse Event|17
1657705|NCT01598090|5793057|P2|Treatment Period|Adverse Event|33
1657706|NCT01598090|5793058|P1|Treatment Period|Adverse Event|2
1657707|NCT01598090|5793056|P3|Treatment Period|Lack of Efficacy|6
1657708|NCT01598090|5793057|P2|Treatment Period|Lack of Efficacy|14
1657709|NCT01598090|5793058|P1|Treatment Period|Lack of Efficacy|5
1657710|NCT01598090|5793056|P3|Treatment Period|No longer meet study criteria|0
1657711|NCT01598090|5793057|P2|Treatment Period|No longer meet study criteria|1
1657712|NCT01598090|5793058|P1|Treatment Period|No longer meet study criteria|0
1657713|NCT01598090|5793056|P3|Treatment Period|Poor/non-compliance|0
1657714|NCT01598090|5793057|P2|Treatment Period|Poor/non-compliance|2
1657715|NCT01598090|5793058|P1|Treatment Period|Poor/non-compliance|0
1657716|NCT01597908|5793105|P2|Overall Study|Ongoing|202
1657717|NCT01597908|5793106|P1|Overall Study|Ongoing|236
1657718|NCT01597908|5793105|P2|Overall Study|Withdrawal by Subject|18
1657719|NCT01597908|5793106|P1|Overall Study|Withdrawal by Subject|10
1657720|NCT01597908|5793105|P2|Overall Study|Physician Decision|1
1657721|NCT01597908|5793106|P1|Overall Study|Physician Decision|2
1657722|NCT01597908|5793105|P2|Overall Study|Lost to Follow-up|9
1657723|NCT01597908|5793106|P1|Overall Study|Lost to Follow-up|4
1657724|NCT01597908|5793105|P2|Overall Study|Death|122
1657725|NCT01597908|5793106|P1|Overall Study|Death|100
1657726|NCT01597791|5793152|P2|Overall Study|Protocol Violation|1
1657727|NCT01597791|5793153|P1|Overall Study|Protocol Violation|0
1657728|NCT01597791|5793152|P2|Overall Study|Subject withdrawal|1
1657729|NCT01597791|5793153|P1|Overall Study|Subject withdrawal|0
1657730|NCT01597791|5793152|P2|Overall Study|Cesarean Section|7
1657731|NCT01597791|5793153|P1|Overall Study|Cesarean Section|6
1657732|NCT01597791|5793152|P2|Overall Study|Physician Decision|1
1657733|NCT01597791|5793153|P1|Overall Study|Physician Decision|2
1657734|NCT01597635|5793240|P3|Part B|Withdrawal by Subject|0
1657735|NCT01597635|5793241|P2|Part B|Withdrawal by Subject|1
1657736|NCT01597635|5793242|P1|Part B|Withdrawal by Subject|0
1657737|NCT01597635|5793240|P3|Part B|Protocol-defined stopping criteria|3
1657738|NCT01597635|5793241|P2|Part B|Protocol-defined stopping criteria|4
1657739|NCT01597635|5793242|P1|Part B|Protocol-defined stopping criteria|0
1657740|NCT01597635|5793240|P3|Part B|Protocol Violation|0
1657741|NCT01597635|5793241|P2|Part B|Protocol Violation|1
1657742|NCT01597635|5793242|P1|Part B|Protocol Violation|0
1657743|NCT01597635|5793240|P3|Part B|Adverse Event|1
1657744|NCT01597635|5793241|P2|Part B|Adverse Event|0
1657745|NCT01597635|5793242|P1|Part B|Adverse Event|0
1657746|NCT01597635|5793240|P3|Part A|Adverse Event|0
1657747|NCT01597635|5793241|P2|Part A|Adverse Event|0
1657748|NCT01597635|5793242|P1|Part A|Adverse Event|3
1657749|NCT01597622|5793305|P1|Overall Study|Death|1
1657750|NCT01597622|5793305|P1|Overall Study|Withdrawal by Subject|20
1657751|NCT01597622|5793305|P1|Overall Study|Investigator Discretion|5
1657752|NCT01597622|5793305|P1|Overall Study|Lost to Follow-up|1
1657753|NCT01597622|5793305|P1|Overall Study|Protocol Violation|1
1657754|NCT01597622|5793305|P1|Overall Study|Lack of Efficacy|3
1657755|NCT01597622|5793305|P1|Overall Study|Adverse Event|7
1657756|NCT01597596|5793312|P2|Overall Study|Physician Decision|1
1657757|NCT01597596|5793313|P1|Overall Study|Physician Decision|0
1657758|NCT01597596|5793312|P2|Overall Study|Study terminated by sponsor|0
1657759|NCT01597596|5793313|P1|Overall Study|Study terminated by sponsor|1
1657760|NCT01597505|5793327|P2|Overall Study|Missing|0
1657761|NCT01597505|5793328|P1|Overall Study|Missing|1
1657762|NCT01597505|5793327|P2|Overall Study|Other|6
1657763|NCT01597505|5793328|P1|Overall Study|Other|5
1657764|NCT01597505|5793327|P2|Overall Study|Withdrawal by Subject|18
1657765|NCT01597505|5793328|P1|Overall Study|Withdrawal by Subject|10
1657766|NCT01597505|5793327|P2|Overall Study|Lost to Follow-up|2
1657767|NCT01597505|5793328|P1|Overall Study|Lost to Follow-up|4
1657768|NCT01597505|5793327|P2|Overall Study|Adverse Event|7
1657769|NCT01597505|5793328|P1|Overall Study|Adverse Event|19
1657770|NCT01597505|5793327|P2|Overall Study|Physician Decision|0
1657771|NCT01597505|5793328|P1|Overall Study|Physician Decision|5
1657772|NCT01597492|5793362|P2|Overall Study|Other Reason|0
1657773|NCT01597492|5793363|P1|Overall Study|Other Reason|2
1657774|NCT01597492|5793362|P2|Overall Study|Lost to Follow-up|2
1657775|NCT01597492|5793363|P1|Overall Study|Lost to Follow-up|0
1657776|NCT01597492|5793362|P2|Overall Study|Adverse Event|0
1657777|NCT01597492|5793363|P1|Overall Study|Adverse Event|3
1657778|NCT01597492|5793362|P2|Overall Study|Withdrawal by Subject|2
1657779|NCT01597492|5793363|P1|Overall Study|Withdrawal by Subject|1
1657780|NCT01597479|5793371|P2|Overall Study|Lost to Follow-up|0
1657781|NCT01597479|5793372|P1|Overall Study|Lost to Follow-up|1
1657782|NCT01597479|5793371|P2|Overall Study|Protocol Violation|0
1657783|NCT01597479|5793372|P1|Overall Study|Protocol Violation|1
1657784|NCT01597375|5793658|P2|Second Intervention|Failed to react at both Aspirin|1
1657785|NCT01597375|5793659|P1|Second Intervention|Failed to react at both Aspirin|1
1657786|NCT01597375|5793658|P2|Washout (2 Weeks)|Adverse Event|0
1657787|NCT01597375|5793659|P1|Washout (2 Weeks)|Adverse Event|1
1657788|NCT01597375|5793658|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
1657789|NCT01597375|5793659|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
1657790|NCT01597375|5793658|P2|First Intervention (4 Weeks)|Needed surgery|0
1657791|NCT01597375|5793659|P1|First Intervention (4 Weeks)|Needed surgery|1
1657792|NCT01597375|5793658|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
1657793|NCT01597375|5793659|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
1657794|NCT01597258|5793676|P1|Overall Study|No Drug Administration|1
1657795|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657796|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657797|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
1657798|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657799|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657800|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657801|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657802|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657803|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657804|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657805|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657806|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657807|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
1657808|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657809|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1657810|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1657811|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1657812|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1657813|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657814|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
1657815|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657816|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657817|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657818|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657819|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657820|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
1657821|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1657822|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1657823|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1657824|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
1657825|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1657826|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1657827|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
1657828|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
1657829|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
1657830|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1657831|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1657832|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1657833|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
1657834|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1657835|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657836|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
1657837|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1657838|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
1657839|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657840|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657841|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657842|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
1657843|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657844|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657845|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657846|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
1657847|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1657848|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
1657849|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
1657850|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1657851|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
1657852|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1657853|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1657854|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
1657855|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
1657856|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1657857|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1657858|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1657859|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
1657860|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1657861|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1657862|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1657863|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
1657864|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
1657865|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
1657866|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1657867|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
1657868|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
1657869|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1657870|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1657871|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1657872|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
1657873|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
1657874|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
1657875|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
1657876|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657877|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
1657878|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657879|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
1657880|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657881|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657882|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657883|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657884|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657885|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
1657886|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657887|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657888|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657889|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
1657890|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657891|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
1657892|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
1657893|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
1657894|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
1657895|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657896|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657897|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657898|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
1657899|NCT01597245|5793685|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657900|NCT01597245|5793686|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657901|NCT01597245|5793687|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657902|NCT01597245|5793688|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657903|NCT01597245|5793689|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657904|NCT01597245|5793690|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657905|NCT01597245|5793691|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1657906|NCT01597245|5793692|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
1657907|NCT01597245|5793693|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657908|NCT01597245|5793694|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657909|NCT01597245|5793695|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657910|NCT01597245|5793696|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657911|NCT01597245|5793697|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
1657912|NCT01597245|5793685|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657913|NCT01597245|5793686|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657914|NCT01597245|5793687|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657915|NCT01597245|5793688|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657916|NCT01597245|5793689|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657917|NCT01597245|5793690|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657918|NCT01597245|5793691|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657919|NCT01597245|5793692|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657920|NCT01597245|5793693|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657921|NCT01597245|5793694|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
1657922|NCT01597245|5793695|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
1657923|NCT01597245|5793696|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1657924|NCT01597245|5793697|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
1657925|NCT01597245|5793685|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657926|NCT01597245|5793686|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657927|NCT01597245|5793687|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657928|NCT01597245|5793688|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657929|NCT01597245|5793689|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657930|NCT01597245|5793690|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657931|NCT01597245|5793691|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657932|NCT01597245|5793692|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657933|NCT01597245|5793693|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657934|NCT01597245|5793694|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
1657935|NCT01597245|5793695|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657936|NCT01597245|5793696|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
1657937|NCT01597245|5793697|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
1657938|NCT01597245|5793685|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657939|NCT01597245|5793686|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657940|NCT01597245|5793687|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657941|NCT01597245|5793688|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657942|NCT01597245|5793689|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657943|NCT01597245|5793690|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657944|NCT01597245|5793691|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657945|NCT01597245|5793692|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657946|NCT01597245|5793693|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657947|NCT01597245|5793694|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
1657948|NCT01597245|5793695|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
1657949|NCT01597245|5793696|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
1657950|NCT01597245|5793697|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
1657951|NCT01597245|5793685|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657952|NCT01597245|5793686|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657953|NCT01597245|5793687|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657954|NCT01597245|5793688|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657955|NCT01597245|5793689|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657956|NCT01597245|5793690|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657957|NCT01597245|5793691|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657958|NCT01597245|5793692|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657959|NCT01597245|5793693|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
1657960|NCT01597245|5793694|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1657961|NCT01597245|5793695|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
1657962|NCT01597245|5793696|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
1657963|NCT01597245|5793697|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
1657964|NCT01597245|5793685|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657965|NCT01597245|5793686|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657966|NCT01597245|5793687|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657967|NCT01597245|5793688|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657968|NCT01597245|5793689|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657969|NCT01597245|5793690|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657970|NCT01597245|5793691|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657971|NCT01597245|5793692|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657972|NCT01597245|5793693|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
1657973|NCT01597245|5793694|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1657974|NCT01597245|5793695|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
1657975|NCT01597245|5793696|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
1657976|NCT01597245|5793697|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
1657977|NCT01597245|5793685|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657978|NCT01597245|5793686|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657979|NCT01597245|5793687|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657980|NCT01597245|5793688|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657981|NCT01597245|5793689|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657982|NCT01597245|5793690|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657983|NCT01597245|5793691|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657984|NCT01597245|5793692|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657985|NCT01597245|5793693|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
1657986|NCT01597245|5793694|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
1657987|NCT01597245|5793695|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
1657988|NCT01597245|5793696|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
1657989|NCT01597245|5793697|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
1657990|NCT01597193|5793787|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1657991|NCT01597193|5793788|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
1657992|NCT01597193|5793789|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1657993|NCT01597193|5793790|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
1657994|NCT01597193|5793791|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1657995|NCT01597193|5793792|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1657996|NCT01597193|5793793|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
1657997|NCT01597193|5793787|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
1657998|NCT01597193|5793788|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
1657999|NCT01597193|5793789|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
1658000|NCT01597193|5793790|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
1658001|NCT01597193|5793791|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
1658002|NCT01597193|5793792|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
1658003|NCT01597193|5793793|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
1658004|NCT01597193|5793787|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
1658005|NCT01597193|5793788|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
1658006|NCT01597193|5793789|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
1658007|NCT01597193|5793790|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
1658008|NCT01597193|5793791|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
1658009|NCT01597193|5793792|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
1658010|NCT01597193|5793793|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
1658011|NCT01597193|5793787|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1658012|NCT01597193|5793788|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
1658013|NCT01597193|5793789|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
1658014|NCT01597193|5793790|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
1658015|NCT01597193|5793791|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1658016|NCT01597193|5793792|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1658017|NCT01597193|5793793|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
1658018|NCT01597193|5793787|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1658019|NCT01597193|5793788|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1658020|NCT01597193|5793789|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1658021|NCT01597193|5793790|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1658022|NCT01597193|5793791|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
1658023|NCT01597193|5793792|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
1658024|NCT01597193|5793793|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
1658025|NCT01597050|5793912|P2|Overall Study|Withdrawal by Subject|0
1658026|NCT01597050|5793913|P1|Overall Study|Withdrawal by Subject|1
1658027|NCT01596972|5793921|P2|Overall Study|Withdrawal by Subject|1
1658028|NCT01596972|5793922|P1|Overall Study|Withdrawal by Subject|0
1658029|NCT01596972|5793921|P2|Overall Study|Lost to Follow-up|4
1658030|NCT01596972|5793922|P1|Overall Study|Lost to Follow-up|0
1658031|NCT01596972|5793921|P2|Overall Study|Physician Decision|9
1658032|NCT01596972|5793922|P1|Overall Study|Physician Decision|1
1658033|NCT01596582|5793945|P2|Overall Study|Missing all outcome data|1
1658034|NCT01596582|5793946|P1|Overall Study|Missing all outcome data|1
1658035|NCT01596582|5793945|P2|Overall Study|Deemed ineligible after study visit|6
1658036|NCT01596582|5793946|P1|Overall Study|Deemed ineligible after study visit|3
1658037|NCT01596504|5793973|P3|Overall Study|Withdrawal by Subject|0
1658038|NCT01596504|5793974|P2|Overall Study|Withdrawal by Subject|0
1658039|NCT01596504|5793975|P1|Overall Study|Withdrawal by Subject|1
1658040|NCT01596504|5793973|P3|Overall Study|Adverse Event|1
1658041|NCT01596504|5793974|P2|Overall Study|Adverse Event|2
1658042|NCT01596504|5793975|P1|Overall Study|Adverse Event|1
1658043|NCT01596504|5793973|P3|Overall Study|Participant's Private Reason|0
1658044|NCT01596504|5793974|P2|Overall Study|Participant's Private Reason|1
1658045|NCT01596504|5793975|P1|Overall Study|Participant's Private Reason|0
1658046|NCT01596335|5794033|P2|Overall Study|exacerbation of primary disease|9
1658047|NCT01596335|5794034|P1|Overall Study|exacerbation of primary disease|5
1658048|NCT01596127|5794070|P1|Overall Study|Patient Ineligible|1
1658049|NCT01596062|5794082|P3|Overall Study|Lack of Efficacy|1
1658050|NCT01596062|5794083|P2|Overall Study|Lack of Efficacy|0
1658051|NCT01596062|5794084|P1|Overall Study|Lack of Efficacy|0
1658052|NCT01596062|5794082|P3|Overall Study|Adverse Event|2
1658053|NCT01596062|5794083|P2|Overall Study|Adverse Event|0
1658054|NCT01596062|5794084|P1|Overall Study|Adverse Event|1
1658055|NCT01595646|5794148|P3|Overall Study|Withdrawal by Subject|0
1658056|NCT01595646|5794149|P2|Overall Study|Withdrawal by Subject|0
1658057|NCT01595646|5794150|P1|Overall Study|Withdrawal by Subject|1
1658058|NCT01595438|5794205|P2|Overall Study|Other Eligibility criteria|9
1658059|NCT01595438|5794206|P1|Overall Study|Other Eligibility criteria|11
1658060|NCT01595438|5794205|P2|Overall Study|Withdrawal by Subject|12
1658061|NCT01595438|5794206|P1|Overall Study|Withdrawal by Subject|12
1658062|NCT01595438|5794205|P2|Overall Study|Lost to Follow-up|20
1658063|NCT01595438|5794206|P1|Overall Study|Lost to Follow-up|20
1658064|NCT01595009|5794374|P4|Extension|Adverse Event|1
1658065|NCT01595009|5794375|P3|Extension|Adverse Event|0
1658066|NCT01595009|5794376|P2|Extension|Adverse Event|0
1658067|NCT01595009|5794377|P1|Extension|Adverse Event|0
1658068|NCT01595009|5794374|P4|Extension|Disease progression|7
1658069|NCT01595009|5794375|P3|Extension|Disease progression|4
1658070|NCT01595009|5794376|P2|Extension|Disease progression|0
1658071|NCT01595009|5794377|P1|Extension|Disease progression|0
1658072|NCT01595009|5794374|P4|Extension|Patients completed per protocol|2
1658073|NCT01595009|5794375|P3|Extension|Patients completed per protocol|0
1658074|NCT01595009|5794376|P2|Extension|Patients completed per protocol|0
1658075|NCT01595009|5794377|P1|Extension|Patients completed per protocol|0
1658076|NCT01595009|5794374|P4|Extension|Administrative problems|1
1658077|NCT01595009|5794375|P3|Extension|Administrative problems|0
1658078|NCT01595009|5794376|P2|Extension|Administrative problems|0
1658079|NCT01595009|5794377|P1|Extension|Administrative problems|0
1658080|NCT01595009|5794374|P4|Core|Administrative problems|0
1658081|NCT01595009|5794375|P3|Core|Administrative problems|0
1658082|NCT01595009|5794376|P2|Core|Administrative problems|1
1658083|NCT01595009|5794377|P1|Core|Administrative problems|0
1658084|NCT01595009|5794374|P4|Core|Protocol deviation|0
1658085|NCT01595009|5794375|P3|Core|Protocol deviation|0
1658086|NCT01595009|5794376|P2|Core|Protocol deviation|1
1658087|NCT01595009|5794377|P1|Core|Protocol deviation|0
1658088|NCT01595009|5794374|P4|Core|Lost to Follow-up|0
1658089|NCT01595009|5794375|P3|Core|Lost to Follow-up|0
1658090|NCT01595009|5794376|P2|Core|Lost to Follow-up|2
1658091|NCT01595009|5794377|P1|Core|Lost to Follow-up|1
1658092|NCT01595009|5794374|P4|Core|Death|0
1658093|NCT01595009|5794375|P3|Core|Death|0
1658094|NCT01595009|5794376|P2|Core|Death|6
1658095|NCT01595009|5794377|P1|Core|Death|3
1658096|NCT01595009|5794374|P4|Core|Withdrawal by Subject|0
1658097|NCT01595009|5794375|P3|Core|Withdrawal by Subject|0
1658098|NCT01595009|5794376|P2|Core|Withdrawal by Subject|17
1658099|NCT01595009|5794377|P1|Core|Withdrawal by Subject|4
1658100|NCT01595009|5794374|P4|Core|Disease progression|0
1658101|NCT01595009|5794375|P3|Core|Disease progression|0
1658102|NCT01595009|5794376|P2|Core|Disease progression|26
1658103|NCT01595009|5794377|P1|Core|Disease progression|14
1658104|NCT01595009|5794374|P4|Core|Adverse Event|0
1658105|NCT01595009|5794375|P3|Core|Adverse Event|0
1658106|NCT01595009|5794376|P2|Core|Adverse Event|23
1658107|NCT01595009|5794377|P1|Core|Adverse Event|19
1658108|NCT01595009|5794374|P4|Core|Patients completed per protocol|0
1658109|NCT01595009|5794375|P3|Core|Patients completed per protocol|0
1658110|NCT01595009|5794376|P2|Core|Patients completed per protocol|44
1658111|NCT01595009|5794377|P1|Core|Patients completed per protocol|85
1658112|NCT01594970|5794412|P3|Overall Study|Lost to Follow-up|37
1658113|NCT01594970|5794413|P2|Overall Study|Lost to Follow-up|54
1658114|NCT01594970|5794414|P1|Overall Study|Lost to Follow-up|54
1658115|NCT01594970|5794412|P3|Overall Study|Adverse Event|23
1658116|NCT01594970|5794413|P2|Overall Study|Adverse Event|23
1658117|NCT01594970|5794414|P1|Overall Study|Adverse Event|17
1658118|NCT01594970|5794412|P3|Overall Study|Non-Adverse Event Related|6
1658119|NCT01594970|5794413|P2|Overall Study|Non-Adverse Event Related|5
1658120|NCT01594970|5794414|P1|Overall Study|Non-Adverse Event Related|4
1658121|NCT01594853|5794433|P2|Overall Study|noncompliance with exercise|1
1658122|NCT01594853|5794434|P1|Overall Study|noncompliance with exercise|0
1658123|NCT01594853|5794433|P2|Overall Study|Lost to Follow-up|1
1658124|NCT01594853|5794434|P1|Overall Study|Lost to Follow-up|1
1658125|NCT01594853|5794433|P2|Overall Study|Withdrawal by Subject|1
1658126|NCT01594853|5794434|P1|Overall Study|Withdrawal by Subject|1
1658127|NCT01594827|5794442|P2|Overall Study|Physician Decision|0
1658128|NCT01594827|5794443|P1|Overall Study|Physician Decision|3
1658129|NCT01594827|5794442|P2|Overall Study|Adverse Event|0
1658130|NCT01594827|5794443|P1|Overall Study|Adverse Event|1
1658131|NCT01594762|5794467|P2|Overall Study|Lost to Follow-up|10
1658132|NCT01594762|5794468|P1|Overall Study|Lost to Follow-up|10
1658133|NCT01594762|5794467|P2|Overall Study|Withdrawal by Subject|0
1658134|NCT01594762|5794468|P1|Overall Study|Withdrawal by Subject|1
1658135|NCT01594749|5794480|P2|Overall Study|Lost Source Documentation|0
1658136|NCT01594749|5794481|P1|Overall Study|Lost Source Documentation|1
1658137|NCT01594749|5794480|P2|Overall Study|Not Treated|10
1658138|NCT01594749|5794481|P1|Overall Study|Not Treated|4
1658139|NCT01594749|5794480|P2|Overall Study|Death|3
1658140|NCT01594749|5794481|P1|Overall Study|Death|9
1658141|NCT01594749|5794480|P2|Overall Study|Lost to Follow-up|0
1658142|NCT01594749|5794481|P1|Overall Study|Lost to Follow-up|1
1658143|NCT01594749|5794480|P2|Overall Study|Non-compliance with Protocol|1
1658144|NCT01594749|5794481|P1|Overall Study|Non-compliance with Protocol|0
1658145|NCT01594749|5794480|P2|Overall Study|Physician Decision|1
1658146|NCT01594749|5794481|P1|Overall Study|Physician Decision|1
1658147|NCT01594749|5794480|P2|Overall Study|Protocol Violation|0
1658148|NCT01594749|5794481|P1|Overall Study|Protocol Violation|2
1658149|NCT01594749|5794480|P2|Overall Study|Withdrawal by Subject|2
1658150|NCT01594749|5794481|P1|Overall Study|Withdrawal by Subject|2
1658151|NCT01594749|5794480|P2|Overall Study|Adverse Event|1
1658152|NCT01594749|5794481|P1|Overall Study|Adverse Event|2
1658153|NCT01594476|5794619|P2|Overall Study|Protocol Violation|3
1658154|NCT01594476|5794620|P1|Overall Study|Protocol Violation|1
1658155|NCT01594411|5794642|P1|Overall Study|Lost to Follow-up|2
1658156|NCT01594281|5794694|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
1658157|NCT01594281|5794695|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
1658158|NCT01594281|5794696|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
1658159|NCT01594281|5794694|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
1658160|NCT01594281|5794695|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
1658161|NCT01594281|5794696|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
1658162|NCT01594281|5794694|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
1658163|NCT01594281|5794695|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
1658164|NCT01594281|5794696|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
1658165|NCT01594281|5794694|P3|Interventional Core Phase|Adverse Event|4
1658166|NCT01594281|5794695|P2|Interventional Core Phase|Adverse Event|4
1658167|NCT01594281|5794696|P1|Interventional Core Phase|Adverse Event|4
1658168|NCT01594281|5794694|P3|Interventional Core Phase|Lost to Follow-up|1
1658169|NCT01594281|5794695|P2|Interventional Core Phase|Lost to Follow-up|4
1658170|NCT01594281|5794696|P1|Interventional Core Phase|Lost to Follow-up|1
1658171|NCT01594281|5794694|P3|Interventional Core Phase|Death|2
1658172|NCT01594281|5794695|P2|Interventional Core Phase|Death|1
1658173|NCT01594281|5794696|P1|Interventional Core Phase|Death|1
1658174|NCT01594281|5794694|P3|Interventional Core Phase|Subject Withdrew Consent|1
1658175|NCT01594281|5794695|P2|Interventional Core Phase|Subject Withdrew Consent|1
1658176|NCT01594281|5794696|P1|Interventional Core Phase|Subject Withdrew Consent|0
1658177|NCT01594281|5794694|P3|Interventional Core Phase|Protocol Deviation|0
1658178|NCT01594281|5794695|P2|Interventional Core Phase|Protocol Deviation|0
1658179|NCT01594281|5794696|P1|Interventional Core Phase|Protocol Deviation|1
1658180|NCT01594125|5794736|P5|Overall Study|Progressive Disease|7
1658181|NCT01594125|5794737|P4|Overall Study|Progressive Disease|3
1658182|NCT01594125|5794738|P3|Overall Study|Progressive Disease|3
1658183|NCT01594125|5794739|P2|Overall Study|Progressive Disease|12
1658184|NCT01594125|5794740|P1|Overall Study|Progressive Disease|3
1658185|NCT01594125|5794736|P5|Overall Study|Withdrawal by Subject|0
1658186|NCT01594125|5794737|P4|Overall Study|Withdrawal by Subject|1
1658187|NCT01594125|5794738|P3|Overall Study|Withdrawal by Subject|0
1658188|NCT01594125|5794739|P2|Overall Study|Withdrawal by Subject|0
1658189|NCT01594125|5794740|P1|Overall Study|Withdrawal by Subject|1
1658190|NCT01593787|5794800|P3|Overall Study|Adverse Event|0
1658191|NCT01593787|5794801|P2|Overall Study|Adverse Event|0
1658192|NCT01593787|5794802|P1|Overall Study|Adverse Event|1
1658193|NCT01593254|5794880|P2|Follow-Up Period|Study Drug Side Effects|1
1658194|NCT01593254|5794881|P1|Follow-Up Period|Study Drug Side Effects|0
1658195|NCT01593254|5794880|P2|Follow-Up Period|Disease Progression|1
1658196|NCT01593254|5794881|P1|Follow-Up Period|Disease Progression|0
1658197|NCT01593254|5794880|P2|Follow-Up Period|Fundus Hemorrhage|1
1658198|NCT01593254|5794881|P1|Follow-Up Period|Fundus Hemorrhage|0
1658199|NCT01593254|5794880|P2|Follow-Up Period|Patient refused to return|1
1658200|NCT01593254|5794881|P1|Follow-Up Period|Patient refused to return|0
1658201|NCT01593254|5794880|P2|Follow-Up Period|Study Drug Toxicity|1
1658202|NCT01593254|5794881|P1|Follow-Up Period|Study Drug Toxicity|0
1658203|NCT01593254|5794880|P2|Follow-Up Period|Pregnancy|1
1658204|NCT01593254|5794881|P1|Follow-Up Period|Pregnancy|0
1658205|NCT01593254|5794880|P2|Follow-Up Period|Subject request to Discontinue|1
1658206|NCT01593254|5794881|P1|Follow-Up Period|Subject request to Discontinue|0
1658207|NCT01593254|5794880|P2|Follow-Up Period|Death|2
1658208|NCT01593254|5794881|P1|Follow-Up Period|Death|2
1658209|NCT01593254|5794880|P2|Follow-Up Period|Non-Compliance|0
1658210|NCT01593254|5794881|P1|Follow-Up Period|Non-Compliance|1
1658211|NCT01593254|5794880|P2|Follow-Up Period|Withdrawal by Subject|2
1658212|NCT01593254|5794881|P1|Follow-Up Period|Withdrawal by Subject|0
1658213|NCT01593254|5794880|P2|Treatment Period|Investigator Decision|1
1658214|NCT01593254|5794881|P1|Treatment Period|Investigator Decision|2
1658215|NCT01593254|5794880|P2|Treatment Period|T315I MUTATION|1
1658216|NCT01593254|5794881|P1|Treatment Period|T315I MUTATION|0
1658217|NCT01593254|5794880|P2|Treatment Period|No Response|0
1658218|NCT01593254|5794881|P1|Treatment Period|No Response|1
1658219|NCT01593254|5794880|P2|Treatment Period|Patient Refused to Return|1
1658220|NCT01593254|5794881|P1|Treatment Period|Patient Refused to Return|0
1658221|NCT01593254|5794880|P2|Treatment Period|Did Not Achieve RCC|1
1658222|NCT01593254|5794881|P1|Treatment Period|Did Not Achieve RCC|0
1658223|NCT01593254|5794880|P2|Treatment Period|Disease Progression|6
1658224|NCT01593254|5794881|P1|Treatment Period|Disease Progression|1
1658225|NCT01593254|5794880|P2|Treatment Period|Study Drug Toxicity|9
1658226|NCT01593254|5794881|P1|Treatment Period|Study Drug Toxicity|3
1658227|NCT01593254|5794880|P2|Treatment Period|Death|1
1658228|NCT01593254|5794881|P1|Treatment Period|Death|2
1658229|NCT01593254|5794880|P2|Treatment Period|AE unrelated to Study Drug|1
1658230|NCT01593254|5794881|P1|Treatment Period|AE unrelated to Study Drug|0
1658231|NCT01593254|5794880|P2|Treatment Period|Subject Request to Discontinue|1
1658232|NCT01593254|5794881|P1|Treatment Period|Subject Request to Discontinue|1
1658233|NCT01593254|5794880|P2|Treatment Period|Subject withdrew consent|5
1658234|NCT01593254|5794881|P1|Treatment Period|Subject withdrew consent|0
1658235|NCT01593254|5794880|P2|Treatment Period|Maximum clinical benefit|0
1658236|NCT01593254|5794881|P1|Treatment Period|Maximum clinical benefit|1
1658237|NCT01593254|5794880|P2|Treatment Period|Poor/Non-Compliance|1
1658238|NCT01593254|5794881|P1|Treatment Period|Poor/Non-Compliance|2
1658239|NCT01593254|5794880|P2|Treatment Period|Pregnancy|1
1658240|NCT01593254|5794881|P1|Treatment Period|Pregnancy|0
1658241|NCT01593254|5794880|P2|Treatment Period|Treatment Failure|2
1658242|NCT01593254|5794881|P1|Treatment Period|Treatment Failure|1
1658243|NCT01592864|5794899|P2|Overall Study|Withdrawal by Subject|1
1658244|NCT01592864|5794900|P1|Overall Study|Withdrawal by Subject|0
1658245|NCT01592786|5794961|P1|Overall Study|Other|3
1658246|NCT01592786|5794961|P1|Overall Study|Lost to Follow-up|19
1658247|NCT01592786|5794961|P1|Overall Study|Withdrawal by Subject|23
1658248|NCT01592786|5794961|P1|Overall Study|Protocol Violation|14
1658249|NCT01592786|5794961|P1|Overall Study|Lack of Efficacy|19
1658250|NCT01592786|5794961|P1|Overall Study|Adverse Event|60
1658251|NCT01592773|5794965|P1|Overall Study|Other Reason|1
1658252|NCT01592773|5794965|P1|Overall Study|Inclusion/exclusion not meet|1
1658253|NCT01592773|5794965|P1|Overall Study|Protocol Violation|2
1658254|NCT01592773|5794965|P1|Overall Study|Lack of Efficacy|9
1658255|NCT01592773|5794965|P1|Overall Study|Adverse Event|17
1658256|NCT01592773|5794965|P1|Overall Study|Lost to Follow-up|19
1658257|NCT01592773|5794965|P1|Overall Study|Withdrawal by Subject|35
1658258|NCT01592773|5794965|P1|Overall Study|Study Terminated by Sponsor|582
1658259|NCT01592760|5794972|P3|24-hour Follow-Up|Lost to Follow-up|2
1658260|NCT01592760|5794973|P2|24-hour Follow-Up|Lost to Follow-up|3
1658261|NCT01592760|5794974|P1|24-hour Follow-Up|Lost to Follow-up|4
1658262|NCT01592747|5795018|P3|Overall Study|Other Reasons|0
1658263|NCT01592747|5795019|P2|Overall Study|Other Reasons|1
1658264|NCT01592747|5795020|P1|Overall Study|Other Reasons|1
1658265|NCT01592747|5795018|P3|Overall Study|Lost to Follow-up|1
1658266|NCT01592747|5795019|P2|Overall Study|Lost to Follow-up|0
1658267|NCT01592747|5795020|P1|Overall Study|Lost to Follow-up|1
1658268|NCT01592747|5795018|P3|Overall Study|Withdrawal by Subject|2
1658269|NCT01592747|5795019|P2|Overall Study|Withdrawal by Subject|0
1658270|NCT01592747|5795020|P1|Overall Study|Withdrawal by Subject|2
1658271|NCT01592747|5795018|P3|Overall Study|Lack of Efficacy|0
1658272|NCT01592747|5795019|P2|Overall Study|Lack of Efficacy|1
1658273|NCT01592747|5795020|P1|Overall Study|Lack of Efficacy|0
1658274|NCT01592747|5795018|P3|Overall Study|Protocol Violation|4
1658275|NCT01592747|5795019|P2|Overall Study|Protocol Violation|0
1658276|NCT01592747|5795020|P1|Overall Study|Protocol Violation|4
1658277|NCT01592747|5795018|P3|Overall Study|Adverse Event|0
1658278|NCT01592747|5795019|P2|Overall Study|Adverse Event|0
1658279|NCT01592747|5795020|P1|Overall Study|Adverse Event|1
1658280|NCT01592747|5795018|P3|Overall Study|Inclusion/Exclusion criteria not met|1
1658281|NCT01592747|5795019|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1658282|NCT01592747|5795020|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1658283|NCT01592747|5795018|P3|Overall Study|Loss of Therapeutic Response|100
1658284|NCT01592747|5795019|P2|Overall Study|Loss of Therapeutic Response|108
1658285|NCT01592747|5795020|P1|Overall Study|Loss of Therapeutic Response|107
1658286|NCT01592708|5795063|P2|Overall Study|Protocol Violation|0
1658287|NCT01592708|5795064|P1|Overall Study|Protocol Violation|3
1658288|NCT01592695|5795080|P2|Overall Study|Lost to Follow-up|4
1658289|NCT01592695|5795081|P1|Overall Study|Lost to Follow-up|8
1658290|NCT01592409|5795136|P2|Overall Study|Withdrawal by Subject|1
1658291|NCT01592409|5795137|P1|Overall Study|Withdrawal by Subject|0
1658292|NCT01592383|5795161|P1|Overall Study|Adverse Event|1
1658293|NCT01592344|5795172|P2|Overall Study|not available at primary outcome visit|4
1658294|NCT01592344|5795173|P1|Overall Study|not available at primary outcome visit|2
1658295|NCT01592344|5795172|P2|Overall Study|Lack of Efficacy|0
1658296|NCT01592344|5795173|P1|Overall Study|Lack of Efficacy|1
1658297|NCT01592344|5795172|P2|Overall Study|Adverse Event|1
1658298|NCT01592344|5795173|P1|Overall Study|Adverse Event|1
1658299|NCT01592292|5795187|P4|Overall Study|Other|1
1658300|NCT01592292|5795188|P3|Overall Study|Other|2
1658301|NCT01592292|5795189|P2|Overall Study|Other|1
1658302|NCT01592292|5795190|P1|Overall Study|Other|1
1658303|NCT01592292|5795187|P4|Overall Study|Withdrew consent|0
1658304|NCT01592292|5795188|P3|Overall Study|Withdrew consent|0
1658305|NCT01592292|5795189|P2|Overall Study|Withdrew consent|1
1658306|NCT01592292|5795190|P1|Overall Study|Withdrew consent|2
1658307|NCT01592292|5795187|P4|Overall Study|Follow-up loss|0
1658308|NCT01592292|5795188|P3|Overall Study|Follow-up loss|1
1658309|NCT01592292|5795189|P2|Overall Study|Follow-up loss|3
1658310|NCT01592292|5795190|P1|Overall Study|Follow-up loss|3
1658311|NCT01592240|5795229|P7|Overall Study|Did Not Meet Entrance Criteria|0
1658312|NCT01592240|5795230|P6|Overall Study|Did Not Meet Entrance Criteria|0
1658313|NCT01592240|5795231|P5|Overall Study|Did Not Meet Entrance Criteria|0
1658314|NCT01592240|5795232|P4|Overall Study|Did Not Meet Entrance Criteria|0
1658315|NCT01592240|5795233|P3|Overall Study|Did Not Meet Entrance Criteria|1
1658316|NCT01592240|5795234|P2|Overall Study|Did Not Meet Entrance Criteria|0
1658317|NCT01592240|5795235|P1|Overall Study|Did Not Meet Entrance Criteria|1
1658318|NCT01592240|5795229|P7|Overall Study|Other|1
1658319|NCT01592240|5795230|P6|Overall Study|Other|0
1658320|NCT01592240|5795231|P5|Overall Study|Other|0
1658321|NCT01592240|5795232|P4|Overall Study|Other|1
1658322|NCT01592240|5795233|P3|Overall Study|Other|1
1658323|NCT01592240|5795234|P2|Overall Study|Other|3
1658324|NCT01592240|5795235|P1|Overall Study|Other|0
1658325|NCT01592240|5795229|P7|Overall Study|Withdrawal by Subject|2
1658326|NCT01592240|5795230|P6|Overall Study|Withdrawal by Subject|0
1658327|NCT01592240|5795231|P5|Overall Study|Withdrawal by Subject|3
1658328|NCT01592240|5795232|P4|Overall Study|Withdrawal by Subject|1
1658329|NCT01592240|5795233|P3|Overall Study|Withdrawal by Subject|4
1658330|NCT01592240|5795234|P2|Overall Study|Withdrawal by Subject|4
1658331|NCT01592240|5795235|P1|Overall Study|Withdrawal by Subject|0
1658332|NCT01592240|5795229|P7|Overall Study|Protocol Violation|0
1658333|NCT01592240|5795230|P6|Overall Study|Protocol Violation|1
1658334|NCT01592240|5795231|P5|Overall Study|Protocol Violation|0
1658335|NCT01592240|5795232|P4|Overall Study|Protocol Violation|0
1658336|NCT01592240|5795233|P3|Overall Study|Protocol Violation|0
1658337|NCT01592240|5795234|P2|Overall Study|Protocol Violation|0
1658338|NCT01592240|5795235|P1|Overall Study|Protocol Violation|0
1658339|NCT01592240|5795229|P7|Overall Study|Lost to Follow-up|0
1658340|NCT01592240|5795230|P6|Overall Study|Lost to Follow-up|2
1658341|NCT01592240|5795231|P5|Overall Study|Lost to Follow-up|3
1658342|NCT01592240|5795232|P4|Overall Study|Lost to Follow-up|0
1658343|NCT01592240|5795233|P3|Overall Study|Lost to Follow-up|1
1658344|NCT01592240|5795234|P2|Overall Study|Lost to Follow-up|3
1658345|NCT01592240|5795235|P1|Overall Study|Lost to Follow-up|1
1658346|NCT01592240|5795229|P7|Overall Study|Death|0
1658347|NCT01592240|5795230|P6|Overall Study|Death|0
1658348|NCT01592240|5795231|P5|Overall Study|Death|0
1658349|NCT01592240|5795232|P4|Overall Study|Death|0
1658350|NCT01592240|5795233|P3|Overall Study|Death|0
1658351|NCT01592240|5795234|P2|Overall Study|Death|1
1658352|NCT01592240|5795235|P1|Overall Study|Death|0
1658353|NCT01592240|5795229|P7|Overall Study|Adverse Event|0
1658354|NCT01592240|5795230|P6|Overall Study|Adverse Event|0
1658355|NCT01592240|5795231|P5|Overall Study|Adverse Event|1
1658356|NCT01592240|5795232|P4|Overall Study|Adverse Event|1
1658357|NCT01592240|5795233|P3|Overall Study|Adverse Event|0
1658358|NCT01592240|5795234|P2|Overall Study|Adverse Event|0
1658359|NCT01592240|5795235|P1|Overall Study|Adverse Event|1
1658360|NCT01592045|5795428|P2|Overall Study|Moved out of country|0
1658361|NCT01592045|5795429|P1|Overall Study|Moved out of country|2
1658362|NCT01592045|5795428|P2|Overall Study|Withdrawal by Subject|0
1658363|NCT01592045|5795429|P1|Overall Study|Withdrawal by Subject|1
1658364|NCT01592045|5795428|P2|Overall Study|Adverse Event|1
1658365|NCT01592045|5795429|P1|Overall Study|Adverse Event|1
1658366|NCT01592045|5795428|P2|Overall Study|Disease Progression|1
1658367|NCT01592045|5795429|P1|Overall Study|Disease Progression|1
1658368|NCT01591863|5795447|P1|Overall Study|Lack of Efficacy|1
1658369|NCT01591863|5795447|P1|Overall Study|recurrence|9
1658370|NCT01591863|5795447|P1|Overall Study|Withdrawal by Subject|1
1658371|NCT01591863|5795447|P1|Overall Study|Adverse Event|3
1658372|NCT01591681|5795504|P1|Overall Study|Failed to use system during run-in|1
1658373|NCT01591681|5795504|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
1658374|NCT01591616|5795530|P1|Overall Study|Withdrawal by Subject|1
1658375|NCT01591499|5795671|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1658376|NCT01591499|5795672|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
1658377|NCT01591499|5795673|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
1658378|NCT01591499|5795674|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
1658379|NCT01591499|5795671|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1658380|NCT01591499|5795672|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1658381|NCT01591499|5795673|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
1658382|NCT01591499|5795674|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
1658383|NCT01591499|5795671|P4|Baseline Visit|Withdrawal by Subject|2
1658384|NCT01591499|5795672|P3|Baseline Visit|Withdrawal by Subject|0
1658385|NCT01591499|5795673|P2|Baseline Visit|Withdrawal by Subject|2
1658386|NCT01591499|5795674|P1|Baseline Visit|Withdrawal by Subject|0
1658387|NCT01591460|5795740|P1|Overall Study|Protocol Violation|1
1658388|NCT01591460|5795740|P1|Overall Study|Withdrawal by Subject|1
1658389|NCT01591460|5795740|P1|Overall Study|Participant Refusal|3
1658390|NCT01591460|5795740|P1|Overall Study|Noncompliance|1
1658391|NCT01591460|5795740|P1|Overall Study|Lost to Follow-up|1
1658392|NCT01591460|5795740|P1|Overall Study|Treatment Discontinued by Error|1
1658393|NCT01591460|5795740|P1|Overall Study|Rebound or Breakthrough|3
1658394|NCT01591460|5795740|P1|Overall Study|Futility Rule (Week 24)|3
1658395|NCT01591460|5795740|P1|Overall Study|Futility Rule (Week 12)|7
1658396|NCT01591460|5795740|P1|Overall Study|Adverse Event or Intercurrent Illness|5
1658397|NCT01591382|5795831|P2|Overall Study|Participant Opted for Morphine PCA|1
1658398|NCT01591382|5795832|P1|Overall Study|Participant Opted for Morphine PCA|1
1658399|NCT01591382|5795831|P2|Overall Study|Discharged Prior to Study Completion|1
1658400|NCT01591382|5795832|P1|Overall Study|Discharged Prior to Study Completion|2
1658401|NCT01591096|5795877|P1|Overall Study|Adverse Event|1
1658402|NCT01590888|5795962|P3|Overall Study|Lost to Follow-up|0
1658403|NCT01590888|5795963|P2|Overall Study|Lost to Follow-up|0
1658404|NCT01590888|5795964|P1|Overall Study|Lost to Follow-up|1
1658405|NCT01590888|5795962|P3|Overall Study|Adverse Event|1
1658406|NCT01590888|5795963|P2|Overall Study|Adverse Event|0
1658407|NCT01590888|5795964|P1|Overall Study|Adverse Event|3
1658408|NCT01590810|5796024|P5|Overall Study|Physician Decision|0
1658409|NCT01590810|5796025|P4|Overall Study|Physician Decision|0
1658410|NCT01590810|5796026|P3|Overall Study|Physician Decision|1
1658411|NCT01590810|5796027|P2|Overall Study|Physician Decision|1
1658412|NCT01590810|5796028|P1|Overall Study|Physician Decision|0
1658413|NCT01590797|5796173|P2|Overall Study|Other Protocol Specified Criteria|4
1658414|NCT01590797|5796174|P1|Overall Study|Other Protocol Specified Criteria|2
1658415|NCT01590797|5796173|P2|Overall Study|Withdrawal by Subject|5
1658416|NCT01590797|5796174|P1|Overall Study|Withdrawal by Subject|7
1658417|NCT01590797|5796173|P2|Overall Study|Protocol Violation|1
1658418|NCT01590797|5796174|P1|Overall Study|Protocol Violation|4
1658419|NCT01590797|5796173|P2|Overall Study|Lost to Follow-up|1
1658420|NCT01590797|5796174|P1|Overall Study|Lost to Follow-up|0
1658421|NCT01590797|5796173|P2|Overall Study|Lack of Efficacy|2
1658422|NCT01590797|5796174|P1|Overall Study|Lack of Efficacy|0
1658423|NCT01590797|5796173|P2|Overall Study|Adverse Event|3
1658424|NCT01590797|5796174|P1|Overall Study|Adverse Event|4
1658425|NCT01590771|5796190|P2|Overall Study|Adverse Event|7
1658426|NCT01590771|5796191|P1|Overall Study|Adverse Event|3
1658427|NCT01590771|5796190|P2|Overall Study|Lack of Efficacy|0
1658428|NCT01590771|5796191|P1|Overall Study|Lack of Efficacy|1
1658429|NCT01590771|5796190|P2|Overall Study|Lost to Follow-up|1
1658430|NCT01590771|5796191|P1|Overall Study|Lost to Follow-up|1
1658431|NCT01590771|5796190|P2|Overall Study|Protocol Violation|2
1658432|NCT01590771|5796191|P1|Overall Study|Protocol Violation|1
1658433|NCT01590771|5796190|P2|Overall Study|Withdrawal by Subject|15
1658434|NCT01590771|5796191|P1|Overall Study|Withdrawal by Subject|8
1658435|NCT01590771|5796190|P2|Overall Study|Other Protocol Specified Criteria|14
1658436|NCT01590771|5796191|P1|Overall Study|Other Protocol Specified Criteria|5
1658437|NCT01590758|5796219|P2|Overall Study|Lost to Follow-up|2
1658438|NCT01590758|5796220|P1|Overall Study|Lost to Follow-up|4
1658439|NCT01590758|5796219|P2|Overall Study|Physician Decision|2
1658440|NCT01590758|5796220|P1|Overall Study|Physician Decision|1
1658441|NCT01590758|5796219|P2|Overall Study|Withdrawal by Subject|3
1658442|NCT01590758|5796220|P1|Overall Study|Withdrawal by Subject|0
1658443|NCT01590563|5796230|P1|Overall Study|simple uterine hyperplasia - not related|1
1658444|NCT01590433|5796244|P2|Overall Study|Adverse Event|3
1658445|NCT01590433|5796245|P1|Overall Study|Adverse Event|11
1658446|NCT01590433|5796244|P2|Overall Study|Withdrawal by Subject|11
1658447|NCT01590433|5796245|P1|Overall Study|Withdrawal by Subject|21
1658448|NCT01590433|5796244|P2|Overall Study|Lost to Follow-up|8
1658449|NCT01590433|5796245|P1|Overall Study|Lost to Follow-up|20
1658450|NCT01590212|5796267|P3|Overall Study|Lost to Follow-up|3
1658451|NCT01590212|5796268|P2|Overall Study|Lost to Follow-up|2
1658452|NCT01590212|5796269|P1|Overall Study|Lost to Follow-up|1
1658453|NCT01590212|5796267|P3|Overall Study|Withdrawal by Subject|2
1658454|NCT01590212|5796268|P2|Overall Study|Withdrawal by Subject|2
1658455|NCT01590212|5796269|P1|Overall Study|Withdrawal by Subject|2
1658456|NCT01590017|5796286|P1|Overall Study|Physician Decision|1
1658457|NCT01590017|5796286|P1|Overall Study|Lack of Efficacy|1
1658458|NCT01590017|5796286|P1|Overall Study|Withdrawal by Subject|1
1658459|NCT01590017|5796286|P1|Overall Study|Adverse Event|1
1658460|NCT01589822|5796339|P3|Overall Study|Missed 90 day visit|1
1658461|NCT01589822|5796340|P2|Overall Study|Missed 90 day visit|1
1658462|NCT01589822|5796341|P1|Overall Study|Missed 90 day visit|2
1658463|NCT01589822|5796339|P3|Overall Study|Death|0
1658464|NCT01589822|5796340|P2|Overall Study|Death|0
1658465|NCT01589822|5796341|P1|Overall Study|Death|1
1658466|NCT01589822|5796339|P3|Overall Study|Withdrawal by Subject|0
1658467|NCT01589822|5796340|P2|Overall Study|Withdrawal by Subject|2
1658468|NCT01589822|5796341|P1|Overall Study|Withdrawal by Subject|1
1658469|NCT01589770|5796360|P2|Overall Study|claustrophobic when entering cardiac MRI|1
1658470|NCT01589770|5796361|P1|Overall Study|claustrophobic when entering cardiac MRI|2
1658471|NCT01589770|5796360|P2|Overall Study|EGFR <60ml/min|4
1658472|NCT01589770|5796361|P1|Overall Study|EGFR <60ml/min|6
1658473|NCT01589653|5796371|P2|Overall Study|Unclassified|3
1658474|NCT01589653|5796372|P1|Overall Study|Unclassified|0
1658475|NCT01589653|5796371|P2|Overall Study|Withdrawal criteria|7
1658476|NCT01589653|5796372|P1|Overall Study|Withdrawal criteria|4
1658477|NCT01589653|5796371|P2|Overall Study|Protocol Violation|1
1658478|NCT01589653|5796372|P1|Overall Study|Protocol Violation|3
1658479|NCT01589497|5796422|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
1658480|NCT01589497|5796423|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
1658481|NCT01589497|5796424|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
1658482|NCT01589497|5796425|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
1658483|NCT01589497|5796422|P4|Overall Study|Death|0
1658484|NCT01589497|5796423|P3|Overall Study|Death|0
1658485|NCT01589497|5796424|P2|Overall Study|Death|0
1658486|NCT01589497|5796425|P1|Overall Study|Death|1
1658487|NCT01589497|5796422|P4|Overall Study|Withdrawal by Subject|1
1658488|NCT01589497|5796423|P3|Overall Study|Withdrawal by Subject|0
1658489|NCT01589497|5796424|P2|Overall Study|Withdrawal by Subject|1
1658490|NCT01589497|5796425|P1|Overall Study|Withdrawal by Subject|0
1658491|NCT01589445|5796531|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
1658492|NCT01589445|5796531|P1|002 (Metformin)-3 Months|Adverse Event|2
1658493|NCT01589445|5796531|P1|002 (Metformin)-3 Months|Protocol Violation|2
1658494|NCT01589445|5796531|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
1658495|NCT01589445|5796531|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
1658496|NCT01589445|5796531|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
1658497|NCT01589445|5796531|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
1658498|NCT01589445|5796531|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
1658499|NCT01589445|5796531|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
1658500|NCT01589445|5796531|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
1658501|NCT01589237|5796574|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
1658502|NCT01589237|5796575|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1658503|NCT01589237|5796576|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1658504|NCT01589237|5796577|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
1658505|NCT01589237|5796574|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
1658506|NCT01589237|5796575|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
1658507|NCT01589237|5796576|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1658508|NCT01589237|5796577|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
1658509|NCT01589237|5796574|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1658510|NCT01589237|5796575|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1658511|NCT01589237|5796576|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
1658512|NCT01589237|5796577|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
1658513|NCT01589237|5796574|P4|Part A (52 Weeks)|Subject/guardian decision|0
1658514|NCT01589237|5796575|P3|Part A (52 Weeks)|Subject/guardian decision|2
1658515|NCT01589237|5796576|P2|Part A (52 Weeks)|Subject/guardian decision|3
1658516|NCT01589237|5796577|P1|Part A (52 Weeks)|Subject/guardian decision|2
1658517|NCT01589094|5796623|P1|Overall Study|Did not receive treatment|2
1658518|NCT01588990|5796630|P1|Phase B|Other|2
1658519|NCT01588990|5796630|P1|Phase B|Physician Decision|4
1658520|NCT01588990|5796630|P1|Phase B|Withdrawal by Subject|3
1658521|NCT01588990|5796630|P1|Phase B|Still on therapy at end of study|5
1658522|NCT01588990|5796630|P1|Phase B|Adverse Event|2
1658523|NCT01588990|5796630|P1|Phase A|Still on therapy at end of study|6
1658524|NCT01588990|5796630|P1|Phase A|Adverse Event|28
1658525|NCT01588990|5796630|P1|Phase A|Death|5
1658526|NCT01588990|5796630|P1|Phase A|Lost to Follow-up|1
1658527|NCT01588990|5796630|P1|Phase A|Other|14
1658528|NCT01588990|5796630|P1|Phase A|Physician Decision|11
1658529|NCT01588990|5796630|P1|Phase A|Withdrawal by Subject|5
1658530|NCT01588951|5796658|P3|Overall Study|Ineligible in retrospect|1
1658531|NCT01588951|5796659|P2|Overall Study|Ineligible in retrospect|0
1658532|NCT01588951|5796660|P1|Overall Study|Ineligible in retrospect|0
1658533|NCT01588548|5796691|P6|Overall Study|Condition Under Investigation Worsened|3
1658534|NCT01588548|5796692|P5|Overall Study|Condition Under Investigation Worsened|3
1658535|NCT01588548|5796693|P4|Overall Study|Condition Under Investigation Worsened|4
1658536|NCT01588548|5796694|P3|Overall Study|Condition Under Investigation Worsened|4
1658537|NCT01588548|5796695|P2|Overall Study|Condition Under Investigation Worsened|6
1658538|NCT01588548|5796696|P1|Overall Study|Condition Under Investigation Worsened|3
1658539|NCT01588548|5796691|P6|Overall Study|Adverse Event|0
1658540|NCT01588548|5796692|P5|Overall Study|Adverse Event|1
1658541|NCT01588548|5796693|P4|Overall Study|Adverse Event|2
1658542|NCT01588548|5796694|P3|Overall Study|Adverse Event|1
1658543|NCT01588548|5796695|P2|Overall Study|Adverse Event|0
1658544|NCT01588548|5796696|P1|Overall Study|Adverse Event|0
1658545|NCT01588548|5796691|P6|Overall Study|Withdrawal by Subject|3
1658546|NCT01588548|5796692|P5|Overall Study|Withdrawal by Subject|2
1658547|NCT01588548|5796693|P4|Overall Study|Withdrawal by Subject|1
1658548|NCT01588548|5796694|P3|Overall Study|Withdrawal by Subject|1
1658549|NCT01588548|5796695|P2|Overall Study|Withdrawal by Subject|1
1658550|NCT01588548|5796696|P1|Overall Study|Withdrawal by Subject|0
1658551|NCT01588509|5796712|P2|Overall Study|Lost to Follow-up|0
1658552|NCT01588509|5796713|P1|Overall Study|Lost to Follow-up|1
1658553|NCT01588496|5796736|P3|Overall Study|Withdrawal by Subject|0
1658554|NCT01588496|5796737|P2|Overall Study|Withdrawal by Subject|1
1658555|NCT01588496|5796738|P1|Overall Study|Withdrawal by Subject|0
1658556|NCT01588405|5796788|P1|Overall Study|Clinical Worsening|1
1658557|NCT01588405|5796788|P1|Overall Study|Adverse Event|1
1658558|NCT01588366|5796817|P6|Overall Study|Adverse Event|2
1658559|NCT01588366|5796818|P5|Overall Study|Adverse Event|0
1658560|NCT01588366|5796819|P4|Overall Study|Adverse Event|1
1658561|NCT01588366|5796820|P3|Overall Study|Adverse Event|0
1658562|NCT01588366|5796821|P2|Overall Study|Adverse Event|1
1658563|NCT01588366|5796822|P1|Overall Study|Adverse Event|0
1658564|NCT01588353|5796850|P3|Step3|Adverse Event|2
1658565|NCT01588353|5796851|P2|Step3|Adverse Event|0
1658566|NCT01588353|5796852|P1|Step3|Adverse Event|0
1658567|NCT01588353|5796850|P3|Step2|Withdrawal by Subject|0
1658568|NCT01588353|5796851|P2|Step2|Withdrawal by Subject|1
1658569|NCT01588353|5796852|P1|Step2|Withdrawal by Subject|0
1658570|NCT01588197|5796901|P2|Overall Study|No MRI|0
1658571|NCT01588197|5796902|P1|Overall Study|No MRI|1
1658572|NCT01588197|5796901|P2|Overall Study|Lack of Efficacy|1
1658573|NCT01588197|5796902|P1|Overall Study|Lack of Efficacy|0
1658574|NCT01588106|5796939|P2|Overall Study|Withdrawal by Subject|4
1658575|NCT01588106|5796940|P1|Overall Study|Withdrawal by Subject|5
1658576|NCT01587989|5796948|P3|Randomized Study Treatment|Physician Decision|1
1658577|NCT01587989|5796949|P2|Randomized Study Treatment|Physician Decision|0
1658578|NCT01587989|5796950|P1|Randomized Study Treatment|Physician Decision|0
1658579|NCT01587989|5796948|P3|Randomized Study Treatment|Screening failure|0
1658580|NCT01587989|5796949|P2|Randomized Study Treatment|Screening failure|1
1658581|NCT01587989|5796950|P1|Randomized Study Treatment|Screening failure|0
1658582|NCT01587989|5796948|P3|Randomized Study Treatment|Withdrawal by Subject|0
1658583|NCT01587989|5796949|P2|Randomized Study Treatment|Withdrawal by Subject|1
1658584|NCT01587989|5796950|P1|Randomized Study Treatment|Withdrawal by Subject|0
1658585|NCT01587989|5796948|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
1658586|NCT01587989|5796949|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
1658587|NCT01587989|5796950|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
1658588|NCT01587989|5796948|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1658589|NCT01587989|5796949|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
1658590|NCT01587989|5796950|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
1658591|NCT01587989|5796948|P3|12-Week Open-Label Run-In Period|Physician Decision|0
1658592|NCT01587989|5796949|P2|12-Week Open-Label Run-In Period|Physician Decision|0
1658593|NCT01587989|5796950|P1|12-Week Open-Label Run-In Period|Physician Decision|7
1658594|NCT01587924|5797015|P4|Overall Study|Withdrawal by Subject|0
1658595|NCT01587924|5797016|P3|Overall Study|Withdrawal by Subject|1
1658596|NCT01587924|5797017|P2|Overall Study|Withdrawal by Subject|1
1658597|NCT01587924|5797018|P1|Overall Study|Withdrawal by Subject|0
1658598|NCT01587924|5797015|P4|Overall Study|Met Hemoglobin stopping criteria|0
1658599|NCT01587924|5797016|P3|Overall Study|Met Hemoglobin stopping criteria|1
1658600|NCT01587924|5797017|P2|Overall Study|Met Hemoglobin stopping criteria|0
1658601|NCT01587924|5797018|P1|Overall Study|Met Hemoglobin stopping criteria|2
1658602|NCT01587924|5797015|P4|Overall Study|Protocol Violation|1
1658603|NCT01587924|5797016|P3|Overall Study|Protocol Violation|2
1658604|NCT01587924|5797017|P2|Overall Study|Protocol Violation|1
1658605|NCT01587924|5797018|P1|Overall Study|Protocol Violation|2
1658606|NCT01587924|5797015|P4|Overall Study|Adverse Event|0
1658607|NCT01587924|5797016|P3|Overall Study|Adverse Event|0
1658608|NCT01587924|5797017|P2|Overall Study|Adverse Event|2
1658609|NCT01587924|5797018|P1|Overall Study|Adverse Event|0
1658610|NCT01587898|5797119|P4|Overall Study|Met haemoglobin stopping criteria|0
1658611|NCT01587898|5797120|P3|Overall Study|Met haemoglobin stopping criteria|1
1658612|NCT01587898|5797121|P2|Overall Study|Met haemoglobin stopping criteria|1
1658613|NCT01587898|5797122|P1|Overall Study|Met haemoglobin stopping criteria|1
1658614|NCT01587898|5797119|P4|Overall Study|Withdrawal by Subject|0
1658615|NCT01587898|5797120|P3|Overall Study|Withdrawal by Subject|0
1658616|NCT01587898|5797121|P2|Overall Study|Withdrawal by Subject|1
1658617|NCT01587898|5797122|P1|Overall Study|Withdrawal by Subject|2
1658618|NCT01587898|5797119|P4|Overall Study|Lost to Follow-up|1
1658619|NCT01587898|5797120|P3|Overall Study|Lost to Follow-up|0
1658620|NCT01587898|5797121|P2|Overall Study|Lost to Follow-up|0
1658621|NCT01587898|5797122|P1|Overall Study|Lost to Follow-up|0
1658622|NCT01587898|5797119|P4|Overall Study|Protocol Violation|1
1658623|NCT01587898|5797120|P3|Overall Study|Protocol Violation|1
1658624|NCT01587898|5797121|P2|Overall Study|Protocol Violation|2
1658625|NCT01587898|5797122|P1|Overall Study|Protocol Violation|0
1658626|NCT01587898|5797119|P4|Overall Study|Adverse Event|0
1658627|NCT01587898|5797120|P3|Overall Study|Adverse Event|0
1658628|NCT01587898|5797121|P2|Overall Study|Adverse Event|1
1658629|NCT01587898|5797122|P1|Overall Study|Adverse Event|1
1658630|NCT01587885|5797298|P2|Treatment Period 1|Protocol Violation|2
1658631|NCT01587885|5797299|P1|Treatment Period 1|Protocol Violation|0
1658632|NCT01587885|5797298|P2|Treatment Period 1|Failure to Return|1
1658633|NCT01587885|5797299|P1|Treatment Period 1|Failure to Return|0
1658634|NCT01587651|5797315|P3|Overall Study|Withdrawal by Subject|0
1658635|NCT01587651|5797316|P2|Overall Study|Withdrawal by Subject|1
1658636|NCT01587651|5797317|P1|Overall Study|Withdrawal by Subject|0
1658637|NCT01587651|5797315|P3|Overall Study|Protocol Violation|1
1658638|NCT01587651|5797316|P2|Overall Study|Protocol Violation|1
1658639|NCT01587651|5797317|P1|Overall Study|Protocol Violation|0
1658640|NCT01587651|5797315|P3|Overall Study|Adverse Event|0
1658641|NCT01587651|5797316|P2|Overall Study|Adverse Event|1
1658642|NCT01587651|5797317|P1|Overall Study|Adverse Event|0
1658643|NCT01587274|5797347|P3|Overall Study|Lost to Follow-up|3
1658644|NCT01587274|5797348|P2|Overall Study|Lost to Follow-up|5
1658645|NCT01587274|5797349|P1|Overall Study|Lost to Follow-up|4
1658646|NCT01587118|5797357|P1|Overall Study|nonresponse|1
1658647|NCT01587118|5797357|P1|Overall Study|Relocation|1
1658648|NCT01587118|5797357|P1|Overall Study|Lost to Follow-up|2
1658649|NCT01587118|5797357|P1|Overall Study|Adverse Event|3
1658650|NCT01587079|5797381|P1|Overall Study|Adverse Event|14
1658651|NCT01587079|5797381|P1|Overall Study|Withdrawal by Subject|7
1658652|NCT01587079|5797381|P1|Overall Study|Physician Decision|2
1658653|NCT01587079|5797381|P1|Overall Study|Lost to Follow-up|2
1658654|NCT01587079|5797381|P1|Overall Study|Protocol Violation|5
1658655|NCT01587079|5797381|P1|Overall Study|Protocol-specified criteria|9
1658656|NCT01587040|5797507|P4|Overall Study|Other than specified|1
1658657|NCT01587040|5797508|P3|Overall Study|Other than specified|11
1658658|NCT01587040|5797509|P2|Overall Study|Other than specified|1
1658659|NCT01587040|5797510|P1|Overall Study|Other than specified|5
1658660|NCT01587040|5797507|P4|Overall Study|Disease progression|3
1658661|NCT01587040|5797508|P3|Overall Study|Disease progression|15
1658662|NCT01587040|5797509|P2|Overall Study|Disease progression|1
1658663|NCT01587040|5797510|P1|Overall Study|Disease progression|12
1658664|NCT01587040|5797507|P4|Overall Study|Adverse Event|0
1658665|NCT01587040|5797508|P3|Overall Study|Adverse Event|10
1658666|NCT01587040|5797509|P2|Overall Study|Adverse Event|1
1658667|NCT01587040|5797510|P1|Overall Study|Adverse Event|0
1658668|NCT01587040|5797507|P4|Overall Study|Protocol Violation|0
1658669|NCT01587040|5797508|P3|Overall Study|Protocol Violation|1
1658670|NCT01587040|5797509|P2|Overall Study|Protocol Violation|0
1658671|NCT01587040|5797510|P1|Overall Study|Protocol Violation|0
1658672|NCT01587014|5797537|P1|Overall Study|Death|2
1658673|NCT01587001|5797544|P2|Overall Study|Insufficient samples to complete testing|1
1658674|NCT01587001|5797545|P1|Overall Study|Insufficient samples to complete testing|4
1658675|NCT01587001|5797544|P2|Overall Study|Lost to Follow-up|0
1658676|NCT01587001|5797545|P1|Overall Study|Lost to Follow-up|2
1658677|NCT01586910|5797574|P2|Overall Study|Physician withdrew Subject|24
1658678|NCT01586910|5797575|P1|Overall Study|Physician withdrew Subject|5
1658679|NCT01586910|5797574|P2|Overall Study|Withdrawal by Subject|43
1658680|NCT01586910|5797575|P1|Overall Study|Withdrawal by Subject|6
1658681|NCT01586910|5797574|P2|Overall Study|Death|4
1658682|NCT01586910|5797575|P1|Overall Study|Death|4
1658683|NCT01586819|5797649|P2|Overall Study|Withdrawal by Subject|0
1658684|NCT01586819|5797650|P1|Overall Study|Withdrawal by Subject|1
1658685|NCT01586806|5797661|P3|Overall Study|Lost to Follow-up|2
1658686|NCT01586806|5797662|P2|Overall Study|Lost to Follow-up|3
1658687|NCT01586806|5797663|P1|Overall Study|Lost to Follow-up|2
1658688|NCT01586806|5797661|P3|Overall Study|Withdrawal by Subject|0
1658689|NCT01586806|5797662|P2|Overall Study|Withdrawal by Subject|0
1658690|NCT01586806|5797663|P1|Overall Study|Withdrawal by Subject|1
1658691|NCT01586806|5797661|P3|Overall Study|Protocol Violation|0
1658692|NCT01586806|5797662|P2|Overall Study|Protocol Violation|1
1658693|NCT01586806|5797663|P1|Overall Study|Protocol Violation|0
1658694|NCT01586364|5797683|P1|Overall Study|Other-Not specified|1
1658695|NCT01586364|5797683|P1|Overall Study|Other-PI discretion, site closing|2
1658696|NCT01586364|5797683|P1|Overall Study|Other-Site closure due to PI illness|1
1658697|NCT01586364|5797683|P1|Overall Study|Other-Subject wasn't getting much relief|1
1658698|NCT01586364|5797683|P1|Overall Study|Other-Did not feel better post-treatment|1
1658699|NCT01586364|5797683|P1|Overall Study|Lack of Efficacy|1
1658700|NCT01586364|5797683|P1|Overall Study|Protocol Violation|16
1658701|NCT01586364|5797683|P1|Overall Study|Lost to Follow-up|17
1658702|NCT01586364|5797683|P1|Overall Study|Adverse Event|37
1658703|NCT01586364|5797683|P1|Overall Study|Withdrawal by Subject|40
1658704|NCT01586338|5797736|P1|Overall Study|Other|1
1658705|NCT01586338|5797736|P1|Overall Study|Withdrawal by participant|3
1658706|NCT01586338|5797736|P1|Overall Study|Lost to Follow-up|1
1658707|NCT01586338|5797736|P1|Overall Study|Adverse Event|3
1658708|NCT01586195|5797759|P1|Overall Study|Reason not specified|9
1658709|NCT01586195|5797759|P1|Overall Study|Started new anti-melanoma therapy|1
1658710|NCT01586195|5797759|P1|Overall Study|Withdrawal of Consent|5
1658711|NCT01586195|5797759|P1|Overall Study|Death|11
1658712|NCT01586156|5797773|P3|Overall Study|Pregnancy|0
1658713|NCT01586156|5797774|P2|Overall Study|Pregnancy|1
1658714|NCT01586156|5797775|P1|Overall Study|Pregnancy|0
1658715|NCT01585987|5797832|P2|Treated|Poor/Non-Compliance|1
1658716|NCT01585987|5797833|P1|Treated|Poor/Non-Compliance|0
1658717|NCT01585987|5797832|P2|Treated|Subject Request|1
1658718|NCT01585987|5797833|P1|Treated|Subject Request|0
1658719|NCT01585987|5797832|P2|Treated|Non-Specified|2
1658720|NCT01585987|5797833|P1|Treated|Non-Specified|1
1658721|NCT01585987|5797832|P2|Treated|Maximum Clinical Benefit|1
1658722|NCT01585987|5797833|P1|Treated|Maximum Clinical Benefit|0
1658723|NCT01585987|5797832|P2|Treated|Lost to Follow-up|1
1658724|NCT01585987|5797833|P1|Treated|Lost to Follow-up|0
1658725|NCT01585987|5797832|P2|Treated|Death|0
1658726|NCT01585987|5797833|P1|Treated|Death|1
1658727|NCT01585987|5797832|P2|Treated|Withdrawal by Subject|2
1658728|NCT01585987|5797833|P1|Treated|Withdrawal by Subject|1
1658729|NCT01585987|5797832|P2|Treated|Adverse Event|0
1658730|NCT01585987|5797833|P1|Treated|Adverse Event|3
1658731|NCT01585987|5797832|P2|Treated|Study Drug Toxicity|5
1658732|NCT01585987|5797833|P1|Treated|Study Drug Toxicity|9
1658733|NCT01585987|5797832|P2|Treated|Disease Progression|36
1658734|NCT01585987|5797833|P1|Treated|Disease Progression|39
1658735|NCT01585987|5797832|P2|Randomized|No longer met criteria|2
1658736|NCT01585987|5797833|P1|Randomized|No longer met criteria|0
1658737|NCT01585987|5797832|P2|Randomized|Withdrawal by Subject|4
1658738|NCT01585987|5797833|P1|Randomized|Withdrawal by Subject|0
1658739|NCT01585961|5797848|P1|Overall Study|Ablation cancelled for slow-heal wound|1
1658740|NCT01585961|5797848|P1|Overall Study|Lost to Follow-up|23
1658741|NCT01585961|5797848|P1|Overall Study|Withdrawal by Subject|1
1658742|NCT01585961|5797848|P1|Overall Study|Decision to use non-study catheter|1
1658743|NCT01585961|5797848|P1|Overall Study|Physician Decision|1
1658744|NCT01585961|5797848|P1|Overall Study|Death|6
1658745|NCT01585766|5797926|P6|Overall Study|Physician Decision|0
1658746|NCT01585766|5797927|P5|Overall Study|Physician Decision|0
1658747|NCT01585766|5797928|P4|Overall Study|Physician Decision|0
1658748|NCT01585766|5797929|P3|Overall Study|Physician Decision|1
1658749|NCT01585766|5797930|P2|Overall Study|Physician Decision|0
1658750|NCT01585766|5797931|P1|Overall Study|Physician Decision|0
1658751|NCT01585766|5797926|P6|Overall Study|Death|0
1658752|NCT01585766|5797927|P5|Overall Study|Death|0
1658753|NCT01585766|5797928|P4|Overall Study|Death|0
1658754|NCT01585766|5797929|P3|Overall Study|Death|0
1658755|NCT01585766|5797930|P2|Overall Study|Death|1
1658756|NCT01585766|5797931|P1|Overall Study|Death|0
1658757|NCT01585766|5797926|P6|Overall Study|Withdrawal by Subject|0
1658758|NCT01585766|5797927|P5|Overall Study|Withdrawal by Subject|0
1658759|NCT01585766|5797928|P4|Overall Study|Withdrawal by Subject|0
1658760|NCT01585766|5797929|P3|Overall Study|Withdrawal by Subject|1
1658761|NCT01585766|5797930|P2|Overall Study|Withdrawal by Subject|1
1658762|NCT01585766|5797931|P1|Overall Study|Withdrawal by Subject|0
1658763|NCT01585584|5798035|P1|Overall Study|Physician Decision|2
1658764|NCT01585584|5798035|P1|Overall Study|Withdrawal by Subject|1
1658765|NCT01585584|5798035|P1|Overall Study|Lack of Efficacy|1
1658766|NCT01585558|5798042|P3|Overall Study|Lack of Efficacy|1
1658767|NCT01585558|5798043|P2|Overall Study|Lack of Efficacy|0
1658768|NCT01585558|5798044|P1|Overall Study|Lack of Efficacy|0
1658769|NCT01585558|5798042|P3|Overall Study|Protocol Violation|2
1658770|NCT01585558|5798043|P2|Overall Study|Protocol Violation|3
1658771|NCT01585558|5798044|P1|Overall Study|Protocol Violation|4
1658772|NCT01585558|5798042|P3|Overall Study|Adverse Event|1
1658773|NCT01585558|5798043|P2|Overall Study|Adverse Event|4
1658774|NCT01585558|5798044|P1|Overall Study|Adverse Event|3
1658775|NCT01585558|5798042|P3|Overall Study|Lost to Follow-up|3
1658776|NCT01585558|5798043|P2|Overall Study|Lost to Follow-up|0
1658777|NCT01585558|5798044|P1|Overall Study|Lost to Follow-up|2
1658778|NCT01585558|5798042|P3|Overall Study|Withdrawal by Subject|8
1658779|NCT01585558|5798043|P2|Overall Study|Withdrawal by Subject|5
1658780|NCT01585558|5798044|P1|Overall Study|Withdrawal by Subject|4
1658781|NCT01585428|5798278|P2|Overall Study|Death during treatment|0
1658782|NCT01585428|5798279|P1|Overall Study|Death during treatment|1
1658783|NCT01585298|5798303|P1|Overall Study|Adverse Event|24
1658784|NCT01585298|5798303|P1|Overall Study|Abnormal test procedure results|1
1658785|NCT01585298|5798303|P1|Overall Study|Withdrawal by Subject|4
1658786|NCT01585298|5798303|P1|Overall Study|Lost to Follow-up|2
1658787|NCT01585298|5798303|P1|Overall Study|Administrative problems|4
1658788|NCT01585298|5798303|P1|Overall Study|Protocol deviation|1
1658789|NCT01585298|5798303|P1|Overall Study|Study completion was not documented.|1
1658790|NCT01585272|5798311|P1|Overall Study|Withdrawal by Subject|10
1658791|NCT01585272|5798311|P1|Overall Study|Protocol Violation|7
1658792|NCT01585272|5798311|P1|Overall Study|Adverse Event|22
1658793|NCT01585246|5798324|P5|Overall Study|Other|0
1658794|NCT01585246|5798325|P4|Overall Study|Other|1
1658795|NCT01585246|5798326|P3|Overall Study|Other|1
1658796|NCT01585246|5798327|P2|Overall Study|Other|1
1658797|NCT01585246|5798328|P1|Overall Study|Other|0
1658798|NCT01585246|5798324|P5|Overall Study|Withdrawal by Subject|1
1658799|NCT01585246|5798325|P4|Overall Study|Withdrawal by Subject|2
1658800|NCT01585246|5798326|P3|Overall Study|Withdrawal by Subject|1
1658801|NCT01585246|5798327|P2|Overall Study|Withdrawal by Subject|0
1658802|NCT01585246|5798328|P1|Overall Study|Withdrawal by Subject|0
1658803|NCT01585246|5798324|P5|Overall Study|Protocol Violation|1
1658804|NCT01585246|5798325|P4|Overall Study|Protocol Violation|0
1658805|NCT01585246|5798326|P3|Overall Study|Protocol Violation|0
1658806|NCT01585246|5798327|P2|Overall Study|Protocol Violation|0
1658807|NCT01585246|5798328|P1|Overall Study|Protocol Violation|0
1658808|NCT01585246|5798324|P5|Overall Study|Lost to Follow-up|0
1658809|NCT01585246|5798325|P4|Overall Study|Lost to Follow-up|1
1658810|NCT01585246|5798326|P3|Overall Study|Lost to Follow-up|2
1658811|NCT01585246|5798327|P2|Overall Study|Lost to Follow-up|0
1658812|NCT01585246|5798328|P1|Overall Study|Lost to Follow-up|0
1658813|NCT01585168|5798349|P4|Overall Study|Lost to Follow-up|1
1658814|NCT01585168|5798350|P3|Overall Study|Lost to Follow-up|1
1658815|NCT01585168|5798351|P2|Overall Study|Lost to Follow-up|1
1658816|NCT01585168|5798352|P1|Overall Study|Lost to Follow-up|3
1658817|NCT01585155|5798372|P1|Overall Study|Worsening ulcerative colitis|2
1658818|NCT01585155|5798372|P1|Overall Study|Lack of Efficacy|2
1658819|NCT01585155|5798372|P1|Overall Study|Adverse Event|1
1658820|NCT01585038|5798394|P2|Overall Study|Adverse Event|2
1658821|NCT01585038|5798395|P1|Overall Study|Adverse Event|2
1658822|NCT01585025|5798410|P3|Overall Study|Withdrawal by Subject|4
1658823|NCT01585025|5798411|P2|Overall Study|Withdrawal by Subject|3
1658824|NCT01585025|5798412|P1|Overall Study|Withdrawal by Subject|0
1658825|NCT01584843|5798442|P6|Second Treatment Period|Withdrawal by Subject|1
1658826|NCT01584843|5798443|P5|Second Treatment Period|Withdrawal by Subject|0
1658827|NCT01584843|5798444|P4|Second Treatment Period|Withdrawal by Subject|0
1658828|NCT01584843|5798445|P3|Second Treatment Period|Withdrawal by Subject|0
1658829|NCT01584843|5798446|P2|Second Treatment Period|Withdrawal by Subject|0
1658830|NCT01584843|5798447|P1|Second Treatment Period|Withdrawal by Subject|0
1658831|NCT01584843|5798442|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
1658832|NCT01584843|5798443|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1658833|NCT01584843|5798444|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1658834|NCT01584843|5798445|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1658835|NCT01584843|5798446|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1658836|NCT01584843|5798447|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
1658837|NCT01584843|5798442|P6|First Treatment Period|Protocol Violation|1
1658838|NCT01584843|5798443|P5|First Treatment Period|Protocol Violation|0
1658839|NCT01584843|5798444|P4|First Treatment Period|Protocol Violation|0
1658840|NCT01584843|5798445|P3|First Treatment Period|Protocol Violation|0
1658841|NCT01584843|5798446|P2|First Treatment Period|Protocol Violation|0
1658842|NCT01584843|5798447|P1|First Treatment Period|Protocol Violation|0
1658843|NCT01584843|5798442|P6|First Treatment Period|Adverse Event|0
1658844|NCT01584843|5798443|P5|First Treatment Period|Adverse Event|0
1658845|NCT01584843|5798444|P4|First Treatment Period|Adverse Event|0
1658846|NCT01584843|5798445|P3|First Treatment Period|Adverse Event|1
1658847|NCT01584843|5798446|P2|First Treatment Period|Adverse Event|0
1658848|NCT01584843|5798447|P1|First Treatment Period|Adverse Event|0
1658849|NCT01584648|5798558|P2|Overall Study|Ongoing|147
1658850|NCT01584648|5798559|P1|Overall Study|Ongoing|154
1658851|NCT01584648|5798558|P2|Overall Study|Death|55
1658852|NCT01584648|5798559|P1|Overall Study|Death|40
1658853|NCT01584648|5798558|P2|Overall Study|Withdrawal by Subject|5
1658854|NCT01584648|5798559|P1|Overall Study|Withdrawal by Subject|11
1658855|NCT01584648|5798558|P2|Overall Study|Physician Decision|2
1658856|NCT01584648|5798559|P1|Overall Study|Physician Decision|2
1658857|NCT01584648|5798558|P2|Overall Study|Lost to Follow-up|3
1658858|NCT01584648|5798559|P1|Overall Study|Lost to Follow-up|4
1658859|NCT01584232|5798687|P2|Overall Study|Lost to Follow-up|0
1658860|NCT01584232|5798688|P1|Overall Study|Lost to Follow-up|1
1658861|NCT01584232|5798687|P2|Overall Study|Physician Decision|1
1658862|NCT01584232|5798688|P1|Overall Study|Physician Decision|2
1658863|NCT01584232|5798687|P2|Overall Study|Withdrawal by Subject|1
1658864|NCT01584232|5798688|P1|Overall Study|Withdrawal by Subject|2
1658865|NCT01584232|5798687|P2|Overall Study|Adverse Event|1
1658866|NCT01584232|5798688|P1|Overall Study|Adverse Event|3
1658867|NCT01584024|5798704|P1|Overall Study|Withdrawal by Subject|3
1658868|NCT01584024|5798704|P1|Overall Study|Lost to Follow-up|10
1658869|NCT01583530|5798784|P6|Overall Study|Lack of compliance|0
1658870|NCT01583530|5798785|P5|Overall Study|Lack of compliance|1
1658871|NCT01583530|5798786|P4|Overall Study|Lack of compliance|0
1658872|NCT01583530|5798787|P3|Overall Study|Lack of compliance|0
1658873|NCT01583530|5798788|P2|Overall Study|Lack of compliance|0
1658874|NCT01583530|5798789|P1|Overall Study|Lack of compliance|0
1658875|NCT01583530|5798784|P6|Overall Study|Lost to Follow-up|0
1658876|NCT01583530|5798785|P5|Overall Study|Lost to Follow-up|3
1658877|NCT01583530|5798786|P4|Overall Study|Lost to Follow-up|0
1658878|NCT01583530|5798787|P3|Overall Study|Lost to Follow-up|0
1658879|NCT01583530|5798788|P2|Overall Study|Lost to Follow-up|0
1658880|NCT01583530|5798789|P1|Overall Study|Lost to Follow-up|0
1658881|NCT01583530|5798784|P6|Overall Study|Withdrawal by Subject|2
1658882|NCT01583530|5798785|P5|Overall Study|Withdrawal by Subject|1
1658883|NCT01583530|5798786|P4|Overall Study|Withdrawal by Subject|1
1658884|NCT01583530|5798787|P3|Overall Study|Withdrawal by Subject|0
1658885|NCT01583530|5798788|P2|Overall Study|Withdrawal by Subject|3
1658886|NCT01583530|5798789|P1|Overall Study|Withdrawal by Subject|0
1658887|NCT01583530|5798784|P6|Overall Study|Adverse Event|1
1658888|NCT01583530|5798785|P5|Overall Study|Adverse Event|0
1658889|NCT01583530|5798786|P4|Overall Study|Adverse Event|0
1658890|NCT01583530|5798787|P3|Overall Study|Adverse Event|0
1658891|NCT01583530|5798788|P2|Overall Study|Adverse Event|0
1658892|NCT01583530|5798789|P1|Overall Study|Adverse Event|0
1658893|NCT01583374|5798851|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
1658894|NCT01583374|5798852|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
1658895|NCT01583374|5798853|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
1658896|NCT01583374|5798854|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
1658897|NCT01583374|5798855|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
1658898|NCT01583374|5798856|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
1658899|NCT01583374|5798857|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
1658900|NCT01583374|5798858|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
1658901|NCT01583374|5798859|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
1658902|NCT01583374|5798851|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1658903|NCT01583374|5798852|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1658904|NCT01583374|5798853|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1658905|NCT01583374|5798854|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1658906|NCT01583374|5798855|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1658907|NCT01583374|5798856|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1658908|NCT01583374|5798857|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1658909|NCT01583374|5798858|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
1658910|NCT01583374|5798859|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
1658911|NCT01583374|5798851|P9|Long-Term Extension Phase Weeks 52-260|Death|0
1658912|NCT01583374|5798852|P8|Long-Term Extension Phase Weeks 52-260|Death|0
1658913|NCT01583374|5798853|P7|Long-Term Extension Phase Weeks 52-260|Death|1
1658914|NCT01583374|5798854|P6|Long-Term Extension Phase Weeks 52-260|Death|0
1658915|NCT01583374|5798855|P5|Long-Term Extension Phase Weeks 52-260|Death|1
1658916|NCT01583374|5798856|P4|Long-Term Extension Phase Weeks 52-260|Death|0
1658917|NCT01583374|5798857|P3|Long-Term Extension Phase Weeks 52-260|Death|0
1658918|NCT01583374|5798858|P2|Long-Term Extension Phase Weeks 52-260|Death|0
1658919|NCT01583374|5798859|P1|Long-Term Extension Phase Weeks 52-260|Death|0
1658920|NCT01583374|5798851|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
1658921|NCT01583374|5798852|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
1658922|NCT01583374|5798853|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
1658923|NCT01583374|5798854|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
1658924|NCT01583374|5798855|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
1658925|NCT01583374|5798856|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
1658926|NCT01583374|5798857|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
1658927|NCT01583374|5798858|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
1658928|NCT01583374|5798859|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
1658929|NCT01583374|5798851|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
1658930|NCT01583374|5798852|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
1658931|NCT01583374|5798853|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1658932|NCT01583374|5798854|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1658933|NCT01583374|5798855|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
1658934|NCT01583374|5798856|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1658935|NCT01583374|5798857|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1658936|NCT01583374|5798858|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1658937|NCT01583374|5798859|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
1658938|NCT01583374|5798851|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
1658939|NCT01583374|5798852|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
1658940|NCT01583374|5798853|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
1658941|NCT01583374|5798854|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
1658942|NCT01583374|5798855|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
1658943|NCT01583374|5798856|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
1658944|NCT01583374|5798857|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
1658945|NCT01583374|5798858|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
1658946|NCT01583374|5798859|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
1658947|NCT01583374|5798851|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
1658948|NCT01583374|5798852|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
1658949|NCT01583374|5798853|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1658950|NCT01583374|5798854|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1658951|NCT01583374|5798855|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
1658952|NCT01583374|5798856|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1658953|NCT01583374|5798857|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
1658954|NCT01583374|5798858|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
1658955|NCT01583374|5798859|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
1658956|NCT01583374|5798851|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1658957|NCT01583374|5798852|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1658958|NCT01583374|5798853|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1658959|NCT01583374|5798854|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
1658960|NCT01583374|5798855|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1658961|NCT01583374|5798856|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1658962|NCT01583374|5798857|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1658963|NCT01583374|5798858|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1658964|NCT01583374|5798859|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1658965|NCT01583374|5798851|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1658966|NCT01583374|5798852|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1658967|NCT01583374|5798853|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1658968|NCT01583374|5798854|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1658969|NCT01583374|5798855|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
1658970|NCT01583374|5798856|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1658971|NCT01583374|5798857|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
1658972|NCT01583374|5798858|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
1658973|NCT01583374|5798859|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
1658974|NCT01583374|5798851|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
1658975|NCT01583374|5798852|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
1658976|NCT01583374|5798853|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
1658977|NCT01583374|5798854|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
1658978|NCT01583374|5798855|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
1658979|NCT01583374|5798856|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
1658980|NCT01583374|5798857|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1658981|NCT01583374|5798858|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
1658982|NCT01583374|5798859|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1658983|NCT01583374|5798851|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1658984|NCT01583374|5798852|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1658985|NCT01583374|5798853|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1658986|NCT01583374|5798854|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1658987|NCT01583374|5798855|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1658988|NCT01583374|5798856|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1658989|NCT01583374|5798857|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
1658990|NCT01583374|5798858|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1658991|NCT01583374|5798859|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
1658992|NCT01583374|5798851|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1658993|NCT01583374|5798852|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
1658994|NCT01583374|5798853|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1658995|NCT01583374|5798854|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1658996|NCT01583374|5798855|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1658997|NCT01583374|5798856|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1658998|NCT01583374|5798857|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1658999|NCT01583374|5798858|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1659000|NCT01583374|5798859|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1659001|NCT01583374|5798851|P9|Placebo-controlled Phase (Week 0-24)|Other|0
1659002|NCT01583374|5798852|P8|Placebo-controlled Phase (Week 0-24)|Other|0
1659003|NCT01583374|5798853|P7|Placebo-controlled Phase (Week 0-24)|Other|0
1659004|NCT01583374|5798854|P6|Placebo-controlled Phase (Week 0-24)|Other|0
1659005|NCT01583374|5798855|P5|Placebo-controlled Phase (Week 0-24)|Other|0
1659006|NCT01583374|5798856|P4|Placebo-controlled Phase (Week 0-24)|Other|0
1659007|NCT01583374|5798857|P3|Placebo-controlled Phase (Week 0-24)|Other|0
1659008|NCT01583374|5798858|P2|Placebo-controlled Phase (Week 0-24)|Other|1
1659009|NCT01583374|5798859|P1|Placebo-controlled Phase (Week 0-24)|Other|0
1659010|NCT01583374|5798851|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659011|NCT01583374|5798852|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659012|NCT01583374|5798853|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659013|NCT01583374|5798854|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659014|NCT01583374|5798855|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659015|NCT01583374|5798856|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659016|NCT01583374|5798857|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
1659017|NCT01583374|5798858|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659018|NCT01583374|5798859|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1659019|NCT01583374|5798851|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1659020|NCT01583374|5798852|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1659021|NCT01583374|5798853|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1659022|NCT01583374|5798854|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1659023|NCT01583374|5798855|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1659024|NCT01583374|5798856|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1659025|NCT01583374|5798857|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
1659026|NCT01583374|5798858|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
1659027|NCT01583374|5798859|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
1659028|NCT01583374|5798851|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1659029|NCT01583374|5798852|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1659030|NCT01583374|5798853|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1659031|NCT01583374|5798854|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1659032|NCT01583374|5798855|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1659033|NCT01583374|5798856|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1659034|NCT01583374|5798857|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
1659035|NCT01583374|5798858|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
1659036|NCT01583374|5798859|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
1659037|NCT01583374|5798851|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1659038|NCT01583374|5798852|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1659039|NCT01583374|5798853|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1659040|NCT01583374|5798854|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1659041|NCT01583374|5798855|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1659042|NCT01583374|5798856|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1659043|NCT01583374|5798857|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1659044|NCT01583374|5798858|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
1659045|NCT01583374|5798859|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
1659046|NCT01583374|5798851|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1659047|NCT01583374|5798852|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1659048|NCT01583374|5798853|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1659049|NCT01583374|5798854|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1659050|NCT01583374|5798855|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1659051|NCT01583374|5798856|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1659052|NCT01583374|5798857|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
1659053|NCT01583374|5798858|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
1659054|NCT01583374|5798859|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
1659055|NCT01583374|5798851|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1659056|NCT01583374|5798852|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1659057|NCT01583374|5798853|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1659058|NCT01583374|5798854|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1659059|NCT01583374|5798855|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1659060|NCT01583374|5798856|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1659061|NCT01583374|5798857|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
1659062|NCT01583374|5798858|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
1659063|NCT01583374|5798859|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
1659064|NCT01583218|5798901|P2|Overall Study|Withdraw of consent on day of random|0
1659065|NCT01583218|5798902|P1|Overall Study|Withdraw of consent on day of random|1
1659066|NCT01583218|5798901|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
1659067|NCT01583218|5798902|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
1659068|NCT01583218|5798901|P2|Overall Study|Patient was randomized due to mistake|0
1659069|NCT01583218|5798902|P1|Overall Study|Patient was randomized due to mistake|1
1659070|NCT01583218|5798901|P2|Overall Study|Patient was early terminated from study|1
1659071|NCT01583218|5798902|P1|Overall Study|Patient was early terminated from study|0
1659072|NCT01583218|5798901|P2|Overall Study|Patient deemed ineligible after random|0
1659073|NCT01583218|5798902|P1|Overall Study|Patient deemed ineligible after random|2
1659074|NCT01583218|5798901|P2|Overall Study|Patient was assessed via phone in person|0
1659075|NCT01583218|5798902|P1|Overall Study|Patient was assessed via phone in person|1
1659076|NCT01583218|5798901|P2|Overall Study|Patient randomized but not dosed|16
1659077|NCT01583218|5798902|P1|Overall Study|Patient randomized but not dosed|17
1659078|NCT01583218|5798901|P2|Overall Study|Patient did not wish to attend visits|1
1659079|NCT01583218|5798902|P1|Overall Study|Patient did not wish to attend visits|0
1659080|NCT01583218|5798901|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
1659081|NCT01583218|5798902|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
1659082|NCT01583218|5798901|P2|Overall Study|Cannot contact patient directly|2
1659083|NCT01583218|5798902|P1|Overall Study|Cannot contact patient directly|1
1659084|NCT01583218|5798901|P2|Overall Study|Patient /Family decision|0
1659085|NCT01583218|5798902|P1|Overall Study|Patient /Family decision|3
1659086|NCT01583218|5798901|P2|Overall Study|Adverse event or serious adverse event|3
1659087|NCT01583218|5798902|P1|Overall Study|Adverse event or serious adverse event|3
1659088|NCT01583218|5798901|P2|Overall Study|Lost to Follow-up|17
1659089|NCT01583218|5798902|P1|Overall Study|Lost to Follow-up|11
1659090|NCT01583218|5798901|P2|Overall Study|Death|211
1659091|NCT01583218|5798902|P1|Overall Study|Death|206
1659092|NCT01583218|5798901|P2|Overall Study|Withdrawal by Subject|29
1659093|NCT01583218|5798902|P1|Overall Study|Withdrawal by Subject|43
1659094|NCT01583179|5798922|P2|Overall Study|Screen failure|2
1659095|NCT01583179|5798923|P1|Overall Study|Screen failure|1
1659096|NCT01583166|5798933|P2|Overall Study|Withdrawal by Subject|6
1659097|NCT01583166|5798934|P1|Overall Study|Withdrawal by Subject|4
1659098|NCT01582971|5798957|P2|Overall Study|Other|13
1659099|NCT01582971|5798958|P1|Overall Study|Other|15
1659100|NCT01582971|5798957|P2|Overall Study|Withdrawal by Subject|2
1659101|NCT01582971|5798958|P1|Overall Study|Withdrawal by Subject|4
1659102|NCT01582971|5798957|P2|Overall Study|Lost to Follow-up|21
1659103|NCT01582971|5798958|P1|Overall Study|Lost to Follow-up|18
1659104|NCT01582971|5798957|P2|Overall Study|Death|1
1659105|NCT01582971|5798958|P1|Overall Study|Death|2
1659106|NCT01582945|5798976|P1|Overall Study|Scheduling conflicts|1
1659107|NCT01582945|5798976|P1|Overall Study|Intolerable side-effects|1
1659108|NCT01582854|5798990|P2|Overall Study|Other Miscellaneous Reason|0
1659109|NCT01582854|5798991|P1|Overall Study|Other Miscellaneous Reason|1
1659110|NCT01582854|5798990|P2|Overall Study|General Anaesthesia|1
1659111|NCT01582854|5798991|P1|Overall Study|General Anaesthesia|0
1659112|NCT01582854|5798990|P2|Overall Study|Carotid or Neurosurgery|1
1659113|NCT01582854|5798991|P1|Overall Study|Carotid or Neurosurgery|0
1659114|NCT01582854|5798990|P2|Overall Study|Disallowed Concomitant Medication|2
1659115|NCT01582854|5798991|P1|Overall Study|Disallowed Concomitant Medication|3
1659116|NCT01582854|5798990|P2|Overall Study|Recurrent Stroke|8
1659117|NCT01582854|5798991|P1|Overall Study|Recurrent Stroke|13
1659118|NCT01582854|5798990|P2|Overall Study|Physician Decision|1
1659119|NCT01582854|5798991|P1|Overall Study|Physician Decision|0
1659120|NCT01582854|5798990|P2|Overall Study|Lost to Follow-up|2
1659121|NCT01582854|5798991|P1|Overall Study|Lost to Follow-up|1
1659122|NCT01582854|5798990|P2|Overall Study|Withdrawal by Participant|11
1659123|NCT01582854|5798991|P1|Overall Study|Withdrawal by Participant|8
1659124|NCT01582854|5798990|P2|Overall Study|Adverse Event|3
1659125|NCT01582854|5798991|P1|Overall Study|Adverse Event|2
1659126|NCT01582854|5798990|P2|Overall Study|Death|5
1659127|NCT01582854|5798991|P1|Overall Study|Death|8
1659128|NCT01582789|5799019|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
1659129|NCT01582789|5799020|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
1659130|NCT01582451|5799080|P2|Overall Study|Sponsor Decision|0
1659131|NCT01582451|5799081|P1|Overall Study|Sponsor Decision|1
1659132|NCT01582451|5799080|P2|Overall Study|Physician Decision|0
1659133|NCT01582451|5799081|P1|Overall Study|Physician Decision|3
1659134|NCT01582451|5799080|P2|Overall Study|Withdrawal by Subject|9
1659135|NCT01582451|5799081|P1|Overall Study|Withdrawal by Subject|13
1659136|NCT01582451|5799080|P2|Overall Study|Protocol Violation|3
1659137|NCT01582451|5799081|P1|Overall Study|Protocol Violation|11
1659138|NCT01582451|5799080|P2|Overall Study|Lost to Follow-up|2
1659139|NCT01582451|5799081|P1|Overall Study|Lost to Follow-up|0
1659140|NCT01582451|5799080|P2|Overall Study|Death|3
1659141|NCT01582451|5799081|P1|Overall Study|Death|3
1659142|NCT01582451|5799080|P2|Overall Study|Adverse Event|3
1659143|NCT01582451|5799081|P1|Overall Study|Adverse Event|1
1659144|NCT01582308|5799123|P10|Period 4|Physician Decision|1
1659145|NCT01582308|5799124|P9|Period 4|Physician Decision|0
1659146|NCT01582308|5799125|P8|Period 4|Physician Decision|0
1659147|NCT01582308|5799126|P7|Period 4|Physician Decision|0
1659148|NCT01582308|5799127|P6|Period 4|Physician Decision|1
1659149|NCT01582308|5799128|P5|Period 4|Physician Decision|0
1659150|NCT01582308|5799129|P4|Period 4|Physician Decision|0
1659151|NCT01582308|5799130|P3|Period 4|Physician Decision|0
1659152|NCT01582308|5799131|P2|Period 4|Physician Decision|0
1659153|NCT01582308|5799132|P1|Period 4|Physician Decision|1
1659154|NCT01582308|5799123|P10|10-day Washout Following Period 1|Physician Decision|0
1659155|NCT01582308|5799124|P9|10-day Washout Following Period 1|Physician Decision|0
1659156|NCT01582308|5799125|P8|10-day Washout Following Period 1|Physician Decision|0
1659157|NCT01582308|5799126|P7|10-day Washout Following Period 1|Physician Decision|0
1659158|NCT01582308|5799127|P6|10-day Washout Following Period 1|Physician Decision|0
1659159|NCT01582308|5799128|P5|10-day Washout Following Period 1|Physician Decision|1
1659160|NCT01582308|5799129|P4|10-day Washout Following Period 1|Physician Decision|0
1659161|NCT01582308|5799130|P3|10-day Washout Following Period 1|Physician Decision|0
1659162|NCT01582308|5799131|P2|10-day Washout Following Period 1|Physician Decision|0
1659163|NCT01582308|5799132|P1|10-day Washout Following Period 1|Physician Decision|0
1659164|NCT01582308|5799123|P10|Period 1|Withdrawal by Subject|0
1659165|NCT01582308|5799124|P9|Period 1|Withdrawal by Subject|0
1659166|NCT01582308|5799125|P8|Period 1|Withdrawal by Subject|0
1659167|NCT01582308|5799126|P7|Period 1|Withdrawal by Subject|1
1659168|NCT01582308|5799127|P6|Period 1|Withdrawal by Subject|0
1659169|NCT01582308|5799128|P5|Period 1|Withdrawal by Subject|0
1659170|NCT01582308|5799129|P4|Period 1|Withdrawal by Subject|0
1659171|NCT01582308|5799130|P3|Period 1|Withdrawal by Subject|0
1659172|NCT01582308|5799131|P2|Period 1|Withdrawal by Subject|0
1659173|NCT01582308|5799132|P1|Period 1|Withdrawal by Subject|0
1659174|NCT01582282|5799160|P3|Overall Study|fasting blood glucose outside Protocol|0
1659175|NCT01582282|5799161|P2|Overall Study|fasting blood glucose outside Protocol|1
1659176|NCT01582282|5799162|P1|Overall Study|fasting blood glucose outside Protocol|0
1659177|NCT01582282|5799160|P3|Overall Study|Lost to Follow-up|0
1659178|NCT01582282|5799161|P2|Overall Study|Lost to Follow-up|0
1659179|NCT01582282|5799162|P1|Overall Study|Lost to Follow-up|1
1659180|NCT01582282|5799160|P3|Overall Study|Adverse Event|0
1659181|NCT01582282|5799161|P2|Overall Study|Adverse Event|1
1659182|NCT01582282|5799162|P1|Overall Study|Adverse Event|1
1659183|NCT01582243|5799185|P1|Overall Study|Lost to Follow-up|1
1659184|NCT01582243|5799185|P1|Overall Study|Adverse Event|1
1659185|NCT01582243|5799185|P1|Overall Study|Withdrawal by Subject|1
1659186|NCT01582178|5799196|P2|Overall Study|Physician Decision|5
1659187|NCT01582178|5799197|P1|Overall Study|Physician Decision|6
1659188|NCT01582152|5799205|P2|Overall Study|Adverse Event|1
1659189|NCT01582152|5799206|P1|Overall Study|Adverse Event|2
1659190|NCT01582152|5799205|P2|Overall Study|Disease Progression|5
1659191|NCT01582152|5799206|P1|Overall Study|Disease Progression|4
1659192|NCT01582100|5799229|P1|Overall Study|Withdrawal by Subject|1
1659193|NCT01582100|5799229|P1|Overall Study|Adverse Event|1
1659194|NCT01582061|5799235|P2|Overall Study|Lost to Follow-up|0
1659195|NCT01582061|5799236|P1|Overall Study|Lost to Follow-up|1
1659196|NCT01582061|5799235|P2|Overall Study|condition no longer requires study drug|0
1659197|NCT01582061|5799236|P1|Overall Study|condition no longer requires study drug|1
1659198|NCT01582061|5799235|P2|Overall Study|Death|1
1659199|NCT01582061|5799236|P1|Overall Study|Death|0
1659200|NCT01582061|5799235|P2|Overall Study|Abnormal laboratory value(s)|0
1659201|NCT01582061|5799236|P1|Overall Study|Abnormal laboratory value(s)|1
1659202|NCT01582061|5799235|P2|Overall Study|Withdrawal by Subject|4
1659203|NCT01582061|5799236|P1|Overall Study|Withdrawal by Subject|10
1659204|NCT01582061|5799235|P2|Overall Study|Adverse Event|8
1659205|NCT01582061|5799236|P1|Overall Study|Adverse Event|12
1659206|NCT01582061|5799235|P2|Overall Study|Lack of Efficacy|23
1659207|NCT01582061|5799236|P1|Overall Study|Lack of Efficacy|3
1659208|NCT01582009|5799286|P1|Overall Study|Physician Decision|1
1659209|NCT01582009|5799286|P1|Overall Study|Withdrawal by Subject|1
1659210|NCT01581931|5799303|P2|Washout|Adverse Event|1
1659211|NCT01581931|5799304|P1|Washout|Adverse Event|0
1659212|NCT01581684|5799357|P10|Overall Study|Other reason not defined|0
1659213|NCT01581684|5799358|P9|Overall Study|Other reason not defined|1
1659214|NCT01581684|5799359|P8|Overall Study|Other reason not defined|0
1659215|NCT01581684|5799360|P7|Overall Study|Other reason not defined|0
1659216|NCT01581684|5799361|P6|Overall Study|Other reason not defined|0
1659217|NCT01581684|5799362|P5|Overall Study|Other reason not defined|0
1659218|NCT01581684|5799363|P4|Overall Study|Other reason not defined|0
1659219|NCT01581684|5799364|P3|Overall Study|Other reason not defined|0
1659220|NCT01581684|5799365|P2|Overall Study|Other reason not defined|0
1659221|NCT01581684|5799366|P1|Overall Study|Other reason not defined|0
1659222|NCT01581619|5799462|P1|Overall Study|Lost to Follow-up|1
1659223|NCT01581619|5799462|P1|Overall Study|Withdrawal by Subject|1
1659224|NCT01581307|5799615|P1|Overall Study|Withdrawal by Subject|1
1659225|NCT01581281|5799624|P3|Overall Study|Early Study Closure|12
1659226|NCT01581281|5799625|P2|Overall Study|Early Study Closure|6
1659227|NCT01581281|5799626|P1|Overall Study|Early Study Closure|15
1659228|NCT01581021|5799648|P2|Overall Study|Lack of Efficacy|1
1659229|NCT01581021|5799649|P1|Overall Study|Lack of Efficacy|0
1659230|NCT01581021|5799648|P2|Overall Study|Lenke 6 Classification|1
1659231|NCT01581021|5799649|P1|Overall Study|Lenke 6 Classification|0
1659232|NCT01581021|5799648|P2|Overall Study|Not Randomized|2
1659233|NCT01581021|5799649|P1|Overall Study|Not Randomized|1
1659234|NCT01581021|5799648|P2|Overall Study|Neuromuscular|1
1659235|NCT01581021|5799649|P1|Overall Study|Neuromuscular|2
1659236|NCT01581021|5799648|P2|Overall Study|More than 2 hooks in thoracic|0
1659237|NCT01581021|5799649|P1|Overall Study|More than 2 hooks in thoracic|3
1659238|NCT01581021|5799648|P2|Overall Study|Lost to Follow-up|6
1659239|NCT01581021|5799649|P1|Overall Study|Lost to Follow-up|4
1659240|NCT01580995|5799676|P2|Overall Study|Lost to Follow-up|2
1659241|NCT01580995|5799677|P1|Overall Study|Lost to Follow-up|2
1659242|NCT01580969|5799686|P3|Overall Study|Physician Decision|0
1659243|NCT01580969|5799687|P2|Overall Study|Physician Decision|0
1659244|NCT01580969|5799688|P1|Overall Study|Physician Decision|3
1659245|NCT01580670|5799735|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
1659246|NCT01580670|5799735|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
1659247|NCT01580488|5799776|P1|Overall Study|Withdrawal by Subject|1
1659248|NCT01580293|5799882|P3|Part B|Part B ongoing|1
1659249|NCT01580293|5799883|P2|Part B|Part B ongoing|0
1659250|NCT01580293|5799884|P1|Part B|Part B ongoing|0
1659251|NCT01580293|5799882|P3|Part B|Other reason|1
1659252|NCT01580293|5799883|P2|Part B|Other reason|0
1659253|NCT01580293|5799884|P1|Part B|Other reason|0
1659254|NCT01580293|5799882|P3|Part B|Withdrawal by Subject|1
1659255|NCT01580293|5799883|P2|Part B|Withdrawal by Subject|0
1659256|NCT01580293|5799884|P1|Part B|Withdrawal by Subject|0
1659257|NCT01580293|5799882|P3|Part A_Extension|Extension ongoing|0
1659258|NCT01580293|5799883|P2|Part A_Extension|Extension ongoing|69
1659259|NCT01580293|5799884|P1|Part A_Extension|Extension ongoing|9
1659260|NCT01580293|5799882|P3|Part A_Extension|Other Reason|0
1659261|NCT01580293|5799883|P2|Part A_Extension|Other Reason|1
1659262|NCT01580293|5799884|P1|Part A_Extension|Other Reason|0
1659263|NCT01580293|5799882|P3|Part A_Extension|Lost to Follow-up|0
1659264|NCT01580293|5799883|P2|Part A_Extension|Lost to Follow-up|1
1659265|NCT01580293|5799884|P1|Part A_Extension|Lost to Follow-up|0
1659266|NCT01580293|5799882|P3|Part A_Extension|Withdrawal by Subject|0
1659267|NCT01580293|5799883|P2|Part A_Extension|Withdrawal by Subject|2
1659268|NCT01580293|5799884|P1|Part A_Extension|Withdrawal by Subject|0
1659269|NCT01580293|5799882|P3|Part A_Extension|Adverse Event|0
1659270|NCT01580293|5799883|P2|Part A_Extension|Adverse Event|2
1659271|NCT01580293|5799884|P1|Part A_Extension|Adverse Event|0
1659272|NCT01580293|5799882|P3|Part A_Main Trial|Non-adherence to the protocol|0
1659273|NCT01580293|5799883|P2|Part A_Main Trial|Non-adherence to the protocol|0
1659274|NCT01580293|5799884|P1|Part A_Main Trial|Non-adherence to the protocol|1
1659275|NCT01580293|5799882|P3|Part A_Main Trial|Withdrawal by Subject|0
1659276|NCT01580293|5799883|P2|Part A_Main Trial|Withdrawal by Subject|4
1659277|NCT01580293|5799884|P1|Part A_Main Trial|Withdrawal by Subject|1
1659278|NCT01580293|5799882|P3|Part A_Main Trial|Adverse Event|0
1659279|NCT01580293|5799883|P2|Part A_Main Trial|Adverse Event|2
1659280|NCT01580293|5799884|P1|Part A_Main Trial|Adverse Event|0
1659281|NCT01580020|5800024|P4|Overall Study|Lost to Follow-up|0
1659282|NCT01580020|5800025|P3|Overall Study|Lost to Follow-up|1
1659283|NCT01580020|5800026|P2|Overall Study|Lost to Follow-up|0
1659284|NCT01580020|5800027|P1|Overall Study|Lost to Follow-up|0
1659285|NCT01580020|5800024|P4|Overall Study|Administrative Problems|0
1659286|NCT01580020|5800025|P3|Overall Study|Administrative Problems|1
1659287|NCT01580020|5800026|P2|Overall Study|Administrative Problems|0
1659288|NCT01580020|5800027|P1|Overall Study|Administrative Problems|0
1659289|NCT01580020|5800024|P4|Overall Study|Adverse Event|1
1659290|NCT01580020|5800025|P3|Overall Study|Adverse Event|1
1659291|NCT01580020|5800026|P2|Overall Study|Adverse Event|1
1659292|NCT01580020|5800027|P1|Overall Study|Adverse Event|1
1659293|NCT01580020|5800024|P4|Overall Study|Withdrawal by Subject|0
1659294|NCT01580020|5800025|P3|Overall Study|Withdrawal by Subject|1
1659295|NCT01580020|5800026|P2|Overall Study|Withdrawal by Subject|1
1659296|NCT01580020|5800027|P1|Overall Study|Withdrawal by Subject|0
1659297|NCT01580020|5800024|P4|Overall Study|Lack of Efficacy|1
1659298|NCT01580020|5800025|P3|Overall Study|Lack of Efficacy|0
1659299|NCT01580020|5800026|P2|Overall Study|Lack of Efficacy|5
1659300|NCT01580020|5800027|P1|Overall Study|Lack of Efficacy|0
1659301|NCT01579916|5800071|P2|Overall Study|Death|0
1659302|NCT01579916|5800072|P1|Overall Study|Death|1
1659303|NCT01579916|5800071|P2|Overall Study|Withdrawal by Subject|1
1659304|NCT01579916|5800072|P1|Overall Study|Withdrawal by Subject|1
1659305|NCT01579916|5800071|P2|Overall Study|Lost to Follow-up|1
1659306|NCT01579916|5800072|P1|Overall Study|Lost to Follow-up|6
1659307|NCT01579812|5800098|P1|Overall Study|Withdrawal by Subject|6
1659308|NCT01579812|5800098|P1|Overall Study|Noncompliance|3
1659309|NCT01579812|5800098|P1|Overall Study|Patient choice|3
1659310|NCT01579812|5800098|P1|Overall Study|Ineligible after treatment start|40
1659311|NCT01579578|5800132|P2|Overall Study|Ongoing|0
1659312|NCT01579578|5800133|P1|Overall Study|Ongoing|3
1659313|NCT01579578|5800132|P2|Overall Study|Eligibility criteria|9
1659314|NCT01579578|5800133|P1|Overall Study|Eligibility criteria|3
1659315|NCT01579578|5800132|P2|Overall Study|Withdrawal by Subject|1
1659316|NCT01579578|5800133|P1|Overall Study|Withdrawal by Subject|2
1659317|NCT01579578|5800132|P2|Overall Study|Lost to Follow-up|1
1659318|NCT01579578|5800133|P1|Overall Study|Lost to Follow-up|1
1659319|NCT01579578|5800132|P2|Overall Study|Death|1
1659320|NCT01579578|5800133|P1|Overall Study|Death|4
1659321|NCT01579565|5800145|P2|Treated|declined to return for final visit|1
1659322|NCT01579565|5800146|P1|Treated|declined to return for final visit|0
1659323|NCT01579565|5800145|P2|Treated|Lost to Follow-up|1
1659324|NCT01579565|5800146|P1|Treated|Lost to Follow-up|2
1659325|NCT01579565|5800145|P2|Treated|Physician Decision|1
1659326|NCT01579565|5800146|P1|Treated|Physician Decision|0
1659327|NCT01579565|5800145|P2|Randomized|prohibited preoperative medication|1
1659328|NCT01579565|5800146|P1|Randomized|prohibited preoperative medication|0
1659329|NCT01579565|5800145|P2|Randomized|prohibited preoperative eating|0
1659330|NCT01579565|5800146|P1|Randomized|prohibited preoperative eating|1
1659331|NCT01579565|5800145|P2|Randomized|inadequate preoperative pupil dilation|1
1659332|NCT01579565|5800146|P1|Randomized|inadequate preoperative pupil dilation|0
1659333|NCT01579565|5800145|P2|Randomized|Withdrawal by Subject|0
1659334|NCT01579565|5800146|P1|Randomized|Withdrawal by Subject|3
1659335|NCT01579565|5800145|P2|Randomized|Adverse Event|3
1659336|NCT01579565|5800146|P1|Randomized|Adverse Event|1
1659337|NCT01579474|5800197|P6|Overall Study|Withdrawal by Subject|0
1659338|NCT01579474|5800198|P5|Overall Study|Withdrawal by Subject|0
1659339|NCT01579474|5800199|P4|Overall Study|Withdrawal by Subject|0
1659340|NCT01579474|5800200|P3|Overall Study|Withdrawal by Subject|0
1659341|NCT01579474|5800201|P2|Overall Study|Withdrawal by Subject|0
1659342|NCT01579474|5800202|P1|Overall Study|Withdrawal by Subject|1
1659343|NCT01579474|5800197|P6|Overall Study|Lack of Efficacy|0
1659344|NCT01579474|5800198|P5|Overall Study|Lack of Efficacy|1
1659345|NCT01579474|5800199|P4|Overall Study|Lack of Efficacy|0
1659346|NCT01579474|5800200|P3|Overall Study|Lack of Efficacy|0
1659347|NCT01579474|5800201|P2|Overall Study|Lack of Efficacy|0
1659348|NCT01579474|5800202|P1|Overall Study|Lack of Efficacy|1
1659349|NCT01579474|5800197|P6|Overall Study|Adverse Event|1
1659350|NCT01579474|5800198|P5|Overall Study|Adverse Event|0
1659351|NCT01579474|5800199|P4|Overall Study|Adverse Event|0
1659352|NCT01579474|5800200|P3|Overall Study|Adverse Event|2
1659353|NCT01579474|5800201|P2|Overall Study|Adverse Event|13
1659354|NCT01579474|5800202|P1|Overall Study|Adverse Event|1
1659355|NCT01579318|5800276|P1|Overall Study|Disease Progression|1
1659356|NCT01579006|5800371|P1|Overall Study|Scheduled surgery|1
1659357|NCT01579006|5800371|P1|Overall Study|Due to participant's health fund|1
1659358|NCT01579006|5800371|P1|Overall Study|Non-compliance|3
1659359|NCT01579006|5800371|P1|Overall Study|Withdrawal by Subject|5
1659360|NCT01579006|5800371|P1|Overall Study|Adverse Event|13
1659361|NCT01579006|5800371|P1|Overall Study|Lack of Efficacy|10
1659362|NCT01578850|5800430|P3|Period 2|Unspecified Reasons|0
1659363|NCT01578850|5800431|P2|Period 2|Unspecified Reasons|1
1659364|NCT01578850|5800432|P1|Period 2|Unspecified Reasons|0
1659365|NCT01578850|5800430|P3|Period 2|Study Terminated by Sponsor|4
1659366|NCT01578850|5800431|P2|Period 2|Study Terminated by Sponsor|5
1659367|NCT01578850|5800432|P1|Period 2|Study Terminated by Sponsor|0
1659368|NCT01578850|5800430|P3|Period 2|Withdrawal by Subject|2
1659369|NCT01578850|5800431|P2|Period 2|Withdrawal by Subject|2
1659370|NCT01578850|5800432|P1|Period 2|Withdrawal by Subject|0
1659371|NCT01578850|5800430|P3|Period 2|Lost to Follow-up|2
1659372|NCT01578850|5800431|P2|Period 2|Lost to Follow-up|1
1659373|NCT01578850|5800432|P1|Period 2|Lost to Follow-up|0
1659374|NCT01578850|5800430|P3|Period 2|Adverse Event|6
1659375|NCT01578850|5800431|P2|Period 2|Adverse Event|3
1659376|NCT01578850|5800432|P1|Period 2|Adverse Event|0
1659377|NCT01578850|5800430|P3|Period 2|Insufficient Clinical Response|0
1659378|NCT01578850|5800431|P2|Period 2|Insufficient Clinical Response|1
1659379|NCT01578850|5800432|P1|Period 2|Insufficient Clinical Response|0
1659380|NCT01578850|5800430|P3|Period 1|Study Terminated by Sponsor|0
1659381|NCT01578850|5800431|P2|Period 1|Study Terminated by Sponsor|0
1659382|NCT01578850|5800432|P1|Period 1|Study Terminated by Sponsor|3
1659383|NCT01578850|5800430|P3|Period 1|Withdrawal by Subject|0
1659384|NCT01578850|5800431|P2|Period 1|Withdrawal by Subject|0
1659385|NCT01578850|5800432|P1|Period 1|Withdrawal by Subject|9
1659386|NCT01578850|5800430|P3|Period 1|Does Not Meet Entrance Criteria|0
1659387|NCT01578850|5800431|P2|Period 1|Does Not Meet Entrance Criteria|0
1659388|NCT01578850|5800432|P1|Period 1|Does Not Meet Entrance Criteria|12
1659389|NCT01578850|5800430|P3|Period 1|Death|0
1659390|NCT01578850|5800431|P2|Period 1|Death|0
1659391|NCT01578850|5800432|P1|Period 1|Death|1
1659392|NCT01578850|5800430|P3|Period 1|Adverse Event|0
1659393|NCT01578850|5800431|P2|Period 1|Adverse Event|0
1659394|NCT01578850|5800432|P1|Period 1|Adverse Event|11
1659395|NCT01578850|5800430|P3|Period 1|Insufficient Clinical Response|0
1659396|NCT01578850|5800431|P2|Period 1|Insufficient Clinical Response|0
1659397|NCT01578850|5800432|P1|Period 1|Insufficient Clinical Response|1
1659398|NCT01578785|5800484|P2|Overall Study|Study terminated by sponsor|118
1659399|NCT01578785|5800485|P1|Overall Study|Study terminated by sponsor|59
1659400|NCT01578785|5800484|P2|Overall Study|Withdrawal by Subject|1
1659401|NCT01578785|5800485|P1|Overall Study|Withdrawal by Subject|0
1659402|NCT01578551|5800550|P2|Overall Study|Adverse Event|0
1659403|NCT01578551|5800551|P1|Overall Study|Adverse Event|1
1659404|NCT01578499|5800563|P2|Overall Study|Died and End of Study Page not Completed|0
1659405|NCT01578499|5800564|P1|Overall Study|Died and End of Study Page not Completed|2
1659406|NCT01578499|5800563|P2|Overall Study|Death|25
1659407|NCT01578499|5800564|P1|Overall Study|Death|20
1659408|NCT01578499|5800563|P2|Overall Study|Withdrawal by Subject|16
1659409|NCT01578499|5800564|P1|Overall Study|Withdrawal by Subject|10
1659410|NCT01578499|5800563|P2|Overall Study|Lost to Follow-up|1
1659411|NCT01578499|5800564|P1|Overall Study|Lost to Follow-up|2
1659412|NCT01578499|5800563|P2|Overall Study|Reason not Specified|1
1659413|NCT01578499|5800564|P1|Overall Study|Reason not Specified|0
1659414|NCT01578486|5800598|P1|Overall Study|Withdrawal by Subject|2
1659415|NCT01578486|5800598|P1|Overall Study|Physician Decision|3
1659416|NCT01578330|5800609|P1|Overall Study|Protocol Violation|5
1659417|NCT01578330|5800609|P1|Overall Study|Adverse Event|2
1659418|NCT01578187|5800634|P1|Usability Phase|Withdrawal by Subject|1
1659419|NCT01577758|5800676|P8|mCRC Expansion Phase|Progression Disease|19
1659420|NCT01577758|5800677|P7|mCRC Expansion Phase|Progression Disease|0
1659421|NCT01577758|5800678|P6|mCRC Expansion Phase|Progression Disease|0
1659422|NCT01577758|5800679|P5|mCRC Expansion Phase|Progression Disease|0
1659423|NCT01577758|5800680|P4|mCRC Expansion Phase|Progression Disease|0
1659424|NCT01577758|5800681|P3|mCRC Expansion Phase|Progression Disease|0
1659425|NCT01577758|5800682|P2|mCRC Expansion Phase|Progression Disease|0
1659426|NCT01577758|5800683|P1|mCRC Expansion Phase|Progression Disease|0
1659427|NCT01577758|5800676|P8|mCRC Expansion Phase|Withdrawal by Subject|2
1659428|NCT01577758|5800677|P7|mCRC Expansion Phase|Withdrawal by Subject|0
1659429|NCT01577758|5800678|P6|mCRC Expansion Phase|Withdrawal by Subject|0
1659430|NCT01577758|5800679|P5|mCRC Expansion Phase|Withdrawal by Subject|0
1659431|NCT01577758|5800680|P4|mCRC Expansion Phase|Withdrawal by Subject|0
1659432|NCT01577758|5800681|P3|mCRC Expansion Phase|Withdrawal by Subject|0
1659433|NCT01577758|5800682|P2|mCRC Expansion Phase|Withdrawal by Subject|0
1659434|NCT01577758|5800683|P1|mCRC Expansion Phase|Withdrawal by Subject|0
1659435|NCT01577758|5800676|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
1659436|NCT01577758|5800677|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
1659437|NCT01577758|5800678|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
1659438|NCT01577758|5800679|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
1659439|NCT01577758|5800680|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
1659440|NCT01577758|5800681|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
1659441|NCT01577758|5800682|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
1659442|NCT01577758|5800683|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
1659443|NCT01577758|5800676|P8|Dose Escalation Phase|Progression Disease|0
1659444|NCT01577758|5800677|P7|Dose Escalation Phase|Progression Disease|0
1659445|NCT01577758|5800678|P6|Dose Escalation Phase|Progression Disease|0
1659446|NCT01577758|5800679|P5|Dose Escalation Phase|Progression Disease|5
1659447|NCT01577758|5800680|P4|Dose Escalation Phase|Progression Disease|2
1659448|NCT01577758|5800681|P3|Dose Escalation Phase|Progression Disease|1
1659449|NCT01577758|5800682|P2|Dose Escalation Phase|Progression Disease|2
1659450|NCT01577758|5800683|P1|Dose Escalation Phase|Progression Disease|2
1659451|NCT01577758|5800676|P8|Dose Escalation Phase|Withdrawal by Subject|0
1659452|NCT01577758|5800677|P7|Dose Escalation Phase|Withdrawal by Subject|0
1659453|NCT01577758|5800678|P6|Dose Escalation Phase|Withdrawal by Subject|1
1659454|NCT01577758|5800679|P5|Dose Escalation Phase|Withdrawal by Subject|0
1659455|NCT01577758|5800680|P4|Dose Escalation Phase|Withdrawal by Subject|0
1659456|NCT01577758|5800681|P3|Dose Escalation Phase|Withdrawal by Subject|0
1659457|NCT01577758|5800682|P2|Dose Escalation Phase|Withdrawal by Subject|0
1659458|NCT01577758|5800683|P1|Dose Escalation Phase|Withdrawal by Subject|0
1659459|NCT01577758|5800676|P8|Dose Escalation Phase|Symptomatic Deterioration|0
1659460|NCT01577758|5800677|P7|Dose Escalation Phase|Symptomatic Deterioration|0
1659461|NCT01577758|5800678|P6|Dose Escalation Phase|Symptomatic Deterioration|1
1659462|NCT01577758|5800679|P5|Dose Escalation Phase|Symptomatic Deterioration|1
1659463|NCT01577758|5800680|P4|Dose Escalation Phase|Symptomatic Deterioration|0
1659464|NCT01577758|5800681|P3|Dose Escalation Phase|Symptomatic Deterioration|1
1659465|NCT01577758|5800682|P2|Dose Escalation Phase|Symptomatic Deterioration|0
1659466|NCT01577758|5800683|P1|Dose Escalation Phase|Symptomatic Deterioration|0
1659467|NCT01577758|5800676|P8|Dose Escalation Phase|Adverse Event|0
1659468|NCT01577758|5800677|P7|Dose Escalation Phase|Adverse Event|1
1659469|NCT01577758|5800678|P6|Dose Escalation Phase|Adverse Event|2
1659470|NCT01577758|5800679|P5|Dose Escalation Phase|Adverse Event|0
1659471|NCT01577758|5800680|P4|Dose Escalation Phase|Adverse Event|0
1659472|NCT01577758|5800681|P3|Dose Escalation Phase|Adverse Event|0
1659473|NCT01577758|5800682|P2|Dose Escalation Phase|Adverse Event|0
1659474|NCT01577758|5800683|P1|Dose Escalation Phase|Adverse Event|0
1659475|NCT01577745|5800722|P6|Overall Study|Alternative Therapy|0
1659476|NCT01577745|5800723|P5|Overall Study|Alternative Therapy|1
1659477|NCT01577745|5800724|P4|Overall Study|Alternative Therapy|1
1659478|NCT01577745|5800725|P3|Overall Study|Alternative Therapy|0
1659479|NCT01577745|5800726|P2|Overall Study|Alternative Therapy|0
1659480|NCT01577745|5800727|P1|Overall Study|Alternative Therapy|0
1659481|NCT01577745|5800722|P6|Overall Study|Lost to Follow-up|1
1659482|NCT01577745|5800723|P5|Overall Study|Lost to Follow-up|0
1659483|NCT01577745|5800724|P4|Overall Study|Lost to Follow-up|0
1659484|NCT01577745|5800725|P3|Overall Study|Lost to Follow-up|0
1659485|NCT01577745|5800726|P2|Overall Study|Lost to Follow-up|0
1659486|NCT01577745|5800727|P1|Overall Study|Lost to Follow-up|0
1659487|NCT01577745|5800722|P6|Overall Study|Physician Decision|0
1659488|NCT01577745|5800723|P5|Overall Study|Physician Decision|1
1659489|NCT01577745|5800724|P4|Overall Study|Physician Decision|1
1659490|NCT01577745|5800725|P3|Overall Study|Physician Decision|0
1659491|NCT01577745|5800726|P2|Overall Study|Physician Decision|0
1659492|NCT01577745|5800727|P1|Overall Study|Physician Decision|0
1659493|NCT01577745|5800722|P6|Overall Study|Death|3
1659494|NCT01577745|5800723|P5|Overall Study|Death|1
1659495|NCT01577745|5800724|P4|Overall Study|Death|1
1659496|NCT01577745|5800725|P3|Overall Study|Death|2
1659497|NCT01577745|5800726|P2|Overall Study|Death|2
1659498|NCT01577745|5800727|P1|Overall Study|Death|3
1659499|NCT01577745|5800722|P6|Overall Study|Withdrawal by Subject|0
1659500|NCT01577745|5800723|P5|Overall Study|Withdrawal by Subject|2
1659501|NCT01577745|5800724|P4|Overall Study|Withdrawal by Subject|3
1659502|NCT01577745|5800725|P3|Overall Study|Withdrawal by Subject|0
1659503|NCT01577745|5800726|P2|Overall Study|Withdrawal by Subject|1
1659504|NCT01577745|5800727|P1|Overall Study|Withdrawal by Subject|0
1659505|NCT01577381|5800928|P4|Overall Study|Ongoing at Date of Cut-Off|0
1659506|NCT01577381|5800929|P3|Overall Study|Ongoing at Date of Cut-Off|1
1659507|NCT01577381|5800930|P2|Overall Study|Ongoing at Date of Cut-Off|2
1659508|NCT01577381|5800931|P1|Overall Study|Ongoing at Date of Cut-Off|0
1659509|NCT01577381|5800928|P4|Overall Study|Discontinued|2
1659510|NCT01577381|5800929|P3|Overall Study|Discontinued|2
1659511|NCT01577381|5800930|P2|Overall Study|Discontinued|1
1659512|NCT01577381|5800931|P1|Overall Study|Discontinued|2
1659513|NCT01577186|5801086|P1|Overall Study|Other|2
1659514|NCT01577186|5801086|P1|Overall Study|Non-Compliant|8
1659515|NCT01577186|5801086|P1|Overall Study|Ineligible to Continue|15
1659516|NCT01577186|5801086|P1|Overall Study|Insufficient Response|18
1659517|NCT01577186|5801086|P1|Overall Study|Withdrawal by Subject|35
1659518|NCT01577186|5801086|P1|Overall Study|Lost to Follow-up|28
1659519|NCT01577186|5801086|P1|Overall Study|Death|1
1659520|NCT01577186|5801086|P1|Overall Study|Adverse Event|23
1659521|NCT01577160|5801094|P1|Overall Study|Other|9
1659522|NCT01577160|5801094|P1|Overall Study|Subject Uncooperative|7
1659523|NCT01577160|5801094|P1|Overall Study|Withdrawal by Subject|18
1659524|NCT01577160|5801094|P1|Overall Study|Lost to Follow-up|40
1659525|NCT01577160|5801094|P1|Overall Study|Lack of Efficacy|15
1659526|NCT01577160|5801094|P1|Overall Study|Adverse Event|9
1659527|NCT01576783|5801149|P2|Overall Study|Withdrawal by Subject|1
1659528|NCT01576783|5801150|P1|Overall Study|Withdrawal by Subject|5
1659529|NCT01576783|5801149|P2|Overall Study|Lost to Follow-up|16
1659530|NCT01576783|5801150|P1|Overall Study|Lost to Follow-up|14
1659531|NCT01576783|5801149|P2|Overall Study|Change in Medical Care|0
1659532|NCT01576783|5801150|P1|Overall Study|Change in Medical Care|1
1659533|NCT01576718|5801172|P7|Treatment Period|Noncompliance to study medication|1
1659534|NCT01576718|5801173|P6|Treatment Period|Noncompliance to study medication|1
1659535|NCT01576718|5801174|P5|Treatment Period|Noncompliance to study medication|0
1659536|NCT01576718|5801175|P4|Treatment Period|Noncompliance to study medication|0
1659537|NCT01576718|5801176|P3|Treatment Period|Noncompliance to study medication|0
1659538|NCT01576718|5801177|P2|Treatment Period|Noncompliance to study medication|0
1659539|NCT01576718|5801178|P1|Treatment Period|Noncompliance to study medication|0
1659540|NCT01576718|5801172|P7|Treatment Period|Lost to Follow-up|0
1659541|NCT01576718|5801173|P6|Treatment Period|Lost to Follow-up|0
1659542|NCT01576718|5801174|P5|Treatment Period|Lost to Follow-up|1
1659543|NCT01576718|5801175|P4|Treatment Period|Lost to Follow-up|0
1659544|NCT01576718|5801176|P3|Treatment Period|Lost to Follow-up|0
1659545|NCT01576718|5801177|P2|Treatment Period|Lost to Follow-up|0
1659546|NCT01576718|5801178|P1|Treatment Period|Lost to Follow-up|0
1659547|NCT01576718|5801172|P7|Treatment Period|Met stopping criteria|15
1659548|NCT01576718|5801173|P6|Treatment Period|Met stopping criteria|33
1659549|NCT01576718|5801174|P5|Treatment Period|Met stopping criteria|16
1659550|NCT01576718|5801175|P4|Treatment Period|Met stopping criteria|19
1659551|NCT01576718|5801176|P3|Treatment Period|Met stopping criteria|13
1659552|NCT01576718|5801177|P2|Treatment Period|Met stopping criteria|16
1659553|NCT01576718|5801178|P1|Treatment Period|Met stopping criteria|0
1659554|NCT01576718|5801172|P7|Treatment Period|Sponsor request|0
1659555|NCT01576718|5801173|P6|Treatment Period|Sponsor request|1
1659556|NCT01576718|5801174|P5|Treatment Period|Sponsor request|0
1659557|NCT01576718|5801175|P4|Treatment Period|Sponsor request|0
1659558|NCT01576718|5801176|P3|Treatment Period|Sponsor request|0
1659559|NCT01576718|5801177|P2|Treatment Period|Sponsor request|1
1659560|NCT01576718|5801178|P1|Treatment Period|Sponsor request|0
1659561|NCT01576718|5801172|P7|Treatment Period|Protocol Violation|12
1659562|NCT01576718|5801173|P6|Treatment Period|Protocol Violation|8
1659563|NCT01576718|5801174|P5|Treatment Period|Protocol Violation|6
1659564|NCT01576718|5801175|P4|Treatment Period|Protocol Violation|10
1659565|NCT01576718|5801176|P3|Treatment Period|Protocol Violation|4
1659566|NCT01576718|5801177|P2|Treatment Period|Protocol Violation|5
1659567|NCT01576718|5801178|P1|Treatment Period|Protocol Violation|0
1659568|NCT01576718|5801172|P7|Treatment Period|Physician Decision|0
1659569|NCT01576718|5801173|P6|Treatment Period|Physician Decision|0
1659570|NCT01576718|5801174|P5|Treatment Period|Physician Decision|1
1659571|NCT01576718|5801175|P4|Treatment Period|Physician Decision|1
1659572|NCT01576718|5801176|P3|Treatment Period|Physician Decision|1
1659573|NCT01576718|5801177|P2|Treatment Period|Physician Decision|1
1659574|NCT01576718|5801178|P1|Treatment Period|Physician Decision|0
1659575|NCT01576718|5801172|P7|Treatment Period|Withdrawal by Subject|2
1659576|NCT01576718|5801173|P6|Treatment Period|Withdrawal by Subject|4
1659577|NCT01576718|5801174|P5|Treatment Period|Withdrawal by Subject|2
1659578|NCT01576718|5801175|P4|Treatment Period|Withdrawal by Subject|0
1659579|NCT01576718|5801176|P3|Treatment Period|Withdrawal by Subject|1
1659580|NCT01576718|5801177|P2|Treatment Period|Withdrawal by Subject|1
1659581|NCT01576718|5801178|P1|Treatment Period|Withdrawal by Subject|0
1659582|NCT01576718|5801172|P7|Treatment Period|Adverse Event|0
1659583|NCT01576718|5801173|P6|Treatment Period|Adverse Event|1
1659584|NCT01576718|5801174|P5|Treatment Period|Adverse Event|1
1659585|NCT01576718|5801175|P4|Treatment Period|Adverse Event|1
1659586|NCT01576718|5801176|P3|Treatment Period|Adverse Event|1
1659587|NCT01576718|5801177|P2|Treatment Period|Adverse Event|1
1659588|NCT01576718|5801178|P1|Treatment Period|Adverse Event|0
1659589|NCT01576718|5801172|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
1659590|NCT01576718|5801173|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
1659591|NCT01576718|5801174|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
1659592|NCT01576718|5801175|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
1659593|NCT01576718|5801176|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
1659594|NCT01576718|5801177|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
1659595|NCT01576718|5801178|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
1659596|NCT01576718|5801172|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1659597|NCT01576718|5801173|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1659598|NCT01576718|5801174|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1659599|NCT01576718|5801175|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1659600|NCT01576718|5801176|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1659601|NCT01576718|5801177|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1659602|NCT01576718|5801178|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
1659603|NCT01576718|5801172|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1659604|NCT01576718|5801173|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1659605|NCT01576718|5801174|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1659606|NCT01576718|5801175|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1659607|NCT01576718|5801176|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1659608|NCT01576718|5801177|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1659609|NCT01576718|5801178|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
1659610|NCT01576718|5801172|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1659611|NCT01576718|5801173|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1659612|NCT01576718|5801174|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1659613|NCT01576718|5801175|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1659614|NCT01576718|5801176|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1659615|NCT01576718|5801177|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1659616|NCT01576718|5801178|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
1659617|NCT01576718|5801172|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1659618|NCT01576718|5801173|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1659619|NCT01576718|5801174|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1659620|NCT01576718|5801175|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1659621|NCT01576718|5801176|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1659622|NCT01576718|5801177|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1659623|NCT01576718|5801178|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
1659624|NCT01576575|5801277|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
1659625|NCT01576575|5801277|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
1659626|NCT01576575|5801277|P1|Buprenorphine Control|Withdrawal by Subject|3
1659627|NCT01576549|5801287|P1|Overall Study|Sponsor Decision|2
1659628|NCT01576406|5801316|P6|Overall Study|Other|0
1659629|NCT01576406|5801317|P5|Overall Study|Other|0
1659630|NCT01576406|5801318|P4|Overall Study|Other|2
1659631|NCT01576406|5801319|P3|Overall Study|Other|2
1659632|NCT01576406|5801320|P2|Overall Study|Other|0
1659633|NCT01576406|5801321|P1|Overall Study|Other|0
1659634|NCT01576406|5801316|P6|Overall Study|Withdrawal the consent|3
1659635|NCT01576406|5801317|P5|Overall Study|Withdrawal the consent|1
1659636|NCT01576406|5801318|P4|Overall Study|Withdrawal the consent|1
1659637|NCT01576406|5801319|P3|Overall Study|Withdrawal the consent|5
1659638|NCT01576406|5801320|P2|Overall Study|Withdrawal the consent|2
1659639|NCT01576406|5801321|P1|Overall Study|Withdrawal the consent|2
1659640|NCT01576406|5801316|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
1659641|NCT01576406|5801317|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
1659642|NCT01576406|5801318|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
1659643|NCT01576406|5801319|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
1659644|NCT01576406|5801320|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
1659645|NCT01576406|5801321|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
1659646|NCT01576406|5801316|P6|Overall Study|Death|9
1659647|NCT01576406|5801317|P5|Overall Study|Death|7
1659648|NCT01576406|5801318|P4|Overall Study|Death|5
1659649|NCT01576406|5801319|P3|Overall Study|Death|8
1659650|NCT01576406|5801320|P2|Overall Study|Death|4
1659651|NCT01576406|5801321|P1|Overall Study|Death|3
1659652|NCT01576406|5801316|P6|Overall Study|Lost to Follow-up|0
1659653|NCT01576406|5801317|P5|Overall Study|Lost to Follow-up|0
1659654|NCT01576406|5801318|P4|Overall Study|Lost to Follow-up|0
1659655|NCT01576406|5801319|P3|Overall Study|Lost to Follow-up|0
1659656|NCT01576406|5801320|P2|Overall Study|Lost to Follow-up|2
1659657|NCT01576406|5801321|P1|Overall Study|Lost to Follow-up|1
1659658|NCT01576367|5801569|P1|Overall Study|Moved to commercial use after 6 months|1
1659659|NCT01576367|5801569|P1|Overall Study|Unsatisfactory therapeutic effect|2
1659660|NCT01576341|5801577|P1|Overall Study|Other|12
1659661|NCT01576341|5801577|P1|Overall Study|Protocol Violation|12
1659662|NCT01576341|5801577|P1|Overall Study|Kidney transplantation|10
1659663|NCT01576341|5801577|P1|Overall Study|Lost to Follow-up|2
1659664|NCT01576341|5801577|P1|Overall Study|Physician Decision|2
1659665|NCT01576341|5801577|P1|Overall Study|Death|21
1659666|NCT01576341|5801577|P1|Overall Study|Adverse Event|10
1659667|NCT01576341|5801577|P1|Overall Study|Withdrawal by Subject|24
1659668|NCT01576159|5801598|P4|Overall Study|Protocol Violation|0
1659669|NCT01576159|5801599|P3|Overall Study|Protocol Violation|0
1659670|NCT01576159|5801600|P2|Overall Study|Protocol Violation|0
1659671|NCT01576159|5801601|P1|Overall Study|Protocol Violation|1
1659672|NCT01576159|5801598|P4|Overall Study|Lost to Follow-up|1
1659673|NCT01576159|5801599|P3|Overall Study|Lost to Follow-up|0
1659674|NCT01576159|5801600|P2|Overall Study|Lost to Follow-up|0
1659675|NCT01576159|5801601|P1|Overall Study|Lost to Follow-up|0
1659676|NCT01576159|5801598|P4|Overall Study|Physician Decision|0
1659677|NCT01576159|5801599|P3|Overall Study|Physician Decision|1
1659678|NCT01576159|5801600|P2|Overall Study|Physician Decision|0
1659679|NCT01576159|5801601|P1|Overall Study|Physician Decision|0
1659680|NCT01576159|5801598|P4|Overall Study|Withdrawal by Subject|0
1659681|NCT01576159|5801599|P3|Overall Study|Withdrawal by Subject|0
1659682|NCT01576159|5801600|P2|Overall Study|Withdrawal by Subject|1
1659683|NCT01576159|5801601|P1|Overall Study|Withdrawal by Subject|0
1659684|NCT01576146|5801619|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
1659685|NCT01576146|5801619|P1|Extension Period 2|Renal Transplant|1
1659686|NCT01576146|5801619|P1|Extension Period 2|Adverse Event|1
1659687|NCT01576146|5801619|P1|Extension Period 2|Death|1
1659688|NCT01576146|5801619|P1|Extension Period 2|Sponsor Decision|13
1659689|NCT01576146|5801619|P1|Extension Period 1|Renal Transplant|1
1659690|NCT01576146|5801619|P1|Extension Period 1|Parathyroidectomy|1
1659691|NCT01576146|5801619|P1|Extension Period 1|Lost to Follow-up|1
1659692|NCT01576146|5801619|P1|Extension Period 1|Withdrawal by Subject|1
1659693|NCT01576146|5801619|P1|Extension Period 1|Physician Decision|2
1659694|NCT01576146|5801619|P1|Extension Period 1|Death|2
1659695|NCT01576146|5801619|P1|Extension Period 1|Adverse Event|2
1659696|NCT01576042|5801652|P2|Overall Study|Physician Decision|0
1659697|NCT01576042|5801653|P1|Overall Study|Physician Decision|2
1659698|NCT01575899|5801689|P3|Overall Study|Protocol Violation|0
1659699|NCT01575899|5801690|P2|Overall Study|Protocol Violation|1
1659700|NCT01575899|5801691|P1|Overall Study|Protocol Violation|2
1659701|NCT01575899|5801689|P3|Overall Study|Lost to Follow-up|2
1659702|NCT01575899|5801690|P2|Overall Study|Lost to Follow-up|4
1659703|NCT01575899|5801691|P1|Overall Study|Lost to Follow-up|3
1659704|NCT01575873|5801705|P4|Overall Study|Other|2
1659705|NCT01575873|5801706|P3|Overall Study|Other|4
1659706|NCT01575873|5801707|P2|Overall Study|Other|0
1659707|NCT01575873|5801708|P1|Overall Study|Other|0
1659708|NCT01575873|5801705|P4|Overall Study|Requirement for Alternative Therapy|1
1659709|NCT01575873|5801706|P3|Overall Study|Requirement for Alternative Therapy|1
1659710|NCT01575873|5801707|P2|Overall Study|Requirement for Alternative Therapy|0
1659711|NCT01575873|5801708|P1|Overall Study|Requirement for Alternative Therapy|0
1659712|NCT01575873|5801705|P4|Overall Study|Protocol deviation|1
1659713|NCT01575873|5801706|P3|Overall Study|Protocol deviation|0
1659714|NCT01575873|5801707|P2|Overall Study|Protocol deviation|1
1659715|NCT01575873|5801708|P1|Overall Study|Protocol deviation|0
1659716|NCT01575873|5801705|P4|Overall Study|Administrative decision|0
1659717|NCT01575873|5801706|P3|Overall Study|Administrative decision|1
1659718|NCT01575873|5801707|P2|Overall Study|Administrative decision|1
1659719|NCT01575873|5801708|P1|Overall Study|Administrative decision|1
1659720|NCT01575873|5801705|P4|Overall Study|Noncompliance|3
1659721|NCT01575873|5801706|P3|Overall Study|Noncompliance|4
1659722|NCT01575873|5801707|P2|Overall Study|Noncompliance|2
1659723|NCT01575873|5801708|P1|Overall Study|Noncompliance|1
1659724|NCT01575873|5801705|P4|Overall Study|Death|9
1659725|NCT01575873|5801706|P3|Overall Study|Death|8
1659726|NCT01575873|5801707|P2|Overall Study|Death|2
1659727|NCT01575873|5801708|P1|Overall Study|Death|3
1659728|NCT01575873|5801705|P4|Overall Study|Lost to Follow-up|5
1659729|NCT01575873|5801706|P3|Overall Study|Lost to Follow-up|13
1659730|NCT01575873|5801707|P2|Overall Study|Lost to Follow-up|3
1659731|NCT01575873|5801708|P1|Overall Study|Lost to Follow-up|1
1659732|NCT01575873|5801705|P4|Overall Study|Adverse Event|12
1659733|NCT01575873|5801706|P3|Overall Study|Adverse Event|9
1659734|NCT01575873|5801707|P2|Overall Study|Adverse Event|7
1659735|NCT01575873|5801708|P1|Overall Study|Adverse Event|7
1659736|NCT01575873|5801705|P4|Overall Study|Withdrawal by Subject|34
1659737|NCT01575873|5801706|P3|Overall Study|Withdrawal by Subject|34
1659738|NCT01575873|5801707|P2|Overall Study|Withdrawal by Subject|20
1659739|NCT01575873|5801708|P1|Overall Study|Withdrawal by Subject|15
1659740|NCT01575834|5801734|P2|Overall Study|Requirement for Alternative Therapy|4
1659741|NCT01575834|5801735|P1|Overall Study|Requirement for Alternative Therapy|2
1659742|NCT01575834|5801734|P2|Overall Study|Protocol Deviation|3
1659743|NCT01575834|5801735|P1|Overall Study|Protocol Deviation|4
1659744|NCT01575834|5801734|P2|Overall Study|Ineligibility Determined|8
1659745|NCT01575834|5801735|P1|Overall Study|Ineligibility Determined|5
1659746|NCT01575834|5801734|P2|Overall Study|Administrative decision|33
1659747|NCT01575834|5801735|P1|Overall Study|Administrative decision|15
1659748|NCT01575834|5801734|P2|Overall Study|Noncompliance|27
1659749|NCT01575834|5801735|P1|Overall Study|Noncompliance|52
1659750|NCT01575834|5801734|P2|Overall Study|Lost to Follow-up|68
1659751|NCT01575834|5801735|P1|Overall Study|Lost to Follow-up|55
1659752|NCT01575834|5801734|P2|Overall Study|Adverse Event|61
1659753|NCT01575834|5801735|P1|Overall Study|Adverse Event|63
1659754|NCT01575834|5801734|P2|Overall Study|Other|70
1659755|NCT01575834|5801735|P1|Overall Study|Other|70
1659756|NCT01575834|5801734|P2|Overall Study|Death|74
1659757|NCT01575834|5801735|P1|Overall Study|Death|81
1659758|NCT01575834|5801734|P2|Overall Study|Withdrawal by Subject|390
1659759|NCT01575834|5801735|P1|Overall Study|Withdrawal by Subject|352
1659760|NCT01575808|5801787|P2|Overall Study|Withdrawal by Subject|0
1659761|NCT01575808|5801788|P1|Overall Study|Withdrawal by Subject|1
1659762|NCT01575808|5801787|P2|Overall Study|Death|0
1659763|NCT01575808|5801788|P1|Overall Study|Death|2
1659764|NCT01575769|5801835|P1|Overall Study|Study terminated by sponsor|40
1659765|NCT01575769|5801835|P1|Overall Study|Adverse Event|1
1659766|NCT01575561|5801893|P1|Overall Study|administration|1
1659767|NCT01575561|5801893|P1|Overall Study|Withdrawal by Subject|11
1659768|NCT01575561|5801893|P1|Overall Study|Protocol Violation|4
1659769|NCT01575561|5801893|P1|Overall Study|Lost to Follow-up|6
1659770|NCT01575561|5801893|P1|Overall Study|Lack of Efficacy|8
1659771|NCT01575561|5801893|P1|Overall Study|Adverse Event|9
1659772|NCT01575197|5801923|P3|Overall Study|Protocol Violation|1
1659773|NCT01575197|5801924|P2|Overall Study|Protocol Violation|1
1659774|NCT01575197|5801925|P1|Overall Study|Protocol Violation|2
1659775|NCT01575197|5801923|P3|Overall Study|Withdrawal by Subject|1
1659776|NCT01575197|5801924|P2|Overall Study|Withdrawal by Subject|1
1659777|NCT01575197|5801925|P1|Overall Study|Withdrawal by Subject|0
1659778|NCT01575197|5801923|P3|Overall Study|Lost to Follow-up|0
1659779|NCT01575197|5801924|P2|Overall Study|Lost to Follow-up|1
1659780|NCT01575197|5801925|P1|Overall Study|Lost to Follow-up|0
1659781|NCT01575197|5801923|P3|Overall Study|SAE|0
1659782|NCT01575197|5801924|P2|Overall Study|SAE|1
1659783|NCT01575197|5801925|P1|Overall Study|SAE|0
1659784|NCT01575197|5801923|P3|Overall Study|Migration out of study area|4
1659785|NCT01575197|5801924|P2|Overall Study|Migration out of study area|5
1659786|NCT01575197|5801925|P1|Overall Study|Migration out of study area|1
1659787|NCT01575054|5801953|P2|Overall Study|Adverse Event|8
1659788|NCT01575054|5801954|P1|Overall Study|Adverse Event|9
1659789|NCT01575054|5801953|P2|Overall Study|Lost to Follow-up|3
1659790|NCT01575054|5801954|P1|Overall Study|Lost to Follow-up|3
1659791|NCT01575054|5801953|P2|Overall Study|Personal Reasons|11
1659792|NCT01575054|5801954|P1|Overall Study|Personal Reasons|10
1659793|NCT01575054|5801953|P2|Overall Study|Protocol Violation|1
1659794|NCT01575054|5801954|P1|Overall Study|Protocol Violation|2
1659795|NCT01575054|5801953|P2|Overall Study|Other Reasons|3
1659796|NCT01575054|5801954|P1|Overall Study|Other Reasons|5
1659797|NCT01575028|5801970|P2|Overall Study|Physician Decision|1
1659798|NCT01575028|5801971|P1|Overall Study|Physician Decision|0
1659799|NCT01574716|5801982|P5|Part 2|Lost to Follow-up|0
1659800|NCT01574716|5801983|P4|Part 2|Lost to Follow-up|3
1659801|NCT01574716|5801984|P3|Part 2|Lost to Follow-up|0
1659802|NCT01574716|5801985|P2|Part 2|Lost to Follow-up|0
1659803|NCT01574716|5801986|P1|Part 2|Lost to Follow-up|0
1659804|NCT01574716|5801982|P5|Part 2|Brain metastases|0
1659805|NCT01574716|5801983|P4|Part 2|Brain metastases|1
1659806|NCT01574716|5801984|P3|Part 2|Brain metastases|0
1659807|NCT01574716|5801985|P2|Part 2|Brain metastases|0
1659808|NCT01574716|5801986|P1|Part 2|Brain metastases|0
1659809|NCT01574716|5801982|P5|Part 2|Withdrawal by Subject|4
1659810|NCT01574716|5801983|P4|Part 2|Withdrawal by Subject|5
1659811|NCT01574716|5801984|P3|Part 2|Withdrawal by Subject|0
1659812|NCT01574716|5801985|P2|Part 2|Withdrawal by Subject|0
1659813|NCT01574716|5801986|P1|Part 2|Withdrawal by Subject|0
1659814|NCT01574716|5801982|P5|Part 2|Discontinuation of study by sponsor|31
1659815|NCT01574716|5801983|P4|Part 2|Discontinuation of study by sponsor|51
1659816|NCT01574716|5801984|P3|Part 2|Discontinuation of study by sponsor|0
1659817|NCT01574716|5801985|P2|Part 2|Discontinuation of study by sponsor|0
1659818|NCT01574716|5801986|P1|Part 2|Discontinuation of study by sponsor|0
1659819|NCT01574716|5801982|P5|Part 2|Death|35
1659820|NCT01574716|5801983|P4|Part 2|Death|76
1659821|NCT01574716|5801984|P3|Part 2|Death|0
1659822|NCT01574716|5801985|P2|Part 2|Death|0
1659823|NCT01574716|5801986|P1|Part 2|Death|0
1659824|NCT01574716|5801982|P5|Part 2|Progressive disease|0
1659825|NCT01574716|5801983|P4|Part 2|Progressive disease|1
1659826|NCT01574716|5801984|P3|Part 2|Progressive disease|0
1659827|NCT01574716|5801985|P2|Part 2|Progressive disease|0
1659828|NCT01574716|5801986|P1|Part 2|Progressive disease|0
1659829|NCT01574716|5801982|P5|Part 1|Lost to Follow-up|0
1659830|NCT01574716|5801983|P4|Part 1|Lost to Follow-up|0
1659831|NCT01574716|5801984|P3|Part 1|Lost to Follow-up|0
1659832|NCT01574716|5801985|P2|Part 1|Lost to Follow-up|1
1659833|NCT01574716|5801986|P1|Part 1|Lost to Follow-up|0
1659834|NCT01574716|5801982|P5|Part 1|Withdrawal by Subject|0
1659835|NCT01574716|5801983|P4|Part 1|Withdrawal by Subject|0
1659836|NCT01574716|5801984|P3|Part 1|Withdrawal by Subject|0
1659837|NCT01574716|5801985|P2|Part 1|Withdrawal by Subject|2
1659838|NCT01574716|5801986|P1|Part 1|Withdrawal by Subject|0
1659839|NCT01574716|5801982|P5|Part 1|Discontinuation of study by sponsor|0
1659840|NCT01574716|5801983|P4|Part 1|Discontinuation of study by sponsor|0
1659841|NCT01574716|5801984|P3|Part 1|Discontinuation of study by sponsor|1
1659842|NCT01574716|5801985|P2|Part 1|Discontinuation of study by sponsor|0
1659843|NCT01574716|5801986|P1|Part 1|Discontinuation of study by sponsor|0
1659844|NCT01574716|5801982|P5|Part 1|Death|0
1659845|NCT01574716|5801983|P4|Part 1|Death|0
1659846|NCT01574716|5801984|P3|Part 1|Death|8
1659847|NCT01574716|5801985|P2|Part 1|Death|1
1659848|NCT01574716|5801986|P1|Part 1|Death|3
1659849|NCT01574703|5802009|P4|Overall Study|Death|0
1659850|NCT01574703|5802010|P3|Overall Study|Death|1
1659851|NCT01574703|5802011|P2|Overall Study|Death|1
1659852|NCT01574703|5802012|P1|Overall Study|Death|2
1659853|NCT01574703|5802009|P4|Overall Study|Lost to Follow-up|35
1659854|NCT01574703|5802010|P3|Overall Study|Lost to Follow-up|46
1659855|NCT01574703|5802011|P2|Overall Study|Lost to Follow-up|41
1659856|NCT01574703|5802012|P1|Overall Study|Lost to Follow-up|43
1659857|NCT01574703|5802009|P4|Overall Study|Met Withdrawal Criteria|0
1659858|NCT01574703|5802010|P3|Overall Study|Met Withdrawal Criteria|1
1659859|NCT01574703|5802011|P2|Overall Study|Met Withdrawal Criteria|1
1659860|NCT01574703|5802012|P1|Overall Study|Met Withdrawal Criteria|0
1659861|NCT01574703|5802009|P4|Overall Study|Withdrawal by Subject|61
1659862|NCT01574703|5802010|P3|Overall Study|Withdrawal by Subject|36
1659863|NCT01574703|5802011|P2|Overall Study|Withdrawal by Subject|52
1659864|NCT01574703|5802012|P1|Overall Study|Withdrawal by Subject|53
1659865|NCT01574703|5802009|P4|Overall Study|Unspecified Reason|16
1659866|NCT01574703|5802010|P3|Overall Study|Unspecified Reason|20
1659867|NCT01574703|5802011|P2|Overall Study|Unspecified Reason|15
1659868|NCT01574703|5802012|P1|Overall Study|Unspecified Reason|27
1659869|NCT01574703|5802009|P4|Overall Study|Protocol Violation|1
1659870|NCT01574703|5802010|P3|Overall Study|Protocol Violation|0
1659871|NCT01574703|5802011|P2|Overall Study|Protocol Violation|0
1659872|NCT01574703|5802012|P1|Overall Study|Protocol Violation|0
1659873|NCT01574703|5802009|P4|Overall Study|Adverse Event|1
1659874|NCT01574703|5802010|P3|Overall Study|Adverse Event|1
1659875|NCT01574703|5802011|P2|Overall Study|Adverse Event|2
1659876|NCT01574703|5802012|P1|Overall Study|Adverse Event|0
1659877|NCT01574651|5802056|P2|Overall Study|Withdrawal by Subject|10
1659878|NCT01574651|5802057|P1|Overall Study|Withdrawal by Subject|9
1659879|NCT01574651|5802056|P2|Overall Study|Protocol Violation|5
1659880|NCT01574651|5802057|P1|Overall Study|Protocol Violation|3
1659881|NCT01574651|5802056|P2|Overall Study|Unsatisfactory therapeutic effect|0
1659882|NCT01574651|5802057|P1|Overall Study|Unsatisfactory therapeutic effect|6
1659883|NCT01574651|5802056|P2|Overall Study|Abnormal test procedure result(s)|1
1659884|NCT01574651|5802057|P1|Overall Study|Abnormal test procedure result(s)|1
1659885|NCT01574651|5802056|P2|Overall Study|Abnormal laboratory value(s)|0
1659886|NCT01574651|5802057|P1|Overall Study|Abnormal laboratory value(s)|1
1659887|NCT01574651|5802056|P2|Overall Study|Adverse Event|27
1659888|NCT01574651|5802057|P1|Overall Study|Adverse Event|36
1659889|NCT01574651|5802056|P2|Overall Study|Patient's inability to use the device|1
1659890|NCT01574651|5802057|P1|Overall Study|Patient's inability to use the device|0
1659891|NCT01574651|5802056|P2|Overall Study|Death|3
1659892|NCT01574651|5802057|P1|Overall Study|Death|3
1659893|NCT01574651|5802056|P2|Overall Study|Administrative problems|1
1659894|NCT01574651|5802057|P1|Overall Study|Administrative problems|0
1659895|NCT01574651|5802056|P2|Overall Study|Lost to Follow-up|4
1659896|NCT01574651|5802057|P1|Overall Study|Lost to Follow-up|2
1659897|NCT01574612|5802079|P1|Overall Study|Lost to Follow-up|2
1659898|NCT01574612|5802079|P1|Overall Study|Withdrawal by Subject|1
1659899|NCT01574612|5802079|P1|Overall Study|non compliant with drug|2
1659900|NCT01574612|5802079|P1|Overall Study|Adverse Event|3
1659901|NCT01574326|5802085|P2|Overall Study|Other: Mainly kidney transplant|8
1659902|NCT01574326|5802086|P1|Overall Study|Other: Mainly kidney transplant|8
1659903|NCT01574326|5802085|P2|Overall Study|Adverse Event|3
1659904|NCT01574326|5802086|P1|Overall Study|Adverse Event|1
1659905|NCT01574326|5802085|P2|Overall Study|Physician Decision|3
1659906|NCT01574326|5802086|P1|Overall Study|Physician Decision|5
1659907|NCT01574326|5802085|P2|Overall Study|Withdrawal by Participant|4
1659908|NCT01574326|5802086|P1|Overall Study|Withdrawal by Participant|2
1659909|NCT01574326|5802085|P2|Overall Study|Randomized but not treated|1
1659910|NCT01574326|5802086|P1|Overall Study|Randomized but not treated|0
1659911|NCT01574248|5802104|P2|Overall Study|Missing primary endpoint data|0
1659912|NCT01574248|5802105|P1|Overall Study|Missing primary endpoint data|1
1659913|NCT01574248|5802104|P2|Overall Study|Withdrawal by Subject|0
1659914|NCT01574248|5802105|P1|Overall Study|Withdrawal by Subject|2
1659915|NCT01574157|5802138|P2|Overall Study|Lost to Follow-up|3
1659916|NCT01574157|5802139|P1|Overall Study|Lost to Follow-up|0
1659917|NCT01574157|5802138|P2|Overall Study|Withdrawal by Subject|5
1659918|NCT01574157|5802139|P1|Overall Study|Withdrawal by Subject|4
1659919|NCT01574079|5802173|P2|Overall Study|Lost to Follow-up|0
1659920|NCT01574079|5802174|P1|Overall Study|Lost to Follow-up|1
1659921|NCT01574079|5802173|P2|Overall Study|Physician Decision|2
1659922|NCT01574079|5802174|P1|Overall Study|Physician Decision|0
1659923|NCT01573910|5802186|P2|Overall Study|Patient decision unrelated to Advs Event|11
1659924|NCT01573910|5802187|P1|Overall Study|Patient decision unrelated to Advs Event|11
1659925|NCT01573910|5802186|P2|Overall Study|Protocol Violation|0
1659926|NCT01573910|5802187|P1|Overall Study|Protocol Violation|3
1659927|NCT01573910|5802186|P2|Overall Study|Withdrawal by Subject|1
1659928|NCT01573910|5802187|P1|Overall Study|Withdrawal by Subject|0
1659929|NCT01573910|5802186|P2|Overall Study|Lost to Follow-up|1
1659930|NCT01573910|5802187|P1|Overall Study|Lost to Follow-up|2
1659931|NCT01573910|5802186|P2|Overall Study|Adverse Event|4
1659932|NCT01573910|5802187|P1|Overall Study|Adverse Event|4
1659933|NCT01573767|5802199|P4|Overall Study|Withdrawal by Subject|0
1659934|NCT01573767|5802200|P3|Overall Study|Withdrawal by Subject|0
1659935|NCT01573767|5802201|P2|Overall Study|Withdrawal by Subject|1
1659936|NCT01573767|5802202|P1|Overall Study|Withdrawal by Subject|0
1659937|NCT01573767|5802199|P4|Overall Study|Physician Decision|2
1659938|NCT01573767|5802200|P3|Overall Study|Physician Decision|0
1659939|NCT01573767|5802201|P2|Overall Study|Physician Decision|2
1659940|NCT01573767|5802202|P1|Overall Study|Physician Decision|1
1659941|NCT01573767|5802199|P4|Overall Study|Lost to Follow-up|1
1659942|NCT01573767|5802200|P3|Overall Study|Lost to Follow-up|1
1659943|NCT01573767|5802201|P2|Overall Study|Lost to Follow-up|1
1659944|NCT01573767|5802202|P1|Overall Study|Lost to Follow-up|0
1659945|NCT01573767|5802199|P4|Overall Study|Protocol Violation|3
1659946|NCT01573767|5802200|P3|Overall Study|Protocol Violation|1
1659947|NCT01573767|5802201|P2|Overall Study|Protocol Violation|1
1659948|NCT01573767|5802202|P1|Overall Study|Protocol Violation|3
1659949|NCT01573767|5802199|P4|Overall Study|Lack of Efficacy|17
1659950|NCT01573767|5802200|P3|Overall Study|Lack of Efficacy|12
1659951|NCT01573767|5802201|P2|Overall Study|Lack of Efficacy|15
1659952|NCT01573767|5802202|P1|Overall Study|Lack of Efficacy|18
1659953|NCT01573767|5802199|P4|Overall Study|Adverse Event|1
1659954|NCT01573767|5802200|P3|Overall Study|Adverse Event|0
1659955|NCT01573767|5802201|P2|Overall Study|Adverse Event|1
1659956|NCT01573767|5802202|P1|Overall Study|Adverse Event|0
1659957|NCT01573624|5802236|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1659958|NCT01573624|5802237|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1659959|NCT01573624|5802238|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1659960|NCT01573624|5802239|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1659961|NCT01573624|5802240|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1659962|NCT01573624|5802241|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
1659963|NCT01573624|5802242|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
1659964|NCT01573624|5802236|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1659965|NCT01573624|5802237|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
1659966|NCT01573624|5802238|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
1659967|NCT01573624|5802239|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1659968|NCT01573624|5802240|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1659969|NCT01573624|5802241|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1659970|NCT01573624|5802242|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
1659971|NCT01573624|5802236|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1659972|NCT01573624|5802237|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1659973|NCT01573624|5802238|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1659974|NCT01573624|5802239|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1659975|NCT01573624|5802240|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1659976|NCT01573624|5802241|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
1659977|NCT01573624|5802242|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
1659978|NCT01573624|5802236|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1659979|NCT01573624|5802237|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1659980|NCT01573624|5802238|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1659981|NCT01573624|5802239|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1659982|NCT01573624|5802240|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1659983|NCT01573624|5802241|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
1659984|NCT01573624|5802242|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
1659985|NCT01573624|5802236|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
1659986|NCT01573624|5802237|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1659987|NCT01573624|5802238|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
1659988|NCT01573624|5802239|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1659989|NCT01573624|5802240|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1659990|NCT01573624|5802241|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
1659991|NCT01573624|5802242|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
1659992|NCT01573624|5802236|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1659993|NCT01573624|5802237|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1659994|NCT01573624|5802238|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1659995|NCT01573624|5802239|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1659996|NCT01573624|5802240|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1659997|NCT01573624|5802241|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
1659998|NCT01573624|5802242|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
1659999|NCT01573624|5802236|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1660000|NCT01573624|5802237|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
1660001|NCT01573624|5802238|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1660002|NCT01573624|5802239|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1660003|NCT01573624|5802240|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1660004|NCT01573624|5802241|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1660005|NCT01573624|5802242|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
1660006|NCT01573624|5802236|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1660007|NCT01573624|5802237|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1660008|NCT01573624|5802238|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1660009|NCT01573624|5802239|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1660010|NCT01573624|5802240|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1660011|NCT01573624|5802241|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
1660012|NCT01573624|5802242|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
1660013|NCT01573624|5802236|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1660014|NCT01573624|5802237|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1660015|NCT01573624|5802238|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1660016|NCT01573624|5802239|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1660017|NCT01573624|5802240|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1660018|NCT01573624|5802241|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
1660019|NCT01573624|5802242|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
1660020|NCT01573624|5802236|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1660021|NCT01573624|5802237|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1660022|NCT01573624|5802238|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1660023|NCT01573624|5802239|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1660024|NCT01573624|5802240|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1660025|NCT01573624|5802241|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
1660026|NCT01573624|5802242|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
1660027|NCT01573624|5802236|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1660028|NCT01573624|5802237|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1660029|NCT01573624|5802238|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1660030|NCT01573624|5802239|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1660031|NCT01573624|5802240|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1660032|NCT01573624|5802241|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
1660033|NCT01573624|5802242|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
1660034|NCT01573624|5802236|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1660035|NCT01573624|5802237|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1660036|NCT01573624|5802238|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1660037|NCT01573624|5802239|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1660038|NCT01573624|5802240|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1660039|NCT01573624|5802241|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
1660040|NCT01573624|5802242|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
1660041|NCT01573624|5802236|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1660042|NCT01573624|5802237|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1660043|NCT01573624|5802238|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1660044|NCT01573624|5802239|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1660045|NCT01573624|5802240|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1660046|NCT01573624|5802241|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1660047|NCT01573624|5802242|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1660048|NCT01573624|5802236|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1660049|NCT01573624|5802237|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1660050|NCT01573624|5802238|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1660051|NCT01573624|5802239|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1660052|NCT01573624|5802240|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1660053|NCT01573624|5802241|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
1660054|NCT01573624|5802242|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
1660055|NCT01573624|5802236|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1660056|NCT01573624|5802237|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
1660057|NCT01573624|5802238|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1660058|NCT01573624|5802239|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1660059|NCT01573624|5802240|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1660060|NCT01573624|5802241|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
1660061|NCT01573624|5802242|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
1660062|NCT01573624|5802236|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
1660063|NCT01573624|5802237|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1660064|NCT01573624|5802238|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
1660065|NCT01573624|5802239|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
1660066|NCT01573624|5802240|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
1660067|NCT01573624|5802241|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
1660068|NCT01573624|5802242|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
1660069|NCT01573624|5802236|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1660070|NCT01573624|5802237|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1660071|NCT01573624|5802238|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1660072|NCT01573624|5802239|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1660073|NCT01573624|5802240|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
1660074|NCT01573624|5802241|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1660075|NCT01573624|5802242|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
1660076|NCT01573624|5802236|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
1660077|NCT01573624|5802237|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1660078|NCT01573624|5802238|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1660079|NCT01573624|5802239|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
1660080|NCT01573624|5802240|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1660081|NCT01573624|5802241|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1660082|NCT01573624|5802242|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
1660083|NCT01573624|5802236|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1660084|NCT01573624|5802237|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
1660085|NCT01573624|5802238|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1660086|NCT01573624|5802239|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1660087|NCT01573624|5802240|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1660088|NCT01573624|5802241|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1660089|NCT01573624|5802242|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
1660090|NCT01573624|5802236|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1660091|NCT01573624|5802237|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1660092|NCT01573624|5802238|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1660093|NCT01573624|5802239|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1660094|NCT01573624|5802240|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
1660095|NCT01573624|5802241|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
1660096|NCT01573624|5802242|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
1660097|NCT01573624|5802236|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1660098|NCT01573624|5802237|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1660099|NCT01573624|5802238|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1660100|NCT01573624|5802239|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1660101|NCT01573624|5802240|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1660102|NCT01573624|5802241|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
1660103|NCT01573624|5802242|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
1660104|NCT01573624|5802236|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1660105|NCT01573624|5802237|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
1660106|NCT01573624|5802238|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1660107|NCT01573624|5802239|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1660108|NCT01573624|5802240|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1660109|NCT01573624|5802241|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1660110|NCT01573624|5802242|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
1660111|NCT01573624|5802236|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1660112|NCT01573624|5802237|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1660113|NCT01573624|5802238|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1660114|NCT01573624|5802239|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1660115|NCT01573624|5802240|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
1660116|NCT01573624|5802241|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1660117|NCT01573624|5802242|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
1660118|NCT01573624|5802236|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1660119|NCT01573624|5802237|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
1660120|NCT01573624|5802238|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1660121|NCT01573624|5802239|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1660122|NCT01573624|5802240|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1660123|NCT01573624|5802241|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
1660124|NCT01573624|5802242|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
1660125|NCT01573624|5802236|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1660126|NCT01573624|5802237|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1660127|NCT01573624|5802238|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1660128|NCT01573624|5802239|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1660129|NCT01573624|5802240|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1660130|NCT01573624|5802241|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
1660131|NCT01573624|5802242|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
1660132|NCT01573624|5802236|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1660133|NCT01573624|5802237|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
1660134|NCT01573624|5802238|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
1660135|NCT01573624|5802239|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
1660136|NCT01573624|5802240|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
1660137|NCT01573624|5802241|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
1660138|NCT01573624|5802242|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
1660139|NCT01573624|5802236|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1660140|NCT01573624|5802237|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1660141|NCT01573624|5802238|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1660142|NCT01573624|5802239|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1660143|NCT01573624|5802240|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
1660144|NCT01573624|5802241|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1660145|NCT01573624|5802242|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
1660146|NCT01573442|5802298|P2|Overall Study|Cancels|10
1660147|NCT01573442|5802299|P1|Overall Study|Cancels|9
1660148|NCT01573000|5802430|P2|Long-Term Follow-Up|Lost to Follow-up|1
1660149|NCT01573000|5802431|P1|Long-Term Follow-Up|Lost to Follow-up|0
1660150|NCT01573000|5802430|P2|Long-Term Follow-Up|Death|0
1660151|NCT01573000|5802431|P1|Long-Term Follow-Up|Death|3
1660152|NCT01573000|5802430|P2|Crossover Phase|Death|3
1660153|NCT01573000|5802431|P1|Crossover Phase|Death|0
1660154|NCT01573000|5802430|P2|Crossover Phase|Lost to Follow-up|2
1660155|NCT01573000|5802431|P1|Crossover Phase|Lost to Follow-up|0
1660156|NCT01573000|5802430|P2|Crossover Phase|Lack of Efficacy|13
1660157|NCT01573000|5802431|P1|Crossover Phase|Lack of Efficacy|0
1660158|NCT01573000|5802430|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
1660159|NCT01573000|5802431|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
1660160|NCT01573000|5802430|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
1660161|NCT01573000|5802431|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
1660162|NCT01573000|5802430|P2|Dosimetric and Therapeutic Treatment|Death|1
1660163|NCT01573000|5802431|P1|Dosimetric and Therapeutic Treatment|Death|0
1660164|NCT01573000|5802430|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
1660165|NCT01573000|5802431|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
1660166|NCT01573000|5802430|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
1660167|NCT01573000|5802431|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
1660168|NCT01572948|5802527|P2|Overall Study|unable to contact|1
1660169|NCT01572948|5802528|P1|Overall Study|unable to contact|0
1660170|NCT01572948|5802527|P2|Overall Study|Lost to Follow-up|0
1660171|NCT01572948|5802528|P1|Overall Study|Lost to Follow-up|1
1660172|NCT01572922|5802544|P1|Overall Study|Death|1
1660173|NCT01572922|5802544|P1|Overall Study|Protocol Violation|1
1660174|NCT01572922|5802544|P1|Overall Study|Adverse Event|1
1660175|NCT01572844|5802554|P2|Overall Study|Physician Decision|1
1660176|NCT01572844|5802555|P1|Overall Study|Physician Decision|1
1660177|NCT01572792|5802573|P5|Extension Study|Site termination/COPD exacerbation/other|6
1660178|NCT01572792|5802574|P4|Extension Study|Site termination/COPD exacerbation/other|6
1660179|NCT01572792|5802575|P3|Extension Study|Site termination/COPD exacerbation/other|4
1660180|NCT01572792|5802576|P2|Extension Study|Site termination/COPD exacerbation/other|8
1660181|NCT01572792|5802577|P1|Extension Study|Site termination/COPD exacerbation/other|3
1660182|NCT01572792|5802573|P5|Extension Study|Adverse Event|4
1660183|NCT01572792|5802574|P4|Extension Study|Adverse Event|6
1660184|NCT01572792|5802575|P3|Extension Study|Adverse Event|5
1660185|NCT01572792|5802576|P2|Extension Study|Adverse Event|6
1660186|NCT01572792|5802577|P1|Extension Study|Adverse Event|7
1660187|NCT01572792|5802573|P5|Extension Study|Lack of Efficacy|2
1660188|NCT01572792|5802574|P4|Extension Study|Lack of Efficacy|2
1660189|NCT01572792|5802575|P3|Extension Study|Lack of Efficacy|3
1660190|NCT01572792|5802576|P2|Extension Study|Lack of Efficacy|3
1660191|NCT01572792|5802577|P1|Extension Study|Lack of Efficacy|2
1660192|NCT01572792|5802573|P5|Extension Study|Protocol Violation|3
1660193|NCT01572792|5802574|P4|Extension Study|Protocol Violation|4
1660194|NCT01572792|5802575|P3|Extension Study|Protocol Violation|3
1660195|NCT01572792|5802576|P2|Extension Study|Protocol Violation|4
1660196|NCT01572792|5802577|P1|Extension Study|Protocol Violation|0
1660197|NCT01572792|5802573|P5|Extension Study|Withdrawal by Subject|14
1660198|NCT01572792|5802574|P4|Extension Study|Withdrawal by Subject|8
1660199|NCT01572792|5802575|P3|Extension Study|Withdrawal by Subject|11
1660200|NCT01572792|5802576|P2|Extension Study|Withdrawal by Subject|6
1660201|NCT01572792|5802577|P1|Extension Study|Withdrawal by Subject|7
1660202|NCT01572792|5802573|P5|Extension Study|Lost to Follow-up|3
1660203|NCT01572792|5802574|P4|Extension Study|Lost to Follow-up|3
1660204|NCT01572792|5802575|P3|Extension Study|Lost to Follow-up|0
1660205|NCT01572792|5802576|P2|Extension Study|Lost to Follow-up|2
1660206|NCT01572792|5802577|P1|Extension Study|Lost to Follow-up|6
1660207|NCT01572792|5802573|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
1660208|NCT01572792|5802574|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
1660209|NCT01572792|5802575|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
1660210|NCT01572792|5802576|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
1660211|NCT01572792|5802577|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
1660212|NCT01572792|5802573|P5|Lead-in Study|Adverse Event|14
1660213|NCT01572792|5802574|P4|Lead-in Study|Adverse Event|16
1660214|NCT01572792|5802575|P3|Lead-in Study|Adverse Event|22
1660215|NCT01572792|5802576|P2|Lead-in Study|Adverse Event|21
1660216|NCT01572792|5802577|P1|Lead-in Study|Adverse Event|21
1660217|NCT01572792|5802573|P5|Lead-in Study|Lack of Efficacy|10
1660218|NCT01572792|5802574|P4|Lead-in Study|Lack of Efficacy|8
1660219|NCT01572792|5802575|P3|Lead-in Study|Lack of Efficacy|4
1660220|NCT01572792|5802576|P2|Lead-in Study|Lack of Efficacy|5
1660221|NCT01572792|5802577|P1|Lead-in Study|Lack of Efficacy|20
1660222|NCT01572792|5802573|P5|Lead-in Study|Protocol Violation|21
1660223|NCT01572792|5802574|P4|Lead-in Study|Protocol Violation|13
1660224|NCT01572792|5802575|P3|Lead-in Study|Protocol Violation|12
1660225|NCT01572792|5802576|P2|Lead-in Study|Protocol Violation|10
1660226|NCT01572792|5802577|P1|Lead-in Study|Protocol Violation|19
1660227|NCT01572792|5802573|P5|Lead-in Study|Withdrawal by Subject|11
1660228|NCT01572792|5802574|P4|Lead-in Study|Withdrawal by Subject|24
1660229|NCT01572792|5802575|P3|Lead-in Study|Withdrawal by Subject|12
1660230|NCT01572792|5802576|P2|Lead-in Study|Withdrawal by Subject|11
1660231|NCT01572792|5802577|P1|Lead-in Study|Withdrawal by Subject|22
1660232|NCT01572792|5802573|P5|Lead-in Study|Lost to Follow-up|4
1660233|NCT01572792|5802574|P4|Lead-in Study|Lost to Follow-up|2
1660234|NCT01572792|5802575|P3|Lead-in Study|Lost to Follow-up|4
1660235|NCT01572792|5802576|P2|Lead-in Study|Lost to Follow-up|9
1660236|NCT01572792|5802577|P1|Lead-in Study|Lost to Follow-up|5
1660237|NCT01572740|5802626|P2|Overall Study|unclassified|3
1660238|NCT01572740|5802627|P1|Overall Study|unclassified|4
1660239|NCT01572740|5802626|P2|Overall Study|Withdrawal by Subject|1
1660240|NCT01572740|5802627|P1|Overall Study|Withdrawal by Subject|1
1660241|NCT01572740|5802626|P2|Overall Study|Adverse Event|1
1660242|NCT01572740|5802627|P1|Overall Study|Adverse Event|1
1660243|NCT01572727|5802657|P2|Overall Study|Untreated|7
1660244|NCT01572727|5802658|P1|Overall Study|Untreated|4
1660245|NCT01572727|5802657|P2|Overall Study|Death|2
1660246|NCT01572727|5802658|P1|Overall Study|Death|2
1660247|NCT01572727|5802657|P2|Overall Study|Parent/guardian decision|9
1660248|NCT01572727|5802658|P1|Overall Study|Parent/guardian decision|14
1660249|NCT01572727|5802657|P2|Overall Study|Study terminated by sponsor|83
1660250|NCT01572727|5802658|P1|Overall Study|Study terminated by sponsor|61
1660251|NCT01572727|5802657|P2|Overall Study|Protocol Violation|1
1660252|NCT01572727|5802658|P1|Overall Study|Protocol Violation|0
1660253|NCT01572727|5802657|P2|Overall Study|Progressive disease|82
1660254|NCT01572727|5802658|P1|Overall Study|Progressive disease|59
1660255|NCT01572727|5802657|P2|Overall Study|Physician Decision|9
1660256|NCT01572727|5802658|P1|Overall Study|Physician Decision|23
1660257|NCT01572727|5802657|P2|Overall Study|Lost to Follow-up|1
1660258|NCT01572727|5802658|P1|Overall Study|Lost to Follow-up|1
1660259|NCT01572727|5802657|P2|Overall Study|Adverse Event|15
1660260|NCT01572727|5802658|P1|Overall Study|Adverse Event|43
1660261|NCT01572675|5802680|P2|Overall Study|Lost to Follow-up|27
1660262|NCT01572675|5802681|P1|Overall Study|Lost to Follow-up|22
1660263|NCT01572675|5802680|P2|Overall Study|Missing data|4
1660264|NCT01572675|5802681|P1|Overall Study|Missing data|1
1660265|NCT01572675|5802680|P2|Overall Study|Rheumatologist new evaluation|1
1660266|NCT01572675|5802681|P1|Overall Study|Rheumatologist new evaluation|0
1660267|NCT01572675|5802680|P2|Overall Study|Unknown reason|1
1660268|NCT01572675|5802681|P1|Overall Study|Unknown reason|1
1660269|NCT01572675|5802680|P2|Overall Study|Other disease detected|1
1660270|NCT01572675|5802681|P1|Overall Study|Other disease detected|1
1660271|NCT01572675|5802680|P2|Overall Study|Death unrelated to coxibs|1
1660272|NCT01572675|5802681|P1|Overall Study|Death unrelated to coxibs|1
1660273|NCT01572675|5802680|P2|Overall Study|Physician Decision|2
1660274|NCT01572675|5802681|P1|Overall Study|Physician Decision|2
1660275|NCT01572675|5802680|P2|Overall Study|Withdrawal by Subject|1
1660276|NCT01572675|5802681|P1|Overall Study|Withdrawal by Subject|5
1660277|NCT01572675|5802680|P2|Overall Study|Surgical intervention|6
1660278|NCT01572675|5802681|P1|Overall Study|Surgical intervention|3
1660279|NCT01572675|5802680|P2|Overall Study|Improved symptoms|2
1660280|NCT01572675|5802681|P1|Overall Study|Improved symptoms|8
1660281|NCT01572675|5802680|P2|Overall Study|Intolerance|5
1660282|NCT01572675|5802681|P1|Overall Study|Intolerance|6
1660283|NCT01572675|5802680|P2|Overall Study|Lack of Efficacy|31
1660284|NCT01572675|5802681|P1|Overall Study|Lack of Efficacy|31
1660285|NCT01572675|5802680|P2|Overall Study|Recovery|23
1660286|NCT01572675|5802681|P1|Overall Study|Recovery|16
1660287|NCT01572675|5802680|P2|Overall Study|End of prescribed treatment|118
1660288|NCT01572675|5802681|P1|Overall Study|End of prescribed treatment|140
1660289|NCT01572389|5802799|P2|Overall Study|Only A1C or Assessment was Collected|2
1660290|NCT01572389|5802800|P1|Overall Study|Only A1C or Assessment was Collected|6
1660291|NCT01572389|5802799|P2|Overall Study|Lost to Follow-up|14
1660292|NCT01572389|5802800|P1|Overall Study|Lost to Follow-up|25
1660293|NCT01572389|5802799|P2|Overall Study|Withdrawal by Subject|2
1660294|NCT01572389|5802800|P1|Overall Study|Withdrawal by Subject|14
1660295|NCT01572389|5802799|P2|Overall Study|Death|3
1660296|NCT01572389|5802800|P1|Overall Study|Death|1
1660297|NCT01571453|5802841|P2|Overall Study|Administrative or other reason(s)|3
1660298|NCT01571453|5802842|P1|Overall Study|Administrative or other reason(s)|4
1660299|NCT01571453|5802841|P2|Overall Study|Lost to Follow-up|2
1660300|NCT01571453|5802842|P1|Overall Study|Lost to Follow-up|4
1660301|NCT01571453|5802841|P2|Overall Study|Withdrawal of consent|13
1660302|NCT01571453|5802842|P1|Overall Study|Withdrawal of consent|5
1660303|NCT01571453|5802841|P2|Overall Study|Protocol Violation|5
1660304|NCT01571453|5802842|P1|Overall Study|Protocol Violation|1
1660305|NCT01571453|5802841|P2|Overall Study|Non-compliance|4
1660306|NCT01571453|5802842|P1|Overall Study|Non-compliance|2
1660307|NCT01571453|5802841|P2|Overall Study|Lack of Efficacy|3
1660308|NCT01571453|5802842|P1|Overall Study|Lack of Efficacy|8
1660309|NCT01571453|5802841|P2|Overall Study|Adverse Event|32
1660310|NCT01571453|5802842|P1|Overall Study|Adverse Event|14
1660311|NCT01571362|5802889|P3|Double-Blind Treatment Period|Other - unspecified|1
1660312|NCT01571362|5802890|P2|Double-Blind Treatment Period|Other - unspecified|6
1660313|NCT01571362|5802891|P1|Double-Blind Treatment Period|Other - unspecified|0
1660314|NCT01571362|5802889|P3|Double-Blind Treatment Period|Insufficient clinical response|4
1660315|NCT01571362|5802890|P2|Double-Blind Treatment Period|Insufficient clinical response|16
1660316|NCT01571362|5802891|P1|Double-Blind Treatment Period|Insufficient clinical response|0
1660317|NCT01571362|5802889|P3|Double-Blind Treatment Period|Lost to Follow-up|6
1660318|NCT01571362|5802890|P2|Double-Blind Treatment Period|Lost to Follow-up|3
1660319|NCT01571362|5802891|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1660320|NCT01571362|5802889|P3|Double-Blind Treatment Period|Adverse Event|14
1660321|NCT01571362|5802890|P2|Double-Blind Treatment Period|Adverse Event|9
1660322|NCT01571362|5802891|P1|Double-Blind Treatment Period|Adverse Event|0
1660323|NCT01571362|5802889|P3|Double-Blind Treatment Period|Protocol Violation|9
1660324|NCT01571362|5802890|P2|Double-Blind Treatment Period|Protocol Violation|8
1660325|NCT01571362|5802891|P1|Double-Blind Treatment Period|Protocol Violation|0
1660326|NCT01571362|5802889|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
1660327|NCT01571362|5802890|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
1660328|NCT01571362|5802891|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1660329|NCT01571362|5802889|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
1660330|NCT01571362|5802890|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
1660331|NCT01571362|5802891|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
1660332|NCT01571362|5802889|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1660333|NCT01571362|5802890|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
1660334|NCT01571362|5802891|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
1660335|NCT01571362|5802889|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1660336|NCT01571362|5802890|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
1660337|NCT01571362|5802891|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
1660338|NCT01571362|5802889|P3|Open-Label Conversion + Titration Period|Adverse Event|0
1660339|NCT01571362|5802890|P2|Open-Label Conversion + Titration Period|Adverse Event|0
1660340|NCT01571362|5802891|P1|Open-Label Conversion + Titration Period|Adverse Event|57
1660341|NCT01571362|5802889|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
1660342|NCT01571362|5802890|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
1660343|NCT01571362|5802891|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
1660344|NCT01571362|5802889|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1660345|NCT01571362|5802890|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
1660346|NCT01571362|5802891|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
1660347|NCT01571284|5803061|P1|Overall Study|Other than specified above|80
1660348|NCT01571284|5803061|P1|Overall Study|Enrolled but not treated|2
1660349|NCT01571284|5803061|P1|Overall Study|Lost to Follow-up|3
1660350|NCT01571284|5803061|P1|Overall Study|Participant's decision|84
1660351|NCT01571232|5803084|P2|Overall Study|Withdrawal by Subject|0
1660352|NCT01571232|5803085|P1|Overall Study|Withdrawal by Subject|1
1660353|NCT01571232|5803084|P2|Overall Study|Lost to Follow-up|1
1660354|NCT01571232|5803085|P1|Overall Study|Lost to Follow-up|0
1660355|NCT01570868|5803097|P2|Overall Study|Withdrawal by Subject|0
1660356|NCT01570868|5803098|P1|Overall Study|Withdrawal by Subject|1
1660357|NCT01570868|5803097|P2|Overall Study|Lost to Follow-up|0
1660358|NCT01570868|5803098|P1|Overall Study|Lost to Follow-up|1
1660359|NCT01570868|5803097|P2|Overall Study|Physician Decision|4
1660360|NCT01570868|5803098|P1|Overall Study|Physician Decision|10
1660361|NCT01570868|5803097|P2|Overall Study|FDA Recommendation|3
1660362|NCT01570868|5803098|P1|Overall Study|FDA Recommendation|23
1660363|NCT01570868|5803097|P2|Overall Study|Adverse Event|1
1660364|NCT01570868|5803098|P1|Overall Study|Adverse Event|8
1660365|NCT01570751|5803110|P2|Period B (16 Weeks)|Protocol Violation|1
1660366|NCT01570751|5803111|P1|Period B (16 Weeks)|Protocol Violation|0
1660367|NCT01570751|5803110|P2|Period B (16 Weeks)|Adverse Event|0
1660368|NCT01570751|5803111|P1|Period B (16 Weeks)|Adverse Event|1
1660369|NCT01570751|5803110|P2|Period A (16 Weeks)|Unclassified|3
1660370|NCT01570751|5803111|P1|Period A (16 Weeks)|Unclassified|2
1660371|NCT01570751|5803110|P2|Period A (16 Weeks)|Withdrawal criteria|1
1660372|NCT01570751|5803111|P1|Period A (16 Weeks)|Withdrawal criteria|0
1660373|NCT01570751|5803110|P2|Period A (16 Weeks)|Protocol Violation|1
1660374|NCT01570751|5803111|P1|Period A (16 Weeks)|Protocol Violation|1
1660375|NCT01570686|5803129|P2|Overall Study|Unsatisfactory therapeutic effect|1
1660376|NCT01570686|5803130|P1|Overall Study|Unsatisfactory therapeutic effect|2
1660377|NCT01570686|5803129|P2|Overall Study|Withdrawal by Subject|4
1660378|NCT01570686|5803130|P1|Overall Study|Withdrawal by Subject|4
1660379|NCT01570686|5803129|P2|Overall Study|Protocol Deviation|0
1660380|NCT01570686|5803130|P1|Overall Study|Protocol Deviation|3
1660381|NCT01570686|5803129|P2|Overall Study|Lost to Follow-up|3
1660382|NCT01570686|5803130|P1|Overall Study|Lost to Follow-up|4
1660383|NCT01570686|5803129|P2|Overall Study|Adverse Event|6
1660384|NCT01570686|5803130|P1|Overall Study|Adverse Event|8
1660385|NCT01570686|5803129|P2|Overall Study|Administrative problems|1
1660386|NCT01570686|5803130|P1|Overall Study|Administrative problems|0
1660387|NCT01570686|5803129|P2|Overall Study|Abnormal test procedure result(s)|1
1660388|NCT01570686|5803130|P1|Overall Study|Abnormal test procedure result(s)|1
1660389|NCT01570491|5803166|P2|Overall Study|treatment: not given or discontinued|0
1660390|NCT01570491|5803167|P1|Overall Study|treatment: not given or discontinued|2
1660391|NCT01570491|5803166|P2|Overall Study|Lost to Follow-up|1
1660392|NCT01570491|5803167|P1|Overall Study|Lost to Follow-up|3
1660393|NCT01570387|5803183|P4|Overall Study|Withdrawal by Subject|1
1660394|NCT01570387|5803184|P3|Overall Study|Withdrawal by Subject|0
1660395|NCT01570387|5803185|P2|Overall Study|Withdrawal by Subject|0
1660396|NCT01570387|5803186|P1|Overall Study|Withdrawal by Subject|0
1660397|NCT01570387|5803183|P4|Overall Study|Death|1
1660398|NCT01570387|5803184|P3|Overall Study|Death|0
1660399|NCT01570387|5803185|P2|Overall Study|Death|0
1660400|NCT01570387|5803186|P1|Overall Study|Death|0
1660401|NCT01570387|5803183|P4|Overall Study|Adverse Event|0
1660402|NCT01570387|5803184|P3|Overall Study|Adverse Event|0
1660403|NCT01570387|5803185|P2|Overall Study|Adverse Event|0
1660404|NCT01570387|5803186|P1|Overall Study|Adverse Event|1
1660405|NCT01570309|5803212|P2|Overall Study|Withdrawal by Subject|3
1660406|NCT01570309|5803213|P1|Overall Study|Withdrawal by Subject|3
1660407|NCT01570283|5803230|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
1660408|NCT01570283|5803231|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1660409|NCT01570283|5803232|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1660410|NCT01570283|5803233|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1660411|NCT01570283|5803234|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1660412|NCT01570283|5803235|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
1660413|NCT01570283|5803230|P6|Cohort 3: Dose Level 3|Death|1
1660414|NCT01570283|5803231|P5|Cohort 3: Dose Level 3|Death|0
1660415|NCT01570283|5803232|P4|Cohort 3: Dose Level 3|Death|0
1660416|NCT01570283|5803233|P3|Cohort 3: Dose Level 3|Death|0
1660417|NCT01570283|5803234|P2|Cohort 3: Dose Level 3|Death|0
1660418|NCT01570283|5803235|P1|Cohort 3: Dose Level 3|Death|0
1660419|NCT01570283|5803230|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1660420|NCT01570283|5803231|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1660421|NCT01570283|5803232|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
1660422|NCT01570283|5803233|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1660423|NCT01570283|5803234|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1660424|NCT01570283|5803235|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
1660425|NCT01570283|5803230|P6|Cohort 2: Dose Level 2|Death|0
1660426|NCT01570283|5803231|P5|Cohort 2: Dose Level 2|Death|0
1660427|NCT01570283|5803232|P4|Cohort 2: Dose Level 2|Death|0
1660428|NCT01570283|5803233|P3|Cohort 2: Dose Level 2|Death|1
1660429|NCT01570283|5803234|P2|Cohort 2: Dose Level 2|Death|0
1660430|NCT01570283|5803235|P1|Cohort 2: Dose Level 2|Death|0
1660431|NCT01570283|5803230|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1660432|NCT01570283|5803231|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1660433|NCT01570283|5803232|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1660434|NCT01570283|5803233|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1660435|NCT01570283|5803234|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
1660436|NCT01570283|5803235|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
1660437|NCT01570283|5803230|P6|Cohort 1: Dose Level 1|Death|0
1660438|NCT01570283|5803231|P5|Cohort 1: Dose Level 1|Death|0
1660439|NCT01570283|5803232|P4|Cohort 1: Dose Level 1|Death|0
1660440|NCT01570283|5803233|P3|Cohort 1: Dose Level 1|Death|0
1660441|NCT01570283|5803234|P2|Cohort 1: Dose Level 1|Death|1
1660442|NCT01570283|5803235|P1|Cohort 1: Dose Level 1|Death|0
1660443|NCT01570244|5803252|P1|Microgynon+Faldaprevir|Adverse Event|1
1660444|NCT01570192|5803274|P2|Overall Study|Physician Decision|1
1660445|NCT01570192|5803275|P1|Overall Study|Physician Decision|0
1660446|NCT01570192|5803274|P2|Overall Study|changed to palliative care|0
1660447|NCT01570192|5803275|P1|Overall Study|changed to palliative care|1
1660448|NCT01570192|5803274|P2|Overall Study|no qualifying organism|12
1660449|NCT01570192|5803275|P1|Overall Study|no qualifying organism|6
1660450|NCT01569841|5803313|P2|Period A (6 Weeks)|Withdrawal by Subject|1
1660451|NCT01569841|5803314|P1|Period A (6 Weeks)|Withdrawal by Subject|0
1660452|NCT01569763|5803403|P2|Overall Study|Adverse Event|0
1660453|NCT01569763|5803404|P1|Overall Study|Adverse Event|1
1660454|NCT01569763|5803403|P2|Overall Study|Lack of Efficacy|7
1660455|NCT01569763|5803404|P1|Overall Study|Lack of Efficacy|2
1660463|NCT01569568|5803449|P2|Overall Study|Physician Decision|2
1660464|NCT01569568|5803450|P1|Overall Study|Physician Decision|0
1660465|NCT01569464|5803473|P2|Overall Study|Other|1
1660466|NCT01569464|5803474|P1|Overall Study|Other|1
1660467|NCT01569464|5803473|P2|Overall Study|Withdrawal by Subject|1
1660468|NCT01569464|5803474|P1|Overall Study|Withdrawal by Subject|1
1660469|NCT01569464|5803473|P2|Overall Study|Lost to Follow-up|3
1660470|NCT01569464|5803474|P1|Overall Study|Lost to Follow-up|2
1660471|NCT01569464|5803473|P2|Overall Study|Protocol Violation|0
1660472|NCT01569464|5803474|P1|Overall Study|Protocol Violation|1
1660473|NCT01569464|5803473|P2|Overall Study|Lack of Efficacy|0
1660474|NCT01569464|5803474|P1|Overall Study|Lack of Efficacy|1
1660475|NCT01569464|5803473|P2|Overall Study|Adverse Event|0
1660476|NCT01569464|5803474|P1|Overall Study|Adverse Event|4
1660477|NCT01569438|5803541|P2|Overall Study|Protocol Violation|0
1660478|NCT01569438|5803542|P1|Overall Study|Protocol Violation|1
1660479|NCT01569438|5803541|P2|Overall Study|Withdrawal by Subject|1
1660480|NCT01569438|5803542|P1|Overall Study|Withdrawal by Subject|0
1660481|NCT01569438|5803541|P2|Overall Study|Lack of Efficacy|1
1660482|NCT01569438|5803542|P1|Overall Study|Lack of Efficacy|1
1660483|NCT01569438|5803541|P2|Overall Study|Adverse Event|7
1660484|NCT01569438|5803542|P1|Overall Study|Adverse Event|0
1660485|NCT01569295|5803556|P2|Overall Study|Lost to Follow-up|0
1660486|NCT01569295|5803557|P1|Overall Study|Lost to Follow-up|1
1660487|NCT01569295|5803556|P2|Overall Study|Other Anticancer/Experimental Therapy|1
1660488|NCT01569295|5803557|P1|Overall Study|Other Anticancer/Experimental Therapy|2
1660489|NCT01569295|5803556|P2|Overall Study|Noncompliance with Study Drug|0
1660490|NCT01569295|5803557|P1|Overall Study|Noncompliance with Study Drug|3
1660491|NCT01569295|5803556|P2|Overall Study|Other|3
1660492|NCT01569295|5803557|P1|Overall Study|Other|4
1660493|NCT01569295|5803556|P2|Overall Study|Physician Decision|19
1660494|NCT01569295|5803557|P1|Overall Study|Physician Decision|7
1660495|NCT01569295|5803556|P2|Overall Study|Withdrawal by Subject|8
1660496|NCT01569295|5803557|P1|Overall Study|Withdrawal by Subject|20
1660497|NCT01569295|5803556|P2|Overall Study|Adverse Event|13
1660498|NCT01569295|5803557|P1|Overall Study|Adverse Event|27
1660499|NCT01569295|5803556|P2|Overall Study|Ongoing in Study|23
1660500|NCT01569295|5803557|P1|Overall Study|Ongoing in Study|70
1660501|NCT01569152|5803594|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
1660502|NCT01569152|5803595|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
1660503|NCT01569152|5803596|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
1660504|NCT01569152|5803594|P3|Safety Extension, Period 3|Physician Decision|2
1660505|NCT01569152|5803595|P2|Safety Extension, Period 3|Physician Decision|0
1660506|NCT01569152|5803596|P1|Safety Extension, Period 3|Physician Decision|0
1660507|NCT01569152|5803594|P3|Safety Extension, Period 3|Withdrawal by Subject|2
1660508|NCT01569152|5803595|P2|Safety Extension, Period 3|Withdrawal by Subject|0
1660509|NCT01569152|5803596|P1|Safety Extension, Period 3|Withdrawal by Subject|0
1660510|NCT01569152|5803594|P3|Safety Extension, Period 3|Adverse Event|4
1660511|NCT01569152|5803595|P2|Safety Extension, Period 3|Adverse Event|0
1660512|NCT01569152|5803596|P1|Safety Extension, Period 3|Adverse Event|0
1660513|NCT01569152|5803594|P3|Phase IIa, Period 1|Withdrawal by Subject|0
1660514|NCT01569152|5803595|P2|Phase IIa, Period 1|Withdrawal by Subject|1
1660515|NCT01569152|5803596|P1|Phase IIa, Period 1|Withdrawal by Subject|2
1660516|NCT01569152|5803594|P3|Phase IIa, Period 1|Protocol Violation|0
1660517|NCT01569152|5803595|P2|Phase IIa, Period 1|Protocol Violation|1
1660518|NCT01569152|5803596|P1|Phase IIa, Period 1|Protocol Violation|0
1660519|NCT01569152|5803594|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
1660520|NCT01569152|5803595|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
1660521|NCT01569152|5803596|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
1660522|NCT01569152|5803594|P3|Phase IIa, Period 1|Lost to Follow-up|0
1660523|NCT01569152|5803595|P2|Phase IIa, Period 1|Lost to Follow-up|0
1660524|NCT01569152|5803596|P1|Phase IIa, Period 1|Lost to Follow-up|1
1660525|NCT01569152|5803594|P3|Phase IIa, Period 1|Adverse Event|0
1660526|NCT01569152|5803595|P2|Phase IIa, Period 1|Adverse Event|0
1660527|NCT01569152|5803596|P1|Phase IIa, Period 1|Adverse Event|4
1660528|NCT01569152|5803594|P3|Phase IIa, Period 1|Early Escape|0
1660529|NCT01569152|5803595|P2|Phase IIa, Period 1|Early Escape|22
1660530|NCT01569152|5803596|P1|Phase IIa, Period 1|Early Escape|5
1660531|NCT01569074|5803732|P5|Overall Study|Adverse Event|0
1660532|NCT01569074|5803733|P4|Overall Study|Adverse Event|0
1660533|NCT01569074|5803734|P3|Overall Study|Adverse Event|3
1660534|NCT01569074|5803735|P2|Overall Study|Adverse Event|0
1660535|NCT01569074|5803736|P1|Overall Study|Adverse Event|1
1660536|NCT01569074|5803732|P5|Overall Study|eg change in circumstances|1
1660537|NCT01569074|5803733|P4|Overall Study|eg change in circumstances|1
1660538|NCT01569074|5803734|P3|Overall Study|eg change in circumstances|0
1660539|NCT01569074|5803735|P2|Overall Study|eg change in circumstances|2
1660540|NCT01569074|5803736|P1|Overall Study|eg change in circumstances|0
1660541|NCT01569074|5803732|P5|Overall Study|Severe non-compliance to protocol|0
1660542|NCT01569074|5803733|P4|Overall Study|Severe non-compliance to protocol|0
1660543|NCT01569074|5803734|P3|Overall Study|Severe non-compliance to protocol|1
1660544|NCT01569074|5803735|P2|Overall Study|Severe non-compliance to protocol|0
1660545|NCT01569074|5803736|P1|Overall Study|Severe non-compliance to protocol|0
1660546|NCT01569074|5803732|P5|Overall Study|Study-specific discontinuation criteria|0
1660547|NCT01569074|5803733|P4|Overall Study|Study-specific discontinuation criteria|0
1660548|NCT01569074|5803734|P3|Overall Study|Study-specific discontinuation criteria|0
1660549|NCT01569074|5803735|P2|Overall Study|Study-specific discontinuation criteria|1
1660550|NCT01569074|5803736|P1|Overall Study|Study-specific discontinuation criteria|0
1660551|NCT01569074|5803732|P5|Overall Study|Study stopped|7
1660552|NCT01569074|5803733|P4|Overall Study|Study stopped|7
1660553|NCT01569074|5803734|P3|Overall Study|Study stopped|8
1660554|NCT01569074|5803735|P2|Overall Study|Study stopped|6
1660555|NCT01569074|5803736|P1|Overall Study|Study stopped|6
1660556|NCT01569022|5803792|P2|Second Intervention|Lost to Follow-up|2
1660557|NCT01569022|5803793|P1|Second Intervention|Lost to Follow-up|2
1660558|NCT01569022|5803792|P2|First Intervention|Lost to Follow-up|1
1660559|NCT01569022|5803793|P1|First Intervention|Lost to Follow-up|2
1660560|NCT01568892|5803829|P2|Open-label Phase|Lost to Follow-up|1
1660561|NCT01568892|5803830|P1|Open-label Phase|Lost to Follow-up|0
1660562|NCT01568892|5803829|P2|Open-label Phase|Lack of Efficacy|2
1660563|NCT01568892|5803830|P1|Open-label Phase|Lack of Efficacy|4
1660564|NCT01568892|5803829|P2|Open-label Phase|Adverse Event|0
1660565|NCT01568892|5803830|P1|Open-label Phase|Adverse Event|2
1660566|NCT01568866|5803900|P2|Overall Study|Randomized but Not Dosed|1
1660567|NCT01568866|5803901|P1|Overall Study|Randomized but Not Dosed|9
1660568|NCT01568866|5803900|P2|Overall Study|Lost to Follow-up|0
1660569|NCT01568866|5803901|P1|Overall Study|Lost to Follow-up|1
1660570|NCT01568866|5803900|P2|Overall Study|Protocol Non-compliance|4
1660571|NCT01568866|5803901|P1|Overall Study|Protocol Non-compliance|2
1660572|NCT01568866|5803900|P2|Overall Study|Death|18
1660573|NCT01568866|5803901|P1|Overall Study|Death|10
1660574|NCT01568866|5803900|P2|Overall Study|Withdrawal by Subject|11
1660575|NCT01568866|5803901|P1|Overall Study|Withdrawal by Subject|19
1660576|NCT01568866|5803900|P2|Overall Study|Physician Decision|32
1660577|NCT01568866|5803901|P1|Overall Study|Physician Decision|40
1660578|NCT01568866|5803900|P2|Overall Study|Patient Request|71
1660579|NCT01568866|5803901|P1|Overall Study|Patient Request|55
1660580|NCT01568866|5803900|P2|Overall Study|Adverse Event|96
1660581|NCT01568866|5803901|P1|Overall Study|Adverse Event|94
1660582|NCT01568866|5803900|P2|Overall Study|Disease Progression|183
1660583|NCT01568866|5803901|P1|Overall Study|Disease Progression|208
1660584|NCT01568593|5803932|P2|Overall Study|Adverse Event|2
1660585|NCT01568593|5803933|P1|Overall Study|Adverse Event|3
1660586|NCT01568593|5803932|P2|Overall Study|Lack of Efficacy|1
1660587|NCT01568593|5803933|P1|Overall Study|Lack of Efficacy|4
1660588|NCT01568112|5803978|P4|Overall Study|Withdrawal by Physician|1
1660589|NCT01568112|5803979|P3|Overall Study|Withdrawal by Physician|1
1660590|NCT01568112|5803980|P2|Overall Study|Withdrawal by Physician|0
1660591|NCT01568112|5803981|P1|Overall Study|Withdrawal by Physician|1
1660592|NCT01568112|5803978|P4|Overall Study|Withdrawal by Subject|7
1660593|NCT01568112|5803979|P3|Overall Study|Withdrawal by Subject|0
1660594|NCT01568112|5803980|P2|Overall Study|Withdrawal by Subject|3
1660595|NCT01568112|5803981|P1|Overall Study|Withdrawal by Subject|2
1660596|NCT01568112|5803978|P4|Overall Study|Lost to Follow-up|1
1660597|NCT01568112|5803979|P3|Overall Study|Lost to Follow-up|0
1660598|NCT01568112|5803980|P2|Overall Study|Lost to Follow-up|0
1660599|NCT01568112|5803981|P1|Overall Study|Lost to Follow-up|0
1660600|NCT01568112|5803978|P4|Overall Study|Withdrew due to Adverse Event|3
1660601|NCT01568112|5803979|P3|Overall Study|Withdrew due to Adverse Event|6
1660602|NCT01568112|5803980|P2|Overall Study|Withdrew due to Adverse Event|4
1660603|NCT01568112|5803981|P1|Overall Study|Withdrew due to Adverse Event|2
1660604|NCT01568112|5803978|P4|Overall Study|Randomized But Not Treated|0
1660605|NCT01568112|5803979|P3|Overall Study|Randomized But Not Treated|0
1660606|NCT01568112|5803980|P2|Overall Study|Randomized But Not Treated|1
1660607|NCT01568112|5803981|P1|Overall Study|Randomized But Not Treated|0
1660608|NCT01568047|5804139|P4|Overall Study|Adverse Event|1
1660609|NCT01568047|5804140|P3|Overall Study|Adverse Event|1
1660610|NCT01568047|5804141|P2|Overall Study|Adverse Event|0
1660611|NCT01568047|5804142|P1|Overall Study|Adverse Event|0
1660612|NCT01568047|5804139|P4|Overall Study|Withdrawal by Subject|0
1660613|NCT01568047|5804140|P3|Overall Study|Withdrawal by Subject|0
1660614|NCT01568047|5804141|P2|Overall Study|Withdrawal by Subject|1
1660615|NCT01568047|5804142|P1|Overall Study|Withdrawal by Subject|0
1660616|NCT01568047|5804139|P4|Overall Study|Ineligibility|0
1660617|NCT01568047|5804140|P3|Overall Study|Ineligibility|0
1660618|NCT01568047|5804141|P2|Overall Study|Ineligibility|0
1660619|NCT01568047|5804142|P1|Overall Study|Ineligibility|1
1660620|NCT01568034|5804160|P4|Overall Study|Withdrawal by Subject|0
1660621|NCT01568034|5804161|P3|Overall Study|Withdrawal by Subject|0
1660622|NCT01568034|5804162|P2|Overall Study|Withdrawal by Subject|0
1660623|NCT01568034|5804163|P1|Overall Study|Withdrawal by Subject|1
1660624|NCT01567865|5804226|P4|Evaluated for Immunogenicity|Missing blood sample|28
1660625|NCT01567865|5804227|P3|Evaluated for Immunogenicity|Missing blood sample|16
1660626|NCT01567865|5804228|P2|Evaluated for Immunogenicity|Missing blood sample|24
1660627|NCT01567865|5804229|P1|Evaluated for Immunogenicity|Missing blood sample|17
1660628|NCT01567865|5804226|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
1660629|NCT01567865|5804227|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
1660630|NCT01567865|5804228|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
1660631|NCT01567865|5804229|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
1660632|NCT01567852|5804259|P2|Overall Study|ECT discontinued|1
1660633|NCT01567852|5804260|P1|Overall Study|ECT discontinued|1
1660634|NCT01567852|5804259|P2|Overall Study|Withdrawal by Subject|6
1660635|NCT01567852|5804260|P1|Overall Study|Withdrawal by Subject|3
1660636|NCT01567826|5804278|P2|Overall Study|Lost to Follow-up|2
1660637|NCT01567826|5804279|P1|Overall Study|Lost to Follow-up|3
1660638|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
1660639|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
1660640|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1660641|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1660642|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
1660643|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
1660644|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
1660645|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1660646|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1660647|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
1660648|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
1660649|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
1660650|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1660651|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1660652|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
1660653|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
1660654|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
1660655|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1660656|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1660657|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
1660658|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
1660659|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
1660660|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1660661|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1660662|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
1660663|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
1660664|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
1660665|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1660666|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1660667|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
1660668|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
1660669|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
1660670|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1660671|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1660672|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
1660673|NCT01567527|5804305|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1660674|NCT01567527|5804306|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
1660675|NCT01567527|5804307|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1660676|NCT01567527|5804308|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1660677|NCT01567527|5804309|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
1660678|NCT01567527|5804305|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
1660679|NCT01567527|5804306|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
1660680|NCT01567527|5804307|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
1660681|NCT01567527|5804308|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
1660682|NCT01567527|5804309|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
1660683|NCT01567527|5804305|P5|IM Depot Stabilization.|Adverse Event|0
1660684|NCT01567527|5804306|P4|IM Depot Stabilization.|Adverse Event|0
1660685|NCT01567527|5804307|P3|IM Depot Stabilization.|Adverse Event|37
1660686|NCT01567527|5804308|P2|IM Depot Stabilization.|Adverse Event|0
1660687|NCT01567527|5804309|P1|IM Depot Stabilization.|Adverse Event|0
1660688|NCT01567527|5804305|P5|IM Depot Stabilization.|Lack of Efficacy|0
1660689|NCT01567527|5804306|P4|IM Depot Stabilization.|Lack of Efficacy|0
1660690|NCT01567527|5804307|P3|IM Depot Stabilization.|Lack of Efficacy|7
1660691|NCT01567527|5804308|P2|IM Depot Stabilization.|Lack of Efficacy|0
1660692|NCT01567527|5804309|P1|IM Depot Stabilization.|Lack of Efficacy|0
1660693|NCT01567527|5804305|P5|IM Depot Stabilization.|Lost to Follow-up|0
1660694|NCT01567527|5804306|P4|IM Depot Stabilization.|Lost to Follow-up|0
1660695|NCT01567527|5804307|P3|IM Depot Stabilization.|Lost to Follow-up|21
1660696|NCT01567527|5804308|P2|IM Depot Stabilization.|Lost to Follow-up|0
1660697|NCT01567527|5804309|P1|IM Depot Stabilization.|Lost to Follow-up|0
1660698|NCT01567527|5804305|P5|IM Depot Stabilization.|Sponsor discontinued study|0
1660699|NCT01567527|5804306|P4|IM Depot Stabilization.|Sponsor discontinued study|0
1660700|NCT01567527|5804307|P3|IM Depot Stabilization.|Sponsor discontinued study|1
1660701|NCT01567527|5804308|P2|IM Depot Stabilization.|Sponsor discontinued study|0
1660702|NCT01567527|5804309|P1|IM Depot Stabilization.|Sponsor discontinued study|0
1660703|NCT01567527|5804305|P5|IM Depot Stabilization.|Withdrawal by Subject|0
1660704|NCT01567527|5804306|P4|IM Depot Stabilization.|Withdrawal by Subject|0
1660705|NCT01567527|5804307|P3|IM Depot Stabilization.|Withdrawal by Subject|56
1660706|NCT01567527|5804308|P2|IM Depot Stabilization.|Withdrawal by Subject|0
1660707|NCT01567527|5804309|P1|IM Depot Stabilization.|Withdrawal by Subject|0
1660708|NCT01567527|5804305|P5|IM Depot Stabilization.|Met withdrawal criteria|0
1660709|NCT01567527|5804306|P4|IM Depot Stabilization.|Met withdrawal criteria|0
1660710|NCT01567527|5804307|P3|IM Depot Stabilization.|Met withdrawal criteria|26
1660711|NCT01567527|5804308|P2|IM Depot Stabilization.|Met withdrawal criteria|0
1660712|NCT01567527|5804309|P1|IM Depot Stabilization.|Met withdrawal criteria|0
1660713|NCT01567527|5804305|P5|IM Depot Stabilization.|Protocol deviation|0
1660714|NCT01567527|5804306|P4|IM Depot Stabilization.|Protocol deviation|0
1660715|NCT01567527|5804307|P3|IM Depot Stabilization.|Protocol deviation|5
1660716|NCT01567527|5804308|P2|IM Depot Stabilization.|Protocol deviation|0
1660717|NCT01567527|5804309|P1|IM Depot Stabilization.|Protocol deviation|0
1660718|NCT01567527|5804305|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1660719|NCT01567527|5804306|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1660720|NCT01567527|5804307|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1660721|NCT01567527|5804308|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
1660722|NCT01567527|5804309|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
1660723|NCT01567527|5804305|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1660724|NCT01567527|5804306|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1660725|NCT01567527|5804307|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1660726|NCT01567527|5804308|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
1660727|NCT01567527|5804309|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
1660728|NCT01567527|5804305|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1660729|NCT01567527|5804306|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1660730|NCT01567527|5804307|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1660731|NCT01567527|5804308|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
1660732|NCT01567527|5804309|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
1660733|NCT01567527|5804305|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1660734|NCT01567527|5804306|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1660735|NCT01567527|5804307|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1660736|NCT01567527|5804308|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
1660737|NCT01567527|5804309|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
1660738|NCT01567527|5804305|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1660739|NCT01567527|5804306|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1660740|NCT01567527|5804307|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1660741|NCT01567527|5804308|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
1660742|NCT01567527|5804309|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
1660743|NCT01567527|5804305|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1660744|NCT01567527|5804306|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1660745|NCT01567527|5804307|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1660746|NCT01567527|5804308|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
1660747|NCT01567527|5804309|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
1660748|NCT01567527|5804305|P5|Conversion Phase.|Withdrawn by the investigator|0
1660749|NCT01567527|5804306|P4|Conversion Phase.|Withdrawn by the investigator|0
1660750|NCT01567527|5804307|P3|Conversion Phase.|Withdrawn by the investigator|0
1660751|NCT01567527|5804308|P2|Conversion Phase.|Withdrawn by the investigator|0
1660752|NCT01567527|5804309|P1|Conversion Phase.|Withdrawn by the investigator|3
1660753|NCT01567527|5804305|P5|Conversion Phase.|Adverse Event|0
1660754|NCT01567527|5804306|P4|Conversion Phase.|Adverse Event|0
1660755|NCT01567527|5804307|P3|Conversion Phase.|Adverse Event|0
1660756|NCT01567527|5804308|P2|Conversion Phase.|Adverse Event|0
1660757|NCT01567527|5804309|P1|Conversion Phase.|Adverse Event|33
1660758|NCT01567527|5804305|P5|Conversion Phase.|Lack of Efficacy|0
1660759|NCT01567527|5804306|P4|Conversion Phase.|Lack of Efficacy|0
1660760|NCT01567527|5804307|P3|Conversion Phase.|Lack of Efficacy|0
1660761|NCT01567527|5804308|P2|Conversion Phase.|Lack of Efficacy|0
1660762|NCT01567527|5804309|P1|Conversion Phase.|Lack of Efficacy|2
1660763|NCT01567527|5804305|P5|Conversion Phase.|Lost to Follow-up|0
1660764|NCT01567527|5804306|P4|Conversion Phase.|Lost to Follow-up|0
1660765|NCT01567527|5804307|P3|Conversion Phase.|Lost to Follow-up|0
1660766|NCT01567527|5804308|P2|Conversion Phase.|Lost to Follow-up|0
1660767|NCT01567527|5804309|P1|Conversion Phase.|Lost to Follow-up|16
1660768|NCT01567527|5804305|P5|Conversion Phase.|Withdrawal by Subject|0
1660769|NCT01567527|5804306|P4|Conversion Phase.|Withdrawal by Subject|0
1660770|NCT01567527|5804307|P3|Conversion Phase.|Withdrawal by Subject|0
1660771|NCT01567527|5804308|P2|Conversion Phase.|Withdrawal by Subject|0
1660772|NCT01567527|5804309|P1|Conversion Phase.|Withdrawal by Subject|32
1660773|NCT01567527|5804305|P5|Conversion Phase.|Met withdrawal criteria|0
1660774|NCT01567527|5804306|P4|Conversion Phase.|Met withdrawal criteria|0
1660775|NCT01567527|5804307|P3|Conversion Phase.|Met withdrawal criteria|0
1660776|NCT01567527|5804308|P2|Conversion Phase.|Met withdrawal criteria|0
1660777|NCT01567527|5804309|P1|Conversion Phase.|Met withdrawal criteria|10
1660778|NCT01567527|5804305|P5|Conversion Phase.|Protocol deviation|0
1660779|NCT01567527|5804306|P4|Conversion Phase.|Protocol deviation|0
1660780|NCT01567527|5804307|P3|Conversion Phase.|Protocol deviation|0
1660781|NCT01567527|5804308|P2|Conversion Phase.|Protocol deviation|0
1660782|NCT01567527|5804309|P1|Conversion Phase.|Protocol deviation|3
1660783|NCT01567462|5804326|P2|Overall Study|Withdrawal by Subject|7
1660784|NCT01567462|5804327|P1|Overall Study|Withdrawal by Subject|4
1660785|NCT01567306|5804350|P6|Overall Study|Withdrawal by Subject|1
1660786|NCT01567306|5804351|P5|Overall Study|Withdrawal by Subject|0
1660787|NCT01567306|5804352|P4|Overall Study|Withdrawal by Subject|0
1660788|NCT01567306|5804353|P3|Overall Study|Withdrawal by Subject|0
1660789|NCT01567306|5804354|P2|Overall Study|Withdrawal by Subject|0
1660790|NCT01567306|5804355|P1|Overall Study|Withdrawal by Subject|0
1660791|NCT01567306|5804350|P6|Overall Study|Lost to Follow-up|0
1660792|NCT01567306|5804351|P5|Overall Study|Lost to Follow-up|2
1660793|NCT01567306|5804352|P4|Overall Study|Lost to Follow-up|0
1660794|NCT01567306|5804353|P3|Overall Study|Lost to Follow-up|0
1660795|NCT01567306|5804354|P2|Overall Study|Lost to Follow-up|0
1660796|NCT01567306|5804355|P1|Overall Study|Lost to Follow-up|0
1660797|NCT01567306|5804350|P6|Overall Study|Adverse Event|1
1660798|NCT01567306|5804351|P5|Overall Study|Adverse Event|4
1660799|NCT01567306|5804352|P4|Overall Study|Adverse Event|2
1660800|NCT01567306|5804353|P3|Overall Study|Adverse Event|0
1660801|NCT01567306|5804354|P2|Overall Study|Adverse Event|0
1660802|NCT01567306|5804355|P1|Overall Study|Adverse Event|0
1660803|NCT01567306|5804350|P6|Overall Study|Change site living|0
1660804|NCT01567306|5804351|P5|Overall Study|Change site living|0
1660805|NCT01567306|5804352|P4|Overall Study|Change site living|0
1660806|NCT01567306|5804353|P3|Overall Study|Change site living|0
1660807|NCT01567306|5804354|P2|Overall Study|Change site living|0
1660808|NCT01567306|5804355|P1|Overall Study|Change site living|1
1660809|NCT01567306|5804350|P6|Overall Study|Protocol Violation|1
1660810|NCT01567306|5804351|P5|Overall Study|Protocol Violation|1
1660811|NCT01567306|5804352|P4|Overall Study|Protocol Violation|3
1660812|NCT01567306|5804353|P3|Overall Study|Protocol Violation|0
1660813|NCT01567306|5804354|P2|Overall Study|Protocol Violation|2
1660814|NCT01567306|5804355|P1|Overall Study|Protocol Violation|2
1660815|NCT01567163|5804369|P1|Overall Study|Lost to Follow-up|2
1660816|NCT01567163|5804369|P1|Overall Study|Progressive Disease|2
1660817|NCT01567085|5804390|P1|Overall Study|Terminal chronic kidney dysfunction|1
1660818|NCT01567085|5804390|P1|Overall Study|Returned to chronic dialysis|1
1660819|NCT01567085|5804390|P1|Overall Study|Renal transplantectomy|1
1660820|NCT01567085|5804390|P1|Overall Study|Graft loss|2
1660821|NCT01567085|5804390|P1|Overall Study|Lost to Follow-up|3
1660822|NCT01567085|5804390|P1|Overall Study|Adverse Event|6
1660823|NCT01567085|5804390|P1|Overall Study|Death|6
1660824|NCT01566981|5804427|P2|Overall Study|Lost to Follow-up|8
1660825|NCT01566981|5804428|P1|Overall Study|Lost to Follow-up|5
1660826|NCT01566773|5804457|P1|Overall Study|Physician Decision|2
1660827|NCT01566773|5804457|P1|Overall Study|Adverse Event|10
1660828|NCT01566773|5804457|P1|Overall Study|Administrative reason|1
1660829|NCT01566773|5804457|P1|Overall Study|Withdrawal by Subject|9
1660830|NCT01566773|5804457|P1|Overall Study|Protocol Violation|4
1660831|NCT01566773|5804457|P1|Overall Study|Protocol specified criteria|4
1660832|NCT01566721|5804666|P2|Overall Study|Withdrew Prior to Treatment|1
1660833|NCT01566721|5804667|P1|Overall Study|Withdrew Prior to Treatment|3
1660834|NCT01566721|5804666|P2|Overall Study|Other|4
1660835|NCT01566721|5804667|P1|Overall Study|Other|10
1660836|NCT01566721|5804666|P2|Overall Study|Death|3
1660837|NCT01566721|5804667|P1|Overall Study|Death|6
1660838|NCT01566721|5804666|P2|Overall Study|Lost to Follow-up|0
1660839|NCT01566721|5804667|P1|Overall Study|Lost to Follow-up|18
1660840|NCT01566721|5804666|P2|Overall Study|Disease Progression/Recurrence|28
1660841|NCT01566721|5804667|P1|Overall Study|Disease Progression/Recurrence|123
1660842|NCT01566721|5804666|P2|Overall Study|Withdrawal by Subject|15
1660843|NCT01566721|5804667|P1|Overall Study|Withdrawal by Subject|58
1660844|NCT01566721|5804666|P2|Overall Study|Ongoing Study|659
1660845|NCT01566721|5804667|P1|Overall Study|Ongoing Study|1649
1660846|NCT01566604|5804753|P2|Overall Study|Withdrawal by Subject|6
1660847|NCT01566604|5804754|P1|Overall Study|Withdrawal by Subject|9
1660848|NCT01566604|5804753|P2|Overall Study|Adverse Event|2
1660849|NCT01566604|5804754|P1|Overall Study|Adverse Event|4
1660850|NCT01566604|5804753|P2|Overall Study|Death|1
1660851|NCT01566604|5804754|P1|Overall Study|Death|4
1660852|NCT01566604|5804753|P2|Overall Study|Abnormal laboratory value|0
1660853|NCT01566604|5804754|P1|Overall Study|Abnormal laboratory value|2
1660854|NCT01566604|5804753|P2|Overall Study|Protocol deviation|0
1660855|NCT01566604|5804754|P1|Overall Study|Protocol deviation|2
1660856|NCT01566604|5804753|P2|Overall Study|Lack of Efficacy|2
1660857|NCT01566604|5804754|P1|Overall Study|Lack of Efficacy|1
1660858|NCT01566604|5804753|P2|Overall Study|Administrative problems|0
1660859|NCT01566604|5804754|P1|Overall Study|Administrative problems|1
1660860|NCT01566604|5804753|P2|Overall Study|Patient's inability to use the device|0
1660861|NCT01566604|5804754|P1|Overall Study|Patient's inability to use the device|1
1660862|NCT01566435|5804910|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
1660863|NCT01566214|5804971|P2|Overall Study|Lost to Follow-up|0
1660864|NCT01566214|5804972|P1|Overall Study|Lost to Follow-up|3
1660865|NCT01566149|5805016|P2|Overall Study|Withdrawal by Subject|0
1660866|NCT01566149|5805017|P1|Overall Study|Withdrawal by Subject|1
1660867|NCT01566149|5805016|P2|Overall Study|Protocol Violation|1
1660868|NCT01566149|5805017|P1|Overall Study|Protocol Violation|0
1660869|NCT01566149|5805016|P2|Overall Study|Non-compliance with study medication|0
1660870|NCT01566149|5805017|P1|Overall Study|Non-compliance with study medication|2
1660871|NCT01566149|5805016|P2|Overall Study|Adverse Event|1
1660872|NCT01566149|5805017|P1|Overall Study|Adverse Event|0
1660873|NCT01565993|5805050|P2|Overall Study|Physician Decision|3
1660874|NCT01565993|5805051|P1|Overall Study|Physician Decision|0
1660875|NCT01565980|5805059|P2|Overall Study|Withdrawal by Subject|3
1660876|NCT01565980|5805060|P1|Overall Study|Withdrawal by Subject|0
1660877|NCT01565980|5805059|P2|Overall Study|stopped medical treatment|0
1660878|NCT01565980|5805060|P1|Overall Study|stopped medical treatment|1
1660879|NCT01565980|5805059|P2|Overall Study|health complications|1
1660880|NCT01565980|5805060|P1|Overall Study|health complications|1
1660881|NCT01565980|5805059|P2|Overall Study|Lost to Follow-up|0
1660882|NCT01565980|5805060|P1|Overall Study|Lost to Follow-up|1
1660883|NCT01565980|5805059|P2|Overall Study|Death|0
1660884|NCT01565980|5805060|P1|Overall Study|Death|1
1660885|NCT01565941|5805080|P2|Overall Study|Randomized; did not receive intevention|2
1660886|NCT01565941|5805081|P1|Overall Study|Randomized; did not receive intevention|8
1660887|NCT01565941|5805080|P2|Overall Study|Withdrawn by parent/guardian|2
1660888|NCT01565941|5805081|P1|Overall Study|Withdrawn by parent/guardian|3
1660889|NCT01565928|5805123|P1|Overall Study|Death|2
1660890|NCT01565928|5805123|P1|Overall Study|Withdrawal by Subject|1
1660891|NCT01565928|5805123|P1|Overall Study|Progressive Disease|13
1660892|NCT01565928|5805123|P1|Overall Study|Other|3
1660893|NCT01565928|5805123|P1|Overall Study|Adverse Event|3
1660894|NCT01565889|5805177|P6|Part B|Lost to Follow-up|1
1660895|NCT01565889|5805178|P5|Part B|Lost to Follow-up|0
1660896|NCT01565889|5805179|P4|Part B|Lost to Follow-up|0
1660897|NCT01565889|5805180|P3|Part B|Lost to Follow-up|0
1660898|NCT01565889|5805181|P2|Part B|Lost to Follow-up|0
1660899|NCT01565889|5805182|P1|Part B|Lost to Follow-up|0
1660900|NCT01565889|5805177|P6|Part B|Lack of Efficacy|2
1660901|NCT01565889|5805178|P5|Part B|Lack of Efficacy|0
1660902|NCT01565889|5805179|P4|Part B|Lack of Efficacy|0
1660903|NCT01565889|5805180|P3|Part B|Lack of Efficacy|0
1660904|NCT01565889|5805181|P2|Part B|Lack of Efficacy|0
1660905|NCT01565889|5805182|P1|Part B|Lack of Efficacy|0
1660906|NCT01565889|5805177|P6|Part B|Withdrawal by Subject|1
1660907|NCT01565889|5805178|P5|Part B|Withdrawal by Subject|0
1660908|NCT01565889|5805179|P4|Part B|Withdrawal by Subject|0
1660909|NCT01565889|5805180|P3|Part B|Withdrawal by Subject|0
1660910|NCT01565889|5805181|P2|Part B|Withdrawal by Subject|0
1660911|NCT01565889|5805182|P1|Part B|Withdrawal by Subject|0
1660912|NCT01565889|5805177|P6|Part A|Withdrawal by Subject|0
1660913|NCT01565889|5805178|P5|Part A|Withdrawal by Subject|0
1660914|NCT01565889|5805179|P4|Part A|Withdrawal by Subject|0
1660915|NCT01565889|5805180|P3|Part A|Withdrawal by Subject|0
1660916|NCT01565889|5805181|P2|Part A|Withdrawal by Subject|0
1660917|NCT01565889|5805182|P1|Part A|Withdrawal by Subject|1
1660918|NCT01565850|5805213|P2|Overall Study|Withdrew Consent|2
1660919|NCT01565850|5805214|P1|Overall Study|Withdrew Consent|4
1660920|NCT01565850|5805213|P2|Overall Study|Participant noncompliance|0
1660921|NCT01565850|5805214|P1|Overall Study|Participant noncompliance|2
1660922|NCT01565850|5805213|P2|Overall Study|Investigator’s Discretion|1
1660923|NCT01565850|5805214|P1|Overall Study|Investigator’s Discretion|2
1660924|NCT01565850|5805213|P2|Overall Study|Lost to Follow-up|4
1660925|NCT01565850|5805214|P1|Overall Study|Lost to Follow-up|12
1660926|NCT01565850|5805213|P2|Overall Study|Adverse Event|1
1660927|NCT01565850|5805214|P1|Overall Study|Adverse Event|0
1660928|NCT01565707|5805234|P4|Overall Study|Miscellaneous|2
1660929|NCT01565707|5805235|P3|Overall Study|Miscellaneous|0
1660930|NCT01565707|5805236|P2|Overall Study|Miscellaneous|1
1660931|NCT01565707|5805237|P1|Overall Study|Miscellaneous|1
1660932|NCT01565707|5805234|P4|Overall Study|Randomized but not evaluable|0
1660933|NCT01565707|5805235|P3|Overall Study|Randomized but not evaluable|0
1660934|NCT01565707|5805236|P2|Overall Study|Randomized but not evaluable|0
1660935|NCT01565707|5805237|P1|Overall Study|Randomized but not evaluable|2
1660936|NCT01565707|5805234|P4|Overall Study|Withdrawal by Subject|1
1660937|NCT01565707|5805235|P3|Overall Study|Withdrawal by Subject|1
1660938|NCT01565707|5805236|P2|Overall Study|Withdrawal by Subject|1
1660939|NCT01565707|5805237|P1|Overall Study|Withdrawal by Subject|3
1660940|NCT01565707|5805234|P4|Overall Study|Protocol Violation|1
1660941|NCT01565707|5805235|P3|Overall Study|Protocol Violation|0
1660942|NCT01565707|5805236|P2|Overall Study|Protocol Violation|0
1660943|NCT01565707|5805237|P1|Overall Study|Protocol Violation|1
1660944|NCT01565707|5805234|P4|Overall Study|Lost to Follow-up|0
1660945|NCT01565707|5805235|P3|Overall Study|Lost to Follow-up|0
1660946|NCT01565707|5805236|P2|Overall Study|Lost to Follow-up|0
1660947|NCT01565707|5805237|P1|Overall Study|Lost to Follow-up|1
1660948|NCT01565707|5805234|P4|Overall Study|Adverse Event|1
1660949|NCT01565707|5805235|P3|Overall Study|Adverse Event|2
1660950|NCT01565707|5805236|P2|Overall Study|Adverse Event|6
1660951|NCT01565707|5805237|P1|Overall Study|Adverse Event|1
1660952|NCT01565694|5805328|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
1660953|NCT01565694|5805328|P1|Dose-Titration Period|Protocol Violation|10
1660954|NCT01565694|5805328|P1|Dose-Titration Period|Adverse Event|4
1660955|NCT01565668|5805349|P2|Overall Study|HSCT Transplant|15
1660956|NCT01565668|5805350|P1|Overall Study|HSCT Transplant|11
1660957|NCT01565668|5805349|P2|Overall Study|Withdrawal by Subject|3
1660958|NCT01565668|5805350|P1|Overall Study|Withdrawal by Subject|1
1660959|NCT01565668|5805349|P2|Overall Study|Progressive disease|14
1660960|NCT01565668|5805350|P1|Overall Study|Progressive disease|13
1660961|NCT01565668|5805349|P2|Overall Study|Randomized, but never received drug|2
1660962|NCT01565668|5805350|P1|Overall Study|Randomized, but never received drug|0
1660963|NCT01565668|5805349|P2|Overall Study|Adverse Event|1
1660964|NCT01565668|5805350|P1|Overall Study|Adverse Event|6
1660965|NCT01565668|5805349|P2|Overall Study|Participant went on Hospice Care|0
1660966|NCT01565668|5805350|P1|Overall Study|Participant went on Hospice Care|1
1660967|NCT01565668|5805349|P2|Overall Study|Lack of Efficacy|2
1660968|NCT01565668|5805350|P1|Overall Study|Lack of Efficacy|4
1660969|NCT01565668|5805349|P2|Overall Study|Death|1
1660970|NCT01565668|5805350|P1|Overall Study|Death|2
1660971|NCT01565642|5805374|P2|Overall Study|Withdrawal by Subject|1
1660972|NCT01565642|5805375|P1|Overall Study|Withdrawal by Subject|2
1660973|NCT01565564|5805410|P2|Overall Study|Lost to Follow-up|1
1660974|NCT01565564|5805411|P1|Overall Study|Lost to Follow-up|5
1660975|NCT01565343|5805461|P3|Overall Study|Administrative decision/technical issues|0
1660976|NCT01565343|5805462|P2|Overall Study|Administrative decision/technical issues|0
1660977|NCT01565343|5805463|P1|Overall Study|Administrative decision/technical issues|1
1660978|NCT01565291|5805493|P2|Overall Study|Withdrawal by Subject|0
1660979|NCT01565291|5805494|P1|Overall Study|Withdrawal by Subject|1
1660980|NCT01565148|5805506|P4|Overall Study|Physician Decision|0
1660981|NCT01565148|5805507|P3|Overall Study|Physician Decision|0
1660982|NCT01565148|5805508|P2|Overall Study|Physician Decision|5
1660983|NCT01565148|5805509|P1|Overall Study|Physician Decision|2
1660984|NCT01565148|5805506|P4|Overall Study|Death|0
1660985|NCT01565148|5805507|P3|Overall Study|Death|1
1660986|NCT01565148|5805508|P2|Overall Study|Death|0
1660987|NCT01565148|5805509|P1|Overall Study|Death|0
1660988|NCT01565148|5805506|P4|Overall Study|Rescue Therapy|8
1660989|NCT01565148|5805507|P3|Overall Study|Rescue Therapy|5
1660990|NCT01565148|5805508|P2|Overall Study|Rescue Therapy|5
1660991|NCT01565148|5805509|P1|Overall Study|Rescue Therapy|8
1660992|NCT01565148|5805506|P4|Overall Study|Lost to Follow-up|3
1660993|NCT01565148|5805507|P3|Overall Study|Lost to Follow-up|0
1660994|NCT01565148|5805508|P2|Overall Study|Lost to Follow-up|4
1660995|NCT01565148|5805509|P1|Overall Study|Lost to Follow-up|4
1660996|NCT01565148|5805506|P4|Overall Study|Withdrawal by Subject|2
1660997|NCT01565148|5805507|P3|Overall Study|Withdrawal by Subject|1
1660998|NCT01565148|5805508|P2|Overall Study|Withdrawal by Subject|1
1660999|NCT01565148|5805509|P1|Overall Study|Withdrawal by Subject|1
1661000|NCT01565083|5805545|P2|Overall Study|Other|5
1661001|NCT01565083|5805546|P1|Overall Study|Other|3
1661002|NCT01565083|5805545|P2|Overall Study|Death|23
1661003|NCT01565083|5805546|P1|Overall Study|Death|22
1661004|NCT01565083|5805545|P2|Overall Study|Lost to Follow-up|7
1661005|NCT01565083|5805546|P1|Overall Study|Lost to Follow-up|2
1661006|NCT01565083|5805545|P2|Overall Study|Withdrawal by Subject|4
1661007|NCT01565083|5805546|P1|Overall Study|Withdrawal by Subject|6
1661008|NCT01564862|5805597|P3|Overall Study|Other reason(s)|0
1661009|NCT01564862|5805598|P2|Overall Study|Other reason(s)|0
1661010|NCT01564862|5805599|P1|Overall Study|Other reason(s)|1
1661011|NCT01564862|5805597|P3|Overall Study|Lack of Efficacy|6
1661012|NCT01564862|5805598|P2|Overall Study|Lack of Efficacy|5
1661013|NCT01564862|5805599|P1|Overall Study|Lack of Efficacy|1
1661014|NCT01564862|5805597|P3|Overall Study|Voluntary Withdrawal|8
1661015|NCT01564862|5805598|P2|Overall Study|Voluntary Withdrawal|6
1661016|NCT01564862|5805599|P1|Overall Study|Voluntary Withdrawal|9
1661017|NCT01564862|5805597|P3|Overall Study|Lost to Follow-up|6
1661018|NCT01564862|5805598|P2|Overall Study|Lost to Follow-up|8
1661019|NCT01564862|5805599|P1|Overall Study|Lost to Follow-up|10
1661020|NCT01564862|5805597|P3|Overall Study|Major Protocol Deviation|4
1661021|NCT01564862|5805598|P2|Overall Study|Major Protocol Deviation|3
1661022|NCT01564862|5805599|P1|Overall Study|Major Protocol Deviation|3
1661023|NCT01564862|5805597|P3|Overall Study|Pretreatment Event or Adverse Event|6
1661024|NCT01564862|5805598|P2|Overall Study|Pretreatment Event or Adverse Event|12
1661025|NCT01564862|5805599|P1|Overall Study|Pretreatment Event or Adverse Event|6
1661026|NCT01564784|5805650|P2|Overall Study|Death|126
1661027|NCT01564784|5805651|P1|Overall Study|Death|131
1661028|NCT01564784|5805650|P2|Overall Study|Lost to Follow-up|1
1661029|NCT01564784|5805651|P1|Overall Study|Lost to Follow-up|1
1661030|NCT01564784|5805650|P2|Overall Study|Subject refused further follow-up|6
1661031|NCT01564784|5805651|P1|Overall Study|Subject refused further follow-up|1
1661032|NCT01564784|5805650|P2|Overall Study|Other|0
1661033|NCT01564784|5805651|P1|Overall Study|Other|1
1661034|NCT01564758|5805678|P1|Overall Study|Other|3
1661035|NCT01564758|5805678|P1|Overall Study|Adverse Event|3
1661036|NCT01564758|5805678|P1|Overall Study|Death|8
1661037|NCT01564732|5805685|P2|Overall Study|Early termination by the study sponsor|5
1661038|NCT01564732|5805686|P1|Overall Study|Early termination by the study sponsor|6
1661039|NCT01564537|5805727|P2|Overall Study|Other Miscellaneous Reasons|2
1661040|NCT01564537|5805728|P1|Overall Study|Other Miscellaneous Reasons|1
1661041|NCT01564537|5805727|P2|Overall Study|Lost to Follow-up|0
1661042|NCT01564537|5805728|P1|Overall Study|Lost to Follow-up|1
1661043|NCT01564537|5805727|P2|Overall Study|Withdrawal by Participant|4
1661044|NCT01564537|5805728|P1|Overall Study|Withdrawal by Participant|4
1661045|NCT01564459|5805751|P3|Double-blind Treatment|Adverse Event|1
1661046|NCT01564459|5805752|P2|Double-blind Treatment|Adverse Event|0
1661047|NCT01564459|5805753|P1|Double-blind Treatment|Adverse Event|0
1661048|NCT01564459|5805751|P3|Run-In|Withdrawal by Subject|0
1661049|NCT01564459|5805752|P2|Run-In|Withdrawal by Subject|0
1661050|NCT01564459|5805753|P1|Run-In|Withdrawal by Subject|1
1661051|NCT01564459|5805751|P3|Run-In|Protocol Violation|0
1661052|NCT01564459|5805752|P2|Run-In|Protocol Violation|0
1661053|NCT01564459|5805753|P1|Run-In|Protocol Violation|1
1661054|NCT01564459|5805751|P3|Run-In|Non-compliance with study drug|0
1661055|NCT01564459|5805752|P2|Run-In|Non-compliance with study drug|0
1661056|NCT01564459|5805753|P1|Run-In|Non-compliance with study drug|2
1661057|NCT01564459|5805751|P3|Run-In|Lost to Follow-up|0
1661058|NCT01564459|5805752|P2|Run-In|Lost to Follow-up|0
1661059|NCT01564459|5805753|P1|Run-In|Lost to Follow-up|1
1661060|NCT01564459|5805751|P3|Run-In|Adverse Event|0
1661061|NCT01564459|5805752|P2|Run-In|Adverse Event|0
1661062|NCT01564459|5805753|P1|Run-In|Adverse Event|7
1661063|NCT01564407|5805777|P5|Overall Study|funding lost, study ended|0
1661064|NCT01564407|5805778|P4|Overall Study|funding lost, study ended|1
1661065|NCT01564407|5805779|P3|Overall Study|funding lost, study ended|0
1661066|NCT01564407|5805780|P2|Overall Study|funding lost, study ended|0
1661067|NCT01564407|5805781|P1|Overall Study|funding lost, study ended|0
1661068|NCT01564407|5805777|P5|Overall Study|Withdrawal by Subject|0
1661069|NCT01564407|5805778|P4|Overall Study|Withdrawal by Subject|0
1661070|NCT01564407|5805779|P3|Overall Study|Withdrawal by Subject|0
1661071|NCT01564407|5805780|P2|Overall Study|Withdrawal by Subject|1
1661072|NCT01564407|5805781|P1|Overall Study|Withdrawal by Subject|0
1661073|NCT01564407|5805777|P5|Overall Study|Lost to Follow-up|0
1661074|NCT01564407|5805778|P4|Overall Study|Lost to Follow-up|0
1661075|NCT01564407|5805779|P3|Overall Study|Lost to Follow-up|0
1661076|NCT01564407|5805780|P2|Overall Study|Lost to Follow-up|1
1661077|NCT01564407|5805781|P1|Overall Study|Lost to Follow-up|0
1661078|NCT01564394|5805822|P2|Overall Study|Withdrawal by Subject|10
1661079|NCT01564394|5805823|P1|Overall Study|Withdrawal by Subject|6
1661080|NCT01564277|5805837|P2|Overall Study|Physician Decision|0
1661081|NCT01564277|5805838|P1|Overall Study|Physician Decision|1
1661082|NCT01564277|5805837|P2|Overall Study|Protocol Violation|1
1661083|NCT01564277|5805838|P1|Overall Study|Protocol Violation|0
1661084|NCT01563978|5805856|P2|Overall Study|Adverse Event|2
1661085|NCT01563978|5805857|P1|Overall Study|Adverse Event|1
1661086|NCT01563978|5805856|P2|Overall Study|Dev. of study specific discont. criteria|0
1661087|NCT01563978|5805857|P1|Overall Study|Dev. of study specific discont. criteria|1
1661088|NCT01563978|5805856|P2|Overall Study|Lost to Follow-up|0
1661089|NCT01563978|5805857|P1|Overall Study|Lost to Follow-up|1
1661090|NCT01563978|5805856|P2|Overall Study|Physician Decision|0
1661091|NCT01563978|5805857|P1|Overall Study|Physician Decision|1
1661092|NCT01563913|5805883|P2|Overall Study|Spouse Passed Away|0
1661093|NCT01563913|5805884|P1|Overall Study|Spouse Passed Away|1
1661094|NCT01563913|5805883|P2|Overall Study|Physician Decision|0
1661095|NCT01563913|5805884|P1|Overall Study|Physician Decision|1
1661096|NCT01563536|5805896|P2|Overall Study|Lost to Follow-up|0
1661097|NCT01563536|5805897|P1|Overall Study|Lost to Follow-up|1
1661098|NCT01563536|5805896|P2|Overall Study|Withdrawal by Subject|2
1661099|NCT01563536|5805897|P1|Overall Study|Withdrawal by Subject|0
1661100|NCT01563185|5805956|P1|Overall Study|Non-Compliance with study drug|1
1661101|NCT01563185|5805956|P1|Overall Study|Withdrawal by Subject|1
1661102|NCT01563172|5805970|P1|Overall Study|Other (Not specified)|1
1661103|NCT01563172|5805970|P1|Overall Study|Other (Protocol deviation)|5
1661104|NCT01563172|5805970|P1|Overall Study|Lost to Follow-up|2
1661105|NCT01563172|5805970|P1|Overall Study|Adverse Event|5
1661106|NCT01563029|5806076|P5|Overall Study|Withdrawal by Subject|3
1661107|NCT01563029|5806077|P4|Overall Study|Withdrawal by Subject|4
1661108|NCT01563029|5806078|P3|Overall Study|Withdrawal by Subject|3
1661109|NCT01563029|5806079|P2|Overall Study|Withdrawal by Subject|1
1661110|NCT01563029|5806080|P1|Overall Study|Withdrawal by Subject|4
1661111|NCT01563029|5806076|P5|Overall Study|Physician Decision|2
1661112|NCT01563029|5806077|P4|Overall Study|Physician Decision|4
1661113|NCT01563029|5806078|P3|Overall Study|Physician Decision|2
1661114|NCT01563029|5806079|P2|Overall Study|Physician Decision|5
1661115|NCT01563029|5806080|P1|Overall Study|Physician Decision|3
1661116|NCT01563029|5806076|P5|Overall Study|Lost to Follow-up|1
1661117|NCT01563029|5806077|P4|Overall Study|Lost to Follow-up|1
1661118|NCT01563029|5806078|P3|Overall Study|Lost to Follow-up|1
1661119|NCT01563029|5806079|P2|Overall Study|Lost to Follow-up|0
1661120|NCT01563029|5806080|P1|Overall Study|Lost to Follow-up|1
1661121|NCT01563029|5806076|P5|Overall Study|Protocol defined stopping criteria|0
1661122|NCT01563029|5806077|P4|Overall Study|Protocol defined stopping criteria|0
1661123|NCT01563029|5806078|P3|Overall Study|Protocol defined stopping criteria|0
1661124|NCT01563029|5806079|P2|Overall Study|Protocol defined stopping criteria|0
1661125|NCT01563029|5806080|P1|Overall Study|Protocol defined stopping criteria|1
1661126|NCT01563029|5806076|P5|Overall Study|Protocol Violation|3
1661127|NCT01563029|5806077|P4|Overall Study|Protocol Violation|1
1661128|NCT01563029|5806078|P3|Overall Study|Protocol Violation|3
1661129|NCT01563029|5806079|P2|Overall Study|Protocol Violation|2
1661130|NCT01563029|5806080|P1|Overall Study|Protocol Violation|1
1661131|NCT01563029|5806076|P5|Overall Study|Lack of Efficacy|19
1661132|NCT01563029|5806077|P4|Overall Study|Lack of Efficacy|21
1661133|NCT01563029|5806078|P3|Overall Study|Lack of Efficacy|23
1661134|NCT01563029|5806079|P2|Overall Study|Lack of Efficacy|16
1661135|NCT01563029|5806080|P1|Overall Study|Lack of Efficacy|42
1661136|NCT01563029|5806076|P5|Overall Study|Adverse Event|1
1661137|NCT01563029|5806077|P4|Overall Study|Adverse Event|2
1661138|NCT01563029|5806078|P3|Overall Study|Adverse Event|1
1661139|NCT01563029|5806079|P2|Overall Study|Adverse Event|0
1661140|NCT01563029|5806080|P1|Overall Study|Adverse Event|1
1661141|NCT01562873|5806146|P2|Overall Study|Clinical PD and adverse event|0
1661142|NCT01562873|5806147|P1|Overall Study|Clinical PD and adverse event|1
1661143|NCT01562873|5806146|P2|Overall Study|Clinical Disease Progression|0
1661144|NCT01562873|5806147|P1|Overall Study|Clinical Disease Progression|9
1661145|NCT01562873|5806146|P2|Overall Study|Adverse Event|0
1661146|NCT01562873|5806147|P1|Overall Study|Adverse Event|1
1661147|NCT01562873|5806146|P2|Overall Study|Disease Progression per RECIST|0
1661148|NCT01562873|5806147|P1|Overall Study|Disease Progression per RECIST|10
1661149|NCT01562782|5806156|P2|Overall Study|screen failure|2
1661150|NCT01562782|5806157|P1|Overall Study|screen failure|1
1661151|NCT01562782|5806156|P2|Overall Study|Withdrawal by Subject|3
1661152|NCT01562782|5806157|P1|Overall Study|Withdrawal by Subject|3
1661153|NCT01562743|5806186|P1|Overall Study|Physician Decision|2
1661154|NCT01562743|5806186|P1|Overall Study|Lost to Follow-up|2
1661155|NCT01562743|5806186|P1|Overall Study|Discontinuation criteria|2
1661156|NCT01562743|5806186|P1|Overall Study|Protocol Violation|1
1661157|NCT01562743|5806186|P1|Overall Study|Withdrawal by Subject|13
1661158|NCT01562743|5806186|P1|Overall Study|Lack of Efficacy|3
1661159|NCT01562743|5806186|P1|Overall Study|Adverse Event|29
1661160|NCT01562613|5806205|P1|Overall Study|Withdrawal by Subject|2
1661161|NCT01562613|5806205|P1|Overall Study|Lost to Follow-up|2
1661162|NCT01562548|5806215|P4|Overall Study|Lost to Follow-up|0
1661163|NCT01562548|5806216|P3|Overall Study|Lost to Follow-up|1
1661164|NCT01562548|5806217|P2|Overall Study|Lost to Follow-up|0
1661165|NCT01562548|5806218|P1|Overall Study|Lost to Follow-up|0
1661166|NCT01562444|5806271|P3|Overall Study|Protocol forbidden medication|0
1661167|NCT01562444|5806272|P2|Overall Study|Protocol forbidden medication|0
1661168|NCT01562444|5806273|P1|Overall Study|Protocol forbidden medication|1
1661169|NCT01562444|5806271|P3|Overall Study|Protocol forbidden concomitant vaccine|1
1661170|NCT01562444|5806272|P2|Overall Study|Protocol forbidden concomitant vaccine|0
1661171|NCT01562444|5806273|P1|Overall Study|Protocol forbidden concomitant vaccine|1
1661172|NCT01562444|5806271|P3|Overall Study|Unavailable serological results|2
1661173|NCT01562444|5806272|P2|Overall Study|Unavailable serological results|2
1661174|NCT01562444|5806273|P1|Overall Study|Unavailable serological results|0
1661175|NCT01562444|5806271|P3|Overall Study|Did not comply with blood draw schedule|1
1661176|NCT01562444|5806272|P2|Overall Study|Did not comply with blood draw schedule|0
1661177|NCT01562444|5806273|P1|Overall Study|Did not comply with blood draw schedule|1
1661178|NCT01562444|5806271|P3|Overall Study|Did not meet entry criteria|3
1661179|NCT01562444|5806272|P2|Overall Study|Did not meet entry criteria|0
1661180|NCT01562444|5806273|P1|Overall Study|Did not meet entry criteria|2
1661181|NCT01562327|5806539|P1|Overall Study|Infusion not received at 6 month window|4
1661182|NCT01562327|5806539|P1|Overall Study|Participant drop-out|1
1661183|NCT01562327|5806539|P1|Overall Study|Lack of Efficacy|1
1661184|NCT01562327|5806539|P1|Overall Study|Adverse Event|2
1661185|NCT01562314|5806569|P2|Overall Study|Withdrawal by Subject|1
1661186|NCT01562314|5806570|P1|Overall Study|Withdrawal by Subject|0
1661187|NCT01562314|5806569|P2|Overall Study|Met Withdrawal Criteria|2
1661188|NCT01562314|5806570|P1|Overall Study|Met Withdrawal Criteria|3
1661189|NCT01562314|5806569|P2|Overall Study|Adverse Event|5
1661190|NCT01562314|5806570|P1|Overall Study|Adverse Event|10
1661191|NCT01562275|5806627|P13|Stage 2|Progression of Disease|4
1661192|NCT01562275|5806628|P12|Stage 2|Progression of Disease|12
1661193|NCT01562275|5806629|P11|Stage 2|Progression of Disease|0
1661194|NCT01562275|5806630|P10|Stage 2|Progression of Disease|0
1661195|NCT01562275|5806631|P9|Stage 2|Progression of Disease|0
1661196|NCT01562275|5806632|P8|Stage 2|Progression of Disease|0
1661197|NCT01562275|5806633|P7|Stage 2|Progression of Disease|0
1661198|NCT01562275|5806634|P6|Stage 2|Progression of Disease|0
1661199|NCT01562275|5806635|P5|Stage 2|Progression of Disease|0
1661200|NCT01562275|5806636|P4|Stage 2|Progression of Disease|0
1661201|NCT01562275|5806637|P3|Stage 2|Progression of Disease|0
1661202|NCT01562275|5806638|P2|Stage 2|Progression of Disease|0
1661203|NCT01562275|5806639|P1|Stage 2|Progression of Disease|0
1661204|NCT01562275|5806627|P13|Stage 2|Death|1
1661205|NCT01562275|5806628|P12|Stage 2|Death|2
1661206|NCT01562275|5806629|P11|Stage 2|Death|0
1661207|NCT01562275|5806630|P10|Stage 2|Death|0
1661208|NCT01562275|5806631|P9|Stage 2|Death|0
1661209|NCT01562275|5806632|P8|Stage 2|Death|0
1661210|NCT01562275|5806633|P7|Stage 2|Death|0
1661211|NCT01562275|5806634|P6|Stage 2|Death|0
1661212|NCT01562275|5806635|P5|Stage 2|Death|0
1661213|NCT01562275|5806636|P4|Stage 2|Death|0
1661214|NCT01562275|5806637|P3|Stage 2|Death|0
1661215|NCT01562275|5806638|P2|Stage 2|Death|0
1661216|NCT01562275|5806639|P1|Stage 2|Death|0
1661217|NCT01562275|5806627|P13|Stage 1|Withdrawal by Subject|0
1661218|NCT01562275|5806628|P12|Stage 1|Withdrawal by Subject|0
1661219|NCT01562275|5806629|P11|Stage 1|Withdrawal by Subject|0
1661220|NCT01562275|5806630|P10|Stage 1|Withdrawal by Subject|1
1661221|NCT01562275|5806631|P9|Stage 1|Withdrawal by Subject|0
1661222|NCT01562275|5806632|P8|Stage 1|Withdrawal by Subject|0
1661223|NCT01562275|5806633|P7|Stage 1|Withdrawal by Subject|1
1661224|NCT01562275|5806634|P6|Stage 1|Withdrawal by Subject|0
1661225|NCT01562275|5806635|P5|Stage 1|Withdrawal by Subject|0
1661226|NCT01562275|5806636|P4|Stage 1|Withdrawal by Subject|2
1661227|NCT01562275|5806637|P3|Stage 1|Withdrawal by Subject|0
1661228|NCT01562275|5806638|P2|Stage 1|Withdrawal by Subject|1
1661229|NCT01562275|5806639|P1|Stage 1|Withdrawal by Subject|0
1661230|NCT01562275|5806627|P13|Stage 1|Progression of Disease|0
1661231|NCT01562275|5806628|P12|Stage 1|Progression of Disease|0
1661232|NCT01562275|5806629|P11|Stage 1|Progression of Disease|3
1661233|NCT01562275|5806630|P10|Stage 1|Progression of Disease|5
1661234|NCT01562275|5806631|P9|Stage 1|Progression of Disease|2
1661235|NCT01562275|5806632|P8|Stage 1|Progression of Disease|7
1661236|NCT01562275|5806633|P7|Stage 1|Progression of Disease|1
1661237|NCT01562275|5806634|P6|Stage 1|Progression of Disease|4
1661238|NCT01562275|5806635|P5|Stage 1|Progression of Disease|2
1661239|NCT01562275|5806636|P4|Stage 1|Progression of Disease|1
1661240|NCT01562275|5806637|P3|Stage 1|Progression of Disease|2
1661241|NCT01562275|5806638|P2|Stage 1|Progression of Disease|6
1661242|NCT01562275|5806639|P1|Stage 1|Progression of Disease|2
1661243|NCT01562275|5806627|P13|Stage 1|Physician Decision|0
1661244|NCT01562275|5806628|P12|Stage 1|Physician Decision|0
1661245|NCT01562275|5806629|P11|Stage 1|Physician Decision|0
1661246|NCT01562275|5806630|P10|Stage 1|Physician Decision|0
1661247|NCT01562275|5806631|P9|Stage 1|Physician Decision|1
1661248|NCT01562275|5806632|P8|Stage 1|Physician Decision|0
1661249|NCT01562275|5806633|P7|Stage 1|Physician Decision|1
1661250|NCT01562275|5806634|P6|Stage 1|Physician Decision|0
1661251|NCT01562275|5806635|P5|Stage 1|Physician Decision|1
1661252|NCT01562275|5806636|P4|Stage 1|Physician Decision|0
1661253|NCT01562275|5806637|P3|Stage 1|Physician Decision|0
1661254|NCT01562275|5806638|P2|Stage 1|Physician Decision|0
1661255|NCT01562275|5806639|P1|Stage 1|Physician Decision|0
1661256|NCT01562275|5806627|P13|Stage 1|Non Compliance|0
1661257|NCT01562275|5806628|P12|Stage 1|Non Compliance|0
1661258|NCT01562275|5806629|P11|Stage 1|Non Compliance|0
1661259|NCT01562275|5806630|P10|Stage 1|Non Compliance|0
1661260|NCT01562275|5806631|P9|Stage 1|Non Compliance|0
1661261|NCT01562275|5806632|P8|Stage 1|Non Compliance|0
1661262|NCT01562275|5806633|P7|Stage 1|Non Compliance|0
1661263|NCT01562275|5806634|P6|Stage 1|Non Compliance|0
1661264|NCT01562275|5806635|P5|Stage 1|Non Compliance|0
1661265|NCT01562275|5806636|P4|Stage 1|Non Compliance|0
1661266|NCT01562275|5806637|P3|Stage 1|Non Compliance|1
1661267|NCT01562275|5806638|P2|Stage 1|Non Compliance|0
1661268|NCT01562275|5806639|P1|Stage 1|Non Compliance|0
1661269|NCT01562275|5806627|P13|Stage 1|Death|0
1661270|NCT01562275|5806628|P12|Stage 1|Death|0
1661271|NCT01562275|5806629|P11|Stage 1|Death|0
1661272|NCT01562275|5806630|P10|Stage 1|Death|0
1661273|NCT01562275|5806631|P9|Stage 1|Death|0
1661274|NCT01562275|5806632|P8|Stage 1|Death|0
1661275|NCT01562275|5806633|P7|Stage 1|Death|0
1661276|NCT01562275|5806634|P6|Stage 1|Death|0
1661277|NCT01562275|5806635|P5|Stage 1|Death|0
1661278|NCT01562275|5806636|P4|Stage 1|Death|0
1661279|NCT01562275|5806637|P3|Stage 1|Death|0
1661280|NCT01562275|5806638|P2|Stage 1|Death|0
1661281|NCT01562275|5806639|P1|Stage 1|Death|1
1661282|NCT01562275|5806627|P13|Stage 1|Adverse Event|0
1661283|NCT01562275|5806628|P12|Stage 1|Adverse Event|0
1661284|NCT01562275|5806629|P11|Stage 1|Adverse Event|0
1661285|NCT01562275|5806630|P10|Stage 1|Adverse Event|1
1661286|NCT01562275|5806631|P9|Stage 1|Adverse Event|0
1661287|NCT01562275|5806632|P8|Stage 1|Adverse Event|0
1661288|NCT01562275|5806633|P7|Stage 1|Adverse Event|0
1661289|NCT01562275|5806634|P6|Stage 1|Adverse Event|0
1661290|NCT01562275|5806635|P5|Stage 1|Adverse Event|1
1661291|NCT01562275|5806636|P4|Stage 1|Adverse Event|1
1661292|NCT01562275|5806637|P3|Stage 1|Adverse Event|0
1661293|NCT01562275|5806638|P2|Stage 1|Adverse Event|0
1661294|NCT01562275|5806639|P1|Stage 1|Adverse Event|0
1661295|NCT01562028|5806780|P2|Overall Study|Lost to Follow-up|1
1661296|NCT01562028|5806781|P1|Overall Study|Lost to Follow-up|2
1661297|NCT01562028|5806780|P2|Overall Study|Withdrawal by Subject|1
1661298|NCT01562028|5806781|P1|Overall Study|Withdrawal by Subject|1
1661299|NCT01561976|5806805|P6|Washout Period 2 (7 Days)|Non-compliance|0
1661300|NCT01561976|5806806|P5|Washout Period 2 (7 Days)|Non-compliance|0
1661301|NCT01561976|5806807|P4|Washout Period 2 (7 Days)|Non-compliance|0
1661302|NCT01561976|5806808|P3|Washout Period 2 (7 Days)|Non-compliance|1
1661303|NCT01561976|5806809|P2|Washout Period 2 (7 Days)|Non-compliance|0
1661304|NCT01561976|5806810|P1|Washout Period 2 (7 Days)|Non-compliance|1
1661305|NCT01561976|5806805|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1661306|NCT01561976|5806806|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1661307|NCT01561976|5806807|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1661308|NCT01561976|5806808|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1661309|NCT01561976|5806809|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1661310|NCT01561976|5806810|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1661311|NCT01561976|5806805|P6|Washout Period 1 (7 Days)|Adverse Event|0
1661312|NCT01561976|5806806|P5|Washout Period 1 (7 Days)|Adverse Event|0
1661313|NCT01561976|5806807|P4|Washout Period 1 (7 Days)|Adverse Event|1
1661314|NCT01561976|5806808|P3|Washout Period 1 (7 Days)|Adverse Event|0
1661315|NCT01561976|5806809|P2|Washout Period 1 (7 Days)|Adverse Event|0
1661316|NCT01561976|5806810|P1|Washout Period 1 (7 Days)|Adverse Event|0
1661317|NCT01561976|5806805|P6|Period 1|Adverse Event|0
1661318|NCT01561976|5806806|P5|Period 1|Adverse Event|0
1661319|NCT01561976|5806807|P4|Period 1|Adverse Event|0
1661320|NCT01561976|5806808|P3|Period 1|Adverse Event|1
1661321|NCT01561976|5806809|P2|Period 1|Adverse Event|0
1661322|NCT01561976|5806810|P1|Period 1|Adverse Event|0
1661323|NCT01561898|5806843|P4|Overall Study|Physician Decision|1
1661324|NCT01561898|5806844|P3|Overall Study|Physician Decision|7
1661325|NCT01561898|5806845|P2|Overall Study|Physician Decision|5
1661326|NCT01561898|5806846|P1|Overall Study|Physician Decision|1
1661327|NCT01561898|5806843|P4|Overall Study|Adverse Event|9
1661328|NCT01561898|5806844|P3|Overall Study|Adverse Event|14
1661329|NCT01561898|5806845|P2|Overall Study|Adverse Event|19
1661330|NCT01561898|5806846|P1|Overall Study|Adverse Event|1
1661331|NCT01561898|5806843|P4|Overall Study|Lost to Follow-up|0
1661332|NCT01561898|5806844|P3|Overall Study|Lost to Follow-up|1
1661333|NCT01561898|5806845|P2|Overall Study|Lost to Follow-up|0
1661334|NCT01561898|5806846|P1|Overall Study|Lost to Follow-up|0
1661335|NCT01561898|5806843|P4|Overall Study|Worsening of complications|0
1661336|NCT01561898|5806844|P3|Overall Study|Worsening of complications|0
1661337|NCT01561898|5806845|P2|Overall Study|Worsening of complications|1
1661338|NCT01561898|5806846|P1|Overall Study|Worsening of complications|0
1661339|NCT01561898|5806843|P4|Overall Study|Lack of Efficacy|5
1661340|NCT01561898|5806844|P3|Overall Study|Lack of Efficacy|10
1661341|NCT01561898|5806845|P2|Overall Study|Lack of Efficacy|8
1661342|NCT01561898|5806846|P1|Overall Study|Lack of Efficacy|0
1661343|NCT01561898|5806843|P4|Overall Study|Withdrawal by Subject|5
1661344|NCT01561898|5806844|P3|Overall Study|Withdrawal by Subject|12
1661345|NCT01561898|5806845|P2|Overall Study|Withdrawal by Subject|8
1661346|NCT01561898|5806846|P1|Overall Study|Withdrawal by Subject|0
1661347|NCT01561755|5806860|P2|Overall Study|Lost to Follow-up|1
1661348|NCT01561755|5806861|P1|Overall Study|Lost to Follow-up|0
1661349|NCT01561560|5806913|P2|Second Two Weeks of Wear|Adverse Event|1
1661350|NCT01561560|5806914|P1|Second Two Weeks of Wear|Adverse Event|0
1661351|NCT01561560|5806913|P2|First Two Weeks of Wear|Adverse Event|1
1661352|NCT01561560|5806914|P1|First Two Weeks of Wear|Adverse Event|0
1661353|NCT01561560|5806913|P2|First Two Weeks of Wear|Time/job conflict|1
1661354|NCT01561560|5806914|P1|First Two Weeks of Wear|Time/job conflict|0
1661355|NCT01561430|5806949|P4|Overall Study|Sponsor Decision|12
1661356|NCT01561430|5806950|P3|Overall Study|Sponsor Decision|13
1661357|NCT01561430|5806951|P2|Overall Study|Sponsor Decision|14
1661358|NCT01561430|5806952|P1|Overall Study|Sponsor Decision|1
1661359|NCT01561430|5806949|P4|Overall Study|Physician Decision|0
1661360|NCT01561430|5806950|P3|Overall Study|Physician Decision|0
1661361|NCT01561430|5806951|P2|Overall Study|Physician Decision|1
1661362|NCT01561430|5806952|P1|Overall Study|Physician Decision|0
1661363|NCT01561430|5806949|P4|Overall Study|Withdrawal by Subject|0
1661364|NCT01561430|5806950|P3|Overall Study|Withdrawal by Subject|1
1661365|NCT01561430|5806951|P2|Overall Study|Withdrawal by Subject|0
1661366|NCT01561430|5806952|P1|Overall Study|Withdrawal by Subject|0
1661367|NCT01561430|5806949|P4|Overall Study|Adverse Event|1
1661368|NCT01561430|5806950|P3|Overall Study|Adverse Event|3
1661369|NCT01561430|5806951|P2|Overall Study|Adverse Event|0
1661370|NCT01561430|5806952|P1|Overall Study|Adverse Event|0
1661371|NCT01561313|5806992|P2|Overall Study|Adverse event and withdrawal by subject|0
1661372|NCT01561313|5806993|P1|Overall Study|Adverse event and withdrawal by subject|1
1661373|NCT01561313|5806992|P2|Overall Study|Withdrawal by Subject|0
1661374|NCT01561313|5806993|P1|Overall Study|Withdrawal by Subject|1
1661375|NCT01561300|5807011|P2|Run in on Placebo|Adverse Event|0
1661376|NCT01561300|5807012|P1|Run in on Placebo|Adverse Event|1
1661377|NCT01561079|5807023|P1|Overall Study|Protocol Violation|2
1661378|NCT01561079|5807023|P1|Overall Study|Withdrawal by Subject|59
1661379|NCT01561079|5807023|P1|Overall Study|Physician Decision|17
1661380|NCT01560988|5807109|P2|Washout (Six Weeks)|Lost to Follow-up|2
1661381|NCT01560988|5807110|P1|Washout (Six Weeks)|Lost to Follow-up|2
1661382|NCT01560988|5807109|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
1661383|NCT01560988|5807110|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
1661384|NCT01560988|5807109|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
1661385|NCT01560988|5807110|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
1661386|NCT01560819|5807148|P2|Overall Study|Physician Decision|0
1661387|NCT01560819|5807149|P1|Overall Study|Physician Decision|1
1661388|NCT01560780|5807155|P2|Overall Study|Patient Preference|11
1661389|NCT01560780|5807156|P1|Overall Study|Patient Preference|11
1661390|NCT01560780|5807155|P2|Overall Study|Death|1
1661391|NCT01560780|5807156|P1|Overall Study|Death|2
1661392|NCT01560507|5807192|P3|Overall Study|Withdrawal by Subject|0
1661393|NCT01560507|5807193|P2|Overall Study|Withdrawal by Subject|1
1661394|NCT01560507|5807194|P1|Overall Study|Withdrawal by Subject|1
1661395|NCT01560507|5807192|P3|Overall Study|Lost to Follow-up|2
1661396|NCT01560507|5807193|P2|Overall Study|Lost to Follow-up|1
1661397|NCT01560507|5807194|P1|Overall Study|Lost to Follow-up|3
1661398|NCT01560429|5807207|P2|Overall Study|Protocol Violation|6
1661399|NCT01560429|5807208|P1|Overall Study|Protocol Violation|3
1661400|NCT01560416|5807218|P2|Randomized Phase|Crossover Participants|0
1661401|NCT01560416|5807219|P1|Randomized Phase|Crossover Participants|7
1661402|NCT01560403|5807237|P2|Overall Study|Lost to Follow-up|1
1661403|NCT01560403|5807238|P1|Overall Study|Lost to Follow-up|0
1661404|NCT01560234|5807286|P8|Overall Study|Lost to Follow-up|2
1661405|NCT01560234|5807287|P7|Overall Study|Lost to Follow-up|0
1661406|NCT01560234|5807288|P6|Overall Study|Lost to Follow-up|2
1661407|NCT01560234|5807289|P5|Overall Study|Lost to Follow-up|0
1661408|NCT01560234|5807290|P4|Overall Study|Lost to Follow-up|0
1661409|NCT01560234|5807291|P3|Overall Study|Lost to Follow-up|1
1661410|NCT01560234|5807292|P2|Overall Study|Lost to Follow-up|0
1661411|NCT01560234|5807293|P1|Overall Study|Lost to Follow-up|3
1661412|NCT01559935|5807388|P1|Maintenance Phase|Non-compliance|2
1661413|NCT01559935|5807388|P1|Maintenance Phase|Withdrawal by Subject|5
1661414|NCT01559935|5807388|P1|Maintenance Phase|Lack of Efficacy|18
1661415|NCT01559935|5807388|P1|Maintenance Phase|Toxicity|1
1661416|NCT01559935|5807388|P1|Maintenance Phase|Remains on study|28
1661417|NCT01559935|5807388|P1|BiRD Phase|Withdrawal by Subject|2
1661418|NCT01559935|5807388|P1|BiRD Phase|Lack of Efficacy|1
1661419|NCT01559935|5807388|P1|BiRD Phase|Toxicity|1
1661420|NCT01559935|5807388|P1|Car Phase|non-compliance|1
1661421|NCT01559935|5807388|P1|Car Phase|Insurance|1
1661422|NCT01559935|5807388|P1|Car Phase|Per protocol|1
1661423|NCT01559935|5807388|P1|Car Phase|Withdrawal by Subject|2
1661424|NCT01559935|5807388|P1|Car Phase|Physician Decision|1
1661425|NCT01559935|5807388|P1|Car Phase|Lost to Follow-up|1
1661426|NCT01559935|5807388|P1|Car Phase|Lack of Efficacy|2
1661427|NCT01559935|5807388|P1|Car Phase|Death|1
1661428|NCT01559935|5807388|P1|Car Phase|Toxicity|4
1661429|NCT01559844|5807424|P1|Overall Study|No Longer A Transplant Candidate|3
1661430|NCT01559844|5807424|P1|Overall Study|Efficacy Failure|10
1661431|NCT01559844|5807424|P1|Overall Study|Death|5
1661432|NCT01559844|5807424|P1|Overall Study|Consent Withdrawn|7
1661433|NCT01559675|5807437|P2|Overall Study|2nd operation on same patient excluded|12
1661434|NCT01559675|5807438|P1|Overall Study|2nd operation on same patient excluded|14
1661435|NCT01559675|5807437|P2|Overall Study|Protocol Violation|2
1661436|NCT01559675|5807438|P1|Overall Study|Protocol Violation|1
1661437|NCT01559454|5807469|P2|Overall Study|Lack of Efficacy|1
1661438|NCT01559454|5807470|P1|Overall Study|Lack of Efficacy|0
1661439|NCT01559454|5807469|P2|Overall Study|Protocol Violation|1
1661440|NCT01559454|5807470|P1|Overall Study|Protocol Violation|0
1661441|NCT01559454|5807469|P2|Overall Study|Physician Decision|1
1661442|NCT01559454|5807470|P1|Overall Study|Physician Decision|0
1661443|NCT01559454|5807469|P2|Overall Study|Withdrawal by Subject|1
1661444|NCT01559454|5807470|P1|Overall Study|Withdrawal by Subject|0
1661445|NCT01559454|5807469|P2|Overall Study|Lost to Follow-up|2
1661446|NCT01559454|5807470|P1|Overall Study|Lost to Follow-up|3
1661447|NCT01559389|5807488|P2|Overall Study|Withdrawal by Subject|20
1661448|NCT01559389|5807489|P1|Overall Study|Withdrawal by Subject|20
1661449|NCT01559311|5807502|P3|Overall Study|Adverse Event|1
1661450|NCT01559311|5807503|P2|Overall Study|Adverse Event|0
1661451|NCT01559311|5807504|P1|Overall Study|Adverse Event|0
1661452|NCT01559311|5807502|P3|Overall Study|Lost to Follow-up|2
1661453|NCT01559311|5807503|P2|Overall Study|Lost to Follow-up|3
1661454|NCT01559311|5807504|P1|Overall Study|Lost to Follow-up|0
1661455|NCT01559311|5807502|P3|Overall Study|Death|3
1661456|NCT01559311|5807503|P2|Overall Study|Death|2
1661457|NCT01559311|5807504|P1|Overall Study|Death|0
1661458|NCT01559311|5807502|P3|Overall Study|Withdrawal by Subject|0
1661459|NCT01559311|5807503|P2|Overall Study|Withdrawal by Subject|1
1661460|NCT01559311|5807504|P1|Overall Study|Withdrawal by Subject|2
1661461|NCT01559311|5807502|P3|Overall Study|Difficulty in cannulating the lateral ve|0
1661462|NCT01559311|5807503|P2|Overall Study|Difficulty in cannulating the lateral ve|0
1661463|NCT01559311|5807504|P1|Overall Study|Difficulty in cannulating the lateral ve|1
1661464|NCT01559311|5807502|P3|Overall Study|Protocol Violation|2
1661465|NCT01559311|5807503|P2|Overall Study|Protocol Violation|0
1661466|NCT01559311|5807504|P1|Overall Study|Protocol Violation|0
1661467|NCT01559129|5807517|P2|Open-label Extension Period|Study Terminated by Sponsor|2
1661468|NCT01559129|5807518|P1|Open-label Extension Period|Study Terminated by Sponsor|5
1661469|NCT01559129|5807517|P2|Open-label Extension Period|Adverse Event|0
1661470|NCT01559129|5807518|P1|Open-label Extension Period|Adverse Event|1
1661471|NCT01559129|5807517|P2|Treatment Phase|Did Not Receive Study Drug|1
1661472|NCT01559129|5807518|P1|Treatment Phase|Did Not Receive Study Drug|0
1661473|NCT01559129|5807517|P2|Treatment Phase|Protocol Exclusion Criteria|0
1661474|NCT01559129|5807518|P1|Treatment Phase|Protocol Exclusion Criteria|1
1661475|NCT01559129|5807517|P2|Treatment Phase|Study Terminated by Sponsor|2
1661476|NCT01559129|5807518|P1|Treatment Phase|Study Terminated by Sponsor|3
1661477|NCT01559129|5807517|P2|Treatment Phase|Lack of Efficacy|1
1661478|NCT01559129|5807518|P1|Treatment Phase|Lack of Efficacy|0
1661479|NCT01559129|5807517|P2|Treatment Phase|Progressive Disease|1
1661480|NCT01559129|5807518|P1|Treatment Phase|Progressive Disease|1
1661481|NCT01559129|5807517|P2|Treatment Phase|Adverse Event|2
1661482|NCT01559129|5807518|P1|Treatment Phase|Adverse Event|0
1661483|NCT01559116|5807594|P1|Overall Study|other than stated above|9
1661484|NCT01559116|5807594|P1|Overall Study|Withdrawal by Subject|4
1661485|NCT01559116|5807594|P1|Overall Study|Protocol Violation|1
1661486|NCT01559116|5807594|P1|Overall Study|Lost to Follow-up|1
1661487|NCT01559116|5807594|P1|Overall Study|Lack of Efficacy|1
1661488|NCT01559116|5807594|P1|Overall Study|Adverse Event|10
1661489|NCT01559090|5807665|P3|Stage II|Withdrawal by Subject|0
1661490|NCT01559090|5807666|P2|Stage II|Withdrawal by Subject|0
1661491|NCT01559090|5807667|P1|Stage II|Withdrawal by Subject|1
1661492|NCT01559090|5807665|P3|Stage I|Withdrawal by Subject|3
1661493|NCT01559090|5807666|P2|Stage I|Withdrawal by Subject|2
1661494|NCT01559090|5807667|P1|Stage I|Withdrawal by Subject|2
1661495|NCT01559012|5807699|P2|Overall Study|Withdrawal by Subject|1
1661496|NCT01559012|5807700|P1|Overall Study|Withdrawal by Subject|0
1661497|NCT01558739|5807738|P1|Overall Study|Protocol Violation|1
1661498|NCT01558739|5807738|P1|Overall Study|Disease Progression|4
1661499|NCT01558739|5807738|P1|Overall Study|Death|3
1661500|NCT01558739|5807738|P1|Overall Study|Withdrawal by Subject|2
1661501|NCT01558739|5807738|P1|Overall Study|Adverse Event|7
1661502|NCT01558674|5807763|P2|Part 1|Withdrawal by Subject|0
1661503|NCT01558674|5807764|P1|Part 1|Withdrawal by Subject|1
1661504|NCT01558674|5807763|P2|Part 1|Study Terminated by Sponsor|0
1661505|NCT01558674|5807764|P1|Part 1|Study Terminated by Sponsor|10
1661506|NCT01558635|5807815|P1|Overall Study|Reveal XT was explanted|1
1661507|NCT01558635|5807815|P1|Overall Study|Subject received other treatment|1
1661508|NCT01558635|5807815|P1|Overall Study|Physician Decision|1
1661509|NCT01558635|5807815|P1|Overall Study|Withdrawal by Subject|2
1661510|NCT01558635|5807815|P1|Overall Study|Death|1
1661511|NCT01558596|5807832|P2|Overall Study|Protocol Violation|0
1661512|NCT01558596|5807833|P1|Overall Study|Protocol Violation|1
1661513|NCT01558596|5807832|P2|Overall Study|surgery elsewhere or cancelled|1
1661514|NCT01558596|5807833|P1|Overall Study|surgery elsewhere or cancelled|1
1661515|NCT01558596|5807832|P2|Overall Study|Withdrawal by Subject|0
1661516|NCT01558596|5807833|P1|Overall Study|Withdrawal by Subject|1
1661517|NCT01558297|5807848|P3|Overall Study|Withdrawal by Subject|1
1661518|NCT01558297|5807849|P2|Overall Study|Withdrawal by Subject|2
1661519|NCT01558297|5807850|P1|Overall Study|Withdrawal by Subject|2
1661520|NCT01558271|5807867|P3|Overall Study|Physician Decision|1
1661521|NCT01558271|5807868|P2|Overall Study|Physician Decision|2
1661522|NCT01558271|5807869|P1|Overall Study|Physician Decision|0
1661523|NCT01558271|5807867|P3|Overall Study|Withdrawal by Subject|12
1661524|NCT01558271|5807868|P2|Overall Study|Withdrawal by Subject|6
1661525|NCT01558271|5807869|P1|Overall Study|Withdrawal by Subject|10
1661526|NCT01558271|5807867|P3|Overall Study|Protocol Violation|0
1661527|NCT01558271|5807868|P2|Overall Study|Protocol Violation|0
1661528|NCT01558271|5807869|P1|Overall Study|Protocol Violation|1
1661529|NCT01558271|5807867|P3|Overall Study|Lost to Follow-up|0
1661530|NCT01558271|5807868|P2|Overall Study|Lost to Follow-up|0
1661531|NCT01558271|5807869|P1|Overall Study|Lost to Follow-up|1
1661532|NCT01558271|5807867|P3|Overall Study|Adverse Event|4
1661533|NCT01558271|5807868|P2|Overall Study|Adverse Event|3
1661534|NCT01558271|5807869|P1|Overall Study|Adverse Event|6
1661535|NCT01558089|5807935|P1|Overall Study|Withdrawal by Subject|6
1661536|NCT01558089|5807935|P1|Overall Study|Lost to Follow-up|5
1661537|NCT01558089|5807935|P1|Overall Study|Lack of Efficacy|1
1661538|NCT01558089|5807935|P1|Overall Study|Adverse Event|1
1661539|NCT01557946|5807988|P2|Overall Study|Adverse Event|0
1661540|NCT01557946|5807989|P1|Overall Study|Adverse Event|3
1661541|NCT01557920|5807995|P2|Overall Study|Lack of Efficacy|0
1661542|NCT01557920|5807996|P1|Overall Study|Lack of Efficacy|1
1661543|NCT01557920|5807995|P2|Overall Study|Withdrawal by Subject|3
1661544|NCT01557920|5807996|P1|Overall Study|Withdrawal by Subject|2
1661545|NCT01557842|5808065|P2|Overall Study|Not Ablated|0
1661546|NCT01557842|5808066|P1|Overall Study|Not Ablated|2
1661547|NCT01557842|5808065|P2|Overall Study|Study Terminated by Sponsor|4
1661548|NCT01557842|5808066|P1|Overall Study|Study Terminated by Sponsor|3
1661549|NCT01557842|5808065|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
1661550|NCT01557842|5808066|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
1661551|NCT01557842|5808065|P2|Overall Study|Lack of Efficacy|1
1661552|NCT01557842|5808066|P1|Overall Study|Lack of Efficacy|0
1661553|NCT01557842|5808065|P2|Overall Study|Death|0
1661554|NCT01557842|5808066|P1|Overall Study|Death|1
1661555|NCT01557842|5808065|P2|Overall Study|Lost to Follow-up|1
1661556|NCT01557842|5808066|P1|Overall Study|Lost to Follow-up|0
1661557|NCT01557751|5808078|P1|Overall Study|Physician Decision|3
1661558|NCT01557582|5808123|P1|Overall Study|Operator error|2
1661559|NCT01557582|5808123|P1|Overall Study|Protocol Violation|4
1661560|NCT01557569|5808131|P2|Overall Study|noncompliance with rules of residential|1
1661561|NCT01557569|5808132|P1|Overall Study|noncompliance with rules of residential|0
1661562|NCT01557569|5808131|P2|Overall Study|Withdrawal by Subject|5
1661563|NCT01557569|5808132|P1|Overall Study|Withdrawal by Subject|3
1661564|NCT01557569|5808131|P2|Overall Study|high blood pressure|1
1661565|NCT01557569|5808132|P1|Overall Study|high blood pressure|0
1661566|NCT01557569|5808131|P2|Overall Study|Adverse Event|0
1661567|NCT01557569|5808132|P1|Overall Study|Adverse Event|2
1661568|NCT01557517|5808140|P2|Overall Study|Pt declined before treatment started|0
1661569|NCT01557517|5808141|P1|Overall Study|Pt declined before treatment started|1
1661570|NCT01557517|5808140|P2|Overall Study|Adverse Event|2
1661571|NCT01557517|5808141|P1|Overall Study|Adverse Event|0
1661572|NCT01557517|5808140|P2|Overall Study|Refused further treatment|2
1661573|NCT01557517|5808141|P1|Overall Study|Refused further treatment|0
1661574|NCT01557517|5808140|P2|Overall Study|Death|0
1661575|NCT01557517|5808141|P1|Overall Study|Death|1
1661576|NCT01557504|5808167|P2|Overall Study|Physician Decision|0
1661577|NCT01557504|5808168|P1|Overall Study|Physician Decision|1
1661578|NCT01557348|5808193|P2|Overall Study|Administrative|11
1661579|NCT01557348|5808194|P1|Overall Study|Administrative|18
1661580|NCT01557348|5808193|P2|Overall Study|Lost to Follow-up|22
1661581|NCT01557348|5808194|P1|Overall Study|Lost to Follow-up|26
1661582|NCT01557348|5808193|P2|Overall Study|Withdrawal by Subject|4
1661583|NCT01557348|5808194|P1|Overall Study|Withdrawal by Subject|5
1661584|NCT01557348|5808193|P2|Overall Study|Insufficient Therapeutic Response|28
1661585|NCT01557348|5808194|P1|Overall Study|Insufficient Therapeutic Response|13
1661586|NCT01557348|5808193|P2|Overall Study|Death|4
1661587|NCT01557348|5808194|P1|Overall Study|Death|7
1661588|NCT01557348|5808193|P2|Overall Study|Infusion reaction event|5
1661589|NCT01557348|5808194|P1|Overall Study|Infusion reaction event|5
1661590|NCT01557348|5808193|P2|Overall Study|Adverse Event|16
1661591|NCT01557348|5808194|P1|Overall Study|Adverse Event|6
1661592|NCT01557283|5808311|P1|Overall Study|Other|6
1661593|NCT01557283|5808311|P1|Overall Study|Worsening of psoriasis|1
1661594|NCT01557283|5808311|P1|Overall Study|Participant’s weight too high for dose|1
1661595|NCT01557283|5808311|P1|Overall Study|Withdrawal by Subject|1
1661596|NCT01557283|5808311|P1|Overall Study|Non-compliance|1
1661597|NCT01557283|5808311|P1|Overall Study|Lack of Efficacy|1
1661598|NCT01557283|5808311|P1|Overall Study|Adverse Event|7
1661599|NCT01557283|5808311|P1|Overall Study|Non-responder|19
1661600|NCT01557283|5808311|P1|Overall Study|Lost to Follow-up|7
1661601|NCT01557166|5808323|P2|Overall Study|Unclassified|5
1661602|NCT01557166|5808324|P1|Overall Study|Unclassified|2
1661603|NCT01557166|5808323|P2|Overall Study|Psychiatric disorder|0
1661604|NCT01557166|5808324|P1|Overall Study|Psychiatric disorder|1
1661605|NCT01557166|5808323|P2|Overall Study|Target dose not tolerated|0
1661606|NCT01557166|5808324|P1|Overall Study|Target dose not tolerated|1
1661607|NCT01557166|5808323|P2|Overall Study|Withdrawn consent|20
1661608|NCT01557166|5808324|P1|Overall Study|Withdrawn consent|12
1661609|NCT01557166|5808323|P2|Overall Study|Protocol Violation|5
1661610|NCT01557166|5808324|P1|Overall Study|Protocol Violation|8
1661611|NCT01557166|5808323|P2|Overall Study|Lack of Efficacy|1
1661612|NCT01557166|5808324|P1|Overall Study|Lack of Efficacy|2
1661613|NCT01557166|5808323|P2|Overall Study|Adverse Event|6
1661614|NCT01557166|5808324|P1|Overall Study|Adverse Event|20
1661615|NCT01556997|5808339|P3|Overall Study|Other|7
1661616|NCT01556997|5808340|P2|Overall Study|Other|3
1661617|NCT01556997|5808341|P1|Overall Study|Other|2
1661618|NCT01556997|5808339|P3|Overall Study|Withdrawal by Subject|8
1661619|NCT01556997|5808340|P2|Overall Study|Withdrawal by Subject|6
1661620|NCT01556997|5808341|P1|Overall Study|Withdrawal by Subject|7
1661621|NCT01556997|5808339|P3|Overall Study|Physician Decision|1
1661622|NCT01556997|5808340|P2|Overall Study|Physician Decision|1
1661623|NCT01556997|5808341|P1|Overall Study|Physician Decision|1
1661624|NCT01556997|5808339|P3|Overall Study|Lost to Follow-up|4
1661625|NCT01556997|5808340|P2|Overall Study|Lost to Follow-up|6
1661626|NCT01556997|5808341|P1|Overall Study|Lost to Follow-up|6
1661627|NCT01556997|5808339|P3|Overall Study|Adverse Event|12
1661628|NCT01556997|5808340|P2|Overall Study|Adverse Event|12
1661629|NCT01556997|5808341|P1|Overall Study|Adverse Event|10
1661630|NCT01556932|5808352|P2|Time Point 60 Minutes|Withdrawal by Subject|1
1661631|NCT01556932|5808353|P1|Time Point 60 Minutes|Withdrawal by Subject|1
1661632|NCT01556763|5808379|P3|Overall Study|Withdrawal by Subject|0
1661633|NCT01556763|5808380|P2|Overall Study|Withdrawal by Subject|1
1661634|NCT01556763|5808381|P1|Overall Study|Withdrawal by Subject|0
1661635|NCT01556438|5808507|P2|Overall Study|Death|1
1661636|NCT01556438|5808508|P1|Overall Study|Death|0
1661637|NCT01556438|5808507|P2|Overall Study|Progressive Disease|6
1661638|NCT01556438|5808508|P1|Overall Study|Progressive Disease|0
1661639|NCT01556438|5808507|P2|Overall Study|Sponsor Decision|2
1661640|NCT01556438|5808508|P1|Overall Study|Sponsor Decision|0
1661641|NCT01556438|5808507|P2|Overall Study|Adverse Event|2
1661642|NCT01556438|5808508|P1|Overall Study|Adverse Event|4
1661643|NCT01556165|5808595|P2|Overall Study|Withdrawal of Consent|1
1661644|NCT01556165|5808596|P1|Overall Study|Withdrawal of Consent|7
1661645|NCT01556165|5808595|P2|Overall Study|Protocol Violation|3
1661646|NCT01556165|5808596|P1|Overall Study|Protocol Violation|0
1661647|NCT01556165|5808595|P2|Overall Study|Adverse Event|3
1661648|NCT01556165|5808596|P1|Overall Study|Adverse Event|5
1661649|NCT01555983|5808626|P6|Overall Study|Withdrawal by Subject|1
1661650|NCT01555983|5808627|P5|Overall Study|Withdrawal by Subject|1
1661651|NCT01555983|5808628|P4|Overall Study|Withdrawal by Subject|0
1661652|NCT01555983|5808629|P3|Overall Study|Withdrawal by Subject|0
1661653|NCT01555983|5808630|P2|Overall Study|Withdrawal by Subject|0
1661654|NCT01555983|5808631|P1|Overall Study|Withdrawal by Subject|1
1661655|NCT01555931|5808641|P2|Overall Study|Lost to Follow-up|5
1661656|NCT01555931|5808642|P1|Overall Study|Lost to Follow-up|2
1661657|NCT01555762|5808650|P1|Overall Study|Death linked to an adverse event|14
1661658|NCT01555762|5808650|P1|Overall Study|Missing data|1
1661659|NCT01555762|5808650|P1|Overall Study|Participant not wishing to continue|5
1661660|NCT01555762|5808650|P1|Overall Study|Investigator's decision|10
1661661|NCT01555762|5808650|P1|Overall Study|Lost follow-up/moved house/changed team|35
1661662|NCT01555762|5808650|P1|Overall Study|Death linked to progression of disease|165
1661663|NCT01555762|5808650|P1|Overall Study|Treatment with Bevacizumab ticked No|24
1661664|NCT01555762|5808650|P1|Overall Study|75 years old or more ticked No|1
1661665|NCT01555762|5808650|P1|Overall Study|Missing start date of infusion|8
1661666|NCT01555762|5808650|P1|Overall Study|No information on Bevacizumab intake|11
1661667|NCT01555463|5808695|P2|Follow up|Other reason|3
1661668|NCT01555463|5808696|P1|Follow up|Other reason|3
1661669|NCT01555463|5808695|P2|Follow up|Protocol Violation|4
1661670|NCT01555463|5808696|P1|Follow up|Protocol Violation|2
1661671|NCT01555463|5808695|P2|Follow up|Lost to Follow-up|10
1661672|NCT01555463|5808696|P1|Follow up|Lost to Follow-up|9
1661673|NCT01555463|5808695|P2|Follow up|Withdrawal by Subject|22
1661674|NCT01555463|5808696|P1|Follow up|Withdrawal by Subject|22
1661675|NCT01555463|5808695|P2|Follow up|Death|1
1661676|NCT01555463|5808696|P1|Follow up|Death|0
1661677|NCT01555463|5808695|P2|Follow up|Adverse Event|5
1661678|NCT01555463|5808696|P1|Follow up|Adverse Event|2
1661679|NCT01555463|5808695|P2|Treatment|Other reason|3
1661680|NCT01555463|5808696|P1|Treatment|Other reason|2
1661681|NCT01555463|5808695|P2|Treatment|Protocol Violation|5
1661682|NCT01555463|5808696|P1|Treatment|Protocol Violation|4
1661683|NCT01555463|5808695|P2|Treatment|Lost to Follow-up|23
1661684|NCT01555463|5808696|P1|Treatment|Lost to Follow-up|28
1661685|NCT01555463|5808695|P2|Treatment|Withdrawal by Subject|36
1661686|NCT01555463|5808696|P1|Treatment|Withdrawal by Subject|24
1661687|NCT01555463|5808695|P2|Treatment|Adverse Event|12
1661688|NCT01555463|5808696|P1|Treatment|Adverse Event|6
1661689|NCT01555164|5808738|P2|Overall Study|Subject Withdrew Consent|11
1661690|NCT01555164|5808739|P1|Overall Study|Subject Withdrew Consent|6
1661691|NCT01555164|5808738|P2|Overall Study|Subject Non-compliance|6
1661692|NCT01555164|5808739|P1|Overall Study|Subject Non-compliance|14
1661693|NCT01555164|5808738|P2|Overall Study|Protocol Violation|5
1661694|NCT01555164|5808739|P1|Overall Study|Protocol Violation|9
1661695|NCT01555164|5808738|P2|Overall Study|Lost to Follow-up|3
1661696|NCT01555164|5808739|P1|Overall Study|Lost to Follow-up|4
1661697|NCT01555164|5808738|P2|Overall Study|Investigator's Discretion|2
1661698|NCT01555164|5808739|P1|Overall Study|Investigator's Discretion|2
1661699|NCT01555164|5808738|P2|Overall Study|Hyperglycemia|1
1661700|NCT01555164|5808739|P1|Overall Study|Hyperglycemia|0
1661701|NCT01555164|5808738|P2|Overall Study|Adverse Event|7
1661702|NCT01555164|5808739|P1|Overall Study|Adverse Event|5
1661703|NCT01555151|5808753|P4|Overall Study|Lost to Follow-up|1
1661704|NCT01555151|5808754|P3|Overall Study|Lost to Follow-up|0
1661705|NCT01555151|5808755|P2|Overall Study|Lost to Follow-up|0
1661706|NCT01555151|5808756|P1|Overall Study|Lost to Follow-up|0
1661707|NCT01555151|5808753|P4|Overall Study|Adverse Event|2
1661708|NCT01555151|5808754|P3|Overall Study|Adverse Event|1
1661709|NCT01555151|5808755|P2|Overall Study|Adverse Event|2
1661710|NCT01555151|5808756|P1|Overall Study|Adverse Event|1
1661711|NCT01555151|5808753|P4|Overall Study|Protocol Violation|5
1661712|NCT01555151|5808754|P3|Overall Study|Protocol Violation|3
1661713|NCT01555151|5808755|P2|Overall Study|Protocol Violation|3
1661714|NCT01555151|5808756|P1|Overall Study|Protocol Violation|3
1661715|NCT01555151|5808753|P4|Overall Study|Administrative|0
1661716|NCT01555151|5808754|P3|Overall Study|Administrative|2
1661717|NCT01555151|5808755|P2|Overall Study|Administrative|1
1661718|NCT01555151|5808756|P1|Overall Study|Administrative|3
1661719|NCT01555151|5808753|P4|Overall Study|Withdrawal by Subject|2
1661720|NCT01555151|5808754|P3|Overall Study|Withdrawal by Subject|0
1661721|NCT01555151|5808755|P2|Overall Study|Withdrawal by Subject|2
1661722|NCT01555151|5808756|P1|Overall Study|Withdrawal by Subject|6
1661723|NCT01555138|5808809|P2|Overall Study|Adverse Event|14
1661724|NCT01555138|5808810|P1|Overall Study|Adverse Event|14
1661725|NCT01555138|5808809|P2|Overall Study|Withdrawal by Subject|15
1661726|NCT01555138|5808810|P1|Overall Study|Withdrawal by Subject|16
1661727|NCT01555138|5808809|P2|Overall Study|Administrative problems|0
1661728|NCT01555138|5808810|P1|Overall Study|Administrative problems|8
1661729|NCT01555138|5808809|P2|Overall Study|Protocol Violation|3
1661730|NCT01555138|5808810|P1|Overall Study|Protocol Violation|5
1661731|NCT01555138|5808809|P2|Overall Study|Lack of Efficacy|2
1661732|NCT01555138|5808810|P1|Overall Study|Lack of Efficacy|2
1661733|NCT01555138|5808809|P2|Overall Study|Abnormal Lab reults|3
1661734|NCT01555138|5808810|P1|Overall Study|Abnormal Lab reults|1
1661735|NCT01555138|5808809|P2|Overall Study|Lost to Follow-up|0
1661736|NCT01555138|5808810|P1|Overall Study|Lost to Follow-up|1
1661737|NCT01555138|5808809|P2|Overall Study|Death|1
1661738|NCT01555138|5808810|P1|Overall Study|Death|0
1661739|NCT01555125|5808839|P5|Follow-Up Period|Subject / guardian decision|0
1661740|NCT01555125|5808840|P4|Follow-Up Period|Subject / guardian decision|1
1661741|NCT01555125|5808841|P3|Follow-Up Period|Subject / guardian decision|1
1661742|NCT01555125|5808842|P2|Follow-Up Period|Subject / guardian decision|1
1661743|NCT01555125|5808843|P1|Follow-Up Period|Subject / guardian decision|3
1661744|NCT01555125|5808839|P5|Follow-Up Period|Lost to Follow-up|0
1661745|NCT01555125|5808840|P4|Follow-Up Period|Lost to Follow-up|0
1661746|NCT01555125|5808841|P3|Follow-Up Period|Lost to Follow-up|0
1661747|NCT01555125|5808842|P2|Follow-Up Period|Lost to Follow-up|0
1661748|NCT01555125|5808843|P1|Follow-Up Period|Lost to Follow-up|1
1661749|NCT01555125|5808839|P5|Extension|Technical Problems|0
1661750|NCT01555125|5808840|P4|Extension|Technical Problems|1
1661751|NCT01555125|5808841|P3|Extension|Technical Problems|0
1661752|NCT01555125|5808842|P2|Extension|Technical Problems|0
1661753|NCT01555125|5808843|P1|Extension|Technical Problems|1
1661754|NCT01555125|5808839|P5|Extension|Subject/guardian decision|0
1661755|NCT01555125|5808840|P4|Extension|Subject/guardian decision|0
1661756|NCT01555125|5808841|P3|Extension|Subject/guardian decision|1
1661757|NCT01555125|5808842|P2|Extension|Subject/guardian decision|9
1661758|NCT01555125|5808843|P1|Extension|Subject/guardian decision|1
1661759|NCT01555125|5808839|P5|Extension|Study terminated by sponsor|0
1661760|NCT01555125|5808840|P4|Extension|Study terminated by sponsor|20
1661761|NCT01555125|5808841|P3|Extension|Study terminated by sponsor|16
1661762|NCT01555125|5808842|P2|Extension|Study terminated by sponsor|33
1661763|NCT01555125|5808843|P1|Extension|Study terminated by sponsor|32
1661764|NCT01555125|5808839|P5|Extension|Lost to Follow-up|0
1661765|NCT01555125|5808840|P4|Extension|Lost to Follow-up|0
1661766|NCT01555125|5808841|P3|Extension|Lost to Follow-up|2
1661767|NCT01555125|5808842|P2|Extension|Lost to Follow-up|1
1661768|NCT01555125|5808843|P1|Extension|Lost to Follow-up|2
1661769|NCT01555125|5808839|P5|Extension|Lack of Efficacy|0
1661770|NCT01555125|5808840|P4|Extension|Lack of Efficacy|0
1661771|NCT01555125|5808841|P3|Extension|Lack of Efficacy|3
1661772|NCT01555125|5808842|P2|Extension|Lack of Efficacy|6
1661773|NCT01555125|5808843|P1|Extension|Lack of Efficacy|7
1661774|NCT01555125|5808839|P5|Extension|Protocol deviation|0
1661775|NCT01555125|5808840|P4|Extension|Protocol deviation|0
1661776|NCT01555125|5808841|P3|Extension|Protocol deviation|0
1661777|NCT01555125|5808842|P2|Extension|Protocol deviation|0
1661778|NCT01555125|5808843|P1|Extension|Protocol deviation|1
1661779|NCT01555125|5808839|P5|Extension|Adverse Event|0
1661780|NCT01555125|5808840|P4|Extension|Adverse Event|1
1661781|NCT01555125|5808841|P3|Extension|Adverse Event|1
1661782|NCT01555125|5808842|P2|Extension|Adverse Event|2
1661783|NCT01555125|5808843|P1|Extension|Adverse Event|1
1661784|NCT01555125|5808839|P5|Maintenance Period|Death|0
1661785|NCT01555125|5808840|P4|Maintenance Period|Death|1
1661786|NCT01555125|5808841|P3|Maintenance Period|Death|0
1661787|NCT01555125|5808842|P2|Maintenance Period|Death|0
1661788|NCT01555125|5808843|P1|Maintenance Period|Death|0
1661789|NCT01555125|5808839|P5|Maintenance Period|Physician Decision|0
1661790|NCT01555125|5808840|P4|Maintenance Period|Physician Decision|0
1661791|NCT01555125|5808841|P3|Maintenance Period|Physician Decision|1
1661792|NCT01555125|5808842|P2|Maintenance Period|Physician Decision|0
1661793|NCT01555125|5808843|P1|Maintenance Period|Physician Decision|0
1661794|NCT01555125|5808839|P5|Maintenance Period|Lack of Efficacy|0
1661795|NCT01555125|5808840|P4|Maintenance Period|Lack of Efficacy|0
1661796|NCT01555125|5808841|P3|Maintenance Period|Lack of Efficacy|3
1661797|NCT01555125|5808842|P2|Maintenance Period|Lack of Efficacy|1
1661798|NCT01555125|5808843|P1|Maintenance Period|Lack of Efficacy|6
1661799|NCT01555125|5808839|P5|Maintenance Period|Lost to Follow-up|0
1661800|NCT01555125|5808840|P4|Maintenance Period|Lost to Follow-up|1
1661801|NCT01555125|5808841|P3|Maintenance Period|Lost to Follow-up|0
1661802|NCT01555125|5808842|P2|Maintenance Period|Lost to Follow-up|0
1661803|NCT01555125|5808843|P1|Maintenance Period|Lost to Follow-up|2
1661804|NCT01555125|5808839|P5|Maintenance Period|Subject / guardian decision|0
1661805|NCT01555125|5808840|P4|Maintenance Period|Subject / guardian decision|0
1661806|NCT01555125|5808841|P3|Maintenance Period|Subject / guardian decision|0
1661807|NCT01555125|5808842|P2|Maintenance Period|Subject / guardian decision|2
1661808|NCT01555125|5808843|P1|Maintenance Period|Subject / guardian decision|1
1661809|NCT01555125|5808839|P5|Maintenance Period|Adverse Event|0
1661810|NCT01555125|5808840|P4|Maintenance Period|Adverse Event|0
1661811|NCT01555125|5808841|P3|Maintenance Period|Adverse Event|0
1661812|NCT01555125|5808842|P2|Maintenance Period|Adverse Event|1
1661813|NCT01555125|5808843|P1|Maintenance Period|Adverse Event|1
1661814|NCT01555125|5808839|P5|Induction Period|Death|0
1661815|NCT01555125|5808840|P4|Induction Period|Death|0
1661816|NCT01555125|5808841|P3|Induction Period|Death|0
1661817|NCT01555125|5808842|P2|Induction Period|Death|0
1661818|NCT01555125|5808843|P1|Induction Period|Death|1
1661819|NCT01555125|5808839|P5|Induction Period|Subject / guardian decision|2
1661820|NCT01555125|5808840|P4|Induction Period|Subject / guardian decision|0
1661821|NCT01555125|5808841|P3|Induction Period|Subject / guardian decision|0
1661822|NCT01555125|5808842|P2|Induction Period|Subject / guardian decision|0
1661823|NCT01555125|5808843|P1|Induction Period|Subject / guardian decision|0
1661824|NCT01555125|5808839|P5|Induction Period|Adverse Event|1
1661825|NCT01555125|5808840|P4|Induction Period|Adverse Event|0
1661826|NCT01555125|5808841|P3|Induction Period|Adverse Event|0
1661827|NCT01555125|5808842|P2|Induction Period|Adverse Event|1
1661828|NCT01555125|5808843|P1|Induction Period|Adverse Event|0
1661829|NCT01555125|5808839|P5|Induction Period|Lost to Follow-up|0
1661830|NCT01555125|5808840|P4|Induction Period|Lost to Follow-up|0
1661831|NCT01555125|5808841|P3|Induction Period|Lost to Follow-up|0
1661832|NCT01555125|5808842|P2|Induction Period|Lost to Follow-up|2
1661833|NCT01555125|5808843|P1|Induction Period|Lost to Follow-up|0
1661834|NCT01555073|5808936|P4|Overall Study|Lost to Follow-up|5
1661835|NCT01555073|5808937|P3|Overall Study|Lost to Follow-up|0
1661836|NCT01555073|5808938|P2|Overall Study|Lost to Follow-up|2
1661837|NCT01555073|5808939|P1|Overall Study|Lost to Follow-up|1
1661838|NCT01555021|5808955|P2|Overall Study|Lost to Follow-up|2
1661839|NCT01555021|5808956|P1|Overall Study|Lost to Follow-up|1
1661840|NCT01554904|5808981|P1|Overall Study|Had sleep apnea on Home Study 1|1
1661841|NCT01554904|5808981|P1|Overall Study|Withdrawal by Subject|3
1661842|NCT01554579|5809001|P2|Overall Study|Withdrawal by Subject|1
1661843|NCT01554579|5809002|P1|Overall Study|Withdrawal by Subject|2
1661844|NCT01554579|5809001|P2|Overall Study|Lack of Efficacy|1
1661845|NCT01554579|5809002|P1|Overall Study|Lack of Efficacy|2
1661846|NCT01554579|5809001|P2|Overall Study|Adverse Event|25
1661847|NCT01554579|5809002|P1|Overall Study|Adverse Event|6
1661848|NCT01554527|5809015|P3|Overall Study|Physician Decision|1
1661849|NCT01554527|5809016|P2|Overall Study|Physician Decision|0
1661850|NCT01554527|5809017|P1|Overall Study|Physician Decision|0
1661851|NCT01554527|5809015|P3|Overall Study|Lost to Follow-up|4
1661852|NCT01554527|5809016|P2|Overall Study|Lost to Follow-up|0
1661853|NCT01554527|5809017|P1|Overall Study|Lost to Follow-up|0
1661854|NCT01554527|5809015|P3|Overall Study|Withdrawal by Subject|3
1661855|NCT01554527|5809016|P2|Overall Study|Withdrawal by Subject|0
1661856|NCT01554527|5809017|P1|Overall Study|Withdrawal by Subject|1
1661857|NCT01554241|5809073|P4|Overall Study|Withdrawal by Subject|0
1661858|NCT01554241|5809074|P3|Overall Study|Withdrawal by Subject|2
1661859|NCT01554241|5809075|P2|Overall Study|Withdrawal by Subject|0
1661860|NCT01554241|5809076|P1|Overall Study|Withdrawal by Subject|0
1661861|NCT01554241|5809073|P4|Overall Study|protocol specified change in eGFR|0
1661862|NCT01554241|5809074|P3|Overall Study|protocol specified change in eGFR|1
1661863|NCT01554241|5809075|P2|Overall Study|protocol specified change in eGFR|0
1661864|NCT01554241|5809076|P1|Overall Study|protocol specified change in eGFR|0
1661865|NCT01554241|5809073|P4|Overall Study|protocol specified renal stone|1
1661866|NCT01554241|5809074|P3|Overall Study|protocol specified renal stone|0
1661867|NCT01554241|5809075|P2|Overall Study|protocol specified renal stone|0
1661868|NCT01554241|5809076|P1|Overall Study|protocol specified renal stone|0
1661869|NCT01554241|5809073|P4|Overall Study|Death|0
1661870|NCT01554241|5809074|P3|Overall Study|Death|1
1661871|NCT01554241|5809075|P2|Overall Study|Death|1
1661872|NCT01554241|5809076|P1|Overall Study|Death|3
1661873|NCT01554176|5809092|P5|Run-out Phase|Protocol Violation|0
1661874|NCT01554176|5809093|P4|Run-out Phase|Protocol Violation|1
1661875|NCT01554176|5809094|P3|Run-out Phase|Protocol Violation|0
1661876|NCT01554176|5809095|P2|Run-out Phase|Protocol Violation|0
1661877|NCT01554176|5809096|P1|Run-out Phase|Protocol Violation|0
1661878|NCT01554176|5809092|P5|Treatment Phase|Lost to Follow-up|0
1661879|NCT01554176|5809093|P4|Treatment Phase|Lost to Follow-up|0
1661880|NCT01554176|5809094|P3|Treatment Phase|Lost to Follow-up|0
1661881|NCT01554176|5809095|P2|Treatment Phase|Lost to Follow-up|0
1661882|NCT01554176|5809096|P1|Treatment Phase|Lost to Follow-up|3
1661883|NCT01554176|5809092|P5|Treatment Phase|Withdrawal by Subject|0
1661884|NCT01554176|5809093|P4|Treatment Phase|Withdrawal by Subject|0
1661885|NCT01554176|5809094|P3|Treatment Phase|Withdrawal by Subject|0
1661886|NCT01554176|5809095|P2|Treatment Phase|Withdrawal by Subject|0
1661887|NCT01554176|5809096|P1|Treatment Phase|Withdrawal by Subject|1
1661888|NCT01554176|5809092|P5|Treatment Phase|Non-compliance with study drug|0
1661889|NCT01554176|5809093|P4|Treatment Phase|Non-compliance with study drug|0
1661890|NCT01554176|5809094|P3|Treatment Phase|Non-compliance with study drug|0
1661891|NCT01554176|5809095|P2|Treatment Phase|Non-compliance with study drug|0
1661892|NCT01554176|5809096|P1|Treatment Phase|Non-compliance with study drug|1
1661893|NCT01554176|5809092|P5|Treatment Phase|Adverse event, non-fatal|0
1661894|NCT01554176|5809093|P4|Treatment Phase|Adverse event, non-fatal|0
1661895|NCT01554176|5809094|P3|Treatment Phase|Adverse event, non-fatal|0
1661896|NCT01554176|5809095|P2|Treatment Phase|Adverse event, non-fatal|1
1661897|NCT01554176|5809096|P1|Treatment Phase|Adverse event, non-fatal|1
1661898|NCT01554176|5809092|P5|Treatment Phase|Lack of Efficacy|0
1661899|NCT01554176|5809093|P4|Treatment Phase|Lack of Efficacy|0
1661900|NCT01554176|5809094|P3|Treatment Phase|Lack of Efficacy|0
1661901|NCT01554176|5809095|P2|Treatment Phase|Lack of Efficacy|1
1661902|NCT01554176|5809096|P1|Treatment Phase|Lack of Efficacy|0
1661903|NCT01554176|5809092|P5|Treatment Phase|Physician Decision|0
1661904|NCT01554176|5809093|P4|Treatment Phase|Physician Decision|0
1661905|NCT01554176|5809094|P3|Treatment Phase|Physician Decision|0
1661906|NCT01554176|5809095|P2|Treatment Phase|Physician Decision|1
1661907|NCT01554176|5809096|P1|Treatment Phase|Physician Decision|1
1661908|NCT01554176|5809092|P5|Treatment Phase|Protocol Violation|0
1661909|NCT01554176|5809093|P4|Treatment Phase|Protocol Violation|0
1661910|NCT01554176|5809094|P3|Treatment Phase|Protocol Violation|0
1661911|NCT01554176|5809095|P2|Treatment Phase|Protocol Violation|2
1661912|NCT01554176|5809096|P1|Treatment Phase|Protocol Violation|1
1661913|NCT01554163|5809123|P2|Overall Study|Not Treated|0
1661914|NCT01554163|5809124|P1|Overall Study|Not Treated|1
1661915|NCT01554163|5809123|P2|Overall Study|Withdrawal by Subject|5
1661916|NCT01554163|5809124|P1|Overall Study|Withdrawal by Subject|1
1661917|NCT01554163|5809123|P2|Overall Study|Protocol Violation|4
1661918|NCT01554163|5809124|P1|Overall Study|Protocol Violation|0
1661919|NCT01554163|5809123|P2|Overall Study|Non-Compliance With Study Drug|1
1661920|NCT01554163|5809124|P1|Overall Study|Non-Compliance With Study Drug|1
1661921|NCT01554163|5809123|P2|Overall Study|Lost to Follow-up|0
1661922|NCT01554163|5809124|P1|Overall Study|Lost to Follow-up|1
1661923|NCT01554163|5809123|P2|Overall Study|Lack of Efficacy|0
1661924|NCT01554163|5809124|P1|Overall Study|Lack of Efficacy|1
1661925|NCT01554163|5809123|P2|Overall Study|Adverse Event|0
1661926|NCT01554163|5809124|P1|Overall Study|Adverse Event|3
1661927|NCT01553916|5809142|P1|Overall Study|Pre-treatment MRI metastatic disease|1
1661928|NCT01553916|5809142|P1|Overall Study|Withdrawal by Subject|2
1661929|NCT01553851|5809159|P1|Overall Study|constipation|1
1661930|NCT01553851|5809159|P1|Overall Study|Adverse Event|2
1661931|NCT01553747|5809174|P3|Overall Study|Physician decision: lack of efficacy|3
1661932|NCT01553747|5809175|P2|Overall Study|Physician decision: lack of efficacy|5
1661933|NCT01553747|5809176|P1|Overall Study|Physician decision: lack of efficacy|1
1661934|NCT01553747|5809174|P3|Overall Study|Sponsor decision, specify|0
1661935|NCT01553747|5809175|P2|Overall Study|Sponsor decision, specify|5
1661936|NCT01553747|5809176|P1|Overall Study|Sponsor decision, specify|7
1661937|NCT01553747|5809174|P3|Overall Study|Lost to Follow-up|6
1661938|NCT01553747|5809175|P2|Overall Study|Lost to Follow-up|5
1661939|NCT01553747|5809176|P1|Overall Study|Lost to Follow-up|11
1661940|NCT01553747|5809174|P3|Overall Study|Physician decision: other|7
1661941|NCT01553747|5809175|P2|Overall Study|Physician decision: other|8
1661942|NCT01553747|5809176|P1|Overall Study|Physician decision: other|10
1661943|NCT01553747|5809174|P3|Overall Study|Adverse event or SAE|19
1661944|NCT01553747|5809175|P2|Overall Study|Adverse event or SAE|28
1661945|NCT01553747|5809176|P1|Overall Study|Adverse event or SAE|32
1661946|NCT01553747|5809174|P3|Overall Study|Voluntarily withdrew|74
1661947|NCT01553747|5809175|P2|Overall Study|Voluntarily withdrew|66
1661948|NCT01553747|5809176|P1|Overall Study|Voluntarily withdrew|70
1661949|NCT01553747|5809174|P3|Overall Study|Protocol Violation|0
1661950|NCT01553747|5809175|P2|Overall Study|Protocol Violation|2
1661951|NCT01553747|5809176|P1|Overall Study|Protocol Violation|0
1661952|NCT01553591|5809238|P3|Overall Study|Randomized and never dispensed drug|0
1661953|NCT01553591|5809239|P2|Overall Study|Randomized and never dispensed drug|1
1661954|NCT01553591|5809240|P1|Overall Study|Randomized and never dispensed drug|0
1661955|NCT01553591|5809238|P3|Overall Study|Sponsor decision|3
1661956|NCT01553591|5809239|P2|Overall Study|Sponsor decision|0
1661957|NCT01553591|5809240|P1|Overall Study|Sponsor decision|1
1661958|NCT01553591|5809238|P3|Overall Study|Protocol Violation|4
1661959|NCT01553591|5809239|P2|Overall Study|Protocol Violation|4
1661960|NCT01553591|5809240|P1|Overall Study|Protocol Violation|3
1661961|NCT01553591|5809238|P3|Overall Study|Physician decision: lack of efficacy|7
1661962|NCT01553591|5809239|P2|Overall Study|Physician decision: lack of efficacy|3
1661963|NCT01553591|5809240|P1|Overall Study|Physician decision: lack of efficacy|2
1661964|NCT01553591|5809238|P3|Overall Study|Physician decision: other|16
1661965|NCT01553591|5809239|P2|Overall Study|Physician decision: other|14
1661966|NCT01553591|5809240|P1|Overall Study|Physician decision: other|11
1661967|NCT01553591|5809238|P3|Overall Study|Lost to Follow-up|16
1661968|NCT01553591|5809239|P2|Overall Study|Lost to Follow-up|23
1661969|NCT01553591|5809240|P1|Overall Study|Lost to Follow-up|25
1661970|NCT01553591|5809238|P3|Overall Study|Adverse Event|16
1661971|NCT01553591|5809239|P2|Overall Study|Adverse Event|45
1661972|NCT01553591|5809240|P1|Overall Study|Adverse Event|36
1661973|NCT01553591|5809238|P3|Overall Study|Voluntarily withdrew|96
1661974|NCT01553591|5809239|P2|Overall Study|Voluntarily withdrew|79
1661975|NCT01553591|5809240|P1|Overall Study|Voluntarily withdrew|94
1661976|NCT01553318|5809300|P2|Overall Study|Protocol Violation|2
1661977|NCT01553318|5809301|P1|Overall Study|Protocol Violation|3
1661978|NCT01553279|5809331|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
1661979|NCT01553279|5809332|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
1661980|NCT01553279|5809331|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
1661981|NCT01553279|5809332|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
1661982|NCT01553279|5809331|P2|Interim Period|Lost to Follow-up|0
1661983|NCT01553279|5809332|P1|Interim Period|Lost to Follow-up|1
1661984|NCT01553279|5809331|P2|Interim Period|Withdrawal by Subject|2
1661985|NCT01553279|5809332|P1|Interim Period|Withdrawal by Subject|2
1661986|NCT01553279|5809331|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
1661987|NCT01553279|5809332|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
1661988|NCT01553279|5809331|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
1661989|NCT01553279|5809332|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
1661990|NCT01553188|5809398|P4|Overall Study|Intercurrent illness and adverse event|0
1661991|NCT01553188|5809399|P3|Overall Study|Intercurrent illness and adverse event|2
1661992|NCT01553188|5809400|P2|Overall Study|Intercurrent illness and adverse event|1
1661993|NCT01553188|5809401|P1|Overall Study|Intercurrent illness and adverse event|0
1661994|NCT01553188|5809398|P4|Overall Study|Patient choice|0
1661995|NCT01553188|5809399|P3|Overall Study|Patient choice|0
1661996|NCT01553188|5809400|P2|Overall Study|Patient choice|0
1661997|NCT01553188|5809401|P1|Overall Study|Patient choice|1
1661998|NCT01553136|5809428|P2|Overall Study|Scheduling Difficulties|4
1661999|NCT01553136|5809429|P1|Overall Study|Scheduling Difficulties|5
1662000|NCT01553136|5809428|P2|Overall Study|Physician Decision|3
1662001|NCT01553136|5809429|P1|Overall Study|Physician Decision|2
1662002|NCT01553136|5809428|P2|Overall Study|Lost to Follow-up|10
1662003|NCT01553136|5809429|P1|Overall Study|Lost to Follow-up|4
1662004|NCT01553136|5809428|P2|Overall Study|Withdrawal by Subject|3
1662005|NCT01553136|5809429|P1|Overall Study|Withdrawal by Subject|2
1662006|NCT01553136|5809428|P2|Overall Study|Adverse Event|2
1662007|NCT01553136|5809429|P1|Overall Study|Adverse Event|3
1662008|NCT01553084|5809446|P3|Overall Study|Withdrawal by Subject|35
1662009|NCT01553084|5809447|P2|Overall Study|Withdrawal by Subject|13
1662010|NCT01553084|5809448|P1|Overall Study|Withdrawal by Subject|15
1662011|NCT01552954|5809530|P2|Overall Study|diagnosed DM|0
1662012|NCT01552954|5809531|P1|Overall Study|diagnosed DM|1
1662013|NCT01552954|5809530|P2|Overall Study|Protocol Violation|2
1662014|NCT01552954|5809531|P1|Overall Study|Protocol Violation|1
1662015|NCT01552954|5809530|P2|Overall Study|Withdrawal by Subject|1
1662016|NCT01552954|5809531|P1|Overall Study|Withdrawal by Subject|1
1662017|NCT01552954|5809530|P2|Overall Study|Lost to Follow-up|1
1662018|NCT01552954|5809531|P1|Overall Study|Lost to Follow-up|1
1662019|NCT01552954|5809530|P2|Overall Study|Adverse Event|2
1662020|NCT01552954|5809531|P1|Overall Study|Adverse Event|1
1662021|NCT01552928|5809547|P4|Period 3|Adverse Event|0
1662022|NCT01552928|5809548|P3|Period 3|Adverse Event|1
1662023|NCT01552928|5809549|P2|Period 3|Adverse Event|0
1662024|NCT01552928|5809550|P1|Period 3|Adverse Event|0
1662025|NCT01552915|5809597|P3|Overall Study|Other|6
1662026|NCT01552915|5809598|P2|Overall Study|Other|0
1662027|NCT01552915|5809599|P1|Overall Study|Other|2
1662028|NCT01552915|5809597|P3|Overall Study|Lack of Efficacy|4
1662029|NCT01552915|5809598|P2|Overall Study|Lack of Efficacy|1
1662030|NCT01552915|5809599|P1|Overall Study|Lack of Efficacy|8
1662031|NCT01552915|5809597|P3|Overall Study|Protocol Violation|4
1662032|NCT01552915|5809598|P2|Overall Study|Protocol Violation|4
1662033|NCT01552915|5809599|P1|Overall Study|Protocol Violation|0
1662034|NCT01552915|5809597|P3|Overall Study|Withdrawal by Subject|5
1662035|NCT01552915|5809598|P2|Overall Study|Withdrawal by Subject|4
1662036|NCT01552915|5809599|P1|Overall Study|Withdrawal by Subject|6
1662037|NCT01552915|5809597|P3|Overall Study|Lost to Follow-up|5
1662038|NCT01552915|5809598|P2|Overall Study|Lost to Follow-up|6
1662039|NCT01552915|5809599|P1|Overall Study|Lost to Follow-up|4
1662040|NCT01552915|5809597|P3|Overall Study|Adverse Event|3
1662041|NCT01552915|5809598|P2|Overall Study|Adverse Event|14
1662042|NCT01552915|5809599|P1|Overall Study|Adverse Event|3
1662043|NCT01552902|5809622|P3|Overall Study|Other|3
1662044|NCT01552902|5809623|P2|Overall Study|Other|4
1662045|NCT01552902|5809624|P1|Overall Study|Other|3
1662046|NCT01552902|5809622|P3|Overall Study|Lost to Follow-up|6
1662047|NCT01552902|5809623|P2|Overall Study|Lost to Follow-up|3
1662048|NCT01552902|5809624|P1|Overall Study|Lost to Follow-up|1
1662049|NCT01552902|5809622|P3|Overall Study|Withdrawal by Subject|6
1662050|NCT01552902|5809623|P2|Overall Study|Withdrawal by Subject|9
1662051|NCT01552902|5809624|P1|Overall Study|Withdrawal by Subject|1
1662052|NCT01552902|5809622|P3|Overall Study|Lack of Efficacy|1
1662053|NCT01552902|5809623|P2|Overall Study|Lack of Efficacy|3
1662054|NCT01552902|5809624|P1|Overall Study|Lack of Efficacy|4
1662055|NCT01552902|5809622|P3|Overall Study|Protocol Violation|3
1662056|NCT01552902|5809623|P2|Overall Study|Protocol Violation|3
1662057|NCT01552902|5809624|P1|Overall Study|Protocol Violation|3
1662058|NCT01552902|5809622|P3|Overall Study|Adverse Event|14
1662059|NCT01552902|5809623|P2|Overall Study|Adverse Event|15
1662060|NCT01552902|5809624|P1|Overall Study|Adverse Event|1
1662061|NCT01552772|5809674|P1|Overall Study|Protocol Deviation|1
1662062|NCT01552772|5809674|P1|Overall Study|Adverse Event|1
1662063|NCT01552772|5809674|P1|Overall Study|Lost to Follow-up|2
1662064|NCT01552694|5809690|P2|Overall Study|Protocol Violation|1
1662065|NCT01552694|5809691|P1|Overall Study|Protocol Violation|0
1662066|NCT01552694|5809690|P2|Overall Study|Lost to Follow-up|1
1662067|NCT01552694|5809691|P1|Overall Study|Lost to Follow-up|0
1662068|NCT01552681|5809707|P2|Overall Study|Subject moved away|1
1662069|NCT01552681|5809708|P1|Overall Study|Subject moved away|0
1662070|NCT01552681|5809707|P2|Overall Study|Physician Decision|0
1662071|NCT01552681|5809708|P1|Overall Study|Physician Decision|1
1662072|NCT01552681|5809707|P2|Overall Study|Withdrawal by Subject|0
1662073|NCT01552681|5809708|P1|Overall Study|Withdrawal by Subject|4
1662074|NCT01552603|5809756|P1|Overall Study|Physician Decision|1
1662075|NCT01552408|5809763|P2|Overall Study|Withdrawal by Subject|1
1662076|NCT01552408|5809764|P1|Overall Study|Withdrawal by Subject|2
1662077|NCT01552408|5809763|P2|Overall Study|Relocation|1
1662078|NCT01552408|5809764|P1|Overall Study|Relocation|0
1662079|NCT01552408|5809763|P2|Overall Study|Lost to Follow-up|0
1662080|NCT01552408|5809764|P1|Overall Study|Lost to Follow-up|2
1662081|NCT01552369|5809786|P2|Overall Study|Did not consent to extended follow up|9
1662082|NCT01552369|5809787|P1|Overall Study|Did not consent to extended follow up|8
1662083|NCT01552057|5809876|P2|Overall Study|Physician Decision|0
1662084|NCT01552057|5809877|P1|Overall Study|Physician Decision|1
1662085|NCT01552057|5809876|P2|Overall Study|Entry Criteria Not Met|2
1662086|NCT01552057|5809877|P1|Overall Study|Entry Criteria Not Met|2
1662087|NCT01552057|5809876|P2|Overall Study|Withdrawal by Subject|8
1662088|NCT01552057|5809877|P1|Overall Study|Withdrawal by Subject|5
1662089|NCT01552057|5809876|P2|Overall Study|Lack of Efficacy|23
1662090|NCT01552057|5809877|P1|Overall Study|Lack of Efficacy|8
1662091|NCT01552057|5809876|P2|Overall Study|Adverse Event|15
1662092|NCT01552057|5809877|P1|Overall Study|Adverse Event|14
1662093|NCT01551758|5809943|P2|Overall Study|Withdrawal by Subject|17
1662094|NCT01551758|5809944|P1|Overall Study|Withdrawal by Subject|14
1662095|NCT01551758|5809943|P2|Overall Study|Physician Decision|3
1662096|NCT01551758|5809944|P1|Overall Study|Physician Decision|9
1662097|NCT01551758|5809943|P2|Overall Study|Lost to Follow-up|25
1662098|NCT01551758|5809944|P1|Overall Study|Lost to Follow-up|29
1662099|NCT01551758|5809943|P2|Overall Study|Met Protocol-defined stopping criteria|10
1662100|NCT01551758|5809944|P1|Overall Study|Met Protocol-defined stopping criteria|8
1662101|NCT01551758|5809943|P2|Overall Study|Protocol Violation|6
1662102|NCT01551758|5809944|P1|Overall Study|Protocol Violation|5
1662103|NCT01551758|5809943|P2|Overall Study|Lack of Efficacy|1
1662104|NCT01551758|5809944|P1|Overall Study|Lack of Efficacy|0
1662105|NCT01551758|5809943|P2|Overall Study|Adverse Event|43
1662106|NCT01551758|5809944|P1|Overall Study|Adverse Event|29
1662107|NCT01551745|5809982|P1|Overall Study|Disease Progression|2
1662108|NCT01551745|5809982|P1|Overall Study|Withdrawal by Subject|1
1662109|NCT01551693|5809991|P2|Overall Study|Withdrawal by Subject|1
1662110|NCT01551693|5809992|P1|Overall Study|Withdrawal by Subject|0
1662111|NCT01551693|5809991|P2|Overall Study|Adverse Event|1
1662112|NCT01551693|5809992|P1|Overall Study|Adverse Event|0
1662113|NCT01551693|5809991|P2|Overall Study|Disease Progression|0
1662114|NCT01551693|5809992|P1|Overall Study|Disease Progression|1
1662115|NCT01551420|5810013|P2|Home Use (Part B)|Withdrawal by staff|1
1662116|NCT01551420|5810014|P1|Home Use (Part B)|Withdrawal by staff|0
1662117|NCT01551420|5810013|P2|Home Use (Part B)|Withdrawal by Subject|0
1662118|NCT01551420|5810014|P1|Home Use (Part B)|Withdrawal by Subject|6
1662119|NCT01551420|5810013|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
1662120|NCT01551420|5810014|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
1662121|NCT01551420|5810013|P2|Screened for Part B Eligibility|Declined participation|1
1662122|NCT01551420|5810014|P1|Screened for Part B Eligibility|Declined participation|8
1662123|NCT01551420|5810013|P2|In-laboratory (Part A)|Scheduling conflict|1
1662124|NCT01551420|5810014|P1|In-laboratory (Part A)|Scheduling conflict|2
1662125|NCT01551420|5810013|P2|In-laboratory (Part A)|Withdrawal by Subject|0
1662126|NCT01551420|5810014|P1|In-laboratory (Part A)|Withdrawal by Subject|2
1662127|NCT01551420|5810013|P2|In-laboratory (Part A)|Lost to Follow-up|1
1662128|NCT01551420|5810014|P1|In-laboratory (Part A)|Lost to Follow-up|2
1662129|NCT01551355|5810044|P6|Overall Study|Lost to Follow-up|6
1662130|NCT01551355|5810045|P5|Overall Study|Lost to Follow-up|9
1662131|NCT01551355|5810046|P4|Overall Study|Lost to Follow-up|24
1662132|NCT01551355|5810047|P3|Overall Study|Lost to Follow-up|34
1662133|NCT01551355|5810048|P2|Overall Study|Lost to Follow-up|49
1662134|NCT01551355|5810049|P1|Overall Study|Lost to Follow-up|51
1662135|NCT01551303|5810063|P2|Overall Study|failed awareness check on vision test|7
1662136|NCT01551303|5810064|P1|Overall Study|failed awareness check on vision test|4
1662137|NCT01551212|5810072|P2|Overall Study|Never Received Study Treatment|4
1662138|NCT01551212|5810073|P1|Overall Study|Never Received Study Treatment|2
1662139|NCT01551212|5810072|P2|Overall Study|Death|4
1662140|NCT01551212|5810073|P1|Overall Study|Death|2
1662141|NCT01551212|5810072|P2|Overall Study|Withdrawal by Subject|7
1662142|NCT01551212|5810073|P1|Overall Study|Withdrawal by Subject|0
1662143|NCT01551212|5810072|P2|Overall Study|Protocol Violation|1
1662144|NCT01551212|5810073|P1|Overall Study|Protocol Violation|0
1662145|NCT01551212|5810072|P2|Overall Study|Lost to Follow-up|1
1662146|NCT01551212|5810073|P1|Overall Study|Lost to Follow-up|0
1662147|NCT01551212|5810072|P2|Overall Study|Administrative problems|2
1662148|NCT01551212|5810073|P1|Overall Study|Administrative problems|1
1662149|NCT01551212|5810072|P2|Overall Study|Graft loss/Retransplantation|1
1662150|NCT01551212|5810073|P1|Overall Study|Graft loss/Retransplantation|0
1662151|NCT01551173|5810108|P2|Overall Study|Other|3
1662152|NCT01551173|5810109|P1|Overall Study|Other|5
1662153|NCT01551173|5810108|P2|Overall Study|Lost to Follow-up|7
1662154|NCT01551173|5810109|P1|Overall Study|Lost to Follow-up|5
1662155|NCT01551173|5810108|P2|Overall Study|Adverse Event|6
1662156|NCT01551173|5810109|P1|Overall Study|Adverse Event|7
1662157|NCT01551173|5810108|P2|Overall Study|Withdrawal by Subject|16
1662158|NCT01551173|5810109|P1|Overall Study|Withdrawal by Subject|11
1662159|NCT01550965|5810186|P1|Overall Study|Other|13
1662160|NCT01550965|5810186|P1|Overall Study|Lack of Efficacy|59
1662161|NCT01550965|5810186|P1|Overall Study|Lost to Follow-up|2
1662162|NCT01550965|5810186|P1|Overall Study|Withdrawal by Subject|10
1662163|NCT01550965|5810186|P1|Overall Study|Adverse Event|26
1662164|NCT01550757|5810230|P4|Overall Study|Withdrawal by Subject|1
1662165|NCT01550757|5810231|P3|Overall Study|Withdrawal by Subject|3
1662166|NCT01550757|5810232|P2|Overall Study|Withdrawal by Subject|0
1662167|NCT01550757|5810233|P1|Overall Study|Withdrawal by Subject|2
1662168|NCT01550757|5810230|P4|Overall Study|Lost to Follow-up|53
1662169|NCT01550757|5810231|P3|Overall Study|Lost to Follow-up|42
1662170|NCT01550757|5810232|P2|Overall Study|Lost to Follow-up|14
1662171|NCT01550757|5810233|P1|Overall Study|Lost to Follow-up|21
1662172|NCT01550744|5810243|P3|Double-Blind|Other|10
1662173|NCT01550744|5810244|P2|Double-Blind|Other|2
1662174|NCT01550744|5810245|P1|Double-Blind|Other|0
1662175|NCT01550744|5810243|P3|Double-Blind|Pregnancy|3
1662176|NCT01550744|5810244|P2|Double-Blind|Pregnancy|0
1662177|NCT01550744|5810245|P1|Double-Blind|Pregnancy|0
1662178|NCT01550744|5810243|P3|Double-Blind|Protocol Violation|4
1662179|NCT01550744|5810244|P2|Double-Blind|Protocol Violation|0
1662180|NCT01550744|5810245|P1|Double-Blind|Protocol Violation|0
1662181|NCT01550744|5810243|P3|Double-Blind|Lack of Efficacy|8
1662182|NCT01550744|5810244|P2|Double-Blind|Lack of Efficacy|2
1662183|NCT01550744|5810245|P1|Double-Blind|Lack of Efficacy|0
1662184|NCT01550744|5810243|P3|Double-Blind|Death|0
1662185|NCT01550744|5810244|P2|Double-Blind|Death|1
1662186|NCT01550744|5810245|P1|Double-Blind|Death|0
1662187|NCT01550744|5810243|P3|Double-Blind|Adverse Event|15
1662188|NCT01550744|5810244|P2|Double-Blind|Adverse Event|4
1662189|NCT01550744|5810245|P1|Double-Blind|Adverse Event|0
1662190|NCT01550744|5810243|P3|Double-Blind|Withdrawal by Subject|15
1662191|NCT01550744|5810244|P2|Double-Blind|Withdrawal by Subject|2
1662192|NCT01550744|5810245|P1|Double-Blind|Withdrawal by Subject|0
1662193|NCT01550744|5810243|P3|Double-Blind|Lost to Follow-up|12
1662194|NCT01550744|5810244|P2|Double-Blind|Lost to Follow-up|6
1662195|NCT01550744|5810245|P1|Double-Blind|Lost to Follow-up|0
1662196|NCT01550744|5810243|P3|Open-Label|Other|0
1662197|NCT01550744|5810244|P2|Open-Label|Other|0
1662198|NCT01550744|5810245|P1|Open-Label|Other|1
1662199|NCT01550744|5810243|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
1662200|NCT01550744|5810244|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
1662201|NCT01550744|5810245|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
1662202|NCT01550744|5810243|P3|Open-Label|Not all 3 study drug injections received|0
1662203|NCT01550744|5810244|P2|Open-Label|Not all 3 study drug injections received|0
1662204|NCT01550744|5810245|P1|Open-Label|Not all 3 study drug injections received|2
1662205|NCT01550744|5810243|P3|Open-Label|Protocol Violation|0
1662206|NCT01550744|5810244|P2|Open-Label|Protocol Violation|0
1662207|NCT01550744|5810245|P1|Open-Label|Protocol Violation|4
1662208|NCT01550744|5810243|P3|Open-Label|Lack of Efficacy|0
1662209|NCT01550744|5810244|P2|Open-Label|Lack of Efficacy|0
1662210|NCT01550744|5810245|P1|Open-Label|Lack of Efficacy|4
1662211|NCT01550744|5810243|P3|Open-Label|Adverse Event|0
1662212|NCT01550744|5810244|P2|Open-Label|Adverse Event|0
1662213|NCT01550744|5810245|P1|Open-Label|Adverse Event|11
1662214|NCT01550744|5810243|P3|Open-Label|Withdrawal by Subject|0
1662215|NCT01550744|5810244|P2|Open-Label|Withdrawal by Subject|0
1662216|NCT01550744|5810245|P1|Open-Label|Withdrawal by Subject|13
1662217|NCT01550744|5810243|P3|Open-Label|Lost to Follow-up|0
1662218|NCT01550744|5810244|P2|Open-Label|Lost to Follow-up|0
1662219|NCT01550744|5810245|P1|Open-Label|Lost to Follow-up|7
1662220|NCT01550289|5810345|P2|Overall Study|Withdrawal by Subject|3
1662221|NCT01550289|5810346|P1|Overall Study|Withdrawal by Subject|11
1662222|NCT01550289|5810345|P2|Overall Study|Lost to Follow-up|1
1662223|NCT01550289|5810346|P1|Overall Study|Lost to Follow-up|1
1662224|NCT01550289|5810345|P2|Overall Study|Protocol Violation|0
1662225|NCT01550289|5810346|P1|Overall Study|Protocol Violation|1
1662226|NCT01549964|5810422|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
1662227|NCT01549964|5810423|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
1662228|NCT01549964|5810424|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1662229|NCT01549964|5810425|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
1662230|NCT01549964|5810422|P4|80-Week Extension Period|Lost to Follow-up|1
1662231|NCT01549964|5810423|P3|80-Week Extension Period|Lost to Follow-up|2
1662232|NCT01549964|5810424|P2|80-Week Extension Period|Lost to Follow-up|0
1662233|NCT01549964|5810425|P1|80-Week Extension Period|Lost to Follow-up|1
1662234|NCT01549964|5810422|P4|80-Week Extension Period|Voluntary Withdrawal|2
1662235|NCT01549964|5810423|P3|80-Week Extension Period|Voluntary Withdrawal|4
1662236|NCT01549964|5810424|P2|80-Week Extension Period|Voluntary Withdrawal|1
1662237|NCT01549964|5810425|P1|80-Week Extension Period|Voluntary Withdrawal|0
1662238|NCT01549964|5810422|P4|80-Week Extension Period|Study Terminated by Sponsor|132
1662239|NCT01549964|5810423|P3|80-Week Extension Period|Study Terminated by Sponsor|132
1662240|NCT01549964|5810424|P2|80-Week Extension Period|Study Terminated by Sponsor|137
1662241|NCT01549964|5810425|P1|80-Week Extension Period|Study Terminated by Sponsor|65
1662242|NCT01549964|5810422|P4|80-Week Extension Period|Pregnancy|0
1662243|NCT01549964|5810423|P3|80-Week Extension Period|Pregnancy|1
1662244|NCT01549964|5810424|P2|80-Week Extension Period|Pregnancy|0
1662245|NCT01549964|5810425|P1|80-Week Extension Period|Pregnancy|0
1662246|NCT01549964|5810422|P4|24-Week Treatment Period|Completion Status Unknown|0
1662247|NCT01549964|5810423|P3|24-Week Treatment Period|Completion Status Unknown|1
1662248|NCT01549964|5810424|P2|24-Week Treatment Period|Completion Status Unknown|0
1662249|NCT01549964|5810425|P1|24-Week Treatment Period|Completion Status Unknown|1
1662250|NCT01549964|5810422|P4|24-Week Treatment Period|Randomized but Not Treated|1
1662251|NCT01549964|5810423|P3|24-Week Treatment Period|Randomized but Not Treated|0
1662252|NCT01549964|5810424|P2|24-Week Treatment Period|Randomized but Not Treated|0
1662253|NCT01549964|5810425|P1|24-Week Treatment Period|Randomized but Not Treated|0
1662254|NCT01549964|5810422|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1662255|NCT01549964|5810423|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
1662256|NCT01549964|5810424|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1662257|NCT01549964|5810425|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
1662258|NCT01549964|5810422|P4|24-Week Treatment Period|Other|0
1662259|NCT01549964|5810423|P3|24-Week Treatment Period|Other|1
1662260|NCT01549964|5810424|P2|24-Week Treatment Period|Other|0
1662261|NCT01549964|5810425|P1|24-Week Treatment Period|Other|1
1662262|NCT01549964|5810422|P4|24-Week Treatment Period|Lack of Efficacy|1
1662263|NCT01549964|5810423|P3|24-Week Treatment Period|Lack of Efficacy|1
1662264|NCT01549964|5810424|P2|24-Week Treatment Period|Lack of Efficacy|0
1662265|NCT01549964|5810425|P1|24-Week Treatment Period|Lack of Efficacy|1
1662266|NCT01549964|5810422|P4|24-Week Treatment Period|Lost to Follow-up|2
1662267|NCT01549964|5810423|P3|24-Week Treatment Period|Lost to Follow-up|1
1662268|NCT01549964|5810424|P2|24-Week Treatment Period|Lost to Follow-up|0
1662269|NCT01549964|5810425|P1|24-Week Treatment Period|Lost to Follow-up|1
1662270|NCT01549964|5810422|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1662271|NCT01549964|5810423|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1662272|NCT01549964|5810424|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
1662273|NCT01549964|5810425|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
1662274|NCT01549964|5810422|P4|24-Week Treatment Period|Voluntary Withdrawal|8
1662275|NCT01549964|5810423|P3|24-Week Treatment Period|Voluntary Withdrawal|3
1662276|NCT01549964|5810424|P2|24-Week Treatment Period|Voluntary Withdrawal|3
1662277|NCT01549964|5810425|P1|24-Week Treatment Period|Voluntary Withdrawal|6
1662278|NCT01549964|5810422|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
1662279|NCT01549964|5810423|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
1662280|NCT01549964|5810424|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
1662281|NCT01549964|5810425|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
1662282|NCT01549951|5810443|P1|Overall Study|Other|2
1662283|NCT01549951|5810443|P1|Overall Study|Symptomatic deterioration|1
1662284|NCT01549951|5810443|P1|Overall Study|Progressive disease|29
1662285|NCT01549951|5810443|P1|Overall Study|Unsatisfactory therapeutic response|1
1662286|NCT01549951|5810443|P1|Overall Study|Withdrawal by Subject|2
1662287|NCT01549951|5810443|P1|Overall Study|Adverse Event|15
1662288|NCT01549873|5810470|P2|Overall Study|Physician Decision|1
1662289|NCT01549873|5810471|P1|Overall Study|Physician Decision|0
1662290|NCT01549860|5810483|P2|Overall Study|Physician Decision|1
1662291|NCT01549860|5810484|P1|Overall Study|Physician Decision|1
1662292|NCT01549860|5810483|P2|Overall Study|Withdrawal by Subject|0
1662293|NCT01549860|5810484|P1|Overall Study|Withdrawal by Subject|1
1662294|NCT01549652|5810497|P4|Overall Study|Withdrawal by Subject|3
1662295|NCT01549652|5810498|P3|Overall Study|Withdrawal by Subject|5
1662296|NCT01549652|5810499|P2|Overall Study|Withdrawal by Subject|0
1662297|NCT01549652|5810500|P1|Overall Study|Withdrawal by Subject|0
1662298|NCT01549652|5810497|P4|Overall Study|Titration Side Effects|3
1662299|NCT01549652|5810498|P3|Overall Study|Titration Side Effects|6
1662300|NCT01549652|5810499|P2|Overall Study|Titration Side Effects|0
1662301|NCT01549652|5810500|P1|Overall Study|Titration Side Effects|0
1662302|NCT01549652|5810497|P4|Overall Study|Titration Non-Compliance|5
1662303|NCT01549652|5810498|P3|Overall Study|Titration Non-Compliance|4
1662304|NCT01549652|5810499|P2|Overall Study|Titration Non-Compliance|3
1662305|NCT01549652|5810500|P1|Overall Study|Titration Non-Compliance|1
1662306|NCT01549652|5810497|P4|Overall Study|Problem with Infusion|0
1662307|NCT01549652|5810498|P3|Overall Study|Problem with Infusion|0
1662308|NCT01549652|5810499|P2|Overall Study|Problem with Infusion|0
1662309|NCT01549652|5810500|P1|Overall Study|Problem with Infusion|1
1662310|NCT01549652|5810497|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
1662311|NCT01549652|5810498|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
1662312|NCT01549652|5810499|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
1662313|NCT01549652|5810500|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
1662314|NCT01549652|5810497|P4|Overall Study|Withdrawal Effect|0
1662315|NCT01549652|5810498|P3|Overall Study|Withdrawal Effect|0
1662316|NCT01549652|5810499|P2|Overall Study|Withdrawal Effect|2
1662317|NCT01549652|5810500|P1|Overall Study|Withdrawal Effect|0
1662318|NCT01549652|5810497|P4|Overall Study|Study Drug Titration Failure|0
1662319|NCT01549652|5810498|P3|Overall Study|Study Drug Titration Failure|0
1662320|NCT01549652|5810499|P2|Overall Study|Study Drug Titration Failure|6
1662321|NCT01549652|5810500|P1|Overall Study|Study Drug Titration Failure|5
1662322|NCT01549652|5810497|P4|Overall Study|Did Not Receive Allocated Intervention|0
1662323|NCT01549652|5810498|P3|Overall Study|Did Not Receive Allocated Intervention|2
1662324|NCT01549652|5810499|P2|Overall Study|Did Not Receive Allocated Intervention|0
1662325|NCT01549652|5810500|P1|Overall Study|Did Not Receive Allocated Intervention|0
1662326|NCT01549613|5810518|P2|Overall Study|Lost to Follow-up|11
1662327|NCT01549613|5810519|P1|Overall Study|Lost to Follow-up|11
1662328|NCT01549392|5810538|P2|Overall Study|Withdrawal by Subject|0
1662329|NCT01549392|5810539|P1|Overall Study|Withdrawal by Subject|1
1662330|NCT01549275|5810558|P2|Overall Study|Lost to Follow-up|0
1662331|NCT01549275|5810559|P1|Overall Study|Lost to Follow-up|1
1662332|NCT01549041|5810582|P2|Overall Study|Adverse Event|4
1662333|NCT01549041|5810583|P1|Overall Study|Adverse Event|0
1662334|NCT01549041|5810582|P2|Overall Study|Lack of Efficacy|4
1662335|NCT01549041|5810583|P1|Overall Study|Lack of Efficacy|2
1662336|NCT01549002|5810593|P2|Overall Study|Moderate sedation required|2
1662337|NCT01549002|5810594|P1|Overall Study|Moderate sedation required|0
1662338|NCT01549002|5810593|P2|Overall Study|Excessive pain|2
1662339|NCT01549002|5810594|P1|Overall Study|Excessive pain|0
1662340|NCT01548638|5810680|P1|Overall Study|Withdrawal by Subject|1
1662341|NCT01548638|5810680|P1|Overall Study|Protocol Violation|3
1662342|NCT01548573|5810690|P1|Overall Study|Withdrawal by Subject|2
1662343|NCT01548573|5810690|P1|Overall Study|Death|3
1662344|NCT01548417|5810699|P2|Overall Study|Withdrawal by Subject|2
1662345|NCT01548417|5810700|P1|Overall Study|Withdrawal by Subject|0
1662346|NCT01548404|5810710|P2|Overall Study|Other than specified above|2
1662347|NCT01548404|5810711|P1|Overall Study|Other than specified above|0
1662348|NCT01548404|5810710|P2|Overall Study|Withdrawal by Subject|3
1662349|NCT01548404|5810711|P1|Overall Study|Withdrawal by Subject|0
1662350|NCT01548404|5810710|P2|Overall Study|Lost to Follow-up|0
1662351|NCT01548404|5810711|P1|Overall Study|Lost to Follow-up|2
1662352|NCT01548404|5810710|P2|Overall Study|Inadequate response to study treatment|7
1662353|NCT01548404|5810711|P1|Overall Study|Inadequate response to study treatment|23
1662354|NCT01548404|5810710|P2|Overall Study|Physician Decision|1
1662355|NCT01548404|5810711|P1|Overall Study|Physician Decision|2
1662356|NCT01548404|5810710|P2|Overall Study|Adverse Event|1
1662357|NCT01548404|5810711|P1|Overall Study|Adverse Event|3
1662358|NCT01548287|5810750|P5|Randomized Period|Adverse Event|0
1662359|NCT01548287|5810751|P4|Randomized Period|Adverse Event|0
1662360|NCT01548287|5810752|P3|Randomized Period|Adverse Event|5
1662361|NCT01548287|5810753|P2|Randomized Period|Adverse Event|2
1662362|NCT01548287|5810754|P1|Randomized Period|Adverse Event|0
1662363|NCT01548287|5810750|P5|Randomized Period|Did not meet inclusion criteria|0
1662364|NCT01548287|5810751|P4|Randomized Period|Did not meet inclusion criteria|0
1662365|NCT01548287|5810752|P3|Randomized Period|Did not meet inclusion criteria|2
1662366|NCT01548287|5810753|P2|Randomized Period|Did not meet inclusion criteria|0
1662367|NCT01548287|5810754|P1|Randomized Period|Did not meet inclusion criteria|0
1662368|NCT01548287|5810750|P5|Screening|Did not meet eligibility criteria|74
1662369|NCT01548287|5810751|P4|Screening|Did not meet eligibility criteria|0
1662370|NCT01548287|5810752|P3|Screening|Did not meet eligibility criteria|0
1662371|NCT01548287|5810753|P2|Screening|Did not meet eligibility criteria|0
1662372|NCT01548287|5810754|P1|Screening|Did not meet eligibility criteria|0
1662373|NCT01548287|5810750|P5|Screening|No reason provided|9
1662374|NCT01548287|5810751|P4|Screening|No reason provided|0
1662375|NCT01548287|5810752|P3|Screening|No reason provided|0
1662376|NCT01548287|5810753|P2|Screening|No reason provided|0
1662377|NCT01548287|5810754|P1|Screening|No reason provided|0
1662378|NCT01547728|5810811|P1|Overall Study|Screen failure|39
1662379|NCT01547728|5810811|P1|Overall Study|Drug not ready for subject|1
1662380|NCT01547728|5810811|P1|Overall Study|Change in procedure and equipment|1
1662381|NCT01547598|5810920|P2|Overall Study|Other Miscellaneous Reasons|1
1662382|NCT01547598|5810921|P1|Overall Study|Other Miscellaneous Reasons|2
1662383|NCT01547598|5810920|P2|Overall Study|Protocol Violation|1
1662384|NCT01547598|5810921|P1|Overall Study|Protocol Violation|1
1662385|NCT01547598|5810920|P2|Overall Study|Adverse Event|1
1662386|NCT01547598|5810921|P1|Overall Study|Adverse Event|1
1662387|NCT01547598|5810920|P2|Overall Study|Lost to Follow-up|1
1662388|NCT01547598|5810921|P1|Overall Study|Lost to Follow-up|1
1662389|NCT01547598|5810920|P2|Overall Study|Withdrew consent|1
1662390|NCT01547598|5810921|P1|Overall Study|Withdrew consent|1
1662391|NCT01547390|5810938|P2|Overall Study|Adverse Event|0
1662392|NCT01547390|5810939|P1|Overall Study|Adverse Event|3
1662393|NCT01547390|5810938|P2|Overall Study|Lost to Follow-up|2
1662394|NCT01547390|5810939|P1|Overall Study|Lost to Follow-up|0
1662395|NCT01547390|5810938|P2|Overall Study|termination of pregnancy|1
1662396|NCT01547390|5810939|P1|Overall Study|termination of pregnancy|0
1662397|NCT01547390|5810938|P2|Overall Study|Withdrawal by Subject|7
1662398|NCT01547390|5810939|P1|Overall Study|Withdrawal by Subject|10
1662399|NCT01547299|5810949|P2|Overall Study|Withdrawal by Subject|2
1662400|NCT01547299|5810950|P1|Overall Study|Withdrawal by Subject|2
1662401|NCT01547286|5811016|P1|Overall Study|Physician Decision|1
1662402|NCT01547286|5811016|P1|Overall Study|Did not meet all eligibility criteria|1
1662403|NCT01547130|5811036|P2|Overall Study|Lost to Follow-up|5
1662404|NCT01547130|5811037|P1|Overall Study|Lost to Follow-up|9
1662405|NCT01546922|5811060|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
1662406|NCT01546922|5811061|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
1662407|NCT01546922|5811060|P2|Second Period of 10 Weeks|Protocol Violation|1
1662408|NCT01546922|5811061|P1|Second Period of 10 Weeks|Protocol Violation|3
1662409|NCT01546922|5811060|P2|First Period of 10 Weeks|Investigator's judgment|0
1662410|NCT01546922|5811061|P1|First Period of 10 Weeks|Investigator's judgment|1
1662411|NCT01546922|5811060|P2|First Period of 10 Weeks|Withdrawal by Subject|1
1662412|NCT01546922|5811061|P1|First Period of 10 Weeks|Withdrawal by Subject|1
1662413|NCT01546922|5811060|P2|First Period of 10 Weeks|Protocol Violation|1
1662414|NCT01546922|5811061|P1|First Period of 10 Weeks|Protocol Violation|3
1662415|NCT01546883|5811067|P1|Overall Study|other unrelated illness|1
1662416|NCT01546883|5811067|P1|Overall Study|early closure of study|2
1662417|NCT01546883|5811067|P1|Overall Study|Lost to Follow-up|2
1662418|NCT01546883|5811067|P1|Overall Study|Adverse Event|4
1662419|NCT01546883|5811067|P1|Overall Study|Withdrawal by Subject|3
1662420|NCT01546688|5811073|P2|Overall Study|Lack of Efficacy|0
1662421|NCT01546688|5811074|P1|Overall Study|Lack of Efficacy|1
1662422|NCT01546688|5811073|P2|Overall Study|Withdrawal by Subject|1
1662423|NCT01546688|5811074|P1|Overall Study|Withdrawal by Subject|2
1662424|NCT01546688|5811073|P2|Overall Study|Adverse Event|4
1662425|NCT01546688|5811074|P1|Overall Study|Adverse Event|0
1662426|NCT01546649|5811106|P2|Overall Study|Withdrawal by Subject|2
1662427|NCT01546649|5811107|P1|Overall Study|Withdrawal by Subject|1
1662428|NCT01546649|5811106|P2|Overall Study|Discovery of secondary cancer|1
1662429|NCT01546649|5811107|P1|Overall Study|Discovery of secondary cancer|0
1662430|NCT01546649|5811106|P2|Overall Study|Recurrence|1
1662431|NCT01546649|5811107|P1|Overall Study|Recurrence|1
1662432|NCT01546649|5811106|P2|Overall Study|Lack of Efficacy|0
1662433|NCT01546649|5811107|P1|Overall Study|Lack of Efficacy|1
1662434|NCT01546649|5811106|P2|Overall Study|Protocol Violation|0
1662435|NCT01546649|5811107|P1|Overall Study|Protocol Violation|1
1662436|NCT01546649|5811106|P2|Overall Study|Adverse Event|5
1662437|NCT01546649|5811107|P1|Overall Study|Adverse Event|4
1662438|NCT01546623|5811142|P2|Overall Study|Did Not Receive Study Drug|1
1662439|NCT01546623|5811143|P1|Overall Study|Did Not Receive Study Drug|1
1662440|NCT01546623|5811142|P2|Overall Study|High Prostate specific antigen|1
1662441|NCT01546623|5811143|P1|Overall Study|High Prostate specific antigen|2
1662442|NCT01546623|5811142|P2|Overall Study|Major Protocol Deviation|1
1662443|NCT01546623|5811143|P1|Overall Study|Major Protocol Deviation|1
1662444|NCT01546623|5811142|P2|Overall Study|Adverse Event|3
1662445|NCT01546623|5811143|P1|Overall Study|Adverse Event|2
1662446|NCT01546519|5811173|P4|Overall Study|Withdrawal by Subject|0
1662447|NCT01546519|5811174|P3|Overall Study|Withdrawal by Subject|0
1662448|NCT01546519|5811175|P2|Overall Study|Withdrawal by Subject|0
1662449|NCT01546519|5811176|P1|Overall Study|Withdrawal by Subject|1
1662450|NCT01546519|5811173|P4|Overall Study|Physician Decision|3
1662451|NCT01546519|5811174|P3|Overall Study|Physician Decision|2
1662452|NCT01546519|5811175|P2|Overall Study|Physician Decision|5
1662453|NCT01546519|5811176|P1|Overall Study|Physician Decision|6
1662454|NCT01546519|5811173|P4|Overall Study|related to disease progression|1
1662455|NCT01546519|5811174|P3|Overall Study|related to disease progression|2
1662456|NCT01546519|5811175|P2|Overall Study|related to disease progression|2
1662457|NCT01546519|5811176|P1|Overall Study|related to disease progression|2
1662458|NCT01546519|5811173|P4|Overall Study|Death|1
1662459|NCT01546519|5811174|P3|Overall Study|Death|3
1662460|NCT01546519|5811175|P2|Overall Study|Death|1
1662461|NCT01546519|5811176|P1|Overall Study|Death|0
1662462|NCT01546519|5811173|P4|Overall Study|Adverse Event|1
1662463|NCT01546519|5811174|P3|Overall Study|Adverse Event|1
1662464|NCT01546519|5811175|P2|Overall Study|Adverse Event|0
1662465|NCT01546519|5811176|P1|Overall Study|Adverse Event|0
1662466|NCT01546207|5811241|P1|Overall Study|Death|1
1662467|NCT01546168|5811256|P2|Overall Study|ineligible after signing consent|0
1662468|NCT01546168|5811257|P1|Overall Study|ineligible after signing consent|2
1662469|NCT01546168|5811256|P2|Overall Study|Withdrawal by Subject|0
1662470|NCT01546168|5811257|P1|Overall Study|Withdrawal by Subject|1
1662471|NCT01546168|5811256|P2|Overall Study|Lost to Follow-up|0
1662472|NCT01546168|5811257|P1|Overall Study|Lost to Follow-up|1
1662473|NCT01546155|5811269|P1|Overall Study|could not tolerate long scan duration|3
1662474|NCT01546142|5811275|P2|Overall Study|Subject Randomized but Not Treated|0
1662475|NCT01546142|5811276|P1|Overall Study|Subject Randomized but Not Treated|1
1662476|NCT01546142|5811275|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
1662477|NCT01546142|5811276|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
1662478|NCT01546142|5811275|P2|Overall Study|Lost to Follow-up|15
1662479|NCT01546142|5811276|P1|Overall Study|Lost to Follow-up|20
1662480|NCT01546142|5811275|P2|Overall Study|Adverse Event|3
1662481|NCT01546142|5811276|P1|Overall Study|Adverse Event|6
1662482|NCT01546142|5811275|P2|Overall Study|Subject Noncompliance|1
1662483|NCT01546142|5811276|P1|Overall Study|Subject Noncompliance|1
1662484|NCT01546142|5811275|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
1662485|NCT01546142|5811276|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
1662486|NCT01546038|5811294|P9|Overall Study|: Randomized, not treated|3
1662487|NCT01546038|5811295|P8|Overall Study|: Randomized, not treated|4
1662488|NCT01546038|5811296|P7|Overall Study|: Randomized, not treated|2
1662489|NCT01546038|5811297|P6|Overall Study|: Randomized, not treated|0
1662490|NCT01546038|5811298|P5|Overall Study|: Randomized, not treated|0
1662491|NCT01546038|5811299|P4|Overall Study|: Randomized, not treated|0
1662492|NCT01546038|5811300|P3|Overall Study|: Randomized, not treated|0
1662493|NCT01546038|5811301|P2|Overall Study|: Randomized, not treated|0
1662494|NCT01546038|5811302|P1|Overall Study|: Randomized, not treated|0
1662495|NCT01546038|5811294|P9|Overall Study|: Study ongoing at cutoff date|1
1662496|NCT01546038|5811295|P8|Overall Study|: Study ongoing at cutoff date|16
1662497|NCT01546038|5811296|P7|Overall Study|: Study ongoing at cutoff date|24
1662498|NCT01546038|5811297|P6|Overall Study|: Study ongoing at cutoff date|2
1662499|NCT01546038|5811298|P5|Overall Study|: Study ongoing at cutoff date|8
1662500|NCT01546038|5811299|P4|Overall Study|: Study ongoing at cutoff date|0
1662501|NCT01546038|5811300|P3|Overall Study|: Study ongoing at cutoff date|0
1662502|NCT01546038|5811301|P2|Overall Study|: Study ongoing at cutoff date|0
1662503|NCT01546038|5811302|P1|Overall Study|: Study ongoing at cutoff date|1
1662504|NCT01546038|5811294|P9|Overall Study|Withdrawal by Subject|0
1662505|NCT01546038|5811295|P8|Overall Study|Withdrawal by Subject|3
1662506|NCT01546038|5811296|P7|Overall Study|Withdrawal by Subject|3
1662507|NCT01546038|5811297|P6|Overall Study|Withdrawal by Subject|1
1662508|NCT01546038|5811298|P5|Overall Study|Withdrawal by Subject|0
1662509|NCT01546038|5811299|P4|Overall Study|Withdrawal by Subject|1
1662510|NCT01546038|5811300|P3|Overall Study|Withdrawal by Subject|0
1662511|NCT01546038|5811301|P2|Overall Study|Withdrawal by Subject|0
1662512|NCT01546038|5811302|P1|Overall Study|Withdrawal by Subject|1
1662513|NCT01546038|5811294|P9|Overall Study|Lost to Follow-up|0
1662514|NCT01546038|5811295|P8|Overall Study|Lost to Follow-up|1
1662515|NCT01546038|5811296|P7|Overall Study|Lost to Follow-up|1
1662516|NCT01546038|5811297|P6|Overall Study|Lost to Follow-up|0
1662517|NCT01546038|5811298|P5|Overall Study|Lost to Follow-up|1
1662518|NCT01546038|5811299|P4|Overall Study|Lost to Follow-up|0
1662519|NCT01546038|5811300|P3|Overall Study|Lost to Follow-up|0
1662520|NCT01546038|5811301|P2|Overall Study|Lost to Follow-up|0
1662521|NCT01546038|5811302|P1|Overall Study|Lost to Follow-up|0
1662522|NCT01546038|5811294|P9|Overall Study|Death|40
1662523|NCT01546038|5811295|P8|Overall Study|Death|64
1662524|NCT01546038|5811296|P7|Overall Study|Death|41
1662525|NCT01546038|5811297|P6|Overall Study|Death|3
1662526|NCT01546038|5811298|P5|Overall Study|Death|7
1662527|NCT01546038|5811299|P4|Overall Study|Death|2
1662528|NCT01546038|5811300|P3|Overall Study|Death|4
1662529|NCT01546038|5811301|P2|Overall Study|Death|6
1662530|NCT01546038|5811302|P1|Overall Study|Death|15
1662531|NCT01545817|5811496|P2|Everolimus|Adverse Event|6
1662532|NCT01545817|5811497|P1|Everolimus|Adverse Event|0
1662533|NCT01545817|5811496|P2|Everolimus|Disease progression|25
1662534|NCT01545817|5811497|P1|Everolimus|Disease progression|0
1662535|NCT01545817|5811496|P2|Everolimus|Other reason|7
1662536|NCT01545817|5811497|P1|Everolimus|Other reason|0
1662537|NCT01545817|5811496|P2|Pazopanib|Other reason|0
1662538|NCT01545817|5811497|P1|Pazopanib|Other reason|4
1662539|NCT01545817|5811496|P2|Pazopanib|Adverse Event|0
1662540|NCT01545817|5811497|P1|Pazopanib|Adverse Event|19
1662541|NCT01545817|5811496|P2|Pazopanib|Disease progression|0
1662542|NCT01545817|5811497|P1|Pazopanib|Disease progression|51
1662543|NCT01545388|5811646|P3|Overall Study|Other|0
1662544|NCT01545388|5811647|P2|Overall Study|Other|1
1662545|NCT01545388|5811648|P1|Overall Study|Other|1
1662546|NCT01545388|5811646|P3|Overall Study|Withdrawal by Subject|2
1662547|NCT01545388|5811647|P2|Overall Study|Withdrawal by Subject|4
1662548|NCT01545388|5811648|P1|Overall Study|Withdrawal by Subject|1
1662549|NCT01545388|5811646|P3|Overall Study|Participant moved or relocated|0
1662550|NCT01545388|5811647|P2|Overall Study|Participant moved or relocated|0
1662551|NCT01545388|5811648|P1|Overall Study|Participant moved or relocated|1
1662552|NCT01545388|5811646|P3|Overall Study|Lack of Efficacy|5
1662553|NCT01545388|5811647|P2|Overall Study|Lack of Efficacy|2
1662554|NCT01545388|5811648|P1|Overall Study|Lack of Efficacy|3
1662555|NCT01545388|5811646|P3|Overall Study|Adverse Event|1
1662556|NCT01545388|5811647|P2|Overall Study|Adverse Event|4
1662557|NCT01545388|5811648|P1|Overall Study|Adverse Event|2
1662558|NCT01545375|5811667|P2|Overall Study|Withdrawal by Subject|55
1662559|NCT01545375|5811668|P1|Overall Study|Withdrawal by Subject|58
1662560|NCT01545375|5811667|P2|Overall Study|Protocol Violation|3
1662561|NCT01545375|5811668|P1|Overall Study|Protocol Violation|3
1662562|NCT01545375|5811667|P2|Overall Study|Lost to Follow-up|31
1662563|NCT01545375|5811668|P1|Overall Study|Lost to Follow-up|34
1662564|NCT01545375|5811667|P2|Overall Study|Adverse Event|1
1662565|NCT01545375|5811668|P1|Overall Study|Adverse Event|2
1662566|NCT01545076|5811783|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1662567|NCT01545076|5811784|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
1662568|NCT01545076|5811785|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
1662569|NCT01545076|5811786|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
1662570|NCT01545076|5811787|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
1662571|NCT01545076|5811783|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1662572|NCT01545076|5811784|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1662573|NCT01545076|5811785|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1662574|NCT01545076|5811786|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
1662575|NCT01545076|5811787|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
1662576|NCT01545076|5811783|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1662577|NCT01545076|5811784|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
1662578|NCT01545076|5811785|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
1662579|NCT01545076|5811786|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
1662580|NCT01545076|5811787|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
1662581|NCT01545076|5811783|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1662582|NCT01545076|5811784|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
1662583|NCT01545076|5811785|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1662584|NCT01545076|5811786|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1662585|NCT01545076|5811787|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
1662586|NCT01545076|5811783|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
1662587|NCT01545076|5811784|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
1662588|NCT01545076|5811785|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
1662589|NCT01545076|5811786|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
1662590|NCT01545076|5811787|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
1662591|NCT01545076|5811783|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1662592|NCT01545076|5811784|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1662593|NCT01545076|5811785|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1662594|NCT01545076|5811786|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
1662595|NCT01545076|5811787|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
1662596|NCT01545076|5811783|P5|IgPro10 Restabilization Period|Protocol Violation|0
1662597|NCT01545076|5811784|P4|IgPro10 Restabilization Period|Protocol Violation|0
1662598|NCT01545076|5811785|P3|IgPro10 Restabilization Period|Protocol Violation|0
1662599|NCT01545076|5811786|P2|IgPro10 Restabilization Period|Protocol Violation|0
1662600|NCT01545076|5811787|P1|IgPro10 Restabilization Period|Protocol Violation|1
1662601|NCT01545076|5811783|P5|IgPro10 Restabilization Period|Physician Decision|0
1662602|NCT01545076|5811784|P4|IgPro10 Restabilization Period|Physician Decision|0
1662603|NCT01545076|5811785|P3|IgPro10 Restabilization Period|Physician Decision|0
1662604|NCT01545076|5811786|P2|IgPro10 Restabilization Period|Physician Decision|0
1662605|NCT01545076|5811787|P1|IgPro10 Restabilization Period|Physician Decision|2
1662606|NCT01545076|5811783|P5|IgPro10 Restabilization Period|Adverse Event|0
1662607|NCT01545076|5811784|P4|IgPro10 Restabilization Period|Adverse Event|0
1662608|NCT01545076|5811785|P3|IgPro10 Restabilization Period|Adverse Event|0
1662609|NCT01545076|5811786|P2|IgPro10 Restabilization Period|Adverse Event|0
1662610|NCT01545076|5811787|P1|IgPro10 Restabilization Period|Adverse Event|4
1662611|NCT01544920|5811858|P2|Overall Study|Withdrawal by Subject|4
1662612|NCT01544920|5811859|P1|Overall Study|Withdrawal by Subject|4
1662613|NCT01544920|5811858|P2|Overall Study|Physician Decision|1
1662614|NCT01544920|5811859|P1|Overall Study|Physician Decision|4
1662615|NCT01544920|5811858|P2|Overall Study|Protocol Violation|2
1662616|NCT01544920|5811859|P1|Overall Study|Protocol Violation|0
1662617|NCT01544920|5811858|P2|Overall Study|Lost to Follow-up|12
1662618|NCT01544920|5811859|P1|Overall Study|Lost to Follow-up|11
1662619|NCT01544920|5811858|P2|Overall Study|Death|1
1662620|NCT01544920|5811859|P1|Overall Study|Death|0
1662621|NCT01544920|5811858|P2|Overall Study|Adverse Event|3
1662622|NCT01544920|5811859|P1|Overall Study|Adverse Event|0
1662623|NCT01544595|5811873|P6|Status at Week 156|Lack of Efficacy|5
1662624|NCT01544595|5811874|P5|Status at Week 156|Lack of Efficacy|10
1662625|NCT01544595|5811875|P4|Status at Week 156|Lack of Efficacy|4
1662626|NCT01544595|5811876|P3|Status at Week 156|Lack of Efficacy|1
1662627|NCT01544595|5811877|P2|Status at Week 156|Lack of Efficacy|0
1662628|NCT01544595|5811878|P1|Status at Week 156|Lack of Efficacy|1
1662629|NCT01544595|5811873|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
1662630|NCT01544595|5811874|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
1662631|NCT01544595|5811875|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
1662632|NCT01544595|5811876|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
1662633|NCT01544595|5811877|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
1662634|NCT01544595|5811878|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
1662635|NCT01544595|5811873|P6|Status at Week 156|Technical problems|0
1662636|NCT01544595|5811874|P5|Status at Week 156|Technical problems|0
1662637|NCT01544595|5811875|P4|Status at Week 156|Technical problems|1
1662638|NCT01544595|5811876|P3|Status at Week 156|Technical problems|0
1662639|NCT01544595|5811877|P2|Status at Week 156|Technical problems|1
1662640|NCT01544595|5811878|P1|Status at Week 156|Technical problems|3
1662641|NCT01544595|5811873|P6|Status at Week 156|Protocol Violation|0
1662642|NCT01544595|5811874|P5|Status at Week 156|Protocol Violation|0
1662643|NCT01544595|5811875|P4|Status at Week 156|Protocol Violation|2
1662644|NCT01544595|5811876|P3|Status at Week 156|Protocol Violation|2
1662645|NCT01544595|5811877|P2|Status at Week 156|Protocol Violation|1
1662646|NCT01544595|5811878|P1|Status at Week 156|Protocol Violation|3
1662647|NCT01544595|5811873|P6|Status at Week 156|Pregnancy|0
1662648|NCT01544595|5811874|P5|Status at Week 156|Pregnancy|0
1662649|NCT01544595|5811875|P4|Status at Week 156|Pregnancy|0
1662650|NCT01544595|5811876|P3|Status at Week 156|Pregnancy|0
1662651|NCT01544595|5811877|P2|Status at Week 156|Pregnancy|3
1662652|NCT01544595|5811878|P1|Status at Week 156|Pregnancy|2
1662653|NCT01544595|5811873|P6|Status at Week 156|Physician Decision|0
1662654|NCT01544595|5811874|P5|Status at Week 156|Physician Decision|0
1662655|NCT01544595|5811875|P4|Status at Week 156|Physician Decision|0
1662656|NCT01544595|5811876|P3|Status at Week 156|Physician Decision|1
1662657|NCT01544595|5811877|P2|Status at Week 156|Physician Decision|3
1662658|NCT01544595|5811878|P1|Status at Week 156|Physician Decision|0
1662659|NCT01544595|5811873|P6|Status at Week 156|Non-compliance with study treatement|1
1662660|NCT01544595|5811874|P5|Status at Week 156|Non-compliance with study treatement|0
1662661|NCT01544595|5811875|P4|Status at Week 156|Non-compliance with study treatement|1
1662662|NCT01544595|5811876|P3|Status at Week 156|Non-compliance with study treatement|0
1662663|NCT01544595|5811877|P2|Status at Week 156|Non-compliance with study treatement|1
1662664|NCT01544595|5811878|P1|Status at Week 156|Non-compliance with study treatement|0
1662665|NCT01544595|5811873|P6|Status at Week 156|Lost to Follow-up|1
1662666|NCT01544595|5811874|P5|Status at Week 156|Lost to Follow-up|4
1662667|NCT01544595|5811875|P4|Status at Week 156|Lost to Follow-up|1
1662668|NCT01544595|5811876|P3|Status at Week 156|Lost to Follow-up|0
1662669|NCT01544595|5811877|P2|Status at Week 156|Lost to Follow-up|4
1662670|NCT01544595|5811878|P1|Status at Week 156|Lost to Follow-up|4
1662671|NCT01544595|5811873|P6|Status at Week 156|Adverse Event|2
1662672|NCT01544595|5811874|P5|Status at Week 156|Adverse Event|4
1662673|NCT01544595|5811875|P4|Status at Week 156|Adverse Event|3
1662674|NCT01544595|5811876|P3|Status at Week 156|Adverse Event|1
1662675|NCT01544595|5811877|P2|Status at Week 156|Adverse Event|11
1662676|NCT01544595|5811878|P1|Status at Week 156|Adverse Event|9
1662677|NCT01544595|5811873|P6|Status at Week 156|Withdrawal by Subject|6
1662678|NCT01544595|5811874|P5|Status at Week 156|Withdrawal by Subject|20
1662679|NCT01544595|5811875|P4|Status at Week 156|Withdrawal by Subject|9
1662680|NCT01544595|5811876|P3|Status at Week 156|Withdrawal by Subject|4
1662681|NCT01544595|5811877|P2|Status at Week 156|Withdrawal by Subject|10
1662682|NCT01544595|5811878|P1|Status at Week 156|Withdrawal by Subject|9
1662683|NCT01544595|5811873|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
1662684|NCT01544595|5811874|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
1662685|NCT01544595|5811875|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
1662686|NCT01544595|5811876|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
1662687|NCT01544595|5811877|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
1662688|NCT01544595|5811878|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
1662689|NCT01544595|5811873|P6|Status at Week 68|Withdrawal by Subject|0
1662690|NCT01544595|5811874|P5|Status at Week 68|Withdrawal by Subject|0
1662691|NCT01544595|5811875|P4|Status at Week 68|Withdrawal by Subject|2
1662692|NCT01544595|5811876|P3|Status at Week 68|Withdrawal by Subject|1
1662693|NCT01544595|5811877|P2|Status at Week 68|Withdrawal by Subject|1
1662694|NCT01544595|5811878|P1|Status at Week 68|Withdrawal by Subject|0
1662695|NCT01544595|5811873|P6|Status at Week 68|Technical problems|0
1662696|NCT01544595|5811874|P5|Status at Week 68|Technical problems|0
1662697|NCT01544595|5811875|P4|Status at Week 68|Technical problems|1
1662698|NCT01544595|5811876|P3|Status at Week 68|Technical problems|0
1662699|NCT01544595|5811877|P2|Status at Week 68|Technical problems|0
1662700|NCT01544595|5811878|P1|Status at Week 68|Technical problems|1
1662701|NCT01544595|5811873|P6|Status at Week 68|Protocol Violation|0
1662702|NCT01544595|5811874|P5|Status at Week 68|Protocol Violation|0
1662703|NCT01544595|5811875|P4|Status at Week 68|Protocol Violation|1
1662704|NCT01544595|5811876|P3|Status at Week 68|Protocol Violation|1
1662705|NCT01544595|5811877|P2|Status at Week 68|Protocol Violation|0
1662706|NCT01544595|5811878|P1|Status at Week 68|Protocol Violation|2
1662707|NCT01544595|5811873|P6|Status at Week 68|Non-compliance with study treatment|0
1662708|NCT01544595|5811874|P5|Status at Week 68|Non-compliance with study treatment|0
1662709|NCT01544595|5811875|P4|Status at Week 68|Non-compliance with study treatment|1
1662710|NCT01544595|5811876|P3|Status at Week 68|Non-compliance with study treatment|0
1662711|NCT01544595|5811877|P2|Status at Week 68|Non-compliance with study treatment|0
1662712|NCT01544595|5811878|P1|Status at Week 68|Non-compliance with study treatment|1
1662713|NCT01544595|5811873|P6|Status at Week 68|Lost to Follow-up|0
1662714|NCT01544595|5811874|P5|Status at Week 68|Lost to Follow-up|0
1662715|NCT01544595|5811875|P4|Status at Week 68|Lost to Follow-up|0
1662716|NCT01544595|5811876|P3|Status at Week 68|Lost to Follow-up|0
1662717|NCT01544595|5811877|P2|Status at Week 68|Lost to Follow-up|1
1662718|NCT01544595|5811878|P1|Status at Week 68|Lost to Follow-up|1
1662719|NCT01544595|5811873|P6|Status at Week 68|Lack of Efficacy|0
1662720|NCT01544595|5811874|P5|Status at Week 68|Lack of Efficacy|0
1662721|NCT01544595|5811875|P4|Status at Week 68|Lack of Efficacy|0
1662722|NCT01544595|5811876|P3|Status at Week 68|Lack of Efficacy|0
1662723|NCT01544595|5811877|P2|Status at Week 68|Lack of Efficacy|0
1662724|NCT01544595|5811878|P1|Status at Week 68|Lack of Efficacy|1
1662725|NCT01544595|5811873|P6|Status at Week 68|Adverse Event|0
1662726|NCT01544595|5811874|P5|Status at Week 68|Adverse Event|0
1662727|NCT01544595|5811875|P4|Status at Week 68|Adverse Event|0
1662728|NCT01544595|5811876|P3|Status at Week 68|Adverse Event|1
1662729|NCT01544595|5811877|P2|Status at Week 68|Adverse Event|2
1662730|NCT01544595|5811878|P1|Status at Week 68|Adverse Event|3
1662731|NCT01544582|5811954|P4|Analysis Population|Participant in Jail|0
1662732|NCT01544582|5811955|P3|Analysis Population|Participant in Jail|1
1662733|NCT01544582|5811956|P2|Analysis Population|Participant in Jail|0
1662734|NCT01544582|5811957|P1|Analysis Population|Participant in Jail|0
1662735|NCT01544582|5811954|P4|Analysis Population|Programmed Surgery|0
1662736|NCT01544582|5811955|P3|Analysis Population|Programmed Surgery|0
1662737|NCT01544582|5811956|P2|Analysis Population|Programmed Surgery|1
1662738|NCT01544582|5811957|P1|Analysis Population|Programmed Surgery|0
1662739|NCT01544582|5811954|P4|Analysis Population|Poor Participant Compliance|0
1662740|NCT01544582|5811955|P3|Analysis Population|Poor Participant Compliance|0
1662741|NCT01544582|5811956|P2|Analysis Population|Poor Participant Compliance|1
1662742|NCT01544582|5811957|P1|Analysis Population|Poor Participant Compliance|0
1662743|NCT01544582|5811954|P4|Analysis Population|Poor Adherence|0
1662744|NCT01544582|5811955|P3|Analysis Population|Poor Adherence|1
1662745|NCT01544582|5811956|P2|Analysis Population|Poor Adherence|0
1662746|NCT01544582|5811957|P1|Analysis Population|Poor Adherence|0
1662747|NCT01544582|5811954|P4|Analysis Population|No Social Insurance|0
1662748|NCT01544582|5811955|P3|Analysis Population|No Social Insurance|1
1662749|NCT01544582|5811956|P2|Analysis Population|No Social Insurance|0
1662750|NCT01544582|5811957|P1|Analysis Population|No Social Insurance|0
1662751|NCT01544582|5811954|P4|Analysis Population|Liver Transplantation|0
1662752|NCT01544582|5811955|P3|Analysis Population|Liver Transplantation|1
1662753|NCT01544582|5811956|P2|Analysis Population|Liver Transplantation|0
1662754|NCT01544582|5811957|P1|Analysis Population|Liver Transplantation|0
1662755|NCT01544582|5811954|P4|Analysis Population|Intolerance|0
1662756|NCT01544582|5811955|P3|Analysis Population|Intolerance|0
1662757|NCT01544582|5811956|P2|Analysis Population|Intolerance|1
1662758|NCT01544582|5811957|P1|Analysis Population|Intolerance|0
1662759|NCT01544582|5811954|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
1662760|NCT01544582|5811955|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
1662761|NCT01544582|5811956|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
1662762|NCT01544582|5811957|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
1662763|NCT01544582|5811954|P4|Analysis Population|Bad Tolerance to Treatment|0
1662764|NCT01544582|5811955|P3|Analysis Population|Bad Tolerance to Treatment|2
1662765|NCT01544582|5811956|P2|Analysis Population|Bad Tolerance to Treatment|0
1662766|NCT01544582|5811957|P1|Analysis Population|Bad Tolerance to Treatment|0
1662767|NCT01544582|5811954|P4|Analysis Population|Lost to Follow-up|5
1662768|NCT01544582|5811955|P3|Analysis Population|Lost to Follow-up|6
1662769|NCT01544582|5811956|P2|Analysis Population|Lost to Follow-up|6
1662770|NCT01544582|5811957|P1|Analysis Population|Lost to Follow-up|0
1662771|NCT01544582|5811954|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
1662772|NCT01544582|5811955|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
1662773|NCT01544582|5811956|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
1662774|NCT01544582|5811957|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
1662775|NCT01544582|5811954|P4|Analysis Population|Effectiveness Reason|12
1662776|NCT01544582|5811955|P3|Analysis Population|Effectiveness Reason|29
1662777|NCT01544582|5811956|P2|Analysis Population|Effectiveness Reason|48
1662778|NCT01544582|5811957|P1|Analysis Population|Effectiveness Reason|0
1662779|NCT01544582|5811954|P4|Analysis Population|Safety Reason|8
1662780|NCT01544582|5811955|P3|Analysis Population|Safety Reason|31
1662781|NCT01544582|5811956|P2|Analysis Population|Safety Reason|33
1662782|NCT01544582|5811957|P1|Analysis Population|Safety Reason|0
1662783|NCT01544582|5811954|P4|Analysis Population|Physician Decision|9
1662784|NCT01544582|5811955|P3|Analysis Population|Physician Decision|10
1662785|NCT01544582|5811956|P2|Analysis Population|Physician Decision|13
1662786|NCT01544582|5811957|P1|Analysis Population|Physician Decision|0
1662787|NCT01544582|5811954|P4|Analysis Population|Participant Refuses to Continue Study|4
1662788|NCT01544582|5811955|P3|Analysis Population|Participant Refuses to Continue Study|17
1662789|NCT01544582|5811956|P2|Analysis Population|Participant Refuses to Continue Study|15
1662790|NCT01544582|5811957|P1|Analysis Population|Participant Refuses to Continue Study|0
1662791|NCT01544582|5811954|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
1662792|NCT01544582|5811955|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
1662793|NCT01544582|5811956|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
1662794|NCT01544582|5811957|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
1662795|NCT01544582|5811954|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
1662796|NCT01544582|5811955|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
1662797|NCT01544582|5811956|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
1662798|NCT01544582|5811957|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
1662799|NCT01544491|5812017|P2|Overall Study|administrative problems|0
1662800|NCT01544491|5812018|P1|Overall Study|administrative problems|2
1662801|NCT01544491|5812017|P2|Overall Study|Lost to Follow-up|1
1662802|NCT01544491|5812018|P1|Overall Study|Lost to Follow-up|0
1662803|NCT01544491|5812017|P2|Overall Study|Withdrawal by Subject|2
1662804|NCT01544491|5812018|P1|Overall Study|Withdrawal by Subject|3
1662805|NCT01544478|5812044|P1|Overall Study|Withdrawal by Subject|52
1662806|NCT01544478|5812044|P1|Overall Study|Pregnancy|1
1662807|NCT01544478|5812044|P1|Overall Study|Physician Decision|15
1662808|NCT01544478|5812044|P1|Overall Study|Lost to Follow-up|48
1662809|NCT01544478|5812044|P1|Overall Study|Death|1
1662810|NCT01544478|5812044|P1|Overall Study|Adverse Event|1
1662811|NCT01544348|5812087|P8|Overall Study|Physician Decision|0
1662812|NCT01544348|5812088|P7|Overall Study|Physician Decision|0
1662813|NCT01544348|5812089|P6|Overall Study|Physician Decision|1
1662814|NCT01544348|5812090|P5|Overall Study|Physician Decision|0
1662815|NCT01544348|5812091|P4|Overall Study|Physician Decision|0
1662816|NCT01544348|5812092|P3|Overall Study|Physician Decision|0
1662817|NCT01544348|5812093|P2|Overall Study|Physician Decision|0
1662818|NCT01544348|5812094|P1|Overall Study|Physician Decision|0
1662819|NCT01544348|5812087|P8|Overall Study|Withdrawal by Subject|0
1662820|NCT01544348|5812088|P7|Overall Study|Withdrawal by Subject|1
1662821|NCT01544348|5812089|P6|Overall Study|Withdrawal by Subject|2
1662822|NCT01544348|5812090|P5|Overall Study|Withdrawal by Subject|1
1662823|NCT01544348|5812091|P4|Overall Study|Withdrawal by Subject|0
1662824|NCT01544348|5812092|P3|Overall Study|Withdrawal by Subject|0
1662825|NCT01544348|5812093|P2|Overall Study|Withdrawal by Subject|0
1662826|NCT01544348|5812094|P1|Overall Study|Withdrawal by Subject|1
1662827|NCT01544348|5812087|P8|Overall Study|Lost to Follow-up|0
1662828|NCT01544348|5812088|P7|Overall Study|Lost to Follow-up|1
1662829|NCT01544348|5812089|P6|Overall Study|Lost to Follow-up|0
1662830|NCT01544348|5812090|P5|Overall Study|Lost to Follow-up|0
1662831|NCT01544348|5812091|P4|Overall Study|Lost to Follow-up|0
1662832|NCT01544348|5812092|P3|Overall Study|Lost to Follow-up|0
1662833|NCT01544348|5812093|P2|Overall Study|Lost to Follow-up|0
1662834|NCT01544348|5812094|P1|Overall Study|Lost to Follow-up|1
1662835|NCT01544309|5812136|P2|Overall Study|Administered prohibit prior medication|0
1662836|NCT01544309|5812137|P1|Overall Study|Administered prohibit prior medication|1
1662837|NCT01544309|5812136|P2|Overall Study|Not performed pre-dose examination|2
1662838|NCT01544309|5812137|P1|Overall Study|Not performed pre-dose examination|1
1662839|NCT01544309|5812136|P2|Overall Study|Physician Decision|1
1662840|NCT01544309|5812137|P1|Overall Study|Physician Decision|4
1662841|NCT01544309|5812136|P2|Overall Study|Protocol Violation|1
1662842|NCT01544309|5812137|P1|Overall Study|Protocol Violation|2
1662843|NCT01544309|5812136|P2|Overall Study|Withdrawal by Subject|7
1662844|NCT01544309|5812137|P1|Overall Study|Withdrawal by Subject|12
1662845|NCT01544179|5812175|P2|Overall Study|Eligibility criteria not fulfilled|0
1662846|NCT01544179|5812176|P1|Overall Study|Eligibility criteria not fulfilled|1
1662847|NCT01544179|5812175|P2|Overall Study|Withdrawal by Subject|7
1662848|NCT01544179|5812176|P1|Overall Study|Withdrawal by Subject|12
1662849|NCT01544179|5812175|P2|Overall Study|Adverse Event|1
1662850|NCT01544179|5812176|P1|Overall Study|Adverse Event|0
1662851|NCT01544179|5812175|P2|Overall Study|Lost to Follow-up|1
1662852|NCT01544179|5812176|P1|Overall Study|Lost to Follow-up|0
1662853|NCT01544179|5812175|P2|Overall Study|Death|37
1662854|NCT01544179|5812176|P1|Overall Study|Death|50
1662855|NCT01544153|5812269|P4|Overall Study|Non-smoker|0
1662856|NCT01544153|5812270|P3|Overall Study|Non-smoker|1
1662857|NCT01544153|5812271|P2|Overall Study|Non-smoker|0
1662858|NCT01544153|5812272|P1|Overall Study|Non-smoker|0
1662859|NCT01544153|5812269|P4|Overall Study|Under 18|0
1662860|NCT01544153|5812270|P3|Overall Study|Under 18|0
1662861|NCT01544153|5812271|P2|Overall Study|Under 18|1
1662862|NCT01544153|5812272|P1|Overall Study|Under 18|0
1662863|NCT01544127|5812289|P3|Overall Study|Went active duty|1
1662864|NCT01544127|5812290|P2|Overall Study|Went active duty|0
1662865|NCT01544127|5812291|P1|Overall Study|Went active duty|0
1662866|NCT01544127|5812289|P3|Overall Study|Researcher withdrew|0
1662867|NCT01544127|5812290|P2|Overall Study|Researcher withdrew|0
1662868|NCT01544127|5812291|P1|Overall Study|Researcher withdrew|1
1662869|NCT01544127|5812289|P3|Overall Study|Became Psychotic|0
1662870|NCT01544127|5812290|P2|Overall Study|Became Psychotic|0
1662871|NCT01544127|5812291|P1|Overall Study|Became Psychotic|1
1662872|NCT01544127|5812289|P3|Overall Study|Jail or Prison|2
1662873|NCT01544127|5812290|P2|Overall Study|Jail or Prison|1
1662874|NCT01544127|5812291|P1|Overall Study|Jail or Prison|1
1662875|NCT01544127|5812289|P3|Overall Study|Death|0
1662876|NCT01544127|5812290|P2|Overall Study|Death|0
1662877|NCT01544127|5812291|P1|Overall Study|Death|1
1662878|NCT01544127|5812289|P3|Overall Study|Discharged out of catchment area|1
1662879|NCT01544127|5812290|P2|Overall Study|Discharged out of catchment area|1
1662880|NCT01544127|5812291|P1|Overall Study|Discharged out of catchment area|1
1662881|NCT01544127|5812289|P3|Overall Study|Withdrawal by Subject|1
1662882|NCT01544127|5812290|P2|Overall Study|Withdrawal by Subject|2
1662883|NCT01544127|5812291|P1|Overall Study|Withdrawal by Subject|2
1662884|NCT01544127|5812289|P3|Overall Study|Lost to Follow-up|9
1662885|NCT01544127|5812290|P2|Overall Study|Lost to Follow-up|2
1662886|NCT01544127|5812291|P1|Overall Study|Lost to Follow-up|4
1662887|NCT01544114|5812311|P3|Overall Study|Protocol Violation|0
1662888|NCT01544114|5812312|P2|Overall Study|Protocol Violation|1
1662889|NCT01544114|5812313|P1|Overall Study|Protocol Violation|0
1662890|NCT01544114|5812311|P3|Overall Study|Adverse Event|2
1662891|NCT01544114|5812312|P2|Overall Study|Adverse Event|1
1662892|NCT01544114|5812313|P1|Overall Study|Adverse Event|1
1662893|NCT01544114|5812311|P3|Overall Study|Lost to Follow-up|0
1662894|NCT01544114|5812312|P2|Overall Study|Lost to Follow-up|2
1662895|NCT01544114|5812313|P1|Overall Study|Lost to Follow-up|0
1662896|NCT01544114|5812311|P3|Overall Study|Withdrawal by Subject|3
1662897|NCT01544114|5812312|P2|Overall Study|Withdrawal by Subject|0
1662898|NCT01544114|5812313|P1|Overall Study|Withdrawal by Subject|0
1662899|NCT01543958|5812411|P1|Overall Study|ART initiation|1
1662900|NCT01543958|5812411|P1|Overall Study|Loss to follow-up|3
1662901|NCT01543828|5812466|P2|Treatment 2|Lost to Follow-up|0
1662902|NCT01543828|5812467|P1|Treatment 2|Lost to Follow-up|1
1662903|NCT01543776|5812477|P2|Overall Study|Withdrawal by Subject|2
1662904|NCT01543776|5812478|P1|Overall Study|Withdrawal by Subject|2
1662905|NCT01543685|5812497|P5|Overall Study|Adverse Event|2
1662906|NCT01543685|5812498|P4|Overall Study|Adverse Event|0
1662907|NCT01543685|5812499|P3|Overall Study|Adverse Event|0
1662908|NCT01543685|5812500|P2|Overall Study|Adverse Event|1
1662909|NCT01543685|5812501|P1|Overall Study|Adverse Event|2
1662910|NCT01543685|5812497|P5|Overall Study|Lack of Efficacy|2
1662911|NCT01543685|5812498|P4|Overall Study|Lack of Efficacy|0
1662912|NCT01543685|5812499|P3|Overall Study|Lack of Efficacy|2
1662913|NCT01543685|5812500|P2|Overall Study|Lack of Efficacy|2
1662914|NCT01543685|5812501|P1|Overall Study|Lack of Efficacy|1
1662915|NCT01543503|5812573|P2|Overall Study|Screen failure|0
1662916|NCT01543503|5812574|P1|Overall Study|Screen failure|1
1662917|NCT01543503|5812573|P2|Overall Study|Participant went to United States|0
1662918|NCT01543503|5812574|P1|Overall Study|Participant went to United States|1
1662919|NCT01543503|5812573|P2|Overall Study|Participant consented to another study|2
1662920|NCT01543503|5812574|P1|Overall Study|Participant consented to another study|0
1662921|NCT01543503|5812573|P2|Overall Study|Moved to other rheumatologic site|1
1662922|NCT01543503|5812574|P1|Overall Study|Moved to other rheumatologic site|0
1662923|NCT01543503|5812573|P2|Overall Study|Participant did not attend a visit|0
1662924|NCT01543503|5812574|P1|Overall Study|Participant did not attend a visit|1
1662925|NCT01543503|5812573|P2|Overall Study|Site stopped participation|1
1662926|NCT01543503|5812574|P1|Overall Study|Site stopped participation|5
1662927|NCT01543503|5812573|P2|Overall Study|Participant recruited after closing date|1
1662928|NCT01543503|5812574|P1|Overall Study|Participant recruited after closing date|0
1662929|NCT01543503|5812573|P2|Overall Study|Investigator did not wish to participate|1
1662930|NCT01543503|5812574|P1|Overall Study|Investigator did not wish to participate|1
1662931|NCT01543503|5812573|P2|Overall Study|Participant decision to stop treatment|0
1662932|NCT01543503|5812574|P1|Overall Study|Participant decision to stop treatment|1
1662933|NCT01543503|5812573|P2|Overall Study|Participant moved to Scotland|0
1662934|NCT01543503|5812574|P1|Overall Study|Participant moved to Scotland|1
1662935|NCT01543503|5812573|P2|Overall Study|Participant transferred to another city|0
1662936|NCT01543503|5812574|P1|Overall Study|Participant transferred to another city|1
1662937|NCT01543503|5812573|P2|Overall Study|Participant will not return for visits|2
1662938|NCT01543503|5812574|P1|Overall Study|Participant will not return for visits|0
1662939|NCT01543503|5812573|P2|Overall Study|Participant moved to another city|0
1662940|NCT01543503|5812574|P1|Overall Study|Participant moved to another city|2
1662941|NCT01543503|5812573|P2|Overall Study|Incorrect medication received|0
1662942|NCT01543503|5812574|P1|Overall Study|Incorrect medication received|1
1662943|NCT01543503|5812573|P2|Overall Study|Refused to continue treatment|0
1662944|NCT01543503|5812574|P1|Overall Study|Refused to continue treatment|7
1662945|NCT01543503|5812573|P2|Overall Study|Participant did not complete last visit|2
1662946|NCT01543503|5812574|P1|Overall Study|Participant did not complete last visit|0
1662947|NCT01543503|5812573|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
1662948|NCT01543503|5812574|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
1662949|NCT01543503|5812573|P2|Overall Study|Intolerance to the biologic treatment|1
1662950|NCT01543503|5812574|P1|Overall Study|Intolerance to the biologic treatment|0
1662951|NCT01543503|5812573|P2|Overall Study|Change of jobs|1
1662952|NCT01543503|5812574|P1|Overall Study|Change of jobs|0
1662953|NCT01543503|5812573|P2|Overall Study|Participant withdrew informed consent|10
1662954|NCT01543503|5812574|P1|Overall Study|Participant withdrew informed consent|8
1662955|NCT01543503|5812573|P2|Overall Study|Lack of Efficacy|16
1662956|NCT01543503|5812574|P1|Overall Study|Lack of Efficacy|4
1662957|NCT01543503|5812573|P2|Overall Study|Adverse Event|13
1662958|NCT01543503|5812574|P1|Overall Study|Adverse Event|9
1662959|NCT01543503|5812573|P2|Overall Study|Lost to Follow-up|36
1662960|NCT01543503|5812574|P1|Overall Study|Lost to Follow-up|32
1662961|NCT01543204|5812618|P1|Overall Study|Lost to Follow-up|1
1662962|NCT01543204|5812618|P1|Overall Study|Requirement for Alternative Therapy|1
1662963|NCT01543204|5812618|P1|Overall Study|Withdrawal by Subject|4
1662964|NCT01543204|5812618|P1|Overall Study|Adverse Event|1
1662965|NCT01543204|5812618|P1|Overall Study|Non-compliance|1
1662966|NCT01542788|5812714|P2|Overall Study|Withdrawal by Subject|0
1662967|NCT01542788|5812715|P1|Overall Study|Withdrawal by Subject|1
1662968|NCT01542788|5812714|P2|Overall Study|Physician Decision|0
1662969|NCT01542788|5812715|P1|Overall Study|Physician Decision|1
1662970|NCT01542788|5812714|P2|Overall Study|Protocol Violation|0
1662971|NCT01542788|5812715|P1|Overall Study|Protocol Violation|2
1662972|NCT01542788|5812714|P2|Overall Study|Death|0
1662973|NCT01542788|5812715|P1|Overall Study|Death|3
1662974|NCT01542788|5812714|P2|Overall Study|Lost to Follow-up|0
1662975|NCT01542788|5812715|P1|Overall Study|Lost to Follow-up|5
1662976|NCT01542788|5812714|P2|Overall Study|Lack of Efficacy|71
1662977|NCT01542788|5812715|P1|Overall Study|Lack of Efficacy|41
1662978|NCT01542788|5812714|P2|Overall Study|Randomized but Not Treated|0
1662979|NCT01542788|5812715|P1|Overall Study|Randomized but Not Treated|2
1662980|NCT01542632|5812762|P6|Overall Study|Sponsor/Investigator Decision|0
1662981|NCT01542632|5812763|P5|Overall Study|Sponsor/Investigator Decision|1
1662982|NCT01542632|5812764|P4|Overall Study|Sponsor/Investigator Decision|0
1662983|NCT01542632|5812765|P3|Overall Study|Sponsor/Investigator Decision|0
1662984|NCT01542632|5812766|P2|Overall Study|Sponsor/Investigator Decision|0
1662985|NCT01542632|5812767|P1|Overall Study|Sponsor/Investigator Decision|0
1662986|NCT01542632|5812762|P6|Overall Study|Lost to Follow-up|0
1662987|NCT01542632|5812763|P5|Overall Study|Lost to Follow-up|0
1662988|NCT01542632|5812764|P4|Overall Study|Lost to Follow-up|0
1662989|NCT01542632|5812765|P3|Overall Study|Lost to Follow-up|0
1662990|NCT01542632|5812766|P2|Overall Study|Lost to Follow-up|1
1662991|NCT01542632|5812767|P1|Overall Study|Lost to Follow-up|0
1662992|NCT01542632|5812762|P6|Overall Study|Adverse Event|0
1662993|NCT01542632|5812763|P5|Overall Study|Adverse Event|0
1662994|NCT01542632|5812764|P4|Overall Study|Adverse Event|0
1662995|NCT01542632|5812765|P3|Overall Study|Adverse Event|1
1662996|NCT01542632|5812766|P2|Overall Study|Adverse Event|0
1662997|NCT01542632|5812767|P1|Overall Study|Adverse Event|0
1662998|NCT01542632|5812762|P6|Overall Study|Withdrawal of Consent|0
1662999|NCT01542632|5812763|P5|Overall Study|Withdrawal of Consent|3
1663000|NCT01542632|5812764|P4|Overall Study|Withdrawal of Consent|2
1663001|NCT01542632|5812765|P3|Overall Study|Withdrawal of Consent|0
1663002|NCT01542632|5812766|P2|Overall Study|Withdrawal of Consent|0
1663003|NCT01542632|5812767|P1|Overall Study|Withdrawal of Consent|0
1663004|NCT01542528|5812824|P2|Overall Study|Withdrawal by Subject|6
1663005|NCT01542528|5812825|P1|Overall Study|Withdrawal by Subject|9
1663006|NCT01542528|5812824|P2|Overall Study|Physician Decision|0
1663007|NCT01542528|5812825|P1|Overall Study|Physician Decision|1
1663008|NCT01542528|5812824|P2|Overall Study|Lost to Follow-up|1
1663009|NCT01542528|5812825|P1|Overall Study|Lost to Follow-up|2
1663010|NCT01542034|5812933|P2|Overall Study|Lost to Follow-up|6
1663011|NCT01542034|5812934|P1|Overall Study|Lost to Follow-up|7
1663012|NCT01542034|5812933|P2|Overall Study|Adverse Event|2
1663013|NCT01542034|5812934|P1|Overall Study|Adverse Event|2
1663014|NCT01542034|5812933|P2|Overall Study|Subject Noncompliance|0
1663015|NCT01542034|5812934|P1|Overall Study|Subject Noncompliance|1
1663016|NCT01542034|5812933|P2|Overall Study|Administrative decision|3
1663017|NCT01542034|5812934|P1|Overall Study|Administrative decision|0
1663018|NCT01542034|5812933|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
1663019|NCT01542034|5812934|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
1663020|NCT01541969|5812948|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
1663021|NCT01541969|5812949|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
1663022|NCT01541969|5812948|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
1663023|NCT01541969|5812949|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
1663024|NCT01541969|5812948|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1663025|NCT01541969|5812949|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
1663026|NCT01541969|5812948|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
1663027|NCT01541969|5812949|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
1663028|NCT01541969|5812948|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1663029|NCT01541969|5812949|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
1663030|NCT01541969|5812948|P2|Double-blind (0-12 Weeks)|Adverse Event|0
1663031|NCT01541969|5812949|P1|Double-blind (0-12 Weeks)|Adverse Event|2
1663032|NCT01541969|5812948|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
1663033|NCT01541969|5812949|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
1663034|NCT01541969|5812948|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
1663035|NCT01541969|5812949|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
1663036|NCT01541969|5812948|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1663037|NCT01541969|5812949|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
1663038|NCT01541969|5812948|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
1663039|NCT01541969|5812949|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
1663040|NCT01541930|5812965|P1|Overall Study|Withdrawal by Subject|1
1663041|NCT01541917|5812987|P2|Overall Study|Withdrawal by Subject|7
1663042|NCT01541917|5812988|P1|Overall Study|Withdrawal by Subject|13
1663043|NCT01541917|5812987|P2|Overall Study|Lost to Follow-up|2
1663044|NCT01541917|5812988|P1|Overall Study|Lost to Follow-up|2
1663045|NCT01541865|5813017|P1|Overall Study|Protocol Violation|1
1663046|NCT01541865|5813017|P1|Overall Study|Adverse Event|1
1663047|NCT01541865|5813017|P1|Overall Study|Withdrawal by Subject|9
1663048|NCT01541865|5813017|P1|Overall Study|Lost to Follow-up|11
1663049|NCT01541826|5813035|P3|Overall Study|Withdrawal by Subject|0
1663050|NCT01541826|5813036|P2|Overall Study|Withdrawal by Subject|0
1663051|NCT01541826|5813037|P1|Overall Study|Withdrawal by Subject|2
1663052|NCT01541826|5813035|P3|Overall Study|Lost to Follow-up|0
1663053|NCT01541826|5813036|P2|Overall Study|Lost to Follow-up|3
1663054|NCT01541826|5813037|P1|Overall Study|Lost to Follow-up|2
1663055|NCT01541644|5813119|P1|Overall Study|Withdrawal by Subject|3
1663056|NCT01541397|5813138|P2|Overall Study|Study ended prior to data collection|2
1663057|NCT01541397|5813139|P1|Overall Study|Study ended prior to data collection|4
1663058|NCT01541371|5813164|P1|Overall Study|Other|6
1663059|NCT01541371|5813164|P1|Overall Study|Study medication non-compliance|3
1663060|NCT01541371|5813164|P1|Overall Study|Protocol Violation|6
1663061|NCT01541371|5813164|P1|Overall Study|Lack of Efficacy|12
1663062|NCT01541371|5813164|P1|Overall Study|Adverse Event|15
1663063|NCT01541371|5813164|P1|Overall Study|Lost to Follow-up|21
1663064|NCT01541371|5813164|P1|Overall Study|Withdrawal by Subject|14
1663065|NCT01541254|5813193|P1|Overall Study|alternate stent used|1
1663066|NCT01541254|5813193|P1|Overall Study|stent not required|1
1663067|NCT01541254|5813193|P1|Overall Study|GI bleed prior to procedure|1
1663068|NCT01541254|5813193|P1|Overall Study|enrolled after study closed|1
1663069|NCT01541254|5813193|P1|Overall Study|excluded - metal allergy|1
1663070|NCT01541254|5813193|P1|Overall Study|Withdrawal by Subject|1
1663071|NCT01541215|5813200|P2|Overall Study|Unclassified|3
1663072|NCT01541215|5813201|P1|Overall Study|Unclassified|0
1663073|NCT01541215|5813200|P2|Overall Study|Adverse Event|1
1663074|NCT01541215|5813201|P1|Overall Study|Adverse Event|0
1663075|NCT01541215|5813200|P2|Overall Study|Non-compliance|4
1663076|NCT01541215|5813201|P1|Overall Study|Non-compliance|4
1663077|NCT01541215|5813200|P2|Overall Study|Withdrawal criteria|8
1663078|NCT01541215|5813201|P1|Overall Study|Withdrawal criteria|6
1663079|NCT01540981|5813339|P2|Overall Study|Withdrawal by Subject|0
1663080|NCT01540981|5813340|P1|Overall Study|Withdrawal by Subject|1
1663081|NCT01540851|5813350|P2|Overall Study|Withdrawal by Subject|3
1663082|NCT01540851|5813351|P1|Overall Study|Withdrawal by Subject|7
1663083|NCT01540851|5813350|P2|Overall Study|Lost to Follow-up|15
1663084|NCT01540851|5813351|P1|Overall Study|Lost to Follow-up|14
1663085|NCT01540838|5813363|P2|Overall Study|Not BM. Other treatment|1
1663086|NCT01540838|5813364|P1|Overall Study|Not BM. Other treatment|3
1663087|NCT01540838|5813363|P2|Overall Study|Died before treatment initiation|1
1663088|NCT01540838|5813364|P1|Overall Study|Died before treatment initiation|1
1663089|NCT01540838|5813363|P2|Overall Study|Additional antibiotic treatment|2
1663090|NCT01540838|5813364|P1|Overall Study|Additional antibiotic treatment|1
1663091|NCT01540838|5813363|P2|Overall Study|Treatment doses missing|12
1663092|NCT01540838|5813364|P1|Overall Study|Treatment doses missing|8
1663093|NCT01540838|5813363|P2|Overall Study|Open nasogastric tube|7
1663094|NCT01540838|5813364|P1|Overall Study|Open nasogastric tube|9
1663095|NCT01540565|5813514|P1|Overall Study|Ineligible|2
1663096|NCT01540487|5813533|P2|Overall Study|Protocol Violation|0
1663097|NCT01540487|5813534|P1|Overall Study|Protocol Violation|1
1663098|NCT01539759|5813681|P2|Overall Study|Lost to Follow-up|8
1663099|NCT01539759|5813682|P1|Overall Study|Lost to Follow-up|6
1663100|NCT01539642|5813694|P2|Overall Study|Withdrawal by Subject|2
1663101|NCT01539642|5813695|P1|Overall Study|Withdrawal by Subject|2
1663102|NCT01539642|5813694|P2|Overall Study|Adverse Event|4
1663103|NCT01539642|5813695|P1|Overall Study|Adverse Event|6
1663104|NCT01539642|5813694|P2|Overall Study|Patient ready for early discharge|7
1663105|NCT01539642|5813695|P1|Overall Study|Patient ready for early discharge|8
1663106|NCT01539642|5813694|P2|Overall Study|Lack of Efficacy|18
1663107|NCT01539642|5813695|P1|Overall Study|Lack of Efficacy|20
1663108|NCT01539538|5813712|P2|Overall Study|PCA no longer required or PCA problem|7
1663109|NCT01539538|5813713|P1|Overall Study|PCA no longer required or PCA problem|3
1663110|NCT01539538|5813712|P2|Overall Study|Withdrawal by Subject|3
1663111|NCT01539538|5813713|P1|Overall Study|Withdrawal by Subject|2
1663112|NCT01539538|5813712|P2|Overall Study|Lack of Efficacy|16
1663113|NCT01539538|5813713|P1|Overall Study|Lack of Efficacy|13
1663114|NCT01539538|5813712|P2|Overall Study|Adverse Event|18
1663115|NCT01539538|5813713|P1|Overall Study|Adverse Event|13
1663116|NCT01539525|5813722|P3|Overall Study|Protocol Violation|4
1663117|NCT01539525|5813723|P2|Overall Study|Protocol Violation|1
1663118|NCT01539525|5813724|P1|Overall Study|Protocol Violation|1
1663119|NCT01539525|5813722|P3|Overall Study|Withdrawal by Subject|2
1663120|NCT01539525|5813723|P2|Overall Study|Withdrawal by Subject|3
1663121|NCT01539525|5813724|P1|Overall Study|Withdrawal by Subject|0
1663122|NCT01539525|5813722|P3|Overall Study|Lost to Follow-up|11
1663123|NCT01539525|5813723|P2|Overall Study|Lost to Follow-up|12
1663124|NCT01539525|5813724|P1|Overall Study|Lost to Follow-up|19
1663125|NCT01539512|5813743|P2|Overall Study|Richter's Transformation|0
1663126|NCT01539512|5813744|P1|Overall Study|Richter's Transformation|1
1663127|NCT01539512|5813743|P2|Overall Study|Withdrawal by Subject|5
1663128|NCT01539512|5813744|P1|Overall Study|Withdrawal by Subject|12
1663129|NCT01539512|5813743|P2|Overall Study|Physician Decision|1
1663130|NCT01539512|5813744|P1|Overall Study|Physician Decision|1
1663131|NCT01539512|5813743|P2|Overall Study|Adverse Event|7
1663132|NCT01539512|5813744|P1|Overall Study|Adverse Event|9
1663133|NCT01539317|5813760|P2|Overall Study|Screening Error. Deleted from analysis.|0
1663134|NCT01539317|5813761|P1|Overall Study|Screening Error. Deleted from analysis.|1
1663135|NCT01539291|5813779|P4|Study GS-US-312-0117|Other|1
1663136|NCT01539291|5813780|P3|Study GS-US-312-0117|Other|1
1663137|NCT01539291|5813781|P2|Study GS-US-312-0117|Other|1
1663138|NCT01539291|5813782|P1|Study GS-US-312-0117|Other|2
1663139|NCT01539291|5813779|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
1663307|NCT01537133|5814224|P4|Overall Study|Withdrawal by Subject|0
1663140|NCT01539291|5813780|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
1663141|NCT01539291|5813781|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
1663142|NCT01539291|5813782|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
1663143|NCT01539291|5813779|P4|Study GS-US-312-0117|Withdrawal by Subject|4
1663144|NCT01539291|5813780|P3|Study GS-US-312-0117|Withdrawal by Subject|6
1663145|NCT01539291|5813781|P2|Study GS-US-312-0117|Withdrawal by Subject|0
1663146|NCT01539291|5813782|P1|Study GS-US-312-0117|Withdrawal by Subject|5
1663147|NCT01539291|5813779|P4|Study GS-US-312-0117|Physician Decision|4
1663148|NCT01539291|5813780|P3|Study GS-US-312-0117|Physician Decision|6
1663149|NCT01539291|5813781|P2|Study GS-US-312-0117|Physician Decision|0
1663150|NCT01539291|5813782|P1|Study GS-US-312-0117|Physician Decision|9
1663151|NCT01539291|5813779|P4|Study GS-US-312-0117|Adverse Event|12
1663152|NCT01539291|5813780|P3|Study GS-US-312-0117|Adverse Event|9
1663153|NCT01539291|5813781|P2|Study GS-US-312-0117|Adverse Event|1
1663154|NCT01539291|5813782|P1|Study GS-US-312-0117|Adverse Event|22
1663155|NCT01539291|5813779|P4|Study GS-US-312-0116|Other|0
1663156|NCT01539291|5813780|P3|Study GS-US-312-0116|Other|0
1663157|NCT01539291|5813781|P2|Study GS-US-312-0116|Other|0
1663158|NCT01539291|5813782|P1|Study GS-US-312-0116|Other|1
1663159|NCT01539291|5813779|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
1663160|NCT01539291|5813780|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
1663161|NCT01539291|5813781|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
1663162|NCT01539291|5813782|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
1663163|NCT01539291|5813779|P4|Study GS-US-312-0116|Withdrawal by Subject|0
1663164|NCT01539291|5813780|P3|Study GS-US-312-0116|Withdrawal by Subject|0
1663165|NCT01539291|5813781|P2|Study GS-US-312-0116|Withdrawal by Subject|0
1663166|NCT01539291|5813782|P1|Study GS-US-312-0116|Withdrawal by Subject|12
1663167|NCT01539291|5813779|P4|Study GS-US-312-0116|Physician Decision|0
1663168|NCT01539291|5813780|P3|Study GS-US-312-0116|Physician Decision|0
1663169|NCT01539291|5813781|P2|Study GS-US-312-0116|Physician Decision|0
1663170|NCT01539291|5813782|P1|Study GS-US-312-0116|Physician Decision|1
1663171|NCT01539291|5813779|P4|Study GS-US-312-0116|Adverse Event|0
1663172|NCT01539291|5813780|P3|Study GS-US-312-0116|Adverse Event|0
1663173|NCT01539291|5813781|P2|Study GS-US-312-0116|Adverse Event|0
1663174|NCT01539291|5813782|P1|Study GS-US-312-0116|Adverse Event|9
1663175|NCT01539239|5813854|P2|Overall Study|Lost to Follow-up|12
1663176|NCT01539239|5813855|P1|Overall Study|Lost to Follow-up|7
1663177|NCT01539239|5813854|P2|Overall Study|Death|5
1663178|NCT01539239|5813855|P1|Overall Study|Death|5
1663179|NCT01539083|5813878|P3|After Randomization (TP and VTP)|Death|11
1663180|NCT01539083|5813879|P2|After Randomization (TP and VTP)|Death|6
1663181|NCT01539083|5813880|P1|After Randomization (TP and VTP)|Death|0
1663182|NCT01539083|5813878|P3|After Randomization (TP and VTP)|Progressive Disease|3
1663183|NCT01539083|5813879|P2|After Randomization (TP and VTP)|Progressive Disease|6
1663184|NCT01539083|5813880|P1|After Randomization (TP and VTP)|Progressive Disease|0
1663185|NCT01539083|5813878|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
1663186|NCT01539083|5813879|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
1663187|NCT01539083|5813880|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
1663188|NCT01539083|5813878|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
1663189|NCT01539083|5813879|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
1663190|NCT01539083|5813880|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
1663191|NCT01539083|5813878|P3|After Randomization (TP and VTP)|Adverse Event|1
1663192|NCT01539083|5813879|P2|After Randomization (TP and VTP)|Adverse Event|1
1663193|NCT01539083|5813880|P1|After Randomization (TP and VTP)|Adverse Event|0
1663194|NCT01539083|5813878|P3|After Randomization (TP and VTP)|Other|1
1663195|NCT01539083|5813879|P2|After Randomization (TP and VTP)|Other|1
1663196|NCT01539083|5813880|P1|After Randomization (TP and VTP)|Other|0
1663197|NCT01539083|5813878|P3|After Randomization (TP and VTP)|Physician Decision|1
1663198|NCT01539083|5813879|P2|After Randomization (TP and VTP)|Physician Decision|0
1663199|NCT01539083|5813880|P1|After Randomization (TP and VTP)|Physician Decision|0
1663200|NCT01539083|5813878|P3|Before Randomization (VCD Induction)|Other|0
1663201|NCT01539083|5813879|P2|Before Randomization (VCD Induction)|Other|0
1663202|NCT01539083|5813880|P1|Before Randomization (VCD Induction)|Other|5
1663203|NCT01539083|5813878|P3|Before Randomization (VCD Induction)|Progressive Disease|0
1663204|NCT01539083|5813879|P2|Before Randomization (VCD Induction)|Progressive Disease|0
1663205|NCT01539083|5813880|P1|Before Randomization (VCD Induction)|Progressive Disease|8
1663206|NCT01539083|5813878|P3|Before Randomization (VCD Induction)|Physician Decision|0
1663207|NCT01539083|5813879|P2|Before Randomization (VCD Induction)|Physician Decision|0
1663208|NCT01539083|5813880|P1|Before Randomization (VCD Induction)|Physician Decision|14
1663209|NCT01539083|5813878|P3|Before Randomization (VCD Induction)|Protocol Violation|0
1663210|NCT01539083|5813879|P2|Before Randomization (VCD Induction)|Protocol Violation|0
1663211|NCT01539083|5813880|P1|Before Randomization (VCD Induction)|Protocol Violation|2
1663212|NCT01539083|5813878|P3|Before Randomization (VCD Induction)|Death|0
1663213|NCT01539083|5813879|P2|Before Randomization (VCD Induction)|Death|0
1663214|NCT01539083|5813880|P1|Before Randomization (VCD Induction)|Death|6
1663215|NCT01539083|5813878|P3|Before Randomization (VCD Induction)|Adverse Event|0
1663216|NCT01539083|5813879|P2|Before Randomization (VCD Induction)|Adverse Event|0
1663217|NCT01539083|5813880|P1|Before Randomization (VCD Induction)|Adverse Event|14
1663218|NCT01539083|5813878|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1663219|NCT01539083|5813879|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
1663220|NCT01539083|5813880|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
1663221|NCT01538719|5813924|P2|Overall Study|Lost to Follow-up|0
1663222|NCT01538719|5813925|P1|Overall Study|Lost to Follow-up|2
1663223|NCT01538472|5813948|P1|Overall Study|Death|1
1663224|NCT01538472|5813948|P1|Overall Study|Disease Progression|3
1663225|NCT01538199|5813959|P4|Overall Study|Lack of Efficacy|0
1663226|NCT01538199|5813960|P3|Overall Study|Lack of Efficacy|0
1663227|NCT01538199|5813961|P2|Overall Study|Lack of Efficacy|1
1663228|NCT01538199|5813962|P1|Overall Study|Lack of Efficacy|0
1663229|NCT01538199|5813959|P4|Overall Study|participant did not have time|2
1663230|NCT01538199|5813960|P3|Overall Study|participant did not have time|0
1663231|NCT01538199|5813961|P2|Overall Study|participant did not have time|0
1663232|NCT01538199|5813962|P1|Overall Study|participant did not have time|1
1663233|NCT01538199|5813959|P4|Overall Study|Lost to Follow-up|0
1663234|NCT01538199|5813960|P3|Overall Study|Lost to Follow-up|1
1663235|NCT01538199|5813961|P2|Overall Study|Lost to Follow-up|2
1663236|NCT01538199|5813962|P1|Overall Study|Lost to Follow-up|1
1663237|NCT01537887|5813996|P6|Period 3|Withdrawal by Subject|0
1663238|NCT01537887|5813997|P5|Period 3|Withdrawal by Subject|0
1663239|NCT01537887|5813998|P4|Period 3|Withdrawal by Subject|0
1663240|NCT01537887|5813999|P3|Period 3|Withdrawal by Subject|0
1663241|NCT01537887|5814000|P2|Period 3|Withdrawal by Subject|1
1663242|NCT01537887|5814001|P1|Period 3|Withdrawal by Subject|0
1663243|NCT01537887|5813996|P6|Period 3|Adverse Event|0
1663244|NCT01537887|5813997|P5|Period 3|Adverse Event|0
1663245|NCT01537887|5813998|P4|Period 3|Adverse Event|0
1663246|NCT01537887|5813999|P3|Period 3|Adverse Event|1
1663247|NCT01537887|5814000|P2|Period 3|Adverse Event|0
1663248|NCT01537887|5814001|P1|Period 3|Adverse Event|0
1663249|NCT01537887|5813996|P6|Period 2|Withdrawal by Subject|0
1663250|NCT01537887|5813997|P5|Period 2|Withdrawal by Subject|0
1663251|NCT01537887|5813998|P4|Period 2|Withdrawal by Subject|0
1663252|NCT01537887|5813999|P3|Period 2|Withdrawal by Subject|0
1663253|NCT01537887|5814000|P2|Period 2|Withdrawal by Subject|1
1663254|NCT01537887|5814001|P1|Period 2|Withdrawal by Subject|0
1663255|NCT01537887|5813996|P6|Period 1|Did not receive treatment|0
1663256|NCT01537887|5813997|P5|Period 1|Did not receive treatment|0
1663257|NCT01537887|5813998|P4|Period 1|Did not receive treatment|0
1663258|NCT01537887|5813999|P3|Period 1|Did not receive treatment|1
1663259|NCT01537887|5814000|P2|Period 1|Did not receive treatment|0
1663260|NCT01537887|5814001|P1|Period 1|Did not receive treatment|0
1663261|NCT01537887|5813996|P6|Period 1|Physician Decision|1
1663262|NCT01537887|5813997|P5|Period 1|Physician Decision|1
1663263|NCT01537887|5813998|P4|Period 1|Physician Decision|0
1663264|NCT01537887|5813999|P3|Period 1|Physician Decision|0
1663265|NCT01537887|5814000|P2|Period 1|Physician Decision|0
1663266|NCT01537887|5814001|P1|Period 1|Physician Decision|0
1663267|NCT01537783|5814030|P2|Overall Study|Lost to Follow-up|2
1663268|NCT01537783|5814031|P1|Overall Study|Lost to Follow-up|11
1663269|NCT01537549|5814082|P1|Overall Study|Withdrawal by Subject|2
1663270|NCT01537549|5814082|P1|Overall Study|Lost to Follow-up|1
1663271|NCT01537432|5814090|P2|Overall Study|Unsatisfactory therapeutic effect|0
1663272|NCT01537432|5814091|P1|Overall Study|Unsatisfactory therapeutic effect|1
1663273|NCT01537432|5814090|P2|Overall Study|Adverse Event|0
1663274|NCT01537432|5814091|P1|Overall Study|Adverse Event|1
1663275|NCT01537432|5814090|P2|Overall Study|Administrative problems|0
1663276|NCT01537432|5814091|P1|Overall Study|Administrative problems|1
1663277|NCT01537432|5814090|P2|Overall Study|Withdrawal by Subject|1
1663278|NCT01537432|5814091|P1|Overall Study|Withdrawal by Subject|0
1663279|NCT01537432|5814090|P2|Overall Study|Lost to Follow-up|1
1663280|NCT01537432|5814091|P1|Overall Study|Lost to Follow-up|3
1663281|NCT01537393|5814114|P2|Overall Study|Censored (severe event unrelated to PT)|1
1663282|NCT01537393|5814115|P1|Overall Study|Censored (severe event unrelated to PT)|1
1663283|NCT01537393|5814114|P2|Overall Study|Failure - Not regrafted|6
1663284|NCT01537393|5814115|P1|Overall Study|Failure - Not regrafted|2
1663285|NCT01537393|5814114|P2|Overall Study|Failure - Regrafted|43
1663286|NCT01537393|5814115|P1|Overall Study|Failure - Regrafted|28
1663287|NCT01537393|5814114|P2|Overall Study|Lost to Follow-up|48
1663288|NCT01537393|5814115|P1|Overall Study|Lost to Follow-up|53
1663289|NCT01537393|5814114|P2|Overall Study|Withdrawal by Subject|17
1663290|NCT01537393|5814115|P1|Overall Study|Withdrawal by Subject|18
1663291|NCT01537393|5814114|P2|Overall Study|Death|32
1663292|NCT01537393|5814115|P1|Overall Study|Death|20
1663293|NCT01537393|5814114|P2|Overall Study|Exclude prior to study|44
1663294|NCT01537393|5814115|P1|Overall Study|Exclude prior to study|32
1663295|NCT01537302|5814151|P1|Overall Study|Withdrawal by Subject|1
1663296|NCT01537302|5814151|P1|Overall Study|Lost to Follow-up|1
1663297|NCT01537211|5814160|P2|Overall Study|Lost to Follow-up|1
1663298|NCT01537211|5814161|P1|Overall Study|Lost to Follow-up|0
1663299|NCT01537198|5814195|P1|Overall Study|Other|111
1663300|NCT01537198|5814195|P1|Overall Study|No Further Visits to the Clinic|37
1663301|NCT01537198|5814195|P1|Overall Study|Adverse Event|4
1663302|NCT01537198|5814195|P1|Overall Study|RSV infection|2
1663303|NCT01537133|5814224|P4|Overall Study|Lost to Follow-up|0
1663304|NCT01537133|5814225|P3|Overall Study|Lost to Follow-up|0
1663305|NCT01537133|5814226|P2|Overall Study|Lost to Follow-up|0
1663306|NCT01537133|5814227|P1|Overall Study|Lost to Follow-up|1
1663308|NCT01537133|5814225|P3|Overall Study|Withdrawal by Subject|0
1663309|NCT01537133|5814226|P2|Overall Study|Withdrawal by Subject|0
1663310|NCT01537133|5814227|P1|Overall Study|Withdrawal by Subject|2
1663311|NCT01537120|5814243|P1|3 Weeks Placebo|Withdrawal by Subject|1
1663312|NCT01537120|5814243|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
1663313|NCT01537081|5814256|P3|Overall Study|Assigned but never dosed|0
1663314|NCT01537081|5814257|P2|Overall Study|Assigned but never dosed|0
1663315|NCT01537081|5814258|P1|Overall Study|Assigned but never dosed|1
1663316|NCT01537081|5814256|P3|Overall Study|Sponsor decision|0
1663317|NCT01537081|5814257|P2|Overall Study|Sponsor decision|1
1663318|NCT01537081|5814258|P1|Overall Study|Sponsor decision|0
1663319|NCT01537081|5814256|P3|Overall Study|Physician Decision|0
1663320|NCT01537081|5814257|P2|Overall Study|Physician Decision|6
1663321|NCT01537081|5814258|P1|Overall Study|Physician Decision|5
1663322|NCT01537081|5814256|P3|Overall Study|Withdrawal by Subject|3
1663323|NCT01537081|5814257|P2|Overall Study|Withdrawal by Subject|11
1663324|NCT01537081|5814258|P1|Overall Study|Withdrawal by Subject|6
1663325|NCT01537081|5814256|P3|Overall Study|Protocol Violation|2
1663326|NCT01537081|5814257|P2|Overall Study|Protocol Violation|2
1663327|NCT01537081|5814258|P1|Overall Study|Protocol Violation|3
1663328|NCT01537081|5814256|P3|Overall Study|Lost to Follow-up|9
1663329|NCT01537081|5814257|P2|Overall Study|Lost to Follow-up|15
1663330|NCT01537081|5814258|P1|Overall Study|Lost to Follow-up|17
1663331|NCT01537081|5814256|P3|Overall Study|Lack of Efficacy|0
1663332|NCT01537081|5814257|P2|Overall Study|Lack of Efficacy|1
1663333|NCT01537081|5814258|P1|Overall Study|Lack of Efficacy|2
1663334|NCT01537081|5814256|P3|Overall Study|Adverse Event|2
1663335|NCT01537081|5814257|P2|Overall Study|Adverse Event|2
1663336|NCT01537081|5814258|P1|Overall Study|Adverse Event|5
1663337|NCT01537068|5814271|P2|Overall Study|Lack of Efficacy|0
1663338|NCT01537068|5814272|P1|Overall Study|Lack of Efficacy|1
1663339|NCT01537068|5814271|P2|Overall Study|Withdrawal by Subject|1
1663340|NCT01537068|5814272|P1|Overall Study|Withdrawal by Subject|1
1663341|NCT01537068|5814271|P2|Overall Study|Adverse Event|1
1663342|NCT01537068|5814272|P1|Overall Study|Adverse Event|0
1663343|NCT01537068|5814271|P2|Overall Study|Lost to Follow-up|1
1663344|NCT01537068|5814272|P1|Overall Study|Lost to Follow-up|2
1663345|NCT01537042|5814284|P2|Overall Study|Other|1
1663346|NCT01537042|5814285|P1|Overall Study|Other|0
1663347|NCT01537042|5814284|P2|Overall Study|Protocol Violation|1
1663348|NCT01537042|5814285|P1|Overall Study|Protocol Violation|0
1663349|NCT01537042|5814284|P2|Overall Study|Lack of Efficacy|1
1663350|NCT01537042|5814285|P1|Overall Study|Lack of Efficacy|0
1663351|NCT01537042|5814284|P2|Overall Study|Adverse Event|2
1663352|NCT01537042|5814285|P1|Overall Study|Adverse Event|0
1663353|NCT01536951|5814327|P9|Second Intervention and Washout Period 2|Adverse Event|0
1663354|NCT01536951|5814328|P8|Second Intervention and Washout Period 2|Adverse Event|1
1663355|NCT01536951|5814329|P7|Second Intervention and Washout Period 2|Adverse Event|0
1663356|NCT01536951|5814330|P6|Second Intervention and Washout Period 2|Adverse Event|0
1663357|NCT01536951|5814331|P5|Second Intervention and Washout Period 2|Adverse Event|0
1663358|NCT01536951|5814332|P4|Second Intervention and Washout Period 2|Adverse Event|0
1663359|NCT01536951|5814333|P3|Second Intervention and Washout Period 2|Adverse Event|0
1663360|NCT01536951|5814334|P2|Second Intervention and Washout Period 2|Adverse Event|0
1663361|NCT01536951|5814335|P1|Second Intervention and Washout Period 2|Adverse Event|0
1663362|NCT01536951|5814327|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663363|NCT01536951|5814328|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663364|NCT01536951|5814329|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663365|NCT01536951|5814330|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663366|NCT01536951|5814331|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663367|NCT01536951|5814332|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663368|NCT01536951|5814333|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
1663369|NCT01536951|5814334|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663370|NCT01536951|5814335|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
1663371|NCT01536860|5814392|P3|Washout Period (3 Days)|Lost to Follow-up|0
1663372|NCT01536860|5814393|P2|Washout Period (3 Days)|Lost to Follow-up|0
1663373|NCT01536860|5814394|P1|Washout Period (3 Days)|Lost to Follow-up|1
1663374|NCT01536704|5814402|P4|Washout Period 3|Adverse Event|0
1663375|NCT01536704|5814403|P3|Washout Period 3|Adverse Event|1
1663376|NCT01536704|5814404|P2|Washout Period 3|Adverse Event|0
1663377|NCT01536704|5814405|P1|Washout Period 3|Adverse Event|0
1663378|NCT01536704|5814402|P4|Period 3|Adverse Event|1
1663379|NCT01536704|5814403|P3|Period 3|Adverse Event|0
1663380|NCT01536704|5814404|P2|Period 3|Adverse Event|0
1663381|NCT01536704|5814405|P1|Period 3|Adverse Event|0
1663382|NCT01536704|5814402|P4|Washout Period 2|Withdrawal by Subject|1
1663383|NCT01536704|5814403|P3|Washout Period 2|Withdrawal by Subject|0
1663384|NCT01536704|5814404|P2|Washout Period 2|Withdrawal by Subject|0
1663385|NCT01536704|5814405|P1|Washout Period 2|Withdrawal by Subject|0
1663386|NCT01536704|5814402|P4|Washout Period 2|Adverse Event|0
1663387|NCT01536704|5814403|P3|Washout Period 2|Adverse Event|0
1663388|NCT01536704|5814404|P2|Washout Period 2|Adverse Event|0
1663389|NCT01536704|5814405|P1|Washout Period 2|Adverse Event|1
1663390|NCT01536704|5814402|P4|Washout Period 1|Withdrawal by Subject|0
1663391|NCT01536704|5814403|P3|Washout Period 1|Withdrawal by Subject|0
1663392|NCT01536704|5814404|P2|Washout Period 1|Withdrawal by Subject|2
1663393|NCT01536704|5814405|P1|Washout Period 1|Withdrawal by Subject|1
1663394|NCT01536587|5814435|P1|Overall Study|Adverse Event|2
1663395|NCT01536574|5814474|P2|Overall Study|Lack of Efficacy|0
1663396|NCT01536574|5814475|P1|Overall Study|Lack of Efficacy|1
1663397|NCT01536574|5814474|P2|Overall Study|Withdrawal by Subject|2
1663398|NCT01536574|5814475|P1|Overall Study|Withdrawal by Subject|1
1663399|NCT01536574|5814474|P2|Overall Study|Adverse Event|5
1663400|NCT01536574|5814475|P1|Overall Study|Adverse Event|4
1663401|NCT01536561|5814493|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
1663402|NCT01536561|5814493|P1|Dosimetric and Therapeutic Treatment|Death|2
1663403|NCT01536561|5814493|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
1663404|NCT01536561|5814493|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
1663405|NCT01536561|5814493|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
1663406|NCT01536561|5814493|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
1663407|NCT01536535|5814533|P2|Overall Study|Participant moved|1
1663408|NCT01536535|5814534|P1|Overall Study|Participant moved|0
1663409|NCT01536535|5814533|P2|Overall Study|Physician Decision|1
1663410|NCT01536535|5814534|P1|Overall Study|Physician Decision|1
1663411|NCT01536535|5814533|P2|Overall Study|Lost to Follow-up|6
1663412|NCT01536535|5814534|P1|Overall Study|Lost to Follow-up|4
1663413|NCT01536535|5814533|P2|Overall Study|Withdrawal by Subject|5
1663414|NCT01536535|5814534|P1|Overall Study|Withdrawal by Subject|10
1663415|NCT01536418|5814583|P2|Overall Study|Withdrawal by Subject|3
1663416|NCT01536418|5814584|P1|Overall Study|Withdrawal by Subject|5
1663417|NCT01536418|5814583|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
1663418|NCT01536418|5814584|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
1663419|NCT01536418|5814583|P2|Overall Study|Adverse Event|4
1663420|NCT01536418|5814584|P1|Overall Study|Adverse Event|9
1663421|NCT01536418|5814583|P2|Overall Study|Lack of Efficacy|16
1663422|NCT01536418|5814584|P1|Overall Study|Lack of Efficacy|10
1663423|NCT01536418|5814583|P2|Overall Study|Study closed/terminated|37
1663424|NCT01536418|5814584|P1|Overall Study|Study closed/terminated|41
1663425|NCT01536418|5814583|P2|Overall Study|Physician Decision|3
1663426|NCT01536418|5814584|P1|Overall Study|Physician Decision|1
1663427|NCT01536418|5814583|P2|Overall Study|Protocol Violation|3
1663428|NCT01536418|5814584|P1|Overall Study|Protocol Violation|2
1663429|NCT01536405|5814604|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1663430|NCT01536405|5814605|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
1663431|NCT01536405|5814604|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
1663432|NCT01536405|5814605|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
1663433|NCT01536405|5814604|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
1663434|NCT01536405|5814605|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
1663435|NCT01536405|5814604|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
1663436|NCT01536405|5814605|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
1663437|NCT01536405|5814604|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
1663438|NCT01536405|5814605|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
1663439|NCT01536405|5814604|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
1663440|NCT01536405|5814605|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
1663441|NCT01536405|5814604|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1663442|NCT01536405|5814605|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
1663443|NCT01536405|5814604|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
1663444|NCT01536405|5814605|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
1663445|NCT01536405|5814604|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1663446|NCT01536405|5814605|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
1663447|NCT01536405|5814604|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
1663448|NCT01536405|5814605|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
1663449|NCT01536405|5814604|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
1663450|NCT01536405|5814605|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
1663451|NCT01536405|5814604|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
1663452|NCT01536405|5814605|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
1663453|NCT01536405|5814604|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
1663454|NCT01536405|5814605|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
1663455|NCT01536379|5814643|P2|Overall Study|Withdrawal by Subject|1
1663456|NCT01536379|5814644|P1|Overall Study|Withdrawal by Subject|1
1663457|NCT01536379|5814643|P2|Overall Study|Adverse Event|2
1663458|NCT01536379|5814644|P1|Overall Study|Adverse Event|1
1663459|NCT01536262|5814736|P3|Overall Study|Other than stated above|0
1663460|NCT01536262|5814737|P2|Overall Study|Other than stated above|0
1663461|NCT01536262|5814738|P1|Overall Study|Other than stated above|1
1663462|NCT01536262|5814736|P3|Overall Study|Withdrawal by Subject|0
1663463|NCT01536262|5814737|P2|Overall Study|Withdrawal by Subject|1
1663464|NCT01536262|5814738|P1|Overall Study|Withdrawal by Subject|1
1663465|NCT01536262|5814736|P3|Overall Study|Adverse Event|2
1663466|NCT01536262|5814737|P2|Overall Study|Adverse Event|1
1663467|NCT01536262|5814738|P1|Overall Study|Adverse Event|6
1663468|NCT01536171|5814780|P1|Overall Study|Withdrawal by Subject|1
1663469|NCT01536145|5814785|P11|Overall Study|Adverse Event|3
1663470|NCT01536145|5814786|P10|Overall Study|Adverse Event|0
1663471|NCT01536145|5814787|P9|Overall Study|Adverse Event|0
1663472|NCT01536145|5814788|P8|Overall Study|Adverse Event|2
1663473|NCT01536145|5814789|P7|Overall Study|Adverse Event|0
1663474|NCT01536145|5814790|P6|Overall Study|Adverse Event|0
1663475|NCT01536145|5814791|P5|Overall Study|Adverse Event|0
1663476|NCT01536145|5814792|P4|Overall Study|Adverse Event|0
1663477|NCT01536145|5814793|P3|Overall Study|Adverse Event|0
1663478|NCT01536145|5814794|P2|Overall Study|Adverse Event|0
1663479|NCT01536145|5814795|P1|Overall Study|Adverse Event|0
1663480|NCT01536145|5814785|P11|Overall Study|Death|0
1663481|NCT01536145|5814786|P10|Overall Study|Death|0
1663482|NCT01536145|5814787|P9|Overall Study|Death|0
1663483|NCT01536145|5814788|P8|Overall Study|Death|0
1663484|NCT01536145|5814789|P7|Overall Study|Death|1
1663485|NCT01536145|5814790|P6|Overall Study|Death|0
1663486|NCT01536145|5814791|P5|Overall Study|Death|0
1663487|NCT01536145|5814792|P4|Overall Study|Death|0
1663488|NCT01536145|5814793|P3|Overall Study|Death|0
1663489|NCT01536145|5814794|P2|Overall Study|Death|0
1663490|NCT01536145|5814795|P1|Overall Study|Death|0
1663491|NCT01536145|5814785|P11|Overall Study|Other|2
1663492|NCT01536145|5814786|P10|Overall Study|Other|3
1663493|NCT01536145|5814787|P9|Overall Study|Other|0
1663494|NCT01536145|5814788|P8|Overall Study|Other|0
1663495|NCT01536145|5814789|P7|Overall Study|Other|0
1663496|NCT01536145|5814790|P6|Overall Study|Other|0
1663497|NCT01536145|5814791|P5|Overall Study|Other|1
1663498|NCT01536145|5814792|P4|Overall Study|Other|0
1663499|NCT01536145|5814793|P3|Overall Study|Other|0
1663500|NCT01536145|5814794|P2|Overall Study|Other|0
1663501|NCT01536145|5814795|P1|Overall Study|Other|0
1663502|NCT01536145|5814785|P11|Overall Study|Withdrawal by Subject|2
1663503|NCT01536145|5814786|P10|Overall Study|Withdrawal by Subject|0
1663504|NCT01536145|5814787|P9|Overall Study|Withdrawal by Subject|2
1663505|NCT01536145|5814788|P8|Overall Study|Withdrawal by Subject|0
1663506|NCT01536145|5814789|P7|Overall Study|Withdrawal by Subject|0
1663507|NCT01536145|5814790|P6|Overall Study|Withdrawal by Subject|1
1663508|NCT01536145|5814791|P5|Overall Study|Withdrawal by Subject|0
1663509|NCT01536145|5814792|P4|Overall Study|Withdrawal by Subject|0
1663510|NCT01536145|5814793|P3|Overall Study|Withdrawal by Subject|1
1663511|NCT01536145|5814794|P2|Overall Study|Withdrawal by Subject|0
1663512|NCT01536145|5814795|P1|Overall Study|Withdrawal by Subject|0
1663513|NCT01536145|5814785|P11|Overall Study|Progressive disease|3
1663514|NCT01536145|5814786|P10|Overall Study|Progressive disease|3
1663515|NCT01536145|5814787|P9|Overall Study|Progressive disease|1
1663516|NCT01536145|5814788|P8|Overall Study|Progressive disease|2
1663517|NCT01536145|5814789|P7|Overall Study|Progressive disease|1
1663518|NCT01536145|5814790|P6|Overall Study|Progressive disease|2
1663519|NCT01536145|5814791|P5|Overall Study|Progressive disease|1
1663520|NCT01536145|5814792|P4|Overall Study|Progressive disease|2
1663521|NCT01536145|5814793|P3|Overall Study|Progressive disease|1
1663522|NCT01536145|5814794|P2|Overall Study|Progressive disease|4
1663523|NCT01536145|5814795|P1|Overall Study|Progressive disease|3
1663524|NCT01536119|5814902|P2|Overall Study|Lost to Follow-up|14
1663525|NCT01536119|5814903|P1|Overall Study|Lost to Follow-up|17
1663526|NCT01536093|5814929|P2|Overall Study|Withdrawal by Subject|1
1663527|NCT01536093|5814930|P1|Overall Study|Withdrawal by Subject|0
1663528|NCT01536093|5814929|P2|Overall Study|absence of maternal colostrum|0
1663529|NCT01536093|5814930|P1|Overall Study|absence of maternal colostrum|2
1663530|NCT01536093|5814929|P2|Overall Study|Death|2
1663531|NCT01536093|5814930|P1|Overall Study|Death|1
1663532|NCT01536067|5814946|P1|Overall Study|Disease Progression|1
1663533|NCT01536015|5814959|P2|Overall Study|Study closure|5
1663534|NCT01536015|5814960|P1|Overall Study|Study closure|5
1663535|NCT01536015|5814959|P2|Overall Study|Inclusion Criterion not met|0
1663536|NCT01536015|5814960|P1|Overall Study|Inclusion Criterion not met|2
1663537|NCT01536015|5814959|P2|Overall Study|Lost to Follow-up|1
1663538|NCT01536015|5814960|P1|Overall Study|Lost to Follow-up|0
1663539|NCT01536015|5814959|P2|Overall Study|Adverse Event|4
1663540|NCT01536015|5814960|P1|Overall Study|Adverse Event|1
1663541|NCT01535807|5814998|P2|Overall Study|Data collection error|1
1663542|NCT01535807|5814999|P1|Overall Study|Data collection error|1
1663543|NCT01535807|5814998|P2|Overall Study|Withdrawal by Subject|1
1663544|NCT01535807|5814999|P1|Overall Study|Withdrawal by Subject|1
1663545|NCT01535729|5815005|P1|Overall Study|No participant record available|5
1663546|NCT01535729|5815005|P1|Overall Study|Not treated|9
1663547|NCT01535729|5815005|P1|Overall Study|Screening failure|1
1663548|NCT01535729|5815005|P1|Overall Study|Protocol Violation|11
1663549|NCT01535729|5815005|P1|Overall Study|NSCLC grade IV histology not confirmed|20
1663550|NCT01535729|5815005|P1|Overall Study|No previous chemotherapy|33
1663551|NCT01535729|5815005|P1|Overall Study|Did not sign informed consent|1
1663552|NCT01535729|5815005|P1|Overall Study|Other|19
1663553|NCT01535729|5815005|P1|Overall Study|Death|52
1663554|NCT01535729|5815005|P1|Overall Study|Lost to Follow-up|8
1663555|NCT01535729|5815005|P1|Overall Study|Discontinued treatment|25
1663556|NCT01535729|5815005|P1|Overall Study|Disease progression|230
1663557|NCT01535729|5815005|P1|Overall Study|Withdrawal by Subject|2
1663558|NCT01535638|5815046|P6|Treatment 3 (Single Dose)|Protocol Violation|0
1663559|NCT01535638|5815047|P5|Treatment 3 (Single Dose)|Protocol Violation|0
1663560|NCT01535638|5815048|P4|Treatment 3 (Single Dose)|Protocol Violation|1
1663561|NCT01535638|5815049|P3|Treatment 3 (Single Dose)|Protocol Violation|0
1663562|NCT01535638|5815050|P2|Treatment 3 (Single Dose)|Protocol Violation|0
1663563|NCT01535638|5815051|P1|Treatment 3 (Single Dose)|Protocol Violation|0
1663564|NCT01535638|5815046|P6|Treatment 1 (Single Dose)|Protocol Violation|1
1663565|NCT01535638|5815047|P5|Treatment 1 (Single Dose)|Protocol Violation|0
1663566|NCT01535638|5815048|P4|Treatment 1 (Single Dose)|Protocol Violation|0
1663567|NCT01535638|5815049|P3|Treatment 1 (Single Dose)|Protocol Violation|0
1663568|NCT01535638|5815050|P2|Treatment 1 (Single Dose)|Protocol Violation|0
1663569|NCT01535638|5815051|P1|Treatment 1 (Single Dose)|Protocol Violation|0
1663570|NCT01535599|5815065|P2|Overall Study|Noncompliance|1
1663571|NCT01535599|5815066|P1|Overall Study|Noncompliance|0
1663572|NCT01535599|5815065|P2|Overall Study|Stopped medication|1
1663573|NCT01535599|5815066|P1|Overall Study|Stopped medication|0
1663574|NCT01535599|5815065|P2|Overall Study|Other|0
1663575|NCT01535599|5815066|P1|Overall Study|Other|1
1663576|NCT01535599|5815065|P2|Overall Study|Did not use product|0
1663577|NCT01535599|5815066|P1|Overall Study|Did not use product|1
1663578|NCT01535599|5815065|P2|Overall Study|Randomized in Error|4
1663579|NCT01535599|5815066|P1|Overall Study|Randomized in Error|2
1663580|NCT01535599|5815065|P2|Overall Study|BL Culture + for Yeast//Fungi|1
1663581|NCT01535599|5815066|P1|Overall Study|BL Culture + for Yeast//Fungi|0
1663582|NCT01535599|5815065|P2|Overall Study|BL Culture + for Group A Strep|1
1663583|NCT01535599|5815066|P1|Overall Study|BL Culture + for Group A Strep|0
1663584|NCT01535599|5815065|P2|Overall Study|Treatment Failure|66
1663585|NCT01535599|5815066|P1|Overall Study|Treatment Failure|33
1663586|NCT01535599|5815065|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
1663587|NCT01535599|5815066|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
1663588|NCT01535599|5815065|P2|Overall Study|Lost to Follow-up|4
1663589|NCT01535599|5815066|P1|Overall Study|Lost to Follow-up|3
1663590|NCT01535599|5815065|P2|Overall Study|Adverse Event|15
1663591|NCT01535599|5815066|P1|Overall Study|Adverse Event|6
1663592|NCT01535560|5815078|P2|Overall Study|Randomized in Error|1
1663593|NCT01535560|5815079|P1|Overall Study|Randomized in Error|0
1663594|NCT01535560|5815078|P2|Overall Study|Other|1
1663595|NCT01535560|5815079|P1|Overall Study|Other|0
1663596|NCT01535560|5815078|P2|Overall Study|Treatment Failure|83
1663597|NCT01535560|5815079|P1|Overall Study|Treatment Failure|21
1663598|NCT01535560|5815078|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
1663599|NCT01535560|5815079|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
1663600|NCT01535560|5815078|P2|Overall Study|Lost to Follow-up|3
1663601|NCT01535560|5815079|P1|Overall Study|Lost to Follow-up|1
1663602|NCT01535560|5815078|P2|Overall Study|Adverse Event|7
1663603|NCT01535560|5815079|P1|Overall Study|Adverse Event|12
1663604|NCT01535443|5815089|P1|Overall Study|Physician Decision|3
1663605|NCT01535287|5815139|P2|Overall Study|drug not prepared in time|6
1663606|NCT01535287|5815140|P1|Overall Study|drug not prepared in time|5
1663607|NCT01535261|5815156|P1|Overall Study|Adverse Event|12
1663608|NCT01535261|5815156|P1|Overall Study|Withdrawal by Subject|14
1663609|NCT01535261|5815156|P1|Overall Study|Lost to Follow-up|8
1663610|NCT01535261|5815156|P1|Overall Study|Death|5
1663611|NCT01535261|5815156|P1|Overall Study|Protocol Violation|3
1663612|NCT01535261|5815156|P1|Overall Study|Physician Decision|8
1663613|NCT01535235|5815169|P2|Overall Study|Adverse Event|0
1663614|NCT01535235|5815170|P1|Overall Study|Adverse Event|1
1663615|NCT01535222|5815184|P6|Overall Study|Inclusion/exclusion|0
1663616|NCT01535222|5815185|P5|Overall Study|Inclusion/exclusion|0
1663617|NCT01535222|5815186|P4|Overall Study|Inclusion/exclusion|0
1663618|NCT01535222|5815187|P3|Overall Study|Inclusion/exclusion|1
1663619|NCT01535222|5815188|P2|Overall Study|Inclusion/exclusion|0
1663620|NCT01535222|5815189|P1|Overall Study|Inclusion/exclusion|0
1663621|NCT01535053|5815220|P2|Overall Study|Ineligible|2
1663622|NCT01535053|5815221|P1|Overall Study|Ineligible|1
1663623|NCT01535040|5815239|P2|Overall Study|Multiple Reasons|1
1663624|NCT01535040|5815240|P1|Overall Study|Multiple Reasons|1
1663625|NCT01535040|5815239|P2|Overall Study|Toxicity|5
1663626|NCT01535040|5815240|P1|Overall Study|Toxicity|7
1663627|NCT01535040|5815239|P2|Overall Study|Never Started|4
1663628|NCT01535040|5815240|P1|Overall Study|Never Started|9
1663629|NCT01535040|5815239|P2|Overall Study|Withdrawal by Subject|10
1663630|NCT01535040|5815240|P1|Overall Study|Withdrawal by Subject|13
1663631|NCT01535040|5815239|P2|Overall Study|Physician Decision|1
1663632|NCT01535040|5815240|P1|Overall Study|Physician Decision|0
1663633|NCT01534962|5815337|P4|Overall Study|Discontinued at AF recurrence|31
1663634|NCT01534962|5815338|P3|Overall Study|Discontinued at AF recurrence|24
1663635|NCT01534962|5815339|P2|Overall Study|Discontinued at AF recurrence|26
1663636|NCT01534962|5815340|P1|Overall Study|Discontinued at AF recurrence|35
1663637|NCT01534962|5815337|P4|Overall Study|Randomized but did not start treatment|1
1663638|NCT01534962|5815338|P3|Overall Study|Randomized but did not start treatment|0
1663639|NCT01534962|5815339|P2|Overall Study|Randomized but did not start treatment|0
1663640|NCT01534962|5815340|P1|Overall Study|Randomized but did not start treatment|2
1663641|NCT01534676|5815397|P2|Overall Study|Study closed due to poor enrollment|1
1663642|NCT01534676|5815398|P1|Overall Study|Study closed due to poor enrollment|2
1663643|NCT01534637|5815404|P1|Overall Study|Liver Mets before treatment|1
1663644|NCT01534637|5815404|P1|Overall Study|Adverse Event|1
1663645|NCT01534637|5815404|P1|Overall Study|Withdrawal by Subject|1
1663646|NCT01534637|5815404|P1|Overall Study|Lack of Efficacy|3
1663647|NCT01534637|5815404|P1|Overall Study|Physician Decision|3
1663648|NCT01534533|5815414|P4|Overall Study|Withdrawal by Subject|1
1663649|NCT01534533|5815415|P3|Overall Study|Withdrawal by Subject|4
1663650|NCT01534533|5815416|P2|Overall Study|Withdrawal by Subject|3
1663651|NCT01534533|5815417|P1|Overall Study|Withdrawal by Subject|5
1663652|NCT01534533|5815414|P4|Overall Study|Lost to Follow-up|3
1663653|NCT01534533|5815415|P3|Overall Study|Lost to Follow-up|4
1663654|NCT01534533|5815416|P2|Overall Study|Lost to Follow-up|0
1663655|NCT01534533|5815417|P1|Overall Study|Lost to Follow-up|3
1663656|NCT01534520|5815445|P2|Overall Study|Adverse Event|1
1663657|NCT01534520|5815446|P1|Overall Study|Adverse Event|0
1663658|NCT01534351|5815480|P3|Overall Study|Study Terminated Early|0
1663659|NCT01534351|5815481|P2|Overall Study|Study Terminated Early|0
1663660|NCT01534351|5815482|P1|Overall Study|Study Terminated Early|1
1663661|NCT01534273|5815503|P7|Period 1|Physician Decision|0
1663662|NCT01534273|5815504|P6|Period 1|Physician Decision|0
1663663|NCT01534273|5815505|P5|Period 1|Physician Decision|0
1663664|NCT01534273|5815506|P4|Period 1|Physician Decision|1
1663665|NCT01534273|5815507|P3|Period 1|Physician Decision|0
1663666|NCT01534273|5815508|P2|Period 1|Physician Decision|0
1663667|NCT01534273|5815509|P1|Period 1|Physician Decision|0
1663668|NCT01534260|5815536|P2|Overall Study|No treatment, per protocol|1
1663669|NCT01534260|5815537|P1|Overall Study|No treatment, per protocol|0
1663670|NCT01534260|5815536|P2|Overall Study|Physician Decision|1
1663671|NCT01534260|5815537|P1|Overall Study|Physician Decision|3
1663672|NCT01534260|5815536|P2|Overall Study|Disease Progression|6
1663673|NCT01534260|5815537|P1|Overall Study|Disease Progression|8
1663674|NCT01534260|5815536|P2|Overall Study|Withdrawal by Subject|3
1663675|NCT01534260|5815537|P1|Overall Study|Withdrawal by Subject|1
1663676|NCT01534260|5815536|P2|Overall Study|Lack of Efficacy|1
1663677|NCT01534260|5815537|P1|Overall Study|Lack of Efficacy|1
1663678|NCT01534260|5815536|P2|Overall Study|Death|0
1663679|NCT01534260|5815537|P1|Overall Study|Death|2
1663680|NCT01534260|5815536|P2|Overall Study|Adverse Event|8
1663681|NCT01534260|5815537|P1|Overall Study|Adverse Event|1
1663682|NCT01534208|5815547|P2|Overall Study|Needed prohibited meds|0
1663683|NCT01534208|5815548|P1|Overall Study|Needed prohibited meds|1
1663684|NCT01534208|5815547|P2|Overall Study|PCP decision|0
1663685|NCT01534208|5815548|P1|Overall Study|PCP decision|1
1663686|NCT01534208|5815547|P2|Overall Study|Eligibility error|0
1663687|NCT01534208|5815548|P1|Overall Study|Eligibility error|3
1663688|NCT01534208|5815547|P2|Overall Study|Lab assessment|1
1663689|NCT01534208|5815548|P1|Overall Study|Lab assessment|2
1663690|NCT01534208|5815547|P2|Overall Study|Subject relocation|0
1663691|NCT01534208|5815548|P1|Overall Study|Subject relocation|2
1663692|NCT01534208|5815547|P2|Overall Study|Sponsor decision|1
1663693|NCT01534208|5815548|P1|Overall Study|Sponsor decision|4
1663694|NCT01534208|5815547|P2|Overall Study|Protocol Violation|2
1663695|NCT01534208|5815548|P1|Overall Study|Protocol Violation|2
1663696|NCT01534208|5815547|P2|Overall Study|Lack of Efficacy|3
1663697|NCT01534208|5815548|P1|Overall Study|Lack of Efficacy|0
1663698|NCT01534208|5815547|P2|Overall Study|Physician Decision|0
1663699|NCT01534208|5815548|P1|Overall Study|Physician Decision|2
1663700|NCT01534208|5815547|P2|Overall Study|Adverse Event|8
1663701|NCT01534208|5815548|P1|Overall Study|Adverse Event|15
1663702|NCT01534208|5815547|P2|Overall Study|Withdrawal by Subject|20
1663703|NCT01534208|5815548|P1|Overall Study|Withdrawal by Subject|6
1663704|NCT01534208|5815547|P2|Overall Study|Lost to Follow-up|14
1663705|NCT01534208|5815548|P1|Overall Study|Lost to Follow-up|19
1663706|NCT01534195|5815566|P2|Overall Study|Withdrawal by Subject|1
1663707|NCT01534195|5815567|P1|Overall Study|Withdrawal by Subject|1
1663708|NCT01534182|5815581|P2|Overall Study|Adverse Event|3
1663709|NCT01534182|5815582|P1|Overall Study|Adverse Event|7
1663710|NCT01534182|5815581|P2|Overall Study|Withdrawal by Subject|7
1663711|NCT01534182|5815582|P1|Overall Study|Withdrawal by Subject|4
1663712|NCT01534182|5815581|P2|Overall Study|Administrative problems|0
1663713|NCT01534182|5815582|P1|Overall Study|Administrative problems|1
1663714|NCT01534078|5815613|P1|Overall Study|Withdrawal by Subject|1
1663715|NCT01534078|5815613|P1|Overall Study|Death|1
1663716|NCT01533935|5815650|P5|Overall Study|Other reason not defined above|1
1663717|NCT01533935|5815651|P4|Overall Study|Other reason not defined above|0
1663718|NCT01533935|5815652|P3|Overall Study|Other reason not defined above|1
1663719|NCT01533935|5815653|P2|Overall Study|Other reason not defined above|0
1663720|NCT01533935|5815654|P1|Overall Study|Other reason not defined above|1
1663721|NCT01533935|5815650|P5|Overall Study|Withdrawal by Subject|4
1663722|NCT01533935|5815651|P4|Overall Study|Withdrawal by Subject|2
1663723|NCT01533935|5815652|P3|Overall Study|Withdrawal by Subject|5
1663724|NCT01533935|5815653|P2|Overall Study|Withdrawal by Subject|4
1663725|NCT01533935|5815654|P1|Overall Study|Withdrawal by Subject|0
1663726|NCT01533935|5815650|P5|Overall Study|Lost to Follow-up|0
1663727|NCT01533935|5815651|P4|Overall Study|Lost to Follow-up|0
1663728|NCT01533935|5815652|P3|Overall Study|Lost to Follow-up|1
1663729|NCT01533935|5815653|P2|Overall Study|Lost to Follow-up|0
1663730|NCT01533935|5815654|P1|Overall Study|Lost to Follow-up|0
1663731|NCT01533935|5815650|P5|Overall Study|Protocol Violation|0
1663732|NCT01533935|5815651|P4|Overall Study|Protocol Violation|0
1663733|NCT01533935|5815652|P3|Overall Study|Protocol Violation|0
1663734|NCT01533935|5815653|P2|Overall Study|Protocol Violation|2
1663735|NCT01533935|5815654|P1|Overall Study|Protocol Violation|0
1663736|NCT01533935|5815650|P5|Overall Study|Adverse Event|3
1663737|NCT01533935|5815651|P4|Overall Study|Adverse Event|5
1663738|NCT01533935|5815652|P3|Overall Study|Adverse Event|1
1663739|NCT01533935|5815653|P2|Overall Study|Adverse Event|7
1663740|NCT01533935|5815654|P1|Overall Study|Adverse Event|5
1663741|NCT01533922|5815681|P5|Overall Study|Other reason not defined above|0
1663742|NCT01533922|5815682|P4|Overall Study|Other reason not defined above|0
1663743|NCT01533922|5815683|P3|Overall Study|Other reason not defined above|1
1663744|NCT01533922|5815684|P2|Overall Study|Other reason not defined above|0
1663745|NCT01533922|5815685|P1|Overall Study|Other reason not defined above|2
1663746|NCT01533922|5815681|P5|Overall Study|Withdrawal by Subject|1
1663747|NCT01533922|5815682|P4|Overall Study|Withdrawal by Subject|2
1663748|NCT01533922|5815683|P3|Overall Study|Withdrawal by Subject|2
1663749|NCT01533922|5815684|P2|Overall Study|Withdrawal by Subject|1
1663750|NCT01533922|5815685|P1|Overall Study|Withdrawal by Subject|3
1663751|NCT01533922|5815681|P5|Overall Study|Protocol Violation|1
1663752|NCT01533922|5815682|P4|Overall Study|Protocol Violation|0
1663753|NCT01533922|5815683|P3|Overall Study|Protocol Violation|0
1663754|NCT01533922|5815684|P2|Overall Study|Protocol Violation|3
1663755|NCT01533922|5815685|P1|Overall Study|Protocol Violation|0
1663756|NCT01533922|5815681|P5|Overall Study|Lack of Efficacy|0
1663757|NCT01533922|5815682|P4|Overall Study|Lack of Efficacy|0
1663758|NCT01533922|5815683|P3|Overall Study|Lack of Efficacy|1
1663759|NCT01533922|5815684|P2|Overall Study|Lack of Efficacy|0
1663760|NCT01533922|5815685|P1|Overall Study|Lack of Efficacy|0
1663761|NCT01533922|5815681|P5|Overall Study|Adverse Event|4
1663762|NCT01533922|5815682|P4|Overall Study|Adverse Event|3
1663763|NCT01533922|5815683|P3|Overall Study|Adverse Event|6
1663764|NCT01533922|5815684|P2|Overall Study|Adverse Event|8
1663765|NCT01533922|5815685|P1|Overall Study|Adverse Event|5
1663766|NCT01533688|5815730|P3|Overall Study|Had colonoscopy at outside hospital|2
1663767|NCT01533688|5815731|P2|Overall Study|Had colonoscopy at outside hospital|3
1663768|NCT01533688|5815732|P1|Overall Study|Had colonoscopy at outside hospital|2
1663769|NCT01533688|5815730|P3|Overall Study|Medically unstable|3
1663770|NCT01533688|5815731|P2|Overall Study|Medically unstable|3
1663771|NCT01533688|5815732|P1|Overall Study|Medically unstable|1
1663772|NCT01533688|5815730|P3|Overall Study|Withdrawal by Subject|3
1663773|NCT01533688|5815731|P2|Overall Study|Withdrawal by Subject|4
1663774|NCT01533688|5815732|P1|Overall Study|Withdrawal by Subject|5
1663775|NCT01533493|5815764|P2|Overall Study|Lost to Follow-up|0
1663776|NCT01533493|5815765|P1|Overall Study|Lost to Follow-up|2
1663777|NCT01533493|5815764|P2|Overall Study|Withdrawal by Subject|2
1663778|NCT01533493|5815765|P1|Overall Study|Withdrawal by Subject|1
1663779|NCT01533493|5815764|P2|Overall Study|Adverse Event|1
1663780|NCT01533493|5815765|P1|Overall Study|Adverse Event|2
1663781|NCT01533428|5815773|P2|Overall Study|Withdrawal by Subject|6
1663782|NCT01533428|5815774|P1|Overall Study|Withdrawal by Subject|7
1663783|NCT01533428|5815773|P2|Overall Study|Lost to Follow-up|1
1663784|NCT01533428|5815774|P1|Overall Study|Lost to Follow-up|2
1663785|NCT01533428|5815773|P2|Overall Study|Adverse Event|1
1663786|NCT01533428|5815774|P1|Overall Study|Adverse Event|0
1663787|NCT01533246|5815820|P1|Overall Study|Withdrawal by Subject|1
1663788|NCT01533246|5815820|P1|Overall Study|Adverse Event|1
1663789|NCT01533181|5815831|P2|Overall Study|Patient withdrawal pre-active treatment|0
1663790|NCT01533181|5815832|P1|Overall Study|Patient withdrawal pre-active treatment|1
1663791|NCT01533181|5815831|P2|Overall Study|Disease progression pre-active treatment|1
1663792|NCT01533181|5815832|P1|Overall Study|Disease progression pre-active treatment|0
1663793|NCT01532999|5815949|P2|Overall Study|New job|2
1663794|NCT01532999|5815950|P1|Overall Study|New job|0
1663795|NCT01532999|5815949|P2|Overall Study|incarcerated|1
1663796|NCT01532999|5815950|P1|Overall Study|incarcerated|0
1663797|NCT01532999|5815949|P2|Overall Study|Adverse Event|1
1663798|NCT01532999|5815950|P1|Overall Study|Adverse Event|0
1663799|NCT01532999|5815949|P2|Overall Study|no show for week 9 assessments|4
1663800|NCT01532999|5815950|P1|Overall Study|no show for week 9 assessments|6
1663801|NCT01532999|5815949|P2|Overall Study|substantial noncompliance|0
1663802|NCT01532999|5815950|P1|Overall Study|substantial noncompliance|2
1663803|NCT01532999|5815949|P2|Overall Study|should not have been randomized|0
1663804|NCT01532999|5815950|P1|Overall Study|should not have been randomized|1
1663805|NCT01532999|5815949|P2|Overall Study|Relocated|0
1663806|NCT01532999|5815950|P1|Overall Study|Relocated|2
1663807|NCT01532999|5815949|P2|Overall Study|Withdrawal by Subject|0
1663808|NCT01532999|5815950|P1|Overall Study|Withdrawal by Subject|5
1663809|NCT01532999|5815949|P2|Overall Study|Physician Decision|2
1663810|NCT01532999|5815950|P1|Overall Study|Physician Decision|1
1663811|NCT01532999|5815949|P2|Overall Study|Lost to Follow-up|8
1663812|NCT01532999|5815950|P1|Overall Study|Lost to Follow-up|14
1663813|NCT01532986|5815974|P2|Overall Study|Physician Decision|5
1663814|NCT01532986|5815975|P1|Overall Study|Physician Decision|7
1663815|NCT01532986|5815974|P2|Overall Study|Withdrawal by Subject|10
1663816|NCT01532986|5815975|P1|Overall Study|Withdrawal by Subject|7
1663817|NCT01532986|5815974|P2|Overall Study|Death|9
1663818|NCT01532986|5815975|P1|Overall Study|Death|9
1663819|NCT01532934|5816059|P2|Overall Study|In controlled environment|2
1663820|NCT01532934|5816060|P1|Overall Study|In controlled environment|3
1663821|NCT01532934|5816059|P2|Overall Study|Lost to Follow-up|11
1663822|NCT01532934|5816060|P1|Overall Study|Lost to Follow-up|11
1663823|NCT01532921|5816070|P1|Overall Study|Device was explanted during procedure|1
1663824|NCT01532921|5816070|P1|Overall Study|Physician Decision|7
1663825|NCT01532921|5816070|P1|Overall Study|Lost to Follow-up|3
1663826|NCT01532921|5816070|P1|Overall Study|Withdrawal by Subject|2
1663827|NCT01532921|5816070|P1|Overall Study|Death|3
1663828|NCT01532869|5816092|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
1663829|NCT01532869|5816093|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
1663830|NCT01532869|5816092|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1663831|NCT01532869|5816093|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
1663832|NCT01532869|5816092|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
1663833|NCT01532869|5816093|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
1663834|NCT01532869|5816092|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
1663835|NCT01532869|5816093|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
1663836|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
1663837|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
1663838|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
1663839|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
1663840|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
1663841|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
1663842|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
1663843|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
1663844|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
1663845|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
1663846|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
1663847|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
1663848|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
1663849|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
1663850|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
1663851|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
1663852|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1663853|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
1663854|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
1663855|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
1663856|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
1663857|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
1663858|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
1663859|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
1663860|NCT01532869|5816092|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
1663861|NCT01532869|5816093|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
1663862|NCT01532648|5816152|P2|Overall Study|Withdrawal by Subject|2
1663863|NCT01532648|5816153|P1|Overall Study|Withdrawal by Subject|16
1663864|NCT01532648|5816152|P2|Overall Study|Adverse Event|9
1663865|NCT01532648|5816153|P1|Overall Study|Adverse Event|12
1663866|NCT01532648|5816152|P2|Overall Study|Protocol Violation|1
1663867|NCT01532648|5816153|P1|Overall Study|Protocol Violation|1
1663868|NCT01532648|5816152|P2|Overall Study|Lack of Efficacy|1
1663869|NCT01532648|5816153|P1|Overall Study|Lack of Efficacy|4
1663870|NCT01532648|5816152|P2|Overall Study|Lost to Follow-up|4
1663871|NCT01532648|5816153|P1|Overall Study|Lost to Follow-up|3
1663872|NCT01532570|5816187|P4|Overall Study|Withdrawal by Subject|0
1663873|NCT01532570|5816188|P3|Overall Study|Withdrawal by Subject|0
1663874|NCT01532570|5816189|P2|Overall Study|Withdrawal by Subject|1
1663875|NCT01532570|5816190|P1|Overall Study|Withdrawal by Subject|0
1663876|NCT01532570|5816187|P4|Overall Study|Lack of Efficacy|0
1663877|NCT01532570|5816188|P3|Overall Study|Lack of Efficacy|0
1663878|NCT01532570|5816189|P2|Overall Study|Lack of Efficacy|0
1663879|NCT01532570|5816190|P1|Overall Study|Lack of Efficacy|1
1663880|NCT01532414|5816235|P3|Overall Study|Withdrawn by sponsor|0
1663881|NCT01532414|5816236|P2|Overall Study|Withdrawn by sponsor|0
1663882|NCT01532414|5816237|P1|Overall Study|Withdrawn by sponsor|1
1663883|NCT01532414|5816235|P3|Overall Study|Unable to complete 24 hour PK|1
1663884|NCT01532414|5816236|P2|Overall Study|Unable to complete 24 hour PK|0
1663885|NCT01532414|5816237|P1|Overall Study|Unable to complete 24 hour PK|0
1663886|NCT01532414|5816235|P3|Overall Study|Adverse Event|1
1663887|NCT01532414|5816236|P2|Overall Study|Adverse Event|1
1663888|NCT01532414|5816237|P1|Overall Study|Adverse Event|0
1663889|NCT01532414|5816235|P3|Overall Study|No V6 semen sample|0
1663890|NCT01532414|5816236|P2|Overall Study|No V6 semen sample|1
1663891|NCT01532414|5816237|P1|Overall Study|No V6 semen sample|0
1663892|NCT01532414|5816235|P3|Overall Study|Withdrawal by Subject|0
1663893|NCT01532414|5816236|P2|Overall Study|Withdrawal by Subject|0
1663894|NCT01532414|5816237|P1|Overall Study|Withdrawal by Subject|3
1663895|NCT01532414|5816235|P3|Overall Study|Lost to Follow-up|1
1663896|NCT01532414|5816236|P2|Overall Study|Lost to Follow-up|0
1663897|NCT01532414|5816237|P1|Overall Study|Lost to Follow-up|3
1663898|NCT01531998|5816320|P1|Overall Study|Withdrawal by Subject|3
1663899|NCT01531894|5816325|P1|Overall Study|Death|1
1663900|NCT01531894|5816325|P1|Overall Study|Physician Decision|8
1663901|NCT01531725|5816329|P1|Overall Study|Protocol Violation|5
1663902|NCT01531673|5816347|P13|Overall Study|Other|0
1663903|NCT01531673|5816348|P12|Overall Study|Other|0
1663904|NCT01531673|5816349|P11|Overall Study|Other|0
1663905|NCT01531673|5816350|P10|Overall Study|Other|1
1663906|NCT01531673|5816351|P9|Overall Study|Other|0
1663907|NCT01531673|5816352|P8|Overall Study|Other|0
1663908|NCT01531673|5816353|P7|Overall Study|Other|0
1663909|NCT01531673|5816354|P6|Overall Study|Other|0
1663910|NCT01531673|5816355|P5|Overall Study|Other|0
1663911|NCT01531673|5816356|P4|Overall Study|Other|1
1663912|NCT01531673|5816357|P3|Overall Study|Other|0
1663913|NCT01531673|5816358|P2|Overall Study|Other|0
1663914|NCT01531673|5816359|P1|Overall Study|Other|0
1663915|NCT01531673|5816347|P13|Overall Study|Lost to Follow-up|0
1663916|NCT01531673|5816348|P12|Overall Study|Lost to Follow-up|0
1663917|NCT01531673|5816349|P11|Overall Study|Lost to Follow-up|0
1663918|NCT01531673|5816350|P10|Overall Study|Lost to Follow-up|0
1663919|NCT01531673|5816351|P9|Overall Study|Lost to Follow-up|0
1663920|NCT01531673|5816352|P8|Overall Study|Lost to Follow-up|0
1663921|NCT01531673|5816353|P7|Overall Study|Lost to Follow-up|0
1663922|NCT01531673|5816354|P6|Overall Study|Lost to Follow-up|0
1663923|NCT01531673|5816355|P5|Overall Study|Lost to Follow-up|1
1663924|NCT01531673|5816356|P4|Overall Study|Lost to Follow-up|0
1663925|NCT01531673|5816357|P3|Overall Study|Lost to Follow-up|0
1663926|NCT01531673|5816358|P2|Overall Study|Lost to Follow-up|0
1663927|NCT01531673|5816359|P1|Overall Study|Lost to Follow-up|0
1663928|NCT01531673|5816347|P13|Overall Study|Adverse Event|0
1663929|NCT01531673|5816348|P12|Overall Study|Adverse Event|0
1663930|NCT01531673|5816349|P11|Overall Study|Adverse Event|0
1663931|NCT01531673|5816350|P10|Overall Study|Adverse Event|0
1663932|NCT01531673|5816351|P9|Overall Study|Adverse Event|0
1663933|NCT01531673|5816352|P8|Overall Study|Adverse Event|0
1663934|NCT01531673|5816353|P7|Overall Study|Adverse Event|0
1663935|NCT01531673|5816354|P6|Overall Study|Adverse Event|0
1663936|NCT01531673|5816355|P5|Overall Study|Adverse Event|0
1663937|NCT01531673|5816356|P4|Overall Study|Adverse Event|0
1663938|NCT01531673|5816357|P3|Overall Study|Adverse Event|0
1663939|NCT01531673|5816358|P2|Overall Study|Adverse Event|1
1663940|NCT01531673|5816359|P1|Overall Study|Adverse Event|0
1663941|NCT01531673|5816347|P13|Overall Study|Non-Compliance|0
1663942|NCT01531673|5816348|P12|Overall Study|Non-Compliance|0
1663943|NCT01531673|5816349|P11|Overall Study|Non-Compliance|0
1663944|NCT01531673|5816350|P10|Overall Study|Non-Compliance|0
1663945|NCT01531673|5816351|P9|Overall Study|Non-Compliance|0
1663946|NCT01531673|5816352|P8|Overall Study|Non-Compliance|0
1663947|NCT01531673|5816353|P7|Overall Study|Non-Compliance|0
1663948|NCT01531673|5816354|P6|Overall Study|Non-Compliance|1
1663949|NCT01531673|5816355|P5|Overall Study|Non-Compliance|0
1663950|NCT01531673|5816356|P4|Overall Study|Non-Compliance|0
1663951|NCT01531673|5816357|P3|Overall Study|Non-Compliance|0
1663952|NCT01531673|5816358|P2|Overall Study|Non-Compliance|0
1663953|NCT01531673|5816359|P1|Overall Study|Non-Compliance|0
1663954|NCT01531387|5816470|P2|Overall Study|Early termination of study|11
1663955|NCT01531387|5816471|P1|Overall Study|Early termination of study|11
1663956|NCT01531205|5816563|P1|Overall Study|Did not proceed to surgery|1
1663957|NCT01531153|5816575|P3|Overall Study|Withdrawal by Subject|15
1663958|NCT01531153|5816576|P2|Overall Study|Withdrawal by Subject|9
1663959|NCT01531153|5816577|P1|Overall Study|Withdrawal by Subject|10
1663960|NCT01530997|5816633|P1|Overall Study|Withdrawal by Subject|1
1663961|NCT01530997|5816633|P1|Overall Study|Physician Decision|1
1663962|NCT01530464|5816677|P2|Washout (24h)|Withdrawal by Subject|1
1663963|NCT01530464|5816678|P1|Washout (24h)|Withdrawal by Subject|0
1663964|NCT01530464|5816677|P2|Washout (24h)|Withdrawal by Subject|0
1663965|NCT01530464|5816678|P1|Washout (24h)|Withdrawal by Subject|1
1663966|NCT01530334|5816730|P1|Overall Study|Progressive disease|47
1663967|NCT01530334|5816730|P1|Overall Study|unknown reason|1
1663968|NCT01530334|5816730|P1|Overall Study|Adverse Event|3
1663969|NCT01530087|5816777|P1|Overall Study|Physician Decision|2
1663970|NCT01529749|5816793|P4|Overall Study|Protocol Violation|1
1663971|NCT01529749|5816794|P3|Overall Study|Protocol Violation|0
1663972|NCT01529749|5816795|P2|Overall Study|Protocol Violation|0
1663973|NCT01529749|5816796|P1|Overall Study|Protocol Violation|0
1663974|NCT01529749|5816793|P4|Overall Study|Withdrawal by Subject|0
1663975|NCT01529749|5816794|P3|Overall Study|Withdrawal by Subject|1
1663976|NCT01529749|5816795|P2|Overall Study|Withdrawal by Subject|1
1663977|NCT01529749|5816796|P1|Overall Study|Withdrawal by Subject|0
1663978|NCT01529749|5816793|P4|Overall Study|Physician Decision|1
1663979|NCT01529749|5816794|P3|Overall Study|Physician Decision|0
1663980|NCT01529749|5816795|P2|Overall Study|Physician Decision|0
1663981|NCT01529749|5816796|P1|Overall Study|Physician Decision|0
1663982|NCT01529749|5816793|P4|Overall Study|Lost to Follow-up|0
1663983|NCT01529749|5816794|P3|Overall Study|Lost to Follow-up|1
1663984|NCT01529749|5816795|P2|Overall Study|Lost to Follow-up|1
1663985|NCT01529749|5816796|P1|Overall Study|Lost to Follow-up|0
1663986|NCT01529645|5816880|P10|Overall Study|Withdrawal by Subject|0
1663987|NCT01529645|5816881|P9|Overall Study|Withdrawal by Subject|0
1663988|NCT01529645|5816882|P8|Overall Study|Withdrawal by Subject|0
1663989|NCT01529645|5816883|P7|Overall Study|Withdrawal by Subject|0
1663990|NCT01529645|5816884|P6|Overall Study|Withdrawal by Subject|1
1663991|NCT01529645|5816885|P5|Overall Study|Withdrawal by Subject|1
1663992|NCT01529645|5816886|P4|Overall Study|Withdrawal by Subject|1
1663993|NCT01529645|5816887|P3|Overall Study|Withdrawal by Subject|0
1663994|NCT01529645|5816888|P2|Overall Study|Withdrawal by Subject|0
1663995|NCT01529645|5816889|P1|Overall Study|Withdrawal by Subject|2
1663996|NCT01529645|5816880|P10|Overall Study|SAE - Premature contractions|0
1663997|NCT01529645|5816881|P9|Overall Study|SAE - Premature contractions|0
1663998|NCT01529645|5816882|P8|Overall Study|SAE - Premature contractions|0
1663999|NCT01529645|5816883|P7|Overall Study|SAE - Premature contractions|0
1664000|NCT01529645|5816884|P6|Overall Study|SAE - Premature contractions|0
1664001|NCT01529645|5816885|P5|Overall Study|SAE - Premature contractions|0
1664002|NCT01529645|5816886|P4|Overall Study|SAE - Premature contractions|0
1664003|NCT01529645|5816887|P3|Overall Study|SAE - Premature contractions|1
1664004|NCT01529645|5816888|P2|Overall Study|SAE - Premature contractions|0
1664005|NCT01529645|5816889|P1|Overall Study|SAE - Premature contractions|0
1664006|NCT01529645|5816880|P10|Overall Study|Lost to Follow-up|0
1664007|NCT01529645|5816881|P9|Overall Study|Lost to Follow-up|1
1664008|NCT01529645|5816882|P8|Overall Study|Lost to Follow-up|0
1664009|NCT01529645|5816883|P7|Overall Study|Lost to Follow-up|2
1664010|NCT01529645|5816884|P6|Overall Study|Lost to Follow-up|0
1664011|NCT01529645|5816885|P5|Overall Study|Lost to Follow-up|1
1664012|NCT01529645|5816886|P4|Overall Study|Lost to Follow-up|1
1664013|NCT01529645|5816887|P3|Overall Study|Lost to Follow-up|1
1664014|NCT01529645|5816888|P2|Overall Study|Lost to Follow-up|1
1664015|NCT01529645|5816889|P1|Overall Study|Lost to Follow-up|0
1664016|NCT01529632|5816987|P2|Overall Study|Adverse Event|1
1664017|NCT01529632|5816988|P1|Overall Study|Adverse Event|1
1664018|NCT01529632|5816987|P2|Overall Study|Protocol Violation|1
1664019|NCT01529632|5816988|P1|Overall Study|Protocol Violation|0
1664020|NCT01529632|5816987|P2|Overall Study|Administrative problem|1
1664021|NCT01529632|5816988|P1|Overall Study|Administrative problem|2
1664022|NCT01529515|5817008|P4|DOUBLE BLIND PHASE|Other|2
1664023|NCT01529515|5817009|P3|DOUBLE BLIND PHASE|Other|9
1664024|NCT01529515|5817010|P2|DOUBLE BLIND PHASE|Other|0
1664025|NCT01529515|5817011|P1|DOUBLE BLIND PHASE|Other|0
1664026|NCT01529515|5817008|P4|DOUBLE BLIND PHASE|Protocol Violation|0
1664027|NCT01529515|5817009|P3|DOUBLE BLIND PHASE|Protocol Violation|1
1664028|NCT01529515|5817010|P2|DOUBLE BLIND PHASE|Protocol Violation|0
1664029|NCT01529515|5817011|P1|DOUBLE BLIND PHASE|Protocol Violation|0
1664030|NCT01529515|5817008|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
1664031|NCT01529515|5817009|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
1664032|NCT01529515|5817010|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1664033|NCT01529515|5817011|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
1664034|NCT01529515|5817008|P4|DOUBLE BLIND PHASE|Pregnancy|0
1664035|NCT01529515|5817009|P3|DOUBLE BLIND PHASE|Pregnancy|1
1664036|NCT01529515|5817010|P2|DOUBLE BLIND PHASE|Pregnancy|0
1664037|NCT01529515|5817011|P1|DOUBLE BLIND PHASE|Pregnancy|0
1664038|NCT01529515|5817008|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
1664039|NCT01529515|5817009|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
1664040|NCT01529515|5817010|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
1664041|NCT01529515|5817011|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
1664042|NCT01529515|5817008|P4|DOUBLE BLIND PHASE|Adverse Event|0
1664043|NCT01529515|5817009|P3|DOUBLE BLIND PHASE|Adverse Event|1
1664044|NCT01529515|5817010|P2|DOUBLE BLIND PHASE|Adverse Event|0
1664045|NCT01529515|5817011|P1|DOUBLE BLIND PHASE|Adverse Event|0
1664046|NCT01529515|5817008|P4|MAINTENANCE PHASE|Other|0
1664047|NCT01529515|5817009|P3|MAINTENANCE PHASE|Other|0
1664048|NCT01529515|5817010|P2|MAINTENANCE PHASE|Other|10
1664049|NCT01529515|5817011|P1|MAINTENANCE PHASE|Other|0
1664050|NCT01529515|5817008|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
1664051|NCT01529515|5817009|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
1664052|NCT01529515|5817010|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
1664053|NCT01529515|5817011|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
1664054|NCT01529515|5817008|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
1664055|NCT01529515|5817009|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
1664056|NCT01529515|5817010|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
1664057|NCT01529515|5817011|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
1664058|NCT01529515|5817008|P4|MAINTENANCE PHASE|Protocol Violation|0
1664059|NCT01529515|5817009|P3|MAINTENANCE PHASE|Protocol Violation|0
1664060|NCT01529515|5817010|P2|MAINTENANCE PHASE|Protocol Violation|12
1664061|NCT01529515|5817011|P1|MAINTENANCE PHASE|Protocol Violation|0
1664062|NCT01529515|5817008|P4|MAINTENANCE PHASE|Lost to Follow-up|0
1664063|NCT01529515|5817009|P3|MAINTENANCE PHASE|Lost to Follow-up|0
1664064|NCT01529515|5817010|P2|MAINTENANCE PHASE|Lost to Follow-up|5
1664065|NCT01529515|5817011|P1|MAINTENANCE PHASE|Lost to Follow-up|0
1664066|NCT01529515|5817008|P4|MAINTENANCE PHASE|Lack of Efficacy|0
1664067|NCT01529515|5817009|P3|MAINTENANCE PHASE|Lack of Efficacy|0
1664068|NCT01529515|5817010|P2|MAINTENANCE PHASE|Lack of Efficacy|9
1664069|NCT01529515|5817011|P1|MAINTENANCE PHASE|Lack of Efficacy|0
1664070|NCT01529515|5817008|P4|MAINTENANCE PHASE|Adverse Event|0
1664071|NCT01529515|5817009|P3|MAINTENANCE PHASE|Adverse Event|0
1664072|NCT01529515|5817010|P2|MAINTENANCE PHASE|Adverse Event|10
1664073|NCT01529515|5817011|P1|MAINTENANCE PHASE|Adverse Event|0
1664074|NCT01529515|5817008|P4|TRANSITION PHASE|Other|0
1664075|NCT01529515|5817009|P3|TRANSITION PHASE|Other|0
1664076|NCT01529515|5817010|P2|TRANSITION PHASE|Other|0
1664077|NCT01529515|5817011|P1|TRANSITION PHASE|Other|9
1664078|NCT01529515|5817008|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1664079|NCT01529515|5817009|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1664080|NCT01529515|5817010|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
1664081|NCT01529515|5817011|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
1664082|NCT01529515|5817008|P4|TRANSITION PHASE|Withdrawal by Subject|0
1664083|NCT01529515|5817009|P3|TRANSITION PHASE|Withdrawal by Subject|0
1664084|NCT01529515|5817010|P2|TRANSITION PHASE|Withdrawal by Subject|0
1664085|NCT01529515|5817011|P1|TRANSITION PHASE|Withdrawal by Subject|51
1664086|NCT01529515|5817008|P4|TRANSITION PHASE|Protocol Violation|0
1664087|NCT01529515|5817009|P3|TRANSITION PHASE|Protocol Violation|0
1664088|NCT01529515|5817010|P2|TRANSITION PHASE|Protocol Violation|0
1664089|NCT01529515|5817011|P1|TRANSITION PHASE|Protocol Violation|4
1664090|NCT01529515|5817008|P4|TRANSITION PHASE|Lost to Follow-up|0
1664091|NCT01529515|5817009|P3|TRANSITION PHASE|Lost to Follow-up|0
1664092|NCT01529515|5817010|P2|TRANSITION PHASE|Lost to Follow-up|0
1664093|NCT01529515|5817011|P1|TRANSITION PHASE|Lost to Follow-up|19
1664094|NCT01529515|5817008|P4|TRANSITION PHASE|Lack of Efficacy|0
1664095|NCT01529515|5817009|P3|TRANSITION PHASE|Lack of Efficacy|0
1664096|NCT01529515|5817010|P2|TRANSITION PHASE|Lack of Efficacy|0
1664097|NCT01529515|5817011|P1|TRANSITION PHASE|Lack of Efficacy|19
1664098|NCT01529515|5817008|P4|TRANSITION PHASE|Death|0
1664099|NCT01529515|5817009|P3|TRANSITION PHASE|Death|0
1664100|NCT01529515|5817010|P2|TRANSITION PHASE|Death|0
1664101|NCT01529515|5817011|P1|TRANSITION PHASE|Death|1
1664102|NCT01529515|5817008|P4|TRANSITION PHASE|Adverse Event|0
1664103|NCT01529515|5817009|P3|TRANSITION PHASE|Adverse Event|0
1664104|NCT01529515|5817010|P2|TRANSITION PHASE|Adverse Event|0
1664105|NCT01529515|5817011|P1|TRANSITION PHASE|Adverse Event|16
1664106|NCT01529385|5817058|P2|Overall Study|Lost to Follow-up|1
1664107|NCT01529385|5817059|P1|Overall Study|Lost to Follow-up|2
1664108|NCT01529346|5817088|P5|Overall Study|Other|0
1664109|NCT01529346|5817089|P4|Overall Study|Other|0
1664110|NCT01529346|5817090|P3|Overall Study|Other|1
1664111|NCT01529346|5817091|P2|Overall Study|Other|1
1664112|NCT01529346|5817092|P1|Overall Study|Other|0
1664113|NCT01529346|5817088|P5|Overall Study|Lost to Follow-up|0
1664114|NCT01529346|5817089|P4|Overall Study|Lost to Follow-up|0
1664115|NCT01529346|5817090|P3|Overall Study|Lost to Follow-up|1
1664116|NCT01529346|5817091|P2|Overall Study|Lost to Follow-up|0
1664117|NCT01529346|5817092|P1|Overall Study|Lost to Follow-up|2
1664118|NCT01529268|5817180|P2|Overall Study|Moved|0
1664119|NCT01529268|5817181|P1|Overall Study|Moved|3
1664120|NCT01529268|5817180|P2|Overall Study|Lost to Follow-up|3
1664121|NCT01529268|5817181|P1|Overall Study|Lost to Follow-up|9
1664122|NCT01529112|5817243|P2|Overall Study|Withdrawal by Subject|3
1664123|NCT01529112|5817244|P1|Overall Study|Withdrawal by Subject|7
1664124|NCT01529112|5817243|P2|Overall Study|Protocol Violation|0
1664125|NCT01529112|5817244|P1|Overall Study|Protocol Violation|1
1664126|NCT01529112|5817243|P2|Overall Study|Death|38
1664127|NCT01529112|5817244|P1|Overall Study|Death|59
1664128|NCT01529112|5817243|P2|Overall Study|Adverse Event|0
1664129|NCT01529112|5817244|P1|Overall Study|Adverse Event|2
1664130|NCT01529034|5817280|P1|Overall Study|Study drug not available|2
1664131|NCT01529034|5817280|P1|Overall Study|Investigator no longer available|2
1664132|NCT01529034|5817280|P1|Overall Study|Lack of Efficacy|4
1664133|NCT01529034|5817280|P1|Overall Study|Protocol Violation|4
1664134|NCT01529034|5817280|P1|Overall Study|Adverse Event|4
1664135|NCT01529034|5817280|P1|Overall Study|Caregiver no longer available|7
1664136|NCT01529034|5817280|P1|Overall Study|Noncompliance|8
1664137|NCT01529034|5817280|P1|Overall Study|No treated SCs within protocol window|13
1664138|NCT01529034|5817280|P1|Overall Study|Withdrawal by Subject|25
1664139|NCT01529034|5817280|P1|Overall Study|Study termination|29
1664140|NCT01529034|5817280|P1|Overall Study|Site closure|62
1664141|NCT01529034|5817280|P1|Overall Study|Discontinued prior to study treatment|14
1664142|NCT01528969|5817295|P2|Overall Study|absent from the school at baseline|0
1664143|NCT01528969|5817296|P1|Overall Study|absent from the school at baseline|2
1664144|NCT01528787|5817329|P4|Overall Study|Family Emergency|0
1664145|NCT01528787|5817330|P3|Overall Study|Family Emergency|1
1664146|NCT01528787|5817331|P2|Overall Study|Family Emergency|0
1664147|NCT01528787|5817332|P1|Overall Study|Family Emergency|0
1664148|NCT01528787|5817329|P4|Overall Study|Withdrawal by Subject|1
1664149|NCT01528787|5817330|P3|Overall Study|Withdrawal by Subject|0
1664150|NCT01528787|5817331|P2|Overall Study|Withdrawal by Subject|0
1664151|NCT01528787|5817332|P1|Overall Study|Withdrawal by Subject|0
1664152|NCT01528735|5817344|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
1664153|NCT01528735|5817345|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
1664154|NCT01528735|5817344|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1664155|NCT01528735|5817345|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
1664156|NCT01528709|5817447|P2|Overall Study|allergy|0
1664157|NCT01528709|5817448|P1|Overall Study|allergy|1
1664158|NCT01528709|5817447|P2|Overall Study|Withdrawal by Subject|15
1664159|NCT01528709|5817448|P1|Overall Study|Withdrawal by Subject|10
1664160|NCT01528709|5817447|P2|Overall Study|Death|0
1664161|NCT01528709|5817448|P1|Overall Study|Death|2
1664162|NCT01528696|5817458|P2|Overall Study|See detailed description|19
1664163|NCT01528696|5817459|P1|Overall Study|See detailed description|18
1664164|NCT01528605|5817475|P6|Overall Study|Death|0
1664165|NCT01528605|5817476|P5|Overall Study|Death|0
1664166|NCT01528605|5817477|P4|Overall Study|Death|0
1664167|NCT01528605|5817478|P3|Overall Study|Death|0
1664168|NCT01528605|5817479|P2|Overall Study|Death|0
1664169|NCT01528605|5817480|P1|Overall Study|Death|1
1664170|NCT01528605|5817475|P6|Overall Study|Lost to Follow-up|0
1664171|NCT01528605|5817476|P5|Overall Study|Lost to Follow-up|0
1664172|NCT01528605|5817477|P4|Overall Study|Lost to Follow-up|1
1664173|NCT01528605|5817478|P3|Overall Study|Lost to Follow-up|1
1664174|NCT01528605|5817479|P2|Overall Study|Lost to Follow-up|0
1664175|NCT01528605|5817480|P1|Overall Study|Lost to Follow-up|1
1664176|NCT01528345|5817510|P2|Overall Study|Subject/Guardian Decision|0
1664177|NCT01528345|5817511|P1|Overall Study|Subject/Guardian Decision|5
1664178|NCT01528345|5817510|P2|Overall Study|Study Terminated by Sponsor|8
1664179|NCT01528345|5817511|P1|Overall Study|Study Terminated by Sponsor|4
1664180|NCT01528345|5817510|P2|Overall Study|Progressive Disease|40
1664181|NCT01528345|5817511|P1|Overall Study|Progressive Disease|26
1664182|NCT01528345|5817510|P2|Overall Study|Non-compliance with study treatment|0
1664183|NCT01528345|5817511|P1|Overall Study|Non-compliance with study treatment|1
1664184|NCT01528345|5817510|P2|Overall Study|Death|1
1664185|NCT01528345|5817511|P1|Overall Study|Death|1
1664186|NCT01528345|5817510|P2|Overall Study|Adverse Event|1
1664187|NCT01528345|5817511|P1|Overall Study|Adverse Event|10
1664188|NCT01528072|5817629|P1|Overall Study|Early Termination of Study|52
1664189|NCT01528072|5817629|P1|Overall Study|Death|2
1664190|NCT01528072|5817629|P1|Overall Study|Site Closure|4
1664191|NCT01528072|5817629|P1|Overall Study|Explanted|2
1664192|NCT01528072|5817629|P1|Overall Study|Lost to Follow-up|5
1664193|NCT01528072|5817629|P1|Overall Study|Missed Visit|2
1664194|NCT01528072|5817629|P1|Overall Study|Determined not eligible by AEAC|1
1664195|NCT01528072|5817629|P1|Overall Study|Physician Decision|1
1664196|NCT01528072|5817629|P1|Overall Study|Withdrawal by Subject|5
1664197|NCT01527682|5817646|P1|Overall Study|Protocol Violation|8
1664198|NCT01527500|5817669|P2|Part B|Adverse Event|0
1664199|NCT01527500|5817670|P1|Part B|Adverse Event|1
1664200|NCT01527500|5817669|P2|Part A|Withdrawal by Subject|0
1664201|NCT01527500|5817670|P1|Part A|Withdrawal by Subject|2
1664202|NCT01527500|5817669|P2|Part A|Protocol Deviation|2
1664203|NCT01527500|5817670|P1|Part A|Protocol Deviation|9
1664204|NCT01527500|5817669|P2|Part A|Lost to Follow-up|1
1664205|NCT01527500|5817670|P1|Part A|Lost to Follow-up|0
1664206|NCT01527500|5817669|P2|Part A|Death|1
1664207|NCT01527500|5817670|P1|Part A|Death|4
1664208|NCT01527500|5817669|P2|Part A|Adverse Event|2
1664209|NCT01527500|5817670|P1|Part A|Adverse Event|4
1664210|NCT01527500|5817669|P2|Part A|Administrative|7
1664211|NCT01527500|5817670|P1|Part A|Administrative|11
1664212|NCT01527487|5817700|P2|Overall Study|Death|1
1664213|NCT01527487|5817701|P1|Overall Study|Death|0
1664214|NCT01527487|5817700|P2|Overall Study|Adverse Event|1
1664215|NCT01527487|5817701|P1|Overall Study|Adverse Event|1
1664216|NCT01527487|5817700|P2|Overall Study|Disease Progression|1
1664217|NCT01527487|5817701|P1|Overall Study|Disease Progression|4
1664218|NCT01527487|5817700|P2|Overall Study|MD Discretion/Lack of Efficacy|4
1664219|NCT01527487|5817701|P1|Overall Study|MD Discretion/Lack of Efficacy|3
1664220|NCT01527383|5817715|P2|Overall Study|Withdrawal by Subject|3
1664221|NCT01527383|5817716|P1|Overall Study|Withdrawal by Subject|2
1664222|NCT01527383|5817715|P2|Overall Study|Participant moved|1
1664223|NCT01527383|5817716|P1|Overall Study|Participant moved|0
1664224|NCT01527383|5817715|P2|Overall Study|Screen failure|0
1664225|NCT01527383|5817716|P1|Overall Study|Screen failure|1
1664226|NCT01527383|5817715|P2|Overall Study|Protocol Violation|0
1664227|NCT01527383|5817716|P1|Overall Study|Protocol Violation|1
1664228|NCT01527383|5817715|P2|Overall Study|Pregnancy|0
1664229|NCT01527383|5817716|P1|Overall Study|Pregnancy|1
1664230|NCT01527383|5817715|P2|Overall Study|Physician Decision|0
1664231|NCT01527383|5817716|P1|Overall Study|Physician Decision|2
1664232|NCT01527383|5817715|P2|Overall Study|Lost to Follow-up|0
1664233|NCT01527383|5817716|P1|Overall Study|Lost to Follow-up|3
1664234|NCT01527383|5817715|P2|Overall Study|Adverse Event|0
1664235|NCT01527383|5817716|P1|Overall Study|Adverse Event|5
1664236|NCT01527370|5817730|P1|Overall Study|Death|1
1664237|NCT01527370|5817730|P1|Overall Study|Physician Decision|1
1664238|NCT01527370|5817730|P1|Overall Study|Withdrawal by Subject|4
1664239|NCT01527357|5817738|P2|Overall Study|Did Not Receive Treatment|0
1664240|NCT01527357|5817739|P1|Overall Study|Did Not Receive Treatment|2
1664241|NCT01527357|5817738|P2|Overall Study|No Day 29 Visit|1
1664242|NCT01527357|5817739|P1|Overall Study|No Day 29 Visit|0
1664243|NCT01527357|5817738|P2|Overall Study|Non-compliance|1
1664244|NCT01527357|5817739|P1|Overall Study|Non-compliance|0
1664245|NCT01527357|5817738|P2|Overall Study|Withdrew Consent|1
1664246|NCT01527357|5817739|P1|Overall Study|Withdrew Consent|1
1664247|NCT01527357|5817738|P2|Overall Study|Lost to Follow-up|4
1664248|NCT01527357|5817739|P1|Overall Study|Lost to Follow-up|6
1664249|NCT01527357|5817738|P2|Overall Study|Death|2
1664250|NCT01527357|5817739|P1|Overall Study|Death|8
1664251|NCT01527292|5817761|P2|Overall Study|Physician Decision|3
1664252|NCT01527292|5817762|P1|Overall Study|Physician Decision|0
1664253|NCT01527110|5817789|P1|Overall Study|Adverse Event|1
1664254|NCT01527006|5817870|P2|Extension Phase|Other|3
1664255|NCT01527006|5817871|P1|Extension Phase|Other|0
1664256|NCT01527006|5817870|P2|Extension Phase|Inadequate therapeutic effect|1
1664257|NCT01527006|5817871|P1|Extension Phase|Inadequate therapeutic effect|1
1664258|NCT01527006|5817870|P2|Extension Phase|Subject Choice|1
1664259|NCT01527006|5817871|P1|Extension Phase|Subject Choice|1
1664260|NCT01527006|5817870|P2|Extension Phase|Lost to Follow-up|1
1664261|NCT01527006|5817871|P1|Extension Phase|Lost to Follow-up|0
1664262|NCT01527006|5817870|P2|Extension Phase|Adverse Event|2
1664263|NCT01527006|5817871|P1|Extension Phase|Adverse Event|4
1664264|NCT01527006|5817870|P2|Core Study|Other|2
1664265|NCT01527006|5817871|P1|Core Study|Other|0
1664266|NCT01527006|5817870|P2|Core Study|Withdrawal by Subject|1
1664267|NCT01527006|5817871|P1|Core Study|Withdrawal by Subject|0
1664268|NCT01527006|5817870|P2|Core Study|Inadequate Therapeutic Effect|0
1664269|NCT01527006|5817871|P1|Core Study|Inadequate Therapeutic Effect|1
1664270|NCT01527006|5817870|P2|Core Study|Subject Choice|0
1664271|NCT01527006|5817871|P1|Core Study|Subject Choice|1
1664272|NCT01527006|5817870|P2|Core Study|Lost to Follow-up|1
1664273|NCT01527006|5817871|P1|Core Study|Lost to Follow-up|0
1664274|NCT01527006|5817870|P2|Core Study|Adverse Event|2
1664275|NCT01527006|5817871|P1|Core Study|Adverse Event|0
1664276|NCT01526928|5817927|P6|Overall Study|Missing|0
1664277|NCT01526928|5817928|P5|Overall Study|Missing|2
1664278|NCT01526928|5817929|P4|Overall Study|Missing|0
1664279|NCT01526928|5817930|P3|Overall Study|Missing|1
1664280|NCT01526928|5817931|P2|Overall Study|Missing|0
1664281|NCT01526928|5817932|P1|Overall Study|Missing|0
1664282|NCT01526928|5817927|P6|Overall Study|Protocol Deviation|0
1664283|NCT01526928|5817928|P5|Overall Study|Protocol Deviation|0
1664284|NCT01526928|5817929|P4|Overall Study|Protocol Deviation|2
1664285|NCT01526928|5817930|P3|Overall Study|Protocol Deviation|0
1664286|NCT01526928|5817931|P2|Overall Study|Protocol Deviation|0
1664287|NCT01526928|5817932|P1|Overall Study|Protocol Deviation|0
1664288|NCT01526928|5817927|P6|Overall Study|Lost to Follow-up|0
1664289|NCT01526928|5817928|P5|Overall Study|Lost to Follow-up|0
1664290|NCT01526928|5817929|P4|Overall Study|Lost to Follow-up|1
1664291|NCT01526928|5817930|P3|Overall Study|Lost to Follow-up|0
1664292|NCT01526928|5817931|P2|Overall Study|Lost to Follow-up|0
1664293|NCT01526928|5817932|P1|Overall Study|Lost to Follow-up|0
1664294|NCT01526928|5817927|P6|Overall Study|Other Reason|0
1664295|NCT01526928|5817928|P5|Overall Study|Other Reason|1
1664296|NCT01526928|5817929|P4|Overall Study|Other Reason|4
1664297|NCT01526928|5817930|P3|Overall Study|Other Reason|11
1664298|NCT01526928|5817931|P2|Overall Study|Other Reason|1
1664299|NCT01526928|5817932|P1|Overall Study|Other Reason|0
1664300|NCT01526928|5817927|P6|Overall Study|Physician Decision|0
1664301|NCT01526928|5817928|P5|Overall Study|Physician Decision|0
1664302|NCT01526928|5817929|P4|Overall Study|Physician Decision|5
1664303|NCT01526928|5817930|P3|Overall Study|Physician Decision|2
1664304|NCT01526928|5817931|P2|Overall Study|Physician Decision|0
1664305|NCT01526928|5817932|P1|Overall Study|Physician Decision|0
1664306|NCT01526928|5817927|P6|Overall Study|Withdrawal by Subject|0
1664307|NCT01526928|5817928|P5|Overall Study|Withdrawal by Subject|3
1664308|NCT01526928|5817929|P4|Overall Study|Withdrawal by Subject|11
1664309|NCT01526928|5817930|P3|Overall Study|Withdrawal by Subject|13
1664310|NCT01526928|5817931|P2|Overall Study|Withdrawal by Subject|0
1664311|NCT01526928|5817932|P1|Overall Study|Withdrawal by Subject|1
1664312|NCT01526928|5817927|P6|Overall Study|Death|0
1664313|NCT01526928|5817928|P5|Overall Study|Death|0
1664314|NCT01526928|5817929|P4|Overall Study|Death|0
1664315|NCT01526928|5817930|P3|Overall Study|Death|3
1664316|NCT01526928|5817931|P2|Overall Study|Death|0
1664317|NCT01526928|5817932|P1|Overall Study|Death|0
1664318|NCT01526928|5817927|P6|Overall Study|Adverse Event|2
1664319|NCT01526928|5817928|P5|Overall Study|Adverse Event|13
1664320|NCT01526928|5817929|P4|Overall Study|Adverse Event|40
1664321|NCT01526928|5817930|P3|Overall Study|Adverse Event|29
1664322|NCT01526928|5817931|P2|Overall Study|Adverse Event|1
1664323|NCT01526928|5817932|P1|Overall Study|Adverse Event|2
1664324|NCT01526928|5817927|P6|Overall Study|Progressive Disease|4
1664325|NCT01526928|5817928|P5|Overall Study|Progressive Disease|76
1664326|NCT01526928|5817929|P4|Overall Study|Progressive Disease|182
1664327|NCT01526928|5817930|P3|Overall Study|Progressive Disease|150
1664328|NCT01526928|5817931|P2|Overall Study|Progressive Disease|17
1664329|NCT01526928|5817932|P1|Overall Study|Progressive Disease|35
1664330|NCT01526889|5818070|P2|Treatment Extension Period|Administrative problems|0
1664331|NCT01526889|5818071|P1|Treatment Extension Period|Administrative problems|1
1664332|NCT01526889|5818070|P2|Treatment Period|Adverse Event|0
1664333|NCT01526889|5818071|P1|Treatment Period|Adverse Event|2
1664334|NCT01526785|5818092|P1|Overall Study|Withdrawal by Subject|2
1664335|NCT01526785|5818092|P1|Overall Study|Physician Decision|1
1664336|NCT01526785|5818092|P1|Overall Study|Death|2
1664337|NCT01526785|5818092|P1|Overall Study|Study Terminated by Sponsor|8
1664338|NCT01526733|5818102|P2|Phase 1|Withdrawal by Subject|1
1664339|NCT01526733|5818103|P1|Phase 1|Withdrawal by Subject|1
1664340|NCT01526733|5818102|P2|Phase 1|Protocol Violation|0
1664341|NCT01526733|5818103|P1|Phase 1|Protocol Violation|1
1664342|NCT01526551|5818142|P1|Overall Study|Lack of returned parental consent form|424
1664343|NCT01526148|5818189|P2|Overall Study|Incarcerated|2
1664344|NCT01526148|5818190|P1|Overall Study|Incarcerated|0
1664345|NCT01526148|5818189|P2|Overall Study|Moved out of state|0
1664346|NCT01526148|5818190|P1|Overall Study|Moved out of state|1
1664347|NCT01526148|5818189|P2|Overall Study|Unable to discontinue concomitant med|0
1664348|NCT01526148|5818190|P1|Overall Study|Unable to discontinue concomitant med|1
1664349|NCT01526148|5818189|P2|Overall Study|Unstable Medical Condition|0
1664350|NCT01526148|5818190|P1|Overall Study|Unstable Medical Condition|1
1664351|NCT01526148|5818189|P2|Overall Study|Withdrawal by Subject|0
1664352|NCT01526148|5818190|P1|Overall Study|Withdrawal by Subject|2
1664353|NCT01526148|5818189|P2|Overall Study|Lost to Follow-up|6
1664354|NCT01526148|5818190|P1|Overall Study|Lost to Follow-up|3
1664355|NCT01526148|5818189|P2|Overall Study|Adverse Event|5
1664356|NCT01526148|5818190|P1|Overall Study|Adverse Event|6
1664357|NCT01526057|5818201|P3|Overall Study|Protocol Violation|1
1664358|NCT01526057|5818202|P2|Overall Study|Protocol Violation|0
1664359|NCT01526057|5818203|P1|Overall Study|Protocol Violation|0
1664360|NCT01526057|5818201|P3|Overall Study|Other|1
1664361|NCT01526057|5818202|P2|Overall Study|Other|0
1664362|NCT01526057|5818203|P1|Overall Study|Other|1
1664363|NCT01526057|5818201|P3|Overall Study|Lost to Follow-up|1
1664364|NCT01526057|5818202|P2|Overall Study|Lost to Follow-up|0
1664365|NCT01526057|5818203|P1|Overall Study|Lost to Follow-up|1
1664366|NCT01526057|5818201|P3|Overall Study|Death|0
1664367|NCT01526057|5818202|P2|Overall Study|Death|0
1664368|NCT01526057|5818203|P1|Overall Study|Death|1
1664369|NCT01526057|5818201|P3|Overall Study|Adverse Event|1
1664370|NCT01526057|5818202|P2|Overall Study|Adverse Event|1
1664371|NCT01526057|5818203|P1|Overall Study|Adverse Event|3
1664372|NCT01526057|5818201|P3|Overall Study|Withdrawal by Subject|2
1664373|NCT01526057|5818202|P2|Overall Study|Withdrawal by Subject|2
1664374|NCT01526057|5818203|P1|Overall Study|Withdrawal by Subject|3
1664375|NCT01525875|5818302|P2|Open-label Period|Lost to Follow-up|2
1664376|NCT01525875|5818303|P1|Open-label Period|Lost to Follow-up|0
1664377|NCT01525875|5818302|P2|Placebo-controlled Period|Withdrawal by Subject|2
1664378|NCT01525875|5818303|P1|Placebo-controlled Period|Withdrawal by Subject|1
1664379|NCT01525849|5818319|P2|Overall Study|Anatomic exclusion criteria identified|3
1664380|NCT01525849|5818320|P1|Overall Study|Anatomic exclusion criteria identified|0
1664381|NCT01525849|5818319|P2|Overall Study|Unrelated medical issue (not treated)|2
1664382|NCT01525849|5818320|P1|Overall Study|Unrelated medical issue (not treated)|1
1664383|NCT01525849|5818319|P2|Overall Study|Withdrawal by Subject|9
1664384|NCT01525849|5818320|P1|Overall Study|Withdrawal by Subject|1
1664385|NCT01525849|5818319|P2|Overall Study|Lost to Follow-up|2
1664386|NCT01525849|5818320|P1|Overall Study|Lost to Follow-up|3
1664387|NCT01525641|5818376|P1|Overall Study|Other than stated above|7
1664388|NCT01525641|5818376|P1|Overall Study|Lost to follow-up (Changing hospital)|19
1664389|NCT01525641|5818376|P1|Overall Study|Lost to follow-up (Unknown reason)|10
1664390|NCT01525641|5818376|P1|Overall Study|Lost to follow-up (relocation)|1
1664391|NCT01525641|5818376|P1|Overall Study|Improvement|5
1664392|NCT01525641|5818376|P1|Overall Study|Lack of Efficacy|24
1664393|NCT01525641|5818376|P1|Overall Study|Adverse Event|73
1664394|NCT01525641|5818376|P1|Overall Study|No visit since the first visit|16
1664395|NCT01525641|5818376|P1|Overall Study|Case report form not collected|25
1664396|NCT01525628|5818390|P5|Overall Study|Other reason not defined above|0
1664397|NCT01525628|5818391|P4|Overall Study|Other reason not defined above|3
1664398|NCT01525628|5818392|P3|Overall Study|Other reason not defined above|0
1664399|NCT01525628|5818393|P2|Overall Study|Other reason not defined above|0
1664400|NCT01525628|5818394|P1|Overall Study|Other reason not defined above|0
1664401|NCT01525628|5818390|P5|Overall Study|Withdrawal by Subject|0
1664402|NCT01525628|5818391|P4|Overall Study|Withdrawal by Subject|0
1664403|NCT01525628|5818392|P3|Overall Study|Withdrawal by Subject|0
1664404|NCT01525628|5818393|P2|Overall Study|Withdrawal by Subject|1
1664405|NCT01525628|5818394|P1|Overall Study|Withdrawal by Subject|0
1664406|NCT01525628|5818390|P5|Overall Study|Lost to Follow-up|0
1664407|NCT01525628|5818391|P4|Overall Study|Lost to Follow-up|0
1664408|NCT01525628|5818392|P3|Overall Study|Lost to Follow-up|0
1664409|NCT01525628|5818393|P2|Overall Study|Lost to Follow-up|1
1664410|NCT01525628|5818394|P1|Overall Study|Lost to Follow-up|1
1664411|NCT01525628|5818390|P5|Overall Study|Protocol Violation|0
1664412|NCT01525628|5818391|P4|Overall Study|Protocol Violation|0
1664413|NCT01525628|5818392|P3|Overall Study|Protocol Violation|1
1664414|NCT01525628|5818393|P2|Overall Study|Protocol Violation|0
1664415|NCT01525628|5818394|P1|Overall Study|Protocol Violation|0
1664416|NCT01525628|5818390|P5|Overall Study|Lack of Efficacy|2
1664417|NCT01525628|5818391|P4|Overall Study|Lack of Efficacy|1
1664418|NCT01525628|5818392|P3|Overall Study|Lack of Efficacy|2
1664419|NCT01525628|5818393|P2|Overall Study|Lack of Efficacy|2
1664420|NCT01525628|5818394|P1|Overall Study|Lack of Efficacy|0
1664421|NCT01525628|5818390|P5|Overall Study|Adverse Event|1
1664422|NCT01525628|5818391|P4|Overall Study|Adverse Event|0
1664423|NCT01525628|5818392|P3|Overall Study|Adverse Event|2
1664424|NCT01525628|5818393|P2|Overall Study|Adverse Event|1
1664425|NCT01525628|5818394|P1|Overall Study|Adverse Event|1
1664426|NCT01525615|5818461|P3|Overall Study|Other reason not described above|1
1664427|NCT01525615|5818462|P2|Overall Study|Other reason not described above|0
1664428|NCT01525615|5818463|P1|Overall Study|Other reason not described above|1
1664429|NCT01525615|5818461|P3|Overall Study|Withdrawal by Subject|0
1664430|NCT01525615|5818462|P2|Overall Study|Withdrawal by Subject|0
1664431|NCT01525615|5818463|P1|Overall Study|Withdrawal by Subject|1
1664432|NCT01525615|5818461|P3|Overall Study|Lost to Follow-up|0
1664433|NCT01525615|5818462|P2|Overall Study|Lost to Follow-up|0
1664434|NCT01525615|5818463|P1|Overall Study|Lost to Follow-up|1
1664435|NCT01525615|5818461|P3|Overall Study|Adverse Event|5
1664436|NCT01525615|5818462|P2|Overall Study|Adverse Event|7
1664437|NCT01525615|5818463|P1|Overall Study|Adverse Event|11
1664438|NCT01525550|5818519|P2|Overall Study|Withdrawal by Subject|0
1664439|NCT01525550|5818520|P1|Overall Study|Withdrawal by Subject|4
1664440|NCT01525550|5818519|P2|Overall Study|Sponsor's Decision|11
1664441|NCT01525550|5818520|P1|Overall Study|Sponsor's Decision|30
1664442|NCT01525550|5818519|P2|Overall Study|Other|4
1664443|NCT01525550|5818520|P1|Overall Study|Other|0
1664444|NCT01525550|5818519|P2|Overall Study|Death|28
1664445|NCT01525550|5818520|P1|Overall Study|Death|19
1664446|NCT01525550|5818519|P2|Overall Study|Lost to Follow-up|2
1664447|NCT01525550|5818520|P1|Overall Study|Lost to Follow-up|8
1664448|NCT01525407|5818591|P2|Overall Study|Delay in Transplant|0
1664449|NCT01525407|5818592|P1|Overall Study|Delay in Transplant|1
1664450|NCT01525407|5818591|P2|Overall Study|Transplant was delayed|1
1664451|NCT01525407|5818592|P1|Overall Study|Transplant was delayed|0
1664452|NCT01525407|5818591|P2|Overall Study|Withdrawal by Subject|1
1664453|NCT01525407|5818592|P1|Overall Study|Withdrawal by Subject|0
1664454|NCT01525407|5818591|P2|Overall Study|Change in recipient treatment plan|2
1664455|NCT01525407|5818592|P1|Overall Study|Change in recipient treatment plan|2
1664456|NCT01525238|5818624|P3|Overall Study|Withdrawal by Subject|0
1664457|NCT01525238|5818625|P2|Overall Study|Withdrawal by Subject|0
1664458|NCT01525238|5818626|P1|Overall Study|Withdrawal by Subject|1
1664459|NCT01525225|5818691|P1|Enrollment|Other|1
1664460|NCT01525225|5818691|P1|Enrollment|No longer met study criteria|1
1664461|NCT01524991|5818705|P1|Overall Study|Symptomatic Deterioration|1
1664462|NCT01524991|5818705|P1|Overall Study|Withdrawal by Subject|2
1664463|NCT01524991|5818705|P1|Overall Study|Other complicating disease|1
1664464|NCT01524991|5818705|P1|Overall Study|Disease ProgressionDu|17
1664465|NCT01524991|5818705|P1|Overall Study|Death|1
1664466|NCT01524991|5818705|P1|Overall Study|Adverse Event|12
1664467|NCT01524978|5818723|P11|Overall Study|Death|17
1664468|NCT01524978|5818724|P10|Overall Study|Death|6
1664469|NCT01524978|5818725|P9|Overall Study|Death|5
1664470|NCT01524978|5818726|P8|Overall Study|Death|9
1664471|NCT01524978|5818727|P7|Overall Study|Death|1
1664472|NCT01524978|5818728|P6|Overall Study|Death|4
1664473|NCT01524978|5818729|P5|Overall Study|Death|4
1664474|NCT01524978|5818730|P4|Overall Study|Death|24
1664475|NCT01524978|5818731|P3|Overall Study|Death|5
1664476|NCT01524978|5818732|P2|Overall Study|Death|2
1664477|NCT01524978|5818733|P1|Overall Study|Death|34
1664478|NCT01524978|5818723|P11|Overall Study|Lost to Follow-up|1
1664479|NCT01524978|5818724|P10|Overall Study|Lost to Follow-up|1
1664480|NCT01524978|5818725|P9|Overall Study|Lost to Follow-up|1
1664481|NCT01524978|5818726|P8|Overall Study|Lost to Follow-up|0
1664482|NCT01524978|5818727|P7|Overall Study|Lost to Follow-up|2
1664483|NCT01524978|5818728|P6|Overall Study|Lost to Follow-up|1
1664484|NCT01524978|5818729|P5|Overall Study|Lost to Follow-up|1
1664485|NCT01524978|5818730|P4|Overall Study|Lost to Follow-up|0
1664486|NCT01524978|5818731|P3|Overall Study|Lost to Follow-up|3
1664487|NCT01524978|5818732|P2|Overall Study|Lost to Follow-up|0
1664488|NCT01524978|5818733|P1|Overall Study|Lost to Follow-up|0
1664489|NCT01524978|5818723|P11|Overall Study|Withdrawal by Subject|5
1664490|NCT01524978|5818724|P10|Overall Study|Withdrawal by Subject|0
1664491|NCT01524978|5818725|P9|Overall Study|Withdrawal by Subject|4
1664492|NCT01524978|5818726|P8|Overall Study|Withdrawal by Subject|2
1664493|NCT01524978|5818727|P7|Overall Study|Withdrawal by Subject|6
1664494|NCT01524978|5818728|P6|Overall Study|Withdrawal by Subject|1
1664495|NCT01524978|5818729|P5|Overall Study|Withdrawal by Subject|3
1664496|NCT01524978|5818730|P4|Overall Study|Withdrawal by Subject|1
1664497|NCT01524978|5818731|P3|Overall Study|Withdrawal by Subject|1
1664498|NCT01524978|5818732|P2|Overall Study|Withdrawal by Subject|0
1664499|NCT01524978|5818733|P1|Overall Study|Withdrawal by Subject|12
1664500|NCT01524978|5818723|P11|Overall Study|Other|5
1664501|NCT01524978|5818724|P10|Overall Study|Other|2
1664502|NCT01524978|5818725|P9|Overall Study|Other|2
1664503|NCT01524978|5818726|P8|Overall Study|Other|1
1664504|NCT01524978|5818727|P7|Overall Study|Other|17
1664505|NCT01524978|5818728|P6|Overall Study|Other|3
1664506|NCT01524978|5818729|P5|Overall Study|Other|1
1664507|NCT01524978|5818730|P4|Overall Study|Other|2
1664508|NCT01524978|5818731|P3|Overall Study|Other|1
1664509|NCT01524978|5818732|P2|Overall Study|Other|2
1664510|NCT01524978|5818733|P1|Overall Study|Other|16
1664511|NCT01524913|5818861|P3|Overall Study|Lost to Follow-up|0
1664512|NCT01524913|5818862|P2|Overall Study|Lost to Follow-up|0
1664513|NCT01524913|5818863|P1|Overall Study|Lost to Follow-up|4
1664514|NCT01524900|5818885|P5|Overall Study|No reason documented|0
1664515|NCT01524900|5818886|P4|Overall Study|No reason documented|1
1664516|NCT01524900|5818887|P3|Overall Study|No reason documented|0
1664517|NCT01524900|5818888|P2|Overall Study|No reason documented|1
1664518|NCT01524900|5818889|P1|Overall Study|No reason documented|2
1664519|NCT01524900|5818885|P5|Overall Study|Other reason than stated above|0
1664520|NCT01524900|5818886|P4|Overall Study|Other reason than stated above|0
1664521|NCT01524900|5818887|P3|Overall Study|Other reason than stated above|0
1664522|NCT01524900|5818888|P2|Overall Study|Other reason than stated above|1
1664523|NCT01524900|5818889|P1|Overall Study|Other reason than stated above|1
1664524|NCT01524900|5818885|P5|Overall Study|Lost to Follow-up|0
1664525|NCT01524900|5818886|P4|Overall Study|Lost to Follow-up|0
1664526|NCT01524900|5818887|P3|Overall Study|Lost to Follow-up|1
1664527|NCT01524900|5818888|P2|Overall Study|Lost to Follow-up|12
1664528|NCT01524900|5818889|P1|Overall Study|Lost to Follow-up|3
1664529|NCT01524887|5818934|P3|Overall Study|Use of prohibited medication|0
1664530|NCT01524887|5818935|P2|Overall Study|Use of prohibited medication|0
1664531|NCT01524887|5818936|P1|Overall Study|Use of prohibited medication|1
1664532|NCT01524887|5818934|P3|Overall Study|Withdrawal by Caregiver|2
1664533|NCT01524887|5818935|P2|Overall Study|Withdrawal by Caregiver|0
1664534|NCT01524887|5818936|P1|Overall Study|Withdrawal by Caregiver|0
1664535|NCT01524887|5818934|P3|Overall Study|Study termination|79
1664536|NCT01524887|5818935|P2|Overall Study|Study termination|87
1664537|NCT01524887|5818936|P1|Overall Study|Study termination|73
1664538|NCT01524887|5818934|P3|Overall Study|Protocol Violation|1
1664539|NCT01524887|5818935|P2|Overall Study|Protocol Violation|0
1664540|NCT01524887|5818936|P1|Overall Study|Protocol Violation|0
1664541|NCT01524887|5818934|P3|Overall Study|Adverse Event|1
1664542|NCT01524887|5818935|P2|Overall Study|Adverse Event|1
1664543|NCT01524887|5818936|P1|Overall Study|Adverse Event|5
1664544|NCT01524887|5818934|P3|Overall Study|Withdrawal by Subject|3
1664545|NCT01524887|5818935|P2|Overall Study|Withdrawal by Subject|2
1664546|NCT01524887|5818936|P1|Overall Study|Withdrawal by Subject|6
1664547|NCT01524796|5818980|P1|Overall Study|Adverse Event and Lack of Efficacy|1
1664548|NCT01524796|5818980|P1|Overall Study|Switch to carbamazapine|1
1664549|NCT01524796|5818980|P1|Overall Study|Nervous about confidentiality|1
1664550|NCT01524796|5818980|P1|Overall Study|Gall stone surgery|1
1664551|NCT01524796|5818980|P1|Overall Study|Deterioration of pains|1
1664552|NCT01524796|5818980|P1|Overall Study|Move|1
1664553|NCT01524796|5818980|P1|Overall Study|Withdrawal by Subject|4
1664554|NCT01524796|5818980|P1|Overall Study|The price|1
1664555|NCT01524796|5818980|P1|Overall Study|Lost to Follow-up|1
1664556|NCT01524796|5818980|P1|Overall Study|Lack of Efficacy|3
1664557|NCT01524796|5818980|P1|Overall Study|Adverse Event|13
1664558|NCT01524783|5818995|P2|Randomized and Treated|Death|1
1664559|NCT01524783|5818996|P1|Randomized and Treated|Death|4
1664560|NCT01524783|5818995|P2|Randomized and Treated|Protocol Violation|1
1664561|NCT01524783|5818996|P1|Randomized and Treated|Protocol Violation|1
1664562|NCT01524783|5818995|P2|Randomized and Treated|Withdrawal by Subject|5
1664563|NCT01524783|5818996|P1|Randomized and Treated|Withdrawal by Subject|15
1664564|NCT01524783|5818995|P2|Randomized and Treated|Disease Progression|70
1664565|NCT01524783|5818996|P1|Randomized and Treated|Disease Progression|76
1664566|NCT01524783|5818995|P2|Randomized and Treated|Adverse Event|7
1664567|NCT01524783|5818996|P1|Randomized and Treated|Adverse Event|59
1664568|NCT01524783|5818995|P2|Randomized But Not Treated|Randomized, did not receive drug|0
1664569|NCT01524783|5818996|P1|Randomized But Not Treated|Randomized, did not receive drug|2
1664570|NCT01524770|5819004|P2|First Intervention|Protocol Violation|0
1664571|NCT01524770|5819005|P1|First Intervention|Protocol Violation|1
1664572|NCT01524770|5819004|P2|First Intervention|Adverse Event|1
1664573|NCT01524770|5819005|P1|First Intervention|Adverse Event|1
1664574|NCT01524770|5819004|P2|First Intervention|Withdrawal by Subject|0
1664575|NCT01524770|5819005|P1|First Intervention|Withdrawal by Subject|1
1664576|NCT01524692|5819015|P1|Overall Study|Withdrawal by Subject|3
1664589|NCT01524627|5819038|P2|Overall Study|Lost to Follow-up|1
1664590|NCT01524627|5819039|P1|Overall Study|Lost to Follow-up|1
1664591|NCT01524627|5819038|P2|Overall Study|Physician Decision|1
1664592|NCT01524627|5819039|P1|Overall Study|Physician Decision|0
1664593|NCT01524289|5819066|P2|Overall Study|Did not take study medication|0
1664594|NCT01524289|5819067|P1|Overall Study|Did not take study medication|1
1664595|NCT01524289|5819066|P2|Overall Study|Adverse Event|5
1664596|NCT01524289|5819067|P1|Overall Study|Adverse Event|12
1664597|NCT01524289|5819066|P2|Overall Study|Withdrawal by Subject|7
1664598|NCT01524289|5819067|P1|Overall Study|Withdrawal by Subject|11
1664599|NCT01524289|5819066|P2|Overall Study|Protocol Violation|1
1664600|NCT01524289|5819067|P1|Overall Study|Protocol Violation|5
1664601|NCT01524289|5819066|P2|Overall Study|Physician Decision|0
1664602|NCT01524289|5819067|P1|Overall Study|Physician Decision|1
1664603|NCT01524289|5819066|P2|Overall Study|Lost to Follow-up|1
1664604|NCT01524289|5819067|P1|Overall Study|Lost to Follow-up|0
1664605|NCT01524224|5819125|P8|Overall Study|Sponsor Decision|0
1664606|NCT01524224|5819126|P7|Overall Study|Sponsor Decision|0
1664607|NCT01524224|5819127|P6|Overall Study|Sponsor Decision|0
1664608|NCT01524224|5819128|P5|Overall Study|Sponsor Decision|1
1664609|NCT01524224|5819129|P4|Overall Study|Sponsor Decision|0
1664610|NCT01524224|5819130|P3|Overall Study|Sponsor Decision|0
1664611|NCT01524224|5819131|P2|Overall Study|Sponsor Decision|0
1664612|NCT01524224|5819132|P1|Overall Study|Sponsor Decision|0
1664613|NCT01524224|5819125|P8|Overall Study|Physician Decision|1
1664614|NCT01524224|5819126|P7|Overall Study|Physician Decision|0
1664615|NCT01524224|5819127|P6|Overall Study|Physician Decision|0
1664616|NCT01524224|5819128|P5|Overall Study|Physician Decision|1
1664617|NCT01524224|5819129|P4|Overall Study|Physician Decision|1
1664618|NCT01524224|5819130|P3|Overall Study|Physician Decision|0
1664619|NCT01524224|5819131|P2|Overall Study|Physician Decision|0
1664620|NCT01524224|5819132|P1|Overall Study|Physician Decision|0
1664621|NCT01524224|5819125|P8|Overall Study|Adverse Event|0
1664622|NCT01524224|5819126|P7|Overall Study|Adverse Event|0
1664623|NCT01524224|5819127|P6|Overall Study|Adverse Event|1
1664624|NCT01524224|5819128|P5|Overall Study|Adverse Event|0
1664625|NCT01524224|5819129|P4|Overall Study|Adverse Event|0
1664626|NCT01524224|5819130|P3|Overall Study|Adverse Event|0
1664627|NCT01524224|5819131|P2|Overall Study|Adverse Event|1
1664628|NCT01524224|5819132|P1|Overall Study|Adverse Event|0
1664629|NCT01524224|5819125|P8|Overall Study|Withdrawal by Subject|0
1664630|NCT01524224|5819126|P7|Overall Study|Withdrawal by Subject|2
1664631|NCT01524224|5819127|P6|Overall Study|Withdrawal by Subject|0
1664632|NCT01524224|5819128|P5|Overall Study|Withdrawal by Subject|0
1664633|NCT01524224|5819129|P4|Overall Study|Withdrawal by Subject|0
1664634|NCT01524224|5819130|P3|Overall Study|Withdrawal by Subject|0
1664635|NCT01524224|5819131|P2|Overall Study|Withdrawal by Subject|0
1664636|NCT01524224|5819132|P1|Overall Study|Withdrawal by Subject|2
1664637|NCT01524224|5819125|P8|Overall Study|Progressive Disease|5
1664638|NCT01524224|5819126|P7|Overall Study|Progressive Disease|1
1664639|NCT01524224|5819127|P6|Overall Study|Progressive Disease|1
1664640|NCT01524224|5819128|P5|Overall Study|Progressive Disease|2
1664641|NCT01524224|5819129|P4|Overall Study|Progressive Disease|1
1664642|NCT01524224|5819130|P3|Overall Study|Progressive Disease|2
1664643|NCT01524224|5819131|P2|Overall Study|Progressive Disease|0
1664644|NCT01524224|5819132|P1|Overall Study|Progressive Disease|1
1664645|NCT01524198|5819168|P2|Overall Study|Withdrawal by Subject|10
1664646|NCT01524198|5819169|P1|Overall Study|Withdrawal by Subject|15
1664647|NCT01524198|5819168|P2|Overall Study|Protocol Violation|6
1664648|NCT01524198|5819169|P1|Overall Study|Protocol Violation|8
1664649|NCT01524133|5819180|P3|Overall Study 52 Weeks|Lost to Follow-up|15
1664650|NCT01524133|5819181|P2|Overall Study 52 Weeks|Lost to Follow-up|15
1664651|NCT01524133|5819182|P1|Overall Study 52 Weeks|Lost to Follow-up|16
1664652|NCT01524133|5819180|P3|Overall Study 52 Weeks|Physician Decision|2
1664653|NCT01524133|5819181|P2|Overall Study 52 Weeks|Physician Decision|0
1664654|NCT01524133|5819182|P1|Overall Study 52 Weeks|Physician Decision|1
1664655|NCT01524133|5819180|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
1664656|NCT01524133|5819181|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
1664657|NCT01524133|5819182|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
1664658|NCT01524133|5819180|P3|Treatment Phase|Lost to Follow-up|2
1664659|NCT01524133|5819181|P2|Treatment Phase|Lost to Follow-up|1
1664660|NCT01524133|5819182|P1|Treatment Phase|Lost to Follow-up|0
1664661|NCT01524133|5819180|P3|Treatment Phase|Physician Decision|3
1664662|NCT01524133|5819181|P2|Treatment Phase|Physician Decision|3
1664663|NCT01524133|5819182|P1|Treatment Phase|Physician Decision|6
1664664|NCT01524133|5819180|P3|Treatment Phase|Withdrawal by Subject|31
1664665|NCT01524133|5819181|P2|Treatment Phase|Withdrawal by Subject|28
1664666|NCT01524133|5819182|P1|Treatment Phase|Withdrawal by Subject|13
1664667|NCT01523886|5819225|P2|Overall Study|surgery cancelled|1
1664668|NCT01523886|5819226|P1|Overall Study|surgery cancelled|0
1664669|NCT01523873|5819232|P1|Overall Study|Protocol Violation|422
1664670|NCT01523756|5819327|P2|Test Period 2|Withdrawal by Subject|1
1664671|NCT01523756|5819328|P1|Test Period 2|Withdrawal by Subject|0
1664672|NCT01523756|5819327|P2|Test Period 1|Adverse Event|0
1664673|NCT01523756|5819328|P1|Test Period 1|Adverse Event|1
1664674|NCT01523756|5819327|P2|Baseline Period|Adverse Event|1
1664675|NCT01523756|5819328|P1|Baseline Period|Adverse Event|0
1664676|NCT01523743|5819336|P2|Period 2|Adverse Event|0
1664677|NCT01523743|5819337|P1|Period 2|Adverse Event|1
1664678|NCT01523743|5819336|P2|Period 2|Withdrawal by Subject|2
1664679|NCT01523743|5819337|P1|Period 2|Withdrawal by Subject|0
1664680|NCT01523743|5819336|P2|Period 1|Felt unable to empty bladder|0
1664681|NCT01523743|5819337|P1|Period 1|Felt unable to empty bladder|1
1664682|NCT01523743|5819336|P2|Period 1|Lack of Efficacy|0
1664683|NCT01523743|5819337|P1|Period 1|Lack of Efficacy|1
1664684|NCT01523743|5819336|P2|Period 1|Lost to Follow-up|0
1664685|NCT01523743|5819337|P1|Period 1|Lost to Follow-up|1
1664686|NCT01523743|5819336|P2|Period 1|Withdrawal by Subject|2
1664687|NCT01523743|5819337|P1|Period 1|Withdrawal by Subject|6
1664688|NCT01523743|5819336|P2|Period 1|Adverse Event|0
1664689|NCT01523743|5819337|P1|Period 1|Adverse Event|1
1664690|NCT01523587|5819360|P2|Overall Study|Randomised but bot treated|2
1664691|NCT01523587|5819361|P1|Overall Study|Randomised but bot treated|6
1664692|NCT01523587|5819360|P2|Overall Study|Withdrew due to Progressive disease|279
1664693|NCT01523587|5819361|P1|Overall Study|Withdrew due to Progressive disease|265
1664694|NCT01523587|5819360|P2|Overall Study|Withdrawal by Subject|20
1664695|NCT01523587|5819361|P1|Overall Study|Withdrawal by Subject|28
1664696|NCT01523587|5819360|P2|Overall Study|Lost to Follow-up|2
1664697|NCT01523587|5819361|P1|Overall Study|Lost to Follow-up|2
1664698|NCT01523587|5819360|P2|Overall Study|Protocol Violation|3
1664699|NCT01523587|5819361|P1|Overall Study|Protocol Violation|5
1664700|NCT01523587|5819360|P2|Overall Study|Adverse Event|52
1664701|NCT01523587|5819361|P1|Overall Study|Adverse Event|68
1664702|NCT01523587|5819360|P2|Overall Study|Worsening of underlying cancer disease|34
1664703|NCT01523587|5819361|P1|Overall Study|Worsening of underlying cancer disease|19
1664704|NCT01523587|5819360|P2|Overall Study|Other than listed|5
1664705|NCT01523587|5819361|P1|Overall Study|Other than listed|5
1664706|NCT01523457|5819404|P2|Overall Study|Withdrawal by Subject|2
1664707|NCT01523457|5819405|P1|Overall Study|Withdrawal by Subject|7
1664708|NCT01523392|5819423|P2|Washout Period - 10 to 14 Days|Adverse Event|0
1664709|NCT01523392|5819424|P1|Washout Period - 10 to 14 Days|Adverse Event|1
1664710|NCT01523392|5819423|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
1664711|NCT01523392|5819424|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
1664712|NCT01523392|5819423|P2|Treatment Period 1|Withdrawal by Subject|0
1664713|NCT01523392|5819424|P1|Treatment Period 1|Withdrawal by Subject|2
1664714|NCT01523366|5819440|P2|Treatment Period 2|Not completed at least 7 days treatment|0
1664715|NCT01523366|5819441|P1|Treatment Period 2|Not completed at least 7 days treatment|1
1664716|NCT01523366|5819440|P2|Treatment Period 1|Withdrawal by Subject|0
1664717|NCT01523366|5819441|P1|Treatment Period 1|Withdrawal by Subject|1
1664718|NCT01523301|5819457|P2|Overall Study|Other Reason|2
1664719|NCT01523301|5819458|P1|Overall Study|Other Reason|0
1664720|NCT01523301|5819457|P2|Overall Study|Withdrawal by Subject|8
1664721|NCT01523301|5819458|P1|Overall Study|Withdrawal by Subject|6
1664722|NCT01523301|5819457|P2|Overall Study|Lost to Follow-up|0
1664723|NCT01523301|5819458|P1|Overall Study|Lost to Follow-up|1
1664724|NCT01523301|5819457|P2|Overall Study|Protocol Violation|4
1664725|NCT01523301|5819458|P1|Overall Study|Protocol Violation|3
1664726|NCT01523301|5819457|P2|Overall Study|Lack of Efficacy|2
1664727|NCT01523301|5819458|P1|Overall Study|Lack of Efficacy|0
1664728|NCT01523301|5819457|P2|Overall Study|Adverse Event|16
1664729|NCT01523301|5819458|P1|Overall Study|Adverse Event|25
1664730|NCT01523275|5819478|P2|Overall Study|Withdrawal by Subject|0
1664731|NCT01523275|5819479|P1|Overall Study|Withdrawal by Subject|1
1664732|NCT01523275|5819478|P2|Overall Study|Lost to Follow-up|2
1664733|NCT01523275|5819479|P1|Overall Study|Lost to Follow-up|1
1664734|NCT01522976|5819492|P3|Overall Study|Not protocol specified|27
1664735|NCT01522976|5819493|P2|Overall Study|Not protocol specified|27
1664736|NCT01522976|5819494|P1|Overall Study|Not protocol specified|22
1664737|NCT01522976|5819492|P3|Overall Study|Refusal unrelated to adverse event|14
1664738|NCT01522976|5819493|P2|Overall Study|Refusal unrelated to adverse event|13
1664739|NCT01522976|5819494|P1|Overall Study|Refusal unrelated to adverse event|10
1664740|NCT01522976|5819492|P3|Overall Study|Adverse Event|18
1664741|NCT01522976|5819493|P2|Overall Study|Adverse Event|7
1664742|NCT01522976|5819494|P1|Overall Study|Adverse Event|17
1664743|NCT01522976|5819492|P3|Overall Study|Disease progression|25
1664744|NCT01522976|5819493|P2|Overall Study|Disease progression|30
1664745|NCT01522976|5819494|P1|Overall Study|Disease progression|28
1664746|NCT01522976|5819492|P3|Overall Study|Still on treatment|6
1664747|NCT01522976|5819493|P2|Overall Study|Still on treatment|9
1664748|NCT01522976|5819494|P1|Overall Study|Still on treatment|9
1664749|NCT01522976|5819492|P3|Overall Study|Death|2
1664750|NCT01522976|5819493|P2|Overall Study|Death|6
1664751|NCT01522976|5819494|P1|Overall Study|Death|7
1664752|NCT01522976|5819492|P3|Overall Study|Ineligible|1
1664753|NCT01522976|5819493|P2|Overall Study|Ineligible|0
1664754|NCT01522976|5819494|P1|Overall Study|Ineligible|4
1664755|NCT01522950|5819539|P3|Overall Study|Study Medication Sensitivity|0
1664756|NCT01522950|5819540|P2|Overall Study|Study Medication Sensitivity|1
1664757|NCT01522950|5819541|P1|Overall Study|Study Medication Sensitivity|0
1664758|NCT01522950|5819539|P3|Overall Study|Death|1
1664759|NCT01522950|5819540|P2|Overall Study|Death|1
1664760|NCT01522950|5819541|P1|Overall Study|Death|0
1664761|NCT01522950|5819539|P3|Overall Study|Protocol Violation|2
1664762|NCT01522950|5819540|P2|Overall Study|Protocol Violation|0
1664763|NCT01522950|5819541|P1|Overall Study|Protocol Violation|0
1664764|NCT01522950|5819539|P3|Overall Study|Adverse Event|1
1664765|NCT01522950|5819540|P2|Overall Study|Adverse Event|1
1664766|NCT01522950|5819541|P1|Overall Study|Adverse Event|3
1664767|NCT01522950|5819539|P3|Overall Study|Withdrawal by Subject|1
1664768|NCT01522950|5819540|P2|Overall Study|Withdrawal by Subject|2
1664769|NCT01522950|5819541|P1|Overall Study|Withdrawal by Subject|3
1664770|NCT01522456|5819604|P1|Overall Study|Tolerability Assessment|1
1664771|NCT01522456|5819604|P1|Overall Study|Pregnancy|1
1664772|NCT01522456|5819604|P1|Overall Study|Withdrawal by Subject|2
1664773|NCT01522456|5819604|P1|Overall Study|Lost to Follow-up|2
1664774|NCT01522456|5819604|P1|Overall Study|Adverse Event|2
1664775|NCT01522443|5819667|P2|Overall Study|Other|3
1664776|NCT01522443|5819668|P1|Overall Study|Other|1
1664777|NCT01522443|5819667|P2|Overall Study|No study treatment given|1
1664778|NCT01522443|5819668|P1|Overall Study|No study treatment given|1
1664779|NCT01522443|5819667|P2|Overall Study|Withdrawal by Subject|8
1664780|NCT01522443|5819668|P1|Overall Study|Withdrawal by Subject|5
1664781|NCT01522443|5819667|P2|Overall Study|Adverse Event|15
1664782|NCT01522443|5819668|P1|Overall Study|Adverse Event|10
1664783|NCT01522443|5819667|P2|Overall Study|No longer receiving clinical benefit|28
1664784|NCT01522443|5819668|P1|Overall Study|No longer receiving clinical benefit|36
1664785|NCT01522404|5819680|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
1664786|NCT01522404|5819681|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
1664787|NCT01522404|5819680|P2|First Intervention (up to Week 29)|Adverse Event|0
1664788|NCT01522404|5819681|P1|First Intervention (up to Week 29)|Adverse Event|1
1664789|NCT01522404|5819680|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
1664790|NCT01522404|5819681|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
1664791|NCT01522248|5819767|P2|Overall Study|Lost to Follow-up|0
1664792|NCT01522248|5819768|P1|Overall Study|Lost to Follow-up|1
1664793|NCT01522235|5819783|P2|Overall Study|Physician Decision|1
1664794|NCT01522235|5819784|P1|Overall Study|Physician Decision|1
1664795|NCT01521923|5819820|P4|Overall Study|AE, captured in Period 1|1
1664796|NCT01521923|5819821|P3|Overall Study|AE, captured in Period 1|0
1664797|NCT01521923|5819822|P2|Overall Study|AE, captured in Period 1|1
1664798|NCT01521923|5819823|P1|Overall Study|AE, captured in Period 1|0
1664799|NCT01521923|5819820|P4|Overall Study|Other|6
1664800|NCT01521923|5819821|P3|Overall Study|Other|3
1664801|NCT01521923|5819822|P2|Overall Study|Other|1
1664802|NCT01521923|5819823|P1|Overall Study|Other|2
1664803|NCT01521923|5819820|P4|Overall Study|Withdrawal by Subject|2
1664804|NCT01521923|5819821|P3|Overall Study|Withdrawal by Subject|1
1664805|NCT01521923|5819822|P2|Overall Study|Withdrawal by Subject|1
1664806|NCT01521923|5819823|P1|Overall Study|Withdrawal by Subject|1
1664807|NCT01521923|5819820|P4|Overall Study|Lost to Follow-up|1
1664808|NCT01521923|5819821|P3|Overall Study|Lost to Follow-up|2
1664809|NCT01521923|5819822|P2|Overall Study|Lost to Follow-up|0
1664810|NCT01521923|5819823|P1|Overall Study|Lost to Follow-up|1
1664811|NCT01521923|5819820|P4|Overall Study|Protocol Violation|0
1664812|NCT01521923|5819821|P3|Overall Study|Protocol Violation|1
1664813|NCT01521923|5819822|P2|Overall Study|Protocol Violation|0
1664814|NCT01521923|5819823|P1|Overall Study|Protocol Violation|0
1664815|NCT01521923|5819820|P4|Overall Study|Lack of Efficacy|0
1664816|NCT01521923|5819821|P3|Overall Study|Lack of Efficacy|0
1664817|NCT01521923|5819822|P2|Overall Study|Lack of Efficacy|1
1664818|NCT01521923|5819823|P1|Overall Study|Lack of Efficacy|1
1664819|NCT01521923|5819820|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
1664820|NCT01521923|5819821|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1664821|NCT01521923|5819822|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1664822|NCT01521923|5819823|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
1664823|NCT01521923|5819820|P4|Overall Study|AE, non-serious, non-fatal|2
1664824|NCT01521923|5819821|P3|Overall Study|AE, non-serious, non-fatal|6
1664825|NCT01521923|5819822|P2|Overall Study|AE, non-serious, non-fatal|3
1664826|NCT01521923|5819823|P1|Overall Study|AE, non-serious, non-fatal|1
1664827|NCT01521923|5819820|P4|Overall Study|SAE, non-fatal|0
1664828|NCT01521923|5819821|P3|Overall Study|SAE, non-fatal|2
1664829|NCT01521923|5819822|P2|Overall Study|SAE, non-fatal|2
1664830|NCT01521923|5819823|P1|Overall Study|SAE, non-fatal|0
1664831|NCT01521923|5819820|P4|Overall Study|AE, serious fatal|0
1664832|NCT01521923|5819821|P3|Overall Study|AE, serious fatal|0
1664833|NCT01521923|5819822|P2|Overall Study|AE, serious fatal|0
1664834|NCT01521923|5819823|P1|Overall Study|AE, serious fatal|1
1664835|NCT01521897|5819943|P1|Overall Study|Lost to Follow-up|5
1664836|NCT01521897|5819943|P1|Overall Study|Protocol Violation|18
1664837|NCT01521884|5819955|P1|Overall Study|Lost to Follow-up|4
1664838|NCT01521884|5819955|P1|Overall Study|Participant non-eligible|1
1664839|NCT01521884|5819955|P1|Overall Study|Protocol Violation|3
1664840|NCT01521884|5819955|P1|Overall Study|Physician Decision|2
1664841|NCT01521884|5819955|P1|Overall Study|Withdrawal by Subject|1
1664842|NCT01521884|5819955|P1|Overall Study|Pregnancy|1
1664843|NCT01521884|5819955|P1|Overall Study|Adverse Event|5
1664844|NCT01521884|5819955|P1|Overall Study|Non Responders|10
1664845|NCT01521559|5820052|P2|Overall Study|Other|2
1664846|NCT01521559|5820053|P1|Overall Study|Other|1
1664847|NCT01521559|5820052|P2|Overall Study|Protocol Violation|0
1664848|NCT01521559|5820053|P1|Overall Study|Protocol Violation|1
1664849|NCT01521559|5820052|P2|Overall Study|Lost to Follow-up|1
1664850|NCT01521559|5820053|P1|Overall Study|Lost to Follow-up|3
1664851|NCT01521559|5820052|P2|Overall Study|Withdrawal by Subject|11
1664852|NCT01521559|5820053|P1|Overall Study|Withdrawal by Subject|9
1664853|NCT01521559|5820052|P2|Overall Study|Death|0
1664854|NCT01521559|5820053|P1|Overall Study|Death|1
1664855|NCT01521559|5820052|P2|Overall Study|Adverse Event|4
1664856|NCT01521559|5820053|P1|Overall Study|Adverse Event|0
1664857|NCT01521507|5820076|P2|Stage 2: Observational Design|Physician Decision|0
1664858|NCT01521507|5820077|P1|Stage 2: Observational Design|Physician Decision|1
1664859|NCT01521507|5820076|P2|Stage 2: Observational Design|Withdrawal by Subject|1
1664860|NCT01521507|5820077|P1|Stage 2: Observational Design|Withdrawal by Subject|3
1664861|NCT01521507|5820076|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
1664862|NCT01521507|5820077|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
1664863|NCT01521507|5820076|P2|Stage 1: Randomized Design|Lost to Follow-up|2
1664864|NCT01521507|5820077|P1|Stage 1: Randomized Design|Lost to Follow-up|0
1664865|NCT01521507|5820076|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
1664866|NCT01521507|5820077|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
1664867|NCT01521507|5820076|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
1664868|NCT01521507|5820077|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
1664869|NCT01521494|5820099|P5|Overall Study|Physician Decision|2
1664870|NCT01521494|5820100|P4|Overall Study|Physician Decision|0
1664871|NCT01521494|5820101|P3|Overall Study|Physician Decision|0
1664872|NCT01521494|5820102|P2|Overall Study|Physician Decision|0
1664873|NCT01521494|5820103|P1|Overall Study|Physician Decision|0
1664874|NCT01521494|5820099|P5|Overall Study|Decrease in serum calcium|1
1664875|NCT01521494|5820100|P4|Overall Study|Decrease in serum calcium|1
1664876|NCT01521494|5820101|P3|Overall Study|Decrease in serum calcium|0
1664877|NCT01521494|5820102|P2|Overall Study|Decrease in serum calcium|0
1664878|NCT01521494|5820103|P1|Overall Study|Decrease in serum calcium|0
1664879|NCT01521494|5820099|P5|Overall Study|Decrease in serum phosphate|0
1664880|NCT01521494|5820100|P4|Overall Study|Decrease in serum phosphate|12
1664881|NCT01521494|5820101|P3|Overall Study|Decrease in serum phosphate|3
1664882|NCT01521494|5820102|P2|Overall Study|Decrease in serum phosphate|2
1664883|NCT01521494|5820103|P1|Overall Study|Decrease in serum phosphate|0
1664884|NCT01521494|5820099|P5|Overall Study|Withdrawal by Subject|0
1664885|NCT01521494|5820100|P4|Overall Study|Withdrawal by Subject|2
1664886|NCT01521494|5820101|P3|Overall Study|Withdrawal by Subject|0
1664887|NCT01521494|5820102|P2|Overall Study|Withdrawal by Subject|1
1664888|NCT01521494|5820103|P1|Overall Study|Withdrawal by Subject|1
1664889|NCT01521494|5820099|P5|Overall Study|Lack of Efficacy|2
1664890|NCT01521494|5820100|P4|Overall Study|Lack of Efficacy|0
1664891|NCT01521494|5820101|P3|Overall Study|Lack of Efficacy|0
1664892|NCT01521494|5820102|P2|Overall Study|Lack of Efficacy|0
1664893|NCT01521494|5820103|P1|Overall Study|Lack of Efficacy|0
1664894|NCT01521494|5820099|P5|Overall Study|Adverse Event|2
1664895|NCT01521494|5820100|P4|Overall Study|Adverse Event|6
1664896|NCT01521494|5820101|P3|Overall Study|Adverse Event|9
1664897|NCT01521494|5820102|P2|Overall Study|Adverse Event|2
1664898|NCT01521494|5820103|P1|Overall Study|Adverse Event|1
1664899|NCT01521364|5820125|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
1664900|NCT01521364|5820125|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
1664901|NCT01520987|5820201|P8|Overall Study|Withdrawal by Subject|0
1664902|NCT01520987|5820202|P7|Overall Study|Withdrawal by Subject|0
1664903|NCT01520987|5820203|P6|Overall Study|Withdrawal by Subject|1
1664904|NCT01520987|5820204|P5|Overall Study|Withdrawal by Subject|0
1664905|NCT01520987|5820205|P4|Overall Study|Withdrawal by Subject|0
1664906|NCT01520987|5820206|P3|Overall Study|Withdrawal by Subject|0
1664907|NCT01520987|5820207|P2|Overall Study|Withdrawal by Subject|0
1664908|NCT01520987|5820208|P1|Overall Study|Withdrawal by Subject|1
1664909|NCT01520922|5820268|P2|Survival Follow-up|Withdrawal by Subject|0
1664910|NCT01520922|5820269|P1|Survival Follow-up|Withdrawal by Subject|1
1664911|NCT01520922|5820268|P2|Follow up|Lost to Follow-up|1
1664912|NCT01520922|5820269|P1|Follow up|Lost to Follow-up|0
1664913|NCT01520922|5820268|P2|Treatment Phase|Adverse Event|5
1664914|NCT01520922|5820269|P1|Treatment Phase|Adverse Event|3
1664915|NCT01520922|5820268|P2|Treatment Phase|Progression|2
1664916|NCT01520922|5820269|P1|Treatment Phase|Progression|0
1664917|NCT01520922|5820268|P2|Treatment Phase|Physician Decision|1
1664918|NCT01520922|5820269|P1|Treatment Phase|Physician Decision|2
1664919|NCT01520909|5820331|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
1664920|NCT01520909|5820332|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1664921|NCT01520909|5820333|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
1664922|NCT01520909|5820331|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
1664923|NCT01520909|5820332|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1664924|NCT01520909|5820333|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
1664925|NCT01520909|5820331|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
1664926|NCT01520909|5820332|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1664927|NCT01520909|5820333|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
1664928|NCT01520909|5820331|P3|Part 1 (Randomized Period)|Adverse Event|0
1664929|NCT01520909|5820332|P2|Part 1 (Randomized Period)|Adverse Event|2
1664930|NCT01520909|5820333|P1|Part 1 (Randomized Period)|Adverse Event|1
1664931|NCT01520714|5820450|P2|Overall Study|Lack of Efficacy|1
1664932|NCT01520714|5820451|P1|Overall Study|Lack of Efficacy|0
1664933|NCT01520714|5820450|P2|Overall Study|Adverse Event|2
1664934|NCT01520714|5820451|P1|Overall Study|Adverse Event|0
1664935|NCT01520714|5820450|P2|Overall Study|Protocol Violation|3
1664936|NCT01520714|5820451|P1|Overall Study|Protocol Violation|0
1664937|NCT01520506|5820481|P1|Overall Study|Withdrawal by Subject|1
1664938|NCT01520506|5820481|P1|Overall Study|Lost to Follow-up|1
1664939|NCT01520506|5820481|P1|Overall Study|Missed Visit|4
1664940|NCT01520402|5820536|P1|Overall Study|Physician Decision|3
1664941|NCT01520402|5820536|P1|Overall Study|Withdrawal by Subject|2
1664942|NCT01520363|5820549|P2|Overall Study|Withdrawal by Subject|0
1664943|NCT01520363|5820550|P1|Overall Study|Withdrawal by Subject|2
1664944|NCT01520324|5820624|P1|Overall Study|Subject discontinued (moderate illness)|1
1664945|NCT01519960|5820653|P3|Overall Study|Lost to Follow-up|0
1664946|NCT01519960|5820654|P2|Overall Study|Lost to Follow-up|1
1664947|NCT01519960|5820655|P1|Overall Study|Lost to Follow-up|0
1664948|NCT01519960|5820653|P3|Overall Study|Withdrawal by Subject|0
1664949|NCT01519960|5820654|P2|Overall Study|Withdrawal by Subject|4
1664950|NCT01519960|5820655|P1|Overall Study|Withdrawal by Subject|0
1664951|NCT01519960|5820653|P3|Overall Study|Adverse Event|0
1664952|NCT01519960|5820654|P2|Overall Study|Adverse Event|1
1664953|NCT01519960|5820655|P1|Overall Study|Adverse Event|0
1664954|NCT01519960|5820653|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
1664955|NCT01519960|5820654|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
1664956|NCT01519960|5820655|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
1664957|NCT01519960|5820653|P3|Overall Study|Ongoing in Follow-Up|10
1664958|NCT01519960|5820654|P2|Overall Study|Ongoing in Follow-Up|11
1664959|NCT01519960|5820655|P1|Overall Study|Ongoing in Follow-Up|101
1664960|NCT01519947|5820765|P4|Overall Study|Adverse Event|1
1664961|NCT01519947|5820766|P3|Overall Study|Adverse Event|1
1664962|NCT01519947|5820767|P2|Overall Study|Adverse Event|0
1664963|NCT01519947|5820768|P1|Overall Study|Adverse Event|1
1664964|NCT01519947|5820765|P4|Overall Study|Poor Response|1
1664965|NCT01519947|5820766|P3|Overall Study|Poor Response|0
1664966|NCT01519947|5820767|P2|Overall Study|Poor Response|0
1664967|NCT01519947|5820768|P1|Overall Study|Poor Response|1
1664968|NCT01519947|5820765|P4|Overall Study|Lost to Follow-up|2
1664969|NCT01519947|5820766|P3|Overall Study|Lost to Follow-up|3
1664970|NCT01519947|5820767|P2|Overall Study|Lost to Follow-up|0
1664971|NCT01519947|5820768|P1|Overall Study|Lost to Follow-up|0
1664972|NCT01519947|5820765|P4|Overall Study|Withdrawal by Subject|1
1664973|NCT01519947|5820766|P3|Overall Study|Withdrawal by Subject|0
1664974|NCT01519947|5820767|P2|Overall Study|Withdrawal by Subject|1
1664975|NCT01519947|5820768|P1|Overall Study|Withdrawal by Subject|0
1664976|NCT01519947|5820765|P4|Overall Study|Blood Transfusion|0
1664977|NCT01519947|5820766|P3|Overall Study|Blood Transfusion|1
1664978|NCT01519947|5820767|P2|Overall Study|Blood Transfusion|1
1664979|NCT01519947|5820768|P1|Overall Study|Blood Transfusion|0
1664980|NCT01519947|5820765|P4|Overall Study|Development of Anemia|1
1664981|NCT01519947|5820766|P3|Overall Study|Development of Anemia|0
1664982|NCT01519947|5820767|P2|Overall Study|Development of Anemia|1
1664983|NCT01519947|5820768|P1|Overall Study|Development of Anemia|0
1664984|NCT01519947|5820765|P4|Overall Study|Peritoneal Dialysis Needed|0
1664985|NCT01519947|5820766|P3|Overall Study|Peritoneal Dialysis Needed|0
1664986|NCT01519947|5820767|P2|Overall Study|Peritoneal Dialysis Needed|1
1664987|NCT01519947|5820768|P1|Overall Study|Peritoneal Dialysis Needed|0
1664988|NCT01519947|5820765|P4|Overall Study|Protocol Violation|1
1664989|NCT01519947|5820766|P3|Overall Study|Protocol Violation|2
1664990|NCT01519947|5820767|P2|Overall Study|Protocol Violation|0
1664991|NCT01519947|5820768|P1|Overall Study|Protocol Violation|0
1664992|NCT01519947|5820765|P4|Overall Study|Death|1
1664993|NCT01519947|5820766|P3|Overall Study|Death|0
1664994|NCT01519947|5820767|P2|Overall Study|Death|0
1664995|NCT01519947|5820768|P1|Overall Study|Death|0
1664996|NCT01519934|5820798|P1|Overall Study|Lost to Follow-up|3
1664997|NCT01519921|5820807|P2|Overall Study|High alanine aminotransferase (ALT)|1
1664998|NCT01519921|5820808|P1|Overall Study|High alanine aminotransferase (ALT)|0
1664999|NCT01519921|5820807|P2|Overall Study|Treatment refusal|1
1665000|NCT01519921|5820808|P1|Overall Study|Treatment refusal|2
1665001|NCT01519921|5820807|P2|Overall Study|Lost to Follow-up|1
1665002|NCT01519921|5820808|P1|Overall Study|Lost to Follow-up|2
1665003|NCT01519921|5820807|P2|Overall Study|Withdrawal by Subject|0
1665004|NCT01519921|5820808|P1|Overall Study|Withdrawal by Subject|3
1665005|NCT01519921|5820807|P2|Overall Study|Lack of Efficacy|3
1665006|NCT01519921|5820808|P1|Overall Study|Lack of Efficacy|4
1665007|NCT01519921|5820807|P2|Overall Study|Adverse Event|9
1665008|NCT01519921|5820808|P1|Overall Study|Adverse Event|10
1665009|NCT01519817|5820857|P4|Overall Study|Off study due to infection|1
1665010|NCT01519817|5820858|P3|Overall Study|Off study due to infection|0
1665011|NCT01519817|5820859|P2|Overall Study|Off study due to infection|0
1665012|NCT01519817|5820860|P1|Overall Study|Off study due to infection|0
1665013|NCT01519817|5820857|P4|Overall Study|Withdrawal by Subject|0
1665014|NCT01519817|5820858|P3|Overall Study|Withdrawal by Subject|0
1665015|NCT01519817|5820859|P2|Overall Study|Withdrawal by Subject|0
1665016|NCT01519817|5820860|P1|Overall Study|Withdrawal by Subject|1
1665017|NCT01519791|5820900|P2|Overall Study|Lost to Follow-up|14
1665018|NCT01519791|5820901|P1|Overall Study|Lost to Follow-up|6
1665019|NCT01519791|5820900|P2|Overall Study|Withdrawal by Subject|37
1665020|NCT01519791|5820901|P1|Overall Study|Withdrawal by Subject|15
1665021|NCT01519791|5820900|P2|Overall Study|AE, non-serious non-fatal|31
1665022|NCT01519791|5820901|P1|Overall Study|AE, non-serious non-fatal|12
1665023|NCT01519791|5820900|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
1665024|NCT01519791|5820901|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
1665025|NCT01519791|5820900|P2|Overall Study|AE, serious fatal|1
1665026|NCT01519791|5820901|P1|Overall Study|AE, serious fatal|0
1665027|NCT01519791|5820900|P2|Overall Study|SAE, non-fatal|22
1665028|NCT01519791|5820901|P1|Overall Study|SAE, non-fatal|6
1665029|NCT01519791|5820900|P2|Overall Study|Lack of Efficacy|20
1665030|NCT01519791|5820901|P1|Overall Study|Lack of Efficacy|16
1665031|NCT01519791|5820900|P2|Overall Study|subjects randomized in error|0
1665032|NCT01519791|5820901|P1|Overall Study|subjects randomized in error|2
1665033|NCT01519791|5820900|P2|Overall Study|Other Reason|222
1665034|NCT01519791|5820901|P1|Overall Study|Other Reason|87
1665035|NCT01519791|5820900|P2|Overall Study|Protocol Violation|19
1665036|NCT01519791|5820901|P1|Overall Study|Protocol Violation|6
1665037|NCT01519791|5820900|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
1665038|NCT01519791|5820901|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
1665039|NCT01519778|5820965|P1|Overall Study|Physician Decision|1
1665040|NCT01519778|5820965|P1|Overall Study|Lost to Follow-up|10
1665041|NCT01519778|5820965|P1|Overall Study|Withdrawal by Subject|3
1665042|NCT01519765|5820971|P2|Overall Study|Withdrawal by Subject|1
1665043|NCT01519765|5820972|P1|Overall Study|Withdrawal by Subject|0
1665044|NCT01519765|5820971|P2|Overall Study|Protocol Violation|0
1665045|NCT01519765|5820972|P1|Overall Study|Protocol Violation|1
1665046|NCT01519765|5820971|P2|Overall Study|Lack of Efficacy|0
1665047|NCT01519765|5820972|P1|Overall Study|Lack of Efficacy|2
1665048|NCT01519765|5820971|P2|Overall Study|Adverse Event|1
1665049|NCT01519765|5820972|P1|Overall Study|Adverse Event|0
1665050|NCT01519700|5821050|P4|Overall Study|Other Reason|4
1665051|NCT01519700|5821051|P3|Overall Study|Other Reason|0
1665052|NCT01519700|5821052|P2|Overall Study|Other Reason|2
1665053|NCT01519700|5821053|P1|Overall Study|Other Reason|2
1665054|NCT01519700|5821050|P4|Overall Study|Withdrawal by Subject|2
1665055|NCT01519700|5821051|P3|Overall Study|Withdrawal by Subject|3
1665056|NCT01519700|5821052|P2|Overall Study|Withdrawal by Subject|3
1665057|NCT01519700|5821053|P1|Overall Study|Withdrawal by Subject|5
1665058|NCT01519700|5821050|P4|Overall Study|Physician Decision|0
1665059|NCT01519700|5821051|P3|Overall Study|Physician Decision|3
1665060|NCT01519700|5821052|P2|Overall Study|Physician Decision|1
1665061|NCT01519700|5821053|P1|Overall Study|Physician Decision|1
1665062|NCT01519700|5821050|P4|Overall Study|Lost to Follow-up|1
1665063|NCT01519700|5821051|P3|Overall Study|Lost to Follow-up|1
1665064|NCT01519700|5821052|P2|Overall Study|Lost to Follow-up|0
1665065|NCT01519700|5821053|P1|Overall Study|Lost to Follow-up|0
1665066|NCT01519700|5821050|P4|Overall Study|Death|0
1665067|NCT01519700|5821051|P3|Overall Study|Death|0
1665068|NCT01519700|5821052|P2|Overall Study|Death|0
1665069|NCT01519700|5821053|P1|Overall Study|Death|1
1665070|NCT01519674|5821088|P3|Overall Study|Unsclassified|3
1665071|NCT01519674|5821089|P2|Overall Study|Unsclassified|4
1665072|NCT01519674|5821090|P1|Overall Study|Unsclassified|10
1665073|NCT01519674|5821088|P3|Overall Study|Withdrawal Criteria|7
1665074|NCT01519674|5821089|P2|Overall Study|Withdrawal Criteria|2
1665075|NCT01519674|5821090|P1|Overall Study|Withdrawal Criteria|7
1665076|NCT01519674|5821088|P3|Overall Study|Protocol Violation|1
1665077|NCT01519674|5821089|P2|Overall Study|Protocol Violation|3
1665078|NCT01519674|5821090|P1|Overall Study|Protocol Violation|0
1665079|NCT01519674|5821088|P3|Overall Study|Lack of Efficacy|1
1665080|NCT01519674|5821089|P2|Overall Study|Lack of Efficacy|1
1665081|NCT01519674|5821090|P1|Overall Study|Lack of Efficacy|1
1665082|NCT01519674|5821088|P3|Overall Study|Adverse Event|0
1665083|NCT01519674|5821089|P2|Overall Study|Adverse Event|3
1665084|NCT01519674|5821090|P1|Overall Study|Adverse Event|3
1665085|NCT01519661|5821128|P1|Overall Study|Adverse Event|29
1665086|NCT01519661|5821128|P1|Overall Study|Lack of Efficacy|6
1665087|NCT01519661|5821128|P1|Overall Study|Withdrawal by Subject|17
1665088|NCT01519661|5821128|P1|Overall Study|Lost to Follow-up|3
1665089|NCT01519661|5821128|P1|Overall Study|Protocol deviation|6
1665090|NCT01519635|5821154|P2|Overall Study|No possibility to put a catheter|2
1665091|NCT01519635|5821155|P1|Overall Study|No possibility to put a catheter|1
1665092|NCT01519635|5821154|P2|Overall Study|Withdrawal by Subject|1
1665093|NCT01519635|5821155|P1|Overall Study|Withdrawal by Subject|0
1665094|NCT01519518|5821172|P2|Overall Study|Consent not available|10
1665095|NCT01519518|5821173|P1|Overall Study|Consent not available|7
1665096|NCT01519427|5821198|P1|Overall Study|disease progression|2
1665097|NCT01519323|5821230|P2|Overall Study|Study terminated by sponsor|1
1665098|NCT01519323|5821231|P1|Overall Study|Study terminated by sponsor|0
1665099|NCT01519323|5821230|P2|Overall Study|Death|2
1665100|NCT01519323|5821231|P1|Overall Study|Death|3
1665101|NCT01519245|5821291|P2|Overall Study|Met exclusion criteria, not analysed|2
1665102|NCT01519245|5821292|P1|Overall Study|Met exclusion criteria, not analysed|1
1665103|NCT01519206|5821304|P1|Overall Study|Missed Visit|2
1665104|NCT01519206|5821304|P1|Overall Study|Lost to Follow-up|3
1665105|NCT01519167|5821318|P2|Overall Study|Physician Decision|1
1665106|NCT01519167|5821319|P1|Overall Study|Physician Decision|0
1665107|NCT01519167|5821318|P2|Overall Study|Medical condition changes&deep sedation|2
1665108|NCT01519167|5821319|P1|Overall Study|Medical condition changes&deep sedation|0
1665109|NCT01519167|5821318|P2|Overall Study|Lack of Efficacy|1
1665110|NCT01519167|5821319|P1|Overall Study|Lack of Efficacy|0
1665111|NCT01519167|5821318|P2|Overall Study|Adverse Event|1
1665112|NCT01519167|5821319|P1|Overall Study|Adverse Event|0
1665113|NCT01519167|5821318|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
1665114|NCT01519167|5821319|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
1665115|NCT01519089|5821345|P2|Overall Study|Not received study drug|1
1665116|NCT01519089|5821346|P1|Overall Study|Not received study drug|0
1665117|NCT01519089|5821345|P2|Overall Study|Other|6
1665118|NCT01519089|5821346|P1|Overall Study|Other|2
1665119|NCT01519089|5821345|P2|Overall Study|Withdrawal by Subject|2
1665120|NCT01519089|5821346|P1|Overall Study|Withdrawal by Subject|0
1665121|NCT01519089|5821345|P2|Overall Study|Lost to Follow-up|0
1665122|NCT01519089|5821346|P1|Overall Study|Lost to Follow-up|1
1665123|NCT01519089|5821345|P2|Overall Study|Lack of Efficacy|2
1665124|NCT01519089|5821346|P1|Overall Study|Lack of Efficacy|0
1665125|NCT01519089|5821345|P2|Overall Study|Adverse Event|4
1665126|NCT01519089|5821346|P1|Overall Study|Adverse Event|4
1665127|NCT01518946|5821488|P3|Randomized Phase (First Intervention)|Other|0
1665128|NCT01518946|5821489|P2|Randomized Phase (First Intervention)|Other|1
1665129|NCT01518946|5821490|P1|Randomized Phase (First Intervention)|Other|0
1665130|NCT01518946|5821488|P3|Open-label Phase|Other|0
1665131|NCT01518946|5821489|P2|Open-label Phase|Other|0
1665132|NCT01518946|5821490|P1|Open-label Phase|Other|4
1665133|NCT01518374|5821501|P1|Overall Study|Lost to Follow-up|2
1665134|NCT01518374|5821501|P1|Overall Study|Protocol Violation|3
1665135|NCT01518374|5821501|P1|Overall Study|Withdrawal by Subject|2
1665136|NCT01518322|5821505|P1|Overall Study|FeNO measurement was missing|13
1665137|NCT01518257|5821526|P2|Overall Study|Other Miscellaneous Reason|0
1665138|NCT01518257|5821527|P1|Overall Study|Other Miscellaneous Reason|1
1665139|NCT01518257|5821526|P2|Overall Study|Lost to Follow-up|0
1665140|NCT01518257|5821527|P1|Overall Study|Lost to Follow-up|1
1665141|NCT01518244|5821549|P1|Overall Study|Adverse Event|3
1665142|NCT01518192|5821557|P3|Overall Study|Lost to Follow-up|35
1665143|NCT01518192|5821558|P2|Overall Study|Lost to Follow-up|26
1665144|NCT01518192|5821559|P1|Overall Study|Lost to Follow-up|29
1665145|NCT01518153|5821580|P3|Donor Lymphocyte Infusion|Death|1
1665146|NCT01518153|5821581|P2|Donor Lymphocyte Infusion|Death|2
1665147|NCT01518153|5821582|P1|Donor Lymphocyte Infusion|Death|0
1665148|NCT01518153|5821580|P3|Stem Cell Transplant|Adverse Event|0
1665149|NCT01518153|5821581|P2|Stem Cell Transplant|Adverse Event|0
1665150|NCT01518153|5821582|P1|Stem Cell Transplant|Adverse Event|1
1665151|NCT01518153|5821580|P3|Stem Cell Transplant|Secondary graft failure|0
1665152|NCT01518153|5821581|P2|Stem Cell Transplant|Secondary graft failure|0
1665153|NCT01518153|5821582|P1|Stem Cell Transplant|Secondary graft failure|1
1665154|NCT01518153|5821580|P3|Stem Cell Transplant|Death|0
1665155|NCT01518153|5821581|P2|Stem Cell Transplant|Death|0
1665156|NCT01518153|5821582|P1|Stem Cell Transplant|Death|2
1665157|NCT01518153|5821580|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1665158|NCT01518153|5821581|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
1665159|NCT01518153|5821582|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
1665160|NCT01517984|5821593|P4|Overall Study|Ineligible for randomization|0
1665161|NCT01517984|5821594|P3|Overall Study|Ineligible for randomization|0
1665162|NCT01517984|5821595|P2|Overall Study|Ineligible for randomization|14
1665163|NCT01517984|5821596|P1|Overall Study|Ineligible for randomization|0
1665164|NCT01517984|5821593|P4|Overall Study|Screen Failure|0
1665165|NCT01517984|5821594|P3|Overall Study|Screen Failure|0
1665166|NCT01517984|5821595|P2|Overall Study|Screen Failure|0
1665167|NCT01517984|5821596|P1|Overall Study|Screen Failure|4
1665168|NCT01517984|5821593|P4|Overall Study|Withdrawal by Subject|1
1665169|NCT01517984|5821594|P3|Overall Study|Withdrawal by Subject|4
1665170|NCT01517984|5821595|P2|Overall Study|Withdrawal by Subject|8
1665171|NCT01517984|5821596|P1|Overall Study|Withdrawal by Subject|1
1665172|NCT01517984|5821593|P4|Overall Study|Lost to Follow-up|0
1665173|NCT01517984|5821594|P3|Overall Study|Lost to Follow-up|0
1665174|NCT01517984|5821595|P2|Overall Study|Lost to Follow-up|1
1665175|NCT01517984|5821596|P1|Overall Study|Lost to Follow-up|0
1665176|NCT01517893|5821622|P2|Overall Study|Withdrawal by Subject|0
1665177|NCT01517893|5821623|P1|Overall Study|Withdrawal by Subject|3
1665178|NCT01517867|5821645|P2|Overall Study|Still in treatment at study end|3
1665179|NCT01517867|5821646|P1|Overall Study|Still in treatment at study end|0
1665180|NCT01517867|5821645|P2|Overall Study|Withdrawal by Subject|30
1665181|NCT01517867|5821646|P1|Overall Study|Withdrawal by Subject|34
1665182|NCT01517867|5821645|P2|Overall Study|never started treatment|32
1665183|NCT01517867|5821646|P1|Overall Study|never started treatment|29
1665184|NCT01517750|5821674|P4|Overall Study|Lost to Follow-up|1
1665185|NCT01517750|5821675|P3|Overall Study|Lost to Follow-up|4
1665186|NCT01517750|5821676|P2|Overall Study|Lost to Follow-up|2
1665187|NCT01517750|5821677|P1|Overall Study|Lost to Follow-up|1
1665188|NCT01517412|5821714|P2|Overall Study|Other than specified above|5
1665189|NCT01517412|5821715|P1|Overall Study|Other than specified above|8
1665190|NCT01517412|5821714|P2|Overall Study|Poor compliance to protocol|3
1665191|NCT01517412|5821715|P1|Overall Study|Poor compliance to protocol|8
1665192|NCT01517412|5821714|P2|Overall Study|Lack of Efficacy|5
1665193|NCT01517412|5821715|P1|Overall Study|Lack of Efficacy|10
1665194|NCT01517412|5821714|P2|Overall Study|Adverse Event|11
1665195|NCT01517412|5821715|P1|Overall Study|Adverse Event|10
1665196|NCT01517373|5821744|P6|Treatment Period|Medication error without AEs|2
1665197|NCT01517373|5821745|P5|Treatment Period|Medication error without AEs|0
1665198|NCT01517373|5821746|P4|Treatment Period|Medication error without AEs|1
1665199|NCT01517373|5821747|P3|Treatment Period|Medication error without AEs|2
1665200|NCT01517373|5821748|P2|Treatment Period|Medication error without AEs|0
1665201|NCT01517373|5821749|P1|Treatment Period|Medication error without AEs|0
1665202|NCT01517373|5821744|P6|Treatment Period|Lack of Efficacy|0
1665203|NCT01517373|5821745|P5|Treatment Period|Lack of Efficacy|2
1665204|NCT01517373|5821746|P4|Treatment Period|Lack of Efficacy|3
1665205|NCT01517373|5821747|P3|Treatment Period|Lack of Efficacy|1
1665206|NCT01517373|5821748|P2|Treatment Period|Lack of Efficacy|1
1665207|NCT01517373|5821749|P1|Treatment Period|Lack of Efficacy|0
1665208|NCT01517373|5821744|P6|Treatment Period|Protocol Violation|0
1665209|NCT01517373|5821745|P5|Treatment Period|Protocol Violation|1
1665210|NCT01517373|5821746|P4|Treatment Period|Protocol Violation|0
1665211|NCT01517373|5821747|P3|Treatment Period|Protocol Violation|0
1665212|NCT01517373|5821748|P2|Treatment Period|Protocol Violation|0
1665213|NCT01517373|5821749|P1|Treatment Period|Protocol Violation|0
1665214|NCT01517373|5821744|P6|Treatment Period|Other|0
1665215|NCT01517373|5821745|P5|Treatment Period|Other|1
1665216|NCT01517373|5821746|P4|Treatment Period|Other|0
1665217|NCT01517373|5821747|P3|Treatment Period|Other|0
1665218|NCT01517373|5821748|P2|Treatment Period|Other|0
1665219|NCT01517373|5821749|P1|Treatment Period|Other|0
1665220|NCT01517373|5821744|P6|Treatment Period|Withdrawal by Subject|3
1665221|NCT01517373|5821745|P5|Treatment Period|Withdrawal by Subject|2
1665222|NCT01517373|5821746|P4|Treatment Period|Withdrawal by Subject|2
1665223|NCT01517373|5821747|P3|Treatment Period|Withdrawal by Subject|2
1665224|NCT01517373|5821748|P2|Treatment Period|Withdrawal by Subject|3
1665225|NCT01517373|5821749|P1|Treatment Period|Withdrawal by Subject|0
1665226|NCT01517373|5821744|P6|Treatment Period|Lost to Follow-up|0
1665227|NCT01517373|5821745|P5|Treatment Period|Lost to Follow-up|0
1665228|NCT01517373|5821746|P4|Treatment Period|Lost to Follow-up|1
1665229|NCT01517373|5821747|P3|Treatment Period|Lost to Follow-up|1
1665230|NCT01517373|5821748|P2|Treatment Period|Lost to Follow-up|0
1665231|NCT01517373|5821749|P1|Treatment Period|Lost to Follow-up|0
1665232|NCT01517373|5821744|P6|Treatment Period|Adverse Event|2
1665233|NCT01517373|5821745|P5|Treatment Period|Adverse Event|0
1665234|NCT01517373|5821746|P4|Treatment Period|Adverse Event|0
1665235|NCT01517373|5821747|P3|Treatment Period|Adverse Event|0
1665236|NCT01517373|5821748|P2|Treatment Period|Adverse Event|0
1665237|NCT01517373|5821749|P1|Treatment Period|Adverse Event|0
1665238|NCT01517373|5821744|P6|Run-in Period|Other|0
1665239|NCT01517373|5821745|P5|Run-in Period|Other|0
1665240|NCT01517373|5821746|P4|Run-in Period|Other|0
1665241|NCT01517373|5821747|P3|Run-in Period|Other|0
1665242|NCT01517373|5821748|P2|Run-in Period|Other|0
1665243|NCT01517373|5821749|P1|Run-in Period|Other|1
1665244|NCT01517373|5821744|P6|Run-in Period|Sponsor Decision|0
1665245|NCT01517373|5821745|P5|Run-in Period|Sponsor Decision|0
1665246|NCT01517373|5821746|P4|Run-in Period|Sponsor Decision|0
1665247|NCT01517373|5821747|P3|Run-in Period|Sponsor Decision|0
1665248|NCT01517373|5821748|P2|Run-in Period|Sponsor Decision|0
1665249|NCT01517373|5821749|P1|Run-in Period|Sponsor Decision|3
1665250|NCT01517373|5821744|P6|Run-in Period|Withdrawal by Subject|0
1665251|NCT01517373|5821745|P5|Run-in Period|Withdrawal by Subject|0
1665252|NCT01517373|5821746|P4|Run-in Period|Withdrawal by Subject|0
1665253|NCT01517373|5821747|P3|Run-in Period|Withdrawal by Subject|0
1665254|NCT01517373|5821748|P2|Run-in Period|Withdrawal by Subject|0
1665255|NCT01517373|5821749|P1|Run-in Period|Withdrawal by Subject|12
1665256|NCT01517373|5821744|P6|Run-in Period|Lost to Follow-up|0
1665257|NCT01517373|5821745|P5|Run-in Period|Lost to Follow-up|0
1665258|NCT01517373|5821746|P4|Run-in Period|Lost to Follow-up|0
1665259|NCT01517373|5821747|P3|Run-in Period|Lost to Follow-up|0
1665260|NCT01517373|5821748|P2|Run-in Period|Lost to Follow-up|0
1665261|NCT01517373|5821749|P1|Run-in Period|Lost to Follow-up|1
1665262|NCT01517373|5821744|P6|Run-in Period|Did not meet eligibility criteria|0
1665263|NCT01517373|5821745|P5|Run-in Period|Did not meet eligibility criteria|0
1665264|NCT01517373|5821746|P4|Run-in Period|Did not meet eligibility criteria|0
1665265|NCT01517373|5821747|P3|Run-in Period|Did not meet eligibility criteria|0
1665266|NCT01517373|5821748|P2|Run-in Period|Did not meet eligibility criteria|0
1665267|NCT01517373|5821749|P1|Run-in Period|Did not meet eligibility criteria|34
1665268|NCT01517373|5821744|P6|Run-in Period|Adverse Event|0
1665269|NCT01517373|5821745|P5|Run-in Period|Adverse Event|0
1665270|NCT01517373|5821746|P4|Run-in Period|Adverse Event|0
1665271|NCT01517373|5821747|P3|Run-in Period|Adverse Event|0
1665272|NCT01517373|5821748|P2|Run-in Period|Adverse Event|0
1665273|NCT01517373|5821749|P1|Run-in Period|Adverse Event|5
1665274|NCT01517373|5821744|P6|Run-in Period|Death|0
1665275|NCT01517373|5821745|P5|Run-in Period|Death|0
1665276|NCT01517373|5821746|P4|Run-in Period|Death|0
1665277|NCT01517373|5821747|P3|Run-in Period|Death|0
1665278|NCT01517373|5821748|P2|Run-in Period|Death|0
1665279|NCT01517373|5821749|P1|Run-in Period|Death|1
1665280|NCT01517295|5821819|P2|Overall Study|Physician Decision|0
1665281|NCT01517295|5821820|P1|Overall Study|Physician Decision|1
1665282|NCT01517282|5821834|P4|Overall Study|Physician Decision|0
1665283|NCT01517282|5821835|P3|Overall Study|Physician Decision|0
1665284|NCT01517282|5821836|P2|Overall Study|Physician Decision|0
1665285|NCT01517282|5821837|P1|Overall Study|Physician Decision|1
1665286|NCT01517282|5821834|P4|Overall Study|Consent withdrawn|1
1665287|NCT01517282|5821835|P3|Overall Study|Consent withdrawn|1
1665288|NCT01517282|5821836|P2|Overall Study|Consent withdrawn|1
1665289|NCT01517282|5821837|P1|Overall Study|Consent withdrawn|0
1665290|NCT01517178|5821871|P2|Period 2|E.g. study termination|2
1665291|NCT01517178|5821872|P1|Period 2|E.g. study termination|2
1665292|NCT01517178|5821871|P2|Period 2|Withdrawal by Subject|0
1665293|NCT01517178|5821872|P1|Period 2|Withdrawal by Subject|3
1665294|NCT01517178|5821871|P2|Period 2|Adverse Event|0
1665295|NCT01517178|5821872|P1|Period 2|Adverse Event|1
1665296|NCT01517178|5821871|P2|Period 1|Withdrawal by Subject|1
1665297|NCT01517178|5821872|P1|Period 1|Withdrawal by Subject|0
1665298|NCT01517178|5821871|P2|Period 1|E.g. study termination|1
1665299|NCT01517178|5821872|P1|Period 1|E.g. study termination|3
1665300|NCT01517178|5821871|P2|Period 1|Lack of Efficacy|1
1665301|NCT01517178|5821872|P1|Period 1|Lack of Efficacy|0
1665302|NCT01517178|5821871|P2|Period 1|Adverse Event|2
1665303|NCT01517178|5821872|P1|Period 1|Adverse Event|1
1665304|NCT01516970|5821891|P2|Overall Study|Other|7
1665305|NCT01516970|5821892|P1|Overall Study|Other|9
1665306|NCT01516970|5821891|P2|Overall Study|Withdrawal by Subject|1
1665307|NCT01516970|5821892|P1|Overall Study|Withdrawal by Subject|1
1665308|NCT01516970|5821891|P2|Overall Study|Adverse Event|5
1665309|NCT01516970|5821892|P1|Overall Study|Adverse Event|1
1665310|NCT01516970|5821891|P2|Overall Study|Lost to Follow-up|8
1665311|NCT01516970|5821892|P1|Overall Study|Lost to Follow-up|7
1665312|NCT01516892|5821904|P1|Overall Study|Missing|1
1665313|NCT01516892|5821904|P1|Overall Study|Other Miscellaneous Reasons|43
1665314|NCT01516892|5821904|P1|Overall Study|Protocol Violation|60
1665315|NCT01516892|5821904|P1|Overall Study|Subject Withdrew Consent|92
1665316|NCT01516892|5821904|P1|Overall Study|Lost to Follow-up|82
1665317|NCT01516892|5821904|P1|Overall Study|Pregnancy|5
1665318|NCT01516892|5821904|P1|Overall Study|Lack of Efficacy|35
1665319|NCT01516892|5821904|P1|Overall Study|Adverse Event|25
1665320|NCT01516879|5821912|P2|Overall Study|Other|10
1665321|NCT01516879|5821913|P1|Overall Study|Other|5
1665322|NCT01516879|5821912|P2|Overall Study|Lost to Follow-up|11
1665323|NCT01516879|5821913|P1|Overall Study|Lost to Follow-up|2
1665324|NCT01516879|5821912|P2|Overall Study|Death|2
1665325|NCT01516879|5821913|P1|Overall Study|Death|0
1665326|NCT01516879|5821912|P2|Overall Study|Withdrawal by Subject|11
1665327|NCT01516879|5821913|P1|Overall Study|Withdrawal by Subject|9
1665328|NCT01516749|5821947|P1|Follow-up Off Therapy|Lost to Follow-up|1
1665329|NCT01516749|5821947|P1|Active Therapy|Lost to Follow-up|1
1665330|NCT01516736|5821956|P2|Overall Study|Other (not specified)|1
1665331|NCT01516736|5821957|P1|Overall Study|Other (not specified)|0
1665332|NCT01516736|5821956|P2|Overall Study|Protocol Violation|1
1665333|NCT01516736|5821957|P1|Overall Study|Protocol Violation|0
1665334|NCT01516736|5821956|P2|Overall Study|Lack of Efficacy|0
1665335|NCT01516736|5821957|P1|Overall Study|Lack of Efficacy|1
1665336|NCT01516736|5821956|P2|Overall Study|Physician Decision|1
1665337|NCT01516736|5821957|P1|Overall Study|Physician Decision|2
1665338|NCT01516736|5821956|P2|Overall Study|Death|1
1665339|NCT01516736|5821957|P1|Overall Study|Death|3
1665340|NCT01516736|5821956|P2|Overall Study|Adverse Event|5
1665341|NCT01516736|5821957|P1|Overall Study|Adverse Event|4
1665342|NCT01516736|5821956|P2|Overall Study|Withdrawal by Subject|4
1665343|NCT01516736|5821957|P1|Overall Study|Withdrawal by Subject|10
1665344|NCT01516437|5822011|P4|Overall Study|Reason not specified|1
1665345|NCT01516437|5822012|P3|Overall Study|Reason not specified|1
1665346|NCT01516437|5822013|P2|Overall Study|Reason not specified|0
1665347|NCT01516437|5822014|P1|Overall Study|Reason not specified|0
1665348|NCT01516034|5822086|P1|Overall Study|Lack of Efficacy|7
1665349|NCT01516034|5822086|P1|Overall Study|Physician Decision|1
1665350|NCT01516008|5822093|P3|Overall Study|Reason not specified|1
1665351|NCT01516008|5822094|P2|Overall Study|Reason not specified|0
1665352|NCT01516008|5822095|P1|Overall Study|Reason not specified|0
1665353|NCT01516008|5822093|P3|Overall Study|Protocol Violation|0
1665354|NCT01516008|5822094|P2|Overall Study|Protocol Violation|0
1665355|NCT01516008|5822095|P1|Overall Study|Protocol Violation|1
1665356|NCT01516008|5822093|P3|Overall Study|Lack of Efficacy|10
1665357|NCT01516008|5822094|P2|Overall Study|Lack of Efficacy|14
1665358|NCT01516008|5822095|P1|Overall Study|Lack of Efficacy|44
1665359|NCT01516008|5822093|P3|Overall Study|Adverse Event|7
1665360|NCT01516008|5822094|P2|Overall Study|Adverse Event|2
1665361|NCT01516008|5822095|P1|Overall Study|Adverse Event|0
1665362|NCT01515865|5822200|P3|Part B (Open-label)|Other|0
1665363|NCT01515865|5822201|P2|Part B (Open-label)|Other|0
1665364|NCT01515865|5822202|P1|Part B (Open-label)|Other|1
1665365|NCT01515865|5822200|P3|Part B (Open-label)|Withdrawal by Subject|0
1665366|NCT01515865|5822201|P2|Part B (Open-label)|Withdrawal by Subject|0
1665367|NCT01515865|5822202|P1|Part B (Open-label)|Withdrawal by Subject|1
1665368|NCT01515865|5822200|P3|Part A (Open-label)|Other|0
1665369|NCT01515865|5822201|P2|Part A (Open-label)|Other|0
1665370|NCT01515865|5822202|P1|Part A (Open-label)|Other|3
1665371|NCT01515475|5822272|P4|Overall Study|Lost to Follow-up|12
1665372|NCT01515475|5822273|P3|Overall Study|Lost to Follow-up|12
1665373|NCT01515475|5822274|P2|Overall Study|Lost to Follow-up|15
1665374|NCT01515475|5822275|P1|Overall Study|Lost to Follow-up|20
1665375|NCT01515423|5822349|P3|DOUBLE BLIND|Blind broken by investigator|0
1665376|NCT01515423|5822350|P2|DOUBLE BLIND|Blind broken by investigator|1
1665377|NCT01515423|5822351|P1|DOUBLE BLIND|Blind broken by investigator|0
1665378|NCT01515423|5822349|P3|DOUBLE BLIND|Other|12
1665379|NCT01515423|5822350|P2|DOUBLE BLIND|Other|6
1665380|NCT01515423|5822351|P1|DOUBLE BLIND|Other|0
1665381|NCT01515423|5822349|P3|DOUBLE BLIND|Withdrawal by Subject|53
1665382|NCT01515423|5822350|P2|DOUBLE BLIND|Withdrawal by Subject|50
1665383|NCT01515423|5822351|P1|DOUBLE BLIND|Withdrawal by Subject|0
1665384|NCT01515423|5822349|P3|DOUBLE BLIND|Pregnancy|0
1665385|NCT01515423|5822350|P2|DOUBLE BLIND|Pregnancy|2
1665386|NCT01515423|5822351|P1|DOUBLE BLIND|Pregnancy|0
1665387|NCT01515423|5822349|P3|DOUBLE BLIND|Lost to Follow-up|12
1665388|NCT01515423|5822350|P2|DOUBLE BLIND|Lost to Follow-up|7
1665389|NCT01515423|5822351|P1|DOUBLE BLIND|Lost to Follow-up|0
1665390|NCT01515423|5822349|P3|DOUBLE BLIND|Death|2
1665391|NCT01515423|5822350|P2|DOUBLE BLIND|Death|1
1665392|NCT01515423|5822351|P1|DOUBLE BLIND|Death|0
1665393|NCT01515423|5822349|P3|DOUBLE BLIND|Adverse Event|13
1665394|NCT01515423|5822350|P2|DOUBLE BLIND|Adverse Event|15
1665395|NCT01515423|5822351|P1|DOUBLE BLIND|Adverse Event|0
1665396|NCT01515423|5822349|P3|Open Label Phase|Other|0
1665397|NCT01515423|5822350|P2|Open Label Phase|Other|0
1665398|NCT01515423|5822351|P1|Open Label Phase|Other|28
1665399|NCT01515423|5822349|P3|Open Label Phase|excluded from DB Phase|0
1665400|NCT01515423|5822350|P2|Open Label Phase|excluded from DB Phase|0
1665401|NCT01515423|5822351|P1|Open Label Phase|excluded from DB Phase|70
1665402|NCT01515423|5822349|P3|Open Label Phase|Withdrawal by Subject|0
1665403|NCT01515423|5822350|P2|Open Label Phase|Withdrawal by Subject|0
1665404|NCT01515423|5822351|P1|Open Label Phase|Withdrawal by Subject|118
1665405|NCT01515423|5822349|P3|Open Label Phase|Lost to Follow-up|0
1665406|NCT01515423|5822350|P2|Open Label Phase|Lost to Follow-up|0
1665407|NCT01515423|5822351|P1|Open Label Phase|Lost to Follow-up|21
1665408|NCT01515423|5822349|P3|Open Label Phase|Lack of Efficacy|0
1665409|NCT01515423|5822350|P2|Open Label Phase|Lack of Efficacy|0
1665410|NCT01515423|5822351|P1|Open Label Phase|Lack of Efficacy|117
1665411|NCT01515423|5822349|P3|Open Label Phase|Death|0
1665412|NCT01515423|5822350|P2|Open Label Phase|Death|0
1665413|NCT01515423|5822351|P1|Open Label Phase|Death|2
1665414|NCT01515423|5822349|P3|Open Label Phase|Adverse Event|0
1665415|NCT01515423|5822350|P2|Open Label Phase|Adverse Event|0
1665416|NCT01515423|5822351|P1|Open Label Phase|Adverse Event|57
1665417|NCT01515306|5822392|P2|Overall Study|Ongoing receiving treatment|14
1665418|NCT01515306|5822393|P1|Overall Study|Ongoing receiving treatment|9
1665419|NCT01515306|5822392|P2|Overall Study|Progressive Disease|0
1665420|NCT01515306|5822393|P1|Overall Study|Progressive Disease|1
1665421|NCT01515306|5822392|P2|Overall Study|Adverse Event|0
1665422|NCT01515306|5822393|P1|Overall Study|Adverse Event|2
1665423|NCT01515189|5822406|P2|First Re-Induction Phase|Other|0
1665424|NCT01515189|5822407|P1|First Re-Induction Phase|Other|1
1665425|NCT01515189|5822406|P2|First Re-Induction Phase|No longer meets study criteria|0
1665426|NCT01515189|5822407|P1|First Re-Induction Phase|No longer meets study criteria|1
1665427|NCT01515189|5822406|P2|First Re-Induction Phase|Withdrawal by Subject|1
1665428|NCT01515189|5822407|P1|First Re-Induction Phase|Withdrawal by Subject|1
1665429|NCT01515189|5822406|P2|First Re-Induction Phase|Study drug toxicity|0
1665430|NCT01515189|5822407|P1|First Re-Induction Phase|Study drug toxicity|5
1665431|NCT01515189|5822406|P2|First Re-Induction Phase|Disease progression|14
1665432|NCT01515189|5822407|P1|First Re-Induction Phase|Disease progression|6
1665433|NCT01515189|5822406|P2|Induction|Other|4
1665434|NCT01515189|5822407|P1|Induction|Other|0
1665435|NCT01515189|5822406|P2|Induction|Lost to Follow-up|0
1665436|NCT01515189|5822407|P1|Induction|Lost to Follow-up|1
1665437|NCT01515189|5822406|P2|Induction|No longer meets study criteria|2
1665438|NCT01515189|5822407|P1|Induction|No longer meets study criteria|0
1665439|NCT01515189|5822406|P2|Induction|Withdrawal by Subject|9
1665440|NCT01515189|5822407|P1|Induction|Withdrawal by Subject|3
1665441|NCT01515189|5822406|P2|Induction|Adverse Event|9
1665442|NCT01515189|5822407|P1|Induction|Adverse Event|14
1665443|NCT01515189|5822406|P2|Induction|Death|17
1665444|NCT01515189|5822407|P1|Induction|Death|24
1665445|NCT01515189|5822406|P2|Induction|Study drug toxicity|36
1665446|NCT01515189|5822407|P1|Induction|Study drug toxicity|86
1665447|NCT01515189|5822406|P2|Induction|Disease Progression|155
1665448|NCT01515189|5822407|P1|Induction|Disease Progression|109
1665449|NCT01514864|5822495|P2|Overall Study|Study drug toxicity|0
1665450|NCT01514864|5822496|P1|Overall Study|Study drug toxicity|2
1665451|NCT01514864|5822495|P2|Overall Study|Disease progression|5
1665452|NCT01514864|5822496|P1|Overall Study|Disease progression|7
1665453|NCT01514760|5822521|P1|Overall Study|Lost to Follow-up|2
1665454|NCT01514682|5822534|P2|Overall Study|Physician Decision|3
1665455|NCT01514682|5822535|P1|Overall Study|Physician Decision|4
1665456|NCT01514682|5822534|P2|Overall Study|Withdrawal by Subject|3
1665457|NCT01514682|5822535|P1|Overall Study|Withdrawal by Subject|2
1665458|NCT01514461|5822569|P3|Overall Study|Death|0
1665459|NCT01514461|5822570|P2|Overall Study|Death|0
1665460|NCT01514461|5822571|P1|Overall Study|Death|1
1665461|NCT01514461|5822569|P3|Overall Study|Patient/guardian decision|1
1665462|NCT01514461|5822570|P2|Overall Study|Patient/guardian decision|1
1665463|NCT01514461|5822571|P1|Overall Study|Patient/guardian decision|1
1665464|NCT01514461|5822569|P3|Overall Study|Physician Decision|0
1665465|NCT01514461|5822570|P2|Overall Study|Physician Decision|1
1665466|NCT01514461|5822571|P1|Overall Study|Physician Decision|1
1665467|NCT01514461|5822569|P3|Overall Study|Adverse Event|3
1665468|NCT01514461|5822570|P2|Overall Study|Adverse Event|1
1665469|NCT01514461|5822571|P1|Overall Study|Adverse Event|2
1665470|NCT01514448|5822610|P2|Overall Study|New Cancer Therapy|0
1665471|NCT01514448|5822611|P1|Overall Study|New Cancer Therapy|1
1665472|NCT01514448|5822610|P2|Overall Study|Lost to Follow-up|0
1665473|NCT01514448|5822611|P1|Overall Study|Lost to Follow-up|2
1665474|NCT01514448|5822610|P2|Overall Study|Withdrawal by Subject|0
1665475|NCT01514448|5822611|P1|Overall Study|Withdrawal by Subject|2
1665476|NCT01514448|5822610|P2|Overall Study|Death|8
1665477|NCT01514448|5822611|P1|Overall Study|Death|7
1665478|NCT01514422|5822626|P1|Overall Study|Lost to Follow-up|1
1665479|NCT01514370|5822644|P2|Overall Study|Other|7
1665480|NCT01514370|5822645|P1|Overall Study|Other|6
1665481|NCT01514370|5822644|P2|Overall Study|Adverse Event|3
1665482|NCT01514370|5822645|P1|Overall Study|Adverse Event|1
1665483|NCT01514370|5822644|P2|Overall Study|Withdrawal by Subject|1
1665484|NCT01514370|5822645|P1|Overall Study|Withdrawal by Subject|2
1665485|NCT01514370|5822644|P2|Overall Study|Lost to Follow-up|2
1665486|NCT01514370|5822645|P1|Overall Study|Lost to Follow-up|0
1665487|NCT01514370|5822644|P2|Overall Study|Protocol Violation|3
1665488|NCT01514370|5822645|P1|Overall Study|Protocol Violation|2
1665489|NCT01514357|5822691|P2|Overall Study|Withdrawal by Subject|0
1665490|NCT01514357|5822692|P1|Overall Study|Withdrawal by Subject|2
1665491|NCT01514357|5822691|P2|Overall Study|Screen failure|0
1665492|NCT01514357|5822692|P1|Overall Study|Screen failure|2
1665493|NCT01514240|5822710|P2|Overall Study|Subject Decision|7
1665494|NCT01514240|5822711|P1|Overall Study|Subject Decision|2
1665495|NCT01514240|5822710|P2|Overall Study|Adverse Event|4
1665496|NCT01514240|5822711|P1|Overall Study|Adverse Event|4
1665497|NCT01514201|5822789|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
1665498|NCT01514201|5822790|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1665499|NCT01514201|5822791|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1665500|NCT01514201|5822792|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1665501|NCT01514201|5822789|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
1665502|NCT01514201|5822790|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1665503|NCT01514201|5822791|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1665579|NCT01514136|5822892|P6|Test Period 2; Test A*|Holiday|0
1665504|NCT01514201|5822792|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1665505|NCT01514201|5822789|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
1665506|NCT01514201|5822790|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
1665507|NCT01514201|5822791|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
1665508|NCT01514201|5822792|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
1665509|NCT01514201|5822789|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
1665510|NCT01514201|5822790|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
1665511|NCT01514201|5822791|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
1665512|NCT01514201|5822792|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
1665513|NCT01514201|5822789|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
1665514|NCT01514201|5822790|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
1665515|NCT01514201|5822791|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
1665516|NCT01514201|5822792|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
1665517|NCT01514201|5822789|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
1665518|NCT01514201|5822790|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
1665519|NCT01514201|5822791|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
1665520|NCT01514201|5822792|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
1665521|NCT01514201|5822789|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
1665522|NCT01514201|5822790|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
1665523|NCT01514201|5822791|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
1665524|NCT01514201|5822792|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
1665525|NCT01514201|5822789|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
1665526|NCT01514201|5822790|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
1665527|NCT01514201|5822791|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
1665528|NCT01514201|5822792|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
1665529|NCT01514201|5822789|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1665530|NCT01514201|5822790|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
1665531|NCT01514201|5822791|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
1665532|NCT01514201|5822792|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
1665533|NCT01514201|5822789|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
1665534|NCT01514201|5822790|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
1665535|NCT01514201|5822791|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
1665536|NCT01514201|5822792|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
1665537|NCT01514201|5822789|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
1665538|NCT01514201|5822790|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
1665539|NCT01514201|5822791|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
1665540|NCT01514201|5822792|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
1665541|NCT01514201|5822789|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
1665542|NCT01514201|5822790|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
1665543|NCT01514201|5822791|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
1665544|NCT01514201|5822792|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
1665545|NCT01514136|5822890|P8|Test Period 2; Test C*|Protocol Violation|0
1665546|NCT01514136|5822891|P7|Test Period 2; Test C*|Protocol Violation|1
1665547|NCT01514136|5822892|P6|Test Period 2; Test C*|Protocol Violation|0
1665548|NCT01514136|5822893|P5|Test Period 2; Test C*|Protocol Violation|0
1665549|NCT01514136|5822894|P4|Test Period 2; Test C*|Protocol Violation|0
1665550|NCT01514136|5822895|P3|Test Period 2; Test C*|Protocol Violation|0
1665551|NCT01514136|5822896|P2|Test Period 2; Test C*|Protocol Violation|0
1665552|NCT01514136|5822897|P1|Test Period 2; Test C*|Protocol Violation|0
1665553|NCT01514136|5822890|P8|Test Period 2; Test C*|holiday|0
1665554|NCT01514136|5822891|P7|Test Period 2; Test C*|holiday|1
1665555|NCT01514136|5822892|P6|Test Period 2; Test C*|holiday|0
1665556|NCT01514136|5822893|P5|Test Period 2; Test C*|holiday|0
1665557|NCT01514136|5822894|P4|Test Period 2; Test C*|holiday|0
1665558|NCT01514136|5822895|P3|Test Period 2; Test C*|holiday|0
1665559|NCT01514136|5822896|P2|Test Period 2; Test C*|holiday|0
1665560|NCT01514136|5822897|P1|Test Period 2; Test C*|holiday|0
1665561|NCT01514136|5822890|P8|Test Period 2; Test C*|Withdrawal by Subject|0
1665562|NCT01514136|5822891|P7|Test Period 2; Test C*|Withdrawal by Subject|1
1665563|NCT01514136|5822892|P6|Test Period 2; Test C*|Withdrawal by Subject|0
1665564|NCT01514136|5822893|P5|Test Period 2; Test C*|Withdrawal by Subject|0
1665565|NCT01514136|5822894|P4|Test Period 2; Test C*|Withdrawal by Subject|0
1665566|NCT01514136|5822895|P3|Test Period 2; Test C*|Withdrawal by Subject|0
1665567|NCT01514136|5822896|P2|Test Period 2; Test C*|Withdrawal by Subject|0
1665568|NCT01514136|5822897|P1|Test Period 2; Test C*|Withdrawal by Subject|0
1665569|NCT01514136|5822890|P8|Test Period 2; Test B*|Withdrawal by Subject|0
1665570|NCT01514136|5822891|P7|Test Period 2; Test B*|Withdrawal by Subject|0
1665571|NCT01514136|5822892|P6|Test Period 2; Test B*|Withdrawal by Subject|2
1665572|NCT01514136|5822893|P5|Test Period 2; Test B*|Withdrawal by Subject|0
1665573|NCT01514136|5822894|P4|Test Period 2; Test B*|Withdrawal by Subject|0
1665574|NCT01514136|5822895|P3|Test Period 2; Test B*|Withdrawal by Subject|0
1665575|NCT01514136|5822896|P2|Test Period 2; Test B*|Withdrawal by Subject|0
1665576|NCT01514136|5822897|P1|Test Period 2; Test B*|Withdrawal by Subject|0
1665577|NCT01514136|5822890|P8|Test Period 2; Test A*|Holiday|0
1665578|NCT01514136|5822891|P7|Test Period 2; Test A*|Holiday|0
1665580|NCT01514136|5822893|P5|Test Period 2; Test A*|Holiday|1
1665581|NCT01514136|5822894|P4|Test Period 2; Test A*|Holiday|0
1665582|NCT01514136|5822895|P3|Test Period 2; Test A*|Holiday|0
1665583|NCT01514136|5822896|P2|Test Period 2; Test A*|Holiday|0
1665584|NCT01514136|5822897|P1|Test Period 2; Test A*|Holiday|0
1665585|NCT01514136|5822890|P8|Test Period 2; Test A*|Adverse Event|0
1665586|NCT01514136|5822891|P7|Test Period 2; Test A*|Adverse Event|0
1665587|NCT01514136|5822892|P6|Test Period 2; Test A*|Adverse Event|0
1665588|NCT01514136|5822893|P5|Test Period 2; Test A*|Adverse Event|1
1665589|NCT01514136|5822894|P4|Test Period 2; Test A*|Adverse Event|0
1665590|NCT01514136|5822895|P3|Test Period 2; Test A*|Adverse Event|0
1665591|NCT01514136|5822896|P2|Test Period 2; Test A*|Adverse Event|0
1665592|NCT01514136|5822897|P1|Test Period 2; Test A*|Adverse Event|0
1665593|NCT01514136|5822890|P8|Test Period 1; Test D|Subject took a break due to holiday|0
1665594|NCT01514136|5822891|P7|Test Period 1; Test D|Subject took a break due to holiday|0
1665595|NCT01514136|5822892|P6|Test Period 1; Test D|Subject took a break due to holiday|0
1665596|NCT01514136|5822893|P5|Test Period 1; Test D|Subject took a break due to holiday|0
1665597|NCT01514136|5822894|P4|Test Period 1; Test D|Subject took a break due to holiday|2
1665598|NCT01514136|5822895|P3|Test Period 1; Test D|Subject took a break due to holiday|0
1665599|NCT01514136|5822896|P2|Test Period 1; Test D|Subject took a break due to holiday|0
1665600|NCT01514136|5822897|P1|Test Period 1; Test D|Subject took a break due to holiday|0
1665601|NCT01514136|5822890|P8|Test Period 1; Test B|Withdrawal by Subject|0
1665602|NCT01514136|5822891|P7|Test Period 1; Test B|Withdrawal by Subject|0
1665603|NCT01514136|5822892|P6|Test Period 1; Test B|Withdrawal by Subject|0
1665604|NCT01514136|5822893|P5|Test Period 1; Test B|Withdrawal by Subject|0
1665605|NCT01514136|5822894|P4|Test Period 1; Test B|Withdrawal by Subject|0
1665606|NCT01514136|5822895|P3|Test Period 1; Test B|Withdrawal by Subject|0
1665607|NCT01514136|5822896|P2|Test Period 1; Test B|Withdrawal by Subject|1
1665608|NCT01514136|5822897|P1|Test Period 1; Test B|Withdrawal by Subject|0
1665609|NCT01514136|5822890|P8|Test Period 1; Test A|Break from study holiday|0
1665610|NCT01514136|5822891|P7|Test Period 1; Test A|Break from study holiday|0
1665611|NCT01514136|5822892|P6|Test Period 1; Test A|Break from study holiday|0
1665612|NCT01514136|5822893|P5|Test Period 1; Test A|Break from study holiday|0
1665613|NCT01514136|5822894|P4|Test Period 1; Test A|Break from study holiday|0
1665614|NCT01514136|5822895|P3|Test Period 1; Test A|Break from study holiday|0
1665615|NCT01514136|5822896|P2|Test Period 1; Test A|Break from study holiday|0
1665616|NCT01514136|5822897|P1|Test Period 1; Test A|Break from study holiday|2
1665617|NCT01514136|5822890|P8|Test Period 1; Test A|Protocol Violation|0
1665618|NCT01514136|5822891|P7|Test Period 1; Test A|Protocol Violation|0
1665619|NCT01514136|5822892|P6|Test Period 1; Test A|Protocol Violation|0
1665620|NCT01514136|5822893|P5|Test Period 1; Test A|Protocol Violation|0
1665621|NCT01514136|5822894|P4|Test Period 1; Test A|Protocol Violation|0
1665622|NCT01514136|5822895|P3|Test Period 1; Test A|Protocol Violation|0
1665623|NCT01514136|5822896|P2|Test Period 1; Test A|Protocol Violation|0
1665624|NCT01514136|5822897|P1|Test Period 1; Test A|Protocol Violation|1
1665625|NCT01513759|5822963|P1|Overall Study|Death during catheter placement|1
1665626|NCT01513759|5822963|P1|Overall Study|Protocol Violation|4
1665627|NCT01513590|5822974|P2|Overall Study|Unclassified|10
1665628|NCT01513590|5822975|P1|Overall Study|Unclassified|5
1665629|NCT01513590|5822974|P2|Overall Study|Withdrawal Criteria|0
1665630|NCT01513590|5822975|P1|Overall Study|Withdrawal Criteria|3
1665631|NCT01513590|5822974|P2|Overall Study|Adverse Event|3
1665632|NCT01513590|5822975|P1|Overall Study|Adverse Event|2
1665633|NCT01513551|5822996|P3|Overall Study|Randomized but not vaccinated|1
1665634|NCT01513551|5822997|P2|Overall Study|Randomized but not vaccinated|0
1665635|NCT01513551|5822998|P1|Overall Study|Randomized but not vaccinated|0
1665636|NCT01513551|5822996|P3|Overall Study|Withdrawal by Subject|2
1665637|NCT01513551|5822997|P2|Overall Study|Withdrawal by Subject|0
1665638|NCT01513551|5822998|P1|Overall Study|Withdrawal by Subject|1
1665639|NCT01513551|5822996|P3|Overall Study|Lost to Follow-up|2
1665640|NCT01513551|5822997|P2|Overall Study|Lost to Follow-up|5
1665641|NCT01513551|5822998|P1|Overall Study|Lost to Follow-up|3
1665642|NCT01513551|5822996|P3|Overall Study|Death|0
1665643|NCT01513551|5822997|P2|Overall Study|Death|1
1665644|NCT01513551|5822998|P1|Overall Study|Death|0
1665645|NCT01513473|5823030|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
1665646|NCT01513473|5823031|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
1665647|NCT01513473|5823030|P2|Extension Trial (26 Weeks)|Adverse Event|1
1665648|NCT01513473|5823031|P1|Extension Trial (26 Weeks)|Adverse Event|0
1665649|NCT01513473|5823030|P2|Main Trial (26 Weeks)|Unclassified|2
1665650|NCT01513473|5823031|P1|Main Trial (26 Weeks)|Unclassified|0
1665651|NCT01513473|5823030|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
1665652|NCT01513473|5823031|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
1665653|NCT01513473|5823030|P2|Main Trial (26 Weeks)|Adverse Event|2
1665654|NCT01513473|5823031|P1|Main Trial (26 Weeks)|Adverse Event|0
1665655|NCT01513460|5823058|P3|Overall Study|Abnormal test procedure|0
1665656|NCT01513460|5823059|P2|Overall Study|Abnormal test procedure|0
1665657|NCT01513460|5823060|P1|Overall Study|Abnormal test procedure|1
1665658|NCT01513460|5823058|P3|Overall Study|Adverse Event|23
1665659|NCT01513460|5823059|P2|Overall Study|Adverse Event|18
1665660|NCT01513460|5823060|P1|Overall Study|Adverse Event|16
1665661|NCT01513460|5823058|P3|Overall Study|Withdrawal by Subject|21
1665662|NCT01513460|5823059|P2|Overall Study|Withdrawal by Subject|8
1665663|NCT01513460|5823060|P1|Overall Study|Withdrawal by Subject|7
1665664|NCT01513460|5823058|P3|Overall Study|Protocol deviations|3
1665665|NCT01513460|5823059|P2|Overall Study|Protocol deviations|4
1665666|NCT01513460|5823060|P1|Overall Study|Protocol deviations|3
1665667|NCT01513460|5823058|P3|Overall Study|Lack of Efficacy|5
1665668|NCT01513460|5823059|P2|Overall Study|Lack of Efficacy|2
1665669|NCT01513460|5823060|P1|Overall Study|Lack of Efficacy|1
1665670|NCT01513460|5823058|P3|Overall Study|Abnormal laboratory value|1
1665671|NCT01513460|5823059|P2|Overall Study|Abnormal laboratory value|0
1665672|NCT01513460|5823060|P1|Overall Study|Abnormal laboratory value|1
1665673|NCT01513460|5823058|P3|Overall Study|Lost to Follow-up|2
1665674|NCT01513460|5823059|P2|Overall Study|Lost to Follow-up|0
1665675|NCT01513460|5823060|P1|Overall Study|Lost to Follow-up|0
1665676|NCT01513460|5823058|P3|Overall Study|Death|1
1665677|NCT01513460|5823059|P2|Overall Study|Death|0
1665678|NCT01513460|5823060|P1|Overall Study|Death|0
1665679|NCT01513330|5823095|P2|Standard Care First,|Other|0
1665680|NCT01513330|5823096|P1|Standard Care First,|Other|1
1665681|NCT01513330|5823095|P2|Standard Care First,|Withdrawal by Subject|2
1665682|NCT01513330|5823096|P1|Standard Care First,|Withdrawal by Subject|1
1665683|NCT01513330|5823095|P2|Standard Care First,|Lack of Efficacy|2
1665684|NCT01513330|5823096|P1|Standard Care First,|Lack of Efficacy|2
1665685|NCT01513330|5823095|P2|SenSura Mio First,|Other|0
1665686|NCT01513330|5823096|P1|SenSura Mio First,|Other|1
1665687|NCT01513330|5823095|P2|SenSura Mio First,|Withdrawal by Subject|1
1665688|NCT01513330|5823096|P1|SenSura Mio First,|Withdrawal by Subject|1
1665689|NCT01513330|5823095|P2|SenSura Mio First,|Lack of Efficacy|1
1665690|NCT01513330|5823096|P1|SenSura Mio First,|Lack of Efficacy|0
1665691|NCT01513330|5823095|P2|SenSura Mio First,|Adverse Event|0
1665692|NCT01513330|5823096|P1|SenSura Mio First,|Adverse Event|2
1665693|NCT01513317|5823104|P2|Overall Study|Other|1
1665694|NCT01513317|5823105|P1|Overall Study|Other|0
1665695|NCT01513317|5823104|P2|Overall Study|Study terminated by sponsor|18
1665696|NCT01513317|5823105|P1|Overall Study|Study terminated by sponsor|18
1665697|NCT01513317|5823104|P2|Overall Study|Death|1
1665698|NCT01513317|5823105|P1|Overall Study|Death|1
1665699|NCT01513317|5823104|P2|Overall Study|Withdrawal by Subject|4
1665700|NCT01513317|5823105|P1|Overall Study|Withdrawal by Subject|15
1665701|NCT01513291|5823123|P5|Run-out Period|Withdrawal by Subject|0
1665702|NCT01513291|5823124|P4|Run-out Period|Withdrawal by Subject|1
1665703|NCT01513291|5823125|P3|Run-out Period|Withdrawal by Subject|0
1665704|NCT01513291|5823126|P2|Run-out Period|Withdrawal by Subject|0
1665705|NCT01513291|5823127|P1|Run-out Period|Withdrawal by Subject|0
1665706|NCT01513291|5823123|P5|Run-out Period|Lost to Follow-up|0
1665707|NCT01513291|5823124|P4|Run-out Period|Lost to Follow-up|1
1665708|NCT01513291|5823125|P3|Run-out Period|Lost to Follow-up|0
1665709|NCT01513291|5823126|P2|Run-out Period|Lost to Follow-up|0
1665710|NCT01513291|5823127|P1|Run-out Period|Lost to Follow-up|0
1665711|NCT01513291|5823123|P5|Treatment Period|Randomized not treated|0
1665712|NCT01513291|5823124|P4|Treatment Period|Randomized not treated|0
1665713|NCT01513291|5823125|P3|Treatment Period|Randomized not treated|0
1665714|NCT01513291|5823126|P2|Treatment Period|Randomized not treated|2
1665715|NCT01513291|5823127|P1|Treatment Period|Randomized not treated|0
1665716|NCT01513291|5823123|P5|Treatment Period|Withdrawal by Subject|0
1665717|NCT01513291|5823124|P4|Treatment Period|Withdrawal by Subject|0
1665718|NCT01513291|5823125|P3|Treatment Period|Withdrawal by Subject|0
1665719|NCT01513291|5823126|P2|Treatment Period|Withdrawal by Subject|5
1665720|NCT01513291|5823127|P1|Treatment Period|Withdrawal by Subject|8
1665721|NCT01513291|5823123|P5|Treatment Period|Protocol Violation|0
1665722|NCT01513291|5823124|P4|Treatment Period|Protocol Violation|0
1665723|NCT01513291|5823125|P3|Treatment Period|Protocol Violation|0
1665724|NCT01513291|5823126|P2|Treatment Period|Protocol Violation|2
1665725|NCT01513291|5823127|P1|Treatment Period|Protocol Violation|1
1665726|NCT01513291|5823123|P5|Treatment Period|Physician Decision|0
1665727|NCT01513291|5823124|P4|Treatment Period|Physician Decision|0
1665728|NCT01513291|5823125|P3|Treatment Period|Physician Decision|0
1665729|NCT01513291|5823126|P2|Treatment Period|Physician Decision|0
1665730|NCT01513291|5823127|P1|Treatment Period|Physician Decision|1
1665731|NCT01513291|5823123|P5|Treatment Period|Lost to Follow-up|0
1665732|NCT01513291|5823124|P4|Treatment Period|Lost to Follow-up|0
1665733|NCT01513291|5823125|P3|Treatment Period|Lost to Follow-up|0
1665734|NCT01513291|5823126|P2|Treatment Period|Lost to Follow-up|3
1665735|NCT01513291|5823127|P1|Treatment Period|Lost to Follow-up|2
1665736|NCT01513291|5823123|P5|Treatment Period|Lack of Efficacy|0
1665737|NCT01513291|5823124|P4|Treatment Period|Lack of Efficacy|0
1665738|NCT01513291|5823125|P3|Treatment Period|Lack of Efficacy|0
1665739|NCT01513291|5823126|P2|Treatment Period|Lack of Efficacy|0
1665740|NCT01513291|5823127|P1|Treatment Period|Lack of Efficacy|3
1665741|NCT01513291|5823123|P5|Treatment Period|Adverse Event|0
1665742|NCT01513291|5823124|P4|Treatment Period|Adverse Event|0
1665743|NCT01513291|5823125|P3|Treatment Period|Adverse Event|0
1665744|NCT01513291|5823126|P2|Treatment Period|Adverse Event|4
1665745|NCT01513291|5823127|P1|Treatment Period|Adverse Event|8
1665746|NCT01513239|5823155|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
1665747|NCT01513239|5823156|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
1665748|NCT01513239|5823157|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
1665749|NCT01513239|5823158|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
1665750|NCT01513239|5823159|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
1665751|NCT01513239|5823160|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
1665752|NCT01513239|5823155|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
1665753|NCT01513239|5823156|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
1665754|NCT01513239|5823157|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
1665755|NCT01513239|5823158|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
1665756|NCT01513239|5823159|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
1665757|NCT01513239|5823160|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
1665758|NCT01513239|5823155|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1665759|NCT01513239|5823156|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
1665760|NCT01513239|5823157|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
1665761|NCT01513239|5823158|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1665762|NCT01513239|5823159|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1665763|NCT01513239|5823160|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
1665764|NCT01513239|5823155|P6|Period 2: 9 Month Extension Phase|Death|2
1665765|NCT01513239|5823156|P5|Period 2: 9 Month Extension Phase|Death|5
1665766|NCT01513239|5823157|P4|Period 2: 9 Month Extension Phase|Death|2
1665767|NCT01513239|5823158|P3|Period 2: 9 Month Extension Phase|Death|0
1665768|NCT01513239|5823159|P2|Period 2: 9 Month Extension Phase|Death|0
1665769|NCT01513239|5823160|P1|Period 2: 9 Month Extension Phase|Death|0
1665770|NCT01513239|5823155|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
1665771|NCT01513239|5823156|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
1665772|NCT01513239|5823157|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
1665773|NCT01513239|5823158|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1665774|NCT01513239|5823159|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1665775|NCT01513239|5823160|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
1665776|NCT01513239|5823155|P6|Period 1: Main Phase|Withdrawal by Subject|0
1665777|NCT01513239|5823156|P5|Period 1: Main Phase|Withdrawal by Subject|0
1665778|NCT01513239|5823157|P4|Period 1: Main Phase|Withdrawal by Subject|0
1665779|NCT01513239|5823158|P3|Period 1: Main Phase|Withdrawal by Subject|42
1665780|NCT01513239|5823159|P2|Period 1: Main Phase|Withdrawal by Subject|29
1665781|NCT01513239|5823160|P1|Period 1: Main Phase|Withdrawal by Subject|27
1665782|NCT01513239|5823155|P6|Period 1: Main Phase|Technical Problems|0
1665783|NCT01513239|5823156|P5|Period 1: Main Phase|Technical Problems|0
1665784|NCT01513239|5823157|P4|Period 1: Main Phase|Technical Problems|0
1665785|NCT01513239|5823158|P3|Period 1: Main Phase|Technical Problems|0
1665786|NCT01513239|5823159|P2|Period 1: Main Phase|Technical Problems|2
1665787|NCT01513239|5823160|P1|Period 1: Main Phase|Technical Problems|1
1665788|NCT01513239|5823155|P6|Period 1: Main Phase|Protocol Violation|0
1665789|NCT01513239|5823156|P5|Period 1: Main Phase|Protocol Violation|0
1665790|NCT01513239|5823157|P4|Period 1: Main Phase|Protocol Violation|0
1665791|NCT01513239|5823158|P3|Period 1: Main Phase|Protocol Violation|2
1665792|NCT01513239|5823159|P2|Period 1: Main Phase|Protocol Violation|2
1665793|NCT01513239|5823160|P1|Period 1: Main Phase|Protocol Violation|2
1665794|NCT01513239|5823155|P6|Period 1: Main Phase|Physician Decision|0
1665795|NCT01513239|5823156|P5|Period 1: Main Phase|Physician Decision|0
1665796|NCT01513239|5823157|P4|Period 1: Main Phase|Physician Decision|0
1665797|NCT01513239|5823158|P3|Period 1: Main Phase|Physician Decision|4
1665798|NCT01513239|5823159|P2|Period 1: Main Phase|Physician Decision|4
1665799|NCT01513239|5823160|P1|Period 1: Main Phase|Physician Decision|4
1665800|NCT01513239|5823155|P6|Period 1: Main Phase|Lost to Follow-up|0
1665801|NCT01513239|5823156|P5|Period 1: Main Phase|Lost to Follow-up|0
1665802|NCT01513239|5823157|P4|Period 1: Main Phase|Lost to Follow-up|0
1665803|NCT01513239|5823158|P3|Period 1: Main Phase|Lost to Follow-up|6
1665804|NCT01513239|5823159|P2|Period 1: Main Phase|Lost to Follow-up|10
1665805|NCT01513239|5823160|P1|Period 1: Main Phase|Lost to Follow-up|11
1665806|NCT01513239|5823155|P6|Period 1: Main Phase|Death|0
1665807|NCT01513239|5823156|P5|Period 1: Main Phase|Death|0
1665808|NCT01513239|5823157|P4|Period 1: Main Phase|Death|0
1665809|NCT01513239|5823158|P3|Period 1: Main Phase|Death|32
1665810|NCT01513239|5823159|P2|Period 1: Main Phase|Death|22
1665811|NCT01513239|5823160|P1|Period 1: Main Phase|Death|29
1665812|NCT01513239|5823155|P6|Period 1: Main Phase|Adverse Event|0
1665813|NCT01513239|5823156|P5|Period 1: Main Phase|Adverse Event|0
1665814|NCT01513239|5823157|P4|Period 1: Main Phase|Adverse Event|0
1665815|NCT01513239|5823158|P3|Period 1: Main Phase|Adverse Event|2
1665816|NCT01513239|5823159|P2|Period 1: Main Phase|Adverse Event|1
1665817|NCT01513239|5823160|P1|Period 1: Main Phase|Adverse Event|1
1665818|NCT01513148|5823213|P2|Overall Study|Protocol Violation|2
1665819|NCT01513148|5823214|P1|Overall Study|Protocol Violation|2
1665820|NCT01512979|5823281|P2|Overall Study|Reason other than stated above|9
1665821|NCT01512979|5823282|P1|Overall Study|Reason other than stated above|13
1665822|NCT01512979|5823281|P2|Overall Study|Withdrawal by Subject|2
1665823|NCT01512979|5823282|P1|Overall Study|Withdrawal by Subject|1
1665824|NCT01512979|5823281|P2|Overall Study|Lost to Follow-up|5
1665825|NCT01512979|5823282|P1|Overall Study|Lost to Follow-up|2
1665826|NCT01512979|5823281|P2|Overall Study|Protocol Violation|4
1665827|NCT01512979|5823282|P1|Overall Study|Protocol Violation|1
1665828|NCT01512979|5823281|P2|Overall Study|Adverse Event|2
1665829|NCT01512979|5823282|P1|Overall Study|Adverse Event|2
1665830|NCT01512745|5823382|P2|Overall Study|Protocol Violation|0
1665831|NCT01512745|5823383|P1|Overall Study|Protocol Violation|1
1665832|NCT01512745|5823382|P2|Overall Study|Lack of Efficacy|2
1665833|NCT01512745|5823383|P1|Overall Study|Lack of Efficacy|2
1665834|NCT01512745|5823382|P2|Overall Study|Lost to Follow-up|0
1665835|NCT01512745|5823383|P1|Overall Study|Lost to Follow-up|4
1665836|NCT01512745|5823382|P2|Overall Study|Withdrawal by Subject|2
1665837|NCT01512745|5823383|P1|Overall Study|Withdrawal by Subject|2
1665838|NCT01512745|5823382|P2|Overall Study|Death|13
1665839|NCT01512745|5823383|P1|Overall Study|Death|9
1665840|NCT01512745|5823382|P2|Overall Study|Adverse Event|3
1665841|NCT01512745|5823383|P1|Overall Study|Adverse Event|22
1665842|NCT01512693|5823399|P2|Overall Study|Withdrawal by Subject|1
1665843|NCT01512693|5823400|P1|Overall Study|Withdrawal by Subject|0
1665844|NCT01512368|5823440|P1|Overall Study|Protocol Violation|3
1665845|NCT01512264|5823453|P4|Overall Study|Lost to Follow-up|1
1665846|NCT01512264|5823454|P3|Overall Study|Lost to Follow-up|0
1665847|NCT01512264|5823455|P2|Overall Study|Lost to Follow-up|0
1665848|NCT01512264|5823456|P1|Overall Study|Lost to Follow-up|0
1665849|NCT01512160|5823595|P4|Overall Study|Withdrawal by Subject|1
1665850|NCT01512160|5823596|P3|Overall Study|Withdrawal by Subject|0
1665851|NCT01512160|5823597|P2|Overall Study|Withdrawal by Subject|0
1665852|NCT01512160|5823598|P1|Overall Study|Withdrawal by Subject|1
1665853|NCT01512160|5823595|P4|Overall Study|Lost to Follow-up|0
1665854|NCT01512160|5823596|P3|Overall Study|Lost to Follow-up|0
1665855|NCT01512160|5823597|P2|Overall Study|Lost to Follow-up|0
1665856|NCT01512160|5823598|P1|Overall Study|Lost to Follow-up|1
1665857|NCT01512108|5823690|P2|Overall Study|Unclassified|3
1665858|NCT01512108|5823691|P1|Overall Study|Unclassified|11
1665859|NCT01512108|5823690|P2|Overall Study|Withdrawal Criteria|0
1665860|NCT01512108|5823691|P1|Overall Study|Withdrawal Criteria|1
1665861|NCT01512108|5823690|P2|Overall Study|Protocol Violation|2
1665862|NCT01512108|5823691|P1|Overall Study|Protocol Violation|1
1665863|NCT01512108|5823690|P2|Overall Study|Adverse Event|4
1665864|NCT01512108|5823691|P1|Overall Study|Adverse Event|9
1665865|NCT01511939|5823717|P3|Overall Study|Withdrawal by Subject|0
1665866|NCT01511939|5823718|P2|Overall Study|Withdrawal by Subject|1
1665867|NCT01511939|5823719|P1|Overall Study|Withdrawal by Subject|2
1665868|NCT01511536|5823748|P3|Phase 2|Other|9
1665869|NCT01511536|5823749|P2|Phase 2|Other|0
1665870|NCT01511536|5823750|P1|Phase 2|Other|0
1665871|NCT01511536|5823748|P3|Phase 1|Other|0
1665872|NCT01511536|5823749|P2|Phase 1|Other|1
1665873|NCT01511536|5823750|P1|Phase 1|Other|0
1665874|NCT01511445|5823772|P2|Overall Study|Protocol Violation|0
1665875|NCT01511445|5823773|P1|Overall Study|Protocol Violation|1
1665876|NCT01511445|5823772|P2|Overall Study|Protocol Violation|3
1665877|NCT01511445|5823773|P1|Overall Study|Protocol Violation|1
1665878|NCT01511445|5823772|P2|Overall Study|Lost to Follow-up|1
1665879|NCT01511445|5823773|P1|Overall Study|Lost to Follow-up|3
1665880|NCT01511419|5823783|P2|Dose 2|Physician Decision|0
1665881|NCT01511419|5823784|P1|Dose 2|Physician Decision|1
1665882|NCT01511250|5823896|P10|Overall Study|Protocol Violation|0
1665883|NCT01511250|5823897|P9|Overall Study|Protocol Violation|0
1665884|NCT01511250|5823898|P8|Overall Study|Protocol Violation|0
1665885|NCT01511250|5823899|P7|Overall Study|Protocol Violation|0
1665886|NCT01511250|5823900|P6|Overall Study|Protocol Violation|0
1665887|NCT01511250|5823901|P5|Overall Study|Protocol Violation|0
1665888|NCT01511250|5823902|P4|Overall Study|Protocol Violation|0
1665889|NCT01511250|5823903|P3|Overall Study|Protocol Violation|1
1665890|NCT01511250|5823904|P2|Overall Study|Protocol Violation|2
1665891|NCT01511250|5823905|P1|Overall Study|Protocol Violation|0
1665892|NCT01511250|5823896|P10|Overall Study|Lost to Follow-up|5
1665893|NCT01511250|5823897|P9|Overall Study|Lost to Follow-up|13
1665894|NCT01511250|5823898|P8|Overall Study|Lost to Follow-up|3
1665895|NCT01511250|5823899|P7|Overall Study|Lost to Follow-up|2
1665896|NCT01511250|5823900|P6|Overall Study|Lost to Follow-up|0
1665897|NCT01511250|5823901|P5|Overall Study|Lost to Follow-up|0
1665898|NCT01511250|5823902|P4|Overall Study|Lost to Follow-up|3
1665899|NCT01511250|5823903|P3|Overall Study|Lost to Follow-up|3
1665900|NCT01511250|5823904|P2|Overall Study|Lost to Follow-up|3
1665901|NCT01511250|5823905|P1|Overall Study|Lost to Follow-up|7
1665902|NCT01511250|5823896|P10|Overall Study|Sponsor/Investigator Decision|0
1665903|NCT01511250|5823897|P9|Overall Study|Sponsor/Investigator Decision|0
1665904|NCT01511250|5823898|P8|Overall Study|Sponsor/Investigator Decision|0
1665905|NCT01511250|5823899|P7|Overall Study|Sponsor/Investigator Decision|0
1665906|NCT01511250|5823900|P6|Overall Study|Sponsor/Investigator Decision|0
1665907|NCT01511250|5823901|P5|Overall Study|Sponsor/Investigator Decision|0
1665908|NCT01511250|5823902|P4|Overall Study|Sponsor/Investigator Decision|0
1665909|NCT01511250|5823903|P3|Overall Study|Sponsor/Investigator Decision|0
1665910|NCT01511250|5823904|P2|Overall Study|Sponsor/Investigator Decision|0
1665911|NCT01511250|5823905|P1|Overall Study|Sponsor/Investigator Decision|1
1665912|NCT01511250|5823896|P10|Overall Study|Withdrawal of Consent|0
1665913|NCT01511250|5823897|P9|Overall Study|Withdrawal of Consent|1
1665914|NCT01511250|5823898|P8|Overall Study|Withdrawal of Consent|1
1665915|NCT01511250|5823899|P7|Overall Study|Withdrawal of Consent|0
1665916|NCT01511250|5823900|P6|Overall Study|Withdrawal of Consent|0
1665917|NCT01511250|5823901|P5|Overall Study|Withdrawal of Consent|0
1665918|NCT01511250|5823902|P4|Overall Study|Withdrawal of Consent|0
1665919|NCT01511250|5823903|P3|Overall Study|Withdrawal of Consent|0
1665920|NCT01511250|5823904|P2|Overall Study|Withdrawal of Consent|0
1665921|NCT01511250|5823905|P1|Overall Study|Withdrawal of Consent|1
1665922|NCT01511107|5824053|P2|Overall Study|Withdrawal by Subject|20
1665923|NCT01511107|5824054|P1|Overall Study|Withdrawal by Subject|9
1665924|NCT01511107|5824053|P2|Overall Study|Lost to Follow-up|19
1665925|NCT01511107|5824054|P1|Overall Study|Lost to Follow-up|10
1665926|NCT01511107|5824053|P2|Overall Study|Ineligible|2
1665927|NCT01511107|5824054|P1|Overall Study|Ineligible|3
1665928|NCT01510912|5824132|P1|Overall Study|Other, including joint replacement|5
1665929|NCT01510912|5824132|P1|Overall Study|Lost to Follow-up|26
1665930|NCT01510912|5824132|P1|Overall Study|Protocol Violation|27
1665931|NCT01510912|5824132|P1|Overall Study|Physician Decision|1
1665932|NCT01510912|5824132|P1|Overall Study|Withdrawal by Subject|49
1665933|NCT01510912|5824132|P1|Overall Study|Non-compliance with trial drug|23
1665934|NCT01510912|5824132|P1|Overall Study|Lack of Efficacy|12
1665935|NCT01510912|5824132|P1|Overall Study|Adverse Event|99
1665936|NCT01510769|5824148|P3|Overall Study|Death|0
1665937|NCT01510769|5824149|P2|Overall Study|Death|1
1665938|NCT01510769|5824150|P1|Overall Study|Death|1
1665939|NCT01510769|5824148|P3|Overall Study|Withdrawal by Subject|3
1665940|NCT01510769|5824149|P2|Overall Study|Withdrawal by Subject|4
1665941|NCT01510769|5824150|P1|Overall Study|Withdrawal by Subject|3
1665942|NCT01510769|5824148|P3|Overall Study|Lost to Follow-up|5
1665943|NCT01510769|5824149|P2|Overall Study|Lost to Follow-up|1
1665944|NCT01510769|5824150|P1|Overall Study|Lost to Follow-up|5
1665945|NCT01510769|5824148|P3|Overall Study|Protocol Violation|9
1665946|NCT01510769|5824149|P2|Overall Study|Protocol Violation|10
1665947|NCT01510769|5824150|P1|Overall Study|Protocol Violation|11
1665948|NCT01510769|5824148|P3|Overall Study|Gout Flare|1
1665949|NCT01510769|5824149|P2|Overall Study|Gout Flare|3
1665950|NCT01510769|5824150|P1|Overall Study|Gout Flare|0
1665951|NCT01510769|5824148|P3|Overall Study|Adverse Event|4
1665952|NCT01510769|5824149|P2|Overall Study|Adverse Event|6
1665953|NCT01510769|5824150|P1|Overall Study|Adverse Event|7
1665954|NCT01510756|5824167|P1|Overall Study|Physician Decision|1
1665955|NCT01510756|5824167|P1|Overall Study|Lack of Efficacy|2
1665956|NCT01510756|5824167|P1|Overall Study|Death|1
1665957|NCT01510717|5824175|P2|Overall Study|Withdrawal by Subject|2
1665958|NCT01510717|5824176|P1|Overall Study|Withdrawal by Subject|0
1665959|NCT01510717|5824175|P2|Overall Study|Lost to Follow-up|1
1665960|NCT01510717|5824176|P1|Overall Study|Lost to Follow-up|0
1665961|NCT01510717|5824175|P2|Overall Study|Death|0
1665962|NCT01510717|5824176|P1|Overall Study|Death|1
1665963|NCT01510717|5824175|P2|Overall Study|Adverse Event|2
1665964|NCT01510717|5824176|P1|Overall Study|Adverse Event|1
1665965|NCT01510158|5824296|P3|Overall Study|Death|0
1665966|NCT01510158|5824297|P2|Overall Study|Death|0
1665967|NCT01510158|5824298|P1|Overall Study|Death|1
1665968|NCT01510158|5824296|P3|Overall Study|Withdrawal by Subject|10
1665969|NCT01510158|5824297|P2|Overall Study|Withdrawal by Subject|13
1665970|NCT01510158|5824298|P1|Overall Study|Withdrawal by Subject|10
1665971|NCT01510158|5824296|P3|Overall Study|Lost to Follow-up|9
1665972|NCT01510158|5824297|P2|Overall Study|Lost to Follow-up|16
1665973|NCT01510158|5824298|P1|Overall Study|Lost to Follow-up|13
1665974|NCT01510158|5824296|P3|Overall Study|Sponsor terminated study.|2
1665975|NCT01510158|5824297|P2|Overall Study|Sponsor terminated study.|0
1665976|NCT01510158|5824298|P1|Overall Study|Sponsor terminated study.|2
1665977|NCT01510158|5824296|P3|Overall Study|Protocol Violation|24
1665978|NCT01510158|5824297|P2|Overall Study|Protocol Violation|16
1665979|NCT01510158|5824298|P1|Overall Study|Protocol Violation|17
1665980|NCT01510158|5824296|P3|Overall Study|Gout flare|0
1665981|NCT01510158|5824297|P2|Overall Study|Gout flare|0
1665982|NCT01510158|5824298|P1|Overall Study|Gout flare|1
1665983|NCT01510158|5824296|P3|Overall Study|Adverse Event|5
1665984|NCT01510158|5824297|P2|Overall Study|Adverse Event|8
1665985|NCT01510158|5824298|P1|Overall Study|Adverse Event|7
1665986|NCT01510145|5824312|P1|Overall Study|Relative reported subject withdrew|1
1665987|NCT01510145|5824312|P1|Overall Study|Withdrawal by Subject|6
1665988|NCT01510145|5824312|P1|Overall Study|Lost to Follow-up|5
1665989|NCT01510145|5824312|P1|Overall Study|Adverse Event|6
1665990|NCT01510028|5824321|P4|Overall Study|Lack of Efficacy|0
1665991|NCT01510028|5824322|P3|Overall Study|Lack of Efficacy|0
1665992|NCT01510028|5824323|P2|Overall Study|Lack of Efficacy|0
1665993|NCT01510028|5824324|P1|Overall Study|Lack of Efficacy|1
1665994|NCT01509664|5824585|P2|Overall Study|Lost to Follow-up|21
1665995|NCT01509664|5824586|P1|Overall Study|Lost to Follow-up|15
1665996|NCT01509547|5824646|P2|Overall Study|Physician Decision|1
1665997|NCT01509547|5824647|P1|Overall Study|Physician Decision|0
1665998|NCT01509547|5824646|P2|Overall Study|Withdrawal by Subject|24
1665999|NCT01509547|5824647|P1|Overall Study|Withdrawal by Subject|11
1666000|NCT01509547|5824646|P2|Overall Study|Lost to Follow-up|14
1666001|NCT01509547|5824647|P1|Overall Study|Lost to Follow-up|24
1666002|NCT01509079|5824714|P2|Overall Study|started an excluded medication|1
1666003|NCT01509079|5824715|P1|Overall Study|started an excluded medication|0
1666004|NCT01509079|5824714|P2|Overall Study|Lack of Efficacy|2
1666005|NCT01509079|5824715|P1|Overall Study|Lack of Efficacy|0
1666006|NCT01509053|5824735|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
1666007|NCT01509053|5824735|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
1666008|NCT01509053|5824735|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
1666009|NCT01509053|5824735|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
1666010|NCT01509053|5824735|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
1666011|NCT01509053|5824735|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
1666012|NCT01508936|5824797|P2|Overall Study|Data from 2 sites deemed invalid|11
1666013|NCT01508936|5824798|P1|Overall Study|Data from 2 sites deemed invalid|4
1666014|NCT01508936|5824797|P2|Overall Study|Other|5
1666015|NCT01508936|5824798|P1|Overall Study|Other|0
1666016|NCT01508936|5824797|P2|Overall Study|Lost to Follow-up|9
1666017|NCT01508936|5824798|P1|Overall Study|Lost to Follow-up|2
1666018|NCT01508936|5824797|P2|Overall Study|Protocol Violation|3
1666019|NCT01508936|5824798|P1|Overall Study|Protocol Violation|2
1666020|NCT01508936|5824797|P2|Overall Study|Withdrawal by Subject|18
1666021|NCT01508936|5824798|P1|Overall Study|Withdrawal by Subject|4
1666022|NCT01508936|5824797|P2|Overall Study|Lack of Efficacy|1
1666023|NCT01508936|5824798|P1|Overall Study|Lack of Efficacy|0
1666024|NCT01508936|5824797|P2|Overall Study|Adverse Event|32
1666025|NCT01508936|5824798|P1|Overall Study|Adverse Event|11
1666026|NCT01508910|5824837|P4|Treatment|Sponsor Decision|1
1666027|NCT01508910|5824838|P3|Treatment|Sponsor Decision|0
1666028|NCT01508910|5824839|P2|Treatment|Sponsor Decision|0
1666029|NCT01508910|5824840|P1|Treatment|Sponsor Decision|0
1666030|NCT01508910|5824837|P4|Treatment|Withdrawal by Subject|1
1666031|NCT01508910|5824838|P3|Treatment|Withdrawal by Subject|6
1666032|NCT01508910|5824839|P2|Treatment|Withdrawal by Subject|1
1666033|NCT01508910|5824840|P1|Treatment|Withdrawal by Subject|0
1666034|NCT01508910|5824837|P4|Treatment|Lost to Follow-up|1
1666035|NCT01508910|5824838|P3|Treatment|Lost to Follow-up|2
1666036|NCT01508910|5824839|P2|Treatment|Lost to Follow-up|0
1666037|NCT01508910|5824840|P1|Treatment|Lost to Follow-up|0
1666038|NCT01508910|5824837|P4|Treatment|Death|0
1666039|NCT01508910|5824838|P3|Treatment|Death|2
1666040|NCT01508910|5824839|P2|Treatment|Death|3
1666041|NCT01508910|5824840|P1|Treatment|Death|2
1666042|NCT01508702|5824873|P2|Overall Study|Withdrawal by Subject|7
1666043|NCT01508702|5824874|P1|Overall Study|Withdrawal by Subject|11
1666044|NCT01508702|5824873|P2|Overall Study|Lost to Follow-up|2
1666045|NCT01508702|5824874|P1|Overall Study|Lost to Follow-up|1
1666046|NCT01508702|5824873|P2|Overall Study|Protocol Violation|1
1666047|NCT01508702|5824874|P1|Overall Study|Protocol Violation|2
1666048|NCT01508702|5824873|P2|Overall Study|Gout flare|0
1666049|NCT01508702|5824874|P1|Overall Study|Gout flare|2
1666050|NCT01508702|5824873|P2|Overall Study|Adverse Event|3
1666051|NCT01508702|5824874|P1|Overall Study|Adverse Event|7
1666052|NCT01508676|5824882|P2|Phase II (2 Weeks)|Medication Exclusion|0
1666053|NCT01508676|5824883|P1|Phase II (2 Weeks)|Medication Exclusion|1
1666054|NCT01508676|5824882|P2|Phase II (2 Weeks)|Skin Sensitivity|1
1666055|NCT01508676|5824883|P1|Phase II (2 Weeks)|Skin Sensitivity|0
1666056|NCT01508676|5824882|P2|Phase I (2 Weeks)|Positive Drug Screen|2
1666057|NCT01508676|5824883|P1|Phase I (2 Weeks)|Positive Drug Screen|0
1666058|NCT01508676|5824882|P2|Phase I (2 Weeks)|Wrong Pain Type|0
1666059|NCT01508676|5824883|P1|Phase I (2 Weeks)|Wrong Pain Type|1
1666060|NCT01508676|5824882|P2|Phase I (2 Weeks)|Medication Exclusion|1
1666061|NCT01508676|5824883|P1|Phase I (2 Weeks)|Medication Exclusion|1
1666062|NCT01508650|5824895|P2|Overall Study|Lost to Follow-up|3
1666063|NCT01508650|5824896|P1|Overall Study|Lost to Follow-up|0
1666064|NCT01508325|5824915|P2|Overall Study|Other|2
1666065|NCT01508325|5824916|P1|Overall Study|Other|2
1666066|NCT01508325|5824915|P2|Overall Study|Lost to Follow-up|6
1666067|NCT01508325|5824916|P1|Overall Study|Lost to Follow-up|5
1666068|NCT01508325|5824915|P2|Overall Study|Adverse Event|0
1666069|NCT01508325|5824916|P1|Overall Study|Adverse Event|1
1666070|NCT01508325|5824915|P2|Overall Study|Physician Decision|1
1666071|NCT01508325|5824916|P1|Overall Study|Physician Decision|2
1666072|NCT01508325|5824915|P2|Overall Study|Protocol Violation|3
1666073|NCT01508325|5824916|P1|Overall Study|Protocol Violation|0
1666074|NCT01508325|5824915|P2|Overall Study|Withdrawal by Subject|9
1666075|NCT01508325|5824916|P1|Overall Study|Withdrawal by Subject|8
1666076|NCT01508169|5824946|P2|Overall Study|Lost to Follow-up|2
1666077|NCT01508169|5824947|P1|Overall Study|Lost to Follow-up|1
1666078|NCT01508169|5824946|P2|Overall Study|Withdrawal by Subject|0
1666079|NCT01508169|5824947|P1|Overall Study|Withdrawal by Subject|1
1666080|NCT01508169|5824946|P2|Overall Study|Adverse Event|0
1666081|NCT01508169|5824947|P1|Overall Study|Adverse Event|1
1666082|NCT01508130|5824961|P2|Overall Study|Administrative|3
1666083|NCT01508130|5824962|P1|Overall Study|Administrative|14
1666084|NCT01508130|5824961|P2|Overall Study|Insufficient therapeutic response|23
1666085|NCT01508130|5824962|P1|Overall Study|Insufficient therapeutic response|74
1666086|NCT01508130|5824961|P2|Overall Study|Subject’s substantial non-compliance|9
1666087|NCT01508130|5824962|P1|Overall Study|Subject’s substantial non-compliance|25
1666088|NCT01508130|5824961|P2|Overall Study|Withdrawal by Subject|3
1666089|NCT01508130|5824962|P1|Overall Study|Withdrawal by Subject|3
1666090|NCT01508130|5824961|P2|Overall Study|Lost to Follow-up|2
1666091|NCT01508130|5824962|P1|Overall Study|Lost to Follow-up|25
1666092|NCT01508130|5824961|P2|Overall Study|Protocol Violation|0
1666093|NCT01508130|5824962|P1|Overall Study|Protocol Violation|2
1666094|NCT01508130|5824961|P2|Overall Study|Death|1
1666095|NCT01508130|5824962|P1|Overall Study|Death|3
1666096|NCT01508130|5824961|P2|Overall Study|Adverse Event|28
1666097|NCT01508130|5824962|P1|Overall Study|Adverse Event|81
1666098|NCT01507896|5825030|P1|Overall Study|The surgery was denied by the sponsor.|1
1666099|NCT01507896|5825030|P1|Overall Study|Withdrawal by Subject|1
1666100|NCT01507831|5825073|P2|Overall Study|Other|6
1666101|NCT01507831|5825074|P1|Overall Study|Other|3
1666102|NCT01507831|5825073|P2|Overall Study|Potential lost to follow-up|0
1666103|NCT01507831|5825074|P1|Overall Study|Potential lost to follow-up|3
1666104|NCT01507831|5825073|P2|Overall Study|Site closure|3
1666105|NCT01507831|5825074|P1|Overall Study|Site closure|0
1666106|NCT01507831|5825073|P2|Overall Study|Selection criteria finally not met|1
1666107|NCT01507831|5825074|P1|Overall Study|Selection criteria finally not met|0
1666108|NCT01507831|5825073|P2|Overall Study|Last visit outside protocol visit window|143
1666109|NCT01507831|5825074|P1|Overall Study|Last visit outside protocol visit window|51
1666110|NCT01507831|5825073|P2|Overall Study|Related to study drug administration|14
1666111|NCT01507831|5825074|P1|Overall Study|Related to study drug administration|5
1666112|NCT01507831|5825073|P2|Overall Study|Consent withdrawn by participant|72
1666113|NCT01507831|5825074|P1|Overall Study|Consent withdrawn by participant|34
1666114|NCT01507831|5825073|P2|Overall Study|Participant moved|19
1666115|NCT01507831|5825074|P1|Overall Study|Participant moved|5
1666116|NCT01507831|5825073|P2|Overall Study|Physician Decision|4
1666117|NCT01507831|5825074|P1|Overall Study|Physician Decision|0
1666118|NCT01507831|5825073|P2|Overall Study|Poor compliance to protocol|60
1666119|NCT01507831|5825074|P1|Overall Study|Poor compliance to protocol|38
1666120|NCT01507831|5825073|P2|Overall Study|Death|2
1666121|NCT01507831|5825074|P1|Overall Study|Death|6
1666122|NCT01507831|5825073|P2|Overall Study|Adverse Event|113
1666123|NCT01507831|5825074|P1|Overall Study|Adverse Event|48
1666124|NCT01507831|5825073|P2|Overall Study|Randomized but not treated|3
1666125|NCT01507831|5825074|P1|Overall Study|Randomized but not treated|0
1666126|NCT01507662|5825194|P2|Overall Study|Proxy interview done|3
1666127|NCT01507662|5825195|P1|Overall Study|Proxy interview done|2
1666128|NCT01507662|5825194|P2|Overall Study|Lost to Follow-up|523
1666129|NCT01507662|5825195|P1|Overall Study|Lost to Follow-up|498
1666130|NCT01507662|5825194|P2|Overall Study|Withdrawal by Subject|287
1666131|NCT01507662|5825195|P1|Overall Study|Withdrawal by Subject|290
1666132|NCT01507662|5825194|P2|Overall Study|Death|18
1666133|NCT01507662|5825195|P1|Overall Study|Death|26
1666134|NCT01507298|5825226|P2|Overall Study|Protocol Violation|6
1666135|NCT01507298|5825227|P1|Overall Study|Protocol Violation|0
1666136|NCT01507246|5825237|P2|Overall Study|Required different surgical procedures|1
1666137|NCT01507246|5825238|P1|Overall Study|Required different surgical procedures|2
1666138|NCT01507090|5825336|P1|Overall Study|incomplete dataset|18
1666139|NCT01507051|5825375|P4|Overall Study|Adverse Event|0
1666140|NCT01507051|5825376|P3|Overall Study|Adverse Event|0
1666141|NCT01507051|5825377|P2|Overall Study|Adverse Event|0
1666142|NCT01507051|5825378|P1|Overall Study|Adverse Event|1
1666143|NCT01507051|5825375|P4|Overall Study|Physician Decision|1
1666144|NCT01507051|5825376|P3|Overall Study|Physician Decision|0
1666145|NCT01507051|5825377|P2|Overall Study|Physician Decision|0
1666146|NCT01507051|5825378|P1|Overall Study|Physician Decision|0
1666147|NCT01507051|5825375|P4|Overall Study|Withdrawal by Subject|6
1666148|NCT01507051|5825376|P3|Overall Study|Withdrawal by Subject|1
1666149|NCT01507051|5825377|P2|Overall Study|Withdrawal by Subject|3
1666150|NCT01507051|5825378|P1|Overall Study|Withdrawal by Subject|1
1666151|NCT01506960|5825496|P1|Overall Study|Did not meet angiographic criteria|47
1666152|NCT01506947|5825502|P1|Overall Study|Did Not Meet Eligibility Criteria|3
1666153|NCT01506947|5825502|P1|Overall Study|Death|1
1666154|NCT01506947|5825502|P1|Overall Study|Adverse Event|5
1666155|NCT01506947|5825502|P1|Overall Study|Lost to Follow-up|7
1666156|NCT01506908|5825520|P2|Overall Study|Adverse Event|0
1666157|NCT01506908|5825521|P1|Overall Study|Adverse Event|1
1666158|NCT01506882|5825539|P2|Overall Study|Other Reason|0
1666159|NCT01506882|5825540|P1|Overall Study|Other Reason|2
1666160|NCT01506882|5825539|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1666161|NCT01506882|5825540|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1666162|NCT01506882|5825539|P2|Overall Study|AE, non-serious non-fatal|1
1666163|NCT01506882|5825540|P1|Overall Study|AE, non-serious non-fatal|3
1666164|NCT01506882|5825539|P2|Overall Study|SAE, non-fatal|0
1666165|NCT01506882|5825540|P1|Overall Study|SAE, non-fatal|2
1666166|NCT01506882|5825539|P2|Overall Study|Withdrawal by Subject|3
1666167|NCT01506882|5825540|P1|Overall Study|Withdrawal by Subject|9
1666168|NCT01506882|5825539|P2|Overall Study|Lost to Follow-up|0
1666169|NCT01506882|5825540|P1|Overall Study|Lost to Follow-up|1
1666170|NCT01506882|5825539|P2|Overall Study|Lack of Efficacy|3
1666171|NCT01506882|5825540|P1|Overall Study|Lack of Efficacy|4
1666172|NCT01506726|5825554|P2|Overall Study|Adverse Event|2
1666173|NCT01506726|5825555|P1|Overall Study|Adverse Event|1
1666174|NCT01506596|5825595|P1|Overall Study|ineligible pathology|1
1666175|NCT01506479|5825606|P3|Overall Study|Adverse Event|0
1666176|NCT01506479|5825607|P2|Overall Study|Adverse Event|1
1666177|NCT01506479|5825608|P1|Overall Study|Adverse Event|0
1666178|NCT01506479|5825606|P3|Overall Study|Missing assessment|0
1666179|NCT01506479|5825607|P2|Overall Study|Missing assessment|0
1666180|NCT01506479|5825608|P1|Overall Study|Missing assessment|1
1666181|NCT01506479|5825606|P3|Overall Study|Withdrawal by Subject|1
1666182|NCT01506479|5825607|P2|Overall Study|Withdrawal by Subject|2
1666183|NCT01506479|5825608|P1|Overall Study|Withdrawal by Subject|1
1666184|NCT01506479|5825606|P3|Overall Study|Lost to Follow-up|2
1666185|NCT01506479|5825607|P2|Overall Study|Lost to Follow-up|2
1666186|NCT01506479|5825608|P1|Overall Study|Lost to Follow-up|1
1666187|NCT01506453|5825622|P2|Overall Study|Withdrawal prior to treatment|2
1666188|NCT01506453|5825623|P1|Overall Study|Withdrawal prior to treatment|0
1666189|NCT01506323|5825639|P2|Overall Study|Started another treatment|0
1666190|NCT01506323|5825640|P1|Overall Study|Started another treatment|1
1666191|NCT01506323|5825639|P2|Overall Study|Schedule or Transportation conflict|0
1666192|NCT01506323|5825640|P1|Overall Study|Schedule or Transportation conflict|8
1666193|NCT01506323|5825639|P2|Overall Study|Moved out of area|2
1666194|NCT01506323|5825640|P1|Overall Study|Moved out of area|5
1666195|NCT01506323|5825639|P2|Overall Study|Lack of Efficacy|3
1666196|NCT01506323|5825640|P1|Overall Study|Lack of Efficacy|1
1666197|NCT01506323|5825639|P2|Overall Study|Withdrawal by Subject|4
1666198|NCT01506323|5825640|P1|Overall Study|Withdrawal by Subject|4
1666199|NCT01506323|5825639|P2|Overall Study|Lost to Follow-up|4
1666200|NCT01506323|5825640|P1|Overall Study|Lost to Follow-up|5
1666201|NCT01506271|5825669|P3|Overall Study|Lost to Follow-up|2
1666202|NCT01506271|5825670|P2|Overall Study|Lost to Follow-up|1
1666203|NCT01506271|5825671|P1|Overall Study|Lost to Follow-up|0
1666204|NCT01506271|5825669|P3|Overall Study|Withdrawal by Subject|1
1666205|NCT01506271|5825670|P2|Overall Study|Withdrawal by Subject|1
1666206|NCT01506271|5825671|P1|Overall Study|Withdrawal by Subject|0
1666207|NCT01506271|5825669|P3|Overall Study|Insufficient supply of study drug|0
1666208|NCT01506271|5825670|P2|Overall Study|Insufficient supply of study drug|0
1666209|NCT01506271|5825671|P1|Overall Study|Insufficient supply of study drug|1
1666210|NCT01506271|5825669|P3|Overall Study|Adverse Event|0
1666211|NCT01506271|5825670|P2|Overall Study|Adverse Event|2
1666212|NCT01506271|5825671|P1|Overall Study|Adverse Event|0
1666213|NCT01506271|5825669|P3|Overall Study|Death|0
1666214|NCT01506271|5825670|P2|Overall Study|Death|1
1666215|NCT01506271|5825671|P1|Overall Study|Death|0
1666216|NCT01506271|5825669|P3|Overall Study|Protocol Violation|0
1666217|NCT01506271|5825670|P2|Overall Study|Protocol Violation|1
1666218|NCT01506271|5825671|P1|Overall Study|Protocol Violation|3
1666219|NCT01506271|5825669|P3|Overall Study|Progressive disease|0
1666220|NCT01506271|5825670|P2|Overall Study|Progressive disease|1
1666221|NCT01506271|5825671|P1|Overall Study|Progressive disease|0
1666222|NCT01506193|5825733|P3|Overall Study|Lost to Follow-up|3
1666223|NCT01506193|5825734|P2|Overall Study|Lost to Follow-up|3
1666224|NCT01506193|5825735|P1|Overall Study|Lost to Follow-up|8
1666225|NCT01506193|5825733|P3|Overall Study|Withdrawal by Subject|8
1666226|NCT01506193|5825734|P2|Overall Study|Withdrawal by Subject|1
1666227|NCT01506193|5825735|P1|Overall Study|Withdrawal by Subject|5
1666228|NCT01506193|5825733|P3|Overall Study|Adverse event, non-fatal|1
1666229|NCT01506193|5825734|P2|Overall Study|Adverse event, non-fatal|0
1666230|NCT01506193|5825735|P1|Overall Study|Adverse event, non-fatal|0
1666231|NCT01506193|5825733|P3|Overall Study|Migrated/moved from study area|1
1666232|NCT01506193|5825734|P2|Overall Study|Migrated/moved from study area|0
1666233|NCT01506193|5825735|P1|Overall Study|Migrated/moved from study area|0
1666234|NCT01506193|5825733|P3|Overall Study|Protocol Violation|1
1666235|NCT01506193|5825734|P2|Overall Study|Protocol Violation|0
1666236|NCT01506193|5825735|P1|Overall Study|Protocol Violation|1
1666237|NCT01505881|5825781|P2|Overall Study|Withdrawal by Subject|0
1666238|NCT01505881|5825782|P1|Overall Study|Withdrawal by Subject|2
1666239|NCT01505881|5825781|P2|Overall Study|Lost to Follow-up|0
1666240|NCT01505881|5825782|P1|Overall Study|Lost to Follow-up|2
1666241|NCT01505881|5825781|P2|Overall Study|Adverse Event|1
1666242|NCT01505881|5825782|P1|Overall Study|Adverse Event|0
1666243|NCT01505647|5825888|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
1666244|NCT01505647|5825889|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
1666245|NCT01505647|5825888|P2|Day 43 Through Day 182 Follow-up|Death|1
1666246|NCT01505647|5825889|P1|Day 43 Through Day 182 Follow-up|Death|0
1666247|NCT01505647|5825888|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
1666248|NCT01505647|5825889|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
1666249|NCT01505647|5825888|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
1666250|NCT01505647|5825889|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
1666251|NCT01505647|5825888|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
1666252|NCT01505647|5825889|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
1666253|NCT01505634|5825906|P3|Overall Study|In a conflict zone|1
1666254|NCT01505634|5825907|P2|Overall Study|In a conflict zone|0
1666255|NCT01505634|5825908|P1|Overall Study|In a conflict zone|0
1666256|NCT01505634|5825906|P3|Overall Study|Death|0
1666257|NCT01505634|5825907|P2|Overall Study|Death|0
1666258|NCT01505634|5825908|P1|Overall Study|Death|1
1666259|NCT01505634|5825906|P3|Overall Study|Lost to Follow-up|4
1666260|NCT01505634|5825907|P2|Overall Study|Lost to Follow-up|4
1666261|NCT01505634|5825908|P1|Overall Study|Lost to Follow-up|1
1666262|NCT01505634|5825906|P3|Overall Study|Protocol Violation|0
1666263|NCT01505634|5825907|P2|Overall Study|Protocol Violation|0
1666264|NCT01505634|5825908|P1|Overall Study|Protocol Violation|2
1666265|NCT01505634|5825906|P3|Overall Study|Insufficient supply of drug at site|0
1666266|NCT01505634|5825907|P2|Overall Study|Insufficient supply of drug at site|0
1666267|NCT01505634|5825908|P1|Overall Study|Insufficient supply of drug at site|1
1666268|NCT01505634|5825906|P3|Overall Study|Adverse Event|0
1666269|NCT01505634|5825907|P2|Overall Study|Adverse Event|0
1666270|NCT01505634|5825908|P1|Overall Study|Adverse Event|1
1666271|NCT01505634|5825906|P3|Overall Study|Physician Decision|0
1666272|NCT01505634|5825907|P2|Overall Study|Physician Decision|1
1666273|NCT01505634|5825908|P1|Overall Study|Physician Decision|1
1666274|NCT01505634|5825906|P3|Overall Study|Withdrawal by Subject|1
1666275|NCT01505634|5825907|P2|Overall Study|Withdrawal by Subject|5
1666276|NCT01505634|5825908|P1|Overall Study|Withdrawal by Subject|2
1666277|NCT01505608|5825963|P2|Phase II|Protocol Violation|1
1666278|NCT01505608|5825964|P1|Phase II|Protocol Violation|0
1666279|NCT01505608|5825963|P2|Phase II|Lack of Efficacy|1
1666280|NCT01505608|5825964|P1|Phase II|Lack of Efficacy|2
1666281|NCT01505608|5825963|P2|Phase I|Withdrawal by Subject|1
1666282|NCT01505608|5825964|P1|Phase I|Withdrawal by Subject|0
1666283|NCT01505608|5825963|P2|Phase I|Adverse Event|1
1666284|NCT01505608|5825964|P1|Phase I|Adverse Event|0
1666285|NCT01505608|5825963|P2|Phase I|Lack of Efficacy|4
1666286|NCT01505608|5825964|P1|Phase I|Lack of Efficacy|0
1666287|NCT01505530|5825983|P3|Overall Study|entry criteria not met|0
1666288|NCT01505530|5825984|P2|Overall Study|entry criteria not met|1
1666289|NCT01505530|5825985|P1|Overall Study|entry criteria not met|0
1666290|NCT01505530|5825983|P3|Overall Study|Death|5
1666291|NCT01505530|5825984|P2|Overall Study|Death|6
1666292|NCT01505530|5825985|P1|Overall Study|Death|7
1666293|NCT01505530|5825983|P3|Overall Study|Sponsor Decision|7
1666294|NCT01505530|5825984|P2|Overall Study|Sponsor Decision|8
1666295|NCT01505530|5825985|P1|Overall Study|Sponsor Decision|1
1666296|NCT01505530|5825983|P3|Overall Study|Physician Decision|5
1666297|NCT01505530|5825984|P2|Overall Study|Physician Decision|2
1666298|NCT01505530|5825985|P1|Overall Study|Physician Decision|6
1666299|NCT01505530|5825983|P3|Overall Study|Withdrawal by Subject|6
1666300|NCT01505530|5825984|P2|Overall Study|Withdrawal by Subject|8
1666301|NCT01505530|5825985|P1|Overall Study|Withdrawal by Subject|7
1666302|NCT01505530|5825983|P3|Overall Study|Adverse Event|0
1666303|NCT01505530|5825984|P2|Overall Study|Adverse Event|1
1666304|NCT01505530|5825985|P1|Overall Study|Adverse Event|1
1666305|NCT01505530|5825983|P3|Overall Study|Progressive Disease|18
1666306|NCT01505530|5825984|P2|Overall Study|Progressive Disease|17
1666307|NCT01505530|5825985|P1|Overall Study|Progressive Disease|19
1666308|NCT01505491|5826029|P3|Overall Study|Lost to Follow-up|1
1666309|NCT01505491|5826030|P2|Overall Study|Lost to Follow-up|0
1666310|NCT01505491|5826031|P1|Overall Study|Lost to Follow-up|0
1666311|NCT01505491|5826029|P3|Overall Study|Withdrawal by Subject|4
1666312|NCT01505491|5826030|P2|Overall Study|Withdrawal by Subject|1
1666313|NCT01505491|5826031|P1|Overall Study|Withdrawal by Subject|1
1666314|NCT01505491|5826029|P3|Overall Study|Other reason not listed|0
1666315|NCT01505491|5826030|P2|Overall Study|Other reason not listed|0
1666316|NCT01505491|5826031|P1|Overall Study|Other reason not listed|1
1666317|NCT01505387|5826070|P2|Overall Study|Withdrawal by Subject|1
1666318|NCT01505387|5826071|P1|Overall Study|Withdrawal by Subject|1
1666319|NCT01505387|5826070|P2|Overall Study|Protocol Violation|0
1666320|NCT01505387|5826071|P1|Overall Study|Protocol Violation|1
1666321|NCT01505374|5826077|P2|Overall Study|Lost to Follow-up|0
1666322|NCT01505374|5826078|P1|Overall Study|Lost to Follow-up|1
1666323|NCT01505114|5826128|P4|Overall Study|investigator decision|0
1666324|NCT01505114|5826129|P3|Overall Study|investigator decision|1
1666325|NCT01505114|5826130|P2|Overall Study|investigator decision|0
1666326|NCT01505114|5826131|P1|Overall Study|investigator decision|1
1666327|NCT01505114|5826128|P4|Overall Study|staff safety concerns|1
1666328|NCT01505114|5826129|P3|Overall Study|staff safety concerns|0
1666329|NCT01505114|5826130|P2|Overall Study|staff safety concerns|0
1666330|NCT01505114|5826131|P1|Overall Study|staff safety concerns|0
1666331|NCT01505114|5826128|P4|Overall Study|inadvertent enrollment due to peanut all|1
1666332|NCT01505114|5826129|P3|Overall Study|inadvertent enrollment due to peanut all|0
1666333|NCT01505114|5826130|P2|Overall Study|inadvertent enrollment due to peanut all|0
1666334|NCT01505114|5826131|P1|Overall Study|inadvertent enrollment due to peanut all|0
1666335|NCT01505114|5826128|P4|Overall Study|relocated|3
1666336|NCT01505114|5826129|P3|Overall Study|relocated|2
1666337|NCT01505114|5826130|P2|Overall Study|relocated|2
1666338|NCT01505114|5826131|P1|Overall Study|relocated|4
1666339|NCT01505114|5826128|P4|Overall Study|Lost to Follow-up|7
1666340|NCT01505114|5826129|P3|Overall Study|Lost to Follow-up|8
1666341|NCT01505114|5826130|P2|Overall Study|Lost to Follow-up|5
1666342|NCT01505114|5826131|P1|Overall Study|Lost to Follow-up|11
1666343|NCT01505114|5826128|P4|Overall Study|unable to adhere to visit schedule|3
1666344|NCT01505114|5826129|P3|Overall Study|unable to adhere to visit schedule|3
1666345|NCT01505114|5826130|P2|Overall Study|unable to adhere to visit schedule|2
1666346|NCT01505114|5826131|P1|Overall Study|unable to adhere to visit schedule|3
1666347|NCT01505114|5826128|P4|Overall Study|Death|1
1666348|NCT01505114|5826129|P3|Overall Study|Death|0
1666349|NCT01505114|5826130|P2|Overall Study|Death|0
1666350|NCT01505114|5826131|P1|Overall Study|Death|1
1666351|NCT01505114|5826128|P4|Overall Study|Withdrawal by Subject|7
1666352|NCT01505114|5826129|P3|Overall Study|Withdrawal by Subject|4
1666353|NCT01505114|5826130|P2|Overall Study|Withdrawal by Subject|4
1666354|NCT01505114|5826131|P1|Overall Study|Withdrawal by Subject|5
1666355|NCT01504971|5826145|P1|Overall Study|Physician Decision|13
1666356|NCT01504867|5826174|P2|Overall Study|Consent revoked|1
1666357|NCT01504867|5826175|P1|Overall Study|Consent revoked|5
1666358|NCT01504867|5826174|P2|Overall Study|Inclusion criteria not met|2
1666359|NCT01504867|5826175|P1|Overall Study|Inclusion criteria not met|2
1666360|NCT01504841|5826213|P3|Overall Study|On study due to Long-term Follow-up|0
1666361|NCT01504841|5826214|P2|Overall Study|On study due to Long-term Follow-up|3
1666362|NCT01504841|5826215|P1|Overall Study|On study due to Long-term Follow-up|15
1666363|NCT01504841|5826213|P3|Overall Study|Withdrawal by Subject|0
1666364|NCT01504841|5826214|P2|Overall Study|Withdrawal by Subject|1
1666365|NCT01504841|5826215|P1|Overall Study|Withdrawal by Subject|1
1666366|NCT01504204|5826250|P2|Overall Study|Lost to Follow-up|1
1666367|NCT01504204|5826251|P1|Overall Study|Lost to Follow-up|1
1666368|NCT01503164|5826308|P2|Overall Study|Withdrawal by Subject|1
1666369|NCT01503164|5826309|P1|Overall Study|Withdrawal by Subject|2
1666370|NCT01503021|5826339|P2|Overall Study|Moved, received transplant, etc.|7
1666371|NCT01503021|5826340|P1|Overall Study|Moved, received transplant, etc.|5
1666372|NCT01503021|5826339|P2|Overall Study|Withdrawal by Subject|8
1666373|NCT01503021|5826340|P1|Overall Study|Withdrawal by Subject|9
1666374|NCT01503021|5826339|P2|Overall Study|Protocol Violation|3
1666375|NCT01503021|5826340|P1|Overall Study|Protocol Violation|1
1666376|NCT01503021|5826339|P2|Overall Study|Physician Decision|0
1666377|NCT01503021|5826340|P1|Overall Study|Physician Decision|3
1666378|NCT01503021|5826339|P2|Overall Study|Lost to Follow-up|0
1666379|NCT01503021|5826340|P1|Overall Study|Lost to Follow-up|2
1666380|NCT01503021|5826339|P2|Overall Study|Death|2
1666381|NCT01503021|5826340|P1|Overall Study|Death|0
1666382|NCT01503021|5826339|P2|Overall Study|Adverse Event|6
1666383|NCT01503021|5826340|P1|Overall Study|Adverse Event|7
1666384|NCT01502956|5826389|P2|Overall Study|Withdrawal by Subject|10
1666385|NCT01502956|5826390|P1|Overall Study|Withdrawal by Subject|8
1666386|NCT01502956|5826389|P2|Overall Study|Physician Decision|3
1666387|NCT01502956|5826390|P1|Overall Study|Physician Decision|2
1666388|NCT01502956|5826389|P2|Overall Study|Lost to Follow-up|11
1666389|NCT01502956|5826390|P1|Overall Study|Lost to Follow-up|14
1666390|NCT01502956|5826389|P2|Overall Study|Death|2
1666391|NCT01502956|5826390|P1|Overall Study|Death|0
1666392|NCT01502709|5826448|P2|Overall Study|Lost to Follow-up|0
1666393|NCT01502709|5826449|P1|Overall Study|Lost to Follow-up|4
1666394|NCT01502644|5826462|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1666395|NCT01502644|5826463|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
1666396|NCT01502644|5826464|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1666397|NCT01502644|5826465|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
1666398|NCT01502644|5826462|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
1666399|NCT01502644|5826463|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
1666400|NCT01502644|5826464|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
1666401|NCT01502644|5826465|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
1666402|NCT01502644|5826462|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1666403|NCT01502644|5826463|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1666404|NCT01502644|5826464|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
1666405|NCT01502644|5826465|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
1666406|NCT01502644|5826462|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1666407|NCT01502644|5826463|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1666408|NCT01502644|5826464|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
1666409|NCT01502644|5826465|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
1666410|NCT01502644|5826462|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1666411|NCT01502644|5826463|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1666412|NCT01502644|5826464|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
1666413|NCT01502644|5826465|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
1666414|NCT01502423|5826475|P2|Overall Study|Withdrawal by Subject|1
1666415|NCT01502423|5826476|P1|Overall Study|Withdrawal by Subject|0
1666416|NCT01502410|5826498|P4|Overall Study|Withdrawal by Subject|0
1666417|NCT01502410|5826499|P3|Overall Study|Withdrawal by Subject|0
1666418|NCT01502410|5826500|P2|Overall Study|Withdrawal by Subject|0
1666419|NCT01502410|5826501|P1|Overall Study|Withdrawal by Subject|2
1666420|NCT01502410|5826498|P4|Overall Study|Physician Decision|0
1666421|NCT01502410|5826499|P3|Overall Study|Physician Decision|0
1666422|NCT01502410|5826500|P2|Overall Study|Physician Decision|1
1666423|NCT01502410|5826501|P1|Overall Study|Physician Decision|0
1666424|NCT01502410|5826498|P4|Overall Study|Lack of Efficacy|0
1666425|NCT01502410|5826499|P3|Overall Study|Lack of Efficacy|0
1666426|NCT01502410|5826500|P2|Overall Study|Lack of Efficacy|7
1666427|NCT01502410|5826501|P1|Overall Study|Lack of Efficacy|7
1666428|NCT01502410|5826498|P4|Overall Study|Adverse Event|0
1666429|NCT01502410|5826499|P3|Overall Study|Adverse Event|0
1666430|NCT01502410|5826500|P2|Overall Study|Adverse Event|2
1666431|NCT01502410|5826501|P1|Overall Study|Adverse Event|1
1666432|NCT01502371|5826519|P5|Overall Study|Excluded Medication|1
1666433|NCT01502371|5826520|P4|Overall Study|Excluded Medication|0
1666434|NCT01502371|5826521|P3|Overall Study|Excluded Medication|1
1666435|NCT01502371|5826522|P2|Overall Study|Excluded Medication|1
1666436|NCT01502371|5826523|P1|Overall Study|Excluded Medication|0
1666437|NCT01502371|5826519|P5|Overall Study|Protocol Violation|10
1666438|NCT01502371|5826520|P4|Overall Study|Protocol Violation|5
1666439|NCT01502371|5826521|P3|Overall Study|Protocol Violation|6
1666440|NCT01502371|5826522|P2|Overall Study|Protocol Violation|5
1666441|NCT01502371|5826523|P1|Overall Study|Protocol Violation|9
1666442|NCT01502371|5826519|P5|Overall Study|Technical Problems|1
1666443|NCT01502371|5826520|P4|Overall Study|Technical Problems|4
1666444|NCT01502371|5826521|P3|Overall Study|Technical Problems|2
1666445|NCT01502371|5826522|P2|Overall Study|Technical Problems|0
1666446|NCT01502371|5826523|P1|Overall Study|Technical Problems|1
1666447|NCT01502371|5826519|P5|Overall Study|Noncompliance with Study Drug|1
1666448|NCT01502371|5826520|P4|Overall Study|Noncompliance with Study Drug|2
1666449|NCT01502371|5826521|P3|Overall Study|Noncompliance with Study Drug|1
1666450|NCT01502371|5826522|P2|Overall Study|Noncompliance with Study Drug|0
1666451|NCT01502371|5826523|P1|Overall Study|Noncompliance with Study Drug|0
1666452|NCT01502371|5826519|P5|Overall Study|Physician Decision|1
1666453|NCT01502371|5826520|P4|Overall Study|Physician Decision|0
1666454|NCT01502371|5826521|P3|Overall Study|Physician Decision|0
1666455|NCT01502371|5826522|P2|Overall Study|Physician Decision|0
1666456|NCT01502371|5826523|P1|Overall Study|Physician Decision|3
1666457|NCT01502371|5826519|P5|Overall Study|Lack of Efficacy|4
1666458|NCT01502371|5826520|P4|Overall Study|Lack of Efficacy|2
1666459|NCT01502371|5826521|P3|Overall Study|Lack of Efficacy|2
1666460|NCT01502371|5826522|P2|Overall Study|Lack of Efficacy|3
1666461|NCT01502371|5826523|P1|Overall Study|Lack of Efficacy|3
1666462|NCT01502371|5826519|P5|Overall Study|Treatment Failure|30
1666463|NCT01502371|5826520|P4|Overall Study|Treatment Failure|19
1666464|NCT01502371|5826521|P3|Overall Study|Treatment Failure|12
1666465|NCT01502371|5826522|P2|Overall Study|Treatment Failure|20
1666466|NCT01502371|5826523|P1|Overall Study|Treatment Failure|22
1666467|NCT01502371|5826519|P5|Overall Study|Adverse Event|3
1666468|NCT01502371|5826520|P4|Overall Study|Adverse Event|4
1666469|NCT01502371|5826521|P3|Overall Study|Adverse Event|0
1666470|NCT01502371|5826522|P2|Overall Study|Adverse Event|1
1666471|NCT01502371|5826523|P1|Overall Study|Adverse Event|2
1666472|NCT01502371|5826519|P5|Overall Study|Withdrawal by Subject|1
1666473|NCT01502371|5826520|P4|Overall Study|Withdrawal by Subject|1
1666474|NCT01502371|5826521|P3|Overall Study|Withdrawal by Subject|1
1666475|NCT01502371|5826522|P2|Overall Study|Withdrawal by Subject|2
1666476|NCT01502371|5826523|P1|Overall Study|Withdrawal by Subject|1
1666477|NCT01502293|5826588|P3|Overall Study|Physician Decision|1
1666478|NCT01502293|5826589|P2|Overall Study|Physician Decision|0
1666479|NCT01502293|5826590|P1|Overall Study|Physician Decision|0
1666480|NCT01502293|5826588|P3|Overall Study|Reason Not Specified|0
1666481|NCT01502293|5826589|P2|Overall Study|Reason Not Specified|0
1666482|NCT01502293|5826590|P1|Overall Study|Reason Not Specified|2
1666483|NCT01502293|5826588|P3|Overall Study|Adverse Event|0
1666484|NCT01502293|5826589|P2|Overall Study|Adverse Event|2
1666485|NCT01502293|5826590|P1|Overall Study|Adverse Event|0
1666486|NCT01502293|5826588|P3|Overall Study|Withdrawal by Subject|1
1666487|NCT01502293|5826589|P2|Overall Study|Withdrawal by Subject|3
1666488|NCT01502293|5826590|P1|Overall Study|Withdrawal by Subject|3
1666489|NCT01502293|5826588|P3|Overall Study|Progressive Disease|2
1666490|NCT01502293|5826589|P2|Overall Study|Progressive Disease|12
1666491|NCT01502293|5826590|P1|Overall Study|Progressive Disease|20
1666492|NCT01502228|5826619|P1|Overall Study|Death|1
1666493|NCT01502033|5826624|P1|Overall Study|1 participant went back to school|1
1666494|NCT01502033|5826624|P1|Overall Study|1 participant had worsening depression|1
1666495|NCT01502033|5826624|P1|Overall Study|1 participant had scalp discomfort|1
1666496|NCT01501955|5826632|P2|Overall Study|Adverse Event|3
1666497|NCT01501955|5826633|P1|Overall Study|Adverse Event|1
1666498|NCT01501955|5826632|P2|Overall Study|Withdrawal by Subject|0
1666499|NCT01501955|5826633|P1|Overall Study|Withdrawal by Subject|1
1666500|NCT01501110|5826697|P2|Overall Study|Death|1
1666501|NCT01501110|5826698|P1|Overall Study|Death|0
1666502|NCT01500720|5826731|P2|Overall Study|Other|8
1666503|NCT01500720|5826732|P1|Overall Study|Other|4
1666504|NCT01500720|5826731|P2|Overall Study|Randomized But Not Treated|1
1666505|NCT01500720|5826732|P1|Overall Study|Randomized But Not Treated|1
1666506|NCT01500694|5826746|P2|Overall Study|Other|3
1666507|NCT01500694|5826747|P1|Overall Study|Other|9
1666508|NCT01500694|5826746|P2|Overall Study|Lack of Efficacy|5
1666509|NCT01500694|5826747|P1|Overall Study|Lack of Efficacy|14
1666510|NCT01500694|5826746|P2|Overall Study|Lost to Follow-up|3
1666511|NCT01500694|5826747|P1|Overall Study|Lost to Follow-up|2
1666512|NCT01500694|5826746|P2|Overall Study|Withdrawal by Subject|14
1666513|NCT01500694|5826747|P1|Overall Study|Withdrawal by Subject|23
1666514|NCT01500694|5826746|P2|Overall Study|Protocol Violation|1
1666515|NCT01500694|5826747|P1|Overall Study|Protocol Violation|0
1666516|NCT01500694|5826746|P2|Overall Study|Adverse Event|3
1666517|NCT01500694|5826747|P1|Overall Study|Adverse Event|4
1666518|NCT01500629|5826773|P2|Washout Period of 14 to 30 Days|Pregnancy|0
1666519|NCT01500629|5826774|P1|Washout Period of 14 to 30 Days|Pregnancy|1
1666520|NCT01500434|5826858|P1|Overall Study|Missed 12-month follow-up|5
1666521|NCT01500434|5826858|P1|Overall Study|Withdrawal by Subject|1
1666522|NCT01500434|5826858|P1|Overall Study|Death|1
1666523|NCT01500382|5826891|P4|Washout Period|Study site went out of business|0
1666524|NCT01500382|5826892|P3|Washout Period|Study site went out of business|1
1666525|NCT01500382|5826893|P2|Washout Period|Study site went out of business|0
1666526|NCT01500382|5826894|P1|Washout Period|Study site went out of business|0
1666527|NCT01500317|5826919|P3|Overall Study|Withdrawal by Subject|0
1666528|NCT01500317|5826920|P2|Overall Study|Withdrawal by Subject|2
1666529|NCT01500317|5826921|P1|Overall Study|Withdrawal by Subject|3
1666530|NCT01500278|5826943|P2|Week 13 - Week 104|Adverse Event|54
1666531|NCT01500278|5826944|P1|Week 13 - Week 104|Adverse Event|54
1666532|NCT01500278|5826943|P2|Week 13 - Week 104|Death|4
1666533|NCT01500278|5826944|P1|Week 13 - Week 104|Death|2
1666534|NCT01500278|5826943|P2|Week 13 - Week 104|Not completed|1
1666535|NCT01500278|5826944|P1|Week 13 - Week 104|Not completed|0
1666536|NCT01500278|5826943|P2|Week 13 - Week 104|Personal reason|1
1666537|NCT01500278|5826944|P1|Week 13 - Week 104|Personal reason|0
1666538|NCT01500278|5826943|P2|Week 13 - Week 104|Medical monitor decision|2
1666539|NCT01500278|5826944|P1|Week 13 - Week 104|Medical monitor decision|0
1666540|NCT01500278|5826943|P2|Week 13 - Week 104|Sponsor decision|2
1666541|NCT01500278|5826944|P1|Week 13 - Week 104|Sponsor decision|0
1666542|NCT01500278|5826943|P2|Week 13 - Week 104|Relocation|1
1666543|NCT01500278|5826944|P1|Week 13 - Week 104|Relocation|0
1666544|NCT01500278|5826943|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
1666545|NCT01500278|5826944|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
1666546|NCT01500278|5826943|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
1666547|NCT01500278|5826944|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
1666548|NCT01500278|5826943|P2|Week 13 - Week 104|Principal investigator retiring|0
1666549|NCT01500278|5826944|P1|Week 13 - Week 104|Principal investigator retiring|1
1666550|NCT01500278|5826943|P2|Week 13 - Week 104|Protocol deviation|0
1666551|NCT01500278|5826944|P1|Week 13 - Week 104|Protocol deviation|1
1666552|NCT01500278|5826943|P2|Week 13 - Week 104|Exclusion criteria not met|0
1666553|NCT01500278|5826944|P1|Week 13 - Week 104|Exclusion criteria not met|1
1666554|NCT01500278|5826943|P2|Week 13 - Week 104|Withdrawn in error|0
1666555|NCT01500278|5826944|P1|Week 13 - Week 104|Withdrawn in error|1
1666556|NCT01500278|5826943|P2|Week 13 - Week 104|Sponsor request|0
1666557|NCT01500278|5826944|P1|Week 13 - Week 104|Sponsor request|4
1666558|NCT01500278|5826943|P2|Week 13 - Week 104|False positive test|2
1666559|NCT01500278|5826944|P1|Week 13 - Week 104|False positive test|1
1666560|NCT01500278|5826943|P2|Week 13 - Week 104|Recurrent infections|0
1666561|NCT01500278|5826944|P1|Week 13 - Week 104|Recurrent infections|1
1666562|NCT01500278|5826943|P2|Week 13 - Week 104|Non/bad compliance|5
1666563|NCT01500278|5826944|P1|Week 13 - Week 104|Non/bad compliance|7
1666564|NCT01500278|5826943|P2|Week 13 - Week 104|Week 24 Non-Responder|16
1666565|NCT01500278|5826944|P1|Week 13 - Week 104|Week 24 Non-Responder|20
1666566|NCT01500278|5826943|P2|Week 13 - Week 104|Withdrawal by Subject|13
1666567|NCT01500278|5826944|P1|Week 13 - Week 104|Withdrawal by Subject|22
1666568|NCT01500278|5826943|P2|Week 13 - Week 104|Lost to Follow-up|5
1666569|NCT01500278|5826944|P1|Week 13 - Week 104|Lost to Follow-up|6
1666570|NCT01500278|5826943|P2|Week 13 - Week 104|Protocol Violation|6
1666571|NCT01500278|5826944|P1|Week 13 - Week 104|Protocol Violation|6
1666572|NCT01500278|5826943|P2|Week 13 - Week 104|Lack of Efficacy|12
1666573|NCT01500278|5826944|P1|Week 13 - Week 104|Lack of Efficacy|11
1666574|NCT01500278|5826943|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
1666575|NCT01500278|5826944|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
1666576|NCT01500278|5826943|P2|Week 0 - Week 12|Other serious disease|1
1666577|NCT01500278|5826944|P1|Week 0 - Week 12|Other serious disease|0
1666578|NCT01500278|5826943|P2|Week 0 - Week 12|Personal reason|1
1666579|NCT01500278|5826944|P1|Week 0 - Week 12|Personal reason|0
1666580|NCT01500278|5826943|P2|Week 0 - Week 12|Sponsor decision|0
1666581|NCT01500278|5826944|P1|Week 0 - Week 12|Sponsor decision|1
1666582|NCT01500278|5826943|P2|Week 0 - Week 12|Prior history of serious disease|0
1666583|NCT01500278|5826944|P1|Week 0 - Week 12|Prior history of serious disease|1
1666584|NCT01500278|5826943|P2|Week 0 - Week 12|Investigator decision|0
1666585|NCT01500278|5826944|P1|Week 0 - Week 12|Investigator decision|1
1666586|NCT01500278|5826943|P2|Week 0 - Week 12|Exclusion criteria not met|0
1666587|NCT01500278|5826944|P1|Week 0 - Week 12|Exclusion criteria not met|1
1666588|NCT01500278|5826943|P2|Week 0 - Week 12|Patient decision|0
1666589|NCT01500278|5826944|P1|Week 0 - Week 12|Patient decision|1
1666590|NCT01500278|5826943|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
1666591|NCT01500278|5826944|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
1666592|NCT01500278|5826943|P2|Week 0 - Week 12|Withdrawal by Subject|2
1666593|NCT01500278|5826944|P1|Week 0 - Week 12|Withdrawal by Subject|7
1666594|NCT01500278|5826943|P2|Week 0 - Week 12|Lost to Follow-up|1
1666595|NCT01500278|5826944|P1|Week 0 - Week 12|Lost to Follow-up|1
1666596|NCT01500278|5826943|P2|Week 0 - Week 12|Protocol Violation|16
1666597|NCT01500278|5826944|P1|Week 0 - Week 12|Protocol Violation|10
1666598|NCT01500278|5826943|P2|Week 0 - Week 12|Lack of Efficacy|1
1666599|NCT01500278|5826944|P1|Week 0 - Week 12|Lack of Efficacy|0
1666600|NCT01500252|5826968|P2|Overall Study|Lost to Follow-up|4
1666601|NCT01500252|5826969|P1|Overall Study|Lost to Follow-up|5
1666602|NCT01500252|5826968|P2|Overall Study|Death|2
1666603|NCT01500252|5826969|P1|Overall Study|Death|4
1666604|NCT01500226|5826995|P2|Overall Study|Other Reasons|16
1666605|NCT01500226|5826996|P1|Overall Study|Other Reasons|19
1666606|NCT01500226|5826995|P2|Overall Study|Lost to Follow-up|5
1666607|NCT01500226|5826996|P1|Overall Study|Lost to Follow-up|9
1666608|NCT01500226|5826995|P2|Overall Study|Lack of Efficacy|30
1666609|NCT01500226|5826996|P1|Overall Study|Lack of Efficacy|14
1666610|NCT01500226|5826995|P2|Overall Study|Physician Decision|15
1666611|NCT01500226|5826996|P1|Overall Study|Physician Decision|17
1666612|NCT01500226|5826995|P2|Overall Study|Protocol Violation|39
1666613|NCT01500226|5826996|P1|Overall Study|Protocol Violation|53
1666614|NCT01500226|5826995|P2|Overall Study|Disease Progression|14
1666615|NCT01500226|5826996|P1|Overall Study|Disease Progression|16
1666616|NCT01500226|5826995|P2|Overall Study|Death|4
1666617|NCT01500226|5826996|P1|Overall Study|Death|12
1666618|NCT01500226|5826995|P2|Overall Study|Withdrawal by Subject|96
1666619|NCT01500226|5826996|P1|Overall Study|Withdrawal by Subject|93
1666620|NCT01500226|5826995|P2|Overall Study|Chemo Completed or Change in Therapy|237
1666621|NCT01500226|5826996|P1|Overall Study|Chemo Completed or Change in Therapy|235
1666622|NCT01500226|5826995|P2|Overall Study|Adverse Event|38
1666623|NCT01500226|5826996|P1|Overall Study|Adverse Event|31
1666624|NCT01500213|5827008|P2|Overall Study|Other Reasons|5
1666625|NCT01500213|5827009|P1|Overall Study|Other Reasons|7
1666626|NCT01500213|5827008|P2|Overall Study|Lost to Follow-up|6
1666627|NCT01500213|5827009|P1|Overall Study|Lost to Follow-up|3
1666628|NCT01500213|5827008|P2|Overall Study|Lack of Efficacy|7
1666629|NCT01500213|5827009|P1|Overall Study|Lack of Efficacy|9
1666630|NCT01500213|5827008|P2|Overall Study|Physician Decision|10
1666631|NCT01500213|5827009|P1|Overall Study|Physician Decision|12
1666632|NCT01500213|5827008|P2|Overall Study|Protocol Violation|19
1666633|NCT01500213|5827009|P1|Overall Study|Protocol Violation|19
1666634|NCT01500213|5827008|P2|Overall Study|Disease Progression|21
1666635|NCT01500213|5827009|P1|Overall Study|Disease Progression|13
1666636|NCT01500213|5827008|P2|Overall Study|Death|3
1666637|NCT01500213|5827009|P1|Overall Study|Death|7
1666638|NCT01500213|5827008|P2|Overall Study|Withdrawal by Subject|37
1666639|NCT01500213|5827009|P1|Overall Study|Withdrawal by Subject|28
1666640|NCT01500213|5827008|P2|Overall Study|Chemo Completed or Change in Therapy|81
1666641|NCT01500213|5827009|P1|Overall Study|Chemo Completed or Change in Therapy|84
1666642|NCT01500213|5827008|P2|Overall Study|Adverse Event|35
1666643|NCT01500213|5827009|P1|Overall Study|Adverse Event|35
1666644|NCT01500200|5827022|P6|Stage 2|Adverse Event|4
1666645|NCT01500200|5827023|P5|Stage 2|Adverse Event|5
1666646|NCT01500200|5827024|P4|Stage 2|Adverse Event|0
1666647|NCT01500200|5827025|P3|Stage 2|Adverse Event|0
1666648|NCT01500200|5827026|P2|Stage 2|Adverse Event|0
1666649|NCT01500200|5827027|P1|Stage 2|Adverse Event|0
1666650|NCT01500200|5827022|P6|Stage 1|Physician Decision|0
1666651|NCT01500200|5827023|P5|Stage 1|Physician Decision|0
1666652|NCT01500200|5827024|P4|Stage 1|Physician Decision|0
1666653|NCT01500200|5827025|P3|Stage 1|Physician Decision|0
1666654|NCT01500200|5827026|P2|Stage 1|Physician Decision|0
1666655|NCT01500200|5827027|P1|Stage 1|Physician Decision|1
1666656|NCT01500200|5827022|P6|Stage 1|Noncompliance with Study Drug|0
1666657|NCT01500200|5827023|P5|Stage 1|Noncompliance with Study Drug|0
1666658|NCT01500200|5827024|P4|Stage 1|Noncompliance with Study Drug|0
1666659|NCT01500200|5827025|P3|Stage 1|Noncompliance with Study Drug|0
1666660|NCT01500200|5827026|P2|Stage 1|Noncompliance with Study Drug|0
1666661|NCT01500200|5827027|P1|Stage 1|Noncompliance with Study Drug|1
1666662|NCT01500200|5827022|P6|Stage 1|Withdrawal by Subject|0
1666663|NCT01500200|5827023|P5|Stage 1|Withdrawal by Subject|0
1666664|NCT01500200|5827024|P4|Stage 1|Withdrawal by Subject|0
1666665|NCT01500200|5827025|P3|Stage 1|Withdrawal by Subject|0
1666666|NCT01500200|5827026|P2|Stage 1|Withdrawal by Subject|0
1666667|NCT01500200|5827027|P1|Stage 1|Withdrawal by Subject|3
1666668|NCT01500200|5827022|P6|Stage 1|Lost to Follow-up|0
1666669|NCT01500200|5827023|P5|Stage 1|Lost to Follow-up|0
1666670|NCT01500200|5827024|P4|Stage 1|Lost to Follow-up|0
1666671|NCT01500200|5827025|P3|Stage 1|Lost to Follow-up|1
1666672|NCT01500200|5827026|P2|Stage 1|Lost to Follow-up|2
1666673|NCT01500200|5827027|P1|Stage 1|Lost to Follow-up|2
1666674|NCT01500200|5827022|P6|Stage 1|Adverse Event|0
1666675|NCT01500200|5827023|P5|Stage 1|Adverse Event|0
1666676|NCT01500200|5827024|P4|Stage 1|Adverse Event|0
1666677|NCT01500200|5827025|P3|Stage 1|Adverse Event|5
1666678|NCT01500200|5827026|P2|Stage 1|Adverse Event|4
1666679|NCT01500200|5827027|P1|Stage 1|Adverse Event|1
1666680|NCT01500187|5827061|P2|Overall Study|Lost to Follow-up|0
1666681|NCT01500187|5827062|P1|Overall Study|Lost to Follow-up|6
1666682|NCT01500135|5827070|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
1666683|NCT01500135|5827071|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
1666684|NCT01500135|5827070|P2|Overall Study|Participant was a Safety Concern|0
1666685|NCT01500135|5827071|P1|Overall Study|Participant was a Safety Concern|1
1666686|NCT01500135|5827070|P2|Overall Study|Patient Missed Scheduled Appointments|1
1666687|NCT01500135|5827071|P1|Overall Study|Patient Missed Scheduled Appointments|0
1666688|NCT01500135|5827070|P2|Overall Study|Principal Investigator (PI) Discretion|0
1666689|NCT01500135|5827071|P1|Overall Study|Principal Investigator (PI) Discretion|1
1666690|NCT01500135|5827070|P2|Overall Study|Fatal Adverse Event (AE)|5
1666691|NCT01500135|5827071|P1|Overall Study|Fatal Adverse Event (AE)|5
1666692|NCT01500135|5827070|P2|Overall Study|Lost to Follow-up|4
1666693|NCT01500135|5827071|P1|Overall Study|Lost to Follow-up|6
1666694|NCT01500135|5827070|P2|Overall Study|Withdrawal of Consent|0
1666695|NCT01500135|5827071|P1|Overall Study|Withdrawal of Consent|4
1666696|NCT01500096|5827098|P4|Overall Study|Lost to Follow-up|2
1666697|NCT01500096|5827099|P3|Overall Study|Lost to Follow-up|0
1666698|NCT01500096|5827100|P2|Overall Study|Lost to Follow-up|0
1666699|NCT01500096|5827101|P1|Overall Study|Lost to Follow-up|1
1666700|NCT01500083|5827157|P2|Overall Study|Other Reasons|5
1666701|NCT01500083|5827158|P1|Overall Study|Other Reasons|2
1666702|NCT01500083|5827157|P2|Overall Study|Investigator Discretion|8
1666703|NCT01500083|5827158|P1|Overall Study|Investigator Discretion|3
1666704|NCT01500083|5827157|P2|Overall Study|Disease Progression|10
1666705|NCT01500083|5827158|P1|Overall Study|Disease Progression|2
1666706|NCT01500083|5827157|P2|Overall Study|Withdrawal of Consent|1
1666707|NCT01500083|5827158|P1|Overall Study|Withdrawal of Consent|0
1666708|NCT01500083|5827157|P2|Overall Study|Lost to Follow-up|0
1666709|NCT01500083|5827158|P1|Overall Study|Lost to Follow-up|1
1666710|NCT01500083|5827157|P2|Overall Study|Death|2
1666711|NCT01500083|5827158|P1|Overall Study|Death|0
1666712|NCT01500083|5827157|P2|Overall Study|Adverse Event|17
1666713|NCT01500083|5827158|P1|Overall Study|Adverse Event|4
1666714|NCT01500057|5827166|P2|Overall Study|Lost to Follow-up|4
1666715|NCT01500057|5827167|P1|Overall Study|Lost to Follow-up|6
1666716|NCT01500031|5827177|P1|Overall Study|Withdrawal by Subject|4
1666717|NCT01500031|5827177|P1|Overall Study|Death|1
1666718|NCT01499849|5827212|P2|Overall Study|Other Reasons|30
1666719|NCT01499849|5827213|P1|Overall Study|Other Reasons|27
1666720|NCT01499849|5827212|P2|Overall Study|Lost to Follow-up|3
1666721|NCT01499849|5827213|P1|Overall Study|Lost to Follow-up|6
1666722|NCT01499849|5827212|P2|Overall Study|Lack of Efficacy|4
1666723|NCT01499849|5827213|P1|Overall Study|Lack of Efficacy|3
1666724|NCT01499849|5827212|P2|Overall Study|Physician Decision|19
1666725|NCT01499849|5827213|P1|Overall Study|Physician Decision|20
1666726|NCT01499849|5827212|P2|Overall Study|Protocol Violation|11
1666727|NCT01499849|5827213|P1|Overall Study|Protocol Violation|11
1666728|NCT01499849|5827212|P2|Overall Study|Disease Progression|10
1666729|NCT01499849|5827213|P1|Overall Study|Disease Progression|11
1666730|NCT01499849|5827212|P2|Overall Study|Death|7
1666731|NCT01499849|5827213|P1|Overall Study|Death|5
1666732|NCT01499849|5827212|P2|Overall Study|Withdrawal by Subject|43
1666733|NCT01499849|5827213|P1|Overall Study|Withdrawal by Subject|43
1666734|NCT01499849|5827212|P2|Overall Study|Chemo completed or Change in Therapy|67
1666735|NCT01499849|5827213|P1|Overall Study|Chemo completed or Change in Therapy|70
1666736|NCT01499849|5827212|P2|Overall Study|Adverse Event|32
1666737|NCT01499849|5827213|P1|Overall Study|Adverse Event|28
1666738|NCT01499810|5827223|P1|Overall Study|Withdrawal by Subject|1
1666739|NCT01499810|5827223|P1|Overall Study|Protocol Violation|1
1666740|NCT01499810|5827223|P1|Overall Study|Lost to Follow-up|10
1666741|NCT01499667|5827273|P3|Overall Study|Lack of Efficacy|0
1666742|NCT01499667|5827274|P2|Overall Study|Lack of Efficacy|0
1666743|NCT01499667|5827275|P1|Overall Study|Lack of Efficacy|2
1666744|NCT01499667|5827273|P3|Overall Study|Withdrawal by Subject|1
1666745|NCT01499667|5827274|P2|Overall Study|Withdrawal by Subject|1
1666746|NCT01499667|5827275|P1|Overall Study|Withdrawal by Subject|2
1666747|NCT01499667|5827273|P3|Overall Study|Adverse Event|2
1666748|NCT01499667|5827274|P2|Overall Study|Adverse Event|2
1666749|NCT01499667|5827275|P1|Overall Study|Adverse Event|0
1666750|NCT01499667|5827273|P3|Overall Study|Protocol Violation|2
1666751|NCT01499667|5827274|P2|Overall Study|Protocol Violation|3
1666752|NCT01499667|5827275|P1|Overall Study|Protocol Violation|1
1666753|NCT01499667|5827273|P3|Overall Study|administrative problems|5
1666754|NCT01499667|5827274|P2|Overall Study|administrative problems|5
1666755|NCT01499667|5827275|P1|Overall Study|administrative problems|4
1666756|NCT01499576|5827323|P1|Overall Study|Withdrawal by Subject|9
1666757|NCT01499576|5827323|P1|Overall Study|Physician Decision|12
1666758|NCT01499511|5827331|P2|Overall Study|Death|0
1666759|NCT01499511|5827332|P1|Overall Study|Death|1
1666760|NCT01499355|5827357|P4|Double-Blind Period|Lost to Follow-up|0
1666761|NCT01499355|5827358|P3|Double-Blind Period|Lost to Follow-up|0
1666762|NCT01499355|5827359|P2|Double-Blind Period|Lost to Follow-up|1
1666763|NCT01499355|5827360|P1|Double-Blind Period|Lost to Follow-up|0
1666764|NCT01499355|5827357|P4|Double-Blind Period|Consent Withdrawn|2
1666765|NCT01499355|5827358|P3|Double-Blind Period|Consent Withdrawn|1
1666766|NCT01499355|5827359|P2|Double-Blind Period|Consent Withdrawn|0
1666767|NCT01499355|5827360|P1|Double-Blind Period|Consent Withdrawn|0
1666768|NCT01499355|5827357|P4|Double-Blind Period|Investigator Decision|3
1666769|NCT01499355|5827358|P3|Double-Blind Period|Investigator Decision|3
1666770|NCT01499355|5827359|P2|Double-Blind Period|Investigator Decision|0
1666771|NCT01499355|5827360|P1|Double-Blind Period|Investigator Decision|0
1666772|NCT01499355|5827357|P4|Double-Blind Period|Death|0
1666773|NCT01499355|5827358|P3|Double-Blind Period|Death|0
1666774|NCT01499355|5827359|P2|Double-Blind Period|Death|1
1666775|NCT01499355|5827360|P1|Double-Blind Period|Death|0
1666776|NCT01499355|5827357|P4|Double-Blind Period|Other|2
1666777|NCT01499355|5827358|P3|Double-Blind Period|Other|2
1666778|NCT01499355|5827359|P2|Double-Blind Period|Other|1
1666779|NCT01499355|5827360|P1|Double-Blind Period|Other|0
1666780|NCT01499355|5827357|P4|Double-Blind Period|Study Termination|14
1666781|NCT01499355|5827358|P3|Double-Blind Period|Study Termination|16
1666782|NCT01499355|5827359|P2|Double-Blind Period|Study Termination|18
1666783|NCT01499355|5827360|P1|Double-Blind Period|Study Termination|0
1666784|NCT01499355|5827357|P4|Double-Blind Period|Adverse Event|2
1666785|NCT01499355|5827358|P3|Double-Blind Period|Adverse Event|3
1666786|NCT01499355|5827359|P2|Double-Blind Period|Adverse Event|2
1666787|NCT01499355|5827360|P1|Double-Blind Period|Adverse Event|0
1666788|NCT01499355|5827357|P4|Run-In Period|Adverse Event|0
1666789|NCT01499355|5827358|P3|Run-In Period|Adverse Event|0
1666790|NCT01499355|5827359|P2|Run-In Period|Adverse Event|0
1666791|NCT01499355|5827360|P1|Run-In Period|Adverse Event|8
1666792|NCT01499355|5827357|P4|Run-In Period|Consent Withdrawn|0
1666793|NCT01499355|5827358|P3|Run-In Period|Consent Withdrawn|0
1666794|NCT01499355|5827359|P2|Run-In Period|Consent Withdrawn|0
1666795|NCT01499355|5827360|P1|Run-In Period|Consent Withdrawn|1
1666796|NCT01499355|5827357|P4|Run-In Period|Investigator Decision|0
1666797|NCT01499355|5827358|P3|Run-In Period|Investigator Decision|0
1666798|NCT01499355|5827359|P2|Run-In Period|Investigator Decision|0
1666799|NCT01499355|5827360|P1|Run-In Period|Investigator Decision|2
1666800|NCT01499355|5827357|P4|Run-In Period|Death|0
1666801|NCT01499355|5827358|P3|Run-In Period|Death|0
1666802|NCT01499355|5827359|P2|Run-In Period|Death|0
1666803|NCT01499355|5827360|P1|Run-In Period|Death|2
1666804|NCT01499355|5827357|P4|Run-In Period|Other|0
1666805|NCT01499355|5827358|P3|Run-In Period|Other|0
1666806|NCT01499355|5827359|P2|Run-In Period|Other|0
1666807|NCT01499355|5827360|P1|Run-In Period|Other|3
1666808|NCT01499355|5827357|P4|Run-In Period|Study Termination|0
1666809|NCT01499355|5827358|P3|Run-In Period|Study Termination|0
1666810|NCT01499355|5827359|P2|Run-In Period|Study Termination|0
1666811|NCT01499355|5827360|P1|Run-In Period|Study Termination|15
1666812|NCT01499303|5827393|P2|Overall Study|Other|1
1666813|NCT01499303|5827394|P1|Overall Study|Other|0
1666814|NCT01499303|5827393|P2|Overall Study|Adverse Event|4
1666815|NCT01499303|5827394|P1|Overall Study|Adverse Event|1
1666816|NCT01499303|5827393|P2|Overall Study|Withdrawal by Subject|1
1666817|NCT01499303|5827394|P1|Overall Study|Withdrawal by Subject|0
1666818|NCT01499303|5827393|P2|Overall Study|Ongoing|1
1666819|NCT01499303|5827394|P1|Overall Study|Ongoing|2
1666820|NCT01499290|5827402|P2|Overall Study|Adverse Event|7
1666821|NCT01499290|5827403|P1|Overall Study|Adverse Event|14
1666822|NCT01499290|5827402|P2|Overall Study|Lack of Efficacy|8
1666823|NCT01499290|5827403|P1|Overall Study|Lack of Efficacy|7
1666824|NCT01499290|5827402|P2|Overall Study|Condition improved/subject recovered|0
1666825|NCT01499290|5827403|P1|Overall Study|Condition improved/subject recovered|1
1666826|NCT01499290|5827402|P2|Overall Study|Not specified in study report|5
1666827|NCT01499290|5827403|P1|Overall Study|Not specified in study report|11
1666828|NCT01499290|5827402|P2|Overall Study|Withdrawal by Subject|15
1666829|NCT01499290|5827403|P1|Overall Study|Withdrawal by Subject|22
1666830|NCT01499277|5827453|P2|Overall Study|Lack of therapeutic response and other|7
1666831|NCT01499277|5827454|P1|Overall Study|Lack of therapeutic response and other|8
1666832|NCT01499277|5827453|P2|Overall Study|Withdrawal by Subject|6
1666833|NCT01499277|5827454|P1|Overall Study|Withdrawal by Subject|16
1666834|NCT01499277|5827453|P2|Overall Study|Protocol Violation|3
1666835|NCT01499277|5827454|P1|Overall Study|Protocol Violation|2
1666836|NCT01499277|5827453|P2|Overall Study|Lost to Follow-up|8
1666837|NCT01499277|5827454|P1|Overall Study|Lost to Follow-up|15
1666838|NCT01499277|5827453|P2|Overall Study|Death|2
1666839|NCT01499277|5827454|P1|Overall Study|Death|3
1666840|NCT01499277|5827453|P2|Overall Study|Adverse Event|6
1666841|NCT01499277|5827454|P1|Overall Study|Adverse Event|3
1666842|NCT01499199|5827476|P1|Overall Study|Lack of Efficacy|1
1666843|NCT01499199|5827476|P1|Overall Study|Adverse Event|1
1666844|NCT01499160|5827505|P1|Overall Study|Withdrawal by Subject|1
1666845|NCT01499160|5827505|P1|Overall Study|Adverse Event|1
1666846|NCT01499134|5827528|P2|Overall Study|Withdrawal by Subject|1
1666847|NCT01499134|5827529|P1|Overall Study|Withdrawal by Subject|0
1666848|NCT01499095|5827551|P2|Overall Study|Perceived Lack of Efficacy|1
1666849|NCT01499095|5827552|P1|Overall Study|Perceived Lack of Efficacy|1
1666850|NCT01499095|5827551|P2|Overall Study|Change in Injection Schedule|0
1666851|NCT01499095|5827552|P1|Overall Study|Change in Injection Schedule|2
1666852|NCT01499095|5827551|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
1666853|NCT01499095|5827552|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
1666854|NCT01499095|5827551|P2|Overall Study|Hypoglycemia|1
1666855|NCT01499095|5827552|P1|Overall Study|Hypoglycemia|3
1666856|NCT01499095|5827551|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
1666857|NCT01499095|5827552|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
1666858|NCT01499095|5827551|P2|Overall Study|Lost to Follow-up|4
1666859|NCT01499095|5827552|P1|Overall Study|Lost to Follow-up|6
1666860|NCT01499095|5827551|P2|Overall Study|Diverse Reasons|25
1666861|NCT01499095|5827552|P1|Overall Study|Diverse Reasons|22
1666862|NCT01499095|5827551|P2|Overall Study|Received Rescue Therapy|40
1666863|NCT01499095|5827552|P1|Overall Study|Received Rescue Therapy|32
1666864|NCT01499095|5827551|P2|Overall Study|Protocol Violation|7
1666865|NCT01499095|5827552|P1|Overall Study|Protocol Violation|6
1666866|NCT01499095|5827551|P2|Overall Study|Lack of Efficacy|1
1666867|NCT01499095|5827552|P1|Overall Study|Lack of Efficacy|2
1666868|NCT01499095|5827551|P2|Overall Study|Adverse Event|7
1666869|NCT01499095|5827552|P1|Overall Study|Adverse Event|12
1666870|NCT01499095|5827551|P2|Overall Study|Randomized But Not Treated|1
1666871|NCT01499095|5827552|P1|Overall Study|Randomized But Not Treated|1
1666872|NCT01499082|5827582|P2|Overall Study|Lost to Follow-up|3
1666873|NCT01499082|5827583|P1|Overall Study|Lost to Follow-up|1
1666874|NCT01499082|5827582|P2|Overall Study|Hypoglycemia|3
1666875|NCT01499082|5827583|P1|Overall Study|Hypoglycemia|2
1666876|NCT01499082|5827582|P2|Overall Study|Site Closure for Noncompliance|2
1666877|NCT01499082|5827583|P1|Overall Study|Site Closure for Noncompliance|5
1666878|NCT01499082|5827582|P2|Overall Study|Diverse Reasons|14
1666879|NCT01499082|5827583|P1|Overall Study|Diverse Reasons|18
1666880|NCT01499082|5827582|P2|Overall Study|Protocol Violation|8
1666881|NCT01499082|5827583|P1|Overall Study|Protocol Violation|6
1666882|NCT01499082|5827582|P2|Overall Study|Lack of Efficacy|1
1666883|NCT01499082|5827583|P1|Overall Study|Lack of Efficacy|1
1666884|NCT01499082|5827582|P2|Overall Study|Adverse Event|16
1666885|NCT01499082|5827583|P1|Overall Study|Adverse Event|12
1666886|NCT01499082|5827582|P2|Overall Study|Randomized but not Treated|1
1666887|NCT01499082|5827583|P1|Overall Study|Randomized but not Treated|0
1666888|NCT01499043|5827611|P1|Overall Study|Adverse Event|1
1666889|NCT01499043|5827611|P1|Overall Study|Withdrawal by Subject|2
1666890|NCT01499043|5827611|P1|Overall Study|Progressive disease (clinical)|1
1666891|NCT01499043|5827611|P1|Overall Study|Progressive disease (radiographic)|2
1666892|NCT01498952|5827654|P5|Overall Study|Death|0
1666893|NCT01498952|5827655|P4|Overall Study|Death|0
1666894|NCT01498952|5827656|P3|Overall Study|Death|0
1666895|NCT01498952|5827657|P2|Overall Study|Death|2
1666896|NCT01498952|5827658|P1|Overall Study|Death|2
1666897|NCT01498887|5827700|P2|Overall Study|Adverse Event|1
1666898|NCT01498887|5827701|P1|Overall Study|Adverse Event|4
1666899|NCT01498887|5827700|P2|Overall Study|Abnormal laboratory value|2
1666900|NCT01498887|5827701|P1|Overall Study|Abnormal laboratory value|2
1666901|NCT01498887|5827700|P2|Overall Study|Abnormal result from test procedure|1
1666902|NCT01498887|5827701|P1|Overall Study|Abnormal result from test procedure|1
1666903|NCT01498887|5827700|P2|Overall Study|Lack of Efficacy|3
1666904|NCT01498887|5827701|P1|Overall Study|Lack of Efficacy|5
1666905|NCT01498887|5827700|P2|Overall Study|Protocol Violation|3
1666906|NCT01498887|5827701|P1|Overall Study|Protocol Violation|1
1666907|NCT01498887|5827700|P2|Overall Study|Withdrawal by Subject|0
1666908|NCT01498887|5827701|P1|Overall Study|Withdrawal by Subject|1
1666909|NCT01498887|5827700|P2|Overall Study|Lost to Follow-up|1
1666910|NCT01498887|5827701|P1|Overall Study|Lost to Follow-up|1
1666911|NCT01498887|5827700|P2|Overall Study|Administrative problems|0
1666912|NCT01498887|5827701|P1|Overall Study|Administrative problems|1
1666913|NCT01498822|5827722|P2|Overall Study|Lost to Follow-up|3
1666914|NCT01498822|5827723|P1|Overall Study|Lost to Follow-up|8
1666915|NCT01498822|5827722|P2|Overall Study|Withdrawal by Subject|25
1666916|NCT01498822|5827723|P1|Overall Study|Withdrawal by Subject|15
1666917|NCT01498822|5827722|P2|Overall Study|Adverse Event, serious fatal|1
1666918|NCT01498822|5827723|P1|Overall Study|Adverse Event, serious fatal|1
1666919|NCT01498822|5827722|P2|Overall Study|SAE, non-fatal|2
1666920|NCT01498822|5827723|P1|Overall Study|SAE, non-fatal|2
1666921|NCT01498822|5827722|P2|Overall Study|AE, non-serious non-fatal|17
1666922|NCT01498822|5827723|P1|Overall Study|AE, non-serious non-fatal|8
1666923|NCT01498822|5827722|P2|Overall Study|Lack of Efficacy|2
1666924|NCT01498822|5827723|P1|Overall Study|Lack of Efficacy|7
1666925|NCT01498822|5827722|P2|Overall Study|Other Reason|2
1666926|NCT01498822|5827723|P1|Overall Study|Other Reason|5
1666927|NCT01498822|5827722|P2|Overall Study|Protocol Violation|4
1666928|NCT01498822|5827723|P1|Overall Study|Protocol Violation|8
1666929|NCT01498692|5827750|P1|Overall Study|Missed 12-month visit|3
1666930|NCT01498692|5827750|P1|Overall Study|Withdrawal by Subject|1
1666931|NCT01498692|5827750|P1|Overall Study|Death|4
1666932|NCT01498679|5827781|P2|Overall Study|Withdrawal by Subject|4
1666933|NCT01498679|5827782|P1|Overall Study|Withdrawal by Subject|12
1666934|NCT01498679|5827781|P2|Overall Study|Physician Decision|2
1666935|NCT01498679|5827782|P1|Overall Study|Physician Decision|0
1666936|NCT01498679|5827781|P2|Overall Study|Protocol Violation|0
1666937|NCT01498679|5827782|P1|Overall Study|Protocol Violation|4
1666938|NCT01498679|5827781|P2|Overall Study|Lack of Efficacy|12
1666939|NCT01498679|5827782|P1|Overall Study|Lack of Efficacy|72
1666940|NCT01498679|5827781|P2|Overall Study|Adverse Event|4
1666941|NCT01498679|5827782|P1|Overall Study|Adverse Event|1
1666942|NCT01498653|5827798|P2|Overall Study|Withdrawal by Subject|3
1666943|NCT01498653|5827799|P1|Overall Study|Withdrawal by Subject|2
1666944|NCT01498653|5827798|P2|Overall Study|Physician Decision|0
1666945|NCT01498653|5827799|P1|Overall Study|Physician Decision|2
1666946|NCT01498653|5827798|P2|Overall Study|Lost to Follow-up|0
1666947|NCT01498653|5827799|P1|Overall Study|Lost to Follow-up|1
1666948|NCT01498653|5827798|P2|Overall Study|Protocol Violation|4
1666949|NCT01498653|5827799|P1|Overall Study|Protocol Violation|0
1666950|NCT01498653|5827798|P2|Overall Study|Lack of Efficacy|26
1666951|NCT01498653|5827799|P1|Overall Study|Lack of Efficacy|12
1666952|NCT01498653|5827798|P2|Overall Study|Adverse Event|2
1666953|NCT01498653|5827799|P1|Overall Study|Adverse Event|2
1666954|NCT01498640|5827813|P1|Overall Study|Other|3
1666955|NCT01498640|5827813|P1|Overall Study|Death|1
1666956|NCT01498640|5827813|P1|Overall Study|Lost to Follow-up|1
1666957|NCT01498575|5827843|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
1666958|NCT01498575|5827844|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
1666959|NCT01498575|5827843|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
1666960|NCT01498575|5827844|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
1666961|NCT01498575|5827843|P2|Overall Sample|Withdrawal by Subject|14
1666962|NCT01498575|5827844|P1|Overall Sample|Withdrawal by Subject|60
1666963|NCT01498458|5827861|P1|Overall Study|Physician Decision|3
1666964|NCT01498458|5827861|P1|Overall Study|Adverse Event|4
1666965|NCT01498289|5827913|P2|Overall Study|Reason under review|1
1666966|NCT01498289|5827914|P1|Overall Study|Reason under review|0
1666967|NCT01498289|5827913|P2|Overall Study|Not protocol specified|2
1666968|NCT01498289|5827914|P1|Overall Study|Not protocol specified|7
1666969|NCT01498289|5827913|P2|Overall Study|Progression/relapse|59
1666970|NCT01498289|5827914|P1|Overall Study|Progression/relapse|53
1666971|NCT01498289|5827913|P2|Overall Study|Withdrawal unrelated to AE|16
1666972|NCT01498289|5827914|P1|Overall Study|Withdrawal unrelated to AE|16
1666973|NCT01498289|5827913|P2|Overall Study|Death|8
1666974|NCT01498289|5827914|P1|Overall Study|Death|6
1666975|NCT01498289|5827913|P2|Overall Study|Adverse Event|18
1666976|NCT01498289|5827914|P1|Overall Study|Adverse Event|16
1666977|NCT01498185|5827935|P5|Overall Study|No longer met criteria, etc|2
1666978|NCT01498185|5827936|P4|Overall Study|No longer met criteria, etc|0
1666979|NCT01498185|5827937|P3|Overall Study|No longer met criteria, etc|0
1666980|NCT01498185|5827938|P2|Overall Study|No longer met criteria, etc|0
1666981|NCT01498185|5827939|P1|Overall Study|No longer met criteria, etc|0
1666982|NCT01498185|5827935|P5|Overall Study|Withdrawal by Subject|1
1666983|NCT01498185|5827936|P4|Overall Study|Withdrawal by Subject|2
1666984|NCT01498185|5827937|P3|Overall Study|Withdrawal by Subject|0
1666985|NCT01498185|5827938|P2|Overall Study|Withdrawal by Subject|1
1666986|NCT01498185|5827939|P1|Overall Study|Withdrawal by Subject|1
1666987|NCT01498185|5827935|P5|Overall Study|Adverse Event|0
1666988|NCT01498185|5827936|P4|Overall Study|Adverse Event|1
1666989|NCT01498185|5827937|P3|Overall Study|Adverse Event|0
1666990|NCT01498185|5827938|P2|Overall Study|Adverse Event|0
1666991|NCT01498185|5827939|P1|Overall Study|Adverse Event|0
1666992|NCT01498120|5827979|P1|Overall Study|Other|4
1666993|NCT01498120|5827979|P1|Overall Study|AE, non-serious non-fatal|3
1666994|NCT01498120|5827979|P1|Overall Study|Withdrawal by Subject|5
1666995|NCT01498120|5827979|P1|Overall Study|Lost to Follow-up|1
1666996|NCT01498068|5827986|P2|Overall Study|Withdrawal by Subject|1
1666997|NCT01498068|5827987|P1|Overall Study|Withdrawal by Subject|1
1666998|NCT01497938|5828005|P2|Overall Study|Device Violation|0
1666999|NCT01497938|5828006|P1|Overall Study|Device Violation|1
1667000|NCT01497938|5828005|P2|Overall Study|Withdrawal by Subject|0
1667001|NCT01497938|5828006|P1|Overall Study|Withdrawal by Subject|4
1667002|NCT01497938|5828005|P2|Overall Study|Physician Decision|1
1667003|NCT01497938|5828006|P1|Overall Study|Physician Decision|0
1667004|NCT01497938|5828005|P2|Overall Study|Adverse Event|1
1667005|NCT01497938|5828006|P1|Overall Study|Adverse Event|0
1667006|NCT01497899|5828018|P4|Open-Label Extension Phase|Lost to Follow-up|5
1667007|NCT01497899|5828019|P3|Open-Label Extension Phase|Lost to Follow-up|5
1667008|NCT01497899|5828020|P2|Open-Label Extension Phase|Lost to Follow-up|3
1667009|NCT01497899|5828021|P1|Open-Label Extension Phase|Lost to Follow-up|9
1667010|NCT01497899|5828018|P4|Open-Label Extension Phase|Protocol Violation|0
1667011|NCT01497899|5828019|P3|Open-Label Extension Phase|Protocol Violation|1
1667012|NCT01497899|5828020|P2|Open-Label Extension Phase|Protocol Violation|0
1667013|NCT01497899|5828021|P1|Open-Label Extension Phase|Protocol Violation|0
1667014|NCT01497899|5828018|P4|Open-Label Extension Phase|Pregnancy|0
1667015|NCT01497899|5828019|P3|Open-Label Extension Phase|Pregnancy|1
1667016|NCT01497899|5828020|P2|Open-Label Extension Phase|Pregnancy|1
1667017|NCT01497899|5828021|P1|Open-Label Extension Phase|Pregnancy|0
1667018|NCT01497899|5828018|P4|Open-Label Extension Phase|Withdrew Consent|0
1667019|NCT01497899|5828019|P3|Open-Label Extension Phase|Withdrew Consent|2
1667020|NCT01497899|5828020|P2|Open-Label Extension Phase|Withdrew Consent|3
1667021|NCT01497899|5828021|P1|Open-Label Extension Phase|Withdrew Consent|8
1667022|NCT01497899|5828018|P4|Open-Label Extension Phase|Death|0
1667023|NCT01497899|5828019|P3|Open-Label Extension Phase|Death|0
1667024|NCT01497899|5828020|P2|Open-Label Extension Phase|Death|0
1667025|NCT01497899|5828021|P1|Open-Label Extension Phase|Death|1
1667026|NCT01497899|5828018|P4|Open-Label Extension Phase|Adverse Event|0
1667027|NCT01497899|5828019|P3|Open-Label Extension Phase|Adverse Event|0
1667028|NCT01497899|5828020|P2|Open-Label Extension Phase|Adverse Event|0
1667029|NCT01497899|5828021|P1|Open-Label Extension Phase|Adverse Event|1
1667030|NCT01497899|5828018|P4|Double-Blind Phase|Subject Non-Compliance|0
1667031|NCT01497899|5828019|P3|Double-Blind Phase|Subject Non-Compliance|0
1667032|NCT01497899|5828020|P2|Double-Blind Phase|Subject Non-Compliance|1
1667033|NCT01497899|5828021|P1|Double-Blind Phase|Subject Non-Compliance|0
1667034|NCT01497899|5828018|P4|Double-Blind Phase|Lost to Follow-up|0
1667035|NCT01497899|5828019|P3|Double-Blind Phase|Lost to Follow-up|0
1667036|NCT01497899|5828020|P2|Double-Blind Phase|Lost to Follow-up|2
1667037|NCT01497899|5828021|P1|Double-Blind Phase|Lost to Follow-up|3
1667038|NCT01497899|5828018|P4|Double-Blind Phase|Withdrew Consent|0
1667039|NCT01497899|5828019|P3|Double-Blind Phase|Withdrew Consent|0
1667040|NCT01497899|5828020|P2|Double-Blind Phase|Withdrew Consent|1
1667041|NCT01497899|5828021|P1|Double-Blind Phase|Withdrew Consent|0
1667042|NCT01497899|5828018|P4|Double-Blind Phase|Investigator's Discretion|0
1667043|NCT01497899|5828019|P3|Double-Blind Phase|Investigator's Discretion|0
1667044|NCT01497899|5828020|P2|Double-Blind Phase|Investigator's Discretion|0
1667045|NCT01497899|5828021|P1|Double-Blind Phase|Investigator's Discretion|1
1667046|NCT01497899|5828018|P4|Double-Blind Phase|Lack of Efficacy|0
1667047|NCT01497899|5828019|P3|Double-Blind Phase|Lack of Efficacy|0
1667048|NCT01497899|5828020|P2|Double-Blind Phase|Lack of Efficacy|1
1667049|NCT01497899|5828021|P1|Double-Blind Phase|Lack of Efficacy|0
1667050|NCT01497899|5828018|P4|Double-Blind Phase|Adverse Event|0
1667051|NCT01497899|5828019|P3|Double-Blind Phase|Adverse Event|0
1667052|NCT01497899|5828020|P2|Double-Blind Phase|Adverse Event|0
1667053|NCT01497899|5828021|P1|Double-Blind Phase|Adverse Event|1
1667054|NCT01497899|5828018|P4|Double-Blind Phase|Randomized but not Treated|0
1667055|NCT01497899|5828019|P3|Double-Blind Phase|Randomized but not Treated|0
1667056|NCT01497899|5828020|P2|Double-Blind Phase|Randomized but not Treated|0
1667057|NCT01497899|5828021|P1|Double-Blind Phase|Randomized but not Treated|1
1667058|NCT01497366|5828092|P2|Overall Study|Randomized but not treated|21
1667059|NCT01497366|5828093|P1|Overall Study|Randomized but not treated|7
1667060|NCT01497366|5828092|P2|Overall Study|Death|1
1667061|NCT01497366|5828093|P1|Overall Study|Death|1
1667062|NCT01497366|5828092|P2|Overall Study|Other|0
1667063|NCT01497366|5828093|P1|Overall Study|Other|5
1667064|NCT01497366|5828092|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
1667065|NCT01497366|5828093|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
1667066|NCT01497366|5828092|P2|Overall Study|Withdrawal by Subject|6
1667067|NCT01497366|5828093|P1|Overall Study|Withdrawal by Subject|6
1667068|NCT01497366|5828092|P2|Overall Study|Lost to Follow-up|10
1667069|NCT01497366|5828093|P1|Overall Study|Lost to Follow-up|11
1667070|NCT01497366|5828092|P2|Overall Study|Virologic failure|50
1667071|NCT01497366|5828093|P1|Overall Study|Virologic failure|2
1667072|NCT01497275|5828111|P1|Overall Study|Adverse Event|1
1667073|NCT01497275|5828111|P1|Overall Study|Death|1
1667074|NCT01497262|5828118|P1|Overall Study|Protocol Violation|1
1667075|NCT01497262|5828118|P1|Overall Study|Adverse Event|2
1667076|NCT01497262|5828118|P1|Overall Study|Withdrawal by Subject|2
1667077|NCT01497262|5828118|P1|Overall Study|Physician Decision|1
1667078|NCT01497262|5828118|P1|Overall Study|Abnormal Test Procedure Result|1
1667079|NCT01497262|5828118|P1|Overall Study|Abnormal Lab Values|4
1667080|NCT01497197|5828125|P2|Overall Study|Other|1
1667081|NCT01497197|5828126|P1|Overall Study|Other|3
1667082|NCT01497197|5828125|P2|Overall Study|All embryos discarded|3
1667083|NCT01497197|5828126|P1|Overall Study|All embryos discarded|0
1667084|NCT01497197|5828125|P2|Overall Study|Intention to freeze all embryos|1
1667085|NCT01497197|5828126|P1|Overall Study|Intention to freeze all embryos|0
1667086|NCT01497197|5828125|P2|Overall Study|No fertilisation|5
1667087|NCT01497197|5828126|P1|Overall Study|No fertilisation|6
1667088|NCT01497197|5828125|P2|Overall Study|No oocytes retrieved|2
1667089|NCT01497197|5828126|P1|Overall Study|No oocytes retrieved|3
1667090|NCT01497197|5828125|P2|Overall Study|Risk of OHSS|0
1667091|NCT01497197|5828126|P1|Overall Study|Risk of OHSS|1
1667092|NCT01497197|5828125|P2|Overall Study|Excessive/lack of response to treatment|0
1667093|NCT01497197|5828126|P1|Overall Study|Excessive/lack of response to treatment|1
1667094|NCT01497197|5828125|P2|Overall Study|Withdrawal by Subject|1
1667095|NCT01497197|5828126|P1|Overall Study|Withdrawal by Subject|2
1667096|NCT01497197|5828125|P2|Overall Study|Protocol Violation|2
1667097|NCT01497197|5828126|P1|Overall Study|Protocol Violation|0
1667098|NCT01497197|5828125|P2|Overall Study|Lost to Follow-up|0
1667099|NCT01497197|5828126|P1|Overall Study|Lost to Follow-up|1
1667100|NCT01497067|5828161|P1|Overall Study|Other|13
1667101|NCT01497067|5828161|P1|Overall Study|Patient decision unrel to Adverse Event|10
1667102|NCT01497067|5828161|P1|Overall Study|Adverse Event|3
1667103|NCT01497067|5828161|P1|Overall Study|Lost to Follow-up|56
1667104|NCT01496846|5828172|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1667105|NCT01496846|5828173|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1667106|NCT01496846|5828174|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1667107|NCT01496846|5828175|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
1667108|NCT01496846|5828176|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1667109|NCT01496846|5828177|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
1667110|NCT01496807|5828188|P1|Overall Study|Change in diagnosis|1
1667111|NCT01496807|5828188|P1|Overall Study|Participant preference/toxicity|8
1667112|NCT01496807|5828188|P1|Overall Study|Progressive Disease|21
1667113|NCT01496469|5828200|P2|Overall Study|Other|1
1667114|NCT01496469|5828201|P1|Overall Study|Other|1
1667115|NCT01496469|5828200|P2|Overall Study|BP exceeds protocol limits|2
1667116|NCT01496469|5828201|P1|Overall Study|BP exceeds protocol limits|1
1667117|NCT01496469|5828200|P2|Overall Study|Withdrawal by Subject|4
1667118|NCT01496469|5828201|P1|Overall Study|Withdrawal by Subject|4
1667119|NCT01496469|5828200|P2|Overall Study|Lost to Follow-up|1
1667120|NCT01496469|5828201|P1|Overall Study|Lost to Follow-up|1
1667121|NCT01496469|5828200|P2|Overall Study|Protocol Violation|0
1667122|NCT01496469|5828201|P1|Overall Study|Protocol Violation|2
1667123|NCT01496469|5828200|P2|Overall Study|Adverse Event|0
1667124|NCT01496469|5828201|P1|Overall Study|Adverse Event|1
1667125|NCT01496456|5828211|P1|Overall Study|Lost to Follow-up|7
1667126|NCT01496456|5828211|P1|Overall Study|Protocol Violation|1
1667127|NCT01496430|5828224|P3|Overall Study|Other|0
1667128|NCT01496430|5828225|P2|Overall Study|Other|0
1667129|NCT01496430|5828226|P1|Overall Study|Other|2
1667130|NCT01496430|5828224|P3|Overall Study|Principal Investigator Discretion|1
1667131|NCT01496430|5828225|P2|Overall Study|Principal Investigator Discretion|1
1667132|NCT01496430|5828226|P1|Overall Study|Principal Investigator Discretion|0
1667133|NCT01496430|5828224|P3|Overall Study|Voluntary Withdrawal|6
1667134|NCT01496430|5828225|P2|Overall Study|Voluntary Withdrawal|1
1667135|NCT01496430|5828226|P1|Overall Study|Voluntary Withdrawal|2
1667136|NCT01496430|5828224|P3|Overall Study|Lost to Follow-up|1
1667137|NCT01496430|5828225|P2|Overall Study|Lost to Follow-up|3
1667138|NCT01496430|5828226|P1|Overall Study|Lost to Follow-up|2
1667139|NCT01496430|5828224|P3|Overall Study|Major Protocol Deviation|1
1667140|NCT01496430|5828225|P2|Overall Study|Major Protocol Deviation|0
1667141|NCT01496430|5828226|P1|Overall Study|Major Protocol Deviation|0
1667142|NCT01496430|5828224|P3|Overall Study|Adverse Event|1
1667143|NCT01496430|5828225|P2|Overall Study|Adverse Event|0
1667144|NCT01496430|5828226|P1|Overall Study|Adverse Event|0
1667145|NCT01496287|5828338|P1|Overall Study|Incomplete anesthesia|5
1667146|NCT01496287|5828338|P1|Overall Study|Lost to Follow-up|1
1667147|NCT01496274|5828348|P2|Overall Study|Lost to Follow-up|3
1667148|NCT01496274|5828349|P1|Overall Study|Lost to Follow-up|0
1667149|NCT01496274|5828348|P2|Overall Study|Withdrawal by Subject|0
1667150|NCT01496274|5828349|P1|Overall Study|Withdrawal by Subject|2
1667151|NCT01496274|5828348|P2|Overall Study|Adverse Event|1
1667152|NCT01496274|5828349|P1|Overall Study|Adverse Event|1
1667153|NCT01496274|5828348|P2|Overall Study|Protocol Violation|1
1667154|NCT01496274|5828349|P1|Overall Study|Protocol Violation|0
1667155|NCT01496183|5828394|P2|Overall Study|Withdrawal by Subject|1
1667156|NCT01496183|5828395|P1|Overall Study|Withdrawal by Subject|0
1667157|NCT01496183|5828394|P2|Overall Study|Physician Decision|1
1667158|NCT01496183|5828395|P1|Overall Study|Physician Decision|3
1667159|NCT01496066|5828447|P2|Overall Study|Death|4
1667160|NCT01496066|5828448|P1|Overall Study|Death|1
1667161|NCT01496066|5828447|P2|Overall Study|Explant|0
1667162|NCT01496066|5828448|P1|Overall Study|Explant|3
1667163|NCT01496066|5828447|P2|Overall Study|Lost to Follow-up|5
1667164|NCT01496066|5828448|P1|Overall Study|Lost to Follow-up|8
1667165|NCT01495975|5828510|P2|Overall Study|Lost to Follow-up|0
1667166|NCT01495975|5828511|P1|Overall Study|Lost to Follow-up|1
1667167|NCT01495793|5828635|P1|Overall Study|Violation of inclusion criteria|1
1667168|NCT01495793|5828635|P1|Overall Study|Lost to Follow-up|1
1667169|NCT01495702|5828648|P2|Randomized Phase|Protocol Violation|1
1667170|NCT01495702|5828649|P1|Randomized Phase|Protocol Violation|3
1667171|NCT01495702|5828648|P2|Randomized Phase|Participant Noncompliance|0
1667172|NCT01495702|5828649|P1|Randomized Phase|Participant Noncompliance|1
1667173|NCT01495702|5828648|P2|Randomized Phase|Lost to Follow-up|3
1667174|NCT01495702|5828649|P1|Randomized Phase|Lost to Follow-up|4
1667175|NCT01495702|5828648|P2|Randomized Phase|Withdrew Consent|18
1667176|NCT01495702|5828649|P1|Randomized Phase|Withdrew Consent|10
1667177|NCT01495702|5828648|P2|Randomized Phase|Investigators Discretion|0
1667178|NCT01495702|5828649|P1|Randomized Phase|Investigators Discretion|2
1667179|NCT01495702|5828648|P2|Randomized Phase|Lack of Efficacy|0
1667180|NCT01495702|5828649|P1|Randomized Phase|Lack of Efficacy|2
1667181|NCT01495702|5828648|P2|Randomized Phase|Death|0
1667182|NCT01495702|5828649|P1|Randomized Phase|Death|1
1667183|NCT01495702|5828648|P2|Randomized Phase|Adverse Event|2
1667184|NCT01495702|5828649|P1|Randomized Phase|Adverse Event|2
1667185|NCT01495702|5828648|P2|Randomized Phase|Randomized But Not Treated|4
1667186|NCT01495702|5828649|P1|Randomized Phase|Randomized But Not Treated|1
1667187|NCT01495000|5828727|P2|Overall Study|Withdrawal by Subject|10
1667188|NCT01495000|5828728|P1|Overall Study|Withdrawal by Subject|10
1667189|NCT01495000|5828727|P2|Overall Study|Protocol Violation|0
1667190|NCT01495000|5828728|P1|Overall Study|Protocol Violation|1
1667191|NCT01495000|5828727|P2|Overall Study|Lost to Follow-up|2
1667192|NCT01495000|5828728|P1|Overall Study|Lost to Follow-up|2
1667193|NCT01494987|5828770|P2|Overall Study|Subject Withdrew Consent|3
1667194|NCT01494987|5828771|P1|Overall Study|Subject Withdrew Consent|2
1667195|NCT01494987|5828770|P2|Overall Study|Subject Non-Compliance|10
1667196|NCT01494987|5828771|P1|Overall Study|Subject Non-Compliance|9
1667197|NCT01494987|5828770|P2|Overall Study|Protocol Violation|3
1667198|NCT01494987|5828771|P1|Overall Study|Protocol Violation|3
1667199|NCT01494987|5828770|P2|Overall Study|Lost to Follow-up|1
1667200|NCT01494987|5828771|P1|Overall Study|Lost to Follow-up|1
1667201|NCT01494987|5828770|P2|Overall Study|Investigator's Discretion|2
1667202|NCT01494987|5828771|P1|Overall Study|Investigator's Discretion|1
1667203|NCT01494987|5828770|P2|Overall Study|Hyperglycemia|4
1667204|NCT01494987|5828771|P1|Overall Study|Hyperglycemia|6
1667205|NCT01494987|5828770|P2|Overall Study|Adverse Event|5
1667206|NCT01494987|5828771|P1|Overall Study|Adverse Event|6
1667207|NCT01494818|5828785|P2|Overall Study|Lost to Follow-up|0
1667208|NCT01494818|5828786|P1|Overall Study|Lost to Follow-up|1
1667209|NCT01494818|5828785|P2|Overall Study|Relocation|2
1667210|NCT01494818|5828786|P1|Overall Study|Relocation|1
1667211|NCT01494649|5828817|P2|Overall Study|Lost to Follow-up|1
1667212|NCT01494649|5828818|P1|Overall Study|Lost to Follow-up|0
1667213|NCT01494610|5828834|P2|Period 4|Protocol Violation|0
1667214|NCT01494610|5828835|P1|Period 4|Protocol Violation|1
1667215|NCT01494610|5828834|P2|Period 3|Withdrawal by Subject|0
1667216|NCT01494610|5828835|P1|Period 3|Withdrawal by Subject|1
1667217|NCT01494610|5828834|P2|Period 3|Adverse Event|0
1667218|NCT01494610|5828835|P1|Period 3|Adverse Event|1
1667219|NCT01494610|5828834|P2|Period 1|Withdrawal by Subject|1
1667220|NCT01494610|5828835|P1|Period 1|Withdrawal by Subject|1
1667221|NCT01494584|5828903|P1|Overall Study|Study Closed/Terminated|1
1667222|NCT01494532|5829035|P6|Overall Study|Withdrawal by Subject|0
1667223|NCT01494532|5829036|P5|Overall Study|Withdrawal by Subject|2
1667224|NCT01494532|5829037|P4|Overall Study|Withdrawal by Subject|3
1667225|NCT01494532|5829038|P3|Overall Study|Withdrawal by Subject|4
1667226|NCT01494532|5829039|P2|Overall Study|Withdrawal by Subject|1
1667227|NCT01494532|5829040|P1|Overall Study|Withdrawal by Subject|3
1667228|NCT01494532|5829035|P6|Overall Study|Physician Decision|0
1667229|NCT01494532|5829036|P5|Overall Study|Physician Decision|0
1667230|NCT01494532|5829037|P4|Overall Study|Physician Decision|2
1667231|NCT01494532|5829038|P3|Overall Study|Physician Decision|1
1667232|NCT01494532|5829039|P2|Overall Study|Physician Decision|1
1667233|NCT01494532|5829040|P1|Overall Study|Physician Decision|0
1667234|NCT01494532|5829035|P6|Overall Study|Lost to Follow-up|0
1667235|NCT01494532|5829036|P5|Overall Study|Lost to Follow-up|0
1667236|NCT01494532|5829037|P4|Overall Study|Lost to Follow-up|2
1667237|NCT01494532|5829038|P3|Overall Study|Lost to Follow-up|0
1667238|NCT01494532|5829039|P2|Overall Study|Lost to Follow-up|0
1667239|NCT01494532|5829040|P1|Overall Study|Lost to Follow-up|1
1667240|NCT01494532|5829035|P6|Overall Study|Protocol-defined stopping criteria|0
1667241|NCT01494532|5829036|P5|Overall Study|Protocol-defined stopping criteria|0
1667242|NCT01494532|5829037|P4|Overall Study|Protocol-defined stopping criteria|0
1667243|NCT01494532|5829038|P3|Overall Study|Protocol-defined stopping criteria|1
1667244|NCT01494532|5829039|P2|Overall Study|Protocol-defined stopping criteria|0
1667245|NCT01494532|5829040|P1|Overall Study|Protocol-defined stopping criteria|0
1667246|NCT01494532|5829035|P6|Overall Study|Protocol deviation|0
1667247|NCT01494532|5829036|P5|Overall Study|Protocol deviation|3
1667248|NCT01494532|5829037|P4|Overall Study|Protocol deviation|2
1667249|NCT01494532|5829038|P3|Overall Study|Protocol deviation|3
1667250|NCT01494532|5829039|P2|Overall Study|Protocol deviation|1
1667251|NCT01494532|5829040|P1|Overall Study|Protocol deviation|2
1667252|NCT01494532|5829035|P6|Overall Study|Lack of Efficacy|0
1667253|NCT01494532|5829036|P5|Overall Study|Lack of Efficacy|2
1667254|NCT01494532|5829037|P4|Overall Study|Lack of Efficacy|0
1667255|NCT01494532|5829038|P3|Overall Study|Lack of Efficacy|0
1667256|NCT01494532|5829039|P2|Overall Study|Lack of Efficacy|0
1667257|NCT01494532|5829040|P1|Overall Study|Lack of Efficacy|0
1667258|NCT01494532|5829035|P6|Overall Study|Adverse Event|0
1667259|NCT01494532|5829036|P5|Overall Study|Adverse Event|5
1667260|NCT01494532|5829037|P4|Overall Study|Adverse Event|6
1667261|NCT01494532|5829038|P3|Overall Study|Adverse Event|8
1667262|NCT01494532|5829039|P2|Overall Study|Adverse Event|1
1667263|NCT01494532|5829040|P1|Overall Study|Adverse Event|4
1667264|NCT01494506|5829195|P3|Overall Study|Other|1
1667265|NCT01494506|5829196|P2|Overall Study|Other|3
1667266|NCT01494506|5829197|P1|Overall Study|Other|0
1667267|NCT01494506|5829195|P3|Overall Study|Sponsor Decision|1
1667268|NCT01494506|5829196|P2|Overall Study|Sponsor Decision|0
1667269|NCT01494506|5829197|P1|Overall Study|Sponsor Decision|0
1667270|NCT01494506|5829195|P3|Overall Study|Clinical Deterioration|13
1667271|NCT01494506|5829196|P2|Overall Study|Clinical Deterioration|17
1667272|NCT01494506|5829197|P1|Overall Study|Clinical Deterioration|21
1667273|NCT01494506|5829195|P3|Overall Study|Withdrawal by Subject|14
1667274|NCT01494506|5829196|P2|Overall Study|Withdrawal by Subject|20
1667275|NCT01494506|5829197|P1|Overall Study|Withdrawal by Subject|17
1667276|NCT01494506|5829195|P3|Overall Study|Physician Decision|4
1667277|NCT01494506|5829196|P2|Overall Study|Physician Decision|5
1667278|NCT01494506|5829197|P1|Overall Study|Physician Decision|7
1667279|NCT01494506|5829195|P3|Overall Study|Death|2
1667280|NCT01494506|5829196|P2|Overall Study|Death|5
1667281|NCT01494506|5829197|P1|Overall Study|Death|9
1667282|NCT01494506|5829195|P3|Overall Study|Adverse Event|11
1667283|NCT01494506|5829196|P2|Overall Study|Adverse Event|10
1667284|NCT01494506|5829197|P1|Overall Study|Adverse Event|17
1667285|NCT01494506|5829195|P3|Overall Study|Lack of Efficacy|57
1667286|NCT01494506|5829196|P2|Overall Study|Lack of Efficacy|83
1667287|NCT01494506|5829197|P1|Overall Study|Lack of Efficacy|77
1667288|NCT01494467|5829234|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
1667289|NCT01494467|5829235|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
1667290|NCT01494467|5829234|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1667291|NCT01494467|5829235|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
1667292|NCT01494467|5829234|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
1667293|NCT01494467|5829235|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
1667294|NCT01494467|5829234|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
1667295|NCT01494467|5829235|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
1667296|NCT01494467|5829234|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1667297|NCT01494467|5829235|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
1667298|NCT01494467|5829234|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1667299|NCT01494467|5829235|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
1667300|NCT01494467|5829234|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
1667301|NCT01494467|5829235|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
1667302|NCT01494467|5829234|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1667303|NCT01494467|5829235|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1667304|NCT01494467|5829234|P2|Part A Vehicle Control (12 Weeks)|Other|1
1667305|NCT01494467|5829235|P1|Part A Vehicle Control (12 Weeks)|Other|1
1667306|NCT01494467|5829234|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1667307|NCT01494467|5829235|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1667308|NCT01494467|5829234|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
1667309|NCT01494467|5829235|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
1667310|NCT01494467|5829234|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
1667311|NCT01494467|5829235|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
1667312|NCT01494467|5829234|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1667313|NCT01494467|5829235|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
1667314|NCT01494467|5829234|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1667315|NCT01494467|5829235|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
1667316|NCT01494350|5829251|P1|Overall Study|Worsening of lesion|1
1667317|NCT01494298|5829261|P2|Overall Study|Protocol Violation|8
1667318|NCT01494298|5829262|P1|Overall Study|Protocol Violation|2
1667319|NCT01494038|5829274|P2|Overall Study|Death|4
1667320|NCT01494038|5829275|P1|Overall Study|Death|2
1667321|NCT01494038|5829274|P2|Overall Study|Not willing to adhere to reqs|9
1667322|NCT01494038|5829275|P1|Overall Study|Not willing to adhere to reqs|2
1667323|NCT01494038|5829274|P2|Overall Study|Not able to get to clinic|15
1667324|NCT01494038|5829275|P1|Overall Study|Not able to get to clinic|21
1667325|NCT01494038|5829274|P2|Overall Study|Withdrawal by Subject|34
1667326|NCT01494038|5829275|P1|Overall Study|Withdrawal by Subject|44
1667327|NCT01494038|5829274|P2|Overall Study|Lost to Follow-up|20
1667328|NCT01494038|5829275|P1|Overall Study|Lost to Follow-up|18
1667329|NCT01494038|5829274|P2|Overall Study|Protocol Violation|1
1667330|NCT01494038|5829275|P1|Overall Study|Protocol Violation|1
1667331|NCT01493960|5829363|P2|Overall Study|Non-specified|4
1667332|NCT01493960|5829364|P1|Overall Study|Non-specified|4
1667333|NCT01493960|5829363|P2|Overall Study|Withdrawal by Subject|4
1667334|NCT01493960|5829364|P1|Overall Study|Withdrawal by Subject|10
1667335|NCT01493960|5829363|P2|Overall Study|Protocol Violation|0
1667336|NCT01493960|5829364|P1|Overall Study|Protocol Violation|3
1667337|NCT01493960|5829363|P2|Overall Study|Lack of Efficacy|9
1667338|NCT01493960|5829364|P1|Overall Study|Lack of Efficacy|15
1667339|NCT01493960|5829363|P2|Overall Study|Adverse Event|1
1667340|NCT01493960|5829364|P1|Overall Study|Adverse Event|0
1667341|NCT01493778|5829395|P1|Overall Study|Withdrawal by Subject|8
1667342|NCT01493687|5829457|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
1667343|NCT01493687|5829458|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
1667344|NCT01493687|5829457|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
1667345|NCT01493687|5829458|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
1667346|NCT01493687|5829457|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
1667347|NCT01493687|5829458|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
1667348|NCT01493687|5829457|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
1667349|NCT01493687|5829458|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
1667350|NCT01493687|5829457|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
1667351|NCT01493687|5829458|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
1667352|NCT01493687|5829457|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
1667353|NCT01493687|5829458|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
1667354|NCT01493687|5829457|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
1667355|NCT01493687|5829458|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
1667356|NCT01493687|5829457|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
1667357|NCT01493687|5829458|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
1667358|NCT01493687|5829457|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1667359|NCT01493687|5829458|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
1667360|NCT01493687|5829457|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
1667361|NCT01493687|5829458|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
1667362|NCT01493687|5829457|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
1667363|NCT01493687|5829458|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
1667364|NCT01493687|5829457|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
1667365|NCT01493687|5829458|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
1667366|NCT01493687|5829457|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
1667367|NCT01493687|5829458|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
1667368|NCT01493687|5829457|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
1667369|NCT01493687|5829458|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
1667370|NCT01493687|5829457|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
1667371|NCT01493687|5829458|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
1667372|NCT01493557|5829477|P3|Adding the Second Strategy|Withdrawal by Subject|0
1667373|NCT01493557|5829478|P2|Adding the Second Strategy|Withdrawal by Subject|1
1667374|NCT01493557|5829479|P1|Adding the Second Strategy|Withdrawal by Subject|0
1667375|NCT01493557|5829477|P3|Adding the Second Strategy|Other adverse event|0
1667376|NCT01493557|5829478|P2|Adding the Second Strategy|Other adverse event|2
1667377|NCT01493557|5829479|P1|Adding the Second Strategy|Other adverse event|1
1667378|NCT01493557|5829477|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
1667379|NCT01493557|5829478|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
1667380|NCT01493557|5829479|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
1667381|NCT01493557|5829477|P3|Randomized to Management Strategies|Other than stated above|0
1667382|NCT01493557|5829478|P2|Randomized to Management Strategies|Other than stated above|3
1667383|NCT01493557|5829479|P1|Randomized to Management Strategies|Other than stated above|1
1667384|NCT01493557|5829477|P3|Randomized to Management Strategies|Withdrawal by Subject|0
1667385|NCT01493557|5829478|P2|Randomized to Management Strategies|Withdrawal by Subject|1
1667386|NCT01493557|5829479|P1|Randomized to Management Strategies|Withdrawal by Subject|0
1667387|NCT01493557|5829477|P3|Randomized to Management Strategies|Protocol Violation|0
1667388|NCT01493557|5829478|P2|Randomized to Management Strategies|Protocol Violation|0
1667389|NCT01493557|5829479|P1|Randomized to Management Strategies|Protocol Violation|3
1667390|NCT01493557|5829477|P3|Randomized to Management Strategies|Other adverse event|0
1667391|NCT01493557|5829478|P2|Randomized to Management Strategies|Other adverse event|5
1667392|NCT01493557|5829479|P1|Randomized to Management Strategies|Other adverse event|8
1667393|NCT01493557|5829477|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
1667394|NCT01493557|5829478|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
1667395|NCT01493557|5829479|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
1667396|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Other than stated above|21
1667397|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Other than stated above|0
1667398|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Other than stated above|0
1667399|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Early termination|34
1667400|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Early termination|0
1667401|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Early termination|0
1667402|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
1667403|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
1667404|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
1667405|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
1667406|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
1667407|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
1667408|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Protocol Violation|1
1667409|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Protocol Violation|0
1667410|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Protocol Violation|0
1667411|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Other adverse event|54
1667412|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Other adverse event|0
1667413|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Other adverse event|0
1667414|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
1667415|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
1667416|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
1667417|NCT01493557|5829477|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
1667418|NCT01493557|5829478|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1667419|NCT01493557|5829479|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
1667420|NCT01493531|5829507|P3|Overall Study|Death|0
1667421|NCT01493531|5829508|P2|Overall Study|Death|1
1667422|NCT01493531|5829509|P1|Overall Study|Death|0
1667423|NCT01493531|5829507|P3|Overall Study|Withdrawal by Subject|11
1667424|NCT01493531|5829508|P2|Overall Study|Withdrawal by Subject|13
1667425|NCT01493531|5829509|P1|Overall Study|Withdrawal by Subject|16
1667426|NCT01493531|5829507|P3|Overall Study|Lost to Follow-up|11
1667427|NCT01493531|5829508|P2|Overall Study|Lost to Follow-up|7
1667428|NCT01493531|5829509|P1|Overall Study|Lost to Follow-up|5
1667429|NCT01493531|5829507|P3|Overall Study|Sponsor terminated study|3
1667430|NCT01493531|5829508|P2|Overall Study|Sponsor terminated study|2
1667431|NCT01493531|5829509|P1|Overall Study|Sponsor terminated study|5
1667432|NCT01493531|5829507|P3|Overall Study|Protocol Violation|12
1667433|NCT01493531|5829508|P2|Overall Study|Protocol Violation|15
1667434|NCT01493531|5829509|P1|Overall Study|Protocol Violation|8
1667435|NCT01493531|5829507|P3|Overall Study|Gout flare|2
1667436|NCT01493531|5829508|P2|Overall Study|Gout flare|0
1667437|NCT01493531|5829509|P1|Overall Study|Gout flare|3
1667438|NCT01493531|5829507|P3|Overall Study|Adverse Event|9
1667439|NCT01493531|5829508|P2|Overall Study|Adverse Event|12
1667440|NCT01493531|5829509|P1|Overall Study|Adverse Event|4
1667441|NCT01493427|5829523|P1|Overall Study|Other|2
1667442|NCT01493427|5829523|P1|Overall Study|Inability to Follow Instructions|2
1667443|NCT01493427|5829523|P1|Overall Study|Lost to Follow-up|2
1667444|NCT01493427|5829523|P1|Overall Study|Personal Reasons|4
1667445|NCT01493427|5829523|P1|Overall Study|Adverse Event|10
1667446|NCT01493414|5829528|P1|Overall Study|Lost to Follow-up|16
1667447|NCT01493414|5829528|P1|Overall Study|Administrative problems|25
1667448|NCT01493414|5829528|P1|Overall Study|Protocol deviation|27
1667449|NCT01493414|5829528|P1|Overall Study|Withdrawal by Subject|79
1667450|NCT01493414|5829528|P1|Overall Study|Physician Decision|93
1667451|NCT01493414|5829528|P1|Overall Study|Death|101
1667452|NCT01493414|5829528|P1|Overall Study|Disease progression|204
1667453|NCT01493414|5829528|P1|Overall Study|Adverse Event|405
1667454|NCT01493284|5829541|P1|Overall Study|Withdrawal by Subject|32
1667455|NCT01493284|5829541|P1|Overall Study|Death|29
1667456|NCT01493089|5829563|P2|Overall Study|Physician Decision|1
1667457|NCT01493089|5829564|P1|Overall Study|Physician Decision|0
1667458|NCT01493089|5829563|P2|Overall Study|Withdrawal by Subject|0
1667459|NCT01493089|5829564|P1|Overall Study|Withdrawal by Subject|1
1667460|NCT01493089|5829563|P2|Overall Study|Protocol Violation|2
1667461|NCT01493089|5829564|P1|Overall Study|Protocol Violation|2
1667462|NCT01492686|5829663|P2|Open-label Phase|Due to a discontinuation criterion|9
1667463|NCT01492686|5829664|P1|Open-label Phase|Due to a discontinuation criterion|4
1667464|NCT01492686|5829663|P2|Open-label Phase|Withdrawal by Subject|7
1667465|NCT01492686|5829664|P1|Open-label Phase|Withdrawal by Subject|6
1667466|NCT01492686|5829663|P2|Open-label Phase|Physician Decision|0
1667467|NCT01492686|5829664|P1|Open-label Phase|Physician Decision|1
1667468|NCT01492686|5829663|P2|Open-label Phase|Adverse Event|2
1667469|NCT01492686|5829664|P1|Open-label Phase|Adverse Event|1
1667470|NCT01492686|5829663|P2|Double-blind Phase|Due to a discontinuation criterion|3
1667471|NCT01492686|5829664|P1|Double-blind Phase|Due to a discontinuation criterion|2
1667472|NCT01492686|5829663|P2|Double-blind Phase|Withdrawal by Subject|2
1667473|NCT01492686|5829664|P1|Double-blind Phase|Withdrawal by Subject|0
1667474|NCT01492686|5829663|P2|Double-blind Phase|Physician Decision|1
1667475|NCT01492686|5829664|P1|Double-blind Phase|Physician Decision|0
1667476|NCT01492686|5829663|P2|Double-blind Phase|Adverse Event|2
1667477|NCT01492686|5829664|P1|Double-blind Phase|Adverse Event|0
1667478|NCT01492439|5829695|P2|Overall Study|Withdrew from RTE|9
1667479|NCT01492439|5829696|P1|Overall Study|Withdrew from RTE|4
1667480|NCT01492426|5829744|P2|Follow-Up|Lost to Follow-up|6
1667481|NCT01492426|5829745|P1|Follow-Up|Lost to Follow-up|12
1667482|NCT01492426|5829744|P2|Follow-Up|Participant Withdrew Consent|1
1667483|NCT01492426|5829745|P1|Follow-Up|Participant Withdrew Consent|6
1667484|NCT01492426|5829744|P2|Follow-Up|Other|2
1667485|NCT01492426|5829745|P1|Follow-Up|Other|4
1667486|NCT01492426|5829744|P2|Follow-Up|Death|0
1667487|NCT01492426|5829745|P1|Follow-Up|Death|1
1667488|NCT01492426|5829744|P2|Follow-Up|Protocol Requires no Follow-Up|1
1667489|NCT01492426|5829745|P1|Follow-Up|Protocol Requires no Follow-Up|2
1667490|NCT01492426|5829744|P2|Treatment|Participant does not meet study criteria|0
1667491|NCT01492426|5829745|P1|Treatment|Participant does not meet study criteria|1
1667492|NCT01492426|5829744|P2|Treatment|Lost to Follow-up|4
1667493|NCT01492426|5829745|P1|Treatment|Lost to Follow-up|9
1667494|NCT01492426|5829744|P2|Treatment|Subject requested discontinue study drug|3
1667495|NCT01492426|5829745|P1|Treatment|Subject requested discontinue study drug|7
1667496|NCT01492426|5829744|P2|Treatment|Poor compliance/noncompliance|0
1667497|NCT01492426|5829745|P1|Treatment|Poor compliance/noncompliance|1
1667498|NCT01492426|5829744|P2|Treatment|Participant withdrew consent|2
1667499|NCT01492426|5829745|P1|Treatment|Participant withdrew consent|1
1667500|NCT01492426|5829744|P2|Treatment|Lack of Efficacy|5
1667501|NCT01492426|5829745|P1|Treatment|Lack of Efficacy|38
1667502|NCT01492426|5829744|P2|Treatment|Adverse Event|25
1667503|NCT01492426|5829745|P1|Treatment|Adverse Event|25
1667504|NCT01492426|5829744|P2|Treatment|Other|0
1667505|NCT01492426|5829745|P1|Treatment|Other|1
1667506|NCT01492426|5829744|P2|Treatment|Death|1
1667507|NCT01492426|5829745|P1|Treatment|Death|0
1667508|NCT01492400|5829763|P2|Overall Study|Adverse Event|5
1667509|NCT01492400|5829764|P1|Overall Study|Adverse Event|10
1667510|NCT01492400|5829763|P2|Overall Study|Lack of Efficacy|1
1667511|NCT01492400|5829764|P1|Overall Study|Lack of Efficacy|1
1667512|NCT01492400|5829763|P2|Overall Study|Pregnancy|1
1667513|NCT01492400|5829764|P1|Overall Study|Pregnancy|0
1667514|NCT01492400|5829763|P2|Overall Study|Lost to Follow-up|1
1667515|NCT01492400|5829764|P1|Overall Study|Lost to Follow-up|3
1667516|NCT01492400|5829763|P2|Overall Study|Personal Reasons|5
1667517|NCT01492400|5829764|P1|Overall Study|Personal Reasons|0
1667518|NCT01492400|5829763|P2|Overall Study|Miscellaneous Reasons|3
1667519|NCT01492400|5829764|P1|Overall Study|Miscellaneous Reasons|2
1667520|NCT01492088|5829788|P3|Overall Study|Alive at Last Follow-up|11
1667521|NCT01492088|5829789|P2|Overall Study|Alive at Last Follow-up|6
1667522|NCT01492088|5829790|P1|Overall Study|Alive at Last Follow-up|0
1667523|NCT01492088|5829788|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
1667524|NCT01492088|5829789|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
1667525|NCT01492088|5829790|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
1667526|NCT01492088|5829788|P3|Overall Study|Death|2
1667527|NCT01492088|5829789|P2|Overall Study|Death|6
1667528|NCT01492088|5829790|P1|Overall Study|Death|1
1667529|NCT01492088|5829788|P3|Overall Study|Withdrawal by Patient|0
1667530|NCT01492088|5829789|P2|Overall Study|Withdrawal by Patient|2
1667531|NCT01492088|5829790|P1|Overall Study|Withdrawal by Patient|0
1667532|NCT01491919|5829871|P3|Overall Study|Insufficient PK sampling|1
1667533|NCT01491919|5829872|P2|Overall Study|Insufficient PK sampling|2
1667534|NCT01491919|5829873|P1|Overall Study|Insufficient PK sampling|1
1667535|NCT01491854|5829944|P1|Overall Study|Lost to Follow-up|33
1667536|NCT01491854|5829944|P1|Overall Study|Withdrawal by Subject|3
1667537|NCT01491854|5829944|P1|Overall Study|Death|1
1667538|NCT01491854|5829944|P1|Overall Study|mainly due to premature termination|93
1667539|NCT01491841|5829955|P1|Overall Study|Withdrawal by Subject|1
1667540|NCT01491841|5829955|P1|Overall Study|Screen Failure|10
1667541|NCT01491802|5829969|P2|Overall Study|Withdrawal by Subject|1
1667542|NCT01491802|5829970|P1|Overall Study|Withdrawal by Subject|0
1667543|NCT01491802|5829969|P2|Overall Study|Adverse Event|1
1667544|NCT01491802|5829970|P1|Overall Study|Adverse Event|1
1667545|NCT01491737|5829997|P2|Overall Study|Reason not specified|3
1667546|NCT01491737|5829998|P1|Overall Study|Reason not specified|2
1667547|NCT01491737|5829997|P2|Overall Study|Death|28
1667548|NCT01491737|5829998|P1|Overall Study|Death|33
1667549|NCT01491737|5829997|P2|Overall Study|Lost to Follow-up|6
1667550|NCT01491737|5829998|P1|Overall Study|Lost to Follow-up|1
1667551|NCT01491737|5829997|P2|Overall Study|Withdrawal of consent|13
1667552|NCT01491737|5829998|P1|Overall Study|Withdrawal of consent|13
1667553|NCT01491672|5830021|P3|Overall Study|Death|0
1667554|NCT01491672|5830022|P2|Overall Study|Death|4
1667555|NCT01491672|5830023|P1|Overall Study|Death|0
1667556|NCT01491672|5830021|P3|Overall Study|Protocol deviation|0
1667557|NCT01491672|5830022|P2|Overall Study|Protocol deviation|1
1667558|NCT01491672|5830023|P1|Overall Study|Protocol deviation|0
1667559|NCT01491672|5830021|P3|Overall Study|Disease progression|6
1667560|NCT01491672|5830022|P2|Overall Study|Disease progression|34
1667561|NCT01491672|5830023|P1|Overall Study|Disease progression|42
1667562|NCT01491672|5830021|P3|Overall Study|Adverse Event|4
1667563|NCT01491672|5830022|P2|Overall Study|Adverse Event|10
1667564|NCT01491672|5830023|P1|Overall Study|Adverse Event|8
1667565|NCT01491672|5830021|P3|Overall Study|Withdrawal by Subject|0
1667566|NCT01491672|5830022|P2|Overall Study|Withdrawal by Subject|7
1667567|NCT01491672|5830023|P1|Overall Study|Withdrawal by Subject|6
1667568|NCT01491672|5830021|P3|Overall Study|Lost to Follow-up|1
1667569|NCT01491672|5830022|P2|Overall Study|Lost to Follow-up|4
1667570|NCT01491672|5830023|P1|Overall Study|Lost to Follow-up|0
1667571|NCT01491607|5830060|P1|Overall Study|Withdrawal by Subject|3
1667572|NCT01491607|5830060|P1|Overall Study|Lost to Follow-up|7
1667573|NCT01491178|5830165|P1|Overall Study|Other than specified above|657
1667574|NCT01491178|5830165|P1|Overall Study|To take a contraindication|20
1667575|NCT01491178|5830165|P1|Overall Study|Lost to follow−up (changing hospital)|545
1667576|NCT01491178|5830165|P1|Overall Study|Lost to follow−up (unknown reason)|287
1667577|NCT01491178|5830165|P1|Overall Study|To conduct invasive treatment|59
1667578|NCT01491178|5830165|P1|Overall Study|Improvement of NVAF|210
1667579|NCT01491178|5830165|P1|Overall Study|Adverse Event|1016
1667580|NCT01491035|5830274|P8|Overall Study|Lost to Follow-up|0
1667581|NCT01491035|5830275|P7|Overall Study|Lost to Follow-up|0
1667582|NCT01491035|5830276|P6|Overall Study|Lost to Follow-up|0
1667583|NCT01491035|5830277|P5|Overall Study|Lost to Follow-up|1
1667584|NCT01491035|5830278|P4|Overall Study|Lost to Follow-up|0
1667585|NCT01491035|5830279|P3|Overall Study|Lost to Follow-up|0
1667586|NCT01491035|5830280|P2|Overall Study|Lost to Follow-up|0
1667587|NCT01491035|5830281|P1|Overall Study|Lost to Follow-up|0
1667588|NCT01490866|5830387|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
1667589|NCT01490866|5830387|P1|Axitinib Maintenance Therapy|Protocol Violation|2
1667590|NCT01490866|5830387|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
1667591|NCT01490866|5830387|P1|Axitinib Maintenance Therapy|Adverse Event|12
1667592|NCT01490866|5830387|P1|Axitinib Maintenance Therapy|Disease Progression|30
1667593|NCT01490866|5830387|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
1667594|NCT01490866|5830387|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
1667595|NCT01490866|5830387|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
1667596|NCT01490866|5830387|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
1667597|NCT01490866|5830387|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
1667598|NCT01490866|5830387|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
1667599|NCT01490840|5830398|P2|Phase 2|Adverse Event|1
1667600|NCT01490840|5830399|P1|Phase 2|Adverse Event|1
1667601|NCT01490840|5830398|P2|Phase 2|Lost to Follow-up|1
1667602|NCT01490840|5830399|P1|Phase 2|Lost to Follow-up|1
1667603|NCT01490840|5830398|P2|Phase 2|Permanent interruption of fingolimod|1
1667604|NCT01490840|5830399|P1|Phase 2|Permanent interruption of fingolimod|0
1667605|NCT01490840|5830398|P2|Phase 2|Withdrawal by Subject|3
1667606|NCT01490840|5830399|P1|Phase 2|Withdrawal by Subject|4
1667607|NCT01490840|5830398|P2|Phase 1|Visit 6a omitted|0
1667608|NCT01490840|5830399|P1|Phase 1|Visit 6a omitted|1
1667609|NCT01490840|5830398|P2|Phase 1|Withdrawal by Subject|5
1667610|NCT01490840|5830399|P1|Phase 1|Withdrawal by Subject|6
1667611|NCT01490840|5830398|P2|Phase 1|Adverse Event|1
1667612|NCT01490840|5830399|P1|Phase 1|Adverse Event|2
1667613|NCT01490840|5830398|P2|Phase 1|Lost to Follow-up|0
1667614|NCT01490840|5830399|P1|Phase 1|Lost to Follow-up|1
1667615|NCT01490814|5830423|P2|Overall Study|Withdrawal by Subject|5
1667616|NCT01490814|5830424|P1|Overall Study|Withdrawal by Subject|0
1667617|NCT01490814|5830423|P2|Overall Study|Physician Decision|0
1667618|NCT01490814|5830424|P1|Overall Study|Physician Decision|1
1667619|NCT01490814|5830423|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
1667620|NCT01490814|5830424|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
1667621|NCT01490697|5830462|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
1667622|NCT01490697|5830463|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
1667623|NCT01490632|5830483|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
1667624|NCT01490632|5830484|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
1667625|NCT01490632|5830485|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
1667626|NCT01490632|5830486|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667627|NCT01490632|5830487|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667628|NCT01490632|5830488|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667629|NCT01490632|5830489|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667630|NCT01490632|5830490|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667631|NCT01490632|5830491|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667632|NCT01490632|5830492|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667633|NCT01490632|5830493|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667634|NCT01490632|5830494|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667635|NCT01490632|5830495|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667636|NCT01490632|5830496|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667637|NCT01490632|5830497|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667638|NCT01490632|5830498|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667639|NCT01490632|5830499|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667640|NCT01490632|5830500|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667641|NCT01490632|5830501|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667642|NCT01490632|5830502|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
1667643|NCT01490632|5830483|P20|Part D: Re-Treatment Period|Protocol Violation|0
1667644|NCT01490632|5830484|P19|Part D: Re-Treatment Period|Protocol Violation|1
1667645|NCT01490632|5830485|P18|Part D: Re-Treatment Period|Protocol Violation|0
1667646|NCT01490632|5830486|P17|Part D: Re-Treatment Period|Protocol Violation|0
1667647|NCT01490632|5830487|P16|Part D: Re-Treatment Period|Protocol Violation|0
1667648|NCT01490632|5830488|P15|Part D: Re-Treatment Period|Protocol Violation|0
1667649|NCT01490632|5830489|P14|Part D: Re-Treatment Period|Protocol Violation|0
1667650|NCT01490632|5830490|P13|Part D: Re-Treatment Period|Protocol Violation|0
1667651|NCT01490632|5830491|P12|Part D: Re-Treatment Period|Protocol Violation|0
1667652|NCT01490632|5830492|P11|Part D: Re-Treatment Period|Protocol Violation|0
1667653|NCT01490632|5830493|P10|Part D: Re-Treatment Period|Protocol Violation|0
1667654|NCT01490632|5830494|P9|Part D: Re-Treatment Period|Protocol Violation|0
1667655|NCT01490632|5830495|P8|Part D: Re-Treatment Period|Protocol Violation|0
1667656|NCT01490632|5830496|P7|Part D: Re-Treatment Period|Protocol Violation|0
1667657|NCT01490632|5830497|P6|Part D: Re-Treatment Period|Protocol Violation|0
1667658|NCT01490632|5830498|P5|Part D: Re-Treatment Period|Protocol Violation|0
1667659|NCT01490632|5830499|P4|Part D: Re-Treatment Period|Protocol Violation|0
1667660|NCT01490632|5830500|P3|Part D: Re-Treatment Period|Protocol Violation|0
1667661|NCT01490632|5830501|P2|Part D: Re-Treatment Period|Protocol Violation|0
1667662|NCT01490632|5830502|P1|Part D: Re-Treatment Period|Protocol Violation|0
1667663|NCT01490632|5830483|P20|Part D: Re-Treatment Period|Physician Decision|1
1667664|NCT01490632|5830484|P19|Part D: Re-Treatment Period|Physician Decision|1
1667665|NCT01490632|5830485|P18|Part D: Re-Treatment Period|Physician Decision|0
1667666|NCT01490632|5830486|P17|Part D: Re-Treatment Period|Physician Decision|0
1667667|NCT01490632|5830487|P16|Part D: Re-Treatment Period|Physician Decision|0
1667668|NCT01490632|5830488|P15|Part D: Re-Treatment Period|Physician Decision|0
1667669|NCT01490632|5830489|P14|Part D: Re-Treatment Period|Physician Decision|0
1667670|NCT01490632|5830490|P13|Part D: Re-Treatment Period|Physician Decision|0
1667671|NCT01490632|5830491|P12|Part D: Re-Treatment Period|Physician Decision|0
1667672|NCT01490632|5830492|P11|Part D: Re-Treatment Period|Physician Decision|0
1667673|NCT01490632|5830493|P10|Part D: Re-Treatment Period|Physician Decision|0
1667674|NCT01490632|5830494|P9|Part D: Re-Treatment Period|Physician Decision|0
1667675|NCT01490632|5830495|P8|Part D: Re-Treatment Period|Physician Decision|0
1667676|NCT01490632|5830496|P7|Part D: Re-Treatment Period|Physician Decision|0
1667677|NCT01490632|5830497|P6|Part D: Re-Treatment Period|Physician Decision|0
1667678|NCT01490632|5830498|P5|Part D: Re-Treatment Period|Physician Decision|0
1667679|NCT01490632|5830499|P4|Part D: Re-Treatment Period|Physician Decision|0
1667680|NCT01490632|5830500|P3|Part D: Re-Treatment Period|Physician Decision|0
1667681|NCT01490632|5830501|P2|Part D: Re-Treatment Period|Physician Decision|0
1667682|NCT01490632|5830502|P1|Part D: Re-Treatment Period|Physician Decision|0
1667683|NCT01490632|5830483|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
1667684|NCT01490632|5830484|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
1667685|NCT01490632|5830485|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
1667686|NCT01490632|5830486|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
1667687|NCT01490632|5830487|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
1667688|NCT01490632|5830488|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
1667689|NCT01490632|5830489|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
1667690|NCT01490632|5830490|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
1667691|NCT01490632|5830491|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
1667692|NCT01490632|5830492|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
1667693|NCT01490632|5830493|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
1667694|NCT01490632|5830494|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
1667695|NCT01490632|5830495|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
1667696|NCT01490632|5830496|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
1667697|NCT01490632|5830497|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
1667698|NCT01490632|5830498|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
1667699|NCT01490632|5830499|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
1667700|NCT01490632|5830500|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
1667701|NCT01490632|5830501|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
1667702|NCT01490632|5830502|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
1667703|NCT01490632|5830483|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
1667704|NCT01490632|5830484|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
1667705|NCT01490632|5830485|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
1667706|NCT01490632|5830486|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
1667707|NCT01490632|5830487|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
1667708|NCT01490632|5830488|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
1667709|NCT01490632|5830489|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
1667710|NCT01490632|5830490|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
1667711|NCT01490632|5830491|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
1667712|NCT01490632|5830492|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
1667713|NCT01490632|5830493|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
1667714|NCT01490632|5830494|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
1667715|NCT01490632|5830495|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
1667716|NCT01490632|5830496|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
1667717|NCT01490632|5830497|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
1667718|NCT01490632|5830498|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
1667719|NCT01490632|5830499|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
1667720|NCT01490632|5830500|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
1667721|NCT01490632|5830501|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
1667722|NCT01490632|5830502|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
1667723|NCT01490632|5830483|P20|Part D: Re-Treatment Period|Death|0
1667724|NCT01490632|5830484|P19|Part D: Re-Treatment Period|Death|1
1667725|NCT01490632|5830485|P18|Part D: Re-Treatment Period|Death|0
1667726|NCT01490632|5830486|P17|Part D: Re-Treatment Period|Death|0
1667727|NCT01490632|5830487|P16|Part D: Re-Treatment Period|Death|0
1667728|NCT01490632|5830488|P15|Part D: Re-Treatment Period|Death|0
1667729|NCT01490632|5830489|P14|Part D: Re-Treatment Period|Death|0
1667730|NCT01490632|5830490|P13|Part D: Re-Treatment Period|Death|0
1667731|NCT01490632|5830491|P12|Part D: Re-Treatment Period|Death|0
1667732|NCT01490632|5830492|P11|Part D: Re-Treatment Period|Death|0
1667733|NCT01490632|5830493|P10|Part D: Re-Treatment Period|Death|0
1667734|NCT01490632|5830494|P9|Part D: Re-Treatment Period|Death|0
1667735|NCT01490632|5830495|P8|Part D: Re-Treatment Period|Death|0
1667736|NCT01490632|5830496|P7|Part D: Re-Treatment Period|Death|0
1667737|NCT01490632|5830497|P6|Part D: Re-Treatment Period|Death|0
1667738|NCT01490632|5830498|P5|Part D: Re-Treatment Period|Death|0
1667739|NCT01490632|5830499|P4|Part D: Re-Treatment Period|Death|0
1667740|NCT01490632|5830500|P3|Part D: Re-Treatment Period|Death|0
1667741|NCT01490632|5830501|P2|Part D: Re-Treatment Period|Death|0
1667742|NCT01490632|5830502|P1|Part D: Re-Treatment Period|Death|0
1667743|NCT01490632|5830483|P20|Part D: Re-Treatment Period|Adverse Event|3
1667744|NCT01490632|5830484|P19|Part D: Re-Treatment Period|Adverse Event|1
1667745|NCT01490632|5830485|P18|Part D: Re-Treatment Period|Adverse Event|1
1667746|NCT01490632|5830486|P17|Part D: Re-Treatment Period|Adverse Event|0
1667747|NCT01490632|5830487|P16|Part D: Re-Treatment Period|Adverse Event|0
1667748|NCT01490632|5830488|P15|Part D: Re-Treatment Period|Adverse Event|0
1667749|NCT01490632|5830489|P14|Part D: Re-Treatment Period|Adverse Event|0
1667750|NCT01490632|5830490|P13|Part D: Re-Treatment Period|Adverse Event|0
1667751|NCT01490632|5830491|P12|Part D: Re-Treatment Period|Adverse Event|0
1667752|NCT01490632|5830492|P11|Part D: Re-Treatment Period|Adverse Event|0
1667753|NCT01490632|5830493|P10|Part D: Re-Treatment Period|Adverse Event|0
1667754|NCT01490632|5830494|P9|Part D: Re-Treatment Period|Adverse Event|0
1667755|NCT01490632|5830495|P8|Part D: Re-Treatment Period|Adverse Event|0
1667756|NCT01490632|5830496|P7|Part D: Re-Treatment Period|Adverse Event|0
1667757|NCT01490632|5830497|P6|Part D: Re-Treatment Period|Adverse Event|0
1667758|NCT01490632|5830498|P5|Part D: Re-Treatment Period|Adverse Event|0
1667759|NCT01490632|5830499|P4|Part D: Re-Treatment Period|Adverse Event|0
1667760|NCT01490632|5830500|P3|Part D: Re-Treatment Period|Adverse Event|0
1667761|NCT01490632|5830501|P2|Part D: Re-Treatment Period|Adverse Event|0
1667762|NCT01490632|5830502|P1|Part D: Re-Treatment Period|Adverse Event|0
1667763|NCT01490632|5830483|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667764|NCT01490632|5830484|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667765|NCT01490632|5830485|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667766|NCT01490632|5830486|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667767|NCT01490632|5830487|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
1667768|NCT01490632|5830488|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
1667769|NCT01490632|5830489|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
1667770|NCT01490632|5830490|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
1667771|NCT01490632|5830491|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667772|NCT01490632|5830492|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667773|NCT01490632|5830493|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667774|NCT01490632|5830494|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667775|NCT01490632|5830495|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667776|NCT01490632|5830496|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667777|NCT01490632|5830497|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667778|NCT01490632|5830498|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667779|NCT01490632|5830499|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667780|NCT01490632|5830500|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667781|NCT01490632|5830501|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667782|NCT01490632|5830502|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
1667783|NCT01490632|5830483|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667784|NCT01490632|5830484|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667785|NCT01490632|5830485|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667786|NCT01490632|5830486|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667787|NCT01490632|5830487|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
1667788|NCT01490632|5830488|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
1667789|NCT01490632|5830489|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667790|NCT01490632|5830490|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667791|NCT01490632|5830491|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667792|NCT01490632|5830492|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667793|NCT01490632|5830493|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1668156|NCT01490125|5830948|P2|Period III|Adverse Event|1
1667794|NCT01490632|5830494|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667795|NCT01490632|5830495|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667796|NCT01490632|5830496|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667797|NCT01490632|5830497|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667798|NCT01490632|5830498|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667799|NCT01490632|5830499|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667800|NCT01490632|5830500|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667801|NCT01490632|5830501|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667802|NCT01490632|5830502|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
1667803|NCT01490632|5830483|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667804|NCT01490632|5830484|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667805|NCT01490632|5830485|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667806|NCT01490632|5830486|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667807|NCT01490632|5830487|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667808|NCT01490632|5830488|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667809|NCT01490632|5830489|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
1667810|NCT01490632|5830490|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667811|NCT01490632|5830491|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667812|NCT01490632|5830492|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667813|NCT01490632|5830493|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667814|NCT01490632|5830494|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667815|NCT01490632|5830495|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667816|NCT01490632|5830496|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667817|NCT01490632|5830497|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667818|NCT01490632|5830498|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667819|NCT01490632|5830499|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667820|NCT01490632|5830500|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667821|NCT01490632|5830501|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667822|NCT01490632|5830502|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
1667823|NCT01490632|5830483|P20|Part C: Washout or Step-Down Period|Adverse Event|0
1667824|NCT01490632|5830484|P19|Part C: Washout or Step-Down Period|Adverse Event|0
1667825|NCT01490632|5830485|P18|Part C: Washout or Step-Down Period|Adverse Event|0
1667826|NCT01490632|5830486|P17|Part C: Washout or Step-Down Period|Adverse Event|0
1667827|NCT01490632|5830487|P16|Part C: Washout or Step-Down Period|Adverse Event|2
1667828|NCT01490632|5830488|P15|Part C: Washout or Step-Down Period|Adverse Event|2
1667829|NCT01490632|5830489|P14|Part C: Washout or Step-Down Period|Adverse Event|0
1667830|NCT01490632|5830490|P13|Part C: Washout or Step-Down Period|Adverse Event|0
1667831|NCT01490632|5830491|P12|Part C: Washout or Step-Down Period|Adverse Event|0
1667832|NCT01490632|5830492|P11|Part C: Washout or Step-Down Period|Adverse Event|0
1667833|NCT01490632|5830493|P10|Part C: Washout or Step-Down Period|Adverse Event|0
1667834|NCT01490632|5830494|P9|Part C: Washout or Step-Down Period|Adverse Event|0
1667835|NCT01490632|5830495|P8|Part C: Washout or Step-Down Period|Adverse Event|0
1667836|NCT01490632|5830496|P7|Part C: Washout or Step-Down Period|Adverse Event|0
1667837|NCT01490632|5830497|P6|Part C: Washout or Step-Down Period|Adverse Event|0
1667838|NCT01490632|5830498|P5|Part C: Washout or Step-Down Period|Adverse Event|0
1667839|NCT01490632|5830499|P4|Part C: Washout or Step-Down Period|Adverse Event|0
1667840|NCT01490632|5830500|P3|Part C: Washout or Step-Down Period|Adverse Event|0
1667841|NCT01490632|5830501|P2|Part C: Washout or Step-Down Period|Adverse Event|0
1667842|NCT01490632|5830502|P1|Part C: Washout or Step-Down Period|Adverse Event|0
1667843|NCT01490632|5830483|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667844|NCT01490632|5830484|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667845|NCT01490632|5830485|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667846|NCT01490632|5830486|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667847|NCT01490632|5830487|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667848|NCT01490632|5830488|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667849|NCT01490632|5830489|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667850|NCT01490632|5830490|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667851|NCT01490632|5830491|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
1667852|NCT01490632|5830492|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
1667853|NCT01490632|5830493|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
1667854|NCT01490632|5830494|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
1667855|NCT01490632|5830495|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1667856|NCT01490632|5830496|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
1667857|NCT01490632|5830497|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
1667858|NCT01490632|5830498|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667859|NCT01490632|5830499|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667860|NCT01490632|5830500|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667861|NCT01490632|5830501|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667862|NCT01490632|5830502|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
1667863|NCT01490632|5830483|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667864|NCT01490632|5830484|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667865|NCT01490632|5830485|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667866|NCT01490632|5830486|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667867|NCT01490632|5830487|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667868|NCT01490632|5830488|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667869|NCT01490632|5830489|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667870|NCT01490632|5830490|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667871|NCT01490632|5830491|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
1667872|NCT01490632|5830492|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1667873|NCT01490632|5830493|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667874|NCT01490632|5830494|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1667875|NCT01490632|5830495|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667876|NCT01490632|5830496|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
1667877|NCT01490632|5830497|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667878|NCT01490632|5830498|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667879|NCT01490632|5830499|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667880|NCT01490632|5830500|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667881|NCT01490632|5830501|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667882|NCT01490632|5830502|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
1667883|NCT01490632|5830483|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667884|NCT01490632|5830484|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667885|NCT01490632|5830485|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667886|NCT01490632|5830486|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667887|NCT01490632|5830487|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667888|NCT01490632|5830488|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667889|NCT01490632|5830489|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667890|NCT01490632|5830490|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667891|NCT01490632|5830491|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667892|NCT01490632|5830492|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667893|NCT01490632|5830493|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667894|NCT01490632|5830494|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667895|NCT01490632|5830495|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667896|NCT01490632|5830496|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667897|NCT01490632|5830497|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
1667898|NCT01490632|5830498|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667899|NCT01490632|5830499|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667900|NCT01490632|5830500|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667901|NCT01490632|5830501|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667902|NCT01490632|5830502|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
1667903|NCT01490632|5830483|P20|Part B: Extension or Step-Up Period|Physician Decision|0
1667904|NCT01490632|5830484|P19|Part B: Extension or Step-Up Period|Physician Decision|0
1667905|NCT01490632|5830485|P18|Part B: Extension or Step-Up Period|Physician Decision|0
1667906|NCT01490632|5830486|P17|Part B: Extension or Step-Up Period|Physician Decision|0
1667907|NCT01490632|5830487|P16|Part B: Extension or Step-Up Period|Physician Decision|0
1667908|NCT01490632|5830488|P15|Part B: Extension or Step-Up Period|Physician Decision|0
1667909|NCT01490632|5830489|P14|Part B: Extension or Step-Up Period|Physician Decision|0
1667910|NCT01490632|5830490|P13|Part B: Extension or Step-Up Period|Physician Decision|0
1667911|NCT01490632|5830491|P12|Part B: Extension or Step-Up Period|Physician Decision|0
1667912|NCT01490632|5830492|P11|Part B: Extension or Step-Up Period|Physician Decision|0
1667913|NCT01490632|5830493|P10|Part B: Extension or Step-Up Period|Physician Decision|0
1667914|NCT01490632|5830494|P9|Part B: Extension or Step-Up Period|Physician Decision|0
1667915|NCT01490632|5830495|P8|Part B: Extension or Step-Up Period|Physician Decision|0
1667916|NCT01490632|5830496|P7|Part B: Extension or Step-Up Period|Physician Decision|1
1667917|NCT01490632|5830497|P6|Part B: Extension or Step-Up Period|Physician Decision|0
1667918|NCT01490632|5830498|P5|Part B: Extension or Step-Up Period|Physician Decision|0
1667919|NCT01490632|5830499|P4|Part B: Extension or Step-Up Period|Physician Decision|0
1667920|NCT01490632|5830500|P3|Part B: Extension or Step-Up Period|Physician Decision|0
1667921|NCT01490632|5830501|P2|Part B: Extension or Step-Up Period|Physician Decision|0
1667922|NCT01490632|5830502|P1|Part B: Extension or Step-Up Period|Physician Decision|0
1667923|NCT01490632|5830483|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667924|NCT01490632|5830484|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667925|NCT01490632|5830485|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667926|NCT01490632|5830486|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667927|NCT01490632|5830487|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667928|NCT01490632|5830488|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667929|NCT01490632|5830489|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667930|NCT01490632|5830490|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667931|NCT01490632|5830491|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1668157|NCT01490125|5830949|P1|Period III|Adverse Event|3
1667932|NCT01490632|5830492|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667933|NCT01490632|5830493|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
1667934|NCT01490632|5830494|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667935|NCT01490632|5830495|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667936|NCT01490632|5830496|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
1667937|NCT01490632|5830497|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667938|NCT01490632|5830498|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667939|NCT01490632|5830499|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667940|NCT01490632|5830500|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667941|NCT01490632|5830501|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667942|NCT01490632|5830502|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
1667943|NCT01490632|5830483|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667944|NCT01490632|5830484|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667945|NCT01490632|5830485|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667946|NCT01490632|5830486|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667947|NCT01490632|5830487|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667948|NCT01490632|5830488|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667949|NCT01490632|5830489|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667950|NCT01490632|5830490|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667951|NCT01490632|5830491|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667952|NCT01490632|5830492|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1667953|NCT01490632|5830493|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
1667954|NCT01490632|5830494|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1667955|NCT01490632|5830495|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667956|NCT01490632|5830496|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
1667957|NCT01490632|5830497|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667958|NCT01490632|5830498|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667959|NCT01490632|5830499|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667960|NCT01490632|5830500|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667961|NCT01490632|5830501|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667962|NCT01490632|5830502|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
1667963|NCT01490632|5830483|P20|Part B: Extension or Step-Up Period|Adverse Event|0
1667964|NCT01490632|5830484|P19|Part B: Extension or Step-Up Period|Adverse Event|0
1667965|NCT01490632|5830485|P18|Part B: Extension or Step-Up Period|Adverse Event|0
1667966|NCT01490632|5830486|P17|Part B: Extension or Step-Up Period|Adverse Event|0
1667967|NCT01490632|5830487|P16|Part B: Extension or Step-Up Period|Adverse Event|0
1667968|NCT01490632|5830488|P15|Part B: Extension or Step-Up Period|Adverse Event|0
1667969|NCT01490632|5830489|P14|Part B: Extension or Step-Up Period|Adverse Event|0
1667970|NCT01490632|5830490|P13|Part B: Extension or Step-Up Period|Adverse Event|0
1667971|NCT01490632|5830491|P12|Part B: Extension or Step-Up Period|Adverse Event|1
1667972|NCT01490632|5830492|P11|Part B: Extension or Step-Up Period|Adverse Event|3
1667973|NCT01490632|5830493|P10|Part B: Extension or Step-Up Period|Adverse Event|2
1667974|NCT01490632|5830494|P9|Part B: Extension or Step-Up Period|Adverse Event|0
1667975|NCT01490632|5830495|P8|Part B: Extension or Step-Up Period|Adverse Event|0
1667976|NCT01490632|5830496|P7|Part B: Extension or Step-Up Period|Adverse Event|2
1667977|NCT01490632|5830497|P6|Part B: Extension or Step-Up Period|Adverse Event|2
1667978|NCT01490632|5830498|P5|Part B: Extension or Step-Up Period|Adverse Event|0
1667979|NCT01490632|5830499|P4|Part B: Extension or Step-Up Period|Adverse Event|0
1667980|NCT01490632|5830500|P3|Part B: Extension or Step-Up Period|Adverse Event|0
1667981|NCT01490632|5830501|P2|Part B: Extension or Step-Up Period|Adverse Event|0
1667982|NCT01490632|5830502|P1|Part B: Extension or Step-Up Period|Adverse Event|0
1667983|NCT01490632|5830483|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667984|NCT01490632|5830484|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667985|NCT01490632|5830485|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667986|NCT01490632|5830486|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667987|NCT01490632|5830487|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667988|NCT01490632|5830488|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667989|NCT01490632|5830489|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667990|NCT01490632|5830490|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667991|NCT01490632|5830491|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667992|NCT01490632|5830492|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667993|NCT01490632|5830493|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667994|NCT01490632|5830494|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667995|NCT01490632|5830495|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667996|NCT01490632|5830496|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667997|NCT01490632|5830497|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1667998|NCT01490632|5830498|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
1667999|NCT01490632|5830499|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1668000|NCT01490632|5830500|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1668158|NCT01490125|5830944|P6|Period II|Withdrawal by Subject|0
1668001|NCT01490632|5830501|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1668002|NCT01490632|5830502|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
1668003|NCT01490632|5830483|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668004|NCT01490632|5830484|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668005|NCT01490632|5830485|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668006|NCT01490632|5830486|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668007|NCT01490632|5830487|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668008|NCT01490632|5830488|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668009|NCT01490632|5830489|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668010|NCT01490632|5830490|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668011|NCT01490632|5830491|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668012|NCT01490632|5830492|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668013|NCT01490632|5830493|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668014|NCT01490632|5830494|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668015|NCT01490632|5830495|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668016|NCT01490632|5830496|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668017|NCT01490632|5830497|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668018|NCT01490632|5830498|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
1668019|NCT01490632|5830499|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
1668020|NCT01490632|5830500|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
1668021|NCT01490632|5830501|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
1668022|NCT01490632|5830502|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
1668023|NCT01490632|5830483|P20|Part A: Initial Treatment Period|Sponsor Decision|0
1668024|NCT01490632|5830484|P19|Part A: Initial Treatment Period|Sponsor Decision|0
1668025|NCT01490632|5830485|P18|Part A: Initial Treatment Period|Sponsor Decision|0
1668026|NCT01490632|5830486|P17|Part A: Initial Treatment Period|Sponsor Decision|0
1668027|NCT01490632|5830487|P16|Part A: Initial Treatment Period|Sponsor Decision|0
1668028|NCT01490632|5830488|P15|Part A: Initial Treatment Period|Sponsor Decision|0
1668029|NCT01490632|5830489|P14|Part A: Initial Treatment Period|Sponsor Decision|0
1668030|NCT01490632|5830490|P13|Part A: Initial Treatment Period|Sponsor Decision|0
1668031|NCT01490632|5830491|P12|Part A: Initial Treatment Period|Sponsor Decision|0
1668032|NCT01490632|5830492|P11|Part A: Initial Treatment Period|Sponsor Decision|0
1668033|NCT01490632|5830493|P10|Part A: Initial Treatment Period|Sponsor Decision|0
1668034|NCT01490632|5830494|P9|Part A: Initial Treatment Period|Sponsor Decision|0
1668035|NCT01490632|5830495|P8|Part A: Initial Treatment Period|Sponsor Decision|0
1668036|NCT01490632|5830496|P7|Part A: Initial Treatment Period|Sponsor Decision|0
1668037|NCT01490632|5830497|P6|Part A: Initial Treatment Period|Sponsor Decision|0
1668038|NCT01490632|5830498|P5|Part A: Initial Treatment Period|Sponsor Decision|0
1668039|NCT01490632|5830499|P4|Part A: Initial Treatment Period|Sponsor Decision|0
1668040|NCT01490632|5830500|P3|Part A: Initial Treatment Period|Sponsor Decision|0
1668041|NCT01490632|5830501|P2|Part A: Initial Treatment Period|Sponsor Decision|0
1668042|NCT01490632|5830502|P1|Part A: Initial Treatment Period|Sponsor Decision|2
1668043|NCT01490632|5830483|P20|Part A: Initial Treatment Period|Physician Decision|0
1668044|NCT01490632|5830484|P19|Part A: Initial Treatment Period|Physician Decision|0
1668045|NCT01490632|5830485|P18|Part A: Initial Treatment Period|Physician Decision|0
1668046|NCT01490632|5830486|P17|Part A: Initial Treatment Period|Physician Decision|0
1668047|NCT01490632|5830487|P16|Part A: Initial Treatment Period|Physician Decision|0
1668048|NCT01490632|5830488|P15|Part A: Initial Treatment Period|Physician Decision|0
1668049|NCT01490632|5830489|P14|Part A: Initial Treatment Period|Physician Decision|0
1668050|NCT01490632|5830490|P13|Part A: Initial Treatment Period|Physician Decision|0
1668051|NCT01490632|5830491|P12|Part A: Initial Treatment Period|Physician Decision|0
1668052|NCT01490632|5830492|P11|Part A: Initial Treatment Period|Physician Decision|0
1668053|NCT01490632|5830493|P10|Part A: Initial Treatment Period|Physician Decision|0
1668054|NCT01490632|5830494|P9|Part A: Initial Treatment Period|Physician Decision|0
1668055|NCT01490632|5830495|P8|Part A: Initial Treatment Period|Physician Decision|0
1668056|NCT01490632|5830496|P7|Part A: Initial Treatment Period|Physician Decision|0
1668057|NCT01490632|5830497|P6|Part A: Initial Treatment Period|Physician Decision|0
1668058|NCT01490632|5830498|P5|Part A: Initial Treatment Period|Physician Decision|0
1668059|NCT01490632|5830499|P4|Part A: Initial Treatment Period|Physician Decision|1
1668060|NCT01490632|5830500|P3|Part A: Initial Treatment Period|Physician Decision|0
1668061|NCT01490632|5830501|P2|Part A: Initial Treatment Period|Physician Decision|1
1668062|NCT01490632|5830502|P1|Part A: Initial Treatment Period|Physician Decision|0
1668063|NCT01490632|5830483|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
1668064|NCT01490632|5830484|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
1668065|NCT01490632|5830485|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
1668066|NCT01490632|5830486|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
1668067|NCT01490632|5830487|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
1668068|NCT01490632|5830488|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
1668069|NCT01490632|5830489|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
1668070|NCT01490632|5830490|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
1668071|NCT01490632|5830491|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
1668072|NCT01490632|5830492|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
1668073|NCT01490632|5830493|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
1668074|NCT01490632|5830494|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
1668075|NCT01490632|5830495|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
1668076|NCT01490632|5830496|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
1668077|NCT01490632|5830497|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
1668078|NCT01490632|5830498|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
1668079|NCT01490632|5830499|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
1668080|NCT01490632|5830500|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
1668081|NCT01490632|5830501|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
1668082|NCT01490632|5830502|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
1668083|NCT01490632|5830483|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
1668084|NCT01490632|5830484|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
1668085|NCT01490632|5830485|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
1668086|NCT01490632|5830486|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
1668087|NCT01490632|5830487|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
1668088|NCT01490632|5830488|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
1668089|NCT01490632|5830489|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
1668090|NCT01490632|5830490|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
1668091|NCT01490632|5830491|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
1668092|NCT01490632|5830492|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
1668093|NCT01490632|5830493|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
1668094|NCT01490632|5830494|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
1668095|NCT01490632|5830495|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
1668096|NCT01490632|5830496|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
1668097|NCT01490632|5830497|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
1668098|NCT01490632|5830498|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
1668099|NCT01490632|5830499|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
1668100|NCT01490632|5830500|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
1668101|NCT01490632|5830501|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
1668102|NCT01490632|5830502|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
1668103|NCT01490632|5830483|P20|Part A: Initial Treatment Period|Adverse Event|0
1668104|NCT01490632|5830484|P19|Part A: Initial Treatment Period|Adverse Event|0
1668105|NCT01490632|5830485|P18|Part A: Initial Treatment Period|Adverse Event|0
1668106|NCT01490632|5830486|P17|Part A: Initial Treatment Period|Adverse Event|0
1668107|NCT01490632|5830487|P16|Part A: Initial Treatment Period|Adverse Event|0
1668108|NCT01490632|5830488|P15|Part A: Initial Treatment Period|Adverse Event|0
1668109|NCT01490632|5830489|P14|Part A: Initial Treatment Period|Adverse Event|0
1668110|NCT01490632|5830490|P13|Part A: Initial Treatment Period|Adverse Event|0
1668111|NCT01490632|5830491|P12|Part A: Initial Treatment Period|Adverse Event|0
1668112|NCT01490632|5830492|P11|Part A: Initial Treatment Period|Adverse Event|0
1668113|NCT01490632|5830493|P10|Part A: Initial Treatment Period|Adverse Event|0
1668114|NCT01490632|5830494|P9|Part A: Initial Treatment Period|Adverse Event|0
1668115|NCT01490632|5830495|P8|Part A: Initial Treatment Period|Adverse Event|0
1668116|NCT01490632|5830496|P7|Part A: Initial Treatment Period|Adverse Event|0
1668117|NCT01490632|5830497|P6|Part A: Initial Treatment Period|Adverse Event|0
1668118|NCT01490632|5830498|P5|Part A: Initial Treatment Period|Adverse Event|4
1668119|NCT01490632|5830499|P4|Part A: Initial Treatment Period|Adverse Event|4
1668120|NCT01490632|5830500|P3|Part A: Initial Treatment Period|Adverse Event|2
1668121|NCT01490632|5830501|P2|Part A: Initial Treatment Period|Adverse Event|0
1668122|NCT01490632|5830502|P1|Part A: Initial Treatment Period|Adverse Event|0
1668123|NCT01490580|5830632|P2|Overall Study|Parents withdrew consent|2
1668124|NCT01490580|5830633|P1|Overall Study|Parents withdrew consent|0
1668125|NCT01490294|5830680|P4|Overall Study|Adverse Event|0
1668126|NCT01490294|5830681|P3|Overall Study|Adverse Event|0
1668127|NCT01490294|5830682|P2|Overall Study|Adverse Event|0
1668128|NCT01490294|5830683|P1|Overall Study|Adverse Event|1
1668129|NCT01490294|5830680|P4|Overall Study|Prematurely discontinuation|1
1668130|NCT01490294|5830681|P3|Overall Study|Prematurely discontinuation|1
1668131|NCT01490294|5830682|P2|Overall Study|Prematurely discontinuation|0
1668132|NCT01490294|5830683|P1|Overall Study|Prematurely discontinuation|4
1668133|NCT01490190|5830917|P1|Overall Study|Ring expulsion|2
1668134|NCT01490190|5830917|P1|Overall Study|Inconvenience|1
1668135|NCT01490190|5830917|P1|Overall Study|Relocation|1
1668136|NCT01490190|5830917|P1|Overall Study|Lost to Follow-up|13
1668137|NCT01490190|5830917|P1|Overall Study|Protocol Violation|5
1668138|NCT01490190|5830917|P1|Overall Study|Adverse Event|17
1668139|NCT01490190|5830917|P1|Overall Study|Withdrawal by Subject|9
1668140|NCT01490125|5830944|P6|Period III|Lack of Efficacy|0
1668141|NCT01490125|5830945|P5|Period III|Lack of Efficacy|1
1668142|NCT01490125|5830946|P4|Period III|Lack of Efficacy|0
1668143|NCT01490125|5830947|P3|Period III|Lack of Efficacy|0
1668144|NCT01490125|5830948|P2|Period III|Lack of Efficacy|0
1668145|NCT01490125|5830949|P1|Period III|Lack of Efficacy|0
1668146|NCT01490125|5830944|P6|Period III|Death|0
1668147|NCT01490125|5830945|P5|Period III|Death|0
1668148|NCT01490125|5830946|P4|Period III|Death|1
1668149|NCT01490125|5830947|P3|Period III|Death|0
1668150|NCT01490125|5830948|P2|Period III|Death|0
1668151|NCT01490125|5830949|P1|Period III|Death|0
1668152|NCT01490125|5830944|P6|Period III|Adverse Event|0
1668153|NCT01490125|5830945|P5|Period III|Adverse Event|0
1668154|NCT01490125|5830946|P4|Period III|Adverse Event|1
1668155|NCT01490125|5830947|P3|Period III|Adverse Event|0
1668159|NCT01490125|5830945|P5|Period II|Withdrawal by Subject|0
1668160|NCT01490125|5830946|P4|Period II|Withdrawal by Subject|0
1668161|NCT01490125|5830947|P3|Period II|Withdrawal by Subject|0
1668162|NCT01490125|5830948|P2|Period II|Withdrawal by Subject|0
1668163|NCT01490125|5830949|P1|Period II|Withdrawal by Subject|1
1668164|NCT01490125|5830944|P6|Period II|Lost to Follow-up|0
1668165|NCT01490125|5830945|P5|Period II|Lost to Follow-up|0
1668166|NCT01490125|5830946|P4|Period II|Lost to Follow-up|0
1668167|NCT01490125|5830947|P3|Period II|Lost to Follow-up|0
1668168|NCT01490125|5830948|P2|Period II|Lost to Follow-up|1
1668169|NCT01490125|5830949|P1|Period II|Lost to Follow-up|0
1668170|NCT01490125|5830944|P6|Period II|Protocol Violation|0
1668171|NCT01490125|5830945|P5|Period II|Protocol Violation|0
1668172|NCT01490125|5830946|P4|Period II|Protocol Violation|1
1668173|NCT01490125|5830947|P3|Period II|Protocol Violation|1
1668174|NCT01490125|5830948|P2|Period II|Protocol Violation|0
1668175|NCT01490125|5830949|P1|Period II|Protocol Violation|0
1668176|NCT01490125|5830944|P6|Period II|Adverse Event|2
1668177|NCT01490125|5830945|P5|Period II|Adverse Event|4
1668178|NCT01490125|5830946|P4|Period II|Adverse Event|2
1668179|NCT01490125|5830947|P3|Period II|Adverse Event|2
1668180|NCT01490125|5830948|P2|Period II|Adverse Event|3
1668181|NCT01490125|5830949|P1|Period II|Adverse Event|2
1668182|NCT01490125|5830944|P6|Period I|Withdrawal by Subject|1
1668183|NCT01490125|5830945|P5|Period I|Withdrawal by Subject|2
1668184|NCT01490125|5830946|P4|Period I|Withdrawal by Subject|1
1668185|NCT01490125|5830947|P3|Period I|Withdrawal by Subject|2
1668186|NCT01490125|5830948|P2|Period I|Withdrawal by Subject|3
1668187|NCT01490125|5830949|P1|Period I|Withdrawal by Subject|1
1668188|NCT01490125|5830944|P6|Period I|Protocol Violation|0
1668189|NCT01490125|5830945|P5|Period I|Protocol Violation|0
1668190|NCT01490125|5830946|P4|Period I|Protocol Violation|1
1668191|NCT01490125|5830947|P3|Period I|Protocol Violation|1
1668192|NCT01490125|5830948|P2|Period I|Protocol Violation|1
1668193|NCT01490125|5830949|P1|Period I|Protocol Violation|1
1668194|NCT01490125|5830944|P6|Period I|Adverse Event|4
1668195|NCT01490125|5830945|P5|Period I|Adverse Event|2
1668196|NCT01490125|5830946|P4|Period I|Adverse Event|3
1668197|NCT01490125|5830947|P3|Period I|Adverse Event|1
1668198|NCT01490125|5830948|P2|Period I|Adverse Event|1
1668199|NCT01490125|5830949|P1|Period I|Adverse Event|4
1668200|NCT01490086|5830977|P5|Overall Study|Subject left hospital|0
1668201|NCT01490086|5830978|P4|Overall Study|Subject left hospital|1
1668202|NCT01490086|5830979|P3|Overall Study|Subject left hospital|0
1668203|NCT01490086|5830980|P2|Overall Study|Subject left hospital|1
1668204|NCT01490086|5830981|P1|Overall Study|Subject left hospital|0
1668205|NCT01490086|5830977|P5|Overall Study|Subject uncontrollable and abusive|0
1668206|NCT01490086|5830978|P4|Overall Study|Subject uncontrollable and abusive|0
1668207|NCT01490086|5830979|P3|Overall Study|Subject uncontrollable and abusive|0
1668208|NCT01490086|5830980|P2|Overall Study|Subject uncontrollable and abusive|1
1668209|NCT01490086|5830981|P1|Overall Study|Subject uncontrollable and abusive|0
1668210|NCT01490086|5830977|P5|Overall Study|Worsening of symptoms|0
1668211|NCT01490086|5830978|P4|Overall Study|Worsening of symptoms|1
1668212|NCT01490086|5830979|P3|Overall Study|Worsening of symptoms|0
1668213|NCT01490086|5830980|P2|Overall Study|Worsening of symptoms|1
1668214|NCT01490086|5830981|P1|Overall Study|Worsening of symptoms|0
1668215|NCT01490086|5830977|P5|Overall Study|Lack of Efficacy|8
1668216|NCT01490086|5830978|P4|Overall Study|Lack of Efficacy|0
1668217|NCT01490086|5830979|P3|Overall Study|Lack of Efficacy|1
1668218|NCT01490086|5830980|P2|Overall Study|Lack of Efficacy|3
1668219|NCT01490086|5830981|P1|Overall Study|Lack of Efficacy|0
1668220|NCT01490086|5830977|P5|Overall Study|Adverse Event|0
1668221|NCT01490086|5830978|P4|Overall Study|Adverse Event|2
1668222|NCT01490086|5830979|P3|Overall Study|Adverse Event|1
1668223|NCT01490086|5830980|P2|Overall Study|Adverse Event|0
1668224|NCT01490086|5830981|P1|Overall Study|Adverse Event|0
1668225|NCT01490086|5830977|P5|Overall Study|Physician Decision|1
1668226|NCT01490086|5830978|P4|Overall Study|Physician Decision|3
1668227|NCT01490086|5830979|P3|Overall Study|Physician Decision|2
1668228|NCT01490086|5830980|P2|Overall Study|Physician Decision|4
1668229|NCT01490086|5830981|P1|Overall Study|Physician Decision|3
1668230|NCT01490086|5830977|P5|Overall Study|Lost to Follow-up|1
1668231|NCT01490086|5830978|P4|Overall Study|Lost to Follow-up|0
1668232|NCT01490086|5830979|P3|Overall Study|Lost to Follow-up|0
1668233|NCT01490086|5830980|P2|Overall Study|Lost to Follow-up|0
1668234|NCT01490086|5830981|P1|Overall Study|Lost to Follow-up|0
1668235|NCT01490086|5830977|P5|Overall Study|Abnormal laboratory findings|0
1668236|NCT01490086|5830978|P4|Overall Study|Abnormal laboratory findings|0
1668237|NCT01490086|5830979|P3|Overall Study|Abnormal laboratory findings|0
1668238|NCT01490086|5830980|P2|Overall Study|Abnormal laboratory findings|0
1668239|NCT01490086|5830981|P1|Overall Study|Abnormal laboratory findings|1
1668240|NCT01490086|5830977|P5|Overall Study|Non-compliance|0
1668241|NCT01490086|5830978|P4|Overall Study|Non-compliance|0
1668242|NCT01490086|5830979|P3|Overall Study|Non-compliance|0
1668243|NCT01490086|5830980|P2|Overall Study|Non-compliance|1
1668244|NCT01490086|5830981|P1|Overall Study|Non-compliance|0
1668245|NCT01490086|5830977|P5|Overall Study|Consent withdrawn|1
1668246|NCT01490086|5830978|P4|Overall Study|Consent withdrawn|0
1668247|NCT01490086|5830979|P3|Overall Study|Consent withdrawn|3
1668248|NCT01490086|5830980|P2|Overall Study|Consent withdrawn|4
1668249|NCT01490086|5830981|P1|Overall Study|Consent withdrawn|4
1668250|NCT01490060|5831026|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
1668251|NCT01490060|5831027|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
1668252|NCT01490060|5831028|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
1668253|NCT01490060|5831029|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
1668254|NCT01490060|5831026|P4|Cycle 2|Non-Compliance|0
1668255|NCT01490060|5831027|P3|Cycle 2|Non-Compliance|1
1668256|NCT01490060|5831028|P2|Cycle 2|Non-Compliance|0
1668257|NCT01490060|5831029|P1|Cycle 2|Non-Compliance|0
1668258|NCT01490060|5831026|P4|Cycle 2|Change of Treatment|0
1668259|NCT01490060|5831027|P3|Cycle 2|Change of Treatment|0
1668260|NCT01490060|5831028|P2|Cycle 2|Change of Treatment|1
1668261|NCT01490060|5831029|P1|Cycle 2|Change of Treatment|1
1668262|NCT01490060|5831026|P4|Cycle 1|Treatment at Another Facility|1
1668263|NCT01490060|5831027|P3|Cycle 1|Treatment at Another Facility|0
1668264|NCT01490060|5831028|P2|Cycle 1|Treatment at Another Facility|0
1668265|NCT01490060|5831029|P1|Cycle 1|Treatment at Another Facility|0
1668266|NCT01490060|5831026|P4|Cycle 1|Withdrawal by Subject|1
1668267|NCT01490060|5831027|P3|Cycle 1|Withdrawal by Subject|0
1668268|NCT01490060|5831028|P2|Cycle 1|Withdrawal by Subject|0
1668269|NCT01490060|5831029|P1|Cycle 1|Withdrawal by Subject|0
1668270|NCT01490060|5831026|P4|Cycle 1|Insurance Denied|0
1668271|NCT01490060|5831027|P3|Cycle 1|Insurance Denied|2
1668272|NCT01490060|5831028|P2|Cycle 1|Insurance Denied|0
1668273|NCT01490060|5831029|P1|Cycle 1|Insurance Denied|0
1668274|NCT01490060|5831026|P4|Cycle 1|Change of Treatment|1
1668275|NCT01490060|5831027|P3|Cycle 1|Change of Treatment|1
1668276|NCT01490060|5831028|P2|Cycle 1|Change of Treatment|1
1668277|NCT01490060|5831029|P1|Cycle 1|Change of Treatment|0
1668278|NCT01489956|5831058|P3|Overall Study|Withdrawal by Subject|1
1668279|NCT01489956|5831059|P2|Overall Study|Withdrawal by Subject|0
1668280|NCT01489956|5831060|P1|Overall Study|Withdrawal by Subject|0
1668281|NCT01489956|5831058|P3|Overall Study|Lost to Follow-up|0
1668282|NCT01489956|5831059|P2|Overall Study|Lost to Follow-up|0
1668283|NCT01489956|5831060|P1|Overall Study|Lost to Follow-up|1
1668284|NCT01489891|5831097|P2|Overall Study|Endoscopy failure|0
1668285|NCT01489891|5831098|P1|Overall Study|Endoscopy failure|1
1668286|NCT01489527|5831253|P2|Overall Study|Not compliant|0
1668287|NCT01489527|5831254|P1|Overall Study|Not compliant|1
1668288|NCT01489527|5831253|P2|Overall Study|Procedures|0
1668289|NCT01489527|5831254|P1|Overall Study|Procedures|1
1668290|NCT01489527|5831253|P2|Overall Study|Lost to Follow-up|1
1668291|NCT01489527|5831254|P1|Overall Study|Lost to Follow-up|5
1668292|NCT01489527|5831253|P2|Overall Study|Withdrawal by Subject|4
1668293|NCT01489527|5831254|P1|Overall Study|Withdrawal by Subject|0
1668294|NCT01489527|5831253|P2|Overall Study|Participant moved|7
1668295|NCT01489527|5831254|P1|Overall Study|Participant moved|6
1668296|NCT01489527|5831253|P2|Overall Study|Pregnancy|14
1668297|NCT01489527|5831254|P1|Overall Study|Pregnancy|9
1668298|NCT01489358|5831271|P3|Overall Study|Lost to Follow-up|2
1668299|NCT01489358|5831272|P2|Overall Study|Lost to Follow-up|0
1668300|NCT01489358|5831273|P1|Overall Study|Lost to Follow-up|0
1668301|NCT01489254|5831323|P4|Open-label Extension Part|Other reasons for not completing study|5
1668302|NCT01489254|5831324|P3|Open-label Extension Part|Other reasons for not completing study|0
1668303|NCT01489254|5831325|P2|Open-label Extension Part|Other reasons for not completing study|0
1668304|NCT01489254|5831326|P1|Open-label Extension Part|Other reasons for not completing study|0
1668305|NCT01489254|5831323|P4|Open-label Extension Part|Lost to Follow-up|9
1668306|NCT01489254|5831324|P3|Open-label Extension Part|Lost to Follow-up|0
1668307|NCT01489254|5831325|P2|Open-label Extension Part|Lost to Follow-up|0
1668308|NCT01489254|5831326|P1|Open-label Extension Part|Lost to Follow-up|0
1668309|NCT01489254|5831323|P4|Open-label Extension Part|Protocol Violation|1
1668310|NCT01489254|5831324|P3|Open-label Extension Part|Protocol Violation|0
1668311|NCT01489254|5831325|P2|Open-label Extension Part|Protocol Violation|0
1668312|NCT01489254|5831326|P1|Open-label Extension Part|Protocol Violation|0
1668313|NCT01489254|5831323|P4|Open-label Extension Part|Withdrawal by Subject|30
1668314|NCT01489254|5831324|P3|Open-label Extension Part|Withdrawal by Subject|0
1668315|NCT01489254|5831325|P2|Open-label Extension Part|Withdrawal by Subject|0
1668316|NCT01489254|5831326|P1|Open-label Extension Part|Withdrawal by Subject|0
1668317|NCT01489254|5831323|P4|Open-label Extension Part|Pregnancy|3
1668318|NCT01489254|5831324|P3|Open-label Extension Part|Pregnancy|0
1668319|NCT01489254|5831325|P2|Open-label Extension Part|Pregnancy|0
1668320|NCT01489254|5831326|P1|Open-label Extension Part|Pregnancy|0
1668321|NCT01489254|5831323|P4|Open-label Extension Part|Adverse Event|10
1668322|NCT01489254|5831324|P3|Open-label Extension Part|Adverse Event|0
1668323|NCT01489254|5831325|P2|Open-label Extension Part|Adverse Event|0
1668324|NCT01489254|5831326|P1|Open-label Extension Part|Adverse Event|0
1668325|NCT01489254|5831323|P4|Double-blind Part|Other reasons for not completing study|0
1668326|NCT01489254|5831324|P3|Double-blind Part|Other reasons for not completing study|0
1668327|NCT01489254|5831325|P2|Double-blind Part|Other reasons for not completing study|6
1668328|NCT01489254|5831326|P1|Double-blind Part|Other reasons for not completing study|4
1668329|NCT01489254|5831323|P4|Double-blind Part|Lost to Follow-up|0
1668330|NCT01489254|5831324|P3|Double-blind Part|Lost to Follow-up|0
1668331|NCT01489254|5831325|P2|Double-blind Part|Lost to Follow-up|2
1668332|NCT01489254|5831326|P1|Double-blind Part|Lost to Follow-up|1
1668333|NCT01489254|5831323|P4|Double-blind Part|Withdrawal by Subject|0
1668334|NCT01489254|5831324|P3|Double-blind Part|Withdrawal by Subject|1
1668335|NCT01489254|5831325|P2|Double-blind Part|Withdrawal by Subject|20
1668336|NCT01489254|5831326|P1|Double-blind Part|Withdrawal by Subject|12
1668337|NCT01489254|5831323|P4|Double-blind Part|Pregnancy|0
1668338|NCT01489254|5831324|P3|Double-blind Part|Pregnancy|0
1668339|NCT01489254|5831325|P2|Double-blind Part|Pregnancy|3
1668340|NCT01489254|5831326|P1|Double-blind Part|Pregnancy|1
1668341|NCT01489254|5831323|P4|Double-blind Part|Adverse Event|0
1668342|NCT01489254|5831324|P3|Double-blind Part|Adverse Event|2
1668343|NCT01489254|5831325|P2|Double-blind Part|Adverse Event|2
1668344|NCT01489254|5831326|P1|Double-blind Part|Adverse Event|7
1668345|NCT01489189|5831337|P2|Overall Study|Missed Visit|4
1668346|NCT01489189|5831338|P1|Overall Study|Missed Visit|1
1668347|NCT01489189|5831337|P2|Overall Study|Death|8
1668348|NCT01489189|5831338|P1|Overall Study|Death|10
1668349|NCT01489189|5831337|P2|Overall Study|Withdrawal by Subject|23
1668350|NCT01489189|5831338|P1|Overall Study|Withdrawal by Subject|20
1668351|NCT01489111|5831363|P1|Overall Study|Withdrawal criterion|1
1668352|NCT01489020|5831384|P6|Overall Study|Concomitant disease|0
1668353|NCT01489020|5831385|P5|Overall Study|Concomitant disease|3
1668354|NCT01489020|5831386|P4|Overall Study|Concomitant disease|0
1668355|NCT01489020|5831387|P3|Overall Study|Concomitant disease|0
1668356|NCT01489020|5831388|P2|Overall Study|Concomitant disease|0
1668357|NCT01489020|5831389|P1|Overall Study|Concomitant disease|0
1668358|NCT01489020|5831384|P6|Overall Study|Adverse Event|0
1668359|NCT01489020|5831385|P5|Overall Study|Adverse Event|3
1668360|NCT01489020|5831386|P4|Overall Study|Adverse Event|0
1668361|NCT01489020|5831387|P3|Overall Study|Adverse Event|3
1668362|NCT01489020|5831388|P2|Overall Study|Adverse Event|0
1668363|NCT01489020|5831389|P1|Overall Study|Adverse Event|0
1668364|NCT01489020|5831384|P6|Overall Study|Withdrawal by Subject|0
1668365|NCT01489020|5831385|P5|Overall Study|Withdrawal by Subject|0
1668366|NCT01489020|5831386|P4|Overall Study|Withdrawal by Subject|0
1668367|NCT01489020|5831387|P3|Overall Study|Withdrawal by Subject|0
1668368|NCT01489020|5831388|P2|Overall Study|Withdrawal by Subject|0
1668369|NCT01489020|5831389|P1|Overall Study|Withdrawal by Subject|1
1668370|NCT01488994|5831423|P2|Overall Study|Withdrawal by Subject|1
1668371|NCT01488994|5831424|P1|Overall Study|Withdrawal by Subject|0
1668372|NCT01488890|5831515|P4|Overall Study|Withdrawal by Subject|2
1668373|NCT01488890|5831516|P3|Overall Study|Withdrawal by Subject|11
1668374|NCT01488890|5831517|P2|Overall Study|Withdrawal by Subject|10
1668375|NCT01488890|5831518|P1|Overall Study|Withdrawal by Subject|14
1668376|NCT01488890|5831515|P4|Overall Study|Lost to Follow-up|3
1668377|NCT01488890|5831516|P3|Overall Study|Lost to Follow-up|20
1668378|NCT01488890|5831517|P2|Overall Study|Lost to Follow-up|10
1668379|NCT01488890|5831518|P1|Overall Study|Lost to Follow-up|13
1668380|NCT01488890|5831515|P4|Overall Study|Protocol Violation|0
1668381|NCT01488890|5831516|P3|Overall Study|Protocol Violation|4
1668382|NCT01488890|5831517|P2|Overall Study|Protocol Violation|0
1668383|NCT01488890|5831518|P1|Overall Study|Protocol Violation|3
1668384|NCT01488890|5831515|P4|Overall Study|Serious adverse event|0
1668385|NCT01488890|5831516|P3|Overall Study|Serious adverse event|0
1668386|NCT01488890|5831517|P2|Overall Study|Serious adverse event|0
1668387|NCT01488890|5831518|P1|Overall Study|Serious adverse event|2
1668388|NCT01488578|5831596|P1|Overall Study|Protocol Violation|1836
1668389|NCT01488487|5831630|P1|Overall Study|Withdrawal by Subject|2
1668390|NCT01488487|5831630|P1|Overall Study|Death|1
1668391|NCT01488487|5831630|P1|Overall Study|Adverse Event|6
1668392|NCT01488448|5831639|P2|Overall Study|Protocol Violation|3
1668393|NCT01488448|5831640|P1|Overall Study|Protocol Violation|4
1668394|NCT01488448|5831639|P2|Overall Study|Physician Decision|9
1668395|NCT01488448|5831640|P1|Overall Study|Physician Decision|4
1668396|NCT01488448|5831639|P2|Overall Study|Adverse Event|4
1668397|NCT01488448|5831640|P1|Overall Study|Adverse Event|9
1668398|NCT01488448|5831639|P2|Overall Study|Withdrawal by Subject|1
1668399|NCT01488448|5831640|P1|Overall Study|Withdrawal by Subject|3
1668400|NCT01488370|5831682|P3|Overall Study|Protocol Violation|1
1668401|NCT01488370|5831683|P2|Overall Study|Protocol Violation|1
1668402|NCT01488370|5831684|P1|Overall Study|Protocol Violation|0
1668403|NCT01488097|5831743|P1|Overall Study|Lost to Follow-up|1
1668404|NCT01488071|5831756|P2|Overall Study|Administrative or Other Reason(s)|4
1668405|NCT01488071|5831757|P1|Overall Study|Administrative or Other Reason(s)|5
1668406|NCT01488071|5831756|P2|Overall Study|Lost to Follow-up|0
1668407|NCT01488071|5831757|P1|Overall Study|Lost to Follow-up|1
1668408|NCT01488071|5831756|P2|Overall Study|Withdrawal of Consent|12
1668409|NCT01488071|5831757|P1|Overall Study|Withdrawal of Consent|14
1668410|NCT01488071|5831756|P2|Overall Study|Protocol Violation|7
1668411|NCT01488071|5831757|P1|Overall Study|Protocol Violation|5
1668412|NCT01488071|5831756|P2|Overall Study|Non-compliance with study drug|0
1668413|NCT01488071|5831757|P1|Overall Study|Non-compliance with study drug|2
1668414|NCT01488071|5831756|P2|Overall Study|Lack of Efficacy|17
1668415|NCT01488071|5831757|P1|Overall Study|Lack of Efficacy|11
1668416|NCT01488071|5831756|P2|Overall Study|Adverse Event|23
1668417|NCT01488071|5831757|P1|Overall Study|Adverse Event|15
1668418|NCT01487863|5831837|P2|Overall Study|Death|19
1668419|NCT01487863|5831838|P1|Overall Study|Death|19
1668420|NCT01487577|5831855|P1|Overall Study|Became ineligible after signing consent|1
1668421|NCT01487525|5831869|P2|Overall Study|Withdrawal by Subject|1
1668422|NCT01487525|5831870|P1|Overall Study|Withdrawal by Subject|0
1668423|NCT01487265|5831886|P1|Overall Study|Still on Treatment|1
1668424|NCT01487265|5831886|P1|Overall Study|Death|2
1668425|NCT01487265|5831886|P1|Overall Study|Disease Progression|21
1668426|NCT01487265|5831886|P1|Overall Study|Withdrawal by Subject|5
1668427|NCT01487265|5831886|P1|Overall Study|Adverse Event|8
1668428|NCT01487200|5831898|P4|Overall Study|Withdrawal by Subject|0
1668429|NCT01487200|5831899|P3|Overall Study|Withdrawal by Subject|0
1668430|NCT01487200|5831900|P2|Overall Study|Withdrawal by Subject|1
1668431|NCT01487200|5831901|P1|Overall Study|Withdrawal by Subject|0
1668432|NCT01487161|5831931|P4|Overall Study|missing data|0
1668433|NCT01487161|5831932|P3|Overall Study|missing data|0
1668434|NCT01487161|5831933|P2|Overall Study|missing data|1
1668435|NCT01487161|5831934|P1|Overall Study|missing data|0
1668436|NCT01487161|5831931|P4|Overall Study|Withdrawal by Subject|2
1668437|NCT01487161|5831932|P3|Overall Study|Withdrawal by Subject|1
1668438|NCT01487161|5831933|P2|Overall Study|Withdrawal by Subject|1
1668439|NCT01487161|5831934|P1|Overall Study|Withdrawal by Subject|1
1668440|NCT01487161|5831931|P4|Overall Study|Adverse Event|0
1668441|NCT01487161|5831932|P3|Overall Study|Adverse Event|0
1668442|NCT01487161|5831933|P2|Overall Study|Adverse Event|0
1668443|NCT01487161|5831934|P1|Overall Study|Adverse Event|1
1668444|NCT01486966|5831999|P2|Overall Study|Withdrawal by Subject|1
1668445|NCT01486966|5832000|P1|Overall Study|Withdrawal by Subject|0
1668446|NCT01486966|5831999|P2|Overall Study|Adverse Event|1
1668447|NCT01486966|5832000|P1|Overall Study|Adverse Event|0
1668448|NCT01486927|5832024|P1|Overall Study|Subject did not reach 6 mo of treatment|1
1668449|NCT01486927|5832024|P1|Overall Study|Withdrawal by Subject|8
1668450|NCT01486927|5832024|P1|Overall Study|50 Exposure days not reached|2
1668451|NCT01486927|5832024|P1|Overall Study|Physician Decision|1
1668452|NCT01486927|5832024|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
1668453|NCT01486758|5832062|P2|Overall Study|Lost to Follow-up|1
1668454|NCT01486758|5832063|P1|Overall Study|Lost to Follow-up|0
1668455|NCT01486446|5832130|P2|Overall Study|Adverse Event|0
1668456|NCT01486446|5832131|P1|Overall Study|Adverse Event|1
1668457|NCT01486316|5832154|P4|Overall Study|Death|0
1668458|NCT01486316|5832155|P3|Overall Study|Death|0
1668459|NCT01486316|5832156|P2|Overall Study|Death|1
1668460|NCT01486316|5832157|P1|Overall Study|Death|0
1668461|NCT01486316|5832154|P4|Overall Study|Physician Decision|0
1668462|NCT01486316|5832155|P3|Overall Study|Physician Decision|1
1668463|NCT01486316|5832156|P2|Overall Study|Physician Decision|0
1668464|NCT01486316|5832157|P1|Overall Study|Physician Decision|0
1668465|NCT01486316|5832154|P4|Overall Study|Withdrawal by Subject|0
1668466|NCT01486316|5832155|P3|Overall Study|Withdrawal by Subject|3
1668467|NCT01486316|5832156|P2|Overall Study|Withdrawal by Subject|0
1668468|NCT01486316|5832157|P1|Overall Study|Withdrawal by Subject|1
1668469|NCT01486316|5832154|P4|Overall Study|Not meeting eligibility criteria|0
1668470|NCT01486316|5832155|P3|Overall Study|Not meeting eligibility criteria|1
1668471|NCT01486316|5832156|P2|Overall Study|Not meeting eligibility criteria|0
1668472|NCT01486316|5832157|P1|Overall Study|Not meeting eligibility criteria|0
1668473|NCT01486316|5832154|P4|Overall Study|Device explanted with/without re-implant|2
1668474|NCT01486316|5832155|P3|Overall Study|Device explanted with/without re-implant|0
1668475|NCT01486316|5832156|P2|Overall Study|Device explanted with/without re-implant|2
1668476|NCT01486316|5832157|P1|Overall Study|Device explanted with/without re-implant|3
1668477|NCT01486264|5832169|P2|Overall Study|Not treated|1
1668478|NCT01486264|5832170|P1|Overall Study|Not treated|0
1668479|NCT01486264|5832169|P2|Overall Study|Other|11
1668480|NCT01486264|5832170|P1|Overall Study|Other|5
1668481|NCT01486264|5832169|P2|Overall Study|Lost to Follow-up|2
1668482|NCT01486264|5832170|P1|Overall Study|Lost to Follow-up|3
1668483|NCT01486264|5832169|P2|Overall Study|Protocol Violation|0
1668484|NCT01486264|5832170|P1|Overall Study|Protocol Violation|3
1668485|NCT01486264|5832169|P2|Overall Study|Physician Decision|1
1668486|NCT01486264|5832170|P1|Overall Study|Physician Decision|1
1668487|NCT01486264|5832169|P2|Overall Study|Withdrawal by Subject|18
1668488|NCT01486264|5832170|P1|Overall Study|Withdrawal by Subject|7
1668489|NCT01486264|5832169|P2|Overall Study|Lack of Efficacy|10
1668490|NCT01486264|5832170|P1|Overall Study|Lack of Efficacy|6
1668491|NCT01486264|5832169|P2|Overall Study|Adverse Event|3
1668492|NCT01486264|5832170|P1|Overall Study|Adverse Event|3
1668493|NCT01486264|5832169|P2|Overall Study|Death|1
1668494|NCT01486264|5832170|P1|Overall Study|Death|1
1668495|NCT01486238|5832202|P2|Overall Study|Lost to Follow-up|3
1668496|NCT01486238|5832203|P1|Overall Study|Lost to Follow-up|0
1668497|NCT01486238|5832202|P2|Overall Study|Withdrawal by Subject|1
1668498|NCT01486238|5832203|P1|Overall Study|Withdrawal by Subject|2
1668499|NCT01486238|5832202|P2|Overall Study|Death|2
1668500|NCT01486238|5832203|P1|Overall Study|Death|0
1668501|NCT01486199|5832211|P2|Two Year Period Between Study Days|Physician Decision|0
1668502|NCT01486199|5832212|P1|Two Year Period Between Study Days|Physician Decision|1
1668503|NCT01485991|5832232|P2|Overall Study|randomized but not treated|2
1668504|NCT01485991|5832233|P1|Overall Study|randomized but not treated|6
1668505|NCT01485991|5832232|P2|Overall Study|Withdrawal by Subject|20
1668506|NCT01485991|5832233|P1|Overall Study|Withdrawal by Subject|13
1668507|NCT01485991|5832232|P2|Overall Study|Lost to Follow-up|10
1668508|NCT01485991|5832233|P1|Overall Study|Lost to Follow-up|13
1668509|NCT01485991|5832232|P2|Overall Study|Adverse Event|4
1668510|NCT01485991|5832233|P1|Overall Study|Adverse Event|0
1668511|NCT01485887|5832243|P1|Overall Study|Primary disease markedly improved|1
1668598|NCT01484977|5832469|P1|Overall Study|Low White Blood Cell Count|1
1668512|NCT01485887|5832243|P1|Overall Study|Deterioration of primary disease|1
1668513|NCT01485887|5832243|P1|Overall Study|Adverse Event|8
1668514|NCT01485887|5832243|P1|Overall Study|Withdrawal by Subject|2
1668515|NCT01485796|5832255|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
1668516|NCT01485796|5832255|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
1668517|NCT01485796|5832255|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
1668518|NCT01485796|5832255|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
1668519|NCT01485796|5832255|P1|Period 2: Epoch 2|Switch to safety follow-up|26
1668520|NCT01485796|5832255|P1|Period 2: Epoch 2|Adverse Event|3
1668521|NCT01485796|5832255|P1|Period 2: Epoch 2|Withdrawal by Subject|6
1668522|NCT01485796|5832255|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
1668523|NCT01485640|5832277|P1|Overall Study|Terminated by Sponsor|95
1668524|NCT01485640|5832277|P1|Overall Study|Withdrawal by Subject|14
1668525|NCT01485640|5832277|P1|Overall Study|Protocol Violation|1
1668526|NCT01485640|5832277|P1|Overall Study|Lack of Efficacy|2
1668527|NCT01485640|5832277|P1|Overall Study|Adverse Event|10
1668528|NCT01485627|5832284|P2|Overall Study|caregiver was not bereaved|35
1668529|NCT01485627|5832285|P1|Overall Study|caregiver was not bereaved|42
1668530|NCT01485627|5832284|P2|Overall Study|Caregiver died|0
1668531|NCT01485627|5832285|P1|Overall Study|Caregiver died|1
1668532|NCT01485627|5832284|P2|Overall Study|Caregiver lost to follow up|12
1668533|NCT01485627|5832285|P1|Overall Study|Caregiver lost to follow up|11
1668534|NCT01485627|5832284|P2|Overall Study|Caregiver withdrew|3
1668535|NCT01485627|5832285|P1|Overall Study|Caregiver withdrew|3
1668536|NCT01485627|5832284|P2|Overall Study|Patient lost to followup|1
1668537|NCT01485627|5832285|P1|Overall Study|Patient lost to followup|0
1668538|NCT01485627|5832284|P2|Overall Study|Patient died|1
1668539|NCT01485627|5832285|P1|Overall Study|Patient died|3
1668540|NCT01485627|5832284|P2|Overall Study|Patient withdrew|5
1668541|NCT01485627|5832285|P1|Overall Study|Patient withdrew|6
1668542|NCT01485536|5832303|P1|Overall Study|Adverse Event|1
1668543|NCT01485536|5832303|P1|Overall Study|Withdrawal by Subject|3
1668544|NCT01485354|5832321|P1|Overall Study|Withdrawal by Subject|5
1668545|NCT01485172|5832335|P6|Overall Study|Withdrawal by Subject|1
1668546|NCT01485172|5832336|P5|Overall Study|Withdrawal by Subject|1
1668547|NCT01485172|5832337|P4|Overall Study|Withdrawal by Subject|1
1668548|NCT01485172|5832338|P3|Overall Study|Withdrawal by Subject|0
1668549|NCT01485172|5832339|P2|Overall Study|Withdrawal by Subject|0
1668550|NCT01485172|5832340|P1|Overall Study|Withdrawal by Subject|2
1668551|NCT01485172|5832335|P6|Overall Study|Physician Decision|0
1668552|NCT01485172|5832336|P5|Overall Study|Physician Decision|1
1668553|NCT01485172|5832337|P4|Overall Study|Physician Decision|0
1668554|NCT01485172|5832338|P3|Overall Study|Physician Decision|0
1668555|NCT01485172|5832339|P2|Overall Study|Physician Decision|0
1668556|NCT01485172|5832340|P1|Overall Study|Physician Decision|0
1668557|NCT01485172|5832335|P6|Overall Study|Lost to Follow-up|1
1668558|NCT01485172|5832336|P5|Overall Study|Lost to Follow-up|0
1668559|NCT01485172|5832337|P4|Overall Study|Lost to Follow-up|0
1668560|NCT01485172|5832338|P3|Overall Study|Lost to Follow-up|1
1668561|NCT01485172|5832339|P2|Overall Study|Lost to Follow-up|0
1668562|NCT01485172|5832340|P1|Overall Study|Lost to Follow-up|0
1668563|NCT01485172|5832335|P6|Overall Study|Protocol defined stopping criteria|0
1668564|NCT01485172|5832336|P5|Overall Study|Protocol defined stopping criteria|1
1668565|NCT01485172|5832337|P4|Overall Study|Protocol defined stopping criteria|0
1668566|NCT01485172|5832338|P3|Overall Study|Protocol defined stopping criteria|0
1668567|NCT01485172|5832339|P2|Overall Study|Protocol defined stopping criteria|0
1668568|NCT01485172|5832340|P1|Overall Study|Protocol defined stopping criteria|1
1668569|NCT01485172|5832335|P6|Overall Study|Protocol Violation|0
1668570|NCT01485172|5832336|P5|Overall Study|Protocol Violation|1
1668571|NCT01485172|5832337|P4|Overall Study|Protocol Violation|5
1668572|NCT01485172|5832338|P3|Overall Study|Protocol Violation|4
1668573|NCT01485172|5832339|P2|Overall Study|Protocol Violation|0
1668574|NCT01485172|5832340|P1|Overall Study|Protocol Violation|0
1668575|NCT01485172|5832335|P6|Overall Study|Lack of Efficacy|0
1668576|NCT01485172|5832336|P5|Overall Study|Lack of Efficacy|0
1668577|NCT01485172|5832337|P4|Overall Study|Lack of Efficacy|0
1668578|NCT01485172|5832338|P3|Overall Study|Lack of Efficacy|0
1668579|NCT01485172|5832339|P2|Overall Study|Lack of Efficacy|0
1668580|NCT01485172|5832340|P1|Overall Study|Lack of Efficacy|2
1668581|NCT01485172|5832335|P6|Overall Study|Adverse Event|2
1668582|NCT01485172|5832336|P5|Overall Study|Adverse Event|1
1668583|NCT01485172|5832337|P4|Overall Study|Adverse Event|2
1668584|NCT01485172|5832338|P3|Overall Study|Adverse Event|2
1668585|NCT01485172|5832339|P2|Overall Study|Adverse Event|1
1668586|NCT01485172|5832340|P1|Overall Study|Adverse Event|2
1668587|NCT01485120|5832414|P1|Overall Study|Withdrawal by Subject|2
1668588|NCT01485094|5832422|P3|Overall Study|Withdrawal by Subject|0
1668589|NCT01485094|5832423|P2|Overall Study|Withdrawal by Subject|1
1668590|NCT01485094|5832424|P1|Overall Study|Withdrawal by Subject|1
1668591|NCT01485094|5832422|P3|Overall Study|Lost to Follow-up|0
1668592|NCT01485094|5832423|P2|Overall Study|Lost to Follow-up|0
1668593|NCT01485094|5832424|P1|Overall Study|Lost to Follow-up|1
1668594|NCT01485094|5832422|P3|Overall Study|Adverse Event|1
1668595|NCT01485094|5832423|P2|Overall Study|Adverse Event|1
1668596|NCT01485094|5832424|P1|Overall Study|Adverse Event|1
1668597|NCT01484977|5832469|P1|Overall Study|Lack of Compliance|1
1668599|NCT01484977|5832469|P1|Overall Study|Moving Overseas|1
1668600|NCT01484977|5832469|P1|Overall Study|Subject Protocol Non-compliant|1
1668601|NCT01484977|5832469|P1|Overall Study|Withdrawal by Subject|4
1668602|NCT01484977|5832469|P1|Overall Study|Lost to Follow-up|1
1668603|NCT01484977|5832469|P1|Overall Study|Protocol Violation|6
1668604|NCT01484977|5832469|P1|Overall Study|Lack of Efficacy|4
1668605|NCT01484977|5832469|P1|Overall Study|Adverse Event|8
1668606|NCT01484951|5832473|P1|Overall Study|Non-Compliance|1
1668607|NCT01484951|5832473|P1|Overall Study|Personal Reasons|1
1668608|NCT01484951|5832473|P1|Overall Study|Adverse Event|3
1668609|NCT01484938|5832478|P1|Overall Study|Noncompliance|1
1668610|NCT01484938|5832478|P1|Overall Study|Lost to Follow-up|1
1668611|NCT01484938|5832478|P1|Overall Study|Adverse Event|2
1668612|NCT01484912|5832485|P2|Overall Study|Physician Decision|1
1668613|NCT01484912|5832486|P1|Overall Study|Physician Decision|0
1668614|NCT01484912|5832485|P2|Overall Study|Withdrawal by Subject|0
1668615|NCT01484912|5832486|P1|Overall Study|Withdrawal by Subject|1
1668616|NCT01484873|5832496|P1|Overall Study|Withdrawal by Subject|2
1668617|NCT01484834|5832508|P4|Overall Study|Lost to Follow-up|4
1668618|NCT01484834|5832509|P3|Overall Study|Lost to Follow-up|1
1668619|NCT01484834|5832510|P2|Overall Study|Lost to Follow-up|8
1668620|NCT01484834|5832511|P1|Overall Study|Lost to Follow-up|5
1668621|NCT01484561|5832552|P2|Overall Study|Adverse Event|4
1668622|NCT01484561|5832553|P1|Overall Study|Adverse Event|1
1668623|NCT01484561|5832552|P2|Overall Study|Other|1
1668624|NCT01484561|5832553|P1|Overall Study|Other|1
1668625|NCT01484561|5832552|P2|Overall Study|Withdrawal by Subject|0
1668626|NCT01484561|5832553|P1|Overall Study|Withdrawal by Subject|3
1668627|NCT01484561|5832552|P2|Overall Study|Lost to Follow-up|0
1668628|NCT01484561|5832553|P1|Overall Study|Lost to Follow-up|1
1668629|NCT01484561|5832552|P2|Overall Study|Lack of Efficacy|1
1668630|NCT01484561|5832553|P1|Overall Study|Lack of Efficacy|3
1668631|NCT01484496|5832643|P4|Period 2|Other|6
1668632|NCT01484496|5832644|P3|Period 2|Other|9
1668633|NCT01484496|5832645|P2|Period 2|Other|0
1668634|NCT01484496|5832646|P1|Period 2|Other|0
1668635|NCT01484496|5832643|P4|Period 2|Adverse Event|13
1668636|NCT01484496|5832644|P3|Period 2|Adverse Event|5
1668637|NCT01484496|5832645|P2|Period 2|Adverse Event|0
1668638|NCT01484496|5832646|P1|Period 2|Adverse Event|0
1668639|NCT01484496|5832643|P4|Period 2|Lack of Efficacy|3
1668640|NCT01484496|5832644|P3|Period 2|Lack of Efficacy|1
1668641|NCT01484496|5832645|P2|Period 2|Lack of Efficacy|0
1668642|NCT01484496|5832646|P1|Period 2|Lack of Efficacy|0
1668643|NCT01484496|5832643|P4|Period 1|Unable to Visit Site|0
1668644|NCT01484496|5832644|P3|Period 1|Unable to Visit Site|0
1668645|NCT01484496|5832645|P2|Period 1|Unable to Visit Site|2
1668646|NCT01484496|5832646|P1|Period 1|Unable to Visit Site|0
1668647|NCT01484496|5832643|P4|Period 1|Lack of Compliance|0
1668648|NCT01484496|5832644|P3|Period 1|Lack of Compliance|0
1668649|NCT01484496|5832645|P2|Period 1|Lack of Compliance|1
1668650|NCT01484496|5832646|P1|Period 1|Lack of Compliance|2
1668651|NCT01484496|5832643|P4|Period 1|Treatment Failure|0
1668652|NCT01484496|5832644|P3|Period 1|Treatment Failure|0
1668653|NCT01484496|5832645|P2|Period 1|Treatment Failure|6
1668654|NCT01484496|5832646|P1|Period 1|Treatment Failure|3
1668655|NCT01484496|5832643|P4|Period 1|Positive Pregnancy|0
1668656|NCT01484496|5832644|P3|Period 1|Positive Pregnancy|0
1668657|NCT01484496|5832645|P2|Period 1|Positive Pregnancy|6
1668658|NCT01484496|5832646|P1|Period 1|Positive Pregnancy|1
1668659|NCT01484496|5832643|P4|Period 1|Lost to Follow-up|0
1668660|NCT01484496|5832644|P3|Period 1|Lost to Follow-up|0
1668661|NCT01484496|5832645|P2|Period 1|Lost to Follow-up|6
1668662|NCT01484496|5832646|P1|Period 1|Lost to Follow-up|2
1668663|NCT01484496|5832643|P4|Period 1|Withdrawal by Subject|0
1668664|NCT01484496|5832644|P3|Period 1|Withdrawal by Subject|0
1668665|NCT01484496|5832645|P2|Period 1|Withdrawal by Subject|12
1668666|NCT01484496|5832646|P1|Period 1|Withdrawal by Subject|15
1668667|NCT01484496|5832643|P4|Period 1|Adverse Event|0
1668668|NCT01484496|5832644|P3|Period 1|Adverse Event|0
1668669|NCT01484496|5832645|P2|Period 1|Adverse Event|40
1668670|NCT01484496|5832646|P1|Period 1|Adverse Event|25
1668671|NCT01484496|5832643|P4|Period 1|Lack of Efficacy|0
1668672|NCT01484496|5832644|P3|Period 1|Lack of Efficacy|0
1668673|NCT01484496|5832645|P2|Period 1|Lack of Efficacy|15
1668674|NCT01484496|5832646|P1|Period 1|Lack of Efficacy|10
1668675|NCT01484496|5832643|P4|Period 1|Physician Decision|0
1668676|NCT01484496|5832644|P3|Period 1|Physician Decision|0
1668677|NCT01484496|5832645|P2|Period 1|Physician Decision|1
1668678|NCT01484496|5832646|P1|Period 1|Physician Decision|5
1668679|NCT01484496|5832643|P4|Period 1|Protocol Violation|0
1668680|NCT01484496|5832644|P3|Period 1|Protocol Violation|0
1668681|NCT01484496|5832645|P2|Period 1|Protocol Violation|4
1668682|NCT01484496|5832646|P1|Period 1|Protocol Violation|3
1668683|NCT01484431|5832661|P3|Period 2|Non-Compliance with Study Drug|0
1668684|NCT01484431|5832662|P2|Period 2|Non-Compliance with Study Drug|0
1668685|NCT01484431|5832663|P1|Period 2|Non-Compliance with Study Drug|1
1668686|NCT01484431|5832661|P3|Period 2|Physician Decision|1
1668687|NCT01484431|5832662|P2|Period 2|Physician Decision|0
1668688|NCT01484431|5832663|P1|Period 2|Physician Decision|0
1668689|NCT01484431|5832661|P3|Period 2|Death|1
1668690|NCT01484431|5832662|P2|Period 2|Death|1
1668691|NCT01484431|5832663|P1|Period 2|Death|0
1668692|NCT01484431|5832661|P3|Period 1: High Dose|Physician Decision|0
1668693|NCT01484431|5832662|P2|Period 1: High Dose|Physician Decision|1
1668694|NCT01484431|5832663|P1|Period 1: High Dose|Physician Decision|0
1668695|NCT01484275|5832701|P2|Overall Study|Lost to Follow-up|1
1668696|NCT01484275|5832702|P1|Overall Study|Lost to Follow-up|1
1668697|NCT01484275|5832701|P2|Overall Study|Withdrawal by Subject|5
1668698|NCT01484275|5832702|P1|Overall Study|Withdrawal by Subject|1
1668699|NCT01484275|5832701|P2|Overall Study|Death|4
1668700|NCT01484275|5832702|P1|Overall Study|Death|3
1668701|NCT01484275|5832701|P2|Overall Study|Other|0
1668702|NCT01484275|5832702|P1|Overall Study|Other|10
1668703|NCT01484275|5832701|P2|Overall Study|Study terminated by sponsor|32
1668704|NCT01484275|5832702|P1|Overall Study|Study terminated by sponsor|28
1668705|NCT01484197|5832724|P4|Treatment Period 2|Subject withdrew consent|1
1668706|NCT01484197|5832725|P3|Treatment Period 2|Subject withdrew consent|0
1668707|NCT01484197|5832726|P2|Treatment Period 2|Subject withdrew consent|0
1668708|NCT01484197|5832727|P1|Treatment Period 2|Subject withdrew consent|0
1668709|NCT01484197|5832724|P4|Treatment Period 1|Adverse Event|0
1668710|NCT01484197|5832725|P3|Treatment Period 1|Adverse Event|0
1668711|NCT01484197|5832726|P2|Treatment Period 1|Adverse Event|0
1668712|NCT01484197|5832727|P1|Treatment Period 1|Adverse Event|1
1668713|NCT01484132|5832810|P1|Overall Study|No post-treatment urine sample collected|10
1668714|NCT01484132|5832810|P1|Overall Study|No pre-treatment urine sample collected|1
1668715|NCT01484132|5832810|P1|Overall Study|Ineligible|1
1668716|NCT01484132|5832810|P1|Overall Study|Difficulty with time commitment|2
1668717|NCT01484132|5832810|P1|Overall Study|Lost to Follow-up|8
1668718|NCT01484054|5832818|P2|Period 1|Withdrawal by Subject|1
1668719|NCT01484054|5832819|P1|Period 1|Withdrawal by Subject|0
1668720|NCT01484028|5832837|P4|Period 1|Lens Discomfort|0
1668721|NCT01484028|5832838|P3|Period 1|Lens Discomfort|0
1668722|NCT01484028|5832839|P2|Period 1|Lens Discomfort|1
1668723|NCT01484028|5832840|P1|Period 1|Lens Discomfort|0
1668724|NCT01484028|5832837|P4|Period 1|Non-Compliance to Protocol|1
1668725|NCT01484028|5832838|P3|Period 1|Non-Compliance to Protocol|0
1668726|NCT01484028|5832839|P2|Period 1|Non-Compliance to Protocol|1
1668727|NCT01484028|5832840|P1|Period 1|Non-Compliance to Protocol|0
1668728|NCT01484028|5832837|P4|Period 1|Lost to Follow-up|0
1668729|NCT01484028|5832838|P3|Period 1|Lost to Follow-up|0
1668730|NCT01484028|5832839|P2|Period 1|Lost to Follow-up|1
1668731|NCT01484028|5832840|P1|Period 1|Lost to Follow-up|0
1668732|NCT01483937|5832933|P2|Overall Study|Withdrawal by Subject|3
1668733|NCT01483937|5832934|P1|Overall Study|Withdrawal by Subject|4
1668734|NCT01483924|5832961|P5|Overall Study|Sponsor concern over ECG result|0
1668735|NCT01483924|5832962|P4|Overall Study|Sponsor concern over ECG result|1
1668736|NCT01483924|5832963|P3|Overall Study|Sponsor concern over ECG result|0
1668737|NCT01483924|5832964|P2|Overall Study|Sponsor concern over ECG result|0
1668738|NCT01483924|5832965|P1|Overall Study|Sponsor concern over ECG result|0
1668739|NCT01483924|5832961|P5|Overall Study|Non-compliance|1
1668740|NCT01483924|5832962|P4|Overall Study|Non-compliance|1
1668741|NCT01483924|5832963|P3|Overall Study|Non-compliance|0
1668742|NCT01483924|5832964|P2|Overall Study|Non-compliance|0
1668743|NCT01483924|5832965|P1|Overall Study|Non-compliance|0
1668744|NCT01483924|5832961|P5|Overall Study|Adverse Event|0
1668745|NCT01483924|5832962|P4|Overall Study|Adverse Event|1
1668746|NCT01483924|5832963|P3|Overall Study|Adverse Event|1
1668747|NCT01483924|5832964|P2|Overall Study|Adverse Event|0
1668748|NCT01483924|5832965|P1|Overall Study|Adverse Event|0
1668749|NCT01483924|5832961|P5|Overall Study|Withdrawal by Subject|1
1668750|NCT01483924|5832962|P4|Overall Study|Withdrawal by Subject|1
1668751|NCT01483924|5832963|P3|Overall Study|Withdrawal by Subject|0
1668752|NCT01483924|5832964|P2|Overall Study|Withdrawal by Subject|0
1668753|NCT01483924|5832965|P1|Overall Study|Withdrawal by Subject|2
1668754|NCT01483820|5833018|P1|Overall Study|Death|1
1668755|NCT01483820|5833018|P1|Overall Study|Adverse Event|1
1668756|NCT01483820|5833018|P1|Overall Study|Lack of Efficacy|6
1668757|NCT01483651|5833039|P6|Overall Study|Withdrawal by Subject|1
1668758|NCT01483651|5833040|P5|Overall Study|Withdrawal by Subject|0
1668759|NCT01483651|5833041|P4|Overall Study|Withdrawal by Subject|0
1668760|NCT01483651|5833042|P3|Overall Study|Withdrawal by Subject|1
1668761|NCT01483651|5833043|P2|Overall Study|Withdrawal by Subject|1
1668762|NCT01483651|5833044|P1|Overall Study|Withdrawal by Subject|0
1668763|NCT01483625|5833054|P2|Overall Study|Due to other reason|0
1668764|NCT01483625|5833055|P1|Overall Study|Due to other reason|1
1668765|NCT01483625|5833054|P2|Overall Study|Refused to continue medication|1
1668766|NCT01483625|5833055|P1|Overall Study|Refused to continue medication|2
1668767|NCT01483625|5833054|P2|Overall Study|Adverse Event|1
1668768|NCT01483625|5833055|P1|Overall Study|Adverse Event|1
1668769|NCT01483599|5833078|P14|After Controlled Period(Week 16-Week 40)|Other|0
1668770|NCT01483599|5833079|P13|After Controlled Period(Week 16-Week 40)|Other|1
1668771|NCT01483599|5833080|P12|After Controlled Period(Week 16-Week 40)|Other|0
1668772|NCT01483599|5833081|P11|After Controlled Period(Week 16-Week 40)|Other|0
1668773|NCT01483599|5833082|P10|After Controlled Period(Week 16-Week 40)|Other|4
1668774|NCT01483599|5833083|P9|After Controlled Period(Week 16-Week 40)|Other|0
1668775|NCT01483599|5833084|P8|After Controlled Period(Week 16-Week 40)|Other|1
1668776|NCT01483599|5833085|P7|After Controlled Period(Week 16-Week 40)|Other|0
1668777|NCT01483599|5833086|P6|After Controlled Period(Week 16-Week 40)|Other|0
1668778|NCT01483599|5833087|P5|After Controlled Period(Week 16-Week 40)|Other|0
1668779|NCT01483599|5833088|P4|After Controlled Period(Week 16-Week 40)|Other|0
1668780|NCT01483599|5833089|P3|After Controlled Period(Week 16-Week 40)|Other|0
1668781|NCT01483599|5833090|P2|After Controlled Period(Week 16-Week 40)|Other|0
1668782|NCT01483599|5833091|P1|After Controlled Period(Week 16-Week 40)|Other|0
1668783|NCT01483599|5833078|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
1668784|NCT01483599|5833079|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
1668785|NCT01483599|5833080|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668786|NCT01483599|5833081|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668787|NCT01483599|5833082|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668788|NCT01483599|5833083|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
1668789|NCT01483599|5833084|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668790|NCT01483599|5833085|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668791|NCT01483599|5833086|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668792|NCT01483599|5833087|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668793|NCT01483599|5833088|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668794|NCT01483599|5833089|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668795|NCT01483599|5833090|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668796|NCT01483599|5833091|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
1668797|NCT01483599|5833078|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1668798|NCT01483599|5833079|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668799|NCT01483599|5833080|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668800|NCT01483599|5833081|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
1668801|NCT01483599|5833082|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668802|NCT01483599|5833083|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
1668803|NCT01483599|5833084|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668804|NCT01483599|5833085|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668805|NCT01483599|5833086|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668806|NCT01483599|5833087|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668807|NCT01483599|5833088|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668808|NCT01483599|5833089|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668809|NCT01483599|5833090|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668810|NCT01483599|5833091|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
1668811|NCT01483599|5833078|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1668812|NCT01483599|5833079|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668813|NCT01483599|5833080|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1668814|NCT01483599|5833081|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668815|NCT01483599|5833082|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668816|NCT01483599|5833083|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
1668817|NCT01483599|5833084|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668818|NCT01483599|5833085|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668819|NCT01483599|5833086|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668820|NCT01483599|5833087|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668821|NCT01483599|5833088|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668822|NCT01483599|5833089|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668823|NCT01483599|5833090|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668824|NCT01483599|5833091|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
1668825|NCT01483599|5833078|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1668826|NCT01483599|5833079|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1668827|NCT01483599|5833080|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668828|NCT01483599|5833081|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668829|NCT01483599|5833082|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668830|NCT01483599|5833083|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1668831|NCT01483599|5833084|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
1668832|NCT01483599|5833085|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668833|NCT01483599|5833086|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668834|NCT01483599|5833087|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668835|NCT01483599|5833088|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668836|NCT01483599|5833089|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668837|NCT01483599|5833090|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668838|NCT01483599|5833091|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
1668839|NCT01483599|5833078|P14|After Controlled Period(Week 16-Week 40)|Death|0
1668840|NCT01483599|5833079|P13|After Controlled Period(Week 16-Week 40)|Death|0
1668841|NCT01483599|5833080|P12|After Controlled Period(Week 16-Week 40)|Death|0
1668842|NCT01483599|5833081|P11|After Controlled Period(Week 16-Week 40)|Death|0
1668843|NCT01483599|5833082|P10|After Controlled Period(Week 16-Week 40)|Death|0
1668844|NCT01483599|5833083|P9|After Controlled Period(Week 16-Week 40)|Death|1
1668845|NCT01483599|5833084|P8|After Controlled Period(Week 16-Week 40)|Death|0
1668846|NCT01483599|5833085|P7|After Controlled Period(Week 16-Week 40)|Death|0
1668847|NCT01483599|5833086|P6|After Controlled Period(Week 16-Week 40)|Death|0
1668848|NCT01483599|5833087|P5|After Controlled Period(Week 16-Week 40)|Death|0
1668849|NCT01483599|5833088|P4|After Controlled Period(Week 16-Week 40)|Death|0
1668850|NCT01483599|5833089|P3|After Controlled Period(Week 16-Week 40)|Death|0
1668851|NCT01483599|5833090|P2|After Controlled Period(Week 16-Week 40)|Death|0
1668852|NCT01483599|5833091|P1|After Controlled Period(Week 16-Week 40)|Death|0
1668853|NCT01483599|5833078|P14|Controlled Period (CP) (up to Week 16)|Other|0
1668854|NCT01483599|5833079|P13|Controlled Period (CP) (up to Week 16)|Other|0
1668855|NCT01483599|5833080|P12|Controlled Period (CP) (up to Week 16)|Other|0
1668856|NCT01483599|5833081|P11|Controlled Period (CP) (up to Week 16)|Other|0
1668857|NCT01483599|5833082|P10|Controlled Period (CP) (up to Week 16)|Other|0
1668858|NCT01483599|5833083|P9|Controlled Period (CP) (up to Week 16)|Other|0
1668859|NCT01483599|5833084|P8|Controlled Period (CP) (up to Week 16)|Other|0
1668860|NCT01483599|5833085|P7|Controlled Period (CP) (up to Week 16)|Other|0
1668861|NCT01483599|5833086|P6|Controlled Period (CP) (up to Week 16)|Other|0
1668862|NCT01483599|5833087|P5|Controlled Period (CP) (up to Week 16)|Other|1
1668863|NCT01483599|5833088|P4|Controlled Period (CP) (up to Week 16)|Other|1
1668864|NCT01483599|5833089|P3|Controlled Period (CP) (up to Week 16)|Other|0
1668865|NCT01483599|5833090|P2|Controlled Period (CP) (up to Week 16)|Other|2
1668866|NCT01483599|5833091|P1|Controlled Period (CP) (up to Week 16)|Other|0
1668867|NCT01483599|5833078|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668868|NCT01483599|5833079|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668869|NCT01483599|5833080|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668870|NCT01483599|5833081|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668871|NCT01483599|5833082|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668872|NCT01483599|5833083|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668873|NCT01483599|5833084|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668874|NCT01483599|5833085|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668875|NCT01483599|5833086|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668876|NCT01483599|5833087|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668877|NCT01483599|5833088|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668878|NCT01483599|5833089|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668879|NCT01483599|5833090|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
1668880|NCT01483599|5833091|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
1668881|NCT01483599|5833078|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668882|NCT01483599|5833079|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668883|NCT01483599|5833080|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668884|NCT01483599|5833081|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668885|NCT01483599|5833082|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668886|NCT01483599|5833083|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668887|NCT01483599|5833084|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668888|NCT01483599|5833085|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1668889|NCT01483599|5833086|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668890|NCT01483599|5833087|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668891|NCT01483599|5833088|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1668892|NCT01483599|5833089|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668893|NCT01483599|5833090|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
1668894|NCT01483599|5833091|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
1668895|NCT01483599|5833078|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668896|NCT01483599|5833079|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668897|NCT01483599|5833080|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668898|NCT01483599|5833081|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668899|NCT01483599|5833082|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668900|NCT01483599|5833083|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668901|NCT01483599|5833084|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668902|NCT01483599|5833085|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
1668903|NCT01483599|5833086|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
1668904|NCT01483599|5833087|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1668905|NCT01483599|5833088|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
1668906|NCT01483599|5833089|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668907|NCT01483599|5833090|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
1668908|NCT01483599|5833091|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
1668909|NCT01483183|5833204|P10|Overall Study|Withdrawal by Subject|1
1668910|NCT01483183|5833205|P9|Overall Study|Withdrawal by Subject|0
1668911|NCT01483183|5833206|P8|Overall Study|Withdrawal by Subject|0
1668912|NCT01483183|5833207|P7|Overall Study|Withdrawal by Subject|0
1668913|NCT01483183|5833208|P6|Overall Study|Withdrawal by Subject|0
1668914|NCT01483183|5833209|P5|Overall Study|Withdrawal by Subject|0
1668915|NCT01483183|5833210|P4|Overall Study|Withdrawal by Subject|0
1668916|NCT01483183|5833211|P3|Overall Study|Withdrawal by Subject|0
1668917|NCT01483183|5833212|P2|Overall Study|Withdrawal by Subject|0
1668918|NCT01483183|5833213|P1|Overall Study|Withdrawal by Subject|0
1668919|NCT01483183|5833204|P10|Overall Study|Physician Decision|0
1668920|NCT01483183|5833205|P9|Overall Study|Physician Decision|0
1668921|NCT01483183|5833206|P8|Overall Study|Physician Decision|0
1668922|NCT01483183|5833207|P7|Overall Study|Physician Decision|2
1668923|NCT01483183|5833208|P6|Overall Study|Physician Decision|0
1668924|NCT01483183|5833209|P5|Overall Study|Physician Decision|0
1668925|NCT01483183|5833210|P4|Overall Study|Physician Decision|0
1668926|NCT01483183|5833211|P3|Overall Study|Physician Decision|0
1668927|NCT01483183|5833212|P2|Overall Study|Physician Decision|0
1668928|NCT01483183|5833213|P1|Overall Study|Physician Decision|0
1668929|NCT01483118|5833283|P2|Overall Study|Lost to Follow-up|16
1668930|NCT01483118|5833284|P1|Overall Study|Lost to Follow-up|12
1668931|NCT01482962|5833296|P2|Overall Study|Did not Receive Study Drug|6
1668932|NCT01482962|5833297|P1|Overall Study|Did not Receive Study Drug|1
1668933|NCT01482962|5833296|P2|Overall Study|Study Terminated by Sponsor|2
1668934|NCT01482962|5833297|P1|Overall Study|Study Terminated by Sponsor|5
1668935|NCT01482962|5833296|P2|Overall Study|Other Reason|5
1668936|NCT01482962|5833297|P1|Overall Study|Other Reason|1
1668937|NCT01482962|5833296|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
1668938|NCT01482962|5833297|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
1668939|NCT01482962|5833296|P2|Overall Study|Withdrawal by Participant|13
1668940|NCT01482962|5833297|P1|Overall Study|Withdrawal by Participant|8
1668941|NCT01482962|5833296|P2|Overall Study|Adverse Event|22
1668942|NCT01482962|5833297|P1|Overall Study|Adverse Event|18
1668943|NCT01482962|5833296|P2|Overall Study|Unsatisfactory Therapeutic Response|23
1668944|NCT01482962|5833297|P1|Overall Study|Unsatisfactory Therapeutic Response|37
1668945|NCT01482962|5833296|P2|Overall Study|Progressive Disease|53
1668946|NCT01482962|5833297|P1|Overall Study|Progressive Disease|65
1668947|NCT01482910|5833330|P2|Overall Study|Death|0
1668948|NCT01482910|5833331|P1|Overall Study|Death|1
1668949|NCT01482910|5833330|P2|Overall Study|Withdrawal by Subject|2
1668950|NCT01482910|5833331|P1|Overall Study|Withdrawal by Subject|7
1668951|NCT01482910|5833330|P2|Overall Study|Protocol Violation|1
1668952|NCT01482910|5833331|P1|Overall Study|Protocol Violation|1
1668953|NCT01482910|5833330|P2|Overall Study|Lost to Follow-up|1
1668954|NCT01482910|5833331|P1|Overall Study|Lost to Follow-up|0
1668955|NCT01482910|5833330|P2|Overall Study|Adverse Event|5
1668956|NCT01482910|5833331|P1|Overall Study|Adverse Event|6
1668957|NCT01482884|5833343|P2|Overall Study|Withdrawal by Subject|13
1668958|NCT01482884|5833344|P1|Overall Study|Withdrawal by Subject|8
1668959|NCT01482884|5833343|P2|Overall Study|Adverse Event|1
1668960|NCT01482884|5833344|P1|Overall Study|Adverse Event|2
1668961|NCT01482884|5833343|P2|Overall Study|Lack of Efficacy|1
1668962|NCT01482884|5833344|P1|Overall Study|Lack of Efficacy|0
1668963|NCT01482884|5833343|P2|Overall Study|Lost to Follow-up|2
1668964|NCT01482884|5833344|P1|Overall Study|Lost to Follow-up|2
1668965|NCT01482884|5833343|P2|Overall Study|Protocol Violation|0
1668966|NCT01482884|5833344|P1|Overall Study|Protocol Violation|1
1668967|NCT01482884|5833343|P2|Overall Study|Medical decision due to lack of efficacy|1
1668968|NCT01482884|5833344|P1|Overall Study|Medical decision due to lack of efficacy|0
1668969|NCT01482819|5833370|P1|Overall Study|Lost to Follow-up|2
1668970|NCT01482767|5833390|P2|Overall Study|Nurse error|0
1668971|NCT01482767|5833391|P1|Overall Study|Nurse error|1
1668972|NCT01482767|5833390|P2|Overall Study|Ineligible|5
1668973|NCT01482767|5833391|P1|Overall Study|Ineligible|0
1668974|NCT01482767|5833390|P2|Overall Study|Alternate HCV treatment|8
1668975|NCT01482767|5833391|P1|Overall Study|Alternate HCV treatment|7
1668976|NCT01482767|5833390|P2|Overall Study|Non-adherence to study requirements|7
1668977|NCT01482767|5833391|P1|Overall Study|Non-adherence to study requirements|4
1668978|NCT01482767|5833390|P2|Overall Study|Site closure|14
1668979|NCT01482767|5833391|P1|Overall Study|Site closure|22
1668980|NCT01482767|5833390|P2|Overall Study|Adverse Event|3
1668981|NCT01482767|5833391|P1|Overall Study|Adverse Event|0
1668982|NCT01482767|5833390|P2|Overall Study|Lost to Follow-up|6
1668983|NCT01482767|5833391|P1|Overall Study|Lost to Follow-up|12
1668984|NCT01482767|5833390|P2|Overall Study|Withdrawal by Subject|5
1668985|NCT01482767|5833391|P1|Overall Study|Withdrawal by Subject|7
1668986|NCT01482767|5833390|P2|Overall Study|Death|1
1668987|NCT01482767|5833391|P1|Overall Study|Death|1
1668988|NCT01482429|5833413|P2|Protocol|Protocol Violation|0
1668989|NCT01482429|5833414|P1|Protocol|Protocol Violation|275
1668990|NCT01482429|5833413|P2|Care Usual|Lost to Follow-up|1
1668991|NCT01482429|5833414|P1|Care Usual|Lost to Follow-up|0
1668992|NCT01482429|5833413|P2|Care Usual|Protocol Violation|172
1668993|NCT01482429|5833414|P1|Care Usual|Protocol Violation|0
1668994|NCT01482312|5833450|P3|Period 2, 90 Minutes of Wear|Other|0
1668995|NCT01482312|5833451|P2|Period 2, 90 Minutes of Wear|Other|0
1668996|NCT01482312|5833452|P1|Period 2, 90 Minutes of Wear|Other|1
1668997|NCT01482312|5833450|P3|Period 1, 90 Minutes of Wear|Other|0
1668998|NCT01482312|5833451|P2|Period 1, 90 Minutes of Wear|Other|0
1668999|NCT01482312|5833452|P1|Period 1, 90 Minutes of Wear|Other|1
1669000|NCT01482221|5833466|P3|Overall Study|Physician Decision|0
1669001|NCT01482221|5833467|P2|Overall Study|Physician Decision|1
1669002|NCT01482221|5833468|P1|Overall Study|Physician Decision|0
1669003|NCT01482221|5833466|P3|Overall Study|Incorrect randomization|0
1669004|NCT01482221|5833467|P2|Overall Study|Incorrect randomization|1
1669005|NCT01482221|5833468|P1|Overall Study|Incorrect randomization|0
1669006|NCT01482221|5833466|P3|Overall Study|Withdrawal by Subject|12
1669007|NCT01482221|5833467|P2|Overall Study|Withdrawal by Subject|7
1669008|NCT01482221|5833468|P1|Overall Study|Withdrawal by Subject|10
1669009|NCT01482221|5833466|P3|Overall Study|Adverse Event|3
1669010|NCT01482221|5833467|P2|Overall Study|Adverse Event|7
1669011|NCT01482221|5833468|P1|Overall Study|Adverse Event|1
1669012|NCT01482221|5833466|P3|Overall Study|Severe Non-Compliance to Protocol|1
1669013|NCT01482221|5833467|P2|Overall Study|Severe Non-Compliance to Protocol|0
1669014|NCT01482221|5833468|P1|Overall Study|Severe Non-Compliance to Protocol|1
1669015|NCT01482221|5833466|P3|Overall Study|Condition under Investigation Worsened|4
1669016|NCT01482221|5833467|P2|Overall Study|Condition under Investigation Worsened|2
1669017|NCT01482221|5833468|P1|Overall Study|Condition under Investigation Worsened|3
1669018|NCT01482221|5833466|P3|Overall Study|Study-Specific Withdrawal Criteria|1
1669019|NCT01482221|5833467|P2|Overall Study|Study-Specific Withdrawal Criteria|0
1669020|NCT01482221|5833468|P1|Overall Study|Study-Specific Withdrawal Criteria|2
1669021|NCT01482221|5833466|P3|Overall Study|Lost to Follow-up|1
1669022|NCT01482221|5833467|P2|Overall Study|Lost to Follow-up|2
1669023|NCT01482221|5833468|P1|Overall Study|Lost to Follow-up|3
1669024|NCT01482221|5833466|P3|Overall Study|Lack of Efficacy|1
1669025|NCT01482221|5833467|P2|Overall Study|Lack of Efficacy|0
1669026|NCT01482221|5833468|P1|Overall Study|Lack of Efficacy|1
1669027|NCT01482169|5833509|P1|Overall Study|Physician Decision|2
1669028|NCT01482065|5833551|P2|Overall Study|Withdrawal by Subject|1
1669029|NCT01482065|5833552|P1|Overall Study|Withdrawal by Subject|0
1669030|NCT01481896|5833573|P1|Overall Study|Lost to Follow-up|12
1669031|NCT01481779|5833589|P2|Overall Study|Sponsor Decision|1
1669032|NCT01481779|5833590|P1|Overall Study|Sponsor Decision|3
1669033|NCT01481779|5833589|P2|Overall Study|Physician Decision|4
1669034|NCT01481779|5833590|P1|Overall Study|Physician Decision|13
1669035|NCT01481779|5833589|P2|Overall Study|Withdrawal by Subject|13
1669036|NCT01481779|5833590|P1|Overall Study|Withdrawal by Subject|26
1669037|NCT01481779|5833589|P2|Overall Study|Protocol Violation|3
1669038|NCT01481779|5833590|P1|Overall Study|Protocol Violation|2
1669039|NCT01481779|5833589|P2|Overall Study|Lost to Follow-up|2
1669040|NCT01481779|5833590|P1|Overall Study|Lost to Follow-up|3
1669041|NCT01481779|5833589|P2|Overall Study|Adverse Event|5
1669042|NCT01481779|5833590|P1|Overall Study|Adverse Event|23
1669043|NCT01481324|5833675|P3|Overall Study|Missing Data|2
1669044|NCT01481324|5833676|P2|Overall Study|Missing Data|2
1669045|NCT01481324|5833677|P1|Overall Study|Missing Data|0
1669046|NCT01481116|5833696|P3|Overall Study|Hypoglycemic Event|0
1669047|NCT01481116|5833697|P2|Overall Study|Hypoglycemic Event|0
1669048|NCT01481116|5833698|P1|Overall Study|Hypoglycemic Event|4
1669049|NCT01481116|5833696|P3|Overall Study|Death|0
1669050|NCT01481116|5833697|P2|Overall Study|Death|1
1669051|NCT01481116|5833698|P1|Overall Study|Death|2
1669052|NCT01481116|5833696|P3|Overall Study|Investigator's Discretion|0
1669053|NCT01481116|5833697|P2|Overall Study|Investigator's Discretion|0
1669054|NCT01481116|5833698|P1|Overall Study|Investigator's Discretion|2
1669055|NCT01481116|5833696|P3|Overall Study|Non-Compliant With Study Drug|1
1669056|NCT01481116|5833697|P2|Overall Study|Non-Compliant With Study Drug|1
1669057|NCT01481116|5833698|P1|Overall Study|Non-Compliant With Study Drug|0
1669058|NCT01481116|5833696|P3|Overall Study|Sponsor Decision|3
1669059|NCT01481116|5833697|P2|Overall Study|Sponsor Decision|1
1669060|NCT01481116|5833698|P1|Overall Study|Sponsor Decision|0
1669061|NCT01481116|5833696|P3|Overall Study|Investigator Decision|1
1669062|NCT01481116|5833697|P2|Overall Study|Investigator Decision|2
1669063|NCT01481116|5833698|P1|Overall Study|Investigator Decision|3
1669064|NCT01481116|5833696|P3|Overall Study|Participant Moved Out of Country|1
1669065|NCT01481116|5833697|P2|Overall Study|Participant Moved Out of Country|0
1669066|NCT01481116|5833698|P1|Overall Study|Participant Moved Out of Country|1
1669067|NCT01481116|5833696|P3|Overall Study|Participant Moved Out of Area|1
1669068|NCT01481116|5833697|P2|Overall Study|Participant Moved Out of Area|0
1669069|NCT01481116|5833698|P1|Overall Study|Participant Moved Out of Area|2
1669070|NCT01481116|5833696|P3|Overall Study|Participant Started Taking Glipizide|0
1669071|NCT01481116|5833697|P2|Overall Study|Participant Started Taking Glipizide|0
1669072|NCT01481116|5833698|P1|Overall Study|Participant Started Taking Glipizide|1
1669073|NCT01481116|5833696|P3|Overall Study|Other|0
1669074|NCT01481116|5833697|P2|Overall Study|Other|1
1669075|NCT01481116|5833698|P1|Overall Study|Other|1
1669076|NCT01481116|5833696|P3|Overall Study|Contraindications|0
1669077|NCT01481116|5833697|P2|Overall Study|Contraindications|1
1669078|NCT01481116|5833698|P1|Overall Study|Contraindications|1
1669079|NCT01481116|5833696|P3|Overall Study|Lack of Efficacy|1
1669080|NCT01481116|5833697|P2|Overall Study|Lack of Efficacy|3
1669081|NCT01481116|5833698|P1|Overall Study|Lack of Efficacy|3
1669082|NCT01481116|5833696|P3|Overall Study|Pregnancy|1
1669083|NCT01481116|5833697|P2|Overall Study|Pregnancy|0
1669084|NCT01481116|5833698|P1|Overall Study|Pregnancy|0
1669085|NCT01481116|5833696|P3|Overall Study|Study Termination|713
1669086|NCT01481116|5833697|P2|Overall Study|Study Termination|729
1669087|NCT01481116|5833698|P1|Overall Study|Study Termination|730
1669088|NCT01481116|5833696|P3|Overall Study|Withdrawal by Subject|37
1669089|NCT01481116|5833697|P2|Overall Study|Withdrawal by Subject|33
1669090|NCT01481116|5833698|P1|Overall Study|Withdrawal by Subject|37
1669091|NCT01481116|5833696|P3|Overall Study|Lost to Follow-up|11
1669092|NCT01481116|5833697|P2|Overall Study|Lost to Follow-up|12
1669093|NCT01481116|5833698|P1|Overall Study|Lost to Follow-up|8
1669094|NCT01481116|5833696|P3|Overall Study|Major Protocol Deviation|1
1669095|NCT01481116|5833697|P2|Overall Study|Major Protocol Deviation|7
1669096|NCT01481116|5833698|P1|Overall Study|Major Protocol Deviation|3
1669097|NCT01481116|5833696|P3|Overall Study|Adverse Event|42
1669098|NCT01481116|5833697|P2|Overall Study|Adverse Event|26
1669099|NCT01481116|5833698|P1|Overall Study|Adverse Event|26
1669100|NCT01480674|5833729|P1|Overall Study|visit not done|10
1669101|NCT01480674|5833729|P1|Overall Study|Lost to Follow-up|2
1669102|NCT01480674|5833729|P1|Overall Study|Death|23
1669103|NCT01480596|5833743|P2|Overall Study|MG exacerbation or change in medication|2
1669104|NCT01480596|5833744|P1|Overall Study|MG exacerbation or change in medication|2
1669105|NCT01480596|5833743|P2|Overall Study|Adverse Event|0
1669106|NCT01480596|5833744|P1|Overall Study|Adverse Event|3
1669107|NCT01480284|5833792|P2|Overall Study|Physician Decision|0
1669108|NCT01480284|5833793|P1|Overall Study|Physician Decision|1
1669109|NCT01480284|5833792|P2|Overall Study|Lost to Follow-up|0
1669110|NCT01480284|5833793|P1|Overall Study|Lost to Follow-up|1
1669111|NCT01480284|5833792|P2|Overall Study|Study closed/terminated|0
1669112|NCT01480284|5833793|P1|Overall Study|Study closed/terminated|3
1669113|NCT01480284|5833792|P2|Overall Study|Adverse Event|0
1669114|NCT01480284|5833793|P1|Overall Study|Adverse Event|1
1669115|NCT01480284|5833792|P2|Overall Study|Withdrawal by Subject|0
1669116|NCT01480284|5833793|P1|Overall Study|Withdrawal by Subject|2
1669117|NCT01480258|5833823|P2|Interim Period|Withdrawal by Subject|6
1669118|NCT01480258|5833824|P1|Interim Period|Withdrawal by Subject|9
1669119|NCT01480258|5833823|P2|Interim Period|Protocol Violation|1
1669120|NCT01480258|5833824|P1|Interim Period|Protocol Violation|0
1669121|NCT01480258|5833823|P2|Interim Period|Physician Decision|0
1669122|NCT01480258|5833824|P1|Interim Period|Physician Decision|1
1669123|NCT01480258|5833823|P2|Interim Period|Lost to Follow-up|2
1669124|NCT01480258|5833824|P1|Interim Period|Lost to Follow-up|0
1669125|NCT01480258|5833823|P2|Infant Series|Withdrawal by Subject|6
1669126|NCT01480258|5833824|P1|Infant Series|Withdrawal by Subject|1
1669127|NCT01480258|5833823|P2|Infant Series|Adverse Event|1
1669128|NCT01480258|5833824|P1|Infant Series|Adverse Event|1
1669129|NCT01480258|5833823|P2|Infant Series|Not Vaccinated|0
1669130|NCT01480258|5833824|P1|Infant Series|Not Vaccinated|3
1669131|NCT01480258|5833823|P2|Infant Series|Physician Decision|1
1669132|NCT01480258|5833824|P1|Infant Series|Physician Decision|0
1669133|NCT01480258|5833823|P2|Infant Series|Protocol Violation|0
1669134|NCT01480258|5833824|P1|Infant Series|Protocol Violation|2
1669135|NCT01480076|5833901|P1|Overall Study|Other|52
1669136|NCT01480076|5833901|P1|Overall Study|Investigator Decision|13
1669137|NCT01480076|5833901|P1|Overall Study|Lost to Follow-up|7
1669138|NCT01480076|5833901|P1|Overall Study|Withdrawal by Subject|105
1669139|NCT01480076|5833901|P1|Overall Study|Non-compliance With Study Protocol|15
1669140|NCT01480076|5833901|P1|Overall Study|Disease Progression|5
1669141|NCT01480076|5833901|P1|Overall Study|Death|2
1669142|NCT01480076|5833901|P1|Overall Study|Adverse Event|39
1669143|NCT01480076|5833901|P1|Overall Study|Run-in Failure|52
1669144|NCT01479868|5834031|P1|Overall Study|Initiation of new HCV Therapy|1
1669145|NCT01479868|5834031|P1|Overall Study|Sponsor's Decision|1
1669146|NCT01479868|5834031|P1|Overall Study|Withdrawal by Subject|1
1669147|NCT01479868|5834031|P1|Overall Study|Protocol Violation|1
1669148|NCT01479868|5834031|P1|Overall Study|Lost to Follow-up|4
1669149|NCT01479868|5834031|P1|Overall Study|Adverse Event|1
1669150|NCT01479777|5834046|P1|Overall Study|Physician Decision|2
1669151|NCT01479764|5834058|P2|Treated|Lost to Follow-up|2
1669152|NCT01479764|5834059|P1|Treated|Lost to Follow-up|0
1669153|NCT01479764|5834058|P2|Randomized|Withdrawal by Subject|0
1669154|NCT01479764|5834059|P1|Randomized|Withdrawal by Subject|1
1669155|NCT01479764|5834058|P2|Randomized|Adverse Event|1
1669156|NCT01479764|5834059|P1|Randomized|Adverse Event|1
1669157|NCT01479621|5834082|P7|Treatment Period|Met stopping criteria|6
1669158|NCT01479621|5834083|P6|Treatment Period|Met stopping criteria|20
1669159|NCT01479621|5834084|P5|Treatment Period|Met stopping criteria|9
1669160|NCT01479621|5834085|P4|Treatment Period|Met stopping criteria|4
1669161|NCT01479621|5834086|P3|Treatment Period|Met stopping criteria|7
1669162|NCT01479621|5834087|P2|Treatment Period|Met stopping criteria|8
1669163|NCT01479621|5834088|P1|Treatment Period|Met stopping criteria|0
1669164|NCT01479621|5834082|P7|Treatment Period|Lost to Follow-up|1
1669165|NCT01479621|5834083|P6|Treatment Period|Lost to Follow-up|2
1669166|NCT01479621|5834084|P5|Treatment Period|Lost to Follow-up|2
1669167|NCT01479621|5834085|P4|Treatment Period|Lost to Follow-up|0
1669168|NCT01479621|5834086|P3|Treatment Period|Lost to Follow-up|1
1669169|NCT01479621|5834087|P2|Treatment Period|Lost to Follow-up|0
1669170|NCT01479621|5834088|P1|Treatment Period|Lost to Follow-up|0
1669171|NCT01479621|5834082|P7|Treatment Period|Sponsor request subject to be withdrawn|3
1669172|NCT01479621|5834083|P6|Treatment Period|Sponsor request subject to be withdrawn|1
1669173|NCT01479621|5834084|P5|Treatment Period|Sponsor request subject to be withdrawn|1
1669174|NCT01479621|5834085|P4|Treatment Period|Sponsor request subject to be withdrawn|1
1669175|NCT01479621|5834086|P3|Treatment Period|Sponsor request subject to be withdrawn|3
1669176|NCT01479621|5834087|P2|Treatment Period|Sponsor request subject to be withdrawn|2
1669177|NCT01479621|5834088|P1|Treatment Period|Sponsor request subject to be withdrawn|0
1669178|NCT01479621|5834082|P7|Treatment Period|Pregnancy|0
1669179|NCT01479621|5834083|P6|Treatment Period|Pregnancy|0
1669180|NCT01479621|5834084|P5|Treatment Period|Pregnancy|0
1669181|NCT01479621|5834085|P4|Treatment Period|Pregnancy|0
1669182|NCT01479621|5834086|P3|Treatment Period|Pregnancy|2
1669183|NCT01479621|5834087|P2|Treatment Period|Pregnancy|0
1669184|NCT01479621|5834088|P1|Treatment Period|Pregnancy|0
1669185|NCT01479621|5834082|P7|Treatment Period|Protocol Violation|6
1669186|NCT01479621|5834083|P6|Treatment Period|Protocol Violation|10
1669187|NCT01479621|5834084|P5|Treatment Period|Protocol Violation|2
1669188|NCT01479621|5834085|P4|Treatment Period|Protocol Violation|5
1669189|NCT01479621|5834086|P3|Treatment Period|Protocol Violation|6
1669190|NCT01479621|5834087|P2|Treatment Period|Protocol Violation|9
1669191|NCT01479621|5834088|P1|Treatment Period|Protocol Violation|0
1669192|NCT01479621|5834082|P7|Treatment Period|Non-compliance to study drug|1
1669193|NCT01479621|5834083|P6|Treatment Period|Non-compliance to study drug|0
1669194|NCT01479621|5834084|P5|Treatment Period|Non-compliance to study drug|0
1669195|NCT01479621|5834085|P4|Treatment Period|Non-compliance to study drug|0
1669196|NCT01479621|5834086|P3|Treatment Period|Non-compliance to study drug|0
1669197|NCT01479621|5834087|P2|Treatment Period|Non-compliance to study drug|1
1669198|NCT01479621|5834088|P1|Treatment Period|Non-compliance to study drug|0
1669199|NCT01479621|5834082|P7|Treatment Period|Physician Decision|0
1669200|NCT01479621|5834083|P6|Treatment Period|Physician Decision|1
1669201|NCT01479621|5834084|P5|Treatment Period|Physician Decision|1
1669202|NCT01479621|5834085|P4|Treatment Period|Physician Decision|0
1669203|NCT01479621|5834086|P3|Treatment Period|Physician Decision|0
1669204|NCT01479621|5834087|P2|Treatment Period|Physician Decision|0
1669205|NCT01479621|5834088|P1|Treatment Period|Physician Decision|0
1669206|NCT01479621|5834082|P7|Treatment Period|Withdrawal by Subject|1
1669207|NCT01479621|5834083|P6|Treatment Period|Withdrawal by Subject|5
1669208|NCT01479621|5834084|P5|Treatment Period|Withdrawal by Subject|5
1669209|NCT01479621|5834085|P4|Treatment Period|Withdrawal by Subject|2
1669210|NCT01479621|5834086|P3|Treatment Period|Withdrawal by Subject|2
1669211|NCT01479621|5834087|P2|Treatment Period|Withdrawal by Subject|4
1669212|NCT01479621|5834088|P1|Treatment Period|Withdrawal by Subject|0
1669213|NCT01479621|5834082|P7|Treatment Period|Adverse Event|2
1669214|NCT01479621|5834083|P6|Treatment Period|Adverse Event|2
1669215|NCT01479621|5834084|P5|Treatment Period|Adverse Event|1
1669216|NCT01479621|5834085|P4|Treatment Period|Adverse Event|0
1669217|NCT01479621|5834086|P3|Treatment Period|Adverse Event|0
1669218|NCT01479621|5834087|P2|Treatment Period|Adverse Event|0
1669219|NCT01479621|5834088|P1|Treatment Period|Adverse Event|0
1669220|NCT01479621|5834082|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
1669221|NCT01479621|5834083|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
1669222|NCT01479621|5834084|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
1669223|NCT01479621|5834085|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
1669224|NCT01479621|5834086|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
1669225|NCT01479621|5834087|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
1669226|NCT01479621|5834088|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
1669227|NCT01479621|5834082|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1669228|NCT01479621|5834083|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1669229|NCT01479621|5834084|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1669230|NCT01479621|5834085|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1669231|NCT01479621|5834086|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1669232|NCT01479621|5834087|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
1669233|NCT01479621|5834088|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
1669234|NCT01479621|5834082|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1669235|NCT01479621|5834083|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1669236|NCT01479621|5834084|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1669237|NCT01479621|5834085|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1669238|NCT01479621|5834086|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1669239|NCT01479621|5834087|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
1669240|NCT01479621|5834088|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
1669241|NCT01479621|5834082|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1669242|NCT01479621|5834083|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1669243|NCT01479621|5834084|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1669244|NCT01479621|5834085|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1669245|NCT01479621|5834086|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1669246|NCT01479621|5834087|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
1669247|NCT01479621|5834088|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
1669248|NCT01479621|5834082|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1669249|NCT01479621|5834083|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1669250|NCT01479621|5834084|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1669251|NCT01479621|5834085|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1669252|NCT01479621|5834086|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1669253|NCT01479621|5834087|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
1669254|NCT01479621|5834088|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
1669255|NCT01479595|5834176|P2|Overall Study|Adverse Event|1
1669256|NCT01479595|5834177|P1|Overall Study|Adverse Event|2
1669257|NCT01479595|5834176|P2|Overall Study|Protocol deviation|1
1669258|NCT01479595|5834177|P1|Overall Study|Protocol deviation|0
1669259|NCT01479530|5834222|P2|Overall Study|Withdrawal of Consent|2
1669260|NCT01479530|5834223|P1|Overall Study|Withdrawal of Consent|3
1669261|NCT01479530|5834222|P2|Overall Study|Protocol Violation|3
1669262|NCT01479530|5834223|P1|Overall Study|Protocol Violation|2
1669263|NCT01479530|5834222|P2|Overall Study|Lack of Efficacy|1
1669264|NCT01479530|5834223|P1|Overall Study|Lack of Efficacy|0
1669265|NCT01479530|5834222|P2|Overall Study|Adverse Event|6
1669266|NCT01479530|5834223|P1|Overall Study|Adverse Event|5
1669267|NCT01479465|5834304|P4|Overall Study|Lost to Follow-up|0
1669268|NCT01479465|5834305|P3|Overall Study|Lost to Follow-up|1
1669269|NCT01479465|5834306|P2|Overall Study|Lost to Follow-up|0
1669270|NCT01479465|5834307|P1|Overall Study|Lost to Follow-up|0
1669271|NCT01479465|5834304|P4|Overall Study|Death|1
1669272|NCT01479465|5834305|P3|Overall Study|Death|0
1669273|NCT01479465|5834306|P2|Overall Study|Death|0
1669274|NCT01479465|5834307|P1|Overall Study|Death|0
1669275|NCT01479465|5834304|P4|Overall Study|Protocol Violation|0
1669276|NCT01479465|5834305|P3|Overall Study|Protocol Violation|1
1669277|NCT01479465|5834306|P2|Overall Study|Protocol Violation|1
1669278|NCT01479465|5834307|P1|Overall Study|Protocol Violation|0
1669279|NCT01479465|5834304|P4|Overall Study|Subject Withdrew Consent|1
1669280|NCT01479465|5834305|P3|Overall Study|Subject Withdrew Consent|2
1669281|NCT01479465|5834306|P2|Overall Study|Subject Withdrew Consent|5
1669282|NCT01479465|5834307|P1|Overall Study|Subject Withdrew Consent|0
1669283|NCT01479465|5834304|P4|Overall Study|Subject Request|2
1669284|NCT01479465|5834305|P3|Overall Study|Subject Request|4
1669285|NCT01479465|5834306|P2|Overall Study|Subject Request|3
1669286|NCT01479465|5834307|P1|Overall Study|Subject Request|1
1669287|NCT01479465|5834304|P4|Overall Study|Investigator Discretion|4
1669288|NCT01479465|5834305|P3|Overall Study|Investigator Discretion|2
1669289|NCT01479465|5834306|P2|Overall Study|Investigator Discretion|4
1669290|NCT01479465|5834307|P1|Overall Study|Investigator Discretion|1
1669291|NCT01479465|5834304|P4|Overall Study|Adverse Event|4
1669292|NCT01479465|5834305|P3|Overall Study|Adverse Event|6
1669293|NCT01479465|5834306|P2|Overall Study|Adverse Event|3
1669294|NCT01479465|5834307|P1|Overall Study|Adverse Event|0
1669295|NCT01479465|5834304|P4|Overall Study|Study Discontinued by Sponsor|3
1669296|NCT01479465|5834305|P3|Overall Study|Study Discontinued by Sponsor|5
1669297|NCT01479465|5834306|P2|Overall Study|Study Discontinued by Sponsor|7
1669298|NCT01479465|5834307|P1|Overall Study|Study Discontinued by Sponsor|0
1669299|NCT01479465|5834304|P4|Overall Study|Disease Progression|70
1669300|NCT01479465|5834305|P3|Overall Study|Disease Progression|65
1669301|NCT01479465|5834306|P2|Overall Study|Disease Progression|61
1669302|NCT01479465|5834307|P1|Overall Study|Disease Progression|9
1669303|NCT01479374|5834343|P3|Overall Study|Other|5
1669304|NCT01479374|5834344|P2|Overall Study|Other|4
1669305|NCT01479374|5834345|P1|Overall Study|Other|0
1669306|NCT01479374|5834343|P3|Overall Study|Decision Unrelated to Adverse Event|0
1669307|NCT01479374|5834344|P2|Overall Study|Decision Unrelated to Adverse Event|1
1669308|NCT01479374|5834345|P1|Overall Study|Decision Unrelated to Adverse Event|0
1669309|NCT01479374|5834343|P3|Overall Study|Lost to Follow-up|0
1669310|NCT01479374|5834344|P2|Overall Study|Lost to Follow-up|2
1669311|NCT01479374|5834345|P1|Overall Study|Lost to Follow-up|1
1669312|NCT01479374|5834343|P3|Overall Study|Adverse Event|0
1669313|NCT01479374|5834344|P2|Overall Study|Adverse Event|1
1669314|NCT01479374|5834345|P1|Overall Study|Adverse Event|2
1669315|NCT01478971|5834431|P1|Peginesatide Treatment Period|Other|4
1669316|NCT01478971|5834431|P1|Peginesatide Treatment Period|Lost to Follow-up|4
1669317|NCT01478971|5834431|P1|Peginesatide Treatment Period|Death|4
1669318|NCT01478971|5834431|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
1669319|NCT01478971|5834431|P1|Peginesatide Treatment Period|Adverse Event|1
1669320|NCT01478971|5834431|P1|Standard of Care Period|Other|4
1669321|NCT01478971|5834431|P1|Standard of Care Period|Lost to Follow-up|9
1669322|NCT01478971|5834431|P1|Standard of Care Period|Death|8
1669323|NCT01478971|5834431|P1|Standard of Care Period|Withdrawal by Subject|3
1669324|NCT01478971|5834431|P1|Standard of Care Period|Adverse Event|1
1669325|NCT01478958|5834448|P3|Overall Study|Unable to comply|2
1669326|NCT01478958|5834449|P2|Overall Study|Unable to comply|0
1669327|NCT01478958|5834450|P1|Overall Study|Unable to comply|0
1669328|NCT01478958|5834448|P3|Overall Study|Re-located|0
1669329|NCT01478958|5834449|P2|Overall Study|Re-located|1
1669330|NCT01478958|5834450|P1|Overall Study|Re-located|0
1669331|NCT01478958|5834448|P3|Overall Study|Weight loss|0
1669332|NCT01478958|5834449|P2|Overall Study|Weight loss|0
1669333|NCT01478958|5834450|P1|Overall Study|Weight loss|1
1669334|NCT01478958|5834448|P3|Overall Study|Withdrawal by Subject|1
1669335|NCT01478958|5834449|P2|Overall Study|Withdrawal by Subject|1
1669336|NCT01478958|5834450|P1|Overall Study|Withdrawal by Subject|1
1669337|NCT01478828|5834470|P1|Overall Study|Adverse Event|1
1669338|NCT01478620|5834481|P1|Overall Study|Lost to Follow-up|6
1669339|NCT01478594|5834487|P2|Overall Study|Study Closed by Sponsor|5
1669340|NCT01478594|5834488|P1|Overall Study|Study Closed by Sponsor|8
1669341|NCT01478594|5834487|P2|Overall Study|Withdrawal by Subject|3
1669342|NCT01478594|5834488|P1|Overall Study|Withdrawal by Subject|9
1669343|NCT01478594|5834487|P2|Overall Study|Lost to Follow-up|1
1669344|NCT01478594|5834488|P1|Overall Study|Lost to Follow-up|3
1669345|NCT01478594|5834487|P2|Overall Study|Death|18
1669346|NCT01478594|5834488|P1|Overall Study|Death|45
1669347|NCT01478594|5834487|P2|Overall Study|Randomized but Never Received Study Drug|1
1669348|NCT01478594|5834488|P1|Overall Study|Randomized but Never Received Study Drug|0
1669349|NCT01478373|5834617|P1|Survival Phase|Progressive Disease|27
1669350|NCT01478373|5834617|P1|Survival Phase|crossover to another study|2
1669351|NCT01478373|5834617|P1|Survival Phase|Protocol Violation|1
1669352|NCT01478373|5834617|P1|Survival Phase|Adverse Event|8
1669353|NCT01478373|5834617|P1|Treatment Phase|Protocol Violation|1
1669354|NCT01478360|5834630|P2|Overall Study|Administrative problems|2
1669355|NCT01478360|5834631|P1|Overall Study|Administrative problems|1
1669356|NCT01478360|5834630|P2|Overall Study|Adverse Event|1
1669357|NCT01478360|5834631|P1|Overall Study|Adverse Event|0
1669358|NCT01478360|5834630|P2|Overall Study|Lost to Follow-up|0
1669359|NCT01478360|5834631|P1|Overall Study|Lost to Follow-up|1
1669360|NCT01478347|5834637|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
1669361|NCT01478347|5834637|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
1669362|NCT01478347|5834637|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
1669363|NCT01478113|5834655|P2|Overall Study|Physician Decision|0
1669364|NCT01478113|5834656|P1|Overall Study|Physician Decision|1
1669365|NCT01478113|5834655|P2|Overall Study|Withdrawal by Subject|1
1669366|NCT01478113|5834656|P1|Overall Study|Withdrawal by Subject|0
1669367|NCT01478087|5834674|P1|Overall Study|due to sponsor closing study|1
1669368|NCT01478048|5834681|P2|Overall Study|no longer meets study criteria|0
1669369|NCT01478048|5834682|P1|Overall Study|no longer meets study criteria|1
1669370|NCT01478048|5834681|P2|Overall Study|poor/non-compliance|1
1669371|NCT01478048|5834682|P1|Overall Study|poor/non-compliance|0
1669372|NCT01478048|5834681|P2|Overall Study|non-specified|4
1669373|NCT01478048|5834682|P1|Overall Study|non-specified|6
1669374|NCT01478048|5834681|P2|Overall Study|Withdrawal by Subject|5
1669375|NCT01478048|5834682|P1|Overall Study|Withdrawal by Subject|2
1669376|NCT01478048|5834681|P2|Overall Study|subject request to discontinue treatment|5
1669377|NCT01478048|5834682|P1|Overall Study|subject request to discontinue treatment|3
1669378|NCT01478048|5834681|P2|Overall Study|Adverse Event|11
1669379|NCT01478048|5834682|P1|Overall Study|Adverse Event|2
1669380|NCT01478048|5834681|P2|Overall Study|study drug toxicity|14
1669381|NCT01478048|5834682|P1|Overall Study|study drug toxicity|11
1669382|NCT01478048|5834681|P2|Overall Study|Disease Progression|35
1669383|NCT01478048|5834682|P1|Overall Study|Disease Progression|52
1669384|NCT01477892|5834711|P2|Overall Study|Withdrawal by Subject|2
1669385|NCT01477892|5834712|P1|Overall Study|Withdrawal by Subject|0
1669386|NCT01477853|5834723|P3|Phase B|Study terminated by sponsor|11
1669387|NCT01477853|5834724|P2|Phase B|Study terminated by sponsor|10
1669388|NCT01477853|5834725|P1|Phase B|Study terminated by sponsor|12
1669389|NCT01477853|5834723|P3|Phase B|Lost to Follow-up|0
1669390|NCT01477853|5834724|P2|Phase B|Lost to Follow-up|1
1669391|NCT01477853|5834725|P1|Phase B|Lost to Follow-up|0
1669392|NCT01477853|5834723|P3|Phase A|Study terminated by sponsor|39
1669393|NCT01477853|5834724|P2|Phase A|Study terminated by sponsor|40
1669394|NCT01477853|5834725|P1|Phase A|Study terminated by sponsor|37
1669395|NCT01477853|5834723|P3|Phase A|Physician Decision|1
1669396|NCT01477853|5834724|P2|Phase A|Physician Decision|0
1669397|NCT01477853|5834725|P1|Phase A|Physician Decision|1
1669398|NCT01477853|5834723|P3|Phase A|Lost to Follow-up|2
1669399|NCT01477853|5834724|P2|Phase A|Lost to Follow-up|3
1669400|NCT01477853|5834725|P1|Phase A|Lost to Follow-up|4
1669401|NCT01477853|5834723|P3|Phase A|Adverse Event|2
1669402|NCT01477853|5834724|P2|Phase A|Adverse Event|2
1669403|NCT01477853|5834725|P1|Phase A|Adverse Event|1
1669404|NCT01477749|5834792|P1|Overall Study|Physician Decision|4
1669405|NCT01477333|5834900|P1|Overall Study|Clinical Deterioration|1
1669406|NCT01477333|5834900|P1|Overall Study|Withdrawal by Subject|1
1669407|NCT01477333|5834900|P1|Overall Study|Adverse Event|1
1669408|NCT01476722|5834951|P1|Overall Study|Adverse Event|1
1669409|NCT01476696|5834958|P3|Overall Study|Withdrawal by Subject|0
1669410|NCT01476696|5834959|P2|Overall Study|Withdrawal by Subject|0
1669411|NCT01476696|5834960|P1|Overall Study|Withdrawal by Subject|1
1669412|NCT01476696|5834958|P3|Overall Study|Sponsor decision|0
1669413|NCT01476696|5834959|P2|Overall Study|Sponsor decision|1
1669414|NCT01476696|5834960|P1|Overall Study|Sponsor decision|2
1669415|NCT01476644|5834974|P1|Overall Study|Withdrawal by Subject|13
1669416|NCT01476644|5834974|P1|Overall Study|Lost to Follow-up|19
1669417|NCT01476644|5834974|P1|Overall Study|moved to another state|2
1669418|NCT01476644|5834974|P1|Overall Study|Death|5
1669419|NCT01476475|5834981|P2|Overall Study|Other reasons|2
1669420|NCT01476475|5834982|P1|Overall Study|Other reasons|4
1669421|NCT01476475|5834981|P2|Overall Study|Poor compliance to protocol|1
1669422|NCT01476475|5834982|P1|Overall Study|Poor compliance to protocol|1
1669423|NCT01476475|5834981|P2|Overall Study|Adverse Event|0
1669424|NCT01476475|5834982|P1|Overall Study|Adverse Event|6
1669425|NCT01475851|5835433|P2|Overall Study|Protocol defined stopping criteria|0
1669426|NCT01475851|5835434|P1|Overall Study|Protocol defined stopping criteria|1
1669427|NCT01475838|5835462|P2|Extension Phase|Participant Noncompliance|0
1669428|NCT01475838|5835463|P1|Extension Phase|Participant Noncompliance|1
1669429|NCT01475838|5835462|P2|Randomized Phase|Protocol Violation|4
1669430|NCT01475838|5835463|P1|Randomized Phase|Protocol Violation|9
1669431|NCT01475838|5835462|P2|Randomized Phase|Participant Noncompliance|5
1669432|NCT01475838|5835463|P1|Randomized Phase|Participant Noncompliance|1
1669433|NCT01475838|5835462|P2|Randomized Phase|Lost to Follow-up|4
1669434|NCT01475838|5835463|P1|Randomized Phase|Lost to Follow-up|3
1669435|NCT01475838|5835462|P2|Randomized Phase|Withdrew Consent|14
1669436|NCT01475838|5835463|P1|Randomized Phase|Withdrew Consent|10
1669437|NCT01475838|5835462|P2|Randomized Phase|Investigators Discretion|2
1669438|NCT01475838|5835463|P1|Randomized Phase|Investigators Discretion|1
1669439|NCT01475838|5835462|P2|Randomized Phase|Pregnancy|1
1669440|NCT01475838|5835463|P1|Randomized Phase|Pregnancy|0
1669441|NCT01475838|5835462|P2|Randomized Phase|Adverse Event|1
1669442|NCT01475838|5835463|P1|Randomized Phase|Adverse Event|6
1669443|NCT01475838|5835462|P2|Randomized Phase|Randomized but Not Treated|5
1669444|NCT01475838|5835463|P1|Randomized Phase|Randomized but Not Treated|0
1669445|NCT01475825|5835480|P4|Overall Study|Did not enter OLC|11
1669446|NCT01475825|5835481|P3|Overall Study|Did not enter OLC|15
1669447|NCT01475825|5835482|P2|Overall Study|Did not enter OLC|11
1669448|NCT01475825|5835483|P1|Overall Study|Did not enter OLC|15
1669449|NCT01475825|5835480|P4|Overall Study|Withdrawal by Subject|7
1669450|NCT01475825|5835481|P3|Overall Study|Withdrawal by Subject|11
1669451|NCT01475825|5835482|P2|Overall Study|Withdrawal by Subject|3
1669452|NCT01475825|5835483|P1|Overall Study|Withdrawal by Subject|8
1669453|NCT01475825|5835480|P4|Overall Study|Physician Decision|0
1669454|NCT01475825|5835481|P3|Overall Study|Physician Decision|0
1669455|NCT01475825|5835482|P2|Overall Study|Physician Decision|1
1669456|NCT01475825|5835483|P1|Overall Study|Physician Decision|0
1669457|NCT01475825|5835480|P4|Overall Study|Protocol Violation|0
1669458|NCT01475825|5835481|P3|Overall Study|Protocol Violation|0
1669459|NCT01475825|5835482|P2|Overall Study|Protocol Violation|0
1669460|NCT01475825|5835483|P1|Overall Study|Protocol Violation|1
1669461|NCT01475825|5835480|P4|Overall Study|Other: Not available|0
1669462|NCT01475825|5835481|P3|Overall Study|Other: Not available|2
1669463|NCT01475825|5835482|P2|Overall Study|Other: Not available|0
1669464|NCT01475825|5835483|P1|Overall Study|Other: Not available|0
1669465|NCT01475825|5835480|P4|Overall Study|Non-compliance with Study Drug|0
1669466|NCT01475825|5835481|P3|Overall Study|Non-compliance with Study Drug|4
1669467|NCT01475825|5835482|P2|Overall Study|Non-compliance with Study Drug|2
1669468|NCT01475825|5835483|P1|Overall Study|Non-compliance with Study Drug|1
1669469|NCT01475825|5835480|P4|Overall Study|Lost to Follow-up|1
1669470|NCT01475825|5835481|P3|Overall Study|Lost to Follow-up|3
1669471|NCT01475825|5835482|P2|Overall Study|Lost to Follow-up|0
1669472|NCT01475825|5835483|P1|Overall Study|Lost to Follow-up|0
1669473|NCT01475825|5835480|P4|Overall Study|Lack of Efficacy|0
1669474|NCT01475825|5835481|P3|Overall Study|Lack of Efficacy|1
1669475|NCT01475825|5835482|P2|Overall Study|Lack of Efficacy|0
1669476|NCT01475825|5835483|P1|Overall Study|Lack of Efficacy|0
1669477|NCT01475825|5835480|P4|Overall Study|Death|0
1669478|NCT01475825|5835481|P3|Overall Study|Death|1
1669479|NCT01475825|5835482|P2|Overall Study|Death|0
1669480|NCT01475825|5835483|P1|Overall Study|Death|1
1669481|NCT01475825|5835480|P4|Overall Study|Adverse Event|11
1669482|NCT01475825|5835481|P3|Overall Study|Adverse Event|27
1669483|NCT01475825|5835482|P2|Overall Study|Adverse Event|15
1669484|NCT01475825|5835483|P1|Overall Study|Adverse Event|41
1669485|NCT01475734|5835515|P2|Overall Study|Physician Decision|1
1669486|NCT01475734|5835516|P1|Overall Study|Physician Decision|0
1669487|NCT01475734|5835515|P2|Overall Study|Protocol Violation|0
1669488|NCT01475734|5835516|P1|Overall Study|Protocol Violation|1
1669489|NCT01475734|5835515|P2|Overall Study|Withdrawal by Subject|0
1669490|NCT01475734|5835516|P1|Overall Study|Withdrawal by Subject|1
1669491|NCT01475721|5835544|P2|Overall Study|Withdrawal by Subject|8
1669492|NCT01475721|5835545|P1|Overall Study|Withdrawal by Subject|8
1669493|NCT01475721|5835544|P2|Overall Study|Death|6
1669494|NCT01475721|5835545|P1|Overall Study|Death|3
1669495|NCT01475487|5835611|P2|Overall Study|had to leave early for personal reasons|1
1669496|NCT01475487|5835612|P1|Overall Study|had to leave early for personal reasons|2
1669497|NCT01475474|5835624|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
1669498|NCT01475474|5835624|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
1669499|NCT01475461|5835635|P7|Treatment Period|Adverse Event|0
1669500|NCT01475461|5835636|P6|Treatment Period|Adverse Event|0
1669501|NCT01475461|5835637|P5|Treatment Period|Adverse Event|0
1669502|NCT01475461|5835638|P4|Treatment Period|Adverse Event|1
1669503|NCT01475461|5835639|P3|Treatment Period|Adverse Event|0
1669504|NCT01475461|5835640|P2|Treatment Period|Adverse Event|0
1669505|NCT01475461|5835641|P1|Treatment Period|Adverse Event|0
1669506|NCT01475461|5835635|P7|Treatment Period|Medication Error|0
1669507|NCT01475461|5835636|P6|Treatment Period|Medication Error|0
1669508|NCT01475461|5835637|P5|Treatment Period|Medication Error|0
1669509|NCT01475461|5835638|P4|Treatment Period|Medication Error|1
1669510|NCT01475461|5835639|P3|Treatment Period|Medication Error|0
1669511|NCT01475461|5835640|P2|Treatment Period|Medication Error|0
1669512|NCT01475461|5835641|P1|Treatment Period|Medication Error|0
1669513|NCT01475461|5835635|P7|Treatment Period|Lack of Efficacy|0
1669514|NCT01475461|5835636|P6|Treatment Period|Lack of Efficacy|1
1669515|NCT01475461|5835637|P5|Treatment Period|Lack of Efficacy|1
1669516|NCT01475461|5835638|P4|Treatment Period|Lack of Efficacy|2
1669517|NCT01475461|5835639|P3|Treatment Period|Lack of Efficacy|0
1669518|NCT01475461|5835640|P2|Treatment Period|Lack of Efficacy|2
1669519|NCT01475461|5835641|P1|Treatment Period|Lack of Efficacy|0
1669520|NCT01475461|5835635|P7|Treatment Period|Protocol Violation|1
1669521|NCT01475461|5835636|P6|Treatment Period|Protocol Violation|0
1669522|NCT01475461|5835637|P5|Treatment Period|Protocol Violation|0
1669523|NCT01475461|5835638|P4|Treatment Period|Protocol Violation|0
1669524|NCT01475461|5835639|P3|Treatment Period|Protocol Violation|0
1669525|NCT01475461|5835640|P2|Treatment Period|Protocol Violation|1
1669526|NCT01475461|5835641|P1|Treatment Period|Protocol Violation|0
1669527|NCT01475461|5835635|P7|Treatment Period|Other|0
1669528|NCT01475461|5835636|P6|Treatment Period|Other|0
1669529|NCT01475461|5835637|P5|Treatment Period|Other|0
1669530|NCT01475461|5835638|P4|Treatment Period|Other|0
1669531|NCT01475461|5835639|P3|Treatment Period|Other|0
1669532|NCT01475461|5835640|P2|Treatment Period|Other|1
1669533|NCT01475461|5835641|P1|Treatment Period|Other|0
1669534|NCT01475461|5835635|P7|Treatment Period|Withdrawal by Subject|0
1669535|NCT01475461|5835636|P6|Treatment Period|Withdrawal by Subject|2
1669536|NCT01475461|5835637|P5|Treatment Period|Withdrawal by Subject|2
1669537|NCT01475461|5835638|P4|Treatment Period|Withdrawal by Subject|0
1669538|NCT01475461|5835639|P3|Treatment Period|Withdrawal by Subject|2
1669539|NCT01475461|5835640|P2|Treatment Period|Withdrawal by Subject|2
1669540|NCT01475461|5835641|P1|Treatment Period|Withdrawal by Subject|0
1669541|NCT01475461|5835635|P7|Treatment Period|Lost to Follow-up|1
1669542|NCT01475461|5835636|P6|Treatment Period|Lost to Follow-up|2
1669543|NCT01475461|5835637|P5|Treatment Period|Lost to Follow-up|1
1669544|NCT01475461|5835638|P4|Treatment Period|Lost to Follow-up|3
1669545|NCT01475461|5835639|P3|Treatment Period|Lost to Follow-up|2
1669546|NCT01475461|5835640|P2|Treatment Period|Lost to Follow-up|3
1669547|NCT01475461|5835641|P1|Treatment Period|Lost to Follow-up|0
1669548|NCT01475461|5835635|P7|Treatment Period|Death|0
1669549|NCT01475461|5835636|P6|Treatment Period|Death|0
1669550|NCT01475461|5835637|P5|Treatment Period|Death|0
1669551|NCT01475461|5835638|P4|Treatment Period|Death|1
1669552|NCT01475461|5835639|P3|Treatment Period|Death|0
1669553|NCT01475461|5835640|P2|Treatment Period|Death|0
1669554|NCT01475461|5835641|P1|Treatment Period|Death|0
1669555|NCT01475461|5835635|P7|Run-in Period|Protocol Violation|0
1669556|NCT01475461|5835636|P6|Run-in Period|Protocol Violation|0
1669557|NCT01475461|5835637|P5|Run-in Period|Protocol Violation|0
1669558|NCT01475461|5835638|P4|Run-in Period|Protocol Violation|0
1669559|NCT01475461|5835639|P3|Run-in Period|Protocol Violation|0
1669560|NCT01475461|5835640|P2|Run-in Period|Protocol Violation|0
1669561|NCT01475461|5835641|P1|Run-in Period|Protocol Violation|4
1669562|NCT01475461|5835635|P7|Run-in Period|Other|0
1669563|NCT01475461|5835636|P6|Run-in Period|Other|0
1669564|NCT01475461|5835637|P5|Run-in Period|Other|0
1669565|NCT01475461|5835638|P4|Run-in Period|Other|0
1669566|NCT01475461|5835639|P3|Run-in Period|Other|0
1669567|NCT01475461|5835640|P2|Run-in Period|Other|0
1669568|NCT01475461|5835641|P1|Run-in Period|Other|3
1669569|NCT01475461|5835635|P7|Run-in Period|Withdrawal by Subject|0
1669570|NCT01475461|5835636|P6|Run-in Period|Withdrawal by Subject|0
1669571|NCT01475461|5835637|P5|Run-in Period|Withdrawal by Subject|0
1669572|NCT01475461|5835638|P4|Run-in Period|Withdrawal by Subject|0
1669573|NCT01475461|5835639|P3|Run-in Period|Withdrawal by Subject|0
1669574|NCT01475461|5835640|P2|Run-in Period|Withdrawal by Subject|0
1669575|NCT01475461|5835641|P1|Run-in Period|Withdrawal by Subject|11
1669576|NCT01475461|5835635|P7|Run-in Period|Lost to Follow-up|0
1669577|NCT01475461|5835636|P6|Run-in Period|Lost to Follow-up|0
1669578|NCT01475461|5835637|P5|Run-in Period|Lost to Follow-up|0
1669579|NCT01475461|5835638|P4|Run-in Period|Lost to Follow-up|0
1669580|NCT01475461|5835639|P3|Run-in Period|Lost to Follow-up|0
1669581|NCT01475461|5835640|P2|Run-in Period|Lost to Follow-up|0
1669582|NCT01475461|5835641|P1|Run-in Period|Lost to Follow-up|7
1669583|NCT01475461|5835635|P7|Run-in Period|Not meet eligibility criteria|0
1669584|NCT01475461|5835636|P6|Run-in Period|Not meet eligibility criteria|0
1669585|NCT01475461|5835637|P5|Run-in Period|Not meet eligibility criteria|0
1669586|NCT01475461|5835638|P4|Run-in Period|Not meet eligibility criteria|0
1669587|NCT01475461|5835639|P3|Run-in Period|Not meet eligibility criteria|0
1669588|NCT01475461|5835640|P2|Run-in Period|Not meet eligibility criteria|0
1669589|NCT01475461|5835641|P1|Run-in Period|Not meet eligibility criteria|16
1669590|NCT01475331|5835721|P2|Overall Study|cyst found to be prohibitively small|1
1669591|NCT01475331|5835722|P1|Overall Study|cyst found to be prohibitively small|0
1669592|NCT01475331|5835721|P2|Overall Study|Sign of malignancy during the procedure|0
1669593|NCT01475331|5835722|P1|Overall Study|Sign of malignancy during the procedure|2
1669594|NCT01475331|5835721|P2|Overall Study|Loss of needle positioning due pt. cough|0
1669595|NCT01475331|5835722|P1|Overall Study|Loss of needle positioning due pt. cough|1
1669596|NCT01475331|5835721|P2|Overall Study|excessive main duct communication|1
1669597|NCT01475331|5835722|P1|Overall Study|excessive main duct communication|1
1669598|NCT01475331|5835721|P2|Overall Study|Osteophyte obstruction of the proximal|0
1669599|NCT01475331|5835722|P1|Overall Study|Osteophyte obstruction of the proximal|1
1669600|NCT01475253|5835774|P4|Randomized, Blinded Study|Lost to Follow-up|0
1669601|NCT01475253|5835775|P3|Randomized, Blinded Study|Lost to Follow-up|0
1669602|NCT01475253|5835776|P2|Randomized, Blinded Study|Lost to Follow-up|0
1669603|NCT01475253|5835777|P1|Randomized, Blinded Study|Lost to Follow-up|1
1669604|NCT01475253|5835774|P4|Randomized, Blinded Study|Withdrawal by Subject|0
1669605|NCT01475253|5835775|P3|Randomized, Blinded Study|Withdrawal by Subject|0
1669606|NCT01475253|5835776|P2|Randomized, Blinded Study|Withdrawal by Subject|1
1669607|NCT01475253|5835777|P1|Randomized, Blinded Study|Withdrawal by Subject|1
1669608|NCT01475214|5835806|P3|Overall Study|Withdrawal by Subject|1
1669609|NCT01475214|5835807|P2|Overall Study|Withdrawal by Subject|4
1669610|NCT01475214|5835808|P1|Overall Study|Withdrawal by Subject|2
1669611|NCT01475214|5835806|P3|Overall Study|Physician Decision|0
1669612|NCT01475214|5835807|P2|Overall Study|Physician Decision|0
1669613|NCT01475214|5835808|P1|Overall Study|Physician Decision|2
1669614|NCT01475214|5835806|P3|Overall Study|Lost to Follow-up|1
1669615|NCT01475214|5835807|P2|Overall Study|Lost to Follow-up|0
1669616|NCT01475214|5835808|P1|Overall Study|Lost to Follow-up|1
1669620|NCT01475097|5835844|P2|Overall Study|Protocol Violation|1
1669621|NCT01475097|5835845|P1|Overall Study|Protocol Violation|1
1669622|NCT01475071|5835853|P1|Overall Study|Lost to Follow-up|1
1669623|NCT01475071|5835853|P1|Overall Study|Withdrawal by Subject|6
1669624|NCT01475071|5835853|P1|Overall Study|Physician Decision|1
1669625|NCT01474993|5835863|P2|Overall Study|Adverse Event|1
1669626|NCT01474993|5835864|P1|Overall Study|Adverse Event|0
1669627|NCT01474993|5835863|P2|Overall Study|Lost to Follow-up|2
1669628|NCT01474993|5835864|P1|Overall Study|Lost to Follow-up|1
1669629|NCT01474876|5835906|P3|Overall Study|Investigator's decision and pt request|0
1669630|NCT01474876|5835907|P2|Overall Study|Investigator's decision and pt request|0
1669631|NCT01474876|5835908|P1|Overall Study|Investigator's decision and pt request|1
1669632|NCT01474876|5835906|P3|Overall Study|Patient's request|0
1669633|NCT01474876|5835907|P2|Overall Study|Patient's request|5
1669634|NCT01474876|5835908|P1|Overall Study|Patient's request|19
1669635|NCT01474876|5835906|P3|Overall Study|Investigator's decision|0
1669636|NCT01474876|5835907|P2|Overall Study|Investigator's decision|6
1669637|NCT01474876|5835908|P1|Overall Study|Investigator's decision|28
1669638|NCT01474876|5835906|P3|Overall Study|Lost to Follow-up|0
1669639|NCT01474876|5835907|P2|Overall Study|Lost to Follow-up|4
1669640|NCT01474876|5835908|P1|Overall Study|Lost to Follow-up|5
1669641|NCT01474876|5835906|P3|Overall Study|Serious Adverse Event|0
1669642|NCT01474876|5835907|P2|Overall Study|Serious Adverse Event|3
1669643|NCT01474876|5835908|P1|Overall Study|Serious Adverse Event|2
1669644|NCT01474876|5835906|P3|Overall Study|Adverse Event|0
1669645|NCT01474876|5835907|P2|Overall Study|Adverse Event|5
1669646|NCT01474876|5835908|P1|Overall Study|Adverse Event|11
1669647|NCT01474772|5835954|P2|Follow-up|AE not Related to Study Drug|1
1669648|NCT01474772|5835955|P1|Follow-up|AE not Related to Study Drug|0
1669649|NCT01474772|5835954|P2|Period 2|Reason not Specified|2
1669650|NCT01474772|5835955|P1|Period 2|Reason not Specified|0
1669651|NCT01474772|5835954|P2|Period 2|Lost to Follow-up|1
1669652|NCT01474772|5835955|P1|Period 2|Lost to Follow-up|1
1669653|NCT01474772|5835954|P2|Period 2|Withdrawal by Subject|4
1669654|NCT01474772|5835955|P1|Period 2|Withdrawal by Subject|3
1669655|NCT01474772|5835954|P2|Period 2|Lack of Efficacy|0
1669656|NCT01474772|5835955|P1|Period 2|Lack of Efficacy|1
1669657|NCT01474772|5835954|P2|Period 2|AE not Related to Study Drug|1
1669658|NCT01474772|5835955|P1|Period 2|AE not Related to Study Drug|4
1669659|NCT01474772|5835954|P2|Period 2|AE Related to Study Drug|1
1669660|NCT01474772|5835955|P1|Period 2|AE Related to Study Drug|0
1669661|NCT01474772|5835954|P2|Period 2|Death|1
1669662|NCT01474772|5835955|P1|Period 2|Death|0
1669663|NCT01474772|5835954|P2|Washout|Reason not Specified|1
1669664|NCT01474772|5835955|P1|Washout|Reason not Specified|0
1669665|NCT01474772|5835954|P2|Washout|Lost to Follow-up|1
1669666|NCT01474772|5835955|P1|Washout|Lost to Follow-up|0
1669667|NCT01474772|5835954|P2|Washout|Withdrawal by Subject|0
1669668|NCT01474772|5835955|P1|Washout|Withdrawal by Subject|1
1669669|NCT01474772|5835954|P2|Washout|AE not Related to Study Drug|0
1669670|NCT01474772|5835955|P1|Washout|AE not Related to Study Drug|2
1669671|NCT01474772|5835954|P2|Period 1|Reason not Specified|1
1669672|NCT01474772|5835955|P1|Period 1|Reason not Specified|1
1669673|NCT01474772|5835954|P2|Period 1|Lost to Follow-up|0
1669674|NCT01474772|5835955|P1|Period 1|Lost to Follow-up|1
1669675|NCT01474772|5835954|P2|Period 1|Withdrawal by Subject|1
1669676|NCT01474772|5835955|P1|Period 1|Withdrawal by Subject|3
1669677|NCT01474772|5835954|P2|Period 1|AE not Related to Study Drug|0
1669678|NCT01474772|5835955|P1|Period 1|AE not Related to Study Drug|1
1669679|NCT01474772|5835954|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
1669680|NCT01474772|5835955|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
1669681|NCT01474746|5836005|P2|Overall Study|Withdrawal by Subject|1
1669682|NCT01474746|5836006|P1|Overall Study|Withdrawal by Subject|2
1669683|NCT01474746|5836005|P2|Overall Study|Lost to Follow-up|1
1669684|NCT01474746|5836006|P1|Overall Study|Lost to Follow-up|1
1669685|NCT01474681|5836070|P4|Overall Study|Death|6
1669686|NCT01474681|5836071|P3|Overall Study|Death|2
1669687|NCT01474681|5836072|P2|Overall Study|Death|3
1669688|NCT01474681|5836073|P1|Overall Study|Death|0
1669689|NCT01474551|5836124|P1|Overall Study|Death|1
1669690|NCT01474538|5836130|P2|Treatment Period 2|Protocol Violation|0
1669691|NCT01474538|5836131|P1|Treatment Period 2|Protocol Violation|1
1669692|NCT01474538|5836130|P2|Treatment Period 2|Physician Decision|1
1669693|NCT01474538|5836131|P1|Treatment Period 2|Physician Decision|0
1669694|NCT01474538|5836130|P2|Treatment Period 2|Sponsor decision|0
1669695|NCT01474538|5836131|P1|Treatment Period 2|Sponsor decision|1
1669696|NCT01474538|5836130|P2|Treatment Period 2|Withdrawal by Subject|0
1669697|NCT01474538|5836131|P1|Treatment Period 2|Withdrawal by Subject|2
1669698|NCT01474538|5836130|P2|Treatment Period 2|Adverse Event|1
1669699|NCT01474538|5836131|P1|Treatment Period 2|Adverse Event|1
1669700|NCT01474538|5836130|P2|Treatment Period 2|Death|0
1669701|NCT01474538|5836131|P1|Treatment Period 2|Death|1
1669702|NCT01474538|5836130|P2|Treatment Period 1|Protocol Violation|1
1669703|NCT01474538|5836131|P1|Treatment Period 1|Protocol Violation|0
1669704|NCT01474538|5836130|P2|Treatment Period 1|Withdrawal by Subject|3
1669705|NCT01474538|5836131|P1|Treatment Period 1|Withdrawal by Subject|1
1669706|NCT01474538|5836130|P2|Treatment Period 1|Physician Decision|0
1669707|NCT01474538|5836131|P1|Treatment Period 1|Physician Decision|1
1669708|NCT01474538|5836130|P2|Treatment Period 1|Death|0
1669709|NCT01474538|5836131|P1|Treatment Period 1|Death|1
1669710|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Death|0
1669711|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Death|1
1669712|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Death|0
1669713|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Death|0
1669714|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Death|0
1669715|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Death|0
1669716|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Death|0
1669717|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Death|0
1669718|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Death|0
1669719|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Death|0
1669720|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Death|0
1669721|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Death|0
1669722|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Death|0
1669723|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Death|0
1669724|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Death|0
1669725|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Death|0
1669726|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Death|0
1669727|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Death|0
1669728|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
1669729|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669730|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669731|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
1669732|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669733|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669734|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669735|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669736|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669737|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669738|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669739|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669740|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669741|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669742|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669743|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669744|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669745|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
1669746|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Sponsor Decision|0
1669747|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Sponsor Decision|4
1669748|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Sponsor Decision|0
1669749|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Sponsor Decision|1
1669750|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Sponsor Decision|0
1669751|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Sponsor Decision|0
1669752|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Sponsor Decision|0
1669753|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Sponsor Decision|0
1669754|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Sponsor Decision|0
1669755|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Sponsor Decision|0
1669756|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Sponsor Decision|0
1669757|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Sponsor Decision|0
1669758|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Sponsor Decision|0
1669759|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Sponsor Decision|0
1669760|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Sponsor Decision|0
1669761|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Sponsor Decision|0
1669762|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Sponsor Decision|0
1669763|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Sponsor Decision|0
1669764|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Protocol Violation|0
1669765|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Protocol Violation|4
1669766|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Protocol Violation|2
1669767|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Protocol Violation|2
1669768|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Protocol Violation|0
1669769|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Protocol Violation|0
1669770|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Protocol Violation|0
1669771|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Protocol Violation|0
1669772|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Protocol Violation|0
1669773|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Protocol Violation|0
1669774|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Protocol Violation|0
1669775|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Protocol Violation|0
1669776|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Protocol Violation|0
1669777|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Protocol Violation|0
1669778|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Protocol Violation|0
1669779|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Protocol Violation|0
1669780|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Protocol Violation|0
1669781|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Protocol Violation|0
1669782|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Clinical Relapse|2
1669783|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Clinical Relapse|6
1669784|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Clinical Relapse|0
1669785|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Clinical Relapse|0
1669786|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Clinical Relapse|0
1669787|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Clinical Relapse|0
1669788|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Clinical Relapse|0
1669789|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Clinical Relapse|0
1669790|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Clinical Relapse|0
1669791|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Clinical Relapse|0
1669792|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Clinical Relapse|0
1669793|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Clinical Relapse|0
1669794|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Clinical Relapse|0
1669795|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Clinical Relapse|0
1669796|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Clinical Relapse|0
1669797|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Clinical Relapse|0
1669798|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Clinical Relapse|0
1669799|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Clinical Relapse|0
1669800|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Physician Decision|5
1669801|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Physician Decision|4
1669802|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Physician Decision|0
1669803|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Physician Decision|0
1669804|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Physician Decision|0
1669805|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Physician Decision|0
1669806|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Physician Decision|0
1669807|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Physician Decision|0
1669808|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Physician Decision|0
1669809|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Physician Decision|0
1669810|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Physician Decision|0
1669811|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Physician Decision|0
1669812|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Physician Decision|0
1669813|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Physician Decision|0
1669814|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Physician Decision|0
1669815|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Physician Decision|0
1669816|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Physician Decision|0
1669817|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Physician Decision|0
1669818|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
1669819|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
1669820|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
1669821|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
1669822|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
1669823|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
1669824|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
1669825|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
1669826|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
1669827|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
1669828|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
1669829|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
1669830|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
1669831|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
1669832|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
1669833|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
1669834|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
1669835|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
1669836|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
1669837|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
1669838|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
1669839|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
1669840|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
1669841|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
1669842|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
1669843|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
1669844|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
1669845|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
1669846|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
1669847|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
1669848|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
1669849|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
1669850|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
1669851|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
1669852|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
1669853|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
1669854|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
1669855|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
1669856|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
1669857|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
1669858|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669859|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669860|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669861|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669862|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669863|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669864|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669865|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669866|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669867|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669868|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669869|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669870|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669871|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
1669872|NCT01474512|5836148|P18|Post-Treatment Follow-Up|Adverse Event|11
1669873|NCT01474512|5836149|P17|Post-Treatment Follow-Up|Adverse Event|58
1669874|NCT01474512|5836150|P16|Post-Treatment Follow-Up|Adverse Event|2
1669875|NCT01474512|5836151|P15|Post-Treatment Follow-Up|Adverse Event|8
1669876|NCT01474512|5836152|P14|Post-Treatment Follow-Up|Adverse Event|0
1669877|NCT01474512|5836153|P13|Post-Treatment Follow-Up|Adverse Event|0
1669878|NCT01474512|5836154|P12|Post-Treatment Follow-Up|Adverse Event|0
1669879|NCT01474512|5836155|P11|Post-Treatment Follow-Up|Adverse Event|0
1669880|NCT01474512|5836156|P10|Post-Treatment Follow-Up|Adverse Event|0
1669881|NCT01474512|5836157|P9|Post-Treatment Follow-Up|Adverse Event|0
1669882|NCT01474512|5836158|P8|Post-Treatment Follow-Up|Adverse Event|0
1669883|NCT01474512|5836159|P7|Post-Treatment Follow-Up|Adverse Event|0
1669884|NCT01474512|5836160|P6|Post-Treatment Follow-Up|Adverse Event|0
1669885|NCT01474512|5836161|P5|Post-Treatment Follow-Up|Adverse Event|0
1669886|NCT01474512|5836162|P4|Post-Treatment Follow-Up|Adverse Event|0
1669887|NCT01474512|5836163|P3|Post-Treatment Follow-Up|Adverse Event|0
1669888|NCT01474512|5836164|P2|Post-Treatment Follow-Up|Adverse Event|0
1669889|NCT01474512|5836165|P1|Post-Treatment Follow-Up|Adverse Event|0
1669890|NCT01474512|5836148|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
1669891|NCT01474512|5836149|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
1669892|NCT01474512|5836150|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
1669893|NCT01474512|5836151|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
1669894|NCT01474512|5836152|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
1669895|NCT01474512|5836153|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
1669896|NCT01474512|5836154|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
1669897|NCT01474512|5836155|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
1669898|NCT01474512|5836156|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
1669899|NCT01474512|5836157|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
1669900|NCT01474512|5836158|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
1669901|NCT01474512|5836159|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
1669902|NCT01474512|5836160|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
1669903|NCT01474512|5836161|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
1669904|NCT01474512|5836162|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
1669905|NCT01474512|5836163|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
1669906|NCT01474512|5836164|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
1669907|NCT01474512|5836165|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
1669908|NCT01474512|5836148|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
1669909|NCT01474512|5836149|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
1669910|NCT01474512|5836150|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
1669911|NCT01474512|5836151|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
1669912|NCT01474512|5836152|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
1669913|NCT01474512|5836153|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
1669914|NCT01474512|5836154|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
1669915|NCT01474512|5836155|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
1669916|NCT01474512|5836156|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
1669917|NCT01474512|5836157|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
1669918|NCT01474512|5836158|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
1669919|NCT01474512|5836159|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
1669920|NCT01474512|5836160|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
1669921|NCT01474512|5836161|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
1669922|NCT01474512|5836162|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
1669923|NCT01474512|5836163|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
1669924|NCT01474512|5836164|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
1669925|NCT01474512|5836165|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
1669926|NCT01474512|5836148|P18|Long-Term Extension Period|Protocol Violation|0
1669927|NCT01474512|5836149|P17|Long-Term Extension Period|Protocol Violation|0
1669928|NCT01474512|5836150|P16|Long-Term Extension Period|Protocol Violation|0
1669929|NCT01474512|5836151|P15|Long-Term Extension Period|Protocol Violation|0
1669930|NCT01474512|5836152|P14|Long-Term Extension Period|Protocol Violation|5
1669931|NCT01474512|5836153|P13|Long-Term Extension Period|Protocol Violation|5
1669932|NCT01474512|5836154|P12|Long-Term Extension Period|Protocol Violation|0
1669933|NCT01474512|5836155|P11|Long-Term Extension Period|Protocol Violation|0
1669934|NCT01474512|5836156|P10|Long-Term Extension Period|Protocol Violation|0
1669935|NCT01474512|5836157|P9|Long-Term Extension Period|Protocol Violation|0
1669936|NCT01474512|5836158|P8|Long-Term Extension Period|Protocol Violation|0
1669937|NCT01474512|5836159|P7|Long-Term Extension Period|Protocol Violation|0
1669938|NCT01474512|5836160|P6|Long-Term Extension Period|Protocol Violation|0
1669939|NCT01474512|5836161|P5|Long-Term Extension Period|Protocol Violation|0
1669940|NCT01474512|5836162|P4|Long-Term Extension Period|Protocol Violation|0
1669941|NCT01474512|5836163|P3|Long-Term Extension Period|Protocol Violation|0
1669942|NCT01474512|5836164|P2|Long-Term Extension Period|Protocol Violation|0
1669943|NCT01474512|5836165|P1|Long-Term Extension Period|Protocol Violation|0
1669944|NCT01474512|5836148|P18|Long-Term Extension Period|Sponsor Decision|0
1669945|NCT01474512|5836149|P17|Long-Term Extension Period|Sponsor Decision|0
1669946|NCT01474512|5836150|P16|Long-Term Extension Period|Sponsor Decision|0
1669947|NCT01474512|5836151|P15|Long-Term Extension Period|Sponsor Decision|0
1669948|NCT01474512|5836152|P14|Long-Term Extension Period|Sponsor Decision|6
1669949|NCT01474512|5836153|P13|Long-Term Extension Period|Sponsor Decision|6
1669950|NCT01474512|5836154|P12|Long-Term Extension Period|Sponsor Decision|0
1669951|NCT01474512|5836155|P11|Long-Term Extension Period|Sponsor Decision|0
1669952|NCT01474512|5836156|P10|Long-Term Extension Period|Sponsor Decision|0
1669953|NCT01474512|5836157|P9|Long-Term Extension Period|Sponsor Decision|0
1669954|NCT01474512|5836158|P8|Long-Term Extension Period|Sponsor Decision|0
1669955|NCT01474512|5836159|P7|Long-Term Extension Period|Sponsor Decision|0
1669956|NCT01474512|5836160|P6|Long-Term Extension Period|Sponsor Decision|0
1669957|NCT01474512|5836161|P5|Long-Term Extension Period|Sponsor Decision|0
1669958|NCT01474512|5836162|P4|Long-Term Extension Period|Sponsor Decision|0
1669959|NCT01474512|5836163|P3|Long-Term Extension Period|Sponsor Decision|0
1669960|NCT01474512|5836164|P2|Long-Term Extension Period|Sponsor Decision|0
1669961|NCT01474512|5836165|P1|Long-Term Extension Period|Sponsor Decision|0
1669962|NCT01474512|5836148|P18|Long-Term Extension Period|Death|0
1669963|NCT01474512|5836149|P17|Long-Term Extension Period|Death|0
1669964|NCT01474512|5836150|P16|Long-Term Extension Period|Death|0
1669965|NCT01474512|5836151|P15|Long-Term Extension Period|Death|0
1669966|NCT01474512|5836152|P14|Long-Term Extension Period|Death|9
1669967|NCT01474512|5836153|P13|Long-Term Extension Period|Death|9
1669968|NCT01474512|5836154|P12|Long-Term Extension Period|Death|0
1669969|NCT01474512|5836155|P11|Long-Term Extension Period|Death|0
1669970|NCT01474512|5836156|P10|Long-Term Extension Period|Death|0
1669971|NCT01474512|5836157|P9|Long-Term Extension Period|Death|0
1669972|NCT01474512|5836158|P8|Long-Term Extension Period|Death|0
1669973|NCT01474512|5836159|P7|Long-Term Extension Period|Death|0
1669974|NCT01474512|5836160|P6|Long-Term Extension Period|Death|0
1669975|NCT01474512|5836161|P5|Long-Term Extension Period|Death|0
1669976|NCT01474512|5836162|P4|Long-Term Extension Period|Death|0
1669977|NCT01474512|5836163|P3|Long-Term Extension Period|Death|0
1669978|NCT01474512|5836164|P2|Long-Term Extension Period|Death|0
1669979|NCT01474512|5836165|P1|Long-Term Extension Period|Death|0
1669980|NCT01474512|5836148|P18|Long-Term Extension Period|Clinical Relapse|0
1669981|NCT01474512|5836149|P17|Long-Term Extension Period|Clinical Relapse|0
1669982|NCT01474512|5836150|P16|Long-Term Extension Period|Clinical Relapse|0
1669983|NCT01474512|5836151|P15|Long-Term Extension Period|Clinical Relapse|0
1669984|NCT01474512|5836152|P14|Long-Term Extension Period|Clinical Relapse|9
1669985|NCT01474512|5836153|P13|Long-Term Extension Period|Clinical Relapse|9
1669986|NCT01474512|5836154|P12|Long-Term Extension Period|Clinical Relapse|0
1669987|NCT01474512|5836155|P11|Long-Term Extension Period|Clinical Relapse|0
1669988|NCT01474512|5836156|P10|Long-Term Extension Period|Clinical Relapse|0
1669989|NCT01474512|5836157|P9|Long-Term Extension Period|Clinical Relapse|0
1669990|NCT01474512|5836158|P8|Long-Term Extension Period|Clinical Relapse|0
1669991|NCT01474512|5836159|P7|Long-Term Extension Period|Clinical Relapse|0
1669992|NCT01474512|5836160|P6|Long-Term Extension Period|Clinical Relapse|0
1669993|NCT01474512|5836161|P5|Long-Term Extension Period|Clinical Relapse|0
1669994|NCT01474512|5836162|P4|Long-Term Extension Period|Clinical Relapse|0
1669995|NCT01474512|5836163|P3|Long-Term Extension Period|Clinical Relapse|0
1669996|NCT01474512|5836164|P2|Long-Term Extension Period|Clinical Relapse|0
1669997|NCT01474512|5836165|P1|Long-Term Extension Period|Clinical Relapse|0
1669998|NCT01474512|5836148|P18|Long-Term Extension Period|Physician Decision|0
1669999|NCT01474512|5836149|P17|Long-Term Extension Period|Physician Decision|0
1670000|NCT01474512|5836150|P16|Long-Term Extension Period|Physician Decision|0
1670001|NCT01474512|5836151|P15|Long-Term Extension Period|Physician Decision|0
1670002|NCT01474512|5836152|P14|Long-Term Extension Period|Physician Decision|21
1670003|NCT01474512|5836153|P13|Long-Term Extension Period|Physician Decision|21
1670004|NCT01474512|5836154|P12|Long-Term Extension Period|Physician Decision|0
1670005|NCT01474512|5836155|P11|Long-Term Extension Period|Physician Decision|0
1670006|NCT01474512|5836156|P10|Long-Term Extension Period|Physician Decision|0
1670007|NCT01474512|5836157|P9|Long-Term Extension Period|Physician Decision|0
1670008|NCT01474512|5836158|P8|Long-Term Extension Period|Physician Decision|0
1670009|NCT01474512|5836159|P7|Long-Term Extension Period|Physician Decision|0
1670010|NCT01474512|5836160|P6|Long-Term Extension Period|Physician Decision|0
1670011|NCT01474512|5836161|P5|Long-Term Extension Period|Physician Decision|0
1670012|NCT01474512|5836162|P4|Long-Term Extension Period|Physician Decision|0
1670013|NCT01474512|5836163|P3|Long-Term Extension Period|Physician Decision|0
1670014|NCT01474512|5836164|P2|Long-Term Extension Period|Physician Decision|0
1670015|NCT01474512|5836165|P1|Long-Term Extension Period|Physician Decision|0
1670016|NCT01474512|5836148|P18|Long-Term Extension Period|Lack of Efficacy|0
1670017|NCT01474512|5836149|P17|Long-Term Extension Period|Lack of Efficacy|0
1670018|NCT01474512|5836150|P16|Long-Term Extension Period|Lack of Efficacy|0
1670019|NCT01474512|5836151|P15|Long-Term Extension Period|Lack of Efficacy|0
1670020|NCT01474512|5836152|P14|Long-Term Extension Period|Lack of Efficacy|25
1670021|NCT01474512|5836153|P13|Long-Term Extension Period|Lack of Efficacy|24
1670022|NCT01474512|5836154|P12|Long-Term Extension Period|Lack of Efficacy|1
1670023|NCT01474512|5836155|P11|Long-Term Extension Period|Lack of Efficacy|0
1670024|NCT01474512|5836156|P10|Long-Term Extension Period|Lack of Efficacy|0
1670025|NCT01474512|5836157|P9|Long-Term Extension Period|Lack of Efficacy|0
1670026|NCT01474512|5836158|P8|Long-Term Extension Period|Lack of Efficacy|0
1670027|NCT01474512|5836159|P7|Long-Term Extension Period|Lack of Efficacy|0
1670028|NCT01474512|5836160|P6|Long-Term Extension Period|Lack of Efficacy|0
1670029|NCT01474512|5836161|P5|Long-Term Extension Period|Lack of Efficacy|0
1670030|NCT01474512|5836162|P4|Long-Term Extension Period|Lack of Efficacy|0
1670031|NCT01474512|5836163|P3|Long-Term Extension Period|Lack of Efficacy|0
1670032|NCT01474512|5836164|P2|Long-Term Extension Period|Lack of Efficacy|0
1670033|NCT01474512|5836165|P1|Long-Term Extension Period|Lack of Efficacy|0
1670034|NCT01474512|5836148|P18|Long-Term Extension Period|Lost to Follow-up|0
1670035|NCT01474512|5836149|P17|Long-Term Extension Period|Lost to Follow-up|0
1670036|NCT01474512|5836150|P16|Long-Term Extension Period|Lost to Follow-up|0
1670037|NCT01474512|5836151|P15|Long-Term Extension Period|Lost to Follow-up|0
1670038|NCT01474512|5836152|P14|Long-Term Extension Period|Lost to Follow-up|25
1670039|NCT01474512|5836153|P13|Long-Term Extension Period|Lost to Follow-up|25
1670040|NCT01474512|5836154|P12|Long-Term Extension Period|Lost to Follow-up|0
1670041|NCT01474512|5836155|P11|Long-Term Extension Period|Lost to Follow-up|0
1670042|NCT01474512|5836156|P10|Long-Term Extension Period|Lost to Follow-up|0
1670043|NCT01474512|5836157|P9|Long-Term Extension Period|Lost to Follow-up|0
1670044|NCT01474512|5836158|P8|Long-Term Extension Period|Lost to Follow-up|0
1670045|NCT01474512|5836159|P7|Long-Term Extension Period|Lost to Follow-up|0
1670046|NCT01474512|5836160|P6|Long-Term Extension Period|Lost to Follow-up|0
1670047|NCT01474512|5836161|P5|Long-Term Extension Period|Lost to Follow-up|0
1670048|NCT01474512|5836162|P4|Long-Term Extension Period|Lost to Follow-up|0
1670049|NCT01474512|5836163|P3|Long-Term Extension Period|Lost to Follow-up|0
1670050|NCT01474512|5836164|P2|Long-Term Extension Period|Lost to Follow-up|0
1670051|NCT01474512|5836165|P1|Long-Term Extension Period|Lost to Follow-up|0
1670052|NCT01474512|5836148|P18|Long-Term Extension Period|Adverse Event|0
1670053|NCT01474512|5836149|P17|Long-Term Extension Period|Adverse Event|0
1670054|NCT01474512|5836150|P16|Long-Term Extension Period|Adverse Event|0
1670055|NCT01474512|5836151|P15|Long-Term Extension Period|Adverse Event|0
1670056|NCT01474512|5836152|P14|Long-Term Extension Period|Adverse Event|58
1670057|NCT01474512|5836153|P13|Long-Term Extension Period|Adverse Event|57
1670058|NCT01474512|5836154|P12|Long-Term Extension Period|Adverse Event|1
1670059|NCT01474512|5836155|P11|Long-Term Extension Period|Adverse Event|0
1670060|NCT01474512|5836156|P10|Long-Term Extension Period|Adverse Event|0
1670061|NCT01474512|5836157|P9|Long-Term Extension Period|Adverse Event|0
1670062|NCT01474512|5836158|P8|Long-Term Extension Period|Adverse Event|0
1670063|NCT01474512|5836159|P7|Long-Term Extension Period|Adverse Event|0
1670064|NCT01474512|5836160|P6|Long-Term Extension Period|Adverse Event|0
1670065|NCT01474512|5836161|P5|Long-Term Extension Period|Adverse Event|0
1670066|NCT01474512|5836162|P4|Long-Term Extension Period|Adverse Event|0
1670067|NCT01474512|5836163|P3|Long-Term Extension Period|Adverse Event|0
1670068|NCT01474512|5836164|P2|Long-Term Extension Period|Adverse Event|0
1670069|NCT01474512|5836165|P1|Long-Term Extension Period|Adverse Event|0
1670070|NCT01474512|5836148|P18|Long-Term Extension Period|Withdrawal by Subject|0
1670071|NCT01474512|5836149|P17|Long-Term Extension Period|Withdrawal by Subject|0
1670072|NCT01474512|5836150|P16|Long-Term Extension Period|Withdrawal by Subject|0
1670073|NCT01474512|5836151|P15|Long-Term Extension Period|Withdrawal by Subject|0
1670074|NCT01474512|5836152|P14|Long-Term Extension Period|Withdrawal by Subject|61
1670075|NCT01474512|5836153|P13|Long-Term Extension Period|Withdrawal by Subject|61
1670076|NCT01474512|5836154|P12|Long-Term Extension Period|Withdrawal by Subject|3
1670077|NCT01474512|5836155|P11|Long-Term Extension Period|Withdrawal by Subject|0
1670078|NCT01474512|5836156|P10|Long-Term Extension Period|Withdrawal by Subject|0
1670079|NCT01474512|5836157|P9|Long-Term Extension Period|Withdrawal by Subject|0
1670080|NCT01474512|5836158|P8|Long-Term Extension Period|Withdrawal by Subject|0
1670081|NCT01474512|5836159|P7|Long-Term Extension Period|Withdrawal by Subject|0
1670082|NCT01474512|5836160|P6|Long-Term Extension Period|Withdrawal by Subject|0
1670083|NCT01474512|5836161|P5|Long-Term Extension Period|Withdrawal by Subject|0
1670084|NCT01474512|5836162|P4|Long-Term Extension Period|Withdrawal by Subject|0
1670085|NCT01474512|5836163|P3|Long-Term Extension Period|Withdrawal by Subject|0
1670086|NCT01474512|5836164|P2|Long-Term Extension Period|Withdrawal by Subject|0
1670087|NCT01474512|5836165|P1|Long-Term Extension Period|Withdrawal by Subject|0
1670088|NCT01474512|5836148|P18|Maintenance Period|Treated but Discontinued in Induction|0
1670089|NCT01474512|5836149|P17|Maintenance Period|Treated but Discontinued in Induction|0
1670090|NCT01474512|5836150|P16|Maintenance Period|Treated but Discontinued in Induction|0
1670091|NCT01474512|5836151|P15|Maintenance Period|Treated but Discontinued in Induction|0
1670092|NCT01474512|5836152|P14|Maintenance Period|Treated but Discontinued in Induction|0
1670093|NCT01474512|5836153|P13|Maintenance Period|Treated but Discontinued in Induction|0
1670094|NCT01474512|5836154|P12|Maintenance Period|Treated but Discontinued in Induction|0
1670095|NCT01474512|5836155|P11|Maintenance Period|Treated but Discontinued in Induction|0
1670096|NCT01474512|5836156|P10|Maintenance Period|Treated but Discontinued in Induction|0
1670097|NCT01474512|5836157|P9|Maintenance Period|Treated but Discontinued in Induction|0
1670098|NCT01474512|5836158|P8|Maintenance Period|Treated but Discontinued in Induction|0
1670099|NCT01474512|5836159|P7|Maintenance Period|Treated but Discontinued in Induction|0
1670100|NCT01474512|5836160|P6|Maintenance Period|Treated but Discontinued in Induction|0
1670101|NCT01474512|5836161|P5|Maintenance Period|Treated but Discontinued in Induction|1
1670102|NCT01474512|5836162|P4|Maintenance Period|Treated but Discontinued in Induction|0
1670103|NCT01474512|5836163|P3|Maintenance Period|Treated but Discontinued in Induction|0
1670104|NCT01474512|5836164|P2|Maintenance Period|Treated but Discontinued in Induction|0
1670105|NCT01474512|5836165|P1|Maintenance Period|Treated but Discontinued in Induction|0
1670106|NCT01474512|5836148|P18|Maintenance Period|Protocol Violation|0
1670107|NCT01474512|5836149|P17|Maintenance Period|Protocol Violation|0
1670108|NCT01474512|5836150|P16|Maintenance Period|Protocol Violation|0
1670109|NCT01474512|5836151|P15|Maintenance Period|Protocol Violation|0
1670110|NCT01474512|5836152|P14|Maintenance Period|Protocol Violation|0
1670111|NCT01474512|5836153|P13|Maintenance Period|Protocol Violation|0
1670112|NCT01474512|5836154|P12|Maintenance Period|Protocol Violation|0
1670113|NCT01474512|5836155|P11|Maintenance Period|Protocol Violation|0
1670114|NCT01474512|5836156|P10|Maintenance Period|Protocol Violation|1
1670115|NCT01474512|5836157|P9|Maintenance Period|Protocol Violation|0
1670116|NCT01474512|5836158|P8|Maintenance Period|Protocol Violation|1
1670117|NCT01474512|5836159|P7|Maintenance Period|Protocol Violation|0
1670118|NCT01474512|5836160|P6|Maintenance Period|Protocol Violation|0
1670119|NCT01474512|5836161|P5|Maintenance Period|Protocol Violation|0
1670120|NCT01474512|5836162|P4|Maintenance Period|Protocol Violation|1
1670121|NCT01474512|5836163|P3|Maintenance Period|Protocol Violation|0
1670122|NCT01474512|5836164|P2|Maintenance Period|Protocol Violation|0
1670123|NCT01474512|5836165|P1|Maintenance Period|Protocol Violation|0
1670124|NCT01474512|5836148|P18|Maintenance Period|Lack of Efficacy|0
1670125|NCT01474512|5836149|P17|Maintenance Period|Lack of Efficacy|0
1670126|NCT01474512|5836150|P16|Maintenance Period|Lack of Efficacy|0
1670127|NCT01474512|5836151|P15|Maintenance Period|Lack of Efficacy|0
1670128|NCT01474512|5836152|P14|Maintenance Period|Lack of Efficacy|0
1670129|NCT01474512|5836153|P13|Maintenance Period|Lack of Efficacy|0
1670130|NCT01474512|5836154|P12|Maintenance Period|Lack of Efficacy|0
1670131|NCT01474512|5836155|P11|Maintenance Period|Lack of Efficacy|0
1670132|NCT01474512|5836156|P10|Maintenance Period|Lack of Efficacy|12
1670133|NCT01474512|5836157|P9|Maintenance Period|Lack of Efficacy|11
1670134|NCT01474512|5836158|P8|Maintenance Period|Lack of Efficacy|11
1670135|NCT01474512|5836159|P7|Maintenance Period|Lack of Efficacy|0
1670136|NCT01474512|5836160|P6|Maintenance Period|Lack of Efficacy|0
1670137|NCT01474512|5836161|P5|Maintenance Period|Lack of Efficacy|0
1670138|NCT01474512|5836162|P4|Maintenance Period|Lack of Efficacy|1
1670139|NCT01474512|5836163|P3|Maintenance Period|Lack of Efficacy|0
1670140|NCT01474512|5836164|P2|Maintenance Period|Lack of Efficacy|0
1670141|NCT01474512|5836165|P1|Maintenance Period|Lack of Efficacy|0
1670142|NCT01474512|5836148|P18|Maintenance Period|Clinical Relapse|0
1670143|NCT01474512|5836149|P17|Maintenance Period|Clinical Relapse|0
1670144|NCT01474512|5836150|P16|Maintenance Period|Clinical Relapse|0
1670145|NCT01474512|5836151|P15|Maintenance Period|Clinical Relapse|0
1670146|NCT01474512|5836152|P14|Maintenance Period|Clinical Relapse|0
1670147|NCT01474512|5836153|P13|Maintenance Period|Clinical Relapse|0
1670148|NCT01474512|5836154|P12|Maintenance Period|Clinical Relapse|0
1670149|NCT01474512|5836155|P11|Maintenance Period|Clinical Relapse|0
1670150|NCT01474512|5836156|P10|Maintenance Period|Clinical Relapse|0
1670151|NCT01474512|5836157|P9|Maintenance Period|Clinical Relapse|0
1670152|NCT01474512|5836158|P8|Maintenance Period|Clinical Relapse|0
1670153|NCT01474512|5836159|P7|Maintenance Period|Clinical Relapse|0
1670154|NCT01474512|5836160|P6|Maintenance Period|Clinical Relapse|0
1670155|NCT01474512|5836161|P5|Maintenance Period|Clinical Relapse|0
1670156|NCT01474512|5836162|P4|Maintenance Period|Clinical Relapse|1
1670157|NCT01474512|5836163|P3|Maintenance Period|Clinical Relapse|0
1670158|NCT01474512|5836164|P2|Maintenance Period|Clinical Relapse|0
1670159|NCT01474512|5836165|P1|Maintenance Period|Clinical Relapse|0
1670160|NCT01474512|5836148|P18|Maintenance Period|Physician Decision|0
1670161|NCT01474512|5836149|P17|Maintenance Period|Physician Decision|0
1670162|NCT01474512|5836150|P16|Maintenance Period|Physician Decision|0
1670163|NCT01474512|5836151|P15|Maintenance Period|Physician Decision|0
1670164|NCT01474512|5836152|P14|Maintenance Period|Physician Decision|0
1670165|NCT01474512|5836153|P13|Maintenance Period|Physician Decision|0
1670166|NCT01474512|5836154|P12|Maintenance Period|Physician Decision|0
1670167|NCT01474512|5836155|P11|Maintenance Period|Physician Decision|0
1670168|NCT01474512|5836156|P10|Maintenance Period|Physician Decision|0
1670169|NCT01474512|5836157|P9|Maintenance Period|Physician Decision|0
1670170|NCT01474512|5836158|P8|Maintenance Period|Physician Decision|2
1670171|NCT01474512|5836159|P7|Maintenance Period|Physician Decision|0
1670172|NCT01474512|5836160|P6|Maintenance Period|Physician Decision|1
1670173|NCT01474512|5836161|P5|Maintenance Period|Physician Decision|0
1670174|NCT01474512|5836162|P4|Maintenance Period|Physician Decision|0
1670175|NCT01474512|5836163|P3|Maintenance Period|Physician Decision|0
1670176|NCT01474512|5836164|P2|Maintenance Period|Physician Decision|0
1670177|NCT01474512|5836165|P1|Maintenance Period|Physician Decision|0
1670178|NCT01474512|5836148|P18|Maintenance Period|Death|0
1670179|NCT01474512|5836149|P17|Maintenance Period|Death|0
1670180|NCT01474512|5836150|P16|Maintenance Period|Death|0
1670181|NCT01474512|5836151|P15|Maintenance Period|Death|0
1670182|NCT01474512|5836152|P14|Maintenance Period|Death|0
1670183|NCT01474512|5836153|P13|Maintenance Period|Death|0
1670184|NCT01474512|5836154|P12|Maintenance Period|Death|0
1670185|NCT01474512|5836155|P11|Maintenance Period|Death|0
1670186|NCT01474512|5836156|P10|Maintenance Period|Death|0
1670187|NCT01474512|5836157|P9|Maintenance Period|Death|0
1670188|NCT01474512|5836158|P8|Maintenance Period|Death|0
1670189|NCT01474512|5836159|P7|Maintenance Period|Death|0
1670190|NCT01474512|5836160|P6|Maintenance Period|Death|2
1670191|NCT01474512|5836161|P5|Maintenance Period|Death|0
1670192|NCT01474512|5836162|P4|Maintenance Period|Death|0
1670193|NCT01474512|5836163|P3|Maintenance Period|Death|0
1670194|NCT01474512|5836164|P2|Maintenance Period|Death|0
1670195|NCT01474512|5836165|P1|Maintenance Period|Death|0
1670196|NCT01474512|5836148|P18|Maintenance Period|Lost to Follow-up|0
1670197|NCT01474512|5836149|P17|Maintenance Period|Lost to Follow-up|0
1670198|NCT01474512|5836150|P16|Maintenance Period|Lost to Follow-up|0
1670199|NCT01474512|5836151|P15|Maintenance Period|Lost to Follow-up|0
1670200|NCT01474512|5836152|P14|Maintenance Period|Lost to Follow-up|0
1670201|NCT01474512|5836153|P13|Maintenance Period|Lost to Follow-up|0
1670202|NCT01474512|5836154|P12|Maintenance Period|Lost to Follow-up|0
1670203|NCT01474512|5836155|P11|Maintenance Period|Lost to Follow-up|0
1670204|NCT01474512|5836156|P10|Maintenance Period|Lost to Follow-up|1
1670205|NCT01474512|5836157|P9|Maintenance Period|Lost to Follow-up|1
1670206|NCT01474512|5836158|P8|Maintenance Period|Lost to Follow-up|2
1670207|NCT01474512|5836159|P7|Maintenance Period|Lost to Follow-up|0
1670208|NCT01474512|5836160|P6|Maintenance Period|Lost to Follow-up|0
1670209|NCT01474512|5836161|P5|Maintenance Period|Lost to Follow-up|3
1670210|NCT01474512|5836162|P4|Maintenance Period|Lost to Follow-up|3
1670211|NCT01474512|5836163|P3|Maintenance Period|Lost to Follow-up|0
1670212|NCT01474512|5836164|P2|Maintenance Period|Lost to Follow-up|0
1670213|NCT01474512|5836165|P1|Maintenance Period|Lost to Follow-up|0
1670214|NCT01474512|5836148|P18|Maintenance Period|Withdrawal by Subject|0
1670215|NCT01474512|5836149|P17|Maintenance Period|Withdrawal by Subject|0
1670216|NCT01474512|5836150|P16|Maintenance Period|Withdrawal by Subject|0
1670217|NCT01474512|5836151|P15|Maintenance Period|Withdrawal by Subject|0
1670218|NCT01474512|5836152|P14|Maintenance Period|Withdrawal by Subject|0
1670219|NCT01474512|5836153|P13|Maintenance Period|Withdrawal by Subject|0
1670220|NCT01474512|5836154|P12|Maintenance Period|Withdrawal by Subject|0
1670221|NCT01474512|5836155|P11|Maintenance Period|Withdrawal by Subject|0
1670222|NCT01474512|5836156|P10|Maintenance Period|Withdrawal by Subject|1
1670223|NCT01474512|5836157|P9|Maintenance Period|Withdrawal by Subject|3
1670224|NCT01474512|5836158|P8|Maintenance Period|Withdrawal by Subject|6
1670225|NCT01474512|5836159|P7|Maintenance Period|Withdrawal by Subject|1
1670226|NCT01474512|5836160|P6|Maintenance Period|Withdrawal by Subject|3
1670227|NCT01474512|5836161|P5|Maintenance Period|Withdrawal by Subject|2
1670228|NCT01474512|5836162|P4|Maintenance Period|Withdrawal by Subject|6
1670229|NCT01474512|5836163|P3|Maintenance Period|Withdrawal by Subject|0
1670230|NCT01474512|5836164|P2|Maintenance Period|Withdrawal by Subject|0
1670231|NCT01474512|5836165|P1|Maintenance Period|Withdrawal by Subject|0
1670232|NCT01474512|5836148|P18|Maintenance Period|Adverse Event|0
1670233|NCT01474512|5836149|P17|Maintenance Period|Adverse Event|0
1670234|NCT01474512|5836150|P16|Maintenance Period|Adverse Event|0
1670235|NCT01474512|5836151|P15|Maintenance Period|Adverse Event|0
1670236|NCT01474512|5836152|P14|Maintenance Period|Adverse Event|0
1670237|NCT01474512|5836153|P13|Maintenance Period|Adverse Event|0
1670238|NCT01474512|5836154|P12|Maintenance Period|Adverse Event|0
1670239|NCT01474512|5836155|P11|Maintenance Period|Adverse Event|0
1670240|NCT01474512|5836156|P10|Maintenance Period|Adverse Event|3
1670241|NCT01474512|5836157|P9|Maintenance Period|Adverse Event|1
1670242|NCT01474512|5836158|P8|Maintenance Period|Adverse Event|19
1670243|NCT01474512|5836159|P7|Maintenance Period|Adverse Event|0
1670244|NCT01474512|5836160|P6|Maintenance Period|Adverse Event|7
1670245|NCT01474512|5836161|P5|Maintenance Period|Adverse Event|2
1670246|NCT01474512|5836162|P4|Maintenance Period|Adverse Event|4
1670247|NCT01474512|5836163|P3|Maintenance Period|Adverse Event|0
1670248|NCT01474512|5836164|P2|Maintenance Period|Adverse Event|0
1670249|NCT01474512|5836165|P1|Maintenance Period|Adverse Event|0
1670250|NCT01474512|5836148|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
1670251|NCT01474512|5836149|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
1670252|NCT01474512|5836150|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
1670253|NCT01474512|5836151|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
1670254|NCT01474512|5836152|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
1670255|NCT01474512|5836153|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
1670256|NCT01474512|5836154|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
1670257|NCT01474512|5836155|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
1670258|NCT01474512|5836156|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
1670259|NCT01474512|5836157|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
1670260|NCT01474512|5836158|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
1670261|NCT01474512|5836159|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
1670262|NCT01474512|5836160|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
1670263|NCT01474512|5836161|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
1670264|NCT01474512|5836162|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
1670265|NCT01474512|5836163|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
1670266|NCT01474512|5836164|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
1670267|NCT01474512|5836165|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
1670268|NCT01474512|5836148|P18|Induction Period|Lost to Follow-up|0
1670269|NCT01474512|5836149|P17|Induction Period|Lost to Follow-up|0
1670270|NCT01474512|5836150|P16|Induction Period|Lost to Follow-up|0
1670271|NCT01474512|5836151|P15|Induction Period|Lost to Follow-up|0
1670272|NCT01474512|5836152|P14|Induction Period|Lost to Follow-up|0
1670273|NCT01474512|5836153|P13|Induction Period|Lost to Follow-up|0
1670274|NCT01474512|5836154|P12|Induction Period|Lost to Follow-up|0
1670275|NCT01474512|5836155|P11|Induction Period|Lost to Follow-up|0
1670276|NCT01474512|5836156|P10|Induction Period|Lost to Follow-up|0
1670277|NCT01474512|5836157|P9|Induction Period|Lost to Follow-up|0
1670278|NCT01474512|5836158|P8|Induction Period|Lost to Follow-up|0
1670279|NCT01474512|5836159|P7|Induction Period|Lost to Follow-up|0
1670280|NCT01474512|5836160|P6|Induction Period|Lost to Follow-up|0
1670281|NCT01474512|5836161|P5|Induction Period|Lost to Follow-up|0
1670282|NCT01474512|5836162|P4|Induction Period|Lost to Follow-up|0
1670283|NCT01474512|5836163|P3|Induction Period|Lost to Follow-up|2
1670284|NCT01474512|5836164|P2|Induction Period|Lost to Follow-up|0
1670285|NCT01474512|5836165|P1|Induction Period|Lost to Follow-up|1
1670286|NCT01474512|5836148|P18|Induction Period|Sponsor Decision|0
1670287|NCT01474512|5836149|P17|Induction Period|Sponsor Decision|0
1670288|NCT01474512|5836150|P16|Induction Period|Sponsor Decision|0
1670289|NCT01474512|5836151|P15|Induction Period|Sponsor Decision|0
1670290|NCT01474512|5836152|P14|Induction Period|Sponsor Decision|0
1670291|NCT01474512|5836153|P13|Induction Period|Sponsor Decision|0
1670292|NCT01474512|5836154|P12|Induction Period|Sponsor Decision|0
1670293|NCT01474512|5836155|P11|Induction Period|Sponsor Decision|0
1670294|NCT01474512|5836156|P10|Induction Period|Sponsor Decision|0
1670295|NCT01474512|5836157|P9|Induction Period|Sponsor Decision|0
1670296|NCT01474512|5836158|P8|Induction Period|Sponsor Decision|0
1670297|NCT01474512|5836159|P7|Induction Period|Sponsor Decision|0
1670298|NCT01474512|5836160|P6|Induction Period|Sponsor Decision|0
1670299|NCT01474512|5836161|P5|Induction Period|Sponsor Decision|0
1670300|NCT01474512|5836162|P4|Induction Period|Sponsor Decision|0
1670301|NCT01474512|5836163|P3|Induction Period|Sponsor Decision|1
1670302|NCT01474512|5836164|P2|Induction Period|Sponsor Decision|1
1670303|NCT01474512|5836165|P1|Induction Period|Sponsor Decision|1
1670304|NCT01474512|5836148|P18|Induction Period|Protocol Violation|0
1670305|NCT01474512|5836149|P17|Induction Period|Protocol Violation|0
1670306|NCT01474512|5836150|P16|Induction Period|Protocol Violation|0
1670307|NCT01474512|5836151|P15|Induction Period|Protocol Violation|0
1670308|NCT01474512|5836152|P14|Induction Period|Protocol Violation|0
1670309|NCT01474512|5836153|P13|Induction Period|Protocol Violation|0
1670310|NCT01474512|5836154|P12|Induction Period|Protocol Violation|0
1670311|NCT01474512|5836155|P11|Induction Period|Protocol Violation|0
1670312|NCT01474512|5836156|P10|Induction Period|Protocol Violation|0
1670313|NCT01474512|5836157|P9|Induction Period|Protocol Violation|0
1670314|NCT01474512|5836158|P8|Induction Period|Protocol Violation|0
1670315|NCT01474512|5836159|P7|Induction Period|Protocol Violation|0
1670316|NCT01474512|5836160|P6|Induction Period|Protocol Violation|0
1670317|NCT01474512|5836161|P5|Induction Period|Protocol Violation|0
1670318|NCT01474512|5836162|P4|Induction Period|Protocol Violation|0
1670319|NCT01474512|5836163|P3|Induction Period|Protocol Violation|0
1670320|NCT01474512|5836164|P2|Induction Period|Protocol Violation|6
1670321|NCT01474512|5836165|P1|Induction Period|Protocol Violation|3
1670322|NCT01474512|5836148|P18|Induction Period|Withdrawal by Subject|0
1670323|NCT01474512|5836149|P17|Induction Period|Withdrawal by Subject|0
1670324|NCT01474512|5836150|P16|Induction Period|Withdrawal by Subject|0
1670325|NCT01474512|5836151|P15|Induction Period|Withdrawal by Subject|0
1670326|NCT01474512|5836152|P14|Induction Period|Withdrawal by Subject|0
1670327|NCT01474512|5836153|P13|Induction Period|Withdrawal by Subject|0
1670328|NCT01474512|5836154|P12|Induction Period|Withdrawal by Subject|0
1670329|NCT01474512|5836155|P11|Induction Period|Withdrawal by Subject|0
1670330|NCT01474512|5836156|P10|Induction Period|Withdrawal by Subject|0
1670331|NCT01474512|5836157|P9|Induction Period|Withdrawal by Subject|0
1670332|NCT01474512|5836158|P8|Induction Period|Withdrawal by Subject|0
1670333|NCT01474512|5836159|P7|Induction Period|Withdrawal by Subject|0
1670334|NCT01474512|5836160|P6|Induction Period|Withdrawal by Subject|0
1670335|NCT01474512|5836161|P5|Induction Period|Withdrawal by Subject|0
1670336|NCT01474512|5836162|P4|Induction Period|Withdrawal by Subject|0
1670337|NCT01474512|5836163|P3|Induction Period|Withdrawal by Subject|5
1670338|NCT01474512|5836164|P2|Induction Period|Withdrawal by Subject|6
1670339|NCT01474512|5836165|P1|Induction Period|Withdrawal by Subject|6
1670340|NCT01474512|5836148|P18|Induction Period|Lack of Efficacy|0
1670341|NCT01474512|5836149|P17|Induction Period|Lack of Efficacy|0
1670342|NCT01474512|5836150|P16|Induction Period|Lack of Efficacy|0
1670343|NCT01474512|5836151|P15|Induction Period|Lack of Efficacy|0
1670344|NCT01474512|5836152|P14|Induction Period|Lack of Efficacy|0
1670345|NCT01474512|5836153|P13|Induction Period|Lack of Efficacy|0
1670346|NCT01474512|5836154|P12|Induction Period|Lack of Efficacy|0
1670347|NCT01474512|5836155|P11|Induction Period|Lack of Efficacy|0
1670348|NCT01474512|5836156|P10|Induction Period|Lack of Efficacy|0
1670349|NCT01474512|5836157|P9|Induction Period|Lack of Efficacy|0
1670350|NCT01474512|5836158|P8|Induction Period|Lack of Efficacy|0
1670351|NCT01474512|5836159|P7|Induction Period|Lack of Efficacy|0
1670352|NCT01474512|5836160|P6|Induction Period|Lack of Efficacy|0
1670353|NCT01474512|5836161|P5|Induction Period|Lack of Efficacy|0
1670354|NCT01474512|5836162|P4|Induction Period|Lack of Efficacy|0
1670355|NCT01474512|5836163|P3|Induction Period|Lack of Efficacy|0
1670356|NCT01474512|5836164|P2|Induction Period|Lack of Efficacy|1
1670357|NCT01474512|5836165|P1|Induction Period|Lack of Efficacy|7
1670358|NCT01474512|5836148|P18|Induction Period|Adverse Event|0
1670359|NCT01474512|5836149|P17|Induction Period|Adverse Event|0
1670360|NCT01474512|5836150|P16|Induction Period|Adverse Event|0
1670361|NCT01474512|5836151|P15|Induction Period|Adverse Event|0
1670362|NCT01474512|5836152|P14|Induction Period|Adverse Event|0
1670363|NCT01474512|5836153|P13|Induction Period|Adverse Event|0
1670364|NCT01474512|5836154|P12|Induction Period|Adverse Event|0
1670365|NCT01474512|5836155|P11|Induction Period|Adverse Event|0
1670366|NCT01474512|5836156|P10|Induction Period|Adverse Event|0
1670367|NCT01474512|5836157|P9|Induction Period|Adverse Event|0
1670368|NCT01474512|5836158|P8|Induction Period|Adverse Event|0
1670369|NCT01474512|5836159|P7|Induction Period|Adverse Event|0
1670370|NCT01474512|5836160|P6|Induction Period|Adverse Event|0
1670371|NCT01474512|5836161|P5|Induction Period|Adverse Event|0
1670372|NCT01474512|5836162|P4|Induction Period|Adverse Event|0
1670373|NCT01474512|5836163|P3|Induction Period|Adverse Event|10
1670374|NCT01474512|5836164|P2|Induction Period|Adverse Event|10
1670375|NCT01474512|5836165|P1|Induction Period|Adverse Event|6
1670376|NCT01474434|5836241|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1670377|NCT01474434|5836242|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1670378|NCT01474434|5836243|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
1670379|NCT01474434|5836244|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
1670380|NCT01474434|5836241|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
1670381|NCT01474434|5836242|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1670382|NCT01474434|5836243|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1670383|NCT01474434|5836244|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
1670384|NCT01474434|5836241|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1670385|NCT01474434|5836242|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
1670386|NCT01474434|5836243|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1670387|NCT01474434|5836244|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
1670388|NCT01474317|5836286|P1|Overall Study|Subject ineligible for study|1
1670389|NCT01474317|5836286|P1|Overall Study|Adverse Event|1
1670390|NCT01474291|5836295|P1|Overall Study|Death|2
1670391|NCT01474291|5836295|P1|Overall Study|No Reason Reported|10
1670392|NCT01474291|5836295|P1|Overall Study|Patient No Longer Wanted to Participate|12
1670393|NCT01474291|5836295|P1|Overall Study|Lost to Follow-up|29
1670394|NCT01474291|5836295|P1|Overall Study|Adverse Event|53
1670395|NCT01474291|5836295|P1|Overall Study|Lack of Treatment Efficacy|88
1670396|NCT01474291|5836295|P1|Overall Study|Not Evaluable for Efficacy|26
1670397|NCT01474239|5836339|P2|Overall Study|Withdrawal for Economic Reason|0
1670398|NCT01474239|5836340|P1|Overall Study|Withdrawal for Economic Reason|1
1670399|NCT01474239|5836339|P2|Overall Study|Clinical Disease Progression|1
1670400|NCT01474239|5836340|P1|Overall Study|Clinical Disease Progression|7
1670401|NCT01474239|5836339|P2|Overall Study|Death|1
1670402|NCT01474239|5836340|P1|Overall Study|Death|1
1670403|NCT01474239|5836339|P2|Overall Study|Withdrawal by Subject|2
1670404|NCT01474239|5836340|P1|Overall Study|Withdrawal by Subject|1
1670405|NCT01474239|5836339|P2|Overall Study|Adverse Event|3
1670406|NCT01474239|5836340|P1|Overall Study|Adverse Event|12
1670407|NCT01474239|5836339|P2|Overall Study|Disease Progression|25
1670408|NCT01474239|5836340|P1|Overall Study|Disease Progression|37
1670409|NCT01474018|5836512|P2|Overall Study|Withdrawal by Subject|2
1670410|NCT01474018|5836513|P1|Overall Study|Withdrawal by Subject|0
1670411|NCT01474018|5836512|P2|Overall Study|Lost to Follow-up|1
1670412|NCT01474018|5836513|P1|Overall Study|Lost to Follow-up|0
1670413|NCT01473953|5836545|P5|Overall Study|Other|0
1670414|NCT01473953|5836546|P4|Overall Study|Other|0
1670415|NCT01473953|5836547|P3|Overall Study|Other|0
1670416|NCT01473953|5836548|P2|Overall Study|Other|0
1670417|NCT01473953|5836549|P1|Overall Study|Other|1
1670418|NCT01473836|5836591|P1|Overall Study|Does not meet entrance criteria|1
1670419|NCT01473836|5836591|P1|Overall Study|Lack of Efficacy|1
1670420|NCT01473836|5836591|P1|Overall Study|Adverse Event|4
1670421|NCT01473758|5836602|P4|Cycle 2|Adverse Event|0
1670422|NCT01473758|5836603|P3|Cycle 2|Adverse Event|5
1670423|NCT01473758|5836604|P2|Cycle 2|Adverse Event|0
1670424|NCT01473758|5836605|P1|Cycle 2|Adverse Event|0
1670425|NCT01473758|5836602|P4|Cycle 1|Withdrawal by Subject|0
1670426|NCT01473758|5836603|P3|Cycle 1|Withdrawal by Subject|0
1670427|NCT01473758|5836604|P2|Cycle 1|Withdrawal by Subject|1
1670428|NCT01473758|5836605|P1|Cycle 1|Withdrawal by Subject|1
1670429|NCT01473758|5836602|P4|Cycle 1|Adverse Event|0
1670430|NCT01473758|5836603|P3|Cycle 1|Adverse Event|0
1670431|NCT01473758|5836604|P2|Cycle 1|Adverse Event|2
1670432|NCT01473758|5836605|P1|Cycle 1|Adverse Event|10
1670433|NCT01473732|5836742|P2|Overall Study|Death|0
1670434|NCT01473732|5836743|P1|Overall Study|Death|1
1670435|NCT01473732|5836742|P2|Overall Study|Adverse Event|0
1670436|NCT01473732|5836743|P1|Overall Study|Adverse Event|1
1670437|NCT01473602|5836751|P2|Overall Study|Physician Decision|0
1670438|NCT01473602|5836752|P1|Overall Study|Physician Decision|1
1670439|NCT01473602|5836751|P2|Overall Study|Withdrawal by Subject|4
1670440|NCT01473602|5836752|P1|Overall Study|Withdrawal by Subject|5
1670441|NCT01473602|5836751|P2|Overall Study|Lost to Follow-up|1
1670442|NCT01473602|5836752|P1|Overall Study|Lost to Follow-up|1
1670443|NCT01473602|5836751|P2|Overall Study|Death|1
1670444|NCT01473602|5836752|P1|Overall Study|Death|0
1670445|NCT01473602|5836751|P2|Overall Study|Adverse Event|2
1670446|NCT01473602|5836752|P1|Overall Study|Adverse Event|1
1670447|NCT01473589|5836788|P2|Overall Study|Entry criteria not met|1
1670448|NCT01473589|5836789|P1|Overall Study|Entry criteria not met|0
1670449|NCT01473589|5836788|P2|Overall Study|Physician Decision|1
1670450|NCT01473589|5836789|P1|Overall Study|Physician Decision|0
1670451|NCT01473589|5836788|P2|Overall Study|Withdrawal by Subject|11
1670452|NCT01473589|5836789|P1|Overall Study|Withdrawal by Subject|5
1670453|NCT01473589|5836788|P2|Overall Study|Protocol Violation|0
1670454|NCT01473589|5836789|P1|Overall Study|Protocol Violation|1
1670455|NCT01473589|5836788|P2|Overall Study|Lost to Follow-up|2
1670456|NCT01473589|5836789|P1|Overall Study|Lost to Follow-up|2
1670457|NCT01473589|5836788|P2|Overall Study|Death|0
1670458|NCT01473589|5836789|P1|Overall Study|Death|2
1670459|NCT01473589|5836788|P2|Overall Study|Adverse Event|1
1670460|NCT01473589|5836789|P1|Overall Study|Adverse Event|1
1670461|NCT01473563|5836823|P1|Overall Study|Lost to FU post tx discontinuation|1
1670462|NCT01473524|5836845|P3|Overall Study|Withdrawal by Subject|1
1670463|NCT01473524|5836846|P2|Overall Study|Withdrawal by Subject|1
1670464|NCT01473524|5836847|P1|Overall Study|Withdrawal by Subject|2
1670465|NCT01473524|5836845|P3|Overall Study|Death|0
1670466|NCT01473524|5836846|P2|Overall Study|Death|0
1670467|NCT01473524|5836847|P1|Overall Study|Death|1
1670468|NCT01473524|5836845|P3|Overall Study|Adverse Event|2
1670469|NCT01473524|5836846|P2|Overall Study|Adverse Event|8
1670470|NCT01473524|5836847|P1|Overall Study|Adverse Event|4
1670471|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
1670472|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
1670473|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
1670474|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
1670475|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
1670476|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
1670477|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
1670478|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
1670479|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Site closure|1
1670480|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Site closure|3
1670481|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
1670482|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
1670483|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
1670484|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
1670485|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
1670486|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
1670487|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
1670488|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
1670489|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Physician Decision|2
1670490|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Physician Decision|1
1670491|NCT01473420|5836880|P2|Maintenance Period (16 Weeks)|Adverse Event|2
1670492|NCT01473420|5836881|P1|Maintenance Period (16 Weeks)|Adverse Event|3
1670493|NCT01473420|5836880|P2|Titration Period (18 Weeks)|Did not meet criteria|32
1670494|NCT01473420|5836881|P1|Titration Period (18 Weeks)|Did not meet criteria|32
1670495|NCT01473420|5836880|P2|Titration Period (18 Weeks)|Adverse Event|6
1670496|NCT01473420|5836881|P1|Titration Period (18 Weeks)|Adverse Event|4
1670497|NCT01473407|5836965|P2|Overall Study|Site Closure|0
1670498|NCT01473407|5836966|P1|Overall Study|Site Closure|1
1670499|NCT01473407|5836965|P2|Overall Study|Sponsor's Decision|10
1670500|NCT01473407|5836966|P1|Overall Study|Sponsor's Decision|10
1670501|NCT01473407|5836965|P2|Overall Study|Transfer to Another Facility/Unit|3
1670502|NCT01473407|5836966|P1|Overall Study|Transfer to Another Facility/Unit|4
1670503|NCT01473407|5836965|P2|Overall Study|Temperature Excursion|3
1670504|NCT01473407|5836966|P1|Overall Study|Temperature Excursion|2
1670505|NCT01473407|5836965|P2|Overall Study|Patient Lost Green Card Status|0
1670506|NCT01473407|5836966|P1|Overall Study|Patient Lost Green Card Status|1
1670507|NCT01473407|5836965|P2|Overall Study|Patient Received Aranesp|0
1670508|NCT01473407|5836966|P1|Overall Study|Patient Received Aranesp|1
1670509|NCT01473407|5836965|P2|Overall Study|Elevated Hemoglobin|0
1670510|NCT01473407|5836966|P1|Overall Study|Elevated Hemoglobin|1
1670511|NCT01473407|5836965|P2|Overall Study|Vacation/Travel|1
1670512|NCT01473407|5836966|P1|Overall Study|Vacation/Travel|1
1670513|NCT01473407|5836965|P2|Overall Study|Kidney Transplant|6
1670514|NCT01473407|5836966|P1|Overall Study|Kidney Transplant|7
1670515|NCT01473407|5836965|P2|Overall Study|Withdrawal by Subject|7
1670516|NCT01473407|5836966|P1|Overall Study|Withdrawal by Subject|4
1670517|NCT01473407|5836965|P2|Overall Study|Randomization Error|1
1670518|NCT01473407|5836966|P1|Overall Study|Randomization Error|3
1670519|NCT01473407|5836965|P2|Overall Study|Adverse Event|8
1670520|NCT01473407|5836966|P1|Overall Study|Adverse Event|8
1670521|NCT01473407|5836965|P2|Overall Study|Lost to Follow-up|4
1670522|NCT01473407|5836966|P1|Overall Study|Lost to Follow-up|10
1670523|NCT01473407|5836965|P2|Overall Study|Physician Decision|4
1670524|NCT01473407|5836966|P1|Overall Study|Physician Decision|1
1670525|NCT01473394|5837020|P2|Overall Study|Lost to Follow-up|11
1670526|NCT01473394|5837021|P1|Overall Study|Lost to Follow-up|9
1670527|NCT01473394|5837020|P2|Overall Study|Withdrew Consent|10
1670528|NCT01473394|5837021|P1|Overall Study|Withdrew Consent|12
1670529|NCT01473394|5837020|P2|Overall Study|Protocol Violation|5
1670530|NCT01473394|5837021|P1|Overall Study|Protocol Violation|7
1670531|NCT01473394|5837020|P2|Overall Study|Insufficient Therapeutic Response|1
1670532|NCT01473394|5837021|P1|Overall Study|Insufficient Therapeutic Response|4
1670533|NCT01473394|5837020|P2|Overall Study|Adverse Event|16
1670534|NCT01473394|5837021|P1|Overall Study|Adverse Event|13
1670535|NCT01473381|5837035|P4|Overall Study|Other Reasons|3
1670536|NCT01473381|5837036|P3|Overall Study|Other Reasons|1
1670537|NCT01473381|5837037|P2|Overall Study|Other Reasons|0
1670538|NCT01473381|5837038|P1|Overall Study|Other Reasons|0
1670539|NCT01473381|5837035|P4|Overall Study|Lost to Follow-up|23
1670540|NCT01473381|5837036|P3|Overall Study|Lost to Follow-up|35
1670541|NCT01473381|5837037|P2|Overall Study|Lost to Follow-up|28
1670542|NCT01473381|5837038|P1|Overall Study|Lost to Follow-up|25
1670543|NCT01473381|5837035|P4|Overall Study|Withdrawal of Consent|26
1670544|NCT01473381|5837036|P3|Overall Study|Withdrawal of Consent|20
1670545|NCT01473381|5837037|P2|Overall Study|Withdrawal of Consent|21
1670546|NCT01473381|5837038|P1|Overall Study|Withdrawal of Consent|20
1670547|NCT01473381|5837035|P4|Overall Study|Protocol Violation|17
1670548|NCT01473381|5837036|P3|Overall Study|Protocol Violation|19
1670549|NCT01473381|5837037|P2|Overall Study|Protocol Violation|23
1670550|NCT01473381|5837038|P1|Overall Study|Protocol Violation|17
1670551|NCT01473381|5837035|P4|Overall Study|Insufficient Therapeutic Response|3
1670552|NCT01473381|5837036|P3|Overall Study|Insufficient Therapeutic Response|2
1670553|NCT01473381|5837037|P2|Overall Study|Insufficient Therapeutic Response|1
1670554|NCT01473381|5837038|P1|Overall Study|Insufficient Therapeutic Response|10
1670555|NCT01473381|5837035|P4|Overall Study|Adverse Event|17
1670556|NCT01473381|5837036|P3|Overall Study|Adverse Event|25
1670557|NCT01473381|5837037|P2|Overall Study|Adverse Event|20
1670558|NCT01473381|5837038|P1|Overall Study|Adverse Event|8
1670559|NCT01473355|5837100|P1|Overall Study|Lost to Follow-up|2
1670560|NCT01473355|5837100|P1|Overall Study|Adverse Event|2
1670561|NCT01473355|5837100|P1|Overall Study|Protocol Violation|2
1670562|NCT01472965|5837129|P2|Overall Study|Withdrawal by Subject|0
1670563|NCT01472965|5837130|P1|Overall Study|Withdrawal by Subject|1
1670564|NCT01472939|5837150|P4|Overall Study|Withdrawal by Subject|4
1670565|NCT01472939|5837151|P3|Overall Study|Withdrawal by Subject|1
1670566|NCT01472939|5837152|P2|Overall Study|Withdrawal by Subject|3
1670567|NCT01472939|5837153|P1|Overall Study|Withdrawal by Subject|9
1670568|NCT01472939|5837150|P4|Overall Study|Protocol Violation|1
1670569|NCT01472939|5837151|P3|Overall Study|Protocol Violation|0
1670570|NCT01472939|5837152|P2|Overall Study|Protocol Violation|3
1670571|NCT01472939|5837153|P1|Overall Study|Protocol Violation|3
1670572|NCT01472939|5837150|P4|Overall Study|Withdrawal By PI|0
1670573|NCT01472939|5837151|P3|Overall Study|Withdrawal By PI|0
1670574|NCT01472939|5837152|P2|Overall Study|Withdrawal By PI|0
1670575|NCT01472939|5837153|P1|Overall Study|Withdrawal By PI|1
1670576|NCT01472939|5837150|P4|Overall Study|Prohibited Medication|0
1670577|NCT01472939|5837151|P3|Overall Study|Prohibited Medication|0
1670578|NCT01472939|5837152|P2|Overall Study|Prohibited Medication|1
1670579|NCT01472939|5837153|P1|Overall Study|Prohibited Medication|0
1670580|NCT01472939|5837150|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
1670581|NCT01472939|5837151|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
1670582|NCT01472939|5837152|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
1670583|NCT01472939|5837153|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
1670584|NCT01472939|5837150|P4|Overall Study|Lost to Follow-up|0
1670585|NCT01472939|5837151|P3|Overall Study|Lost to Follow-up|2
1670586|NCT01472939|5837152|P2|Overall Study|Lost to Follow-up|0
1670587|NCT01472939|5837153|P1|Overall Study|Lost to Follow-up|3
1670588|NCT01472939|5837150|P4|Overall Study|Lack of Efficacy|1
1670589|NCT01472939|5837151|P3|Overall Study|Lack of Efficacy|0
1670590|NCT01472939|5837152|P2|Overall Study|Lack of Efficacy|0
1670591|NCT01472939|5837153|P1|Overall Study|Lack of Efficacy|1
1670592|NCT01472939|5837150|P4|Overall Study|Adverse Event|14
1670593|NCT01472939|5837151|P3|Overall Study|Adverse Event|7
1670594|NCT01472939|5837152|P2|Overall Study|Adverse Event|7
1670595|NCT01472939|5837153|P1|Overall Study|Adverse Event|3
1670596|NCT01472835|5837197|P2|Overall Study|Lost to Follow-up|0
1670597|NCT01472835|5837198|P1|Overall Study|Lost to Follow-up|2
1670598|NCT01472380|5837323|P1|1 Day Period Between Dosing|Protocol Violation|1
1670599|NCT01472380|5837323|P1|Efavirenz Alone|Withdrawal by Subject|1
1670600|NCT01472341|5837334|P1|Overall Study|Death|9
1670601|NCT01472341|5837334|P1|Overall Study|Laboratory parameters unavailable|25
1670602|NCT01472341|5837334|P1|Overall Study|Lost to Follow-up|52
1670603|NCT01472341|5837334|P1|Overall Study|Withdrawal by Subject|39
1670604|NCT01472341|5837334|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
1670605|NCT01472341|5837334|P1|Overall Study|Started insulin therapy|55
1670606|NCT01472289|5837340|P1|Overall Study|Death|2
1670607|NCT01472185|5837352|P2|Overall Study|Subject Withdrew Consent|3
1670608|NCT01472185|5837353|P1|Overall Study|Subject Withdrew Consent|6
1670609|NCT01472185|5837352|P2|Overall Study|Subject Noncompliance|15
1670610|NCT01472185|5837353|P1|Overall Study|Subject Noncompliance|8
1670611|NCT01472185|5837352|P2|Overall Study|Protocol Violation|1
1670612|NCT01472185|5837353|P1|Overall Study|Protocol Violation|5
1670613|NCT01472185|5837352|P2|Overall Study|Lost to Follow-up|1
1670614|NCT01472185|5837353|P1|Overall Study|Lost to Follow-up|4
1670615|NCT01472185|5837352|P2|Overall Study|Investigator’s Discretion|1
1670616|NCT01472185|5837353|P1|Overall Study|Investigator’s Discretion|3
1670617|NCT01472185|5837352|P2|Overall Study|Hyperglycemia|2
1670618|NCT01472185|5837353|P1|Overall Study|Hyperglycemia|5
1670619|NCT01472185|5837352|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
1670620|NCT01472185|5837353|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
1670621|NCT01472185|5837352|P2|Overall Study|Randomized but Not Treated|1
1670622|NCT01472185|5837353|P1|Overall Study|Randomized but Not Treated|0
1670623|NCT01472081|5837373|P6|Overall Study|Subject request to discontinue treatment|0
1670624|NCT01472081|5837374|P5|Overall Study|Subject request to discontinue treatment|0
1670625|NCT01472081|5837375|P4|Overall Study|Subject request to discontinue treatment|1
1670626|NCT01472081|5837376|P3|Overall Study|Subject request to discontinue treatment|1
1670627|NCT01472081|5837377|P2|Overall Study|Subject request to discontinue treatment|3
1670628|NCT01472081|5837378|P1|Overall Study|Subject request to discontinue treatment|0
1670629|NCT01472081|5837373|P6|Overall Study|No longer meets study criteria|0
1670630|NCT01472081|5837374|P5|Overall Study|No longer meets study criteria|0
1670631|NCT01472081|5837375|P4|Overall Study|No longer meets study criteria|0
1670632|NCT01472081|5837376|P3|Overall Study|No longer meets study criteria|1
1670633|NCT01472081|5837377|P2|Overall Study|No longer meets study criteria|0
1670634|NCT01472081|5837378|P1|Overall Study|No longer meets study criteria|0
1670635|NCT01472081|5837373|P6|Overall Study|Poor/non-compliance|0
1670636|NCT01472081|5837374|P5|Overall Study|Poor/non-compliance|1
1670637|NCT01472081|5837375|P4|Overall Study|Poor/non-compliance|0
1670638|NCT01472081|5837376|P3|Overall Study|Poor/non-compliance|1
1670639|NCT01472081|5837377|P2|Overall Study|Poor/non-compliance|0
1670640|NCT01472081|5837378|P1|Overall Study|Poor/non-compliance|0
1670641|NCT01472081|5837373|P6|Overall Study|Withdrawal by Subject|1
1670642|NCT01472081|5837374|P5|Overall Study|Withdrawal by Subject|0
1670643|NCT01472081|5837375|P4|Overall Study|Withdrawal by Subject|0
1670644|NCT01472081|5837376|P3|Overall Study|Withdrawal by Subject|0
1670645|NCT01472081|5837377|P2|Overall Study|Withdrawal by Subject|0
1670646|NCT01472081|5837378|P1|Overall Study|Withdrawal by Subject|0
1670647|NCT01472081|5837373|P6|Overall Study|Adverse Event unrelated to study drug|0
1670648|NCT01472081|5837374|P5|Overall Study|Adverse Event unrelated to study drug|1
1670649|NCT01472081|5837375|P4|Overall Study|Adverse Event unrelated to study drug|0
1670650|NCT01472081|5837376|P3|Overall Study|Adverse Event unrelated to study drug|0
1670651|NCT01472081|5837377|P2|Overall Study|Adverse Event unrelated to study drug|0
1670652|NCT01472081|5837378|P1|Overall Study|Adverse Event unrelated to study drug|0
1670653|NCT01472081|5837373|P6|Overall Study|Death|0
1670654|NCT01472081|5837374|P5|Overall Study|Death|1
1670655|NCT01472081|5837375|P4|Overall Study|Death|0
1670656|NCT01472081|5837376|P3|Overall Study|Death|0
1670657|NCT01472081|5837377|P2|Overall Study|Death|0
1670658|NCT01472081|5837378|P1|Overall Study|Death|0
1670659|NCT01472081|5837373|P6|Overall Study|Study drug toxicity|2
1670660|NCT01472081|5837374|P5|Overall Study|Study drug toxicity|13
1670661|NCT01472081|5837375|P4|Overall Study|Study drug toxicity|6
1670662|NCT01472081|5837376|P3|Overall Study|Study drug toxicity|4
1670663|NCT01472081|5837377|P2|Overall Study|Study drug toxicity|9
1670664|NCT01472081|5837378|P1|Overall Study|Study drug toxicity|2
1670665|NCT01472081|5837373|P6|Overall Study|Disease Progression|3
1670666|NCT01472081|5837374|P5|Overall Study|Disease Progression|22
1670667|NCT01472081|5837375|P4|Overall Study|Disease Progression|31
1670668|NCT01472081|5837376|P3|Overall Study|Disease Progression|12
1670669|NCT01472081|5837377|P2|Overall Study|Disease Progression|10
1670670|NCT01472081|5837378|P1|Overall Study|Disease Progression|4
1670671|NCT01472081|5837373|P6|Overall Study|Continuing treatment at time of analysis|0
1670672|NCT01472081|5837374|P5|Overall Study|Continuing treatment at time of analysis|9
1670673|NCT01472081|5837375|P4|Overall Study|Continuing treatment at time of analysis|8
1670674|NCT01472081|5837376|P3|Overall Study|Continuing treatment at time of analysis|1
1670675|NCT01472081|5837377|P2|Overall Study|Continuing treatment at time of analysis|4
1670676|NCT01472081|5837378|P1|Overall Study|Continuing treatment at time of analysis|1
1670677|NCT01471782|5837427|P6|Overall Study|Death|1
1670678|NCT01471782|5837428|P5|Overall Study|Death|0
1670679|NCT01471782|5837429|P4|Overall Study|Death|0
1670680|NCT01471782|5837430|P3|Overall Study|Death|0
1670681|NCT01471782|5837431|P2|Overall Study|Death|0
1670682|NCT01471782|5837432|P1|Overall Study|Death|0
1670683|NCT01471782|5837427|P6|Overall Study|Withdrawal by Parent/Guardian|0
1670684|NCT01471782|5837428|P5|Overall Study|Withdrawal by Parent/Guardian|1
1670685|NCT01471782|5837429|P4|Overall Study|Withdrawal by Parent/Guardian|0
1670686|NCT01471782|5837430|P3|Overall Study|Withdrawal by Parent/Guardian|0
1670687|NCT01471782|5837431|P2|Overall Study|Withdrawal by Parent/Guardian|0
1670688|NCT01471782|5837432|P1|Overall Study|Withdrawal by Parent/Guardian|0
1670689|NCT01471782|5837427|P6|Overall Study|Physician Decision|8
1670690|NCT01471782|5837428|P5|Overall Study|Physician Decision|3
1670691|NCT01471782|5837429|P4|Overall Study|Physician Decision|0
1670692|NCT01471782|5837430|P3|Overall Study|Physician Decision|0
1670693|NCT01471782|5837431|P2|Overall Study|Physician Decision|0
1670694|NCT01471782|5837432|P1|Overall Study|Physician Decision|0
1670695|NCT01471782|5837427|P6|Overall Study|Disease Relapse|1
1670696|NCT01471782|5837428|P5|Overall Study|Disease Relapse|2
1670697|NCT01471782|5837429|P4|Overall Study|Disease Relapse|1
1670698|NCT01471782|5837430|P3|Overall Study|Disease Relapse|0
1670699|NCT01471782|5837431|P2|Overall Study|Disease Relapse|0
1670700|NCT01471782|5837432|P1|Overall Study|Disease Relapse|0
1670701|NCT01471782|5837427|P6|Overall Study|Change of Chemotherapy|4
1670702|NCT01471782|5837428|P5|Overall Study|Change of Chemotherapy|1
1670703|NCT01471782|5837429|P4|Overall Study|Change of Chemotherapy|0
1670704|NCT01471782|5837430|P3|Overall Study|Change of Chemotherapy|0
1670705|NCT01471782|5837431|P2|Overall Study|Change of Chemotherapy|1
1670706|NCT01471782|5837432|P1|Overall Study|Change of Chemotherapy|1
1670707|NCT01471782|5837427|P6|Overall Study|Other|5
1670708|NCT01471782|5837428|P5|Overall Study|Other|6
1670709|NCT01471782|5837429|P4|Overall Study|Other|1
1670710|NCT01471782|5837430|P3|Overall Study|Other|1
1670711|NCT01471782|5837431|P2|Overall Study|Other|0
1670712|NCT01471782|5837432|P1|Overall Study|Other|0
1670713|NCT01471782|5837427|P6|Overall Study|Adverse Event|1
1670714|NCT01471782|5837428|P5|Overall Study|Adverse Event|3
1670715|NCT01471782|5837429|P4|Overall Study|Adverse Event|2
1670716|NCT01471782|5837430|P3|Overall Study|Adverse Event|2
1670717|NCT01471782|5837431|P2|Overall Study|Adverse Event|1
1670718|NCT01471782|5837432|P1|Overall Study|Adverse Event|1
1670719|NCT01471782|5837427|P6|Overall Study|Lack of Efficacy|18
1670720|NCT01471782|5837428|P5|Overall Study|Lack of Efficacy|5
1670721|NCT01471782|5837429|P4|Overall Study|Lack of Efficacy|1
1670722|NCT01471782|5837430|P3|Overall Study|Lack of Efficacy|1
1670723|NCT01471782|5837431|P2|Overall Study|Lack of Efficacy|2
1670724|NCT01471782|5837432|P1|Overall Study|Lack of Efficacy|1
1670725|NCT01471782|5837427|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
1670726|NCT01471782|5837428|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
1670727|NCT01471782|5837429|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
1670728|NCT01471782|5837430|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
1670729|NCT01471782|5837431|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
1670730|NCT01471782|5837432|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
1670731|NCT01471691|5837486|P2|Overall Study|Lack of Efficacy|1
1670732|NCT01471691|5837487|P1|Overall Study|Lack of Efficacy|0
1670733|NCT01471379|5837496|P3|Overall Study|Study terminated|0
1670734|NCT01471379|5837497|P2|Overall Study|Study terminated|1
1670735|NCT01471379|5837498|P1|Overall Study|Study terminated|0
1670736|NCT01471379|5837496|P3|Overall Study|Adverse Event|0
1670737|NCT01471379|5837497|P2|Overall Study|Adverse Event|0
1670738|NCT01471379|5837498|P1|Overall Study|Adverse Event|1
1670739|NCT01471353|5837518|P1|Overall Study|remain on study|3
1670740|NCT01471340|5837529|P2|Overall Study|Invalid informed consent|0
1670741|NCT01471340|5837530|P1|Overall Study|Invalid informed consent|1
1670742|NCT01471340|5837529|P2|Overall Study|Investigational site closure|1
1670743|NCT01471340|5837530|P1|Overall Study|Investigational site closure|0
1670744|NCT01471340|5837529|P2|Overall Study|Lost to Follow-up|1
1670745|NCT01471340|5837530|P1|Overall Study|Lost to Follow-up|0
1670746|NCT01471340|5837529|P2|Overall Study|Death|4
1670747|NCT01471340|5837530|P1|Overall Study|Death|5
1670748|NCT01471574|5837553|P4|Follow-up Period|Follow-up no longer required|0
1670749|NCT01471574|5837554|P3|Follow-up Period|Follow-up no longer required|0
1670750|NCT01471574|5837555|P2|Follow-up Period|Follow-up no longer required|1
1670751|NCT01471574|5837556|P1|Follow-up Period|Follow-up no longer required|0
1670752|NCT01471574|5837553|P4|Follow-up Period|Death|0
1670753|NCT01471574|5837554|P3|Follow-up Period|Death|1
1670754|NCT01471574|5837555|P2|Follow-up Period|Death|0
1670755|NCT01471574|5837556|P1|Follow-up Period|Death|0
1670756|NCT01471574|5837553|P4|Follow-up Period|Lost to Follow-up|2
1670757|NCT01471574|5837554|P3|Follow-up Period|Lost to Follow-up|3
1670758|NCT01471574|5837555|P2|Follow-up Period|Lost to Follow-up|1
1670759|NCT01471574|5837556|P1|Follow-up Period|Lost to Follow-up|4
1670760|NCT01471574|5837553|P4|Follow-up Period|Withdrawal by Subject|1
1670761|NCT01471574|5837554|P3|Follow-up Period|Withdrawal by Subject|3
1670762|NCT01471574|5837555|P2|Follow-up Period|Withdrawal by Subject|0
1670763|NCT01471574|5837556|P1|Follow-up Period|Withdrawal by Subject|3
1670764|NCT01471574|5837553|P4|Treatment Period|Other|0
1670765|NCT01471574|5837554|P3|Treatment Period|Other|0
1670766|NCT01471574|5837555|P2|Treatment Period|Other|0
1670767|NCT01471574|5837556|P1|Treatment Period|Other|1
1670768|NCT01471574|5837553|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
1670769|NCT01471574|5837554|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
1670770|NCT01471574|5837555|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
1670771|NCT01471574|5837556|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
1670772|NCT01471574|5837553|P4|Treatment Period|Lost to Follow-up|0
1670773|NCT01471574|5837554|P3|Treatment Period|Lost to Follow-up|2
1670774|NCT01471574|5837555|P2|Treatment Period|Lost to Follow-up|2
1670775|NCT01471574|5837556|P1|Treatment Period|Lost to Follow-up|1
1670776|NCT01471574|5837553|P4|Treatment Period|Patient Requested Discontinue Study drug|1
1670777|NCT01471574|5837554|P3|Treatment Period|Patient Requested Discontinue Study drug|1
1670778|NCT01471574|5837555|P2|Treatment Period|Patient Requested Discontinue Study drug|0
1670779|NCT01471574|5837556|P1|Treatment Period|Patient Requested Discontinue Study drug|4
1670780|NCT01471574|5837553|P4|Treatment Period|Withdrawal by Subject|0
1670781|NCT01471574|5837554|P3|Treatment Period|Withdrawal by Subject|1
1670782|NCT01471574|5837555|P2|Treatment Period|Withdrawal by Subject|1
1670783|NCT01471574|5837556|P1|Treatment Period|Withdrawal by Subject|5
1670784|NCT01471574|5837553|P4|Treatment Period|Adverse Event|1
1670785|NCT01471574|5837554|P3|Treatment Period|Adverse Event|6
1670786|NCT01471574|5837555|P2|Treatment Period|Adverse Event|3
1670787|NCT01471574|5837556|P1|Treatment Period|Adverse Event|7
1670788|NCT01471574|5837553|P4|Treatment Period|Lack of Efficacy|1
1670789|NCT01471574|5837554|P3|Treatment Period|Lack of Efficacy|14
1670790|NCT01471574|5837555|P2|Treatment Period|Lack of Efficacy|4
1670791|NCT01471574|5837556|P1|Treatment Period|Lack of Efficacy|12
1670792|NCT01471197|5837587|P2|Overall Study|Study Drug Toxicity|0
1670793|NCT01471197|5837588|P1|Overall Study|Study Drug Toxicity|1
1670794|NCT01471197|5837587|P2|Overall Study|Death|0
1670795|NCT01471197|5837588|P1|Overall Study|Death|1
1670796|NCT01471197|5837587|P2|Overall Study|Disease Progression|2
1670797|NCT01471197|5837588|P1|Overall Study|Disease Progression|4
1670798|NCT01471171|5837598|P2|Treatment Period 2|Adverse Event|0
1670799|NCT01471171|5837599|P1|Treatment Period 2|Adverse Event|1
1670800|NCT01471171|5837598|P2|Treatment Period 1|Adverse Event|1
1670801|NCT01471171|5837599|P1|Treatment Period 1|Adverse Event|4
1670802|NCT01471054|5837611|P2|Overall Study|Study terminated prematurely|0
1670803|NCT01471054|5837612|P1|Overall Study|Study terminated prematurely|4
1670804|NCT01471028|5837635|P2|VTI-208E|Lost to Follow-up|2
1670805|NCT01471028|5837636|P1|VTI-208E|Lost to Follow-up|0
1670806|NCT01471028|5837635|P2|VTI-208E|Withdrawal by Subject|0
1670807|NCT01471028|5837636|P1|VTI-208E|Withdrawal by Subject|1
1670808|NCT01471028|5837635|P2|VTI-208E|Death|10
1670809|NCT01471028|5837636|P1|VTI-208E|Death|7
1670810|NCT01471028|5837635|P2|VTI-208|Lost to Follow-up|1
1670811|NCT01471028|5837636|P1|VTI-208|Lost to Follow-up|1
1670812|NCT01471028|5837635|P2|VTI-208|Withdrawal by Subject|2
1670813|NCT01471028|5837636|P1|VTI-208|Withdrawal by Subject|0
1670814|NCT01471028|5837635|P2|VTI-208|Adverse Event|41
1670815|NCT01471028|5837636|P1|VTI-208|Adverse Event|39
1670816|NCT01471015|5837651|P3|Overall Study|Death|1
1670817|NCT01471015|5837652|P2|Overall Study|Death|1
1670818|NCT01471015|5837653|P1|Overall Study|Death|0
1670819|NCT01470599|5837695|P2|Overall Study|Adverse event not related to study drug|5
1670820|NCT01470599|5837696|P1|Overall Study|Adverse event not related to study drug|1
1670821|NCT01470599|5837695|P2|Overall Study|Insufficient clinical response|27
1670822|NCT01470599|5837696|P1|Overall Study|Insufficient clinical response|6
1670823|NCT01470599|5837695|P2|Overall Study|Adverse event related to study drug|5
1670824|NCT01470599|5837696|P1|Overall Study|Adverse event related to study drug|2
1670825|NCT01470599|5837695|P2|Overall Study|Protocol Violation|1
1670826|NCT01470599|5837696|P1|Overall Study|Protocol Violation|3
1670827|NCT01470599|5837695|P2|Overall Study|Other|0
1670828|NCT01470599|5837696|P1|Overall Study|Other|1
1670829|NCT01470599|5837695|P2|Overall Study|Withdrawal by Subject|4
1670830|NCT01470599|5837696|P1|Overall Study|Withdrawal by Subject|3
1670831|NCT01470599|5837695|P2|Overall Study|Lost to Follow-up|1
1670832|NCT01470599|5837696|P1|Overall Study|Lost to Follow-up|2
1670833|NCT01470599|5837695|P2|Overall Study|Did not meet entrance criteria|0
1670834|NCT01470599|5837696|P1|Overall Study|Did not meet entrance criteria|1
1670835|NCT01470469|5837760|P2|Overall Study|Other|1
1670836|NCT01470469|5837761|P1|Overall Study|Other|2
1670837|NCT01470469|5837760|P2|Overall Study|Protocol Violation|1
1670838|NCT01470469|5837761|P1|Overall Study|Protocol Violation|1
1670839|NCT01470469|5837760|P2|Overall Study|Lost to Follow-up|2
1670840|NCT01470469|5837761|P1|Overall Study|Lost to Follow-up|2
1670841|NCT01470469|5837760|P2|Overall Study|Adverse Event|7
1670842|NCT01470469|5837761|P1|Overall Study|Adverse Event|0
1670843|NCT01470469|5837760|P2|Overall Study|Lack of Efficacy|7
1670844|NCT01470469|5837761|P1|Overall Study|Lack of Efficacy|1
1670845|NCT01470469|5837760|P2|Overall Study|Withdrawal by Subject|6
1670846|NCT01470469|5837761|P1|Overall Study|Withdrawal by Subject|4
1670847|NCT01470417|5837781|P2|Overall Study|Disease progression|2
1670848|NCT01470417|5837782|P1|Overall Study|Disease progression|0
1670849|NCT01470326|5837794|P1|Overall Study|No Visit After 1st Day of Treatment|119
1670850|NCT01470326|5837794|P1|Overall Study|No Drug Administration Information|2
1670851|NCT01470326|5837794|P1|Overall Study|Protocol Violation|32
1670852|NCT01470248|5837805|P1|Overall Study|Withdrawal by Subject|1
1670853|NCT01470144|5837861|P1|Overall Study|Patient’s and investigator’s decision|1
1670854|NCT01470144|5837861|P1|Overall Study|Lung transplant|6
1670855|NCT01470144|5837861|P1|Overall Study|Death|1
1670856|NCT01470144|5837861|P1|Overall Study|Adverse Event|2
1670857|NCT01470001|5837966|P2|Overall Study|Withdrawal by Subject|1
1670858|NCT01470001|5837967|P1|Overall Study|Withdrawal by Subject|2
1670859|NCT01470001|5837966|P2|Overall Study|Physician Decision|0
1670860|NCT01470001|5837967|P1|Overall Study|Physician Decision|2
1670861|NCT01470001|5837966|P2|Overall Study|Lost to Follow-up|1
1670862|NCT01470001|5837967|P1|Overall Study|Lost to Follow-up|1
1670863|NCT01469819|5837977|P1|Overall Study|Technical malfunction of SmartPill data|3
1670864|NCT01469819|5837977|P1|Overall Study|Could not swallow SmartPill|2
1670865|NCT01469819|5837977|P1|Overall Study|Did not meet inclusionary criteria|2
1670866|NCT01469819|5837977|P1|Overall Study|Withdrawal by Subject|1
1670867|NCT01469637|5838001|P2|Second Intervention|Incarcerated|0
1670868|NCT01469637|5838002|P1|Second Intervention|Incarcerated|1
1670869|NCT01469637|5838001|P2|First Intervention|Unacceptable behavior|1
1670870|NCT01469637|5838002|P1|First Intervention|Unacceptable behavior|0
1670871|NCT01469546|5838010|P1|Received 5 mg Dose|Physician Decision|3
1670872|NCT01469546|5838010|P1|Received 5 mg Dose|Progressive Disease|3
1670873|NCT01469546|5838010|P1|Received 5 mg Dose|Protocol Violation|2
1670874|NCT01469546|5838010|P1|Received 5 mg Dose|Death|2
1670875|NCT01469546|5838010|P1|Received 5 mg Dose|Adverse Event|13
1670876|NCT01469377|5838020|P3|Overall Study|Other Miscellaneous Reasons|0
1670877|NCT01469377|5838021|P2|Overall Study|Other Miscellaneous Reasons|0
1670878|NCT01469377|5838022|P1|Overall Study|Other Miscellaneous Reasons|2
1670879|NCT01469377|5838020|P3|Overall Study|Insufficient Therapeutic Response|0
1670880|NCT01469377|5838021|P2|Overall Study|Insufficient Therapeutic Response|4
1670881|NCT01469377|5838022|P1|Overall Study|Insufficient Therapeutic Response|3
1670882|NCT01469377|5838020|P3|Overall Study|Adverse Event|36
1670883|NCT01469377|5838021|P2|Overall Study|Adverse Event|18
1670884|NCT01469377|5838022|P1|Overall Study|Adverse Event|8
1670885|NCT01469377|5838020|P3|Overall Study|Withdrawal of Consent|15
1670886|NCT01469377|5838021|P2|Overall Study|Withdrawal of Consent|14
1670887|NCT01469377|5838022|P1|Overall Study|Withdrawal of Consent|12
1670888|NCT01469377|5838020|P3|Overall Study|Lost to Follow-up|5
1670889|NCT01469377|5838021|P2|Overall Study|Lost to Follow-up|2
1670890|NCT01469377|5838022|P1|Overall Study|Lost to Follow-up|3
1670891|NCT01469377|5838020|P3|Overall Study|Protocol Deviation|10
1670892|NCT01469377|5838021|P2|Overall Study|Protocol Deviation|10
1670893|NCT01469377|5838022|P1|Overall Study|Protocol Deviation|7
1670894|NCT01469364|5838033|P1|Overall Study|Withdrawal by Subject|1
1670895|NCT01469364|5838033|P1|Overall Study|Adverse Event|1
1670896|NCT01469221|5838084|P3|Double Blind Phase|Sponsor Terminate Study|0
1670897|NCT01469221|5838085|P2|Double Blind Phase|Sponsor Terminate Study|16
1670898|NCT01469221|5838086|P1|Double Blind Phase|Sponsor Terminate Study|12
1670899|NCT01469221|5838084|P3|Double Blind Phase|Physician Decision|0
1670900|NCT01469221|5838085|P2|Double Blind Phase|Physician Decision|1
1670901|NCT01469221|5838086|P1|Double Blind Phase|Physician Decision|1
1670902|NCT01469221|5838084|P3|Double Blind Phase|Protocol Violation|0
1670903|NCT01469221|5838085|P2|Double Blind Phase|Protocol Violation|0
1670904|NCT01469221|5838086|P1|Double Blind Phase|Protocol Violation|1
1670905|NCT01469182|5838097|P2|Overall Study|Did not meet Protocol Eligibility|0
1670906|NCT01469182|5838098|P1|Overall Study|Did not meet Protocol Eligibility|3
1670907|NCT01469182|5838097|P2|Overall Study|Protocol Violation|2
1670908|NCT01469182|5838098|P1|Overall Study|Protocol Violation|4
1670909|NCT01469182|5838097|P2|Overall Study|Withdrawal by Subject|1
1670910|NCT01469182|5838098|P1|Overall Study|Withdrawal by Subject|4
1670911|NCT01469182|5838097|P2|Overall Study|Lost to Follow-up|0
1670912|NCT01469182|5838098|P1|Overall Study|Lost to Follow-up|3
1670913|NCT01469182|5838097|P2|Overall Study|Adverse Event|3
1670914|NCT01469182|5838098|P1|Overall Study|Adverse Event|21
1670915|NCT01469065|5838125|P5|Overall Study|Other|0
1670916|NCT01469065|5838126|P4|Overall Study|Other|0
1670917|NCT01469065|5838127|P3|Overall Study|Other|0
1670918|NCT01469065|5838128|P2|Overall Study|Other|1
1670919|NCT01469065|5838129|P1|Overall Study|Other|0
1670920|NCT01469065|5838125|P5|Overall Study|Lack of Efficacy|1
1670921|NCT01469065|5838126|P4|Overall Study|Lack of Efficacy|0
1670922|NCT01469065|5838127|P3|Overall Study|Lack of Efficacy|0
1670923|NCT01469065|5838128|P2|Overall Study|Lack of Efficacy|0
1670924|NCT01469065|5838129|P1|Overall Study|Lack of Efficacy|0
1670925|NCT01469052|5838225|P6|Overall Study|Other|0
1670926|NCT01469052|5838226|P5|Overall Study|Other|1
1670927|NCT01469052|5838227|P4|Overall Study|Other|0
1670928|NCT01469052|5838228|P3|Overall Study|Other|0
1670929|NCT01469052|5838229|P2|Overall Study|Other|1
1670930|NCT01469052|5838230|P1|Overall Study|Other|0
1670931|NCT01469052|5838225|P6|Overall Study|Moved to rollover protocol|1
1670932|NCT01469052|5838226|P5|Overall Study|Moved to rollover protocol|0
1670933|NCT01469052|5838227|P4|Overall Study|Moved to rollover protocol|0
1670934|NCT01469052|5838228|P3|Overall Study|Moved to rollover protocol|1
1670935|NCT01469052|5838229|P2|Overall Study|Moved to rollover protocol|0
1670936|NCT01469052|5838230|P1|Overall Study|Moved to rollover protocol|1
1670937|NCT01469052|5838225|P6|Overall Study|Lack of Efficacy|2
1670938|NCT01469052|5838226|P5|Overall Study|Lack of Efficacy|0
1670939|NCT01469052|5838227|P4|Overall Study|Lack of Efficacy|0
1670940|NCT01469052|5838228|P3|Overall Study|Lack of Efficacy|0
1670941|NCT01469052|5838229|P2|Overall Study|Lack of Efficacy|0
1670942|NCT01469052|5838230|P1|Overall Study|Lack of Efficacy|0
1670943|NCT01469052|5838225|P6|Overall Study|Progressive disease|2
1670944|NCT01469052|5838226|P5|Overall Study|Progressive disease|7
1670945|NCT01469052|5838227|P4|Overall Study|Progressive disease|3
1670946|NCT01469052|5838228|P3|Overall Study|Progressive disease|5
1670947|NCT01469052|5838229|P2|Overall Study|Progressive disease|0
1670948|NCT01469052|5838230|P1|Overall Study|Progressive disease|3
1670949|NCT01469052|5838225|P6|Overall Study|Adverse Event|1
1670950|NCT01469052|5838226|P5|Overall Study|Adverse Event|0
1670951|NCT01469052|5838227|P4|Overall Study|Adverse Event|2
1670952|NCT01469052|5838228|P3|Overall Study|Adverse Event|0
1670953|NCT01469052|5838229|P2|Overall Study|Adverse Event|3
1670954|NCT01469052|5838230|P1|Overall Study|Adverse Event|2
1670955|NCT01469013|5838295|P13|Part B (Extension Period)|Withdrawal by Subject|3
1670956|NCT01469013|5838296|P12|Part B (Extension Period)|Withdrawal by Subject|0
1670957|NCT01469013|5838297|P11|Part B (Extension Period)|Withdrawal by Subject|1
1670958|NCT01469013|5838298|P10|Part B (Extension Period)|Withdrawal by Subject|0
1670959|NCT01469013|5838299|P9|Part B (Extension Period)|Withdrawal by Subject|1
1670960|NCT01469013|5838300|P8|Part B (Extension Period)|Withdrawal by Subject|0
1670961|NCT01469013|5838301|P7|Part B (Extension Period)|Withdrawal by Subject|0
1670962|NCT01469013|5838302|P6|Part B (Extension Period)|Withdrawal by Subject|0
1670963|NCT01469013|5838303|P5|Part B (Extension Period)|Withdrawal by Subject|0
1670964|NCT01469013|5838304|P4|Part B (Extension Period)|Withdrawal by Subject|0
1670965|NCT01469013|5838305|P3|Part B (Extension Period)|Withdrawal by Subject|0
1670966|NCT01469013|5838306|P2|Part B (Extension Period)|Withdrawal by Subject|0
1670967|NCT01469013|5838307|P1|Part B (Extension Period)|Withdrawal by Subject|0
1670968|NCT01469013|5838295|P13|Part B (Extension Period)|Adverse Event|3
1670969|NCT01469013|5838296|P12|Part B (Extension Period)|Adverse Event|6
1670970|NCT01469013|5838297|P11|Part B (Extension Period)|Adverse Event|1
1670971|NCT01469013|5838298|P10|Part B (Extension Period)|Adverse Event|3
1670972|NCT01469013|5838299|P9|Part B (Extension Period)|Adverse Event|3
1670973|NCT01469013|5838300|P8|Part B (Extension Period)|Adverse Event|5
1670974|NCT01469013|5838301|P7|Part B (Extension Period)|Adverse Event|5
1670975|NCT01469013|5838302|P6|Part B (Extension Period)|Adverse Event|2
1670976|NCT01469013|5838303|P5|Part B (Extension Period)|Adverse Event|0
1670977|NCT01469013|5838304|P4|Part B (Extension Period)|Adverse Event|0
1670978|NCT01469013|5838305|P3|Part B (Extension Period)|Adverse Event|0
1670979|NCT01469013|5838306|P2|Part B (Extension Period)|Adverse Event|0
1670980|NCT01469013|5838307|P1|Part B (Extension Period)|Adverse Event|0
1670981|NCT01469013|5838295|P13|Part A (Treatment Period)|Withdrawal by Subject|0
1670982|NCT01469013|5838296|P12|Part A (Treatment Period)|Withdrawal by Subject|0
1670983|NCT01469013|5838297|P11|Part A (Treatment Period)|Withdrawal by Subject|0
1670984|NCT01469013|5838298|P10|Part A (Treatment Period)|Withdrawal by Subject|0
1670985|NCT01469013|5838299|P9|Part A (Treatment Period)|Withdrawal by Subject|0
1670986|NCT01469013|5838300|P8|Part A (Treatment Period)|Withdrawal by Subject|0
1670987|NCT01469013|5838301|P7|Part A (Treatment Period)|Withdrawal by Subject|0
1670988|NCT01469013|5838302|P6|Part A (Treatment Period)|Withdrawal by Subject|0
1670989|NCT01469013|5838303|P5|Part A (Treatment Period)|Withdrawal by Subject|0
1670990|NCT01469013|5838304|P4|Part A (Treatment Period)|Withdrawal by Subject|0
1670991|NCT01469013|5838305|P3|Part A (Treatment Period)|Withdrawal by Subject|1
1670992|NCT01469013|5838306|P2|Part A (Treatment Period)|Withdrawal by Subject|0
1670993|NCT01469013|5838307|P1|Part A (Treatment Period)|Withdrawal by Subject|0
1670994|NCT01469013|5838295|P13|Part A (Treatment Period)|Adverse Event|0
1670995|NCT01469013|5838296|P12|Part A (Treatment Period)|Adverse Event|0
1670996|NCT01469013|5838297|P11|Part A (Treatment Period)|Adverse Event|0
1670997|NCT01469013|5838298|P10|Part A (Treatment Period)|Adverse Event|0
1670998|NCT01469013|5838299|P9|Part A (Treatment Period)|Adverse Event|0
1670999|NCT01469013|5838300|P8|Part A (Treatment Period)|Adverse Event|0
1671000|NCT01469013|5838301|P7|Part A (Treatment Period)|Adverse Event|0
1671001|NCT01469013|5838302|P6|Part A (Treatment Period)|Adverse Event|0
1671002|NCT01469013|5838303|P5|Part A (Treatment Period)|Adverse Event|1
1671003|NCT01469013|5838304|P4|Part A (Treatment Period)|Adverse Event|0
1671004|NCT01469013|5838305|P3|Part A (Treatment Period)|Adverse Event|0
1671005|NCT01469013|5838306|P2|Part A (Treatment Period)|Adverse Event|0
1671006|NCT01469013|5838307|P1|Part A (Treatment Period)|Adverse Event|1
1671007|NCT01469000|5838392|P2|Overall Study|Sponsor Decision|1
1671008|NCT01469000|5838393|P1|Overall Study|Sponsor Decision|4
1671009|NCT01469000|5838392|P2|Overall Study|Withdrawal by Subject|3
1671010|NCT01469000|5838393|P1|Overall Study|Withdrawal by Subject|16
1671011|NCT01468987|5838413|P2|Overall Study|Sponsor Decision|0
1671012|NCT01468987|5838414|P1|Overall Study|Sponsor Decision|1
1671013|NCT01468987|5838413|P2|Overall Study|Physician Decision|15
1671014|NCT01468987|5838414|P1|Overall Study|Physician Decision|8
1671015|NCT01468987|5838413|P2|Overall Study|Withdrawal by Subject|28
1671016|NCT01468987|5838414|P1|Overall Study|Withdrawal by Subject|28
1671017|NCT01468987|5838413|P2|Overall Study|Protocol Violation|2
1671018|NCT01468987|5838414|P1|Overall Study|Protocol Violation|8
1671019|NCT01468987|5838413|P2|Overall Study|Lost to Follow-up|5
1671020|NCT01468987|5838414|P1|Overall Study|Lost to Follow-up|10
1671021|NCT01468987|5838413|P2|Overall Study|Death|1
1671022|NCT01468987|5838414|P1|Overall Study|Death|4
1671023|NCT01468987|5838413|P2|Overall Study|Adverse Event|9
1671024|NCT01468987|5838414|P1|Overall Study|Adverse Event|12
1671025|NCT01468909|5838591|P2|Overall Study|Never Treated|2
1671026|NCT01468909|5838592|P1|Overall Study|Never Treated|2
1671027|NCT01468818|5838625|P1|Overall Study|Death during treatment|2
1671028|NCT01468311|5838683|P1|Overall Study|Withdrawal by Subject|1
1671029|NCT01468311|5838683|P1|Overall Study|mobilization failure|1
1671030|NCT01468233|5838695|P6|Treatment Period 2|Other|0
1671031|NCT01468233|5838696|P5|Treatment Period 2|Other|1
1671032|NCT01468233|5838697|P4|Treatment Period 2|Other|0
1671033|NCT01468233|5838698|P3|Treatment Period 2|Other|3
1671034|NCT01468233|5838699|P2|Treatment Period 2|Other|0
1671035|NCT01468233|5838700|P1|Treatment Period 2|Other|0
1671036|NCT01468233|5838695|P6|Treatment Period 2|Lost to Follow-up|0
1671037|NCT01468233|5838696|P5|Treatment Period 2|Lost to Follow-up|2
1671038|NCT01468233|5838697|P4|Treatment Period 2|Lost to Follow-up|0
1671039|NCT01468233|5838698|P3|Treatment Period 2|Lost to Follow-up|3
1671040|NCT01468233|5838699|P2|Treatment Period 2|Lost to Follow-up|0
1671041|NCT01468233|5838700|P1|Treatment Period 2|Lost to Follow-up|0
1671042|NCT01468233|5838695|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
1671043|NCT01468233|5838696|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
1671044|NCT01468233|5838697|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
1671045|NCT01468233|5838698|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
1671046|NCT01468233|5838699|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
1671047|NCT01468233|5838700|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
1671048|NCT01468233|5838695|P6|Treatment Period 2|Withdrawal by Subject|1
1671049|NCT01468233|5838696|P5|Treatment Period 2|Withdrawal by Subject|1
1671050|NCT01468233|5838697|P4|Treatment Period 2|Withdrawal by Subject|1
1671051|NCT01468233|5838698|P3|Treatment Period 2|Withdrawal by Subject|9
1671052|NCT01468233|5838699|P2|Treatment Period 2|Withdrawal by Subject|0
1671053|NCT01468233|5838700|P1|Treatment Period 2|Withdrawal by Subject|0
1671054|NCT01468233|5838695|P6|Treatment Period 2|Lack of Efficacy|1
1671055|NCT01468233|5838696|P5|Treatment Period 2|Lack of Efficacy|0
1671056|NCT01468233|5838697|P4|Treatment Period 2|Lack of Efficacy|2
1671057|NCT01468233|5838698|P3|Treatment Period 2|Lack of Efficacy|9
1671058|NCT01468233|5838699|P2|Treatment Period 2|Lack of Efficacy|0
1671059|NCT01468233|5838700|P1|Treatment Period 2|Lack of Efficacy|0
1671060|NCT01468233|5838695|P6|Treatment Period 2|Adverse Event|1
1671061|NCT01468233|5838696|P5|Treatment Period 2|Adverse Event|2
1671062|NCT01468233|5838697|P4|Treatment Period 2|Adverse Event|0
1671063|NCT01468233|5838698|P3|Treatment Period 2|Adverse Event|3
1671064|NCT01468233|5838699|P2|Treatment Period 2|Adverse Event|0
1671065|NCT01468233|5838700|P1|Treatment Period 2|Adverse Event|0
1671066|NCT01468233|5838695|P6|Treatment Period 1|Other|0
1671067|NCT01468233|5838696|P5|Treatment Period 1|Other|0
1671068|NCT01468233|5838697|P4|Treatment Period 1|Other|0
1671069|NCT01468233|5838698|P3|Treatment Period 1|Other|0
1671070|NCT01468233|5838699|P2|Treatment Period 1|Other|1
1671071|NCT01468233|5838700|P1|Treatment Period 1|Other|1
1671072|NCT01468233|5838695|P6|Treatment Period 1|Lost to Follow-up|0
1671073|NCT01468233|5838696|P5|Treatment Period 1|Lost to Follow-up|0
1671074|NCT01468233|5838697|P4|Treatment Period 1|Lost to Follow-up|0
1671075|NCT01468233|5838698|P3|Treatment Period 1|Lost to Follow-up|0
1671076|NCT01468233|5838699|P2|Treatment Period 1|Lost to Follow-up|0
1671077|NCT01468233|5838700|P1|Treatment Period 1|Lost to Follow-up|3
1671078|NCT01468233|5838695|P6|Treatment Period 1|Withdrawal by Subject|0
1671079|NCT01468233|5838696|P5|Treatment Period 1|Withdrawal by Subject|0
1671080|NCT01468233|5838697|P4|Treatment Period 1|Withdrawal by Subject|0
1671081|NCT01468233|5838698|P3|Treatment Period 1|Withdrawal by Subject|0
1671082|NCT01468233|5838699|P2|Treatment Period 1|Withdrawal by Subject|4
1671083|NCT01468233|5838700|P1|Treatment Period 1|Withdrawal by Subject|3
1671084|NCT01468233|5838695|P6|Treatment Period 1|Adverse Event|0
1671085|NCT01468233|5838696|P5|Treatment Period 1|Adverse Event|0
1671086|NCT01468233|5838697|P4|Treatment Period 1|Adverse Event|0
1671087|NCT01468233|5838698|P3|Treatment Period 1|Adverse Event|0
1671088|NCT01468233|5838699|P2|Treatment Period 1|Adverse Event|3
1671089|NCT01468233|5838700|P1|Treatment Period 1|Adverse Event|5
1671090|NCT01468207|5838722|P6|Treatment Period 2|Other|2
1671091|NCT01468207|5838723|P5|Treatment Period 2|Other|1
1671092|NCT01468207|5838724|P4|Treatment Period 2|Other|1
1671093|NCT01468207|5838725|P3|Treatment Period 2|Other|5
1671094|NCT01468207|5838726|P2|Treatment Period 2|Other|0
1671095|NCT01468207|5838727|P1|Treatment Period 2|Other|0
1671096|NCT01468207|5838722|P6|Treatment Period 2|Lost to Follow-up|0
1671097|NCT01468207|5838723|P5|Treatment Period 2|Lost to Follow-up|0
1671098|NCT01468207|5838724|P4|Treatment Period 2|Lost to Follow-up|1
1671099|NCT01468207|5838725|P3|Treatment Period 2|Lost to Follow-up|5
1671100|NCT01468207|5838726|P2|Treatment Period 2|Lost to Follow-up|0
1671101|NCT01468207|5838727|P1|Treatment Period 2|Lost to Follow-up|0
1671102|NCT01468207|5838722|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
1671103|NCT01468207|5838723|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
1671104|NCT01468207|5838724|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
1671105|NCT01468207|5838725|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
1671106|NCT01468207|5838726|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
1671107|NCT01468207|5838727|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
1671108|NCT01468207|5838722|P6|Treatment Period 2|Withdrawal by Subject|2
1671109|NCT01468207|5838723|P5|Treatment Period 2|Withdrawal by Subject|0
1671110|NCT01468207|5838724|P4|Treatment Period 2|Withdrawal by Subject|0
1671111|NCT01468207|5838725|P3|Treatment Period 2|Withdrawal by Subject|5
1671112|NCT01468207|5838726|P2|Treatment Period 2|Withdrawal by Subject|0
1671113|NCT01468207|5838727|P1|Treatment Period 2|Withdrawal by Subject|0
1671114|NCT01468207|5838722|P6|Treatment Period 2|Lack of Efficacy|2
1671115|NCT01468207|5838723|P5|Treatment Period 2|Lack of Efficacy|0
1671116|NCT01468207|5838724|P4|Treatment Period 2|Lack of Efficacy|1
1671117|NCT01468207|5838725|P3|Treatment Period 2|Lack of Efficacy|1
1671118|NCT01468207|5838726|P2|Treatment Period 2|Lack of Efficacy|0
1671119|NCT01468207|5838727|P1|Treatment Period 2|Lack of Efficacy|0
1671120|NCT01468207|5838722|P6|Treatment Period 2|Adverse Event|1
1671121|NCT01468207|5838723|P5|Treatment Period 2|Adverse Event|2
1671122|NCT01468207|5838724|P4|Treatment Period 2|Adverse Event|1
1671123|NCT01468207|5838725|P3|Treatment Period 2|Adverse Event|6
1671124|NCT01468207|5838726|P2|Treatment Period 2|Adverse Event|0
1671125|NCT01468207|5838727|P1|Treatment Period 2|Adverse Event|0
1671126|NCT01468207|5838722|P6|Treatment Period 1|Other|0
1671127|NCT01468207|5838723|P5|Treatment Period 1|Other|0
1671128|NCT01468207|5838724|P4|Treatment Period 1|Other|0
1671129|NCT01468207|5838725|P3|Treatment Period 1|Other|0
1671130|NCT01468207|5838726|P2|Treatment Period 1|Other|2
1671131|NCT01468207|5838727|P1|Treatment Period 1|Other|0
1671132|NCT01468207|5838722|P6|Treatment Period 1|Lost to Follow-up|0
1671133|NCT01468207|5838723|P5|Treatment Period 1|Lost to Follow-up|0
1671134|NCT01468207|5838724|P4|Treatment Period 1|Lost to Follow-up|0
1671135|NCT01468207|5838725|P3|Treatment Period 1|Lost to Follow-up|0
1671136|NCT01468207|5838726|P2|Treatment Period 1|Lost to Follow-up|1
1671137|NCT01468207|5838727|P1|Treatment Period 1|Lost to Follow-up|2
1671138|NCT01468207|5838722|P6|Treatment Period 1|Withdrawal by Subject|0
1671139|NCT01468207|5838723|P5|Treatment Period 1|Withdrawal by Subject|0
1671140|NCT01468207|5838724|P4|Treatment Period 1|Withdrawal by Subject|0
1671141|NCT01468207|5838725|P3|Treatment Period 1|Withdrawal by Subject|0
1671142|NCT01468207|5838726|P2|Treatment Period 1|Withdrawal by Subject|4
1671143|NCT01468207|5838727|P1|Treatment Period 1|Withdrawal by Subject|5
1671144|NCT01468207|5838722|P6|Treatment Period 1|Protocol Violation|0
1671145|NCT01468207|5838723|P5|Treatment Period 1|Protocol Violation|0
1671146|NCT01468207|5838724|P4|Treatment Period 1|Protocol Violation|0
1671147|NCT01468207|5838725|P3|Treatment Period 1|Protocol Violation|0
1671148|NCT01468207|5838726|P2|Treatment Period 1|Protocol Violation|1
1671149|NCT01468207|5838727|P1|Treatment Period 1|Protocol Violation|1
1671150|NCT01468207|5838722|P6|Treatment Period 1|Adverse Event|0
1671151|NCT01468207|5838723|P5|Treatment Period 1|Adverse Event|0
1671152|NCT01468207|5838724|P4|Treatment Period 1|Adverse Event|0
1671153|NCT01468207|5838725|P3|Treatment Period 1|Adverse Event|0
1671154|NCT01468207|5838726|P2|Treatment Period 1|Adverse Event|0
1671155|NCT01468207|5838727|P1|Treatment Period 1|Adverse Event|1
1671156|NCT01468181|5838752|P5|Overall Study|Withdrawal by Subject|0
1671157|NCT01468181|5838753|P4|Overall Study|Withdrawal by Subject|0
1671158|NCT01468181|5838754|P3|Overall Study|Withdrawal by Subject|0
1671159|NCT01468181|5838755|P2|Overall Study|Withdrawal by Subject|1
1671160|NCT01468181|5838756|P1|Overall Study|Withdrawal by Subject|0
1671161|NCT01468181|5838752|P5|Overall Study|Lost to Follow-up|1
1671162|NCT01468181|5838753|P4|Overall Study|Lost to Follow-up|0
1671163|NCT01468181|5838754|P3|Overall Study|Lost to Follow-up|1
1671164|NCT01468181|5838755|P2|Overall Study|Lost to Follow-up|0
1671165|NCT01468181|5838756|P1|Overall Study|Lost to Follow-up|0
1671166|NCT01468181|5838752|P5|Overall Study|Physician Decision|1
1671167|NCT01468181|5838753|P4|Overall Study|Physician Decision|1
1671168|NCT01468181|5838754|P3|Overall Study|Physician Decision|0
1671169|NCT01468181|5838755|P2|Overall Study|Physician Decision|0
1671170|NCT01468181|5838756|P1|Overall Study|Physician Decision|0
1671171|NCT01468181|5838752|P5|Overall Study|Protocol Violation|1
1671172|NCT01468181|5838753|P4|Overall Study|Protocol Violation|0
1671173|NCT01468181|5838754|P3|Overall Study|Protocol Violation|1
1671174|NCT01468181|5838755|P2|Overall Study|Protocol Violation|0
1671175|NCT01468181|5838756|P1|Overall Study|Protocol Violation|2
1671176|NCT01468181|5838752|P5|Overall Study|Adverse Event|2
1671177|NCT01468181|5838753|P4|Overall Study|Adverse Event|2
1671178|NCT01468181|5838754|P3|Overall Study|Adverse Event|6
1671179|NCT01468181|5838755|P2|Overall Study|Adverse Event|1
1671180|NCT01468181|5838756|P1|Overall Study|Adverse Event|8
1671181|NCT01468077|5838805|P2|Overall Study|Physician Decision|0
1671182|NCT01468077|5838806|P1|Overall Study|Physician Decision|1
1671183|NCT01468077|5838805|P2|Overall Study|Lack of Efficacy|1
1671184|NCT01468077|5838806|P1|Overall Study|Lack of Efficacy|1
1671185|NCT01468077|5838805|P2|Overall Study|Adverse Event|2
1671186|NCT01468077|5838806|P1|Overall Study|Adverse Event|2
1671187|NCT01467960|5838868|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
1671188|NCT01467960|5838869|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
1671189|NCT01467960|5838870|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
1671190|NCT01467960|5838871|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
1671191|NCT01467960|5838872|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
1671192|NCT01467960|5838873|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
1671193|NCT01467713|5838932|P4|Overall Study|Reason not Specified|7
1671194|NCT01467713|5838933|P3|Overall Study|Reason not Specified|8
1671195|NCT01467713|5838934|P2|Overall Study|Reason not Specified|11
1671196|NCT01467713|5838935|P1|Overall Study|Reason not Specified|6
1671197|NCT01467713|5838932|P4|Overall Study|Relapse|35
1671198|NCT01467713|5838933|P3|Overall Study|Relapse|28
1671199|NCT01467713|5838934|P2|Overall Study|Relapse|25
1671200|NCT01467713|5838935|P1|Overall Study|Relapse|35
1671201|NCT01467713|5838932|P4|Overall Study|Pregnancy|3
1671202|NCT01467713|5838933|P3|Overall Study|Pregnancy|1
1671203|NCT01467713|5838934|P2|Overall Study|Pregnancy|1
1671204|NCT01467713|5838935|P1|Overall Study|Pregnancy|0
1671205|NCT01467713|5838932|P4|Overall Study|Study Termination|29
1671206|NCT01467713|5838933|P3|Overall Study|Study Termination|28
1671207|NCT01467713|5838934|P2|Overall Study|Study Termination|33
1671208|NCT01467713|5838935|P1|Overall Study|Study Termination|23
1671209|NCT01467713|5838932|P4|Overall Study|Voluntary Withdrawal|20
1671210|NCT01467713|5838933|P3|Overall Study|Voluntary Withdrawal|21
1671211|NCT01467713|5838934|P2|Overall Study|Voluntary Withdrawal|14
1671212|NCT01467713|5838935|P1|Overall Study|Voluntary Withdrawal|18
1671213|NCT01467713|5838932|P4|Overall Study|Lost to Follow-up|9
1671214|NCT01467713|5838933|P3|Overall Study|Lost to Follow-up|6
1671215|NCT01467713|5838934|P2|Overall Study|Lost to Follow-up|12
1671216|NCT01467713|5838935|P1|Overall Study|Lost to Follow-up|9
1671217|NCT01467713|5838932|P4|Overall Study|Major Protocol Deviation|1
1671218|NCT01467713|5838933|P3|Overall Study|Major Protocol Deviation|4
1671219|NCT01467713|5838934|P2|Overall Study|Major Protocol Deviation|4
1671220|NCT01467713|5838935|P1|Overall Study|Major Protocol Deviation|2
1671221|NCT01467713|5838932|P4|Overall Study|Pretreatment Event or Adverse Event|5
1671222|NCT01467713|5838933|P3|Overall Study|Pretreatment Event or Adverse Event|6
1671223|NCT01467713|5838934|P2|Overall Study|Pretreatment Event or Adverse Event|4
1671224|NCT01467713|5838935|P1|Overall Study|Pretreatment Event or Adverse Event|9
1671225|NCT01467700|5838989|P4|Overall Study|Reason not Specified|8
1671226|NCT01467700|5838990|P3|Overall Study|Reason not Specified|2
1671227|NCT01467700|5838991|P2|Overall Study|Reason not Specified|3
1671228|NCT01467700|5838992|P1|Overall Study|Reason not Specified|1
1671229|NCT01467700|5838989|P4|Overall Study|Lack of Efficacy|1
1671230|NCT01467700|5838990|P3|Overall Study|Lack of Efficacy|2
1671231|NCT01467700|5838991|P2|Overall Study|Lack of Efficacy|0
1671232|NCT01467700|5838992|P1|Overall Study|Lack of Efficacy|2
1671233|NCT01467700|5838989|P4|Overall Study|Pregnancy|0
1671234|NCT01467700|5838990|P3|Overall Study|Pregnancy|1
1671235|NCT01467700|5838991|P2|Overall Study|Pregnancy|1
1671236|NCT01467700|5838992|P1|Overall Study|Pregnancy|0
1671237|NCT01467700|5838989|P4|Overall Study|Study Termination|7
1671238|NCT01467700|5838990|P3|Overall Study|Study Termination|10
1671239|NCT01467700|5838991|P2|Overall Study|Study Termination|5
1671240|NCT01467700|5838992|P1|Overall Study|Study Termination|6
1671241|NCT01467700|5838989|P4|Overall Study|Voluntary Withdrawal|2
1671242|NCT01467700|5838990|P3|Overall Study|Voluntary Withdrawal|6
1671243|NCT01467700|5838991|P2|Overall Study|Voluntary Withdrawal|7
1671244|NCT01467700|5838992|P1|Overall Study|Voluntary Withdrawal|5
1671245|NCT01467700|5838989|P4|Overall Study|Lost to Follow-up|3
1671246|NCT01467700|5838990|P3|Overall Study|Lost to Follow-up|2
1671247|NCT01467700|5838991|P2|Overall Study|Lost to Follow-up|5
1671248|NCT01467700|5838992|P1|Overall Study|Lost to Follow-up|6
1671249|NCT01467700|5838989|P4|Overall Study|Major Protocol Deviation|3
1671250|NCT01467700|5838990|P3|Overall Study|Major Protocol Deviation|2
1671251|NCT01467700|5838991|P2|Overall Study|Major Protocol Deviation|3
1671252|NCT01467700|5838992|P1|Overall Study|Major Protocol Deviation|3
1671253|NCT01467700|5838989|P4|Overall Study|Pretreatment Event or Adverse Event|3
1671254|NCT01467700|5838990|P3|Overall Study|Pretreatment Event or Adverse Event|2
1671255|NCT01467700|5838991|P2|Overall Study|Pretreatment Event or Adverse Event|4
1671256|NCT01467700|5838992|P1|Overall Study|Pretreatment Event or Adverse Event|6
1671257|NCT01467661|5839034|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
1671258|NCT01467661|5839034|P1|Overall Study|Lack of Efficacy|3
1671259|NCT01467661|5839034|P1|Overall Study|Withdrawal by Subject|1
1671260|NCT01467661|5839034|P1|Overall Study|Adverse Event|16
1671261|NCT01467583|5839054|P3|Overall Study|Protocol Violation|2
1671262|NCT01467583|5839055|P2|Overall Study|Protocol Violation|0
1671263|NCT01467583|5839056|P1|Overall Study|Protocol Violation|0
1671264|NCT01467583|5839054|P3|Overall Study|Withdrawal by Subject|0
1671265|NCT01467583|5839055|P2|Overall Study|Withdrawal by Subject|0
1671266|NCT01467583|5839056|P1|Overall Study|Withdrawal by Subject|1
1671267|NCT01467583|5839054|P3|Overall Study|Death|0
1671268|NCT01467583|5839055|P2|Overall Study|Death|1
1671269|NCT01467583|5839056|P1|Overall Study|Death|1
1671270|NCT01467570|5839069|P2|Overall Study|Lost to Follow-up|9
1671271|NCT01467570|5839070|P1|Overall Study|Lost to Follow-up|8
1671272|NCT01467505|5839107|P2|Overall Study|Study Terminated by Sponsor|3
1671273|NCT01467505|5839108|P1|Overall Study|Study Terminated by Sponsor|28
1671274|NCT01467505|5839107|P2|Overall Study|Withdrawal by Subject|0
1671275|NCT01467505|5839108|P1|Overall Study|Withdrawal by Subject|4
1671276|NCT01467505|5839107|P2|Overall Study|Adverse Event|0
1671277|NCT01467505|5839108|P1|Overall Study|Adverse Event|1
1671278|NCT01467492|5839140|P2|Overall Study|Enrolled But Not Treated|0
1671279|NCT01467492|5839141|P1|Overall Study|Enrolled But Not Treated|1
1671280|NCT01467492|5839140|P2|Overall Study|Undefined|0
1671281|NCT01467492|5839141|P1|Overall Study|Undefined|2
1671282|NCT01467492|5839140|P2|Overall Study|Lost to Follow-up|2
1671283|NCT01467492|5839141|P1|Overall Study|Lost to Follow-up|3
1671284|NCT01467492|5839140|P2|Overall Study|Adverse Event|3
1671285|NCT01467492|5839141|P1|Overall Study|Adverse Event|4
1671286|NCT01467492|5839140|P2|Overall Study|Study Terminated by Sponsor|4
1671287|NCT01467492|5839141|P1|Overall Study|Study Terminated by Sponsor|6
1671288|NCT01467492|5839140|P2|Overall Study|Withdrawal by Subject|4
1671289|NCT01467492|5839141|P1|Overall Study|Withdrawal by Subject|6
1671290|NCT01467479|5839165|P3|Overall Study|Other|0
1671291|NCT01467479|5839166|P2|Overall Study|Other|0
1671292|NCT01467479|5839167|P1|Overall Study|Other|1
1671293|NCT01467479|5839165|P3|Overall Study|Study Terminated by Sponsor|3
1671294|NCT01467479|5839166|P2|Overall Study|Study Terminated by Sponsor|3
1671295|NCT01467479|5839167|P1|Overall Study|Study Terminated by Sponsor|1
1671296|NCT01467479|5839165|P3|Overall Study|Withdrawal of Consent|7
1671297|NCT01467479|5839166|P2|Overall Study|Withdrawal of Consent|7
1671298|NCT01467479|5839167|P1|Overall Study|Withdrawal of Consent|3
1671299|NCT01467479|5839165|P3|Overall Study|Lost to Follow-up|3
1671300|NCT01467479|5839166|P2|Overall Study|Lost to Follow-up|5
1671301|NCT01467479|5839167|P1|Overall Study|Lost to Follow-up|2
1671302|NCT01467479|5839165|P3|Overall Study|Death|1
1671303|NCT01467479|5839166|P2|Overall Study|Death|0
1671304|NCT01467479|5839167|P1|Overall Study|Death|0
1671305|NCT01467479|5839165|P3|Overall Study|Adverse Event|0
1671306|NCT01467479|5839166|P2|Overall Study|Adverse Event|2
1671307|NCT01467479|5839167|P1|Overall Study|Adverse Event|1
1671308|NCT01467479|5839165|P3|Overall Study|No Study Medication|2
1671309|NCT01467479|5839166|P2|Overall Study|No Study Medication|0
1671310|NCT01467479|5839167|P1|Overall Study|No Study Medication|1
1671311|NCT01467466|5839198|P4|Overall Study|No Endpoint Blood Draw|43
1671312|NCT01467466|5839199|P3|Overall Study|No Endpoint Blood Draw|51
1671313|NCT01467466|5839200|P2|Overall Study|No Endpoint Blood Draw|32
1671314|NCT01467466|5839201|P1|Overall Study|No Endpoint Blood Draw|38
1671315|NCT01467466|5839198|P4|Overall Study|Procedure Cancelled|29
1671316|NCT01467466|5839199|P3|Overall Study|Procedure Cancelled|25
1671317|NCT01467466|5839200|P2|Overall Study|Procedure Cancelled|45
1671318|NCT01467466|5839201|P1|Overall Study|Procedure Cancelled|46
1671319|NCT01467466|5839198|P4|Overall Study|Revoked Consent Prior To Procedure|5
1671320|NCT01467466|5839199|P3|Overall Study|Revoked Consent Prior To Procedure|15
1671321|NCT01467466|5839200|P2|Overall Study|Revoked Consent Prior To Procedure|9
1671322|NCT01467466|5839201|P1|Overall Study|Revoked Consent Prior To Procedure|10
1671323|NCT01467466|5839198|P4|Overall Study|Withdrawal by Subject|11
1671324|NCT01467466|5839199|P3|Overall Study|Withdrawal by Subject|13
1671325|NCT01467466|5839200|P2|Overall Study|Withdrawal by Subject|18
1671326|NCT01467466|5839201|P1|Overall Study|Withdrawal by Subject|15
1671333|NCT01467271|5839232|P1|Overall Study|Other reason|14
1671334|NCT01467271|5839232|P1|Overall Study|Retraction of patient's consent|21
1671335|NCT01467271|5839232|P1|Overall Study|Lost to Follow-up|83
1671336|NCT01467271|5839232|P1|Overall Study|Death|84
1671337|NCT01467076|5839239|P3|Overall Study|Lost to Follow-up|0
1671338|NCT01467076|5839240|P2|Overall Study|Lost to Follow-up|0
1671339|NCT01467076|5839241|P1|Overall Study|Lost to Follow-up|1
1671340|NCT01466881|5839307|P1|Overall Study|Other reason not protocol specified|5
1671341|NCT01466881|5839307|P1|Overall Study|Death|4
1671342|NCT01466881|5839307|P1|Overall Study|Progression/relapse|20
1671343|NCT01466881|5839307|P1|Overall Study|Adverse Event|6
1671344|NCT01466881|5839307|P1|Overall Study|Ineligible|5
1671345|NCT01466790|5839324|P8|Overall Study|Withdrawal by Subject|1
1671346|NCT01466790|5839325|P7|Overall Study|Withdrawal by Subject|1
1671347|NCT01466790|5839326|P6|Overall Study|Withdrawal by Subject|0
1671348|NCT01466790|5839327|P5|Overall Study|Withdrawal by Subject|1
1671349|NCT01466790|5839328|P4|Overall Study|Withdrawal by Subject|0
1671350|NCT01466790|5839329|P3|Overall Study|Withdrawal by Subject|0
1671351|NCT01466790|5839330|P2|Overall Study|Withdrawal by Subject|1
1671352|NCT01466790|5839331|P1|Overall Study|Withdrawal by Subject|1
1671353|NCT01466790|5839324|P8|Overall Study|Lost to Follow-up|0
1671354|NCT01466790|5839325|P7|Overall Study|Lost to Follow-up|0
1671355|NCT01466790|5839326|P6|Overall Study|Lost to Follow-up|0
1671356|NCT01466790|5839327|P5|Overall Study|Lost to Follow-up|0
1671357|NCT01466790|5839328|P4|Overall Study|Lost to Follow-up|0
1671358|NCT01466790|5839329|P3|Overall Study|Lost to Follow-up|0
1671359|NCT01466790|5839330|P2|Overall Study|Lost to Follow-up|0
1671360|NCT01466790|5839331|P1|Overall Study|Lost to Follow-up|2
1671361|NCT01466790|5839324|P8|Overall Study|Adverse Event|0
1671362|NCT01466790|5839325|P7|Overall Study|Adverse Event|0
1671363|NCT01466790|5839326|P6|Overall Study|Adverse Event|0
1671364|NCT01466790|5839327|P5|Overall Study|Adverse Event|2
1671365|NCT01466790|5839328|P4|Overall Study|Adverse Event|0
1671366|NCT01466790|5839329|P3|Overall Study|Adverse Event|0
1671367|NCT01466790|5839330|P2|Overall Study|Adverse Event|0
1671368|NCT01466790|5839331|P1|Overall Study|Adverse Event|1
1671369|NCT01466673|5839427|P2|Overall Study|Adverse Event|1
1671370|NCT01466673|5839428|P1|Overall Study|Adverse Event|2
1671371|NCT01466673|5839427|P2|Overall Study|Lost to Follow-up|5
1671372|NCT01466673|5839428|P1|Overall Study|Lost to Follow-up|3
1671373|NCT01466673|5839427|P2|Overall Study|Non-compliance with study treatment|0
1671374|NCT01466673|5839428|P1|Overall Study|Non-compliance with study treatment|2
1671375|NCT01466660|5839454|P2|Overall Study|Other reason not defined above|6
1671376|NCT01466660|5839455|P1|Overall Study|Other reason not defined above|3
1671377|NCT01466660|5839454|P2|Overall Study|Refused continuation of trial medication|3
1671378|NCT01466660|5839455|P1|Overall Study|Refused continuation of trial medication|4
1671379|NCT01466660|5839454|P2|Overall Study|Protocol Violation|1
1671380|NCT01466660|5839455|P1|Overall Study|Protocol Violation|1
1671381|NCT01466660|5839454|P2|Overall Study|Other adverse event|17
1671382|NCT01466660|5839455|P1|Overall Study|Other adverse event|18
1671383|NCT01466660|5839454|P2|Overall Study|Worsening of underlying cancer disease|2
1671384|NCT01466660|5839455|P1|Overall Study|Worsening of underlying cancer disease|5
1671385|NCT01466660|5839454|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
1671386|NCT01466660|5839455|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
1671387|NCT01466595|5839481|P2|Overall Study|Withdrawal by Subject|1
1671388|NCT01466595|5839482|P1|Overall Study|Withdrawal by Subject|0
1671389|NCT01466491|5839576|P4|Overall Study|Missing Data|0
1671390|NCT01466491|5839577|P3|Overall Study|Missing Data|1
1671391|NCT01466491|5839578|P2|Overall Study|Missing Data|0
1671392|NCT01466491|5839579|P1|Overall Study|Missing Data|0
1671393|NCT01466491|5839576|P4|Overall Study|Protocol Violation|0
1671394|NCT01466491|5839577|P3|Overall Study|Protocol Violation|2
1671395|NCT01466491|5839578|P2|Overall Study|Protocol Violation|3
1671396|NCT01466491|5839579|P1|Overall Study|Protocol Violation|0
1671397|NCT01466387|5839599|P6|Overall Study|Protocol Violation|0
1671398|NCT01466387|5839600|P5|Overall Study|Protocol Violation|0
1671399|NCT01466387|5839601|P4|Overall Study|Protocol Violation|1
1671400|NCT01466387|5839602|P3|Overall Study|Protocol Violation|0
1671401|NCT01466387|5839603|P2|Overall Study|Protocol Violation|0
1671402|NCT01466387|5839604|P1|Overall Study|Protocol Violation|1
1671403|NCT01466387|5839599|P6|Overall Study|Lost to Follow-up|1
1671404|NCT01466387|5839600|P5|Overall Study|Lost to Follow-up|0
1671405|NCT01466387|5839601|P4|Overall Study|Lost to Follow-up|0
1671406|NCT01466387|5839602|P3|Overall Study|Lost to Follow-up|0
1671407|NCT01466387|5839603|P2|Overall Study|Lost to Follow-up|0
1671408|NCT01466387|5839604|P1|Overall Study|Lost to Follow-up|0
1671409|NCT01466387|5839599|P6|Overall Study|Adverse Event|0
1671410|NCT01466387|5839600|P5|Overall Study|Adverse Event|0
1671411|NCT01466387|5839601|P4|Overall Study|Adverse Event|1
1671412|NCT01466387|5839602|P3|Overall Study|Adverse Event|1
1671413|NCT01466387|5839603|P2|Overall Study|Adverse Event|0
1671414|NCT01466387|5839604|P1|Overall Study|Adverse Event|0
1671415|NCT01466348|5839665|P2|Period I - First Intervention|Withdrawal by Subject|1
1671416|NCT01466348|5839666|P1|Period I - First Intervention|Withdrawal by Subject|0
1671417|NCT01466270|5839694|P2|Overall Study|Multiple|1
1671418|NCT01466270|5839695|P1|Overall Study|Multiple|1
1671419|NCT01466270|5839694|P2|Overall Study|Toxicity|1
1671420|NCT01466270|5839695|P1|Overall Study|Toxicity|4
1671421|NCT01466270|5839694|P2|Overall Study|Progression|0
1671422|NCT01466270|5839695|P1|Overall Study|Progression|1
1671423|NCT01466270|5839694|P2|Overall Study|Lost to Follow-up|3
1671424|NCT01466270|5839695|P1|Overall Study|Lost to Follow-up|1
1671425|NCT01466270|5839694|P2|Overall Study|Physician Decision|0
1671426|NCT01466270|5839695|P1|Overall Study|Physician Decision|1
1671427|NCT01466270|5839694|P2|Overall Study|Withdrawal by Subject|1
1671428|NCT01466270|5839695|P1|Overall Study|Withdrawal by Subject|4
1671429|NCT01466192|5839707|P1|Overall Study|Withdrawal by Subject|3
1671430|NCT01466192|5839707|P1|Overall Study|Physician Decision|1
1671431|NCT01466179|5839711|P1|Overall Study|Other|3
1671432|NCT01466179|5839711|P1|Overall Study|Protocol Violation|2
1671433|NCT01466179|5839711|P1|Overall Study|Withdrawal by Subject|7
1671434|NCT01466179|5839711|P1|Overall Study|Death|7
1671435|NCT01466179|5839711|P1|Overall Study|Lack of Efficacy|14
1671436|NCT01466179|5839711|P1|Overall Study|Disease relapse|23
1671437|NCT01466179|5839711|P1|Overall Study|Adverse Event|32
1671438|NCT01466179|5839711|P1|Overall Study|Progressive disease|43
1671439|NCT01466179|5839711|P1|Overall Study|Physician Decision|46
1671440|NCT01466179|5839711|P1|Overall Study|Ongoing in core study|2
1671441|NCT01466166|5839731|P1|Overall Study|Other|20
1671442|NCT01466166|5839731|P1|Overall Study|Protocol Violation/Noncompliance|2
1671443|NCT01466166|5839731|P1|Overall Study|Sponsor Decision|4
1671444|NCT01466166|5839731|P1|Overall Study|Withdrawal by Subject|13
1671445|NCT01466166|5839731|P1|Overall Study|Elevated Serum Uric Acid|78
1671446|NCT01466166|5839731|P1|Overall Study|Adverse Event (Other than IR)|11
1671447|NCT01466166|5839731|P1|Overall Study|Infusion Reaction (IR)|27
1671448|NCT01466166|5839731|P1|Overall Study|Lost to Follow-up|7
1671449|NCT01466166|5839731|P1|Overall Study|Death|1
1671450|NCT01466153|5839745|P3|Overall Study|Other-Unspecified|2
1671451|NCT01466153|5839746|P2|Overall Study|Other-Unspecified|4
1671452|NCT01466153|5839747|P1|Overall Study|Other-Unspecified|6
1671453|NCT01466153|5839745|P3|Overall Study|Randomized-Not Treated|4
1671454|NCT01466153|5839746|P2|Overall Study|Randomized-Not Treated|3
1671455|NCT01466153|5839747|P1|Overall Study|Randomized-Not Treated|2
1671456|NCT01466153|5839745|P3|Overall Study|Investigator Discretion|2
1671457|NCT01466153|5839746|P2|Overall Study|Investigator Discretion|2
1671458|NCT01466153|5839747|P1|Overall Study|Investigator Discretion|3
1671459|NCT01466153|5839745|P3|Overall Study|Withdrawal of Consent|0
1671460|NCT01466153|5839746|P2|Overall Study|Withdrawal of Consent|0
1671461|NCT01466153|5839747|P1|Overall Study|Withdrawal of Consent|2
1671462|NCT01466153|5839745|P3|Overall Study|Adverse Event|17
1671463|NCT01466153|5839746|P2|Overall Study|Adverse Event|13
1671464|NCT01466153|5839747|P1|Overall Study|Adverse Event|14
1671465|NCT01466153|5839745|P3|Overall Study|Disease Progression|0
1671466|NCT01466153|5839746|P2|Overall Study|Disease Progression|2
1671467|NCT01466153|5839747|P1|Overall Study|Disease Progression|2
1671468|NCT01466062|5839802|P1|Overall Study|Withdrawal by Subject|1
1671469|NCT01466062|5839802|P1|Overall Study|Adverse Event|1
1671470|NCT01465997|5839825|P2|Overall Study|subject left participation SP0993|1
1671471|NCT01465997|5839826|P1|Overall Study|subject left participation SP0993|0
1671472|NCT01465997|5839825|P2|Overall Study|decision by site staff|1
1671473|NCT01465997|5839826|P1|Overall Study|decision by site staff|0
1671474|NCT01465997|5839825|P2|Overall Study|withdrew before follow-up|13
1671475|NCT01465997|5839826|P1|Overall Study|withdrew before follow-up|0
1671476|NCT01465997|5839825|P2|Overall Study|local lab unblinded site|0
1671477|NCT01465997|5839826|P1|Overall Study|local lab unblinded site|1
1671478|NCT01465997|5839825|P2|Overall Study|subject withdrew consent|0
1671479|NCT01465997|5839826|P1|Overall Study|subject withdrew consent|1
1671480|NCT01465997|5839825|P2|Overall Study|sponsor's decision|1
1671481|NCT01465997|5839826|P1|Overall Study|sponsor's decision|1
1671482|NCT01465997|5839825|P2|Overall Study|Death|1
1671483|NCT01465997|5839826|P1|Overall Study|Death|0
1671484|NCT01465997|5839825|P2|Overall Study|investigator's decision|1
1671485|NCT01465997|5839826|P1|Overall Study|investigator's decision|1
1671486|NCT01465997|5839825|P2|Overall Study|Withdrawal by Subject|35
1671487|NCT01465997|5839826|P1|Overall Study|Withdrawal by Subject|32
1671488|NCT01465997|5839825|P2|Overall Study|Lost to Follow-up|9
1671489|NCT01465997|5839826|P1|Overall Study|Lost to Follow-up|6
1671490|NCT01465997|5839825|P2|Overall Study|Protocol Violation|4
1671491|NCT01465997|5839826|P1|Overall Study|Protocol Violation|1
1671492|NCT01465997|5839825|P2|Overall Study|Lack of Efficacy|1
1671493|NCT01465997|5839826|P1|Overall Study|Lack of Efficacy|13
1671494|NCT01465997|5839825|P2|Overall Study|Adverse Event|22
1671495|NCT01465997|5839826|P1|Overall Study|Adverse Event|12
1671496|NCT01465958|5839836|P2|Subcutaneous (SC) Phase|Adverse Event|1
1671497|NCT01465958|5839837|P1|Subcutaneous (SC) Phase|Adverse Event|0
1671498|NCT01465958|5839836|P2|Run-in Phase|Protocol Violation|0
1671499|NCT01465958|5839837|P1|Run-in Phase|Protocol Violation|1
1671500|NCT01465802|5839850|P5|Overall Study|Death|2
1671501|NCT01465802|5839851|P4|Overall Study|Death|10
1671502|NCT01465802|5839852|P3|Overall Study|Death|0
1671503|NCT01465802|5839853|P2|Overall Study|Death|12
1671504|NCT01465802|5839854|P1|Overall Study|Death|15
1671505|NCT01465802|5839850|P5|Overall Study|Reason not specified|2
1671506|NCT01465802|5839851|P4|Overall Study|Reason not specified|10
1671507|NCT01465802|5839852|P3|Overall Study|Reason not specified|0
1671508|NCT01465802|5839853|P2|Overall Study|Reason not specified|4
1671509|NCT01465802|5839854|P1|Overall Study|Reason not specified|9
1671510|NCT01465802|5839850|P5|Overall Study|Lost to Follow-up|0
1671511|NCT01465802|5839851|P4|Overall Study|Lost to Follow-up|0
1671512|NCT01465802|5839852|P3|Overall Study|Lost to Follow-up|0
1671513|NCT01465802|5839853|P2|Overall Study|Lost to Follow-up|1
1671514|NCT01465802|5839854|P1|Overall Study|Lost to Follow-up|1
1671515|NCT01465802|5839850|P5|Overall Study|Withdrawal by Subject|1
1671516|NCT01465802|5839851|P4|Overall Study|Withdrawal by Subject|8
1671517|NCT01465802|5839852|P3|Overall Study|Withdrawal by Subject|0
1671518|NCT01465802|5839853|P2|Overall Study|Withdrawal by Subject|7
1671519|NCT01465802|5839854|P1|Overall Study|Withdrawal by Subject|7
1671520|NCT01465802|5839850|P5|Overall Study|Study terminated by sponsor|7
1671521|NCT01465802|5839851|P4|Overall Study|Study terminated by sponsor|1
1671522|NCT01465802|5839852|P3|Overall Study|Study terminated by sponsor|0
1671523|NCT01465802|5839853|P2|Overall Study|Study terminated by sponsor|0
1671524|NCT01465802|5839854|P1|Overall Study|Study terminated by sponsor|1
1671525|NCT01465763|5839906|P3|Overall Study|Death|0
1671526|NCT01465763|5839907|P2|Overall Study|Death|0
1671527|NCT01465763|5839908|P1|Overall Study|Death|1
1671528|NCT01465763|5839906|P3|Overall Study|Protocol Violation|1
1671529|NCT01465763|5839907|P2|Overall Study|Protocol Violation|1
1671530|NCT01465763|5839908|P1|Overall Study|Protocol Violation|4
1671531|NCT01465763|5839906|P3|Overall Study|Other|0
1671532|NCT01465763|5839907|P2|Overall Study|Other|0
1671533|NCT01465763|5839908|P1|Overall Study|Other|2
1671534|NCT01465763|5839906|P3|Overall Study|Adverse Event|1
1671535|NCT01465763|5839907|P2|Overall Study|Adverse Event|0
1671536|NCT01465763|5839908|P1|Overall Study|Adverse Event|9
1671537|NCT01465763|5839906|P3|Overall Study|Insufficient Clinical Response|1
1671538|NCT01465763|5839907|P2|Overall Study|Insufficient Clinical Response|0
1671539|NCT01465763|5839908|P1|Overall Study|Insufficient Clinical Response|11
1671540|NCT01465763|5839906|P3|Overall Study|Withdrawal by Subject|1
1671541|NCT01465763|5839907|P2|Overall Study|Withdrawal by Subject|0
1671542|NCT01465763|5839908|P1|Overall Study|Withdrawal by Subject|4
1671543|NCT01465464|5839935|P2|Overall Study|Ongoing treatment at cutoff date|166
1671544|NCT01465464|5839936|P1|Overall Study|Ongoing treatment at cutoff date|140
1671545|NCT01465464|5839935|P2|Overall Study|Other|3
1671546|NCT01465464|5839936|P1|Overall Study|Other|9
1671547|NCT01465464|5839935|P2|Overall Study|Withdrawal by Subject|30
1671548|NCT01465464|5839936|P1|Overall Study|Withdrawal by Subject|46
1671549|NCT01465464|5839935|P2|Overall Study|Protocol Violation|1
1671550|NCT01465464|5839936|P1|Overall Study|Protocol Violation|1
1671551|NCT01465464|5839935|P2|Overall Study|Physician Decision|5
1671552|NCT01465464|5839936|P1|Overall Study|Physician Decision|13
1671553|NCT01465464|5839935|P2|Overall Study|Lack of Efficacy|190
1671554|NCT01465464|5839936|P1|Overall Study|Lack of Efficacy|139
1671555|NCT01465464|5839935|P2|Overall Study|Adverse Event|49
1671556|NCT01465464|5839936|P1|Overall Study|Adverse Event|96
1671557|NCT01465386|5839989|P1|Overall Study|Adverse Event|1
1671558|NCT01465386|5839989|P1|Overall Study|Lack of Efficacy|3
1671559|NCT01465347|5839993|P2|Overall Study|Admitted to hospice|1
1671560|NCT01465347|5839994|P1|Overall Study|Admitted to hospice|0
1671561|NCT01465347|5839993|P2|Overall Study|Physician Decision|1
1671562|NCT01465347|5839994|P1|Overall Study|Physician Decision|0
1671563|NCT01465347|5839993|P2|Overall Study|Withdrawal by Subject|1
1671564|NCT01465347|5839994|P1|Overall Study|Withdrawal by Subject|1
1671565|NCT01465334|5840006|P2|Overall Study|Refractory Disease|3
1671566|NCT01465334|5840007|P1|Overall Study|Refractory Disease|0
1671567|NCT01465334|5840006|P2|Overall Study|Richter's transformation|3
1671568|NCT01465334|5840007|P1|Overall Study|Richter's transformation|0
1671569|NCT01465334|5840006|P2|Overall Study|Adverse Event|0
1671570|NCT01465334|5840007|P1|Overall Study|Adverse Event|1
1671571|NCT01465334|5840006|P2|Overall Study|Disease Progression|0
1671572|NCT01465334|5840007|P1|Overall Study|Disease Progression|1
1671573|NCT01465230|5840033|P1|Overall Study|Withdrawal by Subject|2
1671574|NCT01465178|5840039|P2|Overall Study|Withdrawal by Subject|0
1671575|NCT01465178|5840040|P1|Overall Study|Withdrawal by Subject|1
1671576|NCT01465022|5840064|P3|Overall Study|Not Randomized|70
1671577|NCT01465022|5840065|P2|Overall Study|Not Randomized|0
1671578|NCT01465022|5840066|P1|Overall Study|Not Randomized|0
1671579|NCT01465022|5840064|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
1671580|NCT01465022|5840065|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
1671581|NCT01465022|5840066|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
1671582|NCT01465022|5840064|P3|Overall Study|Lost to Follow-up|0
1671583|NCT01465022|5840065|P2|Overall Study|Lost to Follow-up|14
1671584|NCT01465022|5840066|P1|Overall Study|Lost to Follow-up|15
1671585|NCT01464931|5840100|P2|Overall Study|Withdrawal by Subject|0
1671586|NCT01464931|5840101|P1|Overall Study|Withdrawal by Subject|1
1671587|NCT01464879|5840138|P1|Overall Study|Non-compliance|1
1671588|NCT01464879|5840138|P1|Overall Study|Physician Decision|1
1671589|NCT01464827|5840199|P14|Overall Study|Not Treated|2
1671590|NCT01464827|5840200|P13|Overall Study|Not Treated|0
1671591|NCT01464827|5840201|P12|Overall Study|Not Treated|1
1671592|NCT01464827|5840202|P11|Overall Study|Not Treated|0
1671593|NCT01464827|5840203|P10|Overall Study|Not Treated|2
1671594|NCT01464827|5840204|P9|Overall Study|Not Treated|0
1671595|NCT01464827|5840205|P8|Overall Study|Not Treated|0
1671596|NCT01464827|5840206|P7|Overall Study|Not Treated|1
1671597|NCT01464827|5840207|P6|Overall Study|Not Treated|0
1671598|NCT01464827|5840208|P5|Overall Study|Not Treated|1
1671599|NCT01464827|5840209|P4|Overall Study|Not Treated|0
1671600|NCT01464827|5840210|P3|Overall Study|Not Treated|0
1671601|NCT01464827|5840211|P2|Overall Study|Not Treated|2
1671602|NCT01464827|5840212|P1|Overall Study|Not Treated|0
1671603|NCT01464827|5840199|P14|Overall Study|Other|0
1671604|NCT01464827|5840200|P13|Overall Study|Other|1
1671605|NCT01464827|5840201|P12|Overall Study|Other|0
1671606|NCT01464827|5840202|P11|Overall Study|Other|2
1671607|NCT01464827|5840203|P10|Overall Study|Other|1
1671608|NCT01464827|5840204|P9|Overall Study|Other|3
1671609|NCT01464827|5840205|P8|Overall Study|Other|0
1671610|NCT01464827|5840206|P7|Overall Study|Other|1
1671611|NCT01464827|5840207|P6|Overall Study|Other|0
1671612|NCT01464827|5840208|P5|Overall Study|Other|3
1671613|NCT01464827|5840209|P4|Overall Study|Other|2
1671614|NCT01464827|5840210|P3|Overall Study|Other|0
1671615|NCT01464827|5840211|P2|Overall Study|Other|3
1671616|NCT01464827|5840212|P1|Overall Study|Other|2
1671617|NCT01464827|5840199|P14|Overall Study|Lost to Follow-up|1
1671618|NCT01464827|5840200|P13|Overall Study|Lost to Follow-up|0
1671619|NCT01464827|5840201|P12|Overall Study|Lost to Follow-up|1
1671620|NCT01464827|5840202|P11|Overall Study|Lost to Follow-up|0
1671621|NCT01464827|5840203|P10|Overall Study|Lost to Follow-up|0
1671622|NCT01464827|5840204|P9|Overall Study|Lost to Follow-up|0
1671623|NCT01464827|5840205|P8|Overall Study|Lost to Follow-up|2
1671624|NCT01464827|5840206|P7|Overall Study|Lost to Follow-up|2
1671625|NCT01464827|5840207|P6|Overall Study|Lost to Follow-up|1
1671626|NCT01464827|5840208|P5|Overall Study|Lost to Follow-up|3
1671627|NCT01464827|5840209|P4|Overall Study|Lost to Follow-up|2
1671628|NCT01464827|5840210|P3|Overall Study|Lost to Follow-up|0
1671629|NCT01464827|5840211|P2|Overall Study|Lost to Follow-up|2
1671630|NCT01464827|5840212|P1|Overall Study|Lost to Follow-up|0
1671631|NCT01464827|5840199|P14|Overall Study|Withdrawal by Subject|0
1671632|NCT01464827|5840200|P13|Overall Study|Withdrawal by Subject|0
1671633|NCT01464827|5840201|P12|Overall Study|Withdrawal by Subject|0
1671634|NCT01464827|5840202|P11|Overall Study|Withdrawal by Subject|0
1671635|NCT01464827|5840203|P10|Overall Study|Withdrawal by Subject|0
1671636|NCT01464827|5840204|P9|Overall Study|Withdrawal by Subject|0
1671637|NCT01464827|5840205|P8|Overall Study|Withdrawal by Subject|1
1671638|NCT01464827|5840206|P7|Overall Study|Withdrawal by Subject|0
1671639|NCT01464827|5840207|P6|Overall Study|Withdrawal by Subject|0
1671640|NCT01464827|5840208|P5|Overall Study|Withdrawal by Subject|1
1671641|NCT01464827|5840209|P4|Overall Study|Withdrawal by Subject|0
1671642|NCT01464827|5840210|P3|Overall Study|Withdrawal by Subject|0
1671643|NCT01464827|5840211|P2|Overall Study|Withdrawal by Subject|0
1671644|NCT01464827|5840212|P1|Overall Study|Withdrawal by Subject|1
1671645|NCT01464827|5840199|P14|Overall Study|Adverse Event|0
1671646|NCT01464827|5840200|P13|Overall Study|Adverse Event|1
1671647|NCT01464827|5840201|P12|Overall Study|Adverse Event|0
1671648|NCT01464827|5840202|P11|Overall Study|Adverse Event|0
1671649|NCT01464827|5840203|P10|Overall Study|Adverse Event|0
1671650|NCT01464827|5840204|P9|Overall Study|Adverse Event|0
1671651|NCT01464827|5840205|P8|Overall Study|Adverse Event|0
1671652|NCT01464827|5840206|P7|Overall Study|Adverse Event|0
1671653|NCT01464827|5840207|P6|Overall Study|Adverse Event|0
1671654|NCT01464827|5840208|P5|Overall Study|Adverse Event|0
1671655|NCT01464827|5840209|P4|Overall Study|Adverse Event|0
1671656|NCT01464827|5840210|P3|Overall Study|Adverse Event|0
1671657|NCT01464827|5840211|P2|Overall Study|Adverse Event|0
1671658|NCT01464827|5840212|P1|Overall Study|Adverse Event|0
1671659|NCT01464788|5840259|P3|Overall Study|Patient had hemorrhage after tPA started|0
1671660|NCT01464788|5840260|P2|Overall Study|Patient had hemorrhage after tPA started|1
1671661|NCT01464788|5840261|P1|Overall Study|Patient had hemorrhage after tPA started|0
1671662|NCT01464788|5840259|P3|Overall Study|Lost to Follow-up|0
1671663|NCT01464788|5840260|P2|Overall Study|Lost to Follow-up|1
1671664|NCT01464788|5840261|P1|Overall Study|Lost to Follow-up|0
1671665|NCT01464619|5840336|P2|Overall Study|Lost to Follow-up|4
1671666|NCT01464619|5840337|P1|Overall Study|Lost to Follow-up|3
1671667|NCT01464424|5840357|P2|Period 1, First 6 Weeks|Adverse Event|1
1671668|NCT01464424|5840358|P1|Period 1, First 6 Weeks|Adverse Event|0
1671669|NCT01464346|5840378|P3|Overall Study|Withdrawal by Subject|1
1671670|NCT01464346|5840379|P2|Overall Study|Withdrawal by Subject|0
1671671|NCT01464346|5840380|P1|Overall Study|Withdrawal by Subject|0
1671672|NCT01464333|5840389|P1|Overall Study|No Hospital Visit|42
1671673|NCT01464333|5840389|P1|Overall Study|Other|4
1671674|NCT01464333|5840389|P1|Overall Study|Withdrawal by Subject|11
1671675|NCT01464333|5840389|P1|Overall Study|Lack of Efficacy|72
1671676|NCT01464333|5840389|P1|Overall Study|Adverse Event|34
1671677|NCT01464307|5840402|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
1671678|NCT01464307|5840403|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
1671679|NCT01464307|5840402|P2|Open-Label Extension Period|Non-compliance|0
1671680|NCT01464307|5840403|P1|Open-Label Extension Period|Non-compliance|9
1671681|NCT01464307|5840402|P2|Open-Label Extension Period|Lost to Follow-up|0
1671682|NCT01464307|5840403|P1|Open-Label Extension Period|Lost to Follow-up|1
1671683|NCT01464307|5840402|P2|Open-Label Extension Period|Death|0
1671684|NCT01464307|5840403|P1|Open-Label Extension Period|Death|1
1671685|NCT01464307|5840402|P2|Open-Label Extension Period|Lack of Efficacy|0
1671686|NCT01464307|5840403|P1|Open-Label Extension Period|Lack of Efficacy|5
1671687|NCT01464307|5840402|P2|Open-Label Extension Period|Withdrawal by Subject|0
1671688|NCT01464307|5840403|P1|Open-Label Extension Period|Withdrawal by Subject|14
1671689|NCT01464307|5840402|P2|Open-Label Extension Period|Adverse Event|0
1671690|NCT01464307|5840403|P1|Open-Label Extension Period|Adverse Event|15
1671691|NCT01464307|5840402|P2|Main Period|Predefined discontinuation criteria|1
1671692|NCT01464307|5840403|P1|Main Period|Predefined discontinuation criteria|2
1671693|NCT01464307|5840402|P2|Main Period|Withdrawal by Subject|2
1671694|NCT01464307|5840403|P1|Main Period|Withdrawal by Subject|5
1671695|NCT01464307|5840402|P2|Main Period|Lack of Efficacy|0
1671696|NCT01464307|5840403|P1|Main Period|Lack of Efficacy|2
1671697|NCT01464307|5840402|P2|Main Period|Adverse Event|1
1671698|NCT01464307|5840403|P1|Main Period|Adverse Event|6
1671699|NCT01464307|5840402|P2|Main Period|Death|1
1671700|NCT01464307|5840403|P1|Main Period|Death|0
1671701|NCT01464255|5840418|P2|Overall Study|unresolve corneal staining|1
1671702|NCT01464255|5840419|P1|Overall Study|unresolve corneal staining|0
1671703|NCT01464021|5840464|P1|Overall Study|various|11
1671704|NCT01464021|5840464|P1|Overall Study|Lack of Efficacy|1
1671705|NCT01464021|5840464|P1|Overall Study|Lost to Follow-up|1
1671706|NCT01464021|5840464|P1|Overall Study|Withdrawal by Subject|13
1671707|NCT01463982|5840480|P4|Overall Study|Treatment delay over 5 week|0
1671708|NCT01463982|5840481|P3|Overall Study|Treatment delay over 5 week|1
1671709|NCT01463982|5840482|P2|Overall Study|Treatment delay over 5 week|0
1671710|NCT01463982|5840483|P1|Overall Study|Treatment delay over 5 week|0
1671711|NCT01463982|5840480|P4|Overall Study|Withdrawal by Subject|0
1671712|NCT01463982|5840481|P3|Overall Study|Withdrawal by Subject|1
1671713|NCT01463982|5840482|P2|Overall Study|Withdrawal by Subject|1
1671714|NCT01463982|5840483|P1|Overall Study|Withdrawal by Subject|0
1671715|NCT01463878|5840499|P2|Overall Study|no longer met criteria for tube feed|2
1671716|NCT01463878|5840500|P1|Overall Study|no longer met criteria for tube feed|2
1671717|NCT01463696|5840514|P8|Overall Study|Not Treated|0
1671718|NCT01463696|5840515|P7|Overall Study|Not Treated|1
1671719|NCT01463696|5840516|P6|Overall Study|Not Treated|0
1671720|NCT01463696|5840517|P5|Overall Study|Not Treated|0
1671721|NCT01463696|5840518|P4|Overall Study|Not Treated|0
1671722|NCT01463696|5840519|P3|Overall Study|Not Treated|0
1671723|NCT01463696|5840520|P2|Overall Study|Not Treated|0
1671724|NCT01463696|5840521|P1|Overall Study|Not Treated|0
1671725|NCT01463696|5840514|P8|Overall Study|Withdrawal by Subject|0
1671726|NCT01463696|5840515|P7|Overall Study|Withdrawal by Subject|2
1671727|NCT01463696|5840516|P6|Overall Study|Withdrawal by Subject|1
1671728|NCT01463696|5840517|P5|Overall Study|Withdrawal by Subject|1
1671729|NCT01463696|5840518|P4|Overall Study|Withdrawal by Subject|1
1671730|NCT01463696|5840519|P3|Overall Study|Withdrawal by Subject|0
1671731|NCT01463696|5840520|P2|Overall Study|Withdrawal by Subject|0
1671732|NCT01463696|5840521|P1|Overall Study|Withdrawal by Subject|0
1671733|NCT01463696|5840514|P8|Overall Study|Progressive Disease|2
1671734|NCT01463696|5840515|P7|Overall Study|Progressive Disease|4
1671735|NCT01463696|5840516|P6|Overall Study|Progressive Disease|1
1671736|NCT01463696|5840517|P5|Overall Study|Progressive Disease|0
1671737|NCT01463696|5840518|P4|Overall Study|Progressive Disease|1
1671738|NCT01463696|5840519|P3|Overall Study|Progressive Disease|0
1671739|NCT01463696|5840520|P2|Overall Study|Progressive Disease|1
1671740|NCT01463696|5840521|P1|Overall Study|Progressive Disease|0
1671741|NCT01463696|5840514|P8|Overall Study|Lost to Follow-up|0
1671742|NCT01463696|5840515|P7|Overall Study|Lost to Follow-up|0
1671743|NCT01463696|5840516|P6|Overall Study|Lost to Follow-up|0
1671744|NCT01463696|5840517|P5|Overall Study|Lost to Follow-up|0
1671745|NCT01463696|5840518|P4|Overall Study|Lost to Follow-up|0
1671746|NCT01463696|5840519|P3|Overall Study|Lost to Follow-up|1
1671747|NCT01463696|5840520|P2|Overall Study|Lost to Follow-up|0
1671748|NCT01463696|5840521|P1|Overall Study|Lost to Follow-up|0
1671749|NCT01463696|5840514|P8|Overall Study|Adverse Event|2
1671750|NCT01463696|5840515|P7|Overall Study|Adverse Event|3
1671751|NCT01463696|5840516|P6|Overall Study|Adverse Event|1
1671752|NCT01463696|5840517|P5|Overall Study|Adverse Event|0
1671753|NCT01463696|5840518|P4|Overall Study|Adverse Event|2
1671754|NCT01463696|5840519|P3|Overall Study|Adverse Event|0
1671755|NCT01463696|5840520|P2|Overall Study|Adverse Event|1
1671756|NCT01463696|5840521|P1|Overall Study|Adverse Event|0
1671757|NCT01463683|5840574|P3|Overall Study|Withdrawal by Subject|2
1671758|NCT01463683|5840575|P2|Overall Study|Withdrawal by Subject|17
1671759|NCT01463683|5840576|P1|Overall Study|Withdrawal by Subject|5
1671760|NCT01463683|5840574|P3|Overall Study|Pregnancy|1
1671761|NCT01463683|5840575|P2|Overall Study|Pregnancy|2
1671762|NCT01463683|5840576|P1|Overall Study|Pregnancy|2
1671763|NCT01463683|5840574|P3|Overall Study|Physician Decision|1
1671764|NCT01463683|5840575|P2|Overall Study|Physician Decision|3
1671765|NCT01463683|5840576|P1|Overall Study|Physician Decision|0
1671766|NCT01463683|5840574|P3|Overall Study|Lost to Follow-up|7
1671767|NCT01463683|5840575|P2|Overall Study|Lost to Follow-up|9
1671768|NCT01463683|5840576|P1|Overall Study|Lost to Follow-up|10
1671769|NCT01463683|5840574|P3|Overall Study|Adverse Event|0
1671770|NCT01463683|5840575|P2|Overall Study|Adverse Event|0
1671771|NCT01463683|5840576|P1|Overall Study|Adverse Event|2
1671772|NCT01463631|5840593|P4|Overall Study|Progressive Disease|5
1671773|NCT01463631|5840594|P3|Overall Study|Progressive Disease|0
1671774|NCT01463631|5840595|P2|Overall Study|Progressive Disease|0
1671775|NCT01463631|5840596|P1|Overall Study|Progressive Disease|0
1671776|NCT01463631|5840593|P4|Overall Study|Death|0
1671777|NCT01463631|5840594|P3|Overall Study|Death|1
1671778|NCT01463631|5840595|P2|Overall Study|Death|0
1671779|NCT01463631|5840596|P1|Overall Study|Death|0
1671780|NCT01463631|5840593|P4|Overall Study|Withdrawal by Subject|1
1671781|NCT01463631|5840594|P3|Overall Study|Withdrawal by Subject|0
1671782|NCT01463631|5840595|P2|Overall Study|Withdrawal by Subject|0
1671783|NCT01463631|5840596|P1|Overall Study|Withdrawal by Subject|0
1671784|NCT01463527|5840618|P2|Overall Study|Crying >20% of sedation|6
1671785|NCT01463527|5840619|P1|Overall Study|Crying >20% of sedation|5
1671786|NCT01463527|5840618|P2|Overall Study|Protocol Violation|1
1671787|NCT01463527|5840619|P1|Overall Study|Protocol Violation|1
1671812|NCT01463293|5840715|P3|Overall Study|Other|2
1671813|NCT01463293|5840716|P2|Overall Study|Other|0
1671814|NCT01463293|5840717|P1|Overall Study|Other|0
1671815|NCT01463293|5840715|P3|Overall Study|Withdrawal by Subject|5
1671816|NCT01463293|5840716|P2|Overall Study|Withdrawal by Subject|10
1671817|NCT01463293|5840717|P1|Overall Study|Withdrawal by Subject|4
1671818|NCT01463293|5840715|P3|Overall Study|Adverse Event|0
1671819|NCT01463293|5840716|P2|Overall Study|Adverse Event|2
1671820|NCT01463293|5840717|P1|Overall Study|Adverse Event|1
1671821|NCT01463293|5840715|P3|Overall Study|Lost to Follow-up|5
1671822|NCT01463293|5840716|P2|Overall Study|Lost to Follow-up|4
1671823|NCT01463293|5840717|P1|Overall Study|Lost to Follow-up|1
1671824|NCT01463111|5840740|P1|Overall Study|Physician Decision|2
1671825|NCT01463111|5840740|P1|Overall Study|Lost to Follow-up|5
1671826|NCT01463111|5840740|P1|Overall Study|Withdrawal by Subject|2
1671827|NCT01463098|5840762|P14|Part B (11 Days)|Participant Choice|0
1671828|NCT01463098|5840763|P13|Part B (11 Days)|Participant Choice|0
1671829|NCT01463098|5840764|P12|Part B (11 Days)|Participant Choice|1
1671830|NCT01463098|5840765|P11|Part B (11 Days)|Participant Choice|0
1671831|NCT01463098|5840766|P10|Part B (11 Days)|Participant Choice|0
1671832|NCT01463098|5840767|P9|Part B (11 Days)|Participant Choice|0
1671833|NCT01463098|5840768|P8|Part B (11 Days)|Participant Choice|0
1671834|NCT01463098|5840769|P7|Part B (11 Days)|Participant Choice|0
1671835|NCT01463098|5840770|P6|Part B (11 Days)|Participant Choice|0
1671836|NCT01463098|5840771|P5|Part B (11 Days)|Participant Choice|0
1671837|NCT01463098|5840772|P4|Part B (11 Days)|Participant Choice|0
1671838|NCT01463098|5840773|P3|Part B (11 Days)|Participant Choice|0
1671839|NCT01463098|5840774|P2|Part B (11 Days)|Participant Choice|0
1671840|NCT01463098|5840775|P1|Part B (11 Days)|Participant Choice|0
1671841|NCT01463098|5840762|P14|Part A (11 Days)|Lost to Follow-up|0
1671842|NCT01463098|5840763|P13|Part A (11 Days)|Lost to Follow-up|0
1671843|NCT01463098|5840764|P12|Part A (11 Days)|Lost to Follow-up|0
1671844|NCT01463098|5840765|P11|Part A (11 Days)|Lost to Follow-up|0
1671845|NCT01463098|5840766|P10|Part A (11 Days)|Lost to Follow-up|0
1671846|NCT01463098|5840767|P9|Part A (11 Days)|Lost to Follow-up|0
1671847|NCT01463098|5840768|P8|Part A (11 Days)|Lost to Follow-up|0
1671848|NCT01463098|5840769|P7|Part A (11 Days)|Lost to Follow-up|0
1671849|NCT01463098|5840770|P6|Part A (11 Days)|Lost to Follow-up|0
1671850|NCT01463098|5840771|P5|Part A (11 Days)|Lost to Follow-up|1
1671851|NCT01463098|5840772|P4|Part A (11 Days)|Lost to Follow-up|0
1671852|NCT01463098|5840773|P3|Part A (11 Days)|Lost to Follow-up|0
1671853|NCT01463098|5840774|P2|Part A (11 Days)|Lost to Follow-up|0
1671854|NCT01463098|5840775|P1|Part A (11 Days)|Lost to Follow-up|0
1671855|NCT01463098|5840762|P14|Part A (11 Days)|Participant Choice|0
1671856|NCT01463098|5840763|P13|Part A (11 Days)|Participant Choice|0
1671857|NCT01463098|5840764|P12|Part A (11 Days)|Participant Choice|0
1671858|NCT01463098|5840765|P11|Part A (11 Days)|Participant Choice|0
1671859|NCT01463098|5840766|P10|Part A (11 Days)|Participant Choice|0
1671860|NCT01463098|5840767|P9|Part A (11 Days)|Participant Choice|1
1671861|NCT01463098|5840768|P8|Part A (11 Days)|Participant Choice|0
1671862|NCT01463098|5840769|P7|Part A (11 Days)|Participant Choice|0
1671863|NCT01463098|5840770|P6|Part A (11 Days)|Participant Choice|0
1671864|NCT01463098|5840771|P5|Part A (11 Days)|Participant Choice|0
1671865|NCT01463098|5840772|P4|Part A (11 Days)|Participant Choice|0
1671866|NCT01463098|5840773|P3|Part A (11 Days)|Participant Choice|0
1671867|NCT01463098|5840774|P2|Part A (11 Days)|Participant Choice|0
1671868|NCT01463098|5840775|P1|Part A (11 Days)|Participant Choice|2
1671869|NCT01463033|5841098|P2|Overall Study|Death|2
1671870|NCT01463033|5841099|P1|Overall Study|Death|3
1671871|NCT01463033|5841098|P2|Overall Study|Lost to Follow-up|4
1671872|NCT01463033|5841099|P1|Overall Study|Lost to Follow-up|4
1671873|NCT01463007|5841106|P1|Overall Study|Physician Decision|1
1671874|NCT01462942|5841117|P5|Overall Study|Protocol Violation|6
1671875|NCT01462942|5841118|P4|Overall Study|Protocol Violation|9
1671876|NCT01462942|5841119|P3|Overall Study|Protocol Violation|9
1671877|NCT01462942|5841120|P2|Overall Study|Protocol Violation|6
1671878|NCT01462942|5841121|P1|Overall Study|Protocol Violation|4
1671879|NCT01462942|5841117|P5|Overall Study|Lost to Follow-up|1
1671880|NCT01462942|5841118|P4|Overall Study|Lost to Follow-up|1
1671881|NCT01462942|5841119|P3|Overall Study|Lost to Follow-up|1
1671882|NCT01462942|5841120|P2|Overall Study|Lost to Follow-up|1
1671883|NCT01462942|5841121|P1|Overall Study|Lost to Follow-up|0
1671884|NCT01462942|5841117|P5|Overall Study|Lack of Efficacy|3
1671885|NCT01462942|5841118|P4|Overall Study|Lack of Efficacy|5
1671886|NCT01462942|5841119|P3|Overall Study|Lack of Efficacy|4
1671887|NCT01462942|5841120|P2|Overall Study|Lack of Efficacy|0
1671888|NCT01462942|5841121|P1|Overall Study|Lack of Efficacy|6
1671889|NCT01462942|5841117|P5|Overall Study|Withdrawal by Subject|19
1671890|NCT01462942|5841118|P4|Overall Study|Withdrawal by Subject|16
1671891|NCT01462942|5841119|P3|Overall Study|Withdrawal by Subject|14
1671892|NCT01462942|5841120|P2|Overall Study|Withdrawal by Subject|10
1671893|NCT01462942|5841121|P1|Overall Study|Withdrawal by Subject|14
1671894|NCT01462942|5841117|P5|Overall Study|Other, including COPD exacerbation|5
1671895|NCT01462942|5841118|P4|Overall Study|Other, including COPD exacerbation|8
1671896|NCT01462942|5841119|P3|Overall Study|Other, including COPD exacerbation|2
1671897|NCT01462942|5841120|P2|Overall Study|Other, including COPD exacerbation|5
1671898|NCT01462942|5841121|P1|Overall Study|Other, including COPD exacerbation|3
1671899|NCT01462942|5841117|P5|Overall Study|Adverse Event|11
1671900|NCT01462942|5841118|P4|Overall Study|Adverse Event|11
1671901|NCT01462942|5841119|P3|Overall Study|Adverse Event|10
1671902|NCT01462942|5841120|P2|Overall Study|Adverse Event|12
1671903|NCT01462942|5841121|P1|Overall Study|Adverse Event|7
1671904|NCT01462929|5841151|P3|Overall Study|Lack of Efficacy|1
1671905|NCT01462929|5841152|P2|Overall Study|Lack of Efficacy|0
1671906|NCT01462929|5841153|P1|Overall Study|Lack of Efficacy|0
1671907|NCT01462929|5841151|P3|Overall Study|Withdrawal by Subject|0
1671908|NCT01462929|5841152|P2|Overall Study|Withdrawal by Subject|1
1671909|NCT01462929|5841153|P1|Overall Study|Withdrawal by Subject|2
1671910|NCT01462929|5841151|P3|Overall Study|Adverse Event|4
1671911|NCT01462929|5841152|P2|Overall Study|Adverse Event|3
1671912|NCT01462929|5841153|P1|Overall Study|Adverse Event|3
1671913|NCT01462695|5841194|P2|Overall Study|Inevaluable (did not receive study drug)|0
1671914|NCT01462695|5841195|P1|Overall Study|Inevaluable (did not receive study drug)|1
1671915|NCT01462695|5841194|P2|Overall Study|Withdrawal by Subject|0
1671916|NCT01462695|5841195|P1|Overall Study|Withdrawal by Subject|2
1671917|NCT01462695|5841194|P2|Overall Study|Physician Decision|0
1671918|NCT01462695|5841195|P1|Overall Study|Physician Decision|5
1671919|NCT01462695|5841194|P2|Overall Study|Lack of Efficacy|12
1671920|NCT01462695|5841195|P1|Overall Study|Lack of Efficacy|6
1671921|NCT01462695|5841194|P2|Overall Study|Death|0
1671922|NCT01462695|5841195|P1|Overall Study|Death|2
1671923|NCT01462695|5841194|P2|Overall Study|Adverse Event|1
1671924|NCT01462695|5841195|P1|Overall Study|Adverse Event|1
1671925|NCT01462435|5841223|P4|Overall Study|Lost to Follow-up|1
1671926|NCT01462435|5841224|P3|Overall Study|Lost to Follow-up|0
1671927|NCT01462435|5841225|P2|Overall Study|Lost to Follow-up|0
1671928|NCT01462435|5841226|P1|Overall Study|Lost to Follow-up|0
1671929|NCT01462435|5841223|P4|Overall Study|Withdrawal by Subject|1
1671930|NCT01462435|5841224|P3|Overall Study|Withdrawal by Subject|0
1671931|NCT01462435|5841225|P2|Overall Study|Withdrawal by Subject|0
1671932|NCT01462435|5841226|P1|Overall Study|Withdrawal by Subject|0
1671933|NCT01462435|5841223|P4|Overall Study|Physician Decision|0
1671934|NCT01462435|5841224|P3|Overall Study|Physician Decision|1
1671935|NCT01462435|5841225|P2|Overall Study|Physician Decision|0
1671936|NCT01462435|5841226|P1|Overall Study|Physician Decision|0
1671937|NCT01462435|5841223|P4|Overall Study|Lack of Efficacy|3
1671938|NCT01462435|5841224|P3|Overall Study|Lack of Efficacy|0
1671939|NCT01462435|5841225|P2|Overall Study|Lack of Efficacy|0
1671940|NCT01462435|5841226|P1|Overall Study|Lack of Efficacy|1
1671941|NCT01462370|5841264|P2|Overall Study|Withdrawal by Subject|3
1671942|NCT01462370|5841265|P1|Overall Study|Withdrawal by Subject|0
1671943|NCT01462370|5841264|P2|Overall Study|Physician Decision|1
1671944|NCT01462370|5841265|P1|Overall Study|Physician Decision|0
1671945|NCT01462370|5841264|P2|Overall Study|Lack of Qualifying Event|1
1671946|NCT01462370|5841265|P1|Overall Study|Lack of Qualifying Event|1
1671947|NCT01462357|5841300|P3|Overall Study|Lost to Follow-up|7
1671948|NCT01462357|5841301|P2|Overall Study|Lost to Follow-up|5
1671949|NCT01462357|5841302|P1|Overall Study|Lost to Follow-up|3
1671950|NCT01462357|5841300|P3|Overall Study|Migrated/moved from study area|1
1671951|NCT01462357|5841301|P2|Overall Study|Migrated/moved from study area|3
1671952|NCT01462357|5841302|P1|Overall Study|Migrated/moved from study area|2
1671953|NCT01462357|5841300|P3|Overall Study|Withdrawal by Subject|3
1671954|NCT01462357|5841301|P2|Overall Study|Withdrawal by Subject|11
1671955|NCT01462357|5841302|P1|Overall Study|Withdrawal by Subject|3
1671956|NCT01462357|5841300|P3|Overall Study|Death|1
1671957|NCT01462357|5841301|P2|Overall Study|Death|0
1671958|NCT01462357|5841302|P1|Overall Study|Death|0
1671959|NCT01462344|5841375|P2|Overall Study|Lost to Follow-up|7
1671960|NCT01462344|5841376|P1|Overall Study|Lost to Follow-up|7
1671961|NCT01462344|5841375|P2|Overall Study|Protocol Violation|53
1671962|NCT01462344|5841376|P1|Overall Study|Protocol Violation|68
1671963|NCT01462344|5841375|P2|Overall Study|Lack of Efficacy|6
1671964|NCT01462344|5841376|P1|Overall Study|Lack of Efficacy|5
1671965|NCT01462344|5841375|P2|Overall Study|Asthma Exacerbation|35
1671966|NCT01462344|5841376|P1|Overall Study|Asthma Exacerbation|34
1671967|NCT01462344|5841375|P2|Overall Study|Adverse Event|23
1671968|NCT01462344|5841376|P1|Overall Study|Adverse Event|24
1671969|NCT01462344|5841375|P2|Overall Study|Withdrawal by Subject|226
1671970|NCT01462344|5841376|P1|Overall Study|Withdrawal by Subject|245
1671971|NCT01462318|5841398|P3|Extension Phase|Adverse Event|22
1671972|NCT01462318|5841399|P2|Extension Phase|Adverse Event|0
1671973|NCT01462318|5841400|P1|Extension Phase|Adverse Event|0
1671974|NCT01462318|5841398|P3|Extension Phase|Investigator Decision|5
1671975|NCT01462318|5841399|P2|Extension Phase|Investigator Decision|0
1671976|NCT01462318|5841400|P1|Extension Phase|Investigator Decision|0
1671977|NCT01462318|5841398|P3|Extension Phase|Withdrawal by Subject|15
1671978|NCT01462318|5841399|P2|Extension Phase|Withdrawal by Subject|0
1671979|NCT01462318|5841400|P1|Extension Phase|Withdrawal by Subject|0
1671980|NCT01462318|5841398|P3|Extension Phase|Disease Progression|1
1671981|NCT01462318|5841399|P2|Extension Phase|Disease Progression|0
1671982|NCT01462318|5841400|P1|Extension Phase|Disease Progression|0
1671983|NCT01462318|5841398|P3|Extension Phase|Other|1
1671984|NCT01462318|5841399|P2|Extension Phase|Other|0
1671985|NCT01462318|5841400|P1|Extension Phase|Other|0
1671986|NCT01462318|5841398|P3|Extension Phase|Lost to Follow-up|1
1671987|NCT01462318|5841399|P2|Extension Phase|Lost to Follow-up|0
1671988|NCT01462318|5841400|P1|Extension Phase|Lost to Follow-up|0
1671989|NCT01462318|5841398|P3|Main Study / TP-DI Study|Adverse Event|0
1671990|NCT01462318|5841399|P2|Main Study / TP-DI Study|Adverse Event|0
1671991|NCT01462318|5841400|P1|Main Study / TP-DI Study|Adverse Event|4
1671992|NCT01462318|5841398|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
1671993|NCT01462318|5841399|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
1671994|NCT01462318|5841400|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
1671995|NCT01462318|5841398|P3|Main Study / TP-DI Study|Other|0
1671996|NCT01462318|5841399|P2|Main Study / TP-DI Study|Other|0
1671997|NCT01462318|5841400|P1|Main Study / TP-DI Study|Other|2
1671998|NCT01462266|5841501|P2|Overall Study|Screen failure|1
1671999|NCT01462266|5841502|P1|Overall Study|Screen failure|1
1672000|NCT01462266|5841501|P2|Overall Study|Withdrawal by Subject|2
1672001|NCT01462266|5841502|P1|Overall Study|Withdrawal by Subject|7
1672002|NCT01462266|5841501|P2|Overall Study|Protocol Violation|3
1672003|NCT01462266|5841502|P1|Overall Study|Protocol Violation|1
1672004|NCT01462266|5841501|P2|Overall Study|Physician Decision|5
1672005|NCT01462266|5841502|P1|Overall Study|Physician Decision|2
1672006|NCT01462266|5841501|P2|Overall Study|Creatinine and eGFR, excluded medication|4
1672007|NCT01462266|5841502|P1|Overall Study|Creatinine and eGFR, excluded medication|8
1672008|NCT01462266|5841501|P2|Overall Study|Non-compliance with study drug|0
1672009|NCT01462266|5841502|P1|Overall Study|Non-compliance with study drug|3
1672010|NCT01462266|5841501|P2|Overall Study|Lost to Follow-up|3
1672011|NCT01462266|5841502|P1|Overall Study|Lost to Follow-up|4
1672012|NCT01462266|5841501|P2|Overall Study|Lack of Efficacy|2
1672013|NCT01462266|5841502|P1|Overall Study|Lack of Efficacy|0
1672014|NCT01462266|5841501|P2|Overall Study|Death|1
1672015|NCT01462266|5841502|P1|Overall Study|Death|2
1672016|NCT01462266|5841501|P2|Overall Study|Adverse Event|6
1672017|NCT01462266|5841502|P1|Overall Study|Adverse Event|7
1672018|NCT01462227|5841527|P4|Second Assignment|Protocol Violation|0
1672019|NCT01462227|5841528|P3|Second Assignment|Protocol Violation|1
1672020|NCT01462227|5841529|P2|Second Assignment|Protocol Violation|1
1672021|NCT01462227|5841530|P1|Second Assignment|Protocol Violation|0
1672022|NCT01462227|5841527|P4|Second Assignment|Lost to Follow-up|0
1672023|NCT01462227|5841528|P3|Second Assignment|Lost to Follow-up|0
1672024|NCT01462227|5841529|P2|Second Assignment|Lost to Follow-up|0
1672025|NCT01462227|5841530|P1|Second Assignment|Lost to Follow-up|1
1672026|NCT01462162|5841548|P1|Overall Study|Other|2
1672027|NCT01462162|5841548|P1|Overall Study|Abnormal laboratory parameters|1
1672028|NCT01462162|5841548|P1|Overall Study|Lack of Efficacy|4
1672029|NCT01462162|5841548|P1|Overall Study|Adverse Event|5
1672030|NCT01462084|5841573|P2|Overall Study|Protocol Violation|1
1672031|NCT01462084|5841574|P1|Overall Study|Protocol Violation|1
1672032|NCT01462084|5841573|P2|Overall Study|Withdrawal by Subject|0
1672033|NCT01462084|5841574|P1|Overall Study|Withdrawal by Subject|1
1672034|NCT01462045|5841585|P3|Overall Study|Family matter|0
1672035|NCT01462045|5841586|P2|Overall Study|Family matter|1
1672036|NCT01462045|5841587|P1|Overall Study|Family matter|0
1672037|NCT01461993|5841601|P3|Overall Study|Other|6
1672038|NCT01461993|5841602|P2|Overall Study|Other|15
1672039|NCT01461993|5841603|P1|Overall Study|Other|13
1672040|NCT01461993|5841601|P3|Overall Study|Did not meet entrance criteria|0
1672041|NCT01461993|5841602|P2|Overall Study|Did not meet entrance criteria|3
1672042|NCT01461993|5841603|P1|Overall Study|Did not meet entrance criteria|2
1672043|NCT01461993|5841601|P3|Overall Study|No longer met eligibility criteria|10
1672044|NCT01461993|5841602|P2|Overall Study|No longer met eligibility criteria|18
1672045|NCT01461993|5841603|P1|Overall Study|No longer met eligibility criteria|13
1672046|NCT01461993|5841601|P3|Overall Study|Adverse Event|3
1672047|NCT01461993|5841602|P2|Overall Study|Adverse Event|11
1672048|NCT01461993|5841603|P1|Overall Study|Adverse Event|9
1672049|NCT01461993|5841601|P3|Overall Study|Protocol Violation|7
1672050|NCT01461993|5841602|P2|Overall Study|Protocol Violation|9
1672051|NCT01461993|5841603|P1|Overall Study|Protocol Violation|10
1672052|NCT01461993|5841601|P3|Overall Study|Lost to Follow-up|22
1672053|NCT01461993|5841602|P2|Overall Study|Lost to Follow-up|48
1672054|NCT01461993|5841603|P1|Overall Study|Lost to Follow-up|44
1672055|NCT01461993|5841601|P3|Overall Study|Withdrawal by Subject|16
1672056|NCT01461993|5841602|P2|Overall Study|Withdrawal by Subject|53
1672057|NCT01461993|5841603|P1|Overall Study|Withdrawal by Subject|60
1672058|NCT01461980|5841628|P3|Overall Study|Randomized but not vaccinated|7
1672059|NCT01461980|5841629|P2|Overall Study|Randomized but not vaccinated|8
1672060|NCT01461980|5841630|P1|Overall Study|Randomized but not vaccinated|4
1672061|NCT01461980|5841628|P3|Overall Study|No longer willing to participate|54
1672062|NCT01461980|5841629|P2|Overall Study|No longer willing to participate|38
1672063|NCT01461980|5841630|P1|Overall Study|No longer willing to participate|52
1672064|NCT01461980|5841628|P3|Overall Study|Lost to Follow-up|51
1672065|NCT01461980|5841629|P2|Overall Study|Lost to Follow-up|53
1672066|NCT01461980|5841630|P1|Overall Study|Lost to Follow-up|52
1672067|NCT01461980|5841628|P3|Overall Study|No longer meets eligibility criteria|19
1672068|NCT01461980|5841629|P2|Overall Study|No longer meets eligibility criteria|9
1672069|NCT01461980|5841630|P1|Overall Study|No longer meets eligibility criteria|18
1672070|NCT01461980|5841628|P3|Overall Study|Protocol Violation|16
1672071|NCT01461980|5841629|P2|Overall Study|Protocol Violation|19
1672072|NCT01461980|5841630|P1|Overall Study|Protocol Violation|12
1672073|NCT01461980|5841628|P3|Overall Study|Adverse Event|6
1672074|NCT01461980|5841629|P2|Overall Study|Adverse Event|5
1672075|NCT01461980|5841630|P1|Overall Study|Adverse Event|12
1672076|NCT01461980|5841628|P3|Overall Study|Medication error|6
1672077|NCT01461980|5841629|P2|Overall Study|Medication error|5
1672078|NCT01461980|5841630|P1|Overall Study|Medication error|7
1672079|NCT01461980|5841628|P3|Overall Study|Other|6
1672080|NCT01461980|5841629|P2|Overall Study|Other|8
1672081|NCT01461980|5841630|P1|Overall Study|Other|9
1672082|NCT01461928|5841660|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
1672083|NCT01461928|5841661|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
1672084|NCT01461928|5841662|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
1672085|NCT01461928|5841660|P3|Maintenance II (15 Months)|Withdrew informed consent|1
1672086|NCT01461928|5841661|P2|Maintenance II (15 Months)|Withdrew informed consent|0
1672087|NCT01461928|5841662|P1|Maintenance II (15 Months)|Withdrew informed consent|0
1672088|NCT01461928|5841660|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
1672089|NCT01461928|5841661|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
1672090|NCT01461928|5841662|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
1672091|NCT01461928|5841660|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
1672092|NCT01461928|5841661|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
1672093|NCT01461928|5841662|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
1672094|NCT01461928|5841660|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
1672095|NCT01461928|5841661|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
1672096|NCT01461928|5841662|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
1672097|NCT01461928|5841660|P3|Maintenance II (15 Months)|Disease progression|3
1672098|NCT01461928|5841661|P2|Maintenance II (15 Months)|Disease progression|0
1672099|NCT01461928|5841662|P1|Maintenance II (15 Months)|Disease progression|0
1672100|NCT01461928|5841660|P3|Maintenance II (15 Months)|Moved to another town|0
1672101|NCT01461928|5841661|P2|Maintenance II (15 Months)|Moved to another town|1
1672102|NCT01461928|5841662|P1|Maintenance II (15 Months)|Moved to another town|0
1672103|NCT01461928|5841660|P3|Maintenance II (15 Months)|Lost to Follow-up|0
1672104|NCT01461928|5841661|P2|Maintenance II (15 Months)|Lost to Follow-up|1
1672105|NCT01461928|5841662|P1|Maintenance II (15 Months)|Lost to Follow-up|0
1672106|NCT01461928|5841660|P3|Maintenance II (15 Months)|Physician Decision|4
1672107|NCT01461928|5841661|P2|Maintenance II (15 Months)|Physician Decision|0
1672108|NCT01461928|5841662|P1|Maintenance II (15 Months)|Physician Decision|0
1672109|NCT01461928|5841660|P3|Maintenance II (15 Months)|Death|8
1672110|NCT01461928|5841661|P2|Maintenance II (15 Months)|Death|10
1672111|NCT01461928|5841662|P1|Maintenance II (15 Months)|Death|0
1672112|NCT01461928|5841660|P3|Maintenance II (15 Months)|Adverse Event|0
1672113|NCT01461928|5841661|P2|Maintenance II (15 Months)|Adverse Event|2
1672114|NCT01461928|5841662|P1|Maintenance II (15 Months)|Adverse Event|0
1672115|NCT01461928|5841660|P3|Maintenance I (24 Months)|Did not meet criteria|0
1672116|NCT01461928|5841661|P2|Maintenance I (24 Months)|Did not meet criteria|0
1672117|NCT01461928|5841662|P1|Maintenance I (24 Months)|Did not meet criteria|5
1672118|NCT01461928|5841660|P3|Maintenance I (24 Months)|Not compliant|0
1672119|NCT01461928|5841661|P2|Maintenance I (24 Months)|Not compliant|0
1672120|NCT01461928|5841662|P1|Maintenance I (24 Months)|Not compliant|1
1672121|NCT01461928|5841660|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
1672122|NCT01461928|5841661|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
1672123|NCT01461928|5841662|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
1672124|NCT01461928|5841660|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
1672125|NCT01461928|5841661|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
1672126|NCT01461928|5841662|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
1672127|NCT01461928|5841660|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
1672128|NCT01461928|5841661|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
1672129|NCT01461928|5841662|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
1672130|NCT01461928|5841660|P3|Maintenance I (24 Months)|Physician Decision|0
1672131|NCT01461928|5841661|P2|Maintenance I (24 Months)|Physician Decision|0
1672132|NCT01461928|5841662|P1|Maintenance I (24 Months)|Physician Decision|9
1672133|NCT01461928|5841660|P3|Maintenance I (24 Months)|Adverse Event|0
1672134|NCT01461928|5841661|P2|Maintenance I (24 Months)|Adverse Event|0
1672135|NCT01461928|5841662|P1|Maintenance I (24 Months)|Adverse Event|70
1672136|NCT01461928|5841660|P3|Maintenance I (24 Months)|Diseases progression|0
1672137|NCT01461928|5841661|P2|Maintenance I (24 Months)|Diseases progression|0
1672138|NCT01461928|5841662|P1|Maintenance I (24 Months)|Diseases progression|91
1672139|NCT01461928|5841660|P3|Maintenance I (24 Months)|Lost to Follow-up|0
1672140|NCT01461928|5841661|P2|Maintenance I (24 Months)|Lost to Follow-up|0
1672141|NCT01461928|5841662|P1|Maintenance I (24 Months)|Lost to Follow-up|2
1672142|NCT01461928|5841660|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
1672143|NCT01461928|5841661|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
1672144|NCT01461928|5841662|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
1672145|NCT01461928|5841660|P3|Maintenance I (24 Months)|Death|0
1672146|NCT01461928|5841661|P2|Maintenance I (24 Months)|Death|0
1672147|NCT01461928|5841662|P1|Maintenance I (24 Months)|Death|3
1672148|NCT01461928|5841660|P3|Induction (up to 8 Months)|Medical advisor request|0
1672149|NCT01461928|5841661|P2|Induction (up to 8 Months)|Medical advisor request|0
1672150|NCT01461928|5841662|P1|Induction (up to 8 Months)|Medical advisor request|1
1672151|NCT01461928|5841660|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
1672152|NCT01461928|5841661|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
1672153|NCT01461928|5841662|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
1672154|NCT01461928|5841660|P3|Induction (up to 8 Months)|Promotor request|0
1672155|NCT01461928|5841661|P2|Induction (up to 8 Months)|Promotor request|0
1672156|NCT01461928|5841662|P1|Induction (up to 8 Months)|Promotor request|1
1672157|NCT01461928|5841660|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
1672158|NCT01461928|5841661|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
1672159|NCT01461928|5841662|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
1672160|NCT01461928|5841660|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
1672161|NCT01461928|5841661|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
1672162|NCT01461928|5841662|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
1672163|NCT01461928|5841660|P3|Induction (up to 8 Months)|Protocol deviation|0
1672164|NCT01461928|5841661|P2|Induction (up to 8 Months)|Protocol deviation|0
1672165|NCT01461928|5841662|P1|Induction (up to 8 Months)|Protocol deviation|2
1672166|NCT01461928|5841660|P3|Induction (up to 8 Months)|Sponsor decision|0
1672167|NCT01461928|5841661|P2|Induction (up to 8 Months)|Sponsor decision|0
1672168|NCT01461928|5841662|P1|Induction (up to 8 Months)|Sponsor decision|1
1672169|NCT01461928|5841660|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
1672170|NCT01461928|5841661|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
1672171|NCT01461928|5841662|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
1672172|NCT01461928|5841660|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
1672173|NCT01461928|5841661|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
1672174|NCT01461928|5841662|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
1672175|NCT01461928|5841660|P3|Induction (up to 8 Months)|Not responding to treatment|0
1672176|NCT01461928|5841661|P2|Induction (up to 8 Months)|Not responding to treatment|0
1672177|NCT01461928|5841662|P1|Induction (up to 8 Months)|Not responding to treatment|11
1672178|NCT01461928|5841660|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
1672179|NCT01461928|5841661|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
1672180|NCT01461928|5841662|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
1672181|NCT01461928|5841660|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
1672182|NCT01461928|5841661|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
1672183|NCT01461928|5841662|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
1672184|NCT01461928|5841660|P3|Induction (up to 8 Months)|Disease progression|0
1672185|NCT01461928|5841661|P2|Induction (up to 8 Months)|Disease progression|0
1672186|NCT01461928|5841662|P1|Induction (up to 8 Months)|Disease progression|45
1672187|NCT01461928|5841660|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
1672188|NCT01461928|5841661|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
1672189|NCT01461928|5841662|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
1672190|NCT01461928|5841660|P3|Induction (up to 8 Months)|Physician Decision|0
1672191|NCT01461928|5841661|P2|Induction (up to 8 Months)|Physician Decision|0
1672192|NCT01461928|5841662|P1|Induction (up to 8 Months)|Physician Decision|9
1672193|NCT01461928|5841660|P3|Induction (up to 8 Months)|Lost to Follow-up|0
1672194|NCT01461928|5841661|P2|Induction (up to 8 Months)|Lost to Follow-up|0
1672195|NCT01461928|5841662|P1|Induction (up to 8 Months)|Lost to Follow-up|5
1672196|NCT01461928|5841660|P3|Induction (up to 8 Months)|Death|0
1672197|NCT01461928|5841661|P2|Induction (up to 8 Months)|Death|0
1672198|NCT01461928|5841662|P1|Induction (up to 8 Months)|Death|3
1672199|NCT01461928|5841660|P3|Induction (up to 8 Months)|Adverse Event|0
1672200|NCT01461928|5841661|P2|Induction (up to 8 Months)|Adverse Event|0
1672201|NCT01461928|5841662|P1|Induction (up to 8 Months)|Adverse Event|76
1672202|NCT01461811|5841713|P2|Overall Study|Noncompliance|1
1672203|NCT01461811|5841714|P1|Overall Study|Noncompliance|1
1672204|NCT01461811|5841713|P2|Overall Study|Subject decision unrelated to an AE|1
1672205|NCT01461811|5841714|P1|Overall Study|Subject decision unrelated to an AE|1
1672206|NCT01461811|5841713|P2|Overall Study|Adverse Event|1
1672207|NCT01461811|5841714|P1|Overall Study|Adverse Event|2
1672208|NCT01461707|5841753|P2|Overall Study|Withdrawal by Subject|0
1672209|NCT01461707|5841754|P1|Overall Study|Withdrawal by Subject|1
1672210|NCT01461551|5841791|P3|Overall Study|Physician Decision|2
1672211|NCT01461551|5841792|P2|Overall Study|Physician Decision|1
1672212|NCT01461551|5841793|P1|Overall Study|Physician Decision|2
1672213|NCT01461538|5841804|P3|Overall Study|Withdrawal by Subject|0
1672214|NCT01461538|5841805|P2|Overall Study|Withdrawal by Subject|1
1672215|NCT01461538|5841806|P1|Overall Study|Withdrawal by Subject|1
1672216|NCT01461538|5841804|P3|Overall Study|Study Stopped by Sponsor|0
1672217|NCT01461538|5841805|P2|Overall Study|Study Stopped by Sponsor|1
1672218|NCT01461538|5841806|P1|Overall Study|Study Stopped by Sponsor|2
1672219|NCT01461538|5841804|P3|Overall Study|Death|2
1672220|NCT01461538|5841805|P2|Overall Study|Death|6
1672221|NCT01461538|5841806|P1|Overall Study|Death|15
1672222|NCT01461369|5841875|P3|Overall Study|Withdrawal by Subject|2
1672223|NCT01461369|5841876|P2|Overall Study|Withdrawal by Subject|3
1672224|NCT01461369|5841877|P1|Overall Study|Withdrawal by Subject|1
1672225|NCT01461369|5841875|P3|Overall Study|Protocol Violation|2
1672226|NCT01461369|5841876|P2|Overall Study|Protocol Violation|2
1672227|NCT01461369|5841877|P1|Overall Study|Protocol Violation|1
1672228|NCT01461369|5841875|P3|Overall Study|Adverse Event|4
1672229|NCT01461369|5841876|P2|Overall Study|Adverse Event|12
1672230|NCT01461369|5841877|P1|Overall Study|Adverse Event|9
1672231|NCT01461369|5841875|P3|Overall Study|Lost to Follow-up|3
1672232|NCT01461369|5841876|P2|Overall Study|Lost to Follow-up|0
1672233|NCT01461369|5841877|P1|Overall Study|Lost to Follow-up|0
1672234|NCT01461369|5841875|P3|Overall Study|Lack of Efficacy|6
1672235|NCT01461369|5841876|P2|Overall Study|Lack of Efficacy|0
1672236|NCT01461369|5841877|P1|Overall Study|Lack of Efficacy|2
1672237|NCT01461096|5841902|P2|Overall Study|Lost to Follow-up|4
1672238|NCT01461096|5841903|P1|Overall Study|Lost to Follow-up|8
1672239|NCT01461096|5841902|P2|Overall Study|Subj not willing to adhere to reqs|4
1672240|NCT01461096|5841903|P1|Overall Study|Subj not willing to adhere to reqs|3
1672241|NCT01461096|5841902|P2|Overall Study|Withdrawal by Subject|3
1672242|NCT01461096|5841903|P1|Overall Study|Withdrawal by Subject|5
1672243|NCT01461096|5841902|P2|Overall Study|Site is closing|30
1672244|NCT01461096|5841903|P1|Overall Study|Site is closing|27
1672245|NCT01461096|5841902|P2|Overall Study|Subj not able to get to clinic|13
1672246|NCT01461096|5841903|P1|Overall Study|Subj not able to get to clinic|15
1672247|NCT01461096|5841902|P2|Overall Study|Severe debilitation, unable to continue|1
1672248|NCT01461096|5841903|P1|Overall Study|Severe debilitation, unable to continue|1
1672249|NCT01461096|5841902|P2|Overall Study|Death|6
1672250|NCT01461096|5841903|P1|Overall Study|Death|3
1672251|NCT01461057|5841919|P2|Overall Study|Study Terminated by Sponsor|0
1672252|NCT01461057|5841920|P1|Overall Study|Study Terminated by Sponsor|2
1672253|NCT01461057|5841919|P2|Overall Study|Progression of Disease|0
1672254|NCT01461057|5841920|P1|Overall Study|Progression of Disease|1
1672255|NCT01461057|5841919|P2|Overall Study|Adverse Event|1
1672256|NCT01461057|5841920|P1|Overall Study|Adverse Event|0
1672257|NCT01461057|5841919|P2|Overall Study|Physician Decision|2
1672258|NCT01461057|5841920|P1|Overall Study|Physician Decision|0
1672259|NCT01461057|5841919|P2|Overall Study|Withdrawal by Subject|3
1672260|NCT01461057|5841920|P1|Overall Study|Withdrawal by Subject|2
1672261|NCT01461057|5841919|P2|Overall Study|Death|9
1672262|NCT01461057|5841920|P1|Overall Study|Death|10
1672263|NCT01461044|5841930|P2|Overall Study|Lost to Follow-up|5
1672264|NCT01461044|5841931|P1|Overall Study|Lost to Follow-up|12
1672265|NCT01461044|5841930|P2|Overall Study|Death|35
1672266|NCT01461044|5841931|P1|Overall Study|Death|58
1672268|NCT01460901|5842027|P1|Overall Study|Withdrawal by Subject|2
1672269|NCT01460719|5842059|P1|Overall Study|Withdrawal by Subject|1
1672270|NCT01460719|5842059|P1|Overall Study|Adverse Event|1
1672271|NCT01460628|5842069|P1|Overall Study|Withdrawal by Subject|2
1672272|NCT01460628|5842069|P1|Overall Study|Adverse Event|3
1672273|NCT01460446|5842081|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
1672274|NCT01460446|5842082|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
1672275|NCT01460446|5842081|P2|Overall Study|Pregnancy|0
1672276|NCT01460446|5842082|P1|Overall Study|Pregnancy|1
1672277|NCT01460446|5842081|P2|Overall Study|Surgery/Illness|1
1672278|NCT01460446|5842082|P1|Overall Study|Surgery/Illness|1
1672279|NCT01460446|5842081|P2|Overall Study|Non-compliance & Consent Withdrawn|3
1672280|NCT01460446|5842082|P1|Overall Study|Non-compliance & Consent Withdrawn|1
1672281|NCT01460446|5842081|P2|Overall Study|Consent Withdrawn|4
1672282|NCT01460446|5842082|P1|Overall Study|Consent Withdrawn|0
1672283|NCT01460446|5842081|P2|Overall Study|Non-compliance|9
1672284|NCT01460446|5842082|P1|Overall Study|Non-compliance|2
1672285|NCT01460407|5842109|P2|Period 2: Day 6 to Day 14|Adverse Event|1
1672286|NCT01460407|5842110|P1|Period 2: Day 6 to Day 14|Adverse Event|0
1672287|NCT01460381|5842123|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
1672288|NCT01460381|5842124|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
1672289|NCT01460368|5842140|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1672290|NCT01460368|5842141|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1672291|NCT01460368|5842142|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1672292|NCT01460368|5842143|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1672293|NCT01460368|5842144|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
1672294|NCT01460368|5842145|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1672295|NCT01460368|5842146|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
1672296|NCT01460368|5842140|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
1672297|NCT01460368|5842141|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
1672298|NCT01460368|5842142|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
1672299|NCT01460368|5842143|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
1672300|NCT01460368|5842144|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
1672301|NCT01460368|5842145|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
1672302|NCT01460368|5842146|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
1672303|NCT01460368|5842140|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1672304|NCT01460368|5842141|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1672305|NCT01460368|5842142|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1672306|NCT01460368|5842143|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1672307|NCT01460368|5842144|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1672308|NCT01460368|5842145|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
1672309|NCT01460368|5842146|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
1672310|NCT01460368|5842140|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
1672311|NCT01460368|5842141|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1672312|NCT01460368|5842142|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1672313|NCT01460368|5842143|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1672314|NCT01460368|5842144|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1672315|NCT01460368|5842145|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
1672316|NCT01460368|5842146|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
1672317|NCT01460368|5842140|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1672318|NCT01460368|5842141|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1672319|NCT01460368|5842142|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
1672320|NCT01460368|5842143|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1672321|NCT01460368|5842144|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1672322|NCT01460368|5842145|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1672323|NCT01460368|5842146|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
1672324|NCT01460342|5842158|P2|Overall Study|Lack of Efficacy|0
1672325|NCT01460342|5842159|P1|Overall Study|Lack of Efficacy|1
1672326|NCT01460342|5842158|P2|Overall Study|Physician Decision|3
1672327|NCT01460342|5842159|P1|Overall Study|Physician Decision|1
1672328|NCT01460342|5842158|P2|Overall Study|Withdrawal by Subject|4
1672329|NCT01460342|5842159|P1|Overall Study|Withdrawal by Subject|3
1672330|NCT01460342|5842158|P2|Overall Study|Protocol Violation|1
1672331|NCT01460342|5842159|P1|Overall Study|Protocol Violation|0
1672332|NCT01460342|5842158|P2|Overall Study|Lost to Follow-up|2
1672333|NCT01460342|5842159|P1|Overall Study|Lost to Follow-up|1
1672334|NCT01460342|5842158|P2|Overall Study|Adverse Event|4
1672335|NCT01460342|5842159|P1|Overall Study|Adverse Event|5
1672336|NCT01460290|5842190|P1|Overall Study|Elevated liver function|1
1672337|NCT01460290|5842190|P1|Overall Study|Adverse Event|3
1672364|NCT01459913|5842259|P4|Overall Study|Did Not Meet Inclusion Criteria|1
1672365|NCT01459913|5842260|P3|Overall Study|Did Not Meet Inclusion Criteria|0
1672366|NCT01459913|5842261|P2|Overall Study|Did Not Meet Inclusion Criteria|0
1672367|NCT01459913|5842262|P1|Overall Study|Did Not Meet Inclusion Criteria|0
1672368|NCT01459913|5842259|P4|Overall Study|Other|1
1672369|NCT01459913|5842260|P3|Overall Study|Other|3
1672370|NCT01459913|5842261|P2|Overall Study|Other|0
1672371|NCT01459913|5842262|P1|Overall Study|Other|0
1672372|NCT01459913|5842259|P4|Overall Study|Study Terminated by Sponsor|11
1672373|NCT01459913|5842260|P3|Overall Study|Study Terminated by Sponsor|9
1672374|NCT01459913|5842261|P2|Overall Study|Study Terminated by Sponsor|15
1672375|NCT01459913|5842262|P1|Overall Study|Study Terminated by Sponsor|30
1672376|NCT01459913|5842259|P4|Overall Study|Physician Decision|0
1672377|NCT01459913|5842260|P3|Overall Study|Physician Decision|0
1672378|NCT01459913|5842261|P2|Overall Study|Physician Decision|1
1672379|NCT01459913|5842262|P1|Overall Study|Physician Decision|0
1672380|NCT01459913|5842259|P4|Overall Study|Non- Compliance|3
1672381|NCT01459913|5842260|P3|Overall Study|Non- Compliance|0
1672382|NCT01459913|5842261|P2|Overall Study|Non- Compliance|0
1672383|NCT01459913|5842262|P1|Overall Study|Non- Compliance|0
1672384|NCT01459913|5842259|P4|Overall Study|Death|1
1672385|NCT01459913|5842260|P3|Overall Study|Death|0
1672386|NCT01459913|5842261|P2|Overall Study|Death|0
1672387|NCT01459913|5842262|P1|Overall Study|Death|0
1672388|NCT01459913|5842259|P4|Overall Study|Lost to Follow-up|8
1672389|NCT01459913|5842260|P3|Overall Study|Lost to Follow-up|1
1672390|NCT01459913|5842261|P2|Overall Study|Lost to Follow-up|4
1672391|NCT01459913|5842262|P1|Overall Study|Lost to Follow-up|7
1672392|NCT01459913|5842259|P4|Overall Study|Withdrawal by Subject|5
1672393|NCT01459913|5842260|P3|Overall Study|Withdrawal by Subject|0
1672394|NCT01459913|5842261|P2|Overall Study|Withdrawal by Subject|0
1672395|NCT01459913|5842262|P1|Overall Study|Withdrawal by Subject|4
1672396|NCT01459913|5842259|P4|Overall Study|Adverse Event|3
1672397|NCT01459913|5842260|P3|Overall Study|Adverse Event|0
1672398|NCT01459913|5842261|P2|Overall Study|Adverse Event|0
1672399|NCT01459913|5842262|P1|Overall Study|Adverse Event|0
1672400|NCT01459796|5842293|P2|Overall Study|Decision by the sponsor|108
1672401|NCT01459796|5842294|P1|Overall Study|Decision by the sponsor|75
1672402|NCT01459796|5842293|P2|Overall Study|Reason unspecified|2
1672403|NCT01459796|5842294|P1|Overall Study|Reason unspecified|1
1672404|NCT01459796|5842293|P2|Overall Study|Lost to Follow-up|4
1672405|NCT01459796|5842294|P1|Overall Study|Lost to Follow-up|5
1672406|NCT01459796|5842293|P2|Overall Study|Withdrawal by Subject|3
1672407|NCT01459796|5842294|P1|Overall Study|Withdrawal by Subject|6
1672408|NCT01459796|5842293|P2|Overall Study|Adverse Event|5
1672409|NCT01459796|5842294|P1|Overall Study|Adverse Event|5
1672410|NCT01459796|5842293|P2|Overall Study|Non compliance with protocol|4
1672411|NCT01459796|5842294|P1|Overall Study|Non compliance with protocol|2
1672412|NCT01459783|5842312|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
1672413|NCT01459783|5842313|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
1672414|NCT01459783|5842312|P2|6 Months to 12 Months|Lost to Follow-up|7
1672415|NCT01459783|5842313|P1|6 Months to 12 Months|Lost to Follow-up|2
1672416|NCT01459783|5842312|P2|6 Months to 12 Months|Withdrawal by Subject|5
1672417|NCT01459783|5842313|P1|6 Months to 12 Months|Withdrawal by Subject|6
1672418|NCT01459783|5842312|P2|6 Months to 12 Months|Death|1
1672419|NCT01459783|5842313|P1|6 Months to 12 Months|Death|0
1672420|NCT01459783|5842312|P2|Baseline to 6 Months|Lost to Follow-up|14
1672421|NCT01459783|5842313|P1|Baseline to 6 Months|Lost to Follow-up|19
1672422|NCT01459783|5842312|P2|Baseline to 6 Months|Withdrawal by Subject|6
1672423|NCT01459783|5842313|P1|Baseline to 6 Months|Withdrawal by Subject|12
1672424|NCT01459783|5842312|P2|Baseline to 6 Months|Death|0
1672425|NCT01459783|5842313|P1|Baseline to 6 Months|Death|1
1672426|NCT01459718|5842321|P1|Overall Study|Adverse Event|1
1672427|NCT01459718|5842321|P1|Overall Study|Lost to Follow-up|1
1672428|NCT01459718|5842321|P1|Overall Study|Physician Decision|1
1672429|NCT01459614|5842503|P2|Overall Study|Adverse Event|0
1672430|NCT01459614|5842504|P1|Overall Study|Adverse Event|1
1672431|NCT01459068|5842545|P2|Overall Study|Death|1
1672432|NCT01459068|5842546|P1|Overall Study|Death|0
1672433|NCT01459068|5842545|P2|Overall Study|Lost to Follow-up|15
1672434|NCT01459068|5842546|P1|Overall Study|Lost to Follow-up|31
1672435|NCT01459068|5842545|P2|Overall Study|Withdrawal by Subject|18
1672436|NCT01459068|5842546|P1|Overall Study|Withdrawal by Subject|8
1672437|NCT01459016|5842562|P1|Overall Study|Amendment Discontinuation Criteria|4
1672438|NCT01459016|5842562|P1|Overall Study|Withdrawal by Subject|11
1672439|NCT01458951|5842590|P3|Overall Study|Insufficient Clinical Response|11
1672440|NCT01458951|5842591|P2|Overall Study|Insufficient Clinical Response|0
1672441|NCT01458951|5842592|P1|Overall Study|Insufficient Clinical Response|17
1672442|NCT01458951|5842590|P3|Overall Study|Adverse Event|2
1672443|NCT01458951|5842591|P2|Overall Study|Adverse Event|0
1672444|NCT01458951|5842592|P1|Overall Study|Adverse Event|7
1672445|NCT01458951|5842590|P3|Overall Study|Withdrawal by Subject|2
1672446|NCT01458951|5842591|P2|Overall Study|Withdrawal by Subject|0
1672447|NCT01458951|5842592|P1|Overall Study|Withdrawal by Subject|2
1672448|NCT01458951|5842590|P3|Overall Study|Protocol Violation|0
1672449|NCT01458951|5842591|P2|Overall Study|Protocol Violation|1
1672450|NCT01458951|5842592|P1|Overall Study|Protocol Violation|5
1672451|NCT01458951|5842590|P3|Overall Study|Other|0
1672452|NCT01458951|5842591|P2|Overall Study|Other|0
1672453|NCT01458951|5842592|P1|Overall Study|Other|1
1672454|NCT01458639|5842617|P1|Overall Study|Inability to obtain subject blood sample|1
1672455|NCT01458639|5842617|P1|Overall Study|Equipment issue|1
1672456|NCT01458639|5842617|P1|Overall Study|Physician Decision|4
1672457|NCT01458587|5842629|P2|Overall Study|Withdrawal by Subject|0
1672458|NCT01458587|5842630|P1|Overall Study|Withdrawal by Subject|1
1672459|NCT01458574|5842793|P3|Overall Study|Randomized but not treated|0
1672460|NCT01458574|5842794|P2|Overall Study|Randomized but not treated|1
1672461|NCT01458574|5842795|P1|Overall Study|Randomized but not treated|0
1672462|NCT01458574|5842793|P3|Overall Study|Other|0
1672463|NCT01458574|5842794|P2|Overall Study|Other|1
1672464|NCT01458574|5842795|P1|Overall Study|Other|2
1672465|NCT01458574|5842793|P3|Overall Study|Withdrawal by Subject|5
1672466|NCT01458574|5842794|P2|Overall Study|Withdrawal by Subject|3
1672467|NCT01458574|5842795|P1|Overall Study|Withdrawal by Subject|6
1672468|NCT01458574|5842793|P3|Overall Study|Protocol Violation|0
1672469|NCT01458574|5842794|P2|Overall Study|Protocol Violation|1
1672470|NCT01458574|5842795|P1|Overall Study|Protocol Violation|0
1672471|NCT01458574|5842793|P3|Overall Study|Pregnancy|0
1672472|NCT01458574|5842794|P2|Overall Study|Pregnancy|1
1672473|NCT01458574|5842795|P1|Overall Study|Pregnancy|1
1672474|NCT01458574|5842793|P3|Overall Study|Lost to Follow-up|1
1672475|NCT01458574|5842794|P2|Overall Study|Lost to Follow-up|2
1672476|NCT01458574|5842795|P1|Overall Study|Lost to Follow-up|3
1672477|NCT01458574|5842793|P3|Overall Study|Lack of Efficacy|132
1672478|NCT01458574|5842794|P2|Overall Study|Lack of Efficacy|53
1672479|NCT01458574|5842795|P1|Overall Study|Lack of Efficacy|70
1672480|NCT01458574|5842793|P3|Overall Study|Adverse Event|7
1672481|NCT01458574|5842794|P2|Overall Study|Adverse Event|9
1672482|NCT01458574|5842795|P1|Overall Study|Adverse Event|5
1672483|NCT01458535|5842925|P6|Overall Study|Adverse Event|0
1672484|NCT01458535|5842926|P5|Overall Study|Adverse Event|0
1672485|NCT01458535|5842927|P4|Overall Study|Adverse Event|1
1672486|NCT01458535|5842928|P3|Overall Study|Adverse Event|0
1672487|NCT01458535|5842929|P2|Overall Study|Adverse Event|0
1672488|NCT01458535|5842930|P1|Overall Study|Adverse Event|0
1672489|NCT01458535|5842925|P6|Overall Study|Lost to Follow-up|2
1672490|NCT01458535|5842926|P5|Overall Study|Lost to Follow-up|2
1672491|NCT01458535|5842927|P4|Overall Study|Lost to Follow-up|3
1672492|NCT01458535|5842928|P3|Overall Study|Lost to Follow-up|0
1672493|NCT01458535|5842929|P2|Overall Study|Lost to Follow-up|2
1672494|NCT01458535|5842930|P1|Overall Study|Lost to Follow-up|0
1672495|NCT01458535|5842925|P6|Overall Study|Withdrawal by Subject|1
1672496|NCT01458535|5842926|P5|Overall Study|Withdrawal by Subject|1
1672497|NCT01458535|5842927|P4|Overall Study|Withdrawal by Subject|0
1672498|NCT01458535|5842928|P3|Overall Study|Withdrawal by Subject|2
1672499|NCT01458535|5842929|P2|Overall Study|Withdrawal by Subject|0
1672500|NCT01458535|5842930|P1|Overall Study|Withdrawal by Subject|0
1672501|NCT01458535|5842925|P6|Overall Study|Other|1
1672502|NCT01458535|5842926|P5|Overall Study|Other|1
1672503|NCT01458535|5842927|P4|Overall Study|Other|0
1672504|NCT01458535|5842928|P3|Overall Study|Other|0
1672505|NCT01458535|5842929|P2|Overall Study|Other|0
1672506|NCT01458535|5842930|P1|Overall Study|Other|0
1672507|NCT01458522|5842982|P2|Overall Study|Physician Decision|9
1672508|NCT01458522|5842983|P1|Overall Study|Physician Decision|1
1672509|NCT01458522|5842982|P2|Overall Study|Withdrawal by Subject|2
1672510|NCT01458522|5842983|P1|Overall Study|Withdrawal by Subject|2
1672511|NCT01458392|5843012|P3|Overall Study|Patient unwilling to comply with protoco|2
1672512|NCT01458392|5843013|P2|Overall Study|Patient unwilling to comply with protoco|0
1672513|NCT01458392|5843014|P1|Overall Study|Patient unwilling to comply with protoco|0
1672514|NCT01458392|5843012|P3|Overall Study|At the discretion of the sponsor|7
1672515|NCT01458392|5843013|P2|Overall Study|At the discretion of the sponsor|2
1672516|NCT01458392|5843014|P1|Overall Study|At the discretion of the sponsor|0
1672517|NCT01458392|5843012|P3|Overall Study|Death|22
1672518|NCT01458392|5843013|P2|Overall Study|Death|11
1672519|NCT01458392|5843014|P1|Overall Study|Death|2
1672520|NCT01458275|5843046|P3|Overall Study|Withdrawal by Subject|1
1672521|NCT01458275|5843047|P2|Overall Study|Withdrawal by Subject|2
1672522|NCT01458275|5843048|P1|Overall Study|Withdrawal by Subject|3
1672523|NCT01458275|5843046|P3|Overall Study|Protocol Violation|2
1672524|NCT01458275|5843047|P2|Overall Study|Protocol Violation|5
1672525|NCT01458275|5843048|P1|Overall Study|Protocol Violation|5
1672526|NCT01458275|5843046|P3|Overall Study|Lost to Follow-up|5
1672527|NCT01458275|5843047|P2|Overall Study|Lost to Follow-up|2
1672528|NCT01458275|5843048|P1|Overall Study|Lost to Follow-up|3
1672529|NCT01458275|5843046|P3|Overall Study|Adverse Event|1
1672530|NCT01458275|5843047|P2|Overall Study|Adverse Event|4
1672531|NCT01458275|5843048|P1|Overall Study|Adverse Event|3
1672532|NCT01458249|5843090|P1|Overall Study|Ongoing|1
1672533|NCT01458249|5843090|P1|Overall Study|Other|2
1672534|NCT01458249|5843090|P1|Overall Study|Adverse Event|4
1672535|NCT01458249|5843090|P1|Overall Study|Not treated|1
1672536|NCT01458210|5843109|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
1672537|NCT01458210|5843109|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
1672538|NCT01458210|5843109|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
1672539|NCT01458210|5843109|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
1672540|NCT01458171|5843126|P1|Overall Study|Adverse Event|1
1672541|NCT01458132|5843149|P2|Overall Study|Other|3
1672542|NCT01458132|5843150|P1|Overall Study|Other|15
1672543|NCT01458119|5843158|P1|Overall Study|Non-compliance With Study Drug|3
1672544|NCT01458119|5843158|P1|Overall Study|Consent Withdrawn by Participant|8
1672545|NCT01458119|5843158|P1|Overall Study|Adverse Event|1
1672546|NCT01458119|5843158|P1|Overall Study|Death|2
1672547|NCT01458119|5843158|P1|Overall Study|Pregnancy|1
1672548|NCT01458119|5843158|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
1672549|NCT01458119|5843158|P1|Overall Study|Physician Decision|4
1672550|NCT01458106|5843165|P2|Overall Study|Withdrawn Per Protocol|1
1672551|NCT01458106|5843166|P1|Overall Study|Withdrawn Per Protocol|0
1672552|NCT01458106|5843165|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
1672553|NCT01458106|5843166|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
1672554|NCT01458106|5843165|P2|Overall Study|Withdrawal by Subject|0
1672555|NCT01458106|5843166|P1|Overall Study|Withdrawal by Subject|2
1672556|NCT01457950|5843243|P4|Open-Label Phase|Withdrawal by Subject|0
1672557|NCT01457950|5843244|P3|Open-Label Phase|Withdrawal by Subject|2
1672558|NCT01457950|5843245|P2|Open-Label Phase|Withdrawal by Subject|0
1672559|NCT01457950|5843246|P1|Open-Label Phase|Withdrawal by Subject|0
1672560|NCT01457950|5843243|P4|Open-Label Phase|Protocol Violation|1
1672561|NCT01457950|5843244|P3|Open-Label Phase|Protocol Violation|0
1672562|NCT01457950|5843245|P2|Open-Label Phase|Protocol Violation|0
1672563|NCT01457950|5843246|P1|Open-Label Phase|Protocol Violation|0
1672564|NCT01457950|5843243|P4|Open-Label Phase|Adverse Event|1
1672565|NCT01457950|5843244|P3|Open-Label Phase|Adverse Event|0
1672566|NCT01457950|5843245|P2|Open-Label Phase|Adverse Event|0
1672567|NCT01457950|5843246|P1|Open-Label Phase|Adverse Event|0
1672568|NCT01457950|5843243|P4|Double-Blind Phase|Withdrawal by Subject|0
1672569|NCT01457950|5843244|P3|Double-Blind Phase|Withdrawal by Subject|0
1672570|NCT01457950|5843245|P2|Double-Blind Phase|Withdrawal by Subject|2
1672571|NCT01457950|5843246|P1|Double-Blind Phase|Withdrawal by Subject|6
1672572|NCT01457950|5843243|P4|Double-Blind Phase|Protocol Violation|0
1672573|NCT01457950|5843244|P3|Double-Blind Phase|Protocol Violation|0
1672574|NCT01457950|5843245|P2|Double-Blind Phase|Protocol Violation|1
1672575|NCT01457950|5843246|P1|Double-Blind Phase|Protocol Violation|2
1672576|NCT01457950|5843243|P4|Double-Blind Phase|Continuation Criteria Not Met|0
1672577|NCT01457950|5843244|P3|Double-Blind Phase|Continuation Criteria Not Met|0
1672578|NCT01457950|5843245|P2|Double-Blind Phase|Continuation Criteria Not Met|0
1672579|NCT01457950|5843246|P1|Double-Blind Phase|Continuation Criteria Not Met|1
1672580|NCT01457924|5843325|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1672581|NCT01457924|5843326|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
1672582|NCT01457924|5843327|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1672583|NCT01457924|5843328|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
1672584|NCT01457924|5843329|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
1672585|NCT01457924|5843325|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
1672586|NCT01457924|5843326|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1672587|NCT01457924|5843327|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
1672588|NCT01457924|5843328|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
1672589|NCT01457924|5843329|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
1672590|NCT01457924|5843325|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1672591|NCT01457924|5843326|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1672592|NCT01457924|5843327|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1672593|NCT01457924|5843328|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
1672594|NCT01457924|5843329|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
1672595|NCT01457924|5843325|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
1672596|NCT01457924|5843326|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
1672597|NCT01457924|5843327|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
1672598|NCT01457924|5843328|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
1672599|NCT01457924|5843329|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
1672600|NCT01457924|5843325|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
1672601|NCT01457924|5843326|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
1672602|NCT01457924|5843327|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
1672603|NCT01457924|5843328|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
1672604|NCT01457924|5843329|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
1672605|NCT01457924|5843325|P5|FUP (Weeks 24-48)|Physician Decision|0
1672606|NCT01457924|5843326|P4|FUP (Weeks 24-48)|Physician Decision|0
1672607|NCT01457924|5843327|P3|FUP (Weeks 24-48)|Physician Decision|1
1672608|NCT01457924|5843328|P2|FUP (Weeks 24-48)|Physician Decision|0
1672609|NCT01457924|5843329|P1|FUP (Weeks 24-48)|Physician Decision|1
1672610|NCT01457924|5843325|P5|FUP (Weeks 24-48)|Adverse Event|0
1672611|NCT01457924|5843326|P4|FUP (Weeks 24-48)|Adverse Event|0
1672612|NCT01457924|5843327|P3|FUP (Weeks 24-48)|Adverse Event|1
1672613|NCT01457924|5843328|P2|FUP (Weeks 24-48)|Adverse Event|0
1672614|NCT01457924|5843329|P1|FUP (Weeks 24-48)|Adverse Event|0
1672615|NCT01457924|5843325|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
1672616|NCT01457924|5843326|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1672617|NCT01457924|5843327|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
1672618|NCT01457924|5843328|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1672619|NCT01457924|5843329|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
1672620|NCT01457924|5843325|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1672621|NCT01457924|5843326|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
1672622|NCT01457924|5843327|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1672623|NCT01457924|5843328|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1672624|NCT01457924|5843329|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
1672625|NCT01457924|5843325|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1672626|NCT01457924|5843326|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1672627|NCT01457924|5843327|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1672628|NCT01457924|5843328|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
1672629|NCT01457924|5843329|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
1672630|NCT01457924|5843325|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1672631|NCT01457924|5843326|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1672632|NCT01457924|5843327|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1672633|NCT01457924|5843328|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
1672634|NCT01457924|5843329|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
1672635|NCT01457924|5843325|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
1672636|NCT01457924|5843326|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
1672637|NCT01457924|5843327|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
1672638|NCT01457924|5843328|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
1672639|NCT01457924|5843329|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
1672640|NCT01457924|5843325|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
1672641|NCT01457924|5843326|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
1672642|NCT01457924|5843327|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
1672643|NCT01457924|5843328|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
1672644|NCT01457924|5843329|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
1672645|NCT01457846|5843399|P2|Overall Study|Lost to Follow-up|0
1672646|NCT01457846|5843400|P1|Overall Study|Lost to Follow-up|1
1672647|NCT01457846|5843399|P2|Overall Study|Withdrawal by Subject|1
1672648|NCT01457846|5843400|P1|Overall Study|Withdrawal by Subject|1
1672649|NCT01457846|5843399|P2|Overall Study|Unclassified reason for not completed|10
1672650|NCT01457846|5843400|P1|Overall Study|Unclassified reason for not completed|11
1672651|NCT01457846|5843399|P2|Overall Study|Death|16
1672652|NCT01457846|5843400|P1|Overall Study|Death|27
1672653|NCT01457846|5843399|P2|Overall Study|Did not receive treatment|1
1672654|NCT01457846|5843400|P1|Overall Study|Did not receive treatment|0
1672655|NCT01457846|5843399|P2|Overall Study|Death before treatment|2
1672656|NCT01457846|5843400|P1|Overall Study|Death before treatment|1
1672657|NCT01457703|5843416|P2|Overall Study|Withdrawal by Subject|4
1672658|NCT01457703|5843417|P1|Overall Study|Withdrawal by Subject|1
1672659|NCT01457703|5843416|P2|Overall Study|Screen Failure|7
1672660|NCT01457703|5843417|P1|Overall Study|Screen Failure|5
1672661|NCT01457352|5843528|P2|Period 3|Sponsor's withdrawal|1
1672662|NCT01457352|5843529|P1|Period 3|Sponsor's withdrawal|0
1672663|NCT01457352|5843528|P2|Period 3|incorrect treatment|1
1672664|NCT01457352|5843529|P1|Period 3|incorrect treatment|0
1672665|NCT01457352|5843528|P2|Period 3|Withdrawal by Subject|2
1672666|NCT01457352|5843529|P1|Period 3|Withdrawal by Subject|0
1672667|NCT01457352|5843528|P2|Period 3|Adverse Event|1
1672668|NCT01457352|5843529|P1|Period 3|Adverse Event|1
1672669|NCT01457352|5843528|P2|Period 2|Did not meet eligibility criteria|0
1672670|NCT01457352|5843529|P1|Period 2|Did not meet eligibility criteria|3
1672671|NCT01457352|5843528|P2|Period 2|Physician Decision|0
1672672|NCT01457352|5843529|P1|Period 2|Physician Decision|1
1672673|NCT01457352|5843528|P2|Period 2|dose change|0
1672674|NCT01457352|5843529|P1|Period 2|dose change|1
1672675|NCT01457352|5843528|P2|Period 2|Lost to Follow-up|0
1672676|NCT01457352|5843529|P1|Period 2|Lost to Follow-up|1
1672677|NCT01457352|5843528|P2|Period 2|Sponsor's withdrawal|0
1672678|NCT01457352|5843529|P1|Period 2|Sponsor's withdrawal|7
1672679|NCT01457352|5843528|P2|Period 2|Protocol Violation|0
1672680|NCT01457352|5843529|P1|Period 2|Protocol Violation|4
1672681|NCT01457352|5843528|P2|Period 2|Lack of Efficacy|0
1672682|NCT01457352|5843529|P1|Period 2|Lack of Efficacy|8
1672683|NCT01457352|5843528|P2|Period 2|no analysis|0
1672684|NCT01457352|5843529|P1|Period 2|no analysis|10
1672685|NCT01457352|5843528|P2|Period 2|Adverse Event|0
1672686|NCT01457352|5843529|P1|Period 2|Adverse Event|22
1672687|NCT01457352|5843528|P2|Period 2|Withdrawal by Subject|0
1672688|NCT01457352|5843529|P1|Period 2|Withdrawal by Subject|23
1672689|NCT01457352|5843528|P2|Period 1|Did not meet eligibility criteria|0
1672690|NCT01457352|5843529|P1|Period 1|Did not meet eligibility criteria|3
1672691|NCT01457352|5843528|P2|Period 1|Protocol Violation|0
1672692|NCT01457352|5843529|P1|Period 1|Protocol Violation|4
1672693|NCT01457352|5843528|P2|Period 1|withdrew per sponsor|0
1672694|NCT01457352|5843529|P1|Period 1|withdrew per sponsor|1
1672695|NCT01457352|5843528|P2|Period 1|Withdrawn|0
1672696|NCT01457352|5843529|P1|Period 1|Withdrawn|1
1672697|NCT01457352|5843528|P2|Period 1|MS related disease progression|0
1672698|NCT01457352|5843529|P1|Period 1|MS related disease progression|1
1672699|NCT01457352|5843528|P2|Period 1|Physician Decision|0
1672700|NCT01457352|5843529|P1|Period 1|Physician Decision|2
1672701|NCT01457352|5843528|P2|Period 1|Withdrawal by Subject|0
1672702|NCT01457352|5843529|P1|Period 1|Withdrawal by Subject|2
1672703|NCT01457352|5843528|P2|Period 1|Adverse Event|0
1672704|NCT01457352|5843529|P1|Period 1|Adverse Event|2
1672705|NCT01457339|5843541|P2|Period 6 (250 mg)|Personal appointment|1
1672706|NCT01457339|5843542|P1|Period 6 (250 mg)|Personal appointment|0
1672707|NCT01457339|5843541|P2|Period 6 (250 mg)|Family Emergency|0
1672708|NCT01457339|5843542|P1|Period 6 (250 mg)|Family Emergency|1
1672709|NCT01457339|5843541|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
1672710|NCT01457339|5843542|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
1672711|NCT01457339|5843541|P2|Period 3 (100 mg)|Adverse Event|1
1672712|NCT01457339|5843542|P1|Period 3 (100 mg)|Adverse Event|0
1672713|NCT01457053|5843714|P2|Overall Study|Unable to undergo selected treatment|1
1672714|NCT01457053|5843715|P1|Overall Study|Unable to undergo selected treatment|1
1672715|NCT01457014|5843721|P4|First Night|Withdrawal by Subject|0
1672716|NCT01457014|5843722|P3|First Night|Withdrawal by Subject|0
1672717|NCT01457014|5843723|P2|First Night|Withdrawal by Subject|0
1672718|NCT01457014|5843724|P1|First Night|Withdrawal by Subject|3
1672719|NCT01457014|5843721|P4|First Night|Didn't meet inclusion/exclusion criteria|0
1672720|NCT01457014|5843722|P3|First Night|Didn't meet inclusion/exclusion criteria|0
1672721|NCT01457014|5843723|P2|First Night|Didn't meet inclusion/exclusion criteria|0
1672722|NCT01457014|5843724|P1|First Night|Didn't meet inclusion/exclusion criteria|37
1672723|NCT01456962|5843741|P2|Overall Study|Lost to Follow-up|1
1672724|NCT01456962|5843742|P1|Overall Study|Lost to Follow-up|2
1672725|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
1672726|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
1672727|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
1672728|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
1672729|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
1672730|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
1672731|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
1672732|NCT01456949|5843748|P1|Study Cryoablation Procedure & Follow-up|Death|5
1672733|NCT01456949|5843748|P1|Enrollment|Withdrawal by Subject|7
1672734|NCT01456949|5843748|P1|Enrollment|Physician Decision|10
1672735|NCT01456949|5843748|P1|Enrollment|I/E criteria not met prior to procedure|13
1672736|NCT01456949|5843748|P1|Enrollment|Death|1
1672737|NCT01456949|5843748|P1|Enrollment|PI death- incomplete data|6
1672738|NCT01456936|5843759|P4|Overall Study|Randomized but not treated|21
1672739|NCT01456936|5843760|P3|Overall Study|Randomized but not treated|16
1672740|NCT01456936|5843761|P2|Overall Study|Randomized but not treated|28
1672741|NCT01456936|5843762|P1|Overall Study|Randomized but not treated|21
1672742|NCT01456936|5843759|P4|Overall Study|Death|3
1672743|NCT01456936|5843760|P3|Overall Study|Death|1
1672744|NCT01456936|5843761|P2|Overall Study|Death|3
1672745|NCT01456936|5843762|P1|Overall Study|Death|0
1672746|NCT01456936|5843759|P4|Overall Study|Adverse event (study drug unrelated)|9
1672747|NCT01456936|5843760|P3|Overall Study|Adverse event (study drug unrelated)|9
1672748|NCT01456936|5843761|P2|Overall Study|Adverse event (study drug unrelated)|7
1672749|NCT01456936|5843762|P1|Overall Study|Adverse event (study drug unrelated)|9
1672750|NCT01456936|5843759|P4|Overall Study|Adverse event (study drug)|17
1672751|NCT01456936|5843760|P3|Overall Study|Adverse event (study drug)|26
1672752|NCT01456936|5843761|P2|Overall Study|Adverse event (study drug)|21
1672753|NCT01456936|5843762|P1|Overall Study|Adverse event (study drug)|25
1672754|NCT01456936|5843759|P4|Overall Study|Medication error|1
1672755|NCT01456936|5843760|P3|Overall Study|Medication error|0
1672756|NCT01456936|5843761|P2|Overall Study|Medication error|1
1672757|NCT01456936|5843762|P1|Overall Study|Medication error|0
1672758|NCT01456936|5843759|P4|Overall Study|Lost to Follow-up|127
1672759|NCT01456936|5843760|P3|Overall Study|Lost to Follow-up|144
1672760|NCT01456936|5843761|P2|Overall Study|Lost to Follow-up|126
1672761|NCT01456936|5843762|P1|Overall Study|Lost to Follow-up|135
1672762|NCT01456936|5843759|P4|Overall Study|No longer willing to participate|248
1672763|NCT01456936|5843760|P3|Overall Study|No longer willing to participate|224
1672764|NCT01456936|5843761|P2|Overall Study|No longer willing to participate|218
1672765|NCT01456936|5843762|P1|Overall Study|No longer willing to participate|195
1672766|NCT01456936|5843759|P4|Overall Study|Insufficient clinical response|13
1672767|NCT01456936|5843760|P3|Overall Study|Insufficient clinical response|14
1672768|NCT01456936|5843761|P2|Overall Study|Insufficient clinical response|4
1672769|NCT01456936|5843762|P1|Overall Study|Insufficient clinical response|4
1672770|NCT01456936|5843759|P4|Overall Study|Pregnancy|1
1672771|NCT01456936|5843760|P3|Overall Study|Pregnancy|0
1672772|NCT01456936|5843761|P2|Overall Study|Pregnancy|0
1672773|NCT01456936|5843762|P1|Overall Study|Pregnancy|1
1672774|NCT01456936|5843759|P4|Overall Study|Protocol Violation|5
1672775|NCT01456936|5843760|P3|Overall Study|Protocol Violation|5
1672776|NCT01456936|5843761|P2|Overall Study|Protocol Violation|2
1672777|NCT01456936|5843762|P1|Overall Study|Protocol Violation|4
1672778|NCT01456936|5843759|P4|Overall Study|No longer meets eligibility criteria|5
1672779|NCT01456936|5843760|P3|Overall Study|No longer meets eligibility criteria|6
1672780|NCT01456936|5843761|P2|Overall Study|No longer meets eligibility criteria|8
1672781|NCT01456936|5843762|P1|Overall Study|No longer meets eligibility criteria|4
1672782|NCT01456936|5843759|P4|Overall Study|Other reason|33
1672783|NCT01456936|5843760|P3|Overall Study|Other reason|36
1672784|NCT01456936|5843761|P2|Overall Study|Other reason|30
1672785|NCT01456936|5843762|P1|Overall Study|Other reason|41
1672786|NCT01456897|5843870|P2|Overall Study|Lack of Efficacy|11
1672787|NCT01456897|5843871|P1|Overall Study|Lack of Efficacy|4
1672788|NCT01456897|5843870|P2|Overall Study|Withdrawal by Subject|17
1672789|NCT01456897|5843871|P1|Overall Study|Withdrawal by Subject|44
1672790|NCT01456897|5843870|P2|Overall Study|Physician Decision|3
1672791|NCT01456897|5843871|P1|Overall Study|Physician Decision|5
1672792|NCT01456897|5843870|P2|Overall Study|Protocol Violation|4
1672793|NCT01456897|5843871|P1|Overall Study|Protocol Violation|3
1672794|NCT01456897|5843870|P2|Overall Study|Adverse Event|22
1672795|NCT01456897|5843871|P1|Overall Study|Adverse Event|19
1672796|NCT01456780|5843890|P3|Overall Study|Lost to Follow-up|0
1672797|NCT01456780|5843891|P2|Overall Study|Lost to Follow-up|3
1672798|NCT01456780|5843892|P1|Overall Study|Lost to Follow-up|3
1672799|NCT01456221|5843941|P2|Overall Study|Incomplete data|2
1672800|NCT01456221|5843942|P1|Overall Study|Incomplete data|4
1672801|NCT01456221|5843941|P2|Overall Study|Received medication|2
1672802|NCT01456221|5843942|P1|Overall Study|Received medication|3
1672803|NCT01456221|5843941|P2|Overall Study|Lost to Follow-up|4
1672804|NCT01456221|5843942|P1|Overall Study|Lost to Follow-up|1
1672805|NCT01456221|5843941|P2|Overall Study|Withdrawal by Subject|49
1672806|NCT01456221|5843942|P1|Overall Study|Withdrawal by Subject|56
1672807|NCT01456195|5843957|P3|Overall Study|Other Reasons|3
1672808|NCT01456195|5843958|P2|Overall Study|Other Reasons|1
1672809|NCT01456195|5843959|P1|Overall Study|Other Reasons|2
1672810|NCT01456195|5843957|P3|Overall Study|Lack of Efficacy|0
1672811|NCT01456195|5843958|P2|Overall Study|Lack of Efficacy|1
1672812|NCT01456195|5843959|P1|Overall Study|Lack of Efficacy|0
1672813|NCT01456195|5843957|P3|Overall Study|Voluntary Withdrawal|7
1672814|NCT01456195|5843958|P2|Overall Study|Voluntary Withdrawal|3
1672815|NCT01456195|5843959|P1|Overall Study|Voluntary Withdrawal|5
1672816|NCT01456195|5843957|P3|Overall Study|Lost to Follow-up|3
1672817|NCT01456195|5843958|P2|Overall Study|Lost to Follow-up|1
1672818|NCT01456195|5843959|P1|Overall Study|Lost to Follow-up|3
1672819|NCT01456195|5843957|P3|Overall Study|Pretreatment Event/Adverse Event|1
1672820|NCT01456195|5843958|P2|Overall Study|Pretreatment Event/Adverse Event|4
1672821|NCT01456195|5843959|P1|Overall Study|Pretreatment Event/Adverse Event|1
1672822|NCT01456169|5843979|P3|Overall Study|Other|0
1672823|NCT01456169|5843980|P2|Overall Study|Other|1
1672824|NCT01456169|5843981|P1|Overall Study|Other|1
1672825|NCT01456169|5843979|P3|Overall Study|Lack of Efficacy|0
1672826|NCT01456169|5843980|P2|Overall Study|Lack of Efficacy|0
1672827|NCT01456169|5843981|P1|Overall Study|Lack of Efficacy|2
1672828|NCT01456169|5843979|P3|Overall Study|Voluntary Withdrawal|2
1672829|NCT01456169|5843980|P2|Overall Study|Voluntary Withdrawal|0
1672830|NCT01456169|5843981|P1|Overall Study|Voluntary Withdrawal|3
1672831|NCT01456169|5843979|P3|Overall Study|Major Protocol Deviation|3
1672832|NCT01456169|5843980|P2|Overall Study|Major Protocol Deviation|2
1672833|NCT01456169|5843981|P1|Overall Study|Major Protocol Deviation|3
1672834|NCT01456169|5843979|P3|Overall Study|Adverse Event|7
1672835|NCT01456169|5843980|P2|Overall Study|Adverse Event|2
1672836|NCT01456169|5843981|P1|Overall Study|Adverse Event|1
1672837|NCT01456130|5844041|P1|Overall Study|Other|1
1672838|NCT01456130|5844041|P1|Overall Study|Lack of Efficacy|4
1672839|NCT01456130|5844041|P1|Overall Study|Voluntary Withdrawal|1
1672840|NCT01456130|5844041|P1|Overall Study|Adverse Event|4
1672841|NCT01456052|5844051|P3|Overall Study|Treatment Failure|1
1672842|NCT01456052|5844052|P2|Overall Study|Treatment Failure|1
1672843|NCT01456052|5844053|P1|Overall Study|Treatment Failure|0
1672844|NCT01456052|5844051|P3|Overall Study|Physician Decision|1
1672845|NCT01456052|5844052|P2|Overall Study|Physician Decision|0
1672846|NCT01456052|5844053|P1|Overall Study|Physician Decision|1
1672847|NCT01456052|5844051|P3|Overall Study|Protocol Violation|0
1672848|NCT01456052|5844052|P2|Overall Study|Protocol Violation|1
1672849|NCT01456052|5844053|P1|Overall Study|Protocol Violation|0
1672850|NCT01456052|5844051|P3|Overall Study|Consent withdrawn|1
1672851|NCT01456052|5844052|P2|Overall Study|Consent withdrawn|2
1672852|NCT01456052|5844053|P1|Overall Study|Consent withdrawn|0
1672853|NCT01456052|5844051|P3|Overall Study|Adverse Event|2
1672854|NCT01456052|5844052|P2|Overall Study|Adverse Event|1
1672855|NCT01456052|5844053|P1|Overall Study|Adverse Event|1
1672856|NCT01456039|5844073|P3|Phase 2 (Second Step)|Other|1
1672857|NCT01456039|5844074|P2|Phase 2 (Second Step)|Other|0
1672858|NCT01456039|5844075|P1|Phase 2 (Second Step)|Other|0
1672859|NCT01456039|5844073|P3|Phase 2 (Second Step)|Protocol Violation|1
1672860|NCT01456039|5844074|P2|Phase 2 (Second Step)|Protocol Violation|0
1672861|NCT01456039|5844075|P1|Phase 2 (Second Step)|Protocol Violation|0
1672862|NCT01456039|5844073|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
1672863|NCT01456039|5844074|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
1672864|NCT01456039|5844075|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
1672865|NCT01456039|5844073|P3|Phase 2 (Second Step)|Adverse Event|10
1672866|NCT01456039|5844074|P2|Phase 2 (Second Step)|Adverse Event|0
1672867|NCT01456039|5844075|P1|Phase 2 (Second Step)|Adverse Event|0
1672868|NCT01456039|5844073|P3|Phase 2 (Second Step)|Disease Progression|17
1672869|NCT01456039|5844074|P2|Phase 2 (Second Step)|Disease Progression|0
1672870|NCT01456039|5844075|P1|Phase 2 (Second Step)|Disease Progression|0
1672871|NCT01456039|5844073|P3|Phase 1 (First Step)|Other|0
1672872|NCT01456039|5844074|P2|Phase 1 (First Step)|Other|1
1672873|NCT01456039|5844075|P1|Phase 1 (First Step)|Other|0
1672874|NCT01456039|5844073|P3|Phase 1 (First Step)|Adverse Event|0
1672875|NCT01456039|5844074|P2|Phase 1 (First Step)|Adverse Event|3
1672876|NCT01456039|5844075|P1|Phase 1 (First Step)|Adverse Event|0
1672877|NCT01456039|5844073|P3|Phase 1 (First Step)|Withdrawal by Subject|0
1672878|NCT01456039|5844074|P2|Phase 1 (First Step)|Withdrawal by Subject|2
1672879|NCT01456039|5844075|P1|Phase 1 (First Step)|Withdrawal by Subject|1
1672880|NCT01456039|5844073|P3|Phase 1 (First Step)|Disease Progression|0
1672881|NCT01456039|5844074|P2|Phase 1 (First Step)|Disease Progression|1
1672882|NCT01456039|5844075|P1|Phase 1 (First Step)|Disease Progression|1
1672883|NCT01455428|5844218|P2|Overall Study|Other|4
1672884|NCT01455428|5844219|P1|Overall Study|Other|2
1672885|NCT01455428|5844218|P2|Overall Study|Did not receive treatment|1
1672886|NCT01455428|5844219|P1|Overall Study|Did not receive treatment|1
1672887|NCT01455428|5844218|P2|Overall Study|Insufficient clinical response|2
1672888|NCT01455428|5844219|P1|Overall Study|Insufficient clinical response|0
1672889|NCT01455428|5844218|P2|Overall Study|Did not meet entrance criteria|2
1672890|NCT01455428|5844219|P1|Overall Study|Did not meet entrance criteria|0
1672891|NCT01455428|5844218|P2|Overall Study|Withdrawal by Subject|5
1672892|NCT01455428|5844219|P1|Overall Study|Withdrawal by Subject|2
1672893|NCT01455428|5844218|P2|Overall Study|Lost to Follow-up|1
1672894|NCT01455428|5844219|P1|Overall Study|Lost to Follow-up|1
1672895|NCT01455428|5844218|P2|Overall Study|Adverse Event|2
1672896|NCT01455428|5844219|P1|Overall Study|Adverse Event|6
1672897|NCT01455428|5844218|P2|Overall Study|Protocol Violation|1
1672898|NCT01455428|5844219|P1|Overall Study|Protocol Violation|2
1672899|NCT01455415|5844275|P2|Follow-up|Unspecified Reason|0
1672900|NCT01455415|5844276|P1|Follow-up|Unspecified Reason|1
1672901|NCT01455415|5844275|P2|Follow-up|Withdrawal by Subject|0
1672902|NCT01455415|5844276|P1|Follow-up|Withdrawal by Subject|2
1672903|NCT01455415|5844275|P2|Follow-up|Lack of Efficacy|1
1672904|NCT01455415|5844276|P1|Follow-up|Lack of Efficacy|0
1672905|NCT01455415|5844275|P2|Follow-up|AE Related to Study Drug|1
1672906|NCT01455415|5844276|P1|Follow-up|AE Related to Study Drug|0
1672907|NCT01455415|5844275|P2|Period 2|Protocol Violation|0
1672908|NCT01455415|5844276|P1|Period 2|Protocol Violation|2
1672909|NCT01455415|5844275|P2|Period 2|Unspecified Reason|3
1672910|NCT01455415|5844276|P1|Period 2|Unspecified Reason|2
1672911|NCT01455415|5844275|P2|Period 2|Withdrawal by Subject|3
1672912|NCT01455415|5844276|P1|Period 2|Withdrawal by Subject|2
1672913|NCT01455415|5844275|P2|Period 2|Lack of Efficacy|0
1672914|NCT01455415|5844276|P1|Period 2|Lack of Efficacy|2
1672915|NCT01455415|5844275|P2|Period 2|AE Not Related to Study Drug|1
1672916|NCT01455415|5844276|P1|Period 2|AE Not Related to Study Drug|2
1672917|NCT01455415|5844275|P2|Period 2|Lost to Follow-up|1
1672918|NCT01455415|5844276|P1|Period 2|Lost to Follow-up|2
1672919|NCT01455415|5844275|P2|Period 2|AE Related to Study Drug|2
1672920|NCT01455415|5844276|P1|Period 2|AE Related to Study Drug|1
1672921|NCT01455415|5844275|P2|Washout|Protocol Violation|1
1672922|NCT01455415|5844276|P1|Washout|Protocol Violation|0
1672923|NCT01455415|5844275|P2|Washout|Unspecified Reason|2
1672924|NCT01455415|5844276|P1|Washout|Unspecified Reason|1
1672925|NCT01455415|5844275|P2|Washout|AE Not Related to Study Drug|3
1672926|NCT01455415|5844276|P1|Washout|AE Not Related to Study Drug|2
1672927|NCT01455415|5844275|P2|Washout|Drug Error not Associated to AE|1
1672928|NCT01455415|5844276|P1|Washout|Drug Error not Associated to AE|2
1672929|NCT01455415|5844275|P2|Washout|Lost to Follow-up|0
1672930|NCT01455415|5844276|P1|Washout|Lost to Follow-up|1
1672931|NCT01455415|5844275|P2|Washout|AE Related to Study Drug|0
1672932|NCT01455415|5844276|P1|Washout|AE Related to Study Drug|2
1672933|NCT01455415|5844275|P2|Period 1|Protocol Violation|2
1672934|NCT01455415|5844276|P1|Period 1|Protocol Violation|0
1672935|NCT01455415|5844275|P2|Period 1|Unspecified Reason|1
1672936|NCT01455415|5844276|P1|Period 1|Unspecified Reason|1
1672937|NCT01455415|5844275|P2|Period 1|Withdrawal by Subject|5
1672938|NCT01455415|5844276|P1|Period 1|Withdrawal by Subject|4
1672939|NCT01455415|5844275|P2|Period 1|AE Not Related to Study Drug|6
1672940|NCT01455415|5844276|P1|Period 1|AE Not Related to Study Drug|2
1672941|NCT01455415|5844275|P2|Period 1|Drug Error not Associated to AE|1
1672942|NCT01455415|5844276|P1|Period 1|Drug Error not Associated to AE|0
1672943|NCT01455415|5844275|P2|Period 1|Lost To Follow-up Related to Study Drug|3
1672944|NCT01455415|5844276|P1|Period 1|Lost To Follow-up Related to Study Drug|3
1672945|NCT01455415|5844275|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
1672946|NCT01455415|5844276|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
1672947|NCT01455220|5844326|P1|Overall Study|screen fail|30
1672948|NCT01455194|5844336|P4|Overall Study|Miscellaneous|4
1672949|NCT01455194|5844337|P3|Overall Study|Miscellaneous|1
1672950|NCT01455194|5844338|P2|Overall Study|Miscellaneous|5
1672951|NCT01455194|5844339|P1|Overall Study|Miscellaneous|4
1672952|NCT01455194|5844336|P4|Overall Study|Discontinuation criterion fulfilled|2
1672953|NCT01455194|5844337|P3|Overall Study|Discontinuation criterion fulfilled|0
1672954|NCT01455194|5844338|P2|Overall Study|Discontinuation criterion fulfilled|2
1672955|NCT01455194|5844339|P1|Overall Study|Discontinuation criterion fulfilled|3
1672956|NCT01455194|5844336|P4|Overall Study|Pregnancy|0
1672957|NCT01455194|5844337|P3|Overall Study|Pregnancy|1
1672958|NCT01455194|5844338|P2|Overall Study|Pregnancy|1
1672959|NCT01455194|5844339|P1|Overall Study|Pregnancy|0
1672960|NCT01455194|5844336|P4|Overall Study|Lost to Follow-up|1
1672961|NCT01455194|5844337|P3|Overall Study|Lost to Follow-up|1
1672962|NCT01455194|5844338|P2|Overall Study|Lost to Follow-up|0
1672963|NCT01455194|5844339|P1|Overall Study|Lost to Follow-up|2
1672964|NCT01455194|5844336|P4|Overall Study|Withdrawal by Subject|9
1672965|NCT01455194|5844337|P3|Overall Study|Withdrawal by Subject|12
1672966|NCT01455194|5844338|P2|Overall Study|Withdrawal by Subject|16
1672967|NCT01455194|5844339|P1|Overall Study|Withdrawal by Subject|21
1672968|NCT01455194|5844336|P4|Overall Study|Adverse Event|3
1672969|NCT01455194|5844337|P3|Overall Study|Adverse Event|1
1672970|NCT01455194|5844338|P2|Overall Study|Adverse Event|1
1672971|NCT01455194|5844339|P1|Overall Study|Adverse Event|1
1672972|NCT01455194|5844336|P4|Overall Study|Deterioration in asthma|9
1672973|NCT01455194|5844337|P3|Overall Study|Deterioration in asthma|14
1672974|NCT01455194|5844338|P2|Overall Study|Deterioration in asthma|6
1672975|NCT01455194|5844339|P1|Overall Study|Deterioration in asthma|12
1672976|NCT01455194|5844336|P4|Overall Study|Randomisation Failure|0
1672977|NCT01455194|5844337|P3|Overall Study|Randomisation Failure|0
1672978|NCT01455194|5844338|P2|Overall Study|Randomisation Failure|0
1672979|NCT01455194|5844339|P1|Overall Study|Randomisation Failure|90
1672980|NCT01455194|5844336|P4|Overall Study|Screen Failure|0
1672981|NCT01455194|5844337|P3|Overall Study|Screen Failure|0
1672982|NCT01455194|5844338|P2|Overall Study|Screen Failure|0
1672983|NCT01455194|5844339|P1|Overall Study|Screen Failure|20
1672984|NCT01455012|5844402|P2|Overall Study|Unknown reason|0
1672985|NCT01455012|5844403|P1|Overall Study|Unknown reason|2
1672986|NCT01455012|5844402|P2|Overall Study|Withdrawal by Subject|1
1672987|NCT01455012|5844403|P1|Overall Study|Withdrawal by Subject|3
1672988|NCT01455012|5844402|P2|Overall Study|Lack of Efficacy|1
1672989|NCT01455012|5844403|P1|Overall Study|Lack of Efficacy|6
1672990|NCT01455012|5844402|P2|Overall Study|Adverse Event|2
1672991|NCT01455012|5844403|P1|Overall Study|Adverse Event|0
1672992|NCT01454934|5844470|P2|Overall Study|Not treated|2
1672993|NCT01454934|5844471|P1|Overall Study|Not treated|1
1672994|NCT01454934|5844470|P2|Overall Study|Lost to Follow-up|1
1672995|NCT01454934|5844471|P1|Overall Study|Lost to Follow-up|0
1672996|NCT01454934|5844470|P2|Overall Study|Disease progression|181
1672997|NCT01454934|5844471|P1|Overall Study|Disease progression|194
1672998|NCT01454934|5844470|P2|Overall Study|Withdrawal by Subject|15
1672999|NCT01454934|5844471|P1|Overall Study|Withdrawal by Subject|11
1673000|NCT01454934|5844470|P2|Overall Study|Withdrawn consent|5
1673001|NCT01454934|5844471|P1|Overall Study|Withdrawn consent|2
1673002|NCT01454934|5844470|P2|Overall Study|Adverse Event|24
1673003|NCT01454934|5844471|P1|Overall Study|Adverse Event|28
1673004|NCT01454934|5844470|P2|Overall Study|Other|17
1673005|NCT01454934|5844471|P1|Overall Study|Other|6
1673006|NCT01454934|5844470|P2|Overall Study|Clinical progression|25
1673007|NCT01454934|5844471|P1|Overall Study|Clinical progression|28
1673008|NCT01454830|5844483|P2|Overall Study|Withdrawal - no polysomnography|2
1673009|NCT01454830|5844484|P1|Overall Study|Withdrawal - no polysomnography|3
1673010|NCT01454830|5844483|P2|Overall Study|Post-allocation Exclude-other treatment|7
1673011|NCT01454830|5844484|P1|Overall Study|Post-allocation Exclude-other treatment|6
1673012|NCT01454830|5844483|P2|Overall Study|Post-allocation Exclude-refused PAP|2
1673013|NCT01454830|5844484|P1|Overall Study|Post-allocation Exclude-refused PAP|0
1673014|NCT01454830|5844483|P2|Overall Study|Post-allocation Exclude- AHI<10|12
1673015|NCT01454830|5844484|P1|Overall Study|Post-allocation Exclude- AHI<10|18
1673016|NCT01454830|5844483|P2|Overall Study|Withdrawal by Subject|4
1673017|NCT01454830|5844484|P1|Overall Study|Withdrawal by Subject|4
1673018|NCT01454778|5844515|P1|Overall Study|Death|1
1673019|NCT01454778|5844515|P1|Overall Study|Lost to Follow-up|2
1673020|NCT01454739|5844526|P2|Overall Study|Adverse Event|1
1673021|NCT01454739|5844527|P1|Overall Study|Adverse Event|0
1673022|NCT01454739|5844526|P2|Overall Study|Lost to Follow-up|1
1673023|NCT01454739|5844527|P1|Overall Study|Lost to Follow-up|0
1673024|NCT01454739|5844526|P2|Overall Study|Physician Decision|5
1673025|NCT01454739|5844527|P1|Overall Study|Physician Decision|0
1673026|NCT01454739|5844526|P2|Overall Study|Other|5
1673027|NCT01454739|5844527|P1|Overall Study|Other|3
1673028|NCT01454739|5844526|P2|Overall Study|Withdrawal by Subject|6
1673029|NCT01454739|5844527|P1|Overall Study|Withdrawal by Subject|2
1673030|NCT01454739|5844526|P2|Overall Study|Protocol Violation|3
1673031|NCT01454739|5844527|P1|Overall Study|Protocol Violation|2
1673032|NCT01454726|5844556|P2|Overall Study|Withdrawal by Subject|1
1673033|NCT01454726|5844557|P1|Overall Study|Withdrawal by Subject|0
1673034|NCT01454596|5844575|P12|Overall Study|Death|0
1673035|NCT01454596|5844576|P11|Overall Study|Death|1
1673036|NCT01454596|5844577|P10|Overall Study|Death|1
1673037|NCT01454596|5844578|P9|Overall Study|Death|0
1673038|NCT01454596|5844579|P8|Overall Study|Death|0
1673039|NCT01454596|5844580|P7|Overall Study|Death|0
1673040|NCT01454596|5844581|P6|Overall Study|Death|0
1673041|NCT01454596|5844582|P5|Overall Study|Death|0
1673042|NCT01454596|5844583|P4|Overall Study|Death|0
1673043|NCT01454596|5844584|P3|Overall Study|Death|0
1673044|NCT01454596|5844585|P2|Overall Study|Death|0
1673045|NCT01454596|5844586|P1|Overall Study|Death|0
1673046|NCT01454583|5844663|P3|3rd Year|Lost to Follow-up|297
1673047|NCT01454583|5844664|P2|3rd Year|Lost to Follow-up|512
1673048|NCT01454583|5844665|P1|3rd Year|Lost to Follow-up|1959
1673049|NCT01454583|5844663|P3|2nd Year|Lost to Follow-up|737
1673050|NCT01454583|5844664|P2|2nd Year|Lost to Follow-up|1049
1673051|NCT01454583|5844665|P1|2nd Year|Lost to Follow-up|3965
1673052|NCT01454583|5844663|P3|1st Year|Lost to Follow-up|180
1673053|NCT01454583|5844664|P2|1st Year|Lost to Follow-up|318
1673054|NCT01454583|5844665|P1|1st Year|Lost to Follow-up|1057
1673055|NCT01454531|5844733|P1|Overall Study|Other|1
1673056|NCT01454531|5844733|P1|Overall Study|Delay in IMP administration|1
1673057|NCT01454531|5844733|P1|Overall Study|Physician Decision|1
1673058|NCT01454531|5844733|P1|Overall Study|Lost to Follow-up|1
1673059|NCT01454531|5844733|P1|Overall Study|Withdrawal by Subject|5
1673060|NCT01454531|5844733|P1|Overall Study|Adverse Event|14
1673061|NCT01454401|5844769|P1|Overall Study|non-adherence|1
1673062|NCT01454401|5844769|P1|Overall Study|osteomyelitis|2
1673063|NCT01454401|5844769|P1|Overall Study|hospitalised|1
1673064|NCT01454401|5844769|P1|Overall Study|Death|1
1673065|NCT01454284|5844793|P2|Overall Study|Sponsor Decision|2
1673066|NCT01454284|5844794|P1|Overall Study|Sponsor Decision|0
1673067|NCT01454284|5844793|P2|Overall Study|Physician Decision|11
1673068|NCT01454284|5844794|P1|Overall Study|Physician Decision|16
1673069|NCT01454284|5844793|P2|Overall Study|Withdrawal by Subject|36
1673070|NCT01454284|5844794|P1|Overall Study|Withdrawal by Subject|58
1673071|NCT01454284|5844793|P2|Overall Study|Protocol Violation|6
1673072|NCT01454284|5844794|P1|Overall Study|Protocol Violation|9
1673073|NCT01454284|5844793|P2|Overall Study|Lost to Follow-up|8
1673074|NCT01454284|5844794|P1|Overall Study|Lost to Follow-up|13
1673075|NCT01454284|5844793|P2|Overall Study|Death|3
1673076|NCT01454284|5844794|P1|Overall Study|Death|0
1673077|NCT01454284|5844793|P2|Overall Study|Adverse Event|7
1673078|NCT01454284|5844794|P1|Overall Study|Adverse Event|20
1673079|NCT01454102|5844864|P16|Overall Study|Continuing in the treatment period|1
1673080|NCT01454102|5844865|P15|Overall Study|Continuing in the treatment period|3
1673081|NCT01454102|5844866|P14|Overall Study|Continuing in the treatment period|4
1673082|NCT01454102|5844867|P13|Overall Study|Continuing in the treatment period|7
1673083|NCT01454102|5844868|P12|Overall Study|Continuing in the treatment period|4
1673084|NCT01454102|5844869|P11|Overall Study|Continuing in the treatment period|0
1673085|NCT01454102|5844870|P10|Overall Study|Continuing in the treatment period|0
1673086|NCT01454102|5844871|P9|Overall Study|Continuing in the treatment period|1
1673087|NCT01454102|5844872|P8|Overall Study|Continuing in the treatment period|0
1673088|NCT01454102|5844873|P7|Overall Study|Continuing in the treatment period|2
1673089|NCT01454102|5844874|P6|Overall Study|Continuing in the treatment period|3
1673090|NCT01454102|5844875|P5|Overall Study|Continuing in the treatment period|3
1673091|NCT01454102|5844876|P4|Overall Study|Continuing in the treatment period|0
1673092|NCT01454102|5844877|P3|Overall Study|Continuing in the treatment period|0
1673093|NCT01454102|5844878|P2|Overall Study|Continuing in the treatment period|0
1673094|NCT01454102|5844879|P1|Overall Study|Continuing in the treatment period|0
1673095|NCT01454076|5844999|P5|Overall Study|Adverse Event|2
1673096|NCT01454076|5845000|P4|Overall Study|Adverse Event|0
1673097|NCT01454076|5845001|P3|Overall Study|Adverse Event|7
1673098|NCT01454076|5845002|P2|Overall Study|Adverse Event|2
1673099|NCT01454076|5845003|P1|Overall Study|Adverse Event|8
1673100|NCT01454076|5844999|P5|Overall Study|Withdrawal by Subject|2
1673101|NCT01454076|5845000|P4|Overall Study|Withdrawal by Subject|1
1673102|NCT01454076|5845001|P3|Overall Study|Withdrawal by Subject|2
1673103|NCT01454076|5845002|P2|Overall Study|Withdrawal by Subject|4
1673104|NCT01454076|5845003|P1|Overall Study|Withdrawal by Subject|3
1673105|NCT01454076|5844999|P5|Overall Study|Other|2
1673106|NCT01454076|5845000|P4|Overall Study|Other|1
1673107|NCT01454076|5845001|P3|Overall Study|Other|0
1673108|NCT01454076|5845002|P2|Overall Study|Other|0
1673109|NCT01454076|5845003|P1|Overall Study|Other|2
1673110|NCT01454063|5845056|P2|Randomized|Protocol Violation|1
1673111|NCT01454063|5845057|P1|Randomized|Protocol Violation|0
1673112|NCT01454063|5845056|P2|Randomized|Adverse Event|1
1673113|NCT01454063|5845057|P1|Randomized|Adverse Event|1
1673114|NCT01453998|5845078|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
1673115|NCT01453998|5845079|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
1673116|NCT01453998|5845080|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
1673117|NCT01453946|5845145|P1|Overall Study|Adverse Event|3
1673118|NCT01453946|5845145|P1|Overall Study|Lack of Efficacy|3
1673119|NCT01453946|5845145|P1|Overall Study|Protocol Violation|2
1673120|NCT01453946|5845145|P1|Overall Study|Did not receive drug for the taper phase|1
1673121|NCT01453855|5845162|P2|Overall Study|Other|1
1673122|NCT01453855|5845163|P1|Overall Study|Other|0
1673123|NCT01453855|5845162|P2|Overall Study|Inadequate Control of IOP|5
1673124|NCT01453855|5845163|P1|Overall Study|Inadequate Control of IOP|1
1673125|NCT01453855|5845162|P2|Overall Study|Noncompliance|0
1673126|NCT01453855|5845163|P1|Overall Study|Noncompliance|1
1673127|NCT01453855|5845162|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
1673128|NCT01453855|5845163|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
1673129|NCT01453855|5845162|P2|Overall Study|Lost to Follow-up|1
1673130|NCT01453855|5845163|P1|Overall Study|Lost to Follow-up|2
1673131|NCT01453855|5845162|P2|Overall Study|Adverse Event|4
1673132|NCT01453855|5845163|P1|Overall Study|Adverse Event|3
1673133|NCT01453725|5845171|P2|Overall Study|Physician Decision|1
1673134|NCT01453725|5845172|P1|Overall Study|Physician Decision|1
1673135|NCT01453725|5845171|P2|Overall Study|Pregnancy|0
1673136|NCT01453725|5845172|P1|Overall Study|Pregnancy|1
1673137|NCT01453725|5845171|P2|Overall Study|Pregnancy Wish|2
1673138|NCT01453725|5845172|P1|Overall Study|Pregnancy Wish|0
1673139|NCT01453725|5845171|P2|Overall Study|Withdrawal by Subject|3
1673140|NCT01453725|5845172|P1|Overall Study|Withdrawal by Subject|2
1673141|NCT01453725|5845171|P2|Overall Study|Protocol Violation|0
1673142|NCT01453725|5845172|P1|Overall Study|Protocol Violation|1
1673143|NCT01453725|5845171|P2|Overall Study|Non-compliance With Protocol|2
1673144|NCT01453725|5845172|P1|Overall Study|Non-compliance With Protocol|1
1673145|NCT01453725|5845171|P2|Overall Study|Lost to Follow-up|0
1673146|NCT01453725|5845172|P1|Overall Study|Lost to Follow-up|4
1673147|NCT01453725|5845171|P2|Overall Study|Adverse Event|3
1673148|NCT01453725|5845172|P1|Overall Study|Adverse Event|3
1673149|NCT01453595|5845195|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
1673150|NCT01453595|5845196|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
1673151|NCT01453595|5845197|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
1673152|NCT01453374|5845316|P1|Overall Study|Incarcerated|2
1673153|NCT01453374|5845316|P1|Overall Study|Withdrawal by Subject|5
1673154|NCT01453374|5845316|P1|Overall Study|Lost to Follow-up|3
1673155|NCT01453374|5845316|P1|Overall Study|Lack of Efficacy|1
1673156|NCT01453374|5845316|P1|Overall Study|Adverse Event|7
1673157|NCT01453361|5845332|P1|Overall Study|Screen-Failures|10
1673158|NCT01453361|5845332|P1|Overall Study|Disease Progression|6
1673159|NCT01453348|5845340|P3|Overall Study|Protocol Violation|0
1673160|NCT01453348|5845341|P2|Overall Study|Protocol Violation|0
1673161|NCT01453348|5845342|P1|Overall Study|Protocol Violation|1
1673162|NCT01453348|5845340|P3|Overall Study|Withdrawal by Subject|0
1673163|NCT01453348|5845341|P2|Overall Study|Withdrawal by Subject|1
1673164|NCT01453348|5845342|P1|Overall Study|Withdrawal by Subject|0
1673165|NCT01453348|5845340|P3|Overall Study|Death|1
1673166|NCT01453348|5845341|P2|Overall Study|Death|0
1673167|NCT01453348|5845342|P1|Overall Study|Death|0
1673168|NCT01453296|5845358|P2|Treatment Period 2|Withdrawal by Subject|0
1673169|NCT01453296|5845359|P1|Treatment Period 2|Withdrawal by Subject|1
1673170|NCT01453296|5845358|P2|Treatment Period 2|Adverse Event|0
1673171|NCT01453296|5845359|P1|Treatment Period 2|Adverse Event|1
1673172|NCT01453296|5845358|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
1673173|NCT01453296|5845359|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
1673174|NCT01453296|5845358|P2|Treatment Period 1|Adverse Event|1
1673175|NCT01453296|5845359|P1|Treatment Period 1|Adverse Event|0
1673176|NCT01453205|5845426|P3|Overall Study|Other|35
1673177|NCT01453205|5845427|P2|Overall Study|Other|27
1673178|NCT01453205|5845428|P1|Overall Study|Other|45
1673179|NCT01453205|5845426|P3|Overall Study|Death|18
1673180|NCT01453205|5845427|P2|Overall Study|Death|22
1673181|NCT01453205|5845428|P1|Overall Study|Death|24
1673182|NCT01453205|5845426|P3|Overall Study|Withdrawal by Subject|0
1673183|NCT01453205|5845427|P2|Overall Study|Withdrawal by Subject|3
1673184|NCT01453205|5845428|P1|Overall Study|Withdrawal by Subject|8
1673185|NCT01453205|5845426|P3|Overall Study|Lost to Follow-up|1
1673186|NCT01453205|5845427|P2|Overall Study|Lost to Follow-up|0
1673187|NCT01453205|5845428|P1|Overall Study|Lost to Follow-up|3
1673188|NCT01453153|5845504|P3|Overall Study|Adverse Event|1
1673189|NCT01453153|5845505|P2|Overall Study|Adverse Event|1
1673190|NCT01453153|5845506|P1|Overall Study|Adverse Event|1
1673191|NCT01453153|5845504|P3|Overall Study|Withdrawal by Subject|2
1673192|NCT01453153|5845505|P2|Overall Study|Withdrawal by Subject|1
1673193|NCT01453153|5845506|P1|Overall Study|Withdrawal by Subject|0
1673194|NCT01453153|5845504|P3|Overall Study|Progressive Disease|16
1673195|NCT01453153|5845505|P2|Overall Study|Progressive Disease|2
1673196|NCT01453153|5845506|P1|Overall Study|Progressive Disease|3
1673197|NCT01453153|5845504|P3|Overall Study|Physician Decision|1
1673198|NCT01453153|5845505|P2|Overall Study|Physician Decision|0
1673199|NCT01453153|5845506|P1|Overall Study|Physician Decision|0
1673200|NCT01453049|5845588|P2|Overall Study|Randomized in Error|0
1673201|NCT01453049|5845589|P1|Overall Study|Randomized in Error|1
1673202|NCT01453049|5845588|P2|Overall Study|Withdrawal by Subject|0
1673203|NCT01453049|5845589|P1|Overall Study|Withdrawal by Subject|1
1673204|NCT01453049|5845588|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
1673205|NCT01453049|5845589|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
1673206|NCT01453049|5845588|P2|Overall Study|Lost to Follow-up|1
1673207|NCT01453049|5845589|P1|Overall Study|Lost to Follow-up|2
1673208|NCT01453049|5845588|P2|Overall Study|Protocol Violation|5
1673209|NCT01453049|5845589|P1|Overall Study|Protocol Violation|2
1673210|NCT01453036|5845662|P3|Overall Study|Lost to Follow-up|31
1673211|NCT01453036|5845663|P2|Overall Study|Lost to Follow-up|115
1673212|NCT01453036|5845664|P1|Overall Study|Lost to Follow-up|26
1673213|NCT01453023|5845672|P2|Treatment Period 2|Protocol Violation|1
1673214|NCT01453023|5845673|P1|Treatment Period 2|Protocol Violation|0
1673215|NCT01453023|5845672|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
1673216|NCT01453023|5845673|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
1673217|NCT01453023|5845672|P2|Treatment Period (TP) 1|Protocol Violation|0
1673218|NCT01453023|5845673|P1|Treatment Period (TP) 1|Protocol Violation|1
1673219|NCT01452529|5845747|P3|Double-blind (DB) Period|Administrative|7
1673220|NCT01452529|5845748|P2|Double-blind (DB) Period|Administrative|11
1673221|NCT01452529|5845749|P1|Double-blind (DB) Period|Administrative|0
1673222|NCT01452529|5845747|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
1673223|NCT01452529|5845748|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
1673224|NCT01452529|5845749|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
1673225|NCT01452529|5845747|P3|Double-blind (DB) Period|Lack of Efficacy|44
1673226|NCT01452529|5845748|P2|Double-blind (DB) Period|Lack of Efficacy|16
1673227|NCT01452529|5845749|P1|Double-blind (DB) Period|Lack of Efficacy|0
1673228|NCT01452529|5845747|P3|Double-blind (DB) Period|Lost to Follow-up|3
1673229|NCT01452529|5845748|P2|Double-blind (DB) Period|Lost to Follow-up|5
1673230|NCT01452529|5845749|P1|Double-blind (DB) Period|Lost to Follow-up|0
1673231|NCT01452529|5845747|P3|Double-blind (DB) Period|Withdrawal by Subject|14
1673232|NCT01452529|5845748|P2|Double-blind (DB) Period|Withdrawal by Subject|15
1673233|NCT01452529|5845749|P1|Double-blind (DB) Period|Withdrawal by Subject|0
1673234|NCT01452529|5845747|P3|Double-blind (DB) Period|Adverse Event|11
1673235|NCT01452529|5845748|P2|Double-blind (DB) Period|Adverse Event|18
1673236|NCT01452529|5845749|P1|Double-blind (DB) Period|Adverse Event|0
1673237|NCT01452529|5845747|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
1673238|NCT01452529|5845748|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
1673239|NCT01452529|5845749|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
1673240|NCT01452529|5845747|P3|Run-in Period|Administrative|0
1673241|NCT01452529|5845748|P2|Run-in Period|Administrative|0
1673242|NCT01452529|5845749|P1|Run-in Period|Administrative|21
1673243|NCT01452529|5845747|P3|Run-in Period|Confirmed or suspected diversion|0
1673244|NCT01452529|5845748|P2|Run-in Period|Confirmed or suspected diversion|0
1673245|NCT01452529|5845749|P1|Run-in Period|Confirmed or suspected diversion|23
1673246|NCT01452529|5845747|P3|Run-in Period|Lack of Efficacy|0
1673247|NCT01452529|5845748|P2|Run-in Period|Lack of Efficacy|0
1673248|NCT01452529|5845749|P1|Run-in Period|Lack of Efficacy|46
1673249|NCT01452529|5845747|P3|Run-in Period|Lost to Follow-up|0
1673250|NCT01452529|5845748|P2|Run-in Period|Lost to Follow-up|0
1673251|NCT01452529|5845749|P1|Run-in Period|Lost to Follow-up|19
1673252|NCT01452529|5845747|P3|Run-in Period|Withdrawal by Subject|0
1673253|NCT01452529|5845748|P2|Run-in Period|Withdrawal by Subject|0
1673254|NCT01452529|5845749|P1|Run-in Period|Withdrawal by Subject|49
1673255|NCT01452529|5845747|P3|Run-in Period|Adverse Event|0
1673256|NCT01452529|5845748|P2|Run-in Period|Adverse Event|0
1673257|NCT01452529|5845749|P1|Run-in Period|Adverse Event|96
1673258|NCT01452412|5845771|P2|Overall Study|Other|0
1673259|NCT01452412|5845772|P1|Overall Study|Other|2
1673260|NCT01452412|5845771|P2|Overall Study|Initiated dialysis|0
1673261|NCT01452412|5845772|P1|Overall Study|Initiated dialysis|1
1673262|NCT01452412|5845771|P2|Overall Study|Death|0
1673263|NCT01452412|5845772|P1|Overall Study|Death|1
1673264|NCT01452412|5845771|P2|Overall Study|Lost to Follow-up|3
1673265|NCT01452412|5845772|P1|Overall Study|Lost to Follow-up|5
1673266|NCT01452412|5845771|P2|Overall Study|Adverse Event|3
1673267|NCT01452412|5845772|P1|Overall Study|Adverse Event|4
1673268|NCT01452412|5845771|P2|Overall Study|Withdrawal by Subject|11
1673269|NCT01452412|5845772|P1|Overall Study|Withdrawal by Subject|15
1673270|NCT01452347|5845788|P2|Overall Study|Other reason not defined above|0
1673271|NCT01452347|5845789|P1|Overall Study|Other reason not defined above|2
1673272|NCT01452347|5845788|P2|Overall Study|Not treated|3
1673273|NCT01452347|5845789|P1|Overall Study|Not treated|6
1673274|NCT01452347|5845788|P2|Overall Study|Withdrawal by Subject|3
1673275|NCT01452347|5845789|P1|Overall Study|Withdrawal by Subject|3
1673276|NCT01452347|5845788|P2|Overall Study|Lost to Follow-up|0
1673277|NCT01452347|5845789|P1|Overall Study|Lost to Follow-up|2
1673278|NCT01452347|5845788|P2|Overall Study|Non compliance protocol|0
1673279|NCT01452347|5845789|P1|Overall Study|Non compliance protocol|2
1673280|NCT01452347|5845788|P2|Overall Study|Adverse Event|1
1673281|NCT01452347|5845789|P1|Overall Study|Adverse Event|2
1673282|NCT01452152|5845849|P3|Overall Study|Study termination by sponsor|4
1673283|NCT01452152|5845850|P2|Overall Study|Study termination by sponsor|0
1673284|NCT01452152|5845851|P1|Overall Study|Study termination by sponsor|5
1673285|NCT01451931|5845923|P3|Overall Study|Withdrawal by Subject|22
1673286|NCT01451931|5845924|P2|Overall Study|Withdrawal by Subject|22
1673287|NCT01451931|5845925|P1|Overall Study|Withdrawal by Subject|16
1673288|NCT01451931|5845923|P3|Overall Study|Lost to Follow-up|21
1673289|NCT01451931|5845924|P2|Overall Study|Lost to Follow-up|36
1673290|NCT01451931|5845925|P1|Overall Study|Lost to Follow-up|17
1673291|NCT01451827|5845949|P4|Overall Study|Withdrawal by Subject|1
1673292|NCT01451827|5845950|P3|Overall Study|Withdrawal by Subject|1
1673293|NCT01451827|5845951|P2|Overall Study|Withdrawal by Subject|0
1673294|NCT01451827|5845952|P1|Overall Study|Withdrawal by Subject|0
1673295|NCT01451827|5845949|P4|Overall Study|Participant met withdrawal criteria|0
1673296|NCT01451827|5845950|P3|Overall Study|Participant met withdrawal criteria|0
1673385|NCT01451437|5846197|P8|Overall Study|Physician Decision|0
1673297|NCT01451827|5845951|P2|Overall Study|Participant met withdrawal criteria|2
1673298|NCT01451827|5845952|P1|Overall Study|Participant met withdrawal criteria|0
1673299|NCT01451827|5845949|P4|Overall Study|Lost to Follow-up|2
1673300|NCT01451827|5845950|P3|Overall Study|Lost to Follow-up|0
1673301|NCT01451827|5845951|P2|Overall Study|Lost to Follow-up|3
1673302|NCT01451827|5845952|P1|Overall Study|Lost to Follow-up|0
1673303|NCT01451827|5845949|P4|Overall Study|Protocol deviation|0
1673304|NCT01451827|5845950|P3|Overall Study|Protocol deviation|0
1673305|NCT01451827|5845951|P2|Overall Study|Protocol deviation|0
1673306|NCT01451827|5845952|P1|Overall Study|Protocol deviation|1
1673307|NCT01451827|5845949|P4|Overall Study|Adverse Event|1
1673308|NCT01451827|5845950|P3|Overall Study|Adverse Event|1
1673309|NCT01451827|5845951|P2|Overall Study|Adverse Event|0
1673310|NCT01451827|5845952|P1|Overall Study|Adverse Event|2
1673311|NCT01451814|5845972|P2|Overall Study|Lost to Follow-up|4
1673312|NCT01451814|5845973|P1|Overall Study|Lost to Follow-up|5
1673313|NCT01451814|5845972|P2|Overall Study|Withdrawal by Subject|1
1673314|NCT01451814|5845973|P1|Overall Study|Withdrawal by Subject|1
1673315|NCT01451762|5846005|P3|Overall Study|Lost to Follow-up|6
1673316|NCT01451762|5846006|P2|Overall Study|Lost to Follow-up|6
1673317|NCT01451762|5846007|P1|Overall Study|Lost to Follow-up|3
1673318|NCT01451749|5846017|P2|Overall Study|Withdrawal by Subject|1
1673319|NCT01451749|5846018|P1|Overall Study|Withdrawal by Subject|0
1673320|NCT01451749|5846017|P2|Overall Study|Adverse Event|0
1673321|NCT01451749|5846018|P1|Overall Study|Adverse Event|2
1673322|NCT01451749|5846017|P2|Overall Study|Meet the exclusion criteria,and|1
1673323|NCT01451749|5846018|P1|Overall Study|Meet the exclusion criteria,and|1
1673324|NCT01451749|5846017|P2|Overall Study|Lost to Follow-up|5
1673325|NCT01451749|5846018|P1|Overall Study|Lost to Follow-up|15
1673326|NCT01451749|5846017|P2|Overall Study|Protocol Violation|7
1673327|NCT01451749|5846018|P1|Overall Study|Protocol Violation|14
1673328|NCT01451723|5846030|P2|Overall Study|study halted|5
1673329|NCT01451723|5846031|P1|Overall Study|study halted|6
1673330|NCT01451645|5846041|P2|Overall Study|Lost to Follow-up|3
1673331|NCT01451645|5846042|P1|Overall Study|Lost to Follow-up|4
1673332|NCT01451645|5846041|P2|Overall Study|Withdrawal by Subject|2
1673333|NCT01451645|5846042|P1|Overall Study|Withdrawal by Subject|4
1673334|NCT01451645|5846041|P2|Overall Study|Adverse Event|3
1673335|NCT01451645|5846042|P1|Overall Study|Adverse Event|0
1673336|NCT01451645|5846041|P2|Overall Study|Protocol Violation|0
1673337|NCT01451645|5846042|P1|Overall Study|Protocol Violation|1
1673338|NCT01451606|5846113|P2|Overall Study|Withdrawal by Subject|3
1673339|NCT01451606|5846114|P1|Overall Study|Withdrawal by Subject|4
1673340|NCT01451554|5846124|P2|Overall Study|Withdrawal by Subject|9
1673341|NCT01451554|5846125|P1|Overall Study|Withdrawal by Subject|14
1673342|NCT01451541|5846136|P3|Overall Study|randomization error, noncompliance|8
1673343|NCT01451541|5846137|P2|Overall Study|randomization error, noncompliance|10
1673344|NCT01451541|5846138|P1|Overall Study|randomization error, noncompliance|11
1673345|NCT01451541|5846136|P3|Overall Study|Withdrawal by Subject|6
1673346|NCT01451541|5846137|P2|Overall Study|Withdrawal by Subject|8
1673347|NCT01451541|5846138|P1|Overall Study|Withdrawal by Subject|15
1673348|NCT01451541|5846136|P3|Overall Study|Lost to Follow-up|7
1673349|NCT01451541|5846137|P2|Overall Study|Lost to Follow-up|4
1673350|NCT01451541|5846138|P1|Overall Study|Lost to Follow-up|4
1673351|NCT01451541|5846136|P3|Overall Study|Lack of Efficacy|0
1673352|NCT01451541|5846137|P2|Overall Study|Lack of Efficacy|0
1673353|NCT01451541|5846138|P1|Overall Study|Lack of Efficacy|2
1673354|NCT01451541|5846136|P3|Overall Study|Adverse Event|6
1673355|NCT01451541|5846137|P2|Overall Study|Adverse Event|3
1673356|NCT01451541|5846138|P1|Overall Study|Adverse Event|4
1673357|NCT01451437|5846196|P9|Overall Study|Withdrawal by Subject|0
1673358|NCT01451437|5846197|P8|Overall Study|Withdrawal by Subject|0
1673359|NCT01451437|5846198|P7|Overall Study|Withdrawal by Subject|1
1673360|NCT01451437|5846199|P6|Overall Study|Withdrawal by Subject|0
1673361|NCT01451437|5846200|P5|Overall Study|Withdrawal by Subject|1
1673362|NCT01451437|5846201|P4|Overall Study|Withdrawal by Subject|0
1673363|NCT01451437|5846202|P3|Overall Study|Withdrawal by Subject|0
1673364|NCT01451437|5846203|P2|Overall Study|Withdrawal by Subject|0
1673365|NCT01451437|5846204|P1|Overall Study|Withdrawal by Subject|0
1673366|NCT01451437|5846196|P9|Overall Study|Protocol Violation|0
1673367|NCT01451437|5846197|P8|Overall Study|Protocol Violation|0
1673368|NCT01451437|5846198|P7|Overall Study|Protocol Violation|1
1673369|NCT01451437|5846199|P6|Overall Study|Protocol Violation|0
1673370|NCT01451437|5846200|P5|Overall Study|Protocol Violation|0
1673371|NCT01451437|5846201|P4|Overall Study|Protocol Violation|0
1673372|NCT01451437|5846202|P3|Overall Study|Protocol Violation|0
1673373|NCT01451437|5846203|P2|Overall Study|Protocol Violation|0
1673374|NCT01451437|5846204|P1|Overall Study|Protocol Violation|0
1673375|NCT01451437|5846196|P9|Overall Study|Disease Progression|3
1673376|NCT01451437|5846197|P8|Overall Study|Disease Progression|1
1673377|NCT01451437|5846198|P7|Overall Study|Disease Progression|3
1673378|NCT01451437|5846199|P6|Overall Study|Disease Progression|2
1673379|NCT01451437|5846200|P5|Overall Study|Disease Progression|3
1673380|NCT01451437|5846201|P4|Overall Study|Disease Progression|1
1673381|NCT01451437|5846202|P3|Overall Study|Disease Progression|1
1673382|NCT01451437|5846203|P2|Overall Study|Disease Progression|0
1673383|NCT01451437|5846204|P1|Overall Study|Disease Progression|0
1673384|NCT01451437|5846196|P9|Overall Study|Physician Decision|0
1673386|NCT01451437|5846198|P7|Overall Study|Physician Decision|0
1673387|NCT01451437|5846199|P6|Overall Study|Physician Decision|0
1673388|NCT01451437|5846200|P5|Overall Study|Physician Decision|0
1673389|NCT01451437|5846201|P4|Overall Study|Physician Decision|0
1673390|NCT01451437|5846202|P3|Overall Study|Physician Decision|2
1673391|NCT01451437|5846203|P2|Overall Study|Physician Decision|1
1673392|NCT01451437|5846204|P1|Overall Study|Physician Decision|1
1673393|NCT01451437|5846196|P9|Overall Study|Adverse Event|1
1673394|NCT01451437|5846197|P8|Overall Study|Adverse Event|2
1673395|NCT01451437|5846198|P7|Overall Study|Adverse Event|1
1673396|NCT01451437|5846199|P6|Overall Study|Adverse Event|1
1673397|NCT01451437|5846200|P5|Overall Study|Adverse Event|0
1673398|NCT01451437|5846201|P4|Overall Study|Adverse Event|0
1673399|NCT01451437|5846202|P3|Overall Study|Adverse Event|0
1673400|NCT01451437|5846203|P2|Overall Study|Adverse Event|0
1673401|NCT01451437|5846204|P1|Overall Study|Adverse Event|0
1673402|NCT01451424|5846336|P4|Overall Study|Adverse Event|1
1673403|NCT01451424|5846337|P3|Overall Study|Adverse Event|0
1673404|NCT01451424|5846338|P2|Overall Study|Adverse Event|0
1673405|NCT01451424|5846339|P1|Overall Study|Adverse Event|0
1673406|NCT01451424|5846336|P4|Overall Study|Physician Decision|1
1673407|NCT01451424|5846337|P3|Overall Study|Physician Decision|1
1673408|NCT01451424|5846338|P2|Overall Study|Physician Decision|0
1673409|NCT01451424|5846339|P1|Overall Study|Physician Decision|0
1673410|NCT01451424|5846336|P4|Overall Study|Lost to Follow-up|1
1673411|NCT01451424|5846337|P3|Overall Study|Lost to Follow-up|0
1673412|NCT01451424|5846338|P2|Overall Study|Lost to Follow-up|1
1673413|NCT01451424|5846339|P1|Overall Study|Lost to Follow-up|0
1673414|NCT01451424|5846336|P4|Overall Study|Withdrawal by Subject|2
1673415|NCT01451424|5846337|P3|Overall Study|Withdrawal by Subject|0
1673416|NCT01451424|5846338|P2|Overall Study|Withdrawal by Subject|1
1673417|NCT01451424|5846339|P1|Overall Study|Withdrawal by Subject|1
1673418|NCT01451398|5846397|P2|Overall Study|Lack of Efficacy|1
1673419|NCT01451398|5846398|P1|Overall Study|Lack of Efficacy|0
1673420|NCT01451398|5846397|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
1673421|NCT01451398|5846398|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
1673422|NCT01451398|5846397|P2|Overall Study|Moved out of country|1
1673423|NCT01451398|5846398|P1|Overall Study|Moved out of country|0
1673424|NCT01451398|5846397|P2|Overall Study|Non-compliance with protocol|1
1673425|NCT01451398|5846398|P1|Overall Study|Non-compliance with protocol|1
1673426|NCT01451398|5846397|P2|Overall Study|Non-compliance with study drug|3
1673427|NCT01451398|5846398|P1|Overall Study|Non-compliance with study drug|1
1673428|NCT01451398|5846397|P2|Overall Study|Lost to Follow-up|4
1673429|NCT01451398|5846398|P1|Overall Study|Lost to Follow-up|6
1673430|NCT01451398|5846397|P2|Overall Study|Withdrawal by Subject|14
1673431|NCT01451398|5846398|P1|Overall Study|Withdrawal by Subject|10
1673432|NCT01451398|5846397|P2|Overall Study|Physician Decision|1
1673433|NCT01451398|5846398|P1|Overall Study|Physician Decision|1
1673434|NCT01451398|5846397|P2|Overall Study|Protocol Violation|2
1673435|NCT01451398|5846398|P1|Overall Study|Protocol Violation|1
1673436|NCT01451398|5846397|P2|Overall Study|Adverse Event|9
1673437|NCT01451398|5846398|P1|Overall Study|Adverse Event|7
1673438|NCT01451203|5846437|P2|Post-treatment Period|Investigator decision|1
1673439|NCT01451203|5846438|P1|Post-treatment Period|Investigator decision|0
1673440|NCT01451203|5846437|P2|Post-treatment Period|Adverse Event|1
1673441|NCT01451203|5846438|P1|Post-treatment Period|Adverse Event|0
1673442|NCT01451203|5846437|P2|Post-treatment Period|Lack of Efficacy|28
1673443|NCT01451203|5846438|P1|Post-treatment Period|Lack of Efficacy|12
1673444|NCT01451203|5846437|P2|Post-treatment Period|Consent withdrawn|4
1673445|NCT01451203|5846438|P1|Post-treatment Period|Consent withdrawn|2
1673446|NCT01451203|5846437|P2|Double-blind Treatment Period|Investigator decision|0
1673447|NCT01451203|5846438|P1|Double-blind Treatment Period|Investigator decision|2
1673448|NCT01451203|5846437|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
1673449|NCT01451203|5846438|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
1673450|NCT01451203|5846437|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
1673451|NCT01451203|5846438|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
1673452|NCT01451203|5846437|P2|Double-blind Treatment Period|Adverse Event|9
1673453|NCT01451203|5846438|P1|Double-blind Treatment Period|Adverse Event|6
1673454|NCT01451203|5846437|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
1673455|NCT01451203|5846438|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
1673456|NCT01451203|5846437|P2|Double-blind Treatment Period|Lack of Efficacy|36
1673457|NCT01451203|5846438|P1|Double-blind Treatment Period|Lack of Efficacy|71
1673458|NCT01451203|5846437|P2|Double-blind Treatment Period|Consent Withdrawn|2
1673459|NCT01451203|5846438|P1|Double-blind Treatment Period|Consent Withdrawn|3
1673460|NCT01451203|5846437|P2|Double-blind Treatment Period|Did not receive treatment|2
1673461|NCT01451203|5846438|P1|Double-blind Treatment Period|Did not receive treatment|1
1673462|NCT01451164|5846456|P4|Overall Study|Lack of Efficacy|7
1673463|NCT01451164|5846457|P3|Overall Study|Lack of Efficacy|9
1673464|NCT01451164|5846458|P2|Overall Study|Lack of Efficacy|9
1673465|NCT01451164|5846459|P1|Overall Study|Lack of Efficacy|7
1673466|NCT01451164|5846456|P4|Overall Study|Protocol Violation|0
1673467|NCT01451164|5846457|P3|Overall Study|Protocol Violation|0
1673468|NCT01451164|5846458|P2|Overall Study|Protocol Violation|1
1673469|NCT01451164|5846459|P1|Overall Study|Protocol Violation|0
1673470|NCT01451164|5846456|P4|Overall Study|Withdrawal by Subject|17
1673471|NCT01451164|5846457|P3|Overall Study|Withdrawal by Subject|16
1673472|NCT01451164|5846458|P2|Overall Study|Withdrawal by Subject|11
1673473|NCT01451164|5846459|P1|Overall Study|Withdrawal by Subject|14
1673474|NCT01451164|5846456|P4|Overall Study|Physician Decision|0
1673475|NCT01451164|5846457|P3|Overall Study|Physician Decision|1
1673476|NCT01451164|5846458|P2|Overall Study|Physician Decision|0
1673477|NCT01451164|5846459|P1|Overall Study|Physician Decision|2
1673478|NCT01451164|5846456|P4|Overall Study|Withdrawal Criteria|1
1673479|NCT01451164|5846457|P3|Overall Study|Withdrawal Criteria|1
1673480|NCT01451164|5846458|P2|Overall Study|Withdrawal Criteria|1
1673481|NCT01451164|5846459|P1|Overall Study|Withdrawal Criteria|1
1673482|NCT01451164|5846456|P4|Overall Study|Adverse Event|21
1673483|NCT01451164|5846457|P3|Overall Study|Adverse Event|18
1673484|NCT01451164|5846458|P2|Overall Study|Adverse Event|12
1673485|NCT01451164|5846459|P1|Overall Study|Adverse Event|19
1673486|NCT01450943|5846488|P3|Overall Study|Screen failure, loss to follow-up|6
1673487|NCT01450943|5846489|P2|Overall Study|Screen failure, loss to follow-up|7
1673488|NCT01450943|5846490|P1|Overall Study|Screen failure, loss to follow-up|2
1673489|NCT01450813|5846523|P4|Overall Study|Physician Decision|3
1673490|NCT01450813|5846524|P3|Overall Study|Physician Decision|0
1673491|NCT01450813|5846525|P2|Overall Study|Physician Decision|1
1673492|NCT01450813|5846526|P1|Overall Study|Physician Decision|1
1673493|NCT01450800|5846540|P2|Overall Study|Protocol Violation|3
1673494|NCT01450800|5846541|P1|Overall Study|Protocol Violation|1
1673495|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
1673496|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
1673497|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
1673498|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
1673499|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Not reported|2
1673500|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Not reported|2
1673501|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
1673502|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
1673503|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
1673504|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
1673505|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
1673506|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
1673507|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
1673508|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
1673509|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Death|6
1673510|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Death|5
1673511|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
1673512|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
1673513|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
1673514|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
1673515|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
1673516|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
1673517|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
1673518|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
1673519|NCT01450761|5846576|P2|Treatment With Blinded Study Therapy|Disease progression|415
1673520|NCT01450761|5846577|P1|Treatment With Blinded Study Therapy|Disease progression|318
1673521|NCT01450761|5846576|P2|Lead-in Chemotherapy|Lost to Follow-up|0
1673522|NCT01450761|5846577|P1|Lead-in Chemotherapy|Lost to Follow-up|2
1673523|NCT01450761|5846576|P2|Lead-in Chemotherapy|Other|2
1673524|NCT01450761|5846577|P1|Lead-in Chemotherapy|Other|2
1673525|NCT01450761|5846576|P2|Lead-in Chemotherapy|Death|3
1673526|NCT01450761|5846577|P1|Lead-in Chemotherapy|Death|3
1673527|NCT01450761|5846576|P2|Lead-in Chemotherapy|No longer meets study criteria|7
1673528|NCT01450761|5846577|P1|Lead-in Chemotherapy|No longer meets study criteria|3
1673529|NCT01450761|5846576|P2|Lead-in Chemotherapy|Study drug toxicity|10
1673530|NCT01450761|5846577|P1|Lead-in Chemotherapy|Study drug toxicity|6
1673531|NCT01450761|5846576|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
1673532|NCT01450761|5846577|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
1673533|NCT01450761|5846576|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
1673534|NCT01450761|5846577|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
1673535|NCT01450761|5846576|P2|Lead-in Chemotherapy|Disease progression|32
1673536|NCT01450761|5846577|P1|Lead-in Chemotherapy|Disease progression|33
1673537|NCT01450761|5846576|P2|Randomization|Other|1
1673538|NCT01450761|5846577|P1|Randomization|Other|0
1673539|NCT01450761|5846576|P2|Randomization|Adverse Event unrelated to study drug|0
1673540|NCT01450761|5846577|P1|Randomization|Adverse Event unrelated to study drug|1
1673541|NCT01450761|5846576|P2|Randomization|Disease progression|2
1673542|NCT01450761|5846577|P1|Randomization|Disease progression|0
1673543|NCT01450761|5846576|P2|Randomization|Withdrawal by Subject|0
1673544|NCT01450761|5846577|P1|Randomization|Withdrawal by Subject|2
1673545|NCT01450761|5846576|P2|Randomization|Subject no longer meets study criteria|2
1673546|NCT01450761|5846577|P1|Randomization|Subject no longer meets study criteria|1
1673547|NCT01450696|5846589|P2|Overall Study|Study Terminated by Sponsor|58
1673548|NCT01450696|5846590|P1|Overall Study|Study Terminated by Sponsor|53
1673549|NCT01450696|5846589|P2|Overall Study|Withdrawal by Subject|2
1673550|NCT01450696|5846590|P1|Overall Study|Withdrawal by Subject|13
1673551|NCT01450696|5846589|P2|Overall Study|Non-Compliance|0
1673552|NCT01450696|5846590|P1|Overall Study|Non-Compliance|1
1673553|NCT01450696|5846589|P2|Overall Study|Lost to Follow-up|3
1673554|NCT01450696|5846590|P1|Overall Study|Lost to Follow-up|3
1673555|NCT01450696|5846589|P2|Overall Study|Death|84
1673556|NCT01450696|5846590|P1|Overall Study|Death|77
1673557|NCT01450696|5846589|P2|Overall Study|Never Treated|1
1673558|NCT01450696|5846590|P1|Overall Study|Never Treated|1
1673559|NCT01450683|5846612|P1|Overall Study|Adverse Event|2
1673560|NCT01450631|5846618|P2|Overall Study|Withdrawal by Subject|0
1673561|NCT01450631|5846619|P1|Overall Study|Withdrawal by Subject|1
1673562|NCT01450631|5846618|P2|Overall Study|Lost to Follow-up|4
1673563|NCT01450631|5846619|P1|Overall Study|Lost to Follow-up|2
1673564|NCT01450137|5846749|P2|Week 12 to Study End|Withdrawal by Subject|1
1673565|NCT01450137|5846750|P1|Week 12 to Study End|Withdrawal by Subject|0
1673566|NCT01450137|5846749|P2|Week 12 to Study End|Death|1
1673567|NCT01450137|5846750|P1|Week 12 to Study End|Death|0
1673568|NCT01450137|5846749|P2|Up to Week 12|Withdrawal by Subject|2
1673569|NCT01450137|5846750|P1|Up to Week 12|Withdrawal by Subject|0
1673570|NCT01450137|5846749|P2|Up to Week 12|Adverse Event|1
1673571|NCT01450137|5846750|P1|Up to Week 12|Adverse Event|2
1673572|NCT01450098|5846764|P2|Period 3|Withdrawal by Subject|2
1673573|NCT01450098|5846765|P1|Period 3|Withdrawal by Subject|0
1673574|NCT01450098|5846764|P2|Period 3|Protocol Violation|1
1673575|NCT01450098|5846765|P1|Period 3|Protocol Violation|0
1673576|NCT01450007|5846784|P3|Overall Study|Adverse Event|0
1673577|NCT01450007|5846785|P2|Overall Study|Adverse Event|1
1673578|NCT01450007|5846786|P1|Overall Study|Adverse Event|0
1673579|NCT01450007|5846784|P3|Overall Study|Protocol Violation|1
1673580|NCT01450007|5846785|P2|Overall Study|Protocol Violation|1
1673581|NCT01450007|5846786|P1|Overall Study|Protocol Violation|0
1673582|NCT01450007|5846784|P3|Overall Study|Late exclusion before treatment|2
1673583|NCT01450007|5846785|P2|Overall Study|Late exclusion before treatment|3
1673584|NCT01450007|5846786|P1|Overall Study|Late exclusion before treatment|2
1673585|NCT01449955|5846805|P2|Overall Study|Withdrawal by Subject|2
1673586|NCT01449955|5846806|P1|Overall Study|Withdrawal by Subject|1
1673587|NCT01449929|5846834|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
1673588|NCT01449929|5846835|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1673589|NCT01449929|5846836|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
1673590|NCT01449929|5846834|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
1673591|NCT01449929|5846835|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1673592|NCT01449929|5846836|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
1673593|NCT01449929|5846834|P3|Extension Phase Approximately 3 Years|Adverse Event|2
1673594|NCT01449929|5846835|P2|Extension Phase Approximately 3 Years|Adverse Event|0
1673595|NCT01449929|5846836|P1|Extension Phase Approximately 3 Years|Adverse Event|0
1673596|NCT01449929|5846834|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
1673597|NCT01449929|5846835|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
1673598|NCT01449929|5846836|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
1673599|NCT01449929|5846834|P3|Randomization Phase 96 Week|Physician Decision|0
1673600|NCT01449929|5846835|P2|Randomization Phase 96 Week|Physician Decision|3
1673601|NCT01449929|5846836|P1|Randomization Phase 96 Week|Physician Decision|2
1673602|NCT01449929|5846834|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
1673603|NCT01449929|5846835|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
1673604|NCT01449929|5846836|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
1673605|NCT01449929|5846834|P3|Randomization Phase 96 Week|Lost to Follow-up|0
1673606|NCT01449929|5846835|P2|Randomization Phase 96 Week|Lost to Follow-up|18
1673607|NCT01449929|5846836|P1|Randomization Phase 96 Week|Lost to Follow-up|15
1673608|NCT01449929|5846834|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1673609|NCT01449929|5846835|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
1673610|NCT01449929|5846836|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
1673611|NCT01449929|5846834|P3|Randomization Phase 96 Week|Protocol Violation|0
1673612|NCT01449929|5846835|P2|Randomization Phase 96 Week|Protocol Violation|6
1673613|NCT01449929|5846836|P1|Randomization Phase 96 Week|Protocol Violation|5
1673614|NCT01449929|5846834|P3|Randomization Phase 96 Week|Lack of Efficacy|0
1673615|NCT01449929|5846835|P2|Randomization Phase 96 Week|Lack of Efficacy|4
1673616|NCT01449929|5846836|P1|Randomization Phase 96 Week|Lack of Efficacy|3
1673617|NCT01449929|5846834|P3|Randomization Phase 96 Week|Adverse Event|0
1673618|NCT01449929|5846835|P2|Randomization Phase 96 Week|Adverse Event|13
1673619|NCT01449929|5846836|P1|Randomization Phase 96 Week|Adverse Event|5
1673620|NCT01449812|5846881|P3|Overall Study|Lost to Follow-up|0
1673621|NCT01449812|5846882|P2|Overall Study|Lost to Follow-up|0
1673622|NCT01449812|5846883|P1|Overall Study|Lost to Follow-up|1
1673623|NCT01449812|5846881|P3|Overall Study|Withdrawal by Subject|1
1673624|NCT01449812|5846882|P2|Overall Study|Withdrawal by Subject|0
1673625|NCT01449812|5846883|P1|Overall Study|Withdrawal by Subject|0
1673626|NCT01449812|5846881|P3|Overall Study|Migrated/moved from study area|0
1673627|NCT01449812|5846882|P2|Overall Study|Migrated/moved from study area|0
1673628|NCT01449812|5846883|P1|Overall Study|Migrated/moved from study area|1
1673629|NCT01449721|5846998|P2|Overall Study|Physician Decision|1
1673630|NCT01449721|5846999|P1|Overall Study|Physician Decision|0
1673631|NCT01449721|5846998|P2|Overall Study|Physician Decision|1
1673632|NCT01449721|5846999|P1|Overall Study|Physician Decision|0
1673633|NCT01449708|5847011|P2|Overall Study|respiratory failure|0
1673634|NCT01449708|5847012|P1|Overall Study|respiratory failure|1
1673635|NCT01449708|5847011|P2|Overall Study|surgical complication|2
1673636|NCT01449708|5847012|P1|Overall Study|surgical complication|1
1673637|NCT01449708|5847011|P2|Overall Study|Protocol Violation|1
1673638|NCT01449708|5847012|P1|Overall Study|Protocol Violation|0
1673639|NCT01449682|5847023|P2|Overall Study|Adverse Event|0
1673640|NCT01449682|5847024|P1|Overall Study|Adverse Event|1
1673641|NCT01449682|5847023|P2|Overall Study|Death|1
1673642|NCT01449682|5847024|P1|Overall Study|Death|0
1673643|NCT01449630|5847045|P9|Period 2|Sponsor Decision|0
1673644|NCT01449630|5847046|P8|Period 2|Sponsor Decision|0
1673645|NCT01449630|5847047|P7|Period 2|Sponsor Decision|1
1673646|NCT01449630|5847048|P6|Period 2|Sponsor Decision|0
1673647|NCT01449630|5847049|P5|Period 2|Sponsor Decision|0
1673648|NCT01449630|5847050|P4|Period 2|Sponsor Decision|0
1673649|NCT01449630|5847051|P3|Period 2|Sponsor Decision|0
1673650|NCT01449630|5847052|P2|Period 2|Sponsor Decision|0
1673651|NCT01449630|5847053|P1|Period 2|Sponsor Decision|0
1673652|NCT01449630|5847045|P9|Period 1|Sponsor Decision|0
1673653|NCT01449630|5847046|P8|Period 1|Sponsor Decision|0
1673654|NCT01449630|5847047|P7|Period 1|Sponsor Decision|0
1673655|NCT01449630|5847048|P6|Period 1|Sponsor Decision|1
1673656|NCT01449630|5847049|P5|Period 1|Sponsor Decision|0
1673657|NCT01449630|5847050|P4|Period 1|Sponsor Decision|0
1673658|NCT01449630|5847051|P3|Period 1|Sponsor Decision|0
1673659|NCT01449630|5847052|P2|Period 1|Sponsor Decision|0
1673660|NCT01449630|5847053|P1|Period 1|Sponsor Decision|0
1673661|NCT01449630|5847045|P9|Period 1|Physician Decision|0
1673662|NCT01449630|5847046|P8|Period 1|Physician Decision|0
1673663|NCT01449630|5847047|P7|Period 1|Physician Decision|0
1673664|NCT01449630|5847048|P6|Period 1|Physician Decision|0
1673665|NCT01449630|5847049|P5|Period 1|Physician Decision|0
1673666|NCT01449630|5847050|P4|Period 1|Physician Decision|1
1673667|NCT01449630|5847051|P3|Period 1|Physician Decision|0
1673668|NCT01449630|5847052|P2|Period 1|Physician Decision|0
1673669|NCT01449630|5847053|P1|Period 1|Physician Decision|1
1673670|NCT01449539|5847123|P1|Overall Study|Toxicity not study related|1
1673671|NCT01449539|5847123|P1|Overall Study|Withdrawal by Subject|3
1673672|NCT01449526|5847129|P2|Overall Study|Cannot maintain visits|1
1673673|NCT01449526|5847130|P1|Overall Study|Cannot maintain visits|0
1673674|NCT01449526|5847129|P2|Overall Study|Lack of Motivation|1
1673675|NCT01449526|5847130|P1|Overall Study|Lack of Motivation|0
1673676|NCT01449526|5847129|P2|Overall Study|Symptoms/complaints|1
1673677|NCT01449526|5847130|P1|Overall Study|Symptoms/complaints|0
1673678|NCT01449526|5847129|P2|Overall Study|Withdrawal by Subject|1
1673679|NCT01449526|5847130|P1|Overall Study|Withdrawal by Subject|1
1673680|NCT01449526|5847129|P2|Overall Study|Lost to Follow-up|2
1673681|NCT01449526|5847130|P1|Overall Study|Lost to Follow-up|1
1673682|NCT01449461|5847199|P6|Overall Study|Reason not specified|1
1673683|NCT01449461|5847200|P5|Overall Study|Reason not specified|0
1673684|NCT01449461|5847201|P4|Overall Study|Reason not specified|3
1673685|NCT01449461|5847202|P3|Overall Study|Reason not specified|0
1673686|NCT01449461|5847203|P2|Overall Study|Reason not specified|1
1673687|NCT01449461|5847204|P1|Overall Study|Reason not specified|0
1673688|NCT01449461|5847199|P6|Overall Study|Clinical progressive disease|3
1673689|NCT01449461|5847200|P5|Overall Study|Clinical progressive disease|3
1673690|NCT01449461|5847201|P4|Overall Study|Clinical progressive disease|0
1673691|NCT01449461|5847202|P3|Overall Study|Clinical progressive disease|0
1673692|NCT01449461|5847203|P2|Overall Study|Clinical progressive disease|1
1673693|NCT01449461|5847204|P1|Overall Study|Clinical progressive disease|2
1673694|NCT01449461|5847199|P6|Overall Study|Documented progressive disease|5
1673695|NCT01449461|5847200|P5|Overall Study|Documented progressive disease|21
1673696|NCT01449461|5847201|P4|Overall Study|Documented progressive disease|11
1673697|NCT01449461|5847202|P3|Overall Study|Documented progressive disease|14
1673698|NCT01449461|5847203|P2|Overall Study|Documented progressive disease|6
1673699|NCT01449461|5847204|P1|Overall Study|Documented progressive disease|4
1673700|NCT01449461|5847199|P6|Overall Study|Death|1
1673701|NCT01449461|5847200|P5|Overall Study|Death|4
1673702|NCT01449461|5847201|P4|Overall Study|Death|0
1673703|NCT01449461|5847202|P3|Overall Study|Death|0
1673704|NCT01449461|5847203|P2|Overall Study|Death|1
1673705|NCT01449461|5847204|P1|Overall Study|Death|0
1673706|NCT01449461|5847199|P6|Overall Study|Adverse Event|3
1673707|NCT01449461|5847200|P5|Overall Study|Adverse Event|3
1673708|NCT01449461|5847201|P4|Overall Study|Adverse Event|3
1673709|NCT01449461|5847202|P3|Overall Study|Adverse Event|2
1673710|NCT01449461|5847203|P2|Overall Study|Adverse Event|3
1673711|NCT01449461|5847204|P1|Overall Study|Adverse Event|0
1673712|NCT01449461|5847199|P6|Overall Study|Ongoing|2
1673713|NCT01449461|5847200|P5|Overall Study|Ongoing|17
1673714|NCT01449461|5847201|P4|Overall Study|Ongoing|15
1673715|NCT01449461|5847202|P3|Overall Study|Ongoing|2
1673716|NCT01449461|5847203|P2|Overall Study|Ongoing|6
1673717|NCT01449461|5847204|P1|Overall Study|Ongoing|0
1673718|NCT01449370|5847341|P25|Overall Study|Death|1
1673719|NCT01449370|5847342|P24|Overall Study|Death|0
1673720|NCT01449370|5847343|P23|Overall Study|Death|0
1673721|NCT01449370|5847344|P22|Overall Study|Death|0
1673722|NCT01449370|5847345|P21|Overall Study|Death|0
1673723|NCT01449370|5847346|P20|Overall Study|Death|0
1673724|NCT01449370|5847347|P19|Overall Study|Death|0
1673725|NCT01449370|5847348|P18|Overall Study|Death|0
1673726|NCT01449370|5847349|P17|Overall Study|Death|0
1673727|NCT01449370|5847350|P16|Overall Study|Death|0
1673728|NCT01449370|5847351|P15|Overall Study|Death|0
1673729|NCT01449370|5847352|P14|Overall Study|Death|0
1673730|NCT01449370|5847353|P13|Overall Study|Death|0
1673731|NCT01449370|5847354|P12|Overall Study|Death|0
1673732|NCT01449370|5847355|P11|Overall Study|Death|0
1673733|NCT01449370|5847356|P10|Overall Study|Death|0
1673734|NCT01449370|5847357|P9|Overall Study|Death|0
1673735|NCT01449370|5847358|P8|Overall Study|Death|0
1673736|NCT01449370|5847359|P7|Overall Study|Death|0
1673737|NCT01449370|5847360|P6|Overall Study|Death|0
1673738|NCT01449370|5847361|P5|Overall Study|Death|0
1673739|NCT01449370|5847362|P4|Overall Study|Death|0
1673740|NCT01449370|5847363|P3|Overall Study|Death|0
1673741|NCT01449370|5847364|P2|Overall Study|Death|0
1673742|NCT01449370|5847365|P1|Overall Study|Death|0
1673743|NCT01449370|5847341|P25|Overall Study|Medication Prohibited by Protocol|0
1673744|NCT01449370|5847342|P24|Overall Study|Medication Prohibited by Protocol|1
1673745|NCT01449370|5847343|P23|Overall Study|Medication Prohibited by Protocol|0
1673746|NCT01449370|5847344|P22|Overall Study|Medication Prohibited by Protocol|0
1673747|NCT01449370|5847345|P21|Overall Study|Medication Prohibited by Protocol|0
1673748|NCT01449370|5847346|P20|Overall Study|Medication Prohibited by Protocol|0
1673749|NCT01449370|5847347|P19|Overall Study|Medication Prohibited by Protocol|0
1673750|NCT01449370|5847348|P18|Overall Study|Medication Prohibited by Protocol|0
1673751|NCT01449370|5847349|P17|Overall Study|Medication Prohibited by Protocol|0
1673752|NCT01449370|5847350|P16|Overall Study|Medication Prohibited by Protocol|0
1673753|NCT01449370|5847351|P15|Overall Study|Medication Prohibited by Protocol|0
1673754|NCT01449370|5847352|P14|Overall Study|Medication Prohibited by Protocol|0
1673755|NCT01449370|5847353|P13|Overall Study|Medication Prohibited by Protocol|0
1673756|NCT01449370|5847354|P12|Overall Study|Medication Prohibited by Protocol|0
1673757|NCT01449370|5847355|P11|Overall Study|Medication Prohibited by Protocol|0
1673758|NCT01449370|5847356|P10|Overall Study|Medication Prohibited by Protocol|0
1673759|NCT01449370|5847357|P9|Overall Study|Medication Prohibited by Protocol|0
1673760|NCT01449370|5847358|P8|Overall Study|Medication Prohibited by Protocol|0
1673761|NCT01449370|5847359|P7|Overall Study|Medication Prohibited by Protocol|0
1673762|NCT01449370|5847360|P6|Overall Study|Medication Prohibited by Protocol|0
1673763|NCT01449370|5847361|P5|Overall Study|Medication Prohibited by Protocol|0
1673764|NCT01449370|5847362|P4|Overall Study|Medication Prohibited by Protocol|0
1673765|NCT01449370|5847363|P3|Overall Study|Medication Prohibited by Protocol|0
1673766|NCT01449370|5847364|P2|Overall Study|Medication Prohibited by Protocol|0
1673767|NCT01449370|5847365|P1|Overall Study|Medication Prohibited by Protocol|0
1673768|NCT01449370|5847341|P25|Overall Study|Other|0
1673769|NCT01449370|5847342|P24|Overall Study|Other|1
1673770|NCT01449370|5847343|P23|Overall Study|Other|1
1673771|NCT01449370|5847344|P22|Overall Study|Other|0
1673772|NCT01449370|5847345|P21|Overall Study|Other|0
1673773|NCT01449370|5847346|P20|Overall Study|Other|0
1673774|NCT01449370|5847347|P19|Overall Study|Other|0
1673775|NCT01449370|5847348|P18|Overall Study|Other|0
1673776|NCT01449370|5847349|P17|Overall Study|Other|0
1673777|NCT01449370|5847350|P16|Overall Study|Other|0
1673778|NCT01449370|5847351|P15|Overall Study|Other|0
1673779|NCT01449370|5847352|P14|Overall Study|Other|0
1673780|NCT01449370|5847353|P13|Overall Study|Other|0
1673781|NCT01449370|5847354|P12|Overall Study|Other|0
1673782|NCT01449370|5847355|P11|Overall Study|Other|0
1673783|NCT01449370|5847356|P10|Overall Study|Other|1
1673784|NCT01449370|5847357|P9|Overall Study|Other|1
1673785|NCT01449370|5847358|P8|Overall Study|Other|0
1673786|NCT01449370|5847359|P7|Overall Study|Other|0
1673787|NCT01449370|5847360|P6|Overall Study|Other|0
1673788|NCT01449370|5847361|P5|Overall Study|Other|0
1673789|NCT01449370|5847362|P4|Overall Study|Other|0
1673790|NCT01449370|5847363|P3|Overall Study|Other|0
1673791|NCT01449370|5847364|P2|Overall Study|Other|0
1673792|NCT01449370|5847365|P1|Overall Study|Other|0
1673793|NCT01449370|5847341|P25|Overall Study|Lost to Follow-up|0
1673794|NCT01449370|5847342|P24|Overall Study|Lost to Follow-up|0
1673795|NCT01449370|5847343|P23|Overall Study|Lost to Follow-up|0
1673796|NCT01449370|5847344|P22|Overall Study|Lost to Follow-up|0
1673797|NCT01449370|5847345|P21|Overall Study|Lost to Follow-up|1
1673798|NCT01449370|5847346|P20|Overall Study|Lost to Follow-up|0
1673799|NCT01449370|5847347|P19|Overall Study|Lost to Follow-up|0
1673800|NCT01449370|5847348|P18|Overall Study|Lost to Follow-up|0
1673801|NCT01449370|5847349|P17|Overall Study|Lost to Follow-up|0
1673802|NCT01449370|5847350|P16|Overall Study|Lost to Follow-up|0
1673803|NCT01449370|5847351|P15|Overall Study|Lost to Follow-up|0
1673804|NCT01449370|5847352|P14|Overall Study|Lost to Follow-up|0
1673805|NCT01449370|5847353|P13|Overall Study|Lost to Follow-up|0
1673806|NCT01449370|5847354|P12|Overall Study|Lost to Follow-up|0
1673807|NCT01449370|5847355|P11|Overall Study|Lost to Follow-up|0
1673808|NCT01449370|5847356|P10|Overall Study|Lost to Follow-up|0
1673809|NCT01449370|5847357|P9|Overall Study|Lost to Follow-up|0
1673810|NCT01449370|5847358|P8|Overall Study|Lost to Follow-up|0
1673811|NCT01449370|5847359|P7|Overall Study|Lost to Follow-up|0
1673812|NCT01449370|5847360|P6|Overall Study|Lost to Follow-up|0
1673813|NCT01449370|5847361|P5|Overall Study|Lost to Follow-up|0
1673814|NCT01449370|5847362|P4|Overall Study|Lost to Follow-up|0
1673815|NCT01449370|5847363|P3|Overall Study|Lost to Follow-up|0
1673816|NCT01449370|5847364|P2|Overall Study|Lost to Follow-up|0
1673817|NCT01449370|5847365|P1|Overall Study|Lost to Follow-up|0
1673818|NCT01449370|5847341|P25|Overall Study|Participant Decision|1
1673819|NCT01449370|5847342|P24|Overall Study|Participant Decision|0
1673820|NCT01449370|5847343|P23|Overall Study|Participant Decision|0
1673821|NCT01449370|5847344|P22|Overall Study|Participant Decision|1
1673822|NCT01449370|5847345|P21|Overall Study|Participant Decision|0
1673823|NCT01449370|5847346|P20|Overall Study|Participant Decision|0
1673824|NCT01449370|5847347|P19|Overall Study|Participant Decision|1
1673825|NCT01449370|5847348|P18|Overall Study|Participant Decision|0
1673826|NCT01449370|5847349|P17|Overall Study|Participant Decision|3
1673827|NCT01449370|5847350|P16|Overall Study|Participant Decision|1
1673828|NCT01449370|5847351|P15|Overall Study|Participant Decision|0
1673829|NCT01449370|5847352|P14|Overall Study|Participant Decision|1
1673830|NCT01449370|5847353|P13|Overall Study|Participant Decision|1
1673831|NCT01449370|5847354|P12|Overall Study|Participant Decision|0
1673832|NCT01449370|5847355|P11|Overall Study|Participant Decision|0
1673833|NCT01449370|5847356|P10|Overall Study|Participant Decision|0
1673834|NCT01449370|5847357|P9|Overall Study|Participant Decision|1
1673835|NCT01449370|5847358|P8|Overall Study|Participant Decision|1
1673836|NCT01449370|5847359|P7|Overall Study|Participant Decision|0
1673837|NCT01449370|5847360|P6|Overall Study|Participant Decision|0
1673838|NCT01449370|5847361|P5|Overall Study|Participant Decision|0
1673839|NCT01449370|5847362|P4|Overall Study|Participant Decision|0
1673840|NCT01449370|5847363|P3|Overall Study|Participant Decision|0
1673841|NCT01449370|5847364|P2|Overall Study|Participant Decision|0
1673842|NCT01449370|5847365|P1|Overall Study|Participant Decision|0
1673843|NCT01449370|5847341|P25|Overall Study|Adverse Event|3
1673844|NCT01449370|5847342|P24|Overall Study|Adverse Event|1
1673845|NCT01449370|5847343|P23|Overall Study|Adverse Event|0
1673846|NCT01449370|5847344|P22|Overall Study|Adverse Event|1
1673847|NCT01449370|5847345|P21|Overall Study|Adverse Event|0
1673848|NCT01449370|5847346|P20|Overall Study|Adverse Event|1
1673849|NCT01449370|5847347|P19|Overall Study|Adverse Event|1
1673850|NCT01449370|5847348|P18|Overall Study|Adverse Event|0
1673851|NCT01449370|5847349|P17|Overall Study|Adverse Event|0
1673852|NCT01449370|5847350|P16|Overall Study|Adverse Event|1
1673853|NCT01449370|5847351|P15|Overall Study|Adverse Event|0
1673854|NCT01449370|5847352|P14|Overall Study|Adverse Event|2
1673855|NCT01449370|5847353|P13|Overall Study|Adverse Event|0
1673856|NCT01449370|5847354|P12|Overall Study|Adverse Event|0
1673857|NCT01449370|5847355|P11|Overall Study|Adverse Event|0
1673858|NCT01449370|5847356|P10|Overall Study|Adverse Event|1
1673859|NCT01449370|5847357|P9|Overall Study|Adverse Event|1
1673860|NCT01449370|5847358|P8|Overall Study|Adverse Event|0
1673861|NCT01449370|5847359|P7|Overall Study|Adverse Event|0
1673862|NCT01449370|5847360|P6|Overall Study|Adverse Event|0
1673863|NCT01449370|5847361|P5|Overall Study|Adverse Event|0
1673864|NCT01449370|5847362|P4|Overall Study|Adverse Event|1
1673865|NCT01449370|5847363|P3|Overall Study|Adverse Event|0
1673866|NCT01449370|5847364|P2|Overall Study|Adverse Event|2
1673867|NCT01449370|5847365|P1|Overall Study|Adverse Event|1
1673868|NCT01449370|5847341|P25|Overall Study|Disease Progression|3
1673869|NCT01449370|5847342|P24|Overall Study|Disease Progression|7
1673870|NCT01449370|5847343|P23|Overall Study|Disease Progression|3
1673871|NCT01449370|5847344|P22|Overall Study|Disease Progression|2
1673872|NCT01449370|5847345|P21|Overall Study|Disease Progression|5
1673873|NCT01449370|5847346|P20|Overall Study|Disease Progression|2
1673874|NCT01449370|5847347|P19|Overall Study|Disease Progression|1
1673875|NCT01449370|5847348|P18|Overall Study|Disease Progression|3
1673876|NCT01449370|5847349|P17|Overall Study|Disease Progression|4
1673877|NCT01449370|5847350|P16|Overall Study|Disease Progression|1
1673878|NCT01449370|5847351|P15|Overall Study|Disease Progression|3
1673879|NCT01449370|5847352|P14|Overall Study|Disease Progression|8
1673880|NCT01449370|5847353|P13|Overall Study|Disease Progression|2
1673881|NCT01449370|5847354|P12|Overall Study|Disease Progression|3
1673882|NCT01449370|5847355|P11|Overall Study|Disease Progression|3
1673883|NCT01449370|5847356|P10|Overall Study|Disease Progression|1
1673884|NCT01449370|5847357|P9|Overall Study|Disease Progression|9
1673885|NCT01449370|5847358|P8|Overall Study|Disease Progression|2
1673886|NCT01449370|5847359|P7|Overall Study|Disease Progression|3
1673887|NCT01449370|5847360|P6|Overall Study|Disease Progression|3
1673888|NCT01449370|5847361|P5|Overall Study|Disease Progression|3
1673889|NCT01449370|5847362|P4|Overall Study|Disease Progression|3
1673890|NCT01449370|5847363|P3|Overall Study|Disease Progression|8
1673891|NCT01449370|5847364|P2|Overall Study|Disease Progression|4
1673892|NCT01449370|5847365|P1|Overall Study|Disease Progression|5
1673893|NCT01449279|5847743|P1|Overall Study|Toxicity|2
1673894|NCT01449279|5847743|P1|Overall Study|Lack of Efficacy|5
1673895|NCT01449006|5847768|P2|Overall Study|Protocol Violation|0
1673896|NCT01449006|5847769|P1|Overall Study|Protocol Violation|1
1673897|NCT01449006|5847768|P2|Overall Study|Withdrawal by Subject|0
1673898|NCT01449006|5847769|P1|Overall Study|Withdrawal by Subject|1
1673899|NCT01449006|5847768|P2|Overall Study|Lost to Follow-up|0
1673900|NCT01449006|5847769|P1|Overall Study|Lost to Follow-up|1
1673901|NCT01448850|5847783|P2|Overall Study|Other|12
1673902|NCT01448850|5847784|P1|Overall Study|Other|15
1673903|NCT01448850|5847783|P2|Overall Study|Lost to Follow-up|1
1673904|NCT01448850|5847784|P1|Overall Study|Lost to Follow-up|3
1673905|NCT01448850|5847783|P2|Overall Study|Withdrawal by Subject|21
1673906|NCT01448850|5847784|P1|Overall Study|Withdrawal by Subject|13
1673907|NCT01448850|5847783|P2|Overall Study|Death|6
1673908|NCT01448850|5847784|P1|Overall Study|Death|3
1673909|NCT01448824|5847815|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
1673910|NCT01448824|5847816|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1673911|NCT01448824|5847817|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1673912|NCT01448824|5847818|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1673913|NCT01448824|5847819|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1673914|NCT01448824|5847820|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1673915|NCT01448824|5847821|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1673916|NCT01448824|5847822|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
1673917|NCT01448824|5847815|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
1673918|NCT01448824|5847816|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1673919|NCT01448824|5847817|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1673920|NCT01448824|5847818|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1673921|NCT01448824|5847819|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1673922|NCT01448824|5847820|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1673923|NCT01448824|5847821|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1673924|NCT01448824|5847822|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
1673925|NCT01448824|5847815|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
1673926|NCT01448824|5847816|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1673927|NCT01448824|5847817|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1673928|NCT01448824|5847818|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1673929|NCT01448824|5847819|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1673930|NCT01448824|5847820|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1673931|NCT01448824|5847821|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1673932|NCT01448824|5847822|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
1673933|NCT01448824|5847815|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
1673934|NCT01448824|5847816|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1673935|NCT01448824|5847817|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1673936|NCT01448824|5847818|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1673937|NCT01448824|5847819|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1673938|NCT01448824|5847820|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1673939|NCT01448824|5847821|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1673940|NCT01448824|5847822|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
1673941|NCT01448824|5847815|P8|Part 1: Washout Period|Lost to Follow-up|0
1673942|NCT01448824|5847816|P7|Part 1: Washout Period|Lost to Follow-up|0
1673943|NCT01448824|5847817|P6|Part 1: Washout Period|Lost to Follow-up|0
1673944|NCT01448824|5847818|P5|Part 1: Washout Period|Lost to Follow-up|0
1673945|NCT01448824|5847819|P4|Part 1: Washout Period|Lost to Follow-up|0
1673946|NCT01448824|5847820|P3|Part 1: Washout Period|Lost to Follow-up|0
1673947|NCT01448824|5847821|P2|Part 1: Washout Period|Lost to Follow-up|0
1673948|NCT01448824|5847822|P1|Part 1: Washout Period|Lost to Follow-up|1
1673949|NCT01448824|5847815|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1673950|NCT01448824|5847816|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1673951|NCT01448824|5847817|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
1673952|NCT01448824|5847818|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1673953|NCT01448824|5847819|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1673954|NCT01448824|5847820|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1673955|NCT01448824|5847821|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1673956|NCT01448824|5847822|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
1673957|NCT01448824|5847815|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1673958|NCT01448824|5847816|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1673959|NCT01448824|5847817|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
1673960|NCT01448824|5847818|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
1673961|NCT01448824|5847819|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
1673962|NCT01448824|5847820|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1673963|NCT01448824|5847821|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1673964|NCT01448824|5847822|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
1673965|NCT01448824|5847815|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1673966|NCT01448824|5847816|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
1673967|NCT01448824|5847817|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1673968|NCT01448824|5847818|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1673969|NCT01448824|5847819|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1673970|NCT01448824|5847820|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1673971|NCT01448824|5847821|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1673972|NCT01448824|5847822|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
1673973|NCT01448707|5847873|P2|Overall Study|Other|4
1673974|NCT01448707|5847874|P1|Overall Study|Other|7
1673975|NCT01448707|5847873|P2|Overall Study|Withdrawal by Subject|7
1673976|NCT01448707|5847874|P1|Overall Study|Withdrawal by Subject|6
1673977|NCT01448707|5847873|P2|Overall Study|Lost to Follow-up|6
1673978|NCT01448707|5847874|P1|Overall Study|Lost to Follow-up|2
1673979|NCT01448707|5847873|P2|Overall Study|Adverse Event|1
1673980|NCT01448707|5847874|P1|Overall Study|Adverse Event|3
1673981|NCT01448616|5847895|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1673982|NCT01448616|5847896|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
1673983|NCT01448616|5847897|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
1673984|NCT01448616|5847898|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
1673985|NCT01448616|5847895|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
1673986|NCT01448616|5847896|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
1673987|NCT01448616|5847897|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
1673988|NCT01448616|5847898|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
1673989|NCT01448616|5847895|P4|Study Drug (Treatment Phase)|Adverse Event|0
1673990|NCT01448616|5847896|P3|Study Drug (Treatment Phase)|Adverse Event|1
1673991|NCT01448616|5847897|P2|Study Drug (Treatment Phase)|Adverse Event|1
1673992|NCT01448616|5847898|P1|Study Drug (Treatment Phase)|Adverse Event|0
1673993|NCT01448616|5847895|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1673994|NCT01448616|5847896|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1673995|NCT01448616|5847897|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
1673996|NCT01448616|5847898|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
1673997|NCT01448616|5847895|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
1673998|NCT01448616|5847896|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
1673999|NCT01448616|5847897|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
1674000|NCT01448616|5847898|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
1674001|NCT01448213|5847945|P2|Overall Study|Protocol Violation|2
1674002|NCT01448213|5847946|P1|Overall Study|Protocol Violation|1
1674003|NCT01448213|5847945|P2|Overall Study|Adverse Event|10
1674004|NCT01448213|5847946|P1|Overall Study|Adverse Event|4
1674005|NCT01448213|5847945|P2|Overall Study|Lost to Follow-up|10
1674006|NCT01448213|5847946|P1|Overall Study|Lost to Follow-up|12
1674007|NCT01448057|5847956|P2|Overall Study|Withdrawal by Subject|0
1674008|NCT01448057|5847957|P1|Overall Study|Withdrawal by Subject|2
1674009|NCT01448057|5847956|P2|Overall Study|Adverse Event|2
1674010|NCT01448057|5847957|P1|Overall Study|Adverse Event|0
1674011|NCT01448057|5847956|P2|Overall Study|Lost to Follow-up|0
1674012|NCT01448057|5847957|P1|Overall Study|Lost to Follow-up|3
1674013|NCT01448057|5847956|P2|Overall Study|Protocol Violation|2
1674014|NCT01448057|5847957|P1|Overall Study|Protocol Violation|3
1674015|NCT01448044|5847967|P2|Follow Up Period|Other|11
1674016|NCT01448044|5847968|P1|Follow Up Period|Other|5
1674017|NCT01448044|5847967|P2|Follow Up Period|Lost to Follow-up|2
1674018|NCT01448044|5847968|P1|Follow Up Period|Lost to Follow-up|6
1674019|NCT01448044|5847967|P2|Follow Up Period|Withdrawal by Subject|1
1674020|NCT01448044|5847968|P1|Follow Up Period|Withdrawal by Subject|1
1674021|NCT01448044|5847967|P2|Treatment Period|Other reason|0
1674022|NCT01448044|5847968|P1|Treatment Period|Other reason|2
1674023|NCT01448044|5847967|P2|Treatment Period|Lost to Follow-up|1
1674024|NCT01448044|5847968|P1|Treatment Period|Lost to Follow-up|2
1674025|NCT01448044|5847967|P2|Treatment Period|Participant does not meet study criteria|0
1674026|NCT01448044|5847968|P1|Treatment Period|Participant does not meet study criteria|1
1674027|NCT01448044|5847967|P2|Treatment Period|Completed 24 weeks treatment period only|0
1674028|NCT01448044|5847968|P1|Treatment Period|Completed 24 weeks treatment period only|8
1674029|NCT01448044|5847967|P2|Treatment Period|Subject requested discontinue study drug|0
1674030|NCT01448044|5847968|P1|Treatment Period|Subject requested discontinue study drug|1
1674031|NCT01448044|5847967|P2|Treatment Period|Lack of Efficacy|12
1674032|NCT01448044|5847968|P1|Treatment Period|Lack of Efficacy|5
1674033|NCT01448044|5847967|P2|Treatment Period|Adverse Event|3
1674034|NCT01448044|5847968|P1|Treatment Period|Adverse Event|4
1674035|NCT01447927|5847984|P2|Overall Study|Withdrawal by Subject|0
1674036|NCT01447927|5847985|P1|Overall Study|Withdrawal by Subject|1
1674037|NCT01447927|5847984|P2|Overall Study|Adverse Event|3
1674038|NCT01447927|5847985|P1|Overall Study|Adverse Event|4
1674039|NCT01447719|5848019|P1|Overall Study|Family withdrew autopsy consent|7
1674040|NCT01447719|5848019|P1|Overall Study|Withdrawal by Subject|2
1674041|NCT01447719|5848019|P1|Overall Study|Subject still living at end of study|79
1674042|NCT01447719|5848019|P1|Overall Study|Invalid image or not imaged|3
1674043|NCT01447719|5848019|P1|Overall Study|Image acquisition failure|2
1674044|NCT01447576|5848045|P1|Overall Study|Physician Decision|6
1674045|NCT01447576|5848045|P1|Overall Study|Lack of Efficacy|68
1674046|NCT01447576|5848045|P1|Overall Study|Protocol deviation|83
1674047|NCT01447576|5848045|P1|Overall Study|Withdrawal by Subject|100
1674048|NCT01447576|5848045|P1|Overall Study|Participant met withdrawal criteria|40
1674049|NCT01447576|5848045|P1|Overall Study|Adverse Event|127
1674050|NCT01447576|5848045|P1|Overall Study|Lost to Follow-up|52
1674051|NCT01447446|5848078|P6|Overall Study|Reason not Specified|0
1674052|NCT01447446|5848079|P5|Overall Study|Reason not Specified|1
1674053|NCT01447446|5848080|P4|Overall Study|Reason not Specified|1
1674054|NCT01447446|5848081|P3|Overall Study|Reason not Specified|1
1674055|NCT01447446|5848082|P2|Overall Study|Reason not Specified|1
1674056|NCT01447446|5848083|P1|Overall Study|Reason not Specified|1
1674057|NCT01447446|5848078|P6|Overall Study|New Treatment Started|0
1674058|NCT01447446|5848079|P5|Overall Study|New Treatment Started|2
1674059|NCT01447446|5848080|P4|Overall Study|New Treatment Started|0
1674060|NCT01447446|5848081|P3|Overall Study|New Treatment Started|1
1674061|NCT01447446|5848082|P2|Overall Study|New Treatment Started|2
1674062|NCT01447446|5848083|P1|Overall Study|New Treatment Started|8
1674063|NCT01447446|5848078|P6|Overall Study|SVR12 Assessment|5
1674064|NCT01447446|5848079|P5|Overall Study|SVR12 Assessment|5
1674065|NCT01447446|5848080|P4|Overall Study|SVR12 Assessment|1
1674066|NCT01447446|5848081|P3|Overall Study|SVR12 Assessment|2
1674067|NCT01447446|5848082|P2|Overall Study|SVR12 Assessment|1
1674068|NCT01447446|5848083|P1|Overall Study|SVR12 Assessment|13
1674069|NCT01447446|5848078|P6|Overall Study|Administrative/Other|4
1674070|NCT01447446|5848079|P5|Overall Study|Administrative/Other|33
1674071|NCT01447446|5848080|P4|Overall Study|Administrative/Other|2
1674072|NCT01447446|5848081|P3|Overall Study|Administrative/Other|10
1674073|NCT01447446|5848082|P2|Overall Study|Administrative/Other|9
1674074|NCT01447446|5848083|P1|Overall Study|Administrative/Other|34
1674075|NCT01447446|5848078|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
1674076|NCT01447446|5848079|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
1674077|NCT01447446|5848080|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
1674078|NCT01447446|5848081|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
1674079|NCT01447446|5848082|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
1674080|NCT01447446|5848083|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
1674081|NCT01447446|5848078|P6|Overall Study|Failure to Return/Consent Withdrawn|9
1674082|NCT01447446|5848079|P5|Overall Study|Failure to Return/Consent Withdrawn|69
1674083|NCT01447446|5848080|P4|Overall Study|Failure to Return/Consent Withdrawn|7
1674084|NCT01447446|5848081|P3|Overall Study|Failure to Return/Consent Withdrawn|31
1674085|NCT01447446|5848082|P2|Overall Study|Failure to Return/Consent Withdrawn|78
1674086|NCT01447446|5848083|P1|Overall Study|Failure to Return/Consent Withdrawn|357
1674087|NCT01447446|5848078|P6|Overall Study|Adverse Event|0
1674088|NCT01447446|5848079|P5|Overall Study|Adverse Event|2
1674089|NCT01447446|5848080|P4|Overall Study|Adverse Event|0
1674090|NCT01447446|5848081|P3|Overall Study|Adverse Event|1
1674091|NCT01447446|5848082|P2|Overall Study|Adverse Event|0
1674092|NCT01447446|5848083|P1|Overall Study|Adverse Event|3
1674093|NCT01447446|5848078|P6|Overall Study|Death|0
1674094|NCT01447446|5848079|P5|Overall Study|Death|7
1674095|NCT01447446|5848080|P4|Overall Study|Death|1
1674096|NCT01447446|5848081|P3|Overall Study|Death|2
1674097|NCT01447446|5848082|P2|Overall Study|Death|3
1674098|NCT01447446|5848083|P1|Overall Study|Death|6
1674099|NCT01447433|5848173|P2|Overall Study|Protocol Violation|1
1674100|NCT01447433|5848174|P1|Overall Study|Protocol Violation|1
1674101|NCT01447433|5848173|P2|Overall Study|Withdrawal by Subject|3
1674102|NCT01447433|5848174|P1|Overall Study|Withdrawal by Subject|3
1674103|NCT01447433|5848173|P2|Overall Study|Lost to Follow-up|2
1674104|NCT01447433|5848174|P1|Overall Study|Lost to Follow-up|0
1674105|NCT01447420|5848201|P3|Overall Study|Lack of Efficacy|8
1674106|NCT01447420|5848202|P2|Overall Study|Lack of Efficacy|19
1674107|NCT01447420|5848203|P1|Overall Study|Lack of Efficacy|1
1674108|NCT01447420|5848201|P3|Overall Study|Withdrawal by Subject|0
1674109|NCT01447420|5848202|P2|Overall Study|Withdrawal by Subject|1
1674110|NCT01447420|5848203|P1|Overall Study|Withdrawal by Subject|4
1674111|NCT01447420|5848201|P3|Overall Study|Protocol Violation|0
1674112|NCT01447420|5848202|P2|Overall Study|Protocol Violation|3
1674113|NCT01447420|5848203|P1|Overall Study|Protocol Violation|3
1674114|NCT01447420|5848201|P3|Overall Study|Adverse Event|2
1674115|NCT01447420|5848202|P2|Overall Study|Adverse Event|4
1674116|NCT01447420|5848203|P1|Overall Study|Adverse Event|2
1674117|NCT01446874|5848319|P3|Overall Study|Withdrawal by Subject|4
1674118|NCT01446874|5848320|P2|Overall Study|Withdrawal by Subject|0
1674119|NCT01446874|5848321|P1|Overall Study|Withdrawal by Subject|0
1674120|NCT01446874|5848319|P3|Overall Study|Antibiotics for pre-op infection|2
1674121|NCT01446874|5848320|P2|Overall Study|Antibiotics for pre-op infection|0
1674122|NCT01446874|5848321|P1|Overall Study|Antibiotics for pre-op infection|0
1674123|NCT01446874|5848319|P3|Overall Study|Non-compliance|0
1674124|NCT01446874|5848320|P2|Overall Study|Non-compliance|4
1674125|NCT01446874|5848321|P1|Overall Study|Non-compliance|0
1674126|NCT01446874|5848319|P3|Overall Study|No surgery/No qualifying surgery|12
1674127|NCT01446874|5848320|P2|Overall Study|No surgery/No qualifying surgery|0
1674128|NCT01446874|5848321|P1|Overall Study|No surgery/No qualifying surgery|1
1674129|NCT01446874|5848319|P3|Overall Study|Not eligible|0
1674130|NCT01446874|5848320|P2|Overall Study|Not eligible|0
1674131|NCT01446874|5848321|P1|Overall Study|Not eligible|1
1674132|NCT01446809|5848349|P3|Overall Study|Failure to complete study procedures|1
1674133|NCT01446809|5848350|P2|Overall Study|Failure to complete study procedures|0
1674134|NCT01446809|5848351|P1|Overall Study|Failure to complete study procedures|0
1674135|NCT01446809|5848349|P3|Overall Study|Adverse Event|1
1674136|NCT01446809|5848350|P2|Overall Study|Adverse Event|0
1674137|NCT01446809|5848351|P1|Overall Study|Adverse Event|0
1674138|NCT01446796|5848364|P2|Overall Study|Withdrawal by Subject|0
1674139|NCT01446796|5848365|P1|Overall Study|Withdrawal by Subject|1
1674140|NCT01446419|5848411|P2|Overall Study|Terminated per protocol|0
1674141|NCT01446419|5848412|P1|Overall Study|Terminated per protocol|3
1674142|NCT01446419|5848411|P2|Overall Study|Withdrawal by Subject|1
1674143|NCT01446419|5848412|P1|Overall Study|Withdrawal by Subject|1
1674144|NCT01446419|5848411|P2|Overall Study|Death|0
1674145|NCT01446419|5848412|P1|Overall Study|Death|1
1674146|NCT01446289|5848426|P4|Overall Study|Withdrawal by Subject|0
1674147|NCT01446289|5848427|P3|Overall Study|Withdrawal by Subject|1
1674148|NCT01446289|5848428|P2|Overall Study|Withdrawal by Subject|0
1674149|NCT01446289|5848429|P1|Overall Study|Withdrawal by Subject|1
1674150|NCT01446237|5848472|P1|Overall Study|Withdrawal by Subject|7
1674151|NCT01446237|5848472|P1|Overall Study|Lost to Follow-up|2
1674152|NCT01446237|5848472|P1|Overall Study|Adverse Event|1
1674153|NCT01446159|5848484|P4|Overall Study|Other|13
1674154|NCT01446159|5848485|P3|Overall Study|Other|14
1674155|NCT01446159|5848486|P2|Overall Study|Other|0
1674156|NCT01446159|5848487|P1|Overall Study|Other|0
1674157|NCT01446159|5848484|P4|Overall Study|Death|36
1674158|NCT01446159|5848485|P3|Overall Study|Death|43
1674159|NCT01446159|5848486|P2|Overall Study|Death|3
1674160|NCT01446159|5848487|P1|Overall Study|Death|2
1674161|NCT01446159|5848484|P4|Overall Study|Lost to Follow-up|2
1674162|NCT01446159|5848485|P3|Overall Study|Lost to Follow-up|1
1674163|NCT01446159|5848486|P2|Overall Study|Lost to Follow-up|0
1674164|NCT01446159|5848487|P1|Overall Study|Lost to Follow-up|0
1674165|NCT01446159|5848484|P4|Overall Study|Withdrawal by Subject|11
1674166|NCT01446159|5848485|P3|Overall Study|Withdrawal by Subject|14
1674167|NCT01446159|5848486|P2|Overall Study|Withdrawal by Subject|0
1674168|NCT01446159|5848487|P1|Overall Study|Withdrawal by Subject|1
1674169|NCT01446042|5848562|P3|Overall Study|Other reasons|1
1674170|NCT01446042|5848563|P2|Overall Study|Other reasons|1
1674171|NCT01446042|5848564|P1|Overall Study|Other reasons|2
1674172|NCT01446042|5848562|P3|Overall Study|Lost to Follow-up|0
1674173|NCT01446042|5848563|P2|Overall Study|Lost to Follow-up|0
1674174|NCT01446042|5848564|P1|Overall Study|Lost to Follow-up|5
1674175|NCT01446042|5848562|P3|Overall Study|Adverse Event|4
1674176|NCT01446042|5848563|P2|Overall Study|Adverse Event|0
1674177|NCT01446042|5848564|P1|Overall Study|Adverse Event|1
1674178|NCT01446042|5848562|P3|Overall Study|Withdrawal by Subject|4
1674179|NCT01446042|5848563|P2|Overall Study|Withdrawal by Subject|2
1674180|NCT01446042|5848564|P1|Overall Study|Withdrawal by Subject|12
1674181|NCT01446003|5848575|P2|Period 2|Adverse Event|0
1674182|NCT01446003|5848576|P1|Period 2|Adverse Event|1
1674183|NCT01446003|5848575|P2|Period 1|Protocol Violation|0
1674184|NCT01446003|5848576|P1|Period 1|Protocol Violation|2
1674185|NCT01445951|5848597|P3|Overall Study|Cough|0
1674186|NCT01445951|5848598|P2|Overall Study|Cough|1
1674187|NCT01445951|5848599|P1|Overall Study|Cough|0
1674188|NCT01445951|5848597|P3|Overall Study|Sponsor decision - subject travel|0
1674189|NCT01445951|5848598|P2|Overall Study|Sponsor decision - subject travel|1
1674190|NCT01445951|5848599|P1|Overall Study|Sponsor decision - subject travel|0
1674191|NCT01445951|5848597|P3|Overall Study|Non-compliance with protocol|0
1674192|NCT01445951|5848598|P2|Overall Study|Non-compliance with protocol|1
1674193|NCT01445951|5848599|P1|Overall Study|Non-compliance with protocol|0
1674194|NCT01445951|5848597|P3|Overall Study|Non-compliance with study drug|0
1674195|NCT01445951|5848598|P2|Overall Study|Non-compliance with study drug|2
1674196|NCT01445951|5848599|P1|Overall Study|Non-compliance with study drug|1
1674197|NCT01445951|5848597|P3|Overall Study|Death|1
1674198|NCT01445951|5848598|P2|Overall Study|Death|0
1674199|NCT01445951|5848599|P1|Overall Study|Death|0
1674200|NCT01445951|5848597|P3|Overall Study|Pregnancy|4
1674201|NCT01445951|5848598|P2|Overall Study|Pregnancy|1
1674202|NCT01445951|5848599|P1|Overall Study|Pregnancy|0
1674203|NCT01445951|5848597|P3|Overall Study|Lost to Follow-up|4
1674204|NCT01445951|5848598|P2|Overall Study|Lost to Follow-up|2
1674205|NCT01445951|5848599|P1|Overall Study|Lost to Follow-up|1
1674206|NCT01445951|5848597|P3|Overall Study|Physician Decision|0
1674207|NCT01445951|5848598|P2|Overall Study|Physician Decision|1
1674208|NCT01445951|5848599|P1|Overall Study|Physician Decision|3
1674209|NCT01445951|5848597|P3|Overall Study|Withdrawal by Subject|8
1674210|NCT01445951|5848598|P2|Overall Study|Withdrawal by Subject|16
1674211|NCT01445951|5848599|P1|Overall Study|Withdrawal by Subject|21
1674212|NCT01445951|5848597|P3|Overall Study|Protocol Violation|2
1674213|NCT01445951|5848598|P2|Overall Study|Protocol Violation|2
1674214|NCT01445951|5848599|P1|Overall Study|Protocol Violation|2
1674215|NCT01445951|5848597|P3|Overall Study|Adverse Event|0
1674216|NCT01445951|5848598|P2|Overall Study|Adverse Event|9
1674217|NCT01445951|5848599|P1|Overall Study|Adverse Event|16
1674218|NCT01445886|5848637|P1|Overall Study|Protocol Violation|3
1674219|NCT01445886|5848637|P1|Overall Study|Lost to Follow-up|2
1674220|NCT01445847|5848677|P2|Overall Study|Missed Data|0
1674221|NCT01445847|5848678|P1|Overall Study|Missed Data|1
1674222|NCT01445847|5848677|P2|Overall Study|Protocol Violation|14
1674223|NCT01445847|5848678|P1|Overall Study|Protocol Violation|13
1674224|NCT01445769|5848684|P1|Overall Study|Lost to Follow-up|5
1674225|NCT01445769|5848684|P1|Overall Study|Disease Progression|1
1674226|NCT01445769|5848684|P1|Overall Study|Consent Withdrawn|2
1674227|NCT01445678|5848704|P2|Overall Study|Withdrawal by Subject|5
1674228|NCT01445678|5848705|P1|Overall Study|Withdrawal by Subject|9
1674229|NCT01445678|5848704|P2|Overall Study|Protocol Violation|1
1674230|NCT01445678|5848705|P1|Overall Study|Protocol Violation|1
1674231|NCT01445678|5848704|P2|Overall Study|Lost to Follow-up|5
1674232|NCT01445678|5848705|P1|Overall Study|Lost to Follow-up|8
1674233|NCT01445678|5848704|P2|Overall Study|Lack of Efficacy|2
1674234|NCT01445678|5848705|P1|Overall Study|Lack of Efficacy|0
1674235|NCT01445678|5848704|P2|Overall Study|Adverse Event|8
1674236|NCT01445678|5848705|P1|Overall Study|Adverse Event|12
1674237|NCT01445652|5848723|P2|Overall Study|Adverse Event|0
1674238|NCT01445652|5848724|P1|Overall Study|Adverse Event|1
1674239|NCT01445652|5848723|P2|Overall Study|Failed teach session|0
1674240|NCT01445652|5848724|P1|Overall Study|Failed teach session|2
1674241|NCT01445652|5848723|P2|Overall Study|Failed to attend scheduled visit|3
1674242|NCT01445652|5848724|P1|Overall Study|Failed to attend scheduled visit|2
1674243|NCT01445652|5848723|P2|Overall Study|Not comfortable in lenses|0
1674244|NCT01445652|5848724|P1|Overall Study|Not comfortable in lenses|5
1674245|NCT01445613|5848742|P1|1-year Follow-up|Received a non-study stent|2
1674246|NCT01445613|5848742|P1|1-year Follow-up|Physician Decision|2
1674247|NCT01445613|5848742|P1|1-year Follow-up|Death|30
1674248|NCT01445613|5848742|P1|1-year Follow-up|Lost to Follow-up|2
1674249|NCT01445613|5848742|P1|1-year Follow-up|Missed visit|29
1674250|NCT01445613|5848742|P1|1-year Follow-up|Withdrawal by Subject|12
1674251|NCT01445613|5848742|P1|30-day Follow-up|Death|3
1674252|NCT01445613|5848742|P1|30-day Follow-up|Missed visit|23
1674253|NCT01445613|5848742|P1|30-day Follow-up|Physician Decision|3
1674254|NCT01445613|5848742|P1|30-day Follow-up|Withdrawal by Subject|6
1674255|NCT01445548|5848760|P1|Overall Study|Adverse Event|1
1674256|NCT01445301|5848785|P3|Overall Study|Withdrawal by Subject|4
1674257|NCT01445301|5848786|P2|Overall Study|Withdrawal by Subject|6
1674258|NCT01445301|5848787|P1|Overall Study|Withdrawal by Subject|5
1674259|NCT01445301|5848785|P3|Overall Study|Physician Decision|0
1674260|NCT01445301|5848786|P2|Overall Study|Physician Decision|2
1674261|NCT01445301|5848787|P1|Overall Study|Physician Decision|0
1674262|NCT01445301|5848785|P3|Overall Study|Protocol-Defined Stopping Criteria|1
1674263|NCT01445301|5848786|P2|Overall Study|Protocol-Defined Stopping Criteria|1
1674264|NCT01445301|5848787|P1|Overall Study|Protocol-Defined Stopping Criteria|0
1674265|NCT01445301|5848785|P3|Overall Study|Protocol Violation|0
1674266|NCT01445301|5848786|P2|Overall Study|Protocol Violation|0
1674267|NCT01445301|5848787|P1|Overall Study|Protocol Violation|1
1674268|NCT01445301|5848785|P3|Overall Study|Lack of Efficacy|0
1674269|NCT01445301|5848786|P2|Overall Study|Lack of Efficacy|1
1674270|NCT01445301|5848787|P1|Overall Study|Lack of Efficacy|0
1674271|NCT01445301|5848785|P3|Overall Study|Adverse Event|4
1674272|NCT01445301|5848786|P2|Overall Study|Adverse Event|25
1674273|NCT01445301|5848787|P1|Overall Study|Adverse Event|15
1674279|NCT01444898|5848878|P1|Overall Study|Withdrawal by Subject|1
1674280|NCT01444781|5848893|P3|Overall Study|Withdrawal by Subject|2
1674281|NCT01444781|5848894|P2|Overall Study|Withdrawal by Subject|1
1674282|NCT01444781|5848895|P1|Overall Study|Withdrawal by Subject|3
1674283|NCT01444781|5848893|P3|Overall Study|Lost to Follow-up|1
1674284|NCT01444781|5848894|P2|Overall Study|Lost to Follow-up|3
1674285|NCT01444781|5848895|P1|Overall Study|Lost to Follow-up|0
1674286|NCT01444742|5848933|P1|Overall Study|Death|1
1674287|NCT01444651|5848940|P2|Overall Study|Missing data|1
1674288|NCT01444651|5848941|P1|Overall Study|Missing data|1
1674289|NCT01444651|5848940|P2|Overall Study|Non-fasting|1
1674290|NCT01444651|5848941|P1|Overall Study|Non-fasting|2
1674291|NCT01444651|5848940|P2|Overall Study|Lost to Follow-up|5
1674292|NCT01444651|5848941|P1|Overall Study|Lost to Follow-up|5
1674293|NCT01444651|5848940|P2|Overall Study|Adverse Event|2
1674294|NCT01444651|5848941|P1|Overall Study|Adverse Event|3
1674295|NCT01444456|5848957|P1|Overall Study|Not treated|104
1674296|NCT01444456|5848957|P1|Overall Study|Other|18
1674297|NCT01444456|5848957|P1|Overall Study|Ineligibility determined|23
1674298|NCT01444456|5848957|P1|Overall Study|Death|73
1674299|NCT01444456|5848957|P1|Overall Study|Lost to Follow-up|37
1674300|NCT01444456|5848957|P1|Overall Study|Physician Decision|9
1674301|NCT01444456|5848957|P1|Overall Study|Withdrawal by Subject|21
1674302|NCT01444430|5848968|P2|Overall Study|CRF termination module not completed.|1
1674303|NCT01444430|5848969|P1|Overall Study|CRF termination module not completed.|0
1674304|NCT01444430|5848968|P2|Overall Study|Lost to Follow-up|0
1674305|NCT01444430|5848969|P1|Overall Study|Lost to Follow-up|2
1674306|NCT01444430|5848968|P2|Overall Study|Death|8
1674307|NCT01444430|5848969|P1|Overall Study|Death|6
1674308|NCT01444430|5848968|P2|Overall Study|Withdrawal by Subject|72
1674309|NCT01444430|5848969|P1|Overall Study|Withdrawal by Subject|53
1674310|NCT01444417|5848991|P2|Overall Study|Withdrawal by Subject|0
1674311|NCT01444417|5848992|P1|Overall Study|Withdrawal by Subject|2
1674312|NCT01444417|5848991|P2|Overall Study|Ineligibility Determined|1
1674313|NCT01444417|5848992|P1|Overall Study|Ineligibility Determined|0
1674314|NCT01444391|5849008|P1|Overall Study|Death|1
1674315|NCT01444378|5849016|P1|Overall Study|Missed Visits|10
1674316|NCT01444378|5849016|P1|Overall Study|Administrative Closure Of The Study|2
1674317|NCT01444378|5849016|P1|Overall Study|Death|3
1674318|NCT01444378|5849016|P1|Overall Study|Withdrawal by Subject|1
1674319|NCT01444378|5849016|P1|Overall Study|Lost to Follow-up|1
1674320|NCT01444300|5849128|P2|Overall Study|Adverse Event|0
1674321|NCT01444300|5849129|P1|Overall Study|Adverse Event|4
1674322|NCT01444092|5849161|P1|Overall Study|Other Eligibility criteria|7
1674323|NCT01444092|5849161|P1|Overall Study|Withdrawal by Subject|1
1674324|NCT01444092|5849161|P1|Overall Study|Protocol Violation|1
1674325|NCT01444092|5849161|P1|Overall Study|Adverse Event|8
1674326|NCT01444027|5849170|P3|Overall Study|Lost to Follow-up|14
1674327|NCT01444027|5849171|P2|Overall Study|Lost to Follow-up|20
1674328|NCT01444027|5849172|P1|Overall Study|Lost to Follow-up|26
1674329|NCT01444027|5849170|P3|Overall Study|Withdrawal by Subject|24
1674330|NCT01444027|5849171|P2|Overall Study|Withdrawal by Subject|10
1674331|NCT01444027|5849172|P1|Overall Study|Withdrawal by Subject|4
1674332|NCT01443923|5849194|P2|Overall Study|Adverse Event|0
1674333|NCT01443923|5849195|P1|Overall Study|Adverse Event|1
1674334|NCT01443858|5849212|P3|Overall Study|Lost to Follow-up|2
1674335|NCT01443858|5849213|P2|Overall Study|Lost to Follow-up|5
1674336|NCT01443858|5849214|P1|Overall Study|Lost to Follow-up|5
1674337|NCT01443858|5849212|P3|Overall Study|Lack of Efficacy|0
1674338|NCT01443858|5849213|P2|Overall Study|Lack of Efficacy|0
1674339|NCT01443858|5849214|P1|Overall Study|Lack of Efficacy|1
1674340|NCT01443858|5849212|P3|Overall Study|Withdrawal by Subject|5
1674341|NCT01443858|5849213|P2|Overall Study|Withdrawal by Subject|8
1674342|NCT01443858|5849214|P1|Overall Study|Withdrawal by Subject|9
1674343|NCT01443845|5849236|P2|Overall Study|Lost to Follow-up|13
1674344|NCT01443845|5849237|P1|Overall Study|Lost to Follow-up|9
1674345|NCT01443845|5849236|P2|Overall Study|Military Conflict - Site Terminated|21
1674346|NCT01443845|5849237|P1|Overall Study|Military Conflict - Site Terminated|20
1674347|NCT01443845|5849236|P2|Overall Study|Withdrawal by Subject|67
1674348|NCT01443845|5849237|P1|Overall Study|Withdrawal by Subject|63
1674349|NCT01443845|5849236|P2|Overall Study|Adverse Event|138
1674350|NCT01443845|5849237|P1|Overall Study|Adverse Event|64
1674351|NCT01443845|5849236|P2|Overall Study|Lack of Efficacy|5
1674352|NCT01443845|5849237|P1|Overall Study|Lack of Efficacy|10
1674353|NCT01443845|5849236|P2|Overall Study|Deterioration in pulmonary function|4
1674354|NCT01443845|5849237|P1|Overall Study|Deterioration in pulmonary function|1
1674355|NCT01443845|5849236|P2|Overall Study|Other reasons, such as COPD exacerbation|44
1674356|NCT01443845|5849237|P1|Overall Study|Other reasons, such as COPD exacerbation|44
1674357|NCT01443845|5849236|P2|Overall Study|Protocol Violation|45
1674358|NCT01443845|5849237|P1|Overall Study|Protocol Violation|43
1674359|NCT01443403|5849292|P4|Overall Study|Other - Miscellaneous|1
1674360|NCT01443403|5849293|P3|Overall Study|Other - Miscellaneous|0
1674361|NCT01443403|5849294|P2|Overall Study|Other - Miscellaneous|0
1674362|NCT01443403|5849295|P1|Overall Study|Other - Miscellaneous|1
1674363|NCT01443403|5849292|P4|Overall Study|Use of Prohibited Treatment|0
1674364|NCT01443403|5849293|P3|Overall Study|Use of Prohibited Treatment|0
1674365|NCT01443403|5849294|P2|Overall Study|Use of Prohibited Treatment|3
1674366|NCT01443403|5849295|P1|Overall Study|Use of Prohibited Treatment|2
1674367|NCT01443403|5849292|P4|Overall Study|Protocol Violation|1
1674368|NCT01443403|5849293|P3|Overall Study|Protocol Violation|1
1674369|NCT01443403|5849294|P2|Overall Study|Protocol Violation|1
1674370|NCT01443403|5849295|P1|Overall Study|Protocol Violation|2
1674371|NCT01443403|5849292|P4|Overall Study|Lost to Follow-up|1
1674372|NCT01443403|5849293|P3|Overall Study|Lost to Follow-up|0
1674373|NCT01443403|5849294|P2|Overall Study|Lost to Follow-up|0
1674374|NCT01443403|5849295|P1|Overall Study|Lost to Follow-up|0
1674375|NCT01443403|5849292|P4|Overall Study|Withdrawal by Subject|1
1674376|NCT01443403|5849293|P3|Overall Study|Withdrawal by Subject|2
1674377|NCT01443403|5849294|P2|Overall Study|Withdrawal by Subject|1
1674378|NCT01443403|5849295|P1|Overall Study|Withdrawal by Subject|0
1674379|NCT01443403|5849292|P4|Overall Study|Adverse Event|5
1674380|NCT01443403|5849293|P3|Overall Study|Adverse Event|4
1674381|NCT01443403|5849294|P2|Overall Study|Adverse Event|1
1674382|NCT01443403|5849295|P1|Overall Study|Adverse Event|1
1674383|NCT01443364|5849442|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1674384|NCT01443364|5849442|P1|Overall Study|AE, non-serious non-fatal|8
1674385|NCT01443364|5849442|P1|Overall Study|SAE, non-fatal|6
1674386|NCT01443364|5849442|P1|Overall Study|Other Reason|4
1674387|NCT01443364|5849442|P1|Overall Study|Withdrawal by Subject|5
1674388|NCT01443364|5849442|P1|Overall Study|Lost to Follow-up|3
1674389|NCT01443364|5849442|P1|Overall Study|Lack of Efficacy|14
1674390|NCT01443130|5849571|P6|Overall Study|Death of Subject's Infant|0
1674391|NCT01443130|5849572|P5|Overall Study|Death of Subject's Infant|0
1674392|NCT01443130|5849573|P4|Overall Study|Death of Subject's Infant|0
1674393|NCT01443130|5849574|P3|Overall Study|Death of Subject's Infant|11
1674394|NCT01443130|5849575|P2|Overall Study|Death of Subject's Infant|10
1674395|NCT01443130|5849576|P1|Overall Study|Death of Subject's Infant|5
1674396|NCT01443130|5849571|P6|Overall Study|Withdrawal by Subject|2
1674397|NCT01443130|5849572|P5|Overall Study|Withdrawal by Subject|7
1674398|NCT01443130|5849573|P4|Overall Study|Withdrawal by Subject|7
1674399|NCT01443130|5849574|P3|Overall Study|Withdrawal by Subject|12
1674400|NCT01443130|5849575|P2|Overall Study|Withdrawal by Subject|14
1674401|NCT01443130|5849576|P1|Overall Study|Withdrawal by Subject|15
1674402|NCT01443130|5849571|P6|Overall Study|Protocol Violation|3
1674403|NCT01443130|5849572|P5|Overall Study|Protocol Violation|2
1674404|NCT01443130|5849573|P4|Overall Study|Protocol Violation|2
1674405|NCT01443130|5849574|P3|Overall Study|Protocol Violation|3
1674406|NCT01443130|5849575|P2|Overall Study|Protocol Violation|1
1674407|NCT01443130|5849576|P1|Overall Study|Protocol Violation|2
1674408|NCT01443130|5849571|P6|Overall Study|Adverse Event|0
1674409|NCT01443130|5849572|P5|Overall Study|Adverse Event|0
1674410|NCT01443130|5849573|P4|Overall Study|Adverse Event|0
1674411|NCT01443130|5849574|P3|Overall Study|Adverse Event|1
1674412|NCT01443130|5849575|P2|Overall Study|Adverse Event|1
1674413|NCT01443130|5849576|P1|Overall Study|Adverse Event|2
1674414|NCT01443130|5849571|P6|Overall Study|Death|8
1674415|NCT01443130|5849572|P5|Overall Study|Death|10
1674416|NCT01443130|5849573|P4|Overall Study|Death|7
1674417|NCT01443130|5849574|P3|Overall Study|Death|0
1674418|NCT01443130|5849575|P2|Overall Study|Death|1
1674419|NCT01443130|5849576|P1|Overall Study|Death|0
1674420|NCT01443130|5849571|P6|Overall Study|Lost to Follow-up|21
1674421|NCT01443130|5849572|P5|Overall Study|Lost to Follow-up|25
1674422|NCT01443130|5849573|P4|Overall Study|Lost to Follow-up|23
1674423|NCT01443130|5849574|P3|Overall Study|Lost to Follow-up|50
1674424|NCT01443130|5849575|P2|Overall Study|Lost to Follow-up|42
1674425|NCT01443130|5849576|P1|Overall Study|Lost to Follow-up|44
1674426|NCT01443078|5849626|P1|Overall Study|Patient had brain mets|1
1674427|NCT01443078|5849626|P1|Overall Study|Withdrawal by Subject|1
1674428|NCT01443078|5849626|P1|Overall Study|Responded to neoadjuvant platinum txt|27
1674429|NCT01443026|5849633|P2|Overall Study|Lost to Follow-up|1
1674430|NCT01443026|5849634|P1|Overall Study|Lost to Follow-up|2
1674431|NCT01443026|5849633|P2|Overall Study|Withdrawal by Subject|3
1674432|NCT01443026|5849634|P1|Overall Study|Withdrawal by Subject|0
1674433|NCT01443026|5849633|P2|Overall Study|Death|1
1674434|NCT01443026|5849634|P1|Overall Study|Death|0
1674435|NCT01443026|5849633|P2|Overall Study|Physician Decision|0
1674436|NCT01443026|5849634|P1|Overall Study|Physician Decision|1
1674437|NCT01442779|5849649|P1|Overall Study|Non-compliance|1
1674438|NCT01442779|5849649|P1|Overall Study|Death|3
1674439|NCT01442779|5849649|P1|Overall Study|Withdrawal by Subject|3
1674440|NCT01442714|5849655|P1|Overall Study|Withdrawal by Subject|1
1674441|NCT01442714|5849655|P1|Overall Study|Death|11
1674442|NCT01442688|5849663|P2|Second Intervention|Adverse Event|0
1674443|NCT01442688|5849664|P1|Second Intervention|Adverse Event|1
1674444|NCT01442688|5849663|P2|First Intervention|subject incarcerated|0
1674445|NCT01442688|5849664|P1|First Intervention|subject incarcerated|1
1674446|NCT01442688|5849663|P2|First Intervention|Withdrawal by Subject|0
1674447|NCT01442688|5849664|P1|First Intervention|Withdrawal by Subject|1
1674448|NCT01442675|5849672|P1|Overall Study|Withdrawal by Subject|4
1674449|NCT01442675|5849672|P1|Overall Study|Lost to Follow-up|2
1674450|NCT01442675|5849672|P1|Overall Study|Protocol Violation|6
1674451|NCT01442493|5849684|P2|Overall Study|withdrawn from study|2
1674452|NCT01442493|5849685|P1|Overall Study|withdrawn from study|3
1674453|NCT01442376|5849706|P3|Overall Study|Not eligible for subsequent cycles|0
1674454|NCT01442376|5849707|P2|Overall Study|Not eligible for subsequent cycles|2
1674455|NCT01442376|5849708|P1|Overall Study|Not eligible for subsequent cycles|1
1674456|NCT01442376|5849706|P3|Overall Study|Patients not treated|1
1674457|NCT01442376|5849707|P2|Overall Study|Patients not treated|3
1674458|NCT01442376|5849708|P1|Overall Study|Patients not treated|2
1674459|NCT01442376|5849706|P3|Overall Study|Withdrawal of consent|1
1674460|NCT01442376|5849707|P2|Overall Study|Withdrawal of consent|0
1674461|NCT01442376|5849708|P1|Overall Study|Withdrawal of consent|0
1674462|NCT01442376|5849706|P3|Overall Study|Death|1
1674463|NCT01442376|5849707|P2|Overall Study|Death|1
1674464|NCT01442376|5849708|P1|Overall Study|Death|0
1674465|NCT01442376|5849706|P3|Overall Study|Adverse Event|2
1674466|NCT01442376|5849707|P2|Overall Study|Adverse Event|3
1674467|NCT01442376|5849708|P1|Overall Study|Adverse Event|0
1674468|NCT01442181|5849721|P2|Overall Study|atrial fibrillation not noted|1
1674469|NCT01442181|5849722|P1|Overall Study|atrial fibrillation not noted|0
1674470|NCT01442181|5849721|P2|Overall Study|patient in an additional study|0
1674471|NCT01442181|5849722|P1|Overall Study|patient in an additional study|1
1674472|NCT01442181|5849721|P2|Overall Study|Lost to Follow-up|1
1674473|NCT01442181|5849722|P1|Overall Study|Lost to Follow-up|1
1674474|NCT01442181|5849721|P2|Overall Study|low ejection factor|1
1674475|NCT01442181|5849722|P1|Overall Study|low ejection factor|0
1674476|NCT01442181|5849721|P2|Overall Study|no insurance for surgery|0
1674477|NCT01442181|5849722|P1|Overall Study|no insurance for surgery|1
1674478|NCT01442181|5849721|P2|Overall Study|patient refused surgery|0
1674479|NCT01442181|5849722|P1|Overall Study|patient refused surgery|1
1674480|NCT01442155|5849746|P1|Overall Study|Lost to Follow-up|2
1674481|NCT01442155|5849746|P1|Overall Study|Adverse Event|2
1674482|NCT01442155|5849746|P1|Overall Study|Recurrence|26
1674483|NCT01442155|5849746|P1|Overall Study|Complete remission|35
1674484|NCT01442103|5849762|P1|Overall Study|Lost to Follow-up|2
1674485|NCT01442064|5849772|P6|Overall Study|Condition mandated other intervention|2
1674486|NCT01442064|5849773|P5|Overall Study|Condition mandated other intervention|0
1674487|NCT01442064|5849774|P4|Overall Study|Condition mandated other intervention|0
1674488|NCT01442064|5849775|P3|Overall Study|Condition mandated other intervention|2
1674489|NCT01442064|5849776|P2|Overall Study|Condition mandated other intervention|1
1674490|NCT01442064|5849777|P1|Overall Study|Condition mandated other intervention|1
1674491|NCT01442064|5849772|P6|Overall Study|Subject non-compliance|2
1674492|NCT01442064|5849773|P5|Overall Study|Subject non-compliance|0
1674493|NCT01442064|5849774|P4|Overall Study|Subject non-compliance|0
1674494|NCT01442064|5849775|P3|Overall Study|Subject non-compliance|0
1674495|NCT01442064|5849776|P2|Overall Study|Subject non-compliance|0
1674496|NCT01442064|5849777|P1|Overall Study|Subject non-compliance|0
1674497|NCT01442064|5849772|P6|Overall Study|Sponsor decision|87
1674498|NCT01442064|5849773|P5|Overall Study|Sponsor decision|95
1674499|NCT01442064|5849774|P4|Overall Study|Sponsor decision|88
1674500|NCT01442064|5849775|P3|Overall Study|Sponsor decision|92
1674501|NCT01442064|5849776|P2|Overall Study|Sponsor decision|88
1674502|NCT01442064|5849777|P1|Overall Study|Sponsor decision|82
1674503|NCT01442064|5849772|P6|Overall Study|Withdrawal by Subject|1
1674504|NCT01442064|5849773|P5|Overall Study|Withdrawal by Subject|2
1674505|NCT01442064|5849774|P4|Overall Study|Withdrawal by Subject|2
1674506|NCT01442064|5849775|P3|Overall Study|Withdrawal by Subject|2
1674507|NCT01442064|5849776|P2|Overall Study|Withdrawal by Subject|3
1674508|NCT01442064|5849777|P1|Overall Study|Withdrawal by Subject|6
1674509|NCT01442064|5849772|P6|Overall Study|Physician Decision|1
1674510|NCT01442064|5849773|P5|Overall Study|Physician Decision|3
1674511|NCT01442064|5849774|P4|Overall Study|Physician Decision|3
1674512|NCT01442064|5849775|P3|Overall Study|Physician Decision|2
1674513|NCT01442064|5849776|P2|Overall Study|Physician Decision|1
1674514|NCT01442064|5849777|P1|Overall Study|Physician Decision|1
1674515|NCT01442064|5849772|P6|Overall Study|Lost to Follow-up|3
1674516|NCT01442064|5849773|P5|Overall Study|Lost to Follow-up|3
1674517|NCT01442064|5849774|P4|Overall Study|Lost to Follow-up|1
1674518|NCT01442064|5849775|P3|Overall Study|Lost to Follow-up|1
1674519|NCT01442064|5849776|P2|Overall Study|Lost to Follow-up|5
1674520|NCT01442064|5849777|P1|Overall Study|Lost to Follow-up|5
1674521|NCT01442064|5849772|P6|Overall Study|Death|3
1674522|NCT01442064|5849773|P5|Overall Study|Death|1
1674523|NCT01442064|5849774|P4|Overall Study|Death|3
1674524|NCT01442064|5849775|P3|Overall Study|Death|3
1674525|NCT01442064|5849776|P2|Overall Study|Death|1
1674526|NCT01442064|5849777|P1|Overall Study|Death|0
1674527|NCT01442064|5849772|P6|Overall Study|Adverse Event|0
1674528|NCT01442064|5849773|P5|Overall Study|Adverse Event|2
1674529|NCT01442064|5849774|P4|Overall Study|Adverse Event|1
1674530|NCT01442064|5849775|P3|Overall Study|Adverse Event|2
1674531|NCT01442064|5849776|P2|Overall Study|Adverse Event|2
1674532|NCT01442064|5849777|P1|Overall Study|Adverse Event|2
1674533|NCT01442038|5849814|P2|Overall Study|Study Terminated By Sponsor|3
1674534|NCT01442038|5849815|P1|Overall Study|Study Terminated By Sponsor|2
1674535|NCT01442038|5849814|P2|Overall Study|Investigator's Discretion|16
1674536|NCT01442038|5849815|P1|Overall Study|Investigator's Discretion|13
1674537|NCT01442038|5849814|P2|Overall Study|Protocol Deviation|20
1674538|NCT01442038|5849815|P1|Overall Study|Protocol Deviation|9
1674539|NCT01442038|5849814|P2|Overall Study|Adverse Event|15
1674540|NCT01442038|5849815|P1|Overall Study|Adverse Event|26
1674541|NCT01442038|5849814|P2|Overall Study|Lost to Follow-up|51
1674542|NCT01442038|5849815|P1|Overall Study|Lost to Follow-up|37
1674543|NCT01442038|5849814|P2|Overall Study|Participant Withdrew Consent|102
1674544|NCT01442038|5849815|P1|Overall Study|Participant Withdrew Consent|137
1674545|NCT01442038|5849814|P2|Overall Study|Investigator-Initiated Early Closure|43
1674546|NCT01442038|5849815|P1|Overall Study|Investigator-Initiated Early Closure|44
1674547|NCT01442038|5849814|P2|Overall Study|Death|29
1674548|NCT01442038|5849815|P1|Overall Study|Death|35
1674549|NCT01441973|5849829|P2|Overall Study|Participant withdrew consent|1
1674550|NCT01441973|5849830|P1|Overall Study|Participant withdrew consent|0
1674551|NCT01441973|5849829|P2|Overall Study|Administrative reason by sponsor|5
1674552|NCT01441973|5849830|P1|Overall Study|Administrative reason by sponsor|3
1674553|NCT01441973|5849829|P2|Overall Study|Poor compliance/noncompliance|1
1674554|NCT01441973|5849830|P1|Overall Study|Poor compliance/noncompliance|0
1674555|NCT01441973|5849829|P2|Overall Study|Participant request to discontinue|1
1674556|NCT01441973|5849830|P1|Overall Study|Participant request to discontinue|1
1674557|NCT01441973|5849829|P2|Overall Study|Adverse event unrelated to study drug|2
1674558|NCT01441973|5849830|P1|Overall Study|Adverse event unrelated to study drug|3
1674559|NCT01441973|5849829|P2|Overall Study|Disease progression|6
1674560|NCT01441973|5849830|P1|Overall Study|Disease progression|8
1674561|NCT01441960|5849852|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
1674562|NCT01441960|5849853|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
1674563|NCT01441960|5849852|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
1674564|NCT01441960|5849853|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
1674565|NCT01441960|5849852|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
1674566|NCT01441960|5849853|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
1674567|NCT01441765|5849878|P2|Overall Study|Death|0
1674568|NCT01441765|5849879|P1|Overall Study|Death|1
1674569|NCT01441596|5849896|P3|Overall Study|Not treated|1
1674570|NCT01441596|5849897|P2|Overall Study|Not treated|1
1674571|NCT01441596|5849898|P1|Overall Study|Not treated|0
1674572|NCT01441596|5849896|P3|Overall Study|Withdrawal by Subject|2
1674573|NCT01441596|5849897|P2|Overall Study|Withdrawal by Subject|0
1674574|NCT01441596|5849898|P1|Overall Study|Withdrawal by Subject|4
1674575|NCT01441596|5849896|P3|Overall Study|Other reason not defined below|1
1674576|NCT01441596|5849897|P2|Overall Study|Other reason not defined below|2
1674577|NCT01441596|5849898|P1|Overall Study|Other reason not defined below|0
1674578|NCT01441440|5849945|P3|Overall Study|Difficllty in keeping the schedule|0
1674579|NCT01441440|5849946|P2|Overall Study|Difficllty in keeping the schedule|1
1674580|NCT01441440|5849947|P1|Overall Study|Difficllty in keeping the schedule|1
1674581|NCT01441440|5849945|P3|Overall Study|Work-related matter|0
1674582|NCT01441440|5849946|P2|Overall Study|Work-related matter|1
1674583|NCT01441440|5849947|P1|Overall Study|Work-related matter|0
1674584|NCT01441440|5849945|P3|Overall Study|Moving|1
1674585|NCT01441440|5849946|P2|Overall Study|Moving|1
1674586|NCT01441440|5849947|P1|Overall Study|Moving|0
1674587|NCT01441440|5849945|P3|Overall Study|Lack of Efficacy|1
1674588|NCT01441440|5849946|P2|Overall Study|Lack of Efficacy|0
1674589|NCT01441440|5849947|P1|Overall Study|Lack of Efficacy|1
1674590|NCT01441440|5849945|P3|Overall Study|Pregnancy|0
1674591|NCT01441440|5849946|P2|Overall Study|Pregnancy|0
1674592|NCT01441440|5849947|P1|Overall Study|Pregnancy|1
1674593|NCT01441440|5849945|P3|Overall Study|Withdrawal by Subject|9
1674594|NCT01441440|5849946|P2|Overall Study|Withdrawal by Subject|9
1674595|NCT01441440|5849947|P1|Overall Study|Withdrawal by Subject|11
1674596|NCT01441440|5849945|P3|Overall Study|Lost to Follow-up|1
1674597|NCT01441440|5849946|P2|Overall Study|Lost to Follow-up|2
1674598|NCT01441440|5849947|P1|Overall Study|Lost to Follow-up|0
1674599|NCT01441440|5849945|P3|Overall Study|Adverse Event|9
1674600|NCT01441440|5849946|P2|Overall Study|Adverse Event|9
1674601|NCT01441440|5849947|P1|Overall Study|Adverse Event|2
1674602|NCT01441440|5849945|P3|Overall Study|Death|1
1674603|NCT01441440|5849946|P2|Overall Study|Death|0
1674604|NCT01441440|5849947|P1|Overall Study|Death|1
1674605|NCT01441414|5849970|P1|Overall Study|Subject refused further follow-up|1
1674606|NCT01441414|5849970|P1|Overall Study|Study terminated by sponsor|2
1674607|NCT01441414|5849970|P1|Overall Study|Other reasons|3
1674608|NCT01441414|5849970|P1|Overall Study|Participant died|9
1674609|NCT01441180|5850049|P3|Overall Study|Discontinued|2
1674610|NCT01441180|5850050|P2|Overall Study|Discontinued|0
1674611|NCT01441180|5850051|P1|Overall Study|Discontinued|0
1674612|NCT01441180|5850049|P3|Overall Study|Lost to Follow-up|1
1674613|NCT01441180|5850050|P2|Overall Study|Lost to Follow-up|1
1674614|NCT01441180|5850051|P1|Overall Study|Lost to Follow-up|1
1674615|NCT01441102|5850062|P1|Overall Study|Withdrawal by Subject|2
1674616|NCT01441102|5850062|P1|Overall Study|Adverse Event|1
1674617|NCT01440972|5850106|P2|Overall Study|Withdrawal by Subject|2
1674618|NCT01440972|5850107|P1|Overall Study|Withdrawal by Subject|3
1674619|NCT01440946|5850131|P2|Overall Study|Physician Decision|0
1674620|NCT01440946|5850132|P1|Overall Study|Physician Decision|1
1674621|NCT01440946|5850131|P2|Overall Study|Lost to Follow-up|1
1674622|NCT01440946|5850132|P1|Overall Study|Lost to Follow-up|1
1674623|NCT01440881|5850171|P2|Overall Study|Death|1
1674624|NCT01440881|5850172|P1|Overall Study|Death|0
1674625|NCT01440816|5850186|P2|Overall Study|To Be Seen By Local Oncologist|2
1674626|NCT01440816|5850187|P1|Overall Study|To Be Seen By Local Oncologist|1
1674627|NCT01440816|5850186|P2|Overall Study|Disease Progression|9
1674628|NCT01440816|5850187|P1|Overall Study|Disease Progression|0
1674629|NCT01440803|5850203|P2|Overall Study|Withdrawal by Subject|1
1674630|NCT01440803|5850204|P1|Overall Study|Withdrawal by Subject|0
1674631|NCT01440803|5850203|P2|Overall Study|Lost to Follow-up|2
1674632|NCT01440803|5850204|P1|Overall Study|Lost to Follow-up|0
1674633|NCT01440803|5850203|P2|Overall Study|Met study stopping rule|1
1674634|NCT01440803|5850204|P1|Overall Study|Met study stopping rule|2
1674635|NCT01440647|5850240|P2|Overall Study|Death|3
1674636|NCT01440647|5850241|P1|Overall Study|Death|2
1674637|NCT01440595|5850260|P3|Overall Study|Study terminated by sponsor.|1
1674638|NCT01440595|5850261|P2|Overall Study|Study terminated by sponsor.|2
1674639|NCT01440595|5850262|P1|Overall Study|Study terminated by sponsor.|1
1674640|NCT01440595|5850260|P3|Overall Study|Lost to Follow-up|0
1674641|NCT01440595|5850261|P2|Overall Study|Lost to Follow-up|1
1674642|NCT01440595|5850262|P1|Overall Study|Lost to Follow-up|0
1674643|NCT01440569|5850282|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
1674644|NCT01440569|5850283|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
1674645|NCT01440569|5850282|P2|Open-Label Rollover Phase|Lost to Follow-up|3
1674646|NCT01440569|5850283|P1|Open-Label Rollover Phase|Lost to Follow-up|26
1674647|NCT01440569|5850282|P2|Open-Label Rollover Phase|Withdrew Consent|1
1674648|NCT01440569|5850283|P1|Open-Label Rollover Phase|Withdrew Consent|11
1674649|NCT01440569|5850282|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
1674650|NCT01440569|5850283|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
1674651|NCT01440569|5850282|P2|Open-Label Rollover Phase|Lack of Efficacy|0
1674652|NCT01440569|5850283|P1|Open-Label Rollover Phase|Lack of Efficacy|2
1674653|NCT01440569|5850282|P2|Open-Label Rollover Phase|Pregnancy|0
1674654|NCT01440569|5850283|P1|Open-Label Rollover Phase|Pregnancy|1
1674655|NCT01440569|5850282|P2|Open-Label Rollover Phase|Adverse Event|0
1674656|NCT01440569|5850283|P1|Open-Label Rollover Phase|Adverse Event|3
1674657|NCT01440569|5850282|P2|Main Study|Protocol Violation|0
1674658|NCT01440569|5850283|P1|Main Study|Protocol Violation|1
1674659|NCT01440569|5850282|P2|Main Study|Subject Non-Compliance|0
1674660|NCT01440569|5850283|P1|Main Study|Subject Non-Compliance|3
1674661|NCT01440569|5850282|P2|Main Study|Lost to Follow-up|2
1674662|NCT01440569|5850283|P1|Main Study|Lost to Follow-up|13
1674663|NCT01440569|5850282|P2|Main Study|Withdrew Consent|1
1674664|NCT01440569|5850283|P1|Main Study|Withdrew Consent|7
1674665|NCT01440569|5850282|P2|Main Study|Investigator's Discretion|1
1674666|NCT01440569|5850283|P1|Main Study|Investigator's Discretion|1
1674667|NCT01440569|5850282|P2|Main Study|Pregnancy|0
1674668|NCT01440569|5850283|P1|Main Study|Pregnancy|1
1674669|NCT01440569|5850282|P2|Main Study|Adverse Event|0
1674670|NCT01440569|5850283|P1|Main Study|Adverse Event|9
1674671|NCT01440569|5850282|P2|Main Study|Enrolled but not treated|0
1674672|NCT01440569|5850283|P1|Main Study|Enrolled but not treated|1
1674673|NCT01440517|5850318|P1|Overall Study|Subject withdrawn prior to dosing|1
1674674|NCT01440374|5850349|P4|Part 3: Extension|Physician Decision|14
1674675|NCT01440374|5850350|P3|Part 3: Extension|Physician Decision|0
1674676|NCT01440374|5850351|P2|Part 3: Extension|Physician Decision|0
1674677|NCT01440374|5850352|P1|Part 3: Extension|Physician Decision|0
1674678|NCT01440374|5850349|P4|Part 3: Extension|Adverse Event|13
1674679|NCT01440374|5850350|P3|Part 3: Extension|Adverse Event|0
1674680|NCT01440374|5850351|P2|Part 3: Extension|Adverse Event|0
1674681|NCT01440374|5850352|P1|Part 3: Extension|Adverse Event|0
1674682|NCT01440374|5850349|P4|Part 3: Extension|Withdrawal by Subject|5
1674683|NCT01440374|5850350|P3|Part 3: Extension|Withdrawal by Subject|0
1674684|NCT01440374|5850351|P2|Part 3: Extension|Withdrawal by Subject|0
1674685|NCT01440374|5850352|P1|Part 3: Extension|Withdrawal by Subject|0
1674686|NCT01440374|5850349|P4|Part 2; Double-blind Phase|Not treated|0
1674687|NCT01440374|5850350|P3|Part 2; Double-blind Phase|Not treated|1
1674688|NCT01440374|5850351|P2|Part 2; Double-blind Phase|Not treated|0
1674689|NCT01440374|5850352|P1|Part 2; Double-blind Phase|Not treated|0
1674690|NCT01440374|5850349|P4|Part 2; Double-blind Phase|Adverse Event|0
1674691|NCT01440374|5850350|P3|Part 2; Double-blind Phase|Adverse Event|31
1674692|NCT01440374|5850351|P2|Part 2; Double-blind Phase|Adverse Event|7
1674693|NCT01440374|5850352|P1|Part 2; Double-blind Phase|Adverse Event|0
1674694|NCT01440374|5850349|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
1674695|NCT01440374|5850350|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
1674696|NCT01440374|5850351|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
1674697|NCT01440374|5850352|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
1674698|NCT01440374|5850349|P4|Part 2; Double-blind Phase|Protocol Violation|0
1674699|NCT01440374|5850350|P3|Part 2; Double-blind Phase|Protocol Violation|1
1674700|NCT01440374|5850351|P2|Part 2; Double-blind Phase|Protocol Violation|0
1674701|NCT01440374|5850352|P1|Part 2; Double-blind Phase|Protocol Violation|0
1674702|NCT01440374|5850349|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
1674703|NCT01440374|5850350|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
1674704|NCT01440374|5850351|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
1674705|NCT01440374|5850352|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
1674706|NCT01440374|5850349|P4|Part 2; Double-blind Phase|Physician Decision|0
1674707|NCT01440374|5850350|P3|Part 2; Double-blind Phase|Physician Decision|17
1674708|NCT01440374|5850351|P2|Part 2; Double-blind Phase|Physician Decision|8
1674709|NCT01440374|5850352|P1|Part 2; Double-blind Phase|Physician Decision|0
1674710|NCT01440374|5850349|P4|Part 1: Open-label Phase|Physician Decision|0
1674711|NCT01440374|5850350|P3|Part 1: Open-label Phase|Physician Decision|0
1674712|NCT01440374|5850351|P2|Part 1: Open-label Phase|Physician Decision|0
1674713|NCT01440374|5850352|P1|Part 1: Open-label Phase|Physician Decision|1
1674714|NCT01440374|5850349|P4|Part 1: Open-label Phase|Adverse Event|0
1674715|NCT01440374|5850350|P3|Part 1: Open-label Phase|Adverse Event|0
1674716|NCT01440374|5850351|P2|Part 1: Open-label Phase|Adverse Event|0
1674717|NCT01440374|5850352|P1|Part 1: Open-label Phase|Adverse Event|5
1674718|NCT01440322|5850387|P2|Overall Study|Other Non-Product Related|0
1674719|NCT01440322|5850388|P1|Overall Study|Other Non-Product Related|1
1674720|NCT01440322|5850387|P2|Overall Study|Unrelated Medical Problem|1
1674721|NCT01440322|5850388|P1|Overall Study|Unrelated Medical Problem|0
1674722|NCT01440322|5850387|P2|Overall Study|Other Product Related|0
1674723|NCT01440322|5850388|P1|Overall Study|Other Product Related|1
1674724|NCT01440322|5850387|P2|Overall Study|Unacceptable Subjective Vision|0
1674725|NCT01440322|5850388|P1|Overall Study|Unacceptable Subjective Vision|1
1674726|NCT01440322|5850387|P2|Overall Study|Symptoms and Problems|0
1674727|NCT01440322|5850388|P1|Overall Study|Symptoms and Problems|1
1674728|NCT01440322|5850387|P2|Overall Study|Biomicroscopy|0
1674729|NCT01440322|5850388|P1|Overall Study|Biomicroscopy|1
1674730|NCT01440322|5850387|P2|Overall Study|Discomfort|0
1674731|NCT01440322|5850388|P1|Overall Study|Discomfort|2
1674732|NCT01440283|5850410|P1|Overall Study|Physician Decision|3
1674733|NCT01440283|5850410|P1|Overall Study|Withdrawal by Subject|4
1674734|NCT01440283|5850410|P1|Overall Study|Death|3
1674735|NCT01440101|5850425|P3|Overall Study|Other|0
1674736|NCT01440101|5850426|P2|Overall Study|Other|1
1674737|NCT01440101|5850427|P1|Overall Study|Other|0
1674738|NCT01440101|5850425|P3|Overall Study|Withdrawal by Subject|1
1674739|NCT01440101|5850426|P2|Overall Study|Withdrawal by Subject|3
1674740|NCT01440101|5850427|P1|Overall Study|Withdrawal by Subject|0
1674741|NCT01440101|5850425|P3|Overall Study|Adverse Event|0
1674742|NCT01440101|5850426|P2|Overall Study|Adverse Event|0
1674743|NCT01440101|5850427|P1|Overall Study|Adverse Event|2
1674744|NCT01440049|5850460|P1|Overall Study|Adverse Event|5
1674745|NCT01439971|5850492|P5|Overall Study|Required number in cohort dosed|1
1674746|NCT01439971|5850493|P4|Overall Study|Required number in cohort dosed|0
1674747|NCT01439971|5850494|P3|Overall Study|Required number in cohort dosed|2
1674748|NCT01439971|5850495|P2|Overall Study|Required number in cohort dosed|1
1674749|NCT01439971|5850496|P1|Overall Study|Required number in cohort dosed|0
1674750|NCT01439945|5850676|P4|Double-Blind Treatment Phase|Ineligible|1
1674751|NCT01439945|5850677|P3|Double-Blind Treatment Phase|Ineligible|0
1674752|NCT01439945|5850678|P2|Double-Blind Treatment Phase|Ineligible|2
1674753|NCT01439945|5850679|P1|Double-Blind Treatment Phase|Ineligible|1
1674754|NCT01439945|5850676|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
1674755|NCT01439945|5850677|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
1674756|NCT01439945|5850678|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
1674757|NCT01439945|5850679|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
1674758|NCT01439880|5850704|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
1674759|NCT01439880|5850705|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
1674760|NCT01439880|5850704|P2|All-IP Period (Years 2 to 5)|Other|31
1674761|NCT01439880|5850705|P1|All-IP Period (Years 2 to 5)|Other|14
1674762|NCT01439880|5850704|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
1674763|NCT01439880|5850705|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
1674764|NCT01439880|5850704|P2|All-IP Period (Years 2 to 5)|Death|13
1674765|NCT01439880|5850705|P1|All-IP Period (Years 2 to 5)|Death|3
1674766|NCT01439880|5850704|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
1674767|NCT01439880|5850705|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
1674768|NCT01439880|5850704|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
1674769|NCT01439880|5850705|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
1674770|NCT01439880|5850704|P2|SOC-controlled Period (Year 1)|Reason Missing|2
1674771|NCT01439880|5850705|P1|SOC-controlled Period (Year 1)|Reason Missing|0
1674772|NCT01439880|5850704|P2|SOC-controlled Period (Year 1)|Other|13
1674773|NCT01439880|5850705|P1|SOC-controlled Period (Year 1)|Other|8
1674774|NCT01439880|5850704|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
1674775|NCT01439880|5850705|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
1674776|NCT01439880|5850704|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
1674777|NCT01439880|5850705|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
1674778|NCT01439880|5850704|P2|SOC-controlled Period (Year 1)|Death|1
1674779|NCT01439880|5850705|P1|SOC-controlled Period (Year 1)|Death|2
1674780|NCT01439880|5850704|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
1674781|NCT01439880|5850705|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
1674782|NCT01439867|5850748|P2|Overall Study|Protocol-specified Criteria|0
1674783|NCT01439867|5850749|P1|Overall Study|Protocol-specified Criteria|1
1674784|NCT01439867|5850748|P2|Overall Study|Administrative Decision|5
1674785|NCT01439867|5850749|P1|Overall Study|Administrative Decision|4
1674786|NCT01439867|5850748|P2|Overall Study|Withdrawal by Subject|2
1674787|NCT01439867|5850749|P1|Overall Study|Withdrawal by Subject|1
1674788|NCT01439867|5850748|P2|Overall Study|Non-compliance|1
1674789|NCT01439867|5850749|P1|Overall Study|Non-compliance|0
1674790|NCT01439724|5850801|P2|Overall Study|missing consultation|8
1674791|NCT01439724|5850802|P1|Overall Study|missing consultation|9
1674792|NCT01439711|5850808|P1|Overall Study|No MRI|9
1674793|NCT01439711|5850808|P1|Overall Study|Noncompliance|3
1674794|NCT01439711|5850808|P1|Overall Study|Progression During Active Tx|3
1674795|NCT01439711|5850808|P1|Overall Study|Withdrawal by Subject|3
1674796|NCT01439711|5850808|P1|Overall Study|Adverse Event|5
1674797|NCT01439711|5850808|P1|Overall Study|Progression Prior to Beginning Tx|1
1674798|NCT01439711|5850808|P1|Overall Study|Cancel|3
1674799|NCT01439711|5850808|P1|Overall Study|Ineligible|13
1674800|NCT01439568|5850846|P2|Overall Study|Withdrawal by Subject|2
1674801|NCT01439568|5850847|P1|Overall Study|Withdrawal by Subject|2
1674802|NCT01439568|5850846|P2|Overall Study|Lost to Follow-up|0
1674803|NCT01439568|5850847|P1|Overall Study|Lost to Follow-up|1
1674804|NCT01439555|5850859|P1|Overall Study|Protocol Violation|1
1674805|NCT01439373|5850871|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
1674806|NCT01439373|5850872|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
1674807|NCT01439373|5850871|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
1674808|NCT01439373|5850872|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
1674809|NCT01439360|5850915|P2|Overall Study|Withdrawal by Subject|129
1674810|NCT01439360|5850916|P1|Overall Study|Withdrawal by Subject|140
1674811|NCT01439360|5850915|P2|Overall Study|Protocol Violation|0
1674812|NCT01439360|5850916|P1|Overall Study|Protocol Violation|1
1674813|NCT01439360|5850915|P2|Overall Study|Others|5
1674814|NCT01439360|5850916|P1|Overall Study|Others|10
1674815|NCT01439360|5850915|P2|Overall Study|Lost to Follow-up|58
1674816|NCT01439360|5850916|P1|Overall Study|Lost to Follow-up|43
1674817|NCT01439360|5850915|P2|Overall Study|Adverse Event|16
1674818|NCT01439360|5850916|P1|Overall Study|Adverse Event|4
1674819|NCT01439282|5850966|P2|Overall Study|Other|1
1674820|NCT01439282|5850967|P1|Overall Study|Other|1
1674821|NCT01439282|5850966|P2|Overall Study|Withdrawal by Subject|0
1674822|NCT01439282|5850967|P1|Overall Study|Withdrawal by Subject|2
1674823|NCT01439282|5850966|P2|Overall Study|Adverse Event|0
1674824|NCT01439282|5850967|P1|Overall Study|Adverse Event|5
1674825|NCT01439204|5850979|P2|Overall Study|poor/non-compliance|0
1674826|NCT01439204|5850980|P1|Overall Study|poor/non-compliance|3
1674827|NCT01439204|5850979|P2|Overall Study|No longer meets study criteria|0
1674828|NCT01439204|5850980|P1|Overall Study|No longer meets study criteria|1
1674829|NCT01439204|5850979|P2|Overall Study|Lost to Follow-up|2
1674830|NCT01439204|5850980|P1|Overall Study|Lost to Follow-up|0
1674831|NCT01439204|5850979|P2|Overall Study|Withdrawal by Subject|1
1674832|NCT01439204|5850980|P1|Overall Study|Withdrawal by Subject|0
1674833|NCT01439165|5851014|P2|Overall Study|Withdrawal by Subject|1
1674834|NCT01439165|5851015|P1|Overall Study|Withdrawal by Subject|7
1674835|NCT01439165|5851014|P2|Overall Study|Lost to Follow-up|1
1674836|NCT01439165|5851015|P1|Overall Study|Lost to Follow-up|11
1674837|NCT01439165|5851014|P2|Overall Study|Protocol Violation|0
1674838|NCT01439165|5851015|P1|Overall Study|Protocol Violation|3
1674839|NCT01439126|5851029|P2|Overall Study|Other-Miscellaneous|12
1674840|NCT01439126|5851030|P1|Overall Study|Other-Miscellaneous|12
1674841|NCT01439126|5851029|P2|Overall Study|Other-Use of prohibited treatment|2
1674842|NCT01439126|5851030|P1|Overall Study|Other-Use of prohibited treatment|0
1674843|NCT01439126|5851029|P2|Overall Study|Lost to Follow-up|3
1674844|NCT01439126|5851030|P1|Overall Study|Lost to Follow-up|6
1674845|NCT01439126|5851029|P2|Overall Study|Protocol Violation|4
1674846|NCT01439126|5851030|P1|Overall Study|Protocol Violation|6
1674847|NCT01439126|5851029|P2|Overall Study|Withdrawal by Subject|21
1674848|NCT01439126|5851030|P1|Overall Study|Withdrawal by Subject|5
1674849|NCT01439126|5851029|P2|Overall Study|Adverse Event|0
1674850|NCT01439126|5851030|P1|Overall Study|Adverse Event|2
1674851|NCT01439074|5851056|P2|Overall Study|Other|4
1674852|NCT01439074|5851057|P1|Overall Study|Other|4
1674853|NCT01439074|5851056|P2|Overall Study|Withdrawal by Subject|5
1674854|NCT01439074|5851057|P1|Overall Study|Withdrawal by Subject|1
1674855|NCT01439074|5851056|P2|Overall Study|Subject shedding|0
1674856|NCT01439074|5851057|P1|Overall Study|Subject shedding|1
1674857|NCT01439074|5851056|P2|Overall Study|Lost to Follow-up|4
1674858|NCT01439074|5851057|P1|Overall Study|Lost to Follow-up|3
1674859|NCT01439009|5851075|P2|Overall Study|Deviation of exclusion criteria|0
1674860|NCT01439009|5851076|P1|Overall Study|Deviation of exclusion criteria|1
1674861|NCT01439009|5851075|P2|Overall Study|Protocol Violation|0
1674862|NCT01439009|5851076|P1|Overall Study|Protocol Violation|2
1674863|NCT01439009|5851075|P2|Overall Study|Physician Decision|3
1674864|NCT01439009|5851076|P1|Overall Study|Physician Decision|5
1674865|NCT01438996|5851109|P3|Overall Study|Not meeting Inclusion Criteria|0
1674866|NCT01438996|5851110|P2|Overall Study|Not meeting Inclusion Criteria|1
1674867|NCT01438996|5851111|P1|Overall Study|Not meeting Inclusion Criteria|4
1674868|NCT01438840|5851145|P3|Extension Phase|Other|1
1674869|NCT01438840|5851146|P2|Extension Phase|Other|0
1674870|NCT01438840|5851147|P1|Extension Phase|Other|0
1674871|NCT01438840|5851145|P3|Extension Phase|Lack of Efficacy|2
1674872|NCT01438840|5851146|P2|Extension Phase|Lack of Efficacy|0
1674873|NCT01438840|5851147|P1|Extension Phase|Lack of Efficacy|0
1674874|NCT01438840|5851145|P3|Extension Phase|Withdrawal by Subject|3
1674875|NCT01438840|5851146|P2|Extension Phase|Withdrawal by Subject|0
1674876|NCT01438840|5851147|P1|Extension Phase|Withdrawal by Subject|0
1674877|NCT01438840|5851145|P3|Extension Phase|Lost to Follow-up|1
1674878|NCT01438840|5851146|P2|Extension Phase|Lost to Follow-up|0
1674879|NCT01438840|5851147|P1|Extension Phase|Lost to Follow-up|0
1674880|NCT01438840|5851145|P3|Extension Phase|Adverse Event|3
1674881|NCT01438840|5851146|P2|Extension Phase|Adverse Event|0
1674882|NCT01438840|5851147|P1|Extension Phase|Adverse Event|0
1674883|NCT01438840|5851145|P3|Core Study|Withdrawal of consent|0
1674884|NCT01438840|5851146|P2|Core Study|Withdrawal of consent|0
1674885|NCT01438840|5851147|P1|Core Study|Withdrawal of consent|1
1674886|NCT01438840|5851145|P3|Core Study|Lack of Efficacy|0
1674887|NCT01438840|5851146|P2|Core Study|Lack of Efficacy|7
1674888|NCT01438840|5851147|P1|Core Study|Lack of Efficacy|15
1674889|NCT01438840|5851145|P3|Core Study|Adverse Event|0
1674890|NCT01438840|5851146|P2|Core Study|Adverse Event|3
1674891|NCT01438840|5851147|P1|Core Study|Adverse Event|0
1674892|NCT01438814|5851160|P2|Overall Study|Other|4
1674893|NCT01438814|5851161|P1|Overall Study|Other|2
1674894|NCT01438814|5851160|P2|Overall Study|Withdrawal by Subject|2
1674895|NCT01438814|5851161|P1|Overall Study|Withdrawal by Subject|4
1674896|NCT01438814|5851160|P2|Overall Study|Lost to Follow-up|3
1674897|NCT01438814|5851161|P1|Overall Study|Lost to Follow-up|4
1674898|NCT01438814|5851160|P2|Overall Study|Protocol Violation|2
1674899|NCT01438814|5851161|P1|Overall Study|Protocol Violation|1
1674900|NCT01438814|5851160|P2|Overall Study|Adverse Event|3
1674901|NCT01438814|5851161|P1|Overall Study|Adverse Event|3
1674902|NCT01438541|5851197|P1|Overall Study|discharge from the hospital|5
1674903|NCT01438541|5851197|P1|Overall Study|Withdrawal by Subject|1
1674904|NCT01438541|5851197|P1|Overall Study|Physician Decision|1
1674905|NCT01438489|5851206|P3|Overall Study|Inadequate venous access|0
1674906|NCT01438489|5851207|P2|Overall Study|Inadequate venous access|2
1674907|NCT01438489|5851208|P1|Overall Study|Inadequate venous access|0
1674908|NCT01438489|5851206|P3|Overall Study|Did not complete all 3 follow-up visits|2
1674909|NCT01438489|5851207|P2|Overall Study|Did not complete all 3 follow-up visits|5
1674910|NCT01438489|5851208|P1|Overall Study|Did not complete all 3 follow-up visits|2
1674911|NCT01438489|5851206|P3|Overall Study|Received prohibited medication|0
1674912|NCT01438489|5851207|P2|Overall Study|Received prohibited medication|0
1674913|NCT01438489|5851208|P1|Overall Study|Received prohibited medication|1
1674914|NCT01438489|5851206|P3|Overall Study|AE/SAEs|1
1674915|NCT01438489|5851207|P2|Overall Study|AE/SAEs|1
1674916|NCT01438489|5851208|P1|Overall Study|AE/SAEs|2
1674917|NCT01438489|5851206|P3|Overall Study|Investigator decision|0
1674918|NCT01438489|5851207|P2|Overall Study|Investigator decision|1
1674919|NCT01438489|5851208|P1|Overall Study|Investigator decision|0
1674920|NCT01438489|5851206|P3|Overall Study|Subject choice/Subject moved|1
1674921|NCT01438489|5851207|P2|Overall Study|Subject choice/Subject moved|1
1674922|NCT01438489|5851208|P1|Overall Study|Subject choice/Subject moved|2
1674923|NCT01438489|5851206|P3|Overall Study|Sponsor decision|4
1674924|NCT01438489|5851207|P2|Overall Study|Sponsor decision|1
1674925|NCT01438489|5851208|P1|Overall Study|Sponsor decision|4
1674926|NCT01438489|5851206|P3|Overall Study|Death|1
1674927|NCT01438489|5851207|P2|Overall Study|Death|0
1674928|NCT01438489|5851208|P1|Overall Study|Death|0
1674929|NCT01438489|5851206|P3|Overall Study|Withdrawal by Subject|8
1674930|NCT01438489|5851207|P2|Overall Study|Withdrawal by Subject|3
1674931|NCT01438489|5851208|P1|Overall Study|Withdrawal by Subject|11
1674932|NCT01438489|5851206|P3|Overall Study|Lost to Follow-up|2
1674933|NCT01438489|5851207|P2|Overall Study|Lost to Follow-up|2
1674934|NCT01438489|5851208|P1|Overall Study|Lost to Follow-up|4
1674935|NCT01438476|5851253|P2|Overall Study|Communication barrier|1
1674936|NCT01438476|5851254|P1|Overall Study|Communication barrier|0
1674937|NCT01438476|5851253|P2|Overall Study|No Surgery- Disease|10
1674938|NCT01438476|5851254|P1|Overall Study|No Surgery- Disease|8
1674939|NCT01438476|5851253|P2|Overall Study|Withdrawal by Subject|0
1674940|NCT01438476|5851254|P1|Overall Study|Withdrawal by Subject|1
1674941|NCT01438476|5851253|P2|Overall Study|Protocol Violation|0
1674942|NCT01438476|5851254|P1|Overall Study|Protocol Violation|1
1674943|NCT01438424|5851260|P1|Overall Study|Participant noncompliance|20
1674944|NCT01438424|5851260|P1|Overall Study|No longer met inclusion criteria|1
1674945|NCT01438424|5851260|P1|Overall Study|Pregnancy|7
1674946|NCT01438424|5851260|P1|Overall Study|Need for drug prohibited by protocol|14
1674947|NCT01438424|5851260|P1|Overall Study|Abnormal laboratory test result|14
1674948|NCT01438424|5851260|P1|Overall Study|Lost to Follow-up|17
1674949|NCT01438424|5851260|P1|Overall Study|Adverse Event|17
1674950|NCT01438424|5851260|P1|Overall Study|Death|22
1674951|NCT01438424|5851260|P1|Overall Study|Progression of chronic hepatitis B|22
1674952|NCT01438424|5851260|P1|Overall Study|Withdrawal by Subject|104
1674953|NCT01438424|5851260|P1|Overall Study|Not identified|55
1674954|NCT01438424|5851260|P1|Overall Study|Minimal virologic response|95
1674955|NCT01438424|5851260|P1|Overall Study|Continuing treatment|29
1674956|NCT01438307|5851298|P2|Overall Study|Death|1
1674957|NCT01438307|5851299|P1|Overall Study|Death|1
1674958|NCT01438294|5851313|P2|Overall Study|Lost to Follow-up|7
1674959|NCT01438294|5851314|P1|Overall Study|Lost to Follow-up|3
1674962|NCT01438151|5851364|P1|Overall Study|study terminated|8
1674963|NCT01438060|5851370|P2|On Study Beyond Week 140|Other Reason|3
1674964|NCT01438060|5851371|P1|On Study Beyond Week 140|Other Reason|0
1674965|NCT01438060|5851370|P2|On Study Beyond Week 140|Death|1
1674966|NCT01438060|5851371|P1|On Study Beyond Week 140|Death|0
1674967|NCT01438060|5851370|P2|On Study Beyond Week 140|Withdrawal by Subject|1
1674968|NCT01438060|5851371|P1|On Study Beyond Week 140|Withdrawal by Subject|0
1674969|NCT01438060|5851370|P2|On Study Beyond Week 140|Lack of Efficacy|1
1674970|NCT01438060|5851371|P1|On Study Beyond Week 140|Lack of Efficacy|0
1674971|NCT01438060|5851370|P2|On Study Beyond Week 140|Adverse Event|2
1674972|NCT01438060|5851371|P1|On Study Beyond Week 140|Adverse Event|0
1674973|NCT01438060|5851370|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
1674974|NCT01438060|5851371|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
1674975|NCT01438060|5851370|P2|Extension Phase: Week 10 to Week 130|Death|12
1674976|NCT01438060|5851371|P1|Extension Phase: Week 10 to Week 130|Death|22
1674977|NCT01438060|5851370|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
1674978|NCT01438060|5851371|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
1674979|NCT01438060|5851370|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
1674980|NCT01438060|5851371|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
1674981|NCT01438060|5851370|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
1674982|NCT01438060|5851371|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
1674983|NCT01438060|5851370|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1674984|NCT01438060|5851371|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
1674985|NCT01438060|5851370|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
1674986|NCT01438060|5851371|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
1674987|NCT01438060|5851370|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
1674988|NCT01438060|5851371|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
1674989|NCT01438060|5851370|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
1674990|NCT01438060|5851371|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
1674991|NCT01438060|5851370|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
1674992|NCT01438060|5851371|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
1674993|NCT01438060|5851370|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
1674994|NCT01438060|5851371|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
1674995|NCT01438060|5851370|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
1674996|NCT01438060|5851371|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
1674997|NCT01438060|5851370|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
1674998|NCT01438060|5851371|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
1674999|NCT01437995|5851452|P3|Overall Study|Lost to Follow-up|20
1675000|NCT01437995|5851453|P2|Overall Study|Lost to Follow-up|18
1675001|NCT01437995|5851454|P1|Overall Study|Lost to Follow-up|11
1675002|NCT01437943|5851476|P2|Overall Study|Adverse Event|0
1675003|NCT01437943|5851477|P1|Overall Study|Adverse Event|2
1675004|NCT01437943|5851476|P2|Overall Study|Subject expressed pregnancy plans|0
1675005|NCT01437943|5851477|P1|Overall Study|Subject expressed pregnancy plans|1
1675006|NCT01437943|5851476|P2|Overall Study|Aliskiren trials terminated by Novartis|2
1675007|NCT01437943|5851477|P1|Overall Study|Aliskiren trials terminated by Novartis|4
1675008|NCT01437878|5851485|P2|Overall Study|Withdrawal by Subject|0
1675009|NCT01437878|5851486|P1|Overall Study|Withdrawal by Subject|1
1675010|NCT01437540|5851553|P2|Overall Study|Withdrawal by Subject|15
1675011|NCT01437540|5851554|P1|Overall Study|Withdrawal by Subject|31
1675012|NCT01437540|5851553|P2|Overall Study|Adverse Event|13
1675013|NCT01437540|5851554|P1|Overall Study|Adverse Event|26
1675014|NCT01437540|5851553|P2|Overall Study|Protocol Violation|12
1675015|NCT01437540|5851554|P1|Overall Study|Protocol Violation|24
1675016|NCT01437540|5851553|P2|Overall Study|Lack of Efficacy|11
1675017|NCT01437540|5851554|P1|Overall Study|Lack of Efficacy|23
1675018|NCT01437540|5851553|P2|Overall Study|Lost to Follow-up|5
1675019|NCT01437540|5851554|P1|Overall Study|Lost to Follow-up|3
1675020|NCT01437540|5851553|P2|Overall Study|COPD exacerbation|3
1675021|NCT01437540|5851554|P1|Overall Study|COPD exacerbation|13
1675022|NCT01437540|5851553|P2|Overall Study|Not listed below|6
1675023|NCT01437540|5851554|P1|Overall Study|Not listed below|7
1675024|NCT01437423|5851591|P1|Overall Study|Off label usage|3
1675025|NCT01437423|5851591|P1|Overall Study|Lost to Follow-up|12
1675026|NCT01437397|5851603|P5|Overall Study|Site termination/COPD exacerbation/other|14
1675027|NCT01437397|5851604|P4|Overall Study|Site termination/COPD exacerbation/other|9
1675028|NCT01437397|5851605|P3|Overall Study|Site termination/COPD exacerbation/other|9
1675029|NCT01437397|5851606|P2|Overall Study|Site termination/COPD exacerbation/other|8
1675030|NCT01437397|5851607|P1|Overall Study|Site termination/COPD exacerbation/other|10
1675031|NCT01437397|5851603|P5|Overall Study|Adverse Event|21
1675032|NCT01437397|5851604|P4|Overall Study|Adverse Event|14
1675033|NCT01437397|5851605|P3|Overall Study|Adverse Event|16
1675034|NCT01437397|5851606|P2|Overall Study|Adverse Event|22
1675035|NCT01437397|5851607|P1|Overall Study|Adverse Event|21
1675036|NCT01437397|5851603|P5|Overall Study|Lack of Efficacy|20
1675037|NCT01437397|5851604|P4|Overall Study|Lack of Efficacy|10
1675038|NCT01437397|5851605|P3|Overall Study|Lack of Efficacy|8
1675039|NCT01437397|5851606|P2|Overall Study|Lack of Efficacy|4
1675040|NCT01437397|5851607|P1|Overall Study|Lack of Efficacy|5
1675041|NCT01437397|5851603|P5|Overall Study|Protocol Violation|19
1675042|NCT01437397|5851604|P4|Overall Study|Protocol Violation|21
1675043|NCT01437397|5851605|P3|Overall Study|Protocol Violation|13
1675044|NCT01437397|5851606|P2|Overall Study|Protocol Violation|12
1675045|NCT01437397|5851607|P1|Overall Study|Protocol Violation|10
1675046|NCT01437397|5851603|P5|Overall Study|Withdrawal by Subject|22
1675047|NCT01437397|5851604|P4|Overall Study|Withdrawal by Subject|11
1675048|NCT01437397|5851605|P3|Overall Study|Withdrawal by Subject|24
1675049|NCT01437397|5851606|P2|Overall Study|Withdrawal by Subject|12
1675050|NCT01437397|5851607|P1|Overall Study|Withdrawal by Subject|11
1675051|NCT01437397|5851603|P5|Overall Study|Lost to Follow-up|5
1675052|NCT01437397|5851604|P4|Overall Study|Lost to Follow-up|4
1675053|NCT01437397|5851605|P3|Overall Study|Lost to Follow-up|2
1675054|NCT01437397|5851606|P2|Overall Study|Lost to Follow-up|4
1675055|NCT01437397|5851607|P1|Overall Study|Lost to Follow-up|9
1675056|NCT01437319|5851634|P3|Phase II|Protocol Violation|0
1675057|NCT01437319|5851635|P2|Phase II|Protocol Violation|1
1675058|NCT01437319|5851636|P1|Phase II|Protocol Violation|0
1675059|NCT01437319|5851634|P3|Phase II|Study related symptoms/complaints|19
1675060|NCT01437319|5851635|P2|Phase II|Study related symptoms/complaints|28
1675061|NCT01437319|5851636|P1|Phase II|Study related symptoms/complaints|0
1675062|NCT01437319|5851634|P3|Phase II|Lost to Follow-up|2
1675063|NCT01437319|5851635|P2|Phase II|Lost to Follow-up|7
1675064|NCT01437319|5851636|P1|Phase II|Lost to Follow-up|0
1675065|NCT01437319|5851634|P3|Phase II|Withdrawal by Subject|16
1675066|NCT01437319|5851635|P2|Phase II|Withdrawal by Subject|8
1675067|NCT01437319|5851636|P1|Phase II|Withdrawal by Subject|0
1675068|NCT01437319|5851634|P3|Phase I|Withdrawal by Subject|0
1675069|NCT01437319|5851635|P2|Phase I|Withdrawal by Subject|0
1675070|NCT01437319|5851636|P1|Phase I|Withdrawal by Subject|25
1675071|NCT01437319|5851634|P3|Phase I|Study related symptoms/complaints|0
1675072|NCT01437319|5851635|P2|Phase I|Study related symptoms/complaints|0
1675073|NCT01437319|5851636|P1|Phase I|Study related symptoms/complaints|27
1675074|NCT01437319|5851634|P3|Phase I|Protocol Violation|0
1675075|NCT01437319|5851635|P2|Phase I|Protocol Violation|0
1675076|NCT01437319|5851636|P1|Phase I|Protocol Violation|1
1675077|NCT01437319|5851634|P3|Phase I|Lost to Follow-up|0
1675078|NCT01437319|5851635|P2|Phase I|Lost to Follow-up|0
1675079|NCT01437319|5851636|P1|Phase I|Lost to Follow-up|2
1675080|NCT01437267|5851651|P6|Overall Study|Protocol Violation|0
1675081|NCT01437267|5851652|P5|Overall Study|Protocol Violation|0
1675082|NCT01437267|5851653|P4|Overall Study|Protocol Violation|0
1675083|NCT01437267|5851654|P3|Overall Study|Protocol Violation|0
1675084|NCT01437267|5851655|P2|Overall Study|Protocol Violation|1
1675085|NCT01437267|5851656|P1|Overall Study|Protocol Violation|0
1675086|NCT01437267|5851651|P6|Overall Study|Withdrawal by Subject|0
1675087|NCT01437267|5851652|P5|Overall Study|Withdrawal by Subject|0
1675088|NCT01437267|5851653|P4|Overall Study|Withdrawal by Subject|1
1675089|NCT01437267|5851654|P3|Overall Study|Withdrawal by Subject|0
1675090|NCT01437267|5851655|P2|Overall Study|Withdrawal by Subject|0
1675091|NCT01437267|5851656|P1|Overall Study|Withdrawal by Subject|0
1675092|NCT01437111|5851699|P1|Overall Study|Protocol Violation|1
1675093|NCT01437111|5851699|P1|Overall Study|Lost to Follow-up|5
1675094|NCT01437111|5851699|P1|Overall Study|Physician Decision|1
1675095|NCT01437111|5851699|P1|Overall Study|Not reported|5
1675096|NCT01437111|5851699|P1|Overall Study|Withdrawal by Subject|4
1675097|NCT01437111|5851699|P1|Overall Study|Adverse Event|2
1675098|NCT01436643|5851777|P4|Core Phase (16 Weeks)|Protocol Violation|0
1675099|NCT01436643|5851778|P3|Core Phase (16 Weeks)|Protocol Violation|1
1675100|NCT01436643|5851779|P2|Core Phase (16 Weeks)|Protocol Violation|1
1675101|NCT01436643|5851780|P1|Core Phase (16 Weeks)|Protocol Violation|1
1675102|NCT01436643|5851777|P4|Core Phase (16 Weeks)|Abnormal Test result|0
1675103|NCT01436643|5851778|P3|Core Phase (16 Weeks)|Abnormal Test result|1
1675104|NCT01436643|5851779|P2|Core Phase (16 Weeks)|Abnormal Test result|0
1675105|NCT01436643|5851780|P1|Core Phase (16 Weeks)|Abnormal Test result|0
1675106|NCT01436643|5851777|P4|Core Phase (16 Weeks)|Adverse Event|0
1675107|NCT01436643|5851778|P3|Core Phase (16 Weeks)|Adverse Event|1
1675108|NCT01436643|5851779|P2|Core Phase (16 Weeks)|Adverse Event|3
1675109|NCT01436643|5851780|P1|Core Phase (16 Weeks)|Adverse Event|0
1675110|NCT01436643|5851777|P4|2-week Pre-treatment|Protocol Violation|4
1675111|NCT01436643|5851778|P3|2-week Pre-treatment|Protocol Violation|0
1675112|NCT01436643|5851779|P2|2-week Pre-treatment|Protocol Violation|0
1675113|NCT01436643|5851780|P1|2-week Pre-treatment|Protocol Violation|0
1675114|NCT01436643|5851777|P4|2-week Pre-treatment|Adverse Event|5
1675115|NCT01436643|5851778|P3|2-week Pre-treatment|Adverse Event|0
1675116|NCT01436643|5851779|P2|2-week Pre-treatment|Adverse Event|0
1675117|NCT01436643|5851780|P1|2-week Pre-treatment|Adverse Event|0
1675118|NCT01436643|5851777|P4|2-week Pre-treatment|Abnormal test result|1
1675119|NCT01436643|5851778|P3|2-week Pre-treatment|Abnormal test result|0
1675120|NCT01436643|5851779|P2|2-week Pre-treatment|Abnormal test result|0
1675121|NCT01436643|5851780|P1|2-week Pre-treatment|Abnormal test result|0
1675122|NCT01436500|5851815|P5|Overall Study|Other|0
1675123|NCT01436500|5851816|P4|Overall Study|Other|1
1675124|NCT01436500|5851817|P3|Overall Study|Other|0
1675125|NCT01436500|5851818|P2|Overall Study|Other|1
1675126|NCT01436500|5851819|P1|Overall Study|Other|0
1675127|NCT01436500|5851815|P5|Overall Study|discontinued study drug|0
1675128|NCT01436500|5851816|P4|Overall Study|discontinued study drug|0
1675129|NCT01436500|5851817|P3|Overall Study|discontinued study drug|0
1675130|NCT01436500|5851818|P2|Overall Study|discontinued study drug|0
1675131|NCT01436500|5851819|P1|Overall Study|discontinued study drug|1
1675132|NCT01436500|5851815|P5|Overall Study|initiation of dialysis|1
1675133|NCT01436500|5851816|P4|Overall Study|initiation of dialysis|0
1675134|NCT01436500|5851817|P3|Overall Study|initiation of dialysis|0
1675135|NCT01436500|5851818|P2|Overall Study|initiation of dialysis|0
1675136|NCT01436500|5851819|P1|Overall Study|initiation of dialysis|0
1675137|NCT01436500|5851815|P5|Overall Study|liver transplant|0
1675138|NCT01436500|5851816|P4|Overall Study|liver transplant|0
1675139|NCT01436500|5851817|P3|Overall Study|liver transplant|0
1675140|NCT01436500|5851818|P2|Overall Study|liver transplant|0
1675141|NCT01436500|5851819|P1|Overall Study|liver transplant|1
1675142|NCT01436500|5851815|P5|Overall Study|Physician Decision|0
1675143|NCT01436500|5851816|P4|Overall Study|Physician Decision|0
1675144|NCT01436500|5851817|P3|Overall Study|Physician Decision|1
1675145|NCT01436500|5851818|P2|Overall Study|Physician Decision|0
1675146|NCT01436500|5851819|P1|Overall Study|Physician Decision|0
1675147|NCT01436500|5851815|P5|Overall Study|Withdrawal by Subject|2
1675148|NCT01436500|5851816|P4|Overall Study|Withdrawal by Subject|0
1675149|NCT01436500|5851817|P3|Overall Study|Withdrawal by Subject|2
1675150|NCT01436500|5851818|P2|Overall Study|Withdrawal by Subject|0
1675151|NCT01436500|5851819|P1|Overall Study|Withdrawal by Subject|0
1675152|NCT01436500|5851815|P5|Overall Study|Adverse Event|1
1675153|NCT01436500|5851816|P4|Overall Study|Adverse Event|0
1675154|NCT01436500|5851817|P3|Overall Study|Adverse Event|2
1675155|NCT01436500|5851818|P2|Overall Study|Adverse Event|2
1675156|NCT01436500|5851819|P1|Overall Study|Adverse Event|0
1675157|NCT01436500|5851815|P5|Overall Study|Death|0
1675158|NCT01436500|5851816|P4|Overall Study|Death|0
1675159|NCT01436500|5851817|P3|Overall Study|Death|0
1675160|NCT01436500|5851818|P2|Overall Study|Death|0
1675161|NCT01436500|5851819|P1|Overall Study|Death|1
1675162|NCT01436396|5851863|P2|Overall Study|Lost to Follow-up|3
1675163|NCT01436396|5851864|P1|Overall Study|Lost to Follow-up|3
1675164|NCT01436396|5851863|P2|Overall Study|Serious adverse event|3
1675165|NCT01436396|5851864|P1|Overall Study|Serious adverse event|2
1675166|NCT01436396|5851863|P2|Overall Study|Withdrawal by Subject|29
1675167|NCT01436396|5851864|P1|Overall Study|Withdrawal by Subject|19
1675168|NCT01436396|5851863|P2|Overall Study|Adverse Event|2
1675169|NCT01436396|5851864|P1|Overall Study|Adverse Event|1
1675170|NCT01436396|5851863|P2|Overall Study|Protocol Violation|5
1675171|NCT01436396|5851864|P1|Overall Study|Protocol Violation|7
1675172|NCT01436370|5851904|P8|Overall Study|Lost to Follow-up|0
1675173|NCT01436370|5851905|P7|Overall Study|Lost to Follow-up|0
1675174|NCT01436370|5851906|P6|Overall Study|Lost to Follow-up|0
1675175|NCT01436370|5851907|P5|Overall Study|Lost to Follow-up|1
1675176|NCT01436370|5851908|P4|Overall Study|Lost to Follow-up|0
1675177|NCT01436370|5851909|P3|Overall Study|Lost to Follow-up|0
1675178|NCT01436370|5851910|P2|Overall Study|Lost to Follow-up|0
1675179|NCT01436370|5851911|P1|Overall Study|Lost to Follow-up|0
1675180|NCT01436357|5851991|P2|Overall Study|Subject in rehab|1
1675181|NCT01436357|5851992|P1|Overall Study|Subject in rehab|0
1675182|NCT01436357|5851991|P2|Overall Study|Moved out of area|2
1675183|NCT01436357|5851992|P1|Overall Study|Moved out of area|1
1675184|NCT01436357|5851991|P2|Overall Study|Physician Decision|4
1675185|NCT01436357|5851992|P1|Overall Study|Physician Decision|3
1675186|NCT01436357|5851991|P2|Overall Study|Withdrawal by Subject|38
1675187|NCT01436357|5851992|P1|Overall Study|Withdrawal by Subject|26
1675188|NCT01436357|5851991|P2|Overall Study|Protocol Violation|0
1675189|NCT01436357|5851992|P1|Overall Study|Protocol Violation|1
1675190|NCT01436357|5851991|P2|Overall Study|Lost to Follow-up|61
1675191|NCT01436357|5851992|P1|Overall Study|Lost to Follow-up|67
1675192|NCT01436357|5851991|P2|Overall Study|Incarceration|20
1675193|NCT01436357|5851992|P1|Overall Study|Incarceration|18
1675194|NCT01436357|5851991|P2|Overall Study|Enrolled but not vaccinated|1
1675195|NCT01436357|5851992|P1|Overall Study|Enrolled but not vaccinated|1
1675196|NCT01436357|5851991|P2|Overall Study|Death|1
1675197|NCT01436357|5851992|P1|Overall Study|Death|5
1675198|NCT01436305|5852013|P3|Overall Study|Withdrawal by Subject|0
1675199|NCT01436305|5852014|P2|Overall Study|Withdrawal by Subject|3
1675200|NCT01436305|5852015|P1|Overall Study|Withdrawal by Subject|1
1675201|NCT01436305|5852013|P3|Overall Study|Lost to Follow-up|0
1675202|NCT01436305|5852014|P2|Overall Study|Lost to Follow-up|1
1675203|NCT01436305|5852015|P1|Overall Study|Lost to Follow-up|0
1675204|NCT01436305|5852013|P3|Overall Study|Death|0
1675205|NCT01436305|5852014|P2|Overall Study|Death|0
1675206|NCT01436305|5852015|P1|Overall Study|Death|1
1675207|NCT01436253|5852142|P1|Overall Study|Not meeting all eligibility criteria|117
1675208|NCT01436253|5852142|P1|Overall Study|Lost to Follow-up|182
1675209|NCT01436201|5852147|P1|Overall Study|Protocol Violation|1
1675210|NCT01436201|5852147|P1|Overall Study|Withdrawal by Subject|1
1675211|NCT01436201|5852147|P1|Overall Study|Adverse Event|2
1675212|NCT01436175|5852157|P1|Overall Study|Other|826
1675213|NCT01436175|5852157|P1|Overall Study|Met blood pressure or pulse withdrawal|63
1675214|NCT01436175|5852157|P1|Overall Study|Lack of Efficacy|24
1675215|NCT01436175|5852157|P1|Overall Study|Lost to Follow-up|89
1675216|NCT01436175|5852157|P1|Overall Study|Withdrawal by Subject|108
1675217|NCT01436175|5852157|P1|Overall Study|Protocol Violation|49
1675218|NCT01436175|5852157|P1|Overall Study|Adverse Event|111
1675219|NCT01436162|5852184|P3|Randomized Phase|Other|4
1675220|NCT01436162|5852185|P2|Randomized Phase|Other|5
1675221|NCT01436162|5852186|P1|Randomized Phase|Other|2
1675222|NCT01436162|5852184|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
1675223|NCT01436162|5852185|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1675224|NCT01436162|5852186|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
1675225|NCT01436162|5852184|P3|Randomized Phase|Lack of Efficacy|1
1675226|NCT01436162|5852185|P2|Randomized Phase|Lack of Efficacy|1
1675227|NCT01436162|5852186|P1|Randomized Phase|Lack of Efficacy|0
1675228|NCT01436162|5852184|P3|Randomized Phase|Lost to Follow-up|4
1675229|NCT01436162|5852185|P2|Randomized Phase|Lost to Follow-up|5
1675230|NCT01436162|5852186|P1|Randomized Phase|Lost to Follow-up|17
1675231|NCT01436162|5852184|P3|Randomized Phase|Withdrawal by Subject|8
1675232|NCT01436162|5852185|P2|Randomized Phase|Withdrawal by Subject|9
1675233|NCT01436162|5852186|P1|Randomized Phase|Withdrawal by Subject|16
1675234|NCT01436162|5852184|P3|Randomized Phase|Protocol Violation|2
1675235|NCT01436162|5852185|P2|Randomized Phase|Protocol Violation|4
1675236|NCT01436162|5852186|P1|Randomized Phase|Protocol Violation|4
1675237|NCT01436162|5852184|P3|Randomized Phase|Adverse Event|6
1675238|NCT01436162|5852185|P2|Randomized Phase|Adverse Event|5
1675239|NCT01436162|5852186|P1|Randomized Phase|Adverse Event|1
1675240|NCT01436162|5852184|P3|Single-blind Lead-in Phase|Other|0
1675241|NCT01436162|5852185|P2|Single-blind Lead-in Phase|Other|0
1675242|NCT01436162|5852186|P1|Single-blind Lead-in Phase|Other|107
1675243|NCT01436162|5852184|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1675244|NCT01436162|5852185|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1675245|NCT01436162|5852186|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
1675246|NCT01436162|5852184|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
1675247|NCT01436162|5852185|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
1675248|NCT01436162|5852186|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
1675249|NCT01436162|5852184|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
1675250|NCT01436162|5852185|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
1675251|NCT01436162|5852186|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
1675252|NCT01436162|5852184|P3|Single-blind Lead-in Phase|Protocol Violation|0
1675253|NCT01436162|5852185|P2|Single-blind Lead-in Phase|Protocol Violation|0
1675254|NCT01436162|5852186|P1|Single-blind Lead-in Phase|Protocol Violation|24
1675255|NCT01436162|5852184|P3|Single-blind Lead-in Phase|Adverse Event|0
1675256|NCT01436162|5852185|P2|Single-blind Lead-in Phase|Adverse Event|0
1675257|NCT01436162|5852186|P1|Single-blind Lead-in Phase|Adverse Event|26
1675258|NCT01436149|5852220|P3|Randomized Phase|Other|11
1675259|NCT01436149|5852221|P2|Randomized Phase|Other|5
1675260|NCT01436149|5852222|P1|Randomized Phase|Other|12
1675261|NCT01436149|5852220|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1675262|NCT01436149|5852221|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
1675263|NCT01436149|5852222|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
1675264|NCT01436149|5852220|P3|Randomized Phase|Lack of Efficacy|1
1675265|NCT01436149|5852221|P2|Randomized Phase|Lack of Efficacy|0
1675266|NCT01436149|5852222|P1|Randomized Phase|Lack of Efficacy|0
1675267|NCT01436149|5852220|P3|Randomized Phase|Lost to Follow-up|6
1675268|NCT01436149|5852221|P2|Randomized Phase|Lost to Follow-up|5
1675269|NCT01436149|5852222|P1|Randomized Phase|Lost to Follow-up|34
1675270|NCT01436149|5852220|P3|Randomized Phase|Withdrawal by Subject|10
1675271|NCT01436149|5852221|P2|Randomized Phase|Withdrawal by Subject|10
1675272|NCT01436149|5852222|P1|Randomized Phase|Withdrawal by Subject|16
1675273|NCT01436149|5852220|P3|Randomized Phase|Protocol Violation|0
1675274|NCT01436149|5852221|P2|Randomized Phase|Protocol Violation|5
1675275|NCT01436149|5852222|P1|Randomized Phase|Protocol Violation|4
1675276|NCT01436149|5852220|P3|Randomized Phase|Adverse Event|11
1675277|NCT01436149|5852221|P2|Randomized Phase|Adverse Event|10
1675278|NCT01436149|5852222|P1|Randomized Phase|Adverse Event|9
1675279|NCT01436149|5852220|P3|Antidepressant Lead-in Phase|Other|0
1675280|NCT01436149|5852221|P2|Antidepressant Lead-in Phase|Other|0
1675281|NCT01436149|5852222|P1|Antidepressant Lead-in Phase|Other|119
1675282|NCT01436149|5852220|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1675283|NCT01436149|5852221|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
1675284|NCT01436149|5852222|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
1675285|NCT01436149|5852220|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
1675286|NCT01436149|5852221|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
1675287|NCT01436149|5852222|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
1675288|NCT01436149|5852220|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1675289|NCT01436149|5852221|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1675290|NCT01436149|5852222|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
1675291|NCT01436149|5852220|P3|Antidepressant Lead-in Phase|Protocol Violation|0
1675292|NCT01436149|5852221|P2|Antidepressant Lead-in Phase|Protocol Violation|0
1675293|NCT01436149|5852222|P1|Antidepressant Lead-in Phase|Protocol Violation|29
1675294|NCT01436149|5852220|P3|Antidepressant Lead-in Phase|Adverse Event|0
1675295|NCT01436149|5852221|P2|Antidepressant Lead-in Phase|Adverse Event|0
1675296|NCT01436149|5852222|P1|Antidepressant Lead-in Phase|Adverse Event|39
1675297|NCT01436110|5852253|P3|Overall Study|Did Not Receive Trial Medication|3
1675298|NCT01436110|5852254|P2|Overall Study|Did Not Receive Trial Medication|0
1675299|NCT01436110|5852255|P1|Overall Study|Did Not Receive Trial Medication|1
1675300|NCT01436110|5852253|P3|Overall Study|Protocol Violation|1
1675301|NCT01436110|5852254|P2|Overall Study|Protocol Violation|1
1675302|NCT01436110|5852255|P1|Overall Study|Protocol Violation|3
1675303|NCT01436110|5852253|P3|Overall Study|Lost to Follow-up|3
1675304|NCT01436110|5852254|P2|Overall Study|Lost to Follow-up|1
1675305|NCT01436110|5852255|P1|Overall Study|Lost to Follow-up|1
1675306|NCT01436110|5852253|P3|Overall Study|Physician Decision|1
1675307|NCT01436110|5852254|P2|Overall Study|Physician Decision|1
1675308|NCT01436110|5852255|P1|Overall Study|Physician Decision|3
1675309|NCT01436110|5852253|P3|Overall Study|Adverse Event|2
1675310|NCT01436110|5852254|P2|Overall Study|Adverse Event|1
1675311|NCT01436110|5852255|P1|Overall Study|Adverse Event|2
1675312|NCT01436110|5852253|P3|Overall Study|Withdrawal by Subject|4
1675313|NCT01436110|5852254|P2|Overall Study|Withdrawal by Subject|8
1675314|NCT01436110|5852255|P1|Overall Study|Withdrawal by Subject|6
1675315|NCT01436110|5852253|P3|Overall Study|Lack of Efficacy|9
1675316|NCT01436110|5852254|P2|Overall Study|Lack of Efficacy|14
1675317|NCT01436110|5852255|P1|Overall Study|Lack of Efficacy|23
1675318|NCT01436084|5852278|P1|Overall Study|Early Closure of Study|1
1675319|NCT01436084|5852278|P1|Overall Study|Withdrawal by Subject|1
1675320|NCT01436084|5852278|P1|Overall Study|Disease Progression|2
1675321|NCT01436071|5852284|P2|Overall Study|Did Not Receive Trial Medication|3
1675322|NCT01436071|5852285|P1|Overall Study|Did Not Receive Trial Medication|3
1675323|NCT01436071|5852284|P2|Overall Study|Withdrawal by Subject|2
1675324|NCT01436071|5852285|P1|Overall Study|Withdrawal by Subject|2
1675325|NCT01436071|5852284|P2|Overall Study|Physician Decision|0
1675326|NCT01436071|5852285|P1|Overall Study|Physician Decision|1
1675327|NCT01436071|5852284|P2|Overall Study|Lost to Follow-up|1
1675328|NCT01436071|5852285|P1|Overall Study|Lost to Follow-up|3
1675329|NCT01436071|5852284|P2|Overall Study|Protocol Violation|1
1675330|NCT01436071|5852285|P1|Overall Study|Protocol Violation|0
1675331|NCT01436071|5852284|P2|Overall Study|Lack of Efficacy|7
1675332|NCT01436071|5852285|P1|Overall Study|Lack of Efficacy|16
1675333|NCT01436071|5852284|P2|Overall Study|Adverse Event|0
1675334|NCT01436071|5852285|P1|Overall Study|Adverse Event|1
1675335|NCT01435928|5852327|P3|Double Blind Phase - 28 Weeks|Administrative|2
1675336|NCT01435928|5852328|P2|Double Blind Phase - 28 Weeks|Administrative|5
1675337|NCT01435928|5852329|P1|Double Blind Phase - 28 Weeks|Administrative|0
1675338|NCT01435928|5852327|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
1675339|NCT01435928|5852328|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
1675340|NCT01435928|5852329|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
1675341|NCT01435928|5852327|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
1675342|NCT01435928|5852328|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
1675343|NCT01435928|5852329|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
1675344|NCT01435928|5852327|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
1675345|NCT01435928|5852328|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
1675346|NCT01435928|5852329|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
1675347|NCT01435928|5852327|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
1675348|NCT01435928|5852328|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
1675349|NCT01435928|5852329|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
1675350|NCT01435928|5852327|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
1675351|NCT01435928|5852328|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
1675352|NCT01435928|5852329|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
1675353|NCT01435928|5852327|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
1675354|NCT01435928|5852328|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
1675355|NCT01435928|5852329|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
1675356|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Administrative|0
1675357|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Administrative|0
1675358|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Administrative|14
1675359|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1675360|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
1675361|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
1675362|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1675363|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
1675364|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
1675365|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1675366|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
1675367|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
1675368|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1675369|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
1675370|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
1675371|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1675372|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
1675373|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
1675374|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1675375|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
1675376|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
1675377|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Death|0
1675378|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Death|0
1675379|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Death|1
1675380|NCT01435928|5852327|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
1675381|NCT01435928|5852328|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
1675382|NCT01435928|5852329|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
1675383|NCT01435798|5852375|P1|Overall Study|Withdrawal by Subject|1
1675384|NCT01435772|5852392|P3|Overall Study|Other - study termination|10
1675385|NCT01435772|5852393|P2|Overall Study|Other - study termination|2
1675386|NCT01435772|5852394|P1|Overall Study|Other - study termination|2
1675387|NCT01435772|5852392|P3|Overall Study|Withdrawal by Subject|3
1675388|NCT01435772|5852393|P2|Overall Study|Withdrawal by Subject|1
1675389|NCT01435772|5852394|P1|Overall Study|Withdrawal by Subject|0
1675390|NCT01435772|5852392|P3|Overall Study|Adverse Event|2
1675391|NCT01435772|5852393|P2|Overall Study|Adverse Event|0
1675392|NCT01435772|5852394|P1|Overall Study|Adverse Event|1
1675393|NCT01435759|5852444|P6|Double-blind Phase|Other|0
1675394|NCT01435759|5852445|P5|Double-blind Phase|Other|0
1675395|NCT01435759|5852446|P4|Double-blind Phase|Other|2
1675396|NCT01435759|5852447|P3|Double-blind Phase|Other|0
1675397|NCT01435759|5852448|P2|Double-blind Phase|Other|2
1675398|NCT01435759|5852449|P1|Double-blind Phase|Other|8
1675399|NCT01435759|5852444|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1675400|NCT01435759|5852445|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
1675401|NCT01435759|5852446|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1675402|NCT01435759|5852447|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1675403|NCT01435759|5852448|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
1675404|NCT01435759|5852449|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
1675405|NCT01435759|5852444|P6|Double-blind Phase|Lost to Follow-up|3
1675406|NCT01435759|5852445|P5|Double-blind Phase|Lost to Follow-up|3
1675407|NCT01435759|5852446|P4|Double-blind Phase|Lost to Follow-up|0
1675408|NCT01435759|5852447|P3|Double-blind Phase|Lost to Follow-up|2
1675409|NCT01435759|5852448|P2|Double-blind Phase|Lost to Follow-up|1
1675410|NCT01435759|5852449|P1|Double-blind Phase|Lost to Follow-up|31
1675411|NCT01435759|5852444|P6|Double-blind Phase|Withdrawal by Subject|2
1675412|NCT01435759|5852445|P5|Double-blind Phase|Withdrawal by Subject|2
1675413|NCT01435759|5852446|P4|Double-blind Phase|Withdrawal by Subject|4
1675414|NCT01435759|5852447|P3|Double-blind Phase|Withdrawal by Subject|3
1675415|NCT01435759|5852448|P2|Double-blind Phase|Withdrawal by Subject|4
1675416|NCT01435759|5852449|P1|Double-blind Phase|Withdrawal by Subject|17
1675417|NCT01435759|5852444|P6|Double-blind Phase|Protocol Violation|1
1675418|NCT01435759|5852445|P5|Double-blind Phase|Protocol Violation|0
1675419|NCT01435759|5852446|P4|Double-blind Phase|Protocol Violation|2
1675420|NCT01435759|5852447|P3|Double-blind Phase|Protocol Violation|1
1675421|NCT01435759|5852448|P2|Double-blind Phase|Protocol Violation|0
1675422|NCT01435759|5852449|P1|Double-blind Phase|Protocol Violation|2
1675423|NCT01435759|5852444|P6|Double-blind Phase|Adverse Event|3
1675424|NCT01435759|5852445|P5|Double-blind Phase|Adverse Event|1
1675425|NCT01435759|5852446|P4|Double-blind Phase|Adverse Event|1
1675426|NCT01435759|5852447|P3|Double-blind Phase|Adverse Event|1
1675427|NCT01435759|5852448|P2|Double-blind Phase|Adverse Event|0
1675428|NCT01435759|5852449|P1|Double-blind Phase|Adverse Event|7
1675429|NCT01435759|5852444|P6|Antidepressant Lead-in Phase|Other|0
1675430|NCT01435759|5852445|P5|Antidepressant Lead-in Phase|Other|0
1675431|NCT01435759|5852446|P4|Antidepressant Lead-in Phase|Other|0
1675432|NCT01435759|5852447|P3|Antidepressant Lead-in Phase|Other|0
1675433|NCT01435759|5852448|P2|Antidepressant Lead-in Phase|Other|0
1675434|NCT01435759|5852449|P1|Antidepressant Lead-in Phase|Other|119
1675435|NCT01435759|5852444|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1675436|NCT01435759|5852445|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1675437|NCT01435759|5852446|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1675438|NCT01435759|5852447|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1675439|NCT01435759|5852448|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
1675440|NCT01435759|5852449|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
1675441|NCT01435759|5852444|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
1675442|NCT01435759|5852445|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
1675443|NCT01435759|5852446|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
1675444|NCT01435759|5852447|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
1675445|NCT01435759|5852448|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
1675446|NCT01435759|5852449|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
1675447|NCT01435759|5852444|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1675448|NCT01435759|5852445|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1675449|NCT01435759|5852446|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1675450|NCT01435759|5852447|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1675451|NCT01435759|5852448|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
1675452|NCT01435759|5852449|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
1675453|NCT01435759|5852444|P6|Antidepressant Lead-in Phase|Protocol Violation|0
1675454|NCT01435759|5852445|P5|Antidepressant Lead-in Phase|Protocol Violation|0
1675455|NCT01435759|5852446|P4|Antidepressant Lead-in Phase|Protocol Violation|0
1675456|NCT01435759|5852447|P3|Antidepressant Lead-in Phase|Protocol Violation|0
1675457|NCT01435759|5852448|P2|Antidepressant Lead-in Phase|Protocol Violation|0
1675458|NCT01435759|5852449|P1|Antidepressant Lead-in Phase|Protocol Violation|16
1675459|NCT01435759|5852444|P6|Antidepressant Lead-in Phase|Adverse Event|0
1675460|NCT01435759|5852445|P5|Antidepressant Lead-in Phase|Adverse Event|0
1675461|NCT01435759|5852446|P4|Antidepressant Lead-in Phase|Adverse Event|0
1675462|NCT01435759|5852447|P3|Antidepressant Lead-in Phase|Adverse Event|0
1675463|NCT01435759|5852448|P2|Antidepressant Lead-in Phase|Adverse Event|0
1675464|NCT01435759|5852449|P1|Antidepressant Lead-in Phase|Adverse Event|40
1675465|NCT01435655|5852476|P1|Overall Study|Other|1
1675466|NCT01435655|5852476|P1|Overall Study|Death|2
1675467|NCT01435616|5852490|P2|Overall Study|Sponsor Decision|0
1675468|NCT01435616|5852491|P1|Overall Study|Sponsor Decision|1
1675469|NCT01435616|5852490|P2|Overall Study|Physician Decision|7
1675470|NCT01435616|5852491|P1|Overall Study|Physician Decision|20
1675471|NCT01435616|5852490|P2|Overall Study|Withdrawal by Subject|24
1675472|NCT01435616|5852491|P1|Overall Study|Withdrawal by Subject|66
1675473|NCT01435616|5852490|P2|Overall Study|Protocol Violation|13
1675474|NCT01435616|5852491|P1|Overall Study|Protocol Violation|16
1675475|NCT01435616|5852490|P2|Overall Study|Lost to Follow-up|13
1675476|NCT01435616|5852491|P1|Overall Study|Lost to Follow-up|22
1675477|NCT01435616|5852490|P2|Overall Study|Death|2
1675478|NCT01435616|5852491|P1|Overall Study|Death|7
1675479|NCT01435616|5852490|P2|Overall Study|Adverse Event|21
1675480|NCT01435616|5852491|P1|Overall Study|Adverse Event|39
1675481|NCT01435577|5852546|P2|Overall Study|Alternative treatment started|1
1675482|NCT01435577|5852547|P1|Overall Study|Alternative treatment started|0
1675483|NCT01435577|5852546|P2|Overall Study|Lack of Efficacy|51
1675484|NCT01435577|5852547|P1|Overall Study|Lack of Efficacy|7
1675485|NCT01435577|5852546|P2|Overall Study|Adverse Event|0
1675486|NCT01435577|5852547|P1|Overall Study|Adverse Event|10
1675487|NCT01435460|5852597|P2|Overall Study|Did not meet eligibility criteria|0
1675488|NCT01435460|5852598|P1|Overall Study|Did not meet eligibility criteria|2
1675489|NCT01435460|5852597|P2|Overall Study|Protocol Violation|1
1675490|NCT01435460|5852598|P1|Overall Study|Protocol Violation|0
1675491|NCT01435460|5852597|P2|Overall Study|Withdrawal by Subject|3
1675492|NCT01435460|5852598|P1|Overall Study|Withdrawal by Subject|1
1675493|NCT01435460|5852597|P2|Overall Study|Lost to Follow-up|1
1675494|NCT01435460|5852598|P1|Overall Study|Lost to Follow-up|6
1675495|NCT01435460|5852597|P2|Overall Study|Adverse Event|1
1675496|NCT01435460|5852598|P1|Overall Study|Adverse Event|2
1675497|NCT01435382|5852614|P4|Overall Study|Withdrawal by Subject|1
1675498|NCT01435382|5852615|P3|Overall Study|Withdrawal by Subject|0
1675499|NCT01435382|5852616|P2|Overall Study|Withdrawal by Subject|2
1675500|NCT01435382|5852617|P1|Overall Study|Withdrawal by Subject|0
1675501|NCT01435382|5852614|P4|Overall Study|Lost to Follow-up|0
1675502|NCT01435382|5852615|P3|Overall Study|Lost to Follow-up|1
1675503|NCT01435382|5852616|P2|Overall Study|Lost to Follow-up|0
1675504|NCT01435382|5852617|P1|Overall Study|Lost to Follow-up|1
1675505|NCT01435356|5852706|P2|Overall Study|Patient moved to another city|1
1675506|NCT01435356|5852707|P1|Overall Study|Patient moved to another city|1
1675507|NCT01435356|5852706|P2|Overall Study|Patient decision|0
1675508|NCT01435356|5852707|P1|Overall Study|Patient decision|3
1675509|NCT01435356|5852706|P2|Overall Study|Physician Decision|0
1675510|NCT01435356|5852707|P1|Overall Study|Physician Decision|1
1675511|NCT01435356|5852706|P2|Overall Study|IC withdrawal due to study cancellation|0
1675512|NCT01435356|5852707|P1|Overall Study|IC withdrawal due to study cancellation|1
1675513|NCT01435356|5852706|P2|Overall Study|Facial palsy|0
1675514|NCT01435356|5852707|P1|Overall Study|Facial palsy|1
1675515|NCT01435356|5852706|P2|Overall Study|Withdrawal by Subject|1
1675516|NCT01435356|5852707|P1|Overall Study|Withdrawal by Subject|1
1675517|NCT01435356|5852706|P2|Overall Study|Study Discontinuation, amendment 4|11
1675518|NCT01435356|5852707|P1|Overall Study|Study Discontinuation, amendment 4|5
1675519|NCT01435356|5852706|P2|Overall Study|Protocol Violation|1
1675520|NCT01435356|5852707|P1|Overall Study|Protocol Violation|0
1675521|NCT01435356|5852706|P2|Overall Study|Disease progression/recurrence|10
1675522|NCT01435356|5852707|P1|Overall Study|Disease progression/recurrence|17
1675523|NCT01435356|5852706|P2|Overall Study|Adverse Event|0
1675524|NCT01435356|5852707|P1|Overall Study|Adverse Event|2
1675525|NCT01435265|5852740|P2|Overall Study|Lost to Follow-up|1
1675526|NCT01435265|5852741|P1|Overall Study|Lost to Follow-up|0
1675527|NCT01435122|5852755|P1|Overall Study|Early withdrawal due to toxicity|8
1675528|NCT01435031|5852764|P1|ITT at 4 Years|Lost to Follow-up|1
1675529|NCT01435031|5852764|P1|ITT at 4 Years|Withdrawal by Subject|2
1675530|NCT01435031|5852764|P1|ITT at 4 Years|Death|4
1675531|NCT01435031|5852764|P1|ITT at 3 Years|Lost to Follow-up|4
1675532|NCT01435031|5852764|P1|ITT at 3 Years|Withdrawal by Subject|2
1675533|NCT01435031|5852764|P1|ITT at 3 Years|Death|5
1675534|NCT01435031|5852764|P1|ITT at 2 Years|Lost to Follow-up|4
1675535|NCT01435031|5852764|P1|ITT at 2 Years|Withdrawal by Subject|2
1675536|NCT01435031|5852764|P1|ITT at 2 Years|Death|7
1675537|NCT01435031|5852764|P1|ITT at 1 Year|Lost to Follow-up|6
1675538|NCT01435031|5852764|P1|ITT at 1 Year|Withdrawal by Subject|2
1675539|NCT01435031|5852764|P1|ITT at 1 Year|Death|1
1675540|NCT01435031|5852764|P1|ITT at 6 Months|Lost to Follow-up|3
1675541|NCT01435031|5852764|P1|ITT at 6 Months|Death|2
1675542|NCT01435031|5852764|P1|ITT at 1 Month|Lost to Follow-up|4
1675543|NCT01435031|5852764|P1|ITT at 1 Month|Death|1
1675544|NCT01435031|5852764|P1|ITT at 1 Month|Withdrawal by Subject|1
1675545|NCT01435018|5852865|P3|Overall Study|Never started chemotherapy|1
1675546|NCT01435018|5852866|P2|Overall Study|Never started chemotherapy|0
1675547|NCT01435018|5852867|P1|Overall Study|Never started chemotherapy|3
1675548|NCT01435018|5852865|P3|Overall Study|Enrollment Violation|0
1675549|NCT01435018|5852866|P2|Overall Study|Enrollment Violation|1
1675550|NCT01435018|5852867|P1|Overall Study|Enrollment Violation|0
1675551|NCT01435018|5852865|P3|Overall Study|Unable to contact participant/parent|0
1675552|NCT01435018|5852866|P2|Overall Study|Unable to contact participant/parent|1
1675553|NCT01435018|5852867|P1|Overall Study|Unable to contact participant/parent|1
1675554|NCT01435018|5852865|P3|Overall Study|Severe debilitation, unable to continue|1
1675555|NCT01435018|5852866|P2|Overall Study|Severe debilitation, unable to continue|0
1675556|NCT01435018|5852867|P1|Overall Study|Severe debilitation, unable to continue|0
1675557|NCT01435018|5852865|P3|Overall Study|Not able to get to clinic|2
1675558|NCT01435018|5852866|P2|Overall Study|Not able to get to clinic|0
1675559|NCT01435018|5852867|P1|Overall Study|Not able to get to clinic|2
1675560|NCT01435018|5852865|P3|Overall Study|Not willing to adhere to requirements|1
1675561|NCT01435018|5852866|P2|Overall Study|Not willing to adhere to requirements|2
1675562|NCT01435018|5852867|P1|Overall Study|Not willing to adhere to requirements|0
1675563|NCT01435018|5852865|P3|Overall Study|Withdrew consent|1
1675564|NCT01435018|5852866|P2|Overall Study|Withdrew consent|3
1675565|NCT01435018|5852867|P1|Overall Study|Withdrew consent|0
1675566|NCT01435018|5852865|P3|Overall Study|Site is closing|7
1675567|NCT01435018|5852866|P2|Overall Study|Site is closing|9
1675568|NCT01435018|5852867|P1|Overall Study|Site is closing|4
1675569|NCT01435018|5852865|P3|Overall Study|Death|22
1675570|NCT01435018|5852866|P2|Overall Study|Death|18
1675571|NCT01435018|5852867|P1|Overall Study|Death|31
1675572|NCT01435018|5852865|P3|Overall Study|On study|73
1675573|NCT01435018|5852866|P2|Overall Study|On study|16
1675574|NCT01435018|5852867|P1|Overall Study|On study|69
1675575|NCT01434823|5852952|P2|Overall Study|Incomplete data in medical record|7
1675576|NCT01434823|5852953|P1|Overall Study|Incomplete data in medical record|4
1675577|NCT01434810|5852971|P2|Overall Study|Missing data/received <5hr phototherapy|7
1675578|NCT01434810|5852972|P1|Overall Study|Missing data/received <5hr phototherapy|12
1675579|NCT01434810|5852971|P2|Overall Study|Did not receive treatment|3
1675580|NCT01434810|5852972|P1|Overall Study|Did not receive treatment|11
1675581|NCT01434693|5853007|P4|Overall Study|Lost to Follow-up|0
1675582|NCT01434693|5853008|P3|Overall Study|Lost to Follow-up|0
1675583|NCT01434693|5853009|P2|Overall Study|Lost to Follow-up|0
1675584|NCT01434693|5853010|P1|Overall Study|Lost to Follow-up|1
1675585|NCT01434693|5853007|P4|Overall Study|Withdrawal by Subject|1
1675586|NCT01434693|5853008|P3|Overall Study|Withdrawal by Subject|1
1675587|NCT01434693|5853009|P2|Overall Study|Withdrawal by Subject|0
1675588|NCT01434693|5853010|P1|Overall Study|Withdrawal by Subject|1
1675589|NCT01434693|5853007|P4|Overall Study|Adverse Event|0
1675590|NCT01434693|5853008|P3|Overall Study|Adverse Event|0
1675591|NCT01434693|5853009|P2|Overall Study|Adverse Event|0
1675592|NCT01434693|5853010|P1|Overall Study|Adverse Event|1
1675593|NCT01434680|5853024|P4|Overall Study|Protocol Violation|0
1675594|NCT01434680|5853025|P3|Overall Study|Protocol Violation|0
1675595|NCT01434680|5853026|P2|Overall Study|Protocol Violation|1
1675596|NCT01434680|5853027|P1|Overall Study|Protocol Violation|1
1675597|NCT01434680|5853024|P4|Overall Study|Lost to Follow-up|0
1675598|NCT01434680|5853025|P3|Overall Study|Lost to Follow-up|0
1675599|NCT01434680|5853026|P2|Overall Study|Lost to Follow-up|1
1675600|NCT01434680|5853027|P1|Overall Study|Lost to Follow-up|1
1675601|NCT01434680|5853024|P4|Overall Study|Withdrawal by Subject|0
1675602|NCT01434680|5853025|P3|Overall Study|Withdrawal by Subject|2
1675603|NCT01434680|5853026|P2|Overall Study|Withdrawal by Subject|0
1675604|NCT01434680|5853027|P1|Overall Study|Withdrawal by Subject|1
1675605|NCT01434667|5853044|P2|Overall Study|Lost to Follow-up|10
1675606|NCT01434667|5853045|P1|Overall Study|Lost to Follow-up|5
1675607|NCT01434654|5853071|P2|Overall Study|Lost to Follow-up|0
1675608|NCT01434654|5853072|P1|Overall Study|Lost to Follow-up|1
1675609|NCT01434654|5853071|P2|Overall Study|Withdrawal by Subject|0
1675610|NCT01434654|5853072|P1|Overall Study|Withdrawal by Subject|1
1675611|NCT01434290|5853119|P2|Overall Study|No protocol treatment|4
1675612|NCT01434290|5853120|P1|Overall Study|No protocol treatment|2
1675613|NCT01434290|5853119|P2|Overall Study|Protocol Violation|3
1675614|NCT01434290|5853120|P1|Overall Study|Protocol Violation|6
1675615|NCT01433978|5853193|P3|Extension Phase|Study Terminated by Sponsor|4
1675616|NCT01433978|5853194|P2|Extension Phase|Study Terminated by Sponsor|0
1675617|NCT01433978|5853195|P1|Extension Phase|Study Terminated by Sponsor|0
1675618|NCT01433978|5853193|P3|Extension Phase|Lack of Efficacy|1
1675619|NCT01433978|5853194|P2|Extension Phase|Lack of Efficacy|0
1675620|NCT01433978|5853195|P1|Extension Phase|Lack of Efficacy|0
1675621|NCT01433978|5853193|P3|Extension Phase|Adverse Event, Non-Fatal|1
1675622|NCT01433978|5853194|P2|Extension Phase|Adverse Event, Non-Fatal|0
1675623|NCT01433978|5853195|P1|Extension Phase|Adverse Event, Non-Fatal|0
1675624|NCT01433978|5853193|P3|Core Study|Study Terminated by Sponsor|0
1675625|NCT01433978|5853194|P2|Core Study|Study Terminated by Sponsor|9
1675626|NCT01433978|5853195|P1|Core Study|Study Terminated by Sponsor|6
1675627|NCT01433978|5853193|P3|Core Study|Lack of Efficacy|0
1675628|NCT01433978|5853194|P2|Core Study|Lack of Efficacy|1
1675629|NCT01433978|5853195|P1|Core Study|Lack of Efficacy|5
1675630|NCT01433978|5853193|P3|Core Study|Adverse Event, Non-Fatal|0
1675631|NCT01433978|5853194|P2|Core Study|Adverse Event, Non-Fatal|1
1675632|NCT01433978|5853195|P1|Core Study|Adverse Event, Non-Fatal|0
1675633|NCT01433549|5853252|P2|Phase 2: Second Study Product|Adverse Event|1
1675634|NCT01433549|5853253|P1|Phase 2: Second Study Product|Adverse Event|0
1675635|NCT01433471|5853263|P2|Overall Study|Withdrawal by Subject|1
1675636|NCT01433471|5853264|P1|Overall Study|Withdrawal by Subject|0
1675637|NCT01433354|5853280|P1|Overall Study|Subject Withdrew Consent|3
1675638|NCT01433354|5853280|P1|Overall Study|Lack of Efficacy|17
1675639|NCT01433354|5853280|P1|Overall Study|Protocol Violation|2
1675640|NCT01433354|5853280|P1|Overall Study|Administrative problems|90
1675641|NCT01433354|5853280|P1|Overall Study|Lost to Follow-up|1
1675642|NCT01433354|5853280|P1|Overall Study|Adverse Event|6
1675643|NCT01433263|5853296|P2|Overall Study|Withdrawal by Subject|7
1675644|NCT01433263|5853297|P1|Overall Study|Withdrawal by Subject|10
1675645|NCT01433263|5853296|P2|Overall Study|Protocol Deviation|0
1675646|NCT01433263|5853297|P1|Overall Study|Protocol Deviation|1
1675647|NCT01433263|5853296|P2|Overall Study|Lost to Follow-up|1
1675648|NCT01433263|5853297|P1|Overall Study|Lost to Follow-up|0
1675649|NCT01433263|5853296|P2|Overall Study|Death|3
1675650|NCT01433263|5853297|P1|Overall Study|Death|5
1675651|NCT01433263|5853296|P2|Overall Study|Adverse Event|1
1675652|NCT01433263|5853297|P1|Overall Study|Adverse Event|3
1675653|NCT01433250|5853326|P2|Overall Study|Withdrawal by Subject|2
1675654|NCT01433250|5853327|P1|Overall Study|Withdrawal by Subject|3
1675655|NCT01433250|5853326|P2|Overall Study|Protocol Violation|1
1675656|NCT01433250|5853327|P1|Overall Study|Protocol Violation|0
1675657|NCT01433172|5853346|P3|Overall Study|Death|0
1675658|NCT01433172|5853347|P2|Overall Study|Death|2
1675659|NCT01433172|5853348|P1|Overall Study|Death|0
1675660|NCT01433172|5853346|P3|Overall Study|Disease Progression|1
1675661|NCT01433172|5853347|P2|Overall Study|Disease Progression|0
1675662|NCT01433172|5853348|P1|Overall Study|Disease Progression|0
1675663|NCT01433172|5853346|P3|Overall Study|Withdrawal by Subject|0
1675664|NCT01433172|5853347|P2|Overall Study|Withdrawal by Subject|1
1675665|NCT01433172|5853348|P1|Overall Study|Withdrawal by Subject|0
1675666|NCT01433159|5853360|P2|Overall Study|Protocol Violation|1
1675667|NCT01433159|5853361|P1|Overall Study|Protocol Violation|0
1675668|NCT01433159|5853360|P2|Overall Study|Physician Decision|0
1675669|NCT01433159|5853361|P1|Overall Study|Physician Decision|1
1675670|NCT01433159|5853360|P2|Overall Study|Adverse Event|0
1675671|NCT01433159|5853361|P1|Overall Study|Adverse Event|1
1675672|NCT01433055|5853393|P2|Overall Study|Severely elevated triglycerides at entry|0
1675673|NCT01433055|5853394|P1|Overall Study|Severely elevated triglycerides at entry|1
1675674|NCT01433055|5853393|P2|Overall Study|Diagnosed with cancer unrelated to study|0
1675675|NCT01433055|5853394|P1|Overall Study|Diagnosed with cancer unrelated to study|1
1675676|NCT01432938|5853416|P2|Second Intervention|Adverse Event|0
1675677|NCT01432938|5853417|P1|Second Intervention|Adverse Event|1
1675678|NCT01432938|5853416|P2|First Intervention|Physician Decision|0
1675679|NCT01432938|5853417|P1|First Intervention|Physician Decision|1
1675680|NCT01432938|5853416|P2|First Intervention|Protocol Violation|0
1675681|NCT01432938|5853417|P1|First Intervention|Protocol Violation|1
1675682|NCT01432756|5853447|P4|Overall Study|Lost to Follow-up|1
1675683|NCT01432756|5853448|P3|Overall Study|Lost to Follow-up|2
1675684|NCT01432756|5853449|P2|Overall Study|Lost to Follow-up|0
1675685|NCT01432756|5853450|P1|Overall Study|Lost to Follow-up|1
1675686|NCT01432626|5853458|P1|Overall Study|Imaging agent not available|1
1675687|NCT01432626|5853458|P1|Overall Study|Only 1 image competed|2
1675688|NCT01432626|5853458|P1|Overall Study|Withdrawal by Subject|2
1675689|NCT01432626|5853458|P1|Overall Study|LV function recovered|2
1675690|NCT01432600|5853465|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
1675691|NCT01432600|5853466|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
1675692|NCT01432600|5853467|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
1675693|NCT01432574|5853483|P1|Overall Study|Not interested|1
1675694|NCT01432574|5853483|P1|Overall Study|Moved|2
1675695|NCT01432457|5853529|P3|Overall Study|Did not take study drug|3
1675696|NCT01432457|5853530|P2|Overall Study|Did not take study drug|6
1675697|NCT01432457|5853531|P1|Overall Study|Did not take study drug|6
1675698|NCT01432457|5853529|P3|Overall Study|Reasons not defined|4
1675699|NCT01432457|5853530|P2|Overall Study|Reasons not defined|3
1675700|NCT01432457|5853531|P1|Overall Study|Reasons not defined|2
1675701|NCT01432457|5853529|P3|Overall Study|Withdrawal by Subject|9
1675702|NCT01432457|5853530|P2|Overall Study|Withdrawal by Subject|11
1675703|NCT01432457|5853531|P1|Overall Study|Withdrawal by Subject|6
1675704|NCT01432457|5853529|P3|Overall Study|Protocol Violation|6
1675705|NCT01432457|5853530|P2|Overall Study|Protocol Violation|2
1675706|NCT01432457|5853531|P1|Overall Study|Protocol Violation|3
1675707|NCT01432457|5853529|P3|Overall Study|Lost to Follow-up|20
1675708|NCT01432457|5853530|P2|Overall Study|Lost to Follow-up|15
1675709|NCT01432457|5853531|P1|Overall Study|Lost to Follow-up|11
1675710|NCT01432457|5853529|P3|Overall Study|Lack of Efficacy|1
1675711|NCT01432457|5853530|P2|Overall Study|Lack of Efficacy|1
1675712|NCT01432457|5853531|P1|Overall Study|Lack of Efficacy|2
1675713|NCT01432457|5853529|P3|Overall Study|Adverse Event|16
1675714|NCT01432457|5853530|P2|Overall Study|Adverse Event|10
1675715|NCT01432457|5853531|P1|Overall Study|Adverse Event|7
1675716|NCT01432444|5853560|P3|Extension Phase|Withdrawal by Subject|13
1675717|NCT01432444|5853561|P2|Extension Phase|Withdrawal by Subject|0
1675718|NCT01432444|5853562|P1|Extension Phase|Withdrawal by Subject|0
1675719|NCT01432444|5853560|P3|Extension Phase|Physician Decision|1
1675720|NCT01432444|5853561|P2|Extension Phase|Physician Decision|0
1675721|NCT01432444|5853562|P1|Extension Phase|Physician Decision|0
1675722|NCT01432444|5853560|P3|Extension Phase|Met Withdrawal Criteria|144
1675723|NCT01432444|5853561|P2|Extension Phase|Met Withdrawal Criteria|0
1675724|NCT01432444|5853562|P1|Extension Phase|Met Withdrawal Criteria|0
1675725|NCT01432444|5853560|P3|Extension Phase|Sponsor Discontinued Trial|7
1675726|NCT01432444|5853561|P2|Extension Phase|Sponsor Discontinued Trial|0
1675727|NCT01432444|5853562|P1|Extension Phase|Sponsor Discontinued Trial|0
1675728|NCT01432444|5853560|P3|Extension Phase|Adverse Event|10
1675729|NCT01432444|5853561|P2|Extension Phase|Adverse Event|0
1675730|NCT01432444|5853562|P1|Extension Phase|Adverse Event|0
1675731|NCT01432444|5853560|P3|Extension Phase|Lost to Follow-up|17
1675732|NCT01432444|5853561|P2|Extension Phase|Lost to Follow-up|0
1675733|NCT01432444|5853562|P1|Extension Phase|Lost to Follow-up|0
1675734|NCT01432444|5853560|P3|Treatment Phase|Lack of Efficacy|0
1675735|NCT01432444|5853561|P2|Treatment Phase|Lack of Efficacy|10
1675736|NCT01432444|5853562|P1|Treatment Phase|Lack of Efficacy|0
1675737|NCT01432444|5853560|P3|Treatment Phase|Protocol Deviation|0
1675738|NCT01432444|5853561|P2|Treatment Phase|Protocol Deviation|3
1675739|NCT01432444|5853562|P1|Treatment Phase|Protocol Deviation|0
1675740|NCT01432444|5853560|P3|Treatment Phase|Withdrawal by Subject|0
1675741|NCT01432444|5853561|P2|Treatment Phase|Withdrawal by Subject|41
1675742|NCT01432444|5853562|P1|Treatment Phase|Withdrawal by Subject|0
1675743|NCT01432444|5853560|P3|Treatment Phase|Physician Decision|0
1675744|NCT01432444|5853561|P2|Treatment Phase|Physician Decision|5
1675745|NCT01432444|5853562|P1|Treatment Phase|Physician Decision|0
1675746|NCT01432444|5853560|P3|Treatment Phase|Met Withdrawal Criteria|0
1675747|NCT01432444|5853561|P2|Treatment Phase|Met Withdrawal Criteria|11
1675748|NCT01432444|5853562|P1|Treatment Phase|Met Withdrawal Criteria|0
1675749|NCT01432444|5853560|P3|Treatment Phase|Adverse Event|0
1675750|NCT01432444|5853561|P2|Treatment Phase|Adverse Event|37
1675751|NCT01432444|5853562|P1|Treatment Phase|Adverse Event|0
1675752|NCT01432444|5853560|P3|Treatment Phase|Lost to Follow-up|0
1675753|NCT01432444|5853561|P2|Treatment Phase|Lost to Follow-up|33
1675754|NCT01432444|5853562|P1|Treatment Phase|Lost to Follow-up|0
1675755|NCT01432444|5853560|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1675756|NCT01432444|5853561|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
1675757|NCT01432444|5853562|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
1675758|NCT01432444|5853560|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
1675759|NCT01432444|5853561|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
1675760|NCT01432444|5853562|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
1675761|NCT01432444|5853560|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1675762|NCT01432444|5853561|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
1675763|NCT01432444|5853562|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
1675764|NCT01432444|5853560|P3|Tolerability/Cross-titration Phase|Physician Decision|0
1675765|NCT01432444|5853561|P2|Tolerability/Cross-titration Phase|Physician Decision|0
1675766|NCT01432444|5853562|P1|Tolerability/Cross-titration Phase|Physician Decision|8
1675767|NCT01432444|5853560|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1675768|NCT01432444|5853561|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
1675769|NCT01432444|5853562|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
1675770|NCT01432444|5853560|P3|Tolerability/Cross-titration Phase|Adverse Event|0
1675771|NCT01432444|5853561|P2|Tolerability/Cross-titration Phase|Adverse Event|0
1675772|NCT01432444|5853562|P1|Tolerability/Cross-titration Phase|Adverse Event|16
1675773|NCT01432444|5853560|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1675774|NCT01432444|5853561|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
1675775|NCT01432444|5853562|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
1675776|NCT01432366|5853588|P1|Overall Study|Other|14
1675777|NCT01432366|5853588|P1|Overall Study|Investigator Forget to Complete Visits|1
1675778|NCT01432366|5853588|P1|Overall Study|Site Closed|20
1675779|NCT01432366|5853588|P1|Overall Study|Lack of Efficacy|1
1675780|NCT01432366|5853588|P1|Overall Study|Lost to Follow-up|13
1675781|NCT01432366|5853588|P1|Overall Study|Pregnancy|1
1675782|NCT01432366|5853588|P1|Overall Study|Withdrawal Due to Non-Compliance|3
1675783|NCT01432366|5853588|P1|Overall Study|Adverse Event|8
1675784|NCT01432366|5853588|P1|Overall Study|Non-Responder|7
1675785|NCT01432327|5853610|P4|Posttest 1 Year|Allergic reaction|1
1675786|NCT01432327|5853611|P3|Posttest 1 Year|Allergic reaction|1
1675787|NCT01432327|5853612|P2|Posttest 1 Year|Allergic reaction|0
1675788|NCT01432327|5853613|P1|Posttest 1 Year|Allergic reaction|0
1675789|NCT01432327|5853610|P4|Posttest 1 Year|Lost to Follow-up|2
1675790|NCT01432327|5853611|P3|Posttest 1 Year|Lost to Follow-up|4
1675791|NCT01432327|5853612|P2|Posttest 1 Year|Lost to Follow-up|0
1675792|NCT01432327|5853613|P1|Posttest 1 Year|Lost to Follow-up|0
1675793|NCT01432327|5853610|P4|Posttest 1 Year|Measurement have to take place in future|20
1675794|NCT01432327|5853611|P3|Posttest 1 Year|Measurement have to take place in future|15
1675795|NCT01432327|5853612|P2|Posttest 1 Year|Measurement have to take place in future|28
1675796|NCT01432327|5853613|P1|Posttest 1 Year|Measurement have to take place in future|24
1675797|NCT01432327|5853610|P4|Posttest 6 Months|Withdrawal by Subject|0
1675798|NCT01432327|5853611|P3|Posttest 6 Months|Withdrawal by Subject|1
1675799|NCT01432327|5853612|P2|Posttest 6 Months|Withdrawal by Subject|0
1675800|NCT01432327|5853613|P1|Posttest 6 Months|Withdrawal by Subject|0
1675801|NCT01432327|5853610|P4|Posttest 6 Months|Allergic reaction|0
1675802|NCT01432327|5853611|P3|Posttest 6 Months|Allergic reaction|1
1675803|NCT01432327|5853612|P2|Posttest 6 Months|Allergic reaction|0
1675804|NCT01432327|5853613|P1|Posttest 6 Months|Allergic reaction|0
1675805|NCT01432327|5853610|P4|Posttest 6 Months|Lost to Follow-up|2
1675806|NCT01432327|5853611|P3|Posttest 6 Months|Lost to Follow-up|3
1675807|NCT01432327|5853612|P2|Posttest 6 Months|Lost to Follow-up|0
1675808|NCT01432327|5853613|P1|Posttest 6 Months|Lost to Follow-up|0
1675809|NCT01432327|5853610|P4|Posttest 3 Months|Allergic reaction|0
1675810|NCT01432327|5853611|P3|Posttest 3 Months|Allergic reaction|0
1675811|NCT01432327|5853612|P2|Posttest 3 Months|Allergic reaction|2
1675812|NCT01432327|5853613|P1|Posttest 3 Months|Allergic reaction|0
1675813|NCT01432327|5853610|P4|Posttest 3 Months|Lost to Follow-up|1
1675814|NCT01432327|5853611|P3|Posttest 3 Months|Lost to Follow-up|2
1675815|NCT01432327|5853612|P2|Posttest 3 Months|Lost to Follow-up|0
1675816|NCT01432327|5853613|P1|Posttest 3 Months|Lost to Follow-up|1
1675817|NCT01432327|5853610|P4|Posttest 3 Months|depression|0
1675818|NCT01432327|5853611|P3|Posttest 3 Months|depression|0
1675819|NCT01432327|5853612|P2|Posttest 3 Months|depression|0
1675820|NCT01432327|5853613|P1|Posttest 3 Months|depression|3
1675821|NCT01432275|5853623|P2|ADC With Calculator (10 Days)|Protocol Violation|1
1675822|NCT01432275|5853624|P1|ADC With Calculator (10 Days)|Protocol Violation|0
1675823|NCT01432275|5853623|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
1675824|NCT01432275|5853624|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
1675825|NCT01432275|5853623|P2|ADC With Calculator (10 Days)|Physician Decision|1
1675826|NCT01432275|5853624|P1|ADC With Calculator (10 Days)|Physician Decision|1
1675827|NCT01432275|5853623|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
1675828|NCT01432275|5853624|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
1675829|NCT01432275|5853623|P2|Second BG Meter System (7 Days)|Physician Decision|1
1675830|NCT01432275|5853624|P1|Second BG Meter System (7 Days)|Physician Decision|0
1675831|NCT01432275|5853623|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
1675832|NCT01432275|5853624|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
1675833|NCT01432275|5853623|P2|Second BG Meter System (7 Days)|Adverse Event|1
1675834|NCT01432275|5853624|P1|Second BG Meter System (7 Days)|Adverse Event|1
1675835|NCT01432275|5853623|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
1675836|NCT01432275|5853624|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
1675837|NCT01432275|5853623|P2|First BG Meter System (7 Days)|Adverse Event|2
1675838|NCT01432275|5853624|P1|First BG Meter System (7 Days)|Adverse Event|0
1675839|NCT01432262|5853633|P2|Overall Study|Withdrawal by Subject|1
1675840|NCT01432262|5853634|P1|Overall Study|Withdrawal by Subject|2
1675841|NCT01432171|5853700|P2|Overall Study|Patient moved to palliative care|0
1675842|NCT01432171|5853701|P1|Overall Study|Patient moved to palliative care|1
1675843|NCT01432171|5853700|P2|Overall Study|Insurance denial trial coverage|0
1675844|NCT01432171|5853701|P1|Overall Study|Insurance denial trial coverage|1
1675845|NCT01432171|5853700|P2|Overall Study|Noncompliance|3
1675846|NCT01432171|5853701|P1|Overall Study|Noncompliance|2
1675847|NCT01432171|5853700|P2|Overall Study|Withdrawal by Subject|1
1675848|NCT01432171|5853701|P1|Overall Study|Withdrawal by Subject|3
1675849|NCT01432171|5853700|P2|Overall Study|Lost to Follow-up|5
1675850|NCT01432171|5853701|P1|Overall Study|Lost to Follow-up|6
1675851|NCT01432171|5853700|P2|Overall Study|Death|2
1675852|NCT01432171|5853701|P1|Overall Study|Death|1
1675853|NCT01431976|5853742|P1|Overall Study|Withdrawal by Subject|1
1675854|NCT01431976|5853742|P1|Overall Study|Physician Decision|1
1675855|NCT01431976|5853742|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
1675856|NCT01431976|5853742|P1|Overall Study|Lack of Efficacy|2
1675857|NCT01431976|5853742|P1|Overall Study|Adverse Event|6
1675858|NCT01431963|5853753|P1|Overall Study|Withdrawal by Subject|3
1675859|NCT01431963|5853753|P1|Overall Study|Physician Decision|4
1675860|NCT01431963|5853753|P1|Overall Study|Protocol-defined Stopping Criteria|2
1675861|NCT01431963|5853753|P1|Overall Study|Protocol Violation|1
1675862|NCT01431963|5853753|P1|Overall Study|Lack of Efficacy|7
1675863|NCT01431963|5853753|P1|Overall Study|Adverse Event|18
1675864|NCT01431950|5853761|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1675865|NCT01431950|5853762|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
1675866|NCT01431950|5853761|P2|Overall Study|Lost to Follow-up|1
1675867|NCT01431950|5853762|P1|Overall Study|Lost to Follow-up|0
1675868|NCT01431950|5853761|P2|Overall Study|Lack of Efficacy|1
1675869|NCT01431950|5853762|P1|Overall Study|Lack of Efficacy|2
1675870|NCT01431950|5853761|P2|Overall Study|Physician Decision|1
1675871|NCT01431950|5853762|P1|Overall Study|Physician Decision|2
1675872|NCT01431950|5853761|P2|Overall Study|Adverse Event|2
1675873|NCT01431950|5853762|P1|Overall Study|Adverse Event|2
1675874|NCT01431950|5853761|P2|Overall Study|Protocol Violation|3
1675875|NCT01431950|5853762|P1|Overall Study|Protocol Violation|2
1675876|NCT01431950|5853761|P2|Overall Study|Withdrawal by Subject|3
1675877|NCT01431950|5853762|P1|Overall Study|Withdrawal by Subject|4
1675878|NCT01431950|5853761|P2|Overall Study|Study Site Closed/Terminated|3
1675879|NCT01431950|5853762|P1|Overall Study|Study Site Closed/Terminated|7
1675880|NCT01431716|5853827|P1|Overall Study|Withdrawal of consent|1
1675881|NCT01431534|5853851|P3|Treatment Phase|Progressive Disease|10
1675882|NCT01431534|5853852|P2|Treatment Phase|Progressive Disease|3
1675883|NCT01431534|5853853|P1|Treatment Phase|Progressive Disease|4
1675884|NCT01431534|5853851|P3|Treatment Phase|Adverse Event|1
1675885|NCT01431534|5853852|P2|Treatment Phase|Adverse Event|0
1675886|NCT01431534|5853853|P1|Treatment Phase|Adverse Event|0
1675887|NCT01431521|5853868|P4|Overall Study|Withdrawal by Subject|0
1675888|NCT01431521|5853869|P3|Overall Study|Withdrawal by Subject|1
1675889|NCT01431521|5853870|P2|Overall Study|Withdrawal by Subject|0
1675890|NCT01431521|5853871|P1|Overall Study|Withdrawal by Subject|0
1675891|NCT01431508|5853892|P1|Overall Study|Unable to Follow Protocol Procedures|1
1675892|NCT01431508|5853892|P1|Overall Study|Lack of Efficacy|1
1675893|NCT01431287|5853977|P5|Overall Study|not stated above|1
1675894|NCT01431287|5853978|P4|Overall Study|not stated above|2
1675895|NCT01431287|5853979|P3|Overall Study|not stated above|2
1675896|NCT01431287|5853980|P2|Overall Study|not stated above|2
1675897|NCT01431287|5853981|P1|Overall Study|not stated above|4
1675898|NCT01431287|5853977|P5|Overall Study|Consent withdrawn not due to AE|29
1675899|NCT01431287|5853978|P4|Overall Study|Consent withdrawn not due to AE|19
1675900|NCT01431287|5853979|P3|Overall Study|Consent withdrawn not due to AE|34
1675901|NCT01431287|5853980|P2|Overall Study|Consent withdrawn not due to AE|30
1675902|NCT01431287|5853981|P1|Overall Study|Consent withdrawn not due to AE|29
1675903|NCT01431287|5853977|P5|Overall Study|Lost to Follow-up|1
1675904|NCT01431287|5853978|P4|Overall Study|Lost to Follow-up|3
1675905|NCT01431287|5853979|P3|Overall Study|Lost to Follow-up|2
1675906|NCT01431287|5853980|P2|Overall Study|Lost to Follow-up|3
1675907|NCT01431287|5853981|P1|Overall Study|Lost to Follow-up|0
1675908|NCT01431287|5853977|P5|Overall Study|Non compliant with protocol|5
1675909|NCT01431287|5853978|P4|Overall Study|Non compliant with protocol|6
1675910|NCT01431287|5853979|P3|Overall Study|Non compliant with protocol|5
1675911|NCT01431287|5853980|P2|Overall Study|Non compliant with protocol|6
1675912|NCT01431287|5853981|P1|Overall Study|Non compliant with protocol|6
1675913|NCT01431287|5853977|P5|Overall Study|Adverse Event|41
1675914|NCT01431287|5853978|P4|Overall Study|Adverse Event|33
1675915|NCT01431287|5853979|P3|Overall Study|Adverse Event|53
1675916|NCT01431287|5853980|P2|Overall Study|Adverse Event|57
1675917|NCT01431287|5853981|P1|Overall Study|Adverse Event|59
1675918|NCT01431287|5853977|P5|Overall Study|not treated|0
1675919|NCT01431287|5853978|P4|Overall Study|not treated|0
1675920|NCT01431287|5853979|P3|Overall Study|not treated|1
1675921|NCT01431287|5853980|P2|Overall Study|not treated|0
1675922|NCT01431287|5853981|P1|Overall Study|not treated|0
1675923|NCT01431274|5854143|P5|Overall Study|Other reason not stated above|4
1675924|NCT01431274|5854144|P4|Overall Study|Other reason not stated above|2
1675925|NCT01431274|5854145|P3|Overall Study|Other reason not stated above|7
1675926|NCT01431274|5854146|P2|Overall Study|Other reason not stated above|5
1675927|NCT01431274|5854147|P1|Overall Study|Other reason not stated above|6
1675928|NCT01431274|5854143|P5|Overall Study|Lost to Follow-up|0
1675929|NCT01431274|5854144|P4|Overall Study|Lost to Follow-up|4
1675930|NCT01431274|5854145|P3|Overall Study|Lost to Follow-up|1
1675931|NCT01431274|5854146|P2|Overall Study|Lost to Follow-up|7
1675932|NCT01431274|5854147|P1|Overall Study|Lost to Follow-up|6
1675933|NCT01431274|5854143|P5|Overall Study|Non compliant with protocol|4
1675934|NCT01431274|5854144|P4|Overall Study|Non compliant with protocol|4
1675935|NCT01431274|5854145|P3|Overall Study|Non compliant with protocol|4
1675936|NCT01431274|5854146|P2|Overall Study|Non compliant with protocol|8
1675937|NCT01431274|5854147|P1|Overall Study|Non compliant with protocol|5
1675938|NCT01431274|5854143|P5|Overall Study|Consent withdrawn not due to AE|11
1675939|NCT01431274|5854144|P4|Overall Study|Consent withdrawn not due to AE|20
1675940|NCT01431274|5854145|P3|Overall Study|Consent withdrawn not due to AE|17
1675941|NCT01431274|5854146|P2|Overall Study|Consent withdrawn not due to AE|20
1675942|NCT01431274|5854147|P1|Overall Study|Consent withdrawn not due to AE|29
1675943|NCT01431274|5854143|P5|Overall Study|Adverse Event|37
1675944|NCT01431274|5854144|P4|Overall Study|Adverse Event|30
1675945|NCT01431274|5854145|P3|Overall Study|Adverse Event|43
1675946|NCT01431274|5854146|P2|Overall Study|Adverse Event|37
1675947|NCT01431274|5854147|P1|Overall Study|Adverse Event|51
1675948|NCT01431144|5854325|P2|Overall Study|Implant mobility and removal|0
1675949|NCT01431144|5854326|P1|Overall Study|Implant mobility and removal|2
1675950|NCT01431079|5854349|P2|Overall Study|Lost to Follow-up|39
1675951|NCT01431079|5854350|P1|Overall Study|Lost to Follow-up|35
1675952|NCT01430754|5854429|P2|Run-In Phase|Lost to Follow-up|0
1675953|NCT01430754|5854430|P1|Run-In Phase|Lost to Follow-up|1
1675954|NCT01430754|5854429|P2|Run-In Phase|Withdrawal by Subject|0
1675955|NCT01430754|5854430|P1|Run-In Phase|Withdrawal by Subject|2
1675956|NCT01430754|5854429|P2|Run-In Phase|Other|0
1675957|NCT01430754|5854430|P1|Run-In Phase|Other|2
1675958|NCT01430754|5854429|P2|Run-In Phase|Adverse Event|0
1675959|NCT01430754|5854430|P1|Run-In Phase|Adverse Event|2
1675960|NCT01430754|5854429|P2|Run-In Phase|Protocol Violation|0
1675961|NCT01430754|5854430|P1|Run-In Phase|Protocol Violation|6
1675962|NCT01430754|5854429|P2|Run-In Phase|Circadian Period Ineligible|0
1675963|NCT01430754|5854430|P1|Run-In Phase|Circadian Period Ineligible|24
1675964|NCT01430624|5854488|P3|Overall Study|technical or eligibility|2
1675965|NCT01430624|5854489|P2|Overall Study|technical or eligibility|5
1675966|NCT01430624|5854490|P1|Overall Study|technical or eligibility|5
1675967|NCT01430624|5854488|P3|Overall Study|Lost to Follow-up|27
1675968|NCT01430624|5854489|P2|Overall Study|Lost to Follow-up|29
1675969|NCT01430624|5854490|P1|Overall Study|Lost to Follow-up|23
1675970|NCT01430611|5854521|P2|Overall Study|Withdrawal by Subject|14
1675971|NCT01430611|5854522|P1|Overall Study|Withdrawal by Subject|15
1675972|NCT01430611|5854521|P2|Overall Study|Lost to Follow-up|0
1675973|NCT01430611|5854522|P1|Overall Study|Lost to Follow-up|1
1675974|NCT01430611|5854521|P2|Overall Study|Protocol Violation|0
1675975|NCT01430611|5854522|P1|Overall Study|Protocol Violation|1
1675976|NCT01430611|5854521|P2|Overall Study|Adverse Event|1
1675977|NCT01430611|5854522|P1|Overall Study|Adverse Event|0
1675978|NCT01430585|5854540|P1|Overall Study|Other|7
1675979|NCT01430585|5854540|P1|Overall Study|Study Terminated by Sponsor|3
1675980|NCT01430585|5854540|P1|Overall Study|Objective Progression or Relapse|3
1675981|NCT01430585|5854540|P1|Overall Study|Death|1
1675982|NCT01430468|5854575|P2|Overall Study|Withdrawal by Subject|1
1675983|NCT01430468|5854576|P1|Overall Study|Withdrawal by Subject|1
1675984|NCT01430468|5854575|P2|Overall Study|Physician Decision|1
1675985|NCT01430468|5854576|P1|Overall Study|Physician Decision|2
1675986|NCT01430455|5854582|P1|Overall Study|Switched to follow-up phase|1
1675987|NCT01430455|5854582|P1|Overall Study|Withdrawal by Subject|1
1675988|NCT01430403|5854589|P3|Overall Study|Withdrawal by Subject|3
1675989|NCT01430403|5854590|P2|Overall Study|Withdrawal by Subject|1
1675990|NCT01430403|5854591|P1|Overall Study|Withdrawal by Subject|9
1675991|NCT01430403|5854589|P3|Overall Study|Protocol Violation|2
1675992|NCT01430403|5854590|P2|Overall Study|Protocol Violation|3
1675993|NCT01430403|5854591|P1|Overall Study|Protocol Violation|2
1675994|NCT01430403|5854589|P3|Overall Study|Physician Decision|0
1675995|NCT01430403|5854590|P2|Overall Study|Physician Decision|0
1675996|NCT01430403|5854591|P1|Overall Study|Physician Decision|1
1675997|NCT01430403|5854589|P3|Overall Study|Lost to Follow-up|3
1675998|NCT01430403|5854590|P2|Overall Study|Lost to Follow-up|5
1675999|NCT01430403|5854591|P1|Overall Study|Lost to Follow-up|5
1676000|NCT01430130|5854698|P1|Overall Study|Infection on Control Side of Incision|1
1676001|NCT01430130|5854698|P1|Overall Study|Lost to Follow-up|1
1676002|NCT01430104|5854704|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
1676003|NCT01429792|5854771|P1|Overall Study|Lost to Follow-up|88
1676004|NCT01429792|5854771|P1|Overall Study|Withdrawal by Subject|70
1676005|NCT01429792|5854771|P1|Overall Study|Positive HCV-RNA at Week 24|50
1676006|NCT01429792|5854771|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
1676007|NCT01429792|5854771|P1|Overall Study|Negative HCV-RNA at Week 12|4
1676008|NCT01429792|5854771|P1|Overall Study|Negative HCV-RNA at Week 4|1
1676009|NCT01429792|5854771|P1|Overall Study|Unknown Disposition|94
1676010|NCT01429792|5854771|P1|Overall Study|Other Reasons|67
1676011|NCT01429623|5854785|P2|Overall Study|No post baseline data|4
1676012|NCT01429623|5854786|P1|Overall Study|No post baseline data|4
1676013|NCT01429623|5854785|P2|Overall Study|Conversion to Alzheimer's disease|21
1676014|NCT01429623|5854786|P1|Overall Study|Conversion to Alzheimer's disease|14
1676015|NCT01429623|5854785|P2|Overall Study|Assorted|2
1676016|NCT01429623|5854786|P1|Overall Study|Assorted|1
1676017|NCT01429623|5854785|P2|Overall Study|Protocol Violation|2
1676018|NCT01429623|5854786|P1|Overall Study|Protocol Violation|3
1676019|NCT01429623|5854785|P2|Overall Study|Physician Decision|3
1676020|NCT01429623|5854786|P1|Overall Study|Physician Decision|2
1676021|NCT01429623|5854785|P2|Overall Study|Withdrawal by Subject|13
1676022|NCT01429623|5854786|P1|Overall Study|Withdrawal by Subject|19
1676023|NCT01429623|5854785|P2|Overall Study|Adverse Event|14
1676024|NCT01429623|5854786|P1|Overall Study|Adverse Event|7
1676025|NCT01429623|5854785|P2|Overall Study|Death|0
1676026|NCT01429623|5854786|P1|Overall Study|Death|1
1676027|NCT01429584|5854800|P2|Overall Study|Protocol Violation|1
1676028|NCT01429584|5854801|P1|Overall Study|Protocol Violation|0
1676029|NCT01429584|5854800|P2|Overall Study|Withdrawal by Subject|0
1676030|NCT01429584|5854801|P1|Overall Study|Withdrawal by Subject|1
1676031|NCT01429441|5854832|P2|Overall Study|Withdrawal by Subject|18
1676032|NCT01429441|5854833|P1|Overall Study|Withdrawal by Subject|27
1676033|NCT01429441|5854832|P2|Overall Study|Physician Decision|0
1676034|NCT01429441|5854833|P1|Overall Study|Physician Decision|1
1676035|NCT01429441|5854832|P2|Overall Study|Lost to Follow-up|2
1676036|NCT01429441|5854833|P1|Overall Study|Lost to Follow-up|5
1676037|NCT01429441|5854832|P2|Overall Study|Death|2
1676038|NCT01429441|5854833|P1|Overall Study|Death|0
1676039|NCT01429441|5854832|P2|Overall Study|Adverse Event|1
1676040|NCT01429441|5854833|P1|Overall Study|Adverse Event|5
1676041|NCT01429298|5854843|P2|Overall Study|Protocol Violation|6
1676042|NCT01429298|5854844|P1|Overall Study|Protocol Violation|4
1676043|NCT01429285|5854860|P2|Overall Study|Erroneously Enrolled Twice|2
1676044|NCT01429285|5854861|P1|Overall Study|Erroneously Enrolled Twice|8
1676045|NCT01429285|5854860|P2|Overall Study|Missing Data|3
1676046|NCT01429285|5854861|P1|Overall Study|Missing Data|5
1676047|NCT01429285|5854860|P2|Overall Study|Protocol Violation|4
1676048|NCT01429285|5854861|P1|Overall Study|Protocol Violation|9
1676049|NCT01429077|5854907|P2|Overall Study|Lost to Follow-up|3
1676050|NCT01429077|5854908|P1|Overall Study|Lost to Follow-up|0
1676051|NCT01429051|5854931|P1|Tolerability Phase|Other|2
1676052|NCT01429051|5854931|P1|Tolerability Phase|Physician Decision|1
1676053|NCT01429051|5854931|P1|Tolerability Phase|Withdrawal by Subject|5
1676054|NCT01429051|5854931|P1|Tolerability Phase|Adverse Event|2
1676055|NCT01429051|5854931|P1|Tolerability Phase|Death|5
1676056|NCT01429051|5854931|P1|Efficacy Phase|Death|1
1676057|NCT01429051|5854931|P1|Efficacy Phase|Adverse Event|1
1676058|NCT01429051|5854931|P1|Titration Phase|Less than 3 BTP episodes per week|2
1676059|NCT01429051|5854931|P1|Titration Phase|Unsuccessful titration at any dose|1
1676060|NCT01429051|5854931|P1|Titration Phase|Physician Decision|1
1676061|NCT01429051|5854931|P1|Titration Phase|Withdrawal by Subject|7
1676062|NCT01429051|5854931|P1|Titration Phase|Death|1
1676063|NCT01428882|5854954|P2|Overall Study|Protocol Violation|3
1676064|NCT01428882|5854955|P1|Overall Study|Protocol Violation|4
1676065|NCT01428882|5854954|P2|Overall Study|Lack of Efficacy|7
1676066|NCT01428882|5854955|P1|Overall Study|Lack of Efficacy|2
1676067|NCT01428713|5854978|P2|Overall Study|Adverse Event|2
1676068|NCT01428713|5854979|P1|Overall Study|Adverse Event|0
1676069|NCT01428713|5854978|P2|Overall Study|Withdrawal by Subject|1
1676070|NCT01428713|5854979|P1|Overall Study|Withdrawal by Subject|1
1676071|NCT01428713|5854978|P2|Overall Study|Non-compliance|2
1676072|NCT01428713|5854979|P1|Overall Study|Non-compliance|2
1676073|NCT01428661|5854988|P3|Open Label Extension|**Various|185
1676074|NCT01428661|5854989|P2|Open Label Extension|**Various|0
1676075|NCT01428661|5854990|P1|Open Label Extension|**Various|0
1676076|NCT01428661|5854988|P3|Open Label Extension|Lack of Efficacy|24
1676077|NCT01428661|5854989|P2|Open Label Extension|Lack of Efficacy|0
1676078|NCT01428661|5854990|P1|Open Label Extension|Lack of Efficacy|0
1676079|NCT01428661|5854988|P3|Open Label Extension|Withdrawal by Subject|49
1676080|NCT01428661|5854989|P2|Open Label Extension|Withdrawal by Subject|0
1676081|NCT01428661|5854990|P1|Open Label Extension|Withdrawal by Subject|0
1676082|NCT01428661|5854988|P3|Open Label Extension|Lost to Follow-up|38
1676083|NCT01428661|5854989|P2|Open Label Extension|Lost to Follow-up|0
1676084|NCT01428661|5854990|P1|Open Label Extension|Lost to Follow-up|0
1676085|NCT01428661|5854988|P3|Open Label Extension|Adverse Event|15
1676086|NCT01428661|5854989|P2|Open Label Extension|Adverse Event|0
1676087|NCT01428661|5854990|P1|Open Label Extension|Adverse Event|0
1676088|NCT01428661|5854988|P3|Open Label Extension|Protocol Violation|9
1676089|NCT01428661|5854989|P2|Open Label Extension|Protocol Violation|0
1676090|NCT01428661|5854990|P1|Open Label Extension|Protocol Violation|0
1676091|NCT01428661|5854988|P3|Double-Masked Phase|*Various|0
1676092|NCT01428661|5854989|P2|Double-Masked Phase|*Various|6
1676093|NCT01428661|5854990|P1|Double-Masked Phase|*Various|1
1676094|NCT01428661|5854988|P3|Double-Masked Phase|Lack of Efficacy|0
1676095|NCT01428661|5854989|P2|Double-Masked Phase|Lack of Efficacy|1
1676096|NCT01428661|5854990|P1|Double-Masked Phase|Lack of Efficacy|2
1676097|NCT01428661|5854988|P3|Double-Masked Phase|Withdrawal by Subject|0
1676098|NCT01428661|5854989|P2|Double-Masked Phase|Withdrawal by Subject|20
1676099|NCT01428661|5854990|P1|Double-Masked Phase|Withdrawal by Subject|18
1676100|NCT01428661|5854988|P3|Double-Masked Phase|Lost to Follow-up|0
1676101|NCT01428661|5854989|P2|Double-Masked Phase|Lost to Follow-up|14
1676102|NCT01428661|5854990|P1|Double-Masked Phase|Lost to Follow-up|14
1676103|NCT01428661|5854988|P3|Double-Masked Phase|Adverse Event|0
1676104|NCT01428661|5854989|P2|Double-Masked Phase|Adverse Event|4
1676105|NCT01428661|5854990|P1|Double-Masked Phase|Adverse Event|13
1676106|NCT01428661|5854988|P3|Double-Masked Phase|Protocol Violation|0
1676107|NCT01428661|5854989|P2|Double-Masked Phase|Protocol Violation|4
1676108|NCT01428661|5854990|P1|Double-Masked Phase|Protocol Violation|9
1676109|NCT01428583|5854998|P1|Overall Study|Other|6
1676110|NCT01428583|5854998|P1|Overall Study|Sponsor’s request|3
1676111|NCT01428583|5854998|P1|Overall Study|Confirmed positive urine drug test|8
1676112|NCT01428583|5854998|P1|Overall Study|Non-compliant|25
1676113|NCT01428583|5854998|P1|Overall Study|Physician Decision|12
1676114|NCT01428583|5854998|P1|Overall Study|Protocol Violation|1
1676115|NCT01428583|5854998|P1|Overall Study|Pregnancy|1
1676116|NCT01428583|5854998|P1|Overall Study|Death|1
1676117|NCT01428583|5854998|P1|Overall Study|Lost to Follow-up|17
1676118|NCT01428583|5854998|P1|Overall Study|Lack of Efficacy|37
1676119|NCT01428583|5854998|P1|Overall Study|Withdrawal by Subject|51
1676120|NCT01428583|5854998|P1|Overall Study|Adverse Event|75
1676121|NCT01428453|5855022|P2|Overall Study|Withdrawal by Subject|1
1676122|NCT01428453|5855023|P1|Overall Study|Withdrawal by Subject|3
1676123|NCT01428453|5855022|P2|Overall Study|Lost to Follow-up|1
1676124|NCT01428453|5855023|P1|Overall Study|Lost to Follow-up|0
1676125|NCT01428453|5855022|P2|Overall Study|Protocol Violation|0
1676126|NCT01428453|5855023|P1|Overall Study|Protocol Violation|1
1676127|NCT01428453|5855022|P2|Overall Study|Adverse Event|7
1676128|NCT01428453|5855023|P1|Overall Study|Adverse Event|2
1676129|NCT01428258|5855062|P2|Intervention 1|Withdrawal by Subject|0
1676130|NCT01428258|5855063|P1|Intervention 1|Withdrawal by Subject|2
1676131|NCT01428219|5855081|P1|Overall Study|25 patients enrolled, 3 were not treated|3
1676132|NCT01428193|5855092|P1|Overall Study|Elevated screening liver enzymes|1
1676133|NCT01428193|5855092|P1|Overall Study|Physician Decision|1
1676134|NCT01428128|5855096|P1|Overall Study|Adverse Event|1
1676135|NCT01428128|5855096|P1|Overall Study|Received Neulasta in one cycle|2
1676136|NCT01428128|5855096|P1|Overall Study|Screen failure by p53|10
1676137|NCT01428128|5855096|P1|Overall Study|Withdrawal by Subject|4
1676138|NCT01428115|5855101|P1|Overall Study|Withdrawal by Subject|4
1676139|NCT01428115|5855101|P1|Overall Study|Protocol Violation|3
1676140|NCT01428115|5855101|P1|Overall Study|Pregnancy|1
1676141|NCT01428115|5855101|P1|Overall Study|Lost to Follow-up|10
1676142|NCT01428115|5855101|P1|Overall Study|Lack of Efficacy|3
1676143|NCT01428076|5855116|P2|Overall Study|Adverse Event|1
1676144|NCT01428076|5855117|P1|Overall Study|Adverse Event|0
1676145|NCT01428063|5855128|P3|Overall Study|No longer meets study criteria|0
1676146|NCT01428063|5855129|P2|Overall Study|No longer meets study criteria|1
1676147|NCT01428063|5855130|P1|Overall Study|No longer meets study criteria|0
1676148|NCT01428063|5855128|P3|Overall Study|Lost to Follow-up|0
1676149|NCT01428063|5855129|P2|Overall Study|Lost to Follow-up|2
1676150|NCT01428063|5855130|P1|Overall Study|Lost to Follow-up|0
1676151|NCT01428063|5855128|P3|Overall Study|Adverse Event|0
1676152|NCT01428063|5855129|P2|Overall Study|Adverse Event|3
1676153|NCT01428063|5855130|P1|Overall Study|Adverse Event|2
1676154|NCT01428063|5855128|P3|Overall Study|Lack of Efficacy|1
1676155|NCT01428063|5855129|P2|Overall Study|Lack of Efficacy|4
1676156|NCT01428063|5855130|P1|Overall Study|Lack of Efficacy|8
1676157|NCT01427972|5855231|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676158|NCT01427972|5855232|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676159|NCT01427972|5855233|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676160|NCT01427972|5855234|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676161|NCT01427972|5855235|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676162|NCT01427972|5855236|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676163|NCT01427972|5855237|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676164|NCT01427972|5855238|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676165|NCT01427972|5855239|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676166|NCT01427972|5855240|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676167|NCT01427972|5855241|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
1676168|NCT01427972|5855242|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
1676169|NCT01427972|5855231|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676170|NCT01427972|5855232|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676171|NCT01427972|5855233|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676172|NCT01427972|5855234|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676173|NCT01427972|5855235|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676174|NCT01427972|5855236|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676175|NCT01427972|5855237|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
1676176|NCT01427972|5855238|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676177|NCT01427972|5855239|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676178|NCT01427972|5855240|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676179|NCT01427972|5855241|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676180|NCT01427972|5855242|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
1676181|NCT01427972|5855231|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
1676182|NCT01427972|5855232|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
1676183|NCT01427972|5855233|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
1676184|NCT01427972|5855234|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
1676185|NCT01427972|5855235|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
1676186|NCT01427972|5855236|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
1676187|NCT01427972|5855237|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
1676188|NCT01427972|5855238|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
1676189|NCT01427972|5855239|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
1676190|NCT01427972|5855240|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
1676191|NCT01427972|5855241|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
1676192|NCT01427972|5855242|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
1676193|NCT01427933|5855268|P2|Overall Study|Investigator's Decision|0
1676194|NCT01427933|5855269|P1|Overall Study|Investigator's Decision|1
1676195|NCT01427933|5855268|P2|Overall Study|Other|0
1676196|NCT01427933|5855269|P1|Overall Study|Other|1
1676197|NCT01427933|5855268|P2|Overall Study|Lost to Follow-up|5
1676198|NCT01427933|5855269|P1|Overall Study|Lost to Follow-up|1
1676199|NCT01427933|5855268|P2|Overall Study|Withdrawal by Subject|8
1676200|NCT01427933|5855269|P1|Overall Study|Withdrawal by Subject|5
1676201|NCT01427920|5855289|P2|Overall Study|Unclassified|8
1676202|NCT01427920|5855290|P1|Overall Study|Unclassified|2
1676203|NCT01427920|5855289|P2|Overall Study|Withdrawal Criteria|4
1676204|NCT01427920|5855290|P1|Overall Study|Withdrawal Criteria|4
1676205|NCT01427920|5855289|P2|Overall Study|Protocol Violation|3
1676206|NCT01427920|5855290|P1|Overall Study|Protocol Violation|1
1676207|NCT01427920|5855289|P2|Overall Study|Lack of Efficacy|0
1676208|NCT01427920|5855290|P1|Overall Study|Lack of Efficacy|1
1676209|NCT01427920|5855289|P2|Overall Study|Adverse Event|2
1676210|NCT01427920|5855290|P1|Overall Study|Adverse Event|1
1676211|NCT01427907|5855310|P2|Overall Study|Withdrawal by Subject|4
1676212|NCT01427907|5855311|P1|Overall Study|Withdrawal by Subject|3
1676213|NCT01427803|5855332|P2|Overall Study|did not take product|0
1676214|NCT01427803|5855333|P1|Overall Study|did not take product|1
1676215|NCT01427803|5855332|P2|Overall Study|Physician Decision|0
1676216|NCT01427803|5855333|P1|Overall Study|Physician Decision|3
1676217|NCT01427803|5855332|P2|Overall Study|Protocol Violation|0
1676218|NCT01427803|5855333|P1|Overall Study|Protocol Violation|1
1676219|NCT01427803|5855332|P2|Overall Study|Unable to complete full treatment period|0
1676220|NCT01427803|5855333|P1|Overall Study|Unable to complete full treatment period|6
1676221|NCT01427803|5855332|P2|Overall Study|Withdrawal by Subject|0
1676222|NCT01427803|5855333|P1|Overall Study|Withdrawal by Subject|20
1676223|NCT01427803|5855332|P2|Overall Study|Lost to Follow-up|26
1676224|NCT01427803|5855333|P1|Overall Study|Lost to Follow-up|32
1676225|NCT01427751|5855347|P2|Overall Study|Other miscellaneous reasons|4
1676226|NCT01427751|5855348|P1|Overall Study|Other miscellaneous reasons|6
1676227|NCT01427751|5855347|P2|Overall Study|Death|0
1676228|NCT01427751|5855348|P1|Overall Study|Death|2
1676229|NCT01427751|5855347|P2|Overall Study|Protocol Violation|4
1676230|NCT01427751|5855348|P1|Overall Study|Protocol Violation|6
1676231|NCT01427751|5855347|P2|Overall Study|Withdrawal of consent|2
1676232|NCT01427751|5855348|P1|Overall Study|Withdrawal of consent|2
1676233|NCT01427751|5855347|P2|Overall Study|Lost to Follow-up|1
1676234|NCT01427751|5855348|P1|Overall Study|Lost to Follow-up|3
1676235|NCT01427751|5855347|P2|Overall Study|No further treatment benefit expected|1
1676236|NCT01427751|5855348|P1|Overall Study|No further treatment benefit expected|5
1676237|NCT01427751|5855347|P2|Overall Study|Adverse Event|2
1676238|NCT01427751|5855348|P1|Overall Study|Adverse Event|18
1676239|NCT01427738|5855368|P2|Overall Study|Lost to Follow-up|5
1676240|NCT01427738|5855369|P1|Overall Study|Lost to Follow-up|1
1676241|NCT01427738|5855368|P2|Overall Study|Subject not willing to adhere to reqs|2
1676242|NCT01427738|5855369|P1|Overall Study|Subject not willing to adhere to reqs|1
1676243|NCT01427738|5855368|P2|Overall Study|Withdrawal by Subject|2
1676244|NCT01427738|5855369|P1|Overall Study|Withdrawal by Subject|0
1676245|NCT01427738|5855368|P2|Overall Study|Subject unable to get to clinic|2
1676246|NCT01427738|5855369|P1|Overall Study|Subject unable to get to clinic|5
1676247|NCT01427738|5855368|P2|Overall Study|Severe debilitation, unable to continue|1
1676248|NCT01427738|5855369|P1|Overall Study|Severe debilitation, unable to continue|0
1676249|NCT01427738|5855368|P2|Overall Study|Death|9
1676250|NCT01427738|5855369|P1|Overall Study|Death|12
1676251|NCT01427608|5855389|P2|Overall Study|Events not attributed to study meds|1
1676252|NCT01427608|5855390|P1|Overall Study|Events not attributed to study meds|0
1676253|NCT01427608|5855389|P2|Overall Study|Relapsed-all cause|34
1676254|NCT01427608|5855390|P1|Overall Study|Relapsed-all cause|13
1676255|NCT01427608|5855389|P2|Overall Study|Withdrawal by Subject|3
1676256|NCT01427608|5855390|P1|Overall Study|Withdrawal by Subject|7
1676257|NCT01427608|5855389|P2|Overall Study|Death|0
1676258|NCT01427608|5855390|P1|Overall Study|Death|1
1676259|NCT01427309|5855447|P4|Overall Study|Withdrawal by Subject|55
1676260|NCT01427309|5855448|P3|Overall Study|Withdrawal by Subject|61
1676261|NCT01427309|5855449|P2|Overall Study|Withdrawal by Subject|148
1676262|NCT01427309|5855450|P1|Overall Study|Withdrawal by Subject|148
1676263|NCT01427309|5855447|P4|Overall Study|Serious adverse event|61
1676264|NCT01427309|5855448|P3|Overall Study|Serious adverse event|50
1676265|NCT01427309|5855449|P2|Overall Study|Serious adverse event|45
1676266|NCT01427309|5855450|P1|Overall Study|Serious adverse event|52
1676267|NCT01427309|5855447|P4|Overall Study|Adverse Event|1
1676268|NCT01427309|5855448|P3|Overall Study|Adverse Event|3
1676269|NCT01427309|5855449|P2|Overall Study|Adverse Event|0
1676270|NCT01427309|5855450|P1|Overall Study|Adverse Event|0
1676271|NCT01427309|5855447|P4|Overall Study|Protocol Violation|124
1676272|NCT01427309|5855448|P3|Overall Study|Protocol Violation|125
1676273|NCT01427309|5855449|P2|Overall Study|Protocol Violation|69
1676274|NCT01427309|5855450|P1|Overall Study|Protocol Violation|42
1676275|NCT01427309|5855447|P4|Overall Study|Lost to Follow-up|135
1676276|NCT01427309|5855448|P3|Overall Study|Lost to Follow-up|122
1676277|NCT01427309|5855449|P2|Overall Study|Lost to Follow-up|145
1676278|NCT01427309|5855450|P1|Overall Study|Lost to Follow-up|130
1676279|NCT01426958|5855497|P1|Overall Study|Adverse Event|2
1676280|NCT01426854|5855526|P2|Overall Study|Other|2
1676281|NCT01426854|5855527|P1|Overall Study|Other|3
1676282|NCT01426854|5855526|P2|Overall Study|Protocol Deviation|1
1676283|NCT01426854|5855527|P1|Overall Study|Protocol Deviation|0
1676284|NCT01426854|5855526|P2|Overall Study|Treatment Failure|16
1676285|NCT01426854|5855527|P1|Overall Study|Treatment Failure|0
1676286|NCT01426854|5855526|P2|Overall Study|Noncompliance|1
1676287|NCT01426854|5855527|P1|Overall Study|Noncompliance|0
1676288|NCT01426854|5855526|P2|Overall Study|Lost to Follow-up|0
1676289|NCT01426854|5855527|P1|Overall Study|Lost to Follow-up|3
1676290|NCT01426854|5855526|P2|Overall Study|Subject Decision Unrelated to AE|6
1676291|NCT01426854|5855527|P1|Overall Study|Subject Decision Unrelated to AE|5
1676292|NCT01426854|5855526|P2|Overall Study|Adverse Event|5
1676293|NCT01426854|5855527|P1|Overall Study|Adverse Event|1
1676294|NCT01426789|5855537|P6|Part 2|Adverse Event|0
1676295|NCT01426789|5855538|P5|Part 2|Adverse Event|1
1676296|NCT01426789|5855539|P4|Part 2|Adverse Event|0
1676297|NCT01426789|5855540|P3|Part 2|Adverse Event|2
1676298|NCT01426789|5855541|P2|Part 2|Adverse Event|0
1676299|NCT01426789|5855542|P1|Part 2|Adverse Event|0
1676300|NCT01426789|5855537|P6|Part 2|Lack of Efficacy|0
1676301|NCT01426789|5855538|P5|Part 2|Lack of Efficacy|2
1676302|NCT01426789|5855539|P4|Part 2|Lack of Efficacy|0
1676303|NCT01426789|5855540|P3|Part 2|Lack of Efficacy|5
1676304|NCT01426789|5855541|P2|Part 2|Lack of Efficacy|0
1676305|NCT01426789|5855542|P1|Part 2|Lack of Efficacy|0
1676306|NCT01426789|5855537|P6|Part 2|Withdrawal by Subject|0
1676307|NCT01426789|5855538|P5|Part 2|Withdrawal by Subject|2
1676308|NCT01426789|5855539|P4|Part 2|Withdrawal by Subject|1
1676309|NCT01426789|5855540|P3|Part 2|Withdrawal by Subject|0
1676310|NCT01426789|5855541|P2|Part 2|Withdrawal by Subject|0
1676311|NCT01426789|5855542|P1|Part 2|Withdrawal by Subject|0
1676312|NCT01426789|5855537|P6|Part 2|Lost to Follow-up|0
1676313|NCT01426789|5855538|P5|Part 2|Lost to Follow-up|1
1676314|NCT01426789|5855539|P4|Part 2|Lost to Follow-up|0
1676315|NCT01426789|5855540|P3|Part 2|Lost to Follow-up|4
1676316|NCT01426789|5855541|P2|Part 2|Lost to Follow-up|0
1676317|NCT01426789|5855542|P1|Part 2|Lost to Follow-up|0
1676318|NCT01426789|5855537|P6|Part 2|Administrative problems|0
1676319|NCT01426789|5855538|P5|Part 2|Administrative problems|1
1676320|NCT01426789|5855539|P4|Part 2|Administrative problems|0
1676321|NCT01426789|5855540|P3|Part 2|Administrative problems|2
1676322|NCT01426789|5855541|P2|Part 2|Administrative problems|0
1676323|NCT01426789|5855542|P1|Part 2|Administrative problems|0
1676324|NCT01426789|5855537|P6|Part 2|Death|0
1676325|NCT01426789|5855538|P5|Part 2|Death|1
1676326|NCT01426789|5855539|P4|Part 2|Death|0
1676327|NCT01426789|5855540|P3|Part 2|Death|1
1676328|NCT01426789|5855541|P2|Part 2|Death|0
1676329|NCT01426789|5855542|P1|Part 2|Death|0
1676330|NCT01426789|5855537|P6|Part 2|Protocol deviation|0
1676331|NCT01426789|5855538|P5|Part 2|Protocol deviation|0
1676332|NCT01426789|5855539|P4|Part 2|Protocol deviation|0
1676333|NCT01426789|5855540|P3|Part 2|Protocol deviation|1
1676334|NCT01426789|5855541|P2|Part 2|Protocol deviation|0
1676335|NCT01426789|5855542|P1|Part 2|Protocol deviation|0
1676336|NCT01426789|5855537|P6|Part 1|Adverse Event|0
1676337|NCT01426789|5855538|P5|Part 1|Adverse Event|0
1676338|NCT01426789|5855539|P4|Part 1|Adverse Event|0
1676339|NCT01426789|5855540|P3|Part 1|Adverse Event|0
1676340|NCT01426789|5855541|P2|Part 1|Adverse Event|0
1676341|NCT01426789|5855542|P1|Part 1|Adverse Event|3
1676342|NCT01426789|5855537|P6|Part 1|Lack of Efficacy|0
1676343|NCT01426789|5855538|P5|Part 1|Lack of Efficacy|0
1676344|NCT01426789|5855539|P4|Part 1|Lack of Efficacy|0
1676345|NCT01426789|5855540|P3|Part 1|Lack of Efficacy|0
1676346|NCT01426789|5855541|P2|Part 1|Lack of Efficacy|1
1676347|NCT01426789|5855542|P1|Part 1|Lack of Efficacy|2
1676348|NCT01426789|5855537|P6|Part 1|Lost to Follow-up|0
1676349|NCT01426789|5855538|P5|Part 1|Lost to Follow-up|0
1676350|NCT01426789|5855539|P4|Part 1|Lost to Follow-up|0
1676351|NCT01426789|5855540|P3|Part 1|Lost to Follow-up|0
1676352|NCT01426789|5855541|P2|Part 1|Lost to Follow-up|2
1676353|NCT01426789|5855542|P1|Part 1|Lost to Follow-up|1
1676354|NCT01426789|5855537|P6|Part 1|Protocol deviation|0
1676355|NCT01426789|5855538|P5|Part 1|Protocol deviation|0
1676356|NCT01426789|5855539|P4|Part 1|Protocol deviation|0
1676357|NCT01426789|5855540|P3|Part 1|Protocol deviation|0
1676358|NCT01426789|5855541|P2|Part 1|Protocol deviation|1
1676359|NCT01426789|5855542|P1|Part 1|Protocol deviation|0
1676360|NCT01426438|5855604|P2|Overall Study|Missed Scan|2
1676361|NCT01426438|5855605|P1|Overall Study|Missed Scan|2
1676362|NCT01426438|5855604|P2|Overall Study|Poor scan quality|2
1676363|NCT01426438|5855605|P1|Overall Study|Poor scan quality|3
1676364|NCT01426438|5855604|P2|Overall Study|Off study Treatment|3
1676365|NCT01426438|5855605|P1|Overall Study|Off study Treatment|9
1676366|NCT01426438|5855604|P2|Overall Study|Lost to Follow-up|3
1676367|NCT01426438|5855605|P1|Overall Study|Lost to Follow-up|1
1676368|NCT01426425|5855637|P1|Overall Study|Met inclusion/exclusion, not treated|2
1676369|NCT01426425|5855637|P1|Overall Study|Inclusion/exclusion criteria not met|151
1676370|NCT01426425|5855637|P1|Overall Study|Exited prior to EP study|22
1676371|NCT01426412|5855652|P9|Overall Study|Withdrawal by Subject|1
1676372|NCT01426412|5855653|P8|Overall Study|Withdrawal by Subject|3
1676373|NCT01426412|5855654|P7|Overall Study|Withdrawal by Subject|0
1676374|NCT01426412|5855655|P6|Overall Study|Withdrawal by Subject|0
1676375|NCT01426412|5855656|P5|Overall Study|Withdrawal by Subject|1
1676376|NCT01426412|5855657|P4|Overall Study|Withdrawal by Subject|0
1676377|NCT01426412|5855658|P3|Overall Study|Withdrawal by Subject|0
1676378|NCT01426412|5855659|P2|Overall Study|Withdrawal by Subject|0
1676379|NCT01426412|5855660|P1|Overall Study|Withdrawal by Subject|1
1676380|NCT01426386|5855723|P6|Overall Study|Personal reasons|0
1676381|NCT01426386|5855724|P5|Overall Study|Personal reasons|1
1676382|NCT01426386|5855725|P4|Overall Study|Personal reasons|0
1676383|NCT01426386|5855726|P3|Overall Study|Personal reasons|0
1676384|NCT01426386|5855727|P2|Overall Study|Personal reasons|0
1676385|NCT01426386|5855728|P1|Overall Study|Personal reasons|0
1676386|NCT01426386|5855723|P6|Overall Study|Poor response|0
1676387|NCT01426386|5855724|P5|Overall Study|Poor response|1
1676388|NCT01426386|5855725|P4|Overall Study|Poor response|0
1676389|NCT01426386|5855726|P3|Overall Study|Poor response|2
1676390|NCT01426386|5855727|P2|Overall Study|Poor response|1
1676391|NCT01426386|5855728|P1|Overall Study|Poor response|2
1676392|NCT01426386|5855723|P6|Overall Study|Did not attend scheduled visit|1
1676393|NCT01426386|5855724|P5|Overall Study|Did not attend scheduled visit|2
1676394|NCT01426386|5855725|P4|Overall Study|Did not attend scheduled visit|0
1676395|NCT01426386|5855726|P3|Overall Study|Did not attend scheduled visit|0
1676396|NCT01426386|5855727|P2|Overall Study|Did not attend scheduled visit|4
1676397|NCT01426386|5855728|P1|Overall Study|Did not attend scheduled visit|1
1676398|NCT01426386|5855723|P6|Overall Study|Adverse Event|0
1676399|NCT01426386|5855724|P5|Overall Study|Adverse Event|0
1676400|NCT01426386|5855725|P4|Overall Study|Adverse Event|0
1676401|NCT01426386|5855726|P3|Overall Study|Adverse Event|0
1676402|NCT01426386|5855727|P2|Overall Study|Adverse Event|1
1676403|NCT01426386|5855728|P1|Overall Study|Adverse Event|0
1676404|NCT01426373|5855784|P1|Overall Study|Miscellaneous Reasons|4
1676405|NCT01426373|5855784|P1|Overall Study|Participant Convenience|10
1676406|NCT01426373|5855784|P1|Overall Study|Lost to Follow-up|14
1676407|NCT01426373|5855784|P1|Overall Study|Adverse Event|6
1676408|NCT01426347|5855817|P2|Overall Study|Withdrawal by Subject|0
1676409|NCT01426347|5855818|P1|Overall Study|Withdrawal by Subject|5
1676410|NCT01426347|5855817|P2|Overall Study|Protocol Violation|0
1676411|NCT01426347|5855818|P1|Overall Study|Protocol Violation|2
1676412|NCT01426347|5855817|P2|Overall Study|Lost to Follow-up|3
1676413|NCT01426347|5855818|P1|Overall Study|Lost to Follow-up|0
1676414|NCT01426269|5855826|P3|Period 2: 40 Weeks|Relapsed|18
1676415|NCT01426269|5855827|P2|Period 2: 40 Weeks|Relapsed|9
1676416|NCT01426269|5855828|P1|Period 2: 40 Weeks|Relapsed|0
1676417|NCT01426269|5855826|P3|Period 2: 40 Weeks|Site closed|5
1676418|NCT01426269|5855827|P2|Period 2: 40 Weeks|Site closed|6
1676419|NCT01426269|5855828|P1|Period 2: 40 Weeks|Site closed|0
1676420|NCT01426269|5855826|P3|Period 2: 40 Weeks|Lost to Follow-up|6
1676421|NCT01426269|5855827|P2|Period 2: 40 Weeks|Lost to Follow-up|8
1676422|NCT01426269|5855828|P1|Period 2: 40 Weeks|Lost to Follow-up|0
1676423|NCT01426269|5855826|P3|Period 2: 40 Weeks|Protocol Violation|5
1676424|NCT01426269|5855827|P2|Period 2: 40 Weeks|Protocol Violation|5
1676425|NCT01426269|5855828|P1|Period 2: 40 Weeks|Protocol Violation|0
1676426|NCT01426269|5855826|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
1676427|NCT01426269|5855827|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
1676428|NCT01426269|5855828|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
1676429|NCT01426269|5855826|P3|Period 2: 40 Weeks|Adverse Event|2
1676430|NCT01426269|5855827|P2|Period 2: 40 Weeks|Adverse Event|1
1676431|NCT01426269|5855828|P1|Period 2: 40 Weeks|Adverse Event|0
1676432|NCT01426269|5855826|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
1676433|NCT01426269|5855827|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
1676434|NCT01426269|5855828|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
1676435|NCT01426269|5855826|P3|Eligibility for Period 2, Randomization|Did not qualify|0
1676436|NCT01426269|5855827|P2|Eligibility for Period 2, Randomization|Did not qualify|0
1676437|NCT01426269|5855828|P1|Eligibility for Period 2, Randomization|Did not qualify|42
1676438|NCT01426269|5855826|P3|Period 1: 12 Weeks|Pregnancy|0
1676439|NCT01426269|5855827|P2|Period 1: 12 Weeks|Pregnancy|0
1676440|NCT01426269|5855828|P1|Period 1: 12 Weeks|Pregnancy|1
1676441|NCT01426269|5855826|P3|Period 1: 12 Weeks|Lost to Follow-up|0
1676442|NCT01426269|5855827|P2|Period 1: 12 Weeks|Lost to Follow-up|0
1676443|NCT01426269|5855828|P1|Period 1: 12 Weeks|Lost to Follow-up|22
1676444|NCT01426269|5855826|P3|Period 1: 12 Weeks|Protocol Violation|0
1676445|NCT01426269|5855827|P2|Period 1: 12 Weeks|Protocol Violation|0
1676446|NCT01426269|5855828|P1|Period 1: 12 Weeks|Protocol Violation|5
1676447|NCT01426269|5855826|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
1676448|NCT01426269|5855827|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
1676449|NCT01426269|5855828|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
1676450|NCT01426269|5855826|P3|Period 1: 12 Weeks|Adverse Event|0
1676451|NCT01426269|5855827|P2|Period 1: 12 Weeks|Adverse Event|0
1676452|NCT01426269|5855828|P1|Period 1: 12 Weeks|Adverse Event|5
1676453|NCT01426217|5855863|P2|Overall Study|lost sample|14
1676454|NCT01426217|5855864|P1|Overall Study|lost sample|8
1676455|NCT01426113|5855877|P2|Overall Study|Adverse Event|1
1676456|NCT01426113|5855878|P1|Overall Study|Adverse Event|0
1676457|NCT01426113|5855877|P2|Overall Study|Study Discontinued|1
1676458|NCT01426113|5855878|P1|Overall Study|Study Discontinued|1
1676459|NCT01426009|5855884|P1|Washout 4|Lost to Follow-up|1
1676460|NCT01426009|5855884|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
1676461|NCT01426009|5855884|P1|Washout 3|personal reasons|1
1676462|NCT01426009|5855884|P1|Washout 2|electrive surgery|1
1676463|NCT01426009|5855884|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
1676464|NCT01426009|5855884|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
1676465|NCT01426009|5855884|P1|Washout 1|Personal Reasons|1
1676466|NCT01426009|5855884|P1|Washout 1|Withdrawal by Subject|1
1676467|NCT01426009|5855884|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
1676468|NCT01426009|5855884|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
1676469|NCT01425814|5855980|P6|Period 5|Stability criteria not fulfilled|1
1676470|NCT01425814|5855981|P5|Period 5|Stability criteria not fulfilled|0
1676471|NCT01425814|5855982|P4|Period 5|Stability criteria not fulfilled|0
1676472|NCT01425814|5855983|P3|Period 5|Stability criteria not fulfilled|1
1676473|NCT01425814|5855984|P2|Period 5|Stability criteria not fulfilled|0
1676474|NCT01425814|5855985|P1|Period 5|Stability criteria not fulfilled|0
1676475|NCT01425814|5855980|P6|Period 4|Adverse Event|0
1676476|NCT01425814|5855981|P5|Period 4|Adverse Event|0
1676477|NCT01425814|5855982|P4|Period 4|Adverse Event|0
1676478|NCT01425814|5855983|P3|Period 4|Adverse Event|1
1676479|NCT01425814|5855984|P2|Period 4|Adverse Event|0
1676480|NCT01425814|5855985|P1|Period 4|Adverse Event|1
1676481|NCT01425814|5855980|P6|Period 3|Adverse Event|1
1676482|NCT01425814|5855981|P5|Period 3|Adverse Event|0
1676483|NCT01425814|5855982|P4|Period 3|Adverse Event|0
1676484|NCT01425814|5855983|P3|Period 3|Adverse Event|0
1676485|NCT01425814|5855984|P2|Period 3|Adverse Event|0
1676486|NCT01425814|5855985|P1|Period 3|Adverse Event|0
1676487|NCT01425814|5855980|P6|Period 2|Stability criteria not fulfilled|0
1676488|NCT01425814|5855981|P5|Period 2|Stability criteria not fulfilled|0
1676489|NCT01425814|5855982|P4|Period 2|Stability criteria not fulfilled|0
1676490|NCT01425814|5855983|P3|Period 2|Stability criteria not fulfilled|0
1676491|NCT01425814|5855984|P2|Period 2|Stability criteria not fulfilled|1
1676492|NCT01425814|5855985|P1|Period 2|Stability criteria not fulfilled|0
1676493|NCT01425814|5855980|P6|Period 1|Stability criteria not fulfilled|0
1676494|NCT01425814|5855981|P5|Period 1|Stability criteria not fulfilled|0
1676495|NCT01425814|5855982|P4|Period 1|Stability criteria not fulfilled|0
1676496|NCT01425814|5855983|P3|Period 1|Stability criteria not fulfilled|0
1676497|NCT01425814|5855984|P2|Period 1|Stability criteria not fulfilled|1
1676498|NCT01425814|5855985|P1|Period 1|Stability criteria not fulfilled|0
1676499|NCT01425801|5856077|P6|Period 4|Not able to maintain visit schedule|0
1676500|NCT01425801|5856078|P5|Period 4|Not able to maintain visit schedule|0
1676501|NCT01425801|5856079|P4|Period 4|Not able to maintain visit schedule|0
1676502|NCT01425801|5856080|P3|Period 4|Not able to maintain visit schedule|1
1676503|NCT01425801|5856081|P2|Period 4|Not able to maintain visit schedule|0
1676504|NCT01425801|5856082|P1|Period 4|Not able to maintain visit schedule|0
1676505|NCT01425801|5856077|P6|Period 3|Stability criteria not fullfilled|0
1676506|NCT01425801|5856078|P5|Period 3|Stability criteria not fullfilled|0
1676507|NCT01425801|5856079|P4|Period 3|Stability criteria not fullfilled|0
1676508|NCT01425801|5856080|P3|Period 3|Stability criteria not fullfilled|1
1676509|NCT01425801|5856081|P2|Period 3|Stability criteria not fullfilled|0
1676510|NCT01425801|5856082|P1|Period 3|Stability criteria not fullfilled|0
1676511|NCT01425801|5856077|P6|Period 2|Withdrawal by Subject|0
1676512|NCT01425801|5856078|P5|Period 2|Withdrawal by Subject|1
1676513|NCT01425801|5856079|P4|Period 2|Withdrawal by Subject|0
1676514|NCT01425801|5856080|P3|Period 2|Withdrawal by Subject|0
1676515|NCT01425801|5856081|P2|Period 2|Withdrawal by Subject|0
1676516|NCT01425801|5856082|P1|Period 2|Withdrawal by Subject|0
1676517|NCT01425801|5856077|P6|Period 1|Withdrawal by Subject|0
1676518|NCT01425801|5856078|P5|Period 1|Withdrawal by Subject|1
1676519|NCT01425801|5856079|P4|Period 1|Withdrawal by Subject|0
1676520|NCT01425801|5856080|P3|Period 1|Withdrawal by Subject|0
1676521|NCT01425801|5856081|P2|Period 1|Withdrawal by Subject|0
1676522|NCT01425801|5856082|P1|Period 1|Withdrawal by Subject|0
1676523|NCT01425749|5856188|P2|Overall Study|progression of melanoma|1
1676524|NCT01425749|5856189|P1|Overall Study|progression of melanoma|0
1676525|NCT01425723|5856206|P2|Overall Study|Other|10
1676526|NCT01425723|5856207|P1|Overall Study|Other|1
1676527|NCT01425723|5856206|P2|Overall Study|Physician Decision|0
1676528|NCT01425723|5856207|P1|Overall Study|Physician Decision|2
1676529|NCT01425723|5856206|P2|Overall Study|Lost to Follow-up|3
1676530|NCT01425723|5856207|P1|Overall Study|Lost to Follow-up|0
1676531|NCT01425723|5856206|P2|Overall Study|Withdrawal by Subject|4
1676532|NCT01425723|5856207|P1|Overall Study|Withdrawal by Subject|1
1676533|NCT01425723|5856206|P2|Overall Study|Lack of Efficacy|1
1676534|NCT01425723|5856207|P1|Overall Study|Lack of Efficacy|0
1676535|NCT01425632|5856237|P3|Overall Study|Withdrawal by Subject|1
1676536|NCT01425632|5856238|P2|Overall Study|Withdrawal by Subject|0
1676537|NCT01425632|5856239|P1|Overall Study|Withdrawal by Subject|0
1676538|NCT01425632|5856237|P3|Overall Study|Protocol Violation|2
1676539|NCT01425632|5856238|P2|Overall Study|Protocol Violation|0
1676540|NCT01425632|5856239|P1|Overall Study|Protocol Violation|0
1676541|NCT01425632|5856237|P3|Overall Study|Physician Decision|0
1676542|NCT01425632|5856238|P2|Overall Study|Physician Decision|0
1676543|NCT01425632|5856239|P1|Overall Study|Physician Decision|1
1676544|NCT01425632|5856237|P3|Overall Study|Adverse Event|1
1676545|NCT01425632|5856238|P2|Overall Study|Adverse Event|1
1676546|NCT01425632|5856239|P1|Overall Study|Adverse Event|0
1676547|NCT01425528|5856249|P2|Overall Study|Withdrawal by Subject|1
1676548|NCT01425528|5856250|P1|Overall Study|Withdrawal by Subject|1
1676549|NCT01425463|5856258|P2|Overall Study|Unknown Reason|7
1676550|NCT01425463|5856259|P1|Overall Study|Unknown Reason|4
1676551|NCT01425463|5856258|P2|Overall Study|Withdrawal by Subject|5
1676552|NCT01425463|5856259|P1|Overall Study|Withdrawal by Subject|7
1676553|NCT01425463|5856258|P2|Overall Study|Lost to Follow-up|2
1676554|NCT01425463|5856259|P1|Overall Study|Lost to Follow-up|5
1676555|NCT01425463|5856258|P2|Overall Study|Protocol Violation|2
1676556|NCT01425463|5856259|P1|Overall Study|Protocol Violation|2
1676557|NCT01425463|5856258|P2|Overall Study|Lack of Efficacy|1
1676558|NCT01425463|5856259|P1|Overall Study|Lack of Efficacy|1
1676559|NCT01425463|5856258|P2|Overall Study|Adverse Event|7
1676560|NCT01425463|5856259|P1|Overall Study|Adverse Event|5
1676561|NCT01425359|5856275|P2|Overall Study|Did Not Meet Qualifying Criteria|5
1676562|NCT01425359|5856276|P1|Overall Study|Did Not Meet Qualifying Criteria|3
1676563|NCT01425359|5856275|P2|Overall Study|Investigator’s Discretion|0
1676564|NCT01425359|5856276|P1|Overall Study|Investigator’s Discretion|2
1676565|NCT01425359|5856275|P2|Overall Study|Subject Withdrew Consent|2
1676566|NCT01425359|5856276|P1|Overall Study|Subject Withdrew Consent|1
1676567|NCT01425359|5856275|P2|Overall Study|Protocol Violation|2
1676568|NCT01425359|5856276|P1|Overall Study|Protocol Violation|1
1676569|NCT01425359|5856275|P2|Overall Study|Unsatisfactory Response|0
1676570|NCT01425359|5856276|P1|Overall Study|Unsatisfactory Response|1
1676571|NCT01425359|5856275|P2|Overall Study|Death|1
1676572|NCT01425359|5856276|P1|Overall Study|Death|0
1676573|NCT01425359|5856275|P2|Overall Study|Revascularization|1
1676574|NCT01425359|5856276|P1|Overall Study|Revascularization|0
1676575|NCT01425359|5856275|P2|Overall Study|Adverse Event|8
1676576|NCT01425359|5856276|P1|Overall Study|Adverse Event|9
1676577|NCT01425359|5856275|P2|Overall Study|Randomized but Not Treated|3
1676578|NCT01425359|5856276|P1|Overall Study|Randomized but Not Treated|2
1676579|NCT01425281|5856307|P2|At 5-year Clinical Follow-up|Refused/terminated|3
1676580|NCT01425281|5856308|P1|At 5-year Clinical Follow-up|Refused/terminated|9
1676581|NCT01425281|5856307|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
1676582|NCT01425281|5856308|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
1676583|NCT01425281|5856307|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
1676584|NCT01425281|5856308|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
1676585|NCT01425281|5856307|P2|At 5-year Clinical Follow-up|Death|0
1676586|NCT01425281|5856308|P1|At 5-year Clinical Follow-up|Death|2
1676587|NCT01425281|5856307|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
1676588|NCT01425281|5856308|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
1676589|NCT01425281|5856307|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
1676590|NCT01425281|5856308|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
1676591|NCT01425281|5856307|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
1676592|NCT01425281|5856308|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
1676593|NCT01425281|5856307|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
1676594|NCT01425281|5856308|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
1676595|NCT01425281|5856307|P2|At 4-year Clinical Follow-up|Death|3
1676596|NCT01425281|5856308|P1|At 4-year Clinical Follow-up|Death|7
1676597|NCT01425281|5856307|P2|At 3-year Clinical Follow-up|Death|3
1676598|NCT01425281|5856308|P1|At 3-year Clinical Follow-up|Death|2
1676599|NCT01425281|5856307|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
1676600|NCT01425281|5856308|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
1676601|NCT01425281|5856307|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
1676602|NCT01425281|5856308|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
1676603|NCT01425281|5856307|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
1676604|NCT01425281|5856308|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
1676605|NCT01425281|5856307|P2|At 2-year Clinical Follow-up|Death|0
1676606|NCT01425281|5856308|P1|At 2-year Clinical Follow-up|Death|2
1676607|NCT01425281|5856307|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
1676608|NCT01425281|5856308|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
1676609|NCT01425281|5856307|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
1676610|NCT01425281|5856308|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
1676611|NCT01425281|5856307|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
1676612|NCT01425281|5856308|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
1676613|NCT01425281|5856307|P2|At 180-day Clinical Follow-up|Death|1
1676614|NCT01425281|5856308|P1|At 180-day Clinical Follow-up|Death|0
1676615|NCT01425281|5856307|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
1676616|NCT01425281|5856308|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
1676617|NCT01425281|5856307|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
1676618|NCT01425281|5856308|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
1676619|NCT01425268|5856526|P2|Overall Study|Physician Decision|0
1676620|NCT01425268|5856527|P1|Overall Study|Physician Decision|1
1676621|NCT01425268|5856526|P2|Overall Study|Sponsor Decision|0
1676622|NCT01425268|5856527|P1|Overall Study|Sponsor Decision|5
1676623|NCT01425268|5856526|P2|Overall Study|Withdrawal by Subject|0
1676624|NCT01425268|5856527|P1|Overall Study|Withdrawal by Subject|2
1676625|NCT01425203|5856548|P3|Crossover Phase|Other virologic failure criteria|3
1676626|NCT01425203|5856549|P2|Crossover Phase|Other virologic failure criteria|0
1676627|NCT01425203|5856550|P1|Crossover Phase|Other virologic failure criteria|0
1676628|NCT01425203|5856548|P3|Crossover Phase|Failure at futility timepoint|3
1676629|NCT01425203|5856549|P2|Crossover Phase|Failure at futility timepoint|0
1676630|NCT01425203|5856550|P1|Crossover Phase|Failure at futility timepoint|0
1676631|NCT01425203|5856548|P3|Treatment Phase|Did not receive treatment|0
1676632|NCT01425203|5856549|P2|Treatment Phase|Did not receive treatment|1
1676633|NCT01425203|5856550|P1|Treatment Phase|Did not receive treatment|0
1676634|NCT01425203|5856548|P3|Treatment Phase|Unidentified reasons|0
1676635|NCT01425203|5856549|P2|Treatment Phase|Unidentified reasons|5
1676636|NCT01425203|5856550|P1|Treatment Phase|Unidentified reasons|11
1676637|NCT01425203|5856548|P3|Treatment Phase|Other virologic failure criteria|0
1676638|NCT01425203|5856549|P2|Treatment Phase|Other virologic failure criteria|3
1676639|NCT01425203|5856550|P1|Treatment Phase|Other virologic failure criteria|5
1676640|NCT01425203|5856548|P3|Treatment Phase|Failure at futility timepoint|0
1676641|NCT01425203|5856549|P2|Treatment Phase|Failure at futility timepoint|27
1676642|NCT01425203|5856550|P1|Treatment Phase|Failure at futility timepoint|8
1676643|NCT01425203|5856548|P3|Treatment Phase|DC during PR Lead-in Phase|0
1676644|NCT01425203|5856549|P2|Treatment Phase|DC during PR Lead-in Phase|1
1676645|NCT01425203|5856550|P1|Treatment Phase|DC during PR Lead-in Phase|3
1676646|NCT01425190|5856567|P3|Overall Study|Full dose not consumed.|0
1676647|NCT01425190|5856568|P2|Overall Study|Full dose not consumed.|0
1676648|NCT01425190|5856569|P1|Overall Study|Full dose not consumed.|1
1676649|NCT01424930|5856605|P2|Overall Study|Reason not specified|6
1676650|NCT01424930|5856606|P1|Overall Study|Reason not specified|0
1676651|NCT01424930|5856605|P2|Overall Study|Screen Failure|1
1676652|NCT01424930|5856606|P1|Overall Study|Screen Failure|0
1676653|NCT01424930|5856605|P2|Overall Study|Progressive Disease|6
1676654|NCT01424930|5856606|P1|Overall Study|Progressive Disease|3
1676655|NCT01424930|5856605|P2|Overall Study|Death|0
1676656|NCT01424930|5856606|P1|Overall Study|Death|1
1676657|NCT01424930|5856605|P2|Overall Study|Adverse Event|1
1676658|NCT01424930|5856606|P1|Overall Study|Adverse Event|0
1676659|NCT01424813|5856620|P2|Overall Study|Other|2
1676660|NCT01424813|5856621|P1|Overall Study|Other|1
1676661|NCT01424813|5856620|P2|Overall Study|Protocol Violation|0
1676662|NCT01424813|5856621|P1|Overall Study|Protocol Violation|1
1676663|NCT01424813|5856620|P2|Overall Study|Withdrawal by Subject|0
1676664|NCT01424813|5856621|P1|Overall Study|Withdrawal by Subject|3
1676665|NCT01424670|5856641|P2|Continuation Period|Withdrawal by Subject|4
1676666|NCT01424670|5856642|P1|Continuation Period|Withdrawal by Subject|13
1676667|NCT01424670|5856641|P2|Continuation Period|Physician Decision|4
1676668|NCT01424670|5856642|P1|Continuation Period|Physician Decision|5
1676669|NCT01424670|5856641|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
1676670|NCT01424670|5856642|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
1676671|NCT01424670|5856641|P2|Continuation Period|Lost to Follow-up|0
1676672|NCT01424670|5856642|P1|Continuation Period|Lost to Follow-up|2
1676673|NCT01424670|5856641|P2|Continuation Period|Adverse Event|5
1676674|NCT01424670|5856642|P1|Continuation Period|Adverse Event|13
1676675|NCT01424670|5856641|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
1676676|NCT01424670|5856642|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
1676677|NCT01424670|5856641|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
1676678|NCT01424670|5856642|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
1676679|NCT01424670|5856641|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
1676680|NCT01424670|5856642|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
1676681|NCT01424670|5856641|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
1676682|NCT01424670|5856642|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
1676683|NCT01424670|5856641|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
1676684|NCT01424670|5856642|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
1676685|NCT01424644|5856664|P2|Overall Study|Unable to Classify|0
1676686|NCT01424644|5856665|P1|Overall Study|Unable to Classify|1
1676687|NCT01424644|5856664|P2|Overall Study|Administrative Reason|0
1676688|NCT01424644|5856665|P1|Overall Study|Administrative Reason|1
1676689|NCT01424644|5856664|P2|Overall Study|Protocol Violation|3
1676690|NCT01424644|5856665|P1|Overall Study|Protocol Violation|4
1676691|NCT01424644|5856664|P2|Overall Study|Lost to Follow-up|12
1676692|NCT01424644|5856665|P1|Overall Study|Lost to Follow-up|16
1676693|NCT01424644|5856664|P2|Overall Study|Withdrawal by Subject|12
1676694|NCT01424644|5856665|P1|Overall Study|Withdrawal by Subject|9
1676695|NCT01424644|5856664|P2|Overall Study|Adverse Event|0
1676696|NCT01424644|5856665|P1|Overall Study|Adverse Event|2
1676697|NCT01424566|5856679|P3|Double-blind Treatment|Lack of Efficacy|1
1676698|NCT01424566|5856680|P2|Double-blind Treatment|Lack of Efficacy|1
1676699|NCT01424566|5856681|P1|Double-blind Treatment|Lack of Efficacy|0
1676700|NCT01424566|5856679|P3|Double-blind Treatment|Withdrawal by Investigator|1
1676701|NCT01424566|5856680|P2|Double-blind Treatment|Withdrawal by Investigator|1
1676702|NCT01424566|5856681|P1|Double-blind Treatment|Withdrawal by Investigator|0
1676703|NCT01424566|5856679|P3|Double-blind Treatment|Withdrawal by Subject|0
1676704|NCT01424566|5856680|P2|Double-blind Treatment|Withdrawal by Subject|2
1676705|NCT01424566|5856681|P1|Double-blind Treatment|Withdrawal by Subject|0
1676706|NCT01424566|5856679|P3|Double-blind Treatment|Adverse Event|13
1676707|NCT01424566|5856680|P2|Double-blind Treatment|Adverse Event|21
1676708|NCT01424566|5856681|P1|Double-blind Treatment|Adverse Event|0
1676709|NCT01424566|5856679|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
1676710|NCT01424566|5856680|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
1676711|NCT01424566|5856681|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
1676712|NCT01424566|5856679|P3|Single-blind Treatment|Met Exclusion Criteria|0
1676713|NCT01424566|5856680|P2|Single-blind Treatment|Met Exclusion Criteria|0
1676714|NCT01424566|5856681|P1|Single-blind Treatment|Met Exclusion Criteria|1
1676715|NCT01424566|5856679|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1676716|NCT01424566|5856680|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
1676717|NCT01424566|5856681|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
1676718|NCT01424566|5856679|P3|Single-blind Treatment|Withdrawal by Investigator|0
1676719|NCT01424566|5856680|P2|Single-blind Treatment|Withdrawal by Investigator|0
1676720|NCT01424566|5856681|P1|Single-blind Treatment|Withdrawal by Investigator|2
1676721|NCT01424566|5856679|P3|Single-blind Treatment|Withdrawal by Subject|0
1676722|NCT01424566|5856680|P2|Single-blind Treatment|Withdrawal by Subject|0
1676723|NCT01424566|5856681|P1|Single-blind Treatment|Withdrawal by Subject|16
1676724|NCT01424566|5856679|P3|Single-blind Treatment|Adverse Event|0
1676725|NCT01424566|5856680|P2|Single-blind Treatment|Adverse Event|0
1676726|NCT01424566|5856681|P1|Single-blind Treatment|Adverse Event|71
1676727|NCT01424514|5856708|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
1676728|NCT01424514|5856709|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
1676729|NCT01424514|5856708|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1676730|NCT01424514|5856709|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
1676731|NCT01424501|5856754|P6|Overall Study|Lost to Follow-up|0
1676732|NCT01424501|5856755|P5|Overall Study|Lost to Follow-up|0
1676733|NCT01424501|5856756|P4|Overall Study|Lost to Follow-up|0
1676734|NCT01424501|5856757|P3|Overall Study|Lost to Follow-up|1
1676735|NCT01424501|5856758|P2|Overall Study|Lost to Follow-up|1
1676736|NCT01424501|5856759|P1|Overall Study|Lost to Follow-up|0
1676737|NCT01424501|5856754|P6|Overall Study|Withdrawal by Subject|0
1676738|NCT01424501|5856755|P5|Overall Study|Withdrawal by Subject|0
1676739|NCT01424501|5856756|P4|Overall Study|Withdrawal by Subject|0
1676740|NCT01424501|5856757|P3|Overall Study|Withdrawal by Subject|1
1676741|NCT01424501|5856758|P2|Overall Study|Withdrawal by Subject|0
1676742|NCT01424501|5856759|P1|Overall Study|Withdrawal by Subject|1
1676743|NCT01424397|5856935|P12|Period-2 (8 Days)|Withdrawal by Subject|0
1676744|NCT01424397|5856936|P11|Period-2 (8 Days)|Withdrawal by Subject|0
1676745|NCT01424397|5856937|P10|Period-2 (8 Days)|Withdrawal by Subject|0
1676746|NCT01424397|5856938|P9|Period-2 (8 Days)|Withdrawal by Subject|0
1676747|NCT01424397|5856939|P8|Period-2 (8 Days)|Withdrawal by Subject|0
1676748|NCT01424397|5856940|P7|Period-2 (8 Days)|Withdrawal by Subject|0
1676749|NCT01424397|5856941|P6|Period-2 (8 Days)|Withdrawal by Subject|0
1676750|NCT01424397|5856942|P5|Period-2 (8 Days)|Withdrawal by Subject|0
1676751|NCT01424397|5856943|P4|Period-2 (8 Days)|Withdrawal by Subject|0
1676752|NCT01424397|5856944|P3|Period-2 (8 Days)|Withdrawal by Subject|1
1676753|NCT01424397|5856945|P2|Period-2 (8 Days)|Withdrawal by Subject|0
1676754|NCT01424397|5856946|P1|Period-2 (8 Days)|Withdrawal by Subject|0
1676755|NCT01424306|5856992|P6|Overall Study|Protocol Violation|0
1676756|NCT01424306|5856993|P5|Overall Study|Protocol Violation|1
1676757|NCT01424306|5856994|P4|Overall Study|Protocol Violation|0
1676758|NCT01424306|5856995|P3|Overall Study|Protocol Violation|0
1676759|NCT01424306|5856996|P2|Overall Study|Protocol Violation|0
1676760|NCT01424306|5856997|P1|Overall Study|Protocol Violation|0
1676761|NCT01424228|5857046|P2|Overall Study|Unplanned journey|1
1676762|NCT01424228|5857047|P1|Overall Study|Unplanned journey|0
1676763|NCT01424228|5857046|P2|Overall Study|Worsening of symptoms|0
1676764|NCT01424228|5857047|P1|Overall Study|Worsening of symptoms|1
1676765|NCT01424228|5857046|P2|Overall Study|Non-compliance|0
1676766|NCT01424228|5857047|P1|Overall Study|Non-compliance|2
1676767|NCT01424228|5857046|P2|Overall Study|inclusion/exclusion criteria not met|2
1676768|NCT01424228|5857047|P1|Overall Study|inclusion/exclusion criteria not met|2
1676769|NCT01424228|5857046|P2|Overall Study|Lack of Efficacy|7
1676770|NCT01424228|5857047|P1|Overall Study|Lack of Efficacy|5
1676771|NCT01424228|5857046|P2|Overall Study|Sponsor's decision|12
1676772|NCT01424228|5857047|P1|Overall Study|Sponsor's decision|9
1676773|NCT01424228|5857046|P2|Overall Study|Adverse Event|14
1676774|NCT01424228|5857047|P1|Overall Study|Adverse Event|10
1676775|NCT01424228|5857046|P2|Overall Study|Withdrawal by Subject|11
1676776|NCT01424228|5857047|P1|Overall Study|Withdrawal by Subject|27
1676777|NCT01424189|5857087|P2|Overall Study|Death|1
1676778|NCT01424189|5857088|P1|Overall Study|Death|3
1676779|NCT01424189|5857087|P2|Overall Study|Subject moved|0
1676780|NCT01424189|5857088|P1|Overall Study|Subject moved|1
1676781|NCT01424189|5857087|P2|Overall Study|Withdrawal by Subject|4
1676782|NCT01424189|5857088|P1|Overall Study|Withdrawal by Subject|4
1676783|NCT01424189|5857087|P2|Overall Study|Lost to Follow-up|1
1676784|NCT01424189|5857088|P1|Overall Study|Lost to Follow-up|4
1676785|NCT01424189|5857087|P2|Overall Study|Adverse Event|0
1676786|NCT01424189|5857088|P1|Overall Study|Adverse Event|1
1676787|NCT01423916|5857129|P3|Overall Study|Protocol Deviation|0
1676788|NCT01423916|5857130|P2|Overall Study|Protocol Deviation|0
1676789|NCT01423916|5857131|P1|Overall Study|Protocol Deviation|1
1676790|NCT01423916|5857129|P3|Overall Study|Withdrawal by Subject|3
1676791|NCT01423916|5857130|P2|Overall Study|Withdrawal by Subject|10
1676792|NCT01423916|5857131|P1|Overall Study|Withdrawal by Subject|3
1676793|NCT01423916|5857129|P3|Overall Study|Physician Decision|1
1676794|NCT01423916|5857130|P2|Overall Study|Physician Decision|0
1676795|NCT01423916|5857131|P1|Overall Study|Physician Decision|1
1676796|NCT01423916|5857129|P3|Overall Study|Met Withdrawal Criteria|1
1676797|NCT01423916|5857130|P2|Overall Study|Met Withdrawal Criteria|1
1676798|NCT01423916|5857131|P1|Overall Study|Met Withdrawal Criteria|1
1676799|NCT01423916|5857129|P3|Overall Study|Adverse Event|2
1676800|NCT01423916|5857130|P2|Overall Study|Adverse Event|9
1676801|NCT01423916|5857131|P1|Overall Study|Adverse Event|5
1676802|NCT01423812|5857187|P2|Overall Study|Withdrawal by Subject|2
1676803|NCT01423812|5857188|P1|Overall Study|Withdrawal by Subject|1
1676804|NCT01423812|5857187|P2|Overall Study|Lost to Follow-up|2
1676805|NCT01423812|5857188|P1|Overall Study|Lost to Follow-up|2
1676806|NCT01423617|5857216|P2|Overall Study|Lost to Follow-up|1
1676807|NCT01423617|5857217|P1|Overall Study|Lost to Follow-up|0
1676808|NCT01423604|5857234|P2|Randomized|Patient decision|9
1676809|NCT01423604|5857235|P1|Randomized|Patient decision|5
1676810|NCT01423604|5857234|P2|Randomized|Other - unspecified|31
1676811|NCT01423604|5857235|P1|Randomized|Other - unspecified|37
1676812|NCT01423604|5857234|P2|Randomized|Physician Decision|13
1676813|NCT01423604|5857235|P1|Randomized|Physician Decision|16
1676814|NCT01423604|5857234|P2|Randomized|Death|0
1676815|NCT01423604|5857235|P1|Randomized|Death|1
1676816|NCT01423604|5857234|P2|Randomized|Adverse Event|10
1676817|NCT01423604|5857235|P1|Randomized|Adverse Event|4
1676818|NCT01423604|5857234|P2|Safety Run-In|Patient decision|0
1676819|NCT01423604|5857235|P1|Safety Run-In|Patient decision|1
1676820|NCT01423604|5857234|P2|Safety Run-In|Disease progression|0
1676821|NCT01423604|5857235|P1|Safety Run-In|Disease progression|3
1676822|NCT01423604|5857234|P2|Safety Run-In|Physician Decision|0
1676823|NCT01423604|5857235|P1|Safety Run-In|Physician Decision|1
1676824|NCT01423604|5857234|P2|Safety Run-In|Death|0
1676825|NCT01423604|5857235|P1|Safety Run-In|Death|1
1676826|NCT01423604|5857234|P2|Safety Run-In|Adverse Event|0
1676827|NCT01423604|5857235|P1|Safety Run-In|Adverse Event|3
1676828|NCT01423253|5857250|P1|Overall Study|Withdrawal by Subject|2
1676829|NCT01423253|5857250|P1|Overall Study|Protocol Violation|2
1676830|NCT01423253|5857250|P1|Overall Study|Lost to Follow-up|1
1676831|NCT01423253|5857250|P1|Overall Study|Lack of Efficacy|2
1676832|NCT01423253|5857250|P1|Overall Study|Adverse Event|2
1676833|NCT01423084|5857272|P2|Overall Study|Withdrawal by Subject|3
1676834|NCT01423084|5857273|P1|Overall Study|Withdrawal by Subject|2
1676835|NCT01423084|5857272|P2|Overall Study|Adverse Event|1
1676836|NCT01423084|5857273|P1|Overall Study|Adverse Event|0
1676837|NCT01422915|5857303|P1|Overall Study|Adverse Event|1
1676838|NCT01422889|5857308|P1|Overall Study|No Data Entered for Study Stent|9
1676839|NCT01422876|5857323|P10|Week 52|Death|0
1676840|NCT01422876|5857324|P9|Week 52|Death|1
1676841|NCT01422876|5857325|P8|Week 52|Death|3
1676842|NCT01422876|5857326|P7|Week 52|Death|1
1676843|NCT01422876|5857327|P6|Week 52|Death|0
1676844|NCT01422876|5857328|P5|Week 52|Death|0
1676845|NCT01422876|5857329|P4|Week 52|Death|1
1676846|NCT01422876|5857330|P3|Week 52|Death|0
1676847|NCT01422876|5857331|P2|Week 52|Death|1
1676848|NCT01422876|5857332|P1|Week 52|Death|0
1676849|NCT01422876|5857323|P10|Week 52|Consent withdrawn|9
1676850|NCT01422876|5857324|P9|Week 52|Consent withdrawn|13
1676851|NCT01422876|5857325|P8|Week 52|Consent withdrawn|12
1676852|NCT01422876|5857326|P7|Week 52|Consent withdrawn|10
1676853|NCT01422876|5857327|P6|Week 52|Consent withdrawn|12
1676854|NCT01422876|5857328|P5|Week 52|Consent withdrawn|7
1676855|NCT01422876|5857329|P4|Week 52|Consent withdrawn|12
1676856|NCT01422876|5857330|P3|Week 52|Consent withdrawn|6
1676857|NCT01422876|5857331|P2|Week 52|Consent withdrawn|4
1676858|NCT01422876|5857332|P1|Week 52|Consent withdrawn|9
1676859|NCT01422876|5857323|P10|Week 52|Lost to Follow-up|8
1676860|NCT01422876|5857324|P9|Week 52|Lost to Follow-up|7
1676861|NCT01422876|5857325|P8|Week 52|Lost to Follow-up|8
1676862|NCT01422876|5857326|P7|Week 52|Lost to Follow-up|5
1676863|NCT01422876|5857327|P6|Week 52|Lost to Follow-up|5
1676864|NCT01422876|5857328|P5|Week 52|Lost to Follow-up|8
1676865|NCT01422876|5857329|P4|Week 52|Lost to Follow-up|5
1676866|NCT01422876|5857330|P3|Week 52|Lost to Follow-up|7
1676867|NCT01422876|5857331|P2|Week 52|Lost to Follow-up|5
1676868|NCT01422876|5857332|P1|Week 52|Lost to Follow-up|3
1676869|NCT01422876|5857323|P10|Week 24|Death|0
1676870|NCT01422876|5857324|P9|Week 24|Death|0
1676871|NCT01422876|5857325|P8|Week 24|Death|0
1676872|NCT01422876|5857326|P7|Week 24|Death|0
1676873|NCT01422876|5857327|P6|Week 24|Death|0
1676874|NCT01422876|5857328|P5|Week 24|Death|0
1676875|NCT01422876|5857329|P4|Week 24|Death|0
1676876|NCT01422876|5857330|P3|Week 24|Death|0
1676877|NCT01422876|5857331|P2|Week 24|Death|1
1676878|NCT01422876|5857332|P1|Week 24|Death|0
1676879|NCT01422876|5857323|P10|Week 24|Consent withdrawn|6
1676880|NCT01422876|5857324|P9|Week 24|Consent withdrawn|3
1676881|NCT01422876|5857325|P8|Week 24|Consent withdrawn|4
1676882|NCT01422876|5857326|P7|Week 24|Consent withdrawn|5
1676883|NCT01422876|5857327|P6|Week 24|Consent withdrawn|6
1676884|NCT01422876|5857328|P5|Week 24|Consent withdrawn|5
1676885|NCT01422876|5857329|P4|Week 24|Consent withdrawn|4
1676886|NCT01422876|5857330|P3|Week 24|Consent withdrawn|3
1676887|NCT01422876|5857331|P2|Week 24|Consent withdrawn|1
1676888|NCT01422876|5857332|P1|Week 24|Consent withdrawn|5
1676889|NCT01422876|5857323|P10|Week 24|Lost to Follow-up|4
1676890|NCT01422876|5857324|P9|Week 24|Lost to Follow-up|3
1676891|NCT01422876|5857325|P8|Week 24|Lost to Follow-up|3
1676892|NCT01422876|5857326|P7|Week 24|Lost to Follow-up|1
1676893|NCT01422876|5857327|P6|Week 24|Lost to Follow-up|0
1676894|NCT01422876|5857328|P5|Week 24|Lost to Follow-up|2
1676895|NCT01422876|5857329|P4|Week 24|Lost to Follow-up|4
1676896|NCT01422876|5857330|P3|Week 24|Lost to Follow-up|2
1676897|NCT01422876|5857331|P2|Week 24|Lost to Follow-up|1
1676898|NCT01422876|5857332|P1|Week 24|Lost to Follow-up|1
1676899|NCT01422850|5857379|P1|Overall Study|Physician Decision|3
1676900|NCT01422824|5857385|P1|Overall Study|Lost to Follow-up|37
1676901|NCT01422824|5857385|P1|Overall Study|Case record form not evaluated|1
1676902|NCT01422720|5857390|P1|Overall Study|Ineligibility|1
1676903|NCT01422720|5857390|P1|Overall Study|Withdrawal by Subject|4
1676904|NCT01422720|5857390|P1|Overall Study|Lack of Efficacy|1
1676905|NCT01422720|5857390|P1|Overall Study|Adverse Event|16
1676906|NCT01422538|5857401|P3|Overall Study|Missed visit|1
1676907|NCT01422538|5857402|P2|Overall Study|Missed visit|1
1676908|NCT01422538|5857403|P1|Overall Study|Missed visit|0
1676909|NCT01422538|5857401|P3|Overall Study|Lost to Follow-up|1
1676910|NCT01422538|5857402|P2|Overall Study|Lost to Follow-up|1
1676911|NCT01422538|5857403|P1|Overall Study|Lost to Follow-up|0
1676912|NCT01422408|5857447|P1|Overall Study|Withdrawal by Subject|3
1676913|NCT01422408|5857447|P1|Overall Study|Adverse Event|1
1676914|NCT01422382|5857476|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
1676915|NCT01422304|5857492|P2|Overall Study|Not Treated|11
1676916|NCT01422304|5857493|P1|Overall Study|Not Treated|3
1676917|NCT01422304|5857492|P2|Overall Study|Did Not Meet Protocol Eligibility|2
1676918|NCT01422304|5857493|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1676919|NCT01422304|5857492|P2|Overall Study|Withdrawal by Subject|2
1676920|NCT01422304|5857493|P1|Overall Study|Withdrawal by Subject|4
1676921|NCT01422304|5857492|P2|Overall Study|Protocol Violation|0
1676922|NCT01422304|5857493|P1|Overall Study|Protocol Violation|1
1676923|NCT01422304|5857492|P2|Overall Study|Never Entered Follow-up|1
1676924|NCT01422304|5857493|P1|Overall Study|Never Entered Follow-up|2
1676925|NCT01422304|5857492|P2|Overall Study|Lost to Follow-up|20
1676926|NCT01422304|5857493|P1|Overall Study|Lost to Follow-up|14
1676927|NCT01422304|5857492|P2|Overall Study|Adverse Event|1
1676928|NCT01422304|5857493|P1|Overall Study|Adverse Event|0
1676929|NCT01422239|5857525|P2|Overall Study|Lost to Follow-up|3
1676930|NCT01422239|5857526|P1|Overall Study|Lost to Follow-up|4
1676931|NCT01422213|5857548|P3|Overall Study|Administrative or Other Reason(s)|2
1676932|NCT01422213|5857549|P2|Overall Study|Administrative or Other Reason(s)|4
1676933|NCT01422213|5857550|P1|Overall Study|Administrative or Other Reason(s)|5
1676934|NCT01422213|5857548|P3|Overall Study|Lost to Follow-up|5
1676935|NCT01422213|5857549|P2|Overall Study|Lost to Follow-up|3
1676936|NCT01422213|5857550|P1|Overall Study|Lost to Follow-up|3
1676937|NCT01422213|5857548|P3|Overall Study|Withdrawal of Consent|5
1676938|NCT01422213|5857549|P2|Overall Study|Withdrawal of Consent|3
1676939|NCT01422213|5857550|P1|Overall Study|Withdrawal of Consent|7
1676940|NCT01422213|5857548|P3|Overall Study|Protocol Violation|4
1676941|NCT01422213|5857549|P2|Overall Study|Protocol Violation|2
1676942|NCT01422213|5857550|P1|Overall Study|Protocol Violation|0
1676943|NCT01422213|5857548|P3|Overall Study|Non-compliance with study drug|0
1676944|NCT01422213|5857549|P2|Overall Study|Non-compliance with study drug|1
1676945|NCT01422213|5857550|P1|Overall Study|Non-compliance with study drug|0
1676946|NCT01422213|5857548|P3|Overall Study|Lack of Efficacy|2
1676947|NCT01422213|5857549|P2|Overall Study|Lack of Efficacy|2
1676948|NCT01422213|5857550|P1|Overall Study|Lack of Efficacy|10
1676949|NCT01422213|5857548|P3|Overall Study|Adverse Event|11
1676950|NCT01422213|5857549|P2|Overall Study|Adverse Event|7
1676951|NCT01422213|5857550|P1|Overall Study|Adverse Event|8
1676952|NCT01422187|5857611|P3|Overall Study|Lost to Follow-up|0
1676953|NCT01422187|5857612|P2|Overall Study|Lost to Follow-up|1
1676954|NCT01422187|5857613|P1|Overall Study|Lost to Follow-up|0
1676955|NCT01422187|5857611|P3|Overall Study|Personal reason|0
1676956|NCT01422187|5857612|P2|Overall Study|Personal reason|0
1676957|NCT01422187|5857613|P1|Overall Study|Personal reason|1
1676958|NCT01421719|5857677|P1|Overall Study|Withdrawal by Subject|4
1676959|NCT01421667|5857686|P4|Overall Study|Lost to Follow-up|0
1676960|NCT01421667|5857687|P3|Overall Study|Lost to Follow-up|0
1676961|NCT01421667|5857688|P2|Overall Study|Lost to Follow-up|1
1676962|NCT01421667|5857689|P1|Overall Study|Lost to Follow-up|0
1676963|NCT01421667|5857686|P4|Overall Study|Withdrawal by Subject|1
1676964|NCT01421667|5857687|P3|Overall Study|Withdrawal by Subject|2
1676965|NCT01421667|5857688|P2|Overall Study|Withdrawal by Subject|1
1676966|NCT01421667|5857689|P1|Overall Study|Withdrawal by Subject|0
1676967|NCT01421641|5857750|P2|Overall Study|Protocol Violation|2
1676968|NCT01421641|5857751|P1|Overall Study|Protocol Violation|2
1676969|NCT01421511|5857773|P2|Overall Study|Death|1
1676970|NCT01421511|5857774|P1|Overall Study|Death|1
1676971|NCT01421511|5857773|P2|Overall Study|Withdrawal by Subject|5
1676972|NCT01421511|5857774|P1|Overall Study|Withdrawal by Subject|6
1676973|NCT01421511|5857773|P2|Overall Study|Physician Decision|1
1676974|NCT01421511|5857774|P1|Overall Study|Physician Decision|0
1676975|NCT01421511|5857773|P2|Overall Study|Randomized but didn't receive study drug|7
1676976|NCT01421511|5857774|P1|Overall Study|Randomized but didn't receive study drug|1
1676977|NCT01421511|5857773|P2|Overall Study|Lost to Follow-up|14
1676978|NCT01421511|5857774|P1|Overall Study|Lost to Follow-up|11
1676979|NCT01421459|5857824|P2|Overall Study|Withdrawal by Subject|16
1676980|NCT01421459|5857825|P1|Overall Study|Withdrawal by Subject|12
1676981|NCT01421459|5857824|P2|Overall Study|Protocol Violation|5
1676982|NCT01421459|5857825|P1|Overall Study|Protocol Violation|8
1676983|NCT01421459|5857824|P2|Overall Study|Physician Decision|9
1676984|NCT01421459|5857825|P1|Overall Study|Physician Decision|9
1676985|NCT01421459|5857824|P2|Overall Study|Lost to Follow-up|9
1676986|NCT01421459|5857825|P1|Overall Study|Lost to Follow-up|8
1676987|NCT01421459|5857824|P2|Overall Study|Lack of Efficacy|2
1676988|NCT01421459|5857825|P1|Overall Study|Lack of Efficacy|1
1676989|NCT01421459|5857824|P2|Overall Study|Death|1
1676990|NCT01421459|5857825|P1|Overall Study|Death|1
1676991|NCT01421459|5857824|P2|Overall Study|Adverse Event|10
1676992|NCT01421459|5857825|P1|Overall Study|Adverse Event|6
1676993|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
1676994|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
1676995|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
1676996|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1676997|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1676998|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
1676999|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
1677000|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
1677001|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
1677002|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
1677003|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
1677004|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
1677005|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
1677006|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
1677007|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
1677008|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
1677009|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
1677010|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
1677011|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
1677012|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
1677013|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
1677014|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
1677015|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
1677016|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
1677017|NCT01421342|5857866|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1677018|NCT01421342|5857867|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
1677019|NCT01421342|5857868|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
1677020|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
1677021|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1677022|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
1677023|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
1677024|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1677025|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
1677026|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1677027|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
1677028|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
1677029|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
1677030|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
1677031|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
1677032|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1677033|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
1677034|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
1677035|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1677036|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
1677037|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
1677038|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
1677039|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
1677040|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
1677041|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
1677042|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
1677043|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
1677044|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
1677045|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
1677046|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
1677047|NCT01421342|5857866|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
1677048|NCT01421342|5857867|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
1677049|NCT01421342|5857868|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
1677050|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
1677051|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
1677052|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
1677053|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1677054|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
1677055|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
1677056|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
1677057|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
1677058|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
1677059|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
1677060|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
1677061|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
1677062|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
1677063|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
1677064|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
1677065|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Death|3
1677066|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Death|0
1677067|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Death|0
1677068|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
1677069|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
1677070|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
1677071|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
1677072|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
1677073|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
1677074|NCT01421342|5857866|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
1677075|NCT01421342|5857867|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
1677076|NCT01421342|5857868|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
1677077|NCT01421303|5857885|P1|Overall Study|Withdrawal by Subject|1
1677078|NCT01421303|5857885|P1|Overall Study|Other|7
1677079|NCT01421303|5857885|P1|Overall Study|Non compliance with study procedure|1
1677080|NCT01421303|5857885|P1|Overall Study|Lost to Follow-up|13
1677081|NCT01421277|5857912|P2|Overall Study|Incomplete baseline data|31
1677082|NCT01421277|5857913|P1|Overall Study|Incomplete baseline data|0
1677083|NCT01421277|5857912|P2|Overall Study|Lack of qualifying event|61
1677084|NCT01421277|5857913|P1|Overall Study|Lack of qualifying event|0
1677085|NCT01421225|5857925|P2|Overall Study|Withdrawal by Subject|1
1677086|NCT01421225|5857926|P1|Overall Study|Withdrawal by Subject|0
1677087|NCT01421147|5857940|P2|Extension Period|Withdrawal by Subject|3
1677088|NCT01421147|5857941|P1|Extension Period|Withdrawal by Subject|5
1677089|NCT01421147|5857940|P2|Extension Period|Physician Decision|0
1677090|NCT01421147|5857941|P1|Extension Period|Physician Decision|1
1677091|NCT01421147|5857940|P2|Extension Period|Lost to Follow-up|5
1677092|NCT01421147|5857941|P1|Extension Period|Lost to Follow-up|2
1677093|NCT01421147|5857940|P2|Extension Period|Death|1
1677094|NCT01421147|5857941|P1|Extension Period|Death|0
1677095|NCT01421147|5857940|P2|Extension Period|Adverse Event|2
1677096|NCT01421147|5857941|P1|Extension Period|Adverse Event|0
1677097|NCT01421147|5857940|P2|Treatment Period|Withdrawal by Subject|5
1677098|NCT01421147|5857941|P1|Treatment Period|Withdrawal by Subject|10
1677099|NCT01421147|5857940|P2|Treatment Period|Physician Decision|2
1677100|NCT01421147|5857941|P1|Treatment Period|Physician Decision|2
1677101|NCT01421147|5857940|P2|Treatment Period|Lost to Follow-up|1
1677102|NCT01421147|5857941|P1|Treatment Period|Lost to Follow-up|2
1677103|NCT01421147|5857940|P2|Treatment Period|Adverse Event|3
1677104|NCT01421147|5857941|P1|Treatment Period|Adverse Event|2
1677105|NCT01421134|5857973|P2|Overall Study|Lost to Follow-up|1
1677106|NCT01421134|5857974|P1|Overall Study|Lost to Follow-up|1
1677107|NCT01421134|5857973|P2|Overall Study|Administrative|1
1677108|NCT01421134|5857974|P1|Overall Study|Administrative|0
1677109|NCT01421134|5857973|P2|Overall Study|Withdrawal by Subject|1
1677110|NCT01421134|5857974|P1|Overall Study|Withdrawal by Subject|1
1677111|NCT01421134|5857973|P2|Overall Study|Protocol Violation|3
1677112|NCT01421134|5857974|P1|Overall Study|Protocol Violation|0
1677113|NCT01421134|5857973|P2|Overall Study|Lack of Efficacy|4
1677114|NCT01421134|5857974|P1|Overall Study|Lack of Efficacy|2
1677115|NCT01421134|5857973|P2|Overall Study|Adverse Event|5
1677116|NCT01421134|5857974|P1|Overall Study|Adverse Event|3
1677117|NCT01420965|5857995|P3|Overall Study|Adverse Event|0
1677118|NCT01420965|5857996|P2|Overall Study|Adverse Event|1
1677119|NCT01420965|5857997|P1|Overall Study|Adverse Event|0
1677120|NCT01420965|5857995|P3|Overall Study|Withdrawal by Subject|0
1677121|NCT01420965|5857996|P2|Overall Study|Withdrawal by Subject|0
1677122|NCT01420965|5857997|P1|Overall Study|Withdrawal by Subject|1
1677135|NCT01420549|5858060|P2|Overall Study|Non-adherence to medication|1
1677136|NCT01420549|5858061|P1|Overall Study|Non-adherence to medication|4
1677137|NCT01420549|5858060|P2|Overall Study|Protocol Violation|1
1677138|NCT01420549|5858061|P1|Overall Study|Protocol Violation|0
1677139|NCT01420549|5858060|P2|Overall Study|Lost to Follow-up|2
1677140|NCT01420549|5858061|P1|Overall Study|Lost to Follow-up|2
1677141|NCT01420549|5858060|P2|Overall Study|Adverse Event|1
1677142|NCT01420549|5858061|P1|Overall Study|Adverse Event|1
1677143|NCT01420081|5858095|P9|Overall Study|Other Reasons|0
1677144|NCT01420081|5858096|P8|Overall Study|Other Reasons|0
1677145|NCT01420081|5858097|P7|Overall Study|Other Reasons|0
1677146|NCT01420081|5858098|P6|Overall Study|Other Reasons|0
1677147|NCT01420081|5858099|P5|Overall Study|Other Reasons|0
1677148|NCT01420081|5858100|P4|Overall Study|Other Reasons|0
1677149|NCT01420081|5858101|P3|Overall Study|Other Reasons|1
1677150|NCT01420081|5858102|P2|Overall Study|Other Reasons|0
1677151|NCT01420081|5858103|P1|Overall Study|Other Reasons|0
1677152|NCT01420081|5858095|P9|Overall Study|Subject Refused Futher Follow-up|0
1677153|NCT01420081|5858096|P8|Overall Study|Subject Refused Futher Follow-up|0
1677154|NCT01420081|5858097|P7|Overall Study|Subject Refused Futher Follow-up|0
1677155|NCT01420081|5858098|P6|Overall Study|Subject Refused Futher Follow-up|0
1677156|NCT01420081|5858099|P5|Overall Study|Subject Refused Futher Follow-up|1
1677157|NCT01420081|5858100|P4|Overall Study|Subject Refused Futher Follow-up|0
1677158|NCT01420081|5858101|P3|Overall Study|Subject Refused Futher Follow-up|1
1677159|NCT01420081|5858102|P2|Overall Study|Subject Refused Futher Follow-up|0
1677160|NCT01420081|5858103|P1|Overall Study|Subject Refused Futher Follow-up|0
1677161|NCT01420081|5858095|P9|Overall Study|Study Terminated by Sponsor|2
1677162|NCT01420081|5858096|P8|Overall Study|Study Terminated by Sponsor|2
1677163|NCT01420081|5858097|P7|Overall Study|Study Terminated by Sponsor|3
1677164|NCT01420081|5858098|P6|Overall Study|Study Terminated by Sponsor|7
1677165|NCT01420081|5858099|P5|Overall Study|Study Terminated by Sponsor|11
1677166|NCT01420081|5858100|P4|Overall Study|Study Terminated by Sponsor|3
1677167|NCT01420081|5858101|P3|Overall Study|Study Terminated by Sponsor|1
1677168|NCT01420081|5858102|P2|Overall Study|Study Terminated by Sponsor|1
1677169|NCT01420081|5858103|P1|Overall Study|Study Terminated by Sponsor|2
1677170|NCT01420081|5858095|P9|Overall Study|Lost to Follow-up|0
1677171|NCT01420081|5858096|P8|Overall Study|Lost to Follow-up|0
1677172|NCT01420081|5858097|P7|Overall Study|Lost to Follow-up|0
1677173|NCT01420081|5858098|P6|Overall Study|Lost to Follow-up|1
1677174|NCT01420081|5858099|P5|Overall Study|Lost to Follow-up|1
1677175|NCT01420081|5858100|P4|Overall Study|Lost to Follow-up|0
1677176|NCT01420081|5858101|P3|Overall Study|Lost to Follow-up|0
1677177|NCT01420081|5858102|P2|Overall Study|Lost to Follow-up|0
1677178|NCT01420081|5858103|P1|Overall Study|Lost to Follow-up|0
1677179|NCT01420081|5858095|P9|Overall Study|Death|1
1677180|NCT01420081|5858096|P8|Overall Study|Death|1
1677181|NCT01420081|5858097|P7|Overall Study|Death|0
1677182|NCT01420081|5858098|P6|Overall Study|Death|12
1677183|NCT01420081|5858099|P5|Overall Study|Death|7
1677184|NCT01420081|5858100|P4|Overall Study|Death|0
1677185|NCT01420081|5858101|P3|Overall Study|Death|8
1677186|NCT01420081|5858102|P2|Overall Study|Death|0
1677187|NCT01420081|5858103|P1|Overall Study|Death|1
1677188|NCT01420068|5858184|P2|Overall Study|Withdrawal by Subject|2
1677189|NCT01420068|5858185|P1|Overall Study|Withdrawal by Subject|1
1677190|NCT01420068|5858184|P2|Overall Study|Administrative problems|3
1677191|NCT01420068|5858185|P1|Overall Study|Administrative problems|1
1677192|NCT01419769|5858256|P1|Overall Study|Not evaluable due to pigtail stents|1
1677193|NCT01419769|5858256|P1|Overall Study|Did not receive the AXIOS stent|3
1677194|NCT01419717|5858269|P1|Overall Study|Noncompliance|1
1677195|NCT01419717|5858269|P1|Overall Study|Administrative Decision|1
1677196|NCT01419717|5858269|P1|Overall Study|Lost to Follow-up|2
1677197|NCT01419717|5858269|P1|Overall Study|Other|4
1677198|NCT01419717|5858269|P1|Overall Study|Disease Progression|9
1677199|NCT01419717|5858269|P1|Overall Study|Withdrawal by Subject|10
1677200|NCT01419717|5858269|P1|Overall Study|Death|17
1677201|NCT01419717|5858269|P1|Overall Study|Adverse Event|19
1677202|NCT01419717|5858269|P1|Overall Study|Protocol-specified Criteria|62
1677203|NCT01419626|5858283|P3|Overall Study|Lost to Follow-up|1
1677204|NCT01419626|5858284|P2|Overall Study|Lost to Follow-up|1
1677205|NCT01419626|5858285|P1|Overall Study|Lost to Follow-up|0
1677206|NCT01419626|5858283|P3|Overall Study|Withdrawal by Subject|0
1677207|NCT01419626|5858284|P2|Overall Study|Withdrawal by Subject|0
1677208|NCT01419626|5858285|P1|Overall Study|Withdrawal by Subject|1
1677209|NCT01419626|5858283|P3|Overall Study|Protocol Violation|2
1677210|NCT01419626|5858284|P2|Overall Study|Protocol Violation|2
1677211|NCT01419626|5858285|P1|Overall Study|Protocol Violation|3
1677212|NCT01419314|5858316|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
1677213|NCT01419314|5858317|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
1677214|NCT01419314|5858316|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
1677215|NCT01419314|5858317|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
1677216|NCT01419314|5858316|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
1677217|NCT01419314|5858317|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
1677218|NCT01419236|5858358|P2|Overall Study|Entry Criteria Not Met|0
1677219|NCT01419236|5858359|P1|Overall Study|Entry Criteria Not Met|1
1677220|NCT01419236|5858358|P2|Overall Study|Withdrawal by Subject|4
1677221|NCT01419236|5858359|P1|Overall Study|Withdrawal by Subject|1
1677222|NCT01419236|5858358|P2|Overall Study|Physician Decision|0
1677223|NCT01419236|5858359|P1|Overall Study|Physician Decision|1
1677224|NCT01419236|5858358|P2|Overall Study|Lost to Follow-up|0
1677225|NCT01419236|5858359|P1|Overall Study|Lost to Follow-up|1
1677226|NCT01419236|5858358|P2|Overall Study|Lack of Efficacy|1
1677227|NCT01419236|5858359|P1|Overall Study|Lack of Efficacy|0
1677228|NCT01419236|5858358|P2|Overall Study|Adverse Event|0
1677229|NCT01419236|5858359|P1|Overall Study|Adverse Event|1
1677230|NCT01419197|5858383|P2|Overall Study|Lost to Follow-up|4
1677231|NCT01419197|5858384|P1|Overall Study|Lost to Follow-up|14
1677232|NCT01419197|5858383|P2|Overall Study|Reason Not Specified|1
1677233|NCT01419197|5858384|P1|Overall Study|Reason Not Specified|0
1677234|NCT01419197|5858383|P2|Overall Study|Study Completed by Sponsor|34
1677235|NCT01419197|5858384|P1|Overall Study|Study Completed by Sponsor|103
1677236|NCT01419197|5858383|P2|Overall Study|Withdrawal by Subject|32
1677237|NCT01419197|5858384|P1|Overall Study|Withdrawal by Subject|33
1677238|NCT01419197|5858383|P2|Overall Study|Non-compliance|1
1677239|NCT01419197|5858384|P1|Overall Study|Non-compliance|3
1677240|NCT01419197|5858383|P2|Overall Study|Physician Decision|4
1677241|NCT01419197|5858384|P1|Overall Study|Physician Decision|4
1677242|NCT01419197|5858383|P2|Overall Study|Death|122
1677243|NCT01419197|5858384|P1|Overall Study|Death|247
1677244|NCT01419184|5858409|P2|Overall Study|Participant randomized, not treated|0
1677245|NCT01419184|5858410|P1|Overall Study|Participant randomized, not treated|1
1677246|NCT01419184|5858409|P2|Overall Study|No IRLOS-No adverse event treatment date|1
1677247|NCT01419184|5858410|P1|Overall Study|No IRLOS-No adverse event treatment date|0
1677248|NCT01419184|5858409|P2|Overall Study|No IRLOS-non trial antibiotic used|2
1677249|NCT01419184|5858410|P1|Overall Study|No IRLOS-non trial antibiotic used|1
1677250|NCT01419184|5858409|P2|Overall Study|No IRLOS-randomized, not treated|4
1677251|NCT01419184|5858410|P1|Overall Study|No IRLOS-randomized, not treated|2
1677252|NCT01419184|5858409|P2|Overall Study|No IRLOS-No in-patient end date reported|6
1677253|NCT01419184|5858410|P1|Overall Study|No IRLOS-No in-patient end date reported|3
1677254|NCT01419184|5858409|P2|Overall Study|Site data not available|2
1677255|NCT01419184|5858410|P1|Overall Study|Site data not available|3
1677256|NCT01419080|5858443|P1|Overall Study|Too Ill|3
1677257|NCT01419080|5858443|P1|Overall Study|Lost to Follow-up|23
1677258|NCT01419080|5858443|P1|Overall Study|Death|30
1677259|NCT01419080|5858443|P1|Overall Study|Withdrawal by Subject|75
1677260|NCT01418937|5858454|P1|Overall Study|Withdrawal by Subject|1
1677261|NCT01418937|5858454|P1|Overall Study|Pregnancy|1
1677262|NCT01418937|5858454|P1|Overall Study|Protocol Violation|1
1677263|NCT01418937|5858454|P1|Overall Study|Lost to Follow-up|5
1677264|NCT01418378|5858485|P2|Overall Study|developed chronic myopathy|1
1677265|NCT01418378|5858486|P1|Overall Study|developed chronic myopathy|0
1677266|NCT01418378|5858485|P2|Overall Study|ligament imbalance|1
1677267|NCT01418378|5858486|P1|Overall Study|ligament imbalance|0
1677268|NCT01418378|5858485|P2|Overall Study|Physician Decision|1
1677269|NCT01418378|5858486|P1|Overall Study|Physician Decision|0
1677270|NCT01418378|5858485|P2|Overall Study|Death|2
1677271|NCT01418378|5858486|P1|Overall Study|Death|1
1677272|NCT01418365|5858560|P2|Second Intervention|Withdrawal by Subject|1
1677273|NCT01418365|5858561|P1|Second Intervention|Withdrawal by Subject|0
1677274|NCT01418365|5858560|P2|First Intervention|Non-compliance|0
1677275|NCT01418365|5858561|P1|First Intervention|Non-compliance|1
1677276|NCT01418365|5858560|P2|First Intervention|Withdrawal by Subject|1
1677277|NCT01418365|5858561|P1|First Intervention|Withdrawal by Subject|0
1677278|NCT01418209|5858572|P3|Overall Study|Did not provide hot flash diary data|3
1677279|NCT01418209|5858573|P2|Overall Study|Did not provide hot flash diary data|3
1677280|NCT01418209|5858574|P1|Overall Study|Did not provide hot flash diary data|1
1677281|NCT01418209|5858572|P3|Overall Study|Withdrawal by Subject|1
1677282|NCT01418209|5858573|P2|Overall Study|Withdrawal by Subject|0
1677283|NCT01418209|5858574|P1|Overall Study|Withdrawal by Subject|1
1677284|NCT01417481|5858638|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
1677285|NCT01417481|5858639|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
1677286|NCT01417377|5858704|P1|Overall Study|Enrolled, but not treated|1
1677287|NCT01417377|5858704|P1|Overall Study|Lost to Follow-up|12
1677288|NCT01417195|5858713|P2|Overall Study|No transfer due to elevated progesterone|0
1677289|NCT01417195|5858714|P1|Overall Study|No transfer due to elevated progesterone|1
1677290|NCT01417195|5858713|P2|Overall Study|No transfer due to risk of OHSS|0
1677291|NCT01417195|5858714|P1|Overall Study|No transfer due to risk of OHSS|1
1677292|NCT01417195|5858713|P2|Overall Study|No embryos for transfer|1
1677293|NCT01417195|5858714|P1|Overall Study|No embryos for transfer|0
1677294|NCT01417195|5858713|P2|Overall Study|Stimulation failure|0
1677295|NCT01417195|5858714|P1|Overall Study|Stimulation failure|1
1677296|NCT01417156|5858730|P1|Overall Study|Protocol Violation|2
1677297|NCT01417156|5858730|P1|Overall Study|Adverse Event|12
1677298|NCT01417104|5858740|P2|Overall Study|Adverse Event|0
1677299|NCT01417104|5858741|P1|Overall Study|Adverse Event|1
1677300|NCT01417104|5858740|P2|Overall Study|Failure to make contact|1
1677301|NCT01417104|5858741|P1|Overall Study|Failure to make contact|0
1677302|NCT01417104|5858740|P2|Overall Study|Withdrawal by Subject|1
1677303|NCT01417104|5858741|P1|Overall Study|Withdrawal by Subject|5
1677304|NCT01417078|5858751|P1|Overall Study|Withdrawal by Subject|1
1677305|NCT01417000|5858776|P2|Overall Study|Study Terminated by Sponsor|1
1677306|NCT01417000|5858777|P1|Overall Study|Study Terminated by Sponsor|1
1677307|NCT01417000|5858776|P2|Overall Study|Lost to Follow-up|0
1677308|NCT01417000|5858777|P1|Overall Study|Lost to Follow-up|1
1677309|NCT01417000|5858776|P2|Overall Study|Death|28
1677310|NCT01417000|5858777|P1|Overall Study|Death|59
1677311|NCT01416805|5858794|P2|Overall Study|Lost to Follow-up|4
1677312|NCT01416805|5858795|P1|Overall Study|Lost to Follow-up|4
1677313|NCT01416610|5858834|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
1677314|NCT01416610|5858834|P1|Overall Study|Lost to Follow-up|7
1677315|NCT01416610|5858834|P1|Overall Study|Withdrawal by Subject|13
1677316|NCT01416610|5858834|P1|Overall Study|No reason given|5
1677317|NCT01416610|5858834|P1|Overall Study|Lack of Efficacy|4
1677318|NCT01416610|5858834|P1|Overall Study|Adverse Event -Patient decision|3
1677319|NCT01416610|5858834|P1|Overall Study|Adverse Event|4
1677320|NCT01416571|5858888|P1|Overall Study|Lost to Follow-up|2
1677321|NCT01416389|5858917|P2|Overall Study|Started New Therapy|0
1677322|NCT01416389|5858918|P1|Overall Study|Started New Therapy|2
1677323|NCT01416389|5858917|P2|Overall Study|Lost to Follow-up|0
1677324|NCT01416389|5858918|P1|Overall Study|Lost to Follow-up|1
1677325|NCT01416272|5858935|P1|Overall Study|Study related complaints|1
1677326|NCT01416272|5858935|P1|Overall Study|Lost to Follow-up|1
1677327|NCT01416272|5858935|P1|Overall Study|Unacceptable distance visual acuity|2
1677328|NCT01416181|5858943|P2|Part 2|Lost to Follow-up|2
1677329|NCT01416181|5858944|P1|Part 2|Lost to Follow-up|2
1677330|NCT01416181|5858943|P2|Part 2|Lack of Efficacy|1
1677331|NCT01416181|5858944|P1|Part 2|Lack of Efficacy|4
1677332|NCT01416181|5858943|P2|Part 2|Withdrawal by Subject|5
1677333|NCT01416181|5858944|P1|Part 2|Withdrawal by Subject|14
1677334|NCT01416181|5858943|P2|Part 2|Investigator Decision|7
1677335|NCT01416181|5858944|P1|Part 2|Investigator Decision|6
1677336|NCT01416181|5858943|P2|Part 2|Other|267
1677337|NCT01416181|5858944|P1|Part 2|Other|234
1677338|NCT01416181|5858943|P2|Part 2|Adverse Event|4
1677339|NCT01416181|5858944|P1|Part 2|Adverse Event|11
1677340|NCT01416181|5858943|P2|Part 1|Ongoing in Follow-Up|8
1677341|NCT01416181|5858944|P1|Part 1|Ongoing in Follow-Up|14
1677342|NCT01416181|5858943|P2|Part 1|Adverse Event|18
1677343|NCT01416181|5858944|P1|Part 1|Adverse Event|15
1677344|NCT01416181|5858943|P2|Part 1|Lost to Follow-up|1
1677345|NCT01416181|5858944|P1|Part 1|Lost to Follow-up|1
1677346|NCT01416181|5858943|P2|Part 1|Lack of Efficacy|8
1677347|NCT01416181|5858944|P1|Part 1|Lack of Efficacy|16
1677348|NCT01416181|5858943|P2|Part 1|Withdrawal by Subject|48
1677349|NCT01416181|5858944|P1|Part 1|Withdrawal by Subject|74
1677350|NCT01416181|5858943|P2|Part 1|Investigator Decision|6
1677351|NCT01416181|5858944|P1|Part 1|Investigator Decision|7
1677352|NCT01416181|5858943|P2|Part 1|Death|1
1677353|NCT01416181|5858944|P1|Part 1|Death|0
1677354|NCT01416181|5858943|P2|Part 1|Other|24
1677355|NCT01416181|5858944|P1|Part 1|Other|10
1677356|NCT01416155|5859006|P1|Overall Study|Other|7
1677357|NCT01416155|5859006|P1|Overall Study|Investigator decision|8
1677358|NCT01416155|5859006|P1|Overall Study|Withdrawal by Subject|33
1677359|NCT01416155|5859006|P1|Overall Study|Positive for anti-BG00002 antibodies|2
1677360|NCT01416155|5859006|P1|Overall Study|Adverse Event|8
1677361|NCT01416142|5859013|P3|PureVision2 HD|Inability to maintain lens wear|1
1677362|NCT01416142|5859014|P2|PureVision2 HD|Inability to maintain lens wear|0
1677363|NCT01416142|5859015|P1|PureVision2 HD|Inability to maintain lens wear|0
1677364|NCT01415986|5859042|P1|Overall Study|Lost to Follow-up|1
1677365|NCT01415921|5859068|P2|Overall Study|Other|0
1677366|NCT01415921|5859069|P1|Overall Study|Other|2
1677367|NCT01415921|5859068|P2|Overall Study|Withdrawal by Subject|1
1677368|NCT01415921|5859069|P1|Overall Study|Withdrawal by Subject|0
1677369|NCT01415921|5859068|P2|Overall Study|Physician Decision|1
1677370|NCT01415921|5859069|P1|Overall Study|Physician Decision|1
1677371|NCT01415921|5859068|P2|Overall Study|Adverse Event|1
1677372|NCT01415921|5859069|P1|Overall Study|Adverse Event|0
1677373|NCT01415908|5859079|P2|Overall Study|Withdrawal by Subject|0
1677374|NCT01415908|5859080|P1|Overall Study|Withdrawal by Subject|1
1677375|NCT01415531|5859117|P2|Overall Study|Other Reasons|2
1677376|NCT01415531|5859118|P1|Overall Study|Other Reasons|3
1677377|NCT01415531|5859117|P2|Overall Study|Lack of Compliance|4
1677378|NCT01415531|5859118|P1|Overall Study|Lack of Compliance|1
1677379|NCT01415531|5859117|P2|Overall Study|Lost to Follow-up|14
1677380|NCT01415531|5859118|P1|Overall Study|Lost to Follow-up|6
1677381|NCT01415531|5859117|P2|Overall Study|Withdrawal by Subject|4
1677382|NCT01415531|5859118|P1|Overall Study|Withdrawal by Subject|5
1677383|NCT01415531|5859117|P2|Overall Study|Protocol Violation|1
1677384|NCT01415531|5859118|P1|Overall Study|Protocol Violation|0
1677385|NCT01415531|5859117|P2|Overall Study|Lack of Efficacy|2
1677386|NCT01415531|5859118|P1|Overall Study|Lack of Efficacy|3
1677387|NCT01415531|5859117|P2|Overall Study|Adverse Event|10
1677388|NCT01415531|5859118|P1|Overall Study|Adverse Event|7
1677389|NCT01415518|5859128|P2|Overall Study|Condition under Investigation Worsened|1
1677390|NCT01415518|5859129|P1|Overall Study|Condition under Investigation Worsened|1
1677391|NCT01415518|5859128|P2|Overall Study|Death|1
1677392|NCT01415518|5859129|P1|Overall Study|Death|1
1677393|NCT01415518|5859128|P2|Overall Study|Adverse Event|4
1677394|NCT01415518|5859129|P1|Overall Study|Adverse Event|3
1677395|NCT01415518|5859128|P2|Overall Study|Lost to Follow-up|5
1677396|NCT01415518|5859129|P1|Overall Study|Lost to Follow-up|3
1677397|NCT01415518|5859128|P2|Overall Study|Protocol Violation|8
1677398|NCT01415518|5859129|P1|Overall Study|Protocol Violation|6
1677399|NCT01415518|5859128|P2|Overall Study|Withdrawal by Subject|12
1677400|NCT01415518|5859129|P1|Overall Study|Withdrawal by Subject|2
1677401|NCT01415440|5859188|P3|Overall Study|Withdrawal by Subject|0
1677402|NCT01415440|5859189|P2|Overall Study|Withdrawal by Subject|0
1677403|NCT01415440|5859190|P1|Overall Study|Withdrawal by Subject|1
1677404|NCT01415440|5859188|P3|Overall Study|Physician Decision|0
1677405|NCT01415440|5859189|P2|Overall Study|Physician Decision|0
1677406|NCT01415440|5859190|P1|Overall Study|Physician Decision|3
1677407|NCT01415440|5859188|P3|Overall Study|Lost to Follow-up|2
1677408|NCT01415440|5859189|P2|Overall Study|Lost to Follow-up|1
1677409|NCT01415440|5859190|P1|Overall Study|Lost to Follow-up|0
1677410|NCT01415401|5859241|P1|Overall Study|Terminated by Sponsor|1
1677411|NCT01415401|5859241|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
1677412|NCT01415401|5859241|P1|Overall Study|Adverse Event|5
1677413|NCT01415349|5859246|P2|Treatment Period 1|Withdrawal by Subject|1
1677414|NCT01415349|5859247|P1|Treatment Period 1|Withdrawal by Subject|0
1677415|NCT01415349|5859246|P2|Treatment Period 1|Adverse Event|1
1677416|NCT01415349|5859247|P1|Treatment Period 1|Adverse Event|0
1677417|NCT01414855|5859259|P1|Overall Study|Withdrawal by Subject|7
1677418|NCT01414855|5859259|P1|Overall Study|Lost to Follow-up|5
1677419|NCT01414855|5859259|P1|Overall Study|Death|17
1677420|NCT01414257|5859308|P1|Overall Study|Protocol Violation|10
1677421|NCT01414257|5859308|P1|Overall Study|No Visit After First Day of Treatment|12
1677422|NCT01414205|5859336|P2|Overall Study|Randomized but not Treated|1
1677423|NCT01414205|5859337|P1|Overall Study|Randomized but not Treated|1
1677424|NCT01414205|5859336|P2|Overall Study|Physician Decision|1
1677425|NCT01414205|5859337|P1|Overall Study|Physician Decision|0
1677426|NCT01414205|5859336|P2|Overall Study|Lost to Follow-up|4
1677427|NCT01414205|5859337|P1|Overall Study|Lost to Follow-up|1
1677428|NCT01414205|5859336|P2|Overall Study|Death|1
1677429|NCT01414205|5859337|P1|Overall Study|Death|5
1677430|NCT01414166|5859406|P2|Overall Study|Withdrawal by Subject|5
1677431|NCT01414166|5859407|P1|Overall Study|Withdrawal by Subject|3
1677432|NCT01414166|5859406|P2|Overall Study|Study terminated by Sponsor|75
1677433|NCT01414166|5859407|P1|Overall Study|Study terminated by Sponsor|68
1677434|NCT01414166|5859406|P2|Overall Study|Protocol Violation|0
1677435|NCT01414166|5859407|P1|Overall Study|Protocol Violation|2
1677436|NCT01414166|5859406|P2|Overall Study|Physician Decision|0
1677437|NCT01414166|5859407|P1|Overall Study|Physician Decision|2
1677438|NCT01414166|5859406|P2|Overall Study|Non-compliance with study drug|0
1677439|NCT01414166|5859407|P1|Overall Study|Non-compliance with study drug|2
1677440|NCT01414166|5859406|P2|Overall Study|Lost to Follow-up|1
1677441|NCT01414166|5859407|P1|Overall Study|Lost to Follow-up|4
1677442|NCT01414166|5859406|P2|Overall Study|Adverse Event|2
1677443|NCT01414166|5859407|P1|Overall Study|Adverse Event|10
1677444|NCT01414114|5859470|P1|Overall Study|Other|2
1677445|NCT01414114|5859470|P1|Overall Study|Withdrawal by Subject|1
1677446|NCT01414114|5859470|P1|Overall Study|Adverse Event|2
1677447|NCT01413958|5859526|P2|Overall Study|Lost to Follow-up|1
1677448|NCT01413958|5859527|P1|Overall Study|Lost to Follow-up|0
1677449|NCT01413542|5859578|P4|Overall Study|Adverse Event|1
1677450|NCT01413542|5859579|P3|Overall Study|Adverse Event|0
1677451|NCT01413542|5859580|P2|Overall Study|Adverse Event|0
1677452|NCT01413542|5859581|P1|Overall Study|Adverse Event|0
1677453|NCT01413542|5859578|P4|Overall Study|Physician Decision|0
1677454|NCT01413542|5859579|P3|Overall Study|Physician Decision|3
1677455|NCT01413542|5859580|P2|Overall Study|Physician Decision|0
1677456|NCT01413542|5859581|P1|Overall Study|Physician Decision|1
1677457|NCT01413503|5859603|P1|Overall Study|Lost to Follow-up|1
1677458|NCT01413360|5859607|P1|Overall Study|Adverse Event|1
1677459|NCT01413360|5859607|P1|Overall Study|Lost to Follow-up|2
1677460|NCT01413204|5859615|P3|Overall Study|Fasting plasma glucose level increased|10
1677461|NCT01413204|5859616|P2|Overall Study|Fasting plasma glucose level increased|0
1677462|NCT01413204|5859617|P1|Overall Study|Fasting plasma glucose level increased|1
1677463|NCT01413204|5859615|P3|Overall Study|Clearly not eligible for the study|1
1677464|NCT01413204|5859616|P2|Overall Study|Clearly not eligible for the study|0
1677465|NCT01413204|5859617|P1|Overall Study|Clearly not eligible for the study|0
1677466|NCT01413204|5859615|P3|Overall Study|Withdrawal by Subject|4
1677467|NCT01413204|5859616|P2|Overall Study|Withdrawal by Subject|4
1677468|NCT01413204|5859617|P1|Overall Study|Withdrawal by Subject|1
1677469|NCT01413204|5859615|P3|Overall Study|Physician Decision|2
1677470|NCT01413204|5859616|P2|Overall Study|Physician Decision|0
1677471|NCT01413204|5859617|P1|Overall Study|Physician Decision|3
1677472|NCT01413204|5859615|P3|Overall Study|Adverse Event|2
1677473|NCT01413204|5859616|P2|Overall Study|Adverse Event|2
1677474|NCT01413204|5859617|P1|Overall Study|Adverse Event|1
1677478|NCT01412983|5859664|P2|1st Period|Inability to maintain wear|1
1677479|NCT01412983|5859665|P1|1st Period|Inability to maintain wear|0
1677480|NCT01412983|5859664|P2|1st Period|Unacceptable lens movement|1
1677481|NCT01412983|5859665|P1|1st Period|Unacceptable lens movement|0
1677482|NCT01412983|5859664|P2|1st Period|Positive slit lamp finding|1
1677483|NCT01412983|5859665|P1|1st Period|Positive slit lamp finding|0
1677484|NCT01412983|5859664|P2|1st Period|Ineligible|1
1677485|NCT01412983|5859665|P1|1st Period|Ineligible|0
1677486|NCT01412957|5859675|P2|Overall Study|Death|133
1677487|NCT01412957|5859676|P1|Overall Study|Death|136
1677488|NCT01412957|5859675|P2|Overall Study|Lost to Follow-up|2
1677489|NCT01412957|5859676|P1|Overall Study|Lost to Follow-up|7
1677490|NCT01412957|5859675|P2|Overall Study|Withdrawal by Subject|22
1677491|NCT01412957|5859676|P1|Overall Study|Withdrawal by Subject|6
1677492|NCT01412944|5859698|P6|Entire: IV + Maintenance|Adverse Event|0
1677493|NCT01412944|5859699|P5|Entire: IV + Maintenance|Adverse Event|0
1677494|NCT01412944|5859700|P4|Entire: IV + Maintenance|Adverse Event|0
1677495|NCT01412944|5859701|P3|Entire: IV + Maintenance|Adverse Event|0
1677496|NCT01412944|5859702|P2|Entire: IV + Maintenance|Adverse Event|1
1677497|NCT01412944|5859703|P1|Entire: IV + Maintenance|Adverse Event|0
1677498|NCT01412944|5859698|P6|Entire: IV + Maintenance|Lack of Efficacy|0
1677499|NCT01412944|5859699|P5|Entire: IV + Maintenance|Lack of Efficacy|0
1677500|NCT01412944|5859700|P4|Entire: IV + Maintenance|Lack of Efficacy|0
1677501|NCT01412944|5859701|P3|Entire: IV + Maintenance|Lack of Efficacy|0
1677502|NCT01412944|5859702|P2|Entire: IV + Maintenance|Lack of Efficacy|1
1677503|NCT01412944|5859703|P1|Entire: IV + Maintenance|Lack of Efficacy|0
1677504|NCT01412944|5859698|P6|Entire: IV + Maintenance|Lost to Follow-up|0
1677505|NCT01412944|5859699|P5|Entire: IV + Maintenance|Lost to Follow-up|0
1677506|NCT01412944|5859700|P4|Entire: IV + Maintenance|Lost to Follow-up|0
1677507|NCT01412944|5859701|P3|Entire: IV + Maintenance|Lost to Follow-up|0
1677508|NCT01412944|5859702|P2|Entire: IV + Maintenance|Lost to Follow-up|1
1677509|NCT01412944|5859703|P1|Entire: IV + Maintenance|Lost to Follow-up|0
1677510|NCT01412944|5859698|P6|Entire: IV + Maintenance|Protocol deviation|0
1677511|NCT01412944|5859699|P5|Entire: IV + Maintenance|Protocol deviation|0
1677512|NCT01412944|5859700|P4|Entire: IV + Maintenance|Protocol deviation|0
1677513|NCT01412944|5859701|P3|Entire: IV + Maintenance|Protocol deviation|0
1677514|NCT01412944|5859702|P2|Entire: IV + Maintenance|Protocol deviation|1
1677515|NCT01412944|5859703|P1|Entire: IV + Maintenance|Protocol deviation|0
1677516|NCT01412944|5859698|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
1677517|NCT01412944|5859699|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
1677518|NCT01412944|5859700|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
1677519|NCT01412944|5859701|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
1677520|NCT01412944|5859702|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
1677521|NCT01412944|5859703|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
1677522|NCT01412944|5859698|P6|Entire: IV + Maintenance|Lack of Efficacy|0
1677523|NCT01412944|5859699|P5|Entire: IV + Maintenance|Lack of Efficacy|1
1677524|NCT01412944|5859700|P4|Entire: IV + Maintenance|Lack of Efficacy|0
1677525|NCT01412944|5859701|P3|Entire: IV + Maintenance|Lack of Efficacy|0
1677526|NCT01412944|5859702|P2|Entire: IV + Maintenance|Lack of Efficacy|0
1677527|NCT01412944|5859703|P1|Entire: IV + Maintenance|Lack of Efficacy|0
1677528|NCT01412944|5859698|P6|Entire: IV + Maintenance|Lost to Follow-up|1
1677529|NCT01412944|5859699|P5|Entire: IV + Maintenance|Lost to Follow-up|0
1677530|NCT01412944|5859700|P4|Entire: IV + Maintenance|Lost to Follow-up|0
1677531|NCT01412944|5859701|P3|Entire: IV + Maintenance|Lost to Follow-up|0
1677532|NCT01412944|5859702|P2|Entire: IV + Maintenance|Lost to Follow-up|0
1677533|NCT01412944|5859703|P1|Entire: IV + Maintenance|Lost to Follow-up|0
1677534|NCT01412944|5859698|P6|Entire: IV + Maintenance|Protocol deviation|1
1677535|NCT01412944|5859699|P5|Entire: IV + Maintenance|Protocol deviation|0
1677536|NCT01412944|5859700|P4|Entire: IV + Maintenance|Protocol deviation|0
1677537|NCT01412944|5859701|P3|Entire: IV + Maintenance|Protocol deviation|0
1677538|NCT01412944|5859702|P2|Entire: IV + Maintenance|Protocol deviation|0
1677539|NCT01412944|5859703|P1|Entire: IV + Maintenance|Protocol deviation|0
1677540|NCT01412944|5859698|P6|Entire: IV + Maintenance|Adverse Event|0
1677541|NCT01412944|5859699|P5|Entire: IV + Maintenance|Adverse Event|1
1677542|NCT01412944|5859700|P4|Entire: IV + Maintenance|Adverse Event|0
1677543|NCT01412944|5859701|P3|Entire: IV + Maintenance|Adverse Event|0
1677544|NCT01412944|5859702|P2|Entire: IV + Maintenance|Adverse Event|0
1677545|NCT01412944|5859703|P1|Entire: IV + Maintenance|Adverse Event|0
1677546|NCT01412944|5859698|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
1677547|NCT01412944|5859699|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
1677548|NCT01412944|5859700|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
1677549|NCT01412944|5859701|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
1677550|NCT01412944|5859702|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
1677551|NCT01412944|5859703|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
1677552|NCT01412944|5859698|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
1677553|NCT01412944|5859699|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
1677554|NCT01412944|5859700|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
1677555|NCT01412944|5859701|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
1677556|NCT01412944|5859702|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
1677557|NCT01412944|5859703|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
1677558|NCT01412944|5859698|P6|IV: Per CAIN457A2307|Protocol deviation|0
1677559|NCT01412944|5859699|P5|IV: Per CAIN457A2307|Protocol deviation|0
1677560|NCT01412944|5859700|P4|IV: Per CAIN457A2307|Protocol deviation|0
1677561|NCT01412944|5859701|P3|IV: Per CAIN457A2307|Protocol deviation|0
1677562|NCT01412944|5859702|P2|IV: Per CAIN457A2307|Protocol deviation|1
1677563|NCT01412944|5859703|P1|IV: Per CAIN457A2307|Protocol deviation|0
1677564|NCT01412944|5859698|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
1677565|NCT01412944|5859699|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
1677566|NCT01412944|5859700|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
1677567|NCT01412944|5859701|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
1677568|NCT01412944|5859702|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
1677569|NCT01412944|5859703|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
1677570|NCT01412944|5859698|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
1677571|NCT01412944|5859699|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1677572|NCT01412944|5859700|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1677573|NCT01412944|5859701|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1677574|NCT01412944|5859702|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1677575|NCT01412944|5859703|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
1677576|NCT01412944|5859698|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
1677577|NCT01412944|5859699|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1677578|NCT01412944|5859700|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1677579|NCT01412944|5859701|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1677580|NCT01412944|5859702|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1677581|NCT01412944|5859703|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
1677582|NCT01412944|5859698|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1677583|NCT01412944|5859699|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1677584|NCT01412944|5859700|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1677585|NCT01412944|5859701|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
1677586|NCT01412944|5859702|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1677587|NCT01412944|5859703|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
1677588|NCT01412879|5859749|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
1677589|NCT01412879|5859750|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
1677590|NCT01412879|5859751|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
1677591|NCT01412879|5859749|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
1677592|NCT01412879|5859750|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
1677593|NCT01412879|5859751|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
1677594|NCT01412879|5859749|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
1677595|NCT01412879|5859750|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
1677596|NCT01412879|5859751|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
1677597|NCT01412879|5859749|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
1677598|NCT01412879|5859750|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
1677599|NCT01412879|5859751|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
1677600|NCT01412879|5859749|P3|Initial Registration (Induction Therapy)|Adverse Event|0
1677601|NCT01412879|5859750|P2|Initial Registration (Induction Therapy)|Adverse Event|3
1677602|NCT01412879|5859751|P1|Initial Registration (Induction Therapy)|Adverse Event|5
1677603|NCT01412801|5859780|P6|Overall Study|Relocated to another area|0
1677604|NCT01412801|5859781|P5|Overall Study|Relocated to another area|0
1677605|NCT01412801|5859782|P4|Overall Study|Relocated to another area|0
1677606|NCT01412801|5859783|P3|Overall Study|Relocated to another area|2
1677607|NCT01412801|5859784|P2|Overall Study|Relocated to another area|0
1677608|NCT01412801|5859785|P1|Overall Study|Relocated to another area|0
1677609|NCT01412801|5859780|P6|Overall Study|Withdrawal by Subject|0
1677610|NCT01412801|5859781|P5|Overall Study|Withdrawal by Subject|0
1677611|NCT01412801|5859782|P4|Overall Study|Withdrawal by Subject|0
1677612|NCT01412801|5859783|P3|Overall Study|Withdrawal by Subject|1
1677613|NCT01412801|5859784|P2|Overall Study|Withdrawal by Subject|2
1677614|NCT01412801|5859785|P1|Overall Study|Withdrawal by Subject|3
1677615|NCT01412801|5859780|P6|Overall Study|Lost to Follow-up|1
1677616|NCT01412801|5859781|P5|Overall Study|Lost to Follow-up|1
1677617|NCT01412801|5859782|P4|Overall Study|Lost to Follow-up|0
1677618|NCT01412801|5859783|P3|Overall Study|Lost to Follow-up|4
1677619|NCT01412801|5859784|P2|Overall Study|Lost to Follow-up|2
1677620|NCT01412801|5859785|P1|Overall Study|Lost to Follow-up|1
1677621|NCT01412801|5859780|P6|Overall Study|Death|2
1677622|NCT01412801|5859781|P5|Overall Study|Death|2
1677623|NCT01412801|5859782|P4|Overall Study|Death|4
1677624|NCT01412801|5859783|P3|Overall Study|Death|0
1677625|NCT01412801|5859784|P2|Overall Study|Death|1
1677626|NCT01412801|5859785|P1|Overall Study|Death|0
1677627|NCT01412424|5859948|P1|Extension Treatment Period|Patient Request|2
1677628|NCT01412424|5859948|P1|Extension Treatment Period|Treatment Failure|2
1677629|NCT01412424|5859948|P1|Extension Treatment Period|Adverse Event|2
1677630|NCT01412424|5859948|P1|Core Treatment Period|Sponsor Request|1
1677631|NCT01412424|5859948|P1|Core Treatment Period|Lost to Follow-up|2
1677632|NCT01412424|5859948|P1|Core Treatment Period|Patient Request|5
1677633|NCT01412424|5859948|P1|Core Treatment Period|Adverse Event|21
1677634|NCT01412424|5859948|P1|Core Treatment Period|Treatment Failure|24
1677635|NCT01412333|5859966|P2|Overall Study|Lost to Follow-up|6
1677636|NCT01412333|5859967|P1|Overall Study|Lost to Follow-up|10
1677637|NCT01412333|5859966|P2|Overall Study|Adverse Event|16
1677638|NCT01412333|5859967|P1|Overall Study|Adverse Event|25
1677639|NCT01412333|5859966|P2|Overall Study|Consent withdrawn by participant|12
1677640|NCT01412333|5859967|P1|Overall Study|Consent withdrawn by participant|25
1677641|NCT01412333|5859966|P2|Overall Study|Pregnancy|0
1677642|NCT01412333|5859967|P1|Overall Study|Pregnancy|3
1677643|NCT01412333|5859966|P2|Overall Study|Lack of Efficacy|6
1677644|NCT01412333|5859967|P1|Overall Study|Lack of Efficacy|15
1677645|NCT01412333|5859966|P2|Overall Study|Non-compliance|3
1677646|NCT01412333|5859967|P1|Overall Study|Non-compliance|1
1677647|NCT01412333|5859966|P2|Overall Study|Protocol Violation|1
1677648|NCT01412333|5859967|P1|Overall Study|Protocol Violation|1
1677649|NCT01412333|5859966|P2|Overall Study|Non-compliance with study drug|1
1677650|NCT01412333|5859967|P1|Overall Study|Non-compliance with study drug|1
1677651|NCT01412333|5859966|P2|Overall Study|Reason not specified|10
1677652|NCT01412333|5859967|P1|Overall Study|Reason not specified|16
1677653|NCT01412333|5859966|P2|Overall Study|Physician Decision|1
1677654|NCT01412333|5859967|P1|Overall Study|Physician Decision|0
1677655|NCT01412333|5859966|P2|Overall Study|Death|1
1677656|NCT01412333|5859967|P1|Overall Study|Death|1
1677657|NCT01412229|5860027|P1|Overall Study|Physician Decision|1
1677658|NCT01412151|5860050|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
1677659|NCT01412151|5860050|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
1677660|NCT01412151|5860050|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
1677661|NCT01412151|5860050|P1|Week 0 - 306 - Treatment Period|Death|1
1677662|NCT01412060|5860061|P3|Double-blind Treatment Phase (DBP)|Relapse|25
1677663|NCT01412060|5860062|P2|Double-blind Treatment Phase (DBP)|Relapse|47
1677664|NCT01412060|5860063|P1|Double-blind Treatment Phase (DBP)|Relapse|0
1677665|NCT01412060|5860061|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
1677666|NCT01412060|5860062|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
1677667|NCT01412060|5860063|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
1677668|NCT01412060|5860061|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
1677669|NCT01412060|5860062|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
1677670|NCT01412060|5860063|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
1677671|NCT01412060|5860061|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
1677672|NCT01412060|5860062|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
1677673|NCT01412060|5860063|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
1677674|NCT01412060|5860061|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
1677675|NCT01412060|5860062|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
1677676|NCT01412060|5860063|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
1677677|NCT01412060|5860061|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
1677678|NCT01412060|5860062|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
1677679|NCT01412060|5860063|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
1677680|NCT01412060|5860061|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
1677681|NCT01412060|5860062|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
1677682|NCT01412060|5860063|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
1677683|NCT01412060|5860061|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
1677684|NCT01412060|5860062|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
1677685|NCT01412060|5860063|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
1677686|NCT01412060|5860061|P3|Period Between SP and DBP|Lost to Follow-up|0
1677687|NCT01412060|5860062|P2|Period Between SP and DBP|Lost to Follow-up|0
1677688|NCT01412060|5860063|P1|Period Between SP and DBP|Lost to Follow-up|1
1677689|NCT01412060|5860061|P3|Period Between SP and DBP|Withdrawal of Consent|0
1677690|NCT01412060|5860062|P2|Period Between SP and DBP|Withdrawal of Consent|0
1677691|NCT01412060|5860063|P1|Period Between SP and DBP|Withdrawal of Consent|2
1677692|NCT01412060|5860061|P3|Period Between SP and DBP|Protocol Violation|0
1677693|NCT01412060|5860062|P2|Period Between SP and DBP|Protocol Violation|0
1677694|NCT01412060|5860063|P1|Period Between SP and DBP|Protocol Violation|2
1677695|NCT01412060|5860061|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
1677696|NCT01412060|5860062|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
1677697|NCT01412060|5860063|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
1677698|NCT01412060|5860061|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
1677699|NCT01412060|5860062|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
1677700|NCT01412060|5860063|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
1677701|NCT01412060|5860061|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
1677702|NCT01412060|5860062|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
1677703|NCT01412060|5860063|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
1677704|NCT01412060|5860061|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
1677705|NCT01412060|5860062|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
1677706|NCT01412060|5860063|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
1677707|NCT01412060|5860061|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
1677708|NCT01412060|5860062|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
1677709|NCT01412060|5860063|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
1677710|NCT01412060|5860061|P3|Open-label Stabilization Period (SP)|Adverse Event|0
1677711|NCT01412060|5860062|P2|Open-label Stabilization Period (SP)|Adverse Event|0
1677712|NCT01412060|5860063|P1|Open-label Stabilization Period (SP)|Adverse Event|9
1677713|NCT01412060|5860061|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
1677714|NCT01412060|5860062|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
1677715|NCT01412060|5860063|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
1677716|NCT01412060|5860061|P3|Period Between RIP and SP|Lost to Follow-up|0
1677717|NCT01412060|5860062|P2|Period Between RIP and SP|Lost to Follow-up|0
1677718|NCT01412060|5860063|P1|Period Between RIP and SP|Lost to Follow-up|5
1677719|NCT01412060|5860061|P3|Period Between RIP and SP|Withdrawal of Consent|0
1677720|NCT01412060|5860062|P2|Period Between RIP and SP|Withdrawal of Consent|0
1677721|NCT01412060|5860063|P1|Period Between RIP and SP|Withdrawal of Consent|1
1677722|NCT01412060|5860061|P3|Period Between RIP and SP|Protocol Violation|0
1677723|NCT01412060|5860062|P2|Period Between RIP and SP|Protocol Violation|0
1677724|NCT01412060|5860063|P1|Period Between RIP and SP|Protocol Violation|2
1677725|NCT01412060|5860061|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
1677726|NCT01412060|5860062|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
1677727|NCT01412060|5860063|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
1677728|NCT01412060|5860061|P3|Period Between RIP and SP|Adverse Event|0
1677729|NCT01412060|5860062|P2|Period Between RIP and SP|Adverse Event|0
1677730|NCT01412060|5860063|P1|Period Between RIP and SP|Adverse Event|4
1677731|NCT01412060|5860061|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
1677732|NCT01412060|5860062|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
1677733|NCT01412060|5860063|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
1677734|NCT01412060|5860061|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
1677735|NCT01412060|5860062|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
1677736|NCT01412060|5860063|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
1677737|NCT01412060|5860061|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
1677738|NCT01412060|5860062|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
1677739|NCT01412060|5860063|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
1677740|NCT01412060|5860061|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
1677741|NCT01412060|5860062|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
1677742|NCT01412060|5860063|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
1677743|NCT01412060|5860061|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
1677744|NCT01412060|5860062|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
1677745|NCT01412060|5860063|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
1677746|NCT01412060|5860061|P3|Open-label Run-in Period (RIP)|Adverse Event|0
1677747|NCT01412060|5860062|P2|Open-label Run-in Period (RIP)|Adverse Event|0
1677748|NCT01412060|5860063|P1|Open-label Run-in Period (RIP)|Adverse Event|86
1677749|NCT01412021|5860073|P1|Overall Study|Transferred to Other Hospital|9
1677750|NCT01412021|5860073|P1|Overall Study|Treatment Prior to Approval|3
1677751|NCT01412021|5860073|P1|Overall Study|Case Report Forms Not Retrieved|7
1677752|NCT01411995|5860110|P2|Overall Study|Failed IUD insertion|1
1677753|NCT01411995|5860111|P1|Overall Study|Failed IUD insertion|0
1677754|NCT01411917|5860119|P2|Overall Study|Patient did not undergo scheduled surger|1
1677755|NCT01411917|5860120|P1|Overall Study|Patient did not undergo scheduled surger|0
1677756|NCT01411891|5860142|P2|Overall Study|Catheter dislodgement or loss to follow-|2
1677757|NCT01411891|5860143|P1|Overall Study|Catheter dislodgement or loss to follow-|3
1677758|NCT01411852|5860153|P2|Hospital Intervention Phase|Vascular access failed|0
1677759|NCT01411852|5860154|P1|Hospital Intervention Phase|Vascular access failed|1
1677760|NCT01411852|5860153|P2|Hospital Intervention Phase|Withdrawal by Subject|0
1677761|NCT01411852|5860154|P1|Hospital Intervention Phase|Withdrawal by Subject|1
1677762|NCT01411852|5860153|P2|Hospital Intervention Phase|Spinal cord injury|0
1677763|NCT01411852|5860154|P1|Hospital Intervention Phase|Spinal cord injury|2
1677764|NCT01411852|5860153|P2|Hospital Intervention Phase|Other ineligible|2
1677765|NCT01411852|5860154|P1|Hospital Intervention Phase|Other ineligible|2
1677766|NCT01411852|5860153|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
1677767|NCT01411852|5860154|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
1677768|NCT01411852|5860153|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
1677769|NCT01411852|5860154|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
1677770|NCT01411852|5860153|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
1677771|NCT01411852|5860154|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
1677772|NCT01411852|5860153|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
1677773|NCT01411852|5860154|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
1677774|NCT01411852|5860153|P2|Hospital Intervention Phase|CPR administered|1
1677775|NCT01411852|5860154|P1|Hospital Intervention Phase|CPR administered|3
1677776|NCT01411852|5860153|P2|Hospital Intervention Phase|Miscommunication error|2
1677777|NCT01411852|5860154|P1|Hospital Intervention Phase|Miscommunication error|1
1677778|NCT01411852|5860153|P2|Hospital Intervention Phase|No qualifying SBP|1
1677779|NCT01411852|5860154|P1|Hospital Intervention Phase|No qualifying SBP|5
1677780|NCT01411852|5860153|P2|Hospital Intervention Phase|Severe head injury|4
1677781|NCT01411852|5860154|P1|Hospital Intervention Phase|Severe head injury|5
1677782|NCT01411852|5860153|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
1677783|NCT01411852|5860154|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
1677784|NCT01411852|5860153|P2|Prehospital Intervention Phase|Found to be under age|1
1677785|NCT01411852|5860154|P1|Prehospital Intervention Phase|Found to be under age|0
1677786|NCT01411852|5860153|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
1677787|NCT01411852|5860154|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
1677788|NCT01411852|5860153|P2|Prehospital Intervention Phase|No qualifying SBP|4
1677789|NCT01411852|5860154|P1|Prehospital Intervention Phase|No qualifying SBP|5
1677790|NCT01411839|5860199|P2|Overall Study|Lost to Follow-up|3
1677791|NCT01411839|5860200|P1|Overall Study|Lost to Follow-up|4
1677792|NCT01411774|5860212|P2|Overall Study|Withdrawal by Subject|3
1677793|NCT01411774|5860213|P1|Overall Study|Withdrawal by Subject|0
1677794|NCT01411241|5860328|P2|Overall Study|Lost to Follow-up|4
1677795|NCT01411241|5860329|P1|Overall Study|Lost to Follow-up|2
1677796|NCT01411241|5860328|P2|Overall Study|Serious Adverse Event|3
1677797|NCT01411241|5860329|P1|Overall Study|Serious Adverse Event|0
1677798|NCT01411241|5860328|P2|Overall Study|Withdrawal by Subject|10
1677799|NCT01411241|5860329|P1|Overall Study|Withdrawal by Subject|9
1677800|NCT01411241|5860328|P2|Overall Study|Protocol Violation|5
1677801|NCT01411241|5860329|P1|Overall Study|Protocol Violation|0
1677802|NCT01411228|5860354|P3|Overall Study|Withdrawal by Subject|0
1677803|NCT01411228|5860355|P2|Overall Study|Withdrawal by Subject|0
1677804|NCT01411228|5860356|P1|Overall Study|Withdrawal by Subject|1
1677805|NCT01411228|5860354|P3|Overall Study|Lost to Follow-up|1
1677806|NCT01411228|5860355|P2|Overall Study|Lost to Follow-up|0
1677807|NCT01411228|5860356|P1|Overall Study|Lost to Follow-up|0
1677808|NCT01411215|5860378|P2|Overall Study|Screen failure|1
1677809|NCT01411215|5860379|P1|Overall Study|Screen failure|0
1677810|NCT01411215|5860378|P2|Overall Study|Other|17
1677811|NCT01411215|5860379|P1|Overall Study|Other|12
1677812|NCT01411215|5860378|P2|Overall Study|Withdrawal by Subject|21
1677813|NCT01411215|5860379|P1|Overall Study|Withdrawal by Subject|34
1677814|NCT01411215|5860378|P2|Overall Study|Protocol Violation|5
1677815|NCT01411215|5860379|P1|Overall Study|Protocol Violation|3
1677816|NCT01411215|5860378|P2|Overall Study|Study terminated by sponsor|15
1677817|NCT01411215|5860379|P1|Overall Study|Study terminated by sponsor|2
1677818|NCT01411215|5860378|P2|Overall Study|Did not meet entrance criteria|1
1677819|NCT01411215|5860379|P1|Overall Study|Did not meet entrance criteria|0
1677820|NCT01411215|5860378|P2|Overall Study|Lost to Follow-up|18
1677821|NCT01411215|5860379|P1|Overall Study|Lost to Follow-up|12
1677822|NCT01411215|5860378|P2|Overall Study|Lack of Efficacy|4
1677823|NCT01411215|5860379|P1|Overall Study|Lack of Efficacy|2
1677824|NCT01411215|5860378|P2|Overall Study|Adverse Event|2
1677825|NCT01411215|5860379|P1|Overall Study|Adverse Event|1
1677826|NCT01411085|5860431|P1|Overall Study|Adverse Event|1
1677827|NCT01411085|5860431|P1|Overall Study|Protocol Violation|1
1677828|NCT01411085|5860431|P1|Overall Study|Physician Decision|1
1677829|NCT01410799|5860451|P1|Overall Study|PI decision|13
1677830|NCT01410604|5860467|P2|Overall Study|Physician Decision|1
1677831|NCT01410604|5860468|P1|Overall Study|Physician Decision|0
1677832|NCT01410604|5860467|P2|Overall Study|Lost to Follow-up|0
1677833|NCT01410604|5860468|P1|Overall Study|Lost to Follow-up|1
1677834|NCT01410604|5860467|P2|Overall Study|Adverse Event|1
1677835|NCT01410604|5860468|P1|Overall Study|Adverse Event|2
1677836|NCT01410474|5860509|P2|Overall Study|Withdrawal by Subject|1
1677837|NCT01410474|5860510|P1|Overall Study|Withdrawal by Subject|0
1677838|NCT01410448|5860533|P2|Overall Study|Death|3
1677839|NCT01410448|5860534|P1|Overall Study|Death|2
1677840|NCT01410448|5860533|P2|Overall Study|Protocol Violation|4
1677841|NCT01410448|5860534|P1|Overall Study|Protocol Violation|0
1677842|NCT01410448|5860533|P2|Overall Study|Withdrawal by Subject|2
1677843|NCT01410448|5860534|P1|Overall Study|Withdrawal by Subject|3
1677844|NCT01410448|5860533|P2|Overall Study|Lost to Follow-up|0
1677845|NCT01410448|5860534|P1|Overall Study|Lost to Follow-up|1
1677846|NCT01410448|5860533|P2|Overall Study|Administrative issues|1
1677847|NCT01410448|5860534|P1|Overall Study|Administrative issues|2
1677848|NCT01410448|5860533|P2|Overall Study|Graft loss|1
1677849|NCT01410448|5860534|P1|Overall Study|Graft loss|4
1677850|NCT01410448|5860533|P2|Overall Study|No conversion to everolimus|24
1677851|NCT01410448|5860534|P1|Overall Study|No conversion to everolimus|0
1677852|NCT01410357|5860599|P2|Overall Study|Lost to Follow-up|21
1677853|NCT01410357|5860600|P1|Overall Study|Lost to Follow-up|23
1677854|NCT01410357|5860599|P2|Overall Study|Withdrawal by Subject|2
1677855|NCT01410357|5860600|P1|Overall Study|Withdrawal by Subject|1
1677856|NCT01410357|5860599|P2|Overall Study|Death|1
1677857|NCT01410357|5860600|P1|Overall Study|Death|2
1677858|NCT01410240|5860671|P3|Overall Study|Missed week 6 assessments|1
1677859|NCT01410240|5860672|P2|Overall Study|Missed week 6 assessments|1
1677860|NCT01410240|5860673|P1|Overall Study|Missed week 6 assessments|1
1677861|NCT01410240|5860671|P3|Overall Study|Physician Decision|1
1677862|NCT01410240|5860672|P2|Overall Study|Physician Decision|0
1677863|NCT01410240|5860673|P1|Overall Study|Physician Decision|0
1677864|NCT01410227|5860744|P4|Overall Study|Met Excl. Criteria After Starting Study|0
1677865|NCT01410227|5860745|P3|Overall Study|Met Excl. Criteria After Starting Study|1
1677866|NCT01410227|5860746|P2|Overall Study|Met Excl. Criteria After Starting Study|0
1677867|NCT01410227|5860747|P1|Overall Study|Met Excl. Criteria After Starting Study|0
1677868|NCT01410227|5860744|P4|Overall Study|Pregnancy|1
1677869|NCT01410227|5860745|P3|Overall Study|Pregnancy|0
1677870|NCT01410227|5860746|P2|Overall Study|Pregnancy|0
1677871|NCT01410227|5860747|P1|Overall Study|Pregnancy|0
1677872|NCT01410227|5860744|P4|Overall Study|Withdrawal by Subject|0
1677873|NCT01410227|5860745|P3|Overall Study|Withdrawal by Subject|1
1677874|NCT01410227|5860746|P2|Overall Study|Withdrawal by Subject|0
1677875|NCT01410227|5860747|P1|Overall Study|Withdrawal by Subject|3
1677876|NCT01410227|5860744|P4|Overall Study|Adverse Event|0
1677877|NCT01410227|5860745|P3|Overall Study|Adverse Event|0
1677878|NCT01410227|5860746|P2|Overall Study|Adverse Event|0
1677879|NCT01410227|5860747|P1|Overall Study|Adverse Event|1
1677880|NCT01410110|5860819|P2|Overall Study|Withdrawal by Subject|2
1677881|NCT01410110|5860820|P1|Overall Study|Withdrawal by Subject|4
1677882|NCT01409993|5860895|P4|Overall Study|Lost to Follow-up|0
1677883|NCT01409993|5860896|P3|Overall Study|Lost to Follow-up|0
1677884|NCT01409993|5860897|P2|Overall Study|Lost to Follow-up|1
1677885|NCT01409993|5860898|P1|Overall Study|Lost to Follow-up|0
1677886|NCT01409993|5860895|P4|Overall Study|Withdrawal by Subject|4
1677887|NCT01409993|5860896|P3|Overall Study|Withdrawal by Subject|0
1677888|NCT01409993|5860897|P2|Overall Study|Withdrawal by Subject|0
1677889|NCT01409993|5860898|P1|Overall Study|Withdrawal by Subject|0
1677890|NCT01409993|5860895|P4|Overall Study|Adverse Event|1
1677891|NCT01409993|5860896|P3|Overall Study|Adverse Event|3
1677892|NCT01409993|5860897|P2|Overall Study|Adverse Event|4
1677893|NCT01409993|5860898|P1|Overall Study|Adverse Event|4
1677894|NCT01409837|5860918|P2|Overall Study|Physician Decision|1
1677895|NCT01409837|5860919|P1|Overall Study|Physician Decision|0
1677896|NCT01409837|5860918|P2|Overall Study|Lost to Follow-up|0
1677897|NCT01409837|5860919|P1|Overall Study|Lost to Follow-up|1
1677898|NCT01409837|5860918|P2|Overall Study|Withdrawal by Subject|1
1677899|NCT01409837|5860919|P1|Overall Study|Withdrawal by Subject|2
1677900|NCT01409707|5860944|P3|Overall Study|Withdrawal by Subject|16
1677901|NCT01409707|5860945|P2|Overall Study|Withdrawal by Subject|17
1677902|NCT01409707|5860946|P1|Overall Study|Withdrawal by Subject|5
1677903|NCT01409564|5860958|P2|Overall Study|brain abnormalities found in T1 MR|2
1677904|NCT01409564|5860959|P1|Overall Study|brain abnormalities found in T1 MR|1
1677905|NCT01409564|5860958|P2|Overall Study|low medication compliance|3
1677906|NCT01409564|5860959|P1|Overall Study|low medication compliance|4
1677907|NCT01409434|5860977|P1|Overall Study|Protocol Violation|4
1677908|NCT01409382|5860987|P2|Overall Study|Had a 2nd trimester loss after accident|0
1677909|NCT01409382|5860988|P1|Overall Study|Had a 2nd trimester loss after accident|1
1677910|NCT01409382|5860987|P2|Overall Study|Did not manage to get pregnant|70
1677911|NCT01409382|5860988|P1|Overall Study|Did not manage to get pregnant|64
1677912|NCT01409382|5860987|P2|Overall Study|Still pregnant when study ended|2
1677913|NCT01409382|5860988|P1|Overall Study|Still pregnant when study ended|13
1677914|NCT01409382|5860987|P2|Overall Study|Multiple pregnancy|4
1677915|NCT01409382|5860988|P1|Overall Study|Multiple pregnancy|2
1677916|NCT01409382|5860987|P2|Overall Study|Protocol Violation|3
1677917|NCT01409382|5860988|P1|Overall Study|Protocol Violation|0
1677918|NCT01409382|5860987|P2|Overall Study|Lost to Follow-up|1
1677919|NCT01409382|5860988|P1|Overall Study|Lost to Follow-up|1
1677920|NCT01409031|5861042|P2|Overall Study|transferred to other hosp|0
1677921|NCT01409031|5861043|P1|Overall Study|transferred to other hosp|1
1677922|NCT01408914|5861074|P3|Overall Study|Change in local TB/HIV norms|1
1677923|NCT01408914|5861075|P2|Overall Study|Change in local TB/HIV norms|1
1677924|NCT01408914|5861076|P1|Overall Study|Change in local TB/HIV norms|0
1677925|NCT01408914|5861074|P3|Overall Study|Late exclusion|3
1677926|NCT01408914|5861075|P2|Overall Study|Late exclusion|3
1677927|NCT01408914|5861076|P1|Overall Study|Late exclusion|0
1677928|NCT01408914|5861074|P3|Overall Study|Moved out of study jurisdiction|0
1677929|NCT01408914|5861075|P2|Overall Study|Moved out of study jurisdiction|1
1677930|NCT01408914|5861076|P1|Overall Study|Moved out of study jurisdiction|1
1677931|NCT01408914|5861074|P3|Overall Study|Withdrawal by Subject|1
1677932|NCT01408914|5861075|P2|Overall Study|Withdrawal by Subject|0
1677933|NCT01408914|5861076|P1|Overall Study|Withdrawal by Subject|1
1677934|NCT01408914|5861074|P3|Overall Study|Physician Decision|0
1677935|NCT01408914|5861075|P2|Overall Study|Physician Decision|1
1677936|NCT01408914|5861076|P1|Overall Study|Physician Decision|1
1677937|NCT01408914|5861074|P3|Overall Study|Lost to Follow-up|2
1677938|NCT01408914|5861075|P2|Overall Study|Lost to Follow-up|1
1677939|NCT01408914|5861076|P1|Overall Study|Lost to Follow-up|4
1677940|NCT01408914|5861074|P3|Overall Study|Could not complete tx in protocol period|6
1677941|NCT01408914|5861075|P2|Overall Study|Could not complete tx in protocol period|5
1677942|NCT01408914|5861076|P1|Overall Study|Could not complete tx in protocol period|5
1677943|NCT01408901|5861094|P4|26-Week Follow-Up|Death|0
1677944|NCT01408901|5861095|P3|26-Week Follow-Up|Death|0
1677945|NCT01408901|5861096|P2|26-Week Follow-Up|Death|1
1677946|NCT01408901|5861097|P1|26-Week Follow-Up|Death|0
1677947|NCT01408901|5861094|P4|26-Week Follow-Up|Lost to Follow-up|1
1677948|NCT01408901|5861095|P3|26-Week Follow-Up|Lost to Follow-up|0
1677949|NCT01408901|5861096|P2|26-Week Follow-Up|Lost to Follow-up|1
1677950|NCT01408901|5861097|P1|26-Week Follow-Up|Lost to Follow-up|1
1677951|NCT01408901|5861094|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
1677952|NCT01408901|5861095|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
1677953|NCT01408901|5861096|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
1677954|NCT01408901|5861097|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
1677955|NCT01408901|5861094|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
1677956|NCT01408901|5861095|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
1677957|NCT01408901|5861096|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
1677958|NCT01408901|5861097|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
1677959|NCT01408901|5861094|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
1677960|NCT01408901|5861095|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
1677961|NCT01408901|5861096|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
1677962|NCT01408901|5861097|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
1677963|NCT01408901|5861094|P4|6-Week Follow-Up|Cancelled visit|2
1677964|NCT01408901|5861095|P3|6-Week Follow-Up|Cancelled visit|0
1677965|NCT01408901|5861096|P2|6-Week Follow-Up|Cancelled visit|1
1677966|NCT01408901|5861097|P1|6-Week Follow-Up|Cancelled visit|0
1677967|NCT01408901|5861094|P4|6-Week Follow-Up|Death|0
1677968|NCT01408901|5861095|P3|6-Week Follow-Up|Death|0
1677969|NCT01408901|5861096|P2|6-Week Follow-Up|Death|0
1677970|NCT01408901|5861097|P1|6-Week Follow-Up|Death|1
1677971|NCT01408901|5861094|P4|6-Week Follow-Up|Lost to Follow-up|2
1677972|NCT01408901|5861095|P3|6-Week Follow-Up|Lost to Follow-up|3
1677973|NCT01408901|5861096|P2|6-Week Follow-Up|Lost to Follow-up|1
1677974|NCT01408901|5861097|P1|6-Week Follow-Up|Lost to Follow-up|2
1677975|NCT01408888|5861123|P2|Second Intervention|Adverse Event|0
1677976|NCT01408888|5861124|P1|Second Intervention|Adverse Event|1
1677977|NCT01408888|5861123|P2|Second Intervention|Withdrawal by Subject|0
1677978|NCT01408888|5861124|P1|Second Intervention|Withdrawal by Subject|1
1677979|NCT01408888|5861123|P2|First Intervention|Withdrawal by Subject|2
1677980|NCT01408888|5861124|P1|First Intervention|Withdrawal by Subject|0
1677981|NCT01408888|5861123|P2|First Intervention|Adverse Event|1
1677982|NCT01408888|5861124|P1|First Intervention|Adverse Event|0
1677983|NCT01408732|5861152|P2|Overall Study|Withdrawal by Subject|2
1677984|NCT01408732|5861153|P1|Overall Study|Withdrawal by Subject|2
1677985|NCT01408706|5861210|P2|Overall Study|Physician Decision|0
1677986|NCT01408706|5861211|P1|Overall Study|Physician Decision|1
1677987|NCT01408641|5861223|P2|Overall Study|Physician Decision|0
1677988|NCT01408641|5861224|P1|Overall Study|Physician Decision|1
1677989|NCT01408628|5861232|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
1677990|NCT01408628|5861232|P1|Completed 6 Month Follow-Up|Protocol Violation|6
1677991|NCT01408628|5861232|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
1677992|NCT01408628|5861232|P1|Consented|Withdrawal by Subject|12
1677993|NCT01408576|5861241|P3|Overall Study|Other|18
1677994|NCT01408576|5861242|P2|Overall Study|Other|16
1677995|NCT01408576|5861243|P1|Overall Study|Other|10
1677996|NCT01408576|5861241|P3|Overall Study|AE, unknown type|0
1677997|NCT01408576|5861242|P2|Overall Study|AE, unknown type|1
1677998|NCT01408576|5861243|P1|Overall Study|AE, unknown type|0
1677999|NCT01408576|5861241|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1678000|NCT01408576|5861242|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1678001|NCT01408576|5861243|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1678002|NCT01408576|5861241|P3|Overall Study|AE, non-serious non-fatal|11
1678003|NCT01408576|5861242|P2|Overall Study|AE, non-serious non-fatal|19
1678004|NCT01408576|5861243|P1|Overall Study|AE, non-serious non-fatal|12
1678005|NCT01408576|5861241|P3|Overall Study|SAE, non-fatal|14
1678006|NCT01408576|5861242|P2|Overall Study|SAE, non-fatal|23
1678007|NCT01408576|5861243|P1|Overall Study|SAE, non-fatal|11
1678008|NCT01408576|5861241|P3|Overall Study|AE, serious fatal|1
1678009|NCT01408576|5861242|P2|Overall Study|AE, serious fatal|4
1678010|NCT01408576|5861243|P1|Overall Study|AE, serious fatal|4
1678011|NCT01408576|5861241|P3|Overall Study|Sponsor terminated study|330
1678012|NCT01408576|5861242|P2|Overall Study|Sponsor terminated study|333
1678013|NCT01408576|5861243|P1|Overall Study|Sponsor terminated study|89
1678014|NCT01408576|5861241|P3|Overall Study|Withdrawal by Subject|66
1678015|NCT01408576|5861242|P2|Overall Study|Withdrawal by Subject|60
1678016|NCT01408576|5861243|P1|Overall Study|Withdrawal by Subject|34
1678017|NCT01408576|5861241|P3|Overall Study|Lost to Follow-up|17
1678018|NCT01408576|5861242|P2|Overall Study|Lost to Follow-up|9
1678019|NCT01408576|5861243|P1|Overall Study|Lost to Follow-up|10
1678020|NCT01408576|5861241|P3|Overall Study|Protocol Violation|2
1678021|NCT01408576|5861242|P2|Overall Study|Protocol Violation|2
1678022|NCT01408576|5861243|P1|Overall Study|Protocol Violation|1
1678023|NCT01408576|5861241|P3|Overall Study|Lack of Efficacy|48
1678024|NCT01408576|5861242|P2|Overall Study|Lack of Efficacy|30
1678025|NCT01408576|5861243|P1|Overall Study|Lack of Efficacy|17
1678026|NCT01408563|5861290|P1|Overall Study|Ineligible after consent/ registration|2
1678027|NCT01408537|5861306|P1|Overall Study|Lost to Follow-up|3
1678028|NCT01408537|5861306|P1|Overall Study|Protocol Violation|3
1678029|NCT01408537|5861306|P1|Overall Study|Withdrawal by Subject|2
1678030|NCT01408485|5861322|P1|Overall Study|Withdrawal by Subject|21
1678031|NCT01408303|5861340|P3|Overall Study|Noncompliance|1
1678032|NCT01408303|5861341|P2|Overall Study|Noncompliance|0
1678033|NCT01408303|5861342|P1|Overall Study|Noncompliance|1
1678034|NCT01408303|5861340|P3|Overall Study|Protocol Violation|0
1678035|NCT01408303|5861341|P2|Overall Study|Protocol Violation|1
1678036|NCT01408303|5861342|P1|Overall Study|Protocol Violation|0
1678037|NCT01408303|5861340|P3|Overall Study|Withdrawal by Subject|1
1678038|NCT01408303|5861341|P2|Overall Study|Withdrawal by Subject|3
1678039|NCT01408303|5861342|P1|Overall Study|Withdrawal by Subject|2
1678040|NCT01408303|5861340|P3|Overall Study|Lost to Follow-up|2
1678041|NCT01408303|5861341|P2|Overall Study|Lost to Follow-up|1
1678042|NCT01408303|5861342|P1|Overall Study|Lost to Follow-up|0
1678043|NCT01408303|5861340|P3|Overall Study|Adverse Event|2
1678044|NCT01408303|5861341|P2|Overall Study|Adverse Event|7
1678045|NCT01408303|5861342|P1|Overall Study|Adverse Event|3
1678046|NCT01408277|5861352|P2|Overall Study|Protocol Violation|0
1678047|NCT01408277|5861353|P1|Overall Study|Protocol Violation|2
1678048|NCT01408277|5861352|P2|Overall Study|Withdrawal by Subject|0
1678049|NCT01408277|5861353|P1|Overall Study|Withdrawal by Subject|2
1678050|NCT01408277|5861352|P2|Overall Study|Lost to Follow-up|0
1678051|NCT01408277|5861353|P1|Overall Study|Lost to Follow-up|1
1678052|NCT01408277|5861352|P2|Overall Study|Adverse Event|4
1678053|NCT01408277|5861353|P1|Overall Study|Adverse Event|3
1678054|NCT01408043|5861359|P1|Overall Study|unable to collect cells|1
1678055|NCT01408030|5861378|P4|Observation Phase (Off Drug)|Other|1
1678056|NCT01408030|5861379|P3|Observation Phase (Off Drug)|Other|1
1678057|NCT01408030|5861380|P2|Observation Phase (Off Drug)|Other|1
1678058|NCT01408030|5861381|P1|Observation Phase (Off Drug)|Other|1
1678059|NCT01408030|5861378|P4|Observation Phase (Off Drug)|Physician Decision|0
1678060|NCT01408030|5861379|P3|Observation Phase (Off Drug)|Physician Decision|2
1678061|NCT01408030|5861380|P2|Observation Phase (Off Drug)|Physician Decision|1
1678062|NCT01408030|5861381|P1|Observation Phase (Off Drug)|Physician Decision|0
1678063|NCT01408030|5861378|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
1678064|NCT01408030|5861379|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
1678065|NCT01408030|5861380|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
1678066|NCT01408030|5861381|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
1678067|NCT01408030|5861378|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
1678068|NCT01408030|5861379|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
1678069|NCT01408030|5861380|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
1678070|NCT01408030|5861381|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
1678071|NCT01408030|5861378|P4|Treatment Phase (on Drug)|Protocol Violation|0
1678072|NCT01408030|5861379|P3|Treatment Phase (on Drug)|Protocol Violation|0
1678073|NCT01408030|5861380|P2|Treatment Phase (on Drug)|Protocol Violation|1
1678074|NCT01408030|5861381|P1|Treatment Phase (on Drug)|Protocol Violation|0
1678075|NCT01408030|5861378|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
1678076|NCT01408030|5861379|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
1678077|NCT01408030|5861380|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
1678078|NCT01408030|5861381|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
1678079|NCT01408030|5861378|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
1678080|NCT01408030|5861379|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
1678081|NCT01408030|5861380|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
1678082|NCT01408030|5861381|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
1678083|NCT01407926|5861440|P1|Overall Study|Lost to Follow-up|55
1678084|NCT01407367|5861488|P2|Overall Study|Lost to Follow-up|2
1678085|NCT01407367|5861489|P1|Overall Study|Lost to Follow-up|0
1678086|NCT01407367|5861488|P2|Overall Study|Withdrawal by Subject|15
1678087|NCT01407367|5861489|P1|Overall Study|Withdrawal by Subject|4
1678088|NCT01407367|5861488|P2|Overall Study|Renal Replacement Therapy (RRT)|29
1678089|NCT01407367|5861489|P1|Overall Study|Renal Replacement Therapy (RRT)|12
1678090|NCT01407367|5861488|P2|Overall Study|Death|32
1678091|NCT01407367|5861489|P1|Overall Study|Death|24
1678092|NCT01407354|5861503|P2|First Intervention|Physician Decision|0
1678093|NCT01407354|5861504|P1|First Intervention|Physician Decision|1
1678094|NCT01407354|5861503|P2|First Intervention|Adverse Event|0
1678095|NCT01407354|5861504|P1|First Intervention|Adverse Event|1
1678096|NCT01407354|5861503|P2|First Intervention|Withdrawal by Subject|2
1678097|NCT01407354|5861504|P1|First Intervention|Withdrawal by Subject|0
1678098|NCT01407276|5861520|P8|Overall Study|Withdrawal by Subject|1
1678099|NCT01407276|5861521|P7|Overall Study|Withdrawal by Subject|0
1678100|NCT01407276|5861522|P6|Overall Study|Withdrawal by Subject|0
1678101|NCT01407276|5861523|P5|Overall Study|Withdrawal by Subject|0
1678102|NCT01407276|5861524|P4|Overall Study|Withdrawal by Subject|0
1678103|NCT01407276|5861525|P3|Overall Study|Withdrawal by Subject|0
1678104|NCT01407276|5861526|P2|Overall Study|Withdrawal by Subject|0
1678105|NCT01407276|5861527|P1|Overall Study|Withdrawal by Subject|0
1678106|NCT01406938|5861679|P6|Follow up|Lost to Follow-up|1
1678107|NCT01406938|5861680|P5|Follow up|Lost to Follow-up|2
1678108|NCT01406938|5861681|P4|Follow up|Lost to Follow-up|1
1678109|NCT01406938|5861682|P3|Follow up|Lost to Follow-up|0
1678110|NCT01406938|5861683|P2|Follow up|Lost to Follow-up|1
1678111|NCT01406938|5861684|P1|Follow up|Lost to Follow-up|1
1678112|NCT01406938|5861679|P6|Follow up|Physician Decision|1
1678113|NCT01406938|5861680|P5|Follow up|Physician Decision|3
1678114|NCT01406938|5861681|P4|Follow up|Physician Decision|0
1678115|NCT01406938|5861682|P3|Follow up|Physician Decision|2
1678116|NCT01406938|5861683|P2|Follow up|Physician Decision|0
1678117|NCT01406938|5861684|P1|Follow up|Physician Decision|0
1678118|NCT01406938|5861679|P6|Follow up|Protocol Violation|0
1678119|NCT01406938|5861680|P5|Follow up|Protocol Violation|0
1678120|NCT01406938|5861681|P4|Follow up|Protocol Violation|0
1678121|NCT01406938|5861682|P3|Follow up|Protocol Violation|1
1678122|NCT01406938|5861683|P2|Follow up|Protocol Violation|0
1678123|NCT01406938|5861684|P1|Follow up|Protocol Violation|0
1678124|NCT01406938|5861679|P6|Follow up|Patient/guardian decision|1
1678125|NCT01406938|5861680|P5|Follow up|Patient/guardian decision|4
1678126|NCT01406938|5861681|P4|Follow up|Patient/guardian decision|2
1678127|NCT01406938|5861682|P3|Follow up|Patient/guardian decision|4
1678128|NCT01406938|5861683|P2|Follow up|Patient/guardian decision|2
1678129|NCT01406938|5861684|P1|Follow up|Patient/guardian decision|4
1678130|NCT01406938|5861679|P6|Follow up|Lack of Efficacy|0
1678131|NCT01406938|5861680|P5|Follow up|Lack of Efficacy|0
1678132|NCT01406938|5861681|P4|Follow up|Lack of Efficacy|0
1678133|NCT01406938|5861682|P3|Follow up|Lack of Efficacy|1
1678134|NCT01406938|5861683|P2|Follow up|Lack of Efficacy|2
1678135|NCT01406938|5861684|P1|Follow up|Lack of Efficacy|3
1678136|NCT01406938|5861679|P6|Maintenance Period|Lack of Efficacy|5
1678137|NCT01406938|5861680|P5|Maintenance Period|Lack of Efficacy|3
1678138|NCT01406938|5861681|P4|Maintenance Period|Lack of Efficacy|1
1678139|NCT01406938|5861682|P3|Maintenance Period|Lack of Efficacy|2
1678140|NCT01406938|5861683|P2|Maintenance Period|Lack of Efficacy|0
1678141|NCT01406938|5861684|P1|Maintenance Period|Lack of Efficacy|0
1678142|NCT01406938|5861679|P6|Maintenance Period|Lost to Follow-up|0
1678143|NCT01406938|5861680|P5|Maintenance Period|Lost to Follow-up|4
1678144|NCT01406938|5861681|P4|Maintenance Period|Lost to Follow-up|0
1678145|NCT01406938|5861682|P3|Maintenance Period|Lost to Follow-up|0
1678146|NCT01406938|5861683|P2|Maintenance Period|Lost to Follow-up|0
1678147|NCT01406938|5861684|P1|Maintenance Period|Lost to Follow-up|0
1678148|NCT01406938|5861679|P6|Maintenance Period|Pregnancy|0
1678149|NCT01406938|5861680|P5|Maintenance Period|Pregnancy|1
1678150|NCT01406938|5861681|P4|Maintenance Period|Pregnancy|0
1678151|NCT01406938|5861682|P3|Maintenance Period|Pregnancy|0
1678152|NCT01406938|5861683|P2|Maintenance Period|Pregnancy|0
1678153|NCT01406938|5861684|P1|Maintenance Period|Pregnancy|0
1678154|NCT01406938|5861679|P6|Maintenance Period|Protocol Violation|2
1678155|NCT01406938|5861680|P5|Maintenance Period|Protocol Violation|2
1678156|NCT01406938|5861681|P4|Maintenance Period|Protocol Violation|2
1678157|NCT01406938|5861682|P3|Maintenance Period|Protocol Violation|2
1678158|NCT01406938|5861683|P2|Maintenance Period|Protocol Violation|0
1678159|NCT01406938|5861684|P1|Maintenance Period|Protocol Violation|0
1678160|NCT01406938|5861679|P6|Maintenance Period|Subject/guardian decision|7
1678161|NCT01406938|5861680|P5|Maintenance Period|Subject/guardian decision|10
1678162|NCT01406938|5861681|P4|Maintenance Period|Subject/guardian decision|7
1678163|NCT01406938|5861682|P3|Maintenance Period|Subject/guardian decision|11
1678164|NCT01406938|5861683|P2|Maintenance Period|Subject/guardian decision|0
1678165|NCT01406938|5861684|P1|Maintenance Period|Subject/guardian decision|0
1678166|NCT01406938|5861679|P6|Maintenance Period|Death|0
1678167|NCT01406938|5861680|P5|Maintenance Period|Death|1
1678168|NCT01406938|5861681|P4|Maintenance Period|Death|0
1678169|NCT01406938|5861682|P3|Maintenance Period|Death|0
1678170|NCT01406938|5861683|P2|Maintenance Period|Death|0
1678171|NCT01406938|5861684|P1|Maintenance Period|Death|0
1678172|NCT01406938|5861679|P6|Maintenance Period|Adverse Event|2
1678173|NCT01406938|5861680|P5|Maintenance Period|Adverse Event|4
1678174|NCT01406938|5861681|P4|Maintenance Period|Adverse Event|8
1678175|NCT01406938|5861682|P3|Maintenance Period|Adverse Event|2
1678176|NCT01406938|5861683|P2|Maintenance Period|Adverse Event|0
1678177|NCT01406938|5861684|P1|Maintenance Period|Adverse Event|0
1678178|NCT01406938|5861679|P6|Induction Period|Lost to Follow-up|0
1678179|NCT01406938|5861680|P5|Induction Period|Lost to Follow-up|0
1678180|NCT01406938|5861681|P4|Induction Period|Lost to Follow-up|0
1678181|NCT01406938|5861682|P3|Induction Period|Lost to Follow-up|0
1678182|NCT01406938|5861683|P2|Induction Period|Lost to Follow-up|3
1678183|NCT01406938|5861684|P1|Induction Period|Lost to Follow-up|2
1678184|NCT01406938|5861679|P6|Induction Period|Lack of Efficacy|0
1678185|NCT01406938|5861680|P5|Induction Period|Lack of Efficacy|0
1678186|NCT01406938|5861681|P4|Induction Period|Lack of Efficacy|0
1678187|NCT01406938|5861682|P3|Induction Period|Lack of Efficacy|0
1678188|NCT01406938|5861683|P2|Induction Period|Lack of Efficacy|0
1678189|NCT01406938|5861684|P1|Induction Period|Lack of Efficacy|1
1678190|NCT01406938|5861679|P6|Induction Period|Adverse Event|0
1678191|NCT01406938|5861680|P5|Induction Period|Adverse Event|0
1678192|NCT01406938|5861681|P4|Induction Period|Adverse Event|0
1678193|NCT01406938|5861682|P3|Induction Period|Adverse Event|0
1678194|NCT01406938|5861683|P2|Induction Period|Adverse Event|9
1678195|NCT01406938|5861684|P1|Induction Period|Adverse Event|8
1678196|NCT01406938|5861679|P6|Induction Period|Protocol deviation|0
1678197|NCT01406938|5861680|P5|Induction Period|Protocol deviation|0
1678198|NCT01406938|5861681|P4|Induction Period|Protocol deviation|0
1678199|NCT01406938|5861682|P3|Induction Period|Protocol deviation|0
1678200|NCT01406938|5861683|P2|Induction Period|Protocol deviation|0
1678201|NCT01406938|5861684|P1|Induction Period|Protocol deviation|1
1678202|NCT01406938|5861679|P6|Induction Period|Subject/guardian decision|0
1678203|NCT01406938|5861680|P5|Induction Period|Subject/guardian decision|0
1678204|NCT01406938|5861681|P4|Induction Period|Subject/guardian decision|0
1678205|NCT01406938|5861682|P3|Induction Period|Subject/guardian decision|0
1678206|NCT01406938|5861683|P2|Induction Period|Subject/guardian decision|8
1678207|NCT01406938|5861684|P1|Induction Period|Subject/guardian decision|6
1678208|NCT01406873|5861802|P2|Overall Study|Withdrawal by Subject|1
1678209|NCT01406873|5861803|P1|Overall Study|Withdrawal by Subject|1
1678210|NCT01406795|5861834|P1|Overall Study|Withdrawal by Subject|1
1678211|NCT01406717|5861850|P2|Overall Study|Non-completion of visit activity|1
1678212|NCT01406717|5861851|P1|Overall Study|Non-completion of visit activity|0
1678213|NCT01406717|5861850|P2|Overall Study|Lack of Efficacy|1
1678214|NCT01406717|5861851|P1|Overall Study|Lack of Efficacy|0
1678215|NCT01406717|5861850|P2|Overall Study|Adverse Event|2
1678216|NCT01406717|5861851|P1|Overall Study|Adverse Event|1
1678217|NCT01406717|5861850|P2|Overall Study|Withdrawal by Subject|15
1678218|NCT01406717|5861851|P1|Overall Study|Withdrawal by Subject|19
1678219|NCT01406717|5861850|P2|Overall Study|Lost to Follow-up|8
1678220|NCT01406717|5861851|P1|Overall Study|Lost to Follow-up|14
1678221|NCT01406717|5861850|P2|Overall Study|Protocol Violation|1
1678222|NCT01406717|5861851|P1|Overall Study|Protocol Violation|5
1678223|NCT01406717|5861850|P2|Overall Study|Subject non-compliance|3
1678224|NCT01406717|5861851|P1|Overall Study|Subject non-compliance|4
1678225|NCT01406652|5861881|P2|Overall Study|Infection not sure|10
1678226|NCT01406652|5861882|P1|Overall Study|Infection not sure|10
1678227|NCT01406652|5861881|P2|Overall Study|Insufficient follow-up|4
1678228|NCT01406652|5861882|P1|Overall Study|Insufficient follow-up|5
1678229|NCT01406652|5861881|P2|Overall Study|Withdrawal by Subject|2
1678230|NCT01406652|5861882|P1|Overall Study|Withdrawal by Subject|2
1678231|NCT01406652|5861881|P2|Overall Study|Lost-to-follow-up|4
1678232|NCT01406652|5861882|P1|Overall Study|Lost-to-follow-up|3
1678233|NCT01406574|5861890|P4|Overall Study|Definite progression of primary disease|0
1678234|NCT01406574|5861891|P3|Overall Study|Definite progression of primary disease|0
1678235|NCT01406574|5861892|P2|Overall Study|Definite progression of primary disease|0
1678236|NCT01406574|5861893|P1|Overall Study|Definite progression of primary disease|1
1678237|NCT01406574|5861890|P4|Overall Study|Withdrawal by Subject|0
1678238|NCT01406574|5861891|P3|Overall Study|Withdrawal by Subject|0
1678239|NCT01406574|5861892|P2|Overall Study|Withdrawal by Subject|1
1678240|NCT01406574|5861893|P1|Overall Study|Withdrawal by Subject|0
1678241|NCT01406574|5861890|P4|Overall Study|Physician Decision|1
1678242|NCT01406574|5861891|P3|Overall Study|Physician Decision|0
1678243|NCT01406574|5861892|P2|Overall Study|Physician Decision|0
1678244|NCT01406574|5861893|P1|Overall Study|Physician Decision|0
1678245|NCT01406574|5861890|P4|Overall Study|Adverse Event|3
1678246|NCT01406574|5861891|P3|Overall Study|Adverse Event|1
1678247|NCT01406574|5861892|P2|Overall Study|Adverse Event|0
1678248|NCT01406574|5861893|P1|Overall Study|Adverse Event|0
1678249|NCT01406015|5861928|P2|Overall Study|Withdrawal by Subject|3
1678250|NCT01406015|5861929|P1|Overall Study|Withdrawal by Subject|3
1678251|NCT01405950|5861945|P4|Overall Study|Withdrawal by Subject|0
1678252|NCT01405950|5861946|P3|Overall Study|Withdrawal by Subject|0
1678253|NCT01405950|5861947|P2|Overall Study|Withdrawal by Subject|0
1678254|NCT01405950|5861948|P1|Overall Study|Withdrawal by Subject|1
1678255|NCT01405924|5861983|P1|Overall Study|Missing/Incomplete Data|2
1678256|NCT01405924|5861983|P1|Overall Study|Protocol Violation|8
1678257|NCT01405911|5861996|P3|Overall Study|Withdrawal by Subject|1
1678258|NCT01405911|5861997|P2|Overall Study|Withdrawal by Subject|1
1678259|NCT01405911|5861998|P1|Overall Study|Withdrawal by Subject|3
1678260|NCT01405911|5861996|P3|Overall Study|Protocol Violation|0
1678261|NCT01405911|5861997|P2|Overall Study|Protocol Violation|0
1678262|NCT01405911|5861998|P1|Overall Study|Protocol Violation|1
1678263|NCT01405911|5861996|P3|Overall Study|Lost to Follow-up|0
1678264|NCT01405911|5861997|P2|Overall Study|Lost to Follow-up|1
1678265|NCT01405911|5861998|P1|Overall Study|Lost to Follow-up|0
1678266|NCT01405911|5861996|P3|Overall Study|Pre-treatment lab AE|0
1678267|NCT01405911|5861997|P2|Overall Study|Pre-treatment lab AE|1
1678268|NCT01405911|5861998|P1|Overall Study|Pre-treatment lab AE|0
1678269|NCT01405898|5862017|P2|Overall Study|Withdrawal by Subject|2
1678270|NCT01405898|5862018|P1|Overall Study|Withdrawal by Subject|2
1678271|NCT01405820|5862042|P6|Open-Label Treatment Period|Adverse Event|0
1678272|NCT01405820|5862043|P5|Open-Label Treatment Period|Adverse Event|0
1678273|NCT01405820|5862044|P4|Open-Label Treatment Period|Adverse Event|1
1678274|NCT01405820|5862045|P3|Open-Label Treatment Period|Adverse Event|0
1678275|NCT01405820|5862046|P2|Open-Label Treatment Period|Adverse Event|0
1678276|NCT01405820|5862047|P1|Open-Label Treatment Period|Adverse Event|0
1678277|NCT01405820|5862042|P6|Open-Label Treatment Period|Physician Decision|0
1678278|NCT01405820|5862043|P5|Open-Label Treatment Period|Physician Decision|1
1678279|NCT01405820|5862044|P4|Open-Label Treatment Period|Physician Decision|2
1678280|NCT01405820|5862045|P3|Open-Label Treatment Period|Physician Decision|1
1678281|NCT01405820|5862046|P2|Open-Label Treatment Period|Physician Decision|0
1678282|NCT01405820|5862047|P1|Open-Label Treatment Period|Physician Decision|0
1678283|NCT01405820|5862042|P6|Open-Label Treatment Period|Other|1
1678284|NCT01405820|5862043|P5|Open-Label Treatment Period|Other|1
1678285|NCT01405820|5862044|P4|Open-Label Treatment Period|Other|1
1678286|NCT01405820|5862045|P3|Open-Label Treatment Period|Other|1
1678287|NCT01405820|5862046|P2|Open-Label Treatment Period|Other|1
1678288|NCT01405820|5862047|P1|Open-Label Treatment Period|Other|1
1678289|NCT01405820|5862042|P6|Open-Label Treatment Period|Withdrawal by Subject|1
1678290|NCT01405820|5862043|P5|Open-Label Treatment Period|Withdrawal by Subject|0
1678291|NCT01405820|5862044|P4|Open-Label Treatment Period|Withdrawal by Subject|1
1678292|NCT01405820|5862045|P3|Open-Label Treatment Period|Withdrawal by Subject|1
1678293|NCT01405820|5862046|P2|Open-Label Treatment Period|Withdrawal by Subject|1
1678294|NCT01405820|5862047|P1|Open-Label Treatment Period|Withdrawal by Subject|3
1678295|NCT01405820|5862042|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
1678296|NCT01405820|5862043|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
1678297|NCT01405820|5862044|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
1678298|NCT01405820|5862045|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
1678299|NCT01405820|5862046|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
1678300|NCT01405820|5862047|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
1678301|NCT01405820|5862042|P6|Randomized Treatment Period|Death|0
1678302|NCT01405820|5862043|P5|Randomized Treatment Period|Death|0
1678303|NCT01405820|5862044|P4|Randomized Treatment Period|Death|1
1678304|NCT01405820|5862045|P3|Randomized Treatment Period|Death|0
1678305|NCT01405820|5862046|P2|Randomized Treatment Period|Death|0
1678306|NCT01405820|5862047|P1|Randomized Treatment Period|Death|0
1678307|NCT01405820|5862042|P6|Randomized Treatment Period|Treatment Arm Closed|28
1678308|NCT01405820|5862043|P5|Randomized Treatment Period|Treatment Arm Closed|33
1678309|NCT01405820|5862044|P4|Randomized Treatment Period|Treatment Arm Closed|36
1678310|NCT01405820|5862045|P3|Randomized Treatment Period|Treatment Arm Closed|20
1678311|NCT01405820|5862046|P2|Randomized Treatment Period|Treatment Arm Closed|0
1678312|NCT01405820|5862047|P1|Randomized Treatment Period|Treatment Arm Closed|0
1678313|NCT01405820|5862042|P6|Randomized Treatment Period|Incorrect Study Treatment|0
1678314|NCT01405820|5862043|P5|Randomized Treatment Period|Incorrect Study Treatment|2
1678315|NCT01405820|5862044|P4|Randomized Treatment Period|Incorrect Study Treatment|0
1678316|NCT01405820|5862045|P3|Randomized Treatment Period|Incorrect Study Treatment|3
1678317|NCT01405820|5862046|P2|Randomized Treatment Period|Incorrect Study Treatment|0
1678318|NCT01405820|5862047|P1|Randomized Treatment Period|Incorrect Study Treatment|0
1678319|NCT01405820|5862042|P6|Randomized Treatment Period|Rescue|8
1678320|NCT01405820|5862043|P5|Randomized Treatment Period|Rescue|8
1678321|NCT01405820|5862044|P4|Randomized Treatment Period|Rescue|10
1678322|NCT01405820|5862045|P3|Randomized Treatment Period|Rescue|13
1678323|NCT01405820|5862046|P2|Randomized Treatment Period|Rescue|1
1678324|NCT01405820|5862047|P1|Randomized Treatment Period|Rescue|0
1678325|NCT01405820|5862042|P6|Randomized Treatment Period|Physician Decision|0
1678326|NCT01405820|5862043|P5|Randomized Treatment Period|Physician Decision|0
1678327|NCT01405820|5862044|P4|Randomized Treatment Period|Physician Decision|0
1678328|NCT01405820|5862045|P3|Randomized Treatment Period|Physician Decision|1
1678329|NCT01405820|5862046|P2|Randomized Treatment Period|Physician Decision|2
1678330|NCT01405820|5862047|P1|Randomized Treatment Period|Physician Decision|0
1678331|NCT01405820|5862042|P6|Randomized Treatment Period|Other|0
1678332|NCT01405820|5862043|P5|Randomized Treatment Period|Other|0
1678333|NCT01405820|5862044|P4|Randomized Treatment Period|Other|1
1678334|NCT01405820|5862045|P3|Randomized Treatment Period|Other|1
1678335|NCT01405820|5862046|P2|Randomized Treatment Period|Other|2
1678336|NCT01405820|5862047|P1|Randomized Treatment Period|Other|2
1678337|NCT01405820|5862042|P6|Randomized Treatment Period|Withdrawal by Subject|0
1678338|NCT01405820|5862043|P5|Randomized Treatment Period|Withdrawal by Subject|0
1678339|NCT01405820|5862044|P4|Randomized Treatment Period|Withdrawal by Subject|2
1678340|NCT01405820|5862045|P3|Randomized Treatment Period|Withdrawal by Subject|2
1678341|NCT01405820|5862046|P2|Randomized Treatment Period|Withdrawal by Subject|2
1678342|NCT01405820|5862047|P1|Randomized Treatment Period|Withdrawal by Subject|6
1678343|NCT01405820|5862042|P6|Randomized Treatment Period|Adverse Event|1
1678344|NCT01405820|5862043|P5|Randomized Treatment Period|Adverse Event|2
1678345|NCT01405820|5862044|P4|Randomized Treatment Period|Adverse Event|0
1678346|NCT01405820|5862045|P3|Randomized Treatment Period|Adverse Event|3
1678347|NCT01405820|5862046|P2|Randomized Treatment Period|Adverse Event|3
1678348|NCT01405820|5862047|P1|Randomized Treatment Period|Adverse Event|3
1678349|NCT01405768|5862143|P2|Overall Study|Didn't complete questionnaire correctly|0
1678350|NCT01405768|5862144|P1|Overall Study|Didn't complete questionnaire correctly|4
1678351|NCT01405742|5862156|P2|Overall Study|Lost to Follow-up|0
1678352|NCT01405742|5862157|P1|Overall Study|Lost to Follow-up|1
1678353|NCT01405560|5862167|P1|Overall Study|Physician Decision|1
1678354|NCT01405508|5862182|P4|Overall Study|AE, non-serious non-fatal|0
1678355|NCT01405508|5862183|P3|Overall Study|AE, non-serious non-fatal|0
1678356|NCT01405508|5862184|P2|Overall Study|AE, non-serious non-fatal|1
1678357|NCT01405508|5862185|P1|Overall Study|AE, non-serious non-fatal|1
1678358|NCT01405456|5862217|P2|Overall Study|Physician Decision|0
1678359|NCT01405456|5862218|P1|Overall Study|Physician Decision|1
1678360|NCT01405456|5862217|P2|Overall Study|Lost to Follow-up|1
1678361|NCT01405456|5862218|P1|Overall Study|Lost to Follow-up|2
1678362|NCT01405196|5862258|P4|Overall Study|Lost to Follow-up|1
1678363|NCT01405196|5862259|P3|Overall Study|Lost to Follow-up|3
1678364|NCT01405196|5862260|P2|Overall Study|Lost to Follow-up|2
1678365|NCT01405196|5862261|P1|Overall Study|Lost to Follow-up|2
1678366|NCT01405196|5862258|P4|Overall Study|Death|0
1678367|NCT01405196|5862259|P3|Overall Study|Death|3
1678368|NCT01405196|5862260|P2|Overall Study|Death|0
1678369|NCT01405196|5862261|P1|Overall Study|Death|1
1678370|NCT01405196|5862258|P4|Overall Study|Adverse Event|2
1678371|NCT01405196|5862259|P3|Overall Study|Adverse Event|0
1678372|NCT01405196|5862260|P2|Overall Study|Adverse Event|2
1678373|NCT01405196|5862261|P1|Overall Study|Adverse Event|2
1678374|NCT01405196|5862258|P4|Overall Study|Withdrawal by Subject|6
1678375|NCT01405196|5862259|P3|Overall Study|Withdrawal by Subject|3
1678376|NCT01405196|5862260|P2|Overall Study|Withdrawal by Subject|6
1678377|NCT01405196|5862261|P1|Overall Study|Withdrawal by Subject|4
1678378|NCT01405196|5862258|P4|Overall Study|Other|0
1678379|NCT01405196|5862259|P3|Overall Study|Other|5
1678380|NCT01405196|5862260|P2|Overall Study|Other|2
1678381|NCT01405196|5862261|P1|Overall Study|Other|2
1678382|NCT01405196|5862258|P4|Overall Study|Study Terminated by Sponsor|0
1678383|NCT01405196|5862259|P3|Overall Study|Study Terminated by Sponsor|9
1678384|NCT01405196|5862260|P2|Overall Study|Study Terminated by Sponsor|0
1678385|NCT01405196|5862261|P1|Overall Study|Study Terminated by Sponsor|0
1678386|NCT01405053|5862348|P2|Overall Study|Other|1
1678387|NCT01405053|5862349|P1|Overall Study|Other|0
1678388|NCT01405053|5862348|P2|Overall Study|Withdrawal by Subject|4
1678389|NCT01405053|5862349|P1|Overall Study|Withdrawal by Subject|3
1678390|NCT01405053|5862348|P2|Overall Study|Inadequate therapeutic effect|1
1678391|NCT01405053|5862349|P1|Overall Study|Inadequate therapeutic effect|2
1678392|NCT01405053|5862348|P2|Overall Study|Participant choice|1
1678393|NCT01405053|5862349|P1|Overall Study|Participant choice|2
1678394|NCT01405053|5862348|P2|Overall Study|Lost to Follow-up|1
1678395|NCT01405053|5862349|P1|Overall Study|Lost to Follow-up|0
1678396|NCT01405053|5862348|P2|Overall Study|Adverse Event|0
1678397|NCT01405053|5862349|P1|Overall Study|Adverse Event|3
1678398|NCT01405027|5862375|P2|Overall Study|Other or Unknown|25
1678399|NCT01405027|5862376|P1|Overall Study|Other or Unknown|12
1678400|NCT01405027|5862375|P2|Overall Study|Death|0
1678401|NCT01405027|5862376|P1|Overall Study|Death|1
1678402|NCT01405027|5862375|P2|Overall Study|Investigator judgement|2
1678403|NCT01405027|5862376|P1|Overall Study|Investigator judgement|0
1678404|NCT01405027|5862375|P2|Overall Study|Lost to Follow-up|24
1678405|NCT01405027|5862376|P1|Overall Study|Lost to Follow-up|16
1678406|NCT01405027|5862375|P2|Overall Study|Withdrawn consent|0
1678407|NCT01405027|5862376|P1|Overall Study|Withdrawn consent|3
1678408|NCT01404988|5862393|P3|Overall Study|Lost to Follow-up|1
1678409|NCT01404988|5862394|P2|Overall Study|Lost to Follow-up|2
1678410|NCT01404988|5862395|P1|Overall Study|Lost to Follow-up|1
1678411|NCT01404988|5862393|P3|Overall Study|Withdrawal by Subject|0
1678412|NCT01404988|5862394|P2|Overall Study|Withdrawal by Subject|2
1678413|NCT01404988|5862395|P1|Overall Study|Withdrawal by Subject|2
1678414|NCT01404988|5862393|P3|Overall Study|Adverse Event|0
1678415|NCT01404988|5862394|P2|Overall Study|Adverse Event|0
1678416|NCT01404988|5862395|P1|Overall Study|Adverse Event|1
1678417|NCT01404988|5862393|P3|Overall Study|Death|2
1678418|NCT01404988|5862394|P2|Overall Study|Death|0
1678419|NCT01404988|5862395|P1|Overall Study|Death|2
1678420|NCT01404325|5862516|P2|Overall Study|non-specified reason|2
1678421|NCT01404325|5862517|P1|Overall Study|non-specified reason|0
1678422|NCT01404325|5862516|P2|Overall Study|Graft loss/Retransplantation|0
1678423|NCT01404325|5862517|P1|Overall Study|Graft loss/Retransplantation|1
1678424|NCT01404325|5862516|P2|Overall Study|Death|0
1678425|NCT01404325|5862517|P1|Overall Study|Death|2
1678426|NCT01404325|5862516|P2|Overall Study|Lost to Follow-up|0
1678427|NCT01404325|5862517|P1|Overall Study|Lost to Follow-up|1
1678428|NCT01404312|5862575|P2|Overall Study|Severe debilitation, unable to continue|2
1678429|NCT01404312|5862576|P1|Overall Study|Severe debilitation, unable to continue|1
1678430|NCT01404312|5862575|P2|Overall Study|Participant not willing to adhere to req|29
1678431|NCT01404312|5862576|P1|Overall Study|Participant not willing to adhere to req|31
1678432|NCT01404312|5862575|P2|Overall Study|Site closed|21
1678433|NCT01404312|5862576|P1|Overall Study|Site closed|22
1678434|NCT01404312|5862575|P2|Overall Study|Lost to Follow-up|111
1678435|NCT01404312|5862576|P1|Overall Study|Lost to Follow-up|115
1678436|NCT01404312|5862575|P2|Overall Study|Participant Unable to get to clinic|103
1678437|NCT01404312|5862576|P1|Overall Study|Participant Unable to get to clinic|93
1678438|NCT01404312|5862575|P2|Overall Study|Withdrawal by Subject|18
1678439|NCT01404312|5862576|P1|Overall Study|Withdrawal by Subject|15
1678440|NCT01404312|5862575|P2|Overall Study|Death|27
1678441|NCT01404312|5862576|P1|Overall Study|Death|21
1678442|NCT01404234|5862605|P1|Overall Study|Withdrawal by Subject|2
1678443|NCT01404208|5862621|P2|Overall Study|Discontinued|0
1678444|NCT01404208|5862622|P1|Overall Study|Discontinued|3
1678445|NCT01403987|5862687|P3|Overall Study|Residents forgot their secret PIN|18
1678446|NCT01403987|5862688|P2|Overall Study|Residents forgot their secret PIN|17
1678447|NCT01403987|5862689|P1|Overall Study|Residents forgot their secret PIN|18
1678448|NCT01403805|5862705|P2|Overall Study|Death|1
1678449|NCT01403805|5862706|P1|Overall Study|Death|0
1678450|NCT01403805|5862705|P2|Overall Study|Lost to Follow-up|2
1678451|NCT01403805|5862706|P1|Overall Study|Lost to Follow-up|0
1678452|NCT01403805|5862705|P2|Overall Study|Withdrawal by Subject|4
1678453|NCT01403805|5862706|P1|Overall Study|Withdrawal by Subject|0
1678454|NCT01403610|5862722|P4|Overall Study|Didn't recover from surgery sufficiently|0
1678455|NCT01403610|5862723|P3|Overall Study|Didn't recover from surgery sufficiently|0
1678456|NCT01403610|5862724|P2|Overall Study|Didn't recover from surgery sufficiently|3
1678457|NCT01403610|5862725|P1|Overall Study|Didn't recover from surgery sufficiently|0
1678458|NCT01403610|5862722|P4|Overall Study|Withdrawal by Subject|0
1678459|NCT01403610|5862723|P3|Overall Study|Withdrawal by Subject|0
1678460|NCT01403610|5862724|P2|Overall Study|Withdrawal by Subject|0
1678461|NCT01403610|5862725|P1|Overall Study|Withdrawal by Subject|2
1678462|NCT01403194|5862771|P1|Overall Study|Lost to Follow-up|8
1678463|NCT01403194|5862771|P1|Overall Study|Screen Failure|2
1678464|NCT01403116|5862779|P2|Overall Study|unable to keep appointments|2
1678465|NCT01403116|5862780|P1|Overall Study|unable to keep appointments|0
1678466|NCT01403116|5862779|P2|Overall Study|Hct >54%|0
1678467|NCT01403116|5862780|P1|Overall Study|Hct >54%|2
1678468|NCT01403116|5862779|P2|Overall Study|undisclosed Hx of Prostate Ca|0
1678469|NCT01403116|5862780|P1|Overall Study|undisclosed Hx of Prostate Ca|1
1678470|NCT01403116|5862779|P2|Overall Study|Protocol Violation|1
1678471|NCT01403116|5862780|P1|Overall Study|Protocol Violation|0
1678472|NCT01403116|5862779|P2|Overall Study|Non-compliance of study drug|0
1678473|NCT01403116|5862780|P1|Overall Study|Non-compliance of study drug|3
1678474|NCT01403116|5862779|P2|Overall Study|Withdrawal by Subject|15
1678475|NCT01403116|5862780|P1|Overall Study|Withdrawal by Subject|12
1678476|NCT01403116|5862779|P2|Overall Study|Lost to Follow-up|5
1678477|NCT01403116|5862780|P1|Overall Study|Lost to Follow-up|7
1678478|NCT01403116|5862779|P2|Overall Study|Adverse Event|4
1678479|NCT01403116|5862780|P1|Overall Study|Adverse Event|7
1678480|NCT01403051|5862793|P2|Overall Study|Lost to Follow-up|5
1678481|NCT01403051|5862794|P1|Overall Study|Lost to Follow-up|5
1678482|NCT01403051|5862793|P2|Overall Study|Withdrawal by Subject|1
1678483|NCT01403051|5862794|P1|Overall Study|Withdrawal by Subject|2
1678484|NCT01403051|5862793|P2|Overall Study|Death|0
1678485|NCT01403051|5862794|P1|Overall Study|Death|1
1678486|NCT01403051|5862793|P2|Overall Study|Protocol Violation|0
1678487|NCT01403051|5862794|P1|Overall Study|Protocol Violation|2
1678488|NCT01402986|5862830|P4|Overall Study|Other|6
1678489|NCT01402986|5862831|P3|Overall Study|Other|1
1678490|NCT01402986|5862832|P2|Overall Study|Other|5
1678491|NCT01402986|5862833|P1|Overall Study|Other|2
1678492|NCT01402986|5862830|P4|Overall Study|Lost to Follow-up|1
1678493|NCT01402986|5862831|P3|Overall Study|Lost to Follow-up|0
1678494|NCT01402986|5862832|P2|Overall Study|Lost to Follow-up|0
1678495|NCT01402986|5862833|P1|Overall Study|Lost to Follow-up|0
1678496|NCT01402986|5862830|P4|Overall Study|Death|2
1678497|NCT01402986|5862831|P3|Overall Study|Death|0
1678498|NCT01402986|5862832|P2|Overall Study|Death|0
1678499|NCT01402986|5862833|P1|Overall Study|Death|0
1678500|NCT01402986|5862830|P4|Overall Study|Withdrawal by Subject|13
1678501|NCT01402986|5862831|P3|Overall Study|Withdrawal by Subject|7
1678502|NCT01402986|5862832|P2|Overall Study|Withdrawal by Subject|10
1678503|NCT01402986|5862833|P1|Overall Study|Withdrawal by Subject|7
1678504|NCT01402947|5862968|P2|First Intervention|Adverse Event|1
1678505|NCT01402947|5862969|P1|First Intervention|Adverse Event|0
1678506|NCT01402869|5862980|P3|Overall Study|Required Tooth Extraction|1
1678507|NCT01402869|5862981|P2|Overall Study|Required Tooth Extraction|0
1678508|NCT01402869|5862982|P1|Overall Study|Required Tooth Extraction|0
1678509|NCT01402817|5862996|P1|Overall Study|Study Suspended by FDA|8
1678510|NCT01402817|5862996|P1|Overall Study|Withdrawal by Subject|3
1678511|NCT01402700|5863001|P1|Overall Study|Missed Visit|1
1678512|NCT01402700|5863001|P1|Overall Study|Withdrawal by Subject|3
1678513|NCT01402700|5863001|P1|Overall Study|Death|3
1678514|NCT01402570|5863005|P1|Overall Study|Adverse Event|1
1678515|NCT01402544|5863012|P1|Overall Study|Withdrawal by Subject|6
1678516|NCT01402284|5863086|P1|Overall Study|Non compliance|2
1678517|NCT01402284|5863086|P1|Overall Study|Disease progression on study|8
1678518|NCT01402284|5863086|P1|Overall Study|Physician Decision|1
1678519|NCT01402284|5863086|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
1678520|NCT01402284|5863086|P1|Overall Study|Withdrawal consent|1
1678521|NCT01402102|5863168|P2|Overall Study|Withdrawal by Subject|2
1678522|NCT01402102|5863169|P1|Overall Study|Withdrawal by Subject|0
1678523|NCT01402102|5863168|P2|Overall Study|Insufficiency of compliance|1
1678524|NCT01402102|5863169|P1|Overall Study|Insufficiency of compliance|1
1678525|NCT01402102|5863168|P2|Overall Study|Protocol Violation|0
1678526|NCT01402102|5863169|P1|Overall Study|Protocol Violation|1
1678529|NCT01402011|5863208|P3|Nine Month Follow-up|Withdrawal by Subject|0
1678530|NCT01402011|5863209|P2|Nine Month Follow-up|Withdrawal by Subject|1
1678531|NCT01402011|5863210|P1|Nine Month Follow-up|Withdrawal by Subject|0
1678532|NCT01402011|5863208|P3|Active Treatment Period|Withdrawal by Subject|0
1678533|NCT01402011|5863209|P2|Active Treatment Period|Withdrawal by Subject|3
1678534|NCT01402011|5863210|P1|Active Treatment Period|Withdrawal by Subject|1
1678535|NCT01402011|5863208|P3|Delayed Treatment Period|Withdrawal by Subject|0
1678536|NCT01402011|5863209|P2|Delayed Treatment Period|Withdrawal by Subject|0
1678537|NCT01402011|5863210|P1|Delayed Treatment Period|Withdrawal by Subject|1
1678538|NCT01401959|5863239|P3|Treated|Protocol Violation|0
1678539|NCT01401959|5863240|P2|Treated|Protocol Violation|1
1678540|NCT01401959|5863241|P1|Treated|Protocol Violation|0
1678541|NCT01401959|5863239|P3|Treated|Withdrawal by Subject|2
1678542|NCT01401959|5863240|P2|Treated|Withdrawal by Subject|2
1678543|NCT01401959|5863241|P1|Treated|Withdrawal by Subject|1
1678544|NCT01401959|5863239|P3|Treated|Adverse Event|2
1678545|NCT01401959|5863240|P2|Treated|Adverse Event|3
1678546|NCT01401959|5863241|P1|Treated|Adverse Event|4
1678547|NCT01401959|5863239|P3|Treated|Disease Progression|1
1678548|NCT01401959|5863240|P2|Treated|Disease Progression|2
1678549|NCT01401959|5863241|P1|Treated|Disease Progression|2
1678550|NCT01401959|5863239|P3|Enrolled|Withdrawal by Subject|0
1678551|NCT01401959|5863240|P2|Enrolled|Withdrawal by Subject|0
1678552|NCT01401959|5863241|P1|Enrolled|Withdrawal by Subject|1
1678553|NCT01401842|5863278|P2|Overall Study|other/unknown|17
1678554|NCT01401842|5863279|P1|Overall Study|other/unknown|28
1678555|NCT01401842|5863278|P2|Overall Study|on profile|5
1678556|NCT01401842|5863279|P1|Overall Study|on profile|9
1678557|NCT01401842|5863278|P2|Overall Study|invalid follow-up strength data|4
1678558|NCT01401842|5863279|P1|Overall Study|invalid follow-up strength data|1
1678559|NCT01401842|5863278|P2|Overall Study|discharged from US Army|4
1678560|NCT01401842|5863279|P1|Overall Study|discharged from US Army|3
1678561|NCT01401842|5863278|P2|Overall Study|changed companies|34
1678562|NCT01401842|5863279|P1|Overall Study|changed companies|20
1678563|NCT01401842|5863278|P2|Overall Study|academic reason|1
1678564|NCT01401842|5863279|P1|Overall Study|academic reason|4
1678565|NCT01401842|5863278|P2|Overall Study|Withdrawal by Subject|2
1678566|NCT01401842|5863279|P1|Overall Study|Withdrawal by Subject|3
1678567|NCT01401647|5863296|P3|Overall Study|Lost to Follow-up|1
1678568|NCT01401647|5863297|P2|Overall Study|Lost to Follow-up|3
1678569|NCT01401647|5863298|P1|Overall Study|Lost to Follow-up|3
1678570|NCT01401647|5863296|P3|Overall Study|Withdrawal by Subject|2
1678571|NCT01401647|5863297|P2|Overall Study|Withdrawal by Subject|5
1678572|NCT01401647|5863298|P1|Overall Study|Withdrawal by Subject|1
1678573|NCT01401530|5863368|P3|Overall Study|Physician Decision|0
1678574|NCT01401530|5863369|P2|Overall Study|Physician Decision|1
1678575|NCT01401530|5863370|P1|Overall Study|Physician Decision|0
1678576|NCT01401530|5863368|P3|Overall Study|Participant Choice|1
1678577|NCT01401530|5863369|P2|Overall Study|Participant Choice|2
1678578|NCT01401530|5863370|P1|Overall Study|Participant Choice|1
1678579|NCT01401530|5863368|P3|Overall Study|Adverse Event|1
1678580|NCT01401530|5863369|P2|Overall Study|Adverse Event|1
1678581|NCT01401530|5863370|P1|Overall Study|Adverse Event|1
1678582|NCT01401530|5863368|P3|Overall Study|Disease Progression|1
1678583|NCT01401530|5863369|P2|Overall Study|Disease Progression|2
1678584|NCT01401530|5863370|P1|Overall Study|Disease Progression|1
1678585|NCT01401478|5863420|P1|Overall Study|Serious adverse event|1
1678586|NCT01401478|5863420|P1|Overall Study|Low intact parathyroid hormone|1
1678587|NCT01401478|5863420|P1|Overall Study|Hyperphosphatemia and adverse event|1
1678588|NCT01401478|5863420|P1|Overall Study|Blood samples not available|1
1678589|NCT01401478|5863420|P1|Overall Study|Withdrawal by Subject|3
1678590|NCT01401478|5863420|P1|Overall Study|Kidney transplantation|3
1678591|NCT01401478|5863420|P1|Overall Study|Lost to Follow-up|5
1678592|NCT01401478|5863420|P1|Overall Study|Hyperphosphatemia|5
1678593|NCT01401478|5863420|P1|Overall Study|Adverse Event|5
1678594|NCT01401478|5863420|P1|Overall Study|Study drug not available|6
1678595|NCT01401465|5863433|P2|Treatment Period 2|Withdrawal by Subject|1
1678596|NCT01401465|5863434|P1|Treatment Period 2|Withdrawal by Subject|0
1678597|NCT01401465|5863433|P2|Treatment Period 2|Lost to Follow-up|1
1678598|NCT01401465|5863434|P1|Treatment Period 2|Lost to Follow-up|0
1678599|NCT01401465|5863433|P2|Treatment Period 1|Scheduling Difficulties|1
1678600|NCT01401465|5863434|P1|Treatment Period 1|Scheduling Difficulties|1
1678601|NCT01401465|5863433|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
1678602|NCT01401465|5863434|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
1678603|NCT01401465|5863433|P2|Treatment Period 1|Non-Compliance to Study Drug|0
1678604|NCT01401465|5863434|P1|Treatment Period 1|Non-Compliance to Study Drug|1
1678605|NCT01401465|5863433|P2|Treatment Period 1|Withdrawal by Subject|4
1678606|NCT01401465|5863434|P1|Treatment Period 1|Withdrawal by Subject|1
1678607|NCT01401465|5863433|P2|Treatment Period 1|Protocol Violation|0
1678608|NCT01401465|5863434|P1|Treatment Period 1|Protocol Violation|5
1678609|NCT01401465|5863433|P2|Treatment Period 1|Pregnancy|1
1678610|NCT01401465|5863434|P1|Treatment Period 1|Pregnancy|0
1678611|NCT01401465|5863433|P2|Treatment Period 1|Adverse Event|1
1678612|NCT01401465|5863434|P1|Treatment Period 1|Adverse Event|4
1678613|NCT01401452|5863497|P1|Overall Study|Participant withdrew consent|1
1678614|NCT01401452|5863497|P1|Overall Study|Subject chose to discontinue treatment|1
1678615|NCT01401452|5863497|P1|Overall Study|Subject withdrew because of Tx success|1
1678616|NCT01401452|5863497|P1|Overall Study|Unsatisfactory output|1
1678617|NCT01401452|5863497|P1|Overall Study|Treatment failure|1
1678618|NCT01401452|5863497|P1|Overall Study|Discontinuation for personal reasons|1
1678619|NCT01401452|5863497|P1|Overall Study|Participant stopped Tx|2
1678620|NCT01401452|5863497|P1|Overall Study|Psoriatic arthritis|1
1678621|NCT01401452|5863497|P1|Overall Study|Subject's wife wants to get pregnant|1
1678622|NCT01401452|5863497|P1|Overall Study|Subject moved to another city|1
1678623|NCT01401452|5863497|P1|Overall Study|Subject didn't return for routine visits|1
1678624|NCT01401452|5863497|P1|Overall Study|Subject did not come to follow up visits|2
1678625|NCT01401452|5863497|P1|Overall Study|No more visits within the 36 wk followup|4
1678626|NCT01401452|5863497|P1|Overall Study|Tx stopped by psychiatrist|1
1678627|NCT01401452|5863497|P1|Overall Study|Tx stopped due to financial reasons|1
1678628|NCT01401452|5863497|P1|Overall Study|Participant developed breast cancer|1
1678629|NCT01401452|5863497|P1|Overall Study|Lack of Efficacy|30
1678630|NCT01401452|5863497|P1|Overall Study|Lost to Follow-up|12
1678631|NCT01401452|5863497|P1|Overall Study|Adverse reaction|9
1678632|NCT01401361|5863509|P1|Overall Study|Subject/family decision post procedure|2
1678633|NCT01401361|5863509|P1|Overall Study|Lost to Follow-up|3
1678634|NCT01401361|5863509|P1|Overall Study|Physician Decision|1
1678635|NCT01401361|5863509|P1|Overall Study|Lack of Efficacy|6
1678636|NCT01401361|5863509|P1|Overall Study|Withdrawal by Subject|16
1678637|NCT01401322|5863515|P1|Overall Study|Physician Decision|1
1678638|NCT01401322|5863515|P1|Overall Study|Withdrawal by Subject|1
1678639|NCT01401283|5863521|P2|Overall Study|suspicion of malignant hyperthermia|1
1678640|NCT01401283|5863522|P1|Overall Study|suspicion of malignant hyperthermia|0
1678641|NCT01401283|5863521|P2|Overall Study|no central venous access|1
1678642|NCT01401283|5863522|P1|Overall Study|no central venous access|0
1678643|NCT01401283|5863521|P2|Overall Study|preoperative arrhythmia|0
1678644|NCT01401283|5863522|P1|Overall Study|preoperative arrhythmia|5
1678645|NCT01401283|5863521|P2|Overall Study|surgery cancelled|8
1678646|NCT01401283|5863522|P1|Overall Study|surgery cancelled|5
1678647|NCT01401153|5863588|P2|Second Test Day|illness|5
1678648|NCT01401153|5863589|P1|Second Test Day|illness|0
1678649|NCT01401153|5863588|P2|First Test Day|Learning disabilities; illness|10
1678650|NCT01401153|5863589|P1|First Test Day|Learning disabilities; illness|1
1678651|NCT01401062|5863636|P2|Overall Study|Withdrawal by Subject|1
1678652|NCT01401062|5863637|P1|Overall Study|Withdrawal by Subject|1
1678653|NCT01401062|5863636|P2|Overall Study|Physician Decision|0
1678654|NCT01401062|5863637|P1|Overall Study|Physician Decision|1
1678655|NCT01401062|5863636|P2|Overall Study|Death|7
1678656|NCT01401062|5863637|P1|Overall Study|Death|9
1678657|NCT01401010|5863664|P2|Overall Study|Could not interpret assay results|0
1678658|NCT01401010|5863665|P1|Overall Study|Could not interpret assay results|1
1678659|NCT01400958|5863690|P2|Overall Study|Adverse Event|0
1678660|NCT01400958|5863691|P1|Overall Study|Adverse Event|1
1678661|NCT01400958|5863690|P2|Overall Study|Withdrawal by Subject|1
1678662|NCT01400958|5863691|P1|Overall Study|Withdrawal by Subject|0
1678663|NCT01400958|5863690|P2|Overall Study|Physician Decision|1
1678664|NCT01400958|5863691|P1|Overall Study|Physician Decision|0
1678665|NCT01400932|5863701|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
1678666|NCT01400932|5863702|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1678667|NCT01400932|5863701|P2|Overall Study|Protocol Deviation|1
1678668|NCT01400932|5863702|P1|Overall Study|Protocol Deviation|0
1678669|NCT01400932|5863701|P2|Overall Study|Lost to Follow-up|0
1678670|NCT01400932|5863702|P1|Overall Study|Lost to Follow-up|1
1678671|NCT01400932|5863701|P2|Overall Study|Withdrawal by Subject|6
1678672|NCT01400932|5863702|P1|Overall Study|Withdrawal by Subject|2
1678673|NCT01400932|5863701|P2|Overall Study|Lack of Efficacy|3
1678674|NCT01400932|5863702|P1|Overall Study|Lack of Efficacy|0
1678675|NCT01400932|5863701|P2|Overall Study|Adverse Event|5
1678676|NCT01400932|5863702|P1|Overall Study|Adverse Event|10
1678677|NCT01400919|5863724|P1|Overall Study|Missed visit|2
1678678|NCT01400919|5863724|P1|Overall Study|Lost to Follow-up|2
1678679|NCT01400919|5863724|P1|Overall Study|Withdrawal by Subject|4
1678680|NCT01400893|5863767|P2|Overall Study|Lost to Follow-up|6
1678681|NCT01400893|5863768|P1|Overall Study|Lost to Follow-up|0
1678682|NCT01400893|5863767|P2|Overall Study|Death|21
1678683|NCT01400893|5863768|P1|Overall Study|Death|27
1678684|NCT01400841|5863780|P1|Extended Study Phase (2 Years)|Adverse Event|2
1678685|NCT01400841|5863780|P1|Initial Study Phase (6 Months)|Death|1
1678686|NCT01400698|5863818|P6|Overall Study|Other|0
1678687|NCT01400698|5863819|P5|Overall Study|Other|1
1678688|NCT01400698|5863820|P4|Overall Study|Other|2
1678689|NCT01400698|5863821|P3|Overall Study|Other|0
1678690|NCT01400698|5863822|P2|Overall Study|Other|2
1678691|NCT01400698|5863823|P1|Overall Study|Other|4
1678692|NCT01400698|5863818|P6|Overall Study|Adverse Event|0
1678693|NCT01400698|5863819|P5|Overall Study|Adverse Event|0
1678694|NCT01400698|5863820|P4|Overall Study|Adverse Event|0
1678695|NCT01400698|5863821|P3|Overall Study|Adverse Event|0
1678696|NCT01400698|5863822|P2|Overall Study|Adverse Event|0
1678697|NCT01400698|5863823|P1|Overall Study|Adverse Event|1
1678698|NCT01400698|5863818|P6|Overall Study|Non-compliance|0
1678699|NCT01400698|5863819|P5|Overall Study|Non-compliance|0
1678700|NCT01400698|5863820|P4|Overall Study|Non-compliance|1
1678701|NCT01400698|5863821|P3|Overall Study|Non-compliance|0
1678702|NCT01400698|5863822|P2|Overall Study|Non-compliance|1
1678703|NCT01400698|5863823|P1|Overall Study|Non-compliance|0
1678704|NCT01400698|5863818|P6|Overall Study|Protocol Violation|0
1678705|NCT01400698|5863819|P5|Overall Study|Protocol Violation|1
1678706|NCT01400698|5863820|P4|Overall Study|Protocol Violation|0
1678707|NCT01400698|5863821|P3|Overall Study|Protocol Violation|0
1678708|NCT01400698|5863822|P2|Overall Study|Protocol Violation|1
1678709|NCT01400698|5863823|P1|Overall Study|Protocol Violation|0
1678710|NCT01400698|5863818|P6|Overall Study|Withdrawal by Subject|3
1678711|NCT01400698|5863819|P5|Overall Study|Withdrawal by Subject|1
1678712|NCT01400698|5863820|P4|Overall Study|Withdrawal by Subject|4
1678713|NCT01400698|5863821|P3|Overall Study|Withdrawal by Subject|0
1678714|NCT01400698|5863822|P2|Overall Study|Withdrawal by Subject|2
1678715|NCT01400698|5863823|P1|Overall Study|Withdrawal by Subject|8
1678716|NCT01400698|5863818|P6|Overall Study|Lost to Follow-up|3
1678717|NCT01400698|5863819|P5|Overall Study|Lost to Follow-up|4
1678718|NCT01400698|5863820|P4|Overall Study|Lost to Follow-up|1
1678719|NCT01400698|5863821|P3|Overall Study|Lost to Follow-up|2
1678720|NCT01400698|5863822|P2|Overall Study|Lost to Follow-up|5
1678721|NCT01400698|5863823|P1|Overall Study|Lost to Follow-up|2
1678722|NCT01400516|5863847|P2|Primary Trial|Withdrawal by Subject|2
1678723|NCT01400516|5863848|P1|Primary Trial|Withdrawal by Subject|0
1678724|NCT01400503|5863858|P1|Overall Study|Other|1
1678725|NCT01400503|5863858|P1|Overall Study|Study Terminated by Sponsor|58
1678726|NCT01400503|5863858|P1|Overall Study|Withdrawal by Subject|1
1678727|NCT01400451|5863881|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
1678728|NCT01400451|5863882|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
1678729|NCT01400451|5863883|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
1678730|NCT01400451|5863881|P3|Combination Treatment (or Intended)|Disease Progression|1
1678731|NCT01400451|5863882|P2|Combination Treatment (or Intended)|Disease Progression|1
1678732|NCT01400451|5863883|P1|Combination Treatment (or Intended)|Disease Progression|3
1678733|NCT01400451|5863881|P3|Combination Treatment (or Intended)|Adverse Event|0
1678734|NCT01400451|5863882|P2|Combination Treatment (or Intended)|Adverse Event|0
1678735|NCT01400451|5863883|P1|Combination Treatment (or Intended)|Adverse Event|1
1678736|NCT01400451|5863881|P3|Combination Treatment (or Intended)|Drug Toxicity|0
1678737|NCT01400451|5863882|P2|Combination Treatment (or Intended)|Drug Toxicity|1
1678738|NCT01400451|5863883|P1|Combination Treatment (or Intended)|Drug Toxicity|0
1678739|NCT01400451|5863881|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
1678740|NCT01400451|5863882|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
1678741|NCT01400451|5863883|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
1678742|NCT01400425|5863897|P1|Overall Study|Withdrawal by Subject|10
1678743|NCT01400412|5863910|P2|Overall Study|Never started study treatment|3
1678744|NCT01400412|5863911|P1|Overall Study|Never started study treatment|0
1678745|NCT01400412|5863910|P2|Overall Study|Unable to complete|3
1678746|NCT01400412|5863911|P1|Overall Study|Unable to complete|3
1678747|NCT01400412|5863910|P2|Overall Study|Withdrawal by Subject|4
1678748|NCT01400412|5863911|P1|Overall Study|Withdrawal by Subject|3
1678749|NCT01400412|5863910|P2|Overall Study|Lost to Follow-up|7
1678750|NCT01400412|5863911|P1|Overall Study|Lost to Follow-up|4
1678751|NCT01400243|5863957|P2|Overall Study|Protocol Violation|11
1678752|NCT01400243|5863958|P1|Overall Study|Protocol Violation|8
1678753|NCT01400139|5863980|P1|HYD Extension Period|Administrative|10
1678754|NCT01400139|5863980|P1|HYD Extension Period|Withdrawal by Subject|5
1678755|NCT01400139|5863980|P1|HYD Extension Period|Adverse Event|8
1678756|NCT01400139|5863980|P1|HYD Core Study|Did not qualify for Maintenance Period|14
1678757|NCT01400139|5863980|P1|HYD Core Study|Administrative|56
1678758|NCT01400139|5863980|P1|HYD Core Study|Confirmed or suspected diversion|20
1678759|NCT01400139|5863980|P1|HYD Core Study|Lost to Follow-up|39
1678760|NCT01400139|5863980|P1|HYD Core Study|Withdrawal by Subject|114
1678761|NCT01400139|5863980|P1|HYD Core Study|Lack of Efficacy|59
1678762|NCT01400139|5863980|P1|HYD Core Study|Adverse Event|210
1678763|NCT01400113|5864003|P2|Overall Study|Withdrawal by Subject|1
1678764|NCT01400113|5864004|P1|Overall Study|Withdrawal by Subject|1
1678765|NCT01399905|5864012|P2|Overall Study|Withdrawal by Subject|1
1678766|NCT01399905|5864013|P1|Overall Study|Withdrawal by Subject|1
1678767|NCT01399788|5864061|P2|First Intervention Period|Adverse Event|0
1678768|NCT01399788|5864062|P1|First Intervention Period|Adverse Event|1
1678769|NCT01399723|5864084|P2|Overall Study|Lost to Follow-up|1
1678770|NCT01399723|5864085|P1|Overall Study|Lost to Follow-up|0
1678771|NCT01399697|5864098|P3|Overall Study|Sponsor Decision|0
1678772|NCT01399697|5864099|P2|Overall Study|Sponsor Decision|0
1678773|NCT01399697|5864100|P1|Overall Study|Sponsor Decision|1
1678774|NCT01399697|5864098|P3|Overall Study|Clinical RA remission|0
1678775|NCT01399697|5864099|P2|Overall Study|Clinical RA remission|0
1678776|NCT01399697|5864100|P1|Overall Study|Clinical RA remission|1
1678777|NCT01399697|5864098|P3|Overall Study|Positive result for hepatitis B|0
1678778|NCT01399697|5864099|P2|Overall Study|Positive result for hepatitis B|0
1678779|NCT01399697|5864100|P1|Overall Study|Positive result for hepatitis B|1
1678780|NCT01399697|5864098|P3|Overall Study|Inclusion Error|0
1678781|NCT01399697|5864099|P2|Overall Study|Inclusion Error|0
1678782|NCT01399697|5864100|P1|Overall Study|Inclusion Error|2
1678783|NCT01399697|5864098|P3|Overall Study|Non-Compliant|0
1678784|NCT01399697|5864099|P2|Overall Study|Non-Compliant|0
1678785|NCT01399697|5864100|P1|Overall Study|Non-Compliant|1
1678786|NCT01399697|5864098|P3|Overall Study|Protocol Violation|0
1678787|NCT01399697|5864099|P2|Overall Study|Protocol Violation|0
1678788|NCT01399697|5864100|P1|Overall Study|Protocol Violation|2
1678789|NCT01399697|5864098|P3|Overall Study|Lack of Efficacy|1
1678790|NCT01399697|5864099|P2|Overall Study|Lack of Efficacy|0
1678791|NCT01399697|5864100|P1|Overall Study|Lack of Efficacy|9
1678792|NCT01399697|5864098|P3|Overall Study|Investigator Decisión|2
1678793|NCT01399697|5864099|P2|Overall Study|Investigator Decisión|0
1678794|NCT01399697|5864100|P1|Overall Study|Investigator Decisión|1
1678795|NCT01399697|5864098|P3|Overall Study|Withdrawal by Subject|0
1678796|NCT01399697|5864099|P2|Overall Study|Withdrawal by Subject|0
1678797|NCT01399697|5864100|P1|Overall Study|Withdrawal by Subject|8
1678798|NCT01399697|5864098|P3|Overall Study|Lost to Follow-up|0
1678799|NCT01399697|5864099|P2|Overall Study|Lost to Follow-up|0
1678800|NCT01399697|5864100|P1|Overall Study|Lost to Follow-up|2
1678801|NCT01399697|5864098|P3|Overall Study|Adverse Event|1
1678802|NCT01399697|5864099|P2|Overall Study|Adverse Event|3
1678803|NCT01399697|5864100|P1|Overall Study|Adverse Event|13
1678804|NCT01399619|5864127|P4|Overall Study|Not treated|2
1678805|NCT01399619|5864128|P3|Overall Study|Not treated|0
1678806|NCT01399619|5864129|P2|Overall Study|Not treated|0
1678807|NCT01399619|5864130|P1|Overall Study|Not treated|0
1678808|NCT01399619|5864127|P4|Overall Study|Protocol Violation|1
1678809|NCT01399619|5864128|P3|Overall Study|Protocol Violation|0
1678810|NCT01399619|5864129|P2|Overall Study|Protocol Violation|0
1678811|NCT01399619|5864130|P1|Overall Study|Protocol Violation|0
1678812|NCT01399619|5864127|P4|Overall Study|Withdrawal by Subject|4
1678813|NCT01399619|5864128|P3|Overall Study|Withdrawal by Subject|3
1678814|NCT01399619|5864129|P2|Overall Study|Withdrawal by Subject|0
1678815|NCT01399619|5864130|P1|Overall Study|Withdrawal by Subject|6
1678816|NCT01399619|5864127|P4|Overall Study|Lack of Efficacy|0
1678817|NCT01399619|5864128|P3|Overall Study|Lack of Efficacy|5
1678818|NCT01399619|5864129|P2|Overall Study|Lack of Efficacy|0
1678819|NCT01399619|5864130|P1|Overall Study|Lack of Efficacy|9
1678820|NCT01399619|5864127|P4|Overall Study|Adverse Event|10
1678821|NCT01399619|5864128|P3|Overall Study|Adverse Event|4
1678822|NCT01399619|5864129|P2|Overall Study|Adverse Event|0
1678823|NCT01399619|5864130|P1|Overall Study|Adverse Event|10
1678824|NCT01399593|5864193|P2|Overall Study|Transplantectomy|1
1678825|NCT01399593|5864194|P1|Overall Study|Transplantectomy|0
1678826|NCT01399593|5864193|P2|Overall Study|Death|1
1678827|NCT01399593|5864194|P1|Overall Study|Death|1
1678828|NCT01399593|5864193|P2|Overall Study|Adverse Event|0
1678829|NCT01399593|5864194|P1|Overall Study|Adverse Event|1
1678830|NCT01399593|5864193|P2|Overall Study|Physician Decision|0
1678831|NCT01399593|5864194|P1|Overall Study|Physician Decision|1
1678832|NCT01399190|5864227|P1|Overall Study|Physician Decision|2
1678833|NCT01399190|5864227|P1|Overall Study|Participant's Request|5
1678834|NCT01399190|5864227|P1|Overall Study|Adverse Event|8
1678835|NCT01399190|5864227|P1|Overall Study|Not Eligible for Final Analysis|5
1678836|NCT01399125|5864235|P2|Overall Study|Protocol Deviation|2
1678837|NCT01399125|5864236|P1|Overall Study|Protocol Deviation|5
1678838|NCT01399125|5864235|P2|Overall Study|Death|1
1678839|NCT01399125|5864236|P1|Overall Study|Death|0
1678840|NCT01399125|5864235|P2|Overall Study|Administrative Problems|11
1678841|NCT01399125|5864236|P1|Overall Study|Administrative Problems|7
1678842|NCT01399125|5864235|P2|Overall Study|Lost to Follow-up|3
1678843|NCT01399125|5864236|P1|Overall Study|Lost to Follow-up|2
1678844|NCT01399125|5864235|P2|Overall Study|Withdrawal by Subject|8
1678845|NCT01399125|5864236|P1|Overall Study|Withdrawal by Subject|5
1678846|NCT01399125|5864235|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
1678847|NCT01399125|5864236|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
1678848|NCT01399125|5864235|P2|Overall Study|Abnormal Lab values|1
1678849|NCT01399125|5864236|P1|Overall Study|Abnormal Lab values|0
1678850|NCT01399125|5864235|P2|Overall Study|Adverse Event|30
1678851|NCT01399125|5864236|P1|Overall Study|Adverse Event|32
1678852|NCT01399099|5864250|P1|Overall Study|Miscellaneous|4
1678853|NCT01399099|5864250|P1|Overall Study|Infection|1
1678854|NCT01399099|5864250|P1|Overall Study|Skin Irritation|13
1678855|NCT01399099|5864250|P1|Overall Study|Protocol Violation|1
1678856|NCT01399099|5864250|P1|Overall Study|Physician Decision|1
1678857|NCT01399099|5864250|P1|Overall Study|Lost to Follow-up|11
1678858|NCT01399047|5864257|P2|Overall Study|Withdrawal by Subject|1
1678859|NCT01399047|5864258|P1|Overall Study|Withdrawal by Subject|0
1678860|NCT01398956|5864294|P1|Overall Study|Subject moved a long distance|1
1678861|NCT01398956|5864294|P1|Overall Study|Withdrawal Criteria No.3|1
1678862|NCT01398956|5864294|P1|Overall Study|AE, non-serious non-fatal|4
1678863|NCT01398956|5864294|P1|Overall Study|Withdrawal by Subject|4
1678864|NCT01398787|5864326|P1|Overall Study|Adverse Event|1
1678865|NCT01398514|5864344|P2|Overall Study|Failure to show a conditioned response|3
1678866|NCT01398514|5864345|P1|Overall Study|Failure to show a conditioned response|4
1678867|NCT01398514|5864344|P2|Overall Study|Physiologic non-responsiveness|3
1678868|NCT01398514|5864345|P1|Overall Study|Physiologic non-responsiveness|1
1678869|NCT01398514|5864344|P2|Overall Study|Non-compliance with study procedures|0
1678870|NCT01398514|5864345|P1|Overall Study|Non-compliance with study procedures|2
1678871|NCT01398514|5864344|P2|Overall Study|Adverse Event|0
1678872|NCT01398514|5864345|P1|Overall Study|Adverse Event|1
1678873|NCT01398410|5864380|P2|Overall Study|Other|29
1678874|NCT01398410|5864381|P1|Overall Study|Other|36
1678875|NCT01398410|5864380|P2|Overall Study|Inadequate Therapeutic Effect|0
1678876|NCT01398410|5864381|P1|Overall Study|Inadequate Therapeutic Effect|2
1678877|NCT01398410|5864380|P2|Overall Study|Participants Choice|11
1678878|NCT01398410|5864381|P1|Overall Study|Participants Choice|8
1678879|NCT01398410|5864380|P2|Overall Study|Adverse Event|16
1678880|NCT01398410|5864381|P1|Overall Study|Adverse Event|12
1678881|NCT01398358|5864392|P3|Overall Study|no longer eligible|1
1678882|NCT01398358|5864393|P2|Overall Study|no longer eligible|0
1678883|NCT01398358|5864394|P1|Overall Study|no longer eligible|1
1678884|NCT01398358|5864392|P3|Overall Study|Withdrawal by Subject|2
1678885|NCT01398358|5864393|P2|Overall Study|Withdrawal by Subject|2
1678886|NCT01398358|5864394|P1|Overall Study|Withdrawal by Subject|3
1678887|NCT01398358|5864392|P3|Overall Study|Lost to Follow-up|18
1678888|NCT01398358|5864393|P2|Overall Study|Lost to Follow-up|21
1678889|NCT01398358|5864394|P1|Overall Study|Lost to Follow-up|11
1678890|NCT01398176|5864416|P2|Overall Study|Physician Decision|3
1678891|NCT01398176|5864417|P1|Overall Study|Physician Decision|2
1678892|NCT01398176|5864416|P2|Overall Study|Lost to Follow-up|3
1678893|NCT01398176|5864417|P1|Overall Study|Lost to Follow-up|1
1678894|NCT01397890|5864450|P2|Overall Study|Others|1
1678895|NCT01397890|5864451|P1|Overall Study|Others|2
1678896|NCT01397890|5864450|P2|Overall Study|Severe Non-Compliance to Protocol|1
1678897|NCT01397890|5864451|P1|Overall Study|Severe Non-Compliance to Protocol|2
1678898|NCT01397890|5864450|P2|Overall Study|Adverse Event|2
1678899|NCT01397890|5864451|P1|Overall Study|Adverse Event|1
1678900|NCT01397890|5864450|P2|Overall Study|Condition under Investigation Worsened|3
1678901|NCT01397890|5864451|P1|Overall Study|Condition under Investigation Worsened|1
1678902|NCT01397890|5864450|P2|Overall Study|Lost to Follow-up|4
1678903|NCT01397890|5864451|P1|Overall Study|Lost to Follow-up|1
1678904|NCT01397890|5864450|P2|Overall Study|Death|3
1678905|NCT01397890|5864451|P1|Overall Study|Death|2
1678906|NCT01397890|5864450|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
1678907|NCT01397890|5864451|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
1678908|NCT01397890|5864450|P2|Overall Study|Withdrawal by Subject|11
1678909|NCT01397890|5864451|P1|Overall Study|Withdrawal by Subject|7
1678910|NCT01397825|5864522|P5|Overall Study|Withdrawal by Subject|0
1678911|NCT01397825|5864523|P4|Overall Study|Withdrawal by Subject|1
1678912|NCT01397825|5864524|P3|Overall Study|Withdrawal by Subject|5
1678913|NCT01397825|5864525|P2|Overall Study|Withdrawal by Subject|0
1678914|NCT01397825|5864526|P1|Overall Study|Withdrawal by Subject|1
1678915|NCT01397825|5864522|P5|Overall Study|Adverse Event|0
1678916|NCT01397825|5864523|P4|Overall Study|Adverse Event|1
1678917|NCT01397825|5864524|P3|Overall Study|Adverse Event|5
1678918|NCT01397825|5864525|P2|Overall Study|Adverse Event|1
1678919|NCT01397825|5864526|P1|Overall Study|Adverse Event|0
1678920|NCT01397825|5864522|P5|Overall Study|Symptomatic Deterioration|0
1678921|NCT01397825|5864523|P4|Overall Study|Symptomatic Deterioration|0
1678922|NCT01397825|5864524|P3|Overall Study|Symptomatic Deterioration|4
1678923|NCT01397825|5864525|P2|Overall Study|Symptomatic Deterioration|0
1678924|NCT01397825|5864526|P1|Overall Study|Symptomatic Deterioration|2
1678925|NCT01397825|5864522|P5|Overall Study|Progressive Disease|0
1678926|NCT01397825|5864523|P4|Overall Study|Progressive Disease|1
1678927|NCT01397825|5864524|P3|Overall Study|Progressive Disease|11
1678928|NCT01397825|5864525|P2|Overall Study|Progressive Disease|3
1678929|NCT01397825|5864526|P1|Overall Study|Progressive Disease|10
1678930|NCT01397786|5864596|P3|Phase B|Lack of Efficacy|14
1678931|NCT01397786|5864597|P2|Phase B|Lack of Efficacy|7
1678932|NCT01397786|5864598|P1|Phase B|Lack of Efficacy|22
1678933|NCT01397786|5864596|P3|Phase B|Protocol Deviation|4
1678934|NCT01397786|5864597|P2|Phase B|Protocol Deviation|2
1678935|NCT01397786|5864598|P1|Phase B|Protocol Deviation|1
1678936|NCT01397786|5864596|P3|Phase B|Withdrawal by Subject|30
1678937|NCT01397786|5864597|P2|Phase B|Withdrawal by Subject|45
1678938|NCT01397786|5864598|P1|Phase B|Withdrawal by Subject|102
1678939|NCT01397786|5864596|P3|Phase B|Physician Decision|3
1678940|NCT01397786|5864597|P2|Phase B|Physician Decision|1
1678941|NCT01397786|5864598|P1|Phase B|Physician Decision|9
1678942|NCT01397786|5864596|P3|Phase B|Subject Met Withdrawal Criteria|38
1678943|NCT01397786|5864597|P2|Phase B|Subject Met Withdrawal Criteria|5
1678944|NCT01397786|5864598|P1|Phase B|Subject Met Withdrawal Criteria|38
1678945|NCT01397786|5864596|P3|Phase B|Adverse Event|27
1678946|NCT01397786|5864597|P2|Phase B|Adverse Event|23
1678947|NCT01397786|5864598|P1|Phase B|Adverse Event|109
1678948|NCT01397786|5864596|P3|Phase B|Lost to Follow-up|22
1678949|NCT01397786|5864597|P2|Phase B|Lost to Follow-up|12
1678950|NCT01397786|5864598|P1|Phase B|Lost to Follow-up|22
1678951|NCT01397786|5864596|P3|Phase A|Lack of Efficacy|1
1678952|NCT01397786|5864597|P2|Phase A|Lack of Efficacy|0
1678953|NCT01397786|5864598|P1|Phase A|Lack of Efficacy|0
1678954|NCT01397786|5864596|P3|Phase A|Withdrawal by Subject|5
1678955|NCT01397786|5864597|P2|Phase A|Withdrawal by Subject|0
1678956|NCT01397786|5864598|P1|Phase A|Withdrawal by Subject|0
1678957|NCT01397786|5864596|P3|Phase A|Physician Decision|1
1678958|NCT01397786|5864597|P2|Phase A|Physician Decision|0
1678959|NCT01397786|5864598|P1|Phase A|Physician Decision|0
1678960|NCT01397786|5864596|P3|Phase A|Subject Met Withdrawal Criteria|7
1678961|NCT01397786|5864597|P2|Phase A|Subject Met Withdrawal Criteria|0
1678962|NCT01397786|5864598|P1|Phase A|Subject Met Withdrawal Criteria|0
1678963|NCT01397786|5864596|P3|Phase A|Adverse Event|8
1678964|NCT01397786|5864597|P2|Phase A|Adverse Event|0
1678965|NCT01397786|5864598|P1|Phase A|Adverse Event|0
1678966|NCT01397786|5864596|P3|Phase A|Lost to Follow-up|6
1678967|NCT01397786|5864597|P2|Phase A|Lost to Follow-up|0
1678968|NCT01397786|5864598|P1|Phase A|Lost to Follow-up|0
1678969|NCT01397747|5864664|P1|Overall Study|FIT excluded|34
1678970|NCT01397747|5864664|P1|Overall Study|Colonoscopy excluded|304
1678971|NCT01397747|5864664|P1|Overall Study|Multitarget DNA test excluded|689
1678972|NCT01397552|5864714|P2|Overall Study|Withdrawal by Subject|1
1678973|NCT01397552|5864715|P1|Overall Study|Withdrawal by Subject|2
1678974|NCT01397552|5864714|P2|Overall Study|Adverse Event|0
1678975|NCT01397552|5864715|P1|Overall Study|Adverse Event|1
1678976|NCT01397461|5864724|P3|Overall Study|Not treated|1
1678977|NCT01397461|5864725|P2|Overall Study|Not treated|0
1678978|NCT01397461|5864726|P1|Overall Study|Not treated|0
1678979|NCT01397461|5864724|P3|Overall Study|Lack of Efficacy|0
1678980|NCT01397461|5864725|P2|Overall Study|Lack of Efficacy|3
1678981|NCT01397461|5864726|P1|Overall Study|Lack of Efficacy|0
1678982|NCT01397461|5864724|P3|Overall Study|Lost to Follow-up|1
1678983|NCT01397461|5864725|P2|Overall Study|Lost to Follow-up|2
1678984|NCT01397461|5864726|P1|Overall Study|Lost to Follow-up|0
1678985|NCT01397461|5864724|P3|Overall Study|Withdrawal by Subject|0
1678986|NCT01397461|5864725|P2|Overall Study|Withdrawal by Subject|1
1678987|NCT01397461|5864726|P1|Overall Study|Withdrawal by Subject|2
1678988|NCT01397448|5864737|P3|Overall Study|Other|4
1678989|NCT01397448|5864738|P2|Overall Study|Other|7
1678990|NCT01397448|5864739|P1|Overall Study|Other|8
1678991|NCT01397448|5864737|P3|Overall Study|Lack of Efficacy|5
1678992|NCT01397448|5864738|P2|Overall Study|Lack of Efficacy|0
1678993|NCT01397448|5864739|P1|Overall Study|Lack of Efficacy|2
1678994|NCT01397448|5864737|P3|Overall Study|Withdrawal by Subject|3
1678995|NCT01397448|5864738|P2|Overall Study|Withdrawal by Subject|4
1678996|NCT01397448|5864739|P1|Overall Study|Withdrawal by Subject|4
1678997|NCT01397448|5864737|P3|Overall Study|Adverse Event|6
1678998|NCT01397448|5864738|P2|Overall Study|Adverse Event|4
1678999|NCT01397448|5864739|P1|Overall Study|Adverse Event|4
1679000|NCT01397422|5864754|P4|Overall Study|Increased bradykinesia related to PD|0
1679001|NCT01397422|5864755|P3|Overall Study|Increased bradykinesia related to PD|0
1679002|NCT01397422|5864756|P2|Overall Study|Increased bradykinesia related to PD|0
1679003|NCT01397422|5864757|P1|Overall Study|Increased bradykinesia related to PD|1
1679004|NCT01397422|5864754|P4|Overall Study|Withdrawal by Subject|0
1679005|NCT01397422|5864755|P3|Overall Study|Withdrawal by Subject|0
1679006|NCT01397422|5864756|P2|Overall Study|Withdrawal by Subject|0
1679007|NCT01397422|5864757|P1|Overall Study|Withdrawal by Subject|1
1679008|NCT01397422|5864754|P4|Overall Study|Adverse Event|8
1679009|NCT01397422|5864755|P3|Overall Study|Adverse Event|3
1679010|NCT01397422|5864756|P2|Overall Study|Adverse Event|3
1679011|NCT01397422|5864757|P1|Overall Study|Adverse Event|0
1679012|NCT01397409|5864797|P10|Stage 3|Other Miscellaneous Reasons|0
1679013|NCT01397409|5864798|P9|Stage 3|Other Miscellaneous Reasons|0
1679014|NCT01397409|5864799|P8|Stage 3|Other Miscellaneous Reasons|1
1679015|NCT01397409|5864800|P7|Stage 3|Other Miscellaneous Reasons|0
1679016|NCT01397409|5864801|P6|Stage 3|Other Miscellaneous Reasons|0
1679017|NCT01397409|5864802|P5|Stage 3|Other Miscellaneous Reasons|0
1679018|NCT01397409|5864803|P4|Stage 3|Other Miscellaneous Reasons|0
1679019|NCT01397409|5864804|P3|Stage 3|Other Miscellaneous Reasons|0
1679020|NCT01397409|5864805|P2|Stage 3|Other Miscellaneous Reasons|0
1679021|NCT01397409|5864806|P1|Stage 3|Other Miscellaneous Reasons|0
1679022|NCT01397409|5864797|P10|Stage 3|Adverse Event|0
1679023|NCT01397409|5864798|P9|Stage 3|Adverse Event|0
1679024|NCT01397409|5864799|P8|Stage 3|Adverse Event|1
1679025|NCT01397409|5864800|P7|Stage 3|Adverse Event|0
1679026|NCT01397409|5864801|P6|Stage 3|Adverse Event|0
1679027|NCT01397409|5864802|P5|Stage 3|Adverse Event|0
1679028|NCT01397409|5864803|P4|Stage 3|Adverse Event|0
1679029|NCT01397409|5864804|P3|Stage 3|Adverse Event|0
1679030|NCT01397409|5864805|P2|Stage 3|Adverse Event|0
1679031|NCT01397409|5864806|P1|Stage 3|Adverse Event|0
1679032|NCT01397409|5864797|P10|Stage 2|Other Miscellaneous Reasons|0
1679033|NCT01397409|5864798|P9|Stage 2|Other Miscellaneous Reasons|0
1679034|NCT01397409|5864799|P8|Stage 2|Other Miscellaneous Reasons|0
1679035|NCT01397409|5864800|P7|Stage 2|Other Miscellaneous Reasons|0
1679036|NCT01397409|5864801|P6|Stage 2|Other Miscellaneous Reasons|1
1679037|NCT01397409|5864802|P5|Stage 2|Other Miscellaneous Reasons|1
1679038|NCT01397409|5864803|P4|Stage 2|Other Miscellaneous Reasons|0
1679039|NCT01397409|5864804|P3|Stage 2|Other Miscellaneous Reasons|0
1679040|NCT01397409|5864805|P2|Stage 2|Other Miscellaneous Reasons|0
1679041|NCT01397409|5864806|P1|Stage 2|Other Miscellaneous Reasons|0
1679042|NCT01397409|5864797|P10|Stage 2|Personal Reasons|0
1679043|NCT01397409|5864798|P9|Stage 2|Personal Reasons|0
1679044|NCT01397409|5864799|P8|Stage 2|Personal Reasons|0
1679045|NCT01397409|5864800|P7|Stage 2|Personal Reasons|0
1679046|NCT01397409|5864801|P6|Stage 2|Personal Reasons|0
1679047|NCT01397409|5864802|P5|Stage 2|Personal Reasons|1
1679048|NCT01397409|5864803|P4|Stage 2|Personal Reasons|0
1679049|NCT01397409|5864804|P3|Stage 2|Personal Reasons|0
1679050|NCT01397409|5864805|P2|Stage 2|Personal Reasons|0
1679051|NCT01397409|5864806|P1|Stage 2|Personal Reasons|0
1679052|NCT01397409|5864797|P10|Stage 2|Adverse Event|0
1679053|NCT01397409|5864798|P9|Stage 2|Adverse Event|0
1679054|NCT01397409|5864799|P8|Stage 2|Adverse Event|0
1679055|NCT01397409|5864800|P7|Stage 2|Adverse Event|0
1679056|NCT01397409|5864801|P6|Stage 2|Adverse Event|3
1679057|NCT01397409|5864802|P5|Stage 2|Adverse Event|6
1679058|NCT01397409|5864803|P4|Stage 2|Adverse Event|0
1679059|NCT01397409|5864804|P3|Stage 2|Adverse Event|0
1679060|NCT01397409|5864805|P2|Stage 2|Adverse Event|0
1679061|NCT01397409|5864806|P1|Stage 2|Adverse Event|0
1679062|NCT01397253|5864846|P2|Overall Study|Reviewed by only 1 pharmacist|149
1679063|NCT01397253|5864847|P1|Overall Study|Reviewed by only 1 pharmacist|126
1679064|NCT01397084|5864853|P1|Overall Study|Used other proton pump inhibitor|1
1679065|NCT01397084|5864853|P1|Overall Study|Lost to Follow-up|1
1679066|NCT01397084|5864853|P1|Overall Study|Withdrawal by Subject|1
1679067|NCT01397084|5864853|P1|Overall Study|Adverse Event|2
1679068|NCT01397084|5864853|P1|Overall Study|Protocol Violation|2
1679069|NCT01397084|5864853|P1|Overall Study|Severe Non-Compliance to Protocol|1
1679070|NCT01396525|5864872|P1|Overall Study|Lost to Follow-up|4
1679071|NCT01396525|5864872|P1|Overall Study|Death|14
1679072|NCT01396525|5864872|P1|Overall Study|Withdrawal by Subject|8
1679073|NCT01396512|5864972|P2|Overall Study|Withdrawal by Subject|1
1679074|NCT01396512|5864973|P1|Overall Study|Withdrawal by Subject|0
1679075|NCT01396447|5864989|P4|Overall Study|Other Miscellaneous Reasons|0
1679076|NCT01396447|5864990|P3|Overall Study|Other Miscellaneous Reasons|1
1679077|NCT01396447|5864991|P2|Overall Study|Other Miscellaneous Reasons|2
1679078|NCT01396447|5864992|P1|Overall Study|Other Miscellaneous Reasons|0
1679079|NCT01396447|5864989|P4|Overall Study|Lost to Follow-up|9
1679080|NCT01396447|5864990|P3|Overall Study|Lost to Follow-up|7
1679081|NCT01396447|5864991|P2|Overall Study|Lost to Follow-up|8
1679082|NCT01396447|5864992|P1|Overall Study|Lost to Follow-up|4
1679083|NCT01396447|5864989|P4|Overall Study|Withdrawal of Consent|15
1679084|NCT01396447|5864990|P3|Overall Study|Withdrawal of Consent|4
1679085|NCT01396447|5864991|P2|Overall Study|Withdrawal of Consent|9
1679086|NCT01396447|5864992|P1|Overall Study|Withdrawal of Consent|11
1679087|NCT01396447|5864989|P4|Overall Study|Protocol Violation|7
1679088|NCT01396447|5864990|P3|Overall Study|Protocol Violation|3
1679089|NCT01396447|5864991|P2|Overall Study|Protocol Violation|2
1679090|NCT01396447|5864992|P1|Overall Study|Protocol Violation|5
1679091|NCT01396447|5864989|P4|Overall Study|Insufficient Therapeutic Response|4
1679092|NCT01396447|5864990|P3|Overall Study|Insufficient Therapeutic Response|2
1679093|NCT01396447|5864991|P2|Overall Study|Insufficient Therapeutic Response|5
1679094|NCT01396447|5864992|P1|Overall Study|Insufficient Therapeutic Response|5
1679095|NCT01396447|5864989|P4|Overall Study|Adverse Event|17
1679096|NCT01396447|5864990|P3|Overall Study|Adverse Event|12
1679097|NCT01396447|5864991|P2|Overall Study|Adverse Event|12
1679098|NCT01396447|5864992|P1|Overall Study|Adverse Event|15
1679099|NCT01396447|5864989|P4|Overall Study|Did Not Receive Treatment|0
1679100|NCT01396447|5864990|P3|Overall Study|Did Not Receive Treatment|1
1679101|NCT01396447|5864991|P2|Overall Study|Did Not Receive Treatment|2
1679102|NCT01396447|5864992|P1|Overall Study|Did Not Receive Treatment|3
1679103|NCT01396434|5865009|P3|Overall Study|Other|0
1679104|NCT01396434|5865010|P2|Overall Study|Other|0
1679105|NCT01396434|5865011|P1|Overall Study|Other|10
1679106|NCT01396434|5865009|P3|Overall Study|Lost to Follow-up|0
1679107|NCT01396434|5865010|P2|Overall Study|Lost to Follow-up|0
1679108|NCT01396434|5865011|P1|Overall Study|Lost to Follow-up|1
1679109|NCT01396421|5865023|P4|Overall Study|Lack of Efficacy|18
1679110|NCT01396421|5865024|P3|Overall Study|Lack of Efficacy|7
1679111|NCT01396421|5865025|P2|Overall Study|Lack of Efficacy|17
1679112|NCT01396421|5865026|P1|Overall Study|Lack of Efficacy|7
1679113|NCT01396421|5865023|P4|Overall Study|Protocol Deviation|0
1679114|NCT01396421|5865024|P3|Overall Study|Protocol Deviation|1
1679115|NCT01396421|5865025|P2|Overall Study|Protocol Deviation|1
1679116|NCT01396421|5865026|P1|Overall Study|Protocol Deviation|2
1679117|NCT01396421|5865023|P4|Overall Study|Withdrawal by Subject|21
1679118|NCT01396421|5865024|P3|Overall Study|Withdrawal by Subject|13
1679119|NCT01396421|5865025|P2|Overall Study|Withdrawal by Subject|24
1679120|NCT01396421|5865026|P1|Overall Study|Withdrawal by Subject|31
1679121|NCT01396421|5865023|P4|Overall Study|Physician Decision|3
1679122|NCT01396421|5865024|P3|Overall Study|Physician Decision|0
1679123|NCT01396421|5865025|P2|Overall Study|Physician Decision|1
1679124|NCT01396421|5865026|P1|Overall Study|Physician Decision|1
1679125|NCT01396421|5865023|P4|Overall Study|Participant Met Withdrawal Criteria|0
1679126|NCT01396421|5865024|P3|Overall Study|Participant Met Withdrawal Criteria|1
1679127|NCT01396421|5865025|P2|Overall Study|Participant Met Withdrawal Criteria|0
1679128|NCT01396421|5865026|P1|Overall Study|Participant Met Withdrawal Criteria|1
1679129|NCT01396421|5865023|P4|Overall Study|Adverse Event|32
1679130|NCT01396421|5865024|P3|Overall Study|Adverse Event|12
1679131|NCT01396421|5865025|P2|Overall Study|Adverse Event|15
1679132|NCT01396421|5865026|P1|Overall Study|Adverse Event|17
1679133|NCT01396421|5865023|P4|Overall Study|Lost to Follow-up|1
1679134|NCT01396421|5865024|P3|Overall Study|Lost to Follow-up|0
1679135|NCT01396421|5865025|P2|Overall Study|Lost to Follow-up|0
1679136|NCT01396421|5865026|P1|Overall Study|Lost to Follow-up|0
1679137|NCT01396395|5865098|P2|Overall Study|Other|1
1679138|NCT01396395|5865099|P1|Overall Study|Other|0
1679139|NCT01396395|5865098|P2|Overall Study|Lost to Follow-up|11
1679140|NCT01396395|5865099|P1|Overall Study|Lost to Follow-up|17
1679141|NCT01396395|5865098|P2|Overall Study|Adverse Event|2
1679142|NCT01396395|5865099|P1|Overall Study|Adverse Event|10
1679143|NCT01396395|5865098|P2|Overall Study|Protocol Violation|1
1679144|NCT01396395|5865099|P1|Overall Study|Protocol Violation|3
1679145|NCT01396395|5865098|P2|Overall Study|Withdrawal by Subject|12
1679146|NCT01396395|5865099|P1|Overall Study|Withdrawal by Subject|10
1679147|NCT01396317|5865141|P2|Overall Study|Adverse Event|0
1679148|NCT01396317|5865142|P1|Overall Study|Adverse Event|1
1679149|NCT01396265|5865156|P1|Rifa+Afatinib|Withdrawal by Subject|1
1679150|NCT01396187|5865245|P5|Overall Study|Other|1
1679151|NCT01396187|5865246|P4|Overall Study|Other|0
1679152|NCT01396187|5865247|P3|Overall Study|Other|0
1679153|NCT01396187|5865248|P2|Overall Study|Other|1
1679154|NCT01396187|5865249|P1|Overall Study|Other|1
1679155|NCT01396187|5865245|P5|Overall Study|Withdrawal by Subject|0
1679156|NCT01396187|5865246|P4|Overall Study|Withdrawal by Subject|0
1679157|NCT01396187|5865247|P3|Overall Study|Withdrawal by Subject|1
1679158|NCT01396187|5865248|P2|Overall Study|Withdrawal by Subject|1
1679159|NCT01396187|5865249|P1|Overall Study|Withdrawal by Subject|0
1679160|NCT01396187|5865245|P5|Overall Study|Adverse Event|0
1679161|NCT01396187|5865246|P4|Overall Study|Adverse Event|0
1679162|NCT01396187|5865247|P3|Overall Study|Adverse Event|0
1679163|NCT01396187|5865248|P2|Overall Study|Adverse Event|1
1679164|NCT01396187|5865249|P1|Overall Study|Adverse Event|0
1679165|NCT01396161|5865349|P7|Overall Study|Other|1
1679166|NCT01396161|5865350|P6|Overall Study|Other|0
1679167|NCT01396161|5865351|P5|Overall Study|Other|0
1679168|NCT01396161|5865352|P4|Overall Study|Other|0
1679169|NCT01396161|5865353|P3|Overall Study|Other|0
1679170|NCT01396161|5865354|P2|Overall Study|Other|0
1679171|NCT01396161|5865355|P1|Overall Study|Other|0
1679172|NCT01396161|5865349|P7|Overall Study|Withdrawal by Subject|0
1679173|NCT01396161|5865350|P6|Overall Study|Withdrawal by Subject|0
1679174|NCT01396161|5865351|P5|Overall Study|Withdrawal by Subject|1
1679175|NCT01396161|5865352|P4|Overall Study|Withdrawal by Subject|0
1679176|NCT01396161|5865353|P3|Overall Study|Withdrawal by Subject|0
1679177|NCT01396161|5865354|P2|Overall Study|Withdrawal by Subject|0
1679178|NCT01396161|5865355|P1|Overall Study|Withdrawal by Subject|0
1679179|NCT01396148|5865408|P1|Overall Study|Patient Decision|1
1679180|NCT01396083|5865438|P2|Overall Study|Lost to Follow-up|0
1679181|NCT01396083|5865439|P1|Overall Study|Lost to Follow-up|1
1679182|NCT01396083|5865438|P2|Overall Study|Administrative problems|0
1679183|NCT01396083|5865439|P1|Overall Study|Administrative problems|1
1679184|NCT01396083|5865438|P2|Overall Study|Abnormal laboratory value(s)|0
1679185|NCT01396083|5865439|P1|Overall Study|Abnormal laboratory value(s)|1
1679186|NCT01396083|5865438|P2|Overall Study|Protocol deviation(s)|1
1679187|NCT01396083|5865439|P1|Overall Study|Protocol deviation(s)|0
1679188|NCT01396083|5865438|P2|Overall Study|Consent withdrawn|5
1679189|NCT01396083|5865439|P1|Overall Study|Consent withdrawn|4
1679190|NCT01396083|5865438|P2|Overall Study|Unsatisfactory therapeutic effect|13
1679191|NCT01396083|5865439|P1|Overall Study|Unsatisfactory therapeutic effect|2
1679192|NCT01396083|5865438|P2|Overall Study|Adverse Event|28
1679193|NCT01396083|5865439|P1|Overall Study|Adverse Event|2
1679194|NCT01396070|5865463|P1|Overall Study|Lack of Efficacy|4
1679195|NCT01396070|5865463|P1|Overall Study|Physician Decision|3
1679196|NCT01396070|5865463|P1|Overall Study|Adverse Event|8
1679197|NCT01396070|5865463|P1|Overall Study|Death|2
1679198|NCT01396070|5865463|P1|Overall Study|Withdrawal by Subject|2
1679199|NCT01396057|5865472|P2|Overall Study|Consent withdrawn|2
1679200|NCT01396057|5865473|P1|Overall Study|Consent withdrawn|3
1679201|NCT01396057|5865472|P2|Overall Study|Protocol deviation|4
1679202|NCT01396057|5865473|P1|Overall Study|Protocol deviation|4
1679203|NCT01396057|5865472|P2|Overall Study|Unsatisfactory therapeutic effect|6
1679204|NCT01396057|5865473|P1|Overall Study|Unsatisfactory therapeutic effect|2
1679205|NCT01396057|5865472|P2|Overall Study|Adverse Event|6
1679206|NCT01396057|5865473|P1|Overall Study|Adverse Event|2
1679207|NCT01396005|5865522|P2|Overall Study|Non-compliance with protocol|1
1679208|NCT01396005|5865523|P1|Overall Study|Non-compliance with protocol|0
1679209|NCT01396005|5865522|P2|Overall Study|Withdrawal by Subject|1
1679210|NCT01396005|5865523|P1|Overall Study|Withdrawal by Subject|0
1679211|NCT01395914|5865554|P2|Overall Study|Lost to Follow-up|2
1679212|NCT01395914|5865555|P1|Overall Study|Lost to Follow-up|6
1679213|NCT01395914|5865554|P2|Overall Study|Study drug-related AE|0
1679214|NCT01395914|5865555|P1|Overall Study|Study drug-related AE|1
1679215|NCT01395914|5865554|P2|Overall Study|Withdrawal by patient|14
1679216|NCT01395914|5865555|P1|Overall Study|Withdrawal by patient|27
1679217|NCT01395914|5865554|P2|Overall Study|Other|3
1679218|NCT01395914|5865555|P1|Overall Study|Other|9
1679219|NCT01395914|5865554|P2|Overall Study|Death|17
1679220|NCT01395914|5865555|P1|Overall Study|Death|23
1679221|NCT01395914|5865554|P2|Overall Study|Unrelated to study drug AE|1
1679222|NCT01395914|5865555|P1|Overall Study|Unrelated to study drug AE|6
1679223|NCT01395901|5865569|P2|Overall Study|Withdrawal of consent|0
1679224|NCT01395901|5865570|P1|Overall Study|Withdrawal of consent|1
1679225|NCT01395901|5865569|P2|Overall Study|Adverse Event|1
1679226|NCT01395901|5865570|P1|Overall Study|Adverse Event|0
1679227|NCT01395901|5865569|P2|Overall Study|Randomized but not received study drug|4
1679228|NCT01395901|5865570|P1|Overall Study|Randomized but not received study drug|5
1679229|NCT01395901|5865569|P2|Overall Study|Lost to Follow-up|0
1679230|NCT01395901|5865570|P1|Overall Study|Lost to Follow-up|4
1679231|NCT01395888|5865586|P3|Treatment Period (TP)|Withdrawal by Subject|3
1679232|NCT01395888|5865587|P2|Treatment Period (TP)|Withdrawal by Subject|2
1679233|NCT01395888|5865588|P1|Treatment Period (TP)|Withdrawal by Subject|0
1679234|NCT01395888|5865586|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
1679235|NCT01395888|5865587|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
1679236|NCT01395888|5865588|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
1679237|NCT01395888|5865586|P3|Treatment Period (TP)|Protocol Violation|5
1679238|NCT01395888|5865587|P2|Treatment Period (TP)|Protocol Violation|1
1679239|NCT01395888|5865588|P1|Treatment Period (TP)|Protocol Violation|0
1679240|NCT01395888|5865586|P3|Treatment Period (TP)|Lack of Efficacy|3
1679241|NCT01395888|5865587|P2|Treatment Period (TP)|Lack of Efficacy|4
1679242|NCT01395888|5865588|P1|Treatment Period (TP)|Lack of Efficacy|0
1679243|NCT01395888|5865586|P3|Treatment Period (TP)|Adverse Event|6
1679244|NCT01395888|5865587|P2|Treatment Period (TP)|Adverse Event|7
1679245|NCT01395888|5865588|P1|Treatment Period (TP)|Adverse Event|0
1679246|NCT01395888|5865586|P3|2-week Run-in Period|Withdrawal by Subject|0
1679247|NCT01395888|5865587|P2|2-week Run-in Period|Withdrawal by Subject|0
1679248|NCT01395888|5865588|P1|2-week Run-in Period|Withdrawal by Subject|4
1679249|NCT01395888|5865586|P3|2-week Run-in Period|Protocol Violation|0
1679250|NCT01395888|5865587|P2|2-week Run-in Period|Protocol Violation|0
1679251|NCT01395888|5865588|P1|2-week Run-in Period|Protocol Violation|2
1679252|NCT01395888|5865586|P3|2-week Run-in Period|Lost to Follow-up|0
1679253|NCT01395888|5865587|P2|2-week Run-in Period|Lost to Follow-up|0
1679254|NCT01395888|5865588|P1|2-week Run-in Period|Lost to Follow-up|1
1679255|NCT01395888|5865586|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1679256|NCT01395888|5865587|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1679257|NCT01395888|5865588|P1|2-week Run-in Period|Continuation Criteria Not Met|13
1679258|NCT01395888|5865586|P3|2-week Run-in Period|Adverse Event|0
1679259|NCT01395888|5865587|P2|2-week Run-in Period|Adverse Event|0
1679260|NCT01395888|5865588|P1|2-week Run-in Period|Adverse Event|2
1679261|NCT01395823|5865596|P2|Overall Study|Withdrawal by Subject|4
1679262|NCT01395823|5865597|P1|Overall Study|Withdrawal by Subject|5
1679263|NCT01395823|5865596|P2|Overall Study|GI symptoms|0
1679264|NCT01395823|5865597|P1|Overall Study|GI symptoms|1
1679265|NCT01395823|5865596|P2|Overall Study|Transplant|0
1679266|NCT01395823|5865597|P1|Overall Study|Transplant|1
1679267|NCT01395823|5865596|P2|Overall Study|Lost to Follow-up|0
1679268|NCT01395823|5865597|P1|Overall Study|Lost to Follow-up|1
1679269|NCT01395823|5865596|P2|Overall Study|Physician Decision|1
1679270|NCT01395823|5865597|P1|Overall Study|Physician Decision|3
1679271|NCT01395823|5865596|P2|Overall Study|Death|4
1679272|NCT01395823|5865597|P1|Overall Study|Death|4
1679273|NCT01395810|5865607|P4|Overall Study|Unclassified|0
1679274|NCT01395810|5865608|P3|Overall Study|Unclassified|0
1679275|NCT01395810|5865609|P2|Overall Study|Unclassified|0
1679276|NCT01395810|5865610|P1|Overall Study|Unclassified|2
1679277|NCT01395810|5865607|P4|Overall Study|Withdrawal criteria|0
1679278|NCT01395810|5865608|P3|Overall Study|Withdrawal criteria|0
1679279|NCT01395810|5865609|P2|Overall Study|Withdrawal criteria|2
1679280|NCT01395810|5865610|P1|Overall Study|Withdrawal criteria|0
1679281|NCT01395810|5865607|P4|Overall Study|Lack of Efficacy|0
1679282|NCT01395810|5865608|P3|Overall Study|Lack of Efficacy|0
1679283|NCT01395810|5865609|P2|Overall Study|Lack of Efficacy|1
1679284|NCT01395810|5865610|P1|Overall Study|Lack of Efficacy|0
1679285|NCT01395810|5865607|P4|Overall Study|Adverse Event|0
1679286|NCT01395810|5865608|P3|Overall Study|Adverse Event|0
1679287|NCT01395810|5865609|P2|Overall Study|Adverse Event|1
1679288|NCT01395810|5865610|P1|Overall Study|Adverse Event|0
1679289|NCT01395784|5865669|P1|Overall Study|Physician Decision|5
1679290|NCT01395784|5865669|P1|Overall Study|Withdrawal by Subject|3
1679291|NCT01395784|5865669|P1|Overall Study|Lost to Follow-up|7
1679292|NCT01395758|5865676|P3|Open-label Treatment Period|Withdrawal by Subject|0
1679293|NCT01395758|5865677|P2|Open-label Treatment Period|Withdrawal by Subject|0
1679294|NCT01395758|5865678|P1|Open-label Treatment Period|Withdrawal by Subject|4
1679295|NCT01395524|5865698|P3|Overall Study|Subject had spinal surgery|1
1679296|NCT01395524|5865699|P2|Overall Study|Subject had spinal surgery|0
1679297|NCT01395524|5865700|P1|Overall Study|Subject had spinal surgery|0
1679298|NCT01395524|5865698|P3|Overall Study|Did not receive treatment|3
1679299|NCT01395524|5865699|P2|Overall Study|Did not receive treatment|1
1679300|NCT01395524|5865700|P1|Overall Study|Did not receive treatment|1
1679301|NCT01395524|5865698|P3|Overall Study|Withdrawal by Subject|8
1679302|NCT01395524|5865699|P2|Overall Study|Withdrawal by Subject|8
1679303|NCT01395524|5865700|P1|Overall Study|Withdrawal by Subject|4
1679304|NCT01395524|5865698|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
1679305|NCT01395524|5865699|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1679306|NCT01395524|5865700|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
1679307|NCT01395524|5865698|P3|Overall Study|Death|0
1679308|NCT01395524|5865699|P2|Overall Study|Death|0
1679309|NCT01395524|5865700|P1|Overall Study|Death|1
1679310|NCT01395524|5865698|P3|Overall Study|Adverse Event|3
1679311|NCT01395524|5865699|P2|Overall Study|Adverse Event|4
1679312|NCT01395524|5865700|P1|Overall Study|Adverse Event|4
1679313|NCT01395524|5865698|P3|Overall Study|Severe noncompliance with protocol|0
1679314|NCT01395524|5865699|P2|Overall Study|Severe noncompliance with protocol|0
1679315|NCT01395524|5865700|P1|Overall Study|Severe noncompliance with protocol|1
1679316|NCT01395524|5865698|P3|Overall Study|Study-Specific Withdrawal Criteria|0
1679317|NCT01395524|5865699|P2|Overall Study|Study-Specific Withdrawal Criteria|2
1679318|NCT01395524|5865700|P1|Overall Study|Study-Specific Withdrawal Criteria|1
1679319|NCT01395524|5865698|P3|Overall Study|Lost to Follow-up|1
1679320|NCT01395524|5865699|P2|Overall Study|Lost to Follow-up|1
1679321|NCT01395524|5865700|P1|Overall Study|Lost to Follow-up|3
1679322|NCT01395524|5865698|P3|Overall Study|Non-compliance with study schedule|1
1679323|NCT01395524|5865699|P2|Overall Study|Non-compliance with study schedule|0
1679324|NCT01395524|5865700|P1|Overall Study|Non-compliance with study schedule|1
1679325|NCT01395394|5865723|P3|Baseline Study Visit|Protocol Violation|0
1679326|NCT01395394|5865724|P2|Baseline Study Visit|Protocol Violation|0
1679327|NCT01395394|5865725|P1|Baseline Study Visit|Protocol Violation|1
1679328|NCT01395368|5865736|P1|Overall Study|Withdrawal by Subject|2
1679329|NCT01395368|5865736|P1|Overall Study|Physician Decision|14
1679330|NCT01395316|5865792|P1|Overall Study|poor MRI quality|1
1679331|NCT01395316|5865792|P1|Overall Study|Lost to Follow-up|2
1679332|NCT01395030|5865812|P1|Overall Study|Did not complete FCH PET/CT|7
1679333|NCT01395017|5865822|P2|Overall Study|Sponsor discontinued study|4
1679334|NCT01395017|5865823|P1|Overall Study|Sponsor discontinued study|1
1679335|NCT01395017|5865822|P2|Overall Study|Disease progression|58
1679336|NCT01395017|5865823|P1|Overall Study|Disease progression|42
1679337|NCT01395017|5865822|P2|Overall Study|Death|3
1679338|NCT01395017|5865823|P1|Overall Study|Death|4
1679339|NCT01395017|5865822|P2|Overall Study|Protocol deviation|2
1679340|NCT01395017|5865823|P1|Overall Study|Protocol deviation|1
1679341|NCT01395017|5865822|P2|Overall Study|Withdrawal by Subject|8
1679342|NCT01395017|5865823|P1|Overall Study|Withdrawal by Subject|14
1679343|NCT01395017|5865822|P2|Overall Study|Physician Decision|15
1679344|NCT01395017|5865823|P1|Overall Study|Physician Decision|11
1679345|NCT01395017|5865822|P2|Overall Study|Adverse Event|12
1679346|NCT01395017|5865823|P1|Overall Study|Adverse Event|26
1679347|NCT01395017|5865822|P2|Overall Study|Lost to Follow-up|0
1679348|NCT01395017|5865823|P1|Overall Study|Lost to Follow-up|1
1679349|NCT01394991|5865833|P2|Overall Study|Prematurely Termination of Trial|10
1679350|NCT01394991|5865834|P1|Overall Study|Prematurely Termination of Trial|9
1679351|NCT01394991|5865833|P2|Overall Study|Disease Progression|7
1679352|NCT01394991|5865834|P1|Overall Study|Disease Progression|7
1679353|NCT01394991|5865833|P2|Overall Study|Chemotherapy Termination|15
1679354|NCT01394991|5865834|P1|Overall Study|Chemotherapy Termination|10
1679355|NCT01394991|5865833|P2|Overall Study|Withdrawal by Subject|17
1679356|NCT01394991|5865834|P1|Overall Study|Withdrawal by Subject|20
1679357|NCT01394991|5865833|P2|Overall Study|Protocol Violation|1
1679358|NCT01394991|5865834|P1|Overall Study|Protocol Violation|1
1679359|NCT01394991|5865833|P2|Overall Study|Physician Decision|3
1679360|NCT01394991|5865834|P1|Overall Study|Physician Decision|1
1679361|NCT01394991|5865833|P2|Overall Study|Lost to Follow-up|8
1679362|NCT01394991|5865834|P1|Overall Study|Lost to Follow-up|6
1679363|NCT01394991|5865833|P2|Overall Study|Lack of Efficacy|7
1679364|NCT01394991|5865834|P1|Overall Study|Lack of Efficacy|5
1679365|NCT01394991|5865833|P2|Overall Study|Adverse Event|4
1679366|NCT01394991|5865834|P1|Overall Study|Adverse Event|0
1679367|NCT01394978|5865856|P2|Overall Study|Death|7
1679368|NCT01394978|5865857|P1|Overall Study|Death|6
1679369|NCT01394978|5865856|P2|Overall Study|Lost to Follow-up|20
1679370|NCT01394978|5865857|P1|Overall Study|Lost to Follow-up|13
1679371|NCT01394978|5865856|P2|Overall Study|Withdrawal by Subject|4
1679372|NCT01394978|5865857|P1|Overall Study|Withdrawal by Subject|2
1679373|NCT01394952|5865865|P2|Overall Study|Sponsor Decision|7
1679374|NCT01394952|5865866|P1|Overall Study|Sponsor Decision|5
1679375|NCT01394952|5865865|P2|Overall Study|Physician Decision|0
1679376|NCT01394952|5865866|P1|Overall Study|Physician Decision|2
1679377|NCT01394952|5865865|P2|Overall Study|Withdrawal by Subject|5
1679378|NCT01394952|5865866|P1|Overall Study|Withdrawal by Subject|10
1679379|NCT01394952|5865865|P2|Overall Study|Lost to Follow-up|5
1679380|NCT01394952|5865866|P1|Overall Study|Lost to Follow-up|0
1679381|NCT01394718|5865893|P2|Overall Study|Met protocol-specific stopping criteria|1
1679382|NCT01394718|5865894|P1|Overall Study|Met protocol-specific stopping criteria|2
1679383|NCT01394627|5865926|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
1679384|NCT01394627|5865927|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
1679385|NCT01394627|5865926|P2|First Intervention (1 Day)|poor intravenous access|1
1679386|NCT01394627|5865927|P1|First Intervention (1 Day)|poor intravenous access|0
1679387|NCT01394523|5865947|P3|Overall Study|Unable to place block|0
1679388|NCT01394523|5865948|P2|Overall Study|Unable to place block|0
1679389|NCT01394523|5865949|P1|Overall Study|Unable to place block|1
1679390|NCT01394276|5865963|P1|Overall Study|Symptoms of concurrent diseases|1
1679391|NCT01394276|5865963|P1|Overall Study|unavailability of drug at the Hospital|2
1679392|NCT01394276|5865963|P1|Overall Study|Pregnancy|1
1679393|NCT01394276|5865963|P1|Overall Study|Participant moved to another site|1
1679394|NCT01394276|5865963|P1|Overall Study|Lost to Follow-up|5
1679395|NCT01394276|5865963|P1|Overall Study|Insufficient compliance|9
1679396|NCT01394276|5865963|P1|Overall Study|Insufficient therapeutic effect|17
1679397|NCT01394276|5865963|P1|Overall Study|Remission of disease|2
1679398|NCT01394276|5865963|P1|Overall Study|Not related AEs|9
1679399|NCT01394276|5865963|P1|Overall Study|Related Adverse event (AEs)|15
1679400|NCT01394250|5865987|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
1679401|NCT01394250|5865988|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
1679402|NCT01394250|5865987|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
1679403|NCT01394250|5865988|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
1679404|NCT01394185|5866002|P6|Overall Study|Protocol Violation|1
1679405|NCT01394185|5866003|P5|Overall Study|Protocol Violation|0
1679406|NCT01394185|5866004|P4|Overall Study|Protocol Violation|1
1679407|NCT01394185|5866005|P3|Overall Study|Protocol Violation|0
1679408|NCT01394185|5866006|P2|Overall Study|Protocol Violation|0
1679409|NCT01394185|5866007|P1|Overall Study|Protocol Violation|1
1679410|NCT01394185|5866002|P6|Overall Study|Change in protocol|0
1679411|NCT01394185|5866003|P5|Overall Study|Change in protocol|3
1679412|NCT01394185|5866004|P4|Overall Study|Change in protocol|0
1679413|NCT01394185|5866005|P3|Overall Study|Change in protocol|0
1679414|NCT01394185|5866006|P2|Overall Study|Change in protocol|0
1679415|NCT01394185|5866007|P1|Overall Study|Change in protocol|3
1679416|NCT01394185|5866002|P6|Overall Study|Withdrawal by Subject|0
1679417|NCT01394185|5866003|P5|Overall Study|Withdrawal by Subject|1
1679418|NCT01394185|5866004|P4|Overall Study|Withdrawal by Subject|0
1679419|NCT01394185|5866005|P3|Overall Study|Withdrawal by Subject|0
1679420|NCT01394185|5866006|P2|Overall Study|Withdrawal by Subject|0
1679421|NCT01394185|5866007|P1|Overall Study|Withdrawal by Subject|2
1679422|NCT01393964|5866096|P3|Overall Study|Subject to receive non-protocol therapy|1
1679423|NCT01393964|5866097|P2|Overall Study|Subject to receive non-protocol therapy|0
1679424|NCT01393964|5866098|P1|Overall Study|Subject to receive non-protocol therapy|0
1679425|NCT01393964|5866096|P3|Overall Study|Subject converted to roll-over study|0
1679426|NCT01393964|5866097|P2|Overall Study|Subject converted to roll-over study|1
1679427|NCT01393964|5866098|P1|Overall Study|Subject converted to roll-over study|0
1679428|NCT01393964|5866096|P3|Overall Study|Investigator removed subject from study|0
1679429|NCT01393964|5866097|P2|Overall Study|Investigator removed subject from study|1
1679430|NCT01393964|5866098|P1|Overall Study|Investigator removed subject from study|0
1679431|NCT01393964|5866096|P3|Overall Study|Subject plateaued in terms of effect|0
1679432|NCT01393964|5866097|P2|Overall Study|Subject plateaued in terms of effect|0
1679433|NCT01393964|5866098|P1|Overall Study|Subject plateaued in terms of effect|1
1679434|NCT01393964|5866096|P3|Overall Study|Subject switched to commercial supply|2
1679435|NCT01393964|5866097|P2|Overall Study|Subject switched to commercial supply|0
1679436|NCT01393964|5866098|P1|Overall Study|Subject switched to commercial supply|1
1679437|NCT01393964|5866096|P3|Overall Study|Subject decided to move to transplant|0
1679438|NCT01393964|5866097|P2|Overall Study|Subject decided to move to transplant|0
1679439|NCT01393964|5866098|P1|Overall Study|Subject decided to move to transplant|1
1679440|NCT01393964|5866096|P3|Overall Study|Subject request stop study treatment|0
1679441|NCT01393964|5866097|P2|Overall Study|Subject request stop study treatment|1
1679442|NCT01393964|5866098|P1|Overall Study|Subject request stop study treatment|0
1679443|NCT01393964|5866096|P3|Overall Study|Adverse event unrelated to study drug|0
1679444|NCT01393964|5866097|P2|Overall Study|Adverse event unrelated to study drug|3
1679445|NCT01393964|5866098|P1|Overall Study|Adverse event unrelated to study drug|0
1679446|NCT01393964|5866096|P3|Overall Study|Withdrawal by Subject|1
1679447|NCT01393964|5866097|P2|Overall Study|Withdrawal by Subject|0
1679448|NCT01393964|5866098|P1|Overall Study|Withdrawal by Subject|0
1679449|NCT01393964|5866096|P3|Overall Study|Study drug toxicity|0
1679450|NCT01393964|5866097|P2|Overall Study|Study drug toxicity|0
1679451|NCT01393964|5866098|P1|Overall Study|Study drug toxicity|1
1679452|NCT01393964|5866096|P3|Overall Study|Disease Progression|5
1679453|NCT01393964|5866097|P2|Overall Study|Disease Progression|3
1679454|NCT01393964|5866098|P1|Overall Study|Disease Progression|4
1679455|NCT01393899|5866139|P3|Overall Study|Adverse Event|3
1679456|NCT01393899|5866140|P2|Overall Study|Adverse Event|5
1679457|NCT01393899|5866141|P1|Overall Study|Adverse Event|1
1679458|NCT01393899|5866139|P3|Overall Study|Lack of Efficacy|16
1679459|NCT01393899|5866140|P2|Overall Study|Lack of Efficacy|21
1679460|NCT01393899|5866141|P1|Overall Study|Lack of Efficacy|26
1679461|NCT01393899|5866139|P3|Overall Study|Does not meet entrance criteria|1
1679462|NCT01393899|5866140|P2|Overall Study|Does not meet entrance criteria|0
1679463|NCT01393899|5866141|P1|Overall Study|Does not meet entrance criteria|1
1679464|NCT01393899|5866139|P3|Overall Study|Lost to Follow-up|1
1679465|NCT01393899|5866140|P2|Overall Study|Lost to Follow-up|0
1679466|NCT01393899|5866141|P1|Overall Study|Lost to Follow-up|0
1679467|NCT01393899|5866139|P3|Overall Study|Withdrawal by Subject|1
1679468|NCT01393899|5866140|P2|Overall Study|Withdrawal by Subject|2
1679469|NCT01393899|5866141|P1|Overall Study|Withdrawal by Subject|2
1679470|NCT01393899|5866139|P3|Overall Study|Other|0
1679471|NCT01393899|5866140|P2|Overall Study|Other|0
1679472|NCT01393899|5866141|P1|Overall Study|Other|1
1679473|NCT01393899|5866139|P3|Overall Study|Study terminated by sponsor|1
1679474|NCT01393899|5866140|P2|Overall Study|Study terminated by sponsor|0
1679475|NCT01393899|5866141|P1|Overall Study|Study terminated by sponsor|1
1679480|NCT01393743|5866210|P3|Extension Phase|Other|14
1679481|NCT01393743|5866211|P2|Extension Phase|Other|0
1679482|NCT01393743|5866212|P1|Extension Phase|Other|0
1679483|NCT01393743|5866210|P3|Extension Phase|Pregnancy|1
1679484|NCT01393743|5866211|P2|Extension Phase|Pregnancy|0
1679485|NCT01393743|5866212|P1|Extension Phase|Pregnancy|0
1679486|NCT01393743|5866210|P3|Extension Phase|Withdrawal by Subject|8
1679487|NCT01393743|5866211|P2|Extension Phase|Withdrawal by Subject|0
1679488|NCT01393743|5866212|P1|Extension Phase|Withdrawal by Subject|0
1679489|NCT01393743|5866210|P3|Extension Phase|Inadequate therapeutic effect|7
1679490|NCT01393743|5866211|P2|Extension Phase|Inadequate therapeutic effect|0
1679491|NCT01393743|5866212|P1|Extension Phase|Inadequate therapeutic effect|0
1679492|NCT01393743|5866210|P3|Extension Phase|Participant choice|16
1679493|NCT01393743|5866211|P2|Extension Phase|Participant choice|0
1679494|NCT01393743|5866212|P1|Extension Phase|Participant choice|0
1679495|NCT01393743|5866210|P3|Extension Phase|Lost to Follow-up|2
1679496|NCT01393743|5866211|P2|Extension Phase|Lost to Follow-up|0
1679497|NCT01393743|5866212|P1|Extension Phase|Lost to Follow-up|0
1679498|NCT01393743|5866210|P3|Extension Phase|Adverse Event|12
1679499|NCT01393743|5866211|P2|Extension Phase|Adverse Event|0
1679500|NCT01393743|5866212|P1|Extension Phase|Adverse Event|0
1679501|NCT01393743|5866210|P3|Core Study|Inadequate therapeutic effect|0
1679502|NCT01393743|5866211|P2|Core Study|Inadequate therapeutic effect|0
1679503|NCT01393743|5866212|P1|Core Study|Inadequate therapeutic effect|2
1679504|NCT01393743|5866210|P3|Core Study|Participant's Choice|0
1679505|NCT01393743|5866211|P2|Core Study|Participant's Choice|3
1679506|NCT01393743|5866212|P1|Core Study|Participant's Choice|2
1679507|NCT01393743|5866210|P3|Core Study|Lost to Follow-up|0
1679508|NCT01393743|5866211|P2|Core Study|Lost to Follow-up|1
1679509|NCT01393743|5866212|P1|Core Study|Lost to Follow-up|1
1679510|NCT01393743|5866210|P3|Core Study|Adverse Event|0
1679511|NCT01393743|5866211|P2|Core Study|Adverse Event|9
1679512|NCT01393743|5866212|P1|Core Study|Adverse Event|5
1679513|NCT01393730|5866235|P1|Overall Study|Adverse Event|1
1679514|NCT01393730|5866235|P1|Overall Study|Other|2
1679515|NCT01393730|5866235|P1|Overall Study|Withdrawal by Subject|3
1679516|NCT01393626|5866281|P4|Overall Study|Protocol Violation|0
1679517|NCT01393626|5866282|P3|Overall Study|Protocol Violation|2
1679518|NCT01393626|5866283|P2|Overall Study|Protocol Violation|0
1679519|NCT01393626|5866284|P1|Overall Study|Protocol Violation|1
1679520|NCT01393626|5866281|P4|Overall Study|Other|0
1679521|NCT01393626|5866282|P3|Overall Study|Other|0
1679522|NCT01393626|5866283|P2|Overall Study|Other|0
1679523|NCT01393626|5866284|P1|Overall Study|Other|1
1679524|NCT01393626|5866281|P4|Overall Study|Withdrawal by Subject|0
1679525|NCT01393626|5866282|P3|Overall Study|Withdrawal by Subject|0
1679526|NCT01393626|5866283|P2|Overall Study|Withdrawal by Subject|4
1679527|NCT01393626|5866284|P1|Overall Study|Withdrawal by Subject|6
1679528|NCT01393626|5866281|P4|Overall Study|Lost to Follow-up|0
1679529|NCT01393626|5866282|P3|Overall Study|Lost to Follow-up|1
1679530|NCT01393626|5866283|P2|Overall Study|Lost to Follow-up|1
1679531|NCT01393626|5866284|P1|Overall Study|Lost to Follow-up|1
1679532|NCT01393626|5866281|P4|Overall Study|Lack of Efficacy|1
1679533|NCT01393626|5866282|P3|Overall Study|Lack of Efficacy|4
1679534|NCT01393626|5866283|P2|Overall Study|Lack of Efficacy|6
1679535|NCT01393626|5866284|P1|Overall Study|Lack of Efficacy|6
1679536|NCT01393626|5866281|P4|Overall Study|Did not meet entrance criteria|0
1679537|NCT01393626|5866282|P3|Overall Study|Did not meet entrance criteria|0
1679538|NCT01393626|5866283|P2|Overall Study|Did not meet entrance criteria|0
1679539|NCT01393626|5866284|P1|Overall Study|Did not meet entrance criteria|1
1679540|NCT01393626|5866281|P4|Overall Study|Adverse Event|0
1679541|NCT01393626|5866282|P3|Overall Study|Adverse Event|5
1679542|NCT01393626|5866283|P2|Overall Study|Adverse Event|1
1679543|NCT01393626|5866284|P1|Overall Study|Adverse Event|2
1679544|NCT01393613|5866364|P4|Overall Study|Lack of Efficacy|21
1679545|NCT01393613|5866365|P3|Overall Study|Lack of Efficacy|16
1679546|NCT01393613|5866366|P2|Overall Study|Lack of Efficacy|20
1679547|NCT01393613|5866367|P1|Overall Study|Lack of Efficacy|9
1679548|NCT01393613|5866364|P4|Overall Study|Protocol Deviation|0
1679549|NCT01393613|5866365|P3|Overall Study|Protocol Deviation|0
1679550|NCT01393613|5866366|P2|Overall Study|Protocol Deviation|1
1679551|NCT01393613|5866367|P1|Overall Study|Protocol Deviation|2
1679552|NCT01393613|5866364|P4|Overall Study|Withdrawal by Subject|21
1679553|NCT01393613|5866365|P3|Overall Study|Withdrawal by Subject|23
1679554|NCT01393613|5866366|P2|Overall Study|Withdrawal by Subject|25
1679555|NCT01393613|5866367|P1|Overall Study|Withdrawal by Subject|15
1679556|NCT01393613|5866364|P4|Overall Study|Physician Decision|1
1679557|NCT01393613|5866365|P3|Overall Study|Physician Decision|0
1679558|NCT01393613|5866366|P2|Overall Study|Physician Decision|0
1679559|NCT01393613|5866367|P1|Overall Study|Physician Decision|2
1679560|NCT01393613|5866364|P4|Overall Study|Participant Met Withdrawal Criteria|1
1679561|NCT01393613|5866365|P3|Overall Study|Participant Met Withdrawal Criteria|2
1679562|NCT01393613|5866366|P2|Overall Study|Participant Met Withdrawal Criteria|0
1679563|NCT01393613|5866367|P1|Overall Study|Participant Met Withdrawal Criteria|0
1679564|NCT01393613|5866364|P4|Overall Study|Adverse Event|22
1679565|NCT01393613|5866365|P3|Overall Study|Adverse Event|13
1679566|NCT01393613|5866366|P2|Overall Study|Adverse Event|11
1679567|NCT01393613|5866367|P1|Overall Study|Adverse Event|11
1679568|NCT01393600|5866429|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1679569|NCT01393600|5866430|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
1679570|NCT01393600|5866431|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1679571|NCT01393600|5866432|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
1679572|NCT01393600|5866429|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1679573|NCT01393600|5866430|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
1679574|NCT01393600|5866431|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1679575|NCT01393600|5866432|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
1679576|NCT01393600|5866429|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1679577|NCT01393600|5866430|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
1679578|NCT01393600|5866431|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1679579|NCT01393600|5866432|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
1679580|NCT01393600|5866429|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
1679581|NCT01393600|5866430|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1679582|NCT01393600|5866431|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1679583|NCT01393600|5866432|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
1679584|NCT01393600|5866429|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
1679585|NCT01393600|5866430|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1679586|NCT01393600|5866431|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1679587|NCT01393600|5866432|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
1679588|NCT01393600|5866429|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1679589|NCT01393600|5866430|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
1679590|NCT01393600|5866431|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1679591|NCT01393600|5866432|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
1679592|NCT01393600|5866429|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1679593|NCT01393600|5866430|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1679594|NCT01393600|5866431|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
1679595|NCT01393600|5866432|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
1679596|NCT01393444|5866468|P1|Overall Study|Determined ineligible during screening.|2
1679597|NCT01393444|5866468|P1|Overall Study|Withdrawal by Subject|1
1679598|NCT01393405|5866473|P3|Maintenance Period Week|Lost to Follow-up|0
1679599|NCT01393405|5866474|P2|Maintenance Period Week|Lost to Follow-up|1
1679600|NCT01393405|5866475|P1|Maintenance Period Week|Lost to Follow-up|0
1679601|NCT01393405|5866473|P3|Maintenance Period Week|Withdrawal by Subject|0
1679602|NCT01393405|5866474|P2|Maintenance Period Week|Withdrawal by Subject|1
1679603|NCT01393405|5866475|P1|Maintenance Period Week|Withdrawal by Subject|0
1679604|NCT01393405|5866473|P3|Maintenance Period Week|Adverse Event|2
1679605|NCT01393405|5866474|P2|Maintenance Period Week|Adverse Event|5
1679606|NCT01393405|5866475|P1|Maintenance Period Week|Adverse Event|0
1679607|NCT01393405|5866473|P3|Maintenance Period Week|Lack of Efficacy|22
1679608|NCT01393405|5866474|P2|Maintenance Period Week|Lack of Efficacy|22
1679609|NCT01393405|5866475|P1|Maintenance Period Week|Lack of Efficacy|0
1679610|NCT01393405|5866473|P3|Induction Period (week1-16)|Withdrawal by Subject|0
1679611|NCT01393405|5866474|P2|Induction Period (week1-16)|Withdrawal by Subject|0
1679612|NCT01393405|5866475|P1|Induction Period (week1-16)|Withdrawal by Subject|9
1679613|NCT01393405|5866473|P3|Induction Period (week1-16)|Adverse Event|0
1679614|NCT01393405|5866474|P2|Induction Period (week1-16)|Adverse Event|0
1679615|NCT01393405|5866475|P1|Induction Period (week1-16)|Adverse Event|16
1679616|NCT01393405|5866473|P3|Induction Period (week1-16)|Lack of Efficacy|0
1679617|NCT01393405|5866474|P2|Induction Period (week1-16)|Lack of Efficacy|0
1679618|NCT01393405|5866475|P1|Induction Period (week1-16)|Lack of Efficacy|70
1679619|NCT01393301|5866513|P2|Overall Study|Completed <7 sessions (intervention)|0
1679620|NCT01393301|5866514|P1|Overall Study|Completed <7 sessions (intervention)|2
1679621|NCT01393301|5866513|P2|Overall Study|Withdrawal by Subject|0
1679622|NCT01393301|5866514|P1|Overall Study|Withdrawal by Subject|2
1679623|NCT01393301|5866513|P2|Overall Study|Lost to Follow-up|3
1679624|NCT01393301|5866514|P1|Overall Study|Lost to Follow-up|5
1679625|NCT01393158|5866527|P2|Overall Study|Adverse Event|0
1679626|NCT01393158|5866528|P1|Overall Study|Adverse Event|1
1679627|NCT01393106|5866555|P1|Overall Study|Lack of Efficacy|1
1679628|NCT01393106|5866555|P1|Overall Study|Withdrawal by Subject|1
1679629|NCT01393106|5866555|P1|Overall Study|Adverse Event|3
1679630|NCT01392963|5866582|P2|Week 24 Follow-up|Lost to Follow-up|0
1679631|NCT01392963|5866583|P1|Week 24 Follow-up|Lost to Follow-up|2
1679632|NCT01392963|5866582|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
1679633|NCT01392963|5866583|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
1679634|NCT01392963|5866582|P2|Week 0 (First Intervention)|Lost to Follow-up|1
1679635|NCT01392963|5866583|P1|Week 0 (First Intervention)|Lost to Follow-up|0
1679636|NCT01392742|5866591|P1|Overall Study|Missing information|13
1679637|NCT01392742|5866591|P1|Overall Study|Other|3
1679638|NCT01392742|5866591|P1|Overall Study|Protocol Violation|14
1679639|NCT01392742|5866591|P1|Overall Study|Adverse event/intercurrent illness|17
1679640|NCT01392742|5866591|P1|Overall Study|ITR and Protocol deviation|1
1679641|NCT01392742|5866591|P1|Overall Study|Insufficient therapeutic response (ITR)|30
1679642|NCT01392742|5866591|P1|Overall Study|Lost to Follow-up|34
1679643|NCT01392742|5866591|P1|Overall Study|No treatment/no cooperation/withdrew|12
1679644|NCT01392742|5866591|P1|Overall Study|Failure to return|35
1679645|NCT01392742|5866591|P1|Overall Study|Premature study termination|42
1679646|NCT01392677|5866637|P2|Overall Study|Other reason|2
1679647|NCT01392677|5866638|P1|Overall Study|Other reason|3
1679648|NCT01392677|5866637|P2|Overall Study|Incorrect enrollment|3
1679649|NCT01392677|5866638|P1|Overall Study|Incorrect enrollment|2
1679650|NCT01392677|5866637|P2|Overall Study|Withdrawal by Subject|2
1679651|NCT01392677|5866638|P1|Overall Study|Withdrawal by Subject|0
1679652|NCT01392677|5866637|P2|Overall Study|Adverse Event|1
1679653|NCT01392677|5866638|P1|Overall Study|Adverse Event|3
1679654|NCT01392573|5866673|P2|Overall Study|Unclassified|6
1679655|NCT01392573|5866674|P1|Overall Study|Unclassified|9
1679656|NCT01392573|5866673|P2|Overall Study|Site closure|7
1679657|NCT01392573|5866674|P1|Overall Study|Site closure|8
1679658|NCT01392573|5866673|P2|Overall Study|Withdrawal Criteria|15
1679659|NCT01392573|5866674|P1|Overall Study|Withdrawal Criteria|13
1679660|NCT01392573|5866673|P2|Overall Study|Protocol Violation|2
1679661|NCT01392573|5866674|P1|Overall Study|Protocol Violation|0
1679662|NCT01392573|5866673|P2|Overall Study|Lack of Efficacy|2
1679663|NCT01392573|5866674|P1|Overall Study|Lack of Efficacy|1
1679664|NCT01392573|5866673|P2|Overall Study|Adverse Event|3
1679665|NCT01392573|5866674|P1|Overall Study|Adverse Event|1
1679666|NCT01392560|5866682|P1|Overall Study|discontinued during placebo run-in|2
1679667|NCT01392560|5866682|P1|Overall Study|not entered|8
1679668|NCT01392560|5866682|P1|Overall Study|Adverse Event|2
1679669|NCT01392547|5866688|P1|Overall Study|Unclassified|1
1679670|NCT01392547|5866688|P1|Overall Study|Withdrawal criteria|3
1679671|NCT01392547|5866688|P1|Overall Study|Non-compliance|2
1679672|NCT01392547|5866688|P1|Overall Study|Adverse Event|2
1679673|NCT01392495|5866702|P1|Overall Study|Adverse Event|3
1679674|NCT01392495|5866702|P1|Overall Study|Withdrawal by Subject|2
1679675|NCT01392495|5866702|P1|Overall Study|Administrative problems|8
1679676|NCT01392495|5866702|P1|Overall Study|Death|3
1679677|NCT01392443|5866714|P1|Overall Study|Protocol Violation|1
1679678|NCT01392443|5866714|P1|Overall Study|Lost to Follow-up|1
1679679|NCT01392443|5866714|P1|Overall Study|Withdrawal by Subject|5
1679680|NCT01392443|5866714|P1|Overall Study|Death|7
1679681|NCT01392443|5866714|P1|Overall Study|Adverse Event|24
1679682|NCT01392443|5866714|P1|Overall Study|Disease progression|30
1679683|NCT01392378|5866727|P5|Toddler Dose|Withdrawal by Parent|1
1679684|NCT01392378|5866728|P4|Toddler Dose|Withdrawal by Parent|1
1679685|NCT01392378|5866729|P3|Toddler Dose|Withdrawal by Parent|0
1679686|NCT01392378|5866730|P2|Toddler Dose|Withdrawal by Parent|1
1679687|NCT01392378|5866731|P1|Toddler Dose|Withdrawal by Parent|0
1679688|NCT01392378|5866727|P5|Toddler Dose|Lost to Follow-up|0
1679689|NCT01392378|5866728|P4|Toddler Dose|Lost to Follow-up|1
1679690|NCT01392378|5866729|P3|Toddler Dose|Lost to Follow-up|0
1679691|NCT01392378|5866730|P2|Toddler Dose|Lost to Follow-up|0
1679692|NCT01392378|5866731|P1|Toddler Dose|Lost to Follow-up|0
1679693|NCT01392378|5866727|P5|After Infant Series|Withdrawal by Parent|1
1679694|NCT01392378|5866728|P4|After Infant Series|Withdrawal by Parent|0
1679695|NCT01392378|5866729|P3|After Infant Series|Withdrawal by Parent|1
1679696|NCT01392378|5866730|P2|After Infant Series|Withdrawal by Parent|1
1679697|NCT01392378|5866731|P1|After Infant Series|Withdrawal by Parent|0
1679698|NCT01392378|5866727|P5|After Infant Series|Lost to Follow-up|0
1679699|NCT01392378|5866728|P4|After Infant Series|Lost to Follow-up|0
1679700|NCT01392378|5866729|P3|After Infant Series|Lost to Follow-up|1
1679701|NCT01392378|5866730|P2|After Infant Series|Lost to Follow-up|0
1679702|NCT01392378|5866731|P1|After Infant Series|Lost to Follow-up|0
1679703|NCT01392378|5866727|P5|Infant Series|Withdrawal by Parent|0
1679704|NCT01392378|5866728|P4|Infant Series|Withdrawal by Parent|0
1679705|NCT01392378|5866729|P3|Infant Series|Withdrawal by Parent|0
1679706|NCT01392378|5866730|P2|Infant Series|Withdrawal by Parent|1
1679707|NCT01392378|5866731|P1|Infant Series|Withdrawal by Parent|4
1679708|NCT01392378|5866727|P5|Infant Series|Protocol Violation|0
1679709|NCT01392378|5866728|P4|Infant Series|Protocol Violation|0
1679710|NCT01392378|5866729|P3|Infant Series|Protocol Violation|0
1679711|NCT01392378|5866730|P2|Infant Series|Protocol Violation|1
1679712|NCT01392378|5866731|P1|Infant Series|Protocol Violation|0
1679713|NCT01392378|5866727|P5|Infant Series|Lost to Follow-up|0
1679714|NCT01392378|5866728|P4|Infant Series|Lost to Follow-up|1
1679715|NCT01392378|5866729|P3|Infant Series|Lost to Follow-up|0
1679716|NCT01392378|5866730|P2|Infant Series|Lost to Follow-up|0
1679717|NCT01392378|5866731|P1|Infant Series|Lost to Follow-up|0
1679718|NCT01392378|5866727|P5|Infant Series|Adverse Event|0
1679719|NCT01392378|5866728|P4|Infant Series|Adverse Event|1
1679720|NCT01392378|5866729|P3|Infant Series|Adverse Event|0
1679721|NCT01392378|5866730|P2|Infant Series|Adverse Event|0
1679722|NCT01392378|5866731|P1|Infant Series|Adverse Event|0
1679723|NCT01392326|5866871|P3|Overall Study|Adverse Event|11
1679724|NCT01392326|5866872|P2|Overall Study|Adverse Event|6
1679725|NCT01392326|5866873|P1|Overall Study|Adverse Event|9
1679726|NCT01392326|5866871|P3|Overall Study|Lack of Efficacy|15
1679727|NCT01392326|5866872|P2|Overall Study|Lack of Efficacy|10
1679728|NCT01392326|5866873|P1|Overall Study|Lack of Efficacy|14
1679729|NCT01392326|5866871|P3|Overall Study|Lost to Follow-up|4
1679730|NCT01392326|5866872|P2|Overall Study|Lost to Follow-up|3
1679731|NCT01392326|5866873|P1|Overall Study|Lost to Follow-up|1
1679732|NCT01392326|5866871|P3|Overall Study|Physician Decision|2
1679733|NCT01392326|5866872|P2|Overall Study|Physician Decision|5
1679734|NCT01392326|5866873|P1|Overall Study|Physician Decision|7
1679735|NCT01392326|5866871|P3|Overall Study|Pregnancy|1
1679736|NCT01392326|5866872|P2|Overall Study|Pregnancy|0
1679737|NCT01392326|5866873|P1|Overall Study|Pregnancy|0
1679738|NCT01392326|5866871|P3|Overall Study|Protocol Violation|0
1679739|NCT01392326|5866872|P2|Overall Study|Protocol Violation|0
1679740|NCT01392326|5866873|P1|Overall Study|Protocol Violation|2
1679741|NCT01392326|5866871|P3|Overall Study|Withdrawal by Subject|15
1679742|NCT01392326|5866872|P2|Overall Study|Withdrawal by Subject|11
1679743|NCT01392326|5866873|P1|Overall Study|Withdrawal by Subject|12
1679744|NCT01392326|5866871|P3|Overall Study|Death|0
1679745|NCT01392326|5866872|P2|Overall Study|Death|0
1679746|NCT01392326|5866873|P1|Overall Study|Death|2
1679747|NCT01392300|5866910|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
1679748|NCT01392300|5866911|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
1679749|NCT01392300|5866912|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
1679750|NCT01392300|5866910|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
1679751|NCT01392300|5866911|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
1679752|NCT01392300|5866912|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
1679753|NCT01392300|5866910|P3|Open Label Extension (OLEX) Period|Adverse Event|7
1679754|NCT01392300|5866911|P2|Open Label Extension (OLEX) Period|Adverse Event|0
1679755|NCT01392300|5866912|P1|Open Label Extension (OLEX) Period|Adverse Event|0
1679756|NCT01392300|5866910|P3|Open Label Extension (OLEX) Period|Death|4
1679757|NCT01392300|5866911|P2|Open Label Extension (OLEX) Period|Death|0
1679758|NCT01392300|5866912|P1|Open Label Extension (OLEX) Period|Death|0
1679759|NCT01392300|5866910|P3|Open Label Extension (OLEX) Period|Non-compliance|1
1679760|NCT01392300|5866911|P2|Open Label Extension (OLEX) Period|Non-compliance|0
1679761|NCT01392300|5866912|P1|Open Label Extension (OLEX) Period|Non-compliance|0
1679762|NCT01392300|5866910|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
1679763|NCT01392300|5866911|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
1679764|NCT01392300|5866912|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
1679765|NCT01392300|5866910|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
1679766|NCT01392300|5866911|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
1679767|NCT01392300|5866912|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
1679768|NCT01392300|5866910|P3|Main Period (MP)|Non-compliance|0
1679769|NCT01392300|5866911|P2|Main Period (MP)|Non-compliance|0
1679770|NCT01392300|5866912|P1|Main Period (MP)|Non-compliance|1
1679771|NCT01392300|5866910|P3|Main Period (MP)|Lost to Follow-up|0
1679772|NCT01392300|5866911|P2|Main Period (MP)|Lost to Follow-up|3
1679773|NCT01392300|5866912|P1|Main Period (MP)|Lost to Follow-up|3
1679774|NCT01392300|5866910|P3|Main Period (MP)|Withdrawal by Subject|0
1679775|NCT01392300|5866911|P2|Main Period (MP)|Withdrawal by Subject|1
1679776|NCT01392300|5866912|P1|Main Period (MP)|Withdrawal by Subject|5
1679777|NCT01392300|5866910|P3|Main Period (MP)|Predefined discontinuation criteria|0
1679778|NCT01392300|5866911|P2|Main Period (MP)|Predefined discontinuation criteria|3
1679779|NCT01392300|5866912|P1|Main Period (MP)|Predefined discontinuation criteria|2
1679780|NCT01392170|5867017|P1|Overall Study|Ineligible|1
1679781|NCT01392170|5867017|P1|Overall Study|Withdrawal by Subject|1
1679782|NCT01391819|5867065|P1|Overall Study|Other|9
1679783|NCT01391819|5867065|P1|Overall Study|Death|3
1679784|NCT01391819|5867065|P1|Overall Study|Lost to Follow-up|252
1679785|NCT01391819|5867065|P1|Overall Study|Migrated/moved from study area|82
1679786|NCT01391819|5867065|P1|Overall Study|Withdrawal by Subject|56
1679787|NCT01391793|5867109|P2|Overall Study|No DMSA|57
1679788|NCT01391793|5867110|P1|Overall Study|No DMSA|73
1679789|NCT01391793|5867109|P2|Overall Study|Urine Culture Negative or Indeterminate|87
1679790|NCT01391793|5867110|P1|Overall Study|Urine Culture Negative or Indeterminate|71
1679791|NCT01391793|5867109|P2|Overall Study|Ineligible|0
1679792|NCT01391793|5867110|P1|Overall Study|Ineligible|3
1679793|NCT01391663|5867124|P4|Overall Study|Withdrawal by Subject|0
1679794|NCT01391663|5867125|P3|Overall Study|Withdrawal by Subject|1
1679795|NCT01391663|5867126|P2|Overall Study|Withdrawal by Subject|0
1679796|NCT01391663|5867127|P1|Overall Study|Withdrawal by Subject|0
1679797|NCT01391546|5867171|P2|Overall Study|History of Herpes Zoster (HZ)|0
1679798|NCT01391546|5867172|P1|Overall Study|History of Herpes Zoster (HZ)|1
1679799|NCT01391507|5867194|P4|Overall Study|Protocol Violation|2
1679800|NCT01391507|5867195|P3|Overall Study|Protocol Violation|1
1679801|NCT01391507|5867196|P2|Overall Study|Protocol Violation|1
1679802|NCT01391507|5867197|P1|Overall Study|Protocol Violation|2
1679803|NCT01391507|5867194|P4|Overall Study|Lack of Efficacy|1
1679804|NCT01391507|5867195|P3|Overall Study|Lack of Efficacy|0
1679805|NCT01391507|5867196|P2|Overall Study|Lack of Efficacy|0
1679806|NCT01391507|5867197|P1|Overall Study|Lack of Efficacy|0
1679807|NCT01391507|5867194|P4|Overall Study|Withdrawal by Subject|1
1679808|NCT01391507|5867195|P3|Overall Study|Withdrawal by Subject|1
1679809|NCT01391507|5867196|P2|Overall Study|Withdrawal by Subject|2
1679810|NCT01391507|5867197|P1|Overall Study|Withdrawal by Subject|1
1679811|NCT01391507|5867194|P4|Overall Study|Adverse Event|2
1679812|NCT01391507|5867195|P3|Overall Study|Adverse Event|2
1679813|NCT01391507|5867196|P2|Overall Study|Adverse Event|1
1679814|NCT01391507|5867197|P1|Overall Study|Adverse Event|1
1679815|NCT01391507|5867194|P4|Overall Study|Death|1
1679816|NCT01391507|5867195|P3|Overall Study|Death|0
1679817|NCT01391507|5867196|P2|Overall Study|Death|0
1679818|NCT01391507|5867197|P1|Overall Study|Death|0
1679819|NCT01391130|5867335|P2|Overall Study|Did not Receive Drug|1
1679820|NCT01391130|5867336|P1|Overall Study|Did not Receive Drug|1
1679821|NCT01391130|5867335|P2|Overall Study|Physician Decision|3
1679822|NCT01391130|5867336|P1|Overall Study|Physician Decision|2
1679823|NCT01391130|5867335|P2|Overall Study|Withdrawal by Subject|2
1679824|NCT01391130|5867336|P1|Overall Study|Withdrawal by Subject|3
1679825|NCT01391000|5867393|P2|Overall Study|Lost to Follow-up|0
1679826|NCT01391000|5867394|P1|Overall Study|Lost to Follow-up|2
1679827|NCT01390948|5867407|P3|Overall Study|Withdrew consent from survival follow-up|0
1679828|NCT01390948|5867408|P2|Overall Study|Withdrew consent from survival follow-up|5
1679829|NCT01390948|5867409|P1|Overall Study|Withdrew consent from survival follow-up|3
1679830|NCT01390948|5867407|P3|Overall Study|Ongoing|0
1679831|NCT01390948|5867408|P2|Overall Study|Ongoing|6
1679832|NCT01390948|5867409|P1|Overall Study|Ongoing|6
1679833|NCT01390948|5867407|P3|Overall Study|Death|2
1679834|NCT01390948|5867408|P2|Overall Study|Death|34
1679835|NCT01390948|5867409|P1|Overall Study|Death|30
1679836|NCT01390948|5867407|P3|Overall Study|Alive in follow-up|1
1679837|NCT01390948|5867408|P2|Overall Study|Alive in follow-up|17
1679838|NCT01390948|5867409|P1|Overall Study|Alive in follow-up|20
1679839|NCT01390857|5867475|P1|Overall Study|No Visit after the First Visit|7
1679840|NCT01390857|5867475|P1|Overall Study|Lost to Follow-up|1
1679841|NCT01390857|5867475|P1|Overall Study|Protocol Violation|2
1679842|NCT01390844|5867486|P4|Follow-Up Phase|Non-Medical Reasons|0
1679843|NCT01390844|5867487|P3|Follow-Up Phase|Non-Medical Reasons|1
1679844|NCT01390844|5867488|P2|Follow-Up Phase|Non-Medical Reasons|1
1679845|NCT01390844|5867489|P1|Follow-Up Phase|Non-Medical Reasons|1
1679846|NCT01390844|5867486|P4|Treatment Phase|Non-GCP Compliant|3
1679847|NCT01390844|5867487|P3|Treatment Phase|Non-GCP Compliant|10
1679848|NCT01390844|5867488|P2|Treatment Phase|Non-GCP Compliant|0
1679849|NCT01390844|5867489|P1|Treatment Phase|Non-GCP Compliant|0
1679850|NCT01390844|5867486|P4|Treatment Phase|Non-Medical Reasons|1
1679851|NCT01390844|5867487|P3|Treatment Phase|Non-Medical Reasons|8
1679852|NCT01390844|5867488|P2|Treatment Phase|Non-Medical Reasons|1
1679853|NCT01390844|5867489|P1|Treatment Phase|Non-Medical Reasons|5
1679854|NCT01390844|5867486|P4|Treatment Phase|Treatment Failure|13
1679855|NCT01390844|5867487|P3|Treatment Phase|Treatment Failure|10
1679856|NCT01390844|5867488|P2|Treatment Phase|Treatment Failure|25
1679857|NCT01390844|5867489|P1|Treatment Phase|Treatment Failure|23
1679858|NCT01390844|5867486|P4|Treatment Phase|Adverse Event|2
1679859|NCT01390844|5867487|P3|Treatment Phase|Adverse Event|3
1679860|NCT01390844|5867488|P2|Treatment Phase|Adverse Event|2
1679861|NCT01390844|5867489|P1|Treatment Phase|Adverse Event|12
1679862|NCT01390779|5867816|P1|Overall Study|Physician Decision|1
1679863|NCT01390649|5867821|P1|Overall Study|Physician Decision|1
1679864|NCT01390441|5867831|P5|Extension Period|Protocol Violation|0
1679865|NCT01390441|5867832|P4|Extension Period|Protocol Violation|1
1679866|NCT01390441|5867833|P3|Extension Period|Protocol Violation|0
1679867|NCT01390441|5867834|P2|Extension Period|Protocol Violation|1
1679868|NCT01390441|5867835|P1|Extension Period|Protocol Violation|3
1679869|NCT01390441|5867831|P5|Treatment Period|Lost to Follow-up|0
1679870|NCT01390441|5867832|P4|Treatment Period|Lost to Follow-up|0
1679871|NCT01390441|5867833|P3|Treatment Period|Lost to Follow-up|0
1679872|NCT01390441|5867834|P2|Treatment Period|Lost to Follow-up|0
1679873|NCT01390441|5867835|P1|Treatment Period|Lost to Follow-up|1
1679874|NCT01390441|5867831|P5|Treatment Period|Withdrawal by Subject|1
1679875|NCT01390441|5867832|P4|Treatment Period|Withdrawal by Subject|0
1679876|NCT01390441|5867833|P3|Treatment Period|Withdrawal by Subject|1
1679877|NCT01390441|5867834|P2|Treatment Period|Withdrawal by Subject|0
1679878|NCT01390441|5867835|P1|Treatment Period|Withdrawal by Subject|0
1679879|NCT01390441|5867831|P5|Treatment Period|Adverse Event|2
1679880|NCT01390441|5867832|P4|Treatment Period|Adverse Event|1
1679881|NCT01390441|5867833|P3|Treatment Period|Adverse Event|1
1679882|NCT01390441|5867834|P2|Treatment Period|Adverse Event|0
1679883|NCT01390441|5867835|P1|Treatment Period|Adverse Event|0
1679884|NCT01390441|5867831|P5|Treatment Period|Unknown due to early stopping of study|7
1679885|NCT01390441|5867832|P4|Treatment Period|Unknown due to early stopping of study|11
1679886|NCT01390441|5867833|P3|Treatment Period|Unknown due to early stopping of study|8
1679887|NCT01390441|5867834|P2|Treatment Period|Unknown due to early stopping of study|0
1679888|NCT01390441|5867835|P1|Treatment Period|Unknown due to early stopping of study|0
1679889|NCT01390441|5867831|P5|Treatment Period|Lack of Efficacy|1
1679890|NCT01390441|5867832|P4|Treatment Period|Lack of Efficacy|0
1679891|NCT01390441|5867833|P3|Treatment Period|Lack of Efficacy|0
1679892|NCT01390441|5867834|P2|Treatment Period|Lack of Efficacy|0
1679893|NCT01390441|5867835|P1|Treatment Period|Lack of Efficacy|0
1679894|NCT01390441|5867831|P5|Treatment Period|Physician Decision|0
1679895|NCT01390441|5867832|P4|Treatment Period|Physician Decision|1
1679896|NCT01390441|5867833|P3|Treatment Period|Physician Decision|0
1679897|NCT01390441|5867834|P2|Treatment Period|Physician Decision|0
1679898|NCT01390441|5867835|P1|Treatment Period|Physician Decision|0
1679899|NCT01390441|5867831|P5|Treatment Period|Protocol Violation|0
1679900|NCT01390441|5867832|P4|Treatment Period|Protocol Violation|0
1679901|NCT01390441|5867833|P3|Treatment Period|Protocol Violation|0
1679902|NCT01390441|5867834|P2|Treatment Period|Protocol Violation|1
1679903|NCT01390441|5867835|P1|Treatment Period|Protocol Violation|0
1679904|NCT01390428|5867900|P6|Overall Study|Withdrawal by Subject|0
1679905|NCT01390428|5867901|P5|Overall Study|Withdrawal by Subject|0
1679906|NCT01390428|5867902|P4|Overall Study|Withdrawal by Subject|0
1679907|NCT01390428|5867903|P3|Overall Study|Withdrawal by Subject|1
1679908|NCT01390428|5867904|P2|Overall Study|Withdrawal by Subject|0
1679909|NCT01390428|5867905|P1|Overall Study|Withdrawal by Subject|0
1679910|NCT01390428|5867900|P6|Overall Study|Elective Surgery|0
1679911|NCT01390428|5867901|P5|Overall Study|Elective Surgery|1
1679912|NCT01390428|5867902|P4|Overall Study|Elective Surgery|0
1679913|NCT01390428|5867903|P3|Overall Study|Elective Surgery|0
1679914|NCT01390428|5867904|P2|Overall Study|Elective Surgery|0
1679915|NCT01390428|5867905|P1|Overall Study|Elective Surgery|0
1679916|NCT01390402|5867968|P1|Overall Study|Disease Progression|4
1679917|NCT01390402|5867968|P1|Overall Study|Death|1
1679918|NCT01390389|5867974|P2|Overall Study|Screen Fail|1
1679919|NCT01390389|5867975|P1|Overall Study|Screen Fail|2
1679920|NCT01390389|5867974|P2|Overall Study|Withdrawal by Subject|0
1679921|NCT01390389|5867975|P1|Overall Study|Withdrawal by Subject|2
1679922|NCT01390298|5867985|P1|Overall Study|Surgery cancelled|1
1679923|NCT01390298|5867985|P1|Overall Study|Lost to Follow-up|7
1679924|NCT01390298|5867985|P1|Overall Study|Withdrawal by Subject|14
1679925|NCT01390298|5867985|P1|Overall Study|long term ICU admission|1
1679926|NCT01390298|5867985|P1|Overall Study|Death|1
1679927|NCT01390272|5867991|P2|Overall Study|Patient moved, no longer eligible|8
1679928|NCT01390272|5867992|P1|Overall Study|Patient moved, no longer eligible|5
1679929|NCT01390272|5867991|P2|Overall Study|Withdrawal by Subject|5
1679930|NCT01390272|5867992|P1|Overall Study|Withdrawal by Subject|9
1679931|NCT01390272|5867991|P2|Overall Study|Death|2
1679932|NCT01390272|5867992|P1|Overall Study|Death|3
1679933|NCT01390220|5868060|P3|Comparative Phase|Withdrawal by Subject|0
1679934|NCT01390220|5868061|P2|Comparative Phase|Withdrawal by Subject|1
1679935|NCT01390220|5868062|P1|Comparative Phase|Withdrawal by Subject|0
1679936|NCT01390220|5868060|P3|Test Dose Phase|Logistical|0
1679937|NCT01390220|5868061|P2|Test Dose Phase|Logistical|0
1679938|NCT01390220|5868062|P1|Test Dose Phase|Logistical|6
1679939|NCT01390220|5868060|P3|Test Dose Phase|Noncompliance|0
1679940|NCT01390220|5868061|P2|Test Dose Phase|Noncompliance|0
1679941|NCT01390220|5868062|P1|Test Dose Phase|Noncompliance|2
1679942|NCT01390220|5868060|P3|Test Dose Phase|Caregiver no longer available|0
1679943|NCT01390220|5868061|P2|Test Dose Phase|Caregiver no longer available|0
1679944|NCT01390220|5868062|P1|Test Dose Phase|Caregiver no longer available|5
1679945|NCT01390220|5868060|P3|Test Dose Phase|Study/Site closure|0
1679946|NCT01390220|5868061|P2|Test Dose Phase|Study/Site closure|0
1679947|NCT01390220|5868062|P1|Test Dose Phase|Study/Site closure|6
1679948|NCT01390220|5868060|P3|Test Dose Phase|No treated seizure cluster episode|0
1679949|NCT01390220|5868061|P2|Test Dose Phase|No treated seizure cluster episode|0
1679950|NCT01390220|5868062|P1|Test Dose Phase|No treated seizure cluster episode|37
1679951|NCT01390220|5868060|P3|Test Dose Phase|Protocol Violation|0
1679952|NCT01390220|5868061|P2|Test Dose Phase|Protocol Violation|0
1679953|NCT01390220|5868062|P1|Test Dose Phase|Protocol Violation|8
1679954|NCT01390220|5868060|P3|Test Dose Phase|Lost to Follow-up|0
1679955|NCT01390220|5868061|P2|Test Dose Phase|Lost to Follow-up|0
1679956|NCT01390220|5868062|P1|Test Dose Phase|Lost to Follow-up|2
1679957|NCT01390220|5868060|P3|Test Dose Phase|Withdrawal by Subject|0
1679958|NCT01390220|5868061|P2|Test Dose Phase|Withdrawal by Subject|0
1679959|NCT01390220|5868062|P1|Test Dose Phase|Withdrawal by Subject|8
1679960|NCT01390220|5868060|P3|Test Dose Phase|Adverse Event|0
1679961|NCT01390220|5868061|P2|Test Dose Phase|Adverse Event|0
1679962|NCT01390220|5868062|P1|Test Dose Phase|Adverse Event|17
1679963|NCT01390181|5868077|P1|Overall Study|Study Terminated due to Low Accrual|3
1679964|NCT01390181|5868077|P1|Overall Study|Lost to Follow-up|1
1679965|NCT01390038|5868090|P1|Overall Study|Simpliciti System Removal|2
1679966|NCT01390038|5868090|P1|Overall Study|Withdrawal by Subject|4
1679967|NCT01390038|5868090|P1|Overall Study|Lost to Follow-up|1
1679968|NCT01390038|5868090|P1|Overall Study|Death|1
1679969|NCT01389973|5868100|P1|Overall Study|Other|10
1679970|NCT01389973|5868100|P1|Overall Study|Trial Stopped by Sponsor|9
1679971|NCT01389973|5868100|P1|Overall Study|Lost to Follow-up|1
1679972|NCT01389882|5868110|P2|Overall Study|Withdrawal by Subject|1
1679973|NCT01389882|5868111|P1|Overall Study|Withdrawal by Subject|0
1679974|NCT01389882|5868110|P2|Overall Study|Respiratory rate > 80/min during study|3
1679975|NCT01389882|5868111|P1|Overall Study|Respiratory rate > 80/min during study|1
1679976|NCT01389817|5868199|P2|Overall Study|Withdrawal by Subject|0
1679977|NCT01389817|5868200|P1|Overall Study|Withdrawal by Subject|2
1679978|NCT01389817|5868199|P2|Overall Study|Lost to Follow-up|0
1679979|NCT01389817|5868200|P1|Overall Study|Lost to Follow-up|1
1679980|NCT01389817|5868199|P2|Overall Study|Physician Decision|0
1679981|NCT01389817|5868200|P1|Overall Study|Physician Decision|1
1679982|NCT01389752|5868217|P2|Study Period 2|Sponsor decision|0
1679983|NCT01389752|5868218|P1|Study Period 2|Sponsor decision|1
1679984|NCT01389752|5868217|P2|Study Period 1|Sponsor decision|2
1679985|NCT01389752|5868218|P1|Study Period 1|Sponsor decision|0
1679986|NCT01389596|5868231|P3|Overall Study|Other Unspecified|0
1679987|NCT01389596|5868232|P2|Overall Study|Other Unspecified|1
1679988|NCT01389596|5868233|P1|Overall Study|Other Unspecified|2
1679989|NCT01389596|5868231|P3|Overall Study|Death|0
1679990|NCT01389596|5868232|P2|Overall Study|Death|1
1679991|NCT01389596|5868233|P1|Overall Study|Death|0
1679992|NCT01389596|5868231|P3|Overall Study|Adverse Event|0
1679993|NCT01389596|5868232|P2|Overall Study|Adverse Event|4
1679994|NCT01389596|5868233|P1|Overall Study|Adverse Event|1
1679995|NCT01389596|5868231|P3|Overall Study|Insufficient Clinical Response|5
1679996|NCT01389596|5868232|P2|Overall Study|Insufficient Clinical Response|4
1679997|NCT01389596|5868233|P1|Overall Study|Insufficient Clinical Response|3
1679998|NCT01389596|5868231|P3|Overall Study|Withdrawal by Subject|2
1679999|NCT01389596|5868232|P2|Overall Study|Withdrawal by Subject|2
1680000|NCT01389596|5868233|P1|Overall Study|Withdrawal by Subject|1
1680001|NCT01389596|5868231|P3|Overall Study|Protocol Violation|3
1680002|NCT01389596|5868232|P2|Overall Study|Protocol Violation|4
1680003|NCT01389596|5868233|P1|Overall Study|Protocol Violation|3
1680004|NCT01389323|5868292|P1|Follow-up Period (up to 48 Weeks)|Other|3
1680005|NCT01389323|5868292|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
1680006|NCT01389323|5868292|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
1680007|NCT01389323|5868292|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
1680008|NCT01389323|5868292|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
1680009|NCT01389323|5868292|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
1680010|NCT01389323|5868292|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
1680011|NCT01389323|5868292|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
1680012|NCT01389323|5868292|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
1680013|NCT01389323|5868292|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
1680014|NCT01389323|5868292|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
1680015|NCT01389258|5868349|P1|Overall Study|Lost to Follow-up|5
1680016|NCT01389128|5868361|P2|Overall Study|Intolerance to procedure|2
1680017|NCT01389128|5868362|P1|Overall Study|Intolerance to procedure|0
1680018|NCT01389128|5868361|P2|Overall Study|Rapid labor evolution|2
1680019|NCT01389128|5868362|P1|Overall Study|Rapid labor evolution|3
1680020|NCT01389128|5868361|P2|Overall Study|Cervix dilation stop|2
1680021|NCT01389128|5868362|P1|Overall Study|Cervix dilation stop|1
1680022|NCT01389128|5868361|P2|Overall Study|Fetal distress|0
1680023|NCT01389128|5868362|P1|Overall Study|Fetal distress|1
1680024|NCT01389102|5868386|P6|Overall Study|Investigator Judgement|0
1680025|NCT01389102|5868387|P5|Overall Study|Investigator Judgement|0
1680026|NCT01389102|5868388|P4|Overall Study|Investigator Judgement|0
1680027|NCT01389102|5868389|P3|Overall Study|Investigator Judgement|0
1680028|NCT01389102|5868390|P2|Overall Study|Investigator Judgement|1
1680029|NCT01389102|5868391|P1|Overall Study|Investigator Judgement|0
1680030|NCT01389102|5868386|P6|Overall Study|Unavailable due to husband's illness|0
1680031|NCT01389102|5868387|P5|Overall Study|Unavailable due to husband's illness|0
1680032|NCT01389102|5868388|P4|Overall Study|Unavailable due to husband's illness|0
1680033|NCT01389102|5868389|P3|Overall Study|Unavailable due to husband's illness|0
1680034|NCT01389102|5868390|P2|Overall Study|Unavailable due to husband's illness|1
1680035|NCT01389102|5868391|P1|Overall Study|Unavailable due to husband's illness|0
1680036|NCT01389102|5868386|P6|Overall Study|Subject Moved|0
1680037|NCT01389102|5868387|P5|Overall Study|Subject Moved|0
1680038|NCT01389102|5868388|P4|Overall Study|Subject Moved|0
1680039|NCT01389102|5868389|P3|Overall Study|Subject Moved|1
1680040|NCT01389102|5868390|P2|Overall Study|Subject Moved|0
1680041|NCT01389102|5868391|P1|Overall Study|Subject Moved|2
1680042|NCT01389102|5868386|P6|Overall Study|Subject Traveling Out of Country|0
1680043|NCT01389102|5868387|P5|Overall Study|Subject Traveling Out of Country|0
1680044|NCT01389102|5868388|P4|Overall Study|Subject Traveling Out of Country|1
1680045|NCT01389102|5868389|P3|Overall Study|Subject Traveling Out of Country|0
1680046|NCT01389102|5868390|P2|Overall Study|Subject Traveling Out of Country|0
1680047|NCT01389102|5868391|P1|Overall Study|Subject Traveling Out of Country|0
1680048|NCT01389102|5868386|P6|Overall Study|Withdrawal by Subject|3
1680049|NCT01389102|5868387|P5|Overall Study|Withdrawal by Subject|3
1680050|NCT01389102|5868388|P4|Overall Study|Withdrawal by Subject|2
1680051|NCT01389102|5868389|P3|Overall Study|Withdrawal by Subject|9
1680052|NCT01389102|5868390|P2|Overall Study|Withdrawal by Subject|4
1680053|NCT01389102|5868391|P1|Overall Study|Withdrawal by Subject|7
1680054|NCT01389102|5868386|P6|Overall Study|Protocol Violation|1
1680055|NCT01389102|5868387|P5|Overall Study|Protocol Violation|1
1680056|NCT01389102|5868388|P4|Overall Study|Protocol Violation|0
1680057|NCT01389102|5868389|P3|Overall Study|Protocol Violation|3
1680058|NCT01389102|5868390|P2|Overall Study|Protocol Violation|0
1680059|NCT01389102|5868391|P1|Overall Study|Protocol Violation|0
1680060|NCT01389102|5868386|P6|Overall Study|Lost to Follow-up|1
1680061|NCT01389102|5868387|P5|Overall Study|Lost to Follow-up|4
1680062|NCT01389102|5868388|P4|Overall Study|Lost to Follow-up|2
1680063|NCT01389102|5868389|P3|Overall Study|Lost to Follow-up|1
1680064|NCT01389102|5868390|P2|Overall Study|Lost to Follow-up|1
1680065|NCT01389102|5868391|P1|Overall Study|Lost to Follow-up|4
1680066|NCT01389102|5868386|P6|Overall Study|Hurricane Katrina|1
1680067|NCT01389102|5868387|P5|Overall Study|Hurricane Katrina|3
1680068|NCT01389102|5868388|P4|Overall Study|Hurricane Katrina|0
1680069|NCT01389102|5868389|P3|Overall Study|Hurricane Katrina|3
1680070|NCT01389102|5868390|P2|Overall Study|Hurricane Katrina|2
1680071|NCT01389102|5868391|P1|Overall Study|Hurricane Katrina|4
1680072|NCT01389102|5868386|P6|Overall Study|Adverse Event|2
1680073|NCT01389102|5868387|P5|Overall Study|Adverse Event|2
1680074|NCT01389102|5868388|P4|Overall Study|Adverse Event|2
1680075|NCT01389102|5868389|P3|Overall Study|Adverse Event|2
1680076|NCT01389102|5868390|P2|Overall Study|Adverse Event|3
1680077|NCT01389102|5868391|P1|Overall Study|Adverse Event|1
1680078|NCT01388985|5868421|P2|Overall Study|Error of nurse|1
1680079|NCT01388985|5868422|P1|Overall Study|Error of nurse|5
1680080|NCT01388985|5868421|P2|Overall Study|Other (no reason)|1
1680081|NCT01388985|5868422|P1|Overall Study|Other (no reason)|0
1680082|NCT01388985|5868421|P2|Overall Study|Subject unavailable|1
1680083|NCT01388985|5868422|P1|Overall Study|Subject unavailable|1
1680084|NCT01388985|5868421|P2|Overall Study|Withdrawal by Subject|4
1680085|NCT01388985|5868422|P1|Overall Study|Withdrawal by Subject|13
1680086|NCT01388985|5868421|P2|Overall Study|Lost to Follow-up|30
1680087|NCT01388985|5868422|P1|Overall Study|Lost to Follow-up|30
1680088|NCT01388985|5868421|P2|Overall Study|Death|1
1680089|NCT01388985|5868422|P1|Overall Study|Death|0
1680090|NCT01388907|5868486|P2|Overall Study|Adverse Event|0
1680091|NCT01388907|5868487|P1|Overall Study|Adverse Event|2
1680092|NCT01388816|5868503|P4|Overall Study|Protocol Violation|0
1680093|NCT01388816|5868504|P3|Overall Study|Protocol Violation|2
1680094|NCT01388816|5868505|P2|Overall Study|Protocol Violation|0
1680095|NCT01388816|5868506|P1|Overall Study|Protocol Violation|0
1680096|NCT01388816|5868503|P4|Overall Study|Withdrawal by Subject|0
1680097|NCT01388816|5868504|P3|Overall Study|Withdrawal by Subject|1
1680098|NCT01388816|5868505|P2|Overall Study|Withdrawal by Subject|1
1680099|NCT01388816|5868506|P1|Overall Study|Withdrawal by Subject|2
1680100|NCT01388816|5868503|P4|Overall Study|Lost to Follow-up|0
1680101|NCT01388816|5868504|P3|Overall Study|Lost to Follow-up|0
1680102|NCT01388816|5868505|P2|Overall Study|Lost to Follow-up|1
1680103|NCT01388816|5868506|P1|Overall Study|Lost to Follow-up|0
1680104|NCT01388816|5868503|P4|Overall Study|Adverse Event|0
1680105|NCT01388816|5868504|P3|Overall Study|Adverse Event|0
1680106|NCT01388816|5868505|P2|Overall Study|Adverse Event|2
1680107|NCT01388816|5868506|P1|Overall Study|Adverse Event|0
1680108|NCT01388790|5868535|P1|Overall Study|Ongoing at data cut−off date|8
1680109|NCT01388647|5868546|P2|Overall Study|Adverse Event|2
1680110|NCT01388647|5868547|P1|Overall Study|Adverse Event|1
1680111|NCT01388543|5868560|P2|Day 14|Adverse Event|4
1680112|NCT01388543|5868561|P1|Day 14|Adverse Event|1
1680113|NCT01388530|5868567|P1|Overall Study|Lost to Follow-up|5
1680114|NCT01388491|5868576|P2|Overall Study|Pregnancy|0
1680115|NCT01388491|5868577|P1|Overall Study|Pregnancy|1
1680116|NCT01388491|5868576|P2|Overall Study|Noncompliance|0
1680117|NCT01388491|5868577|P1|Overall Study|Noncompliance|2
1680118|NCT01388491|5868576|P2|Overall Study|Protocol Violation|0
1680119|NCT01388491|5868577|P1|Overall Study|Protocol Violation|2
1680120|NCT01388491|5868576|P2|Overall Study|Lost to Follow-up|3
1680121|NCT01388491|5868577|P1|Overall Study|Lost to Follow-up|4
1680122|NCT01388491|5868576|P2|Overall Study|Withdrawal by Subject|10
1680123|NCT01388491|5868577|P1|Overall Study|Withdrawal by Subject|6
1680124|NCT01388491|5868576|P2|Overall Study|Sponsor Request|7
1680125|NCT01388491|5868577|P1|Overall Study|Sponsor Request|9
1680126|NCT01388491|5868576|P2|Overall Study|Adverse Event|9
1680127|NCT01388491|5868577|P1|Overall Study|Adverse Event|10
1680128|NCT01388361|5868612|P3|Overall Study|Unclassified|1
1680129|NCT01388361|5868613|P2|Overall Study|Unclassified|0
1680130|NCT01388361|5868614|P1|Overall Study|Unclassified|0
1680131|NCT01388361|5868612|P3|Overall Study|Withdrawal criteria|10
1680132|NCT01388361|5868613|P2|Overall Study|Withdrawal criteria|7
1680133|NCT01388361|5868614|P1|Overall Study|Withdrawal criteria|12
1680134|NCT01388361|5868612|P3|Overall Study|Protocol Violation|2
1680135|NCT01388361|5868613|P2|Overall Study|Protocol Violation|0
1680136|NCT01388361|5868614|P1|Overall Study|Protocol Violation|0
1680137|NCT01388361|5868612|P3|Overall Study|Adverse Event|1
1680138|NCT01388361|5868613|P2|Overall Study|Adverse Event|5
1680139|NCT01388361|5868614|P1|Overall Study|Adverse Event|0
1680140|NCT01388166|5868631|P1|Overall Study|Others than specified above|13
1680141|NCT01388166|5868631|P1|Overall Study|Lost to Follow-up|30
1680142|NCT01388166|5868631|P1|Overall Study|Adverse Event|16
1680143|NCT01387789|5868934|P1|Overall Study|Lost to Follow-up|1
1680144|NCT01387789|5868934|P1|Overall Study|Lack of Efficacy|2
1680145|NCT01387789|5868934|P1|Overall Study|Adverse Event|5
1680146|NCT01387737|5868948|P2|Overall Study|Clearly not eligible for the study|3
1680147|NCT01387737|5868949|P1|Overall Study|Clearly not eligible for the study|1
1680148|NCT01387737|5868948|P2|Overall Study|Withdrawal by Subject|31
1680149|NCT01387737|5868949|P1|Overall Study|Withdrawal by Subject|27
1680150|NCT01387737|5868948|P2|Overall Study|Physician Decision|10
1680151|NCT01387737|5868949|P1|Overall Study|Physician Decision|3
1680152|NCT01387737|5868948|P2|Overall Study|Lack of Efficacy|0
1680153|NCT01387737|5868949|P1|Overall Study|Lack of Efficacy|1
1680154|NCT01387737|5868948|P2|Overall Study|Adverse Event|30
1680155|NCT01387737|5868949|P1|Overall Study|Adverse Event|20
1680156|NCT01387607|5868983|P2|Overall Study|Randomized, not treated|6
1680157|NCT01387607|5868984|P1|Overall Study|Randomized, not treated|3
1680158|NCT01387607|5868983|P2|Overall Study|Other|1
1680159|NCT01387607|5868984|P1|Overall Study|Other|1
1680160|NCT01387607|5868983|P2|Overall Study|Withdrawal by Subject|14
1680161|NCT01387607|5868984|P1|Overall Study|Withdrawal by Subject|13
1680162|NCT01387607|5868983|P2|Overall Study|Protocol Violation|5
1680163|NCT01387607|5868984|P1|Overall Study|Protocol Violation|1
1680164|NCT01387607|5868983|P2|Overall Study|No longer meets eligibility criteria|1
1680165|NCT01387607|5868984|P1|Overall Study|No longer meets eligibility criteria|0
1680166|NCT01387607|5868983|P2|Overall Study|Lost to Follow-up|1
1680167|NCT01387607|5868984|P1|Overall Study|Lost to Follow-up|2
1680168|NCT01387607|5868983|P2|Overall Study|Lack of Efficacy|6
1680169|NCT01387607|5868984|P1|Overall Study|Lack of Efficacy|8
1680170|NCT01387607|5868983|P2|Overall Study|Adverse Event|11
1680171|NCT01387607|5868984|P1|Overall Study|Adverse Event|23
1680172|NCT01387594|5869038|P2|Overall Study|Lost to Follow-up|1
1680173|NCT01387594|5869039|P1|Overall Study|Lost to Follow-up|0
1680174|NCT01387594|5869038|P2|Overall Study|Withdrawal by Subject|2
1680175|NCT01387594|5869039|P1|Overall Study|Withdrawal by Subject|0
1680176|NCT01387542|5869067|P1|Overall Study|Lost to Follow-up|1
1680177|NCT01387542|5869067|P1|Overall Study|Non-compliant|1
1680178|NCT01387542|5869067|P1|Overall Study|Insufficient response|1
1680179|NCT01387542|5869067|P1|Overall Study|Changed diagnosis|1
1680180|NCT01387542|5869067|P1|Overall Study|Withdrawal by Subject|1
1680181|NCT01387542|5869067|P1|Overall Study|Adverse Event|3
1680182|NCT01387347|5869085|P2|Overall Study|Lost to Follow-up|1
1680183|NCT01387347|5869086|P1|Overall Study|Lost to Follow-up|2
1680184|NCT01387282|5869098|P2|Overall Study|Lost to Follow-up|1
1680185|NCT01387282|5869099|P1|Overall Study|Lost to Follow-up|4
1680186|NCT01387282|5869098|P2|Overall Study|Study drug-related AE|2
1680187|NCT01387282|5869099|P1|Overall Study|Study drug-related AE|2
1680188|NCT01387282|5869098|P2|Overall Study|Withdrawal by patient|23
1680189|NCT01387282|5869099|P1|Overall Study|Withdrawal by patient|33
1680190|NCT01387282|5869098|P2|Overall Study|Unrelated AE|4
1680191|NCT01387282|5869099|P1|Overall Study|Unrelated AE|6
1680192|NCT01387282|5869098|P2|Overall Study|Other|1
1680193|NCT01387282|5869099|P1|Overall Study|Other|5
1680194|NCT01387282|5869098|P2|Overall Study|Death|16
1680195|NCT01387282|5869099|P1|Overall Study|Death|47
1680196|NCT01387269|5869115|P2|Overall Study|Lost to Follow-up|0
1680197|NCT01387269|5869116|P1|Overall Study|Lost to Follow-up|1
1680198|NCT01387269|5869115|P2|Overall Study|Study drug-related AE|0
1680199|NCT01387269|5869116|P1|Overall Study|Study drug-related AE|1
1680200|NCT01387269|5869115|P2|Overall Study|Withdrawal by patient|10
1680201|NCT01387269|5869116|P1|Overall Study|Withdrawal by patient|32
1680202|NCT01387269|5869115|P2|Overall Study|Unrelated AE|3
1680203|NCT01387269|5869116|P1|Overall Study|Unrelated AE|12
1680204|NCT01387269|5869115|P2|Overall Study|Other|7
1680205|NCT01387269|5869116|P1|Overall Study|Other|8
1680206|NCT01387269|5869115|P2|Overall Study|Death|20
1680207|NCT01387269|5869116|P1|Overall Study|Death|38
1680208|NCT01387230|5869133|P3|Overall Study|Withdrawal by Subject|0
1680209|NCT01387230|5869134|P2|Overall Study|Withdrawal by Subject|1
1680210|NCT01387230|5869135|P1|Overall Study|Withdrawal by Subject|4
1680211|NCT01387230|5869133|P3|Overall Study|Lost to Follow-up|1
1680212|NCT01387230|5869134|P2|Overall Study|Lost to Follow-up|0
1680213|NCT01387230|5869135|P1|Overall Study|Lost to Follow-up|0
1680214|NCT01387230|5869133|P3|Overall Study|Protocol-defined Stopping Criteria|5
1680215|NCT01387230|5869134|P2|Overall Study|Protocol-defined Stopping Criteria|0
1680216|NCT01387230|5869135|P1|Overall Study|Protocol-defined Stopping Criteria|6
1680217|NCT01387230|5869133|P3|Overall Study|Lack of Efficacy|4
1680218|NCT01387230|5869134|P2|Overall Study|Lack of Efficacy|5
1680219|NCT01387230|5869135|P1|Overall Study|Lack of Efficacy|8
1680220|NCT01387230|5869133|P3|Overall Study|Adverse Event|3
1680221|NCT01387230|5869134|P2|Overall Study|Adverse Event|1
1680222|NCT01387230|5869135|P1|Overall Study|Adverse Event|0
1680223|NCT01387074|5869181|P1|Overall Study|Lack of Efficacy|1
1680224|NCT01387074|5869181|P1|Overall Study|Lost to Follow-up|7
1680225|NCT01387022|5869194|P2|Overall Study|Lost to Follow-up|3
1680226|NCT01387022|5869195|P1|Overall Study|Lost to Follow-up|0
1680227|NCT01387022|5869194|P2|Overall Study|Death|1
1680228|NCT01387022|5869195|P1|Overall Study|Death|1
1680229|NCT01386944|5869222|P1|Overall Study|Unspecified reason|8
1680230|NCT01386944|5869222|P1|Overall Study|Lost to Follow-up|8
1680231|NCT01386944|5869222|P1|Overall Study|Lack of Efficacy|14
1680232|NCT01386944|5869222|P1|Overall Study|Adverse Event|26
1680233|NCT01386788|5869232|P1|Overall Study|Lost to Follow-up|2
1680234|NCT01386684|5869237|P1|Overall Study|Missing|3
1680235|NCT01386684|5869237|P1|Overall Study|Protocol Violation|4
1680236|NCT01386684|5869237|P1|Overall Study|Noncompliance|8
1680237|NCT01386684|5869237|P1|Overall Study|Adverse Event|20
1680238|NCT01386684|5869237|P1|Overall Study|Disease Progression|28
1680239|NCT01386684|5869237|P1|Overall Study|Alternative Therapy Required|37
1680240|NCT01386684|5869237|P1|Overall Study|Withdrawal of Consent|44
1680241|NCT01386684|5869237|P1|Overall Study|Death|47
1680242|NCT01386684|5869237|P1|Overall Study|Other|51
1680243|NCT01386684|5869237|P1|Overall Study|Lost to Follow-up|51
1680244|NCT01386658|5869278|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
1680245|NCT01386658|5869279|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
1680246|NCT01386658|5869278|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
1680247|NCT01386658|5869279|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
1680248|NCT01386606|5869357|P4|Overall Study|T levels too high|0
1680249|NCT01386606|5869358|P3|Overall Study|T levels too high|1
1680250|NCT01386606|5869359|P2|Overall Study|T levels too high|1
1680251|NCT01386606|5869360|P1|Overall Study|T levels too high|0
1680252|NCT01386606|5869357|P4|Overall Study|Unable to draw PK|0
1680253|NCT01386606|5869358|P3|Overall Study|Unable to draw PK|0
1680254|NCT01386606|5869359|P2|Overall Study|Unable to draw PK|0
1680255|NCT01386606|5869360|P1|Overall Study|Unable to draw PK|1
1680256|NCT01386606|5869357|P4|Overall Study|Subject incarcerated|0
1680257|NCT01386606|5869358|P3|Overall Study|Subject incarcerated|0
1680258|NCT01386606|5869359|P2|Overall Study|Subject incarcerated|1
1680259|NCT01386606|5869360|P1|Overall Study|Subject incarcerated|0
1680260|NCT01386606|5869357|P4|Overall Study|Lost to Follow-up|0
1680261|NCT01386606|5869358|P3|Overall Study|Lost to Follow-up|0
1680262|NCT01386606|5869359|P2|Overall Study|Lost to Follow-up|0
1680263|NCT01386606|5869360|P1|Overall Study|Lost to Follow-up|2
1680264|NCT01386606|5869357|P4|Overall Study|Protocol Violation|1
1680265|NCT01386606|5869358|P3|Overall Study|Protocol Violation|1
1680266|NCT01386606|5869359|P2|Overall Study|Protocol Violation|0
1680267|NCT01386606|5869360|P1|Overall Study|Protocol Violation|1
1680268|NCT01386606|5869357|P4|Overall Study|Withdrawal by Subject|0
1680269|NCT01386606|5869358|P3|Overall Study|Withdrawal by Subject|1
1680270|NCT01386606|5869359|P2|Overall Study|Withdrawal by Subject|1
1680271|NCT01386606|5869360|P1|Overall Study|Withdrawal by Subject|0
1680272|NCT01386606|5869357|P4|Overall Study|Adverse Event|0
1680273|NCT01386606|5869358|P3|Overall Study|Adverse Event|0
1680274|NCT01386606|5869359|P2|Overall Study|Adverse Event|1
1680275|NCT01386606|5869360|P1|Overall Study|Adverse Event|0
1680276|NCT01386554|5869391|P3|Overall Study|Reason not collected|0
1680277|NCT01386554|5869392|P2|Overall Study|Reason not collected|1
1680278|NCT01386554|5869393|P1|Overall Study|Reason not collected|0
1680279|NCT01386554|5869391|P3|Overall Study|Investigator discretion|1
1680280|NCT01386554|5869392|P2|Overall Study|Investigator discretion|0
1680281|NCT01386554|5869393|P1|Overall Study|Investigator discretion|0
1680282|NCT01386554|5869391|P3|Overall Study|Administration of live vaccines|0
1680283|NCT01386554|5869392|P2|Overall Study|Administration of live vaccines|1
1680284|NCT01386554|5869393|P1|Overall Study|Administration of live vaccines|0
1680285|NCT01386554|5869391|P3|Overall Study|Progressive disease|2
1680286|NCT01386554|5869392|P2|Overall Study|Progressive disease|2
1680287|NCT01386554|5869393|P1|Overall Study|Progressive disease|1
1680288|NCT01386554|5869391|P3|Overall Study|Adverse Event|2
1680289|NCT01386554|5869392|P2|Overall Study|Adverse Event|5
1680290|NCT01386554|5869393|P1|Overall Study|Adverse Event|2
1680291|NCT01386554|5869391|P3|Overall Study|Lost to Follow-up|1
1680292|NCT01386554|5869392|P2|Overall Study|Lost to Follow-up|0
1680293|NCT01386554|5869393|P1|Overall Study|Lost to Follow-up|0
1680294|NCT01386125|5869416|P2|Overall Study|Participant Leaving Country|0
1680295|NCT01386125|5869417|P1|Overall Study|Participant Leaving Country|1
1680296|NCT01386125|5869416|P2|Overall Study|Lack of Efficacy|1
1680297|NCT01386125|5869417|P1|Overall Study|Lack of Efficacy|0
1680298|NCT01386125|5869416|P2|Overall Study|Adverse Event|5
1680299|NCT01386125|5869417|P1|Overall Study|Adverse Event|2
1680300|NCT01386125|5869416|P2|Overall Study|Withdrawal by Subject|12
1680301|NCT01386125|5869417|P1|Overall Study|Withdrawal by Subject|13
1680302|NCT01386125|5869416|P2|Overall Study|Disease Progress|2
1680303|NCT01386125|5869417|P1|Overall Study|Disease Progress|1
1680304|NCT01386125|5869416|P2|Overall Study|Protocol Violation|7
1680305|NCT01386125|5869417|P1|Overall Study|Protocol Violation|5
1680306|NCT01386125|5869416|P2|Overall Study|Physician Decision|1
1680307|NCT01386125|5869417|P1|Overall Study|Physician Decision|0
1680308|NCT01386125|5869416|P2|Overall Study|Lost to Follow-up|9
1680309|NCT01386125|5869417|P1|Overall Study|Lost to Follow-up|3
1680310|NCT01386008|5869425|P1|Overall Study|Adverse Event|3
1680311|NCT01386008|5869425|P1|Overall Study|exited w/o incident /study discontinued|17
1680312|NCT01385995|5869434|P2|Period 1, 2 Months|Physician Decision|0
1680313|NCT01385995|5869435|P1|Period 1, 2 Months|Physician Decision|1
1680314|NCT01385748|5869452|P3|Overall Study|Adverse Event|1
1680315|NCT01385748|5869453|P2|Overall Study|Adverse Event|2
1680316|NCT01385748|5869454|P1|Overall Study|Adverse Event|4
1680317|NCT01385748|5869452|P3|Overall Study|Other|1
1680318|NCT01385748|5869453|P2|Overall Study|Other|7
1680319|NCT01385748|5869454|P1|Overall Study|Other|1
1680320|NCT01385748|5869452|P3|Overall Study|Noncompliance|6
1680321|NCT01385748|5869453|P2|Overall Study|Noncompliance|1
1680322|NCT01385748|5869454|P1|Overall Study|Noncompliance|3
1680323|NCT01385748|5869452|P3|Overall Study|Withdrawal by Subject|5
1680324|NCT01385748|5869453|P2|Overall Study|Withdrawal by Subject|4
1680325|NCT01385748|5869454|P1|Overall Study|Withdrawal by Subject|7
1680326|NCT01385566|5869539|P6|Overall Study|Withdrawal by Subject|0
1680327|NCT01385566|5869540|P5|Overall Study|Withdrawal by Subject|0
1680328|NCT01385566|5869541|P4|Overall Study|Withdrawal by Subject|1
1680329|NCT01385566|5869542|P3|Overall Study|Withdrawal by Subject|0
1680330|NCT01385566|5869543|P2|Overall Study|Withdrawal by Subject|0
1680331|NCT01385566|5869544|P1|Overall Study|Withdrawal by Subject|0
1680332|NCT01385566|5869539|P6|Overall Study|Lost to Follow-up|0
1680333|NCT01385566|5869540|P5|Overall Study|Lost to Follow-up|0
1680334|NCT01385566|5869541|P4|Overall Study|Lost to Follow-up|0
1680335|NCT01385566|5869542|P3|Overall Study|Lost to Follow-up|0
1680336|NCT01385566|5869543|P2|Overall Study|Lost to Follow-up|0
1680337|NCT01385566|5869544|P1|Overall Study|Lost to Follow-up|1
1680338|NCT01385371|5869598|P2|Overall Study|Administrative|2
1680339|NCT01385371|5869599|P1|Overall Study|Administrative|2
1680340|NCT01385371|5869598|P2|Overall Study|Protocol Violation|21
1680341|NCT01385371|5869599|P1|Overall Study|Protocol Violation|25
1680342|NCT01385371|5869598|P2|Overall Study|Withdrawal by Subject|39
1680343|NCT01385371|5869599|P1|Overall Study|Withdrawal by Subject|52
1680344|NCT01385371|5869598|P2|Overall Study|Lost to Follow-up|16
1680345|NCT01385371|5869599|P1|Overall Study|Lost to Follow-up|16
1680346|NCT01385371|5869598|P2|Overall Study|Adverse Event|19
1680347|NCT01385371|5869599|P1|Overall Study|Adverse Event|54
1680348|NCT01385202|5869647|P1|Overall Study|Withdrawn|1
1680349|NCT01385202|5869647|P1|Overall Study|Not Eligible|11
1680350|NCT01385202|5869647|P1|Overall Study|Lost to Follow-up|6
1680351|NCT01385176|5869684|P2|6-18 Month All VNS Active|Heart Transplant|0
1680352|NCT01385176|5869685|P1|6-18 Month All VNS Active|Heart Transplant|1
1680353|NCT01385176|5869684|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
1680354|NCT01385176|5869685|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
1680355|NCT01385176|5869684|P2|6-18 Month All VNS Active|Physician Decision|1
1680356|NCT01385176|5869685|P1|6-18 Month All VNS Active|Physician Decision|0
1680357|NCT01385176|5869684|P2|6-18 Month All VNS Active|Death|2
1680358|NCT01385176|5869685|P1|6-18 Month All VNS Active|Death|1
1680359|NCT01385176|5869684|P2|Randomization Phase|Death|2
1680360|NCT01385176|5869685|P1|Randomization Phase|Death|1
1680361|NCT01385098|5869716|P1|Overall Study|Lost to Follow-up|4
1680362|NCT01385098|5869716|P1|Overall Study|Adverse Event|10
1680363|NCT01384877|5869738|P2|Treatment 2|Lost to Follow-up|2
1680364|NCT01384877|5869739|P1|Treatment 2|Lost to Follow-up|2
1680365|NCT01384760|5869765|P2|Overall Study|Protocol Violation|0
1680366|NCT01384760|5869766|P1|Overall Study|Protocol Violation|16
1680367|NCT01384760|5869765|P2|Overall Study|Lost to Follow-up|6
1680368|NCT01384760|5869766|P1|Overall Study|Lost to Follow-up|0
1680369|NCT01384734|5869779|P5|Overall Study|Physician Decision|0
1680370|NCT01384734|5869780|P4|Overall Study|Physician Decision|0
1680371|NCT01384734|5869781|P3|Overall Study|Physician Decision|0
1680372|NCT01384734|5869782|P2|Overall Study|Physician Decision|0
1680373|NCT01384734|5869783|P1|Overall Study|Physician Decision|1
1680374|NCT01384734|5869779|P5|Overall Study|Early termination|1
1680375|NCT01384734|5869780|P4|Overall Study|Early termination|0
1680376|NCT01384734|5869781|P3|Overall Study|Early termination|0
1680377|NCT01384734|5869782|P2|Overall Study|Early termination|0
1680378|NCT01384734|5869783|P1|Overall Study|Early termination|0
1680379|NCT01384734|5869779|P5|Overall Study|Adhesion problem|0
1680380|NCT01384734|5869780|P4|Overall Study|Adhesion problem|1
1680381|NCT01384734|5869781|P3|Overall Study|Adhesion problem|0
1680382|NCT01384734|5869782|P2|Overall Study|Adhesion problem|0
1680383|NCT01384734|5869783|P1|Overall Study|Adhesion problem|0
1680384|NCT01384734|5869779|P5|Overall Study|Missed End of treatment visit|0
1680385|NCT01384734|5869780|P4|Overall Study|Missed End of treatment visit|1
1680386|NCT01384734|5869781|P3|Overall Study|Missed End of treatment visit|0
1680387|NCT01384734|5869782|P2|Overall Study|Missed End of treatment visit|0
1680388|NCT01384734|5869783|P1|Overall Study|Missed End of treatment visit|0
1680389|NCT01384734|5869779|P5|Overall Study|As per Exclusion criteria|0
1680390|NCT01384734|5869780|P4|Overall Study|As per Exclusion criteria|0
1680391|NCT01384734|5869781|P3|Overall Study|As per Exclusion criteria|0
1680392|NCT01384734|5869782|P2|Overall Study|As per Exclusion criteria|1
1680393|NCT01384734|5869783|P1|Overall Study|As per Exclusion criteria|0
1680394|NCT01384734|5869779|P5|Overall Study|Prison|0
1680395|NCT01384734|5869780|P4|Overall Study|Prison|0
1680396|NCT01384734|5869781|P3|Overall Study|Prison|1
1680397|NCT01384734|5869782|P2|Overall Study|Prison|0
1680398|NCT01384734|5869783|P1|Overall Study|Prison|0
1680399|NCT01384734|5869779|P5|Overall Study|Unable to come back for visit|0
1680400|NCT01384734|5869780|P4|Overall Study|Unable to come back for visit|1
1680401|NCT01384734|5869781|P3|Overall Study|Unable to come back for visit|1
1680402|NCT01384734|5869782|P2|Overall Study|Unable to come back for visit|0
1680403|NCT01384734|5869783|P1|Overall Study|Unable to come back for visit|1
1680404|NCT01384734|5869779|P5|Overall Study|Investigator relocating|1
1680405|NCT01384734|5869780|P4|Overall Study|Investigator relocating|3
1680406|NCT01384734|5869781|P3|Overall Study|Investigator relocating|0
1680407|NCT01384734|5869782|P2|Overall Study|Investigator relocating|2
1680408|NCT01384734|5869783|P1|Overall Study|Investigator relocating|0
1680409|NCT01384734|5869779|P5|Overall Study|Withdrawal by Subject|9
1680410|NCT01384734|5869780|P4|Overall Study|Withdrawal by Subject|7
1680411|NCT01384734|5869781|P3|Overall Study|Withdrawal by Subject|6
1680412|NCT01384734|5869782|P2|Overall Study|Withdrawal by Subject|5
1680413|NCT01384734|5869783|P1|Overall Study|Withdrawal by Subject|5
1680414|NCT01384734|5869779|P5|Overall Study|Sponsor terminated|1
1680415|NCT01384734|5869780|P4|Overall Study|Sponsor terminated|0
1680416|NCT01384734|5869781|P3|Overall Study|Sponsor terminated|0
1680417|NCT01384734|5869782|P2|Overall Study|Sponsor terminated|0
1680418|NCT01384734|5869783|P1|Overall Study|Sponsor terminated|0
1680419|NCT01384734|5869779|P5|Overall Study|Pregnancy|1
1680420|NCT01384734|5869780|P4|Overall Study|Pregnancy|0
1680421|NCT01384734|5869781|P3|Overall Study|Pregnancy|0
1680422|NCT01384734|5869782|P2|Overall Study|Pregnancy|1
1680423|NCT01384734|5869783|P1|Overall Study|Pregnancy|0
1680424|NCT01384734|5869779|P5|Overall Study|Non-compliance with study drug|2
1680425|NCT01384734|5869780|P4|Overall Study|Non-compliance with study drug|0
1680426|NCT01384734|5869781|P3|Overall Study|Non-compliance with study drug|6
1680427|NCT01384734|5869782|P2|Overall Study|Non-compliance with study drug|2
1680428|NCT01384734|5869783|P1|Overall Study|Non-compliance with study drug|1
1680429|NCT01384734|5869779|P5|Overall Study|Lost to Follow-up|5
1680430|NCT01384734|5869780|P4|Overall Study|Lost to Follow-up|8
1680431|NCT01384734|5869781|P3|Overall Study|Lost to Follow-up|3
1680432|NCT01384734|5869782|P2|Overall Study|Lost to Follow-up|3
1680433|NCT01384734|5869783|P1|Overall Study|Lost to Follow-up|5
1680434|NCT01384734|5869779|P5|Overall Study|Lack of Efficacy|2
1680435|NCT01384734|5869780|P4|Overall Study|Lack of Efficacy|4
1680436|NCT01384734|5869781|P3|Overall Study|Lack of Efficacy|4
1680437|NCT01384734|5869782|P2|Overall Study|Lack of Efficacy|7
1680438|NCT01384734|5869783|P1|Overall Study|Lack of Efficacy|3
1680439|NCT01384734|5869779|P5|Overall Study|Continuation criteria not met|0
1680440|NCT01384734|5869780|P4|Overall Study|Continuation criteria not met|1
1680441|NCT01384734|5869781|P3|Overall Study|Continuation criteria not met|1
1680442|NCT01384734|5869782|P2|Overall Study|Continuation criteria not met|0
1680443|NCT01384734|5869783|P1|Overall Study|Continuation criteria not met|0
1680444|NCT01384734|5869779|P5|Overall Study|Death|0
1680445|NCT01384734|5869780|P4|Overall Study|Death|0
1680446|NCT01384734|5869781|P3|Overall Study|Death|1
1680447|NCT01384734|5869782|P2|Overall Study|Death|0
1680448|NCT01384734|5869783|P1|Overall Study|Death|1
1680449|NCT01384734|5869779|P5|Overall Study|Adverse Event|7
1680450|NCT01384734|5869780|P4|Overall Study|Adverse Event|2
1680451|NCT01384734|5869781|P3|Overall Study|Adverse Event|0
1680452|NCT01384734|5869782|P2|Overall Study|Adverse Event|3
1680453|NCT01384734|5869783|P1|Overall Study|Adverse Event|0
1680454|NCT01384292|5870012|P3|Part B|Severe non-compliance to protocol|0
1680455|NCT01384292|5870013|P2|Part B|Severe non-compliance to protocol|0
1680456|NCT01384292|5870014|P1|Part B|Severe non-compliance to protocol|1
1680457|NCT01384019|5870026|P2|Overall Study|MRI refusal|6
1680458|NCT01384019|5870027|P1|Overall Study|MRI refusal|6
1680459|NCT01384019|5870026|P2|Overall Study|Death|0
1680460|NCT01384019|5870027|P1|Overall Study|Death|1
1680461|NCT01384019|5870026|P2|Overall Study|Withdrawal by Subject|0
1680462|NCT01384019|5870027|P1|Overall Study|Withdrawal by Subject|3
1680463|NCT01383993|5870036|P3|Overall Study|Marketed voriconazole in post-therapy|0
1680464|NCT01383993|5870037|P2|Overall Study|Marketed voriconazole in post-therapy|0
1680465|NCT01383993|5870038|P1|Overall Study|Marketed voriconazole in post-therapy|2
1680466|NCT01383993|5870036|P3|Overall Study|Withdrawal by Subject|1
1680467|NCT01383993|5870037|P2|Overall Study|Withdrawal by Subject|0
1680468|NCT01383993|5870038|P1|Overall Study|Withdrawal by Subject|0
1680469|NCT01383993|5870036|P3|Overall Study|Adverse Event|0
1680470|NCT01383993|5870037|P2|Overall Study|Adverse Event|1
1680471|NCT01383993|5870038|P1|Overall Study|Adverse Event|1
1680472|NCT01383954|5870085|P1|Overall Study|Reason Not Specified|9
1680473|NCT01383954|5870085|P1|Overall Study|Adverse Event|1
1680474|NCT01383954|5870085|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
1680475|NCT01383954|5870085|P1|Overall Study|Lack of Efficacy|2
1680476|NCT01383928|5870093|P3|Overall Study|Unsatisfactory Therapeutic Response|1
1680477|NCT01383928|5870094|P2|Overall Study|Unsatisfactory Therapeutic Response|0
1680478|NCT01383928|5870095|P1|Overall Study|Unsatisfactory Therapeutic Response|0
1680479|NCT01383928|5870093|P3|Overall Study|Withdrawal by Subject|4
1680480|NCT01383928|5870094|P2|Overall Study|Withdrawal by Subject|0
1680481|NCT01383928|5870095|P1|Overall Study|Withdrawal by Subject|0
1680482|NCT01383928|5870093|P3|Overall Study|Progressive Disease|5
1680483|NCT01383928|5870094|P2|Overall Study|Progressive Disease|1
1680484|NCT01383928|5870095|P1|Overall Study|Progressive Disease|1
1680485|NCT01383928|5870093|P3|Overall Study|Other|4
1680486|NCT01383928|5870094|P2|Overall Study|Other|3
1680487|NCT01383928|5870095|P1|Overall Study|Other|1
1680488|NCT01383928|5870093|P3|Overall Study|Adverse Event|8
1680489|NCT01383928|5870094|P2|Overall Study|Adverse Event|2
1680490|NCT01383928|5870095|P1|Overall Study|Adverse Event|1
1680491|NCT01383928|5870093|P3|Overall Study|Initiation of ASCT|18
1680492|NCT01383928|5870094|P2|Overall Study|Initiation of ASCT|1
1680493|NCT01383928|5870095|P1|Overall Study|Initiation of ASCT|2
1680494|NCT01383707|5870159|P1|Overall Study|Progressive disease|23
1680495|NCT01383707|5870159|P1|Overall Study|Adverse Event|14
1680496|NCT01383707|5870159|P1|Overall Study|Sponsor's decision|2
1680497|NCT01383707|5870159|P1|Overall Study|Other|8
1680498|NCT01383707|5870159|P1|Overall Study|Death|19
1680499|NCT01383707|5870159|P1|Overall Study|Consent withdrawal|6
1680500|NCT01383499|5870199|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
1680501|NCT01383499|5870200|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
1680502|NCT01383499|5870201|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
1680503|NCT01383499|5870202|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
1680504|NCT01383486|5870252|P1|Overall Study|Did not take any product|6
1680505|NCT01383486|5870252|P1|Overall Study|Incomplete information for analysis|2
1680506|NCT01383486|5870252|P1|Overall Study|Lost to Follow-up|10
1680507|NCT01383356|5870329|P2|Period 1|Personal|2
1680508|NCT01383356|5870330|P1|Period 1|Personal|0
1680509|NCT01383356|5870329|P2|Period 1|Out of Range Mid-study-Test|1
1680510|NCT01383356|5870330|P1|Period 1|Out of Range Mid-study-Test|0
1680511|NCT01383356|5870329|P2|Period 1|Non-compliance|0
1680512|NCT01383356|5870330|P1|Period 1|Non-compliance|3
1680513|NCT01383356|5870329|P2|Period 1|Adverse Event|3
1680514|NCT01383356|5870330|P1|Period 1|Adverse Event|5
1680515|NCT01383317|5870342|P2|Overall Study|Adverse Event|1
1680516|NCT01383317|5870343|P1|Overall Study|Adverse Event|0
1680517|NCT01383317|5870342|P2|Overall Study|Death|0
1680518|NCT01383317|5870343|P1|Overall Study|Death|1
1680519|NCT01383317|5870342|P2|Overall Study|Lost to Follow-up|1
1680520|NCT01383317|5870343|P1|Overall Study|Lost to Follow-up|2
1680521|NCT01383174|5870385|P2|6 Month Assessment|Refused to complete|0
1680522|NCT01383174|5870386|P1|6 Month Assessment|Refused to complete|4
1680523|NCT01383174|5870385|P2|6 Month Assessment|Lost to Follow-up|1
1680524|NCT01383174|5870386|P1|6 Month Assessment|Lost to Follow-up|1
1680525|NCT01383174|5870385|P2|3 Month Assessment|Refused to complete|0
1680526|NCT01383174|5870386|P1|3 Month Assessment|Refused to complete|4
1680527|NCT01383174|5870385|P2|3 Month Assessment|Lost to Follow-up|0
1680528|NCT01383174|5870386|P1|3 Month Assessment|Lost to Follow-up|2
1680529|NCT01383174|5870385|P2|3 Month Assessment|Death|1
1680530|NCT01383174|5870386|P1|3 Month Assessment|Death|0
1680531|NCT01383161|5870412|P2|Overall Study|Lack of Efficacy|1
1680532|NCT01383161|5870413|P1|Overall Study|Lack of Efficacy|0
1680533|NCT01383161|5870412|P2|Overall Study|Withdrawal by Subject|2
1680534|NCT01383161|5870413|P1|Overall Study|Withdrawal by Subject|0
1680535|NCT01383161|5870412|P2|Overall Study|Adverse Event|1
1680536|NCT01383161|5870413|P1|Overall Study|Adverse Event|5
1680537|NCT01383096|5870432|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
1680538|NCT01383096|5870433|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
1680539|NCT01383096|5870434|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
1680540|NCT01383096|5870432|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
1680541|NCT01383096|5870433|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
1680542|NCT01383096|5870434|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
1680543|NCT01383096|5870432|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
1680544|NCT01383096|5870433|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
1680545|NCT01383096|5870434|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
1680546|NCT01383096|5870432|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1680547|NCT01383096|5870433|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1680548|NCT01383096|5870434|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1680549|NCT01383096|5870432|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
1680550|NCT01383096|5870433|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
1680551|NCT01383096|5870434|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
1680552|NCT01383096|5870432|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
1680553|NCT01383096|5870433|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
1680554|NCT01383096|5870434|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
1680555|NCT01383096|5870432|P3|Third Intervention (8 Days)|Adverse Event|0
1680556|NCT01383096|5870433|P2|Third Intervention (8 Days)|Adverse Event|0
1680557|NCT01383096|5870434|P1|Third Intervention (8 Days)|Adverse Event|1
1680558|NCT01383096|5870432|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1680559|NCT01383096|5870433|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
1680560|NCT01383096|5870434|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
1680561|NCT01383096|5870432|P3|Third Intervention (8 Days)|Elevated AST|0
1680562|NCT01383096|5870433|P2|Third Intervention (8 Days)|Elevated AST|1
1680563|NCT01383096|5870434|P1|Third Intervention (8 Days)|Elevated AST|0
1680564|NCT01383096|5870432|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1680565|NCT01383096|5870433|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
1680566|NCT01383096|5870434|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
1680567|NCT01383096|5870432|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
1680568|NCT01383096|5870433|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1680569|NCT01383096|5870434|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
1680580|NCT01382940|5870542|P1|Overall Study|Protocol Violation|20
1680581|NCT01382940|5870542|P1|Overall Study|Withdrawal by Subject|23
1680582|NCT01382940|5870542|P1|Overall Study|Physician Decision|7
1680583|NCT01382940|5870542|P1|Overall Study|Lost to Follow-up|4
1680584|NCT01382940|5870542|P1|Overall Study|Adverse Event|19
1680585|NCT01382602|5870604|P2|Overall Study|Withdrawal by Subject|1
1680586|NCT01382602|5870605|P1|Overall Study|Withdrawal by Subject|0
1680587|NCT01382602|5870604|P2|Overall Study|Protocol Violation|3
1680588|NCT01382602|5870605|P1|Overall Study|Protocol Violation|0
1680589|NCT01382446|5870613|P2|Overall Study|Removal from Mechanical Ventilation|3
1680590|NCT01382446|5870614|P1|Overall Study|Removal from Mechanical Ventilation|3
1680591|NCT01382446|5870613|P2|Overall Study|Withdrawal by Subject|1
1680592|NCT01382446|5870614|P1|Overall Study|Withdrawal by Subject|0
1680593|NCT01382251|5870641|P2|Overall Study|Contacted after study closed|1
1680594|NCT01382251|5870642|P1|Overall Study|Contacted after study closed|1
1680595|NCT01382251|5870641|P2|Overall Study|Lost to Follow-up|4
1680596|NCT01382251|5870642|P1|Overall Study|Lost to Follow-up|4
1680597|NCT01382251|5870641|P2|Overall Study|Surgeries cancelled or delayed|16
1680598|NCT01382251|5870642|P1|Overall Study|Surgeries cancelled or delayed|16
1680599|NCT01382225|5870655|P2|Overall Study|Other|2
1680600|NCT01382225|5870656|P1|Overall Study|Other|4
1680601|NCT01382225|5870655|P2|Overall Study|Subject Withdrew Consent|2
1680602|NCT01382225|5870656|P1|Overall Study|Subject Withdrew Consent|5
1680603|NCT01382225|5870655|P2|Overall Study|Protocol Violation|1
1680604|NCT01382225|5870656|P1|Overall Study|Protocol Violation|2
1680605|NCT01382225|5870655|P2|Overall Study|Adverse Event|2
1680606|NCT01382225|5870656|P1|Overall Study|Adverse Event|3
1680607|NCT01382212|5870678|P1|Overall Study|Withdrew consent|1
1680608|NCT01382212|5870678|P1|Overall Study|Kidney transplant|1
1680609|NCT01381926|5870741|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
1680610|NCT01381926|5870742|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
1680611|NCT01381926|5870741|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
1680612|NCT01381926|5870742|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
1680613|NCT01381900|5870755|P3|Overall Study|Early withdraw|1
1680614|NCT01381900|5870756|P2|Overall Study|Early withdraw|1
1680615|NCT01381900|5870757|P1|Overall Study|Early withdraw|3
1680616|NCT01381900|5870755|P3|Overall Study|Withdrawal by Subject|1
1680617|NCT01381900|5870756|P2|Overall Study|Withdrawal by Subject|0
1680618|NCT01381900|5870757|P1|Overall Study|Withdrawal by Subject|0
1680619|NCT01381900|5870755|P3|Overall Study|Protocol Violation|1
1680620|NCT01381900|5870756|P2|Overall Study|Protocol Violation|1
1680621|NCT01381900|5870757|P1|Overall Study|Protocol Violation|0
1680622|NCT01381900|5870755|P3|Overall Study|Physician Decision|1
1680623|NCT01381900|5870756|P2|Overall Study|Physician Decision|1
1680624|NCT01381900|5870757|P1|Overall Study|Physician Decision|0
1680625|NCT01381900|5870755|P3|Overall Study|Noncompliance with study drug|1
1680626|NCT01381900|5870756|P2|Overall Study|Noncompliance with study drug|0
1680627|NCT01381900|5870757|P1|Overall Study|Noncompliance with study drug|0
1680628|NCT01381900|5870755|P3|Overall Study|Adverse Event|7
1680629|NCT01381900|5870756|P2|Overall Study|Adverse Event|6
1680630|NCT01381900|5870757|P1|Overall Study|Adverse Event|4
1680631|NCT01381900|5870755|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
1680632|NCT01381900|5870756|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
1680633|NCT01381900|5870757|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
1680634|NCT01381874|5870780|P3|Overall Study|Other|67
1680635|NCT01381874|5870781|P2|Overall Study|Other|52
1680636|NCT01381874|5870782|P1|Overall Study|Other|67
1680637|NCT01381874|5870780|P3|Overall Study|Withdrawal by Subject|9
1680638|NCT01381874|5870781|P2|Overall Study|Withdrawal by Subject|10
1680639|NCT01381874|5870782|P1|Overall Study|Withdrawal by Subject|9
1680640|NCT01381874|5870780|P3|Overall Study|Lost to Follow-up|0
1680641|NCT01381874|5870781|P2|Overall Study|Lost to Follow-up|1
1680642|NCT01381874|5870782|P1|Overall Study|Lost to Follow-up|1
1680643|NCT01381679|5870819|P1|Overall Study|Lost to Follow-up|885
1680644|NCT01381679|5870819|P1|Overall Study|Adverse Event|3
1680645|NCT01381575|5870834|P3|Overall Study|Lost to Follow-up|9
1680646|NCT01381575|5870835|P2|Overall Study|Lost to Follow-up|17
1680647|NCT01381575|5870836|P1|Overall Study|Lost to Follow-up|8
1680648|NCT01381575|5870834|P3|Overall Study|Migrated/moved from study area|2
1680649|NCT01381575|5870835|P2|Overall Study|Migrated/moved from study area|12
1680650|NCT01381575|5870836|P1|Overall Study|Migrated/moved from study area|2
1680651|NCT01381575|5870834|P3|Overall Study|Withdrawal by Subject|7
1680652|NCT01381575|5870835|P2|Overall Study|Withdrawal by Subject|9
1680653|NCT01381575|5870836|P1|Overall Study|Withdrawal by Subject|15
1680654|NCT01381575|5870834|P3|Overall Study|Protocol Violation|1
1680655|NCT01381575|5870835|P2|Overall Study|Protocol Violation|1
1680656|NCT01381575|5870836|P1|Overall Study|Protocol Violation|0
1680657|NCT01381575|5870834|P3|Overall Study|Non-Serious Adverse Event|1
1680658|NCT01381575|5870835|P2|Overall Study|Non-Serious Adverse Event|0
1680659|NCT01381575|5870836|P1|Overall Study|Non-Serious Adverse Event|0
1680660|NCT01381575|5870834|P3|Overall Study|Serious Adverse Event|0
1680661|NCT01381575|5870835|P2|Overall Study|Serious Adverse Event|0
1680662|NCT01381575|5870836|P1|Overall Study|Serious Adverse Event|1
1680663|NCT01381562|5870893|P3|Overall Study|Adverse Event|0
1680664|NCT01381562|5870894|P2|Overall Study|Adverse Event|1
1680665|NCT01381562|5870895|P1|Overall Study|Adverse Event|0
1680666|NCT01381549|5870963|P3|Overall Study|Ineligible: No organisms isolated|1
1680667|NCT01381549|5870964|P2|Overall Study|Ineligible: No organisms isolated|0
1680668|NCT01381549|5870965|P1|Overall Study|Ineligible: No organisms isolated|0
1680669|NCT01381068|5871091|P2|Overall Study|Death|0
1680670|NCT01381068|5871092|P1|Overall Study|Death|1
1680671|NCT01381016|5871112|P2|Overall Study|Physician Decision|2
1680672|NCT01381016|5871113|P1|Overall Study|Physician Decision|0
1680673|NCT01381016|5871112|P2|Overall Study|Withdrawal by Subject|1
1680674|NCT01381016|5871113|P1|Overall Study|Withdrawal by Subject|0
1680675|NCT01381016|5871112|P2|Overall Study|Screen Failure|2
1680676|NCT01381016|5871113|P1|Overall Study|Screen Failure|2
1680677|NCT01381016|5871112|P2|Overall Study|Lost to Follow-up|1
1680678|NCT01381016|5871113|P1|Overall Study|Lost to Follow-up|1
1680679|NCT01380834|5871123|P2|Overall Study|Physician Decision|0
1680680|NCT01380834|5871124|P1|Overall Study|Physician Decision|1
1680681|NCT01380782|5871136|P4|Overall Study|Withdrawal by Subject|1
1680682|NCT01380782|5871137|P3|Overall Study|Withdrawal by Subject|1
1680683|NCT01380782|5871138|P2|Overall Study|Withdrawal by Subject|0
1680684|NCT01380782|5871139|P1|Overall Study|Withdrawal by Subject|0
1680685|NCT01380782|5871136|P4|Overall Study|Physician Decision|0
1680686|NCT01380782|5871137|P3|Overall Study|Physician Decision|0
1680687|NCT01380782|5871138|P2|Overall Study|Physician Decision|0
1680688|NCT01380782|5871139|P1|Overall Study|Physician Decision|1
1680689|NCT01380782|5871136|P4|Overall Study|Lack of Efficacy|3
1680690|NCT01380782|5871137|P3|Overall Study|Lack of Efficacy|10
1680691|NCT01380782|5871138|P2|Overall Study|Lack of Efficacy|9
1680692|NCT01380782|5871139|P1|Overall Study|Lack of Efficacy|10
1680693|NCT01380782|5871136|P4|Overall Study|Death|0
1680694|NCT01380782|5871137|P3|Overall Study|Death|0
1680695|NCT01380782|5871138|P2|Overall Study|Death|0
1680696|NCT01380782|5871139|P1|Overall Study|Death|1
1680697|NCT01380782|5871136|P4|Overall Study|Adverse Event|0
1680698|NCT01380782|5871137|P3|Overall Study|Adverse Event|0
1680699|NCT01380782|5871138|P2|Overall Study|Adverse Event|1
1680700|NCT01380782|5871139|P1|Overall Study|Adverse Event|0
1680701|NCT01380769|5871162|P2|Overall Study|Protocol Violation|1
1680702|NCT01380769|5871163|P1|Overall Study|Protocol Violation|0
1680703|NCT01380769|5871162|P2|Overall Study|Adverse Event|1
1680704|NCT01380769|5871163|P1|Overall Study|Adverse Event|1
1680705|NCT01380769|5871162|P2|Overall Study|Physician Decision|1
1680706|NCT01380769|5871163|P1|Overall Study|Physician Decision|1
1680707|NCT01380769|5871162|P2|Overall Study|Withdrawal by Subject|11
1680708|NCT01380769|5871163|P1|Overall Study|Withdrawal by Subject|7
1680709|NCT01380730|5871224|P8|Overall Study|Death|0
1680710|NCT01380730|5871225|P7|Overall Study|Death|0
1680711|NCT01380730|5871226|P6|Overall Study|Death|0
1680712|NCT01380730|5871227|P5|Overall Study|Death|1
1680713|NCT01380730|5871228|P4|Overall Study|Death|0
1680714|NCT01380730|5871229|P3|Overall Study|Death|0
1680715|NCT01380730|5871230|P2|Overall Study|Death|0
1680716|NCT01380730|5871231|P1|Overall Study|Death|0
1680717|NCT01380691|5871289|P4|Washout (7 Days)|Withdrawal by Subject|0
1680718|NCT01380691|5871290|P3|Washout (7 Days)|Withdrawal by Subject|1
1680719|NCT01380691|5871291|P2|Washout (7 Days)|Withdrawal by Subject|0
1680720|NCT01380691|5871292|P1|Washout (7 Days)|Withdrawal by Subject|0
1680721|NCT01380691|5871289|P4|Washout (7 Days)|Protocol Violation|1
1680722|NCT01380691|5871290|P3|Washout (7 Days)|Protocol Violation|0
1680723|NCT01380691|5871291|P2|Washout (7 Days)|Protocol Violation|0
1680724|NCT01380691|5871292|P1|Washout (7 Days)|Protocol Violation|0
1680737|NCT01380379|5871360|P1|Overall Study|Pregnancy|1
1680738|NCT01380327|5871373|P3|Overall Study|Questionable onset of epilepsy|1
1680739|NCT01380327|5871374|P2|Overall Study|Questionable onset of epilepsy|0
1680740|NCT01380327|5871375|P1|Overall Study|Questionable onset of epilepsy|0
1680741|NCT01380327|5871373|P3|Overall Study|Housing situation precluded ability to k|1
1680742|NCT01380327|5871374|P2|Overall Study|Housing situation precluded ability to k|0
1680743|NCT01380327|5871375|P1|Overall Study|Housing situation precluded ability to k|0
1680744|NCT01380327|5871373|P3|Overall Study|Withdrawal by Subject|1
1680745|NCT01380327|5871374|P2|Overall Study|Withdrawal by Subject|0
1680746|NCT01380327|5871375|P1|Overall Study|Withdrawal by Subject|0
1680747|NCT01380327|5871373|P3|Overall Study|Protocol Violation|3
1680748|NCT01380327|5871374|P2|Overall Study|Protocol Violation|2
1680749|NCT01380327|5871375|P1|Overall Study|Protocol Violation|3
1680750|NCT01380327|5871373|P3|Overall Study|Lost to Follow-up|1
1680751|NCT01380327|5871374|P2|Overall Study|Lost to Follow-up|1
1680752|NCT01380327|5871375|P1|Overall Study|Lost to Follow-up|0
1680753|NCT01380184|5871406|P1|Part 2|Lost to Follow-up|1
1680754|NCT01380184|5871406|P1|Part 2|Disease Progression|8
1680755|NCT01380184|5871406|P1|Part 2|Adverse Event|5
1680756|NCT01380184|5871406|P1|Part 1 (19 Days)|Adverse Event|1
1680757|NCT01380145|5871417|P1|Overall Study|Progressive disease|4
1680758|NCT01380093|5871425|P9|Treatment Phase: Third Intervention|Other|1
1680759|NCT01380093|5871426|P8|Treatment Phase: Third Intervention|Other|0
1680760|NCT01380093|5871427|P7|Treatment Phase: Third Intervention|Other|0
1680761|NCT01380093|5871428|P6|Treatment Phase: Third Intervention|Other|0
1680762|NCT01380093|5871429|P5|Treatment Phase: Third Intervention|Other|0
1680763|NCT01380093|5871430|P4|Treatment Phase: Third Intervention|Other|0
1680764|NCT01380093|5871431|P3|Treatment Phase: Third Intervention|Other|0
1680765|NCT01380093|5871432|P2|Treatment Phase: Third Intervention|Other|0
1680766|NCT01380093|5871433|P1|Treatment Phase: Third Intervention|Other|0
1680767|NCT01380093|5871425|P9|Treatment Phase: Third Intervention|Non-compliance|1
1680768|NCT01380093|5871426|P8|Treatment Phase: Third Intervention|Non-compliance|0
1680769|NCT01380093|5871427|P7|Treatment Phase: Third Intervention|Non-compliance|0
1680770|NCT01380093|5871428|P6|Treatment Phase: Third Intervention|Non-compliance|0
1680771|NCT01380093|5871429|P5|Treatment Phase: Third Intervention|Non-compliance|0
1680772|NCT01380093|5871430|P4|Treatment Phase: Third Intervention|Non-compliance|0
1680773|NCT01380093|5871431|P3|Treatment Phase: Third Intervention|Non-compliance|0
1680774|NCT01380093|5871432|P2|Treatment Phase: Third Intervention|Non-compliance|0
1680775|NCT01380093|5871433|P1|Treatment Phase: Third Intervention|Non-compliance|0
1680776|NCT01380093|5871425|P9|Treatment Phase: Second Intervention|Other|0
1680777|NCT01380093|5871426|P8|Treatment Phase: Second Intervention|Other|0
1680778|NCT01380093|5871427|P7|Treatment Phase: Second Intervention|Other|0
1680779|NCT01380093|5871428|P6|Treatment Phase: Second Intervention|Other|0
1680780|NCT01380093|5871429|P5|Treatment Phase: Second Intervention|Other|0
1680781|NCT01380093|5871430|P4|Treatment Phase: Second Intervention|Other|1
1680782|NCT01380093|5871431|P3|Treatment Phase: Second Intervention|Other|0
1680783|NCT01380093|5871432|P2|Treatment Phase: Second Intervention|Other|0
1680784|NCT01380093|5871433|P1|Treatment Phase: Second Intervention|Other|0
1680785|NCT01380093|5871425|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680786|NCT01380093|5871426|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680787|NCT01380093|5871427|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680788|NCT01380093|5871428|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680789|NCT01380093|5871429|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680790|NCT01380093|5871430|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680791|NCT01380093|5871431|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
1680792|NCT01380093|5871432|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680793|NCT01380093|5871433|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
1680794|NCT01380093|5871425|P9|Drug Discrimination Phase: Day 2|Backup participant|0
1680795|NCT01380093|5871426|P8|Drug Discrimination Phase: Day 2|Backup participant|0
1680796|NCT01380093|5871427|P7|Drug Discrimination Phase: Day 2|Backup participant|0
1680797|NCT01380093|5871428|P6|Drug Discrimination Phase: Day 2|Backup participant|0
1680798|NCT01380093|5871429|P5|Drug Discrimination Phase: Day 2|Backup participant|0
1680799|NCT01380093|5871430|P4|Drug Discrimination Phase: Day 2|Backup participant|0
1680800|NCT01380093|5871431|P3|Drug Discrimination Phase: Day 2|Backup participant|1
1680801|NCT01380093|5871432|P2|Drug Discrimination Phase: Day 2|Backup participant|0
1680802|NCT01380093|5871433|P1|Drug Discrimination Phase: Day 2|Backup participant|0
1680803|NCT01380093|5871425|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1680804|NCT01380093|5871426|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1680805|NCT01380093|5871427|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1680806|NCT01380093|5871428|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1680807|NCT01380093|5871429|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1680808|NCT01380093|5871430|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1680809|NCT01380093|5871431|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
1680810|NCT01380093|5871432|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
1680811|NCT01380093|5871433|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
1680812|NCT01380093|5871425|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
1680813|NCT01380093|5871426|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
1680814|NCT01380093|5871427|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
1680815|NCT01380093|5871428|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
1680816|NCT01380093|5871429|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
1680817|NCT01380093|5871430|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
1680818|NCT01380093|5871431|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
1680819|NCT01380093|5871432|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
1680820|NCT01380093|5871433|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
1680821|NCT01380093|5871425|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680822|NCT01380093|5871426|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680823|NCT01380093|5871427|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680824|NCT01380093|5871428|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680825|NCT01380093|5871429|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680826|NCT01380093|5871430|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680827|NCT01380093|5871431|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680828|NCT01380093|5871432|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
1680829|NCT01380093|5871433|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
1680830|NCT01380093|5871425|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
1680831|NCT01380093|5871426|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
1680832|NCT01380093|5871427|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
1680833|NCT01380093|5871428|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
1680834|NCT01380093|5871429|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
1680835|NCT01380093|5871430|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
1680836|NCT01380093|5871431|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
1680837|NCT01380093|5871432|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
1680838|NCT01380093|5871433|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
1680839|NCT01380093|5871425|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680840|NCT01380093|5871426|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680841|NCT01380093|5871427|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680842|NCT01380093|5871428|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680843|NCT01380093|5871429|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680844|NCT01380093|5871430|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680845|NCT01380093|5871431|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680846|NCT01380093|5871432|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
1680847|NCT01380093|5871433|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
1680848|NCT01380093|5871425|P9|Naloxone Challenge Phase|Screen failures|0
1680849|NCT01380093|5871426|P8|Naloxone Challenge Phase|Screen failures|0
1680850|NCT01380093|5871427|P7|Naloxone Challenge Phase|Screen failures|0
1680851|NCT01380093|5871428|P6|Naloxone Challenge Phase|Screen failures|0
1680852|NCT01380093|5871429|P5|Naloxone Challenge Phase|Screen failures|0
1680853|NCT01380093|5871430|P4|Naloxone Challenge Phase|Screen failures|0
1680854|NCT01380093|5871431|P3|Naloxone Challenge Phase|Screen failures|0
1680855|NCT01380093|5871432|P2|Naloxone Challenge Phase|Screen failures|0
1680856|NCT01380093|5871433|P1|Naloxone Challenge Phase|Screen failures|21
1680857|NCT01380080|5871725|P2|Overall Study|Lost to Follow-up|0
1680858|NCT01380080|5871726|P1|Overall Study|Lost to Follow-up|2
1680859|NCT01380080|5871725|P2|Overall Study|Not willing to adhere to requirements|1
1680860|NCT01380080|5871726|P1|Overall Study|Not willing to adhere to requirements|3
1680861|NCT01380080|5871725|P2|Overall Study|Not able to get to clinic|0
1680862|NCT01380080|5871726|P1|Overall Study|Not able to get to clinic|4
1680863|NCT01380080|5871725|P2|Overall Study|Withdrawal by Subject|0
1680864|NCT01380080|5871726|P1|Overall Study|Withdrawal by Subject|4
1680865|NCT01380080|5871725|P2|Overall Study|Death|22
1680866|NCT01380080|5871726|P1|Overall Study|Death|20
1680867|NCT01379937|5871751|P4|Overall Study|Lost to Follow-up|0
1680868|NCT01379937|5871752|P3|Overall Study|Lost to Follow-up|2
1680869|NCT01379937|5871753|P2|Overall Study|Lost to Follow-up|2
1680870|NCT01379937|5871754|P1|Overall Study|Lost to Follow-up|1
1680871|NCT01379937|5871751|P4|Overall Study|Consent withdrawal|0
1680872|NCT01379937|5871752|P3|Overall Study|Consent withdrawal|0
1680873|NCT01379937|5871753|P2|Overall Study|Consent withdrawal|1
1680874|NCT01379937|5871754|P1|Overall Study|Consent withdrawal|0
1680875|NCT01379937|5871751|P4|Overall Study|Protocol Violation|1
1680876|NCT01379937|5871752|P3|Overall Study|Protocol Violation|0
1680877|NCT01379937|5871753|P2|Overall Study|Protocol Violation|0
1680878|NCT01379937|5871754|P1|Overall Study|Protocol Violation|0
1680879|NCT01379781|5871836|P2|Overall Study|Lost to Follow-up|8
1680880|NCT01379781|5871837|P1|Overall Study|Lost to Follow-up|11
1680881|NCT01379768|5871846|P3|Overall Study|Lost to Follow-up|0
1680882|NCT01379768|5871847|P2|Overall Study|Lost to Follow-up|0
1680883|NCT01379768|5871848|P1|Overall Study|Lost to Follow-up|2
1680884|NCT01379768|5871846|P3|Overall Study|Adverse Event|0
1680885|NCT01379768|5871847|P2|Overall Study|Adverse Event|1
1680886|NCT01379768|5871848|P1|Overall Study|Adverse Event|1
1680887|NCT01379703|5871871|P3|9 Months Through 18 Months|Reason Unknown|0
1680888|NCT01379703|5871872|P2|9 Months Through 18 Months|Reason Unknown|23
1680889|NCT01379703|5871873|P1|9 Months Through 18 Months|Reason Unknown|0
1680890|NCT01379703|5871871|P3|9 Months Through 18 Months|Fatigue|0
1680891|NCT01379703|5871872|P2|9 Months Through 18 Months|Fatigue|1
1680892|NCT01379703|5871873|P1|9 Months Through 18 Months|Fatigue|0
1680893|NCT01379703|5871871|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
1680894|NCT01379703|5871872|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
1680895|NCT01379703|5871873|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
1680896|NCT01379703|5871871|P3|9 Months Through 18 Months|Patient Noncompliance|0
1680897|NCT01379703|5871872|P2|9 Months Through 18 Months|Patient Noncompliance|4
1680898|NCT01379703|5871873|P1|9 Months Through 18 Months|Patient Noncompliance|0
1680899|NCT01379703|5871871|P3|9 Months Through 18 Months|Treatment failure|0
1680900|NCT01379703|5871872|P2|9 Months Through 18 Months|Treatment failure|5
1680901|NCT01379703|5871873|P1|9 Months Through 18 Months|Treatment failure|0
1680902|NCT01379703|5871871|P3|9 Months Through 18 Months|Adverse Event|0
1680903|NCT01379703|5871872|P2|9 Months Through 18 Months|Adverse Event|6
1680904|NCT01379703|5871873|P1|9 Months Through 18 Months|Adverse Event|0
1680905|NCT01379703|5871871|P3|9 Months Through 18 Months|Withdrawal by Subject|0
1680906|NCT01379703|5871872|P2|9 Months Through 18 Months|Withdrawal by Subject|11
1680907|NCT01379703|5871873|P1|9 Months Through 18 Months|Withdrawal by Subject|0
1680908|NCT01379703|5871871|P3|9 Months Through 18 Months|Lost to Follow-up|0
1680909|NCT01379703|5871872|P2|9 Months Through 18 Months|Lost to Follow-up|178
1680910|NCT01379703|5871873|P1|9 Months Through 18 Months|Lost to Follow-up|0
1680911|NCT01379703|5871871|P3|Study Start Through 9 Months|Reason unknown|24
1680912|NCT01379703|5871872|P2|Study Start Through 9 Months|Reason unknown|31
1680913|NCT01379703|5871873|P1|Study Start Through 9 Months|Reason unknown|2
1680914|NCT01379703|5871871|P3|Study Start Through 9 Months|Increased triglycerides|0
1680915|NCT01379703|5871872|P2|Study Start Through 9 Months|Increased triglycerides|1
1680916|NCT01379703|5871873|P1|Study Start Through 9 Months|Increased triglycerides|0
1680917|NCT01379703|5871871|P3|Study Start Through 9 Months|Poor general condition|0
1680918|NCT01379703|5871872|P2|Study Start Through 9 Months|Poor general condition|1
1680919|NCT01379703|5871873|P1|Study Start Through 9 Months|Poor general condition|0
1680920|NCT01379703|5871871|P3|Study Start Through 9 Months|Medication not available|1
1680921|NCT01379703|5871872|P2|Study Start Through 9 Months|Medication not available|2
1680922|NCT01379703|5871873|P1|Study Start Through 9 Months|Medication not available|0
1680923|NCT01379703|5871871|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
1680924|NCT01379703|5871872|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
1680925|NCT01379703|5871873|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
1680926|NCT01379703|5871871|P3|Study Start Through 9 Months|Patient Noncompliance|1
1680927|NCT01379703|5871872|P2|Study Start Through 9 Months|Patient Noncompliance|0
1680928|NCT01379703|5871873|P1|Study Start Through 9 Months|Patient Noncompliance|0
1680929|NCT01379703|5871871|P3|Study Start Through 9 Months|Treatment Failure|2
1680930|NCT01379703|5871872|P2|Study Start Through 9 Months|Treatment Failure|2
1680931|NCT01379703|5871873|P1|Study Start Through 9 Months|Treatment Failure|0
1680932|NCT01379703|5871871|P3|Study Start Through 9 Months|Withdrawal by Subject|1
1680933|NCT01379703|5871872|P2|Study Start Through 9 Months|Withdrawal by Subject|6
1680934|NCT01379703|5871873|P1|Study Start Through 9 Months|Withdrawal by Subject|0
1680935|NCT01379703|5871871|P3|Study Start Through 9 Months|Adverse Event|10
1680936|NCT01379703|5871872|P2|Study Start Through 9 Months|Adverse Event|14
1680937|NCT01379703|5871873|P1|Study Start Through 9 Months|Adverse Event|0
1680938|NCT01379703|5871871|P3|Study Start Through 9 Months|Lost to Follow-up|104
1680939|NCT01379703|5871872|P2|Study Start Through 9 Months|Lost to Follow-up|61
1680940|NCT01379703|5871873|P1|Study Start Through 9 Months|Lost to Follow-up|2
1680941|NCT01379534|5871973|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
1680942|NCT01379534|5871974|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
1680943|NCT01379534|5871973|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
1680944|NCT01379534|5871974|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
1680945|NCT01379534|5871973|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
1680946|NCT01379534|5871974|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
1680947|NCT01379534|5871973|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
1680948|NCT01379534|5871974|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
1680949|NCT01379534|5871973|P2|Treatment Phase|Adverse Event|7
1680950|NCT01379534|5871974|P1|Treatment Phase|Adverse Event|7
1680951|NCT01379534|5871973|P2|Treatment Phase|Progressive disease|22
1680952|NCT01379534|5871974|P1|Treatment Phase|Progressive disease|13
1680953|NCT01379534|5871973|P2|Treatment Phase|Withdrawal by Subject|2
1680954|NCT01379534|5871974|P1|Treatment Phase|Withdrawal by Subject|2
1680955|NCT01379521|5871994|P2|Post-Treatment Evaluations|Death|0
1680956|NCT01379521|5871995|P1|Post-Treatment Evaluations|Death|1
1680957|NCT01379521|5871994|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
1680958|NCT01379521|5871995|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
1680959|NCT01379521|5871994|P2|Post-Treatment Evaluations|Disease Progression|20
1680960|NCT01379521|5871995|P1|Post-Treatment Evaluations|Disease Progression|22
1680961|NCT01379521|5871994|P2|Overall Study -Treatment Period|Death|1
1680962|NCT01379521|5871995|P1|Overall Study -Treatment Period|Death|2
1680963|NCT01379521|5871994|P2|Overall Study -Treatment Period|Administrative Problems|0
1680964|NCT01379521|5871995|P1|Overall Study -Treatment Period|Administrative Problems|1
1680965|NCT01379521|5871994|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
1680966|NCT01379521|5871995|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
1680967|NCT01379521|5871994|P2|Overall Study -Treatment Period|Protocol Deviation|2
1680968|NCT01379521|5871995|P1|Overall Study -Treatment Period|Protocol Deviation|0
1680969|NCT01379521|5871994|P2|Overall Study -Treatment Period|New Cancer Therapy|0
1680970|NCT01379521|5871995|P1|Overall Study -Treatment Period|New Cancer Therapy|1
1680971|NCT01379521|5871994|P2|Overall Study -Treatment Period|Disease Progression|22
1680972|NCT01379521|5871995|P1|Overall Study -Treatment Period|Disease Progression|23
1680973|NCT01379521|5871994|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
1680974|NCT01379521|5871995|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
1680975|NCT01379521|5871994|P2|Overall Study -Treatment Period|Adverse Event|0
1680976|NCT01379521|5871995|P1|Overall Study -Treatment Period|Adverse Event|3
1680977|NCT01379508|5872017|P4|Extension Period Weeks 109-156|Protocol Violation|0
1680978|NCT01379508|5872018|P3|Extension Period Weeks 109-156|Protocol Violation|0
1680979|NCT01379508|5872019|P2|Extension Period Weeks 109-156|Protocol Violation|1
1680980|NCT01379508|5872020|P1|Extension Period Weeks 109-156|Protocol Violation|2
1680981|NCT01379508|5872017|P4|Extension Period Weeks 109-156|Administrative problems|0
1680982|NCT01379508|5872018|P3|Extension Period Weeks 109-156|Administrative problems|1
1680983|NCT01379508|5872019|P2|Extension Period Weeks 109-156|Administrative problems|0
1680984|NCT01379508|5872020|P1|Extension Period Weeks 109-156|Administrative problems|3
1680985|NCT01379508|5872017|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
1680986|NCT01379508|5872018|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
1680987|NCT01379508|5872019|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
1680988|NCT01379508|5872020|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
1680989|NCT01379508|5872017|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
1680990|NCT01379508|5872018|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
1680991|NCT01379508|5872019|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
1680992|NCT01379508|5872020|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
1680993|NCT01379508|5872017|P4|Treatment to Week 104|Protocol Violation|0
1680994|NCT01379508|5872018|P3|Treatment to Week 104|Protocol Violation|1
1680995|NCT01379508|5872019|P2|Treatment to Week 104|Protocol Violation|1
1680996|NCT01379508|5872020|P1|Treatment to Week 104|Protocol Violation|1
1680997|NCT01379508|5872017|P4|Treatment to Week 104|Administrative problems|0
1680998|NCT01379508|5872018|P3|Treatment to Week 104|Administrative problems|0
1680999|NCT01379508|5872019|P2|Treatment to Week 104|Administrative problems|1
1681000|NCT01379508|5872020|P1|Treatment to Week 104|Administrative problems|3
1681001|NCT01379508|5872017|P4|Treatment to Week 104|Lost to Follow-up|0
1681002|NCT01379508|5872018|P3|Treatment to Week 104|Lost to Follow-up|3
1681003|NCT01379508|5872019|P2|Treatment to Week 104|Lost to Follow-up|0
1681004|NCT01379508|5872020|P1|Treatment to Week 104|Lost to Follow-up|5
1681005|NCT01379508|5872017|P4|Treatment to Week 104|Withdrawal by Subject|0
1681006|NCT01379508|5872018|P3|Treatment to Week 104|Withdrawal by Subject|4
1681007|NCT01379508|5872019|P2|Treatment to Week 104|Withdrawal by Subject|1
1681008|NCT01379508|5872020|P1|Treatment to Week 104|Withdrawal by Subject|6
1681009|NCT01379508|5872017|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
1681010|NCT01379508|5872018|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
1681011|NCT01379508|5872019|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
1681012|NCT01379508|5872020|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
1681013|NCT01379508|5872017|P4|Treatment to Week 104|Abnormal lab value|0
1681014|NCT01379508|5872018|P3|Treatment to Week 104|Abnormal lab value|0
1681015|NCT01379508|5872019|P2|Treatment to Week 104|Abnormal lab value|0
1681016|NCT01379508|5872020|P1|Treatment to Week 104|Abnormal lab value|1
1681017|NCT01379508|5872017|P4|Treatment to Week 104|Adverse Event|0
1681018|NCT01379508|5872018|P3|Treatment to Week 104|Adverse Event|5
1681019|NCT01379508|5872019|P2|Treatment to Week 104|Adverse Event|0
1681020|NCT01379508|5872020|P1|Treatment to Week 104|Adverse Event|2
1681021|NCT01378975|5872102|P2|Overall Study|Withdrew Consent|3
1681022|NCT01378975|5872103|P1|Overall Study|Withdrew Consent|4
1681023|NCT01378975|5872102|P2|Overall Study|Lost to Follow-up|1
1681024|NCT01378975|5872103|P1|Overall Study|Lost to Follow-up|4
1681025|NCT01378975|5872102|P2|Overall Study|Investigator Request|0
1681026|NCT01378975|5872103|P1|Overall Study|Investigator Request|1
1681027|NCT01378975|5872102|P2|Overall Study|Death|46
1681028|NCT01378975|5872103|P1|Overall Study|Death|77
1681029|NCT01378962|5872129|P1|Overall Study|Other|2
1681030|NCT01378962|5872129|P1|Overall Study|Lost to Follow-up|1
1681031|NCT01378962|5872129|P1|Overall Study|Death|14
1681032|NCT01378429|5872155|P2|Overall Study|Noncompliance with study drug|0
1681033|NCT01378429|5872156|P1|Overall Study|Noncompliance with study drug|1
1681034|NCT01378325|5872269|P2|Overall Study|Protocol Violation|1
1681035|NCT01378325|5872270|P1|Overall Study|Protocol Violation|0
1681036|NCT01378195|5872324|P2|Overall Study|Lost to Follow-up|18
1681037|NCT01378195|5872325|P1|Overall Study|Lost to Follow-up|29
1681038|NCT01378117|5872338|P3|Overall Study|discharged before med given|1
1681039|NCT01378117|5872339|P2|Overall Study|discharged before med given|0
1681040|NCT01378117|5872340|P1|Overall Study|discharged before med given|2
1681041|NCT01378117|5872338|P3|Overall Study|withdrawal|2
1681042|NCT01378117|5872339|P2|Overall Study|withdrawal|1
1681043|NCT01378117|5872340|P1|Overall Study|withdrawal|2
1681044|NCT01378104|5872374|P2|Overall Study|Withdrawal by Subject|13
1681045|NCT01378104|5872375|P1|Overall Study|Withdrawal by Subject|12
1681046|NCT01378104|5872374|P2|Overall Study|Lack of Efficacy|5
1681047|NCT01378104|5872375|P1|Overall Study|Lack of Efficacy|7
1681048|NCT01378104|5872374|P2|Overall Study|Adverse Event|8
1681049|NCT01378104|5872375|P1|Overall Study|Adverse Event|8
1681050|NCT01377987|5872420|P2|Washout (7 Days)|Withdrawal by Subject|1
1681051|NCT01377987|5872421|P1|Washout (7 Days)|Withdrawal by Subject|1
1681052|NCT01377922|5872439|P2|Overall Study|rescue tx after part 2, entered part 4|0
1681053|NCT01377922|5872440|P1|Overall Study|rescue tx after part 2, entered part 4|1
1681054|NCT01377480|5872525|P4|Overall Study|Other|6
1681055|NCT01377480|5872526|P3|Overall Study|Other|7
1681056|NCT01377480|5872527|P2|Overall Study|Other|0
1681057|NCT01377480|5872528|P1|Overall Study|Other|0
1681058|NCT01377480|5872525|P4|Overall Study|Serious adverse event|1
1681059|NCT01377480|5872526|P3|Overall Study|Serious adverse event|1
1681060|NCT01377480|5872527|P2|Overall Study|Serious adverse event|0
1681061|NCT01377480|5872528|P1|Overall Study|Serious adverse event|0
1681062|NCT01377480|5872525|P4|Overall Study|Withdrawal by Subject|0
1681063|NCT01377480|5872526|P3|Overall Study|Withdrawal by Subject|1
1681064|NCT01377480|5872527|P2|Overall Study|Withdrawal by Subject|0
1681065|NCT01377480|5872528|P1|Overall Study|Withdrawal by Subject|0
1681066|NCT01377480|5872525|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
1681067|NCT01377480|5872526|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
1681068|NCT01377480|5872527|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
1681069|NCT01377480|5872528|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
1681070|NCT01377480|5872525|P4|Overall Study|Protocol Violation|4
1681071|NCT01377480|5872526|P3|Overall Study|Protocol Violation|0
1681072|NCT01377480|5872527|P2|Overall Study|Protocol Violation|0
1681073|NCT01377480|5872528|P1|Overall Study|Protocol Violation|0
1681074|NCT01377389|5872604|P1|Overall Study|Screen failure|2
1681075|NCT01377389|5872604|P1|Overall Study|Withdrawal by Subject|1
1681076|NCT01377233|5872618|P5|Double-blind|Administrative or other|1
1681077|NCT01377233|5872619|P4|Double-blind|Administrative or other|1
1681078|NCT01377233|5872620|P3|Double-blind|Administrative or other|0
1681079|NCT01377233|5872621|P2|Double-blind|Administrative or other|0
1681080|NCT01377233|5872622|P1|Double-blind|Administrative or other|0
1681081|NCT01377233|5872618|P5|Double-blind|Withdrawal by Subject|0
1681082|NCT01377233|5872619|P4|Double-blind|Withdrawal by Subject|1
1681083|NCT01377233|5872620|P3|Double-blind|Withdrawal by Subject|0
1681084|NCT01377233|5872621|P2|Double-blind|Withdrawal by Subject|0
1681085|NCT01377233|5872622|P1|Double-blind|Withdrawal by Subject|0
1681086|NCT01377233|5872618|P5|Double-blind|Protocol Violation|1
1681087|NCT01377233|5872619|P4|Double-blind|Protocol Violation|0
1681088|NCT01377233|5872620|P3|Double-blind|Protocol Violation|0
1681089|NCT01377233|5872621|P2|Double-blind|Protocol Violation|0
1681090|NCT01377233|5872622|P1|Double-blind|Protocol Violation|0
1681091|NCT01377233|5872618|P5|Double-blind|Adverse Event|0
1681092|NCT01377233|5872619|P4|Double-blind|Adverse Event|2
1681093|NCT01377233|5872620|P3|Double-blind|Adverse Event|2
1681094|NCT01377233|5872621|P2|Double-blind|Adverse Event|1
1681095|NCT01377233|5872622|P1|Double-blind|Adverse Event|0
1681096|NCT01377233|5872618|P5|Open-label|Withdrawal by Subject|0
1681097|NCT01377233|5872619|P4|Open-label|Withdrawal by Subject|0
1681098|NCT01377233|5872620|P3|Open-label|Withdrawal by Subject|0
1681099|NCT01377233|5872621|P2|Open-label|Withdrawal by Subject|0
1681100|NCT01377233|5872622|P1|Open-label|Withdrawal by Subject|3
1681101|NCT01377233|5872618|P5|Open-label|Adverse Event|0
1681102|NCT01377233|5872619|P4|Open-label|Adverse Event|0
1681103|NCT01377233|5872620|P3|Open-label|Adverse Event|0
1681104|NCT01377233|5872621|P2|Open-label|Adverse Event|0
1681105|NCT01377233|5872622|P1|Open-label|Adverse Event|1
1681106|NCT01377194|5872649|P3|Overall Study|Lost to Follow-up|11
1681107|NCT01377194|5872650|P2|Overall Study|Lost to Follow-up|8
1681108|NCT01377194|5872651|P1|Overall Study|Lost to Follow-up|14
1681109|NCT01377194|5872649|P3|Overall Study|Withdrawal by Subject|7
1681110|NCT01377194|5872650|P2|Overall Study|Withdrawal by Subject|10
1681111|NCT01377194|5872651|P1|Overall Study|Withdrawal by Subject|8
1681112|NCT01377194|5872649|P3|Overall Study|Protocol Violation|6
1681113|NCT01377194|5872650|P2|Overall Study|Protocol Violation|10
1681114|NCT01377194|5872651|P1|Overall Study|Protocol Violation|4
1681115|NCT01377194|5872649|P3|Overall Study|Lack of Efficacy|3
1681116|NCT01377194|5872650|P2|Overall Study|Lack of Efficacy|3
1681117|NCT01377194|5872651|P1|Overall Study|Lack of Efficacy|3
1681118|NCT01377194|5872649|P3|Overall Study|Adverse Event|19
1681119|NCT01377194|5872650|P2|Overall Study|Adverse Event|12
1681120|NCT01377194|5872651|P1|Overall Study|Adverse Event|3
1681121|NCT01377012|5872665|P3|Extension Study, Weeks 104-260|Adverse Event|1
1681122|NCT01377012|5872666|P2|Extension Study, Weeks 104-260|Adverse Event|2
1681123|NCT01377012|5872667|P1|Extension Study, Weeks 104-260|Adverse Event|0
1681124|NCT01377012|5872665|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
1681125|NCT01377012|5872666|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
1681126|NCT01377012|5872667|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
1681127|NCT01377012|5872665|P3|Extension Study, Weeks 104-260|Physician Decision|0
1681128|NCT01377012|5872666|P2|Extension Study, Weeks 104-260|Physician Decision|0
1681129|NCT01377012|5872667|P1|Extension Study, Weeks 104-260|Physician Decision|1
1681130|NCT01377012|5872665|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
1681131|NCT01377012|5872666|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
1681132|NCT01377012|5872667|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
1681133|NCT01377012|5872665|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
1681134|NCT01377012|5872666|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
1681135|NCT01377012|5872667|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
1681136|NCT01377012|5872665|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
1681137|NCT01377012|5872666|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
1681138|NCT01377012|5872667|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
1681139|NCT01377012|5872665|P3|Core Study|Adverse Event|13
1681140|NCT01377012|5872666|P2|Core Study|Adverse Event|14
1681141|NCT01377012|5872667|P1|Core Study|Adverse Event|10
1681142|NCT01377012|5872665|P3|Core Study|Death|1
1681143|NCT01377012|5872666|P2|Core Study|Death|1
1681144|NCT01377012|5872667|P1|Core Study|Death|1
1681145|NCT01377012|5872665|P3|Core Study|Lack of Efficacy|37
1681146|NCT01377012|5872666|P2|Core Study|Lack of Efficacy|28
1681147|NCT01377012|5872667|P1|Core Study|Lack of Efficacy|41
1681148|NCT01377012|5872665|P3|Core Study|Lost to Follow-up|4
1681149|NCT01377012|5872666|P2|Core Study|Lost to Follow-up|5
1681150|NCT01377012|5872667|P1|Core Study|Lost to Follow-up|7
1681151|NCT01377012|5872665|P3|Core Study|No Longer require treatment|1
1681152|NCT01377012|5872666|P2|Core Study|No Longer require treatment|0
1681153|NCT01377012|5872667|P1|Core Study|No Longer require treatment|0
1681154|NCT01377012|5872665|P3|Core Study|Non-Compliant with study treatment|1
1681155|NCT01377012|5872666|P2|Core Study|Non-Compliant with study treatment|0
1681156|NCT01377012|5872667|P1|Core Study|Non-Compliant with study treatment|0
1681157|NCT01377012|5872665|P3|Core Study|Physician Decision|10
1681158|NCT01377012|5872666|P2|Core Study|Physician Decision|4
1681159|NCT01377012|5872667|P1|Core Study|Physician Decision|5
1681160|NCT01377012|5872665|P3|Core Study|Pregnancy|1
1681161|NCT01377012|5872666|P2|Core Study|Pregnancy|0
1681162|NCT01377012|5872667|P1|Core Study|Pregnancy|0
1681163|NCT01377012|5872665|P3|Core Study|Protocol Violation|2
1681164|NCT01377012|5872666|P2|Core Study|Protocol Violation|3
1681165|NCT01377012|5872667|P1|Core Study|Protocol Violation|7
1681166|NCT01377012|5872665|P3|Core Study|Withdrawal by Subject|18
1681167|NCT01377012|5872666|P2|Core Study|Withdrawal by Subject|23
1681168|NCT01377012|5872667|P1|Core Study|Withdrawal by Subject|15
1681169|NCT01377012|5872665|P3|Core Study|Technical problems|0
1681170|NCT01377012|5872666|P2|Core Study|Technical problems|0
1681171|NCT01377012|5872667|P1|Core Study|Technical problems|1
1681172|NCT01377012|5872665|P3|Core Study|Study terminated by Sponsor|46
1681173|NCT01377012|5872666|P2|Core Study|Study terminated by Sponsor|54
1681174|NCT01377012|5872667|P1|Core Study|Study terminated by Sponsor|47
1681175|NCT01376908|5872704|P2|Overall Study|Withdrawal by Subject|2
1681176|NCT01376908|5872705|P1|Overall Study|Withdrawal by Subject|1
1681177|NCT01376908|5872704|P2|Overall Study|Protocol Violation|1
1681178|NCT01376908|5872705|P1|Overall Study|Protocol Violation|1
1681179|NCT01376804|5872738|P1|Treatment Period|Patient did not receive study drug|1
1681180|NCT01376804|5872738|P1|Treatment Period|Adverse Event|6
1681181|NCT01376804|5872738|P1|Treatment Period|Withdrawal by Subject|1
1681182|NCT01376700|5872749|P1|Overall Study|Low or high titer inhibitor|8
1681183|NCT01376700|5872749|P1|Overall Study|Sponsor terminated study early|8
1681184|NCT01376388|5872811|P1|Overall Study|Withdrawal by Subject|3
1681185|NCT01376388|5872811|P1|Overall Study|Lack of Efficacy|2
1681186|NCT01376388|5872811|P1|Overall Study|Adverse Event|13
1681187|NCT01376349|5872849|P3|Raondomized Treatment|Alternative Treatment|1
1681188|NCT01376349|5872850|P2|Raondomized Treatment|Alternative Treatment|0
1681189|NCT01376349|5872851|P1|Raondomized Treatment|Alternative Treatment|0
1681190|NCT01376349|5872849|P3|Raondomized Treatment|Unkown|1
1681191|NCT01376349|5872850|P2|Raondomized Treatment|Unkown|2
1681192|NCT01376349|5872851|P1|Raondomized Treatment|Unkown|1
1681193|NCT01376349|5872849|P3|Raondomized Treatment|Adverse Event|14
1681194|NCT01376349|5872850|P2|Raondomized Treatment|Adverse Event|17
1681195|NCT01376349|5872851|P1|Raondomized Treatment|Adverse Event|13
1681196|NCT01376349|5872849|P3|Raondomized Treatment|Withdrawal by Subject|13
1681197|NCT01376349|5872850|P2|Raondomized Treatment|Withdrawal by Subject|16
1681198|NCT01376349|5872851|P1|Raondomized Treatment|Withdrawal by Subject|10
1681199|NCT01376323|5872865|P5|Overall Study|Withdrawal by Subject|0
1681200|NCT01376323|5872866|P4|Overall Study|Withdrawal by Subject|0
1681201|NCT01376323|5872867|P3|Overall Study|Withdrawal by Subject|1
1681202|NCT01376323|5872868|P2|Overall Study|Withdrawal by Subject|1
1681203|NCT01376323|5872869|P1|Overall Study|Withdrawal by Subject|0
1681204|NCT01376323|5872865|P5|Overall Study|Physician Decision|1
1681205|NCT01376323|5872866|P4|Overall Study|Physician Decision|1
1681206|NCT01376323|5872867|P3|Overall Study|Physician Decision|2
1681207|NCT01376323|5872868|P2|Overall Study|Physician Decision|0
1681208|NCT01376323|5872869|P1|Overall Study|Physician Decision|1
1681209|NCT01376323|5872865|P5|Overall Study|Lost to Follow-up|0
1681210|NCT01376323|5872866|P4|Overall Study|Lost to Follow-up|2
1681211|NCT01376323|5872867|P3|Overall Study|Lost to Follow-up|0
1681212|NCT01376323|5872868|P2|Overall Study|Lost to Follow-up|0
1681213|NCT01376323|5872869|P1|Overall Study|Lost to Follow-up|0
1681214|NCT01376323|5872865|P5|Overall Study|Adverse Event|0
1681215|NCT01376323|5872866|P4|Overall Study|Adverse Event|2
1681216|NCT01376323|5872867|P3|Overall Study|Adverse Event|0
1681217|NCT01376323|5872868|P2|Overall Study|Adverse Event|0
1681218|NCT01376323|5872869|P1|Overall Study|Adverse Event|1
1681219|NCT01376310|5872953|P2|Overall Study|Lost to Follow-up|0
1681220|NCT01376310|5872954|P1|Overall Study|Lost to Follow-up|1
1681221|NCT01376310|5872953|P2|Overall Study|Physician Decision|7
1681222|NCT01376310|5872954|P1|Overall Study|Physician Decision|26
1681223|NCT01376310|5872953|P2|Overall Study|Withdrawal by Subject|2
1681224|NCT01376310|5872954|P1|Overall Study|Withdrawal by Subject|8
1681225|NCT01376310|5872953|P2|Overall Study|Study closed/terminated|2
1681226|NCT01376310|5872954|P1|Overall Study|Study closed/terminated|1
1681227|NCT01376245|5872973|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
1681228|NCT01376245|5872974|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
1681229|NCT01376245|5872975|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1681230|NCT01376245|5872976|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
1681231|NCT01376245|5872977|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1681232|NCT01376245|5872973|P5|24-week, Double-blind Treatment Period|Physician Decision|0
1681233|NCT01376245|5872974|P4|24-week, Double-blind Treatment Period|Physician Decision|1
1681234|NCT01376245|5872975|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1681235|NCT01376245|5872976|P2|24-week, Double-blind Treatment Period|Physician Decision|0
1681236|NCT01376245|5872977|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1681237|NCT01376245|5872973|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1681238|NCT01376245|5872974|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1681239|NCT01376245|5872975|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1681240|NCT01376245|5872976|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1681241|NCT01376245|5872977|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1681242|NCT01376245|5872973|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1681243|NCT01376245|5872974|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
1681244|NCT01376245|5872975|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
1681245|NCT01376245|5872976|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
1681246|NCT01376245|5872977|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1681247|NCT01376245|5872973|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
1681248|NCT01376245|5872974|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1681249|NCT01376245|5872975|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
1681250|NCT01376245|5872976|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
1681251|NCT01376245|5872977|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1681252|NCT01376245|5872973|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
1681253|NCT01376245|5872974|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
1681335|NCT01375764|5873201|P2|Overall Study|Withdrawal by Subject|0
1681254|NCT01376245|5872975|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
1681255|NCT01376245|5872976|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
1681256|NCT01376245|5872977|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
1681257|NCT01376245|5872973|P5|24-week, Double-blind Treatment Period|Adverse Event|18
1681258|NCT01376245|5872974|P4|24-week, Double-blind Treatment Period|Adverse Event|8
1681259|NCT01376245|5872975|P3|24-week, Double-blind Treatment Period|Adverse Event|7
1681260|NCT01376245|5872976|P2|24-week, Double-blind Treatment Period|Adverse Event|16
1681261|NCT01376245|5872977|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1681262|NCT01376245|5872973|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1681263|NCT01376245|5872974|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1681264|NCT01376245|5872975|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1681265|NCT01376245|5872976|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
1681266|NCT01376245|5872977|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
1681267|NCT01376245|5872973|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1681268|NCT01376245|5872974|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1681269|NCT01376245|5872975|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1681270|NCT01376245|5872976|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
1681271|NCT01376245|5872977|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
1681272|NCT01376245|5872973|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1681273|NCT01376245|5872974|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1681274|NCT01376245|5872975|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1681275|NCT01376245|5872976|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
1681276|NCT01376245|5872977|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
1681277|NCT01376245|5872973|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1681278|NCT01376245|5872974|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1681279|NCT01376245|5872975|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1681280|NCT01376245|5872976|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
1681281|NCT01376245|5872977|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
1681282|NCT01376245|5872973|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1681283|NCT01376245|5872974|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1681284|NCT01376245|5872975|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1681285|NCT01376245|5872976|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
1681286|NCT01376245|5872977|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
1681287|NCT01376167|5872994|P3|Overall Study|Withdrawal by Subject|4
1681288|NCT01376167|5872995|P2|Overall Study|Withdrawal by Subject|5
1681289|NCT01376167|5872996|P1|Overall Study|Withdrawal by Subject|1
1681290|NCT01376167|5872994|P3|Overall Study|Physician Decision|0
1681291|NCT01376167|5872995|P2|Overall Study|Physician Decision|1
1681292|NCT01376167|5872996|P1|Overall Study|Physician Decision|1
1681293|NCT01376167|5872994|P3|Overall Study|Lost to Follow-up|2
1681294|NCT01376167|5872995|P2|Overall Study|Lost to Follow-up|4
1681295|NCT01376167|5872996|P1|Overall Study|Lost to Follow-up|2
1681296|NCT01376089|5873067|P2|Overall Study|Patient received no contrast media|4
1681297|NCT01376089|5873068|P1|Overall Study|Patient received no contrast media|3
1681298|NCT01376037|5873091|P2|Overall Study|Lost to Follow-up|2
1681299|NCT01376037|5873092|P1|Overall Study|Lost to Follow-up|0
1681300|NCT01375777|5873120|P9|Overall Study|Other|1
1681301|NCT01375777|5873121|P8|Overall Study|Other|0
1681302|NCT01375777|5873122|P7|Overall Study|Other|0
1681303|NCT01375777|5873123|P6|Overall Study|Other|0
1681304|NCT01375777|5873124|P5|Overall Study|Other|0
1681305|NCT01375777|5873125|P4|Overall Study|Other|0
1681306|NCT01375777|5873126|P3|Overall Study|Other|0
1681307|NCT01375777|5873127|P2|Overall Study|Other|1
1681308|NCT01375777|5873128|P1|Overall Study|Other|1
1681309|NCT01375777|5873120|P9|Overall Study|Lost to Follow-up|0
1681310|NCT01375777|5873121|P8|Overall Study|Lost to Follow-up|0
1681311|NCT01375777|5873122|P7|Overall Study|Lost to Follow-up|1
1681312|NCT01375777|5873123|P6|Overall Study|Lost to Follow-up|0
1681313|NCT01375777|5873124|P5|Overall Study|Lost to Follow-up|0
1681314|NCT01375777|5873125|P4|Overall Study|Lost to Follow-up|0
1681315|NCT01375777|5873126|P3|Overall Study|Lost to Follow-up|0
1681316|NCT01375777|5873127|P2|Overall Study|Lost to Follow-up|0
1681317|NCT01375777|5873128|P1|Overall Study|Lost to Follow-up|1
1681318|NCT01375777|5873120|P9|Overall Study|Withdrawal by Subject|1
1681319|NCT01375777|5873121|P8|Overall Study|Withdrawal by Subject|2
1681320|NCT01375777|5873122|P7|Overall Study|Withdrawal by Subject|1
1681321|NCT01375777|5873123|P6|Overall Study|Withdrawal by Subject|1
1681322|NCT01375777|5873124|P5|Overall Study|Withdrawal by Subject|1
1681323|NCT01375777|5873125|P4|Overall Study|Withdrawal by Subject|0
1681324|NCT01375777|5873126|P3|Overall Study|Withdrawal by Subject|1
1681325|NCT01375777|5873127|P2|Overall Study|Withdrawal by Subject|2
1681326|NCT01375777|5873128|P1|Overall Study|Withdrawal by Subject|0
1681327|NCT01375764|5873198|P5|Overall Study|Other|0
1681328|NCT01375764|5873199|P4|Overall Study|Other|1
1681329|NCT01375764|5873200|P3|Overall Study|Other|0
1681330|NCT01375764|5873201|P2|Overall Study|Other|0
1681331|NCT01375764|5873202|P1|Overall Study|Other|0
1681332|NCT01375764|5873198|P5|Overall Study|Withdrawal by Subject|1
1681333|NCT01375764|5873199|P4|Overall Study|Withdrawal by Subject|0
1681334|NCT01375764|5873200|P3|Overall Study|Withdrawal by Subject|0
1681336|NCT01375764|5873202|P1|Overall Study|Withdrawal by Subject|2
1681337|NCT01375764|5873198|P5|Overall Study|Lost to Follow-up|0
1681338|NCT01375764|5873199|P4|Overall Study|Lost to Follow-up|0
1681339|NCT01375764|5873200|P3|Overall Study|Lost to Follow-up|0
1681340|NCT01375764|5873201|P2|Overall Study|Lost to Follow-up|1
1681341|NCT01375764|5873202|P1|Overall Study|Lost to Follow-up|0
1681342|NCT01375751|5873248|P3|Overall Study|Other|0
1681343|NCT01375751|5873249|P2|Overall Study|Other|1
1681344|NCT01375751|5873250|P1|Overall Study|Other|0
1681345|NCT01375608|5873294|P1|Overall Study|Withdrawal by Subject|2
1681346|NCT01375374|5873322|P1|Overall Study|Adverse Event|1
1681347|NCT01375205|5873331|P2|Overall Study|Withdrawal by Subject|1
1681348|NCT01375205|5873332|P1|Overall Study|Withdrawal by Subject|6
1681349|NCT01375205|5873331|P2|Overall Study|Lost to Follow-up|12
1681350|NCT01375205|5873332|P1|Overall Study|Lost to Follow-up|15
1681351|NCT01375075|5873405|P6|Overall Study|Withdrawal by Subject|1
1681352|NCT01375075|5873406|P5|Overall Study|Withdrawal by Subject|0
1681353|NCT01375075|5873407|P4|Overall Study|Withdrawal by Subject|0
1681354|NCT01375075|5873408|P3|Overall Study|Withdrawal by Subject|0
1681355|NCT01375075|5873409|P2|Overall Study|Withdrawal by Subject|1
1681356|NCT01375075|5873410|P1|Overall Study|Withdrawal by Subject|0
1681357|NCT01375075|5873405|P6|Overall Study|Entry Criterion Not Met|1
1681358|NCT01375075|5873406|P5|Overall Study|Entry Criterion Not Met|0
1681359|NCT01375075|5873407|P4|Overall Study|Entry Criterion Not Met|0
1681360|NCT01375075|5873408|P3|Overall Study|Entry Criterion Not Met|0
1681361|NCT01375075|5873409|P2|Overall Study|Entry Criterion Not Met|0
1681362|NCT01375075|5873410|P1|Overall Study|Entry Criterion Not Met|1
1681363|NCT01375075|5873405|P6|Overall Study|Adverse Event|1
1681364|NCT01375075|5873406|P5|Overall Study|Adverse Event|0
1681365|NCT01375075|5873407|P4|Overall Study|Adverse Event|1
1681366|NCT01375075|5873408|P3|Overall Study|Adverse Event|3
1681367|NCT01375075|5873409|P2|Overall Study|Adverse Event|0
1681368|NCT01375075|5873410|P1|Overall Study|Adverse Event|0
1681369|NCT01375049|5873494|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
1681370|NCT01375049|5873494|P1|Overall Study|Withdrawal by Subject|2
1681371|NCT01375049|5873494|P1|Overall Study|Lost to Follow-up|1
1681372|NCT01375049|5873494|P1|Overall Study|Adverse Event|2
1681373|NCT01375010|5873511|P2|Overall Study|Withdrawal by Subject|2
1681374|NCT01375010|5873512|P1|Overall Study|Withdrawal by Subject|4
1681375|NCT01375010|5873511|P2|Overall Study|Lost to Follow-up|2
1681376|NCT01375010|5873512|P1|Overall Study|Lost to Follow-up|8
1681377|NCT01374971|5873526|P1|Overall Study|Withdrawal by Subject|1
1681378|NCT01374919|5873531|P1|Overall Study|Withdrawal by Subject|2
1681379|NCT01374906|5873538|P2|Overall Study|Unsatisfactory therapeutic effect|19
1681380|NCT01374906|5873539|P1|Overall Study|Unsatisfactory therapeutic effect|11
1681381|NCT01374906|5873538|P2|Overall Study|Withdrawal by Subject|9
1681382|NCT01374906|5873539|P1|Overall Study|Withdrawal by Subject|15
1681383|NCT01374906|5873538|P2|Overall Study|Protocol Violation|2
1681384|NCT01374906|5873539|P1|Overall Study|Protocol Violation|2
1681385|NCT01374906|5873538|P2|Overall Study|Death|2
1681386|NCT01374906|5873539|P1|Overall Study|Death|0
1681387|NCT01374906|5873538|P2|Overall Study|Adverse Event|11
1681388|NCT01374906|5873539|P1|Overall Study|Adverse Event|10
1681389|NCT01374906|5873538|P2|Overall Study|Administrative problems|2
1681390|NCT01374906|5873539|P1|Overall Study|Administrative problems|2
1681391|NCT01374906|5873538|P2|Overall Study|Abnormal laboratory value(s)|3
1681392|NCT01374906|5873539|P1|Overall Study|Abnormal laboratory value(s)|0
1681393|NCT01374568|5873620|P2|Overall Study|Lab unable to analyze BTM|2
1681394|NCT01374568|5873621|P1|Overall Study|Lab unable to analyze BTM|0
1681395|NCT01374516|5873631|P2|Surveillance Expansion Period|Serious adverse event|5
1681396|NCT01374516|5873632|P1|Surveillance Expansion Period|Serious adverse event|20
1681397|NCT01374516|5873631|P2|Surveillance Expansion Period|Lost to Follow-up|45
1681398|NCT01374516|5873632|P1|Surveillance Expansion Period|Lost to Follow-up|73
1681399|NCT01374516|5873631|P2|Surveillance Expansion Period|Withdrawal by Subject|986
1681400|NCT01374516|5873632|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
1681401|NCT01374516|5873631|P2|Surveillance Expansion Period|Protocol Violation|217
1681402|NCT01374516|5873632|P1|Surveillance Expansion Period|Protocol Violation|386
1681403|NCT01374516|5873631|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
1681404|NCT01374516|5873632|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
1681405|NCT01374516|5873631|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
1681406|NCT01374516|5873632|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
1681407|NCT01374516|5873631|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
1681408|NCT01374516|5873632|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
1681409|NCT01374516|5873631|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
1681410|NCT01374516|5873632|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
1681411|NCT01374516|5873631|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
1681412|NCT01374516|5873632|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
1681413|NCT01374451|5873666|P2|Overall Study|Administrative problems|0
1681414|NCT01374451|5873667|P1|Overall Study|Administrative problems|1
1681415|NCT01374425|5873713|P2|Overall Study|Other|43
1681416|NCT01374425|5873714|P1|Overall Study|Other|41
1681417|NCT01374425|5873713|P2|Overall Study|Lost to Follow-up|1
1681418|NCT01374425|5873714|P1|Overall Study|Lost to Follow-up|2
1681419|NCT01374425|5873713|P2|Overall Study|Sponsor Decision|1
1681420|NCT01374425|5873714|P1|Overall Study|Sponsor Decision|0
1681421|NCT01374425|5873713|P2|Overall Study|Protocol Violation|3
1681422|NCT01374425|5873714|P1|Overall Study|Protocol Violation|2
1681423|NCT01374425|5873713|P2|Overall Study|Refused Treatment|24
1681424|NCT01374425|5873714|P1|Overall Study|Refused Treatment|10
1681425|NCT01374425|5873713|P2|Overall Study|Withdrawal by Subject|7
1681426|NCT01374425|5873714|P1|Overall Study|Withdrawal by Subject|6
1681427|NCT01374425|5873713|P2|Overall Study|Death (Adverse Event)|4
1681428|NCT01374425|5873714|P1|Overall Study|Death (Adverse Event)|2
1681429|NCT01374425|5873713|P2|Overall Study|Death (Progression of Disease)|0
1681430|NCT01374425|5873714|P1|Overall Study|Death (Progression of Disease)|1
1681431|NCT01374425|5873713|P2|Overall Study|Adverse Event|18
1681432|NCT01374425|5873714|P1|Overall Study|Adverse Event|29
1681433|NCT01374425|5873713|P2|Overall Study|Clinical Disease Progression|6
1681434|NCT01374425|5873714|P1|Overall Study|Clinical Disease Progression|9
1681435|NCT01374425|5873713|P2|Overall Study|Radiographic Disease Progression|81
1681436|NCT01374425|5873714|P1|Overall Study|Radiographic Disease Progression|86
1681437|NCT01374269|5873794|P2|Overall Study|closed research|2
1681438|NCT01374269|5873795|P1|Overall Study|closed research|1
1681439|NCT01374269|5873794|P2|Overall Study|Lost to Follow-up|3
1681440|NCT01374269|5873795|P1|Overall Study|Lost to Follow-up|1
1681441|NCT01374269|5873794|P2|Overall Study|Withdrawal by Subject|0
1681442|NCT01374269|5873795|P1|Overall Study|Withdrawal by Subject|4
1681443|NCT01374217|5873923|P1|Overall Study|Lack of Efficacy|13
1681444|NCT01374178|5873931|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
1681445|NCT01374178|5873932|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
1681446|NCT01374178|5873931|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
1681447|NCT01374178|5873932|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
1681448|NCT01374087|5873950|P2|Overall Study|Study discontinued|13
1681449|NCT01374087|5873951|P1|Overall Study|Study discontinued|13
1681450|NCT01374087|5873950|P2|Overall Study|Disease progression|2
1681451|NCT01374087|5873951|P1|Overall Study|Disease progression|2
1681452|NCT01374087|5873950|P2|Overall Study|Adverse Event|0
1681453|NCT01374087|5873951|P1|Overall Study|Adverse Event|1
1681454|NCT01373931|5873971|P2|Period 1|Withdrawal by Subject|2
1681455|NCT01373931|5873972|P1|Period 1|Withdrawal by Subject|0
1681456|NCT01373931|5873971|P2|Period 1|Adverse Event|0
1681457|NCT01373931|5873972|P1|Period 1|Adverse Event|2
1681458|NCT01373931|5873971|P2|Lead-in Period|Adverse Event|0
1681459|NCT01373931|5873972|P1|Lead-in Period|Adverse Event|2
1681460|NCT01373918|5873985|P2|Overall Study|Physician Decision|1
1681461|NCT01373918|5873986|P1|Overall Study|Physician Decision|0
1681462|NCT01373346|5874045|P1|Overall Study|Death|1
1681463|NCT01373294|5874068|P2|Overall Study|Adverse Event|0
1681464|NCT01373294|5874069|P1|Overall Study|Adverse Event|1
1681465|NCT01373281|5874078|P2|Surveillance Expansion Period|Serious adverse event|4
1681466|NCT01373281|5874079|P1|Surveillance Expansion Period|Serious adverse event|3
1681467|NCT01373281|5874078|P2|Surveillance Expansion Period|Lost to Follow-up|8
1681468|NCT01373281|5874079|P1|Surveillance Expansion Period|Lost to Follow-up|10
1681469|NCT01373281|5874078|P2|Surveillance Expansion Period|Protocol Violation|1
1681470|NCT01373281|5874079|P1|Surveillance Expansion Period|Protocol Violation|9
1681471|NCT01373281|5874078|P2|Surveillance Expansion Period|Withdrawal by Subject|105
1681472|NCT01373281|5874079|P1|Surveillance Expansion Period|Withdrawal by Subject|180
1681473|NCT01373281|5874078|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
1681474|NCT01373281|5874079|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
1681475|NCT01373281|5874078|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
1681476|NCT01373281|5874079|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
1681477|NCT01373281|5874078|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
1681478|NCT01373281|5874079|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
1681479|NCT01373281|5874078|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
1681480|NCT01373281|5874079|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
1681481|NCT01373229|5874127|P1|Overall Study|Physician Decision|3
1681482|NCT01373229|5874127|P1|Overall Study|Death|3
1681483|NCT01373164|5874141|P5|Overall Study|Withdrawal by Subject|2
1681484|NCT01373164|5874142|P4|Overall Study|Withdrawal by Subject|10
1681485|NCT01373164|5874143|P3|Overall Study|Withdrawal by Subject|0
1681486|NCT01373164|5874144|P2|Overall Study|Withdrawal by Subject|1
1681487|NCT01373164|5874145|P1|Overall Study|Withdrawal by Subject|0
1681488|NCT01373164|5874141|P5|Overall Study|Lost to Follow-up|0
1681489|NCT01373164|5874142|P4|Overall Study|Lost to Follow-up|2
1681490|NCT01373164|5874143|P3|Overall Study|Lost to Follow-up|1
1681491|NCT01373164|5874144|P2|Overall Study|Lost to Follow-up|0
1681492|NCT01373164|5874145|P1|Overall Study|Lost to Follow-up|0
1681493|NCT01372995|5874179|P3|Overall Study|Physician Decision|1
1681494|NCT01372995|5874180|P2|Overall Study|Physician Decision|0
1681495|NCT01372995|5874181|P1|Overall Study|Physician Decision|0
1681496|NCT01372995|5874179|P3|Overall Study|Spouse withdrew participant from study|0
1681497|NCT01372995|5874180|P2|Overall Study|Spouse withdrew participant from study|1
1681498|NCT01372995|5874181|P1|Overall Study|Spouse withdrew participant from study|0
1681499|NCT01372878|5874228|P1|Overall Study|incomplete study procedure|104
1681500|NCT01372878|5874228|P1|Overall Study|Protocol Violation|17
1681501|NCT01372878|5874228|P1|Overall Study|Withdrawal by Subject|63
1681502|NCT01372774|5874248|P2|Overall Study|Withdrawal prior to treatment|5
1681503|NCT01372774|5874249|P1|Overall Study|Withdrawal prior to treatment|4
1681504|NCT01372748|5874265|P2|Overall Study|Withdrawal by Subject|5
1681505|NCT01372748|5874266|P1|Overall Study|Withdrawal by Subject|7
1681506|NCT01372748|5874265|P2|Overall Study|Lost to Follow-up|34
1681507|NCT01372748|5874266|P1|Overall Study|Lost to Follow-up|16
1681508|NCT01372618|5874274|P1|Overall Study|PI Died. Study Terminated|9
1681509|NCT01372605|5874282|P2|Overall Study|Changed medical home|0
1681510|NCT01372605|5874283|P1|Overall Study|Changed medical home|2
1681511|NCT01372605|5874282|P2|Overall Study|Moved|0
1681512|NCT01372605|5874283|P1|Overall Study|Moved|3
1681513|NCT01372605|5874282|P2|Overall Study|Withdrawal by Subject|7
1681514|NCT01372605|5874283|P1|Overall Study|Withdrawal by Subject|4
1681515|NCT01372605|5874282|P2|Overall Study|Lost to Follow-up|1
1681516|NCT01372605|5874283|P1|Overall Study|Lost to Follow-up|2
1681517|NCT01372605|5874282|P2|Overall Study|Death|2
1681518|NCT01372605|5874283|P1|Overall Study|Death|1
1681519|NCT01372501|5874309|P1|Overall Study|Device migration|1
1681520|NCT01372501|5874309|P1|Overall Study|Adverse Event|4
1681521|NCT01372410|5874332|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
1681522|NCT01372410|5874333|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
1681523|NCT01372410|5874334|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
1681524|NCT01372410|5874335|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
1681525|NCT01372410|5874336|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
1681526|NCT01372410|5874337|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
1681527|NCT01372410|5874338|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
1681528|NCT01372410|5874339|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
1681529|NCT01372410|5874332|P8|Treatment Period 3 (7 Days)|Adverse Event|0
1681530|NCT01372410|5874333|P7|Treatment Period 3 (7 Days)|Adverse Event|0
1681531|NCT01372410|5874334|P6|Treatment Period 3 (7 Days)|Adverse Event|0
1681532|NCT01372410|5874335|P5|Treatment Period 3 (7 Days)|Adverse Event|0
1681533|NCT01372410|5874336|P4|Treatment Period 3 (7 Days)|Adverse Event|0
1681534|NCT01372410|5874337|P3|Treatment Period 3 (7 Days)|Adverse Event|1
1681535|NCT01372410|5874338|P2|Treatment Period 3 (7 Days)|Adverse Event|0
1681536|NCT01372410|5874339|P1|Treatment Period 3 (7 Days)|Adverse Event|0
1681537|NCT01372410|5874332|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
1681538|NCT01372410|5874333|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1681539|NCT01372410|5874334|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1681540|NCT01372410|5874335|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1681541|NCT01372410|5874336|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1681542|NCT01372410|5874337|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1681543|NCT01372410|5874338|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1681544|NCT01372410|5874339|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
1681545|NCT01372410|5874332|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1681546|NCT01372410|5874333|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1681547|NCT01372410|5874334|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1681548|NCT01372410|5874335|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
1681549|NCT01372410|5874336|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1681550|NCT01372410|5874337|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1681551|NCT01372410|5874338|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1681552|NCT01372410|5874339|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
1681553|NCT01372410|5874332|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
1681554|NCT01372410|5874333|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
1681555|NCT01372410|5874334|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
1681556|NCT01372410|5874335|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
1681557|NCT01372410|5874336|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
1681558|NCT01372410|5874337|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
1681559|NCT01372410|5874338|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
1681560|NCT01372410|5874339|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
1681561|NCT01372410|5874332|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
1681562|NCT01372410|5874333|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1681563|NCT01372410|5874334|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1681564|NCT01372410|5874335|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1681565|NCT01372410|5874336|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1681566|NCT01372410|5874337|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1681567|NCT01372410|5874338|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
1681568|NCT01372410|5874339|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
1681569|NCT01372410|5874332|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1681570|NCT01372410|5874333|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
1681571|NCT01372410|5874334|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1681572|NCT01372410|5874335|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1681573|NCT01372410|5874336|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1681574|NCT01372410|5874337|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1681575|NCT01372410|5874338|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1681576|NCT01372410|5874339|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
1681577|NCT01372410|5874332|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1681578|NCT01372410|5874333|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1681579|NCT01372410|5874334|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1681580|NCT01372410|5874335|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
1681581|NCT01372410|5874336|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1681582|NCT01372410|5874337|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1681583|NCT01372410|5874338|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1681584|NCT01372410|5874339|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
1681585|NCT01372410|5874332|P8|Treatment Period 1 (7 Days)|Adverse Event|0
1681586|NCT01372410|5874333|P7|Treatment Period 1 (7 Days)|Adverse Event|1
1681587|NCT01372410|5874334|P6|Treatment Period 1 (7 Days)|Adverse Event|0
1681588|NCT01372410|5874335|P5|Treatment Period 1 (7 Days)|Adverse Event|0
1681589|NCT01372410|5874336|P4|Treatment Period 1 (7 Days)|Adverse Event|0
1681590|NCT01372410|5874337|P3|Treatment Period 1 (7 Days)|Adverse Event|0
1681591|NCT01372410|5874338|P2|Treatment Period 1 (7 Days)|Adverse Event|1
1681592|NCT01372410|5874339|P1|Treatment Period 1 (7 Days)|Adverse Event|0
1681593|NCT01372410|5874332|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1681594|NCT01372410|5874333|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1681595|NCT01372410|5874334|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1681596|NCT01372410|5874335|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1681597|NCT01372410|5874336|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1681598|NCT01372410|5874337|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
1681599|NCT01372410|5874338|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1681600|NCT01372410|5874339|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
1681601|NCT01372384|5874376|P1|Overall Study|Progression of disease|3
1681602|NCT01372150|5874408|P3|Overall Study|Randomized but not treated|0
1681603|NCT01372150|5874409|P2|Overall Study|Randomized but not treated|1
1681604|NCT01372150|5874410|P1|Overall Study|Randomized but not treated|0
1681605|NCT01372150|5874408|P3|Overall Study|Adverse Event|2
1681606|NCT01372150|5874409|P2|Overall Study|Adverse Event|1
1681607|NCT01372150|5874410|P1|Overall Study|Adverse Event|2
1681608|NCT01372150|5874408|P3|Overall Study|Other|2
1681609|NCT01372150|5874409|P2|Overall Study|Other|0
1681610|NCT01372150|5874410|P1|Overall Study|Other|1
1681611|NCT01372150|5874408|P3|Overall Study|Withdrawal by Subject|2
1681612|NCT01372150|5874409|P2|Overall Study|Withdrawal by Subject|7
1681613|NCT01372150|5874410|P1|Overall Study|Withdrawal by Subject|2
1681614|NCT01372150|5874408|P3|Overall Study|Protocol Violation|3
1681615|NCT01372150|5874409|P2|Overall Study|Protocol Violation|0
1681616|NCT01372150|5874410|P1|Overall Study|Protocol Violation|1
1681617|NCT01372150|5874408|P3|Overall Study|Lost to Follow-up|6
1681618|NCT01372150|5874409|P2|Overall Study|Lost to Follow-up|5
1681619|NCT01372150|5874410|P1|Overall Study|Lost to Follow-up|4
1681620|NCT01372150|5874408|P3|Overall Study|Lack of Efficacy|1
1681621|NCT01372150|5874409|P2|Overall Study|Lack of Efficacy|0
1681622|NCT01372150|5874410|P1|Overall Study|Lack of Efficacy|3
1681623|NCT01372085|5874437|P10|Washout Period 3|Withdrawal by Subject|0
1681624|NCT01372085|5874438|P9|Washout Period 3|Withdrawal by Subject|0
1681625|NCT01372085|5874439|P8|Washout Period 3|Withdrawal by Subject|0
1681626|NCT01372085|5874440|P7|Washout Period 3|Withdrawal by Subject|0
1681627|NCT01372085|5874441|P6|Washout Period 3|Withdrawal by Subject|2
1681628|NCT01372085|5874442|P5|Washout Period 3|Withdrawal by Subject|0
1681629|NCT01372085|5874443|P4|Washout Period 3|Withdrawal by Subject|0
1681630|NCT01372085|5874444|P3|Washout Period 3|Withdrawal by Subject|0
1681631|NCT01372085|5874445|P2|Washout Period 3|Withdrawal by Subject|0
1681632|NCT01372085|5874446|P1|Washout Period 3|Withdrawal by Subject|0
1681633|NCT01372085|5874437|P10|Washout Period 2|Physician Decision|0
1681634|NCT01372085|5874438|P9|Washout Period 2|Physician Decision|0
1681635|NCT01372085|5874439|P8|Washout Period 2|Physician Decision|0
1681636|NCT01372085|5874440|P7|Washout Period 2|Physician Decision|0
1681637|NCT01372085|5874441|P6|Washout Period 2|Physician Decision|0
1681638|NCT01372085|5874442|P5|Washout Period 2|Physician Decision|1
1681639|NCT01372085|5874443|P4|Washout Period 2|Physician Decision|0
1681640|NCT01372085|5874444|P3|Washout Period 2|Physician Decision|0
1681641|NCT01372085|5874445|P2|Washout Period 2|Physician Decision|0
1681642|NCT01372085|5874446|P1|Washout Period 2|Physician Decision|0
1681643|NCT01371994|5874478|P2|Overall Study|Miscellaneous Reasons|4
1681644|NCT01371994|5874479|P1|Overall Study|Miscellaneous Reasons|6
1681645|NCT01371994|5874478|P2|Overall Study|Physician Decision|1
1681646|NCT01371994|5874479|P1|Overall Study|Physician Decision|1
1681647|NCT01371994|5874478|P2|Overall Study|Randomized but Never Received Study Drug|6
1681648|NCT01371994|5874479|P1|Overall Study|Randomized but Never Received Study Drug|6
1681649|NCT01371994|5874478|P2|Overall Study|Protocol Violation|17
1681650|NCT01371994|5874479|P1|Overall Study|Protocol Violation|24
1681651|NCT01371994|5874478|P2|Overall Study|Lost to Follow-up|1
1681652|NCT01371994|5874479|P1|Overall Study|Lost to Follow-up|1
1681653|NCT01371994|5874478|P2|Overall Study|Withdrawal by Subject|7
1681654|NCT01371994|5874479|P1|Overall Study|Withdrawal by Subject|13
1681655|NCT01371994|5874478|P2|Overall Study|Lack of Efficacy|0
1681656|NCT01371994|5874479|P1|Overall Study|Lack of Efficacy|3
1681657|NCT01371994|5874478|P2|Overall Study|Adverse Event|6
1681658|NCT01371994|5874479|P1|Overall Study|Adverse Event|3
1681659|NCT01371877|5874523|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
1681660|NCT01371877|5874524|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
1681661|NCT01371851|5874536|P2|Overall Study|Blood Pressure outside study parameters|0
1681662|NCT01371851|5874537|P1|Overall Study|Blood Pressure outside study parameters|2
1681663|NCT01371851|5874536|P2|Overall Study|non study related adverse event|0
1681664|NCT01371851|5874537|P1|Overall Study|non study related adverse event|1
1681665|NCT01371851|5874536|P2|Overall Study|was arrested and put in jail|1
1681666|NCT01371851|5874537|P1|Overall Study|was arrested and put in jail|0
1681667|NCT01371851|5874536|P2|Overall Study|Lost to Follow-up|8
1681668|NCT01371851|5874537|P1|Overall Study|Lost to Follow-up|5
1681669|NCT01371838|5874545|P2|Overall Study|Surgery|0
1681670|NCT01371838|5874546|P1|Overall Study|Surgery|1
1681671|NCT01371838|5874545|P2|Overall Study|Lack of therapeutic response|1
1681672|NCT01371838|5874546|P1|Overall Study|Lack of therapeutic response|0
1681673|NCT01371838|5874545|P2|Overall Study|Last follow-up visit not conducted|0
1681674|NCT01371838|5874546|P1|Overall Study|Last follow-up visit not conducted|2
1681675|NCT01371838|5874545|P2|Overall Study|Investigator Decision|8
1681676|NCT01371838|5874546|P1|Overall Study|Investigator Decision|3
1681677|NCT01371838|5874545|P2|Overall Study|Protocol Violation|0
1681678|NCT01371838|5874546|P1|Overall Study|Protocol Violation|3
1681679|NCT01371838|5874545|P2|Overall Study|Death|4
1681680|NCT01371838|5874546|P1|Overall Study|Death|3
1681681|NCT01371838|5874545|P2|Overall Study|Lost to Follow-up|20
1681682|NCT01371838|5874546|P1|Overall Study|Lost to Follow-up|10
1681683|NCT01371838|5874545|P2|Overall Study|Withdrawal by Subject|33
1681684|NCT01371838|5874546|P1|Overall Study|Withdrawal by Subject|27
1681685|NCT01371825|5874582|P1|Overall Study|Death|4
1681686|NCT01371747|5874616|P6|Overall Study|Other Reasons|1
1681687|NCT01371747|5874617|P5|Overall Study|Other Reasons|0
1681688|NCT01371747|5874618|P4|Overall Study|Other Reasons|0
1681689|NCT01371747|5874619|P3|Overall Study|Other Reasons|2
1681690|NCT01371747|5874620|P2|Overall Study|Other Reasons|1
1681691|NCT01371747|5874621|P1|Overall Study|Other Reasons|2
1681692|NCT01371747|5874616|P6|Overall Study|Withdrawal by Subject|4
1681693|NCT01371747|5874617|P5|Overall Study|Withdrawal by Subject|2
1681694|NCT01371747|5874618|P4|Overall Study|Withdrawal by Subject|2
1681695|NCT01371747|5874619|P3|Overall Study|Withdrawal by Subject|5
1681696|NCT01371747|5874620|P2|Overall Study|Withdrawal by Subject|12
1681697|NCT01371747|5874621|P1|Overall Study|Withdrawal by Subject|6
1681698|NCT01371747|5874616|P6|Overall Study|Physician Decision|0
1681699|NCT01371747|5874617|P5|Overall Study|Physician Decision|1
1681700|NCT01371747|5874618|P4|Overall Study|Physician Decision|0
1681701|NCT01371747|5874619|P3|Overall Study|Physician Decision|0
1681702|NCT01371747|5874620|P2|Overall Study|Physician Decision|0
1681703|NCT01371747|5874621|P1|Overall Study|Physician Decision|0
1681704|NCT01371747|5874616|P6|Overall Study|Non-Compliance|1
1681705|NCT01371747|5874617|P5|Overall Study|Non-Compliance|0
1681706|NCT01371747|5874618|P4|Overall Study|Non-Compliance|0
1681707|NCT01371747|5874619|P3|Overall Study|Non-Compliance|3
1681708|NCT01371747|5874620|P2|Overall Study|Non-Compliance|4
1681709|NCT01371747|5874621|P1|Overall Study|Non-Compliance|3
1681710|NCT01371747|5874616|P6|Overall Study|Protocol Violation|0
1681711|NCT01371747|5874617|P5|Overall Study|Protocol Violation|0
1681712|NCT01371747|5874618|P4|Overall Study|Protocol Violation|0
1681713|NCT01371747|5874619|P3|Overall Study|Protocol Violation|1
1681714|NCT01371747|5874620|P2|Overall Study|Protocol Violation|0
1681715|NCT01371747|5874621|P1|Overall Study|Protocol Violation|0
1681716|NCT01371747|5874616|P6|Overall Study|Low Serum Potassium Results|3
1681717|NCT01371747|5874617|P5|Overall Study|Low Serum Potassium Results|0
1681718|NCT01371747|5874618|P4|Overall Study|Low Serum Potassium Results|1
1681719|NCT01371747|5874619|P3|Overall Study|Low Serum Potassium Results|1
1681720|NCT01371747|5874620|P2|Overall Study|Low Serum Potassium Results|1
1681721|NCT01371747|5874621|P1|Overall Study|Low Serum Potassium Results|1
1681722|NCT01371747|5874616|P6|Overall Study|High Serum Potassium Results|2
1681723|NCT01371747|5874617|P5|Overall Study|High Serum Potassium Results|0
1681724|NCT01371747|5874618|P4|Overall Study|High Serum Potassium Results|2
1681725|NCT01371747|5874619|P3|Overall Study|High Serum Potassium Results|1
1681726|NCT01371747|5874620|P2|Overall Study|High Serum Potassium Results|1
1681727|NCT01371747|5874621|P1|Overall Study|High Serum Potassium Results|1
1681728|NCT01371747|5874616|P6|Overall Study|Abnormal Renal Function|1
1681729|NCT01371747|5874617|P5|Overall Study|Abnormal Renal Function|0
1681730|NCT01371747|5874618|P4|Overall Study|Abnormal Renal Function|1
1681731|NCT01371747|5874619|P3|Overall Study|Abnormal Renal Function|0
1681732|NCT01371747|5874620|P2|Overall Study|Abnormal Renal Function|2
1681733|NCT01371747|5874621|P1|Overall Study|Abnormal Renal Function|0
1681734|NCT01371747|5874616|P6|Overall Study|Death|0
1681735|NCT01371747|5874617|P5|Overall Study|Death|2
1681736|NCT01371747|5874618|P4|Overall Study|Death|1
1681737|NCT01371747|5874619|P3|Overall Study|Death|4
1681738|NCT01371747|5874620|P2|Overall Study|Death|0
1681739|NCT01371747|5874621|P1|Overall Study|Death|1
1681740|NCT01371747|5874616|P6|Overall Study|Adverse Event|2
1681741|NCT01371747|5874617|P5|Overall Study|Adverse Event|2
1681742|NCT01371747|5874618|P4|Overall Study|Adverse Event|2
1681743|NCT01371747|5874619|P3|Overall Study|Adverse Event|7
1681744|NCT01371747|5874620|P2|Overall Study|Adverse Event|2
1681745|NCT01371747|5874621|P1|Overall Study|Adverse Event|4
1681746|NCT01371734|5874686|P3|Overall Study|Lack of Efficacy|0
1681747|NCT01371734|5874687|P2|Overall Study|Lack of Efficacy|2
1681748|NCT01371734|5874688|P1|Overall Study|Lack of Efficacy|2
1681749|NCT01371734|5874686|P3|Overall Study|Adverse Event|3
1681750|NCT01371734|5874687|P2|Overall Study|Adverse Event|8
1681751|NCT01371734|5874688|P1|Overall Study|Adverse Event|8
1681752|NCT01371734|5874686|P3|Overall Study|Protocol Violation|2
1681753|NCT01371734|5874687|P2|Overall Study|Protocol Violation|1
1681754|NCT01371734|5874688|P1|Overall Study|Protocol Violation|3
1681755|NCT01371734|5874686|P3|Overall Study|Lost to Follow-up|1
1681756|NCT01371734|5874687|P2|Overall Study|Lost to Follow-up|3
1681757|NCT01371734|5874688|P1|Overall Study|Lost to Follow-up|5
1681758|NCT01371734|5874686|P3|Overall Study|Withdrawal by Subject|9
1681759|NCT01371734|5874687|P2|Overall Study|Withdrawal by Subject|4
1681760|NCT01371734|5874688|P1|Overall Study|Withdrawal by Subject|3
1681761|NCT01371734|5874686|P3|Overall Study|Other|2
1681762|NCT01371734|5874687|P2|Overall Study|Other|1
1681763|NCT01371734|5874688|P1|Overall Study|Other|2
1681764|NCT01371721|5874708|P3|Overall Study|Randomized but not treated|0
1681765|NCT01371721|5874709|P2|Overall Study|Randomized but not treated|0
1681766|NCT01371721|5874710|P1|Overall Study|Randomized but not treated|1
1681767|NCT01371721|5874708|P3|Overall Study|Lack of Efficacy|3
1681768|NCT01371721|5874709|P2|Overall Study|Lack of Efficacy|4
1681769|NCT01371721|5874710|P1|Overall Study|Lack of Efficacy|2
1681770|NCT01371721|5874708|P3|Overall Study|Other|0
1681771|NCT01371721|5874709|P2|Overall Study|Other|3
1681772|NCT01371721|5874710|P1|Overall Study|Other|2
1681773|NCT01371721|5874708|P3|Overall Study|Withdrawal by Subject|11
1681774|NCT01371721|5874709|P2|Overall Study|Withdrawal by Subject|7
1681775|NCT01371721|5874710|P1|Overall Study|Withdrawal by Subject|5
1681776|NCT01371721|5874708|P3|Overall Study|Lost to Follow-up|6
1681777|NCT01371721|5874709|P2|Overall Study|Lost to Follow-up|2
1681778|NCT01371721|5874710|P1|Overall Study|Lost to Follow-up|8
1681779|NCT01371721|5874708|P3|Overall Study|Protocol Violation|5
1681780|NCT01371721|5874709|P2|Overall Study|Protocol Violation|4
1681781|NCT01371721|5874710|P1|Overall Study|Protocol Violation|6
1681782|NCT01371721|5874708|P3|Overall Study|Adverse Event|5
1681783|NCT01371721|5874709|P2|Overall Study|Adverse Event|4
1681784|NCT01371721|5874710|P1|Overall Study|Adverse Event|5
1681785|NCT01371708|5874743|P3|Overall Study|Started but did not receive treatment|1
1681786|NCT01371708|5874744|P2|Overall Study|Started but did not receive treatment|0
1681787|NCT01371708|5874745|P1|Overall Study|Started but did not receive treatment|1
1681788|NCT01371708|5874743|P3|Overall Study|Adverse Event|12
1681789|NCT01371708|5874744|P2|Overall Study|Adverse Event|8
1681790|NCT01371708|5874745|P1|Overall Study|Adverse Event|5
1681791|NCT01371708|5874743|P3|Overall Study|Other|4
1681792|NCT01371708|5874744|P2|Overall Study|Other|2
1681793|NCT01371708|5874745|P1|Overall Study|Other|3
1681794|NCT01371708|5874743|P3|Overall Study|Medication error/not related to AE|0
1681795|NCT01371708|5874744|P2|Overall Study|Medication error/not related to AE|1
1681796|NCT01371708|5874745|P1|Overall Study|Medication error/not related to AE|0
1681797|NCT01371708|5874743|P3|Overall Study|No longer willing to participate|13
1681798|NCT01371708|5874744|P2|Overall Study|No longer willing to participate|7
1681799|NCT01371708|5874745|P1|Overall Study|No longer willing to participate|7
1681800|NCT01371708|5874743|P3|Overall Study|Protocol Violation|2
1681801|NCT01371708|5874744|P2|Overall Study|Protocol Violation|1
1681802|NCT01371708|5874745|P1|Overall Study|Protocol Violation|2
1681803|NCT01371708|5874743|P3|Overall Study|Lost to Follow-up|7
1681804|NCT01371708|5874744|P2|Overall Study|Lost to Follow-up|9
1681805|NCT01371708|5874745|P1|Overall Study|Lost to Follow-up|5
1681806|NCT01371708|5874743|P3|Overall Study|Insufficient clinical response|0
1681807|NCT01371708|5874744|P2|Overall Study|Insufficient clinical response|2
1681808|NCT01371708|5874745|P1|Overall Study|Insufficient clinical response|3
1681809|NCT01371656|5874777|P2|Overall Study|Ineligible|3
1681810|NCT01371656|5874778|P1|Overall Study|Ineligible|4
1681811|NCT01371656|5874777|P2|Overall Study|Withdrawal by Subject|0
1681812|NCT01371656|5874778|P1|Overall Study|Withdrawal by Subject|7
1681813|NCT01371656|5874777|P2|Overall Study|Physician Decision|7
1681814|NCT01371656|5874778|P1|Overall Study|Physician Decision|46
1681815|NCT01371656|5874777|P2|Overall Study|Death|4
1681816|NCT01371656|5874778|P1|Overall Study|Death|7
1681817|NCT01371643|5874798|P2|Overall Study|Withdrawal by Subject|0
1681818|NCT01371643|5874799|P1|Overall Study|Withdrawal by Subject|3
1681819|NCT01371565|5874809|P1|Overall Study|Resection of neuroendocrine tumor|1
1681820|NCT01371565|5874809|P1|Overall Study|Death|1
1681821|NCT01371565|5874809|P1|Overall Study|Withdrawal by Subject|1
1681822|NCT01371552|5874813|P6|Part 1, First 3 Days|Inconvenience|0
1681823|NCT01371552|5874814|P5|Part 1, First 3 Days|Inconvenience|0
1681824|NCT01371552|5874815|P4|Part 1, First 3 Days|Inconvenience|0
1681825|NCT01371552|5874816|P3|Part 1, First 3 Days|Inconvenience|1
1681826|NCT01371552|5874817|P2|Part 1, First 3 Days|Inconvenience|0
1681827|NCT01371552|5874818|P1|Part 1, First 3 Days|Inconvenience|0
1681828|NCT01371539|5874845|P2|Period Two: One Week|Time/job conflict|1
1681829|NCT01371539|5874846|P1|Period Two: One Week|Time/job conflict|0
1681830|NCT01371539|5874845|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
1681831|NCT01371539|5874846|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
1681832|NCT01371539|5874845|P2|Period Two: One Week|Lost to Follow-up|1
1681833|NCT01371539|5874846|P1|Period Two: One Week|Lost to Follow-up|0
1681834|NCT01371539|5874845|P2|Period One: One Week|Lost to Follow-up|1
1681835|NCT01371539|5874846|P1|Period One: One Week|Lost to Follow-up|0
1681836|NCT01371006|5874867|P2|Overall Study|Adverse Event|0
1681837|NCT01371006|5874868|P1|Overall Study|Adverse Event|1
1681838|NCT01370863|5874909|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1681839|NCT01370863|5874910|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
1681840|NCT01370863|5874909|P2|Overall Study|Did not want second pH/MII monitoring|1
1681841|NCT01370863|5874910|P1|Overall Study|Did not want second pH/MII monitoring|1
1681842|NCT01370863|5874909|P2|Overall Study|Adverse Event|1
1681843|NCT01370863|5874910|P1|Overall Study|Adverse Event|1
1681844|NCT01370733|5874935|P2|Overall Study|Protocol Violation|3
1681845|NCT01370733|5874936|P1|Overall Study|Protocol Violation|1
1681846|NCT01370733|5874935|P2|Overall Study|Physician Decision|2
1681847|NCT01370733|5874936|P1|Overall Study|Physician Decision|0
1681848|NCT01370733|5874935|P2|Overall Study|Lack of Efficacy|5
1681849|NCT01370733|5874936|P1|Overall Study|Lack of Efficacy|3
1681850|NCT01370733|5874935|P2|Overall Study|Adverse Event|4
1681851|NCT01370733|5874936|P1|Overall Study|Adverse Event|2
1681852|NCT01370733|5874935|P2|Overall Study|Lost to Follow-up|0
1681853|NCT01370733|5874936|P1|Overall Study|Lost to Follow-up|3
1681854|NCT01370733|5874935|P2|Overall Study|Withdrawal by Subject|8
1681855|NCT01370733|5874936|P1|Overall Study|Withdrawal by Subject|8
1681856|NCT01370694|5874958|P1|Overall Study|Progressive disease|2
1681857|NCT01370694|5874958|P1|Overall Study|Switched to rituximab|4
1681858|NCT01370655|5874980|P12|Period 2|Withdrawal by Subject|0
1681859|NCT01370655|5874981|P11|Period 2|Withdrawal by Subject|0
1681860|NCT01370655|5874982|P10|Period 2|Withdrawal by Subject|0
1681861|NCT01370655|5874983|P9|Period 2|Withdrawal by Subject|1
1681862|NCT01370655|5874984|P8|Period 2|Withdrawal by Subject|0
1681863|NCT01370655|5874985|P7|Period 2|Withdrawal by Subject|0
1681864|NCT01370655|5874986|P6|Period 2|Withdrawal by Subject|0
1681865|NCT01370655|5874987|P5|Period 2|Withdrawal by Subject|0
1681866|NCT01370655|5874988|P4|Period 2|Withdrawal by Subject|0
1681867|NCT01370655|5874989|P3|Period 2|Withdrawal by Subject|0
1681868|NCT01370655|5874990|P2|Period 2|Withdrawal by Subject|0
1681869|NCT01370655|5874991|P1|Period 2|Withdrawal by Subject|0
1681870|NCT01370655|5874980|P12|Period 2|met protocol specified stopping criteria|0
1681871|NCT01370655|5874981|P11|Period 2|met protocol specified stopping criteria|1
1681872|NCT01370655|5874982|P10|Period 2|met protocol specified stopping criteria|0
1681873|NCT01370655|5874983|P9|Period 2|met protocol specified stopping criteria|1
1681874|NCT01370655|5874984|P8|Period 2|met protocol specified stopping criteria|0
1681875|NCT01370655|5874985|P7|Period 2|met protocol specified stopping criteria|1
1681876|NCT01370655|5874986|P6|Period 2|met protocol specified stopping criteria|0
1681877|NCT01370655|5874987|P5|Period 2|met protocol specified stopping criteria|0
1681878|NCT01370655|5874988|P4|Period 2|met protocol specified stopping criteria|0
1681879|NCT01370655|5874989|P3|Period 2|met protocol specified stopping criteria|1
1681880|NCT01370655|5874990|P2|Period 2|met protocol specified stopping criteria|0
1681881|NCT01370655|5874991|P1|Period 2|met protocol specified stopping criteria|0
1681882|NCT01370655|5874980|P12|Period 2|Adverse Event|0
1681883|NCT01370655|5874981|P11|Period 2|Adverse Event|0
1681884|NCT01370655|5874982|P10|Period 2|Adverse Event|0
1681885|NCT01370655|5874983|P9|Period 2|Adverse Event|0
1681886|NCT01370655|5874984|P8|Period 2|Adverse Event|1
1681887|NCT01370655|5874985|P7|Period 2|Adverse Event|0
1681888|NCT01370655|5874986|P6|Period 2|Adverse Event|0
1681889|NCT01370655|5874987|P5|Period 2|Adverse Event|1
1681890|NCT01370655|5874988|P4|Period 2|Adverse Event|0
1681891|NCT01370655|5874989|P3|Period 2|Adverse Event|1
1681892|NCT01370655|5874990|P2|Period 2|Adverse Event|0
1681893|NCT01370655|5874991|P1|Period 2|Adverse Event|0
1681894|NCT01370655|5874980|P12|Period 1|Adverse Event|0
1681895|NCT01370655|5874981|P11|Period 1|Adverse Event|0
1681896|NCT01370655|5874982|P10|Period 1|Adverse Event|0
1681897|NCT01370655|5874983|P9|Period 1|Adverse Event|0
1681898|NCT01370655|5874984|P8|Period 1|Adverse Event|0
1681899|NCT01370655|5874985|P7|Period 1|Adverse Event|1
1681900|NCT01370655|5874986|P6|Period 1|Adverse Event|0
1681901|NCT01370655|5874987|P5|Period 1|Adverse Event|0
1681902|NCT01370655|5874988|P4|Period 1|Adverse Event|0
1681903|NCT01370655|5874989|P3|Period 1|Adverse Event|0
1681904|NCT01370655|5874990|P2|Period 1|Adverse Event|0
1681905|NCT01370655|5874991|P1|Period 1|Adverse Event|2
1681906|NCT01370642|5875028|P3|Overall Study|Withdrawal by Subject|3
1681907|NCT01370642|5875029|P2|Overall Study|Withdrawal by Subject|4
1681908|NCT01370642|5875030|P1|Overall Study|Withdrawal by Subject|2
1681909|NCT01370642|5875028|P3|Overall Study|Physician Decision|2
1681910|NCT01370642|5875029|P2|Overall Study|Physician Decision|1
1681911|NCT01370642|5875030|P1|Overall Study|Physician Decision|4
1681912|NCT01370642|5875028|P3|Overall Study|Lost to Follow-up|1
1681913|NCT01370642|5875029|P2|Overall Study|Lost to Follow-up|0
1681914|NCT01370642|5875030|P1|Overall Study|Lost to Follow-up|0
1681915|NCT01370642|5875028|P3|Overall Study|Detectable HCV RNA|22
1681916|NCT01370642|5875029|P2|Overall Study|Detectable HCV RNA|0
1681917|NCT01370642|5875030|P1|Overall Study|Detectable HCV RNA|0
1681918|NCT01370642|5875028|P3|Overall Study|Adverse Event|1
1681919|NCT01370642|5875029|P2|Overall Study|Adverse Event|1
1681920|NCT01370642|5875030|P1|Overall Study|Adverse Event|2
1681921|NCT01370616|5875069|P2|Overall Study|Withdrawal by Subject|34
1681922|NCT01370616|5875070|P1|Overall Study|Withdrawal by Subject|34
1681923|NCT01370616|5875069|P2|Overall Study|Technical Problems|5
1681924|NCT01370616|5875070|P1|Overall Study|Technical Problems|3
1681925|NCT01370616|5875069|P2|Overall Study|Recovery|0
1681926|NCT01370616|5875070|P1|Overall Study|Recovery|1
1681927|NCT01370616|5875069|P2|Overall Study|Progressive Disease|1
1681928|NCT01370616|5875070|P1|Overall Study|Progressive Disease|0
1681929|NCT01370616|5875069|P2|Overall Study|Physician Decision|6
1681930|NCT01370616|5875070|P1|Overall Study|Physician Decision|6
1681931|NCT01370616|5875069|P2|Overall Study|Lost to Follow-up|3
1681932|NCT01370616|5875070|P1|Overall Study|Lost to Follow-up|0
1681933|NCT01370616|5875069|P2|Overall Study|Lack of Efficacy|2
1681934|NCT01370616|5875070|P1|Overall Study|Lack of Efficacy|6
1681935|NCT01370616|5875069|P2|Overall Study|Death|0
1681936|NCT01370616|5875070|P1|Overall Study|Death|1
1681937|NCT01370616|5875069|P2|Overall Study|Adverse Event|16
1681938|NCT01370616|5875070|P1|Overall Study|Adverse Event|11
1681939|NCT01370603|5875094|P2|Period 2|Withdrawal by Subject|0
1681940|NCT01370603|5875095|P1|Period 2|Withdrawal by Subject|1
1681941|NCT01370603|5875094|P2|Period 2|Lost to Follow-up|0
1681942|NCT01370603|5875095|P1|Period 2|Lost to Follow-up|1
1681943|NCT01370603|5875094|P2|Period 2|Adverse Event|4
1681944|NCT01370603|5875095|P1|Period 2|Adverse Event|1
1681945|NCT01370603|5875094|P2|Crossover Washout|Non-compliance with Study Drug|2
1681946|NCT01370603|5875095|P1|Crossover Washout|Non-compliance with Study Drug|0
1681947|NCT01370603|5875094|P2|Crossover Washout|Withdrawal by Subject|1
1681948|NCT01370603|5875095|P1|Crossover Washout|Withdrawal by Subject|4
1681949|NCT01370603|5875094|P2|Crossover Washout|Protocol Violation|0
1681950|NCT01370603|5875095|P1|Crossover Washout|Protocol Violation|1
1681951|NCT01370603|5875094|P2|Crossover Washout|Lost to Follow-up|0
1681952|NCT01370603|5875095|P1|Crossover Washout|Lost to Follow-up|2
1681953|NCT01370603|5875094|P2|Crossover Washout|Adverse Event|1
1681954|NCT01370603|5875095|P1|Crossover Washout|Adverse Event|2
1681955|NCT01370603|5875094|P2|Period 1|Withdrawal by Subject|5
1681956|NCT01370603|5875095|P1|Period 1|Withdrawal by Subject|5
1681957|NCT01370603|5875094|P2|Period 1|Protocol Violation|2
1681958|NCT01370603|5875095|P1|Period 1|Protocol Violation|2
1681959|NCT01370603|5875094|P2|Period 1|Lost to Follow-up|0
1681960|NCT01370603|5875095|P1|Period 1|Lost to Follow-up|2
1681961|NCT01370603|5875094|P2|Period 1|Adverse Event|3
1681962|NCT01370603|5875095|P1|Period 1|Adverse Event|5
1681963|NCT01370590|5875113|P2|Period 2|Withdrawal by Subject|1
1681964|NCT01370590|5875114|P1|Period 2|Withdrawal by Subject|1
1681965|NCT01370590|5875113|P2|Period 2|Adverse Event|1
1681966|NCT01370590|5875114|P1|Period 2|Adverse Event|0
1681967|NCT01370590|5875113|P2|Crossover Washout Period|Withdrawal by Subject|2
1681968|NCT01370590|5875114|P1|Crossover Washout Period|Withdrawal by Subject|2
1681969|NCT01370590|5875113|P2|Crossover Washout Period|Non-compliance with Study Drug|0
1681970|NCT01370590|5875114|P1|Crossover Washout Period|Non-compliance with Study Drug|1
1681971|NCT01370590|5875113|P2|Crossover Washout Period|Lost to Follow-up|0
1681972|NCT01370590|5875114|P1|Crossover Washout Period|Lost to Follow-up|2
1681973|NCT01370590|5875113|P2|Crossover Washout Period|Adverse Event|4
1681974|NCT01370590|5875114|P1|Crossover Washout Period|Adverse Event|1
1681975|NCT01370590|5875113|P2|Period 1|Could not access randomization system|1
1681976|NCT01370590|5875114|P1|Period 1|Could not access randomization system|0
1681977|NCT01370590|5875113|P2|Period 1|Withdrawal by Subject|2
1681978|NCT01370590|5875114|P1|Period 1|Withdrawal by Subject|4
1681979|NCT01370590|5875113|P2|Period 1|Protocol Violation|2
1681980|NCT01370590|5875114|P1|Period 1|Protocol Violation|2
1681981|NCT01370590|5875113|P2|Period 1|Lost to Follow-up|2
1681982|NCT01370590|5875114|P1|Period 1|Lost to Follow-up|2
1681983|NCT01370590|5875113|P2|Period 1|Adverse Event|4
1681984|NCT01370590|5875114|P1|Period 1|Adverse Event|8
1681985|NCT01370538|5875142|P2|Overall Study|Lost to follow up|10
1681986|NCT01370538|5875143|P1|Overall Study|Lost to follow up|6
1681987|NCT01370538|5875142|P2|Overall Study|Development of study specific withdrawal|1
1681988|NCT01370538|5875143|P1|Overall Study|Development of study specific withdrawal|1
1681989|NCT01370538|5875142|P2|Overall Study|Protocol Violation|5
1681990|NCT01370538|5875143|P1|Overall Study|Protocol Violation|8
1681991|NCT01370538|5875142|P2|Overall Study|Adverse Event|0
1681992|NCT01370538|5875143|P1|Overall Study|Adverse Event|1
1681993|NCT01370538|5875142|P2|Overall Study|Eligibility criteria not fulfilled|1
1681994|NCT01370538|5875143|P1|Overall Study|Eligibility criteria not fulfilled|0
1681995|NCT01370538|5875142|P2|Overall Study|Voluntary Discontinuation by Subject|2
1681996|NCT01370538|5875143|P1|Overall Study|Voluntary Discontinuation by Subject|3
1681997|NCT01370525|5875159|P2|Overall Study|Lost to follow up|6
1681998|NCT01370525|5875160|P1|Overall Study|Lost to follow up|2
1681999|NCT01370525|5875159|P2|Overall Study|Protocol Violation|1
1682000|NCT01370525|5875160|P1|Overall Study|Protocol Violation|2
1682001|NCT01370525|5875159|P2|Overall Study|Adverse Event|1
1682002|NCT01370525|5875160|P1|Overall Study|Adverse Event|0
1682003|NCT01370525|5875159|P2|Overall Study|Eligibility criteria not fulfilled|0
1682004|NCT01370525|5875160|P1|Overall Study|Eligibility criteria not fulfilled|2
1682005|NCT01370525|5875159|P2|Overall Study|Voluntary Discontinuation by Subject|3
1682006|NCT01370525|5875160|P1|Overall Study|Voluntary Discontinuation by Subject|2
1682007|NCT01370499|5875176|P2|Overall Study|Sponsor Decision|15
1682008|NCT01370499|5875177|P1|Overall Study|Sponsor Decision|41
1682009|NCT01370499|5875176|P2|Overall Study|Withdrawal by Subject|7
1682010|NCT01370499|5875177|P1|Overall Study|Withdrawal by Subject|18
1682011|NCT01370499|5875176|P2|Overall Study|Protocol Violation|4
1682012|NCT01370499|5875177|P1|Overall Study|Protocol Violation|5
1682013|NCT01370499|5875176|P2|Overall Study|Physician Decision|3
1682014|NCT01370499|5875177|P1|Overall Study|Physician Decision|3
1682015|NCT01370499|5875176|P2|Overall Study|Lost to Follow-up|1
1682016|NCT01370499|5875177|P1|Overall Study|Lost to Follow-up|2
1682017|NCT01370499|5875176|P2|Overall Study|Lack of Efficacy|2
1682018|NCT01370499|5875177|P1|Overall Study|Lack of Efficacy|4
1682019|NCT01370499|5875176|P2|Overall Study|Adverse Event|12
1682020|NCT01370499|5875177|P1|Overall Study|Adverse Event|38
1682021|NCT01370408|5875219|P1|Overall Study|treatment failure|9
1682022|NCT01370356|5875279|P2|Overall Study|AE Not Related to Study Drug|4
1682023|NCT01370356|5875280|P1|Overall Study|AE Not Related to Study Drug|1
1682024|NCT01370356|5875279|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
1682025|NCT01370356|5875280|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
1682026|NCT01370356|5875279|P2|Overall Study|Protocol Violation|3
1682027|NCT01370356|5875280|P1|Overall Study|Protocol Violation|3
1682028|NCT01370356|5875279|P2|Overall Study|Reason not specified|43
1682029|NCT01370356|5875280|P1|Overall Study|Reason not specified|39
1682030|NCT01370356|5875279|P2|Overall Study|Withdrawal by Subject|59
1682031|NCT01370356|5875280|P1|Overall Study|Withdrawal by Subject|54
1682032|NCT01370356|5875279|P2|Overall Study|Lost to Follow-up|81
1682033|NCT01370356|5875280|P1|Overall Study|Lost to Follow-up|76
1682034|NCT01370356|5875279|P2|Overall Study|Lack of Efficacy|28
1682035|NCT01370356|5875280|P1|Overall Study|Lack of Efficacy|6
1682036|NCT01370356|5875279|P2|Overall Study|Death|0
1682037|NCT01370356|5875280|P1|Overall Study|Death|1
1682038|NCT01370317|5875296|P2|Overall Study|Protocol deviation|1
1682039|NCT01370317|5875297|P1|Overall Study|Protocol deviation|0
1682040|NCT01370317|5875296|P2|Overall Study|Participant withdrew consent|0
1682041|NCT01370317|5875297|P1|Overall Study|Participant withdrew consent|1
1682042|NCT01370265|5875308|P2|First Intervention|Adverse Event|1
1682043|NCT01370265|5875309|P1|First Intervention|Adverse Event|1
1682044|NCT01370213|5875329|P3|Overall Study|Not evaluable|0
1682045|NCT01370213|5875330|P2|Overall Study|Not evaluable|2
1682046|NCT01370213|5875331|P1|Overall Study|Not evaluable|0
1682047|NCT01370213|5875329|P3|Overall Study|Early Death|0
1682048|NCT01370213|5875330|P2|Overall Study|Early Death|0
1682049|NCT01370213|5875331|P1|Overall Study|Early Death|1
1682050|NCT01370083|5875351|P2|Overall Study|Adverse Event|1
1682051|NCT01370083|5875352|P1|Overall Study|Adverse Event|0
1682052|NCT01370083|5875351|P2|Overall Study|Lost to Follow-up|0
1682053|NCT01370083|5875352|P1|Overall Study|Lost to Follow-up|2
1682054|NCT01370005|5875365|P3|Overall Study|Other reason not defined above|2
1682055|NCT01370005|5875366|P2|Overall Study|Other reason not defined above|0
1682056|NCT01370005|5875367|P1|Overall Study|Other reason not defined above|3
1682057|NCT01370005|5875365|P3|Overall Study|Patient refusal to continue,not due toAE|0
1682058|NCT01370005|5875366|P2|Overall Study|Patient refusal to continue,not due toAE|4
1682059|NCT01370005|5875367|P1|Overall Study|Patient refusal to continue,not due toAE|5
1682060|NCT01370005|5875365|P3|Overall Study|Lost to Follow-up|1
1682061|NCT01370005|5875366|P2|Overall Study|Lost to Follow-up|1
1682062|NCT01370005|5875367|P1|Overall Study|Lost to Follow-up|1
1682063|NCT01370005|5875365|P3|Overall Study|Non compliant with protocol|2
1682064|NCT01370005|5875366|P2|Overall Study|Non compliant with protocol|1
1682065|NCT01370005|5875367|P1|Overall Study|Non compliant with protocol|0
1682066|NCT01370005|5875365|P3|Overall Study|Lack of Efficacy|0
1682067|NCT01370005|5875366|P2|Overall Study|Lack of Efficacy|0
1682068|NCT01370005|5875367|P1|Overall Study|Lack of Efficacy|1
1682069|NCT01370005|5875365|P3|Overall Study|Adverse Event|6
1682070|NCT01370005|5875366|P2|Overall Study|Adverse Event|5
1682071|NCT01370005|5875367|P1|Overall Study|Adverse Event|5
1682072|NCT01370005|5875365|P3|Overall Study|Not treated|0
1682073|NCT01370005|5875366|P2|Overall Study|Not treated|0
1682074|NCT01370005|5875367|P1|Overall Study|Not treated|1
1682075|NCT01369849|5875449|P3|Overall Study|Ineligible after receiving treatment|0
1682076|NCT01369849|5875450|P2|Overall Study|Ineligible after receiving treatment|1
1682077|NCT01369849|5875451|P1|Overall Study|Ineligible after receiving treatment|0
1682078|NCT01369849|5875449|P3|Overall Study|Ineligible prior to treatment|1
1682079|NCT01369849|5875450|P2|Overall Study|Ineligible prior to treatment|0
1682080|NCT01369849|5875451|P1|Overall Study|Ineligible prior to treatment|0
1682081|NCT01369784|5875473|P1|Overall Study|Protocol Violation|12
1682082|NCT01369680|5875561|P4|Overall Study|Lost to Follow-up|2
1682083|NCT01369680|5875562|P3|Overall Study|Lost to Follow-up|1
1682084|NCT01369680|5875563|P2|Overall Study|Lost to Follow-up|0
1682085|NCT01369680|5875564|P1|Overall Study|Lost to Follow-up|0
1682086|NCT01369641|5875585|P1|Overall Study|Withdrawal by Subject|1
1682087|NCT01369615|5875591|P2|Overall Study|Lost to Follow-up|1
1682088|NCT01369615|5875592|P1|Overall Study|Lost to Follow-up|0
1682089|NCT01369615|5875591|P2|Overall Study|Withdrawal by Subject|1
1682090|NCT01369615|5875592|P1|Overall Study|Withdrawal by Subject|0
1682091|NCT01369511|5875602|P4|Overall Study|Withdrawal by Subject|6
1682092|NCT01369511|5875603|P3|Overall Study|Withdrawal by Subject|4
1682093|NCT01369511|5875604|P2|Overall Study|Withdrawal by Subject|6
1682094|NCT01369511|5875605|P1|Overall Study|Withdrawal by Subject|5
1682095|NCT01369511|5875602|P4|Overall Study|Sponsor decision|0
1682096|NCT01369511|5875603|P3|Overall Study|Sponsor decision|1
1682097|NCT01369511|5875604|P2|Overall Study|Sponsor decision|0
1682098|NCT01369511|5875605|P1|Overall Study|Sponsor decision|2
1682099|NCT01369511|5875602|P4|Overall Study|Physician Decision|0
1682100|NCT01369511|5875603|P3|Overall Study|Physician Decision|0
1682101|NCT01369511|5875604|P2|Overall Study|Physician Decision|4
1682102|NCT01369511|5875605|P1|Overall Study|Physician Decision|3
1682103|NCT01369511|5875602|P4|Overall Study|Protocol Violation|2
1682104|NCT01369511|5875603|P3|Overall Study|Protocol Violation|0
1682105|NCT01369511|5875604|P2|Overall Study|Protocol Violation|1
1682106|NCT01369511|5875605|P1|Overall Study|Protocol Violation|0
1682107|NCT01369511|5875602|P4|Overall Study|Lost to Follow-up|2
1682108|NCT01369511|5875603|P3|Overall Study|Lost to Follow-up|1
1682109|NCT01369511|5875604|P2|Overall Study|Lost to Follow-up|1
1682110|NCT01369511|5875605|P1|Overall Study|Lost to Follow-up|0
1682111|NCT01369511|5875602|P4|Overall Study|Entry criteria not met|1
1682112|NCT01369511|5875603|P3|Overall Study|Entry criteria not met|0
1682113|NCT01369511|5875604|P2|Overall Study|Entry criteria not met|0
1682114|NCT01369511|5875605|P1|Overall Study|Entry criteria not met|2
1682115|NCT01369511|5875602|P4|Overall Study|Adverse Event|0
1682116|NCT01369511|5875603|P3|Overall Study|Adverse Event|5
1682117|NCT01369511|5875604|P2|Overall Study|Adverse Event|1
1682118|NCT01369511|5875605|P1|Overall Study|Adverse Event|1
1682119|NCT01369485|5875621|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
1682120|NCT01369485|5875622|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
1682121|NCT01369485|5875621|P2|Open Label Phase (Week 12 to Month 12)|Death|1
1682122|NCT01369485|5875622|P1|Open Label Phase (Week 12 to Month 12)|Death|0
1682123|NCT01369485|5875621|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
1682124|NCT01369485|5875622|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
1682125|NCT01369485|5875621|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
1682126|NCT01369485|5875622|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
1682127|NCT01369485|5875621|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
1682128|NCT01369485|5875622|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
1682129|NCT01369485|5875621|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
1682130|NCT01369485|5875622|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
1682131|NCT01369485|5875621|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
1682132|NCT01369485|5875622|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
1682133|NCT01369485|5875621|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
1682134|NCT01369485|5875622|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
1682135|NCT01369485|5875621|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
1682136|NCT01369485|5875622|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
1682137|NCT01369485|5875621|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
1682138|NCT01369485|5875622|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
1682139|NCT01369355|5875668|P6|Overall Study|Not Treated|0
1682140|NCT01369355|5875669|P5|Overall Study|Not Treated|0
1682141|NCT01369355|5875670|P4|Overall Study|Not Treated|0
1682142|NCT01369355|5875671|P3|Overall Study|Not Treated|1
1682143|NCT01369355|5875672|P2|Overall Study|Not Treated|0
1682144|NCT01369355|5875673|P1|Overall Study|Not Treated|0
1682145|NCT01369355|5875668|P6|Overall Study|Other|0
1682146|NCT01369355|5875669|P5|Overall Study|Other|1
1682147|NCT01369355|5875670|P4|Overall Study|Other|0
1682148|NCT01369355|5875671|P3|Overall Study|Other|0
1682149|NCT01369355|5875672|P2|Overall Study|Other|0
1682150|NCT01369355|5875673|P1|Overall Study|Other|0
1682151|NCT01369355|5875668|P6|Overall Study|Withdrawal by Subject|22
1682152|NCT01369355|5875669|P5|Overall Study|Withdrawal by Subject|8
1682153|NCT01369355|5875670|P4|Overall Study|Withdrawal by Subject|6
1682154|NCT01369355|5875671|P3|Overall Study|Withdrawal by Subject|7
1682155|NCT01369355|5875672|P2|Overall Study|Withdrawal by Subject|2
1682156|NCT01369355|5875673|P1|Overall Study|Withdrawal by Subject|6
1682157|NCT01369355|5875668|P6|Overall Study|Lost to Follow-up|6
1682158|NCT01369355|5875669|P5|Overall Study|Lost to Follow-up|5
1682159|NCT01369355|5875670|P4|Overall Study|Lost to Follow-up|2
1682160|NCT01369355|5875671|P3|Overall Study|Lost to Follow-up|1
1682161|NCT01369355|5875672|P2|Overall Study|Lost to Follow-up|0
1682162|NCT01369355|5875673|P1|Overall Study|Lost to Follow-up|1
1682163|NCT01369355|5875668|P6|Overall Study|Protocol Violation|2
1682164|NCT01369355|5875669|P5|Overall Study|Protocol Violation|0
1682165|NCT01369355|5875670|P4|Overall Study|Protocol Violation|0
1682166|NCT01369355|5875671|P3|Overall Study|Protocol Violation|1
1682167|NCT01369355|5875672|P2|Overall Study|Protocol Violation|1
1682168|NCT01369355|5875673|P1|Overall Study|Protocol Violation|0
1682169|NCT01369355|5875668|P6|Overall Study|Lack of Efficacy|217
1682170|NCT01369355|5875669|P5|Overall Study|Lack of Efficacy|126
1682171|NCT01369355|5875670|P4|Overall Study|Lack of Efficacy|15
1682172|NCT01369355|5875671|P3|Overall Study|Lack of Efficacy|15
1682173|NCT01369355|5875672|P2|Overall Study|Lack of Efficacy|14
1682174|NCT01369355|5875673|P1|Overall Study|Lack of Efficacy|15
1682175|NCT01369355|5875668|P6|Overall Study|Adverse Event|25
1682176|NCT01369355|5875669|P5|Overall Study|Adverse Event|14
1682177|NCT01369355|5875670|P4|Overall Study|Adverse Event|7
1682178|NCT01369355|5875671|P3|Overall Study|Adverse Event|6
1682179|NCT01369355|5875672|P2|Overall Study|Adverse Event|12
1682180|NCT01369355|5875673|P1|Overall Study|Adverse Event|9
1682181|NCT01369342|5875702|P3|Overall Study|Not Treated|0
1682182|NCT01369342|5875703|P2|Overall Study|Not Treated|0
1682183|NCT01369342|5875704|P1|Overall Study|Not Treated|1
1682184|NCT01369342|5875702|P3|Overall Study|Lost to Follow-up|1
1682185|NCT01369342|5875703|P2|Overall Study|Lost to Follow-up|2
1682186|NCT01369342|5875704|P1|Overall Study|Lost to Follow-up|5
1682187|NCT01369342|5875702|P3|Overall Study|Withdrawal by Subject|2
1682188|NCT01369342|5875703|P2|Overall Study|Withdrawal by Subject|7
1682189|NCT01369342|5875704|P1|Overall Study|Withdrawal by Subject|7
1682190|NCT01369329|5875727|P3|Overall Study|Other|2
1682191|NCT01369329|5875728|P2|Overall Study|Other|3
1682192|NCT01369329|5875729|P1|Overall Study|Other|2
1682193|NCT01369329|5875727|P3|Overall Study|Lost to Follow-up|2
1682194|NCT01369329|5875728|P2|Overall Study|Lost to Follow-up|2
1682195|NCT01369329|5875729|P1|Overall Study|Lost to Follow-up|2
1682196|NCT01369329|5875727|P3|Overall Study|Withdrawal by Subject|10
1682197|NCT01369329|5875728|P2|Overall Study|Withdrawal by Subject|6
1682198|NCT01369329|5875729|P1|Overall Study|Withdrawal by Subject|8
1682199|NCT01369225|5875755|P6|Overall Study|Adverse Event|0
1682200|NCT01369225|5875756|P5|Overall Study|Adverse Event|1
1682201|NCT01369225|5875757|P4|Overall Study|Adverse Event|1
1682202|NCT01369225|5875758|P3|Overall Study|Adverse Event|0
1682203|NCT01369225|5875759|P2|Overall Study|Adverse Event|0
1682204|NCT01369225|5875760|P1|Overall Study|Adverse Event|0
1682205|NCT01369225|5875755|P6|Overall Study|Other|0
1682206|NCT01369225|5875756|P5|Overall Study|Other|1
1682207|NCT01369225|5875757|P4|Overall Study|Other|0
1682208|NCT01369225|5875758|P3|Overall Study|Other|0
1682209|NCT01369225|5875759|P2|Overall Study|Other|0
1682210|NCT01369225|5875760|P1|Overall Study|Other|1
1682211|NCT01369225|5875755|P6|Overall Study|Does Not Meet Entrance Criteria|0
1682212|NCT01369225|5875756|P5|Overall Study|Does Not Meet Entrance Criteria|0
1682213|NCT01369225|5875757|P4|Overall Study|Does Not Meet Entrance Criteria|0
1682214|NCT01369225|5875758|P3|Overall Study|Does Not Meet Entrance Criteria|1
1682215|NCT01369225|5875759|P2|Overall Study|Does Not Meet Entrance Criteria|0
1682216|NCT01369225|5875760|P1|Overall Study|Does Not Meet Entrance Criteria|0
1682217|NCT01369225|5875755|P6|Overall Study|Withdrawal by Subject|0
1682218|NCT01369225|5875756|P5|Overall Study|Withdrawal by Subject|0
1682219|NCT01369225|5875757|P4|Overall Study|Withdrawal by Subject|1
1682220|NCT01369225|5875758|P3|Overall Study|Withdrawal by Subject|2
1682221|NCT01369225|5875759|P2|Overall Study|Withdrawal by Subject|0
1682222|NCT01369225|5875760|P1|Overall Study|Withdrawal by Subject|1
1682225|NCT01369069|5875883|P2|Overall Study|Withdrawal by Subject|7
1682226|NCT01369069|5875884|P1|Overall Study|Withdrawal by Subject|9
1682227|NCT01369069|5875883|P2|Overall Study|Lost to Follow-up|9
1682228|NCT01369069|5875884|P1|Overall Study|Lost to Follow-up|8
1682229|NCT01368965|5875906|P1|Overall Study|Lost to Follow-up|12
1682230|NCT01368900|5875915|P1|Overall Study|Lost to Follow-up|7
1682231|NCT01368835|5875990|P1|Overall Study|Lost to Follow-up|11
1682232|NCT01368835|5875990|P1|Overall Study|Inclusion criteria/photography quality|22
1682233|NCT01368614|5876029|P4|Study Period|Lost to Follow-up|0
1682234|NCT01368614|5876030|P3|Study Period|Lost to Follow-up|1
1682235|NCT01368614|5876031|P2|Study Period|Lost to Follow-up|0
1682236|NCT01368614|5876032|P1|Study Period|Lost to Follow-up|0
1682237|NCT01368614|5876029|P4|Study Period|Withdrawal by Subject|3
1682238|NCT01368614|5876030|P3|Study Period|Withdrawal by Subject|1
1682239|NCT01368614|5876031|P2|Study Period|Withdrawal by Subject|1
1682240|NCT01368614|5876032|P1|Study Period|Withdrawal by Subject|0
1682241|NCT01368614|5876029|P4|Screening Period|Screen Failure|0
1682242|NCT01368614|5876030|P3|Screening Period|Screen Failure|0
1682243|NCT01368614|5876031|P2|Screening Period|Screen Failure|0
1682244|NCT01368614|5876032|P1|Screening Period|Screen Failure|58
1682245|NCT01368562|5876085|P1|Overall Study|Other than specified|2
1682246|NCT01368562|5876085|P1|Overall Study|Other|3
1682247|NCT01368562|5876085|P1|Overall Study|Unresponsive to treatment|5
1682248|NCT01368562|5876085|P1|Overall Study|Death|6
1682249|NCT01368562|5876085|P1|Overall Study|Lost to Follow-up|1
1682250|NCT01368562|5876085|P1|Overall Study|Disease progression|1
1682251|NCT01368562|5876085|P1|Overall Study|Adverse Event|1
1682252|NCT01368536|5876092|P3|Overall Study|Protocol deviation|1
1682253|NCT01368536|5876093|P2|Overall Study|Protocol deviation|3
1682254|NCT01368536|5876094|P1|Overall Study|Protocol deviation|0
1682255|NCT01368536|5876092|P3|Overall Study|Administrative problems|35
1682256|NCT01368536|5876093|P2|Overall Study|Administrative problems|39
1682257|NCT01368536|5876094|P1|Overall Study|Administrative problems|34
1682258|NCT01368536|5876092|P3|Overall Study|Lost to Follow-up|5
1682259|NCT01368536|5876093|P2|Overall Study|Lost to Follow-up|3
1682260|NCT01368536|5876094|P1|Overall Study|Lost to Follow-up|3
1682261|NCT01368536|5876092|P3|Overall Study|Withdrawal by Subject|4
1682262|NCT01368536|5876093|P2|Overall Study|Withdrawal by Subject|5
1682263|NCT01368536|5876094|P1|Overall Study|Withdrawal by Subject|2
1682264|NCT01368536|5876092|P3|Overall Study|No longer required study medication|1
1682265|NCT01368536|5876093|P2|Overall Study|No longer required study medication|0
1682266|NCT01368536|5876094|P1|Overall Study|No longer required study medication|0
1682267|NCT01368536|5876092|P3|Overall Study|Unsatisfactory therapeutic effect|2
1682268|NCT01368536|5876093|P2|Overall Study|Unsatisfactory therapeutic effect|2
1682269|NCT01368536|5876094|P1|Overall Study|Unsatisfactory therapeutic effect|7
1682270|NCT01368536|5876092|P3|Overall Study|Abnormal test procedure result(s)|1
1682271|NCT01368536|5876093|P2|Overall Study|Abnormal test procedure result(s)|0
1682272|NCT01368536|5876094|P1|Overall Study|Abnormal test procedure result(s)|0
1682273|NCT01368536|5876092|P3|Overall Study|Abnormal laboratory value(s)|2
1682274|NCT01368536|5876093|P2|Overall Study|Abnormal laboratory value(s)|1
1682275|NCT01368536|5876094|P1|Overall Study|Abnormal laboratory value(s)|0
1682276|NCT01368536|5876092|P3|Overall Study|Adverse Event|8
1682277|NCT01368536|5876093|P2|Overall Study|Adverse Event|6
1682278|NCT01368536|5876094|P1|Overall Study|Adverse Event|5
1682279|NCT01368497|5876115|P1|Overall Study|Lost to Follow-up|2
1682280|NCT01368432|5876143|P2|Overall Study|Lost to Follow-up|1
1682281|NCT01368432|5876144|P1|Overall Study|Lost to Follow-up|0
1682282|NCT01368406|5876178|P2|Overall Study|started working|3
1682283|NCT01368406|5876179|P1|Overall Study|started working|2
1682284|NCT01368406|5876178|P2|Overall Study|relapse of the disease|2
1682285|NCT01368406|5876179|P1|Overall Study|relapse of the disease|3
1682286|NCT01368406|5876178|P2|Overall Study|Withdrawal by Subject|4
1682287|NCT01368406|5876179|P1|Overall Study|Withdrawal by Subject|8
1682288|NCT01368406|5876178|P2|Overall Study|Lost to Follow-up|4
1682289|NCT01368406|5876179|P1|Overall Study|Lost to Follow-up|8
1682290|NCT01368276|5876187|P2|Overall Study|Death|10
1682291|NCT01368276|5876188|P1|Overall Study|Death|1
1682292|NCT01368211|5876225|P2|Second Platelets Transfusion|No need for additional transfusion|2
1682293|NCT01368211|5876226|P1|Second Platelets Transfusion|No need for additional transfusion|1
1682294|NCT01368081|5876254|P13|Overall Study|Other reason not defined above|3
1682295|NCT01368081|5876255|P12|Overall Study|Other reason not defined above|0
1682296|NCT01368081|5876256|P11|Overall Study|Other reason not defined above|0
1682297|NCT01368081|5876257|P10|Overall Study|Other reason not defined above|1
1682298|NCT01368081|5876258|P9|Overall Study|Other reason not defined above|0
1682299|NCT01368081|5876259|P8|Overall Study|Other reason not defined above|0
1682300|NCT01368081|5876260|P7|Overall Study|Other reason not defined above|2
1682301|NCT01368081|5876261|P6|Overall Study|Other reason not defined above|1
1682302|NCT01368081|5876262|P5|Overall Study|Other reason not defined above|0
1682303|NCT01368081|5876263|P4|Overall Study|Other reason not defined above|1
1682304|NCT01368081|5876264|P3|Overall Study|Other reason not defined above|0
1682305|NCT01368081|5876265|P2|Overall Study|Other reason not defined above|0
1682306|NCT01368081|5876266|P1|Overall Study|Other reason not defined above|2
1682307|NCT01368081|5876254|P13|Overall Study|Withdrawal by Subject|0
1682308|NCT01368081|5876255|P12|Overall Study|Withdrawal by Subject|2
1682309|NCT01368081|5876256|P11|Overall Study|Withdrawal by Subject|3
1682310|NCT01368081|5876257|P10|Overall Study|Withdrawal by Subject|4
1682311|NCT01368081|5876258|P9|Overall Study|Withdrawal by Subject|5
1682312|NCT01368081|5876259|P8|Overall Study|Withdrawal by Subject|2
1682313|NCT01368081|5876260|P7|Overall Study|Withdrawal by Subject|4
1682314|NCT01368081|5876261|P6|Overall Study|Withdrawal by Subject|3
1682315|NCT01368081|5876262|P5|Overall Study|Withdrawal by Subject|0
1682316|NCT01368081|5876263|P4|Overall Study|Withdrawal by Subject|1
1682317|NCT01368081|5876264|P3|Overall Study|Withdrawal by Subject|1
1682318|NCT01368081|5876265|P2|Overall Study|Withdrawal by Subject|4
1682319|NCT01368081|5876266|P1|Overall Study|Withdrawal by Subject|4
1682320|NCT01368081|5876254|P13|Overall Study|Lost to Follow-up|1
1682321|NCT01368081|5876255|P12|Overall Study|Lost to Follow-up|0
1682322|NCT01368081|5876256|P11|Overall Study|Lost to Follow-up|0
1682323|NCT01368081|5876257|P10|Overall Study|Lost to Follow-up|0
1682324|NCT01368081|5876258|P9|Overall Study|Lost to Follow-up|0
1682325|NCT01368081|5876259|P8|Overall Study|Lost to Follow-up|0
1682326|NCT01368081|5876260|P7|Overall Study|Lost to Follow-up|0
1682327|NCT01368081|5876261|P6|Overall Study|Lost to Follow-up|0
1682328|NCT01368081|5876262|P5|Overall Study|Lost to Follow-up|0
1682329|NCT01368081|5876263|P4|Overall Study|Lost to Follow-up|0
1682330|NCT01368081|5876264|P3|Overall Study|Lost to Follow-up|0
1682331|NCT01368081|5876265|P2|Overall Study|Lost to Follow-up|0
1682332|NCT01368081|5876266|P1|Overall Study|Lost to Follow-up|0
1682333|NCT01368081|5876254|P13|Overall Study|Protocol Violation|0
1682334|NCT01368081|5876255|P12|Overall Study|Protocol Violation|0
1682335|NCT01368081|5876256|P11|Overall Study|Protocol Violation|0
1682336|NCT01368081|5876257|P10|Overall Study|Protocol Violation|0
1682337|NCT01368081|5876258|P9|Overall Study|Protocol Violation|0
1682338|NCT01368081|5876259|P8|Overall Study|Protocol Violation|1
1682339|NCT01368081|5876260|P7|Overall Study|Protocol Violation|0
1682340|NCT01368081|5876261|P6|Overall Study|Protocol Violation|1
1682341|NCT01368081|5876262|P5|Overall Study|Protocol Violation|0
1682342|NCT01368081|5876263|P4|Overall Study|Protocol Violation|0
1682343|NCT01368081|5876264|P3|Overall Study|Protocol Violation|0
1682344|NCT01368081|5876265|P2|Overall Study|Protocol Violation|0
1682345|NCT01368081|5876266|P1|Overall Study|Protocol Violation|0
1682346|NCT01368081|5876254|P13|Overall Study|Lack of Efficacy|0
1682347|NCT01368081|5876255|P12|Overall Study|Lack of Efficacy|0
1682348|NCT01368081|5876256|P11|Overall Study|Lack of Efficacy|0
1682349|NCT01368081|5876257|P10|Overall Study|Lack of Efficacy|0
1682350|NCT01368081|5876258|P9|Overall Study|Lack of Efficacy|0
1682351|NCT01368081|5876259|P8|Overall Study|Lack of Efficacy|2
1682352|NCT01368081|5876260|P7|Overall Study|Lack of Efficacy|0
1682353|NCT01368081|5876261|P6|Overall Study|Lack of Efficacy|0
1682354|NCT01368081|5876262|P5|Overall Study|Lack of Efficacy|0
1682355|NCT01368081|5876263|P4|Overall Study|Lack of Efficacy|1
1682356|NCT01368081|5876264|P3|Overall Study|Lack of Efficacy|0
1682357|NCT01368081|5876265|P2|Overall Study|Lack of Efficacy|1
1682358|NCT01368081|5876266|P1|Overall Study|Lack of Efficacy|0
1682359|NCT01368081|5876254|P13|Overall Study|Adverse Event|3
1682360|NCT01368081|5876255|P12|Overall Study|Adverse Event|1
1682361|NCT01368081|5876256|P11|Overall Study|Adverse Event|6
1682362|NCT01368081|5876257|P10|Overall Study|Adverse Event|5
1682363|NCT01368081|5876258|P9|Overall Study|Adverse Event|3
1682364|NCT01368081|5876259|P8|Overall Study|Adverse Event|2
1682365|NCT01368081|5876260|P7|Overall Study|Adverse Event|6
1682366|NCT01368081|5876261|P6|Overall Study|Adverse Event|5
1682367|NCT01368081|5876262|P5|Overall Study|Adverse Event|2
1682368|NCT01368081|5876263|P4|Overall Study|Adverse Event|2
1682369|NCT01368081|5876264|P3|Overall Study|Adverse Event|3
1682370|NCT01368081|5876265|P2|Overall Study|Adverse Event|4
1682371|NCT01368081|5876266|P1|Overall Study|Adverse Event|4
1682372|NCT01368042|5876320|P1|Overall Study|Transplanted|1
1682373|NCT01368042|5876320|P1|Overall Study|Lost to Follow-up|4
1682374|NCT01368042|5876320|P1|Overall Study|Protocol Violation|11
1682375|NCT01368042|5876320|P1|Overall Study|Death|14
1682376|NCT01367886|5876340|P1|Overall Study|Death|1
1682377|NCT01367886|5876340|P1|Overall Study|Lack of Efficacy|2
1682378|NCT01367886|5876340|P1|Overall Study|Lost to Follow-up|4
1682379|NCT01367847|5876390|P2|Overall Study|Withdrawal by Subject|2
1682380|NCT01367847|5876391|P1|Overall Study|Withdrawal by Subject|2
1682381|NCT01367834|5876407|P2|Overall Study|Study was ended.|1
1682382|NCT01367834|5876408|P1|Overall Study|Study was ended.|0
1682383|NCT01367834|5876407|P2|Overall Study|Withdrawal by Subject|2
1682384|NCT01367834|5876408|P1|Overall Study|Withdrawal by Subject|2
1682385|NCT01367704|5876432|P2|Overall Study|Lost to Follow-up|161
1682386|NCT01367704|5876433|P1|Overall Study|Lost to Follow-up|47
1682387|NCT01367665|5876445|P2|Overall Study|Not Done|14
1682388|NCT01367665|5876446|P1|Overall Study|Not Done|118
1682389|NCT01367665|5876445|P2|Overall Study|Lost to Follow-up|22
1682390|NCT01367665|5876446|P1|Overall Study|Lost to Follow-up|222
1682391|NCT01367665|5876445|P2|Overall Study|Death|19
1682392|NCT01367665|5876446|P1|Overall Study|Death|102
1682393|NCT01367457|5876477|P3|Overall Study|Suspected DP/suspected active infection|0
1682394|NCT01367457|5876478|P2|Overall Study|Suspected DP/suspected active infection|0
1682395|NCT01367457|5876479|P1|Overall Study|Suspected DP/suspected active infection|1
1682396|NCT01367457|5876477|P3|Overall Study|Palliative. Overall decline|0
1682397|NCT01367457|5876478|P2|Overall Study|Palliative. Overall decline|0
1682398|NCT01367457|5876479|P1|Overall Study|Palliative. Overall decline|1
1682399|NCT01367457|5876477|P3|Overall Study|Patient's Wish|0
1682400|NCT01367457|5876478|P2|Overall Study|Patient's Wish|0
1682401|NCT01367457|5876479|P1|Overall Study|Patient's Wish|1
1682402|NCT01367457|5876477|P3|Overall Study|CD, Suspected disease progression (DP)|0
1682403|NCT01367457|5876478|P2|Overall Study|CD, Suspected disease progression (DP)|0
1682404|NCT01367457|5876479|P1|Overall Study|CD, Suspected disease progression (DP)|1
1682405|NCT01367457|5876477|P3|Overall Study|Death from septic shock|0
1682406|NCT01367457|5876478|P2|Overall Study|Death from septic shock|0
1682407|NCT01367457|5876479|P1|Overall Study|Death from septic shock|1
1682408|NCT01367457|5876477|P3|Overall Study|Lost to Follow-up|0
1682409|NCT01367457|5876478|P2|Overall Study|Lost to Follow-up|0
1682410|NCT01367457|5876479|P1|Overall Study|Lost to Follow-up|1
1682411|NCT01367457|5876477|P3|Overall Study|Rejection of treatment|0
1682412|NCT01367457|5876478|P2|Overall Study|Rejection of treatment|0
1682413|NCT01367457|5876479|P1|Overall Study|Rejection of treatment|1
1682414|NCT01367457|5876477|P3|Overall Study|Overall decline|0
1682415|NCT01367457|5876478|P2|Overall Study|Overall decline|0
1682416|NCT01367457|5876479|P1|Overall Study|Overall decline|1
1682417|NCT01367457|5876477|P3|Overall Study|Intestinal obstruction with necrosis|0
1682418|NCT01367457|5876478|P2|Overall Study|Intestinal obstruction with necrosis|0
1682419|NCT01367457|5876479|P1|Overall Study|Intestinal obstruction with necrosis|1
1682420|NCT01367457|5876477|P3|Overall Study|No clinical benefit|0
1682421|NCT01367457|5876478|P2|Overall Study|No clinical benefit|0
1682422|NCT01367457|5876479|P1|Overall Study|No clinical benefit|1
1682423|NCT01367457|5876477|P3|Overall Study|Stabilisation + frequent infections|0
1682424|NCT01367457|5876478|P2|Overall Study|Stabilisation + frequent infections|0
1682425|NCT01367457|5876479|P1|Overall Study|Stabilisation + frequent infections|1
1682426|NCT01367457|5876477|P3|Overall Study|Overall status worsens to grade 4|0
1682427|NCT01367457|5876478|P2|Overall Study|Overall status worsens to grade 4|0
1682428|NCT01367457|5876479|P1|Overall Study|Overall status worsens to grade 4|1
1682429|NCT01367457|5876477|P3|Overall Study|Uncontrolled pain|0
1682430|NCT01367457|5876478|P2|Overall Study|Uncontrolled pain|0
1682431|NCT01367457|5876479|P1|Overall Study|Uncontrolled pain|1
1682432|NCT01367457|5876477|P3|Overall Study|CD, associated leukaemia|0
1682433|NCT01367457|5876478|P2|Overall Study|CD, associated leukaemia|0
1682434|NCT01367457|5876479|P1|Overall Study|CD, associated leukaemia|1
1682435|NCT01367457|5876477|P3|Overall Study|Withdrawal by Subject|0
1682436|NCT01367457|5876478|P2|Overall Study|Withdrawal by Subject|0
1682437|NCT01367457|5876479|P1|Overall Study|Withdrawal by Subject|1
1682438|NCT01367457|5876477|P3|Overall Study|Choledocolithiasis and pancreatitis|0
1682439|NCT01367457|5876478|P2|Overall Study|Choledocolithiasis and pancreatitis|0
1682440|NCT01367457|5876479|P1|Overall Study|Choledocolithiasis and pancreatitis|1
1682441|NCT01367457|5876477|P3|Overall Study|low grade toxicities + stable disease|0
1682442|NCT01367457|5876478|P2|Overall Study|low grade toxicities + stable disease|0
1682443|NCT01367457|5876479|P1|Overall Study|low grade toxicities + stable disease|1
1682444|NCT01367457|5876477|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
1682445|NCT01367457|5876478|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
1682446|NCT01367457|5876479|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
1682447|NCT01367457|5876477|P3|Overall Study|Bleeding from cavernous haemangioma|0
1682448|NCT01367457|5876478|P2|Overall Study|Bleeding from cavernous haemangioma|0
1682449|NCT01367457|5876479|P1|Overall Study|Bleeding from cavernous haemangioma|1
1682450|NCT01367457|5876477|P3|Overall Study|Investigator's opinion, stable disease|0
1682451|NCT01367457|5876478|P2|Overall Study|Investigator's opinion, stable disease|0
1682452|NCT01367457|5876479|P1|Overall Study|Investigator's opinion, stable disease|1
1682453|NCT01367457|5876477|P3|Overall Study|Patient asks for rest + slow progression|0
1682454|NCT01367457|5876478|P2|Overall Study|Patient asks for rest + slow progression|0
1682455|NCT01367457|5876479|P1|Overall Study|Patient asks for rest + slow progression|1
1682456|NCT01367457|5876477|P3|Overall Study|Progression|0
1682457|NCT01367457|5876478|P2|Overall Study|Progression|0
1682458|NCT01367457|5876479|P1|Overall Study|Progression|137
1682459|NCT01367457|5876477|P3|Overall Study|Toxicity|0
1682460|NCT01367457|5876478|P2|Overall Study|Toxicity|0
1682461|NCT01367457|5876479|P1|Overall Study|Toxicity|16
1682462|NCT01367457|5876477|P3|Overall Study|Progression and death|0
1682463|NCT01367457|5876478|P2|Overall Study|Progression and death|0
1682464|NCT01367457|5876479|P1|Overall Study|Progression and death|8
1682465|NCT01367457|5876477|P3|Overall Study|Clinical decline (CD)|0
1682466|NCT01367457|5876478|P2|Overall Study|Clinical decline (CD)|0
1682467|NCT01367457|5876479|P1|Overall Study|Clinical decline (CD)|2
1682468|NCT01367457|5876477|P3|Overall Study|Investigator's decision|0
1682469|NCT01367457|5876478|P2|Overall Study|Investigator's decision|0
1682470|NCT01367457|5876479|P1|Overall Study|Investigator's decision|2
1682471|NCT01367457|5876477|P3|Overall Study|Death|0
1682472|NCT01367457|5876478|P2|Overall Study|Death|0
1682473|NCT01367457|5876479|P1|Overall Study|Death|2
1682474|NCT01367249|5876512|P2|Overall Study|Other|10
1682475|NCT01367249|5876513|P1|Overall Study|Other|3
1682476|NCT01367249|5876512|P2|Overall Study|Withdrawal by Subject|6
1682477|NCT01367249|5876513|P1|Overall Study|Withdrawal by Subject|6
1682478|NCT01367236|5876523|P2|Overall Study|Withdrawal by Subject|1
1682479|NCT01367236|5876524|P1|Overall Study|Withdrawal by Subject|3
1682480|NCT01367158|5876543|P11|Overall Study|Protocol Violation|0
1682481|NCT01367158|5876544|P10|Overall Study|Protocol Violation|0
1682482|NCT01367158|5876545|P9|Overall Study|Protocol Violation|0
1682483|NCT01367158|5876546|P8|Overall Study|Protocol Violation|0
1682484|NCT01367158|5876547|P7|Overall Study|Protocol Violation|0
1682485|NCT01367158|5876548|P6|Overall Study|Protocol Violation|0
1682486|NCT01367158|5876549|P5|Overall Study|Protocol Violation|0
1682487|NCT01367158|5876550|P4|Overall Study|Protocol Violation|0
1682488|NCT01367158|5876551|P3|Overall Study|Protocol Violation|0
1682489|NCT01367158|5876552|P2|Overall Study|Protocol Violation|1
1682490|NCT01367158|5876553|P1|Overall Study|Protocol Violation|0
1682491|NCT01367158|5876543|P11|Overall Study|Lost to Follow-up|1
1682492|NCT01367158|5876544|P10|Overall Study|Lost to Follow-up|0
1682493|NCT01367158|5876545|P9|Overall Study|Lost to Follow-up|0
1682494|NCT01367158|5876546|P8|Overall Study|Lost to Follow-up|1
1682495|NCT01367158|5876547|P7|Overall Study|Lost to Follow-up|0
1682496|NCT01367158|5876548|P6|Overall Study|Lost to Follow-up|2
1682497|NCT01367158|5876549|P5|Overall Study|Lost to Follow-up|0
1682498|NCT01367158|5876550|P4|Overall Study|Lost to Follow-up|1
1682499|NCT01367158|5876551|P3|Overall Study|Lost to Follow-up|0
1682500|NCT01367158|5876552|P2|Overall Study|Lost to Follow-up|0
1682501|NCT01367158|5876553|P1|Overall Study|Lost to Follow-up|0
1682502|NCT01367158|5876543|P11|Overall Study|Withdrew consent|0
1682503|NCT01367158|5876544|P10|Overall Study|Withdrew consent|0
1682504|NCT01367158|5876545|P9|Overall Study|Withdrew consent|0
1682505|NCT01367158|5876546|P8|Overall Study|Withdrew consent|1
1682506|NCT01367158|5876547|P7|Overall Study|Withdrew consent|0
1682507|NCT01367158|5876548|P6|Overall Study|Withdrew consent|0
1682508|NCT01367158|5876549|P5|Overall Study|Withdrew consent|2
1682509|NCT01367158|5876550|P4|Overall Study|Withdrew consent|0
1682510|NCT01367158|5876551|P3|Overall Study|Withdrew consent|1
1682511|NCT01367158|5876552|P2|Overall Study|Withdrew consent|2
1682512|NCT01367158|5876553|P1|Overall Study|Withdrew consent|0
1682513|NCT01367119|5876697|P2|Overall Study|Withdrawal by Subject|1
1682514|NCT01367119|5876698|P1|Overall Study|Withdrawal by Subject|1
1682515|NCT01367119|5876697|P2|Overall Study|Adverse Event|0
1682516|NCT01367119|5876698|P1|Overall Study|Adverse Event|1
1682517|NCT01366846|5876753|P4|Overall Study|Scheduling Conflicts|0
1682518|NCT01366846|5876754|P3|Overall Study|Scheduling Conflicts|1
1682519|NCT01366846|5876755|P2|Overall Study|Scheduling Conflicts|0
1682520|NCT01366846|5876756|P1|Overall Study|Scheduling Conflicts|0
1682521|NCT01366846|5876753|P4|Overall Study|Communication Difficulties|1
1682522|NCT01366846|5876754|P3|Overall Study|Communication Difficulties|0
1682523|NCT01366846|5876755|P2|Overall Study|Communication Difficulties|4
1682524|NCT01366846|5876756|P1|Overall Study|Communication Difficulties|1
1682525|NCT01366846|5876753|P4|Overall Study|Withdrawal by Subject|0
1682526|NCT01366846|5876754|P3|Overall Study|Withdrawal by Subject|0
1682527|NCT01366846|5876755|P2|Overall Study|Withdrawal by Subject|0
1682528|NCT01366846|5876756|P1|Overall Study|Withdrawal by Subject|2
1682529|NCT01366638|5876779|P3|Overall Study|Other|0
1682530|NCT01366638|5876780|P2|Overall Study|Other|0
1682531|NCT01366638|5876781|P1|Overall Study|Other|1
1682532|NCT01366638|5876779|P3|Overall Study|Withdrawal by Subject|6
1682533|NCT01366638|5876780|P2|Overall Study|Withdrawal by Subject|0
1682534|NCT01366638|5876781|P1|Overall Study|Withdrawal by Subject|0
1682535|NCT01366534|5876818|P3|Overall Study|Declined challenged|0
1682536|NCT01366534|5876819|P2|Overall Study|Declined challenged|1
1682537|NCT01366534|5876820|P1|Overall Study|Declined challenged|0
1682538|NCT01366534|5876818|P3|Overall Study|Migrated|0
1682539|NCT01366534|5876819|P2|Overall Study|Migrated|1
1682540|NCT01366534|5876820|P1|Overall Study|Migrated|1
1682541|NCT01366534|5876818|P3|Overall Study|Lost to Follow-up|0
1682542|NCT01366534|5876819|P2|Overall Study|Lost to Follow-up|0
1682543|NCT01366534|5876820|P1|Overall Study|Lost to Follow-up|1
1682544|NCT01366521|5876870|P4|Overall Study|Withdrawal by Subject|0
1682545|NCT01366521|5876871|P3|Overall Study|Withdrawal by Subject|0
1682546|NCT01366521|5876872|P2|Overall Study|Withdrawal by Subject|1
1682547|NCT01366521|5876873|P1|Overall Study|Withdrawal by Subject|0
1682548|NCT01366521|5876870|P4|Overall Study|Physician Decision|0
1682549|NCT01366521|5876871|P3|Overall Study|Physician Decision|1
1682550|NCT01366521|5876872|P2|Overall Study|Physician Decision|0
1682551|NCT01366521|5876873|P1|Overall Study|Physician Decision|0
1682552|NCT01366521|5876870|P4|Overall Study|Protocol Violation|0
1682553|NCT01366521|5876871|P3|Overall Study|Protocol Violation|1
1682554|NCT01366521|5876872|P2|Overall Study|Protocol Violation|0
1682555|NCT01366521|5876873|P1|Overall Study|Protocol Violation|0
1682556|NCT01366521|5876870|P4|Overall Study|Adverse Event|0
1682557|NCT01366521|5876871|P3|Overall Study|Adverse Event|0
1682558|NCT01366521|5876872|P2|Overall Study|Adverse Event|0
1682559|NCT01366521|5876873|P1|Overall Study|Adverse Event|1
1682560|NCT01366443|5876969|P1|Overall Study|Under 18 yo|1
1682561|NCT01366443|5876969|P1|Overall Study|Lost to Follow-up|2
1682562|NCT01366209|5876983|P2|Overall Study|Withdrew consent|3
1682563|NCT01366209|5876984|P1|Overall Study|Withdrew consent|4
1682564|NCT01366209|5876983|P2|Overall Study|Sponsors decision|1
1682565|NCT01366209|5876984|P1|Overall Study|Sponsors decision|0
1682566|NCT01366209|5876983|P2|Overall Study|Physician Decision|0
1682567|NCT01366209|5876984|P1|Overall Study|Physician Decision|1
1682568|NCT01366209|5876983|P2|Overall Study|Lost to Follow-up|1
1682569|NCT01366209|5876984|P1|Overall Study|Lost to Follow-up|2
1682570|NCT01366209|5876983|P2|Overall Study|Lung transplantation|1
1682571|NCT01366209|5876984|P1|Overall Study|Lung transplantation|6
1682572|NCT01366209|5876983|P2|Overall Study|Death|19
1682573|NCT01366209|5876984|P1|Overall Study|Death|12
1682574|NCT01366209|5876983|P2|Overall Study|Withdrawal by Subject|4
1682575|NCT01366209|5876984|P1|Overall Study|Withdrawal by Subject|4
1682576|NCT01366209|5876983|P2|Overall Study|Adverse Event|7
1682577|NCT01366209|5876984|P1|Overall Study|Adverse Event|6
1682578|NCT01366092|5877007|P1|Overall Study|Withdrawal by Subject|1
1682579|NCT01366092|5877007|P1|Overall Study|Physician Decision|1
1682580|NCT01366092|5877007|P1|Overall Study|Progressive cGVHD|2
1682581|NCT01365910|5877016|P1|Overall Study|pt did not get tx, nausea/vomiting|1
1682582|NCT01365910|5877016|P1|Overall Study|other complicating disease|1
1682583|NCT01365910|5877016|P1|Overall Study|Adverse Event|3
1682584|NCT01365910|5877016|P1|Overall Study|disease progression|18
1682585|NCT01365910|5877016|P1|Overall Study|Withdrawal by Subject|7
1682586|NCT01365546|5877152|P1|Overall Study|Study termination|1
1682587|NCT01365546|5877152|P1|Overall Study|Screen failure|9
1682588|NCT01365546|5877152|P1|Overall Study|Withdrawal by Subject|1
1682589|NCT01365507|5877162|P2|Overall Study|Unclassified|4
1682590|NCT01365507|5877163|P1|Overall Study|Unclassified|1
1682591|NCT01365507|5877162|P2|Overall Study|Withdrawal Criteria|5
1682592|NCT01365507|5877163|P1|Overall Study|Withdrawal Criteria|8
1682593|NCT01365494|5877179|P2|Overall Study|Lost to Follow-up|2
1682594|NCT01365494|5877180|P1|Overall Study|Lost to Follow-up|1
1682595|NCT01365494|5877179|P2|Overall Study|Withdrawal by Subject|1
1682596|NCT01365494|5877180|P1|Overall Study|Withdrawal by Subject|0
1682597|NCT01365494|5877179|P2|Overall Study|Adverse Event|0
1682598|NCT01365494|5877180|P1|Overall Study|Adverse Event|1
1682599|NCT01365481|5877196|P4|Overall Study|Unsatisfactory therapeutic effect|0
1682600|NCT01365481|5877197|P3|Overall Study|Unsatisfactory therapeutic effect|1
1682601|NCT01365481|5877198|P2|Overall Study|Unsatisfactory therapeutic effect|0
1682602|NCT01365481|5877199|P1|Overall Study|Unsatisfactory therapeutic effect|0
1682603|NCT01365481|5877196|P4|Overall Study|Protocol deviation|1
1682604|NCT01365481|5877197|P3|Overall Study|Protocol deviation|0
1682605|NCT01365481|5877198|P2|Overall Study|Protocol deviation|1
1682606|NCT01365481|5877199|P1|Overall Study|Protocol deviation|0
1682607|NCT01365481|5877196|P4|Overall Study|Administrative problems|0
1682608|NCT01365481|5877197|P3|Overall Study|Administrative problems|0
1682609|NCT01365481|5877198|P2|Overall Study|Administrative problems|1
1682610|NCT01365481|5877199|P1|Overall Study|Administrative problems|0
1682611|NCT01365481|5877196|P4|Overall Study|Abnormal laboratory value(s)|0
1682612|NCT01365481|5877197|P3|Overall Study|Abnormal laboratory value(s)|0
1682613|NCT01365481|5877198|P2|Overall Study|Abnormal laboratory value(s)|1
1682614|NCT01365481|5877199|P1|Overall Study|Abnormal laboratory value(s)|0
1682615|NCT01365481|5877196|P4|Overall Study|Lost to Follow-up|3
1682616|NCT01365481|5877197|P3|Overall Study|Lost to Follow-up|2
1682617|NCT01365481|5877198|P2|Overall Study|Lost to Follow-up|1
1682618|NCT01365481|5877199|P1|Overall Study|Lost to Follow-up|1
1682619|NCT01365481|5877196|P4|Overall Study|Withdrawal by Subject|1
1682620|NCT01365481|5877197|P3|Overall Study|Withdrawal by Subject|1
1682621|NCT01365481|5877198|P2|Overall Study|Withdrawal by Subject|2
1682622|NCT01365481|5877199|P1|Overall Study|Withdrawal by Subject|0
1682623|NCT01365481|5877196|P4|Overall Study|Adverse Event|2
1682624|NCT01365481|5877197|P3|Overall Study|Adverse Event|0
1682625|NCT01365481|5877198|P2|Overall Study|Adverse Event|9
1682626|NCT01365481|5877199|P1|Overall Study|Adverse Event|6
1682627|NCT01365468|5877219|P2|Overall Study|Lost to Follow-up|0
1682628|NCT01365468|5877220|P1|Overall Study|Lost to Follow-up|2
1682629|NCT01365468|5877219|P2|Overall Study|Disease progression|0
1682630|NCT01365468|5877220|P1|Overall Study|Disease progression|1
1682631|NCT01365468|5877219|P2|Overall Study|Physician Decision|0
1682632|NCT01365468|5877220|P1|Overall Study|Physician Decision|1
1682633|NCT01365455|5877235|P5|Maintenance Period|Subject/guardian decision|1
1682634|NCT01365455|5877236|P4|Maintenance Period|Subject/guardian decision|4
1682635|NCT01365455|5877237|P3|Maintenance Period|Subject/guardian decision|2
1682636|NCT01365455|5877238|P2|Maintenance Period|Subject/guardian decision|6
1682637|NCT01365455|5877239|P1|Maintenance Period|Subject/guardian decision|4
1682638|NCT01365455|5877235|P5|Maintenance Period|Protocol deviation|0
1682639|NCT01365455|5877236|P4|Maintenance Period|Protocol deviation|0
1682640|NCT01365455|5877237|P3|Maintenance Period|Protocol deviation|0
1682641|NCT01365455|5877238|P2|Maintenance Period|Protocol deviation|1
1682642|NCT01365455|5877239|P1|Maintenance Period|Protocol deviation|1
1682643|NCT01365455|5877235|P5|Maintenance Period|Pregnancy|2
1682644|NCT01365455|5877236|P4|Maintenance Period|Pregnancy|0
1682645|NCT01365455|5877237|P3|Maintenance Period|Pregnancy|0
1682646|NCT01365455|5877238|P2|Maintenance Period|Pregnancy|4
1682647|NCT01365455|5877239|P1|Maintenance Period|Pregnancy|0
1682648|NCT01365455|5877235|P5|Maintenance Period|Physician Decision|1
1682649|NCT01365455|5877236|P4|Maintenance Period|Physician Decision|0
1682650|NCT01365455|5877237|P3|Maintenance Period|Physician Decision|0
1682651|NCT01365455|5877238|P2|Maintenance Period|Physician Decision|1
1682652|NCT01365455|5877239|P1|Maintenance Period|Physician Decision|0
1682653|NCT01365455|5877235|P5|Maintenance Period|Non-compliance with study treatment|0
1682654|NCT01365455|5877236|P4|Maintenance Period|Non-compliance with study treatment|1
1682655|NCT01365455|5877237|P3|Maintenance Period|Non-compliance with study treatment|0
1682656|NCT01365455|5877238|P2|Maintenance Period|Non-compliance with study treatment|0
1682657|NCT01365455|5877239|P1|Maintenance Period|Non-compliance with study treatment|0
1682658|NCT01365455|5877235|P5|Maintenance Period|Lost to Follow-up|3
1682659|NCT01365455|5877236|P4|Maintenance Period|Lost to Follow-up|0
1682660|NCT01365455|5877237|P3|Maintenance Period|Lost to Follow-up|0
1682661|NCT01365455|5877238|P2|Maintenance Period|Lost to Follow-up|4
1682662|NCT01365455|5877239|P1|Maintenance Period|Lost to Follow-up|2
1682663|NCT01365455|5877235|P5|Maintenance Period|Lack of Efficacy|2
1682664|NCT01365455|5877236|P4|Maintenance Period|Lack of Efficacy|2
1682665|NCT01365455|5877237|P3|Maintenance Period|Lack of Efficacy|0
1682666|NCT01365455|5877238|P2|Maintenance Period|Lack of Efficacy|2
1682667|NCT01365455|5877239|P1|Maintenance Period|Lack of Efficacy|10
1682668|NCT01365455|5877235|P5|Maintenance Period|Adverse Event|4
1682669|NCT01365455|5877236|P4|Maintenance Period|Adverse Event|2
1682670|NCT01365455|5877237|P3|Maintenance Period|Adverse Event|1
1682671|NCT01365455|5877238|P2|Maintenance Period|Adverse Event|5
1682672|NCT01365455|5877239|P1|Maintenance Period|Adverse Event|12
1682673|NCT01365455|5877235|P5|Induction Period|Lost to Follow-up|0
1682674|NCT01365455|5877236|P4|Induction Period|Lost to Follow-up|0
1682675|NCT01365455|5877237|P3|Induction Period|Lost to Follow-up|3
1682676|NCT01365455|5877238|P2|Induction Period|Lost to Follow-up|0
1682677|NCT01365455|5877239|P1|Induction Period|Lost to Follow-up|0
1682678|NCT01365455|5877235|P5|Induction Period|Subject/guardian decision|0
1682679|NCT01365455|5877236|P4|Induction Period|Subject/guardian decision|0
1682680|NCT01365455|5877237|P3|Induction Period|Subject/guardian decision|8
1682681|NCT01365455|5877238|P2|Induction Period|Subject/guardian decision|1
1682682|NCT01365455|5877239|P1|Induction Period|Subject/guardian decision|9
1682683|NCT01365455|5877235|P5|Induction Period|Protocol deviation|0
1682684|NCT01365455|5877236|P4|Induction Period|Protocol deviation|0
1682685|NCT01365455|5877237|P3|Induction Period|Protocol deviation|1
1682686|NCT01365455|5877238|P2|Induction Period|Protocol deviation|1
1682687|NCT01365455|5877239|P1|Induction Period|Protocol deviation|0
1682688|NCT01365455|5877235|P5|Induction Period|Pregnancy|0
1682689|NCT01365455|5877236|P4|Induction Period|Pregnancy|0
1682690|NCT01365455|5877237|P3|Induction Period|Pregnancy|0
1682691|NCT01365455|5877238|P2|Induction Period|Pregnancy|1
1682692|NCT01365455|5877239|P1|Induction Period|Pregnancy|0
1682693|NCT01365455|5877235|P5|Induction Period|Lack of Efficacy|0
1682694|NCT01365455|5877236|P4|Induction Period|Lack of Efficacy|0
1682695|NCT01365455|5877237|P3|Induction Period|Lack of Efficacy|0
1682696|NCT01365455|5877238|P2|Induction Period|Lack of Efficacy|1
1682697|NCT01365455|5877239|P1|Induction Period|Lack of Efficacy|1
1682698|NCT01365455|5877235|P5|Induction Period|Adverse Event|0
1682699|NCT01365455|5877236|P4|Induction Period|Adverse Event|0
1682700|NCT01365455|5877237|P3|Induction Period|Adverse Event|4
1682701|NCT01365455|5877238|P2|Induction Period|Adverse Event|3
1682702|NCT01365455|5877239|P1|Induction Period|Adverse Event|5
1682703|NCT01365273|5877329|P2|Overall Study|Physician Decision|0
1682704|NCT01365273|5877330|P1|Overall Study|Physician Decision|1
1682705|NCT01365273|5877329|P2|Overall Study|Protocol Violation|1
1682706|NCT01365273|5877330|P1|Overall Study|Protocol Violation|0
1682707|NCT01365273|5877329|P2|Overall Study|Lost to Follow-up|0
1682708|NCT01365273|5877330|P1|Overall Study|Lost to Follow-up|1
1682709|NCT01365130|5877340|P1|Overall Study|Progression/worsening of Dx prior to txt|2
1682710|NCT01365091|5877349|P4|Period 2|Adverse Event|0
1682711|NCT01365091|5877350|P3|Period 2|Adverse Event|1
1682712|NCT01365091|5877351|P2|Period 2|Adverse Event|0
1682713|NCT01365091|5877352|P1|Period 2|Adverse Event|0
1682714|NCT01365091|5877349|P4|Period 2|Withdrawal by Subject|0
1682715|NCT01365091|5877350|P3|Period 2|Withdrawal by Subject|0
1682716|NCT01365091|5877351|P2|Period 2|Withdrawal by Subject|0
1682717|NCT01365091|5877352|P1|Period 2|Withdrawal by Subject|1
1682718|NCT01365091|5877349|P4|Period 1|Personal reasons|0
1682719|NCT01365091|5877350|P3|Period 1|Personal reasons|1
1682720|NCT01365091|5877351|P2|Period 1|Personal reasons|0
1682721|NCT01365091|5877352|P1|Period 1|Personal reasons|0
1682722|NCT01365091|5877349|P4|Period 1|Withdrawal by Subject|0
1682723|NCT01365091|5877350|P3|Period 1|Withdrawal by Subject|0
1682724|NCT01365091|5877351|P2|Period 1|Withdrawal by Subject|1
1682725|NCT01365091|5877352|P1|Period 1|Withdrawal by Subject|0
1682726|NCT01365091|5877349|P4|Period 1|No longer met study criteria|0
1682727|NCT01365091|5877350|P3|Period 1|No longer met study criteria|0
1682728|NCT01365091|5877351|P2|Period 1|No longer met study criteria|1
1682729|NCT01365091|5877352|P1|Period 1|No longer met study criteria|0
1682730|NCT01365091|5877349|P4|Period 1|Positive test result for drugs of abuse|0
1682731|NCT01365091|5877350|P3|Period 1|Positive test result for drugs of abuse|0
1682732|NCT01365091|5877351|P2|Period 1|Positive test result for drugs of abuse|0
1682733|NCT01365091|5877352|P1|Period 1|Positive test result for drugs of abuse|1
1682734|NCT01365091|5877349|P4|Period 1|Adverse Event|3
1682735|NCT01365091|5877350|P3|Period 1|Adverse Event|2
1682736|NCT01365091|5877351|P2|Period 1|Adverse Event|0
1682737|NCT01365091|5877352|P1|Period 1|Adverse Event|1
1682738|NCT01365052|5877380|P2|Overall Study|Adverse Event|4
1682739|NCT01365052|5877381|P1|Overall Study|Adverse Event|4
1682740|NCT01365039|5877397|P2|Overall Study|Study related symptoms and complaints|0
1682741|NCT01365039|5877398|P1|Overall Study|Study related symptoms and complaints|1
1682742|NCT01364922|5877409|P3|Double-Blind (DB) Period|Other, Unspecified|0
1682743|NCT01364922|5877410|P2|Double-Blind (DB) Period|Other, Unspecified|1
1682744|NCT01364922|5877411|P1|Double-Blind (DB) Period|Other, Unspecified|0
1682745|NCT01364922|5877409|P3|Double-Blind (DB) Period|Adverse Event|1
1682746|NCT01364922|5877410|P2|Double-Blind (DB) Period|Adverse Event|0
1682747|NCT01364922|5877411|P1|Double-Blind (DB) Period|Adverse Event|0
1682748|NCT01364922|5877409|P3|Double-Blind (DB) Period|Subject Noncompliant|0
1682749|NCT01364922|5877410|P2|Double-Blind (DB) Period|Subject Noncompliant|1
1682750|NCT01364922|5877411|P1|Double-Blind (DB) Period|Subject Noncompliant|0
1682751|NCT01364922|5877409|P3|Double-Blind (DB) Period|Lack of Efficacy|4
1682752|NCT01364922|5877410|P2|Double-Blind (DB) Period|Lack of Efficacy|3
1682753|NCT01364922|5877411|P1|Double-Blind (DB) Period|Lack of Efficacy|0
1682754|NCT01364922|5877409|P3|Open-label (OL) Period|Other, Unspecified|0
1682755|NCT01364922|5877410|P2|Open-label (OL) Period|Other, Unspecified|0
1682756|NCT01364922|5877411|P1|Open-label (OL) Period|Other, Unspecified|1
1682757|NCT01364922|5877409|P3|Open-label (OL) Period|Lost to Follow-up|0
1682758|NCT01364922|5877410|P2|Open-label (OL) Period|Lost to Follow-up|0
1682759|NCT01364922|5877411|P1|Open-label (OL) Period|Lost to Follow-up|1
1682760|NCT01364922|5877409|P3|Open-label (OL) Period|Lack of Efficacy|0
1682761|NCT01364922|5877410|P2|Open-label (OL) Period|Lack of Efficacy|0
1682762|NCT01364922|5877411|P1|Open-label (OL) Period|Lack of Efficacy|3
1682763|NCT01364922|5877409|P3|Open-label (OL) Period|Withdrawal by Subject|0
1682764|NCT01364922|5877410|P2|Open-label (OL) Period|Withdrawal by Subject|0
1682765|NCT01364922|5877411|P1|Open-label (OL) Period|Withdrawal by Subject|4
1682766|NCT01364922|5877409|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
1682767|NCT01364922|5877410|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
1682768|NCT01364922|5877411|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
1682769|NCT01364922|5877409|P3|Open-label (OL) Period|Adverse Event|0
1682770|NCT01364922|5877410|P2|Open-label (OL) Period|Adverse Event|0
1682771|NCT01364922|5877411|P1|Open-label (OL) Period|Adverse Event|7
1682772|NCT01364870|5877433|P3|Overall Study|Protocol Violation|0
1682773|NCT01364870|5877434|P2|Overall Study|Protocol Violation|0
1682774|NCT01364870|5877435|P1|Overall Study|Protocol Violation|1
1682775|NCT01364870|5877433|P3|Overall Study|Adverse Event|4
1682776|NCT01364870|5877434|P2|Overall Study|Adverse Event|6
1682777|NCT01364870|5877435|P1|Overall Study|Adverse Event|8
1682778|NCT01364870|5877433|P3|Overall Study|Withdrawal by Subject|10
1682779|NCT01364870|5877434|P2|Overall Study|Withdrawal by Subject|24
1682780|NCT01364870|5877435|P1|Overall Study|Withdrawal by Subject|13
1682781|NCT01364727|5877454|P1|Overall Study|Not Eligible|2
1682782|NCT01364649|5877462|P2|Overall Study|Other|1
1682783|NCT01364649|5877463|P1|Overall Study|Other|4
1682784|NCT01364649|5877462|P2|Overall Study|Lost to Follow-up|13
1682785|NCT01364649|5877463|P1|Overall Study|Lost to Follow-up|12
1682786|NCT01364649|5877462|P2|Overall Study|Withdrawal of Consent|7
1682787|NCT01364649|5877463|P1|Overall Study|Withdrawal of Consent|9
1682788|NCT01364649|5877462|P2|Overall Study|Protocol Deviations|8
1682789|NCT01364649|5877463|P1|Overall Study|Protocol Deviations|4
1682790|NCT01364649|5877462|P2|Overall Study|Non-compliance with Investigational Drug|0
1682791|NCT01364649|5877463|P1|Overall Study|Non-compliance with Investigational Drug|1
1682792|NCT01364649|5877462|P2|Overall Study|Lack of Efficacy|0
1682793|NCT01364649|5877463|P1|Overall Study|Lack of Efficacy|6
1682794|NCT01364649|5877462|P2|Overall Study|Pretreatment Event or Adverse Event|14
1682795|NCT01364649|5877463|P1|Overall Study|Pretreatment Event or Adverse Event|20
1682796|NCT01364428|5877551|P2|Overall Study|Other|3
1682797|NCT01364428|5877552|P1|Overall Study|Other|3
1682798|NCT01364428|5877551|P2|Overall Study|Withdrawal Criteria|10
1682799|NCT01364428|5877552|P1|Overall Study|Withdrawal Criteria|14
1682800|NCT01364428|5877551|P2|Overall Study|Protocol Violation|0
1682801|NCT01364428|5877552|P1|Overall Study|Protocol Violation|2
1682802|NCT01364428|5877551|P2|Overall Study|Adverse Event|2
1682803|NCT01364428|5877552|P1|Overall Study|Adverse Event|1
1682804|NCT01364389|5877569|P3|Overall Study|Adverse Event|0
1682805|NCT01364389|5877570|P2|Overall Study|Adverse Event|0
1682806|NCT01364389|5877571|P1|Overall Study|Adverse Event|1
1682807|NCT01364389|5877569|P3|Overall Study|Administrative problems|0
1682808|NCT01364389|5877570|P2|Overall Study|Administrative problems|0
1682809|NCT01364389|5877571|P1|Overall Study|Administrative problems|1
1682810|NCT01364389|5877569|P3|Overall Study|Protocol deviation|1
1682811|NCT01364389|5877570|P2|Overall Study|Protocol deviation|0
1682812|NCT01364389|5877571|P1|Overall Study|Protocol deviation|0
1682813|NCT01364389|5877569|P3|Overall Study|Withdrawal by Subject|0
1682814|NCT01364389|5877570|P2|Overall Study|Withdrawal by Subject|1
1682815|NCT01364389|5877571|P1|Overall Study|Withdrawal by Subject|0
1682816|NCT01364298|5877590|P2|Overall Study|Other|3
1682817|NCT01364298|5877591|P1|Overall Study|Other|1
1682818|NCT01364298|5877590|P2|Overall Study|Withdrawal by Subject|3
1682819|NCT01364298|5877591|P1|Overall Study|Withdrawal by Subject|3
1682820|NCT01364298|5877590|P2|Overall Study|Lost to Follow-up|10
1682821|NCT01364298|5877591|P1|Overall Study|Lost to Follow-up|5
1682822|NCT01364298|5877590|P2|Overall Study|Lack of Efficacy|0
1682823|NCT01364298|5877591|P1|Overall Study|Lack of Efficacy|1
1682824|NCT01364298|5877590|P2|Overall Study|Lack of adherence to treatment|3
1682825|NCT01364298|5877591|P1|Overall Study|Lack of adherence to treatment|1
1682826|NCT01364298|5877590|P2|Overall Study|Adverse Event|4
1682827|NCT01364298|5877591|P1|Overall Study|Adverse Event|3
1682828|NCT01364233|5877624|P1|Overall Study|Lost to Follow-up|1
1682829|NCT01363986|5877669|P1|Overall Study|Disease progression|1
1682830|NCT01363908|5877679|P2|Chronic Dosing (CD) Phase|Early study termination|3
1682831|NCT01363908|5877680|P1|Chronic Dosing (CD) Phase|Early study termination|9
1682832|NCT01363908|5877679|P2|Chronic Dosing (CD) Phase|Physician Decision|1
1682833|NCT01363908|5877680|P1|Chronic Dosing (CD) Phase|Physician Decision|0
1682834|NCT01363908|5877679|P2|Chronic Dosing (CD) Phase|Patient decision|1
1682835|NCT01363908|5877680|P1|Chronic Dosing (CD) Phase|Patient decision|0
1682836|NCT01363908|5877679|P2|Chronic Dosing (CD) Phase|Adverse Event|1
1682837|NCT01363908|5877680|P1|Chronic Dosing (CD) Phase|Adverse Event|1
1682838|NCT01363765|5877717|P2|Overall Study|smear during intervention|0
1682839|NCT01363765|5877718|P1|Overall Study|smear during intervention|2170
1682840|NCT01363765|5877717|P2|Overall Study|age not recorded (used for cross-linkage|354
1682841|NCT01363765|5877718|P1|Overall Study|age not recorded (used for cross-linkage|117
1682842|NCT01363765|5877717|P2|Overall Study|non-resident|76
1682843|NCT01363765|5877718|P1|Overall Study|non-resident|156
1682844|NCT01363765|5877717|P2|Overall Study|duplicate records|3177
1682845|NCT01363765|5877718|P1|Overall Study|duplicate records|736
1682846|NCT01363765|5877717|P2|Overall Study|non-diagnostic|1124
1682847|NCT01363765|5877718|P1|Overall Study|non-diagnostic|2621
1682848|NCT01363713|5877730|P1|Overall Study|Withdrawal by Subject|2
1682849|NCT01363713|5877730|P1|Overall Study|Protocol Violation|3
1682850|NCT01363713|5877730|P1|Overall Study|Adverse Event|1
1682851|NCT01363700|5877739|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1682852|NCT01363700|5877740|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1682853|NCT01363700|5877741|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1682854|NCT01363700|5877742|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
1682855|NCT01363700|5877743|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
1682856|NCT01363661|5877762|P2|Overall Study|Lost to Follow-up|1
1682857|NCT01363661|5877763|P1|Overall Study|Lost to Follow-up|3
1682858|NCT01363661|5877762|P2|Overall Study|Protocol Violation|0
1682859|NCT01363661|5877763|P1|Overall Study|Protocol Violation|1
1682860|NCT01363661|5877762|P2|Overall Study|Withdrawal by Subject|1
1682861|NCT01363661|5877763|P1|Overall Study|Withdrawal by Subject|1
1682862|NCT01363661|5877762|P2|Overall Study|Adverse Event|2
1682863|NCT01363661|5877763|P1|Overall Study|Adverse Event|9
1682864|NCT01363440|5877804|P3|Overall Study|Other|2
1682865|NCT01363440|5877805|P2|Overall Study|Other|5
1682866|NCT01363440|5877806|P1|Overall Study|Other|4
1682867|NCT01363440|5877804|P3|Overall Study|Lost to Follow-up|5
1682868|NCT01363440|5877805|P2|Overall Study|Lost to Follow-up|4
1682869|NCT01363440|5877806|P1|Overall Study|Lost to Follow-up|2
1682870|NCT01363440|5877804|P3|Overall Study|Withdrawal by Subject|11
1682871|NCT01363440|5877805|P2|Overall Study|Withdrawal by Subject|11
1682872|NCT01363440|5877806|P1|Overall Study|Withdrawal by Subject|9
1682873|NCT01363440|5877804|P3|Overall Study|Death|5
1682874|NCT01363440|5877805|P2|Overall Study|Death|7
1682875|NCT01363440|5877806|P1|Overall Study|Death|3
1682876|NCT01363440|5877804|P3|Overall Study|Adverse Event|4
1682877|NCT01363440|5877805|P2|Overall Study|Adverse Event|4
1682878|NCT01363440|5877806|P1|Overall Study|Adverse Event|5
1682879|NCT01363349|5877852|P2|Overall Study|missing|2
1682880|NCT01363349|5877853|P1|Overall Study|missing|1
1682881|NCT01363349|5877852|P2|Overall Study|Not reported|37
1682882|NCT01363349|5877853|P1|Overall Study|Not reported|36
1682883|NCT01363349|5877852|P2|Overall Study|Lost to Follow-up|6
1682884|NCT01363349|5877853|P1|Overall Study|Lost to Follow-up|5
1682885|NCT01363349|5877852|P2|Overall Study|Withdrawal by Subject|6
1682886|NCT01363349|5877853|P1|Overall Study|Withdrawal by Subject|14
1682887|NCT01363349|5877852|P2|Overall Study|Non compliance/Protocol deviations|2
1682888|NCT01363349|5877853|P1|Overall Study|Non compliance/Protocol deviations|2
1682889|NCT01363349|5877852|P2|Overall Study|Lack of Efficacy|10
1682890|NCT01363349|5877853|P1|Overall Study|Lack of Efficacy|3
1682891|NCT01363349|5877852|P2|Overall Study|Adverse Event|7
1682892|NCT01363349|5877853|P1|Overall Study|Adverse Event|6
1682893|NCT01363297|5877864|P5|Overall Study|Death|30
1682894|NCT01363297|5877865|P4|Overall Study|Death|10
1682895|NCT01363297|5877866|P3|Overall Study|Death|6
1682896|NCT01363297|5877867|P2|Overall Study|Death|6
1682897|NCT01363297|5877868|P1|Overall Study|Death|3
1682898|NCT01363297|5877864|P5|Overall Study|Other|1
1682899|NCT01363297|5877865|P4|Overall Study|Other|0
1682900|NCT01363297|5877866|P3|Overall Study|Other|0
1682901|NCT01363297|5877867|P2|Overall Study|Other|0
1682902|NCT01363297|5877868|P1|Overall Study|Other|0
1682903|NCT01363076|5877971|P2|Overall Study|Withdrawal by Subject|1
1682904|NCT01363076|5877972|P1|Overall Study|Withdrawal by Subject|0
1682905|NCT01363011|5878004|P2|Extension Phase|Rolled Over to Another Gilead Study|1
1682906|NCT01363011|5878005|P1|Extension Phase|Rolled Over to Another Gilead Study|2
1682907|NCT01363011|5878004|P2|Extension Phase|Lost to Follow-up|2
1682908|NCT01363011|5878005|P1|Extension Phase|Lost to Follow-up|0
1682909|NCT01363011|5878004|P2|Extension Phase|Withdrew Consent|1
1682910|NCT01363011|5878005|P1|Extension Phase|Withdrew Consent|0
1682911|NCT01363011|5878004|P2|Extension Phase|Investigator's Discretion|2
1682912|NCT01363011|5878005|P1|Extension Phase|Investigator's Discretion|2
1682913|NCT01363011|5878004|P2|Extension Phase|Lack of Efficacy|1
1682914|NCT01363011|5878005|P1|Extension Phase|Lack of Efficacy|0
1682915|NCT01363011|5878004|P2|Extension Phase|Adverse Event|1
1682916|NCT01363011|5878005|P1|Extension Phase|Adverse Event|1
1682917|NCT01363011|5878004|P2|Main Study|Protocol Violation|1
1682918|NCT01363011|5878005|P1|Main Study|Protocol Violation|0
1682919|NCT01363011|5878004|P2|Main Study|Withdrew Consent|4
1682920|NCT01363011|5878005|P1|Main Study|Withdrew Consent|1
1682921|NCT01363011|5878004|P2|Main Study|Investigator's Discretion|1
1682922|NCT01363011|5878005|P1|Main Study|Investigator's Discretion|1
1682923|NCT01363011|5878004|P2|Main Study|Adverse Event|3
1682924|NCT01363011|5878005|P1|Main Study|Adverse Event|2
1682925|NCT01362790|5878132|P7|Dose De-escalation of Regimen A|Progressive disease|0
1682926|NCT01362790|5878133|P6|Dose De-escalation of Regimen A|Progressive disease|0
1682927|NCT01362790|5878134|P5|Dose De-escalation of Regimen A|Progressive disease|2
1682928|NCT01362790|5878135|P4|Dose De-escalation of Regimen A|Progressive disease|0
1682929|NCT01362790|5878136|P3|Dose De-escalation of Regimen A|Progressive disease|0
1682930|NCT01362790|5878137|P2|Dose De-escalation of Regimen A|Progressive disease|0
1682931|NCT01362790|5878138|P1|Dose De-escalation of Regimen A|Progressive disease|0
1682932|NCT01362790|5878132|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
1682933|NCT01362790|5878133|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
1682934|NCT01362790|5878134|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
1682935|NCT01362790|5878135|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
1682936|NCT01362790|5878136|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
1682937|NCT01362790|5878137|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
1682938|NCT01362790|5878138|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
1682939|NCT01362790|5878132|P7|Dose De-escalation of Regimen A|Adverse Event|0
1682940|NCT01362790|5878133|P6|Dose De-escalation of Regimen A|Adverse Event|0
1682941|NCT01362790|5878134|P5|Dose De-escalation of Regimen A|Adverse Event|1
1682942|NCT01362790|5878135|P4|Dose De-escalation of Regimen A|Adverse Event|0
1682943|NCT01362790|5878136|P3|Dose De-escalation of Regimen A|Adverse Event|0
1682944|NCT01362790|5878137|P2|Dose De-escalation of Regimen A|Adverse Event|0
1682945|NCT01362790|5878138|P1|Dose De-escalation of Regimen A|Adverse Event|0
1682946|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Death on study|0
1682947|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Death on study|0
1682948|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Death on study|0
1682949|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Death on study|1
1682950|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Death on study|0
1682951|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Death on study|0
1682952|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Death on study|0
1682953|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
1682954|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
1682955|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
1682956|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
1682957|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
1682958|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
1682959|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
1682960|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
1682961|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
1682962|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
1682963|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
1682964|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
1682965|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
1682966|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
1682967|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Progressive disease|0
1682968|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Progressive disease|2
1682969|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Progressive disease|0
1682970|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Progressive disease|3
1682971|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Progressive disease|2
1682972|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Progressive disease|2
1682973|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Progressive disease|1
1682974|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Refused further treatment|0
1682975|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Refused further treatment|0
1682976|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Refused further treatment|0
1682977|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Refused further treatment|0
1682978|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Refused further treatment|0
1682979|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Refused further treatment|1
1682980|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Refused further treatment|0
1682981|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Developed antibodies|0
1682982|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Developed antibodies|0
1682983|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Developed antibodies|0
1682984|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Developed antibodies|8
1682985|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Developed antibodies|3
1682986|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Developed antibodies|2
1682987|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Developed antibodies|7
1682988|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Physician Decision|0
1682989|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Physician Decision|0
1682990|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Physician Decision|0
1682991|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Physician Decision|1
1682992|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Physician Decision|0
1682993|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Physician Decision|0
1682994|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Physician Decision|0
1682995|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Adverse Event|0
1682996|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Adverse Event|2
1682997|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Adverse Event|0
1682998|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Adverse Event|1
1682999|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Adverse Event|0
1683000|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Adverse Event|1
1683001|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Adverse Event|0
1683002|NCT01362790|5878132|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
1683003|NCT01362790|5878133|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
1683004|NCT01362790|5878134|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
1683005|NCT01362790|5878135|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
1683006|NCT01362790|5878136|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
1683007|NCT01362790|5878137|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
1683008|NCT01362790|5878138|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
1683009|NCT01362608|5878206|P2|Overall Study|Adverse Event|2
1683010|NCT01362608|5878207|P1|Overall Study|Adverse Event|0
1683011|NCT01362608|5878206|P2|Overall Study|Lack of Efficacy|2
1683012|NCT01362608|5878207|P1|Overall Study|Lack of Efficacy|0
1683013|NCT01362608|5878206|P2|Overall Study|Withdrawal by Subject|2
1683014|NCT01362608|5878207|P1|Overall Study|Withdrawal by Subject|1
1683015|NCT01362608|5878206|P2|Overall Study|Lost to Follow-up|1
1683016|NCT01362608|5878207|P1|Overall Study|Lost to Follow-up|3
1683017|NCT01362608|5878206|P2|Overall Study|Protocol Violation|1
1683018|NCT01362608|5878207|P1|Overall Study|Protocol Violation|0
1683019|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
1683020|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
1683021|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
1683022|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
1683023|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
1683024|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
1683025|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
1683026|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
1683027|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
1683028|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
1683029|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
1683030|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
1683031|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
1683032|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
1683033|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
1683034|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
1683035|NCT01362530|5878245|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
1683036|NCT01362530|5878246|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
1683037|NCT01362530|5878245|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
1683038|NCT01362530|5878246|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
1683039|NCT01362530|5878245|P2|Base Study (Cycle 1)|Protocol Violation|0
1683040|NCT01362530|5878246|P1|Base Study (Cycle 1)|Protocol Violation|2
1683041|NCT01362530|5878245|P2|Base Study (Cycle 1)|Physician Decision|1
1683042|NCT01362530|5878246|P1|Base Study (Cycle 1)|Physician Decision|0
1683043|NCT01362530|5878245|P2|Base Study (Cycle 1)|Adverse Event|0
1683044|NCT01362530|5878246|P1|Base Study (Cycle 1)|Adverse Event|2
1683045|NCT01362517|5878259|P1|Overall Study|Lost to Follow-up|1
1683046|NCT01362517|5878259|P1|Overall Study|Protocol Violation|1
1683047|NCT01362491|5878270|P3|Overall Study|Ineligible|0
1683048|NCT01362491|5878271|P2|Overall Study|Ineligible|0
1683049|NCT01362491|5878272|P1|Overall Study|Ineligible|1
1683050|NCT01362439|5878320|P1|Overall Study|Participant who withdrew consent|8
1683051|NCT01362439|5878320|P1|Overall Study|Study medication non-compliant|1
1683052|NCT01362439|5878320|P1|Overall Study|Lost to Follow-up|2
1683053|NCT01362439|5878320|P1|Overall Study|Lack of Efficacy|3
1683054|NCT01362439|5878320|P1|Overall Study|Adverse Event|1
1683055|NCT01362348|5878335|P1|Overall Study|Study closed/terminated|5
1683056|NCT01362348|5878335|P1|Overall Study|Protocol-defined stopping criteria|9
1683057|NCT01362322|5878354|P2|Overall Study|Lost to Follow-up|6
1683058|NCT01362322|5878355|P1|Overall Study|Lost to Follow-up|2
1683059|NCT01362322|5878354|P2|Overall Study|Withdrawal by Subject|1
1683060|NCT01362322|5878355|P1|Overall Study|Withdrawal by Subject|3
1683061|NCT01362296|5878387|P4|Crossover Phase|Study Closed/Terminated|0
1683062|NCT01362296|5878388|P3|Crossover Phase|Study Closed/Terminated|1
1683063|NCT01362296|5878389|P2|Crossover Phase|Study Closed/Terminated|0
1683064|NCT01362296|5878390|P1|Crossover Phase|Study Closed/Terminated|0
1683065|NCT01362296|5878387|P4|Crossover Phase|Adverse Event|0
1683066|NCT01362296|5878388|P3|Crossover Phase|Adverse Event|4
1683067|NCT01362296|5878389|P2|Crossover Phase|Adverse Event|0
1683068|NCT01362296|5878390|P1|Crossover Phase|Adverse Event|0
1683069|NCT01362296|5878387|P4|Crossover Phase|Withdrawal by Subject|1
1683070|NCT01362296|5878388|P3|Crossover Phase|Withdrawal by Subject|2
1683071|NCT01362296|5878389|P2|Crossover Phase|Withdrawal by Subject|0
1683072|NCT01362296|5878390|P1|Crossover Phase|Withdrawal by Subject|0
1683073|NCT01362296|5878387|P4|Crossover Phase|PD including Death due to PD|1
1683074|NCT01362296|5878388|P3|Crossover Phase|PD including Death due to PD|16
1683075|NCT01362296|5878389|P2|Crossover Phase|PD including Death due to PD|0
1683076|NCT01362296|5878390|P1|Crossover Phase|PD including Death due to PD|0
1683077|NCT01362296|5878387|P4|Randomized Phase (RP)|Study Closed/Terminated|0
1683078|NCT01362296|5878388|P3|Randomized Phase (RP)|Study Closed/Terminated|0
1683079|NCT01362296|5878389|P2|Randomized Phase (RP)|Study Closed/Terminated|1
1683080|NCT01362296|5878390|P1|Randomized Phase (RP)|Study Closed/Terminated|8
1683081|NCT01362296|5878387|P4|Randomized Phase (RP)|Adverse Event|0
1683082|NCT01362296|5878388|P3|Randomized Phase (RP)|Adverse Event|0
1683083|NCT01362296|5878389|P2|Randomized Phase (RP)|Adverse Event|4
1683084|NCT01362296|5878390|P1|Randomized Phase (RP)|Adverse Event|20
1683085|NCT01362296|5878387|P4|Randomized Phase (RP)|Withdrawal by Subject|0
1683086|NCT01362296|5878388|P3|Randomized Phase (RP)|Withdrawal by Subject|0
1683087|NCT01362296|5878389|P2|Randomized Phase (RP)|Withdrawal by Subject|1
1683088|NCT01362296|5878390|P1|Randomized Phase (RP)|Withdrawal by Subject|2
1683089|NCT01362296|5878387|P4|Randomized Phase (RP)|Physician Decision|0
1683090|NCT01362296|5878388|P3|Randomized Phase (RP)|Physician Decision|0
1683091|NCT01362296|5878389|P2|Randomized Phase (RP)|Physician Decision|9
1683092|NCT01362296|5878390|P1|Randomized Phase (RP)|Physician Decision|1
1683093|NCT01362296|5878387|P4|Randomized Phase (RP)|PD including Death due to PD|0
1683094|NCT01362296|5878388|P3|Randomized Phase (RP)|PD including Death due to PD|0
1683095|NCT01362296|5878389|P2|Randomized Phase (RP)|PD including Death due to PD|28
1683096|NCT01362296|5878390|P1|Randomized Phase (RP)|PD including Death due to PD|56
1683097|NCT01362244|5878438|P2|Overall Study|Protocol Defined Stopping Criteria|1
1683098|NCT01362244|5878439|P1|Overall Study|Protocol Defined Stopping Criteria|0
1683099|NCT01362244|5878438|P2|Overall Study|Did not Meet Continuation Criteria|11
1683100|NCT01362244|5878439|P1|Overall Study|Did not Meet Continuation Criteria|17
1683101|NCT01362244|5878438|P2|Overall Study|Withdrawal by Subject|1
1683102|NCT01362244|5878439|P1|Overall Study|Withdrawal by Subject|2
1683103|NCT01362244|5878438|P2|Overall Study|Protocol Violation|1
1683104|NCT01362244|5878439|P1|Overall Study|Protocol Violation|5
1683105|NCT01362244|5878438|P2|Overall Study|Lost to Follow-up|2
1683106|NCT01362244|5878439|P1|Overall Study|Lost to Follow-up|0
1683107|NCT01362244|5878438|P2|Overall Study|Lack of Efficacy|11
1683108|NCT01362244|5878439|P1|Overall Study|Lack of Efficacy|5
1683109|NCT01362244|5878438|P2|Overall Study|Adverse Event|5
1683110|NCT01362244|5878439|P1|Overall Study|Adverse Event|3
1683111|NCT01362140|5878551|P2|Overall Study|Discontinued Without Receiving Treatment|1
1683112|NCT01362140|5878552|P1|Overall Study|Discontinued Without Receiving Treatment|0
1683113|NCT01362140|5878551|P2|Overall Study|Protocol-specified Criteria|2
1683114|NCT01362140|5878552|P1|Overall Study|Protocol-specified Criteria|1
1683115|NCT01362140|5878551|P2|Overall Study|Other|1
1683116|NCT01362140|5878552|P1|Overall Study|Other|1
1683117|NCT01362140|5878551|P2|Overall Study|Death|1
1683118|NCT01362140|5878552|P1|Overall Study|Death|2
1683119|NCT01362140|5878551|P2|Overall Study|Administrative Decision|1
1683120|NCT01362140|5878552|P1|Overall Study|Administrative Decision|0
1683121|NCT01362140|5878551|P2|Overall Study|Withdrawal by Subject|3
1683122|NCT01362140|5878552|P1|Overall Study|Withdrawal by Subject|3
1683123|NCT01362140|5878551|P2|Overall Study|Adverse Event|2
1683124|NCT01362140|5878552|P1|Overall Study|Adverse Event|2
1683125|NCT01362140|5878551|P2|Overall Study|Noncompliance|0
1683126|NCT01362140|5878552|P1|Overall Study|Noncompliance|1
1683127|NCT01362062|5878576|P2|Overall Study|Had significant improvement|0
1683128|NCT01362062|5878577|P1|Overall Study|Had significant improvement|9
1683129|NCT01362062|5878576|P2|Overall Study|Detected with Spondylo-arthritis|0
1683130|NCT01362062|5878577|P1|Overall Study|Detected with Spondylo-arthritis|1
1683131|NCT01362062|5878576|P2|Overall Study|Non-compliant participant|0
1683132|NCT01362062|5878577|P1|Overall Study|Non-compliant participant|2
1683133|NCT01362062|5878576|P2|Overall Study|Withdrawal by Subject|0
1683134|NCT01362062|5878577|P1|Overall Study|Withdrawal by Subject|2
1683135|NCT01362062|5878576|P2|Overall Study|Lost to Follow-up|0
1683136|NCT01362062|5878577|P1|Overall Study|Lost to Follow-up|11
1683137|NCT01362062|5878576|P2|Overall Study|Adverse Event|0
1683138|NCT01362062|5878577|P1|Overall Study|Adverse Event|1
1683139|NCT01362049|5878598|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
1683140|NCT01362049|5878599|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
1683141|NCT01362049|5878600|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
1683142|NCT01362049|5878601|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
1683143|NCT01362049|5878598|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
1683144|NCT01362049|5878599|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
1683145|NCT01362049|5878600|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
1683146|NCT01362049|5878601|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
1683147|NCT01361919|5878642|P3|Overall Study|technical issues|10
1683148|NCT01361919|5878643|P2|Overall Study|technical issues|12
1683149|NCT01361919|5878644|P1|Overall Study|technical issues|10
1683150|NCT01361607|5878685|P2|Overall Study|Met Withdrawal Criteria|1
1683151|NCT01361607|5878686|P1|Overall Study|Met Withdrawal Criteria|1
1683152|NCT01361607|5878685|P2|Overall Study|Lost to Follow-up|0
1683153|NCT01361607|5878686|P1|Overall Study|Lost to Follow-up|1
1683154|NCT01361607|5878685|P2|Overall Study|Withdrawal by Investigator|3
1683155|NCT01361607|5878686|P1|Overall Study|Withdrawal by Investigator|5
1683156|NCT01361607|5878685|P2|Overall Study|Withdrawal by Subject|8
1683157|NCT01361607|5878686|P1|Overall Study|Withdrawal by Subject|19
1683158|NCT01361607|5878685|P2|Overall Study|Adverse Event|29
1683159|NCT01361607|5878686|P1|Overall Study|Adverse Event|38
1683160|NCT01361594|5878714|P2|Overall Study|Withdrawal by Subject|2
1683161|NCT01361594|5878715|P1|Overall Study|Withdrawal by Subject|1
1683162|NCT01361568|5878729|P6|Overall Study|Withdrawal by Subject|1
1683163|NCT01361568|5878730|P5|Overall Study|Withdrawal by Subject|0
1683164|NCT01361568|5878731|P4|Overall Study|Withdrawal by Subject|0
1683165|NCT01361568|5878732|P3|Overall Study|Withdrawal by Subject|0
1683166|NCT01361568|5878733|P2|Overall Study|Withdrawal by Subject|1
1683167|NCT01361568|5878734|P1|Overall Study|Withdrawal by Subject|2
1683168|NCT01361568|5878729|P6|Overall Study|Physician Decision|1
1683169|NCT01361568|5878730|P5|Overall Study|Physician Decision|0
1683170|NCT01361568|5878731|P4|Overall Study|Physician Decision|0
1683171|NCT01361568|5878732|P3|Overall Study|Physician Decision|0
1683172|NCT01361568|5878733|P2|Overall Study|Physician Decision|0
1683173|NCT01361568|5878734|P1|Overall Study|Physician Decision|0
1683174|NCT01361568|5878729|P6|Overall Study|Adverse Event|0
1683175|NCT01361568|5878730|P5|Overall Study|Adverse Event|1
1683176|NCT01361568|5878731|P4|Overall Study|Adverse Event|0
1683177|NCT01361568|5878732|P3|Overall Study|Adverse Event|0
1683178|NCT01361568|5878733|P2|Overall Study|Adverse Event|0
1683179|NCT01361568|5878734|P1|Overall Study|Adverse Event|0
1683180|NCT01361464|5878764|P1|Overall Study|Withdrawal by Subject|2
1683181|NCT01361464|5878764|P1|Overall Study|Death|1
1683182|NCT01361308|5878773|P2|Overall Study|Other|1
1683183|NCT01361308|5878774|P1|Overall Study|Other|0
1683184|NCT01361308|5878773|P2|Overall Study|Failed C-SSRS|2
1683185|NCT01361308|5878774|P1|Overall Study|Failed C-SSRS|5
1683186|NCT01361308|5878773|P2|Overall Study|Eligibility Criteria Not Met|3
1683187|NCT01361308|5878774|P1|Overall Study|Eligibility Criteria Not Met|2
1683188|NCT01361308|5878773|P2|Overall Study|Adverse Event|4
1683189|NCT01361308|5878774|P1|Overall Study|Adverse Event|8
1683190|NCT01361308|5878773|P2|Overall Study|Lost to Follow-up|4
1683191|NCT01361308|5878774|P1|Overall Study|Lost to Follow-up|5
1683192|NCT01361308|5878773|P2|Overall Study|Protocol Violation|0
1683193|NCT01361308|5878774|P1|Overall Study|Protocol Violation|1
1683194|NCT01361308|5878773|P2|Overall Study|Lack of Efficacy|0
1683195|NCT01361308|5878774|P1|Overall Study|Lack of Efficacy|2
1683196|NCT01361308|5878773|P2|Overall Study|Physician Decision|3
1683197|NCT01361308|5878774|P1|Overall Study|Physician Decision|3
1683198|NCT01361308|5878773|P2|Overall Study|Withdrawal by Subject|13
1683199|NCT01361308|5878774|P1|Overall Study|Withdrawal by Subject|9
1683200|NCT01361178|5878822|P2|Overall Study|Death|0
1683201|NCT01361178|5878823|P1|Overall Study|Death|13
1683202|NCT01361126|5878831|P2|Overall Study|Sponsor decision|2
1683203|NCT01361126|5878832|P1|Overall Study|Sponsor decision|0
1683204|NCT01361009|5878871|P1|Overall Study|Protocol Violation|116
1683205|NCT01360996|5878881|P3|Overall Study|Noncompliant|0
1683206|NCT01360996|5878882|P2|Overall Study|Noncompliant|0
1683207|NCT01360996|5878883|P1|Overall Study|Noncompliant|2
1683208|NCT01360996|5878881|P3|Overall Study|Withdrawal by Subject|2
1683209|NCT01360996|5878882|P2|Overall Study|Withdrawal by Subject|3
1683210|NCT01360996|5878883|P1|Overall Study|Withdrawal by Subject|4
1683211|NCT01360866|5878906|P4|Overall Study|Lack of Efficacy|4
1683212|NCT01360866|5878907|P3|Overall Study|Lack of Efficacy|30
1683213|NCT01360866|5878908|P2|Overall Study|Lack of Efficacy|40
1683214|NCT01360866|5878909|P1|Overall Study|Lack of Efficacy|30
1683215|NCT01360866|5878906|P4|Overall Study|Protocol Deviation|2
1683216|NCT01360866|5878907|P3|Overall Study|Protocol Deviation|61
1683217|NCT01360866|5878908|P2|Overall Study|Protocol Deviation|33
1683218|NCT01360866|5878909|P1|Overall Study|Protocol Deviation|25
1683219|NCT01360866|5878906|P4|Overall Study|Withdrawal by participant|8
1683220|NCT01360866|5878907|P3|Overall Study|Withdrawal by participant|168
1683221|NCT01360866|5878908|P2|Overall Study|Withdrawal by participant|89
1683222|NCT01360866|5878909|P1|Overall Study|Withdrawal by participant|79
1683223|NCT01360866|5878906|P4|Overall Study|Withdrawn by Investigator|2
1683224|NCT01360866|5878907|P3|Overall Study|Withdrawn by Investigator|31
1683225|NCT01360866|5878908|P2|Overall Study|Withdrawn by Investigator|8
1683226|NCT01360866|5878909|P1|Overall Study|Withdrawn by Investigator|9
1683227|NCT01360866|5878906|P4|Overall Study|Paticipant met withdrawal criteria|0
1683228|NCT01360866|5878907|P3|Overall Study|Paticipant met withdrawal criteria|54
1683229|NCT01360866|5878908|P2|Overall Study|Paticipant met withdrawal criteria|28
1683230|NCT01360866|5878909|P1|Overall Study|Paticipant met withdrawal criteria|11
1683231|NCT01360866|5878906|P4|Overall Study|Adverse Event|6
1683232|NCT01360866|5878907|P3|Overall Study|Adverse Event|134
1683233|NCT01360866|5878908|P2|Overall Study|Adverse Event|61
1683234|NCT01360866|5878909|P1|Overall Study|Adverse Event|56
1683235|NCT01360866|5878906|P4|Overall Study|Lost to Follow-up|0
1683236|NCT01360866|5878907|P3|Overall Study|Lost to Follow-up|41
1683237|NCT01360866|5878908|P2|Overall Study|Lost to Follow-up|28
1683238|NCT01360866|5878909|P1|Overall Study|Lost to Follow-up|11
1683239|NCT01360840|5878938|P3|Overall Study|Ongoing at data cut-off|9
1683240|NCT01360840|5878939|P2|Overall Study|Ongoing at data cut-off|10
1683241|NCT01360840|5878940|P1|Overall Study|Ongoing at data cut-off|10
1683242|NCT01360762|5878990|P1|Whole Study Period|Discontinuation of study drug for safety|1
1683243|NCT01360762|5878990|P1|Whole Study Period|Patient relapsed|18
1683244|NCT01360762|5878990|P1|Whole Study Period|Death|7
1683245|NCT01360762|5878990|P1|Whole Study Period|Lost to Follow-up|10
1683246|NCT01360762|5878990|P1|Main Study Period (12-month Treatment)|Discontinuation|1
1683247|NCT01360762|5878990|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
1683248|NCT01360762|5878990|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
1683249|NCT01360762|5878990|P1|Main Study Period (12-month Treatment)|Death|5
1683250|NCT01360762|5878990|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
1683251|NCT01360645|5879000|P4|Phase A+|Protocol Deviation|4
1683252|NCT01360645|5879001|P3|Phase A+|Protocol Deviation|0
1683253|NCT01360645|5879002|P2|Phase A+|Protocol Deviation|0
1683254|NCT01360645|5879003|P1|Phase A+|Protocol Deviation|0
1683255|NCT01360645|5879000|P4|Phase A+|Withdrawal by Subject|5
1683256|NCT01360645|5879001|P3|Phase A+|Withdrawal by Subject|0
1683257|NCT01360645|5879002|P2|Phase A+|Withdrawal by Subject|0
1683258|NCT01360645|5879003|P1|Phase A+|Withdrawal by Subject|0
1683259|NCT01360645|5879000|P4|Phase A+|Physician Decision|2
1683260|NCT01360645|5879001|P3|Phase A+|Physician Decision|0
1683261|NCT01360645|5879002|P2|Phase A+|Physician Decision|0
1683262|NCT01360645|5879003|P1|Phase A+|Physician Decision|0
1683263|NCT01360645|5879000|P4|Phase A+|Met Withdrawal Criteria|4
1683264|NCT01360645|5879001|P3|Phase A+|Met Withdrawal Criteria|0
1683265|NCT01360645|5879002|P2|Phase A+|Met Withdrawal Criteria|0
1683266|NCT01360645|5879003|P1|Phase A+|Met Withdrawal Criteria|0
1683267|NCT01360645|5879000|P4|Phase A+|Adverse Event|2
1683268|NCT01360645|5879001|P3|Phase A+|Adverse Event|0
1683269|NCT01360645|5879002|P2|Phase A+|Adverse Event|0
1683270|NCT01360645|5879003|P1|Phase A+|Adverse Event|0
1683271|NCT01360645|5879000|P4|Phase A+|Lost to Follow-up|7
1683272|NCT01360645|5879001|P3|Phase A+|Lost to Follow-up|0
1683273|NCT01360645|5879002|P2|Phase A+|Lost to Follow-up|0
1683274|NCT01360645|5879003|P1|Phase A+|Lost to Follow-up|0
1683275|NCT01360645|5879000|P4|Phase B (6 Weeks)|Protocol Deviation|0
1683276|NCT01360645|5879001|P3|Phase B (6 Weeks)|Protocol Deviation|3
1683277|NCT01360645|5879002|P2|Phase B (6 Weeks)|Protocol Deviation|1
1683278|NCT01360645|5879003|P1|Phase B (6 Weeks)|Protocol Deviation|0
1683279|NCT01360645|5879000|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
1683280|NCT01360645|5879001|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
1683281|NCT01360645|5879002|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
1683282|NCT01360645|5879003|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
1683283|NCT01360645|5879000|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1683284|NCT01360645|5879001|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
1683285|NCT01360645|5879002|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
1683286|NCT01360645|5879003|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1683287|NCT01360645|5879000|P4|Phase B (6 Weeks)|Adverse Event|0
1683288|NCT01360645|5879001|P3|Phase B (6 Weeks)|Adverse Event|0
1683289|NCT01360645|5879002|P2|Phase B (6 Weeks)|Adverse Event|6
1683290|NCT01360645|5879003|P1|Phase B (6 Weeks)|Adverse Event|0
1683291|NCT01360645|5879000|P4|Phase B (6 Weeks)|Lost to Follow-up|0
1683292|NCT01360645|5879001|P3|Phase B (6 Weeks)|Lost to Follow-up|0
1683293|NCT01360645|5879002|P2|Phase B (6 Weeks)|Lost to Follow-up|1
1683294|NCT01360645|5879003|P1|Phase B (6 Weeks)|Lost to Follow-up|0
1683295|NCT01360645|5879000|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1683296|NCT01360645|5879001|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1683297|NCT01360645|5879002|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
1683298|NCT01360645|5879003|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
1683299|NCT01360645|5879000|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1683300|NCT01360645|5879001|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1683301|NCT01360645|5879002|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
1683302|NCT01360645|5879003|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
1683303|NCT01360645|5879000|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1683304|NCT01360645|5879001|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1683390|NCT01360632|5879059|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
1683305|NCT01360645|5879002|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
1683306|NCT01360645|5879003|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
1683307|NCT01360645|5879000|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1683308|NCT01360645|5879001|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1683309|NCT01360645|5879002|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
1683310|NCT01360645|5879003|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
1683311|NCT01360645|5879000|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1683312|NCT01360645|5879001|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1683313|NCT01360645|5879002|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
1683314|NCT01360645|5879003|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
1683315|NCT01360645|5879000|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1683316|NCT01360645|5879001|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1683317|NCT01360645|5879002|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
1683318|NCT01360645|5879003|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
1683319|NCT01360632|5879058|P5|Phase A+|Protocol Deviation|3
1683320|NCT01360632|5879059|P4|Phase A+|Protocol Deviation|0
1683321|NCT01360632|5879060|P3|Phase A+|Protocol Deviation|0
1683322|NCT01360632|5879061|P2|Phase A+|Protocol Deviation|0
1683323|NCT01360632|5879062|P1|Phase A+|Protocol Deviation|0
1683324|NCT01360632|5879058|P5|Phase A+|Withdrawal by Subject|8
1683325|NCT01360632|5879059|P4|Phase A+|Withdrawal by Subject|0
1683326|NCT01360632|5879060|P3|Phase A+|Withdrawal by Subject|0
1683327|NCT01360632|5879061|P2|Phase A+|Withdrawal by Subject|0
1683328|NCT01360632|5879062|P1|Phase A+|Withdrawal by Subject|0
1683329|NCT01360632|5879058|P5|Phase A+|Physician Decision|3
1683330|NCT01360632|5879059|P4|Phase A+|Physician Decision|0
1683331|NCT01360632|5879060|P3|Phase A+|Physician Decision|0
1683332|NCT01360632|5879061|P2|Phase A+|Physician Decision|0
1683333|NCT01360632|5879062|P1|Phase A+|Physician Decision|0
1683334|NCT01360632|5879058|P5|Phase A+|Met Withdrawal Criteria|7
1683335|NCT01360632|5879059|P4|Phase A+|Met Withdrawal Criteria|0
1683336|NCT01360632|5879060|P3|Phase A+|Met Withdrawal Criteria|0
1683337|NCT01360632|5879061|P2|Phase A+|Met Withdrawal Criteria|0
1683338|NCT01360632|5879062|P1|Phase A+|Met Withdrawal Criteria|0
1683339|NCT01360632|5879058|P5|Phase A+|Adverse Event|2
1683340|NCT01360632|5879059|P4|Phase A+|Adverse Event|0
1683341|NCT01360632|5879060|P3|Phase A+|Adverse Event|0
1683342|NCT01360632|5879061|P2|Phase A+|Adverse Event|0
1683343|NCT01360632|5879062|P1|Phase A+|Adverse Event|0
1683344|NCT01360632|5879058|P5|Phase A+|Lost to Follow-up|2
1683345|NCT01360632|5879059|P4|Phase A+|Lost to Follow-up|0
1683346|NCT01360632|5879060|P3|Phase A+|Lost to Follow-up|0
1683347|NCT01360632|5879061|P2|Phase A+|Lost to Follow-up|0
1683348|NCT01360632|5879062|P1|Phase A+|Lost to Follow-up|0
1683349|NCT01360632|5879058|P5|Phase B (6 Weeks)|Lack of Efficacy|0
1683350|NCT01360632|5879059|P4|Phase B (6 Weeks)|Lack of Efficacy|0
1683351|NCT01360632|5879060|P3|Phase B (6 Weeks)|Lack of Efficacy|0
1683352|NCT01360632|5879061|P2|Phase B (6 Weeks)|Lack of Efficacy|1
1683353|NCT01360632|5879062|P1|Phase B (6 Weeks)|Lack of Efficacy|0
1683354|NCT01360632|5879058|P5|Phase B (6 Weeks)|Protocol Deviation|0
1683355|NCT01360632|5879059|P4|Phase B (6 Weeks)|Protocol Deviation|1
1683356|NCT01360632|5879060|P3|Phase B (6 Weeks)|Protocol Deviation|4
1683357|NCT01360632|5879061|P2|Phase B (6 Weeks)|Protocol Deviation|1
1683358|NCT01360632|5879062|P1|Phase B (6 Weeks)|Protocol Deviation|0
1683359|NCT01360632|5879058|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
1683360|NCT01360632|5879059|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
1683361|NCT01360632|5879060|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
1683362|NCT01360632|5879061|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
1683363|NCT01360632|5879062|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
1683364|NCT01360632|5879058|P5|Phase B (6 Weeks)|Physician Decision|0
1683365|NCT01360632|5879059|P4|Phase B (6 Weeks)|Physician Decision|1
1683366|NCT01360632|5879060|P3|Phase B (6 Weeks)|Physician Decision|0
1683367|NCT01360632|5879061|P2|Phase B (6 Weeks)|Physician Decision|0
1683368|NCT01360632|5879062|P1|Phase B (6 Weeks)|Physician Decision|0
1683369|NCT01360632|5879058|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1683370|NCT01360632|5879059|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
1683371|NCT01360632|5879060|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
1683372|NCT01360632|5879061|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1683373|NCT01360632|5879062|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
1683374|NCT01360632|5879058|P5|Phase B (6 Weeks)|Adverse Event|0
1683375|NCT01360632|5879059|P4|Phase B (6 Weeks)|Adverse Event|3
1683376|NCT01360632|5879060|P3|Phase B (6 Weeks)|Adverse Event|9
1683377|NCT01360632|5879061|P2|Phase B (6 Weeks)|Adverse Event|3
1683378|NCT01360632|5879062|P1|Phase B (6 Weeks)|Adverse Event|0
1683379|NCT01360632|5879058|P5|Phase B (6 Weeks)|Lost to Follow-up|0
1683380|NCT01360632|5879059|P4|Phase B (6 Weeks)|Lost to Follow-up|0
1683381|NCT01360632|5879060|P3|Phase B (6 Weeks)|Lost to Follow-up|1
1683382|NCT01360632|5879061|P2|Phase B (6 Weeks)|Lost to Follow-up|1
1683383|NCT01360632|5879062|P1|Phase B (6 Weeks)|Lost to Follow-up|0
1683384|NCT01360632|5879058|P5|Phase A (8 Weeks)|Protocol Deviation|0
1683385|NCT01360632|5879059|P4|Phase A (8 Weeks)|Protocol Deviation|0
1683386|NCT01360632|5879060|P3|Phase A (8 Weeks)|Protocol Deviation|0
1683387|NCT01360632|5879061|P2|Phase A (8 Weeks)|Protocol Deviation|0
1683388|NCT01360632|5879062|P1|Phase A (8 Weeks)|Protocol Deviation|39
1683389|NCT01360632|5879058|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
1683391|NCT01360632|5879060|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
1683392|NCT01360632|5879061|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
1683393|NCT01360632|5879062|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
1683394|NCT01360632|5879058|P5|Phase A (8 Weeks)|Physician Decision|0
1683395|NCT01360632|5879059|P4|Phase A (8 Weeks)|Physician Decision|0
1683396|NCT01360632|5879060|P3|Phase A (8 Weeks)|Physician Decision|0
1683397|NCT01360632|5879061|P2|Phase A (8 Weeks)|Physician Decision|0
1683398|NCT01360632|5879062|P1|Phase A (8 Weeks)|Physician Decision|10
1683399|NCT01360632|5879058|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1683400|NCT01360632|5879059|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1683401|NCT01360632|5879060|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1683402|NCT01360632|5879061|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
1683403|NCT01360632|5879062|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
1683404|NCT01360632|5879058|P5|Phase A (8 Weeks)|Adverse Event|0
1683405|NCT01360632|5879059|P4|Phase A (8 Weeks)|Adverse Event|0
1683406|NCT01360632|5879060|P3|Phase A (8 Weeks)|Adverse Event|0
1683407|NCT01360632|5879061|P2|Phase A (8 Weeks)|Adverse Event|0
1683408|NCT01360632|5879062|P1|Phase A (8 Weeks)|Adverse Event|60
1683409|NCT01360632|5879058|P5|Phase A (8 Weeks)|Lost to Follow-up|0
1683410|NCT01360632|5879059|P4|Phase A (8 Weeks)|Lost to Follow-up|0
1683411|NCT01360632|5879060|P3|Phase A (8 Weeks)|Lost to Follow-up|0
1683412|NCT01360632|5879061|P2|Phase A (8 Weeks)|Lost to Follow-up|0
1683413|NCT01360632|5879062|P1|Phase A (8 Weeks)|Lost to Follow-up|27
1683414|NCT01360554|5879141|P2|Overall Study|Randomized but not treated.|3
1683415|NCT01360554|5879142|P1|Overall Study|Randomized but not treated.|3
1683416|NCT01360554|5879141|P2|Overall Study|Other, not specified|0
1683417|NCT01360554|5879142|P1|Overall Study|Other, not specified|1
1683418|NCT01360554|5879141|P2|Overall Study|Study terminated by sponsor|37
1683419|NCT01360554|5879142|P1|Overall Study|Study terminated by sponsor|49
1683420|NCT01360554|5879141|P2|Overall Study|Withdrawal by Subject|24
1683421|NCT01360554|5879142|P1|Overall Study|Withdrawal by Subject|23
1683422|NCT01360554|5879141|P2|Overall Study|Lost to Follow-up|4
1683423|NCT01360554|5879142|P1|Overall Study|Lost to Follow-up|4
1683424|NCT01360554|5879141|P2|Overall Study|Death|371
1683425|NCT01360554|5879142|P1|Overall Study|Death|359
1683426|NCT01360398|5879191|P1|Overall Study|Migrated/moved from study area|1
1683427|NCT01360398|5879191|P1|Overall Study|Other|7
1683428|NCT01360398|5879191|P1|Overall Study|Withdrawal by Subject|14
1683429|NCT01360021|5879225|P3|Overall Study|Adverse Event|3
1683430|NCT01360021|5879226|P2|Overall Study|Adverse Event|3
1683431|NCT01360021|5879227|P1|Overall Study|Adverse Event|2
1683432|NCT01360021|5879225|P3|Overall Study|Withdrawal by Subject|2
1683433|NCT01360021|5879226|P2|Overall Study|Withdrawal by Subject|0
1683434|NCT01360021|5879227|P1|Overall Study|Withdrawal by Subject|4
1683435|NCT01360021|5879225|P3|Overall Study|Protocol Violation|1
1683436|NCT01360021|5879226|P2|Overall Study|Protocol Violation|0
1683437|NCT01360021|5879227|P1|Overall Study|Protocol Violation|0
1683438|NCT01360021|5879225|P3|Overall Study|Eligibility criteria + other|1
1683439|NCT01360021|5879226|P2|Overall Study|Eligibility criteria + other|1
1683440|NCT01360021|5879227|P1|Overall Study|Eligibility criteria + other|2
1683441|NCT01359943|5879253|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
1683442|NCT01359943|5879254|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
1683443|NCT01359943|5879255|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
1683444|NCT01359943|5879253|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
1683445|NCT01359943|5879254|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
1683446|NCT01359943|5879255|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
1683447|NCT01359943|5879253|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1683448|NCT01359943|5879254|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1683449|NCT01359943|5879255|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
1683450|NCT01359943|5879253|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
1683451|NCT01359943|5879254|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
1683452|NCT01359943|5879255|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
1683453|NCT01359943|5879253|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
1683454|NCT01359943|5879254|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
1683455|NCT01359943|5879255|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
1683456|NCT01359943|5879253|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
1683457|NCT01359943|5879254|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
1683458|NCT01359943|5879255|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
1683459|NCT01359943|5879253|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
1683460|NCT01359943|5879254|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
1683461|NCT01359943|5879255|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
1683462|NCT01359943|5879253|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
1683463|NCT01359943|5879254|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
1683464|NCT01359943|5879255|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
1683465|NCT01359943|5879253|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1683466|NCT01359943|5879254|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1683467|NCT01359943|5879255|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
1683468|NCT01359943|5879253|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
1683469|NCT01359943|5879254|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
1683470|NCT01359943|5879255|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
1683471|NCT01359943|5879253|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
1683472|NCT01359943|5879254|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
1683473|NCT01359943|5879255|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
1683474|NCT01359943|5879253|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
1683475|NCT01359943|5879254|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
1683476|NCT01359943|5879255|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
1683477|NCT01359943|5879253|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
1683478|NCT01359943|5879254|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
1683479|NCT01359943|5879255|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
1683480|NCT01359943|5879253|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
1683481|NCT01359943|5879254|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
1683482|NCT01359943|5879255|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
1683483|NCT01359943|5879253|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
1683484|NCT01359943|5879254|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
1683485|NCT01359943|5879255|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
1683486|NCT01359904|5879303|P2|Overall Study|Withdrawal by Subject|0
1683487|NCT01359904|5879304|P1|Overall Study|Withdrawal by Subject|1
1683488|NCT01359644|5879358|P10|Follow-up Period|Lost to Follow-up|0
1683489|NCT01359644|5879359|P9|Follow-up Period|Lost to Follow-up|0
1683490|NCT01359644|5879360|P8|Follow-up Period|Lost to Follow-up|2
1683491|NCT01359644|5879361|P7|Follow-up Period|Lost to Follow-up|1
1683492|NCT01359644|5879362|P6|Follow-up Period|Lost to Follow-up|0
1683493|NCT01359644|5879363|P5|Follow-up Period|Lost to Follow-up|0
1683494|NCT01359644|5879364|P4|Follow-up Period|Lost to Follow-up|0
1683495|NCT01359644|5879365|P3|Follow-up Period|Lost to Follow-up|0
1683496|NCT01359644|5879366|P2|Follow-up Period|Lost to Follow-up|0
1683497|NCT01359644|5879367|P1|Follow-up Period|Lost to Follow-up|0
1683498|NCT01359644|5879358|P10|Follow-up Period|Withdrawal by Subject|0
1683499|NCT01359644|5879359|P9|Follow-up Period|Withdrawal by Subject|0
1683500|NCT01359644|5879360|P8|Follow-up Period|Withdrawal by Subject|0
1683501|NCT01359644|5879361|P7|Follow-up Period|Withdrawal by Subject|0
1683502|NCT01359644|5879362|P6|Follow-up Period|Withdrawal by Subject|1
1683503|NCT01359644|5879363|P5|Follow-up Period|Withdrawal by Subject|0
1683504|NCT01359644|5879364|P4|Follow-up Period|Withdrawal by Subject|0
1683505|NCT01359644|5879365|P3|Follow-up Period|Withdrawal by Subject|0
1683506|NCT01359644|5879366|P2|Follow-up Period|Withdrawal by Subject|0
1683507|NCT01359644|5879367|P1|Follow-up Period|Withdrawal by Subject|0
1683508|NCT01359644|5879358|P10|Treatment Period|Lost to Follow-up|0
1683509|NCT01359644|5879359|P9|Treatment Period|Lost to Follow-up|0
1683510|NCT01359644|5879360|P8|Treatment Period|Lost to Follow-up|0
1683511|NCT01359644|5879361|P7|Treatment Period|Lost to Follow-up|0
1683512|NCT01359644|5879362|P6|Treatment Period|Lost to Follow-up|1
1683513|NCT01359644|5879363|P5|Treatment Period|Lost to Follow-up|0
1683514|NCT01359644|5879364|P4|Treatment Period|Lost to Follow-up|0
1683515|NCT01359644|5879365|P3|Treatment Period|Lost to Follow-up|0
1683516|NCT01359644|5879366|P2|Treatment Period|Lost to Follow-up|0
1683517|NCT01359644|5879367|P1|Treatment Period|Lost to Follow-up|0
1683518|NCT01359644|5879358|P10|Treatment Period|Adverse Event|0
1683519|NCT01359644|5879359|P9|Treatment Period|Adverse Event|0
1683520|NCT01359644|5879360|P8|Treatment Period|Adverse Event|0
1683521|NCT01359644|5879361|P7|Treatment Period|Adverse Event|0
1683522|NCT01359644|5879362|P6|Treatment Period|Adverse Event|1
1683523|NCT01359644|5879363|P5|Treatment Period|Adverse Event|0
1683524|NCT01359644|5879364|P4|Treatment Period|Adverse Event|0
1683525|NCT01359644|5879365|P3|Treatment Period|Adverse Event|1
1683526|NCT01359644|5879366|P2|Treatment Period|Adverse Event|0
1683527|NCT01359644|5879367|P1|Treatment Period|Adverse Event|0
1683528|NCT01359644|5879358|P10|Treatment Period|Lack of Efficacy|0
1683529|NCT01359644|5879359|P9|Treatment Period|Lack of Efficacy|0
1683530|NCT01359644|5879360|P8|Treatment Period|Lack of Efficacy|0
1683531|NCT01359644|5879361|P7|Treatment Period|Lack of Efficacy|0
1683532|NCT01359644|5879362|P6|Treatment Period|Lack of Efficacy|0
1683533|NCT01359644|5879363|P5|Treatment Period|Lack of Efficacy|0
1683534|NCT01359644|5879364|P4|Treatment Period|Lack of Efficacy|0
1683535|NCT01359644|5879365|P3|Treatment Period|Lack of Efficacy|0
1683536|NCT01359644|5879366|P2|Treatment Period|Lack of Efficacy|1
1683537|NCT01359644|5879367|P1|Treatment Period|Lack of Efficacy|0
1683538|NCT01359449|5879411|P2|Overall Study|Withdrawal by Subject|2
1683539|NCT01359449|5879412|P1|Overall Study|Withdrawal by Subject|3
1683540|NCT01359449|5879411|P2|Overall Study|Protocol Violation|2
1683541|NCT01359449|5879412|P1|Overall Study|Protocol Violation|0
1683542|NCT01359449|5879411|P2|Overall Study|Lost to Follow-up|0
1683543|NCT01359449|5879412|P1|Overall Study|Lost to Follow-up|1
1683544|NCT01359254|5879458|P2|Overall Study|Death|0
1683545|NCT01359254|5879459|P1|Overall Study|Death|1
1683546|NCT01359150|5879469|P2|Overall Study|Other|0
1683547|NCT01359150|5879470|P1|Overall Study|Other|1
1683548|NCT01359150|5879469|P2|Overall Study|Adverse Event|3
1683549|NCT01359150|5879470|P1|Overall Study|Adverse Event|4
1683550|NCT01359150|5879469|P2|Overall Study|Withdrawal by Subject|1
1683551|NCT01359150|5879470|P1|Overall Study|Withdrawal by Subject|1
1683552|NCT01359150|5879469|P2|Overall Study|Lack of Efficacy|1
1683553|NCT01359150|5879470|P1|Overall Study|Lack of Efficacy|1
1683554|NCT01359046|5879501|P2|Overall Study|Physician Decision|11
1683555|NCT01359046|5879502|P1|Overall Study|Physician Decision|1
1683556|NCT01359046|5879501|P2|Overall Study|Did not receive allocated intervention|6
1683557|NCT01359046|5879502|P1|Overall Study|Did not receive allocated intervention|6
1683558|NCT01358981|5879525|P7|Period 1|Withdrawal by Subject|0
1683559|NCT01358981|5879526|P6|Period 1|Withdrawal by Subject|0
1683560|NCT01358981|5879527|P5|Period 1|Withdrawal by Subject|0
1683561|NCT01358981|5879528|P4|Period 1|Withdrawal by Subject|1
1683562|NCT01358981|5879529|P3|Period 1|Withdrawal by Subject|0
1683563|NCT01358981|5879530|P2|Period 1|Withdrawal by Subject|0
1683564|NCT01358981|5879531|P1|Period 1|Withdrawal by Subject|0
1683565|NCT01358968|5879592|P4|Continued Access Phase|Death|1
1683566|NCT01358968|5879593|P3|Continued Access Phase|Death|1
1683567|NCT01358968|5879594|P2|Continued Access Phase|Death|0
1683568|NCT01358968|5879595|P1|Continued Access Phase|Death|0
1683569|NCT01358968|5879592|P4|Continued Access Phase|Withdrawal by Subject|0
1683570|NCT01358968|5879593|P3|Continued Access Phase|Withdrawal by Subject|3
1683571|NCT01358968|5879594|P2|Continued Access Phase|Withdrawal by Subject|0
1683572|NCT01358968|5879595|P1|Continued Access Phase|Withdrawal by Subject|0
1683573|NCT01358968|5879592|P4|Continued Access Phase|Protocol Violation|2
1683574|NCT01358968|5879593|P3|Continued Access Phase|Protocol Violation|0
1683575|NCT01358968|5879594|P2|Continued Access Phase|Protocol Violation|0
1683576|NCT01358968|5879595|P1|Continued Access Phase|Protocol Violation|0
1683577|NCT01358968|5879592|P4|Continued Access Phase|Progression of Disease|4
1683578|NCT01358968|5879593|P3|Continued Access Phase|Progression of Disease|8
1683579|NCT01358968|5879594|P2|Continued Access Phase|Progression of Disease|0
1683580|NCT01358968|5879595|P1|Continued Access Phase|Progression of Disease|0
1683581|NCT01358968|5879592|P4|Period 2|Adverse Event|0
1683582|NCT01358968|5879593|P3|Period 2|Adverse Event|0
1683583|NCT01358968|5879594|P2|Period 2|Adverse Event|1
1683584|NCT01358968|5879595|P1|Period 2|Adverse Event|0
1683585|NCT01358877|5879611|P2|Overall Study|Other|129
1683586|NCT01358877|5879612|P1|Overall Study|Other|142
1683587|NCT01358877|5879611|P2|Overall Study|Ongoing follow-up for overall survival|5
1683588|NCT01358877|5879612|P1|Overall Study|Ongoing follow-up for overall survival|7
1683589|NCT01358877|5879611|P2|Overall Study|Ongoing follow-up for IDFS event|2073
1683590|NCT01358877|5879612|P1|Overall Study|Ongoing follow-up for IDFS event|2084
1683591|NCT01358877|5879611|P2|Overall Study|Ongoing follow-up for post-recurrence|108
1683592|NCT01358877|5879612|P1|Overall Study|Ongoing follow-up for post-recurrence|87
1683593|NCT01358877|5879611|P2|Overall Study|Death|89
1683594|NCT01358877|5879612|P1|Overall Study|Death|80
1683595|NCT01358864|5879682|P8|Overall Study|Not treated|0
1683596|NCT01358864|5879683|P7|Overall Study|Not treated|1
1683597|NCT01358864|5879684|P6|Overall Study|Not treated|0
1683598|NCT01358864|5879685|P5|Overall Study|Not treated|0
1683599|NCT01358864|5879686|P4|Overall Study|Not treated|0
1683600|NCT01358864|5879687|P3|Overall Study|Not treated|0
1683601|NCT01358864|5879688|P2|Overall Study|Not treated|0
1683602|NCT01358864|5879689|P1|Overall Study|Not treated|0
1683603|NCT01358864|5879682|P8|Overall Study|Other reason not defined above|0
1683604|NCT01358864|5879683|P7|Overall Study|Other reason not defined above|2
1683605|NCT01358864|5879684|P6|Overall Study|Other reason not defined above|0
1683606|NCT01358864|5879685|P5|Overall Study|Other reason not defined above|0
1683607|NCT01358864|5879686|P4|Overall Study|Other reason not defined above|0
1683608|NCT01358864|5879687|P3|Overall Study|Other reason not defined above|0
1683609|NCT01358864|5879688|P2|Overall Study|Other reason not defined above|0
1683610|NCT01358864|5879689|P1|Overall Study|Other reason not defined above|2
1683611|NCT01358864|5879682|P8|Overall Study|Withdrawal by Subject|3
1683612|NCT01358864|5879683|P7|Overall Study|Withdrawal by Subject|1
1683613|NCT01358864|5879684|P6|Overall Study|Withdrawal by Subject|1
1683614|NCT01358864|5879685|P5|Overall Study|Withdrawal by Subject|0
1683615|NCT01358864|5879686|P4|Overall Study|Withdrawal by Subject|0
1683616|NCT01358864|5879687|P3|Overall Study|Withdrawal by Subject|2
1683617|NCT01358864|5879688|P2|Overall Study|Withdrawal by Subject|4
1683618|NCT01358864|5879689|P1|Overall Study|Withdrawal by Subject|3
1683619|NCT01358864|5879682|P8|Overall Study|Lost to Follow-up|1
1683620|NCT01358864|5879683|P7|Overall Study|Lost to Follow-up|0
1683621|NCT01358864|5879684|P6|Overall Study|Lost to Follow-up|0
1683622|NCT01358864|5879685|P5|Overall Study|Lost to Follow-up|0
1683623|NCT01358864|5879686|P4|Overall Study|Lost to Follow-up|0
1683624|NCT01358864|5879687|P3|Overall Study|Lost to Follow-up|1
1683625|NCT01358864|5879688|P2|Overall Study|Lost to Follow-up|0
1683626|NCT01358864|5879689|P1|Overall Study|Lost to Follow-up|0
1683627|NCT01358864|5879682|P8|Overall Study|Lack of Efficacy|44
1683628|NCT01358864|5879683|P7|Overall Study|Lack of Efficacy|49
1683629|NCT01358864|5879684|P6|Overall Study|Lack of Efficacy|4
1683630|NCT01358864|5879685|P5|Overall Study|Lack of Efficacy|7
1683631|NCT01358864|5879686|P4|Overall Study|Lack of Efficacy|19
1683632|NCT01358864|5879687|P3|Overall Study|Lack of Efficacy|4
1683633|NCT01358864|5879688|P2|Overall Study|Lack of Efficacy|3
1683634|NCT01358864|5879689|P1|Overall Study|Lack of Efficacy|26
1683635|NCT01358864|5879682|P8|Overall Study|Adverse Event|7
1683636|NCT01358864|5879683|P7|Overall Study|Adverse Event|12
1683637|NCT01358864|5879684|P6|Overall Study|Adverse Event|8
1683638|NCT01358864|5879685|P5|Overall Study|Adverse Event|4
1683639|NCT01358864|5879686|P4|Overall Study|Adverse Event|0
1683640|NCT01358864|5879687|P3|Overall Study|Adverse Event|9
1683641|NCT01358864|5879688|P2|Overall Study|Adverse Event|6
1683642|NCT01358864|5879689|P1|Overall Study|Adverse Event|0
1683643|NCT01358825|5879780|P2|Overall Study|Blood sample not drawn|1
1683644|NCT01358825|5879781|P1|Overall Study|Blood sample not drawn|0
1683645|NCT01358760|5879805|P3|Overall Study|Entry criteria not met/Non-compliance|16
1683646|NCT01358760|5879806|P2|Overall Study|Entry criteria not met/Non-compliance|12
1683647|NCT01358760|5879807|P1|Overall Study|Entry criteria not met/Non-compliance|12
1683648|NCT01358760|5879805|P3|Overall Study|Physician Decision|1
1683649|NCT01358760|5879806|P2|Overall Study|Physician Decision|0
1683650|NCT01358760|5879807|P1|Overall Study|Physician Decision|1
1683651|NCT01358760|5879805|P3|Overall Study|Withdrawal by Subject|2
1683652|NCT01358760|5879806|P2|Overall Study|Withdrawal by Subject|3
1683653|NCT01358760|5879807|P1|Overall Study|Withdrawal by Subject|5
1683654|NCT01358760|5879805|P3|Overall Study|Lost to Follow-up|3
1683655|NCT01358760|5879806|P2|Overall Study|Lost to Follow-up|1
1683656|NCT01358760|5879807|P1|Overall Study|Lost to Follow-up|1
1683657|NCT01358760|5879805|P3|Overall Study|Adverse Event|3
1683658|NCT01358760|5879806|P2|Overall Study|Adverse Event|4
1683659|NCT01358760|5879807|P1|Overall Study|Adverse Event|3
1683660|NCT01358734|5879842|P3|Overall Study|Protocol Violation|2
1683661|NCT01358734|5879843|P2|Overall Study|Protocol Violation|0
1683662|NCT01358734|5879844|P1|Overall Study|Protocol Violation|0
1683663|NCT01358734|5879842|P3|Overall Study|Other|4
1683664|NCT01358734|5879843|P2|Overall Study|Other|5
1683665|NCT01358734|5879844|P1|Overall Study|Other|2
1683666|NCT01358734|5879842|P3|Overall Study|Non-compliance with study drug|1
1683667|NCT01358734|5879843|P2|Overall Study|Non-compliance with study drug|0
1683668|NCT01358734|5879844|P1|Overall Study|Non-compliance with study drug|0
1683669|NCT01358734|5879842|P3|Overall Study|Progressive Disease|16
1683670|NCT01358734|5879843|P2|Overall Study|Progressive Disease|13
1683671|NCT01358734|5879844|P1|Overall Study|Progressive Disease|5
1683672|NCT01358734|5879842|P3|Overall Study|Death|2
1683673|NCT01358734|5879843|P2|Overall Study|Death|7
1683674|NCT01358734|5879844|P1|Overall Study|Death|3
1683675|NCT01358734|5879842|P3|Overall Study|Withdrawal by Subject|3
1683676|NCT01358734|5879843|P2|Overall Study|Withdrawal by Subject|6
1683677|NCT01358734|5879844|P1|Overall Study|Withdrawal by Subject|1
1683678|NCT01358734|5879842|P3|Overall Study|Lack of Efficacy|3
1683679|NCT01358734|5879843|P2|Overall Study|Lack of Efficacy|1
1683680|NCT01358734|5879844|P1|Overall Study|Lack of Efficacy|0
1683681|NCT01358734|5879842|P3|Overall Study|Adverse Event|3
1683682|NCT01358734|5879843|P2|Overall Study|Adverse Event|7
1683683|NCT01358734|5879844|P1|Overall Study|Adverse Event|4
1683684|NCT01358721|5879892|P4|Overall Study|Out of State/Unmet Criteria|0
1683685|NCT01358721|5879893|P3|Overall Study|Out of State/Unmet Criteria|1
1683686|NCT01358721|5879894|P2|Overall Study|Out of State/Unmet Criteria|0
1683687|NCT01358721|5879895|P1|Overall Study|Out of State/Unmet Criteria|0
1683688|NCT01358721|5879892|P4|Overall Study|Disease Progression|15
1683689|NCT01358721|5879893|P3|Overall Study|Disease Progression|17
1683690|NCT01358721|5879894|P2|Overall Study|Disease Progression|15
1683691|NCT01358721|5879895|P1|Overall Study|Disease Progression|19
1683692|NCT01358721|5879892|P4|Overall Study|Adverse Event related to study drug|1
1683693|NCT01358721|5879893|P3|Overall Study|Adverse Event related to study drug|0
1683694|NCT01358721|5879894|P2|Overall Study|Adverse Event related to study drug|0
1683695|NCT01358721|5879895|P1|Overall Study|Adverse Event related to study drug|1
1683696|NCT01358721|5879892|P4|Overall Study|Subject No Longer Meets Study Criteria|1
1683697|NCT01358721|5879893|P3|Overall Study|Subject No Longer Meets Study Criteria|0
1683698|NCT01358721|5879894|P2|Overall Study|Subject No Longer Meets Study Criteria|2
1683699|NCT01358721|5879895|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1683700|NCT01358721|5879892|P4|Overall Study|SUBJ request to discontinue study TRT|1
1683701|NCT01358721|5879893|P3|Overall Study|SUBJ request to discontinue study TRT|0
1683702|NCT01358721|5879894|P2|Overall Study|SUBJ request to discontinue study TRT|0
1683703|NCT01358721|5879895|P1|Overall Study|SUBJ request to discontinue study TRT|0
1683704|NCT01358721|5879892|P4|Overall Study|Study Drug Toxicity|5
1683705|NCT01358721|5879893|P3|Overall Study|Study Drug Toxicity|4
1683706|NCT01358721|5879894|P2|Overall Study|Study Drug Toxicity|3
1683707|NCT01358721|5879895|P1|Overall Study|Study Drug Toxicity|1
1683708|NCT01358721|5879892|P4|Overall Study|Death|0
1683709|NCT01358721|5879893|P3|Overall Study|Death|0
1683710|NCT01358721|5879894|P2|Overall Study|Death|2
1683711|NCT01358721|5879895|P1|Overall Study|Death|0
1683712|NCT01358721|5879892|P4|Overall Study|Withdrawal by Subject|1
1683713|NCT01358721|5879893|P3|Overall Study|Withdrawal by Subject|0
1683714|NCT01358721|5879894|P2|Overall Study|Withdrawal by Subject|0
1683715|NCT01358721|5879895|P1|Overall Study|Withdrawal by Subject|0
1683716|NCT01358708|5879947|P2|Double-Blind Treatment Phase|Protocol Violation|0
1683717|NCT01358708|5879948|P1|Double-Blind Treatment Phase|Protocol Violation|1
1683718|NCT01358708|5879947|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
1683719|NCT01358708|5879948|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
1683720|NCT01358578|5879971|P6|Follow-up Period|Physician Decision|0
1683721|NCT01358578|5879972|P5|Follow-up Period|Physician Decision|0
1683722|NCT01358578|5879973|P4|Follow-up Period|Physician Decision|2
1683723|NCT01358578|5879974|P3|Follow-up Period|Physician Decision|0
1683724|NCT01358578|5879975|P2|Follow-up Period|Physician Decision|1
1683725|NCT01358578|5879976|P1|Follow-up Period|Physician Decision|1
1683726|NCT01358578|5879971|P6|Follow-up Period|Withdrawal by Subject|0
1683727|NCT01358578|5879972|P5|Follow-up Period|Withdrawal by Subject|0
1683728|NCT01358578|5879973|P4|Follow-up Period|Withdrawal by Subject|12
1683729|NCT01358578|5879974|P3|Follow-up Period|Withdrawal by Subject|1
1683730|NCT01358578|5879975|P2|Follow-up Period|Withdrawal by Subject|3
1683731|NCT01358578|5879976|P1|Follow-up Period|Withdrawal by Subject|3
1683732|NCT01358578|5879971|P6|Follow-up Period|Pregnancy|0
1683733|NCT01358578|5879972|P5|Follow-up Period|Pregnancy|0
1683734|NCT01358578|5879973|P4|Follow-up Period|Pregnancy|0
1683735|NCT01358578|5879974|P3|Follow-up Period|Pregnancy|0
1683736|NCT01358578|5879975|P2|Follow-up Period|Pregnancy|0
1683737|NCT01358578|5879976|P1|Follow-up Period|Pregnancy|1
1683738|NCT01358578|5879971|P6|Follow-up Period|non- compliance with study treatment|0
1683739|NCT01358578|5879972|P5|Follow-up Period|non- compliance with study treatment|0
1683740|NCT01358578|5879973|P4|Follow-up Period|non- compliance with study treatment|0
1683741|NCT01358578|5879974|P3|Follow-up Period|non- compliance with study treatment|0
1683742|NCT01358578|5879975|P2|Follow-up Period|non- compliance with study treatment|0
1683743|NCT01358578|5879976|P1|Follow-up Period|non- compliance with study treatment|1
1683744|NCT01358578|5879971|P6|Follow-up Period|Lost to Follow-up|0
1683745|NCT01358578|5879972|P5|Follow-up Period|Lost to Follow-up|0
1683746|NCT01358578|5879973|P4|Follow-up Period|Lost to Follow-up|4
1683747|NCT01358578|5879974|P3|Follow-up Period|Lost to Follow-up|0
1683748|NCT01358578|5879975|P2|Follow-up Period|Lost to Follow-up|1
1683749|NCT01358578|5879976|P1|Follow-up Period|Lost to Follow-up|0
1683750|NCT01358578|5879971|P6|Follow-up Period|Lack of Efficacy|0
1683751|NCT01358578|5879972|P5|Follow-up Period|Lack of Efficacy|0
1683752|NCT01358578|5879973|P4|Follow-up Period|Lack of Efficacy|1
1683753|NCT01358578|5879974|P3|Follow-up Period|Lack of Efficacy|4
1683754|NCT01358578|5879975|P2|Follow-up Period|Lack of Efficacy|0
1683755|NCT01358578|5879976|P1|Follow-up Period|Lack of Efficacy|3
1683756|NCT01358578|5879971|P6|Follow-up Period|Adverse Event|0
1683757|NCT01358578|5879972|P5|Follow-up Period|Adverse Event|0
1683758|NCT01358578|5879973|P4|Follow-up Period|Adverse Event|0
1683759|NCT01358578|5879974|P3|Follow-up Period|Adverse Event|0
1683760|NCT01358578|5879975|P2|Follow-up Period|Adverse Event|1
1683761|NCT01358578|5879976|P1|Follow-up Period|Adverse Event|1
1683762|NCT01358578|5879971|P6|Maintenance Period|Withdrawal by Subject|3
1683763|NCT01358578|5879972|P5|Maintenance Period|Withdrawal by Subject|6
1683764|NCT01358578|5879973|P4|Maintenance Period|Withdrawal by Subject|15
1683765|NCT01358578|5879974|P3|Maintenance Period|Withdrawal by Subject|2
1683766|NCT01358578|5879975|P2|Maintenance Period|Withdrawal by Subject|7
1683767|NCT01358578|5879976|P1|Maintenance Period|Withdrawal by Subject|12
1683768|NCT01358578|5879971|P6|Maintenance Period|Protocol deviation|2
1683769|NCT01358578|5879972|P5|Maintenance Period|Protocol deviation|2
1683770|NCT01358578|5879973|P4|Maintenance Period|Protocol deviation|2
1683771|NCT01358578|5879974|P3|Maintenance Period|Protocol deviation|0
1683772|NCT01358578|5879975|P2|Maintenance Period|Protocol deviation|4
1683773|NCT01358578|5879976|P1|Maintenance Period|Protocol deviation|7
1683774|NCT01358578|5879971|P6|Maintenance Period|Pregnancy|0
1683775|NCT01358578|5879972|P5|Maintenance Period|Pregnancy|0
1683776|NCT01358578|5879973|P4|Maintenance Period|Pregnancy|0
1683777|NCT01358578|5879974|P3|Maintenance Period|Pregnancy|0
1683778|NCT01358578|5879975|P2|Maintenance Period|Pregnancy|0
1683779|NCT01358578|5879976|P1|Maintenance Period|Pregnancy|1
1683780|NCT01358578|5879971|P6|Maintenance Period|Physician Decision|0
1683781|NCT01358578|5879972|P5|Maintenance Period|Physician Decision|0
1683782|NCT01358578|5879973|P4|Maintenance Period|Physician Decision|1
1683783|NCT01358578|5879974|P3|Maintenance Period|Physician Decision|0
1683784|NCT01358578|5879975|P2|Maintenance Period|Physician Decision|1
1683785|NCT01358578|5879976|P1|Maintenance Period|Physician Decision|0
1683786|NCT01358578|5879971|P6|Maintenance Period|Non-compliance with study treatment|2
1683787|NCT01358578|5879972|P5|Maintenance Period|Non-compliance with study treatment|1
1683788|NCT01358578|5879973|P4|Maintenance Period|Non-compliance with study treatment|2
1683789|NCT01358578|5879974|P3|Maintenance Period|Non-compliance with study treatment|0
1683790|NCT01358578|5879975|P2|Maintenance Period|Non-compliance with study treatment|1
1683791|NCT01358578|5879976|P1|Maintenance Period|Non-compliance with study treatment|3
1683792|NCT01358578|5879971|P6|Maintenance Period|Lost to Follow-up|1
1683793|NCT01358578|5879972|P5|Maintenance Period|Lost to Follow-up|1
1683794|NCT01358578|5879973|P4|Maintenance Period|Lost to Follow-up|5
1683795|NCT01358578|5879974|P3|Maintenance Period|Lost to Follow-up|0
1683796|NCT01358578|5879975|P2|Maintenance Period|Lost to Follow-up|0
1683797|NCT01358578|5879976|P1|Maintenance Period|Lost to Follow-up|4
1683798|NCT01358578|5879971|P6|Maintenance Period|Lack of Efficacy|0
1683799|NCT01358578|5879972|P5|Maintenance Period|Lack of Efficacy|3
1683800|NCT01358578|5879973|P4|Maintenance Period|Lack of Efficacy|11
1683801|NCT01358578|5879974|P3|Maintenance Period|Lack of Efficacy|0
1683802|NCT01358578|5879975|P2|Maintenance Period|Lack of Efficacy|2
1683803|NCT01358578|5879976|P1|Maintenance Period|Lack of Efficacy|10
1683804|NCT01358578|5879971|P6|Maintenance Period|Adverse Event|3
1683805|NCT01358578|5879972|P5|Maintenance Period|Adverse Event|4
1683806|NCT01358578|5879973|P4|Maintenance Period|Adverse Event|6
1683807|NCT01358578|5879974|P3|Maintenance Period|Adverse Event|0
1683808|NCT01358578|5879975|P2|Maintenance Period|Adverse Event|7
1683809|NCT01358578|5879976|P1|Maintenance Period|Adverse Event|2
1683810|NCT01358578|5879971|P6|Induction Period|Withdrawal by Subject|0
1683811|NCT01358578|5879972|P5|Induction Period|Withdrawal by Subject|0
1683812|NCT01358578|5879973|P4|Induction Period|Withdrawal by Subject|6
1683813|NCT01358578|5879974|P3|Induction Period|Withdrawal by Subject|10
1683814|NCT01358578|5879975|P2|Induction Period|Withdrawal by Subject|5
1683815|NCT01358578|5879976|P1|Induction Period|Withdrawal by Subject|5
1683816|NCT01358578|5879971|P6|Induction Period|technical problems|0
1683817|NCT01358578|5879972|P5|Induction Period|technical problems|0
1683818|NCT01358578|5879973|P4|Induction Period|technical problems|1
1683819|NCT01358578|5879974|P3|Induction Period|technical problems|1
1683820|NCT01358578|5879975|P2|Induction Period|technical problems|0
1683821|NCT01358578|5879976|P1|Induction Period|technical problems|0
1683822|NCT01358578|5879971|P6|Induction Period|Protocol Deviation|0
1683823|NCT01358578|5879972|P5|Induction Period|Protocol Deviation|0
1683824|NCT01358578|5879973|P4|Induction Period|Protocol Deviation|3
1683825|NCT01358578|5879974|P3|Induction Period|Protocol Deviation|0
1683826|NCT01358578|5879975|P2|Induction Period|Protocol Deviation|5
1683827|NCT01358578|5879976|P1|Induction Period|Protocol Deviation|3
1683828|NCT01358578|5879971|P6|Induction Period|Physician Decision|0
1683829|NCT01358578|5879972|P5|Induction Period|Physician Decision|0
1683830|NCT01358578|5879973|P4|Induction Period|Physician Decision|0
1683831|NCT01358578|5879974|P3|Induction Period|Physician Decision|2
1683832|NCT01358578|5879975|P2|Induction Period|Physician Decision|1
1683833|NCT01358578|5879976|P1|Induction Period|Physician Decision|2
1683834|NCT01358578|5879971|P6|Induction Period|Lost to Follow-up|0
1683835|NCT01358578|5879972|P5|Induction Period|Lost to Follow-up|0
1683836|NCT01358578|5879973|P4|Induction Period|Lost to Follow-up|4
1683837|NCT01358578|5879974|P3|Induction Period|Lost to Follow-up|1
1683838|NCT01358578|5879975|P2|Induction Period|Lost to Follow-up|0
1683839|NCT01358578|5879976|P1|Induction Period|Lost to Follow-up|0
1683840|NCT01358578|5879971|P6|Induction Period|Lack of Efficacy|0
1683841|NCT01358578|5879972|P5|Induction Period|Lack of Efficacy|0
1683842|NCT01358578|5879973|P4|Induction Period|Lack of Efficacy|1
1683843|NCT01358578|5879974|P3|Induction Period|Lack of Efficacy|9
1683844|NCT01358578|5879975|P2|Induction Period|Lack of Efficacy|0
1683845|NCT01358578|5879976|P1|Induction Period|Lack of Efficacy|0
1683846|NCT01358578|5879971|P6|Induction Period|Adverse Event|0
1683847|NCT01358578|5879972|P5|Induction Period|Adverse Event|0
1683848|NCT01358578|5879973|P4|Induction Period|Adverse Event|6
1683849|NCT01358578|5879974|P3|Induction Period|Adverse Event|2
1683850|NCT01358578|5879975|P2|Induction Period|Adverse Event|4
1683851|NCT01358578|5879976|P1|Induction Period|Adverse Event|2
1683852|NCT01358526|5880028|P3|Double-blind Phase|Administrative|10
1683853|NCT01358526|5880029|P2|Double-blind Phase|Administrative|6
1683854|NCT01358526|5880030|P1|Double-blind Phase|Administrative|0
1683855|NCT01358526|5880028|P3|Double-blind Phase|Confirmed or suspected diversion|6
1683856|NCT01358526|5880029|P2|Double-blind Phase|Confirmed or suspected diversion|5
1683857|NCT01358526|5880030|P1|Double-blind Phase|Confirmed or suspected diversion|0
1683858|NCT01358526|5880028|P3|Double-blind Phase|Lack of Efficacy|73
1683859|NCT01358526|5880029|P2|Double-blind Phase|Lack of Efficacy|31
1683860|NCT01358526|5880030|P1|Double-blind Phase|Lack of Efficacy|0
1683861|NCT01358526|5880028|P3|Double-blind Phase|Lost to Follow-up|1
1683862|NCT01358526|5880029|P2|Double-blind Phase|Lost to Follow-up|4
1683863|NCT01358526|5880030|P1|Double-blind Phase|Lost to Follow-up|0
1683864|NCT01358526|5880028|P3|Double-blind Phase|Withdrawal by Subject|8
1683865|NCT01358526|5880029|P2|Double-blind Phase|Withdrawal by Subject|10
1683866|NCT01358526|5880030|P1|Double-blind Phase|Withdrawal by Subject|0
1683867|NCT01358526|5880028|P3|Double-blind Phase|Adverse Event|23
1683868|NCT01358526|5880029|P2|Double-blind Phase|Adverse Event|24
1683869|NCT01358526|5880030|P1|Double-blind Phase|Adverse Event|0
1683870|NCT01358526|5880028|P3|Open-label Titration Period|Did not qualify|0
1683871|NCT01358526|5880029|P2|Open-label Titration Period|Did not qualify|0
1683872|NCT01358526|5880030|P1|Open-label Titration Period|Did not qualify|178
1683873|NCT01358526|5880028|P3|Open-label Titration Period|Administrative|0
1683874|NCT01358526|5880029|P2|Open-label Titration Period|Administrative|0
1683875|NCT01358526|5880030|P1|Open-label Titration Period|Administrative|8
1683876|NCT01358526|5880028|P3|Open-label Titration Period|Confirmed or suspected diversion|0
1683877|NCT01358526|5880029|P2|Open-label Titration Period|Confirmed or suspected diversion|0
1683878|NCT01358526|5880030|P1|Open-label Titration Period|Confirmed or suspected diversion|16
1683879|NCT01358526|5880028|P3|Open-label Titration Period|Lack of Efficacy|0
1683880|NCT01358526|5880029|P2|Open-label Titration Period|Lack of Efficacy|0
1683881|NCT01358526|5880030|P1|Open-label Titration Period|Lack of Efficacy|107
1683882|NCT01358526|5880028|P3|Open-label Titration Period|Lost to Follow-up|0
1683883|NCT01358526|5880029|P2|Open-label Titration Period|Lost to Follow-up|0
1683884|NCT01358526|5880030|P1|Open-label Titration Period|Lost to Follow-up|25
1683885|NCT01358526|5880028|P3|Open-label Titration Period|Withdrawal by Subject|0
1683886|NCT01358526|5880029|P2|Open-label Titration Period|Withdrawal by Subject|0
1683887|NCT01358526|5880030|P1|Open-label Titration Period|Withdrawal by Subject|65
1683888|NCT01358526|5880028|P3|Open-label Titration Period|Adverse Event|0
1683889|NCT01358526|5880029|P2|Open-label Titration Period|Adverse Event|0
1683890|NCT01358526|5880030|P1|Open-label Titration Period|Adverse Event|95
1683891|NCT01358357|5880047|P3|Double-Blind Phase|Administrative|0
1683892|NCT01358357|5880048|P2|Double-Blind Phase|Administrative|1
1683893|NCT01358357|5880049|P1|Double-Blind Phase|Administrative|0
1683894|NCT01358357|5880047|P3|Double-Blind Phase|Recurrence of mood event|0
1683895|NCT01358357|5880048|P2|Double-Blind Phase|Recurrence of mood event|64
1683896|NCT01358357|5880049|P1|Double-Blind Phase|Recurrence of mood event|48
1683897|NCT01358357|5880047|P3|Double-Blind Phase|Terminated at study completion|0
1683898|NCT01358357|5880048|P2|Double-Blind Phase|Terminated at study completion|0
1683899|NCT01358357|5880049|P1|Double-Blind Phase|Terminated at study completion|2
1683900|NCT01358357|5880047|P3|Double-Blind Phase|Protocol Violation|0
1683901|NCT01358357|5880048|P2|Double-Blind Phase|Protocol Violation|12
1683902|NCT01358357|5880049|P1|Double-Blind Phase|Protocol Violation|16
1683903|NCT01358357|5880047|P3|Double-Blind Phase|Protocol Violation|0
1683904|NCT01358357|5880048|P2|Double-Blind Phase|Protocol Violation|11
1683905|NCT01358357|5880049|P1|Double-Blind Phase|Protocol Violation|1
1683906|NCT01358357|5880047|P3|Double-Blind Phase|Lost to Follow-up|0
1683907|NCT01358357|5880048|P2|Double-Blind Phase|Lost to Follow-up|7
1683908|NCT01358357|5880049|P1|Double-Blind Phase|Lost to Follow-up|5
1683909|NCT01358357|5880047|P3|Double-Blind Phase|Adverse Event|0
1683910|NCT01358357|5880048|P2|Double-Blind Phase|Adverse Event|5
1683911|NCT01358357|5880049|P1|Double-Blind Phase|Adverse Event|8
1683912|NCT01358357|5880047|P3|Open Label Phase|Mood episode|42
1683913|NCT01358357|5880048|P2|Open Label Phase|Mood episode|0
1683914|NCT01358357|5880049|P1|Open Label Phase|Mood episode|0
1683915|NCT01358357|5880047|P3|Open Label Phase|Terminated at study completion|5
1683916|NCT01358357|5880048|P2|Open Label Phase|Terminated at study completion|0
1683917|NCT01358357|5880049|P1|Open Label Phase|Terminated at study completion|0
1683918|NCT01358357|5880047|P3|Open Label Phase|Did not meet criteria for DB phase|16
1683919|NCT01358357|5880048|P2|Open Label Phase|Did not meet criteria for DB phase|0
1683920|NCT01358357|5880049|P1|Open Label Phase|Did not meet criteria for DB phase|0
1683921|NCT01358357|5880047|P3|Open Label Phase|Withdrawal by Subject|112
1683922|NCT01358357|5880048|P2|Open Label Phase|Withdrawal by Subject|0
1683923|NCT01358357|5880049|P1|Open Label Phase|Withdrawal by Subject|0
1683924|NCT01358357|5880047|P3|Open Label Phase|Protocol Violation|45
1683925|NCT01358357|5880048|P2|Open Label Phase|Protocol Violation|0
1683926|NCT01358357|5880049|P1|Open Label Phase|Protocol Violation|0
1683927|NCT01358357|5880047|P3|Open Label Phase|Lost to Follow-up|76
1683928|NCT01358357|5880048|P2|Open Label Phase|Lost to Follow-up|0
1683929|NCT01358357|5880049|P1|Open Label Phase|Lost to Follow-up|0
1683930|NCT01358357|5880047|P3|Open Label Phase|Lack of Efficacy|107
1683931|NCT01358357|5880048|P2|Open Label Phase|Lack of Efficacy|0
1683932|NCT01358357|5880049|P1|Open Label Phase|Lack of Efficacy|0
1683933|NCT01358357|5880047|P3|Open Label Phase|Adverse Event|59
1683934|NCT01358357|5880048|P2|Open Label Phase|Adverse Event|0
1683935|NCT01358357|5880049|P1|Open Label Phase|Adverse Event|0
1683936|NCT01358175|5880114|P3|Overall Study|Adverse Event|11
1683937|NCT01358175|5880115|P2|Overall Study|Adverse Event|11
1683938|NCT01358175|5880116|P1|Overall Study|Adverse Event|6
1683939|NCT01358175|5880114|P3|Overall Study|Lack of Efficacy|6
1683940|NCT01358175|5880115|P2|Overall Study|Lack of Efficacy|8
1683941|NCT01358175|5880116|P1|Overall Study|Lack of Efficacy|3
1683942|NCT01358175|5880114|P3|Overall Study|Lost to Follow-up|3
1683943|NCT01358175|5880115|P2|Overall Study|Lost to Follow-up|1
1683944|NCT01358175|5880116|P1|Overall Study|Lost to Follow-up|1
1683945|NCT01358175|5880114|P3|Overall Study|Non Compliance with Study Treatment|1
1683946|NCT01358175|5880115|P2|Overall Study|Non Compliance with Study Treatment|1
1683947|NCT01358175|5880116|P1|Overall Study|Non Compliance with Study Treatment|0
1683948|NCT01358175|5880114|P3|Overall Study|Physician Decision|0
1683949|NCT01358175|5880115|P2|Overall Study|Physician Decision|0
1683950|NCT01358175|5880116|P1|Overall Study|Physician Decision|1
1683951|NCT01358175|5880114|P3|Overall Study|Pregnancy|0
1683952|NCT01358175|5880115|P2|Overall Study|Pregnancy|1
1683953|NCT01358175|5880116|P1|Overall Study|Pregnancy|0
1683954|NCT01358175|5880114|P3|Overall Study|Technical issues|0
1683955|NCT01358175|5880115|P2|Overall Study|Technical issues|1
1683956|NCT01358175|5880116|P1|Overall Study|Technical issues|0
1683957|NCT01358175|5880114|P3|Overall Study|Withdrawal by Subject|10
1683958|NCT01358175|5880115|P2|Overall Study|Withdrawal by Subject|5
1683959|NCT01358175|5880116|P1|Overall Study|Withdrawal by Subject|9
1683960|NCT01358175|5880114|P3|Overall Study|Death|1
1683961|NCT01358175|5880115|P2|Overall Study|Death|0
1683962|NCT01358175|5880116|P1|Overall Study|Death|1
1683963|NCT01357980|5880153|P4|Overall Study|Consent withdrawn|0
1683964|NCT01357980|5880154|P3|Overall Study|Consent withdrawn|1
1683965|NCT01357980|5880155|P2|Overall Study|Consent withdrawn|0
1683966|NCT01357980|5880156|P1|Overall Study|Consent withdrawn|0
1683967|NCT01357980|5880153|P4|Overall Study|Lack of Efficacy|0
1683968|NCT01357980|5880154|P3|Overall Study|Lack of Efficacy|0
1683969|NCT01357980|5880155|P2|Overall Study|Lack of Efficacy|1
1683970|NCT01357980|5880156|P1|Overall Study|Lack of Efficacy|0
1683971|NCT01357915|5880200|P2|Overall Study|Lost to Follow-up|0
1683972|NCT01357915|5880201|P1|Overall Study|Lost to Follow-up|3
1683973|NCT01357889|5880219|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
1683974|NCT01357889|5880220|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
1683975|NCT01357889|5880219|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
1683976|NCT01357889|5880220|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
1683977|NCT01357889|5880219|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
1683978|NCT01357889|5880220|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
1683979|NCT01357889|5880219|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
1683980|NCT01357889|5880220|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
1683981|NCT01357889|5880219|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
1683982|NCT01357889|5880220|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
1683983|NCT01357889|5880219|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
1683984|NCT01357889|5880220|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
1683985|NCT01357889|5880219|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
1683986|NCT01357889|5880220|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
1683987|NCT01357889|5880219|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
1683988|NCT01357889|5880220|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
1683989|NCT01357889|5880219|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
1683990|NCT01357889|5880220|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
1683991|NCT01357889|5880219|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
1683992|NCT01357889|5880220|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
1683993|NCT01357889|5880219|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
1683994|NCT01357889|5880220|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
1683995|NCT01357889|5880219|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
1683996|NCT01357889|5880220|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
1683997|NCT01357889|5880219|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
1683998|NCT01357889|5880220|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
1683999|NCT01357850|5880264|P4|Overall Study|Lost to Follow-up|0
1684000|NCT01357850|5880265|P3|Overall Study|Lost to Follow-up|0
1684001|NCT01357850|5880266|P2|Overall Study|Lost to Follow-up|0
1684002|NCT01357850|5880267|P1|Overall Study|Lost to Follow-up|1
1684003|NCT01357655|5880358|P2|Overall Study|Subject Withdrew Consent|0
1684004|NCT01357655|5880359|P1|Overall Study|Subject Withdrew Consent|1
1684005|NCT01357655|5880358|P2|Overall Study|Study Drug Toxicity|0
1684006|NCT01357655|5880359|P1|Overall Study|Study Drug Toxicity|11
1684007|NCT01357655|5880358|P2|Overall Study|Reason Unspecified|0
1684008|NCT01357655|5880359|P1|Overall Study|Reason Unspecified|1
1684009|NCT01357655|5880358|P2|Overall Study|Maximum Clinical Benefit|0
1684010|NCT01357655|5880359|P1|Overall Study|Maximum Clinical Benefit|2
1684011|NCT01357655|5880358|P2|Overall Study|Lost to Follow-up|0
1684012|NCT01357655|5880359|P1|Overall Study|Lost to Follow-up|2
1684013|NCT01357655|5880358|P2|Overall Study|Disease Progression|0
1684014|NCT01357655|5880359|P1|Overall Study|Disease Progression|1
1684015|NCT01357655|5880358|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
1684016|NCT01357655|5880359|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
1684017|NCT01357655|5880358|P2|Overall Study|Administrative Reason by Sponsor|0
1684018|NCT01357655|5880359|P1|Overall Study|Administrative Reason by Sponsor|45
1684019|NCT01357616|5880376|P2|Overall Study|Withdrawal by Subject|0
1684020|NCT01357616|5880377|P1|Overall Study|Withdrawal by Subject|1
1684021|NCT01357616|5880376|P2|Overall Study|Decision Unrelated to Adverse Event|1
1684022|NCT01357616|5880377|P1|Overall Study|Decision Unrelated to Adverse Event|3
1684023|NCT01357616|5880376|P2|Overall Study|Inadequate Control of IOP|2
1684024|NCT01357616|5880377|P1|Overall Study|Inadequate Control of IOP|1
1684025|NCT01357616|5880376|P2|Overall Study|Protocol Violation|2
1684026|NCT01357616|5880377|P1|Overall Study|Protocol Violation|0
1684027|NCT01357616|5880376|P2|Overall Study|Lost to Follow-up|3
1684028|NCT01357616|5880377|P1|Overall Study|Lost to Follow-up|4
1684029|NCT01357616|5880376|P2|Overall Study|Adverse Event|1
1684030|NCT01357616|5880377|P1|Overall Study|Adverse Event|1
1684031|NCT01357577|5880391|P2|Overall Study|look at data in database?|2
1684032|NCT01357577|5880392|P1|Overall Study|look at data in database?|1
1684033|NCT01357577|5880391|P2|Overall Study|Withdrawal by Subject|8
1684034|NCT01357577|5880392|P1|Overall Study|Withdrawal by Subject|16
1684035|NCT01357577|5880391|P2|Overall Study|Lost to Follow-up|16
1684036|NCT01357577|5880392|P1|Overall Study|Lost to Follow-up|20
1684037|NCT01357551|5880419|P2|Overall Study|Lost to Follow-up|6
1684038|NCT01357551|5880420|P1|Overall Study|Lost to Follow-up|16
1684039|NCT01357551|5880419|P2|Overall Study|Death|1
1684040|NCT01357551|5880420|P1|Overall Study|Death|0
1684041|NCT01357551|5880419|P2|Overall Study|Withdrawal by Subject|4
1684042|NCT01357551|5880420|P1|Overall Study|Withdrawal by Subject|6
1684043|NCT01357239|5880447|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
1684044|NCT01357239|5880448|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
1684045|NCT01357239|5880449|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
1684046|NCT01357239|5880450|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
1684047|NCT01357239|5880447|P4|Stratum II: Partially-Methylated|Adverse Event|1
1684048|NCT01357239|5880448|P3|Stratum II: Partially-Methylated|Adverse Event|0
1684049|NCT01357239|5880449|P2|Stratum II: Partially-Methylated|Adverse Event|0
1684050|NCT01357239|5880450|P1|Stratum II: Partially-Methylated|Adverse Event|0
1684051|NCT01357239|5880447|P4|Stratum I: Fully-Methylated|Adverse Event|0
1684052|NCT01357239|5880448|P3|Stratum I: Fully-Methylated|Adverse Event|1
1684053|NCT01357239|5880449|P2|Stratum I: Fully-Methylated|Adverse Event|0
1684054|NCT01357239|5880450|P1|Stratum I: Fully-Methylated|Adverse Event|0
1684055|NCT01357239|5880447|P4|Stratum: All Patients|Subject withdrew consent|1
1684056|NCT01357239|5880448|P3|Stratum: All Patients|Subject withdrew consent|1
1684057|NCT01357239|5880449|P2|Stratum: All Patients|Subject withdrew consent|0
1684058|NCT01357239|5880450|P1|Stratum: All Patients|Subject withdrew consent|0
1684059|NCT01357239|5880447|P4|Stratum: All Patients|Adverse Event|1
1684060|NCT01357239|5880448|P3|Stratum: All Patients|Adverse Event|1
1684061|NCT01357239|5880449|P2|Stratum: All Patients|Adverse Event|0
1684062|NCT01357239|5880450|P1|Stratum: All Patients|Adverse Event|0
1684063|NCT01357161|5880508|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
1684064|NCT01357161|5880509|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
1684065|NCT01357161|5880510|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
1684066|NCT01357161|5880508|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
1684067|NCT01357161|5880509|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
1684068|NCT01357161|5880510|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
1684069|NCT01357161|5880508|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
1684070|NCT01357161|5880509|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
1684071|NCT01357161|5880510|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
1684072|NCT01357161|5880508|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
1684073|NCT01357161|5880509|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
1684074|NCT01357161|5880510|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
1684075|NCT01357161|5880508|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
1684076|NCT01357161|5880509|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
1684077|NCT01357161|5880510|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
1684078|NCT01357161|5880508|P3|Part 2 (Double-Blind Comparison)|Death|19
1684079|NCT01357161|5880509|P2|Part 2 (Double-Blind Comparison)|Death|22
1684080|NCT01357161|5880510|P1|Part 2 (Double-Blind Comparison)|Death|0
1684081|NCT01357161|5880508|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
1684082|NCT01357161|5880509|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
1684083|NCT01357161|5880510|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
1684084|NCT01357161|5880508|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
1684085|NCT01357161|5880509|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
1684086|NCT01357161|5880510|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
1684087|NCT01357161|5880508|P3|Part 1 (Open Label Run-in)|Physician Decision|0
1684088|NCT01357161|5880509|P2|Part 1 (Open Label Run-in)|Physician Decision|0
1684089|NCT01357161|5880510|P1|Part 1 (Open Label Run-in)|Physician Decision|1
1684090|NCT01357161|5880508|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
1684091|NCT01357161|5880509|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
1684092|NCT01357161|5880510|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
1684093|NCT01357161|5880508|P3|Part 1 (Open Label Run-in)|Death|0
1684094|NCT01357161|5880509|P2|Part 1 (Open Label Run-in)|Death|0
1684095|NCT01357161|5880510|P1|Part 1 (Open Label Run-in)|Death|5
1684096|NCT01356966|5880562|P2|Overall Study|Physician Decision|0
1684097|NCT01356966|5880563|P1|Overall Study|Physician Decision|1
1684098|NCT01356966|5880562|P2|Overall Study|Withdrawal by Subject|2
1684099|NCT01356966|5880563|P1|Overall Study|Withdrawal by Subject|1
1684100|NCT01356940|5880575|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
1684101|NCT01356940|5880576|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
1684102|NCT01356940|5880575|P2|First Intervention (28 Days)|Adverse Event|0
1684103|NCT01356940|5880576|P1|First Intervention (28 Days)|Adverse Event|1
1684104|NCT01356602|5880605|P3|Overall Study|Adverse Event|1
1684105|NCT01356602|5880606|P2|Overall Study|Adverse Event|1
1684106|NCT01356602|5880607|P1|Overall Study|Adverse Event|0
1684107|NCT01356602|5880605|P3|Overall Study|Lack of Efficacy|4
1684108|NCT01356602|5880606|P2|Overall Study|Lack of Efficacy|1
1684109|NCT01356602|5880607|P1|Overall Study|Lack of Efficacy|0
1684110|NCT01356602|5880605|P3|Overall Study|Withdrawal by Subject|7
1684111|NCT01356602|5880606|P2|Overall Study|Withdrawal by Subject|3
1684112|NCT01356602|5880607|P1|Overall Study|Withdrawal by Subject|4
1684113|NCT01356602|5880605|P3|Overall Study|Lost to Follow-up|6
1684114|NCT01356602|5880606|P2|Overall Study|Lost to Follow-up|5
1684115|NCT01356602|5880607|P1|Overall Study|Lost to Follow-up|4
1684116|NCT01356602|5880605|P3|Overall Study|Administrative Problems|5
1684117|NCT01356602|5880606|P2|Overall Study|Administrative Problems|4
1684118|NCT01356602|5880607|P1|Overall Study|Administrative Problems|1
1684119|NCT01356602|5880605|P3|Overall Study|Protocol Deviation|1
1684120|NCT01356602|5880606|P2|Overall Study|Protocol Deviation|1
1684121|NCT01356602|5880607|P1|Overall Study|Protocol Deviation|0
1684122|NCT01356589|5880666|P1|Overall Study|Dose data not recorded|2
1684123|NCT01356589|5880666|P1|Overall Study|Enrolled, but not treated|3
1684124|NCT01356407|5880723|P2|Overall Study|Not complete Endoscopy|2
1684125|NCT01356407|5880724|P1|Overall Study|Not complete Endoscopy|2
1684126|NCT01356407|5880723|P2|Overall Study|Could not afford IMP administration|1
1684127|NCT01356407|5880724|P1|Overall Study|Could not afford IMP administration|0
1684128|NCT01356407|5880723|P2|Overall Study|Patient Withdrew Consent|1
1684129|NCT01356407|5880724|P1|Overall Study|Patient Withdrew Consent|2
1684130|NCT01356407|5880723|P2|Overall Study|Lost to Follow-up|0
1684131|NCT01356407|5880724|P1|Overall Study|Lost to Follow-up|2
1684132|NCT01355679|5880796|P1|Overall Study|benign tumor types found at biopsy|2
1684133|NCT01355627|5880805|P2|Overall Study|Other|1
1684134|NCT01355627|5880806|P1|Overall Study|Other|1
1684135|NCT01355627|5880805|P2|Overall Study|Fatal Adverse Event|23
1684136|NCT01355627|5880806|P1|Overall Study|Fatal Adverse Event|19
1684137|NCT01355627|5880805|P2|Overall Study|Lost to Follow-up|7
1684138|NCT01355627|5880806|P1|Overall Study|Lost to Follow-up|8
1684139|NCT01355627|5880805|P2|Overall Study|Request By the Patient to Discontinue|7
1684140|NCT01355627|5880806|P1|Overall Study|Request By the Patient to Discontinue|5
1684141|NCT01355523|5880845|P2|Overall Study|Adverse Event|2
1684142|NCT01355523|5880846|P1|Overall Study|Adverse Event|0
1684143|NCT01355523|5880845|P2|Overall Study|Protocol Violation|2
1684144|NCT01355523|5880846|P1|Overall Study|Protocol Violation|0
1684145|NCT01355523|5880845|P2|Overall Study|Lost to Follow-up|2
1684146|NCT01355523|5880846|P1|Overall Study|Lost to Follow-up|0
1684147|NCT01355523|5880845|P2|Overall Study|Withdrawal by Subject|4
1684148|NCT01355523|5880846|P1|Overall Study|Withdrawal by Subject|1
1684149|NCT01355302|5880922|P3|Phase 1b|Study terminated by sponsor|0
1684150|NCT01355302|5880923|P2|Phase 1b|Study terminated by sponsor|0
1684151|NCT01355302|5880924|P1|Phase 1b|Study terminated by sponsor|2
1684152|NCT01355302|5880922|P3|Phase 1b|Death|0
1684153|NCT01355302|5880923|P2|Phase 1b|Death|0
1684154|NCT01355302|5880924|P1|Phase 1b|Death|4
1684155|NCT01355289|5880939|P5|Open Label Extension|Other|3
1684156|NCT01355289|5880940|P4|Open Label Extension|Other|0
1684157|NCT01355289|5880941|P3|Open Label Extension|Other|0
1684158|NCT01355289|5880942|P2|Open Label Extension|Other|0
1684159|NCT01355289|5880943|P1|Open Label Extension|Other|0
1684160|NCT01355289|5880939|P5|Open Label Extension|Inadequate Therapeutic Effect|29
1684161|NCT01355289|5880940|P4|Open Label Extension|Inadequate Therapeutic Effect|0
1684162|NCT01355289|5880941|P3|Open Label Extension|Inadequate Therapeutic Effect|0
1684163|NCT01355289|5880942|P2|Open Label Extension|Inadequate Therapeutic Effect|0
1684164|NCT01355289|5880943|P1|Open Label Extension|Inadequate Therapeutic Effect|0
1684165|NCT01355289|5880939|P5|Open Label Extension|Lost to Follow-up|1
1684166|NCT01355289|5880940|P4|Open Label Extension|Lost to Follow-up|0
1684167|NCT01355289|5880941|P3|Open Label Extension|Lost to Follow-up|0
1684168|NCT01355289|5880942|P2|Open Label Extension|Lost to Follow-up|0
1684169|NCT01355289|5880943|P1|Open Label Extension|Lost to Follow-up|0
1684170|NCT01355289|5880939|P5|Open Label Extension|Adverse Event, Non-Fatal|1
1684171|NCT01355289|5880940|P4|Open Label Extension|Adverse Event, Non-Fatal|0
1684172|NCT01355289|5880941|P3|Open Label Extension|Adverse Event, Non-Fatal|0
1684173|NCT01355289|5880942|P2|Open Label Extension|Adverse Event, Non-Fatal|0
1684174|NCT01355289|5880943|P1|Open Label Extension|Adverse Event, Non-Fatal|0
1684175|NCT01355289|5880939|P5|Core Study|Other|0
1684176|NCT01355289|5880940|P4|Core Study|Other|1
1684177|NCT01355289|5880941|P3|Core Study|Other|0
1684178|NCT01355289|5880942|P2|Core Study|Other|0
1684179|NCT01355289|5880943|P1|Core Study|Other|0
1684180|NCT01355289|5880939|P5|Core Study|Inadequate Therapeutic Effect|0
1684181|NCT01355289|5880940|P4|Core Study|Inadequate Therapeutic Effect|1
1684182|NCT01355289|5880941|P3|Core Study|Inadequate Therapeutic Effect|0
1684183|NCT01355289|5880942|P2|Core Study|Inadequate Therapeutic Effect|0
1684184|NCT01355289|5880943|P1|Core Study|Inadequate Therapeutic Effect|0
1684185|NCT01355289|5880939|P5|Core Study|Adverse Event, Non-Fatal|0
1684186|NCT01355289|5880940|P4|Core Study|Adverse Event, Non-Fatal|0
1684187|NCT01355289|5880941|P3|Core Study|Adverse Event, Non-Fatal|0
1684188|NCT01355289|5880942|P2|Core Study|Adverse Event, Non-Fatal|0
1684189|NCT01355289|5880943|P1|Core Study|Adverse Event, Non-Fatal|1
1684190|NCT01355081|5880996|P3|Overall Study|Non Compliance with Study Medication|0
1684191|NCT01355081|5880997|P2|Overall Study|Non Compliance with Study Medication|1
1684192|NCT01355081|5880998|P1|Overall Study|Non Compliance with Study Medication|0
1684193|NCT01355081|5880996|P3|Overall Study|Lack of Efficacy|1
1684194|NCT01355081|5880997|P2|Overall Study|Lack of Efficacy|1
1684195|NCT01355081|5880998|P1|Overall Study|Lack of Efficacy|2
1684196|NCT01355081|5880996|P3|Overall Study|Withdrawal of Consent|3
1684197|NCT01355081|5880997|P2|Overall Study|Withdrawal of Consent|3
1684198|NCT01355081|5880998|P1|Overall Study|Withdrawal of Consent|2
1684199|NCT01355081|5880996|P3|Overall Study|Lost to Follow-up|1
1684200|NCT01355081|5880997|P2|Overall Study|Lost to Follow-up|0
1684201|NCT01355081|5880998|P1|Overall Study|Lost to Follow-up|0
1684202|NCT01355081|5880996|P3|Overall Study|Major Protocol Deviation|0
1684203|NCT01355081|5880997|P2|Overall Study|Major Protocol Deviation|1
1684204|NCT01355081|5880998|P1|Overall Study|Major Protocol Deviation|0
1684205|NCT01355081|5880996|P3|Overall Study|Pretreatment Event or Adverse Event|6
1684206|NCT01355081|5880997|P2|Overall Study|Pretreatment Event or Adverse Event|4
1684207|NCT01355081|5880998|P1|Overall Study|Pretreatment Event or Adverse Event|3
1684208|NCT01355068|5881021|P2|First Intervention Period|Withdrawal by Subject|1
1684209|NCT01355068|5881022|P1|First Intervention Period|Withdrawal by Subject|0
1684210|NCT01355068|5881021|P2|First Intervention Period|Adverse Event|1
1684211|NCT01355068|5881022|P1|First Intervention Period|Adverse Event|0
1684212|NCT01354938|5881052|P1|Overall Study|Lost to Follow-up|1
1684213|NCT01354899|5881058|P1|Overall Study|Protocol Violation|1
1684214|NCT01354899|5881058|P1|Overall Study|discharge from the hospital|2
1684215|NCT01354496|5881093|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
1684216|NCT01354496|5881094|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
1684217|NCT01354496|5881095|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
1684218|NCT01354496|5881096|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
1684219|NCT01354496|5881097|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
1684220|NCT01354496|5881098|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
1684221|NCT01354496|5881093|P6|Period 2|Adverse Event|0
1684222|NCT01354496|5881094|P5|Period 2|Adverse Event|0
1684223|NCT01354496|5881095|P4|Period 2|Adverse Event|1
1684224|NCT01354496|5881096|P3|Period 2|Adverse Event|0
1684225|NCT01354496|5881097|P2|Period 2|Adverse Event|0
1684226|NCT01354496|5881098|P1|Period 2|Adverse Event|0
1684227|NCT01354496|5881093|P6|Period 1|Physician Decision|0
1684228|NCT01354496|5881094|P5|Period 1|Physician Decision|0
1684229|NCT01354496|5881095|P4|Period 1|Physician Decision|0
1684230|NCT01354496|5881096|P3|Period 1|Physician Decision|1
1684231|NCT01354496|5881097|P2|Period 1|Physician Decision|0
1684232|NCT01354496|5881098|P1|Period 1|Physician Decision|0
1684233|NCT01354496|5881093|P6|Period 1|Adverse Event|0
1684234|NCT01354496|5881094|P5|Period 1|Adverse Event|0
1684235|NCT01354496|5881095|P4|Period 1|Adverse Event|0
1684236|NCT01354496|5881096|P3|Period 1|Adverse Event|1
1684237|NCT01354496|5881097|P2|Period 1|Adverse Event|0
1684238|NCT01354496|5881098|P1|Period 1|Adverse Event|0
1684239|NCT01354431|5881141|P3|Participants Treated|Withdrawal by Subject|1
1684240|NCT01354431|5881142|P2|Participants Treated|Withdrawal by Subject|2
1684241|NCT01354431|5881143|P1|Participants Treated|Withdrawal by Subject|1
1684242|NCT01354431|5881141|P3|Participants Treated|Adverse Event|4
1684243|NCT01354431|5881142|P2|Participants Treated|Adverse Event|2
1684244|NCT01354431|5881143|P1|Participants Treated|Adverse Event|1
1684245|NCT01354431|5881141|P3|Participants Treated|Death|0
1684246|NCT01354431|5881142|P2|Participants Treated|Death|1
1684247|NCT01354431|5881143|P1|Participants Treated|Death|0
1684248|NCT01354431|5881141|P3|Participants Treated|Study Drug Toxicity|4
1684249|NCT01354431|5881142|P2|Participants Treated|Study Drug Toxicity|7
1684250|NCT01354431|5881143|P1|Participants Treated|Study Drug Toxicity|2
1684251|NCT01354431|5881141|P3|Participants Treated|Disease Progression|41
1684252|NCT01354431|5881142|P2|Participants Treated|Disease Progression|40
1684253|NCT01354431|5881143|P1|Participants Treated|Disease Progression|49
1684254|NCT01354431|5881141|P3|Participants Treated|Continuing Treatment|4
1684255|NCT01354431|5881142|P2|Participants Treated|Continuing Treatment|2
1684256|NCT01354431|5881143|P1|Participants Treated|Continuing Treatment|6
1684257|NCT01354431|5881141|P3|Randomized to Enter Treatment Period|No longer met criteria|0
1684258|NCT01354431|5881142|P2|Randomized to Enter Treatment Period|No longer met criteria|0
1684259|NCT01354431|5881143|P1|Randomized to Enter Treatment Period|No longer met criteria|1
1684260|NCT01354314|5881167|P4|Overall Study|Less than 90% Adherence|4
1684261|NCT01354314|5881168|P3|Overall Study|Less than 90% Adherence|6
1684262|NCT01354314|5881169|P2|Overall Study|Less than 90% Adherence|2
1684263|NCT01354314|5881170|P1|Overall Study|Less than 90% Adherence|4
1684264|NCT01354314|5881167|P4|Overall Study|Protocol Violation|0
1684265|NCT01354314|5881168|P3|Overall Study|Protocol Violation|0
1684266|NCT01354314|5881169|P2|Overall Study|Protocol Violation|1
1684267|NCT01354314|5881170|P1|Overall Study|Protocol Violation|1
1684268|NCT01354314|5881167|P4|Overall Study|Adverse Event|1
1684269|NCT01354314|5881168|P3|Overall Study|Adverse Event|0
1684270|NCT01354314|5881169|P2|Overall Study|Adverse Event|0
1684271|NCT01354314|5881170|P1|Overall Study|Adverse Event|0
1684272|NCT01354314|5881167|P4|Overall Study|Withdrawal by Subject|0
1684273|NCT01354314|5881168|P3|Overall Study|Withdrawal by Subject|1
1684274|NCT01354314|5881169|P2|Overall Study|Withdrawal by Subject|0
1684275|NCT01354314|5881170|P1|Overall Study|Withdrawal by Subject|0
1684276|NCT01354314|5881167|P4|Overall Study|Lost to Follow-up|1
1684277|NCT01354314|5881168|P3|Overall Study|Lost to Follow-up|1
1684278|NCT01354314|5881169|P2|Overall Study|Lost to Follow-up|0
1684279|NCT01354314|5881170|P1|Overall Study|Lost to Follow-up|1
1684280|NCT01354223|5881306|P2|Overall Study|Withdrawal by Subject|1
1684281|NCT01354223|5881307|P1|Overall Study|Withdrawal by Subject|3
1684282|NCT01354132|5881366|P2|1 Month Post Study Medication|Withdrawal by Subject|3
1684283|NCT01354132|5881367|P1|1 Month Post Study Medication|Withdrawal by Subject|1
1684284|NCT01354132|5881366|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
1684285|NCT01354132|5881367|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
1684286|NCT01354132|5881366|P2|Double Blind (Visits 1-7)|Adverse Event|0
1684287|NCT01354132|5881367|P1|Double Blind (Visits 1-7)|Adverse Event|1
1684288|NCT01354132|5881366|P2|Randomization|Withdrawal by Subject|1
1684289|NCT01354132|5881367|P1|Randomization|Withdrawal by Subject|0
1684290|NCT01354132|5881366|P2|Randomization|Physician Decision|0
1684291|NCT01354132|5881367|P1|Randomization|Physician Decision|1
1684292|NCT01354106|5881405|P1|Overall Study|Withdrawal by Subject|2
1684293|NCT01354028|5881411|P2|Overall Study|No quiet alert state|1
1684294|NCT01354028|5881412|P1|Overall Study|No quiet alert state|0
1684295|NCT01354028|5881411|P2|Overall Study|Discharged before study start|2
1684296|NCT01354028|5881412|P1|Overall Study|Discharged before study start|2
1684297|NCT01354028|5881411|P2|Overall Study|Physician Decision|2
1684298|NCT01354028|5881412|P1|Overall Study|Physician Decision|0
1684299|NCT01353963|5881448|P1|Overall Study|Adverse Event|2
1684300|NCT01353911|5881466|P8|Overall Study|Status Not Recorded|0
1684301|NCT01353911|5881467|P7|Overall Study|Status Not Recorded|0
1684302|NCT01353911|5881468|P6|Overall Study|Status Not Recorded|0
1684303|NCT01353911|5881469|P5|Overall Study|Status Not Recorded|0
1684304|NCT01353911|5881470|P4|Overall Study|Status Not Recorded|0
1684305|NCT01353911|5881471|P3|Overall Study|Status Not Recorded|1
1684306|NCT01353911|5881472|P2|Overall Study|Status Not Recorded|0
1684307|NCT01353911|5881473|P1|Overall Study|Status Not Recorded|4
1684308|NCT01353911|5881466|P8|Overall Study|Withdrawal by Subject|9
1684309|NCT01353911|5881467|P7|Overall Study|Withdrawal by Subject|3
1684310|NCT01353911|5881468|P6|Overall Study|Withdrawal by Subject|3
1684311|NCT01353911|5881469|P5|Overall Study|Withdrawal by Subject|2
1684312|NCT01353911|5881470|P4|Overall Study|Withdrawal by Subject|2
1684313|NCT01353911|5881471|P3|Overall Study|Withdrawal by Subject|4
1684314|NCT01353911|5881472|P2|Overall Study|Withdrawal by Subject|3
1684315|NCT01353911|5881473|P1|Overall Study|Withdrawal by Subject|2
1684316|NCT01353911|5881466|P8|Overall Study|Lost to Follow-up|6
1684317|NCT01353911|5881467|P7|Overall Study|Lost to Follow-up|3
1684318|NCT01353911|5881468|P6|Overall Study|Lost to Follow-up|4
1684319|NCT01353911|5881469|P5|Overall Study|Lost to Follow-up|4
1684320|NCT01353911|5881470|P4|Overall Study|Lost to Follow-up|0
1684321|NCT01353911|5881471|P3|Overall Study|Lost to Follow-up|4
1684322|NCT01353911|5881472|P2|Overall Study|Lost to Follow-up|6
1684323|NCT01353911|5881473|P1|Overall Study|Lost to Follow-up|2
1684324|NCT01353898|5881553|P6|Overall Study|Study site terminated|1
1684325|NCT01353898|5881554|P5|Overall Study|Study site terminated|0
1684326|NCT01353898|5881555|P4|Overall Study|Study site terminated|0
1684327|NCT01353898|5881556|P3|Overall Study|Study site terminated|0
1684328|NCT01353898|5881557|P2|Overall Study|Study site terminated|0
1684329|NCT01353898|5881558|P1|Overall Study|Study site terminated|0
1684330|NCT01353859|5881584|P1|Overall Study|Lack of Efficacy|1
1684331|NCT01353859|5881584|P1|Overall Study|Adverse Event|3
1684332|NCT01353703|5881599|P2|Overall Study|Migrated/moved from study area|0
1684333|NCT01353703|5881600|P1|Overall Study|Migrated/moved from study area|1
1684334|NCT01353664|5881646|P1|Overall Study|Disease Progression|16
1684335|NCT01353664|5881646|P1|Overall Study|Other|3
1684336|NCT01353586|5881652|P2|Overall Study|Neurological exam not done|1
1684337|NCT01353586|5881653|P1|Overall Study|Neurological exam not done|0
1684338|NCT01353586|5881652|P2|Overall Study|Never had insertion of study catheter|1
1684339|NCT01353586|5881653|P1|Overall Study|Never had insertion of study catheter|4
1684340|NCT01353586|5881652|P2|Overall Study|Procedure terminated prior to ablation|0
1684341|NCT01353586|5881653|P1|Overall Study|Procedure terminated prior to ablation|3
1684342|NCT01353508|5881671|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1684343|NCT01353508|5881672|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1684344|NCT01353508|5881673|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
1684345|NCT01353508|5881674|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
1684346|NCT01353508|5881671|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
1684347|NCT01353508|5881672|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
1684348|NCT01353508|5881673|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
1684349|NCT01353508|5881674|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
1684350|NCT01353274|5881752|P1|Overall Study|No case report form (CRF) collected|28
1684351|NCT01353222|5881762|P2|Overall Study|Site closed research department|0
1684352|NCT01353222|5881763|P1|Overall Study|Site closed research department|1
1684353|NCT01353222|5881762|P2|Overall Study|Study Terminated|37
1684354|NCT01353222|5881763|P1|Overall Study|Study Terminated|31
1684355|NCT01353222|5881762|P2|Overall Study|Withdrawal by Subject|5
1684356|NCT01353222|5881763|P1|Overall Study|Withdrawal by Subject|8
1684357|NCT01353222|5881762|P2|Overall Study|Death|30
1684358|NCT01353222|5881763|P1|Overall Study|Death|30
1684359|NCT01352845|5881806|P2|Overall Study|Death|0
1684360|NCT01352845|5881807|P1|Overall Study|Death|3
1684361|NCT01352845|5881806|P2|Overall Study|Protocol Violation|6
1684362|NCT01352845|5881807|P1|Overall Study|Protocol Violation|12
1684363|NCT01352845|5881806|P2|Overall Study|Other|7
1684364|NCT01352845|5881807|P1|Overall Study|Other|17
1684365|NCT01352845|5881806|P2|Overall Study|Adverse Event|6
1684366|NCT01352845|5881807|P1|Overall Study|Adverse Event|22
1684367|NCT01352845|5881806|P2|Overall Study|Pregnancy|7
1684368|NCT01352845|5881807|P1|Overall Study|Pregnancy|27
1684369|NCT01352845|5881806|P2|Overall Study|No Longer Meets Eligibility Criteria|11
1684370|NCT01352845|5881807|P1|Overall Study|No Longer Meets Eligibility Criteria|24
1684371|NCT01352845|5881806|P2|Overall Study|Withdrawal by Subject|16
1684372|NCT01352845|5881807|P1|Overall Study|Withdrawal by Subject|48
1684373|NCT01352845|5881806|P2|Overall Study|No Longer Willing to Participate|58
1684374|NCT01352845|5881807|P1|Overall Study|No Longer Willing to Participate|205
1684375|NCT01352845|5881806|P2|Overall Study|Lost to Follow-up|92
1684376|NCT01352845|5881807|P1|Overall Study|Lost to Follow-up|313
1684377|NCT01352793|5881896|P2|Overall Study|No longer meets eligibility criteria|15
1684378|NCT01352793|5881897|P1|Overall Study|No longer meets eligibility criteria|25
1684379|NCT01352793|5881896|P2|Overall Study|Randomized but not vaccinated|0
1684380|NCT01352793|5881897|P1|Overall Study|Randomized but not vaccinated|8
1684381|NCT01352793|5881896|P2|Overall Study|Death|0
1684382|NCT01352793|5881897|P1|Overall Study|Death|1
1684383|NCT01352793|5881896|P2|Overall Study|Medication error|2
1684384|NCT01352793|5881897|P1|Overall Study|Medication error|2
1684385|NCT01352793|5881896|P2|Overall Study|Other|7
1684386|NCT01352793|5881897|P1|Overall Study|Other|25
1684387|NCT01352793|5881896|P2|Overall Study|Pregnancy|8
1684388|NCT01352793|5881897|P1|Overall Study|Pregnancy|26
1684389|NCT01352793|5881896|P2|Overall Study|Physician Decision|0
1684390|NCT01352793|5881897|P1|Overall Study|Physician Decision|1
1684391|NCT01352793|5881896|P2|Overall Study|Adverse Event|10
1684392|NCT01352793|5881897|P1|Overall Study|Adverse Event|44
1684393|NCT01352793|5881896|P2|Overall Study|Protocol Violation|23
1684394|NCT01352793|5881897|P1|Overall Study|Protocol Violation|44
1684395|NCT01352793|5881896|P2|Overall Study|Withdrawal by Subject|55
1684396|NCT01352793|5881897|P1|Overall Study|Withdrawal by Subject|120
1684397|NCT01352793|5881896|P2|Overall Study|Lost to Follow-up|125
1684398|NCT01352793|5881897|P1|Overall Study|Lost to Follow-up|289
1684399|NCT01352741|5881921|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
1684400|NCT01352741|5881922|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
1684401|NCT01352741|5881921|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
1684402|NCT01352741|5881922|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
1684403|NCT01352741|5881921|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
1684404|NCT01352741|5881922|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
1684405|NCT01352741|5881921|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
1684406|NCT01352741|5881922|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
1684407|NCT01352741|5881921|P2|Double-blind Comparative Period|Other|2
1684408|NCT01352741|5881922|P1|Double-blind Comparative Period|Other|1
1684409|NCT01352741|5881921|P2|Double-blind Comparative Period|Withdrawal of consent|3
1684410|NCT01352741|5881922|P1|Double-blind Comparative Period|Withdrawal of consent|8
1684411|NCT01352741|5881921|P2|Double-blind Comparative Period|Death|1
1684412|NCT01352741|5881922|P1|Double-blind Comparative Period|Death|0
1684413|NCT01352741|5881921|P2|Double-blind Comparative Period|Lost to Follow-up|0
1684414|NCT01352741|5881922|P1|Double-blind Comparative Period|Lost to Follow-up|1
1684415|NCT01352741|5881921|P2|Double-blind Comparative Period|Adverse Event|17
1684416|NCT01352741|5881922|P1|Double-blind Comparative Period|Adverse Event|16
1684417|NCT01352741|5881921|P2|Double-blind Comparative Period|Lack of Efficacy|3
1684418|NCT01352741|5881922|P1|Double-blind Comparative Period|Lack of Efficacy|0
1684419|NCT01352741|5881921|P2|Double-blind Comparative Period|Protocol Violation|0
1684420|NCT01352741|5881922|P1|Double-blind Comparative Period|Protocol Violation|2
1684421|NCT01352741|5881921|P2|Open-label Tapentadol Titration Period|Other|0
1684422|NCT01352741|5881922|P1|Open-label Tapentadol Titration Period|Other|4
1684423|NCT01352741|5881921|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
1684424|NCT01352741|5881922|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
1684425|NCT01352741|5881921|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
1684426|NCT01352741|5881922|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
1684427|NCT01352741|5881921|P2|Open-label Tapentadol Titration Period|Adverse Event|0
1684428|NCT01352741|5881922|P1|Open-label Tapentadol Titration Period|Adverse Event|34
1684429|NCT01352741|5881921|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
1684430|NCT01352741|5881922|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
1684431|NCT01352741|5881921|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
1684432|NCT01352741|5881922|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
1684433|NCT01352715|5882016|P2|Overall Study|major ineligibility|1
1684434|NCT01352715|5882017|P1|Overall Study|major ineligibility|2
1684435|NCT01352715|5882016|P2|Overall Study|no final visit in closeout period|12
1684436|NCT01352715|5882017|P1|Overall Study|no final visit in closeout period|15
1684437|NCT01352715|5882016|P2|Overall Study|site closure|15
1684438|NCT01352715|5882017|P1|Overall Study|site closure|16
1684439|NCT01352715|5882016|P2|Overall Study|Withdrawal by Subject|8
1684440|NCT01352715|5882017|P1|Overall Study|Withdrawal by Subject|4
1684441|NCT01352715|5882016|P2|Overall Study|Lost to Follow-up|7
1684442|NCT01352715|5882017|P1|Overall Study|Lost to Follow-up|5
1684443|NCT01352715|5882016|P2|Overall Study|Death|3
1684444|NCT01352715|5882017|P1|Overall Study|Death|3
1684445|NCT01352585|5882056|P1|Overall Study|Other|7
1684446|NCT01352585|5882056|P1|Overall Study|Lost to Follow-up|1
1684447|NCT01352585|5882056|P1|Overall Study|Adverse Event|3
1684448|NCT01352507|5882073|P2|Treatment Period 2|Lack of Efficacy|0
1684449|NCT01352507|5882074|P1|Treatment Period 2|Lack of Efficacy|1
1684450|NCT01352507|5882073|P2|Treatment Period 2|Withdrawal by Subject|3
1684451|NCT01352507|5882074|P1|Treatment Period 2|Withdrawal by Subject|4
1684452|NCT01352507|5882073|P2|Treatment Period 2|Entry Criteria Not Met|0
1684453|NCT01352507|5882074|P1|Treatment Period 2|Entry Criteria Not Met|1
1684454|NCT01352507|5882073|P2|Washout Period|Withdrawal by Subject|1
1684455|NCT01352507|5882074|P1|Washout Period|Withdrawal by Subject|0
1684456|NCT01352507|5882073|P2|Treatment Period 1|Physician Decision|0
1684457|NCT01352507|5882074|P1|Treatment Period 1|Physician Decision|1
1684458|NCT01352507|5882073|P2|Treatment Period 1|Withdrawal by Subject|5
1684459|NCT01352507|5882074|P1|Treatment Period 1|Withdrawal by Subject|7
1684460|NCT01352507|5882073|P2|Treatment Period 1|Lost to Follow-up|4
1684461|NCT01352507|5882074|P1|Treatment Period 1|Lost to Follow-up|3
1684462|NCT01352507|5882073|P2|Treatment Period 1|Adverse Event|0
1684463|NCT01352507|5882074|P1|Treatment Period 1|Adverse Event|3
1684464|NCT01352416|5882127|P4|Overall Study|Physician Decision|1
1684465|NCT01352416|5882128|P3|Overall Study|Physician Decision|2
1684466|NCT01352416|5882129|P2|Overall Study|Physician Decision|2
1684467|NCT01352416|5882130|P1|Overall Study|Physician Decision|1
1684468|NCT01352221|5882152|P4|Open-label Phase|Worsening of IBD|0
1684469|NCT01352221|5882153|P3|Open-label Phase|Worsening of IBD|1
1684470|NCT01352221|5882154|P2|Open-label Phase|Worsening of IBD|0
1684471|NCT01352221|5882155|P1|Open-label Phase|Worsening of IBD|0
1684472|NCT01352221|5882152|P4|Open-label Phase|Withdrawal by Subject|6
1684473|NCT01352221|5882153|P3|Open-label Phase|Withdrawal by Subject|1
1684474|NCT01352221|5882154|P2|Open-label Phase|Withdrawal by Subject|0
1684475|NCT01352221|5882155|P1|Open-label Phase|Withdrawal by Subject|0
1684476|NCT01352221|5882152|P4|Open-label Phase|Adverse Event|4
1684477|NCT01352221|5882153|P3|Open-label Phase|Adverse Event|8
1684478|NCT01352221|5882154|P2|Open-label Phase|Adverse Event|0
1684479|NCT01352221|5882155|P1|Open-label Phase|Adverse Event|0
1684480|NCT01352221|5882152|P4|Open-label Phase|Pregnancy|0
1684481|NCT01352221|5882153|P3|Open-label Phase|Pregnancy|1
1684482|NCT01352221|5882154|P2|Open-label Phase|Pregnancy|0
1684483|NCT01352221|5882155|P1|Open-label Phase|Pregnancy|0
1684484|NCT01352221|5882152|P4|Open-label Phase|Physician Decision|1
1684485|NCT01352221|5882153|P3|Open-label Phase|Physician Decision|2
1684486|NCT01352221|5882154|P2|Open-label Phase|Physician Decision|0
1684487|NCT01352221|5882155|P1|Open-label Phase|Physician Decision|0
1684488|NCT01352221|5882152|P4|Double-blind Phase|Protocol Violation|0
1684489|NCT01352221|5882153|P3|Double-blind Phase|Protocol Violation|0
1684490|NCT01352221|5882154|P2|Double-blind Phase|Protocol Violation|1
1684491|NCT01352221|5882155|P1|Double-blind Phase|Protocol Violation|0
1684492|NCT01352221|5882152|P4|Double-blind Phase|Lost to Follow-up|0
1684493|NCT01352221|5882153|P3|Double-blind Phase|Lost to Follow-up|0
1684494|NCT01352221|5882154|P2|Double-blind Phase|Lost to Follow-up|1
1684495|NCT01352221|5882155|P1|Double-blind Phase|Lost to Follow-up|0
1684496|NCT01352221|5882152|P4|Double-blind Phase|Withdrawal by Subject|0
1684497|NCT01352221|5882153|P3|Double-blind Phase|Withdrawal by Subject|0
1684498|NCT01352221|5882154|P2|Double-blind Phase|Withdrawal by Subject|5
1684499|NCT01352221|5882155|P1|Double-blind Phase|Withdrawal by Subject|3
1684500|NCT01352221|5882152|P4|Double-blind Phase|Adverse Event|0
1684501|NCT01352221|5882153|P3|Double-blind Phase|Adverse Event|0
1684502|NCT01352221|5882154|P2|Double-blind Phase|Adverse Event|4
1684503|NCT01352221|5882155|P1|Double-blind Phase|Adverse Event|6
1684504|NCT01352117|5882215|P2|Overall Study|Ineligible (no KS diagnosis)|0
1684505|NCT01352117|5882216|P1|Overall Study|Ineligible (no KS diagnosis)|1
1684506|NCT01352117|5882215|P2|Overall Study|Did not initiate study treatment|0
1684507|NCT01352117|5882216|P1|Overall Study|Did not initiate study treatment|1
1684508|NCT01352117|5882215|P2|Overall Study|Non-adherent to study requirements|1
1684509|NCT01352117|5882216|P1|Overall Study|Non-adherent to study requirements|1
1684510|NCT01352117|5882215|P2|Overall Study|Lost to Follow-up|7
1684511|NCT01352117|5882216|P1|Overall Study|Lost to Follow-up|2
1684512|NCT01352117|5882215|P2|Overall Study|Withdrawal by Subject|0
1684513|NCT01352117|5882216|P1|Overall Study|Withdrawal by Subject|1
1684514|NCT01352117|5882215|P2|Overall Study|Death|16
1684515|NCT01352117|5882216|P1|Overall Study|Death|15
1684516|NCT01351623|5882279|P1|Overall Study|Death|2
1684517|NCT01351623|5882279|P1|Overall Study|Withdrawal by Subject|1
1684518|NCT01351623|5882279|P1|Overall Study|Adverse Event|4
1684519|NCT01351623|5882279|P1|Overall Study|Protocol Violation|2
1684520|NCT01351415|5882305|P2|Overall Study|Never Started|5
1684521|NCT01351415|5882306|P1|Overall Study|Never Started|5
1684522|NCT01351415|5882305|P2|Overall Study|Reason unknown|2
1684523|NCT01351415|5882306|P1|Overall Study|Reason unknown|0
1684524|NCT01351415|5882305|P2|Overall Study|Physician Decision|3
1684525|NCT01351415|5882306|P1|Overall Study|Physician Decision|2
1684526|NCT01351415|5882305|P2|Overall Study|Death|187
1684527|NCT01351415|5882306|P1|Overall Study|Death|190
1684528|NCT01351415|5882305|P2|Overall Study|Lost to Follow-up|7
1684529|NCT01351415|5882306|P1|Overall Study|Lost to Follow-up|5
1684530|NCT01351415|5882305|P2|Overall Study|Trial termination by the Sponsor|19
1684531|NCT01351415|5882306|P1|Overall Study|Trial termination by the Sponsor|28
1684532|NCT01351415|5882305|P2|Overall Study|Withdrawal by Subject|17
1684533|NCT01351415|5882306|P1|Overall Study|Withdrawal by Subject|15
1684534|NCT01351350|5882342|P5|Overall Study|Enrolled but not Treated|0
1684535|NCT01351350|5882343|P4|Overall Study|Enrolled but not Treated|0
1684536|NCT01351350|5882344|P3|Overall Study|Enrolled but not Treated|1
1684537|NCT01351350|5882345|P2|Overall Study|Enrolled but not Treated|0
1684538|NCT01351350|5882346|P1|Overall Study|Enrolled but not Treated|0
1684539|NCT01351350|5882342|P5|Overall Study|Participant Decision|2
1684540|NCT01351350|5882343|P4|Overall Study|Participant Decision|3
1684541|NCT01351350|5882344|P3|Overall Study|Participant Decision|3
1684542|NCT01351350|5882345|P2|Overall Study|Participant Decision|6
1684543|NCT01351350|5882346|P1|Overall Study|Participant Decision|2
1684544|NCT01351350|5882342|P5|Overall Study|Adverse Event|0
1684545|NCT01351350|5882343|P4|Overall Study|Adverse Event|2
1684546|NCT01351350|5882344|P3|Overall Study|Adverse Event|1
1684547|NCT01351350|5882345|P2|Overall Study|Adverse Event|10
1684548|NCT01351350|5882346|P1|Overall Study|Adverse Event|1
1684549|NCT01351350|5882342|P5|Overall Study|Disease Progression|5
1684550|NCT01351350|5882343|P4|Overall Study|Disease Progression|8
1684551|NCT01351350|5882344|P3|Overall Study|Disease Progression|6
1684552|NCT01351350|5882345|P2|Overall Study|Disease Progression|13
1684553|NCT01351350|5882346|P1|Overall Study|Disease Progression|5
1684554|NCT01351025|5882517|P2|Week 24 - 44|unable to get to clinic|1
1684555|NCT01351025|5882518|P1|Week 24 - 44|unable to get to clinic|1
1684556|NCT01351025|5882517|P2|Week 24 - 44|Site closed|1
1684557|NCT01351025|5882518|P1|Week 24 - 44|Site closed|0
1684558|NCT01351025|5882517|P2|Week 24 - 44|Lost to Follow-up|2
1684559|NCT01351025|5882518|P1|Week 24 - 44|Lost to Follow-up|0
1684560|NCT01351025|5882517|P2|Week 0 - 20|Withdrawal by Subject|0
1684561|NCT01351025|5882518|P1|Week 0 - 20|Withdrawal by Subject|1
1684562|NCT01351025|5882517|P2|Week 0 - 20|Lost to Follow-up|1
1684563|NCT01351025|5882518|P1|Week 0 - 20|Lost to Follow-up|2
1684564|NCT01350999|5882551|P3|Overall Study|Difficulty Making it to Study Visit|5
1684565|NCT01350999|5882552|P2|Overall Study|Difficulty Making it to Study Visit|1
1684566|NCT01350999|5882553|P1|Overall Study|Difficulty Making it to Study Visit|1
1684567|NCT01350999|5882551|P3|Overall Study|Voluntary withdrawal|6
1684568|NCT01350999|5882552|P2|Overall Study|Voluntary withdrawal|4
1684569|NCT01350999|5882553|P1|Overall Study|Voluntary withdrawal|3
1684570|NCT01350999|5882551|P3|Overall Study|Adverse Event|10
1684571|NCT01350999|5882552|P2|Overall Study|Adverse Event|9
1684572|NCT01350999|5882553|P1|Overall Study|Adverse Event|4
1684573|NCT01350973|5882591|P3|Overall Study|Voluntary Withdrawal|1
1684574|NCT01350973|5882592|P2|Overall Study|Voluntary Withdrawal|1
1684575|NCT01350973|5882593|P1|Overall Study|Voluntary Withdrawal|2
1684576|NCT01350973|5882591|P3|Overall Study|Adverse Event|7
1684577|NCT01350973|5882592|P2|Overall Study|Adverse Event|7
1684578|NCT01350973|5882593|P1|Overall Study|Adverse Event|4
1684579|NCT01350934|5882634|P2|Extension Study|Withdrawal by Subject|1
1684580|NCT01350934|5882635|P1|Extension Study|Withdrawal by Subject|0
1684581|NCT01350934|5882634|P2|Extension Study|Lack of Efficacy|1
1684582|NCT01350934|5882635|P1|Extension Study|Lack of Efficacy|0
1684583|NCT01350934|5882634|P2|Extension Study|Protocol Violation|1
1684584|NCT01350934|5882635|P1|Extension Study|Protocol Violation|1
1684585|NCT01350934|5882634|P2|Extension Study|Lost to Follow-up|0
1684586|NCT01350934|5882635|P1|Extension Study|Lost to Follow-up|2
1684587|NCT01350934|5882634|P2|Extension Study|Adverse Event|1
1684588|NCT01350934|5882635|P1|Extension Study|Adverse Event|2
1684589|NCT01350934|5882634|P2|Base Study|Non-Compliance With Study Drug|0
1684590|NCT01350934|5882635|P1|Base Study|Non-Compliance With Study Drug|2
1684591|NCT01350934|5882634|P2|Base Study|Withdrawal by Subject|2
1684592|NCT01350934|5882635|P1|Base Study|Withdrawal by Subject|1
1684593|NCT01350934|5882634|P2|Base Study|Protocol Violation|1
1684594|NCT01350934|5882635|P1|Base Study|Protocol Violation|1
1684595|NCT01350934|5882634|P2|Base Study|Lost to Follow-up|0
1684596|NCT01350934|5882635|P1|Base Study|Lost to Follow-up|1
1684597|NCT01350934|5882634|P2|Base Study|Adverse Event|0
1684598|NCT01350934|5882635|P1|Base Study|Adverse Event|6
1684599|NCT01350804|5882657|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
1684600|NCT01350804|5882658|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
1684601|NCT01350804|5882659|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
1684602|NCT01350804|5882660|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
1684603|NCT01350804|5882657|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
1684604|NCT01350804|5882658|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
1684605|NCT01350804|5882659|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
1684606|NCT01350804|5882660|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
1684607|NCT01350804|5882657|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1684608|NCT01350804|5882658|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1684609|NCT01350804|5882659|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
1684610|NCT01350804|5882660|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
1684611|NCT01350804|5882657|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
1684612|NCT01350804|5882658|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
1684613|NCT01350804|5882659|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
1684614|NCT01350804|5882660|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
1684615|NCT01350804|5882657|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
1684616|NCT01350804|5882658|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
1684617|NCT01350804|5882659|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
1684618|NCT01350804|5882660|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
1684619|NCT01350804|5882657|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
1684620|NCT01350804|5882658|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
1684621|NCT01350804|5882659|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
1684622|NCT01350804|5882660|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
1684623|NCT01350804|5882657|P4|Core Study|Adverse Event|8
1684624|NCT01350804|5882658|P3|Core Study|Adverse Event|8
1684625|NCT01350804|5882659|P2|Core Study|Adverse Event|10
1684626|NCT01350804|5882660|P1|Core Study|Adverse Event|8
1684627|NCT01350804|5882657|P4|Core Study|Death|0
1684628|NCT01350804|5882658|P3|Core Study|Death|1
1684629|NCT01350804|5882659|P2|Core Study|Death|1
1684630|NCT01350804|5882660|P1|Core Study|Death|1
1684631|NCT01350804|5882657|P4|Core Study|Lack of Efficacy|5
1684632|NCT01350804|5882658|P3|Core Study|Lack of Efficacy|18
1684633|NCT01350804|5882659|P2|Core Study|Lack of Efficacy|19
1684634|NCT01350804|5882660|P1|Core Study|Lack of Efficacy|16
1684635|NCT01350804|5882657|P4|Core Study|Lost to Follow-up|1
1684636|NCT01350804|5882658|P3|Core Study|Lost to Follow-up|2
1684637|NCT01350804|5882659|P2|Core Study|Lost to Follow-up|0
1684638|NCT01350804|5882660|P1|Core Study|Lost to Follow-up|3
1684639|NCT01350804|5882657|P4|Core Study|Physician Decision|3
1684640|NCT01350804|5882658|P3|Core Study|Physician Decision|1
1684641|NCT01350804|5882659|P2|Core Study|Physician Decision|0
1684642|NCT01350804|5882660|P1|Core Study|Physician Decision|1
1684643|NCT01350804|5882657|P4|Core Study|Protocol deviation|0
1684644|NCT01350804|5882658|P3|Core Study|Protocol deviation|1
1684645|NCT01350804|5882659|P2|Core Study|Protocol deviation|0
1684646|NCT01350804|5882660|P1|Core Study|Protocol deviation|1
1684647|NCT01350804|5882657|P4|Core Study|Study terminated by Sponsor|2
1684648|NCT01350804|5882658|P3|Core Study|Study terminated by Sponsor|0
1684649|NCT01350804|5882659|P2|Core Study|Study terminated by Sponsor|0
1684650|NCT01350804|5882660|P1|Core Study|Study terminated by Sponsor|0
1684651|NCT01350804|5882657|P4|Core Study|Withdrawal by Subject|7
1684652|NCT01350804|5882658|P3|Core Study|Withdrawal by Subject|16
1684653|NCT01350804|5882659|P2|Core Study|Withdrawal by Subject|17
1684654|NCT01350804|5882660|P1|Core Study|Withdrawal by Subject|11
1684655|NCT01350544|5882757|P2|Overall Study|Lost to Follow-up|15
1684656|NCT01350544|5882758|P1|Overall Study|Lost to Follow-up|18
1684657|NCT01350544|5882757|P2|Overall Study|Incarceration|0
1684658|NCT01350544|5882758|P1|Overall Study|Incarceration|1
1684659|NCT01350544|5882757|P2|Overall Study|Withdrawal by Subject|1
1684660|NCT01350544|5882758|P1|Overall Study|Withdrawal by Subject|0
1684661|NCT01350544|5882757|P2|Overall Study|Medical Issues|1
1684662|NCT01350544|5882758|P1|Overall Study|Medical Issues|1
1684663|NCT01350544|5882757|P2|Overall Study|Moved out of LA County|2
1684664|NCT01350544|5882758|P1|Overall Study|Moved out of LA County|2
1684665|NCT01350544|5882757|P2|Overall Study|Death|2
1684666|NCT01350544|5882758|P1|Overall Study|Death|1
1684667|NCT01350544|5882757|P2|Overall Study|Administrative Withdrawal|1
1684668|NCT01350544|5882758|P1|Overall Study|Administrative Withdrawal|0
1684669|NCT01350505|5882764|P1|Overall Study|Lost to Follow-up|4
1684670|NCT01350414|5882794|P1|Overall Study|Physician Decision|2
1684671|NCT01350414|5882794|P1|Overall Study|Withdrawal by Subject|4
1684672|NCT01350414|5882794|P1|Overall Study|Lost to Follow-up|13
1684673|NCT01350271|5882843|P3|Overall Study|Lost to Follow-up|26
1684674|NCT01350271|5882844|P2|Overall Study|Lost to Follow-up|17
1684675|NCT01350271|5882845|P1|Overall Study|Lost to Follow-up|21
1684676|NCT01350141|5882887|P3|Overall Study|Randomized but not treated|0
1684677|NCT01350141|5882888|P2|Overall Study|Randomized but not treated|0
1684678|NCT01350141|5882889|P1|Overall Study|Randomized but not treated|1
1684679|NCT01350141|5882887|P3|Overall Study|Withdrawal by Subject|0
1684680|NCT01350141|5882888|P2|Overall Study|Withdrawal by Subject|0
1684681|NCT01350141|5882889|P1|Overall Study|Withdrawal by Subject|1
1684682|NCT01350141|5882887|P3|Overall Study|Lost to Follow-up|1
1684683|NCT01350141|5882888|P2|Overall Study|Lost to Follow-up|0
1684684|NCT01350141|5882889|P1|Overall Study|Lost to Follow-up|1
1684685|NCT01350128|5882923|P1|Overall Study|Lost to Follow-up|2
1684686|NCT01350128|5882923|P1|Overall Study|Physician Decision|1
1684687|NCT01350128|5882923|P1|Overall Study|Protocol discontinuation criteria|8
1684688|NCT01350128|5882923|P1|Overall Study|Withdrawal by Subject|3
1684689|NCT01350115|5882987|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
1684690|NCT01350115|5882988|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
1684691|NCT01350115|5882987|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
1684692|NCT01350115|5882988|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
1684693|NCT01350115|5882987|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
1684694|NCT01350115|5882988|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
1684695|NCT01350102|5883004|P4|Overall Study|Adverse Event|0
1684696|NCT01350102|5883005|P3|Overall Study|Adverse Event|1
1684697|NCT01350102|5883006|P2|Overall Study|Adverse Event|0
1684698|NCT01350102|5883007|P1|Overall Study|Adverse Event|0
1684699|NCT01349959|5883044|P1|Overall Study|Adverse Event|7
1684700|NCT01349907|5883085|P2|Overall Study|Administrative|1
1684701|NCT01349907|5883086|P1|Overall Study|Administrative|1
1684702|NCT01349907|5883085|P2|Overall Study|Protocol Violation|13
1684703|NCT01349907|5883086|P1|Overall Study|Protocol Violation|33
1684704|NCT01349907|5883085|P2|Overall Study|Withdrawal by Subject|8
1684705|NCT01349907|5883086|P1|Overall Study|Withdrawal by Subject|30
1684706|NCT01349907|5883085|P2|Overall Study|Lost to Follow-up|6
1684707|NCT01349907|5883086|P1|Overall Study|Lost to Follow-up|25
1684708|NCT01349907|5883085|P2|Overall Study|Treatment failure|4
1684709|NCT01349907|5883086|P1|Overall Study|Treatment failure|13
1684710|NCT01349907|5883085|P2|Overall Study|Adverse Event|11
1684711|NCT01349907|5883086|P1|Overall Study|Adverse Event|37
1684712|NCT01349829|5883124|P2|Overall Study|Migrated/moved|7
1684713|NCT01349829|5883125|P1|Overall Study|Migrated/moved|2
1684714|NCT01349829|5883124|P2|Overall Study|Consent withdrawal|8
1684715|NCT01349829|5883125|P1|Overall Study|Consent withdrawal|3
1684716|NCT01349829|5883124|P2|Overall Study|Lost to Follow-up|8
1684717|NCT01349829|5883125|P1|Overall Study|Lost to Follow-up|4
1684718|NCT01349816|5883143|P1|Overall Study|Protocol-specified criteria|8
1684719|NCT01349816|5883143|P1|Overall Study|Protocol Violation|1
1684720|NCT01349816|5883143|P1|Overall Study|Lost to Follow-up|2
1684721|NCT01349816|5883143|P1|Overall Study|Adverse Event|14
1684722|NCT01349816|5883143|P1|Overall Study|Physician Decision|1
1684723|NCT01349816|5883143|P1|Overall Study|Withdrawal by Subject|4
1684724|NCT01349803|5883209|P4|Overall Study|Protocol-specified criteria|0
1684725|NCT01349803|5883210|P3|Overall Study|Protocol-specified criteria|3
1684726|NCT01349803|5883211|P2|Overall Study|Protocol-specified criteria|1
1684727|NCT01349803|5883212|P1|Overall Study|Protocol-specified criteria|0
1684728|NCT01349803|5883209|P4|Overall Study|Withdrawal by Subject|0
1684729|NCT01349803|5883210|P3|Overall Study|Withdrawal by Subject|0
1684730|NCT01349803|5883211|P2|Overall Study|Withdrawal by Subject|0
1684731|NCT01349803|5883212|P1|Overall Study|Withdrawal by Subject|1
1684732|NCT01349803|5883209|P4|Overall Study|Adverse Event|2
1684733|NCT01349803|5883210|P3|Overall Study|Adverse Event|0
1684734|NCT01349803|5883211|P2|Overall Study|Adverse Event|0
1684735|NCT01349803|5883212|P1|Overall Study|Adverse Event|0
1684736|NCT01349790|5883282|P1|Overall Study|Lost to Follow-up|1
1684737|NCT01349790|5883282|P1|Overall Study|Adverse Event|1
1684738|NCT01349790|5883282|P1|Overall Study|Withdrawal by Patient|2
1684739|NCT01349790|5883282|P1|Overall Study|Death|2
1684740|NCT01349790|5883282|P1|Overall Study|Investigator Judgement|3
1684741|NCT01349673|5883301|P1|Overall Study|Lack of Efficacy|8
1684742|NCT01349673|5883301|P1|Overall Study|Study Terminated By Sponsor|50
1684743|NCT01349673|5883301|P1|Overall Study|Adverse Event|17
1684744|NCT01349673|5883301|P1|Overall Study|Lost to Follow-up|6
1684745|NCT01349673|5883301|P1|Overall Study|Withdrawal by Subject|21
1684746|NCT01349673|5883301|P1|Overall Study|Site Closure|10
1684747|NCT01349673|5883301|P1|Overall Study|No Longer Qualified For Study|1
1684748|NCT01349673|5883301|P1|Overall Study|Progression Of Disease Past 40 cm|1
1684749|NCT01349660|5883311|P3|Overall Study|Declining Performance Status|1
1684750|NCT01349660|5883312|P2|Overall Study|Declining Performance Status|0
1684751|NCT01349660|5883313|P1|Overall Study|Declining Performance Status|0
1684752|NCT01349660|5883311|P3|Overall Study|Study Compliance|1
1684753|NCT01349660|5883312|P2|Overall Study|Study Compliance|0
1684754|NCT01349660|5883313|P1|Overall Study|Study Compliance|0
1684755|NCT01349660|5883311|P3|Overall Study|Non-Permitted Interventions|2
1684756|NCT01349660|5883312|P2|Overall Study|Non-Permitted Interventions|0
1684757|NCT01349660|5883313|P1|Overall Study|Non-Permitted Interventions|0
1684758|NCT01349660|5883311|P3|Overall Study|Death|0
1684759|NCT01349660|5883312|P2|Overall Study|Death|1
1684760|NCT01349660|5883313|P1|Overall Study|Death|1
1684761|NCT01349660|5883311|P3|Overall Study|Withdrawal by Subject|9
1684762|NCT01349660|5883312|P2|Overall Study|Withdrawal by Subject|0
1684763|NCT01349660|5883313|P1|Overall Study|Withdrawal by Subject|2
1684764|NCT01349660|5883311|P3|Overall Study|Adverse Event|12
1684765|NCT01349660|5883312|P2|Overall Study|Adverse Event|1
1684766|NCT01349660|5883313|P1|Overall Study|Adverse Event|1
1684767|NCT01349660|5883311|P3|Overall Study|Disease Progression|50
1684768|NCT01349660|5883312|P2|Overall Study|Disease Progression|4
1684769|NCT01349660|5883313|P1|Overall Study|Disease Progression|2
1684770|NCT01349660|5883311|P3|Overall Study|Still Receiving Study Treatment|1
1684771|NCT01349660|5883312|P2|Overall Study|Still Receiving Study Treatment|0
1684772|NCT01349660|5883313|P1|Overall Study|Still Receiving Study Treatment|0
1684773|NCT01349595|5883331|P2|Overall Study|Lack of funding|2
1684774|NCT01349595|5883332|P1|Overall Study|Lack of funding|2
1684775|NCT01349569|5883338|P1|Overall Study|Lack of Efficacy|4
1684776|NCT01349465|5883359|P2|Overall Study|Subject Ineligible To Continue The Trial|19
1684777|NCT01349465|5883360|P1|Overall Study|Subject Ineligible To Continue The Trial|0
1684778|NCT01349465|5883359|P2|Overall Study|Withdrawal by Subject|2
1684779|NCT01349465|5883360|P1|Overall Study|Withdrawal by Subject|4
1684780|NCT01349465|5883359|P2|Overall Study|Lost to Follow-up|1
1684781|NCT01349465|5883360|P1|Overall Study|Lost to Follow-up|10
1684782|NCT01349465|5883359|P2|Overall Study|Death|0
1684783|NCT01349465|5883360|P1|Overall Study|Death|3
1684784|NCT01349465|5883359|P2|Overall Study|Adverse Event|0
1684785|NCT01349465|5883360|P1|Overall Study|Adverse Event|1
1684786|NCT01349192|5883381|P2|Overall Study|Failure to adhere to Protocol|0
1684787|NCT01349192|5883382|P1|Overall Study|Failure to adhere to Protocol|2
1684788|NCT01349192|5883381|P2|Overall Study|Lost to Follow-up|3
1684789|NCT01349192|5883382|P1|Overall Study|Lost to Follow-up|1
1684790|NCT01349192|5883381|P2|Overall Study|Withdrawal by Subject|2
1684791|NCT01349192|5883382|P1|Overall Study|Withdrawal by Subject|0
1684792|NCT01349192|5883381|P2|Overall Study|Protocol Violation|1
1684793|NCT01349192|5883382|P1|Overall Study|Protocol Violation|0
1684794|NCT01349049|5883414|P9|Overall Study|Withdrawal by Subject|6
1684795|NCT01349049|5883415|P8|Overall Study|Withdrawal by Subject|0
1684796|NCT01349049|5883416|P7|Overall Study|Withdrawal by Subject|0
1684797|NCT01349049|5883417|P6|Overall Study|Withdrawal by Subject|0
1684798|NCT01349049|5883418|P5|Overall Study|Withdrawal by Subject|0
1684799|NCT01349049|5883419|P4|Overall Study|Withdrawal by Subject|0
1684800|NCT01349049|5883420|P3|Overall Study|Withdrawal by Subject|0
1684801|NCT01349049|5883421|P2|Overall Study|Withdrawal by Subject|0
1684802|NCT01349049|5883422|P1|Overall Study|Withdrawal by Subject|0
1684803|NCT01349049|5883414|P9|Overall Study|Non-compliance|0
1684804|NCT01349049|5883415|P8|Overall Study|Non-compliance|0
1684805|NCT01349049|5883416|P7|Overall Study|Non-compliance|0
1684806|NCT01349049|5883417|P6|Overall Study|Non-compliance|0
1684807|NCT01349049|5883418|P5|Overall Study|Non-compliance|0
1684808|NCT01349049|5883419|P4|Overall Study|Non-compliance|1
1684809|NCT01349049|5883420|P3|Overall Study|Non-compliance|0
1684810|NCT01349049|5883421|P2|Overall Study|Non-compliance|0
1684811|NCT01349049|5883422|P1|Overall Study|Non-compliance|0
1684812|NCT01349049|5883414|P9|Overall Study|Death|5
1684813|NCT01349049|5883415|P8|Overall Study|Death|1
1684814|NCT01349049|5883416|P7|Overall Study|Death|0
1684815|NCT01349049|5883417|P6|Overall Study|Death|0
1684816|NCT01349049|5883418|P5|Overall Study|Death|0
1684817|NCT01349049|5883419|P4|Overall Study|Death|0
1684818|NCT01349049|5883420|P3|Overall Study|Death|0
1684819|NCT01349049|5883421|P2|Overall Study|Death|0
1684820|NCT01349049|5883422|P1|Overall Study|Death|0
1684821|NCT01349049|5883414|P9|Overall Study|Other|4
1684822|NCT01349049|5883415|P8|Overall Study|Other|0
1684823|NCT01349049|5883416|P7|Overall Study|Other|0
1684824|NCT01349049|5883417|P6|Overall Study|Other|1
1684825|NCT01349049|5883418|P5|Overall Study|Other|0
1684826|NCT01349049|5883419|P4|Overall Study|Other|0
1684827|NCT01349049|5883420|P3|Overall Study|Other|0
1684828|NCT01349049|5883421|P2|Overall Study|Other|0
1684829|NCT01349049|5883422|P1|Overall Study|Other|0
1684830|NCT01349049|5883414|P9|Overall Study|Hematopoietic stem cell transplant|0
1684831|NCT01349049|5883415|P8|Overall Study|Hematopoietic stem cell transplant|1
1684832|NCT01349049|5883416|P7|Overall Study|Hematopoietic stem cell transplant|1
1684833|NCT01349049|5883417|P6|Overall Study|Hematopoietic stem cell transplant|0
1684834|NCT01349049|5883418|P5|Overall Study|Hematopoietic stem cell transplant|1
1684835|NCT01349049|5883419|P4|Overall Study|Hematopoietic stem cell transplant|0
1684836|NCT01349049|5883420|P3|Overall Study|Hematopoietic stem cell transplant|0
1684837|NCT01349049|5883421|P2|Overall Study|Hematopoietic stem cell transplant|0
1684838|NCT01349049|5883422|P1|Overall Study|Hematopoietic stem cell transplant|0
1684839|NCT01349049|5883414|P9|Overall Study|Protocol Violation|1
1684840|NCT01349049|5883415|P8|Overall Study|Protocol Violation|0
1684841|NCT01349049|5883416|P7|Overall Study|Protocol Violation|0
1684842|NCT01349049|5883417|P6|Overall Study|Protocol Violation|0
1684843|NCT01349049|5883418|P5|Overall Study|Protocol Violation|0
1684844|NCT01349049|5883419|P4|Overall Study|Protocol Violation|0
1684845|NCT01349049|5883420|P3|Overall Study|Protocol Violation|0
1684846|NCT01349049|5883421|P2|Overall Study|Protocol Violation|0
1684847|NCT01349049|5883422|P1|Overall Study|Protocol Violation|0
1684848|NCT01349049|5883414|P9|Overall Study|Physician Decision|2
1684849|NCT01349049|5883415|P8|Overall Study|Physician Decision|0
1684850|NCT01349049|5883416|P7|Overall Study|Physician Decision|0
1684851|NCT01349049|5883417|P6|Overall Study|Physician Decision|0
1684852|NCT01349049|5883418|P5|Overall Study|Physician Decision|0
1684853|NCT01349049|5883419|P4|Overall Study|Physician Decision|0
1684854|NCT01349049|5883420|P3|Overall Study|Physician Decision|0
1684855|NCT01349049|5883421|P2|Overall Study|Physician Decision|1
1684856|NCT01349049|5883422|P1|Overall Study|Physician Decision|0
1684857|NCT01349049|5883414|P9|Overall Study|Adverse Event|4
1684858|NCT01349049|5883415|P8|Overall Study|Adverse Event|0
1684859|NCT01349049|5883416|P7|Overall Study|Adverse Event|1
1684860|NCT01349049|5883417|P6|Overall Study|Adverse Event|3
1684861|NCT01349049|5883418|P5|Overall Study|Adverse Event|0
1684862|NCT01349049|5883419|P4|Overall Study|Adverse Event|0
1684863|NCT01349049|5883420|P3|Overall Study|Adverse Event|0
1684864|NCT01349049|5883421|P2|Overall Study|Adverse Event|1
1684865|NCT01349049|5883422|P1|Overall Study|Adverse Event|0
1684866|NCT01349049|5883414|P9|Overall Study|Disease progression|33
1684867|NCT01349049|5883415|P8|Overall Study|Disease progression|2
1684868|NCT01349049|5883416|P7|Overall Study|Disease progression|3
1684869|NCT01349049|5883417|P6|Overall Study|Disease progression|2
1684870|NCT01349049|5883418|P5|Overall Study|Disease progression|2
1684871|NCT01349049|5883419|P4|Overall Study|Disease progression|2
1684872|NCT01349049|5883420|P3|Overall Study|Disease progression|3
1684873|NCT01349049|5883421|P2|Overall Study|Disease progression|5
1684874|NCT01349049|5883422|P1|Overall Study|Disease progression|3
1684875|NCT01349036|5883476|P2|Overall Study|Withdrawal by Subject|2
1684876|NCT01349036|5883477|P1|Overall Study|Withdrawal by Subject|0
1684877|NCT01349036|5883476|P2|Overall Study|Other|0
1684878|NCT01349036|5883477|P1|Overall Study|Other|1
1684879|NCT01349036|5883476|P2|Overall Study|Disease progression|22
1684880|NCT01349036|5883477|P1|Overall Study|Disease progression|13
1684881|NCT01348854|5883495|P2|Overall Study|Withdrawal by Subject|0
1684882|NCT01348854|5883496|P1|Overall Study|Withdrawal by Subject|1
1684883|NCT01348854|5883495|P2|Overall Study|Lost to Follow-up|1
1684884|NCT01348854|5883496|P1|Overall Study|Lost to Follow-up|2
1684885|NCT01348789|5883504|P1|Overall Study|Withdrawal by Subject|2
1684886|NCT01348789|5883504|P1|Overall Study|Protocol Violation|2
1684887|NCT01348776|5883515|P1|Overall Study|Lost to Follow-up|3
1684888|NCT01348763|5883528|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
1684889|NCT01348763|5883528|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
1684890|NCT01348698|5883533|P1|Overall Study|PI decision to close study|68
1684891|NCT01348698|5883533|P1|Overall Study|Death|3
1684892|NCT01348698|5883533|P1|Overall Study|Does not meet lesion size criteria|1
1684895|NCT01348490|5883575|P1|Overall Study|Other Unspecified|8
1684896|NCT01348490|5883575|P1|Overall Study|Termination of clinical trial by sponsor|1
1684897|NCT01348490|5883575|P1|Overall Study|Lost to Follow-up|1
1684898|NCT01348490|5883575|P1|Overall Study|Disease progression|3
1684899|NCT01348490|5883575|P1|Overall Study|Consent withdrawn|7
1684900|NCT01348490|5883575|P1|Overall Study|Adverse Event|3
1684901|NCT01348490|5883575|P1|Overall Study|Death|1
1684902|NCT01348425|5883633|P2|Overall Study|Imaging was not taken.|1
1684903|NCT01348425|5883634|P1|Overall Study|Imaging was not taken.|1
1684904|NCT01348347|5883642|P3|Overall Study|Progressive disease|5
1684905|NCT01348347|5883643|P2|Overall Study|Progressive disease|5
1684906|NCT01348347|5883644|P1|Overall Study|Progressive disease|2
1684907|NCT01348347|5883642|P3|Overall Study|Withdrawal by Subject|1
1684908|NCT01348347|5883643|P2|Overall Study|Withdrawal by Subject|1
1684909|NCT01348347|5883644|P1|Overall Study|Withdrawal by Subject|1
1684910|NCT01348165|5883675|P7|Overall Study|Adverse Event|1
1684911|NCT01348165|5883676|P6|Overall Study|Adverse Event|0
1684912|NCT01348165|5883677|P5|Overall Study|Adverse Event|0
1684913|NCT01348165|5883678|P4|Overall Study|Adverse Event|0
1684914|NCT01348165|5883679|P3|Overall Study|Adverse Event|0
1684915|NCT01348165|5883680|P2|Overall Study|Adverse Event|0
1684916|NCT01348165|5883681|P1|Overall Study|Adverse Event|0
1684917|NCT01348139|5883810|P6|Period 1|Adverse Event|0
1684918|NCT01348139|5883811|P5|Period 1|Adverse Event|0
1684919|NCT01348139|5883812|P4|Period 1|Adverse Event|0
1684920|NCT01348139|5883813|P3|Period 1|Adverse Event|0
1684921|NCT01348139|5883814|P2|Period 1|Adverse Event|0
1684922|NCT01348139|5883815|P1|Period 1|Adverse Event|1
1684923|NCT01348100|5883896|P7|Overall Study|Administrative Problems|1
1684924|NCT01348100|5883897|P6|Overall Study|Administrative Problems|1
1684925|NCT01348100|5883898|P5|Overall Study|Administrative Problems|0
1684926|NCT01348100|5883899|P4|Overall Study|Administrative Problems|0
1684927|NCT01348100|5883900|P3|Overall Study|Administrative Problems|0
1684928|NCT01348100|5883901|P2|Overall Study|Administrative Problems|0
1684929|NCT01348100|5883902|P1|Overall Study|Administrative Problems|0
1684930|NCT01348100|5883896|P7|Overall Study|Lost to Follow-up|1
1684931|NCT01348100|5883897|P6|Overall Study|Lost to Follow-up|0
1684932|NCT01348100|5883898|P5|Overall Study|Lost to Follow-up|0
1684933|NCT01348100|5883899|P4|Overall Study|Lost to Follow-up|0
1684934|NCT01348100|5883900|P3|Overall Study|Lost to Follow-up|0
1684935|NCT01348100|5883901|P2|Overall Study|Lost to Follow-up|0
1684936|NCT01348100|5883902|P1|Overall Study|Lost to Follow-up|0
1684937|NCT01348100|5883896|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
1684938|NCT01348100|5883897|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
1684939|NCT01348100|5883898|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
1684940|NCT01348100|5883899|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
1684941|NCT01348100|5883900|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
1684942|NCT01348100|5883901|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1684943|NCT01348100|5883902|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
1684944|NCT01348100|5883896|P7|Overall Study|Protocol Deviation|0
1684945|NCT01348100|5883897|P6|Overall Study|Protocol Deviation|0
1684946|NCT01348100|5883898|P5|Overall Study|Protocol Deviation|0
1684947|NCT01348100|5883899|P4|Overall Study|Protocol Deviation|1
1684948|NCT01348100|5883900|P3|Overall Study|Protocol Deviation|0
1684949|NCT01348100|5883901|P2|Overall Study|Protocol Deviation|0
1684950|NCT01348100|5883902|P1|Overall Study|Protocol Deviation|0
1684951|NCT01348100|5883896|P7|Overall Study|Subject Withdrew Consent|1
1684952|NCT01348100|5883897|P6|Overall Study|Subject Withdrew Consent|0
1684953|NCT01348100|5883898|P5|Overall Study|Subject Withdrew Consent|1
1684954|NCT01348100|5883899|P4|Overall Study|Subject Withdrew Consent|0
1684955|NCT01348100|5883900|P3|Overall Study|Subject Withdrew Consent|2
1684956|NCT01348100|5883901|P2|Overall Study|Subject Withdrew Consent|0
1684957|NCT01348100|5883902|P1|Overall Study|Subject Withdrew Consent|0
1684958|NCT01348087|5883947|P1|Overall Study|Adverse Event|25
1684959|NCT01348087|5883947|P1|Overall Study|Subject withdrew consent|7
1684960|NCT01348087|5883947|P1|Overall Study|Lost to Follow-up|1
1684961|NCT01348087|5883947|P1|Overall Study|protocol deviation|1
1684962|NCT01348087|5883947|P1|Overall Study|Administrative problems|79
1684963|NCT01348087|5883947|P1|Overall Study|Unsatisfactory therapeutic effect|35
1684964|NCT01347931|5883961|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
1684965|NCT01347879|5883973|P2|Overall Study|Other|3
1684966|NCT01347879|5883974|P1|Overall Study|Other|2
1684967|NCT01347879|5883973|P2|Overall Study|Withdrawal by Subject|2
1684968|NCT01347879|5883974|P1|Overall Study|Withdrawal by Subject|3
1684969|NCT01347879|5883973|P2|Overall Study|Lost to Follow-up|0
1684970|NCT01347879|5883974|P1|Overall Study|Lost to Follow-up|2
1684971|NCT01347879|5883973|P2|Overall Study|Adverse Event|12
1684972|NCT01347879|5883974|P1|Overall Study|Adverse Event|0
1684973|NCT01347866|5884023|P17|Overall Study|Subject refused further follow-up|2
1684974|NCT01347866|5884024|P16|Overall Study|Subject refused further follow-up|0
1684975|NCT01347866|5884025|P15|Overall Study|Subject refused further follow-up|1
1684976|NCT01347866|5884026|P14|Overall Study|Subject refused further follow-up|3
1684977|NCT01347866|5884027|P13|Overall Study|Subject refused further follow-up|1
1684978|NCT01347866|5884028|P12|Overall Study|Subject refused further follow-up|0
1684979|NCT01347866|5884029|P11|Overall Study|Subject refused further follow-up|0
1684980|NCT01347866|5884030|P10|Overall Study|Subject refused further follow-up|1
1684981|NCT01347866|5884031|P9|Overall Study|Subject refused further follow-up|4
1684982|NCT01347866|5884032|P8|Overall Study|Subject refused further follow-up|0
1684983|NCT01347866|5884033|P7|Overall Study|Subject refused further follow-up|0
1684984|NCT01347866|5884034|P6|Overall Study|Subject refused further follow-up|1
1684985|NCT01347866|5884035|P5|Overall Study|Subject refused further follow-up|0
1684986|NCT01347866|5884036|P4|Overall Study|Subject refused further follow-up|2
1684987|NCT01347866|5884037|P3|Overall Study|Subject refused further follow-up|0
1684988|NCT01347866|5884038|P2|Overall Study|Subject refused further follow-up|0
1684989|NCT01347866|5884039|P1|Overall Study|Subject refused further follow-up|2
1684990|NCT01347866|5884023|P17|Overall Study|Other|0
1684991|NCT01347866|5884024|P16|Overall Study|Other|3
1684992|NCT01347866|5884025|P15|Overall Study|Other|2
1684993|NCT01347866|5884026|P14|Overall Study|Other|4
1684994|NCT01347866|5884027|P13|Overall Study|Other|4
1684995|NCT01347866|5884028|P12|Overall Study|Other|3
1684996|NCT01347866|5884029|P11|Overall Study|Other|0
1684997|NCT01347866|5884030|P10|Overall Study|Other|5
1684998|NCT01347866|5884031|P9|Overall Study|Other|22
1684999|NCT01347866|5884032|P8|Overall Study|Other|3
1685000|NCT01347866|5884033|P7|Overall Study|Other|5
1685001|NCT01347866|5884034|P6|Overall Study|Other|0
1685002|NCT01347866|5884035|P5|Overall Study|Other|5
1685003|NCT01347866|5884036|P4|Overall Study|Other|4
1685004|NCT01347866|5884037|P3|Overall Study|Other|1
1685005|NCT01347866|5884038|P2|Overall Study|Other|1
1685006|NCT01347866|5884039|P1|Overall Study|Other|3
1685007|NCT01347866|5884023|P17|Overall Study|Lost to Follow-up|0
1685008|NCT01347866|5884024|P16|Overall Study|Lost to Follow-up|0
1685009|NCT01347866|5884025|P15|Overall Study|Lost to Follow-up|0
1685010|NCT01347866|5884026|P14|Overall Study|Lost to Follow-up|0
1685011|NCT01347866|5884027|P13|Overall Study|Lost to Follow-up|0
1685012|NCT01347866|5884028|P12|Overall Study|Lost to Follow-up|0
1685013|NCT01347866|5884029|P11|Overall Study|Lost to Follow-up|0
1685014|NCT01347866|5884030|P10|Overall Study|Lost to Follow-up|0
1685015|NCT01347866|5884031|P9|Overall Study|Lost to Follow-up|1
1685016|NCT01347866|5884032|P8|Overall Study|Lost to Follow-up|1
1685017|NCT01347866|5884033|P7|Overall Study|Lost to Follow-up|0
1685018|NCT01347866|5884034|P6|Overall Study|Lost to Follow-up|0
1685019|NCT01347866|5884035|P5|Overall Study|Lost to Follow-up|0
1685020|NCT01347866|5884036|P4|Overall Study|Lost to Follow-up|0
1685021|NCT01347866|5884037|P3|Overall Study|Lost to Follow-up|0
1685022|NCT01347866|5884038|P2|Overall Study|Lost to Follow-up|0
1685023|NCT01347866|5884039|P1|Overall Study|Lost to Follow-up|0
1685024|NCT01347866|5884023|P17|Overall Study|Death|0
1685025|NCT01347866|5884024|P16|Overall Study|Death|1
1685026|NCT01347866|5884025|P15|Overall Study|Death|0
1685027|NCT01347866|5884026|P14|Overall Study|Death|0
1685028|NCT01347866|5884027|P13|Overall Study|Death|2
1685029|NCT01347866|5884028|P12|Overall Study|Death|1
1685030|NCT01347866|5884029|P11|Overall Study|Death|3
1685031|NCT01347866|5884030|P10|Overall Study|Death|1
1685032|NCT01347866|5884031|P9|Overall Study|Death|4
1685033|NCT01347866|5884032|P8|Overall Study|Death|0
1685034|NCT01347866|5884033|P7|Overall Study|Death|1
1685035|NCT01347866|5884034|P6|Overall Study|Death|2
1685036|NCT01347866|5884035|P5|Overall Study|Death|2
1685037|NCT01347866|5884036|P4|Overall Study|Death|1
1685038|NCT01347866|5884037|P3|Overall Study|Death|0
1685039|NCT01347866|5884038|P2|Overall Study|Death|0
1685040|NCT01347866|5884039|P1|Overall Study|Death|0
1685041|NCT01347840|5884413|P1|Overall Study|Withdrawal by Subject|1
1685042|NCT01347762|5884440|P4|Overall Study|Withdrawal by Subject|3
1685043|NCT01347762|5884441|P3|Overall Study|Withdrawal by Subject|3
1685044|NCT01347762|5884442|P2|Overall Study|Withdrawal by Subject|1
1685045|NCT01347762|5884443|P1|Overall Study|Withdrawal by Subject|4
1685046|NCT01347762|5884440|P4|Overall Study|Lost to Follow-up|5
1685047|NCT01347762|5884441|P3|Overall Study|Lost to Follow-up|6
1685048|NCT01347762|5884442|P2|Overall Study|Lost to Follow-up|1
1685049|NCT01347762|5884443|P1|Overall Study|Lost to Follow-up|0
1685050|NCT01347710|5884469|P1|Overall Study|Other|3
1685051|NCT01347710|5884469|P1|Overall Study|Physician Decision|2
1685052|NCT01347710|5884469|P1|Overall Study|Lost to Follow-up|1
1685053|NCT01347710|5884469|P1|Overall Study|issue with vitals prior to dosing|1
1685054|NCT01347710|5884469|P1|Overall Study|Angio or SPECT not completed|18
1685055|NCT01347710|5884469|P1|Overall Study|Adverse Event|4
1685056|NCT01347710|5884469|P1|Overall Study|Withdrawal by Subject|2
1685057|NCT01347580|5884491|P2|Overall Study|Had other reason|6
1685058|NCT01347580|5884492|P1|Overall Study|Had other reason|9
1685059|NCT01347580|5884491|P2|Overall Study|Lost to Follow-up|1
1685060|NCT01347580|5884492|P1|Overall Study|Lost to Follow-up|3
1685061|NCT01347580|5884491|P2|Overall Study|Protocol Violation|7
1685062|NCT01347580|5884492|P1|Overall Study|Protocol Violation|10
1685063|NCT01347580|5884491|P2|Overall Study|Death|19
1685064|NCT01347580|5884492|P1|Overall Study|Death|30
1685065|NCT01347580|5884491|P2|Overall Study|Withdrawal by Subject|23
1685066|NCT01347580|5884492|P1|Overall Study|Withdrawal by Subject|13
1685067|NCT01347554|5884522|P2|Overall Study|Lack of Efficacy|11
1685068|NCT01347554|5884523|P1|Overall Study|Lack of Efficacy|7
1685069|NCT01347112|5884560|P2|Overall Study|Lost to Follow-up|5
1685070|NCT01347112|5884561|P1|Overall Study|Lost to Follow-up|3
1685071|NCT01347112|5884560|P2|Overall Study|Withdrawal by Subject|7
1685072|NCT01347112|5884561|P1|Overall Study|Withdrawal by Subject|1
1685073|NCT01347086|5884581|P10|Overall Study|failed screening visit|1
1685074|NCT01347086|5884582|P9|Overall Study|failed screening visit|0
1685075|NCT01347086|5884583|P8|Overall Study|failed screening visit|1
1685076|NCT01347086|5884584|P7|Overall Study|failed screening visit|1
1685077|NCT01347086|5884585|P6|Overall Study|failed screening visit|0
1685078|NCT01347086|5884586|P5|Overall Study|failed screening visit|0
1685079|NCT01347086|5884587|P4|Overall Study|failed screening visit|0
1685080|NCT01347086|5884588|P3|Overall Study|failed screening visit|1
1685081|NCT01347086|5884589|P2|Overall Study|failed screening visit|0
1685082|NCT01347086|5884590|P1|Overall Study|failed screening visit|0
1685083|NCT01347073|5884689|P1|Overall Study|Liver Transplant|1
1685084|NCT01347073|5884689|P1|Overall Study|Adverse Event|1
1685085|NCT01346774|5884768|P2|Overall Study|Adverse Event|2
1685086|NCT01346774|5884769|P1|Overall Study|Adverse Event|1
1685087|NCT01346774|5884768|P2|Overall Study|Protocol Violation|3
1685088|NCT01346774|5884769|P1|Overall Study|Protocol Violation|2
1685089|NCT01346774|5884768|P2|Overall Study|Withdrawal by Subject|4
1685090|NCT01346774|5884769|P1|Overall Study|Withdrawal by Subject|1
1685091|NCT01346774|5884768|P2|Overall Study|Lost to Follow-up|4
1685092|NCT01346774|5884769|P1|Overall Study|Lost to Follow-up|3
1685093|NCT01346774|5884768|P2|Overall Study|Did not take a single dose|4
1685094|NCT01346774|5884769|P1|Overall Study|Did not take a single dose|6
1685095|NCT01346696|5884775|P1|Overall Study|Death|1
1685096|NCT01346592|5884797|P3|Overall Study|Unable to Classify|6
1685097|NCT01346592|5884798|P2|Overall Study|Unable to Classify|3
1685098|NCT01346592|5884799|P1|Overall Study|Unable to Classify|7
1685099|NCT01346592|5884797|P3|Overall Study|Administrative reason|0
1685100|NCT01346592|5884798|P2|Overall Study|Administrative reason|0
1685101|NCT01346592|5884799|P1|Overall Study|Administrative reason|1
1685102|NCT01346592|5884797|P3|Overall Study|Inappropriate enrollment|1
1685103|NCT01346592|5884798|P2|Overall Study|Inappropriate enrollment|1
1685104|NCT01346592|5884799|P1|Overall Study|Inappropriate enrollment|3
1685105|NCT01346592|5884797|P3|Overall Study|Withdrawal by Subject|38
1685106|NCT01346592|5884798|P2|Overall Study|Withdrawal by Subject|51
1685107|NCT01346592|5884799|P1|Overall Study|Withdrawal by Subject|77
1685108|NCT01346592|5884797|P3|Overall Study|Adverse Event|0
1685109|NCT01346592|5884798|P2|Overall Study|Adverse Event|1
1685110|NCT01346592|5884799|P1|Overall Study|Adverse Event|0
1685111|NCT01346592|5884797|P3|Overall Study|Death|4
1685112|NCT01346592|5884798|P2|Overall Study|Death|3
1685113|NCT01346592|5884799|P1|Overall Study|Death|1
1685114|NCT01346592|5884797|P3|Overall Study|Protocol Violation|0
1685115|NCT01346592|5884798|P2|Overall Study|Protocol Violation|1
1685116|NCT01346592|5884799|P1|Overall Study|Protocol Violation|2
1685117|NCT01346592|5884797|P3|Overall Study|Lost to Follow-up|29
1685118|NCT01346592|5884798|P2|Overall Study|Lost to Follow-up|29
1685119|NCT01346592|5884799|P1|Overall Study|Lost to Follow-up|62
1685120|NCT01346540|5884891|P2|Overall Study|Adverse Event|4
1685121|NCT01346540|5884892|P1|Overall Study|Adverse Event|0
1685122|NCT01346540|5884891|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
1685123|NCT01346540|5884892|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
1685124|NCT01346514|5884903|P2|Overall Study|Death|4
1685125|NCT01346514|5884904|P1|Overall Study|Death|3
1685126|NCT01346514|5884903|P2|Overall Study|Withdrawal by Subject|3
1685127|NCT01346514|5884904|P1|Overall Study|Withdrawal by Subject|7
1685128|NCT01346514|5884903|P2|Overall Study|Lost to Follow-up|30
1685129|NCT01346514|5884904|P1|Overall Study|Lost to Follow-up|19
1685130|NCT01346501|5884924|P2|Overall Study|Other|12
1685131|NCT01346501|5884925|P1|Overall Study|Other|8
1685132|NCT01346501|5884924|P2|Overall Study|Initiated Other Biological Agents|1
1685133|NCT01346501|5884925|P1|Overall Study|Initiated Other Biological Agents|3
1685134|NCT01346475|5884958|P2|First Intervention|Lost to Follow-up|3
1685135|NCT01346475|5884959|P1|First Intervention|Lost to Follow-up|4
1685137|NCT01346293|5884989|P2|Overall Study|Other|0
1685138|NCT01346293|5884990|P1|Overall Study|Other|1
1685139|NCT01346293|5884989|P2|Overall Study|Withdrawal by Subject|4
1685140|NCT01346293|5884990|P1|Overall Study|Withdrawal by Subject|15
1685141|NCT01346293|5884989|P2|Overall Study|Lost to Follow-up|8
1685142|NCT01346293|5884990|P1|Overall Study|Lost to Follow-up|21
1685143|NCT01346293|5884989|P2|Overall Study|Protocol Violation|9
1685144|NCT01346293|5884990|P1|Overall Study|Protocol Violation|30
1685145|NCT01346189|5885020|P4|Overall Study|Travel|3
1685146|NCT01346189|5885021|P3|Overall Study|Travel|0
1685147|NCT01346189|5885022|P2|Overall Study|Travel|0
1685148|NCT01346189|5885023|P1|Overall Study|Travel|0
1685149|NCT01346189|5885020|P4|Overall Study|Non-health system primary care physician|0
1685150|NCT01346189|5885021|P3|Overall Study|Non-health system primary care physician|0
1685151|NCT01346189|5885022|P2|Overall Study|Non-health system primary care physician|5
1685152|NCT01346189|5885023|P1|Overall Study|Non-health system primary care physician|0
1685153|NCT01346189|5885020|P4|Overall Study|Death|0
1685154|NCT01346189|5885021|P3|Overall Study|Death|0
1685155|NCT01346189|5885022|P2|Overall Study|Death|3
1685156|NCT01346189|5885023|P1|Overall Study|Death|0
1685157|NCT01346189|5885020|P4|Overall Study|Other|3
1685158|NCT01346189|5885021|P3|Overall Study|Other|7
1685159|NCT01346189|5885022|P2|Overall Study|Other|4
1685160|NCT01346189|5885023|P1|Overall Study|Other|2
1685161|NCT01346189|5885020|P4|Overall Study|Moved|0
1685162|NCT01346189|5885021|P3|Overall Study|Moved|4
1685163|NCT01346189|5885022|P2|Overall Study|Moved|0
1685164|NCT01346189|5885023|P1|Overall Study|Moved|3
1685165|NCT01346189|5885020|P4|Overall Study|Physician Decision|0
1685166|NCT01346189|5885021|P3|Overall Study|Physician Decision|0
1685167|NCT01346189|5885022|P2|Overall Study|Physician Decision|0
1685168|NCT01346189|5885023|P1|Overall Study|Physician Decision|4
1685169|NCT01346189|5885020|P4|Overall Study|Withdrawal by Subject|5
1685170|NCT01346189|5885021|P3|Overall Study|Withdrawal by Subject|3
1685171|NCT01346189|5885022|P2|Overall Study|Withdrawal by Subject|5
1685172|NCT01346189|5885023|P1|Overall Study|Withdrawal by Subject|7
1685173|NCT01346176|5885040|P3|Completed Satisfaction Survey|Lost to Follow-up|4
1685174|NCT01346176|5885041|P2|Completed Satisfaction Survey|Lost to Follow-up|4
1685175|NCT01346176|5885042|P1|Completed Satisfaction Survey|Lost to Follow-up|3
1685176|NCT01346176|5885040|P3|Completed Satisfaction Survey|Death|2
1685177|NCT01346176|5885041|P2|Completed Satisfaction Survey|Death|0
1685178|NCT01346176|5885042|P1|Completed Satisfaction Survey|Death|3
1685179|NCT01346176|5885040|P3|Completed Advance Directive|Other reason did not complete AD|7
1685180|NCT01346176|5885041|P2|Completed Advance Directive|Other reason did not complete AD|12
1685181|NCT01346176|5885042|P1|Completed Advance Directive|Other reason did not complete AD|7
1685182|NCT01346176|5885040|P3|Completed Advance Directive|Became Ineligible|1
1685183|NCT01346176|5885041|P2|Completed Advance Directive|Became Ineligible|0
1685184|NCT01346176|5885042|P1|Completed Advance Directive|Became Ineligible|3
1685185|NCT01346176|5885040|P3|Completed Advance Directive|Death|2
1685186|NCT01346176|5885041|P2|Completed Advance Directive|Death|2
1685187|NCT01346176|5885042|P1|Completed Advance Directive|Death|3
1685188|NCT01346176|5885040|P3|Recruited|Protocol Violation|0
1685189|NCT01346176|5885041|P2|Recruited|Protocol Violation|0
1685190|NCT01346176|5885042|P1|Recruited|Protocol Violation|1
1685191|NCT01346059|5885071|P2|Overall Study|Withdrawal by Subject|0
1685192|NCT01346059|5885072|P1|Overall Study|Withdrawal by Subject|1
1685193|NCT01345929|5885084|P2|Overall Study|Patient withdrawal|1
1685194|NCT01345929|5885085|P1|Overall Study|Patient withdrawal|0
1685195|NCT01345929|5885084|P2|Overall Study|40,000 CFU/ML|0
1685196|NCT01345929|5885085|P1|Overall Study|40,000 CFU/ML|1
1685197|NCT01345929|5885084|P2|Overall Study|Didn't meet eligibility criteria|0
1685198|NCT01345929|5885085|P1|Overall Study|Didn't meet eligibility criteria|2
1685199|NCT01345929|5885084|P2|Overall Study|Adverse Event|1
1685200|NCT01345929|5885085|P1|Overall Study|Adverse Event|0
1685201|NCT01345929|5885084|P2|Overall Study|Lost to Follow-up|9
1685202|NCT01345929|5885085|P1|Overall Study|Lost to Follow-up|9
1685203|NCT01345929|5885084|P2|Overall Study|Withdrawal by Subject|8
1685204|NCT01345929|5885085|P1|Overall Study|Withdrawal by Subject|9
1685205|NCT01345786|5885097|P4|Overall Study|Lost to Follow-up|2
1685206|NCT01345786|5885098|P3|Overall Study|Lost to Follow-up|0
1685207|NCT01345786|5885099|P2|Overall Study|Lost to Follow-up|0
1685208|NCT01345786|5885100|P1|Overall Study|Lost to Follow-up|0
1685209|NCT01345786|5885097|P4|Overall Study|Administrative|0
1685210|NCT01345786|5885098|P3|Overall Study|Administrative|0
1685211|NCT01345786|5885099|P2|Overall Study|Administrative|5
1685212|NCT01345786|5885100|P1|Overall Study|Administrative|3
1685213|NCT01345786|5885097|P4|Overall Study|Noncompliance with protocol|0
1685214|NCT01345786|5885098|P3|Overall Study|Noncompliance with protocol|1
1685215|NCT01345786|5885099|P2|Overall Study|Noncompliance with protocol|0
1685216|NCT01345786|5885100|P1|Overall Study|Noncompliance with protocol|1
1685217|NCT01345786|5885097|P4|Overall Study|Subject withdrew consent|0
1685218|NCT01345786|5885098|P3|Overall Study|Subject withdrew consent|1
1685219|NCT01345786|5885099|P2|Overall Study|Subject withdrew consent|2
1685220|NCT01345786|5885100|P1|Overall Study|Subject withdrew consent|2
1685221|NCT01345786|5885097|P4|Overall Study|Adverse Event|1
1685222|NCT01345786|5885098|P3|Overall Study|Adverse Event|3
1685223|NCT01345786|5885099|P2|Overall Study|Adverse Event|1
1685224|NCT01345786|5885100|P1|Overall Study|Adverse Event|0
1685225|NCT01345682|5885180|P2|Overall Study|Reason other than those specified above|3
1685226|NCT01345682|5885181|P1|Overall Study|Reason other than those specified above|4
1685227|NCT01345682|5885180|P2|Overall Study|Not treated|1
1685228|NCT01345682|5885181|P1|Overall Study|Not treated|2
1685229|NCT01345682|5885180|P2|Overall Study|Refused to continue trial medication|9
1685230|NCT01345682|5885181|P1|Overall Study|Refused to continue trial medication|16
1685231|NCT01345682|5885180|P2|Overall Study|Lost to Follow-up|1
1685232|NCT01345682|5885181|P1|Overall Study|Lost to Follow-up|0
1685233|NCT01345682|5885180|P2|Overall Study|Non-compliance with protocol|1
1685234|NCT01345682|5885181|P1|Overall Study|Non-compliance with protocol|0
1685235|NCT01345682|5885180|P2|Overall Study|Adverse Event|41
1685236|NCT01345682|5885181|P1|Overall Study|Adverse Event|51
1685237|NCT01345682|5885180|P2|Overall Study|Worsening of underlying cancer disease|12
1685238|NCT01345682|5885181|P1|Overall Study|Worsening of underlying cancer disease|23
1685239|NCT01345682|5885180|P2|Overall Study|Progressive disease per RECIST|93
1685240|NCT01345682|5885181|P1|Overall Study|Progressive disease per RECIST|226
1685241|NCT01345669|5885215|P2|Overall Study|Other Reasons|60
1685242|NCT01345669|5885216|P1|Overall Study|Other Reasons|111
1685243|NCT01345669|5885215|P2|Overall Study|Withdrawal by Subject|13
1685244|NCT01345669|5885216|P1|Overall Study|Withdrawal by Subject|52
1685245|NCT01345669|5885215|P2|Overall Study|Lost to Follow-up|1
1685246|NCT01345669|5885216|P1|Overall Study|Lost to Follow-up|1
1685247|NCT01345669|5885215|P2|Overall Study|Protocol Violation|1
1685248|NCT01345669|5885216|P1|Overall Study|Protocol Violation|3
1685249|NCT01345669|5885215|P2|Overall Study|Adverse Event|9
1685250|NCT01345669|5885216|P1|Overall Study|Adverse Event|63
1685251|NCT01345669|5885215|P2|Overall Study|Second primary tumour|3
1685252|NCT01345669|5885216|P1|Overall Study|Second primary tumour|4
1685253|NCT01345669|5885215|P2|Overall Study|Primary tumour recurrence|32
1685254|NCT01345669|5885216|P1|Overall Study|Primary tumour recurrence|53
1685255|NCT01345630|5885234|P2|Overall Study|Insufficient clinical response|11
1685256|NCT01345630|5885235|P1|Overall Study|Insufficient clinical response|48
1685257|NCT01345630|5885234|P2|Overall Study|No longer willing to participate|12
1685258|NCT01345630|5885235|P1|Overall Study|No longer willing to participate|9
1685259|NCT01345630|5885234|P2|Overall Study|Withdrawn due to pregnancy|2
1685260|NCT01345630|5885235|P1|Overall Study|Withdrawn due to pregnancy|1
1685261|NCT01345630|5885234|P2|Overall Study|Other reasons|8
1685262|NCT01345630|5885235|P1|Overall Study|Other reasons|6
1685263|NCT01345630|5885234|P2|Overall Study|Study terminated by sponsor|285
1685264|NCT01345630|5885235|P1|Overall Study|Study terminated by sponsor|254
1685265|NCT01345630|5885234|P2|Overall Study|Medication error without associated AE|1
1685266|NCT01345630|5885235|P1|Overall Study|Medication error without associated AE|0
1685267|NCT01345630|5885234|P2|Overall Study|Protocol Violation|1
1685268|NCT01345630|5885235|P1|Overall Study|Protocol Violation|4
1685269|NCT01345630|5885234|P2|Overall Study|Lost to Follow-up|16
1685270|NCT01345630|5885235|P1|Overall Study|Lost to Follow-up|17
1685271|NCT01345630|5885234|P2|Overall Study|Adverse Event|23
1685272|NCT01345630|5885235|P1|Overall Study|Adverse Event|22
1685273|NCT01345591|5885291|P1|Overall Study|Lost to Follow-up|1
1685274|NCT01345318|5885300|P1|Overall Study|Other|3
1685275|NCT01345318|5885300|P1|Overall Study|Withdrawal by Subject|41
1685276|NCT01345318|5885300|P1|Overall Study|Protocol Violation|1
1685277|NCT01345318|5885300|P1|Overall Study|Lost to Follow-up|2
1685278|NCT01345318|5885300|P1|Overall Study|Lack of Efficacy|17
1685279|NCT01345318|5885300|P1|Overall Study|Adverse Event|16
1685280|NCT01345292|5885308|P3|Overall Study|Withdrawal by Subject|1
1685281|NCT01345292|5885309|P2|Overall Study|Withdrawal by Subject|0
1685282|NCT01345292|5885310|P1|Overall Study|Withdrawal by Subject|2
1685283|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
1685284|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
1685285|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
1685286|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
1685287|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
1685288|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
1685289|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
1685290|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
1685291|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
1685292|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
1685293|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
1685294|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
1685295|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
1685296|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
1685297|NCT01345253|5885341|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
1685298|NCT01345253|5885342|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
1685299|NCT01345253|5885341|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
1685300|NCT01345253|5885342|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
1685301|NCT01345253|5885341|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
1685302|NCT01345253|5885342|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
1685303|NCT01345253|5885341|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
1685304|NCT01345253|5885342|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
1685305|NCT01345253|5885341|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
1685306|NCT01345253|5885342|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
1685307|NCT01345253|5885341|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
1685308|NCT01345253|5885342|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
1685309|NCT01345253|5885341|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
1685310|NCT01345253|5885342|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
1685311|NCT01345253|5885341|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
1685312|NCT01345253|5885342|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
1685313|NCT01345240|5885363|P5|Overall Study|Lost to Follow-up|9
1685314|NCT01345240|5885364|P4|Overall Study|Lost to Follow-up|7
1685315|NCT01345240|5885365|P3|Overall Study|Lost to Follow-up|14
1685316|NCT01345240|5885366|P2|Overall Study|Lost to Follow-up|9
1685317|NCT01345240|5885367|P1|Overall Study|Lost to Follow-up|8
1685318|NCT01345240|5885363|P5|Overall Study|Adverse Event|1
1685319|NCT01345240|5885364|P4|Overall Study|Adverse Event|2
1685320|NCT01345240|5885365|P3|Overall Study|Adverse Event|4
1685321|NCT01345240|5885366|P2|Overall Study|Adverse Event|5
1685322|NCT01345240|5885367|P1|Overall Study|Adverse Event|3
1685323|NCT01345188|5885487|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
1685324|NCT01345188|5885487|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
1685325|NCT01345162|5885499|P2|Overall Study|Protocol Violation|4
1685326|NCT01345162|5885500|P1|Overall Study|Protocol Violation|2
1685327|NCT01345123|5885509|P3|Overall Study|participants no longer with health plan|88
1685328|NCT01345123|5885510|P2|Overall Study|participants no longer with health plan|85
1685329|NCT01345123|5885511|P1|Overall Study|participants no longer with health plan|79
1685330|NCT01345058|5885533|P2|Overall Study|Participant No-Show at Multiple Visits|0
1685331|NCT01345058|5885534|P1|Overall Study|Participant No-Show at Multiple Visits|1
1685332|NCT01345058|5885533|P2|Overall Study|Participant Stopped Taking Study Drug|0
1685333|NCT01345058|5885534|P1|Overall Study|Participant Stopped Taking Study Drug|1
1685334|NCT01345058|5885533|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
1685335|NCT01345058|5885534|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
1685336|NCT01345058|5885533|P2|Overall Study|Participant Reported Increase in Events|0
1685337|NCT01345058|5885534|P1|Overall Study|Participant Reported Increase in Events|1
1685338|NCT01345058|5885533|P2|Overall Study|Withdrawal by Subject|0
1685339|NCT01345058|5885534|P1|Overall Study|Withdrawal by Subject|1
1685340|NCT01345019|5885550|P2|Overall Study|Other|3
1685341|NCT01345019|5885551|P1|Overall Study|Other|1
1685342|NCT01345019|5885550|P2|Overall Study|Protocol Deviation|0
1685343|NCT01345019|5885551|P1|Overall Study|Protocol Deviation|5
1685344|NCT01345019|5885550|P2|Overall Study|Lost to Follow-up|2
1685345|NCT01345019|5885551|P1|Overall Study|Lost to Follow-up|4
1685346|NCT01345019|5885550|P2|Overall Study|Ineligibility Determined|6
1685347|NCT01345019|5885551|P1|Overall Study|Ineligibility Determined|1
1685348|NCT01345019|5885550|P2|Overall Study|Noncompliance|4
1685349|NCT01345019|5885551|P1|Overall Study|Noncompliance|4
1685350|NCT01345019|5885550|P2|Overall Study|Administrative Decision|5
1685351|NCT01345019|5885551|P1|Overall Study|Administrative Decision|8
1685352|NCT01345019|5885550|P2|Overall Study|Adverse Event|13
1685353|NCT01345019|5885551|P1|Overall Study|Adverse Event|4
1685354|NCT01345019|5885550|P2|Overall Study|Disease Progression|8
1685355|NCT01345019|5885551|P1|Overall Study|Disease Progression|11
1685356|NCT01345019|5885550|P2|Overall Study|Completed Survival Follow-up|4
1685357|NCT01345019|5885551|P1|Overall Study|Completed Survival Follow-up|16
1685358|NCT01345019|5885550|P2|Overall Study|Withdrawal by Subject|107
1685359|NCT01345019|5885551|P1|Overall Study|Withdrawal by Subject|82
1685360|NCT01345019|5885550|P2|Overall Study|Death|120
1685361|NCT01345019|5885551|P1|Overall Study|Death|127
1685362|NCT01344876|5885571|P5|Overall Study|Definite progression of primary disease|0
1685363|NCT01344876|5885572|P4|Overall Study|Definite progression of primary disease|3
1685364|NCT01344876|5885573|P3|Overall Study|Definite progression of primary disease|0
1685365|NCT01344876|5885574|P2|Overall Study|Definite progression of primary disease|0
1685366|NCT01344876|5885575|P1|Overall Study|Definite progression of primary disease|1
1685367|NCT01344876|5885571|P5|Overall Study|Withdrawal by Subject|0
1685368|NCT01344876|5885572|P4|Overall Study|Withdrawal by Subject|0
1685369|NCT01344876|5885573|P3|Overall Study|Withdrawal by Subject|1
1685370|NCT01344876|5885574|P2|Overall Study|Withdrawal by Subject|0
1685371|NCT01344876|5885575|P1|Overall Study|Withdrawal by Subject|0
1685372|NCT01344876|5885571|P5|Overall Study|Adverse Event|1
1685373|NCT01344876|5885572|P4|Overall Study|Adverse Event|0
1685374|NCT01344876|5885573|P3|Overall Study|Adverse Event|0
1685375|NCT01344876|5885574|P2|Overall Study|Adverse Event|0
1685376|NCT01344876|5885575|P1|Overall Study|Adverse Event|0
1685377|NCT01344824|5885589|P1|Overall Study|Progression|15
1685378|NCT01344824|5885589|P1|Overall Study|Other complicating disease|1
1685379|NCT01344824|5885589|P1|Overall Study|Withdrawal by Subject|6
1685380|NCT01344824|5885589|P1|Overall Study|Adverse Event|15
1685381|NCT01344759|5885597|P2|Overall Study|Patients failed to reach sedation level|2
1685382|NCT01344759|5885598|P1|Overall Study|Patients failed to reach sedation level|0
1685383|NCT01344629|5885630|P2|Crossover Period 2|Withdrawal by Subject|1
1685384|NCT01344629|5885631|P1|Crossover Period 2|Withdrawal by Subject|0
1685385|NCT01344538|5885660|P2|Overall Study|Lost to Follow-up|0
1685386|NCT01344538|5885661|P1|Overall Study|Lost to Follow-up|1
1685387|NCT01344538|5885660|P2|Overall Study|Adverse Event|1
1685388|NCT01344538|5885661|P1|Overall Study|Adverse Event|1
1685389|NCT01344460|5885667|P1|Overall Study|Lost to Follow-up|2
1685390|NCT01344460|5885667|P1|Overall Study|Withdrawal by Subject|1
1685391|NCT01344447|5885712|P1|Overall Study|Error of power injector|1
1685392|NCT01344447|5885712|P1|Overall Study|Bolus tracking failed|1
1685393|NCT01344447|5885712|P1|Overall Study|MRA unsuccessful|1
1685394|NCT01344447|5885712|P1|Overall Study|Physician Decision|1
1685395|NCT01344447|5885712|P1|Overall Study|The contrast was not seen|1
1685396|NCT01344447|5885712|P1|Overall Study|Withdrawal by Subject|1
1685397|NCT01344447|5885712|P1|Overall Study|Protocol Violation|1
1685398|NCT01344447|5885712|P1|Overall Study|Adverse Event|1
1685399|NCT01344369|5885756|P2|Second Intervention|Emesis within 2 x Tmax|1
1685400|NCT01344369|5885757|P1|Second Intervention|Emesis within 2 x Tmax|0
1685401|NCT01344369|5885756|P2|Washout of 28 Days|Physician Decision|1
1685402|NCT01344369|5885757|P1|Washout of 28 Days|Physician Decision|0
1685403|NCT01344369|5885756|P2|Washout of 28 Days|Withdrawal by Subject|0
1685404|NCT01344369|5885757|P1|Washout of 28 Days|Withdrawal by Subject|1
1685405|NCT01344226|5885773|P1|Overall Study|Lack of Efficacy|3
1685406|NCT01344226|5885773|P1|Overall Study|Withdrawal by Subject|3
1685407|NCT01344226|5885773|P1|Overall Study|Protocol Violation|2
1685408|NCT01344161|5885782|P2|Overall Study|Protocol Violation|1
1685409|NCT01344161|5885783|P1|Overall Study|Protocol Violation|1
1685410|NCT01344161|5885782|P2|Overall Study|Pregnancy|1
1685411|NCT01344161|5885783|P1|Overall Study|Pregnancy|0
1685412|NCT01344161|5885782|P2|Overall Study|Lost to Follow-up|1
1685413|NCT01344161|5885783|P1|Overall Study|Lost to Follow-up|4
1685414|NCT01344057|5885795|P1|Overall Study|Premature Withdrawal|1
1685415|NCT01343901|5885802|P1|Overall Study|Participant decision|1
1685416|NCT01343901|5885802|P1|Overall Study|Management by another medical team|11
1685417|NCT01343901|5885802|P1|Overall Study|Lost to Follow-up|12
1685418|NCT01343901|5885802|P1|Overall Study|Physician Decision|4
1685419|NCT01343901|5885802|P1|Overall Study|Death|85
1685420|NCT01343888|5885826|P3|Overall Study|other than stated above|1
1685421|NCT01343888|5885827|P2|Overall Study|other than stated above|0
1685422|NCT01343888|5885828|P1|Overall Study|other than stated above|0
1685423|NCT01343888|5885826|P3|Overall Study|Withdrawal by Subject|2
1685424|NCT01343888|5885827|P2|Overall Study|Withdrawal by Subject|4
1685425|NCT01343888|5885828|P1|Overall Study|Withdrawal by Subject|4
1685426|NCT01343888|5885826|P3|Overall Study|Protocol Violation|0
1685427|NCT01343888|5885827|P2|Overall Study|Protocol Violation|2
1685428|NCT01343888|5885828|P1|Overall Study|Protocol Violation|0
1685429|NCT01343888|5885826|P3|Overall Study|Lost to Follow-up|1
1685430|NCT01343888|5885827|P2|Overall Study|Lost to Follow-up|2
1685431|NCT01343888|5885828|P1|Overall Study|Lost to Follow-up|0
1685432|NCT01343888|5885826|P3|Overall Study|Lack of Efficacy|13
1685433|NCT01343888|5885827|P2|Overall Study|Lack of Efficacy|9
1685434|NCT01343888|5885828|P1|Overall Study|Lack of Efficacy|9
1685435|NCT01343888|5885826|P3|Overall Study|Adverse Event|5
1685436|NCT01343888|5885827|P2|Overall Study|Adverse Event|22
1685437|NCT01343888|5885828|P1|Overall Study|Adverse Event|12
1685438|NCT01343823|5885870|P4|Overall Study|Withdrawal by Subject|0
1685439|NCT01343823|5885871|P3|Overall Study|Withdrawal by Subject|0
1685440|NCT01343823|5885872|P2|Overall Study|Withdrawal by Subject|0
1685441|NCT01343823|5885873|P1|Overall Study|Withdrawal by Subject|1
1685442|NCT01343823|5885870|P4|Overall Study|Study Terminated|1
1685443|NCT01343823|5885871|P3|Overall Study|Study Terminated|0
1685444|NCT01343823|5885872|P2|Overall Study|Study Terminated|0
1685445|NCT01343823|5885873|P1|Overall Study|Study Terminated|1
1685446|NCT01343693|5885887|P1|Overall Study|Lost to Follow-up|9
1685447|NCT01343407|5885910|P6|Second Washout (Part 2)|Withdrawal by Subject|0
1685448|NCT01343407|5885911|P5|Second Washout (Part 2)|Withdrawal by Subject|0
1685449|NCT01343407|5885912|P4|Second Washout (Part 2)|Withdrawal by Subject|0
1685450|NCT01343407|5885913|P3|Second Washout (Part 2)|Withdrawal by Subject|1
1685451|NCT01343407|5885914|P2|Second Washout (Part 2)|Withdrawal by Subject|0
1685452|NCT01343407|5885915|P1|Second Washout (Part 2)|Withdrawal by Subject|0
1685453|NCT01343407|5885910|P6|Second Treatment Period (Part 2)|Adverse Event|0
1685454|NCT01343407|5885911|P5|Second Treatment Period (Part 2)|Adverse Event|0
1685455|NCT01343407|5885912|P4|Second Treatment Period (Part 2)|Adverse Event|0
1685456|NCT01343407|5885913|P3|Second Treatment Period (Part 2)|Adverse Event|1
1685457|NCT01343407|5885914|P2|Second Treatment Period (Part 2)|Adverse Event|0
1685458|NCT01343407|5885915|P1|Second Treatment Period (Part 2)|Adverse Event|0
1685459|NCT01343368|5885943|P2|Overall Study|Lost to Follow-up|0
1685460|NCT01343368|5885944|P1|Overall Study|Lost to Follow-up|1
1685461|NCT01343368|5885943|P2|Overall Study|Death|0
1685462|NCT01343368|5885944|P1|Overall Study|Death|1
1685463|NCT01343277|5885980|P2|Overall Study|Subsequent anticancer therapy|0
1685464|NCT01343277|5885981|P1|Overall Study|Subsequent anticancer therapy|1
1685465|NCT01343277|5885980|P2|Overall Study|Treatment ongoing|2
1685466|NCT01343277|5885981|P1|Overall Study|Treatment ongoing|8
1685467|NCT01343277|5885980|P2|Overall Study|Randomized not treated|21
1685468|NCT01343277|5885981|P1|Overall Study|Randomized not treated|6
1685469|NCT01343277|5885980|P2|Overall Study|Disease progression|138
1685470|NCT01343277|5885981|P1|Overall Study|Disease progression|270
1685471|NCT01343277|5885980|P2|Overall Study|Adverse Event|13
1685472|NCT01343277|5885981|P1|Overall Study|Adverse Event|67
1685473|NCT01343277|5885980|P2|Overall Study|Death|1
1685474|NCT01343277|5885981|P1|Overall Study|Death|10
1685475|NCT01343277|5885980|P2|Overall Study|Physician Decision|2
1685476|NCT01343277|5885981|P1|Overall Study|Physician Decision|1
1685477|NCT01343277|5885980|P2|Overall Study|Withdrawal by Subject|13
1685478|NCT01343277|5885981|P1|Overall Study|Withdrawal by Subject|18
1685479|NCT01343277|5885980|P2|Overall Study|Other|3
1685480|NCT01343277|5885981|P1|Overall Study|Other|3
1685481|NCT01343082|5886042|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
1685482|NCT01343082|5886043|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
1685483|NCT01343082|5886044|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
1685484|NCT01343082|5886042|P3|Treatment Period , Switched to DE-111|Physician Decision|2
1685485|NCT01343082|5886043|P2|Treatment Period , Switched to DE-111|Physician Decision|2
1685486|NCT01343082|5886044|P1|Treatment Period , Switched to DE-111|Physician Decision|0
1685487|NCT01343082|5886042|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
1685488|NCT01343082|5886043|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
1685489|NCT01343082|5886044|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
1685490|NCT01343082|5886042|P3|Treatment Period , Switched to DE-111|Adverse Event|3
1685491|NCT01343082|5886043|P2|Treatment Period , Switched to DE-111|Adverse Event|4
1685492|NCT01343082|5886044|P1|Treatment Period , Switched to DE-111|Adverse Event|1
1685493|NCT01343082|5886042|P3|The run-in Period|Not meeting criteria|5
1685494|NCT01343082|5886043|P2|The run-in Period|Not meeting criteria|4
1685495|NCT01343082|5886044|P1|The run-in Period|Not meeting criteria|3
1685496|NCT01343056|5886052|P4|Overall Study|Lost to Follow-up|9
1685497|NCT01343056|5886053|P3|Overall Study|Lost to Follow-up|3
1685498|NCT01343056|5886054|P2|Overall Study|Lost to Follow-up|5
1685499|NCT01343056|5886055|P1|Overall Study|Lost to Follow-up|7
1685500|NCT01342965|5886123|P2|Overall Study|Withdrawal by Subject|9
1685501|NCT01342965|5886124|P1|Overall Study|Withdrawal by Subject|2
1685502|NCT01342965|5886123|P2|Overall Study|Other Reasons- Unspecified|38
1685503|NCT01342965|5886124|P1|Overall Study|Other Reasons- Unspecified|44
1685504|NCT01342965|5886123|P2|Overall Study|Lost to Follow-up|3
1685505|NCT01342965|5886124|P1|Overall Study|Lost to Follow-up|5
1685506|NCT01342965|5886123|P2|Overall Study|Death|57
1685507|NCT01342965|5886124|P1|Overall Study|Death|58
1685508|NCT01342926|5886142|P4|Overall Study|Withdrawal by Subject|5
1685509|NCT01342926|5886143|P3|Overall Study|Withdrawal by Subject|3
1685510|NCT01342926|5886144|P2|Overall Study|Withdrawal by Subject|4
1685511|NCT01342926|5886145|P1|Overall Study|Withdrawal by Subject|2
1685512|NCT01342926|5886142|P4|Overall Study|Investigator Discretion|0
1685513|NCT01342926|5886143|P3|Overall Study|Investigator Discretion|0
1685514|NCT01342926|5886144|P2|Overall Study|Investigator Discretion|2
1685515|NCT01342926|5886145|P1|Overall Study|Investigator Discretion|2
1685516|NCT01342926|5886142|P4|Overall Study|Lost to Follow-up|0
1685517|NCT01342926|5886143|P3|Overall Study|Lost to Follow-up|1
1685518|NCT01342926|5886144|P2|Overall Study|Lost to Follow-up|1
1685519|NCT01342926|5886145|P1|Overall Study|Lost to Follow-up|0
1685520|NCT01342926|5886142|P4|Overall Study|Adverse Event|7
1685521|NCT01342926|5886143|P3|Overall Study|Adverse Event|10
1685522|NCT01342926|5886144|P2|Overall Study|Adverse Event|8
1685523|NCT01342926|5886145|P1|Overall Study|Adverse Event|5
1685524|NCT01342913|5886225|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
1685525|NCT01342913|5886226|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
1685526|NCT01342913|5886227|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1685527|NCT01342913|5886225|P3|Double-Blind Treatment Period|Physician Decision|0
1685612|NCT01342081|5886583|P2|Overall Study|Physician Decision|1
1685528|NCT01342913|5886226|P2|Double-Blind Treatment Period|Physician Decision|2
1685529|NCT01342913|5886227|P1|Double-Blind Treatment Period|Physician Decision|0
1685530|NCT01342913|5886225|P3|Double-Blind Treatment Period|Lost to Follow-up|3
1685531|NCT01342913|5886226|P2|Double-Blind Treatment Period|Lost to Follow-up|1
1685532|NCT01342913|5886227|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1685533|NCT01342913|5886225|P3|Double-Blind Treatment Period|Protocol Violation|9
1685534|NCT01342913|5886226|P2|Double-Blind Treatment Period|Protocol Violation|6
1685535|NCT01342913|5886227|P1|Double-Blind Treatment Period|Protocol Violation|0
1685536|NCT01342913|5886225|P3|Double-Blind Treatment Period|Lack of Efficacy|3
1685537|NCT01342913|5886226|P2|Double-Blind Treatment Period|Lack of Efficacy|2
1685538|NCT01342913|5886227|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1685539|NCT01342913|5886225|P3|Double-Blind Treatment Period|Adverse Event|6
1685540|NCT01342913|5886226|P2|Double-Blind Treatment Period|Adverse Event|3
1685541|NCT01342913|5886227|P1|Double-Blind Treatment Period|Adverse Event|0
1685542|NCT01342913|5886225|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1685543|NCT01342913|5886226|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1685544|NCT01342913|5886227|P1|2-week Run-in Period|Continuation Criteria Not Met|88
1685545|NCT01342913|5886225|P3|2-week Run-in Period|Protocol Violation|0
1685546|NCT01342913|5886226|P2|2-week Run-in Period|Protocol Violation|0
1685547|NCT01342913|5886227|P1|2-week Run-in Period|Protocol Violation|5
1685548|NCT01342913|5886225|P3|2-week Run-in Period|Adverse Event|0
1685549|NCT01342913|5886226|P2|2-week Run-in Period|Adverse Event|0
1685550|NCT01342913|5886227|P1|2-week Run-in Period|Adverse Event|2
1685551|NCT01342913|5886225|P3|2-week Run-in Period|Withdrawal by Subject|0
1685552|NCT01342913|5886226|P2|2-week Run-in Period|Withdrawal by Subject|0
1685553|NCT01342913|5886227|P1|2-week Run-in Period|Withdrawal by Subject|7
1685554|NCT01342913|5886225|P3|2-week Run-in Period|Physician Decision|0
1685555|NCT01342913|5886226|P2|2-week Run-in Period|Physician Decision|0
1685556|NCT01342913|5886227|P1|2-week Run-in Period|Physician Decision|6
1685557|NCT01342913|5886225|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1685558|NCT01342913|5886226|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
1685559|NCT01342913|5886227|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
1685560|NCT01342887|5886237|P1|Overall Study|Death|2
1685561|NCT01342640|5886278|P1|Overall Study|Other|1
1685562|NCT01342640|5886278|P1|Overall Study|Lost to Follow-up|21
1685563|NCT01342640|5886278|P1|Overall Study|Protocol Violation|16
1685564|NCT01342640|5886278|P1|Overall Study|Adverse Event|3
1685565|NCT01342510|5886373|P4|Overall Study|Protocol Violation|11
1685566|NCT01342510|5886374|P3|Overall Study|Protocol Violation|13
1685567|NCT01342510|5886375|P2|Overall Study|Protocol Violation|6
1685568|NCT01342510|5886376|P1|Overall Study|Protocol Violation|12
1685569|NCT01342484|5886393|P3|Overall Study|Withdrawal by Subject|0
1685570|NCT01342484|5886394|P2|Overall Study|Withdrawal by Subject|0
1685571|NCT01342484|5886395|P1|Overall Study|Withdrawal by Subject|1
1685572|NCT01342484|5886393|P3|Overall Study|Protocol Violation|1
1685573|NCT01342484|5886394|P2|Overall Study|Protocol Violation|0
1685574|NCT01342484|5886395|P1|Overall Study|Protocol Violation|0
1685575|NCT01342484|5886393|P3|Overall Study|Other Reasons|0
1685576|NCT01342484|5886394|P2|Overall Study|Other Reasons|0
1685577|NCT01342484|5886395|P1|Overall Study|Other Reasons|1
1685578|NCT01342445|5886451|P2|Overall Study|Experienced side effects|2
1685579|NCT01342445|5886452|P1|Overall Study|Experienced side effects|0
1685580|NCT01342341|5886468|P2|Overall Study|Lost to Follow-up|4
1685581|NCT01342341|5886469|P1|Overall Study|Lost to Follow-up|4
1685582|NCT01342211|5886480|P5|Overall Study|Randomized, but not Treated|1
1685583|NCT01342211|5886481|P4|Overall Study|Randomized, but not Treated|0
1685584|NCT01342211|5886482|P3|Overall Study|Randomized, but not Treated|0
1685585|NCT01342211|5886483|P2|Overall Study|Randomized, but not Treated|2
1685586|NCT01342211|5886484|P1|Overall Study|Randomized, but not Treated|0
1685587|NCT01342211|5886480|P5|Overall Study|Withdrawal by Subject|0
1685588|NCT01342211|5886481|P4|Overall Study|Withdrawal by Subject|1
1685589|NCT01342211|5886482|P3|Overall Study|Withdrawal by Subject|0
1685590|NCT01342211|5886483|P2|Overall Study|Withdrawal by Subject|0
1685591|NCT01342211|5886484|P1|Overall Study|Withdrawal by Subject|0
1685592|NCT01342211|5886480|P5|Overall Study|Adverse Event|1
1685593|NCT01342211|5886481|P4|Overall Study|Adverse Event|0
1685594|NCT01342211|5886482|P3|Overall Study|Adverse Event|0
1685595|NCT01342211|5886483|P2|Overall Study|Adverse Event|0
1685596|NCT01342211|5886484|P1|Overall Study|Adverse Event|0
1685597|NCT01342211|5886480|P5|Overall Study|Lost to Follow-up|0
1685598|NCT01342211|5886481|P4|Overall Study|Lost to Follow-up|1
1685599|NCT01342211|5886482|P3|Overall Study|Lost to Follow-up|0
1685600|NCT01342211|5886483|P2|Overall Study|Lost to Follow-up|0
1685601|NCT01342211|5886484|P1|Overall Study|Lost to Follow-up|0
1685602|NCT01342094|5886572|P2|Overall Study|Withdrawal by Subject|2
1685603|NCT01342094|5886573|P1|Overall Study|Withdrawal by Subject|0
1685604|NCT01342094|5886572|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1685605|NCT01342094|5886573|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
1685606|NCT01342094|5886572|P2|Overall Study|Adverse Event|0
1685607|NCT01342094|5886573|P1|Overall Study|Adverse Event|5
1685608|NCT01342081|5886582|P3|Overall Study|Withdrawal by Subject|0
1685609|NCT01342081|5886583|P2|Overall Study|Withdrawal by Subject|1
1685610|NCT01342081|5886584|P1|Overall Study|Withdrawal by Subject|1
1685611|NCT01342081|5886582|P3|Overall Study|Physician Decision|0
1685613|NCT01342081|5886584|P1|Overall Study|Physician Decision|0
1685614|NCT01342081|5886582|P3|Overall Study|Adverse Event|0
1685615|NCT01342081|5886583|P2|Overall Study|Adverse Event|0
1685616|NCT01342081|5886584|P1|Overall Study|Adverse Event|1
1685617|NCT01342081|5886582|P3|Overall Study|Did not receive allocated intervention|1
1685618|NCT01342081|5886583|P2|Overall Study|Did not receive allocated intervention|0
1685619|NCT01342081|5886584|P1|Overall Study|Did not receive allocated intervention|0
1685620|NCT01341990|5886603|P2|Overall Study|Withdrawal by Subject|0
1685621|NCT01341990|5886604|P1|Overall Study|Withdrawal by Subject|2
1685622|NCT01341990|5886603|P2|Overall Study|Torn Study Lens|0
1685623|NCT01341990|5886604|P1|Overall Study|Torn Study Lens|1
1685624|NCT01341990|5886603|P2|Overall Study|Adverse Event|1
1685625|NCT01341990|5886604|P1|Overall Study|Adverse Event|0
1685626|NCT01341782|5886628|P2|Overall Study|Other|0
1685627|NCT01341782|5886629|P1|Overall Study|Other|5
1685628|NCT01341782|5886628|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
1685629|NCT01341782|5886629|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
1685630|NCT01341782|5886628|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
1685631|NCT01341782|5886629|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
1685632|NCT01341782|5886628|P2|Overall Study|Missed 3 consecutive doses|4
1685633|NCT01341782|5886629|P1|Overall Study|Missed 3 consecutive doses|0
1685634|NCT01341782|5886628|P2|Overall Study|Withdrawal by Subject|5
1685635|NCT01341782|5886629|P1|Overall Study|Withdrawal by Subject|6
1685636|NCT01341782|5886628|P2|Overall Study|Adverse Event|1
1685637|NCT01341782|5886629|P1|Overall Study|Adverse Event|1
1685638|NCT01341639|5886647|P2|Post-Treatment|Adverse Event|2
1685639|NCT01341639|5886648|P1|Post-Treatment|Adverse Event|0
1685640|NCT01341639|5886647|P2|Post-Treatment|Withdrawal by Subject|1
1685641|NCT01341639|5886648|P1|Post-Treatment|Withdrawal by Subject|0
1685642|NCT01341639|5886647|P2|Interim Period|Protocol Violation|1
1685643|NCT01341639|5886648|P1|Interim Period|Protocol Violation|0
1685644|NCT01341639|5886647|P2|Interim Period|Physician Decision|1
1685645|NCT01341639|5886648|P1|Interim Period|Physician Decision|0
1685646|NCT01341639|5886647|P2|Interim Period|Lost to Follow-up|0
1685647|NCT01341639|5886648|P1|Interim Period|Lost to Follow-up|2
1685648|NCT01341639|5886647|P2|Interim Period|Withdrawal by Subject|7
1685649|NCT01341639|5886648|P1|Interim Period|Withdrawal by Subject|6
1685650|NCT01341639|5886647|P2|Infant Series|Site 0048 Participants|16
1685651|NCT01341639|5886648|P1|Infant Series|Site 0048 Participants|17
1685652|NCT01341639|5886647|P2|Infant Series|Lost to Follow-up|2
1685653|NCT01341639|5886648|P1|Infant Series|Lost to Follow-up|0
1685654|NCT01341639|5886647|P2|Infant Series|Withdrawal by Subject|8
1685655|NCT01341639|5886648|P1|Infant Series|Withdrawal by Subject|11
1685656|NCT01341639|5886647|P2|Infant Series|Adverse Event|5
1685657|NCT01341639|5886648|P1|Infant Series|Adverse Event|0
1685658|NCT01341639|5886647|P2|Infant Series|Not Vaccinated|1
1685659|NCT01341639|5886648|P1|Infant Series|Not Vaccinated|0
1685660|NCT01341639|5886647|P2|Infant Series|Protocol Violation|0
1685661|NCT01341639|5886648|P1|Infant Series|Protocol Violation|1
1685662|NCT01341587|5886693|P2|Overall Study|stopped using the meters|10
1685663|NCT01341587|5886694|P1|Overall Study|stopped using the meters|2
1685664|NCT01341587|5886693|P2|Overall Study|Lost to Follow-up|0
1685665|NCT01341587|5886694|P1|Overall Study|Lost to Follow-up|2
1685666|NCT01341470|5886706|P6|Overall Study|Sponsor decision|1
1685667|NCT01341470|5886707|P5|Overall Study|Sponsor decision|0
1685668|NCT01341470|5886708|P4|Overall Study|Sponsor decision|1
1685669|NCT01341470|5886709|P3|Overall Study|Sponsor decision|1
1685670|NCT01341470|5886710|P2|Overall Study|Sponsor decision|0
1685671|NCT01341470|5886711|P1|Overall Study|Sponsor decision|0
1685672|NCT01341457|5886745|P2|Overall Study|Adverse Event|0
1685673|NCT01341457|5886746|P1|Overall Study|Adverse Event|2
1685674|NCT01340976|5886791|P6|Overall Study|Adverse Event|0
1685675|NCT01340976|5886792|P5|Overall Study|Adverse Event|0
1685676|NCT01340976|5886793|P4|Overall Study|Adverse Event|0
1685677|NCT01340976|5886794|P3|Overall Study|Adverse Event|0
1685678|NCT01340976|5886795|P2|Overall Study|Adverse Event|1
1685679|NCT01340976|5886796|P1|Overall Study|Adverse Event|0
1685680|NCT01340976|5886791|P6|Overall Study|Other anemia treatment|1
1685681|NCT01340976|5886792|P5|Overall Study|Other anemia treatment|0
1685682|NCT01340976|5886793|P4|Overall Study|Other anemia treatment|1
1685683|NCT01340976|5886794|P3|Overall Study|Other anemia treatment|2
1685684|NCT01340976|5886795|P2|Overall Study|Other anemia treatment|0
1685685|NCT01340976|5886796|P1|Overall Study|Other anemia treatment|1
1685686|NCT01340976|5886791|P6|Overall Study|Withdrawal by Subject|0
1685687|NCT01340976|5886792|P5|Overall Study|Withdrawal by Subject|1
1685688|NCT01340976|5886793|P4|Overall Study|Withdrawal by Subject|1
1685689|NCT01340976|5886794|P3|Overall Study|Withdrawal by Subject|0
1685690|NCT01340976|5886795|P2|Overall Study|Withdrawal by Subject|0
1685691|NCT01340976|5886796|P1|Overall Study|Withdrawal by Subject|0
1685692|NCT01340976|5886791|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1685693|NCT01340976|5886792|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1685694|NCT01340976|5886793|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1685695|NCT01340976|5886794|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1685696|NCT01340976|5886795|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
1685697|NCT01340976|5886796|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
1685698|NCT01340976|5886791|P6|Overall Study|Death|0
1685699|NCT01340976|5886792|P5|Overall Study|Death|0
1685700|NCT01340976|5886793|P4|Overall Study|Death|0
1685701|NCT01340976|5886794|P3|Overall Study|Death|0
1685702|NCT01340976|5886795|P2|Overall Study|Death|1
1685703|NCT01340976|5886796|P1|Overall Study|Death|0
1685704|NCT01340976|5886791|P6|Overall Study|Physician Decision|0
1685705|NCT01340976|5886792|P5|Overall Study|Physician Decision|1
1685706|NCT01340976|5886793|P4|Overall Study|Physician Decision|1
1685707|NCT01340976|5886794|P3|Overall Study|Physician Decision|1
1685708|NCT01340976|5886795|P2|Overall Study|Physician Decision|0
1685709|NCT01340976|5886796|P1|Overall Study|Physician Decision|2
1685710|NCT01340937|5886834|P4|Period 3: Toddler Vaccinations|Technical problem|0
1685711|NCT01340937|5886835|P3|Period 3: Toddler Vaccinations|Technical problem|1
1685712|NCT01340937|5886836|P2|Period 3: Toddler Vaccinations|Technical problem|1
1685713|NCT01340937|5886837|P1|Period 3: Toddler Vaccinations|Technical problem|1
1685714|NCT01340937|5886834|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
1685715|NCT01340937|5886835|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
1685716|NCT01340937|5886836|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
1685717|NCT01340937|5886837|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
1685718|NCT01340937|5886834|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
1685719|NCT01340937|5886835|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
1685720|NCT01340937|5886836|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
1685721|NCT01340937|5886837|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
1685722|NCT01340937|5886834|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
1685723|NCT01340937|5886835|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
1685724|NCT01340937|5886836|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
1685725|NCT01340937|5886837|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
1685726|NCT01340937|5886834|P4|Period 2: Interim Period|Technical problems|3
1685727|NCT01340937|5886835|P3|Period 2: Interim Period|Technical problems|6
1685728|NCT01340937|5886836|P2|Period 2: Interim Period|Technical problems|4
1685729|NCT01340937|5886837|P1|Period 2: Interim Period|Technical problems|4
1685730|NCT01340937|5886834|P4|Period 2: Interim Period|Protocol Violation|3
1685731|NCT01340937|5886835|P3|Period 2: Interim Period|Protocol Violation|6
1685732|NCT01340937|5886836|P2|Period 2: Interim Period|Protocol Violation|3
1685733|NCT01340937|5886837|P1|Period 2: Interim Period|Protocol Violation|5
1685734|NCT01340937|5886834|P4|Period 2: Interim Period|Physician Decision|0
1685735|NCT01340937|5886835|P3|Period 2: Interim Period|Physician Decision|1
1685736|NCT01340937|5886836|P2|Period 2: Interim Period|Physician Decision|1
1685737|NCT01340937|5886837|P1|Period 2: Interim Period|Physician Decision|0
1685738|NCT01340937|5886834|P4|Period 2: Interim Period|Lost to Follow-up|23
1685739|NCT01340937|5886835|P3|Period 2: Interim Period|Lost to Follow-up|53
1685740|NCT01340937|5886836|P2|Period 2: Interim Period|Lost to Follow-up|48
1685741|NCT01340937|5886837|P1|Period 2: Interim Period|Lost to Follow-up|29
1685742|NCT01340937|5886834|P4|Period 2: Interim Period|Adverse Event|0
1685743|NCT01340937|5886835|P3|Period 2: Interim Period|Adverse Event|1
1685744|NCT01340937|5886836|P2|Period 2: Interim Period|Adverse Event|0
1685745|NCT01340937|5886837|P1|Period 2: Interim Period|Adverse Event|1
1685746|NCT01340937|5886834|P4|Period 2: Interim Period|Withdrawal by Subject|12
1685747|NCT01340937|5886835|P3|Period 2: Interim Period|Withdrawal by Subject|17
1685748|NCT01340937|5886836|P2|Period 2: Interim Period|Withdrawal by Subject|23
1685749|NCT01340937|5886837|P1|Period 2: Interim Period|Withdrawal by Subject|28
1685750|NCT01340937|5886834|P4|Period 1: Infant Series|Randomized but not vaccinated|1
1685751|NCT01340937|5886835|P3|Period 1: Infant Series|Randomized but not vaccinated|2
1685752|NCT01340937|5886836|P2|Period 1: Infant Series|Randomized but not vaccinated|5
1685753|NCT01340937|5886837|P1|Period 1: Infant Series|Randomized but not vaccinated|0
1685754|NCT01340937|5886834|P4|Period 1: Infant Series|Withdrawal by Subject|15
1685755|NCT01340937|5886835|P3|Period 1: Infant Series|Withdrawal by Subject|30
1685756|NCT01340937|5886836|P2|Period 1: Infant Series|Withdrawal by Subject|32
1685757|NCT01340937|5886837|P1|Period 1: Infant Series|Withdrawal by Subject|33
1685758|NCT01340937|5886834|P4|Period 1: Infant Series|Protocol Violation|3
1685759|NCT01340937|5886835|P3|Period 1: Infant Series|Protocol Violation|4
1685760|NCT01340937|5886836|P2|Period 1: Infant Series|Protocol Violation|4
1685761|NCT01340937|5886837|P1|Period 1: Infant Series|Protocol Violation|1
1685762|NCT01340937|5886834|P4|Period 1: Infant Series|Physician Decision|0
1685763|NCT01340937|5886835|P3|Period 1: Infant Series|Physician Decision|1
1685764|NCT01340937|5886836|P2|Period 1: Infant Series|Physician Decision|3
1685765|NCT01340937|5886837|P1|Period 1: Infant Series|Physician Decision|2
1685766|NCT01340937|5886834|P4|Period 1: Infant Series|Lost to Follow-up|13
1685767|NCT01340937|5886835|P3|Period 1: Infant Series|Lost to Follow-up|12
1685768|NCT01340937|5886836|P2|Period 1: Infant Series|Lost to Follow-up|14
1685769|NCT01340937|5886837|P1|Period 1: Infant Series|Lost to Follow-up|20
1685770|NCT01340937|5886834|P4|Period 1: Infant Series|Death|0
1685771|NCT01340937|5886835|P3|Period 1: Infant Series|Death|2
1685772|NCT01340937|5886836|P2|Period 1: Infant Series|Death|0
1685773|NCT01340937|5886837|P1|Period 1: Infant Series|Death|2
1685774|NCT01340937|5886834|P4|Period 1: Infant Series|Adverse Event|0
1685775|NCT01340937|5886835|P3|Period 1: Infant Series|Adverse Event|4
1685776|NCT01340937|5886836|P2|Period 1: Infant Series|Adverse Event|1
1685777|NCT01340937|5886837|P1|Period 1: Infant Series|Adverse Event|0
1685778|NCT01340937|5886834|P4|Period 1: Infant Series|Other protocol criterion not met|0
1685779|NCT01340937|5886835|P3|Period 1: Infant Series|Other protocol criterion not met|1
1685780|NCT01340937|5886836|P2|Period 1: Infant Series|Other protocol criterion not met|1
1685781|NCT01340937|5886837|P1|Period 1: Infant Series|Other protocol criterion not met|0
1685782|NCT01340898|5886997|P3|Booster Phase|Lost to Follow-up|3
1685783|NCT01340898|5886998|P2|Booster Phase|Lost to Follow-up|2
1685784|NCT01340898|5886999|P1|Booster Phase|Lost to Follow-up|4
1685785|NCT01340898|5886997|P3|Booster Phase|Migrated/moved from study area|0
1685786|NCT01340898|5886998|P2|Booster Phase|Migrated/moved from study area|0
1685787|NCT01340898|5886999|P1|Booster Phase|Migrated/moved from study area|3
1685788|NCT01340898|5886997|P3|Booster Phase|Withdrawal by Subject|4
1685789|NCT01340898|5886998|P2|Booster Phase|Withdrawal by Subject|0
1685790|NCT01340898|5886999|P1|Booster Phase|Withdrawal by Subject|3
1685791|NCT01340898|5886997|P3|Primary Phase|Lost to Follow-up|0
1685792|NCT01340898|5886998|P2|Primary Phase|Lost to Follow-up|1
1685793|NCT01340898|5886999|P1|Primary Phase|Lost to Follow-up|4
1685794|NCT01340898|5886997|P3|Primary Phase|Migrated/moved from study area|0
1685795|NCT01340898|5886998|P2|Primary Phase|Migrated/moved from study area|1
1685796|NCT01340898|5886999|P1|Primary Phase|Migrated/moved from study area|4
1685797|NCT01340898|5886997|P3|Primary Phase|Withdrawal by Subject|5
1685798|NCT01340898|5886998|P2|Primary Phase|Withdrawal by Subject|7
1685799|NCT01340898|5886999|P1|Primary Phase|Withdrawal by Subject|8
1685800|NCT01340898|5886997|P3|Primary Phase|Serious Adverse Events|1
1685801|NCT01340898|5886998|P2|Primary Phase|Serious Adverse Events|0
1685802|NCT01340898|5886999|P1|Primary Phase|Serious Adverse Events|0
1685803|NCT01340872|5887101|P4|Open-label Phase|Worsening of IBD|0
1685804|NCT01340872|5887102|P3|Open-label Phase|Worsening of IBD|1
1685805|NCT01340872|5887103|P2|Open-label Phase|Worsening of IBD|0
1685806|NCT01340872|5887104|P1|Open-label Phase|Worsening of IBD|0
1685807|NCT01340872|5887101|P4|Open-label Phase|Withdrawal by Subject|6
1685808|NCT01340872|5887102|P3|Open-label Phase|Withdrawal by Subject|1
1685809|NCT01340872|5887103|P2|Open-label Phase|Withdrawal by Subject|0
1685810|NCT01340872|5887104|P1|Open-label Phase|Withdrawal by Subject|0
1685811|NCT01340872|5887101|P4|Open-label Phase|Adverse Event|4
1685812|NCT01340872|5887102|P3|Open-label Phase|Adverse Event|8
1685813|NCT01340872|5887103|P2|Open-label Phase|Adverse Event|0
1685814|NCT01340872|5887104|P1|Open-label Phase|Adverse Event|0
1685815|NCT01340872|5887101|P4|Open-label Phase|Pregnancy|0
1685816|NCT01340872|5887102|P3|Open-label Phase|Pregnancy|1
1685817|NCT01340872|5887103|P2|Open-label Phase|Pregnancy|0
1685818|NCT01340872|5887104|P1|Open-label Phase|Pregnancy|0
1685819|NCT01340872|5887101|P4|Open-label Phase|Physician Decision|1
1685820|NCT01340872|5887102|P3|Open-label Phase|Physician Decision|2
1685821|NCT01340872|5887103|P2|Open-label Phase|Physician Decision|0
1685822|NCT01340872|5887104|P1|Open-label Phase|Physician Decision|0
1685823|NCT01340872|5887101|P4|Double-blind Phase|Protocol Violation|0
1685824|NCT01340872|5887102|P3|Double-blind Phase|Protocol Violation|0
1685825|NCT01340872|5887103|P2|Double-blind Phase|Protocol Violation|1
1685826|NCT01340872|5887104|P1|Double-blind Phase|Protocol Violation|0
1685827|NCT01340872|5887101|P4|Double-blind Phase|Lost to Follow-up|0
1685828|NCT01340872|5887102|P3|Double-blind Phase|Lost to Follow-up|0
1685829|NCT01340872|5887103|P2|Double-blind Phase|Lost to Follow-up|1
1685830|NCT01340872|5887104|P1|Double-blind Phase|Lost to Follow-up|0
1685831|NCT01340872|5887101|P4|Double-blind Phase|Withdrawal by Subject|0
1685832|NCT01340872|5887102|P3|Double-blind Phase|Withdrawal by Subject|0
1685833|NCT01340872|5887103|P2|Double-blind Phase|Withdrawal by Subject|5
1685834|NCT01340872|5887104|P1|Double-blind Phase|Withdrawal by Subject|3
1685835|NCT01340872|5887101|P4|Double-blind Phase|Adverse Event|0
1685836|NCT01340872|5887102|P3|Double-blind Phase|Adverse Event|0
1685837|NCT01340872|5887103|P2|Double-blind Phase|Adverse Event|4
1685838|NCT01340872|5887104|P1|Double-blind Phase|Adverse Event|6
1685839|NCT01340794|5887164|P2|Overall Study|Withdrawal by Subject|1
1685840|NCT01340794|5887165|P1|Overall Study|Withdrawal by Subject|0
1685841|NCT01340768|5887181|P2|Overall Study|Other|0
1685842|NCT01340768|5887182|P1|Overall Study|Other|2
1685843|NCT01340768|5887181|P2|Overall Study|Withdrawal by Subject|1
1685844|NCT01340768|5887182|P1|Overall Study|Withdrawal by Subject|5
1685845|NCT01340768|5887181|P2|Overall Study|Lost to Follow-up|4
1685846|NCT01340768|5887182|P1|Overall Study|Lost to Follow-up|10
1685847|NCT01340664|5887193|P3|Overall Study|Other|2
1685848|NCT01340664|5887194|P2|Overall Study|Other|2
1685849|NCT01340664|5887195|P1|Overall Study|Other|1
1685850|NCT01340664|5887193|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
1685851|NCT01340664|5887194|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
1685852|NCT01340664|5887195|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
1685853|NCT01340664|5887193|P3|Overall Study|Glycemic withdrawal criteria|0
1685854|NCT01340664|5887194|P2|Overall Study|Glycemic withdrawal criteria|0
1685855|NCT01340664|5887195|P1|Overall Study|Glycemic withdrawal criteria|2
1685856|NCT01340664|5887193|P3|Overall Study|Withdrawal by Subject|0
1685857|NCT01340664|5887194|P2|Overall Study|Withdrawal by Subject|4
1685858|NCT01340664|5887195|P1|Overall Study|Withdrawal by Subject|2
1685859|NCT01340664|5887193|P3|Overall Study|Lost to Follow-up|2
1685860|NCT01340664|5887194|P2|Overall Study|Lost to Follow-up|0
1685861|NCT01340664|5887195|P1|Overall Study|Lost to Follow-up|2
1685862|NCT01340664|5887193|P3|Overall Study|Adverse Event|7
1685863|NCT01340664|5887194|P2|Overall Study|Adverse Event|1
1685864|NCT01340664|5887195|P1|Overall Study|Adverse Event|0
1685865|NCT01340651|5887212|P1|Overall Study|Commercial Supply per Sponsor|12
1685866|NCT01340651|5887212|P1|Overall Study|Consent Withdrawn|2
1685867|NCT01340651|5887212|P1|Overall Study|Adverse Event|3
1685868|NCT01340625|5887228|P2|Washout Period of 28 Days|Withdrawal by Subject|0
1685869|NCT01340625|5887229|P1|Washout Period of 28 Days|Withdrawal by Subject|1
1685870|NCT01340625|5887228|P2|First Intervention|Adverse Event|0
1685871|NCT01340625|5887229|P1|First Intervention|Adverse Event|1
1685872|NCT01340495|5887334|P1|Overall Study|Withdrawal by Subject|1
1685873|NCT01340300|5887345|P4|Overall Study|Unrelated sickness|1
1685874|NCT01340300|5887346|P3|Overall Study|Unrelated sickness|0
1685875|NCT01340300|5887347|P2|Overall Study|Unrelated sickness|2
1685876|NCT01340300|5887348|P1|Overall Study|Unrelated sickness|0
1685877|NCT01340300|5887345|P4|Overall Study|Physician Decision|0
1685878|NCT01340300|5887346|P3|Overall Study|Physician Decision|0
1685879|NCT01340300|5887347|P2|Overall Study|Physician Decision|1
1685880|NCT01340300|5887348|P1|Overall Study|Physician Decision|0
1685881|NCT01340300|5887345|P4|Overall Study|Adverse Event|0
1685882|NCT01340300|5887346|P3|Overall Study|Adverse Event|4
1685883|NCT01340300|5887347|P2|Overall Study|Adverse Event|0
1685884|NCT01340300|5887348|P1|Overall Study|Adverse Event|1
1685885|NCT01340300|5887345|P4|Overall Study|Withdrawal by Subject|3
1685886|NCT01340300|5887346|P3|Overall Study|Withdrawal by Subject|6
1685887|NCT01340300|5887347|P2|Overall Study|Withdrawal by Subject|6
1685888|NCT01340300|5887348|P1|Overall Study|Withdrawal by Subject|5
1685889|NCT01340300|5887345|P4|Overall Study|Lost to Follow-up|10
1685890|NCT01340300|5887346|P3|Overall Study|Lost to Follow-up|5
1685891|NCT01340300|5887347|P2|Overall Study|Lost to Follow-up|0
1685892|NCT01340300|5887348|P1|Overall Study|Lost to Follow-up|3
1685893|NCT01340209|5887381|P3|Overall Study|Other reason not defined above|4
1685894|NCT01340209|5887382|P2|Overall Study|Other reason not defined above|5
1685895|NCT01340209|5887383|P1|Overall Study|Other reason not defined above|3
1685896|NCT01340209|5887381|P3|Overall Study|Withdrawal by Subject|1
1685897|NCT01340209|5887382|P2|Overall Study|Withdrawal by Subject|0
1685898|NCT01340209|5887383|P1|Overall Study|Withdrawal by Subject|0
1685899|NCT01340209|5887381|P3|Overall Study|Protocol Violation|1
1685900|NCT01340209|5887382|P2|Overall Study|Protocol Violation|2
1685901|NCT01340209|5887383|P1|Overall Study|Protocol Violation|1
1685902|NCT01340209|5887381|P3|Overall Study|Adverse Event|2
1685903|NCT01340209|5887382|P2|Overall Study|Adverse Event|1
1685904|NCT01340209|5887383|P1|Overall Study|Adverse Event|1
1685905|NCT01340196|5887418|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
1685906|NCT01340066|5887458|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
1685907|NCT01340066|5887459|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
1685908|NCT01340066|5887460|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
1685909|NCT01340066|5887458|P3|5 Week Double Blind Randomization Period|Physician Decision|0
1685910|NCT01340066|5887459|P2|5 Week Double Blind Randomization Period|Physician Decision|1
1685911|NCT01340066|5887460|P1|5 Week Double Blind Randomization Period|Physician Decision|0
1685912|NCT01340066|5887458|P3|5 Week Double Blind Randomization Period|Adverse Event|2
1685913|NCT01340066|5887459|P2|5 Week Double Blind Randomization Period|Adverse Event|2
1685914|NCT01340066|5887460|P1|5 Week Double Blind Randomization Period|Adverse Event|0
1685915|NCT01340066|5887458|P3|Placebo Run in Period|Screen Failures|0
1685916|NCT01340066|5887459|P2|Placebo Run in Period|Screen Failures|0
1685917|NCT01340066|5887460|P1|Placebo Run in Period|Screen Failures|27
1685918|NCT01340027|5887500|P12|Overall Study|Miscellaneous|0
1685919|NCT01340027|5887501|P11|Overall Study|Miscellaneous|1
1685920|NCT01340027|5887502|P10|Overall Study|Miscellaneous|0
1685921|NCT01340027|5887503|P9|Overall Study|Miscellaneous|0
1685922|NCT01340027|5887504|P8|Overall Study|Miscellaneous|0
1685923|NCT01340027|5887505|P7|Overall Study|Miscellaneous|0
1685924|NCT01340027|5887506|P6|Overall Study|Miscellaneous|0
1685925|NCT01340027|5887507|P5|Overall Study|Miscellaneous|0
1685926|NCT01340027|5887508|P4|Overall Study|Miscellaneous|1
1685927|NCT01340027|5887509|P3|Overall Study|Miscellaneous|0
1685928|NCT01340027|5887510|P2|Overall Study|Miscellaneous|0
1685929|NCT01340027|5887511|P1|Overall Study|Miscellaneous|0
1685930|NCT01340027|5887500|P12|Overall Study|Withdrawal by Subject|1
1685931|NCT01340027|5887501|P11|Overall Study|Withdrawal by Subject|0
1685932|NCT01340027|5887502|P10|Overall Study|Withdrawal by Subject|2
1685933|NCT01340027|5887503|P9|Overall Study|Withdrawal by Subject|1
1685934|NCT01340027|5887504|P8|Overall Study|Withdrawal by Subject|4
1685935|NCT01340027|5887505|P7|Overall Study|Withdrawal by Subject|3
1685936|NCT01340027|5887506|P6|Overall Study|Withdrawal by Subject|2
1685937|NCT01340027|5887507|P5|Overall Study|Withdrawal by Subject|3
1685938|NCT01340027|5887508|P4|Overall Study|Withdrawal by Subject|3
1685939|NCT01340027|5887509|P3|Overall Study|Withdrawal by Subject|1
1685940|NCT01340027|5887510|P2|Overall Study|Withdrawal by Subject|3
1685941|NCT01340027|5887511|P1|Overall Study|Withdrawal by Subject|4
1685942|NCT01340027|5887500|P12|Overall Study|Protocol Violation|0
1685943|NCT01340027|5887501|P11|Overall Study|Protocol Violation|0
1685944|NCT01340027|5887502|P10|Overall Study|Protocol Violation|2
1685945|NCT01340027|5887503|P9|Overall Study|Protocol Violation|2
1685946|NCT01340027|5887504|P8|Overall Study|Protocol Violation|1
1685947|NCT01340027|5887505|P7|Overall Study|Protocol Violation|0
1685948|NCT01340027|5887506|P6|Overall Study|Protocol Violation|0
1685949|NCT01340027|5887507|P5|Overall Study|Protocol Violation|6
1685950|NCT01340027|5887508|P4|Overall Study|Protocol Violation|0
1685951|NCT01340027|5887509|P3|Overall Study|Protocol Violation|0
1685952|NCT01340027|5887510|P2|Overall Study|Protocol Violation|2
1685953|NCT01340027|5887511|P1|Overall Study|Protocol Violation|1
1685954|NCT01340027|5887500|P12|Overall Study|Lost to Follow-up|0
1685955|NCT01340027|5887501|P11|Overall Study|Lost to Follow-up|0
1685956|NCT01340027|5887502|P10|Overall Study|Lost to Follow-up|1
1685957|NCT01340027|5887503|P9|Overall Study|Lost to Follow-up|0
1685958|NCT01340027|5887504|P8|Overall Study|Lost to Follow-up|0
1685959|NCT01340027|5887505|P7|Overall Study|Lost to Follow-up|1
1685960|NCT01340027|5887506|P6|Overall Study|Lost to Follow-up|0
1685961|NCT01340027|5887507|P5|Overall Study|Lost to Follow-up|0
1685962|NCT01340027|5887508|P4|Overall Study|Lost to Follow-up|0
1685963|NCT01340027|5887509|P3|Overall Study|Lost to Follow-up|0
1685964|NCT01340027|5887510|P2|Overall Study|Lost to Follow-up|1
1685965|NCT01340027|5887511|P1|Overall Study|Lost to Follow-up|0
1685966|NCT01340027|5887500|P12|Overall Study|Lack of Efficacy|0
1685967|NCT01340027|5887501|P11|Overall Study|Lack of Efficacy|0
1685968|NCT01340027|5887502|P10|Overall Study|Lack of Efficacy|0
1685969|NCT01340027|5887503|P9|Overall Study|Lack of Efficacy|1
1685970|NCT01340027|5887504|P8|Overall Study|Lack of Efficacy|1
1685971|NCT01340027|5887505|P7|Overall Study|Lack of Efficacy|1
1685972|NCT01340027|5887506|P6|Overall Study|Lack of Efficacy|0
1685973|NCT01340027|5887507|P5|Overall Study|Lack of Efficacy|0
1685974|NCT01340027|5887508|P4|Overall Study|Lack of Efficacy|0
1685975|NCT01340027|5887509|P3|Overall Study|Lack of Efficacy|0
1685976|NCT01340027|5887510|P2|Overall Study|Lack of Efficacy|0
1685977|NCT01340027|5887511|P1|Overall Study|Lack of Efficacy|0
1685978|NCT01340027|5887500|P12|Overall Study|Adverse Event|3
1685979|NCT01340027|5887501|P11|Overall Study|Adverse Event|1
1685980|NCT01340027|5887502|P10|Overall Study|Adverse Event|1
1685981|NCT01340027|5887503|P9|Overall Study|Adverse Event|4
1685982|NCT01340027|5887504|P8|Overall Study|Adverse Event|1
1685983|NCT01340027|5887505|P7|Overall Study|Adverse Event|2
1685984|NCT01340027|5887506|P6|Overall Study|Adverse Event|2
1685985|NCT01340027|5887507|P5|Overall Study|Adverse Event|1
1685986|NCT01340027|5887508|P4|Overall Study|Adverse Event|0
1685987|NCT01340027|5887509|P3|Overall Study|Adverse Event|2
1685988|NCT01340027|5887510|P2|Overall Study|Adverse Event|1
1685989|NCT01340027|5887511|P1|Overall Study|Adverse Event|0
1685990|NCT01340027|5887500|P12|Overall Study|Randomized but Never Received Study Drug|0
1685991|NCT01340027|5887501|P11|Overall Study|Randomized but Never Received Study Drug|0
1685992|NCT01340027|5887502|P10|Overall Study|Randomized but Never Received Study Drug|0
1685993|NCT01340027|5887503|P9|Overall Study|Randomized but Never Received Study Drug|0
1685994|NCT01340027|5887504|P8|Overall Study|Randomized but Never Received Study Drug|0
1685995|NCT01340027|5887505|P7|Overall Study|Randomized but Never Received Study Drug|0
1685996|NCT01340027|5887506|P6|Overall Study|Randomized but Never Received Study Drug|0
1685997|NCT01340027|5887507|P5|Overall Study|Randomized but Never Received Study Drug|0
1685998|NCT01340027|5887508|P4|Overall Study|Randomized but Never Received Study Drug|0
1685999|NCT01340027|5887509|P3|Overall Study|Randomized but Never Received Study Drug|1
1686000|NCT01340027|5887510|P2|Overall Study|Randomized but Never Received Study Drug|0
1686001|NCT01340027|5887511|P1|Overall Study|Randomized but Never Received Study Drug|0
1686002|NCT01340014|5887887|P2|Period 2, Second 7 Days|Adverse Event|1
1686003|NCT01340014|5887888|P1|Period 2, Second 7 Days|Adverse Event|0
1686004|NCT01340014|5887887|P2|Period 1, First 7 Days|Personal Reasons|0
1686005|NCT01340014|5887888|P1|Period 1, First 7 Days|Personal Reasons|1
1686006|NCT01340014|5887887|P2|Period 1, First 7 Days|Adverse Event|0
1686007|NCT01340014|5887888|P1|Period 1, First 7 Days|Adverse Event|1
1686008|NCT01339923|5887909|P7|Overall Study|Withdrawal by Subject|2
1686009|NCT01339923|5887910|P6|Overall Study|Withdrawal by Subject|3
1686010|NCT01339923|5887911|P5|Overall Study|Withdrawal by Subject|4
1686011|NCT01339923|5887912|P4|Overall Study|Withdrawal by Subject|1
1686012|NCT01339923|5887913|P3|Overall Study|Withdrawal by Subject|6
1686013|NCT01339923|5887914|P2|Overall Study|Withdrawal by Subject|11
1686014|NCT01339923|5887915|P1|Overall Study|Withdrawal by Subject|7
1686015|NCT01339923|5887909|P7|Overall Study|Unable to Classify|5
1686016|NCT01339923|5887910|P6|Overall Study|Unable to Classify|1
1686017|NCT01339923|5887911|P5|Overall Study|Unable to Classify|0
1686018|NCT01339923|5887912|P4|Overall Study|Unable to Classify|0
1686019|NCT01339923|5887913|P3|Overall Study|Unable to Classify|1
1686020|NCT01339923|5887914|P2|Overall Study|Unable to Classify|0
1686021|NCT01339923|5887915|P1|Overall Study|Unable to Classify|1
1686022|NCT01339923|5887909|P7|Overall Study|Protocol Violation|1
1686023|NCT01339923|5887910|P6|Overall Study|Protocol Violation|3
1686024|NCT01339923|5887911|P5|Overall Study|Protocol Violation|0
1686025|NCT01339923|5887912|P4|Overall Study|Protocol Violation|0
1686026|NCT01339923|5887913|P3|Overall Study|Protocol Violation|0
1686027|NCT01339923|5887914|P2|Overall Study|Protocol Violation|0
1686028|NCT01339923|5887915|P1|Overall Study|Protocol Violation|0
1686029|NCT01339923|5887909|P7|Overall Study|Lost to Follow-up|5
1686030|NCT01339923|5887910|P6|Overall Study|Lost to Follow-up|1
1686031|NCT01339923|5887911|P5|Overall Study|Lost to Follow-up|1
1686032|NCT01339923|5887912|P4|Overall Study|Lost to Follow-up|3
1686033|NCT01339923|5887913|P3|Overall Study|Lost to Follow-up|0
1686034|NCT01339923|5887914|P2|Overall Study|Lost to Follow-up|4
1686035|NCT01339923|5887915|P1|Overall Study|Lost to Follow-up|4
1686036|NCT01339923|5887909|P7|Overall Study|Inappropriate Enrollment|0
1686037|NCT01339923|5887910|P6|Overall Study|Inappropriate Enrollment|1
1686038|NCT01339923|5887911|P5|Overall Study|Inappropriate Enrollment|0
1686039|NCT01339923|5887912|P4|Overall Study|Inappropriate Enrollment|0
1686040|NCT01339923|5887913|P3|Overall Study|Inappropriate Enrollment|0
1686041|NCT01339923|5887914|P2|Overall Study|Inappropriate Enrollment|0
1686042|NCT01339923|5887915|P1|Overall Study|Inappropriate Enrollment|1
1686043|NCT01339923|5887909|P7|Overall Study|Adverse Event|1
1686044|NCT01339923|5887910|P6|Overall Study|Adverse Event|0
1686045|NCT01339923|5887911|P5|Overall Study|Adverse Event|0
1686046|NCT01339923|5887912|P4|Overall Study|Adverse Event|0
1686047|NCT01339923|5887913|P3|Overall Study|Adverse Event|1
1686048|NCT01339923|5887914|P2|Overall Study|Adverse Event|1
1686049|NCT01339923|5887915|P1|Overall Study|Adverse Event|1
1686050|NCT01339910|5887986|P2|Overall Study|Disease relapse|4
1686051|NCT01339910|5887987|P1|Overall Study|Disease relapse|1
1686052|NCT01339910|5887986|P2|Overall Study|Physician Decision|0
1686053|NCT01339910|5887987|P1|Overall Study|Physician Decision|1
1686054|NCT01339910|5887986|P2|Overall Study|Withdrawal by Subject|0
1686055|NCT01339910|5887987|P1|Overall Study|Withdrawal by Subject|1
1686056|NCT01339897|5888025|P4|Overall Study|Adverse Event|1
1686057|NCT01339897|5888026|P3|Overall Study|Adverse Event|0
1686058|NCT01339897|5888027|P2|Overall Study|Adverse Event|0
1686059|NCT01339897|5888028|P1|Overall Study|Adverse Event|1
1686060|NCT01339832|5888081|P1|Overall Study|Death|11
1686061|NCT01339832|5888081|P1|Overall Study|Lost to Follow-up|3
1686062|NCT01339429|5888092|P1|Overall Study|Physician Decision|3
1686063|NCT01339429|5888092|P1|Overall Study|Withdrawal by Subject|1
1686064|NCT01339390|5888132|P2|Overall Study|Lost to Follow-up|127
1686065|NCT01339390|5888133|P1|Overall Study|Lost to Follow-up|125
1686066|NCT01339390|5888132|P2|Overall Study|Death|29
1686067|NCT01339390|5888133|P1|Overall Study|Death|32
1686068|NCT01339273|5888150|P2|Overall Study|Lost to Follow-up|8
1686069|NCT01339273|5888151|P1|Overall Study|Lost to Follow-up|8
1686070|NCT01339052|5888226|P2|Overall Study|Physician Decision|0
1686071|NCT01339052|5888227|P1|Overall Study|Physician Decision|1
1686072|NCT01339052|5888226|P2|Overall Study|Withdrawal by Subject|3
1686073|NCT01339052|5888227|P1|Overall Study|Withdrawal by Subject|0
1686074|NCT01339052|5888226|P2|Overall Study|Adverse Event|1
1686075|NCT01339052|5888227|P1|Overall Study|Adverse Event|1
1686076|NCT01339052|5888226|P2|Overall Study|Disease progression|46
1686077|NCT01339052|5888227|P1|Overall Study|Disease progression|13
1686078|NCT01339000|5888253|P2|Overall Study|study closed due to lack of drug supply|0
1686079|NCT01339000|5888254|P1|Overall Study|study closed due to lack of drug supply|1
1686080|NCT01338987|5888273|P5|Overall Study|Disease progression on study|0
1686081|NCT01338987|5888274|P4|Overall Study|Disease progression on study|0
1686082|NCT01338987|5888275|P3|Overall Study|Disease progression on study|1
1686083|NCT01338987|5888276|P2|Overall Study|Disease progression on study|1
1686084|NCT01338987|5888277|P1|Overall Study|Disease progression on study|2
1686085|NCT01338987|5888273|P5|Overall Study|enrolled on new protocol|0
1686086|NCT01338987|5888274|P4|Overall Study|enrolled on new protocol|0
1686087|NCT01338987|5888275|P3|Overall Study|enrolled on new protocol|1
1686088|NCT01338987|5888276|P2|Overall Study|enrolled on new protocol|0
1686089|NCT01338987|5888277|P1|Overall Study|enrolled on new protocol|0
1686090|NCT01338870|5888298|P6|Overall Study|Adverse Event|1
1686091|NCT01338870|5888299|P5|Overall Study|Adverse Event|4
1686092|NCT01338870|5888300|P4|Overall Study|Adverse Event|5
1686093|NCT01338870|5888301|P3|Overall Study|Adverse Event|1
1686094|NCT01338870|5888302|P2|Overall Study|Adverse Event|4
1686095|NCT01338870|5888303|P1|Overall Study|Adverse Event|4
1686096|NCT01338870|5888298|P6|Overall Study|Protocol Violation|1
1686097|NCT01338870|5888299|P5|Overall Study|Protocol Violation|1
1686098|NCT01338870|5888300|P4|Overall Study|Protocol Violation|2
1686099|NCT01338870|5888301|P3|Overall Study|Protocol Violation|2
1686100|NCT01338870|5888302|P2|Overall Study|Protocol Violation|2
1686101|NCT01338870|5888303|P1|Overall Study|Protocol Violation|0
1686102|NCT01338870|5888298|P6|Overall Study|Other|2
1686103|NCT01338870|5888299|P5|Overall Study|Other|0
1686104|NCT01338870|5888300|P4|Overall Study|Other|2
1686105|NCT01338870|5888301|P3|Overall Study|Other|3
1686106|NCT01338870|5888302|P2|Overall Study|Other|3
1686107|NCT01338870|5888303|P1|Overall Study|Other|3
1686108|NCT01338870|5888298|P6|Overall Study|Withdrawal by Subject|2
1686109|NCT01338870|5888299|P5|Overall Study|Withdrawal by Subject|0
1686110|NCT01338870|5888300|P4|Overall Study|Withdrawal by Subject|0
1686111|NCT01338870|5888301|P3|Overall Study|Withdrawal by Subject|4
1686112|NCT01338870|5888302|P2|Overall Study|Withdrawal by Subject|3
1686113|NCT01338870|5888303|P1|Overall Study|Withdrawal by Subject|2
1686114|NCT01338870|5888298|P6|Overall Study|Lost to Follow-up|0
1686115|NCT01338870|5888299|P5|Overall Study|Lost to Follow-up|1
1686116|NCT01338870|5888300|P4|Overall Study|Lost to Follow-up|0
1686117|NCT01338870|5888301|P3|Overall Study|Lost to Follow-up|1
1686118|NCT01338870|5888302|P2|Overall Study|Lost to Follow-up|0
1686119|NCT01338870|5888303|P1|Overall Study|Lost to Follow-up|0
1686120|NCT01338818|5888358|P1|Overall Study|Protocol Deviation|4
1686121|NCT01338818|5888358|P1|Overall Study|Administrative problems|3
1686122|NCT01338818|5888358|P1|Overall Study|Lost to Follow-up|4
1686123|NCT01338818|5888358|P1|Overall Study|Withdrawal by Subject|11
1686124|NCT01338818|5888358|P1|Overall Study|no longer require study drug|1
1686125|NCT01338818|5888358|P1|Overall Study|Lack of Efficacy|5
1686126|NCT01338818|5888358|P1|Overall Study|Adverse Event|8
1686127|NCT01338792|5888364|P1|Overall Study|Withdrawal by Subject|1
1686128|NCT01338792|5888364|P1|Overall Study|Death|1
1686129|NCT01338792|5888364|P1|Overall Study|Adverse Event|2
1686130|NCT01338636|5888379|P1|Overall Study|Withdrawn due to lack of improvement|8
1686131|NCT01338610|5888393|P3|Overall Study|Adverse Event|0
1686132|NCT01338610|5888394|P2|Overall Study|Adverse Event|0
1686133|NCT01338610|5888395|P1|Overall Study|Adverse Event|3
1686134|NCT01338610|5888393|P3|Overall Study|Protocol Violation|1
1686135|NCT01338610|5888394|P2|Overall Study|Protocol Violation|0
1686136|NCT01338610|5888395|P1|Overall Study|Protocol Violation|1
1686137|NCT01338610|5888393|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
1686138|NCT01338610|5888394|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
1686139|NCT01338610|5888395|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
1686140|NCT01338493|5888421|P1|12 Months Follow up|Lost to Follow-up|9
1686141|NCT01338493|5888421|P1|6 Months Follow up|Missed visit|8
1686142|NCT01338493|5888421|P1|6 Months Follow up|Lost to Follow-up|11
1686143|NCT01338493|5888421|P1|Discharge|Missed visit|1
1686144|NCT01338493|5888421|P1|Discharge|Death|1
1686145|NCT01338493|5888421|P1|Enrolled|Patient not implanted|4
1686146|NCT01338493|5888421|P1|Enrolled|Withdrawal by Subject|1
1686155|NCT01338298|5888451|P2|Overall Study|Non-adherence|0
1686156|NCT01338298|5888452|P1|Overall Study|Non-adherence|1
1686157|NCT01338298|5888451|P2|Overall Study|Depressive symptoms and nausea|0
1686158|NCT01338298|5888452|P1|Overall Study|Depressive symptoms and nausea|1
1686159|NCT01338298|5888451|P2|Overall Study|Positive symptom worsening|0
1686160|NCT01338298|5888452|P1|Overall Study|Positive symptom worsening|1
1686161|NCT01338298|5888451|P2|Overall Study|Administrative error|1
1686162|NCT01338298|5888452|P1|Overall Study|Administrative error|0
1686163|NCT01338298|5888451|P2|Overall Study|Abdominal Pain and scheduled surgery|1
1686164|NCT01338298|5888452|P1|Overall Study|Abdominal Pain and scheduled surgery|0
1686165|NCT01338298|5888451|P2|Overall Study|Withdrawal by Subject|1
1686166|NCT01338298|5888452|P1|Overall Study|Withdrawal by Subject|1
1686167|NCT01338025|5888462|P2|Overall Study|Found ineligible after starting|0
1686168|NCT01338025|5888463|P1|Overall Study|Found ineligible after starting|1
1686169|NCT01338025|5888462|P2|Overall Study|Withdrawal by Subject|2
1686170|NCT01338025|5888463|P1|Overall Study|Withdrawal by Subject|0
1686171|NCT01338025|5888462|P2|Overall Study|Unexpected closure of study|9
1686172|NCT01338025|5888463|P1|Overall Study|Unexpected closure of study|10
1686173|NCT01338012|5888475|P1|Overall Study|Study terminated|4
1686174|NCT01338012|5888475|P1|Overall Study|Death|4
1686175|NCT01337986|5888481|P2|Overall Study|Protocol Violation|3
1686176|NCT01337986|5888482|P1|Overall Study|Protocol Violation|0
1686177|NCT01337986|5888481|P2|Overall Study|Lost to Follow-up|0
1686178|NCT01337986|5888482|P1|Overall Study|Lost to Follow-up|1
1686179|NCT01337986|5888481|P2|Overall Study|Adverse Event|2
1686180|NCT01337986|5888482|P1|Overall Study|Adverse Event|2
1686181|NCT01337973|5888519|P3|Overall Study|missing data on primary outcome|3
1686182|NCT01337973|5888520|P2|Overall Study|missing data on primary outcome|1
1686183|NCT01337973|5888521|P1|Overall Study|missing data on primary outcome|3
1686184|NCT01337973|5888519|P3|Overall Study|Withdrawal by Subject|4
1686185|NCT01337973|5888520|P2|Overall Study|Withdrawal by Subject|8
1686186|NCT01337973|5888521|P1|Overall Study|Withdrawal by Subject|10
1686187|NCT01337973|5888519|P3|Overall Study|Death|1
1686188|NCT01337973|5888520|P2|Overall Study|Death|2
1686189|NCT01337973|5888521|P1|Overall Study|Death|1
1686190|NCT01337973|5888519|P3|Overall Study|Lost to Follow-up|3
1686191|NCT01337973|5888520|P2|Overall Study|Lost to Follow-up|4
1686192|NCT01337973|5888521|P1|Overall Study|Lost to Follow-up|2
1686193|NCT01337960|5888535|P3|Overall Study|Withdrawal by Subject|0
1686194|NCT01337960|5888536|P2|Overall Study|Withdrawal by Subject|0
1686195|NCT01337960|5888537|P1|Overall Study|Withdrawal by Subject|1
1686196|NCT01337960|5888535|P3|Overall Study|Lost to Follow-up|0
1686197|NCT01337960|5888536|P2|Overall Study|Lost to Follow-up|0
1686198|NCT01337960|5888537|P1|Overall Study|Lost to Follow-up|1
1686199|NCT01337674|5888570|P4|Treatment Period 2|Withdrawal by Subject|0
1686200|NCT01337674|5888571|P3|Treatment Period 2|Withdrawal by Subject|1
1686201|NCT01337674|5888572|P2|Treatment Period 2|Withdrawal by Subject|0
1686202|NCT01337674|5888573|P1|Treatment Period 2|Withdrawal by Subject|0
1686203|NCT01337674|5888570|P4|Treatment Period 1|Discontinued due to blood draws|1
1686204|NCT01337674|5888571|P3|Treatment Period 1|Discontinued due to blood draws|0
1686205|NCT01337674|5888572|P2|Treatment Period 1|Discontinued due to blood draws|0
1686206|NCT01337674|5888573|P1|Treatment Period 1|Discontinued due to blood draws|0
1686207|NCT01337674|5888570|P4|Treatment Period 1|Adverse Event|0
1686208|NCT01337674|5888571|P3|Treatment Period 1|Adverse Event|0
1686209|NCT01337674|5888572|P2|Treatment Period 1|Adverse Event|1
1686210|NCT01337674|5888573|P1|Treatment Period 1|Adverse Event|0
1686211|NCT01337635|5888591|P2|Overall Study|Lost to Follow-up|1
1686212|NCT01337635|5888592|P1|Overall Study|Lost to Follow-up|0
1686213|NCT01337596|5888634|P9|Overall Study|Withdrawal by Subject|0
1686214|NCT01337596|5888635|P8|Overall Study|Withdrawal by Subject|0
1686215|NCT01337596|5888636|P7|Overall Study|Withdrawal by Subject|0
1686216|NCT01337596|5888637|P6|Overall Study|Withdrawal by Subject|0
1686217|NCT01337596|5888638|P5|Overall Study|Withdrawal by Subject|2
1686218|NCT01337596|5888639|P4|Overall Study|Withdrawal by Subject|0
1686219|NCT01337596|5888640|P3|Overall Study|Withdrawal by Subject|0
1686220|NCT01337596|5888641|P2|Overall Study|Withdrawal by Subject|0
1686221|NCT01337596|5888642|P1|Overall Study|Withdrawal by Subject|0
1686222|NCT01337297|5888693|P2|Overall Study|Lost to Follow-up|3
1686223|NCT01337297|5888694|P1|Overall Study|Lost to Follow-up|1
1686224|NCT01337297|5888693|P2|Overall Study|They entered to single anodal tDCS|3
1686225|NCT01337297|5888694|P1|Overall Study|They entered to single anodal tDCS|4
1686226|NCT01337167|5888702|P2|Toddler Vaccinations|Withdrawal by Subject|0
1686227|NCT01337167|5888703|P1|Toddler Vaccinations|Withdrawal by Subject|3
1686228|NCT01337167|5888702|P2|Toddler Vaccinations|Protocol Violation|1
1686229|NCT01337167|5888703|P1|Toddler Vaccinations|Protocol Violation|0
1686230|NCT01337167|5888702|P2|Toddler Vaccinations|Lost to Follow-up|12
1686231|NCT01337167|5888703|P1|Toddler Vaccinations|Lost to Follow-up|11
1686232|NCT01337167|5888702|P2|Interim Period|Other protocol criterion not met|1
1686233|NCT01337167|5888703|P1|Interim Period|Other protocol criterion not met|0
1686234|NCT01337167|5888702|P2|Interim Period|Withdrawal by Subject|10
1686235|NCT01337167|5888703|P1|Interim Period|Withdrawal by Subject|18
1686236|NCT01337167|5888702|P2|Interim Period|Protocol Violation|3
1686237|NCT01337167|5888703|P1|Interim Period|Protocol Violation|5
1686238|NCT01337167|5888702|P2|Interim Period|Physician Decision|3
1686239|NCT01337167|5888703|P1|Interim Period|Physician Decision|6
1686240|NCT01337167|5888702|P2|Interim Period|Non-compliance with study drug|0
1686241|NCT01337167|5888703|P1|Interim Period|Non-compliance with study drug|1
1686242|NCT01337167|5888702|P2|Interim Period|Lost to Follow-up|23
1686243|NCT01337167|5888703|P1|Interim Period|Lost to Follow-up|51
1686244|NCT01337167|5888702|P2|Infant Series|Randomized but not vaccinated|3
1686245|NCT01337167|5888703|P1|Infant Series|Randomized but not vaccinated|5
1686246|NCT01337167|5888702|P2|Infant Series|Withdrawal by Subject|4
1686247|NCT01337167|5888703|P1|Infant Series|Withdrawal by Subject|15
1686248|NCT01337167|5888702|P2|Infant Series|Protocol Violation|9
1686249|NCT01337167|5888703|P1|Infant Series|Protocol Violation|22
1686250|NCT01337167|5888702|P2|Infant Series|Physician Decision|1
1686251|NCT01337167|5888703|P1|Infant Series|Physician Decision|3
1686252|NCT01337167|5888702|P2|Infant Series|Non-compliance with study drug|1
1686253|NCT01337167|5888703|P1|Infant Series|Non-compliance with study drug|2
1686254|NCT01337167|5888702|P2|Infant Series|Lost to Follow-up|7
1686255|NCT01337167|5888703|P1|Infant Series|Lost to Follow-up|13
1686256|NCT01337167|5888702|P2|Infant Series|Death|1
1686257|NCT01337167|5888703|P1|Infant Series|Death|1
1686258|NCT01337167|5888702|P2|Infant Series|Adverse Event|1
1686259|NCT01337167|5888703|P1|Infant Series|Adverse Event|1
1686260|NCT01337115|5888771|P2|Overall Study|Protocol Violation|0
1686261|NCT01337115|5888772|P1|Overall Study|Protocol Violation|2
1686262|NCT01337089|5888784|P1|Overall Study|Lost to Follow-up|2
1686263|NCT01337089|5888784|P1|Overall Study|Met Withdrawal Criteria|3
1686264|NCT01337089|5888784|P1|Overall Study|Withdrawal by Investigator|33
1686265|NCT01337089|5888784|P1|Overall Study|Withdrawal by Subject|129
1686266|NCT01337089|5888784|P1|Overall Study|Adverse Event|237
1686267|NCT01337050|5888799|P3|Overall Study|Participants refused further follow-up|7
1686268|NCT01337050|5888800|P2|Overall Study|Participants refused further follow-up|7
1686269|NCT01337050|5888801|P1|Overall Study|Participants refused further follow-up|0
1686270|NCT01337050|5888799|P3|Overall Study|Other|8
1686271|NCT01337050|5888800|P2|Overall Study|Other|6
1686272|NCT01337050|5888801|P1|Overall Study|Other|4
1686273|NCT01337050|5888799|P3|Overall Study|Death|4
1686274|NCT01337050|5888800|P2|Overall Study|Death|0
1686275|NCT01337050|5888801|P1|Overall Study|Death|0
1686276|NCT01336972|5888862|P3|Overall Study|Adverse Event|0
1686277|NCT01336972|5888863|P2|Overall Study|Adverse Event|1
1686278|NCT01336972|5888864|P1|Overall Study|Adverse Event|1
1686279|NCT01336894|5888926|P2|Follow-up|Study terminated prematurely|7
1686280|NCT01336894|5888927|P1|Follow-up|Study terminated prematurely|2
1686281|NCT01336764|5888959|P2|Overall Study|Withdrawal by Subject|5
1686282|NCT01336764|5888960|P1|Overall Study|Withdrawal by Subject|5
1686283|NCT01336738|5888971|P5|Overall Study|Other|4
1686284|NCT01336738|5888972|P4|Overall Study|Other|3
1686285|NCT01336738|5888973|P3|Overall Study|Other|2
1686286|NCT01336738|5888974|P2|Overall Study|Other|3
1686287|NCT01336738|5888975|P1|Overall Study|Other|3
1686288|NCT01336738|5888971|P5|Overall Study|Withdrawal by Subject|1
1686289|NCT01336738|5888972|P4|Overall Study|Withdrawal by Subject|1
1686290|NCT01336738|5888973|P3|Overall Study|Withdrawal by Subject|2
1686291|NCT01336738|5888974|P2|Overall Study|Withdrawal by Subject|0
1686292|NCT01336738|5888975|P1|Overall Study|Withdrawal by Subject|2
1686293|NCT01336738|5888971|P5|Overall Study|Protocol Violation|0
1686294|NCT01336738|5888972|P4|Overall Study|Protocol Violation|0
1686295|NCT01336738|5888973|P3|Overall Study|Protocol Violation|0
1686296|NCT01336738|5888974|P2|Overall Study|Protocol Violation|1
1686297|NCT01336738|5888975|P1|Overall Study|Protocol Violation|0
1686298|NCT01336738|5888971|P5|Overall Study|Did not meet entrance criteria|0
1686299|NCT01336738|5888972|P4|Overall Study|Did not meet entrance criteria|0
1686300|NCT01336738|5888973|P3|Overall Study|Did not meet entrance criteria|0
1686301|NCT01336738|5888974|P2|Overall Study|Did not meet entrance criteria|1
1686302|NCT01336738|5888975|P1|Overall Study|Did not meet entrance criteria|0
1686303|NCT01336738|5888971|P5|Overall Study|Lost to Follow-up|2
1686304|NCT01336738|5888972|P4|Overall Study|Lost to Follow-up|2
1686305|NCT01336738|5888973|P3|Overall Study|Lost to Follow-up|2
1686306|NCT01336738|5888974|P2|Overall Study|Lost to Follow-up|1
1686307|NCT01336738|5888975|P1|Overall Study|Lost to Follow-up|2
1686308|NCT01336738|5888971|P5|Overall Study|Adverse Event|3
1686309|NCT01336738|5888972|P4|Overall Study|Adverse Event|1
1686310|NCT01336738|5888973|P3|Overall Study|Adverse Event|2
1686311|NCT01336738|5888974|P2|Overall Study|Adverse Event|3
1686312|NCT01336738|5888975|P1|Overall Study|Adverse Event|0
1686313|NCT01336712|5889017|P1|Overall Study|Lack of Efficacy|1
1686314|NCT01336712|5889017|P1|Overall Study|Death|2
1686315|NCT01336647|5889030|P3|Overall Study|Lost to Follow-up|3
1686316|NCT01336647|5889031|P2|Overall Study|Lost to Follow-up|1
1686317|NCT01336647|5889032|P1|Overall Study|Lost to Follow-up|4
1686318|NCT01336634|5889046|P3|Overall Study|Ongoing|24
1686319|NCT01336634|5889047|P2|Overall Study|Ongoing|22
1686320|NCT01336634|5889048|P1|Overall Study|Ongoing|15
1686321|NCT01336634|5889046|P3|Overall Study|Physician Decision|0
1686322|NCT01336634|5889047|P2|Overall Study|Physician Decision|1
1686323|NCT01336634|5889048|P1|Overall Study|Physician Decision|1
1686324|NCT01336634|5889046|P3|Overall Study|Withdrawal by Subject|1
1686325|NCT01336634|5889047|P2|Overall Study|Withdrawal by Subject|0
1686326|NCT01336634|5889048|P1|Overall Study|Withdrawal by Subject|6
1686327|NCT01336634|5889046|P3|Overall Study|Lost to Follow-up|1
1686328|NCT01336634|5889047|P2|Overall Study|Lost to Follow-up|1
1686329|NCT01336634|5889048|P1|Overall Study|Lost to Follow-up|2
1686330|NCT01336634|5889046|P3|Overall Study|Death|10
1686331|NCT01336634|5889047|P2|Overall Study|Death|33
1686332|NCT01336634|5889048|P1|Overall Study|Death|60
1686333|NCT01336621|5889089|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
1686334|NCT01336621|5889089|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
1686335|NCT01336621|5889089|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
1686336|NCT01336621|5889089|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
1686337|NCT01336621|5889089|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
1686338|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
1686339|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
1686340|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
1686341|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
1686342|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
1686343|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
1686344|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
1686345|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
1686346|NCT01336621|5889089|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
1686347|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
1686348|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
1686349|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1686350|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1686351|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Physician Decision|1
1686352|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1686353|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Physician Decision|3
1686354|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1686355|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1686356|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1686357|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1686358|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1686359|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
1686360|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
1686361|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
1686362|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
1686363|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
1686364|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
1686365|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
1686366|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1686367|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
1686368|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1686369|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1686370|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1686371|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1686372|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1686373|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1686374|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1686375|NCT01336608|5889139|P4|24-week, Double-blind Treatment Period|Adverse Event|7
1686376|NCT01336608|5889140|P3|24-week, Double-blind Treatment Period|Adverse Event|6
1686377|NCT01336608|5889141|P2|24-week, Double-blind Treatment Period|Adverse Event|8
1686378|NCT01336608|5889142|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1686379|NCT01336608|5889139|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1686380|NCT01336608|5889140|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1686381|NCT01336608|5889141|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1686382|NCT01336608|5889142|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
1686383|NCT01336608|5889139|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1686384|NCT01336608|5889140|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1686385|NCT01336608|5889141|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1686386|NCT01336608|5889142|P1|2-week, Single-blind Run-In Period|Physician Decision|1
1686387|NCT01336608|5889139|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1686388|NCT01336608|5889140|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1686389|NCT01336608|5889141|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1686390|NCT01336608|5889142|P1|2-week, Single-blind Run-In Period|Adverse Event|1
1686391|NCT01336608|5889139|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1686392|NCT01336608|5889140|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1686393|NCT01336608|5889141|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1686394|NCT01336608|5889142|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
1686395|NCT01336608|5889139|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1686396|NCT01336608|5889140|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1686397|NCT01336608|5889141|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1686398|NCT01336608|5889142|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
1686399|NCT01336569|5889156|P1|Overall Study|Lost to Follow-up|4
1686400|NCT01336205|5889204|P2|Overall Study|Did not receive treatment|0
1686401|NCT01336205|5889205|P1|Overall Study|Did not receive treatment|4
1686402|NCT01336205|5889204|P2|Overall Study|Withdrawal by Subject|38
1686403|NCT01336205|5889205|P1|Overall Study|Withdrawal by Subject|72
1686404|NCT01336205|5889204|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
1686405|NCT01336205|5889205|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
1686406|NCT01336205|5889204|P2|Overall Study|Death|1
1686407|NCT01336205|5889205|P1|Overall Study|Death|1
1686408|NCT01336205|5889204|P2|Overall Study|Adverse Event|6
1686409|NCT01336205|5889205|P1|Overall Study|Adverse Event|56
1686410|NCT01336205|5889204|P2|Overall Study|Severe noncompliance with protocol|2
1686411|NCT01336205|5889205|P1|Overall Study|Severe noncompliance with protocol|9
1686412|NCT01336205|5889204|P2|Overall Study|Lack of Efficacy|0
1686413|NCT01336205|5889205|P1|Overall Study|Lack of Efficacy|4
1686414|NCT01336205|5889204|P2|Overall Study|Study-Specific Withdrawal Criteria|7
1686415|NCT01336205|5889205|P1|Overall Study|Study-Specific Withdrawal Criteria|16
1686416|NCT01336205|5889204|P2|Overall Study|Lost to Follow-up|20
1686417|NCT01336205|5889205|P1|Overall Study|Lost to Follow-up|40
1686418|NCT01336205|5889204|P2|Overall Study|Other|9
1686419|NCT01336205|5889205|P1|Overall Study|Other|22
1686420|NCT01336023|5889233|P3|Week 27 to 52|Unclassified|9
1686421|NCT01336023|5889234|P2|Week 27 to 52|Unclassified|18
1686422|NCT01336023|5889235|P1|Week 27 to 52|Unclassified|13
1686423|NCT01336023|5889233|P3|Week 27 to 52|Withdrawal Criteria|16
1686424|NCT01336023|5889234|P2|Week 27 to 52|Withdrawal Criteria|19
1686425|NCT01336023|5889235|P1|Week 27 to 52|Withdrawal Criteria|14
1686426|NCT01336023|5889233|P3|Week 27 to 52|Protocol Violation|1
1686427|NCT01336023|5889234|P2|Week 27 to 52|Protocol Violation|2
1686428|NCT01336023|5889235|P1|Week 27 to 52|Protocol Violation|0
1686429|NCT01336023|5889233|P3|Week 27 to 52|Adverse Event|2
1686430|NCT01336023|5889234|P2|Week 27 to 52|Adverse Event|5
1686431|NCT01336023|5889235|P1|Week 27 to 52|Adverse Event|1
1686432|NCT01336023|5889233|P3|Week 0 to Week 26|Unclassified|9
1686433|NCT01336023|5889234|P2|Week 0 to Week 26|Unclassified|16
1686434|NCT01336023|5889235|P1|Week 0 to Week 26|Unclassified|5
1686435|NCT01336023|5889233|P3|Week 0 to Week 26|Withdrawal Criteria|40
1686436|NCT01336023|5889234|P2|Week 0 to Week 26|Withdrawal Criteria|69
1686437|NCT01336023|5889235|P1|Week 0 to Week 26|Withdrawal Criteria|34
1686438|NCT01336023|5889233|P3|Week 0 to Week 26|Protocol Violation|0
1686439|NCT01336023|5889234|P2|Week 0 to Week 26|Protocol Violation|2
1686440|NCT01336023|5889235|P1|Week 0 to Week 26|Protocol Violation|1
1686441|NCT01336023|5889233|P3|Week 0 to Week 26|Lack of Efficacy|0
1686442|NCT01336023|5889234|P2|Week 0 to Week 26|Lack of Efficacy|1
1686443|NCT01336023|5889235|P1|Week 0 to Week 26|Lack of Efficacy|0
1686444|NCT01336023|5889233|P3|Week 0 to Week 26|Adverse Event|24
1686445|NCT01336023|5889234|P2|Week 0 to Week 26|Adverse Event|10
1686446|NCT01336023|5889235|P1|Week 0 to Week 26|Adverse Event|8
1686447|NCT01335997|5889256|P2|Period III|Lost to Follow-up|0
1686448|NCT01335997|5889257|P1|Period III|Lost to Follow-up|1
1686449|NCT01335997|5889256|P2|Period III|Protocol Violation|1
1686450|NCT01335997|5889257|P1|Period III|Protocol Violation|0
1686451|NCT01335997|5889256|P2|Period III|Study Terminated by Sponsor|76
1686452|NCT01335997|5889257|P1|Period III|Study Terminated by Sponsor|77
1686453|NCT01335997|5889256|P2|Period III|Adverse Event|2
1686454|NCT01335997|5889257|P1|Period III|Adverse Event|0
1686455|NCT01335997|5889256|P2|Period I and II|Physician Decision|1
1686456|NCT01335997|5889257|P1|Period I and II|Physician Decision|2
1686457|NCT01335997|5889256|P2|Period I and II|Protocol Violation|10
1686458|NCT01335997|5889257|P1|Period I and II|Protocol Violation|9
1686459|NCT01335997|5889256|P2|Period I and II|Study Terminated by Sponsor|415
1686460|NCT01335997|5889257|P1|Period I and II|Study Terminated by Sponsor|406
1686461|NCT01335997|5889256|P2|Period I and II|Withdrawal by Subject|4
1686462|NCT01335997|5889257|P1|Period I and II|Withdrawal by Subject|9
1686463|NCT01335997|5889256|P2|Period I and II|Lost to Follow-up|5
1686464|NCT01335997|5889257|P1|Period I and II|Lost to Follow-up|3
1686465|NCT01335997|5889256|P2|Period I and II|Noncompliance with Study Drug|1
1686466|NCT01335997|5889257|P1|Period I and II|Noncompliance with Study Drug|1
1686467|NCT01335997|5889256|P2|Period I and II|Adverse Event|43
1686468|NCT01335997|5889257|P1|Period I and II|Adverse Event|63
1686469|NCT01335971|5889270|P3|Overall Study|Did not complete bronchoscopy|1
1686470|NCT01335971|5889271|P2|Overall Study|Did not complete bronchoscopy|1
1686471|NCT01335971|5889272|P1|Overall Study|Did not complete bronchoscopy|1
1686472|NCT01335971|5889270|P3|Overall Study|Withdrawal by Subject|0
1686473|NCT01335971|5889271|P2|Overall Study|Withdrawal by Subject|0
1686474|NCT01335971|5889272|P1|Overall Study|Withdrawal by Subject|1
1686475|NCT01335698|5889515|P5|Treatment Stage 2|Switched to another formulation|0
1686476|NCT01335698|5889516|P4|Treatment Stage 2|Switched to another formulation|0
1686477|NCT01335698|5889517|P3|Treatment Stage 2|Switched to another formulation|0
1686478|NCT01335698|5889518|P2|Treatment Stage 2|Switched to another formulation|1
1686479|NCT01335698|5889519|P1|Treatment Stage 2|Switched to another formulation|1
1686480|NCT01335698|5889515|P5|Treatment Stage 2|Subject no longer meets study criteria|0
1686481|NCT01335698|5889516|P4|Treatment Stage 2|Subject no longer meets study criteria|1
1686482|NCT01335698|5889517|P3|Treatment Stage 2|Subject no longer meets study criteria|0
1686483|NCT01335698|5889518|P2|Treatment Stage 2|Subject no longer meets study criteria|0
1686484|NCT01335698|5889519|P1|Treatment Stage 2|Subject no longer meets study criteria|0
1686485|NCT01335698|5889515|P5|Treatment Stage 2|Capsules received at state hospital|0
1686486|NCT01335698|5889516|P4|Treatment Stage 2|Capsules received at state hospital|0
1686487|NCT01335698|5889517|P3|Treatment Stage 2|Capsules received at state hospital|0
1686488|NCT01335698|5889518|P2|Treatment Stage 2|Capsules received at state hospital|0
1686489|NCT01335698|5889519|P1|Treatment Stage 2|Capsules received at state hospital|1
1686490|NCT01335698|5889515|P5|Treatment Stage 2|Lost to Follow-up|0
1686491|NCT01335698|5889516|P4|Treatment Stage 2|Lost to Follow-up|0
1686492|NCT01335698|5889517|P3|Treatment Stage 2|Lost to Follow-up|0
1686493|NCT01335698|5889518|P2|Treatment Stage 2|Lost to Follow-up|0
1686494|NCT01335698|5889519|P1|Treatment Stage 2|Lost to Follow-up|1
1686495|NCT01335698|5889515|P5|Treatment Stage 2|Poor compliance/noncompliance|1
1686496|NCT01335698|5889516|P4|Treatment Stage 2|Poor compliance/noncompliance|3
1686497|NCT01335698|5889517|P3|Treatment Stage 2|Poor compliance/noncompliance|1
1686498|NCT01335698|5889518|P2|Treatment Stage 2|Poor compliance/noncompliance|0
1686499|NCT01335698|5889519|P1|Treatment Stage 2|Poor compliance/noncompliance|1
1686500|NCT01335698|5889515|P5|Treatment Stage 2|Withdrawal by Subject|0
1686501|NCT01335698|5889516|P4|Treatment Stage 2|Withdrawal by Subject|0
1686502|NCT01335698|5889517|P3|Treatment Stage 2|Withdrawal by Subject|1
1686503|NCT01335698|5889518|P2|Treatment Stage 2|Withdrawal by Subject|1
1686504|NCT01335698|5889519|P1|Treatment Stage 2|Withdrawal by Subject|3
1686505|NCT01335698|5889515|P5|Treatment Stage 2|Adverse Event|0
1686506|NCT01335698|5889516|P4|Treatment Stage 2|Adverse Event|3
1686507|NCT01335698|5889517|P3|Treatment Stage 2|Adverse Event|0
1686508|NCT01335698|5889518|P2|Treatment Stage 2|Adverse Event|0
1686509|NCT01335698|5889519|P1|Treatment Stage 2|Adverse Event|2
1686510|NCT01335698|5889515|P5|Treatment Stage 2|Lack of Efficacy|0
1686511|NCT01335698|5889516|P4|Treatment Stage 2|Lack of Efficacy|1
1686512|NCT01335698|5889517|P3|Treatment Stage 2|Lack of Efficacy|3
1686513|NCT01335698|5889518|P2|Treatment Stage 2|Lack of Efficacy|1
1686514|NCT01335698|5889519|P1|Treatment Stage 2|Lack of Efficacy|2
1686515|NCT01335698|5889515|P5|Treatment Stage 1|Other|0
1686516|NCT01335698|5889516|P4|Treatment Stage 1|Other|1
1686517|NCT01335698|5889517|P3|Treatment Stage 1|Other|0
1686518|NCT01335698|5889518|P2|Treatment Stage 1|Other|0
1686519|NCT01335698|5889519|P1|Treatment Stage 1|Other|1
1686520|NCT01335698|5889515|P5|Treatment Stage 1|No longer meets study criteria|0
1686521|NCT01335698|5889516|P4|Treatment Stage 1|No longer meets study criteria|1
1686522|NCT01335698|5889517|P3|Treatment Stage 1|No longer meets study criteria|0
1686523|NCT01335698|5889518|P2|Treatment Stage 1|No longer meets study criteria|1
1686524|NCT01335698|5889519|P1|Treatment Stage 1|No longer meets study criteria|1
1686525|NCT01335698|5889515|P5|Treatment Stage 1|Poor compliance/noncompliance|0
1686526|NCT01335698|5889516|P4|Treatment Stage 1|Poor compliance/noncompliance|2
1686527|NCT01335698|5889517|P3|Treatment Stage 1|Poor compliance/noncompliance|0
1686528|NCT01335698|5889518|P2|Treatment Stage 1|Poor compliance/noncompliance|1
1686529|NCT01335698|5889519|P1|Treatment Stage 1|Poor compliance/noncompliance|0
1686530|NCT01335698|5889515|P5|Treatment Stage 1|Lost to Follow-up|0
1686531|NCT01335698|5889516|P4|Treatment Stage 1|Lost to Follow-up|0
1686532|NCT01335698|5889517|P3|Treatment Stage 1|Lost to Follow-up|0
1686533|NCT01335698|5889518|P2|Treatment Stage 1|Lost to Follow-up|1
1686534|NCT01335698|5889519|P1|Treatment Stage 1|Lost to Follow-up|1
1686535|NCT01335698|5889515|P5|Treatment Stage 1|Withdrawal by Subject|0
1686536|NCT01335698|5889516|P4|Treatment Stage 1|Withdrawal by Subject|1
1686537|NCT01335698|5889517|P3|Treatment Stage 1|Withdrawal by Subject|0
1686538|NCT01335698|5889518|P2|Treatment Stage 1|Withdrawal by Subject|2
1686539|NCT01335698|5889519|P1|Treatment Stage 1|Withdrawal by Subject|1
1686540|NCT01335698|5889515|P5|Treatment Stage 1|Adverse Event|1
1686541|NCT01335698|5889516|P4|Treatment Stage 1|Adverse Event|1
1686542|NCT01335698|5889517|P3|Treatment Stage 1|Adverse Event|2
1686543|NCT01335698|5889518|P2|Treatment Stage 1|Adverse Event|2
1686544|NCT01335698|5889519|P1|Treatment Stage 1|Adverse Event|1
1686545|NCT01335698|5889515|P5|Treatment Stage 1|Lack of Efficacy|1
1686546|NCT01335698|5889516|P4|Treatment Stage 1|Lack of Efficacy|3
1686547|NCT01335698|5889517|P3|Treatment Stage 1|Lack of Efficacy|3
1686548|NCT01335698|5889518|P2|Treatment Stage 1|Lack of Efficacy|1
1686549|NCT01335698|5889519|P1|Treatment Stage 1|Lack of Efficacy|3
1686550|NCT01335685|5889584|P8|Overall Study|Reason not Specified|0
1686551|NCT01335685|5889585|P7|Overall Study|Reason not Specified|0
1686552|NCT01335685|5889586|P6|Overall Study|Reason not Specified|1
1686553|NCT01335685|5889587|P5|Overall Study|Reason not Specified|0
1686554|NCT01335685|5889588|P4|Overall Study|Reason not Specified|0
1686555|NCT01335685|5889589|P3|Overall Study|Reason not Specified|1
1686556|NCT01335685|5889590|P2|Overall Study|Reason not Specified|0
1686557|NCT01335685|5889591|P1|Overall Study|Reason not Specified|0
1686558|NCT01335685|5889584|P8|Overall Study|Withdrawal by Subject|0
1686559|NCT01335685|5889585|P7|Overall Study|Withdrawal by Subject|0
1686560|NCT01335685|5889586|P6|Overall Study|Withdrawal by Subject|0
1686561|NCT01335685|5889587|P5|Overall Study|Withdrawal by Subject|0
1686562|NCT01335685|5889588|P4|Overall Study|Withdrawal by Subject|1
1686563|NCT01335685|5889589|P3|Overall Study|Withdrawal by Subject|0
1686564|NCT01335685|5889590|P2|Overall Study|Withdrawal by Subject|0
1686565|NCT01335685|5889591|P1|Overall Study|Withdrawal by Subject|1
1686566|NCT01335685|5889584|P8|Overall Study|Study Terminated by Sponsor|3
1686567|NCT01335685|5889585|P7|Overall Study|Study Terminated by Sponsor|2
1686568|NCT01335685|5889586|P6|Overall Study|Study Terminated by Sponsor|4
1686569|NCT01335685|5889587|P5|Overall Study|Study Terminated by Sponsor|0
1686570|NCT01335685|5889588|P4|Overall Study|Study Terminated by Sponsor|10
1686571|NCT01335685|5889589|P3|Overall Study|Study Terminated by Sponsor|1
1686572|NCT01335685|5889590|P2|Overall Study|Study Terminated by Sponsor|1
1686573|NCT01335685|5889591|P1|Overall Study|Study Terminated by Sponsor|2
1686574|NCT01335477|5889711|P2|Overall Study|Reason other than those stated above|2
1686575|NCT01335477|5889712|P1|Overall Study|Reason other than those stated above|2
1686576|NCT01335477|5889711|P2|Overall Study|Not treated|2
1686577|NCT01335477|5889712|P1|Overall Study|Not treated|1
1686578|NCT01335477|5889711|P2|Overall Study|Consent withdrawn, not due to AE|9
1686579|NCT01335477|5889712|P1|Overall Study|Consent withdrawn, not due to AE|7
1686580|NCT01335477|5889711|P2|Overall Study|Lost to Follow-up|2
1686581|NCT01335477|5889712|P1|Overall Study|Lost to Follow-up|1
1686582|NCT01335477|5889711|P2|Overall Study|Non compliant with protocol|2
1686583|NCT01335477|5889712|P1|Overall Study|Non compliant with protocol|0
1686584|NCT01335477|5889711|P2|Overall Study|Adverse Event|42
1686585|NCT01335477|5889712|P1|Overall Study|Adverse Event|30
1686586|NCT01335464|5889776|P2|Overall Study|Reason other than those stated above|1
1686587|NCT01335464|5889777|P1|Overall Study|Reason other than those stated above|1
1686588|NCT01335464|5889776|P2|Overall Study|Not treated|0
1686589|NCT01335464|5889777|P1|Overall Study|Not treated|2
1686590|NCT01335464|5889776|P2|Overall Study|Consent withdrawn, not due to AE|23
1686591|NCT01335464|5889777|P1|Overall Study|Consent withdrawn, not due to AE|12
1686592|NCT01335464|5889776|P2|Overall Study|Non compliant with protocol|0
1686593|NCT01335464|5889777|P1|Overall Study|Non compliant with protocol|2
1686594|NCT01335464|5889776|P2|Overall Study|Adverse Event|25
1686595|NCT01335464|5889777|P1|Overall Study|Adverse Event|15
1686596|NCT01334918|5889946|P2|Overall Study|Withdrawal by Subject|1
1686597|NCT01334918|5889947|P1|Overall Study|Withdrawal by Subject|0
1686598|NCT01334918|5889946|P2|Overall Study|Adverse Event|0
1686599|NCT01334918|5889947|P1|Overall Study|Adverse Event|2
1686600|NCT01334918|5889946|P2|Overall Study|Did not receive study drug|0
1686601|NCT01334918|5889947|P1|Overall Study|Did not receive study drug|6
1686602|NCT01334866|5889973|P1|Overall Study|medically necessary post-procedure|1
1686603|NCT01334866|5889973|P1|Overall Study|medically necessary prior to procedure|2
1686604|NCT01334866|5889973|P1|Overall Study|Physician Decision|3
1686605|NCT01334866|5889973|P1|Overall Study|Lost to Follow-up|3
1686606|NCT01334866|5889973|P1|Overall Study|Withdrawal by Subject|10
1686607|NCT01334710|5890010|P1|Overall Study|Trial was terminated|3
1686608|NCT01334606|5890015|P1|Overall Study|Study Terminated due to slow enrolment|18
1686609|NCT01334554|5890023|P2|Overall Study|Adverse Event|2
1686610|NCT01334554|5890024|P1|Overall Study|Adverse Event|4
1686611|NCT01334515|5890034|P2|Overall Study|Withdrawal by Subject|1
1686612|NCT01334515|5890035|P1|Overall Study|Withdrawal by Subject|1
1686613|NCT01334515|5890034|P2|Overall Study|Physician Decision|1
1686614|NCT01334515|5890035|P1|Overall Study|Physician Decision|1
1686615|NCT01334515|5890034|P2|Overall Study|Lack of Efficacy|21
1686616|NCT01334515|5890035|P1|Overall Study|Lack of Efficacy|8
1686617|NCT01334515|5890034|P2|Overall Study|Death|0
1686618|NCT01334515|5890035|P1|Overall Study|Death|1
1686619|NCT01334515|5890034|P2|Overall Study|Adverse Event|6
1686620|NCT01334515|5890035|P1|Overall Study|Adverse Event|1
1686621|NCT01334125|5890073|P2|Overall Study|Lost to Follow-up|3
1686622|NCT01334125|5890074|P1|Overall Study|Lost to Follow-up|3
1686623|NCT01333956|5890090|P4|Overall Study|Withdrawal by Subject|0
1686624|NCT01333956|5890091|P3|Overall Study|Withdrawal by Subject|1
1686625|NCT01333956|5890092|P2|Overall Study|Withdrawal by Subject|2
1686626|NCT01333956|5890093|P1|Overall Study|Withdrawal by Subject|0
1686627|NCT01333956|5890090|P4|Overall Study|Unable to complete study procedure|1
1686628|NCT01333956|5890091|P3|Overall Study|Unable to complete study procedure|0
1686629|NCT01333956|5890092|P2|Overall Study|Unable to complete study procedure|0
1686630|NCT01333956|5890093|P1|Overall Study|Unable to complete study procedure|1
1686631|NCT01333956|5890090|P4|Overall Study|Lost to Follow-up|1
1686632|NCT01333956|5890091|P3|Overall Study|Lost to Follow-up|0
1686633|NCT01333956|5890092|P2|Overall Study|Lost to Follow-up|2
1686634|NCT01333956|5890093|P1|Overall Study|Lost to Follow-up|1
1686635|NCT01333943|5890129|P2|Overall Study|Known neuropathy|0
1686636|NCT01333943|5890130|P1|Overall Study|Known neuropathy|1
1686637|NCT01333865|5890146|P1|Overall Study|Adverse Event|2
1686638|NCT01333722|5890166|P2|Overall Study|Withdrawal by Subject|1
1686639|NCT01333722|5890167|P1|Overall Study|Withdrawal by Subject|0
1686640|NCT01333722|5890166|P2|Overall Study|Lack of Efficacy|2
1686641|NCT01333722|5890167|P1|Overall Study|Lack of Efficacy|0
1686642|NCT01333501|5890192|P2|Overall Study|Withdrawn consent|12
1686643|NCT01333501|5890193|P1|Overall Study|Withdrawn consent|3
1686644|NCT01333501|5890192|P2|Overall Study|Unsatisfactory therapeutic effect|7
1686645|NCT01333501|5890193|P1|Overall Study|Unsatisfactory therapeutic effect|1
1686646|NCT01333501|5890192|P2|Overall Study|Abnormal laboratory value|1
1686647|NCT01333501|5890193|P1|Overall Study|Abnormal laboratory value|2
1686648|NCT01333501|5890192|P2|Overall Study|Adverse Event|1
1686649|NCT01333501|5890193|P1|Overall Study|Adverse Event|3
1686650|NCT01333475|5890260|P2|Overall Study|Toxicity|3
1686651|NCT01333475|5890261|P1|Overall Study|Toxicity|1
1686652|NCT01333475|5890260|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
1686653|NCT01333475|5890261|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
1686654|NCT01333397|5890287|P5|Overall Study|Lost to Follow-up|0
1686655|NCT01333397|5890288|P4|Overall Study|Lost to Follow-up|1
1686656|NCT01333397|5890289|P3|Overall Study|Lost to Follow-up|0
1686657|NCT01333397|5890290|P2|Overall Study|Lost to Follow-up|0
1686658|NCT01333397|5890291|P1|Overall Study|Lost to Follow-up|1
1686659|NCT01333189|5890365|P2|Overall Study|Moved from region|1
1686660|NCT01333189|5890366|P1|Overall Study|Moved from region|0
1686661|NCT01333189|5890365|P2|Overall Study|Transportation difficulties|1
1686662|NCT01333189|5890366|P1|Overall Study|Transportation difficulties|0
1686663|NCT01333189|5890365|P2|Overall Study|Adverse Event|0
1686664|NCT01333189|5890366|P1|Overall Study|Adverse Event|1
1686665|NCT01333189|5890365|P2|Overall Study|Time constraints|0
1686666|NCT01333189|5890366|P1|Overall Study|Time constraints|1
1686667|NCT01333111|5890397|P3|Overall Study|Ineffective therapy|1
1686668|NCT01333111|5890398|P2|Overall Study|Ineffective therapy|0
1686669|NCT01333111|5890399|P1|Overall Study|Ineffective therapy|0
1686670|NCT01333111|5890397|P3|Overall Study|Non-compliance|0
1686671|NCT01333111|5890398|P2|Overall Study|Non-compliance|0
1686672|NCT01333111|5890399|P1|Overall Study|Non-compliance|1
1686673|NCT01333111|5890397|P3|Overall Study|withdrawal criteria|0
1686674|NCT01333111|5890398|P2|Overall Study|withdrawal criteria|1
1686675|NCT01333111|5890399|P1|Overall Study|withdrawal criteria|0
1686676|NCT01333111|5890397|P3|Overall Study|unclassified|0
1686677|NCT01333111|5890398|P2|Overall Study|unclassified|0
1686678|NCT01333111|5890399|P1|Overall Study|unclassified|1
1686679|NCT01333111|5890397|P3|Overall Study|personal reasons|1
1686680|NCT01333111|5890398|P2|Overall Study|personal reasons|0
1686681|NCT01333111|5890399|P1|Overall Study|personal reasons|0
1686682|NCT01333111|5890397|P3|Overall Study|patient undergoing major surgery|0
1686683|NCT01333111|5890398|P2|Overall Study|patient undergoing major surgery|2
1686684|NCT01333111|5890399|P1|Overall Study|patient undergoing major surgery|0
1686685|NCT01333072|5890434|P2|Overall Study|Physician Decision|0
1686686|NCT01333072|5890435|P1|Overall Study|Physician Decision|1
1686687|NCT01333072|5890434|P2|Overall Study|Adverse Event|4
1686688|NCT01333072|5890435|P1|Overall Study|Adverse Event|2
1686689|NCT01333072|5890434|P2|Overall Study|Lost to Follow-up|0
1686690|NCT01333072|5890435|P1|Overall Study|Lost to Follow-up|3
1686691|NCT01333059|5890443|P2|Overall Study|Protocol Violation|0
1686692|NCT01333059|5890444|P1|Overall Study|Protocol Violation|3
1686693|NCT01333059|5890443|P2|Overall Study|Physician Decision|3
1686694|NCT01333059|5890444|P1|Overall Study|Physician Decision|3
1686695|NCT01332994|5890454|P1|Overall Study|Other|8
1686696|NCT01332994|5890454|P1|Overall Study|Administrative Problem|2
1686697|NCT01332994|5890454|P1|Overall Study|Withdrawal by Subject|15
1686698|NCT01332994|5890454|P1|Overall Study|Protocol Violation|6
1686699|NCT01332994|5890454|P1|Overall Study|Lost to Follow-up|4
1686700|NCT01332994|5890454|P1|Overall Study|Lack of Efficacy|1
1686701|NCT01332994|5890454|P1|Overall Study|Death|1
1686702|NCT01332994|5890454|P1|Overall Study|Adverse Event|34
1686703|NCT01332968|5890523|P8|Follow-Up Period|Lost to Follow-up|2
1686704|NCT01332968|5890524|P7|Follow-Up Period|Lost to Follow-up|1
1686705|NCT01332968|5890525|P6|Follow-Up Period|Lost to Follow-up|0
1686706|NCT01332968|5890526|P5|Follow-Up Period|Lost to Follow-up|0
1686707|NCT01332968|5890527|P4|Follow-Up Period|Lost to Follow-up|0
1686708|NCT01332968|5890528|P3|Follow-Up Period|Lost to Follow-up|0
1686709|NCT01332968|5890529|P2|Follow-Up Period|Lost to Follow-up|0
1686710|NCT01332968|5890530|P1|Follow-Up Period|Lost to Follow-up|0
1686711|NCT01332968|5890523|P8|Follow-Up Period|Withdrawal by Subject|2
1686712|NCT01332968|5890524|P7|Follow-Up Period|Withdrawal by Subject|1
1686713|NCT01332968|5890525|P6|Follow-Up Period|Withdrawal by Subject|0
1686714|NCT01332968|5890526|P5|Follow-Up Period|Withdrawal by Subject|0
1686715|NCT01332968|5890527|P4|Follow-Up Period|Withdrawal by Subject|0
1686716|NCT01332968|5890528|P3|Follow-Up Period|Withdrawal by Subject|0
1686717|NCT01332968|5890529|P2|Follow-Up Period|Withdrawal by Subject|0
1686718|NCT01332968|5890530|P1|Follow-Up Period|Withdrawal by Subject|0
1686719|NCT01332968|5890523|P8|Follow-Up Period|Follow-up ongoing|505
1686720|NCT01332968|5890524|P7|Follow-Up Period|Follow-up ongoing|502
1686721|NCT01332968|5890525|P6|Follow-Up Period|Follow-up ongoing|0
1686722|NCT01332968|5890526|P5|Follow-Up Period|Follow-up ongoing|0
1686723|NCT01332968|5890527|P4|Follow-Up Period|Follow-up ongoing|0
1686724|NCT01332968|5890528|P3|Follow-Up Period|Follow-up ongoing|0
1686725|NCT01332968|5890529|P2|Follow-Up Period|Follow-up ongoing|0
1686726|NCT01332968|5890530|P1|Follow-Up Period|Follow-up ongoing|0
1686727|NCT01332968|5890523|P8|Follow-Up Period|Death|22
1686728|NCT01332968|5890524|P7|Follow-Up Period|Death|38
1686729|NCT01332968|5890525|P6|Follow-Up Period|Death|0
1686730|NCT01332968|5890526|P5|Follow-Up Period|Death|0
1686731|NCT01332968|5890527|P4|Follow-Up Period|Death|0
1686732|NCT01332968|5890528|P3|Follow-Up Period|Death|0
1686733|NCT01332968|5890529|P2|Follow-Up Period|Death|0
1686734|NCT01332968|5890530|P1|Follow-Up Period|Death|0
1686735|NCT01332968|5890523|P8|Maintenance/Observation Period|Treatment ongoing|0
1686736|NCT01332968|5890524|P7|Maintenance/Observation Period|Treatment ongoing|0
1686737|NCT01332968|5890525|P6|Maintenance/Observation Period|Treatment ongoing|8
1686738|NCT01332968|5890526|P5|Maintenance/Observation Period|Treatment ongoing|10
1686739|NCT01332968|5890527|P4|Maintenance/Observation Period|Treatment ongoing|62
1686740|NCT01332968|5890528|P3|Maintenance/Observation Period|Treatment ongoing|54
1686741|NCT01332968|5890529|P2|Maintenance/Observation Period|Treatment ongoing|0
1686742|NCT01332968|5890530|P1|Maintenance/Observation Period|Treatment ongoing|0
1686743|NCT01332968|5890523|P8|Maintenance/Observation Period|Adverse Event|0
1686744|NCT01332968|5890524|P7|Maintenance/Observation Period|Adverse Event|0
1686745|NCT01332968|5890525|P6|Maintenance/Observation Period|Adverse Event|0
1686746|NCT01332968|5890526|P5|Maintenance/Observation Period|Adverse Event|0
1686747|NCT01332968|5890527|P4|Maintenance/Observation Period|Adverse Event|65
1686748|NCT01332968|5890528|P3|Maintenance/Observation Period|Adverse Event|50
1686749|NCT01332968|5890529|P2|Maintenance/Observation Period|Adverse Event|0
1686750|NCT01332968|5890530|P1|Maintenance/Observation Period|Adverse Event|0
1686751|NCT01332968|5890523|P8|Maintenance/Observation Period|Death|0
1686752|NCT01332968|5890524|P7|Maintenance/Observation Period|Death|0
1686753|NCT01332968|5890525|P6|Maintenance/Observation Period|Death|0
1686754|NCT01332968|5890526|P5|Maintenance/Observation Period|Death|0
1686755|NCT01332968|5890527|P4|Maintenance/Observation Period|Death|6
1686756|NCT01332968|5890528|P3|Maintenance/Observation Period|Death|5
1686757|NCT01332968|5890529|P2|Maintenance/Observation Period|Death|0
1686758|NCT01332968|5890530|P1|Maintenance/Observation Period|Death|0
1686759|NCT01332968|5890523|P8|Maintenance/Observation Period|Lost to Follow-up|0
1686760|NCT01332968|5890524|P7|Maintenance/Observation Period|Lost to Follow-up|0
1686761|NCT01332968|5890525|P6|Maintenance/Observation Period|Lost to Follow-up|0
1686762|NCT01332968|5890526|P5|Maintenance/Observation Period|Lost to Follow-up|0
1686763|NCT01332968|5890527|P4|Maintenance/Observation Period|Lost to Follow-up|2
1686764|NCT01332968|5890528|P3|Maintenance/Observation Period|Lost to Follow-up|1
1686765|NCT01332968|5890529|P2|Maintenance/Observation Period|Lost to Follow-up|0
1686766|NCT01332968|5890530|P1|Maintenance/Observation Period|Lost to Follow-up|0
1686767|NCT01332968|5890523|P8|Maintenance/Observation Period|Non-compliance|0
1686768|NCT01332968|5890524|P7|Maintenance/Observation Period|Non-compliance|0
1686769|NCT01332968|5890525|P6|Maintenance/Observation Period|Non-compliance|1
1686770|NCT01332968|5890526|P5|Maintenance/Observation Period|Non-compliance|0
1686771|NCT01332968|5890527|P4|Maintenance/Observation Period|Non-compliance|3
1686772|NCT01332968|5890528|P3|Maintenance/Observation Period|Non-compliance|2
1686773|NCT01332968|5890529|P2|Maintenance/Observation Period|Non-compliance|0
1686774|NCT01332968|5890530|P1|Maintenance/Observation Period|Non-compliance|0
1686775|NCT01332968|5890523|P8|Maintenance/Observation Period|Other|0
1686776|NCT01332968|5890524|P7|Maintenance/Observation Period|Other|0
1686777|NCT01332968|5890525|P6|Maintenance/Observation Period|Other|0
1686778|NCT01332968|5890526|P5|Maintenance/Observation Period|Other|0
1686779|NCT01332968|5890527|P4|Maintenance/Observation Period|Other|5
1686780|NCT01332968|5890528|P3|Maintenance/Observation Period|Other|4
1686781|NCT01332968|5890529|P2|Maintenance/Observation Period|Other|0
1686782|NCT01332968|5890530|P1|Maintenance/Observation Period|Other|0
1686783|NCT01332968|5890523|P8|Maintenance/Observation Period|Physician Decision|0
1686784|NCT01332968|5890524|P7|Maintenance/Observation Period|Physician Decision|0
1686785|NCT01332968|5890525|P6|Maintenance/Observation Period|Physician Decision|0
1686786|NCT01332968|5890526|P5|Maintenance/Observation Period|Physician Decision|0
1686787|NCT01332968|5890527|P4|Maintenance/Observation Period|Physician Decision|19
1686788|NCT01332968|5890528|P3|Maintenance/Observation Period|Physician Decision|14
1686789|NCT01332968|5890529|P2|Maintenance/Observation Period|Physician Decision|0
1686790|NCT01332968|5890530|P1|Maintenance/Observation Period|Physician Decision|0
1686791|NCT01332968|5890523|P8|Maintenance/Observation Period|Progressive disease|0
1686792|NCT01332968|5890524|P7|Maintenance/Observation Period|Progressive disease|0
1686793|NCT01332968|5890525|P6|Maintenance/Observation Period|Progressive disease|0
1686794|NCT01332968|5890526|P5|Maintenance/Observation Period|Progressive disease|0
1686795|NCT01332968|5890527|P4|Maintenance/Observation Period|Progressive disease|39
1686796|NCT01332968|5890528|P3|Maintenance/Observation Period|Progressive disease|72
1686797|NCT01332968|5890529|P2|Maintenance/Observation Period|Progressive disease|0
1686798|NCT01332968|5890530|P1|Maintenance/Observation Period|Progressive disease|0
1686799|NCT01332968|5890523|P8|Maintenance/Observation Period|Protocol Violation|0
1686800|NCT01332968|5890524|P7|Maintenance/Observation Period|Protocol Violation|0
1686801|NCT01332968|5890525|P6|Maintenance/Observation Period|Protocol Violation|0
1686802|NCT01332968|5890526|P5|Maintenance/Observation Period|Protocol Violation|0
1686803|NCT01332968|5890527|P4|Maintenance/Observation Period|Protocol Violation|1
1686804|NCT01332968|5890528|P3|Maintenance/Observation Period|Protocol Violation|1
1686805|NCT01332968|5890529|P2|Maintenance/Observation Period|Protocol Violation|0
1686806|NCT01332968|5890530|P1|Maintenance/Observation Period|Protocol Violation|0
1686807|NCT01332968|5890523|P8|Maintenance/Observation Period|Withdrawal by Subject|0
1686808|NCT01332968|5890524|P7|Maintenance/Observation Period|Withdrawal by Subject|0
1686809|NCT01332968|5890525|P6|Maintenance/Observation Period|Withdrawal by Subject|0
1686810|NCT01332968|5890526|P5|Maintenance/Observation Period|Withdrawal by Subject|0
1686811|NCT01332968|5890527|P4|Maintenance/Observation Period|Withdrawal by Subject|5
1686812|NCT01332968|5890528|P3|Maintenance/Observation Period|Withdrawal by Subject|10
1686813|NCT01332968|5890529|P2|Maintenance/Observation Period|Withdrawal by Subject|0
1686814|NCT01332968|5890530|P1|Maintenance/Observation Period|Withdrawal by Subject|0
1686815|NCT01332968|5890523|P8|Induction Period|Randomized, but not treated|0
1686816|NCT01332968|5890524|P7|Induction Period|Randomized, but not treated|0
1686817|NCT01332968|5890525|P6|Induction Period|Randomized, but not treated|0
1686818|NCT01332968|5890526|P5|Induction Period|Randomized, but not treated|0
1686819|NCT01332968|5890527|P4|Induction Period|Randomized, but not treated|0
1686820|NCT01332968|5890528|P3|Induction Period|Randomized, but not treated|0
1686821|NCT01332968|5890529|P2|Induction Period|Randomized, but not treated|7
1686822|NCT01332968|5890530|P1|Induction Period|Randomized, but not treated|4
1686823|NCT01332968|5890523|P8|Induction Period|Adverse Event|0
1686824|NCT01332968|5890524|P7|Induction Period|Adverse Event|0
1686825|NCT01332968|5890525|P6|Induction Period|Adverse Event|0
1686826|NCT01332968|5890526|P5|Induction Period|Adverse Event|0
1686827|NCT01332968|5890527|P4|Induction Period|Adverse Event|0
1686828|NCT01332968|5890528|P3|Induction Period|Adverse Event|0
1686829|NCT01332968|5890529|P2|Induction Period|Adverse Event|26
1686830|NCT01332968|5890530|P1|Induction Period|Adverse Event|23
1686831|NCT01332968|5890523|P8|Induction Period|Death|0
1686832|NCT01332968|5890524|P7|Induction Period|Death|0
1686833|NCT01332968|5890525|P6|Induction Period|Death|0
1686834|NCT01332968|5890526|P5|Induction Period|Death|0
1686835|NCT01332968|5890527|P4|Induction Period|Death|0
1686836|NCT01332968|5890528|P3|Induction Period|Death|0
1686837|NCT01332968|5890529|P2|Induction Period|Death|4
1686838|NCT01332968|5890530|P1|Induction Period|Death|1
1686839|NCT01332968|5890523|P8|Induction Period|Non-compliance|0
1686840|NCT01332968|5890524|P7|Induction Period|Non-compliance|0
1686841|NCT01332968|5890525|P6|Induction Period|Non-compliance|0
1686842|NCT01332968|5890526|P5|Induction Period|Non-compliance|0
1686843|NCT01332968|5890527|P4|Induction Period|Non-compliance|0
1686844|NCT01332968|5890528|P3|Induction Period|Non-compliance|0
1686845|NCT01332968|5890529|P2|Induction Period|Non-compliance|0
1686846|NCT01332968|5890530|P1|Induction Period|Non-compliance|1
1686847|NCT01332968|5890523|P8|Induction Period|Other|0
1686848|NCT01332968|5890524|P7|Induction Period|Other|0
1686849|NCT01332968|5890525|P6|Induction Period|Other|0
1686850|NCT01332968|5890526|P5|Induction Period|Other|0
1686851|NCT01332968|5890527|P4|Induction Period|Other|0
1686852|NCT01332968|5890528|P3|Induction Period|Other|0
1686853|NCT01332968|5890529|P2|Induction Period|Other|2
1686854|NCT01332968|5890530|P1|Induction Period|Other|2
1686855|NCT01332968|5890523|P8|Induction Period|Physician Decision|0
1686856|NCT01332968|5890524|P7|Induction Period|Physician Decision|0
1686857|NCT01332968|5890525|P6|Induction Period|Physician Decision|0
1686858|NCT01332968|5890526|P5|Induction Period|Physician Decision|0
1686859|NCT01332968|5890527|P4|Induction Period|Physician Decision|0
1686860|NCT01332968|5890528|P3|Induction Period|Physician Decision|0
1686861|NCT01332968|5890529|P2|Induction Period|Physician Decision|1
1686862|NCT01332968|5890530|P1|Induction Period|Physician Decision|6
1686863|NCT01332968|5890523|P8|Induction Period|Progressive disease|0
1686864|NCT01332968|5890524|P7|Induction Period|Progressive disease|0
1686865|NCT01332968|5890525|P6|Induction Period|Progressive disease|0
1686866|NCT01332968|5890526|P5|Induction Period|Progressive disease|0
1686867|NCT01332968|5890527|P4|Induction Period|Progressive disease|0
1686868|NCT01332968|5890528|P3|Induction Period|Progressive disease|0
1686869|NCT01332968|5890529|P2|Induction Period|Progressive disease|7
1686870|NCT01332968|5890530|P1|Induction Period|Progressive disease|15
1686871|NCT01332968|5890523|P8|Induction Period|Protocol Violation|0
1686872|NCT01332968|5890524|P7|Induction Period|Protocol Violation|0
1686873|NCT01332968|5890525|P6|Induction Period|Protocol Violation|0
1686874|NCT01332968|5890526|P5|Induction Period|Protocol Violation|0
1686875|NCT01332968|5890527|P4|Induction Period|Protocol Violation|0
1686876|NCT01332968|5890528|P3|Induction Period|Protocol Violation|0
1686877|NCT01332968|5890529|P2|Induction Period|Protocol Violation|4
1686878|NCT01332968|5890530|P1|Induction Period|Protocol Violation|3
1686879|NCT01332968|5890523|P8|Induction Period|Withdrawal by Subject|0
1686880|NCT01332968|5890524|P7|Induction Period|Withdrawal by Subject|0
1686881|NCT01332968|5890525|P6|Induction Period|Withdrawal by Subject|0
1686882|NCT01332968|5890526|P5|Induction Period|Withdrawal by Subject|0
1686883|NCT01332968|5890527|P4|Induction Period|Withdrawal by Subject|0
1686884|NCT01332968|5890528|P3|Induction Period|Withdrawal by Subject|0
1686885|NCT01332968|5890529|P2|Induction Period|Withdrawal by Subject|5
1686886|NCT01332968|5890530|P1|Induction Period|Withdrawal by Subject|3
1686887|NCT01332851|5890596|P2|Overall Study|Lost to Follow-up|11
1686888|NCT01332851|5890597|P1|Overall Study|Lost to Follow-up|7
1686889|NCT01332851|5890596|P2|Overall Study|Withdrawal by Subject|2
1686890|NCT01332851|5890597|P1|Overall Study|Withdrawal by Subject|4
1686891|NCT01332799|5890631|P2|Overall Study|Insufficient funding|10
1686892|NCT01332799|5890632|P1|Overall Study|Insufficient funding|10
1686893|NCT01332630|5890648|P1|Overall Study|Withdrawal by Subject|3
1686894|NCT01332331|5890764|P2|Overall Study|Physician Decision|0
1686895|NCT01332331|5890765|P1|Overall Study|Physician Decision|1
1686896|NCT01332331|5890764|P2|Overall Study|Adverse Event|1
1686897|NCT01332331|5890765|P1|Overall Study|Adverse Event|1
1686898|NCT01332331|5890764|P2|Overall Study|Lost to Follow-up|1
1686899|NCT01332331|5890765|P1|Overall Study|Lost to Follow-up|0
1686900|NCT01332318|5890817|P4|Overall Study|Protocol Violation|1
1686901|NCT01332318|5890818|P3|Overall Study|Protocol Violation|1
1686902|NCT01332318|5890819|P2|Overall Study|Protocol Violation|0
1686903|NCT01332318|5890820|P1|Overall Study|Protocol Violation|1
1686904|NCT01332318|5890817|P4|Overall Study|Withdrawal by Subject|1
1686905|NCT01332318|5890818|P3|Overall Study|Withdrawal by Subject|0
1686906|NCT01332318|5890819|P2|Overall Study|Withdrawal by Subject|1
1686907|NCT01332318|5890820|P1|Overall Study|Withdrawal by Subject|1
1686908|NCT01332318|5890817|P4|Overall Study|Adverse Event|0
1686909|NCT01332318|5890818|P3|Overall Study|Adverse Event|0
1686910|NCT01332318|5890819|P2|Overall Study|Adverse Event|3
1686911|NCT01332318|5890820|P1|Overall Study|Adverse Event|0
1686912|NCT01332305|5890931|P5|Overall Study|Physician Decision|0
1686913|NCT01332305|5890932|P4|Overall Study|Physician Decision|1
1686914|NCT01332305|5890933|P3|Overall Study|Physician Decision|0
1686915|NCT01332305|5890934|P2|Overall Study|Physician Decision|0
1686916|NCT01332305|5890935|P1|Overall Study|Physician Decision|0
1686917|NCT01332305|5890931|P5|Overall Study|Treatment Failure|0
1686918|NCT01332305|5890932|P4|Overall Study|Treatment Failure|0
1686919|NCT01332305|5890933|P3|Overall Study|Treatment Failure|0
1686920|NCT01332305|5890934|P2|Overall Study|Treatment Failure|1
1686921|NCT01332305|5890935|P1|Overall Study|Treatment Failure|1
1686922|NCT01332305|5890931|P5|Overall Study|Withdrawal by Sponsor|1
1686923|NCT01332305|5890932|P4|Overall Study|Withdrawal by Sponsor|1
1686924|NCT01332305|5890933|P3|Overall Study|Withdrawal by Sponsor|0
1686925|NCT01332305|5890934|P2|Overall Study|Withdrawal by Sponsor|0
1686926|NCT01332305|5890935|P1|Overall Study|Withdrawal by Sponsor|1
1686927|NCT01332305|5890931|P5|Overall Study|Protocol Violation|3
1686928|NCT01332305|5890932|P4|Overall Study|Protocol Violation|0
1686929|NCT01332305|5890933|P3|Overall Study|Protocol Violation|1
1686930|NCT01332305|5890934|P2|Overall Study|Protocol Violation|2
1686931|NCT01332305|5890935|P1|Overall Study|Protocol Violation|1
1686932|NCT01332305|5890931|P5|Overall Study|Lost to Follow-up|3
1686933|NCT01332305|5890932|P4|Overall Study|Lost to Follow-up|2
1686934|NCT01332305|5890933|P3|Overall Study|Lost to Follow-up|3
1686935|NCT01332305|5890934|P2|Overall Study|Lost to Follow-up|2
1686936|NCT01332305|5890935|P1|Overall Study|Lost to Follow-up|0
1686937|NCT01332305|5890931|P5|Overall Study|Withdrawal by Subject|0
1686938|NCT01332305|5890932|P4|Overall Study|Withdrawal by Subject|1
1686939|NCT01332305|5890933|P3|Overall Study|Withdrawal by Subject|4
1686940|NCT01332305|5890934|P2|Overall Study|Withdrawal by Subject|5
1686941|NCT01332305|5890935|P1|Overall Study|Withdrawal by Subject|6
1686942|NCT01332305|5890931|P5|Overall Study|Adverse Event|5
1686943|NCT01332305|5890932|P4|Overall Study|Adverse Event|3
1686944|NCT01332305|5890933|P3|Overall Study|Adverse Event|6
1686945|NCT01332305|5890934|P2|Overall Study|Adverse Event|4
1686946|NCT01332305|5890935|P1|Overall Study|Adverse Event|1
1686947|NCT01332292|5890957|P2|Treatment Period 2 (14 Days)|Physician Decision|1
1686948|NCT01332292|5890958|P1|Treatment Period 2 (14 Days)|Physician Decision|1
1686949|NCT01332292|5890957|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
1686950|NCT01332292|5890958|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
1686951|NCT01332292|5890957|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1686952|NCT01332292|5890958|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1686953|NCT01332227|5891049|P2|Overall Study|Patient began prohibited medication|1
1686954|NCT01332227|5891050|P1|Overall Study|Patient began prohibited medication|0
1686955|NCT01332227|5891049|P2|Overall Study|Patient moved from area|0
1686956|NCT01332227|5891050|P1|Overall Study|Patient moved from area|1
1686957|NCT01332227|5891049|P2|Overall Study|Poor compliance/noncompliance|1
1686958|NCT01332227|5891050|P1|Overall Study|Poor compliance/noncompliance|1
1686959|NCT01332227|5891049|P2|Overall Study|Lack of Efficacy|1
1686960|NCT01332227|5891050|P1|Overall Study|Lack of Efficacy|3
1686961|NCT01332227|5891049|P2|Overall Study|Lost to Follow-up|0
1686962|NCT01332227|5891050|P1|Overall Study|Lost to Follow-up|2
1686963|NCT01332227|5891049|P2|Overall Study|Withdrawal by Subject|1
1686964|NCT01332227|5891050|P1|Overall Study|Withdrawal by Subject|5
1686965|NCT01332227|5891049|P2|Overall Study|Adverse Event|1
1686966|NCT01332227|5891050|P1|Overall Study|Adverse Event|4
1686967|NCT01332149|5891231|P2|Overall Study|Randomized but not treated|2
1686968|NCT01332149|5891232|P1|Overall Study|Randomized but not treated|1
1686969|NCT01332149|5891231|P2|Overall Study|Did not meet entrance criteria|4
1686970|NCT01332149|5891232|P1|Overall Study|Did not meet entrance criteria|3
1686971|NCT01332149|5891231|P2|Overall Study|Insufficient clinical response|7
1686972|NCT01332149|5891232|P1|Overall Study|Insufficient clinical response|4
1686973|NCT01332149|5891231|P2|Overall Study|Lost to Follow-up|1
1686974|NCT01332149|5891232|P1|Overall Study|Lost to Follow-up|1
1686975|NCT01332149|5891231|P2|Overall Study|Withdrawal by Subject|5
1686976|NCT01332149|5891232|P1|Overall Study|Withdrawal by Subject|4
1686977|NCT01332149|5891231|P2|Overall Study|Protocol Violation|3
1686978|NCT01332149|5891232|P1|Overall Study|Protocol Violation|1
1686979|NCT01332149|5891231|P2|Overall Study|Other unspecified|7
1686980|NCT01332149|5891232|P1|Overall Study|Other unspecified|5
1686981|NCT01332149|5891231|P2|Overall Study|Adverse Event|9
1686982|NCT01332149|5891232|P1|Overall Study|Adverse Event|11
1686983|NCT01332019|5891310|P2|Overall Study|Adverse Event|22
1686984|NCT01332019|5891311|P1|Overall Study|Adverse Event|13
1686985|NCT01332019|5891310|P2|Overall Study|Lost to Follow-up|7
1686986|NCT01332019|5891311|P1|Overall Study|Lost to Follow-up|4
1686987|NCT01332019|5891310|P2|Overall Study|Withdrawal by Subject|71
1686988|NCT01332019|5891311|P1|Overall Study|Withdrawal by Subject|73
1686989|NCT01332019|5891310|P2|Overall Study|Physician Decision|3
1686990|NCT01332019|5891311|P1|Overall Study|Physician Decision|4
1686991|NCT01332019|5891310|P2|Overall Study|Death|1
1686992|NCT01332019|5891311|P1|Overall Study|Death|2
1686993|NCT01332019|5891310|P2|Overall Study|Other|18
1686994|NCT01332019|5891311|P1|Overall Study|Other|16
1686995|NCT01332019|5891310|P2|Overall Study|Was Not Dosed|0
1686996|NCT01332019|5891311|P1|Overall Study|Was Not Dosed|1
1686997|NCT01331837|5891395|P2|Overall Study|Withdrawal by Subject|16
1686998|NCT01331837|5891396|P1|Overall Study|Withdrawal by Subject|13
1686999|NCT01331837|5891395|P2|Overall Study|Info not recorded|16
1687000|NCT01331837|5891396|P1|Overall Study|Info not recorded|10
1687001|NCT01331837|5891395|P2|Overall Study|Lost to Follow-up|1
1687002|NCT01331837|5891396|P1|Overall Study|Lost to Follow-up|3
1687003|NCT01331837|5891395|P2|Overall Study|Death|34
1687004|NCT01331837|5891396|P1|Overall Study|Death|30
1687005|NCT01331824|5891436|P1|Overall Study|Withdrawal by Subject|1
1687006|NCT01331824|5891436|P1|Overall Study|Disease Progression|9
1687007|NCT01331824|5891436|P1|Overall Study|Death|1
1687008|NCT01331824|5891436|P1|Overall Study|Adverse Event|2
1687009|NCT01331681|5891471|P3|Overall Study|Not Received Study Treatment|2
1687010|NCT01331681|5891472|P2|Overall Study|Not Received Study Treatment|0
1687011|NCT01331681|5891473|P1|Overall Study|Not Received Study Treatment|0
1687012|NCT01331681|5891471|P3|Overall Study|Switching to other therapy|1
1687013|NCT01331681|5891472|P2|Overall Study|Switching to other therapy|0
1687014|NCT01331681|5891473|P1|Overall Study|Switching to other therapy|0
1687015|NCT01331681|5891471|P3|Overall Study|Sponsor decision|0
1687016|NCT01331681|5891472|P2|Overall Study|Sponsor decision|1
1687017|NCT01331681|5891473|P1|Overall Study|Sponsor decision|1
1687018|NCT01331681|5891471|P3|Overall Study|Therapeutic procedure required|0
1687019|NCT01331681|5891472|P2|Overall Study|Therapeutic procedure required|0
1687020|NCT01331681|5891473|P1|Overall Study|Therapeutic procedure required|1
1687021|NCT01331681|5891471|P3|Overall Study|Physician Decision|4
1687022|NCT01331681|5891472|P2|Overall Study|Physician Decision|0
1687023|NCT01331681|5891473|P1|Overall Study|Physician Decision|2
1687024|NCT01331681|5891471|P3|Overall Study|Lost to Follow-up|1
1687025|NCT01331681|5891472|P2|Overall Study|Lost to Follow-up|4
1687026|NCT01331681|5891473|P1|Overall Study|Lost to Follow-up|2
1687027|NCT01331681|5891471|P3|Overall Study|Protocol Violation|0
1687028|NCT01331681|5891472|P2|Overall Study|Protocol Violation|1
1687029|NCT01331681|5891473|P1|Overall Study|Protocol Violation|1
1687030|NCT01331681|5891471|P3|Overall Study|Withdrawal by Subject|15
1687031|NCT01331681|5891472|P2|Overall Study|Withdrawal by Subject|8
1687032|NCT01331681|5891473|P1|Overall Study|Withdrawal by Subject|12
1687033|NCT01331681|5891471|P3|Overall Study|Lack of Efficacy|0
1687034|NCT01331681|5891472|P2|Overall Study|Lack of Efficacy|1
1687035|NCT01331681|5891473|P1|Overall Study|Lack of Efficacy|0
1687036|NCT01331681|5891471|P3|Overall Study|Death|2
1687037|NCT01331681|5891472|P2|Overall Study|Death|6
1687038|NCT01331681|5891473|P1|Overall Study|Death|6
1687039|NCT01331681|5891471|P3|Overall Study|Adverse Event|10
1687040|NCT01331681|5891472|P2|Overall Study|Adverse Event|13
1687041|NCT01331681|5891473|P1|Overall Study|Adverse Event|10
1687042|NCT01331291|5891522|P2|Overall Study|Death|1
1687043|NCT01331291|5891523|P1|Overall Study|Death|0
1687044|NCT01331291|5891522|P2|Overall Study|Lack of Efficacy|8
1687045|NCT01331291|5891523|P1|Overall Study|Lack of Efficacy|2
1687046|NCT01331161|5891557|P2|Overall Study|Pregnancy|1
1687047|NCT01331161|5891558|P1|Overall Study|Pregnancy|0
1687048|NCT01331161|5891557|P2|Overall Study|Lost to Follow-up|1
1687049|NCT01331161|5891558|P1|Overall Study|Lost to Follow-up|0
1687050|NCT01331161|5891557|P2|Overall Study|Physician Decision|0
1687051|NCT01331161|5891558|P1|Overall Study|Physician Decision|1
1687052|NCT01331109|5891566|P1|Overall Study|Study Terminated by Sponsor|38
1687053|NCT01331109|5891566|P1|Overall Study|Lost to Follow-up|1
1687054|NCT01331109|5891566|P1|Overall Study|Withdrawal by Subject|7
1687055|NCT01331109|5891566|P1|Overall Study|Protocol Violation|3
1687056|NCT01331109|5891566|P1|Overall Study|Lack of Efficacy|2
1687057|NCT01331109|5891566|P1|Overall Study|Adverse Event|6
1687058|NCT01331005|5891578|P2|Overall Study|Withdrawal by Subject|3
1687059|NCT01331005|5891579|P1|Overall Study|Withdrawal by Subject|2
1687060|NCT01331005|5891578|P2|Overall Study|Lost to Follow-up|1
1687061|NCT01331005|5891579|P1|Overall Study|Lost to Follow-up|2
1687062|NCT01330914|5891650|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
1687063|NCT01330914|5891650|P1|Overall Study|Withdrawal by Subject|4
1687064|NCT01330628|5891658|P2|Overall Study|Didn't receive study treatment|0
1687065|NCT01330628|5891659|P1|Overall Study|Didn't receive study treatment|1
1687066|NCT01330628|5891658|P2|Overall Study|Withdrawn|6
1687067|NCT01330628|5891659|P1|Overall Study|Withdrawn|18
1687068|NCT01330628|5891658|P2|Overall Study|Adverse Event|25
1687069|NCT01330628|5891659|P1|Overall Study|Adverse Event|44
1687070|NCT01330628|5891658|P2|Overall Study|Lost to Follow-up|6
1687071|NCT01330628|5891659|P1|Overall Study|Lost to Follow-up|5
1687072|NCT01330628|5891658|P2|Overall Study|Death|3
1687073|NCT01330628|5891659|P1|Overall Study|Death|2
1687074|NCT01330459|5891669|P2|Overall Study|Physician Decision|2
1687075|NCT01330459|5891670|P1|Overall Study|Physician Decision|0
1687076|NCT01330433|5891686|P2|Overall Study|Lost to Follow-up|0
1687077|NCT01330433|5891687|P1|Overall Study|Lost to Follow-up|1
1687078|NCT01330433|5891686|P2|Overall Study|Death|3
1687079|NCT01330433|5891687|P1|Overall Study|Death|1
1687080|NCT01330381|5891726|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
1687081|NCT01330381|5891727|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
1687082|NCT01330381|5891728|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
1687083|NCT01330381|5891726|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
1687084|NCT01330381|5891727|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
1687085|NCT01330381|5891728|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
1687086|NCT01330381|5891726|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
1687087|NCT01330381|5891727|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
1687088|NCT01330381|5891728|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
1687089|NCT01330381|5891726|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
1687090|NCT01330381|5891727|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
1687091|NCT01330381|5891728|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
1687092|NCT01330381|5891726|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
1687093|NCT01330381|5891727|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
1687094|NCT01330381|5891728|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
1687095|NCT01330381|5891726|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
1687096|NCT01330381|5891727|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
1687097|NCT01330381|5891728|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
1687098|NCT01330381|5891726|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
1687099|NCT01330381|5891727|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
1687100|NCT01330381|5891728|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
1687101|NCT01330381|5891726|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
1687102|NCT01330381|5891727|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
1687103|NCT01330381|5891728|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
1687104|NCT01330381|5891726|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
1687105|NCT01330381|5891727|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
1687106|NCT01330381|5891728|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
1687107|NCT01330381|5891726|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
1687108|NCT01330381|5891727|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
1687109|NCT01330381|5891728|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
1687110|NCT01330316|5891789|P2|Overall Study|other than above|1
1687111|NCT01330316|5891790|P1|Overall Study|other than above|0
1687112|NCT01330316|5891789|P2|Overall Study|Withdrawal by Subject|1
1687113|NCT01330316|5891790|P1|Overall Study|Withdrawal by Subject|0
1687114|NCT01330316|5891789|P2|Overall Study|Lost to Follow-up|1
1687115|NCT01330316|5891790|P1|Overall Study|Lost to Follow-up|0
1687116|NCT01330316|5891789|P2|Overall Study|Lack of Efficacy|10
1687117|NCT01330316|5891790|P1|Overall Study|Lack of Efficacy|0
1687118|NCT01330316|5891789|P2|Overall Study|Adverse Event|2
1687119|NCT01330316|5891790|P1|Overall Study|Adverse Event|2
1687120|NCT01330303|5891826|P2|Period 1|Withdrawal by Subject|1
1687121|NCT01330303|5891827|P1|Period 1|Withdrawal by Subject|0
1687122|NCT01330303|5891826|P2|Period 1|Protocol Violation|1
1687123|NCT01330303|5891827|P1|Period 1|Protocol Violation|0
1687124|NCT01330303|5891826|P2|Period 1|Adverse Event|0
1687125|NCT01330303|5891827|P1|Period 1|Adverse Event|1
1687126|NCT01330108|5891874|P1|Overall Study|Withdrawal by Subject|4
1687127|NCT01330030|5891892|P2|Overall Study|Lost to Follow-up|17
1687128|NCT01330030|5891893|P1|Overall Study|Lost to Follow-up|16
1687129|NCT01330017|5891904|P5|Overall Study|Unknown Reason|2
1687130|NCT01330017|5891905|P4|Overall Study|Unknown Reason|7
1687131|NCT01330017|5891906|P3|Overall Study|Unknown Reason|5
1687132|NCT01330017|5891907|P2|Overall Study|Unknown Reason|3
1687133|NCT01330017|5891908|P1|Overall Study|Unknown Reason|5
1687134|NCT01330017|5891904|P5|Overall Study|Protocol Violation|0
1687135|NCT01330017|5891905|P4|Overall Study|Protocol Violation|1
1687136|NCT01330017|5891906|P3|Overall Study|Protocol Violation|0
1687137|NCT01330017|5891907|P2|Overall Study|Protocol Violation|0
1687138|NCT01330017|5891908|P1|Overall Study|Protocol Violation|0
1687139|NCT01330017|5891904|P5|Overall Study|Lost to Follow-up|0
1687140|NCT01330017|5891905|P4|Overall Study|Lost to Follow-up|0
1687141|NCT01330017|5891906|P3|Overall Study|Lost to Follow-up|1
1687142|NCT01330017|5891907|P2|Overall Study|Lost to Follow-up|0
1687143|NCT01330017|5891908|P1|Overall Study|Lost to Follow-up|0
1687144|NCT01330017|5891904|P5|Overall Study|Withdrawal by Subject|1
1687145|NCT01330017|5891905|P4|Overall Study|Withdrawal by Subject|0
1687146|NCT01330017|5891906|P3|Overall Study|Withdrawal by Subject|1
1687147|NCT01330017|5891907|P2|Overall Study|Withdrawal by Subject|0
1687148|NCT01330017|5891908|P1|Overall Study|Withdrawal by Subject|0
1687149|NCT01330017|5891904|P5|Overall Study|Adverse Event|0
1687150|NCT01330017|5891905|P4|Overall Study|Adverse Event|4
1687151|NCT01330017|5891906|P3|Overall Study|Adverse Event|1
1687152|NCT01330017|5891907|P2|Overall Study|Adverse Event|1
1687153|NCT01330017|5891908|P1|Overall Study|Adverse Event|0
1687154|NCT01329978|5891957|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
1687155|NCT01329978|5891958|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
1687156|NCT01329978|5891959|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
1687157|NCT01329978|5891960|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
1687158|NCT01329978|5891961|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
1687159|NCT01329978|5891957|P5|Rerandomization Treatment Period|Lost to Follow-up|3
1687160|NCT01329978|5891958|P4|Rerandomization Treatment Period|Lost to Follow-up|5
1687161|NCT01329978|5891959|P3|Rerandomization Treatment Period|Lost to Follow-up|0
1687162|NCT01329978|5891960|P2|Rerandomization Treatment Period|Lost to Follow-up|0
1687163|NCT01329978|5891961|P1|Rerandomization Treatment Period|Lost to Follow-up|0
1687164|NCT01329978|5891957|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1687165|NCT01329978|5891958|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1687166|NCT01329978|5891959|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1687167|NCT01329978|5891960|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
1687168|NCT01329978|5891961|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
1687169|NCT01329978|5891957|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1687170|NCT01329978|5891958|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1687171|NCT01329978|5891959|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1687172|NCT01329978|5891960|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
1687173|NCT01329978|5891961|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
1687174|NCT01329978|5891957|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
1687175|NCT01329978|5891958|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
1687176|NCT01329978|5891959|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
1687177|NCT01329978|5891960|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
1687178|NCT01329978|5891961|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
1687179|NCT01329978|5891957|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
1687180|NCT01329978|5891958|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
1687181|NCT01329978|5891959|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
1687182|NCT01329978|5891960|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
1687183|NCT01329978|5891961|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
1687184|NCT01329978|5891957|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1687185|NCT01329978|5891958|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1687186|NCT01329978|5891959|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
1687187|NCT01329978|5891960|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
1687188|NCT01329978|5891961|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
1687189|NCT01329939|5892035|P4|Overall Study|Adverse Event|3
1687190|NCT01329939|5892036|P3|Overall Study|Adverse Event|0
1687191|NCT01329939|5892037|P2|Overall Study|Adverse Event|0
1687192|NCT01329939|5892038|P1|Overall Study|Adverse Event|0
1687193|NCT01329939|5892035|P4|Overall Study|Withdrawal by Subject|0
1687194|NCT01329939|5892036|P3|Overall Study|Withdrawal by Subject|0
1687195|NCT01329939|5892037|P2|Overall Study|Withdrawal by Subject|1
1687196|NCT01329939|5892038|P1|Overall Study|Withdrawal by Subject|0
1687197|NCT01329939|5892035|P4|Overall Study|Lost to Follow-up|2
1687198|NCT01329939|5892036|P3|Overall Study|Lost to Follow-up|1
1687199|NCT01329939|5892037|P2|Overall Study|Lost to Follow-up|0
1687200|NCT01329939|5892038|P1|Overall Study|Lost to Follow-up|3
1687201|NCT01329562|5892102|P2|Overall Study|Physician Decision|1
1687202|NCT01329562|5892103|P1|Overall Study|Physician Decision|0
1687203|NCT01329562|5892102|P2|Overall Study|Subject withdrew due to personal issues.|2
1687204|NCT01329562|5892103|P1|Overall Study|Subject withdrew due to personal issues.|3
1687205|NCT01329562|5892102|P2|Overall Study|Lost to Follow-up|1
1687206|NCT01329562|5892103|P1|Overall Study|Lost to Follow-up|1
1687207|NCT01329562|5892102|P2|Overall Study|Protocol Violation|3
1687208|NCT01329562|5892103|P1|Overall Study|Protocol Violation|5
1687209|NCT01329549|5892152|P1|Overall Study|Adverse Event|1
1687210|NCT01329549|5892152|P1|Overall Study|Withdrawal by Subject|1
1687211|NCT01329419|5892163|P1|Overall Study|Protocol Violation|235
1687212|NCT01329263|5892181|P2|Overall Study|Withdrawal by Subject|2
1687213|NCT01329263|5892182|P1|Overall Study|Withdrawal by Subject|1
1687214|NCT01329263|5892181|P2|Overall Study|Lost to Follow-up|21
1687215|NCT01329263|5892182|P1|Overall Study|Lost to Follow-up|4
1687216|NCT01329029|5892219|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
1687217|NCT01329029|5892220|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
1687218|NCT01329029|5892219|P2|Overall Study|Lost to Follow-up|5
1687219|NCT01329029|5892220|P1|Overall Study|Lost to Follow-up|8
1687220|NCT01329029|5892219|P2|Overall Study|Physician Decision|13
1687221|NCT01329029|5892220|P1|Overall Study|Physician Decision|16
1687222|NCT01329029|5892219|P2|Overall Study|COPD Exacerbation|18
1687223|NCT01329029|5892220|P1|Overall Study|COPD Exacerbation|11
1687224|NCT01329029|5892219|P2|Overall Study|Other|20
1687225|NCT01329029|5892220|P1|Overall Study|Other|14
1687226|NCT01329029|5892219|P2|Overall Study|Death|19
1687227|NCT01329029|5892220|P1|Overall Study|Death|16
1687228|NCT01329029|5892219|P2|Overall Study|Adverse Event|29
1687229|NCT01329029|5892220|P1|Overall Study|Adverse Event|82
1687230|NCT01329029|5892219|P2|Overall Study|Withdrawal by Subject|87
1687231|NCT01329029|5892220|P1|Overall Study|Withdrawal by Subject|117
1687232|NCT01328951|5892310|P2|Overall Study|Other|6
1687233|NCT01328951|5892311|P1|Overall Study|Other|11
1687234|NCT01328951|5892310|P2|Overall Study|Study Closed by the Sponsor|31
1687235|NCT01328951|5892311|P1|Overall Study|Study Closed by the Sponsor|36
1687236|NCT01328951|5892310|P2|Overall Study|Withdrawal by Subject|6
1687237|NCT01328951|5892311|P1|Overall Study|Withdrawal by Subject|6
1687238|NCT01328951|5892310|P2|Overall Study|Lost to Follow-up|7
1687239|NCT01328951|5892311|P1|Overall Study|Lost to Follow-up|6
1687240|NCT01328951|5892310|P2|Overall Study|Death|258
1687241|NCT01328951|5892311|P1|Overall Study|Death|243
1687242|NCT01328951|5892310|P2|Overall Study|Adverse Event|0
1687243|NCT01328951|5892311|P1|Overall Study|Adverse Event|2
1687244|NCT01328951|5892310|P2|Overall Study|Disease Progression|14
1687245|NCT01328951|5892311|P1|Overall Study|Disease Progression|17
1687246|NCT01328756|5892380|P1|Overall Study|Other|29
1687247|NCT01328756|5892380|P1|Overall Study|Lost to Follow-up|5
1687248|NCT01328756|5892380|P1|Overall Study|Withdrawal by Subject|41
1687249|NCT01328756|5892380|P1|Overall Study|Lack of Efficacy|5
1687250|NCT01328756|5892380|P1|Overall Study|Adverse Event|39
1687251|NCT01328756|5892380|P1|Overall Study|Protocol Violation|4
1687252|NCT01328717|5892416|P1|Overall Study|Adverse Event|1
1687253|NCT01328574|5892425|P1|Overall Study|Refused further treatment|1
1687254|NCT01328548|5892439|P2|Overall Study|Protocol Violation|0
1687255|NCT01328548|5892440|P1|Overall Study|Protocol Violation|1
1687256|NCT01328548|5892439|P2|Overall Study|Death|0
1687257|NCT01328548|5892440|P1|Overall Study|Death|3
1687258|NCT01328535|5892458|P1|Overall Study|Ineligible|1
1687259|NCT01328496|5892469|P2|Overall Study|Significant Change in Health Status|0
1687260|NCT01328496|5892470|P1|Overall Study|Significant Change in Health Status|1
1687261|NCT01328444|5892488|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1687262|NCT01328444|5892489|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1687263|NCT01328444|5892490|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1687264|NCT01328444|5892491|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1687265|NCT01328444|5892492|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1687266|NCT01328444|5892493|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1687267|NCT01328444|5892488|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
1687268|NCT01328444|5892489|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1687269|NCT01328444|5892490|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1687270|NCT01328444|5892491|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1687271|NCT01328444|5892492|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1687272|NCT01328444|5892493|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1687273|NCT01328444|5892488|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1687274|NCT01328444|5892489|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
1687275|NCT01328444|5892490|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
1687276|NCT01328444|5892491|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1687277|NCT01328444|5892492|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1687278|NCT01328444|5892493|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
1687279|NCT01328444|5892488|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1687280|NCT01328444|5892489|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
1687281|NCT01328444|5892490|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1687282|NCT01328444|5892491|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1687283|NCT01328444|5892492|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
1687284|NCT01328444|5892493|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
1687285|NCT01328444|5892488|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
1687286|NCT01328444|5892489|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
1687287|NCT01328444|5892490|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1687288|NCT01328444|5892491|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1687289|NCT01328444|5892492|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1687290|NCT01328444|5892493|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
1687291|NCT01328444|5892488|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
1687292|NCT01328444|5892489|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
1687293|NCT01328444|5892490|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
1687294|NCT01328444|5892491|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
1687295|NCT01328444|5892492|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
1687296|NCT01328444|5892493|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
1687297|NCT01328444|5892488|P6|Washout Period (14 Days)|Withdrawal by Subject|1
1687298|NCT01328444|5892489|P5|Washout Period (14 Days)|Withdrawal by Subject|0
1687299|NCT01328444|5892490|P4|Washout Period (14 Days)|Withdrawal by Subject|0
1687300|NCT01328444|5892491|P3|Washout Period (14 Days)|Withdrawal by Subject|0
1687301|NCT01328444|5892492|P2|Washout Period (14 Days)|Withdrawal by Subject|0
1687302|NCT01328444|5892493|P1|Washout Period (14 Days)|Withdrawal by Subject|0
1687303|NCT01328444|5892488|P6|Washout Period (14 Days)|Lack of Efficacy|1
1687304|NCT01328444|5892489|P5|Washout Period (14 Days)|Lack of Efficacy|0
1687305|NCT01328444|5892490|P4|Washout Period (14 Days)|Lack of Efficacy|0
1687306|NCT01328444|5892491|P3|Washout Period (14 Days)|Lack of Efficacy|0
1687307|NCT01328444|5892492|P2|Washout Period (14 Days)|Lack of Efficacy|0
1687308|NCT01328444|5892493|P1|Washout Period (14 Days)|Lack of Efficacy|0
1687309|NCT01328444|5892488|P6|Washout Period (14 Days)|Adverse Event|2
1687310|NCT01328444|5892489|P5|Washout Period (14 Days)|Adverse Event|1
1687311|NCT01328444|5892490|P4|Washout Period (14 Days)|Adverse Event|1
1687312|NCT01328444|5892491|P3|Washout Period (14 Days)|Adverse Event|0
1687313|NCT01328444|5892492|P2|Washout Period (14 Days)|Adverse Event|1
1687314|NCT01328444|5892493|P1|Washout Period (14 Days)|Adverse Event|1
1687315|NCT01328444|5892488|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1687316|NCT01328444|5892489|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1687317|NCT01328444|5892490|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
1687318|NCT01328444|5892491|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1687319|NCT01328444|5892492|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
1687320|NCT01328444|5892493|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1687321|NCT01328444|5892488|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1687322|NCT01328444|5892489|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1687323|NCT01328444|5892490|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1687324|NCT01328444|5892491|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1687325|NCT01328444|5892492|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1687326|NCT01328444|5892493|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
1687327|NCT01328444|5892488|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1687328|NCT01328444|5892489|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
1687329|NCT01328444|5892490|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1687330|NCT01328444|5892491|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1687331|NCT01328444|5892492|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
1687332|NCT01328444|5892493|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
1687333|NCT01328444|5892488|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1687334|NCT01328444|5892489|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1687335|NCT01328444|5892490|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1687336|NCT01328444|5892491|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1687337|NCT01328444|5892492|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1687338|NCT01328444|5892493|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1687339|NCT01328444|5892488|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
1687340|NCT01328444|5892489|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1687341|NCT01328444|5892490|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1687342|NCT01328444|5892491|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1687343|NCT01328444|5892492|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1687344|NCT01328444|5892493|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1687345|NCT01328444|5892488|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
1687346|NCT01328444|5892489|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
1687347|NCT01328444|5892490|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
1687348|NCT01328444|5892491|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
1687349|NCT01328444|5892492|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
1687350|NCT01328444|5892493|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
1687351|NCT01328431|5892539|P2|12 Month (12M)|Lost to Follow-up|91
1687352|NCT01328431|5892540|P1|12 Month (12M)|Lost to Follow-up|82
1687353|NCT01328431|5892539|P2|12 Month (12M)|Death|6
1687354|NCT01328431|5892540|P1|12 Month (12M)|Death|2
1687355|NCT01328431|5892539|P2|3 Month (3M)|Lost to Follow-up|70
1687356|NCT01328431|5892540|P1|3 Month (3M)|Lost to Follow-up|75
1687357|NCT01328431|5892539|P2|3 Month (3M)|Death|2
1687358|NCT01328431|5892540|P1|3 Month (3M)|Death|2
1687359|NCT01328431|5892539|P2|1 Month (1M)|Lost to Follow-up|58
1687360|NCT01328431|5892540|P1|1 Month (1M)|Lost to Follow-up|55
1687361|NCT01328431|5892539|P2|Baseline|Protocol Violation|2
1687362|NCT01328431|5892540|P1|Baseline|Protocol Violation|0
1687363|NCT01328366|5892596|P1|Overall Study|Lost to Follow-up|7
1687364|NCT01328366|5892596|P1|Overall Study|Withdrawal by Subject|2
1687365|NCT01328366|5892596|P1|Overall Study|Death|1
1687366|NCT01328249|5892616|P2|Overall Study|Protocol Violation|1
1687367|NCT01328249|5892617|P1|Overall Study|Protocol Violation|0
1687368|NCT01328249|5892616|P2|Overall Study|Subject choice|1
1687369|NCT01328249|5892617|P1|Overall Study|Subject choice|1
1687370|NCT01328249|5892616|P2|Overall Study|Moved before end of treatment visit|0
1687371|NCT01328249|5892617|P1|Overall Study|Moved before end of treatment visit|1
1687372|NCT01328249|5892616|P2|Overall Study|Withdrawal by Subject|1
1687373|NCT01328249|5892617|P1|Overall Study|Withdrawal by Subject|1
1687374|NCT01328249|5892616|P2|Overall Study|Disease progression|0
1687375|NCT01328249|5892617|P1|Overall Study|Disease progression|1
1687376|NCT01328249|5892616|P2|Overall Study|Adverse Event|0
1687377|NCT01328249|5892617|P1|Overall Study|Adverse Event|3
1687378|NCT01328080|5892703|P1|Overall Study|Lost to Follow-up|5
1687379|NCT01328054|5892707|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
1687380|NCT01328054|5892708|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
1687381|NCT01328054|5892707|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
1687382|NCT01328054|5892708|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
1687383|NCT01328054|5892707|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
1687384|NCT01328054|5892708|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
1687385|NCT01328041|5892733|P1|Overall Study|Withdrawal by Subject|7
1687386|NCT01328041|5892733|P1|Overall Study|Physician Decision|2
1687387|NCT01328041|5892733|P1|Overall Study|Lost to Follow-up|7
1687388|NCT01328041|5892733|P1|Overall Study|Protocol Violation|7
1687389|NCT01328041|5892733|P1|Overall Study|Lack of Efficacy|27
1687390|NCT01328041|5892733|P1|Overall Study|Adverse Event|7
1687391|NCT01328002|5892755|P2|Double-Blind Period|Lack of Efficacy|0
1687392|NCT01328002|5892756|P1|Double-Blind Period|Lack of Efficacy|1
1687393|NCT01328002|5892755|P2|Double-Blind Period|Adverse Event|0
1687394|NCT01328002|5892756|P1|Double-Blind Period|Adverse Event|1
1687395|NCT01328002|5892755|P2|Open-Label Period|Other Reason|0
1687396|NCT01328002|5892756|P1|Open-Label Period|Other Reason|2
1687397|NCT01328002|5892755|P2|Open-Label Period|Lost to Follow-up|0
1687398|NCT01328002|5892756|P1|Open-Label Period|Lost to Follow-up|6
1687399|NCT01328002|5892755|P2|Open-Label Period|Withdrawal by Subject|0
1687400|NCT01328002|5892756|P1|Open-Label Period|Withdrawal by Subject|9
1687401|NCT01328002|5892755|P2|Open-Label Period|Protocol Violation|0
1687402|NCT01328002|5892756|P1|Open-Label Period|Protocol Violation|2
1687403|NCT01328002|5892755|P2|Open-Label Period|Lack of Efficacy|0
1687404|NCT01328002|5892756|P1|Open-Label Period|Lack of Efficacy|3
1687405|NCT01328002|5892755|P2|Open-Label Period|Adverse Event|0
1687406|NCT01328002|5892756|P1|Open-Label Period|Adverse Event|8
1687407|NCT01328002|5892755|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
1687408|NCT01328002|5892756|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
1687409|NCT01327885|5892792|P2|Overall Study|Ongoing|1
1687410|NCT01327885|5892793|P1|Overall Study|Ongoing|1
1687411|NCT01327885|5892792|P2|Overall Study|Not treated|1
1687412|NCT01327885|5892793|P1|Overall Study|Not treated|1
1687413|NCT01327885|5892792|P2|Overall Study|Withdrawal of consent from study|4
1687414|NCT01327885|5892793|P1|Overall Study|Withdrawal of consent from study|2
1687415|NCT01327885|5892792|P2|Overall Study|Other|6
1687416|NCT01327885|5892793|P1|Overall Study|Other|8
1687417|NCT01327885|5892792|P2|Overall Study|Subject choice|10
1687418|NCT01327885|5892793|P1|Overall Study|Subject choice|5
1687419|NCT01327885|5892792|P2|Overall Study|Adverse Event|10
1687420|NCT01327885|5892793|P1|Overall Study|Adverse Event|14
1687421|NCT01327885|5892792|P2|Overall Study|Clinical progression|27
1687422|NCT01327885|5892793|P1|Overall Study|Clinical progression|24
1687423|NCT01327885|5892792|P2|Overall Study|Disease progression-according to RECIST|165
1687424|NCT01327885|5892793|P1|Overall Study|Disease progression-according to RECIST|173
1687425|NCT01327846|5892809|P4|Extension Phase|Technical Problems|2
1687426|NCT01327846|5892810|P3|Extension Phase|Technical Problems|2
1687427|NCT01327846|5892811|P2|Extension Phase|Technical Problems|4
1687428|NCT01327846|5892812|P1|Extension Phase|Technical Problems|2
1687429|NCT01327846|5892809|P4|Extension Phase|Lost to Follow-up|7
1687430|NCT01327846|5892810|P3|Extension Phase|Lost to Follow-up|4
1687431|NCT01327846|5892811|P2|Extension Phase|Lost to Follow-up|3
1687432|NCT01327846|5892812|P1|Extension Phase|Lost to Follow-up|4
1687433|NCT01327846|5892809|P4|Extension Phase|Withdrawal by Subject|37
1687434|NCT01327846|5892810|P3|Extension Phase|Withdrawal by Subject|19
1687435|NCT01327846|5892811|P2|Extension Phase|Withdrawal by Subject|13
1687436|NCT01327846|5892812|P1|Extension Phase|Withdrawal by Subject|20
1687437|NCT01327846|5892809|P4|Extension Phase|Study terminated by sponsor|1660
1687438|NCT01327846|5892810|P3|Extension Phase|Study terminated by sponsor|1067
1687439|NCT01327846|5892811|P2|Extension Phase|Study terminated by sponsor|1124
1687440|NCT01327846|5892812|P1|Extension Phase|Study terminated by sponsor|1073
1687441|NCT01327846|5892809|P4|Core Phase|Lost to Follow-up|5
1687442|NCT01327846|5892810|P3|Core Phase|Lost to Follow-up|4
1687443|NCT01327846|5892811|P2|Core Phase|Lost to Follow-up|3
1687444|NCT01327846|5892812|P1|Core Phase|Lost to Follow-up|3
1687445|NCT01327846|5892809|P4|Core Phase|Subject decision (vital stat: alive)|20
1687446|NCT01327846|5892810|P3|Core Phase|Subject decision (vital stat: alive)|13
1687447|NCT01327846|5892811|P2|Core Phase|Subject decision (vital stat: alive)|24
1687448|NCT01327846|5892812|P1|Core Phase|Subject decision (vital stat: alive)|23
1687449|NCT01327846|5892809|P4|Core Phase|Subject decision (vital stat: dead)|4
1687450|NCT01327846|5892810|P3|Core Phase|Subject decision (vital stat: dead)|4
1687451|NCT01327846|5892811|P2|Core Phase|Subject decision (vital stat: dead)|3
1687452|NCT01327846|5892812|P1|Core Phase|Subject decision (vital stat: dead)|1
1687453|NCT01327846|5892809|P4|Core Phase|Subject decision (vital stat: unkn)|3
1687454|NCT01327846|5892810|P3|Core Phase|Subject decision (vital stat: unkn)|3
1687455|NCT01327846|5892811|P2|Core Phase|Subject decision (vital stat: unkn)|0
1687456|NCT01327846|5892812|P1|Core Phase|Subject decision (vital stat: unkn)|0
1687457|NCT01327846|5892809|P4|Core Phase|Subject decision (vital status: missing)|1
1687458|NCT01327846|5892810|P3|Core Phase|Subject decision (vital status: missing)|2
1687459|NCT01327846|5892811|P2|Core Phase|Subject decision (vital status: missing)|2
1687460|NCT01327846|5892812|P1|Core Phase|Subject decision (vital status: missing)|1
1687461|NCT01327703|5892887|P2|Second Treatment Period|Protocol Violation|1
1687462|NCT01327703|5892888|P1|Second Treatment Period|Protocol Violation|0
1687463|NCT01327703|5892887|P2|Second Treatment Period|Adverse Event|1
1687464|NCT01327703|5892888|P1|Second Treatment Period|Adverse Event|1
1687465|NCT01327651|5892944|P9|Post Study Follow-up|Lost to Follow-up|2
1687466|NCT01327651|5892945|P8|Post Study Follow-up|Lost to Follow-up|1
1687467|NCT01327651|5892946|P7|Post Study Follow-up|Lost to Follow-up|4
1687468|NCT01327651|5892947|P6|Post Study Follow-up|Lost to Follow-up|0
1687469|NCT01327651|5892948|P5|Post Study Follow-up|Lost to Follow-up|0
1687470|NCT01327651|5892949|P4|Post Study Follow-up|Lost to Follow-up|0
1687471|NCT01327651|5892950|P3|Post Study Follow-up|Lost to Follow-up|1
1687472|NCT01327651|5892951|P2|Post Study Follow-up|Lost to Follow-up|1
1687473|NCT01327651|5892952|P1|Post Study Follow-up|Lost to Follow-up|0
1687474|NCT01327651|5892944|P9|Self-administered Dosing Period|Withdrawal by Subject|1
1687475|NCT01327651|5892945|P8|Self-administered Dosing Period|Withdrawal by Subject|1
1687476|NCT01327651|5892946|P7|Self-administered Dosing Period|Withdrawal by Subject|2
1687477|NCT01327651|5892947|P6|Self-administered Dosing Period|Withdrawal by Subject|0
1687478|NCT01327651|5892948|P5|Self-administered Dosing Period|Withdrawal by Subject|0
1687479|NCT01327651|5892949|P4|Self-administered Dosing Period|Withdrawal by Subject|1
1687480|NCT01327651|5892950|P3|Self-administered Dosing Period|Withdrawal by Subject|0
1687481|NCT01327651|5892951|P2|Self-administered Dosing Period|Withdrawal by Subject|1
1687482|NCT01327651|5892952|P1|Self-administered Dosing Period|Withdrawal by Subject|0
1687483|NCT01327651|5892944|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687484|NCT01327651|5892945|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687485|NCT01327651|5892946|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687486|NCT01327651|5892947|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687487|NCT01327651|5892948|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687488|NCT01327651|5892949|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687489|NCT01327651|5892950|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687490|NCT01327651|5892951|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
1687491|NCT01327651|5892952|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
1687492|NCT01327651|5892944|P9|Self-administered Dosing Period|Lost to Follow-up|10
1687493|NCT01327651|5892945|P8|Self-administered Dosing Period|Lost to Follow-up|9
1687494|NCT01327651|5892946|P7|Self-administered Dosing Period|Lost to Follow-up|8
1687495|NCT01327651|5892947|P6|Self-administered Dosing Period|Lost to Follow-up|0
1687496|NCT01327651|5892948|P5|Self-administered Dosing Period|Lost to Follow-up|3
1687497|NCT01327651|5892949|P4|Self-administered Dosing Period|Lost to Follow-up|2
1687498|NCT01327651|5892950|P3|Self-administered Dosing Period|Lost to Follow-up|4
1687499|NCT01327651|5892951|P2|Self-administered Dosing Period|Lost to Follow-up|2
1687500|NCT01327651|5892952|P1|Self-administered Dosing Period|Lost to Follow-up|3
1687501|NCT01327599|5893071|P1|Overall Study|Withdrawal of Consent|1
1687502|NCT01327599|5893071|P1|Overall Study|Could Not Attend Visit|1
1687503|NCT01327599|5893071|P1|Overall Study|Adverse Event|1
1687504|NCT01327573|5893081|P2|Overall Study|Physician Decision|1
1687505|NCT01327573|5893082|P1|Overall Study|Physician Decision|3
1687506|NCT01327547|5893093|P2|Overall Study|By investigator in subject’s interest|1
1687507|NCT01327547|5893094|P1|Overall Study|By investigator in subject’s interest|0
1687508|NCT01327547|5893093|P2|Overall Study|Non-compliance with study procedures|0
1687509|NCT01327547|5893094|P1|Overall Study|Non-compliance with study procedures|1
1687510|NCT01327547|5893093|P2|Overall Study|Required prohibited medication|0
1687511|NCT01327547|5893094|P1|Overall Study|Required prohibited medication|2
1687512|NCT01327547|5893093|P2|Overall Study|Non-compliance due to alcohol intake|1
1687513|NCT01327547|5893094|P1|Overall Study|Non-compliance due to alcohol intake|0
1687514|NCT01327547|5893093|P2|Overall Study|Protocol Violation|0
1687515|NCT01327547|5893094|P1|Overall Study|Protocol Violation|1
1687516|NCT01327547|5893093|P2|Overall Study|Does Not Meet Entrance Criteria|2
1687517|NCT01327547|5893094|P1|Overall Study|Does Not Meet Entrance Criteria|2
1687518|NCT01327547|5893093|P2|Overall Study|Withdrawal by Subject|7
1687519|NCT01327547|5893094|P1|Overall Study|Withdrawal by Subject|3
1687520|NCT01327547|5893093|P2|Overall Study|Non-Compliance With Study Treatment|2
1687521|NCT01327547|5893094|P1|Overall Study|Non-Compliance With Study Treatment|0
1687522|NCT01327547|5893093|P2|Overall Study|Lost to Follow-up|6
1687523|NCT01327547|5893094|P1|Overall Study|Lost to Follow-up|6
1687524|NCT01327547|5893093|P2|Overall Study|Death|2
1687525|NCT01327547|5893094|P1|Overall Study|Death|1
1687526|NCT01327547|5893093|P2|Overall Study|Adverse Event|1
1687527|NCT01327547|5893094|P1|Overall Study|Adverse Event|4
1687528|NCT01327495|5893162|P6|Overall Study|Physician Decision|0
1687529|NCT01327495|5893163|P5|Overall Study|Physician Decision|2
1687530|NCT01327495|5893164|P4|Overall Study|Physician Decision|0
1687531|NCT01327495|5893165|P3|Overall Study|Physician Decision|0
1687532|NCT01327495|5893166|P2|Overall Study|Physician Decision|0
1687533|NCT01327495|5893167|P1|Overall Study|Physician Decision|0
1687534|NCT01327495|5893162|P6|Overall Study|Withdrawal by Subject|0
1687535|NCT01327495|5893163|P5|Overall Study|Withdrawal by Subject|1
1687536|NCT01327495|5893164|P4|Overall Study|Withdrawal by Subject|0
1687537|NCT01327495|5893165|P3|Overall Study|Withdrawal by Subject|1
1687538|NCT01327495|5893166|P2|Overall Study|Withdrawal by Subject|1
1687539|NCT01327495|5893167|P1|Overall Study|Withdrawal by Subject|0
1687540|NCT01327495|5893162|P6|Overall Study|Adverse Event|2
1687541|NCT01327495|5893163|P5|Overall Study|Adverse Event|0
1687542|NCT01327495|5893164|P4|Overall Study|Adverse Event|0
1687543|NCT01327495|5893165|P3|Overall Study|Adverse Event|1
1687544|NCT01327495|5893166|P2|Overall Study|Adverse Event|1
1687545|NCT01327495|5893167|P1|Overall Study|Adverse Event|2
1687546|NCT01327482|5893259|P1|Overall Study|Adverse Event|1
1687547|NCT01327339|5893264|P1|Overall Study|Protocol Violation|8
1687548|NCT01327300|5893399|P2|Washout (3 Weeks)|Withdrawal by Subject|0
1687549|NCT01327300|5893400|P1|Washout (3 Weeks)|Withdrawal by Subject|1
1687550|NCT01327053|5893440|P2|Overall Study|Untreated|1
1687551|NCT01327053|5893441|P1|Overall Study|Untreated|0
1687552|NCT01327053|5893440|P2|Overall Study|Protocol Violation|1
1687553|NCT01327053|5893441|P1|Overall Study|Protocol Violation|0
1687554|NCT01327053|5893440|P2|Overall Study|Progressive disease|26
1687555|NCT01327053|5893441|P1|Overall Study|Progressive disease|31
1687556|NCT01327053|5893440|P2|Overall Study|Study terminated by Sponsor|3
1687557|NCT01327053|5893441|P1|Overall Study|Study terminated by Sponsor|1
1687558|NCT01327053|5893440|P2|Overall Study|Non-compliance with study treatment|5
1687559|NCT01327053|5893441|P1|Overall Study|Non-compliance with study treatment|0
1687560|NCT01327053|5893440|P2|Overall Study|Lost to Follow-up|4
1687561|NCT01327053|5893441|P1|Overall Study|Lost to Follow-up|2
1687562|NCT01327053|5893440|P2|Overall Study|Death|5
1687563|NCT01327053|5893441|P1|Overall Study|Death|1
1687564|NCT01327053|5893440|P2|Overall Study|Physician Decision|14
1687565|NCT01327053|5893441|P1|Overall Study|Physician Decision|10
1687566|NCT01327053|5893440|P2|Overall Study|Patient/guardian decision|35
1687567|NCT01327053|5893441|P1|Overall Study|Patient/guardian decision|11
1687568|NCT01327053|5893440|P2|Overall Study|Adverse Event|57
1687569|NCT01327053|5893441|P1|Overall Study|Adverse Event|23
1687570|NCT01326962|5893515|P1|Overall Study|Other|2
1687571|NCT01326962|5893515|P1|Overall Study|Lost to Follow-up|3
1687572|NCT01326962|5893515|P1|Overall Study|Withdrawal by Subject|1
1687573|NCT01326962|5893515|P1|Overall Study|Adverse Event|1
1687574|NCT01326910|5893533|P2|Overall Study|Protocol Violation|1
1687575|NCT01326910|5893534|P1|Overall Study|Protocol Violation|1
1687576|NCT01326910|5893533|P2|Overall Study|Withdrawal by Subject|2
1687577|NCT01326910|5893534|P1|Overall Study|Withdrawal by Subject|3
1687578|NCT01326845|5893548|P2|Overall Study|Misisng|3
1687579|NCT01326845|5893549|P1|Overall Study|Misisng|1
1687580|NCT01326845|5893548|P2|Overall Study|Adverse Event|0
1687581|NCT01326845|5893549|P1|Overall Study|Adverse Event|1
1687582|NCT01326845|5893548|P2|Overall Study|Administrative Problems|2
1687583|NCT01326845|5893549|P1|Overall Study|Administrative Problems|5
1687584|NCT01326728|5893610|P2|Overall Study|Early closure of study|9
1687585|NCT01326728|5893611|P1|Overall Study|Early closure of study|34
1687586|NCT01326728|5893610|P2|Overall Study|Death|0
1687587|NCT01326728|5893611|P1|Overall Study|Death|13
1687588|NCT01326702|5893635|P7|Overall Study|Not Treated|0
1687589|NCT01326702|5893636|P6|Overall Study|Not Treated|1
1687590|NCT01326702|5893637|P5|Overall Study|Not Treated|0
1687591|NCT01326702|5893638|P4|Overall Study|Not Treated|1
1687592|NCT01326702|5893639|P3|Overall Study|Not Treated|0
1687593|NCT01326702|5893640|P2|Overall Study|Not Treated|0
1687594|NCT01326702|5893641|P1|Overall Study|Not Treated|0
1687595|NCT01326702|5893635|P7|Overall Study|Withdrawal by Subject|3
1687596|NCT01326702|5893636|P6|Overall Study|Withdrawal by Subject|1
1687597|NCT01326702|5893637|P5|Overall Study|Withdrawal by Subject|1
1687598|NCT01326702|5893638|P4|Overall Study|Withdrawal by Subject|0
1687599|NCT01326702|5893639|P3|Overall Study|Withdrawal by Subject|1
1687600|NCT01326702|5893640|P2|Overall Study|Withdrawal by Subject|0
1687601|NCT01326702|5893641|P1|Overall Study|Withdrawal by Subject|0
1687602|NCT01326702|5893635|P7|Overall Study|Adverse Event|1
1687603|NCT01326702|5893636|P6|Overall Study|Adverse Event|3
1687604|NCT01326702|5893637|P5|Overall Study|Adverse Event|0
1687605|NCT01326702|5893638|P4|Overall Study|Adverse Event|1
1687606|NCT01326702|5893639|P3|Overall Study|Adverse Event|1
1687607|NCT01326702|5893640|P2|Overall Study|Adverse Event|0
1687608|NCT01326702|5893641|P1|Overall Study|Adverse Event|0
1687609|NCT01326702|5893635|P7|Overall Study|Death|0
1687610|NCT01326702|5893636|P6|Overall Study|Death|0
1687611|NCT01326702|5893637|P5|Overall Study|Death|0
1687612|NCT01326702|5893638|P4|Overall Study|Death|0
1687613|NCT01326702|5893639|P3|Overall Study|Death|0
1687614|NCT01326702|5893640|P2|Overall Study|Death|1
1687615|NCT01326702|5893641|P1|Overall Study|Death|0
1687616|NCT01326702|5893635|P7|Overall Study|progressive disease|3
1687617|NCT01326702|5893636|P6|Overall Study|progressive disease|2
1687618|NCT01326702|5893637|P5|Overall Study|progressive disease|3
1687619|NCT01326702|5893638|P4|Overall Study|progressive disease|1
1687620|NCT01326702|5893639|P3|Overall Study|progressive disease|3
1687621|NCT01326702|5893640|P2|Overall Study|progressive disease|1
1687622|NCT01326702|5893641|P1|Overall Study|progressive disease|1
1687623|NCT01326702|5893635|P7|Overall Study|Other|0
1687624|NCT01326702|5893636|P6|Overall Study|Other|1
1687625|NCT01326702|5893637|P5|Overall Study|Other|0
1687626|NCT01326702|5893638|P4|Overall Study|Other|0
1687627|NCT01326702|5893639|P3|Overall Study|Other|0
1687628|NCT01326702|5893640|P2|Overall Study|Other|0
1687629|NCT01326702|5893641|P1|Overall Study|Other|1
1687630|NCT01326546|5893697|P2|Overall Study|Withdrawal by Subject|1
1687631|NCT01326546|5893698|P1|Overall Study|Withdrawal by Subject|5
1687632|NCT01326546|5893697|P2|Overall Study|Adverse Event|0
1687633|NCT01326546|5893698|P1|Overall Study|Adverse Event|1
1687634|NCT01326546|5893697|P2|Overall Study|Pregnancy|1
1687635|NCT01326546|5893698|P1|Overall Study|Pregnancy|0
1687636|NCT01326546|5893697|P2|Overall Study|Protocol Violation|4
1687637|NCT01326546|5893698|P1|Overall Study|Protocol Violation|3
1687638|NCT01326546|5893697|P2|Overall Study|Lost to Follow-up|7
1687639|NCT01326546|5893698|P1|Overall Study|Lost to Follow-up|8
1687640|NCT01326533|5893706|P2|Overall Study|Adverse Event|0
1687641|NCT01326533|5893707|P1|Overall Study|Adverse Event|1
1687642|NCT01326533|5893706|P2|Overall Study|Withdrawal by Subject|0
1687643|NCT01326533|5893707|P1|Overall Study|Withdrawal by Subject|1
1687644|NCT01326533|5893706|P2|Overall Study|Lost to Follow-up|0
1687645|NCT01326533|5893707|P1|Overall Study|Lost to Follow-up|2
1687646|NCT01326481|5893715|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
1687647|NCT01326026|5893724|P2|Overall Study|Other|3
1687648|NCT01326026|5893725|P1|Overall Study|Other|3
1687649|NCT01326026|5893724|P2|Overall Study|Withdrawal Criteria|7
1687650|NCT01326026|5893725|P1|Overall Study|Withdrawal Criteria|5
1687651|NCT01326026|5893724|P2|Overall Study|Adverse Event|3
1687652|NCT01326026|5893725|P1|Overall Study|Adverse Event|4
1687653|NCT01325701|5893790|P2|Overall Study|Rollerover Extension Study|0
1687654|NCT01325701|5893791|P1|Overall Study|Rollerover Extension Study|4
1687655|NCT01325701|5893790|P2|Overall Study|Withdrawal by Subject|1
1687656|NCT01325701|5893791|P1|Overall Study|Withdrawal by Subject|2
1687657|NCT01325701|5893790|P2|Overall Study|Physician Decision|2
1687658|NCT01325701|5893791|P1|Overall Study|Physician Decision|2
1687659|NCT01325701|5893790|P2|Overall Study|Protocol Violation|0
1687660|NCT01325701|5893791|P1|Overall Study|Protocol Violation|1
1687661|NCT01325701|5893790|P2|Overall Study|Adverse Event|0
1687662|NCT01325701|5893791|P1|Overall Study|Adverse Event|12
1687663|NCT01325623|5893801|P1|Overall Study|Withdrawal by Subject|3
1687664|NCT01325584|5893843|P1|Overall Study|Death|1
1687665|NCT01325532|5893853|P2|Overall Study|Withdrawal by Subject|0
1687666|NCT01325532|5893854|P1|Overall Study|Withdrawal by Subject|2
1687667|NCT01325493|5893866|P2|Overall Study|Allergy|0
1687668|NCT01325493|5893867|P1|Overall Study|Allergy|1
1687669|NCT01325493|5893866|P2|Overall Study|loss of neuromonitoring signals|2
1687670|NCT01325493|5893867|P1|Overall Study|loss of neuromonitoring signals|0
1687671|NCT01325493|5893866|P2|Overall Study|Protocol Violation|1
1687672|NCT01325493|5893867|P1|Overall Study|Protocol Violation|0
1687673|NCT01325428|5893879|P1|Part B|Other reason not defined above|1
1687674|NCT01325428|5893879|P1|Part B|Refused continue taking trial medication|2
1687675|NCT01325428|5893879|P1|Part A|Other reason not defined above|2
1687676|NCT01325428|5893879|P1|Part A|Refused continue taking trial medication|2
1687677|NCT01325428|5893879|P1|Part A|Other adverse event|1
1687678|NCT01325428|5893879|P1|Part A|Clinical signs, symptoms of progression|2
1687679|NCT01325428|5893879|P1|Part A|Progressive disease according to RECIST|9
1687680|NCT01325350|5893899|P5|Overall Study|Did Not Receive Treatment|1
1687681|NCT01325350|5893900|P4|Overall Study|Did Not Receive Treatment|0
1687682|NCT01325350|5893901|P3|Overall Study|Did Not Receive Treatment|1
1687683|NCT01325350|5893902|P2|Overall Study|Did Not Receive Treatment|1
1687684|NCT01325350|5893903|P1|Overall Study|Did Not Receive Treatment|0
1687685|NCT01325350|5893899|P5|Overall Study|Withdrawal by Subject|0
1687686|NCT01325350|5893900|P4|Overall Study|Withdrawal by Subject|1
1687687|NCT01325350|5893901|P3|Overall Study|Withdrawal by Subject|1
1687688|NCT01325350|5893902|P2|Overall Study|Withdrawal by Subject|0
1687689|NCT01325350|5893903|P1|Overall Study|Withdrawal by Subject|0
1687690|NCT01325350|5893899|P5|Overall Study|Protocol Violation|0
1687691|NCT01325350|5893900|P4|Overall Study|Protocol Violation|1
1687692|NCT01325350|5893901|P3|Overall Study|Protocol Violation|0
1687693|NCT01325350|5893902|P2|Overall Study|Protocol Violation|0
1687694|NCT01325350|5893903|P1|Overall Study|Protocol Violation|0
1687695|NCT01325350|5893899|P5|Overall Study|Personal Reasons|3
1687696|NCT01325350|5893900|P4|Overall Study|Personal Reasons|5
1687697|NCT01325350|5893901|P3|Overall Study|Personal Reasons|6
1687698|NCT01325350|5893902|P2|Overall Study|Personal Reasons|1
1687699|NCT01325350|5893903|P1|Overall Study|Personal Reasons|2
1687700|NCT01325350|5893899|P5|Overall Study|Lost to Follow-up|5
1687701|NCT01325350|5893900|P4|Overall Study|Lost to Follow-up|1
1687702|NCT01325350|5893901|P3|Overall Study|Lost to Follow-up|5
1687703|NCT01325350|5893902|P2|Overall Study|Lost to Follow-up|0
1687704|NCT01325350|5893903|P1|Overall Study|Lost to Follow-up|1
1687705|NCT01325350|5893899|P5|Overall Study|Pregnancy|1
1687706|NCT01325350|5893900|P4|Overall Study|Pregnancy|0
1687707|NCT01325350|5893901|P3|Overall Study|Pregnancy|1
1687708|NCT01325350|5893902|P2|Overall Study|Pregnancy|0
1687709|NCT01325350|5893903|P1|Overall Study|Pregnancy|0
1687710|NCT01325350|5893899|P5|Overall Study|Adverse Event|2
1687711|NCT01325350|5893900|P4|Overall Study|Adverse Event|1
1687712|NCT01325350|5893901|P3|Overall Study|Adverse Event|3
1687713|NCT01325350|5893902|P2|Overall Study|Adverse Event|3
1687714|NCT01325350|5893903|P1|Overall Study|Adverse Event|3
1687715|NCT01325337|5893945|P5|Overall Study|Withdrawal by Subject|1
1687716|NCT01325337|5893946|P4|Overall Study|Withdrawal by Subject|0
1687717|NCT01325337|5893947|P3|Overall Study|Withdrawal by Subject|1
1687718|NCT01325337|5893948|P2|Overall Study|Withdrawal by Subject|0
1687719|NCT01325337|5893949|P1|Overall Study|Withdrawal by Subject|1
1687720|NCT01325337|5893945|P5|Overall Study|Personal Reasons|3
1687721|NCT01325337|5893946|P4|Overall Study|Personal Reasons|8
1687722|NCT01325337|5893947|P3|Overall Study|Personal Reasons|4
1687723|NCT01325337|5893948|P2|Overall Study|Personal Reasons|5
1687724|NCT01325337|5893949|P1|Overall Study|Personal Reasons|2
1687725|NCT01325337|5893945|P5|Overall Study|Lost to Follow-up|2
1687726|NCT01325337|5893946|P4|Overall Study|Lost to Follow-up|1
1687727|NCT01325337|5893947|P3|Overall Study|Lost to Follow-up|2
1687728|NCT01325337|5893948|P2|Overall Study|Lost to Follow-up|2
1687729|NCT01325337|5893949|P1|Overall Study|Lost to Follow-up|2
1687730|NCT01325337|5893945|P5|Overall Study|Adverse Event|2
1687731|NCT01325337|5893946|P4|Overall Study|Adverse Event|1
1687732|NCT01325337|5893947|P3|Overall Study|Adverse Event|2
1687733|NCT01325337|5893948|P2|Overall Study|Adverse Event|2
1687734|NCT01325337|5893949|P1|Overall Study|Adverse Event|0
1687735|NCT01325207|5894029|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
1687736|NCT01325207|5894030|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
1687737|NCT01325207|5894031|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
1687738|NCT01325207|5894032|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
1687739|NCT01325207|5894033|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
1687740|NCT01325207|5894034|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
1687741|NCT01325207|5894029|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
1687742|NCT01325207|5894030|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
1687743|NCT01325207|5894031|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
1687744|NCT01325207|5894032|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
1687745|NCT01325207|5894033|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
1687746|NCT01325207|5894034|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
1687747|NCT01325207|5894029|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
1687748|NCT01325207|5894030|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
1687749|NCT01325207|5894031|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
1687750|NCT01325207|5894032|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
1687751|NCT01325207|5894033|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
1687752|NCT01325207|5894034|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
1687753|NCT01325207|5894029|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
1687754|NCT01325207|5894030|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
1687755|NCT01325207|5894031|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
1687756|NCT01325207|5894032|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
1687757|NCT01325207|5894033|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
1687758|NCT01325207|5894034|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
1687759|NCT01325207|5894029|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
1687760|NCT01325207|5894030|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
1687761|NCT01325207|5894031|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
1687762|NCT01325207|5894032|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
1687763|NCT01325207|5894033|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
1687764|NCT01325207|5894034|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
1687765|NCT01325207|5894029|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
1687766|NCT01325207|5894030|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
1687767|NCT01325207|5894031|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
1687768|NCT01325207|5894032|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
1687769|NCT01325207|5894033|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
1687770|NCT01325207|5894034|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
1687771|NCT01325207|5894029|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
1687772|NCT01325207|5894030|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
1687773|NCT01325207|5894031|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
1687774|NCT01325207|5894032|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
1687775|NCT01325207|5894033|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
1687776|NCT01325207|5894034|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
1687777|NCT01324999|5894066|P1|Overall Study|Withdrawal by Subject|2
1687778|NCT01324999|5894066|P1|Overall Study|Adverse Event|3
1687779|NCT01324947|5894077|P1|Overall Study|1 discontinued before starting drug|1
1687780|NCT01324947|5894077|P1|Overall Study|Withdrawal by Subject|3
1687781|NCT01324947|5894077|P1|Overall Study|Progressive Disease|50
1687782|NCT01324947|5894077|P1|Overall Study|Other|3
1687783|NCT01324947|5894077|P1|Overall Study|Death|10
1687784|NCT01324947|5894077|P1|Overall Study|Adverse Event|7
1687785|NCT01324830|5894118|P19|Overall Study|Withdrawal by Subject|1
1687786|NCT01324830|5894119|P18|Overall Study|Withdrawal by Subject|0
1687787|NCT01324830|5894120|P17|Overall Study|Withdrawal by Subject|0
1687788|NCT01324830|5894121|P16|Overall Study|Withdrawal by Subject|0
1687789|NCT01324830|5894122|P15|Overall Study|Withdrawal by Subject|0
1687790|NCT01324830|5894123|P14|Overall Study|Withdrawal by Subject|0
1687791|NCT01324830|5894124|P13|Overall Study|Withdrawal by Subject|0
1687792|NCT01324830|5894125|P12|Overall Study|Withdrawal by Subject|0
1687793|NCT01324830|5894126|P11|Overall Study|Withdrawal by Subject|1
1687794|NCT01324830|5894127|P10|Overall Study|Withdrawal by Subject|0
1687795|NCT01324830|5894128|P9|Overall Study|Withdrawal by Subject|0
1687796|NCT01324830|5894129|P8|Overall Study|Withdrawal by Subject|0
1687797|NCT01324830|5894130|P7|Overall Study|Withdrawal by Subject|0
1687798|NCT01324830|5894131|P6|Overall Study|Withdrawal by Subject|1
1687799|NCT01324830|5894132|P5|Overall Study|Withdrawal by Subject|0
1687800|NCT01324830|5894133|P4|Overall Study|Withdrawal by Subject|0
1687801|NCT01324830|5894134|P3|Overall Study|Withdrawal by Subject|0
1687802|NCT01324830|5894135|P2|Overall Study|Withdrawal by Subject|0
1687803|NCT01324830|5894136|P1|Overall Study|Withdrawal by Subject|0
1687804|NCT01324830|5894118|P19|Overall Study|Adverse Event, non-fatal|0
1687805|NCT01324830|5894119|P18|Overall Study|Adverse Event, non-fatal|1
1687806|NCT01324830|5894120|P17|Overall Study|Adverse Event, non-fatal|0
1687807|NCT01324830|5894121|P16|Overall Study|Adverse Event, non-fatal|0
1687808|NCT01324830|5894122|P15|Overall Study|Adverse Event, non-fatal|0
1687809|NCT01324830|5894123|P14|Overall Study|Adverse Event, non-fatal|0
1687810|NCT01324830|5894124|P13|Overall Study|Adverse Event, non-fatal|0
1687811|NCT01324830|5894125|P12|Overall Study|Adverse Event, non-fatal|0
1687812|NCT01324830|5894126|P11|Overall Study|Adverse Event, non-fatal|1
1687813|NCT01324830|5894127|P10|Overall Study|Adverse Event, non-fatal|0
1687814|NCT01324830|5894128|P9|Overall Study|Adverse Event, non-fatal|2
1687815|NCT01324830|5894129|P8|Overall Study|Adverse Event, non-fatal|0
1687816|NCT01324830|5894130|P7|Overall Study|Adverse Event, non-fatal|0
1687817|NCT01324830|5894131|P6|Overall Study|Adverse Event, non-fatal|0
1687818|NCT01324830|5894132|P5|Overall Study|Adverse Event, non-fatal|0
1687819|NCT01324830|5894133|P4|Overall Study|Adverse Event, non-fatal|0
1687820|NCT01324830|5894134|P3|Overall Study|Adverse Event, non-fatal|0
1687821|NCT01324830|5894135|P2|Overall Study|Adverse Event, non-fatal|0
1687822|NCT01324830|5894136|P1|Overall Study|Adverse Event, non-fatal|0
1687823|NCT01324830|5894118|P19|Overall Study|Adverse Event, serious fatal|0
1687824|NCT01324830|5894119|P18|Overall Study|Adverse Event, serious fatal|0
1687825|NCT01324830|5894120|P17|Overall Study|Adverse Event, serious fatal|0
1687826|NCT01324830|5894121|P16|Overall Study|Adverse Event, serious fatal|0
1687827|NCT01324830|5894122|P15|Overall Study|Adverse Event, serious fatal|0
1687828|NCT01324830|5894123|P14|Overall Study|Adverse Event, serious fatal|0
1687829|NCT01324830|5894124|P13|Overall Study|Adverse Event, serious fatal|0
1687830|NCT01324830|5894125|P12|Overall Study|Adverse Event, serious fatal|0
1687831|NCT01324830|5894126|P11|Overall Study|Adverse Event, serious fatal|0
1687832|NCT01324830|5894127|P10|Overall Study|Adverse Event, serious fatal|0
1687833|NCT01324830|5894128|P9|Overall Study|Adverse Event, serious fatal|0
1687834|NCT01324830|5894129|P8|Overall Study|Adverse Event, serious fatal|0
1687835|NCT01324830|5894130|P7|Overall Study|Adverse Event, serious fatal|0
1687836|NCT01324830|5894131|P6|Overall Study|Adverse Event, serious fatal|0
1687837|NCT01324830|5894132|P5|Overall Study|Adverse Event, serious fatal|0
1687838|NCT01324830|5894133|P4|Overall Study|Adverse Event, serious fatal|0
1687839|NCT01324830|5894134|P3|Overall Study|Adverse Event, serious fatal|0
1687840|NCT01324830|5894135|P2|Overall Study|Adverse Event, serious fatal|1
1687841|NCT01324830|5894136|P1|Overall Study|Adverse Event, serious fatal|0
1687842|NCT01324830|5894118|P19|Overall Study|Reason not mentioned above|0
1687843|NCT01324830|5894119|P18|Overall Study|Reason not mentioned above|1
1687844|NCT01324830|5894120|P17|Overall Study|Reason not mentioned above|0
1687845|NCT01324830|5894121|P16|Overall Study|Reason not mentioned above|0
1687846|NCT01324830|5894122|P15|Overall Study|Reason not mentioned above|0
1687847|NCT01324830|5894123|P14|Overall Study|Reason not mentioned above|0
1687848|NCT01324830|5894124|P13|Overall Study|Reason not mentioned above|0
1687849|NCT01324830|5894125|P12|Overall Study|Reason not mentioned above|0
1687850|NCT01324830|5894126|P11|Overall Study|Reason not mentioned above|0
1687851|NCT01324830|5894127|P10|Overall Study|Reason not mentioned above|0
1687852|NCT01324830|5894128|P9|Overall Study|Reason not mentioned above|0
1687853|NCT01324830|5894129|P8|Overall Study|Reason not mentioned above|0
1687854|NCT01324830|5894130|P7|Overall Study|Reason not mentioned above|0
1687855|NCT01324830|5894131|P6|Overall Study|Reason not mentioned above|0
1687856|NCT01324830|5894132|P5|Overall Study|Reason not mentioned above|0
1687857|NCT01324830|5894133|P4|Overall Study|Reason not mentioned above|0
1687858|NCT01324830|5894134|P3|Overall Study|Reason not mentioned above|0
1687859|NCT01324830|5894135|P2|Overall Study|Reason not mentioned above|0
1687860|NCT01324830|5894136|P1|Overall Study|Reason not mentioned above|0
1687861|NCT01324830|5894118|P19|Overall Study|Dose limiting toxicity|1
1687862|NCT01324830|5894119|P18|Overall Study|Dose limiting toxicity|1
1687863|NCT01324830|5894120|P17|Overall Study|Dose limiting toxicity|1
1687864|NCT01324830|5894121|P16|Overall Study|Dose limiting toxicity|0
1687865|NCT01324830|5894122|P15|Overall Study|Dose limiting toxicity|0
1687866|NCT01324830|5894123|P14|Overall Study|Dose limiting toxicity|0
1687867|NCT01324830|5894124|P13|Overall Study|Dose limiting toxicity|0
1687868|NCT01324830|5894125|P12|Overall Study|Dose limiting toxicity|0
1687869|NCT01324830|5894126|P11|Overall Study|Dose limiting toxicity|0
1687870|NCT01324830|5894127|P10|Overall Study|Dose limiting toxicity|0
1687871|NCT01324830|5894128|P9|Overall Study|Dose limiting toxicity|0
1687872|NCT01324830|5894129|P8|Overall Study|Dose limiting toxicity|0
1687873|NCT01324830|5894130|P7|Overall Study|Dose limiting toxicity|0
1687874|NCT01324830|5894131|P6|Overall Study|Dose limiting toxicity|0
1687875|NCT01324830|5894132|P5|Overall Study|Dose limiting toxicity|1
1687876|NCT01324830|5894133|P4|Overall Study|Dose limiting toxicity|0
1687877|NCT01324830|5894134|P3|Overall Study|Dose limiting toxicity|0
1687878|NCT01324830|5894135|P2|Overall Study|Dose limiting toxicity|0
1687879|NCT01324830|5894136|P1|Overall Study|Dose limiting toxicity|0
1687880|NCT01324830|5894118|P19|Overall Study|Progressive Disease|4
1687881|NCT01324830|5894119|P18|Overall Study|Progressive Disease|3
1687882|NCT01324830|5894120|P17|Overall Study|Progressive Disease|2
1687883|NCT01324830|5894121|P16|Overall Study|Progressive Disease|3
1687884|NCT01324830|5894122|P15|Overall Study|Progressive Disease|1
1687885|NCT01324830|5894123|P14|Overall Study|Progressive Disease|1
1687886|NCT01324830|5894124|P13|Overall Study|Progressive Disease|1
1687887|NCT01324830|5894125|P12|Overall Study|Progressive Disease|1
1687888|NCT01324830|5894126|P11|Overall Study|Progressive Disease|2
1687889|NCT01324830|5894127|P10|Overall Study|Progressive Disease|6
1687890|NCT01324830|5894128|P9|Overall Study|Progressive Disease|3
1687891|NCT01324830|5894129|P8|Overall Study|Progressive Disease|3
1687892|NCT01324830|5894130|P7|Overall Study|Progressive Disease|3
1687893|NCT01324830|5894131|P6|Overall Study|Progressive Disease|6
1687894|NCT01324830|5894132|P5|Overall Study|Progressive Disease|6
1687895|NCT01324830|5894133|P4|Overall Study|Progressive Disease|3
1687896|NCT01324830|5894134|P3|Overall Study|Progressive Disease|3
1687897|NCT01324830|5894135|P2|Overall Study|Progressive Disease|2
1687898|NCT01324830|5894136|P1|Overall Study|Progressive Disease|3
1687899|NCT01324622|5894282|P2|Overall Study|Lack of Efficacy|0
1687900|NCT01324622|5894283|P1|Overall Study|Lack of Efficacy|1
1687901|NCT01324622|5894282|P2|Overall Study|Death|0
1687902|NCT01324622|5894283|P1|Overall Study|Death|1
1687903|NCT01324622|5894282|P2|Overall Study|Lost to Follow-up|7
1687904|NCT01324622|5894283|P1|Overall Study|Lost to Follow-up|7
1687905|NCT01324570|5894313|P2|Overall Study|Administrative|2
1687906|NCT01324570|5894314|P1|Overall Study|Administrative|0
1687907|NCT01324570|5894313|P2|Overall Study|Confirmed or suspected diversion|1
1687908|NCT01324570|5894314|P1|Overall Study|Confirmed or suspected diversion|0
1687909|NCT01324570|5894313|P2|Overall Study|Lack of Efficacy|1
1687910|NCT01324570|5894314|P1|Overall Study|Lack of Efficacy|0
1687911|NCT01324570|5894313|P2|Overall Study|Withdrawal by Subject|3
1687912|NCT01324570|5894314|P1|Overall Study|Withdrawal by Subject|0
1687913|NCT01324570|5894313|P2|Overall Study|Adverse Event|7
1687914|NCT01324570|5894314|P1|Overall Study|Adverse Event|4
1687915|NCT01324440|5894351|P2|Overall Study|Subject moved|1
1687916|NCT01324440|5894352|P1|Overall Study|Subject moved|0
1687917|NCT01324401|5894366|P2|Overall Study|Adverse Event|3
1687918|NCT01324401|5894367|P1|Overall Study|Adverse Event|1
1687919|NCT01324401|5894366|P2|Overall Study|Withdrawn before any treatment|3
1687920|NCT01324401|5894367|P1|Overall Study|Withdrawn before any treatment|0
1687921|NCT01324388|5894378|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1687922|NCT01324388|5894379|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
1687923|NCT01324388|5894380|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1687924|NCT01324388|5894381|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
1687925|NCT01324388|5894378|P4|Part 2 of Study: First Intervention|Protocol Violation|1
1687926|NCT01324388|5894379|P3|Part 2 of Study: First Intervention|Protocol Violation|0
1687927|NCT01324388|5894380|P2|Part 2 of Study: First Intervention|Protocol Violation|0
1687928|NCT01324388|5894381|P1|Part 2 of Study: First Intervention|Protocol Violation|0
1687929|NCT01324388|5894378|P4|Part 1 of Study|Physician Decision|0
1687930|NCT01324388|5894379|P3|Part 1 of Study|Physician Decision|0
1687931|NCT01324388|5894380|P2|Part 1 of Study|Physician Decision|0
1687932|NCT01324388|5894381|P1|Part 1 of Study|Physician Decision|1
1687933|NCT01324388|5894378|P4|Part 1 of Study|Protocol Violation|0
1687934|NCT01324388|5894379|P3|Part 1 of Study|Protocol Violation|0
1687935|NCT01324388|5894380|P2|Part 1 of Study|Protocol Violation|2
1687936|NCT01324388|5894381|P1|Part 1 of Study|Protocol Violation|1
1687937|NCT01324388|5894378|P4|Part 1 of Study|Adverse Event|0
1687938|NCT01324388|5894379|P3|Part 1 of Study|Adverse Event|0
1687939|NCT01324388|5894380|P2|Part 1 of Study|Adverse Event|0
1687940|NCT01324388|5894381|P1|Part 1 of Study|Adverse Event|2
1687941|NCT01324349|5894402|P2|Overall Study|Withdrawal by Subject|1
1687942|NCT01324349|5894403|P1|Overall Study|Withdrawal by Subject|0
1687943|NCT01324349|5894402|P2|Overall Study|Death|1
1687944|NCT01324349|5894403|P1|Overall Study|Death|1
1687945|NCT01324323|5894413|P1|Overall Study|Withdrawal by Subject|1
1687946|NCT01324310|5894433|P1|Overall Study|Disease Progression|1
1687947|NCT01324310|5894433|P1|Overall Study|Adverse Event|1
1687948|NCT01324271|5894453|P2|Overall Study|Physician Decision|0
1687949|NCT01324271|5894454|P1|Overall Study|Physician Decision|1
1687950|NCT01324271|5894453|P2|Overall Study|Lost to Follow-up|0
1687951|NCT01324271|5894454|P1|Overall Study|Lost to Follow-up|3
1687952|NCT01324102|5894477|P2|Overall Study|illness|6
1687953|NCT01324102|5894478|P1|Overall Study|illness|1
1687954|NCT01324024|5894485|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1687955|NCT01324024|5894486|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
1687956|NCT01323972|5894524|P4|Overall Study|Lost to Follow-up|1
1687957|NCT01323972|5894525|P3|Overall Study|Lost to Follow-up|1
1687958|NCT01323972|5894526|P2|Overall Study|Lost to Follow-up|1
1687959|NCT01323972|5894527|P1|Overall Study|Lost to Follow-up|0
1687960|NCT01323972|5894524|P4|Overall Study|Migrated/moved from study area|0
1687961|NCT01323972|5894525|P3|Overall Study|Migrated/moved from study area|0
1687962|NCT01323972|5894526|P2|Overall Study|Migrated/moved from study area|2
1687963|NCT01323972|5894527|P1|Overall Study|Migrated/moved from study area|1
1687964|NCT01323972|5894524|P4|Overall Study|Withdrawal by Subject|0
1687965|NCT01323972|5894525|P3|Overall Study|Withdrawal by Subject|1
1687966|NCT01323972|5894526|P2|Overall Study|Withdrawal by Subject|0
1687967|NCT01323972|5894527|P1|Overall Study|Withdrawal by Subject|1
1687968|NCT01323946|5894623|P3|Overall Study|Withdrawal by Subject|0
1687969|NCT01323946|5894624|P2|Overall Study|Withdrawal by Subject|2
1687970|NCT01323946|5894625|P1|Overall Study|Withdrawal by Subject|2
1687971|NCT01323946|5894623|P3|Overall Study|Parents refused the last blood draw|0
1687972|NCT01323946|5894624|P2|Overall Study|Parents refused the last blood draw|0
1687973|NCT01323946|5894625|P1|Overall Study|Parents refused the last blood draw|1
1687974|NCT01323946|5894623|P3|Overall Study|Lost to Follow-up|0
1687975|NCT01323946|5894624|P2|Overall Study|Lost to Follow-up|1
1687976|NCT01323946|5894625|P1|Overall Study|Lost to Follow-up|0
1687977|NCT01323920|5894746|P1|Overall Study|Withdrawal by Subject|1
1687978|NCT01323920|5894746|P1|Overall Study|Death|5
1687979|NCT01323790|5894787|P3|Overall Study|Severe non-compliance with protocol|2
1687980|NCT01323790|5894788|P2|Overall Study|Severe non-compliance with protocol|2
1687981|NCT01323790|5894789|P1|Overall Study|Severe non-compliance with protocol|2
1687982|NCT01323790|5894787|P3|Overall Study|Did Not Receive Treatment|1
1687983|NCT01323790|5894788|P2|Overall Study|Did Not Receive Treatment|0
1687984|NCT01323790|5894789|P1|Overall Study|Did Not Receive Treatment|2
1687985|NCT01323790|5894787|P3|Overall Study|Withdrawal by Subject|13
1687986|NCT01323790|5894788|P2|Overall Study|Withdrawal by Subject|20
1687987|NCT01323790|5894789|P1|Overall Study|Withdrawal by Subject|23
1687988|NCT01323790|5894787|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
1687989|NCT01323790|5894788|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1687990|NCT01323790|5894789|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1687991|NCT01323790|5894787|P3|Overall Study|Adverse Event|12
1687992|NCT01323790|5894788|P2|Overall Study|Adverse Event|24
1687993|NCT01323790|5894789|P1|Overall Study|Adverse Event|11
1687994|NCT01323790|5894787|P3|Overall Study|Lack of Efficacy|3
1687995|NCT01323790|5894788|P2|Overall Study|Lack of Efficacy|0
1687996|NCT01323790|5894789|P1|Overall Study|Lack of Efficacy|3
1687997|NCT01323790|5894787|P3|Overall Study|Study-Specific Withdrawal Criteria|3
1687998|NCT01323790|5894788|P2|Overall Study|Study-Specific Withdrawal Criteria|3
1687999|NCT01323790|5894789|P1|Overall Study|Study-Specific Withdrawal Criteria|0
1688000|NCT01323790|5894787|P3|Overall Study|Lost to Follow-up|9
1688001|NCT01323790|5894788|P2|Overall Study|Lost to Follow-up|9
1688002|NCT01323790|5894789|P1|Overall Study|Lost to Follow-up|11
1688003|NCT01323790|5894787|P3|Overall Study|Other|1
1688004|NCT01323790|5894788|P2|Overall Study|Other|2
1688005|NCT01323790|5894789|P1|Overall Study|Other|3
1688006|NCT01323673|5894840|P2|Overall Study|Withdrawal by Subject|3
1688007|NCT01323673|5894841|P1|Overall Study|Withdrawal by Subject|2
1688008|NCT01323673|5894840|P2|Overall Study|Protocol Violation|0
1688009|NCT01323673|5894841|P1|Overall Study|Protocol Violation|1
1688010|NCT01323673|5894840|P2|Overall Study|Lost to Follow-up|1
1688011|NCT01323673|5894841|P1|Overall Study|Lost to Follow-up|0
1688012|NCT01323673|5894840|P2|Overall Study|Adverse Event|1
1688013|NCT01323673|5894841|P1|Overall Study|Adverse Event|0
1688014|NCT01323660|5894861|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1688015|NCT01323660|5894862|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
1688016|NCT01323660|5894863|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
1688017|NCT01323660|5894864|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1688018|NCT01323660|5894865|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1688019|NCT01323660|5894866|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
1688020|NCT01323660|5894861|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1688021|NCT01323660|5894862|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1688022|NCT01323660|5894863|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1688023|NCT01323660|5894864|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1688024|NCT01323660|5894865|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
1688025|NCT01323660|5894866|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
1688026|NCT01323660|5894861|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
1688027|NCT01323660|5894862|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1688028|NCT01323660|5894863|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1688029|NCT01323660|5894864|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1688030|NCT01323660|5894865|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1688031|NCT01323660|5894866|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
1688032|NCT01323660|5894861|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
1688033|NCT01323660|5894862|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
1688034|NCT01323660|5894863|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1688035|NCT01323660|5894864|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
1688036|NCT01323660|5894865|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
1688037|NCT01323660|5894866|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
1688038|NCT01323660|5894861|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
1688039|NCT01323660|5894862|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
1688040|NCT01323660|5894863|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
1688041|NCT01323660|5894864|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
1688042|NCT01323660|5894865|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
1688043|NCT01323660|5894866|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
1688044|NCT01323660|5894861|P6|Washout Period (14 Days)|Lack of Efficacy|2
1688045|NCT01323660|5894862|P5|Washout Period (14 Days)|Lack of Efficacy|2
1688046|NCT01323660|5894863|P4|Washout Period (14 Days)|Lack of Efficacy|3
1688047|NCT01323660|5894864|P3|Washout Period (14 Days)|Lack of Efficacy|1
1688048|NCT01323660|5894865|P2|Washout Period (14 Days)|Lack of Efficacy|0
1688049|NCT01323660|5894866|P1|Washout Period (14 Days)|Lack of Efficacy|0
1688050|NCT01323660|5894861|P6|Washout Period (14 Days)|Adverse Event|0
1688051|NCT01323660|5894862|P5|Washout Period (14 Days)|Adverse Event|1
1688052|NCT01323660|5894863|P4|Washout Period (14 Days)|Adverse Event|0
1688053|NCT01323660|5894864|P3|Washout Period (14 Days)|Adverse Event|0
1688054|NCT01323660|5894865|P2|Washout Period (14 Days)|Adverse Event|0
1688055|NCT01323660|5894866|P1|Washout Period (14 Days)|Adverse Event|0
1688056|NCT01323660|5894861|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1688057|NCT01323660|5894862|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
1688058|NCT01323660|5894863|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1688059|NCT01323660|5894864|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
1688060|NCT01323660|5894865|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
1688061|NCT01323660|5894866|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
1688062|NCT01323660|5894861|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1688063|NCT01323660|5894862|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1688064|NCT01323660|5894863|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1688065|NCT01323660|5894864|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1688066|NCT01323660|5894865|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1688067|NCT01323660|5894866|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1688068|NCT01323660|5894861|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1688069|NCT01323660|5894862|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
1688070|NCT01323660|5894863|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1688071|NCT01323660|5894864|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1688072|NCT01323660|5894865|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1688073|NCT01323660|5894866|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
1688074|NCT01323660|5894861|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1688075|NCT01323660|5894862|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1688076|NCT01323660|5894863|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1688077|NCT01323660|5894864|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
1688078|NCT01323660|5894865|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
1688079|NCT01323660|5894866|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1688080|NCT01323660|5894861|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
1688081|NCT01323660|5894862|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
1688082|NCT01323660|5894863|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
1688083|NCT01323660|5894864|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
1688084|NCT01323660|5894865|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
1688085|NCT01323660|5894866|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
1688086|NCT01323660|5894861|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
1688087|NCT01323660|5894862|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
1688088|NCT01323660|5894863|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
1688089|NCT01323660|5894864|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
1688090|NCT01323660|5894865|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
1688091|NCT01323660|5894866|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
1688092|NCT01323647|5894912|P2|Overall Study|Lost to Follow-up|0
1688093|NCT01323647|5894913|P1|Overall Study|Lost to Follow-up|2
1688094|NCT01323647|5894912|P2|Overall Study|Withdrawal by Subject|0
1688095|NCT01323647|5894913|P1|Overall Study|Withdrawal by Subject|5
1688096|NCT01323647|5894912|P2|Overall Study|Migrated/moved from study area|0
1688097|NCT01323647|5894913|P1|Overall Study|Migrated/moved from study area|2
1688098|NCT01323634|5894930|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
1688099|NCT01323634|5894931|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
1688100|NCT01323634|5894932|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
1688101|NCT01323634|5894930|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
1688102|NCT01323634|5894931|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
1688103|NCT01323634|5894932|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
1688104|NCT01323634|5894930|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
1688105|NCT01323634|5894931|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
1688106|NCT01323634|5894932|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
1688107|NCT01323634|5894930|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1688108|NCT01323634|5894931|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
1688109|NCT01323634|5894932|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
1688110|NCT01323634|5894930|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
1688111|NCT01323634|5894931|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
1688112|NCT01323634|5894932|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
1688113|NCT01323634|5894930|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
1688114|NCT01323634|5894931|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1688115|NCT01323634|5894932|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
1688116|NCT01323634|5894930|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
1688117|NCT01323634|5894931|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
1688118|NCT01323634|5894932|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
1688119|NCT01323634|5894930|P3|2-week Run-in Period|Adverse Event|0
1688120|NCT01323634|5894931|P2|2-week Run-in Period|Adverse Event|0
1688121|NCT01323634|5894932|P1|2-week Run-in Period|Adverse Event|1
1688122|NCT01323634|5894930|P3|2-week Run-in Period|Protocol Violation|0
1688123|NCT01323634|5894931|P2|2-week Run-in Period|Protocol Violation|0
1688124|NCT01323634|5894932|P1|2-week Run-in Period|Protocol Violation|1
1688125|NCT01323634|5894930|P3|2-week Run-in Period|Physician Decision|0
1688126|NCT01323634|5894931|P2|2-week Run-in Period|Physician Decision|0
1688127|NCT01323634|5894932|P1|2-week Run-in Period|Physician Decision|5
1688128|NCT01323634|5894930|P3|2-week Run-in Period|Withdrawal by Subject|0
1688129|NCT01323634|5894931|P2|2-week Run-in Period|Withdrawal by Subject|0
1688130|NCT01323634|5894932|P1|2-week Run-in Period|Withdrawal by Subject|7
1688131|NCT01323634|5894930|P3|2-week Run-in Period|Continuation Criteria not Met|0
1688132|NCT01323634|5894931|P2|2-week Run-in Period|Continuation Criteria not Met|0
1688133|NCT01323634|5894932|P1|2-week Run-in Period|Continuation Criteria not Met|73
1688134|NCT01323634|5894930|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
1688135|NCT01323634|5894931|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
1688136|NCT01323634|5894932|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
1688137|NCT01323621|5894942|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
1688138|NCT01323621|5894943|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
1688139|NCT01323621|5894944|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
1688140|NCT01323621|5894942|P3|12-week, Double-blind Treatment Period|Physician Decision|1
1688141|NCT01323621|5894943|P2|12-week, Double-blind Treatment Period|Physician Decision|2
1688142|NCT01323621|5894944|P1|12-week, Double-blind Treatment Period|Physician Decision|0
1688143|NCT01323621|5894942|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
1688144|NCT01323621|5894943|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
1688145|NCT01323621|5894944|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
1688146|NCT01323621|5894942|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
1688147|NCT01323621|5894943|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
1688148|NCT01323621|5894944|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
1688149|NCT01323621|5894942|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
1688150|NCT01323621|5894943|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
1688151|NCT01323621|5894944|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
1688152|NCT01323621|5894942|P3|12-week, Double-blind Treatment Period|Adverse Event|5
1688153|NCT01323621|5894943|P2|12-week, Double-blind Treatment Period|Adverse Event|1
1688154|NCT01323621|5894944|P1|12-week, Double-blind Treatment Period|Adverse Event|0
1688155|NCT01323621|5894942|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
1688156|NCT01323621|5894943|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
1688157|NCT01323621|5894944|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
1688158|NCT01323621|5894942|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
1688159|NCT01323621|5894943|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
1688160|NCT01323621|5894944|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
1688161|NCT01323621|5894942|P3|2-week, Single-blind Run In Period|Protocol Violation|0
1688162|NCT01323621|5894943|P2|2-week, Single-blind Run In Period|Protocol Violation|0
1688163|NCT01323621|5894944|P1|2-week, Single-blind Run In Period|Protocol Violation|1
1688164|NCT01323621|5894942|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
1688165|NCT01323621|5894943|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
1688166|NCT01323621|5894944|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
1688167|NCT01323621|5894942|P3|2-week, Single-blind Run In Period|Physician Decision|0
1688168|NCT01323621|5894943|P2|2-week, Single-blind Run In Period|Physician Decision|0
1688169|NCT01323621|5894944|P1|2-week, Single-blind Run In Period|Physician Decision|7
1688170|NCT01323621|5894942|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
1688171|NCT01323621|5894943|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
1688172|NCT01323621|5894944|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
1688173|NCT01323582|5894965|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
1688174|NCT01323582|5894966|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
1688175|NCT01323582|5894965|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
1688176|NCT01323582|5894966|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
1688177|NCT01323582|5894965|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
1688178|NCT01323582|5894966|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
1688179|NCT01323478|5894989|P1|Overall Study|Administrative or Other Reasons|8
1688180|NCT01323478|5894989|P1|Overall Study|Withdrawal of Consent|1
1688181|NCT01323478|5894989|P1|Overall Study|Protocol Violation|1
1688182|NCT01323478|5894989|P1|Overall Study|Non-compliance With Study Product|3
1688183|NCT01323478|5894989|P1|Overall Study|Lack of Efficacy|4
1688184|NCT01323478|5894989|P1|Overall Study|Adverse Event|7
1688185|NCT01323387|5895002|P1|Overall Study|Randomized but Never Treated|16
1688186|NCT01323387|5895002|P1|Overall Study|Protocol Violation|12
1688187|NCT01323387|5895002|P1|Overall Study|Revision|14
1688188|NCT01323387|5895002|P1|Overall Study|Radiographic Data Unavailable|1
1688189|NCT01323387|5895002|P1|Overall Study|Withdrawal by Subject|41
1688190|NCT01323270|5895015|P2|Overall Study|Randomized, but not vaccinated|0
1688191|NCT01323270|5895016|P1|Overall Study|Randomized, but not vaccinated|1
1688192|NCT01323270|5895015|P2|Overall Study|Death|0
1688193|NCT01323270|5895016|P1|Overall Study|Death|1
1688194|NCT01323270|5895015|P2|Overall Study|Not eligible|1
1688195|NCT01323270|5895016|P1|Overall Study|Not eligible|1
1688196|NCT01323270|5895015|P2|Overall Study|Physician Decision|2
1688197|NCT01323270|5895016|P1|Overall Study|Physician Decision|0
1688198|NCT01323270|5895015|P2|Overall Study|Other|3
1688199|NCT01323270|5895016|P1|Overall Study|Other|0
1688200|NCT01323270|5895015|P2|Overall Study|Adverse Event|0
1688201|NCT01323270|5895016|P1|Overall Study|Adverse Event|8
1688202|NCT01323270|5895015|P2|Overall Study|Lost to Follow-up|6
1688203|NCT01323270|5895016|P1|Overall Study|Lost to Follow-up|4
1688204|NCT01323270|5895015|P2|Overall Study|Protocol Violation|7
1688205|NCT01323270|5895016|P1|Overall Study|Protocol Violation|9
1688206|NCT01323270|5895015|P2|Overall Study|Withdrawal by Subject|10
1688207|NCT01323270|5895016|P1|Overall Study|Withdrawal by Subject|19
1688208|NCT01323192|5895038|P2|Overall Study|Nonmedical reasons|1
1688209|NCT01323192|5895039|P1|Overall Study|Nonmedical reasons|0
1688210|NCT01323192|5895038|P2|Overall Study|Noncompliance with study medication|3
1688211|NCT01323192|5895039|P1|Overall Study|Noncompliance with study medication|0
1688212|NCT01323192|5895038|P2|Overall Study|Withdrawal by Subject|1
1688213|NCT01323192|5895039|P1|Overall Study|Withdrawal by Subject|3
1688214|NCT01323192|5895038|P2|Overall Study|Adverse Event|1
1688215|NCT01323192|5895039|P1|Overall Study|Adverse Event|6
1688216|NCT01322490|5895288|P3|Long Term Follow-up Period|Unknown/Missing|1
1688217|NCT01322490|5895289|P2|Long Term Follow-up Period|Unknown/Missing|1
1688218|NCT01322490|5895290|P1|Long Term Follow-up Period|Unknown/Missing|0
1688219|NCT01322490|5895288|P3|Long Term Follow-up Period|Other per report|2
1688220|NCT01322490|5895289|P2|Long Term Follow-up Period|Other per report|2
1688221|NCT01322490|5895290|P1|Long Term Follow-up Period|Other per report|3
1688222|NCT01322490|5895288|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
1688223|NCT01322490|5895289|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
1688224|NCT01322490|5895290|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
1688225|NCT01322490|5895288|P3|Long Term Follow-up Period|Withdrawal by Subject|6
1688226|NCT01322490|5895289|P2|Long Term Follow-up Period|Withdrawal by Subject|6
1688227|NCT01322490|5895290|P1|Long Term Follow-up Period|Withdrawal by Subject|9
1688228|NCT01322490|5895288|P3|Long Term Follow-up Period|Lost to Follow-up|3
1688229|NCT01322490|5895289|P2|Long Term Follow-up Period|Lost to Follow-up|2
1688230|NCT01322490|5895290|P1|Long Term Follow-up Period|Lost to Follow-up|2
1688231|NCT01322490|5895288|P3|Long Term Follow-up Period|Death|236
1688232|NCT01322490|5895289|P2|Long Term Follow-up Period|Death|239
1688233|NCT01322490|5895290|P1|Long Term Follow-up Period|Death|235
1688234|NCT01322490|5895288|P3|Treatment Period|Randomized but Not Treated|5
1688235|NCT01322490|5895289|P2|Treatment Period|Randomized but Not Treated|3
1688236|NCT01322490|5895290|P1|Treatment Period|Randomized but Not Treated|3
1688237|NCT01322490|5895288|P3|Treatment Period|Other per report|1
1688238|NCT01322490|5895289|P2|Treatment Period|Other per report|2
1688239|NCT01322490|5895290|P1|Treatment Period|Other per report|2
1688240|NCT01322490|5895288|P3|Treatment Period|Non-compliance with study drug|1
1688241|NCT01322490|5895289|P2|Treatment Period|Non-compliance with study drug|0
1688242|NCT01322490|5895290|P1|Treatment Period|Non-compliance with study drug|0
1688243|NCT01322490|5895288|P3|Treatment Period|Withdrawal by Subject|11
1688244|NCT01322490|5895289|P2|Treatment Period|Withdrawal by Subject|16
1688245|NCT01322490|5895290|P1|Treatment Period|Withdrawal by Subject|14
1688246|NCT01322490|5895288|P3|Treatment Period|Protocol Violation|4
1688247|NCT01322490|5895289|P2|Treatment Period|Protocol Violation|5
1688248|NCT01322490|5895290|P1|Treatment Period|Protocol Violation|7
1688249|NCT01322490|5895288|P3|Treatment Period|Physician Decision|1
1688250|NCT01322490|5895289|P2|Treatment Period|Physician Decision|2
1688251|NCT01322490|5895290|P1|Treatment Period|Physician Decision|0
1688252|NCT01322490|5895288|P3|Treatment Period|Lack of Efficacy|112
1688253|NCT01322490|5895289|P2|Treatment Period|Lack of Efficacy|100
1688254|NCT01322490|5895290|P1|Treatment Period|Lack of Efficacy|89
1688255|NCT01322490|5895288|P3|Treatment Period|Death|3
1688256|NCT01322490|5895289|P2|Treatment Period|Death|7
1688257|NCT01322490|5895290|P1|Treatment Period|Death|5
1688258|NCT01322490|5895288|P3|Treatment Period|Adverse Event|15
1688259|NCT01322490|5895289|P2|Treatment Period|Adverse Event|18
1688260|NCT01322490|5895290|P1|Treatment Period|Adverse Event|12
1688261|NCT01322386|5895303|P2|Overall Study|Physician Decision|1
1688262|NCT01322386|5895304|P1|Overall Study|Physician Decision|0
1688263|NCT01322386|5895303|P2|Overall Study|Protocol Violation|1
1688264|NCT01322386|5895304|P1|Overall Study|Protocol Violation|0
1688265|NCT01322347|5895319|P2|Overall Study|moved/changed dialysis|4
1688266|NCT01322347|5895320|P1|Overall Study|moved/changed dialysis|2
1688267|NCT01322347|5895319|P2|Overall Study|study drug withheld > 12 wks|1
1688268|NCT01322347|5895320|P1|Overall Study|study drug withheld > 12 wks|0
1688269|NCT01322347|5895319|P2|Overall Study|kidney transplant|1
1688270|NCT01322347|5895320|P1|Overall Study|kidney transplant|3
1688271|NCT01322347|5895319|P2|Overall Study|ineligible|3
1688272|NCT01322347|5895320|P1|Overall Study|ineligible|6
1688273|NCT01322347|5895319|P2|Overall Study|sponsor decision|3
1688274|NCT01322347|5895320|P1|Overall Study|sponsor decision|1
1688275|NCT01322347|5895319|P2|Overall Study|blood transfusion|5
1688276|NCT01322347|5895320|P1|Overall Study|blood transfusion|5
1688277|NCT01322347|5895319|P2|Overall Study|non-protocol change to ESA or IV iron|6
1688278|NCT01322347|5895320|P1|Overall Study|non-protocol change to ESA or IV iron|14
1688279|NCT01322347|5895319|P2|Overall Study|Withdrawal by Subject|4
1688280|NCT01322347|5895320|P1|Overall Study|Withdrawal by Subject|1
1688281|NCT01322347|5895319|P2|Overall Study|Protocol Violation|2
1688282|NCT01322347|5895320|P1|Overall Study|Protocol Violation|5
1688283|NCT01322347|5895319|P2|Overall Study|Physician Decision|1
1688284|NCT01322347|5895320|P1|Overall Study|Physician Decision|2
1688285|NCT01322347|5895319|P2|Overall Study|Death|3
1688286|NCT01322347|5895320|P1|Overall Study|Death|5
1688287|NCT01322347|5895319|P2|Overall Study|Adverse Event|2
1688288|NCT01322347|5895320|P1|Overall Study|Adverse Event|7
1688289|NCT01322009|5895383|P2|Overall Study|ng tube discontinued|1
1688290|NCT01322009|5895384|P1|Overall Study|ng tube discontinued|0
1688291|NCT01322009|5895383|P2|Overall Study|Adverse Event|1
1688292|NCT01322009|5895384|P1|Overall Study|Adverse Event|0
1688293|NCT01322009|5895383|P2|Overall Study|Death|1
1688294|NCT01322009|5895384|P1|Overall Study|Death|0
1688295|NCT01321879|5895392|P1|Overall Study|Withdrawal by Subject|1
1688296|NCT01321879|5895392|P1|Overall Study|Death|3
1688297|NCT01321879|5895392|P1|Overall Study|Adverse Event|5
1688298|NCT01321879|5895392|P1|Overall Study|Lack of Efficacy|5
1688299|NCT01321749|5895398|P2|Overall Study|Withdrawal by Subject|4
1688300|NCT01321749|5895399|P1|Overall Study|Withdrawal by Subject|5
1688301|NCT01321749|5895398|P2|Overall Study|Protocol Violation|7
1688302|NCT01321749|5895399|P1|Overall Study|Protocol Violation|4
1688303|NCT01321749|5895398|P2|Overall Study|Lost to Follow-up|11
1688304|NCT01321749|5895399|P1|Overall Study|Lost to Follow-up|4
1688305|NCT01321723|5895408|P3|Overall Study|Withdrawal by Subject|2
1688306|NCT01321723|5895409|P2|Overall Study|Withdrawal by Subject|0
1688307|NCT01321723|5895410|P1|Overall Study|Withdrawal by Subject|2
1688308|NCT01321723|5895408|P3|Overall Study|Adverse Event|2
1688309|NCT01321723|5895409|P2|Overall Study|Adverse Event|5
1688310|NCT01321723|5895410|P1|Overall Study|Adverse Event|3
1688311|NCT01321710|5895432|P3|Overall Study|Lost to Follow-up|0
1688312|NCT01321710|5895433|P2|Overall Study|Lost to Follow-up|5
1688313|NCT01321710|5895434|P1|Overall Study|Lost to Follow-up|4
1688314|NCT01321697|5895449|P1|Overall Study|Study Terminated|7
1688315|NCT01321606|5895455|P4|Overall Study|Lost to Follow-up|1
1688316|NCT01321606|5895456|P3|Overall Study|Lost to Follow-up|0
1688317|NCT01321606|5895457|P2|Overall Study|Lost to Follow-up|0
1688318|NCT01321606|5895458|P1|Overall Study|Lost to Follow-up|0
1688319|NCT01321554|5895478|P4|OOL Lenvatinib Treatment Period|Death|1
1688320|NCT01321554|5895479|P3|OOL Lenvatinib Treatment Period|Death|1
1688321|NCT01321554|5895480|P2|OOL Lenvatinib Treatment Period|Death|0
1688322|NCT01321554|5895481|P1|OOL Lenvatinib Treatment Period|Death|0
1688323|NCT01321554|5895478|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
1688324|NCT01321554|5895479|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
1688325|NCT01321554|5895480|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
1688326|NCT01321554|5895481|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
1688327|NCT01321554|5895478|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1688328|NCT01321554|5895479|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
1688329|NCT01321554|5895480|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1688330|NCT01321554|5895481|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
1688331|NCT01321554|5895478|P4|OOL Lenvatinib Treatment Period|Other|0
1688332|NCT01321554|5895479|P3|OOL Lenvatinib Treatment Period|Other|5
1688333|NCT01321554|5895480|P2|OOL Lenvatinib Treatment Period|Other|0
1688334|NCT01321554|5895481|P1|OOL Lenvatinib Treatment Period|Other|0
1688335|NCT01321554|5895478|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1688336|NCT01321554|5895479|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
1688337|NCT01321554|5895480|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1688338|NCT01321554|5895481|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
1688339|NCT01321554|5895478|P4|OOL Lenvatinib Treatment Period|Participant choice|0
1688340|NCT01321554|5895479|P3|OOL Lenvatinib Treatment Period|Participant choice|3
1688341|NCT01321554|5895480|P2|OOL Lenvatinib Treatment Period|Participant choice|0
1688342|NCT01321554|5895481|P1|OOL Lenvatinib Treatment Period|Participant choice|0
1688343|NCT01321554|5895478|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
1688344|NCT01321554|5895479|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
1688345|NCT01321554|5895480|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
1688346|NCT01321554|5895481|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
1688347|NCT01321554|5895478|P4|Randomization Phase|Death|0
1688348|NCT01321554|5895479|P3|Randomization Phase|Death|0
1688349|NCT01321554|5895480|P2|Randomization Phase|Death|1
1688350|NCT01321554|5895481|P1|Randomization Phase|Death|0
1688351|NCT01321554|5895478|P4|Randomization Phase|Withdrawal by Subject|0
1688352|NCT01321554|5895479|P3|Randomization Phase|Withdrawal by Subject|0
1688353|NCT01321554|5895480|P2|Randomization Phase|Withdrawal by Subject|0
1688354|NCT01321554|5895481|P1|Randomization Phase|Withdrawal by Subject|4
1688355|NCT01321554|5895478|P4|Randomization Phase|Participant choice|0
1688356|NCT01321554|5895479|P3|Randomization Phase|Participant choice|0
1688357|NCT01321554|5895480|P2|Randomization Phase|Participant choice|0
1688358|NCT01321554|5895481|P1|Randomization Phase|Participant choice|4
1688359|NCT01321554|5895478|P4|Randomization Phase|Adverse Event|0
1688360|NCT01321554|5895479|P3|Randomization Phase|Adverse Event|0
1688361|NCT01321554|5895480|P2|Randomization Phase|Adverse Event|3
1688362|NCT01321554|5895481|P1|Randomization Phase|Adverse Event|37
1688363|NCT01321073|5895494|P1|Overall Study|Death|3
1688364|NCT01321073|5895494|P1|Overall Study|Did not attempt implant|4
1688365|NCT01321008|5895498|P1|Overall Study|Early Study Termination|1
1688366|NCT01320943|5895504|P2|Overall Study|Randomized but not Treated|1
1688367|NCT01320943|5895505|P1|Overall Study|Randomized but not Treated|0
1688368|NCT01320943|5895504|P2|Overall Study|Physician Decision|1
1688369|NCT01320943|5895505|P1|Overall Study|Physician Decision|0
1688370|NCT01320943|5895504|P2|Overall Study|Lost to Follow-up|0
1688371|NCT01320943|5895505|P1|Overall Study|Lost to Follow-up|1
1688372|NCT01320735|5895539|P1|Overall Study|Investigator Unable to be Contacted|17
1688373|NCT01320735|5895539|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
1688374|NCT01320735|5895539|P1|Overall Study|Other|1
1688375|NCT01320735|5895539|P1|Overall Study|Protocol Violation|1
1688376|NCT01320735|5895539|P1|Overall Study|Progression/Hormone-Refractory Pca|55
1688377|NCT01320735|5895539|P1|Overall Study|Administrative Reason|6
1688378|NCT01320735|5895539|P1|Overall Study|Lost to Follow-up|13
1688379|NCT01320735|5895539|P1|Overall Study|Withdrawal by Subject|3
1688380|NCT01320735|5895539|P1|Overall Study|Adverse Event|3
1688381|NCT01320722|5895561|P5|Overall Study|Withdrew due to Health Condition|1
1688382|NCT01320722|5895562|P4|Overall Study|Withdrew due to Health Condition|0
1688383|NCT01320722|5895563|P3|Overall Study|Withdrew due to Health Condition|0
1688384|NCT01320722|5895564|P2|Overall Study|Withdrew due to Health Condition|0
1688385|NCT01320722|5895565|P1|Overall Study|Withdrew due to Health Condition|0
1688386|NCT01320722|5895561|P5|Overall Study|Started an Exclusionary Medication|1
1688387|NCT01320722|5895562|P4|Overall Study|Started an Exclusionary Medication|0
1688388|NCT01320722|5895563|P3|Overall Study|Started an Exclusionary Medication|0
1688389|NCT01320722|5895564|P2|Overall Study|Started an Exclusionary Medication|0
1688390|NCT01320722|5895565|P1|Overall Study|Started an Exclusionary Medication|0
1688391|NCT01320722|5895561|P5|Overall Study|Pregnancy|0
1688392|NCT01320722|5895562|P4|Overall Study|Pregnancy|1
1688393|NCT01320722|5895563|P3|Overall Study|Pregnancy|0
1688394|NCT01320722|5895564|P2|Overall Study|Pregnancy|0
1688395|NCT01320722|5895565|P1|Overall Study|Pregnancy|0
1688396|NCT01320722|5895561|P5|Overall Study|Not Compliant with Study Procedures|0
1688397|NCT01320722|5895562|P4|Overall Study|Not Compliant with Study Procedures|4
1688398|NCT01320722|5895563|P3|Overall Study|Not Compliant with Study Procedures|0
1688399|NCT01320722|5895564|P2|Overall Study|Not Compliant with Study Procedures|0
1688400|NCT01320722|5895565|P1|Overall Study|Not Compliant with Study Procedures|0
1688401|NCT01320722|5895561|P5|Overall Study|Adverse Event|0
1688402|NCT01320722|5895562|P4|Overall Study|Adverse Event|6
1688403|NCT01320722|5895563|P3|Overall Study|Adverse Event|3
1688404|NCT01320722|5895564|P2|Overall Study|Adverse Event|0
1688405|NCT01320722|5895565|P1|Overall Study|Adverse Event|0
1688406|NCT01320722|5895561|P5|Overall Study|Non-compliant with Medication|0
1688407|NCT01320722|5895562|P4|Overall Study|Non-compliant with Medication|0
1688408|NCT01320722|5895563|P3|Overall Study|Non-compliant with Medication|1
1688409|NCT01320722|5895564|P2|Overall Study|Non-compliant with Medication|0
1688410|NCT01320722|5895565|P1|Overall Study|Non-compliant with Medication|0
1688411|NCT01320722|5895561|P5|Overall Study|Participant Developed a Rash|1
1688412|NCT01320722|5895562|P4|Overall Study|Participant Developed a Rash|1
1688413|NCT01320722|5895563|P3|Overall Study|Participant Developed a Rash|2
1688414|NCT01320722|5895564|P2|Overall Study|Participant Developed a Rash|0
1688415|NCT01320722|5895565|P1|Overall Study|Participant Developed a Rash|0
1688416|NCT01320722|5895561|P5|Overall Study|Not Available for the 8 Week Visit|0
1688417|NCT01320722|5895562|P4|Overall Study|Not Available for the 8 Week Visit|0
1688418|NCT01320722|5895563|P3|Overall Study|Not Available for the 8 Week Visit|0
1688419|NCT01320722|5895564|P2|Overall Study|Not Available for the 8 Week Visit|3
1688420|NCT01320722|5895565|P1|Overall Study|Not Available for the 8 Week Visit|0
1688421|NCT01320722|5895561|P5|Overall Study|Lost to Follow-up|3
1688422|NCT01320722|5895562|P4|Overall Study|Lost to Follow-up|1
1688423|NCT01320722|5895563|P3|Overall Study|Lost to Follow-up|0
1688424|NCT01320722|5895564|P2|Overall Study|Lost to Follow-up|1
1688425|NCT01320722|5895565|P1|Overall Study|Lost to Follow-up|0
1688426|NCT01320722|5895561|P5|Overall Study|Did not Receive Intervention|2
1688427|NCT01320722|5895562|P4|Overall Study|Did not Receive Intervention|1
1688428|NCT01320722|5895563|P3|Overall Study|Did not Receive Intervention|1
1688429|NCT01320722|5895564|P2|Overall Study|Did not Receive Intervention|2
1688430|NCT01320722|5895565|P1|Overall Study|Did not Receive Intervention|3
1688431|NCT01320683|5895602|P1|Overall Study|Positive antibody response|1
1688432|NCT01320293|5895628|P1|Overall Study|Adverse Event|1
1688433|NCT01320293|5895628|P1|Overall Study|Lack of Efficacy|1
1688434|NCT01320202|5895636|P2|Overall Study|regained renal function|0
1688435|NCT01320202|5895637|P1|Overall Study|regained renal function|1
1688436|NCT01320202|5895636|P2|Overall Study|ineligible|0
1688437|NCT01320202|5895637|P1|Overall Study|ineligible|3
1688438|NCT01320202|5895636|P2|Overall Study|sponsor request|0
1688439|NCT01320202|5895637|P1|Overall Study|sponsor request|2
1688440|NCT01320202|5895636|P2|Overall Study|moved/changed dialysis|2
1688441|NCT01320202|5895637|P1|Overall Study|moved/changed dialysis|5
1688442|NCT01320202|5895636|P2|Overall Study|blood transfusion|7
1688443|NCT01320202|5895637|P1|Overall Study|blood transfusion|1
1688444|NCT01320202|5895636|P2|Overall Study|kidney transplant|2
1688445|NCT01320202|5895637|P1|Overall Study|kidney transplant|1
1688446|NCT01320202|5895636|P2|Overall Study|non-protocol change to ESA or IV iron|20
1688447|NCT01320202|5895637|P1|Overall Study|non-protocol change to ESA or IV iron|17
1688448|NCT01320202|5895636|P2|Overall Study|Withdrawal by Subject|3
1688449|NCT01320202|5895637|P1|Overall Study|Withdrawal by Subject|10
1688450|NCT01320202|5895636|P2|Overall Study|Protocol Violation|1
1688451|NCT01320202|5895637|P1|Overall Study|Protocol Violation|2
1688452|NCT01320202|5895636|P2|Overall Study|Physician Decision|1
1688453|NCT01320202|5895637|P1|Overall Study|Physician Decision|3
1688454|NCT01320202|5895636|P2|Overall Study|Lost to Follow-up|0
1688455|NCT01320202|5895637|P1|Overall Study|Lost to Follow-up|1
1688456|NCT01320202|5895636|P2|Overall Study|Death|3
1688457|NCT01320202|5895637|P1|Overall Study|Death|5
1688458|NCT01320202|5895636|P2|Overall Study|Adverse Event|5
1688459|NCT01320202|5895637|P1|Overall Study|Adverse Event|5
1688460|NCT01320150|5895674|P1|Overall Study|Lost to Follow-up|44
1688461|NCT01320150|5895674|P1|Overall Study|Death|2
1688462|NCT01320150|5895674|P1|Overall Study|Withdrawal by Subject|5
1688463|NCT01320150|5895674|P1|Overall Study|Protocol Violation|15
1688464|NCT01320033|5895708|P3|Overall Study|Other|1
1688465|NCT01320033|5895709|P2|Overall Study|Other|3
1688466|NCT01320033|5895710|P1|Overall Study|Other|2
1688467|NCT01320033|5895708|P3|Overall Study|Lost to Follow-up|17
1688468|NCT01320033|5895709|P2|Overall Study|Lost to Follow-up|26
1688469|NCT01320033|5895710|P1|Overall Study|Lost to Follow-up|22
1688470|NCT01320033|5895708|P3|Overall Study|Protocol Violation|3
1688471|NCT01320033|5895709|P2|Overall Study|Protocol Violation|5
1688472|NCT01320033|5895710|P1|Overall Study|Protocol Violation|3
1688473|NCT01320033|5895708|P3|Overall Study|Withdrawal by Subject|23
1688474|NCT01320033|5895709|P2|Overall Study|Withdrawal by Subject|23
1688475|NCT01320033|5895710|P1|Overall Study|Withdrawal by Subject|22
1688476|NCT01320033|5895708|P3|Overall Study|Adverse Event|8
1688477|NCT01320033|5895709|P2|Overall Study|Adverse Event|7
1688478|NCT01320033|5895710|P1|Overall Study|Adverse Event|9
1688479|NCT01320033|5895708|P3|Overall Study|Lack of Efficacy|1
1688480|NCT01320033|5895709|P2|Overall Study|Lack of Efficacy|0
1688481|NCT01320033|5895710|P1|Overall Study|Lack of Efficacy|0
1688482|NCT01319994|5895738|P2|Overall Study|Protocol Violation|6
1688483|NCT01319994|5895739|P1|Overall Study|Protocol Violation|7
1688484|NCT01319877|5895749|P2|Overall Study|Reason Not Specified|5
1688485|NCT01319877|5895750|P1|Overall Study|Reason Not Specified|4
1688486|NCT01319877|5895749|P2|Overall Study|Withdrawal by Subject|1
1688487|NCT01319877|5895750|P1|Overall Study|Withdrawal by Subject|0
1688488|NCT01319877|5895749|P2|Overall Study|Disease Progression|2
1688489|NCT01319877|5895750|P1|Overall Study|Disease Progression|2
1688490|NCT01319877|5895749|P2|Overall Study|Physician Decision|0
1688491|NCT01319877|5895750|P1|Overall Study|Physician Decision|2
1688492|NCT01319877|5895749|P2|Overall Study|Lost to Follow-up|37
1688493|NCT01319877|5895750|P1|Overall Study|Lost to Follow-up|100
1688494|NCT01319721|5895918|P2|Overall Study|Lost to Follow-up|6
1688495|NCT01319721|5895919|P1|Overall Study|Lost to Follow-up|1
1688496|NCT01319422|5895972|P2|Overall Study|Withdrawal by Subject|0
1688497|NCT01319422|5895973|P1|Overall Study|Withdrawal by Subject|1
1688498|NCT01319383|5895991|P2|Overall Study|No in vivo response to interval doses|1
1688499|NCT01319383|5895992|P1|Overall Study|No in vivo response to interval doses|0
1688500|NCT01319383|5895991|P2|Overall Study|Lack of Efficacy|9
1688501|NCT01319383|5895992|P1|Overall Study|Lack of Efficacy|5
1688502|NCT01319383|5895991|P2|Overall Study|Physician Decision|0
1688503|NCT01319383|5895992|P1|Overall Study|Physician Decision|3
1688504|NCT01319383|5895991|P2|Overall Study|No ex vivo or in vivo response|0
1688505|NCT01319383|5895992|P1|Overall Study|No ex vivo or in vivo response|4
1688506|NCT01318993|5896031|P1|Overall Study|Withdrawal by Subject|24
1688507|NCT01318993|5896031|P1|Overall Study|Physician Decision|13
1688508|NCT01318993|5896031|P1|Overall Study|Lost to Follow-up|4
1688509|NCT01318993|5896031|P1|Overall Study|Study closed or terminated|174
1688510|NCT01318993|5896031|P1|Overall Study|Protocol based stopping criteria|6
1688511|NCT01318993|5896031|P1|Overall Study|Protocol Violation|3
1688512|NCT01318993|5896031|P1|Overall Study|Lack of Efficacy|121
1688513|NCT01318993|5896031|P1|Overall Study|Adverse Event|53
1688514|NCT01318915|5896052|P1|Overall Study|Lost to Follow-up|1
1688515|NCT01318876|5896077|P1|Day 29 Survey|survey not completed-don't know why|1825
1688516|NCT01318876|5896077|P1|Day 8 Survey|survey not completed-don't know why|1724
1688517|NCT01318876|5896077|P1|Day 8 Survey|email address invalid|96
1688518|NCT01318811|5896084|P2|Overall Study|CRRT stopped for head MRI|1
1688519|NCT01318811|5896085|P1|Overall Study|CRRT stopped for head MRI|0
1688520|NCT01318811|5896084|P2|Overall Study|Death|1
1688521|NCT01318811|5896085|P1|Overall Study|Death|0
1688522|NCT01318811|5896084|P2|Overall Study|CRRT stopped for head CT|1
1688523|NCT01318811|5896085|P1|Overall Study|CRRT stopped for head CT|0
1688524|NCT01318811|5896084|P2|Overall Study|Physician Decision|1
1688525|NCT01318811|5896085|P1|Overall Study|Physician Decision|1
1688526|NCT01318512|5896186|P1|Maintenance Period (6 Months)|Protocol Violation|9
1688527|NCT01318512|5896186|P1|Maintenance Period (6 Months)|Death|2
1688528|NCT01318499|5896205|P3|Overall Study|Other|22
1688529|NCT01318499|5896206|P2|Overall Study|Other|10
1688530|NCT01318499|5896207|P1|Overall Study|Other|7
1688531|NCT01318499|5896205|P3|Overall Study|Patient Did Not Use Study Medication|14
1688532|NCT01318499|5896206|P2|Overall Study|Patient Did Not Use Study Medication|28
1688533|NCT01318499|5896207|P1|Overall Study|Patient Did Not Use Study Medication|18
1688534|NCT01318499|5896205|P3|Overall Study|Protocol Violation|2
1688535|NCT01318499|5896206|P2|Overall Study|Protocol Violation|4
1688536|NCT01318499|5896207|P1|Overall Study|Protocol Violation|2
1688537|NCT01318499|5896205|P3|Overall Study|Treatment Failure|101
1688538|NCT01318499|5896206|P2|Overall Study|Treatment Failure|19
1688539|NCT01318499|5896207|P1|Overall Study|Treatment Failure|19
1688540|NCT01318499|5896205|P3|Overall Study|Noncompliance|0
1688541|NCT01318499|5896206|P2|Overall Study|Noncompliance|3
1688542|NCT01318499|5896207|P1|Overall Study|Noncompliance|2
1688543|NCT01318499|5896205|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
1688544|NCT01318499|5896206|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
1688545|NCT01318499|5896207|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
1688546|NCT01318499|5896205|P3|Overall Study|Adverse Event|6
1688547|NCT01318499|5896206|P2|Overall Study|Adverse Event|11
1688548|NCT01318499|5896207|P1|Overall Study|Adverse Event|16
1688549|NCT01318382|5896230|P1|Overall Study|Protocol Violation|1
1688550|NCT01318382|5896230|P1|Overall Study|Device Malfunction|10
1688551|NCT01318382|5896230|P1|Overall Study|Physician Decision|2
1688552|NCT01318135|5896288|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
1688553|NCT01318135|5896289|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1688554|NCT01318135|5896290|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1688555|NCT01318135|5896291|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1688556|NCT01318135|5896292|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1688557|NCT01318135|5896293|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1688558|NCT01318135|5896294|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1688559|NCT01318135|5896295|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
1688560|NCT01318135|5896288|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
1688561|NCT01318135|5896289|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
1688562|NCT01318135|5896290|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
1688563|NCT01318135|5896291|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
1688564|NCT01318135|5896292|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
1688565|NCT01318135|5896293|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
1688566|NCT01318135|5896294|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
1688567|NCT01318135|5896295|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
1688568|NCT01318135|5896288|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1688569|NCT01318135|5896289|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1688570|NCT01318135|5896290|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1688571|NCT01318135|5896291|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1688572|NCT01318135|5896292|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1688573|NCT01318135|5896293|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1688574|NCT01318135|5896294|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1688575|NCT01318135|5896295|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1688576|NCT01318135|5896288|P8|Entered - Long-Term Extension Study|Protocol Violation|0
1688577|NCT01318135|5896289|P7|Entered - Long-Term Extension Study|Protocol Violation|0
1688578|NCT01318135|5896290|P6|Entered - Long-Term Extension Study|Protocol Violation|0
1688579|NCT01318135|5896291|P5|Entered - Long-Term Extension Study|Protocol Violation|1
1688580|NCT01318135|5896292|P4|Entered - Long-Term Extension Study|Protocol Violation|0
1688581|NCT01318135|5896293|P3|Entered - Long-Term Extension Study|Protocol Violation|0
1688582|NCT01318135|5896294|P2|Entered - Long-Term Extension Study|Protocol Violation|1
1688583|NCT01318135|5896295|P1|Entered - Long-Term Extension Study|Protocol Violation|1
1688584|NCT01318135|5896288|P8|Entered - Long-Term Extension Study|Adverse Event|0
1688585|NCT01318135|5896289|P7|Entered - Long-Term Extension Study|Adverse Event|0
1688586|NCT01318135|5896290|P6|Entered - Long-Term Extension Study|Adverse Event|2
1688587|NCT01318135|5896291|P5|Entered - Long-Term Extension Study|Adverse Event|4
1688588|NCT01318135|5896292|P4|Entered - Long-Term Extension Study|Adverse Event|3
1688589|NCT01318135|5896293|P3|Entered - Long-Term Extension Study|Adverse Event|4
1688590|NCT01318135|5896294|P2|Entered - Long-Term Extension Study|Adverse Event|3
1688591|NCT01318135|5896295|P1|Entered - Long-Term Extension Study|Adverse Event|9
1688592|NCT01318135|5896288|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
1688593|NCT01318135|5896289|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
1688594|NCT01318135|5896290|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
1688595|NCT01318135|5896291|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
1688596|NCT01318135|5896292|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
1688597|NCT01318135|5896293|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
1688598|NCT01318135|5896294|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
1688599|NCT01318135|5896295|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
1688600|NCT01318135|5896288|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
1688601|NCT01318135|5896289|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
1688602|NCT01318135|5896290|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
1688603|NCT01318135|5896291|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
1688604|NCT01318135|5896292|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
1688605|NCT01318135|5896293|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
1688606|NCT01318135|5896294|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1688607|NCT01318135|5896295|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
1688608|NCT01318122|5896427|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
1688609|NCT01318122|5896428|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
1688610|NCT01318122|5896429|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
1688611|NCT01318122|5896430|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
1688612|NCT01318122|5896427|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1688613|NCT01318122|5896428|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1688614|NCT01318122|5896429|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
1688615|NCT01318122|5896430|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1688616|NCT01318122|5896427|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
1688617|NCT01318122|5896428|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
1688618|NCT01318122|5896429|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
1688619|NCT01318122|5896430|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
1688620|NCT01318122|5896427|P4|Entered - Long-Term Extension Study|Adverse Event|4
1688621|NCT01318122|5896428|P3|Entered - Long-Term Extension Study|Adverse Event|2
1688622|NCT01318122|5896429|P2|Entered - Long-Term Extension Study|Adverse Event|6
1688623|NCT01318122|5896430|P1|Entered - Long-Term Extension Study|Adverse Event|6
1688624|NCT01318122|5896427|P4|Enrolled - Long-Term Extension Study|Other|0
1688625|NCT01318122|5896428|P3|Enrolled - Long-Term Extension Study|Other|0
1688626|NCT01318122|5896429|P2|Enrolled - Long-Term Extension Study|Other|0
1688627|NCT01318122|5896430|P1|Enrolled - Long-Term Extension Study|Other|1
1688628|NCT01318122|5896427|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
1688629|NCT01318122|5896428|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
1688630|NCT01318122|5896429|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1688631|NCT01318122|5896430|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
1688632|NCT01318109|5896499|P3|Overall Study|Schedule Conflict|0
1688633|NCT01318109|5896500|P2|Overall Study|Schedule Conflict|1
1688634|NCT01318109|5896501|P1|Overall Study|Schedule Conflict|0
1688635|NCT01318109|5896499|P3|Overall Study|Withdrawal by Subject|0
1688636|NCT01318109|5896500|P2|Overall Study|Withdrawal by Subject|0
1688637|NCT01318109|5896501|P1|Overall Study|Withdrawal by Subject|1
1688638|NCT01318109|5896499|P3|Overall Study|Adverse Event|0
1688639|NCT01318109|5896500|P2|Overall Study|Adverse Event|2
1688640|NCT01318109|5896501|P1|Overall Study|Adverse Event|0
1688641|NCT01318083|5896536|P3|Overall Study|Lack of Study Medication Compliance|0
1688642|NCT01318083|5896537|P2|Overall Study|Lack of Study Medication Compliance|1
1688643|NCT01318083|5896538|P1|Overall Study|Lack of Study Medication Compliance|0
1688644|NCT01318083|5896536|P3|Overall Study|Treatment Complications|0
1688645|NCT01318083|5896537|P2|Overall Study|Treatment Complications|0
1688646|NCT01318083|5896538|P1|Overall Study|Treatment Complications|1
1688647|NCT01318083|5896536|P3|Overall Study|Lack of Efficacy|1
1688648|NCT01318083|5896537|P2|Overall Study|Lack of Efficacy|0
1688649|NCT01318083|5896538|P1|Overall Study|Lack of Efficacy|0
1688650|NCT01318083|5896536|P3|Overall Study|Withdrawal by Subject|2
1688651|NCT01318083|5896537|P2|Overall Study|Withdrawal by Subject|0
1688652|NCT01318083|5896538|P1|Overall Study|Withdrawal by Subject|1
1688653|NCT01318083|5896536|P3|Overall Study|Adverse Event|2
1688654|NCT01318083|5896537|P2|Overall Study|Adverse Event|1
1688655|NCT01318083|5896538|P1|Overall Study|Adverse Event|4
1688656|NCT01318070|5896573|P3|Overall Study|Principal Investigator Discretion|0
1688657|NCT01318070|5896574|P2|Overall Study|Principal Investigator Discretion|0
1688658|NCT01318070|5896575|P1|Overall Study|Principal Investigator Discretion|1
1688659|NCT01318070|5896573|P3|Overall Study|Lack of Efficacy|1
1688660|NCT01318070|5896574|P2|Overall Study|Lack of Efficacy|0
1688661|NCT01318070|5896575|P1|Overall Study|Lack of Efficacy|0
1688662|NCT01318070|5896573|P3|Overall Study|Withdrawal by Subject|1
1688663|NCT01318070|5896574|P2|Overall Study|Withdrawal by Subject|1
1688664|NCT01318070|5896575|P1|Overall Study|Withdrawal by Subject|0
1688665|NCT01318070|5896573|P3|Overall Study|Adverse Event|5
1688666|NCT01318070|5896574|P2|Overall Study|Adverse Event|1
1688667|NCT01318070|5896575|P1|Overall Study|Adverse Event|1
1688668|NCT01317797|5896628|P3|Overall Study|Withdrawal of Patient|1
1688669|NCT01317797|5896629|P2|Overall Study|Withdrawal of Patient|0
1688670|NCT01317797|5896630|P1|Overall Study|Withdrawal of Patient|0
1688671|NCT01317797|5896628|P3|Overall Study|Other|0
1688672|NCT01317797|5896629|P2|Overall Study|Other|1
1688673|NCT01317797|5896630|P1|Overall Study|Other|0
1688674|NCT01317641|5896707|P9|Overall Study|Withdrawal by Subject|0
1688675|NCT01317641|5896708|P8|Overall Study|Withdrawal by Subject|0
1688676|NCT01317641|5896709|P7|Overall Study|Withdrawal by Subject|1
1688677|NCT01317641|5896710|P6|Overall Study|Withdrawal by Subject|0
1688678|NCT01317641|5896711|P5|Overall Study|Withdrawal by Subject|0
1688679|NCT01317641|5896712|P4|Overall Study|Withdrawal by Subject|0
1688680|NCT01317641|5896713|P3|Overall Study|Withdrawal by Subject|0
1688681|NCT01317641|5896714|P2|Overall Study|Withdrawal by Subject|0
1688682|NCT01317641|5896715|P1|Overall Study|Withdrawal by Subject|0
1688683|NCT01317641|5896707|P9|Overall Study|Disease progression|4
1688684|NCT01317641|5896708|P8|Overall Study|Disease progression|3
1688685|NCT01317641|5896709|P7|Overall Study|Disease progression|0
1688686|NCT01317641|5896710|P6|Overall Study|Disease progression|0
1688687|NCT01317641|5896711|P5|Overall Study|Disease progression|0
1688688|NCT01317641|5896712|P4|Overall Study|Disease progression|0
1688689|NCT01317641|5896713|P3|Overall Study|Disease progression|0
1688690|NCT01317641|5896714|P2|Overall Study|Disease progression|0
1688691|NCT01317641|5896715|P1|Overall Study|Disease progression|0
1688692|NCT01317641|5896707|P9|Overall Study|Protocol Violation|0
1688693|NCT01317641|5896708|P8|Overall Study|Protocol Violation|0
1688694|NCT01317641|5896709|P7|Overall Study|Protocol Violation|0
1688695|NCT01317641|5896710|P6|Overall Study|Protocol Violation|0
1688696|NCT01317641|5896711|P5|Overall Study|Protocol Violation|0
1688697|NCT01317641|5896712|P4|Overall Study|Protocol Violation|0
1688698|NCT01317641|5896713|P3|Overall Study|Protocol Violation|0
1688699|NCT01317641|5896714|P2|Overall Study|Protocol Violation|0
1688700|NCT01317641|5896715|P1|Overall Study|Protocol Violation|1
1688701|NCT01317641|5896707|P9|Overall Study|Adverse Event|0
1688702|NCT01317641|5896708|P8|Overall Study|Adverse Event|1
1688703|NCT01317641|5896709|P7|Overall Study|Adverse Event|2
1688704|NCT01317641|5896710|P6|Overall Study|Adverse Event|0
1688705|NCT01317641|5896711|P5|Overall Study|Adverse Event|0
1688706|NCT01317641|5896712|P4|Overall Study|Adverse Event|1
1688707|NCT01317641|5896713|P3|Overall Study|Adverse Event|0
1688708|NCT01317641|5896714|P2|Overall Study|Adverse Event|1
1688709|NCT01317641|5896715|P1|Overall Study|Adverse Event|0
1688710|NCT01317641|5896707|P9|Overall Study|Not treated|1
1688711|NCT01317641|5896708|P8|Overall Study|Not treated|1
1688712|NCT01317641|5896709|P7|Overall Study|Not treated|0
1688713|NCT01317641|5896710|P6|Overall Study|Not treated|0
1688714|NCT01317641|5896711|P5|Overall Study|Not treated|0
1688715|NCT01317641|5896712|P4|Overall Study|Not treated|0
1688716|NCT01317641|5896713|P3|Overall Study|Not treated|0
1688717|NCT01317641|5896714|P2|Overall Study|Not treated|0
1688718|NCT01317641|5896715|P1|Overall Study|Not treated|0
1688719|NCT01317615|5896817|P1|Overall Study|Adverse Event|7
1688720|NCT01317615|5896817|P1|Overall Study|Abnormal laboratory value(s)|1
1688721|NCT01317615|5896817|P1|Overall Study|Withdrawal by Subject|5
1688722|NCT01317615|5896817|P1|Overall Study|Death|6
1688723|NCT01317615|5896817|P1|Overall Study|New cancer therapy|5
1688724|NCT01317615|5896817|P1|Overall Study|Disease progression|25
1688725|NCT01317550|5896830|P4|Overall Study|Lack of compliance study med|0
1688726|NCT01317550|5896831|P3|Overall Study|Lack of compliance study med|0
1688727|NCT01317550|5896832|P2|Overall Study|Lack of compliance study med|0
1688728|NCT01317550|5896833|P1|Overall Study|Lack of compliance study med|1
1688729|NCT01317550|5896830|P4|Overall Study|Withdrawal by Subject|0
1688730|NCT01317550|5896831|P3|Overall Study|Withdrawal by Subject|0
1688731|NCT01317550|5896832|P2|Overall Study|Withdrawal by Subject|0
1688732|NCT01317550|5896833|P1|Overall Study|Withdrawal by Subject|1
1688733|NCT01317472|5896845|P2|Overall Study|Unrelated hospitalization|0
1688734|NCT01317472|5896846|P1|Overall Study|Unrelated hospitalization|1
1688735|NCT01317472|5896845|P2|Overall Study|Withdrawal by Subject|0
1688736|NCT01317472|5896846|P1|Overall Study|Withdrawal by Subject|1
1688737|NCT01317199|5896856|P4|Randomized Phase 2|Patient transferred to other facility|0
1688738|NCT01317199|5896857|P3|Randomized Phase 2|Patient transferred to other facility|1
1688739|NCT01317199|5896858|P2|Randomized Phase 2|Patient transferred to other facility|0
1688740|NCT01317199|5896859|P1|Randomized Phase 2|Patient transferred to other facility|0
1688741|NCT01317199|5896856|P4|Randomized Phase 2|Patient stopped taking study drug|1
1688742|NCT01317199|5896857|P3|Randomized Phase 2|Patient stopped taking study drug|0
1688743|NCT01317199|5896858|P2|Randomized Phase 2|Patient stopped taking study drug|0
1688744|NCT01317199|5896859|P1|Randomized Phase 2|Patient stopped taking study drug|0
1688745|NCT01317199|5896856|P4|Randomized Phase 2|Disenrolled before treatment|2
1688746|NCT01317199|5896857|P3|Randomized Phase 2|Disenrolled before treatment|1
1688747|NCT01317199|5896858|P2|Randomized Phase 2|Disenrolled before treatment|1
1688748|NCT01317199|5896859|P1|Randomized Phase 2|Disenrolled before treatment|0
1688749|NCT01317199|5896856|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
1688750|NCT01317199|5896857|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
1688751|NCT01317199|5896858|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
1688752|NCT01317199|5896859|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
1688753|NCT01317199|5896856|P4|Randomized Phase 2|Comorbidities|2
1688754|NCT01317199|5896857|P3|Randomized Phase 2|Comorbidities|2
1688755|NCT01317199|5896858|P2|Randomized Phase 2|Comorbidities|2
1688756|NCT01317199|5896859|P1|Randomized Phase 2|Comorbidities|0
1688757|NCT01317199|5896856|P4|Randomized Phase 2|Adverse Event|1
1688758|NCT01317199|5896857|P3|Randomized Phase 2|Adverse Event|0
1688759|NCT01317199|5896858|P2|Randomized Phase 2|Adverse Event|0
1688760|NCT01317199|5896859|P1|Randomized Phase 2|Adverse Event|0
1688761|NCT01317199|5896856|P4|Randomized Phase 2|Withdrawal by Subject|4
1688762|NCT01317199|5896857|P3|Randomized Phase 2|Withdrawal by Subject|5
1688763|NCT01317199|5896858|P2|Randomized Phase 2|Withdrawal by Subject|3
1688764|NCT01317199|5896859|P1|Randomized Phase 2|Withdrawal by Subject|0
1688765|NCT01317199|5896856|P4|Randomized Phase 2|Disease progression|5
1688766|NCT01317199|5896857|P3|Randomized Phase 2|Disease progression|7
1688767|NCT01317199|5896858|P2|Randomized Phase 2|Disease progression|3
1688768|NCT01317199|5896859|P1|Randomized Phase 2|Disease progression|0
1688769|NCT01317199|5896856|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1688770|NCT01317199|5896857|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1688771|NCT01317199|5896858|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
1688772|NCT01317199|5896859|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
1688773|NCT01317199|5896856|P4|Dose-escalation Phase 1|Disease progression|0
1688774|NCT01317199|5896857|P3|Dose-escalation Phase 1|Disease progression|0
1688775|NCT01317199|5896858|P2|Dose-escalation Phase 1|Disease progression|0
1688776|NCT01317199|5896859|P1|Dose-escalation Phase 1|Disease progression|1
1688777|NCT01317199|5896856|P4|Dose-escalation Phase 1|Physician Decision|0
1688778|NCT01317199|5896857|P3|Dose-escalation Phase 1|Physician Decision|0
1688779|NCT01317199|5896858|P2|Dose-escalation Phase 1|Physician Decision|0
1688780|NCT01317199|5896859|P1|Dose-escalation Phase 1|Physician Decision|5
1688787|NCT01317004|5896923|P2|Overall Study|Adverse Event|3
1688788|NCT01317004|5896924|P1|Overall Study|Adverse Event|3
1688789|NCT01317004|5896923|P2|Overall Study|Protocol Violation|2
1688790|NCT01317004|5896924|P1|Overall Study|Protocol Violation|0
1688791|NCT01317004|5896923|P2|Overall Study|Withdrawal by Subject|4
1688792|NCT01317004|5896924|P1|Overall Study|Withdrawal by Subject|1
1688793|NCT01316939|5896945|P3|Overall Study|Protocol Violation|0
1688794|NCT01316939|5896946|P2|Overall Study|Protocol Violation|1
1688795|NCT01316939|5896947|P1|Overall Study|Protocol Violation|0
1688796|NCT01316939|5896945|P3|Overall Study|Met Liver chemistry stopping criteria|1
1688797|NCT01316939|5896946|P2|Overall Study|Met Liver chemistry stopping criteria|0
1688798|NCT01316939|5896947|P1|Overall Study|Met Liver chemistry stopping criteria|1
1688799|NCT01316939|5896945|P3|Overall Study|Lost to Follow-up|2
1688800|NCT01316939|5896946|P2|Overall Study|Lost to Follow-up|0
1688801|NCT01316939|5896947|P1|Overall Study|Lost to Follow-up|0
1688802|NCT01316939|5896945|P3|Overall Study|Physician Decision|1
1688803|NCT01316939|5896946|P2|Overall Study|Physician Decision|2
1688804|NCT01316939|5896947|P1|Overall Study|Physician Decision|2
1688805|NCT01316939|5896945|P3|Overall Study|Withdrawal by Subject|6
1688806|NCT01316939|5896946|P2|Overall Study|Withdrawal by Subject|3
1688807|NCT01316939|5896947|P1|Overall Study|Withdrawal by Subject|1
1688808|NCT01316939|5896945|P3|Overall Study|Adverse Event|11
1688809|NCT01316939|5896946|P2|Overall Study|Adverse Event|12
1688810|NCT01316939|5896947|P1|Overall Study|Adverse Event|9
1688811|NCT01316939|5896945|P3|Overall Study|Lack of Efficacy|25
1688812|NCT01316939|5896946|P2|Overall Study|Lack of Efficacy|25
1688813|NCT01316939|5896947|P1|Overall Study|Lack of Efficacy|24
1688814|NCT01316939|5896945|P3|Overall Study|Study closed/terminated|23
1688815|NCT01316939|5896946|P2|Overall Study|Study closed/terminated|25
1688816|NCT01316939|5896947|P1|Overall Study|Study closed/terminated|26
1688817|NCT01316913|5897042|P4|Overall Study|Withdrawal by Subject|6
1688818|NCT01316913|5897043|P3|Overall Study|Withdrawal by Subject|10
1688819|NCT01316913|5897044|P2|Overall Study|Withdrawal by Subject|9
1688820|NCT01316913|5897045|P1|Overall Study|Withdrawal by Subject|10
1688821|NCT01316913|5897042|P4|Overall Study|Lost to Follow-up|2
1688822|NCT01316913|5897043|P3|Overall Study|Lost to Follow-up|0
1688823|NCT01316913|5897044|P2|Overall Study|Lost to Follow-up|1
1688824|NCT01316913|5897045|P1|Overall Study|Lost to Follow-up|0
1688825|NCT01316913|5897042|P4|Overall Study|Protocol-defined Stopping Criteria|6
1688826|NCT01316913|5897043|P3|Overall Study|Protocol-defined Stopping Criteria|11
1688827|NCT01316913|5897044|P2|Overall Study|Protocol-defined Stopping Criteria|8
1688828|NCT01316913|5897045|P1|Overall Study|Protocol-defined Stopping Criteria|7
1688829|NCT01316913|5897042|P4|Overall Study|Protocol Violation|1
1688830|NCT01316913|5897043|P3|Overall Study|Protocol Violation|4
1688831|NCT01316913|5897044|P2|Overall Study|Protocol Violation|4
1688832|NCT01316913|5897045|P1|Overall Study|Protocol Violation|1
1688833|NCT01316913|5897042|P4|Overall Study|Lack of Efficacy|13
1688834|NCT01316913|5897043|P3|Overall Study|Lack of Efficacy|9
1688835|NCT01316913|5897044|P2|Overall Study|Lack of Efficacy|12
1688836|NCT01316913|5897045|P1|Overall Study|Lack of Efficacy|22
1688837|NCT01316913|5897042|P4|Overall Study|Adverse Event|11
1688838|NCT01316913|5897043|P3|Overall Study|Adverse Event|15
1688839|NCT01316913|5897044|P2|Overall Study|Adverse Event|20
1688840|NCT01316913|5897045|P1|Overall Study|Adverse Event|17
1688841|NCT01316900|5897067|P4|Overall Study|Withdrawal by Subject|9
1688842|NCT01316900|5897068|P3|Overall Study|Withdrawal by Subject|6
1688843|NCT01316900|5897069|P2|Overall Study|Withdrawal by Subject|8
1688844|NCT01316900|5897070|P1|Overall Study|Withdrawal by Subject|7
1688845|NCT01316900|5897067|P4|Overall Study|Lost to Follow-up|1
1688846|NCT01316900|5897068|P3|Overall Study|Lost to Follow-up|1
1688847|NCT01316900|5897069|P2|Overall Study|Lost to Follow-up|0
1688848|NCT01316900|5897070|P1|Overall Study|Lost to Follow-up|1
1688849|NCT01316900|5897067|P4|Overall Study|Protocol-defined Stopping Criteria|5
1688850|NCT01316900|5897068|P3|Overall Study|Protocol-defined Stopping Criteria|10
1688851|NCT01316900|5897069|P2|Overall Study|Protocol-defined Stopping Criteria|3
1688852|NCT01316900|5897070|P1|Overall Study|Protocol-defined Stopping Criteria|2
1688853|NCT01316900|5897067|P4|Overall Study|Protocol Violation|0
1688854|NCT01316900|5897068|P3|Overall Study|Protocol Violation|4
1688855|NCT01316900|5897069|P2|Overall Study|Protocol Violation|1
1688856|NCT01316900|5897070|P1|Overall Study|Protocol Violation|7
1688857|NCT01316900|5897067|P4|Overall Study|Lack of Efficacy|7
1688858|NCT01316900|5897068|P3|Overall Study|Lack of Efficacy|5
1688859|NCT01316900|5897069|P2|Overall Study|Lack of Efficacy|9
1688860|NCT01316900|5897070|P1|Overall Study|Lack of Efficacy|17
1688861|NCT01316900|5897067|P4|Overall Study|Adverse Event|9
1688862|NCT01316900|5897068|P3|Overall Study|Adverse Event|15
1688863|NCT01316900|5897069|P2|Overall Study|Adverse Event|10
1688864|NCT01316900|5897070|P1|Overall Study|Adverse Event|10
1688865|NCT01316887|5897091|P3|Overall Study|Withdrawal by Subject|15
1688866|NCT01316887|5897092|P2|Overall Study|Withdrawal by Subject|16
1688867|NCT01316887|5897093|P1|Overall Study|Withdrawal by Subject|8
1688868|NCT01316887|5897091|P3|Overall Study|Lost to Follow-up|5
1688869|NCT01316887|5897092|P2|Overall Study|Lost to Follow-up|7
1688870|NCT01316887|5897093|P1|Overall Study|Lost to Follow-up|1
1688871|NCT01316887|5897091|P3|Overall Study|Study Closed/Terminated|3
1688872|NCT01316887|5897092|P2|Overall Study|Study Closed/Terminated|4
1688873|NCT01316887|5897093|P1|Overall Study|Study Closed/Terminated|2
1688874|NCT01316887|5897091|P3|Overall Study|Protocol-defined Stopping Criteria|36
1688875|NCT01316887|5897092|P2|Overall Study|Protocol-defined Stopping Criteria|37
1688876|NCT01316887|5897093|P1|Overall Study|Protocol-defined Stopping Criteria|8
1688877|NCT01316887|5897091|P3|Overall Study|Protocol Violation|6
1688878|NCT01316887|5897092|P2|Overall Study|Protocol Violation|6
1688879|NCT01316887|5897093|P1|Overall Study|Protocol Violation|2
1688880|NCT01316887|5897091|P3|Overall Study|Lack of Efficacy|1
1688881|NCT01316887|5897092|P2|Overall Study|Lack of Efficacy|3
1688882|NCT01316887|5897093|P1|Overall Study|Lack of Efficacy|9
1688883|NCT01316887|5897091|P3|Overall Study|Adverse Event|17
1688884|NCT01316887|5897092|P2|Overall Study|Adverse Event|21
1688885|NCT01316887|5897093|P1|Overall Study|Adverse Event|13
1688886|NCT01316692|5897218|P1|Overall Study|Disease Progression|7
1688887|NCT01316692|5897218|P1|Overall Study|Adverse Event|5
1688888|NCT01316614|5897227|P1|Overall Study|Medically unstable|1
1688889|NCT01316614|5897227|P1|Overall Study|Inadequate number of passes|2
1688890|NCT01316614|5897227|P1|Overall Study|Cystic lesion|5
1688891|NCT01316614|5897227|P1|Overall Study|Cytology slides not available for review|4
1688892|NCT01316614|5897227|P1|Overall Study|No solid lesion and FNA not indicated|25
1688893|NCT01316575|5897244|P2|Overall Study|Required alternate treatment|1
1688894|NCT01316575|5897245|P1|Overall Study|Required alternate treatment|0
1688895|NCT01316575|5897244|P2|Overall Study|Withdrawal by Subject|0
1688896|NCT01316575|5897245|P1|Overall Study|Withdrawal by Subject|2
1688897|NCT01316419|5897268|P1|Overall Study|Lost to Follow-up|19
1688898|NCT01316419|5897268|P1|Overall Study|Violated inclusion/exclusion criterion|143
1688899|NCT01316419|5897268|P1|Overall Study|Not treated|103
1688900|NCT01316380|5897294|P3|Overall Study|Not treated|0
1688901|NCT01316380|5897295|P2|Overall Study|Not treated|0
1688902|NCT01316380|5897296|P1|Overall Study|Not treated|1
1688903|NCT01316380|5897294|P3|Overall Study|Other|1
1688904|NCT01316380|5897295|P2|Overall Study|Other|1
1688905|NCT01316380|5897296|P1|Overall Study|Other|0
1688906|NCT01316380|5897294|P3|Overall Study|Withdrawal by Subject|0
1688907|NCT01316380|5897295|P2|Overall Study|Withdrawal by Subject|2
1688908|NCT01316380|5897296|P1|Overall Study|Withdrawal by Subject|1
1688909|NCT01316380|5897294|P3|Overall Study|Protocol Violation|1
1688910|NCT01316380|5897295|P2|Overall Study|Protocol Violation|0
1688911|NCT01316380|5897296|P1|Overall Study|Protocol Violation|0
1688912|NCT01316380|5897294|P3|Overall Study|Adverse Event|1
1688913|NCT01316380|5897295|P2|Overall Study|Adverse Event|2
1688914|NCT01316380|5897296|P1|Overall Study|Adverse Event|0
1688915|NCT01316276|5897433|P1|Overall Study|Other|22
1688916|NCT01316276|5897433|P1|Overall Study|Lost to Follow-up|1
1688917|NCT01316276|5897433|P1|Overall Study|Withdrawal of consent|24
1688918|NCT01316276|5897433|P1|Overall Study|Adverse Event|19
1688919|NCT01316276|5897433|P1|Overall Study|Death|1
1688920|NCT01316224|5897481|P1|Overall Study|Other|1
1688921|NCT01316224|5897481|P1|Overall Study|Adverse Event With Treatment Failure|1
1688922|NCT01316224|5897481|P1|Overall Study|Withdrawal by Subject|1
1688923|NCT01316224|5897481|P1|Overall Study|Lack of Efficacy|1
1688924|NCT01316224|5897481|P1|Overall Study|Adverse Event|3
1688925|NCT01316224|5897481|P1|Overall Study|Protocol Violation|3
1688926|NCT01316055|5897498|P3|Overall Study|Lost to Follow-up|0
1688927|NCT01316055|5897499|P2|Overall Study|Lost to Follow-up|0
1688928|NCT01316055|5897500|P1|Overall Study|Lost to Follow-up|1
1688929|NCT01315847|5897531|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
1688930|NCT01315847|5897532|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
1688931|NCT01315847|5897531|P2|Part I, Period 1|Reached maximum number of arterial lines|0
1688932|NCT01315847|5897532|P1|Part I, Period 1|Reached maximum number of arterial lines|3
1688933|NCT01315678|5897546|P2|Overall Study|similar reason to those listed above|2
1688934|NCT01315678|5897547|P1|Overall Study|similar reason to those listed above|3
1688935|NCT01315678|5897546|P2|Overall Study|Lost to Follow-up|0
1688936|NCT01315678|5897547|P1|Overall Study|Lost to Follow-up|1
1688937|NCT01315678|5897546|P2|Overall Study|Adverse Event|1
1688938|NCT01315678|5897547|P1|Overall Study|Adverse Event|3
1688939|NCT01315678|5897546|P2|Overall Study|Withdrawal by Subject|3
1688940|NCT01315678|5897547|P1|Overall Study|Withdrawal by Subject|7
1688941|NCT01315353|5897598|P3|Overall Study|Inadvertent randomization/assignment|2
1688942|NCT01315353|5897599|P2|Overall Study|Inadvertent randomization/assignment|0
1688943|NCT01315353|5897600|P1|Overall Study|Inadvertent randomization/assignment|0
1688944|NCT01315353|5897598|P3|Overall Study|Taken off study by site in error|0
1688945|NCT01315353|5897599|P2|Overall Study|Taken off study by site in error|1
1688946|NCT01315353|5897600|P1|Overall Study|Taken off study by site in error|0
1688947|NCT01315353|5897598|P3|Overall Study|Site closing|0
1688948|NCT01315353|5897599|P2|Overall Study|Site closing|4
1688949|NCT01315353|5897600|P1|Overall Study|Site closing|7
1688950|NCT01315353|5897598|P3|Overall Study|Unwilling to adhere to requirements|4
1688951|NCT01315353|5897599|P2|Overall Study|Unwilling to adhere to requirements|5
1688952|NCT01315353|5897600|P1|Overall Study|Unwilling to adhere to requirements|5
1688953|NCT01315353|5897598|P3|Overall Study|Lost to Follow-up|6
1688954|NCT01315353|5897599|P2|Overall Study|Lost to Follow-up|6
1688955|NCT01315353|5897600|P1|Overall Study|Lost to Follow-up|13
1688956|NCT01315353|5897598|P3|Overall Study|Withdrawal by Subject|1
1688957|NCT01315353|5897599|P2|Overall Study|Withdrawal by Subject|6
1688958|NCT01315353|5897600|P1|Overall Study|Withdrawal by Subject|2
1688959|NCT01315353|5897598|P3|Overall Study|Death|0
1688960|NCT01315353|5897599|P2|Overall Study|Death|1
1688961|NCT01315353|5897600|P1|Overall Study|Death|2
1688962|NCT01315249|5897627|P2|Overall Study|Death|1
1688963|NCT01315249|5897628|P1|Overall Study|Death|0
1688964|NCT01315249|5897627|P2|Overall Study|Lost to Follow-up|2
1688965|NCT01315249|5897628|P1|Overall Study|Lost to Follow-up|0
1688966|NCT01315249|5897627|P2|Overall Study|Lack of Efficacy|1
1688967|NCT01315249|5897628|P1|Overall Study|Lack of Efficacy|0
1688968|NCT01315249|5897627|P2|Overall Study|inability to use device|0
1688969|NCT01315249|5897628|P1|Overall Study|inability to use device|1
1688970|NCT01315249|5897627|P2|Overall Study|Administrative problems|0
1688971|NCT01315249|5897628|P1|Overall Study|Administrative problems|1
1688972|NCT01315249|5897627|P2|Overall Study|Abnormal test results|2
1688973|NCT01315249|5897628|P1|Overall Study|Abnormal test results|1
1688974|NCT01315249|5897627|P2|Overall Study|Protocol Violation|5
1688975|NCT01315249|5897628|P1|Overall Study|Protocol Violation|8
1688976|NCT01315249|5897627|P2|Overall Study|Withdrawal by Subject|10
1688977|NCT01315249|5897628|P1|Overall Study|Withdrawal by Subject|11
1688978|NCT01315249|5897627|P2|Overall Study|Adverse Event|26
1688979|NCT01315249|5897628|P1|Overall Study|Adverse Event|22
1688980|NCT01315236|5897656|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
1688981|NCT01315236|5897657|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
1688982|NCT01315236|5897656|P2|12-Month Follow-up Period|Death|1
1688983|NCT01315236|5897657|P1|12-Month Follow-up Period|Death|0
1688984|NCT01315236|5897656|P2|Open-label Phase|Other|1
1688985|NCT01315236|5897657|P1|Open-label Phase|Other|0
1688986|NCT01315236|5897656|P2|Open-label Phase|Adverse Event|1
1688987|NCT01315236|5897657|P1|Open-label Phase|Adverse Event|0
1688988|NCT01315236|5897656|P2|Open-label Phase|Death|0
1688989|NCT01315236|5897657|P1|Open-label Phase|Death|1
1688990|NCT01315236|5897656|P2|Double-blind Phase|Lost to Follow-up|0
1688991|NCT01315236|5897657|P1|Double-blind Phase|Lost to Follow-up|1
1688992|NCT01315236|5897656|P2|Double-blind Phase|Withdrawal of Consent|0
1688993|NCT01315236|5897657|P1|Double-blind Phase|Withdrawal of Consent|1
1688994|NCT01315236|5897656|P2|Double-blind Phase|Adverse Event|0
1688995|NCT01315236|5897657|P1|Double-blind Phase|Adverse Event|1
1688996|NCT01315236|5897656|P2|Double-blind Phase|Death|0
1688997|NCT01315236|5897657|P1|Double-blind Phase|Death|1
1688998|NCT01315132|5897713|P1|Overall Study|not treated due to disease progression|1
1688999|NCT01315028|5897720|P2|Overall Study|Death|1
1689000|NCT01315028|5897721|P1|Overall Study|Death|0
1689001|NCT01315028|5897720|P2|Overall Study|Lost to Follow-up|0
1689002|NCT01315028|5897721|P1|Overall Study|Lost to Follow-up|1
1689003|NCT01314911|5897748|P2|Overall Study|Never Started Treatment|0
1689004|NCT01314911|5897749|P1|Overall Study|Never Started Treatment|1
1689005|NCT01314911|5897748|P2|Overall Study|Received Non-randomized Study Drug|1
1689006|NCT01314911|5897749|P1|Overall Study|Received Non-randomized Study Drug|0
1689007|NCT01314911|5897748|P2|Overall Study|Withdrawal by Subject|3
1689008|NCT01314911|5897749|P1|Overall Study|Withdrawal by Subject|1
1689009|NCT01314911|5897748|P2|Overall Study|Lost to Follow-up|2
1689010|NCT01314911|5897749|P1|Overall Study|Lost to Follow-up|3
1689011|NCT01314872|5897800|P15|Period 2|Lost to Follow-up|6
1689012|NCT01314872|5897801|P14|Period 2|Lost to Follow-up|2
1689013|NCT01314872|5897802|P13|Period 2|Lost to Follow-up|7
1689014|NCT01314872|5897803|P12|Period 2|Lost to Follow-up|6
1689015|NCT01314872|5897804|P11|Period 2|Lost to Follow-up|0
1689016|NCT01314872|5897805|P10|Period 2|Lost to Follow-up|0
1689017|NCT01314872|5897806|P9|Period 2|Lost to Follow-up|0
1689018|NCT01314872|5897807|P8|Period 2|Lost to Follow-up|0
1689019|NCT01314872|5897808|P7|Period 2|Lost to Follow-up|0
1689020|NCT01314872|5897809|P6|Period 2|Lost to Follow-up|0
1689021|NCT01314872|5897810|P5|Period 2|Lost to Follow-up|0
1689022|NCT01314872|5897811|P4|Period 2|Lost to Follow-up|0
1689023|NCT01314872|5897812|P3|Period 2|Lost to Follow-up|0
1689024|NCT01314872|5897813|P2|Period 2|Lost to Follow-up|0
1689025|NCT01314872|5897814|P1|Period 2|Lost to Follow-up|0
1689026|NCT01314872|5897800|P15|Period 2|Withdrawal by Subject|4
1689027|NCT01314872|5897801|P14|Period 2|Withdrawal by Subject|12
1689028|NCT01314872|5897802|P13|Period 2|Withdrawal by Subject|17
1689029|NCT01314872|5897803|P12|Period 2|Withdrawal by Subject|14
1689030|NCT01314872|5897804|P11|Period 2|Withdrawal by Subject|0
1689031|NCT01314872|5897805|P10|Period 2|Withdrawal by Subject|0
1689032|NCT01314872|5897806|P9|Period 2|Withdrawal by Subject|0
1689033|NCT01314872|5897807|P8|Period 2|Withdrawal by Subject|0
1689034|NCT01314872|5897808|P7|Period 2|Withdrawal by Subject|0
1689035|NCT01314872|5897809|P6|Period 2|Withdrawal by Subject|0
1689036|NCT01314872|5897810|P5|Period 2|Withdrawal by Subject|0
1689037|NCT01314872|5897811|P4|Period 2|Withdrawal by Subject|0
1689038|NCT01314872|5897812|P3|Period 2|Withdrawal by Subject|0
1689039|NCT01314872|5897813|P2|Period 2|Withdrawal by Subject|0
1689040|NCT01314872|5897814|P1|Period 2|Withdrawal by Subject|0
1689041|NCT01314872|5897800|P15|Period 2|Adverse event, non-fatal|9
1689042|NCT01314872|5897801|P14|Period 2|Adverse event, non-fatal|24
1689043|NCT01314872|5897802|P13|Period 2|Adverse event, non-fatal|16
1689044|NCT01314872|5897803|P12|Period 2|Adverse event, non-fatal|13
1689045|NCT01314872|5897804|P11|Period 2|Adverse event, non-fatal|0
1689046|NCT01314872|5897805|P10|Period 2|Adverse event, non-fatal|0
1689047|NCT01314872|5897806|P9|Period 2|Adverse event, non-fatal|0
1689048|NCT01314872|5897807|P8|Period 2|Adverse event, non-fatal|0
1689049|NCT01314872|5897808|P7|Period 2|Adverse event, non-fatal|0
1689050|NCT01314872|5897809|P6|Period 2|Adverse event, non-fatal|0
1689051|NCT01314872|5897810|P5|Period 2|Adverse event, non-fatal|0
1689052|NCT01314872|5897811|P4|Period 2|Adverse event, non-fatal|0
1689053|NCT01314872|5897812|P3|Period 2|Adverse event, non-fatal|0
1689054|NCT01314872|5897813|P2|Period 2|Adverse event, non-fatal|0
1689055|NCT01314872|5897814|P1|Period 2|Adverse event, non-fatal|0
1689056|NCT01314872|5897800|P15|Period 2|Study terminated by Sponsor|0
1689057|NCT01314872|5897801|P14|Period 2|Study terminated by Sponsor|3
1689058|NCT01314872|5897802|P13|Period 2|Study terminated by Sponsor|2
1689059|NCT01314872|5897803|P12|Period 2|Study terminated by Sponsor|2
1689060|NCT01314872|5897804|P11|Period 2|Study terminated by Sponsor|0
1689061|NCT01314872|5897805|P10|Period 2|Study terminated by Sponsor|0
1689062|NCT01314872|5897806|P9|Period 2|Study terminated by Sponsor|0
1689063|NCT01314872|5897807|P8|Period 2|Study terminated by Sponsor|0
1689064|NCT01314872|5897808|P7|Period 2|Study terminated by Sponsor|0
1689065|NCT01314872|5897809|P6|Period 2|Study terminated by Sponsor|0
1689066|NCT01314872|5897810|P5|Period 2|Study terminated by Sponsor|0
1689067|NCT01314872|5897811|P4|Period 2|Study terminated by Sponsor|0
1689068|NCT01314872|5897812|P3|Period 2|Study terminated by Sponsor|0
1689069|NCT01314872|5897813|P2|Period 2|Study terminated by Sponsor|0
1689070|NCT01314872|5897814|P1|Period 2|Study terminated by Sponsor|0
1689071|NCT01314872|5897800|P15|Period 2|Pregnancy|1
1689072|NCT01314872|5897801|P14|Period 2|Pregnancy|0
1689073|NCT01314872|5897802|P13|Period 2|Pregnancy|0
1689074|NCT01314872|5897803|P12|Period 2|Pregnancy|0
1689075|NCT01314872|5897804|P11|Period 2|Pregnancy|0
1689076|NCT01314872|5897805|P10|Period 2|Pregnancy|0
1689077|NCT01314872|5897806|P9|Period 2|Pregnancy|0
1689078|NCT01314872|5897807|P8|Period 2|Pregnancy|0
1689079|NCT01314872|5897808|P7|Period 2|Pregnancy|0
1689080|NCT01314872|5897809|P6|Period 2|Pregnancy|0
1689081|NCT01314872|5897810|P5|Period 2|Pregnancy|0
1689082|NCT01314872|5897811|P4|Period 2|Pregnancy|0
1689083|NCT01314872|5897812|P3|Period 2|Pregnancy|0
1689084|NCT01314872|5897813|P2|Period 2|Pregnancy|0
1689085|NCT01314872|5897814|P1|Period 2|Pregnancy|0
1689086|NCT01314872|5897800|P15|Period 2|Lack of Efficacy|2
1689087|NCT01314872|5897801|P14|Period 2|Lack of Efficacy|9
1689088|NCT01314872|5897802|P13|Period 2|Lack of Efficacy|12
1689089|NCT01314872|5897803|P12|Period 2|Lack of Efficacy|7
1689090|NCT01314872|5897804|P11|Period 2|Lack of Efficacy|0
1689091|NCT01314872|5897805|P10|Period 2|Lack of Efficacy|0
1689092|NCT01314872|5897806|P9|Period 2|Lack of Efficacy|0
1689093|NCT01314872|5897807|P8|Period 2|Lack of Efficacy|0
1689094|NCT01314872|5897808|P7|Period 2|Lack of Efficacy|0
1689095|NCT01314872|5897809|P6|Period 2|Lack of Efficacy|0
1689096|NCT01314872|5897810|P5|Period 2|Lack of Efficacy|0
1689097|NCT01314872|5897811|P4|Period 2|Lack of Efficacy|0
1689098|NCT01314872|5897812|P3|Period 2|Lack of Efficacy|0
1689099|NCT01314872|5897813|P2|Period 2|Lack of Efficacy|0
1689100|NCT01314872|5897814|P1|Period 2|Lack of Efficacy|0
1689101|NCT01314872|5897800|P15|Period 2|Non-compliance with study drug|2
1689102|NCT01314872|5897801|P14|Period 2|Non-compliance with study drug|1
1689103|NCT01314872|5897802|P13|Period 2|Non-compliance with study drug|3
1689104|NCT01314872|5897803|P12|Period 2|Non-compliance with study drug|3
1689105|NCT01314872|5897804|P11|Period 2|Non-compliance with study drug|0
1689106|NCT01314872|5897805|P10|Period 2|Non-compliance with study drug|0
1689107|NCT01314872|5897806|P9|Period 2|Non-compliance with study drug|0
1689108|NCT01314872|5897807|P8|Period 2|Non-compliance with study drug|0
1689109|NCT01314872|5897808|P7|Period 2|Non-compliance with study drug|0
1689110|NCT01314872|5897809|P6|Period 2|Non-compliance with study drug|0
1689111|NCT01314872|5897810|P5|Period 2|Non-compliance with study drug|0
1689112|NCT01314872|5897811|P4|Period 2|Non-compliance with study drug|0
1689113|NCT01314872|5897812|P3|Period 2|Non-compliance with study drug|0
1689114|NCT01314872|5897813|P2|Period 2|Non-compliance with study drug|0
1689115|NCT01314872|5897814|P1|Period 2|Non-compliance with study drug|0
1689116|NCT01314872|5897800|P15|Period 2|Protocol Violation|0
1689117|NCT01314872|5897801|P14|Period 2|Protocol Violation|2
1689118|NCT01314872|5897802|P13|Period 2|Protocol Violation|3
1689119|NCT01314872|5897803|P12|Period 2|Protocol Violation|3
1689120|NCT01314872|5897804|P11|Period 2|Protocol Violation|0
1689121|NCT01314872|5897805|P10|Period 2|Protocol Violation|0
1689122|NCT01314872|5897806|P9|Period 2|Protocol Violation|0
1689123|NCT01314872|5897807|P8|Period 2|Protocol Violation|0
1689124|NCT01314872|5897808|P7|Period 2|Protocol Violation|0
1689125|NCT01314872|5897809|P6|Period 2|Protocol Violation|0
1689126|NCT01314872|5897810|P5|Period 2|Protocol Violation|0
1689127|NCT01314872|5897811|P4|Period 2|Protocol Violation|0
1689128|NCT01314872|5897812|P3|Period 2|Protocol Violation|0
1689129|NCT01314872|5897813|P2|Period 2|Protocol Violation|0
1689130|NCT01314872|5897814|P1|Period 2|Protocol Violation|0
1689131|NCT01314872|5897800|P15|Treatment Period 1|Lost to Follow-up|0
1689132|NCT01314872|5897801|P14|Treatment Period 1|Lost to Follow-up|0
1689133|NCT01314872|5897802|P13|Treatment Period 1|Lost to Follow-up|0
1689134|NCT01314872|5897803|P12|Treatment Period 1|Lost to Follow-up|0
1689135|NCT01314872|5897804|P11|Treatment Period 1|Lost to Follow-up|0
1689136|NCT01314872|5897805|P10|Treatment Period 1|Lost to Follow-up|0
1689137|NCT01314872|5897806|P9|Treatment Period 1|Lost to Follow-up|1
1689138|NCT01314872|5897807|P8|Treatment Period 1|Lost to Follow-up|1
1689139|NCT01314872|5897808|P7|Treatment Period 1|Lost to Follow-up|1
1689140|NCT01314872|5897809|P6|Treatment Period 1|Lost to Follow-up|1
1689141|NCT01314872|5897810|P5|Treatment Period 1|Lost to Follow-up|1
1689142|NCT01314872|5897811|P4|Treatment Period 1|Lost to Follow-up|2
1689143|NCT01314872|5897812|P3|Treatment Period 1|Lost to Follow-up|2
1689144|NCT01314872|5897813|P2|Treatment Period 1|Lost to Follow-up|1
1689145|NCT01314872|5897814|P1|Treatment Period 1|Lost to Follow-up|0
1689146|NCT01314872|5897800|P15|Treatment Period 1|Withdrawal by Subject|0
1689147|NCT01314872|5897801|P14|Treatment Period 1|Withdrawal by Subject|0
1689148|NCT01314872|5897802|P13|Treatment Period 1|Withdrawal by Subject|0
1689149|NCT01314872|5897803|P12|Treatment Period 1|Withdrawal by Subject|0
1689150|NCT01314872|5897804|P11|Treatment Period 1|Withdrawal by Subject|1
1689151|NCT01314872|5897805|P10|Treatment Period 1|Withdrawal by Subject|2
1689152|NCT01314872|5897806|P9|Treatment Period 1|Withdrawal by Subject|2
1689153|NCT01314872|5897807|P8|Treatment Period 1|Withdrawal by Subject|2
1689154|NCT01314872|5897808|P7|Treatment Period 1|Withdrawal by Subject|3
1689155|NCT01314872|5897809|P6|Treatment Period 1|Withdrawal by Subject|1
1689156|NCT01314872|5897810|P5|Treatment Period 1|Withdrawal by Subject|3
1689157|NCT01314872|5897811|P4|Treatment Period 1|Withdrawal by Subject|2
1689158|NCT01314872|5897812|P3|Treatment Period 1|Withdrawal by Subject|0
1689159|NCT01314872|5897813|P2|Treatment Period 1|Withdrawal by Subject|1
1689160|NCT01314872|5897814|P1|Treatment Period 1|Withdrawal by Subject|3
1689161|NCT01314872|5897800|P15|Treatment Period 1|Adverse event, non-fatal|0
1689162|NCT01314872|5897801|P14|Treatment Period 1|Adverse event, non-fatal|0
1689163|NCT01314872|5897802|P13|Treatment Period 1|Adverse event, non-fatal|0
1689164|NCT01314872|5897803|P12|Treatment Period 1|Adverse event, non-fatal|0
1689165|NCT01314872|5897804|P11|Treatment Period 1|Adverse event, non-fatal|1
1689166|NCT01314872|5897805|P10|Treatment Period 1|Adverse event, non-fatal|0
1689167|NCT01314872|5897806|P9|Treatment Period 1|Adverse event, non-fatal|3
1689168|NCT01314872|5897807|P8|Treatment Period 1|Adverse event, non-fatal|2
1689169|NCT01314872|5897808|P7|Treatment Period 1|Adverse event, non-fatal|4
1689170|NCT01314872|5897809|P6|Treatment Period 1|Adverse event, non-fatal|4
1689171|NCT01314872|5897810|P5|Treatment Period 1|Adverse event, non-fatal|2
1689172|NCT01314872|5897811|P4|Treatment Period 1|Adverse event, non-fatal|2
1689173|NCT01314872|5897812|P3|Treatment Period 1|Adverse event, non-fatal|3
1689174|NCT01314872|5897813|P2|Treatment Period 1|Adverse event, non-fatal|2
1689175|NCT01314872|5897814|P1|Treatment Period 1|Adverse event, non-fatal|4
1689176|NCT01314872|5897800|P15|Treatment Period 1|Lack of Efficacy|0
1689177|NCT01314872|5897801|P14|Treatment Period 1|Lack of Efficacy|0
1689178|NCT01314872|5897802|P13|Treatment Period 1|Lack of Efficacy|0
1689179|NCT01314872|5897803|P12|Treatment Period 1|Lack of Efficacy|0
1689180|NCT01314872|5897804|P11|Treatment Period 1|Lack of Efficacy|0
1689181|NCT01314872|5897805|P10|Treatment Period 1|Lack of Efficacy|0
1689182|NCT01314872|5897806|P9|Treatment Period 1|Lack of Efficacy|0
1689183|NCT01314872|5897807|P8|Treatment Period 1|Lack of Efficacy|2
1689184|NCT01314872|5897808|P7|Treatment Period 1|Lack of Efficacy|0
1689185|NCT01314872|5897809|P6|Treatment Period 1|Lack of Efficacy|1
1689186|NCT01314872|5897810|P5|Treatment Period 1|Lack of Efficacy|0
1689187|NCT01314872|5897811|P4|Treatment Period 1|Lack of Efficacy|0
1689188|NCT01314872|5897812|P3|Treatment Period 1|Lack of Efficacy|0
1689189|NCT01314872|5897813|P2|Treatment Period 1|Lack of Efficacy|0
1689190|NCT01314872|5897814|P1|Treatment Period 1|Lack of Efficacy|1
1689191|NCT01314872|5897800|P15|Treatment Period 1|Physician Decision|0
1689192|NCT01314872|5897801|P14|Treatment Period 1|Physician Decision|0
1689193|NCT01314872|5897802|P13|Treatment Period 1|Physician Decision|0
1689194|NCT01314872|5897803|P12|Treatment Period 1|Physician Decision|0
1689195|NCT01314872|5897804|P11|Treatment Period 1|Physician Decision|0
1689196|NCT01314872|5897805|P10|Treatment Period 1|Physician Decision|1
1689197|NCT01314872|5897806|P9|Treatment Period 1|Physician Decision|0
1689198|NCT01314872|5897807|P8|Treatment Period 1|Physician Decision|0
1689199|NCT01314872|5897808|P7|Treatment Period 1|Physician Decision|0
1689200|NCT01314872|5897809|P6|Treatment Period 1|Physician Decision|0
1689201|NCT01314872|5897810|P5|Treatment Period 1|Physician Decision|0
1689202|NCT01314872|5897811|P4|Treatment Period 1|Physician Decision|1
1689203|NCT01314872|5897812|P3|Treatment Period 1|Physician Decision|0
1689204|NCT01314872|5897813|P2|Treatment Period 1|Physician Decision|1
1689205|NCT01314872|5897814|P1|Treatment Period 1|Physician Decision|0
1689206|NCT01314872|5897800|P15|Treatment Period 1|Protocol Violation|0
1689207|NCT01314872|5897801|P14|Treatment Period 1|Protocol Violation|0
1689208|NCT01314872|5897802|P13|Treatment Period 1|Protocol Violation|0
1689209|NCT01314872|5897803|P12|Treatment Period 1|Protocol Violation|0
1689210|NCT01314872|5897804|P11|Treatment Period 1|Protocol Violation|1
1689211|NCT01314872|5897805|P10|Treatment Period 1|Protocol Violation|1
1689212|NCT01314872|5897806|P9|Treatment Period 1|Protocol Violation|0
1689213|NCT01314872|5897807|P8|Treatment Period 1|Protocol Violation|0
1689214|NCT01314872|5897808|P7|Treatment Period 1|Protocol Violation|0
1689215|NCT01314872|5897809|P6|Treatment Period 1|Protocol Violation|0
1689216|NCT01314872|5897810|P5|Treatment Period 1|Protocol Violation|1
1689217|NCT01314872|5897811|P4|Treatment Period 1|Protocol Violation|0
1689218|NCT01314872|5897812|P3|Treatment Period 1|Protocol Violation|1
1689219|NCT01314872|5897813|P2|Treatment Period 1|Protocol Violation|1
1689220|NCT01314872|5897814|P1|Treatment Period 1|Protocol Violation|2
1689221|NCT01314716|5897918|P2|Open-Label Phase|Physician Decision|4
1689222|NCT01314716|5897919|P1|Open-Label Phase|Physician Decision|5
1689223|NCT01314716|5897918|P2|Open-Label Phase|Withdrawal by Subject|2
1689224|NCT01314716|5897919|P1|Open-Label Phase|Withdrawal by Subject|1
1689225|NCT01314716|5897918|P2|Open-Label Phase|Adverse Event|6
1689226|NCT01314716|5897919|P1|Open-Label Phase|Adverse Event|4
1689227|NCT01314716|5897918|P2|Double-Blind Phase|Physician Decision|1
1689228|NCT01314716|5897919|P1|Double-Blind Phase|Physician Decision|0
1689229|NCT01314716|5897918|P2|Double-Blind Phase|Sponsor request|2
1689230|NCT01314716|5897919|P1|Double-Blind Phase|Sponsor request|1
1689231|NCT01314716|5897918|P2|Double-Blind Phase|Lost to Follow-up|1
1689232|NCT01314716|5897919|P1|Double-Blind Phase|Lost to Follow-up|0
1689233|NCT01314716|5897918|P2|Double-Blind Phase|Withdrawal by Subject|6
1689234|NCT01314716|5897919|P1|Double-Blind Phase|Withdrawal by Subject|5
1689235|NCT01314716|5897918|P2|Double-Blind Phase|Adverse Event|4
1689236|NCT01314716|5897919|P1|Double-Blind Phase|Adverse Event|10
1689237|NCT01314716|5897918|P2|Double-Blind Phase|Randomized but not treated|1
1689238|NCT01314716|5897919|P1|Double-Blind Phase|Randomized but not treated|1
1689239|NCT01314703|5897931|P1|Overall Study|screen failure and closed enrollment|8
1689240|NCT01314443|5897940|P4|Overall Study|Protocol Violation|1
1689241|NCT01314443|5897941|P3|Overall Study|Protocol Violation|1
1689242|NCT01314443|5897942|P2|Overall Study|Protocol Violation|2
1689243|NCT01314443|5897943|P1|Overall Study|Protocol Violation|2
1689244|NCT01314443|5897940|P4|Overall Study|Withdrawal by Subject|1
1689245|NCT01314443|5897941|P3|Overall Study|Withdrawal by Subject|1
1689246|NCT01314443|5897942|P2|Overall Study|Withdrawal by Subject|1
1689247|NCT01314443|5897943|P1|Overall Study|Withdrawal by Subject|2
1689248|NCT01314261|5898013|P4|Overall Study|Virologic Failure|1
1689249|NCT01314261|5898014|P3|Overall Study|Virologic Failure|0
1689250|NCT01314261|5898015|P2|Overall Study|Virologic Failure|1
1689251|NCT01314261|5898016|P1|Overall Study|Virologic Failure|0
1689252|NCT01314261|5898013|P4|Overall Study|Lost to Follow-up|2
1689253|NCT01314261|5898014|P3|Overall Study|Lost to Follow-up|2
1689254|NCT01314261|5898015|P2|Overall Study|Lost to Follow-up|0
1689255|NCT01314261|5898016|P1|Overall Study|Lost to Follow-up|1
1689256|NCT01314261|5898013|P4|Overall Study|Withdrawal by Subject|0
1689257|NCT01314261|5898014|P3|Overall Study|Withdrawal by Subject|1
1689258|NCT01314261|5898015|P2|Overall Study|Withdrawal by Subject|3
1689259|NCT01314261|5898016|P1|Overall Study|Withdrawal by Subject|0
1689260|NCT01314261|5898013|P4|Overall Study|Adverse Event|0
1689261|NCT01314261|5898014|P3|Overall Study|Adverse Event|0
1689262|NCT01314261|5898015|P2|Overall Study|Adverse Event|0
1689263|NCT01314261|5898016|P1|Overall Study|Adverse Event|1
1689264|NCT01314118|5898067|P1|Overall Study|Ongoing|62
1689265|NCT01314118|5898067|P1|Overall Study|Other|2
1689266|NCT01314118|5898067|P1|Overall Study|Withdrawal by Subject|11
1689267|NCT01314118|5898067|P1|Overall Study|Protocol Violation|5
1689268|NCT01314118|5898067|P1|Overall Study|Death|4
1689269|NCT01314118|5898067|P1|Overall Study|Physician Decision|11
1689270|NCT01314118|5898067|P1|Overall Study|Progressive disease|27
1689271|NCT01314118|5898067|P1|Overall Study|Adverse Event|9
1689272|NCT01314105|5898076|P2|Overall Study|Other Adverse Event|1
1689273|NCT01314105|5898077|P1|Overall Study|Other Adverse Event|1
1689274|NCT01314105|5898076|P2|Overall Study|Refused to continue taking medication|1
1689275|NCT01314105|5898077|P1|Overall Study|Refused to continue taking medication|0
1689276|NCT01314105|5898076|P2|Overall Study|Progressive Disease|10
1689277|NCT01314105|5898077|P1|Overall Study|Progressive Disease|6
1689278|NCT01313923|5898195|P1|Overall Study|Physician Decision|3
1689279|NCT01313884|5898211|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
1689280|NCT01313858|5898219|P3|Overall Study|Lost to Follow-up|47
1689281|NCT01313858|5898220|P2|Overall Study|Lost to Follow-up|51
1689282|NCT01313858|5898221|P1|Overall Study|Lost to Follow-up|35
1689283|NCT01313858|5898219|P3|Overall Study|Premature Treatment Termination|191
1689284|NCT01313858|5898220|P2|Overall Study|Premature Treatment Termination|219
1689285|NCT01313858|5898221|P1|Overall Study|Premature Treatment Termination|251
1689286|NCT01313780|5898244|P2|Overall Study|missing data|3
1689287|NCT01313780|5898245|P1|Overall Study|missing data|3
1689288|NCT01313780|5898244|P2|Overall Study|Protocol Violation|4
1689289|NCT01313780|5898245|P1|Overall Study|Protocol Violation|10
1689290|NCT01313780|5898244|P2|Overall Study|Withdrawal by Subject|8
1689291|NCT01313780|5898245|P1|Overall Study|Withdrawal by Subject|2
1689292|NCT01313780|5898244|P2|Overall Study|Adverse Event|11
1689293|NCT01313780|5898245|P1|Overall Study|Adverse Event|6
1689294|NCT01313780|5898244|P2|Overall Study|Lack of Efficacy|2
1689295|NCT01313780|5898245|P1|Overall Study|Lack of Efficacy|4
1689296|NCT01313767|5898255|P2|Overall Study|Protocol Violation|1
1689297|NCT01313767|5898256|P1|Overall Study|Protocol Violation|3
1689298|NCT01313767|5898255|P2|Overall Study|Withdrawal by Subject|1
1689299|NCT01313767|5898256|P1|Overall Study|Withdrawal by Subject|2
1689300|NCT01313767|5898255|P2|Overall Study|Lost to Follow-up|0
1689301|NCT01313767|5898256|P1|Overall Study|Lost to Follow-up|1
1689302|NCT01313767|5898255|P2|Overall Study|Adverse Event|0
1689303|NCT01313767|5898256|P1|Overall Study|Adverse Event|1
1689304|NCT01313728|5898298|P1|Informed Consent to Baseline|Withdrawal by Subject|1
1689305|NCT01313689|5898318|P5|24-Week Randomization 2|Physician Decision|4
1689306|NCT01313689|5898319|P4|24-Week Randomization 2|Physician Decision|0
1689307|NCT01313689|5898320|P3|24-Week Randomization 2|Physician Decision|0
1689308|NCT01313689|5898321|P2|24-Week Randomization 2|Physician Decision|0
1689309|NCT01313689|5898322|P1|24-Week Randomization 2|Physician Decision|0
1689310|NCT01313689|5898318|P5|24-Week Randomization 2|Withdrawal by Subject|3
1689311|NCT01313689|5898319|P4|24-Week Randomization 2|Withdrawal by Subject|1
1689312|NCT01313689|5898320|P3|24-Week Randomization 2|Withdrawal by Subject|1
1689313|NCT01313689|5898321|P2|24-Week Randomization 2|Withdrawal by Subject|0
1689314|NCT01313689|5898322|P1|24-Week Randomization 2|Withdrawal by Subject|0
1689315|NCT01313689|5898318|P5|24-Week Randomization 2|Adverse Event|8
1689316|NCT01313689|5898319|P4|24-Week Randomization 2|Adverse Event|0
1689317|NCT01313689|5898320|P3|24-Week Randomization 2|Adverse Event|2
1689318|NCT01313689|5898321|P2|24-Week Randomization 2|Adverse Event|0
1689319|NCT01313689|5898322|P1|24-Week Randomization 2|Adverse Event|0
1689320|NCT01313689|5898318|P5|24-Week Randomization 1|Withdrawal by Subject|0
1689321|NCT01313689|5898319|P4|24-Week Randomization 1|Withdrawal by Subject|0
1689322|NCT01313689|5898320|P3|24-Week Randomization 1|Withdrawal by Subject|0
1689323|NCT01313689|5898321|P2|24-Week Randomization 1|Withdrawal by Subject|0
1689324|NCT01313689|5898322|P1|24-Week Randomization 1|Withdrawal by Subject|5
1689325|NCT01313689|5898318|P5|24-Week Randomization 1|Physician Decision|0
1689326|NCT01313689|5898319|P4|24-Week Randomization 1|Physician Decision|0
1689327|NCT01313689|5898320|P3|24-Week Randomization 1|Physician Decision|0
1689328|NCT01313689|5898321|P2|24-Week Randomization 1|Physician Decision|5
1689329|NCT01313689|5898322|P1|24-Week Randomization 1|Physician Decision|4
1689330|NCT01313689|5898318|P5|24-Week Randomization 1|Adverse Event|0
1689331|NCT01313689|5898319|P4|24-Week Randomization 1|Adverse Event|0
1689332|NCT01313689|5898320|P3|24-Week Randomization 1|Adverse Event|0
1689333|NCT01313689|5898321|P2|24-Week Randomization 1|Adverse Event|5
1689334|NCT01313689|5898322|P1|24-Week Randomization 1|Adverse Event|10
1689335|NCT01313676|5898401|P4|Overall Study|Missing|0
1689336|NCT01313676|5898402|P3|Overall Study|Missing|1
1689337|NCT01313676|5898403|P2|Overall Study|Missing|1
1689338|NCT01313676|5898404|P1|Overall Study|Missing|1
1689339|NCT01313676|5898401|P4|Overall Study|Investigator Site Closed|10
1689340|NCT01313676|5898402|P3|Overall Study|Investigator Site Closed|15
1689341|NCT01313676|5898403|P2|Overall Study|Investigator Site Closed|11
1689342|NCT01313676|5898404|P1|Overall Study|Investigator Site Closed|12
1689343|NCT01313676|5898401|P4|Overall Study|Sponsor Terminated Study Treatment|1
1689344|NCT01313676|5898402|P3|Overall Study|Sponsor Terminated Study Treatment|0
1689345|NCT01313676|5898403|P2|Overall Study|Sponsor Terminated Study Treatment|1
1689346|NCT01313676|5898404|P1|Overall Study|Sponsor Terminated Study Treatment|1
1689347|NCT01313676|5898401|P4|Overall Study|Decision by Participant or Proxy|492
1689348|NCT01313676|5898402|P3|Overall Study|Decision by Participant or Proxy|515
1689349|NCT01313676|5898403|P2|Overall Study|Decision by Participant or Proxy|527
1689350|NCT01313676|5898404|P1|Overall Study|Decision by Participant or Proxy|643
1689351|NCT01313676|5898401|P4|Overall Study|Physician Decision|48
1689352|NCT01313676|5898402|P3|Overall Study|Physician Decision|62
1689353|NCT01313676|5898403|P2|Overall Study|Physician Decision|64
1689354|NCT01313676|5898404|P1|Overall Study|Physician Decision|53
1689355|NCT01313676|5898401|P4|Overall Study|Lost to Follow-up|0
1689356|NCT01313676|5898402|P3|Overall Study|Lost to Follow-up|1
1689357|NCT01313676|5898403|P2|Overall Study|Lost to Follow-up|0
1689358|NCT01313676|5898404|P1|Overall Study|Lost to Follow-up|0
1689359|NCT01313676|5898401|P4|Overall Study|Study Closed/terminated|9
1689360|NCT01313676|5898402|P3|Overall Study|Study Closed/terminated|9
1689361|NCT01313676|5898403|P2|Overall Study|Study Closed/terminated|6
1689362|NCT01313676|5898404|P1|Overall Study|Study Closed/terminated|7
1689363|NCT01313676|5898401|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
1689364|NCT01313676|5898402|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
1689365|NCT01313676|5898403|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
1689366|NCT01313676|5898404|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
1689367|NCT01313676|5898401|P4|Overall Study|Protocol Violation|44
1689368|NCT01313676|5898402|P3|Overall Study|Protocol Violation|46
1689369|NCT01313676|5898403|P2|Overall Study|Protocol Violation|44
1689370|NCT01313676|5898404|P1|Overall Study|Protocol Violation|37
1689371|NCT01313676|5898401|P4|Overall Study|Lack of Efficacy|46
1689372|NCT01313676|5898402|P3|Overall Study|Lack of Efficacy|65
1689373|NCT01313676|5898403|P2|Overall Study|Lack of Efficacy|90
1689374|NCT01313676|5898404|P1|Overall Study|Lack of Efficacy|98
1689375|NCT01313676|5898401|P4|Overall Study|Adverse Event|333
1689376|NCT01313676|5898402|P3|Overall Study|Adverse Event|372
1689377|NCT01313676|5898403|P2|Overall Study|Adverse Event|365
1689378|NCT01313676|5898404|P1|Overall Study|Adverse Event|395
1689379|NCT01313663|5898424|P2|Overall Study|Withdrawal by Subject|1
1689380|NCT01313663|5898425|P1|Overall Study|Withdrawal by Subject|2
1689381|NCT01313663|5898424|P2|Overall Study|Physician Decision|2
1689382|NCT01313663|5898425|P1|Overall Study|Physician Decision|0
1689383|NCT01313663|5898424|P2|Overall Study|Lost to Follow-up|1
1689384|NCT01313663|5898425|P1|Overall Study|Lost to Follow-up|0
1689385|NCT01313663|5898424|P2|Overall Study|Study Closed/Terminated|4
1689386|NCT01313663|5898425|P1|Overall Study|Study Closed/Terminated|2
1689387|NCT01313650|5898463|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
1689388|NCT01313650|5898464|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
1689389|NCT01313650|5898465|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
1689390|NCT01313650|5898466|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
1689391|NCT01313650|5898463|P4|Overall Study|Protocol Violation|6
1689392|NCT01313650|5898464|P3|Overall Study|Protocol Violation|5
1689393|NCT01313650|5898465|P2|Overall Study|Protocol Violation|7
1689394|NCT01313650|5898466|P1|Overall Study|Protocol Violation|4
1689395|NCT01313650|5898463|P4|Overall Study|Withdrawal by Subject|15
1689396|NCT01313650|5898464|P3|Overall Study|Withdrawal by Subject|15
1689397|NCT01313650|5898465|P2|Overall Study|Withdrawal by Subject|20
1689398|NCT01313650|5898466|P1|Overall Study|Withdrawal by Subject|16
1689399|NCT01313650|5898463|P4|Overall Study|Lost to Follow-up|2
1689400|NCT01313650|5898464|P3|Overall Study|Lost to Follow-up|3
1689401|NCT01313650|5898465|P2|Overall Study|Lost to Follow-up|0
1689402|NCT01313650|5898466|P1|Overall Study|Lost to Follow-up|1
1689403|NCT01313650|5898463|P4|Overall Study|Lack of Efficacy|20
1689404|NCT01313650|5898464|P3|Overall Study|Lack of Efficacy|32
1689405|NCT01313650|5898465|P2|Overall Study|Lack of Efficacy|20
1689406|NCT01313650|5898466|P1|Overall Study|Lack of Efficacy|37
1689407|NCT01313650|5898463|P4|Overall Study|Adverse Event|23
1689408|NCT01313650|5898464|P3|Overall Study|Adverse Event|24
1689409|NCT01313650|5898465|P2|Overall Study|Adverse Event|34
1689410|NCT01313650|5898466|P1|Overall Study|Adverse Event|9
1689411|NCT01313637|5898492|P4|Overall Study|Withdrawal by Subject|15
1689412|NCT01313637|5898493|P3|Overall Study|Withdrawal by Subject|18
1689413|NCT01313637|5898494|P2|Overall Study|Withdrawal by Subject|13
1689414|NCT01313637|5898495|P1|Overall Study|Withdrawal by Subject|11
1689415|NCT01313637|5898492|P4|Overall Study|Lost to Follow-up|3
1689416|NCT01313637|5898493|P3|Overall Study|Lost to Follow-up|1
1689417|NCT01313637|5898494|P2|Overall Study|Lost to Follow-up|2
1689418|NCT01313637|5898495|P1|Overall Study|Lost to Follow-up|0
1689419|NCT01313637|5898492|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
1689420|NCT01313637|5898493|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
1689421|NCT01313637|5898494|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
1689422|NCT01313637|5898495|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
1689423|NCT01313637|5898492|P4|Overall Study|Protocol Violation|5
1689424|NCT01313637|5898493|P3|Overall Study|Protocol Violation|11
1689425|NCT01313637|5898494|P2|Overall Study|Protocol Violation|3
1689426|NCT01313637|5898495|P1|Overall Study|Protocol Violation|4
1689427|NCT01313637|5898492|P4|Overall Study|Lack of Efficacy|24
1689428|NCT01313637|5898493|P3|Overall Study|Lack of Efficacy|37
1689429|NCT01313637|5898494|P2|Overall Study|Lack of Efficacy|38
1689430|NCT01313637|5898495|P1|Overall Study|Lack of Efficacy|44
1689431|NCT01313637|5898492|P4|Overall Study|Adverse Event|18
1689432|NCT01313637|5898493|P3|Overall Study|Adverse Event|25
1689433|NCT01313637|5898494|P2|Overall Study|Adverse Event|24
1689434|NCT01313637|5898495|P1|Overall Study|Adverse Event|17
1689435|NCT01313624|5898519|P2|Open-Label Phase|Lost to Follow-up|1
1689436|NCT01313624|5898520|P1|Open-Label Phase|Lost to Follow-up|1
1689437|NCT01313624|5898519|P2|Open-Label Phase|Withdrawal by Subject|2
1689438|NCT01313624|5898520|P1|Open-Label Phase|Withdrawal by Subject|2
1689439|NCT01313624|5898519|P2|Open-Label Phase|Adverse Event|10
1689440|NCT01313624|5898520|P1|Open-Label Phase|Adverse Event|1
1689441|NCT01313624|5898519|P2|Double-Blind Phase|Lack of Efficacy|0
1689442|NCT01313624|5898520|P1|Double-Blind Phase|Lack of Efficacy|1
1689443|NCT01313624|5898519|P2|Double-Blind Phase|Physician Decision|0
1689444|NCT01313624|5898520|P1|Double-Blind Phase|Physician Decision|1
1689445|NCT01313624|5898519|P2|Double-Blind Phase|Lost to Follow-up|2
1689446|NCT01313624|5898520|P1|Double-Blind Phase|Lost to Follow-up|0
1689447|NCT01313624|5898519|P2|Double-Blind Phase|Withdrawal by Subject|4
1689448|NCT01313624|5898520|P1|Double-Blind Phase|Withdrawal by Subject|9
1689449|NCT01313624|5898519|P2|Double-Blind Phase|Adverse Event|4
1689450|NCT01313624|5898520|P1|Double-Blind Phase|Adverse Event|27
1689451|NCT01313559|5898534|P2|Overall Study|Rising PSA|0
1689452|NCT01313559|5898535|P1|Overall Study|Rising PSA|2
1689453|NCT01313559|5898534|P2|Overall Study|Disease progression|0
1689454|NCT01313559|5898535|P1|Overall Study|Disease progression|1
1689455|NCT01313559|5898534|P2|Overall Study|Withdrawal by Subject|2
1689456|NCT01313559|5898535|P1|Overall Study|Withdrawal by Subject|1
1689457|NCT01313312|5898636|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
1689458|NCT01313312|5898636|P1|Overall Study|Subject Withdrawn Early in Error|4
1689459|NCT01313312|5898636|P1|Overall Study|Observational Phase|1
1689460|NCT01313312|5898636|P1|Overall Study|Investigator Decision|1
1689461|NCT01313312|5898636|P1|Overall Study|Lack of Efficacy|3
1689462|NCT01313312|5898636|P1|Overall Study|Withdrawal by Subject|18
1689463|NCT01313312|5898636|P1|Overall Study|Adverse Event|5
1689464|NCT01313299|5898683|P3|Overall Study|Lack of subject compliance|1
1689465|NCT01313299|5898684|P2|Overall Study|Lack of subject compliance|0
1689466|NCT01313299|5898685|P1|Overall Study|Lack of subject compliance|0
1689467|NCT01313299|5898683|P3|Overall Study|Family reason and moved out of state|0
1689468|NCT01313299|5898684|P2|Overall Study|Family reason and moved out of state|2
1689469|NCT01313299|5898685|P1|Overall Study|Family reason and moved out of state|0
1689470|NCT01313299|5898683|P3|Overall Study|Withdrawal by Subject|2
1689471|NCT01313299|5898684|P2|Overall Study|Withdrawal by Subject|0
1689472|NCT01313299|5898685|P1|Overall Study|Withdrawal by Subject|1
1689473|NCT01313299|5898683|P3|Overall Study|Protocol Violation|0
1689474|NCT01313299|5898684|P2|Overall Study|Protocol Violation|0
1689475|NCT01313299|5898685|P1|Overall Study|Protocol Violation|2
1689476|NCT01313299|5898683|P3|Overall Study|Lost to Follow-up|0
1689477|NCT01313299|5898684|P2|Overall Study|Lost to Follow-up|0
1689478|NCT01313299|5898685|P1|Overall Study|Lost to Follow-up|1
1689479|NCT01313299|5898683|P3|Overall Study|Adverse Event|1
1689480|NCT01313299|5898684|P2|Overall Study|Adverse Event|1
1689481|NCT01313299|5898685|P1|Overall Study|Adverse Event|3
1689482|NCT01313286|5898699|P2|Period 1|Withdrawal by Subject|0
1689483|NCT01313286|5898700|P1|Period 1|Withdrawal by Subject|2
1689484|NCT01313273|5898710|P2|Overall Study|Screening Chromogranin A-in normal range|1
1689485|NCT01313273|5898711|P1|Overall Study|Screening Chromogranin A-in normal range|0
1689486|NCT01313273|5898710|P2|Overall Study|Withdrawal by Subject|0
1689487|NCT01313273|5898711|P1|Overall Study|Withdrawal by Subject|1
1689488|NCT01313273|5898710|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
1689489|NCT01313273|5898711|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
1689490|NCT01313221|5898726|P3|Overall Study|Pregnancy|2
1689491|NCT01313221|5898727|P2|Overall Study|Pregnancy|0
1689492|NCT01313221|5898728|P1|Overall Study|Pregnancy|0
1689493|NCT01313221|5898726|P3|Overall Study|Physician Decision|2
1689494|NCT01313221|5898727|P2|Overall Study|Physician Decision|0
1689495|NCT01313221|5898728|P1|Overall Study|Physician Decision|0
1689496|NCT01313221|5898726|P3|Overall Study|Disease progression|2
1689497|NCT01313221|5898727|P2|Overall Study|Disease progression|0
1689498|NCT01313221|5898728|P1|Overall Study|Disease progression|0
1689499|NCT01313221|5898726|P3|Overall Study|Adverse Event|7
1689500|NCT01313221|5898727|P2|Overall Study|Adverse Event|0
1689501|NCT01313221|5898728|P1|Overall Study|Adverse Event|0
1689502|NCT01313221|5898726|P3|Overall Study|Other|0
1689503|NCT01313221|5898727|P2|Overall Study|Other|0
1689504|NCT01313221|5898728|P1|Overall Study|Other|1
1689505|NCT01313221|5898726|P3|Overall Study|Lost to Follow-up|1
1689506|NCT01313221|5898727|P2|Overall Study|Lost to Follow-up|3
1689507|NCT01313221|5898728|P1|Overall Study|Lost to Follow-up|6
1689508|NCT01313221|5898726|P3|Overall Study|Requirement for alternative therapy|1
1689509|NCT01313221|5898727|P2|Overall Study|Requirement for alternative therapy|1
1689510|NCT01313221|5898728|P1|Overall Study|Requirement for alternative therapy|0
1689511|NCT01313221|5898726|P3|Overall Study|Withdrawal by Subject|5
1689512|NCT01313221|5898727|P2|Overall Study|Withdrawal by Subject|3
1689513|NCT01313221|5898728|P1|Overall Study|Withdrawal by Subject|2
1689514|NCT01313221|5898726|P3|Overall Study|Non-compliance|2
1689515|NCT01313221|5898727|P2|Overall Study|Non-compliance|0
1689516|NCT01313221|5898728|P1|Overall Study|Non-compliance|3
1689517|NCT01313221|5898726|P3|Overall Study|Protocol Violation|1
1689518|NCT01313221|5898727|P2|Overall Study|Protocol Violation|1
1689519|NCT01313221|5898728|P1|Overall Study|Protocol Violation|0
1689520|NCT01313208|5898780|P2|Open-label Phase (Weeks 13 - 24)|Other|0
1689521|NCT01313208|5898781|P1|Open-label Phase (Weeks 13 - 24)|Other|2
1689522|NCT01313208|5898780|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
1689523|NCT01313208|5898781|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
1689524|NCT01313208|5898780|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
1689525|NCT01313208|5898781|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
1689526|NCT01313208|5898780|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
1689527|NCT01313208|5898781|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
1689528|NCT01313208|5898780|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
1689529|NCT01313208|5898781|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
1689530|NCT01313208|5898780|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
1689531|NCT01313208|5898781|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
1689532|NCT01313208|5898780|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
1689533|NCT01313208|5898781|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
1689534|NCT01313208|5898780|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
1689535|NCT01313208|5898781|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
1689536|NCT01313208|5898780|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
1689537|NCT01313208|5898781|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
1689538|NCT01313182|5898871|P2|Overall Study|Protocol Violation|92
1689539|NCT01313182|5898872|P1|Overall Study|Protocol Violation|66
1689540|NCT01313117|5898884|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
1689541|NCT01313117|5898884|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
1689542|NCT01313078|5898891|P1|Overall Study|Withdrawal by Subject|1
1689543|NCT01313078|5898891|P1|Overall Study|Discontinued study drug|1
1689544|NCT01313078|5898891|P1|Overall Study|Death|1
1689545|NCT01313039|5898896|P1|Overall Study|Adverse Event|1
1689546|NCT01313039|5898896|P1|Overall Study|Physician Decision|1
1689547|NCT01312961|5898902|P2|Overall Study|Other than specified above|3
1689548|NCT01312961|5898903|P1|Overall Study|Other than specified above|2
1689549|NCT01312961|5898902|P2|Overall Study|Poor compliance to protocol|0
1689550|NCT01312961|5898903|P1|Overall Study|Poor compliance to protocol|1
1689551|NCT01312961|5898902|P2|Overall Study|Lack of Efficacy|1
1689552|NCT01312961|5898903|P1|Overall Study|Lack of Efficacy|11
1689553|NCT01312961|5898902|P2|Overall Study|Adverse Event|3
1689554|NCT01312961|5898903|P1|Overall Study|Adverse Event|3
1689555|NCT01312909|5898939|P3|Overall Study|Entrance criteria not met|2
1689556|NCT01312909|5898940|P2|Overall Study|Entrance criteria not met|0
1689557|NCT01312909|5898941|P1|Overall Study|Entrance criteria not met|0
1689558|NCT01312909|5898939|P3|Overall Study|Insufficient clinical response|1
1689559|NCT01312909|5898940|P2|Overall Study|Insufficient clinical response|0
1689560|NCT01312909|5898941|P1|Overall Study|Insufficient clinical response|0
1689561|NCT01312909|5898939|P3|Overall Study|Lost to Follow-up|20
1689562|NCT01312909|5898940|P2|Overall Study|Lost to Follow-up|17
1689563|NCT01312909|5898941|P1|Overall Study|Lost to Follow-up|21
1689564|NCT01312909|5898939|P3|Overall Study|Withdrawal by Subject|7
1689565|NCT01312909|5898940|P2|Overall Study|Withdrawal by Subject|10
1689566|NCT01312909|5898941|P1|Overall Study|Withdrawal by Subject|8
1689567|NCT01312909|5898939|P3|Overall Study|Other|11
1689568|NCT01312909|5898940|P2|Overall Study|Other|6
1689569|NCT01312909|5898941|P1|Overall Study|Other|9
1689570|NCT01312909|5898939|P3|Overall Study|Protocol Violation|2
1689571|NCT01312909|5898940|P2|Overall Study|Protocol Violation|0
1689572|NCT01312909|5898941|P1|Overall Study|Protocol Violation|2
1689573|NCT01312909|5898939|P3|Overall Study|Adverse Event|3
1689574|NCT01312909|5898940|P2|Overall Study|Adverse Event|0
1689575|NCT01312909|5898941|P1|Overall Study|Adverse Event|1
1689576|NCT01312909|5898939|P3|Overall Study|Randomized but not treated|1
1689577|NCT01312909|5898940|P2|Overall Study|Randomized but not treated|3
1689578|NCT01312909|5898941|P1|Overall Study|Randomized but not treated|1
1689579|NCT01312467|5899081|P1|Overall Study|Ineligible|4
1689580|NCT01312467|5899081|P1|Overall Study|Another medical condition|1
1689581|NCT01312467|5899081|P1|Overall Study|Deported to country of origin|1
1689582|NCT01312467|5899081|P1|Overall Study|Withdrawal by Subject|2
1689583|NCT01312467|5899081|P1|Overall Study|Lost to Follow-up|1
1689584|NCT01312467|5899081|P1|Overall Study|Adverse Event|4
1689585|NCT01312428|5899090|P2|Overall Study|Study Termination|4
1689586|NCT01312428|5899091|P1|Overall Study|Study Termination|3
1689587|NCT01312129|5899161|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
1689588|NCT01312129|5899162|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
1689589|NCT01311661|5899247|P1|Overall Study|Withdrawal by Subject|2
1689590|NCT01311661|5899247|P1|Overall Study|Protocol Violation|3
1689591|NCT01311661|5899247|P1|Overall Study|Adverse Event|2
1689592|NCT01311557|5899391|P2|Overall Study|Withdrawal by Subject|2
1689593|NCT01311557|5899392|P1|Overall Study|Withdrawal by Subject|1
1689594|NCT01311557|5899391|P2|Overall Study|Lost to Follow-up|1
1689595|NCT01311557|5899392|P1|Overall Study|Lost to Follow-up|0
1689596|NCT01311557|5899391|P2|Overall Study|Protocol Violation|2
1689597|NCT01311557|5899392|P1|Overall Study|Protocol Violation|4
1689598|NCT01311557|5899391|P2|Overall Study|Serious adverse event|1
1689599|NCT01311557|5899392|P1|Overall Study|Serious adverse event|0
1689600|NCT01311505|5899408|P2|First Intervention Period|Protocol Violation|1
1689601|NCT01311505|5899409|P1|First Intervention Period|Protocol Violation|0
1689602|NCT01311024|5899465|P2|Overall Study|Protocol Violation|22
1689603|NCT01311024|5899466|P1|Overall Study|Protocol Violation|35
1689604|NCT01310868|5899472|P1|Overall Study|Do not have histologically confirmed GBM|13
1689605|NCT01310803|5899489|P2|Overall Study|Subject terminated by Sponsor|0
1689606|NCT01310803|5899490|P1|Overall Study|Subject terminated by Sponsor|1
1689607|NCT01310777|5899501|P3|Overall Study|Other|2
1689608|NCT01310777|5899502|P2|Overall Study|Other|1
1689609|NCT01310777|5899503|P1|Overall Study|Other|4
1689610|NCT01310777|5899501|P3|Overall Study|Inadequate Control of IOP|10
1689611|NCT01310777|5899502|P2|Overall Study|Inadequate Control of IOP|7
1689612|NCT01310777|5899503|P1|Overall Study|Inadequate Control of IOP|5
1689613|NCT01310777|5899501|P3|Overall Study|Patient's Decision Unrelated to AE|2
1689614|NCT01310777|5899502|P2|Overall Study|Patient's Decision Unrelated to AE|1
1689615|NCT01310777|5899503|P1|Overall Study|Patient's Decision Unrelated to AE|1
1689616|NCT01310777|5899501|P3|Overall Study|Lost to Follow-up|1
1689617|NCT01310777|5899502|P2|Overall Study|Lost to Follow-up|4
1689618|NCT01310777|5899503|P1|Overall Study|Lost to Follow-up|0
1689619|NCT01310777|5899501|P3|Overall Study|Adverse Event|15
1689620|NCT01310777|5899502|P2|Overall Study|Adverse Event|1
1689621|NCT01310777|5899503|P1|Overall Study|Adverse Event|23
1689622|NCT01310699|5899513|P2|Overall Study|Patients did not complete tandem.|6
1689623|NCT01310699|5899514|P1|Overall Study|Patients did not complete tandem.|4
1689624|NCT01310413|5899541|P7|From Day U0 to Day U385|Lost to Follow-up|2
1689625|NCT01310413|5899542|P6|From Day U0 to Day U385|Lost to Follow-up|0
1689626|NCT01310413|5899543|P5|From Day U0 to Day U385|Lost to Follow-up|0
1689627|NCT01310413|5899544|P4|From Day U0 to Day U385|Lost to Follow-up|0
1689628|NCT01310413|5899545|P3|From Day U0 to Day U385|Lost to Follow-up|0
1689629|NCT01310413|5899546|P2|From Day U0 to Day U385|Lost to Follow-up|0
1689630|NCT01310413|5899547|P1|From Day U0 to Day U385|Lost to Follow-up|0
1689631|NCT01310413|5899541|P7|From Day U0 to Day U385|Withdrawal by Subject|1
1689632|NCT01310413|5899542|P6|From Day U0 to Day U385|Withdrawal by Subject|0
1689633|NCT01310413|5899543|P5|From Day U0 to Day U385|Withdrawal by Subject|0
1689634|NCT01310413|5899544|P4|From Day U0 to Day U385|Withdrawal by Subject|0
1689635|NCT01310413|5899545|P3|From Day U0 to Day U385|Withdrawal by Subject|0
1689636|NCT01310413|5899546|P2|From Day U0 to Day U385|Withdrawal by Subject|0
1689637|NCT01310413|5899547|P1|From Day U0 to Day U385|Withdrawal by Subject|0
1689638|NCT01310413|5899541|P7|Day 0 to Day 385|Other|0
1689639|NCT01310413|5899542|P6|Day 0 to Day 385|Other|0
1689640|NCT01310413|5899543|P5|Day 0 to Day 385|Other|0
1689641|NCT01310413|5899544|P4|Day 0 to Day 385|Other|0
1689642|NCT01310413|5899545|P3|Day 0 to Day 385|Other|3
1689643|NCT01310413|5899546|P2|Day 0 to Day 385|Other|0
1689644|NCT01310413|5899547|P1|Day 0 to Day 385|Other|1
1689645|NCT01310413|5899541|P7|Day 0 to Day 385|Migrated/moved from study area|0
1689646|NCT01310413|5899542|P6|Day 0 to Day 385|Migrated/moved from study area|0
1689647|NCT01310413|5899543|P5|Day 0 to Day 385|Migrated/moved from study area|1
1689648|NCT01310413|5899544|P4|Day 0 to Day 385|Migrated/moved from study area|1
1689649|NCT01310413|5899545|P3|Day 0 to Day 385|Migrated/moved from study area|1
1689650|NCT01310413|5899546|P2|Day 0 to Day 385|Migrated/moved from study area|3
1689651|NCT01310413|5899547|P1|Day 0 to Day 385|Migrated/moved from study area|3
1689652|NCT01310413|5899541|P7|Day 0 to Day 385|Lost to Follow-up|0
1689653|NCT01310413|5899542|P6|Day 0 to Day 385|Lost to Follow-up|2
1689654|NCT01310413|5899543|P5|Day 0 to Day 385|Lost to Follow-up|1
1689655|NCT01310413|5899544|P4|Day 0 to Day 385|Lost to Follow-up|5
1689656|NCT01310413|5899545|P3|Day 0 to Day 385|Lost to Follow-up|3
1689657|NCT01310413|5899546|P2|Day 0 to Day 385|Lost to Follow-up|3
1689658|NCT01310413|5899547|P1|Day 0 to Day 385|Lost to Follow-up|18
1689659|NCT01310413|5899541|P7|Day 0 to Day 385|Withdrawal by Subject|0
1689660|NCT01310413|5899542|P6|Day 0 to Day 385|Withdrawal by Subject|1
1689661|NCT01310413|5899543|P5|Day 0 to Day 385|Withdrawal by Subject|1
1689662|NCT01310413|5899544|P4|Day 0 to Day 385|Withdrawal by Subject|2
1689663|NCT01310413|5899545|P3|Day 0 to Day 385|Withdrawal by Subject|0
1689664|NCT01310413|5899546|P2|Day 0 to Day 385|Withdrawal by Subject|2
1689665|NCT01310413|5899547|P1|Day 0 to Day 385|Withdrawal by Subject|5
1689666|NCT01310127|5899729|P2|Overall Study|advanced psc cataract outlier|0
1689667|NCT01310127|5899730|P1|Overall Study|advanced psc cataract outlier|1
1689668|NCT01310127|5899729|P2|Overall Study|Protocol Violation|1
1689669|NCT01310127|5899730|P1|Overall Study|Protocol Violation|1
1689670|NCT01310075|5899744|P2|Overall Study|Withdrawal by Subject|1
1689671|NCT01310075|5899745|P1|Overall Study|Withdrawal by Subject|1
1689672|NCT01310075|5899744|P2|Overall Study|Protocol Violation|2
1689673|NCT01310075|5899745|P1|Overall Study|Protocol Violation|2
1689674|NCT01310075|5899744|P2|Overall Study|Physician Decision|7
1689675|NCT01310075|5899745|P1|Overall Study|Physician Decision|10
1689676|NCT01310075|5899744|P2|Overall Study|Lost to Follow-up|0
1689677|NCT01310075|5899745|P1|Overall Study|Lost to Follow-up|1
1689678|NCT01310036|5899751|P1|Overall Study|Adverse event or intercurrent illness|12
1689679|NCT01310036|5899751|P1|Overall Study|Death|1
1689680|NCT01310036|5899751|P1|Overall Study|Progression of Disease|164
1689681|NCT01310036|5899751|P1|Overall Study|Refused Treatment/Did not Cooperate|4
1689682|NCT01310036|5899751|P1|Overall Study|Withdrew Consent|11
1689683|NCT01310036|5899751|P1|Overall Study|Administrative/other|10
1689684|NCT01309997|5899764|P2|Overall Study|Withdrawal by Subject|1
1689685|NCT01309997|5899765|P1|Overall Study|Withdrawal by Subject|1
1689686|NCT01309997|5899764|P2|Overall Study|Lack of Efficacy|2
1689687|NCT01309997|5899765|P1|Overall Study|Lack of Efficacy|2
1689688|NCT01309997|5899764|P2|Overall Study|Death|3
1689689|NCT01309997|5899765|P1|Overall Study|Death|1
1689690|NCT01309997|5899764|P2|Overall Study|Adverse Event|0
1689691|NCT01309997|5899765|P1|Overall Study|Adverse Event|1
1689692|NCT01309919|5899789|P2|Overall Study|Did not receive a postpartum IUD|48
1689693|NCT01309919|5899790|P1|Overall Study|Did not receive a postpartum IUD|17
1689694|NCT01309893|5899802|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
1689695|NCT01309893|5899803|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
1689696|NCT01309893|5899802|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
1689697|NCT01309893|5899803|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
1689698|NCT01309841|5899827|P3|Overall Study|Severe non-compliance with protocol|2
1689699|NCT01309841|5899828|P2|Overall Study|Severe non-compliance with protocol|5
1689700|NCT01309841|5899829|P1|Overall Study|Severe non-compliance with protocol|0
1689701|NCT01309841|5899827|P3|Overall Study|Did Not Receive Treatment|1
1689702|NCT01309841|5899828|P2|Overall Study|Did Not Receive Treatment|0
1689703|NCT01309841|5899829|P1|Overall Study|Did Not Receive Treatment|2
1689704|NCT01309841|5899827|P3|Overall Study|Withdrawal by Subject|13
1689705|NCT01309841|5899828|P2|Overall Study|Withdrawal by Subject|6
1689706|NCT01309841|5899829|P1|Overall Study|Withdrawal by Subject|17
1689707|NCT01309841|5899827|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
1689708|NCT01309841|5899828|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
1689709|NCT01309841|5899829|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
1689710|NCT01309841|5899827|P3|Overall Study|Death|0
1689711|NCT01309841|5899828|P2|Overall Study|Death|0
1689712|NCT01309841|5899829|P1|Overall Study|Death|1
1689713|NCT01309841|5899827|P3|Overall Study|Adverse Event|11
1689714|NCT01309841|5899828|P2|Overall Study|Adverse Event|22
1689715|NCT01309841|5899829|P1|Overall Study|Adverse Event|9
1689716|NCT01309841|5899827|P3|Overall Study|Lack of Efficacy|2
1689717|NCT01309841|5899828|P2|Overall Study|Lack of Efficacy|0
1689718|NCT01309841|5899829|P1|Overall Study|Lack of Efficacy|0
1689719|NCT01309841|5899827|P3|Overall Study|Study-Specific Withdrawal Criteria|2
1689720|NCT01309841|5899828|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1689721|NCT01309841|5899829|P1|Overall Study|Study-Specific Withdrawal Criteria|3
1689722|NCT01309841|5899827|P3|Overall Study|Lost to Follow-up|4
1689723|NCT01309841|5899828|P2|Overall Study|Lost to Follow-up|6
1689724|NCT01309841|5899829|P1|Overall Study|Lost to Follow-up|7
1689725|NCT01309841|5899827|P3|Overall Study|Other|1
1689726|NCT01309841|5899828|P2|Overall Study|Other|1
1689727|NCT01309841|5899829|P1|Overall Study|Other|0
1689728|NCT01309828|5899869|P2|Overall Study|Other|0
1689729|NCT01309828|5899870|P1|Overall Study|Other|1
1689730|NCT01309828|5899869|P2|Overall Study|Major Protocol Deviation|1
1689731|NCT01309828|5899870|P1|Overall Study|Major Protocol Deviation|0
1689732|NCT01309828|5899869|P2|Overall Study|Voluntary Withdrawal|4
1689733|NCT01309828|5899870|P1|Overall Study|Voluntary Withdrawal|5
1689734|NCT01309828|5899869|P2|Overall Study|Adverse Event|11
1689735|NCT01309828|5899870|P1|Overall Study|Adverse Event|10
1689736|NCT01309737|5899904|P5|Week 16 to 52|Other|0
1689737|NCT01309737|5899905|P4|Week 16 to 52|Other|2
1689738|NCT01309737|5899906|P3|Week 16 to 52|Other|0
1689739|NCT01309737|5899907|P2|Week 16 to 52|Other|12
1689740|NCT01309737|5899908|P1|Week 16 to 52|Other|10
1689741|NCT01309737|5899904|P5|Week 16 to 52|Withdrawal by Subject|2
1689742|NCT01309737|5899905|P4|Week 16 to 52|Withdrawal by Subject|0
1689743|NCT01309737|5899906|P3|Week 16 to 52|Withdrawal by Subject|0
1689744|NCT01309737|5899907|P2|Week 16 to 52|Withdrawal by Subject|6
1689745|NCT01309737|5899908|P1|Week 16 to 52|Withdrawal by Subject|5
1689746|NCT01309737|5899904|P5|Week 16 to 52|Lost to Follow-up|4
1689747|NCT01309737|5899905|P4|Week 16 to 52|Lost to Follow-up|1
1689748|NCT01309737|5899906|P3|Week 16 to 52|Lost to Follow-up|0
1689749|NCT01309737|5899907|P2|Week 16 to 52|Lost to Follow-up|2
1689750|NCT01309737|5899908|P1|Week 16 to 52|Lost to Follow-up|4
1689751|NCT01309737|5899904|P5|Week 16 to 52|Lack of Efficacy|21
1689752|NCT01309737|5899905|P4|Week 16 to 52|Lack of Efficacy|25
1689753|NCT01309737|5899906|P3|Week 16 to 52|Lack of Efficacy|0
1689754|NCT01309737|5899907|P2|Week 16 to 52|Lack of Efficacy|76
1689755|NCT01309737|5899908|P1|Week 16 to 52|Lack of Efficacy|107
1689756|NCT01309737|5899904|P5|Week 16 to 52|Adverse Event|5
1689757|NCT01309737|5899905|P4|Week 16 to 52|Adverse Event|6
1689758|NCT01309737|5899906|P3|Week 16 to 52|Adverse Event|0
1689759|NCT01309737|5899907|P2|Week 16 to 52|Adverse Event|7
1689760|NCT01309737|5899908|P1|Week 16 to 52|Adverse Event|7
1689761|NCT01309737|5899904|P5|Week 16 to 52|Death|1
1689762|NCT01309737|5899905|P4|Week 16 to 52|Death|0
1689763|NCT01309737|5899906|P3|Week 16 to 52|Death|0
1689764|NCT01309737|5899907|P2|Week 16 to 52|Death|0
1689765|NCT01309737|5899908|P1|Week 16 to 52|Death|0
1689766|NCT01309737|5899904|P5|Week 0 to 16|Randomized, but not treated|0
1689767|NCT01309737|5899905|P4|Week 0 to 16|Randomized, but not treated|0
1689768|NCT01309737|5899906|P3|Week 0 to 16|Randomized, but not treated|0
1689769|NCT01309737|5899907|P2|Week 0 to 16|Randomized, but not treated|0
1689770|NCT01309737|5899908|P1|Week 0 to 16|Randomized, but not treated|1
1689771|NCT01309737|5899904|P5|Week 0 to 16|Other|0
1689772|NCT01309737|5899905|P4|Week 0 to 16|Other|0
1689773|NCT01309737|5899906|P3|Week 0 to 16|Other|4
1689774|NCT01309737|5899907|P2|Week 0 to 16|Other|14
1689775|NCT01309737|5899908|P1|Week 0 to 16|Other|10
1689776|NCT01309737|5899904|P5|Week 0 to 16|Withdrawal by Subject|0
1689777|NCT01309737|5899905|P4|Week 0 to 16|Withdrawal by Subject|0
1689778|NCT01309737|5899906|P3|Week 0 to 16|Withdrawal by Subject|7
1689779|NCT01309737|5899907|P2|Week 0 to 16|Withdrawal by Subject|6
1689780|NCT01309737|5899908|P1|Week 0 to 16|Withdrawal by Subject|7
1689781|NCT01309737|5899904|P5|Week 0 to 16|Lost to Follow-up|0
1689782|NCT01309737|5899905|P4|Week 0 to 16|Lost to Follow-up|0
1689783|NCT01309737|5899906|P3|Week 0 to 16|Lost to Follow-up|3
1689784|NCT01309737|5899907|P2|Week 0 to 16|Lost to Follow-up|8
1689785|NCT01309737|5899908|P1|Week 0 to 16|Lost to Follow-up|7
1689786|NCT01309737|5899904|P5|Week 0 to 16|Lack of Efficacy|0
1689787|NCT01309737|5899905|P4|Week 0 to 16|Lack of Efficacy|0
1689788|NCT01309737|5899906|P3|Week 0 to 16|Lack of Efficacy|24
1689789|NCT01309737|5899907|P2|Week 0 to 16|Lack of Efficacy|2
1689790|NCT01309737|5899908|P1|Week 0 to 16|Lack of Efficacy|15
1689791|NCT01309737|5899904|P5|Week 0 to 16|Adverse Event|0
1689792|NCT01309737|5899905|P4|Week 0 to 16|Adverse Event|0
1689793|NCT01309737|5899906|P3|Week 0 to 16|Adverse Event|5
1689794|NCT01309737|5899907|P2|Week 0 to 16|Adverse Event|10
1689795|NCT01309737|5899908|P1|Week 0 to 16|Adverse Event|11
1689796|NCT01309737|5899904|P5|Week 0 to 16|Death|0
1689797|NCT01309737|5899905|P4|Week 0 to 16|Death|0
1689798|NCT01309737|5899906|P3|Week 0 to 16|Death|1
1689799|NCT01309737|5899907|P2|Week 0 to 16|Death|0
1689800|NCT01309737|5899908|P1|Week 0 to 16|Death|1
1689801|NCT01309672|5900103|P1|Overall Study|Withdrawal by Subject|3
1689802|NCT01309672|5900103|P1|Overall Study|Adverse Event|5
1689803|NCT01309672|5900103|P1|Overall Study|Other|9
1689804|NCT01309672|5900103|P1|Overall Study|Lack of Efficacy|20
1689805|NCT01309659|5900113|P2|Overall Study|Protocol Violation|1
1689806|NCT01309659|5900114|P1|Overall Study|Protocol Violation|0
1689807|NCT01309386|5900219|P2|Overall Study|Adverse Event|8
1689808|NCT01309386|5900220|P1|Overall Study|Adverse Event|5
1689809|NCT01309386|5900219|P2|Overall Study|Lack of Efficacy|1
1689810|NCT01309386|5900220|P1|Overall Study|Lack of Efficacy|3
1689811|NCT01309386|5900219|P2|Overall Study|Physician Decision|1
1689812|NCT01309386|5900220|P1|Overall Study|Physician Decision|1
1689813|NCT01309386|5900219|P2|Overall Study|Progressive disease|11
1689814|NCT01309386|5900220|P1|Overall Study|Progressive disease|9
1689815|NCT01309386|5900219|P2|Overall Study|Withdrawal by Subject|0
1689816|NCT01309386|5900220|P1|Overall Study|Withdrawal by Subject|2
1689817|NCT01309386|5900219|P2|Overall Study|Other|0
1689818|NCT01309386|5900220|P1|Overall Study|Other|2
1689819|NCT01309308|5900268|P2|Overall Study|Lost to Follow-up|4
1689820|NCT01309308|5900269|P1|Overall Study|Lost to Follow-up|6
1689821|NCT01309282|5900277|P1|Overall Study|Lost to Follow-up|1
1689822|NCT01309269|5900294|P1|Overall Study|Enrolled but not Treated|107
1689823|NCT01309269|5900294|P1|Overall Study|Study Completion Data Not Recorded|95
1689824|NCT01309269|5900294|P1|Overall Study|Other|1
1689825|NCT01309269|5900294|P1|Overall Study|Other|256
1689826|NCT01309269|5900294|P1|Overall Study|Administrative Problems|141
1689827|NCT01309269|5900294|P1|Overall Study|Kidney Transplant|25
1689828|NCT01309269|5900294|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
1689829|NCT01309269|5900294|P1|Overall Study|Lack of Acceptance|15
1689830|NCT01309269|5900294|P1|Overall Study|Withdrawal by Subject|25
1689831|NCT01309269|5900294|P1|Overall Study|Adverse Event|56
1689832|NCT01309243|5900302|P2|Extension Phase|Lost to Follow-up|0
1689833|NCT01309243|5900303|P1|Extension Phase|Lost to Follow-up|6
1689834|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Protocol Violation|1
1689835|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Protocol Violation|1
1689836|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
1689837|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
1689838|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
1689839|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
1689840|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Withdrew Consent|18
1689841|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Withdrew Consent|12
1689842|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Investigators Discretion|6
1689843|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Investigators Discretion|3
1689844|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
1689845|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
1689846|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Pregnancy|0
1689847|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Pregnancy|2
1689848|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Death|1
1689849|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Death|0
1689850|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Adverse Event|43
1689851|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Adverse Event|12
1689852|NCT01309243|5900302|P2|Randomized Phase Through Week 96|Randomized but not treated|7
1689853|NCT01309243|5900303|P1|Randomized Phase Through Week 96|Randomized but not treated|6
1689854|NCT01309204|5900329|P2|Overall Study|Other|1
1689855|NCT01309204|5900330|P1|Overall Study|Other|4
1689856|NCT01309204|5900329|P2|Overall Study|Inadequate control of IOP|4
1689857|NCT01309204|5900330|P1|Overall Study|Inadequate control of IOP|4
1689858|NCT01309204|5900329|P2|Overall Study|Subject's decision unrelated to an AE|10
1689859|NCT01309204|5900330|P1|Overall Study|Subject's decision unrelated to an AE|9
1689860|NCT01309204|5900329|P2|Overall Study|Lost to Follow-up|2
1689861|NCT01309204|5900330|P1|Overall Study|Lost to Follow-up|2
1689862|NCT01309204|5900329|P2|Overall Study|Adverse Event|58
1689863|NCT01309204|5900330|P1|Overall Study|Adverse Event|48
1689864|NCT01309165|5900338|P2|Overall Study|Admitted to hospital for second stroke|0
1689865|NCT01309165|5900339|P1|Overall Study|Admitted to hospital for second stroke|1
1689866|NCT01309165|5900338|P2|Overall Study|No transportation|1
1689867|NCT01309165|5900339|P1|Overall Study|No transportation|0
1689868|NCT01309165|5900338|P2|Overall Study|Left country|1
1689869|NCT01309165|5900339|P1|Overall Study|Left country|0
1689870|NCT01309165|5900338|P2|Overall Study|Return to work|2
1689871|NCT01309165|5900339|P1|Overall Study|Return to work|1
1689872|NCT01309165|5900338|P2|Overall Study|Lost to Follow-up|3
1689873|NCT01309165|5900339|P1|Overall Study|Lost to Follow-up|4
1689874|NCT01309100|5900351|P1|Overall Study|Positive Slit lamp finding|1
1689875|NCT01309100|5900351|P1|Overall Study|Protocol Violation|1
1689876|NCT01308853|5900369|P1|Overall Study|Insertion of permanent implants|1
1689877|NCT01308853|5900369|P1|Overall Study|Lost to Follow-up|2
1689878|NCT01308853|5900369|P1|Overall Study|Adverse Event|1
1689879|NCT01308788|5900404|P2|2-year Treatment|medication change by treating physician|11
1689880|NCT01308788|5900405|P1|2-year Treatment|medication change by treating physician|4
1689881|NCT01308762|5900440|P3|Overall Study|Protocol Violation|0
1689882|NCT01308762|5900441|P2|Overall Study|Protocol Violation|1
1689883|NCT01308762|5900442|P1|Overall Study|Protocol Violation|0
1689884|NCT01308749|5900455|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
1689885|NCT01308749|5900456|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
1689886|NCT01308749|5900455|P2|Period 2: Open Label Treatment|Adverse Event|1
1689887|NCT01308749|5900456|P1|Period 2: Open Label Treatment|Adverse Event|0
1689888|NCT01308749|5900455|P2|Period 1: Double Blind Treatment|Adverse Event|0
1689889|NCT01308749|5900456|P1|Period 1: Double Blind Treatment|Adverse Event|1
1689890|NCT01308736|5900486|P2|Overall Study|Did not attend a single session|5
1689891|NCT01308736|5900487|P1|Overall Study|Did not attend a single session|6
1689892|NCT01308580|5900510|P2|Overall Study|Lost to Follow-up|7
1689893|NCT01308580|5900511|P1|Overall Study|Lost to Follow-up|12
1689894|NCT01308567|5900554|P3|Overall Study|Lost to Follow-up|4
1689895|NCT01308567|5900555|P2|Overall Study|Lost to Follow-up|4
1689896|NCT01308567|5900556|P1|Overall Study|Lost to Follow-up|2
1689897|NCT01308476|5900596|P2|Overall Study|Other|0
1689898|NCT01308476|5900597|P1|Overall Study|Other|1
1689899|NCT01308476|5900596|P2|Overall Study|Lost to Follow-up|2
1689900|NCT01308476|5900597|P1|Overall Study|Lost to Follow-up|2
1689901|NCT01308463|5900617|P1|Overall Study|Revision|2
1689902|NCT01308463|5900617|P1|Overall Study|Death|4
1689903|NCT01308463|5900617|P1|Overall Study|Study Discontinued|23
1689904|NCT01308424|5900630|P3|Randomization|Physician Decision|1
1689905|NCT01308424|5900631|P2|Randomization|Physician Decision|1
1689906|NCT01308424|5900632|P1|Randomization|Physician Decision|0
1689907|NCT01308424|5900630|P3|Randomization|Lost to Follow-up|0
1689908|NCT01308424|5900631|P2|Randomization|Lost to Follow-up|1
1689909|NCT01308424|5900632|P1|Randomization|Lost to Follow-up|0
1689910|NCT01308424|5900630|P3|Randomization|Adverse Event|1
1689911|NCT01308424|5900631|P2|Randomization|Adverse Event|1
1689912|NCT01308424|5900632|P1|Randomization|Adverse Event|0
1689913|NCT01308424|5900630|P3|Baseline Eligibility|Screen Failures|0
1689914|NCT01308424|5900631|P2|Baseline Eligibility|Screen Failures|0
1689915|NCT01308424|5900632|P1|Baseline Eligibility|Screen Failures|71
1689916|NCT01308008|5900641|P2|4 Weeks|Illness, disinterest, time|2
1689917|NCT01308008|5900642|P1|4 Weeks|Illness, disinterest, time|9
1689918|NCT01307891|5900665|P2|Overall Study|Progressive Disease|1
1689919|NCT01307891|5900666|P1|Overall Study|Progressive Disease|3
1689920|NCT01307787|5900678|P2|Overall Study|Withdrawal by Subject|0
1689921|NCT01307787|5900679|P1|Overall Study|Withdrawal by Subject|2
1689922|NCT01307579|5900748|P2|Overall Study|Ineligible|4
1689923|NCT01307579|5900749|P1|Overall Study|Ineligible|3
1689924|NCT01307579|5900748|P2|Overall Study|Refractory or relapsed AML|23
1689925|NCT01307579|5900749|P1|Overall Study|Refractory or relapsed AML|38
1689926|NCT01307579|5900748|P2|Overall Study|Begin conditioning for HSCT|44
1689927|NCT01307579|5900749|P1|Overall Study|Begin conditioning for HSCT|42
1689928|NCT01307579|5900748|P2|Overall Study|Institutional diagnosis of IFD|36
1689929|NCT01307579|5900749|P1|Overall Study|Institutional diagnosis of IFD|21
1689930|NCT01307579|5900748|P2|Overall Study|Withdrawal by Subject|3
1689931|NCT01307579|5900749|P1|Overall Study|Withdrawal by Subject|7
1689932|NCT01307579|5900748|P2|Overall Study|Physician Decision|29
1689933|NCT01307579|5900749|P1|Overall Study|Physician Decision|26
1689934|NCT01307579|5900748|P2|Overall Study|Death|6
1689935|NCT01307579|5900749|P1|Overall Study|Death|3
1689936|NCT01307501|5900761|P1|Overall Study|Starting Hospice|1
1689937|NCT01307501|5900761|P1|Overall Study|Lost to Follow-up|1
1689938|NCT01307501|5900761|P1|Overall Study|Death|20
1689939|NCT01307501|5900761|P1|Overall Study|Treatment Failure|1
1689940|NCT01307449|5900791|P4|Overall Study|Adverse Event|0
1689941|NCT01307449|5900792|P3|Overall Study|Adverse Event|0
1689942|NCT01307449|5900793|P2|Overall Study|Adverse Event|0
1689943|NCT01307449|5900794|P1|Overall Study|Adverse Event|1
1689944|NCT01307423|5900827|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
1689945|NCT01307423|5900828|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
1689946|NCT01307423|5900829|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
1689947|NCT01307423|5900830|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
1689948|NCT01307423|5900831|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
1689949|NCT01307423|5900832|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
1689950|NCT01307423|5900833|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
1689951|NCT01307423|5900834|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
1689952|NCT01307423|5900835|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
1689953|NCT01307423|5900827|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689954|NCT01307423|5900828|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689955|NCT01307423|5900829|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689956|NCT01307423|5900830|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689957|NCT01307423|5900831|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689958|NCT01307423|5900832|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689959|NCT01307423|5900833|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689960|NCT01307423|5900834|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
1689961|NCT01307423|5900835|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
1689962|NCT01307423|5900827|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1689963|NCT01307423|5900828|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1689964|NCT01307423|5900829|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1689965|NCT01307423|5900830|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1689966|NCT01307423|5900831|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1689967|NCT01307423|5900832|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1689968|NCT01307423|5900833|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
1689969|NCT01307423|5900834|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
1689970|NCT01307423|5900835|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1689971|NCT01307423|5900827|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1689972|NCT01307423|5900828|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1689973|NCT01307423|5900829|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1689974|NCT01307423|5900830|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1689975|NCT01307423|5900831|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1689976|NCT01307423|5900832|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1689977|NCT01307423|5900833|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
1689978|NCT01307423|5900834|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
1689979|NCT01307423|5900835|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1689980|NCT01307423|5900827|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
1689981|NCT01307423|5900828|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
1689982|NCT01307423|5900829|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
1689983|NCT01307423|5900830|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
1689984|NCT01307423|5900831|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
1689985|NCT01307423|5900832|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
1689986|NCT01307423|5900833|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
1689987|NCT01307423|5900834|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
1689988|NCT01307423|5900835|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
1689989|NCT01307423|5900827|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689990|NCT01307423|5900828|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
1689991|NCT01307423|5900829|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689992|NCT01307423|5900830|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689993|NCT01307423|5900831|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689994|NCT01307423|5900832|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689995|NCT01307423|5900833|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689996|NCT01307423|5900834|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689997|NCT01307423|5900835|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
1689998|NCT01307423|5900827|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1689999|NCT01307423|5900828|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1690000|NCT01307423|5900829|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1690001|NCT01307423|5900830|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1690002|NCT01307423|5900831|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1690003|NCT01307423|5900832|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1690004|NCT01307423|5900833|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
1690005|NCT01307423|5900834|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1690006|NCT01307423|5900835|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1690007|NCT01307423|5900827|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
1690008|NCT01307423|5900828|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
1690009|NCT01307423|5900829|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1690010|NCT01307423|5900830|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1690011|NCT01307423|5900831|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1690012|NCT01307423|5900832|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1690013|NCT01307423|5900833|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
1690014|NCT01307423|5900834|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
1690015|NCT01307423|5900835|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1690016|NCT01307423|5900827|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
1690017|NCT01307423|5900828|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1690018|NCT01307423|5900829|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1690019|NCT01307423|5900830|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1690020|NCT01307423|5900831|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1690021|NCT01307423|5900832|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1690022|NCT01307423|5900833|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1690023|NCT01307423|5900834|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
1690024|NCT01307423|5900835|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1690025|NCT01307423|5900827|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
1690026|NCT01307423|5900828|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
1690027|NCT01307423|5900829|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
1690028|NCT01307423|5900830|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
1690029|NCT01307423|5900831|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
1690030|NCT01307423|5900832|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
1690031|NCT01307423|5900833|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
1690032|NCT01307423|5900834|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
1690033|NCT01307423|5900835|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
1690034|NCT01307423|5900827|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
1690035|NCT01307423|5900828|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
1690036|NCT01307423|5900829|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
1690037|NCT01307423|5900830|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
1690038|NCT01307423|5900831|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
1690039|NCT01307423|5900832|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
1690040|NCT01307423|5900833|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
1690041|NCT01307423|5900834|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
1690042|NCT01307423|5900835|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
1690043|NCT01307423|5900827|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
1690044|NCT01307423|5900828|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
1690045|NCT01307423|5900829|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1690046|NCT01307423|5900830|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1690047|NCT01307423|5900831|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1690048|NCT01307423|5900832|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1690049|NCT01307423|5900833|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
1690050|NCT01307423|5900834|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
1690051|NCT01307423|5900835|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1690052|NCT01307423|5900827|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
1690053|NCT01307423|5900828|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
1690054|NCT01307423|5900829|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1690055|NCT01307423|5900830|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1690056|NCT01307423|5900831|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1690057|NCT01307423|5900832|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1690058|NCT01307423|5900833|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
1690059|NCT01307423|5900834|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
1690060|NCT01307423|5900835|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1690061|NCT01307423|5900827|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1690062|NCT01307423|5900828|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1690063|NCT01307423|5900829|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1690064|NCT01307423|5900830|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1690065|NCT01307423|5900831|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1690066|NCT01307423|5900832|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1690067|NCT01307423|5900833|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
1690068|NCT01307423|5900834|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
1690069|NCT01307423|5900835|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
1690143|NCT01307423|5900828|P8|Active Treatment Phase (Week 25-52)|Other|0
1690070|NCT01307423|5900827|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1690071|NCT01307423|5900828|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
1690072|NCT01307423|5900829|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1690073|NCT01307423|5900830|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1690074|NCT01307423|5900831|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1690075|NCT01307423|5900832|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1690076|NCT01307423|5900833|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
1690077|NCT01307423|5900834|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1690078|NCT01307423|5900835|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1690079|NCT01307423|5900827|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
1690080|NCT01307423|5900828|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
1690081|NCT01307423|5900829|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
1690082|NCT01307423|5900830|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
1690083|NCT01307423|5900831|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
1690084|NCT01307423|5900832|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
1690085|NCT01307423|5900833|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
1690086|NCT01307423|5900834|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
1690087|NCT01307423|5900835|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
1690088|NCT01307423|5900827|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
1690089|NCT01307423|5900828|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
1690090|NCT01307423|5900829|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
1690091|NCT01307423|5900830|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
1690092|NCT01307423|5900831|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
1690093|NCT01307423|5900832|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
1690094|NCT01307423|5900833|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
1690095|NCT01307423|5900834|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
1690096|NCT01307423|5900835|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
1690097|NCT01307423|5900827|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
1690098|NCT01307423|5900828|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
1690099|NCT01307423|5900829|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1690100|NCT01307423|5900830|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1690101|NCT01307423|5900831|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1690102|NCT01307423|5900832|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1690103|NCT01307423|5900833|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
1690104|NCT01307423|5900834|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
1690105|NCT01307423|5900835|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1690106|NCT01307423|5900827|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690107|NCT01307423|5900828|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690108|NCT01307423|5900829|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690109|NCT01307423|5900830|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690110|NCT01307423|5900831|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690111|NCT01307423|5900832|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690112|NCT01307423|5900833|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
1690113|NCT01307423|5900834|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690114|NCT01307423|5900835|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
1690115|NCT01307423|5900827|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
1690116|NCT01307423|5900828|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
1690117|NCT01307423|5900829|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1690118|NCT01307423|5900830|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1690119|NCT01307423|5900831|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1690120|NCT01307423|5900832|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1690121|NCT01307423|5900833|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
1690122|NCT01307423|5900834|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
1690123|NCT01307423|5900835|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1690124|NCT01307423|5900827|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
1690125|NCT01307423|5900828|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
1690126|NCT01307423|5900829|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
1690127|NCT01307423|5900830|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
1690128|NCT01307423|5900831|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
1690129|NCT01307423|5900832|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
1690130|NCT01307423|5900833|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
1690131|NCT01307423|5900834|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
1690132|NCT01307423|5900835|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
1690133|NCT01307423|5900827|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690134|NCT01307423|5900828|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690135|NCT01307423|5900829|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690136|NCT01307423|5900830|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
1690137|NCT01307423|5900831|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690138|NCT01307423|5900832|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690139|NCT01307423|5900833|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690140|NCT01307423|5900834|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690141|NCT01307423|5900835|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
1690142|NCT01307423|5900827|P9|Active Treatment Phase (Week 25-52)|Other|0
1690144|NCT01307423|5900829|P7|Active Treatment Phase (Week 25-52)|Other|0
1690145|NCT01307423|5900830|P6|Active Treatment Phase (Week 25-52)|Other|0
1690146|NCT01307423|5900831|P5|Active Treatment Phase (Week 25-52)|Other|0
1690147|NCT01307423|5900832|P4|Active Treatment Phase (Week 25-52)|Other|1
1690148|NCT01307423|5900833|P3|Active Treatment Phase (Week 25-52)|Other|0
1690149|NCT01307423|5900834|P2|Active Treatment Phase (Week 25-52)|Other|0
1690150|NCT01307423|5900835|P1|Active Treatment Phase (Week 25-52)|Other|0
1690151|NCT01307423|5900827|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690152|NCT01307423|5900828|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690153|NCT01307423|5900829|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690154|NCT01307423|5900830|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690155|NCT01307423|5900831|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690156|NCT01307423|5900832|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
1690157|NCT01307423|5900833|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690158|NCT01307423|5900834|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690159|NCT01307423|5900835|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
1690160|NCT01307423|5900827|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1690161|NCT01307423|5900828|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1690162|NCT01307423|5900829|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
1690163|NCT01307423|5900830|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
1690164|NCT01307423|5900831|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1690165|NCT01307423|5900832|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1690166|NCT01307423|5900833|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
1690167|NCT01307423|5900834|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
1690168|NCT01307423|5900835|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
1690169|NCT01307423|5900827|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690170|NCT01307423|5900828|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690171|NCT01307423|5900829|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690172|NCT01307423|5900830|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
1690173|NCT01307423|5900831|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690174|NCT01307423|5900832|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690175|NCT01307423|5900833|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690176|NCT01307423|5900834|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690177|NCT01307423|5900835|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
1690178|NCT01307423|5900827|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1690179|NCT01307423|5900828|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1690180|NCT01307423|5900829|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1690181|NCT01307423|5900830|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1690182|NCT01307423|5900831|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
1690183|NCT01307423|5900832|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
1690184|NCT01307423|5900833|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
1690185|NCT01307423|5900834|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
1690186|NCT01307423|5900835|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
1690187|NCT01307423|5900827|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
1690188|NCT01307423|5900828|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
1690189|NCT01307423|5900829|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
1690190|NCT01307423|5900830|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
1690191|NCT01307423|5900831|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
1690192|NCT01307423|5900832|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
1690193|NCT01307423|5900833|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
1690194|NCT01307423|5900834|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
1690195|NCT01307423|5900835|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
1690196|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1690197|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1690198|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1690199|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1690200|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1690201|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1690202|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
1690203|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
1690204|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
1690205|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
1690206|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
1690207|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
1690208|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
1690209|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
1690210|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
1690211|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
1690212|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
1690213|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
1690214|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690215|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690216|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690217|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690218|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690219|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690220|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690221|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1690222|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1690223|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1690224|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1690225|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1690226|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1690227|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1690228|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1690229|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
1690230|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1690231|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
1690232|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690233|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690234|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690235|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690236|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690237|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690238|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
1690239|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690240|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1690241|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1690242|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1690243|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1690244|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1690245|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1690246|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1690247|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
1690248|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1690249|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
1690250|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1690251|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1690252|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1690253|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1690254|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1690255|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1690256|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1690257|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1690258|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
1690259|NCT01307423|5900827|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1690260|NCT01307423|5900828|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1690261|NCT01307423|5900829|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1690262|NCT01307423|5900830|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1690263|NCT01307423|5900831|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1690264|NCT01307423|5900832|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1690265|NCT01307423|5900833|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
1690266|NCT01307423|5900834|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1690267|NCT01307423|5900835|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1690268|NCT01307319|5901041|P3|Overall Study|Other|3
1690269|NCT01307319|5901042|P2|Overall Study|Other|4
1690270|NCT01307319|5901043|P1|Overall Study|Other|0
1690271|NCT01307319|5901041|P3|Overall Study|Withdrawal by Subject|2
1690272|NCT01307319|5901042|P2|Overall Study|Withdrawal by Subject|1
1690273|NCT01307319|5901043|P1|Overall Study|Withdrawal by Subject|0
1690274|NCT01307319|5901041|P3|Overall Study|Protocol Violation|0
1690275|NCT01307319|5901042|P2|Overall Study|Protocol Violation|1
1690276|NCT01307319|5901043|P1|Overall Study|Protocol Violation|1
1690277|NCT01307319|5901041|P3|Overall Study|Lost to Follow-up|1
1690278|NCT01307319|5901042|P2|Overall Study|Lost to Follow-up|0
1690279|NCT01307319|5901043|P1|Overall Study|Lost to Follow-up|1
1690280|NCT01307319|5901041|P3|Overall Study|Adverse Event|1
1690281|NCT01307319|5901042|P2|Overall Study|Adverse Event|2
1690282|NCT01307319|5901043|P1|Overall Study|Adverse Event|2
1690283|NCT01307111|5901057|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
1690284|NCT01307111|5901058|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
1690285|NCT01307111|5901057|P2|IUD Insertion|Lost to Follow-up|0
1690286|NCT01307111|5901058|P1|IUD Insertion|Lost to Follow-up|2
1690287|NCT01307046|5901081|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
1690288|NCT01307046|5901082|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
1690289|NCT01307046|5901081|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
1690290|NCT01307046|5901082|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
1690291|NCT01307046|5901081|P2|Overall Study|Withdrawal by Subject|1
1690292|NCT01307046|5901082|P1|Overall Study|Withdrawal by Subject|1
1690293|NCT01307046|5901081|P2|Overall Study|Physician Decision|0
1690294|NCT01307046|5901082|P1|Overall Study|Physician Decision|2
1690295|NCT01307046|5901081|P2|Overall Study|Lack of Efficacy|2
1690296|NCT01307046|5901082|P1|Overall Study|Lack of Efficacy|0
1690297|NCT01307046|5901081|P2|Overall Study|Adverse Event|3
1690298|NCT01307046|5901082|P1|Overall Study|Adverse Event|3
1690299|NCT01307033|5901094|P4|44-week Open-label Extension|Death|1
1690300|NCT01307033|5901095|P3|44-week Open-label Extension|Death|0
1690301|NCT01307033|5901096|P2|44-week Open-label Extension|Death|0
1690302|NCT01307033|5901097|P1|44-week Open-label Extension|Death|0
1690303|NCT01307033|5901094|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
1690304|NCT01307033|5901095|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
1690305|NCT01307033|5901096|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1690306|NCT01307033|5901097|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
1690307|NCT01307033|5901094|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
1690308|NCT01307033|5901095|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1690309|NCT01307033|5901096|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1690310|NCT01307033|5901097|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
1690311|NCT01307033|5901094|P4|44-week Open-label Extension|Physician Decision|0
1690312|NCT01307033|5901095|P3|44-week Open-label Extension|Physician Decision|1
1690313|NCT01307033|5901096|P2|44-week Open-label Extension|Physician Decision|0
1690314|NCT01307033|5901097|P1|44-week Open-label Extension|Physician Decision|0
1690315|NCT01307033|5901094|P4|44-week Open-label Extension|Withdrawal by Subject|1
1690316|NCT01307033|5901095|P3|44-week Open-label Extension|Withdrawal by Subject|2
1690317|NCT01307033|5901096|P2|44-week Open-label Extension|Withdrawal by Subject|0
1690318|NCT01307033|5901097|P1|44-week Open-label Extension|Withdrawal by Subject|0
1690319|NCT01307033|5901094|P4|44-week Open-label Extension|Adverse Event|1
1690320|NCT01307033|5901095|P3|44-week Open-label Extension|Adverse Event|2
1690321|NCT01307033|5901096|P2|44-week Open-label Extension|Adverse Event|0
1690322|NCT01307033|5901097|P1|44-week Open-label Extension|Adverse Event|0
1690323|NCT01307033|5901094|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1690324|NCT01307033|5901095|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
1690325|NCT01307033|5901096|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
1690326|NCT01307033|5901097|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
1690327|NCT01307033|5901094|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1690328|NCT01307033|5901095|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1690329|NCT01307033|5901096|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
1690330|NCT01307033|5901097|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
1690331|NCT01307033|5901094|P4|8-week Double-blind Period|Lack of Efficacy|0
1690332|NCT01307033|5901095|P3|8-week Double-blind Period|Lack of Efficacy|0
1690333|NCT01307033|5901096|P2|8-week Double-blind Period|Lack of Efficacy|0
1690334|NCT01307033|5901097|P1|8-week Double-blind Period|Lack of Efficacy|1
1690335|NCT01307033|5901094|P4|8-week Double-blind Period|Withdrawal by Subject|0
1690336|NCT01307033|5901095|P3|8-week Double-blind Period|Withdrawal by Subject|0
1690337|NCT01307033|5901096|P2|8-week Double-blind Period|Withdrawal by Subject|1
1690338|NCT01307033|5901097|P1|8-week Double-blind Period|Withdrawal by Subject|4
1690339|NCT01307033|5901094|P4|8-week Double-blind Period|Adverse Event|0
1690340|NCT01307033|5901095|P3|8-week Double-blind Period|Adverse Event|0
1690341|NCT01307033|5901096|P2|8-week Double-blind Period|Adverse Event|0
1690342|NCT01307033|5901097|P1|8-week Double-blind Period|Adverse Event|2
1690343|NCT01307020|5901119|P10|Overall Study|Electronic data capture failure|0
1690344|NCT01307020|5901120|P9|Overall Study|Electronic data capture failure|0
1690345|NCT01307020|5901121|P8|Overall Study|Electronic data capture failure|0
1690346|NCT01307020|5901122|P7|Overall Study|Electronic data capture failure|0
1690347|NCT01307020|5901123|P6|Overall Study|Electronic data capture failure|0
1690348|NCT01307020|5901124|P5|Overall Study|Electronic data capture failure|0
1690349|NCT01307020|5901125|P4|Overall Study|Electronic data capture failure|0
1690350|NCT01307020|5901126|P3|Overall Study|Electronic data capture failure|0
1690351|NCT01307020|5901127|P2|Overall Study|Electronic data capture failure|1
1690352|NCT01307020|5901128|P1|Overall Study|Electronic data capture failure|0
1690353|NCT01307020|5901119|P10|Overall Study|Lost to Follow-up|0
1690354|NCT01307020|5901120|P9|Overall Study|Lost to Follow-up|0
1690355|NCT01307020|5901121|P8|Overall Study|Lost to Follow-up|0
1690356|NCT01307020|5901122|P7|Overall Study|Lost to Follow-up|1
1690357|NCT01307020|5901123|P6|Overall Study|Lost to Follow-up|0
1690358|NCT01307020|5901124|P5|Overall Study|Lost to Follow-up|0
1690359|NCT01307020|5901125|P4|Overall Study|Lost to Follow-up|1
1690360|NCT01307020|5901126|P3|Overall Study|Lost to Follow-up|1
1690361|NCT01307020|5901127|P2|Overall Study|Lost to Follow-up|0
1690362|NCT01307020|5901128|P1|Overall Study|Lost to Follow-up|0
1690363|NCT01306968|5901183|P4|Overall Study|Withdrew over privacy concerns|1
1690364|NCT01306968|5901184|P3|Overall Study|Withdrew over privacy concerns|0
1690365|NCT01306968|5901185|P2|Overall Study|Withdrew over privacy concerns|0
1690366|NCT01306968|5901186|P1|Overall Study|Withdrew over privacy concerns|0
1690367|NCT01306968|5901183|P4|Overall Study|Withdrew - time commitment|2
1690368|NCT01306968|5901184|P3|Overall Study|Withdrew - time commitment|0
1690369|NCT01306968|5901185|P2|Overall Study|Withdrew - time commitment|0
1690370|NCT01306968|5901186|P1|Overall Study|Withdrew - time commitment|0
1690371|NCT01306968|5901183|P4|Overall Study|Relocated and left active duty|1
1690372|NCT01306968|5901184|P3|Overall Study|Relocated and left active duty|1
1690373|NCT01306968|5901185|P2|Overall Study|Relocated and left active duty|1
1690374|NCT01306968|5901186|P1|Overall Study|Relocated and left active duty|0
1690375|NCT01306968|5901183|P4|Overall Study|Physician Decision|0
1690376|NCT01306968|5901184|P3|Overall Study|Physician Decision|0
1690377|NCT01306968|5901185|P2|Overall Study|Physician Decision|1
1690378|NCT01306968|5901186|P1|Overall Study|Physician Decision|0
1690379|NCT01306968|5901183|P4|Overall Study|Lost to Follow-up|0
1690380|NCT01306968|5901184|P3|Overall Study|Lost to Follow-up|0
1690381|NCT01306968|5901185|P2|Overall Study|Lost to Follow-up|1
1690382|NCT01306968|5901186|P1|Overall Study|Lost to Follow-up|1
1690383|NCT01306942|5901211|P4|Phase II|Protocol Violation|1
1690384|NCT01306942|5901212|P3|Phase II|Protocol Violation|0
1690385|NCT01306942|5901213|P2|Phase II|Protocol Violation|0
1690386|NCT01306942|5901214|P1|Phase II|Protocol Violation|0
1690387|NCT01306942|5901211|P4|Phase II|Not finished treatment|1
1690388|NCT01306942|5901212|P3|Phase II|Not finished treatment|0
1690389|NCT01306942|5901213|P2|Phase II|Not finished treatment|0
1690390|NCT01306942|5901214|P1|Phase II|Not finished treatment|0
1690391|NCT01306942|5901211|P4|Phase II|Death|1
1690392|NCT01306942|5901212|P3|Phase II|Death|0
1690393|NCT01306942|5901213|P2|Phase II|Death|0
1690394|NCT01306942|5901214|P1|Phase II|Death|0
1690395|NCT01306942|5901211|P4|Phase II|Withdrawal by Subject|2
1690396|NCT01306942|5901212|P3|Phase II|Withdrawal by Subject|0
1690397|NCT01306942|5901213|P2|Phase II|Withdrawal by Subject|0
1690398|NCT01306942|5901214|P1|Phase II|Withdrawal by Subject|0
1690399|NCT01306942|5901211|P4|Phase II|Physician Decision|5
1690400|NCT01306942|5901212|P3|Phase II|Physician Decision|0
1690401|NCT01306942|5901213|P2|Phase II|Physician Decision|0
1690402|NCT01306942|5901214|P1|Phase II|Physician Decision|2
1690403|NCT01306942|5901211|P4|Phase II|Adverse Event|6
1690404|NCT01306942|5901212|P3|Phase II|Adverse Event|0
1690405|NCT01306942|5901213|P2|Phase II|Adverse Event|0
1690406|NCT01306942|5901214|P1|Phase II|Adverse Event|0
1690407|NCT01306942|5901211|P4|Phase I|Physician Decision|0
1690408|NCT01306942|5901212|P3|Phase I|Physician Decision|0
1690409|NCT01306942|5901213|P2|Phase I|Physician Decision|1
1690410|NCT01306942|5901214|P1|Phase I|Physician Decision|3
1690411|NCT01306942|5901211|P4|Phase I|Adverse Event|0
1690412|NCT01306942|5901212|P3|Phase I|Adverse Event|0
1690413|NCT01306942|5901213|P2|Phase I|Adverse Event|2
1690414|NCT01306942|5901214|P1|Phase I|Adverse Event|2
1690415|NCT01306890|5901246|P1|Overall Study|No discontinuation documentation|41
1690416|NCT01306890|5901246|P1|Overall Study|Study Termination|3
1690417|NCT01306890|5901246|P1|Overall Study|Unspecified reasons|104
1690418|NCT01306890|5901246|P1|Overall Study|Withdrawal by Subject|88
1690419|NCT01306890|5901246|P1|Overall Study|Lost to Follow-up|58
1690420|NCT01306890|5901246|P1|Overall Study|Death|1223
1690421|NCT01306890|5901246|P1|Overall Study|Adverse Event|2
1690422|NCT01306877|5901253|P2|Overall Study|Physician Decision|1
1690423|NCT01306877|5901254|P1|Overall Study|Physician Decision|0
1690424|NCT01306877|5901253|P2|Overall Study|Lost to Follow-up|3
1690425|NCT01306877|5901254|P1|Overall Study|Lost to Follow-up|3
1690426|NCT01306656|5901274|P2|Overall Study|Lost to Follow-up|0
1690427|NCT01306656|5901275|P1|Overall Study|Lost to Follow-up|1
1690428|NCT01306643|5901287|P1|Overall Study|Other: Change in Eligibility Status|1
1690429|NCT01306643|5901287|P1|Overall Study|Disease Progression|7
1690430|NCT01306643|5901287|P1|Overall Study|Adverse Event|5
1690431|NCT01306617|5901299|P3|Overall Study|Non-compliance|0
1690432|NCT01306617|5901300|P2|Overall Study|Non-compliance|1
1690433|NCT01306617|5901301|P1|Overall Study|Non-compliance|0
1690434|NCT01306617|5901299|P3|Overall Study|Virologic Failure|5
1690435|NCT01306617|5901300|P2|Overall Study|Virologic Failure|0
1690436|NCT01306617|5901301|P1|Overall Study|Virologic Failure|0
1690437|NCT01306617|5901299|P3|Overall Study|Adverse Event|0
1690438|NCT01306617|5901300|P2|Overall Study|Adverse Event|0
1690439|NCT01306617|5901301|P1|Overall Study|Adverse Event|1
1690440|NCT01306305|5901344|P2|Overall Study|Withdrew consent|0
1690441|NCT01306305|5901345|P1|Overall Study|Withdrew consent|1
1690442|NCT01306305|5901344|P2|Overall Study|Lost to Follow-up|0
1690443|NCT01306305|5901345|P1|Overall Study|Lost to Follow-up|1
1690444|NCT01306253|5901382|P2|Overall Study|Lost to Follow-up|1
1690445|NCT01306253|5901383|P1|Overall Study|Lost to Follow-up|1
1690446|NCT01306214|5901400|P3|Overall Study|Not treated|1
1690447|NCT01306214|5901401|P2|Overall Study|Not treated|1
1690448|NCT01306214|5901402|P1|Overall Study|Not treated|1
1690449|NCT01306214|5901400|P3|Overall Study|Withdrawal by Subject|16
1690450|NCT01306214|5901401|P2|Overall Study|Withdrawal by Subject|22
1690451|NCT01306214|5901402|P1|Overall Study|Withdrawal by Subject|24
1690452|NCT01306214|5901400|P3|Overall Study|Lost to Follow-up|4
1690453|NCT01306214|5901401|P2|Overall Study|Lost to Follow-up|5
1690454|NCT01306214|5901402|P1|Overall Study|Lost to Follow-up|3
1690455|NCT01306214|5901400|P3|Overall Study|Death|1
1690456|NCT01306214|5901401|P2|Overall Study|Death|0
1690457|NCT01306214|5901402|P1|Overall Study|Death|0
1690458|NCT01306201|5901419|P1|Overall Study|Files unreadable|3
1690459|NCT01306201|5901419|P1|Overall Study|Files could not be processed|3
1690460|NCT01306201|5901419|P1|Overall Study|Arrhythmia|4
1690461|NCT01306162|5901441|P4|Washout 1|Non-compliance to protocol|0
1690462|NCT01306162|5901442|P3|Washout 1|Non-compliance to protocol|0
1690463|NCT01306162|5901443|P2|Washout 1|Non-compliance to protocol|1
1690464|NCT01306162|5901444|P1|Washout 1|Non-compliance to protocol|0
1690465|NCT01306162|5901441|P4|Period 1|Adverse Event|1
1690466|NCT01306162|5901442|P3|Period 1|Adverse Event|0
1690467|NCT01306162|5901443|P2|Period 1|Adverse Event|0
1690468|NCT01306162|5901444|P1|Period 1|Adverse Event|0
1690469|NCT01306058|5901472|P1|Overall Study|Enrolled but did not get treatment|1
1690470|NCT01306058|5901472|P1|Overall Study|Death|1
1690471|NCT01306032|5901499|P6|Disease Progression/Crossover|other/symptomatic progression|0
1690472|NCT01306032|5901500|P5|Disease Progression/Crossover|other/symptomatic progression|0
1690473|NCT01306032|5901501|P4|Disease Progression/Crossover|other/symptomatic progression|2
1690474|NCT01306032|5901502|P3|Disease Progression/Crossover|other/symptomatic progression|0
1690475|NCT01306032|5901503|P2|Disease Progression/Crossover|other/symptomatic progression|2
1690476|NCT01306032|5901504|P1|Disease Progression/Crossover|other/symptomatic progression|0
1690477|NCT01306032|5901499|P6|Disease Progression/Crossover|Withdrawal by Subject|0
1690478|NCT01306032|5901500|P5|Disease Progression/Crossover|Withdrawal by Subject|0
1690479|NCT01306032|5901501|P4|Disease Progression/Crossover|Withdrawal by Subject|1
1690480|NCT01306032|5901502|P3|Disease Progression/Crossover|Withdrawal by Subject|0
1690481|NCT01306032|5901503|P2|Disease Progression/Crossover|Withdrawal by Subject|0
1690482|NCT01306032|5901504|P1|Disease Progression/Crossover|Withdrawal by Subject|0
1690483|NCT01306032|5901499|P6|First Intervention|Progressive disease|0
1690484|NCT01306032|5901500|P5|First Intervention|Progressive disease|2
1690485|NCT01306032|5901501|P4|First Intervention|Progressive disease|0
1690486|NCT01306032|5901502|P3|First Intervention|Progressive disease|0
1690487|NCT01306032|5901503|P2|First Intervention|Progressive disease|0
1690488|NCT01306032|5901504|P1|First Intervention|Progressive disease|0
1690489|NCT01306032|5901499|P6|First Intervention|Ineligible|1
1690490|NCT01306032|5901500|P5|First Intervention|Ineligible|0
1690491|NCT01306032|5901501|P4|First Intervention|Ineligible|0
1690492|NCT01306032|5901502|P3|First Intervention|Ineligible|0
1690493|NCT01306032|5901503|P2|First Intervention|Ineligible|0
1690494|NCT01306032|5901504|P1|First Intervention|Ineligible|0
1690495|NCT01306032|5901499|P6|First Intervention|Death|0
1690496|NCT01306032|5901500|P5|First Intervention|Death|0
1690497|NCT01306032|5901501|P4|First Intervention|Death|0
1690498|NCT01306032|5901502|P3|First Intervention|Death|1
1690499|NCT01306032|5901503|P2|First Intervention|Death|0
1690500|NCT01306032|5901504|P1|First Intervention|Death|0
1690501|NCT01306032|5901499|P6|First Intervention|Withdrawal by Subject|0
1690502|NCT01306032|5901500|P5|First Intervention|Withdrawal by Subject|0
1690503|NCT01306032|5901501|P4|First Intervention|Withdrawal by Subject|1
1690504|NCT01306032|5901502|P3|First Intervention|Withdrawal by Subject|0
1690505|NCT01306032|5901503|P2|First Intervention|Withdrawal by Subject|2
1690506|NCT01306032|5901504|P1|First Intervention|Withdrawal by Subject|0
1690507|NCT01306032|5901499|P6|First Intervention|Adverse Event|1
1690508|NCT01306032|5901500|P5|First Intervention|Adverse Event|0
1690509|NCT01306032|5901501|P4|First Intervention|Adverse Event|0
1690510|NCT01306032|5901502|P3|First Intervention|Adverse Event|1
1690511|NCT01306032|5901503|P2|First Intervention|Adverse Event|0
1690512|NCT01306032|5901504|P1|First Intervention|Adverse Event|1
1690513|NCT01305941|5901556|P1|Overall Study|Death|1
1690514|NCT01305941|5901556|P1|Overall Study|Withdrawal by Subject|1
1690515|NCT01305941|5901556|P1|Overall Study|Clinical decline|2
1690516|NCT01305941|5901556|P1|Overall Study|Adverse Event|6
1690517|NCT01305577|5901596|P3|Overall Study|Protocol Deviation|1
1690518|NCT01305577|5901597|P2|Overall Study|Protocol Deviation|1
1690519|NCT01305577|5901598|P1|Overall Study|Protocol Deviation|0
1690520|NCT01305577|5901596|P3|Overall Study|Lost to Follow-up|2
1690521|NCT01305577|5901597|P2|Overall Study|Lost to Follow-up|3
1690522|NCT01305577|5901598|P1|Overall Study|Lost to Follow-up|4
1690523|NCT01305577|5901596|P3|Overall Study|Withdrawal by Subject|6
1690524|NCT01305577|5901597|P2|Overall Study|Withdrawal by Subject|5
1690525|NCT01305577|5901598|P1|Overall Study|Withdrawal by Subject|7
1690526|NCT01305577|5901596|P3|Overall Study|Adverse Event|1
1690527|NCT01305577|5901597|P2|Overall Study|Adverse Event|2
1690528|NCT01305577|5901598|P1|Overall Study|Adverse Event|2
1690529|NCT01305564|5901627|P1|Overall Study|Physician Decision|3
1690530|NCT01305564|5901627|P1|Overall Study|Withdrawal by Subject|1
1690531|NCT01305564|5901627|P1|Overall Study|Lost to Follow-up|12
1690532|NCT01305564|5901627|P1|Overall Study|Death|21
1690533|NCT01305408|5901654|P2|Overall Study|Other|0
1690534|NCT01305408|5901655|P1|Overall Study|Other|1
1690535|NCT01305408|5901654|P2|Overall Study|Noncompliance with study procedures|1
1690536|NCT01305408|5901655|P1|Overall Study|Noncompliance with study procedures|0
1690537|NCT01305408|5901654|P2|Overall Study|Noncompliance with study medication|1
1690538|NCT01305408|5901655|P1|Overall Study|Noncompliance with study medication|0
1690539|NCT01305408|5901654|P2|Overall Study|Lost to Follow-up|3
1690540|NCT01305408|5901655|P1|Overall Study|Lost to Follow-up|5
1690541|NCT01305408|5901654|P2|Overall Study|Protocol Violation|6
1690542|NCT01305408|5901655|P1|Overall Study|Protocol Violation|4
1690543|NCT01305408|5901654|P2|Overall Study|Withdrawal by Subject|9
1690544|NCT01305408|5901655|P1|Overall Study|Withdrawal by Subject|9
1690545|NCT01305408|5901654|P2|Overall Study|Lack of Efficacy|4
1690546|NCT01305408|5901655|P1|Overall Study|Lack of Efficacy|3
1690547|NCT01305408|5901654|P2|Overall Study|Adverse Event|7
1690548|NCT01305408|5901655|P1|Overall Study|Adverse Event|10
1690549|NCT01305239|5901748|P1|Overall Study|Exemestane taken prior to inclusion only|1
1690550|NCT01305239|5901748|P1|Overall Study|Adverse Event|22
1690551|NCT01305200|5901778|P3|Overall Study|Death|0
1690552|NCT01305200|5901779|P2|Overall Study|Death|2
1690553|NCT01305200|5901780|P1|Overall Study|Death|0
1690554|NCT01305200|5901778|P3|Overall Study|Ineligible|1
1690555|NCT01305200|5901779|P2|Overall Study|Ineligible|2
1690556|NCT01305200|5901780|P1|Overall Study|Ineligible|1
1690557|NCT01305200|5901778|P3|Overall Study|Withdrawal by Subject|1
1690558|NCT01305200|5901779|P2|Overall Study|Withdrawal by Subject|21
1690559|NCT01305200|5901780|P1|Overall Study|Withdrawal by Subject|24
1690560|NCT01305200|5901778|P3|Overall Study|Physician Decision|1
1690561|NCT01305200|5901779|P2|Overall Study|Physician Decision|6
1690562|NCT01305200|5901780|P1|Overall Study|Physician Decision|4
1690563|NCT01305044|5901810|P2|Overall Study|Withdrawal by Subject|6
1690564|NCT01305044|5901811|P1|Overall Study|Withdrawal by Subject|3
1690565|NCT01304940|5901843|P2|Overall Study|not meet symptom severity requirement|0
1690566|NCT01304940|5901844|P1|Overall Study|not meet symptom severity requirement|3
1690567|NCT01304706|5901850|P1|Overall Study|Discontinued due to failed drug admin.|1
1690568|NCT01304706|5901850|P1|Overall Study|Lost to Follow-up|7
1690569|NCT01304706|5901850|P1|Overall Study|Withdrawal by Subject|3
1690570|NCT01304706|5901850|P1|Overall Study|Death|3
1690571|NCT01304706|5901850|P1|Overall Study|Lack of Efficacy|1
1690572|NCT01304706|5901850|P1|Overall Study|Adverse Event|2
1690573|NCT01304693|5901859|P5|Overall Study|Decision Unrelated to an Adverse Event|0
1690574|NCT01304693|5901860|P4|Overall Study|Decision Unrelated to an Adverse Event|1
1690575|NCT01304693|5901861|P3|Overall Study|Decision Unrelated to an Adverse Event|1
1690576|NCT01304693|5901862|P2|Overall Study|Decision Unrelated to an Adverse Event|0
1690577|NCT01304693|5901863|P1|Overall Study|Decision Unrelated to an Adverse Event|0
1690578|NCT01304693|5901859|P5|Overall Study|Adverse Event|1
1690579|NCT01304693|5901860|P4|Overall Study|Adverse Event|0
1690580|NCT01304693|5901861|P3|Overall Study|Adverse Event|0
1690581|NCT01304693|5901862|P2|Overall Study|Adverse Event|0
1690582|NCT01304693|5901863|P1|Overall Study|Adverse Event|0
1690583|NCT01304498|5901910|P2|Overall Study|Lost to Follow-up|1
1690584|NCT01304498|5901911|P1|Overall Study|Lost to Follow-up|2
1690585|NCT01304498|5901910|P2|Overall Study|Protocol Violation|0
1690586|NCT01304498|5901911|P1|Overall Study|Protocol Violation|1
1690587|NCT01304498|5901910|P2|Overall Study|Withdrawal by Subject|3
1690588|NCT01304498|5901911|P1|Overall Study|Withdrawal by Subject|2
1690589|NCT01304498|5901910|P2|Overall Study|Adverse Event|1
1690590|NCT01304498|5901911|P1|Overall Study|Adverse Event|1
1690591|NCT01304329|5901931|P6|Third Intervention (3 Days)|Adverse Event|0
1690592|NCT01304329|5901932|P5|Third Intervention (3 Days)|Adverse Event|0
1690593|NCT01304329|5901933|P4|Third Intervention (3 Days)|Adverse Event|0
1690594|NCT01304329|5901934|P3|Third Intervention (3 Days)|Adverse Event|0
1690595|NCT01304329|5901935|P2|Third Intervention (3 Days)|Adverse Event|1
1690596|NCT01304329|5901936|P1|Third Intervention (3 Days)|Adverse Event|0
1690597|NCT01304147|5902070|P2|Second Intervention (7days)|Withdrawal by Subject|1
1690598|NCT01304147|5902071|P1|Second Intervention (7days)|Withdrawal by Subject|1
1690599|NCT01303965|5902102|P2|Overall Study|Disease Progression|6
1690600|NCT01303965|5902103|P1|Overall Study|Disease Progression|1
1690601|NCT01303965|5902102|P2|Overall Study|Withdrawal by Subject|0
1690602|NCT01303965|5902103|P1|Overall Study|Withdrawal by Subject|1
1690603|NCT01303965|5902102|P2|Overall Study|Death|3
1690604|NCT01303965|5902103|P1|Overall Study|Death|0
1690605|NCT01303965|5902102|P2|Overall Study|Adverse Event|1
1690606|NCT01303965|5902103|P1|Overall Study|Adverse Event|1
1690607|NCT01303861|5902131|P4|Overall Study|Pregnancy|0
1690608|NCT01303861|5902132|P3|Overall Study|Pregnancy|0
1690609|NCT01303861|5902133|P2|Overall Study|Pregnancy|0
1690610|NCT01303861|5902134|P1|Overall Study|Pregnancy|1
1690611|NCT01303861|5902131|P4|Overall Study|Adverse Event|5
1690612|NCT01303861|5902132|P3|Overall Study|Adverse Event|0
1690613|NCT01303861|5902133|P2|Overall Study|Adverse Event|1
1690614|NCT01303861|5902134|P1|Overall Study|Adverse Event|4
1690615|NCT01303861|5902131|P4|Overall Study|Withdrawal by Subject|23
1690616|NCT01303861|5902132|P3|Overall Study|Withdrawal by Subject|8
1690617|NCT01303861|5902133|P2|Overall Study|Withdrawal by Subject|8
1690618|NCT01303861|5902134|P1|Overall Study|Withdrawal by Subject|16
1690619|NCT01303861|5902131|P4|Overall Study|Lack of Efficacy|0
1690620|NCT01303861|5902132|P3|Overall Study|Lack of Efficacy|1
1690621|NCT01303861|5902133|P2|Overall Study|Lack of Efficacy|2
1690622|NCT01303861|5902134|P1|Overall Study|Lack of Efficacy|3
1690623|NCT01303861|5902131|P4|Overall Study|Lost to Follow-up|31
1690624|NCT01303861|5902132|P3|Overall Study|Lost to Follow-up|27
1690625|NCT01303861|5902133|P2|Overall Study|Lost to Follow-up|14
1690626|NCT01303861|5902134|P1|Overall Study|Lost to Follow-up|34
1690627|NCT01303627|5902193|P2|Overall Study|the failure while performing URS|1
1690628|NCT01303627|5902194|P1|Overall Study|the failure while performing URS|0
1690629|NCT01303510|5902202|P2|Overall Study|Lost to Follow-up|0
1690630|NCT01303510|5902203|P1|Overall Study|Lost to Follow-up|1
1690631|NCT01303445|5902217|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
1690632|NCT01303445|5902218|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
1690633|NCT01303445|5902217|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
1690634|NCT01303445|5902218|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
1690635|NCT01303445|5902217|P2|Washout (14 Days)|Lost to Follow-up|2
1690636|NCT01303445|5902218|P1|Washout (14 Days)|Lost to Follow-up|0
1690637|NCT01303445|5902217|P2|Washout (14 Days)|Protocol Violation|0
1690638|NCT01303445|5902218|P1|Washout (14 Days)|Protocol Violation|1
1690639|NCT01303445|5902217|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
1690640|NCT01303445|5902218|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
1690641|NCT01303445|5902217|P2|Second Intervention (7 Days)|Adverse Event|2
1690642|NCT01303445|5902218|P1|Second Intervention (7 Days)|Adverse Event|0
1690643|NCT01303445|5902217|P2|First Intervention (7 Days)|Withdrawal by Subject|0
1690644|NCT01303445|5902218|P1|First Intervention (7 Days)|Withdrawal by Subject|1
1690645|NCT01303419|5902248|P1|Overall Study|Did not meet all I/E after screening|31
1690646|NCT01303419|5902248|P1|Overall Study|Did not complete both imaging methods|5
1690647|NCT01303419|5902248|P1|Overall Study|Discontinuation of study|60
1690648|NCT01303380|5902267|P1|Overall Study|Lack of compliance to study procedures|1
1690649|NCT01303159|5902326|P1|Overall Study|Study Termination|7
1690650|NCT01303159|5902326|P1|Overall Study|Death|16
1690651|NCT01302964|5902344|P2|Overall Study|Adverse Event|0
1690652|NCT01302964|5902345|P1|Overall Study|Adverse Event|1
1690653|NCT01302938|5902355|P2|Overall Study|Adverse Event|0
1690654|NCT01302938|5902356|P1|Overall Study|Adverse Event|1
1690655|NCT01302938|5902355|P2|Overall Study|Withdrawal by Subject|0
1690656|NCT01302938|5902356|P1|Overall Study|Withdrawal by Subject|1
1690657|NCT01302899|5902401|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
1690658|NCT01302899|5902402|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
1690659|NCT01302899|5902401|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
1690660|NCT01302899|5902402|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
1690661|NCT01302834|5902466|P2|Overall Study|HIV positive|3
1690662|NCT01302834|5902467|P1|Overall Study|HIV positive|1
1690663|NCT01302834|5902466|P2|Overall Study|Protocol Violation|23
1690664|NCT01302834|5902467|P1|Overall Study|Protocol Violation|17
1690665|NCT01302691|5902527|P2|Overall Study|Protocol Violation|0
1690666|NCT01302691|5902528|P1|Overall Study|Protocol Violation|1
1690667|NCT01302691|5902527|P2|Overall Study|Physician Decision|1
1690668|NCT01302691|5902528|P1|Overall Study|Physician Decision|0
1690669|NCT01302691|5902527|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
1690670|NCT01302691|5902528|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
1690671|NCT01302691|5902527|P2|Overall Study|Lost to Follow-up|0
1690672|NCT01302691|5902528|P1|Overall Study|Lost to Follow-up|1
1690673|NCT01302691|5902527|P2|Overall Study|Death|1
1690674|NCT01302691|5902528|P1|Overall Study|Death|0
1690675|NCT01302691|5902527|P2|Overall Study|Adverse Event|0
1690676|NCT01302691|5902528|P1|Overall Study|Adverse Event|2
1690677|NCT01302548|5902548|P2|Overall Study|Lost to Follow-up|1
1690678|NCT01302548|5902549|P1|Overall Study|Lost to Follow-up|2
1690679|NCT01302418|5902599|P1|Overall Study|Non-evaluable|9
1690680|NCT01302418|5902599|P1|Overall Study|Protocol Violation|9
1690681|NCT01302392|5902605|P2|Overall Study|Withdrawal by Subject|1
1690682|NCT01302392|5902606|P1|Overall Study|Withdrawal by Subject|6
1690683|NCT01302392|5902605|P2|Overall Study|Lost to Follow-up|0
1690684|NCT01302392|5902606|P1|Overall Study|Lost to Follow-up|1
1690685|NCT01302366|5902626|P1|Overall Study|patient choice or noncompliance|5
1690686|NCT01302119|5902634|P2|Overall Study|Non-specific|1
1690687|NCT01302119|5902635|P1|Overall Study|Non-specific|4
1690688|NCT01302119|5902634|P2|Overall Study|Non-compliance|2
1690689|NCT01302119|5902635|P1|Overall Study|Non-compliance|4
1690690|NCT01302119|5902634|P2|Overall Study|Adverse Event|1
1690691|NCT01302119|5902635|P1|Overall Study|Adverse Event|2
1690692|NCT01302119|5902634|P2|Overall Study|Lost to Follow-up|4
1690693|NCT01302119|5902635|P1|Overall Study|Lost to Follow-up|10
1690694|NCT01302119|5902634|P2|Overall Study|Withdrawal by Subject|20
1690695|NCT01302119|5902635|P1|Overall Study|Withdrawal by Subject|30
1690696|NCT01302067|5902650|P3|Overall Study|Adverse Event|45
1690697|NCT01302067|5902651|P2|Overall Study|Adverse Event|14
1690698|NCT01302067|5902652|P1|Overall Study|Adverse Event|27
1690699|NCT01302067|5902650|P3|Overall Study|Protocol Violation|8
1690700|NCT01302067|5902651|P2|Overall Study|Protocol Violation|0
1690701|NCT01302067|5902652|P1|Overall Study|Protocol Violation|11
1690702|NCT01302067|5902650|P3|Overall Study|Other|3
1690703|NCT01302067|5902651|P2|Overall Study|Other|1
1690704|NCT01302067|5902652|P1|Overall Study|Other|1
1690705|NCT01302067|5902650|P3|Overall Study|Withdrawal by Subject|10
1690706|NCT01302067|5902651|P2|Overall Study|Withdrawal by Subject|6
1690707|NCT01302067|5902652|P1|Overall Study|Withdrawal by Subject|13
1690708|NCT01302067|5902650|P3|Overall Study|Lost to Follow-up|15
1690709|NCT01302067|5902651|P2|Overall Study|Lost to Follow-up|4
1690710|NCT01302067|5902652|P1|Overall Study|Lost to Follow-up|9
1690711|NCT01302067|5902650|P3|Overall Study|Lack of Efficacy|2
1690712|NCT01302067|5902651|P2|Overall Study|Lack of Efficacy|4
1690713|NCT01302067|5902652|P1|Overall Study|Lack of Efficacy|8
1690714|NCT01302067|5902650|P3|Overall Study|Physician Decision|14
1690715|NCT01302067|5902651|P2|Overall Study|Physician Decision|5
1690716|NCT01302067|5902652|P1|Overall Study|Physician Decision|9
1690717|NCT01302067|5902650|P3|Overall Study|Death|1
1690718|NCT01302067|5902651|P2|Overall Study|Death|0
1690719|NCT01302067|5902652|P1|Overall Study|Death|0
1690720|NCT01302054|5902723|P3|Double-Blind Treatment Phase|Other|9
1690721|NCT01302054|5902724|P2|Double-Blind Treatment Phase|Other|4
1690722|NCT01302054|5902725|P1|Double-Blind Treatment Phase|Other|0
1690802|NCT01301456|5902968|P12|Stage 2|Adverse Event|0
1690723|NCT01302054|5902723|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
1690724|NCT01302054|5902724|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
1690725|NCT01302054|5902725|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
1690726|NCT01302054|5902723|P3|Double-Blind Treatment Phase|Adverse Event|10
1690727|NCT01302054|5902724|P2|Double-Blind Treatment Phase|Adverse Event|10
1690728|NCT01302054|5902725|P1|Double-Blind Treatment Phase|Adverse Event|0
1690729|NCT01302054|5902723|P3|Double-Blind Treatment Phase|Protocol Violation|6
1690730|NCT01302054|5902724|P2|Double-Blind Treatment Phase|Protocol Violation|3
1690731|NCT01302054|5902725|P1|Double-Blind Treatment Phase|Protocol Violation|0
1690732|NCT01302054|5902723|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
1690733|NCT01302054|5902724|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
1690734|NCT01302054|5902725|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
1690735|NCT01302054|5902723|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
1690736|NCT01302054|5902724|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
1690737|NCT01302054|5902725|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
1690738|NCT01302054|5902723|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
1690739|NCT01302054|5902724|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
1690740|NCT01302054|5902725|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
1690741|NCT01302054|5902723|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
1690742|NCT01302054|5902724|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
1690743|NCT01302054|5902725|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
1690744|NCT01302054|5902723|P3|Tolterodine Open-Label Run-In Phase|Other|0
1690745|NCT01302054|5902724|P2|Tolterodine Open-Label Run-In Phase|Other|0
1690746|NCT01302054|5902725|P1|Tolterodine Open-Label Run-In Phase|Other|7
1690747|NCT01302054|5902723|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
1690748|NCT01302054|5902724|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
1690749|NCT01302054|5902725|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
1690750|NCT01302054|5902723|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
1690751|NCT01302054|5902724|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
1690752|NCT01302054|5902725|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
1690753|NCT01302054|5902723|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
1690754|NCT01302054|5902724|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
1690755|NCT01302054|5902725|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
1690756|NCT01302054|5902723|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
1690757|NCT01302054|5902724|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
1690758|NCT01302054|5902725|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
1690759|NCT01302054|5902723|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
1690760|NCT01302054|5902724|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
1690761|NCT01302054|5902725|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
1690762|NCT01302054|5902723|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
1690763|NCT01302054|5902724|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
1690764|NCT01302054|5902725|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
1690765|NCT01302041|5902752|P1|Overall Study|Other-Miscellaneous Reason|2
1690766|NCT01302041|5902752|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
1690767|NCT01302041|5902752|P1|Overall Study|Withdrawal by Subject|4
1690768|NCT01302041|5902752|P1|Overall Study|Death|5
1690769|NCT01301950|5902794|P2|Overall Study|Surgery was cancelled by patient|1
1690770|NCT01301950|5902795|P1|Overall Study|Surgery was cancelled by patient|0
1690771|NCT01301833|5902813|P4|Overall Study|Personal matter|0
1690772|NCT01301833|5902814|P3|Overall Study|Personal matter|0
1690773|NCT01301833|5902815|P2|Overall Study|Personal matter|0
1690774|NCT01301833|5902816|P1|Overall Study|Personal matter|1
1690775|NCT01301833|5902813|P4|Overall Study|Withdrawal by Subject|2
1690776|NCT01301833|5902814|P3|Overall Study|Withdrawal by Subject|1
1690777|NCT01301833|5902815|P2|Overall Study|Withdrawal by Subject|1
1690778|NCT01301833|5902816|P1|Overall Study|Withdrawal by Subject|3
1690779|NCT01301833|5902813|P4|Overall Study|Physician Decision|0
1690780|NCT01301833|5902814|P3|Overall Study|Physician Decision|1
1690781|NCT01301833|5902815|P2|Overall Study|Physician Decision|1
1690782|NCT01301833|5902816|P1|Overall Study|Physician Decision|3
1690783|NCT01301833|5902813|P4|Overall Study|Lack of Efficacy|0
1690784|NCT01301833|5902814|P3|Overall Study|Lack of Efficacy|0
1690785|NCT01301833|5902815|P2|Overall Study|Lack of Efficacy|1
1690786|NCT01301833|5902816|P1|Overall Study|Lack of Efficacy|1
1690787|NCT01301833|5902813|P4|Overall Study|Adverse Event|5
1690788|NCT01301833|5902814|P3|Overall Study|Adverse Event|5
1690789|NCT01301833|5902815|P2|Overall Study|Adverse Event|5
1690790|NCT01301833|5902816|P1|Overall Study|Adverse Event|7
1690791|NCT01301729|5902854|P1|Overall Study|Violated Selection Criteria|1
1690792|NCT01301729|5902854|P1|Overall Study|Participant did not Return for Treatment|1
1690793|NCT01301729|5902854|P1|Overall Study|Withdrawal by Subject|2
1690794|NCT01301625|5902865|P1|Overall Study|Lost to Follow-up|1
1690795|NCT01301625|5902865|P1|Overall Study|Expected|8
1690796|NCT01301625|5902865|P1|Overall Study|Not Due|21
1690797|NCT01301625|5902865|P1|Overall Study|Death|5
1690798|NCT01301508|5902937|P2|Overall Study|Lost to Follow-up|1
1690799|NCT01301508|5902938|P1|Overall Study|Lost to Follow-up|0
1690800|NCT01301508|5902937|P2|Overall Study|Withdrawal by Subject|2
1690801|NCT01301508|5902938|P1|Overall Study|Withdrawal by Subject|1
1690803|NCT01301456|5902969|P11|Stage 2|Adverse Event|1
1690804|NCT01301456|5902970|P10|Stage 2|Adverse Event|0
1690805|NCT01301456|5902971|P9|Stage 2|Adverse Event|0
1690806|NCT01301456|5902972|P8|Stage 2|Adverse Event|0
1690807|NCT01301456|5902973|P7|Stage 2|Adverse Event|0
1690808|NCT01301456|5902974|P6|Stage 2|Adverse Event|0
1690809|NCT01301456|5902975|P5|Stage 2|Adverse Event|0
1690810|NCT01301456|5902976|P4|Stage 2|Adverse Event|0
1690811|NCT01301456|5902977|P3|Stage 2|Adverse Event|0
1690812|NCT01301456|5902978|P2|Stage 2|Adverse Event|0
1690813|NCT01301456|5902979|P1|Stage 2|Adverse Event|0
1690814|NCT01301456|5902968|P12|Stage 1|Randomized but not treated|0
1690815|NCT01301456|5902969|P11|Stage 1|Randomized but not treated|0
1690816|NCT01301456|5902970|P10|Stage 1|Randomized but not treated|0
1690817|NCT01301456|5902971|P9|Stage 1|Randomized but not treated|0
1690818|NCT01301456|5902972|P8|Stage 1|Randomized but not treated|0
1690819|NCT01301456|5902973|P7|Stage 1|Randomized but not treated|1
1690820|NCT01301456|5902974|P6|Stage 1|Randomized but not treated|0
1690821|NCT01301456|5902975|P5|Stage 1|Randomized but not treated|0
1690822|NCT01301456|5902976|P4|Stage 1|Randomized but not treated|0
1690823|NCT01301456|5902977|P3|Stage 1|Randomized but not treated|0
1690824|NCT01301456|5902978|P2|Stage 1|Randomized but not treated|0
1690825|NCT01301456|5902979|P1|Stage 1|Randomized but not treated|0
1690826|NCT01301456|5902968|P12|Stage 1|Withdrawal by Subject|0
1690827|NCT01301456|5902969|P11|Stage 1|Withdrawal by Subject|0
1690828|NCT01301456|5902970|P10|Stage 1|Withdrawal by Subject|0
1690829|NCT01301456|5902971|P9|Stage 1|Withdrawal by Subject|0
1690830|NCT01301456|5902972|P8|Stage 1|Withdrawal by Subject|0
1690831|NCT01301456|5902973|P7|Stage 1|Withdrawal by Subject|0
1690832|NCT01301456|5902974|P6|Stage 1|Withdrawal by Subject|0
1690833|NCT01301456|5902975|P5|Stage 1|Withdrawal by Subject|1
1690834|NCT01301456|5902976|P4|Stage 1|Withdrawal by Subject|0
1690835|NCT01301456|5902977|P3|Stage 1|Withdrawal by Subject|1
1690836|NCT01301456|5902978|P2|Stage 1|Withdrawal by Subject|0
1690837|NCT01301456|5902979|P1|Stage 1|Withdrawal by Subject|0
1690838|NCT01301391|5903205|P1|Overall Study|Sponsor's decision|8
1690839|NCT01301391|5903205|P1|Overall Study|Physician Decision|2
1690840|NCT01301391|5903205|P1|Overall Study|Lost to Follow-up|3
1690841|NCT01301391|5903205|P1|Overall Study|Death|13
1690842|NCT01301274|5903217|P2|Overall Study|Physician Decision|1
1690843|NCT01301274|5903218|P1|Overall Study|Physician Decision|2
1690844|NCT01301092|5903233|P3|Overall Study|Lost to Follow-up|1
1690845|NCT01301092|5903234|P2|Overall Study|Lost to Follow-up|0
1690846|NCT01301092|5903235|P1|Overall Study|Lost to Follow-up|0
1690847|NCT01301079|5903252|P2|Overall Study|Lost to Follow-up|2
1690848|NCT01301079|5903253|P1|Overall Study|Lost to Follow-up|2
1690849|NCT01301066|5903331|P2|Overall Study|Other|0
1690850|NCT01301066|5903332|P1|Overall Study|Other|2
1690851|NCT01301066|5903331|P2|Overall Study|Physician Decision|1
1690852|NCT01301066|5903332|P1|Overall Study|Physician Decision|0
1690853|NCT01301066|5903331|P2|Overall Study|Sponsor Decision|1
1690854|NCT01301066|5903332|P1|Overall Study|Sponsor Decision|2
1690855|NCT01301066|5903331|P2|Overall Study|Adverse Event|6
1690856|NCT01301066|5903332|P1|Overall Study|Adverse Event|6
1690857|NCT01301066|5903331|P2|Overall Study|Withdrawal by Subject|9
1690858|NCT01301066|5903332|P1|Overall Study|Withdrawal by Subject|4
1690859|NCT01301066|5903331|P2|Overall Study|Protocol Violation|7
1690860|NCT01301066|5903332|P1|Overall Study|Protocol Violation|8
1690861|NCT01301066|5903331|P2|Overall Study|Lost to Follow-up|11
1690862|NCT01301066|5903332|P1|Overall Study|Lost to Follow-up|5
1690863|NCT01301027|5903340|P2|Overall Study|Volume Overload|0
1690864|NCT01301027|5903341|P1|Overall Study|Volume Overload|3
1690865|NCT01301027|5903340|P2|Overall Study|Transplant|2
1690866|NCT01301027|5903341|P1|Overall Study|Transplant|0
1690867|NCT01301027|5903340|P2|Overall Study|Fracture|3
1690868|NCT01301027|5903341|P1|Overall Study|Fracture|1
1690869|NCT01301027|5903340|P2|Overall Study|Adverse Event|2
1690870|NCT01301027|5903341|P1|Overall Study|Adverse Event|0
1690871|NCT01301027|5903340|P2|Overall Study|Withdrawal by Subject|3
1690872|NCT01301027|5903341|P1|Overall Study|Withdrawal by Subject|2
1690873|NCT01301027|5903340|P2|Overall Study|Physician Decision|0
1690874|NCT01301027|5903341|P1|Overall Study|Physician Decision|2
1690875|NCT01301001|5903353|P2|Second Intervention|Withdrawal by Subject|0
1690876|NCT01301001|5903354|P1|Second Intervention|Withdrawal by Subject|2
1690877|NCT01301001|5903353|P2|Second Intervention|Adverse Event|0
1690878|NCT01301001|5903354|P1|Second Intervention|Adverse Event|2
1690879|NCT01301001|5903353|P2|First Intervention|Protocol Violation|1
1690880|NCT01301001|5903354|P1|First Intervention|Protocol Violation|0
1690881|NCT01301001|5903353|P2|First Intervention|Adverse Event|0
1690882|NCT01301001|5903354|P1|First Intervention|Adverse Event|5
1690883|NCT01301001|5903353|P2|First Intervention|Withdrawal by Subject|4
1690884|NCT01301001|5903354|P1|First Intervention|Withdrawal by Subject|1
1690885|NCT01301001|5903353|P2|First Intervention|Lost to Follow-up|4
1690886|NCT01301001|5903354|P1|First Intervention|Lost to Follow-up|4
1690887|NCT01300923|5903377|P2|Overall Study|Physician Decision|2
1690888|NCT01300923|5903378|P1|Overall Study|Physician Decision|0
1690889|NCT01300819|5903391|P2|Overall Study|Follow up call was not done|0
1690890|NCT01300819|5903392|P1|Overall Study|Follow up call was not done|1
1690891|NCT01300819|5903391|P2|Overall Study|Safety follow up not done by mistake|1
1690979|NCT01299909|5903752|P3|Overall Study|Lost to Follow-up|17
1690892|NCT01300819|5903392|P1|Overall Study|Safety follow up not done by mistake|0
1690893|NCT01300819|5903391|P2|Overall Study|Administrative reason|1
1690894|NCT01300819|5903392|P1|Overall Study|Administrative reason|0
1690895|NCT01300819|5903391|P2|Overall Study|Refusal to down titrate study drug|1
1690896|NCT01300819|5903392|P1|Overall Study|Refusal to down titrate study drug|0
1690897|NCT01300819|5903391|P2|Overall Study|Patient was 1 month late for Visit 10|1
1690898|NCT01300819|5903392|P1|Overall Study|Patient was 1 month late for Visit 10|0
1690899|NCT01300819|5903391|P2|Overall Study|Withdrawal by Subject|12
1690900|NCT01300819|5903392|P1|Overall Study|Withdrawal by Subject|10
1690901|NCT01300819|5903391|P2|Overall Study|Lack of Efficacy|1
1690902|NCT01300819|5903392|P1|Overall Study|Lack of Efficacy|2
1690903|NCT01300819|5903391|P2|Overall Study|Adverse Event|27
1690904|NCT01300819|5903392|P1|Overall Study|Adverse Event|9
1690905|NCT01300767|5903420|P1|Overall Study|Unacceptable fit|1
1690906|NCT01300767|5903420|P1|Overall Study|Biomicroscopy|1
1690907|NCT01300767|5903420|P1|Overall Study|Discomfort|2
1690908|NCT01300741|5903448|P1|Overall Study|Discomfort|1
1690909|NCT01300741|5903448|P1|Overall Study|Lost to Follow-up|1
1690910|NCT01300741|5903448|P1|Overall Study|Lens deposits|1
1690911|NCT01300728|5903478|P2|Overall Study|Physician Decision|0
1690912|NCT01300728|5903479|P1|Overall Study|Physician Decision|1
1690913|NCT01300728|5903478|P2|Overall Study|Withdrawal by Subject|1
1690914|NCT01300728|5903479|P1|Overall Study|Withdrawal by Subject|1
1690915|NCT01300650|5903493|P1|Overall Study|Adverse Event|1
1690916|NCT01300572|5903509|P1|Overall Study|HAMA + post dosimetry|1
1690917|NCT01300546|5903533|P2|Overall Study|Adverse Event|1
1690918|NCT01300546|5903534|P1|Overall Study|Adverse Event|0
1690919|NCT01300546|5903533|P2|Overall Study|Lack of Efficacy|3
1690920|NCT01300546|5903534|P1|Overall Study|Lack of Efficacy|0
1690921|NCT01300546|5903533|P2|Overall Study|Lost to Follow-up|2
1690922|NCT01300546|5903534|P1|Overall Study|Lost to Follow-up|0
1690923|NCT01300546|5903533|P2|Overall Study|Withdrawal by Subject|0
1690924|NCT01300546|5903534|P1|Overall Study|Withdrawal by Subject|1
1690925|NCT01300455|5903564|P2|Washout|Withdrawal by Subject|0
1690926|NCT01300455|5903565|P1|Washout|Withdrawal by Subject|1
1690927|NCT01300351|5903585|P2|Overall Study|Withdrawal by Subject|10
1690928|NCT01300351|5903586|P1|Overall Study|Withdrawal by Subject|7
1690929|NCT01300351|5903585|P2|Overall Study|Adverse Event|4
1690930|NCT01300351|5903586|P1|Overall Study|Adverse Event|0
1690931|NCT01300351|5903585|P2|Overall Study|Lost to Follow-up|1
1690932|NCT01300351|5903586|P1|Overall Study|Lost to Follow-up|0
1690933|NCT01300351|5903585|P2|Overall Study|Ongoing treatment at data cut-off|23
1690934|NCT01300351|5903586|P1|Overall Study|Ongoing treatment at data cut-off|27
1690935|NCT01300351|5903585|P2|Overall Study|Did not receive treatment|0
1690936|NCT01300351|5903586|P1|Overall Study|Did not receive treatment|2
1690937|NCT01300338|5903602|P2|Overall Study|Lost to Follow-up|0
1690938|NCT01300338|5903603|P1|Overall Study|Lost to Follow-up|5
1690939|NCT01300286|5903611|P1|Overall Study|did not get dosed|1
1690940|NCT01300260|5903621|P2|Period 2 of Study: Second Intervention|Adverse Event|1
1690941|NCT01300260|5903622|P1|Period 2 of Study: Second Intervention|Adverse Event|0
1690942|NCT01300260|5903621|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
1690943|NCT01300260|5903622|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
1690944|NCT01300260|5903621|P2|Period 1 of Study: First Intervention|Adverse Event|1
1690945|NCT01300260|5903622|P1|Period 1 of Study: First Intervention|Adverse Event|0
1690946|NCT01300247|5903654|P2|Overall Study|Non-Compliance|1
1690947|NCT01300247|5903655|P1|Overall Study|Non-Compliance|0
1690948|NCT01300247|5903654|P2|Overall Study|Withdrawal by Subject|0
1690949|NCT01300247|5903655|P1|Overall Study|Withdrawal by Subject|1
1690950|NCT01300247|5903654|P2|Overall Study|Lost to Follow-up|0
1690951|NCT01300247|5903655|P1|Overall Study|Lost to Follow-up|2
1690952|NCT01300247|5903654|P2|Overall Study|Death|1
1690953|NCT01300247|5903655|P1|Overall Study|Death|1
1690954|NCT01300234|5903687|P2|Overall Study|Participant refused return to hospital|0
1690955|NCT01300234|5903688|P1|Overall Study|Participant refused return to hospital|1
1690956|NCT01300234|5903687|P2|Overall Study|Participant stopped medication|1
1690957|NCT01300234|5903688|P1|Overall Study|Participant stopped medication|1
1690958|NCT01300234|5903687|P2|Overall Study|Participant reached stopping critera|0
1690959|NCT01300234|5903688|P1|Overall Study|Participant reached stopping critera|2
1690960|NCT01300234|5903687|P2|Overall Study|Pregnancy|1
1690961|NCT01300234|5903688|P1|Overall Study|Pregnancy|2
1690962|NCT01300234|5903687|P2|Overall Study|Lost to Follow-up|12
1690963|NCT01300234|5903688|P1|Overall Study|Lost to Follow-up|14
1690964|NCT01300234|5903687|P2|Overall Study|Withdrawal by Subject|9
1690965|NCT01300234|5903688|P1|Overall Study|Withdrawal by Subject|5
1690966|NCT01300234|5903687|P2|Overall Study|Protocol Violation|3
1690967|NCT01300234|5903688|P1|Overall Study|Protocol Violation|2
1690968|NCT01300234|5903687|P2|Overall Study|Adverse Event|1
1690969|NCT01300234|5903688|P1|Overall Study|Adverse Event|1
1690970|NCT01300052|5903724|P2|Overall Study|Protocol Violation|1
1690971|NCT01300052|5903725|P1|Overall Study|Protocol Violation|1
1690972|NCT01300052|5903724|P2|Overall Study|Withdrawal by Subject|2
1690973|NCT01300052|5903725|P1|Overall Study|Withdrawal by Subject|2
1690974|NCT01300052|5903724|P2|Overall Study|Adverse Event|0
1690975|NCT01300052|5903725|P1|Overall Study|Adverse Event|3
1690976|NCT01299961|5903743|P1|Overall Study|Lost to Follow-up|1
1690977|NCT01299961|5903743|P1|Overall Study|Lack of Efficacy|2
1690978|NCT01299961|5903743|P1|Overall Study|Adverse Event|3
1690980|NCT01299909|5903753|P2|Overall Study|Lost to Follow-up|18
1690981|NCT01299909|5903754|P1|Overall Study|Lost to Follow-up|22
1690982|NCT01299896|5903769|P2|Overall Study|Lost to Follow-up|11
1690983|NCT01299896|5903770|P1|Overall Study|Lost to Follow-up|0
1690984|NCT01299896|5903769|P2|Overall Study|Withdrawal by Subject|7
1690985|NCT01299896|5903770|P1|Overall Study|Withdrawal by Subject|1
1690986|NCT01299805|5903778|P2|Overall Study|Adverse Event|0
1690987|NCT01299805|5903779|P1|Overall Study|Adverse Event|2
1690988|NCT01299766|5903809|P2|Overall Study|Withdrawal by Subject|19
1690989|NCT01299766|5903810|P1|Overall Study|Withdrawal by Subject|29
1690990|NCT01299766|5903809|P2|Overall Study|Death|4
1690991|NCT01299766|5903810|P1|Overall Study|Death|5
1690992|NCT01299584|5903868|P1|Overall Study|Protocol Violation|9
1690993|NCT01299571|5903875|P1|Overall Study|Protocol Violation|107
1690994|NCT01299480|5903886|P5|Overall Study|Started, but not vaccinated|0
1690995|NCT01299480|5903887|P4|Overall Study|Started, but not vaccinated|1
1690996|NCT01299480|5903888|P3|Overall Study|Started, but not vaccinated|1
1690997|NCT01299480|5903889|P2|Overall Study|Started, but not vaccinated|0
1690998|NCT01299480|5903890|P1|Overall Study|Started, but not vaccinated|0
1690999|NCT01299480|5903886|P5|Overall Study|Other|3
1691000|NCT01299480|5903887|P4|Overall Study|Other|0
1691001|NCT01299480|5903888|P3|Overall Study|Other|3
1691002|NCT01299480|5903889|P2|Overall Study|Other|2
1691003|NCT01299480|5903890|P1|Overall Study|Other|3
1691004|NCT01299480|5903886|P5|Overall Study|Lost to Follow-up|2
1691005|NCT01299480|5903887|P4|Overall Study|Lost to Follow-up|1
1691006|NCT01299480|5903888|P3|Overall Study|Lost to Follow-up|2
1691007|NCT01299480|5903889|P2|Overall Study|Lost to Follow-up|1
1691008|NCT01299480|5903890|P1|Overall Study|Lost to Follow-up|3
1691009|NCT01299480|5903886|P5|Overall Study|Physician Decision|0
1691010|NCT01299480|5903887|P4|Overall Study|Physician Decision|2
1691011|NCT01299480|5903888|P3|Overall Study|Physician Decision|0
1691012|NCT01299480|5903889|P2|Overall Study|Physician Decision|1
1691013|NCT01299480|5903890|P1|Overall Study|Physician Decision|1
1691014|NCT01299480|5903886|P5|Overall Study|Withdrawal due to pregnancy|0
1691015|NCT01299480|5903887|P4|Overall Study|Withdrawal due to pregnancy|0
1691016|NCT01299480|5903888|P3|Overall Study|Withdrawal due to pregnancy|1
1691017|NCT01299480|5903889|P2|Overall Study|Withdrawal due to pregnancy|1
1691018|NCT01299480|5903890|P1|Overall Study|Withdrawal due to pregnancy|0
1691019|NCT01299480|5903886|P5|Overall Study|Adverse Event|0
1691020|NCT01299480|5903887|P4|Overall Study|Adverse Event|4
1691021|NCT01299480|5903888|P3|Overall Study|Adverse Event|5
1691022|NCT01299480|5903889|P2|Overall Study|Adverse Event|4
1691023|NCT01299480|5903890|P1|Overall Study|Adverse Event|6
1691024|NCT01299480|5903886|P5|Overall Study|Withdrawal by Subject|4
1691025|NCT01299480|5903887|P4|Overall Study|Withdrawal by Subject|3
1691026|NCT01299480|5903888|P3|Overall Study|Withdrawal by Subject|7
1691027|NCT01299480|5903889|P2|Overall Study|Withdrawal by Subject|4
1691028|NCT01299480|5903890|P1|Overall Study|Withdrawal by Subject|3
1691029|NCT01299480|5903886|P5|Overall Study|Protocol Violation|1
1691030|NCT01299480|5903887|P4|Overall Study|Protocol Violation|1
1691031|NCT01299480|5903888|P3|Overall Study|Protocol Violation|8
1691032|NCT01299480|5903889|P2|Overall Study|Protocol Violation|5
1691033|NCT01299480|5903890|P1|Overall Study|Protocol Violation|7
1691034|NCT01299480|5903886|P5|Overall Study|No longer willing to participate|10
1691035|NCT01299480|5903887|P4|Overall Study|No longer willing to participate|13
1691036|NCT01299480|5903888|P3|Overall Study|No longer willing to participate|14
1691037|NCT01299480|5903889|P2|Overall Study|No longer willing to participate|17
1691038|NCT01299480|5903890|P1|Overall Study|No longer willing to participate|19
1691039|NCT01299389|5904092|P4|Post-observational|Other|6
1691040|NCT01299389|5904093|P3|Post-observational|Other|12
1691041|NCT01299389|5904094|P2|Post-observational|Other|0
1691042|NCT01299389|5904095|P1|Post-observational|Other|0
1691043|NCT01299389|5904092|P4|Double-blind|fail to meet “study population” criteria|0
1691044|NCT01299389|5904093|P3|Double-blind|fail to meet “study population” criteria|0
1691045|NCT01299389|5904094|P2|Double-blind|fail to meet “study population” criteria|1
1691046|NCT01299389|5904095|P1|Double-blind|fail to meet “study population” criteria|0
1691047|NCT01299389|5904092|P4|Double-blind|Other|0
1691048|NCT01299389|5904093|P3|Double-blind|Other|0
1691049|NCT01299389|5904094|P2|Double-blind|Other|1
1691050|NCT01299389|5904095|P1|Double-blind|Other|1
1691051|NCT01299389|5904092|P4|Double-blind|Withdrawal by Subject|0
1691052|NCT01299389|5904093|P3|Double-blind|Withdrawal by Subject|0
1691053|NCT01299389|5904094|P2|Double-blind|Withdrawal by Subject|13
1691054|NCT01299389|5904095|P1|Double-blind|Withdrawal by Subject|16
1691055|NCT01299389|5904092|P4|Double-blind|Lost to Follow-up|0
1691056|NCT01299389|5904093|P3|Double-blind|Lost to Follow-up|0
1691057|NCT01299389|5904094|P2|Double-blind|Lost to Follow-up|1
1691058|NCT01299389|5904095|P1|Double-blind|Lost to Follow-up|2
1691059|NCT01299389|5904092|P4|Double-blind|Lack of Efficacy|0
1691060|NCT01299389|5904093|P3|Double-blind|Lack of Efficacy|0
1691061|NCT01299389|5904094|P2|Double-blind|Lack of Efficacy|21
1691062|NCT01299389|5904095|P1|Double-blind|Lack of Efficacy|45
1691063|NCT01299389|5904092|P4|Double-blind|Adverse Event|0
1691064|NCT01299389|5904093|P3|Double-blind|Adverse Event|0
1691065|NCT01299389|5904094|P2|Double-blind|Adverse Event|27
1691066|NCT01299389|5904095|P1|Double-blind|Adverse Event|45
1691067|NCT01299376|5904117|P2|Extension (Weeks 9 to 52)|Physician Decision|0
1691068|NCT01299376|5904118|P1|Extension (Weeks 9 to 52)|Physician Decision|1
1691069|NCT01299376|5904117|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
1691070|NCT01299376|5904118|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
1691071|NCT01299376|5904117|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
1691072|NCT01299376|5904118|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
1691073|NCT01299376|5904117|P2|Extension (Weeks 9 to 52)|Adverse Event|3
1691074|NCT01299376|5904118|P1|Extension (Weeks 9 to 52)|Adverse Event|2
1691075|NCT01299376|5904117|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
1691076|NCT01299376|5904118|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
1691077|NCT01299376|5904117|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
1691078|NCT01299376|5904118|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
1691079|NCT01299376|5904117|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
1691080|NCT01299376|5904118|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
1691081|NCT01299376|5904117|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
1691082|NCT01299376|5904118|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
1691083|NCT01299376|5904117|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
1691084|NCT01299376|5904118|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
1691085|NCT01299376|5904117|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
1691086|NCT01299376|5904118|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
1691087|NCT01299376|5904117|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
1691088|NCT01299376|5904118|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
1691089|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
1691090|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
1691091|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
1691092|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
1691093|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Physician Decision|1
1691094|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Physician Decision|2
1691095|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Physician Decision|0
1691096|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Physician Decision|0
1691097|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
1691098|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
1691099|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
1691100|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
1691101|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
1691102|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
1691103|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
1691104|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
1691105|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
1691106|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
1691107|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
1691108|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
1691109|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Adverse Event|9
1691110|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Adverse Event|8
1691111|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Adverse Event|0
1691112|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Adverse Event|0
1691113|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
1691114|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
1691115|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
1691116|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
1691117|NCT01299272|5904161|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
1691118|NCT01299272|5904162|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
1691119|NCT01299272|5904163|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
1691120|NCT01299272|5904164|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
1691121|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Physician Decision|0
1691122|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Physician Decision|0
1691123|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Physician Decision|3
1691124|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Physician Decision|0
1691125|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1691126|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1691127|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
1691128|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
1691129|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1691130|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1691131|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
1691132|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
1691133|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1691134|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1691135|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
1691136|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
1691137|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
1691138|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
1691139|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
1691140|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
1691141|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1691142|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1691143|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
1691144|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
1691145|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Adverse Event|0
1691146|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Adverse Event|0
1691147|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Adverse Event|42
1691148|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Adverse Event|0
1691149|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
1691150|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
1691151|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
1691152|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
1691153|NCT01299272|5904161|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1691154|NCT01299272|5904162|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1691155|NCT01299272|5904163|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
1691156|NCT01299272|5904164|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
1691157|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Physician Decision|0
1691158|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Physician Decision|0
1691159|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Physician Decision|0
1691160|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Physician Decision|5
1691161|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
1691162|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
1691163|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
1691164|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
1691165|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Sponsor Decision|0
1691166|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Sponsor Decision|0
1691167|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Sponsor Decision|0
1691168|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Sponsor Decision|13
1691169|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
1691170|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
1691171|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
1691172|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
1691173|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Protocol Violation|0
1691174|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Protocol Violation|0
1691175|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Protocol Violation|0
1691176|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Protocol Violation|36
1691177|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
1691178|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
1691179|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
1691180|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
1691181|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Adverse Event|0
1691182|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Adverse Event|0
1691183|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Adverse Event|0
1691184|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Adverse Event|140
1691185|NCT01299272|5904161|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1691186|NCT01299272|5904162|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1691187|NCT01299272|5904163|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
1691188|NCT01299272|5904164|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
1691189|NCT01299116|5904219|P3|Overall Study|Lost to Follow-up|11
1691190|NCT01299116|5904220|P2|Overall Study|Lost to Follow-up|9
1691191|NCT01299116|5904221|P1|Overall Study|Lost to Follow-up|65
1691192|NCT01299038|5904266|P2|Overall Study|Withdrawal by Subject|0
1691193|NCT01299038|5904267|P1|Overall Study|Withdrawal by Subject|1
1691194|NCT01299025|5904275|P2|Overall Study|Lost to Follow-up|0
1691195|NCT01299025|5904276|P1|Overall Study|Lost to Follow-up|1
1691196|NCT01299025|5904275|P2|Overall Study|Withdrawal by Subject|1
1691197|NCT01299025|5904276|P1|Overall Study|Withdrawal by Subject|2
1691198|NCT01298778|5904301|P2|Overall Study|not meet inclusion/exclusion criteria|1
1691199|NCT01298778|5904302|P1|Overall Study|not meet inclusion/exclusion criteria|0
1691200|NCT01298778|5904301|P2|Overall Study|Protocol Violation|1
1691201|NCT01298778|5904302|P1|Overall Study|Protocol Violation|0
1691202|NCT01298778|5904301|P2|Overall Study|Withdrawal by Subject|1
1691203|NCT01298778|5904302|P1|Overall Study|Withdrawal by Subject|0
1691204|NCT01298778|5904301|P2|Overall Study|Incorrect use of VAS|0
1691205|NCT01298778|5904302|P1|Overall Study|Incorrect use of VAS|1
1691206|NCT01298778|5904301|P2|Overall Study|Lost to Follow-up|3
1691207|NCT01298778|5904302|P1|Overall Study|Lost to Follow-up|2
1691208|NCT01298765|5904322|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
1691209|NCT01298765|5904322|P1|Long-Term Treatment Period|Physician Decision|1
1691210|NCT01298765|5904322|P1|Long-Term Treatment Period|Withdrawal by Subject|19
1691211|NCT01298765|5904322|P1|Long-Term Treatment Period|Lost to Follow-up|8
1691212|NCT01298765|5904322|P1|Long-Term Treatment Period|Lack of Efficacy|6
1691213|NCT01298765|5904322|P1|Long-Term Treatment Period|Adverse Event|19
1691214|NCT01298765|5904322|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
1691215|NCT01298765|5904322|P1|Titration Period|Withdrawal by Subject|10
1691216|NCT01298765|5904322|P1|Titration Period|Physician Decision|1
1691217|NCT01298765|5904322|P1|Titration Period|Lost to Follow-up|9
1691218|NCT01298765|5904322|P1|Titration Period|Lack of Efficacy|21
1691219|NCT01298765|5904322|P1|Titration Period|Death|1
1691220|NCT01298765|5904322|P1|Titration Period|Adverse Event|26
1691221|NCT01298700|5904332|P2|Overall Study|Did not Receive Study Drug|5
1691222|NCT01298700|5904333|P1|Overall Study|Did not Receive Study Drug|3
1691223|NCT01298700|5904332|P2|Overall Study|Other Miscellaneous Reasons|15
1691224|NCT01298700|5904333|P1|Overall Study|Other Miscellaneous Reasons|16
1691225|NCT01298700|5904332|P2|Overall Study|Protocol Violation|4
1691226|NCT01298700|5904333|P1|Overall Study|Protocol Violation|6
1691227|NCT01298700|5904332|P2|Overall Study|Withdrawal by Subject|9
1691228|NCT01298700|5904333|P1|Overall Study|Withdrawal by Subject|12
1691229|NCT01298700|5904332|P2|Overall Study|Lost to Follow-up|2
1691230|NCT01298700|5904333|P1|Overall Study|Lost to Follow-up|5
1691231|NCT01298700|5904332|P2|Overall Study|Lack of Efficacy|14
1691232|NCT01298700|5904333|P1|Overall Study|Lack of Efficacy|9
1691233|NCT01298700|5904332|P2|Overall Study|Adverse Event|51
1691234|NCT01298700|5904333|P1|Overall Study|Adverse Event|50
1691235|NCT01298661|5904344|P3|Overall Study|Withdrawal by Subject|2
1691236|NCT01298661|5904345|P2|Overall Study|Withdrawal by Subject|0
1691237|NCT01298661|5904346|P1|Overall Study|Withdrawal by Subject|2
1691238|NCT01298648|5904424|P1|Overall Study|Lost to Follow-up|21
1691239|NCT01298648|5904424|P1|Overall Study|Withdrawal by Subject|2
1691240|NCT01298596|5904435|P2|Overall Study|Referred for further management|15
1691241|NCT01298596|5904436|P1|Overall Study|Referred for further management|16
1691242|NCT01298596|5904435|P2|Overall Study|Lost to Follow-up|14
1691243|NCT01298596|5904436|P1|Overall Study|Lost to Follow-up|6
1691244|NCT01298596|5904435|P2|Overall Study|Death|3
1691245|NCT01298596|5904436|P1|Overall Study|Death|5
1691246|NCT01298596|5904435|P2|Overall Study|Withdrawal by Subject|1
1691247|NCT01298596|5904436|P1|Overall Study|Withdrawal by Subject|1
1691248|NCT01298570|5904446|P2|Overall Study|Ineligibility|1
1691249|NCT01298570|5904447|P1|Overall Study|Ineligibility|0
1691250|NCT01298570|5904446|P2|Overall Study|Death|1
1691251|NCT01298570|5904447|P1|Overall Study|Death|0
1691252|NCT01298570|5904446|P2|Overall Study|Symptomatic progression/deterioration|2
1691253|NCT01298570|5904447|P1|Overall Study|Symptomatic progression/deterioration|3
1691254|NCT01298570|5904446|P2|Overall Study|Surgery|1
1691255|NCT01298570|5904447|P1|Overall Study|Surgery|2
1691256|NCT01298570|5904446|P2|Overall Study|Other complicating disease|1
1691257|NCT01298570|5904447|P1|Overall Study|Other complicating disease|2
1691258|NCT01298570|5904446|P2|Overall Study|Physician Decision|2
1691259|NCT01298570|5904447|P1|Overall Study|Physician Decision|4
1691260|NCT01298570|5904446|P2|Overall Study|Treatment delay > 4 weeks|5
1691261|NCT01298570|5904447|P1|Overall Study|Treatment delay > 4 weeks|4
1691262|NCT01298570|5904446|P2|Overall Study|Withdrawal by Subject|6
1691263|NCT01298570|5904447|P1|Overall Study|Withdrawal by Subject|21
1691264|NCT01298570|5904446|P2|Overall Study|Adverse Event|2
1691265|NCT01298570|5904447|P1|Overall Study|Adverse Event|20
1691266|NCT01298570|5904446|P2|Overall Study|Disease progression, relapse during acti|40
1691267|NCT01298570|5904447|P1|Overall Study|Disease progression, relapse during acti|64
1691268|NCT01298531|5904474|P2|Overall Study|Other|1
1691269|NCT01298531|5904475|P1|Overall Study|Other|2
1691270|NCT01298531|5904474|P2|Overall Study|Does not meet entrance criteria|1
1691271|NCT01298531|5904475|P1|Overall Study|Does not meet entrance criteria|0
1691272|NCT01298531|5904474|P2|Overall Study|Adverse Event|3
1691273|NCT01298531|5904475|P1|Overall Study|Adverse Event|4
1691274|NCT01298531|5904474|P2|Overall Study|Protocol Violation|1
1691275|NCT01298531|5904475|P1|Overall Study|Protocol Violation|1
1691276|NCT01298531|5904474|P2|Overall Study|Lost to Follow-up|0
1691277|NCT01298531|5904475|P1|Overall Study|Lost to Follow-up|2
1691278|NCT01298531|5904474|P2|Overall Study|Lack of Efficacy|1
1691279|NCT01298531|5904475|P1|Overall Study|Lack of Efficacy|0
1691280|NCT01298518|5904604|P3|Overall Study|Withdrawal by Subject|1
1691281|NCT01298518|5904605|P2|Overall Study|Withdrawal by Subject|0
1691282|NCT01298518|5904606|P1|Overall Study|Withdrawal by Subject|0
1691283|NCT01298492|5904658|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
1691284|NCT01298492|5904658|P1|Overall Study|Adverse Event(Related to Study Drug)|8
1691285|NCT01298492|5904658|P1|Overall Study|Protocol Violation|2
1691286|NCT01298492|5904658|P1|Overall Study|Withdrawn Due to Pregnancy|1
1691287|NCT01298492|5904658|P1|Overall Study|Other (Unspecified)|7
1691288|NCT01298492|5904658|P1|Overall Study|Withdrawal by Subject|47
1691289|NCT01298492|5904658|P1|Overall Study|Lost to Follow-up|12
1691290|NCT01298492|5904658|P1|Overall Study|Insufficient Clinical Response|22
1691291|NCT01298492|5904658|P1|Overall Study|Death|2
1691292|NCT01298362|5904666|P2|Overall Study|Did not provide 12month BMD measurements|43
1691293|NCT01298362|5904667|P1|Overall Study|Did not provide 12month BMD measurements|38
1691294|NCT01298323|5904687|P2|Overall Study|Eligibility criteria not fulfilled|1
1691295|NCT01298323|5904688|P1|Overall Study|Eligibility criteria not fulfilled|0
1691296|NCT01298323|5904687|P2|Overall Study|Ongoing|55
1691297|NCT01298323|5904688|P1|Overall Study|Ongoing|55
1691298|NCT01298323|5904687|P2|Overall Study|Other|9
1691299|NCT01298323|5904688|P1|Overall Study|Other|10
1691300|NCT01298323|5904687|P2|Overall Study|Protocol Violation|0
1691301|NCT01298323|5904688|P1|Overall Study|Protocol Violation|1
1691302|NCT01298323|5904687|P2|Overall Study|Withdrawal by Subject|3
1691303|NCT01298323|5904688|P1|Overall Study|Withdrawal by Subject|6
1691304|NCT01298323|5904687|P2|Overall Study|Lost to Follow-up|0
1691305|NCT01298323|5904688|P1|Overall Study|Lost to Follow-up|1
1691306|NCT01298323|5904687|P2|Overall Study|Death|16
1691307|NCT01298323|5904688|P1|Overall Study|Death|11
1691308|NCT01298323|5904687|P2|Overall Study|Adverse Event|4
1691309|NCT01298323|5904688|P1|Overall Study|Adverse Event|2
1691310|NCT01298193|5904711|P1|Efficacy Phase (Second Cycle)|Death|1
1691311|NCT01298193|5904711|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
1691312|NCT01298193|5904711|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
1691313|NCT01298193|5904711|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
1691314|NCT01298141|5904733|P1|Overall Study|Not treated|4
1691315|NCT01298141|5904733|P1|Overall Study|Death|6
1691316|NCT01298141|5904733|P1|Overall Study|Lost to Follow-up|1
1691317|NCT01298141|5904733|P1|Overall Study|Other|5
1691318|NCT01298141|5904733|P1|Overall Study|Termination of Study by the Investigator|5
1691319|NCT01298141|5904733|P1|Overall Study|Withdrawal by Subject|6
1691320|NCT01298141|5904733|P1|Overall Study|Refusal of Required Study Procedures|1
1691321|NCT01298141|5904733|P1|Overall Study|Adverse Event|3
1691322|NCT01297920|5904808|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
1691323|NCT01297920|5904809|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
1691324|NCT01297920|5904810|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
1691325|NCT01297920|5904808|P3|Overall Study|Inadequate Control of IOP|17
1691326|NCT01297920|5904809|P2|Overall Study|Inadequate Control of IOP|9
1691327|NCT01297920|5904810|P1|Overall Study|Inadequate Control of IOP|7
1691328|NCT01297920|5904808|P3|Overall Study|Protocol Violation|0
1691329|NCT01297920|5904809|P2|Overall Study|Protocol Violation|3
1691330|NCT01297920|5904810|P1|Overall Study|Protocol Violation|1
1691331|NCT01297920|5904808|P3|Overall Study|Noncompliance|0
1691332|NCT01297920|5904809|P2|Overall Study|Noncompliance|0
1691333|NCT01297920|5904810|P1|Overall Study|Noncompliance|1
1691334|NCT01297920|5904808|P3|Overall Study|Patient Decision Unrelated to AE|2
1691335|NCT01297920|5904809|P2|Overall Study|Patient Decision Unrelated to AE|5
1691336|NCT01297920|5904810|P1|Overall Study|Patient Decision Unrelated to AE|6
1691337|NCT01297920|5904808|P3|Overall Study|Adverse Event|38
1691338|NCT01297920|5904809|P2|Overall Study|Adverse Event|10
1691339|NCT01297920|5904810|P1|Overall Study|Adverse Event|42
1691340|NCT01297517|5904854|P3|Overall Study|Inadequate Control of IOP|2
1691341|NCT01297517|5904855|P2|Overall Study|Inadequate Control of IOP|1
1691342|NCT01297517|5904856|P1|Overall Study|Inadequate Control of IOP|1
1691343|NCT01297517|5904854|P3|Overall Study|Protocol Violation|1
1691344|NCT01297517|5904855|P2|Overall Study|Protocol Violation|1
1691345|NCT01297517|5904856|P1|Overall Study|Protocol Violation|1
1691346|NCT01297517|5904854|P3|Overall Study|Noncompliance|0
1691347|NCT01297517|5904855|P2|Overall Study|Noncompliance|0
1691348|NCT01297517|5904856|P1|Overall Study|Noncompliance|1
1691349|NCT01297517|5904854|P3|Overall Study|Patient Decision Unrelated to AE|7
1691350|NCT01297517|5904855|P2|Overall Study|Patient Decision Unrelated to AE|3
1691351|NCT01297517|5904856|P1|Overall Study|Patient Decision Unrelated to AE|2
1691352|NCT01297517|5904854|P3|Overall Study|Lost to Follow-up|1
1691353|NCT01297517|5904855|P2|Overall Study|Lost to Follow-up|0
1691354|NCT01297517|5904856|P1|Overall Study|Lost to Follow-up|1
1691355|NCT01297517|5904854|P3|Overall Study|Adverse Event|16
1691356|NCT01297517|5904855|P2|Overall Study|Adverse Event|7
1691357|NCT01297517|5904856|P1|Overall Study|Adverse Event|21
1691358|NCT01297504|5904864|P1|Overall Study|Protocol Violation|3
1691359|NCT01297504|5904864|P1|Overall Study|Site Closure|3
1691360|NCT01297504|5904864|P1|Overall Study|Withdrawal by Subject|9
1691361|NCT01297504|5904864|P1|Overall Study|Lost to Follow-up|43
1691362|NCT01297504|5904864|P1|Overall Study|Death|3
1691363|NCT01297504|5904864|P1|Overall Study|No Study Visits|4
1691364|NCT01297504|5904864|P1|Overall Study|Received Palivizumab in Previous Season|1
1691365|NCT01297504|5904864|P1|Overall Study|Invalid Consent|1
1691366|NCT01297491|5904878|P2|Overall Study|Death|1
1691367|NCT01297491|5904879|P1|Overall Study|Death|2
1691368|NCT01297491|5904878|P2|Overall Study|Patient/Guardian decision|4
1691369|NCT01297491|5904879|P1|Overall Study|Patient/Guardian decision|3
1691370|NCT01297491|5904878|P2|Overall Study|Progressive disease|20
1691371|NCT01297491|5904879|P1|Overall Study|Progressive disease|11
1691372|NCT01297491|5904878|P2|Overall Study|Physician Decision|2
1691373|NCT01297491|5904879|P1|Overall Study|Physician Decision|3
1691374|NCT01297491|5904878|P2|Overall Study|Adverse Event|6
1691375|NCT01297491|5904879|P1|Overall Study|Adverse Event|11
1691376|NCT01297465|5904897|P2|Overall Study|Intention to Freeze all Embryos|1
1691377|NCT01297465|5904898|P1|Overall Study|Intention to Freeze all Embryos|0
1691378|NCT01297465|5904897|P2|Overall Study|All Embryos Discarded|1
1691379|NCT01297465|5904898|P1|Overall Study|All Embryos Discarded|0
1691380|NCT01297465|5904897|P2|Overall Study|No Fertilization|4
1691381|NCT01297465|5904898|P1|Overall Study|No Fertilization|6
1691382|NCT01297465|5904897|P2|Overall Study|Poor oocyte quality|1
1691383|NCT01297465|5904898|P1|Overall Study|Poor oocyte quality|0
1691384|NCT01297465|5904897|P2|Overall Study|No Oocytes Retrieved|1
1691385|NCT01297465|5904898|P1|Overall Study|No Oocytes Retrieved|1
1691386|NCT01297465|5904897|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
1691387|NCT01297465|5904898|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
1691388|NCT01297465|5904897|P2|Overall Study|Lack of Ovarian Response|1
1691389|NCT01297465|5904898|P1|Overall Study|Lack of Ovarian Response|1
1691390|NCT01297322|5904951|P2|Overall Study|Protocol Violation|3
1691391|NCT01297322|5904952|P1|Overall Study|Protocol Violation|0
1691392|NCT01297322|5904951|P2|Overall Study|Withdrawal by Subject|1
1691393|NCT01297322|5904952|P1|Overall Study|Withdrawal by Subject|0
1691394|NCT01297322|5904951|P2|Overall Study|Lost to Follow-up|0
1691395|NCT01297322|5904952|P1|Overall Study|Lost to Follow-up|1
1691396|NCT01297309|5904971|P1|Overall Study|Participant not entering extensionperiod|1
1691397|NCT01297309|5904971|P1|Overall Study|Death|1
1691398|NCT01297309|5904971|P1|Overall Study|Investigator Decision|2
1691399|NCT01297309|5904971|P1|Overall Study|Adverse Event|1
1691400|NCT01297309|5904971|P1|Overall Study|Withdrawal by Subject|5
1691401|NCT01297309|5904971|P1|Overall Study|Screen failure|2
1691402|NCT01297309|5904971|P1|Overall Study|Eligibility failure|2
1691403|NCT01297270|5904996|P3|Overall Study|Not treated|0
1691404|NCT01297270|5904997|P2|Overall Study|Not treated|1
1691405|NCT01297270|5904998|P1|Overall Study|Not treated|0
1691406|NCT01297270|5904996|P3|Overall Study|Other reason not defined above|1
1691407|NCT01297270|5904997|P2|Overall Study|Other reason not defined above|3
1691408|NCT01297270|5904998|P1|Overall Study|Other reason not defined above|3
1691409|NCT01297270|5904996|P3|Overall Study|Withdrawal by Subject|7
1691410|NCT01297270|5904997|P2|Overall Study|Withdrawal by Subject|15
1691411|NCT01297270|5904998|P1|Overall Study|Withdrawal by Subject|7
1691412|NCT01297270|5904996|P3|Overall Study|Protocol Violation|0
1691413|NCT01297270|5904997|P2|Overall Study|Protocol Violation|2
1691414|NCT01297270|5904998|P1|Overall Study|Protocol Violation|0
1691415|NCT01297270|5904996|P3|Overall Study|Lost to Follow-up|1
1691416|NCT01297270|5904997|P2|Overall Study|Lost to Follow-up|2
1691417|NCT01297270|5904998|P1|Overall Study|Lost to Follow-up|1
1691418|NCT01297270|5904996|P3|Overall Study|Lack of Efficacy|15
1691419|NCT01297270|5904997|P2|Overall Study|Lack of Efficacy|17
1691420|NCT01297270|5904998|P1|Overall Study|Lack of Efficacy|15
1691421|NCT01297270|5904996|P3|Overall Study|Adverse Event|5
1691422|NCT01297270|5904997|P2|Overall Study|Adverse Event|32
1691423|NCT01297270|5904998|P1|Overall Study|Adverse Event|19
1691424|NCT01297062|5905047|P7|Overall Study|Subject Decision|2
1691425|NCT01297062|5905048|P6|Overall Study|Subject Decision|1
1691426|NCT01297062|5905049|P5|Overall Study|Subject Decision|1
1691427|NCT01297062|5905050|P4|Overall Study|Subject Decision|1
1691428|NCT01297062|5905051|P3|Overall Study|Subject Decision|0
1691429|NCT01297062|5905052|P2|Overall Study|Subject Decision|1
1691430|NCT01297062|5905053|P1|Overall Study|Subject Decision|1
1691431|NCT01297062|5905047|P7|Overall Study|Protocol Violation|0
1691432|NCT01297062|5905048|P6|Overall Study|Protocol Violation|0
1691433|NCT01297062|5905049|P5|Overall Study|Protocol Violation|1
1691434|NCT01297062|5905050|P4|Overall Study|Protocol Violation|0
1691435|NCT01297062|5905051|P3|Overall Study|Protocol Violation|0
1691436|NCT01297062|5905052|P2|Overall Study|Protocol Violation|0
1691437|NCT01297062|5905053|P1|Overall Study|Protocol Violation|0
1691438|NCT01297062|5905047|P7|Overall Study|Physician Decision|6
1691439|NCT01297062|5905048|P6|Overall Study|Physician Decision|0
1691440|NCT01297062|5905049|P5|Overall Study|Physician Decision|0
1691441|NCT01297062|5905050|P4|Overall Study|Physician Decision|0
1691442|NCT01297062|5905051|P3|Overall Study|Physician Decision|1
1691443|NCT01297062|5905052|P2|Overall Study|Physician Decision|0
1691444|NCT01297062|5905053|P1|Overall Study|Physician Decision|1
1691445|NCT01297062|5905047|P7|Overall Study|Adverse Event|0
1691446|NCT01297062|5905048|P6|Overall Study|Adverse Event|0
1691447|NCT01297062|5905049|P5|Overall Study|Adverse Event|0
1691448|NCT01297062|5905050|P4|Overall Study|Adverse Event|0
1691449|NCT01297062|5905051|P3|Overall Study|Adverse Event|1
1691450|NCT01297062|5905052|P2|Overall Study|Adverse Event|0
1691451|NCT01297062|5905053|P1|Overall Study|Adverse Event|2
1691452|NCT01296698|5905115|P2|Overall Study|Study Terminated by Sponsor|12
1691453|NCT01296698|5905116|P1|Overall Study|Study Terminated by Sponsor|209
1691454|NCT01296698|5905115|P2|Overall Study|Difficulty Contacting Subject|0
1691455|NCT01296698|5905116|P1|Overall Study|Difficulty Contacting Subject|2
1691456|NCT01296698|5905115|P2|Overall Study|Withdrawal by Subject|0
1691457|NCT01296698|5905116|P1|Overall Study|Withdrawal by Subject|12
1691458|NCT01296698|5905115|P2|Overall Study|Lost to Follow-up|1
1691459|NCT01296698|5905116|P1|Overall Study|Lost to Follow-up|19
1691460|NCT01296698|5905115|P2|Overall Study|Death|0
1691461|NCT01296698|5905116|P1|Overall Study|Death|1
1691462|NCT01296698|5905115|P2|Overall Study|Adverse Event|0
1691463|NCT01296698|5905116|P1|Overall Study|Adverse Event|1
1691464|NCT01296672|5905170|P2|Overall Study|Lost to Follow-up|18
1691465|NCT01296672|5905171|P1|Overall Study|Lost to Follow-up|73
1691466|NCT01296568|5905192|P1|Continued Access Phase|Disease Progression|1
1691467|NCT01296568|5905192|P1|Continued Access Phase|Withdrawal by Subject|1
1691468|NCT01296568|5905192|P1|Continued Access Phase|Lost to Follow-up|1
1691469|NCT01296412|5905208|P2|Overall Study|Withdrawal by Subject|13
1691470|NCT01296412|5905209|P1|Overall Study|Withdrawal by Subject|10
1691471|NCT01296412|5905208|P2|Overall Study|Pregnancy|1
1691472|NCT01296412|5905209|P1|Overall Study|Pregnancy|0
1691473|NCT01296412|5905208|P2|Overall Study|Physician Decision|3
1691474|NCT01296412|5905209|P1|Overall Study|Physician Decision|1
1691475|NCT01296412|5905208|P2|Overall Study|Other reason not specified|15
1691476|NCT01296412|5905209|P1|Overall Study|Other reason not specified|20
1691477|NCT01296412|5905208|P2|Overall Study|Non-compliance with study drug|2
1691478|NCT01296412|5905209|P1|Overall Study|Non-compliance with study drug|1
1691479|NCT01296412|5905208|P2|Overall Study|Lost to Follow-up|7
1691480|NCT01296412|5905209|P1|Overall Study|Lost to Follow-up|10
1691481|NCT01296412|5905208|P2|Overall Study|Lack of Efficacy|0
1691482|NCT01296412|5905209|P1|Overall Study|Lack of Efficacy|1
1691483|NCT01296412|5905208|P2|Overall Study|Adverse Event|29
1691484|NCT01296412|5905209|P1|Overall Study|Adverse Event|8
1691485|NCT01296347|5905232|P2|12 Month Follow up|Withdrawal by Subject|1
1691486|NCT01296347|5905233|P1|12 Month Follow up|Withdrawal by Subject|0
1691487|NCT01296347|5905232|P2|12 Month Follow up|Death|1
1691488|NCT01296347|5905233|P1|12 Month Follow up|Death|1
1691489|NCT01296347|5905232|P2|12 Month Follow up|Lost to Follow-up|1
1691490|NCT01296347|5905233|P1|12 Month Follow up|Lost to Follow-up|3
1691491|NCT01296347|5905232|P2|6 Month Follow up|Lost to Follow-up|1
1691492|NCT01296347|5905233|P1|6 Month Follow up|Lost to Follow-up|0
1691493|NCT01296347|5905232|P2|6 Month Follow up|Death|1
1691494|NCT01296347|5905233|P1|6 Month Follow up|Death|2
1691495|NCT01296347|5905232|P2|3 Month Follow up|Lost to Follow-up|1
1691496|NCT01296347|5905233|P1|3 Month Follow up|Lost to Follow-up|0
1691497|NCT01296347|5905232|P2|3 Month Follow up|Death|0
1691498|NCT01296347|5905233|P1|3 Month Follow up|Death|1
1691499|NCT01296347|5905232|P2|6 Week Follow up|Death|1
1691500|NCT01296347|5905233|P1|6 Week Follow up|Death|0
1691501|NCT01296347|5905232|P2|Allocation|not received infusion|0
1691502|NCT01296347|5905233|P1|Allocation|not received infusion|1
1691503|NCT01296347|5905232|P2|Allocation|Lack of Efficacy|2
1691504|NCT01296347|5905233|P1|Allocation|Lack of Efficacy|1
1691505|NCT01296347|5905232|P2|Allocation|Withdrawal by Subject|2
1691506|NCT01296347|5905233|P1|Allocation|Withdrawal by Subject|1
1691507|NCT01296152|5905258|P1|Overall Study|Unwilling to adhere to study requirement|1
1691508|NCT01296035|5905285|P1|Overall Study|Withdrawal by Subject|1
1691509|NCT01295905|5905292|P2|Overall Study|Met exclusion criteria|0
1691510|NCT01295905|5905293|P1|Overall Study|Met exclusion criteria|1
1691511|NCT01295905|5905292|P2|Overall Study|Did not meet inclusion criteria|0
1691512|NCT01295905|5905293|P1|Overall Study|Did not meet inclusion criteria|1
1691513|NCT01295827|5905337|P15|Overall Study|Other|0
1691514|NCT01295827|5905338|P14|Overall Study|Other|0
1691515|NCT01295827|5905339|P13|Overall Study|Other|0
1691516|NCT01295827|5905340|P12|Overall Study|Other|0
1691517|NCT01295827|5905341|P11|Overall Study|Other|2
1691518|NCT01295827|5905342|P10|Overall Study|Other|0
1691519|NCT01295827|5905343|P9|Overall Study|Other|1
1691520|NCT01295827|5905344|P8|Overall Study|Other|1
1691521|NCT01295827|5905345|P7|Overall Study|Other|1
1691522|NCT01295827|5905346|P6|Overall Study|Other|0
1691523|NCT01295827|5905347|P5|Overall Study|Other|0
1691524|NCT01295827|5905348|P4|Overall Study|Other|0
1691525|NCT01295827|5905349|P3|Overall Study|Other|0
1691526|NCT01295827|5905350|P2|Overall Study|Other|0
1691527|NCT01295827|5905351|P1|Overall Study|Other|0
1691528|NCT01295827|5905337|P15|Overall Study|Withdrawal by Subject|0
1691529|NCT01295827|5905338|P14|Overall Study|Withdrawal by Subject|0
1691530|NCT01295827|5905339|P13|Overall Study|Withdrawal by Subject|0
1691531|NCT01295827|5905340|P12|Overall Study|Withdrawal by Subject|13
1691532|NCT01295827|5905341|P11|Overall Study|Withdrawal by Subject|18
1691533|NCT01295827|5905342|P10|Overall Study|Withdrawal by Subject|2
1691534|NCT01295827|5905343|P9|Overall Study|Withdrawal by Subject|11
1691535|NCT01295827|5905344|P8|Overall Study|Withdrawal by Subject|35
1691536|NCT01295827|5905345|P7|Overall Study|Withdrawal by Subject|13
1691537|NCT01295827|5905346|P6|Overall Study|Withdrawal by Subject|1
1691538|NCT01295827|5905347|P5|Overall Study|Withdrawal by Subject|0
1691539|NCT01295827|5905348|P4|Overall Study|Withdrawal by Subject|0
1691540|NCT01295827|5905349|P3|Overall Study|Withdrawal by Subject|2
1691541|NCT01295827|5905350|P2|Overall Study|Withdrawal by Subject|0
1691542|NCT01295827|5905351|P1|Overall Study|Withdrawal by Subject|1
1691543|NCT01295827|5905337|P15|Overall Study|Screen Failure|0
1691544|NCT01295827|5905338|P14|Overall Study|Screen Failure|0
1691545|NCT01295827|5905339|P13|Overall Study|Screen Failure|0
1691546|NCT01295827|5905340|P12|Overall Study|Screen Failure|0
1691547|NCT01295827|5905341|P11|Overall Study|Screen Failure|1
1691548|NCT01295827|5905342|P10|Overall Study|Screen Failure|0
1691549|NCT01295827|5905343|P9|Overall Study|Screen Failure|2
1691550|NCT01295827|5905344|P8|Overall Study|Screen Failure|2
1691551|NCT01295827|5905345|P7|Overall Study|Screen Failure|2
1691552|NCT01295827|5905346|P6|Overall Study|Screen Failure|0
1691553|NCT01295827|5905347|P5|Overall Study|Screen Failure|0
1691554|NCT01295827|5905348|P4|Overall Study|Screen Failure|0
1691555|NCT01295827|5905349|P3|Overall Study|Screen Failure|0
1691556|NCT01295827|5905350|P2|Overall Study|Screen Failure|0
1691557|NCT01295827|5905351|P1|Overall Study|Screen Failure|0
1691558|NCT01295827|5905337|P15|Overall Study|Progressive Disease|0
1691559|NCT01295827|5905338|P14|Overall Study|Progressive Disease|0
1691560|NCT01295827|5905339|P13|Overall Study|Progressive Disease|0
1691561|NCT01295827|5905340|P12|Overall Study|Progressive Disease|136
1691562|NCT01295827|5905341|P11|Overall Study|Progressive Disease|175
1691563|NCT01295827|5905342|P10|Overall Study|Progressive Disease|40
1691564|NCT01295827|5905343|P9|Overall Study|Progressive Disease|85
1691565|NCT01295827|5905344|P8|Overall Study|Progressive Disease|144
1691566|NCT01295827|5905345|P7|Overall Study|Progressive Disease|87
1691567|NCT01295827|5905346|P6|Overall Study|Progressive Disease|1
1691568|NCT01295827|5905347|P5|Overall Study|Progressive Disease|0
1691569|NCT01295827|5905348|P4|Overall Study|Progressive Disease|2
1691570|NCT01295827|5905349|P3|Overall Study|Progressive Disease|5
1691571|NCT01295827|5905350|P2|Overall Study|Progressive Disease|1
1691572|NCT01295827|5905351|P1|Overall Study|Progressive Disease|2
1691573|NCT01295827|5905337|P15|Overall Study|Not Reported|0
1691574|NCT01295827|5905338|P14|Overall Study|Not Reported|0
1691575|NCT01295827|5905339|P13|Overall Study|Not Reported|0
1691576|NCT01295827|5905340|P12|Overall Study|Not Reported|13
1691577|NCT01295827|5905341|P11|Overall Study|Not Reported|23
1691578|NCT01295827|5905342|P10|Overall Study|Not Reported|2
1691579|NCT01295827|5905343|P9|Overall Study|Not Reported|41
1691580|NCT01295827|5905344|P8|Overall Study|Not Reported|58
1691581|NCT01295827|5905345|P7|Overall Study|Not Reported|24
1691582|NCT01295827|5905346|P6|Overall Study|Not Reported|0
1691583|NCT01295827|5905347|P5|Overall Study|Not Reported|0
1691584|NCT01295827|5905348|P4|Overall Study|Not Reported|1
1691585|NCT01295827|5905349|P3|Overall Study|Not Reported|0
1691586|NCT01295827|5905350|P2|Overall Study|Not Reported|0
1691587|NCT01295827|5905351|P1|Overall Study|Not Reported|0
1691588|NCT01295827|5905337|P15|Overall Study|Lost to Follow-up|0
1691589|NCT01295827|5905338|P14|Overall Study|Lost to Follow-up|0
1691590|NCT01295827|5905339|P13|Overall Study|Lost to Follow-up|0
1691591|NCT01295827|5905340|P12|Overall Study|Lost to Follow-up|3
1691592|NCT01295827|5905341|P11|Overall Study|Lost to Follow-up|7
1691593|NCT01295827|5905342|P10|Overall Study|Lost to Follow-up|4
1691594|NCT01295827|5905343|P9|Overall Study|Lost to Follow-up|7
1691595|NCT01295827|5905344|P8|Overall Study|Lost to Follow-up|8
1691596|NCT01295827|5905345|P7|Overall Study|Lost to Follow-up|4
1691597|NCT01295827|5905346|P6|Overall Study|Lost to Follow-up|0
1691598|NCT01295827|5905347|P5|Overall Study|Lost to Follow-up|1
1691599|NCT01295827|5905348|P4|Overall Study|Lost to Follow-up|0
1691600|NCT01295827|5905349|P3|Overall Study|Lost to Follow-up|3
1691601|NCT01295827|5905350|P2|Overall Study|Lost to Follow-up|0
1691602|NCT01295827|5905351|P1|Overall Study|Lost to Follow-up|0
1691603|NCT01295827|5905337|P15|Overall Study|Adverse Event|0
1691604|NCT01295827|5905338|P14|Overall Study|Adverse Event|0
1691605|NCT01295827|5905339|P13|Overall Study|Adverse Event|0
1691606|NCT01295827|5905340|P12|Overall Study|Adverse Event|21
1691607|NCT01295827|5905341|P11|Overall Study|Adverse Event|50
1691608|NCT01295827|5905342|P10|Overall Study|Adverse Event|7
1691609|NCT01295827|5905343|P9|Overall Study|Adverse Event|22
1691610|NCT01295827|5905344|P8|Overall Study|Adverse Event|49
1691611|NCT01295827|5905345|P7|Overall Study|Adverse Event|15
1691612|NCT01295827|5905346|P6|Overall Study|Adverse Event|4
1691613|NCT01295827|5905347|P5|Overall Study|Adverse Event|1
1691614|NCT01295827|5905348|P4|Overall Study|Adverse Event|1
1691615|NCT01295827|5905349|P3|Overall Study|Adverse Event|2
1691616|NCT01295827|5905350|P2|Overall Study|Adverse Event|2
1691617|NCT01295827|5905351|P1|Overall Study|Adverse Event|1
1691618|NCT01295814|5905724|P2|Overall Study|Withdrawal by Subject|0
1691619|NCT01295814|5905725|P1|Overall Study|Withdrawal by Subject|2
1691620|NCT01295814|5905724|P2|Overall Study|Lack of Efficacy|2
1691621|NCT01295814|5905725|P1|Overall Study|Lack of Efficacy|0
1691622|NCT01295671|5905805|P3|Overall Study|Withdrawal by Subject|0
1691623|NCT01295671|5905806|P2|Overall Study|Withdrawal by Subject|1
1691624|NCT01295671|5905807|P1|Overall Study|Withdrawal by Subject|3
1691625|NCT01295671|5905805|P3|Overall Study|Lost to Follow-up|3
1691626|NCT01295671|5905806|P2|Overall Study|Lost to Follow-up|6
1691627|NCT01295671|5905807|P1|Overall Study|Lost to Follow-up|4
1691628|NCT01295320|5905853|P1|Overall Study|Unable to travel|1
1691629|NCT01295320|5905853|P1|Overall Study|Subject was bedridden|1
1691630|NCT01295320|5905853|P1|Overall Study|Withdrawal by Subject|2
1691631|NCT01295320|5905853|P1|Overall Study|Lost to Follow-up|4
1691632|NCT01295320|5905853|P1|Overall Study|Adverse Event|2
1691633|NCT01295281|5905870|P2|First Intervention (7 Days)|Death|1
1691634|NCT01295281|5905871|P1|First Intervention (7 Days)|Death|0
1691635|NCT01295034|5905909|P2|Overall Study|Lost to Follow-up|5
1691636|NCT01295034|5905910|P1|Overall Study|Lost to Follow-up|5
1691637|NCT01294917|5905918|P1|Overall Study|Inconvenience|1
1691638|NCT01294917|5905918|P1|Overall Study|Relocation|5
1691639|NCT01294800|5905928|P4|Overall Study|Did Not Meet Protocol Eligibility|0
1691640|NCT01294800|5905929|P3|Overall Study|Did Not Meet Protocol Eligibility|1
1691641|NCT01294800|5905930|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1691642|NCT01294800|5905931|P1|Overall Study|Did Not Meet Protocol Eligibility|2
1691643|NCT01294800|5905928|P4|Overall Study|Non-compliance With Protocol|0
1691644|NCT01294800|5905929|P3|Overall Study|Non-compliance With Protocol|1
1691645|NCT01294800|5905930|P2|Overall Study|Non-compliance With Protocol|1
1691646|NCT01294800|5905931|P1|Overall Study|Non-compliance With Protocol|0
1691647|NCT01294800|5905928|P4|Overall Study|Lost to Follow-up|0
1691648|NCT01294800|5905929|P3|Overall Study|Lost to Follow-up|1
1691649|NCT01294800|5905930|P2|Overall Study|Lost to Follow-up|0
1691650|NCT01294800|5905931|P1|Overall Study|Lost to Follow-up|0
1691651|NCT01294800|5905928|P4|Overall Study|Subject Withdrew Consent|11
1691652|NCT01294800|5905929|P3|Overall Study|Subject Withdrew Consent|2
1691653|NCT01294800|5905930|P2|Overall Study|Subject Withdrew Consent|2
1691654|NCT01294800|5905931|P1|Overall Study|Subject Withdrew Consent|2
1691655|NCT01294800|5905928|P4|Overall Study|Adverse Event|5
1691656|NCT01294800|5905929|P3|Overall Study|Adverse Event|12
1691657|NCT01294800|5905930|P2|Overall Study|Adverse Event|6
1691658|NCT01294800|5905931|P1|Overall Study|Adverse Event|7
1691659|NCT01294787|5905957|P6|Period 3|Adverse Event|0
1691660|NCT01294787|5905958|P5|Period 3|Adverse Event|1
1691661|NCT01294787|5905959|P4|Period 3|Adverse Event|0
1691662|NCT01294787|5905960|P3|Period 3|Adverse Event|0
1691663|NCT01294787|5905961|P2|Period 3|Adverse Event|0
1691664|NCT01294787|5905962|P1|Period 3|Adverse Event|0
1691665|NCT01294787|5905957|P6|Period 2|No longer needs study drug|0
1691666|NCT01294787|5905958|P5|Period 2|No longer needs study drug|0
1691667|NCT01294787|5905959|P4|Period 2|No longer needs study drug|1
1691668|NCT01294787|5905960|P3|Period 2|No longer needs study drug|0
1691669|NCT01294787|5905961|P2|Period 2|No longer needs study drug|0
1691670|NCT01294787|5905962|P1|Period 2|No longer needs study drug|0
1691671|NCT01294787|5905957|P6|Period 2|Adverse Event|0
1691672|NCT01294787|5905958|P5|Period 2|Adverse Event|0
1691673|NCT01294787|5905959|P4|Period 2|Adverse Event|1
1691674|NCT01294787|5905960|P3|Period 2|Adverse Event|0
1691675|NCT01294787|5905961|P2|Period 2|Adverse Event|3
1691676|NCT01294787|5905962|P1|Period 2|Adverse Event|0
1691677|NCT01294787|5905957|P6|Period 1|Administrative problem|1
1691678|NCT01294787|5905958|P5|Period 1|Administrative problem|0
1691679|NCT01294787|5905959|P4|Period 1|Administrative problem|0
1691680|NCT01294787|5905960|P3|Period 1|Administrative problem|1
1691681|NCT01294787|5905961|P2|Period 1|Administrative problem|0
1691682|NCT01294787|5905962|P1|Period 1|Administrative problem|0
1691683|NCT01294787|5905957|P6|Period 1|Withdrawal by Subject|1
1691684|NCT01294787|5905958|P5|Period 1|Withdrawal by Subject|1
1691685|NCT01294787|5905959|P4|Period 1|Withdrawal by Subject|1
1691686|NCT01294787|5905960|P3|Period 1|Withdrawal by Subject|0
1691687|NCT01294787|5905961|P2|Period 1|Withdrawal by Subject|0
1691688|NCT01294787|5905962|P1|Period 1|Withdrawal by Subject|0
1691689|NCT01294787|5905957|P6|Period 1|Adverse Event|0
1691690|NCT01294787|5905958|P5|Period 1|Adverse Event|1
1691691|NCT01294787|5905959|P4|Period 1|Adverse Event|0
1691692|NCT01294787|5905960|P3|Period 1|Adverse Event|0
1691693|NCT01294787|5905961|P2|Period 1|Adverse Event|0
1691694|NCT01294787|5905962|P1|Period 1|Adverse Event|0
1691695|NCT01294696|5906053|P1|Overall Study|Site closure|52
1691696|NCT01294696|5906053|P1|Overall Study|Missing BPI Response|7
1691697|NCT01294696|5906053|P1|Overall Study|Protocol Violation|8
1691698|NCT01294696|5906053|P1|Overall Study|Screening failures|7
1691699|NCT01294683|5906067|P2|Post Crossover (Period III)|Withdrawal by Subject|2
1691700|NCT01294683|5906068|P1|Post Crossover (Period III)|Withdrawal by Subject|3
1691701|NCT01294683|5906067|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
1691702|NCT01294683|5906068|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
1691703|NCT01294683|5906067|P2|Post Crossover (Period III)|Lost to Follow-up|3
1691704|NCT01294683|5906068|P1|Post Crossover (Period III)|Lost to Follow-up|1
1691705|NCT01294683|5906067|P2|Post Crossover (Period III)|Adverse Event|6
1691706|NCT01294683|5906068|P1|Post Crossover (Period III)|Adverse Event|6
1691707|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
1691708|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
1691709|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Technical Problems|1
1691710|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Technical Problems|0
1691711|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
1691712|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
1691713|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Protocol Violation|5
1691714|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Protocol Violation|5
1691715|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Physician Decision|0
1691716|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Physician Decision|1
1691717|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
1691718|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
1691719|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
1691720|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
1691721|NCT01294683|5906067|P2|Precrossover (Periods I/II)|Adverse Event|52
1691722|NCT01294683|5906068|P1|Precrossover (Periods I/II)|Adverse Event|49
1691723|NCT01294644|5906121|P3|Overall Study|Miscellaneous Reason|4
1691724|NCT01294644|5906122|P2|Overall Study|Miscellaneous Reason|1
1691725|NCT01294644|5906123|P1|Overall Study|Miscellaneous Reason|2
1691726|NCT01294644|5906121|P3|Overall Study|Lost to Follow-up|5
1691727|NCT01294644|5906122|P2|Overall Study|Lost to Follow-up|2
1691728|NCT01294644|5906123|P1|Overall Study|Lost to Follow-up|3
1691729|NCT01294644|5906121|P3|Overall Study|Withdrawal by Subject|4
1691730|NCT01294644|5906122|P2|Overall Study|Withdrawal by Subject|7
1691731|NCT01294644|5906123|P1|Overall Study|Withdrawal by Subject|3
1691732|NCT01294644|5906121|P3|Overall Study|Adverse Event|1
1691733|NCT01294644|5906122|P2|Overall Study|Adverse Event|0
1691734|NCT01294644|5906123|P1|Overall Study|Adverse Event|2
1691735|NCT01294592|5906154|P2|Overall Study|Withdrawal by Subject|28
1691736|NCT01294592|5906155|P1|Overall Study|Withdrawal by Subject|28
1691737|NCT01294592|5906154|P2|Overall Study|Physician Decision|11
1691738|NCT01294592|5906155|P1|Overall Study|Physician Decision|6
1691739|NCT01294592|5906154|P2|Overall Study|Lost to Follow-up|9
1691740|NCT01294592|5906155|P1|Overall Study|Lost to Follow-up|7
1691741|NCT01294592|5906154|P2|Overall Study|Protocol Violation|7
1691742|NCT01294592|5906155|P1|Overall Study|Protocol Violation|1
1691743|NCT01294592|5906154|P2|Overall Study|Lack of Efficacy|5
1691744|NCT01294592|5906155|P1|Overall Study|Lack of Efficacy|7
1691745|NCT01294592|5906154|P2|Overall Study|Adverse Event|13
1691746|NCT01294592|5906155|P1|Overall Study|Adverse Event|28
1691747|NCT01294579|5906183|P1|Overall Study|Withdrawal by Subject|5
1691748|NCT01294579|5906183|P1|Overall Study|Physician Decision|3
1691749|NCT01294579|5906183|P1|Overall Study|Lost to Follow-up|1
1691750|NCT01294579|5906183|P1|Overall Study|Study closed/terminated|3
1691751|NCT01294579|5906183|P1|Overall Study|Adverse Event|11
1691752|NCT01294579|5906183|P1|Overall Study|Disease progression|12
1691753|NCT01294553|5906193|P1|Overall Study|Protocol Violation|268
1691754|NCT01294553|5906193|P1|Overall Study|Duplicated Participants|1
1691755|NCT01294514|5906199|P1|Overall Study|Excluded due to Arrhythmia|1
1691756|NCT01294462|5906209|P2|Overall Study|Withdrawal by Subject|63
1691757|NCT01294462|5906210|P1|Overall Study|Withdrawal by Subject|65
1691758|NCT01294462|5906209|P2|Overall Study|Lost to Follow-up|0
1691759|NCT01294462|5906210|P1|Overall Study|Lost to Follow-up|1
1691760|NCT01294449|5906224|P2|Overall Study|Withdrawal by Subject|3
1691761|NCT01294449|5906225|P1|Overall Study|Withdrawal by Subject|1
1691762|NCT01294449|5906224|P2|Overall Study|Death|12
1691763|NCT01294449|5906225|P1|Overall Study|Death|11
1691764|NCT01294436|5906233|P2|Overall Study|poor/non-compliance|5
1691765|NCT01294436|5906234|P1|Overall Study|poor/non-compliance|2
1691766|NCT01294436|5906233|P2|Overall Study|subject no longer meets study criteria|20
1691767|NCT01294436|5906234|P1|Overall Study|subject no longer meets study criteria|5
1691768|NCT01294436|5906233|P2|Overall Study|Withdrawal by Subject|28
1691769|NCT01294436|5906234|P1|Overall Study|Withdrawal by Subject|11
1691770|NCT01294436|5906233|P2|Overall Study|Adverse Event|17
1691771|NCT01294436|5906234|P1|Overall Study|Adverse Event|10
1691772|NCT01294423|5906269|P3|Overall Study|poor/non-compliance|1
1691773|NCT01294423|5906270|P2|Overall Study|poor/non-compliance|0
1691774|NCT01294423|5906271|P1|Overall Study|poor/non-compliance|1
1691775|NCT01294423|5906269|P3|Overall Study|subject no longer meets study criteria|2
1691776|NCT01294423|5906270|P2|Overall Study|subject no longer meets study criteria|5
1691777|NCT01294423|5906271|P1|Overall Study|subject no longer meets study criteria|2
1691778|NCT01294423|5906269|P3|Overall Study|Withdrawal by Subject|2
1691779|NCT01294423|5906270|P2|Overall Study|Withdrawal by Subject|2
1691780|NCT01294423|5906271|P1|Overall Study|Withdrawal by Subject|1
1691781|NCT01294423|5906269|P3|Overall Study|Adverse Event|3
1691782|NCT01294423|5906270|P2|Overall Study|Adverse Event|2
1691783|NCT01294423|5906271|P1|Overall Study|Adverse Event|1
1691784|NCT01294397|5906285|P1|Overall Study|Administrative Decision|1
1691785|NCT01294397|5906285|P1|Overall Study|Withdrawal by Subject|1
1691786|NCT01294371|5906329|P1|Overall Study|Other|14
1691787|NCT01294371|5906329|P1|Overall Study|Administrative Reason|1
1691788|NCT01294371|5906329|P1|Overall Study|Lost to Follow-up|6
1691789|NCT01294371|5906329|P1|Overall Study|Withdrawal by Subject|12
1691790|NCT01294371|5906329|P1|Overall Study|Adverse Event|1
1691791|NCT01294358|5906337|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
1691792|NCT01294358|5906338|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1691793|NCT01294358|5906339|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1691794|NCT01294358|5906340|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1691795|NCT01294358|5906341|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
1691796|NCT01294358|5906337|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1691797|NCT01294358|5906338|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
1691798|NCT01294358|5906339|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1691799|NCT01294358|5906340|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1691800|NCT01294358|5906341|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
1691801|NCT01294358|5906337|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1691802|NCT01294358|5906338|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1691803|NCT01294358|5906339|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
1691804|NCT01294358|5906340|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1691805|NCT01294358|5906341|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
1691806|NCT01294358|5906337|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1691807|NCT01294358|5906338|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1691808|NCT01294358|5906339|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1691809|NCT01294358|5906340|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
1691810|NCT01294358|5906341|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
1691811|NCT01294150|5906469|P2|Overall Study|Physician Decision|2
1691812|NCT01294150|5906470|P1|Overall Study|Physician Decision|2
1691813|NCT01294046|5906499|P1|Overall Study|Stimulation response inadqequate|1
1691814|NCT01294046|5906499|P1|Overall Study|Eligibility criteria expanded|1
1691815|NCT01294046|5906499|P1|Overall Study|Infection and surgical explant|1
1691816|NCT01293968|5906514|P2|Overall Study|non-cooperation|3
1691817|NCT01293968|5906515|P1|Overall Study|non-cooperation|3
1691818|NCT01293695|5906535|P2|Overall Study|Lost to Follow-up|6
1691819|NCT01293695|5906536|P1|Overall Study|Lost to Follow-up|8
1691820|NCT01293695|5906535|P2|Overall Study|Withdrawal by Subject|1
1691821|NCT01293695|5906536|P1|Overall Study|Withdrawal by Subject|7
1691822|NCT01293539|5906555|P1|Overall Study|Physician Decision|1
1691823|NCT01293240|5906559|P1|Overall Study|Noncompliance|2
1691824|NCT01293123|5906576|P2|Overall Study|Lost to Follow-up|1
1691825|NCT01293123|5906577|P1|Overall Study|Lost to Follow-up|0
1691826|NCT01293084|5906591|P1|Overall Study|Withdrawal by Subject|2
1691827|NCT01293084|5906591|P1|Overall Study|Physician Decision|3
1691828|NCT01293032|5906603|P4|Treatment|Disease Progression, relapse|0
1691829|NCT01293032|5906604|P3|Treatment|Disease Progression, relapse|0
1691830|NCT01293032|5906605|P2|Treatment|Disease Progression, relapse|1
1691831|NCT01293032|5906606|P1|Treatment|Disease Progression, relapse|0
1691832|NCT01293032|5906603|P4|Treatment|Withdrawal by Subject|0
1691833|NCT01293032|5906604|P3|Treatment|Withdrawal by Subject|0
1691834|NCT01293032|5906605|P2|Treatment|Withdrawal by Subject|4
1691835|NCT01293032|5906606|P1|Treatment|Withdrawal by Subject|2
1691836|NCT01293032|5906603|P4|Treatment|Adverse Event|1
1691837|NCT01293032|5906604|P3|Treatment|Adverse Event|1
1691838|NCT01293032|5906605|P2|Treatment|Adverse Event|0
1691839|NCT01293032|5906606|P1|Treatment|Adverse Event|0
1691840|NCT01293032|5906603|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1691841|NCT01293032|5906604|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
1691842|NCT01293032|5906605|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1691843|NCT01293032|5906606|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
1691844|NCT01293006|5906617|P4|Period 2|Lost to Follow-up|0
1691845|NCT01293006|5906618|P3|Period 2|Lost to Follow-up|0
1691846|NCT01293006|5906619|P2|Period 2|Lost to Follow-up|0
1691847|NCT01293006|5906620|P1|Period 2|Lost to Follow-up|1
1691848|NCT01292928|5906641|P1|Overall Study|Physician Decision|2
1691849|NCT01292928|5906641|P1|Overall Study|Lost to Follow-up|6
1691850|NCT01292928|5906641|P1|Overall Study|Withdrawal by Subject|8
1691851|NCT01292928|5906641|P1|Overall Study|Death|8
1691852|NCT01292876|5906658|P1|Overall Study|Physician Decision|4
1691853|NCT01292837|5906664|P1|Overall Study|Further treatment determined|1
1691854|NCT01292837|5906664|P1|Overall Study|Adverse Event|1
1691855|NCT01292603|5906701|P6|Overall Survival Status|Death|10
1691856|NCT01292603|5906702|P5|Overall Survival Status|Death|16
1691857|NCT01292603|5906703|P4|Overall Survival Status|Death|1
1691858|NCT01292603|5906704|P3|Overall Survival Status|Death|3
1691859|NCT01292603|5906705|P2|Overall Survival Status|Death|1
1691860|NCT01292603|5906706|P1|Overall Survival Status|Death|3
1691861|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Adverse Event|2
1691862|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Adverse Event|2
1691863|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Adverse Event|0
1691864|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Adverse Event|0
1691865|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Adverse Event|0
1691866|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Adverse Event|0
1691867|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
1691868|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
1691869|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
1691870|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
1691871|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
1691872|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
1691873|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Physician Decision|0
1691874|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Physician Decision|2
1691875|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Physician Decision|0
1691876|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Physician Decision|0
1691877|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Physician Decision|0
1691878|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Physician Decision|0
1691879|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Protocol Violation|0
1691880|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Protocol Violation|2
1691881|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Protocol Violation|0
1691882|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Protocol Violation|0
1691883|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Protocol Violation|0
1691884|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Protocol Violation|0
1691885|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
1691886|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1691887|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1691888|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1691889|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1691890|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
1691891|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Noncompliance|0
1691892|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Noncompliance|1
1691893|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Noncompliance|0
1691894|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Noncompliance|0
1691895|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Noncompliance|0
1691896|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Noncompliance|0
1691897|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Disease Progression|5
1691898|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Disease Progression|5
1691899|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Disease Progression|0
1691900|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Disease Progression|0
1691901|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Disease Progression|0
1691902|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Disease Progression|0
1691903|NCT01292603|5906701|P6|Part 2: Regular Follow-Up|Death|3
1691904|NCT01292603|5906702|P5|Part 2: Regular Follow-Up|Death|6
1691905|NCT01292603|5906703|P4|Part 2: Regular Follow-Up|Death|0
1691906|NCT01292603|5906704|P3|Part 2: Regular Follow-Up|Death|0
1691907|NCT01292603|5906705|P2|Part 2: Regular Follow-Up|Death|0
1691908|NCT01292603|5906706|P1|Part 2: Regular Follow-Up|Death|0
1691909|NCT01292603|5906701|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
1691910|NCT01292603|5906702|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1691986|NCT01292473|5906774|P3|Overall Study|Disease Progression|3
1691911|NCT01292603|5906703|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1691912|NCT01292603|5906704|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1691913|NCT01292603|5906705|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1691914|NCT01292603|5906706|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
1691915|NCT01292603|5906701|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
1691916|NCT01292603|5906702|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
1691917|NCT01292603|5906703|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
1691918|NCT01292603|5906704|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
1691919|NCT01292603|5906705|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
1691920|NCT01292603|5906706|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
1691921|NCT01292603|5906701|P6|Part 2: Dose Confirmation Period|Adverse Event|9
1691922|NCT01292603|5906702|P5|Part 2: Dose Confirmation Period|Adverse Event|7
1691923|NCT01292603|5906703|P4|Part 2: Dose Confirmation Period|Adverse Event|0
1691924|NCT01292603|5906704|P3|Part 2: Dose Confirmation Period|Adverse Event|0
1691925|NCT01292603|5906705|P2|Part 2: Dose Confirmation Period|Adverse Event|0
1691926|NCT01292603|5906706|P1|Part 2: Dose Confirmation Period|Adverse Event|0
1691927|NCT01292603|5906701|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
1691928|NCT01292603|5906702|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
1691929|NCT01292603|5906703|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1691930|NCT01292603|5906704|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1691931|NCT01292603|5906705|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1691932|NCT01292603|5906706|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
1691933|NCT01292603|5906701|P6|Part 2: Dose Confirmation Period|Physician Decision|0
1691934|NCT01292603|5906702|P5|Part 2: Dose Confirmation Period|Physician Decision|2
1691935|NCT01292603|5906703|P4|Part 2: Dose Confirmation Period|Physician Decision|0
1691936|NCT01292603|5906704|P3|Part 2: Dose Confirmation Period|Physician Decision|0
1691937|NCT01292603|5906705|P2|Part 2: Dose Confirmation Period|Physician Decision|0
1691938|NCT01292603|5906706|P1|Part 2: Dose Confirmation Period|Physician Decision|0
1691939|NCT01292603|5906701|P6|Part 2: Dose Confirmation Period|Death|0
1691940|NCT01292603|5906702|P5|Part 2: Dose Confirmation Period|Death|1
1691941|NCT01292603|5906703|P4|Part 2: Dose Confirmation Period|Death|0
1691942|NCT01292603|5906704|P3|Part 2: Dose Confirmation Period|Death|0
1691943|NCT01292603|5906705|P2|Part 2: Dose Confirmation Period|Death|0
1691944|NCT01292603|5906706|P1|Part 2: Dose Confirmation Period|Death|0
1691945|NCT01292603|5906701|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
1691946|NCT01292603|5906702|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
1691947|NCT01292603|5906703|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
1691948|NCT01292603|5906704|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
1691949|NCT01292603|5906705|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
1691950|NCT01292603|5906706|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
1691951|NCT01292603|5906701|P6|Part 1: Regular Follow-Up Period|Death|0
1691952|NCT01292603|5906702|P5|Part 1: Regular Follow-Up Period|Death|0
1691953|NCT01292603|5906703|P4|Part 1: Regular Follow-Up Period|Death|1
1691954|NCT01292603|5906704|P3|Part 1: Regular Follow-Up Period|Death|3
1691955|NCT01292603|5906705|P2|Part 1: Regular Follow-Up Period|Death|1
1691956|NCT01292603|5906706|P1|Part 1: Regular Follow-Up Period|Death|3
1691957|NCT01292603|5906701|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1691958|NCT01292603|5906702|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1691959|NCT01292603|5906703|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
1691960|NCT01292603|5906704|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1691961|NCT01292603|5906705|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1691962|NCT01292603|5906706|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
1691963|NCT01292603|5906701|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1691964|NCT01292603|5906702|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1691965|NCT01292603|5906703|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
1691966|NCT01292603|5906704|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1691967|NCT01292603|5906705|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1691968|NCT01292603|5906706|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
1691969|NCT01292603|5906701|P6|Part 1: Pilot Dose Selection Period|Death|0
1691970|NCT01292603|5906702|P5|Part 1: Pilot Dose Selection Period|Death|0
1691971|NCT01292603|5906703|P4|Part 1: Pilot Dose Selection Period|Death|1
1691972|NCT01292603|5906704|P3|Part 1: Pilot Dose Selection Period|Death|0
1691973|NCT01292603|5906705|P2|Part 1: Pilot Dose Selection Period|Death|0
1691974|NCT01292603|5906706|P1|Part 1: Pilot Dose Selection Period|Death|0
1691975|NCT01292603|5906701|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
1691976|NCT01292603|5906702|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
1691977|NCT01292603|5906703|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
1691978|NCT01292603|5906704|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
1691979|NCT01292603|5906705|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
1691980|NCT01292603|5906706|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
1691981|NCT01292486|5906759|P1|Overall Study|Physician Decision|1
1691982|NCT01292486|5906759|P1|Overall Study|Adverse Event|1
1691983|NCT01292486|5906759|P1|Overall Study|Did not meet screening criteria|2
1691984|NCT01292486|5906759|P1|Overall Study|Protocol Violation|2
1691985|NCT01292473|5906773|P4|Overall Study|Disease Progression|6
1691987|NCT01292473|5906775|P2|Overall Study|Disease Progression|1
1691988|NCT01292473|5906776|P1|Overall Study|Disease Progression|0
1691989|NCT01292473|5906773|P4|Overall Study|Physician Decision|0
1691990|NCT01292473|5906774|P3|Overall Study|Physician Decision|0
1691991|NCT01292473|5906775|P2|Overall Study|Physician Decision|1
1691992|NCT01292473|5906776|P1|Overall Study|Physician Decision|0
1691993|NCT01292473|5906773|P4|Overall Study|Withdrawal by Subject|3
1691994|NCT01292473|5906774|P3|Overall Study|Withdrawal by Subject|3
1691995|NCT01292473|5906775|P2|Overall Study|Withdrawal by Subject|4
1691996|NCT01292473|5906776|P1|Overall Study|Withdrawal by Subject|3
1691997|NCT01292473|5906773|P4|Overall Study|Lost to Follow-up|2
1691998|NCT01292473|5906774|P3|Overall Study|Lost to Follow-up|2
1691999|NCT01292473|5906775|P2|Overall Study|Lost to Follow-up|1
1692000|NCT01292473|5906776|P1|Overall Study|Lost to Follow-up|1
1692001|NCT01292473|5906773|P4|Overall Study|Adverse Event|1
1692002|NCT01292473|5906774|P3|Overall Study|Adverse Event|1
1692003|NCT01292473|5906775|P2|Overall Study|Adverse Event|0
1692004|NCT01292473|5906776|P1|Overall Study|Adverse Event|1
1692005|NCT01292239|5906835|P2|Overall Study|Withdrawal by Subject|6
1692006|NCT01292239|5906836|P1|Overall Study|Withdrawal by Subject|3
1692007|NCT01292239|5906835|P2|Overall Study|Other|1
1692008|NCT01292239|5906836|P1|Overall Study|Other|1
1692009|NCT01292226|5906857|P1|Overall Study|Other|2
1692010|NCT01292226|5906857|P1|Overall Study|Withdrawal by Subject|1
1692011|NCT01292226|5906857|P1|Overall Study|Protocol Violation|3
1692012|NCT01292226|5906857|P1|Overall Study|Graft loss|1
1692013|NCT01292226|5906857|P1|Overall Study|Death|1
1692014|NCT01292226|5906857|P1|Overall Study|Adverse Event|5
1692015|NCT01292187|5906890|P2|Overall Study|All other reasons|3
1692016|NCT01292187|5906891|P1|Overall Study|All other reasons|1
1692017|NCT01292187|5906890|P2|Overall Study|Withdrawal by Subject|5
1692018|NCT01292187|5906891|P1|Overall Study|Withdrawal by Subject|6
1692019|NCT01292187|5906890|P2|Overall Study|Adverse Event|5
1692020|NCT01292187|5906891|P1|Overall Study|Adverse Event|10
1692021|NCT01292057|5906926|P2|Overall Study|Lost to Follow-up|1
1692022|NCT01292057|5906927|P1|Overall Study|Lost to Follow-up|1
1692023|NCT01292057|5906926|P2|Overall Study|Protocol Violation|1
1692024|NCT01292057|5906927|P1|Overall Study|Protocol Violation|1
1692025|NCT01291277|5906999|P2|Overall Study|Lost to Follow-up|1
1692026|NCT01291277|5907000|P1|Overall Study|Lost to Follow-up|3
1692027|NCT01291277|5906999|P2|Overall Study|Death|2
1692028|NCT01291277|5907000|P1|Overall Study|Death|2
1692029|NCT01291225|5907012|P2|Overall Study|Lost to Follow-up|39
1692030|NCT01291225|5907013|P1|Overall Study|Lost to Follow-up|85
1692031|NCT01291173|5907027|P4|Overall Study|Excluded therapy|0
1692032|NCT01291173|5907028|P3|Overall Study|Excluded therapy|1
1692033|NCT01291173|5907029|P2|Overall Study|Excluded therapy|0
1692034|NCT01291173|5907030|P1|Overall Study|Excluded therapy|0
1692035|NCT01291173|5907027|P4|Overall Study|Subject was unblinded|0
1692036|NCT01291173|5907028|P3|Overall Study|Subject was unblinded|1
1692037|NCT01291173|5907029|P2|Overall Study|Subject was unblinded|0
1692038|NCT01291173|5907030|P1|Overall Study|Subject was unblinded|0
1692039|NCT01291173|5907027|P4|Overall Study|Lack of compliance|1
1692040|NCT01291173|5907028|P3|Overall Study|Lack of compliance|0
1692041|NCT01291173|5907029|P2|Overall Study|Lack of compliance|0
1692042|NCT01291173|5907030|P1|Overall Study|Lack of compliance|0
1692043|NCT01291173|5907027|P4|Overall Study|Unable to meet visit schedule|0
1692044|NCT01291173|5907028|P3|Overall Study|Unable to meet visit schedule|1
1692045|NCT01291173|5907029|P2|Overall Study|Unable to meet visit schedule|0
1692046|NCT01291173|5907030|P1|Overall Study|Unable to meet visit schedule|0
1692047|NCT01291173|5907027|P4|Overall Study|Lost to Follow-up|2
1692048|NCT01291173|5907028|P3|Overall Study|Lost to Follow-up|3
1692049|NCT01291173|5907029|P2|Overall Study|Lost to Follow-up|6
1692050|NCT01291173|5907030|P1|Overall Study|Lost to Follow-up|4
1692051|NCT01291173|5907027|P4|Overall Study|Withdrawal by Subject|2
1692052|NCT01291173|5907028|P3|Overall Study|Withdrawal by Subject|4
1692053|NCT01291173|5907029|P2|Overall Study|Withdrawal by Subject|4
1692054|NCT01291173|5907030|P1|Overall Study|Withdrawal by Subject|6
1692055|NCT01291173|5907027|P4|Overall Study|Protocol Violation|5
1692056|NCT01291173|5907028|P3|Overall Study|Protocol Violation|2
1692057|NCT01291173|5907029|P2|Overall Study|Protocol Violation|2
1692058|NCT01291173|5907030|P1|Overall Study|Protocol Violation|7
1692059|NCT01291173|5907027|P4|Overall Study|Adverse Event|3
1692060|NCT01291173|5907028|P3|Overall Study|Adverse Event|1
1692061|NCT01291173|5907029|P2|Overall Study|Adverse Event|3
1692062|NCT01291173|5907030|P1|Overall Study|Adverse Event|0
1692063|NCT01291017|5907139|P1|Overall Study|Withdrawal by Subject|3
1692064|NCT01291017|5907139|P1|Overall Study|Lost to Follow-up|2
1692065|NCT01290887|5907172|P2|Overall Study|Other|6
1692066|NCT01290887|5907173|P1|Overall Study|Other|3
1692067|NCT01290887|5907172|P2|Overall Study|Sponsor closure of study|476
1692068|NCT01290887|5907173|P1|Overall Study|Sponsor closure of study|420
1692069|NCT01290887|5907172|P2|Overall Study|Non-compliance to study medications|0
1692070|NCT01290887|5907173|P1|Overall Study|Non-compliance to study medications|1
1692071|NCT01290887|5907172|P2|Overall Study|Non-compliance to study procedures|1
1692072|NCT01290887|5907173|P1|Overall Study|Non-compliance to study procedures|0
1692073|NCT01290887|5907172|P2|Overall Study|Lost to Follow-up|4
1692074|NCT01290887|5907173|P1|Overall Study|Lost to Follow-up|4
1692075|NCT01290887|5907172|P2|Overall Study|Protocol Violation|1
1692076|NCT01290887|5907173|P1|Overall Study|Protocol Violation|2
1692077|NCT01290887|5907172|P2|Overall Study|Withdrawal by Subject|32
1692078|NCT01290887|5907173|P1|Overall Study|Withdrawal by Subject|26
1692079|NCT01290887|5907172|P2|Overall Study|Lack of Efficacy|5
1692080|NCT01290887|5907173|P1|Overall Study|Lack of Efficacy|4
1692081|NCT01290887|5907172|P2|Overall Study|Adverse Event|11
1692082|NCT01290887|5907173|P1|Overall Study|Adverse Event|6
1692083|NCT01290822|5907234|P1|Overall Study|Physician Decision|10
1692084|NCT01290822|5907234|P1|Overall Study|Withdrawal by Subject|1
1692085|NCT01290796|5907243|P1|Overall Study|Withdrawal by Sponsor|1
1692086|NCT01290796|5907243|P1|Overall Study|Secondary Surgical Intervention|2
1692087|NCT01290796|5907243|P1|Overall Study|Physician Decision|2
1692088|NCT01290796|5907243|P1|Overall Study|Withdrawal by Subject|4
1692089|NCT01290796|5907243|P1|Overall Study|Lost to Follow-up|21
1692090|NCT01290757|5907259|P2|Overall Study|Other|1
1692091|NCT01290757|5907260|P1|Overall Study|Other|0
1692092|NCT01290757|5907259|P2|Overall Study|Protocol Violation|1
1692093|NCT01290757|5907260|P1|Overall Study|Protocol Violation|1
1692094|NCT01290757|5907259|P2|Overall Study|Adverse Event|0
1692095|NCT01290757|5907260|P1|Overall Study|Adverse Event|1
1692096|NCT01290731|5907276|P1|Overall Study|Withdrawal by Subject|1
1692097|NCT01290718|5907288|P1|Overall Study|Early termination of the study|4
1692098|NCT01290679|5907297|P2|Overall Study|Subject Entered Another Trial|5
1692099|NCT01290679|5907298|P1|Overall Study|Subject Entered Another Trial|0
1692100|NCT01290679|5907297|P2|Overall Study|Withdrawal by Subject|5
1692101|NCT01290679|5907298|P1|Overall Study|Withdrawal by Subject|6
1692102|NCT01290679|5907297|P2|Overall Study|Protocol Violation|1
1692103|NCT01290679|5907298|P1|Overall Study|Protocol Violation|0
1692104|NCT01290679|5907297|P2|Overall Study|Lost to Follow-up|10
1692105|NCT01290679|5907298|P1|Overall Study|Lost to Follow-up|8
1692106|NCT01290679|5907297|P2|Overall Study|Adverse Event|0
1692107|NCT01290679|5907298|P1|Overall Study|Adverse Event|2
1692108|NCT01290666|5907367|P1|Overall Study|Early Termination of Study|4
1692109|NCT01290666|5907367|P1|Overall Study|Withdrawal by Subject|23
1692110|NCT01290666|5907367|P1|Overall Study|Lost to Follow-up|11
1692111|NCT01290601|5907420|P4|Overall Study|Protocol Violation|0
1692112|NCT01290601|5907421|P3|Overall Study|Protocol Violation|0
1692113|NCT01290601|5907422|P2|Overall Study|Protocol Violation|0
1692114|NCT01290601|5907423|P1|Overall Study|Protocol Violation|1
1692115|NCT01290601|5907420|P4|Overall Study|Other|0
1692116|NCT01290601|5907421|P3|Overall Study|Other|0
1692117|NCT01290601|5907422|P2|Overall Study|Other|0
1692118|NCT01290601|5907423|P1|Overall Study|Other|1
1692119|NCT01290601|5907420|P4|Overall Study|Lost to Follow-up|0
1692120|NCT01290601|5907421|P3|Overall Study|Lost to Follow-up|0
1692121|NCT01290601|5907422|P2|Overall Study|Lost to Follow-up|2
1692122|NCT01290601|5907423|P1|Overall Study|Lost to Follow-up|7
1692123|NCT01290601|5907420|P4|Overall Study|Lack of Efficacy|0
1692124|NCT01290601|5907421|P3|Overall Study|Lack of Efficacy|0
1692125|NCT01290601|5907422|P2|Overall Study|Lack of Efficacy|1
1692126|NCT01290601|5907423|P1|Overall Study|Lack of Efficacy|2
1692127|NCT01290601|5907420|P4|Overall Study|Adverse Event|0
1692128|NCT01290601|5907421|P3|Overall Study|Adverse Event|0
1692129|NCT01290601|5907422|P2|Overall Study|Adverse Event|2
1692130|NCT01290601|5907423|P1|Overall Study|Adverse Event|0
1692131|NCT01290523|5907444|P1|Overall Study|Death|3
1692132|NCT01290341|5907483|P2|Overall Study|Negative baseline culture and others|11
1692133|NCT01290341|5907484|P1|Overall Study|Negative baseline culture and others|44
1692134|NCT01290341|5907483|P2|Overall Study|Withdrawal by Subject|5
1692135|NCT01290341|5907484|P1|Overall Study|Withdrawal by Subject|19
1692136|NCT01290341|5907483|P2|Overall Study|Lost to Follow-up|10
1692137|NCT01290341|5907484|P1|Overall Study|Lost to Follow-up|21
1692138|NCT01290341|5907483|P2|Overall Study|Adverse Event|0
1692139|NCT01290341|5907484|P1|Overall Study|Adverse Event|1
1692140|NCT01290341|5907483|P2|Overall Study|Protocol Violation|3
1692141|NCT01290341|5907484|P1|Overall Study|Protocol Violation|7
1692142|NCT01290315|5907496|P4|Overall Study|Withdrawal by Subject|0
1692143|NCT01290315|5907497|P3|Overall Study|Withdrawal by Subject|0
1692144|NCT01290315|5907498|P2|Overall Study|Withdrawal by Subject|1
1692145|NCT01290315|5907499|P1|Overall Study|Withdrawal by Subject|1
1692146|NCT01290315|5907496|P4|Overall Study|Lost to Follow-up|0
1692147|NCT01290315|5907497|P3|Overall Study|Lost to Follow-up|0
1692148|NCT01290315|5907498|P2|Overall Study|Lost to Follow-up|1
1692149|NCT01290315|5907499|P1|Overall Study|Lost to Follow-up|0
1692150|NCT01290315|5907496|P4|Overall Study|Selection criteria/compliance|2
1692151|NCT01290315|5907497|P3|Overall Study|Selection criteria/compliance|0
1692152|NCT01290315|5907498|P2|Overall Study|Selection criteria/compliance|1
1692153|NCT01290315|5907499|P1|Overall Study|Selection criteria/compliance|2
1692154|NCT01290315|5907496|P4|Overall Study|Adverse Event|3
1692155|NCT01290315|5907497|P3|Overall Study|Adverse Event|0
1692156|NCT01290315|5907498|P2|Overall Study|Adverse Event|0
1692157|NCT01290315|5907499|P1|Overall Study|Adverse Event|0
1692158|NCT01290263|5907521|P5|Overall Study|Participant Non-Compliance|1
1692159|NCT01290263|5907522|P4|Overall Study|Participant Non-Compliance|1
1692160|NCT01290263|5907523|P3|Overall Study|Participant Non-Compliance|0
1692161|NCT01290263|5907524|P2|Overall Study|Participant Non-Compliance|0
1692162|NCT01290263|5907525|P1|Overall Study|Participant Non-Compliance|0
1692163|NCT01290263|5907521|P5|Overall Study|Withdrawal by Subject|2
1692164|NCT01290263|5907522|P4|Overall Study|Withdrawal by Subject|1
1692165|NCT01290263|5907523|P3|Overall Study|Withdrawal by Subject|0
1692166|NCT01290263|5907524|P2|Overall Study|Withdrawal by Subject|1
1692167|NCT01290263|5907525|P1|Overall Study|Withdrawal by Subject|3
1692168|NCT01290263|5907521|P5|Overall Study|Lack of Efficacy|33
1692169|NCT01290263|5907522|P4|Overall Study|Lack of Efficacy|24
1692170|NCT01290263|5907523|P3|Overall Study|Lack of Efficacy|7
1692171|NCT01290263|5907524|P2|Overall Study|Lack of Efficacy|2
1692172|NCT01290263|5907525|P1|Overall Study|Lack of Efficacy|8
1692173|NCT01290263|5907521|P5|Overall Study|Adverse Event|1
1692174|NCT01290263|5907522|P4|Overall Study|Adverse Event|1
1692175|NCT01290263|5907523|P3|Overall Study|Adverse Event|0
1692176|NCT01290263|5907524|P2|Overall Study|Adverse Event|0
1692177|NCT01290263|5907525|P1|Overall Study|Adverse Event|0
1692178|NCT01290224|5907552|P1|Overall Study|Refused Further Treatment|4
1692179|NCT01290224|5907552|P1|Overall Study|Adverse Event|1
1692180|NCT01290094|5907563|P1|Overall Study|Lost to Follow-up|5
1692181|NCT01290094|5907563|P1|Overall Study|Withdrawal by Subject|1
1692182|NCT01290068|5907576|P2|Overall Study|Other|1
1692183|NCT01290068|5907577|P1|Overall Study|Other|3
1692184|NCT01290068|5907576|P2|Overall Study|Withdrawal by subject prior to implant|2
1692185|NCT01290068|5907577|P1|Overall Study|Withdrawal by subject prior to implant|0
1692186|NCT01290068|5907576|P2|Overall Study|Lost to Follow-up|0
1692187|NCT01290068|5907577|P1|Overall Study|Lost to Follow-up|3
1692188|NCT01290068|5907576|P2|Overall Study|Adverse Event|3
1692189|NCT01290068|5907577|P1|Overall Study|Adverse Event|1
1692190|NCT01290029|5907589|P1|Overall Study|Other|2
1692191|NCT01289990|5907615|P13|Overall Study|Not treated|0
1692192|NCT01289990|5907616|P12|Overall Study|Not treated|2
1692193|NCT01289990|5907617|P11|Overall Study|Not treated|1
1692194|NCT01289990|5907618|P10|Overall Study|Not treated|0
1692195|NCT01289990|5907619|P9|Overall Study|Not treated|1
1692196|NCT01289990|5907620|P8|Overall Study|Not treated|0
1692197|NCT01289990|5907621|P7|Overall Study|Not treated|1
1692198|NCT01289990|5907622|P6|Overall Study|Not treated|0
1692199|NCT01289990|5907623|P5|Overall Study|Not treated|0
1692200|NCT01289990|5907624|P4|Overall Study|Not treated|0
1692201|NCT01289990|5907625|P3|Overall Study|Not treated|0
1692202|NCT01289990|5907626|P2|Overall Study|Not treated|0
1692203|NCT01289990|5907627|P1|Overall Study|Not treated|0
1692204|NCT01289990|5907615|P13|Overall Study|did not continue in extension|56
1692205|NCT01289990|5907616|P12|Overall Study|did not continue in extension|34
1692206|NCT01289990|5907617|P11|Overall Study|did not continue in extension|45
1692207|NCT01289990|5907618|P10|Overall Study|did not continue in extension|48
1692208|NCT01289990|5907619|P9|Overall Study|did not continue in extension|44
1692209|NCT01289990|5907620|P8|Overall Study|did not continue in extension|36
1692210|NCT01289990|5907621|P7|Overall Study|did not continue in extension|54
1692211|NCT01289990|5907622|P6|Overall Study|did not continue in extension|50
1692212|NCT01289990|5907623|P5|Overall Study|did not continue in extension|48
1692213|NCT01289990|5907624|P4|Overall Study|did not continue in extension|51
1692214|NCT01289990|5907625|P3|Overall Study|did not continue in extension|51
1692215|NCT01289990|5907626|P2|Overall Study|did not continue in extension|45
1692216|NCT01289990|5907627|P1|Overall Study|did not continue in extension|41
1692217|NCT01289990|5907615|P13|Overall Study|discontinued in preceding trial|24
1692218|NCT01289990|5907616|P12|Overall Study|discontinued in preceding trial|17
1692219|NCT01289990|5907617|P11|Overall Study|discontinued in preceding trial|17
1692220|NCT01289990|5907618|P10|Overall Study|discontinued in preceding trial|21
1692221|NCT01289990|5907619|P9|Overall Study|discontinued in preceding trial|17
1692222|NCT01289990|5907620|P8|Overall Study|discontinued in preceding trial|8
1692223|NCT01289990|5907621|P7|Overall Study|discontinued in preceding trial|18
1692224|NCT01289990|5907622|P6|Overall Study|discontinued in preceding trial|12
1692225|NCT01289990|5907623|P5|Overall Study|discontinued in preceding trial|11
1692226|NCT01289990|5907624|P4|Overall Study|discontinued in preceding trial|17
1692227|NCT01289990|5907625|P3|Overall Study|discontinued in preceding trial|41
1692228|NCT01289990|5907626|P2|Overall Study|discontinued in preceding trial|20
1692229|NCT01289990|5907627|P1|Overall Study|discontinued in preceding trial|18
1692230|NCT01289990|5907615|P13|Overall Study|Withdrawal by Subject|16
1692231|NCT01289990|5907616|P12|Overall Study|Withdrawal by Subject|13
1692232|NCT01289990|5907617|P11|Overall Study|Withdrawal by Subject|11
1692233|NCT01289990|5907618|P10|Overall Study|Withdrawal by Subject|13
1692234|NCT01289990|5907619|P9|Overall Study|Withdrawal by Subject|12
1692235|NCT01289990|5907620|P8|Overall Study|Withdrawal by Subject|9
1692236|NCT01289990|5907621|P7|Overall Study|Withdrawal by Subject|13
1692237|NCT01289990|5907622|P6|Overall Study|Withdrawal by Subject|7
1692238|NCT01289990|5907623|P5|Overall Study|Withdrawal by Subject|8
1692239|NCT01289990|5907624|P4|Overall Study|Withdrawal by Subject|13
1692240|NCT01289990|5907625|P3|Overall Study|Withdrawal by Subject|12
1692241|NCT01289990|5907626|P2|Overall Study|Withdrawal by Subject|14
1692242|NCT01289990|5907627|P1|Overall Study|Withdrawal by Subject|15
1692243|NCT01289990|5907615|P13|Overall Study|Lost to Follow-up|2
1692244|NCT01289990|5907616|P12|Overall Study|Lost to Follow-up|1
1692245|NCT01289990|5907617|P11|Overall Study|Lost to Follow-up|2
1692246|NCT01289990|5907618|P10|Overall Study|Lost to Follow-up|4
1692247|NCT01289990|5907619|P9|Overall Study|Lost to Follow-up|1
1692248|NCT01289990|5907620|P8|Overall Study|Lost to Follow-up|2
1692249|NCT01289990|5907621|P7|Overall Study|Lost to Follow-up|2
1692250|NCT01289990|5907622|P6|Overall Study|Lost to Follow-up|4
1692251|NCT01289990|5907623|P5|Overall Study|Lost to Follow-up|3
1692252|NCT01289990|5907624|P4|Overall Study|Lost to Follow-up|5
1692253|NCT01289990|5907625|P3|Overall Study|Lost to Follow-up|5
1692254|NCT01289990|5907626|P2|Overall Study|Lost to Follow-up|2
1692255|NCT01289990|5907627|P1|Overall Study|Lost to Follow-up|3
1692256|NCT01289990|5907615|P13|Overall Study|Death|0
1692257|NCT01289990|5907616|P12|Overall Study|Death|1
1692258|NCT01289990|5907617|P11|Overall Study|Death|0
1692259|NCT01289990|5907618|P10|Overall Study|Death|0
1692260|NCT01289990|5907619|P9|Overall Study|Death|0
1692261|NCT01289990|5907620|P8|Overall Study|Death|0
1692262|NCT01289990|5907621|P7|Overall Study|Death|0
1692263|NCT01289990|5907622|P6|Overall Study|Death|1
1692264|NCT01289990|5907623|P5|Overall Study|Death|2
1692265|NCT01289990|5907624|P4|Overall Study|Death|1
1692266|NCT01289990|5907625|P3|Overall Study|Death|0
1692267|NCT01289990|5907626|P2|Overall Study|Death|0
1692268|NCT01289990|5907627|P1|Overall Study|Death|0
1692269|NCT01289847|5907844|P1|Overall Study|Patient could not comply with visits|1
1692270|NCT01289821|5907853|P1|Survival Follow-up Period|Clinical endpoint reached|16
1692271|NCT01289821|5907853|P1|Survival Follow-up Period|Lost to Follow-up|1
1692272|NCT01289821|5907853|P1|Survival Follow-up Period|Protocol Violation|1
1692273|NCT01289821|5907853|P1|Safety Follow-up Period|Unspecified reason|1
1692274|NCT01289821|5907853|P1|Safety Follow-up Period|Protocol Violation|3
1692275|NCT01289821|5907853|P1|Safety Follow-up Period|Withdrawal by Subject|1
1692276|NCT01289821|5907853|P1|Treatment Period|Therapeutic procedure required|1
1692277|NCT01289821|5907853|P1|Treatment Period|Clinical Progression|2
1692278|NCT01289821|5907853|P1|Treatment Period|Radiological Progression|43
1692279|NCT01289821|5907853|P1|Treatment Period|Adverse Event|4
1692280|NCT01289821|5907853|P1|Treatment Period|Physician Decision|3
1692281|NCT01289821|5907853|P1|Treatment Period|Withdrawal by Subject|1
1692282|NCT01289782|5907864|P2|Overall Study|Reason not specified|2
1692283|NCT01289782|5907865|P1|Overall Study|Reason not specified|1
1692284|NCT01289782|5907864|P2|Overall Study|Sponsor's Decision|0
1692285|NCT01289782|5907865|P1|Overall Study|Sponsor's Decision|1
1692286|NCT01289782|5907864|P2|Overall Study|Withdrawal by Subject|2
1692287|NCT01289782|5907865|P1|Overall Study|Withdrawal by Subject|8
1692288|NCT01289782|5907864|P2|Overall Study|Protocol Violation|1
1692289|NCT01289782|5907865|P1|Overall Study|Protocol Violation|1
1692290|NCT01289782|5907864|P2|Overall Study|Lost to Follow-up|7
1692291|NCT01289782|5907865|P1|Overall Study|Lost to Follow-up|14
1692292|NCT01289678|5907934|P1|Overall Study|Physician Decision|6
1692293|NCT01289639|5907941|P3|Overall Study|Lost to Follow-up|0
1692294|NCT01289639|5907942|P2|Overall Study|Lost to Follow-up|0
1692295|NCT01289639|5907943|P1|Overall Study|Lost to Follow-up|1
1692296|NCT01289574|5907969|P3|Overall Study|Subject wanted alternate treatment|0
1692297|NCT01289574|5907970|P2|Overall Study|Subject wanted alternate treatment|1
1692298|NCT01289574|5907971|P1|Overall Study|Subject wanted alternate treatment|0
1692299|NCT01289574|5907969|P3|Overall Study|Adverse Event|0
1692300|NCT01289574|5907970|P2|Overall Study|Adverse Event|1
1692301|NCT01289574|5907971|P1|Overall Study|Adverse Event|0
1692302|NCT01289574|5907969|P3|Overall Study|Withdrawal by Subject|1
1692303|NCT01289574|5907970|P2|Overall Study|Withdrawal by Subject|1
1692304|NCT01289574|5907971|P1|Overall Study|Withdrawal by Subject|1
1692305|NCT01289574|5907969|P3|Overall Study|Lost to Follow-up|1
1692306|NCT01289574|5907970|P2|Overall Study|Lost to Follow-up|0
1692307|NCT01289574|5907971|P1|Overall Study|Lost to Follow-up|2
1692308|NCT01289574|5907969|P3|Overall Study|Lack of Efficacy|1
1692309|NCT01289574|5907970|P2|Overall Study|Lack of Efficacy|0
1692310|NCT01289574|5907971|P1|Overall Study|Lack of Efficacy|4
1692311|NCT01289418|5908065|P1|Day 29 Survey|participants did not complete the survey|2185
1692312|NCT01289418|5908065|P1|Day 29 Survey|email address invalid|283
1692313|NCT01289418|5908065|P1|Day 8 Survey|participants did not complete the survey|1935
1692314|NCT01289418|5908065|P1|Day 8 Survey|email address invalid|283
1692315|NCT01289210|5908113|P1|Overall Study|Adverse Event|1
1692316|NCT01289119|5908123|P6|Overall Study|Other|0
1692317|NCT01289119|5908124|P5|Overall Study|Other|0
1692318|NCT01289119|5908125|P4|Overall Study|Other|0
1692319|NCT01289119|5908126|P3|Overall Study|Other|1
1692320|NCT01289119|5908127|P2|Overall Study|Other|0
1692321|NCT01289119|5908128|P1|Overall Study|Other|1
1692322|NCT01289119|5908123|P6|Overall Study|Lack of Efficacy|1
1692323|NCT01289119|5908124|P5|Overall Study|Lack of Efficacy|1
1692324|NCT01289119|5908125|P4|Overall Study|Lack of Efficacy|1
1692325|NCT01289119|5908126|P3|Overall Study|Lack of Efficacy|1
1692326|NCT01289119|5908127|P2|Overall Study|Lack of Efficacy|1
1692327|NCT01289119|5908128|P1|Overall Study|Lack of Efficacy|0
1692328|NCT01289119|5908123|P6|Overall Study|Pregnancy|0
1692329|NCT01289119|5908124|P5|Overall Study|Pregnancy|0
1692330|NCT01289119|5908125|P4|Overall Study|Pregnancy|0
1692331|NCT01289119|5908126|P3|Overall Study|Pregnancy|0
1692332|NCT01289119|5908127|P2|Overall Study|Pregnancy|1
1692333|NCT01289119|5908128|P1|Overall Study|Pregnancy|0
1692334|NCT01289119|5908123|P6|Overall Study|Withdrawal by Subject|1
1692335|NCT01289119|5908124|P5|Overall Study|Withdrawal by Subject|1
1692336|NCT01289119|5908125|P4|Overall Study|Withdrawal by Subject|3
1692337|NCT01289119|5908126|P3|Overall Study|Withdrawal by Subject|4
1692338|NCT01289119|5908127|P2|Overall Study|Withdrawal by Subject|2
1692339|NCT01289119|5908128|P1|Overall Study|Withdrawal by Subject|4
1692340|NCT01289119|5908123|P6|Overall Study|Lost to Follow-up|1
1692341|NCT01289119|5908124|P5|Overall Study|Lost to Follow-up|0
1692342|NCT01289119|5908125|P4|Overall Study|Lost to Follow-up|0
1692343|NCT01289119|5908126|P3|Overall Study|Lost to Follow-up|0
1692344|NCT01289119|5908127|P2|Overall Study|Lost to Follow-up|3
1692345|NCT01289119|5908128|P1|Overall Study|Lost to Follow-up|0
1692346|NCT01289119|5908123|P6|Overall Study|Major Protocol Deviation|1
1692347|NCT01289119|5908124|P5|Overall Study|Major Protocol Deviation|2
1692348|NCT01289119|5908125|P4|Overall Study|Major Protocol Deviation|0
1692349|NCT01289119|5908126|P3|Overall Study|Major Protocol Deviation|3
1692350|NCT01289119|5908127|P2|Overall Study|Major Protocol Deviation|1
1692351|NCT01289119|5908128|P1|Overall Study|Major Protocol Deviation|2
1692352|NCT01289119|5908123|P6|Overall Study|Adverse Event|0
1692353|NCT01289119|5908124|P5|Overall Study|Adverse Event|1
1692354|NCT01289119|5908125|P4|Overall Study|Adverse Event|2
1692355|NCT01289119|5908126|P3|Overall Study|Adverse Event|0
1692356|NCT01289119|5908127|P2|Overall Study|Adverse Event|1
1692357|NCT01289119|5908128|P1|Overall Study|Adverse Event|2
1692358|NCT01289041|5908249|P1|Overall Study|Death|1
1692359|NCT01289041|5908249|P1|Overall Study|Withdrawal by Subject|3
1692360|NCT01289041|5908249|P1|Overall Study|Progressive Disease|41
1692361|NCT01289041|5908249|P1|Overall Study|Physician Decision|1
1692362|NCT01289041|5908249|P1|Overall Study|Adverse Event|24
1692363|NCT01289028|5908261|P1|Overall Study|Missing reason for discon|1
1692364|NCT01289028|5908261|P1|Overall Study|Abnormal Lab Value|1
1692365|NCT01289028|5908261|P1|Overall Study|New Cancer Therapy|2
1692366|NCT01289028|5908261|P1|Overall Study|Lost to Follow-up|2
1692367|NCT01289028|5908261|P1|Overall Study|No longer required|2
1692368|NCT01289028|5908261|P1|Overall Study|Lack of Efficacy|2
1692369|NCT01289028|5908261|P1|Overall Study|Death|4
1692370|NCT01289028|5908261|P1|Overall Study|Withdrawal by Subject|6
1692371|NCT01289028|5908261|P1|Overall Study|Adverse Event|14
1692372|NCT01289028|5908261|P1|Overall Study|Progressive Disease|49
1692373|NCT01289015|5908275|P2|Overall Study|Negative baseline culture and others|20
1692374|NCT01289015|5908276|P1|Overall Study|Negative baseline culture and others|33
1692375|NCT01289015|5908275|P2|Overall Study|Disease progression|0
1692376|NCT01289015|5908276|P1|Overall Study|Disease progression|1
1692377|NCT01289015|5908275|P2|Overall Study|Withdrawal by Subject|8
1692378|NCT01289015|5908276|P1|Overall Study|Withdrawal by Subject|17
1692379|NCT01289015|5908275|P2|Overall Study|Lost to Follow-up|17
1692380|NCT01289015|5908276|P1|Overall Study|Lost to Follow-up|33
1692381|NCT01289015|5908275|P2|Overall Study|Adverse Event|0
1692382|NCT01289015|5908276|P1|Overall Study|Adverse Event|3
1692383|NCT01289015|5908275|P2|Overall Study|Protocol Violation|9
1692384|NCT01289015|5908276|P1|Overall Study|Protocol Violation|12
1692385|NCT01288989|5908289|P5|Overall Study|Withdrawal by Subject|3
1692386|NCT01288989|5908290|P4|Overall Study|Withdrawal by Subject|0
1692387|NCT01288989|5908291|P3|Overall Study|Withdrawal by Subject|0
1692388|NCT01288989|5908292|P2|Overall Study|Withdrawal by Subject|0
1692389|NCT01288989|5908293|P1|Overall Study|Withdrawal by Subject|0
1692390|NCT01288989|5908289|P5|Overall Study|Physician Decision|1
1692391|NCT01288989|5908290|P4|Overall Study|Physician Decision|0
1692392|NCT01288989|5908291|P3|Overall Study|Physician Decision|0
1692393|NCT01288989|5908292|P2|Overall Study|Physician Decision|0
1692394|NCT01288989|5908293|P1|Overall Study|Physician Decision|0
1692395|NCT01288989|5908289|P5|Overall Study|Adverse Event|2
1692396|NCT01288989|5908290|P4|Overall Study|Adverse Event|0
1692397|NCT01288989|5908291|P3|Overall Study|Adverse Event|0
1692398|NCT01288989|5908292|P2|Overall Study|Adverse Event|0
1692399|NCT01288989|5908293|P1|Overall Study|Adverse Event|0
1692400|NCT01288989|5908289|P5|Overall Study|Dose limiting toxicity|0
1692401|NCT01288989|5908290|P4|Overall Study|Dose limiting toxicity|0
1692402|NCT01288989|5908291|P3|Overall Study|Dose limiting toxicity|0
1692403|NCT01288989|5908292|P2|Overall Study|Dose limiting toxicity|0
1692404|NCT01288989|5908293|P1|Overall Study|Dose limiting toxicity|1
1692405|NCT01288989|5908289|P5|Overall Study|Death|0
1692406|NCT01288989|5908290|P4|Overall Study|Death|1
1692407|NCT01288989|5908291|P3|Overall Study|Death|0
1692408|NCT01288989|5908292|P2|Overall Study|Death|0
1692409|NCT01288989|5908293|P1|Overall Study|Death|0
1692410|NCT01288976|5908354|P3|Overall Study|Data unavailable|7
1692411|NCT01288976|5908355|P2|Overall Study|Data unavailable|9
1692412|NCT01288976|5908356|P1|Overall Study|Data unavailable|22
1692413|NCT01288976|5908354|P3|Overall Study|Death|4
1692414|NCT01288976|5908355|P2|Overall Study|Death|6
1692415|NCT01288976|5908356|P1|Overall Study|Death|98
1692416|NCT01288976|5908354|P3|Overall Study|Withdrawal by Subject|9
1692417|NCT01288976|5908355|P2|Overall Study|Withdrawal by Subject|12
1692418|NCT01288976|5908356|P1|Overall Study|Withdrawal by Subject|58
1692419|NCT01288911|5908385|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
1692420|NCT01288911|5908386|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
1692421|NCT01288911|5908385|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
1692422|NCT01288911|5908386|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
1692423|NCT01288911|5908385|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
1692424|NCT01288911|5908386|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
1692425|NCT01288911|5908385|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
1692426|NCT01288911|5908386|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
1692427|NCT01288911|5908385|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
1692428|NCT01288911|5908386|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
1692429|NCT01288911|5908385|P2|Open-label Period (All Enzalutamide)|Death|1
1692430|NCT01288911|5908386|P1|Open-label Period (All Enzalutamide)|Death|0
1692431|NCT01288911|5908385|P2|Double-blind Period|Randomized but never received study drug|2
1692432|NCT01288911|5908386|P1|Double-blind Period|Randomized but never received study drug|1
1692433|NCT01288911|5908385|P2|Double-blind Period|Miscellaneous Reason|42
1692434|NCT01288911|5908386|P1|Double-blind Period|Miscellaneous Reason|29
1692435|NCT01288911|5908385|P2|Double-blind Period|Withdrawal by Subject|26
1692436|NCT01288911|5908386|P1|Double-blind Period|Withdrawal by Subject|25
1692437|NCT01288911|5908385|P2|Double-blind Period|Protocol Violation|0
1692438|NCT01288911|5908386|P1|Double-blind Period|Protocol Violation|1
1692439|NCT01288911|5908385|P2|Double-blind Period|Progressive Disease|103
1692440|NCT01288911|5908386|P1|Double-blind Period|Progressive Disease|75
1692441|NCT01288911|5908385|P2|Double-blind Period|Lost to Follow-up|2
1692442|NCT01288911|5908386|P1|Double-blind Period|Lost to Follow-up|0
1692443|NCT01288911|5908385|P2|Double-blind Period|Death|7
1692444|NCT01288911|5908386|P1|Double-blind Period|Death|11
1692445|NCT01288729|5908496|P2|Overall Study|Withdrawal by Subject|0
1692446|NCT01288729|5908497|P1|Overall Study|Withdrawal by Subject|1
1692447|NCT01288612|5908506|P3|Overall Study|Unable to intubate|0
1692448|NCT01288612|5908507|P2|Overall Study|Unable to intubate|3
1692449|NCT01288612|5908508|P1|Overall Study|Unable to intubate|0
1692450|NCT01288612|5908506|P3|Overall Study|Declined|62
1692451|NCT01288612|5908507|P2|Overall Study|Declined|63
1692452|NCT01288612|5908508|P1|Overall Study|Declined|78
1692453|NCT01288612|5908506|P3|Overall Study|Unable to contact|20
1692454|NCT01288612|5908507|P2|Overall Study|Unable to contact|16
1692455|NCT01288612|5908508|P1|Overall Study|Unable to contact|11
1692456|NCT01288469|5908557|P3|Overall Study|Exclusion criteria finally met|0
1692457|NCT01288469|5908558|P2|Overall Study|Exclusion criteria finally met|0
1692458|NCT01288469|5908559|P1|Overall Study|Exclusion criteria finally met|1
1692459|NCT01288469|5908557|P3|Overall Study|Consent withdrawn by subject|1
1692460|NCT01288469|5908558|P2|Overall Study|Consent withdrawn by subject|1
1692461|NCT01288469|5908559|P1|Overall Study|Consent withdrawn by subject|1
1692462|NCT01288469|5908557|P3|Overall Study|Participant Moved|0
1692463|NCT01288469|5908558|P2|Overall Study|Participant Moved|0
1692464|NCT01288469|5908559|P1|Overall Study|Participant Moved|1
1692465|NCT01288469|5908557|P3|Overall Study|Poor compliance to protocol|0
1692466|NCT01288469|5908558|P2|Overall Study|Poor compliance to protocol|1
1692467|NCT01288469|5908559|P1|Overall Study|Poor compliance to protocol|0
1692468|NCT01288469|5908557|P3|Overall Study|Adverse Event|1
1692469|NCT01288469|5908558|P2|Overall Study|Adverse Event|1
1692470|NCT01288469|5908559|P1|Overall Study|Adverse Event|4
1692471|NCT01288443|5908591|P6|Overall Study|Other than above|0
1692472|NCT01288443|5908592|P5|Overall Study|Other than above|1
1692473|NCT01288443|5908593|P4|Overall Study|Other than above|2
1692474|NCT01288443|5908594|P3|Overall Study|Other than above|0
1692475|NCT01288443|5908595|P2|Overall Study|Other than above|0
1692476|NCT01288443|5908596|P1|Overall Study|Other than above|0
1692477|NCT01288443|5908591|P6|Overall Study|Study drug auto-injector administration|1
1692478|NCT01288443|5908592|P5|Overall Study|Study drug auto-injector administration|1
1692479|NCT01288443|5908593|P4|Overall Study|Study drug auto-injector administration|0
1692480|NCT01288443|5908594|P3|Overall Study|Study drug auto-injector administration|0
1692481|NCT01288443|5908595|P2|Overall Study|Study drug auto-injector administration|0
1692482|NCT01288443|5908596|P1|Overall Study|Study drug auto-injector administration|0
1692483|NCT01288443|5908591|P6|Overall Study|Lost to Follow-up|0
1692484|NCT01288443|5908592|P5|Overall Study|Lost to Follow-up|0
1692485|NCT01288443|5908593|P4|Overall Study|Lost to Follow-up|0
1692486|NCT01288443|5908594|P3|Overall Study|Lost to Follow-up|0
1692487|NCT01288443|5908595|P2|Overall Study|Lost to Follow-up|1
1692488|NCT01288443|5908596|P1|Overall Study|Lost to Follow-up|0
1692489|NCT01288443|5908591|P6|Overall Study|Consent withdrawn by Participant|1
1692490|NCT01288443|5908592|P5|Overall Study|Consent withdrawn by Participant|0
1692491|NCT01288443|5908593|P4|Overall Study|Consent withdrawn by Participant|0
1692492|NCT01288443|5908594|P3|Overall Study|Consent withdrawn by Participant|0
1692493|NCT01288443|5908595|P2|Overall Study|Consent withdrawn by Participant|0
1692494|NCT01288443|5908596|P1|Overall Study|Consent withdrawn by Participant|0
1692495|NCT01288443|5908591|P6|Overall Study|Participant Moved|1
1692496|NCT01288443|5908592|P5|Overall Study|Participant Moved|2
1692497|NCT01288443|5908593|P4|Overall Study|Participant Moved|1
1692498|NCT01288443|5908594|P3|Overall Study|Participant Moved|0
1692499|NCT01288443|5908595|P2|Overall Study|Participant Moved|0
1692500|NCT01288443|5908596|P1|Overall Study|Participant Moved|0
1692501|NCT01288443|5908591|P6|Overall Study|Poor compliance to protocol|1
1692502|NCT01288443|5908592|P5|Overall Study|Poor compliance to protocol|0
1692503|NCT01288443|5908593|P4|Overall Study|Poor compliance to protocol|0
1692504|NCT01288443|5908594|P3|Overall Study|Poor compliance to protocol|0
1692505|NCT01288443|5908595|P2|Overall Study|Poor compliance to protocol|0
1692506|NCT01288443|5908596|P1|Overall Study|Poor compliance to protocol|0
1692507|NCT01288443|5908591|P6|Overall Study|Adverse Event|1
1692508|NCT01288443|5908592|P5|Overall Study|Adverse Event|3
1692509|NCT01288443|5908593|P4|Overall Study|Adverse Event|1
1692510|NCT01288443|5908594|P3|Overall Study|Adverse Event|1
1692511|NCT01288443|5908595|P2|Overall Study|Adverse Event|0
1692512|NCT01288443|5908596|P1|Overall Study|Adverse Event|0
1692513|NCT01288287|5908646|P1|Overall Study|Unknown Status|7
1692514|NCT01288287|5908646|P1|Overall Study|Unknown Reason|1
1692515|NCT01288287|5908646|P1|Overall Study|Other Reason|13
1692516|NCT01288287|5908646|P1|Overall Study|Lack of Efficacy|13
1692517|NCT01288287|5908646|P1|Overall Study|Withdrawal by Subject|4
1692518|NCT01288287|5908646|P1|Overall Study|Lost to Follow-up|8
1692519|NCT01288209|5908661|P2|Overall Study|Other|0
1692520|NCT01288209|5908662|P1|Overall Study|Other|1
1692521|NCT01288209|5908661|P2|Overall Study|Withdrawal by Subject|3
1692522|NCT01288209|5908662|P1|Overall Study|Withdrawal by Subject|1
1692523|NCT01288079|5908692|P4|Overall Study|Other or Study Termination|8
1692524|NCT01288079|5908693|P3|Overall Study|Other or Study Termination|14
1692525|NCT01288079|5908694|P2|Overall Study|Other or Study Termination|15
1692526|NCT01288079|5908695|P1|Overall Study|Other or Study Termination|11
1692527|NCT01288079|5908692|P4|Overall Study|Lost to Follow-up|0
1692528|NCT01288079|5908693|P3|Overall Study|Lost to Follow-up|1
1692529|NCT01288079|5908694|P2|Overall Study|Lost to Follow-up|1
1692530|NCT01288079|5908695|P1|Overall Study|Lost to Follow-up|1
1692531|NCT01288079|5908692|P4|Overall Study|Study-Specific Withdrawal Criteria|0
1692532|NCT01288079|5908693|P3|Overall Study|Study-Specific Withdrawal Criteria|0
1692533|NCT01288079|5908694|P2|Overall Study|Study-Specific Withdrawal Criteria|1
1692534|NCT01288079|5908695|P1|Overall Study|Study-Specific Withdrawal Criteria|1
1692535|NCT01288079|5908692|P4|Overall Study|Lack of Efficacy|2
1692536|NCT01288079|5908693|P3|Overall Study|Lack of Efficacy|0
1692537|NCT01288079|5908694|P2|Overall Study|Lack of Efficacy|2
1692538|NCT01288079|5908695|P1|Overall Study|Lack of Efficacy|2
1692539|NCT01288079|5908692|P4|Overall Study|Condition under Investigation Worsened|1
1692540|NCT01288079|5908693|P3|Overall Study|Condition under Investigation Worsened|0
1692541|NCT01288079|5908694|P2|Overall Study|Condition under Investigation Worsened|0
1692542|NCT01288079|5908695|P1|Overall Study|Condition under Investigation Worsened|0
1692543|NCT01288079|5908692|P4|Overall Study|Severe Non-Compliance to Protocol|3
1692544|NCT01288079|5908693|P3|Overall Study|Severe Non-Compliance to Protocol|1
1692545|NCT01288079|5908694|P2|Overall Study|Severe Non-Compliance to Protocol|3
1692546|NCT01288079|5908695|P1|Overall Study|Severe Non-Compliance to Protocol|1
1692547|NCT01288079|5908692|P4|Overall Study|Adverse Event|3
1692548|NCT01288079|5908693|P3|Overall Study|Adverse Event|2
1692549|NCT01288079|5908694|P2|Overall Study|Adverse Event|1
1692550|NCT01288079|5908695|P1|Overall Study|Adverse Event|2
1692551|NCT01288079|5908692|P4|Overall Study|Withdrawal by Subject|0
1692552|NCT01288079|5908693|P3|Overall Study|Withdrawal by Subject|1
1692553|NCT01288079|5908694|P2|Overall Study|Withdrawal by Subject|4
1692554|NCT01288079|5908695|P1|Overall Study|Withdrawal by Subject|2
1692555|NCT01288053|5908705|P1|Overall Study|Death|1
1692556|NCT01287897|5908723|P4|Overall Study|Other|0
1692557|NCT01287897|5908724|P3|Overall Study|Other|1
1692558|NCT01287897|5908725|P2|Overall Study|Other|0
1692559|NCT01287897|5908726|P1|Overall Study|Other|1
1692560|NCT01287897|5908723|P4|Overall Study|Not meeting entrance criteria|0
1692561|NCT01287897|5908724|P3|Overall Study|Not meeting entrance criteria|0
1692562|NCT01287897|5908725|P2|Overall Study|Not meeting entrance criteria|1
1692563|NCT01287897|5908726|P1|Overall Study|Not meeting entrance criteria|1
1692564|NCT01287897|5908723|P4|Overall Study|Not consented properly|0
1692565|NCT01287897|5908724|P3|Overall Study|Not consented properly|0
1692566|NCT01287897|5908725|P2|Overall Study|Not consented properly|1
1692567|NCT01287897|5908726|P1|Overall Study|Not consented properly|0
1692568|NCT01287897|5908723|P4|Overall Study|Withdrawal by Subject|2
1692569|NCT01287897|5908724|P3|Overall Study|Withdrawal by Subject|3
1692570|NCT01287897|5908725|P2|Overall Study|Withdrawal by Subject|5
1692571|NCT01287897|5908726|P1|Overall Study|Withdrawal by Subject|1
1692572|NCT01287897|5908723|P4|Overall Study|Lost to Follow-up|0
1692573|NCT01287897|5908724|P3|Overall Study|Lost to Follow-up|2
1692574|NCT01287897|5908725|P2|Overall Study|Lost to Follow-up|0
1692575|NCT01287897|5908726|P1|Overall Study|Lost to Follow-up|0
1692576|NCT01287897|5908723|P4|Overall Study|Protocol Violation|1
1692577|NCT01287897|5908724|P3|Overall Study|Protocol Violation|0
1692578|NCT01287897|5908725|P2|Overall Study|Protocol Violation|1
1692579|NCT01287897|5908726|P1|Overall Study|Protocol Violation|1
1692580|NCT01287897|5908723|P4|Overall Study|Lack of Efficacy|0
1692581|NCT01287897|5908724|P3|Overall Study|Lack of Efficacy|0
1692582|NCT01287897|5908725|P2|Overall Study|Lack of Efficacy|0
1692583|NCT01287897|5908726|P1|Overall Study|Lack of Efficacy|2
1692584|NCT01287897|5908723|P4|Overall Study|Adverse Event|4
1692585|NCT01287897|5908724|P3|Overall Study|Adverse Event|6
1692586|NCT01287897|5908725|P2|Overall Study|Adverse Event|3
1692587|NCT01287897|5908726|P1|Overall Study|Adverse Event|5
1692588|NCT01287832|5908777|P2|Overall Study|Death|1
1692589|NCT01287832|5908778|P1|Overall Study|Death|0
1692590|NCT01287832|5908777|P2|Overall Study|Adverse Event|0
1692591|NCT01287832|5908778|P1|Overall Study|Adverse Event|1
1692592|NCT01287754|5908786|P2|Overall Study|Protocol Violation|3
1692593|NCT01287754|5908787|P1|Overall Study|Protocol Violation|0
1692594|NCT01287754|5908786|P2|Overall Study|Lost to Follow-up|6
1692595|NCT01287754|5908787|P1|Overall Study|Lost to Follow-up|1
1692596|NCT01287754|5908786|P2|Overall Study|Death|12
1692597|NCT01287754|5908787|P1|Overall Study|Death|2
1692598|NCT01287741|5908799|P2|Overall Study|Reason not specified|9
1692599|NCT01287741|5908800|P1|Overall Study|Reason not specified|23
1692600|NCT01287741|5908799|P2|Overall Study|Progressive disease|166
1692601|NCT01287741|5908800|P1|Overall Study|Progressive disease|190
1692602|NCT01287741|5908799|P2|Overall Study|Study terminated by Sponsor|315
1692603|NCT01287741|5908800|P1|Overall Study|Study terminated by Sponsor|307
1692604|NCT01287741|5908799|P2|Overall Study|Adverse Event|6
1692605|NCT01287741|5908800|P1|Overall Study|Adverse Event|4
1692606|NCT01287741|5908799|P2|Overall Study|Death|44
1692607|NCT01287741|5908800|P1|Overall Study|Death|32
1692608|NCT01287741|5908799|P2|Overall Study|Lost to Follow-up|8
1692609|NCT01287741|5908800|P1|Overall Study|Lost to Follow-up|10
1692610|NCT01287741|5908799|P2|Overall Study|Non-compliance|6
1692611|NCT01287741|5908800|P1|Overall Study|Non-compliance|8
1692612|NCT01287741|5908799|P2|Overall Study|Physician Decision|23
1692613|NCT01287741|5908800|P1|Overall Study|Physician Decision|15
1692614|NCT01287741|5908799|P2|Overall Study|Protocol Violation|0
1692615|NCT01287741|5908800|P1|Overall Study|Protocol Violation|2
1692616|NCT01287741|5908799|P2|Overall Study|Withdrawal by Subject|38
1692617|NCT01287741|5908800|P1|Overall Study|Withdrawal by Subject|35
1692618|NCT01287611|5908836|P2|Overall Study|Exclusion due to expanded Kerr incision|3
1692619|NCT01287611|5908837|P1|Overall Study|Exclusion due to expanded Kerr incision|4
1692620|NCT01287611|5908836|P2|Overall Study|Lost to Follow-up|16
1692621|NCT01287611|5908837|P1|Overall Study|Lost to Follow-up|29
1692622|NCT01287520|5908854|P9|Overall Study|Withdrawal by Subject|1
1692623|NCT01287520|5908855|P8|Overall Study|Withdrawal by Subject|0
1692624|NCT01287520|5908856|P7|Overall Study|Withdrawal by Subject|0
1692625|NCT01287520|5908857|P6|Overall Study|Withdrawal by Subject|1
1692626|NCT01287520|5908858|P5|Overall Study|Withdrawal by Subject|0
1692627|NCT01287520|5908859|P4|Overall Study|Withdrawal by Subject|0
1692628|NCT01287520|5908860|P3|Overall Study|Withdrawal by Subject|0
1692629|NCT01287520|5908861|P2|Overall Study|Withdrawal by Subject|0
1692630|NCT01287520|5908862|P1|Overall Study|Withdrawal by Subject|0
1692631|NCT01287520|5908854|P9|Overall Study|Progressive disease|4
1692632|NCT01287520|5908855|P8|Overall Study|Progressive disease|2
1692633|NCT01287520|5908856|P7|Overall Study|Progressive disease|2
1692634|NCT01287520|5908857|P6|Overall Study|Progressive disease|0
1692635|NCT01287520|5908858|P5|Overall Study|Progressive disease|1
1692636|NCT01287520|5908859|P4|Overall Study|Progressive disease|6
1692637|NCT01287520|5908860|P3|Overall Study|Progressive disease|1
1692638|NCT01287520|5908861|P2|Overall Study|Progressive disease|4
1692639|NCT01287520|5908862|P1|Overall Study|Progressive disease|0
1692640|NCT01287520|5908854|P9|Overall Study|Physician Decision|0
1692641|NCT01287520|5908855|P8|Overall Study|Physician Decision|1
1692642|NCT01287520|5908856|P7|Overall Study|Physician Decision|0
1692643|NCT01287520|5908857|P6|Overall Study|Physician Decision|1
1692644|NCT01287520|5908858|P5|Overall Study|Physician Decision|1
1692645|NCT01287520|5908859|P4|Overall Study|Physician Decision|0
1692646|NCT01287520|5908860|P3|Overall Study|Physician Decision|2
1692647|NCT01287520|5908861|P2|Overall Study|Physician Decision|1
1692648|NCT01287520|5908862|P1|Overall Study|Physician Decision|1
1692649|NCT01287520|5908854|P9|Overall Study|Adverse Event|0
1692650|NCT01287520|5908855|P8|Overall Study|Adverse Event|2
1692651|NCT01287520|5908856|P7|Overall Study|Adverse Event|0
1692652|NCT01287520|5908857|P6|Overall Study|Adverse Event|2
1692653|NCT01287520|5908858|P5|Overall Study|Adverse Event|1
1692654|NCT01287520|5908859|P4|Overall Study|Adverse Event|1
1692655|NCT01287520|5908860|P3|Overall Study|Adverse Event|2
1692656|NCT01287520|5908861|P2|Overall Study|Adverse Event|2
1692657|NCT01287520|5908862|P1|Overall Study|Adverse Event|2
1692658|NCT01287416|5908926|P2|6 Month Follow-up|Lost to Follow-up|2
1692659|NCT01287416|5908927|P1|6 Month Follow-up|Lost to Follow-up|3
1692660|NCT01287416|5908926|P2|Pre-post Training|Lost to Follow-up|1
1692661|NCT01287416|5908927|P1|Pre-post Training|Lost to Follow-up|5
1692662|NCT01287416|5908926|P2|Pre-post Training|Withdrawal by Subject|24
1692663|NCT01287416|5908927|P1|Pre-post Training|Withdrawal by Subject|17
1692664|NCT01287403|5908963|P1|1st Intervention (1 Day)|Adverse Event|1
1692665|NCT01287364|5908995|P2|Overall Study|Other Reason|2
1692666|NCT01287364|5908996|P1|Overall Study|Other Reason|4
1692667|NCT01287364|5908995|P2|Overall Study|Protocol Violation|5
1692668|NCT01287364|5908996|P1|Overall Study|Protocol Violation|5
1692669|NCT01287364|5908995|P2|Overall Study|Adverse Event|3
1692670|NCT01287364|5908996|P1|Overall Study|Adverse Event|0
1692671|NCT01287221|5909018|P2|Overall Study|Withdrawal by Subject|1
1692672|NCT01287221|5909019|P1|Overall Study|Withdrawal by Subject|0
1692673|NCT01287221|5909018|P2|Overall Study|Adverse Event|3
1692674|NCT01287221|5909019|P1|Overall Study|Adverse Event|3
1692675|NCT01287221|5909018|P2|Overall Study|Lack of Perceived Benefit|1
1692676|NCT01287221|5909019|P1|Overall Study|Lack of Perceived Benefit|1
1692677|NCT01287195|5909054|P1|Overall Study|Withdrawal by Subject|2
1692678|NCT01287117|5909069|P4|Overall Study|Disease Progression|5
1692679|NCT01287117|5909070|P3|Overall Study|Disease Progression|6
1692680|NCT01287117|5909071|P2|Overall Study|Disease Progression|5
1692681|NCT01287117|5909072|P1|Overall Study|Disease Progression|10
1692682|NCT01287117|5909069|P4|Overall Study|Patient/Legal Guardian's Decision|5
1692683|NCT01287117|5909070|P3|Overall Study|Patient/Legal Guardian's Decision|8
1692684|NCT01287117|5909071|P2|Overall Study|Patient/Legal Guardian's Decision|6
1692685|NCT01287117|5909072|P1|Overall Study|Patient/Legal Guardian's Decision|2
1692686|NCT01287117|5909069|P4|Overall Study|Physician Decision|1
1692687|NCT01287117|5909070|P3|Overall Study|Physician Decision|1
1692688|NCT01287117|5909071|P2|Overall Study|Physician Decision|1
1692689|NCT01287117|5909072|P1|Overall Study|Physician Decision|0
1692690|NCT01287117|5909069|P4|Overall Study|Lost to Follow-up|0
1692691|NCT01287117|5909070|P3|Overall Study|Lost to Follow-up|0
1692692|NCT01287117|5909071|P2|Overall Study|Lost to Follow-up|1
1692693|NCT01287117|5909072|P1|Overall Study|Lost to Follow-up|1
1692694|NCT01287117|5909069|P4|Overall Study|Adverse Event|1
1692695|NCT01287117|5909070|P3|Overall Study|Adverse Event|1
1692696|NCT01287117|5909071|P2|Overall Study|Adverse Event|1
1692697|NCT01287117|5909072|P1|Overall Study|Adverse Event|2
1692698|NCT01287104|5909122|P4|Overall Study|NK cells did not meet release criteria|0
1692699|NCT01287104|5909123|P3|Overall Study|NK cells did not meet release criteria|0
1692700|NCT01287104|5909124|P2|Overall Study|NK cells did not meet release criteria|1
1692701|NCT01287104|5909125|P1|Overall Study|NK cells did not meet release criteria|0
1692702|NCT01287104|5909122|P4|Overall Study|Low donor chimerism|0
1692703|NCT01287104|5909123|P3|Overall Study|Low donor chimerism|0
1692704|NCT01287104|5909124|P2|Overall Study|Low donor chimerism|1
1692705|NCT01287104|5909125|P1|Overall Study|Low donor chimerism|0
1692706|NCT01287104|5909122|P4|Overall Study|Developed GVHD or complications of BMT|0
1692707|NCT01287104|5909123|P3|Overall Study|Developed GVHD or complications of BMT|4
1692708|NCT01287104|5909124|P2|Overall Study|Developed GVHD or complications of BMT|1
1692709|NCT01287104|5909125|P1|Overall Study|Developed GVHD or complications of BMT|0
1692710|NCT01287104|5909122|P4|Overall Study|Donor anaphylaxis|1
1692711|NCT01287104|5909123|P3|Overall Study|Donor anaphylaxis|0
1692712|NCT01287104|5909124|P2|Overall Study|Donor anaphylaxis|1
1692713|NCT01287104|5909125|P1|Overall Study|Donor anaphylaxis|0
1692714|NCT01287104|5909122|P4|Overall Study|Patient developed progressive disease|2
1692715|NCT01287104|5909123|P3|Overall Study|Patient developed progressive disease|3
1692716|NCT01287104|5909124|P2|Overall Study|Patient developed progressive disease|1
1692717|NCT01287104|5909125|P1|Overall Study|Patient developed progressive disease|1
1692718|NCT01287065|5909158|P6|Treatment Period 1|Withdrawal by Subject|1
1692719|NCT01287065|5909159|P5|Treatment Period 1|Withdrawal by Subject|0
1692720|NCT01287065|5909160|P4|Treatment Period 1|Withdrawal by Subject|0
1692721|NCT01287065|5909161|P3|Treatment Period 1|Withdrawal by Subject|0
1692722|NCT01287065|5909162|P2|Treatment Period 1|Withdrawal by Subject|0
1692723|NCT01287065|5909163|P1|Treatment Period 1|Withdrawal by Subject|0
1692724|NCT01287065|5909158|P6|Treatment Period 1|Adverse Event|0
1692725|NCT01287065|5909159|P5|Treatment Period 1|Adverse Event|1
1692726|NCT01287065|5909160|P4|Treatment Period 1|Adverse Event|0
1692727|NCT01287065|5909161|P3|Treatment Period 1|Adverse Event|0
1692728|NCT01287065|5909162|P2|Treatment Period 1|Adverse Event|0
1692729|NCT01287065|5909163|P1|Treatment Period 1|Adverse Event|0
1692730|NCT01287039|5909182|P2|Overall Study|Lost to Follow-up|2
1692731|NCT01287039|5909183|P1|Overall Study|Lost to Follow-up|3
1692732|NCT01287039|5909182|P2|Overall Study|Withdrawal by Subject|11
1692733|NCT01287039|5909183|P1|Overall Study|Withdrawal by Subject|14
1692734|NCT01287039|5909182|P2|Overall Study|Adverse Event|4
1692735|NCT01287039|5909183|P1|Overall Study|Adverse Event|7
1692736|NCT01287039|5909182|P2|Overall Study|Change of residence|0
1692737|NCT01287039|5909183|P1|Overall Study|Change of residence|1
1692738|NCT01287039|5909182|P2|Overall Study|Death|0
1692739|NCT01287039|5909183|P1|Overall Study|Death|1
1692740|NCT01287039|5909182|P2|Overall Study|Problem with travel|1
1692741|NCT01287039|5909183|P1|Overall Study|Problem with travel|0
1692742|NCT01287039|5909182|P2|Overall Study|Noncompliance with study medication|1
1692743|NCT01287039|5909183|P1|Overall Study|Noncompliance with study medication|0
1692744|NCT01287039|5909182|P2|Overall Study|Excluded medication taken|0
1692745|NCT01287039|5909183|P1|Overall Study|Excluded medication taken|1
1692746|NCT01287039|5909182|P2|Overall Study|Protocol Violation|3
1692747|NCT01287039|5909183|P1|Overall Study|Protocol Violation|2
1692748|NCT01287039|5909182|P2|Overall Study|Elective surgery|1
1692749|NCT01287039|5909183|P1|Overall Study|Elective surgery|0
1692750|NCT01287039|5909182|P2|Overall Study|Change of location/residence|3
1692751|NCT01287039|5909183|P1|Overall Study|Change of location/residence|0
1692752|NCT01287039|5909182|P2|Overall Study|Noncompliance with study procedures|1
1692753|NCT01287039|5909183|P1|Overall Study|Noncompliance with study procedures|0
1692754|NCT01287013|5909216|P3|Overall Study|Non-evaluable|21
1692755|NCT01287013|5909217|P2|Overall Study|Non-evaluable|5
1692756|NCT01287013|5909218|P1|Overall Study|Non-evaluable|3
1692757|NCT01286987|5909248|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
1692758|NCT01286987|5909249|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
1692759|NCT01286987|5909250|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
1692760|NCT01286987|5909251|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
1692761|NCT01286987|5909252|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
1692762|NCT01286987|5909253|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
1692763|NCT01286987|5909254|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
1692764|NCT01286987|5909255|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
1692765|NCT01286987|5909256|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
1692766|NCT01286987|5909257|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
1692767|NCT01286987|5909258|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
1692768|NCT01286987|5909259|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
1692769|NCT01286987|5909260|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
1692770|NCT01286987|5909261|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
1692771|NCT01286987|5909262|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
1692772|NCT01286987|5909248|P15|Part 2: Dose Expansion|Clinical Progression|0
1692773|NCT01286987|5909249|P14|Part 2: Dose Expansion|Clinical Progression|2
1692774|NCT01286987|5909250|P13|Part 2: Dose Expansion|Clinical Progression|0
1692775|NCT01286987|5909251|P12|Part 2: Dose Expansion|Clinical Progression|2
1692776|NCT01286987|5909252|P11|Part 2: Dose Expansion|Clinical Progression|2
1692777|NCT01286987|5909253|P10|Part 2: Dose Expansion|Clinical Progression|0
1692778|NCT01286987|5909254|P9|Part 2: Dose Expansion|Clinical Progression|0
1692779|NCT01286987|5909255|P8|Part 2: Dose Expansion|Clinical Progression|0
1692780|NCT01286987|5909256|P7|Part 2: Dose Expansion|Clinical Progression|0
1692781|NCT01286987|5909257|P6|Part 2: Dose Expansion|Clinical Progression|0
1692782|NCT01286987|5909258|P5|Part 2: Dose Expansion|Clinical Progression|0
1692783|NCT01286987|5909259|P4|Part 2: Dose Expansion|Clinical Progression|0
1692784|NCT01286987|5909260|P3|Part 2: Dose Expansion|Clinical Progression|0
1692785|NCT01286987|5909261|P2|Part 2: Dose Expansion|Clinical Progression|0
1692786|NCT01286987|5909262|P1|Part 2: Dose Expansion|Clinical Progression|0
1692787|NCT01286987|5909248|P15|Part 2: Dose Expansion|Progressive Disease|2
1692788|NCT01286987|5909249|P14|Part 2: Dose Expansion|Progressive Disease|19
1692789|NCT01286987|5909250|P13|Part 2: Dose Expansion|Progressive Disease|11
1692790|NCT01286987|5909251|P12|Part 2: Dose Expansion|Progressive Disease|7
1692791|NCT01286987|5909252|P11|Part 2: Dose Expansion|Progressive Disease|6
1692792|NCT01286987|5909253|P10|Part 2: Dose Expansion|Progressive Disease|11
1692793|NCT01286987|5909254|P9|Part 2: Dose Expansion|Progressive Disease|0
1692794|NCT01286987|5909255|P8|Part 2: Dose Expansion|Progressive Disease|0
1692795|NCT01286987|5909256|P7|Part 2: Dose Expansion|Progressive Disease|0
1692796|NCT01286987|5909257|P6|Part 2: Dose Expansion|Progressive Disease|0
1692797|NCT01286987|5909258|P5|Part 2: Dose Expansion|Progressive Disease|0
1692798|NCT01286987|5909259|P4|Part 2: Dose Expansion|Progressive Disease|0
1692799|NCT01286987|5909260|P3|Part 2: Dose Expansion|Progressive Disease|0
1692800|NCT01286987|5909261|P2|Part 2: Dose Expansion|Progressive Disease|0
1692801|NCT01286987|5909262|P1|Part 2: Dose Expansion|Progressive Disease|0
1692802|NCT01286987|5909248|P15|Part 2: Dose Expansion|Other|0
1692803|NCT01286987|5909249|P14|Part 2: Dose Expansion|Other|1
1692804|NCT01286987|5909250|P13|Part 2: Dose Expansion|Other|0
1692805|NCT01286987|5909251|P12|Part 2: Dose Expansion|Other|0
1692806|NCT01286987|5909252|P11|Part 2: Dose Expansion|Other|0
1692807|NCT01286987|5909253|P10|Part 2: Dose Expansion|Other|0
1692808|NCT01286987|5909254|P9|Part 2: Dose Expansion|Other|0
1692809|NCT01286987|5909255|P8|Part 2: Dose Expansion|Other|0
1692810|NCT01286987|5909256|P7|Part 2: Dose Expansion|Other|0
1692811|NCT01286987|5909257|P6|Part 2: Dose Expansion|Other|0
1692812|NCT01286987|5909258|P5|Part 2: Dose Expansion|Other|0
1692813|NCT01286987|5909259|P4|Part 2: Dose Expansion|Other|0
1692814|NCT01286987|5909260|P3|Part 2: Dose Expansion|Other|0
1692815|NCT01286987|5909261|P2|Part 2: Dose Expansion|Other|0
1692816|NCT01286987|5909262|P1|Part 2: Dose Expansion|Other|0
1692817|NCT01286987|5909248|P15|Part 2: Dose Expansion|Physician Decision|0
1692818|NCT01286987|5909249|P14|Part 2: Dose Expansion|Physician Decision|1
1692819|NCT01286987|5909250|P13|Part 2: Dose Expansion|Physician Decision|0
1692820|NCT01286987|5909251|P12|Part 2: Dose Expansion|Physician Decision|1
1692821|NCT01286987|5909252|P11|Part 2: Dose Expansion|Physician Decision|1
1692822|NCT01286987|5909253|P10|Part 2: Dose Expansion|Physician Decision|0
1692823|NCT01286987|5909254|P9|Part 2: Dose Expansion|Physician Decision|0
1692824|NCT01286987|5909255|P8|Part 2: Dose Expansion|Physician Decision|0
1692825|NCT01286987|5909256|P7|Part 2: Dose Expansion|Physician Decision|0
1692826|NCT01286987|5909257|P6|Part 2: Dose Expansion|Physician Decision|0
1692827|NCT01286987|5909258|P5|Part 2: Dose Expansion|Physician Decision|0
1692828|NCT01286987|5909259|P4|Part 2: Dose Expansion|Physician Decision|0
1692829|NCT01286987|5909260|P3|Part 2: Dose Expansion|Physician Decision|0
1692830|NCT01286987|5909261|P2|Part 2: Dose Expansion|Physician Decision|0
1692831|NCT01286987|5909262|P1|Part 2: Dose Expansion|Physician Decision|0
1692832|NCT01286987|5909248|P15|Part 2: Dose Expansion|Death|0
1692833|NCT01286987|5909249|P14|Part 2: Dose Expansion|Death|1
1692834|NCT01286987|5909250|P13|Part 2: Dose Expansion|Death|1
1692835|NCT01286987|5909251|P12|Part 2: Dose Expansion|Death|0
1692836|NCT01286987|5909252|P11|Part 2: Dose Expansion|Death|0
1692837|NCT01286987|5909253|P10|Part 2: Dose Expansion|Death|0
1692838|NCT01286987|5909254|P9|Part 2: Dose Expansion|Death|0
1692839|NCT01286987|5909255|P8|Part 2: Dose Expansion|Death|0
1692840|NCT01286987|5909256|P7|Part 2: Dose Expansion|Death|0
1692841|NCT01286987|5909257|P6|Part 2: Dose Expansion|Death|0
1692842|NCT01286987|5909258|P5|Part 2: Dose Expansion|Death|0
1692843|NCT01286987|5909259|P4|Part 2: Dose Expansion|Death|0
1692844|NCT01286987|5909260|P3|Part 2: Dose Expansion|Death|0
1692845|NCT01286987|5909261|P2|Part 2: Dose Expansion|Death|0
1692846|NCT01286987|5909262|P1|Part 2: Dose Expansion|Death|0
1692847|NCT01286987|5909248|P15|Part 1: Dose Escalation|Physician Decision|0
1692848|NCT01286987|5909249|P14|Part 1: Dose Escalation|Physician Decision|0
1692849|NCT01286987|5909250|P13|Part 1: Dose Escalation|Physician Decision|0
1692850|NCT01286987|5909251|P12|Part 1: Dose Escalation|Physician Decision|0
1692851|NCT01286987|5909252|P11|Part 1: Dose Escalation|Physician Decision|0
1692852|NCT01286987|5909253|P10|Part 1: Dose Escalation|Physician Decision|0
1692853|NCT01286987|5909254|P9|Part 1: Dose Escalation|Physician Decision|0
1692854|NCT01286987|5909255|P8|Part 1: Dose Escalation|Physician Decision|0
1692855|NCT01286987|5909256|P7|Part 1: Dose Escalation|Physician Decision|0
1692856|NCT01286987|5909257|P6|Part 1: Dose Escalation|Physician Decision|0
1692857|NCT01286987|5909258|P5|Part 1: Dose Escalation|Physician Decision|1
1692858|NCT01286987|5909259|P4|Part 1: Dose Escalation|Physician Decision|0
1692859|NCT01286987|5909260|P3|Part 1: Dose Escalation|Physician Decision|0
1692860|NCT01286987|5909261|P2|Part 1: Dose Escalation|Physician Decision|0
1692861|NCT01286987|5909262|P1|Part 1: Dose Escalation|Physician Decision|0
1692862|NCT01286987|5909248|P15|Part 1: Dose Escalation|Progressive Disease|0
1692863|NCT01286987|5909249|P14|Part 1: Dose Escalation|Progressive Disease|0
1692864|NCT01286987|5909250|P13|Part 1: Dose Escalation|Progressive Disease|0
1692865|NCT01286987|5909251|P12|Part 1: Dose Escalation|Progressive Disease|0
1692866|NCT01286987|5909252|P11|Part 1: Dose Escalation|Progressive Disease|0
1692867|NCT01286987|5909253|P10|Part 1: Dose Escalation|Progressive Disease|0
1692868|NCT01286987|5909254|P9|Part 1: Dose Escalation|Progressive Disease|5
1692869|NCT01286987|5909255|P8|Part 1: Dose Escalation|Progressive Disease|3
1692870|NCT01286987|5909256|P7|Part 1: Dose Escalation|Progressive Disease|5
1692871|NCT01286987|5909257|P6|Part 1: Dose Escalation|Progressive Disease|5
1692872|NCT01286987|5909258|P5|Part 1: Dose Escalation|Progressive Disease|1
1692873|NCT01286987|5909259|P4|Part 1: Dose Escalation|Progressive Disease|2
1692874|NCT01286987|5909260|P3|Part 1: Dose Escalation|Progressive Disease|3
1692875|NCT01286987|5909261|P2|Part 1: Dose Escalation|Progressive Disease|2
1692876|NCT01286987|5909262|P1|Part 1: Dose Escalation|Progressive Disease|2
1692877|NCT01286987|5909248|P15|Part 1: Dose Escalation|Clinical Progression|0
1692878|NCT01286987|5909249|P14|Part 1: Dose Escalation|Clinical Progression|0
1692879|NCT01286987|5909250|P13|Part 1: Dose Escalation|Clinical Progression|0
1692880|NCT01286987|5909251|P12|Part 1: Dose Escalation|Clinical Progression|0
1692881|NCT01286987|5909252|P11|Part 1: Dose Escalation|Clinical Progression|0
1692882|NCT01286987|5909253|P10|Part 1: Dose Escalation|Clinical Progression|0
1692883|NCT01286987|5909254|P9|Part 1: Dose Escalation|Clinical Progression|1
1692884|NCT01286987|5909255|P8|Part 1: Dose Escalation|Clinical Progression|2
1692885|NCT01286987|5909256|P7|Part 1: Dose Escalation|Clinical Progression|0
1692886|NCT01286987|5909257|P6|Part 1: Dose Escalation|Clinical Progression|1
1692887|NCT01286987|5909258|P5|Part 1: Dose Escalation|Clinical Progression|1
1692888|NCT01286987|5909259|P4|Part 1: Dose Escalation|Clinical Progression|1
1692889|NCT01286987|5909260|P3|Part 1: Dose Escalation|Clinical Progression|0
1692890|NCT01286987|5909261|P2|Part 1: Dose Escalation|Clinical Progression|1
1692891|NCT01286987|5909262|P1|Part 1: Dose Escalation|Clinical Progression|1
1692892|NCT01286779|5909443|P1|Overall Study|Discontinued by sponsor|1
1692893|NCT01286779|5909443|P1|Overall Study|Participant moved to another country|1
1692894|NCT01286779|5909443|P1|Overall Study|Participant had scheduled surgery|1
1692895|NCT01286779|5909443|P1|Overall Study|Physician Decision|2
1692896|NCT01286779|5909443|P1|Overall Study|Protocol Violation|5
1692897|NCT01286779|5909443|P1|Overall Study|Withdrawal by Subject|9
1692898|NCT01286753|5909495|P2|Overall Study|Participant to Receive Radiotherapy|0
1692899|NCT01286753|5909496|P1|Overall Study|Participant to Receive Radiotherapy|1
1692900|NCT01286753|5909495|P2|Overall Study|Discontinued to Join Extension Study|4
1692901|NCT01286753|5909496|P1|Overall Study|Discontinued to Join Extension Study|6
1692902|NCT01286753|5909495|P2|Overall Study|Withdrawal of Consent|2
1692903|NCT01286753|5909496|P1|Overall Study|Withdrawal of Consent|0
1692904|NCT01286753|5909495|P2|Overall Study|Refused Treatment|0
1692905|NCT01286753|5909496|P1|Overall Study|Refused Treatment|1
1692906|NCT01286753|5909495|P2|Overall Study|Progression|13
1692907|NCT01286753|5909496|P1|Overall Study|Progression|11
1692908|NCT01286753|5909495|P2|Overall Study|Adverse Event|6
1692909|NCT01286753|5909496|P1|Overall Study|Adverse Event|7
1692910|NCT01286740|5909514|P1|Overall Study|Protocol Violation|1
1692911|NCT01286740|5909514|P1|Overall Study|Enrolled but not treated|1
1692912|NCT01286558|5909532|P2|Overall Study|Withdrawal by Subject|1
1692913|NCT01286558|5909533|P1|Overall Study|Withdrawal by Subject|0
1692914|NCT01286558|5909532|P2|Overall Study|Adverse Event|1
1692915|NCT01286558|5909533|P1|Overall Study|Adverse Event|1
1692916|NCT01286480|5909569|P2|Overall Study|Withdrawal by Subject|3
1692917|NCT01286480|5909570|P1|Overall Study|Withdrawal by Subject|5
1692918|NCT01286311|5909677|P2|Overall Study|Physician did not want outreach sent|0
1692919|NCT01286311|5909678|P1|Overall Study|Physician did not want outreach sent|14
1692920|NCT01286272|5909694|P2|Overall Study|Ineligible after beginning treatment|3
1692921|NCT01286272|5909695|P1|Overall Study|Ineligible after beginning treatment|1
1692922|NCT01286207|5909708|P3|Overall Study|Other|13
1692923|NCT01286207|5909709|P2|Overall Study|Other|47
1692924|NCT01286207|5909710|P1|Overall Study|Other|37
1692925|NCT01286207|5909708|P3|Overall Study|Lack of Response|8
1692926|NCT01286207|5909709|P2|Overall Study|Lack of Response|38
1692927|NCT01286207|5909710|P1|Overall Study|Lack of Response|92
1692928|NCT01286207|5909708|P3|Overall Study|Withdrawal by Subject|41
1692929|NCT01286207|5909709|P2|Overall Study|Withdrawal by Subject|79
1692930|NCT01286207|5909710|P1|Overall Study|Withdrawal by Subject|93
1692931|NCT01286207|5909708|P3|Overall Study|Lost to Follow-up|20
1692932|NCT01286207|5909709|P2|Overall Study|Lost to Follow-up|43
1692933|NCT01286207|5909710|P1|Overall Study|Lost to Follow-up|49
1692934|NCT01286207|5909708|P3|Overall Study|Adverse Event|8
1692935|NCT01286207|5909709|P2|Overall Study|Adverse Event|41
1692936|NCT01286207|5909710|P1|Overall Study|Adverse Event|27
1692937|NCT01286168|5909730|P1|Overall Study|Surgical Drains Fell Out at Home|2
1692938|NCT01286168|5909730|P1|Overall Study|Withdrawal by Subject|1
1692939|NCT01286129|5909744|P2|Overall Study|Could not comply with study requirements|4
1692940|NCT01286129|5909745|P1|Overall Study|Could not comply with study requirements|4
1692941|NCT01286129|5909744|P2|Overall Study|Withdrawal by Subject|1
1692942|NCT01286129|5909745|P1|Overall Study|Withdrawal by Subject|4
1692943|NCT01286077|5909755|P2|Overall Study|refill medication not received in time|0
1692944|NCT01286077|5909756|P1|Overall Study|refill medication not received in time|1
1692945|NCT01286077|5909755|P2|Overall Study|Progression of disease|1
1692946|NCT01286077|5909756|P1|Overall Study|Progression of disease|0
1692947|NCT01286077|5909755|P2|Overall Study|Patient's decision to stop treatment|0
1692948|NCT01286077|5909756|P1|Overall Study|Patient's decision to stop treatment|3
1692949|NCT01286077|5909755|P2|Overall Study|The subject starts with alternative MMY|3
1692950|NCT01286077|5909756|P1|Overall Study|The subject starts with alternative MMY|0
1692951|NCT01286077|5909755|P2|Overall Study|Non-compliance|0
1692952|NCT01286077|5909756|P1|Overall Study|Non-compliance|1
1692953|NCT01286077|5909755|P2|Overall Study|Intercurrent illness|0
1692954|NCT01286077|5909756|P1|Overall Study|Intercurrent illness|1
1692955|NCT01286077|5909755|P2|Overall Study|Withdrawal by Subject|2
1692956|NCT01286077|5909756|P1|Overall Study|Withdrawal by Subject|0
1692957|NCT01286077|5909755|P2|Overall Study|Protocol Violation|1
1692958|NCT01286077|5909756|P1|Overall Study|Protocol Violation|1
1692959|NCT01286077|5909755|P2|Overall Study|Death|0
1692960|NCT01286077|5909756|P1|Overall Study|Death|1
1692961|NCT01286077|5909755|P2|Overall Study|Adverse Event|0
1692962|NCT01286077|5909756|P1|Overall Study|Adverse Event|2
1692963|NCT01286012|5909792|P2|Overall Study|peritoneal dialysis, randomized in error|3
1692964|NCT01286012|5909793|P1|Overall Study|peritoneal dialysis, randomized in error|1
1692965|NCT01286012|5909792|P2|Overall Study|Physician Decision|0
1692966|NCT01286012|5909793|P1|Overall Study|Physician Decision|2
1692967|NCT01286012|5909792|P2|Overall Study|Withdrawal by Subject|4
1692968|NCT01286012|5909793|P1|Overall Study|Withdrawal by Subject|4
1692969|NCT01286012|5909792|P2|Overall Study|Protocol Violation|1
1692970|NCT01286012|5909793|P1|Overall Study|Protocol Violation|1
1692971|NCT01286012|5909792|P2|Overall Study|Death|3
1692972|NCT01286012|5909793|P1|Overall Study|Death|2
1692973|NCT01286012|5909792|P2|Overall Study|Adverse Event|3
1692974|NCT01286012|5909793|P1|Overall Study|Adverse Event|3
1692975|NCT01285960|5909807|P1|Overall Study|2 subjects received less 10 sonications|2
1692976|NCT01285960|5909807|P1|Overall Study|Lost to Follow-up|2
1692977|NCT01285960|5909807|P1|Overall Study|Withdrawal by Subject|2
1692978|NCT01285908|5909820|P3|Baseline Measurement|unable to tolerate procedure|0
1692979|NCT01285908|5909821|P2|Baseline Measurement|unable to tolerate procedure|0
1692980|NCT01285908|5909822|P1|Baseline Measurement|unable to tolerate procedure|1
1692981|NCT01285908|5909820|P3|Baseline Measurement|History of stroke, exclusion criteria|0
1692982|NCT01285908|5909821|P2|Baseline Measurement|History of stroke, exclusion criteria|0
1692983|NCT01285908|5909822|P1|Baseline Measurement|History of stroke, exclusion criteria|1
1692984|NCT01285908|5909820|P3|Baseline Measurement|unable to insert catheter|0
1692985|NCT01285908|5909821|P2|Baseline Measurement|unable to insert catheter|0
1692986|NCT01285908|5909822|P1|Baseline Measurement|unable to insert catheter|1
1692987|NCT01285609|5909916|P2|Treated With Blinded Therapy|Worsening of general condition|1
1692988|NCT01285609|5909917|P1|Treated With Blinded Therapy|Worsening of general condition|0
1692989|NCT01285609|5909916|P2|Treated With Blinded Therapy|PI decision to discontinue|1
1692990|NCT01285609|5909917|P1|Treated With Blinded Therapy|PI decision to discontinue|0
1692991|NCT01285609|5909916|P2|Treated With Blinded Therapy|Investigator's assessment|0
1692992|NCT01285609|5909917|P1|Treated With Blinded Therapy|Investigator's assessment|1
1692993|NCT01285609|5909916|P2|Treated With Blinded Therapy|Participant hospitalized|0
1692994|NCT01285609|5909917|P1|Treated With Blinded Therapy|Participant hospitalized|1
1692995|NCT01285609|5909916|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
1692996|NCT01285609|5909917|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
1692997|NCT01285609|5909916|P2|Treated With Blinded Therapy|Participant refused participation|0
1692998|NCT01285609|5909917|P1|Treated With Blinded Therapy|Participant refused participation|1
1692999|NCT01285609|5909916|P2|Treated With Blinded Therapy|Physician and Patient decision|3
1693000|NCT01285609|5909917|P1|Treated With Blinded Therapy|Physician and Patient decision|1
1693001|NCT01285609|5909916|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
1693002|NCT01285609|5909917|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
1693003|NCT01285609|5909916|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
1693004|NCT01285609|5909917|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
1693005|NCT01285609|5909916|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
1693006|NCT01285609|5909917|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
1693007|NCT01285609|5909916|P2|Treated With Blinded Therapy|Not Reported|2
1693008|NCT01285609|5909917|P1|Treated With Blinded Therapy|Not Reported|0
1693009|NCT01285609|5909916|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
1693010|NCT01285609|5909917|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
1693011|NCT01285609|5909916|P2|Treated With Blinded Therapy|Death|3
1693012|NCT01285609|5909917|P1|Treated With Blinded Therapy|Death|11
1693013|NCT01285609|5909916|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
1693014|NCT01285609|5909917|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
1693015|NCT01285609|5909916|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
1693016|NCT01285609|5909917|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
1693017|NCT01285609|5909916|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
1693018|NCT01285609|5909917|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
1693019|NCT01285609|5909916|P2|Treated With Blinded Therapy|Progressive Disease|305
1693020|NCT01285609|5909917|P1|Treated With Blinded Therapy|Progressive Disease|223
1693021|NCT01285609|5909916|P2|Randomized|Randomized but not Treated|4
1693022|NCT01285609|5909917|P1|Randomized|Randomized but not Treated|4
1693023|NCT01285609|5909916|P2|Randomized|Undisclosed Reasons|0
1693024|NCT01285609|5909917|P1|Randomized|Undisclosed Reasons|1
1693025|NCT01285609|5909916|P2|Randomized|Subject No Longer Met Study Criteria|1
1693026|NCT01285609|5909917|P1|Randomized|Subject No Longer Met Study Criteria|1
1693027|NCT01285609|5909916|P2|Randomized|Withdrawal by Subject|11
1693028|NCT01285609|5909917|P1|Randomized|Withdrawal by Subject|8
1693029|NCT01285609|5909916|P2|Randomized|Death|7
1693030|NCT01285609|5909917|P1|Randomized|Death|5
1693031|NCT01285609|5909916|P2|Randomized|Study Drug Toxicity|14
1693032|NCT01285609|5909917|P1|Randomized|Study Drug Toxicity|13
1693033|NCT01285609|5909916|P2|Randomized|Adverse Event Unrelated to Study Drug|18
1693034|NCT01285609|5909917|P1|Randomized|Adverse Event Unrelated to Study Drug|18
1693035|NCT01285609|5909916|P2|Randomized|Progressive Disease|61
1693036|NCT01285609|5909917|P1|Randomized|Progressive Disease|41
1693037|NCT01285518|5909935|P8|Overall Study|Lost to Follow-up|0
1693038|NCT01285518|5909936|P7|Overall Study|Lost to Follow-up|0
1693039|NCT01285518|5909937|P6|Overall Study|Lost to Follow-up|1
1693040|NCT01285518|5909938|P5|Overall Study|Lost to Follow-up|0
1693041|NCT01285518|5909939|P4|Overall Study|Lost to Follow-up|0
1693042|NCT01285518|5909940|P3|Overall Study|Lost to Follow-up|0
1693043|NCT01285518|5909941|P2|Overall Study|Lost to Follow-up|0
1693044|NCT01285518|5909942|P1|Overall Study|Lost to Follow-up|0
1693045|NCT01285492|5910202|P2|Overall Study|Death|0
1693046|NCT01285492|5910203|P1|Overall Study|Death|1
1693047|NCT01285492|5910202|P2|Overall Study|Withdrawal by Subject|1
1693048|NCT01285492|5910203|P1|Overall Study|Withdrawal by Subject|2
1693049|NCT01285492|5910202|P2|Overall Study|Protocol Violation|0
1693050|NCT01285492|5910203|P1|Overall Study|Protocol Violation|3
1693051|NCT01285492|5910202|P2|Overall Study|Adverse Event|0
1693052|NCT01285492|5910203|P1|Overall Study|Adverse Event|11
1693053|NCT01285401|5910235|P2|Overall Study|Prematurely withdrawn from the study|29
1693054|NCT01285401|5910236|P1|Overall Study|Prematurely withdrawn from the study|17
1693055|NCT01285349|5910277|P3|Overall Study|Lost to Follow-up|27
1693056|NCT01285349|5910278|P2|Overall Study|Lost to Follow-up|20
1693057|NCT01285349|5910279|P1|Overall Study|Lost to Follow-up|27
1693058|NCT01285323|5910292|P2|Overall Study|Other|3
1693059|NCT01285323|5910293|P1|Overall Study|Other|1
1693060|NCT01285323|5910292|P2|Overall Study|Lost to Follow-up|1
1693061|NCT01285323|5910293|P1|Overall Study|Lost to Follow-up|1
1693062|NCT01285323|5910292|P2|Overall Study|Non-compliance with study procedures|3
1693063|NCT01285323|5910293|P1|Overall Study|Non-compliance with study procedures|2
1693064|NCT01285323|5910292|P2|Overall Study|Protocol Violation|2
1693065|NCT01285323|5910293|P1|Overall Study|Protocol Violation|1
1693066|NCT01285323|5910292|P2|Overall Study|Withdrawal by Subject|11
1693067|NCT01285323|5910293|P1|Overall Study|Withdrawal by Subject|15
1693068|NCT01285323|5910292|P2|Overall Study|Lack of Efficacy|2
1693069|NCT01285323|5910293|P1|Overall Study|Lack of Efficacy|4
1693070|NCT01285323|5910292|P2|Overall Study|Adverse Event|8
1693071|NCT01285323|5910293|P1|Overall Study|Adverse Event|9
1693072|NCT01285310|5910328|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
1693073|NCT01285310|5910329|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1693074|NCT01285310|5910330|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1693075|NCT01285310|5910331|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
1693076|NCT01285310|5910332|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
1693077|NCT01285310|5910328|P5|Active Treatment Phase: Weeks 25-52|Other|0
1693078|NCT01285310|5910329|P4|Active Treatment Phase: Weeks 25-52|Other|0
1693079|NCT01285310|5910330|P3|Active Treatment Phase: Weeks 25-52|Other|0
1693080|NCT01285310|5910331|P2|Active Treatment Phase: Weeks 25-52|Other|1
1693081|NCT01285310|5910332|P1|Active Treatment Phase: Weeks 25-52|Other|0
1693082|NCT01285310|5910328|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
1693083|NCT01285310|5910329|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
1693084|NCT01285310|5910330|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
1693085|NCT01285310|5910331|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
1693086|NCT01285310|5910332|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
1693087|NCT01285310|5910328|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
1693088|NCT01285310|5910329|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
1693089|NCT01285310|5910330|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
1693090|NCT01285310|5910331|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
1693091|NCT01285310|5910332|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
1693092|NCT01285310|5910328|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
1693093|NCT01285310|5910329|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
1693094|NCT01285310|5910330|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
1693095|NCT01285310|5910331|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
1693096|NCT01285310|5910332|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
1693097|NCT01285310|5910328|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
1693098|NCT01285310|5910329|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
1693099|NCT01285310|5910330|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
1693100|NCT01285310|5910331|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
1693101|NCT01285310|5910332|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
1693102|NCT01285310|5910328|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
1693103|NCT01285310|5910329|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
1693104|NCT01285310|5910330|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
1693105|NCT01285310|5910331|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
1693106|NCT01285310|5910332|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
1693107|NCT01285310|5910328|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1693108|NCT01285310|5910329|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1693109|NCT01285310|5910330|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
1693110|NCT01285310|5910331|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
1693111|NCT01285310|5910332|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
1693112|NCT01285310|5910328|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
1693113|NCT01285310|5910329|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
1693114|NCT01285310|5910330|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
1693115|NCT01285310|5910331|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
1693116|NCT01285310|5910332|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
1693117|NCT01285310|5910328|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1693118|NCT01285310|5910329|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1693119|NCT01285310|5910330|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
1693120|NCT01285310|5910331|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
1693121|NCT01285310|5910332|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
1693122|NCT01285310|5910328|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
1693123|NCT01285310|5910329|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
1693124|NCT01285310|5910330|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
1693125|NCT01285310|5910331|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
1693126|NCT01285310|5910332|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
1693127|NCT01285310|5910328|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
1693128|NCT01285310|5910329|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
1693129|NCT01285310|5910330|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
1693130|NCT01285310|5910331|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
1693131|NCT01285310|5910332|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
1693132|NCT01284959|5910597|P3|Overall Study|Adverse Event|1
1693133|NCT01284959|5910598|P2|Overall Study|Adverse Event|0
1693134|NCT01284959|5910599|P1|Overall Study|Adverse Event|0
1693135|NCT01284959|5910597|P3|Overall Study|Withdrawal by Subject|0
1693136|NCT01284959|5910598|P2|Overall Study|Withdrawal by Subject|0
1693137|NCT01284959|5910599|P1|Overall Study|Withdrawal by Subject|1
1693138|NCT01284634|5910629|P4|Overall Study|Adverse Event|1
1693139|NCT01284634|5910630|P3|Overall Study|Adverse Event|2
1693140|NCT01284634|5910631|P2|Overall Study|Adverse Event|0
1693141|NCT01284634|5910632|P1|Overall Study|Adverse Event|1
1693142|NCT01284621|5910662|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1693143|NCT01284621|5910663|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
1693144|NCT01284621|5910664|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1693145|NCT01284621|5910665|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1693146|NCT01284621|5910666|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1693147|NCT01284621|5910667|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
1693148|NCT01284491|5910735|P1|Overall Study|Study termination|13
1693149|NCT01284361|5910745|P1|Overall Study|Lost to Follow-up|2
1693150|NCT01284361|5910745|P1|Overall Study|Adverse Event|1
1693151|NCT01284361|5910745|P1|Overall Study|Protocol Violation|5
1693152|NCT01284361|5910745|P1|Overall Study|Withdrawal by Subject|1
1693153|NCT01284140|5910841|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
1693154|NCT01284140|5910842|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
1693155|NCT01284140|5910841|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
1693156|NCT01284140|5910842|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
1693157|NCT01284127|5910856|P1|Overall Study|Physician Decision|1
1693158|NCT01284127|5910856|P1|Overall Study|Withdrawal by Subject|4
1693159|NCT01284127|5910856|P1|Overall Study|Adverse Event|2
1693160|NCT01284114|5910865|P1|Overall Study|dizziness|1
1693161|NCT01284114|5910865|P1|Overall Study|Symptomatic hypotension|1
1693162|NCT01284114|5910865|P1|Overall Study|From the results of ALLTITUDE study|1
1693163|NCT01284114|5910865|P1|Overall Study|viral infection|1
1693164|NCT01284062|5910877|P4|Overall Study|Site Closed|0
1693165|NCT01284062|5910878|P3|Overall Study|Site Closed|1
1693166|NCT01284062|5910879|P2|Overall Study|Site Closed|0
1693167|NCT01284062|5910880|P1|Overall Study|Site Closed|0
1693168|NCT01284062|5910877|P4|Overall Study|Other|1
1693169|NCT01284062|5910878|P3|Overall Study|Other|0
1693170|NCT01284062|5910879|P2|Overall Study|Other|0
1693171|NCT01284062|5910880|P1|Overall Study|Other|0
1693172|NCT01284062|5910877|P4|Overall Study|Withdrawal by Subject|5
1693173|NCT01284062|5910878|P3|Overall Study|Withdrawal by Subject|2
1693174|NCT01284062|5910879|P2|Overall Study|Withdrawal by Subject|1
1693175|NCT01284062|5910880|P1|Overall Study|Withdrawal by Subject|3
1693176|NCT01284062|5910877|P4|Overall Study|Protocol Violation|2
1693177|NCT01284062|5910878|P3|Overall Study|Protocol Violation|0
1693178|NCT01284062|5910879|P2|Overall Study|Protocol Violation|0
1693179|NCT01284062|5910880|P1|Overall Study|Protocol Violation|1
1693180|NCT01284062|5910877|P4|Overall Study|Medication error without adverse event|0
1693181|NCT01284062|5910878|P3|Overall Study|Medication error without adverse event|1
1693182|NCT01284062|5910879|P2|Overall Study|Medication error without adverse event|0
1693183|NCT01284062|5910880|P1|Overall Study|Medication error without adverse event|0
1693184|NCT01284062|5910877|P4|Overall Study|Lack of Efficacy|1
1693185|NCT01284062|5910878|P3|Overall Study|Lack of Efficacy|2
1693186|NCT01284062|5910879|P2|Overall Study|Lack of Efficacy|2
1693187|NCT01284062|5910880|P1|Overall Study|Lack of Efficacy|3
1693188|NCT01284062|5910877|P4|Overall Study|Adverse Event|5
1693189|NCT01284062|5910878|P3|Overall Study|Adverse Event|0
1693190|NCT01284062|5910879|P2|Overall Study|Adverse Event|5
1693191|NCT01284062|5910880|P1|Overall Study|Adverse Event|4
1693192|NCT01283971|5910954|P2|Overall Study|Administrative reasons|1
1693193|NCT01283971|5910955|P1|Overall Study|Administrative reasons|1
1693194|NCT01283971|5910954|P2|Overall Study|Failure to return|1
1693195|NCT01283971|5910955|P1|Overall Study|Failure to return|0
1693196|NCT01283971|5910954|P2|Overall Study|Refused treatment|1
1693197|NCT01283971|5910955|P1|Overall Study|Refused treatment|3
1693198|NCT01283971|5910954|P2|Overall Study|Protocol Violation|1
1693199|NCT01283971|5910955|P1|Overall Study|Protocol Violation|5
1693200|NCT01283971|5910954|P2|Overall Study|Insufficient therapeutic responses|3
1693201|NCT01283971|5910955|P1|Overall Study|Insufficient therapeutic responses|3
1693202|NCT01283971|5910954|P2|Overall Study|Adverse Event|5
1693203|NCT01283971|5910955|P1|Overall Study|Adverse Event|3
1693204|NCT01283581|5911002|P3|Overall Study|"Early termination"|1
1693205|NCT01283581|5911003|P2|Overall Study|"Early termination"|0
1693206|NCT01283581|5911004|P1|Overall Study|"Early termination"|0
1693207|NCT01283581|5911002|P3|Overall Study|Investigator unblinded|1
1693208|NCT01283581|5911003|P2|Overall Study|Investigator unblinded|0
1693209|NCT01283581|5911004|P1|Overall Study|Investigator unblinded|0
1693210|NCT01283581|5911002|P3|Overall Study|Noncompliance|0
1693211|NCT01283581|5911003|P2|Overall Study|Noncompliance|0
1693212|NCT01283581|5911004|P1|Overall Study|Noncompliance|1
1693213|NCT01283581|5911002|P3|Overall Study|Protocol Violation|2
1693214|NCT01283581|5911003|P2|Overall Study|Protocol Violation|1
1693215|NCT01283581|5911004|P1|Overall Study|Protocol Violation|0
1693216|NCT01283581|5911002|P3|Overall Study|Physician Decision|2
1693217|NCT01283581|5911003|P2|Overall Study|Physician Decision|1
1693218|NCT01283581|5911004|P1|Overall Study|Physician Decision|0
1693219|NCT01283581|5911002|P3|Overall Study|Adverse Event|4
1693220|NCT01283581|5911003|P2|Overall Study|Adverse Event|1
1693221|NCT01283581|5911004|P1|Overall Study|Adverse Event|1
1693222|NCT01283581|5911002|P3|Overall Study|Withdrawal by Subject|2
1693223|NCT01283581|5911003|P2|Overall Study|Withdrawal by Subject|5
1693224|NCT01283581|5911004|P1|Overall Study|Withdrawal by Subject|2
1693225|NCT01283581|5911002|P3|Overall Study|Lost to Follow-up|8
1693226|NCT01283581|5911003|P2|Overall Study|Lost to Follow-up|6
1693227|NCT01283581|5911004|P1|Overall Study|Lost to Follow-up|8
1693228|NCT01283542|5911074|P1|Extension Phase|Administrative problems|1
1693229|NCT01283542|5911074|P1|Extension Phase|Adverse Event|1
1693230|NCT01283542|5911074|P1|Extension Phase|Physician Decision|1
1693231|NCT01283542|5911074|P1|Main Phase|abnormal laboratory values|5
1693232|NCT01283542|5911074|P1|Main Phase|Uncontrolled diabetes mellitus|1
1693233|NCT01283542|5911074|P1|Main Phase|Acute or progressive vision loss|1
1693234|NCT01283516|5911139|P9|Overall Study|Lost to Follow-up|1
1693235|NCT01283516|5911140|P8|Overall Study|Lost to Follow-up|0
1693236|NCT01283516|5911141|P7|Overall Study|Lost to Follow-up|0
1693237|NCT01283516|5911142|P6|Overall Study|Lost to Follow-up|0
1693238|NCT01283516|5911143|P5|Overall Study|Lost to Follow-up|0
1693239|NCT01283516|5911144|P4|Overall Study|Lost to Follow-up|0
1693240|NCT01283516|5911145|P3|Overall Study|Lost to Follow-up|0
1693241|NCT01283516|5911146|P2|Overall Study|Lost to Follow-up|0
1693242|NCT01283516|5911147|P1|Overall Study|Lost to Follow-up|0
1693243|NCT01283516|5911139|P9|Overall Study|Administrative problems|39
1693244|NCT01283516|5911140|P8|Overall Study|Administrative problems|1
1693245|NCT01283516|5911141|P7|Overall Study|Administrative problems|1
1693246|NCT01283516|5911142|P6|Overall Study|Administrative problems|1
1693247|NCT01283516|5911143|P5|Overall Study|Administrative problems|0
1693248|NCT01283516|5911144|P4|Overall Study|Administrative problems|0
1693249|NCT01283516|5911145|P3|Overall Study|Administrative problems|0
1693250|NCT01283516|5911146|P2|Overall Study|Administrative problems|0
1693251|NCT01283516|5911147|P1|Overall Study|Administrative problems|0
1693252|NCT01283516|5911139|P9|Overall Study|Withdrawal by Subject|36
1693253|NCT01283516|5911140|P8|Overall Study|Withdrawal by Subject|0
1693254|NCT01283516|5911141|P7|Overall Study|Withdrawal by Subject|1
1693255|NCT01283516|5911142|P6|Overall Study|Withdrawal by Subject|0
1693256|NCT01283516|5911143|P5|Overall Study|Withdrawal by Subject|1
1693257|NCT01283516|5911144|P4|Overall Study|Withdrawal by Subject|0
1693258|NCT01283516|5911145|P3|Overall Study|Withdrawal by Subject|0
1693259|NCT01283516|5911146|P2|Overall Study|Withdrawal by Subject|0
1693260|NCT01283516|5911147|P1|Overall Study|Withdrawal by Subject|0
1693261|NCT01283516|5911139|P9|Overall Study|Disease Progression|139
1693262|NCT01283516|5911140|P8|Overall Study|Disease Progression|3
1693263|NCT01283516|5911141|P7|Overall Study|Disease Progression|6
1693264|NCT01283516|5911142|P6|Overall Study|Disease Progression|8
1693265|NCT01283516|5911143|P5|Overall Study|Disease Progression|13
1693266|NCT01283516|5911144|P4|Overall Study|Disease Progression|3
1693267|NCT01283516|5911145|P3|Overall Study|Disease Progression|3
1693268|NCT01283516|5911146|P2|Overall Study|Disease Progression|2
1693269|NCT01283516|5911147|P1|Overall Study|Disease Progression|2
1693270|NCT01283516|5911139|P9|Overall Study|Death|12
1693271|NCT01283516|5911140|P8|Overall Study|Death|1
1693272|NCT01283516|5911141|P7|Overall Study|Death|0
1693273|NCT01283516|5911142|P6|Overall Study|Death|1
1693274|NCT01283516|5911143|P5|Overall Study|Death|0
1693275|NCT01283516|5911144|P4|Overall Study|Death|0
1693276|NCT01283516|5911145|P3|Overall Study|Death|0
1693277|NCT01283516|5911146|P2|Overall Study|Death|0
1693278|NCT01283516|5911147|P1|Overall Study|Death|0
1693279|NCT01283516|5911139|P9|Overall Study|Adverse Event|28
1693280|NCT01283516|5911140|P8|Overall Study|Adverse Event|0
1693281|NCT01283516|5911141|P7|Overall Study|Adverse Event|2
1693282|NCT01283516|5911142|P6|Overall Study|Adverse Event|0
1693283|NCT01283516|5911143|P5|Overall Study|Adverse Event|0
1693284|NCT01283516|5911144|P4|Overall Study|Adverse Event|0
1693285|NCT01283516|5911145|P3|Overall Study|Adverse Event|0
1693286|NCT01283516|5911146|P2|Overall Study|Adverse Event|0
1693287|NCT01283516|5911147|P1|Overall Study|Adverse Event|0
1693288|NCT01283464|5911269|P2|Overall Study|Physician Decision|0
1693289|NCT01283464|5911270|P1|Overall Study|Physician Decision|1
1693290|NCT01283464|5911269|P2|Overall Study|Withdrawal by Subject|0
1693291|NCT01283464|5911270|P1|Overall Study|Withdrawal by Subject|1
1693292|NCT01283464|5911269|P2|Overall Study|Lost to Follow-up|1
1693293|NCT01283464|5911270|P1|Overall Study|Lost to Follow-up|0
1693294|NCT01283386|5911278|P2|Overall Study|Protocol Violation|1
1693295|NCT01283386|5911279|P1|Overall Study|Protocol Violation|0
1693296|NCT01283386|5911278|P2|Overall Study|Reason not specified|0
1693297|NCT01283386|5911279|P1|Overall Study|Reason not specified|1
1693298|NCT01283386|5911278|P2|Overall Study|Progression of underlying disease|7
1693299|NCT01283386|5911279|P1|Overall Study|Progression of underlying disease|2
1693300|NCT01283386|5911278|P2|Overall Study|Relapse of underlying disease|3
1693301|NCT01283386|5911279|P1|Overall Study|Relapse of underlying disease|1
1693302|NCT01283386|5911278|P2|Overall Study|Withdrawal by Subject|1
1693303|NCT01283386|5911279|P1|Overall Study|Withdrawal by Subject|2
1693304|NCT01283386|5911278|P2|Overall Study|Death|0
1693305|NCT01283386|5911279|P1|Overall Study|Death|2
1693306|NCT01283334|5911303|P1|Overall Study|Physician Decision|1
1693307|NCT01283334|5911303|P1|Overall Study|Adverse Event|4
1693308|NCT01283334|5911303|P1|Overall Study|Inability to Swallow Everolimus Pills|1
1693309|NCT01283334|5911303|P1|Overall Study|Withdrawal by Subject|1
1693310|NCT01283282|5911326|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
1693311|NCT01283282|5911327|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
1693312|NCT01283282|5911326|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
1693313|NCT01283282|5911327|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
1693314|NCT01283282|5911326|P2|First Intervention (6 Weeks)|Physician Decision|1
1693315|NCT01283282|5911327|P1|First Intervention (6 Weeks)|Physician Decision|0
1693316|NCT01283152|5911347|P2|Overall Study|Refused HESA|0
1693317|NCT01283152|5911348|P1|Overall Study|Refused HESA|1
1693318|NCT01283152|5911347|P2|Overall Study|Discharged prior to 24 hr assessment|0
1693319|NCT01283152|5911348|P1|Overall Study|Discharged prior to 24 hr assessment|1
1693320|NCT01283139|5911362|P4|Overall Study|Participant randomized in error|0
1693321|NCT01283139|5911363|P3|Overall Study|Participant randomized in error|1
1693322|NCT01283139|5911364|P2|Overall Study|Participant randomized in error|0
1693323|NCT01283139|5911365|P1|Overall Study|Participant randomized in error|0
1693324|NCT01283139|5911362|P4|Overall Study|Missed follow-up visit|2
1693325|NCT01283139|5911363|P3|Overall Study|Missed follow-up visit|2
1693326|NCT01283139|5911364|P2|Overall Study|Missed follow-up visit|1
1693327|NCT01283139|5911365|P1|Overall Study|Missed follow-up visit|0
1693328|NCT01283139|5911362|P4|Overall Study|Pregnancy|0
1693329|NCT01283139|5911363|P3|Overall Study|Pregnancy|1
1693330|NCT01283139|5911364|P2|Overall Study|Pregnancy|1
1693331|NCT01283139|5911365|P1|Overall Study|Pregnancy|0
1693332|NCT01283139|5911362|P4|Overall Study|Participant's refusal to continue|1
1693333|NCT01283139|5911363|P3|Overall Study|Participant's refusal to continue|1
1693334|NCT01283139|5911364|P2|Overall Study|Participant's refusal to continue|3
1693335|NCT01283139|5911365|P1|Overall Study|Participant's refusal to continue|0
1693336|NCT01283139|5911362|P4|Overall Study|Early termination due to AE/SAE|0
1693337|NCT01283139|5911363|P3|Overall Study|Early termination due to AE/SAE|0
1693338|NCT01283139|5911364|P2|Overall Study|Early termination due to AE/SAE|1
1693339|NCT01283139|5911365|P1|Overall Study|Early termination due to AE/SAE|1
1693340|NCT01283139|5911362|P4|Overall Study|Lack of Efficacy|1
1693341|NCT01283139|5911363|P3|Overall Study|Lack of Efficacy|2
1693342|NCT01283139|5911364|P2|Overall Study|Lack of Efficacy|2
1693343|NCT01283139|5911365|P1|Overall Study|Lack of Efficacy|1
1693344|NCT01283139|5911362|P4|Overall Study|Death|2
1693345|NCT01283139|5911363|P3|Overall Study|Death|2
1693346|NCT01283139|5911364|P2|Overall Study|Death|0
1693347|NCT01283139|5911365|P1|Overall Study|Death|2
1693348|NCT01283139|5911362|P4|Overall Study|Withdrawal by Subject|8
1693349|NCT01283139|5911363|P3|Overall Study|Withdrawal by Subject|6
1693350|NCT01283139|5911364|P2|Overall Study|Withdrawal by Subject|8
1693351|NCT01283139|5911365|P1|Overall Study|Withdrawal by Subject|8
1693352|NCT01283139|5911362|P4|Overall Study|Lost to Follow-up|1
1693353|NCT01283139|5911363|P3|Overall Study|Lost to Follow-up|3
1693354|NCT01283139|5911364|P2|Overall Study|Lost to Follow-up|2
1693355|NCT01283139|5911365|P1|Overall Study|Lost to Follow-up|5
1693356|NCT01283035|5911407|P1|Overall Study|Subject later found ineligible|1
1693357|NCT01282866|5911422|P1|Overall Study|Adverse Event|1
1693358|NCT01282814|5911430|P2|Washout of 7 Days|Withdrawal by Subject|0
1693359|NCT01282814|5911431|P1|Washout of 7 Days|Withdrawal by Subject|2
1693360|NCT01282814|5911430|P2|First Intervention|Emesis During Dosing Interval|3
1693361|NCT01282814|5911431|P1|First Intervention|Emesis During Dosing Interval|0
1693362|NCT01282801|5911443|P2|Second Intervention|Emesis During Critical Breakfast|1
1693363|NCT01282801|5911444|P1|Second Intervention|Emesis During Critical Breakfast|0
1693364|NCT01282476|5911468|P1|Overall Study|Death|11
1693365|NCT01282463|5911477|P3|Overall Study|Physician Decision|0
1693366|NCT01282463|5911478|P2|Overall Study|Physician Decision|0
1693367|NCT01282463|5911479|P1|Overall Study|Physician Decision|1
1693368|NCT01282463|5911477|P3|Overall Study|Protocol Violation|1
1693369|NCT01282463|5911478|P2|Overall Study|Protocol Violation|0
1693370|NCT01282463|5911479|P1|Overall Study|Protocol Violation|0
1693371|NCT01282463|5911477|P3|Overall Study|"Never Treated PD"|0
1693372|NCT01282463|5911478|P2|Overall Study|"Never Treated PD"|1
1693373|NCT01282463|5911479|P1|Overall Study|"Never Treated PD"|0
1693374|NCT01282463|5911477|P3|Overall Study|"Never Treated Death"|0
1693375|NCT01282463|5911478|P2|Overall Study|"Never Treated Death"|1
1693376|NCT01282463|5911479|P1|Overall Study|"Never Treated Death"|0
1693377|NCT01282463|5911477|P3|Overall Study|Withdrawal by Subject|3
1693378|NCT01282463|5911478|P2|Overall Study|Withdrawal by Subject|2
1693379|NCT01282463|5911479|P1|Overall Study|Withdrawal by Subject|6
1693380|NCT01282463|5911477|P3|Overall Study|Lost to Follow-up|0
1693381|NCT01282463|5911478|P2|Overall Study|Lost to Follow-up|0
1693382|NCT01282463|5911479|P1|Overall Study|Lost to Follow-up|1
1693383|NCT01282424|5911517|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
1693384|NCT01282424|5911517|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
1693385|NCT01282424|5911517|P1|Long-term Follow-up Period (5 Years)|Death|40
1693386|NCT01282424|5911517|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
1693387|NCT01282424|5911517|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
1693388|NCT01282424|5911517|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
1693389|NCT01282424|5911517|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
1693390|NCT01282424|5911517|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
1693391|NCT01282372|5911534|P1|Overall Study|Adverse Event|12
1693392|NCT01282372|5911534|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
1693393|NCT01282372|5911534|P1|Overall Study|Presence of AE, Regression of Symptoms|1
1693394|NCT01282372|5911534|P1|Overall Study|Presence of AE, Lack of Efficacy|1
1693395|NCT01282372|5911534|P1|Overall Study|Death|1
1693396|NCT01282372|5911534|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
1693397|NCT01282372|5911534|P1|Overall Study|Withdrawal by Subject|11
1693398|NCT01282372|5911534|P1|Overall Study|Lost to Follow-up|23
1693399|NCT01282372|5911534|P1|Overall Study|Lack of Efficacy / Exacerbation|25
1693400|NCT01282294|5911562|P1|Overall Study|Physician Decision|1
1693401|NCT01282294|5911562|P1|Overall Study|Patient non-compliance|2
1693402|NCT01282294|5911562|P1|Overall Study|Adverse Event|1
1693403|NCT01282294|5911562|P1|Overall Study|Screening failure|1
1693404|NCT01282294|5911562|P1|Overall Study|Lost to Follow-up|14
1693405|NCT01282229|5911591|P1|Overall Study|Protocol Violation|2
1693406|NCT01282216|5911623|P4|Overall Study|Death|0
1693407|NCT01282216|5911624|P3|Overall Study|Death|2
1693408|NCT01282216|5911625|P2|Overall Study|Death|0
1693409|NCT01282216|5911626|P1|Overall Study|Death|0
1693410|NCT01282216|5911623|P4|Overall Study|Relapse|6
1693411|NCT01282216|5911624|P3|Overall Study|Relapse|17
1693412|NCT01282216|5911625|P2|Overall Study|Relapse|0
1693413|NCT01282216|5911626|P1|Overall Study|Relapse|0
1693414|NCT01282216|5911623|P4|Overall Study|Physician Decision|0
1693415|NCT01282216|5911624|P3|Overall Study|Physician Decision|11
1693416|NCT01282216|5911625|P2|Overall Study|Physician Decision|0
1693417|NCT01282216|5911626|P1|Overall Study|Physician Decision|0
1693418|NCT01282216|5911623|P4|Overall Study|Graft failure|2
1693419|NCT01282216|5911624|P3|Overall Study|Graft failure|3
1693420|NCT01282216|5911625|P2|Overall Study|Graft failure|0
1693421|NCT01282216|5911626|P1|Overall Study|Graft failure|0
1693422|NCT01282203|5911636|P1|Overall Study|Adverse Event|1
1693423|NCT01282164|5911658|P2|Overall Study|Lack of hypoglycemia during ITT|0
1693424|NCT01282164|5911659|P1|Overall Study|Lack of hypoglycemia during ITT|1
1693425|NCT01281956|5911710|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
1693426|NCT01281956|5911711|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
1693427|NCT01281917|5911742|P1|Overall Study|Withdrawal by Subject|1
1693428|NCT01281865|5911754|P2|Overall Study|Lack of Efficacy|0
1693429|NCT01281865|5911755|P1|Overall Study|Lack of Efficacy|1
1693430|NCT01281865|5911754|P2|Overall Study|Withdrawal by Subject|0
1693431|NCT01281865|5911755|P1|Overall Study|Withdrawal by Subject|1
1693432|NCT01281865|5911754|P2|Overall Study|Adverse Event|1
1693433|NCT01281865|5911755|P1|Overall Study|Adverse Event|1
1693434|NCT01281839|5911763|P2|Overall Study|Reason not specified|1
1693435|NCT01281839|5911764|P1|Overall Study|Reason not specified|0
1693436|NCT01281839|5911763|P2|Overall Study|Withdrawal by Subject|10
1693437|NCT01281839|5911764|P1|Overall Study|Withdrawal by Subject|4
1693438|NCT01281839|5911763|P2|Overall Study|Lost to Follow-up|3
1693439|NCT01281839|5911764|P1|Overall Study|Lost to Follow-up|6
1693440|NCT01281644|5911825|P1|Overall Study|Withdrawal by Subject|2
1693441|NCT01281644|5911825|P1|Overall Study|Lost to Follow-up|3
1693442|NCT01281306|5911866|P7|Overall Study|Randomized in error|0
1693443|NCT01281306|5911867|P6|Overall Study|Randomized in error|0
1693444|NCT01281306|5911868|P5|Overall Study|Randomized in error|0
1693445|NCT01281306|5911869|P4|Overall Study|Randomized in error|1
1693446|NCT01281306|5911870|P3|Overall Study|Randomized in error|0
1693447|NCT01281306|5911871|P2|Overall Study|Randomized in error|0
1693448|NCT01281306|5911872|P1|Overall Study|Randomized in error|1
1693449|NCT01281306|5911866|P7|Overall Study|Adverse Event|3
1693450|NCT01281306|5911867|P6|Overall Study|Adverse Event|3
1693451|NCT01281306|5911868|P5|Overall Study|Adverse Event|5
1693452|NCT01281306|5911869|P4|Overall Study|Adverse Event|3
1693453|NCT01281306|5911870|P3|Overall Study|Adverse Event|2
1693454|NCT01281306|5911871|P2|Overall Study|Adverse Event|2
1693455|NCT01281306|5911872|P1|Overall Study|Adverse Event|3
1693456|NCT01281306|5911866|P7|Overall Study|Death|0
1693457|NCT01281306|5911867|P6|Overall Study|Death|0
1693458|NCT01281306|5911868|P5|Overall Study|Death|0
1693459|NCT01281306|5911869|P4|Overall Study|Death|0
1693460|NCT01281306|5911870|P3|Overall Study|Death|0
1693461|NCT01281306|5911871|P2|Overall Study|Death|0
1693462|NCT01281306|5911872|P1|Overall Study|Death|1
1693463|NCT01281306|5911866|P7|Overall Study|Lost to Follow-up|1
1693464|NCT01281306|5911867|P6|Overall Study|Lost to Follow-up|0
1693465|NCT01281306|5911868|P5|Overall Study|Lost to Follow-up|0
1693466|NCT01281306|5911869|P4|Overall Study|Lost to Follow-up|2
1693467|NCT01281306|5911870|P3|Overall Study|Lost to Follow-up|0
1693468|NCT01281306|5911871|P2|Overall Study|Lost to Follow-up|0
1693469|NCT01281306|5911872|P1|Overall Study|Lost to Follow-up|1
1693470|NCT01281306|5911866|P7|Overall Study|Condition no longer requires study drug|1
1693471|NCT01281306|5911867|P6|Overall Study|Condition no longer requires study drug|1
1693472|NCT01281306|5911868|P5|Overall Study|Condition no longer requires study drug|0
1693473|NCT01281306|5911869|P4|Overall Study|Condition no longer requires study drug|0
1693474|NCT01281306|5911870|P3|Overall Study|Condition no longer requires study drug|0
1693475|NCT01281306|5911871|P2|Overall Study|Condition no longer requires study drug|0
1693476|NCT01281306|5911872|P1|Overall Study|Condition no longer requires study drug|1
1693477|NCT01281306|5911866|P7|Overall Study|Protocol deviation|0
1693478|NCT01281306|5911867|P6|Overall Study|Protocol deviation|0
1693479|NCT01281306|5911868|P5|Overall Study|Protocol deviation|1
1693480|NCT01281306|5911869|P4|Overall Study|Protocol deviation|1
1693481|NCT01281306|5911870|P3|Overall Study|Protocol deviation|1
1693482|NCT01281306|5911871|P2|Overall Study|Protocol deviation|1
1693483|NCT01281306|5911872|P1|Overall Study|Protocol deviation|0
1693484|NCT01281306|5911866|P7|Overall Study|Withdrawal by Subject|1
1693485|NCT01281306|5911867|P6|Overall Study|Withdrawal by Subject|3
1693486|NCT01281306|5911868|P5|Overall Study|Withdrawal by Subject|1
1693487|NCT01281306|5911869|P4|Overall Study|Withdrawal by Subject|4
1693488|NCT01281306|5911870|P3|Overall Study|Withdrawal by Subject|2
1693489|NCT01281306|5911871|P2|Overall Study|Withdrawal by Subject|0
1693490|NCT01281306|5911872|P1|Overall Study|Withdrawal by Subject|1
1693491|NCT01281306|5911866|P7|Overall Study|Lack of Efficacy|1
1693492|NCT01281306|5911867|P6|Overall Study|Lack of Efficacy|0
1693493|NCT01281306|5911868|P5|Overall Study|Lack of Efficacy|2
1693494|NCT01281306|5911869|P4|Overall Study|Lack of Efficacy|0
1693495|NCT01281306|5911870|P3|Overall Study|Lack of Efficacy|3
1693496|NCT01281306|5911871|P2|Overall Study|Lack of Efficacy|1
1693497|NCT01281306|5911872|P1|Overall Study|Lack of Efficacy|0
1693498|NCT01281202|5911988|P2|Overall Study|Incarceration|3
1693499|NCT01281202|5911989|P1|Overall Study|Incarceration|0
1693500|NCT01281202|5911988|P2|Overall Study|Lost to Follow-up|13
1693501|NCT01281202|5911989|P1|Overall Study|Lost to Follow-up|11
1693502|NCT01281202|5911988|P2|Overall Study|Administrative|8
1693503|NCT01281202|5911989|P1|Overall Study|Administrative|2
1693504|NCT01281202|5911988|P2|Overall Study|Protocol Violation|10
1693505|NCT01281202|5911989|P1|Overall Study|Protocol Violation|11
1693506|NCT01281202|5911988|P2|Overall Study|Withdrawal by Subject|2
1693507|NCT01281202|5911989|P1|Overall Study|Withdrawal by Subject|2
1693508|NCT01281202|5911988|P2|Overall Study|Adverse Event|0
1693509|NCT01281202|5911989|P1|Overall Study|Adverse Event|2
1693510|NCT01281124|5911997|P1|Overall Study|Death|1
1693511|NCT01280981|5912012|P1|Overall Study|Study site closure|1
1693512|NCT01280981|5912012|P1|Overall Study|Elective surgery|2
1693513|NCT01280981|5912012|P1|Overall Study|Withdrawal of consent|3
1693514|NCT01280981|5912012|P1|Overall Study|Non-compliance with protocol|3
1693515|NCT01280981|5912012|P1|Overall Study|Failed to return|45
1693516|NCT01280981|5912012|P1|Overall Study|Irregular or discontinued menses|3
1693517|NCT01280981|5912012|P1|Overall Study|Adverse Event|6
1693518|NCT01280981|5912012|P1|Overall Study|Lost to Follow-up|3
1693519|NCT01280981|5912012|P1|Overall Study|Lack of Efficacy|13
1693520|NCT01280981|5912012|P1|Overall Study|Protocol Violation|2
1693521|NCT01280981|5912012|P1|Overall Study|Withdrawal by Subject|11
1693522|NCT01280968|5912023|P2|Overall Study|Unable to Smoke in Supine Position|0
1693523|NCT01280968|5912024|P1|Overall Study|Unable to Smoke in Supine Position|1
1693524|NCT01280968|5912023|P2|Overall Study|Pre-existing Neurological Condition|0
1693525|NCT01280968|5912024|P1|Overall Study|Pre-existing Neurological Condition|1
1693526|NCT01280968|5912023|P2|Overall Study|Scheduling Conflicts|1
1693527|NCT01280968|5912024|P1|Overall Study|Scheduling Conflicts|1
1693528|NCT01280968|5912023|P2|Overall Study|Adverse Event|0
1693529|NCT01280968|5912024|P1|Overall Study|Adverse Event|1
1693530|NCT01280968|5912023|P2|Overall Study|Anxiety|0
1693531|NCT01280968|5912024|P1|Overall Study|Anxiety|2
1693532|NCT01280968|5912023|P2|Overall Study|Commuting Problems|0
1693533|NCT01280968|5912024|P1|Overall Study|Commuting Problems|2
1693534|NCT01280968|5912023|P2|Overall Study|Unable to Follow Experimental Protocol|0
1693535|NCT01280968|5912024|P1|Overall Study|Unable to Follow Experimental Protocol|2
1693536|NCT01280968|5912023|P2|Overall Study|Lost to Follow-up|2
1693537|NCT01280968|5912024|P1|Overall Study|Lost to Follow-up|8
1693538|NCT01280955|5912040|P1|Overall Study|Withdrawal by Subject|1
1693539|NCT01280955|5912040|P1|Overall Study|Death|2
1693540|NCT01280903|5912084|P2|Overall Study|Lost to Follow-up|16
1693541|NCT01280903|5912085|P1|Overall Study|Lost to Follow-up|23
1693542|NCT01280721|5912149|P1|Overall Study|No tolerability for the lowest dose|2
1693543|NCT01280721|5912149|P1|Overall Study|eGFR under the withdrawal criteria|7
1693544|NCT01280721|5912149|P1|Overall Study|Withdrawal by Subject|6
1693545|NCT01280721|5912149|P1|Overall Study|Physician Decision|3
1693546|NCT01280721|5912149|P1|Overall Study|Adverse Event|4
1693547|NCT01280656|5912213|P3|Overall Study|Other|7
1693548|NCT01280656|5912214|P2|Overall Study|Other|7
1693549|NCT01280656|5912215|P1|Overall Study|Other|1
1693550|NCT01280656|5912213|P3|Overall Study|Treatment shortening (RGT)|5
1693551|NCT01280656|5912214|P2|Overall Study|Treatment shortening (RGT)|4
1693552|NCT01280656|5912215|P1|Overall Study|Treatment shortening (RGT)|0
1693553|NCT01280656|5912213|P3|Overall Study|Lack of Efficacy|38
1693554|NCT01280656|5912214|P2|Overall Study|Lack of Efficacy|22
1693555|NCT01280656|5912215|P1|Overall Study|Lack of Efficacy|1
1693556|NCT01280656|5912213|P3|Overall Study|Adverse Event|13
1693557|NCT01280656|5912214|P2|Overall Study|Adverse Event|14
1693558|NCT01280656|5912215|P1|Overall Study|Adverse Event|1
1693559|NCT01280591|5912282|P4|Overall Study|Does not meet exclusion #27 criteria|1
1693560|NCT01280591|5912283|P3|Overall Study|Does not meet exclusion #27 criteria|0
1693561|NCT01280591|5912284|P2|Overall Study|Does not meet exclusion #27 criteria|0
1693562|NCT01280591|5912285|P1|Overall Study|Does not meet exclusion #27 criteria|0
1693563|NCT01280591|5912282|P4|Overall Study|Withdrawal by Subject|2
1693564|NCT01280591|5912283|P3|Overall Study|Withdrawal by Subject|0
1693565|NCT01280591|5912284|P2|Overall Study|Withdrawal by Subject|0
1693566|NCT01280591|5912285|P1|Overall Study|Withdrawal by Subject|0
1693567|NCT01280357|5912423|P1|Overall Study|IInsufficient data/No data supplied|12
1693568|NCT01280357|5912423|P1|Overall Study|Excluded no internal monitoring|14
1693569|NCT01280266|5912432|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
1693570|NCT01280266|5912433|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
1693571|NCT01280266|5912432|P2|First Intervention (Week 1-4)|Adverse Event|0
1693572|NCT01280266|5912433|P1|First Intervention (Week 1-4)|Adverse Event|1
1693573|NCT01279954|5912524|P2|Overall Study|Lack of Efficacy|4
1693574|NCT01279954|5912525|P1|Overall Study|Lack of Efficacy|3
1693575|NCT01279850|5912536|P1|Overall Study|No Visit After Treatment|34
1693576|NCT01279850|5912536|P1|Overall Study|No Drug Administration Information|7
1693577|NCT01279850|5912536|P1|Overall Study|Protocol Violation|50
1693578|NCT01279681|5912552|P2|Overall Study|Other Reason|2
1693579|NCT01279681|5912553|P1|Overall Study|Other Reason|0
1693580|NCT01279681|5912552|P2|Overall Study|Physician Decision|0
1693581|NCT01279681|5912553|P1|Overall Study|Physician Decision|1
1693582|NCT01279681|5912552|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
1693583|NCT01279681|5912553|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
1693584|NCT01279681|5912552|P2|Overall Study|Death|1
1693585|NCT01279681|5912553|P1|Overall Study|Death|0
1693586|NCT01279681|5912552|P2|Overall Study|Adverse Event|3
1693587|NCT01279681|5912553|P1|Overall Study|Adverse Event|2
1693588|NCT01279681|5912552|P2|Overall Study|Withdrawal by Subject|4
1693589|NCT01279681|5912553|P1|Overall Study|Withdrawal by Subject|3
1693590|NCT01279681|5912552|P2|Overall Study|Disease Progression|6
1693591|NCT01279681|5912553|P1|Overall Study|Disease Progression|9
1693592|NCT01279616|5912565|P1|Overall Study|no signs of sickle cell disease|2
1693593|NCT01279616|5912565|P1|Overall Study|donor could not be located|5
1693594|NCT01279486|5912578|P1|Overall Study|Lost to Follow-up|1
1693595|NCT01279447|5912584|P2|Overall Study|Lost to Follow-up|1
1693596|NCT01279447|5912585|P1|Overall Study|Lost to Follow-up|3
1693597|NCT01279343|5912593|P2|Overall Study|Did not receive treatment|6
1693598|NCT01279343|5912594|P1|Overall Study|Did not receive treatment|2
1693599|NCT01279200|5912639|P2|Overall Study|Adverse Event|0
1693600|NCT01279200|5912640|P1|Overall Study|Adverse Event|1
1693601|NCT01279200|5912639|P2|Overall Study|Lost to Follow-up|1
1693602|NCT01279200|5912640|P1|Overall Study|Lost to Follow-up|0
1693603|NCT01279200|5912639|P2|Overall Study|ultrasound screening failure|1
1693604|NCT01279200|5912640|P1|Overall Study|ultrasound screening failure|0
1693605|NCT01279200|5912639|P2|Overall Study|Inconvenience of ultrasound visit|1
1693606|NCT01279200|5912640|P1|Overall Study|Inconvenience of ultrasound visit|0
1693607|NCT01279200|5912639|P2|Overall Study|Patient withdrawal due to high cost|1
1693608|NCT01279200|5912640|P1|Overall Study|Patient withdrawal due to high cost|0
1693609|NCT01279200|5912639|P2|Overall Study|Withdrawal by Subject|3
1693610|NCT01279200|5912640|P1|Overall Study|Withdrawal by Subject|1
1693611|NCT01279070|5912678|P2|Overall Study|Acute exacerbation|1
1693612|NCT01279070|5912679|P1|Overall Study|Acute exacerbation|3
1693613|NCT01279070|5912678|P2|Overall Study|Withdrawal by Subject|3
1693614|NCT01279070|5912679|P1|Overall Study|Withdrawal by Subject|2
1693615|NCT01279044|5912698|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
1693616|NCT01279044|5912699|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
1693617|NCT01279044|5912700|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
1693618|NCT01279044|5912698|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
1693619|NCT01279044|5912699|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
1693620|NCT01279044|5912700|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
1693621|NCT01279044|5912698|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
1693622|NCT01279044|5912699|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
1693623|NCT01279044|5912700|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
1693624|NCT01278862|5912776|P2|Overall Study|Lost to Follow-up|1
1693625|NCT01278862|5912777|P1|Overall Study|Lost to Follow-up|1
1693626|NCT01278797|5912785|P2|Period 1|Protocol Violation|0
1693627|NCT01278797|5912786|P1|Period 1|Protocol Violation|1
1693628|NCT01278797|5912785|P2|Period 1|Adverse Event|1
1693629|NCT01278797|5912786|P1|Period 1|Adverse Event|0
1693630|NCT01278745|5912798|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
1693631|NCT01278745|5912799|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
1693632|NCT01278745|5912800|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
1693633|NCT01278745|5912801|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
1693634|NCT01278745|5912798|P4|Overall Study|Ineligible|61
1693635|NCT01278745|5912799|P3|Overall Study|Ineligible|42
1693636|NCT01278745|5912800|P2|Overall Study|Ineligible|0
1693637|NCT01278745|5912801|P1|Overall Study|Ineligible|0
1693638|NCT01278745|5912798|P4|Overall Study|Sponsor Decision|6
1693639|NCT01278745|5912799|P3|Overall Study|Sponsor Decision|62
1693640|NCT01278745|5912800|P2|Overall Study|Sponsor Decision|0
1693641|NCT01278745|5912801|P1|Overall Study|Sponsor Decision|1
1693642|NCT01278745|5912798|P4|Overall Study|Withdrawal by Subject|1
1693643|NCT01278745|5912799|P3|Overall Study|Withdrawal by Subject|5
1693644|NCT01278745|5912800|P2|Overall Study|Withdrawal by Subject|1
1693645|NCT01278745|5912801|P1|Overall Study|Withdrawal by Subject|1
1693646|NCT01278745|5912798|P4|Overall Study|Physician Decision|9
1693647|NCT01278745|5912799|P3|Overall Study|Physician Decision|0
1693648|NCT01278745|5912800|P2|Overall Study|Physician Decision|0
1693649|NCT01278745|5912801|P1|Overall Study|Physician Decision|1
1693650|NCT01278745|5912798|P4|Overall Study|Death|0
1693651|NCT01278745|5912799|P3|Overall Study|Death|7
1693652|NCT01278745|5912800|P2|Overall Study|Death|5
1693653|NCT01278745|5912801|P1|Overall Study|Death|2
1693654|NCT01278615|5912833|P1|Overall Study|Withdrawal by Subject|2
1693655|NCT01278407|5912859|P5|Extension Phase|Other|3
1693656|NCT01278407|5912860|P4|Extension Phase|Other|1
1693657|NCT01278407|5912861|P3|Extension Phase|Other|0
1693658|NCT01278407|5912862|P2|Extension Phase|Other|0
1693659|NCT01278407|5912863|P1|Extension Phase|Other|0
1693660|NCT01278407|5912859|P5|Extension Phase|Participant's Choice|11
1693661|NCT01278407|5912860|P4|Extension Phase|Participant's Choice|4
1693662|NCT01278407|5912861|P3|Extension Phase|Participant's Choice|0
1693663|NCT01278407|5912862|P2|Extension Phase|Participant's Choice|0
1693664|NCT01278407|5912863|P1|Extension Phase|Participant's Choice|0
1693665|NCT01278407|5912859|P5|Extension Phase|Adverse Event|16
1693666|NCT01278407|5912860|P4|Extension Phase|Adverse Event|7
1693667|NCT01278407|5912861|P3|Extension Phase|Adverse Event|0
1693668|NCT01278407|5912862|P2|Extension Phase|Adverse Event|0
1693669|NCT01278407|5912863|P1|Extension Phase|Adverse Event|0
1693670|NCT01278407|5912859|P5|Confirmatory Phase|Other|0
1693671|NCT01278407|5912860|P4|Confirmatory Phase|Other|0
1693672|NCT01278407|5912861|P3|Confirmatory Phase|Other|2
1693673|NCT01278407|5912862|P2|Confirmatory Phase|Other|1
1693674|NCT01278407|5912863|P1|Confirmatory Phase|Other|1
1693675|NCT01278407|5912859|P5|Confirmatory Phase|Participant's Choice|0
1693676|NCT01278407|5912860|P4|Confirmatory Phase|Participant's Choice|0
1693677|NCT01278407|5912861|P3|Confirmatory Phase|Participant's Choice|3
1693678|NCT01278407|5912862|P2|Confirmatory Phase|Participant's Choice|5
1693679|NCT01278407|5912863|P1|Confirmatory Phase|Participant's Choice|3
1693680|NCT01278407|5912859|P5|Confirmatory Phase|Adverse Event|0
1693681|NCT01278407|5912860|P4|Confirmatory Phase|Adverse Event|0
1693682|NCT01278407|5912861|P3|Confirmatory Phase|Adverse Event|1
1693683|NCT01278407|5912862|P2|Confirmatory Phase|Adverse Event|10
1693684|NCT01278407|5912863|P1|Confirmatory Phase|Adverse Event|5
1693685|NCT01278394|5912876|P1|Overall Study|Lost to Follow-up|1
1693686|NCT01278342|5912889|P3|Overall Study|Other|0
1693687|NCT01278342|5912890|P2|Overall Study|Other|0
1693688|NCT01278342|5912891|P1|Overall Study|Other|1
1693689|NCT01278342|5912889|P3|Overall Study|Administrative problems|0
1693690|NCT01278342|5912890|P2|Overall Study|Administrative problems|0
1693691|NCT01278342|5912891|P1|Overall Study|Administrative problems|2
1693692|NCT01278342|5912889|P3|Overall Study|Lost to Follow-up|0
1693693|NCT01278342|5912890|P2|Overall Study|Lost to Follow-up|0
1693694|NCT01278342|5912891|P1|Overall Study|Lost to Follow-up|1
1693695|NCT01278342|5912889|P3|Overall Study|Physician Decision|0
1693696|NCT01278342|5912890|P2|Overall Study|Physician Decision|1
1693697|NCT01278342|5912891|P1|Overall Study|Physician Decision|0
1693698|NCT01278173|5912911|P1|Overall Study|Withdrawal by Subject|1
1693699|NCT01278173|5912911|P1|Overall Study|Protocol Violation|1
1693700|NCT01278173|5912911|P1|Overall Study|Administrative or other reason|4
1693701|NCT01278173|5912911|P1|Overall Study|Adverse Event|8
1693702|NCT01278173|5912911|P1|Overall Study|Lack of Efficacy|13
1693703|NCT01278160|5912918|P2|Overall Study|Unclassified|2
1693704|NCT01278160|5912919|P1|Overall Study|Unclassified|1
1693705|NCT01278160|5912918|P2|Overall Study|Withdrawal by Subject|2
1693706|NCT01278160|5912919|P1|Overall Study|Withdrawal by Subject|3
1693707|NCT01278160|5912918|P2|Overall Study|Lost to Follow-up|1
1693708|NCT01278160|5912919|P1|Overall Study|Lost to Follow-up|0
1693709|NCT01278160|5912918|P2|Overall Study|Adverse Event|1
1693710|NCT01278160|5912919|P1|Overall Study|Adverse Event|1
1693711|NCT01278030|5912935|P2|Overall Study|Withdrawal by Subject|4
1693712|NCT01278030|5912936|P1|Overall Study|Withdrawal by Subject|8
1693713|NCT01277887|5912944|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
1693714|NCT01277887|5912945|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
1693715|NCT01277887|5912944|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
1693716|NCT01277887|5912945|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
1693717|NCT01277887|5912944|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
1693718|NCT01277887|5912945|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
1693719|NCT01277861|5912957|P2|Overall Study|Physician Decision|2
1693720|NCT01277861|5912958|P1|Overall Study|Physician Decision|2
1693721|NCT01277822|5912970|P2|Overall Study|Participant moved|0
1693722|NCT01277822|5912971|P1|Overall Study|Participant moved|1
1693723|NCT01277822|5912970|P2|Overall Study|Contraindicated medication used|1
1693724|NCT01277822|5912971|P1|Overall Study|Contraindicated medication used|2
1693725|NCT01277822|5912970|P2|Overall Study|Lost to Follow-up|1
1693726|NCT01277822|5912971|P1|Overall Study|Lost to Follow-up|2
1693727|NCT01277822|5912970|P2|Overall Study|Protocol Violation|0
1693728|NCT01277822|5912971|P1|Overall Study|Protocol Violation|1
1693729|NCT01277822|5912970|P2|Overall Study|Physician Decision|1
1693730|NCT01277822|5912971|P1|Overall Study|Physician Decision|1
1693731|NCT01277822|5912970|P2|Overall Study|Withdrawal by Subject|7
1693732|NCT01277822|5912971|P1|Overall Study|Withdrawal by Subject|6
1693733|NCT01277822|5912970|P2|Overall Study|Adverse Event|1
1693734|NCT01277822|5912971|P1|Overall Study|Adverse Event|2
1693735|NCT01277757|5913007|P1|Overall Study|Withdrawal by Subject|1
1693736|NCT01277757|5913007|P1|Overall Study|Disease Progression|1
1693737|NCT01277744|5913014|P1|Overall Study|Physician Decision|2
1693738|NCT01277718|5913019|P2|Period 2 - Second Intervention|Physician Decision|2
1693739|NCT01277718|5913020|P1|Period 2 - Second Intervention|Physician Decision|0
1693740|NCT01277718|5913019|P2|Period 2 - Second Intervention|Protocol Violation|1
1693741|NCT01277718|5913020|P1|Period 2 - Second Intervention|Protocol Violation|0
1693742|NCT01277666|5913034|P3|Overall Study|Death|1
1693743|NCT01277666|5913035|P2|Overall Study|Death|0
1693744|NCT01277666|5913036|P1|Overall Study|Death|0
1693745|NCT01277666|5913034|P3|Overall Study|Withdrawal by Subject|6
1693746|NCT01277666|5913035|P2|Overall Study|Withdrawal by Subject|8
1693747|NCT01277666|5913036|P1|Overall Study|Withdrawal by Subject|7
1693748|NCT01277666|5913034|P3|Overall Study|Lost to Follow-up|2
1693749|NCT01277666|5913035|P2|Overall Study|Lost to Follow-up|1
1693750|NCT01277666|5913036|P1|Overall Study|Lost to Follow-up|1
1693751|NCT01277666|5913034|P3|Overall Study|Protocol Defined Stopping criteria|6
1693752|NCT01277666|5913035|P2|Overall Study|Protocol Defined Stopping criteria|2
1693753|NCT01277666|5913036|P1|Overall Study|Protocol Defined Stopping criteria|1
1693754|NCT01277666|5913034|P3|Overall Study|Protocol Violation|2
1693755|NCT01277666|5913035|P2|Overall Study|Protocol Violation|3
1693756|NCT01277666|5913036|P1|Overall Study|Protocol Violation|2
1693757|NCT01277666|5913034|P3|Overall Study|Lack of Efficacy|12
1693758|NCT01277666|5913035|P2|Overall Study|Lack of Efficacy|20
1693759|NCT01277666|5913036|P1|Overall Study|Lack of Efficacy|8
1693760|NCT01277666|5913034|P3|Overall Study|Adverse Event|20
1693761|NCT01277666|5913035|P2|Overall Study|Adverse Event|25
1693762|NCT01277666|5913036|P1|Overall Study|Adverse Event|26
1693763|NCT01277601|5913069|P4|Overall Study|Subject Terminated from Study by Sponsor|2
1693764|NCT01277601|5913070|P3|Overall Study|Subject Terminated from Study by Sponsor|0
1693765|NCT01277601|5913071|P2|Overall Study|Subject Terminated from Study by Sponsor|1
1693766|NCT01277601|5913072|P1|Overall Study|Subject Terminated from Study by Sponsor|0
1693767|NCT01277601|5913069|P4|Overall Study|Protocol Violation|0
1693768|NCT01277601|5913070|P3|Overall Study|Protocol Violation|5
1693769|NCT01277601|5913071|P2|Overall Study|Protocol Violation|2
1693770|NCT01277601|5913072|P1|Overall Study|Protocol Violation|0
1693771|NCT01277601|5913069|P4|Overall Study|Subject Never Dosed with Study Drug|1
1693772|NCT01277601|5913070|P3|Overall Study|Subject Never Dosed with Study Drug|3
1693773|NCT01277601|5913071|P2|Overall Study|Subject Never Dosed with Study Drug|2
1693774|NCT01277601|5913072|P1|Overall Study|Subject Never Dosed with Study Drug|1
1693775|NCT01277601|5913069|P4|Overall Study|Noncompliance with Study Drug|0
1693776|NCT01277601|5913070|P3|Overall Study|Noncompliance with Study Drug|2
1693777|NCT01277601|5913071|P2|Overall Study|Noncompliance with Study Drug|3
1693778|NCT01277601|5913072|P1|Overall Study|Noncompliance with Study Drug|1
1693779|NCT01277601|5913069|P4|Overall Study|Pregnancy|1
1693780|NCT01277601|5913070|P3|Overall Study|Pregnancy|4
1693781|NCT01277601|5913071|P2|Overall Study|Pregnancy|2
1693782|NCT01277601|5913072|P1|Overall Study|Pregnancy|2
1693783|NCT01277601|5913069|P4|Overall Study|Physician Decision|6
1693784|NCT01277601|5913070|P3|Overall Study|Physician Decision|1
1693785|NCT01277601|5913071|P2|Overall Study|Physician Decision|5
1693786|NCT01277601|5913072|P1|Overall Study|Physician Decision|3
1693787|NCT01277601|5913069|P4|Overall Study|Lost to Follow-up|2
1693788|NCT01277601|5913070|P3|Overall Study|Lost to Follow-up|4
1693789|NCT01277601|5913071|P2|Overall Study|Lost to Follow-up|9
1693790|NCT01277601|5913072|P1|Overall Study|Lost to Follow-up|7
1693791|NCT01277601|5913069|P4|Overall Study|Withdrawal by Subject|17
1693792|NCT01277601|5913070|P3|Overall Study|Withdrawal by Subject|8
1693793|NCT01277601|5913071|P2|Overall Study|Withdrawal by Subject|21
1693794|NCT01277601|5913072|P1|Overall Study|Withdrawal by Subject|18
1693795|NCT01277601|5913069|P4|Overall Study|Adverse Event|7
1693796|NCT01277601|5913070|P3|Overall Study|Adverse Event|0
1693797|NCT01277601|5913071|P2|Overall Study|Adverse Event|3
1693798|NCT01277601|5913072|P1|Overall Study|Adverse Event|5
1693799|NCT01277549|5913163|P2|Overall Study|Physician Decision|1
1693800|NCT01277549|5913164|P1|Overall Study|Physician Decision|2
1693801|NCT01277549|5913163|P2|Overall Study|Protocol Violation|1
1693802|NCT01277549|5913164|P1|Overall Study|Protocol Violation|10
1693803|NCT01277549|5913163|P2|Overall Study|Withdrawal by Subject|3
1693804|NCT01277549|5913164|P1|Overall Study|Withdrawal by Subject|1
1693805|NCT01277549|5913163|P2|Overall Study|Failed to meet eligibility criteria|9
1693806|NCT01277549|5913164|P1|Overall Study|Failed to meet eligibility criteria|13
1693807|NCT01277523|5913181|P3|Overall Study|Other Reason not Defined|0
1693808|NCT01277523|5913182|P2|Overall Study|Other Reason not Defined|1
1693809|NCT01277523|5913183|P1|Overall Study|Other Reason not Defined|0
1693810|NCT01277523|5913181|P3|Overall Study|Protocol Violation|0
1693811|NCT01277523|5913182|P2|Overall Study|Protocol Violation|0
1693812|NCT01277523|5913183|P1|Overall Study|Protocol Violation|2
1693813|NCT01277523|5913181|P3|Overall Study|Adverse Event|0
1693814|NCT01277523|5913182|P2|Overall Study|Adverse Event|0
1693815|NCT01277523|5913183|P1|Overall Study|Adverse Event|1
1693816|NCT01277510|5913235|P2|Open-label Phase|Never received investigational product|0
1693817|NCT01277510|5913236|P1|Open-label Phase|Never received investigational product|2
1693818|NCT01277510|5913235|P2|Open-label Phase|Protocol-specified criteria|0
1693819|NCT01277510|5913236|P1|Open-label Phase|Protocol-specified criteria|1
1693820|NCT01277510|5913235|P2|Open-label Phase|Administrative decision|3
1693821|NCT01277510|5913236|P1|Open-label Phase|Administrative decision|4
1693822|NCT01277510|5913235|P2|Double-blind Phase|Other|1
1693823|NCT01277510|5913236|P1|Double-blind Phase|Other|1
1693824|NCT01277510|5913235|P2|Double-blind Phase|Protocol-specified criteria|6
1693825|NCT01277510|5913236|P1|Double-blind Phase|Protocol-specified criteria|2
1693826|NCT01277510|5913235|P2|Double-blind Phase|Death|1
1693827|NCT01277510|5913236|P1|Double-blind Phase|Death|0
1693828|NCT01277510|5913235|P2|Double-blind Phase|Administrative decision|9
1693829|NCT01277510|5913236|P1|Double-blind Phase|Administrative decision|7
1693830|NCT01277510|5913235|P2|Double-blind Phase|Withdrawal by Subject|0
1693831|NCT01277510|5913236|P1|Double-blind Phase|Withdrawal by Subject|2
1693832|NCT01277510|5913235|P2|Double-blind Phase|Adverse Event|0
1693833|NCT01277510|5913236|P1|Double-blind Phase|Adverse Event|1
1693834|NCT01277510|5913235|P2|Double-blind Phase|Non-compliance|1
1693835|NCT01277510|5913236|P1|Double-blind Phase|Non-compliance|0
1693836|NCT01277302|5913270|P3|8-Month Alternate Dose Regimen Period|Relocation|1
1693837|NCT01277302|5913271|P2|8-Month Alternate Dose Regimen Period|Relocation|0
1693838|NCT01277302|5913272|P1|8-Month Alternate Dose Regimen Period|Relocation|1
1693839|NCT01277302|5913270|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
1693840|NCT01277302|5913271|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
1693841|NCT01277302|5913272|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
1693842|NCT01277302|5913270|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
1693843|NCT01277302|5913271|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
1693844|NCT01277302|5913272|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
1693845|NCT01277302|5913270|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
1693846|NCT01277302|5913271|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
1693847|NCT01277302|5913272|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
1693848|NCT01277302|5913270|P3|8-Month Alternate Dose Regimen Period|Death|0
1693849|NCT01277302|5913271|P2|8-Month Alternate Dose Regimen Period|Death|1
1693850|NCT01277302|5913272|P1|8-Month Alternate Dose Regimen Period|Death|0
1693851|NCT01277302|5913270|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
1693852|NCT01277302|5913271|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
1693853|NCT01277302|5913272|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
1693854|NCT01277302|5913270|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
1693855|NCT01277302|5913271|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
1693856|NCT01277302|5913272|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
1693857|NCT01277302|5913270|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
1693858|NCT01277302|5913271|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
1693859|NCT01277302|5913272|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
1693860|NCT01277302|5913270|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
1693861|NCT01277302|5913271|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
1693862|NCT01277302|5913272|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
1693863|NCT01277211|5913304|P2|Overall Study|Discontinued prior to treatment|13
1693864|NCT01277211|5913305|P1|Overall Study|Discontinued prior to treatment|24
1693865|NCT01277211|5913304|P2|Overall Study|Pregnancy wish|2
1693866|NCT01277211|5913305|P1|Overall Study|Pregnancy wish|0
1693867|NCT01277211|5913304|P2|Overall Study|Administrative|0
1693868|NCT01277211|5913305|P1|Overall Study|Administrative|3
1693869|NCT01277211|5913304|P2|Overall Study|Did not meet protocol eligibility|0
1693870|NCT01277211|5913305|P1|Overall Study|Did not meet protocol eligibility|1
1693871|NCT01277211|5913304|P2|Overall Study|Non-compliance with protocol|4
1693872|NCT01277211|5913305|P1|Overall Study|Non-compliance with protocol|13
1693873|NCT01277211|5913304|P2|Overall Study|Withdrew Consent|9
1693874|NCT01277211|5913305|P1|Overall Study|Withdrew Consent|9
1693875|NCT01277211|5913304|P2|Overall Study|Did not wish to continue|0
1693876|NCT01277211|5913305|P1|Overall Study|Did not wish to continue|17
1693877|NCT01277211|5913304|P2|Overall Study|Lost to Follow-up|9
1693878|NCT01277211|5913305|P1|Overall Study|Lost to Follow-up|14
1693879|NCT01277211|5913304|P2|Overall Study|Pregnancy|4
1693880|NCT01277211|5913305|P1|Overall Study|Pregnancy|9
1693881|NCT01277211|5913304|P2|Overall Study|Adverse Event|22
1693882|NCT01277211|5913305|P1|Overall Study|Adverse Event|60
1693883|NCT01277042|5913357|P2|Overall Study|Withdrawal by Subject|0
1693884|NCT01277042|5913358|P1|Overall Study|Withdrawal by Subject|2
1693885|NCT01277042|5913357|P2|Overall Study|Lost to Follow-up|2
1693886|NCT01277042|5913358|P1|Overall Study|Lost to Follow-up|2
1693887|NCT01277042|5913357|P2|Overall Study|Adverse Event|3
1693888|NCT01277042|5913358|P1|Overall Study|Adverse Event|4
1693889|NCT01276847|5913383|P3|Overall Study|Withdrawal by Subject|0
1693890|NCT01276847|5913384|P2|Overall Study|Withdrawal by Subject|0
1693891|NCT01276847|5913385|P1|Overall Study|Withdrawal by Subject|1
1693892|NCT01276821|5913395|P2|Overall Study|Protocol Violation|1
1693893|NCT01276821|5913396|P1|Overall Study|Protocol Violation|0
1693894|NCT01276756|5913416|P2|Overall Study|Adverse Event|2
1693895|NCT01276756|5913417|P1|Overall Study|Adverse Event|3
1693896|NCT01276756|5913416|P2|Overall Study|Lost to Follow-up|0
1693897|NCT01276756|5913417|P1|Overall Study|Lost to Follow-up|2
1693898|NCT01276639|5913462|P5|Week 16 to 52|Other|3
1693899|NCT01276639|5913463|P4|Week 16 to 52|Other|1
1693900|NCT01276639|5913464|P3|Week 16 to 52|Other|0
1693901|NCT01276639|5913465|P2|Week 16 to 52|Other|12
1693902|NCT01276639|5913466|P1|Week 16 to 52|Other|10
1693903|NCT01276639|5913462|P5|Week 16 to 52|Withdrawal by Subject|1
1693904|NCT01276639|5913463|P4|Week 16 to 52|Withdrawal by Subject|0
1693905|NCT01276639|5913464|P3|Week 16 to 52|Withdrawal by Subject|0
1693906|NCT01276639|5913465|P2|Week 16 to 52|Withdrawal by Subject|4
1693907|NCT01276639|5913466|P1|Week 16 to 52|Withdrawal by Subject|4
1693908|NCT01276639|5913462|P5|Week 16 to 52|Lost to Follow-up|1
1693909|NCT01276639|5913463|P4|Week 16 to 52|Lost to Follow-up|0
1693910|NCT01276639|5913464|P3|Week 16 to 52|Lost to Follow-up|0
1693911|NCT01276639|5913465|P2|Week 16 to 52|Lost to Follow-up|1
1693912|NCT01276639|5913466|P1|Week 16 to 52|Lost to Follow-up|3
1693913|NCT01276639|5913462|P5|Week 16 to 52|Lack of Efficacy|13
1693914|NCT01276639|5913463|P4|Week 16 to 52|Lack of Efficacy|14
1693915|NCT01276639|5913464|P3|Week 16 to 52|Lack of Efficacy|0
1693916|NCT01276639|5913465|P2|Week 16 to 52|Lack of Efficacy|71
1693917|NCT01276639|5913466|P1|Week 16 to 52|Lack of Efficacy|99
1693918|NCT01276639|5913462|P5|Week 16 to 52|Adverse Event|3
1693919|NCT01276639|5913463|P4|Week 16 to 52|Adverse Event|1
1693920|NCT01276639|5913464|P3|Week 16 to 52|Adverse Event|0
1693921|NCT01276639|5913465|P2|Week 16 to 52|Adverse Event|13
1693922|NCT01276639|5913466|P1|Week 16 to 52|Adverse Event|10
1693923|NCT01276639|5913462|P5|Week 16 to 52|Death|0
1693924|NCT01276639|5913463|P4|Week 16 to 52|Death|0
1693925|NCT01276639|5913464|P3|Week 16 to 52|Death|0
1693926|NCT01276639|5913465|P2|Week 16 to 52|Death|0
1693927|NCT01276639|5913466|P1|Week 16 to 52|Death|1
1693928|NCT01276639|5913462|P5|Week 0 to 16|Randomized, But Not Treated|0
1693929|NCT01276639|5913463|P4|Week 0 to 16|Randomized, But Not Treated|0
1693930|NCT01276639|5913464|P3|Week 0 to 16|Randomized, But Not Treated|0
1693931|NCT01276639|5913465|P2|Week 0 to 16|Randomized, But Not Treated|1
1693932|NCT01276639|5913466|P1|Week 0 to 16|Randomized, But Not Treated|0
1693933|NCT01276639|5913462|P5|Week 0 to 16|Other|0
1693934|NCT01276639|5913463|P4|Week 0 to 16|Other|0
1693935|NCT01276639|5913464|P3|Week 0 to 16|Other|2
1693936|NCT01276639|5913465|P2|Week 0 to 16|Other|7
1693937|NCT01276639|5913466|P1|Week 0 to 16|Other|7
1693938|NCT01276639|5913462|P5|Week 0 to 16|Withdrawal by Subject|0
1693939|NCT01276639|5913463|P4|Week 0 to 16|Withdrawal by Subject|0
1693940|NCT01276639|5913464|P3|Week 0 to 16|Withdrawal by Subject|4
1693941|NCT01276639|5913465|P2|Week 0 to 16|Withdrawal by Subject|5
1693942|NCT01276639|5913466|P1|Week 0 to 16|Withdrawal by Subject|8
1693943|NCT01276639|5913462|P5|Week 0 to 16|Lost to Follow-up|0
1693944|NCT01276639|5913463|P4|Week 0 to 16|Lost to Follow-up|0
1693945|NCT01276639|5913464|P3|Week 0 to 16|Lost to Follow-up|3
1693946|NCT01276639|5913465|P2|Week 0 to 16|Lost to Follow-up|5
1693947|NCT01276639|5913466|P1|Week 0 to 16|Lost to Follow-up|3
1693948|NCT01276639|5913462|P5|Week 0 to 16|Lack of Efficacy|0
1693949|NCT01276639|5913463|P4|Week 0 to 16|Lack of Efficacy|0
1693950|NCT01276639|5913464|P3|Week 0 to 16|Lack of Efficacy|25
1693951|NCT01276639|5913465|P2|Week 0 to 16|Lack of Efficacy|15
1693952|NCT01276639|5913466|P1|Week 0 to 16|Lack of Efficacy|20
1693953|NCT01276639|5913462|P5|Week 0 to 16|Adverse Event|0
1693954|NCT01276639|5913463|P4|Week 0 to 16|Adverse Event|0
1693955|NCT01276639|5913464|P3|Week 0 to 16|Adverse Event|11
1693956|NCT01276639|5913465|P2|Week 0 to 16|Adverse Event|8
1693957|NCT01276639|5913466|P1|Week 0 to 16|Adverse Event|11
1693958|NCT01276639|5913462|P5|Week 0 to 16|Death|0
1693959|NCT01276639|5913463|P4|Week 0 to 16|Death|0
1693960|NCT01276639|5913464|P3|Week 0 to 16|Death|0
1693961|NCT01276639|5913465|P2|Week 0 to 16|Death|0
1693962|NCT01276639|5913466|P1|Week 0 to 16|Death|1
1693963|NCT01276509|5913671|P4|Overall Study|Other|0
1693964|NCT01276509|5913672|P3|Overall Study|Other|0
1693965|NCT01276509|5913673|P2|Overall Study|Other|1
1693966|NCT01276509|5913674|P1|Overall Study|Other|0
1693967|NCT01276509|5913671|P4|Overall Study|Withdrawal by Subject|0
1693968|NCT01276509|5913672|P3|Overall Study|Withdrawal by Subject|0
1693969|NCT01276509|5913673|P2|Overall Study|Withdrawal by Subject|2
1693970|NCT01276509|5913674|P1|Overall Study|Withdrawal by Subject|1
1693971|NCT01276509|5913671|P4|Overall Study|Pregnancy|0
1693972|NCT01276509|5913672|P3|Overall Study|Pregnancy|0
1693973|NCT01276509|5913673|P2|Overall Study|Pregnancy|0
1693974|NCT01276509|5913674|P1|Overall Study|Pregnancy|1
1693975|NCT01276509|5913671|P4|Overall Study|Lack of Efficacy|2
1693976|NCT01276509|5913672|P3|Overall Study|Lack of Efficacy|1
1693977|NCT01276509|5913673|P2|Overall Study|Lack of Efficacy|1
1693978|NCT01276509|5913674|P1|Overall Study|Lack of Efficacy|2
1693979|NCT01276509|5913671|P4|Overall Study|Adverse Event|3
1693980|NCT01276509|5913672|P3|Overall Study|Adverse Event|4
1693981|NCT01276509|5913673|P2|Overall Study|Adverse Event|8
1693982|NCT01276509|5913674|P1|Overall Study|Adverse Event|9
1693983|NCT01276457|5913727|P2|Extension Study|Lack of Efficacy|1
1693984|NCT01276457|5913728|P1|Extension Study|Lack of Efficacy|3
1693985|NCT01276457|5913727|P2|Extension Study|Death|1
1693986|NCT01276457|5913728|P1|Extension Study|Death|0
1693987|NCT01276457|5913727|P2|Extension Study|Lost to Follow-up|0
1693988|NCT01276457|5913728|P1|Extension Study|Lost to Follow-up|3
1693989|NCT01276457|5913727|P2|Core Study|Lack of Efficacy|12
1693990|NCT01276457|5913728|P1|Core Study|Lack of Efficacy|3
1693991|NCT01276457|5913727|P2|Core Study|Death|2
1693992|NCT01276457|5913728|P1|Core Study|Death|2
1693993|NCT01276457|5913727|P2|Core Study|Administrative problems|1
1693994|NCT01276457|5913728|P1|Core Study|Administrative problems|1
1693995|NCT01276457|5913727|P2|Core Study|Lost to Follow-up|2
1693996|NCT01276457|5913728|P1|Core Study|Lost to Follow-up|1
1693997|NCT01276457|5913727|P2|Core Study|Adverse Event|3
1693998|NCT01276457|5913728|P1|Core Study|Adverse Event|6
1693999|NCT01276353|5913742|P2|Extension|Prohibited concomitant medications|1
1694000|NCT01276353|5913743|P1|Extension|Prohibited concomitant medications|0
1694001|NCT01276353|5913742|P2|Extension|Physician Decision|0
1694002|NCT01276353|5913743|P1|Extension|Physician Decision|1
1694003|NCT01276353|5913742|P2|Extension|Withdrawal of study drug 4 days in a row|1
1694004|NCT01276353|5913743|P1|Extension|Withdrawal of study drug 4 days in a row|3
1694005|NCT01276353|5913742|P2|Extension|Withdrawal by Subject|2
1694006|NCT01276353|5913743|P1|Extension|Withdrawal by Subject|1
1694007|NCT01276353|5913742|P2|Extension|Adverse Event|5
1694008|NCT01276353|5913743|P1|Extension|Adverse Event|2
1694009|NCT01276353|5913742|P2|Double-blind|Withdrawal by Subject|0
1694010|NCT01276353|5913743|P1|Double-blind|Withdrawal by Subject|1
1694011|NCT01276353|5913742|P2|Double-blind|Adverse Event|0
1694012|NCT01276353|5913743|P1|Double-blind|Adverse Event|2
1694013|NCT01276327|5913755|P2|Overall Study|Withdrawal by Subject|0
1694014|NCT01276327|5913756|P1|Overall Study|Withdrawal by Subject|1
1694015|NCT01276327|5913755|P2|Overall Study|Adverse Event|3
1694016|NCT01276327|5913756|P1|Overall Study|Adverse Event|1
1694017|NCT01276288|5913823|P4|Overall Study|not treated|0
1694018|NCT01276288|5913824|P3|Overall Study|not treated|0
1694019|NCT01276288|5913825|P2|Overall Study|not treated|0
1694020|NCT01276288|5913826|P1|Overall Study|not treated|1
1694021|NCT01276288|5913823|P4|Overall Study|Adverse Event|0
1694022|NCT01276288|5913824|P3|Overall Study|Adverse Event|0
1694023|NCT01276288|5913825|P2|Overall Study|Adverse Event|1
1694024|NCT01276288|5913826|P1|Overall Study|Adverse Event|1
1694025|NCT01276223|5913953|P3|Overall Study|Protocol Violation|0
1694026|NCT01276223|5913954|P2|Overall Study|Protocol Violation|0
1694027|NCT01276223|5913955|P1|Overall Study|Protocol Violation|1
1694028|NCT01276223|5913953|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
1694029|NCT01276223|5913954|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
1694030|NCT01276223|5913955|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
1694031|NCT01276223|5913953|P3|Overall Study|Other|1
1694032|NCT01276223|5913954|P2|Overall Study|Other|0
1694033|NCT01276223|5913955|P1|Overall Study|Other|0
1694034|NCT01276223|5913953|P3|Overall Study|Lost to Follow-up|1
1694035|NCT01276223|5913954|P2|Overall Study|Lost to Follow-up|0
1694036|NCT01276223|5913955|P1|Overall Study|Lost to Follow-up|0
1694037|NCT01276223|5913953|P3|Overall Study|Adverse Event|1
1694038|NCT01276223|5913954|P2|Overall Study|Adverse Event|4
1694039|NCT01276223|5913955|P1|Overall Study|Adverse Event|7
1694040|NCT01276106|5913996|P4|Overall Study|Insufficient therapeutic effects|0
1694041|NCT01276106|5913997|P3|Overall Study|Insufficient therapeutic effects|2
1694042|NCT01276106|5913998|P2|Overall Study|Insufficient therapeutic effects|0
1694043|NCT01276106|5913999|P1|Overall Study|Insufficient therapeutic effects|0
1694044|NCT01276106|5913996|P4|Overall Study|Protocol Violation|2
1694045|NCT01276106|5913997|P3|Overall Study|Protocol Violation|0
1694046|NCT01276106|5913998|P2|Overall Study|Protocol Violation|1
1694047|NCT01276106|5913999|P1|Overall Study|Protocol Violation|1
1694048|NCT01276106|5913996|P4|Overall Study|Physician Decision|1
1694049|NCT01276106|5913997|P3|Overall Study|Physician Decision|1
1694050|NCT01276106|5913998|P2|Overall Study|Physician Decision|0
1694051|NCT01276106|5913999|P1|Overall Study|Physician Decision|0
1694052|NCT01276106|5913996|P4|Overall Study|Lost to Follow-up|0
1694053|NCT01276106|5913997|P3|Overall Study|Lost to Follow-up|1
1694054|NCT01276106|5913998|P2|Overall Study|Lost to Follow-up|1
1694055|NCT01276106|5913999|P1|Overall Study|Lost to Follow-up|2
1694056|NCT01276106|5913996|P4|Overall Study|Lack of Efficacy|1
1694057|NCT01276106|5913997|P3|Overall Study|Lack of Efficacy|0
1694058|NCT01276106|5913998|P2|Overall Study|Lack of Efficacy|1
1694059|NCT01276106|5913999|P1|Overall Study|Lack of Efficacy|0
1694060|NCT01276106|5913996|P4|Overall Study|Withdrawal by Subject|6
1694061|NCT01276106|5913997|P3|Overall Study|Withdrawal by Subject|1
1694062|NCT01276106|5913998|P2|Overall Study|Withdrawal by Subject|3
1694063|NCT01276106|5913999|P1|Overall Study|Withdrawal by Subject|6
1694064|NCT01276106|5913996|P4|Overall Study|Adverse Event|3
1694065|NCT01276106|5913997|P3|Overall Study|Adverse Event|11
1694066|NCT01276106|5913998|P2|Overall Study|Adverse Event|3
1694067|NCT01276106|5913999|P1|Overall Study|Adverse Event|3
1694068|NCT01276054|5914011|P2|Overall Study|No one to oversee trial after P.I. left|2
1694069|NCT01276054|5914012|P1|Overall Study|No one to oversee trial after P.I. left|2
1694070|NCT01275833|5914020|P2|Overall Study|Study terminated|1
1694071|NCT01275833|5914021|P1|Overall Study|Study terminated|1
1694072|NCT01275755|5914029|P2|Run-out Placebo Period|Lost to Follow-up|0
1694073|NCT01275755|5914030|P1|Run-out Placebo Period|Lost to Follow-up|1
1694074|NCT01275755|5914029|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1694075|NCT01275755|5914030|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1694076|NCT01275755|5914029|P2|Double-blind Treatment Period|Lost to Follow-up|1
1694077|NCT01275755|5914030|P1|Double-blind Treatment Period|Lost to Follow-up|1
1694078|NCT01275755|5914029|P2|Double-blind Treatment Period|Adverse Event|2
1694079|NCT01275755|5914030|P1|Double-blind Treatment Period|Adverse Event|0
1694080|NCT01275625|5914044|P1|Overall Study|Other|1
1694081|NCT01275625|5914044|P1|Overall Study|Adverse Event|4
1694082|NCT01275625|5914044|P1|Overall Study|Protocol Violation|1
1694083|NCT01275625|5914044|P1|Overall Study|Withdrawal by Subject|3
1694084|NCT01275625|5914044|P1|Overall Study|Lost to Follow-up|1
1694085|NCT01275625|5914044|P1|Overall Study|Lack of Efficacy|2
1694086|NCT01275625|5914044|P1|Overall Study|Death|1
1694087|NCT01275430|5914062|P1|Overall Study|Inability to achieve maximum p-wave|1
1694088|NCT01275430|5914062|P1|Overall Study|Device Malfunction|1
1694089|NCT01275430|5914062|P1|Overall Study|No Contrast Injection|6
1694090|NCT01275430|5914062|P1|Overall Study|Adverse Event|1
1694091|NCT01275339|5914127|P4|Overall Study|Withdrawal by Subject|0
1694092|NCT01275339|5914128|P3|Overall Study|Withdrawal by Subject|1
1694093|NCT01275339|5914129|P2|Overall Study|Withdrawal by Subject|0
1694094|NCT01275339|5914130|P1|Overall Study|Withdrawal by Subject|0
1694095|NCT01275339|5914127|P4|Overall Study|Referred for surgery for AS symptoms|0
1694096|NCT01275339|5914128|P3|Overall Study|Referred for surgery for AS symptoms|0
1694097|NCT01275339|5914129|P2|Overall Study|Referred for surgery for AS symptoms|0
1694098|NCT01275339|5914130|P1|Overall Study|Referred for surgery for AS symptoms|1
1694099|NCT01275196|5914151|P2|Overall Study|Suboptimal response/treatment failure|6
1694100|NCT01275196|5914152|P1|Overall Study|Suboptimal response/treatment failure|5
1694101|NCT01275196|5914151|P2|Overall Study|Protocol Violation|0
1694102|NCT01275196|5914152|P1|Overall Study|Protocol Violation|1
1694103|NCT01275196|5914151|P2|Overall Study|Disease Progression|5
1694104|NCT01275196|5914152|P1|Overall Study|Disease Progression|6
1694105|NCT01275196|5914151|P2|Overall Study|Lost to Follow-up|0
1694106|NCT01275196|5914152|P1|Overall Study|Lost to Follow-up|1
1694107|NCT01275196|5914151|P2|Overall Study|Withdrawal by Subject|5
1694108|NCT01275196|5914152|P1|Overall Study|Withdrawal by Subject|4
1694109|NCT01275196|5914151|P2|Overall Study|Adverse Event|5
1694110|NCT01275196|5914152|P1|Overall Study|Adverse Event|3
1694111|NCT01275170|5914199|P8|Part 1: Period 1|Equipment malfunction before study drug|0
1694112|NCT01275170|5914200|P7|Part 1: Period 1|Equipment malfunction before study drug|0
1694113|NCT01275170|5914201|P6|Part 1: Period 1|Equipment malfunction before study drug|0
1694114|NCT01275170|5914202|P5|Part 1: Period 1|Equipment malfunction before study drug|0
1694115|NCT01275170|5914203|P4|Part 1: Period 1|Equipment malfunction before study drug|0
1694116|NCT01275170|5914204|P3|Part 1: Period 1|Equipment malfunction before study drug|0
1694117|NCT01275170|5914205|P2|Part 1: Period 1|Equipment malfunction before study drug|0
1694118|NCT01275170|5914206|P1|Part 1: Period 1|Equipment malfunction before study drug|1
1694119|NCT01275144|5914424|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
1694120|NCT01275144|5914425|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
1694121|NCT01275131|5914483|P4|Period 2 (Crossover)|Withdrawal by Subject|2
1694122|NCT01275131|5914484|P3|Period 2 (Crossover)|Withdrawal by Subject|1
1694123|NCT01275131|5914485|P2|Period 2 (Crossover)|Withdrawal by Subject|0
1694124|NCT01275131|5914486|P1|Period 2 (Crossover)|Withdrawal by Subject|1
1694125|NCT01275131|5914483|P4|Period 2 (Crossover)|Adverse Event|0
1694126|NCT01275131|5914484|P3|Period 2 (Crossover)|Adverse Event|0
1694127|NCT01275131|5914485|P2|Period 2 (Crossover)|Adverse Event|1
1694128|NCT01275131|5914486|P1|Period 2 (Crossover)|Adverse Event|0
1694129|NCT01275131|5914483|P4|Period 1|Physician Decision|0
1694130|NCT01275131|5914484|P3|Period 1|Physician Decision|0
1694131|NCT01275131|5914485|P2|Period 1|Physician Decision|0
1694132|NCT01275131|5914486|P1|Period 1|Physician Decision|1
1694133|NCT01275131|5914483|P4|Period 1|Withdrawal by Subject|2
1694134|NCT01275131|5914484|P3|Period 1|Withdrawal by Subject|3
1694135|NCT01275131|5914485|P2|Period 1|Withdrawal by Subject|0
1694136|NCT01275131|5914486|P1|Period 1|Withdrawal by Subject|1
1694137|NCT01275066|5914529|P3|Overall Study|Not Diagnosed w/ Disease|0
1694138|NCT01275066|5914530|P2|Overall Study|Not Diagnosed w/ Disease|0
1694139|NCT01275066|5914531|P1|Overall Study|Not Diagnosed w/ Disease|1
1694140|NCT01275066|5914529|P3|Overall Study|Withdrawal by Subject|1
1694141|NCT01275066|5914530|P2|Overall Study|Withdrawal by Subject|0
1694142|NCT01275066|5914531|P1|Overall Study|Withdrawal by Subject|0
1694143|NCT01274715|5914564|P1|Overall Study|After consent, met exclusion criteria.|1
1694144|NCT01274715|5914564|P1|Overall Study|After consent, met exclusion criteria.|1
1694145|NCT01274715|5914564|P1|Overall Study|After consent, met exclusion criteria.|1
1694146|NCT01274715|5914564|P1|Overall Study|Lost to Follow-up|1
1694147|NCT01274637|5914571|P2|Overall Study|Lost to Follow-up|1
1694148|NCT01274637|5914572|P1|Overall Study|Lost to Follow-up|0
1694149|NCT01274637|5914571|P2|Overall Study|Withdrawal by Subject|1
1694150|NCT01274637|5914572|P1|Overall Study|Withdrawal by Subject|0
1694151|NCT01274559|5914611|P2|Overall Study|Withdrawal by Subject|13
1694152|NCT01274559|5914612|P1|Overall Study|Withdrawal by Subject|25
1694153|NCT01274559|5914611|P2|Overall Study|Study Terminated by Sponsor|87
1694154|NCT01274559|5914612|P1|Overall Study|Study Terminated by Sponsor|79
1694155|NCT01274559|5914611|P2|Overall Study|Protocol Violation|23
1694156|NCT01274559|5914612|P1|Overall Study|Protocol Violation|28
1694157|NCT01274559|5914611|P2|Overall Study|Physician Decision|1
1694158|NCT01274559|5914612|P1|Overall Study|Physician Decision|2
1694159|NCT01274559|5914611|P2|Overall Study|Non-compliance with Study Drug|4
1694160|NCT01274559|5914612|P1|Overall Study|Non-compliance with Study Drug|2
1694161|NCT01274559|5914611|P2|Overall Study|Lost to Follow-up|3
1694162|NCT01274559|5914612|P1|Overall Study|Lost to Follow-up|3
1694163|NCT01274559|5914611|P2|Overall Study|Death|1
1694164|NCT01274559|5914612|P1|Overall Study|Death|1
1694165|NCT01274559|5914611|P2|Overall Study|Adverse Event|13
1694166|NCT01274559|5914612|P1|Overall Study|Adverse Event|57
1694167|NCT01274533|5914662|P1|Overall Study|Disease progression|2
1694168|NCT01274533|5914662|P1|Overall Study|Non-compliance|1
1694169|NCT01274533|5914662|P1|Overall Study|Withdrawal by Subject|1
1694170|NCT01274429|5914667|P1|Overall Study|Study closed do to lack of funding|5
1694171|NCT01274182|5914675|P3|Overall Study|Death|1
1694172|NCT01274182|5914676|P2|Overall Study|Death|0
1694173|NCT01274182|5914677|P1|Overall Study|Death|1
1694174|NCT01274182|5914675|P3|Overall Study|Protocol Violation|0
1694175|NCT01274182|5914676|P2|Overall Study|Protocol Violation|2
1694176|NCT01274182|5914677|P1|Overall Study|Protocol Violation|3
1694177|NCT01274182|5914675|P3|Overall Study|Lost to Follow-up|1
1694178|NCT01274182|5914676|P2|Overall Study|Lost to Follow-up|3
1694179|NCT01274182|5914677|P1|Overall Study|Lost to Follow-up|2
1694180|NCT01274182|5914675|P3|Overall Study|Withdrawal by Subject|3
1694181|NCT01274182|5914676|P2|Overall Study|Withdrawal by Subject|5
1694182|NCT01274182|5914677|P1|Overall Study|Withdrawal by Subject|5
1694183|NCT01274182|5914675|P3|Overall Study|Adverse Event|3
1694184|NCT01274182|5914676|P2|Overall Study|Adverse Event|5
1694185|NCT01274182|5914677|P1|Overall Study|Adverse Event|4
1694186|NCT01274182|5914675|P3|Overall Study|Unsatisfactory therapeutic effect|4
1694187|NCT01274182|5914676|P2|Overall Study|Unsatisfactory therapeutic effect|3
1694188|NCT01274182|5914677|P1|Overall Study|Unsatisfactory therapeutic effect|6
1694189|NCT01273883|5914718|P2|Second Intervention|Lack of Efficacy|0
1694190|NCT01273883|5914719|P1|Second Intervention|Lack of Efficacy|1
1694191|NCT01273883|5914718|P2|Second Intervention|Lost to Follow-up|1
1694192|NCT01273883|5914719|P1|Second Intervention|Lost to Follow-up|1
1694193|NCT01273883|5914718|P2|First Intervention|Adverse Event|1
1694194|NCT01273883|5914719|P1|First Intervention|Adverse Event|2
1694195|NCT01273818|5914745|P3|Overall Study|Physician Decision|9
1694196|NCT01273818|5914746|P2|Overall Study|Physician Decision|2
1694197|NCT01273818|5914747|P1|Overall Study|Physician Decision|13
1694198|NCT01273805|5914757|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
1694199|NCT01273805|5914758|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
1694200|NCT01273623|5914789|P1|Overall Study|did not meet IVUS criteria|29
1694201|NCT01273597|5914796|P1|Overall Study|Reason Not Reported|1
1694202|NCT01273597|5914796|P1|Overall Study|Underwent Kidney Transplantation|2
1694203|NCT01273597|5914796|P1|Overall Study|Adverse Event|5
1694204|NCT01273519|5914811|P3|Overall Study|Other|1
1694205|NCT01273519|5914812|P2|Overall Study|Other|1
1694206|NCT01273519|5914813|P1|Overall Study|Other|6
1694207|NCT01273519|5914811|P3|Overall Study|Lack of Efficacy|4
1694208|NCT01273519|5914812|P2|Overall Study|Lack of Efficacy|3
1694209|NCT01273519|5914813|P1|Overall Study|Lack of Efficacy|8
1694210|NCT01273519|5914811|P3|Overall Study|Lost to Follow-up|3
1694211|NCT01273519|5914812|P2|Overall Study|Lost to Follow-up|1
1694212|NCT01273519|5914813|P1|Overall Study|Lost to Follow-up|2
1694213|NCT01273519|5914811|P3|Overall Study|Adverse Event|0
1694214|NCT01273519|5914812|P2|Overall Study|Adverse Event|0
1694215|NCT01273519|5914813|P1|Overall Study|Adverse Event|3
1694216|NCT01273181|5914850|P4|Phase 2, Dose 2|Death during treatment|1
1694217|NCT01273181|5914851|P3|Phase 2, Dose 2|Death during treatment|0
1694218|NCT01273181|5914852|P2|Phase 2, Dose 2|Death during treatment|0
1694219|NCT01273181|5914853|P1|Phase 2, Dose 2|Death during treatment|0
1694220|NCT01273181|5914850|P4|Phase 2, Dose 1|Study termination|0
1694221|NCT01273181|5914851|P3|Phase 2, Dose 1|Study termination|1
1694222|NCT01273181|5914852|P2|Phase 2, Dose 1|Study termination|0
1694223|NCT01273181|5914853|P1|Phase 2, Dose 1|Study termination|0
1694224|NCT01273181|5914850|P4|Phase I, Dose 2|Death during treatment|0
1694225|NCT01273181|5914851|P3|Phase I, Dose 2|Death during treatment|0
1694226|NCT01273181|5914852|P2|Phase I, Dose 2|Death during treatment|1
1694227|NCT01273181|5914853|P1|Phase I, Dose 2|Death during treatment|0
1694228|NCT01273181|5914850|P4|Phase I, Dose 1|Study termination|0
1694229|NCT01273181|5914851|P3|Phase I, Dose 1|Study termination|0
1694230|NCT01273181|5914852|P2|Phase I, Dose 1|Study termination|0
1694231|NCT01273181|5914853|P1|Phase I, Dose 1|Study termination|1
1694232|NCT01273155|5914871|P7|Overall Study|Withdrew during C1/refused further trmt|0
1694233|NCT01273155|5914872|P6|Overall Study|Withdrew during C1/refused further trmt|1
1694234|NCT01273155|5914873|P5|Overall Study|Withdrew during C1/refused further trmt|1
1694235|NCT01273155|5914874|P4|Overall Study|Withdrew during C1/refused further trmt|0
1694236|NCT01273155|5914875|P3|Overall Study|Withdrew during C1/refused further trmt|1
1694237|NCT01273155|5914876|P2|Overall Study|Withdrew during C1/refused further trmt|0
1694238|NCT01273155|5914877|P1|Overall Study|Withdrew during C1/refused further trmt|0
1694239|NCT01273155|5914871|P7|Overall Study|Died during Cycle 1|2
1694240|NCT01273155|5914872|P6|Overall Study|Died during Cycle 1|2
1694241|NCT01273155|5914873|P5|Overall Study|Died during Cycle 1|0
1694242|NCT01273155|5914874|P4|Overall Study|Died during Cycle 1|1
1694243|NCT01273155|5914875|P3|Overall Study|Died during Cycle 1|1
1694244|NCT01273155|5914876|P2|Overall Study|Died during Cycle 1|0
1694245|NCT01273155|5914877|P1|Overall Study|Died during Cycle 1|0
1694246|NCT01273155|5914871|P7|Overall Study|Off study prior to C1/due to toxicity|1
1694247|NCT01273155|5914872|P6|Overall Study|Off study prior to C1/due to toxicity|0
1694248|NCT01273155|5914873|P5|Overall Study|Off study prior to C1/due to toxicity|0
1694249|NCT01273155|5914874|P4|Overall Study|Off study prior to C1/due to toxicity|0
1694250|NCT01273155|5914875|P3|Overall Study|Off study prior to C1/due to toxicity|2
1694251|NCT01273155|5914876|P2|Overall Study|Off study prior to C1/due to toxicity|0
1694252|NCT01273155|5914877|P1|Overall Study|Off study prior to C1/due to toxicity|0
1694253|NCT01273155|5914871|P7|Overall Study|Change in liver function/no longer eval.|0
1694254|NCT01273155|5914872|P6|Overall Study|Change in liver function/no longer eval.|0
1694255|NCT01273155|5914873|P5|Overall Study|Change in liver function/no longer eval.|1
1694256|NCT01273155|5914874|P4|Overall Study|Change in liver function/no longer eval.|0
1694257|NCT01273155|5914875|P3|Overall Study|Change in liver function/no longer eval.|0
1694258|NCT01273155|5914876|P2|Overall Study|Change in liver function/no longer eval.|1
1694259|NCT01273155|5914877|P1|Overall Study|Change in liver function/no longer eval.|0
1694260|NCT01273155|5914871|P7|Overall Study|Off study trmt prior to end of C1/PD|3
1694261|NCT01273155|5914872|P6|Overall Study|Off study trmt prior to end of C1/PD|2
1694262|NCT01273155|5914873|P5|Overall Study|Off study trmt prior to end of C1/PD|0
1694263|NCT01273155|5914874|P4|Overall Study|Off study trmt prior to end of C1/PD|0
1694264|NCT01273155|5914875|P3|Overall Study|Off study trmt prior to end of C1/PD|8
1694265|NCT01273155|5914876|P2|Overall Study|Off study trmt prior to end of C1/PD|3
1694266|NCT01273155|5914877|P1|Overall Study|Off study trmt prior to end of C1/PD|2
1694267|NCT01273064|5914954|P5|Overall Study|Physician Decision|1
1694268|NCT01273064|5914955|P4|Overall Study|Physician Decision|0
1694269|NCT01273064|5914956|P3|Overall Study|Physician Decision|0
1694270|NCT01273064|5914957|P2|Overall Study|Physician Decision|0
1694271|NCT01273064|5914958|P1|Overall Study|Physician Decision|0
1694272|NCT01273064|5914954|P5|Overall Study|Lost to Follow-up|0
1694273|NCT01273064|5914955|P4|Overall Study|Lost to Follow-up|0
1694274|NCT01273064|5914956|P3|Overall Study|Lost to Follow-up|0
1694275|NCT01273064|5914957|P2|Overall Study|Lost to Follow-up|0
1694276|NCT01273064|5914958|P1|Overall Study|Lost to Follow-up|1
1694277|NCT01273064|5914954|P5|Overall Study|Study Termination|8
1694278|NCT01273064|5914955|P4|Overall Study|Study Termination|16
1694279|NCT01273064|5914956|P3|Overall Study|Study Termination|26
1694280|NCT01273064|5914957|P2|Overall Study|Study Termination|27
1694281|NCT01273064|5914958|P1|Overall Study|Study Termination|13
1694282|NCT01273064|5914954|P5|Overall Study|Withdrawal by Subject|0
1694283|NCT01273064|5914955|P4|Overall Study|Withdrawal by Subject|2
1694284|NCT01273064|5914956|P3|Overall Study|Withdrawal by Subject|2
1694285|NCT01273064|5914957|P2|Overall Study|Withdrawal by Subject|2
1694286|NCT01273064|5914958|P1|Overall Study|Withdrawal by Subject|4
1694287|NCT01273064|5914954|P5|Overall Study|Adverse Event|1
1694288|NCT01273064|5914955|P4|Overall Study|Adverse Event|2
1694289|NCT01273064|5914956|P3|Overall Study|Adverse Event|3
1694290|NCT01273064|5914957|P2|Overall Study|Adverse Event|1
1694291|NCT01273064|5914958|P1|Overall Study|Adverse Event|5
1694292|NCT01273038|5914977|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
1694293|NCT01273038|5914978|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
1694294|NCT01273038|5914977|P2|Second Intervention (14 Days)|Adverse Event|1
1694295|NCT01273038|5914978|P1|Second Intervention (14 Days)|Adverse Event|0
1694296|NCT01272947|5915001|P2|Overall Study|Abnormal Laboratory Value|2
1694297|NCT01272947|5915002|P1|Overall Study|Abnormal Laboratory Value|2
1694298|NCT01272934|5915012|P2|Overall Study|Abnormal Laboratory Value|1
1694299|NCT01272934|5915013|P1|Overall Study|Abnormal Laboratory Value|0
1694300|NCT01272934|5915012|P2|Overall Study|Adverse Event|1
1694301|NCT01272934|5915013|P1|Overall Study|Adverse Event|0
1694302|NCT01272921|5915023|P2|Overall Study|Protocol Violation|1
1694303|NCT01272921|5915024|P1|Overall Study|Protocol Violation|2
1694304|NCT01272908|5915032|P1|Re-Treatment Period|Withdrawal by Subject|1
1694305|NCT01272908|5915032|P1|Re-Treatment Period|Lack of Efficacy|3
1694306|NCT01272908|5915032|P1|Re-Treatment Period|Adverse Event|2
1694307|NCT01272908|5915032|P1|Initial Treatment Period|Withdrawal by Subject|1
1694308|NCT01272908|5915032|P1|Initial Treatment Period|Protocol Violation|1
1694309|NCT01272908|5915032|P1|Initial Treatment Period|Lack of Efficacy|5
1694310|NCT01272908|5915032|P1|Initial Treatment Period|Adverse Event|1
1694311|NCT01272869|5915072|P2|Period 2 (14 Days)|Adverse Event|0
1694312|NCT01272869|5915073|P1|Period 2 (14 Days)|Adverse Event|1
1694313|NCT01272804|5915100|P6|Overall Study|Adverse Event|1
1694314|NCT01272804|5915101|P5|Overall Study|Adverse Event|2
1694315|NCT01272804|5915102|P4|Overall Study|Adverse Event|0
1694316|NCT01272804|5915103|P3|Overall Study|Adverse Event|0
1694317|NCT01272804|5915104|P2|Overall Study|Adverse Event|0
1694318|NCT01272804|5915105|P1|Overall Study|Adverse Event|1
1694319|NCT01272661|5915263|P3|Overall Study|lost to followup/case closed/ no birth|72
1694320|NCT01272661|5915264|P2|Overall Study|lost to followup/case closed/ no birth|209
1694321|NCT01272661|5915265|P1|Overall Study|lost to followup/case closed/ no birth|126
1694322|NCT01272635|5915290|P4|Overall Study|Lost to Follow-up|23
1694323|NCT01272635|5915291|P3|Overall Study|Lost to Follow-up|31
1694324|NCT01272635|5915292|P2|Overall Study|Lost to Follow-up|20
1694325|NCT01272635|5915293|P1|Overall Study|Lost to Follow-up|31
1694326|NCT01272232|5915377|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
1694327|NCT01272232|5915378|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
1694328|NCT01272232|5915379|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
1694329|NCT01272232|5915377|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
1694330|NCT01272232|5915378|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
1694331|NCT01272232|5915379|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
1694332|NCT01272232|5915377|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
1694333|NCT01272232|5915378|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
1694334|NCT01272232|5915379|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
1694335|NCT01272232|5915377|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
1694336|NCT01272232|5915378|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
1694337|NCT01272232|5915379|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
1694338|NCT01272232|5915377|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
1694339|NCT01272232|5915378|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
1694340|NCT01272232|5915379|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
1694341|NCT01272232|5915377|P3|Weeks 0-56|Unclassified|12
1694342|NCT01272232|5915378|P2|Weeks 0-56|Unclassified|7
1694343|NCT01272232|5915379|P1|Weeks 0-56|Unclassified|16
1694344|NCT01272232|5915377|P3|Weeks 0-56|Withdrawal criteria|37
1694345|NCT01272232|5915378|P2|Weeks 0-56|Withdrawal criteria|14
1694346|NCT01272232|5915379|P1|Weeks 0-56|Withdrawal criteria|32
1694347|NCT01272232|5915377|P3|Weeks 0-56|Protocol Violation|13
1694348|NCT01272232|5915378|P2|Weeks 0-56|Protocol Violation|8
1694349|NCT01272232|5915379|P1|Weeks 0-56|Protocol Violation|12
1694350|NCT01272232|5915377|P3|Weeks 0-56|Lack of Efficacy|3
1694351|NCT01272232|5915378|P2|Weeks 0-56|Lack of Efficacy|0
1694352|NCT01272232|5915379|P1|Weeks 0-56|Lack of Efficacy|0
1694353|NCT01272232|5915377|P3|Weeks 0-56|Adverse Event|7
1694354|NCT01272232|5915378|P2|Weeks 0-56|Adverse Event|18
1694355|NCT01272232|5915379|P1|Weeks 0-56|Adverse Event|39
1694356|NCT01272219|5915424|P6|Main + Extension Period: Week 0-172|Unclassified|51
1694357|NCT01272219|5915425|P5|Main + Extension Period: Week 0-172|Unclassified|61
1694358|NCT01272219|5915426|P4|Main + Extension Period: Week 0-172|Unclassified|0
1694359|NCT01272219|5915427|P3|Main + Extension Period: Week 0-172|Unclassified|0
1694360|NCT01272219|5915428|P2|Main + Extension Period: Week 0-172|Unclassified|0
1694361|NCT01272219|5915429|P1|Main + Extension Period: Week 0-172|Unclassified|0
1694362|NCT01272219|5915424|P6|Main + Extension Period: Week 0-172|Missing reason|0
1694363|NCT01272219|5915425|P5|Main + Extension Period: Week 0-172|Missing reason|1
1694364|NCT01272219|5915426|P4|Main + Extension Period: Week 0-172|Missing reason|0
1694365|NCT01272219|5915427|P3|Main + Extension Period: Week 0-172|Missing reason|0
1694366|NCT01272219|5915428|P2|Main + Extension Period: Week 0-172|Missing reason|0
1694367|NCT01272219|5915429|P1|Main + Extension Period: Week 0-172|Missing reason|0
1694368|NCT01272219|5915424|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
1694369|NCT01272219|5915425|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
1694370|NCT01272219|5915426|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1694371|NCT01272219|5915427|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1694372|NCT01272219|5915428|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1694373|NCT01272219|5915429|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
1694374|NCT01272219|5915424|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
1694375|NCT01272219|5915425|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
1694376|NCT01272219|5915426|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
1694377|NCT01272219|5915427|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
1694378|NCT01272219|5915428|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
1694379|NCT01272219|5915429|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
1694380|NCT01272219|5915424|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
1694381|NCT01272219|5915425|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
1694382|NCT01272219|5915426|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1694383|NCT01272219|5915427|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1694384|NCT01272219|5915428|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1694385|NCT01272219|5915429|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
1694386|NCT01272219|5915424|P6|Main + Extension Period: Week 0-172|Adverse Event|43
1694387|NCT01272219|5915425|P5|Main + Extension Period: Week 0-172|Adverse Event|191
1694388|NCT01272219|5915426|P4|Main + Extension Period: Week 0-172|Adverse Event|0
1694389|NCT01272219|5915427|P3|Main + Extension Period: Week 0-172|Adverse Event|0
1694390|NCT01272219|5915428|P2|Main + Extension Period: Week 0-172|Adverse Event|0
1694391|NCT01272219|5915429|P1|Main + Extension Period: Week 0-172|Adverse Event|0
1694392|NCT01272219|5915424|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1694393|NCT01272219|5915425|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1694394|NCT01272219|5915426|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
1694395|NCT01272219|5915427|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
1694396|NCT01272219|5915428|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
1694397|NCT01272219|5915429|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
1694398|NCT01272219|5915424|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1694399|NCT01272219|5915425|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1694400|NCT01272219|5915426|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
1694401|NCT01272219|5915427|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
1694402|NCT01272219|5915428|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
1694403|NCT01272219|5915429|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
1694404|NCT01272219|5915424|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1694405|NCT01272219|5915425|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1694406|NCT01272219|5915426|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
1694407|NCT01272219|5915427|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1694408|NCT01272219|5915428|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
1694409|NCT01272219|5915429|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
1694410|NCT01272219|5915424|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1694411|NCT01272219|5915425|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1694412|NCT01272219|5915426|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
1694413|NCT01272219|5915427|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1694414|NCT01272219|5915428|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1694415|NCT01272219|5915429|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
1694416|NCT01272219|5915424|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1694417|NCT01272219|5915425|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1694418|NCT01272219|5915426|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
1694419|NCT01272219|5915427|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
1694420|NCT01272219|5915428|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
1694421|NCT01272219|5915429|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
1694422|NCT01272219|5915424|P6|Main Period: Week 0 to Week 56|Unclassified|34
1694423|NCT01272219|5915425|P5|Main Period: Week 0 to Week 56|Unclassified|42
1694424|NCT01272219|5915426|P4|Main Period: Week 0 to Week 56|Unclassified|29
1694425|NCT01272219|5915427|P3|Main Period: Week 0 to Week 56|Unclassified|0
1694426|NCT01272219|5915428|P2|Main Period: Week 0 to Week 56|Unclassified|0
1694427|NCT01272219|5915429|P1|Main Period: Week 0 to Week 56|Unclassified|36
1694428|NCT01272219|5915424|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
1694429|NCT01272219|5915425|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
1694430|NCT01272219|5915426|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
1694431|NCT01272219|5915427|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
1694432|NCT01272219|5915428|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
1694433|NCT01272219|5915429|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
1694434|NCT01272219|5915424|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
1694435|NCT01272219|5915425|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
1694436|NCT01272219|5915426|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
1694437|NCT01272219|5915427|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
1694438|NCT01272219|5915428|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
1694439|NCT01272219|5915429|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
1694440|NCT01272219|5915424|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
1694441|NCT01272219|5915425|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
1694442|NCT01272219|5915426|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
1694443|NCT01272219|5915427|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
1694444|NCT01272219|5915428|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
1694445|NCT01272219|5915429|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
1694446|NCT01272219|5915424|P6|Main Period: Week 0 to Week 56|Adverse Event|29
1694447|NCT01272219|5915425|P5|Main Period: Week 0 to Week 56|Adverse Event|152
1694448|NCT01272219|5915426|P4|Main Period: Week 0 to Week 56|Adverse Event|16
1694449|NCT01272219|5915427|P3|Main Period: Week 0 to Week 56|Adverse Event|0
1694450|NCT01272219|5915428|P2|Main Period: Week 0 to Week 56|Adverse Event|0
1694451|NCT01272219|5915429|P1|Main Period: Week 0 to Week 56|Adverse Event|86
1694452|NCT01272193|5915463|P2|Overall Study|Unclassified|7
1694453|NCT01272193|5915464|P1|Overall Study|Unclassified|8
1694454|NCT01272193|5915463|P2|Overall Study|Withdrawal Criteria|1
1694455|NCT01272193|5915464|P1|Overall Study|Withdrawal Criteria|1
1694456|NCT01272193|5915463|P2|Overall Study|Lack of Efficacy|3
1694457|NCT01272193|5915464|P1|Overall Study|Lack of Efficacy|0
1694458|NCT01272193|5915463|P2|Overall Study|Adverse Event|1
1694459|NCT01272193|5915464|P1|Overall Study|Adverse Event|1
1694460|NCT01272180|5915484|P4|Overall Study|Protocol Violation|1
1694461|NCT01272180|5915485|P3|Overall Study|Protocol Violation|0
1694462|NCT01272180|5915486|P2|Overall Study|Protocol Violation|1
1694463|NCT01272180|5915487|P1|Overall Study|Protocol Violation|0
1694464|NCT01272180|5915484|P4|Overall Study|Inappropriate enrollment|1
1694465|NCT01272180|5915485|P3|Overall Study|Inappropriate enrollment|1
1694466|NCT01272180|5915486|P2|Overall Study|Inappropriate enrollment|0
1694467|NCT01272180|5915487|P1|Overall Study|Inappropriate enrollment|0
1694468|NCT01272180|5915484|P4|Overall Study|Lost to Follow-up|10
1694469|NCT01272180|5915485|P3|Overall Study|Lost to Follow-up|8
1694470|NCT01272180|5915486|P2|Overall Study|Lost to Follow-up|14
1694471|NCT01272180|5915487|P1|Overall Study|Lost to Follow-up|15
1694472|NCT01272180|5915484|P4|Overall Study|Withdrawal by Subject|2
1694473|NCT01272180|5915485|P3|Overall Study|Withdrawal by Subject|3
1694474|NCT01272180|5915486|P2|Overall Study|Withdrawal by Subject|6
1694475|NCT01272180|5915487|P1|Overall Study|Withdrawal by Subject|2
1694476|NCT01272180|5915484|P4|Overall Study|Adverse Event|0
1694477|NCT01272180|5915485|P3|Overall Study|Adverse Event|1
1694478|NCT01272180|5915486|P2|Overall Study|Adverse Event|0
1694479|NCT01272180|5915487|P1|Overall Study|Adverse Event|0
1694480|NCT01272011|5915536|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
1694481|NCT01272011|5915537|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
1694482|NCT01272011|5915538|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
1694483|NCT01271933|5915574|P3|Double-Blind Phase|Participant request-personal reason|0
1694484|NCT01271933|5915575|P2|Double-Blind Phase|Participant request-personal reason|1
1694485|NCT01271933|5915576|P1|Double-Blind Phase|Participant request-personal reason|0
1694486|NCT01271933|5915574|P3|Double-Blind Phase|Adverse Event|0
1694487|NCT01271933|5915575|P2|Double-Blind Phase|Adverse Event|3
1694488|NCT01271933|5915576|P1|Double-Blind Phase|Adverse Event|0
1694489|NCT01271933|5915574|P3|Double-Blind Phase|Withdrawal by Subject|1
1694490|NCT01271933|5915575|P2|Double-Blind Phase|Withdrawal by Subject|6
1694491|NCT01271933|5915576|P1|Double-Blind Phase|Withdrawal by Subject|0
1694492|NCT01271933|5915574|P3|Double-Blind Phase|Lost to Follow-up|1
1694493|NCT01271933|5915575|P2|Double-Blind Phase|Lost to Follow-up|1
1694494|NCT01271933|5915576|P1|Double-Blind Phase|Lost to Follow-up|0
1694495|NCT01271933|5915574|P3|Double-Blind Phase|Lack of Efficacy|9
1694496|NCT01271933|5915575|P2|Double-Blind Phase|Lack of Efficacy|6
1694497|NCT01271933|5915576|P1|Double-Blind Phase|Lack of Efficacy|0
1694498|NCT01271933|5915574|P3|Double-Blind Phase|Randomized but not treated|1
1694499|NCT01271933|5915575|P2|Double-Blind Phase|Randomized but not treated|0
1694500|NCT01271933|5915576|P1|Double-Blind Phase|Randomized but not treated|0
1694501|NCT01271933|5915574|P3|Single-Blind Phase|(Participant request-personal reason)|0
1694502|NCT01271933|5915575|P2|Single-Blind Phase|(Participant request-personal reason)|0
1694503|NCT01271933|5915576|P1|Single-Blind Phase|(Participant request-personal reason)|1
1694504|NCT01271933|5915574|P3|Single-Blind Phase|(Protocol non-compliance)|0
1694505|NCT01271933|5915575|P2|Single-Blind Phase|(Protocol non-compliance)|0
1694506|NCT01271933|5915576|P1|Single-Blind Phase|(Protocol non-compliance)|2
1694507|NCT01271933|5915574|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
1694508|NCT01271933|5915575|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
1694509|NCT01271933|5915576|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
1694510|NCT01271933|5915574|P3|Single-Blind Phase|Adverse Event|0
1694511|NCT01271933|5915575|P2|Single-Blind Phase|Adverse Event|0
1694512|NCT01271933|5915576|P1|Single-Blind Phase|Adverse Event|52
1694513|NCT01271933|5915574|P3|Single-Blind Phase|Protocol Violation|0
1694514|NCT01271933|5915575|P2|Single-Blind Phase|Protocol Violation|0
1694515|NCT01271933|5915576|P1|Single-Blind Phase|Protocol Violation|3
1694516|NCT01271933|5915574|P3|Single-Blind Phase|Withdrawal by Subject|0
1694517|NCT01271933|5915575|P2|Single-Blind Phase|Withdrawal by Subject|0
1694518|NCT01271933|5915576|P1|Single-Blind Phase|Withdrawal by Subject|15
1694519|NCT01271933|5915574|P3|Single-Blind Phase|Lost to Follow-up|0
1694520|NCT01271933|5915575|P2|Single-Blind Phase|Lost to Follow-up|0
1694521|NCT01271933|5915576|P1|Single-Blind Phase|Lost to Follow-up|10
1694522|NCT01271933|5915574|P3|Single-Blind Phase|Lack of Efficacy|0
1694523|NCT01271933|5915575|P2|Single-Blind Phase|Lack of Efficacy|0
1694524|NCT01271933|5915576|P1|Single-Blind Phase|Lack of Efficacy|37
1694525|NCT01271803|5915719|P3|Overall Study|Lost to Follow-up|0
1694526|NCT01271803|5915720|P2|Overall Study|Lost to Follow-up|0
1694527|NCT01271803|5915721|P1|Overall Study|Lost to Follow-up|1
1694528|NCT01271803|5915719|P3|Overall Study|Withdrawal by Subject|0
1694529|NCT01271803|5915720|P2|Overall Study|Withdrawal by Subject|5
1694530|NCT01271803|5915721|P1|Overall Study|Withdrawal by Subject|1
1694531|NCT01271803|5915719|P3|Overall Study|Death|0
1694532|NCT01271803|5915720|P2|Overall Study|Death|34
1694533|NCT01271803|5915721|P1|Overall Study|Death|53
1694534|NCT01271803|5915719|P3|Overall Study|Progressive disease|2
1694535|NCT01271803|5915720|P2|Overall Study|Progressive disease|0
1694536|NCT01271803|5915721|P1|Overall Study|Progressive disease|0
1694537|NCT01271725|5915883|P2|Part B|Withdrawal by Subject|6
1694538|NCT01271725|5915884|P1|Part B|Withdrawal by Subject|0
1694539|NCT01271725|5915883|P2|Part B|Protocol Violation|1
1694540|NCT01271725|5915884|P1|Part B|Protocol Violation|0
1694541|NCT01271725|5915883|P2|Part B|Other Adverse Event|1
1694542|NCT01271725|5915884|P1|Part B|Other Adverse Event|0
1694543|NCT01271725|5915883|P2|Part B|Clinical signs/symptoms of progression|2
1694544|NCT01271725|5915884|P1|Part B|Clinical signs/symptoms of progression|0
1694545|NCT01271725|5915883|P2|Part B|Other than specified|2
1694546|NCT01271725|5915884|P1|Part B|Other than specified|0
1694547|NCT01271725|5915883|P2|Part A|Protocol Violation|0
1694548|NCT01271725|5915884|P1|Part A|Protocol Violation|1
1694549|NCT01271725|5915883|P2|Part A|Other than specified|0
1694550|NCT01271725|5915884|P1|Part A|Other than specified|3
1694551|NCT01271725|5915883|P2|Part A|Withdrawal by Subject|0
1694552|NCT01271725|5915884|P1|Part A|Withdrawal by Subject|12
1694553|NCT01271725|5915883|P2|Part A|Lost to Follow-up|0
1694554|NCT01271725|5915884|P1|Part A|Lost to Follow-up|1
1694555|NCT01271725|5915883|P2|Part A|Other Adverse Event|0
1694556|NCT01271725|5915884|P1|Part A|Other Adverse Event|8
1694557|NCT01271725|5915883|P2|Part A|Clinical signs/symptoms of progression|0
1694558|NCT01271725|5915884|P1|Part A|Clinical signs/symptoms of progression|2
1694559|NCT01271725|5915883|P2|Part A|Progressive disease according to RECIST|0
1694560|NCT01271725|5915884|P1|Part A|Progressive disease according to RECIST|8
1694561|NCT01271712|5915913|P2|Survival Follow-up|Ongoing survival follow-up|6
1694562|NCT01271712|5915914|P1|Survival Follow-up|Ongoing survival follow-up|15
1694563|NCT01271712|5915913|P2|Safety Follow-up|Progressive disease|0
1694564|NCT01271712|5915914|P1|Safety Follow-up|Progressive disease|1
1694565|NCT01271712|5915913|P2|Safety Follow-up|No follow-up|1
1694566|NCT01271712|5915914|P1|Safety Follow-up|No follow-up|1
1694567|NCT01271712|5915913|P2|Safety Follow-up|Ongoing safety follow-up|4
1694568|NCT01271712|5915914|P1|Safety Follow-up|Ongoing safety follow-up|3
1694569|NCT01271712|5915913|P2|Safety Follow-up|Protocol Violation|1
1694570|NCT01271712|5915914|P1|Safety Follow-up|Protocol Violation|1
1694571|NCT01271712|5915913|P2|Safety Follow-up|Withdrawal by Subject|2
1694572|NCT01271712|5915914|P1|Safety Follow-up|Withdrawal by Subject|4
1694573|NCT01271712|5915913|P2|Safety Follow-up|Death|7
1694574|NCT01271712|5915914|P1|Safety Follow-up|Death|11
1694575|NCT01271712|5915913|P2|Open Label Treatment|Switching to other therapy|1
1694576|NCT01271712|5915914|P1|Open Label Treatment|Switching to other therapy|2
1694577|NCT01271712|5915913|P2|Open Label Treatment|Protocol Violation|1
1694578|NCT01271712|5915914|P1|Open Label Treatment|Protocol Violation|0
1694579|NCT01271712|5915913|P2|Open Label Treatment|Non-compliance with study drug|0
1694580|NCT01271712|5915914|P1|Open Label Treatment|Non-compliance with study drug|1
1694581|NCT01271712|5915913|P2|Open Label Treatment|Ongoing with open-label treatment|1
1694582|NCT01271712|5915914|P1|Open Label Treatment|Ongoing with open-label treatment|6
1694583|NCT01271712|5915913|P2|Open Label Treatment|Progressive disease|31
1694584|NCT01271712|5915914|P1|Open Label Treatment|Progressive disease|56
1694585|NCT01271712|5915913|P2|Open Label Treatment|Adverse Event|8
1694586|NCT01271712|5915914|P1|Open Label Treatment|Adverse Event|12
1694587|NCT01271712|5915913|P2|Open Label Treatment|Physician Decision|0
1694588|NCT01271712|5915914|P1|Open Label Treatment|Physician Decision|2
1694589|NCT01271712|5915913|P2|Open Label Treatment|Withdrawal by Subject|11
1694590|NCT01271712|5915914|P1|Open Label Treatment|Withdrawal by Subject|6
1694591|NCT01271712|5915913|P2|Open Label Treatment|Death|5
1694592|NCT01271712|5915914|P1|Open Label Treatment|Death|6
1694593|NCT01271712|5915913|P2|Double Blind Treatment|receive no study drug|0
1694594|NCT01271712|5915914|P1|Double Blind Treatment|receive no study drug|1
1694595|NCT01271712|5915913|P2|Double Blind Treatment|Non compliance with study drug|0
1694596|NCT01271712|5915914|P1|Double Blind Treatment|Non compliance with study drug|2
1694597|NCT01271712|5915913|P2|Double Blind Treatment|Withdrawal by Subject|1
1694598|NCT01271712|5915914|P1|Double Blind Treatment|Withdrawal by Subject|4
1694599|NCT01271712|5915913|P2|Double Blind Treatment|Progressive disease|3
1694600|NCT01271712|5915914|P1|Double Blind Treatment|Progressive disease|23
1694601|NCT01271712|5915913|P2|Double Blind Treatment|Adverse Event|4
1694602|NCT01271712|5915914|P1|Double Blind Treatment|Adverse Event|9
1694603|NCT01271712|5915913|P2|Double Blind Treatment|Lack of Efficacy|0
1694604|NCT01271712|5915914|P1|Double Blind Treatment|Lack of Efficacy|1
1694605|NCT01271712|5915913|P2|Double Blind Treatment|Death|0
1694606|NCT01271712|5915914|P1|Double Blind Treatment|Death|2
1694607|NCT01271010|5916010|P1|Overall Study|Disease progression|27
1694608|NCT01271010|5916010|P1|Overall Study|Withdrawal by Subject|18
1694609|NCT01271010|5916010|P1|Overall Study|Progression and relapse of disease|1
1694610|NCT01271010|5916010|P1|Overall Study|Death|2
1694611|NCT01271010|5916010|P1|Overall Study|Protocol Violation|1
1694612|NCT01271010|5916010|P1|Overall Study|Start of new CLL therapy|1
1694613|NCT01271010|5916010|P1|Overall Study|Reason not specified|11
1694614|NCT01270971|5916025|P2|Overall Study|Non-specific|3
1694615|NCT01270971|5916026|P1|Overall Study|Non-specific|7
1694616|NCT01270971|5916025|P2|Overall Study|Non compliance|2
1694617|NCT01270971|5916026|P1|Overall Study|Non compliance|2
1694618|NCT01270971|5916025|P2|Overall Study|Adverse Event|2
1694619|NCT01270971|5916026|P1|Overall Study|Adverse Event|1
1694620|NCT01270971|5916025|P2|Overall Study|Lost to Follow-up|5
1694621|NCT01270971|5916026|P1|Overall Study|Lost to Follow-up|18
1694622|NCT01270971|5916025|P2|Overall Study|Withdrawal by Subject|11
1694623|NCT01270971|5916026|P1|Overall Study|Withdrawal by Subject|24
1694624|NCT01270958|5916038|P1|Overall Study|Did not meet inclusion criteria for age|2
1694625|NCT01270958|5916038|P1|Overall Study|Lost to Follow-up|2
1694626|NCT01270880|5916067|P1|Overall Study|Never rec'd treatment, but registered.|1
1694627|NCT01270841|5916097|P4|Overall Study|Enrolled in error|0
1694628|NCT01270841|5916098|P3|Overall Study|Enrolled in error|0
1694629|NCT01270841|5916099|P2|Overall Study|Enrolled in error|1
1694630|NCT01270841|5916100|P1|Overall Study|Enrolled in error|0
1694631|NCT01270841|5916097|P4|Overall Study|Protocol Violation|0
1694632|NCT01270841|5916098|P3|Overall Study|Protocol Violation|0
1694633|NCT01270841|5916099|P2|Overall Study|Protocol Violation|5
1694634|NCT01270841|5916100|P1|Overall Study|Protocol Violation|1
1694635|NCT01270841|5916097|P4|Overall Study|Did not qualify|5
1694636|NCT01270841|5916098|P3|Overall Study|Did not qualify|4
1694637|NCT01270841|5916099|P2|Overall Study|Did not qualify|3
1694638|NCT01270841|5916100|P1|Overall Study|Did not qualify|6
1694639|NCT01270841|5916097|P4|Overall Study|Physician Decision|0
1694640|NCT01270841|5916098|P3|Overall Study|Physician Decision|0
1694641|NCT01270841|5916099|P2|Overall Study|Physician Decision|1
1694642|NCT01270841|5916100|P1|Overall Study|Physician Decision|0
1694643|NCT01270841|5916097|P4|Overall Study|Lost to Follow-up|2
1694644|NCT01270841|5916098|P3|Overall Study|Lost to Follow-up|4
1694645|NCT01270841|5916099|P2|Overall Study|Lost to Follow-up|1
1694646|NCT01270841|5916100|P1|Overall Study|Lost to Follow-up|3
1694647|NCT01270841|5916097|P4|Overall Study|Withdrawal by Subject|3
1694648|NCT01270841|5916098|P3|Overall Study|Withdrawal by Subject|3
1694649|NCT01270841|5916099|P2|Overall Study|Withdrawal by Subject|2
1694650|NCT01270841|5916100|P1|Overall Study|Withdrawal by Subject|3
1694651|NCT01270841|5916097|P4|Overall Study|Adverse Event|3
1694652|NCT01270841|5916098|P3|Overall Study|Adverse Event|0
1694653|NCT01270841|5916099|P2|Overall Study|Adverse Event|1
1694654|NCT01270841|5916100|P1|Overall Study|Adverse Event|0
1694655|NCT01270828|5916124|P3|Double Blind Phase|Adverse event related to study drug|0
1694656|NCT01270828|5916125|P2|Double Blind Phase|Adverse event related to study drug|7
1694657|NCT01270828|5916126|P1|Double Blind Phase|Adverse event related to study drug|5
1694658|NCT01270828|5916124|P3|Double Blind Phase|Adverse event not related to study drug|0
1694659|NCT01270828|5916125|P2|Double Blind Phase|Adverse event not related to study drug|1
1694660|NCT01270828|5916126|P1|Double Blind Phase|Adverse event not related to study drug|1
1694661|NCT01270828|5916124|P3|Double Blind Phase|Lack of Efficacy|0
1694662|NCT01270828|5916125|P2|Double Blind Phase|Lack of Efficacy|11
1694663|NCT01270828|5916126|P1|Double Blind Phase|Lack of Efficacy|2
1694664|NCT01270828|5916124|P3|Double Blind Phase|Lost to Follow-up|0
1694665|NCT01270828|5916125|P2|Double Blind Phase|Lost to Follow-up|2
1694666|NCT01270828|5916126|P1|Double Blind Phase|Lost to Follow-up|1
1694667|NCT01270828|5916124|P3|Double Blind Phase|Withdrawal by Subject|0
1694668|NCT01270828|5916125|P2|Double Blind Phase|Withdrawal by Subject|15
1694669|NCT01270828|5916126|P1|Double Blind Phase|Withdrawal by Subject|6
1694670|NCT01270828|5916124|P3|Double Blind Phase|Reason Unspecified|0
1694671|NCT01270828|5916125|P2|Double Blind Phase|Reason Unspecified|4
1694672|NCT01270828|5916126|P1|Double Blind Phase|Reason Unspecified|7
1694673|NCT01270828|5916124|P3|Double Blind Phase|Protocol and GCP non-compliance|0
1694674|NCT01270828|5916125|P2|Double Blind Phase|Protocol and GCP non-compliance|3
1694675|NCT01270828|5916126|P1|Double Blind Phase|Protocol and GCP non-compliance|4
1694676|NCT01270828|5916124|P3|Double Blind Phase|Protocol Violation|0
1694677|NCT01270828|5916125|P2|Double Blind Phase|Protocol Violation|1
1694678|NCT01270828|5916126|P1|Double Blind Phase|Protocol Violation|0
1694679|NCT01270828|5916124|P3|Double Blind Phase|Death|0
1694680|NCT01270828|5916125|P2|Double Blind Phase|Death|1
1694681|NCT01270828|5916126|P1|Double Blind Phase|Death|0
1694682|NCT01270828|5916124|P3|Pregabalin CR SB|Protocol Violation|8
1694683|NCT01270828|5916125|P2|Pregabalin CR SB|Protocol Violation|0
1694684|NCT01270828|5916126|P1|Pregabalin CR SB|Protocol Violation|0
1694685|NCT01270828|5916124|P3|Pregabalin CR SB|Unrelated AE|8
1694686|NCT01270828|5916125|P2|Pregabalin CR SB|Unrelated AE|0
1694687|NCT01270828|5916126|P1|Pregabalin CR SB|Unrelated AE|0
1694688|NCT01270828|5916124|P3|Pregabalin CR SB|Lost to Follow-up|10
1694689|NCT01270828|5916125|P2|Pregabalin CR SB|Lost to Follow-up|0
1694690|NCT01270828|5916126|P1|Pregabalin CR SB|Lost to Follow-up|0
1694691|NCT01270828|5916124|P3|Pregabalin CR SB|Withdrawal by Subject|29
1694692|NCT01270828|5916125|P2|Pregabalin CR SB|Withdrawal by Subject|0
1694693|NCT01270828|5916126|P1|Pregabalin CR SB|Withdrawal by Subject|0
1694694|NCT01270828|5916124|P3|Pregabalin CR SB|Lack of Efficacy|32
1694695|NCT01270828|5916125|P2|Pregabalin CR SB|Lack of Efficacy|0
1694696|NCT01270828|5916126|P1|Pregabalin CR SB|Lack of Efficacy|0
1694697|NCT01270828|5916124|P3|Pregabalin CR SB|Related adverse event|46
1694698|NCT01270828|5916125|P2|Pregabalin CR SB|Related adverse event|0
1694699|NCT01270828|5916126|P1|Pregabalin CR SB|Related adverse event|0
1694700|NCT01270828|5916124|P3|Pregabalin CR SB|Enrolled but not treated|5
1694701|NCT01270828|5916125|P2|Pregabalin CR SB|Enrolled but not treated|0
1694702|NCT01270828|5916126|P1|Pregabalin CR SB|Enrolled but not treated|0
1694703|NCT01270828|5916124|P3|Pregabalin CR SB|Reason Unspecified|8
1694704|NCT01270828|5916125|P2|Pregabalin CR SB|Reason Unspecified|0
1694705|NCT01270828|5916126|P1|Pregabalin CR SB|Reason Unspecified|0
1694706|NCT01270802|5916168|P2|Overall Study|Lost to Follow-up|1
1694707|NCT01270802|5916169|P1|Overall Study|Lost to Follow-up|0
1694708|NCT01270802|5916168|P2|Overall Study|Adverse Event|0
1694709|NCT01270802|5916169|P1|Overall Study|Adverse Event|1
1694710|NCT01270802|5916168|P2|Overall Study|Withdrawal by Subject|0
1694711|NCT01270802|5916169|P1|Overall Study|Withdrawal by Subject|1
1694712|NCT01270620|5916316|P2|Overall Study|Withdrawal by Subject|3
1694713|NCT01270620|5916317|P1|Overall Study|Withdrawal by Subject|1
1694714|NCT01270503|5916412|P1|Overall Study|Lost to Follow-up|1
1694715|NCT01270464|5916420|P3|Overall Study|Other|3
1694716|NCT01270464|5916421|P2|Overall Study|Other|1
1694717|NCT01270464|5916422|P1|Overall Study|Other|1
1694718|NCT01270464|5916420|P3|Overall Study|Lost to Follow-up|1
1694719|NCT01270464|5916421|P2|Overall Study|Lost to Follow-up|3
1694720|NCT01270464|5916422|P1|Overall Study|Lost to Follow-up|2
1694721|NCT01270464|5916420|P3|Overall Study|Withdrawal by Subject|4
1694722|NCT01270464|5916421|P2|Overall Study|Withdrawal by Subject|1
1694723|NCT01270464|5916422|P1|Overall Study|Withdrawal by Subject|2
1694724|NCT01270464|5916420|P3|Overall Study|Adverse Event|7
1694725|NCT01270464|5916421|P2|Overall Study|Adverse Event|1
1694726|NCT01270464|5916422|P1|Overall Study|Adverse Event|9
1694727|NCT01270464|5916420|P3|Overall Study|Lack of Efficacy|1
1694728|NCT01270464|5916421|P2|Overall Study|Lack of Efficacy|3
1694729|NCT01270464|5916422|P1|Overall Study|Lack of Efficacy|2
1694730|NCT01270464|5916420|P3|Overall Study|Protocol Violation|2
1694731|NCT01270464|5916421|P2|Overall Study|Protocol Violation|3
1694732|NCT01270464|5916422|P1|Overall Study|Protocol Violation|4
1694733|NCT01270256|5916471|P2|Overall Study|Withdrawal by Subject|0
1694734|NCT01270256|5916472|P1|Overall Study|Withdrawal by Subject|1
1694735|NCT01270139|5916481|P3|Overall Study|Lost to Follow-up|2
1694736|NCT01270139|5916482|P2|Overall Study|Lost to Follow-up|9
1694737|NCT01270139|5916483|P1|Overall Study|Lost to Follow-up|10
1694738|NCT01270139|5916481|P3|Overall Study|Adverse Event|18
1694739|NCT01270139|5916482|P2|Overall Study|Adverse Event|17
1694740|NCT01270139|5916483|P1|Overall Study|Adverse Event|8
1694741|NCT01269918|5916552|P2|Overall Study|Did not receive study drug|3
1694742|NCT01269918|5916553|P1|Overall Study|Did not receive study drug|0
1694743|NCT01269346|5916628|P1|Extension Phase|Started a prohibited con med|1
1694744|NCT01269346|5916628|P1|Extension Phase|Clinical progression|1
1694745|NCT01269346|5916628|P1|Extension Phase|Physician decision or participant choice|9
1694746|NCT01269346|5916628|P1|Extension Phase|Disease progression|22
1694747|NCT01269346|5916628|P1|Extension Phase|Withdrawal by Subject|4
1694748|NCT01269346|5916628|P1|Extension Phase|Adverse Event|6
1694749|NCT01269346|5916628|P1|Treatment Phase|Other|2
1694750|NCT01269346|5916628|P1|Treatment Phase|Withdrawal by Subject|1
1694751|NCT01269346|5916628|P1|Treatment Phase|Adverse Event|3
1694752|NCT01269346|5916628|P1|Treatment Phase|Disease progression|3
1694753|NCT01269125|5916639|P3|Overall Study|Lost to Follow-up|0
1694754|NCT01269125|5916640|P2|Overall Study|Lost to Follow-up|0
1694755|NCT01269125|5916641|P1|Overall Study|Lost to Follow-up|4
1694756|NCT01269125|5916639|P3|Overall Study|Adverse Event|0
1694757|NCT01269125|5916640|P2|Overall Study|Adverse Event|5
1694758|NCT01269125|5916641|P1|Overall Study|Adverse Event|3
1694759|NCT01268891|5916700|P2|Overall Study|Administrative or other reason(s)|0
1694760|NCT01268891|5916701|P1|Overall Study|Administrative or other reason(s)|1
1694761|NCT01268891|5916700|P2|Overall Study|Withdrawal of Consent|1
1694762|NCT01268891|5916701|P1|Overall Study|Withdrawal of Consent|3
1694763|NCT01268891|5916700|P2|Overall Study|Lack of Efficacy|0
1694764|NCT01268891|5916701|P1|Overall Study|Lack of Efficacy|1
1694765|NCT01268891|5916700|P2|Overall Study|Adverse Event|7
1694766|NCT01268891|5916701|P1|Overall Study|Adverse Event|3
1694767|NCT01268566|5916727|P1|Overall Study|Death|30
1694768|NCT01268566|5916727|P1|Overall Study|Withdrawal by Subject|12
1694769|NCT01268566|5916727|P1|Overall Study|Lost to Follow-up|1
1694770|NCT01268514|5916754|P1|Overall Study|Withdrawal by Surgeon|5
1694771|NCT01268514|5916754|P1|Overall Study|Withdrawal by Subject|3
1694772|NCT01268514|5916754|P1|Overall Study|Lost to Follow-up|5
1694773|NCT01268514|5916754|P1|Overall Study|Death|8
1694774|NCT01268514|5916754|P1|Overall Study|Adverse Event|20
1694775|NCT01268501|5916763|P1|Overall Study|Handling Difficulties|2
1694776|NCT01268501|5916763|P1|Overall Study|Unacceptable Subjective Vision|3
1694777|NCT01268501|5916763|P1|Overall Study|Withdrawal by Subject|3
1694778|NCT01268501|5916763|P1|Overall Study|Lost to Follow-up|1
1694779|NCT01268488|5916767|P1|Overall Study|Physician Decision|2
1694780|NCT01268488|5916767|P1|Overall Study|Adverse Event|3
1694781|NCT01268306|5916774|P1|Overall Study|Lost to Follow-up|1
1694782|NCT01268293|5916778|P1|Overall Study|Subject choice|1
1694783|NCT01268293|5916778|P1|Overall Study|Adverse Event|1
1694784|NCT01268293|5916778|P1|Overall Study|Disease progression|7
1694785|NCT01268267|5916783|P1|Overall Study|Protocol Violation|1
1694786|NCT01268150|5916804|P1|Extension Phase|Other|6
1694787|NCT01268150|5916804|P1|Extension Phase|Disease progression|18
1694788|NCT01268150|5916804|P1|Extension Phase|Adverse Event|3
1694789|NCT01268150|5916804|P1|Treatment Phase|Other|4
1694790|NCT01268150|5916804|P1|Treatment Phase|Withdrawal by Subject|3
1694791|NCT01268150|5916804|P1|Treatment Phase|Adverse Event|3
1694792|NCT01268150|5916804|P1|Treatment Phase|Progression of disease|18
1694793|NCT01268098|5916823|P2|Overall Study|Adverse Event|0
1694794|NCT01268098|5916824|P1|Overall Study|Adverse Event|1
1694795|NCT01268046|5916836|P4|Overall Study|Lost to Follow-up|0
1694796|NCT01268046|5916837|P3|Overall Study|Lost to Follow-up|1
1694797|NCT01268046|5916838|P2|Overall Study|Lost to Follow-up|0
1694798|NCT01268046|5916839|P1|Overall Study|Lost to Follow-up|0
1694799|NCT01268046|5916836|P4|Overall Study|Withdrawal by Subject|1
1694800|NCT01268046|5916837|P3|Overall Study|Withdrawal by Subject|0
1694801|NCT01268046|5916838|P2|Overall Study|Withdrawal by Subject|0
1694802|NCT01268046|5916839|P1|Overall Study|Withdrawal by Subject|1
1694803|NCT01267994|5916849|P1|Overall Study|Adverse Event|2
1694804|NCT01267955|5916854|P1|Stage 2 (6 Months)|Protocol Violation|1
1694805|NCT01267955|5916854|P1|Stage 2 (6 Months)|Death|5
1694806|NCT01267955|5916854|P1|Stage 1 (6 Months)|Death|3
1694807|NCT01267825|5916891|P2|Overall Study|study terminated. no data collected.|0
1694808|NCT01267825|5916892|P1|Overall Study|study terminated. no data collected.|1
1694809|NCT01267266|5916967|P2|Lead-in Phase|Withdrawal by Subject|0
1694810|NCT01267266|5916968|P1|Lead-in Phase|Withdrawal by Subject|1
1694811|NCT01267266|5916967|P2|Lead-in Phase|Adverse Event|0
1694812|NCT01267266|5916968|P1|Lead-in Phase|Adverse Event|2
1694813|NCT01267266|5916967|P2|Lead-in Phase|Lack of Efficacy|0
1694814|NCT01267266|5916968|P1|Lead-in Phase|Lack of Efficacy|20
1694815|NCT01267266|5916967|P2|Enrollment Phase|Withdrawal by Subject|0
1694816|NCT01267266|5916968|P1|Enrollment Phase|Withdrawal by Subject|2
1694817|NCT01267253|5916981|P1|Overall Study|Inevaluable-never received study treatme|2
1694818|NCT01267253|5916981|P1|Overall Study|Ineligible - required test not done|1
1694819|NCT01267201|5917020|P6|Second Intervention Period|Withdrawal by Subject|0
1694820|NCT01267201|5917021|P5|Second Intervention Period|Withdrawal by Subject|0
1694821|NCT01267201|5917022|P4|Second Intervention Period|Withdrawal by Subject|0
1694822|NCT01267201|5917023|P3|Second Intervention Period|Withdrawal by Subject|0
1694823|NCT01267201|5917024|P2|Second Intervention Period|Withdrawal by Subject|1
1694824|NCT01267201|5917025|P1|Second Intervention Period|Withdrawal by Subject|0
1694825|NCT01267201|5917020|P6|First Intervention Period|Withdrawal by Subject|0
1694826|NCT01267201|5917021|P5|First Intervention Period|Withdrawal by Subject|0
1694827|NCT01267201|5917022|P4|First Intervention Period|Withdrawal by Subject|0
1694828|NCT01267201|5917023|P3|First Intervention Period|Withdrawal by Subject|0
1694829|NCT01267201|5917024|P2|First Intervention Period|Withdrawal by Subject|0
1694830|NCT01267201|5917025|P1|First Intervention Period|Withdrawal by Subject|1
1694831|NCT01267175|5917042|P1|Overall Study|Lost to Follow-up|1
1694832|NCT01267175|5917042|P1|Overall Study|Withdrawal by Subject|1
1694833|NCT01266993|5917114|P2|Booster Phase (Month 69)|Withdrawal by Subject|1
1694834|NCT01266993|5917115|P1|Booster Phase (Month 69)|Withdrawal by Subject|0
1694835|NCT01266993|5917114|P2|Booster Phase (Month 69)|Lost to Follow-up|1
1694836|NCT01266993|5917115|P1|Booster Phase (Month 69)|Lost to Follow-up|5
1694837|NCT01266967|5917185|P2|Overall Study|Withdrawal by Subject|3
1694838|NCT01266967|5917186|P1|Overall Study|Withdrawal by Subject|3
1694839|NCT01266967|5917185|P2|Overall Study|Physician Decision|1
1694840|NCT01266967|5917186|P1|Overall Study|Physician Decision|0
1694841|NCT01266967|5917185|P2|Overall Study|Lost to Follow-up|1
1694842|NCT01266967|5917186|P1|Overall Study|Lost to Follow-up|2
1694843|NCT01266967|5917185|P2|Overall Study|Study Closed/Terminated|17
1694844|NCT01266967|5917186|P1|Overall Study|Study Closed/Terminated|15
1694845|NCT01266967|5917185|P2|Overall Study|Death|61
1694846|NCT01266967|5917186|P1|Overall Study|Death|69
1694847|NCT01266876|5917238|P5|Overall Study|Adverse Event|0
1694848|NCT01266876|5917239|P4|Overall Study|Adverse Event|1
1694849|NCT01266876|5917240|P3|Overall Study|Adverse Event|0
1694850|NCT01266876|5917241|P2|Overall Study|Adverse Event|0
1694851|NCT01266876|5917242|P1|Overall Study|Adverse Event|0
1694852|NCT01266850|5917349|P5|Overall Study|Site Closure|0
1694853|NCT01266850|5917350|P4|Overall Study|Site Closure|1
1694854|NCT01266850|5917351|P3|Overall Study|Site Closure|1
1694855|NCT01266850|5917352|P2|Overall Study|Site Closure|1
1694856|NCT01266850|5917353|P1|Overall Study|Site Closure|0
1694857|NCT01266850|5917349|P5|Overall Study|Adverse Event|1
1694858|NCT01266850|5917350|P4|Overall Study|Adverse Event|0
1694859|NCT01266850|5917351|P3|Overall Study|Adverse Event|0
1694860|NCT01266850|5917352|P2|Overall Study|Adverse Event|0
1694861|NCT01266850|5917353|P1|Overall Study|Adverse Event|0
1694862|NCT01266850|5917349|P5|Overall Study|Protocol Violation|2
1694863|NCT01266850|5917350|P4|Overall Study|Protocol Violation|1
1694864|NCT01266850|5917351|P3|Overall Study|Protocol Violation|0
1694865|NCT01266850|5917352|P2|Overall Study|Protocol Violation|1
1694866|NCT01266850|5917353|P1|Overall Study|Protocol Violation|0
1694867|NCT01266850|5917349|P5|Overall Study|Physician Decision|3
1694868|NCT01266850|5917350|P4|Overall Study|Physician Decision|4
1694869|NCT01266850|5917351|P3|Overall Study|Physician Decision|4
1694870|NCT01266850|5917352|P2|Overall Study|Physician Decision|6
1694871|NCT01266850|5917353|P1|Overall Study|Physician Decision|3
1694872|NCT01266850|5917349|P5|Overall Study|Withdrawal by Subject|12
1694873|NCT01266850|5917350|P4|Overall Study|Withdrawal by Subject|9
1694874|NCT01266850|5917351|P3|Overall Study|Withdrawal by Subject|6
1694875|NCT01266850|5917352|P2|Overall Study|Withdrawal by Subject|9
1694876|NCT01266850|5917353|P1|Overall Study|Withdrawal by Subject|8
1694877|NCT01266850|5917349|P5|Overall Study|Lost to Follow-up|12
1694878|NCT01266850|5917350|P4|Overall Study|Lost to Follow-up|13
1694879|NCT01266850|5917351|P3|Overall Study|Lost to Follow-up|13
1694880|NCT01266850|5917352|P2|Overall Study|Lost to Follow-up|19
1694881|NCT01266850|5917353|P1|Overall Study|Lost to Follow-up|19
1694882|NCT01266824|5917407|P2|Overall Study|Study terminated prior to completion|3
1694883|NCT01266824|5917408|P1|Overall Study|Study terminated prior to completion|2
1694888|NCT01266590|5917426|P1|Overall Study|Physician Decision|1
1694889|NCT01266590|5917426|P1|Overall Study|Withdrawal by Subject|1
1694890|NCT01266590|5917426|P1|Overall Study|Lost to Follow-up|1
1694891|NCT01266590|5917426|P1|Overall Study|Adverse Event|3
1694892|NCT01266317|5917446|P1|Overall Study|Withdrawal by Subject|2
1694893|NCT01266291|5917451|P1|Overall Study|Adverse Event|1
1694894|NCT01266265|5917458|P2|Overall Study|Clinical worsening|1
1694895|NCT01266265|5917459|P1|Overall Study|Clinical worsening|1
1694896|NCT01266265|5917458|P2|Overall Study|Site closed early|3
1694897|NCT01266265|5917459|P1|Overall Study|Site closed early|4
1694898|NCT01266265|5917458|P2|Overall Study|Lung transplant|5
1694899|NCT01266265|5917459|P1|Overall Study|Lung transplant|6
1694900|NCT01266265|5917458|P2|Overall Study|Non-compliance|5
1694901|NCT01266265|5917459|P1|Overall Study|Non-compliance|8
1694902|NCT01266265|5917458|P2|Overall Study|Enrolled in another clinical study|26
1694903|NCT01266265|5917459|P1|Overall Study|Enrolled in another clinical study|15
1694904|NCT01266265|5917458|P2|Overall Study|Stopped/changed PAH medication(s)|9
1694905|NCT01266265|5917459|P1|Overall Study|Stopped/changed PAH medication(s)|16
1694906|NCT01266265|5917458|P2|Overall Study|Transferred care to another provider|28
1694907|NCT01266265|5917459|P1|Overall Study|Transferred care to another provider|22
1694908|NCT01266265|5917458|P2|Overall Study|Respiratory-related adverse event|1
1694909|NCT01266265|5917459|P1|Overall Study|Respiratory-related adverse event|2
1694910|NCT01266265|5917458|P2|Overall Study|Withdrawal by Subject|11
1694911|NCT01266265|5917459|P1|Overall Study|Withdrawal by Subject|13
1694912|NCT01266265|5917458|P2|Overall Study|Lost to Follow-up|28
1694913|NCT01266265|5917459|P1|Overall Study|Lost to Follow-up|23
1694914|NCT01266265|5917458|P2|Overall Study|Death|73
1694915|NCT01266265|5917459|P1|Overall Study|Death|95
1694916|NCT01266161|5917467|P2|Overall Study|Vomited within 4 hours of dosing|0
1694917|NCT01266161|5917468|P1|Overall Study|Vomited within 4 hours of dosing|3
1694918|NCT01266161|5917467|P2|Overall Study|Lack of Efficacy|1
1694919|NCT01266161|5917468|P1|Overall Study|Lack of Efficacy|0
1694920|NCT01266161|5917467|P2|Overall Study|Ineligible|0
1694921|NCT01266161|5917468|P1|Overall Study|Ineligible|1
1694922|NCT01266148|5917500|P2|Overall Study|missing mGFR value + AE|0
1694923|NCT01266148|5917501|P1|Overall Study|missing mGFR value + AE|1
1694924|NCT01266148|5917500|P2|Overall Study|Death|3
1694925|NCT01266148|5917501|P1|Overall Study|Death|2
1694926|NCT01266148|5917500|P2|Overall Study|2 2R rejections|0
1694927|NCT01266148|5917501|P1|Overall Study|2 2R rejections|1
1694928|NCT01266148|5917500|P2|Overall Study|Ongoing rejection|0
1694929|NCT01266148|5917501|P1|Overall Study|Ongoing rejection|1
1694930|NCT01266148|5917500|P2|Overall Study|Adverse Event|0
1694931|NCT01266148|5917501|P1|Overall Study|Adverse Event|2
1694932|NCT01266122|5917529|P2|Overall Study|Lost to Follow-up|6
1694933|NCT01266122|5917530|P1|Overall Study|Lost to Follow-up|6
1694934|NCT01266070|5917538|P1|Overall Study|Protocol Violation|1
1694935|NCT01266070|5917538|P1|Overall Study|Adverse Event|3
1694936|NCT01266031|5917546|P3|Overall Study|Not treated|2
1694937|NCT01266031|5917547|P2|Overall Study|Not treated|3
1694938|NCT01266031|5917548|P1|Overall Study|Not treated|0
1694939|NCT01266018|5917575|P2|Overall Study|Progressive disease|1
1694940|NCT01266018|5917576|P1|Overall Study|Progressive disease|0
1694941|NCT01266018|5917575|P2|Overall Study|Physician Decision|0
1694942|NCT01266018|5917576|P1|Overall Study|Physician Decision|1
1694943|NCT01265992|5917587|P1|Overall Study|Did not receive treatment|1
1694944|NCT01265992|5917587|P1|Overall Study|Stopped treatment|3
1694945|NCT01265992|5917587|P1|Overall Study|Administrative reasons|2
1694946|NCT01265992|5917587|P1|Overall Study|Adverse Event|1
1694947|NCT01265992|5917587|P1|Overall Study|Withdrawal by Subject|1
1694948|NCT01265992|5917587|P1|Overall Study|Lost to Follow-up|1
1694949|NCT01265953|5917615|P2|Overall Study|Non compliance|3
1694950|NCT01265953|5917616|P1|Overall Study|Non compliance|5
1694951|NCT01265875|5917628|P1|Overall Study|Uncooperative/unreliable|1
1694952|NCT01265823|5917636|P1|Overall Study|Participant Request|1
1694953|NCT01265823|5917636|P1|Overall Study|Protocol Violation|1
1694954|NCT01265823|5917636|P1|Overall Study|Failure to Return|4
1694955|NCT01265823|5917636|P1|Overall Study|Unsatisfactory Response Efficacy|1
1694956|NCT01265797|5917665|P2|Open Label Month|Lost to Follow-up|1
1694957|NCT01265797|5917666|P1|Open Label Month|Lost to Follow-up|0
1694958|NCT01265797|5917665|P2|Blinded Month|Diary data incomplete|1
1694959|NCT01265797|5917666|P1|Blinded Month|Diary data incomplete|0
1694960|NCT01265797|5917665|P2|Blinded Month|Adverse Event|0
1694961|NCT01265797|5917666|P1|Blinded Month|Adverse Event|2
1694962|NCT01265797|5917665|P2|Blinded Month|Protocol Violation|1
1694963|NCT01265797|5917666|P1|Blinded Month|Protocol Violation|2
1694964|NCT01265797|5917665|P2|Blinded Month|Lost to Follow-up|0
1694965|NCT01265797|5917666|P1|Blinded Month|Lost to Follow-up|1
1694966|NCT01265797|5917665|P2|Blinded Month|Lack of Efficacy|0
1694967|NCT01265797|5917666|P1|Blinded Month|Lack of Efficacy|5
1694968|NCT01265797|5917665|P2|Run-in Month|1st seizure during run-in month|1
1694969|NCT01265797|5917666|P1|Run-in Month|1st seizure during run-in month|0
1694970|NCT01265797|5917665|P2|Run-in Month|Withdrawal by Subject|4
1694971|NCT01265797|5917666|P1|Run-in Month|Withdrawal by Subject|0
1694972|NCT01265784|5917697|P3|Overall Study|Incorrectly Randomized|1
1694973|NCT01265784|5917698|P2|Overall Study|Incorrectly Randomized|0
1694974|NCT01265784|5917699|P1|Overall Study|Incorrectly Randomized|0
1694975|NCT01265784|5917697|P3|Overall Study|Protocol Violation|0
1694976|NCT01265784|5917698|P2|Overall Study|Protocol Violation|0
1694977|NCT01265784|5917699|P1|Overall Study|Protocol Violation|2
1694978|NCT01265784|5917697|P3|Overall Study|Death|0
1694979|NCT01265784|5917698|P2|Overall Study|Death|0
1694980|NCT01265784|5917699|P1|Overall Study|Death|3
1694981|NCT01265784|5917697|P3|Overall Study|Adverse Event|0
1694982|NCT01265784|5917698|P2|Overall Study|Adverse Event|0
1694983|NCT01265784|5917699|P1|Overall Study|Adverse Event|1
1694984|NCT01265784|5917697|P3|Overall Study|Physician Decision|1
1694985|NCT01265784|5917698|P2|Overall Study|Physician Decision|0
1694986|NCT01265784|5917699|P1|Overall Study|Physician Decision|1
1694987|NCT01265784|5917697|P3|Overall Study|Withdrawal by Subject|0
1694988|NCT01265784|5917698|P2|Overall Study|Withdrawal by Subject|5
1694989|NCT01265784|5917699|P1|Overall Study|Withdrawal by Subject|0
1694990|NCT01265784|5917697|P3|Overall Study|Lost to Follow-up|2
1694991|NCT01265784|5917698|P2|Overall Study|Lost to Follow-up|3
1694992|NCT01265784|5917699|P1|Overall Study|Lost to Follow-up|5
1694993|NCT01265719|5917767|P2|Overall Study|Adverse Event|0
1694994|NCT01265719|5917768|P1|Overall Study|Adverse Event|2
1694995|NCT01265719|5917767|P2|Overall Study|Lost to Follow-up|7
1694996|NCT01265719|5917768|P1|Overall Study|Lost to Follow-up|2
1694997|NCT01265719|5917767|P2|Overall Study|Withdrawal by Subject|3
1694998|NCT01265719|5917768|P1|Overall Study|Withdrawal by Subject|8
1694999|NCT01265719|5917767|P2|Overall Study|Other reasons|0
1695000|NCT01265719|5917768|P1|Overall Study|Other reasons|2
1695001|NCT01265719|5917767|P2|Overall Study|Does not meet entrance criteria|3
1695002|NCT01265719|5917768|P1|Overall Study|Does not meet entrance criteria|0
1695003|NCT01265615|5917819|P4|Overall Study|Protocol Violation|3
1695004|NCT01265615|5917820|P3|Overall Study|Protocol Violation|4
1695005|NCT01265615|5917821|P2|Overall Study|Protocol Violation|2
1695006|NCT01265615|5917822|P1|Overall Study|Protocol Violation|2
1695007|NCT01265563|5917873|P5|Overall Study|Withdrawal by Subject|2
1695008|NCT01265563|5917874|P4|Overall Study|Withdrawal by Subject|0
1695009|NCT01265563|5917875|P3|Overall Study|Withdrawal by Subject|1
1695010|NCT01265563|5917876|P2|Overall Study|Withdrawal by Subject|1
1695011|NCT01265563|5917877|P1|Overall Study|Withdrawal by Subject|0
1695012|NCT01265550|5917903|P4|Pre Randomization|Functional heartburn|99
1695013|NCT01265550|5917904|P3|Pre Randomization|Functional heartburn|0
1695014|NCT01265550|5917905|P2|Pre Randomization|Functional heartburn|0
1695015|NCT01265550|5917906|P1|Pre Randomization|Functional heartburn|0
1695016|NCT01265550|5917903|P4|Pre Randomization|Non-GERD organic disorders|23
1695017|NCT01265550|5917904|P3|Pre Randomization|Non-GERD organic disorders|0
1695018|NCT01265550|5917905|P2|Pre Randomization|Non-GERD organic disorders|0
1695019|NCT01265550|5917906|P1|Pre Randomization|Non-GERD organic disorders|0
1695020|NCT01265550|5917903|P4|Pre Randomization|GERD, PPI-Responsive|42
1695021|NCT01265550|5917904|P3|Pre Randomization|GERD, PPI-Responsive|0
1695022|NCT01265550|5917905|P2|Pre Randomization|GERD, PPI-Responsive|0
1695023|NCT01265550|5917906|P1|Pre Randomization|GERD, PPI-Responsive|0
1695024|NCT01265550|5917903|P4|Pre Randomization|Technical Exclusions|54
1695025|NCT01265550|5917904|P3|Pre Randomization|Technical Exclusions|0
1695026|NCT01265550|5917905|P2|Pre Randomization|Technical Exclusions|0
1695027|NCT01265550|5917906|P1|Pre Randomization|Technical Exclusions|0
1695028|NCT01265550|5917903|P4|Pre Randomization|Withdrawal by Subject|70
1695029|NCT01265550|5917904|P3|Pre Randomization|Withdrawal by Subject|0
1695030|NCT01265550|5917905|P2|Pre Randomization|Withdrawal by Subject|0
1695031|NCT01265550|5917906|P1|Pre Randomization|Withdrawal by Subject|0
1695032|NCT01265537|5917998|P2|Overall Study|Physician Decision|1
1695033|NCT01265537|5917999|P1|Overall Study|Physician Decision|0
1695034|NCT01265537|5917998|P2|Overall Study|Adverse Event|1
1695035|NCT01265537|5917999|P1|Overall Study|Adverse Event|2
1695036|NCT01265511|5918050|P2|Overall Study|Met stopping rules|2
1695037|NCT01265511|5918051|P1|Overall Study|Met stopping rules|0
1695038|NCT01265511|5918050|P2|Overall Study|Lack of Efficacy|1
1695039|NCT01265511|5918051|P1|Overall Study|Lack of Efficacy|2
1695040|NCT01265498|5918065|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
1695041|NCT01265498|5918066|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
1695042|NCT01265420|5918202|P1|Overall Study|Lost to Follow-up|1
1695043|NCT01265394|5918206|P1|Overall Study|Subjects withdrawn|37
1695044|NCT01265056|5918213|P2|Follow up|Lost to Follow-up|3
1695045|NCT01265056|5918214|P1|Follow up|Lost to Follow-up|7
1695046|NCT01265056|5918213|P2|Initial Study Period|Withdrawal by Subject|1
1695047|NCT01265056|5918214|P1|Initial Study Period|Withdrawal by Subject|1
1695048|NCT01265056|5918213|P2|Initial Study Period|Withdrawal by Subject|1
1695049|NCT01265056|5918214|P1|Initial Study Period|Withdrawal by Subject|1
1695050|NCT01264939|5918245|P2|Overall Study|Disease Progression|11
1695051|NCT01264939|5918246|P1|Overall Study|Disease Progression|8
1695052|NCT01264939|5918245|P2|Overall Study|Patient/Guardian Decision|10
1695053|NCT01264939|5918246|P1|Overall Study|Patient/Guardian Decision|8
1695054|NCT01264939|5918245|P2|Overall Study|Physician Decision|1
1695055|NCT01264939|5918246|P1|Overall Study|Physician Decision|1
1695056|NCT01264939|5918245|P2|Overall Study|Lost to Follow-up|3
1695057|NCT01264939|5918246|P1|Overall Study|Lost to Follow-up|0
1695058|NCT01264939|5918245|P2|Overall Study|Adverse Event|3
1695059|NCT01264939|5918246|P1|Overall Study|Adverse Event|1
1695060|NCT01264887|5918272|P1|Overall Study|Other|2
1695061|NCT01264887|5918272|P1|Overall Study|Sponsor Decision Administrative Reasons|2
1695062|NCT01264887|5918272|P1|Overall Study|Withdrawal by Subject|6
1695063|NCT01264887|5918272|P1|Overall Study|Physician Decision|4
1695064|NCT01264887|5918272|P1|Overall Study|Lack of Efficacy|5
1695065|NCT01264887|5918272|P1|Overall Study|Death|7
1695066|NCT01264887|5918272|P1|Overall Study|Adverse Event|5
1695067|NCT01264835|5918283|P1|Overall Study|Lost to Follow-up|1
1695068|NCT01264770|5918293|P6|Overall Study|Adverse Event|1
1695069|NCT01264770|5918294|P5|Overall Study|Adverse Event|2
1695070|NCT01264770|5918295|P4|Overall Study|Adverse Event|0
1695071|NCT01264770|5918296|P3|Overall Study|Adverse Event|8
1695072|NCT01264770|5918297|P2|Overall Study|Adverse Event|7
1695073|NCT01264770|5918298|P1|Overall Study|Adverse Event|7
1695074|NCT01264770|5918293|P6|Overall Study|Lost to Follow-up|0
1695075|NCT01264770|5918294|P5|Overall Study|Lost to Follow-up|0
1695076|NCT01264770|5918295|P4|Overall Study|Lost to Follow-up|1
1695077|NCT01264770|5918296|P3|Overall Study|Lost to Follow-up|1
1695078|NCT01264770|5918297|P2|Overall Study|Lost to Follow-up|0
1695079|NCT01264770|5918298|P1|Overall Study|Lost to Follow-up|0
1695080|NCT01264770|5918293|P6|Overall Study|Dev. of study specific discont. criteria|1
1695081|NCT01264770|5918294|P5|Overall Study|Dev. of study specific discont. criteria|1
1695082|NCT01264770|5918295|P4|Overall Study|Dev. of study specific discont. criteria|0
1695083|NCT01264770|5918296|P3|Overall Study|Dev. of study specific discont. criteria|0
1695084|NCT01264770|5918297|P2|Overall Study|Dev. of study specific discont. criteria|0
1695085|NCT01264770|5918298|P1|Overall Study|Dev. of study specific discont. criteria|2
1695086|NCT01264770|5918293|P6|Overall Study|Lack of therapeutic response|0
1695087|NCT01264770|5918294|P5|Overall Study|Lack of therapeutic response|1
1695088|NCT01264770|5918295|P4|Overall Study|Lack of therapeutic response|1
1695089|NCT01264770|5918296|P3|Overall Study|Lack of therapeutic response|2
1695090|NCT01264770|5918297|P2|Overall Study|Lack of therapeutic response|0
1695091|NCT01264770|5918298|P1|Overall Study|Lack of therapeutic response|1
1695092|NCT01264770|5918293|P6|Overall Study|Severe non-compliance to protocol|0
1695093|NCT01264770|5918294|P5|Overall Study|Severe non-compliance to protocol|0
1695094|NCT01264770|5918295|P4|Overall Study|Severe non-compliance to protocol|1
1695095|NCT01264770|5918296|P3|Overall Study|Severe non-compliance to protocol|1
1695096|NCT01264770|5918297|P2|Overall Study|Severe non-compliance to protocol|0
1695097|NCT01264770|5918298|P1|Overall Study|Severe non-compliance to protocol|0
1695098|NCT01264770|5918293|P6|Overall Study|e.g., change in circumstances|4
1695099|NCT01264770|5918294|P5|Overall Study|e.g., change in circumstances|4
1695100|NCT01264770|5918295|P4|Overall Study|e.g., change in circumstances|3
1695101|NCT01264770|5918296|P3|Overall Study|e.g., change in circumstances|3
1695102|NCT01264770|5918297|P2|Overall Study|e.g., change in circumstances|3
1695103|NCT01264770|5918298|P1|Overall Study|e.g., change in circumstances|8
1695104|NCT01264770|5918293|P6|Overall Study|Not reported|0
1695105|NCT01264770|5918294|P5|Overall Study|Not reported|0
1695106|NCT01264770|5918295|P4|Overall Study|Not reported|0
1695107|NCT01264770|5918296|P3|Overall Study|Not reported|1
1695108|NCT01264770|5918297|P2|Overall Study|Not reported|0
1695109|NCT01264770|5918298|P1|Overall Study|Not reported|0
1695110|NCT01264718|5918384|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
1695111|NCT01264718|5918385|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
1695112|NCT01264718|5918384|P2|Overall Study|Withdrawal by Subject|15
1695113|NCT01264718|5918385|P1|Overall Study|Withdrawal by Subject|9
1695114|NCT01264718|5918384|P2|Overall Study|Lost to Follow-up|2
1695115|NCT01264718|5918385|P1|Overall Study|Lost to Follow-up|3
1695116|NCT01264679|5918397|P1|Overall Study|Withdrawal by Subject|1
1695117|NCT01264679|5918397|P1|Overall Study|Sponsor's Suspension of Dosing|2
1695118|NCT01264679|5918397|P1|Overall Study|Physician Decision|1
1695119|NCT01264679|5918397|P1|Overall Study|Participation in Another Clinical Trial|1
1695121|NCT01264380|5918436|P3|Period C|Adverse Event|1
1695122|NCT01264380|5918437|P2|Period C|Adverse Event|0
1695123|NCT01264380|5918438|P1|Period C|Adverse Event|0
1695124|NCT01264380|5918436|P3|Period C|Withdrawal by Subject|1
1695125|NCT01264380|5918437|P2|Period C|Withdrawal by Subject|0
1695126|NCT01264380|5918438|P1|Period C|Withdrawal by Subject|0
1695127|NCT01264380|5918436|P3|Period C|Follow-up for survival status|6
1695128|NCT01264380|5918437|P2|Period C|Follow-up for survival status|0
1695129|NCT01264380|5918438|P1|Period C|Follow-up for survival status|0
1695130|NCT01264380|5918436|P3|Period C|Death|2
1695131|NCT01264380|5918437|P2|Period C|Death|0
1695132|NCT01264380|5918438|P1|Period C|Death|0
1695133|NCT01264380|5918436|P3|Period C|Disease Progression|4
1695134|NCT01264380|5918437|P2|Period C|Disease Progression|0
1695135|NCT01264380|5918438|P1|Period C|Disease Progression|0
1695136|NCT01264081|5918459|P1|Started Treatment|Not complete cycle 1 due to death|1
1695137|NCT01264081|5918459|P1|Started Treatment|Withdrawal by Subject|1
1695138|NCT01264081|5918459|P1|Participants Screened|Screening failures|30
1695139|NCT01264016|5918464|P1|Overall Study|Felt faint at sight of blood|1
1695140|NCT01264016|5918464|P1|Overall Study|Withdrawal by Subject|1
1695141|NCT01263925|5918479|P2|Overall Study|Withdrawal/ Not specified|1
1695142|NCT01263925|5918480|P1|Overall Study|Withdrawal/ Not specified|0
1695143|NCT01263925|5918479|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
1695144|NCT01263925|5918480|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
1695145|NCT01263925|5918479|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
1695146|NCT01263925|5918480|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
1695147|NCT01263925|5918479|P2|Overall Study|AE/ Withdrawal|4
1695148|NCT01263925|5918480|P1|Overall Study|AE/ Withdrawal|1
1695149|NCT01263925|5918479|P2|Overall Study|AE/ Unsatisfactory Compliance|2
1695150|NCT01263925|5918480|P1|Overall Study|AE/ Unsatisfactory Compliance|2
1695151|NCT01263925|5918479|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
1695152|NCT01263925|5918480|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
1695153|NCT01263925|5918479|P2|Overall Study|Lost to Follow-up|1
1695154|NCT01263925|5918480|P1|Overall Study|Lost to Follow-up|3
1695155|NCT01263925|5918479|P2|Overall Study|Other|4
1695156|NCT01263925|5918480|P1|Overall Study|Other|4
1695157|NCT01263925|5918479|P2|Overall Study|Withdrawal by Subject|8
1695158|NCT01263925|5918480|P1|Overall Study|Withdrawal by Subject|6
1695159|NCT01263925|5918479|P2|Overall Study|Unsatisfactory Compliance of Subject|5
1695160|NCT01263925|5918480|P1|Overall Study|Unsatisfactory Compliance of Subject|8
1695161|NCT01263925|5918479|P2|Overall Study|Adverse Event|22
1695162|NCT01263925|5918480|P1|Overall Study|Adverse Event|23
1695163|NCT01263925|5918479|P2|Overall Study|Lack of Efficacy|1
1695164|NCT01263925|5918480|P1|Overall Study|Lack of Efficacy|0
1695165|NCT01263925|5918479|P2|Overall Study|Protocol Violation|0
1695166|NCT01263925|5918480|P1|Overall Study|Protocol Violation|1
1695167|NCT01263873|5918514|P2|Overall Study|One provider unable to complete numbers|1
1695168|NCT01263873|5918515|P1|Overall Study|One provider unable to complete numbers|1
1695169|NCT01263782|5918529|P4|Overall Study|Inevaluable|0
1695170|NCT01263782|5918530|P3|Overall Study|Inevaluable|1
1695171|NCT01263782|5918531|P2|Overall Study|Inevaluable|0
1695172|NCT01263782|5918532|P1|Overall Study|Inevaluable|0
1695173|NCT01263782|5918529|P4|Overall Study|Too early|0
1695174|NCT01263782|5918530|P3|Overall Study|Too early|1
1695175|NCT01263782|5918531|P2|Overall Study|Too early|0
1695176|NCT01263782|5918532|P1|Overall Study|Too early|0
1695177|NCT01263782|5918529|P4|Overall Study|Progressive disease|1
1695178|NCT01263782|5918530|P3|Overall Study|Progressive disease|0
1695179|NCT01263782|5918531|P2|Overall Study|Progressive disease|0
1695180|NCT01263782|5918532|P1|Overall Study|Progressive disease|0
1695181|NCT01263782|5918529|P4|Overall Study|Death|0
1695182|NCT01263782|5918530|P3|Overall Study|Death|1
1695183|NCT01263782|5918531|P2|Overall Study|Death|0
1695184|NCT01263782|5918532|P1|Overall Study|Death|0
1695185|NCT01263704|5918577|P1|Overall Study|Principal Investigator (PI) decision|1
1695186|NCT01263704|5918577|P1|Overall Study|Colon metastases|1
1695187|NCT01263704|5918577|P1|Overall Study|Lost to Follow-up|1
1695188|NCT01263704|5918577|P1|Overall Study|Eligibility criteria not fulfilled|1
1695189|NCT01263704|5918577|P1|Overall Study|Patient withdrew consent|2
1695190|NCT01263704|5918577|P1|Overall Study|Death|2
1695191|NCT01263704|5918577|P1|Overall Study|Adverse Event|3
1695192|NCT01263704|5918577|P1|Overall Study|Progressive disease|18
1695193|NCT01263691|5918592|P6|Overall Study|Adverse Event|0
1695194|NCT01263691|5918593|P5|Overall Study|Adverse Event|0
1695195|NCT01263691|5918594|P4|Overall Study|Adverse Event|0
1695196|NCT01263691|5918595|P3|Overall Study|Adverse Event|0
1695197|NCT01263691|5918596|P2|Overall Study|Adverse Event|0
1695198|NCT01263691|5918597|P1|Overall Study|Adverse Event|1
1695199|NCT01263691|5918592|P6|Overall Study|Withdrawal by Subject|0
1695200|NCT01263691|5918593|P5|Overall Study|Withdrawal by Subject|0
1695201|NCT01263691|5918594|P4|Overall Study|Withdrawal by Subject|0
1695202|NCT01263691|5918595|P3|Overall Study|Withdrawal by Subject|0
1695203|NCT01263691|5918596|P2|Overall Study|Withdrawal by Subject|0
1695204|NCT01263691|5918597|P1|Overall Study|Withdrawal by Subject|1
1695205|NCT01263691|5918592|P6|Overall Study|Lost to Follow-up|0
1695206|NCT01263691|5918593|P5|Overall Study|Lost to Follow-up|0
1695207|NCT01263691|5918594|P4|Overall Study|Lost to Follow-up|1
1695208|NCT01263691|5918595|P3|Overall Study|Lost to Follow-up|1
1695209|NCT01263691|5918596|P2|Overall Study|Lost to Follow-up|0
1695210|NCT01263691|5918597|P1|Overall Study|Lost to Follow-up|1
1695211|NCT01263665|5918707|P1|Overall Study|Surgical Bypass|2
1695212|NCT01263665|5918707|P1|Overall Study|Amputation above the ankle|1
1695213|NCT01263665|5918707|P1|Overall Study|Death|2
1695214|NCT01263665|5918707|P1|Overall Study|Lost to Follow-up|3
1695215|NCT01263665|5918707|P1|Overall Study|Withdrew Consent|1
1695216|NCT01263639|5918714|P2|Overall Study|Exclusion =Admission greater than 7 days|9
1695217|NCT01263639|5918715|P1|Overall Study|Exclusion =Admission greater than 7 days|7
1695218|NCT01263639|5918714|P2|Overall Study|Lost to Follow-up|70
1695219|NCT01263639|5918715|P1|Overall Study|Lost to Follow-up|66
1695220|NCT01263561|5918723|P2|Overall Study|Death|2
1695221|NCT01263561|5918724|P1|Overall Study|Death|1
1695222|NCT01263509|5918736|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
1695223|NCT01263509|5918737|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1695224|NCT01263509|5918738|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1695225|NCT01263509|5918739|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
1695226|NCT01263509|5918736|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
1695227|NCT01263509|5918737|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
1695228|NCT01263509|5918738|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
1695229|NCT01263509|5918739|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
1695230|NCT01263509|5918736|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1695231|NCT01263509|5918737|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1695232|NCT01263509|5918738|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1695233|NCT01263509|5918739|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1695234|NCT01263509|5918736|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
1695235|NCT01263509|5918737|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
1695236|NCT01263509|5918738|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
1695237|NCT01263509|5918739|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
1695238|NCT01263509|5918736|P4|Entered - Long-Term Extension Study|Adverse Event|1
1695239|NCT01263509|5918737|P3|Entered - Long-Term Extension Study|Adverse Event|4
1695240|NCT01263509|5918738|P2|Entered - Long-Term Extension Study|Adverse Event|5
1695241|NCT01263509|5918739|P1|Entered - Long-Term Extension Study|Adverse Event|5
1695242|NCT01263496|5918868|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
1695243|NCT01263496|5918869|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
1695244|NCT01263496|5918870|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
1695245|NCT01263496|5918871|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
1695246|NCT01263496|5918872|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
1695247|NCT01263496|5918873|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
1695248|NCT01263496|5918874|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
1695249|NCT01263496|5918875|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
1695250|NCT01263496|5918876|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
1695251|NCT01263496|5918868|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
1695252|NCT01263496|5918869|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
1695253|NCT01263496|5918870|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
1695254|NCT01263496|5918871|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
1695255|NCT01263496|5918872|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
1695256|NCT01263496|5918873|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
1695257|NCT01263496|5918874|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
1695258|NCT01263496|5918875|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
1695259|NCT01263496|5918876|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
1695260|NCT01263496|5918868|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1695261|NCT01263496|5918869|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1695262|NCT01263496|5918870|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1695263|NCT01263496|5918871|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1695264|NCT01263496|5918872|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
1695265|NCT01263496|5918873|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1695266|NCT01263496|5918874|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
1695267|NCT01263496|5918875|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
1695268|NCT01263496|5918876|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
1695269|NCT01263496|5918868|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695270|NCT01263496|5918869|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695271|NCT01263496|5918870|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695272|NCT01263496|5918871|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695273|NCT01263496|5918872|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695274|NCT01263496|5918873|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695275|NCT01263496|5918874|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695276|NCT01263496|5918875|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
1695277|NCT01263496|5918876|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
1695278|NCT01263496|5918868|P9|Entered - Long-Term Extension Study|Adverse Event|1
1695279|NCT01263496|5918869|P8|Entered - Long-Term Extension Study|Adverse Event|0
1695280|NCT01263496|5918870|P7|Entered - Long-Term Extension Study|Adverse Event|0
1695281|NCT01263496|5918871|P6|Entered - Long-Term Extension Study|Adverse Event|0
1695282|NCT01263496|5918872|P5|Entered - Long-Term Extension Study|Adverse Event|1
1695283|NCT01263496|5918873|P4|Entered - Long-Term Extension Study|Adverse Event|3
1695284|NCT01263496|5918874|P3|Entered - Long-Term Extension Study|Adverse Event|6
1695285|NCT01263496|5918875|P2|Entered - Long-Term Extension Study|Adverse Event|5
1695286|NCT01263496|5918876|P1|Entered - Long-Term Extension Study|Adverse Event|0
1695287|NCT01263496|5918868|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
1695288|NCT01263496|5918869|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
1695289|NCT01263496|5918870|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
1695290|NCT01263496|5918871|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
1695291|NCT01263496|5918872|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
1695292|NCT01263496|5918873|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
1695293|NCT01263496|5918874|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
1695294|NCT01263496|5918875|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
1695295|NCT01263496|5918876|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
1695296|NCT01263496|5918868|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695297|NCT01263496|5918869|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695298|NCT01263496|5918870|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695299|NCT01263496|5918871|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695300|NCT01263496|5918872|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695301|NCT01263496|5918873|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695302|NCT01263496|5918874|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695303|NCT01263496|5918875|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
1695304|NCT01263496|5918876|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
1695305|NCT01263483|5919171|P3|Overall Study|Participant Unavailability|1
1695306|NCT01263483|5919172|P2|Overall Study|Participant Unavailability|1
1695307|NCT01263483|5919173|P1|Overall Study|Participant Unavailability|0
1695308|NCT01263483|5919171|P3|Overall Study|Protocol Violation|1
1695309|NCT01263483|5919172|P2|Overall Study|Protocol Violation|1
1695310|NCT01263483|5919173|P1|Overall Study|Protocol Violation|0
1695311|NCT01263483|5919171|P3|Overall Study|Lack of Efficacy|0
1695312|NCT01263483|5919172|P2|Overall Study|Lack of Efficacy|0
1695313|NCT01263483|5919173|P1|Overall Study|Lack of Efficacy|2
1695314|NCT01263483|5919171|P3|Overall Study|Withdrawal by Subject|0
1695315|NCT01263483|5919172|P2|Overall Study|Withdrawal by Subject|0
1695316|NCT01263483|5919173|P1|Overall Study|Withdrawal by Subject|1
1695317|NCT01263483|5919171|P3|Overall Study|Adverse Event|3
1695318|NCT01263483|5919172|P2|Overall Study|Adverse Event|0
1695319|NCT01263483|5919173|P1|Overall Study|Adverse Event|4
1695320|NCT01263470|5919235|P6|Overall Study|Study Drug Non-compliance|0
1695321|NCT01263470|5919236|P5|Overall Study|Study Drug Non-compliance|1
1695322|NCT01263470|5919237|P4|Overall Study|Study Drug Non-compliance|0
1695323|NCT01263470|5919238|P3|Overall Study|Study Drug Non-compliance|0
1695324|NCT01263470|5919239|P2|Overall Study|Study Drug Non-compliance|0
1695325|NCT01263470|5919240|P1|Overall Study|Study Drug Non-compliance|0
1695326|NCT01263470|5919235|P6|Overall Study|Participant Unavailability|0
1695327|NCT01263470|5919236|P5|Overall Study|Participant Unavailability|0
1695328|NCT01263470|5919237|P4|Overall Study|Participant Unavailability|0
1695329|NCT01263470|5919238|P3|Overall Study|Participant Unavailability|0
1695330|NCT01263470|5919239|P2|Overall Study|Participant Unavailability|1
1695331|NCT01263470|5919240|P1|Overall Study|Participant Unavailability|0
1695332|NCT01263470|5919235|P6|Overall Study|Lack of Efficacy|0
1695333|NCT01263470|5919236|P5|Overall Study|Lack of Efficacy|0
1695334|NCT01263470|5919237|P4|Overall Study|Lack of Efficacy|0
1695335|NCT01263470|5919238|P3|Overall Study|Lack of Efficacy|2
1695336|NCT01263470|5919239|P2|Overall Study|Lack of Efficacy|0
1695337|NCT01263470|5919240|P1|Overall Study|Lack of Efficacy|0
1695338|NCT01263470|5919235|P6|Overall Study|Withdrawal by Subject|2
1695339|NCT01263470|5919236|P5|Overall Study|Withdrawal by Subject|0
1695340|NCT01263470|5919237|P4|Overall Study|Withdrawal by Subject|2
1695341|NCT01263470|5919238|P3|Overall Study|Withdrawal by Subject|1
1695342|NCT01263470|5919239|P2|Overall Study|Withdrawal by Subject|1
1695343|NCT01263470|5919240|P1|Overall Study|Withdrawal by Subject|0
1695344|NCT01263470|5919235|P6|Overall Study|Protocol Violation|1
1695345|NCT01263470|5919236|P5|Overall Study|Protocol Violation|0
1695346|NCT01263470|5919237|P4|Overall Study|Protocol Violation|0
1695347|NCT01263470|5919238|P3|Overall Study|Protocol Violation|0
1695348|NCT01263470|5919239|P2|Overall Study|Protocol Violation|1
1695349|NCT01263470|5919240|P1|Overall Study|Protocol Violation|0
1695350|NCT01263470|5919235|P6|Overall Study|Adverse Event|2
1695351|NCT01263470|5919236|P5|Overall Study|Adverse Event|2
1695352|NCT01263470|5919237|P4|Overall Study|Adverse Event|1
1695353|NCT01263470|5919238|P3|Overall Study|Adverse Event|1
1695354|NCT01263470|5919239|P2|Overall Study|Adverse Event|2
1695355|NCT01263470|5919240|P1|Overall Study|Adverse Event|2
1695356|NCT01263444|5919350|P1|Overall Study|Protocol Violation|1
1695357|NCT01263444|5919350|P1|Overall Study|Withdrawal by Subject|1
1695358|NCT01263444|5919350|P1|Overall Study|Adverse Event|8
1695359|NCT01263223|5919487|P2|7-day Follow-up|Lost to Follow-up|0
1695360|NCT01263223|5919488|P1|7-day Follow-up|Lost to Follow-up|1
1695361|NCT01263223|5919487|P2|7-day Follow-up|Withdrawal by Subject|1
1695362|NCT01263223|5919488|P1|7-day Follow-up|Withdrawal by Subject|0
1695363|NCT01263223|5919487|P2|Period 2|Withdrawal by Subject|1
1695364|NCT01263223|5919488|P1|Period 2|Withdrawal by Subject|0
1695365|NCT01263197|5919511|P6|Third Intervention (Period 3)|Adverse Event|0
1695366|NCT01263197|5919512|P5|Third Intervention (Period 3)|Adverse Event|0
1695367|NCT01263197|5919513|P4|Third Intervention (Period 3)|Adverse Event|0
1695368|NCT01263197|5919514|P3|Third Intervention (Period 3)|Adverse Event|0
1695369|NCT01263197|5919515|P2|Third Intervention (Period 3)|Adverse Event|1
1695370|NCT01263197|5919516|P1|Third Intervention (Period 3)|Adverse Event|0
1695371|NCT01263197|5919511|P6|Washout Period 2|Protocol Violation|0
1695372|NCT01263197|5919512|P5|Washout Period 2|Protocol Violation|0
1695373|NCT01263197|5919513|P4|Washout Period 2|Protocol Violation|1
1695374|NCT01263197|5919514|P3|Washout Period 2|Protocol Violation|0
1695375|NCT01263197|5919515|P2|Washout Period 2|Protocol Violation|0
1695376|NCT01263197|5919516|P1|Washout Period 2|Protocol Violation|0
1695377|NCT01263197|5919511|P6|Washout Period 2|Physician Decision|1
1695378|NCT01263197|5919512|P5|Washout Period 2|Physician Decision|0
1695379|NCT01263197|5919513|P4|Washout Period 2|Physician Decision|0
1695380|NCT01263197|5919514|P3|Washout Period 2|Physician Decision|0
1695381|NCT01263197|5919515|P2|Washout Period 2|Physician Decision|0
1695382|NCT01263197|5919516|P1|Washout Period 2|Physician Decision|0
1695383|NCT01263197|5919511|P6|Washout Period 1|Protocol Violation|0
1695384|NCT01263197|5919512|P5|Washout Period 1|Protocol Violation|1
1695385|NCT01263197|5919513|P4|Washout Period 1|Protocol Violation|0
1695386|NCT01263197|5919514|P3|Washout Period 1|Protocol Violation|0
1695387|NCT01263197|5919515|P2|Washout Period 1|Protocol Violation|0
1695388|NCT01263197|5919516|P1|Washout Period 1|Protocol Violation|0
1695389|NCT01263197|5919511|P6|First Intervention (Period 1)|Adverse Event|1
1695390|NCT01263197|5919512|P5|First Intervention (Period 1)|Adverse Event|0
1695391|NCT01263197|5919513|P4|First Intervention (Period 1)|Adverse Event|0
1695392|NCT01263197|5919514|P3|First Intervention (Period 1)|Adverse Event|0
1695393|NCT01263197|5919515|P2|First Intervention (Period 1)|Adverse Event|0
1695394|NCT01263197|5919516|P1|First Intervention (Period 1)|Adverse Event|0
1695395|NCT01263119|5919559|P1|Period 2|Adverse Event|2
1695396|NCT01263119|5919559|P1|Period 1|Protocol Violation|2
1695397|NCT01263106|5919580|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
1695398|NCT01263106|5919581|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
1695399|NCT01263093|5919596|P2|Period 2|Adverse Event|0
1695400|NCT01263093|5919597|P1|Period 2|Adverse Event|1
1695401|NCT01263093|5919596|P2|Washout|Physician Decision|0
1695402|NCT01263093|5919597|P1|Washout|Physician Decision|1
1695403|NCT01263054|5919614|P2|Overall Study|Other|1
1695404|NCT01263054|5919615|P1|Overall Study|Other|0
1695405|NCT01263054|5919614|P2|Overall Study|Qualification Violation|0
1695406|NCT01263054|5919615|P1|Overall Study|Qualification Violation|1
1695407|NCT01263054|5919614|P2|Overall Study|Withdrawal by Subject|3
1695408|NCT01263054|5919615|P1|Overall Study|Withdrawal by Subject|1
1695409|NCT01263054|5919614|P2|Overall Study|Lost to Follow-up|2
1695410|NCT01263054|5919615|P1|Overall Study|Lost to Follow-up|2
1695411|NCT01263054|5919614|P2|Overall Study|Death|0
1695412|NCT01263054|5919615|P1|Overall Study|Death|1
1695413|NCT01263028|5919633|P1|Overall Study|Study terminated due to low enrollment.|4
1695414|NCT01263028|5919633|P1|Overall Study|Adverse Event|1
1695415|NCT01263028|5919633|P1|Overall Study|Withdrawal by Subject|1
1695416|NCT01263015|5919643|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
1695417|NCT01263015|5919644|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
1695418|NCT01263015|5919643|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
1695419|NCT01263015|5919644|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
1695420|NCT01263015|5919643|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
1695421|NCT01263015|5919644|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
1695422|NCT01263015|5919643|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
1695423|NCT01263015|5919644|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
1695424|NCT01263015|5919643|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
1695425|NCT01263015|5919644|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
1695426|NCT01263015|5919643|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
1695427|NCT01263015|5919644|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
1695428|NCT01263015|5919643|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
1695429|NCT01263015|5919644|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
1695430|NCT01263015|5919643|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
1695431|NCT01263015|5919644|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
1695432|NCT01263015|5919643|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
1695433|NCT01263015|5919644|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
1695434|NCT01263015|5919643|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
1695435|NCT01263015|5919644|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
1695436|NCT01263015|5919643|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
1695437|NCT01263015|5919644|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
1695438|NCT01263015|5919643|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
1695439|NCT01263015|5919644|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
1695440|NCT01262989|5919670|P2|Period 2|Intercurrent disease|1
1695441|NCT01262989|5919671|P1|Period 2|Intercurrent disease|0
1695442|NCT01262989|5919670|P2|Period 1|Positive answer for exclusion criteria|1
1695443|NCT01262989|5919671|P1|Period 1|Positive answer for exclusion criteria|0
1695444|NCT01262989|5919670|P2|Period 1|Intercurrent disease|1
1695445|NCT01262989|5919671|P1|Period 1|Intercurrent disease|0
1695446|NCT01262989|5919670|P2|Period 1|Lost to Follow-up|1
1695447|NCT01262989|5919671|P1|Period 1|Lost to Follow-up|1
1695448|NCT01262976|5919687|P6|Up to Year 3|Other|0
1695449|NCT01262976|5919688|P5|Up to Year 3|Other|0
1695450|NCT01262976|5919689|P4|Up to Year 3|Other|0
1695451|NCT01262976|5919690|P3|Up to Year 3|Other|0
1695452|NCT01262976|5919691|P2|Up to Year 3|Other|0
1695453|NCT01262976|5919692|P1|Up to Year 3|Other|3
1695454|NCT01262976|5919687|P6|Up to Year 3|Subjects with unknown completion status|0
1695455|NCT01262976|5919688|P5|Up to Year 3|Subjects with unknown completion status|0
1695456|NCT01262976|5919689|P4|Up to Year 3|Subjects with unknown completion status|0
1695457|NCT01262976|5919690|P3|Up to Year 3|Subjects with unknown completion status|1
1695458|NCT01262976|5919691|P2|Up to Year 3|Subjects with unknown completion status|0
1695459|NCT01262976|5919692|P1|Up to Year 3|Subjects with unknown completion status|0
1695460|NCT01262976|5919687|P6|Up to Year 3|Lost to Follow-up|3
1695461|NCT01262976|5919688|P5|Up to Year 3|Lost to Follow-up|1
1695462|NCT01262976|5919689|P4|Up to Year 3|Lost to Follow-up|3
1695463|NCT01262976|5919690|P3|Up to Year 3|Lost to Follow-up|4
1695464|NCT01262976|5919691|P2|Up to Year 3|Lost to Follow-up|2
1695465|NCT01262976|5919692|P1|Up to Year 3|Lost to Follow-up|2
1695466|NCT01262976|5919687|P6|Up to Year 3|Migrated/moved from study area|1
1695467|NCT01262976|5919688|P5|Up to Year 3|Migrated/moved from study area|1
1695468|NCT01262976|5919689|P4|Up to Year 3|Migrated/moved from study area|2
1695469|NCT01262976|5919690|P3|Up to Year 3|Migrated/moved from study area|0
1695470|NCT01262976|5919691|P2|Up to Year 3|Migrated/moved from study area|0
1695471|NCT01262976|5919692|P1|Up to Year 3|Migrated/moved from study area|0
1695472|NCT01262976|5919687|P6|Up to Year 3|Withdrawal by Subject|0
1695473|NCT01262976|5919688|P5|Up to Year 3|Withdrawal by Subject|0
1695474|NCT01262976|5919689|P4|Up to Year 3|Withdrawal by Subject|0
1695475|NCT01262976|5919690|P3|Up to Year 3|Withdrawal by Subject|0
1695476|NCT01262976|5919691|P2|Up to Year 3|Withdrawal by Subject|0
1695477|NCT01262976|5919692|P1|Up to Year 3|Withdrawal by Subject|1
1695478|NCT01262976|5919687|P6|Up to Year 3|Serious Adverse Event|0
1695479|NCT01262976|5919688|P5|Up to Year 3|Serious Adverse Event|0
1695480|NCT01262976|5919689|P4|Up to Year 3|Serious Adverse Event|0
1695481|NCT01262976|5919690|P3|Up to Year 3|Serious Adverse Event|2
1695482|NCT01262976|5919691|P2|Up to Year 3|Serious Adverse Event|0
1695483|NCT01262976|5919692|P1|Up to Year 3|Serious Adverse Event|0
1695484|NCT01262976|5919687|P6|Up to Year 2|Other|0
1695485|NCT01262976|5919688|P5|Up to Year 2|Other|0
1695486|NCT01262976|5919689|P4|Up to Year 2|Other|0
1695487|NCT01262976|5919690|P3|Up to Year 2|Other|0
1695488|NCT01262976|5919691|P2|Up to Year 2|Other|0
1695489|NCT01262976|5919692|P1|Up to Year 2|Other|3
1695490|NCT01262976|5919687|P6|Up to Year 2|Subjects with unknown completion status|0
1695491|NCT01262976|5919688|P5|Up to Year 2|Subjects with unknown completion status|0
1695492|NCT01262976|5919689|P4|Up to Year 2|Subjects with unknown completion status|0
1695493|NCT01262976|5919690|P3|Up to Year 2|Subjects with unknown completion status|1
1695494|NCT01262976|5919691|P2|Up to Year 2|Subjects with unknown completion status|0
1695495|NCT01262976|5919692|P1|Up to Year 2|Subjects with unknown completion status|0
1695496|NCT01262976|5919687|P6|Up to Year 2|Lost to Follow-up|3
1695497|NCT01262976|5919688|P5|Up to Year 2|Lost to Follow-up|3
1695498|NCT01262976|5919689|P4|Up to Year 2|Lost to Follow-up|2
1695499|NCT01262976|5919690|P3|Up to Year 2|Lost to Follow-up|2
1695500|NCT01262976|5919691|P2|Up to Year 2|Lost to Follow-up|1
1695501|NCT01262976|5919692|P1|Up to Year 2|Lost to Follow-up|1
1695502|NCT01262976|5919687|P6|Up to Year 2|Migrated/moved from study area|2
1695503|NCT01262976|5919688|P5|Up to Year 2|Migrated/moved from study area|1
1695504|NCT01262976|5919689|P4|Up to Year 2|Migrated/moved from study area|2
1695505|NCT01262976|5919690|P3|Up to Year 2|Migrated/moved from study area|0
1695506|NCT01262976|5919691|P2|Up to Year 2|Migrated/moved from study area|0
1695507|NCT01262976|5919692|P1|Up to Year 2|Migrated/moved from study area|0
1695508|NCT01262976|5919687|P6|Up to Year 2|Withdrawal by Subject|0
1695509|NCT01262976|5919688|P5|Up to Year 2|Withdrawal by Subject|0
1695510|NCT01262976|5919689|P4|Up to Year 2|Withdrawal by Subject|0
1695511|NCT01262976|5919690|P3|Up to Year 2|Withdrawal by Subject|0
1695512|NCT01262976|5919691|P2|Up to Year 2|Withdrawal by Subject|0
1695513|NCT01262976|5919692|P1|Up to Year 2|Withdrawal by Subject|1
1695514|NCT01262976|5919687|P6|Up to Year 2|Serious Adverse Event|0
1695515|NCT01262976|5919688|P5|Up to Year 2|Serious Adverse Event|0
1695516|NCT01262976|5919689|P4|Up to Year 2|Serious Adverse Event|0
1695517|NCT01262976|5919690|P3|Up to Year 2|Serious Adverse Event|2
1695518|NCT01262976|5919691|P2|Up to Year 2|Serious Adverse Event|0
1695519|NCT01262976|5919692|P1|Up to Year 2|Serious Adverse Event|0
1695520|NCT01262976|5919687|P6|Up to Year 1|Subjects with unknown completion status|1
1695521|NCT01262976|5919688|P5|Up to Year 1|Subjects with unknown completion status|0
1695522|NCT01262976|5919689|P4|Up to Year 1|Subjects with unknown completion status|0
1695523|NCT01262976|5919690|P3|Up to Year 1|Subjects with unknown completion status|1
1695524|NCT01262976|5919691|P2|Up to Year 1|Subjects with unknown completion status|0
1695525|NCT01262976|5919692|P1|Up to Year 1|Subjects with unknown completion status|0
1695526|NCT01262976|5919687|P6|Up to Year 1|Other|1
1695527|NCT01262976|5919688|P5|Up to Year 1|Other|2
1695528|NCT01262976|5919689|P4|Up to Year 1|Other|0
1695529|NCT01262976|5919690|P3|Up to Year 1|Other|0
1695530|NCT01262976|5919691|P2|Up to Year 1|Other|1
1695531|NCT01262976|5919692|P1|Up to Year 1|Other|3
1695532|NCT01262976|5919687|P6|Up to Year 1|Lost to Follow-up|5
1695533|NCT01262976|5919688|P5|Up to Year 1|Lost to Follow-up|6
1695534|NCT01262976|5919689|P4|Up to Year 1|Lost to Follow-up|1
1695535|NCT01262976|5919690|P3|Up to Year 1|Lost to Follow-up|0
1695536|NCT01262976|5919691|P2|Up to Year 1|Lost to Follow-up|0
1695537|NCT01262976|5919692|P1|Up to Year 1|Lost to Follow-up|4
1695538|NCT01262976|5919687|P6|Up to Year 1|Migrated/moved from study area|2
1695539|NCT01262976|5919688|P5|Up to Year 1|Migrated/moved from study area|3
1695540|NCT01262976|5919689|P4|Up to Year 1|Migrated/moved from study area|3
1695541|NCT01262976|5919690|P3|Up to Year 1|Migrated/moved from study area|0
1695542|NCT01262976|5919691|P2|Up to Year 1|Migrated/moved from study area|0
1695543|NCT01262976|5919692|P1|Up to Year 1|Migrated/moved from study area|1
1695544|NCT01262976|5919687|P6|Up to Year 1|Withdrawal by Subject|0
1695545|NCT01262976|5919688|P5|Up to Year 1|Withdrawal by Subject|0
1695546|NCT01262976|5919689|P4|Up to Year 1|Withdrawal by Subject|0
1695547|NCT01262976|5919690|P3|Up to Year 1|Withdrawal by Subject|0
1695548|NCT01262976|5919691|P2|Up to Year 1|Withdrawal by Subject|0
1695549|NCT01262976|5919692|P1|Up to Year 1|Withdrawal by Subject|1
1695550|NCT01262976|5919687|P6|Up to Year 1|Serious Adverse Event|0
1695551|NCT01262976|5919688|P5|Up to Year 1|Serious Adverse Event|0
1695552|NCT01262976|5919689|P4|Up to Year 1|Serious Adverse Event|0
1695553|NCT01262976|5919690|P3|Up to Year 1|Serious Adverse Event|2
1695554|NCT01262976|5919691|P2|Up to Year 1|Serious Adverse Event|0
1695555|NCT01262976|5919692|P1|Up to Year 1|Serious Adverse Event|0
1695556|NCT01262976|5919687|P6|Up to Month 7|Other|0
1695557|NCT01262976|5919688|P5|Up to Month 7|Other|0
1695558|NCT01262976|5919689|P4|Up to Month 7|Other|0
1695559|NCT01262976|5919690|P3|Up to Month 7|Other|2
1695560|NCT01262976|5919691|P2|Up to Month 7|Other|0
1695561|NCT01262976|5919692|P1|Up to Month 7|Other|3
1695562|NCT01262976|5919687|P6|Up to Month 7|Lost to Follow-up|3
1695563|NCT01262976|5919688|P5|Up to Month 7|Lost to Follow-up|1
1695564|NCT01262976|5919689|P4|Up to Month 7|Lost to Follow-up|3
1695565|NCT01262976|5919690|P3|Up to Month 7|Lost to Follow-up|1
1695566|NCT01262976|5919691|P2|Up to Month 7|Lost to Follow-up|0
1695567|NCT01262976|5919692|P1|Up to Month 7|Lost to Follow-up|1
1695568|NCT01262976|5919687|P6|Up to Month 7|Migrated/moved from study area|1
1695569|NCT01262976|5919688|P5|Up to Month 7|Migrated/moved from study area|1
1695570|NCT01262976|5919689|P4|Up to Month 7|Migrated/moved from study area|3
1695571|NCT01262976|5919690|P3|Up to Month 7|Migrated/moved from study area|1
1695572|NCT01262976|5919691|P2|Up to Month 7|Migrated/moved from study area|0
1695573|NCT01262976|5919692|P1|Up to Month 7|Migrated/moved from study area|0
1695574|NCT01262976|5919687|P6|Up to Month 7|Withdrawal by Subject|0
1695575|NCT01262976|5919688|P5|Up to Month 7|Withdrawal by Subject|0
1695576|NCT01262976|5919689|P4|Up to Month 7|Withdrawal by Subject|0
1695577|NCT01262976|5919690|P3|Up to Month 7|Withdrawal by Subject|0
1695578|NCT01262976|5919691|P2|Up to Month 7|Withdrawal by Subject|0
1695579|NCT01262976|5919692|P1|Up to Month 7|Withdrawal by Subject|1
1695580|NCT01262976|5919687|P6|Up to Month 7|Serious Adverse Event|0
1695581|NCT01262976|5919688|P5|Up to Month 7|Serious Adverse Event|0
1695582|NCT01262976|5919689|P4|Up to Month 7|Serious Adverse Event|0
1695583|NCT01262976|5919690|P3|Up to Month 7|Serious Adverse Event|2
1695584|NCT01262976|5919691|P2|Up to Month 7|Serious Adverse Event|0
1695585|NCT01262976|5919692|P1|Up to Month 7|Serious Adverse Event|0
1695586|NCT01262976|5919687|P6|Up to Month 2|Other|2
1695587|NCT01262976|5919688|P5|Up to Month 2|Other|0
1695588|NCT01262976|5919689|P4|Up to Month 2|Other|1
1695589|NCT01262976|5919690|P3|Up to Month 2|Other|0
1695590|NCT01262976|5919691|P2|Up to Month 2|Other|0
1695591|NCT01262976|5919692|P1|Up to Month 2|Other|1
1695592|NCT01262976|5919687|P6|Up to Month 2|Lost to Follow-up|1
1695593|NCT01262976|5919688|P5|Up to Month 2|Lost to Follow-up|1
1695594|NCT01262976|5919689|P4|Up to Month 2|Lost to Follow-up|1
1695595|NCT01262976|5919690|P3|Up to Month 2|Lost to Follow-up|0
1695596|NCT01262976|5919691|P2|Up to Month 2|Lost to Follow-up|0
1695597|NCT01262976|5919692|P1|Up to Month 2|Lost to Follow-up|1
1695598|NCT01262976|5919687|P6|Up to Month 2|Migrated/moved from study area|1
1695599|NCT01262976|5919688|P5|Up to Month 2|Migrated/moved from study area|1
1695600|NCT01262976|5919689|P4|Up to Month 2|Migrated/moved from study area|0
1695601|NCT01262976|5919690|P3|Up to Month 2|Migrated/moved from study area|0
1695602|NCT01262976|5919691|P2|Up to Month 2|Migrated/moved from study area|1
1695603|NCT01262976|5919692|P1|Up to Month 2|Migrated/moved from study area|0
1695604|NCT01262976|5919687|P6|Up to Month 2|Withdrawal by Subject|0
1695605|NCT01262976|5919688|P5|Up to Month 2|Withdrawal by Subject|0
1695606|NCT01262976|5919689|P4|Up to Month 2|Withdrawal by Subject|0
1695607|NCT01262976|5919690|P3|Up to Month 2|Withdrawal by Subject|0
1695608|NCT01262976|5919691|P2|Up to Month 2|Withdrawal by Subject|0
1695609|NCT01262976|5919692|P1|Up to Month 2|Withdrawal by Subject|1
1695610|NCT01262976|5919687|P6|Up to Month 2|Serious Adverse Event|0
1695611|NCT01262976|5919688|P5|Up to Month 2|Serious Adverse Event|0
1695612|NCT01262976|5919689|P4|Up to Month 2|Serious Adverse Event|0
1695613|NCT01262976|5919690|P3|Up to Month 2|Serious Adverse Event|1
1695614|NCT01262976|5919691|P2|Up to Month 2|Serious Adverse Event|0
1695615|NCT01262976|5919692|P1|Up to Month 2|Serious Adverse Event|0
1695616|NCT01262898|5919848|P4|Overall Study|Withdrawal by Subject|0
1695617|NCT01262898|5919849|P3|Overall Study|Withdrawal by Subject|0
1695618|NCT01262898|5919850|P2|Overall Study|Withdrawal by Subject|1
1695619|NCT01262898|5919851|P1|Overall Study|Withdrawal by Subject|1
1695620|NCT01262898|5919848|P4|Overall Study|Lost to Follow-up|0
1695621|NCT01262898|5919849|P3|Overall Study|Lost to Follow-up|0
1695622|NCT01262898|5919850|P2|Overall Study|Lost to Follow-up|0
1695623|NCT01262898|5919851|P1|Overall Study|Lost to Follow-up|1
1695624|NCT01262898|5919848|P4|Overall Study|Protocol Violation|0
1695625|NCT01262898|5919849|P3|Overall Study|Protocol Violation|0
1695626|NCT01262898|5919850|P2|Overall Study|Protocol Violation|1
1695627|NCT01262898|5919851|P1|Overall Study|Protocol Violation|1
1695628|NCT01262872|5919979|P8|Step 2|Migrated/moved from study area|3
1695629|NCT01262872|5919980|P7|Step 2|Migrated/moved from study area|2
1695630|NCT01262872|5919981|P6|Step 2|Migrated/moved from study area|6
1695631|NCT01262872|5919982|P5|Step 2|Migrated/moved from study area|2
1695632|NCT01262872|5919983|P4|Step 2|Migrated/moved from study area|3
1695633|NCT01262872|5919984|P3|Step 2|Migrated/moved from study area|4
1695634|NCT01262872|5919985|P2|Step 2|Migrated/moved from study area|0
1695635|NCT01262872|5919986|P1|Step 2|Migrated/moved from study area|0
1695636|NCT01262872|5919979|P8|Step 2|Withdrawal by Subject|1
1695637|NCT01262872|5919980|P7|Step 2|Withdrawal by Subject|2
1695638|NCT01262872|5919981|P6|Step 2|Withdrawal by Subject|1
1695639|NCT01262872|5919982|P5|Step 2|Withdrawal by Subject|3
1695640|NCT01262872|5919983|P4|Step 2|Withdrawal by Subject|6
1695641|NCT01262872|5919984|P3|Step 2|Withdrawal by Subject|4
1695642|NCT01262872|5919985|P2|Step 2|Withdrawal by Subject|0
1695643|NCT01262872|5919986|P1|Step 2|Withdrawal by Subject|0
1695644|NCT01262872|5919979|P8|Step 2|Protocol Violation|1
1695645|NCT01262872|5919980|P7|Step 2|Protocol Violation|3
1695646|NCT01262872|5919981|P6|Step 2|Protocol Violation|0
1695647|NCT01262872|5919982|P5|Step 2|Protocol Violation|0
1695648|NCT01262872|5919983|P4|Step 2|Protocol Violation|0
1695649|NCT01262872|5919984|P3|Step 2|Protocol Violation|1
1695650|NCT01262872|5919985|P2|Step 2|Protocol Violation|0
1695651|NCT01262872|5919986|P1|Step 2|Protocol Violation|0
1695652|NCT01262872|5919979|P8|Step 2|Death|1
1695653|NCT01262872|5919980|P7|Step 2|Death|2
1695654|NCT01262872|5919981|P6|Step 2|Death|2
1695655|NCT01262872|5919982|P5|Step 2|Death|0
1695656|NCT01262872|5919983|P4|Step 2|Death|1
1695657|NCT01262872|5919984|P3|Step 2|Death|0
1695658|NCT01262872|5919985|P2|Step 2|Death|0
1695659|NCT01262872|5919986|P1|Step 2|Death|0
1695660|NCT01262820|5920260|P1|Overall Study|Drug held for 21+ days|1
1695661|NCT01262820|5920260|P1|Overall Study|Lack of Efficacy|9
1695662|NCT01262820|5920260|P1|Overall Study|Adverse Event|5
1695663|NCT01262677|5920274|P3|Overall Study|Adverse Event (AE) related to study drug|3
1695664|NCT01262677|5920275|P2|Overall Study|Adverse Event (AE) related to study drug|8
1695665|NCT01262677|5920276|P1|Overall Study|Adverse Event (AE) related to study drug|3
1695666|NCT01262677|5920274|P3|Overall Study|Protocol Violation|1
1695667|NCT01262677|5920275|P2|Overall Study|Protocol Violation|1
1695668|NCT01262677|5920276|P1|Overall Study|Protocol Violation|0
1695669|NCT01262677|5920274|P3|Overall Study|Reason not provided|3
1695670|NCT01262677|5920275|P2|Overall Study|Reason not provided|1
1695671|NCT01262677|5920276|P1|Overall Study|Reason not provided|2
1695672|NCT01262677|5920274|P3|Overall Study|No longer willing to participate|2
1695673|NCT01262677|5920275|P2|Overall Study|No longer willing to participate|3
1695674|NCT01262677|5920276|P1|Overall Study|No longer willing to participate|3
1695675|NCT01262677|5920274|P3|Overall Study|Lost to Follow-up|2
1695676|NCT01262677|5920275|P2|Overall Study|Lost to Follow-up|0
1695677|NCT01262677|5920276|P1|Overall Study|Lost to Follow-up|1
1695678|NCT01262677|5920274|P3|Overall Study|Insufficient clinical response|1
1695679|NCT01262677|5920275|P2|Overall Study|Insufficient clinical response|0
1695680|NCT01262677|5920276|P1|Overall Study|Insufficient clinical response|0
1695681|NCT01262677|5920274|P3|Overall Study|Does not meet entrance criteria|0
1695682|NCT01262677|5920275|P2|Overall Study|Does not meet entrance criteria|2
1695683|NCT01262677|5920276|P1|Overall Study|Does not meet entrance criteria|0
1695684|NCT01262651|5920367|P2|Overall Study|Met Withdrawal Criteria|0
1695685|NCT01262651|5920368|P1|Overall Study|Met Withdrawal Criteria|1
1695686|NCT01262651|5920367|P2|Overall Study|Withdrawal by Investigator|2
1695687|NCT01262651|5920368|P1|Overall Study|Withdrawal by Investigator|2
1695688|NCT01262651|5920367|P2|Overall Study|Withdrawal by Subject|11
1695689|NCT01262651|5920368|P1|Overall Study|Withdrawal by Subject|15
1695690|NCT01262651|5920367|P2|Overall Study|Adverse Event|35
1695691|NCT01262651|5920368|P1|Overall Study|Adverse Event|40
1695692|NCT01262573|5920409|P2|Overall Study|Withdrawal by Subject|1
1695693|NCT01262573|5920410|P1|Overall Study|Withdrawal by Subject|0
1695694|NCT01262560|5920421|P3|Overall Study|Protocol Violation|2
1695695|NCT01262560|5920422|P2|Overall Study|Protocol Violation|1
1695696|NCT01262560|5920423|P1|Overall Study|Protocol Violation|0
1695697|NCT01262456|5920472|P3|1-Month Open-Label Extension Period|Other Reason|0
1695698|NCT01262456|5920473|P2|1-Month Open-Label Extension Period|Other Reason|1
1695699|NCT01262456|5920474|P1|1-Month Open-Label Extension Period|Other Reason|0
1695700|NCT01262456|5920472|P3|1-Month Open-Label Extension Period|Protocol Violation|2
1695701|NCT01262456|5920473|P2|1-Month Open-Label Extension Period|Protocol Violation|0
1695702|NCT01262456|5920474|P1|1-Month Open-Label Extension Period|Protocol Violation|1
1695703|NCT01262456|5920472|P3|1-Month Open-Label Extension Period|Adverse Event|2
1695704|NCT01262456|5920473|P2|1-Month Open-Label Extension Period|Adverse Event|0
1695705|NCT01262456|5920474|P1|1-Month Open-Label Extension Period|Adverse Event|2
1695706|NCT01262456|5920472|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
1695707|NCT01262456|5920473|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
1695708|NCT01262456|5920474|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
1695709|NCT01262456|5920472|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1695710|NCT01262456|5920473|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1695711|NCT01262456|5920474|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
1695712|NCT01262456|5920472|P3|3-Month Double-Blind Period|Protocol Violation|6
1695713|NCT01262456|5920473|P2|3-Month Double-Blind Period|Protocol Violation|6
1695714|NCT01262456|5920474|P1|3-Month Double-Blind Period|Protocol Violation|3
1695715|NCT01262456|5920472|P3|3-Month Double-Blind Period|Adverse Event|8
1695716|NCT01262456|5920473|P2|3-Month Double-Blind Period|Adverse Event|4
1695717|NCT01262456|5920474|P1|3-Month Double-Blind Period|Adverse Event|6
1695718|NCT01262456|5920472|P3|3-Month Double-Blind Period|Lost to Follow-up|3
1695719|NCT01262456|5920473|P2|3-Month Double-Blind Period|Lost to Follow-up|5
1695720|NCT01262456|5920474|P1|3-Month Double-Blind Period|Lost to Follow-up|4
1695721|NCT01262456|5920472|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
1695722|NCT01262456|5920473|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
1695723|NCT01262456|5920474|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
1695724|NCT01262365|5920518|P3|Overall Study|Patient unavailable|1
1695725|NCT01262365|5920519|P2|Overall Study|Patient unavailable|0
1695726|NCT01262365|5920520|P1|Overall Study|Patient unavailable|0
1695727|NCT01262365|5920518|P3|Overall Study|Cannot tolerate the protocol|0
1695728|NCT01262365|5920519|P2|Overall Study|Cannot tolerate the protocol|1
1695729|NCT01262365|5920520|P1|Overall Study|Cannot tolerate the protocol|0
1695730|NCT01262365|5920518|P3|Overall Study|Toxicity related to study drug|0
1695731|NCT01262365|5920519|P2|Overall Study|Toxicity related to study drug|1
1695732|NCT01262365|5920520|P1|Overall Study|Toxicity related to study drug|0
1695733|NCT01262365|5920518|P3|Overall Study|Patient pregnant|1
1695734|NCT01262365|5920519|P2|Overall Study|Patient pregnant|0
1695735|NCT01262365|5920520|P1|Overall Study|Patient pregnant|1
1695736|NCT01262365|5920518|P3|Overall Study|Suspected pregnancy|0
1695737|NCT01262365|5920519|P2|Overall Study|Suspected pregnancy|0
1695738|NCT01262365|5920520|P1|Overall Study|Suspected pregnancy|1
1695739|NCT01262365|5920518|P3|Overall Study|Non-compliance|2
1695740|NCT01262365|5920519|P2|Overall Study|Non-compliance|0
1695741|NCT01262365|5920520|P1|Overall Study|Non-compliance|1
1695742|NCT01262365|5920518|P3|Overall Study|Randomization error|2
1695743|NCT01262365|5920519|P2|Overall Study|Randomization error|0
1695744|NCT01262365|5920520|P1|Overall Study|Randomization error|1
1695745|NCT01262365|5920518|P3|Overall Study|sponsor decision|0
1695746|NCT01262365|5920519|P2|Overall Study|sponsor decision|1
1695747|NCT01262365|5920520|P1|Overall Study|sponsor decision|1
1695748|NCT01262365|5920518|P3|Overall Study|Adverse Event|11
1695749|NCT01262365|5920519|P2|Overall Study|Adverse Event|16
1695750|NCT01262365|5920520|P1|Overall Study|Adverse Event|26
1695751|NCT01262365|5920518|P3|Overall Study|Death|1
1695752|NCT01262365|5920519|P2|Overall Study|Death|2
1695753|NCT01262365|5920520|P1|Overall Study|Death|1
1695754|NCT01262365|5920518|P3|Overall Study|Withdrawal by Subject|22
1695755|NCT01262365|5920519|P2|Overall Study|Withdrawal by Subject|22
1695756|NCT01262365|5920520|P1|Overall Study|Withdrawal by Subject|17
1695757|NCT01262365|5920518|P3|Overall Study|Lost to Follow-up|6
1695758|NCT01262365|5920519|P2|Overall Study|Lost to Follow-up|7
1695759|NCT01262365|5920520|P1|Overall Study|Lost to Follow-up|3
1695760|NCT01262365|5920518|P3|Overall Study|Protocol Violation|1
1695761|NCT01262365|5920519|P2|Overall Study|Protocol Violation|1
1695762|NCT01262365|5920520|P1|Overall Study|Protocol Violation|3
1695763|NCT01262365|5920518|P3|Overall Study|Lack of Efficacy|47
1695764|NCT01262365|5920519|P2|Overall Study|Lack of Efficacy|30
1695765|NCT01262365|5920520|P1|Overall Study|Lack of Efficacy|35
1695766|NCT01262352|5920545|P2|Washout|Extended Washout|1
1695767|NCT01262352|5920546|P1|Washout|Extended Washout|0
1695768|NCT01262352|5920545|P2|Washout|Adverse Event|1
1695769|NCT01262352|5920546|P1|Washout|Adverse Event|1
1695770|NCT01262352|5920545|P2|Period 1|Illness after randomization|0
1695771|NCT01262352|5920546|P1|Period 1|Illness after randomization|1
1695772|NCT01262287|5920564|P2|Overall Study|Lost to Follow-up|1
1695773|NCT01262287|5920565|P1|Overall Study|Lost to Follow-up|2
1695774|NCT01262092|5920626|P2|Gabapentin Taper|noncompliance - missed medications|0
1695775|NCT01262092|5920627|P1|Gabapentin Taper|noncompliance - missed medications|1
1695776|NCT01262092|5920626|P2|Buprenorphine Taper|noncompliance - missed medication|1
1695777|NCT01262092|5920627|P1|Buprenorphine Taper|noncompliance - missed medication|1
1695778|NCT01262092|5920626|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
1695779|NCT01262092|5920627|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
1695780|NCT01262092|5920626|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
1695781|NCT01262092|5920627|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
1695782|NCT01262027|5920633|P1|Overall Study|Protocol Violation|1
1695783|NCT01262027|5920633|P1|Overall Study|Withdrawal by Subject|3
1695784|NCT01262027|5920633|P1|Overall Study|Adverse Event|1
1695785|NCT01261975|5920638|P1|Overall Study|Surgical complication|1
1695786|NCT01261793|5920660|P3|Overall Study|Patient unable to start IV line|1
1695787|NCT01261793|5920661|P2|Overall Study|Patient unable to start IV line|0
1695788|NCT01261793|5920662|P1|Overall Study|Patient unable to start IV line|0
1695789|NCT01261793|5920660|P3|Overall Study|Randomization error|0
1695790|NCT01261793|5920661|P2|Overall Study|Randomization error|1
1695791|NCT01261793|5920662|P1|Overall Study|Randomization error|0
1695792|NCT01261793|5920660|P3|Overall Study|Patient withdrew after cardiology visit|0
1695793|NCT01261793|5920661|P2|Overall Study|Patient withdrew after cardiology visit|1
1695794|NCT01261793|5920662|P1|Overall Study|Patient withdrew after cardiology visit|0
1695795|NCT01261793|5920660|P3|Overall Study|Lack of efficacy & patient not available|0
1695796|NCT01261793|5920661|P2|Overall Study|Lack of efficacy & patient not available|1
1695797|NCT01261793|5920662|P1|Overall Study|Lack of efficacy & patient not available|0
1695798|NCT01261793|5920660|P3|Overall Study|Outside the study area|1
1695799|NCT01261793|5920661|P2|Overall Study|Outside the study area|2
1695800|NCT01261793|5920662|P1|Overall Study|Outside the study area|0
1695801|NCT01261793|5920660|P3|Overall Study|Patient pregnant|0
1695802|NCT01261793|5920661|P2|Overall Study|Patient pregnant|0
1695803|NCT01261793|5920662|P1|Overall Study|Patient pregnant|1
1695804|NCT01261793|5920660|P3|Overall Study|Patient non-compliance|1
1695805|NCT01261793|5920661|P2|Overall Study|Patient non-compliance|0
1695806|NCT01261793|5920662|P1|Overall Study|Patient non-compliance|1
1695807|NCT01261793|5920660|P3|Overall Study|Suspected pregnancy|0
1695808|NCT01261793|5920661|P2|Overall Study|Suspected pregnancy|1
1695809|NCT01261793|5920662|P1|Overall Study|Suspected pregnancy|1
1695810|NCT01261793|5920660|P3|Overall Study|Patient non-availability|1
1695811|NCT01261793|5920661|P2|Overall Study|Patient non-availability|1
1695812|NCT01261793|5920662|P1|Overall Study|Patient non-availability|1
1695813|NCT01261793|5920660|P3|Overall Study|Adverse Event|19
1695814|NCT01261793|5920661|P2|Overall Study|Adverse Event|24
1695815|NCT01261793|5920662|P1|Overall Study|Adverse Event|9
1695816|NCT01261793|5920660|P3|Overall Study|Death|0
1695817|NCT01261793|5920661|P2|Overall Study|Death|1
1695818|NCT01261793|5920662|P1|Overall Study|Death|3
1695819|NCT01261793|5920660|P3|Overall Study|Withdrawal by Subject|14
1695820|NCT01261793|5920661|P2|Overall Study|Withdrawal by Subject|14
1695821|NCT01261793|5920662|P1|Overall Study|Withdrawal by Subject|12
1695822|NCT01261793|5920660|P3|Overall Study|Lost to Follow-up|7
1695823|NCT01261793|5920661|P2|Overall Study|Lost to Follow-up|3
1695824|NCT01261793|5920662|P1|Overall Study|Lost to Follow-up|10
1695825|NCT01261793|5920660|P3|Overall Study|Protocol Violation|6
1695826|NCT01261793|5920661|P2|Overall Study|Protocol Violation|5
1695827|NCT01261793|5920662|P1|Overall Study|Protocol Violation|3
1695828|NCT01261793|5920660|P3|Overall Study|Lack of Efficacy|32
1695829|NCT01261793|5920661|P2|Overall Study|Lack of Efficacy|37
1695830|NCT01261793|5920662|P1|Overall Study|Lack of Efficacy|44
1695831|NCT01261780|5920687|P2|Overall Study|Event not related to subject|2
1695832|NCT01261780|5920688|P1|Overall Study|Event not related to subject|1
1695833|NCT01261780|5920687|P2|Overall Study|Withdrawal by Subject|0
1695834|NCT01261780|5920688|P1|Overall Study|Withdrawal by Subject|1
1695835|NCT01261624|5920698|P2|Week 13 to Week 24|Insufficient Response|1
1695836|NCT01261624|5920699|P1|Week 13 to Week 24|Insufficient Response|0
1695837|NCT01261624|5920698|P2|Week 0 to Week 12|Insufficient Response|2
1695838|NCT01261624|5920699|P1|Week 0 to Week 12|Insufficient Response|0
1695839|NCT01261624|5920698|P2|Week 0 to Week 12|Disease Progression|1
1695840|NCT01261624|5920699|P1|Week 0 to Week 12|Disease Progression|1
1695841|NCT01261611|5920719|P3|Treatment Cycle 5|Lost to Follow-up|0
1695842|NCT01261611|5920720|P2|Treatment Cycle 5|Lost to Follow-up|0
1695843|NCT01261611|5920721|P1|Treatment Cycle 5|Lost to Follow-up|1
1695844|NCT01261611|5920719|P3|Treatment Cycle 5|Adverse Event|0
1695845|NCT01261611|5920720|P2|Treatment Cycle 5|Adverse Event|0
1695846|NCT01261611|5920721|P1|Treatment Cycle 5|Adverse Event|1
1695847|NCT01261611|5920719|P3|Treatment Cycle 5|Withdrawal by Subject|0
1695848|NCT01261611|5920720|P2|Treatment Cycle 5|Withdrawal by Subject|0
1695849|NCT01261611|5920721|P1|Treatment Cycle 5|Withdrawal by Subject|1
1695850|NCT01261611|5920719|P3|Treatment Cycle 4|Not otherwise specified|0
1695851|NCT01261611|5920720|P2|Treatment Cycle 4|Not otherwise specified|0
1695852|NCT01261611|5920721|P1|Treatment Cycle 4|Not otherwise specified|3
1695853|NCT01261611|5920719|P3|Treatment Cycle 4|Lost to Follow-up|0
1695854|NCT01261611|5920720|P2|Treatment Cycle 4|Lost to Follow-up|0
1695855|NCT01261611|5920721|P1|Treatment Cycle 4|Lost to Follow-up|2
1695856|NCT01261611|5920719|P3|Treatment Cycle 4|Adverse Event|0
1695857|NCT01261611|5920720|P2|Treatment Cycle 4|Adverse Event|0
1695858|NCT01261611|5920721|P1|Treatment Cycle 4|Adverse Event|1
1695859|NCT01261611|5920719|P3|Treatment Cycle 4|Withdrawal by Subject|0
1695860|NCT01261611|5920720|P2|Treatment Cycle 4|Withdrawal by Subject|0
1695861|NCT01261611|5920721|P1|Treatment Cycle 4|Withdrawal by Subject|3
1695862|NCT01261611|5920719|P3|Treatment Cycle 4|Completed study|0
1695863|NCT01261611|5920720|P2|Treatment Cycle 4|Completed study|0
1695864|NCT01261611|5920721|P1|Treatment Cycle 4|Completed study|87
1695865|NCT01261611|5920719|P3|Treatment Cycle 3|Lost to Follow-up|0
1695866|NCT01261611|5920720|P2|Treatment Cycle 3|Lost to Follow-up|0
1695867|NCT01261611|5920721|P1|Treatment Cycle 3|Lost to Follow-up|1
1695868|NCT01261611|5920719|P3|Treatment Cycle 3|Adverse Event|0
1695869|NCT01261611|5920720|P2|Treatment Cycle 3|Adverse Event|0
1695870|NCT01261611|5920721|P1|Treatment Cycle 3|Adverse Event|1
1695871|NCT01261611|5920719|P3|Treatment Cycle 3|Withdrawal by Subject|0
1695872|NCT01261611|5920720|P2|Treatment Cycle 3|Withdrawal by Subject|0
1695873|NCT01261611|5920721|P1|Treatment Cycle 3|Withdrawal by Subject|4
1695874|NCT01261611|5920719|P3|Treatment Cycle 3|Completed study|0
1695875|NCT01261611|5920720|P2|Treatment Cycle 3|Completed study|0
1695876|NCT01261611|5920721|P1|Treatment Cycle 3|Completed study|24
1695877|NCT01261611|5920719|P3|Treatment Cycle 2|Not otherwise specified|0
1695878|NCT01261611|5920720|P2|Treatment Cycle 2|Not otherwise specified|0
1695879|NCT01261611|5920721|P1|Treatment Cycle 2|Not otherwise specified|2
1695880|NCT01261611|5920719|P3|Treatment Cycle 2|Protocol Violation|0
1695881|NCT01261611|5920720|P2|Treatment Cycle 2|Protocol Violation|0
1695882|NCT01261611|5920721|P1|Treatment Cycle 2|Protocol Violation|2
1695883|NCT01261611|5920719|P3|Treatment Cycle 2|Adverse Event|0
1695884|NCT01261611|5920720|P2|Treatment Cycle 2|Adverse Event|0
1695885|NCT01261611|5920721|P1|Treatment Cycle 2|Adverse Event|1
1695886|NCT01261611|5920719|P3|Treatment Cycle 2|Withdrawal by Subject|0
1695887|NCT01261611|5920720|P2|Treatment Cycle 2|Withdrawal by Subject|0
1695888|NCT01261611|5920721|P1|Treatment Cycle 2|Withdrawal by Subject|4
1695889|NCT01261611|5920719|P3|Treatment Cycle 2|Completed study|0
1695890|NCT01261611|5920720|P2|Treatment Cycle 2|Completed study|0
1695891|NCT01261611|5920721|P1|Treatment Cycle 2|Completed study|4
1695892|NCT01261611|5920719|P3|Treatment Cycle 1|Protocol Violation|2
1695893|NCT01261611|5920720|P2|Treatment Cycle 1|Protocol Violation|0
1695894|NCT01261611|5920721|P1|Treatment Cycle 1|Protocol Violation|0
1695895|NCT01261611|5920719|P3|Treatment Cycle 1|Adverse Event|0
1695896|NCT01261611|5920720|P2|Treatment Cycle 1|Adverse Event|1
1695897|NCT01261611|5920721|P1|Treatment Cycle 1|Adverse Event|0
1695898|NCT01261611|5920719|P3|Treatment Cycle 1|Lost to Follow-up|0
1695899|NCT01261611|5920720|P2|Treatment Cycle 1|Lost to Follow-up|0
1695900|NCT01261611|5920721|P1|Treatment Cycle 1|Lost to Follow-up|1
1695901|NCT01261611|5920719|P3|Treatment Cycle 1|Withdrawal by Subject|0
1695902|NCT01261611|5920720|P2|Treatment Cycle 1|Withdrawal by Subject|2
1695903|NCT01261611|5920721|P1|Treatment Cycle 1|Withdrawal by Subject|3
1695904|NCT01261390|5920785|P4|Overall Study|Lost to Follow-up|6
1695905|NCT01261390|5920786|P3|Overall Study|Lost to Follow-up|5
1695906|NCT01261390|5920787|P2|Overall Study|Lost to Follow-up|6
1695907|NCT01261390|5920788|P1|Overall Study|Lost to Follow-up|1
1695908|NCT01261390|5920785|P4|Overall Study|Loss of Interest in the Study|0
1695909|NCT01261390|5920786|P3|Overall Study|Loss of Interest in the Study|0
1695910|NCT01261390|5920787|P2|Overall Study|Loss of Interest in the Study|1
1695911|NCT01261390|5920788|P1|Overall Study|Loss of Interest in the Study|3
1695912|NCT01261390|5920785|P4|Overall Study|Relocation|0
1695913|NCT01261390|5920786|P3|Overall Study|Relocation|0
1695914|NCT01261390|5920787|P2|Overall Study|Relocation|1
1695915|NCT01261390|5920788|P1|Overall Study|Relocation|0
1695916|NCT01261390|5920785|P4|Overall Study|Dissatisfaction with Treatment|2
1695917|NCT01261390|5920786|P3|Overall Study|Dissatisfaction with Treatment|1
1695918|NCT01261390|5920787|P2|Overall Study|Dissatisfaction with Treatment|1
1695919|NCT01261390|5920788|P1|Overall Study|Dissatisfaction with Treatment|2
1695920|NCT01261390|5920785|P4|Overall Study|Significant Concurrent Illness|0
1695921|NCT01261390|5920786|P3|Overall Study|Significant Concurrent Illness|1
1695922|NCT01261390|5920787|P2|Overall Study|Significant Concurrent Illness|0
1695923|NCT01261390|5920788|P1|Overall Study|Significant Concurrent Illness|1
1695924|NCT01261325|5920953|P3|Overall Study|AE, serious fatal|2
1695925|NCT01261325|5920954|P2|Overall Study|AE, serious fatal|0
1695926|NCT01261325|5920955|P1|Overall Study|AE, serious fatal|0
1695927|NCT01261325|5920953|P3|Overall Study|Lost to Follow-up|3
1695928|NCT01261325|5920954|P2|Overall Study|Lost to Follow-up|1
1695929|NCT01261325|5920955|P1|Overall Study|Lost to Follow-up|0
1695930|NCT01261325|5920953|P3|Overall Study|Protocol Violation|1
1695931|NCT01261325|5920954|P2|Overall Study|Protocol Violation|3
1695932|NCT01261325|5920955|P1|Overall Study|Protocol Violation|0
1695933|NCT01261325|5920953|P3|Overall Study|Randomized in Error|1
1695934|NCT01261325|5920954|P2|Overall Study|Randomized in Error|0
1695935|NCT01261325|5920955|P1|Overall Study|Randomized in Error|0
1695936|NCT01261325|5920953|P3|Overall Study|Screen Failure|0
1695937|NCT01261325|5920954|P2|Overall Study|Screen Failure|0
1695938|NCT01261325|5920955|P1|Overall Study|Screen Failure|1
1695939|NCT01261325|5920953|P3|Overall Study|Erroneously Randomized|0
1695940|NCT01261325|5920954|P2|Overall Study|Erroneously Randomized|0
1695941|NCT01261325|5920955|P1|Overall Study|Erroneously Randomized|1
1695942|NCT01261325|5920953|P3|Overall Study|Patient Randomized by Mistake|0
1695943|NCT01261325|5920954|P2|Overall Study|Patient Randomized by Mistake|1
1695944|NCT01261325|5920955|P1|Overall Study|Patient Randomized by Mistake|0
1695945|NCT01261325|5920953|P3|Overall Study|Non Compliance|0
1695946|NCT01261325|5920954|P2|Overall Study|Non Compliance|0
1695947|NCT01261325|5920955|P1|Overall Study|Non Compliance|2
1695948|NCT01261325|5920953|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1695949|NCT01261325|5920954|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1695950|NCT01261325|5920955|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1695951|NCT01261325|5920953|P3|Overall Study|AE, non-serious non-fatal|13
1695952|NCT01261325|5920954|P2|Overall Study|AE, non-serious non-fatal|15
1695953|NCT01261325|5920955|P1|Overall Study|AE, non-serious non-fatal|9
1695954|NCT01261325|5920953|P3|Overall Study|SAE, non-fatal|1
1695955|NCT01261325|5920954|P2|Overall Study|SAE, non-fatal|5
1695956|NCT01261325|5920955|P1|Overall Study|SAE, non-fatal|1
1695957|NCT01261325|5920953|P3|Overall Study|Withdrawal by Subject|4
1695958|NCT01261325|5920954|P2|Overall Study|Withdrawal by Subject|2
1695959|NCT01261325|5920955|P1|Overall Study|Withdrawal by Subject|2
1695960|NCT01261325|5920953|P3|Overall Study|Lack of Efficacy|0
1695961|NCT01261325|5920954|P2|Overall Study|Lack of Efficacy|1
1695962|NCT01261325|5920955|P1|Overall Study|Lack of Efficacy|1
1695963|NCT01261247|5920987|P1|Overall Study|Ineligible|2
1695964|NCT01261000|5921000|P1|Overall Study|Screen failure|1
1695965|NCT01260948|5921006|P2|Second Intervention|Emesis|1
1695966|NCT01260948|5921007|P1|Second Intervention|Emesis|0
1695967|NCT01260948|5921006|P2|Washout of 28 Days|Withdrawal by Subject|3
1695968|NCT01260948|5921007|P1|Washout of 28 Days|Withdrawal by Subject|1
1695969|NCT01260922|5921017|P2|Second Intervention|Emesis|2
1695970|NCT01260922|5921018|P1|Second Intervention|Emesis|0
1695971|NCT01260922|5921017|P2|Washout of 28 Days|Withdrawal by Subject|2
1695972|NCT01260922|5921018|P1|Washout of 28 Days|Withdrawal by Subject|4
1695973|NCT01260922|5921017|P2|First Intervention|Withdrawal by Subject|1
1695974|NCT01260922|5921018|P1|First Intervention|Withdrawal by Subject|0
1695975|NCT01260896|5921028|P2|First Intervention|Withdrawn Due to Emesis|0
1695976|NCT01260896|5921029|P1|First Intervention|Withdrawn Due to Emesis|2
1695977|NCT01260701|5921087|P1|Overall Study|Did not begin protocol therapy|1
1695978|NCT01260701|5921087|P1|Overall Study|Ineligible|4
1695979|NCT01260701|5921087|P1|Overall Study|Under review|1
1695980|NCT01260701|5921087|P1|Overall Study|Not protocol specified|3
1695981|NCT01260701|5921087|P1|Overall Study|Death|2
1695982|NCT01260701|5921087|P1|Overall Study|Progression|53
1695983|NCT01260701|5921087|P1|Overall Study|Withdrawal by Subject|2
1695984|NCT01260701|5921087|P1|Overall Study|Adverse Event|9
1695985|NCT01260584|5921168|P4|Period 2|Withdrawal by Subject|0
1695986|NCT01260584|5921169|P3|Period 2|Withdrawal by Subject|0
1695987|NCT01260584|5921170|P2|Period 2|Withdrawal by Subject|1
1695988|NCT01260584|5921171|P1|Period 2|Withdrawal by Subject|0
1695989|NCT01260584|5921168|P4|Period 2|Adverse Event|0
1695990|NCT01260584|5921169|P3|Period 2|Adverse Event|2
1695991|NCT01260584|5921170|P2|Period 2|Adverse Event|0
1695992|NCT01260584|5921171|P1|Period 2|Adverse Event|1
1695993|NCT01260584|5921168|P4|Period 2|Protocol Violation|1
1695994|NCT01260584|5921169|P3|Period 2|Protocol Violation|3
1695995|NCT01260584|5921170|P2|Period 2|Protocol Violation|2
1695996|NCT01260584|5921171|P1|Period 2|Protocol Violation|0
1695997|NCT01260584|5921168|P4|Period 1|Adverse Event|0
1695998|NCT01260584|5921169|P3|Period 1|Adverse Event|1
1695999|NCT01260584|5921170|P2|Period 1|Adverse Event|0
1696000|NCT01260584|5921171|P1|Period 1|Adverse Event|0
1696001|NCT01260584|5921168|P4|Period 1|Protocol Violation|1
1696002|NCT01260584|5921169|P3|Period 1|Protocol Violation|1
1696003|NCT01260584|5921170|P2|Period 1|Protocol Violation|0
1696004|NCT01260584|5921171|P1|Period 1|Protocol Violation|0
1696005|NCT01260467|5921214|P1|Overall Study|Withdrawal by Subject|2
1696006|NCT01260350|5921246|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696007|NCT01260350|5921247|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696008|NCT01260350|5921248|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696009|NCT01260350|5921249|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696010|NCT01260350|5921250|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696011|NCT01260350|5921251|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696012|NCT01260350|5921252|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696013|NCT01260350|5921253|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696014|NCT01260350|5921254|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696015|NCT01260350|5921255|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696016|NCT01260350|5921256|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696017|NCT01260350|5921257|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696018|NCT01260350|5921258|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696019|NCT01260350|5921259|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
1696020|NCT01260350|5921260|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696021|NCT01260350|5921261|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696022|NCT01260350|5921262|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696023|NCT01260350|5921263|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696024|NCT01260350|5921264|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696025|NCT01260350|5921265|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696026|NCT01260350|5921266|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696027|NCT01260350|5921267|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
1696028|NCT01260350|5921246|P22|Overall Study|Lack of Efficacy|0
1696029|NCT01260350|5921247|P21|Overall Study|Lack of Efficacy|3
1696030|NCT01260350|5921248|P20|Overall Study|Lack of Efficacy|0
1696031|NCT01260350|5921249|P19|Overall Study|Lack of Efficacy|0
1696032|NCT01260350|5921250|P18|Overall Study|Lack of Efficacy|1
1696033|NCT01260350|5921251|P17|Overall Study|Lack of Efficacy|0
1696034|NCT01260350|5921252|P16|Overall Study|Lack of Efficacy|0
1696035|NCT01260350|5921253|P15|Overall Study|Lack of Efficacy|0
1696036|NCT01260350|5921254|P14|Overall Study|Lack of Efficacy|0
1696037|NCT01260350|5921255|P13|Overall Study|Lack of Efficacy|0
1696038|NCT01260350|5921256|P12|Overall Study|Lack of Efficacy|0
1696039|NCT01260350|5921257|P11|Overall Study|Lack of Efficacy|0
1696040|NCT01260350|5921258|P10|Overall Study|Lack of Efficacy|0
1696041|NCT01260350|5921259|P9|Overall Study|Lack of Efficacy|0
1696042|NCT01260350|5921260|P8|Overall Study|Lack of Efficacy|0
1696043|NCT01260350|5921261|P7|Overall Study|Lack of Efficacy|0
1696044|NCT01260350|5921262|P6|Overall Study|Lack of Efficacy|0
1696045|NCT01260350|5921263|P5|Overall Study|Lack of Efficacy|0
1696046|NCT01260350|5921264|P4|Overall Study|Lack of Efficacy|0
1696047|NCT01260350|5921265|P3|Overall Study|Lack of Efficacy|0
1696048|NCT01260350|5921266|P2|Overall Study|Lack of Efficacy|0
1696049|NCT01260350|5921267|P1|Overall Study|Lack of Efficacy|0
1696050|NCT01260311|5921474|P1|Overall Study|Fesoterodine Started Before Enrollment|1
1696051|NCT01260311|5921474|P1|Overall Study|Medication Stopped|1
1696052|NCT01260311|5921474|P1|Overall Study|Gone to Province|2
1696053|NCT01260311|5921474|P1|Overall Study|Financial Constraints|77
1696054|NCT01260311|5921474|P1|Overall Study|Withdrawal by Subject|6
1696055|NCT01260311|5921474|P1|Overall Study|Lost to Follow-up|25
1696056|NCT01260311|5921474|P1|Overall Study|Lack of Efficacy|4
1696057|NCT01260311|5921474|P1|Overall Study|Adverse Event|11
1696058|NCT01260194|5921505|P1|Overall Study|Withdrawal of Consent|1
1696059|NCT01260181|5921517|P1|Overall Study|Decision of Investigator|1
1696060|NCT01260142|5921532|P6|Treatment Period 1|Withdrawal by Subject|1
1696061|NCT01260142|5921533|P5|Treatment Period 1|Withdrawal by Subject|0
1696062|NCT01260142|5921534|P4|Treatment Period 1|Withdrawal by Subject|0
1696063|NCT01260142|5921535|P3|Treatment Period 1|Withdrawal by Subject|0
1696064|NCT01260142|5921536|P2|Treatment Period 1|Withdrawal by Subject|0
1696065|NCT01260142|5921537|P1|Treatment Period 1|Withdrawal by Subject|0
1696066|NCT01260142|5921532|P6|Treatment Period 1|Unexplained elevated sys. BP|0
1696067|NCT01260142|5921533|P5|Treatment Period 1|Unexplained elevated sys. BP|1
1696068|NCT01260142|5921534|P4|Treatment Period 1|Unexplained elevated sys. BP|0
1696069|NCT01260142|5921535|P3|Treatment Period 1|Unexplained elevated sys. BP|0
1696070|NCT01260142|5921536|P2|Treatment Period 1|Unexplained elevated sys. BP|0
1696071|NCT01260142|5921537|P1|Treatment Period 1|Unexplained elevated sys. BP|0
1696072|NCT01260142|5921532|P6|Treatment Period 1|Study on hold|2
1696073|NCT01260142|5921533|P5|Treatment Period 1|Study on hold|1
1696074|NCT01260142|5921534|P4|Treatment Period 1|Study on hold|0
1696075|NCT01260142|5921535|P3|Treatment Period 1|Study on hold|0
1696076|NCT01260142|5921536|P2|Treatment Period 1|Study on hold|1
1696077|NCT01260142|5921537|P1|Treatment Period 1|Study on hold|1
1696078|NCT01259856|5921589|P2|Overall Study|Unknown/missing|2
1696079|NCT01259856|5921590|P1|Overall Study|Unknown/missing|2
1696080|NCT01259856|5921589|P2|Overall Study|Transfer to another study|1
1696081|NCT01259856|5921590|P1|Overall Study|Transfer to another study|0
1696082|NCT01259856|5921589|P2|Overall Study|Patient developed other disease|1
1696083|NCT01259856|5921590|P1|Overall Study|Patient developed other disease|0
1696084|NCT01259856|5921589|P2|Overall Study|Study closure by sponsor|41
1696085|NCT01259856|5921590|P1|Overall Study|Study closure by sponsor|40
1696086|NCT01259856|5921589|P2|Overall Study|Treatment never started|6
1696087|NCT01259856|5921590|P1|Overall Study|Treatment never started|0
1696088|NCT01259856|5921589|P2|Overall Study|Withdrawal by Subject|10
1696089|NCT01259856|5921590|P1|Overall Study|Withdrawal by Subject|9
1696090|NCT01259856|5921589|P2|Overall Study|Physician Decision|1
1696091|NCT01259856|5921590|P1|Overall Study|Physician Decision|2
1696092|NCT01259856|5921589|P2|Overall Study|Lost to Follow-up|1
1696093|NCT01259856|5921590|P1|Overall Study|Lost to Follow-up|1
1696094|NCT01259856|5921589|P2|Overall Study|Lack of Efficacy|1
1696095|NCT01259856|5921590|P1|Overall Study|Lack of Efficacy|3
1696096|NCT01259856|5921589|P2|Overall Study|Death|1
1696097|NCT01259856|5921590|P1|Overall Study|Death|0
1696098|NCT01259856|5921589|P2|Overall Study|Adverse Event|9
1696099|NCT01259856|5921590|P1|Overall Study|Adverse Event|12
1696100|NCT01259726|5921614|P4|Overall Study|Lost to Follow-up|3
1696101|NCT01259726|5921615|P3|Overall Study|Lost to Follow-up|1
1696102|NCT01259726|5921616|P2|Overall Study|Lost to Follow-up|1
1696103|NCT01259726|5921617|P1|Overall Study|Lost to Follow-up|1
1696104|NCT01259726|5921614|P4|Overall Study|Withdrawal by Subject|1
1696105|NCT01259726|5921615|P3|Overall Study|Withdrawal by Subject|2
1696106|NCT01259726|5921616|P2|Overall Study|Withdrawal by Subject|3
1696107|NCT01259726|5921617|P1|Overall Study|Withdrawal by Subject|1
1696108|NCT01259726|5921614|P4|Overall Study|Physician Decision|1
1696109|NCT01259726|5921615|P3|Overall Study|Physician Decision|1
1696110|NCT01259726|5921616|P2|Overall Study|Physician Decision|0
1696111|NCT01259726|5921617|P1|Overall Study|Physician Decision|2
1696112|NCT01259726|5921614|P4|Overall Study|Death|0
1696113|NCT01259726|5921615|P3|Overall Study|Death|0
1696114|NCT01259726|5921616|P2|Overall Study|Death|0
1696115|NCT01259726|5921617|P1|Overall Study|Death|1
1696116|NCT01259713|5921649|P2|Overall Study|Subject Withdrew Consent|7
1696117|NCT01259713|5921650|P1|Overall Study|Subject Withdrew Consent|12
1696118|NCT01259713|5921649|P2|Overall Study|Protocol Violation|4
1696119|NCT01259713|5921650|P1|Overall Study|Protocol Violation|5
1696120|NCT01259713|5921649|P2|Overall Study|Lack of Efficacy|0
1696121|NCT01259713|5921650|P1|Overall Study|Lack of Efficacy|2
1696122|NCT01259713|5921649|P2|Overall Study|Investigators Discretion|6
1696123|NCT01259713|5921650|P1|Overall Study|Investigators Discretion|14
1696124|NCT01259713|5921649|P2|Overall Study|Death Not Related to IFI|1
1696125|NCT01259713|5921650|P1|Overall Study|Death Not Related to IFI|8
1696126|NCT01259713|5921649|P2|Overall Study|Adverse Event|23
1696127|NCT01259713|5921650|P1|Overall Study|Adverse Event|54
1696128|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
1696129|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
1696130|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
1696131|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
1696132|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1696133|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
1696134|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1696135|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
1696136|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
1696137|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
1696138|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
1696139|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
1696140|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
1696141|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
1696142|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
1696143|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
1696144|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1696145|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1696146|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
1696147|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
1696148|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
1696149|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
1696150|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
1696151|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
1696152|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1696153|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
1696154|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1696155|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
1696156|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
1696157|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1696158|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1696159|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
1696160|NCT01259492|5921697|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
1696161|NCT01259492|5921698|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
1696162|NCT01259492|5921699|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
1696243|NCT01259297|5921833|P2|Double Blind Randomized Period|Death|1
1696163|NCT01259492|5921700|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
1696164|NCT01259492|5921697|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
1696165|NCT01259492|5921698|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
1696166|NCT01259492|5921699|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
1696167|NCT01259492|5921700|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
1696168|NCT01259492|5921697|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1696169|NCT01259492|5921698|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
1696170|NCT01259492|5921699|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1696171|NCT01259492|5921700|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
1696172|NCT01259492|5921697|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
1696173|NCT01259492|5921698|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
1696174|NCT01259492|5921699|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
1696175|NCT01259492|5921700|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
1696176|NCT01259492|5921697|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
1696177|NCT01259492|5921698|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
1696178|NCT01259492|5921699|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
1696179|NCT01259492|5921700|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
1696180|NCT01259492|5921697|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
1696181|NCT01259492|5921698|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
1696182|NCT01259492|5921699|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
1696183|NCT01259492|5921700|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
1696184|NCT01259492|5921697|P4|Period 1 (9 Weeks)|Protocol Violation|1
1696185|NCT01259492|5921698|P3|Period 1 (9 Weeks)|Protocol Violation|3
1696186|NCT01259492|5921699|P2|Period 1 (9 Weeks)|Protocol Violation|6
1696187|NCT01259492|5921700|P1|Period 1 (9 Weeks)|Protocol Violation|5
1696188|NCT01259492|5921697|P4|Period 1 (9 Weeks)|Administrative Problems|2
1696189|NCT01259492|5921698|P3|Period 1 (9 Weeks)|Administrative Problems|1
1696190|NCT01259492|5921699|P2|Period 1 (9 Weeks)|Administrative Problems|1
1696191|NCT01259492|5921700|P1|Period 1 (9 Weeks)|Administrative Problems|0
1696192|NCT01259492|5921697|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
1696193|NCT01259492|5921698|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
1696194|NCT01259492|5921699|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
1696195|NCT01259492|5921700|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
1696196|NCT01259492|5921697|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
1696197|NCT01259492|5921698|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
1696198|NCT01259492|5921699|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
1696199|NCT01259492|5921700|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
1696200|NCT01259492|5921697|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
1696201|NCT01259492|5921698|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
1696202|NCT01259492|5921699|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
1696203|NCT01259492|5921700|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
1696204|NCT01259492|5921697|P4|Period 1 (9 Weeks)|Adverse Event|3
1696205|NCT01259492|5921698|P3|Period 1 (9 Weeks)|Adverse Event|26
1696206|NCT01259492|5921699|P2|Period 1 (9 Weeks)|Adverse Event|18
1696207|NCT01259492|5921700|P1|Period 1 (9 Weeks)|Adverse Event|13
1696208|NCT01259466|5921749|P2|Overall Study|Withdrawal by Subject|9
1696209|NCT01259466|5921750|P1|Overall Study|Withdrawal by Subject|1
1696210|NCT01259401|5921788|P2|4-month Follow-up|Lost to Follow-up|1
1696211|NCT01259401|5921789|P1|4-month Follow-up|Lost to Follow-up|0
1696212|NCT01259401|5921788|P2|4-month Follow-up|Death|1
1696213|NCT01259401|5921789|P1|4-month Follow-up|Death|0
1696214|NCT01259388|5921799|P2|Overall Study|Physician Decision|0
1696215|NCT01259388|5921800|P1|Overall Study|Physician Decision|1
1696216|NCT01259388|5921799|P2|Overall Study|Withdrawal by Subject|1
1696217|NCT01259388|5921800|P1|Overall Study|Withdrawal by Subject|1
1696218|NCT01259388|5921799|P2|Overall Study|Adverse Event|0
1696219|NCT01259388|5921800|P1|Overall Study|Adverse Event|3
1696220|NCT01259375|5921810|P1|Overall Study|Adverse Event|1
1696221|NCT01259297|5921827|P8|Double Blind Randomized Period|Other reasons|1
1696222|NCT01259297|5921828|P7|Double Blind Randomized Period|Other reasons|3
1696223|NCT01259297|5921829|P6|Double Blind Randomized Period|Other reasons|2
1696224|NCT01259297|5921830|P5|Double Blind Randomized Period|Other reasons|1
1696225|NCT01259297|5921831|P4|Double Blind Randomized Period|Other reasons|0
1696226|NCT01259297|5921832|P3|Double Blind Randomized Period|Other reasons|0
1696227|NCT01259297|5921833|P2|Double Blind Randomized Period|Other reasons|1
1696228|NCT01259297|5921834|P1|Double Blind Randomized Period|Other reasons|0
1696229|NCT01259297|5921827|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1696230|NCT01259297|5921828|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1696231|NCT01259297|5921829|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1696232|NCT01259297|5921830|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
1696233|NCT01259297|5921831|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
1696234|NCT01259297|5921832|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
1696235|NCT01259297|5921833|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1696236|NCT01259297|5921834|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
1696237|NCT01259297|5921827|P8|Double Blind Randomized Period|Death|1
1696238|NCT01259297|5921828|P7|Double Blind Randomized Period|Death|2
1696239|NCT01259297|5921829|P6|Double Blind Randomized Period|Death|5
1696240|NCT01259297|5921830|P5|Double Blind Randomized Period|Death|1
1696241|NCT01259297|5921831|P4|Double Blind Randomized Period|Death|2
1696242|NCT01259297|5921832|P3|Double Blind Randomized Period|Death|1
1696244|NCT01259297|5921834|P1|Double Blind Randomized Period|Death|1
1696245|NCT01259284|5921865|P3|Overall Study|Study Termination|0
1696246|NCT01259284|5921866|P2|Overall Study|Study Termination|0
1696247|NCT01259284|5921867|P1|Overall Study|Study Termination|2
1696248|NCT01259245|5921877|P2|Overall Study|Death|2
1696249|NCT01259245|5921878|P1|Overall Study|Death|1
1696250|NCT01259245|5921877|P2|Overall Study|Withdrawal by Subject|24
1696251|NCT01259245|5921878|P1|Overall Study|Withdrawal by Subject|27
1696252|NCT01259115|5921902|P2|Period 2|Adverse Event|0
1696253|NCT01259115|5921903|P1|Period 2|Adverse Event|1
1696254|NCT01259115|5921902|P2|Period 1|Lost to Follow-up|1
1696255|NCT01259115|5921903|P1|Period 1|Lost to Follow-up|0
1696256|NCT01259115|5921902|P2|Period 1|Protocol Violation|0
1696257|NCT01259115|5921903|P1|Period 1|Protocol Violation|2
1696258|NCT01259115|5921902|P2|Period 1|Adverse Event|0
1696259|NCT01259115|5921903|P1|Period 1|Adverse Event|1
1696260|NCT01259102|5921939|P5|Overall Study|Other|1
1696261|NCT01259102|5921940|P4|Overall Study|Other|1
1696262|NCT01259102|5921941|P3|Overall Study|Other|1
1696263|NCT01259102|5921942|P2|Overall Study|Other|0
1696264|NCT01259102|5921943|P1|Overall Study|Other|0
1696265|NCT01259102|5921939|P5|Overall Study|Adverse Event|0
1696266|NCT01259102|5921940|P4|Overall Study|Adverse Event|1
1696267|NCT01259102|5921941|P3|Overall Study|Adverse Event|1
1696268|NCT01259102|5921942|P2|Overall Study|Adverse Event|0
1696269|NCT01259102|5921943|P1|Overall Study|Adverse Event|1
1696270|NCT01259089|5922000|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
1696271|NCT01259089|5922001|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
1696272|NCT01259089|5922002|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
1696273|NCT01259089|5922003|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
1696274|NCT01259089|5922004|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
1696275|NCT01259089|5922005|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
1696276|NCT01259089|5922000|P6|Survival Follow up for Two Years|Lost to Follow-up|2
1696277|NCT01259089|5922001|P5|Survival Follow up for Two Years|Lost to Follow-up|0
1696278|NCT01259089|5922002|P4|Survival Follow up for Two Years|Lost to Follow-up|0
1696279|NCT01259089|5922003|P3|Survival Follow up for Two Years|Lost to Follow-up|0
1696280|NCT01259089|5922004|P2|Survival Follow up for Two Years|Lost to Follow-up|0
1696281|NCT01259089|5922005|P1|Survival Follow up for Two Years|Lost to Follow-up|0
1696282|NCT01259089|5922000|P6|Survival Follow up for Two Years|Death|13
1696283|NCT01259089|5922001|P5|Survival Follow up for Two Years|Death|6
1696284|NCT01259089|5922002|P4|Survival Follow up for Two Years|Death|3
1696285|NCT01259089|5922003|P3|Survival Follow up for Two Years|Death|2
1696286|NCT01259089|5922004|P2|Survival Follow up for Two Years|Death|2
1696287|NCT01259089|5922005|P1|Survival Follow up for Two Years|Death|3
1696288|NCT01259089|5922000|P6|Continued Treatment After 8 Weeks|Progressive disease|0
1696289|NCT01259089|5922001|P5|Continued Treatment After 8 Weeks|Progressive disease|0
1696290|NCT01259089|5922002|P4|Continued Treatment After 8 Weeks|Progressive disease|1
1696291|NCT01259089|5922003|P3|Continued Treatment After 8 Weeks|Progressive disease|1
1696292|NCT01259089|5922004|P2|Continued Treatment After 8 Weeks|Progressive disease|1
1696293|NCT01259089|5922005|P1|Continued Treatment After 8 Weeks|Progressive disease|1
1696294|NCT01259089|5922000|P6|Continued Treatment After 8 Weeks|Adverse Event|1
1696295|NCT01259089|5922001|P5|Continued Treatment After 8 Weeks|Adverse Event|2
1696296|NCT01259089|5922002|P4|Continued Treatment After 8 Weeks|Adverse Event|0
1696297|NCT01259089|5922003|P3|Continued Treatment After 8 Weeks|Adverse Event|0
1696298|NCT01259089|5922004|P2|Continued Treatment After 8 Weeks|Adverse Event|0
1696299|NCT01259089|5922005|P1|Continued Treatment After 8 Weeks|Adverse Event|0
1696300|NCT01259089|5922000|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1696301|NCT01259089|5922001|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1696302|NCT01259089|5922002|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1696303|NCT01259089|5922003|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1696304|NCT01259089|5922004|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
1696305|NCT01259089|5922005|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
1696306|NCT01259089|5922000|P6|Confirmed Response at 8 Weeks|Progressive disease|7
1696307|NCT01259089|5922001|P5|Confirmed Response at 8 Weeks|Progressive disease|3
1696308|NCT01259089|5922002|P4|Confirmed Response at 8 Weeks|Progressive disease|1
1696309|NCT01259089|5922003|P3|Confirmed Response at 8 Weeks|Progressive disease|1
1696310|NCT01259089|5922004|P2|Confirmed Response at 8 Weeks|Progressive disease|0
1696311|NCT01259089|5922005|P1|Confirmed Response at 8 Weeks|Progressive disease|0
1696312|NCT01259089|5922000|P6|Confirmed Response at 8 Weeks|Adverse Event|2
1696313|NCT01259089|5922001|P5|Confirmed Response at 8 Weeks|Adverse Event|1
1696314|NCT01259089|5922002|P4|Confirmed Response at 8 Weeks|Adverse Event|0
1696315|NCT01259089|5922003|P3|Confirmed Response at 8 Weeks|Adverse Event|0
1696316|NCT01259089|5922004|P2|Confirmed Response at 8 Weeks|Adverse Event|0
1696317|NCT01259089|5922005|P1|Confirmed Response at 8 Weeks|Adverse Event|0
1696318|NCT01259089|5922000|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
1696319|NCT01259089|5922001|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1696320|NCT01259089|5922002|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1696321|NCT01259089|5922003|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1696322|NCT01259089|5922004|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1696323|NCT01259089|5922005|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
1696324|NCT01259089|5922000|P6|Reached First Response at 4 Weeks|Adverse Event|1
1696325|NCT01259089|5922001|P5|Reached First Response at 4 Weeks|Adverse Event|0
1696326|NCT01259089|5922002|P4|Reached First Response at 4 Weeks|Adverse Event|0
1696327|NCT01259089|5922003|P3|Reached First Response at 4 Weeks|Adverse Event|0
1696328|NCT01259089|5922004|P2|Reached First Response at 4 Weeks|Adverse Event|0
1696329|NCT01259089|5922005|P1|Reached First Response at 4 Weeks|Adverse Event|0
1696330|NCT01259089|5922000|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
1696331|NCT01259089|5922001|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
1696332|NCT01259089|5922002|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
1696333|NCT01259089|5922003|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
1696334|NCT01259089|5922004|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
1696335|NCT01259089|5922005|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
1696336|NCT01259024|5922033|P1|Overall Study|Physician Decision|1
1696337|NCT01258998|5922053|P1|Overall Study|Ineligible|1
1696338|NCT01258803|5922107|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
1696339|NCT01258803|5922108|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
1696340|NCT01258803|5922109|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
1696341|NCT01258803|5922110|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
1696342|NCT01258803|5922111|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
1696343|NCT01258803|5922112|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
1696344|NCT01258803|5922107|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1696345|NCT01258803|5922108|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1696346|NCT01258803|5922109|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1696347|NCT01258803|5922110|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1696348|NCT01258803|5922111|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
1696349|NCT01258803|5922112|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
1696350|NCT01258803|5922107|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
1696351|NCT01258803|5922108|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
1696352|NCT01258803|5922109|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
1696353|NCT01258803|5922110|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
1696354|NCT01258803|5922111|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
1696355|NCT01258803|5922112|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
1696356|NCT01258738|5922149|P2|Open-label Period|Withdrawn due to pregnancy|1
1696357|NCT01258738|5922150|P1|Open-label Period|Withdrawn due to pregnancy|1
1696358|NCT01258738|5922149|P2|Open-label Period|Other Reasons|1
1696359|NCT01258738|5922150|P1|Open-label Period|Other Reasons|0
1696360|NCT01258738|5922149|P2|Open-label Period|Adverse Event|5
1696361|NCT01258738|5922150|P1|Open-label Period|Adverse Event|4
1696362|NCT01258738|5922149|P2|Open-label Period|Protocol Violation|2
1696363|NCT01258738|5922150|P1|Open-label Period|Protocol Violation|2
1696364|NCT01258738|5922149|P2|Open-label Period|Withdrawal by Subject|6
1696365|NCT01258738|5922150|P1|Open-label Period|Withdrawal by Subject|5
1696366|NCT01258738|5922149|P2|Open-label Period|Lost to Follow-up|2
1696367|NCT01258738|5922150|P1|Open-label Period|Lost to Follow-up|0
1696368|NCT01258738|5922149|P2|Open-label Period|Insufficient clinical response|3
1696369|NCT01258738|5922150|P1|Open-label Period|Insufficient clinical response|5
1696370|NCT01258738|5922149|P2|Open-label Period|Did not meet inclusion criteria|1
1696371|NCT01258738|5922150|P1|Open-label Period|Did not meet inclusion criteria|0
1696372|NCT01258738|5922149|P2|Double-blind Period|Adverse Event|1
1696373|NCT01258738|5922150|P1|Double-blind Period|Adverse Event|3
1696374|NCT01258738|5922149|P2|Double-blind Period|Protocol Violation|1
1696375|NCT01258738|5922150|P1|Double-blind Period|Protocol Violation|1
1696376|NCT01258738|5922149|P2|Double-blind Period|Withdrawal by Subject|2
1696377|NCT01258738|5922150|P1|Double-blind Period|Withdrawal by Subject|2
1696378|NCT01258738|5922149|P2|Double-blind Period|Did not meet inclusion criteria|3
1696379|NCT01258738|5922150|P1|Double-blind Period|Did not meet inclusion criteria|3
1696380|NCT01258660|5922288|P2|Overall Study|Invalid for primary analysis data set|6
1696381|NCT01258660|5922289|P1|Overall Study|Invalid for primary analysis data set|4
1696382|NCT01258660|5922288|P2|Overall Study|Protocol Violation|1
1696383|NCT01258660|5922289|P1|Overall Study|Protocol Violation|0
1696384|NCT01258660|5922288|P2|Overall Study|due to relocation|0
1696385|NCT01258660|5922289|P1|Overall Study|due to relocation|2
1696386|NCT01258660|5922288|P2|Overall Study|Withdrawal by Subject|0
1696387|NCT01258660|5922289|P1|Overall Study|Withdrawal by Subject|3
1696388|NCT01258660|5922288|P2|Overall Study|Adverse Event|4
1696389|NCT01258660|5922289|P1|Overall Study|Adverse Event|2
1696390|NCT01258608|5922308|P2|Overall Study|Withdrawal by Subject|5
1696391|NCT01258608|5922309|P1|Overall Study|Withdrawal by Subject|6
1696392|NCT01258608|5922308|P2|Overall Study|Adverse Event|10
1696393|NCT01258608|5922309|P1|Overall Study|Adverse Event|6
1696394|NCT01258608|5922308|P2|Overall Study|Lack of Efficacy|1
1696395|NCT01258608|5922309|P1|Overall Study|Lack of Efficacy|0
1696396|NCT01258608|5922308|P2|Overall Study|Lack of compliance|0
1696397|NCT01258608|5922309|P1|Overall Study|Lack of compliance|1
1696398|NCT01258608|5922308|P2|Overall Study|Lost to Follow-up|1
1696399|NCT01258608|5922309|P1|Overall Study|Lost to Follow-up|0
1696400|NCT01258608|5922308|P2|Overall Study|Physician Decision|1
1696401|NCT01258608|5922309|P1|Overall Study|Physician Decision|6
1696402|NCT01258608|5922308|P2|Overall Study|Sponsor decision|1
1696403|NCT01258608|5922309|P1|Overall Study|Sponsor decision|0
1696404|NCT01258608|5922308|P2|Overall Study|Clinical progression|0
1696405|NCT01258608|5922309|P1|Overall Study|Clinical progression|1
1696406|NCT01258608|5922308|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
1696407|NCT01258608|5922309|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
1696408|NCT01258595|5922357|P2|Overall Study|Withdrawal by Subject|1
1696409|NCT01258595|5922358|P1|Overall Study|Withdrawal by Subject|0
1696410|NCT01258595|5922357|P2|Overall Study|Lost to Follow-up|0
1696411|NCT01258595|5922358|P1|Overall Study|Lost to Follow-up|1
1696412|NCT01258348|5922455|P5|Overall Study|Withdrawal by Subject|0
1696413|NCT01258348|5922456|P4|Overall Study|Withdrawal by Subject|0
1696414|NCT01258348|5922457|P3|Overall Study|Withdrawal by Subject|0
1696415|NCT01258348|5922458|P2|Overall Study|Withdrawal by Subject|1
1696416|NCT01258348|5922459|P1|Overall Study|Withdrawal by Subject|0
1696417|NCT01258348|5922455|P5|Overall Study|Physician Decision|0
1696418|NCT01258348|5922456|P4|Overall Study|Physician Decision|2
1696419|NCT01258348|5922457|P3|Overall Study|Physician Decision|0
1696420|NCT01258348|5922458|P2|Overall Study|Physician Decision|0
1696421|NCT01258348|5922459|P1|Overall Study|Physician Decision|0
1696422|NCT01258348|5922455|P5|Overall Study|Progressive Disease|2
1696423|NCT01258348|5922456|P4|Overall Study|Progressive Disease|2
1696424|NCT01258348|5922457|P3|Overall Study|Progressive Disease|0
1696425|NCT01258348|5922458|P2|Overall Study|Progressive Disease|3
1696426|NCT01258348|5922459|P1|Overall Study|Progressive Disease|0
1696427|NCT01258348|5922455|P5|Overall Study|Adverse Event|4
1696428|NCT01258348|5922456|P4|Overall Study|Adverse Event|2
1696429|NCT01258348|5922457|P3|Overall Study|Adverse Event|3
1696430|NCT01258348|5922458|P2|Overall Study|Adverse Event|1
1696431|NCT01258348|5922459|P1|Overall Study|Adverse Event|1
1696432|NCT01258101|5922516|P4|Overall Study|Other reason|8
1696433|NCT01258101|5922517|P3|Overall Study|Other reason|1
1696434|NCT01258101|5922518|P2|Overall Study|Other reason|8
1696435|NCT01258101|5922519|P1|Overall Study|Other reason|7
1696436|NCT01258101|5922516|P4|Overall Study|PCR positive at week 24|1
1696437|NCT01258101|5922517|P3|Overall Study|PCR positive at week 24|0
1696438|NCT01258101|5922518|P2|Overall Study|PCR positive at week 24|0
1696439|NCT01258101|5922519|P1|Overall Study|PCR positive at week 24|0
1696440|NCT01258101|5922516|P4|Overall Study|Lost to Follow-up|6
1696441|NCT01258101|5922517|P3|Overall Study|Lost to Follow-up|0
1696442|NCT01258101|5922518|P2|Overall Study|Lost to Follow-up|5
1696443|NCT01258101|5922519|P1|Overall Study|Lost to Follow-up|5
1696444|NCT01258101|5922516|P4|Overall Study|Patient´s compliance|2
1696445|NCT01258101|5922517|P3|Overall Study|Patient´s compliance|1
1696446|NCT01258101|5922518|P2|Overall Study|Patient´s compliance|3
1696447|NCT01258101|5922519|P1|Overall Study|Patient´s compliance|4
1696448|NCT01258101|5922516|P4|Overall Study|Patient is not able to attend visits|6
1696449|NCT01258101|5922517|P3|Overall Study|Patient is not able to attend visits|7
1696450|NCT01258101|5922518|P2|Overall Study|Patient is not able to attend visits|9
1696451|NCT01258101|5922519|P1|Overall Study|Patient is not able to attend visits|8
1696452|NCT01258101|5922516|P4|Overall Study|Informed consent has been withdrawn|1
1696453|NCT01258101|5922517|P3|Overall Study|Informed consent has been withdrawn|1
1696454|NCT01258101|5922518|P2|Overall Study|Informed consent has been withdrawn|2
1696455|NCT01258101|5922519|P1|Overall Study|Informed consent has been withdrawn|2
1696456|NCT01258101|5922516|P4|Overall Study|Extra exclusion criterion amended|1
1696457|NCT01258101|5922517|P3|Overall Study|Extra exclusion criterion amended|1
1696458|NCT01258101|5922518|P2|Overall Study|Extra exclusion criterion amended|1
1696459|NCT01258101|5922519|P1|Overall Study|Extra exclusion criterion amended|2
1696460|NCT01258101|5922516|P4|Overall Study|Adverse Event|0
1696461|NCT01258101|5922517|P3|Overall Study|Adverse Event|0
1696462|NCT01258101|5922518|P2|Overall Study|Adverse Event|6
1696463|NCT01258101|5922519|P1|Overall Study|Adverse Event|5
1696464|NCT01257737|5922649|P2|Overall Study|Withdrew from study|1
1696465|NCT01257737|5922650|P1|Overall Study|Withdrew from study|0
1696466|NCT01257737|5922649|P2|Overall Study|Relocation out of the country|1
1696467|NCT01257737|5922650|P1|Overall Study|Relocation out of the country|0
1696468|NCT01257737|5922649|P2|Overall Study|Liver transplant|0
1696469|NCT01257737|5922650|P1|Overall Study|Liver transplant|1
1696470|NCT01257737|5922649|P2|Overall Study|Lost to Follow-up|2
1696471|NCT01257737|5922650|P1|Overall Study|Lost to Follow-up|1
1696472|NCT01257698|5922670|P2|Overall Study|Protocol Violation|0
1696473|NCT01257698|5922671|P1|Overall Study|Protocol Violation|4
1696474|NCT01257581|5922680|P3|Overall Study|Death|4
1696475|NCT01257581|5922681|P2|Overall Study|Death|2
1696476|NCT01257581|5922682|P1|Overall Study|Death|2
1696477|NCT01257581|5922680|P3|Overall Study|Early Termination|2
1696478|NCT01257581|5922681|P2|Overall Study|Early Termination|1
1696479|NCT01257581|5922682|P1|Overall Study|Early Termination|3
1696480|NCT01257568|5922720|P1|Overall Study|Component Revision|24
1696481|NCT01257568|5922720|P1|Overall Study|Terminated|1
1696482|NCT01257568|5922720|P1|Overall Study|Withdrawal by Subject|6
1696483|NCT01257568|5922720|P1|Overall Study|Lost to Follow-up|2
1696484|NCT01257542|5922734|P2|Overall Study|Withdrawal by Subject|2
1696485|NCT01257542|5922735|P1|Overall Study|Withdrawal by Subject|0
1696486|NCT01257542|5922734|P2|Overall Study|Protocol Violation|5
1696487|NCT01257542|5922735|P1|Overall Study|Protocol Violation|3
1696488|NCT01257503|5922755|P2|Overall Study|strep culture positive at enrollment|0
1696489|NCT01257503|5922756|P1|Overall Study|strep culture positive at enrollment|1
1696490|NCT01257503|5922755|P2|Overall Study|Over 5 years old at enrollment|1
1696491|NCT01257503|5922756|P1|Overall Study|Over 5 years old at enrollment|0
1696492|NCT01257503|5922755|P2|Overall Study|Lost to Follow-up|10
1696493|NCT01257503|5922756|P1|Overall Study|Lost to Follow-up|7
1696494|NCT01257425|5922785|P2|Overall Study|Death|0
1696495|NCT01257425|5922786|P1|Overall Study|Death|1
1696496|NCT01257425|5922785|P2|Overall Study|Withdrawal by Subject|1
1696497|NCT01257425|5922786|P1|Overall Study|Withdrawal by Subject|0
1696498|NCT01257425|5922785|P2|Overall Study|Protocol Violation|1
1696499|NCT01257425|5922786|P1|Overall Study|Protocol Violation|1
1696500|NCT01257425|5922785|P2|Overall Study|Adverse Event|1
1696501|NCT01257425|5922786|P1|Overall Study|Adverse Event|1
1696502|NCT01257425|5922785|P2|Overall Study|Lack of Efficacy|3
1696503|NCT01257425|5922786|P1|Overall Study|Lack of Efficacy|3
1696504|NCT01257230|5922828|P3|Overall Study|Other reason not defined above|3
1696505|NCT01257230|5922829|P2|Overall Study|Other reason not defined above|5
1696506|NCT01257230|5922830|P1|Overall Study|Other reason not defined above|1
1696507|NCT01257230|5922828|P3|Overall Study|Withdrawal by Subject|1
1696508|NCT01257230|5922829|P2|Overall Study|Withdrawal by Subject|4
1696509|NCT01257230|5922830|P1|Overall Study|Withdrawal by Subject|0
1696510|NCT01257230|5922828|P3|Overall Study|Protocol Violation|1
1696511|NCT01257230|5922829|P2|Overall Study|Protocol Violation|0
1696512|NCT01257230|5922830|P1|Overall Study|Protocol Violation|3
1696513|NCT01257230|5922828|P3|Overall Study|Lack of Efficacy|0
1696514|NCT01257230|5922829|P2|Overall Study|Lack of Efficacy|1
1696515|NCT01257230|5922830|P1|Overall Study|Lack of Efficacy|0
1696516|NCT01257230|5922828|P3|Overall Study|Adverse Event|0
1696517|NCT01257230|5922829|P2|Overall Study|Adverse Event|0
1696518|NCT01257230|5922830|P1|Overall Study|Adverse Event|2
1696519|NCT01257230|5922828|P3|Overall Study|Not Treated|1
1696520|NCT01257230|5922829|P2|Overall Study|Not Treated|0
1696521|NCT01257230|5922830|P1|Overall Study|Not Treated|0
1696522|NCT01257204|5922907|P3|Follow-up Period (up to Week 48)|Other|5
1696523|NCT01257204|5922908|P2|Follow-up Period (up to Week 48)|Other|0
1696524|NCT01257204|5922909|P1|Follow-up Period (up to Week 48)|Other|0
1696525|NCT01257204|5922907|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
1696526|NCT01257204|5922908|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
1696527|NCT01257204|5922909|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
1696528|NCT01257204|5922907|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
1696529|NCT01257204|5922908|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
1696530|NCT01257204|5922909|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
1696531|NCT01257204|5922907|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
1696532|NCT01257204|5922908|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
1696533|NCT01257204|5922909|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
1696534|NCT01257204|5922907|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
1696535|NCT01257204|5922908|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
1696536|NCT01257204|5922909|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
1696537|NCT01257204|5922907|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
1696538|NCT01257204|5922908|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
1696539|NCT01257204|5922909|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
1696540|NCT01257204|5922907|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1696541|NCT01257204|5922908|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
1696542|NCT01257204|5922909|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
1696543|NCT01257204|5922907|P3|Treatment Period (up to Week 24)|Adverse Event|2
1696544|NCT01257204|5922908|P2|Treatment Period (up to Week 24)|Adverse Event|1
1696545|NCT01257204|5922909|P1|Treatment Period (up to Week 24)|Adverse Event|3
1696546|NCT01257204|5922907|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
1696547|NCT01257204|5922908|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
1696548|NCT01257204|5922909|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
1696549|NCT01256879|5923004|P1|Overall Study|Withdrawal by Subject|1
1696550|NCT01256788|5923030|P3|Overall Study|Lost to Follow-up|3
1696551|NCT01256788|5923031|P2|Overall Study|Lost to Follow-up|8
1696552|NCT01256788|5923032|P1|Overall Study|Lost to Follow-up|5
1696553|NCT01256684|5923043|P3|Overall Study|Entry criteria not met/non-compliance|6
1696554|NCT01256684|5923044|P2|Overall Study|Entry criteria not met/non-compliance|7
1696555|NCT01256684|5923045|P1|Overall Study|Entry criteria not met/non-compliance|4
1696556|NCT01256684|5923043|P3|Overall Study|Lack of Efficacy|1
1696557|NCT01256684|5923044|P2|Overall Study|Lack of Efficacy|1
1696558|NCT01256684|5923045|P1|Overall Study|Lack of Efficacy|0
1696559|NCT01256684|5923043|P3|Overall Study|Physician Decision|0
1696560|NCT01256684|5923044|P2|Overall Study|Physician Decision|1
1696561|NCT01256684|5923045|P1|Overall Study|Physician Decision|0
1696562|NCT01256684|5923043|P3|Overall Study|Withdrawal by Subject|2
1696563|NCT01256684|5923044|P2|Overall Study|Withdrawal by Subject|0
1696564|NCT01256684|5923045|P1|Overall Study|Withdrawal by Subject|4
1696565|NCT01256684|5923043|P3|Overall Study|Adverse Event|2
1696566|NCT01256684|5923044|P2|Overall Study|Adverse Event|4
1696567|NCT01256684|5923045|P1|Overall Study|Adverse Event|1
1696568|NCT01256671|5923077|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
1696569|NCT01256671|5923077|P1|Overall Study|Lack of Efficacy|4
1696570|NCT01256671|5923077|P1|Overall Study|Physician Decision|3
1696571|NCT01256671|5923077|P1|Overall Study|Withdrawal by Subject|31
1696572|NCT01256671|5923077|P1|Overall Study|Lost to Follow-up|16
1696573|NCT01256671|5923077|P1|Overall Study|Adverse Event|29
1696574|NCT01256658|5923090|P2|Period 1|Death|44
1696575|NCT01256658|5923091|P1|Period 1|Death|48
1696576|NCT01256658|5923090|P2|Period 1|Withdrawal by Subject|43
1696577|NCT01256658|5923091|P1|Period 1|Withdrawal by Subject|35
1696578|NCT01256658|5923090|P2|Period 1|Lost to Follow-up|661
1696579|NCT01256658|5923091|P1|Period 1|Lost to Follow-up|837
1696580|NCT01256593|5923141|P1|Overall Study|No Visit After Treatment|186
1696581|NCT01256593|5923141|P1|Overall Study|No Drug Administration Information|2
1696582|NCT01256593|5923141|P1|Overall Study|Protocol Violation|26
1696583|NCT01256567|5923155|P1|Overall Study|Withdrawal by Subject|1
1696584|NCT01256502|5923165|P1|Overall Study|Protocol deviation|1
1696585|NCT01256502|5923165|P1|Overall Study|Personal reasons|5
1696586|NCT01256502|5923165|P1|Overall Study|Had scaffold removed|4
1696587|NCT01256476|5923177|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
1696588|NCT01256476|5923178|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
1696589|NCT01256476|5923177|P2|Overall Study|Subject non-compliance|1
1696590|NCT01256476|5923178|P1|Overall Study|Subject non-compliance|0
1696591|NCT01256476|5923177|P2|Overall Study|Physician Decision|1
1696592|NCT01256476|5923178|P1|Overall Study|Physician Decision|0
1696593|NCT01256476|5923177|P2|Overall Study|Persistent ALT or AST elevation|0
1696594|NCT01256476|5923178|P1|Overall Study|Persistent ALT or AST elevation|1
1696595|NCT01256476|5923177|P2|Overall Study|Lost to Follow-up|2
1696596|NCT01256476|5923178|P1|Overall Study|Lost to Follow-up|1
1696597|NCT01256476|5923177|P2|Overall Study|Withdrawal by Subject|1
1696598|NCT01256476|5923178|P1|Overall Study|Withdrawal by Subject|2
1696599|NCT01256476|5923177|P2|Overall Study|Adverse Event|1
1696600|NCT01256476|5923178|P1|Overall Study|Adverse Event|2
1696601|NCT01256450|5923186|P3|Double-blind Treatment|Other|12
1696602|NCT01256450|5923187|P2|Double-blind Treatment|Other|9
1696603|NCT01256450|5923188|P1|Double-blind Treatment|Other|0
1696604|NCT01256450|5923186|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
1696605|NCT01256450|5923187|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
1696606|NCT01256450|5923188|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
1696607|NCT01256450|5923186|P3|Double-blind Treatment|Non-compliance|4
1696608|NCT01256450|5923187|P2|Double-blind Treatment|Non-compliance|5
1696609|NCT01256450|5923188|P1|Double-blind Treatment|Non-compliance|0
1696610|NCT01256450|5923186|P3|Double-blind Treatment|Lack of analgesic effect|6
1696611|NCT01256450|5923187|P2|Double-blind Treatment|Lack of analgesic effect|5
1696612|NCT01256450|5923188|P1|Double-blind Treatment|Lack of analgesic effect|0
1696613|NCT01256450|5923186|P3|Double-blind Treatment|Withdrawal by Subject|1
1696614|NCT01256450|5923187|P2|Double-blind Treatment|Withdrawal by Subject|0
1696615|NCT01256450|5923188|P1|Double-blind Treatment|Withdrawal by Subject|0
1696616|NCT01256450|5923186|P3|Double-blind Treatment|Lost to Follow-up|7
1696617|NCT01256450|5923187|P2|Double-blind Treatment|Lost to Follow-up|1
1696618|NCT01256450|5923188|P1|Double-blind Treatment|Lost to Follow-up|0
1696619|NCT01256450|5923186|P3|Double-blind Treatment|Adverse Event|6
1696620|NCT01256450|5923187|P2|Double-blind Treatment|Adverse Event|8
1696621|NCT01256450|5923188|P1|Double-blind Treatment|Adverse Event|0
1696622|NCT01256450|5923186|P3|Open-label Titration|Other|0
1696623|NCT01256450|5923187|P2|Open-label Titration|Other|0
1696624|NCT01256450|5923188|P1|Open-label Titration|Other|13
1696625|NCT01256450|5923186|P3|Open-label Titration|Screen failure|0
1696626|NCT01256450|5923187|P2|Open-label Titration|Screen failure|0
1696627|NCT01256450|5923188|P1|Open-label Titration|Screen failure|1
1696628|NCT01256450|5923186|P3|Open-label Titration|Non-compliance|0
1696629|NCT01256450|5923187|P2|Open-label Titration|Non-compliance|0
1696630|NCT01256450|5923188|P1|Open-label Titration|Non-compliance|9
1696631|NCT01256450|5923186|P3|Open-label Titration|Lack of analgesic effect|0
1696632|NCT01256450|5923187|P2|Open-label Titration|Lack of analgesic effect|0
1696633|NCT01256450|5923188|P1|Open-label Titration|Lack of analgesic effect|30
1696634|NCT01256450|5923186|P3|Open-label Titration|Lost to Follow-up|0
1696635|NCT01256450|5923187|P2|Open-label Titration|Lost to Follow-up|0
1696636|NCT01256450|5923188|P1|Open-label Titration|Lost to Follow-up|7
1696637|NCT01256450|5923186|P3|Open-label Titration|Adverse Event|0
1696638|NCT01256450|5923187|P2|Open-label Titration|Adverse Event|0
1696639|NCT01256450|5923188|P1|Open-label Titration|Adverse Event|39
1696640|NCT01256411|5923246|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
1696641|NCT01256411|5923247|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
1696642|NCT01256411|5923248|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1696643|NCT01256411|5923249|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1696644|NCT01256411|5923250|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1696645|NCT01256411|5923251|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
1696646|NCT01256411|5923246|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
1696647|NCT01256411|5923247|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
1696648|NCT01256411|5923248|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1696649|NCT01256411|5923249|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1696650|NCT01256411|5923250|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1696651|NCT01256411|5923251|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
1696652|NCT01256411|5923246|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1696653|NCT01256411|5923247|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
1696654|NCT01256411|5923248|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1696655|NCT01256411|5923249|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1696656|NCT01256411|5923250|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1696657|NCT01256411|5923251|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
1696658|NCT01256411|5923246|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
1696659|NCT01256411|5923247|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
1696660|NCT01256411|5923248|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
1696661|NCT01256411|5923249|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
1696662|NCT01256411|5923250|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
1696663|NCT01256411|5923251|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
1696664|NCT01256411|5923246|P6|Extension by Mono or Combination Therapy|Adverse Event|1
1696665|NCT01256411|5923247|P5|Extension by Mono or Combination Therapy|Adverse Event|6
1696666|NCT01256411|5923248|P4|Extension by Mono or Combination Therapy|Adverse Event|0
1696667|NCT01256411|5923249|P3|Extension by Mono or Combination Therapy|Adverse Event|0
1696668|NCT01256411|5923250|P2|Extension by Mono or Combination Therapy|Adverse Event|0
1696669|NCT01256411|5923251|P1|Extension by Mono or Combination Therapy|Adverse Event|0
1696670|NCT01256411|5923246|P6|Extension by Maximum Treatment|Adverse Event|0
1696671|NCT01256411|5923247|P5|Extension by Maximum Treatment|Adverse Event|0
1696672|NCT01256411|5923248|P4|Extension by Maximum Treatment|Adverse Event|0
1696673|NCT01256411|5923249|P3|Extension by Maximum Treatment|Adverse Event|1
1696674|NCT01256411|5923250|P2|Extension by Maximum Treatment|Adverse Event|2
1696675|NCT01256411|5923251|P1|Extension by Maximum Treatment|Adverse Event|4
1696676|NCT01256411|5923246|P6|Extension by Maximum Treatment|Lack of Efficacy|0
1696677|NCT01256411|5923247|P5|Extension by Maximum Treatment|Lack of Efficacy|0
1696678|NCT01256411|5923248|P4|Extension by Maximum Treatment|Lack of Efficacy|0
1696679|NCT01256411|5923249|P3|Extension by Maximum Treatment|Lack of Efficacy|1
1696680|NCT01256411|5923250|P2|Extension by Maximum Treatment|Lack of Efficacy|0
1696681|NCT01256411|5923251|P1|Extension by Maximum Treatment|Lack of Efficacy|1
1696682|NCT01256411|5923246|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
1696683|NCT01256411|5923247|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
1696684|NCT01256411|5923248|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
1696685|NCT01256411|5923249|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
1696686|NCT01256411|5923250|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
1696687|NCT01256411|5923251|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
1696688|NCT01256411|5923246|P6|Extension by Maximum Treatment|Lost to Follow-up|0
1696689|NCT01256411|5923247|P5|Extension by Maximum Treatment|Lost to Follow-up|0
1696690|NCT01256411|5923248|P4|Extension by Maximum Treatment|Lost to Follow-up|0
1696691|NCT01256411|5923249|P3|Extension by Maximum Treatment|Lost to Follow-up|0
1696692|NCT01256411|5923250|P2|Extension by Maximum Treatment|Lost to Follow-up|2
1696693|NCT01256411|5923251|P1|Extension by Maximum Treatment|Lost to Follow-up|1
1696694|NCT01256411|5923246|P6|Extension by Maximum Treatment|Protocol deviation|0
1696695|NCT01256411|5923247|P5|Extension by Maximum Treatment|Protocol deviation|0
1696696|NCT01256411|5923248|P4|Extension by Maximum Treatment|Protocol deviation|0
1696697|NCT01256411|5923249|P3|Extension by Maximum Treatment|Protocol deviation|1
1696698|NCT01256411|5923250|P2|Extension by Maximum Treatment|Protocol deviation|0
1696699|NCT01256411|5923251|P1|Extension by Maximum Treatment|Protocol deviation|0
1696700|NCT01256398|5923275|P1|Overall Study|Withdrawal by Subject|1
1696701|NCT01256385|5923281|P2|Overall Study|Withdrawal by Subject|2
1696702|NCT01256385|5923282|P1|Overall Study|Withdrawal by Subject|2
1696703|NCT01256385|5923281|P2|Overall Study|Physician Decision|1
1696704|NCT01256385|5923282|P1|Overall Study|Physician Decision|1
1696705|NCT01256294|5923302|P2|Overall Study|Protocol deviation|1
1696706|NCT01256294|5923303|P1|Overall Study|Protocol deviation|2
1696707|NCT01256294|5923302|P2|Overall Study|Withdrawal by Subject|1
1696708|NCT01256294|5923303|P1|Overall Study|Withdrawal by Subject|1
1696709|NCT01256294|5923302|P2|Overall Study|Adverse Event|0
1696710|NCT01256294|5923303|P1|Overall Study|Adverse Event|1
1696711|NCT01256190|5923325|P2|Overall Study|Lost to Follow-up|0
1696712|NCT01256190|5923326|P1|Overall Study|Lost to Follow-up|2
1696713|NCT01256177|5923342|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
1696714|NCT01256177|5923343|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
1696715|NCT01256177|5923342|P2|Overall Study|Lack of Efficacy|2
1696716|NCT01256177|5923343|P1|Overall Study|Lack of Efficacy|11
1696717|NCT01256177|5923342|P2|Overall Study|Condition under Investigation Worsened|0
1696718|NCT01256177|5923343|P1|Overall Study|Condition under Investigation Worsened|1
1696719|NCT01256177|5923342|P2|Overall Study|Severe Non-Compliance to Protocol|2
1696720|NCT01256177|5923343|P1|Overall Study|Severe Non-Compliance to Protocol|4
1696721|NCT01256177|5923342|P2|Overall Study|Adverse Event|9
1696722|NCT01256177|5923343|P1|Overall Study|Adverse Event|8
1696723|NCT01256177|5923342|P2|Overall Study|Lost to Follow-up|2
1696724|NCT01256177|5923343|P1|Overall Study|Lost to Follow-up|2
1696725|NCT01256177|5923342|P2|Overall Study|Withdrawal by Subject|22
1696726|NCT01256177|5923343|P1|Overall Study|Withdrawal by Subject|23
1696727|NCT01256060|5923399|P4|Overall Study|Lost to Follow-up|0
1696728|NCT01256060|5923400|P3|Overall Study|Lost to Follow-up|0
1696729|NCT01256060|5923401|P2|Overall Study|Lost to Follow-up|1
1696730|NCT01256060|5923402|P1|Overall Study|Lost to Follow-up|0
1696731|NCT01256008|5923421|P3|Overall Study|Withdrawal by Subject|10
1696732|NCT01256008|5923422|P2|Overall Study|Withdrawal by Subject|3
1696733|NCT01256008|5923423|P1|Overall Study|Withdrawal by Subject|2
1696734|NCT01256008|5923421|P3|Overall Study|Lost to Follow-up|11
1696735|NCT01256008|5923422|P2|Overall Study|Lost to Follow-up|4
1696736|NCT01256008|5923423|P1|Overall Study|Lost to Follow-up|6
1696737|NCT01255904|5923445|P2|Overall Study|Physician Decision|4
1696738|NCT01255904|5923446|P1|Overall Study|Physician Decision|1
1696739|NCT01255787|5923456|P4|Overall Study|Noncompliance with Study Drug|0
1696740|NCT01255787|5923457|P3|Overall Study|Noncompliance with Study Drug|0
1696741|NCT01255787|5923458|P2|Overall Study|Noncompliance with Study Drug|1
1696742|NCT01255787|5923459|P1|Overall Study|Noncompliance with Study Drug|3
1696743|NCT01255787|5923456|P4|Overall Study|Lack of Efficacy|2
1696744|NCT01255787|5923457|P3|Overall Study|Lack of Efficacy|2
1696745|NCT01255787|5923458|P2|Overall Study|Lack of Efficacy|2
1696746|NCT01255787|5923459|P1|Overall Study|Lack of Efficacy|2
1696747|NCT01255787|5923456|P4|Overall Study|Pregnancy|1
1696748|NCT01255787|5923457|P3|Overall Study|Pregnancy|0
1696749|NCT01255787|5923458|P2|Overall Study|Pregnancy|0
1696750|NCT01255787|5923459|P1|Overall Study|Pregnancy|0
1696751|NCT01255787|5923456|P4|Overall Study|Withdrawal of Consent|4
1696752|NCT01255787|5923457|P3|Overall Study|Withdrawal of Consent|3
1696753|NCT01255787|5923458|P2|Overall Study|Withdrawal of Consent|9
1696754|NCT01255787|5923459|P1|Overall Study|Withdrawal of Consent|3
1696755|NCT01255787|5923456|P4|Overall Study|Lost to Follow-up|2
1696756|NCT01255787|5923457|P3|Overall Study|Lost to Follow-up|4
1696757|NCT01255787|5923458|P2|Overall Study|Lost to Follow-up|2
1696758|NCT01255787|5923459|P1|Overall Study|Lost to Follow-up|1
1696759|NCT01255787|5923456|P4|Overall Study|Major Protocol Deviation|4
1696760|NCT01255787|5923457|P3|Overall Study|Major Protocol Deviation|0
1696761|NCT01255787|5923458|P2|Overall Study|Major Protocol Deviation|1
1696762|NCT01255787|5923459|P1|Overall Study|Major Protocol Deviation|1
1696763|NCT01255787|5923456|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
1696764|NCT01255787|5923457|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
1696765|NCT01255787|5923458|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
1696766|NCT01255787|5923459|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
1696767|NCT01255761|5923487|P2|Overall Study|Other Reasons|18
1696768|NCT01255761|5923488|P1|Overall Study|Other Reasons|37
1696769|NCT01255761|5923487|P2|Overall Study|Withdrawal by Subject|27
1696770|NCT01255761|5923488|P1|Overall Study|Withdrawal by Subject|11
1696771|NCT01255761|5923487|P2|Overall Study|Lost to Follow-up|8
1696772|NCT01255761|5923488|P1|Overall Study|Lost to Follow-up|10
1696773|NCT01255761|5923487|P2|Overall Study|Protocol Violation|5
1696774|NCT01255761|5923488|P1|Overall Study|Protocol Violation|9
1696775|NCT01255761|5923487|P2|Overall Study|Lack of Efficacy|74
1696776|NCT01255761|5923488|P1|Overall Study|Lack of Efficacy|86
1696777|NCT01255761|5923487|P2|Overall Study|Adverse Event|43
1696778|NCT01255761|5923488|P1|Overall Study|Adverse Event|29
1696779|NCT01255722|5923573|P3|Overall Study|beta-blocker contraindicated|0
1696780|NCT01255722|5923574|P2|Overall Study|beta-blocker contraindicated|0
1696781|NCT01255722|5923575|P1|Overall Study|beta-blocker contraindicated|2
1696782|NCT01255722|5923573|P3|Overall Study|asymptomatic patient|0
1696783|NCT01255722|5923574|P2|Overall Study|asymptomatic patient|0
1696784|NCT01255722|5923575|P1|Overall Study|asymptomatic patient|1
1696785|NCT01255722|5923573|P3|Overall Study|Adverse Event|1
1696786|NCT01255722|5923574|P2|Overall Study|Adverse Event|1
1696787|NCT01255722|5923575|P1|Overall Study|Adverse Event|0
1696788|NCT01255631|5923600|P2|Overall Study|poor enrollment, no data analyzed|6
1696789|NCT01255631|5923601|P1|Overall Study|poor enrollment, no data analyzed|9
1696790|NCT01255592|5923619|P2|Overall Study|Other|1
1696791|NCT01255592|5923620|P1|Overall Study|Other|0
1696792|NCT01255592|5923619|P2|Overall Study|Withdrawal by Subject|0
1696793|NCT01255592|5923620|P1|Overall Study|Withdrawal by Subject|1
1696794|NCT01255592|5923619|P2|Overall Study|Adverse Event|0
1696795|NCT01255592|5923620|P1|Overall Study|Adverse Event|5
1696796|NCT01255436|5923683|P2|Overall Study|Death, stroke, or MI|3
1696797|NCT01255436|5923684|P1|Overall Study|Death, stroke, or MI|4
1696798|NCT01255436|5923683|P2|Overall Study|Lost to Follow-up|191
1696799|NCT01255436|5923684|P1|Overall Study|Lost to Follow-up|178
1696800|NCT01255423|5923698|P2|Overall Study|Use of prohibited medications|1
1696801|NCT01255423|5923699|P1|Overall Study|Use of prohibited medications|0
1696802|NCT01255423|5923698|P2|Overall Study|Abnormal Laboratory value|2
1696803|NCT01255423|5923699|P1|Overall Study|Abnormal Laboratory value|3
1696804|NCT01255306|5923715|P2|Overall Study|Physician Decision|1
1696805|NCT01255306|5923716|P1|Overall Study|Physician Decision|1
1696806|NCT01255163|5923727|P2|Overall Study|AstraZeneca stopped support of the study|3
1696807|NCT01255163|5923728|P1|Overall Study|AstraZeneca stopped support of the study|1
1696808|NCT01255163|5923727|P2|Overall Study|Adverse Event|2
1696809|NCT01255163|5923728|P1|Overall Study|Adverse Event|0
1696810|NCT01255163|5923727|P2|Overall Study|Lost to Follow-up|0
1696811|NCT01255163|5923728|P1|Overall Study|Lost to Follow-up|2
1696812|NCT01255163|5923727|P2|Overall Study|Withdrawal by Subject|0
1696813|NCT01255163|5923728|P1|Overall Study|Withdrawal by Subject|1
1696814|NCT01254890|5923757|P2|Overall Study|Disease Progression|5
1696815|NCT01254890|5923758|P1|Overall Study|Disease Progression|0
1696816|NCT01254890|5923757|P2|Overall Study|Withdrawal by Subject|2
1696817|NCT01254890|5923758|P1|Overall Study|Withdrawal by Subject|1
1696818|NCT01254890|5923757|P2|Overall Study|Ineligible|3
1696819|NCT01254890|5923758|P1|Overall Study|Ineligible|0
1696820|NCT01254747|5923820|P4|Overall Study|Discomfort|0
1696821|NCT01254747|5923821|P3|Overall Study|Discomfort|0
1696822|NCT01254747|5923822|P2|Overall Study|Discomfort|4
1696823|NCT01254747|5923823|P1|Overall Study|Discomfort|0
1696824|NCT01254747|5923820|P4|Overall Study|Biomicroscopy|0
1696825|NCT01254747|5923821|P3|Overall Study|Biomicroscopy|1
1696826|NCT01254747|5923822|P2|Overall Study|Biomicroscopy|0
1696827|NCT01254747|5923823|P1|Overall Study|Biomicroscopy|0
1696828|NCT01254747|5923820|P4|Overall Study|Lost to Follow-up|0
1696829|NCT01254747|5923821|P3|Overall Study|Lost to Follow-up|1
1696830|NCT01254747|5923822|P2|Overall Study|Lost to Follow-up|0
1696831|NCT01254747|5923823|P1|Overall Study|Lost to Follow-up|0
1696832|NCT01254747|5923820|P4|Overall Study|Symptoms and problems|0
1696833|NCT01254747|5923821|P3|Overall Study|Symptoms and problems|1
1696834|NCT01254747|5923822|P2|Overall Study|Symptoms and problems|2
1696835|NCT01254747|5923823|P1|Overall Study|Symptoms and problems|0
1696836|NCT01254747|5923820|P4|Overall Study|Difficult removal handling|0
1696837|NCT01254747|5923821|P3|Overall Study|Difficult removal handling|1
1696838|NCT01254747|5923822|P2|Overall Study|Difficult removal handling|0
1696839|NCT01254747|5923823|P1|Overall Study|Difficult removal handling|0
1696840|NCT01254747|5923820|P4|Overall Study|Unacceptable subjective vision|2
1696841|NCT01254747|5923821|P3|Overall Study|Unacceptable subjective vision|0
1696842|NCT01254747|5923822|P2|Overall Study|Unacceptable subjective vision|0
1696843|NCT01254747|5923823|P1|Overall Study|Unacceptable subjective vision|0
1696844|NCT01254721|5923863|P2|Overall Study|Wrongly randomization|1
1696845|NCT01254721|5923864|P1|Overall Study|Wrongly randomization|0
1696846|NCT01254721|5923863|P2|Overall Study|Withdrawal by Subject|11
1696847|NCT01254721|5923864|P1|Overall Study|Withdrawal by Subject|8
1696848|NCT01254721|5923863|P2|Overall Study|Adverse Event|3
1696849|NCT01254721|5923864|P1|Overall Study|Adverse Event|2
1696850|NCT01254721|5923863|P2|Overall Study|technical problum|0
1696851|NCT01254721|5923864|P1|Overall Study|technical problum|1
1696852|NCT01254721|5923863|P2|Overall Study|Death|1
1696853|NCT01254721|5923864|P1|Overall Study|Death|0
1696854|NCT01254721|5923863|P2|Overall Study|Lack of Efficacy|2
1696855|NCT01254721|5923864|P1|Overall Study|Lack of Efficacy|4
1696856|NCT01254721|5923863|P2|Overall Study|Lost to Follow-up|4
1696857|NCT01254721|5923864|P1|Overall Study|Lost to Follow-up|0
1696858|NCT01254669|5923874|P2|Overall Study|called to clinic during intervention|1
1696859|NCT01254669|5923875|P1|Overall Study|called to clinic during intervention|1
1696860|NCT01254669|5923874|P2|Overall Study|time constraint|2
1696861|NCT01254669|5923875|P1|Overall Study|time constraint|2
1696862|NCT01254669|5923874|P2|Overall Study|Withdrawal by Subject|1
1696863|NCT01254669|5923875|P1|Overall Study|Withdrawal by Subject|0
1696864|NCT01254656|5923886|P3|Overall Study|Death|0
1696865|NCT01254656|5923887|P2|Overall Study|Death|1
1696866|NCT01254656|5923888|P1|Overall Study|Death|0
1696867|NCT01254656|5923886|P3|Overall Study|Adverse Event|0
1696868|NCT01254656|5923887|P2|Overall Study|Adverse Event|1
1696869|NCT01254656|5923888|P1|Overall Study|Adverse Event|1
1696870|NCT01254656|5923886|P3|Overall Study|Pregnancy|2
1696871|NCT01254656|5923887|P2|Overall Study|Pregnancy|0
1696872|NCT01254656|5923888|P1|Overall Study|Pregnancy|0
1696873|NCT01254656|5923886|P3|Overall Study|Withdrawal by Subject|1
1696874|NCT01254656|5923887|P2|Overall Study|Withdrawal by Subject|2
1696875|NCT01254656|5923888|P1|Overall Study|Withdrawal by Subject|2
1696876|NCT01254656|5923886|P3|Overall Study|Lost to Follow-up|2
1696877|NCT01254656|5923887|P2|Overall Study|Lost to Follow-up|0
1696878|NCT01254656|5923888|P1|Overall Study|Lost to Follow-up|1
1696879|NCT01254656|5923886|P3|Overall Study|Lack of Efficacy|0
1696880|NCT01254656|5923887|P2|Overall Study|Lack of Efficacy|0
1696881|NCT01254656|5923888|P1|Overall Study|Lack of Efficacy|3
1696882|NCT01254656|5923886|P3|Overall Study|Discontinued due to termination of study|13
1696883|NCT01254656|5923887|P2|Overall Study|Discontinued due to termination of study|39
1696884|NCT01254656|5923888|P1|Overall Study|Discontinued due to termination of study|40
1696885|NCT01254643|5923914|P1|Overall Study|Withdrawal by Subject|1
1696886|NCT01254630|5923926|P4|Overall Study|Status not recorded|0
1696887|NCT01254630|5923927|P3|Overall Study|Status not recorded|1
1696888|NCT01254630|5923928|P2|Overall Study|Status not recorded|0
1696889|NCT01254630|5923929|P1|Overall Study|Status not recorded|0
1696890|NCT01254630|5923926|P4|Overall Study|Study terminated by sponsor|1010
1696891|NCT01254630|5923927|P3|Overall Study|Study terminated by sponsor|0
1696892|NCT01254630|5923928|P2|Overall Study|Study terminated by sponsor|994
1696893|NCT01254630|5923929|P1|Overall Study|Study terminated by sponsor|0
1696894|NCT01254630|5923926|P4|Overall Study|Withdrawal by Subject|89
1696895|NCT01254630|5923927|P3|Overall Study|Withdrawal by Subject|188
1696896|NCT01254630|5923928|P2|Overall Study|Withdrawal by Subject|94
1696897|NCT01254630|5923929|P1|Overall Study|Withdrawal by Subject|201
1696898|NCT01254630|5923926|P4|Overall Study|Physician Decision|7
1696899|NCT01254630|5923927|P3|Overall Study|Physician Decision|16
1696900|NCT01254630|5923928|P2|Overall Study|Physician Decision|8
1696901|NCT01254630|5923929|P1|Overall Study|Physician Decision|24
1696902|NCT01254630|5923926|P4|Overall Study|Lost to Follow-up|32
1696903|NCT01254630|5923927|P3|Overall Study|Lost to Follow-up|89
1696904|NCT01254630|5923928|P2|Overall Study|Lost to Follow-up|26
1696905|NCT01254630|5923929|P1|Overall Study|Lost to Follow-up|80
1696906|NCT01254630|5923926|P4|Overall Study|Death|139
1696907|NCT01254630|5923927|P3|Overall Study|Death|478
1696908|NCT01254630|5923928|P2|Overall Study|Death|151
1696909|NCT01254630|5923929|P1|Overall Study|Death|461
1696910|NCT01254630|5923926|P4|Overall Study|Adverse Event|8
1696911|NCT01254630|5923927|P3|Overall Study|Adverse Event|40
1696912|NCT01254630|5923928|P2|Overall Study|Adverse Event|15
1696913|NCT01254630|5923929|P1|Overall Study|Adverse Event|36
1696914|NCT01254604|5923949|P2|Overall Study|Adverse Event|2
1696915|NCT01254604|5923950|P1|Overall Study|Adverse Event|3
1696916|NCT01254604|5923949|P2|Overall Study|Withdrawal by Subject|4
1696917|NCT01254604|5923950|P1|Overall Study|Withdrawal by Subject|2
1696918|NCT01254604|5923949|P2|Overall Study|Protocol Violation|2
1696919|NCT01254604|5923950|P1|Overall Study|Protocol Violation|2
1696920|NCT01254604|5923949|P2|Overall Study|Lost to Follow-up|1
1696921|NCT01254604|5923950|P1|Overall Study|Lost to Follow-up|1
1696922|NCT01254565|5923968|P6|Overall Study|Other|0
1696923|NCT01254565|5923969|P5|Overall Study|Other|0
1696924|NCT01254565|5923970|P4|Overall Study|Other|1
1696925|NCT01254565|5923971|P3|Overall Study|Other|0
1696926|NCT01254565|5923972|P2|Overall Study|Other|0
1696927|NCT01254565|5923973|P1|Overall Study|Other|0
1696928|NCT01254565|5923968|P6|Overall Study|Did not Receive Treatment|4
1696929|NCT01254565|5923969|P5|Overall Study|Did not Receive Treatment|3
1696930|NCT01254565|5923970|P4|Overall Study|Did not Receive Treatment|0
1696931|NCT01254565|5923971|P3|Overall Study|Did not Receive Treatment|0
1696932|NCT01254565|5923972|P2|Overall Study|Did not Receive Treatment|1
1696933|NCT01254565|5923973|P1|Overall Study|Did not Receive Treatment|1
1696934|NCT01254565|5923968|P6|Overall Study|Non-compliance to Study Procedures|0
1696935|NCT01254565|5923969|P5|Overall Study|Non-compliance to Study Procedures|1
1696936|NCT01254565|5923970|P4|Overall Study|Non-compliance to Study Procedures|0
1696937|NCT01254565|5923971|P3|Overall Study|Non-compliance to Study Procedures|0
1696938|NCT01254565|5923972|P2|Overall Study|Non-compliance to Study Procedures|0
1696939|NCT01254565|5923973|P1|Overall Study|Non-compliance to Study Procedures|0
1696940|NCT01254422|5924033|P2|Overall Study|Lost to Follow-up|0
1696941|NCT01254422|5924034|P1|Overall Study|Lost to Follow-up|1
1696942|NCT01254422|5924033|P2|Overall Study|Serious adverse event|1
1696943|NCT01254422|5924034|P1|Overall Study|Serious adverse event|0
1696944|NCT01254422|5924033|P2|Overall Study|Adverse Event|0
1696945|NCT01254422|5924034|P1|Overall Study|Adverse Event|1
1696946|NCT01254422|5924033|P2|Overall Study|Protocol Violation|0
1696947|NCT01254422|5924034|P1|Overall Study|Protocol Violation|1
1696948|NCT01254409|5924062|P4|Overall Study|Adverse Event|0
1696949|NCT01254409|5924063|P3|Overall Study|Adverse Event|0
1696950|NCT01254409|5924064|P2|Overall Study|Adverse Event|1
1696951|NCT01254409|5924065|P1|Overall Study|Adverse Event|0
1696952|NCT01254344|5924134|P2|Overall Study|Withdrawal by Subject|6
1696953|NCT01254344|5924135|P1|Overall Study|Withdrawal by Subject|3
1696954|NCT01254344|5924134|P2|Overall Study|Protocol Violation|4
1696955|NCT01254344|5924135|P1|Overall Study|Protocol Violation|1
1696956|NCT01254344|5924134|P2|Overall Study|Physician Decision|4
1696957|NCT01254344|5924135|P1|Overall Study|Physician Decision|7
1696958|NCT01254344|5924134|P2|Overall Study|Adverse Event|5
1696959|NCT01254344|5924135|P1|Overall Study|Adverse Event|2
1696960|NCT01254331|5924143|P1|Extension Phase|Lost to Follow-up|3
1696961|NCT01254331|5924143|P1|Extension Phase|Lack of Efficacy|1
1696962|NCT01254331|5924143|P1|Initial Phase|Pregnancy|1
1696963|NCT01254331|5924143|P1|Initial Phase|Withdrawal by Subject|1
1696964|NCT01254331|5924143|P1|Initial Phase|Adverse Event|3
1696965|NCT01254318|5924161|P1|Overall Study|Death|47
1696966|NCT01254318|5924161|P1|Overall Study|Lost to Follow-up|5
1696967|NCT01254305|5924170|P3|Overall Study|Other Reasons|2
1696968|NCT01254305|5924171|P2|Overall Study|Other Reasons|0
1696969|NCT01254305|5924172|P1|Overall Study|Other Reasons|0
1696970|NCT01254305|5924170|P3|Overall Study|Lost to Follow-up|5
1696971|NCT01254305|5924171|P2|Overall Study|Lost to Follow-up|6
1696972|NCT01254305|5924172|P1|Overall Study|Lost to Follow-up|10
1696973|NCT01254305|5924170|P3|Overall Study|Withdrawal by Subject|4
1696974|NCT01254305|5924171|P2|Overall Study|Withdrawal by Subject|2
1696975|NCT01254305|5924172|P1|Overall Study|Withdrawal by Subject|4
1696976|NCT01254305|5924170|P3|Overall Study|Protocol Violation|3
1696977|NCT01254305|5924171|P2|Overall Study|Protocol Violation|7
1696978|NCT01254305|5924172|P1|Overall Study|Protocol Violation|1
1696979|NCT01254305|5924170|P3|Overall Study|Lack of Efficacy|1
1696980|NCT01254305|5924171|P2|Overall Study|Lack of Efficacy|0
1696981|NCT01254305|5924172|P1|Overall Study|Lack of Efficacy|1
1696982|NCT01254305|5924170|P3|Overall Study|Adverse Event|2
1696983|NCT01254305|5924171|P2|Overall Study|Adverse Event|3
1696984|NCT01254305|5924172|P1|Overall Study|Adverse Event|6
1696985|NCT01254292|5924188|P2|LCS12 Extension Phase|Lost to Follow-up|0
1696986|NCT01254292|5924189|P1|LCS12 Extension Phase|Lost to Follow-up|1
1696987|NCT01254292|5924188|P2|LCS12 Extension Phase|Pregnancy|0
1696988|NCT01254292|5924189|P1|LCS12 Extension Phase|Pregnancy|2
1696989|NCT01254292|5924188|P2|LCS12 Extension Phase|Other unknown|0
1696990|NCT01254292|5924189|P1|LCS12 Extension Phase|Other unknown|4
1696991|NCT01254292|5924188|P2|LCS12 Extension Phase|Withdrawal by Subject|0
1696992|NCT01254292|5924189|P1|LCS12 Extension Phase|Withdrawal by Subject|7
1696993|NCT01254292|5924188|P2|LCS12 Extension Phase|Adverse Event|0
1696994|NCT01254292|5924189|P1|LCS12 Extension Phase|Adverse Event|9
1696995|NCT01254292|5924188|P2|LCS12 Extension Phase|Wish for pregnancy|0
1696996|NCT01254292|5924189|P1|LCS12 Extension Phase|Wish for pregnancy|14
1696997|NCT01254292|5924188|P2|Comparative Phase|Wish for pregnancy|6
1696998|NCT01254292|5924189|P1|Comparative Phase|Wish for pregnancy|4
1696999|NCT01254292|5924188|P2|Comparative Phase|Protocol Violation|2
1697000|NCT01254292|5924189|P1|Comparative Phase|Protocol Violation|1
1697001|NCT01254292|5924188|P2|Comparative Phase|Withdrawal by Subject|21
1697002|NCT01254292|5924189|P1|Comparative Phase|Withdrawal by Subject|20
1697003|NCT01254292|5924188|P2|Comparative Phase|Pregnancy|6
1697004|NCT01254292|5924189|P1|Comparative Phase|Pregnancy|2
1697005|NCT01254292|5924188|P2|Comparative Phase|Lost to Follow-up|21
1697006|NCT01254292|5924189|P1|Comparative Phase|Lost to Follow-up|3
1697007|NCT01254292|5924188|P2|Comparative Phase|Adverse Event|25
1697008|NCT01254292|5924189|P1|Comparative Phase|Adverse Event|25
1697009|NCT01254188|5924266|P1|Overall Study|per investigator discretion|20
1697010|NCT01254188|5924266|P1|Overall Study|Adverse Event|43
1697011|NCT01254188|5924266|P1|Overall Study|Withdrawal by Subject|7
1697012|NCT01254188|5924266|P1|Overall Study|Lost to Follow-up|5
1697013|NCT01254188|5924266|P1|Overall Study|Death|4
1697014|NCT01254188|5924266|P1|Overall Study|Pregnancy|2
1697015|NCT01254188|5924266|P1|Overall Study|Protocol Violation|6
1697016|NCT01254188|5924266|P1|Overall Study|Disease Progression|6
1697017|NCT01254045|5924277|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1697018|NCT01254045|5924278|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1697019|NCT01254045|5924279|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1697020|NCT01254045|5924280|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1697021|NCT01254045|5924281|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
1697022|NCT01254045|5924282|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
1697023|NCT01254019|5924295|P2|Overall Study|Withdrawal by Subject|2
1697024|NCT01254019|5924296|P1|Overall Study|Withdrawal by Subject|0
1697025|NCT01254019|5924295|P2|Overall Study|Protocol Violation|0
1697026|NCT01254019|5924296|P1|Overall Study|Protocol Violation|1
1697027|NCT01254019|5924295|P2|Overall Study|Adverse Event|2
1697028|NCT01254019|5924296|P1|Overall Study|Adverse Event|0
1697029|NCT01253811|5924390|P1|Overall Study|Withdrawal criteria|1
1697030|NCT01253577|5924421|P1|Overall Study|Lost to Follow-up|3
1697031|NCT01253564|5924429|P1|Overall Study|Serious Adverse Event|1
1697032|NCT01253564|5924429|P1|Overall Study|Withdrawal by Subject|1
1697033|NCT01253564|5924429|P1|Overall Study|Disease Progression|22
1697034|NCT01253447|5924478|P1|Overall Study|Adverse Event|2
1697035|NCT01253421|5924488|P5|Drug+Scanning Visit|Physician Decision|1
1697036|NCT01253421|5924489|P4|Drug+Scanning Visit|Physician Decision|0
1697037|NCT01253421|5924490|P3|Drug+Scanning Visit|Physician Decision|0
1697038|NCT01253421|5924491|P2|Drug+Scanning Visit|Physician Decision|0
1697039|NCT01253421|5924492|P1|Drug+Scanning Visit|Physician Decision|0
1697040|NCT01253421|5924488|P5|Assessment and Scheduling|Physician Decision|0
1697041|NCT01253421|5924489|P4|Assessment and Scheduling|Physician Decision|0
1697042|NCT01253421|5924490|P3|Assessment and Scheduling|Physician Decision|0
1697043|NCT01253421|5924491|P2|Assessment and Scheduling|Physician Decision|0
1697044|NCT01253421|5924492|P1|Assessment and Scheduling|Physician Decision|1
1697045|NCT01253421|5924488|P5|Assessment and Scheduling|Withdrawal by Subject|0
1697046|NCT01253421|5924489|P4|Assessment and Scheduling|Withdrawal by Subject|0
1697047|NCT01253421|5924490|P3|Assessment and Scheduling|Withdrawal by Subject|0
1697048|NCT01253421|5924491|P2|Assessment and Scheduling|Withdrawal by Subject|0
1697049|NCT01253421|5924492|P1|Assessment and Scheduling|Withdrawal by Subject|7
1697050|NCT01253421|5924488|P5|Assessment and Scheduling|Lost to Follow-up|0
1697051|NCT01253421|5924489|P4|Assessment and Scheduling|Lost to Follow-up|0
1697052|NCT01253421|5924490|P3|Assessment and Scheduling|Lost to Follow-up|0
1697053|NCT01253421|5924491|P2|Assessment and Scheduling|Lost to Follow-up|0
1697054|NCT01253421|5924492|P1|Assessment and Scheduling|Lost to Follow-up|17
1697055|NCT01253421|5924488|P5|Assessment and Scheduling|Found to be Ineligible|0
1697056|NCT01253421|5924489|P4|Assessment and Scheduling|Found to be Ineligible|0
1697057|NCT01253421|5924490|P3|Assessment and Scheduling|Found to be Ineligible|0
1697058|NCT01253421|5924491|P2|Assessment and Scheduling|Found to be Ineligible|0
1697059|NCT01253421|5924492|P1|Assessment and Scheduling|Found to be Ineligible|74
1697060|NCT01253408|5924541|P3|Overall Study|Adverse Event|0
1697061|NCT01253408|5924542|P2|Overall Study|Adverse Event|1
1697062|NCT01253408|5924543|P1|Overall Study|Adverse Event|0
1697063|NCT01253369|5924566|P1|Overall Study|Not Evaluable|3
1697064|NCT01253369|5924566|P1|Overall Study|Progressive disease|23
1697065|NCT01253369|5924566|P1|Overall Study|Death|1
1697066|NCT01253369|5924566|P1|Overall Study|Withdrawal by Subject|2
1697067|NCT01253369|5924566|P1|Overall Study|Adverse Event|4
1697068|NCT01253317|5924596|P1|Overall Study|Adverse Event|2
1697069|NCT01253304|5924608|P4|Overall Study|Adverse Event|1
1697070|NCT01253304|5924609|P3|Overall Study|Adverse Event|0
1697071|NCT01253304|5924610|P2|Overall Study|Adverse Event|0
1697072|NCT01253304|5924611|P1|Overall Study|Adverse Event|0
1697073|NCT01253291|5924650|P5|Overall Study|Physician Decision|2
1697074|NCT01253291|5924651|P4|Overall Study|Physician Decision|0
1697075|NCT01253291|5924652|P3|Overall Study|Physician Decision|0
1697076|NCT01253291|5924653|P2|Overall Study|Physician Decision|0
1697077|NCT01253291|5924654|P1|Overall Study|Physician Decision|2
1697078|NCT01253291|5924650|P5|Overall Study|Lack of Efficacy|0
1697079|NCT01253291|5924651|P4|Overall Study|Lack of Efficacy|0
1697080|NCT01253291|5924652|P3|Overall Study|Lack of Efficacy|0
1697081|NCT01253291|5924653|P2|Overall Study|Lack of Efficacy|0
1697082|NCT01253291|5924654|P1|Overall Study|Lack of Efficacy|1
1697083|NCT01253291|5924650|P5|Overall Study|Adverse Event|0
1697084|NCT01253291|5924651|P4|Overall Study|Adverse Event|0
1697085|NCT01253291|5924652|P3|Overall Study|Adverse Event|0
1697086|NCT01253291|5924653|P2|Overall Study|Adverse Event|1
1697087|NCT01253291|5924654|P1|Overall Study|Adverse Event|0
1697088|NCT01253291|5924650|P5|Overall Study|Withdrawal by Subject|0
1697089|NCT01253291|5924651|P4|Overall Study|Withdrawal by Subject|0
1697090|NCT01253291|5924652|P3|Overall Study|Withdrawal by Subject|0
1697091|NCT01253291|5924653|P2|Overall Study|Withdrawal by Subject|1
1697092|NCT01253291|5924654|P1|Overall Study|Withdrawal by Subject|1
1697093|NCT01253265|5924678|P5|Overall Study|Withdrawal by Subject|1
1697094|NCT01253265|5924679|P4|Overall Study|Withdrawal by Subject|0
1697095|NCT01253265|5924680|P3|Overall Study|Withdrawal by Subject|0
1697096|NCT01253265|5924681|P2|Overall Study|Withdrawal by Subject|0
1697097|NCT01253265|5924682|P1|Overall Study|Withdrawal by Subject|0
1697098|NCT01253265|5924678|P5|Overall Study|Met Predefined Discontinuation Criteria|0
1697099|NCT01253265|5924679|P4|Overall Study|Met Predefined Discontinuation Criteria|0
1697100|NCT01253265|5924680|P3|Overall Study|Met Predefined Discontinuation Criteria|0
1697101|NCT01253265|5924681|P2|Overall Study|Met Predefined Discontinuation Criteria|0
1697102|NCT01253265|5924682|P1|Overall Study|Met Predefined Discontinuation Criteria|1
1697103|NCT01253226|5924731|P5|Overall Study|Withdrawal by Subject|0
1697104|NCT01253226|5924732|P4|Overall Study|Withdrawal by Subject|1
1697105|NCT01253226|5924733|P3|Overall Study|Withdrawal by Subject|0
1697106|NCT01253226|5924734|P2|Overall Study|Withdrawal by Subject|0
1697107|NCT01253226|5924735|P1|Overall Study|Withdrawal by Subject|0
1697108|NCT01253226|5924731|P5|Overall Study|Physician Decision|2
1697109|NCT01253226|5924732|P4|Overall Study|Physician Decision|0
1697110|NCT01253226|5924733|P3|Overall Study|Physician Decision|0
1697111|NCT01253226|5924734|P2|Overall Study|Physician Decision|0
1697112|NCT01253226|5924735|P1|Overall Study|Physician Decision|0
1697113|NCT01253226|5924731|P5|Overall Study|Death|0
1697114|NCT01253226|5924732|P4|Overall Study|Death|0
1697115|NCT01253226|5924733|P3|Overall Study|Death|0
1697116|NCT01253226|5924734|P2|Overall Study|Death|1
1697117|NCT01253226|5924735|P1|Overall Study|Death|0
1697118|NCT01253226|5924731|P5|Overall Study|Adverse Event|0
1697119|NCT01253226|5924732|P4|Overall Study|Adverse Event|0
1697120|NCT01253226|5924733|P3|Overall Study|Adverse Event|1
1697121|NCT01253226|5924734|P2|Overall Study|Adverse Event|0
1697122|NCT01253226|5924735|P1|Overall Study|Adverse Event|0
1697123|NCT01253200|5924795|P5|Overall Study|Attempts|0
1697124|NCT01253200|5924796|P4|Overall Study|Attempts|2
1697125|NCT01253200|5924797|P3|Overall Study|Attempts|1
1697126|NCT01253200|5924798|P2|Overall Study|Attempts|4
1697127|NCT01253200|5924799|P1|Overall Study|Attempts|6
1697128|NCT01253200|5924795|P5|Overall Study|intents|0
1697129|NCT01253200|5924796|P4|Overall Study|intents|3
1697130|NCT01253200|5924797|P3|Overall Study|intents|1
1697131|NCT01253200|5924798|P2|Overall Study|intents|10
1697132|NCT01253200|5924799|P1|Overall Study|intents|10
1697133|NCT01253200|5924795|P5|Overall Study|Protocol Violation|5
1697134|NCT01253200|5924796|P4|Overall Study|Protocol Violation|0
1697135|NCT01253200|5924797|P3|Overall Study|Protocol Violation|0
1697136|NCT01253200|5924798|P2|Overall Study|Protocol Violation|4
1697137|NCT01253200|5924799|P1|Overall Study|Protocol Violation|1
1697138|NCT01253200|5924795|P5|Overall Study|Withdrawal by Subject|0
1697139|NCT01253200|5924796|P4|Overall Study|Withdrawal by Subject|0
1697140|NCT01253200|5924797|P3|Overall Study|Withdrawal by Subject|0
1697141|NCT01253200|5924798|P2|Overall Study|Withdrawal by Subject|0
1697142|NCT01253200|5924799|P1|Overall Study|Withdrawal by Subject|2
1697143|NCT01253200|5924795|P5|Overall Study|Lost to Follow-up|0
1697144|NCT01253200|5924796|P4|Overall Study|Lost to Follow-up|0
1697145|NCT01253200|5924797|P3|Overall Study|Lost to Follow-up|0
1697146|NCT01253200|5924798|P2|Overall Study|Lost to Follow-up|1
1697147|NCT01253200|5924799|P1|Overall Study|Lost to Follow-up|1
1697148|NCT01253200|5924795|P5|Overall Study|Death|0
1697149|NCT01253200|5924796|P4|Overall Study|Death|0
1697150|NCT01253200|5924797|P3|Overall Study|Death|0
1697151|NCT01253200|5924798|P2|Overall Study|Death|0
1697152|NCT01253200|5924799|P1|Overall Study|Death|1
1697153|NCT01253187|5924814|P6|Period 3|non-compliance|0
1697154|NCT01253187|5924815|P5|Period 3|non-compliance|1
1697155|NCT01253187|5924816|P4|Period 3|non-compliance|0
1697156|NCT01253187|5924817|P3|Period 3|non-compliance|0
1697157|NCT01253187|5924818|P2|Period 3|non-compliance|0
1697158|NCT01253187|5924819|P1|Period 3|non-compliance|0
1697159|NCT01253187|5924814|P6|Period 3|difficulty with blood sampling|0
1697160|NCT01253187|5924815|P5|Period 3|difficulty with blood sampling|0
1697161|NCT01253187|5924816|P4|Period 3|difficulty with blood sampling|0
1697162|NCT01253187|5924817|P3|Period 3|difficulty with blood sampling|0
1697163|NCT01253187|5924818|P2|Period 3|difficulty with blood sampling|1
1697164|NCT01253187|5924819|P1|Period 3|difficulty with blood sampling|0
1697165|NCT01253187|5924814|P6|Period 3|Pregnancy|0
1697166|NCT01253187|5924815|P5|Period 3|Pregnancy|0
1697167|NCT01253187|5924816|P4|Period 3|Pregnancy|0
1697168|NCT01253187|5924817|P3|Period 3|Pregnancy|0
1697169|NCT01253187|5924818|P2|Period 3|Pregnancy|0
1697170|NCT01253187|5924819|P1|Period 3|Pregnancy|1
1697171|NCT01253187|5924814|P6|Period 2|Withdrawal by Subject|0
1697172|NCT01253187|5924815|P5|Period 2|Withdrawal by Subject|1
1697173|NCT01253187|5924816|P4|Period 2|Withdrawal by Subject|0
1697174|NCT01253187|5924817|P3|Period 2|Withdrawal by Subject|0
1697175|NCT01253187|5924818|P2|Period 2|Withdrawal by Subject|0
1697176|NCT01253187|5924819|P1|Period 2|Withdrawal by Subject|0
1697177|NCT01253174|5924848|P6|Period 3|Pregnancy|0
1697178|NCT01253174|5924849|P5|Period 3|Pregnancy|0
1697179|NCT01253174|5924850|P4|Period 3|Pregnancy|0
1697180|NCT01253174|5924851|P3|Period 3|Pregnancy|1
1697181|NCT01253174|5924852|P2|Period 3|Pregnancy|0
1697182|NCT01253174|5924853|P1|Period 3|Pregnancy|0
1697183|NCT01253174|5924848|P6|Period 3|Withdrawal by Subject|0
1697184|NCT01253174|5924849|P5|Period 3|Withdrawal by Subject|1
1697185|NCT01253174|5924850|P4|Period 3|Withdrawal by Subject|0
1697186|NCT01253174|5924851|P3|Period 3|Withdrawal by Subject|0
1697187|NCT01253174|5924852|P2|Period 3|Withdrawal by Subject|1
1697188|NCT01253174|5924853|P1|Period 3|Withdrawal by Subject|0
1697189|NCT01253174|5924848|P6|Period 2|Adverse Event|0
1697190|NCT01253174|5924849|P5|Period 2|Adverse Event|0
1697191|NCT01253174|5924850|P4|Period 2|Adverse Event|0
1697192|NCT01253174|5924851|P3|Period 2|Adverse Event|1
1697193|NCT01253174|5924852|P2|Period 2|Adverse Event|0
1697194|NCT01253174|5924853|P1|Period 2|Adverse Event|0
1697195|NCT01253174|5924848|P6|Period 1|Randomized but not treated|0
1697196|NCT01253174|5924849|P5|Period 1|Randomized but not treated|1
1697197|NCT01253174|5924850|P4|Period 1|Randomized but not treated|0
1697198|NCT01253174|5924851|P3|Period 1|Randomized but not treated|1
1697199|NCT01253174|5924852|P2|Period 1|Randomized but not treated|1
1697200|NCT01253174|5924853|P1|Period 1|Randomized but not treated|0
1697201|NCT01253135|5924888|P1|Amended Protocol|Non-compliance|1
1697202|NCT01253135|5924888|P1|Original Protocol|Protocol Amendment|15
1697203|NCT01253044|5924907|P2|Overall Study|Lost to Follow-up|29
1697204|NCT01253044|5924908|P1|Overall Study|Lost to Follow-up|38
1697205|NCT01253018|5924918|P2|Overall Study|Withdrawal by Subject|1
1697206|NCT01253018|5924919|P1|Overall Study|Withdrawal by Subject|1
1697207|NCT01253018|5924918|P2|Overall Study|Robot Repair Issues|0
1697208|NCT01253018|5924919|P1|Overall Study|Robot Repair Issues|2
1697209|NCT01253018|5924918|P2|Overall Study|Lost to Follow-up|1
1697210|NCT01253018|5924919|P1|Overall Study|Lost to Follow-up|1
1697211|NCT01252966|5924933|P2|Overall Study|Withdrawal by Subject|3
1697212|NCT01252966|5924934|P1|Overall Study|Withdrawal by Subject|7
1697213|NCT01252966|5924933|P2|Overall Study|Lost to Follow-up|10
1697214|NCT01252966|5924934|P1|Overall Study|Lost to Follow-up|16
1697215|NCT01252953|5924950|P2|Overall Study|Lost to Follow-up|21
1697216|NCT01252953|5924951|P1|Overall Study|Lost to Follow-up|22
1697217|NCT01252953|5924950|P2|Overall Study|Withdrawal by Subject|17
1697218|NCT01252953|5924951|P1|Overall Study|Withdrawal by Subject|16
1697219|NCT01252940|5924965|P2|Extension Phase|Withdrawal by Subject|1
1697220|NCT01252940|5924966|P1|Extension Phase|Withdrawal by Subject|1
1697221|NCT01252940|5924965|P2|Extension Phase|Subject Non-compliance|0
1697222|NCT01252940|5924966|P1|Extension Phase|Subject Non-compliance|1
1697223|NCT01252940|5924965|P2|Extension Phase|Physician Decision|1
1697224|NCT01252940|5924966|P1|Extension Phase|Physician Decision|0
1697225|NCT01252940|5924965|P2|Extension Phase|Lost to Follow-up|0
1697226|NCT01252940|5924966|P1|Extension Phase|Lost to Follow-up|5
1697227|NCT01252940|5924965|P2|Extension Phase|Lack of Efficacy|0
1697228|NCT01252940|5924966|P1|Extension Phase|Lack of Efficacy|1
1697229|NCT01252940|5924965|P2|Extension Phase|Adverse Event|1
1697230|NCT01252940|5924966|P1|Extension Phase|Adverse Event|2
1697231|NCT01252940|5924965|P2|Main Study Phase|Subject Non-compliance|1
1697232|NCT01252940|5924966|P1|Main Study Phase|Subject Non-compliance|1
1697233|NCT01252940|5924965|P2|Main Study Phase|Withdrawal by Subject|5
1697234|NCT01252940|5924966|P1|Main Study Phase|Withdrawal by Subject|6
1697235|NCT01252940|5924965|P2|Main Study Phase|Protocol Violation|2
1697236|NCT01252940|5924966|P1|Main Study Phase|Protocol Violation|4
1697237|NCT01252940|5924965|P2|Main Study Phase|Physician Decision|0
1697238|NCT01252940|5924966|P1|Main Study Phase|Physician Decision|1
1697239|NCT01252940|5924965|P2|Main Study Phase|Lost to Follow-up|1
1697240|NCT01252940|5924966|P1|Main Study Phase|Lost to Follow-up|6
1697241|NCT01252940|5924965|P2|Main Study Phase|Lack of Efficacy|0
1697242|NCT01252940|5924966|P1|Main Study Phase|Lack of Efficacy|1
1697243|NCT01252940|5924965|P2|Main Study Phase|Adverse Event|1
1697244|NCT01252940|5924966|P1|Main Study Phase|Adverse Event|3
1697245|NCT01252940|5924965|P2|Main Study Phase|Randomized but not treated|2
1697246|NCT01252940|5924966|P1|Main Study Phase|Randomized but not treated|4
1697247|NCT01252810|5924997|P2|Overall Study|Various reasons|0
1697248|NCT01252810|5924998|P1|Overall Study|Various reasons|8
1697249|NCT01252810|5924997|P2|Overall Study|Physician Decision|1
1697250|NCT01252810|5924998|P1|Overall Study|Physician Decision|2
1697251|NCT01252810|5924997|P2|Overall Study|Lost to Follow-up|1
1697252|NCT01252810|5924998|P1|Overall Study|Lost to Follow-up|0
1697253|NCT01252810|5924997|P2|Overall Study|Withdrawal by Subject|1
1697254|NCT01252810|5924998|P1|Overall Study|Withdrawal by Subject|4
1697255|NCT01252563|5925027|P1|Overall Study|No drug administration|6
1697256|NCT01252563|5925027|P1|Overall Study|No visit after first day of treatment|194
1697257|NCT01252563|5925027|P1|Overall Study|Lost to Follow-up|161
1697258|NCT01252563|5925027|P1|Overall Study|Centralized Registration Deviation|30
1697259|NCT01252563|5925027|P1|Overall Study|Contract Deviation|41
1697260|NCT01252355|5925067|P3|Overall Study|Other Than Above|7
1697261|NCT01252355|5925068|P2|Overall Study|Other Than Above|7
1697262|NCT01252355|5925069|P1|Overall Study|Other Than Above|8
1697263|NCT01252355|5925067|P3|Overall Study|Randomized but not Treated|0
1697264|NCT01252355|5925068|P2|Overall Study|Randomized but not Treated|0
1697265|NCT01252355|5925069|P1|Overall Study|Randomized but not Treated|2
1697266|NCT01252355|5925067|P3|Overall Study|Sponsor Early Termination of Study|146
1697267|NCT01252355|5925068|P2|Overall Study|Sponsor Early Termination of Study|149
1697268|NCT01252355|5925069|P1|Overall Study|Sponsor Early Termination of Study|149
1697269|NCT01252355|5925067|P3|Overall Study|Progressive Disease|0
1697270|NCT01252355|5925068|P2|Overall Study|Progressive Disease|0
1697271|NCT01252355|5925069|P1|Overall Study|Progressive Disease|2
1697272|NCT01252355|5925067|P3|Overall Study|Poor Compliance to Protocol|1
1697273|NCT01252355|5925068|P2|Overall Study|Poor Compliance to Protocol|1
1697274|NCT01252355|5925069|P1|Overall Study|Poor Compliance to Protocol|1
1697275|NCT01252355|5925067|P3|Overall Study|Lost to Follow-up|1
1697276|NCT01252355|5925068|P2|Overall Study|Lost to Follow-up|0
1697277|NCT01252355|5925069|P1|Overall Study|Lost to Follow-up|0
1697278|NCT01252355|5925067|P3|Overall Study|Lack of Efficacy|2
1697279|NCT01252355|5925068|P2|Overall Study|Lack of Efficacy|4
1697280|NCT01252355|5925069|P1|Overall Study|Lack of Efficacy|6
1697281|NCT01252355|5925067|P3|Overall Study|Adverse Event|22
1697282|NCT01252355|5925068|P2|Overall Study|Adverse Event|17
1697283|NCT01252355|5925069|P1|Overall Study|Adverse Event|9
1697284|NCT01252290|5925107|P1|Overall Study|Withdrawal by Subject|1
1697285|NCT01252251|5925123|P1|Overall Study|Withdrawal by Subject|1
1697286|NCT01252238|5925135|P3|Overall Study|Sponsor terminated study|4
1697287|NCT01252238|5925136|P2|Overall Study|Sponsor terminated study|4
1697288|NCT01252238|5925137|P1|Overall Study|Sponsor terminated study|4
1697289|NCT01252186|5925154|P3|Overall Study|Other - Miscellaneous Reasons|7
1697290|NCT01252186|5925155|P2|Overall Study|Other - Miscellaneous Reasons|5
1697291|NCT01252186|5925156|P1|Overall Study|Other - Miscellaneous Reasons|5
1697292|NCT01252186|5925154|P3|Overall Study|Lost to Follow-up|11
1697293|NCT01252186|5925155|P2|Overall Study|Lost to Follow-up|10
1697294|NCT01252186|5925156|P1|Overall Study|Lost to Follow-up|10
1697295|NCT01252186|5925154|P3|Overall Study|Sponsor Request|0
1697296|NCT01252186|5925155|P2|Overall Study|Sponsor Request|1
1697297|NCT01252186|5925156|P1|Overall Study|Sponsor Request|2
1697298|NCT01252186|5925154|P3|Overall Study|Pregnancy|0
1697299|NCT01252186|5925155|P2|Overall Study|Pregnancy|2
1697300|NCT01252186|5925156|P1|Overall Study|Pregnancy|2
1697301|NCT01252186|5925154|P3|Overall Study|Protocol Violation|1
1697302|NCT01252186|5925155|P2|Overall Study|Protocol Violation|0
1697303|NCT01252186|5925156|P1|Overall Study|Protocol Violation|0
1697304|NCT01252186|5925154|P3|Overall Study|Non-compliance|4
1697305|NCT01252186|5925155|P2|Overall Study|Non-compliance|3
1697306|NCT01252186|5925156|P1|Overall Study|Non-compliance|0
1697307|NCT01252186|5925154|P3|Overall Study|Physician Decision|1
1697308|NCT01252186|5925155|P2|Overall Study|Physician Decision|0
1697309|NCT01252186|5925156|P1|Overall Study|Physician Decision|0
1697310|NCT01252186|5925154|P3|Overall Study|Withdrawal by Subject|2
1697311|NCT01252186|5925155|P2|Overall Study|Withdrawal by Subject|5
1697312|NCT01252186|5925156|P1|Overall Study|Withdrawal by Subject|2
1697313|NCT01252186|5925154|P3|Overall Study|Adverse Event|8
1697314|NCT01252186|5925155|P2|Overall Study|Adverse Event|6
1697315|NCT01252186|5925156|P1|Overall Study|Adverse Event|9
1697316|NCT01252134|5925229|P6|Period 1, 8 Hours|Personal Reasons|0
1697317|NCT01252134|5925230|P5|Period 1, 8 Hours|Personal Reasons|0
1697318|NCT01252134|5925231|P4|Period 1, 8 Hours|Personal Reasons|0
1697319|NCT01252134|5925232|P3|Period 1, 8 Hours|Personal Reasons|1
1697320|NCT01252134|5925233|P2|Period 1, 8 Hours|Personal Reasons|1
1697321|NCT01252134|5925234|P1|Period 1, 8 Hours|Personal Reasons|0
1697322|NCT01252095|5925253|P2|Overall Study|Disease progression|0
1697323|NCT01252095|5925254|P1|Overall Study|Disease progression|1
1697324|NCT01251965|5925275|P3|Overall Study|Death|11
1697325|NCT01251965|5925276|P2|Overall Study|Death|0
1697326|NCT01251965|5925277|P1|Overall Study|Death|0
1697327|NCT01251965|5925275|P3|Overall Study|Participant/physician decision|0
1697328|NCT01251965|5925276|P2|Overall Study|Participant/physician decision|2
1697329|NCT01251965|5925277|P1|Overall Study|Participant/physician decision|1
1697330|NCT01251952|5925289|P1|Overall Study|Adverse Event|1
1697331|NCT01251861|5925295|P2|Overall Study|Potential interaction of drugs|1
1697332|NCT01251861|5925296|P1|Overall Study|Potential interaction of drugs|0
1697333|NCT01251861|5925295|P2|Overall Study|Never started therapy|1
1697334|NCT01251861|5925296|P1|Overall Study|Never started therapy|4
1697335|NCT01251861|5925295|P2|Overall Study|Other|0
1697336|NCT01251861|5925296|P1|Overall Study|Other|1
1697337|NCT01251861|5925295|P2|Overall Study|Continued treatment beyond 18 cycles|0
1697338|NCT01251861|5925296|P1|Overall Study|Continued treatment beyond 18 cycles|1
1697339|NCT01251861|5925295|P2|Overall Study|Physician Decision|0
1697340|NCT01251861|5925296|P1|Overall Study|Physician Decision|1
1697341|NCT01251861|5925295|P2|Overall Study|Other complicating disease|1
1697342|NCT01251861|5925296|P1|Overall Study|Other complicating disease|0
1697343|NCT01251861|5925295|P2|Overall Study|Alternative therapy|0
1697344|NCT01251861|5925296|P1|Overall Study|Alternative therapy|1
1697345|NCT01251861|5925295|P2|Overall Study|Withdrawal by Subject|2
1697346|NCT01251861|5925296|P1|Overall Study|Withdrawal by Subject|2
1697347|NCT01251861|5925295|P2|Overall Study|Adverse Event|17
1697348|NCT01251861|5925296|P1|Overall Study|Adverse Event|2
1697349|NCT01251861|5925295|P2|Overall Study|Disease progression|6
1697350|NCT01251861|5925296|P1|Overall Study|Disease progression|6
1697351|NCT01251770|5925324|P2|Overall Study|Protocol Violation|7
1697352|NCT01251770|5925325|P1|Overall Study|Protocol Violation|13
1697353|NCT01251744|5925369|P2|Overall Study|Lost to Follow-up|0
1697354|NCT01251744|5925370|P1|Overall Study|Lost to Follow-up|1
1697355|NCT01251653|5925428|P9|Overall Study|Other reason not mentioned above|0
1697356|NCT01251653|5925429|P8|Overall Study|Other reason not mentioned above|2
1697357|NCT01251653|5925430|P7|Overall Study|Other reason not mentioned above|0
1697358|NCT01251653|5925431|P6|Overall Study|Other reason not mentioned above|0
1697359|NCT01251653|5925432|P5|Overall Study|Other reason not mentioned above|0
1697360|NCT01251653|5925433|P4|Overall Study|Other reason not mentioned above|0
1697361|NCT01251653|5925434|P3|Overall Study|Other reason not mentioned above|0
1697362|NCT01251653|5925435|P2|Overall Study|Other reason not mentioned above|0
1697363|NCT01251653|5925436|P1|Overall Study|Other reason not mentioned above|0
1697364|NCT01251653|5925428|P9|Overall Study|Withdrawal by Subject|0
1697365|NCT01251653|5925429|P8|Overall Study|Withdrawal by Subject|1
1697366|NCT01251653|5925430|P7|Overall Study|Withdrawal by Subject|0
1697367|NCT01251653|5925431|P6|Overall Study|Withdrawal by Subject|1
1697368|NCT01251653|5925432|P5|Overall Study|Withdrawal by Subject|1
1697369|NCT01251653|5925433|P4|Overall Study|Withdrawal by Subject|0
1697370|NCT01251653|5925434|P3|Overall Study|Withdrawal by Subject|1
1697371|NCT01251653|5925435|P2|Overall Study|Withdrawal by Subject|0
1697372|NCT01251653|5925436|P1|Overall Study|Withdrawal by Subject|1
1697373|NCT01251653|5925428|P9|Overall Study|Adverse Event|1
1697374|NCT01251653|5925429|P8|Overall Study|Adverse Event|2
1697375|NCT01251653|5925430|P7|Overall Study|Adverse Event|2
1697376|NCT01251653|5925431|P6|Overall Study|Adverse Event|0
1697377|NCT01251653|5925432|P5|Overall Study|Adverse Event|1
1697378|NCT01251653|5925433|P4|Overall Study|Adverse Event|1
1697379|NCT01251653|5925434|P3|Overall Study|Adverse Event|2
1697380|NCT01251653|5925435|P2|Overall Study|Adverse Event|0
1697381|NCT01251653|5925436|P1|Overall Study|Adverse Event|1
1697382|NCT01251653|5925428|P9|Overall Study|Dose-limiting toxicity|0
1697383|NCT01251653|5925429|P8|Overall Study|Dose-limiting toxicity|0
1697384|NCT01251653|5925430|P7|Overall Study|Dose-limiting toxicity|2
1697385|NCT01251653|5925431|P6|Overall Study|Dose-limiting toxicity|0
1697386|NCT01251653|5925432|P5|Overall Study|Dose-limiting toxicity|0
1697387|NCT01251653|5925433|P4|Overall Study|Dose-limiting toxicity|1
1697388|NCT01251653|5925434|P3|Overall Study|Dose-limiting toxicity|1
1697389|NCT01251653|5925435|P2|Overall Study|Dose-limiting toxicity|1
1697390|NCT01251653|5925436|P1|Overall Study|Dose-limiting toxicity|0
1697391|NCT01251653|5925428|P9|Overall Study|Progressive Disease|5
1697392|NCT01251653|5925429|P8|Overall Study|Progressive Disease|7
1697393|NCT01251653|5925430|P7|Overall Study|Progressive Disease|14
1697394|NCT01251653|5925431|P6|Overall Study|Progressive Disease|17
1697395|NCT01251653|5925432|P5|Overall Study|Progressive Disease|0
1697396|NCT01251653|5925433|P4|Overall Study|Progressive Disease|4
1697397|NCT01251653|5925434|P3|Overall Study|Progressive Disease|16
1697398|NCT01251653|5925435|P2|Overall Study|Progressive Disease|7
1697399|NCT01251653|5925436|P1|Overall Study|Progressive Disease|1
1697400|NCT01251614|5925564|P3|Overall Study|Lost to Follow-up|0
1697401|NCT01251614|5925565|P2|Overall Study|Lost to Follow-up|1
1697402|NCT01251614|5925566|P1|Overall Study|Lost to Follow-up|0
1697403|NCT01251614|5925564|P3|Overall Study|Withdrawal by Subject|1
1697404|NCT01251614|5925565|P2|Overall Study|Withdrawal by Subject|2
1697405|NCT01251614|5925566|P1|Overall Study|Withdrawal by Subject|0
1697406|NCT01251614|5925564|P3|Overall Study|Loss of Disease Control|0
1697407|NCT01251614|5925565|P2|Overall Study|Loss of Disease Control|1
1697408|NCT01251614|5925566|P1|Overall Study|Loss of Disease Control|0
1697409|NCT01251614|5925564|P3|Overall Study|Pregnancy|2
1697410|NCT01251614|5925565|P2|Overall Study|Pregnancy|0
1697411|NCT01251614|5925566|P1|Overall Study|Pregnancy|0
1697412|NCT01251614|5925564|P3|Overall Study|Clearing of Psoriatic Lesions|0
1697413|NCT01251614|5925565|P2|Overall Study|Clearing of Psoriatic Lesions|0
1697414|NCT01251614|5925566|P1|Overall Study|Clearing of Psoriatic Lesions|1
1697415|NCT01251614|5925564|P3|Overall Study|Lack of Efficacy|4
1697416|NCT01251614|5925565|P2|Overall Study|Lack of Efficacy|9
1697417|NCT01251614|5925566|P1|Overall Study|Lack of Efficacy|1
1697418|NCT01251614|5925564|P3|Overall Study|Adverse Event|1
1697419|NCT01251614|5925565|P2|Overall Study|Adverse Event|0
1697420|NCT01251614|5925566|P1|Overall Study|Adverse Event|1
1697421|NCT01251380|5925755|P1|Overall Study|Lost to Follow-up|2
1697422|NCT01251380|5925755|P1|Overall Study|Adverse Event|1
1697423|NCT01251380|5925755|P1|Overall Study|Lack of Efficacy|1
1697424|NCT01251380|5925755|P1|Overall Study|Withdrawal by Subject|6
1697425|NCT01251380|5925755|P1|Overall Study|Other (Not otherwise specified)|12
1697426|NCT01251367|5925779|P1|Overall Study|End of Study Visit Performed in Error|1
1697427|NCT01251367|5925779|P1|Overall Study|Subject had Personal or Medical Issues|4
1697428|NCT01251367|5925779|P1|Overall Study|No Study Drug Available|1
1697429|NCT01251367|5925779|P1|Overall Study|Subject Required Alternative Treatment|7
1697430|NCT01251367|5925779|P1|Overall Study|Lost to Follow-up|5
1697431|NCT01251367|5925779|P1|Overall Study|Withdrawal by Subject|36
1697432|NCT01251367|5925779|P1|Overall Study|Adverse Event|19
1697433|NCT01251367|5925779|P1|Overall Study|Lack of Efficacy|2
1697434|NCT01251367|5925779|P1|Overall Study|Protocol Violation|1
1697435|NCT01251354|5925814|P1|Overall Study|Disease Progression|4
1697436|NCT01251354|5925814|P1|Overall Study|Investigator's Decision|1
1697437|NCT01251354|5925814|P1|Overall Study|Adverse Event|1
1697438|NCT01251276|5925857|P2|Overall Study|Lost to Follow-up|1
1697439|NCT01251276|5925858|P1|Overall Study|Lost to Follow-up|0
1697440|NCT01251276|5925857|P2|Overall Study|Protocol Violation|0
1697441|NCT01251276|5925858|P1|Overall Study|Protocol Violation|1
1697442|NCT01251146|5925876|P2|Overall Study|Lost to Follow-up|10
1697443|NCT01251146|5925877|P1|Overall Study|Lost to Follow-up|3
1697444|NCT01251120|5925899|P2|Overall Study|Lack of Efficacy|1
1697445|NCT01251120|5925900|P1|Overall Study|Lack of Efficacy|0
1697446|NCT01250925|5925980|P3|Overall Study|Adverse Event|1
1697447|NCT01250925|5925981|P2|Overall Study|Adverse Event|0
1697448|NCT01250925|5925982|P1|Overall Study|Adverse Event|0
1697449|NCT01250925|5925980|P3|Overall Study|Physician Decision|1
1697450|NCT01250925|5925981|P2|Overall Study|Physician Decision|2
1697451|NCT01250925|5925982|P1|Overall Study|Physician Decision|0
1697452|NCT01250925|5925980|P3|Overall Study|Protocol Violation|0
1697453|NCT01250925|5925981|P2|Overall Study|Protocol Violation|0
1697454|NCT01250925|5925982|P1|Overall Study|Protocol Violation|2
1697455|NCT01250925|5925980|P3|Overall Study|Withdrawal by Subject|0
1697456|NCT01250925|5925981|P2|Overall Study|Withdrawal by Subject|0
1697457|NCT01250925|5925982|P1|Overall Study|Withdrawal by Subject|2
1697458|NCT01250925|5925980|P3|Overall Study|Lost to Follow-up|0
1697459|NCT01250925|5925981|P2|Overall Study|Lost to Follow-up|1
1697460|NCT01250925|5925982|P1|Overall Study|Lost to Follow-up|1
1697461|NCT01250873|5926027|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
1697462|NCT01250873|5926027|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
1697463|NCT01250769|5926059|P4|Overall Study|Adverse Event|0
1697464|NCT01250769|5926060|P3|Overall Study|Adverse Event|1
1697465|NCT01250769|5926061|P2|Overall Study|Adverse Event|0
1697466|NCT01250769|5926062|P1|Overall Study|Adverse Event|0
1697467|NCT01250769|5926059|P4|Overall Study|Withdrawal by Subject|0
1697468|NCT01250769|5926060|P3|Overall Study|Withdrawal by Subject|1
1697469|NCT01250769|5926061|P2|Overall Study|Withdrawal by Subject|1
1697470|NCT01250769|5926062|P1|Overall Study|Withdrawal by Subject|0
1697471|NCT01250756|5926094|P2|After Toddler Dose|Adverse Event|1
1697472|NCT01250756|5926095|P1|After Toddler Dose|Adverse Event|0
1697473|NCT01250756|5926094|P2|Toddler Dose|Adverse Event|1
1697474|NCT01250756|5926095|P1|Toddler Dose|Adverse Event|0
1697475|NCT01250756|5926094|P2|After Infant Series|Other|1
1697476|NCT01250756|5926095|P1|After Infant Series|Other|2
1697477|NCT01250756|5926094|P2|After Infant Series|Withdrawal by Subject|1
1697478|NCT01250756|5926095|P1|After Infant Series|Withdrawal by Subject|4
1697479|NCT01250756|5926094|P2|After Infant Series|Adverse Event|2
1697480|NCT01250756|5926095|P1|After Infant Series|Adverse Event|5
1697481|NCT01250756|5926094|P2|Infant Series|Other|0
1697482|NCT01250756|5926095|P1|Infant Series|Other|22
1697483|NCT01250756|5926094|P2|Infant Series|Randomized, Not Vaccinated|2
1697484|NCT01250756|5926095|P1|Infant Series|Randomized, Not Vaccinated|2
1697485|NCT01250756|5926094|P2|Infant Series|Withdrawal by Subject|5
1697486|NCT01250756|5926095|P1|Infant Series|Withdrawal by Subject|4
1697487|NCT01250509|5926212|P2|Overall Study|Lost to Follow-up|2
1697488|NCT01250509|5926213|P1|Overall Study|Lost to Follow-up|5
1697489|NCT01250418|5926227|P2|Overall Study|monitor data failure|1
1697490|NCT01250418|5926228|P1|Overall Study|monitor data failure|1
1697491|NCT01250379|5926236|P2|Overall Study|Participant noncompliance|0
1697492|NCT01250379|5926237|P1|Overall Study|Participant noncompliance|2
1697493|NCT01250379|5926236|P2|Overall Study|Other|4
1697494|NCT01250379|5926237|P1|Overall Study|Other|0
1697495|NCT01250379|5926236|P2|Overall Study|Adverse Event|4
1697496|NCT01250379|5926237|P1|Overall Study|Adverse Event|5
1697497|NCT01250379|5926236|P2|Overall Study|Lost to Follow-up|6
1697498|NCT01250379|5926237|P1|Overall Study|Lost to Follow-up|9
1697499|NCT01250379|5926236|P2|Overall Study|Protocol Violation|8
1697500|NCT01250379|5926237|P1|Overall Study|Protocol Violation|2
1697501|NCT01250379|5926236|P2|Overall Study|Physician Decision|3
1697502|NCT01250379|5926237|P1|Overall Study|Physician Decision|11
1697503|NCT01250379|5926236|P2|Overall Study|Withdrawal by Subject|20
1697504|NCT01250379|5926237|P1|Overall Study|Withdrawal by Subject|32
1697505|NCT01250379|5926236|P2|Overall Study|Death|148
1697506|NCT01250379|5926237|P1|Overall Study|Death|141
1697507|NCT01250171|5926342|P3|Overall Study|Administrative reasons|0
1697508|NCT01250171|5926343|P2|Overall Study|Administrative reasons|0
1697509|NCT01250171|5926344|P1|Overall Study|Administrative reasons|1
1697510|NCT01250145|5926375|P2|Overall Study|Withdrawal by Subject|4
1697511|NCT01250145|5926376|P1|Overall Study|Withdrawal by Subject|0
1697512|NCT01250145|5926375|P2|Overall Study|Adverse Event|1
1697513|NCT01250145|5926376|P1|Overall Study|Adverse Event|2
1697514|NCT01250119|5926396|P2|Treatment Phase|Unknown reason|4
1697515|NCT01250119|5926397|P1|Treatment Phase|Unknown reason|0
1697516|NCT01250119|5926396|P2|Treatment Phase|Adverse Event|2
1697517|NCT01250119|5926397|P1|Treatment Phase|Adverse Event|0
1697518|NCT01250119|5926396|P2|Treatment Phase|Withdrawal by Subject|1
1697519|NCT01250119|5926397|P1|Treatment Phase|Withdrawal by Subject|0
1697520|NCT01250119|5926396|P2|Treatment Phase|Death|2
1697521|NCT01250119|5926397|P1|Treatment Phase|Death|0
1697522|NCT01250119|5926396|P2|Treatment Phase|Progressive Disease|32
1697523|NCT01250119|5926397|P1|Treatment Phase|Progressive Disease|0
1697524|NCT01250119|5926396|P2|Diagnostic Phase|Participants Not Tested|0
1697525|NCT01250119|5926397|P1|Diagnostic Phase|Participants Not Tested|44
1697526|NCT01250119|5926396|P2|Diagnostic Phase|Failed to Produce a Test Results|0
1697527|NCT01250119|5926397|P1|Diagnostic Phase|Failed to Produce a Test Results|69
1697528|NCT01250054|5926412|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
1697529|NCT01250054|5926413|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
1697530|NCT01250002|5926421|P2|Overall Study|Change to open surgical procedure|3
1697531|NCT01250002|5926422|P1|Overall Study|Change to open surgical procedure|4
1697532|NCT01249833|5926487|P2|Overall Study|Lost to Follow-up|1
1697533|NCT01249833|5926488|P1|Overall Study|Lost to Follow-up|0
1697534|NCT01249664|5926502|P2|Overall Study|Adverse Event|0
1697535|NCT01249664|5926503|P1|Overall Study|Adverse Event|1
1697536|NCT01249664|5926502|P2|Overall Study|Withdrawal by Subject|0
1697537|NCT01249664|5926503|P1|Overall Study|Withdrawal by Subject|5
1697538|NCT01249651|5926553|P1|Overall Study|Sponsor Decision|1
1697539|NCT01249651|5926553|P1|Overall Study|Protocol Violation|1
1697540|NCT01249651|5926553|P1|Overall Study|Adverse Event|1
1697541|NCT01249651|5926553|P1|Overall Study|Withdrawal by Subject|4
1697542|NCT01249417|5926582|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
1697543|NCT01249417|5926583|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
1697544|NCT01249417|5926584|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
1697545|NCT01249417|5926582|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
1697546|NCT01249417|5926583|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
1697547|NCT01249417|5926584|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
1697548|NCT01249417|5926582|P3|Treatment Phase - ITT Population|Adverse Event|1
1697549|NCT01249417|5926583|P2|Treatment Phase - ITT Population|Adverse Event|0
1697550|NCT01249417|5926584|P1|Treatment Phase - ITT Population|Adverse Event|0
1697551|NCT01249417|5926582|P3|Treatment Phase - ITT Population|Other|1
1697552|NCT01249417|5926583|P2|Treatment Phase - ITT Population|Other|0
1697553|NCT01249417|5926584|P1|Treatment Phase - ITT Population|Other|0
1697554|NCT01249417|5926582|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
1697555|NCT01249417|5926583|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
1697556|NCT01249417|5926584|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
1697557|NCT01249417|5926582|P3|Randomised Population|Study treatment not received|2
1697558|NCT01249417|5926583|P2|Randomised Population|Study treatment not received|0
1697559|NCT01249417|5926584|P1|Randomised Population|Study treatment not received|0
1697560|NCT01249404|5926601|P3|Overall Study|Non compliance to visit schedule|0
1697561|NCT01249404|5926602|P2|Overall Study|Non compliance to visit schedule|1
1697562|NCT01249404|5926603|P1|Overall Study|Non compliance to visit schedule|0
1697563|NCT01249404|5926601|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
1697564|NCT01249404|5926602|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
1697565|NCT01249404|5926603|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
1697566|NCT01249404|5926601|P3|Overall Study|Withdrawal by Subject|0
1697567|NCT01249404|5926602|P2|Overall Study|Withdrawal by Subject|2
1697568|NCT01249404|5926603|P1|Overall Study|Withdrawal by Subject|2
1697569|NCT01249404|5926601|P3|Overall Study|Adverse Event|2
1697570|NCT01249404|5926602|P2|Overall Study|Adverse Event|2
1697571|NCT01249404|5926603|P1|Overall Study|Adverse Event|2
1697572|NCT01249404|5926601|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
1697573|NCT01249404|5926602|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
1697574|NCT01249404|5926603|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
1697575|NCT01249404|5926601|P3|Overall Study|Study treatment not received|2
1697576|NCT01249404|5926602|P2|Overall Study|Study treatment not received|1
1697577|NCT01249404|5926603|P1|Overall Study|Study treatment not received|0
1697578|NCT01249365|5926680|P1|Overall Study|Lost to Follow-up|1
1697579|NCT01249274|5926688|P2|Overall Study|Received inpatient substance treatment|2
1697580|NCT01249274|5926689|P1|Overall Study|Received inpatient substance treatment|1
1697581|NCT01249274|5926688|P2|Overall Study|Lost to Follow-up|4
1697582|NCT01249274|5926689|P1|Overall Study|Lost to Follow-up|3
1697583|NCT01249261|5926715|P2|Overall Study|Withdrawal by Subject|0
1697584|NCT01249261|5926716|P1|Overall Study|Withdrawal by Subject|1
1697585|NCT01249157|5926744|P1|Overall Study|Withdrawal by Subject|1
1697586|NCT01249131|5926748|P6|Washout Period of 10 Days|Adverse Event|0
1697587|NCT01249131|5926749|P5|Washout Period of 10 Days|Adverse Event|1
1697588|NCT01249131|5926750|P4|Washout Period of 10 Days|Adverse Event|0
1697589|NCT01249131|5926751|P3|Washout Period of 10 Days|Adverse Event|0
1697590|NCT01249131|5926752|P2|Washout Period of 10 Days|Adverse Event|0
1697591|NCT01249131|5926753|P1|Washout Period of 10 Days|Adverse Event|0
1697592|NCT01249118|5926773|P3|First Washout Period|Physician Decision|0
1697593|NCT01249118|5926774|P2|First Washout Period|Physician Decision|1
1697594|NCT01249118|5926775|P1|First Washout Period|Physician Decision|0
1697595|NCT01249092|5926809|P1|Overall Study|Unable to tolerate expected SE -nausea|1
1697596|NCT01249092|5926809|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
1697597|NCT01248962|5926886|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
1697598|NCT01248962|5926887|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
1697599|NCT01248962|5926886|P2|Overall Study|Complete Response after 3 Cycles|1
1697600|NCT01248962|5926887|P1|Overall Study|Complete Response after 3 Cycles|0
1697601|NCT01248962|5926886|P2|Overall Study|Complete Response after 4 Cycles|0
1697602|NCT01248962|5926887|P1|Overall Study|Complete Response after 4 Cycles|1
1697603|NCT01248962|5926886|P2|Overall Study|Adverse Event|1
1697604|NCT01248962|5926887|P1|Overall Study|Adverse Event|2
1697605|NCT01248962|5926886|P2|Overall Study|Withdrawal by Subject|1
1697606|NCT01248962|5926887|P1|Overall Study|Withdrawal by Subject|1
1697607|NCT01248949|5926903|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1697608|NCT01248949|5926904|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1697609|NCT01248949|5926905|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
1697610|NCT01248949|5926906|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1697611|NCT01248949|5926907|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
1697612|NCT01248949|5926903|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
1697613|NCT01248949|5926904|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
1697614|NCT01248949|5926905|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
1697615|NCT01248949|5926906|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
1697616|NCT01248949|5926907|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
1697617|NCT01248949|5926903|P5|Overall Study|Pi Decision Due To Declining Status|0
1697618|NCT01248949|5926904|P4|Overall Study|Pi Decision Due To Declining Status|0
1697619|NCT01248949|5926905|P3|Overall Study|Pi Decision Due To Declining Status|1
1697620|NCT01248949|5926906|P2|Overall Study|Pi Decision Due To Declining Status|0
1697621|NCT01248949|5926907|P1|Overall Study|Pi Decision Due To Declining Status|0
1697622|NCT01248949|5926903|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
1697623|NCT01248949|5926904|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
1697624|NCT01248949|5926905|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
1697625|NCT01248949|5926906|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
1697626|NCT01248949|5926907|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
1697627|NCT01248949|5926903|P5|Overall Study|Participant Went To Hospice|0
1697628|NCT01248949|5926904|P4|Overall Study|Participant Went To Hospice|0
1697629|NCT01248949|5926905|P3|Overall Study|Participant Went To Hospice|1
1697630|NCT01248949|5926906|P2|Overall Study|Participant Went To Hospice|0
1697631|NCT01248949|5926907|P1|Overall Study|Participant Went To Hospice|0
1697632|NCT01248949|5926903|P5|Overall Study|Entered Hospice And Refused Follow Up|1
1697633|NCT01248949|5926904|P4|Overall Study|Entered Hospice And Refused Follow Up|0
1697634|NCT01248949|5926905|P3|Overall Study|Entered Hospice And Refused Follow Up|0
1697635|NCT01248949|5926906|P2|Overall Study|Entered Hospice And Refused Follow Up|0
1697636|NCT01248949|5926907|P1|Overall Study|Entered Hospice And Refused Follow Up|0
1697637|NCT01248949|5926903|P5|Overall Study|Palliative Radiation To Brain Metastases|0
1697638|NCT01248949|5926904|P4|Overall Study|Palliative Radiation To Brain Metastases|0
1697639|NCT01248949|5926905|P3|Overall Study|Palliative Radiation To Brain Metastases|0
1697640|NCT01248949|5926906|P2|Overall Study|Palliative Radiation To Brain Metastases|0
1697641|NCT01248949|5926907|P1|Overall Study|Palliative Radiation To Brain Metastases|1
1697642|NCT01248949|5926903|P5|Overall Study|Alternative Therapy.|0
1697643|NCT01248949|5926904|P4|Overall Study|Alternative Therapy.|0
1697644|NCT01248949|5926905|P3|Overall Study|Alternative Therapy.|0
1697645|NCT01248949|5926906|P2|Overall Study|Alternative Therapy.|0
1697646|NCT01248949|5926907|P1|Overall Study|Alternative Therapy.|1
1697647|NCT01248949|5926903|P5|Overall Study|Alternative Therapy|0
1697648|NCT01248949|5926904|P4|Overall Study|Alternative Therapy|0
1697649|NCT01248949|5926905|P3|Overall Study|Alternative Therapy|0
1697650|NCT01248949|5926906|P2|Overall Study|Alternative Therapy|0
1697651|NCT01248949|5926907|P1|Overall Study|Alternative Therapy|1
1697652|NCT01248949|5926903|P5|Overall Study|Death|2
1697653|NCT01248949|5926904|P4|Overall Study|Death|6
1697654|NCT01248949|5926905|P3|Overall Study|Death|21
1697655|NCT01248949|5926906|P2|Overall Study|Death|7
1697656|NCT01248949|5926907|P1|Overall Study|Death|22
1697657|NCT01248949|5926903|P5|Overall Study|Withdrawal by Subject|1
1697658|NCT01248949|5926904|P4|Overall Study|Withdrawal by Subject|3
1697659|NCT01248949|5926905|P3|Overall Study|Withdrawal by Subject|11
1697660|NCT01248949|5926906|P2|Overall Study|Withdrawal by Subject|3
1697661|NCT01248949|5926907|P1|Overall Study|Withdrawal by Subject|5
1697662|NCT01248949|5926903|P5|Overall Study|Lost to Follow-up|0
1697663|NCT01248949|5926904|P4|Overall Study|Lost to Follow-up|1
1697664|NCT01248949|5926905|P3|Overall Study|Lost to Follow-up|2
1697665|NCT01248949|5926906|P2|Overall Study|Lost to Follow-up|2
1697666|NCT01248949|5926907|P1|Overall Study|Lost to Follow-up|2
1697667|NCT01248936|5927019|P1|Overall Study|Other reason|3
1697668|NCT01248936|5927019|P1|Overall Study|Refused Treatment|1
1697669|NCT01248936|5927019|P1|Overall Study|Lost to Follow-up|7
1697670|NCT01248936|5927019|P1|Overall Study|Adverse Event|8
1697671|NCT01248936|5927019|P1|Overall Study|Withdrawal of Consent|20
1697672|NCT01248936|5927019|P1|Overall Study|Death|26
1697673|NCT01248936|5927019|P1|Overall Study|Progression of Disease|50
1697674|NCT01248936|5927019|P1|Overall Study|Sponsor Decision|259
1697675|NCT01248884|5927032|P3|Overall Study|Adverse Event|0
1697676|NCT01248884|5927033|P2|Overall Study|Adverse Event|0
1697677|NCT01248884|5927034|P1|Overall Study|Adverse Event|1
1697678|NCT01248884|5927032|P3|Overall Study|Withdrawal by Subject|1
1697679|NCT01248884|5927033|P2|Overall Study|Withdrawal by Subject|3
1697680|NCT01248884|5927034|P1|Overall Study|Withdrawal by Subject|1
1697681|NCT01248793|5927092|P2|Overall Study|Withdrawal by Subject|3
1697682|NCT01248793|5927093|P1|Overall Study|Withdrawal by Subject|3
1697683|NCT01248793|5927092|P2|Overall Study|Protocol Violation|1
1697684|NCT01248793|5927093|P1|Overall Study|Protocol Violation|0
1697685|NCT01248793|5927092|P2|Overall Study|Adverse Event|1
1697686|NCT01248793|5927093|P1|Overall Study|Adverse Event|1
1697687|NCT01248793|5927092|P2|Overall Study|Lost to Follow-up|1
1697688|NCT01248793|5927093|P1|Overall Study|Lost to Follow-up|0
1697689|NCT01248780|5927107|P2|Overall Study|Not treated|1
1697690|NCT01248780|5927108|P1|Overall Study|Not treated|0
1697691|NCT01248780|5927107|P2|Overall Study|Withdrawal by Subject|4
1697692|NCT01248780|5927108|P1|Overall Study|Withdrawal by Subject|4
1697693|NCT01248780|5927107|P2|Overall Study|Protocol Violation|1
1697694|NCT01248780|5927108|P1|Overall Study|Protocol Violation|1
1697695|NCT01248780|5927107|P2|Overall Study|Adverse Event|7
1697696|NCT01248780|5927108|P1|Overall Study|Adverse Event|2
1697697|NCT01248780|5927107|P2|Overall Study|Death|1
1697698|NCT01248780|5927108|P1|Overall Study|Death|0
1697699|NCT01248780|5927107|P2|Overall Study|Lost to Follow-up|1
1697700|NCT01248780|5927108|P1|Overall Study|Lost to Follow-up|0
1697701|NCT01248780|5927107|P2|Overall Study|Lack of Efficacy|0
1697702|NCT01248780|5927108|P1|Overall Study|Lack of Efficacy|2
1697703|NCT01248728|5927122|P2|Overall Study|Lack of Efficacy|0
1697704|NCT01248728|5927123|P1|Overall Study|Lack of Efficacy|1
1697705|NCT01248728|5927122|P2|Overall Study|Withdrawal by Subject|1
1697706|NCT01248728|5927123|P1|Overall Study|Withdrawal by Subject|2
1697707|NCT01248728|5927122|P2|Overall Study|Adverse Event|1
1697708|NCT01248728|5927123|P1|Overall Study|Adverse Event|1
1697709|NCT01248715|5927139|P2|Overall Study|Not influenza positive|510
1697710|NCT01248715|5927140|P1|Overall Study|Not influenza positive|501
1697711|NCT01248468|5927161|P3|Overall Study|Withdrawal by Subject|0
1697712|NCT01248468|5927162|P2|Overall Study|Withdrawal by Subject|2
1697713|NCT01248468|5927163|P1|Overall Study|Withdrawal by Subject|4
1697714|NCT01248468|5927161|P3|Overall Study|Pregnancy|0
1697715|NCT01248468|5927162|P2|Overall Study|Pregnancy|0
1697716|NCT01248468|5927163|P1|Overall Study|Pregnancy|1
1697717|NCT01248468|5927161|P3|Overall Study|Lost to Follow-up|4
1697718|NCT01248468|5927162|P2|Overall Study|Lost to Follow-up|12
1697719|NCT01248468|5927163|P1|Overall Study|Lost to Follow-up|9
1697720|NCT01248468|5927161|P3|Overall Study|Administrative problem|0
1697721|NCT01248468|5927162|P2|Overall Study|Administrative problem|0
1697722|NCT01248468|5927163|P1|Overall Study|Administrative problem|1
1697723|NCT01248455|5927180|P1|Overall Study|switched to alternate treatment|1
1697724|NCT01248364|5927225|P4|Overall Study|Adverse Event|0
1697725|NCT01248364|5927226|P3|Overall Study|Adverse Event|0
1697726|NCT01248364|5927227|P2|Overall Study|Adverse Event|1
1697727|NCT01248364|5927228|P1|Overall Study|Adverse Event|0
1697728|NCT01248130|5927291|P2|Overall Study|Ineligible|0
1697729|NCT01248130|5927292|P1|Overall Study|Ineligible|1
1697730|NCT01248130|5927291|P2|Overall Study|Protocol Violation|0
1697731|NCT01248130|5927292|P1|Overall Study|Protocol Violation|1
1697732|NCT01248065|5927302|P2|Overall Study|Other|5
1697733|NCT01248065|5927303|P1|Overall Study|Other|3
1697734|NCT01248065|5927302|P2|Overall Study|Third treatment failure event|1
1697735|NCT01248065|5927303|P1|Overall Study|Third treatment failure event|3
1697736|NCT01248065|5927302|P2|Overall Study|Adverse Event|0
1697737|NCT01248065|5927303|P1|Overall Study|Adverse Event|3
1697738|NCT01248065|5927302|P2|Overall Study|Withdrawal by Subject|11
1697739|NCT01248065|5927303|P1|Overall Study|Withdrawal by Subject|14
1697740|NCT01248065|5927302|P2|Overall Study|Lost to Follow-up|5
1697741|NCT01248065|5927303|P1|Overall Study|Lost to Follow-up|3
1697742|NCT01248013|5927313|P1|Overall Study|Withdrawal by Subject|14
1697743|NCT01247922|5927328|P1|Overall Study|Disease progression|4
1697744|NCT01247350|5927426|P5|Overall Study|Entry criteria not met|1
1697745|NCT01247350|5927427|P4|Overall Study|Entry criteria not met|0
1697746|NCT01247350|5927428|P3|Overall Study|Entry criteria not met|0
1697747|NCT01247350|5927429|P2|Overall Study|Entry criteria not met|0
1697748|NCT01247350|5927430|P1|Overall Study|Entry criteria not met|0
1697749|NCT01247350|5927426|P5|Overall Study|Withdrawal by Subject|0
1697750|NCT01247350|5927427|P4|Overall Study|Withdrawal by Subject|1
1697751|NCT01247350|5927428|P3|Overall Study|Withdrawal by Subject|0
1697752|NCT01247350|5927429|P2|Overall Study|Withdrawal by Subject|0
1697753|NCT01247350|5927430|P1|Overall Study|Withdrawal by Subject|0
1697754|NCT01247350|5927426|P5|Overall Study|Adverse Event|0
1697755|NCT01247350|5927427|P4|Overall Study|Adverse Event|0
1697756|NCT01247350|5927428|P3|Overall Study|Adverse Event|1
1697757|NCT01247350|5927429|P2|Overall Study|Adverse Event|0
1697758|NCT01247350|5927430|P1|Overall Study|Adverse Event|0
1697759|NCT01247324|5927488|P2|Overall Study|Lost to Follow-up|1
1697760|NCT01247324|5927489|P1|Overall Study|Lost to Follow-up|1
1697761|NCT01247324|5927488|P2|Overall Study|Adverse Event|13
1697762|NCT01247324|5927489|P1|Overall Study|Adverse Event|25
1697763|NCT01247324|5927488|P2|Overall Study|Consent withdrawn by participant|8
1697764|NCT01247324|5927489|P1|Overall Study|Consent withdrawn by participant|13
1697765|NCT01247324|5927488|P2|Overall Study|Reason not specified|8
1697766|NCT01247324|5927489|P1|Overall Study|Reason not specified|11
1697767|NCT01247324|5927488|P2|Overall Study|Protocol Violation|2
1697768|NCT01247324|5927489|P1|Overall Study|Protocol Violation|1
1697769|NCT01247324|5927488|P2|Overall Study|Pregnancy|3
1697770|NCT01247324|5927489|P1|Overall Study|Pregnancy|2
1697771|NCT01247324|5927488|P2|Overall Study|Non-compliance|0
1697772|NCT01247324|5927489|P1|Overall Study|Non-compliance|2
1697773|NCT01247324|5927488|P2|Overall Study|Lack of Efficacy|8
1697774|NCT01247324|5927489|P1|Overall Study|Lack of Efficacy|12
1697775|NCT01247324|5927488|P2|Overall Study|Non-compliance with study drug|0
1697776|NCT01247324|5927489|P1|Overall Study|Non-compliance with study drug|3
1697777|NCT01247324|5927488|P2|Overall Study|Physician Decision|1
1697778|NCT01247324|5927489|P1|Overall Study|Physician Decision|0
1697779|NCT01247324|5927488|P2|Overall Study|Death|0
1697780|NCT01247324|5927489|P1|Overall Study|Death|1
1697781|NCT01247090|5927582|P3|Overall Study|Withdrawal by Subject|0
1697782|NCT01247090|5927583|P2|Overall Study|Withdrawal by Subject|1
1697783|NCT01247090|5927584|P1|Overall Study|Withdrawal by Subject|0
1697784|NCT01247090|5927582|P3|Overall Study|Physician Decision|0
1697785|NCT01247090|5927583|P2|Overall Study|Physician Decision|0
1697786|NCT01247090|5927584|P1|Overall Study|Physician Decision|1
1697787|NCT01246999|5927613|P4|Overall Study|Withdrawal by Subject|2
1697788|NCT01246999|5927614|P3|Overall Study|Withdrawal by Subject|0
1697789|NCT01246999|5927615|P2|Overall Study|Withdrawal by Subject|0
1697790|NCT01246999|5927616|P1|Overall Study|Withdrawal by Subject|0
1697791|NCT01246999|5927613|P4|Overall Study|Lost to Follow-up|0
1697792|NCT01246999|5927614|P3|Overall Study|Lost to Follow-up|0
1697793|NCT01246999|5927615|P2|Overall Study|Lost to Follow-up|1
1697794|NCT01246999|5927616|P1|Overall Study|Lost to Follow-up|0
1697795|NCT01246973|5927651|P2|Overall Study|Withdrawal by Subject|13
1697796|NCT01246973|5927652|P1|Overall Study|Withdrawal by Subject|7
1697797|NCT01246973|5927651|P2|Overall Study|Adverse Event|9
1697798|NCT01246973|5927652|P1|Overall Study|Adverse Event|16
1697799|NCT01246973|5927651|P2|Overall Study|Other|25
1697800|NCT01246973|5927652|P1|Overall Study|Other|38
1697801|NCT01246960|5927662|P2|Overall Study|Withdrawal (by participant or physician)|3
1697802|NCT01246960|5927663|P1|Overall Study|Withdrawal (by participant or physician)|3
1697803|NCT01246960|5927662|P2|Overall Study|Lost to Follow-up|1
1697804|NCT01246960|5927663|P1|Overall Study|Lost to Follow-up|3
1697805|NCT01246206|5927771|P1|Overall Study|Patient did not receive study regiments.|1
1697806|NCT01246011|5927849|P3|Overall Study|Withdrawal by Subject|1
1697807|NCT01246011|5927850|P2|Overall Study|Withdrawal by Subject|0
1697808|NCT01246011|5927851|P1|Overall Study|Withdrawal by Subject|0
1697809|NCT01246011|5927849|P3|Overall Study|If needed warfarin clinically, withdrawn|3
1697810|NCT01246011|5927850|P2|Overall Study|If needed warfarin clinically, withdrawn|0
1697811|NCT01246011|5927851|P1|Overall Study|If needed warfarin clinically, withdrawn|0
1697812|NCT01245764|5927879|P4|Study Phase A|Lost to Follow-up|0
1697813|NCT01245764|5927880|P3|Study Phase A|Lost to Follow-up|5
1697814|NCT01245764|5927881|P2|Study Phase A|Lost to Follow-up|0
1697815|NCT01245764|5927882|P1|Study Phase A|Lost to Follow-up|0
1697816|NCT01245764|5927879|P4|Study Phase A|Protocol Violation|2
1697817|NCT01245764|5927880|P3|Study Phase A|Protocol Violation|2
1697818|NCT01245764|5927881|P2|Study Phase A|Protocol Violation|3
1697819|NCT01245764|5927882|P1|Study Phase A|Protocol Violation|6
1697820|NCT01245764|5927879|P4|Study Phase A|Other|1
1697821|NCT01245764|5927880|P3|Study Phase A|Other|3
1697822|NCT01245764|5927881|P2|Study Phase A|Other|2
1697823|NCT01245764|5927882|P1|Study Phase A|Other|3
1697824|NCT01245751|5927920|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1697825|NCT01245751|5927921|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1697826|NCT01245751|5927922|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
1697827|NCT01245751|5927923|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
1697828|NCT01245751|5927920|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
1697829|NCT01245751|5927921|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1697830|NCT01245751|5927922|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1697831|NCT01245751|5927923|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
1697832|NCT01245751|5927920|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
1697833|NCT01245751|5927921|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
1697834|NCT01245751|5927922|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
1697835|NCT01245751|5927923|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
1697836|NCT01245387|5928036|P1|Overall Study|Missing discontinuation status|369
1697837|NCT01245387|5928036|P1|Overall Study|Other|131
1697838|NCT01245387|5928036|P1|Overall Study|Death|3
1697839|NCT01245387|5928036|P1|Overall Study|Adverse Event|9
1697840|NCT01245387|5928036|P1|Overall Study|Lack of Efficacy|195
1697841|NCT01245387|5928036|P1|Overall Study|Lost to Follow-up|106
1697842|NCT01245374|5928085|P1|Overall Study|Withdrawal by Subject|3
1697843|NCT01245374|5928085|P1|Overall Study|Protocol Violation|1
1697844|NCT01245283|5928108|P3|Overall Study|Lost to Follow-up|11
1697845|NCT01245283|5928109|P2|Overall Study|Lost to Follow-up|11
1697846|NCT01245283|5928110|P1|Overall Study|Lost to Follow-up|14
1697847|NCT01245140|5928155|P2|Overall Study|Refused Treatment/Did Not Coopera|1
1697848|NCT01245140|5928156|P1|Overall Study|Refused Treatment/Did Not Coopera|0
1697849|NCT01245140|5928155|P2|Overall Study|Withdrawal by Subject|1
1697850|NCT01245140|5928156|P1|Overall Study|Withdrawal by Subject|0
1697851|NCT01245140|5928155|P2|Overall Study|Protocol Violation|1
1697852|NCT01245140|5928156|P1|Overall Study|Protocol Violation|0
1697853|NCT01245140|5928155|P2|Overall Study|Lack of Efficacy|4
1697854|NCT01245140|5928156|P1|Overall Study|Lack of Efficacy|2
1697855|NCT01245140|5928155|P2|Overall Study|Adverse Event|3
1697856|NCT01245140|5928156|P1|Overall Study|Adverse Event|1
1697857|NCT01245101|5928212|P2|Period 3 (Treatment)|Withdrawal by Subject|0
1697858|NCT01245101|5928213|P1|Period 3 (Treatment)|Withdrawal by Subject|1
1697859|NCT01245101|5928212|P2|Period 2 (Washout)|Withdrawal by Subject|0
1697860|NCT01245101|5928213|P1|Period 2 (Washout)|Withdrawal by Subject|1
1697861|NCT01245101|5928212|P2|Period 1 (Treatment)|Withdrawal by Subject|0
1697862|NCT01245101|5928213|P1|Period 1 (Treatment)|Withdrawal by Subject|2
1697863|NCT01245062|5928223|P3|Cross-over Phase|Study closed/ terminated|11
1697864|NCT01245062|5928224|P2|Cross-over Phase|Study closed/ terminated|0
1697865|NCT01245062|5928225|P1|Cross-over Phase|Study closed/ terminated|0
1697866|NCT01245062|5928223|P3|Cross-over Phase|Withdrew Consent|4
1697867|NCT01245062|5928224|P2|Cross-over Phase|Withdrew Consent|0
1697868|NCT01245062|5928225|P1|Cross-over Phase|Withdrew Consent|0
1697869|NCT01245062|5928223|P3|Cross-over Phase|Physician Decision|1
1697870|NCT01245062|5928224|P2|Cross-over Phase|Physician Decision|0
1697871|NCT01245062|5928225|P1|Cross-over Phase|Physician Decision|0
1697872|NCT01245062|5928223|P3|Cross-over Phase|Lost to Follow-up|1
1697873|NCT01245062|5928224|P2|Cross-over Phase|Lost to Follow-up|0
1697874|NCT01245062|5928225|P1|Cross-over Phase|Lost to Follow-up|0
1697875|NCT01245062|5928223|P3|Randomization and Crossover Phase|Study closed/ terminated|0
1697876|NCT01245062|5928224|P2|Randomization and Crossover Phase|Study closed/ terminated|14
1697877|NCT01245062|5928225|P1|Randomization and Crossover Phase|Study closed/ terminated|23
1697878|NCT01245062|5928223|P3|Randomization and Crossover Phase|Withdrew Consent|0
1697879|NCT01245062|5928224|P2|Randomization and Crossover Phase|Withdrew Consent|11
1697880|NCT01245062|5928225|P1|Randomization and Crossover Phase|Withdrew Consent|12
1697881|NCT01245062|5928223|P3|Randomization and Crossover Phase|Physician Decision|0
1697882|NCT01245062|5928224|P2|Randomization and Crossover Phase|Physician Decision|4
1697883|NCT01245062|5928225|P1|Randomization and Crossover Phase|Physician Decision|2
1697884|NCT01245062|5928223|P3|Randomization and Crossover Phase|Lost to Follow-up|0
1697885|NCT01245062|5928224|P2|Randomization and Crossover Phase|Lost to Follow-up|2
1697886|NCT01245062|5928225|P1|Randomization and Crossover Phase|Lost to Follow-up|4
1697887|NCT01245049|5928263|P2|Overall Study|Lost to Follow-up|2
1697888|NCT01245049|5928264|P1|Overall Study|Lost to Follow-up|1
1697889|NCT01245049|5928263|P2|Overall Study|Withdrawal by Subject|1
1697890|NCT01245049|5928264|P1|Overall Study|Withdrawal by Subject|0
1697891|NCT01245049|5928263|P2|Overall Study|Migrated/moved from study area|1
1697892|NCT01245049|5928264|P1|Overall Study|Migrated/moved from study area|0
1697893|NCT01244984|5928317|P3|Overall Study|Withdrawal by Subject|2
1697894|NCT01244984|5928318|P2|Overall Study|Withdrawal by Subject|2
1697895|NCT01244984|5928319|P1|Overall Study|Withdrawal by Subject|1
1697896|NCT01244984|5928317|P3|Overall Study|Protocol Defined Stopping Criteria|0
1697897|NCT01244984|5928318|P2|Overall Study|Protocol Defined Stopping Criteria|1
1697898|NCT01244984|5928319|P1|Overall Study|Protocol Defined Stopping Criteria|1
1697899|NCT01244984|5928317|P3|Overall Study|Protocol Violation|0
1697900|NCT01244984|5928318|P2|Overall Study|Protocol Violation|0
1697901|NCT01244984|5928319|P1|Overall Study|Protocol Violation|1
1697902|NCT01244984|5928317|P3|Overall Study|Adverse Event|2
1697903|NCT01244984|5928318|P2|Overall Study|Adverse Event|11
1697904|NCT01244984|5928319|P1|Overall Study|Adverse Event|2
1697905|NCT01244906|5928393|P1|Overall Study|Progression of disease post treatment|6
1697906|NCT01244906|5928393|P1|Overall Study|Death|2
1697907|NCT01244893|5928402|P2|1-Week Follow Up|Lost to Follow-up|0
1697908|NCT01244893|5928403|P1|1-Week Follow Up|Lost to Follow-up|1
1697909|NCT01244893|5928402|P2|Baseline|Protocol Violation|1
1697910|NCT01244893|5928403|P1|Baseline|Protocol Violation|0
1697911|NCT01244828|5928415|P1|Overall Study|Other reason (not specified)|1
1697912|NCT01244828|5928415|P1|Overall Study|Lost to Follow-up|2
1697913|NCT01244828|5928415|P1|Overall Study|Lack of Efficacy|7
1697914|NCT01244828|5928415|P1|Overall Study|Withdrawal by Subject|31
1697915|NCT01244828|5928415|P1|Overall Study|Adverse Event|37
1697916|NCT01244815|5928431|P4|Overall Study|Did Not Meet Protocol Eligibility|0
1697917|NCT01244815|5928432|P3|Overall Study|Did Not Meet Protocol Eligibility|0
1697918|NCT01244815|5928433|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1697919|NCT01244815|5928434|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1697920|NCT01244815|5928431|P4|Overall Study|Protocol Violation|1
1697921|NCT01244815|5928432|P3|Overall Study|Protocol Violation|3
1697922|NCT01244815|5928433|P2|Overall Study|Protocol Violation|4
1697923|NCT01244815|5928434|P1|Overall Study|Protocol Violation|7
1697924|NCT01244815|5928431|P4|Overall Study|Withdrawal by Subject|3
1697925|NCT01244815|5928432|P3|Overall Study|Withdrawal by Subject|0
1697926|NCT01244815|5928433|P2|Overall Study|Withdrawal by Subject|2
1697927|NCT01244815|5928434|P1|Overall Study|Withdrawal by Subject|0
1697928|NCT01244815|5928431|P4|Overall Study|Lost to Follow-up|2
1697929|NCT01244815|5928432|P3|Overall Study|Lost to Follow-up|3
1697930|NCT01244815|5928433|P2|Overall Study|Lost to Follow-up|2
1697931|NCT01244815|5928434|P1|Overall Study|Lost to Follow-up|3
1697932|NCT01244815|5928431|P4|Overall Study|Treatment Failure|1
1697933|NCT01244815|5928432|P3|Overall Study|Treatment Failure|0
1697934|NCT01244815|5928433|P2|Overall Study|Treatment Failure|0
1697935|NCT01244815|5928434|P1|Overall Study|Treatment Failure|0
1697936|NCT01244815|5928431|P4|Overall Study|Adverse Event|5
1697937|NCT01244815|5928432|P3|Overall Study|Adverse Event|5
1697938|NCT01244815|5928433|P2|Overall Study|Adverse Event|7
1697939|NCT01244815|5928434|P1|Overall Study|Adverse Event|4
1697940|NCT01244815|5928431|P4|Overall Study|Not Treated|0
1697941|NCT01244815|5928432|P3|Overall Study|Not Treated|0
1697942|NCT01244815|5928433|P2|Overall Study|Not Treated|1
1697943|NCT01244815|5928434|P1|Overall Study|Not Treated|0
1697944|NCT01244620|5928521|P4|Overall Study|Study terminated|4
1697945|NCT01244620|5928522|P3|Overall Study|Study terminated|4
1697946|NCT01244620|5928523|P2|Overall Study|Study terminated|4
1697947|NCT01244620|5928524|P1|Overall Study|Study terminated|4
1697948|NCT01244516|5928583|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
1697949|NCT01244516|5928584|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
1697950|NCT01244516|5928585|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
1697951|NCT01244516|5928583|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
1697952|NCT01244516|5928584|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
1697953|NCT01244516|5928585|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
1697954|NCT01244516|5928583|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
1697955|NCT01244516|5928584|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
1697956|NCT01244516|5928585|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
1697957|NCT01244516|5928583|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
1697958|NCT01244516|5928584|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
1697959|NCT01244516|5928585|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
1697960|NCT01244516|5928583|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
1697961|NCT01244516|5928584|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
1697962|NCT01244516|5928585|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
1697963|NCT01244516|5928583|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
1697964|NCT01244516|5928584|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
1697965|NCT01244516|5928585|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
1697966|NCT01244516|5928583|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
1697967|NCT01244516|5928584|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
1697968|NCT01244516|5928585|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
1697969|NCT01244490|5928606|P3|Overall Study|Other|1
1697970|NCT01244490|5928607|P2|Overall Study|Other|0
1697971|NCT01244490|5928608|P1|Overall Study|Other|0
1697972|NCT01244490|5928606|P3|Overall Study|Lost to Follow-up|3
1697973|NCT01244490|5928607|P2|Overall Study|Lost to Follow-up|6
1697974|NCT01244490|5928608|P1|Overall Study|Lost to Follow-up|0
1697975|NCT01244490|5928606|P3|Overall Study|Adverse Event|5
1697976|NCT01244490|5928607|P2|Overall Study|Adverse Event|9
1697977|NCT01244490|5928608|P1|Overall Study|Adverse Event|1
1697978|NCT01244490|5928606|P3|Overall Study|Withdrawal by Subject|9
1697979|NCT01244490|5928607|P2|Overall Study|Withdrawal by Subject|4
1697980|NCT01244490|5928608|P1|Overall Study|Withdrawal by Subject|4
1697981|NCT01244490|5928606|P3|Overall Study|Lack of Efficacy|5
1697982|NCT01244490|5928607|P2|Overall Study|Lack of Efficacy|5
1697983|NCT01244490|5928608|P1|Overall Study|Lack of Efficacy|14
1697984|NCT01244425|5928685|P2|Overall Study|Adverse Event|1
1697985|NCT01244425|5928686|P1|Overall Study|Adverse Event|1
1697986|NCT01244425|5928685|P2|Overall Study|Withdrawal by Subject|2
1697987|NCT01244425|5928686|P1|Overall Study|Withdrawal by Subject|2
1697988|NCT01244126|5928718|P3|Overall Study|Protocol Violation|9
1697989|NCT01244126|5928719|P2|Overall Study|Protocol Violation|3
1697990|NCT01244126|5928720|P1|Overall Study|Protocol Violation|3
1697991|NCT01244061|5928733|P2|Overall Study|Randomized but not treated|2
1697992|NCT01244061|5928734|P1|Overall Study|Randomized but not treated|2
1697993|NCT01244061|5928733|P2|Overall Study|Adverse Event|2
1697994|NCT01244061|5928734|P1|Overall Study|Adverse Event|5
1697995|NCT01244061|5928733|P2|Overall Study|Protocol Violation|1
1697996|NCT01244061|5928734|P1|Overall Study|Protocol Violation|1
1697997|NCT01244061|5928733|P2|Overall Study|Other|19
1697998|NCT01244061|5928734|P1|Overall Study|Other|8
1697999|NCT01244061|5928733|P2|Overall Study|Withdrawal by Subject|46
1698000|NCT01244061|5928734|P1|Overall Study|Withdrawal by Subject|29
1698001|NCT01244061|5928733|P2|Overall Study|Lost to Follow-up|30
1698002|NCT01244061|5928734|P1|Overall Study|Lost to Follow-up|34
1698003|NCT01244061|5928733|P2|Overall Study|Lack of Efficacy|3
1698004|NCT01244061|5928734|P1|Overall Study|Lack of Efficacy|1
1698005|NCT01244061|5928733|P2|Overall Study|Did not meet entrance criteria|0
1698006|NCT01244061|5928734|P1|Overall Study|Did not meet entrance criteria|1
1698007|NCT01244061|5928733|P2|Overall Study|Death|0
1698008|NCT01244061|5928734|P1|Overall Study|Death|1
1698009|NCT01244035|5928746|P6|Part 1: Period 3|Protocol Deviation|0
1698010|NCT01244035|5928747|P5|Part 1: Period 3|Protocol Deviation|0
1698011|NCT01244035|5928748|P4|Part 1: Period 3|Protocol Deviation|0
1698012|NCT01244035|5928749|P3|Part 1: Period 3|Protocol Deviation|0
1698013|NCT01244035|5928750|P2|Part 1: Period 3|Protocol Deviation|1
1698014|NCT01244035|5928751|P1|Part 1: Period 3|Protocol Deviation|0
1698015|NCT01244035|5928746|P6|Part 1: Period 3|Withdrawal by Subject|0
1698016|NCT01244035|5928747|P5|Part 1: Period 3|Withdrawal by Subject|1
1698017|NCT01244035|5928748|P4|Part 1: Period 3|Withdrawal by Subject|0
1698018|NCT01244035|5928749|P3|Part 1: Period 3|Withdrawal by Subject|0
1698019|NCT01244035|5928750|P2|Part 1: Period 3|Withdrawal by Subject|0
1698020|NCT01244035|5928751|P1|Part 1: Period 3|Withdrawal by Subject|0
1698021|NCT01244035|5928746|P6|Part 1: Period 3|Adverse Event|1
1698022|NCT01244035|5928747|P5|Part 1: Period 3|Adverse Event|0
1698023|NCT01244035|5928748|P4|Part 1: Period 3|Adverse Event|0
1698024|NCT01244035|5928749|P3|Part 1: Period 3|Adverse Event|0
1698025|NCT01244035|5928750|P2|Part 1: Period 3|Adverse Event|0
1698026|NCT01244035|5928751|P1|Part 1: Period 3|Adverse Event|0
1698027|NCT01244035|5928746|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
1698028|NCT01244035|5928747|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
1698029|NCT01244035|5928748|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
1698030|NCT01244035|5928749|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
1698031|NCT01244035|5928750|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
1698032|NCT01244035|5928751|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
1698033|NCT01244035|5928746|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
1698034|NCT01244035|5928747|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
1698035|NCT01244035|5928748|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
1698036|NCT01244035|5928749|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
1698037|NCT01244035|5928750|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
1698038|NCT01244035|5928751|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
1698039|NCT01244035|5928746|P6|Part 1: Period 1|Withdrawal by Subject|0
1698040|NCT01244035|5928747|P5|Part 1: Period 1|Withdrawal by Subject|0
1698041|NCT01244035|5928748|P4|Part 1: Period 1|Withdrawal by Subject|0
1698042|NCT01244035|5928749|P3|Part 1: Period 1|Withdrawal by Subject|0
1698043|NCT01244035|5928750|P2|Part 1: Period 1|Withdrawal by Subject|2
1698044|NCT01244035|5928751|P1|Part 1: Period 1|Withdrawal by Subject|0
1698045|NCT01244035|5928746|P6|Part 1: Period 1|Adverse Event|1
1698046|NCT01244035|5928747|P5|Part 1: Period 1|Adverse Event|0
1698047|NCT01244035|5928748|P4|Part 1: Period 1|Adverse Event|0
1698048|NCT01244035|5928749|P3|Part 1: Period 1|Adverse Event|0
1698049|NCT01244035|5928750|P2|Part 1: Period 1|Adverse Event|0
1698050|NCT01244035|5928751|P1|Part 1: Period 1|Adverse Event|0
1698051|NCT01243944|5928792|P2|Overall Study|Non-compliance with study treatment|0
1698052|NCT01243944|5928793|P1|Overall Study|Non-compliance with study treatment|1
1698053|NCT01243944|5928792|P2|Overall Study|Death|3
1698054|NCT01243944|5928793|P1|Overall Study|Death|2
1698055|NCT01243944|5928792|P2|Overall Study|Participant decision|15
1698056|NCT01243944|5928793|P1|Overall Study|Participant decision|10
1698057|NCT01243944|5928792|P2|Overall Study|Protocol deviation|1
1698058|NCT01243944|5928793|P1|Overall Study|Protocol deviation|1
1698059|NCT01243944|5928792|P2|Overall Study|Disease progression|11
1698060|NCT01243944|5928793|P1|Overall Study|Disease progression|12
1698061|NCT01243944|5928792|P2|Overall Study|Physician Decision|7
1698062|NCT01243944|5928793|P1|Overall Study|Physician Decision|2
1698063|NCT01243944|5928792|P2|Overall Study|Lost to Follow-up|1
1698064|NCT01243944|5928793|P1|Overall Study|Lost to Follow-up|2
1698065|NCT01243944|5928792|P2|Overall Study|Adverse Event|13
1698066|NCT01243944|5928793|P1|Overall Study|Adverse Event|15
1698067|NCT01243892|5928821|P2|Overall Study|Did not meet eligibility criteria|0
1698068|NCT01243892|5928822|P1|Overall Study|Did not meet eligibility criteria|2
1698069|NCT01243775|5928832|P1|Overall Study|Withdrawal by Subject|2
1698070|NCT01243762|5928846|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1698071|NCT01243762|5928847|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1698072|NCT01243762|5928848|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
1698073|NCT01243762|5928849|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
1698074|NCT01243762|5928850|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1698075|NCT01243762|5928851|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1698076|NCT01243762|5928852|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
1698077|NCT01243762|5928846|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1698078|NCT01243762|5928847|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1698079|NCT01243762|5928848|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
1698080|NCT01243762|5928849|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1698081|NCT01243762|5928850|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1698082|NCT01243762|5928851|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
1698083|NCT01243762|5928852|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
1698084|NCT01243762|5928846|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
1698085|NCT01243762|5928847|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
1698086|NCT01243762|5928848|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
1698087|NCT01243762|5928849|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
1698088|NCT01243762|5928850|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
1698089|NCT01243762|5928851|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
1698090|NCT01243762|5928852|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
1698091|NCT01243762|5928846|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
1698092|NCT01243762|5928847|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1698093|NCT01243762|5928848|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1698094|NCT01243762|5928849|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1698095|NCT01243762|5928850|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1698096|NCT01243762|5928851|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
1698097|NCT01243762|5928852|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
1698098|NCT01243762|5928846|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1698099|NCT01243762|5928847|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1698100|NCT01243762|5928848|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1698101|NCT01243762|5928849|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1698102|NCT01243762|5928850|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1698103|NCT01243762|5928851|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
1698104|NCT01243762|5928852|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
1698105|NCT01243762|5928846|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
1698106|NCT01243762|5928847|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
1698107|NCT01243762|5928848|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
1698108|NCT01243762|5928849|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
1698109|NCT01243762|5928850|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
1698110|NCT01243762|5928851|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
1698111|NCT01243762|5928852|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
1698112|NCT01243762|5928846|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1698113|NCT01243762|5928847|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1698114|NCT01243762|5928848|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1698115|NCT01243762|5928849|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
1698116|NCT01243762|5928850|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1698117|NCT01243762|5928851|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
1698118|NCT01243762|5928852|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
1698119|NCT01243762|5928846|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1698120|NCT01243762|5928847|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
1698121|NCT01243762|5928848|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
1698122|NCT01243762|5928849|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1698123|NCT01243762|5928850|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1698124|NCT01243762|5928851|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
1698125|NCT01243762|5928852|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
1698126|NCT01243671|5928871|P1|Overall Study|Other|1
1698127|NCT01243671|5928871|P1|Overall Study|Anti-adalimumab antibody positive|1
1698128|NCT01243671|5928871|P1|Overall Study|Adverse Event|3
1698129|NCT01243424|5928950|P2|Discontinuation From Treatment|Other than listed above|211
1698130|NCT01243424|5928951|P1|Discontinuation From Treatment|Other than listed above|230
1698131|NCT01243424|5928950|P2|Discontinuation From Treatment|Withdrawal by Subject|328
1698132|NCT01243424|5928951|P1|Discontinuation From Treatment|Withdrawal by Subject|309
1698133|NCT01243424|5928950|P2|Discontinuation From Treatment|Lost to Follow-up|28
1698134|NCT01243424|5928951|P1|Discontinuation From Treatment|Lost to Follow-up|24
1698135|NCT01243424|5928950|P2|Discontinuation From Treatment|Protocol Violation|47
1698136|NCT01243424|5928951|P1|Discontinuation From Treatment|Protocol Violation|46
1698137|NCT01243424|5928950|P2|Discontinuation From Treatment|Lack of Efficacy|41
1698138|NCT01243424|5928951|P1|Discontinuation From Treatment|Lack of Efficacy|61
1698139|NCT01243424|5928950|P2|Discontinuation From Treatment|Adverse Event|523
1698140|NCT01243424|5928951|P1|Discontinuation From Treatment|Adverse Event|457
1698141|NCT01243424|5928950|P2|Discontinuation From Treatment|Not treated|4
1698142|NCT01243424|5928951|P1|Discontinuation From Treatment|Not treated|5
1698143|NCT01243424|5928950|P2|Discontinuation From Study (Treated Set)|Not treated|4
1698144|NCT01243424|5928951|P1|Discontinuation From Study (Treated Set)|Not treated|5
1698145|NCT01243424|5928950|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusUnknown)|8
1698146|NCT01243424|5928951|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusUnknown)|8
1698147|NCT01243424|5928950|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusAlive)|35
1698148|NCT01243424|5928951|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusAlive)|38
1698149|NCT01243424|5928950|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
1698150|NCT01243424|5928951|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
1698151|NCT01243424|5928950|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
1698152|NCT01243424|5928951|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
1698153|NCT01243424|5928950|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
1698154|NCT01243424|5928951|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
1698155|NCT01243424|5928950|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
1698156|NCT01243424|5928951|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
1698157|NCT01243411|5928993|P1|Overall Study|Other|8
1698158|NCT01243411|5928993|P1|Overall Study|Adverse Event|5
1698159|NCT01243411|5928993|P1|Overall Study|Lost to Follow-up|10
1698160|NCT01243411|5928993|P1|Overall Study|Withdrawal by Subject|18
1698161|NCT01243268|5929104|P1|Overall Study|Duplicate subject|2
1698162|NCT01243268|5929104|P1|Overall Study|Deviation with contract date|7
1698163|NCT01243268|5929104|P1|Overall Study|Protocol Violation|51
1698164|NCT01243268|5929104|P1|Overall Study|Lost to Follow-up|4
1698165|NCT01243242|5929114|P2|Overall Study|non compliance|0
1698166|NCT01243242|5929115|P1|Overall Study|non compliance|1
1698167|NCT01243242|5929114|P2|Overall Study|sponsor decision|1
1698168|NCT01243242|5929115|P1|Overall Study|sponsor decision|0
1698169|NCT01243242|5929114|P2|Overall Study|Physician Decision|1
1698170|NCT01243242|5929115|P1|Overall Study|Physician Decision|0
1698171|NCT01243242|5929114|P2|Overall Study|Withdrawal by Subject|1
1698172|NCT01243242|5929115|P1|Overall Study|Withdrawal by Subject|1
1698173|NCT01243242|5929114|P2|Overall Study|Adverse Event|1
1698174|NCT01243242|5929115|P1|Overall Study|Adverse Event|1
1698175|NCT01243177|5929129|P2|Overall Study|Other Reason|12
1698176|NCT01243177|5929130|P1|Overall Study|Other Reason|11
1698177|NCT01243177|5929129|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1698178|NCT01243177|5929130|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1698179|NCT01243177|5929129|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
1698180|NCT01243177|5929130|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
1698181|NCT01243177|5929129|P2|Overall Study|AE, non-serious non-fatal|58
1698182|NCT01243177|5929130|P1|Overall Study|AE, non-serious non-fatal|40
1698183|NCT01243177|5929129|P2|Overall Study|SAE, non-fatal|9
1698184|NCT01243177|5929130|P1|Overall Study|SAE, non-fatal|7
1698185|NCT01243177|5929129|P2|Overall Study|AE, serious fatal|1
1698186|NCT01243177|5929130|P1|Overall Study|AE, serious fatal|0
1698187|NCT01243177|5929129|P2|Overall Study|Withdrawal by Subject|38
1698188|NCT01243177|5929130|P1|Overall Study|Withdrawal by Subject|46
1698189|NCT01243177|5929129|P2|Overall Study|Lost to Follow-up|18
1698190|NCT01243177|5929130|P1|Overall Study|Lost to Follow-up|15
1698191|NCT01243177|5929129|P2|Overall Study|Protocol Violation|10
1698192|NCT01243177|5929130|P1|Overall Study|Protocol Violation|11
1698193|NCT01243177|5929129|P2|Overall Study|Lack of Efficacy|31
1698194|NCT01243177|5929130|P1|Overall Study|Lack of Efficacy|47
1698195|NCT01243151|5929151|P5|Overall Study|Randomized but not treated|0
1698196|NCT01243151|5929152|P4|Overall Study|Randomized but not treated|1
1698197|NCT01243151|5929153|P3|Overall Study|Randomized but not treated|0
1698198|NCT01243151|5929154|P2|Overall Study|Randomized but not treated|0
1698199|NCT01243151|5929155|P1|Overall Study|Randomized but not treated|0
1698200|NCT01243151|5929151|P5|Overall Study|Other|0
1698201|NCT01243151|5929152|P4|Overall Study|Other|1
1698202|NCT01243151|5929153|P3|Overall Study|Other|0
1698203|NCT01243151|5929154|P2|Overall Study|Other|0
1698204|NCT01243151|5929155|P1|Overall Study|Other|0
1698205|NCT01243151|5929151|P5|Overall Study|Protocol Violation|0
1698206|NCT01243151|5929152|P4|Overall Study|Protocol Violation|0
1698207|NCT01243151|5929153|P3|Overall Study|Protocol Violation|1
1698208|NCT01243151|5929154|P2|Overall Study|Protocol Violation|0
1698209|NCT01243151|5929155|P1|Overall Study|Protocol Violation|0
1698210|NCT01243151|5929151|P5|Overall Study|Adverse Event|0
1698211|NCT01243151|5929152|P4|Overall Study|Adverse Event|0
1698212|NCT01243151|5929153|P3|Overall Study|Adverse Event|0
1698213|NCT01243151|5929154|P2|Overall Study|Adverse Event|1
1698214|NCT01243151|5929155|P1|Overall Study|Adverse Event|0
1698215|NCT01242813|5929399|P1|Overall Study|Lost to Follow-up|2
1698216|NCT01242748|5929421|P2|Overall Study|Miscellaneous reasons|3
1698217|NCT01242748|5929422|P1|Overall Study|Miscellaneous reasons|8
1698218|NCT01242748|5929421|P2|Overall Study|Withdrawal by Subject|2
1698219|NCT01242748|5929422|P1|Overall Study|Withdrawal by Subject|10
1698220|NCT01242748|5929421|P2|Overall Study|Protocol Violation|0
1698221|NCT01242748|5929422|P1|Overall Study|Protocol Violation|1
1698222|NCT01242748|5929421|P2|Overall Study|Physician Decision|2
1698223|NCT01242748|5929422|P1|Overall Study|Physician Decision|3
1698224|NCT01242748|5929421|P2|Overall Study|Lost to Follow-up|2
1698225|NCT01242748|5929422|P1|Overall Study|Lost to Follow-up|6
1698226|NCT01242748|5929421|P2|Overall Study|Adverse Event|5
1698227|NCT01242748|5929422|P1|Overall Study|Adverse Event|10
1698228|NCT01242514|5929462|P3|Overall Study|Adverse Event|19
1698229|NCT01242514|5929463|P2|Overall Study|Adverse Event|18
1698230|NCT01242514|5929464|P1|Overall Study|Adverse Event|129
1698231|NCT01242514|5929462|P3|Overall Study|Lost to Follow-up|4
1698232|NCT01242514|5929463|P2|Overall Study|Lost to Follow-up|5
1698233|NCT01242514|5929464|P1|Overall Study|Lost to Follow-up|14
1698234|NCT01242514|5929462|P3|Overall Study|Dev. of study specific discont. criteria|5
1698235|NCT01242514|5929463|P2|Overall Study|Dev. of study specific discont. criteria|3
1698236|NCT01242514|5929464|P1|Overall Study|Dev. of study specific discont. criteria|21
1698237|NCT01242514|5929462|P3|Overall Study|Lack of therapeutic response|10
1698238|NCT01242514|5929463|P2|Overall Study|Lack of therapeutic response|16
1698239|NCT01242514|5929464|P1|Overall Study|Lack of therapeutic response|99
1698240|NCT01242514|5929462|P3|Overall Study|Severe non-compliance to protocol|1
1698241|NCT01242514|5929463|P2|Overall Study|Severe non-compliance to protocol|2
1698242|NCT01242514|5929464|P1|Overall Study|Severe non-compliance to protocol|5
1698243|NCT01242514|5929462|P3|Overall Study|Subject decision|2
1698244|NCT01242514|5929463|P2|Overall Study|Subject decision|8
1698245|NCT01242514|5929464|P1|Overall Study|Subject decision|33
1698246|NCT01242514|5929462|P3|Overall Study|e.g., project closure|171
1698247|NCT01242514|5929463|P2|Overall Study|e.g., project closure|305
1698248|NCT01242514|5929464|P1|Overall Study|e.g., project closure|1042
1698249|NCT01242371|5929483|P2|Overall Study|Protocol Violation|3
1698250|NCT01242371|5929484|P1|Overall Study|Protocol Violation|0
1698251|NCT01242371|5929483|P2|Overall Study|Withdrawal by Subject|2
1698252|NCT01242371|5929484|P1|Overall Study|Withdrawal by Subject|2
1698253|NCT01242176|5929490|P2|Washout Period of 7 Days|Non-compliant with protocol|0
1698254|NCT01242176|5929491|P1|Washout Period of 7 Days|Non-compliant with protocol|1
1698255|NCT01242176|5929490|P2|Washout Period of 7 Days|Adverse Event|2
1698256|NCT01242176|5929491|P1|Washout Period of 7 Days|Adverse Event|0
1698257|NCT01242111|5929501|P1|Overall Study|Did not consent to MOR-100 follow-up|1
1698258|NCT01242111|5929501|P1|Overall Study|Withdrawal by Subject|1
1698259|NCT01242111|5929501|P1|Overall Study|Adverse Event|1
1698260|NCT01242085|5929513|P3|Overall Study|medically unable to have surgery|0
1698261|NCT01242085|5929514|P2|Overall Study|medically unable to have surgery|5
1698262|NCT01242085|5929515|P1|Overall Study|medically unable to have surgery|4
1698263|NCT01242085|5929513|P3|Overall Study|Withdrawal by Subject|0
1698264|NCT01242085|5929514|P2|Overall Study|Withdrawal by Subject|2
1698265|NCT01242085|5929515|P1|Overall Study|Withdrawal by Subject|4
1698266|NCT01242020|5929525|P2|Overall Study|Failed screening|0
1698267|NCT01242020|5929526|P1|Overall Study|Failed screening|1
1698268|NCT01242020|5929525|P2|Overall Study|Withdrawal by Subject|0
1698269|NCT01242020|5929526|P1|Overall Study|Withdrawal by Subject|2
1698270|NCT01241760|5929556|P2|Overall Study|Other|1
1698271|NCT01241760|5929557|P1|Overall Study|Other|1
1698272|NCT01241760|5929556|P2|Overall Study|Switch To Commercially Available Medicat|4
1698273|NCT01241760|5929557|P1|Overall Study|Switch To Commercially Available Medicat|1
1698274|NCT01241760|5929556|P2|Overall Study|Withdrawal by Subject|13
1698275|NCT01241760|5929557|P1|Overall Study|Withdrawal by Subject|13
1698276|NCT01241760|5929556|P2|Overall Study|Lost to Follow-up|22
1698277|NCT01241760|5929557|P1|Overall Study|Lost to Follow-up|18
1698278|NCT01241760|5929556|P2|Overall Study|Adverse Event|0
1698279|NCT01241760|5929557|P1|Overall Study|Adverse Event|1
1698280|NCT01241604|5929576|P3|Screening Period|Screen Failure|0
1698281|NCT01241604|5929577|P2|Screening Period|Screen Failure|0
1698282|NCT01241604|5929578|P1|Screening Period|Screen Failure|3
1698283|NCT01241591|5929623|P4|Overall Study|Adverse Event|4
1698284|NCT01241591|5929624|P3|Overall Study|Adverse Event|12
1698285|NCT01241591|5929625|P2|Overall Study|Adverse Event|11
1698286|NCT01241591|5929626|P1|Overall Study|Adverse Event|3
1698287|NCT01241591|5929623|P4|Overall Study|Other|1
1698288|NCT01241591|5929624|P3|Overall Study|Other|0
1698289|NCT01241591|5929625|P2|Overall Study|Other|1
1698290|NCT01241591|5929626|P1|Overall Study|Other|0
1698291|NCT01241591|5929623|P4|Overall Study|Withdrawal by Subject|2
1698292|NCT01241591|5929624|P3|Overall Study|Withdrawal by Subject|2
1698293|NCT01241591|5929625|P2|Overall Study|Withdrawal by Subject|4
1698294|NCT01241591|5929626|P1|Overall Study|Withdrawal by Subject|6
1698295|NCT01241591|5929623|P4|Overall Study|Screen Failure|0
1698296|NCT01241591|5929624|P3|Overall Study|Screen Failure|1
1698297|NCT01241591|5929625|P2|Overall Study|Screen Failure|2
1698298|NCT01241591|5929626|P1|Overall Study|Screen Failure|3
1698299|NCT01241591|5929623|P4|Overall Study|Lost to Follow-up|2
1698300|NCT01241591|5929624|P3|Overall Study|Lost to Follow-up|2
1698301|NCT01241591|5929625|P2|Overall Study|Lost to Follow-up|2
1698302|NCT01241591|5929626|P1|Overall Study|Lost to Follow-up|1
1698303|NCT01241591|5929623|P4|Overall Study|Protocol Violation|0
1698304|NCT01241591|5929624|P3|Overall Study|Protocol Violation|3
1698305|NCT01241591|5929625|P2|Overall Study|Protocol Violation|2
1698306|NCT01241591|5929626|P1|Overall Study|Protocol Violation|5
1698307|NCT01241591|5929623|P4|Overall Study|Lack of Efficacy|3
1698308|NCT01241591|5929624|P3|Overall Study|Lack of Efficacy|2
1698309|NCT01241591|5929625|P2|Overall Study|Lack of Efficacy|2
1698310|NCT01241591|5929626|P1|Overall Study|Lack of Efficacy|5
1698311|NCT01241552|5929829|P4|Overall Study|Lost to Follow-up|16
1698312|NCT01241552|5929830|P3|Overall Study|Lost to Follow-up|15
1698313|NCT01241552|5929831|P2|Overall Study|Lost to Follow-up|11
1698314|NCT01241552|5929832|P1|Overall Study|Lost to Follow-up|2
1698315|NCT01241552|5929829|P4|Overall Study|Physician Decision|3
1698316|NCT01241552|5929830|P3|Overall Study|Physician Decision|2
1698317|NCT01241552|5929831|P2|Overall Study|Physician Decision|4
1698318|NCT01241552|5929832|P1|Overall Study|Physician Decision|2
1698319|NCT01241552|5929829|P4|Overall Study|Withdrawal by Subject|15
1698320|NCT01241552|5929830|P3|Overall Study|Withdrawal by Subject|14
1698321|NCT01241552|5929831|P2|Overall Study|Withdrawal by Subject|15
1698322|NCT01241552|5929832|P1|Overall Study|Withdrawal by Subject|7
1698323|NCT01241552|5929829|P4|Overall Study|Protocol Violation|1
1698324|NCT01241552|5929830|P3|Overall Study|Protocol Violation|6
1698325|NCT01241552|5929831|P2|Overall Study|Protocol Violation|2
1698326|NCT01241552|5929832|P1|Overall Study|Protocol Violation|0
1698327|NCT01241552|5929829|P4|Overall Study|Progressive Disease|2
1698328|NCT01241552|5929830|P3|Overall Study|Progressive Disease|1
1698329|NCT01241552|5929831|P2|Overall Study|Progressive Disease|0
1698330|NCT01241552|5929832|P1|Overall Study|Progressive Disease|0
1698331|NCT01241552|5929829|P4|Overall Study|Technical Problems|2
1698332|NCT01241552|5929830|P3|Overall Study|Technical Problems|2
1698333|NCT01241552|5929831|P2|Overall Study|Technical Problems|0
1698334|NCT01241552|5929832|P1|Overall Study|Technical Problems|2
1698335|NCT01241552|5929829|P4|Overall Study|Adverse Event|0
1698336|NCT01241552|5929830|P3|Overall Study|Adverse Event|0
1698337|NCT01241552|5929831|P2|Overall Study|Adverse Event|1
1698338|NCT01241552|5929832|P1|Overall Study|Adverse Event|1
1698339|NCT01241552|5929829|P4|Overall Study|Death|25
1698340|NCT01241552|5929830|P3|Overall Study|Death|20
1698341|NCT01241552|5929831|P2|Overall Study|Death|30
1698342|NCT01241552|5929832|P1|Overall Study|Death|26
1698343|NCT01241552|5929829|P4|Overall Study|Lack of Efficacy|0
1698344|NCT01241552|5929830|P3|Overall Study|Lack of Efficacy|0
1698345|NCT01241552|5929831|P2|Overall Study|Lack of Efficacy|0
1698346|NCT01241552|5929832|P1|Overall Study|Lack of Efficacy|1
1698347|NCT01241461|5929927|P2|Overall Study|Progressive Disease|6
1698348|NCT01241461|5929928|P1|Overall Study|Progressive Disease|3
1698349|NCT01241448|5929948|P4|Overall Study|Excluded due to data integrity issues|2
1698350|NCT01241448|5929949|P3|Overall Study|Excluded due to data integrity issues|2
1698351|NCT01241448|5929950|P2|Overall Study|Excluded due to data integrity issues|2
1698352|NCT01241448|5929951|P1|Overall Study|Excluded due to data integrity issues|3
1698353|NCT01241448|5929948|P4|Overall Study|Withdrawal by Subject|6
1698354|NCT01241448|5929949|P3|Overall Study|Withdrawal by Subject|3
1698355|NCT01241448|5929950|P2|Overall Study|Withdrawal by Subject|5
1698356|NCT01241448|5929951|P1|Overall Study|Withdrawal by Subject|4
1698357|NCT01241448|5929948|P4|Overall Study|Sponsor Decision|6
1698358|NCT01241448|5929949|P3|Overall Study|Sponsor Decision|12
1698359|NCT01241448|5929950|P2|Overall Study|Sponsor Decision|14
1698360|NCT01241448|5929951|P1|Overall Study|Sponsor Decision|17
1698361|NCT01241448|5929948|P4|Overall Study|Protocol Violation|6
1698362|NCT01241448|5929949|P3|Overall Study|Protocol Violation|3
1698363|NCT01241448|5929950|P2|Overall Study|Protocol Violation|5
1698364|NCT01241448|5929951|P1|Overall Study|Protocol Violation|10
1698365|NCT01241448|5929948|P4|Overall Study|Physician Decision|0
1698366|NCT01241448|5929949|P3|Overall Study|Physician Decision|0
1698367|NCT01241448|5929950|P2|Overall Study|Physician Decision|2
1698368|NCT01241448|5929951|P1|Overall Study|Physician Decision|0
1698369|NCT01241448|5929948|P4|Overall Study|Lost to Follow-up|1
1698370|NCT01241448|5929949|P3|Overall Study|Lost to Follow-up|1
1698371|NCT01241448|5929950|P2|Overall Study|Lost to Follow-up|1
1698372|NCT01241448|5929951|P1|Overall Study|Lost to Follow-up|2
1698373|NCT01241448|5929948|P4|Overall Study|Adverse Event|2
1698374|NCT01241448|5929949|P3|Overall Study|Adverse Event|2
1698375|NCT01241448|5929950|P2|Overall Study|Adverse Event|0
1698376|NCT01241448|5929951|P1|Overall Study|Adverse Event|1
1698377|NCT01241318|5930042|P2|Overall Study|Woman: Stillborn infant|146
1698378|NCT01241318|5930043|P1|Overall Study|Woman: Stillborn infant|129
1698379|NCT01241318|5930042|P2|Overall Study|Withdrew/LTF after delivery|38
1698380|NCT01241318|5930043|P1|Overall Study|Withdrew/LTF after delivery|60
1698381|NCT01241318|5930042|P2|Overall Study|Death|4
1698382|NCT01241318|5930043|P1|Overall Study|Death|2
1698383|NCT01241318|5930042|P2|Overall Study|Lost to Follow-up|455
1698384|NCT01241318|5930043|P1|Overall Study|Lost to Follow-up|740
1698385|NCT01241318|5930042|P2|Overall Study|Withdrawal by Subject|46
1698386|NCT01241318|5930043|P1|Overall Study|Withdrawal by Subject|175
1698387|NCT01241318|5930042|P2|Overall Study|Woman: miscarriage/abortion|38
1698388|NCT01241318|5930043|P1|Overall Study|Woman: miscarriage/abortion|46
1698389|NCT01241318|5930042|P2|Overall Study|Woman: false pregnancies|15
1698390|NCT01241318|5930043|P1|Overall Study|Woman: false pregnancies|27
1698391|NCT01241292|5930056|P2|Overall Study|Participant Discontinued Treatment|2
1698392|NCT01241292|5930057|P1|Overall Study|Participant Discontinued Treatment|0
1698393|NCT01241292|5930056|P2|Overall Study|Study Drug Toxicity|1
1698394|NCT01241292|5930057|P1|Overall Study|Study Drug Toxicity|0
1698395|NCT01241292|5930056|P2|Overall Study|Disease Progression|0
1698396|NCT01241292|5930057|P1|Overall Study|Disease Progression|2
1698397|NCT01241292|5930056|P2|Overall Study|Administrative Reason by Sponsor|0
1698398|NCT01241292|5930057|P1|Overall Study|Administrative Reason by Sponsor|1
1698399|NCT01241279|5930081|P2|Overall Study|Lost to Follow-up|1
1698400|NCT01241279|5930082|P1|Overall Study|Lost to Follow-up|0
1698401|NCT01241240|5930092|P2|Overall Study|Personal Reasons|1
1698402|NCT01241240|5930093|P1|Overall Study|Personal Reasons|1
1698403|NCT01241240|5930092|P2|Overall Study|Lost to Follow-up|4
1698404|NCT01241240|5930093|P1|Overall Study|Lost to Follow-up|2
1698405|NCT01241240|5930092|P2|Overall Study|Adverse Event|4
1698406|NCT01241240|5930093|P1|Overall Study|Adverse Event|5
1698407|NCT01240915|5930111|P9|Overall Study|Insufficient Clinical Response|3
1698408|NCT01240915|5930112|P8|Overall Study|Insufficient Clinical Response|0
1698409|NCT01240915|5930113|P7|Overall Study|Insufficient Clinical Response|6
1698410|NCT01240915|5930114|P6|Overall Study|Insufficient Clinical Response|3
1698411|NCT01240915|5930115|P5|Overall Study|Insufficient Clinical Response|1
1698412|NCT01240915|5930116|P4|Overall Study|Insufficient Clinical Response|0
1698413|NCT01240915|5930117|P3|Overall Study|Insufficient Clinical Response|0
1698414|NCT01240915|5930118|P2|Overall Study|Insufficient Clinical Response|0
1698415|NCT01240915|5930119|P1|Overall Study|Insufficient Clinical Response|0
1698416|NCT01240915|5930111|P9|Overall Study|Other|0
1698417|NCT01240915|5930112|P8|Overall Study|Other|0
1698418|NCT01240915|5930113|P7|Overall Study|Other|0
1698419|NCT01240915|5930114|P6|Overall Study|Other|0
1698420|NCT01240915|5930115|P5|Overall Study|Other|2
1698421|NCT01240915|5930116|P4|Overall Study|Other|0
1698422|NCT01240915|5930117|P3|Overall Study|Other|0
1698423|NCT01240915|5930118|P2|Overall Study|Other|0
1698424|NCT01240915|5930119|P1|Overall Study|Other|0
1698425|NCT01240915|5930111|P9|Overall Study|Withdrawal by Subject|3
1698426|NCT01240915|5930112|P8|Overall Study|Withdrawal by Subject|3
1698427|NCT01240915|5930113|P7|Overall Study|Withdrawal by Subject|2
1698428|NCT01240915|5930114|P6|Overall Study|Withdrawal by Subject|4
1698429|NCT01240915|5930115|P5|Overall Study|Withdrawal by Subject|0
1698430|NCT01240915|5930116|P4|Overall Study|Withdrawal by Subject|2
1698431|NCT01240915|5930117|P3|Overall Study|Withdrawal by Subject|0
1698432|NCT01240915|5930118|P2|Overall Study|Withdrawal by Subject|1
1698433|NCT01240915|5930119|P1|Overall Study|Withdrawal by Subject|2
1698434|NCT01240915|5930111|P9|Overall Study|Lost to Follow-up|1
1698435|NCT01240915|5930112|P8|Overall Study|Lost to Follow-up|1
1698436|NCT01240915|5930113|P7|Overall Study|Lost to Follow-up|0
1698437|NCT01240915|5930114|P6|Overall Study|Lost to Follow-up|1
1698438|NCT01240915|5930115|P5|Overall Study|Lost to Follow-up|1
1698439|NCT01240915|5930116|P4|Overall Study|Lost to Follow-up|0
1698440|NCT01240915|5930117|P3|Overall Study|Lost to Follow-up|0
1698441|NCT01240915|5930118|P2|Overall Study|Lost to Follow-up|0
1698442|NCT01240915|5930119|P1|Overall Study|Lost to Follow-up|0
1698443|NCT01240915|5930111|P9|Overall Study|Adverse Event|1
1698444|NCT01240915|5930112|P8|Overall Study|Adverse Event|0
1698445|NCT01240915|5930113|P7|Overall Study|Adverse Event|0
1698446|NCT01240915|5930114|P6|Overall Study|Adverse Event|2
1698447|NCT01240915|5930115|P5|Overall Study|Adverse Event|0
1698448|NCT01240915|5930116|P4|Overall Study|Adverse Event|1
1698449|NCT01240915|5930117|P3|Overall Study|Adverse Event|0
1698450|NCT01240915|5930118|P2|Overall Study|Adverse Event|0
1698451|NCT01240915|5930119|P1|Overall Study|Adverse Event|0
1698452|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
1698453|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
1698454|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
1698455|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Other|5
1698456|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Other|1
1698457|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Other|0
1698458|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
1698537|NCT01240382|5930608|P1|Overall Study|Fear of adverse events|0
1698459|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
1698460|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
1698461|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
1698462|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
1698463|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
1698464|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
1698465|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
1698466|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
1698467|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
1698468|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
1698469|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
1698470|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
1698471|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
1698472|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
1698473|NCT01240863|5930393|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
1698474|NCT01240863|5930394|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
1698475|NCT01240863|5930395|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
1698476|NCT01240863|5930393|P3|Open-label Titration Period|Other|0
1698477|NCT01240863|5930394|P2|Open-label Titration Period|Other|0
1698478|NCT01240863|5930395|P1|Open-label Titration Period|Other|7
1698479|NCT01240863|5930393|P3|Open-label Titration Period|Dropped out prior to dosing|0
1698480|NCT01240863|5930394|P2|Open-label Titration Period|Dropped out prior to dosing|0
1698481|NCT01240863|5930395|P1|Open-label Titration Period|Dropped out prior to dosing|2
1698482|NCT01240863|5930393|P3|Open-label Titration Period|Noncompliance to study procedures|0
1698483|NCT01240863|5930394|P2|Open-label Titration Period|Noncompliance to study procedures|0
1698484|NCT01240863|5930395|P1|Open-label Titration Period|Noncompliance to study procedures|3
1698485|NCT01240863|5930393|P3|Open-label Titration Period|Noncompliance to study drug admin|0
1698486|NCT01240863|5930394|P2|Open-label Titration Period|Noncompliance to study drug admin|0
1698487|NCT01240863|5930395|P1|Open-label Titration Period|Noncompliance to study drug admin|3
1698488|NCT01240863|5930393|P3|Open-label Titration Period|Protocol Violation|0
1698489|NCT01240863|5930394|P2|Open-label Titration Period|Protocol Violation|0
1698490|NCT01240863|5930395|P1|Open-label Titration Period|Protocol Violation|7
1698491|NCT01240863|5930393|P3|Open-label Titration Period|Withdrawal by Subject|0
1698492|NCT01240863|5930394|P2|Open-label Titration Period|Withdrawal by Subject|0
1698493|NCT01240863|5930395|P1|Open-label Titration Period|Withdrawal by Subject|9
1698494|NCT01240863|5930393|P3|Open-label Titration Period|Lack of Efficacy|0
1698495|NCT01240863|5930394|P2|Open-label Titration Period|Lack of Efficacy|0
1698496|NCT01240863|5930395|P1|Open-label Titration Period|Lack of Efficacy|19
1698497|NCT01240863|5930393|P3|Open-label Titration Period|Adverse Event|0
1698498|NCT01240863|5930394|P2|Open-label Titration Period|Adverse Event|0
1698499|NCT01240863|5930395|P1|Open-label Titration Period|Adverse Event|47
1698500|NCT01240811|5930457|P3|Overall Study|Withdrawal by Subject|1
1698501|NCT01240811|5930458|P2|Overall Study|Withdrawal by Subject|0
1698502|NCT01240811|5930459|P1|Overall Study|Withdrawal by Subject|0
1698503|NCT01240811|5930457|P3|Overall Study|Physician Decision|0
1698504|NCT01240811|5930458|P2|Overall Study|Physician Decision|1
1698505|NCT01240811|5930459|P1|Overall Study|Physician Decision|0
1698506|NCT01240785|5930475|P2|Overall Study|Protocol Violation|3
1698507|NCT01240785|5930476|P1|Overall Study|Protocol Violation|0
1698508|NCT01240785|5930475|P2|Overall Study|Lost to Follow-up|0
1698509|NCT01240785|5930476|P1|Overall Study|Lost to Follow-up|1
1698510|NCT01240746|5930507|P3|Overall Study|Withdrawal by Subject|59
1698511|NCT01240746|5930508|P2|Overall Study|Withdrawal by Subject|13
1698512|NCT01240746|5930509|P1|Overall Study|Withdrawal by Subject|10
1698513|NCT01240746|5930507|P3|Overall Study|Protocol Violation|72
1698514|NCT01240746|5930508|P2|Overall Study|Protocol Violation|15
1698515|NCT01240746|5930509|P1|Overall Study|Protocol Violation|24
1698516|NCT01240746|5930507|P3|Overall Study|Lost to Follow-up|102
1698517|NCT01240746|5930508|P2|Overall Study|Lost to Follow-up|20
1698518|NCT01240746|5930509|P1|Overall Study|Lost to Follow-up|23
1698519|NCT01240746|5930507|P3|Overall Study|Adverse Event|10
1698520|NCT01240746|5930508|P2|Overall Study|Adverse Event|0
1698521|NCT01240746|5930509|P1|Overall Study|Adverse Event|2
1698522|NCT01240590|5930564|P5|Phase II|Refused further treatment|1
1698523|NCT01240590|5930565|P4|Phase II|Refused further treatment|2
1698524|NCT01240590|5930566|P3|Phase II|Refused further treatment|0
1698525|NCT01240590|5930567|P2|Phase II|Refused further treatment|0
1698526|NCT01240590|5930568|P1|Phase II|Refused further treatment|0
1698527|NCT01240590|5930564|P5|Phase I|Refused further treatment|0
1698528|NCT01240590|5930565|P4|Phase I|Refused further treatment|0
1698529|NCT01240590|5930566|P3|Phase I|Refused further treatment|3
1698530|NCT01240590|5930567|P2|Phase I|Refused further treatment|0
1698531|NCT01240590|5930568|P1|Phase I|Refused further treatment|0
1698532|NCT01240551|5930596|P2|Overall Study|Lost to Follow-up|1
1698533|NCT01240551|5930597|P1|Overall Study|Lost to Follow-up|1
1698534|NCT01240551|5930596|P2|Overall Study|Refused further treatment|2
1698535|NCT01240551|5930597|P1|Overall Study|Refused further treatment|3
1698536|NCT01240382|5930607|P2|Overall Study|Fear of adverse events|1
1698538|NCT01240382|5930607|P2|Overall Study|Lack of Efficacy|2
1698539|NCT01240382|5930608|P1|Overall Study|Lack of Efficacy|0
1698540|NCT01240382|5930607|P2|Overall Study|Adverse Event|1
1698541|NCT01240382|5930608|P1|Overall Study|Adverse Event|2
1698542|NCT01240356|5930618|P2|Overall Study|MRI contraindication|0
1698543|NCT01240356|5930619|P1|Overall Study|MRI contraindication|1
1698544|NCT01240356|5930618|P2|Overall Study|Withdrawal by Subject|0
1698545|NCT01240356|5930619|P1|Overall Study|Withdrawal by Subject|2
1698546|NCT01240200|5930642|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
1698547|NCT01240200|5930643|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
1698548|NCT01240135|5930661|P2|Period Two, 14 Days of Wear|Adverse Event|1
1698549|NCT01240135|5930662|P1|Period Two, 14 Days of Wear|Adverse Event|0
1698550|NCT01240135|5930661|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
1698551|NCT01240135|5930662|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
1698552|NCT01239992|5930679|P1|Overall Study|Withdrawal by Subject|2
1698553|NCT01239797|5930688|P2|Treated Participants|Poor/Non-compliance|1
1698554|NCT01239797|5930689|P1|Treated Participants|Poor/Non-compliance|0
1698555|NCT01239797|5930688|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
1698556|NCT01239797|5930689|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
1698557|NCT01239797|5930688|P2|Treated Participants|Death|1
1698558|NCT01239797|5930689|P1|Treated Participants|Death|1
1698559|NCT01239797|5930688|P2|Treated Participants|Non-specified|11
1698560|NCT01239797|5930689|P1|Treated Participants|Non-specified|1
1698561|NCT01239797|5930688|P2|Treated Participants|Withdrawal by Subject|23
1698562|NCT01239797|5930689|P1|Treated Participants|Withdrawal by Subject|27
1698563|NCT01239797|5930688|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
1698564|NCT01239797|5930689|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
1698565|NCT01239797|5930688|P2|Treated Participants|Study Drug Toxicity|44
1698566|NCT01239797|5930689|P1|Treated Participants|Study Drug Toxicity|30
1698567|NCT01239797|5930688|P2|Treated Participants|Disease Progression|161
1698568|NCT01239797|5930689|P1|Treated Participants|Disease Progression|153
1698569|NCT01239745|5930697|P1|Overall Study|Adverse Event|1
1698570|NCT01239745|5930697|P1|Overall Study|Study terminated by sponsor|45
1698571|NCT01239732|5930708|P1|Overall Study|Other|19
1698572|NCT01239732|5930708|P1|Overall Study|Treatment failure|2
1698573|NCT01239732|5930708|P1|Overall Study|Investigator's decision|4
1698574|NCT01239732|5930708|P1|Overall Study|Study termination by sponsor|2
1698575|NCT01239732|5930708|P1|Overall Study|Participant non compliance|5
1698576|NCT01239732|5930708|P1|Overall Study|Protocol Violation|3
1698577|NCT01239732|5930708|P1|Overall Study|Adverse Event|6
1698578|NCT01239732|5930708|P1|Overall Study|Withdrawal by Subject|87
1698579|NCT01239732|5930708|P1|Overall Study|Death|226
1698580|NCT01239732|5930708|P1|Overall Study|Termination of study per protocol|667
1698581|NCT01239680|5930721|P2|Overall Study|Withdrawal by Subject|0
1698582|NCT01239680|5930722|P1|Overall Study|Withdrawal by Subject|2
1698583|NCT01239472|5930747|P2|Overall Study|Lack of Efficacy|1
1698584|NCT01239472|5930748|P1|Overall Study|Lack of Efficacy|0
1698585|NCT01239472|5930747|P2|Overall Study|Adverse Event|1
1698586|NCT01239472|5930748|P1|Overall Study|Adverse Event|0
1698587|NCT01239472|5930747|P2|Overall Study|Withdrawal by Subject|1
1698588|NCT01239472|5930748|P1|Overall Study|Withdrawal by Subject|5
1698589|NCT01239394|5930756|P1|Overall Study|Adverse Event|1
1698590|NCT01239381|5930763|P1|Overall Study|Withdrawal by Subject|1
1698591|NCT01239381|5930763|P1|Overall Study|Protocol Violation|1
1698592|NCT01239368|5930783|P10|Overall Study|Death|0
1698593|NCT01239368|5930784|P9|Overall Study|Death|0
1698594|NCT01239368|5930785|P8|Overall Study|Death|0
1698595|NCT01239368|5930786|P7|Overall Study|Death|1
1698596|NCT01239368|5930787|P6|Overall Study|Death|0
1698597|NCT01239368|5930788|P5|Overall Study|Death|0
1698598|NCT01239368|5930789|P4|Overall Study|Death|0
1698599|NCT01239368|5930790|P3|Overall Study|Death|0
1698600|NCT01239368|5930791|P2|Overall Study|Death|0
1698601|NCT01239368|5930792|P1|Overall Study|Death|0
1698602|NCT01239368|5930783|P10|Overall Study|Refused further treatment|1
1698603|NCT01239368|5930784|P9|Overall Study|Refused further treatment|0
1698604|NCT01239368|5930785|P8|Overall Study|Refused further treatment|0
1698605|NCT01239368|5930786|P7|Overall Study|Refused further treatment|0
1698606|NCT01239368|5930787|P6|Overall Study|Refused further treatment|0
1698607|NCT01239368|5930788|P5|Overall Study|Refused further treatment|0
1698608|NCT01239368|5930789|P4|Overall Study|Refused further treatment|0
1698609|NCT01239368|5930790|P3|Overall Study|Refused further treatment|0
1698610|NCT01239368|5930791|P2|Overall Study|Refused further treatment|0
1698611|NCT01239368|5930792|P1|Overall Study|Refused further treatment|0
1698612|NCT01239368|5930783|P10|Overall Study|Disease progression on study|2
1698613|NCT01239368|5930784|P9|Overall Study|Disease progression on study|0
1698614|NCT01239368|5930785|P8|Overall Study|Disease progression on study|0
1698615|NCT01239368|5930786|P7|Overall Study|Disease progression on study|5
1698616|NCT01239368|5930787|P6|Overall Study|Disease progression on study|2
1698617|NCT01239368|5930788|P5|Overall Study|Disease progression on study|4
1698618|NCT01239368|5930789|P4|Overall Study|Disease progression on study|1
1698619|NCT01239368|5930790|P3|Overall Study|Disease progression on study|1
1698620|NCT01239368|5930791|P2|Overall Study|Disease progression on study|1
1698621|NCT01239368|5930792|P1|Overall Study|Disease progression on study|1
1698622|NCT01239368|5930783|P10|Overall Study|Principal investigator discretion|1
1698623|NCT01239368|5930784|P9|Overall Study|Principal investigator discretion|0
1698624|NCT01239368|5930785|P8|Overall Study|Principal investigator discretion|0
1698625|NCT01239368|5930786|P7|Overall Study|Principal investigator discretion|0
1698626|NCT01239368|5930787|P6|Overall Study|Principal investigator discretion|2
1698627|NCT01239368|5930788|P5|Overall Study|Principal investigator discretion|1
1698628|NCT01239368|5930789|P4|Overall Study|Principal investigator discretion|0
1698629|NCT01239368|5930790|P3|Overall Study|Principal investigator discretion|0
1698630|NCT01239368|5930791|P2|Overall Study|Principal investigator discretion|0
1698631|NCT01239368|5930792|P1|Overall Study|Principal investigator discretion|1
1698632|NCT01239342|5930844|P2|Overall Study|Reason Unknown|1
1698633|NCT01239342|5930845|P1|Overall Study|Reason Unknown|1
1698634|NCT01239342|5930844|P2|Overall Study|Withdrawal by Subject|5
1698635|NCT01239342|5930845|P1|Overall Study|Withdrawal by Subject|1
1698636|NCT01239342|5930844|P2|Overall Study|Adverse Event|0
1698637|NCT01239342|5930845|P1|Overall Study|Adverse Event|1
1698638|NCT01239316|5930861|P1|Overall Study|Adverse Event|1
1698639|NCT01239316|5930861|P1|Overall Study|Progression/Relapse|11
1698640|NCT01239121|5930876|P3|Overall Study|Withdrawal by Subject|0
1698641|NCT01239121|5930877|P2|Overall Study|Withdrawal by Subject|4
1698642|NCT01239121|5930878|P1|Overall Study|Withdrawal by Subject|2
1698643|NCT01239043|5930900|P2|Overall Study|Protocol Violation|1
1698644|NCT01239043|5930901|P1|Overall Study|Protocol Violation|2
1698645|NCT01238991|5930929|P10|Overall Study|Admission to a nursing home|0
1698646|NCT01238991|5930930|P9|Overall Study|Admission to a nursing home|0
1698647|NCT01238991|5930931|P8|Overall Study|Admission to a nursing home|0
1698648|NCT01238991|5930932|P7|Overall Study|Admission to a nursing home|0
1698649|NCT01238991|5930933|P6|Overall Study|Admission to a nursing home|0
1698650|NCT01238991|5930934|P5|Overall Study|Admission to a nursing home|0
1698651|NCT01238991|5930935|P4|Overall Study|Admission to a nursing home|0
1698652|NCT01238991|5930936|P3|Overall Study|Admission to a nursing home|1
1698653|NCT01238991|5930937|P2|Overall Study|Admission to a nursing home|0
1698654|NCT01238991|5930938|P1|Overall Study|Admission to a nursing home|1
1698655|NCT01238991|5930929|P10|Overall Study|Caregiver's request|0
1698656|NCT01238991|5930930|P9|Overall Study|Caregiver's request|1
1698657|NCT01238991|5930931|P8|Overall Study|Caregiver's request|0
1698658|NCT01238991|5930932|P7|Overall Study|Caregiver's request|0
1698659|NCT01238991|5930933|P6|Overall Study|Caregiver's request|0
1698660|NCT01238991|5930934|P5|Overall Study|Caregiver's request|0
1698661|NCT01238991|5930935|P4|Overall Study|Caregiver's request|0
1698662|NCT01238991|5930936|P3|Overall Study|Caregiver's request|0
1698663|NCT01238991|5930937|P2|Overall Study|Caregiver's request|0
1698664|NCT01238991|5930938|P1|Overall Study|Caregiver's request|0
1698665|NCT01238991|5930929|P10|Overall Study|Study Terminated by Sponsor|2
1698666|NCT01238991|5930930|P9|Overall Study|Study Terminated by Sponsor|2
1698667|NCT01238991|5930931|P8|Overall Study|Study Terminated by Sponsor|4
1698668|NCT01238991|5930932|P7|Overall Study|Study Terminated by Sponsor|7
1698669|NCT01238991|5930933|P6|Overall Study|Study Terminated by Sponsor|0
1698670|NCT01238991|5930934|P5|Overall Study|Study Terminated by Sponsor|1
1698671|NCT01238991|5930935|P4|Overall Study|Study Terminated by Sponsor|0
1698672|NCT01238991|5930936|P3|Overall Study|Study Terminated by Sponsor|0
1698673|NCT01238991|5930937|P2|Overall Study|Study Terminated by Sponsor|0
1698674|NCT01238991|5930938|P1|Overall Study|Study Terminated by Sponsor|0
1698675|NCT01238991|5930929|P10|Overall Study|Withdrawal by Subject|0
1698676|NCT01238991|5930930|P9|Overall Study|Withdrawal by Subject|0
1698677|NCT01238991|5930931|P8|Overall Study|Withdrawal by Subject|0
1698678|NCT01238991|5930932|P7|Overall Study|Withdrawal by Subject|0
1698679|NCT01238991|5930933|P6|Overall Study|Withdrawal by Subject|0
1698680|NCT01238991|5930934|P5|Overall Study|Withdrawal by Subject|0
1698681|NCT01238991|5930935|P4|Overall Study|Withdrawal by Subject|0
1698682|NCT01238991|5930936|P3|Overall Study|Withdrawal by Subject|1
1698683|NCT01238991|5930937|P2|Overall Study|Withdrawal by Subject|0
1698684|NCT01238991|5930938|P1|Overall Study|Withdrawal by Subject|0
1698685|NCT01238991|5930929|P10|Overall Study|Lack of Efficacy|0
1698686|NCT01238991|5930930|P9|Overall Study|Lack of Efficacy|1
1698687|NCT01238991|5930931|P8|Overall Study|Lack of Efficacy|0
1698688|NCT01238991|5930932|P7|Overall Study|Lack of Efficacy|0
1698689|NCT01238991|5930933|P6|Overall Study|Lack of Efficacy|0
1698690|NCT01238991|5930934|P5|Overall Study|Lack of Efficacy|0
1698691|NCT01238991|5930935|P4|Overall Study|Lack of Efficacy|0
1698692|NCT01238991|5930936|P3|Overall Study|Lack of Efficacy|1
1698693|NCT01238991|5930937|P2|Overall Study|Lack of Efficacy|0
1698694|NCT01238991|5930938|P1|Overall Study|Lack of Efficacy|0
1698695|NCT01238991|5930929|P10|Overall Study|Death|0
1698696|NCT01238991|5930930|P9|Overall Study|Death|0
1698697|NCT01238991|5930931|P8|Overall Study|Death|0
1698698|NCT01238991|5930932|P7|Overall Study|Death|0
1698699|NCT01238991|5930933|P6|Overall Study|Death|0
1698700|NCT01238991|5930934|P5|Overall Study|Death|0
1698701|NCT01238991|5930935|P4|Overall Study|Death|1
1698702|NCT01238991|5930936|P3|Overall Study|Death|0
1698703|NCT01238991|5930937|P2|Overall Study|Death|0
1698704|NCT01238991|5930938|P1|Overall Study|Death|0
1698705|NCT01238991|5930929|P10|Overall Study|Adverse Event|0
1698706|NCT01238991|5930930|P9|Overall Study|Adverse Event|0
1698707|NCT01238991|5930931|P8|Overall Study|Adverse Event|1
1698708|NCT01238991|5930932|P7|Overall Study|Adverse Event|1
1698709|NCT01238991|5930933|P6|Overall Study|Adverse Event|0
1698710|NCT01238991|5930934|P5|Overall Study|Adverse Event|1
1698711|NCT01238991|5930935|P4|Overall Study|Adverse Event|1
1698712|NCT01238991|5930936|P3|Overall Study|Adverse Event|3
1698713|NCT01238991|5930937|P2|Overall Study|Adverse Event|0
1698714|NCT01238991|5930938|P1|Overall Study|Adverse Event|1
1698715|NCT01238900|5931025|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
1698716|NCT01238900|5931025|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
1698717|NCT01238861|5931039|P6|Overall Study|Withdrawal by Subject|9
1698718|NCT01238861|5931040|P5|Overall Study|Withdrawal by Subject|10
1698719|NCT01238861|5931041|P4|Overall Study|Withdrawal by Subject|8
1698720|NCT01238861|5931042|P3|Overall Study|Withdrawal by Subject|4
1698721|NCT01238861|5931043|P2|Overall Study|Withdrawal by Subject|5
1698722|NCT01238861|5931044|P1|Overall Study|Withdrawal by Subject|6
1698723|NCT01238861|5931039|P6|Overall Study|Adverse Event|0
1698724|NCT01238861|5931040|P5|Overall Study|Adverse Event|0
1698725|NCT01238861|5931041|P4|Overall Study|Adverse Event|0
1698726|NCT01238861|5931042|P3|Overall Study|Adverse Event|0
1698727|NCT01238861|5931043|P2|Overall Study|Adverse Event|1
1698728|NCT01238861|5931044|P1|Overall Study|Adverse Event|0
1698729|NCT01238861|5931039|P6|Overall Study|Lack of compliance|1
1698730|NCT01238861|5931040|P5|Overall Study|Lack of compliance|0
1698731|NCT01238861|5931041|P4|Overall Study|Lack of compliance|0
1698732|NCT01238861|5931042|P3|Overall Study|Lack of compliance|0
1698733|NCT01238861|5931043|P2|Overall Study|Lack of compliance|0
1698734|NCT01238861|5931044|P1|Overall Study|Lack of compliance|0
1698735|NCT01238861|5931039|P6|Overall Study|Serious adverse event|1
1698736|NCT01238861|5931040|P5|Overall Study|Serious adverse event|0
1698737|NCT01238861|5931041|P4|Overall Study|Serious adverse event|0
1698738|NCT01238861|5931042|P3|Overall Study|Serious adverse event|0
1698739|NCT01238861|5931043|P2|Overall Study|Serious adverse event|0
1698740|NCT01238861|5931044|P1|Overall Study|Serious adverse event|0
1698741|NCT01238861|5931039|P6|Overall Study|Unable to continue visits|1
1698742|NCT01238861|5931040|P5|Overall Study|Unable to continue visits|0
1698743|NCT01238861|5931041|P4|Overall Study|Unable to continue visits|1
1698744|NCT01238861|5931042|P3|Overall Study|Unable to continue visits|0
1698745|NCT01238861|5931043|P2|Overall Study|Unable to continue visits|0
1698746|NCT01238861|5931044|P1|Overall Study|Unable to continue visits|0
1698747|NCT01238861|5931039|P6|Overall Study|Personal problems|0
1698748|NCT01238861|5931040|P5|Overall Study|Personal problems|0
1698749|NCT01238861|5931041|P4|Overall Study|Personal problems|1
1698750|NCT01238861|5931042|P3|Overall Study|Personal problems|0
1698751|NCT01238861|5931043|P2|Overall Study|Personal problems|0
1698752|NCT01238861|5931044|P1|Overall Study|Personal problems|0
1698753|NCT01238861|5931039|P6|Overall Study|Strongyloides stercoralis antibodies +|0
1698754|NCT01238861|5931040|P5|Overall Study|Strongyloides stercoralis antibodies +|0
1698755|NCT01238861|5931041|P4|Overall Study|Strongyloides stercoralis antibodies +|1
1698756|NCT01238861|5931042|P3|Overall Study|Strongyloides stercoralis antibodies +|0
1698757|NCT01238861|5931043|P2|Overall Study|Strongyloides stercoralis antibodies +|0
1698758|NCT01238861|5931044|P1|Overall Study|Strongyloides stercoralis antibodies +|0
1698759|NCT01238861|5931039|P6|Overall Study|Subject moved out of state/area|0
1698760|NCT01238861|5931040|P5|Overall Study|Subject moved out of state/area|0
1698761|NCT01238861|5931041|P4|Overall Study|Subject moved out of state/area|1
1698762|NCT01238861|5931042|P3|Overall Study|Subject moved out of state/area|1
1698763|NCT01238861|5931043|P2|Overall Study|Subject moved out of state/area|0
1698764|NCT01238861|5931044|P1|Overall Study|Subject moved out of state/area|0
1698765|NCT01238861|5931039|P6|Overall Study|Subject traveled to Argentina by 1 year|0
1698766|NCT01238861|5931040|P5|Overall Study|Subject traveled to Argentina by 1 year|0
1698767|NCT01238861|5931041|P4|Overall Study|Subject traveled to Argentina by 1 year|0
1698768|NCT01238861|5931042|P3|Overall Study|Subject traveled to Argentina by 1 year|1
1698769|NCT01238861|5931043|P2|Overall Study|Subject traveled to Argentina by 1 year|0
1698770|NCT01238861|5931044|P1|Overall Study|Subject traveled to Argentina by 1 year|0
1698771|NCT01238861|5931039|P6|Overall Study|Incorrect enrollment/randomization|0
1698772|NCT01238861|5931040|P5|Overall Study|Incorrect enrollment/randomization|1
1698773|NCT01238861|5931041|P4|Overall Study|Incorrect enrollment/randomization|0
1698774|NCT01238861|5931042|P3|Overall Study|Incorrect enrollment/randomization|1
1698775|NCT01238861|5931043|P2|Overall Study|Incorrect enrollment/randomization|0
1698776|NCT01238861|5931044|P1|Overall Study|Incorrect enrollment/randomization|0
1698777|NCT01238861|5931039|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
1698778|NCT01238861|5931040|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
1698779|NCT01238861|5931041|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
1698780|NCT01238861|5931042|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
1698781|NCT01238861|5931043|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
1698782|NCT01238861|5931044|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
1698783|NCT01238861|5931039|P6|Overall Study|Unplanned surgery|0
1698784|NCT01238861|5931040|P5|Overall Study|Unplanned surgery|0
1698785|NCT01238861|5931041|P4|Overall Study|Unplanned surgery|0
1698786|NCT01238861|5931042|P3|Overall Study|Unplanned surgery|0
1698787|NCT01238861|5931043|P2|Overall Study|Unplanned surgery|0
1698788|NCT01238861|5931044|P1|Overall Study|Unplanned surgery|1
1698789|NCT01238861|5931039|P6|Overall Study|Lost to Follow-up|2
1698790|NCT01238861|5931040|P5|Overall Study|Lost to Follow-up|1
1698791|NCT01238861|5931041|P4|Overall Study|Lost to Follow-up|1
1698792|NCT01238861|5931042|P3|Overall Study|Lost to Follow-up|3
1698793|NCT01238861|5931043|P2|Overall Study|Lost to Follow-up|2
1698794|NCT01238861|5931044|P1|Overall Study|Lost to Follow-up|4
1698795|NCT01238848|5931124|P2|Overall Study|Physician Decision|5
1698796|NCT01238848|5931125|P1|Overall Study|Physician Decision|13
1698797|NCT01238822|5931133|P1|Overall Study|COULD NOT SWALLOW PILLS|3
1698798|NCT01238588|5931160|P1|Overall Study|Physician Decision|2
1698799|NCT01238588|5931160|P1|Overall Study|Withdrawal by Subject|1
1698800|NCT01238575|5931173|P2|Overall Study|Adverse Event|0
1698801|NCT01238575|5931174|P1|Overall Study|Adverse Event|2
1698802|NCT01238575|5931173|P2|Overall Study|Lack of Efficacy|4
1698803|NCT01238575|5931174|P1|Overall Study|Lack of Efficacy|2
1698804|NCT01238211|5931258|P1|Overall Study|Investigator/Patient Decision|3
1698805|NCT01238211|5931258|P1|Overall Study|Non-protocol treatment|4
1698806|NCT01238211|5931258|P1|Overall Study|Withdrawal by Subject|7
1698807|NCT01238211|5931258|P1|Overall Study|Relapse/Progression|2
1698808|NCT01238211|5931258|P1|Overall Study|Death|4
1698809|NCT01238211|5931258|P1|Overall Study|Adverse Event|7
1698810|NCT01238211|5931258|P1|Overall Study|Continues active treatment|31
1698811|NCT01238172|5931264|P2|Overall Study|Ineligible: based on Central Path Review|19
1698812|NCT01238172|5931265|P1|Overall Study|Ineligible: based on Central Path Review|9
1698813|NCT01238172|5931264|P2|Overall Study|Ineligible: based on Eligibility Review|5
1698814|NCT01238172|5931265|P1|Overall Study|Ineligible: based on Eligibility Review|2
1698815|NCT01237899|5931288|P11|Washout Period of at Least 7 Days|Adverse Event|0
1698816|NCT01237899|5931289|P10|Washout Period of at Least 7 Days|Adverse Event|0
1698817|NCT01237899|5931290|P9|Washout Period of at Least 7 Days|Adverse Event|0
1698818|NCT01237899|5931291|P8|Washout Period of at Least 7 Days|Adverse Event|0
1698819|NCT01237899|5931292|P7|Washout Period of at Least 7 Days|Adverse Event|0
1698820|NCT01237899|5931293|P6|Washout Period of at Least 7 Days|Adverse Event|0
1698821|NCT01237899|5931294|P5|Washout Period of at Least 7 Days|Adverse Event|0
1698822|NCT01237899|5931295|P4|Washout Period of at Least 7 Days|Adverse Event|0
1698823|NCT01237899|5931296|P3|Washout Period of at Least 7 Days|Adverse Event|1
1698824|NCT01237899|5931297|P2|Washout Period of at Least 7 Days|Adverse Event|0
1698825|NCT01237899|5931298|P1|Washout Period of at Least 7 Days|Adverse Event|0
1698826|NCT01237678|5931378|P3|Phase II|Randomized but were not treated|3
1698827|NCT01237678|5931379|P2|Phase II|Randomized but were not treated|4
1698828|NCT01237678|5931380|P1|Phase II|Randomized but were not treated|0
1698829|NCT01237678|5931378|P3|Phase II|Sponsor Decision/Study Closed|7
1698830|NCT01237678|5931379|P2|Phase II|Sponsor Decision/Study Closed|18
1698831|NCT01237678|5931380|P1|Phase II|Sponsor Decision/Study Closed|0
1698832|NCT01237678|5931378|P3|Phase II|Completed Cycles 4-6|21
1698833|NCT01237678|5931379|P2|Phase II|Completed Cycles 4-6|11
1698834|NCT01237678|5931380|P1|Phase II|Completed Cycles 4-6|0
1698835|NCT01237678|5931378|P3|Phase II|Withdrawal by Subject|5
1698836|NCT01237678|5931379|P2|Phase II|Withdrawal by Subject|1
1698837|NCT01237678|5931380|P1|Phase II|Withdrawal by Subject|0
1698838|NCT01237678|5931378|P3|Phase II|Lack of Efficacy|3
1698839|NCT01237678|5931379|P2|Phase II|Lack of Efficacy|25
1698840|NCT01237678|5931380|P1|Phase II|Lack of Efficacy|0
1698841|NCT01237678|5931378|P3|Phase II|Death|2
1698842|NCT01237678|5931379|P2|Phase II|Death|0
1698843|NCT01237678|5931380|P1|Phase II|Death|0
1698844|NCT01237678|5931378|P3|Phase II|Adverse Event|9
1698845|NCT01237678|5931379|P2|Phase II|Adverse Event|39
1698846|NCT01237678|5931380|P1|Phase II|Adverse Event|0
1698847|NCT01237678|5931378|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
1698848|NCT01237678|5931379|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
1698849|NCT01237678|5931380|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
1698850|NCT01237678|5931378|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
1698851|NCT01237678|5931379|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
1698852|NCT01237678|5931380|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
1698853|NCT01237678|5931378|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
1698854|NCT01237678|5931379|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
1698855|NCT01237678|5931380|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
1698856|NCT01237678|5931378|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
1698857|NCT01237678|5931379|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
1698858|NCT01237678|5931380|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
1698859|NCT01237587|5931425|P2|Taper Phase|Withdrawal by Subject|1
1698860|NCT01237587|5931426|P1|Taper Phase|Withdrawal by Subject|0
1698861|NCT01237587|5931425|P2|Taper Phase|Sponsor Decision|0
1698862|NCT01237587|5931426|P1|Taper Phase|Sponsor Decision|1
1698863|NCT01237587|5931425|P2|Taper Phase|Parent/Guardian Decision|2
1698864|NCT01237587|5931426|P1|Taper Phase|Parent/Guardian Decision|0
1698865|NCT01237587|5931425|P2|Taper Phase|Lack of Efficacy|5
1698866|NCT01237587|5931426|P1|Taper Phase|Lack of Efficacy|2
1698867|NCT01237587|5931425|P2|Taper Phase|Protocol Violation|0
1698868|NCT01237587|5931426|P1|Taper Phase|Protocol Violation|2
1698869|NCT01237587|5931425|P2|Taper Phase|Adverse Event|2
1698870|NCT01237587|5931426|P1|Taper Phase|Adverse Event|0
1698871|NCT01237587|5931425|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
1698872|NCT01237587|5931426|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
1698873|NCT01237587|5931425|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
1698874|NCT01237587|5931426|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
1698875|NCT01237587|5931425|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
1698876|NCT01237587|5931426|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
1698877|NCT01237587|5931425|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
1698878|NCT01237587|5931426|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
1698879|NCT01237587|5931425|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
1698880|NCT01237587|5931426|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
1698881|NCT01237587|5931425|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
1698882|NCT01237587|5931426|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
1698883|NCT01237587|5931425|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
1698884|NCT01237587|5931426|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
1698885|NCT01237587|5931425|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
1698886|NCT01237587|5931426|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
1698887|NCT01237587|5931425|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
1698888|NCT01237587|5931426|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
1698889|NCT01237587|5931425|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
1698890|NCT01237587|5931426|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
1698891|NCT01237587|5931425|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
1698892|NCT01237587|5931426|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
1698893|NCT01237587|5931425|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
1698894|NCT01237587|5931426|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
1698895|NCT01237587|5931425|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
1698896|NCT01237587|5931426|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
1698897|NCT01237340|5931478|P1|Overall Study|Early termination of the trial|36
1698898|NCT01237340|5931478|P1|Overall Study|Withdrawal by Subject|1
1698899|NCT01237340|5931478|P1|Overall Study|Adverse Event|3
1698900|NCT01237327|5931492|P2|Overall Study|Lost to Follow-up|0
1698901|NCT01237327|5931493|P1|Overall Study|Lost to Follow-up|3
1698902|NCT01237327|5931492|P2|Overall Study|Withdrawal by Subject|3
1698903|NCT01237327|5931493|P1|Overall Study|Withdrawal by Subject|1
1698904|NCT01237327|5931492|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
1698905|NCT01237327|5931493|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
1698906|NCT01237327|5931492|P2|Overall Study|Progression of Disease: Extension Study|13
1698907|NCT01237327|5931493|P1|Overall Study|Progression of Disease: Extension Study|15
1698908|NCT01237327|5931492|P2|Overall Study|Progression of Disease: Core Study|22
1698909|NCT01237327|5931493|P1|Overall Study|Progression of Disease: Core Study|18
1698910|NCT01237327|5931492|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
1698911|NCT01237327|5931493|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
1698912|NCT01237327|5931492|P2|Overall Study|Protocol Violation: Core Study|0
1698913|NCT01237327|5931493|P1|Overall Study|Protocol Violation: Core Study|1
1698914|NCT01237223|5931528|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1698915|NCT01237223|5931529|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1698916|NCT01237223|5931530|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
1698917|NCT01237223|5931531|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1698918|NCT01237223|5931532|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
1698919|NCT01237223|5931533|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
1698920|NCT01237223|5931528|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
1698921|NCT01237223|5931529|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1698922|NCT01237223|5931530|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1698923|NCT01237223|5931531|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1698924|NCT01237223|5931532|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1698925|NCT01237223|5931533|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
1698926|NCT01237223|5931528|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1698927|NCT01237223|5931529|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1698928|NCT01237223|5931530|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
1698929|NCT01237223|5931531|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
1698930|NCT01237223|5931532|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
1698931|NCT01237223|5931533|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
1698932|NCT01237223|5931528|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
1698933|NCT01237223|5931529|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
1698934|NCT01237223|5931530|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
1698935|NCT01237223|5931531|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
1698936|NCT01237223|5931532|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
1698937|NCT01237223|5931533|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
1698938|NCT01237223|5931528|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
1698939|NCT01237223|5931529|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
1698940|NCT01237223|5931530|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
1698941|NCT01237223|5931531|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
1698942|NCT01237223|5931532|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
1698943|NCT01237223|5931533|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
1698944|NCT01237223|5931528|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1698945|NCT01237223|5931529|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1698946|NCT01237223|5931530|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1698947|NCT01237223|5931531|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1698948|NCT01237223|5931532|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
1698949|NCT01237223|5931533|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
1698950|NCT01237223|5931528|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1698951|NCT01237223|5931529|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1698952|NCT01237223|5931530|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1698953|NCT01237223|5931531|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1698954|NCT01237223|5931532|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
1698955|NCT01237223|5931533|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
1698956|NCT01237223|5931528|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1698957|NCT01237223|5931529|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1698958|NCT01237223|5931530|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1698959|NCT01237223|5931531|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1698960|NCT01237223|5931532|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
1698961|NCT01237223|5931533|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
1698962|NCT01237223|5931528|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1698963|NCT01237223|5931529|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1698964|NCT01237223|5931530|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1698965|NCT01237223|5931531|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1698966|NCT01237223|5931532|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
1698967|NCT01237223|5931533|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
1698968|NCT01237223|5931528|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1698969|NCT01237223|5931529|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1698970|NCT01237223|5931530|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1698971|NCT01237223|5931531|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1698972|NCT01237223|5931532|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
1698973|NCT01237223|5931533|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
1698974|NCT01237054|5931592|P1|Overall Study|imaging 10C0096|1
1698975|NCT01236755|5931661|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
1698976|NCT01236755|5931661|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
1698977|NCT01236755|5931661|P1|Spectacles Wearing Phase|Lost to Follow-up|9
1698978|NCT01236755|5931661|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
1698979|NCT01236534|5931684|P2|Overall Study|Adverse Event|0
1698980|NCT01236534|5931685|P1|Overall Study|Adverse Event|3
1698981|NCT01236365|5931703|P2|Overall Study|Dropped at Randomization due to high LFT|0
1698982|NCT01236365|5931704|P1|Overall Study|Dropped at Randomization due to high LFT|1
1698983|NCT01236365|5931703|P2|Overall Study|Moved Out of State|0
1698984|NCT01236365|5931704|P1|Overall Study|Moved Out of State|1
1698985|NCT01236365|5931703|P2|Overall Study|Lost to Follow-up|2
1698986|NCT01236365|5931704|P1|Overall Study|Lost to Follow-up|0
1698987|NCT01236339|5931728|P2|Overall Study|Termination of study by sponsor|13
1698988|NCT01236339|5931729|P1|Overall Study|Termination of study by sponsor|11
1698989|NCT01235793|5931758|P1|Overall Study|Death|6
1698990|NCT01236573|5931774|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
1698991|NCT01236573|5931775|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698992|NCT01236573|5931776|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698993|NCT01236573|5931777|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698994|NCT01236573|5931778|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698995|NCT01236573|5931779|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698996|NCT01236573|5931780|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698997|NCT01236573|5931781|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698998|NCT01236573|5931782|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1698999|NCT01236573|5931783|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1699000|NCT01236573|5931784|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
1699001|NCT01236573|5931774|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699002|NCT01236573|5931775|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699003|NCT01236573|5931776|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
1699004|NCT01236573|5931777|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699005|NCT01236573|5931778|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699006|NCT01236573|5931779|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699007|NCT01236573|5931780|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699008|NCT01236573|5931781|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699009|NCT01236573|5931782|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699010|NCT01236573|5931783|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699011|NCT01236573|5931784|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
1699012|NCT01236573|5931774|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699013|NCT01236573|5931775|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1699014|NCT01236573|5931776|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1699015|NCT01236573|5931777|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699016|NCT01236573|5931778|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
1699017|NCT01236573|5931779|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699018|NCT01236573|5931780|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699019|NCT01236573|5931781|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699020|NCT01236573|5931782|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699021|NCT01236573|5931783|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699022|NCT01236573|5931784|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
1699023|NCT01236521|5931822|P2|Overall Study|Lost to Follow-up|7
1699024|NCT01236521|5931823|P1|Overall Study|Lost to Follow-up|7
1699025|NCT01236521|5931822|P2|Overall Study|Death|1
1699026|NCT01236521|5931823|P1|Overall Study|Death|2
1699027|NCT01236521|5931822|P2|Overall Study|Withdrawal by Subject|17
1699028|NCT01236521|5931823|P1|Overall Study|Withdrawal by Subject|12
1699029|NCT01236352|5931874|P11|Overall Study|Patient transferred to IST|6
1699030|NCT01236352|5931875|P10|Overall Study|Patient transferred to IST|2
1699031|NCT01236352|5931876|P9|Overall Study|Patient transferred to IST|0
1699032|NCT01236352|5931877|P8|Overall Study|Patient transferred to IST|0
1699033|NCT01236352|5931878|P7|Overall Study|Patient transferred to IST|0
1699034|NCT01236352|5931879|P6|Overall Study|Patient transferred to IST|0
1699035|NCT01236352|5931880|P5|Overall Study|Patient transferred to IST|0
1699036|NCT01236352|5931881|P4|Overall Study|Patient transferred to IST|0
1699037|NCT01236352|5931882|P3|Overall Study|Patient transferred to IST|0
1699038|NCT01236352|5931883|P2|Overall Study|Patient transferred to IST|0
1699039|NCT01236352|5931884|P1|Overall Study|Patient transferred to IST|0
1699040|NCT01236352|5931874|P11|Overall Study|Lack of response to drug|1
1699041|NCT01236352|5931875|P10|Overall Study|Lack of response to drug|1
1699042|NCT01236352|5931876|P9|Overall Study|Lack of response to drug|0
1699043|NCT01236352|5931877|P8|Overall Study|Lack of response to drug|0
1699044|NCT01236352|5931878|P7|Overall Study|Lack of response to drug|0
1699045|NCT01236352|5931879|P6|Overall Study|Lack of response to drug|0
1699046|NCT01236352|5931880|P5|Overall Study|Lack of response to drug|0
1699047|NCT01236352|5931881|P4|Overall Study|Lack of response to drug|0
1699048|NCT01236352|5931882|P3|Overall Study|Lack of response to drug|0
1699049|NCT01236352|5931883|P2|Overall Study|Lack of response to drug|0
1699050|NCT01236352|5931884|P1|Overall Study|Lack of response to drug|0
1699051|NCT01236352|5931874|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
1699052|NCT01236352|5931875|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
1699053|NCT01236352|5931876|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
1699054|NCT01236352|5931877|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
1699055|NCT01236352|5931878|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
1699056|NCT01236352|5931879|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
1699057|NCT01236352|5931880|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
1699058|NCT01236352|5931881|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
1699059|NCT01236352|5931882|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
1699060|NCT01236352|5931883|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
1699061|NCT01236352|5931884|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
1699062|NCT01236352|5931874|P11|Overall Study|Patient moving to allogeneic transplant|0
1699063|NCT01236352|5931875|P10|Overall Study|Patient moving to allogeneic transplant|0
1699064|NCT01236352|5931876|P9|Overall Study|Patient moving to allogeneic transplant|0
1699065|NCT01236352|5931877|P8|Overall Study|Patient moving to allogeneic transplant|0
1699066|NCT01236352|5931878|P7|Overall Study|Patient moving to allogeneic transplant|1
1699067|NCT01236352|5931879|P6|Overall Study|Patient moving to allogeneic transplant|0
1699068|NCT01236352|5931880|P5|Overall Study|Patient moving to allogeneic transplant|0
1699069|NCT01236352|5931881|P4|Overall Study|Patient moving to allogeneic transplant|0
1699070|NCT01236352|5931882|P3|Overall Study|Patient moving to allogeneic transplant|0
1699071|NCT01236352|5931883|P2|Overall Study|Patient moving to allogeneic transplant|0
1699072|NCT01236352|5931884|P1|Overall Study|Patient moving to allogeneic transplant|0
1699073|NCT01236352|5931874|P11|Overall Study|Subject to receive drug via EAP|0
1699074|NCT01236352|5931875|P10|Overall Study|Subject to receive drug via EAP|4
1699075|NCT01236352|5931876|P9|Overall Study|Subject to receive drug via EAP|0
1699076|NCT01236352|5931877|P8|Overall Study|Subject to receive drug via EAP|2
1699077|NCT01236352|5931878|P7|Overall Study|Subject to receive drug via EAP|0
1699078|NCT01236352|5931879|P6|Overall Study|Subject to receive drug via EAP|0
1699079|NCT01236352|5931880|P5|Overall Study|Subject to receive drug via EAP|0
1699080|NCT01236352|5931881|P4|Overall Study|Subject to receive drug via EAP|0
1699081|NCT01236352|5931882|P3|Overall Study|Subject to receive drug via EAP|1
1699082|NCT01236352|5931883|P2|Overall Study|Subject to receive drug via EAP|1
1699083|NCT01236352|5931884|P1|Overall Study|Subject to receive drug via EAP|1
1699084|NCT01236352|5931874|P11|Overall Study|Subject request to discontinue treatment|4
1699085|NCT01236352|5931875|P10|Overall Study|Subject request to discontinue treatment|1
1699086|NCT01236352|5931876|P9|Overall Study|Subject request to discontinue treatment|0
1699087|NCT01236352|5931877|P8|Overall Study|Subject request to discontinue treatment|0
1699088|NCT01236352|5931878|P7|Overall Study|Subject request to discontinue treatment|0
1699089|NCT01236352|5931879|P6|Overall Study|Subject request to discontinue treatment|1
1699090|NCT01236352|5931880|P5|Overall Study|Subject request to discontinue treatment|0
1699091|NCT01236352|5931881|P4|Overall Study|Subject request to discontinue treatment|1
1699092|NCT01236352|5931882|P3|Overall Study|Subject request to discontinue treatment|1
1699093|NCT01236352|5931883|P2|Overall Study|Subject request to discontinue treatment|0
1699094|NCT01236352|5931884|P1|Overall Study|Subject request to discontinue treatment|0
1699095|NCT01236352|5931874|P11|Overall Study|Maximum clinical benefit|2
1699096|NCT01236352|5931875|P10|Overall Study|Maximum clinical benefit|4
1699097|NCT01236352|5931876|P9|Overall Study|Maximum clinical benefit|1
1699098|NCT01236352|5931877|P8|Overall Study|Maximum clinical benefit|1
1699099|NCT01236352|5931878|P7|Overall Study|Maximum clinical benefit|3
1699100|NCT01236352|5931879|P6|Overall Study|Maximum clinical benefit|0
1699101|NCT01236352|5931880|P5|Overall Study|Maximum clinical benefit|2
1699102|NCT01236352|5931881|P4|Overall Study|Maximum clinical benefit|0
1699103|NCT01236352|5931882|P3|Overall Study|Maximum clinical benefit|1
1699104|NCT01236352|5931883|P2|Overall Study|Maximum clinical benefit|1
1699105|NCT01236352|5931884|P1|Overall Study|Maximum clinical benefit|1
1699106|NCT01236352|5931874|P11|Overall Study|Poor/Non-compliance|0
1699107|NCT01236352|5931875|P10|Overall Study|Poor/Non-compliance|0
1699108|NCT01236352|5931876|P9|Overall Study|Poor/Non-compliance|0
1699109|NCT01236352|5931877|P8|Overall Study|Poor/Non-compliance|0
1699110|NCT01236352|5931878|P7|Overall Study|Poor/Non-compliance|0
1699111|NCT01236352|5931879|P6|Overall Study|Poor/Non-compliance|0
1699112|NCT01236352|5931880|P5|Overall Study|Poor/Non-compliance|0
1699113|NCT01236352|5931881|P4|Overall Study|Poor/Non-compliance|0
1699114|NCT01236352|5931882|P3|Overall Study|Poor/Non-compliance|0
1699115|NCT01236352|5931883|P2|Overall Study|Poor/Non-compliance|0
1699116|NCT01236352|5931884|P1|Overall Study|Poor/Non-compliance|1
1699117|NCT01236352|5931874|P11|Overall Study|Disease progression|2
1699118|NCT01236352|5931875|P10|Overall Study|Disease progression|2
1699119|NCT01236352|5931876|P9|Overall Study|Disease progression|2
1699120|NCT01236352|5931877|P8|Overall Study|Disease progression|3
1699121|NCT01236352|5931878|P7|Overall Study|Disease progression|1
1699122|NCT01236352|5931879|P6|Overall Study|Disease progression|2
1699123|NCT01236352|5931880|P5|Overall Study|Disease progression|2
1699124|NCT01236352|5931881|P4|Overall Study|Disease progression|2
1699125|NCT01236352|5931882|P3|Overall Study|Disease progression|1
1699126|NCT01236352|5931883|P2|Overall Study|Disease progression|2
1699127|NCT01236352|5931884|P1|Overall Study|Disease progression|1
1699128|NCT01236352|5931874|P11|Overall Study|Study drug toxicity|2
1699129|NCT01236352|5931875|P10|Overall Study|Study drug toxicity|2
1699130|NCT01236352|5931876|P9|Overall Study|Study drug toxicity|0
1699131|NCT01236352|5931877|P8|Overall Study|Study drug toxicity|0
1699132|NCT01236352|5931878|P7|Overall Study|Study drug toxicity|1
1699133|NCT01236352|5931879|P6|Overall Study|Study drug toxicity|1
1699134|NCT01236352|5931880|P5|Overall Study|Study drug toxicity|0
1699135|NCT01236352|5931881|P4|Overall Study|Study drug toxicity|0
1699136|NCT01236352|5931882|P3|Overall Study|Study drug toxicity|0
1699137|NCT01236352|5931883|P2|Overall Study|Study drug toxicity|0
1699138|NCT01236352|5931884|P1|Overall Study|Study drug toxicity|0
1699139|NCT01236352|5931874|P11|Overall Study|Adverse Event|1
1699140|NCT01236352|5931875|P10|Overall Study|Adverse Event|4
1699141|NCT01236352|5931876|P9|Overall Study|Adverse Event|0
1699142|NCT01236352|5931877|P8|Overall Study|Adverse Event|0
1699143|NCT01236352|5931878|P7|Overall Study|Adverse Event|2
1699144|NCT01236352|5931879|P6|Overall Study|Adverse Event|0
1699145|NCT01236352|5931880|P5|Overall Study|Adverse Event|0
1699146|NCT01236352|5931881|P4|Overall Study|Adverse Event|0
1699147|NCT01236352|5931882|P3|Overall Study|Adverse Event|0
1699148|NCT01236352|5931883|P2|Overall Study|Adverse Event|0
1699149|NCT01236352|5931884|P1|Overall Study|Adverse Event|0
1699150|NCT01236352|5931874|P11|Overall Study|Withdrawal by Subject|1
1699151|NCT01236352|5931875|P10|Overall Study|Withdrawal by Subject|2
1699152|NCT01236352|5931876|P9|Overall Study|Withdrawal by Subject|0
1699153|NCT01236352|5931877|P8|Overall Study|Withdrawal by Subject|0
1699154|NCT01236352|5931878|P7|Overall Study|Withdrawal by Subject|0
1699155|NCT01236352|5931879|P6|Overall Study|Withdrawal by Subject|0
1699156|NCT01236352|5931880|P5|Overall Study|Withdrawal by Subject|0
1699157|NCT01236352|5931881|P4|Overall Study|Withdrawal by Subject|0
1699158|NCT01236352|5931882|P3|Overall Study|Withdrawal by Subject|0
1699159|NCT01236352|5931883|P2|Overall Study|Withdrawal by Subject|0
1699160|NCT01236352|5931884|P1|Overall Study|Withdrawal by Subject|0
1699161|NCT01236352|5931874|P11|Overall Study|Death|0
1699162|NCT01236352|5931875|P10|Overall Study|Death|0
1699163|NCT01236352|5931876|P9|Overall Study|Death|0
1699164|NCT01236352|5931877|P8|Overall Study|Death|1
1699165|NCT01236352|5931878|P7|Overall Study|Death|0
1699166|NCT01236352|5931879|P6|Overall Study|Death|0
1699167|NCT01236352|5931880|P5|Overall Study|Death|0
1699168|NCT01236352|5931881|P4|Overall Study|Death|0
1699169|NCT01236352|5931882|P3|Overall Study|Death|0
1699170|NCT01236352|5931883|P2|Overall Study|Death|0
1699171|NCT01236352|5931884|P1|Overall Study|Death|0
1699172|NCT01236118|5932102|P3|Overall Study|Withdrawal by Subject|1
1699173|NCT01236118|5932103|P2|Overall Study|Withdrawal by Subject|0
1699174|NCT01236118|5932104|P1|Overall Study|Withdrawal by Subject|0
1699175|NCT01236118|5932102|P3|Overall Study|Physician Decision|0
1699176|NCT01236118|5932103|P2|Overall Study|Physician Decision|1
1699177|NCT01236118|5932104|P1|Overall Study|Physician Decision|0
1699178|NCT01236118|5932102|P3|Overall Study|Adverse Event|2
1699179|NCT01236118|5932103|P2|Overall Study|Adverse Event|0
1699180|NCT01236118|5932104|P1|Overall Study|Adverse Event|2
1699181|NCT01236001|5932305|P2|Overall Study|Planned Visit After End of Study|1
1699182|NCT01236001|5932306|P1|Overall Study|Planned Visit After End of Study|0
1699183|NCT01236001|5932305|P2|Overall Study|Incompliance|0
1699184|NCT01236001|5932306|P1|Overall Study|Incompliance|1
1699185|NCT01236001|5932305|P2|Overall Study|Lost to Follow-up|1
1699186|NCT01236001|5932306|P1|Overall Study|Lost to Follow-up|6
1699187|NCT01236001|5932305|P2|Overall Study|Lack of Efficacy|6
1699188|NCT01236001|5932306|P1|Overall Study|Lack of Efficacy|6
1699189|NCT01236001|5932305|P2|Overall Study|Adverse Event|14
1699190|NCT01236001|5932306|P1|Overall Study|Adverse Event|5
1699191|NCT01235975|5932338|P2|Overall Study|Lost to Follow-up|3
1699192|NCT01235975|5932339|P1|Overall Study|Lost to Follow-up|7
1699193|NCT01235975|5932338|P2|Overall Study|Migrated/moved from study area|1
1699194|NCT01235975|5932339|P1|Overall Study|Migrated/moved from study area|2
1699195|NCT01235975|5932338|P2|Overall Study|Withdrawal by Subject|2
1699196|NCT01235975|5932339|P1|Overall Study|Withdrawal by Subject|8
1699197|NCT01235975|5932338|P2|Overall Study|Serious Adverse Event|1
1699198|NCT01235975|5932339|P1|Overall Study|Serious Adverse Event|0
1699199|NCT01235949|5932389|P18|Booster Phase|Lost to Follow-up|1
1699200|NCT01235949|5932390|P17|Booster Phase|Lost to Follow-up|0
1699201|NCT01235949|5932391|P16|Booster Phase|Lost to Follow-up|0
1699202|NCT01235949|5932392|P15|Booster Phase|Lost to Follow-up|0
1699203|NCT01235949|5932393|P14|Booster Phase|Lost to Follow-up|0
1699204|NCT01235949|5932394|P13|Booster Phase|Lost to Follow-up|0
1699205|NCT01235949|5932395|P12|Booster Phase|Lost to Follow-up|1
1699206|NCT01235949|5932396|P11|Booster Phase|Lost to Follow-up|1
1699207|NCT01235949|5932397|P10|Booster Phase|Lost to Follow-up|1
1699208|NCT01235949|5932398|P9|Booster Phase|Lost to Follow-up|1
1699209|NCT01235949|5932399|P8|Booster Phase|Lost to Follow-up|0
1699210|NCT01235949|5932400|P7|Booster Phase|Lost to Follow-up|0
1699211|NCT01235949|5932401|P6|Booster Phase|Lost to Follow-up|0
1699212|NCT01235949|5932402|P5|Booster Phase|Lost to Follow-up|0
1699213|NCT01235949|5932403|P4|Booster Phase|Lost to Follow-up|0
1699214|NCT01235949|5932404|P3|Booster Phase|Lost to Follow-up|0
1699215|NCT01235949|5932405|P2|Booster Phase|Lost to Follow-up|0
1699216|NCT01235949|5932406|P1|Booster Phase|Lost to Follow-up|0
1699217|NCT01235949|5932389|P18|Booster Phase|Withdrawal by Subject|0
1699218|NCT01235949|5932390|P17|Booster Phase|Withdrawal by Subject|0
1699219|NCT01235949|5932391|P16|Booster Phase|Withdrawal by Subject|0
1699220|NCT01235949|5932392|P15|Booster Phase|Withdrawal by Subject|2
1699221|NCT01235949|5932393|P14|Booster Phase|Withdrawal by Subject|0
1699222|NCT01235949|5932394|P13|Booster Phase|Withdrawal by Subject|2
1699223|NCT01235949|5932395|P12|Booster Phase|Withdrawal by Subject|1
1699224|NCT01235949|5932396|P11|Booster Phase|Withdrawal by Subject|1
1699225|NCT01235949|5932397|P10|Booster Phase|Withdrawal by Subject|0
1699226|NCT01235949|5932398|P9|Booster Phase|Withdrawal by Subject|1
1699227|NCT01235949|5932399|P8|Booster Phase|Withdrawal by Subject|1
1699228|NCT01235949|5932400|P7|Booster Phase|Withdrawal by Subject|0
1699229|NCT01235949|5932401|P6|Booster Phase|Withdrawal by Subject|0
1699230|NCT01235949|5932402|P5|Booster Phase|Withdrawal by Subject|0
1699231|NCT01235949|5932403|P4|Booster Phase|Withdrawal by Subject|0
1699232|NCT01235949|5932404|P3|Booster Phase|Withdrawal by Subject|0
1699233|NCT01235949|5932405|P2|Booster Phase|Withdrawal by Subject|0
1699234|NCT01235949|5932406|P1|Booster Phase|Withdrawal by Subject|0
1699235|NCT01235949|5932389|P18|Booster Phase|Adverse Event|0
1699236|NCT01235949|5932390|P17|Booster Phase|Adverse Event|0
1699237|NCT01235949|5932391|P16|Booster Phase|Adverse Event|1
1699238|NCT01235949|5932392|P15|Booster Phase|Adverse Event|0
1699239|NCT01235949|5932393|P14|Booster Phase|Adverse Event|0
1699240|NCT01235949|5932394|P13|Booster Phase|Adverse Event|0
1699241|NCT01235949|5932395|P12|Booster Phase|Adverse Event|0
1699242|NCT01235949|5932396|P11|Booster Phase|Adverse Event|0
1699243|NCT01235949|5932397|P10|Booster Phase|Adverse Event|0
1699244|NCT01235949|5932398|P9|Booster Phase|Adverse Event|0
1699245|NCT01235949|5932399|P8|Booster Phase|Adverse Event|0
1699246|NCT01235949|5932400|P7|Booster Phase|Adverse Event|0
1699247|NCT01235949|5932401|P6|Booster Phase|Adverse Event|0
1699248|NCT01235949|5932402|P5|Booster Phase|Adverse Event|0
1699249|NCT01235949|5932403|P4|Booster Phase|Adverse Event|0
1699250|NCT01235949|5932404|P3|Booster Phase|Adverse Event|0
1699251|NCT01235949|5932405|P2|Booster Phase|Adverse Event|0
1699252|NCT01235949|5932406|P1|Booster Phase|Adverse Event|0
1699253|NCT01235949|5932389|P18|Booster Phase|Migrated/moved from study area|1
1699254|NCT01235949|5932390|P17|Booster Phase|Migrated/moved from study area|0
1699255|NCT01235949|5932391|P16|Booster Phase|Migrated/moved from study area|0
1699256|NCT01235949|5932392|P15|Booster Phase|Migrated/moved from study area|0
1699257|NCT01235949|5932393|P14|Booster Phase|Migrated/moved from study area|0
1699258|NCT01235949|5932394|P13|Booster Phase|Migrated/moved from study area|1
1699259|NCT01235949|5932395|P12|Booster Phase|Migrated/moved from study area|1
1699260|NCT01235949|5932396|P11|Booster Phase|Migrated/moved from study area|0
1699261|NCT01235949|5932397|P10|Booster Phase|Migrated/moved from study area|0
1699262|NCT01235949|5932398|P9|Booster Phase|Migrated/moved from study area|0
1699263|NCT01235949|5932399|P8|Booster Phase|Migrated/moved from study area|0
1699264|NCT01235949|5932400|P7|Booster Phase|Migrated/moved from study area|0
1699265|NCT01235949|5932401|P6|Booster Phase|Migrated/moved from study area|0
1699266|NCT01235949|5932402|P5|Booster Phase|Migrated/moved from study area|0
1699267|NCT01235949|5932403|P4|Booster Phase|Migrated/moved from study area|0
1699268|NCT01235949|5932404|P3|Booster Phase|Migrated/moved from study area|0
1699269|NCT01235949|5932405|P2|Booster Phase|Migrated/moved from study area|0
1699270|NCT01235949|5932406|P1|Booster Phase|Migrated/moved from study area|0
1699271|NCT01235949|5932389|P18|Primary Phase|Lost to Follow-up|0
1699272|NCT01235949|5932390|P17|Primary Phase|Lost to Follow-up|0
1699273|NCT01235949|5932391|P16|Primary Phase|Lost to Follow-up|0
1699274|NCT01235949|5932392|P15|Primary Phase|Lost to Follow-up|0
1699275|NCT01235949|5932393|P14|Primary Phase|Lost to Follow-up|0
1699276|NCT01235949|5932394|P13|Primary Phase|Lost to Follow-up|0
1699277|NCT01235949|5932395|P12|Primary Phase|Lost to Follow-up|0
1699278|NCT01235949|5932396|P11|Primary Phase|Lost to Follow-up|0
1699279|NCT01235949|5932397|P10|Primary Phase|Lost to Follow-up|0
1699280|NCT01235949|5932398|P9|Primary Phase|Lost to Follow-up|0
1699281|NCT01235949|5932399|P8|Primary Phase|Lost to Follow-up|0
1699282|NCT01235949|5932400|P7|Primary Phase|Lost to Follow-up|0
1699283|NCT01235949|5932401|P6|Primary Phase|Lost to Follow-up|2
1699284|NCT01235949|5932402|P5|Primary Phase|Lost to Follow-up|0
1699285|NCT01235949|5932403|P4|Primary Phase|Lost to Follow-up|1
1699286|NCT01235949|5932404|P3|Primary Phase|Lost to Follow-up|1
1699287|NCT01235949|5932405|P2|Primary Phase|Lost to Follow-up|0
1699288|NCT01235949|5932406|P1|Primary Phase|Lost to Follow-up|0
1699289|NCT01235949|5932389|P18|Primary Phase|Withdrawal by Subject|0
1699290|NCT01235949|5932390|P17|Primary Phase|Withdrawal by Subject|0
1699291|NCT01235949|5932391|P16|Primary Phase|Withdrawal by Subject|0
1699292|NCT01235949|5932392|P15|Primary Phase|Withdrawal by Subject|0
1699293|NCT01235949|5932393|P14|Primary Phase|Withdrawal by Subject|0
1699294|NCT01235949|5932394|P13|Primary Phase|Withdrawal by Subject|0
1699295|NCT01235949|5932395|P12|Primary Phase|Withdrawal by Subject|0
1699296|NCT01235949|5932396|P11|Primary Phase|Withdrawal by Subject|0
1699297|NCT01235949|5932397|P10|Primary Phase|Withdrawal by Subject|0
1699298|NCT01235949|5932398|P9|Primary Phase|Withdrawal by Subject|0
1699299|NCT01235949|5932399|P8|Primary Phase|Withdrawal by Subject|0
1699300|NCT01235949|5932400|P7|Primary Phase|Withdrawal by Subject|0
1699301|NCT01235949|5932401|P6|Primary Phase|Withdrawal by Subject|3
1699302|NCT01235949|5932402|P5|Primary Phase|Withdrawal by Subject|0
1699303|NCT01235949|5932403|P4|Primary Phase|Withdrawal by Subject|0
1699304|NCT01235949|5932404|P3|Primary Phase|Withdrawal by Subject|2
1699305|NCT01235949|5932405|P2|Primary Phase|Withdrawal by Subject|2
1699306|NCT01235949|5932406|P1|Primary Phase|Withdrawal by Subject|3
1699307|NCT01235949|5932389|P18|Primary Phase|Adverse Event|0
1699308|NCT01235949|5932390|P17|Primary Phase|Adverse Event|0
1699309|NCT01235949|5932391|P16|Primary Phase|Adverse Event|0
1699310|NCT01235949|5932392|P15|Primary Phase|Adverse Event|0
1699311|NCT01235949|5932393|P14|Primary Phase|Adverse Event|0
1699312|NCT01235949|5932394|P13|Primary Phase|Adverse Event|0
1699313|NCT01235949|5932395|P12|Primary Phase|Adverse Event|0
1699314|NCT01235949|5932396|P11|Primary Phase|Adverse Event|0
1699315|NCT01235949|5932397|P10|Primary Phase|Adverse Event|0
1699316|NCT01235949|5932398|P9|Primary Phase|Adverse Event|0
1699317|NCT01235949|5932399|P8|Primary Phase|Adverse Event|0
1699318|NCT01235949|5932400|P7|Primary Phase|Adverse Event|0
1699319|NCT01235949|5932401|P6|Primary Phase|Adverse Event|0
1699320|NCT01235949|5932402|P5|Primary Phase|Adverse Event|0
1699321|NCT01235949|5932403|P4|Primary Phase|Adverse Event|1
1699322|NCT01235949|5932404|P3|Primary Phase|Adverse Event|0
1699323|NCT01235949|5932405|P2|Primary Phase|Adverse Event|0
1699324|NCT01235949|5932406|P1|Primary Phase|Adverse Event|0
1699325|NCT01235949|5932389|P18|Primary Phase|Migrated/moved from study area|0
1699326|NCT01235949|5932390|P17|Primary Phase|Migrated/moved from study area|0
1699327|NCT01235949|5932391|P16|Primary Phase|Migrated/moved from study area|0
1699328|NCT01235949|5932392|P15|Primary Phase|Migrated/moved from study area|0
1699329|NCT01235949|5932393|P14|Primary Phase|Migrated/moved from study area|0
1699330|NCT01235949|5932394|P13|Primary Phase|Migrated/moved from study area|0
1699331|NCT01235949|5932395|P12|Primary Phase|Migrated/moved from study area|0
1699332|NCT01235949|5932396|P11|Primary Phase|Migrated/moved from study area|0
1699333|NCT01235949|5932397|P10|Primary Phase|Migrated/moved from study area|0
1699334|NCT01235949|5932398|P9|Primary Phase|Migrated/moved from study area|0
1699335|NCT01235949|5932399|P8|Primary Phase|Migrated/moved from study area|0
1699336|NCT01235949|5932400|P7|Primary Phase|Migrated/moved from study area|0
1699337|NCT01235949|5932401|P6|Primary Phase|Migrated/moved from study area|2
1699338|NCT01235949|5932402|P5|Primary Phase|Migrated/moved from study area|1
1699339|NCT01235949|5932403|P4|Primary Phase|Migrated/moved from study area|0
1699340|NCT01235949|5932404|P3|Primary Phase|Migrated/moved from study area|0
1699341|NCT01235949|5932405|P2|Primary Phase|Migrated/moved from study area|1
1699342|NCT01235949|5932406|P1|Primary Phase|Migrated/moved from study area|1
1699343|NCT01235741|5932656|P3|Follow-Up Post Treatment up to Month 6|Other|0
1699344|NCT01235741|5932657|P2|Follow-Up Post Treatment up to Month 6|Other|1
1699345|NCT01235741|5932658|P1|Follow-Up Post Treatment up to Month 6|Other|0
1699346|NCT01235741|5932656|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
1699347|NCT01235741|5932657|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
1699348|NCT01235741|5932658|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
1699349|NCT01235741|5932656|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
1699350|NCT01235741|5932657|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
1699351|NCT01235741|5932658|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
1699352|NCT01235741|5932656|P3|Randomized to Treatment|Sponsor terminated study|34
1699353|NCT01235741|5932657|P2|Randomized to Treatment|Sponsor terminated study|35
1699354|NCT01235741|5932658|P1|Randomized to Treatment|Sponsor terminated study|0
1699355|NCT01235741|5932656|P3|Randomized to Treatment|Adverse Event|1
1699356|NCT01235741|5932657|P2|Randomized to Treatment|Adverse Event|1
1699357|NCT01235741|5932658|P1|Randomized to Treatment|Adverse Event|0
1699358|NCT01235741|5932656|P3|Randomized to Treatment|Withdrawal by Subject|1
1699359|NCT01235741|5932657|P2|Randomized to Treatment|Withdrawal by Subject|0
1699360|NCT01235741|5932658|P1|Randomized to Treatment|Withdrawal by Subject|0
1699361|NCT01235741|5932656|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
1699362|NCT01235741|5932657|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
1699363|NCT01235741|5932658|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
1699364|NCT01235741|5932656|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
1699365|NCT01235741|5932657|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
1699366|NCT01235741|5932658|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
1699367|NCT01235741|5932656|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
1699368|NCT01235741|5932657|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
1699369|NCT01235741|5932658|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
1699370|NCT01235741|5932656|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
1699371|NCT01235741|5932657|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
1699372|NCT01235741|5932658|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
1699373|NCT01235741|5932656|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
1699374|NCT01235741|5932657|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
1699375|NCT01235741|5932658|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
1699376|NCT01235741|5932656|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
1699377|NCT01235741|5932657|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
1699378|NCT01235741|5932658|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
1699379|NCT01235728|5932685|P8|Overall Study|Protocol Violation|0
1699380|NCT01235728|5932686|P7|Overall Study|Protocol Violation|0
1699381|NCT01235728|5932687|P6|Overall Study|Protocol Violation|0
1699382|NCT01235728|5932688|P5|Overall Study|Protocol Violation|0
1699383|NCT01235728|5932689|P4|Overall Study|Protocol Violation|1
1699384|NCT01235728|5932690|P3|Overall Study|Protocol Violation|0
1699385|NCT01235728|5932691|P2|Overall Study|Protocol Violation|0
1699386|NCT01235728|5932692|P1|Overall Study|Protocol Violation|0
1699387|NCT01235715|5932702|P2|Overall Study|Physician Decision|2
1699388|NCT01235715|5932703|P1|Overall Study|Physician Decision|0
1699389|NCT01235689|5932743|P2|Overall Study|Miscellaneous|5
1699390|NCT01235689|5932744|P1|Overall Study|Miscellaneous|1
1699391|NCT01235689|5932743|P2|Overall Study|Lost to Follow-up|2
1699392|NCT01235689|5932744|P1|Overall Study|Lost to Follow-up|1
1699393|NCT01235689|5932743|P2|Overall Study|Withdrawal by Subject|4
1699394|NCT01235689|5932744|P1|Overall Study|Withdrawal by Subject|3
1699395|NCT01235689|5932743|P2|Overall Study|Lack of Efficacy|5
1699396|NCT01235689|5932744|P1|Overall Study|Lack of Efficacy|12
1699397|NCT01235689|5932743|P2|Overall Study|Adverse Event|16
1699398|NCT01235689|5932744|P1|Overall Study|Adverse Event|12
1699399|NCT01235598|5932816|P2|Overall Study|Withdrawal by Subject|0
1699400|NCT01235598|5932817|P1|Overall Study|Withdrawal by Subject|1
1699401|NCT01235598|5932816|P2|Overall Study|Lack of Efficacy|1
1699402|NCT01235598|5932817|P1|Overall Study|Lack of Efficacy|0
1699403|NCT01235598|5932816|P2|Overall Study|Adverse Event|3
1699404|NCT01235598|5932817|P1|Overall Study|Adverse Event|0
1699405|NCT01235546|5932862|P2|Overall Study|Protocol Violation|1
1699406|NCT01235546|5932863|P1|Overall Study|Protocol Violation|1
1699407|NCT01235546|5932862|P2|Overall Study|Staff error, medication not administered|0
1699408|NCT01235546|5932863|P1|Overall Study|Staff error, medication not administered|1
1699409|NCT01235507|5932887|P1|Overall Study|Withdrawal by Subject|1
1699410|NCT01235507|5932887|P1|Overall Study|Adverse Event|1
1699411|NCT01235442|5932901|P2|Overall Study|Other unspecified|2
1699412|NCT01235442|5932902|P1|Overall Study|Other unspecified|1
1699413|NCT01235442|5932901|P2|Overall Study|Administrative decision|2
1699414|NCT01235442|5932902|P1|Overall Study|Administrative decision|1
1699415|NCT01235442|5932901|P2|Overall Study|Noncompliance|2
1699416|NCT01235442|5932902|P1|Overall Study|Noncompliance|1
1699417|NCT01235442|5932901|P2|Overall Study|Lack of Efficacy|3
1699418|NCT01235442|5932902|P1|Overall Study|Lack of Efficacy|1
1699419|NCT01235442|5932901|P2|Overall Study|Withdrawal by Subject|9
1699420|NCT01235442|5932902|P1|Overall Study|Withdrawal by Subject|15
1699421|NCT01235442|5932901|P2|Overall Study|Adverse Event|6
1699422|NCT01235442|5932902|P1|Overall Study|Adverse Event|4
1699423|NCT01235442|5932901|P2|Overall Study|Protocol Violation|3
1699424|NCT01235442|5932902|P1|Overall Study|Protocol Violation|3
1699425|NCT01235442|5932901|P2|Overall Study|Ineligibility determined|4
1699426|NCT01235442|5932902|P1|Overall Study|Ineligibility determined|5
1699427|NCT01235442|5932901|P2|Overall Study|Pregnancy|1
1699428|NCT01235442|5932902|P1|Overall Study|Pregnancy|1
1699429|NCT01235442|5932901|P2|Overall Study|Death|2
1699430|NCT01235442|5932902|P1|Overall Study|Death|0
1699431|NCT01235442|5932901|P2|Overall Study|Lost to Follow-up|10
1699432|NCT01235442|5932902|P1|Overall Study|Lost to Follow-up|12
1699433|NCT01235403|5932920|P1|Overall Study|Other reasons for premature termination|4
1699434|NCT01235403|5932920|P1|Overall Study|Lack of Efficacy|2
1699435|NCT01235403|5932920|P1|Overall Study|Withdrawal by Subject|4
1699436|NCT01235403|5932920|P1|Overall Study|Lost to Follow-up|2
1699437|NCT01235403|5932920|P1|Overall Study|Adverse Event|14
1699438|NCT01235351|5932937|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
1699439|NCT01235351|5932938|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
1699440|NCT01235338|5932950|P2|Overall Study|Prohibited meds|0
1699441|NCT01235338|5932951|P1|Overall Study|Prohibited meds|1
1699442|NCT01235338|5932950|P2|Overall Study|Positive drug screen|1
1699443|NCT01235338|5932951|P1|Overall Study|Positive drug screen|0
1699444|NCT01235338|5932950|P2|Overall Study|Exclusion criteria violations|1
1699445|NCT01235338|5932951|P1|Overall Study|Exclusion criteria violations|1
1699446|NCT01235338|5932950|P2|Overall Study|Withdrawal by Subject|0
1699447|NCT01235338|5932951|P1|Overall Study|Withdrawal by Subject|5
1699448|NCT01235338|5932950|P2|Overall Study|Protocol Violation|1
1699449|NCT01235338|5932951|P1|Overall Study|Protocol Violation|1
1699450|NCT01235338|5932950|P2|Overall Study|Adverse Event|2
1699451|NCT01235338|5932951|P1|Overall Study|Adverse Event|3
1699452|NCT01235234|5932996|P3|Overall Study|Adverse Event|1
1699453|NCT01235234|5932997|P2|Overall Study|Adverse Event|2
1699454|NCT01235234|5932998|P1|Overall Study|Adverse Event|2
1699455|NCT01234883|5933046|P2|Overall Study|Inclusion/exclusion failure|0
1699456|NCT01234883|5933047|P1|Overall Study|Inclusion/exclusion failure|1
1699457|NCT01234883|5933046|P2|Overall Study|Technical difficulties with IV infusion|1
1699458|NCT01234883|5933047|P1|Overall Study|Technical difficulties with IV infusion|0
1699459|NCT01234883|5933046|P2|Overall Study|Parent/guardian withdrew consent|2
1699460|NCT01234883|5933047|P1|Overall Study|Parent/guardian withdrew consent|1
1699461|NCT01234883|5933046|P2|Overall Study|Early treatment release|10
1699462|NCT01234883|5933047|P1|Overall Study|Early treatment release|8
1699463|NCT01234675|5933094|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
1699464|NCT01234675|5933095|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
1699465|NCT01234675|5933094|P2|First Intervention (6 Weeks)|Adverse Event|1
1699466|NCT01234675|5933095|P1|First Intervention (6 Weeks)|Adverse Event|0
1699467|NCT01234649|5933127|P2|Overall Study|Lack of Efficacy|3
1699468|NCT01234649|5933128|P1|Overall Study|Lack of Efficacy|0
1699469|NCT01234649|5933127|P2|Overall Study|Allergic reaction|0
1699470|NCT01234649|5933128|P1|Overall Study|Allergic reaction|1
1699471|NCT01234649|5933127|P2|Overall Study|intolerant to side effects|3
1699472|NCT01234649|5933128|P1|Overall Study|intolerant to side effects|4
1699473|NCT01234649|5933127|P2|Overall Study|Pregnancy|6
1699474|NCT01234649|5933128|P1|Overall Study|Pregnancy|6
1699475|NCT01234649|5933127|P2|Overall Study|Withdrawal by Subject|26
1699476|NCT01234649|5933128|P1|Overall Study|Withdrawal by Subject|32
1699477|NCT01234467|5933176|P1|Overall Study|Other complicating disease (stroke)|1
1699478|NCT01234467|5933176|P1|Overall Study|Physician Decision|1
1699479|NCT01234467|5933176|P1|Overall Study|Clinical deterioration|1
1699480|NCT01234467|5933176|P1|Overall Study|Disease Progression|2
1699481|NCT01234467|5933176|P1|Overall Study|Withdrawal by Subject|2
1699482|NCT01234467|5933176|P1|Overall Study|Death|2
1699483|NCT01234467|5933176|P1|Overall Study|Adverse Event|3
1699484|NCT01234402|5933188|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
1699485|NCT01234402|5933189|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
1699486|NCT01234402|5933190|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
1699487|NCT01234402|5933188|P3|Overall Study|Never treated: Withdrawal By Subject|0
1699488|NCT01234402|5933189|P2|Overall Study|Never treated: Withdrawal By Subject|1
1699489|NCT01234402|5933190|P1|Overall Study|Never treated: Withdrawal By Subject|0
1699490|NCT01234402|5933188|P3|Overall Study|Never treated: Death|1
1699491|NCT01234402|5933189|P2|Overall Study|Never treated: Death|0
1699492|NCT01234402|5933190|P1|Overall Study|Never treated: Death|0
1699493|NCT01234402|5933188|P3|Overall Study|Withdrawal by Subject|4
1699494|NCT01234402|5933189|P2|Overall Study|Withdrawal by Subject|3
1699495|NCT01234402|5933190|P1|Overall Study|Withdrawal by Subject|1
1699496|NCT01234402|5933188|P3|Overall Study|Lost to Follow-up|3
1699497|NCT01234402|5933189|P2|Overall Study|Lost to Follow-up|1
1699498|NCT01234402|5933190|P1|Overall Study|Lost to Follow-up|0
1699499|NCT01234350|5933231|P2|Overall Study|Covers a diverse set of reasons|92
1699500|NCT01234350|5933232|P1|Overall Study|Covers a diverse set of reasons|234
1699501|NCT01234350|5933231|P2|Overall Study|Lost to Follow-up|47
1699502|NCT01234350|5933232|P1|Overall Study|Lost to Follow-up|115
1699503|NCT01234350|5933231|P2|Overall Study|Withdrawal by Subject|36
1699504|NCT01234350|5933232|P1|Overall Study|Withdrawal by Subject|61
1699505|NCT01234350|5933231|P2|Overall Study|Adverse Event|92
1699506|NCT01234350|5933232|P1|Overall Study|Adverse Event|277
1699507|NCT01234337|5933258|P2|Overall Study|Switch to commercial drug|1
1699508|NCT01234337|5933259|P1|Overall Study|Switch to commercial drug|0
1699509|NCT01234337|5933258|P2|Overall Study|Death|1
1699510|NCT01234337|5933259|P1|Overall Study|Death|0
1699511|NCT01234337|5933258|P2|Overall Study|Withdrawal by Subject|9
1699512|NCT01234337|5933259|P1|Overall Study|Withdrawal by Subject|11
1699513|NCT01234337|5933258|P2|Overall Study|Protocol Violation|3
1699514|NCT01234337|5933259|P1|Overall Study|Protocol Violation|2
1699515|NCT01234337|5933258|P2|Overall Study|Lost to Follow-up|1
1699516|NCT01234337|5933259|P1|Overall Study|Lost to Follow-up|0
1699517|NCT01234337|5933258|P2|Overall Study|Randomized but not treated|4
1699518|NCT01234337|5933259|P1|Overall Study|Randomized but not treated|6
1699519|NCT01234337|5933258|P2|Overall Study|Non-compliant with study medication|2
1699520|NCT01234337|5933259|P1|Overall Study|Non-compliant with study medication|3
1699521|NCT01234337|5933258|P2|Overall Study|Investi. decision not protocol driven|6
1699604|NCT01233284|5933513|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
1699522|NCT01234337|5933259|P1|Overall Study|Investi. decision not protocol driven|5
1699523|NCT01234337|5933258|P2|Overall Study|Disease progression/recurrence/relapse|223
1699524|NCT01234337|5933259|P1|Overall Study|Disease progression/recurrence/relapse|181
1699525|NCT01234337|5933258|P2|Overall Study|Adverse Event|21
1699526|NCT01234337|5933259|P1|Overall Study|Adverse Event|58
1699527|NCT01233999|5933319|P1|Overall Study|Lost to Follow-up|1
1699528|NCT01233999|5933319|P1|Overall Study|Withdrawal by Subject|1
1699529|NCT01233869|5933338|P4|Extended Treatment Period (46 Months)|Adverse Event|1
1699530|NCT01233869|5933339|P3|Extended Treatment Period (46 Months)|Adverse Event|0
1699531|NCT01233869|5933340|P2|Extended Treatment Period (46 Months)|Adverse Event|0
1699532|NCT01233869|5933341|P1|Extended Treatment Period (46 Months)|Adverse Event|1
1699533|NCT01233869|5933338|P4|Extended Treatment Period (46 Months)|Other|3
1699534|NCT01233869|5933339|P3|Extended Treatment Period (46 Months)|Other|0
1699535|NCT01233869|5933340|P2|Extended Treatment Period (46 Months)|Other|0
1699536|NCT01233869|5933341|P1|Extended Treatment Period (46 Months)|Other|3
1699537|NCT01233869|5933338|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
1699538|NCT01233869|5933339|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
1699539|NCT01233869|5933340|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
1699540|NCT01233869|5933341|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
1699541|NCT01233869|5933338|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
1699542|NCT01233869|5933339|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1699543|NCT01233869|5933340|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1699544|NCT01233869|5933341|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
1699545|NCT01233869|5933338|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
1699546|NCT01233869|5933339|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
1699547|NCT01233869|5933340|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
1699548|NCT01233869|5933341|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
1699549|NCT01233869|5933338|P4|Initial Treatment Period (24 Months)|Adverse Event|3
1699550|NCT01233869|5933339|P3|Initial Treatment Period (24 Months)|Adverse Event|0
1699551|NCT01233869|5933340|P2|Initial Treatment Period (24 Months)|Adverse Event|17
1699552|NCT01233869|5933341|P1|Initial Treatment Period (24 Months)|Adverse Event|9
1699553|NCT01233869|5933338|P4|Initial Treatment Period (24 Months)|Death|0
1699554|NCT01233869|5933339|P3|Initial Treatment Period (24 Months)|Death|0
1699555|NCT01233869|5933340|P2|Initial Treatment Period (24 Months)|Death|0
1699556|NCT01233869|5933341|P1|Initial Treatment Period (24 Months)|Death|1
1699557|NCT01233817|5933427|P1|Overall Study|Withdrawal by Subject|2
1699558|NCT01233817|5933427|P1|Overall Study|Lost to Follow-up|1
1699559|NCT01233687|5933474|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
1699560|NCT01233687|5933474|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
1699561|NCT01233687|5933474|P1|Phase II AMG 102 + Erlotinib|Death|1
1699562|NCT01233609|5933484|P2|Overall Study|Withdrawal by Subject|0
1699563|NCT01233609|5933485|P1|Overall Study|Withdrawal by Subject|3
1699564|NCT01233609|5933484|P2|Overall Study|Adverse Event|1
1699565|NCT01233609|5933485|P1|Overall Study|Adverse Event|2
1699566|NCT01233609|5933484|P2|Overall Study|Lost to Follow-up|1
1699567|NCT01233609|5933485|P1|Overall Study|Lost to Follow-up|3
1699568|NCT01233609|5933484|P2|Overall Study|Death|0
1699569|NCT01233609|5933485|P1|Overall Study|Death|1
1699570|NCT01233284|5933509|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
1699571|NCT01233284|5933510|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
1699572|NCT01233284|5933511|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
1699573|NCT01233284|5933512|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
1699574|NCT01233284|5933513|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
1699575|NCT01233284|5933509|P5|Period 4 (4 Weeks)|Adverse Event|0
1699576|NCT01233284|5933510|P4|Period 4 (4 Weeks)|Adverse Event|0
1699577|NCT01233284|5933511|P3|Period 4 (4 Weeks)|Adverse Event|0
1699578|NCT01233284|5933512|P2|Period 4 (4 Weeks)|Adverse Event|1
1699579|NCT01233284|5933513|P1|Period 4 (4 Weeks)|Adverse Event|0
1699580|NCT01233284|5933509|P5|Period 3 (4 Weeks)|Other|0
1699581|NCT01233284|5933510|P4|Period 3 (4 Weeks)|Other|1
1699582|NCT01233284|5933511|P3|Period 3 (4 Weeks)|Other|0
1699583|NCT01233284|5933512|P2|Period 3 (4 Weeks)|Other|0
1699584|NCT01233284|5933513|P1|Period 3 (4 Weeks)|Other|0
1699585|NCT01233284|5933509|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
1699586|NCT01233284|5933510|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
1699587|NCT01233284|5933511|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
1699588|NCT01233284|5933512|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
1699589|NCT01233284|5933513|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
1699590|NCT01233284|5933509|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
1699591|NCT01233284|5933510|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
1699592|NCT01233284|5933511|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
1699593|NCT01233284|5933512|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
1699594|NCT01233284|5933513|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
1699595|NCT01233284|5933509|P5|Period 1 (4 Weeks)|Other|0
1699596|NCT01233284|5933510|P4|Period 1 (4 Weeks)|Other|0
1699597|NCT01233284|5933511|P3|Period 1 (4 Weeks)|Other|1
1699598|NCT01233284|5933512|P2|Period 1 (4 Weeks)|Other|0
1699599|NCT01233284|5933513|P1|Period 1 (4 Weeks)|Other|0
1699600|NCT01233284|5933509|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
1699601|NCT01233284|5933510|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
1699602|NCT01233284|5933511|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
1699603|NCT01233284|5933512|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
1699605|NCT01233284|5933509|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
1699606|NCT01233284|5933510|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
1699607|NCT01233284|5933511|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
1699608|NCT01233284|5933512|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
1699609|NCT01233284|5933513|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
1699610|NCT01233258|5933594|P6|First Intervention (6 Months)|Non-compliance with study medication|0
1699611|NCT01233258|5933595|P5|First Intervention (6 Months)|Non-compliance with study medication|0
1699612|NCT01233258|5933596|P4|First Intervention (6 Months)|Non-compliance with study medication|0
1699613|NCT01233258|5933597|P3|First Intervention (6 Months)|Non-compliance with study medication|0
1699614|NCT01233258|5933598|P2|First Intervention (6 Months)|Non-compliance with study medication|0
1699615|NCT01233258|5933599|P1|First Intervention (6 Months)|Non-compliance with study medication|1
1699616|NCT01233258|5933594|P6|First Intervention (6 Months)|Protocol Violation|0
1699617|NCT01233258|5933595|P5|First Intervention (6 Months)|Protocol Violation|0
1699618|NCT01233258|5933596|P4|First Intervention (6 Months)|Protocol Violation|0
1699619|NCT01233258|5933597|P3|First Intervention (6 Months)|Protocol Violation|1
1699620|NCT01233258|5933598|P2|First Intervention (6 Months)|Protocol Violation|0
1699621|NCT01233258|5933599|P1|First Intervention (6 Months)|Protocol Violation|0
1699622|NCT01233258|5933594|P6|First Intervention (6 Months)|Withdrawal by Subject|1
1699623|NCT01233258|5933595|P5|First Intervention (6 Months)|Withdrawal by Subject|0
1699624|NCT01233258|5933596|P4|First Intervention (6 Months)|Withdrawal by Subject|1
1699625|NCT01233258|5933597|P3|First Intervention (6 Months)|Withdrawal by Subject|0
1699626|NCT01233258|5933598|P2|First Intervention (6 Months)|Withdrawal by Subject|0
1699627|NCT01233258|5933599|P1|First Intervention (6 Months)|Withdrawal by Subject|0
1699628|NCT01233232|5933619|P3|Overall Study|Voluntary Discontinuation by Subject|0
1699629|NCT01233232|5933620|P2|Overall Study|Voluntary Discontinuation by Subject|0
1699630|NCT01233232|5933621|P1|Overall Study|Voluntary Discontinuation by Subject|1
1699631|NCT01233076|5933674|P2|Period 2, One Week|Lost to Follow-up|0
1699632|NCT01233076|5933675|P1|Period 2, One Week|Lost to Follow-up|1
1699633|NCT01233050|5933683|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
1699634|NCT01233050|5933684|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
1699635|NCT01232894|5933736|P2|Overall Study|Physician Decision|1
1699636|NCT01232894|5933737|P1|Overall Study|Physician Decision|2
1699637|NCT01232894|5933736|P2|Overall Study|Withdrawal by Subject|5
1699638|NCT01232894|5933737|P1|Overall Study|Withdrawal by Subject|8
1699639|NCT01232894|5933736|P2|Overall Study|Protocol Violation|1
1699640|NCT01232894|5933737|P1|Overall Study|Protocol Violation|1
1699641|NCT01232894|5933736|P2|Overall Study|Death|0
1699642|NCT01232894|5933737|P1|Overall Study|Death|1
1699643|NCT01232894|5933736|P2|Overall Study|Lost to Follow-up|1
1699644|NCT01232894|5933737|P1|Overall Study|Lost to Follow-up|0
1699645|NCT01232868|5933745|P2|Overall Study|Lost to Follow-up|4
1699646|NCT01232868|5933746|P1|Overall Study|Lost to Follow-up|2
1699647|NCT01232790|5933760|P2|Second Crossover|Withdrawal by Subject|2
1699648|NCT01232790|5933761|P1|Second Crossover|Withdrawal by Subject|1
1699649|NCT01232790|5933760|P2|First Crossover|Withdrawal by Subject|0
1699650|NCT01232790|5933761|P1|First Crossover|Withdrawal by Subject|1
1699651|NCT01232790|5933760|P2|Initial Assessment|Withdrawal by Subject|1
1699652|NCT01232790|5933761|P1|Initial Assessment|Withdrawal by Subject|0
1699653|NCT01232790|5933760|P2|Randomization|Physician Decision|1
1699654|NCT01232790|5933761|P1|Randomization|Physician Decision|0
1699655|NCT01232790|5933760|P2|Randomization|Protocol Violation|1
1699656|NCT01232790|5933761|P1|Randomization|Protocol Violation|0
1699657|NCT01232790|5933760|P2|Randomization|Withdrawal by Subject|0
1699658|NCT01232790|5933761|P1|Randomization|Withdrawal by Subject|2
1699659|NCT01232738|5933815|P1|Overall Study|Adverse Event|5
1699660|NCT01232738|5933815|P1|Overall Study|Withdrawal by Subject|2
1699661|NCT01232738|5933815|P1|Overall Study|Lost to Follow-up|1
1699662|NCT01232738|5933815|P1|Overall Study|Physician Decision|2
1699663|NCT01232738|5933815|P1|Overall Study|Death|3
1699664|NCT01232569|5933831|P4|Double-blind Treatment Period|Death|0
1699665|NCT01232569|5933832|P3|Double-blind Treatment Period|Death|0
1699666|NCT01232569|5933833|P2|Double-blind Treatment Period|Death|0
1699667|NCT01232569|5933834|P1|Double-blind Treatment Period|Death|2
1699668|NCT01232569|5933831|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
1699669|NCT01232569|5933832|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
1699670|NCT01232569|5933833|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
1699671|NCT01232569|5933834|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
1699672|NCT01232569|5933831|P4|Double-blind Treatment Period|Physician Decision|0
1699673|NCT01232569|5933832|P3|Double-blind Treatment Period|Physician Decision|0
1699674|NCT01232569|5933833|P2|Double-blind Treatment Period|Physician Decision|0
1699675|NCT01232569|5933834|P1|Double-blind Treatment Period|Physician Decision|1
1699676|NCT01232569|5933831|P4|Double-blind Treatment Period|Lack of Efficacy|0
1699677|NCT01232569|5933832|P3|Double-blind Treatment Period|Lack of Efficacy|0
1699678|NCT01232569|5933833|P2|Double-blind Treatment Period|Lack of Efficacy|2
1699679|NCT01232569|5933834|P1|Double-blind Treatment Period|Lack of Efficacy|1
1699680|NCT01232569|5933831|P4|Double-blind Treatment Period|Lost to Follow-up|0
1699681|NCT01232569|5933832|P3|Double-blind Treatment Period|Lost to Follow-up|0
1699682|NCT01232569|5933833|P2|Double-blind Treatment Period|Lost to Follow-up|0
1699683|NCT01232569|5933834|P1|Double-blind Treatment Period|Lost to Follow-up|4
1699684|NCT01232569|5933831|P4|Double-blind Treatment Period|Escape|0
1699685|NCT01232569|5933832|P3|Double-blind Treatment Period|Escape|0
1699686|NCT01232569|5933833|P2|Double-blind Treatment Period|Escape|2
1699687|NCT01232569|5933834|P1|Double-blind Treatment Period|Escape|2
1699688|NCT01232569|5933831|P4|Double-blind Treatment Period|Withdrawal by Subject|0
1699689|NCT01232569|5933832|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1699690|NCT01232569|5933833|P2|Double-blind Treatment Period|Withdrawal by Subject|2
1699691|NCT01232569|5933834|P1|Double-blind Treatment Period|Withdrawal by Subject|9
1699692|NCT01232556|5933877|P2|Overall Study|Other|4
1699693|NCT01232556|5933878|P1|Overall Study|Other|6
1699694|NCT01232556|5933877|P2|Overall Study|Terminated by Sponsor|51
1699695|NCT01232556|5933878|P1|Overall Study|Terminated by Sponsor|35
1699696|NCT01232556|5933877|P2|Overall Study|Lost to Follow-up|2
1699697|NCT01232556|5933878|P1|Overall Study|Lost to Follow-up|0
1699698|NCT01232556|5933877|P2|Overall Study|Death|97
1699699|NCT01232556|5933878|P1|Overall Study|Death|97
1699700|NCT01232556|5933877|P2|Overall Study|Withdrawal by Subject|17
1699701|NCT01232556|5933878|P1|Overall Study|Withdrawal by Subject|21
1699702|NCT01232491|5933937|P2|Overall Study|Other|18
1699703|NCT01232491|5933938|P1|Overall Study|Other|21
1699704|NCT01232491|5933937|P2|Overall Study|Withdrawal Criteria|21
1699705|NCT01232491|5933938|P1|Overall Study|Withdrawal Criteria|12
1699706|NCT01232491|5933937|P2|Overall Study|Protocol Violation|11
1699707|NCT01232491|5933938|P1|Overall Study|Protocol Violation|13
1699708|NCT01232491|5933937|P2|Overall Study|Lack of Efficacy|5
1699709|NCT01232491|5933938|P1|Overall Study|Lack of Efficacy|1
1699710|NCT01232491|5933937|P2|Overall Study|Adverse Event|8
1699711|NCT01232491|5933938|P1|Overall Study|Adverse Event|13
1699712|NCT01232452|5933967|P2|Overall Study|Protocol Violation|1
1699713|NCT01232452|5933968|P1|Overall Study|Protocol Violation|0
1699714|NCT01232452|5933967|P2|Overall Study|Sponsor Decision|1
1699715|NCT01232452|5933968|P1|Overall Study|Sponsor Decision|3
1699716|NCT01232452|5933967|P2|Overall Study|Protocol entry criterion not met|2
1699717|NCT01232452|5933968|P1|Overall Study|Protocol entry criterion not met|0
1699718|NCT01232452|5933967|P2|Overall Study|Physician Decision|12
1699719|NCT01232452|5933968|P1|Overall Study|Physician Decision|8
1699720|NCT01232452|5933967|P2|Overall Study|Withdrawal by Subject|8
1699721|NCT01232452|5933968|P1|Overall Study|Withdrawal by Subject|11
1699722|NCT01232452|5933967|P2|Overall Study|Adverse Event|15
1699723|NCT01232452|5933968|P1|Overall Study|Adverse Event|17
1699724|NCT01232296|5933994|P2|Overall Study|Death|6
1699725|NCT01232296|5933995|P1|Overall Study|Death|1
1699726|NCT01232296|5933994|P2|Overall Study|Subject/guardian decision|2
1699727|NCT01232296|5933995|P1|Overall Study|Subject/guardian decision|10
1699728|NCT01232296|5933994|P2|Overall Study|Technical problems|0
1699729|NCT01232296|5933995|P1|Overall Study|Technical problems|3
1699730|NCT01232296|5933994|P2|Overall Study|Study terminated by sponsor|1
1699731|NCT01232296|5933995|P1|Overall Study|Study terminated by sponsor|0
1699732|NCT01232296|5933994|P2|Overall Study|Progressive disease|61
1699733|NCT01232296|5933995|P1|Overall Study|Progressive disease|43
1699734|NCT01232296|5933994|P2|Overall Study|Physician Decision|1
1699735|NCT01232296|5933995|P1|Overall Study|Physician Decision|1
1699736|NCT01232296|5933994|P2|Overall Study|Adverse Event|12
1699737|NCT01232296|5933995|P1|Overall Study|Adverse Event|24
1699738|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
1699739|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
1699740|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699741|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699742|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699743|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699744|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699745|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699746|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699747|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
1699748|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699749|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
1699750|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699751|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699752|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699753|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699754|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699755|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699756|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699757|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
1699758|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699759|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
1699760|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699761|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699762|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699763|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699764|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699765|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699766|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699767|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
1699768|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
1699769|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
1699770|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699771|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699772|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699773|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699774|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699775|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699776|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699777|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
1699778|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
1699779|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
1699780|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699781|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699782|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699783|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699784|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699785|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699786|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699787|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
1699788|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
1699789|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
1699790|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699791|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699792|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699793|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699794|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699795|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699796|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699797|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
1699798|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
1699799|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
1699800|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699801|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699802|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699803|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699804|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699805|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699806|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699807|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
1699808|NCT01232283|5934012|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
1699809|NCT01232283|5934013|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
1699810|NCT01232283|5934014|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699811|NCT01232283|5934015|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699812|NCT01232283|5934016|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699813|NCT01232283|5934017|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699814|NCT01232283|5934018|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699815|NCT01232283|5934019|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699816|NCT01232283|5934020|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699817|NCT01232283|5934021|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
1699818|NCT01232283|5934012|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699819|NCT01232283|5934013|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699820|NCT01232283|5934014|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699821|NCT01232283|5934015|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699822|NCT01232283|5934016|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
1699823|NCT01232283|5934017|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699824|NCT01232283|5934018|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699825|NCT01232283|5934019|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699826|NCT01232283|5934020|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699827|NCT01232283|5934021|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
1699828|NCT01232283|5934012|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699829|NCT01232283|5934013|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699830|NCT01232283|5934014|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
1699831|NCT01232283|5934015|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699832|NCT01232283|5934016|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699833|NCT01232283|5934017|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699834|NCT01232283|5934018|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699835|NCT01232283|5934019|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699836|NCT01232283|5934020|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699837|NCT01232283|5934021|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
1699838|NCT01232283|5934012|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1699839|NCT01232283|5934013|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1699840|NCT01232283|5934014|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
1699841|NCT01232283|5934015|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
1699842|NCT01232283|5934016|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1699843|NCT01232283|5934017|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
1699844|NCT01232283|5934018|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1699845|NCT01232283|5934019|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1699846|NCT01232283|5934020|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1699847|NCT01232283|5934021|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
1699848|NCT01232283|5934012|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699849|NCT01232283|5934013|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699850|NCT01232283|5934014|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699851|NCT01232283|5934015|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699852|NCT01232283|5934016|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699853|NCT01232283|5934017|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
1699854|NCT01232283|5934018|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699855|NCT01232283|5934019|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699856|NCT01232283|5934020|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699857|NCT01232283|5934021|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
1699858|NCT01232283|5934012|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1699859|NCT01232283|5934013|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1699860|NCT01232283|5934014|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
1699861|NCT01232283|5934015|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1699862|NCT01232283|5934016|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1699863|NCT01232283|5934017|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
1699864|NCT01232283|5934018|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1699865|NCT01232283|5934019|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1699866|NCT01232283|5934020|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1699867|NCT01232283|5934021|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
1699868|NCT01232283|5934012|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1699869|NCT01232283|5934013|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1699870|NCT01232283|5934014|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
1699871|NCT01232283|5934015|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
1699872|NCT01232283|5934016|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1699873|NCT01232283|5934017|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
1699874|NCT01232283|5934018|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1699875|NCT01232283|5934019|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1699876|NCT01232283|5934020|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1699877|NCT01232283|5934021|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
1699878|NCT01232283|5934012|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1699879|NCT01232283|5934013|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1699880|NCT01232283|5934014|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
1699881|NCT01232283|5934015|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1699882|NCT01232283|5934016|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
1699883|NCT01232283|5934017|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
1699884|NCT01232283|5934018|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1699885|NCT01232283|5934019|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1699886|NCT01232283|5934020|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1699887|NCT01232283|5934021|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
1699888|NCT01232283|5934012|P10|Maintenance Phase (Weeks16-32)|Other|0
1699889|NCT01232283|5934013|P9|Maintenance Phase (Weeks16-32)|Other|0
1699890|NCT01232283|5934014|P8|Maintenance Phase (Weeks16-32)|Other|0
1699891|NCT01232283|5934015|P7|Maintenance Phase (Weeks16-32)|Other|0
1699892|NCT01232283|5934016|P6|Maintenance Phase (Weeks16-32)|Other|0
1699893|NCT01232283|5934017|P5|Maintenance Phase (Weeks16-32)|Other|0
1699894|NCT01232283|5934018|P4|Maintenance Phase (Weeks16-32)|Other|0
1699895|NCT01232283|5934019|P3|Maintenance Phase (Weeks16-32)|Other|2
1699896|NCT01232283|5934020|P2|Maintenance Phase (Weeks16-32)|Other|0
1699897|NCT01232283|5934021|P1|Maintenance Phase (Weeks16-32)|Other|0
1699898|NCT01232283|5934012|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699899|NCT01232283|5934013|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699900|NCT01232283|5934014|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699901|NCT01232283|5934015|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699902|NCT01232283|5934016|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699903|NCT01232283|5934017|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699904|NCT01232283|5934018|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
1699905|NCT01232283|5934019|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
1699906|NCT01232283|5934020|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699907|NCT01232283|5934021|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
1699908|NCT01232283|5934012|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699909|NCT01232283|5934013|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699910|NCT01232283|5934014|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699911|NCT01232283|5934015|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699912|NCT01232283|5934016|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699913|NCT01232283|5934017|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699914|NCT01232283|5934018|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
1699915|NCT01232283|5934019|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
1699916|NCT01232283|5934020|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699917|NCT01232283|5934021|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
1699918|NCT01232283|5934012|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699919|NCT01232283|5934013|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699920|NCT01232283|5934014|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699921|NCT01232283|5934015|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699922|NCT01232283|5934016|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699923|NCT01232283|5934017|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699924|NCT01232283|5934018|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699925|NCT01232283|5934019|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
1699926|NCT01232283|5934020|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699927|NCT01232283|5934021|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
1699928|NCT01232283|5934012|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699929|NCT01232283|5934013|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699930|NCT01232283|5934014|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699931|NCT01232283|5934015|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699932|NCT01232283|5934016|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699933|NCT01232283|5934017|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699934|NCT01232283|5934018|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
1699935|NCT01232283|5934019|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
1699936|NCT01232283|5934020|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699937|NCT01232283|5934021|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
1699938|NCT01232283|5934012|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699939|NCT01232283|5934013|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699940|NCT01232283|5934014|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699941|NCT01232283|5934015|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699942|NCT01232283|5934016|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699943|NCT01232283|5934017|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699944|NCT01232283|5934018|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
1699945|NCT01232283|5934019|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
1699946|NCT01232283|5934020|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699947|NCT01232283|5934021|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
1699948|NCT01232283|5934012|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699949|NCT01232283|5934013|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699950|NCT01232283|5934014|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699951|NCT01232283|5934015|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699952|NCT01232283|5934016|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699953|NCT01232283|5934017|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699954|NCT01232283|5934018|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699955|NCT01232283|5934019|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
1699956|NCT01232283|5934020|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
1699957|NCT01232283|5934021|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
1699958|NCT01232283|5934012|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699959|NCT01232283|5934013|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699960|NCT01232283|5934014|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699961|NCT01232283|5934015|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699962|NCT01232283|5934016|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699963|NCT01232283|5934017|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699964|NCT01232283|5934018|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699965|NCT01232283|5934019|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
1699966|NCT01232283|5934020|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
1699967|NCT01232283|5934021|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
1699968|NCT01232283|5934012|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699969|NCT01232283|5934013|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699970|NCT01232283|5934014|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699971|NCT01232283|5934015|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699972|NCT01232283|5934016|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699973|NCT01232283|5934017|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699974|NCT01232283|5934018|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699975|NCT01232283|5934019|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
1699976|NCT01232283|5934020|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
1699977|NCT01232283|5934021|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
1699978|NCT01232283|5934012|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699979|NCT01232283|5934013|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699980|NCT01232283|5934014|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699981|NCT01232283|5934015|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699982|NCT01232283|5934016|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699983|NCT01232283|5934017|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699984|NCT01232283|5934018|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699985|NCT01232283|5934019|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
1699986|NCT01232283|5934020|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
1699987|NCT01232283|5934021|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
1699988|NCT01232283|5934012|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699989|NCT01232283|5934013|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699990|NCT01232283|5934014|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699991|NCT01232283|5934015|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699992|NCT01232283|5934016|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699993|NCT01232283|5934017|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699994|NCT01232283|5934018|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699995|NCT01232283|5934019|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699996|NCT01232283|5934020|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
1699997|NCT01232283|5934021|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
1699998|NCT01232283|5934012|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1699999|NCT01232283|5934013|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1700000|NCT01232283|5934014|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1700001|NCT01232283|5934015|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1700002|NCT01232283|5934016|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1700003|NCT01232283|5934017|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1700004|NCT01232283|5934018|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1700005|NCT01232283|5934019|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
1700006|NCT01232283|5934020|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
1700007|NCT01232283|5934021|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
1700008|NCT01232283|5934012|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700009|NCT01232283|5934013|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700010|NCT01232283|5934014|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700011|NCT01232283|5934015|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700012|NCT01232283|5934016|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700013|NCT01232283|5934017|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700014|NCT01232283|5934018|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700015|NCT01232283|5934019|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
1700016|NCT01232283|5934020|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
1700017|NCT01232283|5934021|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
1700018|NCT01232127|5934062|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
1700019|NCT01232127|5934063|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
1700020|NCT01232127|5934064|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
1700021|NCT01231984|5934088|P4|Study Period 2|Did not continue to meet I/E Criteria|1
1700022|NCT01231984|5934089|P3|Study Period 2|Did not continue to meet I/E Criteria|0
1700023|NCT01231984|5934090|P2|Study Period 2|Did not continue to meet I/E Criteria|1
1700024|NCT01231984|5934091|P1|Study Period 2|Did not continue to meet I/E Criteria|1
1700025|NCT01231984|5934088|P4|Study Period 2|Lost to Follow-up|3
1700026|NCT01231984|5934089|P3|Study Period 2|Lost to Follow-up|0
1700027|NCT01231984|5934090|P2|Study Period 2|Lost to Follow-up|0
1700028|NCT01231984|5934091|P1|Study Period 2|Lost to Follow-up|1
1700029|NCT01231984|5934088|P4|Study Period 2|Withdrawal by Subject|0
1700030|NCT01231984|5934089|P3|Study Period 2|Withdrawal by Subject|0
1700031|NCT01231984|5934090|P2|Study Period 2|Withdrawal by Subject|1
1700032|NCT01231984|5934091|P1|Study Period 2|Withdrawal by Subject|1
1700033|NCT01231984|5934088|P4|Study Period 1|Other|1
1700034|NCT01231984|5934089|P3|Study Period 1|Other|0
1700035|NCT01231984|5934090|P2|Study Period 1|Other|0
1700036|NCT01231984|5934091|P1|Study Period 1|Other|0
1700037|NCT01231984|5934088|P4|Study Period 1|Adverse Event|0
1700038|NCT01231984|5934089|P3|Study Period 1|Adverse Event|0
1700039|NCT01231984|5934090|P2|Study Period 1|Adverse Event|0
1700040|NCT01231984|5934091|P1|Study Period 1|Adverse Event|1
1700041|NCT01231984|5934088|P4|Study Period 1|Protocol Violation|3
1700042|NCT01231984|5934089|P3|Study Period 1|Protocol Violation|2
1700043|NCT01231984|5934090|P2|Study Period 1|Protocol Violation|4
1700044|NCT01231984|5934091|P1|Study Period 1|Protocol Violation|3
1700045|NCT01231984|5934088|P4|Study Period 1|Non-compliance with study requirements|1
1700046|NCT01231984|5934089|P3|Study Period 1|Non-compliance with study requirements|2
1700047|NCT01231984|5934090|P2|Study Period 1|Non-compliance with study requirements|0
1700048|NCT01231984|5934091|P1|Study Period 1|Non-compliance with study requirements|5
1700049|NCT01231984|5934088|P4|Study Period 1|Screen Failure|1
1700050|NCT01231984|5934089|P3|Study Period 1|Screen Failure|0
1700051|NCT01231984|5934090|P2|Study Period 1|Screen Failure|0
1700052|NCT01231984|5934091|P1|Study Period 1|Screen Failure|0
1700053|NCT01231984|5934088|P4|Study Period 1|Did not continue to meet I/E Criteria|2
1700054|NCT01231984|5934089|P3|Study Period 1|Did not continue to meet I/E Criteria|2
1700055|NCT01231984|5934090|P2|Study Period 1|Did not continue to meet I/E Criteria|2
1700056|NCT01231984|5934091|P1|Study Period 1|Did not continue to meet I/E Criteria|2
1700057|NCT01231984|5934088|P4|Study Period 1|Lost to Follow-up|0
1700058|NCT01231984|5934089|P3|Study Period 1|Lost to Follow-up|1
1700059|NCT01231984|5934090|P2|Study Period 1|Lost to Follow-up|1
1700060|NCT01231984|5934091|P1|Study Period 1|Lost to Follow-up|1
1700061|NCT01231984|5934088|P4|Study Period 1|Withdrawal by Subject|1
1700062|NCT01231984|5934089|P3|Study Period 1|Withdrawal by Subject|0
1700063|NCT01231984|5934090|P2|Study Period 1|Withdrawal by Subject|0
1700064|NCT01231984|5934091|P1|Study Period 1|Withdrawal by Subject|0
1700065|NCT01231620|5934160|P3|Overall Study|Lost to Follow-up|9
1700066|NCT01231620|5934161|P2|Overall Study|Lost to Follow-up|4
1700067|NCT01231620|5934162|P1|Overall Study|Lost to Follow-up|3
1700068|NCT01231620|5934160|P3|Overall Study|Withdrawal by Subject|8
1700069|NCT01231620|5934161|P2|Overall Study|Withdrawal by Subject|6
1700070|NCT01231620|5934162|P1|Overall Study|Withdrawal by Subject|6
1700071|NCT01231620|5934160|P3|Overall Study|Adverse Event|1
1700072|NCT01231620|5934161|P2|Overall Study|Adverse Event|2
1700073|NCT01231620|5934162|P1|Overall Study|Adverse Event|2
1700074|NCT01231620|5934160|P3|Overall Study|Death|11
1700075|NCT01231620|5934161|P2|Overall Study|Death|14
1700076|NCT01231620|5934162|P1|Overall Study|Death|12
1700077|NCT01231620|5934160|P3|Overall Study|Physician Decision|10
1700078|NCT01231620|5934161|P2|Overall Study|Physician Decision|5
1700079|NCT01231620|5934162|P1|Overall Study|Physician Decision|3
1700080|NCT01231607|5934268|P5|Overall Study|Withdrawal by Subject|9
1700081|NCT01231607|5934269|P4|Overall Study|Withdrawal by Subject|17
1700082|NCT01231607|5934270|P3|Overall Study|Withdrawal by Subject|14
1700083|NCT01231607|5934271|P2|Overall Study|Withdrawal by Subject|9
1700084|NCT01231607|5934272|P1|Overall Study|Withdrawal by Subject|9
1700085|NCT01231607|5934268|P5|Overall Study|Protocol Violation|2
1700086|NCT01231607|5934269|P4|Overall Study|Protocol Violation|2
1700087|NCT01231607|5934270|P3|Overall Study|Protocol Violation|0
1700088|NCT01231607|5934271|P2|Overall Study|Protocol Violation|2
1700089|NCT01231607|5934272|P1|Overall Study|Protocol Violation|3
1700090|NCT01231607|5934268|P5|Overall Study|Physician Decision|4
1700091|NCT01231607|5934269|P4|Overall Study|Physician Decision|5
1700092|NCT01231607|5934270|P3|Overall Study|Physician Decision|3
1700093|NCT01231607|5934271|P2|Overall Study|Physician Decision|4
1700094|NCT01231607|5934272|P1|Overall Study|Physician Decision|4
1700095|NCT01231607|5934268|P5|Overall Study|Lost to Follow-up|4
1700096|NCT01231607|5934269|P4|Overall Study|Lost to Follow-up|10
1700097|NCT01231607|5934270|P3|Overall Study|Lost to Follow-up|10
1700098|NCT01231607|5934271|P2|Overall Study|Lost to Follow-up|11
1700099|NCT01231607|5934272|P1|Overall Study|Lost to Follow-up|13
1700100|NCT01231607|5934268|P5|Overall Study|Adverse Event|5
1700101|NCT01231607|5934269|P4|Overall Study|Adverse Event|4
1700102|NCT01231607|5934270|P3|Overall Study|Adverse Event|4
1700103|NCT01231607|5934271|P2|Overall Study|Adverse Event|8
1700104|NCT01231607|5934272|P1|Overall Study|Adverse Event|0
1700105|NCT01231581|5934364|P2|Overall Study|Ongoing|0
1700106|NCT01231581|5934365|P1|Overall Study|Ongoing|1
1700107|NCT01231581|5934364|P2|Overall Study|Death|64
1700108|NCT01231581|5934365|P1|Overall Study|Death|65
1700109|NCT01231581|5934364|P2|Overall Study|Study Closed/Terminated|5
1700110|NCT01231581|5934365|P1|Overall Study|Study Closed/Terminated|6
1700111|NCT01231581|5934364|P2|Overall Study|Withdrawal by Subject|9
1700112|NCT01231581|5934365|P1|Overall Study|Withdrawal by Subject|6
1700113|NCT01231581|5934364|P2|Overall Study|Lost to Follow-up|2
1700114|NCT01231581|5934365|P1|Overall Study|Lost to Follow-up|2
1700115|NCT01231555|5934386|P3|Overall Study|Withdrawal by Subject|0
1700116|NCT01231555|5934387|P2|Overall Study|Withdrawal by Subject|2
1700117|NCT01231555|5934388|P1|Overall Study|Withdrawal by Subject|0
1700118|NCT01231555|5934386|P3|Overall Study|Study terminated|8
1700119|NCT01231555|5934387|P2|Overall Study|Study terminated|5
1700120|NCT01231555|5934388|P1|Overall Study|Study terminated|8
1700121|NCT01231516|5934419|P2|Open-label Phase|Ongoing at the time of analysis|23
1700122|NCT01231516|5934420|P1|Open-label Phase|Ongoing at the time of analysis|282
1700123|NCT01231516|5934419|P2|Open-label Phase|Withdrawal by Subject|0
1700124|NCT01231516|5934420|P1|Open-label Phase|Withdrawal by Subject|1
1700125|NCT01231516|5934419|P2|Open-label Phase|Lost to Follow-up|0
1700126|NCT01231516|5934420|P1|Open-label Phase|Lost to Follow-up|3
1700127|NCT01231516|5934419|P2|Open-label Phase|Protocol Violation|0
1700128|NCT01231516|5934420|P1|Open-label Phase|Protocol Violation|2
1700129|NCT01231516|5934419|P2|Open-label Phase|Lack of Efficacy|3
1700130|NCT01231516|5934420|P1|Open-label Phase|Lack of Efficacy|7
1700131|NCT01231516|5934419|P2|48 Week Double-blind Phase|Site Closed|1
1700132|NCT01231516|5934420|P1|48 Week Double-blind Phase|Site Closed|3
1700133|NCT01231516|5934419|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
1700134|NCT01231516|5934420|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
1700135|NCT01231516|5934419|P2|48 Week Double-blind Phase|Physician Decision|1
1700136|NCT01231516|5934420|P1|48 Week Double-blind Phase|Physician Decision|1
1700137|NCT01231516|5934419|P2|48 Week Double-blind Phase|Lost to Follow-up|10
1700138|NCT01231516|5934420|P1|48 Week Double-blind Phase|Lost to Follow-up|5
1700139|NCT01231516|5934419|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
1700140|NCT01231516|5934420|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
1700141|NCT01231516|5934419|P2|48 Week Double-blind Phase|Protocol Violation|6
1700142|NCT01231516|5934420|P1|48 Week Double-blind Phase|Protocol Violation|9
1700143|NCT01231516|5934419|P2|48 Week Double-blind Phase|Lack of Efficacy|42
1700144|NCT01231516|5934420|P1|48 Week Double-blind Phase|Lack of Efficacy|20
1700145|NCT01231516|5934419|P2|48 Week Double-blind Phase|Adverse Event|11
1700146|NCT01231516|5934420|P1|48 Week Double-blind Phase|Adverse Event|4
1700147|NCT01231503|5934450|P8|Overall Study|Protocol Violation|0
1700148|NCT01231503|5934451|P7|Overall Study|Protocol Violation|0
1700149|NCT01231503|5934452|P6|Overall Study|Protocol Violation|0
1700150|NCT01231503|5934453|P5|Overall Study|Protocol Violation|0
1700151|NCT01231503|5934454|P4|Overall Study|Protocol Violation|1
1700152|NCT01231503|5934455|P3|Overall Study|Protocol Violation|0
1700153|NCT01231503|5934456|P2|Overall Study|Protocol Violation|0
1700154|NCT01231503|5934457|P1|Overall Study|Protocol Violation|0
1700155|NCT01231503|5934450|P8|Overall Study|Lost to Follow-up|6
1700156|NCT01231503|5934451|P7|Overall Study|Lost to Follow-up|6
1700157|NCT01231503|5934452|P6|Overall Study|Lost to Follow-up|9
1700158|NCT01231503|5934453|P5|Overall Study|Lost to Follow-up|7
1700159|NCT01231503|5934454|P4|Overall Study|Lost to Follow-up|5
1700160|NCT01231503|5934455|P3|Overall Study|Lost to Follow-up|8
1700161|NCT01231503|5934456|P2|Overall Study|Lost to Follow-up|10
1700162|NCT01231503|5934457|P1|Overall Study|Lost to Follow-up|8
1700163|NCT01231503|5934450|P8|Overall Study|Withdrawal by Subject|2
1700164|NCT01231503|5934451|P7|Overall Study|Withdrawal by Subject|1
1700165|NCT01231503|5934452|P6|Overall Study|Withdrawal by Subject|5
1700166|NCT01231503|5934453|P5|Overall Study|Withdrawal by Subject|3
1700167|NCT01231503|5934454|P4|Overall Study|Withdrawal by Subject|1
1700168|NCT01231503|5934455|P3|Overall Study|Withdrawal by Subject|3
1700169|NCT01231503|5934456|P2|Overall Study|Withdrawal by Subject|3
1700170|NCT01231503|5934457|P1|Overall Study|Withdrawal by Subject|6
1700171|NCT01231503|5934450|P8|Overall Study|Adverse event, serious fatal|0
1700172|NCT01231503|5934451|P7|Overall Study|Adverse event, serious fatal|0
1700173|NCT01231503|5934452|P6|Overall Study|Adverse event, serious fatal|1
1700174|NCT01231503|5934453|P5|Overall Study|Adverse event, serious fatal|0
1700175|NCT01231503|5934454|P4|Overall Study|Adverse event, serious fatal|1
1700176|NCT01231503|5934455|P3|Overall Study|Adverse event, serious fatal|1
1700177|NCT01231503|5934456|P2|Overall Study|Adverse event, serious fatal|0
1700178|NCT01231503|5934457|P1|Overall Study|Adverse event, serious fatal|0
1700179|NCT01231503|5934450|P8|Overall Study|Adverse Event|0
1700180|NCT01231503|5934451|P7|Overall Study|Adverse Event|0
1700181|NCT01231503|5934452|P6|Overall Study|Adverse Event|1
1700182|NCT01231503|5934453|P5|Overall Study|Adverse Event|0
1700183|NCT01231503|5934454|P4|Overall Study|Adverse Event|0
1700184|NCT01231503|5934455|P3|Overall Study|Adverse Event|0
1700185|NCT01231503|5934456|P2|Overall Study|Adverse Event|0
1700186|NCT01231503|5934457|P1|Overall Study|Adverse Event|0
1700187|NCT01231464|5934697|P2|Overall Study|Withdrawal by Subject|2
1700188|NCT01231464|5934698|P1|Overall Study|Withdrawal by Subject|3
1700189|NCT01231464|5934697|P2|Overall Study|Lost to Follow-up|2
1700190|NCT01231464|5934698|P1|Overall Study|Lost to Follow-up|1
1700191|NCT01231464|5934697|P2|Overall Study|Protocol Violation|2
1700192|NCT01231464|5934698|P1|Overall Study|Protocol Violation|1
1700193|NCT01231464|5934697|P2|Overall Study|Adverse Event|1
1700194|NCT01231464|5934698|P1|Overall Study|Adverse Event|0
1700195|NCT01231373|5934747|P4|Overall Study|Withdrew Consent|0
1700196|NCT01231373|5934748|P3|Overall Study|Withdrew Consent|0
1700197|NCT01231373|5934749|P2|Overall Study|Withdrew Consent|0
1700198|NCT01231373|5934750|P1|Overall Study|Withdrew Consent|1
1700199|NCT01231373|5934747|P4|Overall Study|Lost to Follow-up|1
1700200|NCT01231373|5934748|P3|Overall Study|Lost to Follow-up|0
1700201|NCT01231373|5934749|P2|Overall Study|Lost to Follow-up|0
1700202|NCT01231373|5934750|P1|Overall Study|Lost to Follow-up|0
1700203|NCT01231373|5934747|P4|Overall Study|Withdrew consent prior to randomization|0
1700204|NCT01231373|5934748|P3|Overall Study|Withdrew consent prior to randomization|0
1700205|NCT01231373|5934749|P2|Overall Study|Withdrew consent prior to randomization|1
1700206|NCT01231373|5934750|P1|Overall Study|Withdrew consent prior to randomization|2
1700207|NCT01231321|5934789|P1|Overall Study|Lack of Efficacy|2
1700208|NCT01231321|5934789|P1|Overall Study|Adverse Event|3
1700209|NCT01230892|5934837|P2|Overall Study|Lost to Follow-up|0
1700210|NCT01230892|5934838|P1|Overall Study|Lost to Follow-up|2
1700211|NCT01230892|5934837|P2|Overall Study|Withdrawal by Subject|1
1700212|NCT01230892|5934838|P1|Overall Study|Withdrawal by Subject|1
1700213|NCT01230827|5934848|P4|Overall Study|Study terminated by Sponsor|63
1700214|NCT01230827|5934849|P3|Overall Study|Study terminated by Sponsor|56
1700215|NCT01230827|5934850|P2|Overall Study|Study terminated by Sponsor|2
1700216|NCT01230827|5934851|P1|Overall Study|Study terminated by Sponsor|0
1700217|NCT01230827|5934848|P4|Overall Study|Recovery|0
1700218|NCT01230827|5934849|P3|Overall Study|Recovery|0
1700219|NCT01230827|5934850|P2|Overall Study|Recovery|6
1700220|NCT01230827|5934851|P1|Overall Study|Recovery|0
1700221|NCT01230827|5934848|P4|Overall Study|Adverse Event|7
1700222|NCT01230827|5934849|P3|Overall Study|Adverse Event|3
1700223|NCT01230827|5934850|P2|Overall Study|Adverse Event|2
1700224|NCT01230827|5934851|P1|Overall Study|Adverse Event|4
1700225|NCT01230827|5934848|P4|Overall Study|Lack of Efficacy|3
1700226|NCT01230827|5934849|P3|Overall Study|Lack of Efficacy|2
1700227|NCT01230827|5934850|P2|Overall Study|Lack of Efficacy|1
1700228|NCT01230827|5934851|P1|Overall Study|Lack of Efficacy|14
1700229|NCT01230827|5934848|P4|Overall Study|Withdrawal by Subject|2
1700230|NCT01230827|5934849|P3|Overall Study|Withdrawal by Subject|3
1700231|NCT01230827|5934850|P2|Overall Study|Withdrawal by Subject|0
1700232|NCT01230827|5934851|P1|Overall Study|Withdrawal by Subject|1
1700233|NCT01230827|5934848|P4|Overall Study|Lost to Follow-up|3
1700234|NCT01230827|5934849|P3|Overall Study|Lost to Follow-up|1
1700235|NCT01230827|5934850|P2|Overall Study|Lost to Follow-up|0
1700236|NCT01230827|5934851|P1|Overall Study|Lost to Follow-up|0
1700237|NCT01230814|5934867|P2|Overall Study|Discontinued (not due to adverse event)|1
1700238|NCT01230814|5934868|P1|Overall Study|Discontinued (not due to adverse event)|2
1700239|NCT01230814|5934867|P2|Overall Study|Lost to Follow-up|3
1700240|NCT01230814|5934868|P1|Overall Study|Lost to Follow-up|11
1700241|NCT01230788|5934918|P1|Overall Study|Prescribed exclusion drug|1
1700242|NCT01230749|5934930|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
1700243|NCT01230749|5934931|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
1700244|NCT01230749|5934932|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
1700245|NCT01230749|5934933|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
1700246|NCT01230749|5934930|P4|Overall Study|Withdrawal by Subject|0
1700247|NCT01230749|5934931|P3|Overall Study|Withdrawal by Subject|0
1700248|NCT01230749|5934932|P2|Overall Study|Withdrawal by Subject|1
1700249|NCT01230749|5934933|P1|Overall Study|Withdrawal by Subject|0
1700250|NCT01230749|5934930|P4|Overall Study|Physician Decision|0
1700251|NCT01230749|5934931|P3|Overall Study|Physician Decision|1
1700252|NCT01230749|5934932|P2|Overall Study|Physician Decision|0
1700253|NCT01230749|5934933|P1|Overall Study|Physician Decision|0
1700254|NCT01230749|5934930|P4|Overall Study|Adverse Event|1
1700255|NCT01230749|5934931|P3|Overall Study|Adverse Event|0
1700256|NCT01230749|5934932|P2|Overall Study|Adverse Event|0
1700257|NCT01230749|5934933|P1|Overall Study|Adverse Event|0
1700258|NCT01230710|5934968|P1|Overall Study|Withdrawal of Consent|1
1700259|NCT01230710|5934968|P1|Overall Study|Death|4
1700260|NCT01230710|5934968|P1|Overall Study|Lost to Follow-up|3
1700261|NCT01230710|5934968|P1|Overall Study|Disease Progression|41
1700262|NCT01230554|5934992|P1|Overall Study|Inability to maintain visit schedule|1
1700263|NCT01230554|5934992|P1|Overall Study|Lost to Follow-up|2
1700264|NCT01230489|5935015|P1|Overall Study|Treatment modality changed|1
1700265|NCT01230489|5935015|P1|Overall Study|Adverse Event|2
1700266|NCT01230489|5935015|P1|Overall Study|Death|2
1700267|NCT01230307|5935050|P2|Overall Study|LVAD Placement|2
1700268|NCT01230307|5935051|P1|Overall Study|LVAD Placement|0
1700269|NCT01230060|5935071|P1|Overall Study|Withdrawal by Subject|1
1700270|NCT01229735|5935144|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1700271|NCT01229735|5935145|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1700272|NCT01229735|5935144|P2|Overall Study|AE, non-serious non-fatal|17
1700273|NCT01229735|5935145|P1|Overall Study|AE, non-serious non-fatal|13
1700274|NCT01229735|5935144|P2|Overall Study|SAE, non-fatal|4
1700275|NCT01229735|5935145|P1|Overall Study|SAE, non-fatal|0
1700276|NCT01229735|5935144|P2|Overall Study|Other Reason|10
1700277|NCT01229735|5935145|P1|Overall Study|Other Reason|13
1700278|NCT01229735|5935144|P2|Overall Study|Withdrawal by Subject|17
1700279|NCT01229735|5935145|P1|Overall Study|Withdrawal by Subject|18
1700280|NCT01229735|5935144|P2|Overall Study|Lost to Follow-up|2
1700281|NCT01229735|5935145|P1|Overall Study|Lost to Follow-up|0
1700282|NCT01229735|5935144|P2|Overall Study|Protocol Violation|8
1700283|NCT01229735|5935145|P1|Overall Study|Protocol Violation|13
1700284|NCT01229735|5935144|P2|Overall Study|Lack of Efficacy|8
1700285|NCT01229735|5935145|P1|Overall Study|Lack of Efficacy|8
1700286|NCT01229449|5935202|P5|Overall Study|Physician Decision|0
1700287|NCT01229449|5935203|P4|Overall Study|Physician Decision|0
1700288|NCT01229449|5935204|P3|Overall Study|Physician Decision|1
1700289|NCT01229449|5935205|P2|Overall Study|Physician Decision|0
1700290|NCT01229449|5935206|P1|Overall Study|Physician Decision|0
1700291|NCT01229449|5935202|P5|Overall Study|Lost to Follow-up|0
1700292|NCT01229449|5935203|P4|Overall Study|Lost to Follow-up|0
1700293|NCT01229449|5935204|P3|Overall Study|Lost to Follow-up|1
1700294|NCT01229449|5935205|P2|Overall Study|Lost to Follow-up|1
1700295|NCT01229449|5935206|P1|Overall Study|Lost to Follow-up|1
1700296|NCT01229449|5935202|P5|Overall Study|Withdrawal by Subject|1
1700297|NCT01229449|5935203|P4|Overall Study|Withdrawal by Subject|1
1700298|NCT01229449|5935204|P3|Overall Study|Withdrawal by Subject|0
1700299|NCT01229449|5935205|P2|Overall Study|Withdrawal by Subject|3
1700300|NCT01229449|5935206|P1|Overall Study|Withdrawal by Subject|0
1700301|NCT01229436|5935263|P1|Overall Study|Lost to Follow-up|3
1700302|NCT01229436|5935263|P1|Overall Study|Withdrawal by Subject|2
1700303|NCT01229397|5935325|P2|Overall Study|Migrated/moved from study area|0
1700304|NCT01229397|5935326|P1|Overall Study|Migrated/moved from study area|1
1700305|NCT01229397|5935325|P2|Overall Study|Lost to Follow-up|6
1700306|NCT01229397|5935326|P1|Overall Study|Lost to Follow-up|7
1700307|NCT01229397|5935325|P2|Overall Study|Withdrawal by Subject|3
1700308|NCT01229397|5935326|P1|Overall Study|Withdrawal by Subject|3
1700309|NCT01229371|5935344|P4|Overall Study|Withdrawal by Subject|0
1700310|NCT01229371|5935345|P3|Overall Study|Withdrawal by Subject|0
1700311|NCT01229371|5935346|P2|Overall Study|Withdrawal by Subject|1
1700312|NCT01229371|5935347|P1|Overall Study|Withdrawal by Subject|0
1700313|NCT01229267|5935374|P5|Overall Study|Lost to Follow-up|22
1700314|NCT01229267|5935375|P4|Overall Study|Lost to Follow-up|3
1700315|NCT01229267|5935376|P3|Overall Study|Lost to Follow-up|8
1700316|NCT01229267|5935377|P2|Overall Study|Lost to Follow-up|5
1700317|NCT01229267|5935378|P1|Overall Study|Lost to Follow-up|6
1700318|NCT01229267|5935374|P5|Overall Study|Physician Decision|25
1700319|NCT01229267|5935375|P4|Overall Study|Physician Decision|3
1700320|NCT01229267|5935376|P3|Overall Study|Physician Decision|8
1700321|NCT01229267|5935377|P2|Overall Study|Physician Decision|11
1700322|NCT01229267|5935378|P1|Overall Study|Physician Decision|8
1700323|NCT01229267|5935374|P5|Overall Study|Progressive disease|1
1700324|NCT01229267|5935375|P4|Overall Study|Progressive disease|0
1700325|NCT01229267|5935376|P3|Overall Study|Progressive disease|0
1700326|NCT01229267|5935377|P2|Overall Study|Progressive disease|0
1700327|NCT01229267|5935378|P1|Overall Study|Progressive disease|0
1700328|NCT01229267|5935374|P5|Overall Study|Protocol Violation|0
1700329|NCT01229267|5935375|P4|Overall Study|Protocol Violation|0
1700330|NCT01229267|5935376|P3|Overall Study|Protocol Violation|0
1700331|NCT01229267|5935377|P2|Overall Study|Protocol Violation|1
1700332|NCT01229267|5935378|P1|Overall Study|Protocol Violation|0
1700333|NCT01229267|5935374|P5|Overall Study|Withdrawal by Subject|59
1700334|NCT01229267|5935375|P4|Overall Study|Withdrawal by Subject|14
1700335|NCT01229267|5935376|P3|Overall Study|Withdrawal by Subject|32
1700336|NCT01229267|5935377|P2|Overall Study|Withdrawal by Subject|22
1700337|NCT01229267|5935378|P1|Overall Study|Withdrawal by Subject|23
1700338|NCT01229267|5935374|P5|Overall Study|Death|103
1700339|NCT01229267|5935375|P4|Overall Study|Death|13
1700340|NCT01229267|5935376|P3|Overall Study|Death|35
1700341|NCT01229267|5935377|P2|Overall Study|Death|37
1700342|NCT01229267|5935378|P1|Overall Study|Death|40
1700343|NCT01229267|5935374|P5|Overall Study|Adverse Event|10
1700344|NCT01229267|5935375|P4|Overall Study|Adverse Event|2
1700345|NCT01229267|5935376|P3|Overall Study|Adverse Event|3
1700346|NCT01229267|5935377|P2|Overall Study|Adverse Event|6
1700347|NCT01229267|5935378|P1|Overall Study|Adverse Event|4
1700348|NCT01229254|5935397|P3|Overall Study|Non-compliance with Study Drug|1
1700349|NCT01229254|5935398|P2|Overall Study|Non-compliance with Study Drug|1
1700350|NCT01229254|5935399|P1|Overall Study|Non-compliance with Study Drug|0
1700351|NCT01229254|5935397|P3|Overall Study|Withdrawal by Subject|1
1700352|NCT01229254|5935398|P2|Overall Study|Withdrawal by Subject|0
1700353|NCT01229254|5935399|P1|Overall Study|Withdrawal by Subject|1
1700354|NCT01229254|5935397|P3|Overall Study|Protocol Violation|5
1700355|NCT01229254|5935398|P2|Overall Study|Protocol Violation|6
1700356|NCT01229254|5935399|P1|Overall Study|Protocol Violation|4
1700357|NCT01229254|5935397|P3|Overall Study|Physician Decision|0
1700358|NCT01229254|5935398|P2|Overall Study|Physician Decision|3
1700359|NCT01229254|5935399|P1|Overall Study|Physician Decision|0
1700360|NCT01229254|5935397|P3|Overall Study|Lost to Follow-up|1
1700361|NCT01229254|5935398|P2|Overall Study|Lost to Follow-up|0
1700362|NCT01229254|5935399|P1|Overall Study|Lost to Follow-up|3
1700363|NCT01229254|5935397|P3|Overall Study|Adverse Event|3
1700364|NCT01229254|5935398|P2|Overall Study|Adverse Event|5
1700365|NCT01229254|5935399|P1|Overall Study|Adverse Event|4
1700366|NCT01229254|5935397|P3|Overall Study|Not Continuing Into Safety Extension|1
1700367|NCT01229254|5935398|P2|Overall Study|Not Continuing Into Safety Extension|1
1700368|NCT01229254|5935399|P1|Overall Study|Not Continuing Into Safety Extension|3
1700369|NCT01229176|5935437|P8|Overall Study|Lost to Follow-up|2
1700370|NCT01229176|5935438|P7|Overall Study|Lost to Follow-up|0
1700371|NCT01229176|5935439|P6|Overall Study|Lost to Follow-up|1
1700372|NCT01229176|5935440|P5|Overall Study|Lost to Follow-up|1
1700373|NCT01229176|5935441|P4|Overall Study|Lost to Follow-up|0
1700374|NCT01229176|5935442|P3|Overall Study|Lost to Follow-up|0
1700375|NCT01229176|5935443|P2|Overall Study|Lost to Follow-up|3
1700376|NCT01229176|5935444|P1|Overall Study|Lost to Follow-up|0
1700377|NCT01229176|5935437|P8|Overall Study|Withdrawal by Subject|1
1700378|NCT01229176|5935438|P7|Overall Study|Withdrawal by Subject|0
1700379|NCT01229176|5935439|P6|Overall Study|Withdrawal by Subject|1
1700380|NCT01229176|5935440|P5|Overall Study|Withdrawal by Subject|1
1700381|NCT01229176|5935441|P4|Overall Study|Withdrawal by Subject|1
1700382|NCT01229176|5935442|P3|Overall Study|Withdrawal by Subject|0
1700383|NCT01229176|5935443|P2|Overall Study|Withdrawal by Subject|0
1700384|NCT01229176|5935444|P1|Overall Study|Withdrawal by Subject|0
1700385|NCT01229150|5935498|P4|Overall Study|Toxicity|0
1700386|NCT01229150|5935499|P3|Overall Study|Toxicity|0
1700387|NCT01229150|5935500|P2|Overall Study|Toxicity|2
1700388|NCT01229150|5935501|P1|Overall Study|Toxicity|2
1700389|NCT01229111|5935558|P1|Overall Study|Death|1
1700390|NCT01228747|5935607|P2|Overall Study|Other Reason|5
1700391|NCT01228747|5935608|P1|Overall Study|Other Reason|2
1700392|NCT01228747|5935607|P2|Overall Study|Withdrawal by Subject|1
1700393|NCT01228747|5935608|P1|Overall Study|Withdrawal by Subject|5
1700394|NCT01228747|5935607|P2|Overall Study|Lost to Follow-up|3
1700395|NCT01228747|5935608|P1|Overall Study|Lost to Follow-up|4
1700396|NCT01228747|5935607|P2|Overall Study|Protocol Violation|5
1700397|NCT01228747|5935608|P1|Overall Study|Protocol Violation|6
1700398|NCT01228747|5935607|P2|Overall Study|Lack of Efficacy|27
1700399|NCT01228747|5935608|P1|Overall Study|Lack of Efficacy|40
1700400|NCT01228747|5935607|P2|Overall Study|Adverse Event|4
1700401|NCT01228747|5935608|P1|Overall Study|Adverse Event|8
1700402|NCT01228734|5935624|P2|Overall Study|Randomized, but not treated|4
1700403|NCT01228734|5935625|P1|Overall Study|Randomized, but not treated|0
1700404|NCT01228591|5935639|P2|Baseline|Lack of Efficacy|2
1700405|NCT01228591|5935640|P1|Baseline|Lack of Efficacy|1
1700406|NCT01228318|5935669|P2|Overall Study|Incarcerated|0
1700407|NCT01228318|5935670|P1|Overall Study|Incarcerated|1
1700408|NCT01228318|5935669|P2|Overall Study|Moved|2
1700409|NCT01228318|5935670|P1|Overall Study|Moved|0
1700410|NCT01228318|5935669|P2|Overall Study|Unable to contact|5
1700411|NCT01228318|5935670|P1|Overall Study|Unable to contact|2
1700412|NCT01228318|5935669|P2|Overall Study|Clinic no show to receive intervention|0
1700413|NCT01228318|5935670|P1|Overall Study|Clinic no show to receive intervention|1
1700414|NCT01228175|5935686|P2|Overall Study|Physician Decision|1
1700415|NCT01228175|5935687|P1|Overall Study|Physician Decision|1
1700416|NCT01228175|5935686|P2|Overall Study|Withdrawal by Subject|2
1700417|NCT01228175|5935687|P1|Overall Study|Withdrawal by Subject|1
1700418|NCT01228175|5935686|P2|Overall Study|Lost to Follow-up|50
1700419|NCT01228175|5935687|P1|Overall Study|Lost to Follow-up|64
1700420|NCT01228071|5935729|P1|Overall Study|Withdrawal by Subject|1
1700421|NCT01228071|5935729|P1|Overall Study|Protocol Violation|1
1700422|NCT01228019|5935735|P1|Overall Study|Violation of Entry Criterion|9
1700423|NCT01228019|5935735|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
1700424|NCT01228019|5935735|P1|Overall Study|Missing pre-treatment data|72
1700425|NCT01228019|5935735|P1|Overall Study|Duplicate enrollment|1
1700426|NCT01228019|5935735|P1|Overall Study|Dose Violation|70
1700427|NCT01227967|5935801|P2|Overall Study|Taking Additional Antiviral Drug|0
1700428|NCT01227967|5935802|P1|Overall Study|Taking Additional Antiviral Drug|1
1700429|NCT01227967|5935801|P2|Overall Study|Never Started Treatment|4
1700430|NCT01227967|5935802|P1|Overall Study|Never Started Treatment|0
1700431|NCT01227967|5935801|P2|Overall Study|Physician Decision|1
1700432|NCT01227967|5935802|P1|Overall Study|Physician Decision|0
1700433|NCT01227967|5935801|P2|Overall Study|Withdrawal by Subject|3
1700434|NCT01227967|5935802|P1|Overall Study|Withdrawal by Subject|4
1700435|NCT01227967|5935801|P2|Overall Study|Lost to Follow-up|3
1700436|NCT01227967|5935802|P1|Overall Study|Lost to Follow-up|8
1700437|NCT01227967|5935801|P2|Overall Study|Death|1
1700438|NCT01227967|5935802|P1|Overall Study|Death|0
1700439|NCT01227967|5935801|P2|Overall Study|Protocol Violation|1
1700440|NCT01227967|5935802|P1|Overall Study|Protocol Violation|3
1700441|NCT01227954|5935836|P1|Overall Study|No protocol treatment|7
1700442|NCT01227954|5935836|P1|Overall Study|Protocol Violation|6
1700443|NCT01227928|5935850|P2|Overall Study|Death|12
1700444|NCT01227928|5935851|P1|Overall Study|Death|14
1700445|NCT01227928|5935850|P2|Overall Study|Withdrawal by Subject|3
1700446|NCT01227928|5935851|P1|Overall Study|Withdrawal by Subject|4
1700447|NCT01227928|5935850|P2|Overall Study|Lost to Follow-up|2
1700448|NCT01227928|5935851|P1|Overall Study|Lost to Follow-up|4
1700449|NCT01227902|5935889|P4|Overall Study|Withdrawal by Subject|3
1700450|NCT01227902|5935890|P3|Overall Study|Withdrawal by Subject|4
1700451|NCT01227902|5935891|P2|Overall Study|Withdrawal by Subject|2
1700452|NCT01227902|5935892|P1|Overall Study|Withdrawal by Subject|4
1700453|NCT01227902|5935889|P4|Overall Study|Physician Decision|0
1700454|NCT01227902|5935890|P3|Overall Study|Physician Decision|1
1700455|NCT01227902|5935891|P2|Overall Study|Physician Decision|1
1700456|NCT01227902|5935892|P1|Overall Study|Physician Decision|0
1700457|NCT01227902|5935889|P4|Overall Study|Lost to Follow-up|2
1700458|NCT01227902|5935890|P3|Overall Study|Lost to Follow-up|1
1700459|NCT01227902|5935891|P2|Overall Study|Lost to Follow-up|0
1700460|NCT01227902|5935892|P1|Overall Study|Lost to Follow-up|0
1700461|NCT01227902|5935889|P4|Overall Study|Protocol Violation|0
1700462|NCT01227902|5935890|P3|Overall Study|Protocol Violation|0
1700463|NCT01227902|5935891|P2|Overall Study|Protocol Violation|0
1700464|NCT01227902|5935892|P1|Overall Study|Protocol Violation|1
1700465|NCT01227902|5935889|P4|Overall Study|Lack of Efficacy|1
1700466|NCT01227902|5935890|P3|Overall Study|Lack of Efficacy|2
1700467|NCT01227902|5935891|P2|Overall Study|Lack of Efficacy|2
1700468|NCT01227902|5935892|P1|Overall Study|Lack of Efficacy|1
1700469|NCT01227902|5935889|P4|Overall Study|Adverse Event|4
1700470|NCT01227902|5935890|P3|Overall Study|Adverse Event|11
1700471|NCT01227902|5935891|P2|Overall Study|Adverse Event|8
1700472|NCT01227902|5935892|P1|Overall Study|Adverse Event|12
1700473|NCT01227889|5935985|P2|Crossover Phase|Withdrawal by Subject|1
1700474|NCT01227889|5935986|P1|Crossover Phase|Withdrawal by Subject|0
1700475|NCT01227889|5935985|P2|Crossover Phase|Study Terminated By Sponsor|1
1700476|NCT01227889|5935986|P1|Crossover Phase|Study Terminated By Sponsor|0
1700477|NCT01227889|5935985|P2|Crossover Phase|Progressive Disease|31
1700478|NCT01227889|5935986|P1|Crossover Phase|Progressive Disease|0
1700479|NCT01227889|5935985|P2|Crossover Phase|Physician Decision|3
1700480|NCT01227889|5935986|P1|Crossover Phase|Physician Decision|0
1700481|NCT01227889|5935985|P2|Crossover Phase|Adverse Event|1
1700482|NCT01227889|5935986|P1|Crossover Phase|Adverse Event|0
1700483|NCT01227889|5935985|P2|Randomized Phase (RP)|Withdrawal by Subject|3
1700484|NCT01227889|5935986|P1|Randomized Phase (RP)|Withdrawal by Subject|15
1700485|NCT01227889|5935985|P2|Randomized Phase (RP)|Missing|3
1700486|NCT01227889|5935986|P1|Randomized Phase (RP)|Missing|1
1700487|NCT01227889|5935985|P2|Randomized Phase (RP)|Study terminated by sponsor|0
1700488|NCT01227889|5935986|P1|Randomized Phase (RP)|Study terminated by sponsor|10
1700489|NCT01227889|5935985|P2|Randomized Phase (RP)|Progressive Disease|52
1700490|NCT01227889|5935986|P1|Randomized Phase (RP)|Progressive Disease|135
1700491|NCT01227889|5935985|P2|Randomized Phase (RP)|Physician Decision|5
1700492|NCT01227889|5935986|P1|Randomized Phase (RP)|Physician Decision|13
1700493|NCT01227889|5935985|P2|Randomized Phase (RP)|Adverse Event|0
1700494|NCT01227889|5935986|P1|Randomized Phase (RP)|Adverse Event|13
1700495|NCT01227824|5936013|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
1700496|NCT01227824|5936014|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
1700497|NCT01227824|5936015|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
1700498|NCT01227824|5936013|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
1700499|NCT01227824|5936014|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
1700500|NCT01227824|5936015|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
1700501|NCT01227824|5936013|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
1700502|NCT01227824|5936014|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
1700503|NCT01227824|5936015|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
1700504|NCT01227824|5936013|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
1700505|NCT01227824|5936014|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
1700506|NCT01227824|5936015|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
1700507|NCT01227824|5936013|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
1700508|NCT01227824|5936014|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
1700509|NCT01227824|5936015|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
1700510|NCT01227824|5936013|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
1700511|NCT01227824|5936014|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
1700512|NCT01227824|5936015|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
1700513|NCT01227824|5936013|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
1700514|NCT01227824|5936014|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
1700515|NCT01227824|5936015|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
1700516|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
1700517|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
1700518|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
1700519|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
1700520|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
1700521|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
1700522|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
1700523|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
1700524|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
1700525|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
1700526|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
1700527|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
1700528|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
1700529|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
1700530|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
1700531|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
1700532|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
1700533|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
1700534|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
1700535|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
1700536|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
1700537|NCT01227824|5936013|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
1700538|NCT01227824|5936014|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
1700539|NCT01227824|5936015|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
1700540|NCT01227707|5936110|P1|Overall Study|Death|1
1700541|NCT01227707|5936110|P1|Overall Study|Medical decision|6
1700542|NCT01227707|5936110|P1|Overall Study|Patient non-compliance|3
1700543|NCT01227707|5936110|P1|Overall Study|Withdrawal by Subject|1
1700544|NCT01227707|5936110|P1|Overall Study|Progression of disease|3
1700545|NCT01227707|5936110|P1|Overall Study|Adverse Event|10
1700546|NCT01227668|5936137|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
1700547|NCT01227668|5936138|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
1700548|NCT01227668|5936137|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
1700549|NCT01227668|5936138|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
1700550|NCT01227668|5936137|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
1700551|NCT01227668|5936138|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
1700552|NCT01227668|5936137|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
1700553|NCT01227668|5936138|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
1700554|NCT01227668|5936137|P2|Phase 2 (Randomization Phase)|Adverse Event|1
1700555|NCT01227668|5936138|P1|Phase 2 (Randomization Phase)|Adverse Event|0
1700556|NCT01227668|5936137|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
1700557|NCT01227668|5936138|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
1700558|NCT01227668|5936137|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
1700559|NCT01227668|5936138|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
1700560|NCT01227668|5936137|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
1700561|NCT01227668|5936138|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
1700562|NCT01227668|5936137|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
1700563|NCT01227668|5936138|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
1700564|NCT01227668|5936137|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
1700565|NCT01227668|5936138|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
1700566|NCT01227668|5936137|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
1700567|NCT01227668|5936138|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
1700568|NCT01227668|5936137|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
1700569|NCT01227668|5936138|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
1700570|NCT01227629|5936184|P10|Overall Study|Other|1
1700571|NCT01227629|5936185|P9|Overall Study|Other|2
1700572|NCT01227629|5936186|P8|Overall Study|Other|0
1700573|NCT01227629|5936187|P7|Overall Study|Other|0
1700574|NCT01227629|5936188|P6|Overall Study|Other|0
1700575|NCT01227629|5936189|P5|Overall Study|Other|0
1700576|NCT01227629|5936190|P4|Overall Study|Other|1
1700577|NCT01227629|5936191|P3|Overall Study|Other|0
1700578|NCT01227629|5936192|P2|Overall Study|Other|0
1700579|NCT01227629|5936193|P1|Overall Study|Other|0
1700580|NCT01227629|5936184|P10|Overall Study|Withdrawal by Subject|1
1700581|NCT01227629|5936185|P9|Overall Study|Withdrawal by Subject|0
1700582|NCT01227629|5936186|P8|Overall Study|Withdrawal by Subject|0
1700583|NCT01227629|5936187|P7|Overall Study|Withdrawal by Subject|2
1700584|NCT01227629|5936188|P6|Overall Study|Withdrawal by Subject|0
1700585|NCT01227629|5936189|P5|Overall Study|Withdrawal by Subject|0
1700586|NCT01227629|5936190|P4|Overall Study|Withdrawal by Subject|0
1700587|NCT01227629|5936191|P3|Overall Study|Withdrawal by Subject|0
1700588|NCT01227629|5936192|P2|Overall Study|Withdrawal by Subject|0
1700589|NCT01227629|5936193|P1|Overall Study|Withdrawal by Subject|0
1700590|NCT01227629|5936184|P10|Overall Study|Lost to Follow-up|0
1700591|NCT01227629|5936185|P9|Overall Study|Lost to Follow-up|0
1700592|NCT01227629|5936186|P8|Overall Study|Lost to Follow-up|0
1700593|NCT01227629|5936187|P7|Overall Study|Lost to Follow-up|0
1700594|NCT01227629|5936188|P6|Overall Study|Lost to Follow-up|0
1700595|NCT01227629|5936189|P5|Overall Study|Lost to Follow-up|1
1700596|NCT01227629|5936190|P4|Overall Study|Lost to Follow-up|0
1700597|NCT01227629|5936191|P3|Overall Study|Lost to Follow-up|0
1700598|NCT01227629|5936192|P2|Overall Study|Lost to Follow-up|0
1700599|NCT01227629|5936193|P1|Overall Study|Lost to Follow-up|0
1700600|NCT01227629|5936184|P10|Overall Study|Protocol Violation|0
1700601|NCT01227629|5936185|P9|Overall Study|Protocol Violation|0
1700602|NCT01227629|5936186|P8|Overall Study|Protocol Violation|0
1700603|NCT01227629|5936187|P7|Overall Study|Protocol Violation|0
1700604|NCT01227629|5936188|P6|Overall Study|Protocol Violation|0
1700605|NCT01227629|5936189|P5|Overall Study|Protocol Violation|0
1700606|NCT01227629|5936190|P4|Overall Study|Protocol Violation|1
1700607|NCT01227629|5936191|P3|Overall Study|Protocol Violation|0
1700608|NCT01227629|5936192|P2|Overall Study|Protocol Violation|0
1700609|NCT01227629|5936193|P1|Overall Study|Protocol Violation|0
1700610|NCT01227629|5936184|P10|Overall Study|Adverse Event|0
1700611|NCT01227629|5936185|P9|Overall Study|Adverse Event|4
1700612|NCT01227629|5936186|P8|Overall Study|Adverse Event|6
1700613|NCT01227629|5936187|P7|Overall Study|Adverse Event|6
1700614|NCT01227629|5936188|P6|Overall Study|Adverse Event|1
1700615|NCT01227629|5936189|P5|Overall Study|Adverse Event|1
1700616|NCT01227629|5936190|P4|Overall Study|Adverse Event|6
1700617|NCT01227629|5936191|P3|Overall Study|Adverse Event|1
1700618|NCT01227629|5936192|P2|Overall Study|Adverse Event|2
1700619|NCT01227629|5936193|P1|Overall Study|Adverse Event|2
1700620|NCT01227577|5936442|P1|Overall Study|Adverse Event|17
1700621|NCT01227577|5936442|P1|Overall Study|Lack of Efficacy|5
1700622|NCT01227577|5936442|P1|Overall Study|Withdrawal by Subject|4
1700623|NCT01227577|5936442|P1|Overall Study|Lost to Follow-up|1
1700624|NCT01227577|5936442|P1|Overall Study|Administrative problems|2
1700625|NCT01227577|5936442|P1|Overall Study|Death|3
1700626|NCT01227577|5936442|P1|Overall Study|Protocol deviation|3
1700627|NCT01227564|5936457|P3|Overall Study|Participant moved to another town|1
1700628|NCT01227564|5936458|P2|Overall Study|Participant moved to another town|0
1700629|NCT01227564|5936459|P1|Overall Study|Participant moved to another town|0
1700630|NCT01227564|5936457|P3|Overall Study|No Longer Willing to Participate|5
1700631|NCT01227564|5936458|P2|Overall Study|No Longer Willing to Participate|2
1700632|NCT01227564|5936459|P1|Overall Study|No Longer Willing to Participate|4
1700633|NCT01227512|5936597|P2|Overall Study|Participant met withdrawal criteria|1
1700634|NCT01227512|5936598|P1|Overall Study|Participant met withdrawal criteria|0
1700635|NCT01227512|5936597|P2|Overall Study|Withdrawal by Subject|0
1700636|NCT01227512|5936598|P1|Overall Study|Withdrawal by Subject|3
1700637|NCT01227512|5936597|P2|Overall Study|Adverse Event|3
1700638|NCT01227512|5936598|P1|Overall Study|Adverse Event|4
1700639|NCT01227512|5936597|P2|Overall Study|Physician Decision|6
1700640|NCT01227512|5936598|P1|Overall Study|Physician Decision|6
1700641|NCT01227421|5936632|P3|Overall Study|Randomized in error|0
1700642|NCT01227421|5936633|P2|Overall Study|Randomized in error|1
1700643|NCT01227421|5936634|P1|Overall Study|Randomized in error|1
1700644|NCT01227421|5936632|P3|Overall Study|Protocol Violation|2
1700645|NCT01227421|5936633|P2|Overall Study|Protocol Violation|1
1700646|NCT01227421|5936634|P1|Overall Study|Protocol Violation|1
1700647|NCT01227421|5936632|P3|Overall Study|Withdrawal by Subject|1
1700648|NCT01227421|5936633|P2|Overall Study|Withdrawal by Subject|2
1700649|NCT01227421|5936634|P1|Overall Study|Withdrawal by Subject|1
1700650|NCT01227421|5936632|P3|Overall Study|Adverse Event|2
1700651|NCT01227421|5936633|P2|Overall Study|Adverse Event|7
1700652|NCT01227421|5936634|P1|Overall Study|Adverse Event|2
1700653|NCT01227421|5936632|P3|Overall Study|Lost to Follow-up|5
1700654|NCT01227421|5936633|P2|Overall Study|Lost to Follow-up|7
1700655|NCT01227421|5936634|P1|Overall Study|Lost to Follow-up|6
1700656|NCT01227395|5936686|P2|Overall Study|Protocol Violation|1
1700657|NCT01227395|5936687|P1|Overall Study|Protocol Violation|0
1700658|NCT01227278|5936727|P2|Overall Study|Other|2
1700659|NCT01227278|5936728|P1|Overall Study|Other|1
1700660|NCT01227278|5936727|P2|Overall Study|Death|2
1700661|NCT01227278|5936728|P1|Overall Study|Death|0
1700662|NCT01227278|5936727|P2|Overall Study|Withdrawal by Subject|4
1700663|NCT01227278|5936728|P1|Overall Study|Withdrawal by Subject|4
1700664|NCT01227265|5936755|P3|Overall Study|Adverse Event|5
1700665|NCT01227265|5936756|P2|Overall Study|Adverse Event|10
1700666|NCT01227265|5936757|P1|Overall Study|Adverse Event|6
1700667|NCT01227265|5936755|P3|Overall Study|Lost to Follow-up|3
1700668|NCT01227265|5936756|P2|Overall Study|Lost to Follow-up|0
1700669|NCT01227265|5936757|P1|Overall Study|Lost to Follow-up|2
1700670|NCT01227265|5936755|P3|Overall Study|Withdrawal by Subject|3
1700671|NCT01227265|5936756|P2|Overall Study|Withdrawal by Subject|7
1700672|NCT01227265|5936757|P1|Overall Study|Withdrawal by Subject|7
1700673|NCT01227265|5936755|P3|Overall Study|Protocol Violation|0
1700674|NCT01227265|5936756|P2|Overall Study|Protocol Violation|1
1700675|NCT01227265|5936757|P1|Overall Study|Protocol Violation|2
1700676|NCT01227265|5936755|P3|Overall Study|Did Not Meet Protocol Eligibility|1
1700677|NCT01227265|5936756|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1700678|NCT01227265|5936757|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1700679|NCT01227265|5936755|P3|Overall Study|Administrative|2
1700680|NCT01227265|5936756|P2|Overall Study|Administrative|0
1700681|NCT01227265|5936757|P1|Overall Study|Administrative|1
1700682|NCT01227265|5936755|P3|Overall Study|Did Not Receive Treatment|0
1700683|NCT01227265|5936756|P2|Overall Study|Did Not Receive Treatment|2
1700684|NCT01227265|5936757|P1|Overall Study|Did Not Receive Treatment|1
1700685|NCT01227252|5936787|P4|Overall Study|Withdrawal by Subject|0
1700686|NCT01227252|5936788|P3|Overall Study|Withdrawal by Subject|0
1700687|NCT01227252|5936789|P2|Overall Study|Withdrawal by Subject|1
1700688|NCT01227252|5936790|P1|Overall Study|Withdrawal by Subject|0
1700689|NCT01227252|5936787|P4|Overall Study|Lost to Follow-up|0
1700690|NCT01227252|5936788|P3|Overall Study|Lost to Follow-up|0
1700691|NCT01227252|5936789|P2|Overall Study|Lost to Follow-up|1
1700692|NCT01227252|5936790|P1|Overall Study|Lost to Follow-up|0
1700693|NCT01227252|5936787|P4|Overall Study|Sponsor Decision|0
1700694|NCT01227252|5936788|P3|Overall Study|Sponsor Decision|0
1700695|NCT01227252|5936789|P2|Overall Study|Sponsor Decision|1
1700696|NCT01227252|5936790|P1|Overall Study|Sponsor Decision|0
1700697|NCT01227044|5936832|P2|Overall Study|Discontinued Intervention|2
1700698|NCT01227044|5936833|P1|Overall Study|Discontinued Intervention|1
1700699|NCT01227044|5936832|P2|Overall Study|Lost to Follow-up|7
1700700|NCT01227044|5936833|P1|Overall Study|Lost to Follow-up|5
1700701|NCT01227018|5936841|P1|Overall Study|Withdrew after beginning treatment|4
1700702|NCT01227018|5936841|P1|Overall Study|Toxicity|2
1700703|NCT01227018|5936841|P1|Overall Study|Disease progression|9
1700704|NCT01226745|5936877|P6|Overall Study|Other|1
1700705|NCT01226745|5936878|P5|Overall Study|Other|3
1700706|NCT01226745|5936879|P4|Overall Study|Other|4
1700707|NCT01226745|5936880|P3|Overall Study|Other|8
1700708|NCT01226745|5936881|P2|Overall Study|Other|7
1700709|NCT01226745|5936882|P1|Overall Study|Other|6
1700710|NCT01226745|5936877|P6|Overall Study|Death|1
1700711|NCT01226745|5936878|P5|Overall Study|Death|0
1700712|NCT01226745|5936879|P4|Overall Study|Death|0
1700713|NCT01226745|5936880|P3|Overall Study|Death|0
1700714|NCT01226745|5936881|P2|Overall Study|Death|0
1700715|NCT01226745|5936882|P1|Overall Study|Death|1
1700716|NCT01226745|5936877|P6|Overall Study|Lost to Follow-up|2
1700717|NCT01226745|5936878|P5|Overall Study|Lost to Follow-up|1
1700718|NCT01226745|5936879|P4|Overall Study|Lost to Follow-up|1
1700719|NCT01226745|5936880|P3|Overall Study|Lost to Follow-up|6
1700720|NCT01226745|5936881|P2|Overall Study|Lost to Follow-up|6
1700721|NCT01226745|5936882|P1|Overall Study|Lost to Follow-up|2
1700722|NCT01226745|5936877|P6|Overall Study|Did not complete schedule of assessments|1
1700723|NCT01226745|5936878|P5|Overall Study|Did not complete schedule of assessments|0
1700724|NCT01226745|5936879|P4|Overall Study|Did not complete schedule of assessments|0
1700725|NCT01226745|5936880|P3|Overall Study|Did not complete schedule of assessments|6
1700726|NCT01226745|5936881|P2|Overall Study|Did not complete schedule of assessments|3
1700727|NCT01226745|5936882|P1|Overall Study|Did not complete schedule of assessments|8
1700728|NCT01226511|5937078|P2|Taper Period|Parent/Caregiver Decision|1
1700729|NCT01226511|5937079|P1|Taper Period|Parent/Caregiver Decision|1
1700730|NCT01226511|5937078|P2|Taper Period|Protocol Violation|0
1700731|NCT01226511|5937079|P1|Taper Period|Protocol Violation|1
1700732|NCT01226511|5937078|P2|Taper Period|Lost to Follow-up|2
1700733|NCT01226511|5937079|P1|Taper Period|Lost to Follow-up|2
1700734|NCT01226511|5937078|P2|Taper Period|Adverse Event|0
1700735|NCT01226511|5937079|P1|Taper Period|Adverse Event|1
1700736|NCT01226511|5937078|P2|Extension Treatment Period|Sponsor Decision|1
1700737|NCT01226511|5937079|P1|Extension Treatment Period|Sponsor Decision|1
1700738|NCT01226511|5937078|P2|Extension Treatment Period|Parent/Caregiver Decision|8
1700739|NCT01226511|5937079|P1|Extension Treatment Period|Parent/Caregiver Decision|8
1700740|NCT01226511|5937078|P2|Extension Treatment Period|Withdrawal by Subject|3
1700741|NCT01226511|5937079|P1|Extension Treatment Period|Withdrawal by Subject|1
1700742|NCT01226511|5937078|P2|Extension Treatment Period|Protocol Violation|2
1700743|NCT01226511|5937079|P1|Extension Treatment Period|Protocol Violation|2
1700744|NCT01226511|5937078|P2|Extension Treatment Period|Lost to Follow-up|3
1700745|NCT01226511|5937079|P1|Extension Treatment Period|Lost to Follow-up|4
1700746|NCT01226511|5937078|P2|Extension Treatment Period|Lack of Efficacy|2
1700747|NCT01226511|5937079|P1|Extension Treatment Period|Lack of Efficacy|3
1700748|NCT01226511|5937078|P2|Extension Treatment Period|Adverse Event|8
1700749|NCT01226511|5937079|P1|Extension Treatment Period|Adverse Event|8
1700750|NCT01226511|5937078|P2|Acute Treatment Period|Withdrawal by Subject|6
1700751|NCT01226511|5937079|P1|Acute Treatment Period|Withdrawal by Subject|10
1700752|NCT01226511|5937078|P2|Acute Treatment Period|Protocol Violation|5
1700753|NCT01226511|5937079|P1|Acute Treatment Period|Protocol Violation|5
1700754|NCT01226511|5937078|P2|Acute Treatment Period|Parent/caregiver decision|7
1700755|NCT01226511|5937079|P1|Acute Treatment Period|Parent/caregiver decision|5
1700756|NCT01226511|5937078|P2|Acute Treatment Period|Lost to Follow-up|6
1700757|NCT01226511|5937079|P1|Acute Treatment Period|Lost to Follow-up|3
1700758|NCT01226511|5937078|P2|Acute Treatment Period|Lack of Efficacy|1
1700759|NCT01226511|5937079|P1|Acute Treatment Period|Lack of Efficacy|2
1700760|NCT01226511|5937078|P2|Acute Treatment Period|Adverse Event|6
1700761|NCT01226511|5937079|P1|Acute Treatment Period|Adverse Event|7
1700762|NCT01226459|5937179|P2|Overall Study|Pregnancy|0
1700763|NCT01226459|5937180|P1|Overall Study|Pregnancy|1
1700764|NCT01226459|5937179|P2|Overall Study|Lost to Follow-up|8
1700765|NCT01226459|5937180|P1|Overall Study|Lost to Follow-up|4
1700766|NCT01226459|5937179|P2|Overall Study|Withdrawal by Subject|13
1700767|NCT01226459|5937180|P1|Overall Study|Withdrawal by Subject|10
1700768|NCT01226459|5937179|P2|Overall Study|Protocol Violation|3
1700769|NCT01226459|5937180|P1|Overall Study|Protocol Violation|4
1700770|NCT01226459|5937179|P2|Overall Study|Adverse Event|8
1700771|NCT01226459|5937180|P1|Overall Study|Adverse Event|2
1700772|NCT01226121|5937198|P3|Overall Study|Lost to Follow-up|1
1700773|NCT01226121|5937199|P2|Overall Study|Lost to Follow-up|0
1700774|NCT01226121|5937200|P1|Overall Study|Lost to Follow-up|2
1700775|NCT01226095|5937211|P1|Overall Study|Poor compliance|1
1700776|NCT01226043|5937236|P4|30-week Observational Phase|Physician Decision|2
1700777|NCT01226043|5937237|P3|30-week Observational Phase|Physician Decision|2
1700778|NCT01226043|5937238|P2|30-week Observational Phase|Physician Decision|0
1700779|NCT01226043|5937239|P1|30-week Observational Phase|Physician Decision|0
1700780|NCT01226043|5937236|P4|30-week Observational Phase|Withdrawal by Subject|7
1700781|NCT01226043|5937237|P3|30-week Observational Phase|Withdrawal by Subject|1
1700782|NCT01226043|5937238|P2|30-week Observational Phase|Withdrawal by Subject|0
1700783|NCT01226043|5937239|P1|30-week Observational Phase|Withdrawal by Subject|0
1700784|NCT01226043|5937236|P4|30-week Observational Phase|Lost to Follow-up|2
1700785|NCT01226043|5937237|P3|30-week Observational Phase|Lost to Follow-up|2
1700786|NCT01226043|5937238|P2|30-week Observational Phase|Lost to Follow-up|0
1700787|NCT01226043|5937239|P1|30-week Observational Phase|Lost to Follow-up|0
1700788|NCT01226043|5937236|P4|30-week Observational Phase|Protocol Violation|1
1700789|NCT01226043|5937237|P3|30-week Observational Phase|Protocol Violation|0
1700790|NCT01226043|5937238|P2|30-week Observational Phase|Protocol Violation|0
1700791|NCT01226043|5937239|P1|30-week Observational Phase|Protocol Violation|0
1700792|NCT01226043|5937236|P4|30-week Observational Phase|Adverse Event|1
1700793|NCT01226043|5937237|P3|30-week Observational Phase|Adverse Event|1
1700794|NCT01226043|5937238|P2|30-week Observational Phase|Adverse Event|0
1700795|NCT01226043|5937239|P1|30-week Observational Phase|Adverse Event|0
1700796|NCT01226043|5937236|P4|6-week Re-randomization Phase|completed in error|1
1700797|NCT01226043|5937237|P3|6-week Re-randomization Phase|completed in error|0
1700798|NCT01226043|5937238|P2|6-week Re-randomization Phase|completed in error|0
1700799|NCT01226043|5937239|P1|6-week Re-randomization Phase|completed in error|0
1700800|NCT01226043|5937236|P4|6-week Re-randomization Phase|Physician Decision|2
1700801|NCT01226043|5937237|P3|6-week Re-randomization Phase|Physician Decision|3
1700802|NCT01226043|5937238|P2|6-week Re-randomization Phase|Physician Decision|0
1700803|NCT01226043|5937239|P1|6-week Re-randomization Phase|Physician Decision|0
1700804|NCT01226043|5937236|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
1700805|NCT01226043|5937237|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
1700806|NCT01226043|5937238|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
1700807|NCT01226043|5937239|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
1700808|NCT01226043|5937236|P4|6-week Re-randomization Phase|Lost to Follow-up|3
1700809|NCT01226043|5937237|P3|6-week Re-randomization Phase|Lost to Follow-up|1
1700810|NCT01226043|5937238|P2|6-week Re-randomization Phase|Lost to Follow-up|0
1700811|NCT01226043|5937239|P1|6-week Re-randomization Phase|Lost to Follow-up|0
1700812|NCT01226043|5937236|P4|6-week Re-randomization Phase|Protocol Violation|1
1700813|NCT01226043|5937237|P3|6-week Re-randomization Phase|Protocol Violation|1
1700814|NCT01226043|5937238|P2|6-week Re-randomization Phase|Protocol Violation|0
1700815|NCT01226043|5937239|P1|6-week Re-randomization Phase|Protocol Violation|0
1700816|NCT01226043|5937236|P4|6-week Re-randomization Phase|Adverse Event|1
1700817|NCT01226043|5937237|P3|6-week Re-randomization Phase|Adverse Event|1
1700818|NCT01226043|5937238|P2|6-week Re-randomization Phase|Adverse Event|0
1700819|NCT01226043|5937239|P1|6-week Re-randomization Phase|Adverse Event|0
1700820|NCT01226043|5937236|P4|4-week Crossover Phase - Period 2|Physician Decision|0
1700821|NCT01226043|5937237|P3|4-week Crossover Phase - Period 2|Physician Decision|0
1700822|NCT01226043|5937238|P2|4-week Crossover Phase - Period 2|Physician Decision|5
1700823|NCT01226043|5937239|P1|4-week Crossover Phase - Period 2|Physician Decision|4
1700824|NCT01226043|5937236|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1700825|NCT01226043|5937237|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1700826|NCT01226043|5937238|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
1700827|NCT01226043|5937239|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
1700828|NCT01226043|5937236|P4|4-week Crossover Phase - Period 1|Physician Decision|0
1700829|NCT01226043|5937237|P3|4-week Crossover Phase - Period 1|Physician Decision|0
1700830|NCT01226043|5937238|P2|4-week Crossover Phase - Period 1|Physician Decision|6
1700831|NCT01226043|5937239|P1|4-week Crossover Phase - Period 1|Physician Decision|0
1700832|NCT01226043|5937236|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1700833|NCT01226043|5937237|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1700834|NCT01226043|5937238|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
1700835|NCT01226043|5937239|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
1700836|NCT01226043|5937236|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1700837|NCT01226043|5937237|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1700838|NCT01226043|5937238|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
1700839|NCT01226043|5937239|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
1700840|NCT01226043|5937236|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
1700841|NCT01226043|5937237|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
1700842|NCT01226043|5937238|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
1700843|NCT01226043|5937239|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
1700844|NCT01225991|5937277|P1|Overall Study|Withdrawal by Subject|6
1700845|NCT01225952|5937288|P3|Overall Study|Surgical complications|0
1700846|NCT01225952|5937289|P2|Overall Study|Surgical complications|0
1700847|NCT01225952|5937290|P1|Overall Study|Surgical complications|1
1700848|NCT01225952|5937288|P3|Overall Study|Withdrawal by Subject|5
1700849|NCT01225952|5937289|P2|Overall Study|Withdrawal by Subject|4
1700850|NCT01225952|5937290|P1|Overall Study|Withdrawal by Subject|4
1700851|NCT01225952|5937288|P3|Overall Study|Study Eye Explanted|1
1700852|NCT01225952|5937289|P2|Overall Study|Study Eye Explanted|0
1700853|NCT01225952|5937290|P1|Overall Study|Study Eye Explanted|0
1700854|NCT01225952|5937288|P3|Overall Study|Lost to Follow-up|0
1700855|NCT01225952|5937289|P2|Overall Study|Lost to Follow-up|0
1700856|NCT01225952|5937290|P1|Overall Study|Lost to Follow-up|1
1700857|NCT01225887|5937382|P1|Overall Study|Ineligible:inadequate pathology|2
1700858|NCT01225887|5937382|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
1700859|NCT01225887|5937382|P1|Overall Study|Ineligible:required test not done|2
1700860|NCT01225835|5937392|P2|Overall Study|Other|1
1700861|NCT01225835|5937393|P1|Overall Study|Other|1
1700862|NCT01225835|5937392|P2|Overall Study|Adverse Event|1
1700863|NCT01225835|5937393|P1|Overall Study|Adverse Event|2
1700864|NCT01225835|5937392|P2|Overall Study|Did not meet hCG criterion|0
1700865|NCT01225835|5937393|P1|Overall Study|Did not meet hCG criterion|2
1700866|NCT01225835|5937392|P2|Overall Study|Completed protocol|1
1700867|NCT01225835|5937393|P1|Overall Study|Completed protocol|2
1700868|NCT01225822|5937441|P5|Overall Study|Other|7
1700869|NCT01225822|5937442|P4|Overall Study|Other|10
1700870|NCT01225822|5937443|P3|Overall Study|Other|7
1700871|NCT01225822|5937444|P2|Overall Study|Other|10
1700872|NCT01225822|5937445|P1|Overall Study|Other|13
1700873|NCT01225822|5937441|P5|Overall Study|Withdrawal by Subject|6
1700874|NCT01225822|5937442|P4|Overall Study|Withdrawal by Subject|11
1700875|NCT01225822|5937443|P3|Overall Study|Withdrawal by Subject|7
1700876|NCT01225822|5937444|P2|Overall Study|Withdrawal by Subject|7
1700877|NCT01225822|5937445|P1|Overall Study|Withdrawal by Subject|6
1700878|NCT01225822|5937441|P5|Overall Study|Lost to Follow-up|0
1700879|NCT01225822|5937442|P4|Overall Study|Lost to Follow-up|1
1700880|NCT01225822|5937443|P3|Overall Study|Lost to Follow-up|0
1700881|NCT01225822|5937444|P2|Overall Study|Lost to Follow-up|0
1700882|NCT01225822|5937445|P1|Overall Study|Lost to Follow-up|0
1700883|NCT01225822|5937441|P5|Overall Study|Protocol Violation|4
1700884|NCT01225822|5937442|P4|Overall Study|Protocol Violation|7
1700885|NCT01225822|5937443|P3|Overall Study|Protocol Violation|6
1700886|NCT01225822|5937444|P2|Overall Study|Protocol Violation|8
1700887|NCT01225822|5937445|P1|Overall Study|Protocol Violation|6
1700888|NCT01225822|5937441|P5|Overall Study|Adverse Event|14
1700889|NCT01225822|5937442|P4|Overall Study|Adverse Event|23
1700890|NCT01225822|5937443|P3|Overall Study|Adverse Event|18
1700891|NCT01225822|5937444|P2|Overall Study|Adverse Event|31
1700892|NCT01225822|5937445|P1|Overall Study|Adverse Event|13
1700893|NCT01225731|5937512|P13|Part 3|Withdrawal by Subject|4
1700894|NCT01225731|5937513|P12|Part 3|Withdrawal by Subject|6
1700895|NCT01225731|5937514|P11|Part 3|Withdrawal by Subject|4
1700896|NCT01225731|5937515|P10|Part 3|Withdrawal by Subject|0
1700897|NCT01225731|5937516|P9|Part 3|Withdrawal by Subject|0
1700898|NCT01225731|5937517|P8|Part 3|Withdrawal by Subject|0
1700899|NCT01225731|5937518|P7|Part 3|Withdrawal by Subject|0
1700900|NCT01225731|5937519|P6|Part 3|Withdrawal by Subject|0
1700901|NCT01225731|5937520|P5|Part 3|Withdrawal by Subject|0
1700902|NCT01225731|5937521|P4|Part 3|Withdrawal by Subject|0
1700903|NCT01225731|5937522|P3|Part 3|Withdrawal by Subject|0
1700904|NCT01225731|5937523|P2|Part 3|Withdrawal by Subject|0
1700905|NCT01225731|5937524|P1|Part 3|Withdrawal by Subject|0
1700906|NCT01225731|5937512|P13|Part 3|Physician Decision|2
1700907|NCT01225731|5937513|P12|Part 3|Physician Decision|1
1700908|NCT01225731|5937514|P11|Part 3|Physician Decision|0
1700909|NCT01225731|5937515|P10|Part 3|Physician Decision|0
1700910|NCT01225731|5937516|P9|Part 3|Physician Decision|0
1700911|NCT01225731|5937517|P8|Part 3|Physician Decision|0
1700912|NCT01225731|5937518|P7|Part 3|Physician Decision|0
1700913|NCT01225731|5937519|P6|Part 3|Physician Decision|0
1700914|NCT01225731|5937520|P5|Part 3|Physician Decision|0
1700915|NCT01225731|5937521|P4|Part 3|Physician Decision|0
1700916|NCT01225731|5937522|P3|Part 3|Physician Decision|0
1700917|NCT01225731|5937523|P2|Part 3|Physician Decision|0
1700918|NCT01225731|5937524|P1|Part 3|Physician Decision|0
1700919|NCT01225731|5937512|P13|Part 3|Lost to Follow-up|1
1700920|NCT01225731|5937513|P12|Part 3|Lost to Follow-up|2
1700921|NCT01225731|5937514|P11|Part 3|Lost to Follow-up|1
1700922|NCT01225731|5937515|P10|Part 3|Lost to Follow-up|0
1700923|NCT01225731|5937516|P9|Part 3|Lost to Follow-up|0
1700924|NCT01225731|5937517|P8|Part 3|Lost to Follow-up|0
1700925|NCT01225731|5937518|P7|Part 3|Lost to Follow-up|0
1700926|NCT01225731|5937519|P6|Part 3|Lost to Follow-up|0
1700927|NCT01225731|5937520|P5|Part 3|Lost to Follow-up|0
1700928|NCT01225731|5937521|P4|Part 3|Lost to Follow-up|0
1700929|NCT01225731|5937522|P3|Part 3|Lost to Follow-up|0
1700930|NCT01225731|5937523|P2|Part 3|Lost to Follow-up|0
1700931|NCT01225731|5937524|P1|Part 3|Lost to Follow-up|0
1700932|NCT01225731|5937512|P13|Part 3|Adverse Event|0
1700933|NCT01225731|5937513|P12|Part 3|Adverse Event|1
1700934|NCT01225731|5937514|P11|Part 3|Adverse Event|1
1700935|NCT01225731|5937515|P10|Part 3|Adverse Event|0
1700936|NCT01225731|5937516|P9|Part 3|Adverse Event|0
1700937|NCT01225731|5937517|P8|Part 3|Adverse Event|0
1700938|NCT01225731|5937518|P7|Part 3|Adverse Event|0
1700939|NCT01225731|5937519|P6|Part 3|Adverse Event|0
1700940|NCT01225731|5937520|P5|Part 3|Adverse Event|0
1700941|NCT01225731|5937521|P4|Part 3|Adverse Event|0
1700942|NCT01225731|5937522|P3|Part 3|Adverse Event|0
1700943|NCT01225731|5937523|P2|Part 3|Adverse Event|0
1700944|NCT01225731|5937524|P1|Part 3|Adverse Event|0
1700945|NCT01225731|5937512|P13|Part 2|Withdrawal by Subject|0
1700946|NCT01225731|5937513|P12|Part 2|Withdrawal by Subject|0
1700947|NCT01225731|5937514|P11|Part 2|Withdrawal by Subject|0
1700948|NCT01225731|5937515|P10|Part 2|Withdrawal by Subject|0
1700949|NCT01225731|5937516|P9|Part 2|Withdrawal by Subject|1
1700950|NCT01225731|5937517|P8|Part 2|Withdrawal by Subject|4
1700951|NCT01225731|5937518|P7|Part 2|Withdrawal by Subject|3
1700952|NCT01225731|5937519|P6|Part 2|Withdrawal by Subject|1
1700953|NCT01225731|5937520|P5|Part 2|Withdrawal by Subject|0
1700954|NCT01225731|5937521|P4|Part 2|Withdrawal by Subject|0
1700955|NCT01225731|5937522|P3|Part 2|Withdrawal by Subject|0
1700956|NCT01225731|5937523|P2|Part 2|Withdrawal by Subject|0
1700957|NCT01225731|5937524|P1|Part 2|Withdrawal by Subject|0
1700958|NCT01225731|5937512|P13|Part 2|Physician Decision|0
1700959|NCT01225731|5937513|P12|Part 2|Physician Decision|0
1700960|NCT01225731|5937514|P11|Part 2|Physician Decision|0
1700961|NCT01225731|5937515|P10|Part 2|Physician Decision|0
1700962|NCT01225731|5937516|P9|Part 2|Physician Decision|2
1700963|NCT01225731|5937517|P8|Part 2|Physician Decision|2
1700964|NCT01225731|5937518|P7|Part 2|Physician Decision|0
1700965|NCT01225731|5937519|P6|Part 2|Physician Decision|0
1700966|NCT01225731|5937520|P5|Part 2|Physician Decision|0
1700967|NCT01225731|5937521|P4|Part 2|Physician Decision|0
1700968|NCT01225731|5937522|P3|Part 2|Physician Decision|0
1700969|NCT01225731|5937523|P2|Part 2|Physician Decision|0
1700970|NCT01225731|5937524|P1|Part 2|Physician Decision|0
1700971|NCT01225731|5937512|P13|Part 2|Lost to Follow-up|0
1700972|NCT01225731|5937513|P12|Part 2|Lost to Follow-up|0
1700973|NCT01225731|5937514|P11|Part 2|Lost to Follow-up|0
1700974|NCT01225731|5937515|P10|Part 2|Lost to Follow-up|0
1700975|NCT01225731|5937516|P9|Part 2|Lost to Follow-up|1
1700976|NCT01225731|5937517|P8|Part 2|Lost to Follow-up|3
1700977|NCT01225731|5937518|P7|Part 2|Lost to Follow-up|0
1700978|NCT01225731|5937519|P6|Part 2|Lost to Follow-up|0
1700979|NCT01225731|5937520|P5|Part 2|Lost to Follow-up|0
1700980|NCT01225731|5937521|P4|Part 2|Lost to Follow-up|0
1700981|NCT01225731|5937522|P3|Part 2|Lost to Follow-up|0
1700982|NCT01225731|5937523|P2|Part 2|Lost to Follow-up|0
1700983|NCT01225731|5937524|P1|Part 2|Lost to Follow-up|0
1700984|NCT01225731|5937512|P13|Part 2|Pregnancy|0
1700985|NCT01225731|5937513|P12|Part 2|Pregnancy|0
1700986|NCT01225731|5937514|P11|Part 2|Pregnancy|0
1700987|NCT01225731|5937515|P10|Part 2|Pregnancy|0
1700988|NCT01225731|5937516|P9|Part 2|Pregnancy|1
1700989|NCT01225731|5937517|P8|Part 2|Pregnancy|0
1700990|NCT01225731|5937518|P7|Part 2|Pregnancy|1
1700991|NCT01225731|5937519|P6|Part 2|Pregnancy|0
1700992|NCT01225731|5937520|P5|Part 2|Pregnancy|0
1700993|NCT01225731|5937521|P4|Part 2|Pregnancy|0
1700994|NCT01225731|5937522|P3|Part 2|Pregnancy|0
1700995|NCT01225731|5937523|P2|Part 2|Pregnancy|0
1700996|NCT01225731|5937524|P1|Part 2|Pregnancy|0
1700997|NCT01225731|5937512|P13|Part 2|Lack of Efficacy|0
1700998|NCT01225731|5937513|P12|Part 2|Lack of Efficacy|0
1700999|NCT01225731|5937514|P11|Part 2|Lack of Efficacy|0
1701000|NCT01225731|5937515|P10|Part 2|Lack of Efficacy|0
1701001|NCT01225731|5937516|P9|Part 2|Lack of Efficacy|3
1701002|NCT01225731|5937517|P8|Part 2|Lack of Efficacy|12
1701003|NCT01225731|5937518|P7|Part 2|Lack of Efficacy|0
1701004|NCT01225731|5937519|P6|Part 2|Lack of Efficacy|1
1701005|NCT01225731|5937520|P5|Part 2|Lack of Efficacy|0
1701006|NCT01225731|5937521|P4|Part 2|Lack of Efficacy|0
1701007|NCT01225731|5937522|P3|Part 2|Lack of Efficacy|0
1701008|NCT01225731|5937523|P2|Part 2|Lack of Efficacy|0
1701009|NCT01225731|5937524|P1|Part 2|Lack of Efficacy|0
1701010|NCT01225731|5937512|P13|Part 2|Adverse Event|0
1701011|NCT01225731|5937513|P12|Part 2|Adverse Event|0
1701012|NCT01225731|5937514|P11|Part 2|Adverse Event|0
1701013|NCT01225731|5937515|P10|Part 2|Adverse Event|0
1701014|NCT01225731|5937516|P9|Part 2|Adverse Event|2
1701015|NCT01225731|5937517|P8|Part 2|Adverse Event|4
1701016|NCT01225731|5937518|P7|Part 2|Adverse Event|4
1701017|NCT01225731|5937519|P6|Part 2|Adverse Event|0
1701018|NCT01225731|5937520|P5|Part 2|Adverse Event|0
1701019|NCT01225731|5937521|P4|Part 2|Adverse Event|0
1701020|NCT01225731|5937522|P3|Part 2|Adverse Event|0
1701021|NCT01225731|5937523|P2|Part 2|Adverse Event|0
1701022|NCT01225731|5937524|P1|Part 2|Adverse Event|0
1701023|NCT01225731|5937512|P13|Part 2|Protocol Violation|0
1701024|NCT01225731|5937513|P12|Part 2|Protocol Violation|0
1701025|NCT01225731|5937514|P11|Part 2|Protocol Violation|0
1701026|NCT01225731|5937515|P10|Part 2|Protocol Violation|0
1701027|NCT01225731|5937516|P9|Part 2|Protocol Violation|1
1701028|NCT01225731|5937517|P8|Part 2|Protocol Violation|0
1701029|NCT01225731|5937518|P7|Part 2|Protocol Violation|0
1701030|NCT01225731|5937519|P6|Part 2|Protocol Violation|1
1701031|NCT01225731|5937520|P5|Part 2|Protocol Violation|0
1701032|NCT01225731|5937521|P4|Part 2|Protocol Violation|0
1701033|NCT01225731|5937522|P3|Part 2|Protocol Violation|0
1701034|NCT01225731|5937523|P2|Part 2|Protocol Violation|0
1701035|NCT01225731|5937524|P1|Part 2|Protocol Violation|0
1701036|NCT01225731|5937512|P13|Part 1|Protocol Violation|0
1701037|NCT01225731|5937513|P12|Part 1|Protocol Violation|0
1701038|NCT01225731|5937514|P11|Part 1|Protocol Violation|0
1701039|NCT01225731|5937515|P10|Part 1|Protocol Violation|0
1701040|NCT01225731|5937516|P9|Part 1|Protocol Violation|0
1701041|NCT01225731|5937517|P8|Part 1|Protocol Violation|0
1701042|NCT01225731|5937518|P7|Part 1|Protocol Violation|0
1701043|NCT01225731|5937519|P6|Part 1|Protocol Violation|0
1701044|NCT01225731|5937520|P5|Part 1|Protocol Violation|0
1701045|NCT01225731|5937521|P4|Part 1|Protocol Violation|1
1701046|NCT01225731|5937522|P3|Part 1|Protocol Violation|0
1701047|NCT01225731|5937523|P2|Part 1|Protocol Violation|0
1701048|NCT01225731|5937524|P1|Part 1|Protocol Violation|0
1701049|NCT01225731|5937512|P13|Part 1|Withdrawal by Subject|0
1701050|NCT01225731|5937513|P12|Part 1|Withdrawal by Subject|0
1701051|NCT01225731|5937514|P11|Part 1|Withdrawal by Subject|0
1701052|NCT01225731|5937515|P10|Part 1|Withdrawal by Subject|0
1701053|NCT01225731|5937516|P9|Part 1|Withdrawal by Subject|0
1701054|NCT01225731|5937517|P8|Part 1|Withdrawal by Subject|0
1701055|NCT01225731|5937518|P7|Part 1|Withdrawal by Subject|0
1701056|NCT01225731|5937519|P6|Part 1|Withdrawal by Subject|0
1701057|NCT01225731|5937520|P5|Part 1|Withdrawal by Subject|4
1701058|NCT01225731|5937521|P4|Part 1|Withdrawal by Subject|0
1701059|NCT01225731|5937522|P3|Part 1|Withdrawal by Subject|0
1701060|NCT01225731|5937523|P2|Part 1|Withdrawal by Subject|3
1701061|NCT01225731|5937524|P1|Part 1|Withdrawal by Subject|0
1701062|NCT01225731|5937512|P13|Part 1|Adverse Event|0
1701063|NCT01225731|5937513|P12|Part 1|Adverse Event|0
1701064|NCT01225731|5937514|P11|Part 1|Adverse Event|0
1701065|NCT01225731|5937515|P10|Part 1|Adverse Event|0
1701066|NCT01225731|5937516|P9|Part 1|Adverse Event|0
1701067|NCT01225731|5937517|P8|Part 1|Adverse Event|0
1701068|NCT01225731|5937518|P7|Part 1|Adverse Event|0
1701069|NCT01225731|5937519|P6|Part 1|Adverse Event|0
1701070|NCT01225731|5937520|P5|Part 1|Adverse Event|1
1701071|NCT01225731|5937521|P4|Part 1|Adverse Event|1
1701072|NCT01225731|5937522|P3|Part 1|Adverse Event|1
1701073|NCT01225731|5937523|P2|Part 1|Adverse Event|2
1701074|NCT01225731|5937524|P1|Part 1|Adverse Event|1
1701075|NCT01225731|5937512|P13|Part 1|Did not meet eligibility criteria|0
1701076|NCT01225731|5937513|P12|Part 1|Did not meet eligibility criteria|0
1701077|NCT01225731|5937514|P11|Part 1|Did not meet eligibility criteria|0
1701078|NCT01225731|5937515|P10|Part 1|Did not meet eligibility criteria|0
1701079|NCT01225731|5937516|P9|Part 1|Did not meet eligibility criteria|0
1701080|NCT01225731|5937517|P8|Part 1|Did not meet eligibility criteria|0
1701081|NCT01225731|5937518|P7|Part 1|Did not meet eligibility criteria|0
1701082|NCT01225731|5937519|P6|Part 1|Did not meet eligibility criteria|0
1701083|NCT01225731|5937520|P5|Part 1|Did not meet eligibility criteria|1
1701084|NCT01225731|5937521|P4|Part 1|Did not meet eligibility criteria|0
1701085|NCT01225731|5937522|P3|Part 1|Did not meet eligibility criteria|0
1701086|NCT01225731|5937523|P2|Part 1|Did not meet eligibility criteria|0
1701087|NCT01225731|5937524|P1|Part 1|Did not meet eligibility criteria|1
1701088|NCT01225562|5937619|P3|Overall Study|Lost to Follow-up|1
1701089|NCT01225562|5937620|P2|Overall Study|Lost to Follow-up|6
1701090|NCT01225562|5937621|P1|Overall Study|Lost to Follow-up|3
1701091|NCT01225562|5937619|P3|Overall Study|Withdrawal by Subject|52
1701092|NCT01225562|5937620|P2|Overall Study|Withdrawal by Subject|50
1701093|NCT01225562|5937621|P1|Overall Study|Withdrawal by Subject|52
1701094|NCT01225549|5937638|P10|Period 6 - Washout|Disallowed medication|0
1701095|NCT01225549|5937639|P9|Period 6 - Washout|Disallowed medication|0
1701096|NCT01225549|5937640|P8|Period 6 - Washout|Disallowed medication|0
1701097|NCT01225549|5937641|P7|Period 6 - Washout|Disallowed medication|0
1701098|NCT01225549|5937642|P6|Period 6 - Washout|Disallowed medication|0
1701099|NCT01225549|5937643|P5|Period 6 - Washout|Disallowed medication|0
1701100|NCT01225549|5937644|P4|Period 6 - Washout|Disallowed medication|1
1701101|NCT01225549|5937645|P3|Period 6 - Washout|Disallowed medication|0
1701102|NCT01225549|5937646|P2|Period 6 - Washout|Disallowed medication|0
1701103|NCT01225549|5937647|P1|Period 6 - Washout|Disallowed medication|0
1701104|NCT01225549|5937638|P10|Period 4 - Washout|Disallowed medication|0
1701105|NCT01225549|5937639|P9|Period 4 - Washout|Disallowed medication|0
1701106|NCT01225549|5937640|P8|Period 4 - Washout|Disallowed medication|0
1701107|NCT01225549|5937641|P7|Period 4 - Washout|Disallowed medication|0
1701108|NCT01225549|5937642|P6|Period 4 - Washout|Disallowed medication|0
1701109|NCT01225549|5937643|P5|Period 4 - Washout|Disallowed medication|0
1701110|NCT01225549|5937644|P4|Period 4 - Washout|Disallowed medication|0
1701111|NCT01225549|5937645|P3|Period 4 - Washout|Disallowed medication|0
1701112|NCT01225549|5937646|P2|Period 4 - Washout|Disallowed medication|1
1701113|NCT01225549|5937647|P1|Period 4 - Washout|Disallowed medication|0
1701114|NCT01225211|5937730|P10|Overall Study|Other|1
1701115|NCT01225211|5937731|P9|Overall Study|Other|0
1701116|NCT01225211|5937732|P8|Overall Study|Other|0
1701117|NCT01225211|5937733|P7|Overall Study|Other|0
1701118|NCT01225211|5937734|P6|Overall Study|Other|0
1701119|NCT01225211|5937735|P5|Overall Study|Other|0
1701120|NCT01225211|5937736|P4|Overall Study|Other|0
1701121|NCT01225211|5937737|P3|Overall Study|Other|0
1701122|NCT01225211|5937738|P2|Overall Study|Other|0
1701123|NCT01225211|5937739|P1|Overall Study|Other|0
1701124|NCT01225211|5937730|P10|Overall Study|Withdrawal by Subject|3
1701125|NCT01225211|5937731|P9|Overall Study|Withdrawal by Subject|1
1701126|NCT01225211|5937732|P8|Overall Study|Withdrawal by Subject|0
1701127|NCT01225211|5937733|P7|Overall Study|Withdrawal by Subject|1
1701128|NCT01225211|5937734|P6|Overall Study|Withdrawal by Subject|0
1701129|NCT01225211|5937735|P5|Overall Study|Withdrawal by Subject|0
1701130|NCT01225211|5937736|P4|Overall Study|Withdrawal by Subject|0
1701131|NCT01225211|5937737|P3|Overall Study|Withdrawal by Subject|0
1701132|NCT01225211|5937738|P2|Overall Study|Withdrawal by Subject|0
1701133|NCT01225211|5937739|P1|Overall Study|Withdrawal by Subject|0
1701134|NCT01225211|5937730|P10|Overall Study|Adverse Event|1
1701135|NCT01225211|5937731|P9|Overall Study|Adverse Event|0
1701136|NCT01225211|5937732|P8|Overall Study|Adverse Event|0
1701137|NCT01225211|5937733|P7|Overall Study|Adverse Event|0
1701138|NCT01225211|5937734|P6|Overall Study|Adverse Event|0
1701139|NCT01225211|5937735|P5|Overall Study|Adverse Event|0
1701140|NCT01225211|5937736|P4|Overall Study|Adverse Event|0
1701141|NCT01225211|5937737|P3|Overall Study|Adverse Event|1
1701142|NCT01225211|5937738|P2|Overall Study|Adverse Event|0
1701143|NCT01225211|5937739|P1|Overall Study|Adverse Event|0
1701144|NCT01225172|5937842|P2|Overall Study|Withdrawal by Subject|0
1701145|NCT01225172|5937843|P1|Overall Study|Withdrawal by Subject|1
1701146|NCT01225172|5937842|P2|Overall Study|Subject no longer meets study criteria|0
1701147|NCT01225172|5937843|P1|Overall Study|Subject no longer meets study criteria|1
1701148|NCT01225172|5937842|P2|Overall Study|Subject request to discontinue treatment|1
1701149|NCT01225172|5937843|P1|Overall Study|Subject request to discontinue treatment|3
1701150|NCT01225172|5937842|P2|Overall Study|Subject decision to stop|0
1701151|NCT01225172|5937843|P1|Overall Study|Subject decision to stop|1
1701152|NCT01225159|5937865|P2|Overall Study|Change operation|0
1701153|NCT01225159|5937866|P1|Overall Study|Change operation|1
1701154|NCT01225146|5937876|P2|Overall Study|Sponsor discontinued making 2mg drug|2
1701155|NCT01225146|5937877|P1|Overall Study|Sponsor discontinued making 2mg drug|0
1701156|NCT01224925|5937945|P2|Overall Study|Lost to Follow-up|2
1701157|NCT01224925|5937946|P1|Overall Study|Lost to Follow-up|3
1701158|NCT01224821|5937954|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
1701159|NCT01224821|5937954|P1|Long-Term Follow-Up|Death|2
1701160|NCT01224821|5937954|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
1701161|NCT01224821|5937954|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
1701162|NCT01224821|5937954|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
1701163|NCT01224821|5937954|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
1701164|NCT01224821|5937954|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
1701165|NCT01224821|5937954|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
1701166|NCT01224782|5937973|P1|Overall Study|Transplantation|1
1701167|NCT01224782|5937973|P1|Overall Study|Deterioration|1
1701168|NCT01224782|5937973|P1|Overall Study|Financial Reasons|1
1701169|NCT01224782|5937973|P1|Overall Study|Change of Treatment|1
1701170|NCT01224782|5937973|P1|Overall Study|Start of Dialysis|3
1701171|NCT01224782|5937973|P1|Overall Study|Other|4
1701172|NCT01224782|5937973|P1|Overall Study|Noncompliance|10
1701173|NCT01224782|5937973|P1|Overall Study|Adverse Reaction|11
1701174|NCT01224782|5937973|P1|Overall Study|Adverse Event|12
1701175|NCT01224782|5937973|P1|Overall Study|Improvement|13
1701176|NCT01224782|5937973|P1|Overall Study|Death|14
1701177|NCT01224782|5937973|P1|Overall Study|Withdrawal by Subject|16
1701178|NCT01224782|5937973|P1|Overall Study|Lost to Follow-up|177
1701179|NCT01224639|5937999|P8|Overall Study|Adverse Event|1
1701180|NCT01224639|5938000|P7|Overall Study|Adverse Event|0
1701181|NCT01224639|5938001|P6|Overall Study|Adverse Event|0
1701182|NCT01224639|5938002|P5|Overall Study|Adverse Event|0
1701183|NCT01224639|5938003|P4|Overall Study|Adverse Event|0
1701184|NCT01224639|5938004|P3|Overall Study|Adverse Event|0
1701185|NCT01224639|5938005|P2|Overall Study|Adverse Event|0
1701186|NCT01224639|5938006|P1|Overall Study|Adverse Event|0
1701187|NCT01224639|5937999|P8|Overall Study|Withdrawal by Subject|1
1701188|NCT01224639|5938000|P7|Overall Study|Withdrawal by Subject|1
1701189|NCT01224639|5938001|P6|Overall Study|Withdrawal by Subject|0
1701190|NCT01224639|5938002|P5|Overall Study|Withdrawal by Subject|2
1701191|NCT01224639|5938003|P4|Overall Study|Withdrawal by Subject|0
1701192|NCT01224639|5938004|P3|Overall Study|Withdrawal by Subject|0
1701193|NCT01224639|5938005|P2|Overall Study|Withdrawal by Subject|0
1701194|NCT01224639|5938006|P1|Overall Study|Withdrawal by Subject|0
1701195|NCT01224431|5938124|P2|Overall Study|no video record|1
1701196|NCT01224431|5938125|P1|Overall Study|no video record|0
1701197|NCT01224431|5938124|P2|Overall Study|not randomized|4
1701198|NCT01224431|5938125|P1|Overall Study|not randomized|0
1701199|NCT01224171|5938146|P2|Overall Study|Lost to Follow-up|3
1701200|NCT01224171|5938147|P1|Overall Study|Lost to Follow-up|0
1701201|NCT01224171|5938146|P2|Overall Study|Withdrawal of Consent|4
1701202|NCT01224171|5938147|P1|Overall Study|Withdrawal of Consent|2
1701203|NCT01224171|5938146|P2|Overall Study|Lack of Efficacy|1
1701204|NCT01224171|5938147|P1|Overall Study|Lack of Efficacy|5
1701205|NCT01224171|5938146|P2|Overall Study|Protocol Violation|1
1701206|NCT01224171|5938147|P1|Overall Study|Protocol Violation|0
1701207|NCT01224171|5938146|P2|Overall Study|Adverse Event|4
1701208|NCT01224171|5938147|P1|Overall Study|Adverse Event|8
1701209|NCT01224158|5938169|P2|Overall Study|Withdrawal by Subject|0
1701210|NCT01224158|5938170|P1|Overall Study|Withdrawal by Subject|1
1701211|NCT01223937|5938206|P2|Overall Study|Other|1
1701212|NCT01223937|5938207|P1|Overall Study|Other|4
1701213|NCT01223937|5938206|P2|Overall Study|Protocol Violation|7
1701214|NCT01223937|5938207|P1|Overall Study|Protocol Violation|8
1701215|NCT01223937|5938206|P2|Overall Study|Adverse Event|4
1701216|NCT01223937|5938207|P1|Overall Study|Adverse Event|1
1701217|NCT01223937|5938206|P2|Overall Study|Lost to Follow-up|4
1701218|NCT01223937|5938207|P1|Overall Study|Lost to Follow-up|1
1701219|NCT01223937|5938206|P2|Overall Study|Withdrawal by Subject|2
1701220|NCT01223937|5938207|P1|Overall Study|Withdrawal by Subject|3
1701221|NCT01223404|5938253|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
1701222|NCT01223404|5938254|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
1701223|NCT01223404|5938255|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
1701224|NCT01223404|5938256|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
1701225|NCT01223404|5938257|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
1701226|NCT01223404|5938258|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
1701227|NCT01223404|5938253|P6|Second Intervention (1 Day)|Adverse Event|0
1701228|NCT01223404|5938254|P5|Second Intervention (1 Day)|Adverse Event|0
1701229|NCT01223404|5938255|P4|Second Intervention (1 Day)|Adverse Event|0
1701230|NCT01223404|5938256|P3|Second Intervention (1 Day)|Adverse Event|0
1701231|NCT01223404|5938257|P2|Second Intervention (1 Day)|Adverse Event|0
1701232|NCT01223404|5938258|P1|Second Intervention (1 Day)|Adverse Event|1
1701233|NCT01223404|5938253|P6|First Intervention (1 Day)|Adverse Event|0
1701234|NCT01223404|5938254|P5|First Intervention (1 Day)|Adverse Event|0
1701235|NCT01223404|5938255|P4|First Intervention (1 Day)|Adverse Event|1
1701236|NCT01223404|5938256|P3|First Intervention (1 Day)|Adverse Event|0
1701237|NCT01223404|5938257|P2|First Intervention (1 Day)|Adverse Event|0
1701238|NCT01223404|5938258|P1|First Intervention (1 Day)|Adverse Event|0
1701239|NCT01223365|5938322|P1|Open-label Treatment Period|Physician Decision|2
1701240|NCT01223365|5938322|P1|Open-label Treatment Period|Starting physical therapy|1
1701241|NCT01223365|5938322|P1|Open-label Treatment Period|"Out of window"|1
1701242|NCT01223365|5938322|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
1701243|NCT01223365|5938322|P1|Open-label Treatment Period|Moved out of area|2
1701244|NCT01223365|5938322|P1|Open-label Treatment Period|Noncompliance with study procedures|6
1701245|NCT01223365|5938322|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
1701246|NCT01223365|5938322|P1|Open-label Treatment Period|Lost to Follow-up|7
1701247|NCT01223365|5938322|P1|Open-label Treatment Period|Protocol Violation|15
1701248|NCT01223365|5938322|P1|Open-label Treatment Period|Withdrawal by Subject|19
1701249|NCT01223365|5938322|P1|Open-label Treatment Period|Lack of Efficacy|2
1701250|NCT01223365|5938322|P1|Open-label Treatment Period|Adverse Event|39
1701251|NCT01223365|5938322|P1|Open-label Titration Period|Starting physical therapy|1
1701252|NCT01223365|5938322|P1|Open-label Titration Period|Noncompliance with study procedures|2
1701253|NCT01223365|5938322|P1|Open-label Titration Period|Noncompliance with study drug admin|1
1701254|NCT01223365|5938322|P1|Open-label Titration Period|Lost to Follow-up|2
1701255|NCT01223365|5938322|P1|Open-label Titration Period|Protocol Violation|1
1701256|NCT01223365|5938322|P1|Open-label Titration Period|Withdrawal by Subject|5
1701257|NCT01223365|5938322|P1|Open-label Titration Period|Lack of Efficacy|3
1701258|NCT01223365|5938322|P1|Open-label Titration Period|Adverse Event|23
1701259|NCT01223365|5938322|P1|Open-label Titration Period|Enrolled but not treated|1
1701260|NCT01223235|5938386|P1|Overall Study|Withdrawal by Subject|1
1701261|NCT01223196|5938394|P2|Overall Study|Withdrawal by Subject|0
1701262|NCT01223196|5938395|P1|Overall Study|Withdrawal by Subject|1
1701263|NCT01223196|5938394|P2|Overall Study|Physician Decision|0
1701264|NCT01223196|5938395|P1|Overall Study|Physician Decision|1
1701265|NCT01223196|5938394|P2|Overall Study|Lost to Follow-up|0
1701266|NCT01223196|5938395|P1|Overall Study|Lost to Follow-up|2
1701267|NCT01223183|5938407|P2|Washout Period (5-24 Days)|Physician Decision|0
1701268|NCT01223183|5938408|P1|Washout Period (5-24 Days)|Physician Decision|1
1701269|NCT01223183|5938407|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
1701270|NCT01223183|5938408|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
1701271|NCT01223183|5938407|P2|Imaging Day 1|Physician Decision|1
1701272|NCT01223183|5938408|P1|Imaging Day 1|Physician Decision|0
1701273|NCT01223027|5938418|P2|Overall Study|Study terminated by sponsor|8
1701274|NCT01223027|5938419|P1|Overall Study|Study terminated by sponsor|2
1701275|NCT01223027|5938418|P2|Overall Study|New therapy for study indication|8
1701276|NCT01223027|5938419|P1|Overall Study|New therapy for study indication|17
1701277|NCT01223027|5938418|P2|Overall Study|Subject/guardian decicion|16
1701278|NCT01223027|5938419|P1|Overall Study|Subject/guardian decicion|18
1701279|NCT01223027|5938418|P2|Overall Study|Protocol Violation|1
1701280|NCT01223027|5938419|P1|Overall Study|Protocol Violation|2
1701281|NCT01223027|5938418|P2|Overall Study|Progressive Disease|183
1701282|NCT01223027|5938419|P1|Overall Study|Progressive Disease|167
1701283|NCT01223027|5938418|P2|Overall Study|Physician Decision|8
1701284|NCT01223027|5938419|P1|Overall Study|Physician Decision|4
1701285|NCT01223027|5938418|P2|Overall Study|Lost to Follow-up|1
1701286|NCT01223027|5938419|P1|Overall Study|Lost to Follow-up|2
1701287|NCT01223027|5938418|P2|Overall Study|Death|42
1701288|NCT01223027|5938419|P1|Overall Study|Death|42
1701289|NCT01223027|5938418|P2|Overall Study|Adverse Event|10
1701290|NCT01223027|5938419|P1|Overall Study|Adverse Event|20
1701291|NCT01222715|5938481|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
1701292|NCT01222715|5938482|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
1701293|NCT01222715|5938481|P2|Overall Study|Ineligible|1
1701294|NCT01222715|5938482|P1|Overall Study|Ineligible|0
1701295|NCT01222715|5938481|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
1701296|NCT01222715|5938482|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
1701297|NCT01222715|5938481|P2|Overall Study|Refusal of further protocol therapy|4
1701298|NCT01222715|5938482|P1|Overall Study|Refusal of further protocol therapy|0
1701299|NCT01222715|5938481|P2|Overall Study|Physician Decision|2
1701300|NCT01222715|5938482|P1|Overall Study|Physician Decision|12
1701301|NCT01222715|5938481|P2|Overall Study|Lack of Efficacy|14
1701302|NCT01222715|5938482|P1|Overall Study|Lack of Efficacy|22
1701303|NCT01222715|5938481|P2|Overall Study|Death|1
1701304|NCT01222715|5938482|P1|Overall Study|Death|0
1701305|NCT01222715|5938481|P2|Overall Study|Adverse Event|4
1701306|NCT01222715|5938482|P1|Overall Study|Adverse Event|0
1701307|NCT01222533|5938521|P1|Overall Study|Other|4
1701308|NCT01222533|5938521|P1|Overall Study|Withdrawal by Subject|5
1701309|NCT01222533|5938521|P1|Overall Study|Adverse Event|5
1701310|NCT01222520|5938660|P2|Double-blind Period|Study medication stolen|0
1701311|NCT01222520|5938661|P1|Double-blind Period|Study medication stolen|1
1701312|NCT01222520|5938660|P2|Double-blind Period|Lack of Efficacy|1
1701313|NCT01222520|5938661|P1|Double-blind Period|Lack of Efficacy|0
1701314|NCT01222520|5938660|P2|Double-blind Period|Adverse Event|1
1701315|NCT01222520|5938661|P1|Double-blind Period|Adverse Event|0
1701316|NCT01222520|5938660|P2|Open-label run-in Period|Number of patients fulfilled|3
1701317|NCT01222520|5938661|P1|Open-label run-in Period|Number of patients fulfilled|0
1701318|NCT01222520|5938660|P2|Open-label run-in Period|Blood pressure criteria not met|18
1701319|NCT01222520|5938661|P1|Open-label run-in Period|Blood pressure criteria not met|0
1701320|NCT01222520|5938660|P2|Open-label run-in Period|Withdrawal by Subject|2
1701321|NCT01222520|5938661|P1|Open-label run-in Period|Withdrawal by Subject|0
1701322|NCT01222507|5938679|P1|Overall Study|Withdrawal by Subject|1
1701323|NCT01222507|5938679|P1|Overall Study|Physician Decision|1
1701324|NCT01222416|5938707|P2|Overall Study|Death|0
1701325|NCT01222416|5938708|P1|Overall Study|Death|1
1701326|NCT01222416|5938707|P2|Overall Study|missed view/scan|0
1701327|NCT01222416|5938708|P1|Overall Study|missed view/scan|1
1701328|NCT01222416|5938707|P2|Overall Study|scheduling|0
1701329|NCT01222416|5938708|P1|Overall Study|scheduling|6
1701330|NCT01222416|5938707|P2|Overall Study|Withdrawal by Subject|0
1701331|NCT01222416|5938708|P1|Overall Study|Withdrawal by Subject|5
1701332|NCT01222416|5938707|P2|Overall Study|Adverse Event|0
1701333|NCT01222416|5938708|P1|Overall Study|Adverse Event|4
1701334|NCT01222416|5938707|P2|Overall Study|ineligible;metastasis|0
1701335|NCT01222416|5938708|P1|Overall Study|ineligible;metastasis|3
1701336|NCT01222403|5938718|P2|Overall Study|Inappropriate enrollment|2
1701337|NCT01222403|5938719|P1|Overall Study|Inappropriate enrollment|0
1701338|NCT01222247|5938756|P2|Overall Study|Lost to Follow-up|2
1701339|NCT01222247|5938757|P1|Overall Study|Lost to Follow-up|2
1701340|NCT01222104|5938893|P1|Overall Study|Death|10
1701341|NCT01222104|5938893|P1|Overall Study|Lost to Follow-up|37
1701342|NCT01222078|5938916|P1|Overall Study|Early termination of the study|1
1701343|NCT01221948|5938950|P1|Overall Study|Protocol Violation|4
1701344|NCT01221948|5938950|P1|Overall Study|Death|1
1701345|NCT01221948|5938950|P1|Overall Study|not disclosed|2
1701346|NCT01221948|5938950|P1|Overall Study|Withdrawal by Subject|2
1701347|NCT01221948|5938950|P1|Overall Study|Physician Decision|5
1701348|NCT01221753|5938969|P1|Overall Study|Adverse Event|1
1701349|NCT01221727|5938976|P2|Overall Study|Withdrawal by Subject|1
1701350|NCT01221727|5938977|P1|Overall Study|Withdrawal by Subject|1
1701351|NCT01221727|5938976|P2|Overall Study|Physician Decision|0
1701352|NCT01221727|5938977|P1|Overall Study|Physician Decision|2
1701353|NCT01221623|5938998|P2|Overall Study|Other|2
1701354|NCT01221623|5938999|P1|Overall Study|Other|5
1701355|NCT01221623|5938998|P2|Overall Study|Death|0
1701356|NCT01221623|5938999|P1|Overall Study|Death|1
1701357|NCT01221623|5938998|P2|Overall Study|Adverse Event|3
1701358|NCT01221623|5938999|P1|Overall Study|Adverse Event|6
1701359|NCT01221623|5938998|P2|Overall Study|Lost to Follow-up|1
1701360|NCT01221623|5938999|P1|Overall Study|Lost to Follow-up|7
1701361|NCT01221623|5938998|P2|Overall Study|Withdrawal by Subject|8
1701362|NCT01221623|5938999|P1|Overall Study|Withdrawal by Subject|19
1701363|NCT01221597|5939023|P2|Overall Study|Death|0
1701364|NCT01221597|5939024|P1|Overall Study|Death|2
1701365|NCT01221597|5939023|P2|Overall Study|Other|4
1701366|NCT01221597|5939024|P1|Overall Study|Other|3
1701367|NCT01221597|5939023|P2|Overall Study|Protocol Violation|0
1701368|NCT01221597|5939024|P1|Overall Study|Protocol Violation|1
1701369|NCT01221597|5939023|P2|Overall Study|Lost to Follow-up|5
1701370|NCT01221597|5939024|P1|Overall Study|Lost to Follow-up|6
1701371|NCT01221597|5939023|P2|Overall Study|Withdrawal by Subject|6
1701372|NCT01221597|5939024|P1|Overall Study|Withdrawal by Subject|20
1701373|NCT01221597|5939023|P2|Overall Study|Adverse Event|1
1701374|NCT01221597|5939024|P1|Overall Study|Adverse Event|4
1701375|NCT01221363|5939081|P2|Overall Study|Withdrawal by Subject|5
1701376|NCT01221363|5939082|P1|Overall Study|Withdrawal by Subject|11
1701377|NCT01221363|5939081|P2|Overall Study|Pregnancy|0
1701378|NCT01221363|5939082|P1|Overall Study|Pregnancy|1
1701379|NCT01221350|5939092|P2|Overall Study|Withdrawal by Subject|2
1701380|NCT01221350|5939093|P1|Overall Study|Withdrawal by Subject|4
1701381|NCT01221350|5939092|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
1701382|NCT01221350|5939093|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
1701383|NCT01221350|5939092|P2|Overall Study|Discontinued intervention (GERD)|0
1701384|NCT01221350|5939093|P1|Overall Study|Discontinued intervention (GERD)|1
1701385|NCT01221285|5939152|P1|Overall Study|Withdrawal by Subject|1
1701386|NCT01221272|5939161|P2|Period 2|Adverse Event|2
1701387|NCT01221272|5939162|P1|Period 2|Adverse Event|0
1701388|NCT01221272|5939161|P2|Period 1|Significant Dosing Noncompliance|1
1701389|NCT01221272|5939162|P1|Period 1|Significant Dosing Noncompliance|0
1701390|NCT01221272|5939161|P2|Period 1|Consent Withdrawal|1
1701391|NCT01221272|5939162|P1|Period 1|Consent Withdrawal|0
1701392|NCT01221272|5939161|P2|Period 1|Adverse Event|0
1701393|NCT01221272|5939162|P1|Period 1|Adverse Event|2
1701394|NCT01221233|5939179|P2|Overall Study|Withdrawal by Subject|1
1701395|NCT01221233|5939180|P1|Overall Study|Withdrawal by Subject|3
1701396|NCT01221181|5939186|P1|Overall Study|Lost to Follow-up|1
1701397|NCT01221090|5939194|P4|Overall Study|Withdrawal by Subject|2
1701398|NCT01221090|5939195|P3|Overall Study|Withdrawal by Subject|27
1701399|NCT01221090|5939196|P2|Overall Study|Withdrawal by Subject|22
1701400|NCT01221090|5939197|P1|Overall Study|Withdrawal by Subject|0
1701401|NCT01221090|5939194|P4|Overall Study|Non-Compliant or Unable to Contact|20
1701402|NCT01221090|5939195|P3|Overall Study|Non-Compliant or Unable to Contact|15
1701403|NCT01221090|5939196|P2|Overall Study|Non-Compliant or Unable to Contact|12
1701404|NCT01221090|5939197|P1|Overall Study|Non-Compliant or Unable to Contact|15
1701405|NCT01220999|5939228|P5|Overall Study|Progressive disease|0
1701406|NCT01220999|5939229|P4|Overall Study|Progressive disease|0
1701407|NCT01220999|5939230|P3|Overall Study|Progressive disease|1
1701408|NCT01220999|5939231|P2|Overall Study|Progressive disease|0
1701409|NCT01220999|5939232|P1|Overall Study|Progressive disease|0
1701410|NCT01220609|5939353|P1|Overall Study|Ineligible-Never treated|1
1701411|NCT01220609|5939353|P1|Overall Study|Ineligible- Wrong cell type|1
1701412|NCT01220609|5939353|P1|Overall Study|Ineligible-Wrong primary cancer site|1
1701413|NCT01220557|5939367|P2|Overall Study|attended less than 6 lessons|2
1701414|NCT01220557|5939368|P1|Overall Study|attended less than 6 lessons|1
1701415|NCT01220557|5939367|P2|Overall Study|Lost to Follow-up|3
1701416|NCT01220557|5939368|P1|Overall Study|Lost to Follow-up|5
1701417|NCT01220414|5939401|P4|Overall Study|Withdrawal by Subject|1
1701418|NCT01220414|5939402|P3|Overall Study|Withdrawal by Subject|0
1701419|NCT01220414|5939403|P2|Overall Study|Withdrawal by Subject|0
1701420|NCT01220414|5939404|P1|Overall Study|Withdrawal by Subject|1
1701421|NCT01220401|5939411|P1|Overall Study|Protocol Violation|1
1701422|NCT01220401|5939411|P1|Overall Study|Withdrawal by Subject|2
1701423|NCT01220297|5939420|P1|Overall Study|Lost to Follow-up|1
1701424|NCT01220297|5939420|P1|Overall Study|Death|2
1701425|NCT01220180|5939437|P1|Overall Study|Randomized but not treated|1
1701426|NCT01220180|5939437|P1|Overall Study|Death|1
1701427|NCT01220180|5939437|P1|Overall Study|Lack of Efficacy|22
1701428|NCT01220180|5939437|P1|Overall Study|Adverse Event|35
1701429|NCT01220180|5939437|P1|Overall Study|Other|72
1701430|NCT01220180|5939437|P1|Overall Study|Lost to Follow-up|76
1701431|NCT01220128|5939467|P7|Overall Study|Consent withdrawn by subject|0
1701432|NCT01220128|5939468|P6|Overall Study|Consent withdrawn by subject|0
1701433|NCT01220128|5939469|P5|Overall Study|Consent withdrawn by subject|0
1701434|NCT01220128|5939470|P4|Overall Study|Consent withdrawn by subject|0
1701435|NCT01220128|5939471|P3|Overall Study|Consent withdrawn by subject|0
1701436|NCT01220128|5939472|P2|Overall Study|Consent withdrawn by subject|0
1701437|NCT01220128|5939473|P1|Overall Study|Consent withdrawn by subject|1
1701438|NCT01220128|5939467|P7|Overall Study|Other|0
1701439|NCT01220128|5939468|P6|Overall Study|Other|0
1701440|NCT01220128|5939469|P5|Overall Study|Other|0
1701441|NCT01220128|5939470|P4|Overall Study|Other|0
1701442|NCT01220128|5939471|P3|Overall Study|Other|1
1701443|NCT01220128|5939472|P2|Overall Study|Other|0
1701444|NCT01220128|5939473|P1|Overall Study|Other|0
1701445|NCT01220128|5939467|P7|Overall Study|Adverse event, non-fatal|3
1701446|NCT01220128|5939468|P6|Overall Study|Adverse event, non-fatal|0
1701447|NCT01220128|5939469|P5|Overall Study|Adverse event, non-fatal|0
1701448|NCT01220128|5939470|P4|Overall Study|Adverse event, non-fatal|0
1701449|NCT01220128|5939471|P3|Overall Study|Adverse event, non-fatal|0
1701450|NCT01220128|5939472|P2|Overall Study|Adverse event, non-fatal|0
1701451|NCT01220128|5939473|P1|Overall Study|Adverse event, non-fatal|1
1701452|NCT01220128|5939467|P7|Overall Study|Adverse event, serious fatal|1
1701453|NCT01220128|5939468|P6|Overall Study|Adverse event, serious fatal|0
1701454|NCT01220128|5939469|P5|Overall Study|Adverse event, serious fatal|0
1701455|NCT01220128|5939470|P4|Overall Study|Adverse event, serious fatal|0
1701456|NCT01220128|5939471|P3|Overall Study|Adverse event, serious fatal|0
1701457|NCT01220128|5939472|P2|Overall Study|Adverse event, serious fatal|0
1701458|NCT01220128|5939473|P1|Overall Study|Adverse event, serious fatal|2
1701459|NCT01220128|5939467|P7|Overall Study|Sponsor study termination|1
1701460|NCT01220128|5939468|P6|Overall Study|Sponsor study termination|0
1701461|NCT01220128|5939469|P5|Overall Study|Sponsor study termination|0
1701462|NCT01220128|5939470|P4|Overall Study|Sponsor study termination|0
1701463|NCT01220128|5939471|P3|Overall Study|Sponsor study termination|0
1701464|NCT01220128|5939472|P2|Overall Study|Sponsor study termination|1
1701465|NCT01220128|5939473|P1|Overall Study|Sponsor study termination|0
1701466|NCT01220128|5939467|P7|Overall Study|Progressive disease|0
1701467|NCT01220128|5939468|P6|Overall Study|Progressive disease|0
1701468|NCT01220128|5939469|P5|Overall Study|Progressive disease|0
1701469|NCT01220128|5939470|P4|Overall Study|Progressive disease|0
1701470|NCT01220128|5939471|P3|Overall Study|Progressive disease|2
1701471|NCT01220128|5939472|P2|Overall Study|Progressive disease|0
1701472|NCT01220128|5939473|P1|Overall Study|Progressive disease|0
1701473|NCT01219985|5939678|P1|Overall Study|Physician Decision|20
1701474|NCT01219959|5939686|P2|Overall Study|Other|0
1701475|NCT01219959|5939687|P1|Overall Study|Other|1
1701476|NCT01219959|5939686|P2|Overall Study|Renal Transplantation|3
1701477|NCT01219959|5939687|P1|Overall Study|Renal Transplantation|0
1701478|NCT01219959|5939686|P2|Overall Study|Withdrawal by Subject|2
1701479|NCT01219959|5939687|P1|Overall Study|Withdrawal by Subject|0
1701480|NCT01219959|5939686|P2|Overall Study|Physician Decision|4
1701481|NCT01219959|5939687|P1|Overall Study|Physician Decision|0
1701482|NCT01219959|5939686|P2|Overall Study|Adverse Event|14
1701483|NCT01219959|5939687|P1|Overall Study|Adverse Event|6
1701484|NCT01219933|5939735|P1|Overall Study|Lack of Efficacy|1
1701485|NCT01219933|5939735|P1|Overall Study|Protocol Violation|8
1701486|NCT01219933|5939735|P1|Overall Study|Withdrawal by Subject|5
1701487|NCT01219933|5939735|P1|Overall Study|GC free|1
1701488|NCT01219933|5939735|P1|Overall Study|Lost to Follow-up|3
1701489|NCT01219933|5939735|P1|Overall Study|No LDA maintained|7
1701490|NCT01219933|5939735|P1|Overall Study|No LDA reached|5
1701491|NCT01219933|5939735|P1|Overall Study|Adverse Event|8
1701492|NCT01218867|5939945|P11|Overall Study|Death during treatment|0
1701493|NCT01218867|5939946|P10|Overall Study|Death during treatment|0
1701494|NCT01218867|5939947|P9|Overall Study|Death during treatment|0
1701495|NCT01218867|5939948|P8|Overall Study|Death during treatment|0
1701496|NCT01218867|5939949|P7|Overall Study|Death during treatment|1
1701497|NCT01218867|5939950|P6|Overall Study|Death during treatment|0
1701498|NCT01218867|5939951|P5|Overall Study|Death during treatment|0
1701499|NCT01218867|5939952|P4|Overall Study|Death during treatment|0
1701500|NCT01218867|5939953|P3|Overall Study|Death during treatment|0
1701501|NCT01218867|5939954|P2|Overall Study|Death during treatment|0
1701502|NCT01218867|5939955|P1|Overall Study|Death during treatment|0
1701503|NCT01218802|5940003|P2|Overall Study|Incarcerated|0
1701504|NCT01218802|5940004|P1|Overall Study|Incarcerated|2
1701505|NCT01218802|5940003|P2|Overall Study|Adverse Event|2
1701506|NCT01218802|5940004|P1|Overall Study|Adverse Event|0
1701507|NCT01218802|5940003|P2|Overall Study|Withdrawal by Subject|10
1701508|NCT01218802|5940004|P1|Overall Study|Withdrawal by Subject|3
1701509|NCT01218802|5940003|P2|Overall Study|Lost to Follow-up|6
1701510|NCT01218802|5940004|P1|Overall Study|Lost to Follow-up|5
1701511|NCT01218659|5940014|P3|12-Month OLE|Declined to participate in the OLE|4
1701512|NCT01218659|5940015|P2|12-Month OLE|Declined to participate in the OLE|0
1701513|NCT01218659|5940016|P1|12-Month OLE|Declined to participate in the OLE|0
1701514|NCT01218659|5940014|P3|12-Month OLE|Lack of Efficacy|1
1701515|NCT01218659|5940015|P2|12-Month OLE|Lack of Efficacy|0
1701516|NCT01218659|5940016|P1|12-Month OLE|Lack of Efficacy|0
1701517|NCT01218659|5940014|P3|12-Month OLE|Pregnancy|1
1701518|NCT01218659|5940015|P2|12-Month OLE|Pregnancy|0
1701519|NCT01218659|5940016|P1|12-Month OLE|Pregnancy|0
1701520|NCT01218659|5940014|P3|12-Month OLE|Lost to Follow-up|1
1701521|NCT01218659|5940015|P2|12-Month OLE|Lost to Follow-up|0
1701522|NCT01218659|5940016|P1|12-Month OLE|Lost to Follow-up|0
1701523|NCT01218659|5940014|P3|12-Month OLE|Physician Decision|1
1701524|NCT01218659|5940015|P2|12-Month OLE|Physician Decision|0
1701525|NCT01218659|5940016|P1|12-Month OLE|Physician Decision|0
1701526|NCT01218659|5940014|P3|12-Month OLE|Withdrawal by Subject|2
1701527|NCT01218659|5940015|P2|12-Month OLE|Withdrawal by Subject|0
1701528|NCT01218659|5940016|P1|12-Month OLE|Withdrawal by Subject|0
1701529|NCT01218659|5940014|P3|18-Month Randomized Period|Did not receive study drug|0
1701530|NCT01218659|5940015|P2|18-Month Randomized Period|Did not receive study drug|3
1701531|NCT01218659|5940016|P1|18-Month Randomized Period|Did not receive study drug|0
1701532|NCT01218659|5940014|P3|18-Month Randomized Period|Withdrawal by Subject|0
1701533|NCT01218659|5940015|P2|18-Month Randomized Period|Withdrawal by Subject|3
1701534|NCT01218659|5940016|P1|18-Month Randomized Period|Withdrawal by Subject|2
1701535|NCT01218646|5940031|P4|Overall Study|Protocol Violation|1
1701536|NCT01218646|5940032|P3|Overall Study|Protocol Violation|1
1701537|NCT01218646|5940033|P2|Overall Study|Protocol Violation|0
1701538|NCT01218646|5940034|P1|Overall Study|Protocol Violation|0
1701539|NCT01218646|5940031|P4|Overall Study|Lost to Follow-up|0
1701540|NCT01218646|5940032|P3|Overall Study|Lost to Follow-up|0
1701541|NCT01218646|5940033|P2|Overall Study|Lost to Follow-up|0
1701542|NCT01218646|5940034|P1|Overall Study|Lost to Follow-up|1
1701543|NCT01218646|5940031|P4|Overall Study|Adverse Event|0
1701544|NCT01218646|5940032|P3|Overall Study|Adverse Event|1
1701545|NCT01218646|5940033|P2|Overall Study|Adverse Event|0
1701546|NCT01218646|5940034|P1|Overall Study|Adverse Event|0
1701547|NCT01218594|5940072|P1|Overall Study|Physician Decision|6
1701548|NCT01218594|5940072|P1|Overall Study|Adverse Event|2
1701549|NCT01218594|5940072|P1|Overall Study|Withdrawal by Subject|3
1701550|NCT01218594|5940072|P1|Overall Study|Death|1
1701551|NCT01218477|5940080|P4|Overall Study|Maximum clinical benefit|0
1701552|NCT01218477|5940081|P3|Overall Study|Maximum clinical benefit|0
1701553|NCT01218477|5940082|P2|Overall Study|Maximum clinical benefit|2
1701554|NCT01218477|5940083|P1|Overall Study|Maximum clinical benefit|0
1701555|NCT01218477|5940080|P4|Overall Study|Administrative reason by sponsor|0
1701556|NCT01218477|5940081|P3|Overall Study|Administrative reason by sponsor|1
1701557|NCT01218477|5940082|P2|Overall Study|Administrative reason by sponsor|0
1701558|NCT01218477|5940083|P1|Overall Study|Administrative reason by sponsor|0
1701559|NCT01218477|5940080|P4|Overall Study|Prepared for cell transplantation|0
1701560|NCT01218477|5940081|P3|Overall Study|Prepared for cell transplantation|1
1701561|NCT01218477|5940082|P2|Overall Study|Prepared for cell transplantation|1
1701562|NCT01218477|5940083|P1|Overall Study|Prepared for cell transplantation|0
1701563|NCT01218477|5940080|P4|Overall Study|Withdrawal by Subject|0
1701564|NCT01218477|5940081|P3|Overall Study|Withdrawal by Subject|1
1701565|NCT01218477|5940082|P2|Overall Study|Withdrawal by Subject|0
1701566|NCT01218477|5940083|P1|Overall Study|Withdrawal by Subject|0
1701567|NCT01218477|5940080|P4|Overall Study|No longer meets study criteria|0
1701568|NCT01218477|5940081|P3|Overall Study|No longer meets study criteria|0
1701569|NCT01218477|5940082|P2|Overall Study|No longer meets study criteria|0
1701570|NCT01218477|5940083|P1|Overall Study|No longer meets study criteria|1
1701571|NCT01218477|5940080|P4|Overall Study|Study drug toxicity|0
1701572|NCT01218477|5940081|P3|Overall Study|Study drug toxicity|5
1701573|NCT01218477|5940082|P2|Overall Study|Study drug toxicity|2
1701574|NCT01218477|5940083|P1|Overall Study|Study drug toxicity|0
1701575|NCT01218477|5940080|P4|Overall Study|Disease progression|2
1701576|NCT01218477|5940081|P3|Overall Study|Disease progression|6
1701577|NCT01218477|5940082|P2|Overall Study|Disease progression|3
1701578|NCT01218477|5940083|P1|Overall Study|Disease progression|2
1701579|NCT01218438|5940100|P1|Epoch 4|Withdrawal by Subject|2
1701580|NCT01218438|5940100|P1|Epoch 4|Physician Decision|1
1701581|NCT01218438|5940100|P1|Epoch 3|Adverse Event|1
1701582|NCT01218438|5940100|P1|Epoch 3|Withdrawal by Subject|3
1701583|NCT01218438|5940100|P1|Epoch 1|Adverse Event|1
1701584|NCT01218438|5940100|P1|Epoch 1|Physician Decision|2
1701585|NCT01218308|5940266|P2|Overall Study|Other|21
1701586|NCT01218308|5940267|P1|Overall Study|Other|14
1701587|NCT01218308|5940266|P2|Overall Study|Lost to Follow-up|31
1701588|NCT01218308|5940267|P1|Overall Study|Lost to Follow-up|27
1701589|NCT01218308|5940266|P2|Overall Study|Withdrawal by Subject|64
1701590|NCT01218308|5940267|P1|Overall Study|Withdrawal by Subject|61
1701591|NCT01218308|5940266|P2|Overall Study|Protocol Violation|2
1701592|NCT01218308|5940267|P1|Overall Study|Protocol Violation|0
1701593|NCT01218308|5940266|P2|Overall Study|Adverse Event|2
1701594|NCT01218308|5940267|P1|Overall Study|Adverse Event|1
1701595|NCT01218243|5940311|P2|Overall Study|Protocol Violation|10
1701596|NCT01218243|5940312|P1|Overall Study|Protocol Violation|5
1701597|NCT01218243|5940311|P2|Overall Study|Lost to Follow-up|3
1701598|NCT01218243|5940312|P1|Overall Study|Lost to Follow-up|3
1701599|NCT01218243|5940311|P2|Overall Study|Lack of Efficacy|1
1701600|NCT01218243|5940312|P1|Overall Study|Lack of Efficacy|1
1701601|NCT01218204|5940328|P4|Part B Pooled Treatment Arm|Protocol Violation|1
1701602|NCT01218204|5940329|P3|Part B Pooled Treatment Arm|Protocol Violation|0
1701603|NCT01218204|5940330|P2|Part B Pooled Treatment Arm|Protocol Violation|0
1701604|NCT01218204|5940331|P1|Part B Pooled Treatment Arm|Protocol Violation|0
1701605|NCT01218204|5940328|P4|Part B Pooled Treatment Arm|Adverse Event|2
1701606|NCT01218204|5940329|P3|Part B Pooled Treatment Arm|Adverse Event|0
1701607|NCT01218204|5940330|P2|Part B Pooled Treatment Arm|Adverse Event|0
1701608|NCT01218204|5940331|P1|Part B Pooled Treatment Arm|Adverse Event|0
1701609|NCT01218204|5940328|P4|Part B Run-in|Withdrawal by Subject|0
1701610|NCT01218204|5940329|P3|Part B Run-in|Withdrawal by Subject|3
1701611|NCT01218204|5940330|P2|Part B Run-in|Withdrawal by Subject|0
1701612|NCT01218204|5940331|P1|Part B Run-in|Withdrawal by Subject|0
1701613|NCT01218204|5940328|P4|Part B Run-in|Protocol Violation|0
1701614|NCT01218204|5940329|P3|Part B Run-in|Protocol Violation|2
1701615|NCT01218204|5940330|P2|Part B Run-in|Protocol Violation|0
1701616|NCT01218204|5940331|P1|Part B Run-in|Protocol Violation|0
1701617|NCT01218204|5940328|P4|Part B Run-in|Adverse Event|0
1701618|NCT01218204|5940329|P3|Part B Run-in|Adverse Event|1
1701619|NCT01218204|5940330|P2|Part B Run-in|Adverse Event|0
1701620|NCT01218204|5940331|P1|Part B Run-in|Adverse Event|0
1701621|NCT01218204|5940328|P4|Part B Washout|Did not meet continuation criteria|0
1701622|NCT01218204|5940329|P3|Part B Washout|Did not meet continuation criteria|0
1701623|NCT01218204|5940330|P2|Part B Washout|Did not meet continuation criteria|112
1701624|NCT01218204|5940331|P1|Part B Washout|Did not meet continuation criteria|0
1701625|NCT01218204|5940328|P4|Part B Washout|Reached defined stopping criteria|0
1701626|NCT01218204|5940329|P3|Part B Washout|Reached defined stopping criteria|0
1701627|NCT01218204|5940330|P2|Part B Washout|Reached defined stopping criteria|2
1701628|NCT01218204|5940331|P1|Part B Washout|Reached defined stopping criteria|0
1701629|NCT01218204|5940328|P4|Part B Washout|Withdrawal by Subject|0
1701630|NCT01218204|5940329|P3|Part B Washout|Withdrawal by Subject|0
1701631|NCT01218204|5940330|P2|Part B Washout|Withdrawal by Subject|14
1701632|NCT01218204|5940331|P1|Part B Washout|Withdrawal by Subject|0
1701633|NCT01218204|5940328|P4|Part B Washout|Physician Decision|0
1701634|NCT01218204|5940329|P3|Part B Washout|Physician Decision|0
1701635|NCT01218204|5940330|P2|Part B Washout|Physician Decision|14
1701636|NCT01218204|5940331|P1|Part B Washout|Physician Decision|0
1701637|NCT01218204|5940328|P4|Part B Washout|Lost to Follow-up|0
1701638|NCT01218204|5940329|P3|Part B Washout|Lost to Follow-up|0
1701639|NCT01218204|5940330|P2|Part B Washout|Lost to Follow-up|2
1701640|NCT01218204|5940331|P1|Part B Washout|Lost to Follow-up|0
1701641|NCT01218204|5940328|P4|Part B Washout|Adverse Event|0
1701642|NCT01218204|5940329|P3|Part B Washout|Adverse Event|0
1701643|NCT01218204|5940330|P2|Part B Washout|Adverse Event|1
1701644|NCT01218204|5940331|P1|Part B Washout|Adverse Event|0
1701645|NCT01218126|5940595|P4|Overall Study|Withdrawal by Subject|6
1701646|NCT01218126|5940596|P3|Overall Study|Withdrawal by Subject|4
1701647|NCT01218126|5940597|P2|Overall Study|Withdrawal by Subject|5
1701648|NCT01218126|5940598|P1|Overall Study|Withdrawal by Subject|2
1701649|NCT01218126|5940595|P4|Overall Study|Physician Decision|2
1701650|NCT01218126|5940596|P3|Overall Study|Physician Decision|4
1701651|NCT01218126|5940597|P2|Overall Study|Physician Decision|2
1701652|NCT01218126|5940598|P1|Overall Study|Physician Decision|1
1701653|NCT01218126|5940595|P4|Overall Study|Lost to Follow-up|2
1701654|NCT01218126|5940596|P3|Overall Study|Lost to Follow-up|0
1701655|NCT01218126|5940597|P2|Overall Study|Lost to Follow-up|0
1701656|NCT01218126|5940598|P1|Overall Study|Lost to Follow-up|0
1701657|NCT01218126|5940595|P4|Overall Study|Protocol-defined stopping criteria|0
1701658|NCT01218126|5940596|P3|Overall Study|Protocol-defined stopping criteria|0
1701659|NCT01218126|5940597|P2|Overall Study|Protocol-defined stopping criteria|1
1701660|NCT01218126|5940598|P1|Overall Study|Protocol-defined stopping criteria|1
1701661|NCT01218126|5940595|P4|Overall Study|Protocol Violation|3
1701662|NCT01218126|5940596|P3|Overall Study|Protocol Violation|2
1701663|NCT01218126|5940597|P2|Overall Study|Protocol Violation|2
1701664|NCT01218126|5940598|P1|Overall Study|Protocol Violation|5
1701665|NCT01218126|5940595|P4|Overall Study|Lack of Efficacy|6
1701666|NCT01218126|5940596|P3|Overall Study|Lack of Efficacy|2
1701667|NCT01218126|5940597|P2|Overall Study|Lack of Efficacy|2
1701668|NCT01218126|5940598|P1|Overall Study|Lack of Efficacy|7
1701669|NCT01218126|5940595|P4|Overall Study|Adverse Event|16
1701670|NCT01218126|5940596|P3|Overall Study|Adverse Event|12
1701671|NCT01218126|5940597|P2|Overall Study|Adverse Event|10
1701672|NCT01218126|5940598|P1|Overall Study|Adverse Event|8
1701673|NCT01218113|5940639|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
1701674|NCT01218113|5940640|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
1701675|NCT01218113|5940641|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
1701676|NCT01218113|5940639|P3|Overall Study|Lost to Follow-up|4
1701677|NCT01218113|5940640|P2|Overall Study|Lost to Follow-up|1
1701678|NCT01218113|5940641|P1|Overall Study|Lost to Follow-up|4
1701679|NCT01218113|5940639|P3|Overall Study|Withdrawal by Subject|1
1701680|NCT01218113|5940640|P2|Overall Study|Withdrawal by Subject|0
1701681|NCT01218113|5940641|P1|Overall Study|Withdrawal by Subject|1
1701682|NCT01218100|5940822|P4|Overall Study|Other Reason|4
1701683|NCT01218100|5940823|P3|Overall Study|Other Reason|6
1701684|NCT01218100|5940824|P2|Overall Study|Other Reason|2
1701685|NCT01218100|5940825|P1|Overall Study|Other Reason|2
1701686|NCT01218100|5940822|P4|Overall Study|Lost to Follow-up|1
1701687|NCT01218100|5940823|P3|Overall Study|Lost to Follow-up|2
1701688|NCT01218100|5940824|P2|Overall Study|Lost to Follow-up|8
1701689|NCT01218100|5940825|P1|Overall Study|Lost to Follow-up|3
1701690|NCT01218100|5940822|P4|Overall Study|Withdrawal by Subject|7
1701691|NCT01218100|5940823|P3|Overall Study|Withdrawal by Subject|6
1701692|NCT01218100|5940824|P2|Overall Study|Withdrawal by Subject|2
1701693|NCT01218100|5940825|P1|Overall Study|Withdrawal by Subject|5
1701694|NCT01218100|5940822|P4|Overall Study|Protocol Violation|1
1701695|NCT01218100|5940823|P3|Overall Study|Protocol Violation|1
1701696|NCT01218100|5940824|P2|Overall Study|Protocol Violation|0
1701697|NCT01218100|5940825|P1|Overall Study|Protocol Violation|0
1701698|NCT01218100|5940822|P4|Overall Study|Lack of Efficacy|12
1701699|NCT01218100|5940823|P3|Overall Study|Lack of Efficacy|5
1701700|NCT01218100|5940824|P2|Overall Study|Lack of Efficacy|6
1701701|NCT01218100|5940825|P1|Overall Study|Lack of Efficacy|9
1701702|NCT01218100|5940822|P4|Overall Study|Adverse Event|7
1701703|NCT01218100|5940823|P3|Overall Study|Adverse Event|6
1701704|NCT01218100|5940824|P2|Overall Study|Adverse Event|6
1701705|NCT01218100|5940825|P1|Overall Study|Adverse Event|4
1701706|NCT01218100|5940822|P4|Overall Study|Did not meet InclusionExclusion criteria|2
1701707|NCT01218100|5940823|P3|Overall Study|Did not meet InclusionExclusion criteria|1
1701708|NCT01218100|5940824|P2|Overall Study|Did not meet InclusionExclusion criteria|1
1701709|NCT01218100|5940825|P1|Overall Study|Did not meet InclusionExclusion criteria|1
1701710|NCT01218087|5940841|P2|Overall Study|Transferred|5
1701711|NCT01218087|5940842|P1|Overall Study|Transferred|8
1701712|NCT01218087|5940841|P2|Overall Study|Withdrawal by Subject|0
1701713|NCT01218087|5940842|P1|Overall Study|Withdrawal by Subject|5
1701714|NCT01218087|5940841|P2|Overall Study|Death|1
1701715|NCT01218087|5940842|P1|Overall Study|Death|2
1701716|NCT01218009|5940864|P2|Overall Study|Sponsor terminated study|163
1701717|NCT01218009|5940865|P1|Overall Study|Sponsor terminated study|161
1701718|NCT01218009|5940864|P2|Overall Study|Withdrawal by Subject|1
1701719|NCT01218009|5940865|P1|Overall Study|Withdrawal by Subject|3
1701720|NCT01218009|5940864|P2|Overall Study|Protocol Violation|1
1701721|NCT01218009|5940865|P1|Overall Study|Protocol Violation|2
1701722|NCT01217957|5940888|P5|Phase 2|Withdrawal by Patient|1
1701723|NCT01217957|5940889|P4|Phase 2|Withdrawal by Patient|0
1701724|NCT01217957|5940890|P3|Phase 2|Withdrawal by Patient|0
1701725|NCT01217957|5940891|P2|Phase 2|Withdrawal by Patient|0
1701726|NCT01217957|5940892|P1|Phase 2|Withdrawal by Patient|0
1701727|NCT01217957|5940888|P5|Phase 1|Withdrawal by Patient|0
1701728|NCT01217957|5940889|P4|Phase 1|Withdrawal by Patient|1
1701729|NCT01217957|5940890|P3|Phase 1|Withdrawal by Patient|1
1701730|NCT01217957|5940891|P2|Phase 1|Withdrawal by Patient|0
1701731|NCT01217957|5940892|P1|Phase 1|Withdrawal by Patient|1
1701732|NCT01217944|5940951|P3|Overall Study|Lack of Efficacy|0
1701733|NCT01217944|5940952|P2|Overall Study|Lack of Efficacy|0
1701734|NCT01217944|5940953|P1|Overall Study|Lack of Efficacy|1
1701735|NCT01217944|5940951|P3|Overall Study|Withdrawal by Subject|0
1701736|NCT01217944|5940952|P2|Overall Study|Withdrawal by Subject|2
1701737|NCT01217944|5940953|P1|Overall Study|Withdrawal by Subject|1
1701738|NCT01217944|5940951|P3|Overall Study|Lost to Follow-up|0
1701739|NCT01217944|5940952|P2|Overall Study|Lost to Follow-up|1
1701740|NCT01217944|5940953|P1|Overall Study|Lost to Follow-up|3
1701741|NCT01217944|5940951|P3|Overall Study|Protocol Violation|0
1701742|NCT01217944|5940952|P2|Overall Study|Protocol Violation|1
1701743|NCT01217944|5940953|P1|Overall Study|Protocol Violation|1
1701744|NCT01217892|5940996|P4|Overall Study|Poor/Non-Compliance|0
1701745|NCT01217892|5940997|P3|Overall Study|Poor/Non-Compliance|1
1701746|NCT01217892|5940998|P2|Overall Study|Poor/Non-Compliance|0
1701747|NCT01217892|5940999|P1|Overall Study|Poor/Non-Compliance|0
1701748|NCT01217892|5940996|P4|Overall Study|Incorrect enrollment|0
1701749|NCT01217892|5940997|P3|Overall Study|Incorrect enrollment|1
1701750|NCT01217892|5940998|P2|Overall Study|Incorrect enrollment|1
1701751|NCT01217892|5940999|P1|Overall Study|Incorrect enrollment|0
1701752|NCT01217892|5940996|P4|Overall Study|Subject no longer meets study criteria|8
1701753|NCT01217892|5940997|P3|Overall Study|Subject no longer meets study criteria|4
1701754|NCT01217892|5940998|P2|Overall Study|Subject no longer meets study criteria|2
1701755|NCT01217892|5940999|P1|Overall Study|Subject no longer meets study criteria|5
1701756|NCT01217892|5940996|P4|Overall Study|Lab value|0
1701757|NCT01217892|5940997|P3|Overall Study|Lab value|1
1701758|NCT01217892|5940998|P2|Overall Study|Lab value|0
1701759|NCT01217892|5940999|P1|Overall Study|Lab value|1
1701760|NCT01217892|5940996|P4|Overall Study|Withdrawal by Subject|0
1701761|NCT01217892|5940997|P3|Overall Study|Withdrawal by Subject|1
1701762|NCT01217892|5940998|P2|Overall Study|Withdrawal by Subject|2
1701763|NCT01217892|5940999|P1|Overall Study|Withdrawal by Subject|0
1701764|NCT01217892|5940996|P4|Overall Study|Adverse Event|0
1701765|NCT01217892|5940997|P3|Overall Study|Adverse Event|1
1701766|NCT01217892|5940998|P2|Overall Study|Adverse Event|1
1701767|NCT01217892|5940999|P1|Overall Study|Adverse Event|1
1701768|NCT01217814|5941062|P3|Overall Study|Lack of Efficacy|1
1701769|NCT01217814|5941063|P2|Overall Study|Lack of Efficacy|0
1701770|NCT01217814|5941064|P1|Overall Study|Lack of Efficacy|0
1701771|NCT01217814|5941062|P3|Overall Study|Adverse Event|0
1701772|NCT01217814|5941063|P2|Overall Study|Adverse Event|1
1701773|NCT01217814|5941064|P1|Overall Study|Adverse Event|1
1701774|NCT01217801|5941090|P2|Period 1|Withdrawal by Subject|1
1701775|NCT01217801|5941091|P1|Period 1|Withdrawal by Subject|0
1701776|NCT01217801|5941090|P2|Period 1|Protocol Violation|1
1701777|NCT01217801|5941091|P1|Period 1|Protocol Violation|1
1701778|NCT01217606|5941120|P2|9-Month Masked Extension|Lack of Efficacy|0
1701779|NCT01217606|5941121|P1|9-Month Masked Extension|Lack of Efficacy|2
1701780|NCT01217606|5941120|P2|9-Month Masked Extension|Pregnancy|0
1701781|NCT01217606|5941121|P1|9-Month Masked Extension|Pregnancy|1
1701782|NCT01217606|5941120|P2|9-Month Masked Extension|Lost to Follow-up|0
1701783|NCT01217606|5941121|P1|9-Month Masked Extension|Lost to Follow-up|1
1701784|NCT01217606|5941120|P2|9-Month Masked Extension|Personal Reasons|1
1701785|NCT01217606|5941121|P1|9-Month Masked Extension|Personal Reasons|2
1701786|NCT01217606|5941120|P2|9-Month Masked Extension|Other Reasons|4
1701787|NCT01217606|5941121|P1|9-Month Masked Extension|Other Reasons|4
1701788|NCT01217606|5941120|P2|9-Month Masked Extension|Adverse Event|6
1701789|NCT01217606|5941121|P1|9-Month Masked Extension|Adverse Event|3
1701790|NCT01217606|5941120|P2|Initial Treatment Phase|Adverse Event|6
1701791|NCT01217606|5941121|P1|Initial Treatment Phase|Adverse Event|10
1701792|NCT01217606|5941120|P2|Initial Treatment Phase|Lack of Efficacy|0
1701793|NCT01217606|5941121|P1|Initial Treatment Phase|Lack of Efficacy|1
1701794|NCT01217606|5941120|P2|Initial Treatment Phase|Personal Reasons|2
1701795|NCT01217606|5941121|P1|Initial Treatment Phase|Personal Reasons|0
1701796|NCT01217606|5941120|P2|Initial Treatment Phase|Protocol Violation|2
1701797|NCT01217606|5941121|P1|Initial Treatment Phase|Protocol Violation|3
1701798|NCT01217606|5941120|P2|Initial Treatment Phase|Other Reasons|2
1701799|NCT01217606|5941121|P1|Initial Treatment Phase|Other Reasons|0
1701800|NCT01217476|5941152|P2|Overall Study|Other|0
1701801|NCT01217476|5941153|P1|Overall Study|Other|2
1701802|NCT01217476|5941152|P2|Overall Study|Protocol Deviation|0
1701803|NCT01217476|5941153|P1|Overall Study|Protocol Deviation|1
1701804|NCT01217476|5941152|P2|Overall Study|Surgery on the Target Limb|2
1701805|NCT01217476|5941153|P1|Overall Study|Surgery on the Target Limb|0
1701806|NCT01217476|5941152|P2|Overall Study|Withdrawal by Subject|3
1701807|NCT01217476|5941153|P1|Overall Study|Withdrawal by Subject|3
1701808|NCT01217476|5941152|P2|Overall Study|Physician Decision|1
1701809|NCT01217476|5941153|P1|Overall Study|Physician Decision|0
1701810|NCT01217476|5941152|P2|Overall Study|Adverse Event|1
1701811|NCT01217476|5941153|P1|Overall Study|Adverse Event|6
1701812|NCT01217463|5941163|P2|Overall Study|Other|1
1701813|NCT01217463|5941164|P1|Overall Study|Other|1
1701814|NCT01217463|5941163|P2|Overall Study|Patient Non-compliant|0
1701815|NCT01217463|5941164|P1|Overall Study|Patient Non-compliant|1
1701816|NCT01217463|5941163|P2|Overall Study|Surgery on the Target Limb|1
1701817|NCT01217463|5941164|P1|Overall Study|Surgery on the Target Limb|0
1701818|NCT01217463|5941163|P2|Overall Study|Withdrawal by Subject|0
1701819|NCT01217463|5941164|P1|Overall Study|Withdrawal by Subject|3
1701820|NCT01217463|5941163|P2|Overall Study|Physician Decision|1
1701821|NCT01217463|5941164|P1|Overall Study|Physician Decision|0
1701822|NCT01217463|5941163|P2|Overall Study|Adverse Event|5
1701823|NCT01217463|5941164|P1|Overall Study|Adverse Event|8
1701824|NCT01217437|5941174|P2|Overall Study|Ineligible|1
1701825|NCT01217437|5941175|P1|Overall Study|Ineligible|1
1701826|NCT01217437|5941174|P2|Overall Study|Withdrawal by Subject|2
1701827|NCT01217437|5941175|P1|Overall Study|Withdrawal by Subject|0
1701828|NCT01217437|5941174|P2|Overall Study|Physician Decision|5
1701829|NCT01217437|5941175|P1|Overall Study|Physician Decision|8
1701830|NCT01217437|5941174|P2|Overall Study|Lack of Efficacy|25
1701831|NCT01217437|5941175|P1|Overall Study|Lack of Efficacy|29
1701832|NCT01217437|5941174|P2|Overall Study|Death|0
1701833|NCT01217437|5941175|P1|Overall Study|Death|5
1701834|NCT01217437|5941174|P2|Overall Study|Adverse Event|8
1701835|NCT01217437|5941175|P1|Overall Study|Adverse Event|0
1701836|NCT01217385|5941196|P1|Overall Study|Normal Breast TOI not available|10
1701837|NCT01217385|5941196|P1|Overall Study|Central Path not Available|1
1701838|NCT01217385|5941196|P1|Overall Study|DOSI not performed/not eval|12
1701839|NCT01217385|5941196|P1|Overall Study|Withdrawal by Subject|3
1701840|NCT01217307|5941208|P2|Overall Study|Withdrawal by Subject|1
1701841|NCT01217307|5941209|P1|Overall Study|Withdrawal by Subject|0
1701842|NCT01217112|5941224|P5|Overall Study|Physician Decision|1
1701843|NCT01217112|5941225|P4|Overall Study|Physician Decision|0
1701844|NCT01217112|5941226|P3|Overall Study|Physician Decision|0
1701845|NCT01217112|5941227|P2|Overall Study|Physician Decision|0
1701846|NCT01217112|5941228|P1|Overall Study|Physician Decision|0
1701847|NCT01217112|5941224|P5|Overall Study|Withdrawal by Subject|0
1701848|NCT01217112|5941225|P4|Overall Study|Withdrawal by Subject|0
1701849|NCT01217112|5941226|P3|Overall Study|Withdrawal by Subject|1
1701850|NCT01217112|5941227|P2|Overall Study|Withdrawal by Subject|0
1701851|NCT01217112|5941228|P1|Overall Study|Withdrawal by Subject|0
1701852|NCT01217112|5941224|P5|Overall Study|Adverse Event|0
1701853|NCT01217112|5941225|P4|Overall Study|Adverse Event|2
1701854|NCT01217112|5941226|P3|Overall Study|Adverse Event|0
1701855|NCT01217112|5941227|P2|Overall Study|Adverse Event|2
1701856|NCT01217112|5941228|P1|Overall Study|Adverse Event|0
1701857|NCT01217073|5941461|P8|Extension Period|Withdrawal by Subject|8
1701858|NCT01217073|5941462|P7|Extension Period|Withdrawal by Subject|30
1701859|NCT01217073|5941463|P6|Extension Period|Withdrawal by Subject|0
1701860|NCT01217073|5941464|P5|Extension Period|Withdrawal by Subject|0
1701861|NCT01217073|5941465|P4|Extension Period|Withdrawal by Subject|0
1701862|NCT01217073|5941466|P3|Extension Period|Withdrawal by Subject|0
1701863|NCT01217073|5941467|P2|Extension Period|Withdrawal by Subject|0
1701864|NCT01217073|5941468|P1|Extension Period|Withdrawal by Subject|0
1701865|NCT01217073|5941461|P8|Extension Period|Site discontinued study participation|2
1701866|NCT01217073|5941462|P7|Extension Period|Site discontinued study participation|7
1701867|NCT01217073|5941463|P6|Extension Period|Site discontinued study participation|0
1701868|NCT01217073|5941464|P5|Extension Period|Site discontinued study participation|0
1701869|NCT01217073|5941465|P4|Extension Period|Site discontinued study participation|0
1701870|NCT01217073|5941466|P3|Extension Period|Site discontinued study participation|0
1701871|NCT01217073|5941467|P2|Extension Period|Site discontinued study participation|0
1701872|NCT01217073|5941468|P1|Extension Period|Site discontinued study participation|0
1701873|NCT01217073|5941461|P8|Extension Period|Protocol Violation|1
1701874|NCT01217073|5941462|P7|Extension Period|Protocol Violation|2
1701875|NCT01217073|5941463|P6|Extension Period|Protocol Violation|0
1701876|NCT01217073|5941464|P5|Extension Period|Protocol Violation|0
1701877|NCT01217073|5941465|P4|Extension Period|Protocol Violation|0
1701878|NCT01217073|5941466|P3|Extension Period|Protocol Violation|0
1701879|NCT01217073|5941467|P2|Extension Period|Protocol Violation|0
1701880|NCT01217073|5941468|P1|Extension Period|Protocol Violation|0
1701881|NCT01217073|5941461|P8|Extension Period|Physician Decision|1
1701882|NCT01217073|5941462|P7|Extension Period|Physician Decision|4
1701883|NCT01217073|5941463|P6|Extension Period|Physician Decision|0
1701884|NCT01217073|5941464|P5|Extension Period|Physician Decision|0
1701885|NCT01217073|5941465|P4|Extension Period|Physician Decision|0
1701886|NCT01217073|5941466|P3|Extension Period|Physician Decision|0
1701887|NCT01217073|5941467|P2|Extension Period|Physician Decision|0
1701888|NCT01217073|5941468|P1|Extension Period|Physician Decision|0
1701889|NCT01217073|5941461|P8|Extension Period|Non-compliance with study drug|1
1701890|NCT01217073|5941462|P7|Extension Period|Non-compliance with study drug|0
1701891|NCT01217073|5941463|P6|Extension Period|Non-compliance with study drug|0
1701892|NCT01217073|5941464|P5|Extension Period|Non-compliance with study drug|0
1701893|NCT01217073|5941465|P4|Extension Period|Non-compliance with study drug|0
1701894|NCT01217073|5941466|P3|Extension Period|Non-compliance with study drug|0
1701895|NCT01217073|5941467|P2|Extension Period|Non-compliance with study drug|0
1701896|NCT01217073|5941468|P1|Extension Period|Non-compliance with study drug|0
1701897|NCT01217073|5941461|P8|Extension Period|Lost to Follow-up|1
1701898|NCT01217073|5941462|P7|Extension Period|Lost to Follow-up|9
1701899|NCT01217073|5941463|P6|Extension Period|Lost to Follow-up|0
1701900|NCT01217073|5941464|P5|Extension Period|Lost to Follow-up|0
1701901|NCT01217073|5941465|P4|Extension Period|Lost to Follow-up|0
1701902|NCT01217073|5941466|P3|Extension Period|Lost to Follow-up|0
1701903|NCT01217073|5941467|P2|Extension Period|Lost to Follow-up|0
1701904|NCT01217073|5941468|P1|Extension Period|Lost to Follow-up|0
1701905|NCT01217073|5941461|P8|Extension Period|Lack of Efficacy|0
1701906|NCT01217073|5941462|P7|Extension Period|Lack of Efficacy|3
1701907|NCT01217073|5941463|P6|Extension Period|Lack of Efficacy|0
1701908|NCT01217073|5941464|P5|Extension Period|Lack of Efficacy|0
1701909|NCT01217073|5941465|P4|Extension Period|Lack of Efficacy|0
1701910|NCT01217073|5941466|P3|Extension Period|Lack of Efficacy|0
1701911|NCT01217073|5941467|P2|Extension Period|Lack of Efficacy|0
1701912|NCT01217073|5941468|P1|Extension Period|Lack of Efficacy|0
1701913|NCT01217073|5941461|P8|Extension Period|Excluded medication|0
1701914|NCT01217073|5941462|P7|Extension Period|Excluded medication|2
1701915|NCT01217073|5941463|P6|Extension Period|Excluded medication|0
1701916|NCT01217073|5941464|P5|Extension Period|Excluded medication|0
1701917|NCT01217073|5941465|P4|Extension Period|Excluded medication|0
1701918|NCT01217073|5941466|P3|Extension Period|Excluded medication|0
1701919|NCT01217073|5941467|P2|Extension Period|Excluded medication|0
1701920|NCT01217073|5941468|P1|Extension Period|Excluded medication|0
1701921|NCT01217073|5941461|P8|Extension Period|Death|0
1701922|NCT01217073|5941462|P7|Extension Period|Death|1
1701923|NCT01217073|5941463|P6|Extension Period|Death|0
1701924|NCT01217073|5941464|P5|Extension Period|Death|0
1701925|NCT01217073|5941465|P4|Extension Period|Death|0
1701926|NCT01217073|5941466|P3|Extension Period|Death|0
1701927|NCT01217073|5941467|P2|Extension Period|Death|0
1701928|NCT01217073|5941468|P1|Extension Period|Death|0
1701929|NCT01217073|5941461|P8|Extension Period|Creatinine/eGFR|1
1701930|NCT01217073|5941462|P7|Extension Period|Creatinine/eGFR|11
1701931|NCT01217073|5941463|P6|Extension Period|Creatinine/eGFR|0
1701932|NCT01217073|5941464|P5|Extension Period|Creatinine/eGFR|0
1701933|NCT01217073|5941465|P4|Extension Period|Creatinine/eGFR|0
1701934|NCT01217073|5941466|P3|Extension Period|Creatinine/eGFR|0
1701935|NCT01217073|5941467|P2|Extension Period|Creatinine/eGFR|0
1701936|NCT01217073|5941468|P1|Extension Period|Creatinine/eGFR|0
1701937|NCT01217073|5941461|P8|Extension Period|Contraindication to study medication|0
1701938|NCT01217073|5941462|P7|Extension Period|Contraindication to study medication|1
1701939|NCT01217073|5941463|P6|Extension Period|Contraindication to study medication|0
1701940|NCT01217073|5941464|P5|Extension Period|Contraindication to study medication|0
1701941|NCT01217073|5941465|P4|Extension Period|Contraindication to study medication|0
1701942|NCT01217073|5941466|P3|Extension Period|Contraindication to study medication|0
1701943|NCT01217073|5941467|P2|Extension Period|Contraindication to study medication|0
1701944|NCT01217073|5941468|P1|Extension Period|Contraindication to study medication|0
1701945|NCT01217073|5941461|P8|Extension Period|ALT/AST|0
1701946|NCT01217073|5941462|P7|Extension Period|ALT/AST|2
1701947|NCT01217073|5941463|P6|Extension Period|ALT/AST|0
1701948|NCT01217073|5941464|P5|Extension Period|ALT/AST|0
1701949|NCT01217073|5941465|P4|Extension Period|ALT/AST|0
1701950|NCT01217073|5941466|P3|Extension Period|ALT/AST|0
1701951|NCT01217073|5941467|P2|Extension Period|ALT/AST|0
1701952|NCT01217073|5941468|P1|Extension Period|ALT/AST|0
1701953|NCT01217073|5941461|P8|Extension Period|Adverse Event|5
1701954|NCT01217073|5941462|P7|Extension Period|Adverse Event|19
1701955|NCT01217073|5941463|P6|Extension Period|Adverse Event|0
1701956|NCT01217073|5941464|P5|Extension Period|Adverse Event|0
1701957|NCT01217073|5941465|P4|Extension Period|Adverse Event|0
1701958|NCT01217073|5941466|P3|Extension Period|Adverse Event|0
1701959|NCT01217073|5941467|P2|Extension Period|Adverse Event|0
1701960|NCT01217073|5941468|P1|Extension Period|Adverse Event|0
1701961|NCT01217073|5941461|P8|Base Period|Withdrawal by Subject|0
1701962|NCT01217073|5941462|P7|Base Period|Withdrawal by Subject|0
1701963|NCT01217073|5941463|P6|Base Period|Withdrawal by Subject|5
1701964|NCT01217073|5941464|P5|Base Period|Withdrawal by Subject|5
1701965|NCT01217073|5941465|P4|Base Period|Withdrawal by Subject|1
1701966|NCT01217073|5941466|P3|Base Period|Withdrawal by Subject|5
1701967|NCT01217073|5941467|P2|Base Period|Withdrawal by Subject|5
1701968|NCT01217073|5941468|P1|Base Period|Withdrawal by Subject|4
1701969|NCT01217073|5941461|P8|Base Period|Protocol Violation|0
1701970|NCT01217073|5941462|P7|Base Period|Protocol Violation|0
1701971|NCT01217073|5941463|P6|Base Period|Protocol Violation|2
1701972|NCT01217073|5941464|P5|Base Period|Protocol Violation|1
1701973|NCT01217073|5941465|P4|Base Period|Protocol Violation|0
1701974|NCT01217073|5941466|P3|Base Period|Protocol Violation|0
1701975|NCT01217073|5941467|P2|Base Period|Protocol Violation|0
1701976|NCT01217073|5941468|P1|Base Period|Protocol Violation|1
1701977|NCT01217073|5941461|P8|Base Period|Physician Decision|0
1701978|NCT01217073|5941462|P7|Base Period|Physician Decision|0
1701979|NCT01217073|5941463|P6|Base Period|Physician Decision|0
1701980|NCT01217073|5941464|P5|Base Period|Physician Decision|1
1701981|NCT01217073|5941465|P4|Base Period|Physician Decision|0
1701982|NCT01217073|5941466|P3|Base Period|Physician Decision|0
1701983|NCT01217073|5941467|P2|Base Period|Physician Decision|0
1701984|NCT01217073|5941468|P1|Base Period|Physician Decision|0
1701985|NCT01217073|5941461|P8|Base Period|Lost to Follow-up|0
1701986|NCT01217073|5941462|P7|Base Period|Lost to Follow-up|0
1701987|NCT01217073|5941463|P6|Base Period|Lost to Follow-up|0
1701988|NCT01217073|5941464|P5|Base Period|Lost to Follow-up|3
1701989|NCT01217073|5941465|P4|Base Period|Lost to Follow-up|1
1701990|NCT01217073|5941466|P3|Base Period|Lost to Follow-up|1
1701991|NCT01217073|5941467|P2|Base Period|Lost to Follow-up|0
1701992|NCT01217073|5941468|P1|Base Period|Lost to Follow-up|0
1701993|NCT01217073|5941461|P8|Base Period|Lack of Efficacy|0
1701994|NCT01217073|5941462|P7|Base Period|Lack of Efficacy|0
1701995|NCT01217073|5941463|P6|Base Period|Lack of Efficacy|1
1701996|NCT01217073|5941464|P5|Base Period|Lack of Efficacy|0
1701997|NCT01217073|5941465|P4|Base Period|Lack of Efficacy|0
1701998|NCT01217073|5941466|P3|Base Period|Lack of Efficacy|0
1701999|NCT01217073|5941467|P2|Base Period|Lack of Efficacy|0
1702000|NCT01217073|5941468|P1|Base Period|Lack of Efficacy|0
1702001|NCT01217073|5941461|P8|Base Period|Excluded medication|0
1702002|NCT01217073|5941462|P7|Base Period|Excluded medication|0
1702003|NCT01217073|5941463|P6|Base Period|Excluded medication|0
1702004|NCT01217073|5941464|P5|Base Period|Excluded medication|1
1702005|NCT01217073|5941465|P4|Base Period|Excluded medication|0
1702006|NCT01217073|5941466|P3|Base Period|Excluded medication|0
1702007|NCT01217073|5941467|P2|Base Period|Excluded medication|0
1702008|NCT01217073|5941468|P1|Base Period|Excluded medication|0
1702009|NCT01217073|5941461|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
1702010|NCT01217073|5941462|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
1702011|NCT01217073|5941463|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
1702012|NCT01217073|5941464|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
1702013|NCT01217073|5941465|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
1702014|NCT01217073|5941466|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
1702015|NCT01217073|5941467|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
1702016|NCT01217073|5941468|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
1702017|NCT01217073|5941461|P8|Base Period|Adverse Event|0
1702018|NCT01217073|5941462|P7|Base Period|Adverse Event|0
1702019|NCT01217073|5941463|P6|Base Period|Adverse Event|1
1702020|NCT01217073|5941464|P5|Base Period|Adverse Event|4
1702021|NCT01217073|5941465|P4|Base Period|Adverse Event|0
1702022|NCT01217073|5941466|P3|Base Period|Adverse Event|1
1702023|NCT01217073|5941467|P2|Base Period|Adverse Event|0
1702024|NCT01217073|5941468|P1|Base Period|Adverse Event|1
1702025|NCT01216332|5941659|P2|Overall Study|Withdrawal by Subject|0
1702026|NCT01216332|5941660|P1|Overall Study|Withdrawal by Subject|4
1702027|NCT01216319|5941678|P1|Overall Study|Unanticipated chemo for breast cancer|2
1702028|NCT01216319|5941678|P1|Overall Study|Lost to Follow-up|2
1702029|NCT01216176|5941695|P3|Overall Study|Physician Decision|1
1702030|NCT01216176|5941696|P2|Overall Study|Physician Decision|0
1702031|NCT01216176|5941697|P1|Overall Study|Physician Decision|0
1702032|NCT01216176|5941695|P3|Overall Study|Adverse Event|0
1702033|NCT01216176|5941696|P2|Overall Study|Adverse Event|8
1702034|NCT01216176|5941697|P1|Overall Study|Adverse Event|0
1702035|NCT01216163|5941720|P3|Overall Study|Withdrawal by Subject|0
1702036|NCT01216163|5941721|P2|Overall Study|Withdrawal by Subject|1
1702037|NCT01216163|5941722|P1|Overall Study|Withdrawal by Subject|1
1702038|NCT01216072|5941774|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
1702039|NCT01216072|5941775|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
1702040|NCT01216072|5941774|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
1702041|NCT01216072|5941775|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
1702042|NCT01216072|5941774|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
1702043|NCT01216072|5941775|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
1702044|NCT01216072|5941774|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
1702045|NCT01216072|5941775|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
1702046|NCT01216072|5941774|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
1702047|NCT01216072|5941775|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
1702048|NCT01216072|5941774|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
1702049|NCT01216072|5941775|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
1702050|NCT01216072|5941774|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
1702051|NCT01216072|5941775|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
1702052|NCT01216072|5941774|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
1702053|NCT01216072|5941775|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
1702054|NCT01216072|5941774|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
1702055|NCT01216072|5941775|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
1702056|NCT01216072|5941774|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
1702057|NCT01216072|5941775|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
1702058|NCT01215981|5941803|P2|Overall Study|Withdrawal by Subject|0
1702059|NCT01215981|5941804|P1|Overall Study|Withdrawal by Subject|1
1702060|NCT01215981|5941803|P2|Overall Study|Protocol Violation|0
1702061|NCT01215981|5941804|P1|Overall Study|Protocol Violation|1
1702062|NCT01215981|5941803|P2|Overall Study|Physician Decision|1
1702063|NCT01215981|5941804|P1|Overall Study|Physician Decision|0
1702064|NCT01215968|5941814|P2|Overall Study|Not received study drug|1
1702065|NCT01215968|5941815|P1|Overall Study|Not received study drug|0
1702066|NCT01215968|5941814|P2|Overall Study|Protocol Violation|4
1702067|NCT01215968|5941815|P1|Overall Study|Protocol Violation|2
1702068|NCT01215968|5941814|P2|Overall Study|Adverse Event|2
1702069|NCT01215968|5941815|P1|Overall Study|Adverse Event|0
1702070|NCT01215955|5941835|P4|Overall Study|Quality Issues|2
1702071|NCT01215955|5941836|P3|Overall Study|Quality Issues|3
1702072|NCT01215955|5941837|P2|Overall Study|Quality Issues|0
1702073|NCT01215955|5941838|P1|Overall Study|Quality Issues|0
1702074|NCT01215955|5941835|P4|Overall Study|Withdrawal by Subject|9
1702075|NCT01215955|5941836|P3|Overall Study|Withdrawal by Subject|13
1702076|NCT01215955|5941837|P2|Overall Study|Withdrawal by Subject|15
1702077|NCT01215955|5941838|P1|Overall Study|Withdrawal by Subject|14
1702078|NCT01215955|5941835|P4|Overall Study|Sponsor Decision|1
1702079|NCT01215955|5941836|P3|Overall Study|Sponsor Decision|0
1702080|NCT01215955|5941837|P2|Overall Study|Sponsor Decision|2
1702081|NCT01215955|5941838|P1|Overall Study|Sponsor Decision|1
1702082|NCT01215955|5941835|P4|Overall Study|Protocol Violation|8
1702083|NCT01215955|5941836|P3|Overall Study|Protocol Violation|8
1702084|NCT01215955|5941837|P2|Overall Study|Protocol Violation|13
1702085|NCT01215955|5941838|P1|Overall Study|Protocol Violation|17
1702086|NCT01215955|5941835|P4|Overall Study|Physician Decision|11
1702087|NCT01215955|5941836|P3|Overall Study|Physician Decision|8
1702088|NCT01215955|5941837|P2|Overall Study|Physician Decision|10
1702089|NCT01215955|5941838|P1|Overall Study|Physician Decision|4
1702090|NCT01215955|5941835|P4|Overall Study|Lost to Follow-up|9
1702091|NCT01215955|5941836|P3|Overall Study|Lost to Follow-up|8
1702092|NCT01215955|5941837|P2|Overall Study|Lost to Follow-up|4
1702093|NCT01215955|5941838|P1|Overall Study|Lost to Follow-up|4
1702094|NCT01215955|5941835|P4|Overall Study|Lack of Efficacy|0
1702095|NCT01215955|5941836|P3|Overall Study|Lack of Efficacy|1
1702096|NCT01215955|5941837|P2|Overall Study|Lack of Efficacy|2
1702097|NCT01215955|5941838|P1|Overall Study|Lack of Efficacy|1
1702098|NCT01215955|5941835|P4|Overall Study|Entry Criteria Not Met|7
1702099|NCT01215955|5941836|P3|Overall Study|Entry Criteria Not Met|4
1702100|NCT01215955|5941837|P2|Overall Study|Entry Criteria Not Met|3
1702101|NCT01215955|5941838|P1|Overall Study|Entry Criteria Not Met|1
1702102|NCT01215955|5941835|P4|Overall Study|Death|3
1702103|NCT01215955|5941836|P3|Overall Study|Death|1
1702104|NCT01215955|5941837|P2|Overall Study|Death|0
1702105|NCT01215955|5941838|P1|Overall Study|Death|2
1702106|NCT01215955|5941835|P4|Overall Study|Adverse Event|3
1702107|NCT01215955|5941836|P3|Overall Study|Adverse Event|2
1702108|NCT01215955|5941837|P2|Overall Study|Adverse Event|4
1702109|NCT01215955|5941838|P1|Overall Study|Adverse Event|1
1702110|NCT01215942|5941906|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
1702111|NCT01215942|5941907|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
1702112|NCT01215942|5941906|P2|Post-Treatment Follow-Up Period|Physician Decision|2
1702113|NCT01215942|5941907|P1|Post-Treatment Follow-Up Period|Physician Decision|1
1702114|NCT01215942|5941906|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
1702115|NCT01215942|5941907|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
1702116|NCT01215942|5941906|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
1702117|NCT01215942|5941907|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
1702118|NCT01215942|5941906|P2|Post-Treatment Follow-Up Period|Death|1
1702119|NCT01215942|5941907|P1|Post-Treatment Follow-Up Period|Death|0
1702120|NCT01215942|5941906|P2|Treatment Period|Sponsor Decision|530
1702121|NCT01215942|5941907|P1|Treatment Period|Sponsor Decision|349
1702122|NCT01215942|5941906|P2|Treatment Period|Protocol Violation|1
1702123|NCT01215942|5941907|P1|Treatment Period|Protocol Violation|0
1702124|NCT01215942|5941906|P2|Treatment Period|Physician Decision|5
1702125|NCT01215942|5941907|P1|Treatment Period|Physician Decision|5
1702126|NCT01215942|5941906|P2|Treatment Period|Withdrawal by Subject|40
1702127|NCT01215942|5941907|P1|Treatment Period|Withdrawal by Subject|17
1702128|NCT01215942|5941906|P2|Treatment Period|Lost to Follow-up|4
1702129|NCT01215942|5941907|P1|Treatment Period|Lost to Follow-up|3
1702130|NCT01215942|5941906|P2|Treatment Period|Lack of Efficacy|62
1702131|NCT01215942|5941907|P1|Treatment Period|Lack of Efficacy|23
1702132|NCT01215942|5941906|P2|Treatment Period|Death|4
1702133|NCT01215942|5941907|P1|Treatment Period|Death|2
1702134|NCT01215942|5941906|P2|Treatment Period|Adverse Event|26
1702135|NCT01215942|5941907|P1|Treatment Period|Adverse Event|15
1702136|NCT01215916|5942040|P9|Overall Study|Physician Decision|0
1702137|NCT01215916|5942041|P8|Overall Study|Physician Decision|0
1702138|NCT01215916|5942042|P7|Overall Study|Physician Decision|0
1702139|NCT01215916|5942043|P6|Overall Study|Physician Decision|0
1702140|NCT01215916|5942044|P5|Overall Study|Physician Decision|0
1702141|NCT01215916|5942045|P4|Overall Study|Physician Decision|1
1702142|NCT01215916|5942046|P3|Overall Study|Physician Decision|1
1702143|NCT01215916|5942047|P2|Overall Study|Physician Decision|0
1702144|NCT01215916|5942048|P1|Overall Study|Physician Decision|0
1702145|NCT01215916|5942040|P9|Overall Study|Death|1
1702146|NCT01215916|5942041|P8|Overall Study|Death|0
1702147|NCT01215916|5942042|P7|Overall Study|Death|0
1702148|NCT01215916|5942043|P6|Overall Study|Death|0
1702149|NCT01215916|5942044|P5|Overall Study|Death|1
1702150|NCT01215916|5942045|P4|Overall Study|Death|0
1702151|NCT01215916|5942046|P3|Overall Study|Death|0
1702152|NCT01215916|5942047|P2|Overall Study|Death|1
1702153|NCT01215916|5942048|P1|Overall Study|Death|0
1702154|NCT01215916|5942040|P9|Overall Study|Withdrawal by Subject|0
1702155|NCT01215916|5942041|P8|Overall Study|Withdrawal by Subject|0
1702156|NCT01215916|5942042|P7|Overall Study|Withdrawal by Subject|1
1702157|NCT01215916|5942043|P6|Overall Study|Withdrawal by Subject|0
1702158|NCT01215916|5942044|P5|Overall Study|Withdrawal by Subject|0
1702159|NCT01215916|5942045|P4|Overall Study|Withdrawal by Subject|2
1702160|NCT01215916|5942046|P3|Overall Study|Withdrawal by Subject|1
1702161|NCT01215916|5942047|P2|Overall Study|Withdrawal by Subject|1
1702162|NCT01215916|5942048|P1|Overall Study|Withdrawal by Subject|0
1702163|NCT01215916|5942040|P9|Overall Study|Adverse Event|0
1702164|NCT01215916|5942041|P8|Overall Study|Adverse Event|0
1702165|NCT01215916|5942042|P7|Overall Study|Adverse Event|3
1702166|NCT01215916|5942043|P6|Overall Study|Adverse Event|0
1702167|NCT01215916|5942044|P5|Overall Study|Adverse Event|0
1702168|NCT01215916|5942045|P4|Overall Study|Adverse Event|1
1702169|NCT01215916|5942046|P3|Overall Study|Adverse Event|0
1702170|NCT01215916|5942047|P2|Overall Study|Adverse Event|1
1702171|NCT01215916|5942048|P1|Overall Study|Adverse Event|1
1702172|NCT01215916|5942040|P9|Overall Study|Progressive Disease|1
1702173|NCT01215916|5942041|P8|Overall Study|Progressive Disease|3
1702174|NCT01215916|5942042|P7|Overall Study|Progressive Disease|5
1702175|NCT01215916|5942043|P6|Overall Study|Progressive Disease|4
1702176|NCT01215916|5942044|P5|Overall Study|Progressive Disease|5
1702177|NCT01215916|5942045|P4|Overall Study|Progressive Disease|2
1702178|NCT01215916|5942046|P3|Overall Study|Progressive Disease|1
1702179|NCT01215916|5942047|P2|Overall Study|Progressive Disease|2
1702180|NCT01215916|5942048|P1|Overall Study|Progressive Disease|0
1702181|NCT01215851|5942082|P6|Follow up Period|Lost to Follow-up|1
1702182|NCT01215851|5942083|P5|Follow up Period|Lost to Follow-up|0
1702183|NCT01215851|5942084|P4|Follow up Period|Lost to Follow-up|0
1702184|NCT01215851|5942085|P3|Follow up Period|Lost to Follow-up|0
1702185|NCT01215851|5942086|P2|Follow up Period|Lost to Follow-up|0
1702186|NCT01215851|5942087|P1|Follow up Period|Lost to Follow-up|0
1702187|NCT01215851|5942082|P6|Treatment Period|Adverse Event|1
1702188|NCT01215851|5942083|P5|Treatment Period|Adverse Event|0
1702189|NCT01215851|5942084|P4|Treatment Period|Adverse Event|3
1702190|NCT01215851|5942085|P3|Treatment Period|Adverse Event|1
1702191|NCT01215851|5942086|P2|Treatment Period|Adverse Event|1
1702192|NCT01215851|5942087|P1|Treatment Period|Adverse Event|1
1702193|NCT01215734|5942146|P2|Overall Study|Death|1
1702194|NCT01215734|5942147|P1|Overall Study|Death|0
1702195|NCT01215721|5942155|P1|Overall Study|Adverse Event|2
1702196|NCT01215513|5942287|P1|Overall Study|Miscellaneous reasons (CS42A)|2
1702197|NCT01215513|5942287|P1|Overall Study|Withdrawal by subject (CS42A)|5
1702198|NCT01215513|5942287|P1|Overall Study|Physician decision (CS42A)|6
1702199|NCT01215513|5942287|P1|Overall Study|Adverse event (CS42A)|2
1702200|NCT01215513|5942287|P1|Overall Study|Not enrolled from CS42 to CS42A|21
1702201|NCT01215513|5942287|P1|Overall Study|Not completed CS42|9
1702202|NCT01215435|5942296|P2|Overall Study|Unclassified|5
1702203|NCT01215435|5942297|P1|Overall Study|Unclassified|5
1702204|NCT01215435|5942296|P2|Overall Study|Lost to Follow-up|0
1702205|NCT01215435|5942297|P1|Overall Study|Lost to Follow-up|3
1702206|NCT01215435|5942296|P2|Overall Study|Withdrawal Criteria|11
1702207|NCT01215435|5942297|P1|Overall Study|Withdrawal Criteria|8
1702208|NCT01215435|5942296|P2|Overall Study|Protocol Violation|0
1702209|NCT01215435|5942297|P1|Overall Study|Protocol Violation|2
1702210|NCT01215435|5942296|P2|Overall Study|Adverse Event|0
1702211|NCT01215435|5942297|P1|Overall Study|Adverse Event|1
1702212|NCT01215422|5942311|P4|Overall Study|Did not complete all intubations|0
1702213|NCT01215422|5942312|P3|Overall Study|Did not complete all intubations|0
1702214|NCT01215422|5942313|P2|Overall Study|Did not complete all intubations|0
1702215|NCT01215422|5942314|P1|Overall Study|Did not complete all intubations|7
1702216|NCT01215422|5942311|P4|Overall Study|Failed intubations|8
1702217|NCT01215422|5942312|P3|Overall Study|Failed intubations|3
1702218|NCT01215422|5942313|P2|Overall Study|Failed intubations|0
1702219|NCT01215422|5942314|P1|Overall Study|Failed intubations|0
1702220|NCT01215422|5942311|P4|Overall Study|Relocation|0
1702221|NCT01215422|5942312|P3|Overall Study|Relocation|0
1702222|NCT01215422|5942313|P2|Overall Study|Relocation|0
1702223|NCT01215422|5942314|P1|Overall Study|Relocation|1
1702224|NCT01215357|5942336|P1|Overall Study|Protocol Violation|9
1702225|NCT01215357|5942336|P1|Overall Study|Withdrawal by Subject|3
1702226|NCT01215253|5942462|P2|Overall Study|Other|12
1702227|NCT01215253|5942463|P1|Overall Study|Other|14
1702228|NCT01215253|5942462|P2|Overall Study|Lost to Follow-up|4
1702229|NCT01215253|5942463|P1|Overall Study|Lost to Follow-up|6
1702230|NCT01215253|5942462|P2|Overall Study|Physician Decision|12
1702231|NCT01215253|5942463|P1|Overall Study|Physician Decision|9
1702232|NCT01215253|5942462|P2|Overall Study|Withdrawal by Subject|35
1702233|NCT01215253|5942463|P1|Overall Study|Withdrawal by Subject|57
1702234|NCT01215227|5942516|P6|Overall Study|Randomized but not treated|1
1702235|NCT01215227|5942517|P5|Overall Study|Randomized but not treated|0
1702236|NCT01215227|5942518|P4|Overall Study|Randomized but not treated|1
1702237|NCT01215227|5942519|P3|Overall Study|Randomized but not treated|1
1702238|NCT01215227|5942520|P2|Overall Study|Randomized but not treated|0
1702239|NCT01215227|5942521|P1|Overall Study|Randomized but not treated|0
1702240|NCT01215227|5942516|P6|Overall Study|Missing Status|0
1702241|NCT01215227|5942517|P5|Overall Study|Missing Status|0
1702242|NCT01215227|5942518|P4|Overall Study|Missing Status|0
1702243|NCT01215227|5942519|P3|Overall Study|Missing Status|0
1702244|NCT01215227|5942520|P2|Overall Study|Missing Status|1
1702245|NCT01215227|5942521|P1|Overall Study|Missing Status|0
1702246|NCT01215227|5942516|P6|Overall Study|Administrative|40
1702247|NCT01215227|5942517|P5|Overall Study|Administrative|28
1702248|NCT01215227|5942518|P4|Overall Study|Administrative|24
1702249|NCT01215227|5942519|P3|Overall Study|Administrative|42
1702250|NCT01215227|5942520|P2|Overall Study|Administrative|73
1702251|NCT01215227|5942521|P1|Overall Study|Administrative|83
1702252|NCT01215227|5942516|P6|Overall Study|Non-Compliance With Protocol|0
1702253|NCT01215227|5942517|P5|Overall Study|Non-Compliance With Protocol|0
1702254|NCT01215227|5942518|P4|Overall Study|Non-Compliance With Protocol|0
1702255|NCT01215227|5942519|P3|Overall Study|Non-Compliance With Protocol|1
1702256|NCT01215227|5942520|P2|Overall Study|Non-Compliance With Protocol|6
1702257|NCT01215227|5942521|P1|Overall Study|Non-Compliance With Protocol|2
1702258|NCT01215227|5942516|P6|Overall Study|Subject Withdrew Consent|8
1702259|NCT01215227|5942517|P5|Overall Study|Subject Withdrew Consent|11
1702260|NCT01215227|5942518|P4|Overall Study|Subject Withdrew Consent|10
1702261|NCT01215227|5942519|P3|Overall Study|Subject Withdrew Consent|7
1702262|NCT01215227|5942520|P2|Overall Study|Subject Withdrew Consent|20
1702263|NCT01215227|5942521|P1|Overall Study|Subject Withdrew Consent|16
1702264|NCT01215227|5942516|P6|Overall Study|Lost to Follow-up|2
1702265|NCT01215227|5942517|P5|Overall Study|Lost to Follow-up|1
1702266|NCT01215227|5942518|P4|Overall Study|Lost to Follow-up|1
1702267|NCT01215227|5942519|P3|Overall Study|Lost to Follow-up|1
1702268|NCT01215227|5942520|P2|Overall Study|Lost to Follow-up|4
1702269|NCT01215227|5942521|P1|Overall Study|Lost to Follow-up|1
1702270|NCT01215227|5942516|P6|Overall Study|Treatment Failure|1
1702271|NCT01215227|5942517|P5|Overall Study|Treatment Failure|1
1702272|NCT01215227|5942518|P4|Overall Study|Treatment Failure|5
1702273|NCT01215227|5942519|P3|Overall Study|Treatment Failure|1
1702274|NCT01215227|5942520|P2|Overall Study|Treatment Failure|4
1702275|NCT01215227|5942521|P1|Overall Study|Treatment Failure|8
1702276|NCT01215227|5942516|P6|Overall Study|Adverse Event|6
1702277|NCT01215227|5942517|P5|Overall Study|Adverse Event|7
1702278|NCT01215227|5942518|P4|Overall Study|Adverse Event|8
1702279|NCT01215227|5942519|P3|Overall Study|Adverse Event|4
1702280|NCT01215227|5942520|P2|Overall Study|Adverse Event|11
1702281|NCT01215227|5942521|P1|Overall Study|Adverse Event|11
1702282|NCT01215188|5942568|P3|Overall Study|Withdrawal by Subject|31
1702283|NCT01215188|5942569|P2|Overall Study|Withdrawal by Subject|34
1702284|NCT01215188|5942570|P1|Overall Study|Withdrawal by Subject|32
1702285|NCT01215188|5942568|P3|Overall Study|Protocol Violation|1
1702286|NCT01215188|5942569|P2|Overall Study|Protocol Violation|1
1702287|NCT01215188|5942570|P1|Overall Study|Protocol Violation|1
1702288|NCT01215188|5942568|P3|Overall Study|Lack of Efficacy|1
1702289|NCT01215188|5942569|P2|Overall Study|Lack of Efficacy|0
1702290|NCT01215188|5942570|P1|Overall Study|Lack of Efficacy|0
1702291|NCT01215188|5942568|P3|Overall Study|Physician Decision|0
1702292|NCT01215188|5942569|P2|Overall Study|Physician Decision|1
1702293|NCT01215188|5942570|P1|Overall Study|Physician Decision|2
1702294|NCT01215188|5942568|P3|Overall Study|Adverse Event|3
1702295|NCT01215188|5942569|P2|Overall Study|Adverse Event|1
1702296|NCT01215188|5942570|P1|Overall Study|Adverse Event|1
1702297|NCT01215188|5942568|P3|Overall Study|Lost to Follow-up|16
1702298|NCT01215188|5942569|P2|Overall Study|Lost to Follow-up|22
1702299|NCT01215188|5942570|P1|Overall Study|Lost to Follow-up|22
1702300|NCT01215175|5942622|P5|Overall Study|Lost to Follow-up|0
1702301|NCT01215175|5942623|P4|Overall Study|Lost to Follow-up|1
1702302|NCT01215175|5942624|P3|Overall Study|Lost to Follow-up|0
1702303|NCT01215175|5942625|P2|Overall Study|Lost to Follow-up|1
1702304|NCT01215175|5942626|P1|Overall Study|Lost to Follow-up|0
1702305|NCT01215097|5942743|P2|Overall Study|patient's private reason|1
1702306|NCT01215097|5942744|P1|Overall Study|patient's private reason|1
1702307|NCT01215097|5942743|P2|Overall Study|patient's refusal to come|2
1702308|NCT01215097|5942744|P1|Overall Study|patient's refusal to come|2
1702309|NCT01215097|5942743|P2|Overall Study|Lack of Efficacy|3
1702310|NCT01215097|5942744|P1|Overall Study|Lack of Efficacy|0
1702311|NCT01215097|5942743|P2|Overall Study|Withdrawal by Subject|3
1702312|NCT01215097|5942744|P1|Overall Study|Withdrawal by Subject|6
1702313|NCT01215097|5942743|P2|Overall Study|Lost to Follow-up|0
1702314|NCT01215097|5942744|P1|Overall Study|Lost to Follow-up|2
1702315|NCT01215097|5942743|P2|Overall Study|Protocol Violation|2
1702316|NCT01215097|5942744|P1|Overall Study|Protocol Violation|0
1702317|NCT01215097|5942743|P2|Overall Study|Adverse Event|3
1702318|NCT01215097|5942744|P1|Overall Study|Adverse Event|1
1702319|NCT01215032|5942776|P1|Overall Study|Lack of Efficacy|17
1702320|NCT01215032|5942776|P1|Overall Study|Adverse Event|3
1702321|NCT01214915|5942801|P1|Overall Study|Lack of Efficacy|3
1702322|NCT01214915|5942801|P1|Overall Study|Adverse Event|8
1702323|NCT01214850|5942812|P3|Overall Study|Unable to classify|1
1702324|NCT01214850|5942813|P2|Overall Study|Unable to classify|1
1702325|NCT01214850|5942814|P1|Overall Study|Unable to classify|2
1702326|NCT01214850|5942812|P3|Overall Study|Administrative reason|0
1702327|NCT01214850|5942813|P2|Overall Study|Administrative reason|0
1702328|NCT01214850|5942814|P1|Overall Study|Administrative reason|1
1702329|NCT01214850|5942812|P3|Overall Study|Inappropriate enrollment|0
1702330|NCT01214850|5942813|P2|Overall Study|Inappropriate enrollment|1
1702331|NCT01214850|5942814|P1|Overall Study|Inappropriate enrollment|2
1702332|NCT01214850|5942812|P3|Overall Study|Adverse event or death|3
1702333|NCT01214850|5942813|P2|Overall Study|Adverse event or death|8
1702334|NCT01214850|5942814|P1|Overall Study|Adverse event or death|11
1702335|NCT01214850|5942812|P3|Overall Study|Protocol Violation|6
1702336|NCT01214850|5942813|P2|Overall Study|Protocol Violation|5
1702337|NCT01214850|5942814|P1|Overall Study|Protocol Violation|5
1702338|NCT01214850|5942812|P3|Overall Study|Lost to Follow-up|123
1702339|NCT01214850|5942813|P2|Overall Study|Lost to Follow-up|98
1702340|NCT01214850|5942814|P1|Overall Study|Lost to Follow-up|124
1702341|NCT01214850|5942812|P3|Overall Study|Withdrawal by Subject|28
1702342|NCT01214850|5942813|P2|Overall Study|Withdrawal by Subject|31
1702343|NCT01214850|5942814|P1|Overall Study|Withdrawal by Subject|38
1702344|NCT01214837|5942898|P3|Overall Study|Unable to Classify|0
1702345|NCT01214837|5942899|P2|Overall Study|Unable to Classify|3
1702346|NCT01214837|5942900|P1|Overall Study|Unable to Classify|1
1702347|NCT01214837|5942898|P3|Overall Study|Protocol Violation|5
1702348|NCT01214837|5942899|P2|Overall Study|Protocol Violation|1
1702349|NCT01214837|5942900|P1|Overall Study|Protocol Violation|3
1702350|NCT01214837|5942898|P3|Overall Study|Administrative Reason|4
1702351|NCT01214837|5942899|P2|Overall Study|Administrative Reason|6
1702352|NCT01214837|5942900|P1|Overall Study|Administrative Reason|2
1702353|NCT01214837|5942898|P3|Overall Study|Inappropriate Enrolment|2
1702354|NCT01214837|5942899|P2|Overall Study|Inappropriate Enrolment|1
1702355|NCT01214837|5942900|P1|Overall Study|Inappropriate Enrolment|0
1702356|NCT01214837|5942898|P3|Overall Study|Lost to Follow-up|21
1702357|NCT01214837|5942899|P2|Overall Study|Lost to Follow-up|15
1702358|NCT01214837|5942900|P1|Overall Study|Lost to Follow-up|20
1702359|NCT01214837|5942898|P3|Overall Study|Withdrawal by Subject|28
1702360|NCT01214837|5942899|P2|Overall Study|Withdrawal by Subject|36
1702361|NCT01214837|5942900|P1|Overall Study|Withdrawal by Subject|27
1702362|NCT01214837|5942898|P3|Overall Study|Adverse Event|1
1702363|NCT01214837|5942899|P2|Overall Study|Adverse Event|2
1702364|NCT01214837|5942900|P1|Overall Study|Adverse Event|1
1702365|NCT01214837|5942898|P3|Overall Study|Death|1
1702366|NCT01214837|5942899|P2|Overall Study|Death|0
1702367|NCT01214837|5942900|P1|Overall Study|Death|0
1702368|NCT01214720|5942956|P2|Overall Study|Lost to Follow-up|2
1702369|NCT01214720|5942957|P1|Overall Study|Lost to Follow-up|6
1702370|NCT01214720|5942956|P2|Overall Study|Alive and in follow-up|48
1702371|NCT01214720|5942957|P1|Overall Study|Alive and in follow-up|45
1702372|NCT01214720|5942956|P2|Overall Study|Alive and still on treatment|18
1702373|NCT01214720|5942957|P1|Overall Study|Alive and still on treatment|34
1702374|NCT01214668|5942980|P6|Overall Study|Withdrawal by Subject|0
1702375|NCT01214668|5942981|P5|Overall Study|Withdrawal by Subject|1
1702376|NCT01214668|5942982|P4|Overall Study|Withdrawal by Subject|0
1702377|NCT01214668|5942983|P3|Overall Study|Withdrawal by Subject|0
1702378|NCT01214668|5942984|P2|Overall Study|Withdrawal by Subject|0
1702379|NCT01214668|5942985|P1|Overall Study|Withdrawal by Subject|0
1702380|NCT01214668|5942980|P6|Overall Study|Progressive Disease|5
1702381|NCT01214668|5942981|P5|Overall Study|Progressive Disease|4
1702382|NCT01214668|5942982|P4|Overall Study|Progressive Disease|4
1702383|NCT01214668|5942983|P3|Overall Study|Progressive Disease|5
1702384|NCT01214668|5942984|P2|Overall Study|Progressive Disease|2
1702385|NCT01214668|5942985|P1|Overall Study|Progressive Disease|4
1702386|NCT01214668|5942980|P6|Overall Study|Death|0
1702387|NCT01214668|5942981|P5|Overall Study|Death|0
1702388|NCT01214668|5942982|P4|Overall Study|Death|0
1702389|NCT01214668|5942983|P3|Overall Study|Death|1
1702390|NCT01214668|5942984|P2|Overall Study|Death|0
1702391|NCT01214668|5942985|P1|Overall Study|Death|0
1702392|NCT01214668|5942980|P6|Overall Study|Adverse Event|1
1702393|NCT01214668|5942981|P5|Overall Study|Adverse Event|1
1702394|NCT01214668|5942982|P4|Overall Study|Adverse Event|2
1702395|NCT01214668|5942983|P3|Overall Study|Adverse Event|0
1702396|NCT01214668|5942984|P2|Overall Study|Adverse Event|1
1702397|NCT01214668|5942985|P1|Overall Study|Adverse Event|0
1702398|NCT01214655|5943022|P3|Part C|Physician Decision|1
1702399|NCT01214655|5943023|P2|Part C|Physician Decision|0
1702400|NCT01214655|5943024|P1|Part C|Physician Decision|0
1702401|NCT01214655|5943022|P3|Part C|Death|1
1702402|NCT01214655|5943023|P2|Part C|Death|0
1702403|NCT01214655|5943024|P1|Part C|Death|0
1702404|NCT01214655|5943022|P3|Part C|Progressive Disease|5
1702405|NCT01214655|5943023|P2|Part C|Progressive Disease|0
1702406|NCT01214655|5943024|P1|Part C|Progressive Disease|0
1702407|NCT01214655|5943022|P3|Part B|Withdrawal by Subject|0
1702408|NCT01214655|5943023|P2|Part B|Withdrawal by Subject|2
1702409|NCT01214655|5943024|P1|Part B|Withdrawal by Subject|0
1702410|NCT01214655|5943022|P3|Part B|Death|0
1702411|NCT01214655|5943023|P2|Part B|Death|1
1702412|NCT01214655|5943024|P1|Part B|Death|0
1702413|NCT01214655|5943022|P3|Part B|Progressive disease|0
1702414|NCT01214655|5943023|P2|Part B|Progressive disease|10
1702415|NCT01214655|5943024|P1|Part B|Progressive disease|0
1702416|NCT01214655|5943022|P3|Part A|Physician Decision|0
1702417|NCT01214655|5943023|P2|Part A|Physician Decision|0
1702418|NCT01214655|5943024|P1|Part A|Physician Decision|1
1702419|NCT01214655|5943022|P3|Part A|Progressive Disease|0
1702420|NCT01214655|5943023|P2|Part A|Progressive Disease|0
1702421|NCT01214655|5943024|P1|Part A|Progressive Disease|7
1702422|NCT01214642|5943097|P12|Overall Study|Physician Decision|2
1702423|NCT01214642|5943098|P11|Overall Study|Physician Decision|0
1702424|NCT01214642|5943099|P10|Overall Study|Physician Decision|0
1702425|NCT01214642|5943100|P9|Overall Study|Physician Decision|0
1702426|NCT01214642|5943101|P8|Overall Study|Physician Decision|0
1702427|NCT01214642|5943102|P7|Overall Study|Physician Decision|0
1702428|NCT01214642|5943103|P6|Overall Study|Physician Decision|0
1702429|NCT01214642|5943104|P5|Overall Study|Physician Decision|1
1702430|NCT01214642|5943105|P4|Overall Study|Physician Decision|1
1702431|NCT01214642|5943106|P3|Overall Study|Physician Decision|1
1702432|NCT01214642|5943107|P2|Overall Study|Physician Decision|0
1702433|NCT01214642|5943108|P1|Overall Study|Physician Decision|0
1702434|NCT01214642|5943097|P12|Overall Study|Withdrawal by Subject|0
1702435|NCT01214642|5943098|P11|Overall Study|Withdrawal by Subject|1
1702436|NCT01214642|5943099|P10|Overall Study|Withdrawal by Subject|1
1702437|NCT01214642|5943100|P9|Overall Study|Withdrawal by Subject|3
1702438|NCT01214642|5943101|P8|Overall Study|Withdrawal by Subject|0
1702439|NCT01214642|5943102|P7|Overall Study|Withdrawal by Subject|0
1702440|NCT01214642|5943103|P6|Overall Study|Withdrawal by Subject|0
1702441|NCT01214642|5943104|P5|Overall Study|Withdrawal by Subject|0
1702442|NCT01214642|5943105|P4|Overall Study|Withdrawal by Subject|0
1702443|NCT01214642|5943106|P3|Overall Study|Withdrawal by Subject|1
1702444|NCT01214642|5943107|P2|Overall Study|Withdrawal by Subject|0
1702445|NCT01214642|5943108|P1|Overall Study|Withdrawal by Subject|0
1702446|NCT01214642|5943097|P12|Overall Study|Death|0
1702447|NCT01214642|5943098|P11|Overall Study|Death|1
1702448|NCT01214642|5943099|P10|Overall Study|Death|0
1702449|NCT01214642|5943100|P9|Overall Study|Death|0
1702450|NCT01214642|5943101|P8|Overall Study|Death|0
1702451|NCT01214642|5943102|P7|Overall Study|Death|0
1702452|NCT01214642|5943103|P6|Overall Study|Death|0
1702453|NCT01214642|5943104|P5|Overall Study|Death|0
1702454|NCT01214642|5943105|P4|Overall Study|Death|0
1702455|NCT01214642|5943106|P3|Overall Study|Death|1
1702456|NCT01214642|5943107|P2|Overall Study|Death|0
1702457|NCT01214642|5943108|P1|Overall Study|Death|0
1702458|NCT01214642|5943097|P12|Overall Study|Adverse Event|0
1702459|NCT01214642|5943098|P11|Overall Study|Adverse Event|1
1702460|NCT01214642|5943099|P10|Overall Study|Adverse Event|1
1702461|NCT01214642|5943100|P9|Overall Study|Adverse Event|0
1702462|NCT01214642|5943101|P8|Overall Study|Adverse Event|0
1702463|NCT01214642|5943102|P7|Overall Study|Adverse Event|1
1702464|NCT01214642|5943103|P6|Overall Study|Adverse Event|0
1702465|NCT01214642|5943104|P5|Overall Study|Adverse Event|0
1702466|NCT01214642|5943105|P4|Overall Study|Adverse Event|0
1702467|NCT01214642|5943106|P3|Overall Study|Adverse Event|0
1702468|NCT01214642|5943107|P2|Overall Study|Adverse Event|1
1702469|NCT01214642|5943108|P1|Overall Study|Adverse Event|0
1702470|NCT01214642|5943097|P12|Overall Study|Progressive Disease|4
1702471|NCT01214642|5943098|P11|Overall Study|Progressive Disease|1
1702472|NCT01214642|5943099|P10|Overall Study|Progressive Disease|2
1702473|NCT01214642|5943100|P9|Overall Study|Progressive Disease|10
1702474|NCT01214642|5943101|P8|Overall Study|Progressive Disease|3
1702475|NCT01214642|5943102|P7|Overall Study|Progressive Disease|5
1702476|NCT01214642|5943103|P6|Overall Study|Progressive Disease|3
1702477|NCT01214642|5943104|P5|Overall Study|Progressive Disease|5
1702478|NCT01214642|5943105|P4|Overall Study|Progressive Disease|5
1702479|NCT01214642|5943106|P3|Overall Study|Progressive Disease|3
1702480|NCT01214642|5943107|P2|Overall Study|Progressive Disease|2
1702481|NCT01214642|5943108|P1|Overall Study|Progressive Disease|3
1702482|NCT01214629|5943188|P11|Overall Study|Withdrawal by Subject|0
1702483|NCT01214629|5943189|P10|Overall Study|Withdrawal by Subject|1
1702484|NCT01214629|5943190|P9|Overall Study|Withdrawal by Subject|0
1702485|NCT01214629|5943191|P8|Overall Study|Withdrawal by Subject|0
1702486|NCT01214629|5943192|P7|Overall Study|Withdrawal by Subject|0
1702487|NCT01214629|5943193|P6|Overall Study|Withdrawal by Subject|0
1702488|NCT01214629|5943194|P5|Overall Study|Withdrawal by Subject|0
1702489|NCT01214629|5943195|P4|Overall Study|Withdrawal by Subject|0
1702490|NCT01214629|5943196|P3|Overall Study|Withdrawal by Subject|0
1702491|NCT01214629|5943197|P2|Overall Study|Withdrawal by Subject|0
1702492|NCT01214629|5943198|P1|Overall Study|Withdrawal by Subject|0
1702493|NCT01214629|5943188|P11|Overall Study|Physician Decision|1
1702494|NCT01214629|5943189|P10|Overall Study|Physician Decision|0
1702495|NCT01214629|5943190|P9|Overall Study|Physician Decision|0
1702496|NCT01214629|5943191|P8|Overall Study|Physician Decision|0
1702497|NCT01214629|5943192|P7|Overall Study|Physician Decision|0
1702498|NCT01214629|5943193|P6|Overall Study|Physician Decision|0
1702499|NCT01214629|5943194|P5|Overall Study|Physician Decision|0
1702500|NCT01214629|5943195|P4|Overall Study|Physician Decision|0
1702501|NCT01214629|5943196|P3|Overall Study|Physician Decision|0
1702502|NCT01214629|5943197|P2|Overall Study|Physician Decision|0
1702503|NCT01214629|5943198|P1|Overall Study|Physician Decision|0
1702504|NCT01214629|5943188|P11|Overall Study|Adverse Event|0
1702505|NCT01214629|5943189|P10|Overall Study|Adverse Event|1
1702506|NCT01214629|5943190|P9|Overall Study|Adverse Event|0
1702507|NCT01214629|5943191|P8|Overall Study|Adverse Event|0
1702508|NCT01214629|5943192|P7|Overall Study|Adverse Event|0
1702509|NCT01214629|5943193|P6|Overall Study|Adverse Event|1
1702510|NCT01214629|5943194|P5|Overall Study|Adverse Event|0
1702511|NCT01214629|5943195|P4|Overall Study|Adverse Event|1
1702512|NCT01214629|5943196|P3|Overall Study|Adverse Event|0
1702513|NCT01214629|5943197|P2|Overall Study|Adverse Event|0
1702514|NCT01214629|5943198|P1|Overall Study|Adverse Event|0
1702515|NCT01214629|5943188|P11|Overall Study|Progressive Disease|1
1702516|NCT01214629|5943189|P10|Overall Study|Progressive Disease|5
1702517|NCT01214629|5943190|P9|Overall Study|Progressive Disease|1
1702518|NCT01214629|5943191|P8|Overall Study|Progressive Disease|1
1702519|NCT01214629|5943192|P7|Overall Study|Progressive Disease|1
1702520|NCT01214629|5943193|P6|Overall Study|Progressive Disease|3
1702521|NCT01214629|5943194|P5|Overall Study|Progressive Disease|2
1702522|NCT01214629|5943195|P4|Overall Study|Progressive Disease|1
1702523|NCT01214629|5943196|P3|Overall Study|Progressive Disease|0
1702524|NCT01214629|5943197|P2|Overall Study|Progressive Disease|1
1702525|NCT01214629|5943198|P1|Overall Study|Progressive Disease|1
1702526|NCT01214616|5943263|P4|Overall Study|Withdrawal by Subject|1
1702527|NCT01214616|5943264|P3|Overall Study|Withdrawal by Subject|0
1702528|NCT01214616|5943265|P2|Overall Study|Withdrawal by Subject|0
1702529|NCT01214616|5943266|P1|Overall Study|Withdrawal by Subject|1
1702530|NCT01214616|5943263|P4|Overall Study|Other adverse events|1
1702531|NCT01214616|5943264|P3|Overall Study|Other adverse events|1
1702532|NCT01214616|5943265|P2|Overall Study|Other adverse events|1
1702533|NCT01214616|5943266|P1|Overall Study|Other adverse events|0
1702534|NCT01214616|5943263|P4|Overall Study|Dose limiting toxicity|0
1702535|NCT01214616|5943264|P3|Overall Study|Dose limiting toxicity|0
1702536|NCT01214616|5943265|P2|Overall Study|Dose limiting toxicity|2
1702537|NCT01214616|5943266|P1|Overall Study|Dose limiting toxicity|0
1702538|NCT01214616|5943263|P4|Overall Study|Progressive disease|4
1702539|NCT01214616|5943264|P3|Overall Study|Progressive disease|2
1702540|NCT01214616|5943265|P2|Overall Study|Progressive disease|2
1702541|NCT01214616|5943266|P1|Overall Study|Progressive disease|2
1702542|NCT01214603|5943303|P3|Overall Study|Progressive Disease|3
1702543|NCT01214603|5943304|P2|Overall Study|Progressive Disease|1
1702544|NCT01214603|5943305|P1|Overall Study|Progressive Disease|4
1702545|NCT01214603|5943303|P3|Overall Study|Death|0
1702546|NCT01214603|5943304|P2|Overall Study|Death|0
1702547|NCT01214603|5943305|P1|Overall Study|Death|1
1702548|NCT01214603|5943303|P3|Overall Study|Adverse Event|1
1702549|NCT01214603|5943304|P2|Overall Study|Adverse Event|0
1702550|NCT01214603|5943305|P1|Overall Study|Adverse Event|0
1702551|NCT01214434|5943328|P2|Overall Study|Site error|0
1702552|NCT01214434|5943329|P1|Overall Study|Site error|1
1702553|NCT01214434|5943328|P2|Overall Study|Lost to Follow-up|2
1702554|NCT01214434|5943329|P1|Overall Study|Lost to Follow-up|2
1702555|NCT01214434|5943328|P2|Overall Study|Withdrawal by Subject|0
1702556|NCT01214434|5943329|P1|Overall Study|Withdrawal by Subject|1
1702557|NCT01214395|5943345|P1|Overall Study|All patients had infection|5
1702558|NCT01214252|5943363|P1|Overall Study|Not eligible per protocol|82
1702559|NCT01214239|5943371|P2|Overall Study|patient's private reason|1
1702560|NCT01214239|5943372|P1|Overall Study|patient's private reason|1
1702561|NCT01214239|5943371|P2|Overall Study|Lack of Efficacy|2
1702562|NCT01214239|5943372|P1|Overall Study|Lack of Efficacy|1
1702563|NCT01214239|5943371|P2|Overall Study|Withdrawal by Subject|9
1702564|NCT01214239|5943372|P1|Overall Study|Withdrawal by Subject|4
1702565|NCT01214239|5943371|P2|Overall Study|Lost to Follow-up|1
1702566|NCT01214239|5943372|P1|Overall Study|Lost to Follow-up|1
1702567|NCT01214239|5943371|P2|Overall Study|Protocol Violation|1
1702568|NCT01214239|5943372|P1|Overall Study|Protocol Violation|2
1702569|NCT01214239|5943371|P2|Overall Study|Adverse Event|4
1702570|NCT01214239|5943372|P1|Overall Study|Adverse Event|3
1702571|NCT01214200|5943404|P1|Overall Study|Withdrawal by Subject|2
1702572|NCT01214200|5943404|P1|Overall Study|Did not meet inclusion/exclusion|9
1702573|NCT01214187|5943418|P2|Overall Study|Withdrawal by Subject|3
1702574|NCT01214187|5943419|P1|Overall Study|Withdrawal by Subject|0
1702575|NCT01214187|5943418|P2|Overall Study|Death|1
1702576|NCT01214187|5943419|P1|Overall Study|Death|1
1702577|NCT01214187|5943418|P2|Overall Study|Adverse Event|2
1702578|NCT01214187|5943419|P1|Overall Study|Adverse Event|6
1702579|NCT01214174|5943436|P3|Overall Study|Withdrawal by Subject|1
1702580|NCT01214174|5943437|P2|Overall Study|Withdrawal by Subject|0
1702581|NCT01214174|5943438|P1|Overall Study|Withdrawal by Subject|0
1702582|NCT01214044|5943588|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
1702583|NCT01214044|5943588|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
1702584|NCT01214044|5943588|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
1702585|NCT01214044|5943588|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
1702586|NCT01214044|5943588|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
1702587|NCT01214044|5943588|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
1702588|NCT01213966|5943602|P4|Overall Study|Protocol Violation|1
1702589|NCT01213966|5943603|P3|Overall Study|Protocol Violation|3
1702590|NCT01213966|5943604|P2|Overall Study|Protocol Violation|0
1702591|NCT01213966|5943605|P1|Overall Study|Protocol Violation|1
1702592|NCT01213836|5943617|P2|Period 1, First Intervention|Withdrawal by Subject|1
1702593|NCT01213836|5943618|P1|Period 1, First Intervention|Withdrawal by Subject|1
1702594|NCT01213836|5943617|P2|Period 1, First Intervention|Protocol Violation|1
1702595|NCT01213836|5943618|P1|Period 1, First Intervention|Protocol Violation|0
1702596|NCT01213836|5943617|P2|Period 1, First Intervention|Adverse Event|1
1702597|NCT01213836|5943618|P1|Period 1, First Intervention|Adverse Event|2
1702598|NCT01213472|5943703|P1|Overall Study|Physician Decision|1
1702599|NCT01213472|5943703|P1|Overall Study|Withdrawal by Subject|1
1702600|NCT01213472|5943703|P1|Overall Study|Recurrence/Progressive disease|25
1702601|NCT01213264|5943752|P3|Overall Study|Lost to Follow-up|6
1702602|NCT01213264|5943753|P2|Overall Study|Lost to Follow-up|2
1702603|NCT01213264|5943754|P1|Overall Study|Lost to Follow-up|1
1702604|NCT01213264|5943752|P3|Overall Study|Adverse Event|0
1702605|NCT01213264|5943753|P2|Overall Study|Adverse Event|0
1702606|NCT01213264|5943754|P1|Overall Study|Adverse Event|1
1702607|NCT01213251|5943774|P3|Overall Study|Missed 18-Month Follow-up|1
1702608|NCT01213251|5943775|P2|Overall Study|Missed 18-Month Follow-up|0
1702609|NCT01213251|5943776|P1|Overall Study|Missed 18-Month Follow-up|0
1702610|NCT01213251|5943774|P3|Overall Study|Protocol Violation|0
1702611|NCT01213251|5943775|P2|Overall Study|Protocol Violation|1
1702612|NCT01213251|5943776|P1|Overall Study|Protocol Violation|1
1702613|NCT01213251|5943774|P3|Overall Study|Exit|8
1702614|NCT01213251|5943775|P2|Overall Study|Exit|2
1702615|NCT01213251|5943776|P1|Overall Study|Exit|3
1702616|NCT01213251|5943774|P3|Overall Study|Death|2
1702617|NCT01213251|5943775|P2|Overall Study|Death|1
1702618|NCT01213251|5943776|P1|Overall Study|Death|2
1702619|NCT01213173|5943803|P2|Overall Study|Incorrect Enrollment|3
1702620|NCT01213173|5943804|P1|Overall Study|Incorrect Enrollment|1
1702621|NCT01213173|5943803|P2|Overall Study|Withdrawal by Subject|5
1702622|NCT01213173|5943804|P1|Overall Study|Withdrawal by Subject|5
1702623|NCT01213173|5943803|P2|Overall Study|Adverse Event|8
1702624|NCT01213173|5943804|P1|Overall Study|Adverse Event|4
1702625|NCT01213173|5943803|P2|Overall Study|Protocol Violation|0
1702626|NCT01213173|5943804|P1|Overall Study|Protocol Violation|2
1702627|NCT01213082|5943837|P3|Overall Study|Physician Decision|1
1702628|NCT01213082|5943838|P2|Overall Study|Physician Decision|0
1702629|NCT01213082|5943839|P1|Overall Study|Physician Decision|0
1702630|NCT01213082|5943837|P3|Overall Study|Lost to Follow-up|4
1702631|NCT01213082|5943838|P2|Overall Study|Lost to Follow-up|7
1702632|NCT01213082|5943839|P1|Overall Study|Lost to Follow-up|6
1702633|NCT01212991|5943881|P2|Overall Study|Continuing Treatment|61
1702634|NCT01212991|5943882|P1|Overall Study|Continuing Treatment|367
1702635|NCT01212991|5943881|P2|Overall Study|Withdrawal by Subject|14
1702636|NCT01212991|5943882|P1|Overall Study|Withdrawal by Subject|4
1702637|NCT01212991|5943881|P2|Overall Study|Death|299
1702638|NCT01212991|5943882|P1|Overall Study|Death|241
1702639|NCT01212991|5943881|P2|Overall Study|Lost to Follow-up|0
1702640|NCT01212991|5943882|P1|Overall Study|Lost to Follow-up|1
1702641|NCT01212770|5943923|P9|Long-term Safety Phase (Year 5)|Death|0
1702642|NCT01212770|5943924|P8|Long-term Safety Phase (Year 5)|Death|1
1702643|NCT01212770|5943925|P7|Long-term Safety Phase (Year 5)|Death|0
1702644|NCT01212770|5943926|P6|Long-term Safety Phase (Year 5)|Death|0
1702645|NCT01212770|5943927|P5|Long-term Safety Phase (Year 5)|Death|0
1702646|NCT01212770|5943928|P4|Long-term Safety Phase (Year 5)|Death|0
1702647|NCT01212770|5943929|P3|Long-term Safety Phase (Year 5)|Death|0
1702648|NCT01212770|5943930|P2|Long-term Safety Phase (Year 5)|Death|0
1702649|NCT01212770|5943931|P1|Long-term Safety Phase (Year 5)|Death|0
1702650|NCT01212770|5943923|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1702651|NCT01212770|5943924|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1702652|NCT01212770|5943925|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1702653|NCT01212770|5943926|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1702654|NCT01212770|5943927|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1702655|NCT01212770|5943928|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1702656|NCT01212770|5943929|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
1702657|NCT01212770|5943930|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
1702658|NCT01212770|5943931|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
1702659|NCT01212770|5943923|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702660|NCT01212770|5943924|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702661|NCT01212770|5943925|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702662|NCT01212770|5943926|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702663|NCT01212770|5943927|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702664|NCT01212770|5943928|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702665|NCT01212770|5943929|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
1702666|NCT01212770|5943930|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702667|NCT01212770|5943931|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
1702668|NCT01212770|5943923|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
1702669|NCT01212770|5943924|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
1702670|NCT01212770|5943925|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
1702671|NCT01212770|5943926|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
1702672|NCT01212770|5943927|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
1702673|NCT01212770|5943928|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
1702674|NCT01212770|5943929|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
1702675|NCT01212770|5943930|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
1702676|NCT01212770|5943931|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
1702677|NCT01212770|5943923|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702678|NCT01212770|5943924|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702679|NCT01212770|5943925|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702680|NCT01212770|5943926|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702681|NCT01212770|5943927|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702682|NCT01212770|5943928|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702683|NCT01212770|5943929|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
1702684|NCT01212770|5943930|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702685|NCT01212770|5943931|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
1702686|NCT01212770|5943923|P9|Long-term Safety Phase (Year 5)|Missing|0
1702687|NCT01212770|5943924|P8|Long-term Safety Phase (Year 5)|Missing|0
1702688|NCT01212770|5943925|P7|Long-term Safety Phase (Year 5)|Missing|0
1702689|NCT01212770|5943926|P6|Long-term Safety Phase (Year 5)|Missing|0
1702690|NCT01212770|5943927|P5|Long-term Safety Phase (Year 5)|Missing|0
1702691|NCT01212770|5943928|P4|Long-term Safety Phase (Year 5)|Missing|0
1702692|NCT01212770|5943929|P3|Long-term Safety Phase (Year 5)|Missing|1
1702693|NCT01212770|5943930|P2|Long-term Safety Phase (Year 5)|Missing|0
1702694|NCT01212770|5943931|P1|Long-term Safety Phase (Year 5)|Missing|0
1702695|NCT01212770|5943923|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
1702696|NCT01212770|5943924|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
1702697|NCT01212770|5943925|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
1702698|NCT01212770|5943926|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
1702699|NCT01212770|5943927|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
1702700|NCT01212770|5943928|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
1702701|NCT01212770|5943929|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
1702702|NCT01212770|5943930|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
1702703|NCT01212770|5943931|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
1702704|NCT01212770|5943923|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702705|NCT01212770|5943924|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702706|NCT01212770|5943925|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702707|NCT01212770|5943926|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702708|NCT01212770|5943927|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702709|NCT01212770|5943928|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702710|NCT01212770|5943929|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
1702711|NCT01212770|5943930|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702712|NCT01212770|5943931|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
1702713|NCT01212770|5943923|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1702714|NCT01212770|5943924|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1702715|NCT01212770|5943925|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1702716|NCT01212770|5943926|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1702717|NCT01212770|5943927|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1702718|NCT01212770|5943928|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1702719|NCT01212770|5943929|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
1702720|NCT01212770|5943930|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
1702721|NCT01212770|5943931|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
1702722|NCT01212770|5943923|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1702723|NCT01212770|5943924|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1702724|NCT01212770|5943925|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1702725|NCT01212770|5943926|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1702726|NCT01212770|5943927|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1702727|NCT01212770|5943928|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1702728|NCT01212770|5943929|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1702729|NCT01212770|5943930|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
1702730|NCT01212770|5943931|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
1702731|NCT01212770|5943923|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1702732|NCT01212770|5943924|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
1702733|NCT01212770|5943925|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1702734|NCT01212770|5943926|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1702735|NCT01212770|5943927|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1702736|NCT01212770|5943928|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1702737|NCT01212770|5943929|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
1702738|NCT01212770|5943930|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
1702739|NCT01212770|5943931|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
1702740|NCT01212770|5943923|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
1702741|NCT01212770|5943924|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
1702742|NCT01212770|5943925|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
1702743|NCT01212770|5943926|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
1702744|NCT01212770|5943927|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
1702745|NCT01212770|5943928|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
1702746|NCT01212770|5943929|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
1702747|NCT01212770|5943930|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
1702748|NCT01212770|5943931|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
1702749|NCT01212770|5943923|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
1702750|NCT01212770|5943924|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
1702751|NCT01212770|5943925|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
1702752|NCT01212770|5943926|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
1702753|NCT01212770|5943927|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
1702754|NCT01212770|5943928|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
1702755|NCT01212770|5943929|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
1702756|NCT01212770|5943930|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
1702757|NCT01212770|5943931|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
1702758|NCT01212770|5943923|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702759|NCT01212770|5943924|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
1702760|NCT01212770|5943925|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702761|NCT01212770|5943926|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702762|NCT01212770|5943927|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702763|NCT01212770|5943928|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702764|NCT01212770|5943929|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702765|NCT01212770|5943930|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702766|NCT01212770|5943931|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
1702767|NCT01212770|5943923|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702768|NCT01212770|5943924|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702769|NCT01212770|5943925|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702770|NCT01212770|5943926|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702771|NCT01212770|5943927|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702772|NCT01212770|5943928|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702773|NCT01212770|5943929|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702774|NCT01212770|5943930|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
1702775|NCT01212770|5943931|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
1702776|NCT01212770|5943923|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
1702777|NCT01212770|5943924|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
1702778|NCT01212770|5943925|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1702779|NCT01212770|5943926|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1702780|NCT01212770|5943927|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1702781|NCT01212770|5943928|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1702782|NCT01212770|5943929|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
1702783|NCT01212770|5943930|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
1702784|NCT01212770|5943931|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
1702785|NCT01212770|5943923|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1702786|NCT01212770|5943924|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
1702787|NCT01212770|5943925|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1702788|NCT01212770|5943926|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1702789|NCT01212770|5943927|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1702790|NCT01212770|5943928|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1702791|NCT01212770|5943929|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
1702792|NCT01212770|5943930|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
1702793|NCT01212770|5943931|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
1702794|NCT01212770|5943923|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
1702795|NCT01212770|5943924|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
1702796|NCT01212770|5943925|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
1702797|NCT01212770|5943926|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
1702798|NCT01212770|5943927|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
1702799|NCT01212770|5943928|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
1702800|NCT01212770|5943929|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
1702801|NCT01212770|5943930|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
1702802|NCT01212770|5943931|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
1702803|NCT01212770|5943923|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
1702804|NCT01212770|5943924|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
1702805|NCT01212770|5943925|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
1702806|NCT01212770|5943926|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
1702807|NCT01212770|5943927|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
1702808|NCT01212770|5943928|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
1702809|NCT01212770|5943929|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
1702810|NCT01212770|5943930|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
1702811|NCT01212770|5943931|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
1702812|NCT01212770|5943923|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1702813|NCT01212770|5943924|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1702814|NCT01212770|5943925|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1702815|NCT01212770|5943926|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1702816|NCT01212770|5943927|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1702817|NCT01212770|5943928|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1702818|NCT01212770|5943929|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
1702819|NCT01212770|5943930|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
1702820|NCT01212770|5943931|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
1702821|NCT01212770|5943923|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
1702822|NCT01212770|5943924|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
1702823|NCT01212770|5943925|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1702824|NCT01212770|5943926|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1702825|NCT01212770|5943927|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1702826|NCT01212770|5943928|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1702827|NCT01212770|5943929|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
1702828|NCT01212770|5943930|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
1702829|NCT01212770|5943931|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
1702830|NCT01212770|5943923|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702831|NCT01212770|5943924|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702832|NCT01212770|5943925|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702833|NCT01212770|5943926|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702834|NCT01212770|5943927|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702835|NCT01212770|5943928|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702836|NCT01212770|5943929|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702837|NCT01212770|5943930|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
1702838|NCT01212770|5943931|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
1702839|NCT01212770|5943923|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
1702840|NCT01212770|5943924|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
1702841|NCT01212770|5943925|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1702842|NCT01212770|5943926|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1702843|NCT01212770|5943927|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1702844|NCT01212770|5943928|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1702845|NCT01212770|5943929|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
1702846|NCT01212770|5943930|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
1702847|NCT01212770|5943931|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
1702848|NCT01212770|5943923|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
1702849|NCT01212770|5943924|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
1702850|NCT01212770|5943925|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
1702851|NCT01212770|5943926|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
1702852|NCT01212770|5943927|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
1702853|NCT01212770|5943928|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
1702854|NCT01212770|5943929|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
1702855|NCT01212770|5943930|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
1702856|NCT01212770|5943931|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
1702857|NCT01212770|5943923|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1702858|NCT01212770|5943924|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1702859|NCT01212770|5943925|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1702860|NCT01212770|5943926|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1702861|NCT01212770|5943927|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1702862|NCT01212770|5943928|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
1702863|NCT01212770|5943929|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
1702864|NCT01212770|5943930|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1702865|NCT01212770|5943931|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
1702866|NCT01212770|5943923|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702867|NCT01212770|5943924|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702868|NCT01212770|5943925|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702869|NCT01212770|5943926|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702870|NCT01212770|5943927|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702871|NCT01212770|5943928|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
1702872|NCT01212770|5943929|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702873|NCT01212770|5943930|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702874|NCT01212770|5943931|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
1702875|NCT01212770|5943923|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702876|NCT01212770|5943924|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702877|NCT01212770|5943925|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702878|NCT01212770|5943926|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702879|NCT01212770|5943927|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702880|NCT01212770|5943928|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702881|NCT01212770|5943929|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
1702882|NCT01212770|5943930|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702883|NCT01212770|5943931|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
1702884|NCT01212770|5943923|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1702885|NCT01212770|5943924|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1702886|NCT01212770|5943925|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1702887|NCT01212770|5943926|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1702888|NCT01212770|5943927|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
1702889|NCT01212770|5943928|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
1702890|NCT01212770|5943929|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
1702891|NCT01212770|5943930|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
1702892|NCT01212770|5943931|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
1702893|NCT01212770|5943923|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1702894|NCT01212770|5943924|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1702895|NCT01212770|5943925|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1702896|NCT01212770|5943926|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
1702897|NCT01212770|5943927|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
1702898|NCT01212770|5943928|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
1702899|NCT01212770|5943929|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
1702900|NCT01212770|5943930|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
1702901|NCT01212770|5943931|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
1702902|NCT01212770|5943923|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1702903|NCT01212770|5943924|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1702904|NCT01212770|5943925|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
1702905|NCT01212770|5943926|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1702906|NCT01212770|5943927|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1702907|NCT01212770|5943928|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
1702908|NCT01212770|5943929|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
1702909|NCT01212770|5943930|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
1702910|NCT01212770|5943931|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
1702911|NCT01212770|5943923|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1702912|NCT01212770|5943924|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1702913|NCT01212770|5943925|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1702914|NCT01212770|5943926|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1702915|NCT01212770|5943927|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1702916|NCT01212770|5943928|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
1702917|NCT01212770|5943929|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
1702918|NCT01212770|5943930|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
1702919|NCT01212770|5943931|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
1702920|NCT01212770|5943923|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702921|NCT01212770|5943924|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702922|NCT01212770|5943925|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702923|NCT01212770|5943926|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702924|NCT01212770|5943927|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702925|NCT01212770|5943928|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702926|NCT01212770|5943929|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1702927|NCT01212770|5943930|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702928|NCT01212770|5943931|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1702929|NCT01212770|5943923|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1702930|NCT01212770|5943924|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1702931|NCT01212770|5943925|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1702932|NCT01212770|5943926|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1702933|NCT01212770|5943927|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1702934|NCT01212770|5943928|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1702935|NCT01212770|5943929|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
1702936|NCT01212770|5943930|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1702937|NCT01212770|5943931|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1702938|NCT01212770|5943923|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1702939|NCT01212770|5943924|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1702940|NCT01212770|5943925|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1702941|NCT01212770|5943926|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1702942|NCT01212770|5943927|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1702943|NCT01212770|5943928|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1702944|NCT01212770|5943929|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
1702945|NCT01212770|5943930|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
1702946|NCT01212770|5943931|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
1702947|NCT01212770|5943923|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1702948|NCT01212770|5943924|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1702949|NCT01212770|5943925|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1702950|NCT01212770|5943926|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1702951|NCT01212770|5943927|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1702952|NCT01212770|5943928|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1702953|NCT01212770|5943929|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
1702954|NCT01212770|5943930|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
1702955|NCT01212770|5943931|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
1702956|NCT01212770|5943923|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1702957|NCT01212770|5943924|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1702958|NCT01212770|5943925|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1702959|NCT01212770|5943926|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1702960|NCT01212770|5943927|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1702961|NCT01212770|5943928|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1702962|NCT01212770|5943929|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
1702963|NCT01212770|5943930|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
1702964|NCT01212770|5943931|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
1702965|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1702966|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1702967|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1702968|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1702969|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1702970|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1702971|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
1702972|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
1702973|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
1702974|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702975|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702976|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702977|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702978|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702979|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702980|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702981|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
1702982|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
1702983|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
1702984|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
1702985|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1702986|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1702987|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1702988|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1702989|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
1702990|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
1702991|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
1702992|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
1702993|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
1702994|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
1702995|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
1702996|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
1702997|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
1702998|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
1702999|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
1703000|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
1703001|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
1703002|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
1703003|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1703004|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1703005|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1703006|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1703007|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
1703008|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
1703009|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
1703010|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703011|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
1703012|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703013|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703014|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703015|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703016|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703017|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703018|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
1703019|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 4)|Death|1
1703020|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 4)|Death|0
1703021|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 4)|Death|0
1703022|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 4)|Death|0
1703023|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 4)|Death|0
1703024|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 4)|Death|0
1703025|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 4)|Death|1
1703026|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 4)|Death|0
1703027|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 4)|Death|0
1703028|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
1703029|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
1703030|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1703031|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1703032|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1703033|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1703034|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
1703035|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
1703036|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
1703037|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
1703038|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
1703039|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1703040|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1703041|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1703042|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1703043|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
1703044|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
1703045|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
1703046|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
1703047|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
1703048|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
1703049|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
1703050|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
1703051|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
1703052|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
1703053|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
1703054|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
1703055|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
1703056|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1703057|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1703058|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1703059|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1703060|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1703061|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1703062|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
1703063|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
1703064|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
1703065|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1703066|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1703067|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1703068|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1703069|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1703070|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
1703071|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1703072|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
1703073|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703074|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703075|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703076|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703077|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703078|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703079|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703080|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
1703081|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
1703082|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
1703083|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703084|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703085|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703086|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703087|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703088|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703089|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703090|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
1703091|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1703092|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1703093|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1703094|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1703095|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1703096|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1703097|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
1703098|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
1703099|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
1703100|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703101|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703102|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703103|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703104|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703105|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703106|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
1703107|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703108|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
1703109|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
1703110|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
1703111|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1703112|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1703113|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1703114|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1703115|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
1703116|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
1703117|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
1703118|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
1703119|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
1703120|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
1703121|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
1703122|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
1703123|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
1703124|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
1703125|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
1703126|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
1703127|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703128|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703129|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703130|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703131|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703132|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703133|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
1703134|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703135|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
1703136|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
1703137|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
1703138|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1703139|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1703140|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1703141|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1703142|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
1703143|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
1703144|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
1703145|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1703146|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
1703147|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1703148|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1703149|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1703150|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1703151|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
1703152|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
1703153|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
1703154|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
1703155|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
1703156|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
1703157|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
1703158|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
1703159|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
1703160|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
1703161|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
1703162|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
1703163|NCT01212757|5944128|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
1703164|NCT01212757|5944129|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703165|NCT01212757|5944130|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703166|NCT01212757|5944131|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703167|NCT01212757|5944132|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703168|NCT01212757|5944133|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703169|NCT01212757|5944134|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703170|NCT01212757|5944135|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703171|NCT01212757|5944136|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
1703172|NCT01212757|5944128|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
1703173|NCT01212757|5944129|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
1703174|NCT01212757|5944130|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
1703175|NCT01212757|5944131|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
1703176|NCT01212757|5944132|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
1703177|NCT01212757|5944133|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
1703178|NCT01212757|5944134|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
1703179|NCT01212757|5944135|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
1703180|NCT01212757|5944136|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
1703181|NCT01212757|5944128|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1703182|NCT01212757|5944129|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1703183|NCT01212757|5944130|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1703184|NCT01212757|5944131|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1703185|NCT01212757|5944132|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1703186|NCT01212757|5944133|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1703187|NCT01212757|5944134|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1703188|NCT01212757|5944135|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
1703189|NCT01212757|5944136|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
1703190|NCT01212757|5944128|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1703191|NCT01212757|5944129|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1703192|NCT01212757|5944130|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1703193|NCT01212757|5944131|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1703194|NCT01212757|5944132|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
1703195|NCT01212757|5944133|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1703196|NCT01212757|5944134|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
1703197|NCT01212757|5944135|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
1703198|NCT01212757|5944136|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
1703199|NCT01212757|5944128|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703200|NCT01212757|5944129|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703201|NCT01212757|5944130|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703202|NCT01212757|5944131|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703203|NCT01212757|5944132|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703204|NCT01212757|5944133|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703205|NCT01212757|5944134|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
1703206|NCT01212757|5944135|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703207|NCT01212757|5944136|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
1703208|NCT01212757|5944128|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1703209|NCT01212757|5944129|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1703210|NCT01212757|5944130|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1703211|NCT01212757|5944131|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
1703212|NCT01212757|5944132|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1703213|NCT01212757|5944133|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
1703214|NCT01212757|5944134|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
1703215|NCT01212757|5944135|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
1703216|NCT01212757|5944136|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
1703217|NCT01212757|5944128|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1703218|NCT01212757|5944129|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1703219|NCT01212757|5944130|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1703220|NCT01212757|5944131|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
1703221|NCT01212757|5944132|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1703222|NCT01212757|5944133|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
1703223|NCT01212757|5944134|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
1703224|NCT01212757|5944135|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
1703225|NCT01212757|5944136|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
1703226|NCT01212757|5944128|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
1703227|NCT01212757|5944129|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
1703228|NCT01212757|5944130|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
1703229|NCT01212757|5944131|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
1703230|NCT01212757|5944132|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
1703231|NCT01212757|5944133|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
1703232|NCT01212757|5944134|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
1703233|NCT01212757|5944135|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
1703234|NCT01212757|5944136|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
1703235|NCT01212757|5944128|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1703236|NCT01212757|5944129|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1703237|NCT01212757|5944130|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1703238|NCT01212757|5944131|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1703239|NCT01212757|5944132|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1703240|NCT01212757|5944133|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1703241|NCT01212757|5944134|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1703242|NCT01212757|5944135|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
1703243|NCT01212757|5944136|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
1703244|NCT01212757|5944128|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1703245|NCT01212757|5944129|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1703246|NCT01212757|5944130|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1703247|NCT01212757|5944131|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1703248|NCT01212757|5944132|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1703249|NCT01212757|5944133|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
1703250|NCT01212757|5944134|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
1703251|NCT01212757|5944135|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1703252|NCT01212757|5944136|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
1703253|NCT01212757|5944128|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1703254|NCT01212757|5944129|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1703255|NCT01212757|5944130|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1703256|NCT01212757|5944131|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1703257|NCT01212757|5944132|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1703258|NCT01212757|5944133|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1703259|NCT01212757|5944134|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
1703260|NCT01212757|5944135|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
1703261|NCT01212757|5944136|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
1703262|NCT01212757|5944128|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1703263|NCT01212757|5944129|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1703264|NCT01212757|5944130|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1703265|NCT01212757|5944131|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1703266|NCT01212757|5944132|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1703267|NCT01212757|5944133|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
1703268|NCT01212757|5944134|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
1703269|NCT01212757|5944135|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
1703270|NCT01212757|5944136|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
1703271|NCT01212757|5944128|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1703272|NCT01212757|5944129|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1703273|NCT01212757|5944130|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1703274|NCT01212757|5944131|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1703275|NCT01212757|5944132|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1703276|NCT01212757|5944133|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
1703277|NCT01212757|5944134|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1703278|NCT01212757|5944135|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
1703279|NCT01212757|5944136|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
1703280|NCT01212757|5944128|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1703281|NCT01212757|5944129|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1703282|NCT01212757|5944130|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1703283|NCT01212757|5944131|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1703284|NCT01212757|5944132|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1703285|NCT01212757|5944133|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
1703286|NCT01212757|5944134|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
1703287|NCT01212757|5944135|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
1703288|NCT01212757|5944136|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
1703289|NCT01212744|5944320|P1|Overall Study|Withdrawal by Subject|1
1703290|NCT01212588|5944339|P2|Overall Study|Protocol Violation|1
1703291|NCT01212588|5944340|P1|Overall Study|Protocol Violation|1
1703292|NCT01212588|5944339|P2|Overall Study|Physician Decision|1
1703293|NCT01212588|5944340|P1|Overall Study|Physician Decision|0
1703294|NCT01212185|5944425|P2|Overall Study|Protocol Violation|1
1703295|NCT01212185|5944426|P1|Overall Study|Protocol Violation|2
1703296|NCT01212159|5944445|P2|Overall Study|Withdrawal by Subject|12
1703297|NCT01212159|5944446|P1|Overall Study|Withdrawal by Subject|12
1703298|NCT01212094|5944545|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
1703299|NCT01212094|5944546|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
1703300|NCT01212094|5944547|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
1703301|NCT01212094|5944545|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
1703302|NCT01212094|5944546|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
1703303|NCT01212094|5944547|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
1703304|NCT01212094|5944545|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
1703305|NCT01212094|5944546|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
1703306|NCT01212094|5944547|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
1703307|NCT01212094|5944545|P3|Year 1: Baseline Monitoring|Started on DMT|0
1703308|NCT01212094|5944546|P2|Year 1: Baseline Monitoring|Started on DMT|0
1703309|NCT01212094|5944547|P1|Year 1: Baseline Monitoring|Started on DMT|2
1703310|NCT01212094|5944545|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
1703311|NCT01212094|5944546|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
1703312|NCT01212094|5944547|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
1703313|NCT01212094|5944545|P3|Year 1: Baseline Monitoring|Study terminated|0
1703314|NCT01212094|5944546|P2|Year 1: Baseline Monitoring|Study terminated|0
1703315|NCT01212094|5944547|P1|Year 1: Baseline Monitoring|Study terminated|7
1703316|NCT01211769|5944606|P4|Overall Study|Adverse Event|1
1703317|NCT01211769|5944607|P3|Overall Study|Adverse Event|1
1703318|NCT01211769|5944608|P2|Overall Study|Adverse Event|1
1703319|NCT01211769|5944609|P1|Overall Study|Adverse Event|0
1703320|NCT01211769|5944606|P4|Overall Study|Physician Decision|1
1703321|NCT01211769|5944607|P3|Overall Study|Physician Decision|2
1703322|NCT01211769|5944608|P2|Overall Study|Physician Decision|0
1703323|NCT01211769|5944609|P1|Overall Study|Physician Decision|2
1703324|NCT01211769|5944606|P4|Overall Study|Lost to Follow-up|9
1703325|NCT01211769|5944607|P3|Overall Study|Lost to Follow-up|5
1703326|NCT01211769|5944608|P2|Overall Study|Lost to Follow-up|9
1703327|NCT01211769|5944609|P1|Overall Study|Lost to Follow-up|7
1703328|NCT01211665|5944664|P2|Overall Study|Death|0
1703329|NCT01211665|5944665|P1|Overall Study|Death|1
1703330|NCT01211665|5944664|P2|Overall Study|Withdrawal by Subject|0
1703331|NCT01211665|5944665|P1|Overall Study|Withdrawal by Subject|1
1703332|NCT01211613|5944692|P3|Overall Study|Withdrawal by Subject|0
1703333|NCT01211613|5944693|P2|Overall Study|Withdrawal by Subject|0
1703334|NCT01211613|5944694|P1|Overall Study|Withdrawal by Subject|1
1703335|NCT01211613|5944692|P3|Overall Study|Lost to Follow-up|2
1703336|NCT01211613|5944693|P2|Overall Study|Lost to Follow-up|2
1703337|NCT01211613|5944694|P1|Overall Study|Lost to Follow-up|2
1703338|NCT01211535|5944740|P2|Overall Study|Adverse Event|1
1703339|NCT01211535|5944741|P1|Overall Study|Adverse Event|0
1703340|NCT01211522|5944750|P3|Overall Study|Withdrawal by Subject|5
1703341|NCT01211522|5944751|P2|Overall Study|Withdrawal by Subject|7
1703342|NCT01211522|5944752|P1|Overall Study|Withdrawal by Subject|3
1703343|NCT01211197|5944800|P6|Washout Period 2 (7 Days)|Adverse Event|0
1703344|NCT01211197|5944801|P5|Washout Period 2 (7 Days)|Adverse Event|0
1703345|NCT01211197|5944802|P4|Washout Period 2 (7 Days)|Adverse Event|0
1703346|NCT01211197|5944803|P3|Washout Period 2 (7 Days)|Adverse Event|0
1703347|NCT01211197|5944804|P2|Washout Period 2 (7 Days)|Adverse Event|0
1703348|NCT01211197|5944805|P1|Washout Period 2 (7 Days)|Adverse Event|1
1703349|NCT01211197|5944800|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1703350|NCT01211197|5944801|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1703351|NCT01211197|5944802|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1703352|NCT01211197|5944803|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
1703353|NCT01211197|5944804|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1703354|NCT01211197|5944805|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
1703355|NCT01211184|5944852|P3|Overall Study|Withdrawal by Subject|1
1703356|NCT01211184|5944853|P2|Overall Study|Withdrawal by Subject|2
1703357|NCT01211184|5944854|P1|Overall Study|Withdrawal by Subject|0
1703358|NCT01211145|5944869|P4|Overall Study|Patient decision|2
1703359|NCT01211145|5944870|P3|Overall Study|Patient decision|0
1703360|NCT01211145|5944871|P2|Overall Study|Patient decision|1
1703361|NCT01211145|5944872|P1|Overall Study|Patient decision|2
1703362|NCT01211145|5944869|P4|Overall Study|Eligibility criteria not fulfilled|15
1703363|NCT01211145|5944870|P3|Overall Study|Eligibility criteria not fulfilled|10
1703364|NCT01211145|5944871|P2|Overall Study|Eligibility criteria not fulfilled|12
1703365|NCT01211145|5944872|P1|Overall Study|Eligibility criteria not fulfilled|16
1703366|NCT01211145|5944869|P4|Overall Study|Severe noncompliance to protocol|0
1703367|NCT01211145|5944870|P3|Overall Study|Severe noncompliance to protocol|0
1703368|NCT01211145|5944871|P2|Overall Study|Severe noncompliance to protocol|0
1703369|NCT01211145|5944872|P1|Overall Study|Severe noncompliance to protocol|1
1703370|NCT01211145|5944869|P4|Overall Study|Study-specific withdrawal criteria|0
1703371|NCT01211145|5944870|P3|Overall Study|Study-specific withdrawal criteria|0
1703372|NCT01211145|5944871|P2|Overall Study|Study-specific withdrawal criteria|0
1703373|NCT01211145|5944872|P1|Overall Study|Study-specific withdrawal criteria|1
1703374|NCT01211145|5944869|P4|Overall Study|Lost to Follow-up|2
1703375|NCT01211145|5944870|P3|Overall Study|Lost to Follow-up|1
1703376|NCT01211145|5944871|P2|Overall Study|Lost to Follow-up|2
1703377|NCT01211145|5944872|P1|Overall Study|Lost to Follow-up|3
1703378|NCT01211145|5944869|P4|Overall Study|Reason not specified|1
1703379|NCT01211145|5944870|P3|Overall Study|Reason not specified|2
1703380|NCT01211145|5944871|P2|Overall Study|Reason not specified|2
1703381|NCT01211145|5944872|P1|Overall Study|Reason not specified|3
1703382|NCT01210807|5944926|P2|Overall Study|Not implanted bilaterally|1
1703383|NCT01210807|5944927|P1|Overall Study|Not implanted bilaterally|2
1703384|NCT01210807|5944926|P2|Overall Study|Lost to Follow-up|2
1703385|NCT01210807|5944927|P1|Overall Study|Lost to Follow-up|1
1703386|NCT01210690|5944942|P1|Overall Study|Patient could not take glucose|1
1703387|NCT01210690|5944942|P1|Overall Study|Patient refused to swallow|1
1703388|NCT01210690|5944942|P1|Overall Study|Withdrawal by Subject|1
1703389|NCT01210690|5944942|P1|Overall Study|Disease Remission|1
1703390|NCT01210690|5944942|P1|Overall Study|Lost to Follow-up|3
1703391|NCT01210690|5944942|P1|Overall Study|Lack of Efficacy|12
1703392|NCT01210690|5944942|P1|Overall Study|Adverse Event|7
1703393|NCT01210664|5944955|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
1703394|NCT01210664|5944956|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1703395|NCT01210664|5944957|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1703396|NCT01210664|5944958|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
1703397|NCT01210664|5944955|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1703398|NCT01210664|5944956|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
1703399|NCT01210664|5944957|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1703400|NCT01210664|5944958|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
1703401|NCT01210664|5944955|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1703402|NCT01210664|5944956|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
1703403|NCT01210664|5944957|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1703404|NCT01210664|5944958|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
1703405|NCT01210651|5944986|P2|Overall Study|Injury outside study|0
1703406|NCT01210651|5944987|P1|Overall Study|Injury outside study|2
1703407|NCT01210651|5944986|P2|Overall Study|Withdrawal by Subject|1
1703408|NCT01210651|5944987|P1|Overall Study|Withdrawal by Subject|1
1703409|NCT01210651|5944986|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
1703410|NCT01210651|5944987|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
1703411|NCT01210651|5944986|P2|Overall Study|schedule conflicts|5
1703412|NCT01210651|5944987|P1|Overall Study|schedule conflicts|1
1703413|NCT01210651|5944986|P2|Overall Study|Lost to Follow-up|1
1703414|NCT01210651|5944987|P1|Overall Study|Lost to Follow-up|1
1703415|NCT01210495|5945107|P4|Overall Study|Other unspecified|0
1703416|NCT01210495|5945108|P3|Overall Study|Other unspecified|6
1703417|NCT01210495|5945109|P2|Overall Study|Other unspecified|0
1703418|NCT01210495|5945110|P1|Overall Study|Other unspecified|0
1703419|NCT01210495|5945107|P4|Overall Study|Lost to Follow-up|1
1703420|NCT01210495|5945108|P3|Overall Study|Lost to Follow-up|1
1703421|NCT01210495|5945109|P2|Overall Study|Lost to Follow-up|0
1703422|NCT01210495|5945110|P1|Overall Study|Lost to Follow-up|0
1703423|NCT01210495|5945107|P4|Overall Study|Study Terminated by Sponsor|11
1703424|NCT01210495|5945108|P3|Overall Study|Study Terminated by Sponsor|4
1703425|NCT01210495|5945109|P2|Overall Study|Study Terminated by Sponsor|0
1703426|NCT01210495|5945110|P1|Overall Study|Study Terminated by Sponsor|0
1703427|NCT01210495|5945107|P4|Overall Study|Death|54
1703428|NCT01210495|5945108|P3|Overall Study|Death|112
1703429|NCT01210495|5945109|P2|Overall Study|Death|7
1703430|NCT01210495|5945110|P1|Overall Study|Death|14
1703431|NCT01210495|5945107|P4|Overall Study|Participant Refused Further Follow-Up|2
1703432|NCT01210495|5945108|P3|Overall Study|Participant Refused Further Follow-Up|11
1703433|NCT01210495|5945109|P2|Overall Study|Participant Refused Further Follow-Up|0
1703434|NCT01210495|5945110|P1|Overall Study|Participant Refused Further Follow-Up|1
1703435|NCT01210443|5945172|P1|Overall Study|Study terminated by sponsor|2
1703436|NCT01210352|5945189|P9|Overall Study|Patient Discharged Early|0
1703437|NCT01210352|5945190|P8|Overall Study|Patient Discharged Early|0
1703438|NCT01210352|5945191|P7|Overall Study|Patient Discharged Early|0
1703439|NCT01210352|5945192|P6|Overall Study|Patient Discharged Early|0
1703440|NCT01210352|5945193|P5|Overall Study|Patient Discharged Early|0
1703441|NCT01210352|5945194|P4|Overall Study|Patient Discharged Early|0
1703442|NCT01210352|5945195|P3|Overall Study|Patient Discharged Early|1
1703443|NCT01210352|5945196|P2|Overall Study|Patient Discharged Early|0
1703444|NCT01210352|5945197|P1|Overall Study|Patient Discharged Early|0
1703445|NCT01210352|5945189|P9|Overall Study|Withdrawal by Subject|1
1703446|NCT01210352|5945190|P8|Overall Study|Withdrawal by Subject|0
1703447|NCT01210352|5945191|P7|Overall Study|Withdrawal by Subject|1
1703448|NCT01210352|5945192|P6|Overall Study|Withdrawal by Subject|0
1703449|NCT01210352|5945193|P5|Overall Study|Withdrawal by Subject|0
1703450|NCT01210352|5945194|P4|Overall Study|Withdrawal by Subject|0
1703451|NCT01210352|5945195|P3|Overall Study|Withdrawal by Subject|1
1703452|NCT01210352|5945196|P2|Overall Study|Withdrawal by Subject|0
1703453|NCT01210352|5945197|P1|Overall Study|Withdrawal by Subject|0
1703454|NCT01210352|5945189|P9|Overall Study|Physician Decision|2
1703455|NCT01210352|5945190|P8|Overall Study|Physician Decision|1
1703456|NCT01210352|5945191|P7|Overall Study|Physician Decision|0
1703457|NCT01210352|5945192|P6|Overall Study|Physician Decision|0
1703458|NCT01210352|5945193|P5|Overall Study|Physician Decision|0
1703459|NCT01210352|5945194|P4|Overall Study|Physician Decision|0
1703460|NCT01210352|5945195|P3|Overall Study|Physician Decision|0
1703461|NCT01210352|5945196|P2|Overall Study|Physician Decision|0
1703462|NCT01210352|5945197|P1|Overall Study|Physician Decision|0
1703463|NCT01210352|5945189|P9|Overall Study|Lack of Efficacy|0
1703464|NCT01210352|5945190|P8|Overall Study|Lack of Efficacy|0
1703465|NCT01210352|5945191|P7|Overall Study|Lack of Efficacy|1
1703466|NCT01210352|5945192|P6|Overall Study|Lack of Efficacy|0
1703467|NCT01210352|5945193|P5|Overall Study|Lack of Efficacy|0
1703468|NCT01210352|5945194|P4|Overall Study|Lack of Efficacy|0
1703469|NCT01210352|5945195|P3|Overall Study|Lack of Efficacy|0
1703470|NCT01210352|5945196|P2|Overall Study|Lack of Efficacy|0
1703471|NCT01210352|5945197|P1|Overall Study|Lack of Efficacy|0
1703472|NCT01210352|5945189|P9|Overall Study|Adverse Event|1
1703473|NCT01210352|5945190|P8|Overall Study|Adverse Event|2
1703474|NCT01210352|5945191|P7|Overall Study|Adverse Event|0
1703475|NCT01210352|5945192|P6|Overall Study|Adverse Event|0
1703476|NCT01210352|5945193|P5|Overall Study|Adverse Event|0
1703477|NCT01210352|5945194|P4|Overall Study|Adverse Event|0
1703478|NCT01210352|5945195|P3|Overall Study|Adverse Event|0
1703479|NCT01210352|5945196|P2|Overall Study|Adverse Event|0
1703480|NCT01210352|5945197|P1|Overall Study|Adverse Event|0
1703481|NCT01210222|5945388|P1|Overall Study|Never treated|1
1703482|NCT01210222|5945388|P1|Overall Study|Ineligible|2
1703483|NCT01210144|5945424|P2|Overall Study|No transfer|0
1703484|NCT01210144|5945425|P1|Overall Study|No transfer|1
1703485|NCT01210144|5945424|P2|Overall Study|No fertilization|0
1703486|NCT01210144|5945425|P1|Overall Study|No fertilization|1
1703487|NCT01210144|5945424|P2|Overall Study|Lack of ovarian response|0
1703488|NCT01210144|5945425|P1|Overall Study|Lack of ovarian response|1
1703489|NCT01210118|5945447|P2|Overall Study|Spontaneous abortion|3
1703490|NCT01210118|5945448|P1|Overall Study|Spontaneous abortion|1
1703491|NCT01210118|5945447|P2|Overall Study|Protocol Violation|1
1703492|NCT01210118|5945448|P1|Overall Study|Protocol Violation|1
1703493|NCT01210118|5945447|P2|Overall Study|Lost to Follow-up|1
1703494|NCT01210118|5945448|P1|Overall Study|Lost to Follow-up|1
1703495|NCT01210001|5945472|P3|Overall Study|Other reason not defined above|1
1703496|NCT01210001|5945473|P2|Overall Study|Other reason not defined above|2
1703497|NCT01210001|5945474|P1|Overall Study|Other reason not defined above|2
1703498|NCT01210001|5945472|P3|Overall Study|Patient refusal to continue,not due toAE|1
1703499|NCT01210001|5945473|P2|Overall Study|Patient refusal to continue,not due toAE|2
1703500|NCT01210001|5945474|P1|Overall Study|Patient refusal to continue,not due toAE|6
1703501|NCT01210001|5945472|P3|Overall Study|Lost to Follow-up|2
1703502|NCT01210001|5945473|P2|Overall Study|Lost to Follow-up|3
1703503|NCT01210001|5945474|P1|Overall Study|Lost to Follow-up|4
1703504|NCT01210001|5945472|P3|Overall Study|Non compliant with protocol|3
1703505|NCT01210001|5945473|P2|Overall Study|Non compliant with protocol|2
1703506|NCT01210001|5945474|P1|Overall Study|Non compliant with protocol|2
1703507|NCT01210001|5945472|P3|Overall Study|Adverse Event|5
1703508|NCT01210001|5945473|P2|Overall Study|Adverse Event|2
1703509|NCT01210001|5945474|P1|Overall Study|Adverse Event|4
1703510|NCT01210001|5945472|P3|Overall Study|Not treated|0
1703511|NCT01210001|5945473|P2|Overall Study|Not treated|0
1703512|NCT01210001|5945474|P1|Overall Study|Not treated|1
1703513|NCT01209949|5945494|P1|Overall Study|Lost to Follow-up|3
1703514|NCT01209832|5945500|P1|Period 2|Sponsor Decision|1
1703515|NCT01209832|5945500|P1|Period 1|Sponsor Decision and was not dosed|1
1703516|NCT01209780|5945519|P5|Overall Study|Inappropriate enrollment|1
1703517|NCT01209780|5945520|P4|Overall Study|Inappropriate enrollment|0
1703518|NCT01209780|5945521|P3|Overall Study|Inappropriate enrollment|0
1703519|NCT01209780|5945522|P2|Overall Study|Inappropriate enrollment|2
1703520|NCT01209780|5945523|P1|Overall Study|Inappropriate enrollment|0
1703521|NCT01209780|5945519|P5|Overall Study|Protocol Violation|0
1703522|NCT01209780|5945520|P4|Overall Study|Protocol Violation|0
1703523|NCT01209780|5945521|P3|Overall Study|Protocol Violation|0
1703524|NCT01209780|5945522|P2|Overall Study|Protocol Violation|1
1703525|NCT01209780|5945523|P1|Overall Study|Protocol Violation|0
1703526|NCT01209780|5945519|P5|Overall Study|Lost to Follow-up|4
1703527|NCT01209780|5945520|P4|Overall Study|Lost to Follow-up|9
1703528|NCT01209780|5945521|P3|Overall Study|Lost to Follow-up|3
1703529|NCT01209780|5945522|P2|Overall Study|Lost to Follow-up|12
1703530|NCT01209780|5945523|P1|Overall Study|Lost to Follow-up|17
1703531|NCT01209780|5945519|P5|Overall Study|Withdrawal by Subject|0
1703532|NCT01209780|5945520|P4|Overall Study|Withdrawal by Subject|1
1703533|NCT01209780|5945521|P3|Overall Study|Withdrawal by Subject|1
1703534|NCT01209780|5945522|P2|Overall Study|Withdrawal by Subject|2
1703535|NCT01209780|5945523|P1|Overall Study|Withdrawal by Subject|9
1703536|NCT01209780|5945519|P5|Overall Study|Adverse Event|0
1703537|NCT01209780|5945520|P4|Overall Study|Adverse Event|0
1703538|NCT01209780|5945521|P3|Overall Study|Adverse Event|0
1703539|NCT01209780|5945522|P2|Overall Study|Adverse Event|1
1703540|NCT01209780|5945523|P1|Overall Study|Adverse Event|0
1703541|NCT01209767|5945549|P1|Overall Study|Lost to Follow-up|3
1703542|NCT01209767|5945549|P1|Overall Study|Withdrawal by Subject|1
1703543|NCT01209689|5945618|P2|Overall Study|Sponsor's Decision to Stop the Study|17
1703544|NCT01209689|5945619|P1|Overall Study|Sponsor's Decision to Stop the Study|68
1703545|NCT01209689|5945618|P2|Overall Study|Failure to Return|0
1703546|NCT01209689|5945619|P1|Overall Study|Failure to Return|3
1703547|NCT01209689|5945618|P2|Overall Study|Violation of Selection Criteria at Entry|0
1703548|NCT01209689|5945619|P1|Overall Study|Violation of Selection Criteria at Entry|1
1703549|NCT01209689|5945618|P2|Overall Study|Adverse Event|0
1703550|NCT01209689|5945619|P1|Overall Study|Adverse Event|4
1703551|NCT01209689|5945618|P2|Overall Study|Refused Treatment|3
1703552|NCT01209689|5945619|P1|Overall Study|Refused Treatment|8
1703553|NCT01209689|5945618|P2|Overall Study|Insufficient Therapeutic Response|2
1703554|NCT01209689|5945619|P1|Overall Study|Insufficient Therapeutic Response|7
1703555|NCT01209624|5945625|P1|Overall Study|Other|4
1703556|NCT01209624|5945625|P1|Overall Study|Lost to Follow-up|290
1703557|NCT01209624|5945625|P1|Overall Study|Lack of Efficacy|17
1703558|NCT01209624|5945625|P1|Overall Study|Adverse Event|13
1703559|NCT01209624|5945625|P1|Overall Study|Death|2
1703560|NCT01209598|5945658|P2|Overall Study|Withdrawal by Subject|0
1703561|NCT01209598|5945659|P1|Overall Study|Withdrawal by Subject|1
1703562|NCT01209520|5945667|P1|Overall Study|Withdrawal by Subject|3
1703563|NCT01209286|5945680|P3|Overall Study|Other|0
1703564|NCT01209286|5945681|P2|Overall Study|Other|1
1703565|NCT01209286|5945682|P1|Overall Study|Other|0
1703566|NCT01209286|5945680|P3|Overall Study|Physician Decision|0
1703567|NCT01209286|5945681|P2|Overall Study|Physician Decision|2
1703568|NCT01209286|5945682|P1|Overall Study|Physician Decision|0
1703569|NCT01209286|5945680|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
1703570|NCT01209286|5945681|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
1703571|NCT01209286|5945682|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
1703572|NCT01209286|5945680|P3|Overall Study|Hematological Relapse After Remission|1
1703573|NCT01209286|5945681|P2|Overall Study|Hematological Relapse After Remission|1
1703574|NCT01209286|5945682|P1|Overall Study|Hematological Relapse After Remission|0
1703575|NCT01209286|5945680|P3|Overall Study|Adverse Event|1
1703576|NCT01209286|5945681|P2|Overall Study|Adverse Event|3
1703577|NCT01209286|5945682|P1|Overall Study|Adverse Event|4
1703578|NCT01209143|5945791|P2|Overall Study|Disease progression|16
1703579|NCT01209143|5945792|P1|Overall Study|Disease progression|11
1703580|NCT01209143|5945791|P2|Overall Study|Withdrawal by Subject|1
1703581|NCT01209143|5945792|P1|Overall Study|Withdrawal by Subject|2
1703582|NCT01209143|5945791|P2|Overall Study|Lost to Follow-up|0
1703583|NCT01209143|5945792|P1|Overall Study|Lost to Follow-up|1
1703584|NCT01209143|5945791|P2|Overall Study|Physician Decision|1
1703585|NCT01209143|5945792|P1|Overall Study|Physician Decision|3
1703586|NCT01209143|5945791|P2|Overall Study|Death|1
1703587|NCT01209143|5945792|P1|Overall Study|Death|0
1703588|NCT01209143|5945791|P2|Overall Study|Adverse Event|1
1703589|NCT01209143|5945792|P1|Overall Study|Adverse Event|2
1703590|NCT01209078|5945802|P2|Overall Study|Withdrawal by Subject|1
1703591|NCT01209078|5945803|P1|Overall Study|Withdrawal by Subject|2
1703592|NCT01209078|5945802|P2|Overall Study|Physician Decision|2
1703593|NCT01209078|5945803|P1|Overall Study|Physician Decision|5
1703594|NCT01209078|5945802|P2|Overall Study|Lost to Follow-up|0
1703595|NCT01209078|5945803|P1|Overall Study|Lost to Follow-up|4
1703596|NCT01209078|5945802|P2|Overall Study|Adverse Event|0
1703597|NCT01209078|5945803|P1|Overall Study|Adverse Event|5
1703598|NCT01208961|5945878|P2|High-Fat Period III|Protocol Violation|0
1703599|NCT01208961|5945879|P1|High-Fat Period III|Protocol Violation|1
1703600|NCT01208870|5945901|P2|Overall Study|Lost to Follow-up|8
1703601|NCT01208870|5945902|P1|Overall Study|Lost to Follow-up|2
1703602|NCT01208415|5945918|P1|Overall Study|Still be eligible for follow-up|33
1703603|NCT01208415|5945918|P1|Overall Study|Device not placed|1
1703604|NCT01208415|5945918|P1|Overall Study|Withdrawal by Subject|3
1703605|NCT01208415|5945918|P1|Overall Study|Lost to Follow-up|2
1703606|NCT01208415|5945918|P1|Overall Study|Death|1
1703607|NCT01208402|5945924|P2|Overall Study|Withdrawal by Subject|0
1703608|NCT01208402|5945925|P1|Overall Study|Withdrawal by Subject|1
1703609|NCT01208337|5945941|P1|Overall Study|Death|3
1703610|NCT01208233|5945955|P6|Overall Study|Withdrawal by Subject|2
1703611|NCT01208233|5945956|P5|Overall Study|Withdrawal by Subject|4
1703612|NCT01208233|5945957|P4|Overall Study|Withdrawal by Subject|1
1703613|NCT01208233|5945958|P3|Overall Study|Withdrawal by Subject|1
1703614|NCT01208233|5945959|P2|Overall Study|Withdrawal by Subject|0
1703615|NCT01208233|5945960|P1|Overall Study|Withdrawal by Subject|1
1703616|NCT01208233|5945955|P6|Overall Study|Other|1
1703617|NCT01208233|5945956|P5|Overall Study|Other|0
1703618|NCT01208233|5945957|P4|Overall Study|Other|0
1703619|NCT01208233|5945958|P3|Overall Study|Other|0
1703620|NCT01208233|5945959|P2|Overall Study|Other|1
1703621|NCT01208233|5945960|P1|Overall Study|Other|2
1703622|NCT01208233|5945955|P6|Overall Study|Protocol Violation|0
1703623|NCT01208233|5945956|P5|Overall Study|Protocol Violation|3
1703624|NCT01208233|5945957|P4|Overall Study|Protocol Violation|0
1703625|NCT01208233|5945958|P3|Overall Study|Protocol Violation|0
1703626|NCT01208233|5945959|P2|Overall Study|Protocol Violation|0
1703627|NCT01208233|5945960|P1|Overall Study|Protocol Violation|0
1703628|NCT01208233|5945955|P6|Overall Study|Study terminated by sponsor|7
1703629|NCT01208233|5945956|P5|Overall Study|Study terminated by sponsor|10
1703630|NCT01208233|5945957|P4|Overall Study|Study terminated by sponsor|0
1703631|NCT01208233|5945958|P3|Overall Study|Study terminated by sponsor|0
1703632|NCT01208233|5945959|P2|Overall Study|Study terminated by sponsor|0
1703633|NCT01208233|5945960|P1|Overall Study|Study terminated by sponsor|0
1703634|NCT01208233|5945955|P6|Overall Study|Medication error without adverse event|1
1703635|NCT01208233|5945956|P5|Overall Study|Medication error without adverse event|0
1703636|NCT01208233|5945957|P4|Overall Study|Medication error without adverse event|0
1703637|NCT01208233|5945958|P3|Overall Study|Medication error without adverse event|0
1703638|NCT01208233|5945959|P2|Overall Study|Medication error without adverse event|0
1703639|NCT01208233|5945960|P1|Overall Study|Medication error without adverse event|0
1703640|NCT01208233|5945955|P6|Overall Study|Did not meet entrance criteria|0
1703641|NCT01208233|5945956|P5|Overall Study|Did not meet entrance criteria|1
1703642|NCT01208233|5945957|P4|Overall Study|Did not meet entrance criteria|0
1703643|NCT01208233|5945958|P3|Overall Study|Did not meet entrance criteria|1
1703644|NCT01208233|5945959|P2|Overall Study|Did not meet entrance criteria|1
1703645|NCT01208233|5945960|P1|Overall Study|Did not meet entrance criteria|2
1703646|NCT01208233|5945955|P6|Overall Study|Death|5
1703647|NCT01208233|5945956|P5|Overall Study|Death|3
1703648|NCT01208233|5945957|P4|Overall Study|Death|0
1703649|NCT01208233|5945958|P3|Overall Study|Death|0
1703650|NCT01208233|5945959|P2|Overall Study|Death|0
1703651|NCT01208233|5945960|P1|Overall Study|Death|0
1703652|NCT01208233|5945955|P6|Overall Study|Adverse Event|5
1703653|NCT01208233|5945956|P5|Overall Study|Adverse Event|3
1703654|NCT01208233|5945957|P4|Overall Study|Adverse Event|0
1703655|NCT01208233|5945958|P3|Overall Study|Adverse Event|2
1703656|NCT01208233|5945959|P2|Overall Study|Adverse Event|1
1703657|NCT01208233|5945960|P1|Overall Study|Adverse Event|0
1703658|NCT01208207|5946085|P7|Part II|Technical Problems|0
1703659|NCT01208207|5946086|P6|Part II|Technical Problems|1
1703660|NCT01208207|5946087|P5|Part II|Technical Problems|0
1703661|NCT01208207|5946088|P4|Part II|Technical Problems|1
1703662|NCT01208207|5946089|P3|Part II|Technical Problems|0
1703663|NCT01208207|5946090|P2|Part II|Technical Problems|0
1703664|NCT01208207|5946091|P1|Part II|Technical Problems|0
1703665|NCT01208207|5946085|P7|Part II|Protocol Violation|0
1703666|NCT01208207|5946086|P6|Part II|Protocol Violation|0
1703667|NCT01208207|5946087|P5|Part II|Protocol Violation|0
1703668|NCT01208207|5946088|P4|Part II|Protocol Violation|1
1703669|NCT01208207|5946089|P3|Part II|Protocol Violation|0
1703670|NCT01208207|5946090|P2|Part II|Protocol Violation|0
1703671|NCT01208207|5946091|P1|Part II|Protocol Violation|0
1703672|NCT01208207|5946085|P7|Part II|Physician Decision|0
1703673|NCT01208207|5946086|P6|Part II|Physician Decision|2
1703674|NCT01208207|5946087|P5|Part II|Physician Decision|0
1703675|NCT01208207|5946088|P4|Part II|Physician Decision|1
1703676|NCT01208207|5946089|P3|Part II|Physician Decision|0
1703677|NCT01208207|5946090|P2|Part II|Physician Decision|0
1703678|NCT01208207|5946091|P1|Part II|Physician Decision|0
1703679|NCT01208207|5946085|P7|Part II|Non-Compliance With Study Drug|0
1703680|NCT01208207|5946086|P6|Part II|Non-Compliance With Study Drug|1
1703681|NCT01208207|5946087|P5|Part II|Non-Compliance With Study Drug|1
1703682|NCT01208207|5946088|P4|Part II|Non-Compliance With Study Drug|4
1703683|NCT01208207|5946089|P3|Part II|Non-Compliance With Study Drug|0
1703684|NCT01208207|5946090|P2|Part II|Non-Compliance With Study Drug|0
1703685|NCT01208207|5946091|P1|Part II|Non-Compliance With Study Drug|0
1703686|NCT01208207|5946085|P7|Part II|Lost to Follow-up|1
1703687|NCT01208207|5946086|P6|Part II|Lost to Follow-up|2
1703688|NCT01208207|5946087|P5|Part II|Lost to Follow-up|0
1703689|NCT01208207|5946088|P4|Part II|Lost to Follow-up|4
1703690|NCT01208207|5946089|P3|Part II|Lost to Follow-up|0
1703691|NCT01208207|5946090|P2|Part II|Lost to Follow-up|0
1703692|NCT01208207|5946091|P1|Part II|Lost to Follow-up|0
1703693|NCT01208207|5946085|P7|Part II|Lack of Efficacy|3
1703694|NCT01208207|5946086|P6|Part II|Lack of Efficacy|3
1703695|NCT01208207|5946087|P5|Part II|Lack of Efficacy|4
1703696|NCT01208207|5946088|P4|Part II|Lack of Efficacy|6
1703697|NCT01208207|5946089|P3|Part II|Lack of Efficacy|0
1703698|NCT01208207|5946090|P2|Part II|Lack of Efficacy|0
1703699|NCT01208207|5946091|P1|Part II|Lack of Efficacy|0
1703700|NCT01208207|5946085|P7|Part II|Adverse Event|2
1703701|NCT01208207|5946086|P6|Part II|Adverse Event|4
1703702|NCT01208207|5946087|P5|Part II|Adverse Event|9
1703703|NCT01208207|5946088|P4|Part II|Adverse Event|5
1703704|NCT01208207|5946089|P3|Part II|Adverse Event|0
1703705|NCT01208207|5946090|P2|Part II|Adverse Event|0
1703706|NCT01208207|5946091|P1|Part II|Adverse Event|0
1703707|NCT01208207|5946085|P7|Part II|Withdrawal by Subject|5
1703708|NCT01208207|5946086|P6|Part II|Withdrawal by Subject|3
1703709|NCT01208207|5946087|P5|Part II|Withdrawal by Subject|9
1703710|NCT01208207|5946088|P4|Part II|Withdrawal by Subject|10
1703711|NCT01208207|5946089|P3|Part II|Withdrawal by Subject|0
1703712|NCT01208207|5946090|P2|Part II|Withdrawal by Subject|0
1703713|NCT01208207|5946091|P1|Part II|Withdrawal by Subject|0
1703714|NCT01208207|5946085|P7|Part I|Withdrawal by Subject|0
1703715|NCT01208207|5946086|P6|Part I|Withdrawal by Subject|0
1703716|NCT01208207|5946087|P5|Part I|Withdrawal by Subject|0
1703717|NCT01208207|5946088|P4|Part I|Withdrawal by Subject|0
1703718|NCT01208207|5946089|P3|Part I|Withdrawal by Subject|4
1703719|NCT01208207|5946090|P2|Part I|Withdrawal by Subject|4
1703720|NCT01208207|5946091|P1|Part I|Withdrawal by Subject|14
1703721|NCT01208207|5946085|P7|Part I|Protocol Violation|0
1703722|NCT01208207|5946086|P6|Part I|Protocol Violation|0
1703723|NCT01208207|5946087|P5|Part I|Protocol Violation|0
1703724|NCT01208207|5946088|P4|Part I|Protocol Violation|0
1703725|NCT01208207|5946089|P3|Part I|Protocol Violation|2
1703726|NCT01208207|5946090|P2|Part I|Protocol Violation|0
1703727|NCT01208207|5946091|P1|Part I|Protocol Violation|8
1703728|NCT01208207|5946085|P7|Part I|Progressive Disease|0
1703729|NCT01208207|5946086|P6|Part I|Progressive Disease|0
1703730|NCT01208207|5946087|P5|Part I|Progressive Disease|0
1703731|NCT01208207|5946088|P4|Part I|Progressive Disease|0
1703732|NCT01208207|5946089|P3|Part I|Progressive Disease|0
1703733|NCT01208207|5946090|P2|Part I|Progressive Disease|0
1703734|NCT01208207|5946091|P1|Part I|Progressive Disease|1
1703735|NCT01208207|5946085|P7|Part I|Physician Decision|0
1703736|NCT01208207|5946086|P6|Part I|Physician Decision|0
1703737|NCT01208207|5946087|P5|Part I|Physician Decision|0
1703738|NCT01208207|5946088|P4|Part I|Physician Decision|0
1703739|NCT01208207|5946089|P3|Part I|Physician Decision|0
1703740|NCT01208207|5946090|P2|Part I|Physician Decision|1
1703741|NCT01208207|5946091|P1|Part I|Physician Decision|0
1703742|NCT01208207|5946085|P7|Part I|Non-Compliance With Study Drug|0
1703743|NCT01208207|5946086|P6|Part I|Non-Compliance With Study Drug|0
1703744|NCT01208207|5946087|P5|Part I|Non-Compliance With Study Drug|0
1703745|NCT01208207|5946088|P4|Part I|Non-Compliance With Study Drug|0
1703746|NCT01208207|5946089|P3|Part I|Non-Compliance With Study Drug|1
1703747|NCT01208207|5946090|P2|Part I|Non-Compliance With Study Drug|0
1703748|NCT01208207|5946091|P1|Part I|Non-Compliance With Study Drug|1
1703749|NCT01208207|5946085|P7|Part I|Lost to Follow-up|0
1703750|NCT01208207|5946086|P6|Part I|Lost to Follow-up|0
1703751|NCT01208207|5946087|P5|Part I|Lost to Follow-up|0
1703752|NCT01208207|5946088|P4|Part I|Lost to Follow-up|0
1703753|NCT01208207|5946089|P3|Part I|Lost to Follow-up|0
1703754|NCT01208207|5946090|P2|Part I|Lost to Follow-up|1
1703755|NCT01208207|5946091|P1|Part I|Lost to Follow-up|6
1703756|NCT01208207|5946085|P7|Part I|Lack of Efficacy|0
1703757|NCT01208207|5946086|P6|Part I|Lack of Efficacy|0
1703758|NCT01208207|5946087|P5|Part I|Lack of Efficacy|0
1703759|NCT01208207|5946088|P4|Part I|Lack of Efficacy|0
1703760|NCT01208207|5946089|P3|Part I|Lack of Efficacy|2
1703761|NCT01208207|5946090|P2|Part I|Lack of Efficacy|3
1703762|NCT01208207|5946091|P1|Part I|Lack of Efficacy|21
1703763|NCT01208207|5946085|P7|Part I|Adverse Event|0
1703764|NCT01208207|5946086|P6|Part I|Adverse Event|0
1703765|NCT01208207|5946087|P5|Part I|Adverse Event|0
1703766|NCT01208207|5946088|P4|Part I|Adverse Event|0
1703767|NCT01208207|5946089|P3|Part I|Adverse Event|6
1703768|NCT01208207|5946090|P2|Part I|Adverse Event|2
1703769|NCT01208207|5946091|P1|Part I|Adverse Event|19
1703770|NCT01208181|5946118|P5|Part 2|Lack of Efficacy|0
1703771|NCT01208181|5946119|P4|Part 2|Lack of Efficacy|7
1703772|NCT01208181|5946120|P3|Part 2|Lack of Efficacy|5
1703773|NCT01208181|5946121|P2|Part 2|Lack of Efficacy|0
1703774|NCT01208181|5946122|P1|Part 2|Lack of Efficacy|0
1703775|NCT01208181|5946118|P5|Part 2|Lost to Follow-up|0
1703776|NCT01208181|5946119|P4|Part 2|Lost to Follow-up|2
1703777|NCT01208181|5946120|P3|Part 2|Lost to Follow-up|1
1703778|NCT01208181|5946121|P2|Part 2|Lost to Follow-up|0
1703779|NCT01208181|5946122|P1|Part 2|Lost to Follow-up|0
1703780|NCT01208181|5946118|P5|Part 2|Non-compliance with study drug|0
1703781|NCT01208181|5946119|P4|Part 2|Non-compliance with study drug|1
1703782|NCT01208181|5946120|P3|Part 2|Non-compliance with study drug|1
1703783|NCT01208181|5946121|P2|Part 2|Non-compliance with study drug|0
1703784|NCT01208181|5946122|P1|Part 2|Non-compliance with study drug|0
1703785|NCT01208181|5946118|P5|Part 2|Physician Decision|0
1703786|NCT01208181|5946119|P4|Part 2|Physician Decision|2
1703787|NCT01208181|5946120|P3|Part 2|Physician Decision|1
1703788|NCT01208181|5946121|P2|Part 2|Physician Decision|0
1703789|NCT01208181|5946122|P1|Part 2|Physician Decision|0
1703790|NCT01208181|5946118|P5|Part 2|Protocol Violation|0
1703791|NCT01208181|5946119|P4|Part 2|Protocol Violation|0
1703792|NCT01208181|5946120|P3|Part 2|Protocol Violation|1
1703793|NCT01208181|5946121|P2|Part 2|Protocol Violation|0
1703794|NCT01208181|5946122|P1|Part 2|Protocol Violation|0
1703795|NCT01208181|5946118|P5|Part 2|Withdrawal by Subject|0
1703796|NCT01208181|5946119|P4|Part 2|Withdrawal by Subject|1
1703797|NCT01208181|5946120|P3|Part 2|Withdrawal by Subject|1
1703798|NCT01208181|5946121|P2|Part 2|Withdrawal by Subject|0
1703799|NCT01208181|5946122|P1|Part 2|Withdrawal by Subject|0
1703800|NCT01208181|5946118|P5|Part 2|Adverse Event|0
1703801|NCT01208181|5946119|P4|Part 2|Adverse Event|7
1703802|NCT01208181|5946120|P3|Part 2|Adverse Event|6
1703803|NCT01208181|5946121|P2|Part 2|Adverse Event|0
1703804|NCT01208181|5946122|P1|Part 2|Adverse Event|0
1703805|NCT01208181|5946118|P5|Part 1|Adverse Event|4
1703806|NCT01208181|5946119|P4|Part 1|Adverse Event|0
1703807|NCT01208181|5946120|P3|Part 1|Adverse Event|0
1703808|NCT01208181|5946121|P2|Part 1|Adverse Event|24
1703809|NCT01208181|5946122|P1|Part 1|Adverse Event|26
1703810|NCT01208181|5946118|P5|Part 1|Lack of Efficacy|17
1703811|NCT01208181|5946119|P4|Part 1|Lack of Efficacy|0
1703812|NCT01208181|5946120|P3|Part 1|Lack of Efficacy|0
1703813|NCT01208181|5946121|P2|Part 1|Lack of Efficacy|12
1703814|NCT01208181|5946122|P1|Part 1|Lack of Efficacy|37
1703815|NCT01208181|5946118|P5|Part 1|Lost to Follow-up|1
1703816|NCT01208181|5946119|P4|Part 1|Lost to Follow-up|0
1703817|NCT01208181|5946120|P3|Part 1|Lost to Follow-up|0
1703818|NCT01208181|5946121|P2|Part 1|Lost to Follow-up|3
1703819|NCT01208181|5946122|P1|Part 1|Lost to Follow-up|5
1703820|NCT01208181|5946118|P5|Part 1|Non-compliance with study drug|0
1703821|NCT01208181|5946119|P4|Part 1|Non-compliance with study drug|0
1703822|NCT01208181|5946120|P3|Part 1|Non-compliance with study drug|0
1703823|NCT01208181|5946121|P2|Part 1|Non-compliance with study drug|1
1703824|NCT01208181|5946122|P1|Part 1|Non-compliance with study drug|1
1703825|NCT01208181|5946118|P5|Part 1|Physician Decision|0
1703826|NCT01208181|5946119|P4|Part 1|Physician Decision|0
1703827|NCT01208181|5946120|P3|Part 1|Physician Decision|0
1703828|NCT01208181|5946121|P2|Part 1|Physician Decision|0
1703829|NCT01208181|5946122|P1|Part 1|Physician Decision|4
1703830|NCT01208181|5946118|P5|Part 1|Protocol Violation|0
1703831|NCT01208181|5946119|P4|Part 1|Protocol Violation|0
1703832|NCT01208181|5946120|P3|Part 1|Protocol Violation|0
1703833|NCT01208181|5946121|P2|Part 1|Protocol Violation|5
1703834|NCT01208181|5946122|P1|Part 1|Protocol Violation|10
1703835|NCT01208181|5946118|P5|Part 1|Technical problem|0
1703836|NCT01208181|5946119|P4|Part 1|Technical problem|0
1703837|NCT01208181|5946120|P3|Part 1|Technical problem|0
1703838|NCT01208181|5946121|P2|Part 1|Technical problem|0
1703839|NCT01208181|5946122|P1|Part 1|Technical problem|5
1703840|NCT01208181|5946118|P5|Part 1|Withdrawal by Subject|0
1703841|NCT01208181|5946119|P4|Part 1|Withdrawal by Subject|0
1703842|NCT01208181|5946120|P3|Part 1|Withdrawal by Subject|0
1703843|NCT01208181|5946121|P2|Part 1|Withdrawal by Subject|10
1703844|NCT01208181|5946122|P1|Part 1|Withdrawal by Subject|11
1703845|NCT01208103|5946151|P1|Overall Study|Withdrawal by Subject|1
1703846|NCT01208103|5946151|P1|Overall Study|Adverse Event|1
1703847|NCT01208038|5946159|P1|Overall Study|Withdrawal by Subject|1
1703848|NCT01207687|5946215|P1|Overall Study|Withdrawal by Subject|1
1703849|NCT01207687|5946215|P1|Overall Study|Adverse Event|1
1703850|NCT01207596|5946253|P1|Overall Study|Withdrawal by Subject|1
1703851|NCT01207596|5946253|P1|Overall Study|Adverse Event|3
1703852|NCT01207596|5946253|P1|Overall Study|Lack of Efficacy|1
1703853|NCT01207596|5946253|P1|Overall Study|Physician Decision|4
1703854|NCT01207583|5946266|P3|Overall Study|Lost to Follow-up|0
1703855|NCT01207583|5946267|P2|Overall Study|Lost to Follow-up|2
1703856|NCT01207583|5946268|P1|Overall Study|Lost to Follow-up|0
1703857|NCT01207583|5946266|P3|Overall Study|Participant failed to return|0
1703858|NCT01207583|5946267|P2|Overall Study|Participant failed to return|0
1703859|NCT01207583|5946268|P1|Overall Study|Participant failed to return|1
1703860|NCT01207583|5946266|P3|Overall Study|Withdrawal by Subject|1
1703861|NCT01207583|5946267|P2|Overall Study|Withdrawal by Subject|3
1703862|NCT01207583|5946268|P1|Overall Study|Withdrawal by Subject|0
1703863|NCT01207492|5946321|P1|Overall Study|Toxicity|1
1703864|NCT01207492|5946321|P1|Overall Study|Progressive disease|3
1703865|NCT01207492|5946321|P1|Overall Study|Physician Decision|1
1703866|NCT01207492|5946321|P1|Overall Study|Withdrawal by Subject|9
1703867|NCT01207492|5946321|P1|Overall Study|Still on study|1
1703868|NCT01207453|5946336|P2|2nd Intervention|Lost to Follow-up|0
1703869|NCT01207453|5946337|P1|2nd Intervention|Lost to Follow-up|1
1703870|NCT01207453|5946336|P2|2nd Intervention|Adverse Event|2
1703871|NCT01207453|5946337|P1|2nd Intervention|Adverse Event|1
1703872|NCT01207453|5946336|P2|Washout|Lost to Follow-up|0
1703873|NCT01207453|5946337|P1|Washout|Lost to Follow-up|1
1703874|NCT01207453|5946336|P2|Washout|Adverse Event|0
1703875|NCT01207453|5946337|P1|Washout|Adverse Event|1
1703876|NCT01207453|5946336|P2|First Intervention|Adverse Event|1
1703877|NCT01207453|5946337|P1|First Intervention|Adverse Event|2
1703878|NCT01207440|5946363|P7|Overall Study|Reason Not Specified|0
1703879|NCT01207440|5946364|P6|Overall Study|Reason Not Specified|3
1703880|NCT01207440|5946365|P5|Overall Study|Reason Not Specified|4
1703881|NCT01207440|5946366|P4|Overall Study|Reason Not Specified|0
1703882|NCT01207440|5946367|P3|Overall Study|Reason Not Specified|7
1703883|NCT01207440|5946368|P2|Overall Study|Reason Not Specified|10
1703884|NCT01207440|5946369|P1|Overall Study|Reason Not Specified|10
1703885|NCT01207440|5946363|P7|Overall Study|Withdrawal by Subject|0
1703886|NCT01207440|5946364|P6|Overall Study|Withdrawal by Subject|2
1703887|NCT01207440|5946365|P5|Overall Study|Withdrawal by Subject|2
1703888|NCT01207440|5946366|P4|Overall Study|Withdrawal by Subject|3
1703889|NCT01207440|5946367|P3|Overall Study|Withdrawal by Subject|5
1703890|NCT01207440|5946368|P2|Overall Study|Withdrawal by Subject|4
1703891|NCT01207440|5946369|P1|Overall Study|Withdrawal by Subject|29
1703892|NCT01207440|5946363|P7|Overall Study|Site Terminated by Sponsor|2
1703893|NCT01207440|5946364|P6|Overall Study|Site Terminated by Sponsor|0
1703894|NCT01207440|5946365|P5|Overall Study|Site Terminated by Sponsor|3
1703895|NCT01207440|5946366|P4|Overall Study|Site Terminated by Sponsor|2
1703896|NCT01207440|5946367|P3|Overall Study|Site Terminated by Sponsor|12
1703897|NCT01207440|5946368|P2|Overall Study|Site Terminated by Sponsor|19
1703898|NCT01207440|5946369|P1|Overall Study|Site Terminated by Sponsor|69
1703899|NCT01207440|5946363|P7|Overall Study|Protocol Violation|0
1703900|NCT01207440|5946364|P6|Overall Study|Protocol Violation|0
1703901|NCT01207440|5946365|P5|Overall Study|Protocol Violation|0
1703902|NCT01207440|5946366|P4|Overall Study|Protocol Violation|0
1703903|NCT01207440|5946367|P3|Overall Study|Protocol Violation|0
1703904|NCT01207440|5946368|P2|Overall Study|Protocol Violation|0
1703905|NCT01207440|5946369|P1|Overall Study|Protocol Violation|2
1703906|NCT01207440|5946363|P7|Overall Study|Progressive Disease|0
1703907|NCT01207440|5946364|P6|Overall Study|Progressive Disease|27
1703908|NCT01207440|5946365|P5|Overall Study|Progressive Disease|23
1703909|NCT01207440|5946366|P4|Overall Study|Progressive Disease|7
1703910|NCT01207440|5946367|P3|Overall Study|Progressive Disease|19
1703911|NCT01207440|5946368|P2|Overall Study|Progressive Disease|10
1703912|NCT01207440|5946369|P1|Overall Study|Progressive Disease|19
1703913|NCT01207440|5946363|P7|Overall Study|Physician Decision|0
1703914|NCT01207440|5946364|P6|Overall Study|Physician Decision|0
1703915|NCT01207440|5946365|P5|Overall Study|Physician Decision|1
1703916|NCT01207440|5946366|P4|Overall Study|Physician Decision|0
1703917|NCT01207440|5946367|P3|Overall Study|Physician Decision|5
1703918|NCT01207440|5946368|P2|Overall Study|Physician Decision|5
1703919|NCT01207440|5946369|P1|Overall Study|Physician Decision|6
1703920|NCT01207440|5946363|P7|Overall Study|Non-compliance with Study Drug|0
1703921|NCT01207440|5946364|P6|Overall Study|Non-compliance with Study Drug|0
1703922|NCT01207440|5946365|P5|Overall Study|Non-compliance with Study Drug|0
1703923|NCT01207440|5946366|P4|Overall Study|Non-compliance with Study Drug|0
1703924|NCT01207440|5946367|P3|Overall Study|Non-compliance with Study Drug|1
1703925|NCT01207440|5946368|P2|Overall Study|Non-compliance with Study Drug|0
1703926|NCT01207440|5946369|P1|Overall Study|Non-compliance with Study Drug|3
1703927|NCT01207440|5946363|P7|Overall Study|Lost to Follow-up|0
1703928|NCT01207440|5946364|P6|Overall Study|Lost to Follow-up|0
1703929|NCT01207440|5946365|P5|Overall Study|Lost to Follow-up|0
1703930|NCT01207440|5946366|P4|Overall Study|Lost to Follow-up|1
1703931|NCT01207440|5946367|P3|Overall Study|Lost to Follow-up|2
1703932|NCT01207440|5946368|P2|Overall Study|Lost to Follow-up|0
1703933|NCT01207440|5946369|P1|Overall Study|Lost to Follow-up|0
1703934|NCT01207440|5946363|P7|Overall Study|Lack of Efficacy|0
1703935|NCT01207440|5946364|P6|Overall Study|Lack of Efficacy|3
1703936|NCT01207440|5946365|P5|Overall Study|Lack of Efficacy|2
1703937|NCT01207440|5946366|P4|Overall Study|Lack of Efficacy|1
1703938|NCT01207440|5946367|P3|Overall Study|Lack of Efficacy|5
1703939|NCT01207440|5946368|P2|Overall Study|Lack of Efficacy|2
1703940|NCT01207440|5946369|P1|Overall Study|Lack of Efficacy|13
1703941|NCT01207440|5946363|P7|Overall Study|Death|1
1703942|NCT01207440|5946364|P6|Overall Study|Death|5
1703943|NCT01207440|5946365|P5|Overall Study|Death|7
1703944|NCT01207440|5946366|P4|Overall Study|Death|2
1703945|NCT01207440|5946367|P3|Overall Study|Death|2
1703946|NCT01207440|5946368|P2|Overall Study|Death|3
1703947|NCT01207440|5946369|P1|Overall Study|Death|6
1703948|NCT01207440|5946363|P7|Overall Study|Adverse Event|2
1703949|NCT01207440|5946364|P6|Overall Study|Adverse Event|6
1703950|NCT01207440|5946365|P5|Overall Study|Adverse Event|6
1703951|NCT01207440|5946366|P4|Overall Study|Adverse Event|2
1703952|NCT01207440|5946367|P3|Overall Study|Adverse Event|7
1703953|NCT01207440|5946368|P2|Overall Study|Adverse Event|11
1703954|NCT01207440|5946369|P1|Overall Study|Adverse Event|46
1703955|NCT01207427|5946436|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1703956|NCT01207427|5946437|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1703957|NCT01207427|5946438|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1703958|NCT01207427|5946436|P3|Double-blind Treatment Period|Protocol Violation|1
1703959|NCT01207427|5946437|P2|Double-blind Treatment Period|Protocol Violation|1
1703960|NCT01207427|5946438|P1|Double-blind Treatment Period|Protocol Violation|2
1703961|NCT01207427|5946436|P3|Double-blind Treatment Period|Lost to Follow-up|1
1703962|NCT01207427|5946437|P2|Double-blind Treatment Period|Lost to Follow-up|0
1703963|NCT01207427|5946438|P1|Double-blind Treatment Period|Lost to Follow-up|0
1703964|NCT01207427|5946436|P3|Double-blind Treatment Period|Adverse Event|0
1703965|NCT01207427|5946437|P2|Double-blind Treatment Period|Adverse Event|1
1703966|NCT01207427|5946438|P1|Double-blind Treatment Period|Adverse Event|0
1703967|NCT01207414|5946448|P2|Overall Study|Randomized in error|0
1703968|NCT01207414|5946449|P1|Overall Study|Randomized in error|1
1703969|NCT01207414|5946448|P2|Overall Study|Protocol deviation|9
1703970|NCT01207414|5946449|P1|Overall Study|Protocol deviation|12
1703971|NCT01207414|5946448|P2|Overall Study|Administrative problems|1
1703972|NCT01207414|5946449|P1|Overall Study|Administrative problems|1
1703973|NCT01207414|5946448|P2|Overall Study|Lost to Follow-up|17
1703974|NCT01207414|5946449|P1|Overall Study|Lost to Follow-up|15
1703975|NCT01207414|5946448|P2|Overall Study|Patient withdrew consent|11
1703976|NCT01207414|5946449|P1|Overall Study|Patient withdrew consent|14
1703977|NCT01207414|5946448|P2|Overall Study|Unsatisfactory therapeutic effect|4
1703978|NCT01207414|5946449|P1|Overall Study|Unsatisfactory therapeutic effect|5
1703979|NCT01207414|5946448|P2|Overall Study|Abnormal test procedure results|1
1703980|NCT01207414|5946449|P1|Overall Study|Abnormal test procedure results|0
1703981|NCT01207414|5946448|P2|Overall Study|Adverse Event|39
1703982|NCT01207414|5946449|P1|Overall Study|Adverse Event|25
1703983|NCT01207388|5946474|P1|Overall Study|Withdrawal by Subject|1
1703984|NCT01207388|5946474|P1|Overall Study|Death|67
1703985|NCT01207219|5946499|P3|Overall Study|Lost to Follow-up|6
1703986|NCT01207219|5946500|P2|Overall Study|Lost to Follow-up|8
1703987|NCT01207219|5946501|P1|Overall Study|Lost to Follow-up|6
1703988|NCT01207219|5946499|P3|Overall Study|changed diagnosis during study period|1
1703989|NCT01207219|5946500|P2|Overall Study|changed diagnosis during study period|3
1703990|NCT01207219|5946501|P1|Overall Study|changed diagnosis during study period|5
1703991|NCT01207102|5946521|P1|Overall Study|Withdrawal by Treating Physician|1
1703992|NCT01207102|5946521|P1|Overall Study|progression|2
1703993|NCT01207102|5946521|P1|Overall Study|Adverse Event|2
1703994|NCT01207102|5946521|P1|Overall Study|Withdrawal by Subject|5
1703995|NCT01206816|5946533|P7|Overall Study|other than stated above|1
1703996|NCT01206816|5946534|P6|Overall Study|other than stated above|0
1703997|NCT01206816|5946535|P5|Overall Study|other than stated above|0
1703998|NCT01206816|5946536|P4|Overall Study|other than stated above|0
1703999|NCT01206816|5946537|P3|Overall Study|other than stated above|1
1704000|NCT01206816|5946538|P2|Overall Study|other than stated above|0
1704001|NCT01206816|5946539|P1|Overall Study|other than stated above|0
1704002|NCT01206816|5946533|P7|Overall Study|Other AE|2
1704003|NCT01206816|5946534|P6|Overall Study|Other AE|3
1704004|NCT01206816|5946535|P5|Overall Study|Other AE|0
1704005|NCT01206816|5946536|P4|Overall Study|Other AE|0
1704006|NCT01206816|5946537|P3|Overall Study|Other AE|4
1704007|NCT01206816|5946538|P2|Overall Study|Other AE|0
1704008|NCT01206816|5946539|P1|Overall Study|Other AE|0
1704009|NCT01206816|5946533|P7|Overall Study|Progressive disease|3
1704010|NCT01206816|5946534|P6|Overall Study|Progressive disease|16
1704011|NCT01206816|5946535|P5|Overall Study|Progressive disease|3
1704012|NCT01206816|5946536|P4|Overall Study|Progressive disease|3
1704013|NCT01206816|5946537|P3|Overall Study|Progressive disease|13
1704014|NCT01206816|5946538|P2|Overall Study|Progressive disease|3
1704015|NCT01206816|5946539|P1|Overall Study|Progressive disease|3
1704016|NCT01206816|5946533|P7|Overall Study|Withdrawal by Subject|0
1704017|NCT01206816|5946534|P6|Overall Study|Withdrawal by Subject|0
1704018|NCT01206816|5946535|P5|Overall Study|Withdrawal by Subject|0
1704019|NCT01206816|5946536|P4|Overall Study|Withdrawal by Subject|0
1704020|NCT01206816|5946537|P3|Overall Study|Withdrawal by Subject|1
1704021|NCT01206816|5946538|P2|Overall Study|Withdrawal by Subject|0
1704022|NCT01206816|5946539|P1|Overall Study|Withdrawal by Subject|0
1704023|NCT01206816|5946533|P7|Overall Study|Protocol Violation|0
1704024|NCT01206816|5946534|P6|Overall Study|Protocol Violation|0
1704025|NCT01206816|5946535|P5|Overall Study|Protocol Violation|0
1704026|NCT01206816|5946536|P4|Overall Study|Protocol Violation|0
1704027|NCT01206816|5946537|P3|Overall Study|Protocol Violation|1
1704028|NCT01206816|5946538|P2|Overall Study|Protocol Violation|0
1704029|NCT01206816|5946539|P1|Overall Study|Protocol Violation|0
1704030|NCT01206777|5946585|P1|Overall Study|Adverse Event|1
1704031|NCT01206777|5946585|P1|Overall Study|Death|1
1704032|NCT01206764|5946591|P1|Overall Study|Protocol deviation|3
1704033|NCT01206764|5946591|P1|Overall Study|Disease progression|88
1704034|NCT01206764|5946591|P1|Overall Study|New cancer therapy|2
1704035|NCT01206764|5946591|P1|Overall Study|Death|11
1704036|NCT01206764|5946591|P1|Overall Study|Lost to Follow-up|6
1704037|NCT01206764|5946591|P1|Overall Study|Patient withdrew consent|5
1704038|NCT01206764|5946591|P1|Overall Study|Abnormal test procedure result|1
1704039|NCT01206764|5946591|P1|Overall Study|Abnormal laboratory value|2
1704040|NCT01206764|5946591|P1|Overall Study|Adverse Event|20
1704041|NCT01206582|5946649|P2|Overall Study|Discontinued intervention before week 8|2
1704042|NCT01206582|5946650|P1|Overall Study|Discontinued intervention before week 8|1
1704043|NCT01206582|5946649|P2|Overall Study|Withdrew prior to study|0
1704044|NCT01206582|5946650|P1|Overall Study|Withdrew prior to study|1
1704045|NCT01206517|5946682|P6|Overall Study|Withdrawal by Subject|0
1704046|NCT01206517|5946683|P5|Overall Study|Withdrawal by Subject|1
1704047|NCT01206517|5946684|P4|Overall Study|Withdrawal by Subject|0
1704048|NCT01206517|5946685|P3|Overall Study|Withdrawal by Subject|2
1704049|NCT01206517|5946686|P2|Overall Study|Withdrawal by Subject|0
1704050|NCT01206517|5946687|P1|Overall Study|Withdrawal by Subject|0
1704051|NCT01206439|5946767|P1|Overall Study|subject did not meet inclusion criteria|1
1704052|NCT01206322|5946790|P4|Overall Study|Adverse Event|1
1704053|NCT01206322|5946791|P3|Overall Study|Adverse Event|0
1704054|NCT01206322|5946792|P2|Overall Study|Adverse Event|0
1704055|NCT01206322|5946793|P1|Overall Study|Adverse Event|0
1704056|NCT01206140|5946809|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
1704057|NCT01206140|5946810|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
1704058|NCT01206101|5946822|P2|Overall Study|Unclassified|0
1704059|NCT01206101|5946823|P1|Overall Study|Unclassified|1
1704060|NCT01206101|5946822|P2|Overall Study|Physician Decision|1
1704061|NCT01206101|5946823|P1|Overall Study|Physician Decision|0
1704062|NCT01206101|5946822|P2|Overall Study|Adverse Event|0
1704063|NCT01206101|5946823|P1|Overall Study|Adverse Event|1
1704064|NCT01205776|5946864|P2|3 Years Follow-up|Withdrawal by Subject|2
1704065|NCT01205776|5946865|P1|3 Years Follow-up|Withdrawal by Subject|1
1704066|NCT01205776|5946864|P2|3 Years Follow-up|Lost to Follow-up|22
1704067|NCT01205776|5946865|P1|3 Years Follow-up|Lost to Follow-up|15
1704068|NCT01205776|5946864|P2|2 Years Follow-up|Withdrawal by Subject|19
1704069|NCT01205776|5946865|P1|2 Years Follow-up|Withdrawal by Subject|4
1704070|NCT01205776|5946864|P2|2 Years Follow-up|Lost to Follow-up|13
1704071|NCT01205776|5946865|P1|2 Years Follow-up|Lost to Follow-up|12
1704072|NCT01205776|5946864|P2|1 Month Follow-up|Withdrawal by Subject|10
1704073|NCT01205776|5946865|P1|1 Month Follow-up|Withdrawal by Subject|5
1704074|NCT01205776|5946864|P2|1 Month Follow-up|Lost to Follow-up|2
1704075|NCT01205776|5946865|P1|1 Month Follow-up|Lost to Follow-up|0
1704076|NCT01205685|5947005|P1|Overall Study|Withdrawal by Subject|1
1704077|NCT01205685|5947005|P1|Overall Study|Disease Progression|10
1704078|NCT01205581|5947025|P6|Overall Study|Withdrawal by Subject|0
1704079|NCT01205581|5947026|P5|Overall Study|Withdrawal by Subject|0
1704080|NCT01205581|5947027|P4|Overall Study|Withdrawal by Subject|0
1704081|NCT01205581|5947028|P3|Overall Study|Withdrawal by Subject|0
1704082|NCT01205581|5947029|P2|Overall Study|Withdrawal by Subject|0
1704083|NCT01205581|5947030|P1|Overall Study|Withdrawal by Subject|1
1704084|NCT01205529|5947100|P1|Overall Study|No longer met criteria|30
1704085|NCT01205529|5947100|P1|Overall Study|Unstable post op|15
1704086|NCT01205529|5947100|P1|Overall Study|Physician Decision|4
1704087|NCT01205529|5947100|P1|Overall Study|Withdrawal by Subject|2
1704088|NCT01205529|5947100|P1|Overall Study|Procedure Cancelled|4
1704089|NCT01205451|5947123|P2|Overall Study|Withdrawal by Subject|9
1704090|NCT01205451|5947124|P1|Overall Study|Withdrawal by Subject|5
1704091|NCT01205451|5947123|P2|Overall Study|Lost to Follow-up|1
1704092|NCT01205451|5947124|P1|Overall Study|Lost to Follow-up|1
1704093|NCT01205438|5947169|P3|Overall Study|Sponsor Decision|1
1704094|NCT01205438|5947170|P2|Overall Study|Sponsor Decision|1
1704095|NCT01205438|5947171|P1|Overall Study|Sponsor Decision|0
1704096|NCT01205438|5947169|P3|Overall Study|Protocol Violation|4
1704097|NCT01205438|5947170|P2|Overall Study|Protocol Violation|7
1704098|NCT01205438|5947171|P1|Overall Study|Protocol Violation|2
1704099|NCT01205438|5947169|P3|Overall Study|Physician Decision|2
1704100|NCT01205438|5947170|P2|Overall Study|Physician Decision|3
1704101|NCT01205438|5947171|P1|Overall Study|Physician Decision|0
1704102|NCT01205438|5947169|P3|Overall Study|Withdrawal by Subject|19
1704103|NCT01205438|5947170|P2|Overall Study|Withdrawal by Subject|25
1704104|NCT01205438|5947171|P1|Overall Study|Withdrawal by Subject|19
1704105|NCT01205438|5947169|P3|Overall Study|Lost to Follow-up|8
1704106|NCT01205438|5947170|P2|Overall Study|Lost to Follow-up|7
1704107|NCT01205438|5947171|P1|Overall Study|Lost to Follow-up|6
1704108|NCT01205438|5947169|P3|Overall Study|Lack of Efficacy|14
1704109|NCT01205438|5947170|P2|Overall Study|Lack of Efficacy|11
1704110|NCT01205438|5947171|P1|Overall Study|Lack of Efficacy|14
1704111|NCT01205438|5947169|P3|Overall Study|Entry Criteria Not Met|13
1704112|NCT01205438|5947170|P2|Overall Study|Entry Criteria Not Met|15
1704113|NCT01205438|5947171|P1|Overall Study|Entry Criteria Not Met|16
1704114|NCT01205438|5947169|P3|Overall Study|Death|3
1704115|NCT01205438|5947170|P2|Overall Study|Death|1
1704116|NCT01205438|5947171|P1|Overall Study|Death|1
1704117|NCT01205438|5947169|P3|Overall Study|Adverse Event|24
1704118|NCT01205438|5947170|P2|Overall Study|Adverse Event|17
1704119|NCT01205438|5947171|P1|Overall Study|Adverse Event|19
1704120|NCT01205269|5947227|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
1704121|NCT01205269|5947228|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
1704122|NCT01205269|5947229|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
1704123|NCT01205269|5947230|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
1704124|NCT01205269|5947231|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
1704125|NCT01205269|5947232|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
1704126|NCT01205230|5947272|P2|Overall Study|Physician Decision|0
1704127|NCT01205230|5947273|P1|Overall Study|Physician Decision|1
1704128|NCT01205230|5947272|P2|Overall Study|Adverse Event|0
1704129|NCT01205230|5947273|P1|Overall Study|Adverse Event|4
1704130|NCT01205165|5947316|P1|Overall Study|Lost to Follow-up|2
1704131|NCT01205152|5947329|P1|Overall Study|Death|1
1704132|NCT01205126|5947342|P2|Maintenance Phase|Withdrawal by Subject|11
1704133|NCT01205126|5947343|P1|Maintenance Phase|Withdrawal by Subject|8
1704134|NCT01205126|5947342|P2|Maintenance Phase|Lost to Follow-up|5
1704135|NCT01205126|5947343|P1|Maintenance Phase|Lost to Follow-up|5
1704136|NCT01205126|5947342|P2|Maintenance Phase|Other|8
1704137|NCT01205126|5947343|P1|Maintenance Phase|Other|11
1704138|NCT01205126|5947342|P2|Maintenance Phase|Prohibited drugs used|0
1704139|NCT01205126|5947343|P1|Maintenance Phase|Prohibited drugs used|1
1704140|NCT01205126|5947342|P2|Maintenance Phase|More than the maximum dosage required|5
1704141|NCT01205126|5947343|P1|Maintenance Phase|More than the maximum dosage required|5
1704142|NCT01205126|5947342|P2|Maintenance Phase|Death|4
1704143|NCT01205126|5947343|P1|Maintenance Phase|Death|4
1704144|NCT01205126|5947342|P2|Maintenance Phase|Adverse Event|7
1704145|NCT01205126|5947343|P1|Maintenance Phase|Adverse Event|3
1704146|NCT01205126|5947342|P2|Between Titration & Maintenance Phase|Other|4
1704147|NCT01205126|5947343|P1|Between Titration & Maintenance Phase|Other|0
1704148|NCT01205126|5947342|P2|Titration Phase|Other|6
1704149|NCT01205126|5947343|P1|Titration Phase|Other|8
1704150|NCT01205126|5947342|P2|Titration Phase|More than maximum dosage required|3
1704151|NCT01205126|5947343|P1|Titration Phase|More than maximum dosage required|2
1704152|NCT01205126|5947342|P2|Titration Phase|No stable titration dose|0
1704153|NCT01205126|5947343|P1|Titration Phase|No stable titration dose|1
1704154|NCT01205126|5947342|P2|Titration Phase|Lost to Follow-up|2
1704155|NCT01205126|5947343|P1|Titration Phase|Lost to Follow-up|2
1704156|NCT01205126|5947342|P2|Titration Phase|Withdrawal by Subject|5
1704157|NCT01205126|5947343|P1|Titration Phase|Withdrawal by Subject|5
1704158|NCT01205126|5947342|P2|Titration Phase|Adverse Event|3
1704159|NCT01205126|5947343|P1|Titration Phase|Adverse Event|5
1704160|NCT01205035|5947361|P2|Overall Study|Physician Decision|0
1704161|NCT01205035|5947362|P1|Overall Study|Physician Decision|1
1704162|NCT01205035|5947361|P2|Overall Study|Withdrawal by Subject|0
1704163|NCT01205035|5947362|P1|Overall Study|Withdrawal by Subject|1
1704164|NCT01204918|5947379|P3|Overall Study|Withdrawal by Subject|5
1704165|NCT01204918|5947380|P2|Overall Study|Withdrawal by Subject|10
1704166|NCT01204918|5947381|P1|Overall Study|Withdrawal by Subject|4
1704167|NCT01204775|5947424|P2|Overall Study|Withdrawal by Subject|0
1704168|NCT01204775|5947425|P1|Overall Study|Withdrawal by Subject|1
1704169|NCT01204775|5947424|P2|Overall Study|Poor/non-compliance|1
1704170|NCT01204775|5947425|P1|Overall Study|Poor/non-compliance|0
1704171|NCT01204710|5947450|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
1704172|NCT01204710|5947451|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
1704173|NCT01204710|5947450|P2|Optional Olaratumab Monotherapy|Physician Decision|1
1704174|NCT01204710|5947451|P1|Optional Olaratumab Monotherapy|Physician Decision|0
1704175|NCT01204710|5947450|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
1704176|NCT01204710|5947451|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
1704177|NCT01204710|5947450|P2|Randomization Treatment|Moved and Followed for Survival|1
1704178|NCT01204710|5947451|P1|Randomization Treatment|Moved and Followed for Survival|0
1704179|NCT01204710|5947450|P2|Randomization Treatment|Worsening of General condition|1
1704180|NCT01204710|5947451|P1|Randomization Treatment|Worsening of General condition|0
1704181|NCT01204710|5947450|P2|Randomization Treatment|Sponsor Decision|1
1704182|NCT01204710|5947451|P1|Randomization Treatment|Sponsor Decision|0
1704183|NCT01204710|5947450|P2|Randomization Treatment|Adverse Event|2
1704184|NCT01204710|5947451|P1|Randomization Treatment|Adverse Event|4
1704185|NCT01204710|5947450|P2|Randomization Treatment|Entry criteria not met|1
1704186|NCT01204710|5947451|P1|Randomization Treatment|Entry criteria not met|0
1704187|NCT01204710|5947450|P2|Randomization Treatment|Physician Decision|2
1704188|NCT01204710|5947451|P1|Randomization Treatment|Physician Decision|3
1704189|NCT01204710|5947450|P2|Randomization Treatment|Withdrawal by Subject|5
1704190|NCT01204710|5947451|P1|Randomization Treatment|Withdrawal by Subject|6
1704191|NCT01204710|5947450|P2|Randomization Treatment|Lost to Follow-up|0
1704192|NCT01204710|5947451|P1|Randomization Treatment|Lost to Follow-up|1
1704193|NCT01204697|5947487|P2|Overall Study|Randomized, but not treated|1
1704194|NCT01204697|5947488|P1|Overall Study|Randomized, but not treated|0
1704195|NCT01204697|5947487|P2|Overall Study|Withdrawal by Subject|4
1704196|NCT01204697|5947488|P1|Overall Study|Withdrawal by Subject|2
1704197|NCT01204697|5947487|P2|Overall Study|Lost to Follow-up|4
1704198|NCT01204697|5947488|P1|Overall Study|Lost to Follow-up|3
1704199|NCT01204697|5947487|P2|Overall Study|Death|27
1704200|NCT01204697|5947488|P1|Overall Study|Death|26
1704201|NCT01204671|5947509|P5|Overall Study|Physician Decision|0
1704202|NCT01204671|5947510|P4|Overall Study|Physician Decision|1
1704203|NCT01204671|5947511|P3|Overall Study|Physician Decision|0
1704204|NCT01204671|5947512|P2|Overall Study|Physician Decision|0
1704205|NCT01204671|5947513|P1|Overall Study|Physician Decision|0
1704206|NCT01204671|5947509|P5|Overall Study|Unknown Completion Status|0
1704207|NCT01204671|5947510|P4|Overall Study|Unknown Completion Status|0
1704208|NCT01204671|5947511|P3|Overall Study|Unknown Completion Status|0
1704209|NCT01204671|5947512|P2|Overall Study|Unknown Completion Status|1
1704210|NCT01204671|5947513|P1|Overall Study|Unknown Completion Status|1
1704211|NCT01204671|5947509|P5|Overall Study|Lost to Follow-up|0
1704212|NCT01204671|5947510|P4|Overall Study|Lost to Follow-up|4
1704213|NCT01204671|5947511|P3|Overall Study|Lost to Follow-up|6
1704214|NCT01204671|5947512|P2|Overall Study|Lost to Follow-up|8
1704215|NCT01204671|5947513|P1|Overall Study|Lost to Follow-up|7
1704216|NCT01204671|5947509|P5|Overall Study|Withdrawal by Subject|3
1704217|NCT01204671|5947510|P4|Overall Study|Withdrawal by Subject|5
1704218|NCT01204671|5947511|P3|Overall Study|Withdrawal by Subject|4
1704219|NCT01204671|5947512|P2|Overall Study|Withdrawal by Subject|3
1704220|NCT01204671|5947513|P1|Overall Study|Withdrawal by Subject|2
1704221|NCT01204671|5947509|P5|Overall Study|Adverse Event|1
1704222|NCT01204671|5947510|P4|Overall Study|Adverse Event|3
1704223|NCT01204671|5947511|P3|Overall Study|Adverse Event|3
1704224|NCT01204671|5947512|P2|Overall Study|Adverse Event|3
1704225|NCT01204671|5947513|P1|Overall Study|Adverse Event|4
1704226|NCT01204658|5947575|P4|Primary Phase|Adverse Event|0
1704227|NCT01204658|5947576|P3|Primary Phase|Adverse Event|1
1704228|NCT01204658|5947577|P2|Primary Phase|Adverse Event|0
1704229|NCT01204658|5947578|P1|Primary Phase|Adverse Event|0
1704230|NCT01204398|5947696|P1|Overall Study|Adverse Event|1
1704231|NCT01204294|5947713|P7|Overall Study|Other (house moving)|0
1704232|NCT01204294|5947714|P6|Overall Study|Other (house moving)|0
1704233|NCT01204294|5947715|P5|Overall Study|Other (house moving)|0
1704234|NCT01204294|5947716|P4|Overall Study|Other (house moving)|0
1704235|NCT01204294|5947717|P3|Overall Study|Other (house moving)|1
1704236|NCT01204294|5947718|P2|Overall Study|Other (house moving)|0
1704237|NCT01204294|5947719|P1|Overall Study|Other (house moving)|0
1704238|NCT01204294|5947713|P7|Overall Study|Lack of Efficacy|0
1704239|NCT01204294|5947714|P6|Overall Study|Lack of Efficacy|0
1704240|NCT01204294|5947715|P5|Overall Study|Lack of Efficacy|0
1704241|NCT01204294|5947716|P4|Overall Study|Lack of Efficacy|2
1704242|NCT01204294|5947717|P3|Overall Study|Lack of Efficacy|0
1704243|NCT01204294|5947718|P2|Overall Study|Lack of Efficacy|0
1704244|NCT01204294|5947719|P1|Overall Study|Lack of Efficacy|0
1704245|NCT01204294|5947713|P7|Overall Study|Withdrawal by Subject|2
1704246|NCT01204294|5947714|P6|Overall Study|Withdrawal by Subject|1
1704247|NCT01204294|5947715|P5|Overall Study|Withdrawal by Subject|1
1704248|NCT01204294|5947716|P4|Overall Study|Withdrawal by Subject|1
1704249|NCT01204294|5947717|P3|Overall Study|Withdrawal by Subject|2
1704250|NCT01204294|5947718|P2|Overall Study|Withdrawal by Subject|2
1704251|NCT01204294|5947719|P1|Overall Study|Withdrawal by Subject|0
1704252|NCT01204294|5947713|P7|Overall Study|Protocol Violation|0
1704253|NCT01204294|5947714|P6|Overall Study|Protocol Violation|0
1704254|NCT01204294|5947715|P5|Overall Study|Protocol Violation|0
1704255|NCT01204294|5947716|P4|Overall Study|Protocol Violation|1
1704256|NCT01204294|5947717|P3|Overall Study|Protocol Violation|2
1704257|NCT01204294|5947718|P2|Overall Study|Protocol Violation|0
1704258|NCT01204294|5947719|P1|Overall Study|Protocol Violation|1
1704259|NCT01204294|5947713|P7|Overall Study|Adverse Event|0
1704260|NCT01204294|5947714|P6|Overall Study|Adverse Event|4
1704261|NCT01204294|5947715|P5|Overall Study|Adverse Event|1
1704262|NCT01204294|5947716|P4|Overall Study|Adverse Event|7
1704263|NCT01204294|5947717|P3|Overall Study|Adverse Event|0
1704264|NCT01204294|5947718|P2|Overall Study|Adverse Event|6
1704265|NCT01204294|5947719|P1|Overall Study|Adverse Event|2
1704266|NCT01203956|5947753|P2|Second Two-week Period|Non-compliant: no evaluable results|6
1704267|NCT01203956|5947754|P1|Second Two-week Period|Non-compliant: no evaluable results|5
1704268|NCT01203930|5947763|P2|Overall Study|Adverse Event|5
1704269|NCT01203930|5947764|P1|Overall Study|Adverse Event|17
1704270|NCT01203930|5947763|P2|Overall Study|Poor tolerance of study drug|1
1704271|NCT01203930|5947764|P1|Overall Study|Poor tolerance of study drug|0
1704272|NCT01203930|5947763|P2|Overall Study|Study Terminated by Sponsor|12
1704273|NCT01203930|5947764|P1|Overall Study|Study Terminated by Sponsor|0
1704274|NCT01203930|5947763|P2|Overall Study|Investigator Request|8
1704275|NCT01203930|5947764|P1|Overall Study|Investigator Request|0
1704276|NCT01203930|5947763|P2|Overall Study|Withdrew Consent|10
1704277|NCT01203930|5947764|P1|Overall Study|Withdrew Consent|1
1704278|NCT01203930|5947763|P2|Overall Study|Death|1
1704279|NCT01203930|5947764|P1|Overall Study|Death|3
1704280|NCT01203930|5947763|P2|Overall Study|Disease Progression|4
1704281|NCT01203930|5947764|P1|Overall Study|Disease Progression|0
1704282|NCT01203917|5947786|P1|Overall Study|Due to EGFR M+I patient|1
1704283|NCT01203917|5947786|P1|Overall Study|Due to objective disease progression|1
1704284|NCT01203917|5947786|P1|Overall Study|Withdrawal by Subject|3
1704285|NCT01203917|5947786|P1|Overall Study|Lost to Follow-up|2
1704286|NCT01203917|5947786|P1|Overall Study|Death|29
1704287|NCT01203878|5947799|P3|Overall Study|Adverse Event|2
1704288|NCT01203878|5947800|P2|Overall Study|Adverse Event|0
1704289|NCT01203878|5947801|P1|Overall Study|Adverse Event|0
1704290|NCT01203878|5947799|P3|Overall Study|Withdrawal by Subject|1
1704291|NCT01203878|5947800|P2|Overall Study|Withdrawal by Subject|0
1704292|NCT01203878|5947801|P1|Overall Study|Withdrawal by Subject|0
1704293|NCT01203852|5947812|P1|Washout 2 Weeks|Physician Decision|46
1704294|NCT01203852|5947812|P1|Metoprolol 8 Weeks|Physician Decision|470
1704295|NCT01203787|5947830|P2|Overall Study|Adverse Event|15
1704296|NCT01203787|5947831|P1|Overall Study|Adverse Event|11
1704297|NCT01203787|5947830|P2|Overall Study|Lost to Follow-up|0
1704298|NCT01203787|5947831|P1|Overall Study|Lost to Follow-up|2
1704299|NCT01203787|5947830|P2|Overall Study|Withdrawal by Subject|2
1704300|NCT01203787|5947831|P1|Overall Study|Withdrawal by Subject|6
1704301|NCT01203787|5947830|P2|Overall Study|Death|10
1704302|NCT01203787|5947831|P1|Overall Study|Death|12
1704303|NCT01203098|5947902|P3|Overall Study|Withdrawal by Subject|3
1704304|NCT01203098|5947903|P2|Overall Study|Withdrawal by Subject|1
1704305|NCT01203098|5947904|P1|Overall Study|Withdrawal by Subject|1
1704306|NCT01203098|5947902|P3|Overall Study|Physician Decision|0
1704307|NCT01203098|5947903|P2|Overall Study|Physician Decision|2
1704308|NCT01203098|5947904|P1|Overall Study|Physician Decision|2
1704309|NCT01203098|5947902|P3|Overall Study|Lost to Follow-up|1
1704310|NCT01203098|5947903|P2|Overall Study|Lost to Follow-up|0
1704311|NCT01203098|5947904|P1|Overall Study|Lost to Follow-up|0
1704312|NCT01203098|5947902|P3|Overall Study|Adverse Event|7
1704313|NCT01203098|5947903|P2|Overall Study|Adverse Event|1
1704314|NCT01203098|5947904|P1|Overall Study|Adverse Event|3
1704315|NCT01203072|5947920|P5|Overall Study|Withdrawal by Subject|3
1704316|NCT01203072|5947921|P4|Overall Study|Withdrawal by Subject|2
1704317|NCT01203072|5947922|P3|Overall Study|Withdrawal by Subject|1
1704318|NCT01203072|5947923|P2|Overall Study|Withdrawal by Subject|2
1704319|NCT01203072|5947924|P1|Overall Study|Withdrawal by Subject|2
1704320|NCT01203072|5947920|P5|Overall Study|Protocol Violation|1
1704321|NCT01203072|5947921|P4|Overall Study|Protocol Violation|0
1704322|NCT01203072|5947922|P3|Overall Study|Protocol Violation|0
1704323|NCT01203072|5947923|P2|Overall Study|Protocol Violation|0
1704324|NCT01203072|5947924|P1|Overall Study|Protocol Violation|2
1704325|NCT01203072|5947920|P5|Overall Study|Lost to Follow-up|0
1704326|NCT01203072|5947921|P4|Overall Study|Lost to Follow-up|0
1704327|NCT01203072|5947922|P3|Overall Study|Lost to Follow-up|0
1704328|NCT01203072|5947923|P2|Overall Study|Lost to Follow-up|1
1704329|NCT01203072|5947924|P1|Overall Study|Lost to Follow-up|0
1704330|NCT01203072|5947920|P5|Overall Study|Lack of Efficacy|0
1704331|NCT01203072|5947921|P4|Overall Study|Lack of Efficacy|0
1704332|NCT01203072|5947922|P3|Overall Study|Lack of Efficacy|0
1704333|NCT01203072|5947923|P2|Overall Study|Lack of Efficacy|0
1704334|NCT01203072|5947924|P1|Overall Study|Lack of Efficacy|1
1704335|NCT01203072|5947920|P5|Overall Study|Adverse Event|2
1704336|NCT01203072|5947921|P4|Overall Study|Adverse Event|4
1704337|NCT01203072|5947922|P3|Overall Study|Adverse Event|2
1704338|NCT01203072|5947923|P2|Overall Study|Adverse Event|3
1704339|NCT01203072|5947924|P1|Overall Study|Adverse Event|5
1704340|NCT01202955|5947959|P2|Period 1: 10 Days|Withdrawal by Subject|2
1704341|NCT01202955|5947960|P1|Period 1: 10 Days|Withdrawal by Subject|0
1704342|NCT01202903|5947972|P2|Overall Study|Withdrawal by Subject|4
1704343|NCT01202903|5947973|P1|Overall Study|Withdrawal by Subject|4
1704344|NCT01202903|5947972|P2|Overall Study|Adverse Event|3
1704345|NCT01202903|5947973|P1|Overall Study|Adverse Event|3
1704346|NCT01202903|5947972|P2|Overall Study|Lack of Efficacy|3
1704347|NCT01202903|5947973|P1|Overall Study|Lack of Efficacy|1
1704348|NCT01202903|5947972|P2|Overall Study|Lost to Follow-up|1
1704349|NCT01202903|5947973|P1|Overall Study|Lost to Follow-up|1
1704350|NCT01202903|5947972|P2|Overall Study|Death|0
1704351|NCT01202903|5947973|P1|Overall Study|Death|1
1704352|NCT01202903|5947972|P2|Overall Study|Protocol Violation|1
1704353|NCT01202903|5947973|P1|Overall Study|Protocol Violation|0
1704354|NCT01202903|5947972|P2|Overall Study|Administrative Probelms|4
1704355|NCT01202903|5947973|P1|Overall Study|Administrative Probelms|1
1704356|NCT01202877|5948000|P3|Overall Study|Death|1
1704357|NCT01202877|5948001|P2|Overall Study|Death|0
1704358|NCT01202877|5948002|P1|Overall Study|Death|0
1704359|NCT01202877|5948000|P3|Overall Study|Withdrawal by Subject|1
1704360|NCT01202877|5948001|P2|Overall Study|Withdrawal by Subject|0
1704361|NCT01202877|5948002|P1|Overall Study|Withdrawal by Subject|0
1704362|NCT01202877|5948000|P3|Overall Study|Adverse Event|2
1704363|NCT01202877|5948001|P2|Overall Study|Adverse Event|0
1704364|NCT01202877|5948002|P1|Overall Study|Adverse Event|0
1704365|NCT01202877|5948000|P3|Overall Study|Disease Progression|2
1704366|NCT01202877|5948001|P2|Overall Study|Disease Progression|1
1704367|NCT01202877|5948002|P1|Overall Study|Disease Progression|0
1704368|NCT01202773|5948016|P3|Overall Study|Sponsor Decision|23
1704369|NCT01202773|5948017|P2|Overall Study|Sponsor Decision|20
1704370|NCT01202773|5948018|P1|Overall Study|Sponsor Decision|19
1704371|NCT01202773|5948016|P3|Overall Study|Protocol Violation|10
1704372|NCT01202773|5948017|P2|Overall Study|Protocol Violation|6
1704373|NCT01202773|5948018|P1|Overall Study|Protocol Violation|11
1704374|NCT01202773|5948016|P3|Overall Study|Physician Decision|0
1704375|NCT01202773|5948017|P2|Overall Study|Physician Decision|0
1704376|NCT01202773|5948018|P1|Overall Study|Physician Decision|2
1704377|NCT01202773|5948016|P3|Overall Study|Withdrawal by Subject|5
1704378|NCT01202773|5948017|P2|Overall Study|Withdrawal by Subject|6
1704379|NCT01202773|5948018|P1|Overall Study|Withdrawal by Subject|13
1704380|NCT01202773|5948016|P3|Overall Study|Lost to Follow-up|2
1704381|NCT01202773|5948017|P2|Overall Study|Lost to Follow-up|2
1704382|NCT01202773|5948018|P1|Overall Study|Lost to Follow-up|1
1704383|NCT01202773|5948016|P3|Overall Study|Entry Criteria Not Met|1
1704384|NCT01202773|5948017|P2|Overall Study|Entry Criteria Not Met|0
1704385|NCT01202773|5948018|P1|Overall Study|Entry Criteria Not Met|2
1704386|NCT01202773|5948016|P3|Overall Study|Lack of Efficacy|9
1704387|NCT01202773|5948017|P2|Overall Study|Lack of Efficacy|4
1704388|NCT01202773|5948018|P1|Overall Study|Lack of Efficacy|5
1704389|NCT01202773|5948016|P3|Overall Study|Adverse Event|5
1704390|NCT01202773|5948017|P2|Overall Study|Adverse Event|5
1704391|NCT01202773|5948018|P1|Overall Study|Adverse Event|4
1704392|NCT01202760|5948095|P3|Overall Study|Sponsor Decision|0
1704393|NCT01202760|5948096|P2|Overall Study|Sponsor Decision|4
1704394|NCT01202760|5948097|P1|Overall Study|Sponsor Decision|4
1704395|NCT01202760|5948095|P3|Overall Study|Protocol Violation|2
1704396|NCT01202760|5948096|P2|Overall Study|Protocol Violation|5
1704397|NCT01202760|5948097|P1|Overall Study|Protocol Violation|7
1704398|NCT01202760|5948095|P3|Overall Study|Physician Decision|0
1704399|NCT01202760|5948096|P2|Overall Study|Physician Decision|1
1704400|NCT01202760|5948097|P1|Overall Study|Physician Decision|0
1704401|NCT01202760|5948095|P3|Overall Study|Withdrawal by Subject|14
1704402|NCT01202760|5948096|P2|Overall Study|Withdrawal by Subject|18
1704403|NCT01202760|5948097|P1|Overall Study|Withdrawal by Subject|17
1704404|NCT01202760|5948095|P3|Overall Study|Parent / Caregiver Decision|0
1704405|NCT01202760|5948096|P2|Overall Study|Parent / Caregiver Decision|1
1704406|NCT01202760|5948097|P1|Overall Study|Parent / Caregiver Decision|0
1704407|NCT01202760|5948095|P3|Overall Study|Lost to Follow-up|1
1704408|NCT01202760|5948096|P2|Overall Study|Lost to Follow-up|2
1704409|NCT01202760|5948097|P1|Overall Study|Lost to Follow-up|0
1704410|NCT01202760|5948095|P3|Overall Study|Lack of Efficacy|7
1704411|NCT01202760|5948096|P2|Overall Study|Lack of Efficacy|8
1704412|NCT01202760|5948097|P1|Overall Study|Lack of Efficacy|6
1704413|NCT01202760|5948095|P3|Overall Study|Death|0
1704414|NCT01202760|5948096|P2|Overall Study|Death|1
1704415|NCT01202760|5948097|P1|Overall Study|Death|2
1704416|NCT01202760|5948095|P3|Overall Study|Adverse Event|10
1704417|NCT01202760|5948096|P2|Overall Study|Adverse Event|9
1704418|NCT01202760|5948097|P1|Overall Study|Adverse Event|11
1704419|NCT01202760|5948095|P3|Overall Study|Entry Criteria Not Met|1
1704420|NCT01202760|5948096|P2|Overall Study|Entry Criteria Not Met|3
1704421|NCT01202760|5948097|P1|Overall Study|Entry Criteria Not Met|0
1704422|NCT01202747|5948165|P1|Overall Study|Withdrawal by Subject|1
1704423|NCT01202591|5948218|P6|Overall Study|Objective Disease Progression|0
1704424|NCT01202591|5948219|P5|Overall Study|Objective Disease Progression|2
1704425|NCT01202591|5948220|P4|Overall Study|Objective Disease Progression|0
1704426|NCT01202591|5948221|P3|Overall Study|Objective Disease Progression|0
1704427|NCT01202591|5948222|P2|Overall Study|Objective Disease Progression|0
1704428|NCT01202591|5948223|P1|Overall Study|Objective Disease Progression|0
1704429|NCT01202591|5948218|P6|Overall Study|Withdrawal by Subject|1
1704430|NCT01202591|5948219|P5|Overall Study|Withdrawal by Subject|2
1704431|NCT01202591|5948220|P4|Overall Study|Withdrawal by Subject|0
1704432|NCT01202591|5948221|P3|Overall Study|Withdrawal by Subject|0
1704433|NCT01202591|5948222|P2|Overall Study|Withdrawal by Subject|0
1704434|NCT01202591|5948223|P1|Overall Study|Withdrawal by Subject|0
1704435|NCT01202591|5948218|P6|Overall Study|Other reason as per investigator|3
1704436|NCT01202591|5948219|P5|Overall Study|Other reason as per investigator|1
1704437|NCT01202591|5948220|P4|Overall Study|Other reason as per investigator|3
1704438|NCT01202591|5948221|P3|Overall Study|Other reason as per investigator|7
1704439|NCT01202591|5948222|P2|Overall Study|Other reason as per investigator|4
1704440|NCT01202591|5948223|P1|Overall Study|Other reason as per investigator|3
1704441|NCT01202591|5948218|P6|Overall Study|Adverse Event|0
1704442|NCT01202591|5948219|P5|Overall Study|Adverse Event|0
1704443|NCT01202591|5948220|P4|Overall Study|Adverse Event|4
1704444|NCT01202591|5948221|P3|Overall Study|Adverse Event|4
1704445|NCT01202591|5948222|P2|Overall Study|Adverse Event|1
1704446|NCT01202591|5948223|P1|Overall Study|Adverse Event|2
1704449|NCT01202279|5948274|P2|Overall Study|study compliance|2
1704450|NCT01202279|5948275|P1|Overall Study|study compliance|5
1704451|NCT01202279|5948274|P2|Overall Study|Protocol Violation|1
1704452|NCT01202279|5948275|P1|Overall Study|Protocol Violation|1
1704453|NCT01202279|5948274|P2|Overall Study|Lost to Follow-up|7
1704454|NCT01202279|5948275|P1|Overall Study|Lost to Follow-up|10
1704455|NCT01202279|5948274|P2|Overall Study|Physician Decision|1
1704456|NCT01202279|5948275|P1|Overall Study|Physician Decision|0
1704457|NCT01202279|5948274|P2|Overall Study|Withdrawal by Subject|10
1704458|NCT01202279|5948275|P1|Overall Study|Withdrawal by Subject|13
1704459|NCT01202279|5948274|P2|Overall Study|Adverse Event|6
1704460|NCT01202279|5948275|P1|Overall Study|Adverse Event|8
1704461|NCT01202227|5948327|P1|Overall Study|Lack of Efficacy|1
1704462|NCT01202227|5948327|P1|Overall Study|Withdrawal by Subject|2
1704463|NCT01202227|5948327|P1|Overall Study|Adverse Event|16
1704464|NCT01202188|5948351|P5|Overall Study|Abnormal test procedure result (s)|0
1704465|NCT01202188|5948352|P4|Overall Study|Abnormal test procedure result (s)|0
1704466|NCT01202188|5948353|P3|Overall Study|Abnormal test procedure result (s)|2
1704467|NCT01202188|5948354|P2|Overall Study|Abnormal test procedure result (s)|0
1704468|NCT01202188|5948355|P1|Overall Study|Abnormal test procedure result (s)|0
1704469|NCT01202188|5948351|P5|Overall Study|Death|0
1704470|NCT01202188|5948352|P4|Overall Study|Death|1
1704471|NCT01202188|5948353|P3|Overall Study|Death|1
1704472|NCT01202188|5948354|P2|Overall Study|Death|1
1704473|NCT01202188|5948355|P1|Overall Study|Death|1
1704474|NCT01202188|5948351|P5|Overall Study|Lost to Follow-up|1
1704475|NCT01202188|5948352|P4|Overall Study|Lost to Follow-up|4
1704476|NCT01202188|5948353|P3|Overall Study|Lost to Follow-up|0
1704477|NCT01202188|5948354|P2|Overall Study|Lost to Follow-up|1
1704478|NCT01202188|5948355|P1|Overall Study|Lost to Follow-up|1
1704479|NCT01202188|5948351|P5|Overall Study|Unsatisfactory therapeutic effect|8
1704480|NCT01202188|5948352|P4|Overall Study|Unsatisfactory therapeutic effect|5
1704481|NCT01202188|5948353|P3|Overall Study|Unsatisfactory therapeutic effect|2
1704482|NCT01202188|5948354|P2|Overall Study|Unsatisfactory therapeutic effect|8
1704483|NCT01202188|5948355|P1|Overall Study|Unsatisfactory therapeutic effect|2
1704484|NCT01202188|5948351|P5|Overall Study|Administrative problems|2
1704485|NCT01202188|5948352|P4|Overall Study|Administrative problems|1
1704486|NCT01202188|5948353|P3|Overall Study|Administrative problems|1
1704487|NCT01202188|5948354|P2|Overall Study|Administrative problems|2
1704488|NCT01202188|5948355|P1|Overall Study|Administrative problems|3
1704489|NCT01202188|5948351|P5|Overall Study|Adverse Event|10
1704490|NCT01202188|5948352|P4|Overall Study|Adverse Event|10
1704491|NCT01202188|5948353|P3|Overall Study|Adverse Event|13
1704492|NCT01202188|5948354|P2|Overall Study|Adverse Event|23
1704493|NCT01202188|5948355|P1|Overall Study|Adverse Event|5
1704494|NCT01202188|5948351|P5|Overall Study|Subject withdrew consent|13
1704495|NCT01202188|5948352|P4|Overall Study|Subject withdrew consent|11
1704496|NCT01202188|5948353|P3|Overall Study|Subject withdrew consent|22
1704497|NCT01202188|5948354|P2|Overall Study|Subject withdrew consent|13
1704498|NCT01202188|5948355|P1|Overall Study|Subject withdrew consent|12
1704499|NCT01202188|5948351|P5|Overall Study|Protocol deviation|11
1704500|NCT01202188|5948352|P4|Overall Study|Protocol deviation|10
1704501|NCT01202188|5948353|P3|Overall Study|Protocol deviation|12
1704502|NCT01202188|5948354|P2|Overall Study|Protocol deviation|8
1704503|NCT01202188|5948355|P1|Overall Study|Protocol deviation|14
1704504|NCT01202175|5948463|P1|Overall Study|Adverse Event|2
1704505|NCT01202175|5948463|P1|Overall Study|Withdrawal by Subject|1
1704506|NCT01202175|5948463|P1|Overall Study|Lost to Follow-up|2
1704507|NCT01201967|5948531|P2|Overall Study|Lost to Follow-up|5
1704508|NCT01201967|5948532|P1|Overall Study|Lost to Follow-up|6
1704509|NCT01201915|5948557|P3|Overall Study|Target Lesion Progression|0
1704510|NCT01201915|5948558|P2|Overall Study|Target Lesion Progression|3
1704511|NCT01201915|5948559|P1|Overall Study|Target Lesion Progression|0
1704512|NCT01201915|5948557|P3|Overall Study|Subject Decision|5
1704513|NCT01201915|5948558|P2|Overall Study|Subject Decision|3
1704514|NCT01201915|5948559|P1|Overall Study|Subject Decision|3
1704515|NCT01201915|5948557|P3|Overall Study|Physician Decision|0
1704516|NCT01201915|5948558|P2|Overall Study|Physician Decision|0
1704517|NCT01201915|5948559|P1|Overall Study|Physician Decision|3
1704518|NCT01201915|5948557|P3|Overall Study|Lost to Follow-up|0
1704519|NCT01201915|5948558|P2|Overall Study|Lost to Follow-up|4
1704520|NCT01201915|5948559|P1|Overall Study|Lost to Follow-up|0
1704521|NCT01201915|5948557|P3|Overall Study|Adverse Event|1
1704522|NCT01201915|5948558|P2|Overall Study|Adverse Event|1
1704523|NCT01201915|5948559|P1|Overall Study|Adverse Event|2
1704524|NCT01201811|5948570|P1|Overall Study|Physician Decision|1
1704525|NCT01201811|5948570|P1|Overall Study|Treatment Failure|2
1704526|NCT01201811|5948570|P1|Overall Study|Death|4
1704527|NCT01201811|5948570|P1|Overall Study|Withdrawal by Subject|3
1704528|NCT01201811|5948570|P1|Overall Study|Disease progression|3
1704529|NCT01201811|5948570|P1|Overall Study|Adverse Event|6
1704530|NCT01201798|5948592|P2|Overall Study|Treatment Failure|8
1704531|NCT01201798|5948593|P1|Overall Study|Treatment Failure|1
1704532|NCT01201798|5948592|P2|Overall Study|Protocol Violation|1
1704533|NCT01201798|5948593|P1|Overall Study|Protocol Violation|1
1704534|NCT01201798|5948592|P2|Overall Study|Noncompliance|0
1704535|NCT01201798|5948593|P1|Overall Study|Noncompliance|1
1704536|NCT01201798|5948592|P2|Overall Study|Decision Unrelated to an Adverse Event|1
1704537|NCT01201798|5948593|P1|Overall Study|Decision Unrelated to an Adverse Event|1
1704538|NCT01201798|5948592|P2|Overall Study|Lost to Follow-up|5
1704539|NCT01201798|5948593|P1|Overall Study|Lost to Follow-up|3
1704540|NCT01201798|5948592|P2|Overall Study|Adverse Event|0
1704541|NCT01201798|5948593|P1|Overall Study|Adverse Event|2
1704542|NCT01201785|5948617|P1|Overall Study|Lost to Follow-up|16
1704543|NCT01201759|5948634|P2|Visit 4 Crossover|Lost to Follow-up|1
1704544|NCT01201759|5948635|P1|Visit 4 Crossover|Lost to Follow-up|0
1704545|NCT01201759|5948634|P2|Visit 3 - Washout|Lost to Follow-up|0
1704546|NCT01201759|5948635|P1|Visit 3 - Washout|Lost to Follow-up|1
1704547|NCT01201759|5948634|P2|Visit 3 - Washout|Adverse Event|3
1704548|NCT01201759|5948635|P1|Visit 3 - Washout|Adverse Event|0
1704549|NCT01201759|5948634|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
1704550|NCT01201759|5948635|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
1704551|NCT01201356|5948664|P1|Overall Study|Protocol Violation|12
1704552|NCT01201356|5948664|P1|Overall Study|Death|16
1704553|NCT01201356|5948664|P1|Overall Study|administrative problems|74
1704554|NCT01201356|5948664|P1|Overall Study|Lost to Follow-up|50
1704555|NCT01201356|5948664|P1|Overall Study|Withdrawal by Subject|144
1704556|NCT01201356|5948664|P1|Overall Study|Condition no longer requires study drug|12
1704557|NCT01201356|5948664|P1|Overall Study|Unsatisfactory therapeutic effect|112
1704558|NCT01201356|5948664|P1|Overall Study|Abnormal test procedure result(s)|3
1704559|NCT01201356|5948664|P1|Overall Study|Abnormal laboratory value(s)|51
1704560|NCT01201356|5948664|P1|Overall Study|Adverse Event|170
1704561|NCT01201343|5948678|P1|Overall Study|Randomized, not treated|3
1704562|NCT01201343|5948678|P1|Overall Study|Participant wrongly included in trial|1
1704563|NCT01201343|5948678|P1|Overall Study|Lack of Efficacy|2
1704564|NCT01201343|5948678|P1|Overall Study|Lost to Follow-up|2
1704565|NCT01201343|5948678|P1|Overall Study|Withdrawal by Subject|5
1704566|NCT01201343|5948678|P1|Overall Study|Adverse Event|6
1704567|NCT01201317|5948692|P3|Overall Study|Safety, possible history of tuberculosis|1
1704568|NCT01201317|5948693|P2|Overall Study|Safety, possible history of tuberculosis|0
1704569|NCT01201317|5948694|P1|Overall Study|Safety, possible history of tuberculosis|0
1704570|NCT01201317|5948692|P3|Overall Study|Lack of Efficacy|0
1704571|NCT01201317|5948693|P2|Overall Study|Lack of Efficacy|0
1704572|NCT01201317|5948694|P1|Overall Study|Lack of Efficacy|1
1704573|NCT01201317|5948692|P3|Overall Study|Decrease in renal function|0
1704574|NCT01201317|5948693|P2|Overall Study|Decrease in renal function|1
1704575|NCT01201317|5948694|P1|Overall Study|Decrease in renal function|0
1704576|NCT01201317|5948692|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
1704577|NCT01201317|5948693|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
1704578|NCT01201317|5948694|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
1704579|NCT01201317|5948692|P3|Overall Study|Study-specific withdrawal criteria|1
1704580|NCT01201317|5948693|P2|Overall Study|Study-specific withdrawal criteria|0
1704581|NCT01201317|5948694|P1|Overall Study|Study-specific withdrawal criteria|0
1704582|NCT01201317|5948692|P3|Overall Study|Death|0
1704583|NCT01201317|5948693|P2|Overall Study|Death|1
1704584|NCT01201317|5948694|P1|Overall Study|Death|0
1704585|NCT01201317|5948692|P3|Overall Study|Protocol Violation|1
1704586|NCT01201317|5948693|P2|Overall Study|Protocol Violation|1
1704587|NCT01201317|5948694|P1|Overall Study|Protocol Violation|0
1704588|NCT01201317|5948692|P3|Overall Study|Screen failure|0
1704589|NCT01201317|5948693|P2|Overall Study|Screen failure|1
1704590|NCT01201317|5948694|P1|Overall Study|Screen failure|1
1704591|NCT01201317|5948692|P3|Overall Study|Adverse Event|2
1704592|NCT01201317|5948693|P2|Overall Study|Adverse Event|2
1704593|NCT01201317|5948694|P1|Overall Study|Adverse Event|2
1704594|NCT01201317|5948692|P3|Overall Study|Withdrawal by Subject|3
1704595|NCT01201317|5948693|P2|Overall Study|Withdrawal by Subject|0
1704596|NCT01201317|5948694|P1|Overall Study|Withdrawal by Subject|5
1704597|NCT01201265|5948714|P1|Overall Study|Disease Progression|4
1704598|NCT01201265|5948714|P1|Overall Study|Withdrawal by Subject|7
1704599|NCT01201265|5948714|P1|Overall Study|Lost to Follow-up|10
1704600|NCT01201265|5948714|P1|Overall Study|Insufficient Therapeutic Response|3
1704601|NCT01201265|5948714|P1|Overall Study|Death|14
1704602|NCT01200992|5948761|P2|Overall Study|Randomized but not treated|0
1704603|NCT01200992|5948762|P1|Overall Study|Randomized but not treated|2
1704604|NCT01200992|5948761|P2|Overall Study|Study terminated early|41
1704605|NCT01200992|5948762|P1|Overall Study|Study terminated early|35
1704606|NCT01200810|5948776|P2|Overall Study|Sponsor stopped making study drug|3
1704607|NCT01200810|5948777|P1|Overall Study|Sponsor stopped making study drug|3
1704608|NCT01200810|5948776|P2|Overall Study|Withdrawal by Subject|2
1704609|NCT01200810|5948777|P1|Overall Study|Withdrawal by Subject|1
1704610|NCT01200810|5948776|P2|Overall Study|Physician Decision|0
1704611|NCT01200810|5948777|P1|Overall Study|Physician Decision|1
1704612|NCT01200797|5948797|P1|Overall Study|Disease Progression|13
1704613|NCT01200797|5948797|P1|Overall Study|Adverse Event|4
1704614|NCT01200797|5948797|P1|Overall Study|symptomatic deterioration|2
1704615|NCT01200758|5948807|P4|Stage 2|Death|5
1704616|NCT01200758|5948808|P3|Stage 2|Death|3
1704617|NCT01200758|5948809|P2|Stage 2|Death|0
1704618|NCT01200758|5948810|P1|Stage 2|Death|0
1704619|NCT01200758|5948807|P4|Stage 2|Protocol Violation|4
1704620|NCT01200758|5948808|P3|Stage 2|Protocol Violation|1
1704621|NCT01200758|5948809|P2|Stage 2|Protocol Violation|0
1704622|NCT01200758|5948810|P1|Stage 2|Protocol Violation|0
1704623|NCT01200758|5948807|P4|Stage 2|Lost to Follow-up|1
1704624|NCT01200758|5948808|P3|Stage 2|Lost to Follow-up|3
1704625|NCT01200758|5948809|P2|Stage 2|Lost to Follow-up|0
1704626|NCT01200758|5948810|P1|Stage 2|Lost to Follow-up|0
1704627|NCT01200758|5948807|P4|Stage 2|Withdrawal by Subject|1
1704628|NCT01200758|5948808|P3|Stage 2|Withdrawal by Subject|4
1704629|NCT01200758|5948809|P2|Stage 2|Withdrawal by Subject|0
1704630|NCT01200758|5948810|P1|Stage 2|Withdrawal by Subject|0
1704631|NCT01200758|5948807|P4|Stage 2|Adverse Event|9
1704632|NCT01200758|5948808|P3|Stage 2|Adverse Event|5
1704633|NCT01200758|5948809|P2|Stage 2|Adverse Event|0
1704634|NCT01200758|5948810|P1|Stage 2|Adverse Event|0
1704635|NCT01200758|5948807|P4|Stage 2|Physician Decision|7
1704636|NCT01200758|5948808|P3|Stage 2|Physician Decision|5
1704637|NCT01200758|5948809|P2|Stage 2|Physician Decision|0
1704638|NCT01200758|5948810|P1|Stage 2|Physician Decision|0
1704639|NCT01200758|5948807|P4|Stage 2|Lack of Efficacy|2
1704640|NCT01200758|5948808|P3|Stage 2|Lack of Efficacy|4
1704641|NCT01200758|5948809|P2|Stage 2|Lack of Efficacy|0
1704642|NCT01200758|5948810|P1|Stage 2|Lack of Efficacy|0
1704643|NCT01200758|5948807|P4|Stage 2|Disease Progression|21
1704644|NCT01200758|5948808|P3|Stage 2|Disease Progression|16
1704645|NCT01200758|5948809|P2|Stage 2|Disease Progression|0
1704646|NCT01200758|5948810|P1|Stage 2|Disease Progression|0
1704647|NCT01200758|5948807|P4|Stage I|Disease Progression|0
1704648|NCT01200758|5948808|P3|Stage I|Disease Progression|0
1704649|NCT01200758|5948809|P2|Stage I|Disease Progression|7
1704650|NCT01200758|5948810|P1|Stage I|Disease Progression|9
1704651|NCT01200758|5948807|P4|Stage I|Withdrawal by Subject|0
1704652|NCT01200758|5948808|P3|Stage I|Withdrawal by Subject|0
1704653|NCT01200758|5948809|P2|Stage I|Withdrawal by Subject|2
1704654|NCT01200758|5948810|P1|Stage I|Withdrawal by Subject|1
1704655|NCT01200758|5948807|P4|Stage I|Adverse Event|0
1704656|NCT01200758|5948808|P3|Stage I|Adverse Event|0
1704657|NCT01200758|5948809|P2|Stage I|Adverse Event|5
1704658|NCT01200758|5948810|P1|Stage I|Adverse Event|5
1704659|NCT01200758|5948807|P4|Stage I|Lack of Efficacy|0
1704660|NCT01200758|5948808|P3|Stage I|Lack of Efficacy|0
1704661|NCT01200758|5948809|P2|Stage I|Lack of Efficacy|1
1704662|NCT01200758|5948810|P1|Stage I|Lack of Efficacy|2
1704663|NCT01200758|5948807|P4|Stage I|Physician Decision|0
1704664|NCT01200758|5948808|P3|Stage I|Physician Decision|0
1704665|NCT01200758|5948809|P2|Stage I|Physician Decision|1
1704666|NCT01200758|5948810|P1|Stage I|Physician Decision|1
1704667|NCT01200758|5948807|P4|Stage I|Death|0
1704668|NCT01200758|5948808|P3|Stage I|Death|0
1704669|NCT01200758|5948809|P2|Stage I|Death|1
1704670|NCT01200758|5948810|P1|Stage I|Death|0
1704671|NCT01200589|5948883|P2|Overall Study|Study terminated|172
1704672|NCT01200589|5948884|P1|Overall Study|Study terminated|170
1704673|NCT01200589|5948883|P2|Overall Study|Lost to Follow-up|4
1704674|NCT01200589|5948884|P1|Overall Study|Lost to Follow-up|5
1704675|NCT01200589|5948883|P2|Overall Study|Physician Decision|2
1704676|NCT01200589|5948884|P1|Overall Study|Physician Decision|2
1704677|NCT01200589|5948883|P2|Overall Study|Withdrawal by Subject|11
1704678|NCT01200589|5948884|P1|Overall Study|Withdrawal by Subject|13
1704679|NCT01200524|5948911|P3|Overall Study|Non availability of study nurse|1
1704680|NCT01200524|5948912|P2|Overall Study|Non availability of study nurse|0
1704681|NCT01200524|5948913|P1|Overall Study|Non availability of study nurse|0
1704682|NCT01200524|5948911|P3|Overall Study|Adverse Event|0
1704683|NCT01200524|5948912|P2|Overall Study|Adverse Event|0
1704684|NCT01200524|5948913|P1|Overall Study|Adverse Event|1
1704685|NCT01200524|5948911|P3|Overall Study|Withdrawal by Subject|3
1704686|NCT01200524|5948912|P2|Overall Study|Withdrawal by Subject|1
1704687|NCT01200524|5948913|P1|Overall Study|Withdrawal by Subject|1
1704688|NCT01200511|5948933|P1|Overall Study|Adverse Event|1
1704689|NCT01200511|5948933|P1|Overall Study|Withdrawal by Subject|1
1704690|NCT01200511|5948933|P1|Overall Study|Lost to Follow-up|3
1704691|NCT01200485|5948945|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
1704692|NCT01200485|5948946|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
1704693|NCT01200485|5948947|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
1704694|NCT01200485|5948945|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
1704695|NCT01200485|5948946|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
1704696|NCT01200485|5948947|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
1704697|NCT01200394|5948981|P2|Overall Study|Other|1
1704698|NCT01200394|5948982|P1|Overall Study|Other|0
1704699|NCT01200394|5948981|P2|Overall Study|Withdrawal by Subject|5
1704700|NCT01200394|5948982|P1|Overall Study|Withdrawal by Subject|0
1704701|NCT01200394|5948981|P2|Overall Study|Protocol Violation|3
1704702|NCT01200394|5948982|P1|Overall Study|Protocol Violation|0
1704703|NCT01200394|5948981|P2|Overall Study|Did Not Meet Entrance Criteria|4
1704704|NCT01200394|5948982|P1|Overall Study|Did Not Meet Entrance Criteria|1
1704705|NCT01200394|5948981|P2|Overall Study|Lost to Follow-up|1
1704706|NCT01200394|5948982|P1|Overall Study|Lost to Follow-up|0
1704707|NCT01200394|5948981|P2|Overall Study|Death|0
1704708|NCT01200394|5948982|P1|Overall Study|Death|1
1704709|NCT01200394|5948981|P2|Overall Study|Adverse Event|14
1704710|NCT01200394|5948982|P1|Overall Study|Adverse Event|0
1704711|NCT01200368|5949020|P3|Toddler Dose|Adverse Event|1
1704712|NCT01200368|5949021|P2|Toddler Dose|Adverse Event|3
1704713|NCT01200368|5949022|P1|Toddler Dose|Adverse Event|0
1704714|NCT01200368|5949020|P3|After Infant Series|Other|2
1704715|NCT01200368|5949021|P2|After Infant Series|Other|2
1704716|NCT01200368|5949022|P1|After Infant Series|Other|1
1704717|NCT01200368|5949020|P3|After Infant Series|Lost to Follow-up|0
1704718|NCT01200368|5949021|P2|After Infant Series|Lost to Follow-up|0
1704719|NCT01200368|5949022|P1|After Infant Series|Lost to Follow-up|1
1704720|NCT01200368|5949020|P3|After Infant Series|Withdrawal by Subject|4
1704721|NCT01200368|5949021|P2|After Infant Series|Withdrawal by Subject|8
1704722|NCT01200368|5949022|P1|After Infant Series|Withdrawal by Subject|10
1704723|NCT01200368|5949020|P3|After Infant Series|Adverse Event|3
1704724|NCT01200368|5949021|P2|After Infant Series|Adverse Event|6
1704725|NCT01200368|5949022|P1|After Infant Series|Adverse Event|6
1704726|NCT01200368|5949020|P3|Infant Series|Other|0
1704727|NCT01200368|5949021|P2|Infant Series|Other|0
1704728|NCT01200368|5949022|P1|Infant Series|Other|1
1704729|NCT01200368|5949020|P3|Infant Series|Randomized, not vaccinated|1
1704730|NCT01200368|5949021|P2|Infant Series|Randomized, not vaccinated|1
1704731|NCT01200368|5949022|P1|Infant Series|Randomized, not vaccinated|0
1704732|NCT01200368|5949020|P3|Infant Series|Did not meet entrance criteria|0
1704733|NCT01200368|5949021|P2|Infant Series|Did not meet entrance criteria|1
1704734|NCT01200368|5949022|P1|Infant Series|Did not meet entrance criteria|0
1704735|NCT01200368|5949020|P3|Infant Series|Withdrawal by Subject|2
1704736|NCT01200368|5949021|P2|Infant Series|Withdrawal by Subject|2
1704737|NCT01200368|5949022|P1|Infant Series|Withdrawal by Subject|0
1704738|NCT01200368|5949020|P3|Infant Series|Adverse Event|3
1704739|NCT01200368|5949021|P2|Infant Series|Adverse Event|2
1704740|NCT01200368|5949022|P1|Infant Series|Adverse Event|2
1704741|NCT01200355|5949088|P2|Overall Study|Death|2
1704742|NCT01200355|5949089|P1|Overall Study|Death|7
1704743|NCT01200342|5949103|P1|Overall Study|Disease Progression|1
1704744|NCT01200329|5949108|P1|Overall Study|Progressive disease|1
1704745|NCT01200329|5949108|P1|Overall Study|Lack of financial coverage|2
1704746|NCT01200290|5949113|P1|Post-Treatment Follow-Up Period|Death|2
1704747|NCT01200290|5949113|P1|Treatment Period|Adverse Event|1
1704748|NCT01200238|5949126|P2|Overall Study|Withdrawal by Subject|1
1704749|NCT01200238|5949127|P1|Overall Study|Withdrawal by Subject|0
1704750|NCT01200238|5949126|P2|Overall Study|Progressive Disease|8
1704751|NCT01200238|5949127|P1|Overall Study|Progressive Disease|5
1704752|NCT01200238|5949126|P2|Overall Study|Adverse Event|1
1704753|NCT01200238|5949127|P1|Overall Study|Adverse Event|2
1704754|NCT01200069|5949151|P2|Overall Study|Withdrawal by Subject|1
1704755|NCT01200069|5949152|P1|Overall Study|Withdrawal by Subject|0
1704756|NCT01199939|5949248|P1|Overall Study|Reached a virologic endpoint|4
1704757|NCT01199939|5949248|P1|Overall Study|Lost to Follow-up|2
1704758|NCT01199939|5949248|P1|Overall Study|Protocol Violation|3
1704759|NCT01199939|5949248|P1|Overall Study|Adverse Event|4
1704760|NCT01199861|5949280|P2|Overall Study|Adverse Event|0
1704761|NCT01199861|5949281|P1|Overall Study|Adverse Event|1
1704762|NCT01199861|5949280|P2|Overall Study|Administrative problems|0
1704763|NCT01199861|5949281|P1|Overall Study|Administrative problems|1
1704764|NCT01199822|5949302|P3|Overall Study|Investigator discontinued therapy|0
1704765|NCT01199822|5949303|P2|Overall Study|Investigator discontinued therapy|1
1704766|NCT01199822|5949304|P1|Overall Study|Investigator discontinued therapy|0
1704767|NCT01199731|5949353|P3|Overall Study|Withdrawal by Subject|0
1704768|NCT01199731|5949354|P2|Overall Study|Withdrawal by Subject|0
1704769|NCT01199731|5949355|P1|Overall Study|Withdrawal by Subject|2
1704770|NCT01199731|5949353|P3|Overall Study|Physician Decision|1
1704771|NCT01199731|5949354|P2|Overall Study|Physician Decision|1
1704772|NCT01199731|5949355|P1|Overall Study|Physician Decision|0
1704773|NCT01199731|5949353|P3|Overall Study|Lost to Follow-up|2
1704774|NCT01199731|5949354|P2|Overall Study|Lost to Follow-up|0
1704775|NCT01199731|5949355|P1|Overall Study|Lost to Follow-up|0
1704776|NCT01199731|5949353|P3|Overall Study|Study closed/terminated|7
1704777|NCT01199731|5949354|P2|Overall Study|Study closed/terminated|9
1704778|NCT01199731|5949355|P1|Overall Study|Study closed/terminated|7
1704779|NCT01199731|5949353|P3|Overall Study|Adverse Event|0
1704780|NCT01199731|5949354|P2|Overall Study|Adverse Event|1
1704781|NCT01199731|5949355|P1|Overall Study|Adverse Event|0
1704782|NCT01199705|5949393|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
1704783|NCT01199601|5949425|P2|Overall Study|Insecurity prevented staff interviewing.|9
1704784|NCT01199601|5949426|P1|Overall Study|Insecurity prevented staff interviewing.|7
1704785|NCT01199601|5949425|P2|Overall Study|Withdrawal by Subject|3
1704786|NCT01199601|5949426|P1|Overall Study|Withdrawal by Subject|15
1704787|NCT01199601|5949425|P2|Overall Study|Lost to Follow-up|66
1704788|NCT01199601|5949426|P1|Overall Study|Lost to Follow-up|47
1704789|NCT01199575|5949436|P1|Overall Study|Withdrawal by Subject|5
1704790|NCT01199471|5949441|P1|Overall Study|Physician Decision|1
1704791|NCT01199471|5949441|P1|Overall Study|Withdrawal by Subject|1
1704792|NCT01199471|5949441|P1|Overall Study|Protocol Violation|4
1704793|NCT01199263|5949452|P2|Overall Study|Never Treated|0
1704794|NCT01199263|5949453|P1|Overall Study|Never Treated|6
1704795|NCT01199263|5949452|P2|Overall Study|Ineligible|2
1704796|NCT01199263|5949453|P1|Overall Study|Ineligible|0
1704797|NCT01199042|5949490|P1|At Home (3 Months)|Lost to Follow-up|1
1704798|NCT01199042|5949490|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
1704799|NCT01199016|5949499|P1|Overall Study|Lost to Follow-up|25
1704800|NCT01199016|5949499|P1|Overall Study|Withdrawal by Subject|21
1704801|NCT01199016|5949499|P1|Overall Study|Other|13
1704802|NCT01199016|5949499|P1|Overall Study|Protocol Violation|9
1704803|NCT01199016|5949499|P1|Overall Study|Entrance criteria|5
1704804|NCT01199016|5949499|P1|Overall Study|No longer meets eligibility criteria|4
1704805|NCT01198977|5949508|P2|Overall Study|Lost to Follow-up|0
1704806|NCT01198977|5949509|P1|Overall Study|Lost to Follow-up|1
1704807|NCT01198873|5949521|P2|Overall Study|Other than above|2
1704808|NCT01198873|5949522|P1|Overall Study|Other than above|4
1704809|NCT01198873|5949521|P2|Overall Study|Study closure|23
1704810|NCT01198873|5949522|P1|Overall Study|Study closure|29
1704811|NCT01198873|5949521|P2|Overall Study|Adverse Event|7
1704812|NCT01198873|5949522|P1|Overall Study|Adverse Event|4
1704813|NCT01198795|5949536|P1|Overall Study|Other Reason|4
1704814|NCT01198795|5949536|P1|Overall Study|Protocol Violation|2
1704815|NCT01198795|5949536|P1|Overall Study|Lack of Efficacy|5
1704816|NCT01198795|5949536|P1|Overall Study|Adverse Event|9
1704817|NCT01198795|5949536|P1|Overall Study|Lost to Follow-up|15
1704818|NCT01198795|5949536|P1|Overall Study|Withdrawal by Subject|17
1704819|NCT01198795|5949536|P1|Overall Study|Did not meet InclusionExclusion criteria|30
1704820|NCT01198756|5949553|P4|Overall Study|Lost to Follow-up|18
1704821|NCT01198756|5949554|P3|Overall Study|Lost to Follow-up|23
1704822|NCT01198756|5949555|P2|Overall Study|Lost to Follow-up|36
1704823|NCT01198756|5949556|P1|Overall Study|Lost to Follow-up|29
1704824|NCT01198756|5949553|P4|Overall Study|Withdrawal by Subject|5
1704825|NCT01198756|5949554|P3|Overall Study|Withdrawal by Subject|7
1704826|NCT01198756|5949555|P2|Overall Study|Withdrawal by Subject|4
1704827|NCT01198756|5949556|P1|Overall Study|Withdrawal by Subject|9
1704828|NCT01198756|5949553|P4|Overall Study|Protocol Violation|2
1704829|NCT01198756|5949554|P3|Overall Study|Protocol Violation|0
1704830|NCT01198756|5949555|P2|Overall Study|Protocol Violation|0
1704831|NCT01198756|5949556|P1|Overall Study|Protocol Violation|0
1704832|NCT01198756|5949553|P4|Overall Study|Adverse Event|1
1704833|NCT01198756|5949554|P3|Overall Study|Adverse Event|0
1704834|NCT01198756|5949555|P2|Overall Study|Adverse Event|0
1704835|NCT01198756|5949556|P1|Overall Study|Adverse Event|0
1704836|NCT01198600|5949667|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1704837|NCT01198600|5949668|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
1704838|NCT01198600|5949669|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1704839|NCT01198600|5949670|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
1704840|NCT01198600|5949667|P4|Phase 2: 56 Days of Wear|Relocation|0
1704841|NCT01198600|5949668|P3|Phase 2: 56 Days of Wear|Relocation|2
1704842|NCT01198600|5949669|P2|Phase 2: 56 Days of Wear|Relocation|0
1704843|NCT01198600|5949670|P1|Phase 2: 56 Days of Wear|Relocation|0
1704844|NCT01198600|5949667|P4|Phase 2: 56 Days of Wear|Inconvenience|0
1704845|NCT01198600|5949668|P3|Phase 2: 56 Days of Wear|Inconvenience|2
1704846|NCT01198600|5949669|P2|Phase 2: 56 Days of Wear|Inconvenience|0
1704847|NCT01198600|5949670|P1|Phase 2: 56 Days of Wear|Inconvenience|0
1704848|NCT01198600|5949667|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1704849|NCT01198600|5949668|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1704850|NCT01198600|5949669|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
1704851|NCT01198600|5949670|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
1704852|NCT01198600|5949667|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1704853|NCT01198600|5949668|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1704854|NCT01198600|5949669|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
1704855|NCT01198600|5949670|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
1704856|NCT01198600|5949667|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1704857|NCT01198600|5949668|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1704858|NCT01198600|5949669|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
1704859|NCT01198600|5949670|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
1704860|NCT01198600|5949667|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1704861|NCT01198600|5949668|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1704862|NCT01198600|5949669|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
1704863|NCT01198600|5949670|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
1704864|NCT01198587|5949696|P4|Overall Study|Lost to Follow-up|0
1704865|NCT01198587|5949697|P3|Overall Study|Lost to Follow-up|9
1704866|NCT01198587|5949698|P2|Overall Study|Lost to Follow-up|0
1704867|NCT01198587|5949699|P1|Overall Study|Lost to Follow-up|8
1704868|NCT01198574|5949721|P4|Overall Study|Resigned from schools|4
1704869|NCT01198574|5949722|P3|Overall Study|Resigned from schools|1
1704870|NCT01198574|5949723|P2|Overall Study|Resigned from schools|1
1704871|NCT01198574|5949724|P1|Overall Study|Resigned from schools|4
1704872|NCT01198548|5949742|P1|Overall Study|Administrative Decision|1
1704873|NCT01198548|5949742|P1|Overall Study|Disease Progression|9
1704874|NCT01198509|5949757|P6|Overall Study|Withdrawal by Subject|0
1704875|NCT01198509|5949758|P5|Overall Study|Withdrawal by Subject|0
1704876|NCT01198509|5949759|P4|Overall Study|Withdrawal by Subject|0
1704877|NCT01198509|5949760|P3|Overall Study|Withdrawal by Subject|0
1704878|NCT01198509|5949761|P2|Overall Study|Withdrawal by Subject|0
1704879|NCT01198509|5949762|P1|Overall Study|Withdrawal by Subject|1
1704880|NCT01198470|5949779|P1|Overall Study|Adverse Event|2
1704881|NCT01198275|5949845|P2|Overall Study|spontaneous return to sinus rhythm|2
1704882|NCT01198275|5949846|P1|Overall Study|spontaneous return to sinus rhythm|4
1704883|NCT01198275|5949845|P2|Overall Study|Adverse Event|3
1704884|NCT01198275|5949846|P1|Overall Study|Adverse Event|2
1704885|NCT01198145|5949869|P2|Overall Study|Withdrawal by Subject|1
1704886|NCT01198145|5949870|P1|Overall Study|Withdrawal by Subject|1
1704887|NCT01198132|5949892|P2|Overall Study|Protocol Violation|0
1704888|NCT01198132|5949893|P1|Overall Study|Protocol Violation|1
1704889|NCT01198132|5949892|P2|Overall Study|Adverse Event|1
1704890|NCT01198132|5949893|P1|Overall Study|Adverse Event|0
1704891|NCT01198132|5949892|P2|Overall Study|Abnormal/clinically significant biologic|1
1704892|NCT01198132|5949893|P1|Overall Study|Abnormal/clinically significant biologic|1
1704893|NCT01198132|5949892|P2|Overall Study|Sign/symptoms of underlying disease|1
1704894|NCT01198132|5949893|P1|Overall Study|Sign/symptoms of underlying disease|2
1704895|NCT01198132|5949892|P2|Overall Study|Lack of Efficacy|3
1704896|NCT01198132|5949893|P1|Overall Study|Lack of Efficacy|2
1704897|NCT01198132|5949892|P2|Overall Study|Other Unspecified|6
1704898|NCT01198132|5949893|P1|Overall Study|Other Unspecified|3
1704899|NCT01198132|5949892|P2|Overall Study|Physician Decision|4
1704900|NCT01198132|5949893|P1|Overall Study|Physician Decision|5
1704901|NCT01198132|5949892|P2|Overall Study|Withdrawal by Subject|5
1704902|NCT01198132|5949893|P1|Overall Study|Withdrawal by Subject|4
1704903|NCT01198002|5949920|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
1704904|NCT01198002|5949921|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
1704905|NCT01198002|5949922|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
1704906|NCT01198002|5949920|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
1704907|NCT01198002|5949921|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
1704908|NCT01198002|5949922|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
1704909|NCT01198002|5949920|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
1704910|NCT01198002|5949921|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
1704911|NCT01198002|5949922|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
1704912|NCT01198002|5949920|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
1704913|NCT01198002|5949921|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
1704914|NCT01198002|5949922|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
1704915|NCT01198002|5949920|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
1704916|NCT01198002|5949921|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
1704917|NCT01198002|5949922|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
1704918|NCT01198002|5949920|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
1704919|NCT01198002|5949921|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
1704920|NCT01198002|5949922|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
1704921|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
1704922|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
1704923|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
1704924|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
1704925|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
1704926|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
1704927|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
1704928|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
1704929|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
1704930|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
1704931|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
1704932|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
1704933|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
1704934|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
1704935|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
1704936|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
1704937|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
1704938|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
1704939|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
1704940|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
1704941|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
1704942|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Death|1
1704943|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Death|0
1704944|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Death|2
1704945|NCT01198002|5949920|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
1704946|NCT01198002|5949921|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
1704947|NCT01198002|5949922|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
1704948|NCT01197911|5950037|P3|Overall Study|Adverse Event|1
1704949|NCT01197911|5950038|P2|Overall Study|Adverse Event|0
1704950|NCT01197911|5950039|P1|Overall Study|Adverse Event|0
1704951|NCT01197794|5950154|P7|Overall Study|Other|4
1704952|NCT01197794|5950155|P6|Overall Study|Other|2
1704953|NCT01197794|5950156|P5|Overall Study|Other|2
1704954|NCT01197794|5950157|P4|Overall Study|Other|0
1704955|NCT01197794|5950158|P3|Overall Study|Other|3
1704956|NCT01197794|5950159|P2|Overall Study|Other|1
1704957|NCT01197794|5950160|P1|Overall Study|Other|1
1704958|NCT01197794|5950154|P7|Overall Study|Lost to Follow-up|0
1704959|NCT01197794|5950155|P6|Overall Study|Lost to Follow-up|1
1704960|NCT01197794|5950156|P5|Overall Study|Lost to Follow-up|0
1704961|NCT01197794|5950157|P4|Overall Study|Lost to Follow-up|1
1704962|NCT01197794|5950158|P3|Overall Study|Lost to Follow-up|0
1704963|NCT01197794|5950159|P2|Overall Study|Lost to Follow-up|1
1704964|NCT01197794|5950160|P1|Overall Study|Lost to Follow-up|1
1704965|NCT01197794|5950154|P7|Overall Study|Withdrawal by Subject|6
1704966|NCT01197794|5950155|P6|Overall Study|Withdrawal by Subject|5
1704967|NCT01197794|5950156|P5|Overall Study|Withdrawal by Subject|1
1704968|NCT01197794|5950157|P4|Overall Study|Withdrawal by Subject|1
1704969|NCT01197794|5950158|P3|Overall Study|Withdrawal by Subject|4
1704970|NCT01197794|5950159|P2|Overall Study|Withdrawal by Subject|3
1704971|NCT01197794|5950160|P1|Overall Study|Withdrawal by Subject|3
1704972|NCT01197794|5950154|P7|Overall Study|Eligibility criteria not fulfilled|6
1704973|NCT01197794|5950155|P6|Overall Study|Eligibility criteria not fulfilled|9
1704974|NCT01197794|5950156|P5|Overall Study|Eligibility criteria not fulfilled|5
1704975|NCT01197794|5950157|P4|Overall Study|Eligibility criteria not fulfilled|5
1704976|NCT01197794|5950158|P3|Overall Study|Eligibility criteria not fulfilled|2
1704977|NCT01197794|5950159|P2|Overall Study|Eligibility criteria not fulfilled|8
1704978|NCT01197794|5950160|P1|Overall Study|Eligibility criteria not fulfilled|5
1704979|NCT01197794|5950154|P7|Overall Study|Development of study withdrawal criteria|1
1704980|NCT01197794|5950155|P6|Overall Study|Development of study withdrawal criteria|0
1704981|NCT01197794|5950156|P5|Overall Study|Development of study withdrawal criteria|0
1704982|NCT01197794|5950157|P4|Overall Study|Development of study withdrawal criteria|1
1704983|NCT01197794|5950158|P3|Overall Study|Development of study withdrawal criteria|0
1704984|NCT01197794|5950159|P2|Overall Study|Development of study withdrawal criteria|0
1704985|NCT01197794|5950160|P1|Overall Study|Development of study withdrawal criteria|3
1704986|NCT01197794|5950154|P7|Overall Study|Protocol Violation|1
1704987|NCT01197794|5950155|P6|Overall Study|Protocol Violation|0
1704988|NCT01197794|5950156|P5|Overall Study|Protocol Violation|2
1704989|NCT01197794|5950157|P4|Overall Study|Protocol Violation|0
1704990|NCT01197794|5950158|P3|Overall Study|Protocol Violation|0
1704991|NCT01197794|5950159|P2|Overall Study|Protocol Violation|0
1704992|NCT01197794|5950160|P1|Overall Study|Protocol Violation|0
1704993|NCT01197794|5950154|P7|Overall Study|Adverse Event|3
1704994|NCT01197794|5950155|P6|Overall Study|Adverse Event|2
1704995|NCT01197794|5950156|P5|Overall Study|Adverse Event|4
1704996|NCT01197794|5950157|P4|Overall Study|Adverse Event|4
1704997|NCT01197794|5950158|P3|Overall Study|Adverse Event|4
1704998|NCT01197794|5950159|P2|Overall Study|Adverse Event|2
1704999|NCT01197794|5950160|P1|Overall Study|Adverse Event|3
1705000|NCT01197755|5950242|P3|Overall Study|eg, change in circumstances|2
1705001|NCT01197755|5950243|P2|Overall Study|eg, change in circumstances|3
1705002|NCT01197755|5950244|P1|Overall Study|eg, change in circumstances|7
1705003|NCT01197755|5950242|P3|Overall Study|Lost to Follow-up|1
1705004|NCT01197755|5950243|P2|Overall Study|Lost to Follow-up|0
1705005|NCT01197755|5950244|P1|Overall Study|Lost to Follow-up|0
1705006|NCT01197755|5950242|P3|Overall Study|Withdrawal by Subject|0
1705007|NCT01197755|5950243|P2|Overall Study|Withdrawal by Subject|0
1705008|NCT01197755|5950244|P1|Overall Study|Withdrawal by Subject|1
1705009|NCT01197755|5950242|P3|Overall Study|Severe non-compliance to the protocol|2
1705010|NCT01197755|5950243|P2|Overall Study|Severe non-compliance to the protocol|1
1705011|NCT01197755|5950244|P1|Overall Study|Severe non-compliance to the protocol|2
1705012|NCT01197755|5950242|P3|Overall Study|Lack of therapeutic response|4
1705013|NCT01197755|5950243|P2|Overall Study|Lack of therapeutic response|7
1705014|NCT01197755|5950244|P1|Overall Study|Lack of therapeutic response|0
1705015|NCT01197755|5950242|P3|Overall Study|Entered the long-term extension study|35
1705016|NCT01197755|5950243|P2|Overall Study|Entered the long-term extension study|21
1705017|NCT01197755|5950244|P1|Overall Study|Entered the long-term extension study|18
1705018|NCT01197755|5950242|P3|Overall Study|Study-specific discontinuation criteria|0
1705019|NCT01197755|5950243|P2|Overall Study|Study-specific discontinuation criteria|1
1705020|NCT01197755|5950244|P1|Overall Study|Study-specific discontinuation criteria|2
1705021|NCT01197755|5950242|P3|Overall Study|Adverse Event|10
1705022|NCT01197755|5950243|P2|Overall Study|Adverse Event|10
1705023|NCT01197755|5950244|P1|Overall Study|Adverse Event|8
1705024|NCT01197560|5950316|P2|Overall Study|Missing|1
1705025|NCT01197560|5950317|P1|Overall Study|Missing|0
1705026|NCT01197560|5950316|P2|Overall Study|Miscellaneous|3
1705027|NCT01197560|5950317|P1|Overall Study|Miscellaneous|4
1705028|NCT01197560|5950316|P2|Overall Study|Disease progression|35
1705029|NCT01197560|5950317|P1|Overall Study|Disease progression|40
1705030|NCT01197560|5950316|P2|Overall Study|Withdrawal by Subject|1
1705031|NCT01197560|5950317|P1|Overall Study|Withdrawal by Subject|1
1705032|NCT01197560|5950316|P2|Overall Study|Death|5
1705033|NCT01197560|5950317|P1|Overall Study|Death|3
1705034|NCT01197560|5950316|P2|Overall Study|Adverse Event|8
1705035|NCT01197560|5950317|P1|Overall Study|Adverse Event|6
1705036|NCT01197534|5950364|P3|Overall Study|Adverse Event|24
1705037|NCT01197534|5950365|P2|Overall Study|Adverse Event|36
1705038|NCT01197534|5950366|P1|Overall Study|Adverse Event|35
1705039|NCT01197534|5950364|P3|Overall Study|Lost to Follow-up|2
1705040|NCT01197534|5950365|P2|Overall Study|Lost to Follow-up|4
1705041|NCT01197534|5950366|P1|Overall Study|Lost to Follow-up|1
1705042|NCT01197534|5950364|P3|Overall Study|Dev. of study specific discont. criteria|2
1705043|NCT01197534|5950365|P2|Overall Study|Dev. of study specific discont. criteria|6
1705044|NCT01197534|5950366|P1|Overall Study|Dev. of study specific discont. criteria|13
1705045|NCT01197534|5950364|P3|Overall Study|Lack of therapeutic response|9
1705046|NCT01197534|5950365|P2|Overall Study|Lack of therapeutic response|4
1705047|NCT01197534|5950366|P1|Overall Study|Lack of therapeutic response|9
1705048|NCT01197534|5950364|P3|Overall Study|Severe non-compliance to protocol|1
1705049|NCT01197534|5950365|P2|Overall Study|Severe non-compliance to protocol|4
1705050|NCT01197534|5950366|P1|Overall Study|Severe non-compliance to protocol|3
1705051|NCT01197534|5950364|P3|Overall Study|Enrolment in long term extension|119
1705052|NCT01197534|5950365|P2|Overall Study|Enrolment in long term extension|66
1705053|NCT01197534|5950366|P1|Overall Study|Enrolment in long term extension|57
1705054|NCT01197534|5950364|P3|Overall Study|Not reported|16
1705055|NCT01197534|5950365|P2|Overall Study|Not reported|10
1705056|NCT01197534|5950366|P1|Overall Study|Not reported|16
1705057|NCT01197521|5950410|P3|Overall Study|Adverse Event|24
1705058|NCT01197521|5950411|P2|Overall Study|Adverse Event|28
1705059|NCT01197521|5950412|P1|Overall Study|Adverse Event|25
1705060|NCT01197521|5950410|P3|Overall Study|Lost to Follow-up|2
1705061|NCT01197521|5950411|P2|Overall Study|Lost to Follow-up|2
1705062|NCT01197521|5950412|P1|Overall Study|Lost to Follow-up|3
1705063|NCT01197521|5950410|P3|Overall Study|Dev. of study specific discont. criteria|2
1705064|NCT01197521|5950411|P2|Overall Study|Dev. of study specific discont. criteria|16
1705065|NCT01197521|5950412|P1|Overall Study|Dev. of study specific discont. criteria|6
1705066|NCT01197521|5950410|P3|Overall Study|Lack of therapeutic response|4
1705067|NCT01197521|5950411|P2|Overall Study|Lack of therapeutic response|3
1705068|NCT01197521|5950412|P1|Overall Study|Lack of therapeutic response|2
1705069|NCT01197521|5950410|P3|Overall Study|Severe non-compliance to protocol|3
1705070|NCT01197521|5950411|P2|Overall Study|Severe non-compliance to protocol|3
1705071|NCT01197521|5950412|P1|Overall Study|Severe non-compliance to protocol|1
1705072|NCT01197521|5950410|P3|Overall Study|Enrolment in long term extension|87
1705073|NCT01197521|5950411|P2|Overall Study|Enrolment in long term extension|36
1705074|NCT01197521|5950412|P1|Overall Study|Enrolment in long term extension|42
1705075|NCT01197521|5950410|P3|Overall Study|Not reported|21
1705076|NCT01197521|5950411|P2|Overall Study|Not reported|25
1705077|NCT01197521|5950412|P1|Overall Study|Not reported|24
1705078|NCT01197508|5950457|P4|Overall Study|Other|2
1705079|NCT01197508|5950458|P3|Overall Study|Other|2
1705080|NCT01197508|5950459|P2|Overall Study|Other|3
1705081|NCT01197508|5950460|P1|Overall Study|Other|2
1705082|NCT01197508|5950457|P4|Overall Study|Lost to Follow-up|0
1705083|NCT01197508|5950458|P3|Overall Study|Lost to Follow-up|2
1705084|NCT01197508|5950459|P2|Overall Study|Lost to Follow-up|1
1705085|NCT01197508|5950460|P1|Overall Study|Lost to Follow-up|1
1705086|NCT01197508|5950457|P4|Overall Study|Study-specific withdrawal criteria|2
1705087|NCT01197508|5950458|P3|Overall Study|Study-specific withdrawal criteria|1
1705088|NCT01197508|5950459|P2|Overall Study|Study-specific withdrawal criteria|0
1705089|NCT01197508|5950460|P1|Overall Study|Study-specific withdrawal criteria|0
1705090|NCT01197508|5950457|P4|Overall Study|Lack of Efficacy|1
1705091|NCT01197508|5950458|P3|Overall Study|Lack of Efficacy|2
1705092|NCT01197508|5950459|P2|Overall Study|Lack of Efficacy|2
1705093|NCT01197508|5950460|P1|Overall Study|Lack of Efficacy|1
1705094|NCT01197508|5950457|P4|Overall Study|Condition under investigation worsened|1
1705095|NCT01197508|5950458|P3|Overall Study|Condition under investigation worsened|1
1705096|NCT01197508|5950459|P2|Overall Study|Condition under investigation worsened|1
1705097|NCT01197508|5950460|P1|Overall Study|Condition under investigation worsened|1
1705098|NCT01197508|5950457|P4|Overall Study|Severe non-compliance to protocol|3
1705099|NCT01197508|5950458|P3|Overall Study|Severe non-compliance to protocol|1
1705100|NCT01197508|5950459|P2|Overall Study|Severe non-compliance to protocol|3
1705101|NCT01197508|5950460|P1|Overall Study|Severe non-compliance to protocol|0
1705102|NCT01197508|5950457|P4|Overall Study|Adverse Event|3
1705103|NCT01197508|5950458|P3|Overall Study|Adverse Event|23
1705104|NCT01197508|5950459|P2|Overall Study|Adverse Event|13
1705105|NCT01197508|5950460|P1|Overall Study|Adverse Event|10
1705106|NCT01197508|5950457|P4|Overall Study|Eligiblity criteria not fulfilled|0
1705107|NCT01197508|5950458|P3|Overall Study|Eligiblity criteria not fulfilled|2
1705108|NCT01197508|5950459|P2|Overall Study|Eligiblity criteria not fulfilled|0
1705109|NCT01197508|5950460|P1|Overall Study|Eligiblity criteria not fulfilled|0
1705110|NCT01197508|5950457|P4|Overall Study|Withdrawal by Subject|4
1705111|NCT01197508|5950458|P3|Overall Study|Withdrawal by Subject|15
1705112|NCT01197508|5950459|P2|Overall Study|Withdrawal by Subject|7
1705113|NCT01197508|5950460|P1|Overall Study|Withdrawal by Subject|8
1705114|NCT01197417|5950570|P2|Overall Study|No 25-hour magnesium level|2
1705115|NCT01197417|5950571|P1|Overall Study|No 25-hour magnesium level|0
1705116|NCT01197417|5950570|P2|Overall Study|Found to be ineligible|5
1705117|NCT01197417|5950571|P1|Overall Study|Found to be ineligible|2
1705118|NCT01197417|5950570|P2|Overall Study|Hypotension|2
1705119|NCT01197417|5950571|P1|Overall Study|Hypotension|1
1705120|NCT01197417|5950570|P2|Overall Study|Not consented in time to receive drug|1
1705121|NCT01197417|5950571|P1|Overall Study|Not consented in time to receive drug|0
1705122|NCT01197417|5950570|P2|Overall Study|Subject transferred to intensive care|1
1705123|NCT01197417|5950571|P1|Overall Study|Subject transferred to intensive care|0
1705124|NCT01197417|5950570|P2|Overall Study|Site miscommunication|1
1705125|NCT01197417|5950571|P1|Overall Study|Site miscommunication|0
1705126|NCT01197417|5950570|P2|Overall Study|Withdrawal by Subject|4
1705127|NCT01197417|5950571|P1|Overall Study|Withdrawal by Subject|2
1705128|NCT01197417|5950570|P2|Overall Study|Physician Decision|2
1705129|NCT01197417|5950571|P1|Overall Study|Physician Decision|3
1705130|NCT01197378|5950589|P1|Overall Study|Other|2
1705131|NCT01197378|5950589|P1|Overall Study|Physician Decision|1
1705132|NCT01197378|5950589|P1|Overall Study|Withdrawal by Subject|1
1705133|NCT01197378|5950589|P1|Overall Study|Adverse Event|3
1705134|NCT01197300|5950608|P2|Overall Study|Protocol Violation|1
1705135|NCT01197300|5950609|P1|Overall Study|Protocol Violation|0
1705136|NCT01197300|5950608|P2|Overall Study|Lost to Follow-up|1
1705137|NCT01197300|5950609|P1|Overall Study|Lost to Follow-up|0
1705138|NCT01196988|5950641|P4|Overall Study|Other|0
1705139|NCT01196988|5950642|P3|Overall Study|Other|0
1705140|NCT01196988|5950643|P2|Overall Study|Other|0
1705141|NCT01196988|5950644|P1|Overall Study|Other|2
1705142|NCT01196988|5950641|P4|Overall Study|Lost to Follow-up|1
1705143|NCT01196988|5950642|P3|Overall Study|Lost to Follow-up|21
1705144|NCT01196988|5950643|P2|Overall Study|Lost to Follow-up|29
1705145|NCT01196988|5950644|P1|Overall Study|Lost to Follow-up|16
1705146|NCT01196988|5950641|P4|Overall Study|Withdrawal by Subject|0
1705147|NCT01196988|5950642|P3|Overall Study|Withdrawal by Subject|4
1705148|NCT01196988|5950643|P2|Overall Study|Withdrawal by Subject|1
1705149|NCT01196988|5950644|P1|Overall Study|Withdrawal by Subject|5
1705150|NCT01196988|5950641|P4|Overall Study|Adverse Event|0
1705151|NCT01196988|5950642|P3|Overall Study|Adverse Event|0
1705152|NCT01196988|5950643|P2|Overall Study|Adverse Event|2
1705153|NCT01196988|5950644|P1|Overall Study|Adverse Event|1
1705154|NCT01196975|5950738|P5|Overall Study|Lost to Follow-up|11
1705155|NCT01196975|5950739|P4|Overall Study|Lost to Follow-up|5
1705156|NCT01196975|5950740|P3|Overall Study|Lost to Follow-up|5
1705157|NCT01196975|5950741|P2|Overall Study|Lost to Follow-up|6
1705158|NCT01196975|5950742|P1|Overall Study|Lost to Follow-up|11
1705159|NCT01196975|5950738|P5|Overall Study|Withdrawal by Subject|0
1705160|NCT01196975|5950739|P4|Overall Study|Withdrawal by Subject|1
1705161|NCT01196975|5950740|P3|Overall Study|Withdrawal by Subject|0
1705162|NCT01196975|5950741|P2|Overall Study|Withdrawal by Subject|1
1705163|NCT01196975|5950742|P1|Overall Study|Withdrawal by Subject|2
1705164|NCT01196975|5950738|P5|Overall Study|Adverse Event|2
1705165|NCT01196975|5950739|P4|Overall Study|Adverse Event|0
1705166|NCT01196975|5950740|P3|Overall Study|Adverse Event|0
1705167|NCT01196975|5950741|P2|Overall Study|Adverse Event|2
1705168|NCT01196975|5950742|P1|Overall Study|Adverse Event|2
1705169|NCT01196741|5951026|P2|Overall Study|Protocol Violation|1
1705170|NCT01196741|5951027|P1|Overall Study|Protocol Violation|2
1705171|NCT01196741|5951026|P2|Overall Study|Other|2
1705172|NCT01196741|5951027|P1|Overall Study|Other|3
1705173|NCT01196741|5951026|P2|Overall Study|Other reason|3
1705174|NCT01196741|5951027|P1|Overall Study|Other reason|3
1705175|NCT01196741|5951026|P2|Overall Study|Withdrawal by Subject|0
1705176|NCT01196741|5951027|P1|Overall Study|Withdrawal by Subject|3
1705177|NCT01196741|5951026|P2|Overall Study|Dose limiting Adverse Event|1
1705178|NCT01196741|5951027|P1|Overall Study|Dose limiting Adverse Event|2
1705179|NCT01196741|5951026|P2|Overall Study|Serious Adverse Event|1
1705180|NCT01196741|5951027|P1|Overall Study|Serious Adverse Event|3
1705181|NCT01196741|5951026|P2|Overall Study|Adverse Event|6
1705182|NCT01196741|5951027|P1|Overall Study|Adverse Event|10
1705183|NCT01196741|5951026|P2|Overall Study|Disease progression|14
1705184|NCT01196741|5951027|P1|Overall Study|Disease progression|34
1705185|NCT01196429|5951057|P2|Overall Study|Refused – Never Treated|0
1705186|NCT01196429|5951058|P1|Overall Study|Refused – Never Treated|1
1705187|NCT01196429|5951057|P2|Overall Study|Ineligible - wrong cell type|0
1705188|NCT01196429|5951058|P1|Overall Study|Ineligible - wrong cell type|1
1705189|NCT01196429|5951057|P2|Overall Study|Ineligible - inadequate pathology|0
1705190|NCT01196429|5951058|P1|Overall Study|Ineligible - inadequate pathology|1
1705191|NCT01196416|5951074|P1|Overall Study|Withdrawal by Subject|2
1705192|NCT01196104|5951107|P2|Overall Study|Various|1
1705193|NCT01196104|5951108|P1|Overall Study|Various|0
1705194|NCT01196104|5951107|P2|Overall Study|Withdrawal by Subject|3
1705195|NCT01196104|5951108|P1|Overall Study|Withdrawal by Subject|3
1705196|NCT01196104|5951107|P2|Overall Study|Physician Decision|1
1705197|NCT01196104|5951108|P1|Overall Study|Physician Decision|0
1705198|NCT01196104|5951107|P2|Overall Study|Lost to Follow-up|0
1705199|NCT01196104|5951108|P1|Overall Study|Lost to Follow-up|1
1705200|NCT01196091|5951151|P3|Overall Study|Randomized, No Study Drug Received|1
1705201|NCT01196091|5951152|P2|Overall Study|Randomized, No Study Drug Received|0
1705202|NCT01196091|5951153|P1|Overall Study|Randomized, No Study Drug Received|1
1705203|NCT01196091|5951151|P3|Overall Study|Excluded Site|8
1705204|NCT01196091|5951152|P2|Overall Study|Excluded Site|11
1705205|NCT01196091|5951153|P1|Overall Study|Excluded Site|5
1705206|NCT01196091|5951151|P3|Overall Study|Sponsor Decision|4
1705207|NCT01196091|5951152|P2|Overall Study|Sponsor Decision|5
1705208|NCT01196091|5951153|P1|Overall Study|Sponsor Decision|6
1705209|NCT01196091|5951151|P3|Overall Study|Protocol Violation|3
1705210|NCT01196091|5951152|P2|Overall Study|Protocol Violation|3
1705211|NCT01196091|5951153|P1|Overall Study|Protocol Violation|1
1705212|NCT01196091|5951151|P3|Overall Study|Physician Decision|4
1705213|NCT01196091|5951152|P2|Overall Study|Physician Decision|3
1705214|NCT01196091|5951153|P1|Overall Study|Physician Decision|3
1705215|NCT01196091|5951151|P3|Overall Study|Withdrawal by Subject|22
1705216|NCT01196091|5951152|P2|Overall Study|Withdrawal by Subject|19
1705217|NCT01196091|5951153|P1|Overall Study|Withdrawal by Subject|16
1705218|NCT01196091|5951151|P3|Overall Study|Parent/Caregiver Decision|1
1705219|NCT01196091|5951152|P2|Overall Study|Parent/Caregiver Decision|0
1705220|NCT01196091|5951153|P1|Overall Study|Parent/Caregiver Decision|0
1705221|NCT01196091|5951151|P3|Overall Study|Lost to Follow-up|6
1705222|NCT01196091|5951152|P2|Overall Study|Lost to Follow-up|5
1705223|NCT01196091|5951153|P1|Overall Study|Lost to Follow-up|5
1705224|NCT01196091|5951151|P3|Overall Study|Lack of Efficacy|17
1705225|NCT01196091|5951152|P2|Overall Study|Lack of Efficacy|12
1705226|NCT01196091|5951153|P1|Overall Study|Lack of Efficacy|15
1705227|NCT01196091|5951151|P3|Overall Study|Entry Criteria Not Met|10
1705228|NCT01196091|5951152|P2|Overall Study|Entry Criteria Not Met|11
1705229|NCT01196091|5951153|P1|Overall Study|Entry Criteria Not Met|11
1705230|NCT01196091|5951151|P3|Overall Study|Death|2
1705231|NCT01196091|5951152|P2|Overall Study|Death|2
1705232|NCT01196091|5951153|P1|Overall Study|Death|3
1705233|NCT01196091|5951151|P3|Overall Study|Adverse Event|26
1705234|NCT01196091|5951152|P2|Overall Study|Adverse Event|27
1705235|NCT01196091|5951153|P1|Overall Study|Adverse Event|22
1705236|NCT01196078|5951205|P2|Overall Study|Death|4
1705237|NCT01196078|5951206|P1|Overall Study|Death|6
1705238|NCT01196078|5951205|P2|Overall Study|Lost to Follow-up|0
1705239|NCT01196078|5951206|P1|Overall Study|Lost to Follow-up|1
1705240|NCT01196078|5951205|P2|Overall Study|Lack of Efficacy|23
1705241|NCT01196078|5951206|P1|Overall Study|Lack of Efficacy|17
1705242|NCT01196078|5951205|P2|Overall Study|Protocol Violation|1
1705243|NCT01196078|5951206|P1|Overall Study|Protocol Violation|2
1705244|NCT01196078|5951205|P2|Overall Study|Adverse Event|4
1705245|NCT01196078|5951206|P1|Overall Study|Adverse Event|4
1705246|NCT01196078|5951205|P2|Overall Study|Withdrawal by Subject|5
1705247|NCT01196078|5951206|P1|Overall Study|Withdrawal by Subject|3
1705248|NCT01196052|5951234|P1|Overall Study|Withdrawal by Subject|6
1705249|NCT01196052|5951234|P1|Overall Study|Reason not Specified|5
1705250|NCT01196052|5951234|P1|Overall Study|Noncompliance to Protocol Requirements|2
1705251|NCT01196052|5951234|P1|Overall Study|Lost to Follow-up|1
1705252|NCT01196052|5951234|P1|Overall Study|Adverse Event|9
1705253|NCT01196026|5951251|P6|Overall Study|Other|0
1705254|NCT01196026|5951252|P5|Overall Study|Other|0
1705255|NCT01196026|5951253|P4|Overall Study|Other|0
1705256|NCT01196026|5951254|P3|Overall Study|Other|0
1705257|NCT01196026|5951255|P2|Overall Study|Other|1
1705258|NCT01196026|5951256|P1|Overall Study|Other|0
1705259|NCT01196026|5951251|P6|Overall Study|Lost to Follow-up|0
1705260|NCT01196026|5951252|P5|Overall Study|Lost to Follow-up|1
1705261|NCT01196026|5951253|P4|Overall Study|Lost to Follow-up|0
1705262|NCT01196026|5951254|P3|Overall Study|Lost to Follow-up|0
1705263|NCT01196026|5951255|P2|Overall Study|Lost to Follow-up|3
1705264|NCT01196026|5951256|P1|Overall Study|Lost to Follow-up|0
1705265|NCT01196026|5951251|P6|Overall Study|Withdrawal by Subject|0
1705266|NCT01196026|5951252|P5|Overall Study|Withdrawal by Subject|0
1705267|NCT01196026|5951253|P4|Overall Study|Withdrawal by Subject|0
1705268|NCT01196026|5951254|P3|Overall Study|Withdrawal by Subject|0
1705269|NCT01196026|5951255|P2|Overall Study|Withdrawal by Subject|4
1705270|NCT01196026|5951256|P1|Overall Study|Withdrawal by Subject|1
1705271|NCT01195948|5951490|P3|Overall Study|Lost to Follow-up|2
1705272|NCT01195948|5951491|P2|Overall Study|Lost to Follow-up|1
1705273|NCT01195948|5951492|P1|Overall Study|Lost to Follow-up|0
1705274|NCT01195844|5951545|P1|Overall Study|Fecal sample not collected|40
1705275|NCT01195831|5951562|P2|Overall Study|Protocol Violation|2
1705276|NCT01195831|5951563|P1|Overall Study|Protocol Violation|0
1705277|NCT01195831|5951562|P2|Overall Study|Adverse Event|2
1705278|NCT01195831|5951563|P1|Overall Study|Adverse Event|4
1705279|NCT01195831|5951562|P2|Overall Study|Withdrawal by Subject|2
1705280|NCT01195831|5951563|P1|Overall Study|Withdrawal by Subject|2
1705281|NCT01195831|5951562|P2|Overall Study|Lost to Follow-up|4
1705282|NCT01195831|5951563|P1|Overall Study|Lost to Follow-up|2
1705283|NCT01195675|5951803|P1|Overall Study|Withdrawal by Subject|2
1705284|NCT01195675|5951803|P1|Overall Study|Adverse Event|1
1705285|NCT01195662|5951836|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
1705286|NCT01195662|5951837|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
1705287|NCT01195662|5951838|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
1705288|NCT01195662|5951836|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
1705289|NCT01195662|5951837|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
1705290|NCT01195662|5951838|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
1705291|NCT01195662|5951836|P3|Double Blind Treatment Period|Missing disposition information|1
1705292|NCT01195662|5951837|P2|Double Blind Treatment Period|Missing disposition information|1
1705293|NCT01195662|5951838|P1|Double Blind Treatment Period|Missing disposition information|0
1705294|NCT01195662|5951836|P3|Double Blind Treatment Period|Non-specified|0
1705295|NCT01195662|5951837|P2|Double Blind Treatment Period|Non-specified|0
1705296|NCT01195662|5951838|P1|Double Blind Treatment Period|Non-specified|3
1705297|NCT01195662|5951836|P3|Double Blind Treatment Period|Lack of Efficacy|0
1705298|NCT01195662|5951837|P2|Double Blind Treatment Period|Lack of Efficacy|0
1705299|NCT01195662|5951838|P1|Double Blind Treatment Period|Lack of Efficacy|2
1705300|NCT01195662|5951836|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
1705301|NCT01195662|5951837|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
1705302|NCT01195662|5951838|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
1705303|NCT01195662|5951836|P3|Double Blind Treatment Period|Requested discontinue treatment|1
1705304|NCT01195662|5951837|P2|Double Blind Treatment Period|Requested discontinue treatment|0
1705305|NCT01195662|5951838|P1|Double Blind Treatment Period|Requested discontinue treatment|1
1705306|NCT01195662|5951836|P3|Double Blind Treatment Period|Administrative reason|1
1705307|NCT01195662|5951837|P2|Double Blind Treatment Period|Administrative reason|1
1705308|NCT01195662|5951838|P1|Double Blind Treatment Period|Administrative reason|2
1705309|NCT01195662|5951836|P3|Double Blind Treatment Period|Lost to Follow-up|3
1705310|NCT01195662|5951837|P2|Double Blind Treatment Period|Lost to Follow-up|2
1705311|NCT01195662|5951838|P1|Double Blind Treatment Period|Lost to Follow-up|3
1705312|NCT01195662|5951836|P3|Double Blind Treatment Period|Withdrawal by Subject|4
1705313|NCT01195662|5951837|P2|Double Blind Treatment Period|Withdrawal by Subject|4
1705314|NCT01195662|5951838|P1|Double Blind Treatment Period|Withdrawal by Subject|6
1705315|NCT01195662|5951836|P3|Double Blind Treatment Period|Adverse Event|2
1705316|NCT01195662|5951837|P2|Double Blind Treatment Period|Adverse Event|1
1705317|NCT01195662|5951838|P1|Double Blind Treatment Period|Adverse Event|4
1705318|NCT01195636|5951868|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
1705319|NCT01195636|5951869|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1705320|NCT01195636|5951868|P2|Second Intervention (3 Weeks)|Adverse Event|1
1705321|NCT01195636|5951869|P1|Second Intervention (3 Weeks)|Adverse Event|1
1705322|NCT01195636|5951868|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
1705323|NCT01195636|5951869|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
1705324|NCT01195636|5951868|P2|Washout Period (2 Weeks)|Adverse Event|1
1705325|NCT01195636|5951869|P1|Washout Period (2 Weeks)|Adverse Event|1
1705326|NCT01195636|5951868|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
1705327|NCT01195636|5951869|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
1705328|NCT01195636|5951868|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
1705329|NCT01195636|5951869|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
1705330|NCT01195636|5951868|P2|First Intervention (3 Weeks)|Protocol Violation|0
1705331|NCT01195636|5951869|P1|First Intervention (3 Weeks)|Protocol Violation|1
1705332|NCT01195636|5951868|P2|First Intervention (3 Weeks)|Adverse Event|3
1705333|NCT01195636|5951869|P1|First Intervention (3 Weeks)|Adverse Event|2
1705334|NCT01195623|5951895|P2|Overall Study|Lost to Follow-up|37
1705335|NCT01195623|5951896|P1|Overall Study|Lost to Follow-up|35
1705336|NCT01195545|5951925|P1|Overall Study|Protocol Violation|4
1705337|NCT01195415|5951937|P1|Overall Study|No repeat biopsy due to progression|2
1705338|NCT01195363|5951946|P2|Overall Study|incarceration|0
1705339|NCT01195363|5951947|P1|Overall Study|incarceration|1
1705340|NCT01195363|5951946|P2|Overall Study|Lack of Efficacy|4
1705341|NCT01195363|5951947|P1|Overall Study|Lack of Efficacy|0
1705342|NCT01195363|5951946|P2|Overall Study|Adverse Event|1
1705343|NCT01195363|5951947|P1|Overall Study|Adverse Event|3
1705344|NCT01195363|5951946|P2|Overall Study|Lost to Follow-up|4
1705345|NCT01195363|5951947|P1|Overall Study|Lost to Follow-up|7
1705346|NCT01195272|5951953|P1|Overall Study|Lack of Efficacy|3
1705347|NCT01195272|5951953|P1|Overall Study|Adverse Event|1
1705348|NCT01195103|5951982|P3|Overall Study|Withdrawal by Subject|0
1705349|NCT01195103|5951983|P2|Overall Study|Withdrawal by Subject|0
1705350|NCT01195103|5951984|P1|Overall Study|Withdrawal by Subject|1
1705351|NCT01195090|5951994|P2|Overall Study|Protocol Violation|4
1705352|NCT01195090|5951995|P1|Overall Study|Protocol Violation|3
1705353|NCT01195090|5951994|P2|Overall Study|Lost to Follow-up|2
1705354|NCT01195090|5951995|P1|Overall Study|Lost to Follow-up|2
1705355|NCT01195090|5951994|P2|Overall Study|Adverse Event|2
1705356|NCT01195090|5951995|P1|Overall Study|Adverse Event|1
1705357|NCT01194999|5952064|P1|Overall Study|Lost to Follow-up|17
1705358|NCT01194973|5952068|P1|26 Week Treatment Period|Pregnancy|1
1705359|NCT01194973|5952068|P1|26 Week Treatment Period|Lack of Efficacy|1
1705360|NCT01194973|5952068|P1|26 Week Treatment Period|Adverse Event|1
1705361|NCT01194973|5952068|P1|Screening Period|Screen Failure|3
1705362|NCT01194869|5952088|P1|Overall Study|Toxicity|2
1705363|NCT01194869|5952088|P1|Overall Study|Disease Progression|2
1705364|NCT01194830|5952119|P2|Overall Study|Other Reason|8
1705365|NCT01194830|5952120|P1|Overall Study|Other Reason|12
1705366|NCT01194830|5952119|P2|Overall Study|Non-compliance issues|4
1705367|NCT01194830|5952120|P1|Overall Study|Non-compliance issues|4
1705368|NCT01194830|5952119|P2|Overall Study|Lack of Efficacy|1
1705369|NCT01194830|5952120|P1|Overall Study|Lack of Efficacy|1
1705370|NCT01194830|5952119|P2|Overall Study|Withdrawal by Subject|1
1705371|NCT01194830|5952120|P1|Overall Study|Withdrawal by Subject|2
1705372|NCT01194830|5952119|P2|Overall Study|Lost to Follow-up|7
1705373|NCT01194830|5952120|P1|Overall Study|Lost to Follow-up|9
1705374|NCT01194830|5952119|P2|Overall Study|Protocol Violation|4
1705375|NCT01194830|5952120|P1|Overall Study|Protocol Violation|5
1705376|NCT01194830|5952119|P2|Overall Study|Adverse Event|2
1705377|NCT01194830|5952120|P1|Overall Study|Adverse Event|3
1705378|NCT01194804|5952142|P1|Overall Study|Withdrawal by Subject|1
1705379|NCT01194570|5952164|P2|Overall Study|Lost to Follow-up|4
1705380|NCT01194570|5952165|P1|Overall Study|Lost to Follow-up|1
1705381|NCT01194570|5952164|P2|Overall Study|Pregnancy|1
1705382|NCT01194570|5952165|P1|Overall Study|Pregnancy|1
1705383|NCT01194570|5952164|P2|Overall Study|Withdrawal by Subject|22
1705384|NCT01194570|5952165|P1|Overall Study|Withdrawal by Subject|21
1705385|NCT01194570|5952164|P2|Overall Study|Lack of Efficacy|21
1705386|NCT01194570|5952165|P1|Overall Study|Lack of Efficacy|27
1705387|NCT01194570|5952164|P2|Overall Study|Non-compliance|2
1705388|NCT01194570|5952165|P1|Overall Study|Non-compliance|2
1705389|NCT01194570|5952164|P2|Overall Study|Adverse Event|18
1705390|NCT01194570|5952165|P1|Overall Study|Adverse Event|12
1705391|NCT01194570|5952164|P2|Overall Study|Non-compliance with study drug|2
1705392|NCT01194570|5952165|P1|Overall Study|Non-compliance with study drug|2
1705393|NCT01194570|5952164|P2|Overall Study|Protocol Violation|2
1705394|NCT01194570|5952165|P1|Overall Study|Protocol Violation|0
1705395|NCT01194570|5952164|P2|Overall Study|Reason not specified|20
1705396|NCT01194570|5952165|P1|Overall Study|Reason not specified|13
1705397|NCT01194570|5952164|P2|Overall Study|Physician Decision|6
1705398|NCT01194570|5952165|P1|Overall Study|Physician Decision|2
1705399|NCT01194570|5952164|P2|Overall Study|Ongoing at CCOD|387
1705400|NCT01194570|5952165|P1|Overall Study|Ongoing at CCOD|162
1705401|NCT01194570|5952164|P2|Overall Study|Death|3
1705402|NCT01194570|5952165|P1|Overall Study|Death|1
1705403|NCT01194531|5952185|P2|Overall Study|Physician Decision|2
1705404|NCT01194531|5952186|P1|Overall Study|Physician Decision|0
1705405|NCT01194531|5952185|P2|Overall Study|Protocol Violation|1
1705406|NCT01194531|5952186|P1|Overall Study|Protocol Violation|4
1705407|NCT01194531|5952185|P2|Overall Study|Withdrawal by Subject|0
1705408|NCT01194531|5952186|P1|Overall Study|Withdrawal by Subject|1
1705409|NCT01194440|5952240|P1|6-months (2nd Dose)|Change in therapy|4
1705410|NCT01194440|5952240|P1|Baseline (First Dose)|Adverse Event|1
1705411|NCT01194440|5952240|P1|Baseline (First Dose)|Change in therapy|1
1705412|NCT01194440|5952240|P1|Baseline (First Dose)|Lack of Efficacy|1
1705413|NCT01194440|5952240|P1|Baseline (First Dose)|Reason not specified|4
1705414|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Death|2
1705415|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Death|0
1705416|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Death|2
1705417|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Death|1
1705418|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
1705419|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
1705420|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
1705421|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
1705422|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Adverse Event|12
1705423|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Adverse Event|2
1705424|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Adverse Event|21
1705425|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Adverse Event|35
1705426|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Protocol Violation|1
1705427|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Protocol Violation|0
1705428|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Protocol Violation|0
1705429|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Protocol Violation|0
1705430|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Other|0
1705431|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Other|0
1705432|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Other|1
1705433|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Other|2
1705434|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Pregnancy|1
1705435|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Pregnancy|1
1705436|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Pregnancy|3
1705437|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Pregnancy|1
1705438|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
1705439|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
1705440|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
1705441|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
1705442|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
1705443|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
1705444|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
1705445|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
1705446|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
1705447|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
1705448|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
1705449|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
1705450|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
1705451|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
1705452|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
1705453|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
1705454|NCT01194414|5952253|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
1705455|NCT01194414|5952254|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
1705456|NCT01194414|5952255|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
1705457|NCT01194414|5952256|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
1705458|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Death|0
1705459|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Death|0
1705460|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Death|1
1705461|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Death|0
1705462|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
1705463|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
1705464|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
1705465|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
1705466|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Adverse Event|0
1705467|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Adverse Event|0
1705468|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Adverse Event|40
1705469|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Adverse Event|28
1705470|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Other|0
1705471|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Other|0
1705472|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Other|1
1705473|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Other|0
1705474|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
1705475|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
1705476|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
1705477|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
1705478|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Pregnancy|0
1705479|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Pregnancy|0
1705480|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Pregnancy|2
1705481|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Pregnancy|2
1705482|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1705483|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1705484|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
1705485|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
1705486|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Protocol Violation|0
1705487|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Protocol Violation|0
1705488|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Protocol Violation|3
1705489|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Protocol Violation|5
1705490|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
1705491|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
1705492|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
1705493|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
1705494|NCT01194414|5952253|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
1705495|NCT01194414|5952254|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
1705496|NCT01194414|5952255|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
1705497|NCT01194414|5952256|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
1705498|NCT01194258|5952327|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
1705499|NCT01194258|5952328|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
1705500|NCT01194258|5952329|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
1705501|NCT01194258|5952330|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
1705502|NCT01194258|5952331|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
1705503|NCT01194258|5952327|P5|Period 2 (12 Weeks)|Adverse Event|0
1705504|NCT01194258|5952328|P4|Period 2 (12 Weeks)|Adverse Event|0
1705505|NCT01194258|5952329|P3|Period 2 (12 Weeks)|Adverse Event|0
1705506|NCT01194258|5952330|P2|Period 2 (12 Weeks)|Adverse Event|1
1705507|NCT01194258|5952331|P1|Period 2 (12 Weeks)|Adverse Event|0
1705508|NCT01194258|5952327|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
1705509|NCT01194258|5952328|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
1705510|NCT01194258|5952329|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
1705511|NCT01194258|5952330|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
1705512|NCT01194258|5952331|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
1705513|NCT01194258|5952327|P5|Period 1 (12 Weeks)|Death|1
1705514|NCT01194258|5952328|P4|Period 1 (12 Weeks)|Death|0
1705515|NCT01194258|5952329|P3|Period 1 (12 Weeks)|Death|0
1705516|NCT01194258|5952330|P2|Period 1 (12 Weeks)|Death|0
1705517|NCT01194258|5952331|P1|Period 1 (12 Weeks)|Death|0
1705518|NCT01194258|5952327|P5|Titration Period|Titration failure|0
1705519|NCT01194258|5952328|P4|Titration Period|Titration failure|0
1705520|NCT01194258|5952329|P3|Titration Period|Titration failure|0
1705521|NCT01194258|5952330|P2|Titration Period|Titration failure|0
1705522|NCT01194258|5952331|P1|Titration Period|Titration failure|3
1705523|NCT01194258|5952327|P5|Titration Period|Lost to Follow-up|0
1705524|NCT01194258|5952328|P4|Titration Period|Lost to Follow-up|0
1705525|NCT01194258|5952329|P3|Titration Period|Lost to Follow-up|0
1705526|NCT01194258|5952330|P2|Titration Period|Lost to Follow-up|0
1705527|NCT01194258|5952331|P1|Titration Period|Lost to Follow-up|2
1705528|NCT01194258|5952327|P5|Titration Period|Withdrawal by Subject|0
1705529|NCT01194258|5952328|P4|Titration Period|Withdrawal by Subject|0
1705530|NCT01194258|5952329|P3|Titration Period|Withdrawal by Subject|0
1705531|NCT01194258|5952330|P2|Titration Period|Withdrawal by Subject|0
1705532|NCT01194258|5952331|P1|Titration Period|Withdrawal by Subject|6
1705533|NCT01194245|5952355|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1705534|NCT01194245|5952356|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1705535|NCT01194245|5952357|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
1705536|NCT01194245|5952358|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
1705537|NCT01194245|5952359|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
1705538|NCT01194245|5952355|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
1705539|NCT01194245|5952356|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1705540|NCT01194245|5952357|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1705541|NCT01194245|5952358|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1705542|NCT01194245|5952359|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
1705543|NCT01194245|5952355|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1705544|NCT01194245|5952356|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1705545|NCT01194245|5952357|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1705546|NCT01194245|5952358|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
1705547|NCT01194245|5952359|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
1705548|NCT01194245|5952355|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
1705549|NCT01194245|5952356|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
1705550|NCT01194245|5952357|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
1705551|NCT01194245|5952358|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
1705552|NCT01194245|5952359|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
1705553|NCT01194245|5952355|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
1705554|NCT01194245|5952356|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
1705555|NCT01194245|5952357|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
1705556|NCT01194245|5952358|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
1705557|NCT01194245|5952359|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
1705558|NCT01194245|5952355|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1705559|NCT01194245|5952356|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1705560|NCT01194245|5952357|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1705561|NCT01194245|5952358|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
1705562|NCT01194245|5952359|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
1705563|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
1705564|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
1705565|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705566|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705567|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705568|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705569|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705570|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705571|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705572|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
1705573|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705574|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
1705575|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705576|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705577|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705578|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705579|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705580|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705581|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705582|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
1705583|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
1705584|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
1705585|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705586|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705587|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705588|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705589|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705590|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705591|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705592|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
1705593|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Death|1
1705594|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Death|1
1705595|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Death|0
1705596|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Death|0
1705597|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Death|0
1705598|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Death|0
1705599|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Death|0
1705600|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Death|0
1705601|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Death|0
1705602|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Death|0
1705603|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
1705604|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
1705605|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705606|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705607|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705608|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705609|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705610|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705611|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705612|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
1705613|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
1705614|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
1705615|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705616|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705617|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705618|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705619|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705620|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705621|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705622|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
1705623|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
1705624|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
1705625|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705626|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705627|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705628|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705629|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705630|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705631|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705632|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
1705633|NCT01194219|5952380|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
1705634|NCT01194219|5952381|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
1705635|NCT01194219|5952382|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705636|NCT01194219|5952383|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705637|NCT01194219|5952384|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705638|NCT01194219|5952385|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705639|NCT01194219|5952386|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705640|NCT01194219|5952387|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705641|NCT01194219|5952388|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705642|NCT01194219|5952389|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
1705643|NCT01194219|5952380|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705644|NCT01194219|5952381|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705645|NCT01194219|5952382|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705646|NCT01194219|5952383|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
1705647|NCT01194219|5952384|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705648|NCT01194219|5952385|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705649|NCT01194219|5952386|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705650|NCT01194219|5952387|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705651|NCT01194219|5952388|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705652|NCT01194219|5952389|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
1705653|NCT01194219|5952380|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705654|NCT01194219|5952381|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705655|NCT01194219|5952382|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
1705656|NCT01194219|5952383|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705657|NCT01194219|5952384|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705658|NCT01194219|5952385|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705659|NCT01194219|5952386|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705660|NCT01194219|5952387|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705661|NCT01194219|5952388|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705662|NCT01194219|5952389|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
1705663|NCT01194219|5952380|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1705664|NCT01194219|5952381|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1705665|NCT01194219|5952382|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1705666|NCT01194219|5952383|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
1705667|NCT01194219|5952384|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
1705668|NCT01194219|5952385|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
1705669|NCT01194219|5952386|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1705670|NCT01194219|5952387|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1705671|NCT01194219|5952388|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1705672|NCT01194219|5952389|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
1705673|NCT01194219|5952380|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1705674|NCT01194219|5952381|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1705675|NCT01194219|5952382|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
1705676|NCT01194219|5952383|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
1705677|NCT01194219|5952384|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1705678|NCT01194219|5952385|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
1705679|NCT01194219|5952386|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1705680|NCT01194219|5952387|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1705681|NCT01194219|5952388|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1705682|NCT01194219|5952389|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
1705683|NCT01194219|5952380|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705684|NCT01194219|5952381|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705685|NCT01194219|5952382|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705686|NCT01194219|5952383|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
1705687|NCT01194219|5952384|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705688|NCT01194219|5952385|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
1705689|NCT01194219|5952386|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705690|NCT01194219|5952387|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705691|NCT01194219|5952388|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705692|NCT01194219|5952389|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
1705693|NCT01194219|5952380|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1705694|NCT01194219|5952381|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1705695|NCT01194219|5952382|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
1705696|NCT01194219|5952383|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
1705697|NCT01194219|5952384|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
1705698|NCT01194219|5952385|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
1705699|NCT01194219|5952386|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1705700|NCT01194219|5952387|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1705701|NCT01194219|5952388|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1705702|NCT01194219|5952389|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
1705703|NCT01194219|5952380|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1705704|NCT01194219|5952381|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1705705|NCT01194219|5952382|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
1705706|NCT01194219|5952383|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
1705707|NCT01194219|5952384|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
1705708|NCT01194219|5952385|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1705709|NCT01194219|5952386|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1705710|NCT01194219|5952387|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1705711|NCT01194219|5952388|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1705712|NCT01194219|5952389|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
1705713|NCT01194219|5952380|P10|Maintenance Phase Weeks16-32|Other|0
1705714|NCT01194219|5952381|P9|Maintenance Phase Weeks16-32|Other|0
1705715|NCT01194219|5952382|P8|Maintenance Phase Weeks16-32|Other|0
1705716|NCT01194219|5952383|P7|Maintenance Phase Weeks16-32|Other|0
1705717|NCT01194219|5952384|P6|Maintenance Phase Weeks16-32|Other|0
1705718|NCT01194219|5952385|P5|Maintenance Phase Weeks16-32|Other|0
1705719|NCT01194219|5952386|P4|Maintenance Phase Weeks16-32|Other|1
1705720|NCT01194219|5952387|P3|Maintenance Phase Weeks16-32|Other|2
1705721|NCT01194219|5952388|P2|Maintenance Phase Weeks16-32|Other|0
1705722|NCT01194219|5952389|P1|Maintenance Phase Weeks16-32|Other|0
1705723|NCT01194219|5952380|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
1705724|NCT01194219|5952381|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
1705725|NCT01194219|5952382|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
1705726|NCT01194219|5952383|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
1705727|NCT01194219|5952384|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
1705728|NCT01194219|5952385|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
1705729|NCT01194219|5952386|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
1705730|NCT01194219|5952387|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
1705731|NCT01194219|5952388|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
1705732|NCT01194219|5952389|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
1705733|NCT01194219|5952380|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705734|NCT01194219|5952381|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705735|NCT01194219|5952382|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705736|NCT01194219|5952383|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705737|NCT01194219|5952384|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705738|NCT01194219|5952385|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705739|NCT01194219|5952386|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705740|NCT01194219|5952387|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
1705741|NCT01194219|5952388|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705742|NCT01194219|5952389|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
1705743|NCT01194219|5952380|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705744|NCT01194219|5952381|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705745|NCT01194219|5952382|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705746|NCT01194219|5952383|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705747|NCT01194219|5952384|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705748|NCT01194219|5952385|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705749|NCT01194219|5952386|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
1705750|NCT01194219|5952387|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
1705751|NCT01194219|5952388|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705752|NCT01194219|5952389|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
1705753|NCT01194219|5952380|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705754|NCT01194219|5952381|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705755|NCT01194219|5952382|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705756|NCT01194219|5952383|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705757|NCT01194219|5952384|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705758|NCT01194219|5952385|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705759|NCT01194219|5952386|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
1705760|NCT01194219|5952387|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
1705761|NCT01194219|5952388|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705762|NCT01194219|5952389|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
1705763|NCT01194219|5952380|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705764|NCT01194219|5952381|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705765|NCT01194219|5952382|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705766|NCT01194219|5952383|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705767|NCT01194219|5952384|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705768|NCT01194219|5952385|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705769|NCT01194219|5952386|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
1705770|NCT01194219|5952387|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
1705771|NCT01194219|5952388|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705772|NCT01194219|5952389|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
1705773|NCT01194219|5952380|P10|Maintenance Phase Weeks16-32|Adverse Event|0
1705774|NCT01194219|5952381|P9|Maintenance Phase Weeks16-32|Adverse Event|0
1705775|NCT01194219|5952382|P8|Maintenance Phase Weeks16-32|Adverse Event|0
1705776|NCT01194219|5952383|P7|Maintenance Phase Weeks16-32|Adverse Event|0
1705777|NCT01194219|5952384|P6|Maintenance Phase Weeks16-32|Adverse Event|0
1705778|NCT01194219|5952385|P5|Maintenance Phase Weeks16-32|Adverse Event|0
1705779|NCT01194219|5952386|P4|Maintenance Phase Weeks16-32|Adverse Event|9
1705780|NCT01194219|5952387|P3|Maintenance Phase Weeks16-32|Adverse Event|8
1705781|NCT01194219|5952388|P2|Maintenance Phase Weeks16-32|Adverse Event|0
1705782|NCT01194219|5952389|P1|Maintenance Phase Weeks16-32|Adverse Event|0
1705783|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705784|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705785|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705786|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705787|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705788|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705789|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705790|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
1705791|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
1705792|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
1705793|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705794|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705795|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705796|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705797|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705798|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705799|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705800|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
1705801|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
1705802|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
1705803|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705804|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705805|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705806|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705807|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705808|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705809|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705810|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
1705811|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
1705812|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
1705813|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
1705814|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
1705815|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
1705816|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
1705817|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
1705818|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
1705819|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
1705820|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
1705821|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
1705822|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
1705823|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705824|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705825|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705826|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705827|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705828|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705829|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705830|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
1705831|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
1705832|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
1705833|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705834|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705835|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705836|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705837|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705838|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705839|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705840|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705841|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
1705842|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
1705843|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705844|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705845|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705846|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705847|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705848|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705849|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705850|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
1705851|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
1705852|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
1705853|NCT01194219|5952380|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705854|NCT01194219|5952381|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705855|NCT01194219|5952382|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705856|NCT01194219|5952383|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705857|NCT01194219|5952384|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705858|NCT01194219|5952385|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705859|NCT01194219|5952386|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705860|NCT01194219|5952387|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
1705861|NCT01194219|5952388|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
1705862|NCT01194219|5952389|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
1705863|NCT01194154|5952423|P2|Overall Study|Did not receive study medication|4
1705864|NCT01194154|5952424|P1|Overall Study|Did not receive study medication|2
1705865|NCT01194154|5952423|P2|Overall Study|Other|0
1705866|NCT01194154|5952424|P1|Overall Study|Other|4
1705867|NCT01194154|5952423|P2|Overall Study|Treatment with prohibited medication|5
1705868|NCT01194154|5952424|P1|Overall Study|Treatment with prohibited medication|4
1705869|NCT01194154|5952423|P2|Overall Study|Skipping of CERA treatment at two visits|0
1705870|NCT01194154|5952424|P1|Overall Study|Skipping of CERA treatment at two visits|3
1705871|NCT01194154|5952423|P2|Overall Study|Hemoglobin increase|3
1705872|NCT01194154|5952424|P1|Overall Study|Hemoglobin increase|12
1705873|NCT01194154|5952423|P2|Overall Study|Hemoglobin decrease|1
1705874|NCT01194154|5952424|P1|Overall Study|Hemoglobin decrease|0
1705875|NCT01194154|5952423|P2|Overall Study|Blood pressure increase|3
1705876|NCT01194154|5952424|P1|Overall Study|Blood pressure increase|5
1705877|NCT01194154|5952423|P2|Overall Study|Withdrawal by Subject|6
1705878|NCT01194154|5952424|P1|Overall Study|Withdrawal by Subject|5
1705879|NCT01194154|5952423|P2|Overall Study|Protocol Violation|1
1705880|NCT01194154|5952424|P1|Overall Study|Protocol Violation|0
1705881|NCT01194154|5952423|P2|Overall Study|Lost to Follow-up|3
1705882|NCT01194154|5952424|P1|Overall Study|Lost to Follow-up|2
1705883|NCT01194154|5952423|P2|Overall Study|Adverse Event|7
1705884|NCT01194154|5952424|P1|Overall Study|Adverse Event|12
1705885|NCT01193920|5952465|P10|Overall Study|Unable to classify|0
1705886|NCT01193920|5952466|P9|Overall Study|Unable to classify|0
1705887|NCT01193920|5952467|P8|Overall Study|Unable to classify|1
1705888|NCT01193920|5952468|P7|Overall Study|Unable to classify|0
1705889|NCT01193920|5952469|P6|Overall Study|Unable to classify|0
1705890|NCT01193920|5952470|P5|Overall Study|Unable to classify|0
1705891|NCT01193920|5952471|P4|Overall Study|Unable to classify|1
1705892|NCT01193920|5952472|P3|Overall Study|Unable to classify|0
1705893|NCT01193920|5952473|P2|Overall Study|Unable to classify|0
1705894|NCT01193920|5952474|P1|Overall Study|Unable to classify|0
1705895|NCT01193920|5952465|P10|Overall Study|Death|4
1705896|NCT01193920|5952466|P9|Overall Study|Death|2
1705897|NCT01193920|5952467|P8|Overall Study|Death|3
1705898|NCT01193920|5952468|P7|Overall Study|Death|2
1705899|NCT01193920|5952469|P6|Overall Study|Death|0
1705900|NCT01193920|5952470|P5|Overall Study|Death|0
1705901|NCT01193920|5952471|P4|Overall Study|Death|1
1705902|NCT01193920|5952472|P3|Overall Study|Death|0
1705903|NCT01193920|5952473|P2|Overall Study|Death|0
1705904|NCT01193920|5952474|P1|Overall Study|Death|0
1705905|NCT01193920|5952465|P10|Overall Study|Protocol Violation|0
1705906|NCT01193920|5952466|P9|Overall Study|Protocol Violation|0
1705907|NCT01193920|5952467|P8|Overall Study|Protocol Violation|0
1705908|NCT01193920|5952468|P7|Overall Study|Protocol Violation|0
1705909|NCT01193920|5952469|P6|Overall Study|Protocol Violation|0
1705910|NCT01193920|5952470|P5|Overall Study|Protocol Violation|0
1705911|NCT01193920|5952471|P4|Overall Study|Protocol Violation|0
1705912|NCT01193920|5952472|P3|Overall Study|Protocol Violation|0
1705913|NCT01193920|5952473|P2|Overall Study|Protocol Violation|0
1705914|NCT01193920|5952474|P1|Overall Study|Protocol Violation|1
1705915|NCT01193920|5952465|P10|Overall Study|Lost to Follow-up|3
1705916|NCT01193920|5952466|P9|Overall Study|Lost to Follow-up|2
1705917|NCT01193920|5952467|P8|Overall Study|Lost to Follow-up|0
1705918|NCT01193920|5952468|P7|Overall Study|Lost to Follow-up|1
1705919|NCT01193920|5952469|P6|Overall Study|Lost to Follow-up|3
1705920|NCT01193920|5952470|P5|Overall Study|Lost to Follow-up|3
1705921|NCT01193920|5952471|P4|Overall Study|Lost to Follow-up|1
1705922|NCT01193920|5952472|P3|Overall Study|Lost to Follow-up|1
1705923|NCT01193920|5952473|P2|Overall Study|Lost to Follow-up|0
1705924|NCT01193920|5952474|P1|Overall Study|Lost to Follow-up|1
1705925|NCT01193920|5952465|P10|Overall Study|Withdrawal by Subject|0
1705926|NCT01193920|5952466|P9|Overall Study|Withdrawal by Subject|1
1705927|NCT01193920|5952467|P8|Overall Study|Withdrawal by Subject|0
1705928|NCT01193920|5952468|P7|Overall Study|Withdrawal by Subject|3
1705929|NCT01193920|5952469|P6|Overall Study|Withdrawal by Subject|1
1705930|NCT01193920|5952470|P5|Overall Study|Withdrawal by Subject|3
1705931|NCT01193920|5952471|P4|Overall Study|Withdrawal by Subject|1
1705932|NCT01193920|5952472|P3|Overall Study|Withdrawal by Subject|5
1705933|NCT01193920|5952473|P2|Overall Study|Withdrawal by Subject|0
1705934|NCT01193920|5952474|P1|Overall Study|Withdrawal by Subject|1
1705935|NCT01193842|5952570|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
1705936|NCT01193842|5952571|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
1705937|NCT01193842|5952572|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1705938|NCT01193842|5952573|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1705939|NCT01193842|5952574|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
1705940|NCT01193842|5952570|P5|Phase II: Randomized Groups|Ineligible|1
1705941|NCT01193842|5952571|P4|Phase II: Randomized Groups|Ineligible|0
1705942|NCT01193842|5952572|P3|Phase II: Randomized Groups|Ineligible|0
1705943|NCT01193842|5952573|P2|Phase II: Randomized Groups|Ineligible|0
1705944|NCT01193842|5952574|P1|Phase II: Randomized Groups|Ineligible|0
1705945|NCT01193842|5952570|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
1705946|NCT01193842|5952571|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
1705947|NCT01193842|5952572|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
1705948|NCT01193842|5952573|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
1705949|NCT01193842|5952574|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
1705950|NCT01193842|5952570|P5|Phase II: Randomized Groups|Adverse Event|3
1705951|NCT01193842|5952571|P4|Phase II: Randomized Groups|Adverse Event|5
1705952|NCT01193842|5952572|P3|Phase II: Randomized Groups|Adverse Event|0
1705953|NCT01193842|5952573|P2|Phase II: Randomized Groups|Adverse Event|0
1705954|NCT01193842|5952574|P1|Phase II: Randomized Groups|Adverse Event|0
1705955|NCT01193842|5952570|P5|Phase II: Randomized Groups|Death|1
1705956|NCT01193842|5952571|P4|Phase II: Randomized Groups|Death|1
1705957|NCT01193842|5952572|P3|Phase II: Randomized Groups|Death|0
1705958|NCT01193842|5952573|P2|Phase II: Randomized Groups|Death|0
1705959|NCT01193842|5952574|P1|Phase II: Randomized Groups|Death|0
1705960|NCT01193842|5952570|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1705961|NCT01193842|5952571|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1705962|NCT01193842|5952572|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
1705963|NCT01193842|5952573|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1705964|NCT01193842|5952574|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
1705965|NCT01193842|5952570|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1705966|NCT01193842|5952571|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1705967|NCT01193842|5952572|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1705968|NCT01193842|5952573|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
1705969|NCT01193842|5952574|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
1705970|NCT01193842|5952570|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1705971|NCT01193842|5952571|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1705972|NCT01193842|5952572|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1705973|NCT01193842|5952573|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
1705974|NCT01193842|5952574|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
1705975|NCT01193686|5952609|P2|Overall Study|Removed by Investigators; unable to matc|0
1705976|NCT01193686|5952610|P1|Overall Study|Removed by Investigators; unable to matc|3
1705977|NCT01193686|5952609|P2|Overall Study|Withdrawal by Subject|1
1705978|NCT01193686|5952610|P1|Overall Study|Withdrawal by Subject|4
1705979|NCT01193660|5952627|P3|Overall Study|Physician Decision|1
1705980|NCT01193660|5952628|P2|Overall Study|Physician Decision|0
1705981|NCT01193660|5952629|P1|Overall Study|Physician Decision|1
1705982|NCT01193660|5952627|P3|Overall Study|Death|0
1705983|NCT01193660|5952628|P2|Overall Study|Death|0
1705984|NCT01193660|5952629|P1|Overall Study|Death|1
1705985|NCT01193660|5952627|P3|Overall Study|Withdrawal by Subject|1
1705986|NCT01193660|5952628|P2|Overall Study|Withdrawal by Subject|3
1705987|NCT01193660|5952629|P1|Overall Study|Withdrawal by Subject|2
1705988|NCT01193608|5952673|P6|Overall Study|Adverse Event|0
1705989|NCT01193608|5952674|P5|Overall Study|Adverse Event|1
1705990|NCT01193608|5952675|P4|Overall Study|Adverse Event|0
1705991|NCT01193608|5952676|P3|Overall Study|Adverse Event|0
1705992|NCT01193608|5952677|P2|Overall Study|Adverse Event|0
1705993|NCT01193608|5952678|P1|Overall Study|Adverse Event|0
1705994|NCT01193608|5952673|P6|Overall Study|Lost to Follow-up|2
1705995|NCT01193608|5952674|P5|Overall Study|Lost to Follow-up|1
1705996|NCT01193608|5952675|P4|Overall Study|Lost to Follow-up|0
1705997|NCT01193608|5952676|P3|Overall Study|Lost to Follow-up|0
1705998|NCT01193608|5952677|P2|Overall Study|Lost to Follow-up|0
1705999|NCT01193608|5952678|P1|Overall Study|Lost to Follow-up|0
1706000|NCT01193608|5952673|P6|Overall Study|Withdrawal by Subject|0
1706001|NCT01193608|5952674|P5|Overall Study|Withdrawal by Subject|3
1706002|NCT01193608|5952675|P4|Overall Study|Withdrawal by Subject|3
1706003|NCT01193608|5952676|P3|Overall Study|Withdrawal by Subject|2
1706004|NCT01193608|5952677|P2|Overall Study|Withdrawal by Subject|1
1706005|NCT01193608|5952678|P1|Overall Study|Withdrawal by Subject|0
1706006|NCT01193608|5952673|P6|Overall Study|Other|0
1706007|NCT01193608|5952674|P5|Overall Study|Other|0
1706008|NCT01193608|5952675|P4|Overall Study|Other|0
1706009|NCT01193608|5952676|P3|Overall Study|Other|0
1706010|NCT01193608|5952677|P2|Overall Study|Other|1
1706011|NCT01193608|5952678|P1|Overall Study|Other|0
1706012|NCT01193582|5952915|P4|12 Month Follow-up|Withdrawal by Subject|11
1706013|NCT01193582|5952916|P3|12 Month Follow-up|Withdrawal by Subject|3
1706014|NCT01193582|5952917|P2|12 Month Follow-up|Withdrawal by Subject|0
1706015|NCT01193582|5952918|P1|12 Month Follow-up|Withdrawal by Subject|6
1706016|NCT01193582|5952915|P4|12 Month Follow-up|Death|0
1706017|NCT01193582|5952916|P3|12 Month Follow-up|Death|1
1706018|NCT01193582|5952917|P2|12 Month Follow-up|Death|0
1706019|NCT01193582|5952918|P1|12 Month Follow-up|Death|0
1706020|NCT01193582|5952915|P4|Vaccination Series|Withdrawal by Subject|3
1706021|NCT01193582|5952916|P3|Vaccination Series|Withdrawal by Subject|8
1706022|NCT01193582|5952917|P2|Vaccination Series|Withdrawal by Subject|13
1706023|NCT01193582|5952918|P1|Vaccination Series|Withdrawal by Subject|11
1706024|NCT01193556|5952948|P2|Overall Study|Study termination|25
1706025|NCT01193556|5952949|P1|Overall Study|Study termination|26
1706026|NCT01193530|5952959|P2|Overall Study|Non-Compliance|1
1706027|NCT01193530|5952960|P1|Overall Study|Non-Compliance|0
1706028|NCT01193530|5952959|P2|Overall Study|Returned home - out of state|1
1706029|NCT01193530|5952960|P1|Overall Study|Returned home - out of state|0
1706030|NCT01193530|5952959|P2|Overall Study|Lost Light Box|1
1706031|NCT01193530|5952960|P1|Overall Study|Lost Light Box|0
1706032|NCT01193530|5952959|P2|Overall Study|Began Contraindicated Therapy|0
1706033|NCT01193530|5952960|P1|Overall Study|Began Contraindicated Therapy|1
1706034|NCT01193530|5952959|P2|Overall Study|Withdrawal by Subject|2
1706035|NCT01193530|5952960|P1|Overall Study|Withdrawal by Subject|2
1706036|NCT01193348|5952966|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
1706037|NCT01193348|5952966|P1|Extension Treatment Period|Physician Decision|1
1706038|NCT01193348|5952966|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
1706039|NCT01193348|5952966|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
1706040|NCT01193348|5952966|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
1706041|NCT01193348|5952966|P1|Screening Period|Screen Failure|5
1706042|NCT01193335|5952986|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
1706043|NCT01193335|5952987|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
1706044|NCT01193335|5952986|P2|2-Year Follow-up|No Longer Willing to Participate|6
1706045|NCT01193335|5952987|P1|2-Year Follow-up|No Longer Willing to Participate|5
1706046|NCT01193335|5952986|P2|1-Year Follow-up|Lost to Follow-up|0
1706047|NCT01193335|5952987|P1|1-Year Follow-up|Lost to Follow-up|4
1706048|NCT01193335|5952986|P2|1-Year Follow-up|No Longer Willing to Participate|9
1706049|NCT01193335|5952987|P1|1-Year Follow-up|No Longer Willing to Participate|7
1706050|NCT01193335|5952986|P2|After Infant Series|No Longer Met Eligibility Criteria|1
1706051|NCT01193335|5952987|P1|After Infant Series|No Longer Met Eligibility Criteria|0
1706052|NCT01193335|5952986|P2|After Infant Series|Lost to Follow-up|2
1706053|NCT01193335|5952987|P1|After Infant Series|Lost to Follow-up|1
1706054|NCT01193283|5953082|P1|Overall Study|Death|1
1706055|NCT01193257|5953088|P2|Overall Study|Unblinded due to futility|251
1706056|NCT01193257|5953089|P1|Overall Study|Unblinded due to futility|135
1706057|NCT01193257|5953088|P2|Overall Study|Lost to Follow-up|3
1706058|NCT01193257|5953089|P1|Overall Study|Lost to Follow-up|2
1706059|NCT01193257|5953088|P2|Overall Study|Withdrawal by Subject|86
1706060|NCT01193257|5953089|P1|Overall Study|Withdrawal by Subject|26
1706061|NCT01193257|5953088|P2|Overall Study|Study termination by sponsor|3
1706062|NCT01193257|5953089|P1|Overall Study|Study termination by sponsor|0
1706063|NCT01193257|5953088|P2|Overall Study|Death|391
1706064|NCT01193257|5953089|P1|Overall Study|Death|202
1706065|NCT01193244|5953139|P2|Overall Study|Lost to Follow-up|15
1706066|NCT01193244|5953140|P1|Overall Study|Lost to Follow-up|6
1706067|NCT01193244|5953139|P2|Overall Study|Other|278
1706068|NCT01193244|5953140|P1|Overall Study|Other|303
1706069|NCT01193244|5953139|P2|Overall Study|Withdrawal by Subject|97
1706070|NCT01193244|5953140|P1|Overall Study|Withdrawal by Subject|79
1706071|NCT01193218|5953195|P8|12-52 Weeks|Other reason than above|0
1706072|NCT01193218|5953196|P7|12-52 Weeks|Other reason than above|0
1706073|NCT01193218|5953197|P6|12-52 Weeks|Other reason than above|0
1706074|NCT01193218|5953198|P5|12-52 Weeks|Other reason than above|1
1706075|NCT01193218|5953199|P4|12-52 Weeks|Other reason than above|1
1706076|NCT01193218|5953200|P3|12-52 Weeks|Other reason than above|0
1706077|NCT01193218|5953201|P2|12-52 Weeks|Other reason than above|0
1706078|NCT01193218|5953202|P1|12-52 Weeks|Other reason than above|1
1706079|NCT01193218|5953195|P8|12-52 Weeks|Withdrawal by Subject|2
1706080|NCT01193218|5953196|P7|12-52 Weeks|Withdrawal by Subject|1
1706081|NCT01193218|5953197|P6|12-52 Weeks|Withdrawal by Subject|2
1706082|NCT01193218|5953198|P5|12-52 Weeks|Withdrawal by Subject|0
1706083|NCT01193218|5953199|P4|12-52 Weeks|Withdrawal by Subject|0
1706084|NCT01193218|5953200|P3|12-52 Weeks|Withdrawal by Subject|3
1706085|NCT01193218|5953201|P2|12-52 Weeks|Withdrawal by Subject|0
1706086|NCT01193218|5953202|P1|12-52 Weeks|Withdrawal by Subject|3
1706087|NCT01193218|5953195|P8|12-52 Weeks|Lack of Efficacy|0
1706088|NCT01193218|5953196|P7|12-52 Weeks|Lack of Efficacy|1
1706089|NCT01193218|5953197|P6|12-52 Weeks|Lack of Efficacy|0
1706090|NCT01193218|5953198|P5|12-52 Weeks|Lack of Efficacy|0
1706091|NCT01193218|5953199|P4|12-52 Weeks|Lack of Efficacy|0
1706092|NCT01193218|5953200|P3|12-52 Weeks|Lack of Efficacy|0
1706093|NCT01193218|5953201|P2|12-52 Weeks|Lack of Efficacy|0
1706094|NCT01193218|5953202|P1|12-52 Weeks|Lack of Efficacy|0
1706095|NCT01193218|5953195|P8|12-52 Weeks|Adverse Event|2
1706096|NCT01193218|5953196|P7|12-52 Weeks|Adverse Event|1
1706097|NCT01193218|5953197|P6|12-52 Weeks|Adverse Event|3
1706098|NCT01193218|5953198|P5|12-52 Weeks|Adverse Event|3
1706099|NCT01193218|5953199|P4|12-52 Weeks|Adverse Event|2
1706100|NCT01193218|5953200|P3|12-52 Weeks|Adverse Event|1
1706101|NCT01193218|5953201|P2|12-52 Weeks|Adverse Event|0
1706102|NCT01193218|5953202|P1|12-52 Weeks|Adverse Event|1
1706103|NCT01193218|5953195|P8|0-12 Weeks|Withdrawal by Subject|0
1706104|NCT01193218|5953196|P7|0-12 Weeks|Withdrawal by Subject|1
1706105|NCT01193218|5953197|P6|0-12 Weeks|Withdrawal by Subject|0
1706106|NCT01193218|5953198|P5|0-12 Weeks|Withdrawal by Subject|0
1706107|NCT01193218|5953199|P4|0-12 Weeks|Withdrawal by Subject|0
1706108|NCT01193218|5953200|P3|0-12 Weeks|Withdrawal by Subject|2
1706109|NCT01193218|5953201|P2|0-12 Weeks|Withdrawal by Subject|0
1706110|NCT01193218|5953202|P1|0-12 Weeks|Withdrawal by Subject|3
1706111|NCT01193218|5953195|P8|0-12 Weeks|Protocol Violation|0
1706112|NCT01193218|5953196|P7|0-12 Weeks|Protocol Violation|0
1706113|NCT01193218|5953197|P6|0-12 Weeks|Protocol Violation|1
1706114|NCT01193218|5953198|P5|0-12 Weeks|Protocol Violation|1
1706115|NCT01193218|5953199|P4|0-12 Weeks|Protocol Violation|0
1706116|NCT01193218|5953200|P3|0-12 Weeks|Protocol Violation|0
1706117|NCT01193218|5953201|P2|0-12 Weeks|Protocol Violation|0
1706118|NCT01193218|5953202|P1|0-12 Weeks|Protocol Violation|0
1706119|NCT01193218|5953195|P8|0-12 Weeks|Adverse Event|0
1706120|NCT01193218|5953196|P7|0-12 Weeks|Adverse Event|2
1706121|NCT01193218|5953197|P6|0-12 Weeks|Adverse Event|2
1706122|NCT01193218|5953198|P5|0-12 Weeks|Adverse Event|0
1706123|NCT01193218|5953199|P4|0-12 Weeks|Adverse Event|0
1706124|NCT01193218|5953200|P3|0-12 Weeks|Adverse Event|1
1706125|NCT01193218|5953201|P2|0-12 Weeks|Adverse Event|0
1706126|NCT01193218|5953202|P1|0-12 Weeks|Adverse Event|6
1706127|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
1706128|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
1706129|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
1706130|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
1706131|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
1706132|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
1706133|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|Pregnancy|0
1706134|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|Pregnancy|1
1706135|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
1706136|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
1706137|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|Death|0
1706138|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|Death|2
1706139|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|Adverse Event|3
1706140|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|Adverse Event|12
1706141|NCT01193153|5953233|P2|Double Blind Relapse Prevention Period|Other|3
1706142|NCT01193153|5953234|P1|Double Blind Relapse Prevention Period|Other|2
1706143|NCT01193153|5953233|P2|Open-label Stabilization Period|Other|0
1706144|NCT01193153|5953234|P1|Open-label Stabilization Period|Other|8
1706145|NCT01193153|5953233|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
1706146|NCT01193153|5953234|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
1706147|NCT01193153|5953233|P2|Open-label Stabilization Period|Withdrawal by Subject|0
1706148|NCT01193153|5953234|P1|Open-label Stabilization Period|Withdrawal by Subject|29
1706149|NCT01193153|5953233|P2|Open-label Stabilization Period|Lack of Efficacy|0
1706150|NCT01193153|5953234|P1|Open-label Stabilization Period|Lack of Efficacy|5
1706151|NCT01193153|5953233|P2|Open-label Stabilization Period|Lost to Follow-up|0
1706152|NCT01193153|5953234|P1|Open-label Stabilization Period|Lost to Follow-up|10
1706153|NCT01193153|5953233|P2|Open-label Stabilization Period|Death|0
1706154|NCT01193153|5953234|P1|Open-label Stabilization Period|Death|2
1706155|NCT01193153|5953233|P2|Open-label Stabilization Period|Adverse Event|0
1706156|NCT01193153|5953234|P1|Open-label Stabilization Period|Adverse Event|9
1706157|NCT01193153|5953233|P2|Open-label Lead in Period|Lack of Efficacy|0
1706158|NCT01193153|5953234|P1|Open-label Lead in Period|Lack of Efficacy|26
1706159|NCT01193153|5953233|P2|Open-label Lead in Period|Death|0
1706160|NCT01193153|5953234|P1|Open-label Lead in Period|Death|1
1706161|NCT01193153|5953233|P2|Open-label Lead in Period|Adverse Event|0
1706162|NCT01193153|5953234|P1|Open-label Lead in Period|Adverse Event|41
1706163|NCT01193153|5953233|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
1706164|NCT01193153|5953234|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
1706165|NCT01193153|5953233|P2|Open-label Lead in Period|Other|0
1706166|NCT01193153|5953234|P1|Open-label Lead in Period|Other|14
1706167|NCT01193153|5953233|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
1706168|NCT01193153|5953234|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
1706169|NCT01193153|5953233|P2|Open-label Lead in Period|Withdrawal by Subject|0
1706170|NCT01193153|5953234|P1|Open-label Lead in Period|Withdrawal by Subject|69
1706171|NCT01193153|5953233|P2|Open-label Lead in Period|Pregnancy|0
1706172|NCT01193153|5953234|P1|Open-label Lead in Period|Pregnancy|1
1706173|NCT01193153|5953233|P2|Open-label Lead in Period|Lost to Follow-up|0
1706174|NCT01193153|5953234|P1|Open-label Lead in Period|Lost to Follow-up|32
1706175|NCT01193127|5953269|P4|Treated|Withdrawal by Subject|1
1706176|NCT01193127|5953270|P3|Treated|Withdrawal by Subject|0
1706177|NCT01193127|5953271|P2|Treated|Withdrawal by Subject|0
1706178|NCT01193127|5953272|P1|Treated|Withdrawal by Subject|0
1706179|NCT01193127|5953269|P4|Randomized|Surgery Cancelled|1
1706180|NCT01193127|5953270|P3|Randomized|Surgery Cancelled|0
1706181|NCT01193127|5953271|P2|Randomized|Surgery Cancelled|0
1706182|NCT01193127|5953272|P1|Randomized|Surgery Cancelled|0
1706183|NCT01193101|5953597|P4|Overall Study|Abnormal test procedure results|0
1706184|NCT01193101|5953598|P3|Overall Study|Abnormal test procedure results|0
1706185|NCT01193101|5953599|P2|Overall Study|Abnormal test procedure results|1
1706186|NCT01193101|5953600|P1|Overall Study|Abnormal test procedure results|0
1706187|NCT01193101|5953597|P4|Overall Study|Administrative problems|0
1706188|NCT01193101|5953598|P3|Overall Study|Administrative problems|1
1706189|NCT01193101|5953599|P2|Overall Study|Administrative problems|0
1706190|NCT01193101|5953600|P1|Overall Study|Administrative problems|0
1706191|NCT01193101|5953597|P4|Overall Study|Withdrawal by Subject|1
1706192|NCT01193101|5953598|P3|Overall Study|Withdrawal by Subject|1
1706193|NCT01193101|5953599|P2|Overall Study|Withdrawal by Subject|4
1706194|NCT01193101|5953600|P1|Overall Study|Withdrawal by Subject|2
1706195|NCT01193101|5953597|P4|Overall Study|Lack of Efficacy|8
1706196|NCT01193101|5953598|P3|Overall Study|Lack of Efficacy|0
1706197|NCT01193101|5953599|P2|Overall Study|Lack of Efficacy|1
1706198|NCT01193101|5953600|P1|Overall Study|Lack of Efficacy|3
1706199|NCT01193101|5953597|P4|Overall Study|Adverse Event|3
1706200|NCT01193101|5953598|P3|Overall Study|Adverse Event|1
1706201|NCT01193101|5953599|P2|Overall Study|Adverse Event|1
1706202|NCT01193101|5953600|P1|Overall Study|Adverse Event|0
1706203|NCT01192776|5953721|P4|Overall Study|Lost to Follow-up|5
1706204|NCT01192776|5953722|P3|Overall Study|Lost to Follow-up|3
1706205|NCT01192776|5953723|P2|Overall Study|Lost to Follow-up|6
1706206|NCT01192776|5953724|P1|Overall Study|Lost to Follow-up|3
1706207|NCT01192776|5953721|P4|Overall Study|Death|15
1706208|NCT01192776|5953722|P3|Overall Study|Death|18
1706209|NCT01192776|5953723|P2|Overall Study|Death|15
1706210|NCT01192776|5953724|P1|Overall Study|Death|8
1706211|NCT01192516|5953802|P3|Overall Study|Unable to follow Actiwatch instructions|0
1706212|NCT01192516|5953803|P2|Overall Study|Unable to follow Actiwatch instructions|2
1706213|NCT01192516|5953804|P1|Overall Study|Unable to follow Actiwatch instructions|4
1706214|NCT01192516|5953802|P3|Overall Study|started new treatment|0
1706215|NCT01192516|5953803|P2|Overall Study|started new treatment|1
1706216|NCT01192516|5953804|P1|Overall Study|started new treatment|5
1706217|NCT01192516|5953802|P3|Overall Study|Withdrawal by Subject|1
1706218|NCT01192516|5953803|P2|Overall Study|Withdrawal by Subject|4
1706219|NCT01192516|5953804|P1|Overall Study|Withdrawal by Subject|4
1706220|NCT01192516|5953802|P3|Overall Study|Lost to Follow-up|7
1706221|NCT01192516|5953803|P2|Overall Study|Lost to Follow-up|10
1706222|NCT01192516|5953804|P1|Overall Study|Lost to Follow-up|7
1706223|NCT01192412|5953838|P2|Overall Study|Withdrawal by Subject|1
1706224|NCT01192412|5953839|P1|Overall Study|Withdrawal by Subject|2
1706225|NCT01192412|5953838|P2|Overall Study|Lost to Follow-up|1
1706226|NCT01192412|5953839|P1|Overall Study|Lost to Follow-up|2
1706227|NCT01192399|5953847|P1|Overall Study|Lack of Efficacy|2
1706228|NCT01192347|5953857|P1|Overall Study|Patient did not show up for visits|1
1706229|NCT01192347|5953857|P1|Overall Study|Patient not visiting hospital regularly|1
1706230|NCT01192347|5953857|P1|Overall Study|Patient seen in different hospital|1
1706231|NCT01192347|5953857|P1|Overall Study|Suspected serious adverse drug reaction|1
1706232|NCT01192347|5953857|P1|Overall Study|Adverse Event|1
1706233|NCT01192347|5953857|P1|Overall Study|Withdrawal by Subject|1
1706234|NCT01192347|5953857|P1|Overall Study|Lost to Follow-up|3
1706235|NCT01192347|5953857|P1|Overall Study|Death|3
1706236|NCT01192295|5953880|P2|Overall Study|Administrative|6
1706237|NCT01192295|5953881|P1|Overall Study|Administrative|4
1706238|NCT01192295|5953880|P2|Overall Study|Lack of Efficacy|5
1706239|NCT01192295|5953881|P1|Overall Study|Lack of Efficacy|0
1706240|NCT01192295|5953880|P2|Overall Study|Lost to Follow-up|1
1706241|NCT01192295|5953881|P1|Overall Study|Lost to Follow-up|0
1706242|NCT01192295|5953880|P2|Overall Study|Withdrawal by Subject|4
1706243|NCT01192295|5953881|P1|Overall Study|Withdrawal by Subject|3
1706244|NCT01192295|5953880|P2|Overall Study|Adverse Event|7
1706245|NCT01192295|5953881|P1|Overall Study|Adverse Event|3
1706246|NCT01192204|5953915|P2|Overall Study|could not keep recall appointments|0
1706247|NCT01192204|5953916|P1|Overall Study|could not keep recall appointments|1
1706248|NCT01192191|5953928|P2|Overall Study|Withdrawal by Subject|6
1706249|NCT01192191|5953929|P1|Overall Study|Withdrawal by Subject|1
1706250|NCT01192191|5953928|P2|Overall Study|Lost to Follow-up|1
1706251|NCT01192191|5953929|P1|Overall Study|Lost to Follow-up|0
1706252|NCT01192191|5953928|P2|Overall Study|Participants Reached Stopping Criteria|2
1706253|NCT01192191|5953929|P1|Overall Study|Participants Reached Stopping Criteria|3
1706254|NCT01192191|5953928|P2|Overall Study|Adverse Event|12
1706255|NCT01192191|5953929|P1|Overall Study|Adverse Event|7
1706256|NCT01192178|5953955|P2|Overall Study|Lack of Efficacy|2
1706257|NCT01192178|5953956|P1|Overall Study|Lack of Efficacy|1
1706258|NCT01192178|5953955|P2|Overall Study|Adverse Event|1
1706259|NCT01192178|5953956|P1|Overall Study|Adverse Event|2
1706260|NCT01192178|5953955|P2|Overall Study|Lost to Follow-up|3
1706261|NCT01192178|5953956|P1|Overall Study|Lost to Follow-up|3
1706262|NCT01192178|5953955|P2|Overall Study|Physician Decision|4
1706263|NCT01192178|5953956|P1|Overall Study|Physician Decision|2
1706264|NCT01192178|5953955|P2|Overall Study|Protocol Violation|3
1706265|NCT01192178|5953956|P1|Overall Study|Protocol Violation|10
1706266|NCT01192178|5953955|P2|Overall Study|Withdrawal by Subject|10
1706267|NCT01192178|5953956|P1|Overall Study|Withdrawal by Subject|6
1706268|NCT01192152|5953976|P2|Period 3|family emergency|0
1706269|NCT01192152|5953977|P1|Period 3|family emergency|1
1706270|NCT01192152|5953976|P2|Period 1|left prematurely (while on treatment B)|1
1706271|NCT01192152|5953977|P1|Period 1|left prematurely (while on treatment B)|0
1706272|NCT01192126|5954148|P2|First Intervention (1 Week)|Lost to Follow-up|1
1706273|NCT01192126|5954149|P1|First Intervention (1 Week)|Lost to Follow-up|1
1706274|NCT01192126|5954148|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
1706275|NCT01192126|5954149|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
1706276|NCT01192022|5954161|P5|Overall Study|Parents did not allow all follow up|0
1706277|NCT01192022|5954162|P4|Overall Study|Parents did not allow all follow up|1
1706278|NCT01192022|5954163|P3|Overall Study|Parents did not allow all follow up|0
1706279|NCT01192022|5954164|P2|Overall Study|Parents did not allow all follow up|0
1706280|NCT01192022|5954165|P1|Overall Study|Parents did not allow all follow up|0
1706281|NCT01192022|5954161|P5|Overall Study|Patient needed surgery|0
1706282|NCT01192022|5954162|P4|Overall Study|Patient needed surgery|0
1706283|NCT01192022|5954163|P3|Overall Study|Patient needed surgery|0
1706284|NCT01192022|5954164|P2|Overall Study|Patient needed surgery|1
1706285|NCT01192022|5954165|P1|Overall Study|Patient needed surgery|0
1706286|NCT01192022|5954161|P5|Overall Study|Patient too sick from chemotherapy|0
1706287|NCT01192022|5954162|P4|Overall Study|Patient too sick from chemotherapy|0
1706288|NCT01192022|5954163|P3|Overall Study|Patient too sick from chemotherapy|0
1706289|NCT01192022|5954164|P2|Overall Study|Patient too sick from chemotherapy|1
1706290|NCT01192022|5954165|P1|Overall Study|Patient too sick from chemotherapy|0
1706291|NCT01192022|5954161|P5|Overall Study|Physician withdrew-patient hardship|0
1706292|NCT01192022|5954162|P4|Overall Study|Physician withdrew-patient hardship|0
1706293|NCT01192022|5954163|P3|Overall Study|Physician withdrew-patient hardship|0
1706294|NCT01192022|5954164|P2|Overall Study|Physician withdrew-patient hardship|0
1706295|NCT01192022|5954165|P1|Overall Study|Physician withdrew-patient hardship|1
1706296|NCT01192022|5954161|P5|Overall Study|Fatal Adverse Event|1
1706297|NCT01192022|5954162|P4|Overall Study|Fatal Adverse Event|0
1706298|NCT01192022|5954163|P3|Overall Study|Fatal Adverse Event|0
1706299|NCT01192022|5954164|P2|Overall Study|Fatal Adverse Event|6
1706300|NCT01192022|5954165|P1|Overall Study|Fatal Adverse Event|4
1706301|NCT01192022|5954161|P5|Overall Study|Adverse Event|0
1706302|NCT01192022|5954162|P4|Overall Study|Adverse Event|0
1706303|NCT01192022|5954163|P3|Overall Study|Adverse Event|0
1706304|NCT01192022|5954164|P2|Overall Study|Adverse Event|0
1706305|NCT01192022|5954165|P1|Overall Study|Adverse Event|1
1706306|NCT01192022|5954161|P5|Overall Study|Lost to Follow-up|0
1706307|NCT01192022|5954162|P4|Overall Study|Lost to Follow-up|1
1706308|NCT01192022|5954163|P3|Overall Study|Lost to Follow-up|1
1706309|NCT01192022|5954164|P2|Overall Study|Lost to Follow-up|2
1706310|NCT01192022|5954165|P1|Overall Study|Lost to Follow-up|4
1706311|NCT01192022|5954161|P5|Overall Study|Withdrawal of Consent|0
1706312|NCT01192022|5954162|P4|Overall Study|Withdrawal of Consent|0
1706313|NCT01192022|5954163|P3|Overall Study|Withdrawal of Consent|0
1706314|NCT01192022|5954164|P2|Overall Study|Withdrawal of Consent|1
1706315|NCT01192022|5954165|P1|Overall Study|Withdrawal of Consent|3
1706316|NCT01191944|5954188|P2|Overall Study|Other|3
1706317|NCT01191944|5954189|P1|Overall Study|Other|1
1706318|NCT01191944|5954188|P2|Overall Study|Withdrawal by Subject|2
1706319|NCT01191944|5954189|P1|Overall Study|Withdrawal by Subject|4
1706320|NCT01191944|5954188|P2|Overall Study|Protocol Violation|2
1706321|NCT01191944|5954189|P1|Overall Study|Protocol Violation|1
1706322|NCT01191944|5954188|P2|Overall Study|Adverse Event|12
1706323|NCT01191944|5954189|P1|Overall Study|Adverse Event|11
1706324|NCT01191840|5954235|P2|Overall Study|Withdrawal by Subject|0
1706325|NCT01191840|5954236|P1|Overall Study|Withdrawal by Subject|2
1706326|NCT01191840|5954235|P2|Overall Study|lab error speciation - non Staph infecti|1
1706327|NCT01191840|5954236|P1|Overall Study|lab error speciation - non Staph infecti|0
1706328|NCT01191840|5954235|P2|Overall Study|IRB approval lapse|2
1706329|NCT01191840|5954236|P1|Overall Study|IRB approval lapse|0
1706330|NCT01191840|5954235|P2|Overall Study|ineligible at enrollment|0
1706331|NCT01191840|5954236|P1|Overall Study|ineligible at enrollment|1
1706332|NCT01191840|5954235|P2|Overall Study|Non Staph Infection|3
1706333|NCT01191840|5954236|P1|Overall Study|Non Staph Infection|4
1706334|NCT01191840|5954235|P2|Overall Study|Lost to Follow-up|6
1706335|NCT01191840|5954236|P1|Overall Study|Lost to Follow-up|4
1706336|NCT01191840|5954235|P2|Overall Study|Subject discontinued treatment|2
1706337|NCT01191840|5954236|P1|Overall Study|Subject discontinued treatment|1
1706338|NCT01191840|5954235|P2|Overall Study|withdrew consent|1
1706339|NCT01191840|5954236|P1|Overall Study|withdrew consent|2
1706340|NCT01191801|5954261|P2|Overall Study|Not Provided|27
1706341|NCT01191801|5954262|P1|Overall Study|Not Provided|45
1706342|NCT01191801|5954261|P2|Overall Study|Withdrawal by Subject|4
1706343|NCT01191801|5954262|P1|Overall Study|Withdrawal by Subject|1
1706344|NCT01191801|5954261|P2|Overall Study|Physician Decision|24
1706345|NCT01191801|5954262|P1|Overall Study|Physician Decision|47
1706346|NCT01191801|5954261|P2|Overall Study|Protocol Violation|4
1706347|NCT01191801|5954262|P1|Overall Study|Protocol Violation|2
1706348|NCT01191801|5954261|P2|Overall Study|Adverse Event|8
1706349|NCT01191801|5954262|P1|Overall Study|Adverse Event|9
1706350|NCT01191801|5954261|P2|Overall Study|Lack of Efficacy|258
1706351|NCT01191801|5954262|P1|Overall Study|Lack of Efficacy|176
1706352|NCT01191801|5954261|P2|Overall Study|Death|12
1706353|NCT01191801|5954262|P1|Overall Study|Death|36
1706354|NCT01191788|5954282|P2|Overall Study|Lost to Follow-up|22
1706355|NCT01191788|5954283|P1|Overall Study|Lost to Follow-up|21
1706356|NCT01191762|5954293|P2|Overall Study|Adverse Event|0
1706357|NCT01191762|5954294|P1|Overall Study|Adverse Event|1
1706358|NCT01191268|5954452|P3|Overall Study|Sponsor Decision|0
1706359|NCT01191268|5954453|P2|Overall Study|Sponsor Decision|2
1706360|NCT01191268|5954454|P1|Overall Study|Sponsor Decision|0
1706361|NCT01191268|5954452|P3|Overall Study|Protocol Violation|1
1706362|NCT01191268|5954453|P2|Overall Study|Protocol Violation|0
1706363|NCT01191268|5954454|P1|Overall Study|Protocol Violation|1
1706364|NCT01191268|5954452|P3|Overall Study|Death|3
1706365|NCT01191268|5954453|P2|Overall Study|Death|1
1706366|NCT01191268|5954454|P1|Overall Study|Death|0
1706367|NCT01191268|5954452|P3|Overall Study|Entry Criteria Not Met|1
1706368|NCT01191268|5954453|P2|Overall Study|Entry Criteria Not Met|1
1706369|NCT01191268|5954454|P1|Overall Study|Entry Criteria Not Met|3
1706370|NCT01191268|5954452|P3|Overall Study|Lost to Follow-up|9
1706371|NCT01191268|5954453|P2|Overall Study|Lost to Follow-up|5
1706372|NCT01191268|5954454|P1|Overall Study|Lost to Follow-up|8
1706373|NCT01191268|5954452|P3|Overall Study|Physician Decision|9
1706374|NCT01191268|5954453|P2|Overall Study|Physician Decision|8
1706375|NCT01191268|5954454|P1|Overall Study|Physician Decision|6
1706376|NCT01191268|5954452|P3|Overall Study|Adverse Event|8
1706377|NCT01191268|5954453|P2|Overall Study|Adverse Event|13
1706378|NCT01191268|5954454|P1|Overall Study|Adverse Event|21
1706379|NCT01191268|5954452|P3|Overall Study|Withdrawal by Subject|21
1706380|NCT01191268|5954453|P2|Overall Study|Withdrawal by Subject|25
1706381|NCT01191268|5954454|P1|Overall Study|Withdrawal by Subject|19
1706382|NCT01191190|5954595|P1|Overall Study|Withdrawal by Subject|1
1706383|NCT01191086|5954608|P1|Overall Study|Other|1
1706384|NCT01191086|5954608|P1|Overall Study|Discontinuation criterion met|1
1706385|NCT01191086|5954608|P1|Overall Study|Withdrawal by Subject|24
1706386|NCT01191086|5954608|P1|Overall Study|Physician Decision|2
1706387|NCT01191086|5954608|P1|Overall Study|Lost to Follow-up|4
1706388|NCT01191086|5954608|P1|Overall Study|Lack of Efficacy|10
1706389|NCT01191086|5954608|P1|Overall Study|Adverse Event|20
1706390|NCT01191008|5954612|P1|Overall Study|Lost to Follow-up|8
1706391|NCT01191008|5954612|P1|Overall Study|Protocol Violation|7
1706392|NCT01190891|5954620|P2|Overall Study|Withdrawal by Subject|0
1706393|NCT01190891|5954621|P1|Overall Study|Withdrawal by Subject|5
1706394|NCT01190891|5954620|P2|Overall Study|Protocol Violation|0
1706395|NCT01190891|5954621|P1|Overall Study|Protocol Violation|1
1706396|NCT01190865|5954646|P1|Overall Study|Non-compliance|2
1706397|NCT01190865|5954646|P1|Overall Study|Withdrawal by Subject|1
1706398|NCT01190839|5954653|P2|Overall Study|Randomized but not treated|4
1706399|NCT01190839|5954654|P1|Overall Study|Randomized but not treated|2
1706400|NCT01190839|5954653|P2|Overall Study|Undefined|31
1706401|NCT01190839|5954654|P1|Overall Study|Undefined|35
1706402|NCT01190839|5954653|P2|Overall Study|Trial stopped by Sponsor|68
1706403|NCT01190839|5954654|P1|Overall Study|Trial stopped by Sponsor|71
1706404|NCT01190839|5954653|P2|Overall Study|Death|0
1706405|NCT01190839|5954654|P1|Overall Study|Death|1
1706406|NCT01190839|5954653|P2|Overall Study|Lost to Follow-up|1
1706407|NCT01190839|5954654|P1|Overall Study|Lost to Follow-up|7
1706408|NCT01190839|5954653|P2|Overall Study|Protocol Violation|2
1706409|NCT01190839|5954654|P1|Overall Study|Protocol Violation|2
1706410|NCT01190839|5954653|P2|Overall Study|Adverse Event|41
1706411|NCT01190839|5954654|P1|Overall Study|Adverse Event|32
1706412|NCT01190813|5954668|P2|Overall Study|Adverse Event|1
1706413|NCT01190813|5954669|P1|Overall Study|Adverse Event|0
1706414|NCT01190813|5954668|P2|Overall Study|Refused study treatment after randomized|0
1706415|NCT01190813|5954669|P1|Overall Study|Refused study treatment after randomized|1
1706416|NCT01190813|5954668|P2|Overall Study|Withdrawal by Subject|1
1706417|NCT01190813|5954669|P1|Overall Study|Withdrawal by Subject|2
1706418|NCT01190813|5954668|P2|Overall Study|Lost to Follow-up|2
1706419|NCT01190813|5954669|P1|Overall Study|Lost to Follow-up|1
1706420|NCT01190514|5954790|P4|Third Intervention (Period 3)|Adverse Event|0
1706421|NCT01190514|5954791|P3|Third Intervention (Period 3)|Adverse Event|0
1706422|NCT01190514|5954792|P2|Third Intervention (Period 3)|Adverse Event|0
1706423|NCT01190514|5954793|P1|Third Intervention (Period 3)|Adverse Event|1
1706424|NCT01190514|5954790|P4|First Intervention (Period 1)|Adverse Event|0
1706425|NCT01190514|5954791|P3|First Intervention (Period 1)|Adverse Event|0
1706426|NCT01190514|5954792|P2|First Intervention (Period 1)|Adverse Event|0
1706427|NCT01190514|5954793|P1|First Intervention (Period 1)|Adverse Event|1
1706428|NCT01190449|5954838|P2|Overall Study|Ineligible|4
1706429|NCT01190449|5954839|P1|Overall Study|Ineligible|0
1706430|NCT01190436|5954847|P1|Overall Study|Other|4
1706431|NCT01190436|5954847|P1|Overall Study|Lost to Follow-up|35
1706432|NCT01190410|5954863|P2|Overall Study|PI discretion|2
1706433|NCT01190410|5954864|P1|Overall Study|PI discretion|0
1706434|NCT01190410|5954863|P2|Overall Study|Administrative decision|0
1706435|NCT01190410|5954864|P1|Overall Study|Administrative decision|1
1706436|NCT01190410|5954863|P2|Overall Study|Withdrawal by Subject|2
1706437|NCT01190410|5954864|P1|Overall Study|Withdrawal by Subject|0
1706438|NCT01190410|5954863|P2|Overall Study|Lack of Efficacy|2
1706439|NCT01190410|5954864|P1|Overall Study|Lack of Efficacy|0
1706440|NCT01190410|5954863|P2|Overall Study|Adverse Event|3
1706441|NCT01190410|5954864|P1|Overall Study|Adverse Event|0
1706442|NCT01190267|5954892|P2|Overall Study|Protocol Violation|1
1706443|NCT01190267|5954893|P1|Overall Study|Protocol Violation|8
1706444|NCT01190267|5954892|P2|Overall Study|Withdrawal by Subject|1
1706445|NCT01190267|5954893|P1|Overall Study|Withdrawal by Subject|13
1706446|NCT01190267|5954892|P2|Overall Study|Lost to Follow-up|0
1706447|NCT01190267|5954893|P1|Overall Study|Lost to Follow-up|2
1706448|NCT01190267|5954892|P2|Overall Study|Treatment Failure|2
1706449|NCT01190267|5954893|P1|Overall Study|Treatment Failure|8
1706450|NCT01190267|5954892|P2|Overall Study|Adverse Event|0
1706451|NCT01190267|5954893|P1|Overall Study|Adverse Event|10
1706452|NCT01190254|5954904|P3|Overall Study|Did not meet protocol eligibility|0
1706453|NCT01190254|5954905|P2|Overall Study|Did not meet protocol eligibility|0
1706454|NCT01190254|5954906|P1|Overall Study|Did not meet protocol eligibility|1
1706455|NCT01190254|5954904|P3|Overall Study|Protocol Violation|2
1706456|NCT01190254|5954905|P2|Overall Study|Protocol Violation|0
1706457|NCT01190254|5954906|P1|Overall Study|Protocol Violation|2
1706458|NCT01190254|5954904|P3|Overall Study|Withdrawal by Subject|7
1706459|NCT01190254|5954905|P2|Overall Study|Withdrawal by Subject|5
1706460|NCT01190254|5954906|P1|Overall Study|Withdrawal by Subject|4
1706461|NCT01190254|5954904|P3|Overall Study|Lost to Follow-up|0
1706462|NCT01190254|5954905|P2|Overall Study|Lost to Follow-up|2
1706463|NCT01190254|5954906|P1|Overall Study|Lost to Follow-up|4
1706464|NCT01190254|5954904|P3|Overall Study|Lack of Efficacy|5
1706465|NCT01190254|5954905|P2|Overall Study|Lack of Efficacy|4
1706466|NCT01190254|5954906|P1|Overall Study|Lack of Efficacy|7
1706467|NCT01190254|5954904|P3|Overall Study|Adverse Event|8
1706468|NCT01190254|5954905|P2|Overall Study|Adverse Event|6
1706469|NCT01190254|5954906|P1|Overall Study|Adverse Event|3
1706470|NCT01190228|5954971|P3|Overall Study|Withdrawal by Subject|0
1706471|NCT01190228|5954972|P2|Overall Study|Withdrawal by Subject|0
1706472|NCT01190228|5954973|P1|Overall Study|Withdrawal by Subject|1
1706473|NCT01190228|5954971|P3|Overall Study|Protocol Violation|0
1706474|NCT01190228|5954972|P2|Overall Study|Protocol Violation|0
1706475|NCT01190228|5954973|P1|Overall Study|Protocol Violation|4
1706476|NCT01190215|5954996|P2|Up to Month 6|Lost to Follow-up|0
1706477|NCT01190215|5954997|P1|Up to Month 6|Lost to Follow-up|2
1706478|NCT01190189|5955065|P1|Overall Study|Migrated/moved from study area|1
1706479|NCT01190189|5955065|P1|Overall Study|Withdrawal by Subject|1
1706480|NCT01190189|5955065|P1|Overall Study|Lost to Follow-up|4
1706481|NCT01190176|5955072|P1|Overall Study|Lost to Follow-up|1
1706482|NCT01190176|5955072|P1|Overall Study|Withdrawal by Subject|1
1706483|NCT01190150|5955093|P2|Washout|Difficulty in adherence|1
1706484|NCT01190150|5955094|P1|Washout|Difficulty in adherence|0
1706485|NCT01190150|5955093|P2|Washout|Withdrawal by Subject|1
1706486|NCT01190150|5955094|P1|Washout|Withdrawal by Subject|0
1706487|NCT01190150|5955093|P2|First Treatment|Withdrawal by Subject|0
1706488|NCT01190150|5955094|P1|First Treatment|Withdrawal by Subject|1
1706489|NCT01190124|5955121|P3|Overall Study|Lost to Follow-up|0
1706490|NCT01190124|5955122|P2|Overall Study|Lost to Follow-up|0
1706491|NCT01190124|5955123|P1|Overall Study|Lost to Follow-up|2
1706492|NCT01190124|5955121|P3|Overall Study|Therapeutic Failure|1
1706493|NCT01190124|5955122|P2|Overall Study|Therapeutic Failure|0
1706494|NCT01190124|5955123|P1|Overall Study|Therapeutic Failure|12
1706495|NCT01190124|5955121|P3|Overall Study|Death|0
1706496|NCT01190124|5955122|P2|Overall Study|Death|0
1706497|NCT01190124|5955123|P1|Overall Study|Death|3
1706498|NCT01190098|5955161|P2|Overall Study|Other|1
1706499|NCT01190098|5955162|P1|Overall Study|Other|0
1706500|NCT01190098|5955161|P2|Overall Study|Lack of transportation|0
1706501|NCT01190098|5955162|P1|Overall Study|Lack of transportation|1
1706502|NCT01190098|5955161|P2|Overall Study|Patient coomorbidity|1
1706503|NCT01190098|5955162|P1|Overall Study|Patient coomorbidity|0
1706504|NCT01190098|5955161|P2|Overall Study|Adverse Event|0
1706505|NCT01190098|5955162|P1|Overall Study|Adverse Event|2
1706506|NCT01190020|5955203|P2|Overall Study|Withdrawal by Subject|0
1706507|NCT01190020|5955204|P1|Overall Study|Withdrawal by Subject|3
1706508|NCT01190020|5955203|P2|Overall Study|Lost to Follow-up|0
1706509|NCT01190020|5955204|P1|Overall Study|Lost to Follow-up|2
1706510|NCT01190020|5955203|P2|Overall Study|Adverse Event|0
1706511|NCT01190020|5955204|P1|Overall Study|Adverse Event|2
1706512|NCT01190007|5955216|P1|Overall Study|Participant was arrested|1
1706513|NCT01190007|5955216|P1|Overall Study|Difficulty of visit for complications|1
1706514|NCT01190007|5955216|P1|Overall Study|Adverse Event|8
1706515|NCT01190007|5955216|P1|Overall Study|Withdrawal by Subject|4
1706516|NCT01189890|5955233|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
1706517|NCT01189890|5955234|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
1706518|NCT01189890|5955233|P2|Overall Study|Physician Decision|4
1706519|NCT01189890|5955234|P1|Overall Study|Physician Decision|5
1706520|NCT01189890|5955233|P2|Overall Study|Non Compliance|1
1706521|NCT01189890|5955234|P1|Overall Study|Non Compliance|0
1706522|NCT01189890|5955233|P2|Overall Study|Withdrawal by Subject|11
1706523|NCT01189890|5955234|P1|Overall Study|Withdrawal by Subject|15
1706524|NCT01189890|5955233|P2|Overall Study|Protocol Violation|5
1706525|NCT01189890|5955234|P1|Overall Study|Protocol Violation|1
1706526|NCT01189890|5955233|P2|Overall Study|Lost to Follow-up|7
1706527|NCT01189890|5955234|P1|Overall Study|Lost to Follow-up|1
1706528|NCT01189890|5955233|P2|Overall Study|Lack of Efficacy|2
1706529|NCT01189890|5955234|P1|Overall Study|Lack of Efficacy|7
1706530|NCT01189890|5955233|P2|Overall Study|Adverse Event|4
1706531|NCT01189890|5955234|P1|Overall Study|Adverse Event|3
1706532|NCT01189812|5955256|P2|Overall Study|Moved out of State|2
1706533|NCT01189812|5955257|P1|Overall Study|Moved out of State|1
1706534|NCT01189812|5955256|P2|Overall Study|Out of Window|3
1706535|NCT01189812|5955257|P1|Overall Study|Out of Window|4
1706536|NCT01189812|5955256|P2|Overall Study|Adverse Event|0
1706537|NCT01189812|5955257|P1|Overall Study|Adverse Event|1
1706538|NCT01189812|5955256|P2|Overall Study|Withdrawal by Subject|3
1706539|NCT01189812|5955257|P1|Overall Study|Withdrawal by Subject|2
1706540|NCT01189604|5955341|P7|Overall Study|Withdrawal by Subject|0
1706541|NCT01189604|5955342|P6|Overall Study|Withdrawal by Subject|0
1706542|NCT01189604|5955343|P5|Overall Study|Withdrawal by Subject|0
1706543|NCT01189604|5955344|P4|Overall Study|Withdrawal by Subject|0
1706544|NCT01189604|5955345|P3|Overall Study|Withdrawal by Subject|0
1706545|NCT01189604|5955346|P2|Overall Study|Withdrawal by Subject|0
1706546|NCT01189604|5955347|P1|Overall Study|Withdrawal by Subject|1
1706547|NCT01189604|5955341|P7|Overall Study|Adverse Event|1
1706548|NCT01189604|5955342|P6|Overall Study|Adverse Event|0
1706549|NCT01189604|5955343|P5|Overall Study|Adverse Event|2
1706550|NCT01189604|5955344|P4|Overall Study|Adverse Event|0
1706551|NCT01189604|5955345|P3|Overall Study|Adverse Event|0
1706552|NCT01189604|5955346|P2|Overall Study|Adverse Event|1
1706553|NCT01189604|5955347|P1|Overall Study|Adverse Event|0
1706554|NCT01189604|5955341|P7|Overall Study|Impossible to visit|0
1706555|NCT01189604|5955342|P6|Overall Study|Impossible to visit|1
1706556|NCT01189604|5955343|P5|Overall Study|Impossible to visit|0
1706557|NCT01189604|5955344|P4|Overall Study|Impossible to visit|0
1706558|NCT01189604|5955345|P3|Overall Study|Impossible to visit|0
1706559|NCT01189604|5955346|P2|Overall Study|Impossible to visit|0
1706560|NCT01189604|5955347|P1|Overall Study|Impossible to visit|0
1706561|NCT01189500|5955391|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
1706562|NCT01189500|5955391|P1|Period 1: TAMOX Alone|Adverse Event|1
1706563|NCT01189487|5955452|P1|Overall Study|Adverse Event|1
1706564|NCT01189487|5955452|P1|Overall Study|Lack of Efficacy|2
1706565|NCT01189461|5955460|P1|Overall Study|Other|8
1706566|NCT01189461|5955460|P1|Overall Study|Did not meet entrance criteria|3
1706567|NCT01189461|5955460|P1|Overall Study|Adverse Event|2
1706568|NCT01189461|5955460|P1|Overall Study|Protocol Violation|1
1706569|NCT01189461|5955460|P1|Overall Study|Withdrawal by Subject|6
1706570|NCT01189461|5955460|P1|Overall Study|Lost to Follow-up|1
1706571|NCT01189461|5955460|P1|Overall Study|Lack of Efficacy|13
1706572|NCT01189435|5955467|P1|Overall Study|Physician Decision|1
1706573|NCT01189435|5955467|P1|Overall Study|Withdrawal by Subject|1
1706574|NCT01189227|5955567|P2|Overall Study|Study terminated due to low accrual|3
1706575|NCT01189227|5955568|P1|Overall Study|Study terminated due to low accrual|6
1706576|NCT01189201|5955574|P1|Overall Study|Adverse Event|1
1706577|NCT01189032|5955677|P3|Overall Study|Protocol Violation|1
1706578|NCT01189032|5955678|P2|Overall Study|Protocol Violation|1
1706579|NCT01189032|5955679|P1|Overall Study|Protocol Violation|1
1706580|NCT01189032|5955677|P3|Overall Study|Withdrawal by Subject|1
1706581|NCT01189032|5955678|P2|Overall Study|Withdrawal by Subject|0
1706582|NCT01189032|5955679|P1|Overall Study|Withdrawal by Subject|1
1706583|NCT01189032|5955677|P3|Overall Study|Lack of Efficacy|0
1706584|NCT01189032|5955678|P2|Overall Study|Lack of Efficacy|3
1706585|NCT01189032|5955679|P1|Overall Study|Lack of Efficacy|2
1706586|NCT01189032|5955677|P3|Overall Study|Adverse Event|4
1706587|NCT01189032|5955678|P2|Overall Study|Adverse Event|3
1706588|NCT01189032|5955679|P1|Overall Study|Adverse Event|1
1706589|NCT01188967|5955689|P2|Overall Study|Lost to Follow-up|2
1706590|NCT01188967|5955690|P1|Overall Study|Lost to Follow-up|3
1706591|NCT01188967|5955689|P2|Overall Study|Physician Decision|1
1706592|NCT01188967|5955690|P1|Overall Study|Physician Decision|1
1706593|NCT01188967|5955689|P2|Overall Study|Withdrawal by Subject|1
1706594|NCT01188967|5955690|P1|Overall Study|Withdrawal by Subject|1
1706595|NCT01188811|5955743|P2|Overall Study|Adverse Event|0
1706596|NCT01188811|5955744|P1|Overall Study|Adverse Event|6
1706597|NCT01188811|5955743|P2|Overall Study|Withdrawal by Subject|2
1706598|NCT01188811|5955744|P1|Overall Study|Withdrawal by Subject|0
1706599|NCT01188798|5955756|P2|Overall Study|Protocol closure|1
1706600|NCT01188798|5955757|P1|Overall Study|Protocol closure|1
1706601|NCT01188798|5955756|P2|Overall Study|Required additional transplant|1
1706602|NCT01188798|5955757|P1|Overall Study|Required additional transplant|1
1706603|NCT01188798|5955756|P2|Overall Study|Death|1
1706604|NCT01188798|5955757|P1|Overall Study|Death|0
1706605|NCT01188772|5955769|P4|Overall Study|Withdrawal by Subject|0
1706606|NCT01188772|5955770|P3|Overall Study|Withdrawal by Subject|2
1706607|NCT01188772|5955771|P2|Overall Study|Withdrawal by Subject|0
1706608|NCT01188772|5955772|P1|Overall Study|Withdrawal by Subject|0
1706609|NCT01188772|5955769|P4|Overall Study|Virologic Failure|0
1706610|NCT01188772|5955770|P3|Overall Study|Virologic Failure|0
1706611|NCT01188772|5955771|P2|Overall Study|Virologic Failure|0
1706612|NCT01188772|5955772|P1|Overall Study|Virologic Failure|1
1706613|NCT01188772|5955769|P4|Overall Study|Treatment Failure|0
1706614|NCT01188772|5955770|P3|Overall Study|Treatment Failure|1
1706615|NCT01188772|5955771|P2|Overall Study|Treatment Failure|0
1706616|NCT01188772|5955772|P1|Overall Study|Treatment Failure|0
1706617|NCT01188772|5955769|P4|Overall Study|Terminated by Sponsor|0
1706618|NCT01188772|5955770|P3|Overall Study|Terminated by Sponsor|1
1706619|NCT01188772|5955771|P2|Overall Study|Terminated by Sponsor|0
1706620|NCT01188772|5955772|P1|Overall Study|Terminated by Sponsor|0
1706621|NCT01188772|5955769|P4|Overall Study|Physician Decision|0
1706622|NCT01188772|5955770|P3|Overall Study|Physician Decision|1
1706623|NCT01188772|5955771|P2|Overall Study|Physician Decision|0
1706624|NCT01188772|5955772|P1|Overall Study|Physician Decision|0
1706625|NCT01188772|5955769|P4|Overall Study|Non-responder|0
1706626|NCT01188772|5955770|P3|Overall Study|Non-responder|3
1706627|NCT01188772|5955771|P2|Overall Study|Non-responder|0
1706628|NCT01188772|5955772|P1|Overall Study|Non-responder|0
1706629|NCT01188772|5955769|P4|Overall Study|Lost to Follow-up|1
1706630|NCT01188772|5955770|P3|Overall Study|Lost to Follow-up|1
1706631|NCT01188772|5955771|P2|Overall Study|Lost to Follow-up|1
1706632|NCT01188772|5955772|P1|Overall Study|Lost to Follow-up|4
1706633|NCT01188772|5955769|P4|Overall Study|Adverse Event|0
1706634|NCT01188772|5955770|P3|Overall Study|Adverse Event|2
1706635|NCT01188772|5955771|P2|Overall Study|Adverse Event|1
1706636|NCT01188772|5955772|P1|Overall Study|Adverse Event|0
1706637|NCT01188772|5955769|P4|Overall Study|Randomized but Not Treated|0
1706638|NCT01188772|5955770|P3|Overall Study|Randomized but Not Treated|0
1706639|NCT01188772|5955771|P2|Overall Study|Randomized but Not Treated|1
1706640|NCT01188772|5955772|P1|Overall Study|Randomized but Not Treated|0
1706641|NCT01188681|5955844|P4|Overall Study|Withdrawal by Subject|1
1706642|NCT01188681|5955845|P3|Overall Study|Withdrawal by Subject|0
1706643|NCT01188681|5955846|P2|Overall Study|Withdrawal by Subject|0
1706644|NCT01188681|5955847|P1|Overall Study|Withdrawal by Subject|0
1706645|NCT01188681|5955844|P4|Overall Study|bladder cancer|0
1706646|NCT01188681|5955845|P3|Overall Study|bladder cancer|1
1706647|NCT01188681|5955846|P2|Overall Study|bladder cancer|0
1706648|NCT01188681|5955847|P1|Overall Study|bladder cancer|0
1706649|NCT01188668|5955861|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
1706650|NCT01188668|5955861|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
1706651|NCT01188668|5955861|P1|Period 1: ARIP Alone|Protocol Violation|2
1706652|NCT01188655|5955894|P1|Overall Study|Other|11
1706653|NCT01188655|5955894|P1|Overall Study|Lost to Follow-up|1
1706654|NCT01188655|5955894|P1|Overall Study|Lack of Efficacy|1
1706655|NCT01188564|5955938|P2|Double-blind Phase|randomized not treated|0
1706656|NCT01188564|5955939|P1|Double-blind Phase|randomized not treated|1
1706657|NCT01188551|5955951|P4|Overall Study|Pharmacy issues|0
1706658|NCT01188551|5955952|P3|Overall Study|Pharmacy issues|0
1706659|NCT01188551|5955953|P2|Overall Study|Pharmacy issues|0
1706660|NCT01188551|5955954|P1|Overall Study|Pharmacy issues|1
1706661|NCT01188538|5955970|P2|Overall Study|Lost to Follow-up|1
1706662|NCT01188538|5955971|P1|Overall Study|Lost to Follow-up|0
1706663|NCT01188343|5956067|P3|Overall Study|Withdrawal by Subject|0
1706664|NCT01188343|5956068|P2|Overall Study|Withdrawal by Subject|24
1706665|NCT01188343|5956069|P1|Overall Study|Withdrawal by Subject|1
1706666|NCT01188343|5956067|P3|Overall Study|Not vaccinated|1
1706667|NCT01188343|5956068|P2|Overall Study|Not vaccinated|2
1706668|NCT01188343|5956069|P1|Overall Study|Not vaccinated|0
1706669|NCT01188226|5956095|P1|Overall Study|Withdrawal by Subject|4
1706670|NCT01187953|5956141|P2|Overall Study|Withdrawal by Subject|3
1706671|NCT01187953|5956142|P1|Overall Study|Withdrawal by Subject|3
1706672|NCT01187953|5956141|P2|Overall Study|Lost to Follow-up|3
1706673|NCT01187953|5956142|P1|Overall Study|Lost to Follow-up|0
1706674|NCT01187953|5956141|P2|Overall Study|Adverse Event|2
1706675|NCT01187953|5956142|P1|Overall Study|Adverse Event|1
1706676|NCT01187953|5956141|P2|Overall Study|Death|13
1706677|NCT01187953|5956142|P1|Overall Study|Death|11
1706678|NCT01187901|5956156|P2|Overall Study|Pregnancy|2
1706679|NCT01187901|5956157|P1|Overall Study|Pregnancy|0
1706680|NCT01187901|5956156|P2|Overall Study|No Endpoint due to Early Study Halt|3
1706681|NCT01187901|5956157|P1|Overall Study|No Endpoint due to Early Study Halt|2
1706682|NCT01187901|5956156|P2|Overall Study|Adverse Event|0
1706683|NCT01187901|5956157|P1|Overall Study|Adverse Event|3
1706684|NCT01187901|5956156|P2|Overall Study|Suspected Allergic Reaction|1
1706685|NCT01187901|5956157|P1|Overall Study|Suspected Allergic Reaction|1
1706686|NCT01187901|5956156|P2|Overall Study|Unrelated Health Reasons|2
1706687|NCT01187901|5956157|P1|Overall Study|Unrelated Health Reasons|1
1706688|NCT01187901|5956156|P2|Overall Study|Lost to Follow-up|2
1706689|NCT01187901|5956157|P1|Overall Study|Lost to Follow-up|1
1706690|NCT01187901|5956156|P2|Overall Study|Protocol Violation|0
1706691|NCT01187901|5956157|P1|Overall Study|Protocol Violation|1
1706692|NCT01187550|5956198|P2|Overall Study|Randomized but not treated|0
1706693|NCT01187550|5956199|P1|Overall Study|Randomized but not treated|8
1706694|NCT01187550|5956198|P2|Overall Study|Other|0
1706695|NCT01187550|5956199|P1|Overall Study|Other|3
1706696|NCT01187550|5956198|P2|Overall Study|Protocol Violation|1
1706697|NCT01187550|5956199|P1|Overall Study|Protocol Violation|3
1706698|NCT01187446|5956355|P2|Overall Study|Patient started non-protocol therapy|1
1706699|NCT01187446|5956356|P1|Overall Study|Patient started non-protocol therapy|0
1706700|NCT01187433|5956372|P2|Overall Study|Withdrawal by Subject|2
1706701|NCT01187433|5956373|P1|Overall Study|Withdrawal by Subject|5
1706702|NCT01187433|5956372|P2|Overall Study|Protocol Violation|2
1706703|NCT01187433|5956373|P1|Overall Study|Protocol Violation|6
1706704|NCT01187407|5956403|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
1706705|NCT01187407|5956404|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1706706|NCT01187407|5956405|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1706707|NCT01187407|5956406|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1706708|NCT01187407|5956407|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1706709|NCT01187407|5956403|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
1706710|NCT01187407|5956404|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
1706711|NCT01187407|5956405|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1706712|NCT01187407|5956406|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1706713|NCT01187407|5956407|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1706714|NCT01187407|5956403|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
1706715|NCT01187407|5956404|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
1706716|NCT01187407|5956405|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1706717|NCT01187407|5956406|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
1706718|NCT01187407|5956407|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1706719|NCT01187407|5956403|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1706720|NCT01187407|5956404|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1706721|NCT01187407|5956405|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1706722|NCT01187407|5956406|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1706723|NCT01187407|5956407|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1706724|NCT01187407|5956403|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
1706725|NCT01187407|5956404|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
1706726|NCT01187407|5956405|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
1706727|NCT01187407|5956406|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
1706728|NCT01187407|5956407|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1706729|NCT01187407|5956403|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
1706730|NCT01187407|5956404|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
1706731|NCT01187407|5956405|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
1706732|NCT01187407|5956406|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
1706733|NCT01187407|5956407|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1706734|NCT01187407|5956403|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
1706735|NCT01187407|5956404|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
1706736|NCT01187407|5956405|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
1706737|NCT01187407|5956406|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1706738|NCT01187407|5956407|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1706739|NCT01187407|5956403|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1706740|NCT01187407|5956404|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1706741|NCT01187407|5956405|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1706742|NCT01187407|5956406|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1706743|NCT01187407|5956407|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
1706744|NCT01187407|5956403|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1706745|NCT01187407|5956404|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1706746|NCT01187407|5956405|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1706747|NCT01187407|5956406|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1706748|NCT01187407|5956407|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
1706749|NCT01187407|5956403|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1706750|NCT01187407|5956404|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1706751|NCT01187407|5956405|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1706752|NCT01187407|5956406|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1706753|NCT01187407|5956407|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
1706754|NCT01187407|5956403|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1706755|NCT01187407|5956404|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1706756|NCT01187407|5956405|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1706757|NCT01187407|5956406|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1706758|NCT01187407|5956407|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
1706759|NCT01187407|5956403|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1706760|NCT01187407|5956404|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1706761|NCT01187407|5956405|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1706762|NCT01187407|5956406|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1706763|NCT01187407|5956407|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
1706764|NCT01187407|5956403|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1706765|NCT01187407|5956404|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1706766|NCT01187407|5956405|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1706767|NCT01187407|5956406|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1706768|NCT01187407|5956407|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
1706769|NCT01187407|5956403|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1706770|NCT01187407|5956404|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1706771|NCT01187407|5956405|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1706772|NCT01187407|5956406|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1706773|NCT01187407|5956407|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
1706774|NCT01187043|5956520|P5|Overall Study|Unable to make scheduled visits|1
1706775|NCT01187043|5956521|P4|Overall Study|Unable to make scheduled visits|0
1706776|NCT01187043|5956522|P3|Overall Study|Unable to make scheduled visits|4
1706777|NCT01187043|5956523|P2|Overall Study|Unable to make scheduled visits|0
1706778|NCT01187043|5956524|P1|Overall Study|Unable to make scheduled visits|1
1706779|NCT01187043|5956520|P5|Overall Study|Adverse Event|1
1706780|NCT01187043|5956521|P4|Overall Study|Adverse Event|0
1706781|NCT01187043|5956522|P3|Overall Study|Adverse Event|0
1706782|NCT01187043|5956523|P2|Overall Study|Adverse Event|0
1706783|NCT01187043|5956524|P1|Overall Study|Adverse Event|0
1706784|NCT01186939|5956550|P1|Overall Study|Transformation to AML|1
1706785|NCT01186939|5956550|P1|Overall Study|Bone marrow transplant|1
1706786|NCT01186939|5956550|P1|Overall Study|Myocardial infarction|1
1706787|NCT01186939|5956550|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
1706788|NCT01186939|5956550|P1|Overall Study|Started additional treatment|1
1706789|NCT01186939|5956550|P1|Overall Study|Sponsor decision|4
1706790|NCT01186939|5956550|P1|Overall Study|Program closed|5
1706791|NCT01186939|5956550|P1|Overall Study|No longer receiving clinical benefit|17
1706792|NCT01186939|5956550|P1|Overall Study|Withdrawal by Subject|2
1706793|NCT01186939|5956550|P1|Overall Study|Death|7
1706794|NCT01186848|5956554|P1|Overall Study|Adverse Event|2
1706795|NCT01186848|5956554|P1|Overall Study|Withdrawal by Subject|2
1706796|NCT01186848|5956554|P1|Overall Study|Lost to Follow-up|4
1706797|NCT01186809|5956560|P1|Overall Study|Death|30
1706798|NCT01186796|5956566|P2|Overall Study|Protocol Violation|1
1706799|NCT01186796|5956567|P1|Overall Study|Protocol Violation|0
1706800|NCT01186796|5956566|P2|Overall Study|Withdrawal by Subject|1
1706801|NCT01186796|5956567|P1|Overall Study|Withdrawal by Subject|1
1706802|NCT01186796|5956566|P2|Overall Study|Adverse Event|0
1706803|NCT01186796|5956567|P1|Overall Study|Adverse Event|3
1706804|NCT01186770|5956585|P4|Overall Study|Other than specified|2
1706805|NCT01186770|5956586|P3|Overall Study|Other than specified|1
1706806|NCT01186770|5956587|P2|Overall Study|Other than specified|1
1706807|NCT01186770|5956588|P1|Overall Study|Other than specified|0
1706808|NCT01186770|5956585|P4|Overall Study|Insufficient response to treatment|7
1706809|NCT01186770|5956586|P3|Overall Study|Insufficient response to treatment|5
1706810|NCT01186770|5956587|P2|Overall Study|Insufficient response to treatment|8
1706811|NCT01186770|5956588|P1|Overall Study|Insufficient response to treatment|7
1706812|NCT01186770|5956585|P4|Overall Study|Lost to Follow-up|9
1706813|NCT01186770|5956586|P3|Overall Study|Lost to Follow-up|14
1706814|NCT01186770|5956587|P2|Overall Study|Lost to Follow-up|6
1706815|NCT01186770|5956588|P1|Overall Study|Lost to Follow-up|10
1706816|NCT01186770|5956585|P4|Overall Study|Withdrawal by Subject|17
1706817|NCT01186770|5956586|P3|Overall Study|Withdrawal by Subject|11
1706818|NCT01186770|5956587|P2|Overall Study|Withdrawal by Subject|13
1706819|NCT01186770|5956588|P1|Overall Study|Withdrawal by Subject|15
1706820|NCT01186770|5956585|P4|Overall Study|Adverse Event|9
1706821|NCT01186770|5956586|P3|Overall Study|Adverse Event|7
1706822|NCT01186770|5956587|P2|Overall Study|Adverse Event|9
1706823|NCT01186770|5956588|P1|Overall Study|Adverse Event|2
1706824|NCT01186770|5956585|P4|Overall Study|Protocol Violation|14
1706825|NCT01186770|5956586|P3|Overall Study|Protocol Violation|12
1706826|NCT01186770|5956587|P2|Overall Study|Protocol Violation|9
1706827|NCT01186770|5956588|P1|Overall Study|Protocol Violation|7
1706828|NCT01186770|5956585|P4|Overall Study|Ineligibility|0
1706829|NCT01186770|5956586|P3|Overall Study|Ineligibility|2
1706830|NCT01186770|5956587|P2|Overall Study|Ineligibility|0
1706831|NCT01186770|5956588|P1|Overall Study|Ineligibility|0
1706832|NCT01186744|5956612|P6|Overall Study|Death|0
1706833|NCT01186744|5956613|P5|Overall Study|Death|0
1706834|NCT01186744|5956614|P4|Overall Study|Death|0
1706835|NCT01186744|5956615|P3|Overall Study|Death|0
1706836|NCT01186744|5956616|P2|Overall Study|Death|0
1706837|NCT01186744|5956617|P1|Overall Study|Death|1
1706838|NCT01186744|5956612|P6|Overall Study|Adverse Event|4
1706839|NCT01186744|5956613|P5|Overall Study|Adverse Event|1
1706840|NCT01186744|5956614|P4|Overall Study|Adverse Event|0
1706841|NCT01186744|5956615|P3|Overall Study|Adverse Event|1
1706842|NCT01186744|5956616|P2|Overall Study|Adverse Event|14
1706843|NCT01186744|5956617|P1|Overall Study|Adverse Event|10
1706844|NCT01186744|5956612|P6|Overall Study|Other|5
1706845|NCT01186744|5956613|P5|Overall Study|Other|1
1706846|NCT01186744|5956614|P4|Overall Study|Other|2
1706847|NCT01186744|5956615|P3|Overall Study|Other|1
1706848|NCT01186744|5956616|P2|Overall Study|Other|10
1706849|NCT01186744|5956617|P1|Overall Study|Other|9
1706850|NCT01186744|5956612|P6|Overall Study|Study terminated by Sponsor|0
1706851|NCT01186744|5956613|P5|Overall Study|Study terminated by Sponsor|0
1706852|NCT01186744|5956614|P4|Overall Study|Study terminated by Sponsor|0
1706853|NCT01186744|5956615|P3|Overall Study|Study terminated by Sponsor|0
1706854|NCT01186744|5956616|P2|Overall Study|Study terminated by Sponsor|0
1706855|NCT01186744|5956617|P1|Overall Study|Study terminated by Sponsor|1
1706856|NCT01186744|5956612|P6|Overall Study|Withdrawal by Subject|6
1706857|NCT01186744|5956613|P5|Overall Study|Withdrawal by Subject|0
1706858|NCT01186744|5956614|P4|Overall Study|Withdrawal by Subject|5
1706859|NCT01186744|5956615|P3|Overall Study|Withdrawal by Subject|2
1706860|NCT01186744|5956616|P2|Overall Study|Withdrawal by Subject|10
1706861|NCT01186744|5956617|P1|Overall Study|Withdrawal by Subject|14
1706862|NCT01186744|5956612|P6|Overall Study|Screen failure|0
1706863|NCT01186744|5956613|P5|Overall Study|Screen failure|0
1706864|NCT01186744|5956614|P4|Overall Study|Screen failure|1
1706865|NCT01186744|5956615|P3|Overall Study|Screen failure|0
1706866|NCT01186744|5956616|P2|Overall Study|Screen failure|1
1706867|NCT01186744|5956617|P1|Overall Study|Screen failure|1
1706868|NCT01186744|5956612|P6|Overall Study|Lost to Follow-up|4
1706869|NCT01186744|5956613|P5|Overall Study|Lost to Follow-up|1
1706870|NCT01186744|5956614|P4|Overall Study|Lost to Follow-up|1
1706871|NCT01186744|5956615|P3|Overall Study|Lost to Follow-up|2
1706872|NCT01186744|5956616|P2|Overall Study|Lost to Follow-up|16
1706873|NCT01186744|5956617|P1|Overall Study|Lost to Follow-up|15
1706874|NCT01186744|5956612|P6|Overall Study|Protocol Violation|2
1706875|NCT01186744|5956613|P5|Overall Study|Protocol Violation|1
1706876|NCT01186744|5956614|P4|Overall Study|Protocol Violation|1
1706877|NCT01186744|5956615|P3|Overall Study|Protocol Violation|0
1706878|NCT01186744|5956616|P2|Overall Study|Protocol Violation|2
1706879|NCT01186744|5956617|P1|Overall Study|Protocol Violation|1
1706880|NCT01186744|5956612|P6|Overall Study|Lack of Efficacy|5
1706881|NCT01186744|5956613|P5|Overall Study|Lack of Efficacy|2
1706882|NCT01186744|5956614|P4|Overall Study|Lack of Efficacy|2
1706883|NCT01186744|5956615|P3|Overall Study|Lack of Efficacy|0
1706884|NCT01186744|5956616|P2|Overall Study|Lack of Efficacy|99
1706885|NCT01186744|5956617|P1|Overall Study|Lack of Efficacy|156
1706886|NCT01186692|5957037|P1|Overall Study|Adverse Event|2
1706887|NCT01186692|5957037|P1|Overall Study|Futher testing contraindicated implant|19
1706888|NCT01186692|5957037|P1|Overall Study|Not Catheterized|11
1706889|NCT01186458|5957064|P1|Overall Study|Adverse Event|1
1706890|NCT01186419|5957073|P2|Overall Study|Other|1
1706891|NCT01186419|5957074|P1|Overall Study|Other|1
1706892|NCT01186419|5957073|P2|Overall Study|Physician Decision|3
1706893|NCT01186419|5957074|P1|Overall Study|Physician Decision|0
1706894|NCT01186419|5957073|P2|Overall Study|Adverse Event|2
1706895|NCT01186419|5957074|P1|Overall Study|Adverse Event|1
1706896|NCT01186419|5957073|P2|Overall Study|Withdrawal by Subject|3
1706897|NCT01186419|5957074|P1|Overall Study|Withdrawal by Subject|5
1706898|NCT01186328|5957088|P3|Overall Study|Death|0
1706899|NCT01186328|5957089|P2|Overall Study|Death|0
1706900|NCT01186328|5957090|P1|Overall Study|Death|1
1706901|NCT01185964|5957120|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
1706902|NCT01185964|5957121|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1706903|NCT01185964|5957122|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1706904|NCT01185964|5957123|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
1706905|NCT01185964|5957120|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
1706906|NCT01185964|5957121|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1706907|NCT01185964|5957122|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1706908|NCT01185964|5957123|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
1706909|NCT01185964|5957120|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
1706910|NCT01185964|5957121|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1706911|NCT01185964|5957122|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1706912|NCT01185964|5957123|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
1706913|NCT01185964|5957120|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
1706914|NCT01185964|5957121|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
1706915|NCT01185964|5957122|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
1706916|NCT01185964|5957123|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
1706917|NCT01185964|5957120|P4|Phase 1b and Phase 2|Adverse Event|0
1706918|NCT01185964|5957121|P3|Phase 1b and Phase 2|Adverse Event|2
1706919|NCT01185964|5957122|P2|Phase 1b and Phase 2|Adverse Event|0
1706920|NCT01185964|5957123|P1|Phase 1b and Phase 2|Adverse Event|1
1706921|NCT01185964|5957120|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1706922|NCT01185964|5957121|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
1706923|NCT01185964|5957122|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1706924|NCT01185964|5957123|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
1706925|NCT01185964|5957120|P4|Phase 1b and Phase 2|Other Therapy Started|0
1706926|NCT01185964|5957121|P3|Phase 1b and Phase 2|Other Therapy Started|3
1706927|NCT01185964|5957122|P2|Phase 1b and Phase 2|Other Therapy Started|3
1706928|NCT01185964|5957123|P1|Phase 1b and Phase 2|Other Therapy Started|0
1706929|NCT01185964|5957120|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
1706930|NCT01185964|5957121|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
1706931|NCT01185964|5957122|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
1706932|NCT01185964|5957123|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
1706933|NCT01185834|5957149|P1|Overall Study|Early exit - Site error|2
1706934|NCT01185834|5957149|P1|Overall Study|Time/Job Conflict|2
1706935|NCT01185834|5957149|P1|Overall Study|Biomicroscopy|4
1706936|NCT01185834|5957149|P1|Overall Study|Discomfort|4
1706937|NCT01185834|5957149|P1|Overall Study|Lost to Follow-up|2
1706938|NCT01185821|5957159|P5|Overall Study|Administrative problems|2
1706939|NCT01185821|5957160|P4|Overall Study|Administrative problems|1
1706940|NCT01185821|5957161|P3|Overall Study|Administrative problems|1
1706941|NCT01185821|5957162|P2|Overall Study|Administrative problems|0
1706942|NCT01185821|5957163|P1|Overall Study|Administrative problems|0
1706943|NCT01185821|5957159|P5|Overall Study|Lost to Follow-up|2
1706944|NCT01185821|5957160|P4|Overall Study|Lost to Follow-up|1
1706945|NCT01185821|5957161|P3|Overall Study|Lost to Follow-up|2
1706946|NCT01185821|5957162|P2|Overall Study|Lost to Follow-up|1
1706947|NCT01185821|5957163|P1|Overall Study|Lost to Follow-up|1
1706948|NCT01185821|5957159|P5|Overall Study|Withdrawal by Subject|3
1706949|NCT01185821|5957160|P4|Overall Study|Withdrawal by Subject|1
1706950|NCT01185821|5957161|P3|Overall Study|Withdrawal by Subject|2
1706951|NCT01185821|5957162|P2|Overall Study|Withdrawal by Subject|2
1706952|NCT01185821|5957163|P1|Overall Study|Withdrawal by Subject|3
1706953|NCT01185821|5957159|P5|Overall Study|Lack of Efficacy|9
1706954|NCT01185821|5957160|P4|Overall Study|Lack of Efficacy|0
1706955|NCT01185821|5957161|P3|Overall Study|Lack of Efficacy|3
1706956|NCT01185821|5957162|P2|Overall Study|Lack of Efficacy|0
1706957|NCT01185821|5957163|P1|Overall Study|Lack of Efficacy|0
1706958|NCT01185821|5957159|P5|Overall Study|Adverse Event|5
1706959|NCT01185821|5957160|P4|Overall Study|Adverse Event|2
1706960|NCT01185821|5957161|P3|Overall Study|Adverse Event|1
1706961|NCT01185821|5957162|P2|Overall Study|Adverse Event|3
1706962|NCT01185821|5957163|P1|Overall Study|Adverse Event|2
1706963|NCT01185821|5957159|P5|Overall Study|Condition no longer required study drug|1
1706964|NCT01185821|5957160|P4|Overall Study|Condition no longer required study drug|0
1706965|NCT01185821|5957161|P3|Overall Study|Condition no longer required study drug|0
1706966|NCT01185821|5957162|P2|Overall Study|Condition no longer required study drug|0
1706967|NCT01185821|5957163|P1|Overall Study|Condition no longer required study drug|0
1706968|NCT01185821|5957159|P5|Overall Study|Death|0
1706969|NCT01185821|5957160|P4|Overall Study|Death|0
1706970|NCT01185821|5957161|P3|Overall Study|Death|0
1706971|NCT01185821|5957162|P2|Overall Study|Death|1
1706972|NCT01185821|5957163|P1|Overall Study|Death|0
1706973|NCT01185821|5957159|P5|Overall Study|Abnormal test procedure result|1
1706974|NCT01185821|5957160|P4|Overall Study|Abnormal test procedure result|0
1706975|NCT01185821|5957161|P3|Overall Study|Abnormal test procedure result|0
1706976|NCT01185821|5957162|P2|Overall Study|Abnormal test procedure result|0
1706977|NCT01185821|5957163|P1|Overall Study|Abnormal test procedure result|0
1706978|NCT01185821|5957159|P5|Overall Study|Protocol Violation|1
1706979|NCT01185821|5957160|P4|Overall Study|Protocol Violation|1
1706980|NCT01185821|5957161|P3|Overall Study|Protocol Violation|0
1706981|NCT01185821|5957162|P2|Overall Study|Protocol Violation|0
1706982|NCT01185821|5957163|P1|Overall Study|Protocol Violation|0
1706983|NCT01185821|5957159|P5|Overall Study|Abnormal laboratory value(s)|0
1706984|NCT01185821|5957160|P4|Overall Study|Abnormal laboratory value(s)|0
1706985|NCT01185821|5957161|P3|Overall Study|Abnormal laboratory value(s)|1
1706986|NCT01185821|5957162|P2|Overall Study|Abnormal laboratory value(s)|2
1706987|NCT01185821|5957163|P1|Overall Study|Abnormal laboratory value(s)|1
1706988|NCT01185782|5957214|P2|Overall Study|Randomized but not treated|4
1706989|NCT01185782|5957215|P1|Overall Study|Randomized but not treated|0
1706990|NCT01185782|5957214|P2|Overall Study|Other|5
1706991|NCT01185782|5957215|P1|Overall Study|Other|2
1706992|NCT01185782|5957214|P2|Overall Study|Poor Response to Treatment|1
1706993|NCT01185782|5957215|P1|Overall Study|Poor Response to Treatment|3
1706994|NCT01185782|5957214|P2|Overall Study|Protocol Violation|0
1706995|NCT01185782|5957215|P1|Overall Study|Protocol Violation|1
1706996|NCT01185782|5957214|P2|Overall Study|Adverse Event|1
1706997|NCT01185782|5957215|P1|Overall Study|Adverse Event|0
1706998|NCT01185704|5957243|P2|Overall Study|Ectopic pregnancy|1
1706999|NCT01185704|5957244|P1|Overall Study|Ectopic pregnancy|0
1707000|NCT01185704|5957243|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
1707001|NCT01185704|5957244|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
1707002|NCT01185704|5957243|P2|Overall Study|Lack of ovarian response|1
1707003|NCT01185704|5957244|P1|Overall Study|Lack of ovarian response|5
1707004|NCT01185704|5957243|P2|Overall Study|Randomized but not treated|3
1707005|NCT01185704|5957244|P1|Overall Study|Randomized but not treated|3
1707006|NCT01185639|5957278|P1|Overall Study|Progressed and didn't receive therapy|2
1707007|NCT01185600|5957288|P2|Overall Study|Hold by DSMB|2
1707008|NCT01185600|5957289|P1|Overall Study|Hold by DSMB|1
1707009|NCT01185600|5957288|P2|Overall Study|Withdrawal by Subject|1
1707010|NCT01185600|5957289|P1|Overall Study|Withdrawal by Subject|1
1707011|NCT01185600|5957288|P2|Overall Study|Physician Decision|35
1707012|NCT01185600|5957289|P1|Overall Study|Physician Decision|29
1707013|NCT01185600|5957288|P2|Overall Study|Lost to Follow-up|5
1707014|NCT01185600|5957289|P1|Overall Study|Lost to Follow-up|0
1707015|NCT01185600|5957288|P2|Overall Study|Death|1
1707016|NCT01185600|5957289|P1|Overall Study|Death|0
1707017|NCT01185600|5957288|P2|Overall Study|Adverse Event|1
1707018|NCT01185600|5957289|P1|Overall Study|Adverse Event|1
1707019|NCT01185561|5957311|P2|Overall Study|Withdrawal by Subject|8
1707020|NCT01185561|5957312|P1|Overall Study|Withdrawal by Subject|2
1707021|NCT01185561|5957311|P2|Overall Study|Lost to Follow-up|4
1707022|NCT01185561|5957312|P1|Overall Study|Lost to Follow-up|0
1707023|NCT01185548|5957324|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
1707024|NCT01185522|5957337|P1|Overall Study|Other reasons|12
1707025|NCT01185522|5957337|P1|Overall Study|Poor tolerance|39
1707026|NCT01185522|5957337|P1|Overall Study|Withdrawal by Subject|10
1707027|NCT01185522|5957337|P1|Overall Study|Lost to Follow-up|19
1707028|NCT01185522|5957337|P1|Overall Study|Lack of Efficacy|28
1707029|NCT01185509|5957363|P2|Overall Study|Intercurrent Illness|1
1707030|NCT01185509|5957364|P1|Overall Study|Intercurrent Illness|0
1707031|NCT01185509|5957363|P2|Overall Study|Death|1
1707032|NCT01185509|5957364|P1|Overall Study|Death|0
1707033|NCT01185509|5957363|P2|Overall Study|Withdrawal by Subject|1
1707034|NCT01185509|5957364|P1|Overall Study|Withdrawal by Subject|0
1707035|NCT01185509|5957363|P2|Overall Study|Physician Decision|2
1707036|NCT01185509|5957364|P1|Overall Study|Physician Decision|2
1707037|NCT01185509|5957363|P2|Overall Study|Progression/Relapse|15
1707038|NCT01185509|5957364|P1|Overall Study|Progression/Relapse|9
1707039|NCT01185353|5957380|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
1707040|NCT01185353|5957381|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
1707041|NCT01185353|5957382|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
1707042|NCT01185353|5957383|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
1707043|NCT01185353|5957384|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
1707044|NCT01185353|5957385|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
1707045|NCT01185353|5957386|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
1707046|NCT01185353|5957387|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
1707047|NCT01185353|5957388|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
1707048|NCT01185353|5957389|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
1707049|NCT01185353|5957380|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
1707050|NCT01185353|5957381|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
1707051|NCT01185353|5957382|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
1707052|NCT01185353|5957383|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1707053|NCT01185353|5957384|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1707054|NCT01185353|5957385|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1707055|NCT01185353|5957386|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1707056|NCT01185353|5957387|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1707057|NCT01185353|5957388|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1707058|NCT01185353|5957389|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
1707059|NCT01185353|5957380|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707060|NCT01185353|5957381|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
1707061|NCT01185353|5957382|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
1707062|NCT01185353|5957383|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707063|NCT01185353|5957384|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707064|NCT01185353|5957385|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707065|NCT01185353|5957386|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707066|NCT01185353|5957387|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707067|NCT01185353|5957388|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707068|NCT01185353|5957389|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
1707069|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Reason missing|0
1707070|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Reason missing|1
1707071|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Reason missing|0
1707072|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Reason missing|0
1707073|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Reason missing|0
1707074|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Reason missing|0
1707075|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Reason missing|0
1707076|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Reason missing|0
1707077|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Reason missing|0
1707078|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Reason missing|0
1707079|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
1707080|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
1707081|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
1707082|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
1707083|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
1707084|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
1707085|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
1707086|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
1707087|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
1707088|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
1707089|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
1707090|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707091|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707092|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707093|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707094|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707095|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707096|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707097|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707098|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
1707099|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Death|1
1707100|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Death|0
1707101|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Death|0
1707102|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Death|0
1707103|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Death|0
1707104|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Death|0
1707105|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Death|0
1707106|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Death|0
1707107|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Death|0
1707108|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Death|0
1707109|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707110|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
1707111|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707112|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707113|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707114|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707115|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707116|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707117|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707118|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
1707119|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
1707120|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
1707121|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
1707122|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1707123|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1707124|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1707125|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1707126|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1707127|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1707128|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
1707129|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
1707130|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
1707131|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
1707132|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1707133|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1707134|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1707135|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1707136|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1707137|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1707138|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
1707139|NCT01185353|5957380|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
1707140|NCT01185353|5957381|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
1707141|NCT01185353|5957382|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
1707142|NCT01185353|5957383|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
1707143|NCT01185353|5957384|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
1707144|NCT01185353|5957385|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
1707145|NCT01185353|5957386|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
1707146|NCT01185353|5957387|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
1707147|NCT01185353|5957388|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
1707148|NCT01185353|5957389|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
1707149|NCT01185353|5957380|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707150|NCT01185353|5957381|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707151|NCT01185353|5957382|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707152|NCT01185353|5957383|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
1707153|NCT01185353|5957384|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707154|NCT01185353|5957385|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707155|NCT01185353|5957386|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707156|NCT01185353|5957387|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707157|NCT01185353|5957388|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707158|NCT01185353|5957389|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
1707159|NCT01185353|5957380|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1707160|NCT01185353|5957381|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1707161|NCT01185353|5957382|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1707162|NCT01185353|5957383|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
1707163|NCT01185353|5957384|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
1707164|NCT01185353|5957385|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1707165|NCT01185353|5957386|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
1707166|NCT01185353|5957387|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
1707167|NCT01185353|5957388|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1707168|NCT01185353|5957389|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
1707169|NCT01185353|5957380|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707170|NCT01185353|5957381|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707171|NCT01185353|5957382|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707172|NCT01185353|5957383|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
1707173|NCT01185353|5957384|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707174|NCT01185353|5957385|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707175|NCT01185353|5957386|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
1707176|NCT01185353|5957387|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707177|NCT01185353|5957388|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707178|NCT01185353|5957389|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
1707179|NCT01185353|5957380|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707180|NCT01185353|5957381|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707181|NCT01185353|5957382|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707182|NCT01185353|5957383|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707183|NCT01185353|5957384|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707184|NCT01185353|5957385|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707185|NCT01185353|5957386|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
1707186|NCT01185353|5957387|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707187|NCT01185353|5957388|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
1707188|NCT01185353|5957389|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
1707189|NCT01185353|5957380|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
1707190|NCT01185353|5957381|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
1707191|NCT01185353|5957382|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
1707192|NCT01185353|5957383|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
1707193|NCT01185353|5957384|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
1707194|NCT01185353|5957385|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
1707195|NCT01185353|5957386|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
1707196|NCT01185353|5957387|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
1707197|NCT01185353|5957388|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
1707198|NCT01185353|5957389|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
1707199|NCT01185353|5957380|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707200|NCT01185353|5957381|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707201|NCT01185353|5957382|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707202|NCT01185353|5957383|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707203|NCT01185353|5957384|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707204|NCT01185353|5957385|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
1707205|NCT01185353|5957386|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707206|NCT01185353|5957387|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707207|NCT01185353|5957388|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
1707208|NCT01185353|5957389|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
1707209|NCT01185353|5957380|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707210|NCT01185353|5957381|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707211|NCT01185353|5957382|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707212|NCT01185353|5957383|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707213|NCT01185353|5957384|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707214|NCT01185353|5957385|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
1707215|NCT01185353|5957386|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707216|NCT01185353|5957387|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707217|NCT01185353|5957388|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707218|NCT01185353|5957389|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
1707219|NCT01185353|5957380|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
1707220|NCT01185353|5957381|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
1707221|NCT01185353|5957382|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
1707222|NCT01185353|5957383|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
1707223|NCT01185353|5957384|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
1707224|NCT01185353|5957385|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
1707225|NCT01185353|5957386|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
1707226|NCT01185353|5957387|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
1707227|NCT01185353|5957388|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
1707228|NCT01185353|5957389|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
1707229|NCT01185353|5957380|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707230|NCT01185353|5957381|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707231|NCT01185353|5957382|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707232|NCT01185353|5957383|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707233|NCT01185353|5957384|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707234|NCT01185353|5957385|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
1707235|NCT01185353|5957386|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707236|NCT01185353|5957387|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707237|NCT01185353|5957388|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
1707238|NCT01185353|5957389|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
1707239|NCT01185353|5957380|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707240|NCT01185353|5957381|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707241|NCT01185353|5957382|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707242|NCT01185353|5957383|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707243|NCT01185353|5957384|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707244|NCT01185353|5957385|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
1707245|NCT01185353|5957386|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707246|NCT01185353|5957387|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707247|NCT01185353|5957388|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707248|NCT01185353|5957389|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
1707249|NCT01185353|5957380|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
1707250|NCT01185353|5957381|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
1707251|NCT01185353|5957382|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
1707252|NCT01185353|5957383|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
1707253|NCT01185353|5957384|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
1707254|NCT01185353|5957385|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
1707255|NCT01185353|5957386|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
1707256|NCT01185353|5957387|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
1707257|NCT01185353|5957388|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
1707258|NCT01185353|5957389|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
1707259|NCT01185340|5957550|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
1707260|NCT01185340|5957551|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
1707261|NCT01185340|5957552|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1707262|NCT01185340|5957553|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1707263|NCT01185340|5957550|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
1707264|NCT01185340|5957551|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
1707265|NCT01185340|5957552|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
1707266|NCT01185340|5957553|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1707267|NCT01185340|5957550|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1707268|NCT01185340|5957551|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
1707269|NCT01185340|5957552|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1707270|NCT01185340|5957553|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1707271|NCT01185340|5957550|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1707272|NCT01185340|5957551|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1707273|NCT01185340|5957552|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1707274|NCT01185340|5957553|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1707275|NCT01185340|5957550|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
1707276|NCT01185340|5957551|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
1707277|NCT01185340|5957552|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
1707278|NCT01185340|5957553|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1707279|NCT01185340|5957550|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
1707280|NCT01185340|5957551|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
1707281|NCT01185340|5957552|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
1707282|NCT01185340|5957553|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1707283|NCT01185340|5957550|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1707284|NCT01185340|5957551|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
1707285|NCT01185340|5957552|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
1707286|NCT01185340|5957553|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1707287|NCT01185340|5957550|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1707288|NCT01185340|5957551|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1707289|NCT01185340|5957552|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1707290|NCT01185340|5957553|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
1707291|NCT01185340|5957550|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1707292|NCT01185340|5957551|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1707293|NCT01185340|5957552|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1707294|NCT01185340|5957553|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
1707295|NCT01185340|5957550|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1707296|NCT01185340|5957551|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1707297|NCT01185340|5957552|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1707298|NCT01185340|5957553|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
1707299|NCT01185340|5957550|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1707300|NCT01185340|5957551|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1707301|NCT01185340|5957552|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1707302|NCT01185340|5957553|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
1707303|NCT01185340|5957550|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1707304|NCT01185340|5957551|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1707305|NCT01185340|5957552|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1707306|NCT01185340|5957553|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
1707307|NCT01185340|5957550|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1707308|NCT01185340|5957551|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1707309|NCT01185340|5957552|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1707310|NCT01185340|5957553|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
1707311|NCT01185340|5957550|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1707312|NCT01185340|5957551|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1707313|NCT01185340|5957552|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1707314|NCT01185340|5957553|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
1707315|NCT01185301|5957605|P4|Overall Study|Other Reason|2
1707316|NCT01185301|5957606|P3|Overall Study|Other Reason|2
1707317|NCT01185301|5957607|P2|Overall Study|Other Reason|2
1707318|NCT01185301|5957608|P1|Overall Study|Other Reason|3
1707319|NCT01185301|5957605|P4|Overall Study|Lost to Follow-up|1
1707320|NCT01185301|5957606|P3|Overall Study|Lost to Follow-up|0
1707321|NCT01185301|5957607|P2|Overall Study|Lost to Follow-up|0
1707322|NCT01185301|5957608|P1|Overall Study|Lost to Follow-up|2
1707323|NCT01185301|5957605|P4|Overall Study|Withdrawal by Subject|3
1707324|NCT01185301|5957606|P3|Overall Study|Withdrawal by Subject|2
1707325|NCT01185301|5957607|P2|Overall Study|Withdrawal by Subject|5
1707326|NCT01185301|5957608|P1|Overall Study|Withdrawal by Subject|7
1707327|NCT01185301|5957605|P4|Overall Study|Adverse Event|3
1707328|NCT01185301|5957606|P3|Overall Study|Adverse Event|2
1707329|NCT01185301|5957607|P2|Overall Study|Adverse Event|0
1707330|NCT01185301|5957608|P1|Overall Study|Adverse Event|3
1707331|NCT01185288|5957668|P2|Overall Study|Noncompliance|1
1707332|NCT01185288|5957669|P1|Overall Study|Noncompliance|0
1707333|NCT01185288|5957668|P2|Overall Study|Did not meet inclusion criteria|0
1707334|NCT01185288|5957669|P1|Overall Study|Did not meet inclusion criteria|1
1707335|NCT01185288|5957668|P2|Overall Study|Investigator discretion|0
1707336|NCT01185288|5957669|P1|Overall Study|Investigator discretion|1
1707337|NCT01185288|5957668|P2|Overall Study|Lack of Efficacy|0
1707338|NCT01185288|5957669|P1|Overall Study|Lack of Efficacy|2
1707339|NCT01185288|5957668|P2|Overall Study|Lost to Follow-up|5
1707340|NCT01185288|5957669|P1|Overall Study|Lost to Follow-up|2
1707341|NCT01185288|5957668|P2|Overall Study|Withdrawal by Subject|4
1707342|NCT01185288|5957669|P1|Overall Study|Withdrawal by Subject|6
1707343|NCT01185288|5957668|P2|Overall Study|Adverse Event|6
1707344|NCT01185288|5957669|P1|Overall Study|Adverse Event|7
1707345|NCT01185249|5957687|P1|Overall Study|Patients discharged or change in status|42
1707346|NCT01185080|5957695|P3|Overall Study|Personal reasons|1
1707347|NCT01185080|5957696|P2|Overall Study|Personal reasons|0
1707348|NCT01185080|5957697|P1|Overall Study|Personal reasons|0
1707349|NCT01185080|5957695|P3|Overall Study|Adverse Event|0
1707350|NCT01185080|5957696|P2|Overall Study|Adverse Event|1
1707351|NCT01185080|5957697|P1|Overall Study|Adverse Event|1
1707352|NCT01184989|5957749|P1|Overall Study|Withdrawal by Subject|1
1707353|NCT01184989|5957749|P1|Overall Study|Adverse Event|11
1707354|NCT01184872|5957769|P2|Overall Study|Protocol deviation|0
1707355|NCT01184872|5957770|P1|Overall Study|Protocol deviation|1
1707356|NCT01184872|5957769|P2|Overall Study|Administrative problems|1
1707357|NCT01184872|5957770|P1|Overall Study|Administrative problems|1
1707358|NCT01184872|5957769|P2|Overall Study|Lost to Follow-up|1
1707359|NCT01184872|5957770|P1|Overall Study|Lost to Follow-up|0
1707360|NCT01184872|5957769|P2|Overall Study|Withdrawal by Subject|0
1707361|NCT01184872|5957770|P1|Overall Study|Withdrawal by Subject|2
1707362|NCT01184872|5957769|P2|Overall Study|Unsatisfactory therapeutic effect|2
1707363|NCT01184872|5957770|P1|Overall Study|Unsatisfactory therapeutic effect|3
1707364|NCT01184872|5957769|P2|Overall Study|Adverse Event|4
1707365|NCT01184872|5957770|P1|Overall Study|Adverse Event|3
1707366|NCT01184859|5957789|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
1707367|NCT01184859|5957790|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
1707368|NCT01184859|5957791|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
1707369|NCT01184859|5957792|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
1707370|NCT01184859|5957793|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
1707371|NCT01184859|5957789|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
1707372|NCT01184859|5957790|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1707373|NCT01184859|5957791|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1707374|NCT01184859|5957792|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1707375|NCT01184859|5957793|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
1707376|NCT01184859|5957789|P5|Period 1: Single Dose|Adverse Event|1
1707377|NCT01184859|5957790|P4|Period 1: Single Dose|Adverse Event|0
1707378|NCT01184859|5957791|P3|Period 1: Single Dose|Adverse Event|0
1707379|NCT01184859|5957792|P2|Period 1: Single Dose|Adverse Event|0
1707380|NCT01184859|5957793|P1|Period 1: Single Dose|Adverse Event|0
1707381|NCT01184859|5957789|P5|Period 1: Single Dose|Protocol Violation|0
1707382|NCT01184859|5957790|P4|Period 1: Single Dose|Protocol Violation|0
1707383|NCT01184859|5957791|P3|Period 1: Single Dose|Protocol Violation|0
1707384|NCT01184859|5957792|P2|Period 1: Single Dose|Protocol Violation|1
1707385|NCT01184859|5957793|P1|Period 1: Single Dose|Protocol Violation|0
1707386|NCT01184859|5957789|P5|Period 1: Single Dose|Insufficient urine production|0
1707387|NCT01184859|5957790|P4|Period 1: Single Dose|Insufficient urine production|0
1707388|NCT01184859|5957791|P3|Period 1: Single Dose|Insufficient urine production|0
1707389|NCT01184859|5957792|P2|Period 1: Single Dose|Insufficient urine production|1
1707390|NCT01184859|5957793|P1|Period 1: Single Dose|Insufficient urine production|0
1707391|NCT01184846|5957885|P1|Overall Study|Insufficient response|1
1707392|NCT01184846|5957885|P1|Overall Study|Adverse Event|2
1707393|NCT01184508|5957918|P2|Overall Study|Randomized, Not Treated|1
1707394|NCT01184508|5957919|P1|Overall Study|Randomized, Not Treated|0
1707395|NCT01184508|5957918|P2|Overall Study|Withdrawal by Subject|3
1707396|NCT01184508|5957919|P1|Overall Study|Withdrawal by Subject|1
1707397|NCT01184508|5957918|P2|Overall Study|Sponsor Decision|2
1707398|NCT01184508|5957919|P1|Overall Study|Sponsor Decision|5
1707399|NCT01184508|5957918|P2|Overall Study|Protocol Violation|1
1707400|NCT01184508|5957919|P1|Overall Study|Protocol Violation|3
1707401|NCT01184508|5957918|P2|Overall Study|Physician Decision|0
1707402|NCT01184508|5957919|P1|Overall Study|Physician Decision|1
1707403|NCT01184508|5957918|P2|Overall Study|Lost to Follow-up|1
1707404|NCT01184508|5957919|P1|Overall Study|Lost to Follow-up|1
1707405|NCT01184508|5957918|P2|Overall Study|Lack of Efficacy|1
1707406|NCT01184508|5957919|P1|Overall Study|Lack of Efficacy|1
1707407|NCT01184508|5957918|P2|Overall Study|Adverse Event|6
1707408|NCT01184508|5957919|P1|Overall Study|Adverse Event|4
1707409|NCT01184326|5957979|P3|Overall Study|Disease Progression|12
1707410|NCT01184326|5957980|P2|Overall Study|Disease Progression|3
1707411|NCT01184326|5957981|P1|Overall Study|Disease Progression|1
1707412|NCT01184326|5957979|P3|Overall Study|Physician Decision|0
1707413|NCT01184326|5957980|P2|Overall Study|Physician Decision|1
1707414|NCT01184326|5957981|P1|Overall Study|Physician Decision|1
1707415|NCT01184326|5957979|P3|Overall Study|Withdrawal by Subject|1
1707416|NCT01184326|5957980|P2|Overall Study|Withdrawal by Subject|0
1707417|NCT01184326|5957981|P1|Overall Study|Withdrawal by Subject|0
1707418|NCT01184326|5957979|P3|Overall Study|Death|1
1707419|NCT01184326|5957980|P2|Overall Study|Death|0
1707420|NCT01184326|5957981|P1|Overall Study|Death|0
1707421|NCT01184326|5957979|P3|Overall Study|Adverse Event|0
1707422|NCT01184326|5957980|P2|Overall Study|Adverse Event|2
1707423|NCT01184326|5957981|P1|Overall Study|Adverse Event|1
1707424|NCT01184118|5957995|P1|Overall Study|Withdrawal by Subject|5
1707425|NCT01184118|5957995|P1|Overall Study|Exclusionary medical condition|2
1707426|NCT01184118|5957995|P1|Overall Study|FEV1 <60% predicted|2
1707427|NCT01184118|5957995|P1|Overall Study|No physiologic confirmation of asthma|8
1707428|NCT01184118|5957995|P1|Overall Study|Only asthma step 1 - screen fail|1
1707429|NCT01184079|5958003|P2|Overall Study|Lost to Follow-up|2
1707430|NCT01184079|5958004|P1|Overall Study|Lost to Follow-up|14
1707431|NCT01184053|5958014|P1|Overall Study|progression while on treatment|3
1707432|NCT01183975|5958030|P1|Overall Study|Lost to Follow-up|73
1707433|NCT01183884|5958047|P1|Overall Study|Other|4
1707434|NCT01183884|5958047|P1|Overall Study|Not Treated|1
1707435|NCT01183884|5958047|P1|Overall Study|Other Complicating Disease|3
1707436|NCT01183884|5958047|P1|Overall Study|Withdrawal by Subject|1
1707437|NCT01183884|5958047|P1|Overall Study|Adverse Event|3
1707438|NCT01183884|5958047|P1|Overall Study|Progressive Disease|26
1707439|NCT01183858|5958055|P2|Overall Study|Lost to Follow-up|1
1707440|NCT01183858|5958056|P1|Overall Study|Lost to Follow-up|1
1707441|NCT01183858|5958055|P2|Overall Study|Death related to Progressive Disease|5
1707442|NCT01183858|5958056|P1|Overall Study|Death related to Progressive Disease|4
1707443|NCT01183858|5958055|P2|Overall Study|Progressive Disease|115
1707444|NCT01183858|5958056|P1|Overall Study|Progressive Disease|112
1707445|NCT01183858|5958055|P2|Overall Study|Administrative/Other|6
1707446|NCT01183858|5958056|P1|Overall Study|Administrative/Other|6
1707447|NCT01183858|5958055|P2|Overall Study|Protocol Violation|0
1707448|NCT01183858|5958056|P1|Overall Study|Protocol Violation|1
1707449|NCT01183858|5958055|P2|Overall Study|Discontinued Smoking|1
1707450|NCT01183858|5958056|P1|Overall Study|Discontinued Smoking|3
1707451|NCT01183858|5958055|P2|Overall Study|Withdrew Consent|4
1707452|NCT01183858|5958056|P1|Overall Study|Withdrew Consent|4
1707453|NCT01183858|5958055|P2|Overall Study|Refused Treatment|4
1707454|NCT01183858|5958056|P1|Overall Study|Refused Treatment|1
1707455|NCT01183858|5958055|P2|Overall Study|Insufficient Therapeutic Response|0
1707456|NCT01183858|5958056|P1|Overall Study|Insufficient Therapeutic Response|2
1707457|NCT01183858|5958055|P2|Overall Study|Investigator's Decision|3
1707458|NCT01183858|5958056|P1|Overall Study|Investigator's Decision|0
1707459|NCT01183858|5958055|P2|Overall Study|Adverse Event|11
1707460|NCT01183858|5958056|P1|Overall Study|Adverse Event|14
1707461|NCT01183858|5958055|P2|Overall Study|Death not related to Progressive Disease|6
1707462|NCT01183858|5958056|P1|Overall Study|Death not related to Progressive Disease|5
1707463|NCT01183780|5958078|P2|Overall Study|Lost to Follow-up|11
1707464|NCT01183780|5958079|P1|Overall Study|Lost to Follow-up|6
1707465|NCT01183780|5958078|P2|Overall Study|Withdrawal by Subject|14
1707466|NCT01183780|5958079|P1|Overall Study|Withdrawal by Subject|25
1707467|NCT01183468|5958212|P4|Overall Study|Withdrawal by Subject|0
1707468|NCT01183468|5958213|P3|Overall Study|Withdrawal by Subject|0
1707469|NCT01183468|5958214|P2|Overall Study|Withdrawal by Subject|1
1707470|NCT01183468|5958215|P1|Overall Study|Withdrawal by Subject|0
1707471|NCT01183468|5958212|P4|Overall Study|Physician Decision|0
1707472|NCT01183468|5958213|P3|Overall Study|Physician Decision|0
1707473|NCT01183468|5958214|P2|Overall Study|Physician Decision|0
1707474|NCT01183468|5958215|P1|Overall Study|Physician Decision|1
1707475|NCT01183468|5958212|P4|Overall Study|Lost to Follow-up|0
1707476|NCT01183468|5958213|P3|Overall Study|Lost to Follow-up|0
1707477|NCT01183468|5958214|P2|Overall Study|Lost to Follow-up|1
1707478|NCT01183468|5958215|P1|Overall Study|Lost to Follow-up|2
1707479|NCT01183390|5958237|P2|First Intervention|Adverse Event|1
1707480|NCT01183390|5958238|P1|First Intervention|Adverse Event|0
1707481|NCT01183260|5958271|P2|Overall Study|Death|0
1707482|NCT01183260|5958272|P1|Overall Study|Death|1
1707483|NCT01183260|5958271|P2|Overall Study|Revised within 30 days|1
1707484|NCT01183260|5958272|P1|Overall Study|Revised within 30 days|0
1707485|NCT01183260|5958271|P2|Overall Study|Withdrawal by Subject|1
1707486|NCT01183260|5958272|P1|Overall Study|Withdrawal by Subject|1
1707487|NCT01183260|5958271|P2|Overall Study|Intraop screen failure|0
1707488|NCT01183260|5958272|P1|Overall Study|Intraop screen failure|2
1707489|NCT01183234|5958282|P2|First Intervention|Adverse Event|0
1707490|NCT01183234|5958283|P1|First Intervention|Adverse Event|1
1707491|NCT01183143|5958375|P1|Overall Study|Subjects enrolled, but not treated|11
1707492|NCT01183143|5958375|P1|Overall Study|Subject Questionnaires not returned|5
1707493|NCT01183143|5958375|P1|Overall Study|Withdrawal by Subject|19
1707494|NCT01183143|5958375|P1|Overall Study|Protocol Violation|115
1707495|NCT01183104|5958391|P2|Overall Study|Did not receive study drug|9
1707496|NCT01183104|5958392|P1|Overall Study|Did not receive study drug|5
1707497|NCT01183104|5958391|P2|Overall Study|Nonparticipation in Extension Study|50
1707498|NCT01183104|5958392|P1|Overall Study|Nonparticipation in Extension Study|39
1707499|NCT01183104|5958391|P2|Overall Study|Withdrawal by Subject|11
1707500|NCT01183104|5958392|P1|Overall Study|Withdrawal by Subject|6
1707501|NCT01183104|5958391|P2|Overall Study|Physician Decision|8
1707502|NCT01183104|5958392|P1|Overall Study|Physician Decision|5
1707503|NCT01183104|5958391|P2|Overall Study|Lost to Follow-up|7
1707504|NCT01183104|5958392|P1|Overall Study|Lost to Follow-up|14
1707505|NCT01183104|5958391|P2|Overall Study|Death|1
1707506|NCT01183104|5958392|P1|Overall Study|Death|0
1707507|NCT01183104|5958391|P2|Overall Study|Adverse Event|6
1707508|NCT01183104|5958392|P1|Overall Study|Adverse Event|8
1707509|NCT01183065|5958408|P1|Overall Study|Patient no longer fits eligibility crite|1
1707510|NCT01183013|5958419|P7|Overall Study|Reasons other than stated above|13
1707511|NCT01183013|5958420|P6|Overall Study|Reasons other than stated above|15
1707512|NCT01183013|5958421|P5|Overall Study|Reasons other than stated above|12
1707513|NCT01183013|5958422|P4|Overall Study|Reasons other than stated above|12
1707514|NCT01183013|5958423|P3|Overall Study|Reasons other than stated above|17
1707515|NCT01183013|5958424|P2|Overall Study|Reasons other than stated above|11
1707516|NCT01183013|5958425|P1|Overall Study|Reasons other than stated above|15
1707517|NCT01183013|5958419|P7|Overall Study|Withdrawal by Subject|10
1707518|NCT01183013|5958420|P6|Overall Study|Withdrawal by Subject|9
1707519|NCT01183013|5958421|P5|Overall Study|Withdrawal by Subject|7
1707520|NCT01183013|5958422|P4|Overall Study|Withdrawal by Subject|8
1707521|NCT01183013|5958423|P3|Overall Study|Withdrawal by Subject|10
1707522|NCT01183013|5958424|P2|Overall Study|Withdrawal by Subject|13
1707523|NCT01183013|5958425|P1|Overall Study|Withdrawal by Subject|9
1707524|NCT01183013|5958419|P7|Overall Study|Lost to Follow-up|5
1707525|NCT01183013|5958420|P6|Overall Study|Lost to Follow-up|6
1707526|NCT01183013|5958421|P5|Overall Study|Lost to Follow-up|2
1707527|NCT01183013|5958422|P4|Overall Study|Lost to Follow-up|3
1707528|NCT01183013|5958423|P3|Overall Study|Lost to Follow-up|4
1707529|NCT01183013|5958424|P2|Overall Study|Lost to Follow-up|3
1707530|NCT01183013|5958425|P1|Overall Study|Lost to Follow-up|7
1707531|NCT01183013|5958419|P7|Overall Study|Protocol Violation|3
1707532|NCT01183013|5958420|P6|Overall Study|Protocol Violation|3
1707533|NCT01183013|5958421|P5|Overall Study|Protocol Violation|4
1707534|NCT01183013|5958422|P4|Overall Study|Protocol Violation|0
1707535|NCT01183013|5958423|P3|Overall Study|Protocol Violation|4
1707536|NCT01183013|5958424|P2|Overall Study|Protocol Violation|2
1707537|NCT01183013|5958425|P1|Overall Study|Protocol Violation|5
1707538|NCT01183013|5958419|P7|Overall Study|Lack of Efficacy|0
1707539|NCT01183013|5958420|P6|Overall Study|Lack of Efficacy|2
1707540|NCT01183013|5958421|P5|Overall Study|Lack of Efficacy|1
1707541|NCT01183013|5958422|P4|Overall Study|Lack of Efficacy|2
1707542|NCT01183013|5958423|P3|Overall Study|Lack of Efficacy|1
1707543|NCT01183013|5958424|P2|Overall Study|Lack of Efficacy|2
1707544|NCT01183013|5958425|P1|Overall Study|Lack of Efficacy|3
1707545|NCT01183013|5958419|P7|Overall Study|Adverse Event|6
1707546|NCT01183013|5958420|P6|Overall Study|Adverse Event|10
1707547|NCT01183013|5958421|P5|Overall Study|Adverse Event|10
1707548|NCT01183013|5958422|P4|Overall Study|Adverse Event|5
1707549|NCT01183013|5958423|P3|Overall Study|Adverse Event|5
1707550|NCT01183013|5958424|P2|Overall Study|Adverse Event|8
1707551|NCT01183013|5958425|P1|Overall Study|Adverse Event|6
1707552|NCT01182441|5958571|P2|Overall Study|Physician Decision|1
1707553|NCT01182441|5958572|P1|Overall Study|Physician Decision|1
1707554|NCT01182441|5958571|P2|Overall Study|Adverse Event|0
1707555|NCT01182441|5958572|P1|Overall Study|Adverse Event|2
1707556|NCT01182441|5958571|P2|Overall Study|Implant Not Attempted|0
1707557|NCT01182441|5958572|P1|Overall Study|Implant Not Attempted|4
1707558|NCT01182441|5958571|P2|Overall Study|Withdrawal by Subject|13
1707559|NCT01182441|5958572|P1|Overall Study|Withdrawal by Subject|6
1707560|NCT01182441|5958571|P2|Overall Study|Lost to Follow-up|8
1707561|NCT01182441|5958572|P1|Overall Study|Lost to Follow-up|5
1707562|NCT01182441|5958571|P2|Overall Study|Implant Attempt Unsuccessful|0
1707563|NCT01182441|5958572|P1|Overall Study|Implant Attempt Unsuccessful|13
1707564|NCT01182441|5958571|P2|Overall Study|Death|25
1707565|NCT01182441|5958572|P1|Overall Study|Death|37
1707566|NCT01182441|5958571|P2|Overall Study|Patient Still in Follow-up|72
1707567|NCT01182441|5958572|P1|Overall Study|Patient Still in Follow-up|152
1707568|NCT01182428|5958583|P2|Overall Study|Withdrawal by Subject|0
1707569|NCT01182428|5958584|P1|Overall Study|Withdrawal by Subject|1
1707570|NCT01182428|5958583|P2|Overall Study|Lost to Follow-up|1
1707571|NCT01182428|5958584|P1|Overall Study|Lost to Follow-up|9
1707572|NCT01182428|5958583|P2|Overall Study|Physician Decision|0
1707573|NCT01182428|5958584|P1|Overall Study|Physician Decision|1
1707574|NCT01182415|5958648|P1|Overall Study|Lost to Follow-up|1
1707575|NCT01182350|5958664|P5|Overall Study|Unevaluable for Biopsy|3
1707576|NCT01182350|5958665|P4|Overall Study|Unevaluable for Biopsy|0
1707577|NCT01182350|5958666|P3|Overall Study|Unevaluable for Biopsy|0
1707578|NCT01182350|5958667|P2|Overall Study|Unevaluable for Biopsy|0
1707579|NCT01182350|5958668|P1|Overall Study|Unevaluable for Biopsy|0
1707580|NCT01182350|5958664|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
1707581|NCT01182350|5958665|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
1707582|NCT01182350|5958666|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
1707583|NCT01182350|5958667|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
1707584|NCT01182350|5958668|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
1707585|NCT01182350|5958664|P5|Overall Study|Alternative Therapy|0
1707586|NCT01182350|5958665|P4|Overall Study|Alternative Therapy|0
1707587|NCT01182350|5958666|P3|Overall Study|Alternative Therapy|1
1707588|NCT01182350|5958667|P2|Overall Study|Alternative Therapy|0
1707589|NCT01182350|5958668|P1|Overall Study|Alternative Therapy|2
1707590|NCT01182350|5958664|P5|Overall Study|Withdrawal by Subject|0
1707591|NCT01182350|5958665|P4|Overall Study|Withdrawal by Subject|1
1707592|NCT01182350|5958666|P3|Overall Study|Withdrawal by Subject|0
1707593|NCT01182350|5958667|P2|Overall Study|Withdrawal by Subject|1
1707594|NCT01182350|5958668|P1|Overall Study|Withdrawal by Subject|3
1707595|NCT01182350|5958664|P5|Overall Study|Death|0
1707596|NCT01182350|5958665|P4|Overall Study|Death|0
1707597|NCT01182350|5958666|P3|Overall Study|Death|1
1707598|NCT01182350|5958667|P2|Overall Study|Death|1
1707599|NCT01182350|5958668|P1|Overall Study|Death|0
1707600|NCT01182350|5958664|P5|Overall Study|Disease Progression|0
1707601|NCT01182350|5958665|P4|Overall Study|Disease Progression|1
1707602|NCT01182350|5958666|P3|Overall Study|Disease Progression|0
1707603|NCT01182350|5958667|P2|Overall Study|Disease Progression|12
1707604|NCT01182350|5958668|P1|Overall Study|Disease Progression|15
1707605|NCT01182350|5958664|P5|Overall Study|Adverse Event|0
1707606|NCT01182350|5958665|P4|Overall Study|Adverse Event|0
1707607|NCT01182350|5958666|P3|Overall Study|Adverse Event|0
1707608|NCT01182350|5958667|P2|Overall Study|Adverse Event|0
1707609|NCT01182350|5958668|P1|Overall Study|Adverse Event|5
1707610|NCT01182337|5958690|P2|Overall Study|Lost to Follow-up|1
1707611|NCT01182337|5958691|P1|Overall Study|Lost to Follow-up|0
1707612|NCT01182337|5958690|P2|Overall Study|Withdrawal by Subject|1
1707613|NCT01182337|5958691|P1|Overall Study|Withdrawal by Subject|3
1707614|NCT01182298|5958709|P1|Overall Study|Withdrawal by Subject|2
1707615|NCT01182298|5958709|P1|Overall Study|Lack of Efficacy|4
1707616|NCT01182285|5958713|P3|Third Intervention Week 11-52|Other|2
1707617|NCT01182285|5958714|P2|Third Intervention Week 11-52|Other|0
1707618|NCT01182285|5958715|P1|Third Intervention Week 11-52|Other|0
1707619|NCT01182285|5958713|P3|Third Intervention Week 11-52|Disease Progression|6
1707620|NCT01182285|5958714|P2|Third Intervention Week 11-52|Disease Progression|0
1707621|NCT01182285|5958715|P1|Third Intervention Week 11-52|Disease Progression|0
1707622|NCT01182285|5958713|P3|First Intervention Week 1-10|Non-compliance|0
1707623|NCT01182285|5958714|P2|First Intervention Week 1-10|Non-compliance|0
1707624|NCT01182285|5958715|P1|First Intervention Week 1-10|Non-compliance|1
1707625|NCT01182285|5958713|P3|First Intervention Week 1-10|Adverse Event|0
1707626|NCT01182285|5958714|P2|First Intervention Week 1-10|Adverse Event|0
1707627|NCT01182285|5958715|P1|First Intervention Week 1-10|Adverse Event|1
1707628|NCT01182285|5958713|P3|First Intervention Week 1-10|Disease progression|0
1707629|NCT01182285|5958714|P2|First Intervention Week 1-10|Disease progression|0
1707630|NCT01182285|5958715|P1|First Intervention Week 1-10|Disease progression|1
1707631|NCT01182207|5958725|P2|Second Intervention|Emeses within 1 hour of dosing|0
1707632|NCT01182207|5958726|P1|Second Intervention|Emeses within 1 hour of dosing|1
1707633|NCT01182207|5958725|P2|First Intervention|Positive Hepatitis Results|1
1707634|NCT01182207|5958726|P1|First Intervention|Positive Hepatitis Results|0
1707635|NCT01182194|5958744|P2|Washout of 28 Days|Withdrawal by Subject|0
1707636|NCT01182194|5958745|P1|Washout of 28 Days|Withdrawal by Subject|1
1707637|NCT01182181|5958763|P2|Washout of 21 Days|Withdrawal by Subject|1
1707638|NCT01182181|5958764|P1|Washout of 21 Days|Withdrawal by Subject|0
1707639|NCT01182181|5958763|P2|First Intervention|Adverse Event|0
1707640|NCT01182181|5958764|P1|First Intervention|Adverse Event|1
1707641|NCT01181986|5958789|P3|Phase 2|Medical condition|0
1707642|NCT01181986|5958790|P2|Phase 2|Medical condition|1
1707643|NCT01181986|5958791|P1|Phase 2|Medical condition|0
1707644|NCT01181986|5958789|P3|Phase 2|Adverse Event|0
1707645|NCT01181986|5958790|P2|Phase 2|Adverse Event|3
1707646|NCT01181986|5958791|P1|Phase 2|Adverse Event|0
1707647|NCT01181986|5958789|P3|Phase 1|Protocol Violation|0
1707648|NCT01181986|5958790|P2|Phase 1|Protocol Violation|0
1707649|NCT01181986|5958791|P1|Phase 1|Protocol Violation|1
1707650|NCT01181986|5958789|P3|Phase 1|Adverse Event|1
1707651|NCT01181986|5958790|P2|Phase 1|Adverse Event|0
1707652|NCT01181986|5958791|P1|Phase 1|Adverse Event|0
1707653|NCT01181986|5958789|P3|Phase 1|Lost to Follow-up|1
1707654|NCT01181986|5958790|P2|Phase 1|Lost to Follow-up|1
1707655|NCT01181986|5958791|P1|Phase 1|Lost to Follow-up|0
1707656|NCT01181921|5958812|P1|Overall Study|Lost to Follow-up|1
1707657|NCT01181895|5958819|P3|Overall Study|Withdrawal by Subject|5
1707658|NCT01181895|5958820|P2|Overall Study|Withdrawal by Subject|0
1707659|NCT01181895|5958821|P1|Overall Study|Withdrawal by Subject|3
1707660|NCT01181895|5958819|P3|Overall Study|Investigator Discretion|1
1707661|NCT01181895|5958820|P2|Overall Study|Investigator Discretion|2
1707662|NCT01181895|5958821|P1|Overall Study|Investigator Discretion|1
1707663|NCT01181895|5958819|P3|Overall Study|Lost to Follow-up|2
1707664|NCT01181895|5958820|P2|Overall Study|Lost to Follow-up|1
1707665|NCT01181895|5958821|P1|Overall Study|Lost to Follow-up|0
1707666|NCT01181895|5958819|P3|Overall Study|Protocol Violation|0
1707667|NCT01181895|5958820|P2|Overall Study|Protocol Violation|1
1707668|NCT01181895|5958821|P1|Overall Study|Protocol Violation|2
1707669|NCT01181895|5958819|P3|Overall Study|Lack of Efficacy|9
1707670|NCT01181895|5958820|P2|Overall Study|Lack of Efficacy|9
1707671|NCT01181895|5958821|P1|Overall Study|Lack of Efficacy|8
1707672|NCT01181895|5958819|P3|Overall Study|Adverse Event|1
1707673|NCT01181895|5958820|P2|Overall Study|Adverse Event|1
1707674|NCT01181895|5958821|P1|Overall Study|Adverse Event|3
1707675|NCT01181778|5958879|P1|Overall Study|Physician Decision|48
1707676|NCT01181726|5958887|P2|First Intervention|Adverse Event|0
1707677|NCT01181726|5958888|P1|First Intervention|Adverse Event|1
1707678|NCT01181609|5958934|P1|Overall Study|Death|50
1707679|NCT01181609|5958934|P1|Overall Study|Lost to Follow-up|1
1707680|NCT01181609|5958934|P1|Overall Study|Withdrawal by Subject|1
1707681|NCT01181609|5958934|P1|Overall Study|Adverse Event|1
1707682|NCT01181531|5958952|P2|Overall Study|Adverse Event|1
1707683|NCT01181531|5958953|P1|Overall Study|Adverse Event|0
1707684|NCT01181531|5958952|P2|Overall Study|Death|12
1707685|NCT01181531|5958953|P1|Overall Study|Death|9
1707686|NCT01181531|5958952|P2|Overall Study|Protocol Violation|6
1707687|NCT01181531|5958953|P1|Overall Study|Protocol Violation|6
1707688|NCT01181531|5958952|P2|Overall Study|Withdrawal by Subject|7
1707689|NCT01181531|5958953|P1|Overall Study|Withdrawal by Subject|8
1707690|NCT01181531|5958952|P2|Overall Study|Pregnancy|1
1707691|NCT01181531|5958953|P1|Overall Study|Pregnancy|0
1707692|NCT01181531|5958952|P2|Overall Study|Protocol Specified Criteria|8
1707693|NCT01181531|5958953|P1|Overall Study|Protocol Specified Criteria|15
1707694|NCT01181531|5958952|P2|Overall Study|Ineligibility determined|2
1707695|NCT01181531|5958953|P1|Overall Study|Ineligibility determined|1
1707696|NCT01181531|5958952|P2|Overall Study|Noncompliance|2
1707697|NCT01181531|5958953|P1|Overall Study|Noncompliance|2
1707698|NCT01181531|5958952|P2|Overall Study|Physician Decision|1
1707699|NCT01181531|5958953|P1|Overall Study|Physician Decision|3
1707700|NCT01181531|5958952|P2|Overall Study|Partial consent by subject withdrawn|1
1707701|NCT01181531|5958953|P1|Overall Study|Partial consent by subject withdrawn|0
1707702|NCT01181531|5958952|P2|Overall Study|Other|12
1707703|NCT01181531|5958953|P1|Overall Study|Other|17
1707704|NCT01181271|5959095|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
1707705|NCT01181271|5959095|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
1707706|NCT01181271|5959095|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
1707707|NCT01181271|5959095|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
1707708|NCT01181167|5959119|P2|Overall Study|Withdrawal by Subject|8
1707709|NCT01181167|5959120|P1|Overall Study|Withdrawal by Subject|6
1707710|NCT01181167|5959119|P2|Overall Study|Protocol Violation|0
1707711|NCT01181167|5959120|P1|Overall Study|Protocol Violation|3
1707712|NCT01181167|5959119|P2|Overall Study|Physician Decision|3
1707713|NCT01181167|5959120|P1|Overall Study|Physician Decision|2
1707714|NCT01181167|5959119|P2|Overall Study|Lost to Follow-up|0
1707715|NCT01181167|5959120|P1|Overall Study|Lost to Follow-up|1
1707716|NCT01181167|5959119|P2|Overall Study|Adverse Event|21
1707717|NCT01181167|5959120|P1|Overall Study|Adverse Event|11
1707718|NCT01181141|5959130|P2|Overall Study|Withdrawal by Subject|1
1707719|NCT01181141|5959131|P1|Overall Study|Withdrawal by Subject|3
1707720|NCT01181141|5959130|P2|Overall Study|Protocol Violation|1
1707721|NCT01181141|5959131|P1|Overall Study|Protocol Violation|3
1707722|NCT01181141|5959130|P2|Overall Study|Physician Decision|0
1707723|NCT01181141|5959131|P1|Overall Study|Physician Decision|2
1707724|NCT01181141|5959130|P2|Overall Study|Lost to Follow-up|1
1707725|NCT01181141|5959131|P1|Overall Study|Lost to Follow-up|1
1707726|NCT01181141|5959130|P2|Overall Study|Lack of Efficacy|0
1707727|NCT01181141|5959131|P1|Overall Study|Lack of Efficacy|1
1707728|NCT01181141|5959130|P2|Overall Study|Adverse Event|1
1707729|NCT01181141|5959131|P1|Overall Study|Adverse Event|2
1707730|NCT01181128|5959140|P3|Overall Study|Other|1
1707731|NCT01181128|5959141|P2|Overall Study|Other|1
1707732|NCT01181128|5959142|P1|Overall Study|Other|1
1707733|NCT01181128|5959140|P3|Overall Study|Adverse Event|0
1707734|NCT01181128|5959141|P2|Overall Study|Adverse Event|2
1707735|NCT01181128|5959142|P1|Overall Study|Adverse Event|0
1707736|NCT01181128|5959140|P3|Overall Study|Physician Decision|0
1707737|NCT01181128|5959141|P2|Overall Study|Physician Decision|0
1707738|NCT01181128|5959142|P1|Overall Study|Physician Decision|2
1707739|NCT01181128|5959140|P3|Overall Study|Death|0
1707740|NCT01181128|5959141|P2|Overall Study|Death|0
1707741|NCT01181128|5959142|P1|Overall Study|Death|1
1707742|NCT01181128|5959140|P3|Overall Study|Withdrawal by Subject|0
1707743|NCT01181128|5959141|P2|Overall Study|Withdrawal by Subject|2
1707744|NCT01181128|5959142|P1|Overall Study|Withdrawal by Subject|2
1707745|NCT01181102|5959230|P2|Overall Study|Withdrawal by Subject|12
1707746|NCT01181102|5959231|P1|Overall Study|Withdrawal by Subject|10
1707747|NCT01181102|5959230|P2|Overall Study|Protocol Violation|6
1707748|NCT01181102|5959231|P1|Overall Study|Protocol Violation|5
1707749|NCT01181102|5959230|P2|Overall Study|Physician Decision|1
1707750|NCT01181102|5959231|P1|Overall Study|Physician Decision|3
1707751|NCT01181102|5959230|P2|Overall Study|Lost to Follow-up|0
1707752|NCT01181102|5959231|P1|Overall Study|Lost to Follow-up|2
1707753|NCT01181102|5959230|P2|Overall Study|Lack of Efficacy|1
1707754|NCT01181102|5959231|P1|Overall Study|Lack of Efficacy|3
1707755|NCT01181102|5959230|P2|Overall Study|Adverse Event|26
1707756|NCT01181102|5959231|P1|Overall Study|Adverse Event|28
1707757|NCT01181011|5959275|P1|Overall Study|Lost to Follow-up|1
1707758|NCT01181011|5959275|P1|Overall Study|Adverse Event|2
1707759|NCT01180998|5959325|P3|Overall Study|Poor lens handling|2
1707760|NCT01180998|5959326|P2|Overall Study|Poor lens handling|0
1707761|NCT01180998|5959327|P1|Overall Study|Poor lens handling|0
1707762|NCT01180998|5959325|P3|Overall Study|Poor comfort|4
1707763|NCT01180998|5959326|P2|Overall Study|Poor comfort|0
1707764|NCT01180998|5959327|P1|Overall Study|Poor comfort|3
1707765|NCT01180998|5959325|P3|Overall Study|Withdrawal by Subject|1
1707766|NCT01180998|5959326|P2|Overall Study|Withdrawal by Subject|0
1707767|NCT01180998|5959327|P1|Overall Study|Withdrawal by Subject|0
1707768|NCT01180998|5959325|P3|Overall Study|Protocol Violation|0
1707769|NCT01180998|5959326|P2|Overall Study|Protocol Violation|2
1707770|NCT01180998|5959327|P1|Overall Study|Protocol Violation|1
1707771|NCT01180998|5959325|P3|Overall Study|Lost to Follow-up|1
1707772|NCT01180998|5959326|P2|Overall Study|Lost to Follow-up|0
1707773|NCT01180998|5959327|P1|Overall Study|Lost to Follow-up|0
1707774|NCT01180998|5959325|P3|Overall Study|Poor Vision|2
1707775|NCT01180998|5959326|P2|Overall Study|Poor Vision|2
1707776|NCT01180998|5959327|P1|Overall Study|Poor Vision|0
1707777|NCT01180985|5959341|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
1707778|NCT01180985|5959342|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
1707779|NCT01180790|5959381|P7|Overall Study|Severe coronary atherosclerosis (death)|0
1707780|NCT01180790|5959382|P6|Overall Study|Severe coronary atherosclerosis (death)|0
1707781|NCT01180790|5959383|P5|Overall Study|Severe coronary atherosclerosis (death)|0
1707782|NCT01180790|5959384|P4|Overall Study|Severe coronary atherosclerosis (death)|0
1707783|NCT01180790|5959385|P3|Overall Study|Severe coronary atherosclerosis (death)|1
1707784|NCT01180790|5959386|P2|Overall Study|Severe coronary atherosclerosis (death)|0
1707785|NCT01180790|5959387|P1|Overall Study|Severe coronary atherosclerosis (death)|0
1707786|NCT01180790|5959381|P7|Overall Study|compliance|0
1707787|NCT01180790|5959382|P6|Overall Study|compliance|0
1707788|NCT01180790|5959383|P5|Overall Study|compliance|0
1707789|NCT01180790|5959384|P4|Overall Study|compliance|0
1707790|NCT01180790|5959385|P3|Overall Study|compliance|0
1707791|NCT01180790|5959386|P2|Overall Study|compliance|1
1707792|NCT01180790|5959387|P1|Overall Study|compliance|0
1707793|NCT01180790|5959381|P7|Overall Study|Lack of Efficacy|0
1707794|NCT01180790|5959382|P6|Overall Study|Lack of Efficacy|3
1707795|NCT01180790|5959383|P5|Overall Study|Lack of Efficacy|1
1707796|NCT01180790|5959384|P4|Overall Study|Lack of Efficacy|6
1707797|NCT01180790|5959385|P3|Overall Study|Lack of Efficacy|5
1707798|NCT01180790|5959386|P2|Overall Study|Lack of Efficacy|2
1707799|NCT01180790|5959387|P1|Overall Study|Lack of Efficacy|1
1707800|NCT01180790|5959381|P7|Overall Study|Physician Decision|0
1707801|NCT01180790|5959382|P6|Overall Study|Physician Decision|0
1707802|NCT01180790|5959383|P5|Overall Study|Physician Decision|0
1707803|NCT01180790|5959384|P4|Overall Study|Physician Decision|1
1707804|NCT01180790|5959385|P3|Overall Study|Physician Decision|0
1707805|NCT01180790|5959386|P2|Overall Study|Physician Decision|0
1707806|NCT01180790|5959387|P1|Overall Study|Physician Decision|1
1707807|NCT01180790|5959381|P7|Overall Study|Lost to Follow-up|1
1707808|NCT01180790|5959382|P6|Overall Study|Lost to Follow-up|0
1707809|NCT01180790|5959383|P5|Overall Study|Lost to Follow-up|1
1707810|NCT01180790|5959384|P4|Overall Study|Lost to Follow-up|2
1707811|NCT01180790|5959385|P3|Overall Study|Lost to Follow-up|0
1707812|NCT01180790|5959386|P2|Overall Study|Lost to Follow-up|1
1707813|NCT01180790|5959387|P1|Overall Study|Lost to Follow-up|3
1707814|NCT01180790|5959381|P7|Overall Study|Withdrawal by Subject|0
1707815|NCT01180790|5959382|P6|Overall Study|Withdrawal by Subject|1
1707816|NCT01180790|5959383|P5|Overall Study|Withdrawal by Subject|2
1707817|NCT01180790|5959384|P4|Overall Study|Withdrawal by Subject|0
1707818|NCT01180790|5959385|P3|Overall Study|Withdrawal by Subject|5
1707819|NCT01180790|5959386|P2|Overall Study|Withdrawal by Subject|0
1707820|NCT01180790|5959387|P1|Overall Study|Withdrawal by Subject|3
1707821|NCT01180790|5959381|P7|Overall Study|Adverse Event|0
1707822|NCT01180790|5959382|P6|Overall Study|Adverse Event|3
1707823|NCT01180790|5959383|P5|Overall Study|Adverse Event|1
1707824|NCT01180790|5959384|P4|Overall Study|Adverse Event|0
1707825|NCT01180790|5959385|P3|Overall Study|Adverse Event|2
1707826|NCT01180790|5959386|P2|Overall Study|Adverse Event|1
1707827|NCT01180790|5959387|P1|Overall Study|Adverse Event|1
1707828|NCT01180777|5959452|P1|Overall Study|Adverse Event|1
1707829|NCT01180777|5959452|P1|Overall Study|Lost to Follow-up|1
1707830|NCT01180777|5959452|P1|Overall Study|Poor lens fit|4
1707831|NCT01180777|5959452|P1|Overall Study|Protocol Violation|6
1707832|NCT01180660|5959466|P2|Overall Study|Changed to open surgery|0
1707833|NCT01180660|5959467|P1|Overall Study|Changed to open surgery|1
1707834|NCT01180647|5959477|P2|Overall Study|Lost to Follow-up|6
1707835|NCT01180647|5959478|P1|Overall Study|Lost to Follow-up|5
1707836|NCT01180400|5959513|P2|Overall Study|Other|1
1707837|NCT01180400|5959514|P1|Overall Study|Other|0
1707838|NCT01180400|5959513|P2|Overall Study|Lost to Follow-up|3
1707839|NCT01180400|5959514|P1|Overall Study|Lost to Follow-up|2
1707840|NCT01180400|5959513|P2|Overall Study|Study-specific withdrawal criteria|2
1707841|NCT01180400|5959514|P1|Overall Study|Study-specific withdrawal criteria|1
1707842|NCT01180400|5959513|P2|Overall Study|Lack of Efficacy|0
1707843|NCT01180400|5959514|P1|Overall Study|Lack of Efficacy|2
1707844|NCT01180400|5959513|P2|Overall Study|Condition under investigation worsened|1
1707845|NCT01180400|5959514|P1|Overall Study|Condition under investigation worsened|2
1707846|NCT01180400|5959513|P2|Overall Study|Severe non-compliance to protocol|2
1707847|NCT01180400|5959514|P1|Overall Study|Severe non-compliance to protocol|1
1707848|NCT01180400|5959513|P2|Overall Study|Adverse Event|10
1707849|NCT01180400|5959514|P1|Overall Study|Adverse Event|12
1707850|NCT01180400|5959513|P2|Overall Study|Eligibility criteria not fulfilled|2
1707851|NCT01180400|5959514|P1|Overall Study|Eligibility criteria not fulfilled|0
1707852|NCT01180400|5959513|P2|Overall Study|Withdrawal by Subject|6
1707853|NCT01180400|5959514|P1|Overall Study|Withdrawal by Subject|5
1707854|NCT01180296|5959562|P2|Overall Study|Protocol Violation|2
1707855|NCT01180296|5959563|P1|Overall Study|Protocol Violation|1
1707856|NCT01180244|5959573|P2|Overall Study|Lost to Follow-up|0
1707857|NCT01180244|5959574|P1|Overall Study|Lost to Follow-up|1
1707858|NCT01180244|5959573|P2|Overall Study|Protocol Violation|0
1707859|NCT01180244|5959574|P1|Overall Study|Protocol Violation|1
1707860|NCT01180244|5959573|P2|Overall Study|Withdrawal by Subject|1
1707861|NCT01180244|5959574|P1|Overall Study|Withdrawal by Subject|0
1707862|NCT01180244|5959573|P2|Overall Study|Adverse Event|0
1707863|NCT01180244|5959574|P1|Overall Study|Adverse Event|1
1707864|NCT01180244|5959573|P2|Overall Study|Physician Decision|0
1707865|NCT01180244|5959574|P1|Overall Study|Physician Decision|3
1707866|NCT01180244|5959573|P2|Overall Study|Lack of Efficacy|7
1707867|NCT01180244|5959574|P1|Overall Study|Lack of Efficacy|0
1707868|NCT01180049|5959619|P2|Overall Study|Death|35
1707869|NCT01180049|5959620|P1|Overall Study|Death|36
1707870|NCT01180049|5959619|P2|Overall Study|Lost to Follow-up|6
1707871|NCT01180049|5959620|P1|Overall Study|Lost to Follow-up|8
1707872|NCT01180049|5959619|P2|Overall Study|Other|7
1707873|NCT01180049|5959620|P1|Overall Study|Other|9
1707874|NCT01179919|5959657|P1|Overall Study|Adverse Event|1
1707875|NCT01179919|5959657|P1|Overall Study|Protocol Violation|1
1707876|NCT01179737|5959666|P4|Extension|The study was terminated|0
1707877|NCT01179737|5959667|P3|Extension|The study was terminated|0
1707878|NCT01179737|5959668|P2|Extension|The study was terminated|0
1707879|NCT01179737|5959669|P1|Extension|The study was terminated|3
1707880|NCT01179737|5959666|P4|Cohort 1 & Cohort 2 Expansion|Death|0
1707881|NCT01179737|5959667|P3|Cohort 1 & Cohort 2 Expansion|Death|0
1707882|NCT01179737|5959668|P2|Cohort 1 & Cohort 2 Expansion|Death|0
1707883|NCT01179737|5959669|P1|Cohort 1 & Cohort 2 Expansion|Death|1
1707884|NCT01179737|5959666|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1707885|NCT01179737|5959667|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1707886|NCT01179737|5959668|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
1707887|NCT01179737|5959669|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
1707888|NCT01179737|5959666|P4|Cohort 1 & Cohort 2|Death|0
1707889|NCT01179737|5959667|P3|Cohort 1 & Cohort 2|Death|1
1707890|NCT01179737|5959668|P2|Cohort 1 & Cohort 2|Death|0
1707891|NCT01179737|5959669|P1|Cohort 1 & Cohort 2|Death|0
1707892|NCT01179737|5959666|P4|Cohort 1 & Cohort 2|Administrative problems|4
1707893|NCT01179737|5959667|P3|Cohort 1 & Cohort 2|Administrative problems|2
1707894|NCT01179737|5959668|P2|Cohort 1 & Cohort 2|Administrative problems|0
1707895|NCT01179737|5959669|P1|Cohort 1 & Cohort 2|Administrative problems|0
1707896|NCT01179737|5959666|P4|Cohort 1 & Cohort 2|Withdrew consent|0
1707897|NCT01179737|5959667|P3|Cohort 1 & Cohort 2|Withdrew consent|0
1707898|NCT01179737|5959668|P2|Cohort 1 & Cohort 2|Withdrew consent|0
1707899|NCT01179737|5959669|P1|Cohort 1 & Cohort 2|Withdrew consent|2
1707900|NCT01179737|5959666|P4|Cohort 1 & Cohort 2|Adverse Event|0
1707901|NCT01179737|5959667|P3|Cohort 1 & Cohort 2|Adverse Event|1
1707902|NCT01179737|5959668|P2|Cohort 1 & Cohort 2|Adverse Event|1
1707903|NCT01179737|5959669|P1|Cohort 1 & Cohort 2|Adverse Event|3
1707904|NCT01179672|5959680|P2|Overall Study|Physician Decision|1
1707905|NCT01179672|5959681|P1|Overall Study|Physician Decision|1
1707906|NCT01179672|5959680|P2|Overall Study|Protocol Violation|2
1707907|NCT01179672|5959681|P1|Overall Study|Protocol Violation|2
1707908|NCT01179672|5959680|P2|Overall Study|Lost to Follow-up|1
1707909|NCT01179672|5959681|P1|Overall Study|Lost to Follow-up|0
1707910|NCT01179672|5959680|P2|Overall Study|Entry Criteria Not Met|2
1707911|NCT01179672|5959681|P1|Overall Study|Entry Criteria Not Met|0
1707912|NCT01179672|5959680|P2|Overall Study|Withdrawal by Subject|12
1707913|NCT01179672|5959681|P1|Overall Study|Withdrawal by Subject|10
1707914|NCT01179672|5959680|P2|Overall Study|Adverse Event|8
1707915|NCT01179672|5959681|P1|Overall Study|Adverse Event|17
1707916|NCT01179516|5959737|P3|Overall Study|Other|2
1707917|NCT01179516|5959738|P2|Overall Study|Other|0
1707918|NCT01179516|5959739|P1|Overall Study|Other|2
1707919|NCT01179516|5959737|P3|Overall Study|Lost to Follow-up|3
1707920|NCT01179516|5959738|P2|Overall Study|Lost to Follow-up|7
1707921|NCT01179516|5959739|P1|Overall Study|Lost to Follow-up|7
1707922|NCT01179516|5959737|P3|Overall Study|Withdrawal of Consent|10
1707923|NCT01179516|5959738|P2|Overall Study|Withdrawal of Consent|6
1707924|NCT01179516|5959739|P1|Overall Study|Withdrawal of Consent|2
1707925|NCT01179516|5959737|P3|Overall Study|Protocol Deviations|3
1707926|NCT01179516|5959738|P2|Overall Study|Protocol Deviations|3
1707927|NCT01179516|5959739|P1|Overall Study|Protocol Deviations|4
1707928|NCT01179516|5959737|P3|Overall Study|Noncompliance with Study Drug|1
1707929|NCT01179516|5959738|P2|Overall Study|Noncompliance with Study Drug|0
1707930|NCT01179516|5959739|P1|Overall Study|Noncompliance with Study Drug|2
1707931|NCT01179516|5959737|P3|Overall Study|Lack of Efficacy|0
1707932|NCT01179516|5959738|P2|Overall Study|Lack of Efficacy|2
1707933|NCT01179516|5959739|P1|Overall Study|Lack of Efficacy|4
1707934|NCT01179516|5959737|P3|Overall Study|Pretreatment Event or Adverse Event|12
1707935|NCT01179516|5959738|P2|Overall Study|Pretreatment Event or Adverse Event|8
1707936|NCT01179516|5959739|P1|Overall Study|Pretreatment Event or Adverse Event|6
1707937|NCT01179477|5959783|P1|Overall Study|Did not complete final visit|27
1707938|NCT01179477|5959783|P1|Overall Study|Non-death withdrawal|438
1707939|NCT01179477|5959783|P1|Overall Study|Unsuccessful implant|80
1707940|NCT01179477|5959783|P1|Overall Study|Death|542
1707941|NCT01179399|5959788|P1|Overall Study|Withdrawal by Subject|1
1707942|NCT01179399|5959788|P1|Overall Study|Lack of Efficacy|30
1707943|NCT01179399|5959788|P1|Overall Study|Adverse Event|1
1707944|NCT01179347|5959794|P2|Open-label Period (12 Weeks)|Other|4
1707945|NCT01179347|5959795|P1|Open-label Period (12 Weeks)|Other|7
1707946|NCT01179347|5959794|P2|Open-label Period (12 Weeks)|Protocol Violation|0
1707947|NCT01179347|5959795|P1|Open-label Period (12 Weeks)|Protocol Violation|1
1707948|NCT01179347|5959794|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
1707949|NCT01179347|5959795|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
1707950|NCT01179347|5959794|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
1707951|NCT01179347|5959795|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
1707952|NCT01179347|5959794|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
1707953|NCT01179347|5959795|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
1707954|NCT01179347|5959794|P2|Open-label Period (12 Weeks)|Adverse Event|9
1707955|NCT01179347|5959795|P1|Open-label Period (12 Weeks)|Adverse Event|5
1707956|NCT01179347|5959794|P2|Double-blind Period (12 Weeks)|Other|4
1707957|NCT01179347|5959795|P1|Double-blind Period (12 Weeks)|Other|2
1707958|NCT01179347|5959794|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
1707959|NCT01179347|5959795|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
1707960|NCT01179347|5959794|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
1707961|NCT01179347|5959795|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
1707962|NCT01179347|5959794|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
1707963|NCT01179347|5959795|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
1707964|NCT01179347|5959794|P2|Double-blind Period (12 Weeks)|Adverse Event|6
1707965|NCT01179347|5959795|P1|Double-blind Period (12 Weeks)|Adverse Event|2
1707966|NCT01179334|5959817|P2|Long-term Extension (LTE) Period|Adverse Event|4
1707967|NCT01179334|5959818|P1|Long-term Extension (LTE) Period|Adverse Event|2
1707968|NCT01179334|5959817|P2|Long-term Extension (LTE) Period|Death|0
1707969|NCT01179334|5959818|P1|Long-term Extension (LTE) Period|Death|3
1707970|NCT01179334|5959817|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
1707971|NCT01179334|5959818|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
1707972|NCT01179334|5959817|P2|Treatment Period|Adverse Event|0
1707973|NCT01179334|5959818|P1|Treatment Period|Adverse Event|1
1707974|NCT01179191|5959873|P1|Maintenance Phase (8 Weeks)|Other|66
1707975|NCT01179191|5959873|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
1707976|NCT01179191|5959873|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
1707977|NCT01179191|5959873|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
1707978|NCT01179191|5959873|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
1707979|NCT01179191|5959873|P1|Titration Phase (up to 6 Weeks)|Other|62
1707980|NCT01179191|5959873|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
1707981|NCT01179191|5959873|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
1707982|NCT01179191|5959873|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
1707983|NCT01179191|5959873|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
1707984|NCT01179191|5959873|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
1707985|NCT01179048|5959905|P2|Overall Study|Alive|142
1707986|NCT01179048|5959906|P1|Overall Study|Alive|127
1707987|NCT01179048|5959905|P2|Overall Study|Lost to Follow-up|9
1707988|NCT01179048|5959906|P1|Overall Study|Lost to Follow-up|8
1707989|NCT01179048|5959905|P2|Overall Study|Withdrawn - does not allow contact|8
1707990|NCT01179048|5959906|P1|Overall Study|Withdrawn - does not allow contact|4
1707991|NCT01178853|5959933|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
1707992|NCT01178853|5959934|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
1707993|NCT01178853|5959933|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
1707994|NCT01178853|5959934|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
1707995|NCT01178853|5959933|P2|Period 3 (Warfarin Titration)|Adverse Event|0
1707996|NCT01178853|5959934|P1|Period 3 (Warfarin Titration)|Adverse Event|1
1707997|NCT01178853|5959933|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
1707998|NCT01178853|5959934|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
1707999|NCT01178853|5959933|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
1708000|NCT01178853|5959934|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
1708001|NCT01178762|5959974|P1|Overall Study|Lost to Follow-up|15
1708002|NCT01178671|5959980|P2|Overall Study|Physician Decision|6
1708003|NCT01178671|5959981|P1|Overall Study|Physician Decision|4
1708004|NCT01178671|5959980|P2|Overall Study|Lost to Follow-up|1
1708005|NCT01178671|5959981|P1|Overall Study|Lost to Follow-up|3
1708006|NCT01178671|5959980|P2|Overall Study|Lack of Efficacy|1
1708007|NCT01178671|5959981|P1|Overall Study|Lack of Efficacy|0
1708008|NCT01178671|5959980|P2|Overall Study|Protocol Violation|1
1708009|NCT01178671|5959981|P1|Overall Study|Protocol Violation|1
1708010|NCT01178671|5959980|P2|Overall Study|Adverse Event|6
1708011|NCT01178671|5959981|P1|Overall Study|Adverse Event|4
1708012|NCT01178385|5960029|P2|Overall Study|Withdrawal by Subject|0
1708013|NCT01178385|5960030|P1|Overall Study|Withdrawal by Subject|2
1708014|NCT01178294|5960099|P1|Overall Study|Completion status could not be verified|1
1708015|NCT01178294|5960099|P1|Overall Study|Subject status is terminal|1
1708016|NCT01178294|5960099|P1|Overall Study|Development of inhibitors to OBI-1|1
1708017|NCT01178294|5960099|P1|Overall Study|Death|1
1708018|NCT01178294|5960099|P1|Overall Study|Lack of Efficacy|1
1708019|NCT01178294|5960099|P1|Overall Study|Lost to Follow-up|2
1708020|NCT01178294|5960099|P1|Overall Study|Adverse Event|4
1708021|NCT01178138|5960379|P1|Overall Study|Physician Decision|8
1708022|NCT01178138|5960379|P1|Overall Study|Withdrawal by Subject|7
1708023|NCT01178138|5960379|P1|Overall Study|Lost to Follow-up|8
1708024|NCT01178125|5960400|P1|Overall Study|Investigator Decision|5
1708025|NCT01178125|5960400|P1|Overall Study|Protocol Violation|17
1708026|NCT01178125|5960400|P1|Overall Study|Sponsor Decision|28
1708027|NCT01178125|5960400|P1|Overall Study|Other Reason|39
1708028|NCT01178125|5960400|P1|Overall Study|Pregnancy|55
1708029|NCT01178125|5960400|P1|Overall Study|Noncompliance|184
1708030|NCT01178125|5960400|P1|Overall Study|Withdrawal by Subject|209
1708031|NCT01178125|5960400|P1|Overall Study|Adverse Event|244
1708032|NCT01178125|5960400|P1|Overall Study|Lost to Follow-up|397
1708033|NCT01178099|5960431|P2|Overall Study|Physician Decision|1
1708034|NCT01178099|5960432|P1|Overall Study|Physician Decision|0
1708035|NCT01178086|5960472|P1|Overall Study|Excluded from EAS|20
1708036|NCT01178086|5960472|P1|Overall Study|Other unspecified|89
1708037|NCT01178086|5960472|P1|Overall Study|Death|59
1708038|NCT01178086|5960472|P1|Overall Study|Switch to other CLL therapy|113
1708039|NCT01178086|5960472|P1|Overall Study|Physician Decision|44
1708040|NCT01178086|5960472|P1|Overall Study|Participant refusal|7
1708041|NCT01178073|5960499|P3|Overall Study|Missing Completion Status|0
1708042|NCT01178073|5960500|P2|Overall Study|Missing Completion Status|0
1708043|NCT01178073|5960501|P1|Overall Study|Missing Completion Status|1
1708044|NCT01178073|5960499|P3|Overall Study|Withdrawal by Subject|8
1708045|NCT01178073|5960500|P2|Overall Study|Withdrawal by Subject|6
1708046|NCT01178073|5960501|P1|Overall Study|Withdrawal by Subject|10
1708047|NCT01178073|5960499|P3|Overall Study|Physician Decision|10
1708048|NCT01178073|5960500|P2|Overall Study|Physician Decision|10
1708049|NCT01178073|5960501|P1|Overall Study|Physician Decision|14
1708050|NCT01178073|5960499|P3|Overall Study|Lost to Follow-up|3
1708051|NCT01178073|5960500|P2|Overall Study|Lost to Follow-up|0
1708052|NCT01178073|5960501|P1|Overall Study|Lost to Follow-up|2
1708053|NCT01178073|5960499|P3|Overall Study|Protocol Violation|1
1708054|NCT01178073|5960500|P2|Overall Study|Protocol Violation|1
1708055|NCT01178073|5960501|P1|Overall Study|Protocol Violation|1
1708056|NCT01178073|5960499|P3|Overall Study|Adverse Event|24
1708057|NCT01178073|5960500|P2|Overall Study|Adverse Event|27
1708058|NCT01178073|5960501|P1|Overall Study|Adverse Event|34
1708059|NCT01177969|5960532|P2|Overall Study|Withdrawal by Subject|2
1708060|NCT01177969|5960533|P1|Overall Study|Withdrawal by Subject|1
1708061|NCT01177969|5960532|P2|Overall Study|Protocol Violation|1
1708062|NCT01177969|5960533|P1|Overall Study|Protocol Violation|2
1708063|NCT01177943|5960556|P2|First Intervention|Withdrawal by Subject|0
1708064|NCT01177943|5960557|P1|First Intervention|Withdrawal by Subject|2
1708065|NCT01177813|5960570|P5|Overall Study|Other reason not defined above|2
1708066|NCT01177813|5960571|P4|Overall Study|Other reason not defined above|3
1708067|NCT01177813|5960572|P3|Overall Study|Other reason not defined above|2
1708068|NCT01177813|5960573|P2|Overall Study|Other reason not defined above|2
1708069|NCT01177813|5960574|P1|Overall Study|Other reason not defined above|5
1708070|NCT01177813|5960570|P5|Overall Study|Withdrawal by Subject|3
1708071|NCT01177813|5960571|P4|Overall Study|Withdrawal by Subject|5
1708072|NCT01177813|5960572|P3|Overall Study|Withdrawal by Subject|6
1708073|NCT01177813|5960573|P2|Overall Study|Withdrawal by Subject|7
1708074|NCT01177813|5960574|P1|Overall Study|Withdrawal by Subject|12
1708075|NCT01177813|5960570|P5|Overall Study|Lost to Follow-up|0
1708076|NCT01177813|5960571|P4|Overall Study|Lost to Follow-up|3
1708077|NCT01177813|5960572|P3|Overall Study|Lost to Follow-up|6
1708078|NCT01177813|5960573|P2|Overall Study|Lost to Follow-up|5
1708079|NCT01177813|5960574|P1|Overall Study|Lost to Follow-up|12
1708080|NCT01177813|5960570|P5|Overall Study|Protocol Violation|1
1708081|NCT01177813|5960571|P4|Overall Study|Protocol Violation|0
1708082|NCT01177813|5960572|P3|Overall Study|Protocol Violation|2
1708083|NCT01177813|5960573|P2|Overall Study|Protocol Violation|2
1708084|NCT01177813|5960574|P1|Overall Study|Protocol Violation|3
1708085|NCT01177813|5960570|P5|Overall Study|Lack of Efficacy|0
1708086|NCT01177813|5960571|P4|Overall Study|Lack of Efficacy|0
1708087|NCT01177813|5960572|P3|Overall Study|Lack of Efficacy|0
1708088|NCT01177813|5960573|P2|Overall Study|Lack of Efficacy|0
1708089|NCT01177813|5960574|P1|Overall Study|Lack of Efficacy|1
1708090|NCT01177813|5960570|P5|Overall Study|Adverse Event|3
1708091|NCT01177813|5960571|P4|Overall Study|Adverse Event|6
1708092|NCT01177813|5960572|P3|Overall Study|Adverse Event|4
1708093|NCT01177813|5960573|P2|Overall Study|Adverse Event|2
1708094|NCT01177813|5960574|P1|Overall Study|Adverse Event|8
1708095|NCT01177800|5960603|P2|Overall Study|Withdrawal of informed consent|1
1708096|NCT01177800|5960604|P1|Overall Study|Withdrawal of informed consent|0
1708097|NCT01177800|5960603|P2|Overall Study|Physician Decision|0
1708098|NCT01177800|5960604|P1|Overall Study|Physician Decision|1
1708099|NCT01177800|5960603|P2|Overall Study|Protocol Violation|1
1708100|NCT01177800|5960604|P1|Overall Study|Protocol Violation|0
1708101|NCT01177800|5960603|P2|Overall Study|Adverse Event|3
1708102|NCT01177800|5960604|P1|Overall Study|Adverse Event|9
1708103|NCT01177722|5960626|P4|Overall Study|Withdrawal by Subject|6
1708104|NCT01177722|5960627|P3|Overall Study|Withdrawal by Subject|4
1708105|NCT01177722|5960628|P2|Overall Study|Withdrawal by Subject|6
1708106|NCT01177722|5960629|P1|Overall Study|Withdrawal by Subject|10
1708107|NCT01177722|5960626|P4|Overall Study|Lost to Follow-up|1
1708108|NCT01177722|5960627|P3|Overall Study|Lost to Follow-up|3
1708109|NCT01177722|5960628|P2|Overall Study|Lost to Follow-up|4
1708110|NCT01177722|5960629|P1|Overall Study|Lost to Follow-up|3
1708111|NCT01177722|5960626|P4|Overall Study|Protocol Violation|0
1708112|NCT01177722|5960627|P3|Overall Study|Protocol Violation|1
1708113|NCT01177722|5960628|P2|Overall Study|Protocol Violation|0
1708114|NCT01177722|5960629|P1|Overall Study|Protocol Violation|0
1708115|NCT01177722|5960626|P4|Overall Study|Serious Adverse Event|0
1708116|NCT01177722|5960627|P3|Overall Study|Serious Adverse Event|1
1708117|NCT01177722|5960628|P2|Overall Study|Serious Adverse Event|0
1708118|NCT01177722|5960629|P1|Overall Study|Serious Adverse Event|0
1708119|NCT01177670|5960661|P1|Overall Study|Withdrawal by Subject|4
1708120|NCT01177670|5960661|P1|Overall Study|Physician Decision|50
1708121|NCT01177670|5960661|P1|Overall Study|Study Terminated|115
1708122|NCT01177553|5960668|P2|Overall Study|babies not yet 6 months of age|0
1708123|NCT01177553|5960669|P1|Overall Study|babies not yet 6 months of age|1
1708124|NCT01177410|5960678|P3|Overall Study|Lost to Follow-up|0
1708125|NCT01177410|5960679|P2|Overall Study|Lost to Follow-up|1
1708126|NCT01177410|5960680|P1|Overall Study|Lost to Follow-up|0
1708127|NCT01177410|5960678|P3|Overall Study|Withdrawal by Subject|3
1708128|NCT01177410|5960679|P2|Overall Study|Withdrawal by Subject|4
1708129|NCT01177410|5960680|P1|Overall Study|Withdrawal by Subject|1
1708130|NCT01177410|5960678|P3|Overall Study|Adverse Event|2
1708131|NCT01177410|5960679|P2|Overall Study|Adverse Event|2
1708132|NCT01177410|5960680|P1|Overall Study|Adverse Event|0
1708133|NCT01177384|5960693|P2|Overall Study|Withdrawal by Subject|12
1708134|NCT01177384|5960694|P1|Overall Study|Withdrawal by Subject|5
1708135|NCT01177384|5960693|P2|Overall Study|Protocol Violation|2
1708136|NCT01177384|5960694|P1|Overall Study|Protocol Violation|0
1708137|NCT01177384|5960693|P2|Overall Study|Physician Decision|3
1708138|NCT01177384|5960694|P1|Overall Study|Physician Decision|0
1708139|NCT01177384|5960693|P2|Overall Study|Lost to Follow-up|4
1708140|NCT01177384|5960694|P1|Overall Study|Lost to Follow-up|3
1708141|NCT01177384|5960693|P2|Overall Study|Lack of Efficacy|1
1708142|NCT01177384|5960694|P1|Overall Study|Lack of Efficacy|0
1708143|NCT01177384|5960693|P2|Overall Study|Adverse Event|4
1708144|NCT01177384|5960694|P1|Overall Study|Adverse Event|6
1708145|NCT01177293|5960706|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
1708146|NCT01177293|5960707|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
1708147|NCT01177228|5960725|P4|Overall Study|Withdrawal by Subject|0
1708148|NCT01177228|5960726|P3|Overall Study|Withdrawal by Subject|0
1708149|NCT01177228|5960727|P2|Overall Study|Withdrawal by Subject|1
1708150|NCT01177228|5960728|P1|Overall Study|Withdrawal by Subject|0
1708151|NCT01177228|5960725|P4|Overall Study|Worsening disease activity|0
1708152|NCT01177228|5960726|P3|Overall Study|Worsening disease activity|0
1708153|NCT01177228|5960727|P2|Overall Study|Worsening disease activity|0
1708154|NCT01177228|5960728|P1|Overall Study|Worsening disease activity|1
1708155|NCT01177228|5960725|P4|Overall Study|Positive tuberculosis test|0
1708156|NCT01177228|5960726|P3|Overall Study|Positive tuberculosis test|0
1708157|NCT01177228|5960727|P2|Overall Study|Positive tuberculosis test|1
1708158|NCT01177228|5960728|P1|Overall Study|Positive tuberculosis test|0
1708159|NCT01177137|5960782|P3|Overall Study|Withdrawal by Subject|2
1708160|NCT01177137|5960783|P2|Overall Study|Withdrawal by Subject|10
1708161|NCT01177137|5960784|P1|Overall Study|Withdrawal by Subject|10
1708162|NCT01177059|5960868|P1|Overall Study|Lost to Follow-up|18
1708163|NCT01177059|5960868|P1|Overall Study|Withdrew consent|2
1708164|NCT01177059|5960868|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
1708165|NCT01177007|5960874|P1|Overall Study|Change in treatment modality|21
1708166|NCT01177007|5960874|P1|Overall Study|Required additional Y90 treatment|6
1708167|NCT01177007|5960874|P1|Overall Study|Entered hospice care|5
1708168|NCT01177007|5960874|P1|Overall Study|Death|4
1708169|NCT01177007|5960874|P1|Overall Study|Lost to Follow-up|2
1708170|NCT01176968|5960888|P2|Overall Study|Reason not defined|3
1708171|NCT01176968|5960889|P1|Overall Study|Reason not defined|5
1708172|NCT01176968|5960888|P2|Overall Study|Study terminated by sponsor|1
1708173|NCT01176968|5960889|P1|Overall Study|Study terminated by sponsor|0
1708174|NCT01176968|5960888|P2|Overall Study|Did Not Meet Entrance Criteria|0
1708175|NCT01176968|5960889|P1|Overall Study|Did Not Meet Entrance Criteria|1
1708176|NCT01176968|5960888|P2|Overall Study|Protocol Violation|1
1708177|NCT01176968|5960889|P1|Overall Study|Protocol Violation|2
1708178|NCT01176968|5960888|P2|Overall Study|Withdrawal by Subject|48
1708179|NCT01176968|5960889|P1|Overall Study|Withdrawal by Subject|48
1708180|NCT01176968|5960888|P2|Overall Study|Lost to Follow-up|14
1708181|NCT01176968|5960889|P1|Overall Study|Lost to Follow-up|16
1708182|NCT01176968|5960888|P2|Overall Study|Lack of Efficacy|1
1708183|NCT01176968|5960889|P1|Overall Study|Lack of Efficacy|0
1708184|NCT01176968|5960888|P2|Overall Study|Death|3
1708185|NCT01176968|5960889|P1|Overall Study|Death|2
1708186|NCT01176968|5960888|P2|Overall Study|Adverse Event|11
1708187|NCT01176968|5960889|P1|Overall Study|Adverse Event|10
1708188|NCT01176773|5960940|P1|Overall Study|Withdrew consent|1
1708189|NCT01176773|5960940|P1|Overall Study|Screen Failure|2
1708190|NCT01176565|5960964|P2|Overall Study|Not Analyzed (any other reason)|2
1708191|NCT01176565|5960965|P1|Overall Study|Not Analyzed (any other reason)|1
1708192|NCT01176565|5960964|P2|Overall Study|Withdrawal by Subject|1
1708193|NCT01176565|5960965|P1|Overall Study|Withdrawal by Subject|7
1708194|NCT01176565|5960964|P2|Overall Study|Lost to Follow-up|16
1708195|NCT01176565|5960965|P1|Overall Study|Lost to Follow-up|12
1708196|NCT01176513|5960983|P1|Overall Study|Withdrew subjects prior to dosing|3
1708197|NCT01176292|5961011|P2|Overall Study|Has not scheduled one-year visit yet|2
1708198|NCT01176292|5961012|P1|Overall Study|Has not scheduled one-year visit yet|2
1708199|NCT01176292|5961011|P2|Overall Study|Physician Decision|2
1708200|NCT01176292|5961012|P1|Overall Study|Physician Decision|0
1708201|NCT01176292|5961011|P2|Overall Study|Adverse Event|1
1708202|NCT01176292|5961012|P1|Overall Study|Adverse Event|1
1708203|NCT01176292|5961011|P2|Overall Study|Lost to Follow-up|4
1708204|NCT01176292|5961012|P1|Overall Study|Lost to Follow-up|2
1708205|NCT01176266|5961030|P1|Overall Study|Withdrawal by Subject|3
1708206|NCT01176266|5961030|P1|Overall Study|Death|6
1708207|NCT01176240|5961054|P2|Study 306B|withdrew prior to dosing|1
1708208|NCT01176240|5961055|P1|Study 306B|withdrew prior to dosing|2
1708209|NCT01176240|5961054|P2|Study 306B|Lost to Follow-up|1
1708210|NCT01176240|5961055|P1|Study 306B|Lost to Follow-up|0
1708211|NCT01176240|5961054|P2|Study 306B|Supine Hypertension|2
1708212|NCT01176240|5961055|P1|Study 306B|Supine Hypertension|1
1708213|NCT01176240|5961054|P2|Study 306B|Physician Decision|1
1708214|NCT01176240|5961055|P1|Study 306B|Physician Decision|2
1708215|NCT01176240|5961054|P2|Study 306B|Withdrawal by Subject|1
1708216|NCT01176240|5961055|P1|Study 306B|Withdrawal by Subject|4
1708217|NCT01176240|5961054|P2|Study 306B|Protocol Violation|3
1708218|NCT01176240|5961055|P1|Study 306B|Protocol Violation|2
1708219|NCT01176240|5961054|P2|Study 306B|Adverse Event|5
1708220|NCT01176240|5961055|P1|Study 306B|Adverse Event|10
1708221|NCT01176240|5961054|P2|Study 306B|Lack of Efficacy|3
1708222|NCT01176240|5961055|P1|Study 306B|Lack of Efficacy|5
1708223|NCT01176240|5961054|P2|Study 306A|Stop due to diverse problems|0
1708224|NCT01176240|5961055|P1|Study 306A|Stop due to diverse problems|1
1708225|NCT01176240|5961054|P2|Study 306A|Withdrawal by Subject|1
1708226|NCT01176240|5961055|P1|Study 306A|Withdrawal by Subject|0
1708227|NCT01176240|5961054|P2|Study 306A|Protocol Violation|1
1708228|NCT01176240|5961055|P1|Study 306A|Protocol Violation|0
1708229|NCT01176240|5961054|P2|Study 306A|Lack of Efficacy|1
1708230|NCT01176240|5961055|P1|Study 306A|Lack of Efficacy|2
1708231|NCT01176058|5961081|P2|Overall Study|Withdrawal by Subject|0
1708232|NCT01176058|5961082|P1|Overall Study|Withdrawal by Subject|1
1708233|NCT01176058|5961081|P2|Overall Study|Insufficient mycological response|1
1708234|NCT01176058|5961082|P1|Overall Study|Insufficient mycological response|0
1708235|NCT01176058|5961081|P2|Overall Study|Insufficient clinical response|2
1708236|NCT01176058|5961082|P1|Overall Study|Insufficient clinical response|2
1708237|NCT01176058|5961081|P2|Overall Study|Adverse Event|0
1708238|NCT01176058|5961082|P1|Overall Study|Adverse Event|1
1708239|NCT01176032|5961106|P2|Overall Study|Other|0
1708240|NCT01176032|5961107|P1|Overall Study|Other|1
1708241|NCT01176032|5961106|P2|Overall Study|Informed consent withdrawn|0
1708242|NCT01176032|5961107|P1|Overall Study|Informed consent withdrawn|3
1708243|NCT01176032|5961106|P2|Overall Study|Protocol Violation|0
1708244|NCT01176032|5961107|P1|Overall Study|Protocol Violation|1
1708245|NCT01176032|5961106|P2|Overall Study|Unsatisfactory therapeutic effect|1
1708246|NCT01176032|5961107|P1|Overall Study|Unsatisfactory therapeutic effect|0
1708247|NCT01176032|5961106|P2|Overall Study|Adverse Event|0
1708248|NCT01176032|5961107|P1|Overall Study|Adverse Event|1
1708249|NCT01175824|5961231|P2|Overall Study|Entry Criteria Not Met|4
1708250|NCT01175824|5961232|P1|Overall Study|Entry Criteria Not Met|6
1708251|NCT01175824|5961231|P2|Overall Study|Sponsor Decision|0
1708252|NCT01175824|5961232|P1|Overall Study|Sponsor Decision|1
1708253|NCT01175824|5961231|P2|Overall Study|Withdrawal by Subject|7
1708254|NCT01175824|5961232|P1|Overall Study|Withdrawal by Subject|3
1708255|NCT01175824|5961231|P2|Overall Study|Protocol Violation|5
1708256|NCT01175824|5961232|P1|Overall Study|Protocol Violation|2
1708257|NCT01175824|5961231|P2|Overall Study|Physician Decision|4
1708258|NCT01175824|5961232|P1|Overall Study|Physician Decision|0
1708259|NCT01175824|5961231|P2|Overall Study|Lost to Follow-up|1
1708260|NCT01175824|5961232|P1|Overall Study|Lost to Follow-up|0
1708261|NCT01175824|5961231|P2|Overall Study|Lack of Efficacy|0
1708262|NCT01175824|5961232|P1|Overall Study|Lack of Efficacy|2
1708263|NCT01175824|5961231|P2|Overall Study|Adverse Event|1
1708264|NCT01175824|5961232|P1|Overall Study|Adverse Event|2
1708265|NCT01175811|5961266|P2|Overall Study|Withdrawal by Subject|7
1708266|NCT01175811|5961267|P1|Overall Study|Withdrawal by Subject|6
1708267|NCT01175811|5961266|P2|Overall Study|Protocol Violation|2
1708268|NCT01175811|5961267|P1|Overall Study|Protocol Violation|1
1708269|NCT01175811|5961266|P2|Overall Study|Physician Decision|1
1708270|NCT01175811|5961267|P1|Overall Study|Physician Decision|1
1708271|NCT01175811|5961266|P2|Overall Study|Lost to Follow-up|2
1708272|NCT01175811|5961267|P1|Overall Study|Lost to Follow-up|3
1708273|NCT01175811|5961266|P2|Overall Study|Lack of Efficacy|0
1708274|NCT01175811|5961267|P1|Overall Study|Lack of Efficacy|1
1708275|NCT01175811|5961266|P2|Overall Study|Entry criteria not met|1
1708276|NCT01175811|5961267|P1|Overall Study|Entry criteria not met|3
1708277|NCT01175811|5961266|P2|Overall Study|Adverse Event|1
1708278|NCT01175811|5961267|P1|Overall Study|Adverse Event|1
1708279|NCT01175707|5961302|P2|Overall Study|Adverse Event|6
1708280|NCT01175707|5961303|P1|Overall Study|Adverse Event|4
1708281|NCT01175668|5961339|P2|Overall Study|Withdrawal by Subject|0
1708282|NCT01175668|5961340|P1|Overall Study|Withdrawal by Subject|2
1708283|NCT01175590|5961350|P2|Overall Study|Protocol Violation|1
1708284|NCT01175590|5961351|P1|Overall Study|Protocol Violation|0
1708285|NCT01175590|5961350|P2|Overall Study|Herpes Simplex Dermatitis|0
1708286|NCT01175590|5961351|P1|Overall Study|Herpes Simplex Dermatitis|1
1708287|NCT01175590|5961350|P2|Overall Study|Treated not as randomized|2
1708288|NCT01175590|5961351|P1|Overall Study|Treated not as randomized|3
1708289|NCT01175590|5961350|P2|Overall Study|Residual Bacterial Conjunctivitis|0
1708290|NCT01175590|5961351|P1|Overall Study|Residual Bacterial Conjunctivitis|1
1708291|NCT01175590|5961350|P2|Overall Study|Lack of Efficacy|1
1708292|NCT01175590|5961351|P1|Overall Study|Lack of Efficacy|1
1708293|NCT01175590|5961350|P2|Overall Study|Physician Decision|4
1708294|NCT01175590|5961351|P1|Overall Study|Physician Decision|1
1708295|NCT01175590|5961350|P2|Overall Study|Adverse Event|0
1708296|NCT01175590|5961351|P1|Overall Study|Adverse Event|4
1708297|NCT01175590|5961350|P2|Overall Study|Withdrawal by Subject|2
1708298|NCT01175590|5961351|P1|Overall Study|Withdrawal by Subject|0
1708299|NCT01175590|5961350|P2|Overall Study|Lost to Follow-up|0
1708300|NCT01175590|5961351|P1|Overall Study|Lost to Follow-up|1
1708301|NCT01175473|5961385|P2|Overall Study|Adverse Event|2
1708302|NCT01175473|5961386|P1|Overall Study|Adverse Event|2
1708303|NCT01175382|5961427|P3|Overall Study|Unable to tolerate study meds|1
1708304|NCT01175382|5961428|P2|Overall Study|Unable to tolerate study meds|1
1708305|NCT01175382|5961429|P1|Overall Study|Unable to tolerate study meds|0
1708306|NCT01175382|5961427|P3|Overall Study|Unwilling to follow protocol|0
1708307|NCT01175382|5961428|P2|Overall Study|Unwilling to follow protocol|1
1708308|NCT01175382|5961429|P1|Overall Study|Unwilling to follow protocol|0
1708309|NCT01175382|5961427|P3|Overall Study|Unable/unwilling to attend visits|2
1708310|NCT01175382|5961428|P2|Overall Study|Unable/unwilling to attend visits|1
1708311|NCT01175382|5961429|P1|Overall Study|Unable/unwilling to attend visits|3
1708312|NCT01175382|5961427|P3|Overall Study|No longer having problem|1
1708313|NCT01175382|5961428|P2|Overall Study|No longer having problem|0
1708314|NCT01175382|5961429|P1|Overall Study|No longer having problem|1
1708315|NCT01175382|5961427|P3|Overall Study|Withdrawal by Subject|1
1708316|NCT01175382|5961428|P2|Overall Study|Withdrawal by Subject|0
1708317|NCT01175382|5961429|P1|Overall Study|Withdrawal by Subject|0
1708318|NCT01175382|5961427|P3|Overall Study|Physician Decision|0
1708319|NCT01175382|5961428|P2|Overall Study|Physician Decision|1
1708320|NCT01175382|5961429|P1|Overall Study|Physician Decision|0
1708321|NCT01175382|5961427|P3|Overall Study|Lost to Follow-up|1
1708322|NCT01175382|5961428|P2|Overall Study|Lost to Follow-up|3
1708323|NCT01175382|5961429|P1|Overall Study|Lost to Follow-up|4
1708324|NCT01175356|5961515|P1|Overall Study|Initiation other tx prior to completion|9
1708325|NCT01175356|5961515|P1|Overall Study|Inadequate stem cell for transplant|1
1708326|NCT01175356|5961515|P1|Overall Study|On other COG study w/tumor tx intent|7
1708327|NCT01175356|5961515|P1|Overall Study|Pts MIBG non-avid after enrollment|2
1708328|NCT01175356|5961515|P1|Overall Study|Refusal by patient/parent/guardian|6
1708329|NCT01175356|5961515|P1|Overall Study|Treatment Slot Not Available|18
1708330|NCT01175356|5961515|P1|Overall Study|Ineligible|1
1708331|NCT01175356|5961515|P1|Overall Study|Physician Decision|23
1708332|NCT01175356|5961515|P1|Overall Study|Lost to Follow-up|1
1708333|NCT01175356|5961515|P1|Overall Study|Lack of Efficacy|12
1708334|NCT01175356|5961515|P1|Overall Study|Death|1
1708335|NCT01175213|5961555|P2|Safety Follow-up|Adverse Event|0
1708336|NCT01175213|5961556|P1|Safety Follow-up|Adverse Event|1
1708337|NCT01175213|5961555|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
1708338|NCT01175213|5961556|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
1708339|NCT01175213|5961555|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
1708340|NCT01175213|5961556|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
1708341|NCT01175213|5961555|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
1708342|NCT01175213|5961556|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
1708343|NCT01175213|5961555|P2|IGSC, 10%/rHuPH20|Death|0
1708344|NCT01175213|5961556|P1|IGSC, 10%/rHuPH20|Death|1
1708345|NCT01175213|5961555|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
1708346|NCT01175213|5961556|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
1708347|NCT01175135|5961613|P4|Overall Study|Randomized But Not Treated|0
1708348|NCT01175135|5961614|P3|Overall Study|Randomized But Not Treated|1
1708349|NCT01175135|5961615|P2|Overall Study|Randomized But Not Treated|0
1708350|NCT01175135|5961616|P1|Overall Study|Randomized But Not Treated|0
1708351|NCT01175135|5961613|P4|Overall Study|Other|0
1708352|NCT01175135|5961614|P3|Overall Study|Other|3
1708353|NCT01175135|5961615|P2|Overall Study|Other|1
1708354|NCT01175135|5961616|P1|Overall Study|Other|3
1708355|NCT01175135|5961613|P4|Overall Study|Withdrawal by Subject|5
1708356|NCT01175135|5961614|P3|Overall Study|Withdrawal by Subject|5
1708357|NCT01175135|5961615|P2|Overall Study|Withdrawal by Subject|8
1708358|NCT01175135|5961616|P1|Overall Study|Withdrawal by Subject|4
1708359|NCT01175135|5961613|P4|Overall Study|Protocol Violation|0
1708360|NCT01175135|5961614|P3|Overall Study|Protocol Violation|0
1708361|NCT01175135|5961615|P2|Overall Study|Protocol Violation|1
1708362|NCT01175135|5961616|P1|Overall Study|Protocol Violation|1
1708363|NCT01175135|5961613|P4|Overall Study|Lost to Follow-up|0
1708364|NCT01175135|5961614|P3|Overall Study|Lost to Follow-up|0
1708365|NCT01175135|5961615|P2|Overall Study|Lost to Follow-up|2
1708366|NCT01175135|5961616|P1|Overall Study|Lost to Follow-up|1
1708367|NCT01175135|5961613|P4|Overall Study|Lack of Efficacy|5
1708368|NCT01175135|5961614|P3|Overall Study|Lack of Efficacy|0
1708369|NCT01175135|5961615|P2|Overall Study|Lack of Efficacy|5
1708370|NCT01175135|5961616|P1|Overall Study|Lack of Efficacy|4
1708371|NCT01175135|5961613|P4|Overall Study|Death|0
1708372|NCT01175135|5961614|P3|Overall Study|Death|0
1708373|NCT01175135|5961615|P2|Overall Study|Death|0
1708374|NCT01175135|5961616|P1|Overall Study|Death|1
1708375|NCT01175135|5961613|P4|Overall Study|Adverse Event|4
1708376|NCT01175135|5961614|P3|Overall Study|Adverse Event|3
1708377|NCT01175135|5961615|P2|Overall Study|Adverse Event|5
1708378|NCT01175135|5961616|P1|Overall Study|Adverse Event|2
1708379|NCT01175083|5961704|P6|Booster Epoch|Withdrawal by Subject|0
1708380|NCT01175083|5961705|P5|Booster Epoch|Withdrawal by Subject|0
1708381|NCT01175083|5961706|P4|Booster Epoch|Withdrawal by Subject|1
1708382|NCT01175083|5961707|P3|Booster Epoch|Withdrawal by Subject|0
1708383|NCT01175083|5961708|P2|Booster Epoch|Withdrawal by Subject|0
1708384|NCT01175083|5961709|P1|Booster Epoch|Withdrawal by Subject|0
1708385|NCT01175083|5961704|P6|Booster Epoch|Death|0
1708386|NCT01175083|5961705|P5|Booster Epoch|Death|0
1708387|NCT01175083|5961706|P4|Booster Epoch|Death|0
1708388|NCT01175083|5961707|P3|Booster Epoch|Death|1
1708389|NCT01175083|5961708|P2|Booster Epoch|Death|0
1708390|NCT01175083|5961709|P1|Booster Epoch|Death|0
1708391|NCT01175083|5961704|P6|Primary Epoch|Lost to Follow-up|1
1708392|NCT01175083|5961705|P5|Primary Epoch|Lost to Follow-up|0
1708393|NCT01175083|5961706|P4|Primary Epoch|Lost to Follow-up|0
1708394|NCT01175083|5961707|P3|Primary Epoch|Lost to Follow-up|0
1708395|NCT01175083|5961708|P2|Primary Epoch|Lost to Follow-up|0
1708396|NCT01175083|5961709|P1|Primary Epoch|Lost to Follow-up|0
1708397|NCT01175083|5961704|P6|Primary Epoch|Withdrawal by Subject|2
1708398|NCT01175083|5961705|P5|Primary Epoch|Withdrawal by Subject|0
1708399|NCT01175083|5961706|P4|Primary Epoch|Withdrawal by Subject|0
1708400|NCT01175083|5961707|P3|Primary Epoch|Withdrawal by Subject|0
1708401|NCT01175083|5961708|P2|Primary Epoch|Withdrawal by Subject|0
1708402|NCT01175083|5961709|P1|Primary Epoch|Withdrawal by Subject|0
1708403|NCT01175018|5961801|P2|Overall Study|Adverse Event|1
1708404|NCT01175018|5961802|P1|Overall Study|Adverse Event|3
1708405|NCT01174563|5961889|P1|Overall Study|Sponsor's decision|1
1708406|NCT01174563|5961889|P1|Overall Study|Rash Adverse Event|1
1708407|NCT01174563|5961889|P1|Overall Study|Participant Withdrew Consent|3
1708408|NCT01174563|5961889|P1|Overall Study|Investigator's Discretion|5
1708409|NCT01174563|5961889|P1|Overall Study|Death|5
1708410|NCT01174563|5961889|P1|Overall Study|Progressive Disease|45
1708411|NCT01174550|5961897|P2|Overall Study|Withdrawal by Subject|289
1708412|NCT01174550|5961898|P1|Overall Study|Withdrawal by Subject|543
1708413|NCT01174550|5961897|P2|Overall Study|Lost to Follow-up|510
1708414|NCT01174550|5961898|P1|Overall Study|Lost to Follow-up|652
1708415|NCT01174550|5961897|P2|Overall Study|Death|74
1708416|NCT01174550|5961898|P1|Overall Study|Death|75
1708417|NCT01174459|5961926|P1|Overall Study|case report form (CRF) not collected|5
1708418|NCT01174446|5961931|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1708419|NCT01174446|5961932|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1708420|NCT01174446|5961933|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
1708421|NCT01174446|5961934|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
1708422|NCT01174446|5961931|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1708423|NCT01174446|5961932|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1708424|NCT01174446|5961933|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
1708425|NCT01174446|5961934|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
1708426|NCT01174446|5961931|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1708427|NCT01174446|5961932|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
1708428|NCT01174446|5961933|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1708429|NCT01174446|5961934|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
1708430|NCT01174446|5961931|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1708431|NCT01174446|5961932|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
1708432|NCT01174446|5961933|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1708433|NCT01174446|5961934|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
1708434|NCT01174368|5962121|P1|Overall Study|Withdrawal by Subject|1
1708435|NCT01174342|5962127|P1|Overall Study|Conversion to cesarean section|4
1708436|NCT01174264|5962134|P3|Steady-state Pharmacokinetics|Not evaluable|2
1708437|NCT01174264|5962135|P2|Steady-state Pharmacokinetics|Not evaluable|0
1708438|NCT01174264|5962136|P1|Steady-state Pharmacokinetics|Not evaluable|6
1708439|NCT01174264|5962134|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
1708440|NCT01174264|5962135|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
1708441|NCT01174264|5962136|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
1708442|NCT01174264|5962134|P3|Single Dose Pharmacokinetics|Early progressive disease|1
1708443|NCT01174264|5962135|P2|Single Dose Pharmacokinetics|Early progressive disease|0
1708444|NCT01174264|5962136|P1|Single Dose Pharmacokinetics|Early progressive disease|1
1708445|NCT01174238|5962168|P1|Overall Study|Lost to Follow-up|2
1708446|NCT01174186|5962179|P2|Overall Study|Withdrawal by Subject|2
1708447|NCT01174186|5962180|P1|Overall Study|Withdrawal by Subject|0
1708448|NCT01174186|5962179|P2|Overall Study|Lost to Follow-up|1
1708449|NCT01174186|5962180|P1|Overall Study|Lost to Follow-up|0
1708450|NCT01174173|5962187|P1|Overall Study|drug-drug interaction|1
1708451|NCT01174160|5962198|P2|Overall Study|Withdrawal by Subject|0
1708452|NCT01174160|5962199|P1|Overall Study|Withdrawal by Subject|1
1708453|NCT01174160|5962198|P2|Overall Study|Protocol Violation|6
1708454|NCT01174160|5962199|P1|Overall Study|Protocol Violation|4
1708455|NCT01174160|5962198|P2|Overall Study|Physician Decision|0
1708456|NCT01174160|5962199|P1|Overall Study|Physician Decision|1
1708457|NCT01174160|5962198|P2|Overall Study|Lost to Follow-up|0
1708458|NCT01174160|5962199|P1|Overall Study|Lost to Follow-up|1
1708459|NCT01174160|5962198|P2|Overall Study|Adverse Event|0
1708460|NCT01174160|5962199|P1|Overall Study|Adverse Event|1
1708461|NCT01174043|5962214|P1|Overall Study|Withdrawal by Subject|2
1708462|NCT01174043|5962214|P1|Overall Study|Death|1
1708463|NCT01174043|5962214|P1|Overall Study|Adverse Event|3
1708464|NCT01174043|5962214|P1|Overall Study|Disease progression|5
1708465|NCT01174004|5962253|P2|Overall Study|Physician Decision|0
1708466|NCT01174004|5962254|P1|Overall Study|Physician Decision|1
1708467|NCT01174004|5962253|P2|Overall Study|Protocol Violation|1
1708468|NCT01174004|5962254|P1|Overall Study|Protocol Violation|0
1708469|NCT01174004|5962253|P2|Overall Study|At Discretion of Sponsor|2
1708470|NCT01174004|5962254|P1|Overall Study|At Discretion of Sponsor|2
1708471|NCT01174004|5962253|P2|Overall Study|Withdrawal by Subject|3
1708472|NCT01174004|5962254|P1|Overall Study|Withdrawal by Subject|2
1708473|NCT01174004|5962253|P2|Overall Study|Adverse Event|10
1708474|NCT01174004|5962254|P1|Overall Study|Adverse Event|2
1708475|NCT01173718|5962285|P1|Overall Study|Abandonment of study graft|27
1708476|NCT01173718|5962285|P1|Overall Study|Death|17
1708477|NCT01173679|5962294|P1|Overall Study|Death|1
1708478|NCT01173653|5962302|P2|Overall Study|Pts unwilling to provide follow-up|41
1708479|NCT01173653|5962303|P1|Overall Study|Pts unwilling to provide follow-up|53
1708480|NCT01173601|5962313|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
1708481|NCT01173601|5962314|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
1708482|NCT01173601|5962315|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1708483|NCT01173601|5962316|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1708484|NCT01173601|5962317|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
1708485|NCT01173601|5962313|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
1708486|NCT01173601|5962314|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
1708487|NCT01173601|5962315|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
1708488|NCT01173601|5962316|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
1708489|NCT01173601|5962317|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
1708490|NCT01173601|5962313|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1708491|NCT01173601|5962314|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
1708492|NCT01173601|5962315|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
1708493|NCT01173601|5962316|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
1708494|NCT01173601|5962317|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
1708495|NCT01173601|5962313|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
1708496|NCT01173601|5962314|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1708497|NCT01173601|5962315|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1708498|NCT01173601|5962316|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
1708499|NCT01173601|5962317|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
1708500|NCT01173601|5962313|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
1708501|NCT01173601|5962314|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
1708502|NCT01173601|5962315|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1708503|NCT01173601|5962316|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
1708504|NCT01173601|5962317|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
1708505|NCT01173601|5962313|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
1708506|NCT01173601|5962314|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
1708507|NCT01173601|5962315|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
1708508|NCT01173601|5962316|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
1708509|NCT01173601|5962317|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
1708510|NCT01173601|5962313|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
1708511|NCT01173601|5962314|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
1708512|NCT01173601|5962315|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
1708513|NCT01173601|5962316|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
1708514|NCT01173601|5962317|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
1708515|NCT01173601|5962313|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1708516|NCT01173601|5962314|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1708517|NCT01173601|5962315|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1708518|NCT01173601|5962316|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
1708519|NCT01173601|5962317|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
1708520|NCT01173601|5962313|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1708521|NCT01173601|5962314|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1708522|NCT01173601|5962315|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1708523|NCT01173601|5962316|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
1708524|NCT01173601|5962317|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
1708525|NCT01173601|5962313|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1708526|NCT01173601|5962314|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1708527|NCT01173601|5962315|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1708528|NCT01173601|5962316|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
1708529|NCT01173601|5962317|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
1708530|NCT01173601|5962313|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1708531|NCT01173601|5962314|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1708532|NCT01173601|5962315|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1708533|NCT01173601|5962316|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
1708534|NCT01173601|5962317|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
1708535|NCT01173601|5962313|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1708536|NCT01173601|5962314|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1708537|NCT01173601|5962315|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1708538|NCT01173601|5962316|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
1708539|NCT01173601|5962317|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
1708540|NCT01173601|5962313|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1708541|NCT01173601|5962314|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1708542|NCT01173601|5962315|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1708543|NCT01173601|5962316|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
1708544|NCT01173601|5962317|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
1708545|NCT01173601|5962313|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1708546|NCT01173601|5962314|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1708547|NCT01173601|5962315|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1708548|NCT01173601|5962316|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
1708549|NCT01173601|5962317|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
1708550|NCT01173523|5962394|P2|Overall Study|Other|3
1708551|NCT01173523|5962395|P1|Overall Study|Other|2
1708552|NCT01173523|5962394|P2|Overall Study|Progressive Disease|8
1708553|NCT01173523|5962395|P1|Overall Study|Progressive Disease|10
1708554|NCT01173523|5962394|P2|Overall Study|Clinical Progression|1
1708555|NCT01173523|5962395|P1|Overall Study|Clinical Progression|1
1708556|NCT01173471|5962411|P4|Overall Study|Reason given as Other|0
1708557|NCT01173471|5962412|P3|Overall Study|Reason given as Other|1
1708558|NCT01173471|5962413|P2|Overall Study|Reason given as Other|0
1708559|NCT01173471|5962414|P1|Overall Study|Reason given as Other|0
1708560|NCT01173471|5962411|P4|Overall Study|Lost to Follow-up|0
1708561|NCT01173471|5962412|P3|Overall Study|Lost to Follow-up|1
1708562|NCT01173471|5962413|P2|Overall Study|Lost to Follow-up|0
1708563|NCT01173471|5962414|P1|Overall Study|Lost to Follow-up|0
1708564|NCT01173471|5962411|P4|Overall Study|Condition under investigation worsened|0
1708565|NCT01173471|5962412|P3|Overall Study|Condition under investigation worsened|0
1708566|NCT01173471|5962413|P2|Overall Study|Condition under investigation worsened|0
1708567|NCT01173471|5962414|P1|Overall Study|Condition under investigation worsened|2
1708568|NCT01173471|5962411|P4|Overall Study|Eligibility criteria not fulfilled|1
1708569|NCT01173471|5962412|P3|Overall Study|Eligibility criteria not fulfilled|1
1708570|NCT01173471|5962413|P2|Overall Study|Eligibility criteria not fulfilled|0
1708571|NCT01173471|5962414|P1|Overall Study|Eligibility criteria not fulfilled|0
1708572|NCT01173120|5962544|P1|Overall Study|Switch-Difficulty With Device|12
1708573|NCT01173120|5962544|P1|Overall Study|Switch-Participant Decision|12
1708574|NCT01173120|5962544|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
1708575|NCT01173120|5962544|P1|Overall Study|Participant Decision|2
1708576|NCT01173120|5962544|P1|Overall Study|Lost to Follow-up|1
1708577|NCT01173120|5962544|P1|Overall Study|Lack of Efficacy|2
1708578|NCT01173055|5962562|P2|Period 2 - Day 64 to 112|Adverse Event|1
1708579|NCT01173055|5962563|P1|Period 2 - Day 64 to 112|Adverse Event|0
1708580|NCT01173055|5962562|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
1708581|NCT01173055|5962563|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
1708582|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
1708583|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708584|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708585|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708586|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708587|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708588|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708589|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708590|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
1708591|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708592|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708593|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708594|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708595|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708596|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708597|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
1708598|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708599|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
1708600|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
1708601|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
1708602|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
1708603|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
1708604|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
1708605|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
1708606|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
1708607|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
1708608|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
1708609|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1708610|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
1708611|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1708612|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1708613|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1708614|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1708615|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
1708616|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
1708617|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
1708618|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1708619|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
1708620|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1708621|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1708622|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1708623|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1708624|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1708625|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
1708626|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
1708627|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708628|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708629|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708630|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708631|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708632|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708633|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
1708634|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708635|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
1708636|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1708637|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1708638|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1708639|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1708640|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1708641|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1708642|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
1708643|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1708644|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
1708645|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708646|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
1708647|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708648|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708649|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708650|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708651|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708652|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708653|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
1708654|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
1708655|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1708656|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1708657|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1708658|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1708659|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1708660|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
1708661|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1708662|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
1708663|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
1708664|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
1708665|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1708666|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1708667|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1708668|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1708669|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
1708670|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
1708671|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
1708672|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
1708673|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
1708674|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1708675|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1708676|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1708677|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1708678|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
1708679|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
1708680|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
1708681|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1708682|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
1708683|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1708684|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1708685|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1708686|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1708687|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
1708688|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
1708689|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
1708690|NCT01172938|5962602|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708691|NCT01172938|5962603|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708692|NCT01172938|5962604|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708693|NCT01172938|5962605|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708694|NCT01172938|5962606|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708695|NCT01172938|5962607|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708696|NCT01172938|5962608|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
1708697|NCT01172938|5962609|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708698|NCT01172938|5962610|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
1708699|NCT01172938|5962602|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708700|NCT01172938|5962603|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708701|NCT01172938|5962604|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708702|NCT01172938|5962605|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708703|NCT01172938|5962606|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708704|NCT01172938|5962607|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708705|NCT01172938|5962608|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708706|NCT01172938|5962609|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
1708707|NCT01172938|5962610|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
1708708|NCT01172938|5962602|P9|Active-Treatment Phase Weeks (104-156)|Death|0
1708709|NCT01172938|5962603|P8|Active-Treatment Phase Weeks (104-156)|Death|1
1708710|NCT01172938|5962604|P7|Active-Treatment Phase Weeks (104-156)|Death|0
1708711|NCT01172938|5962605|P6|Active-Treatment Phase Weeks (104-156)|Death|0
1708712|NCT01172938|5962606|P5|Active-Treatment Phase Weeks (104-156)|Death|0
1708713|NCT01172938|5962607|P4|Active-Treatment Phase Weeks (104-156)|Death|0
1708714|NCT01172938|5962608|P3|Active-Treatment Phase Weeks (104-156)|Death|0
1708715|NCT01172938|5962609|P2|Active-Treatment Phase Weeks (104-156)|Death|0
1708716|NCT01172938|5962610|P1|Active-Treatment Phase Weeks (104-156)|Death|0
1708717|NCT01172938|5962602|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
1708718|NCT01172938|5962603|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
1708719|NCT01172938|5962604|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1708720|NCT01172938|5962605|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1708721|NCT01172938|5962606|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1708722|NCT01172938|5962607|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1708723|NCT01172938|5962608|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
1708724|NCT01172938|5962609|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
1708725|NCT01172938|5962610|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
1708726|NCT01172938|5962602|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1708727|NCT01172938|5962603|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1708728|NCT01172938|5962604|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1708729|NCT01172938|5962605|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1708730|NCT01172938|5962606|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1708731|NCT01172938|5962607|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1708732|NCT01172938|5962608|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
1708733|NCT01172938|5962609|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
1708734|NCT01172938|5962610|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
1708735|NCT01172938|5962602|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
1708736|NCT01172938|5962603|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708737|NCT01172938|5962604|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708738|NCT01172938|5962605|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708739|NCT01172938|5962606|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708740|NCT01172938|5962607|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708741|NCT01172938|5962608|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708742|NCT01172938|5962609|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708743|NCT01172938|5962610|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
1708744|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708745|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708746|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708747|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708748|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708749|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708750|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708751|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
1708752|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
1708753|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
1708754|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1708755|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1708756|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1708757|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1708758|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1708759|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1708760|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
1708761|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
1708762|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1708763|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
1708764|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1708765|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1708766|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1708767|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1708768|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
1708769|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
1708770|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
1708771|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
1708772|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
1708773|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
1708774|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
1708775|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
1708776|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
1708777|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
1708778|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
1708779|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
1708780|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
1708781|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
1708782|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1708783|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1708784|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1708785|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1708786|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
1708787|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
1708788|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
1708789|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708790|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708791|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708792|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708793|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708794|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708795|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
1708796|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708945|NCT01172821|5962837|P3|Overall Study|Lost to Follow-up|2
1708797|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
1708798|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1708799|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
1708800|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1708801|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1708802|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1708803|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1708804|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
1708805|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
1708806|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
1708807|NCT01172938|5962602|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
1708808|NCT01172938|5962603|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
1708809|NCT01172938|5962604|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1708810|NCT01172938|5962605|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1708811|NCT01172938|5962606|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1708812|NCT01172938|5962607|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1708813|NCT01172938|5962608|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
1708814|NCT01172938|5962609|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
1708815|NCT01172938|5962610|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
1708816|NCT01172938|5962602|P9|Active Treatment Phase (Weeks 25-52)|Other|0
1708817|NCT01172938|5962603|P8|Active Treatment Phase (Weeks 25-52)|Other|0
1708818|NCT01172938|5962604|P7|Active Treatment Phase (Weeks 25-52)|Other|1
1708819|NCT01172938|5962605|P6|Active Treatment Phase (Weeks 25-52)|Other|1
1708820|NCT01172938|5962606|P5|Active Treatment Phase (Weeks 25-52)|Other|0
1708821|NCT01172938|5962607|P4|Active Treatment Phase (Weeks 25-52)|Other|0
1708822|NCT01172938|5962608|P3|Active Treatment Phase (Weeks 25-52)|Other|0
1708823|NCT01172938|5962609|P2|Active Treatment Phase (Weeks 25-52)|Other|0
1708824|NCT01172938|5962610|P1|Active Treatment Phase (Weeks 25-52)|Other|0
1708825|NCT01172938|5962602|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1708826|NCT01172938|5962603|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1708827|NCT01172938|5962604|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1708828|NCT01172938|5962605|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1708829|NCT01172938|5962606|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1708830|NCT01172938|5962607|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1708831|NCT01172938|5962608|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1708832|NCT01172938|5962609|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
1708833|NCT01172938|5962610|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
1708834|NCT01172938|5962602|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1708835|NCT01172938|5962603|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1708836|NCT01172938|5962604|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
1708837|NCT01172938|5962605|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
1708838|NCT01172938|5962606|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
1708839|NCT01172938|5962607|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
1708840|NCT01172938|5962608|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
1708841|NCT01172938|5962609|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
1708842|NCT01172938|5962610|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
1708843|NCT01172938|5962602|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708844|NCT01172938|5962603|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708845|NCT01172938|5962604|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708846|NCT01172938|5962605|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708847|NCT01172938|5962606|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708848|NCT01172938|5962607|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708849|NCT01172938|5962608|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
1708850|NCT01172938|5962609|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708851|NCT01172938|5962610|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
1708852|NCT01172938|5962602|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1708853|NCT01172938|5962603|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1708854|NCT01172938|5962604|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1708855|NCT01172938|5962605|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
1708856|NCT01172938|5962606|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
1708857|NCT01172938|5962607|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
1708858|NCT01172938|5962608|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
1708859|NCT01172938|5962609|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
1708860|NCT01172938|5962610|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
1708861|NCT01172938|5962602|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1708862|NCT01172938|5962603|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1708863|NCT01172938|5962604|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1708864|NCT01172938|5962605|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
1708865|NCT01172938|5962606|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
1708866|NCT01172938|5962607|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
1708867|NCT01172938|5962608|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
1708868|NCT01172938|5962609|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
1708869|NCT01172938|5962610|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
1708870|NCT01172938|5962602|P9|Placebo-controlled Phase (Week 0-24)|Other|0
1708871|NCT01172938|5962603|P8|Placebo-controlled Phase (Week 0-24)|Other|0
1708872|NCT01172938|5962604|P7|Placebo-controlled Phase (Week 0-24)|Other|0
1708873|NCT01172938|5962605|P6|Placebo-controlled Phase (Week 0-24)|Other|0
1708874|NCT01172938|5962606|P5|Placebo-controlled Phase (Week 0-24)|Other|0
1708875|NCT01172938|5962607|P4|Placebo-controlled Phase (Week 0-24)|Other|0
1708876|NCT01172938|5962608|P3|Placebo-controlled Phase (Week 0-24)|Other|1
1708877|NCT01172938|5962609|P2|Placebo-controlled Phase (Week 0-24)|Other|2
1708878|NCT01172938|5962610|P1|Placebo-controlled Phase (Week 0-24)|Other|0
1708879|NCT01172938|5962602|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708880|NCT01172938|5962603|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708881|NCT01172938|5962604|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708882|NCT01172938|5962605|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708883|NCT01172938|5962606|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708884|NCT01172938|5962607|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708885|NCT01172938|5962608|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708886|NCT01172938|5962609|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
1708887|NCT01172938|5962610|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
1708888|NCT01172938|5962602|P9|Placebo-controlled Phase (Week 0-24)|Death|0
1708889|NCT01172938|5962603|P8|Placebo-controlled Phase (Week 0-24)|Death|0
1708890|NCT01172938|5962604|P7|Placebo-controlled Phase (Week 0-24)|Death|0
1708891|NCT01172938|5962605|P6|Placebo-controlled Phase (Week 0-24)|Death|0
1708892|NCT01172938|5962606|P5|Placebo-controlled Phase (Week 0-24)|Death|0
1708893|NCT01172938|5962607|P4|Placebo-controlled Phase (Week 0-24)|Death|0
1708894|NCT01172938|5962608|P3|Placebo-controlled Phase (Week 0-24)|Death|0
1708895|NCT01172938|5962609|P2|Placebo-controlled Phase (Week 0-24)|Death|1
1708896|NCT01172938|5962610|P1|Placebo-controlled Phase (Week 0-24)|Death|0
1708897|NCT01172938|5962602|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1708898|NCT01172938|5962603|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1708899|NCT01172938|5962604|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1708900|NCT01172938|5962605|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1708901|NCT01172938|5962606|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1708902|NCT01172938|5962607|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
1708903|NCT01172938|5962608|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
1708904|NCT01172938|5962609|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
1708905|NCT01172938|5962610|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
1708906|NCT01172938|5962602|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1708907|NCT01172938|5962603|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1708908|NCT01172938|5962604|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1708909|NCT01172938|5962605|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1708910|NCT01172938|5962606|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1708911|NCT01172938|5962607|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1708912|NCT01172938|5962608|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
1708913|NCT01172938|5962609|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
1708914|NCT01172938|5962610|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
1708915|NCT01172938|5962602|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1708916|NCT01172938|5962603|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1708917|NCT01172938|5962604|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1708918|NCT01172938|5962605|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1708919|NCT01172938|5962606|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1708920|NCT01172938|5962607|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
1708921|NCT01172938|5962608|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
1708922|NCT01172938|5962609|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
1708923|NCT01172938|5962610|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
1708924|NCT01172938|5962602|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1708925|NCT01172938|5962603|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1708926|NCT01172938|5962604|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1708927|NCT01172938|5962605|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1708928|NCT01172938|5962606|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1708929|NCT01172938|5962607|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
1708930|NCT01172938|5962608|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
1708931|NCT01172938|5962609|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
1708932|NCT01172938|5962610|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
1708933|NCT01172873|5962796|P2|Overall Study|Withdrawal by Subject|2
1708934|NCT01172873|5962797|P1|Overall Study|Withdrawal by Subject|3
1708935|NCT01172847|5962807|P1|Overall Study|Withdrawal by Subject|3
1708936|NCT01172821|5962836|P4|Overall Study|Other|3
1708937|NCT01172821|5962837|P3|Overall Study|Other|5
1708938|NCT01172821|5962838|P2|Overall Study|Other|4
1708939|NCT01172821|5962839|P1|Overall Study|Other|3
1708940|NCT01172821|5962836|P4|Overall Study|Withdrawal by Subject|3
1708941|NCT01172821|5962837|P3|Overall Study|Withdrawal by Subject|3
1708942|NCT01172821|5962838|P2|Overall Study|Withdrawal by Subject|3
1708943|NCT01172821|5962839|P1|Overall Study|Withdrawal by Subject|2
1708944|NCT01172821|5962836|P4|Overall Study|Lost to Follow-up|2
1708946|NCT01172821|5962838|P2|Overall Study|Lost to Follow-up|1
1708947|NCT01172821|5962839|P1|Overall Study|Lost to Follow-up|4
1708948|NCT01172821|5962836|P4|Overall Study|Protocol Violation|2
1708949|NCT01172821|5962837|P3|Overall Study|Protocol Violation|1
1708950|NCT01172821|5962838|P2|Overall Study|Protocol Violation|2
1708951|NCT01172821|5962839|P1|Overall Study|Protocol Violation|0
1708952|NCT01172821|5962836|P4|Overall Study|Adverse Event|7
1708953|NCT01172821|5962837|P3|Overall Study|Adverse Event|2
1708954|NCT01172821|5962838|P2|Overall Study|Adverse Event|2
1708955|NCT01172821|5962839|P1|Overall Study|Adverse Event|5
1708956|NCT01172808|5962929|P4|Overall Study|Other|7
1708957|NCT01172808|5962930|P3|Overall Study|Other|9
1708958|NCT01172808|5962931|P2|Overall Study|Other|5
1708959|NCT01172808|5962932|P1|Overall Study|Other|6
1708960|NCT01172808|5962929|P4|Overall Study|Withdrawal by Subject|2
1708961|NCT01172808|5962930|P3|Overall Study|Withdrawal by Subject|3
1708962|NCT01172808|5962931|P2|Overall Study|Withdrawal by Subject|1
1708963|NCT01172808|5962932|P1|Overall Study|Withdrawal by Subject|4
1708964|NCT01172808|5962929|P4|Overall Study|Lost to Follow-up|3
1708965|NCT01172808|5962930|P3|Overall Study|Lost to Follow-up|1
1708966|NCT01172808|5962931|P2|Overall Study|Lost to Follow-up|1
1708967|NCT01172808|5962932|P1|Overall Study|Lost to Follow-up|0
1708968|NCT01172808|5962929|P4|Overall Study|Protocol Violation|0
1708969|NCT01172808|5962930|P3|Overall Study|Protocol Violation|2
1708970|NCT01172808|5962931|P2|Overall Study|Protocol Violation|2
1708971|NCT01172808|5962932|P1|Overall Study|Protocol Violation|2
1708972|NCT01172808|5962929|P4|Overall Study|Lack of Efficacy|0
1708973|NCT01172808|5962930|P3|Overall Study|Lack of Efficacy|0
1708974|NCT01172808|5962931|P2|Overall Study|Lack of Efficacy|0
1708975|NCT01172808|5962932|P1|Overall Study|Lack of Efficacy|1
1708976|NCT01172808|5962929|P4|Overall Study|Adverse Event|3
1708977|NCT01172808|5962930|P3|Overall Study|Adverse Event|8
1708978|NCT01172808|5962931|P2|Overall Study|Adverse Event|4
1708979|NCT01172808|5962932|P1|Overall Study|Adverse Event|8
1708980|NCT01172639|5963023|P5|Overall Study|Withdrawal by Subject|0
1708981|NCT01172639|5963024|P4|Overall Study|Withdrawal by Subject|5
1708982|NCT01172639|5963025|P3|Overall Study|Withdrawal by Subject|5
1708983|NCT01172639|5963026|P2|Overall Study|Withdrawal by Subject|3
1708984|NCT01172639|5963027|P1|Overall Study|Withdrawal by Subject|3
1708985|NCT01172639|5963023|P5|Overall Study|Lost to Follow-up|6
1708986|NCT01172639|5963024|P4|Overall Study|Lost to Follow-up|6
1708987|NCT01172639|5963025|P3|Overall Study|Lost to Follow-up|11
1708988|NCT01172639|5963026|P2|Overall Study|Lost to Follow-up|7
1708989|NCT01172639|5963027|P1|Overall Study|Lost to Follow-up|9
1708990|NCT01172639|5963023|P5|Overall Study|Death|0
1708991|NCT01172639|5963024|P4|Overall Study|Death|0
1708992|NCT01172639|5963025|P3|Overall Study|Death|0
1708993|NCT01172639|5963026|P2|Overall Study|Death|1
1708994|NCT01172639|5963027|P1|Overall Study|Death|1
1708995|NCT01172535|5963102|P1|Overall Study|Unwilling to adhere to study requirement|1
1708996|NCT01172535|5963102|P1|Overall Study|Ineligible at study entry|1
1708997|NCT01172535|5963102|P1|Overall Study|Lost to Follow-up|1
1708998|NCT01172535|5963102|P1|Overall Study|Withdrawal by Subject|2
1708999|NCT01172535|5963102|P1|Overall Study|Death|3
1709000|NCT01172288|5963155|P2|Overall Study|Protocol Violation|1
1709001|NCT01172288|5963156|P1|Overall Study|Protocol Violation|0
1709002|NCT01172288|5963155|P2|Overall Study|Adverse Event|0
1709003|NCT01172288|5963156|P1|Overall Study|Adverse Event|1
1709004|NCT01172275|5963172|P2|Overall Study|Protocol Violation|0
1709005|NCT01172275|5963173|P1|Overall Study|Protocol Violation|1
1709006|NCT01172275|5963172|P2|Overall Study|Lost to Follow-up|0
1709007|NCT01172275|5963173|P1|Overall Study|Lost to Follow-up|1
1709008|NCT01171989|5963231|P3|Overall Study|Lost to Follow-up|1
1709009|NCT01171989|5963232|P2|Overall Study|Lost to Follow-up|0
1709010|NCT01171989|5963233|P1|Overall Study|Lost to Follow-up|0
1709011|NCT01171976|5963307|P3|Overall Study|Adverse Event|5
1709012|NCT01171976|5963308|P2|Overall Study|Adverse Event|2
1709013|NCT01171976|5963309|P1|Overall Study|Adverse Event|6
1709014|NCT01171976|5963307|P3|Overall Study|Abnormal test result|0
1709015|NCT01171976|5963308|P2|Overall Study|Abnormal test result|0
1709016|NCT01171976|5963309|P1|Overall Study|Abnormal test result|1
1709017|NCT01171976|5963307|P3|Overall Study|Withdrawal by Subject|6
1709018|NCT01171976|5963308|P2|Overall Study|Withdrawal by Subject|5
1709019|NCT01171976|5963309|P1|Overall Study|Withdrawal by Subject|1
1709020|NCT01171976|5963307|P3|Overall Study|Lost to Follow-up|2
1709021|NCT01171976|5963308|P2|Overall Study|Lost to Follow-up|0
1709022|NCT01171976|5963309|P1|Overall Study|Lost to Follow-up|4
1709023|NCT01171976|5963307|P3|Overall Study|Death|1
1709024|NCT01171976|5963308|P2|Overall Study|Death|4
1709025|NCT01171976|5963309|P1|Overall Study|Death|2
1709026|NCT01171976|5963307|P3|Overall Study|Protocol Violation|1
1709027|NCT01171976|5963308|P2|Overall Study|Protocol Violation|0
1709028|NCT01171976|5963309|P1|Overall Study|Protocol Violation|0
1709029|NCT01171963|5963346|P2|Overall Study|Withdrawal by Subject|129
1709030|NCT01171963|5963347|P1|Overall Study|Withdrawal by Subject|114
1709031|NCT01171963|5963346|P2|Overall Study|Other - diarrhoea|0
1709032|NCT01171963|5963347|P1|Overall Study|Other - diarrhoea|1
1709033|NCT01171963|5963346|P2|Overall Study|Lost to Follow-up|24
1709034|NCT01171963|5963347|P1|Overall Study|Lost to Follow-up|23
1709035|NCT01171963|5963346|P2|Overall Study|Adverse Event|15
1709036|NCT01171963|5963347|P1|Overall Study|Adverse Event|10
1709037|NCT01171898|5963416|P4|Overall Study|Other|2
1709038|NCT01171898|5963417|P3|Overall Study|Other|0
1709039|NCT01171898|5963418|P2|Overall Study|Other|5
1709040|NCT01171898|5963419|P1|Overall Study|Other|1
1709041|NCT01171898|5963416|P4|Overall Study|Ongoing|0
1709042|NCT01171898|5963417|P3|Overall Study|Ongoing|3
1709043|NCT01171898|5963418|P2|Overall Study|Ongoing|9
1709044|NCT01171898|5963419|P1|Overall Study|Ongoing|1
1709045|NCT01171898|5963416|P4|Overall Study|Terminated by Sponsor|0
1709046|NCT01171898|5963417|P3|Overall Study|Terminated by Sponsor|0
1709047|NCT01171898|5963418|P2|Overall Study|Terminated by Sponsor|0
1709048|NCT01171898|5963419|P1|Overall Study|Terminated by Sponsor|1
1709049|NCT01171898|5963416|P4|Overall Study|Withdrawal by Subject|3
1709050|NCT01171898|5963417|P3|Overall Study|Withdrawal by Subject|6
1709051|NCT01171898|5963418|P2|Overall Study|Withdrawal by Subject|4
1709052|NCT01171898|5963419|P1|Overall Study|Withdrawal by Subject|1
1709053|NCT01171898|5963416|P4|Overall Study|Lost to Follow-up|1
1709054|NCT01171898|5963417|P3|Overall Study|Lost to Follow-up|1
1709055|NCT01171898|5963418|P2|Overall Study|Lost to Follow-up|1
1709056|NCT01171898|5963419|P1|Overall Study|Lost to Follow-up|0
1709057|NCT01171898|5963416|P4|Overall Study|Death|0
1709058|NCT01171898|5963417|P3|Overall Study|Death|2
1709059|NCT01171898|5963418|P2|Overall Study|Death|0
1709060|NCT01171898|5963419|P1|Overall Study|Death|0
1709061|NCT01171820|5963443|P2|Overall Study|1-Year Missed Visit|1
1709062|NCT01171820|5963444|P1|Overall Study|1-Year Missed Visit|1
1709063|NCT01171820|5963443|P2|Overall Study|Physician Decision|1
1709064|NCT01171820|5963444|P1|Overall Study|Physician Decision|0
1709065|NCT01171820|5963443|P2|Overall Study|Withdrawal by Subject|0
1709066|NCT01171820|5963444|P1|Overall Study|Withdrawal by Subject|2
1709067|NCT01171820|5963443|P2|Overall Study|Lost to Follow-up|1
1709068|NCT01171820|5963444|P1|Overall Study|Lost to Follow-up|0
1709069|NCT01171820|5963443|P2|Overall Study|Death|3
1709070|NCT01171820|5963444|P1|Overall Study|Death|3
1709071|NCT01171677|5963522|P2|Overall Study|completed <70% IntenSati classes|0
1709072|NCT01171677|5963523|P1|Overall Study|completed <70% IntenSati classes|5
1709073|NCT01171677|5963522|P2|Overall Study|Adverse Event|0
1709074|NCT01171677|5963523|P1|Overall Study|Adverse Event|1
1709075|NCT01171677|5963522|P2|Overall Study|Withdrawal by Subject|3
1709076|NCT01171677|5963523|P1|Overall Study|Withdrawal by Subject|0
1709077|NCT01171612|5963555|P1|Overall Study|Lost to Follow-up|51
1709078|NCT01171534|5963565|P2|Overall Study|screen failure|1
1709079|NCT01171534|5963566|P1|Overall Study|screen failure|0
1709080|NCT01171534|5963565|P2|Overall Study|Lost to Follow-up|2
1709081|NCT01171534|5963566|P1|Overall Study|Lost to Follow-up|0
1709082|NCT01171521|5963578|P1|Overall Study|screen failure|1
1709083|NCT01171521|5963578|P1|Overall Study|Lost to Follow-up|5
1709084|NCT01171183|5963585|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
1709085|NCT01171183|5963586|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
1709086|NCT01171183|5963585|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
1709087|NCT01171183|5963586|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
1709088|NCT01171183|5963585|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
1709089|NCT01171183|5963586|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
1709090|NCT01171183|5963585|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
1709091|NCT01171183|5963586|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
1709092|NCT01171183|5963585|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
1709093|NCT01171183|5963586|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
1709094|NCT01171183|5963585|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
1709095|NCT01171183|5963586|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
1709096|NCT01170962|5963607|P3|Follow up Period|Others|3
1709097|NCT01170962|5963608|P2|Follow up Period|Others|7
1709098|NCT01170962|5963609|P1|Follow up Period|Others|10
1709099|NCT01170962|5963607|P3|Follow up Period|Death|0
1709100|NCT01170962|5963608|P2|Follow up Period|Death|2
1709101|NCT01170962|5963609|P1|Follow up Period|Death|2
1709102|NCT01170962|5963607|P3|Follow up Period|Lost to Follow-up|1
1709103|NCT01170962|5963608|P2|Follow up Period|Lost to Follow-up|8
1709104|NCT01170962|5963609|P1|Follow up Period|Lost to Follow-up|13
1709105|NCT01170962|5963607|P3|Follow up Period|Withdrawal by Subject|2
1709106|NCT01170962|5963608|P2|Follow up Period|Withdrawal by Subject|10
1709107|NCT01170962|5963609|P1|Follow up Period|Withdrawal by Subject|14
1709108|NCT01170962|5963607|P3|Treatment Period|Completed 24 Week treatment period only|0
1709109|NCT01170962|5963608|P2|Treatment Period|Completed 24 Week treatment period only|2
1709110|NCT01170962|5963609|P1|Treatment Period|Completed 24 Week treatment period only|10
1709111|NCT01170962|5963607|P3|Treatment Period|Request to discontinue treatment|1
1709112|NCT01170962|5963608|P2|Treatment Period|Request to discontinue treatment|3
1709113|NCT01170962|5963609|P1|Treatment Period|Request to discontinue treatment|7
1709114|NCT01170962|5963607|P3|Treatment Period|Participant no longer meets criteria|0
1709115|NCT01170962|5963608|P2|Treatment Period|Participant no longer meets criteria|1
1709116|NCT01170962|5963609|P1|Treatment Period|Participant no longer meets criteria|0
1709117|NCT01170962|5963607|P3|Treatment Period|Lost to Follow-up|1
1709118|NCT01170962|5963608|P2|Treatment Period|Lost to Follow-up|1
1709119|NCT01170962|5963609|P1|Treatment Period|Lost to Follow-up|1
1709120|NCT01170962|5963607|P3|Treatment Period|Withdrawal by Subject|0
1709121|NCT01170962|5963608|P2|Treatment Period|Withdrawal by Subject|1
1709122|NCT01170962|5963609|P1|Treatment Period|Withdrawal by Subject|2
1709123|NCT01170962|5963607|P3|Treatment Period|Adverse Event|3
1709124|NCT01170962|5963608|P2|Treatment Period|Adverse Event|12
1709125|NCT01170962|5963609|P1|Treatment Period|Adverse Event|11
1709126|NCT01170962|5963607|P3|Treatment Period|Lack of Efficacy|7
1709127|NCT01170962|5963608|P2|Treatment Period|Lack of Efficacy|91
1709128|NCT01170962|5963609|P1|Treatment Period|Lack of Efficacy|96
1709129|NCT01170663|5963704|P2|Overall Study|Withdrawal of consent without follow-up|11
1709130|NCT01170663|5963705|P1|Overall Study|Withdrawal of consent without follow-up|11
1709131|NCT01170663|5963704|P2|Overall Study|Lost to Follow-up|9
1709132|NCT01170663|5963705|P1|Overall Study|Lost to Follow-up|3
1709133|NCT01170598|5963733|P1|Overall Study|Refused|1
1709134|NCT01170598|5963733|P1|Overall Study|Lost to Follow-up|1
1709135|NCT01170598|5963733|P1|Overall Study|Death|3
1709136|NCT01170598|5963733|P1|Overall Study|Withdrawal by Subject|1
1709137|NCT01170364|5963796|P2|Overall Study|Protocol Violation|1
1709138|NCT01170364|5963797|P1|Overall Study|Protocol Violation|4
1709139|NCT01170273|5963805|P2|Overall Study|Adverse Event|1
1709140|NCT01170273|5963806|P1|Overall Study|Adverse Event|0
1709141|NCT01170273|5963805|P2|Overall Study|Death|0
1709142|NCT01170273|5963806|P1|Overall Study|Death|1
1709143|NCT01170273|5963805|P2|Overall Study|Protocol Violation|0
1709144|NCT01170273|5963806|P1|Overall Study|Protocol Violation|1
1709145|NCT01170273|5963805|P2|Overall Study|Lost to Follow-up|8
1709146|NCT01170273|5963806|P1|Overall Study|Lost to Follow-up|6
1709147|NCT01170221|5963823|P2|Overall Study|Randomized but not treated|0
1709148|NCT01170221|5963824|P1|Overall Study|Randomized but not treated|1
1709149|NCT01170221|5963823|P2|Overall Study|Subject completed only screening and LFU|0
1709150|NCT01170221|5963824|P1|Overall Study|Subject completed only screening and LFU|1
1709151|NCT01170221|5963823|P2|Overall Study|Withdrawal by Subject|7
1709152|NCT01170221|5963824|P1|Overall Study|Withdrawal by Subject|9
1709153|NCT01170221|5963823|P2|Overall Study|Lost to Follow-up|21
1709154|NCT01170221|5963824|P1|Overall Study|Lost to Follow-up|22
1709155|NCT01170208|5963847|P3|Overall Study|Protocol Violation|1
1709156|NCT01170208|5963848|P2|Overall Study|Protocol Violation|0
1709157|NCT01170208|5963849|P1|Overall Study|Protocol Violation|1
1709158|NCT01170208|5963847|P3|Overall Study|Withdrawal by Subject|1
1709159|NCT01170208|5963848|P2|Overall Study|Withdrawal by Subject|0
1709160|NCT01170208|5963849|P1|Overall Study|Withdrawal by Subject|5
1709161|NCT01170091|5963877|P1|Overall Study|Treatment duration is less than 4 weeks|21
1709162|NCT01170091|5963877|P1|Overall Study|Missing efficacy evaluation|3
1709163|NCT01170065|5963887|P3|Overall Study|Ongoing after planned observation time|10
1709164|NCT01170065|5963888|P2|Overall Study|Ongoing after planned observation time|26
1709165|NCT01170065|5963889|P1|Overall Study|Ongoing after planned observation time|5
1709166|NCT01170065|5963887|P3|Overall Study|Reason other than specified|3
1709167|NCT01170065|5963888|P2|Overall Study|Reason other than specified|8
1709168|NCT01170065|5963889|P1|Overall Study|Reason other than specified|3
1709169|NCT01170065|5963887|P3|Overall Study|Consent withdrawn, not due to AE|2
1709170|NCT01170065|5963888|P2|Overall Study|Consent withdrawn, not due to AE|4
1709171|NCT01170065|5963889|P1|Overall Study|Consent withdrawn, not due to AE|2
1709172|NCT01170065|5963887|P3|Overall Study|Lost to Follow-up|1
1709173|NCT01170065|5963888|P2|Overall Study|Lost to Follow-up|4
1709174|NCT01170065|5963889|P1|Overall Study|Lost to Follow-up|1
1709175|NCT01170065|5963887|P3|Overall Study|Adverse Event|10
1709176|NCT01170065|5963888|P2|Overall Study|Adverse Event|50
1709177|NCT01170065|5963889|P1|Overall Study|Adverse Event|17
1709178|NCT01170039|5963920|P2|Overall Study|Lack of funding, drug not available|3
1709179|NCT01170039|5963921|P1|Overall Study|Lack of funding, drug not available|3
1709180|NCT01170039|5963920|P2|Overall Study|Withdrawal by Subject|3
1709181|NCT01170039|5963921|P1|Overall Study|Withdrawal by Subject|5
1709182|NCT01169987|5963933|P1|Overall Study|Other|4
1709183|NCT01169987|5963933|P1|Overall Study|Lost to Follow-up|24
1709184|NCT01169987|5963933|P1|Overall Study|Withdrawal by Subject|3
1709185|NCT01169779|5963999|P2|Overall Study|Familial and personal reasons|3
1709186|NCT01169779|5964000|P1|Overall Study|Familial and personal reasons|3
1709187|NCT01169779|5963999|P2|Overall Study|Withdrawal by Subject|2
1709188|NCT01169779|5964000|P1|Overall Study|Withdrawal by Subject|3
1709189|NCT01169779|5963999|P2|Overall Study|Protocol Violation|1
1709190|NCT01169779|5964000|P1|Overall Study|Protocol Violation|1
1709191|NCT01169779|5963999|P2|Overall Study|Lack of Efficacy|0
1709192|NCT01169779|5964000|P1|Overall Study|Lack of Efficacy|1
1709193|NCT01169779|5963999|P2|Overall Study|Adverse Event|11
1709194|NCT01169779|5964000|P1|Overall Study|Adverse Event|3
1709195|NCT01169701|5964035|P2|Overall Study|Sponsor decision|1
1709196|NCT01169701|5964036|P1|Overall Study|Sponsor decision|0
1709197|NCT01169701|5964035|P2|Overall Study|Serious adverse event|1
1709198|NCT01169701|5964036|P1|Overall Study|Serious adverse event|0
1709199|NCT01169701|5964035|P2|Overall Study|Administrative problems|1
1709200|NCT01169701|5964036|P1|Overall Study|Administrative problems|0
1709201|NCT01169701|5964035|P2|Overall Study|Death|1
1709202|NCT01169701|5964036|P1|Overall Study|Death|0
1709203|NCT01169701|5964035|P2|Overall Study|Exclusion criteria|0
1709204|NCT01169701|5964036|P1|Overall Study|Exclusion criteria|2
1709205|NCT01169701|5964035|P2|Overall Study|Adverse Event|2
1709206|NCT01169701|5964036|P1|Overall Study|Adverse Event|1
1709207|NCT01169701|5964035|P2|Overall Study|Withdrawal by Subject|3
1709208|NCT01169701|5964036|P1|Overall Study|Withdrawal by Subject|1
1709209|NCT01169701|5964035|P2|Overall Study|Lost to Follow-up|1
1709210|NCT01169701|5964036|P1|Overall Study|Lost to Follow-up|1
1709211|NCT01169675|5964073|P5|Overall Study|Other Reason Not Defined Above|1
1709212|NCT01169675|5964074|P4|Overall Study|Other Reason Not Defined Above|1
1709213|NCT01169675|5964075|P3|Overall Study|Other Reason Not Defined Above|0
1709214|NCT01169675|5964076|P2|Overall Study|Other Reason Not Defined Above|0
1709215|NCT01169675|5964077|P1|Overall Study|Other Reason Not Defined Above|0
1709216|NCT01169675|5964073|P5|Overall Study|Withdrawal by Subject|2
1709217|NCT01169675|5964074|P4|Overall Study|Withdrawal by Subject|1
1709218|NCT01169675|5964075|P3|Overall Study|Withdrawal by Subject|0
1709219|NCT01169675|5964076|P2|Overall Study|Withdrawal by Subject|0
1709220|NCT01169675|5964077|P1|Overall Study|Withdrawal by Subject|1
1709221|NCT01169675|5964073|P5|Overall Study|Adverse Event|0
1709222|NCT01169675|5964074|P4|Overall Study|Adverse Event|0
1709223|NCT01169675|5964075|P3|Overall Study|Adverse Event|2
1709224|NCT01169675|5964076|P2|Overall Study|Adverse Event|1
1709225|NCT01169675|5964077|P1|Overall Study|Adverse Event|5
1709226|NCT01169675|5964073|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
1709227|NCT01169675|5964074|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1709228|NCT01169675|5964075|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
1709229|NCT01169675|5964076|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1709230|NCT01169675|5964077|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
1709231|NCT01169675|5964073|P5|Overall Study|Progressive disease|1
1709232|NCT01169675|5964074|P4|Overall Study|Progressive disease|15
1709233|NCT01169675|5964075|P3|Overall Study|Progressive disease|5
1709234|NCT01169675|5964076|P2|Overall Study|Progressive disease|2
1709235|NCT01169675|5964077|P1|Overall Study|Progressive disease|13
1709236|NCT01169649|5964114|P1|Overall Study|Patient Not Treated|3
1709237|NCT01169558|5964126|P1|Overall Study|Partial response|2
1709238|NCT01169558|5964126|P1|Overall Study|Protocol Violation|2
1709239|NCT01169558|5964126|P1|Overall Study|Non-compliance|2
1709240|NCT01169558|5964126|P1|Overall Study|Need for Surgery|4
1709241|NCT01169558|5964126|P1|Overall Study|Lost to Follow-up|4
1709242|NCT01169558|5964126|P1|Overall Study|Stable Disease|4
1709243|NCT01169558|5964126|P1|Overall Study|Medical Decision|7
1709244|NCT01169558|5964126|P1|Overall Study|Withdrawal of Consent|8
1709245|NCT01169558|5964126|P1|Overall Study|Adverse Event|25
1709246|NCT01169558|5964126|P1|Overall Study|Disease progression|98
1709247|NCT01169493|5964151|P6|Period 3 (6 Months)|Physician Decision|0
1709248|NCT01169493|5964152|P5|Period 3 (6 Months)|Physician Decision|0
1709249|NCT01169493|5964153|P4|Period 3 (6 Months)|Physician Decision|0
1709250|NCT01169493|5964154|P3|Period 3 (6 Months)|Physician Decision|1
1709251|NCT01169493|5964155|P2|Period 3 (6 Months)|Physician Decision|1
1709252|NCT01169493|5964156|P1|Period 3 (6 Months)|Physician Decision|0
1709253|NCT01169493|5964151|P6|Period 3 (6 Months)|Adverse Event|0
1709254|NCT01169493|5964152|P5|Period 3 (6 Months)|Adverse Event|0
1709255|NCT01169493|5964153|P4|Period 3 (6 Months)|Adverse Event|0
1709256|NCT01169493|5964154|P3|Period 3 (6 Months)|Adverse Event|0
1709257|NCT01169493|5964155|P2|Period 3 (6 Months)|Adverse Event|1
1709258|NCT01169493|5964156|P1|Period 3 (6 Months)|Adverse Event|0
1709259|NCT01169493|5964151|P6|Period 1 (6 Months)|Withdrawal by Subject|3
1709260|NCT01169493|5964152|P5|Period 1 (6 Months)|Withdrawal by Subject|0
1709261|NCT01169493|5964153|P4|Period 1 (6 Months)|Withdrawal by Subject|0
1709262|NCT01169493|5964154|P3|Period 1 (6 Months)|Withdrawal by Subject|2
1709263|NCT01169493|5964155|P2|Period 1 (6 Months)|Withdrawal by Subject|1
1709264|NCT01169493|5964156|P1|Period 1 (6 Months)|Withdrawal by Subject|0
1709265|NCT01169350|5964202|P1|Overall Study|Lost to Follow-up|2
1709266|NCT01169350|5964202|P1|Overall Study|Physician Decision|3
1709267|NCT01169103|5964332|P2|Overall Study|Withdrawal by Subject|1
1709268|NCT01169103|5964333|P1|Overall Study|Withdrawal by Subject|3
1709269|NCT01169103|5964332|P2|Overall Study|Lost to Follow-up|3
1709270|NCT01169103|5964333|P1|Overall Study|Lost to Follow-up|3
1709271|NCT01169038|5964360|P1|Overall Study|Required antibiotic administration|1
1709272|NCT01169038|5964360|P1|Overall Study|Adverse Event|5
1709273|NCT01169038|5964360|P1|Overall Study|Death|1
1709274|NCT01168999|5964368|P4|Overall Study|Lost to Follow-up|0
1709275|NCT01168999|5964369|P3|Overall Study|Lost to Follow-up|0
1709276|NCT01168999|5964370|P2|Overall Study|Lost to Follow-up|1
1709277|NCT01168999|5964371|P1|Overall Study|Lost to Follow-up|2
1709278|NCT01168973|5964437|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
1709279|NCT01168973|5964438|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
1709280|NCT01168973|5964437|P2|Overall Study|Sponsor Decision|1
1709281|NCT01168973|5964438|P1|Overall Study|Sponsor Decision|2
1709282|NCT01168973|5964437|P2|Overall Study|Physician Decision|19
1709283|NCT01168973|5964438|P1|Overall Study|Physician Decision|37
1709284|NCT01168973|5964437|P2|Overall Study|Death|45
1709285|NCT01168973|5964438|P1|Overall Study|Death|42
1709286|NCT01168973|5964437|P2|Overall Study|Withdrawal by Subject|53
1709287|NCT01168973|5964438|P1|Overall Study|Withdrawal by Subject|90
1709288|NCT01168973|5964437|P2|Overall Study|Adverse Event|55
1709289|NCT01168973|5964438|P1|Overall Study|Adverse Event|94
1709290|NCT01168973|5964437|P2|Overall Study|Progressive Disease|429
1709291|NCT01168973|5964438|P1|Overall Study|Progressive Disease|341
1709292|NCT01168856|5964513|P2|Overall Study|Protocol Violation|6
1709293|NCT01168856|5964514|P1|Overall Study|Protocol Violation|4
1709294|NCT01168856|5964513|P2|Overall Study|Other|291
1709295|NCT01168856|5964514|P1|Overall Study|Other|1
1709296|NCT01168856|5964513|P2|Overall Study|Death|2
1709297|NCT01168856|5964514|P1|Overall Study|Death|0
1709298|NCT01168856|5964513|P2|Overall Study|Participant received anti-HCV treatment|0
1709299|NCT01168856|5964514|P1|Overall Study|Participant received anti-HCV treatment|1
1709300|NCT01168856|5964513|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
1709301|NCT01168856|5964514|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
1709302|NCT01168856|5964513|P2|Overall Study|Physician Decision|1
1709303|NCT01168856|5964514|P1|Overall Study|Physician Decision|2
1709304|NCT01168856|5964513|P2|Overall Study|Withdrawal by Subject|8
1709305|NCT01168856|5964514|P1|Overall Study|Withdrawal by Subject|6
1709306|NCT01168856|5964513|P2|Overall Study|Lost to Follow-up|34
1709307|NCT01168856|5964514|P1|Overall Study|Lost to Follow-up|4
1709308|NCT01168596|5964612|P2|Overall Study|Withdrawal by Subject|1
1709309|NCT01168596|5964613|P1|Overall Study|Withdrawal by Subject|3
1709310|NCT01168427|5964657|P1|Overall Study|Patient exited prior to implant|1
1709311|NCT01168401|5964673|P11|Overall Study|Withdrawal by Subject|0
1709312|NCT01168401|5964674|P10|Overall Study|Withdrawal by Subject|0
1709313|NCT01168401|5964675|P9|Overall Study|Withdrawal by Subject|0
1709314|NCT01168401|5964676|P8|Overall Study|Withdrawal by Subject|0
1709315|NCT01168401|5964677|P7|Overall Study|Withdrawal by Subject|0
1709316|NCT01168401|5964678|P6|Overall Study|Withdrawal by Subject|0
1709317|NCT01168401|5964679|P5|Overall Study|Withdrawal by Subject|0
1709318|NCT01168401|5964680|P4|Overall Study|Withdrawal by Subject|1
1709319|NCT01168401|5964681|P3|Overall Study|Withdrawal by Subject|0
1709320|NCT01168401|5964682|P2|Overall Study|Withdrawal by Subject|0
1709321|NCT01168401|5964683|P1|Overall Study|Withdrawal by Subject|0
1709322|NCT01168401|5964673|P11|Overall Study|Lost to Follow-up|0
1709323|NCT01168401|5964674|P10|Overall Study|Lost to Follow-up|0
1709324|NCT01168401|5964675|P9|Overall Study|Lost to Follow-up|0
1709325|NCT01168401|5964676|P8|Overall Study|Lost to Follow-up|0
1709326|NCT01168401|5964677|P7|Overall Study|Lost to Follow-up|0
1709327|NCT01168401|5964678|P6|Overall Study|Lost to Follow-up|0
1709328|NCT01168401|5964679|P5|Overall Study|Lost to Follow-up|0
1709329|NCT01168401|5964680|P4|Overall Study|Lost to Follow-up|1
1709330|NCT01168401|5964681|P3|Overall Study|Lost to Follow-up|2
1709331|NCT01168401|5964682|P2|Overall Study|Lost to Follow-up|1
1709332|NCT01168401|5964683|P1|Overall Study|Lost to Follow-up|1
1709333|NCT01168349|5964916|P1|Overall Study|Protocol Violation|76
1709334|NCT01168349|5964916|P1|Overall Study|Other|22
1709335|NCT01168349|5964916|P1|Overall Study|Kidney transplantation|3
1709336|NCT01168349|5964916|P1|Overall Study|Withdrawal by Subject|9
1709337|NCT01168349|5964916|P1|Overall Study|Lost to Follow-up|34
1709338|NCT01168349|5964916|P1|Overall Study|Death|157
1709339|NCT01168232|5965022|P1|Overall Study|Ineligible-Inadequate pathology|1
1709340|NCT01168232|5965022|P1|Overall Study|Ineligible- Wrong cell type|6
1709341|NCT01168232|5965022|P1|Overall Study|Ineligible-Second primary cancer site|1
1709342|NCT01168219|5965029|P1|Overall Study|ineligible due to CML|2
1709343|NCT01168219|5965029|P1|Overall Study|withdrew before transplant|1
1709344|NCT01168219|5965029|P1|Overall Study|off study before starting treatment|2
1709345|NCT01167907|5965052|P2|Overall Study|saphenous catheter dislodged before comp|1
1709346|NCT01167907|5965053|P1|Overall Study|saphenous catheter dislodged before comp|1
1709347|NCT01167907|5965052|P2|Overall Study|Protocol Violation|0
1709348|NCT01167907|5965053|P1|Overall Study|Protocol Violation|1
1709349|NCT01167881|5965071|P2|Overall Study|Other not defined above|55
1709350|NCT01167881|5965072|P1|Overall Study|Other not defined above|31
1709351|NCT01167881|5965071|P2|Overall Study|Not treated|0
1709352|NCT01167881|5965072|P1|Overall Study|Not treated|4
1709353|NCT01167881|5965071|P2|Overall Study|Patient refusal to cont., not due to AE|40
1709354|NCT01167881|5965072|P1|Overall Study|Patient refusal to cont., not due to AE|45
1709355|NCT01167881|5965071|P2|Overall Study|Lost to Follow-up|20
1709356|NCT01167881|5965072|P1|Overall Study|Lost to Follow-up|19
1709357|NCT01167881|5965071|P2|Overall Study|Non compliant with protocol|18
1709358|NCT01167881|5965072|P1|Overall Study|Non compliant with protocol|9
1709359|NCT01167881|5965071|P2|Overall Study|Lack of Efficacy|7
1709360|NCT01167881|5965072|P1|Overall Study|Lack of Efficacy|4
1709361|NCT01167881|5965071|P2|Overall Study|Adverse Event|51
1709362|NCT01167881|5965072|P1|Overall Study|Adverse Event|47
1709363|NCT01167634|5965126|P4|Overall Study|Withdrawal by Subject|0
1709364|NCT01167634|5965127|P3|Overall Study|Withdrawal by Subject|0
1709365|NCT01167634|5965128|P2|Overall Study|Withdrawal by Subject|1
1709366|NCT01167634|5965129|P1|Overall Study|Withdrawal by Subject|1
1709367|NCT01167634|5965126|P4|Overall Study|Lost to Follow-up|4
1709368|NCT01167634|5965127|P3|Overall Study|Lost to Follow-up|3
1709369|NCT01167634|5965128|P2|Overall Study|Lost to Follow-up|3
1709370|NCT01167634|5965129|P1|Overall Study|Lost to Follow-up|1
1709371|NCT01167582|5965150|P2|Overall Study|Lost to Follow-up|1
1709372|NCT01167582|5965151|P1|Overall Study|Lost to Follow-up|0
1709373|NCT01167426|5965191|P1|Overall Study|Sponsor Decision|1
1709374|NCT01167426|5965191|P1|Overall Study|Withdrawal by Subject|2
1709375|NCT01167426|5965191|P1|Overall Study|Protocol Violation|1
1709376|NCT01167426|5965191|P1|Overall Study|Lost to Follow-up|6
1709377|NCT01167257|5965199|P2|Overall Study|Withdrew consent|1
1709378|NCT01167257|5965200|P1|Overall Study|Withdrew consent|1
1709379|NCT01167257|5965199|P2|Overall Study|Lost to Follow-up|2
1709380|NCT01167257|5965200|P1|Overall Study|Lost to Follow-up|2
1709381|NCT01167192|5965222|P1|Overall Study|Insurance denial|1
1709382|NCT01167192|5965222|P1|Overall Study|Withdrawal by Subject|1
1709383|NCT01167192|5965222|P1|Overall Study|Death|1
1709384|NCT01167192|5965222|P1|Overall Study|Adverse Event|1
1709385|NCT01167179|5965239|P2|Overall Study|diverse|5
1709386|NCT01167179|5965240|P1|Overall Study|diverse|6
1709387|NCT01167179|5965239|P2|Overall Study|Withdrawal by Subject|2
1709388|NCT01167179|5965240|P1|Overall Study|Withdrawal by Subject|1
1709389|NCT01167179|5965239|P2|Overall Study|Death|10
1709390|NCT01167179|5965240|P1|Overall Study|Death|4
1709391|NCT01167179|5965239|P2|Overall Study|disease recurrence|4
1709392|NCT01167179|5965240|P1|Overall Study|disease recurrence|4
1709393|NCT01167153|5965250|P2|Overall Study|Subject initiation withdrawal, Other|8
1709394|NCT01167153|5965251|P1|Overall Study|Subject initiation withdrawal, Other|5
1709395|NCT01167153|5965250|P2|Overall Study|Withdrawal consent|1
1709396|NCT01167153|5965251|P1|Overall Study|Withdrawal consent|1
1709397|NCT01167153|5965250|P2|Overall Study|Investigator initiation withdrawal,Other|1
1709398|NCT01167153|5965251|P1|Overall Study|Investigator initiation withdrawal,Other|1
1709399|NCT01167153|5965250|P2|Overall Study|Non-compliance to concomitant medication|2
1709400|NCT01167153|5965251|P1|Overall Study|Non-compliance to concomitant medication|0
1709401|NCT01167153|5965250|P2|Overall Study|Lost to Follow-up|9
1709402|NCT01167153|5965251|P1|Overall Study|Lost to Follow-up|7
1709403|NCT01167153|5965250|P2|Overall Study|Hypotension|0
1709404|NCT01167153|5965251|P1|Overall Study|Hypotension|1
1709405|NCT01167153|5965250|P2|Overall Study|AE including clinical laboratory AE|8
1709406|NCT01167153|5965251|P1|Overall Study|AE including clinical laboratory AE|2
1709407|NCT01167153|5965250|P2|Overall Study|Non-effective therapy|4
1709408|NCT01167153|5965251|P1|Overall Study|Non-effective therapy|1
1709409|NCT01167140|5965269|P1|Overall Study|Withdrawal by Subject|1
1709410|NCT01167023|5965277|P3|Overall Study|Withdrawal by Subject|1
1709411|NCT01167023|5965278|P2|Overall Study|Withdrawal by Subject|0
1709412|NCT01167023|5965279|P1|Overall Study|Withdrawal by Subject|0
1709413|NCT01167023|5965277|P3|Overall Study|Sponsor Decision|0
1709414|NCT01167023|5965278|P2|Overall Study|Sponsor Decision|1
1709415|NCT01167023|5965279|P1|Overall Study|Sponsor Decision|0
1709416|NCT01167023|5965277|P3|Overall Study|Screen Failure|0
1709417|NCT01167023|5965278|P2|Overall Study|Screen Failure|1
1709418|NCT01167023|5965279|P1|Overall Study|Screen Failure|0
1709419|NCT01167023|5965277|P3|Overall Study|Lost to Follow-up|1
1709420|NCT01167023|5965278|P2|Overall Study|Lost to Follow-up|1
1709421|NCT01167023|5965279|P1|Overall Study|Lost to Follow-up|0
1709422|NCT01166958|5965319|P2|Overall Study|Withdrawal by Subject|0
1709423|NCT01166958|5965320|P1|Overall Study|Withdrawal by Subject|1
1709424|NCT01166945|5965336|P2|Day 30|Lost to Follow-up|3
1709425|NCT01166945|5965337|P1|Day 30|Lost to Follow-up|4
1709426|NCT01166945|5965336|P2|Day 15|NonCompliance/Lost to Follow Up|1
1709427|NCT01166945|5965337|P1|Day 15|NonCompliance/Lost to Follow Up|2
1709428|NCT01166945|5965336|P2|Day 10|NonCompliance/Lost to Follow Up|2
1709429|NCT01166945|5965337|P1|Day 10|NonCompliance/Lost to Follow Up|3
1709430|NCT01166945|5965336|P2|Randomized|diagnosed with Group A strep|4
1709431|NCT01166945|5965337|P1|Randomized|diagnosed with Group A strep|4
1709432|NCT01166763|5965345|P1|Overall Study|Withdrawal by Subject|3
1709433|NCT01166750|5965353|P2|Overall Study|Lost to Follow-up|0
1709434|NCT01166750|5965354|P1|Overall Study|Lost to Follow-up|1
1709435|NCT01166659|5965371|P1|Overall Study|Study Closed at Site|1
1709436|NCT01166659|5965371|P1|Overall Study|Lost to Follow-up|1
1709437|NCT01166659|5965371|P1|Overall Study|Death|1
1709438|NCT01166659|5965371|P1|Overall Study|Investigator Decision|2
1709439|NCT01166659|5965371|P1|Overall Study|Subject Decision|8
1709440|NCT01166646|5965380|P2|Overall Study|Adverse Event|0
1709441|NCT01166646|5965381|P1|Overall Study|Adverse Event|1
1709442|NCT01166646|5965380|P2|Overall Study|Protocol Violation|1
1709443|NCT01166646|5965381|P1|Overall Study|Protocol Violation|0
1709444|NCT01166568|5965400|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
1709445|NCT01166568|5965401|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
1709446|NCT01166568|5965402|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
1709447|NCT01166568|5965400|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
1709448|NCT01166568|5965401|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
1709449|NCT01166568|5965402|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
1709450|NCT01166568|5965400|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
1709451|NCT01166568|5965401|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
1709452|NCT01166568|5965402|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
1709453|NCT01166438|5965415|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
1709454|NCT01166438|5965416|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
1709455|NCT01166438|5965415|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
1709456|NCT01166438|5965416|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
1709457|NCT01166438|5965415|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
1709458|NCT01166438|5965416|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
1709459|NCT01166438|5965415|P2|Double-blind Phase: 1st 6 Months|Not treated|1
1709460|NCT01166438|5965416|P1|Double-blind Phase: 1st 6 Months|Not treated|1
1709461|NCT01166438|5965415|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
1709462|NCT01166438|5965416|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
1709463|NCT01166438|5965415|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
1709464|NCT01166438|5965416|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
1709465|NCT01166282|5965465|P3|Open-label Period|Irregular Compliance|1
1709466|NCT01166282|5965466|P2|Open-label Period|Irregular Compliance|0
1709467|NCT01166282|5965467|P1|Open-label Period|Irregular Compliance|0
1709468|NCT01166282|5965465|P3|Open-label Period|Remission|4
1709469|NCT01166282|5965466|P2|Open-label Period|Remission|0
1709470|NCT01166282|5965467|P1|Open-label Period|Remission|0
1709471|NCT01166282|5965465|P3|Open-label Period|Lack of Efficacy|2
1709472|NCT01166282|5965466|P2|Open-label Period|Lack of Efficacy|0
1709473|NCT01166282|5965467|P1|Open-label Period|Lack of Efficacy|0
1709474|NCT01166282|5965465|P3|Open-label Period|Withdrawal by Subject|4
1709475|NCT01166282|5965466|P2|Open-label Period|Withdrawal by Subject|0
1709476|NCT01166282|5965467|P1|Open-label Period|Withdrawal by Subject|0
1709477|NCT01166282|5965465|P3|Open-label Period|Adverse Event|6
1709478|NCT01166282|5965466|P2|Open-label Period|Adverse Event|0
1709479|NCT01166282|5965467|P1|Open-label Period|Adverse Event|0
1709480|NCT01166178|5965506|P2|Overall Study|Study was terminated|8
1709481|NCT01166178|5965507|P1|Overall Study|Study was terminated|20
1709482|NCT01166178|5965506|P2|Overall Study|Withdrawal by Subject|0
1709483|NCT01166178|5965507|P1|Overall Study|Withdrawal by Subject|1
1709484|NCT01165996|5965546|P1|Overall Study|Physician Decision|1
1709485|NCT01165996|5965546|P1|Overall Study|Death|1
1709486|NCT01165684|5965617|P2|Overall Study|Unclassified|22
1709487|NCT01165684|5965618|P1|Overall Study|Unclassified|16
1709488|NCT01165684|5965617|P2|Overall Study|Withdrawal Criteria|13
1709489|NCT01165684|5965618|P1|Overall Study|Withdrawal Criteria|2
1709490|NCT01165684|5965617|P2|Overall Study|Protocol Violation|15
1709491|NCT01165684|5965618|P1|Overall Study|Protocol Violation|7
1709492|NCT01165684|5965617|P2|Overall Study|Lack of Efficacy|1
1709493|NCT01165684|5965618|P1|Overall Study|Lack of Efficacy|2
1709494|NCT01165684|5965617|P2|Overall Study|Adverse Event|1
1709495|NCT01165684|5965618|P1|Overall Study|Adverse Event|1
1709496|NCT01165554|5965652|P1|Overall Study|Withdrawal by Subject|23
1709497|NCT01165424|5965675|P1|Overall Study|Participant moved (relocated)|1
1709498|NCT01165424|5965675|P1|Overall Study|Did not meet entry criteria|1
1709499|NCT01165424|5965675|P1|Overall Study|Laboratory adverse experiences|1
1709500|NCT01165424|5965675|P1|Overall Study|Clinical adverse experiences|1
1709501|NCT01165320|5965682|P3|Overall Study|Reason unknown|0
1709502|NCT01165320|5965683|P2|Overall Study|Reason unknown|1
1709503|NCT01165320|5965684|P1|Overall Study|Reason unknown|0
1709504|NCT01165320|5965682|P3|Overall Study|Lack of Efficacy|0
1709505|NCT01165320|5965683|P2|Overall Study|Lack of Efficacy|2
1709506|NCT01165320|5965684|P1|Overall Study|Lack of Efficacy|0
1709507|NCT01165320|5965682|P3|Overall Study|Laboratory adverse experience|0
1709508|NCT01165320|5965683|P2|Overall Study|Laboratory adverse experience|0
1709509|NCT01165320|5965684|P1|Overall Study|Laboratory adverse experience|1
1709510|NCT01165320|5965682|P3|Overall Study|Clinical adverse experience|0
1709511|NCT01165320|5965683|P2|Overall Study|Clinical adverse experience|1
1709512|NCT01165320|5965684|P1|Overall Study|Clinical adverse experience|2
1709513|NCT01165307|5965694|P2|Overall Study|Subject not available for contact|0
1709514|NCT01165307|5965695|P1|Overall Study|Subject not available for contact|1
1709515|NCT01165307|5965694|P2|Overall Study|Withdrawal by Subject|0
1709516|NCT01165307|5965695|P1|Overall Study|Withdrawal by Subject|2
1709517|NCT01165307|5965694|P2|Overall Study|Lost to Follow-up|3
1709518|NCT01165307|5965695|P1|Overall Study|Lost to Follow-up|11
1709519|NCT01165281|5965725|P2|Overall Study|Other|0
1709520|NCT01165281|5965726|P1|Overall Study|Other|6
1709521|NCT01165281|5965725|P2|Overall Study|Progressive Disease|14
1709522|NCT01165281|5965726|P1|Overall Study|Progressive Disease|10
1709523|NCT01165281|5965725|P2|Overall Study|Noncompliance with Study Drug|4
1709524|NCT01165281|5965726|P1|Overall Study|Noncompliance with Study Drug|1
1709525|NCT01165281|5965725|P2|Overall Study|Withdrawal by Subject|7
1709526|NCT01165281|5965726|P1|Overall Study|Withdrawal by Subject|8
1709527|NCT01165281|5965725|P2|Overall Study|Protocol Violation|5
1709528|NCT01165281|5965726|P1|Overall Study|Protocol Violation|6
1709529|NCT01165281|5965725|P2|Overall Study|Physician Decision|1
1709530|NCT01165281|5965726|P1|Overall Study|Physician Decision|8
1709531|NCT01165281|5965725|P2|Overall Study|Lost to Follow-up|1
1709532|NCT01165281|5965726|P1|Overall Study|Lost to Follow-up|0
1709533|NCT01165281|5965725|P2|Overall Study|Lack of Efficacy|1
1709534|NCT01165281|5965726|P1|Overall Study|Lack of Efficacy|4
1709535|NCT01165281|5965725|P2|Overall Study|Death|4
1709536|NCT01165281|5965726|P1|Overall Study|Death|3
1709537|NCT01165281|5965725|P2|Overall Study|Adverse Event|14
1709538|NCT01165281|5965726|P1|Overall Study|Adverse Event|12
1709539|NCT01165242|5965747|P3|Overall Study|Lost to Follow-up|10
1709540|NCT01165242|5965748|P2|Overall Study|Lost to Follow-up|7
1709541|NCT01165242|5965749|P1|Overall Study|Lost to Follow-up|9
1709542|NCT01165242|5965747|P3|Overall Study|Extended Holiday|1
1709543|NCT01165242|5965748|P2|Overall Study|Extended Holiday|0
1709544|NCT01165242|5965749|P1|Overall Study|Extended Holiday|0
1709545|NCT01165242|5965747|P3|Overall Study|Withdrawal by Subject|2
1709546|NCT01165242|5965748|P2|Overall Study|Withdrawal by Subject|2
1709547|NCT01165242|5965749|P1|Overall Study|Withdrawal by Subject|0
1709548|NCT01165242|5965747|P3|Overall Study|Visit 2 Declined by Subject|1
1709549|NCT01165242|5965748|P2|Overall Study|Visit 2 Declined by Subject|0
1709550|NCT01165242|5965749|P1|Overall Study|Visit 2 Declined by Subject|0
1709551|NCT01165242|5965747|P3|Overall Study|Incarcerated Subjects|0
1709552|NCT01165242|5965748|P2|Overall Study|Incarcerated Subjects|1
1709553|NCT01165242|5965749|P1|Overall Study|Incarcerated Subjects|0
1709554|NCT01165242|5965747|P3|Overall Study|Unreachable Subjects|0
1709555|NCT01165242|5965748|P2|Overall Study|Unreachable Subjects|0
1709556|NCT01165242|5965749|P1|Overall Study|Unreachable Subjects|1
1709557|NCT01165229|5965783|P2|Overall Study|Screening criteria unmet|0
1709558|NCT01165229|5965784|P1|Overall Study|Screening criteria unmet|1
1709559|NCT01165229|5965783|P2|Overall Study|Lack of time|0
1709560|NCT01165229|5965784|P1|Overall Study|Lack of time|1
1709561|NCT01165229|5965783|P2|Overall Study|Missed visit|0
1709562|NCT01165229|5965784|P1|Overall Study|Missed visit|1
1709563|NCT01165229|5965783|P2|Overall Study|Sponsor study termination|0
1709564|NCT01165229|5965784|P1|Overall Study|Sponsor study termination|1
1709565|NCT01165229|5965783|P2|Overall Study|Investigator decision|2
1709566|NCT01165229|5965784|P1|Overall Study|Investigator decision|0
1709567|NCT01165229|5965783|P2|Overall Study|Personal reason|4
1709568|NCT01165229|5965784|P1|Overall Study|Personal reason|10
1709569|NCT01165229|5965783|P2|Overall Study|Site closure|20
1709570|NCT01165229|5965784|P1|Overall Study|Site closure|18
1709571|NCT01165229|5965783|P2|Overall Study|Health issues|56
1709572|NCT01165229|5965784|P1|Overall Study|Health issues|61
1709573|NCT01165229|5965783|P2|Overall Study|Patient not eligible|1
1709574|NCT01165229|5965784|P1|Overall Study|Patient not eligible|0
1709575|NCT01165229|5965783|P2|Overall Study|Page entered in error|1
1709576|NCT01165229|5965784|P1|Overall Study|Page entered in error|0
1709577|NCT01165229|5965783|P2|Overall Study|No reason from the subject|1
1709578|NCT01165229|5965784|P1|Overall Study|No reason from the subject|0
1709579|NCT01165229|5965783|P2|Overall Study|Suspected HZ Episode|2
1709580|NCT01165229|5965784|P1|Overall Study|Suspected HZ Episode|0
1709581|NCT01165229|5965783|P2|Overall Study|Lost to Follow-up|138
1709582|NCT01165229|5965784|P1|Overall Study|Lost to Follow-up|124
1709583|NCT01165229|5965783|P2|Overall Study|Migrated/moved from study area|46
1709584|NCT01165229|5965784|P1|Overall Study|Migrated/moved from study area|51
1709585|NCT01165229|5965783|P2|Overall Study|Withdrawal by Subject|403
1709586|NCT01165229|5965784|P1|Overall Study|Withdrawal by Subject|396
1709587|NCT01165229|5965783|P2|Overall Study|Protocol Violation|12
1709588|NCT01165229|5965784|P1|Overall Study|Protocol Violation|10
1709589|NCT01165229|5965783|P2|Overall Study|Non-Serious Adverse Event|15
1709590|NCT01165229|5965784|P1|Overall Study|Non-Serious Adverse Event|47
1709591|NCT01165229|5965783|P2|Overall Study|Serious Adverse Event|487
1709592|NCT01165229|5965784|P1|Overall Study|Serious Adverse Event|459
1709593|NCT01165229|5965783|P2|Overall Study|Unknown completion status|1
1709594|NCT01165229|5965784|P1|Overall Study|Unknown completion status|0
1709595|NCT01165216|5965912|P2|Overall Study|Disease progression|3
1709596|NCT01165216|5965913|P1|Overall Study|Disease progression|1
1709597|NCT01165216|5965912|P2|Overall Study|Withdrawal by Subject|1
1709598|NCT01165216|5965913|P1|Overall Study|Withdrawal by Subject|1
1709599|NCT01165216|5965912|P2|Overall Study|Adverse Event|3
1709600|NCT01165216|5965913|P1|Overall Study|Adverse Event|6
1709601|NCT01165203|5965935|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
1709602|NCT01165203|5965936|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
1709603|NCT01165203|5965935|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
1709604|NCT01165203|5965936|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
1709605|NCT01165203|5965935|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
1709606|NCT01165203|5965936|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
1709607|NCT01165203|5965935|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
1709608|NCT01165203|5965936|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
1709609|NCT01165203|5965935|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
1709610|NCT01165203|5965936|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
1709611|NCT01165203|5965935|P2|Active Phase|Lost to Follow-up|0
1709612|NCT01165203|5965936|P1|Active Phase|Lost to Follow-up|2
1709613|NCT01165203|5965935|P2|Active Phase|Migrated/moved from study area|1
1709614|NCT01165203|5965936|P1|Active Phase|Migrated/moved from study area|0
1709615|NCT01165203|5965935|P2|Active Phase|Withdrawal by Subject|1
1709616|NCT01165203|5965936|P1|Active Phase|Withdrawal by Subject|2
1709617|NCT01165203|5965935|P2|Active Phase|Serious Adverse Event|0
1709618|NCT01165203|5965936|P1|Active Phase|Serious Adverse Event|1
1709619|NCT01165177|5966026|P2|Overall Study|Death|1
1709620|NCT01165177|5966027|P1|Overall Study|Death|0
1709621|NCT01165177|5966026|P2|Overall Study|Personal Reasons|4
1709622|NCT01165177|5966027|P1|Overall Study|Personal Reasons|1
1709623|NCT01165177|5966026|P2|Overall Study|Physician Decision|1
1709624|NCT01165177|5966027|P1|Overall Study|Physician Decision|0
1709625|NCT01165177|5966026|P2|Overall Study|Non-serious Adverse Event|20
1709626|NCT01165177|5966027|P1|Overall Study|Non-serious Adverse Event|32
1709627|NCT01165177|5966026|P2|Overall Study|Migrated/moved from study area|43
1709628|NCT01165177|5966027|P1|Overall Study|Migrated/moved from study area|48
1709629|NCT01165177|5966026|P2|Overall Study|Subject missed visit|2
1709630|NCT01165177|5966027|P1|Overall Study|Subject missed visit|5
1709631|NCT01165177|5966026|P2|Overall Study|Previous health issues worsening|11
1709632|NCT01165177|5966027|P1|Overall Study|Previous health issues worsening|9
1709633|NCT01165177|5966026|P2|Overall Study|Subject non-compliant with procedures|2
1709634|NCT01165177|5966027|P1|Overall Study|Subject non-compliant with procedures|12
1709635|NCT01165177|5966026|P2|Overall Study|Site closure|5
1709636|NCT01165177|5966027|P1|Overall Study|Site closure|7
1709637|NCT01165177|5966026|P2|Overall Study|Protocol Violation|22
1709638|NCT01165177|5966027|P1|Overall Study|Protocol Violation|19
1709639|NCT01165177|5966026|P2|Overall Study|Lost to Follow-up|195
1709640|NCT01165177|5966027|P1|Overall Study|Lost to Follow-up|188
1709641|NCT01165177|5966026|P2|Overall Study|Serious Adverse Event|240
1709642|NCT01165177|5966027|P1|Overall Study|Serious Adverse Event|229
1709643|NCT01165177|5966026|P2|Overall Study|Withdrawal by Subject|356
1709644|NCT01165177|5966027|P1|Overall Study|Withdrawal by Subject|372
1709645|NCT01165138|5966152|P4|Overall Study|Withdrawal by Subject|3
1709646|NCT01165138|5966153|P3|Overall Study|Withdrawal by Subject|6
1709647|NCT01165138|5966154|P2|Overall Study|Withdrawal by Subject|6
1709648|NCT01165138|5966155|P1|Overall Study|Withdrawal by Subject|0
1709649|NCT01165138|5966152|P4|Overall Study|Physician Decision|6
1709650|NCT01165138|5966153|P3|Overall Study|Physician Decision|7
1709651|NCT01165138|5966154|P2|Overall Study|Physician Decision|6
1709652|NCT01165138|5966155|P1|Overall Study|Physician Decision|0
1709653|NCT01165138|5966152|P4|Overall Study|Lost to Follow-up|2
1709654|NCT01165138|5966153|P3|Overall Study|Lost to Follow-up|1
1709655|NCT01165138|5966154|P2|Overall Study|Lost to Follow-up|0
1709656|NCT01165138|5966155|P1|Overall Study|Lost to Follow-up|0
1709657|NCT01165138|5966152|P4|Overall Study|Protocol Violation|2
1709658|NCT01165138|5966153|P3|Overall Study|Protocol Violation|0
1709659|NCT01165138|5966154|P2|Overall Study|Protocol Violation|7
1709660|NCT01165138|5966155|P1|Overall Study|Protocol Violation|0
1709661|NCT01165138|5966152|P4|Overall Study|Lack of Efficacy|7
1709662|NCT01165138|5966153|P3|Overall Study|Lack of Efficacy|6
1709663|NCT01165138|5966154|P2|Overall Study|Lack of Efficacy|32
1709664|NCT01165138|5966155|P1|Overall Study|Lack of Efficacy|0
1709665|NCT01165138|5966152|P4|Overall Study|Adverse Event|2
1709666|NCT01165138|5966153|P3|Overall Study|Adverse Event|0
1709667|NCT01165138|5966154|P2|Overall Study|Adverse Event|1
1709668|NCT01165138|5966155|P1|Overall Study|Adverse Event|0
1709669|NCT01165021|5966225|P1|Overall Study|Death|1
1709670|NCT01164956|5966233|P3|Overall Study|Side Effects|1
1709671|NCT01164956|5966234|P2|Overall Study|Side Effects|0
1709672|NCT01164956|5966235|P1|Overall Study|Side Effects|1
1709673|NCT01164891|5966243|P1|Overall Study|Adverse Event|1
1709674|NCT01164891|5966243|P1|Overall Study|Disease Progression|5
1709675|NCT01164865|5966263|P2|Overall Study|Lost to Follow-up|1
1709676|NCT01164865|5966264|P1|Overall Study|Lost to Follow-up|2
1709677|NCT01164722|5966274|P2|Overall Study|enrolled on other study, concomitant med|3
1709678|NCT01164722|5966275|P1|Overall Study|enrolled on other study, concomitant med|1
1709679|NCT01164722|5966274|P2|Overall Study|met protocol criteria for non-treatment|1
1709680|NCT01164722|5966275|P1|Overall Study|met protocol criteria for non-treatment|11
1709681|NCT01164722|5966274|P2|Overall Study|Lost to Follow-up|6
1709682|NCT01164722|5966275|P1|Overall Study|Lost to Follow-up|3
1709683|NCT01164722|5966274|P2|Overall Study|Withdrawal by Subject|4
1709684|NCT01164722|5966275|P1|Overall Study|Withdrawal by Subject|3
1709685|NCT01164722|5966274|P2|Overall Study|Adverse Event|1
1709686|NCT01164722|5966275|P1|Overall Study|Adverse Event|0
1709687|NCT01164579|5966305|P3|Overall Study|Reason not specified|0
1709688|NCT01164579|5966306|P2|Overall Study|Reason not specified|0
1709689|NCT01164579|5966307|P1|Overall Study|Reason not specified|1
1709690|NCT01164579|5966305|P3|Overall Study|Adverse Event|5
1709691|NCT01164579|5966306|P2|Overall Study|Adverse Event|2
1709692|NCT01164579|5966307|P1|Overall Study|Adverse Event|4
1709693|NCT01164579|5966305|P3|Overall Study|Protocol Violation|2
1709694|NCT01164579|5966306|P2|Overall Study|Protocol Violation|1
1709695|NCT01164579|5966307|P1|Overall Study|Protocol Violation|0
1709696|NCT01164579|5966305|P3|Overall Study|Withdrawal by Subject|3
1709697|NCT01164579|5966306|P2|Overall Study|Withdrawal by Subject|5
1709698|NCT01164579|5966307|P1|Overall Study|Withdrawal by Subject|2
1709699|NCT01164579|5966305|P3|Overall Study|Lost to Follow-up|0
1709700|NCT01164579|5966306|P2|Overall Study|Lost to Follow-up|1
1709701|NCT01164579|5966307|P1|Overall Study|Lost to Follow-up|1
1709702|NCT01164579|5966305|P3|Overall Study|Lack of Efficacy|6
1709703|NCT01164579|5966306|P2|Overall Study|Lack of Efficacy|0
1709704|NCT01164579|5966307|P1|Overall Study|Lack of Efficacy|0
1709705|NCT01164501|5966387|P3|Overall Study|Other reason not defined above|4
1709706|NCT01164501|5966388|P2|Overall Study|Other reason not defined above|1
1709707|NCT01164501|5966389|P1|Overall Study|Other reason not defined above|9
1709708|NCT01164501|5966387|P3|Overall Study|Patient refusal to continue,not due toAE|8
1709709|NCT01164501|5966388|P2|Overall Study|Patient refusal to continue,not due toAE|4
1709710|NCT01164501|5966389|P1|Overall Study|Patient refusal to continue,not due toAE|10
1709711|NCT01164501|5966387|P3|Overall Study|Lost to Follow-up|3
1709712|NCT01164501|5966388|P2|Overall Study|Lost to Follow-up|0
1709713|NCT01164501|5966389|P1|Overall Study|Lost to Follow-up|3
1709714|NCT01164501|5966387|P3|Overall Study|Non compliant with protocol|4
1709715|NCT01164501|5966388|P2|Overall Study|Non compliant with protocol|1
1709716|NCT01164501|5966389|P1|Overall Study|Non compliant with protocol|1
1709717|NCT01164501|5966387|P3|Overall Study|Lack of Efficacy|1
1709718|NCT01164501|5966388|P2|Overall Study|Lack of Efficacy|0
1709719|NCT01164501|5966389|P1|Overall Study|Lack of Efficacy|0
1709720|NCT01164501|5966387|P3|Overall Study|Adverse Event|21
1709721|NCT01164501|5966388|P2|Overall Study|Adverse Event|4
1709722|NCT01164501|5966389|P1|Overall Study|Adverse Event|18
1709723|NCT01164501|5966387|P3|Overall Study|Not treated|1
1709724|NCT01164501|5966388|P2|Overall Study|Not treated|0
1709725|NCT01164501|5966389|P1|Overall Study|Not treated|2
1709726|NCT01164475|5966406|P2|Overall Study|Protocol Violation|0
1709727|NCT01164475|5966407|P1|Overall Study|Protocol Violation|1
1709728|NCT01164475|5966406|P2|Overall Study|Progressive disease|1
1709729|NCT01164475|5966407|P1|Overall Study|Progressive disease|0
1709730|NCT01164475|5966406|P2|Overall Study|Other|1
1709731|NCT01164475|5966407|P1|Overall Study|Other|0
1709732|NCT01164475|5966406|P2|Overall Study|Lack of Efficacy|0
1709733|NCT01164475|5966407|P1|Overall Study|Lack of Efficacy|1
1709734|NCT01164007|5966461|P1|Overall Study|Medical Decision|3
1709735|NCT01164007|5966461|P1|Overall Study|Withdrawal by Subject|1
1709736|NCT01164007|5966461|P1|Overall Study|Protocol Violation|1
1709737|NCT01164007|5966461|P1|Overall Study|Progression of Disease|30
1709738|NCT01164007|5966461|P1|Overall Study|Adverse Event|5
1709739|NCT01163916|5966487|P3|Overall Study|Other|16
1709740|NCT01163916|5966488|P2|Overall Study|Other|4
1709741|NCT01163916|5966489|P1|Overall Study|Other|24
1709742|NCT01163916|5966487|P3|Overall Study|Lack of Efficacy|1
1709743|NCT01163916|5966488|P2|Overall Study|Lack of Efficacy|0
1709744|NCT01163916|5966489|P1|Overall Study|Lack of Efficacy|2
1709745|NCT01163916|5966487|P3|Overall Study|Adverse Event|1
1709746|NCT01163916|5966488|P2|Overall Study|Adverse Event|0
1709747|NCT01163916|5966489|P1|Overall Study|Adverse Event|2
1709748|NCT01163916|5966487|P3|Overall Study|Withdrawal by Subject|2
1709749|NCT01163916|5966488|P2|Overall Study|Withdrawal by Subject|0
1709750|NCT01163916|5966489|P1|Overall Study|Withdrawal by Subject|2
1709751|NCT01163851|5966527|P2|Overall Study|Enrolled but not treated|0
1709752|NCT01163851|5966528|P1|Overall Study|Enrolled but not treated|1
1709753|NCT01163851|5966527|P2|Overall Study|Site Closure|1
1709754|NCT01163851|5966528|P1|Overall Study|Site Closure|0
1709755|NCT01163747|5966623|P2|Overall Study|Refused Treatment|4
1709756|NCT01163747|5966624|P1|Overall Study|Refused Treatment|6
1709757|NCT01163747|5966623|P2|Overall Study|Protocol Violation|1
1709758|NCT01163747|5966624|P1|Overall Study|Protocol Violation|0
1709759|NCT01163747|5966623|P2|Overall Study|Insufficient Therapeutic Response|1
1709760|NCT01163747|5966624|P1|Overall Study|Insufficient Therapeutic Response|0
1709761|NCT01163747|5966623|P2|Overall Study|Adverse Event|5
1709762|NCT01163747|5966624|P1|Overall Study|Adverse Event|0
1709763|NCT01163721|5966644|P2|Overall Study|Physician Decision|1
1709764|NCT01163721|5966645|P1|Overall Study|Physician Decision|0
1709765|NCT01163721|5966644|P2|Overall Study|Lost to Follow-up|1
1709766|NCT01163721|5966645|P1|Overall Study|Lost to Follow-up|0
1709767|NCT01163721|5966644|P2|Overall Study|Withdrawal by Subject|4
1709768|NCT01163721|5966645|P1|Overall Study|Withdrawal by Subject|3
1709769|NCT01163721|5966644|P2|Overall Study|Adverse Event|6
1709770|NCT01163721|5966645|P1|Overall Study|Adverse Event|5
1709771|NCT01163617|5966664|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1709772|NCT01163617|5966665|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1709773|NCT01163617|5966666|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1709774|NCT01163617|5966667|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1709775|NCT01163617|5966668|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1709776|NCT01163617|5966669|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
1709777|NCT01163617|5966670|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1709778|NCT01163617|5966671|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
1709779|NCT01163617|5966664|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1709780|NCT01163617|5966665|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1709781|NCT01163617|5966666|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1709782|NCT01163617|5966667|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1709783|NCT01163617|5966668|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1709784|NCT01163617|5966669|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1709785|NCT01163617|5966670|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
1709786|NCT01163617|5966671|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
1709787|NCT01163617|5966664|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1709788|NCT01163617|5966665|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1709789|NCT01163617|5966666|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1709790|NCT01163617|5966667|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1709791|NCT01163617|5966668|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1709792|NCT01163617|5966669|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1709793|NCT01163617|5966670|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
1709794|NCT01163617|5966671|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
1709795|NCT01163474|5966700|P1|Overall Study|Lost to Follow-up|3
1709796|NCT01163474|5966700|P1|Overall Study|Tech barriers to videoteleconference vis|12
1709797|NCT01163474|5966700|P1|Overall Study|Withdrawal by Subject|1
1709798|NCT01163318|5966712|P1|Overall Study|Multiple Reasons Per Participant|224
1709799|NCT01163318|5966712|P1|Overall Study|Participants Without Case Report Form|7
1709800|NCT01163318|5966712|P1|Overall Study|History/comorbidity of malignant tumor|3
1709801|NCT01163318|5966712|P1|Overall Study|Did Not Continue Use of Adalimumab|26
1709802|NCT01163318|5966712|P1|Overall Study|Off-Label Use of Adalimumab|8
1709803|NCT01163292|5966721|P2|Overall Study|No further visits|7
1709804|NCT01163292|5966722|P1|Overall Study|No further visits|5
1709805|NCT01163292|5966721|P2|Overall Study|Economic reasons|0
1709806|NCT01163292|5966722|P1|Overall Study|Economic reasons|6
1709807|NCT01163292|5966721|P2|Overall Study|Refusal to receive adalimumab|0
1709808|NCT01163292|5966722|P1|Overall Study|Refusal to receive adalimumab|7
1709809|NCT01163292|5966721|P2|Overall Study|Sufficient response to adalimumab|0
1709810|NCT01163292|5966722|P1|Overall Study|Sufficient response to adalimumab|8
1709811|NCT01163292|5966721|P2|Overall Study|Initiation of biological therapy|15
1709812|NCT01163292|5966722|P1|Overall Study|Initiation of biological therapy|0
1709813|NCT01163292|5966721|P2|Overall Study|Adverse Event|0
1709814|NCT01163292|5966722|P1|Overall Study|Adverse Event|6
1709815|NCT01163292|5966721|P2|Overall Study|Lack of Efficacy|0
1709816|NCT01163292|5966722|P1|Overall Study|Lack of Efficacy|9
1709817|NCT01163279|5966738|P2|Overall Study|Withdrawal by Subject|0
1709818|NCT01163279|5966739|P1|Overall Study|Withdrawal by Subject|2
1709819|NCT01163266|5966768|P3|Overall Study|Other|2
1709820|NCT01163266|5966769|P2|Overall Study|Other|1
1709821|NCT01163266|5966770|P1|Overall Study|Other|1
1709822|NCT01163266|5966768|P3|Overall Study|Lost to Follow-up|10
1709823|NCT01163266|5966769|P2|Overall Study|Lost to Follow-up|7
1709824|NCT01163266|5966770|P1|Overall Study|Lost to Follow-up|7
1709825|NCT01163266|5966768|P3|Overall Study|Withdrawal of Consent|3
1709826|NCT01163266|5966769|P2|Overall Study|Withdrawal of Consent|7
1709827|NCT01163266|5966770|P1|Overall Study|Withdrawal of Consent|5
1709828|NCT01163266|5966768|P3|Overall Study|Protocol Deviations|5
1709829|NCT01163266|5966769|P2|Overall Study|Protocol Deviations|2
1709830|NCT01163266|5966770|P1|Overall Study|Protocol Deviations|2
1709831|NCT01163266|5966768|P3|Overall Study|Noncompliance with Study Drug|0
1709832|NCT01163266|5966769|P2|Overall Study|Noncompliance with Study Drug|2
1709833|NCT01163266|5966770|P1|Overall Study|Noncompliance with Study Drug|0
1709834|NCT01163266|5966768|P3|Overall Study|Lack of Efficacy|1
1709835|NCT01163266|5966769|P2|Overall Study|Lack of Efficacy|3
1709836|NCT01163266|5966770|P1|Overall Study|Lack of Efficacy|1
1709837|NCT01163266|5966768|P3|Overall Study|Pretreatment Event or Adverse Event|7
1709838|NCT01163266|5966769|P2|Overall Study|Pretreatment Event or Adverse Event|9
1709839|NCT01163266|5966770|P1|Overall Study|Pretreatment Event or Adverse Event|2
1709840|NCT01163253|5966795|P2|Overall Study|Other Unspecified|34
1709841|NCT01163253|5966796|P1|Overall Study|Other Unspecified|170
1709842|NCT01163253|5966795|P2|Overall Study|Ongoing|4
1709843|NCT01163253|5966796|P1|Overall Study|Ongoing|13
1709844|NCT01163253|5966795|P2|Overall Study|Death|5
1709845|NCT01163253|5966796|P1|Overall Study|Death|17
1709846|NCT01163253|5966795|P2|Overall Study|Adverse Event|78
1709847|NCT01163253|5966796|P1|Overall Study|Adverse Event|300
1709848|NCT01163253|5966795|P2|Overall Study|Insufficient Clinical Response|29
1709849|NCT01163253|5966796|P1|Overall Study|Insufficient Clinical Response|423
1709850|NCT01163253|5966795|P2|Overall Study|Lost to Follow-up|23
1709851|NCT01163253|5966796|P1|Overall Study|Lost to Follow-up|125
1709852|NCT01163253|5966795|P2|Overall Study|Medication Error|0
1709853|NCT01163253|5966796|P1|Overall Study|Medication Error|1
1709854|NCT01163253|5966795|P2|Overall Study|Withdrawal by Subject|50
1709855|NCT01163253|5966796|P1|Overall Study|Withdrawal by Subject|199
1709856|NCT01163253|5966795|P2|Overall Study|Protocol Violation|12
1709857|NCT01163253|5966796|P1|Overall Study|Protocol Violation|43
1709858|NCT01163253|5966795|P2|Overall Study|Study Terminated by Sponsor|349
1709859|NCT01163253|5966796|P1|Overall Study|Study Terminated by Sponsor|978
1709860|NCT01163253|5966795|P2|Overall Study|Withdrawn Due to Pregnancy|2
1709861|NCT01163253|5966796|P1|Overall Study|Withdrawn Due to Pregnancy|12
1709862|NCT01163149|5966984|P3|Extension Treatment Period|Noncompliance|1
1709863|NCT01163149|5966985|P2|Extension Treatment Period|Noncompliance|0
1709864|NCT01163149|5966986|P1|Extension Treatment Period|Noncompliance|0
1709865|NCT01163149|5966984|P3|Extension Treatment Period|Adverse Event|0
1709866|NCT01163149|5966985|P2|Extension Treatment Period|Adverse Event|1
1709867|NCT01163149|5966986|P1|Extension Treatment Period|Adverse Event|0
1709868|NCT01163149|5966984|P3|Extension Treatment Period|Withdrawal by Subject|1
1709869|NCT01163149|5966985|P2|Extension Treatment Period|Withdrawal by Subject|0
1709870|NCT01163149|5966986|P1|Extension Treatment Period|Withdrawal by Subject|2
1709871|NCT01163032|5967095|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
1709872|NCT01163032|5967096|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
1709873|NCT01163032|5967097|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
1709874|NCT01163032|5967095|P3|Open Label Extension Phase|Study Termination|7
1709875|NCT01163032|5967096|P2|Open Label Extension Phase|Study Termination|0
1709876|NCT01163032|5967097|P1|Open Label Extension Phase|Study Termination|0
1709877|NCT01163032|5967095|P3|Open Label Extension Phase|Protocol Violation|1
1709878|NCT01163032|5967096|P2|Open Label Extension Phase|Protocol Violation|0
1709879|NCT01163032|5967097|P1|Open Label Extension Phase|Protocol Violation|0
1709880|NCT01163032|5967095|P3|Open Label Extension Phase|Withdrawal by Subject|3
1709881|NCT01163032|5967096|P2|Open Label Extension Phase|Withdrawal by Subject|0
1709882|NCT01163032|5967097|P1|Open Label Extension Phase|Withdrawal by Subject|0
1709883|NCT01163032|5967095|P3|Open Label Extension Phase|Adverse Event|3
1709884|NCT01163032|5967096|P2|Open Label Extension Phase|Adverse Event|0
1709885|NCT01163032|5967097|P1|Open Label Extension Phase|Adverse Event|0
1709886|NCT01163032|5967095|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
1709887|NCT01163032|5967096|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
1709888|NCT01163032|5967097|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
1709889|NCT01163032|5967095|P3|Randomization Phase|Various*|0
1709890|NCT01163032|5967096|P2|Randomization Phase|Various*|4
1709891|NCT01163032|5967097|P1|Randomization Phase|Various*|5
1709892|NCT01163032|5967095|P3|Randomization Phase|Protocol Violation|0
1709893|NCT01163032|5967096|P2|Randomization Phase|Protocol Violation|1
1709894|NCT01163032|5967097|P1|Randomization Phase|Protocol Violation|0
1709895|NCT01163032|5967095|P3|Randomization Phase|Adverse Event|0
1709896|NCT01163032|5967096|P2|Randomization Phase|Adverse Event|3
1709897|NCT01163032|5967097|P1|Randomization Phase|Adverse Event|3
1709898|NCT01163032|5967095|P3|Randomization Phase|Withdrawal by Subject|0
1709899|NCT01163032|5967096|P2|Randomization Phase|Withdrawal by Subject|3
1709900|NCT01163032|5967097|P1|Randomization Phase|Withdrawal by Subject|2
1709901|NCT01162863|5967130|P3|Overall Study|Adverse Event|0
1709902|NCT01162863|5967131|P2|Overall Study|Adverse Event|1
1709903|NCT01162863|5967132|P1|Overall Study|Adverse Event|0
1709904|NCT01162863|5967130|P3|Overall Study|Lack of Efficacy|0
1709905|NCT01162863|5967131|P2|Overall Study|Lack of Efficacy|0
1709906|NCT01162863|5967132|P1|Overall Study|Lack of Efficacy|1
1709907|NCT01162499|5967162|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
1709908|NCT01162499|5967163|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
1709909|NCT01162486|5967188|P5|Overall Study|Pregnancy|0
1709910|NCT01162486|5967189|P4|Overall Study|Pregnancy|1
1709911|NCT01162486|5967190|P3|Overall Study|Pregnancy|0
1709912|NCT01162486|5967191|P2|Overall Study|Pregnancy|0
1709913|NCT01162486|5967192|P1|Overall Study|Pregnancy|0
1709914|NCT01162486|5967188|P5|Overall Study|elevated LFTs|0
1709915|NCT01162486|5967189|P4|Overall Study|elevated LFTs|0
1709916|NCT01162486|5967190|P3|Overall Study|elevated LFTs|1
1709917|NCT01162486|5967191|P2|Overall Study|elevated LFTs|0
1709918|NCT01162486|5967192|P1|Overall Study|elevated LFTs|0
1709919|NCT01162486|5967188|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
1709920|NCT01162486|5967189|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
1709921|NCT01162486|5967190|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
1709922|NCT01162486|5967191|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
1709923|NCT01162486|5967192|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
1709924|NCT01162486|5967188|P5|Overall Study|low ANC|0
1709925|NCT01162486|5967189|P4|Overall Study|low ANC|0
1709926|NCT01162486|5967190|P3|Overall Study|low ANC|0
1709927|NCT01162486|5967191|P2|Overall Study|low ANC|0
1709928|NCT01162486|5967192|P1|Overall Study|low ANC|1
1709929|NCT01162473|5967225|P2|Overall Study|Withdrawal by Subject|4
1709930|NCT01162473|5967226|P1|Overall Study|Withdrawal by Subject|0
1709931|NCT01162473|5967225|P2|Overall Study|Adverse Event|1
1709932|NCT01162473|5967226|P1|Overall Study|Adverse Event|2
1709933|NCT01162421|5967234|P2|Overall Study|Other|3
1709934|NCT01162421|5967235|P1|Overall Study|Other|2
1709935|NCT01162421|5967234|P2|Overall Study|Lack of Efficacy|2
1709936|NCT01162421|5967235|P1|Overall Study|Lack of Efficacy|2
1709937|NCT01162421|5967234|P2|Overall Study|Lost to Follow-up|2
1709938|NCT01162421|5967235|P1|Overall Study|Lost to Follow-up|0
1709939|NCT01162421|5967234|P2|Overall Study|Adverse Event|5
1709940|NCT01162421|5967235|P1|Overall Study|Adverse Event|2
1709941|NCT01162421|5967234|P2|Overall Study|Did not receive study drug|1
1709942|NCT01162421|5967235|P1|Overall Study|Did not receive study drug|2
1709943|NCT01162343|5967318|P1|Overall Study|Refused psychiatrist assessment|12
1709944|NCT01162343|5967318|P1|Overall Study|Left ED prior to psychiatrist assessment|80
1709945|NCT01162304|5967333|P1|Overall Study|Beck scale to high|11
1709946|NCT01162135|5967347|P1|Overall Study|Ineligible|1
1709947|NCT01162135|5967347|P1|Overall Study|Severe back pain|1
1709948|NCT01162135|5967347|P1|Overall Study|Withdrawal by Subject|1
1709949|NCT01162122|5967353|P2|Overall Study|Missing primary reason|0
1709950|NCT01162122|5967354|P1|Overall Study|Missing primary reason|1
1709951|NCT01162122|5967353|P2|Overall Study|Unable to classify|7
1709952|NCT01162122|5967354|P1|Overall Study|Unable to classify|3
1709953|NCT01162122|5967353|P2|Overall Study|Administrative reason|1
1709954|NCT01162122|5967354|P1|Overall Study|Administrative reason|1
1709955|NCT01162122|5967353|P2|Overall Study|Inappropriate enrollment|4
1709956|NCT01162122|5967354|P1|Overall Study|Inappropriate enrollment|5
1709957|NCT01162122|5967353|P2|Overall Study|Protocol Violation|2
1709958|NCT01162122|5967354|P1|Overall Study|Protocol Violation|2
1709959|NCT01162122|5967353|P2|Overall Study|Death|46
1709960|NCT01162122|5967354|P1|Overall Study|Death|51
1709961|NCT01162122|5967353|P2|Overall Study|Adverse Event|2
1709962|NCT01162122|5967354|P1|Overall Study|Adverse Event|3
1709963|NCT01162122|5967353|P2|Overall Study|Lost to Follow-up|91
1709964|NCT01162122|5967354|P1|Overall Study|Lost to Follow-up|73
1709965|NCT01162122|5967353|P2|Overall Study|Withdrawal by Subject|43
1709966|NCT01162122|5967354|P1|Overall Study|Withdrawal by Subject|52
1709967|NCT01161628|5967460|P1|Overall Study|Lack of Efficacy|2
1709968|NCT01161628|5967460|P1|Overall Study|Death|6
1709969|NCT01161537|5967483|P1|Part B|Withdrawal by Subject|2
1709970|NCT01161524|5967501|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
1709971|NCT01161524|5967502|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
1709972|NCT01161524|5967503|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
1709973|NCT01161524|5967501|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
1709974|NCT01161524|5967502|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
1709975|NCT01161524|5967503|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
1709976|NCT01161524|5967501|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
1709977|NCT01161524|5967502|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
1709978|NCT01161524|5967503|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
1709979|NCT01161524|5967501|P3|Extension Phase (Approximately 83 Weeks)|Other|6
1709980|NCT01161524|5967502|P2|Extension Phase (Approximately 83 Weeks)|Other|0
1709981|NCT01161524|5967503|P1|Extension Phase (Approximately 83 Weeks)|Other|0
1709982|NCT01161524|5967501|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
1709983|NCT01161524|5967502|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
1709984|NCT01161524|5967503|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
1709985|NCT01161524|5967501|P3|Core Study (23 Weeks)|Subject Choice|0
1709986|NCT01161524|5967502|P2|Core Study (23 Weeks)|Subject Choice|2
1709987|NCT01161524|5967503|P1|Core Study (23 Weeks)|Subject Choice|3
1709988|NCT01161524|5967501|P3|Core Study (23 Weeks)|Lost to Follow-up|0
1709989|NCT01161524|5967502|P2|Core Study (23 Weeks)|Lost to Follow-up|2
1709990|NCT01161524|5967503|P1|Core Study (23 Weeks)|Lost to Follow-up|1
1709991|NCT01161524|5967501|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
1709992|NCT01161524|5967502|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
1709993|NCT01161524|5967503|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
1709994|NCT01161524|5967501|P3|Core Study (23 Weeks)|Other|0
1709995|NCT01161524|5967502|P2|Core Study (23 Weeks)|Other|0
1709996|NCT01161524|5967503|P1|Core Study (23 Weeks)|Other|1
1709997|NCT01161524|5967501|P3|Core Study (23 Weeks)|Adverse Event|0
1709998|NCT01161524|5967502|P2|Core Study (23 Weeks)|Adverse Event|0
1709999|NCT01161524|5967503|P1|Core Study (23 Weeks)|Adverse Event|3
1710000|NCT01161498|5967542|P2|Overall Study|Disease Progression|1
1710001|NCT01161498|5967543|P1|Overall Study|Disease Progression|0
1710002|NCT01161472|5967567|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1710003|NCT01161472|5967568|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1710004|NCT01161472|5967569|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
1710005|NCT01161472|5967570|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
1710006|NCT01161446|5967626|P2|Overall Study|Withdrawal by Subject|1
1710007|NCT01161446|5967627|P1|Overall Study|Withdrawal by Subject|0
1710008|NCT01161446|5967626|P2|Overall Study|Lost to Follow-up|14
1710009|NCT01161446|5967627|P1|Overall Study|Lost to Follow-up|18
1710010|NCT01161407|5967653|P2|Overall Study|Protocol Violation|1
1710011|NCT01161407|5967654|P1|Overall Study|Protocol Violation|3
1710012|NCT01161173|5967709|P1|Overall Study|Reasons Not Specified|23
1710013|NCT01161173|5967709|P1|Overall Study|End of Study|2
1710014|NCT01161173|5967709|P1|Overall Study|Death|194
1710015|NCT01161173|5967709|P1|Overall Study|Unacceptable Toxicity|21
1710016|NCT01161173|5967709|P1|Overall Study|Withdrawal of Consent|5
1710017|NCT01161173|5967709|P1|Overall Study|Progressive Disease|82
1710018|NCT01161173|5967709|P1|Overall Study|Lost to Follow-up|7
1710019|NCT01161173|5967709|P1|Overall Study|Protocol Violation|13
1710020|NCT01160822|5967836|P7|Overall Study|Protocol deviation|0
1710021|NCT01160822|5967837|P6|Overall Study|Protocol deviation|0
1710022|NCT01160822|5967838|P5|Overall Study|Protocol deviation|2
1710023|NCT01160822|5967839|P4|Overall Study|Protocol deviation|0
1710024|NCT01160822|5967840|P3|Overall Study|Protocol deviation|0
1710025|NCT01160822|5967841|P2|Overall Study|Protocol deviation|0
1710026|NCT01160822|5967842|P1|Overall Study|Protocol deviation|0
1710027|NCT01160822|5967836|P7|Overall Study|Administrative problems|0
1710028|NCT01160822|5967837|P6|Overall Study|Administrative problems|0
1710029|NCT01160822|5967838|P5|Overall Study|Administrative problems|1
1710030|NCT01160822|5967839|P4|Overall Study|Administrative problems|0
1710031|NCT01160822|5967840|P3|Overall Study|Administrative problems|0
1710032|NCT01160822|5967841|P2|Overall Study|Administrative problems|0
1710033|NCT01160822|5967842|P1|Overall Study|Administrative problems|0
1710034|NCT01160822|5967836|P7|Overall Study|Lost to Follow-up|0
1710035|NCT01160822|5967837|P6|Overall Study|Lost to Follow-up|0
1710036|NCT01160822|5967838|P5|Overall Study|Lost to Follow-up|1
1710037|NCT01160822|5967839|P4|Overall Study|Lost to Follow-up|0
1710038|NCT01160822|5967840|P3|Overall Study|Lost to Follow-up|0
1710039|NCT01160822|5967841|P2|Overall Study|Lost to Follow-up|0
1710040|NCT01160822|5967842|P1|Overall Study|Lost to Follow-up|0
1710041|NCT01160822|5967836|P7|Overall Study|Withdrawal by Subject|1
1710042|NCT01160822|5967837|P6|Overall Study|Withdrawal by Subject|0
1710043|NCT01160822|5967838|P5|Overall Study|Withdrawal by Subject|0
1710044|NCT01160822|5967839|P4|Overall Study|Withdrawal by Subject|0
1710045|NCT01160822|5967840|P3|Overall Study|Withdrawal by Subject|0
1710046|NCT01160822|5967841|P2|Overall Study|Withdrawal by Subject|0
1710047|NCT01160822|5967842|P1|Overall Study|Withdrawal by Subject|0
1710048|NCT01160822|5967836|P7|Overall Study|Unsatisfactory therapeutic effect|3
1710049|NCT01160822|5967837|P6|Overall Study|Unsatisfactory therapeutic effect|5
1710050|NCT01160822|5967838|P5|Overall Study|Unsatisfactory therapeutic effect|4
1710051|NCT01160822|5967839|P4|Overall Study|Unsatisfactory therapeutic effect|0
1710052|NCT01160822|5967840|P3|Overall Study|Unsatisfactory therapeutic effect|0
1710053|NCT01160822|5967841|P2|Overall Study|Unsatisfactory therapeutic effect|0
1710054|NCT01160822|5967842|P1|Overall Study|Unsatisfactory therapeutic effect|0
1710055|NCT01160822|5967836|P7|Overall Study|Adverse Event|5
1710056|NCT01160822|5967837|P6|Overall Study|Adverse Event|2
1710057|NCT01160822|5967838|P5|Overall Study|Adverse Event|1
1710058|NCT01160822|5967839|P4|Overall Study|Adverse Event|0
1710059|NCT01160822|5967840|P3|Overall Study|Adverse Event|0
1710060|NCT01160822|5967841|P2|Overall Study|Adverse Event|0
1710061|NCT01160822|5967842|P1|Overall Study|Adverse Event|0
1710062|NCT01160770|5967931|P1|Overall Study|Other Reasons|1
1710063|NCT01160770|5967931|P1|Overall Study|Lack of Efficacy|15
1710064|NCT01160770|5967931|P1|Overall Study|Death|9
1710065|NCT01160770|5967931|P1|Overall Study|Study termination or sponsor request|1
1710066|NCT01160770|5967931|P1|Overall Study|Lost to Follow-up|7
1710067|NCT01160770|5967931|P1|Overall Study|Physician Decision|1
1710068|NCT01160770|5967931|P1|Overall Study|Subject/parent/caregiver request|33
1710069|NCT01160770|5967931|P1|Overall Study|Protocol Violation|2
1710070|NCT01160770|5967931|P1|Overall Study|Adverse Event|10
1710071|NCT01160744|5967944|P4|Overall Study|Not meet inclusion/exclusion criteria|0
1710072|NCT01160744|5967945|P3|Overall Study|Not meet inclusion/exclusion criteria|1
1710073|NCT01160744|5967946|P2|Overall Study|Not meet inclusion/exclusion criteria|0
1710074|NCT01160744|5967947|P1|Overall Study|Not meet inclusion/exclusion criteria|0
1710075|NCT01160744|5967944|P4|Overall Study|Withdrawal by Subject|4
1710076|NCT01160744|5967945|P3|Overall Study|Withdrawal by Subject|6
1710077|NCT01160744|5967946|P2|Overall Study|Withdrawal by Subject|5
1710078|NCT01160744|5967947|P1|Overall Study|Withdrawal by Subject|11
1710079|NCT01160640|5967983|P2|Overall Study|Withdrawal by Subject|3
1710080|NCT01160640|5967984|P1|Overall Study|Withdrawal by Subject|0
1710081|NCT01160640|5967983|P2|Overall Study|Incarceration|0
1710082|NCT01160640|5967984|P1|Overall Study|Incarceration|1
1710083|NCT01160640|5967983|P2|Overall Study|Physician Decision|3
1710084|NCT01160640|5967984|P1|Overall Study|Physician Decision|3
1710085|NCT01160614|5968000|P2|Overall Study|Withdrawal by Subject|2
1710086|NCT01160614|5968001|P1|Overall Study|Withdrawal by Subject|0
1710087|NCT01160484|5968049|P1|Overall Study|inclusion/exclusion criteria failure|1
1710088|NCT01160484|5968049|P1|Overall Study|Withdrawal by Subject|2
1710089|NCT01160484|5968049|P1|Overall Study|Adverse Event|6
1710090|NCT01160484|5968049|P1|Overall Study|Lack of Efficacy|9
1710091|NCT01160354|5968102|P3|Overall Study|Death|1
1710092|NCT01160354|5968103|P2|Overall Study|Death|1
1710093|NCT01160354|5968104|P1|Overall Study|Death|0
1710094|NCT01160289|5968123|P6|Post-Randomization Period|Sponsor Decision|0
1710095|NCT01160289|5968124|P5|Post-Randomization Period|Sponsor Decision|0
1710096|NCT01160289|5968125|P4|Post-Randomization Period|Sponsor Decision|0
1710097|NCT01160289|5968126|P3|Post-Randomization Period|Sponsor Decision|0
1710098|NCT01160289|5968127|P2|Post-Randomization Period|Sponsor Decision|1
1710099|NCT01160289|5968128|P1|Post-Randomization Period|Sponsor Decision|0
1710100|NCT01160289|5968123|P6|Post-Randomization Period|Entry Criteria Not Met|0
1710101|NCT01160289|5968124|P5|Post-Randomization Period|Entry Criteria Not Met|0
1710102|NCT01160289|5968125|P4|Post-Randomization Period|Entry Criteria Not Met|2
1710103|NCT01160289|5968126|P3|Post-Randomization Period|Entry Criteria Not Met|2
1710104|NCT01160289|5968127|P2|Post-Randomization Period|Entry Criteria Not Met|2
1710105|NCT01160289|5968128|P1|Post-Randomization Period|Entry Criteria Not Met|0
1710106|NCT01160289|5968123|P6|Post-Randomization Period|Withdrawal by Subject|7
1710107|NCT01160289|5968124|P5|Post-Randomization Period|Withdrawal by Subject|5
1710108|NCT01160289|5968125|P4|Post-Randomization Period|Withdrawal by Subject|8
1710109|NCT01160289|5968126|P3|Post-Randomization Period|Withdrawal by Subject|13
1710110|NCT01160289|5968127|P2|Post-Randomization Period|Withdrawal by Subject|5
1710111|NCT01160289|5968128|P1|Post-Randomization Period|Withdrawal by Subject|0
1710112|NCT01160289|5968123|P6|Post-Randomization Period|Protocol Violation|3
1710113|NCT01160289|5968124|P5|Post-Randomization Period|Protocol Violation|1
1710114|NCT01160289|5968125|P4|Post-Randomization Period|Protocol Violation|0
1710115|NCT01160289|5968126|P3|Post-Randomization Period|Protocol Violation|2
1710116|NCT01160289|5968127|P2|Post-Randomization Period|Protocol Violation|4
1710117|NCT01160289|5968128|P1|Post-Randomization Period|Protocol Violation|0
1710118|NCT01160289|5968123|P6|Post-Randomization Period|Physician Decision|0
1710119|NCT01160289|5968124|P5|Post-Randomization Period|Physician Decision|0
1710120|NCT01160289|5968125|P4|Post-Randomization Period|Physician Decision|0
1710121|NCT01160289|5968126|P3|Post-Randomization Period|Physician Decision|1
1710122|NCT01160289|5968127|P2|Post-Randomization Period|Physician Decision|0
1710123|NCT01160289|5968128|P1|Post-Randomization Period|Physician Decision|0
1710124|NCT01160289|5968123|P6|Post-Randomization Period|Lost to Follow-up|4
1710125|NCT01160289|5968124|P5|Post-Randomization Period|Lost to Follow-up|3
1710126|NCT01160289|5968125|P4|Post-Randomization Period|Lost to Follow-up|5
1710127|NCT01160289|5968126|P3|Post-Randomization Period|Lost to Follow-up|2
1710128|NCT01160289|5968127|P2|Post-Randomization Period|Lost to Follow-up|3
1710129|NCT01160289|5968128|P1|Post-Randomization Period|Lost to Follow-up|0
1710130|NCT01160289|5968123|P6|Post-Randomization Period|Lack of Efficacy|0
1710131|NCT01160289|5968124|P5|Post-Randomization Period|Lack of Efficacy|0
1710132|NCT01160289|5968125|P4|Post-Randomization Period|Lack of Efficacy|3
1710133|NCT01160289|5968126|P3|Post-Randomization Period|Lack of Efficacy|0
1710134|NCT01160289|5968127|P2|Post-Randomization Period|Lack of Efficacy|1
1710135|NCT01160289|5968128|P1|Post-Randomization Period|Lack of Efficacy|0
1710136|NCT01160289|5968123|P6|Post-Randomization Period|Death|0
1710137|NCT01160289|5968124|P5|Post-Randomization Period|Death|0
1710138|NCT01160289|5968125|P4|Post-Randomization Period|Death|1
1710139|NCT01160289|5968126|P3|Post-Randomization Period|Death|0
1710140|NCT01160289|5968127|P2|Post-Randomization Period|Death|0
1710141|NCT01160289|5968128|P1|Post-Randomization Period|Death|0
1710142|NCT01160289|5968123|P6|Post-Randomization Period|Adverse Event|0
1710143|NCT01160289|5968124|P5|Post-Randomization Period|Adverse Event|0
1710144|NCT01160289|5968125|P4|Post-Randomization Period|Adverse Event|2
1710145|NCT01160289|5968126|P3|Post-Randomization Period|Adverse Event|4
1710146|NCT01160289|5968127|P2|Post-Randomization Period|Adverse Event|4
1710147|NCT01160289|5968128|P1|Post-Randomization Period|Adverse Event|0
1710148|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
1710149|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
1710150|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
1710151|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
1710152|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
1710153|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
1710154|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
1710155|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
1710156|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
1710157|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
1710158|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
1710159|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
1710160|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
1710161|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
1710162|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
1710163|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
1710164|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
1710165|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
1710166|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
1710167|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
1710168|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
1710169|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
1710170|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
1710171|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
1710172|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
1710173|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
1710174|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
1710175|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
1710176|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
1710177|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
1710178|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
1710179|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
1710180|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
1710181|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
1710182|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
1710183|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
1710184|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
1710185|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
1710186|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
1710187|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
1710188|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
1710189|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
1710190|NCT01160289|5968123|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
1710191|NCT01160289|5968124|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
1710192|NCT01160289|5968125|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
1710193|NCT01160289|5968126|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
1710194|NCT01160289|5968127|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
1710195|NCT01160289|5968128|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
1710196|NCT01160211|5968217|P3|Overall Study|Lost to Follow-up|5
1710197|NCT01160211|5968218|P2|Overall Study|Lost to Follow-up|7
1710198|NCT01160211|5968219|P1|Overall Study|Lost to Follow-up|4
1710199|NCT01160211|5968217|P3|Overall Study|Physician Decision|0
1710200|NCT01160211|5968218|P2|Overall Study|Physician Decision|0
1710201|NCT01160211|5968219|P1|Overall Study|Physician Decision|2
1710202|NCT01160211|5968217|P3|Overall Study|Withdrawal by Subject|3
1710203|NCT01160211|5968218|P2|Overall Study|Withdrawal by Subject|5
1710204|NCT01160211|5968219|P1|Overall Study|Withdrawal by Subject|3
1710205|NCT01160211|5968217|P3|Overall Study|ongoing|79
1710206|NCT01160211|5968218|P2|Overall Study|ongoing|75
1710207|NCT01160211|5968219|P1|Overall Study|ongoing|90
1710208|NCT01160198|5968252|P3|Overall Study|Participant lost drug; withdrew consent|1
1710209|NCT01160198|5968253|P2|Overall Study|Participant lost drug; withdrew consent|0
1710210|NCT01160198|5968254|P1|Overall Study|Participant lost drug; withdrew consent|0
1710211|NCT01160198|5968252|P3|Overall Study|Lost to Follow-up|0
1710212|NCT01160198|5968253|P2|Overall Study|Lost to Follow-up|1
1710213|NCT01160198|5968254|P1|Overall Study|Lost to Follow-up|0
1710214|NCT01160198|5968252|P3|Overall Study|Adverse Event|0
1710215|NCT01160198|5968253|P2|Overall Study|Adverse Event|1
1710216|NCT01160198|5968254|P1|Overall Study|Adverse Event|0
1710217|NCT01160198|5968252|P3|Overall Study|Withdrawal by Subject|0
1710218|NCT01160198|5968253|P2|Overall Study|Withdrawal by Subject|1
1710219|NCT01160198|5968254|P1|Overall Study|Withdrawal by Subject|2
1710220|NCT01159938|5968276|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
1710221|NCT01159938|5968277|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
1710222|NCT01159938|5968278|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
1710223|NCT01159938|5968279|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
1710224|NCT01159938|5968280|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
1710225|NCT01159912|5968343|P3|Overall Study|Withdrawal by Subject|3
1710226|NCT01159912|5968344|P2|Overall Study|Withdrawal by Subject|3
1710227|NCT01159912|5968345|P1|Overall Study|Withdrawal by Subject|10
1710228|NCT01159912|5968343|P3|Overall Study|Physician Decision|3
1710229|NCT01159912|5968344|P2|Overall Study|Physician Decision|0
1710230|NCT01159912|5968345|P1|Overall Study|Physician Decision|0
1710231|NCT01159912|5968343|P3|Overall Study|Lost to Follow-up|0
1710232|NCT01159912|5968344|P2|Overall Study|Lost to Follow-up|0
1710233|NCT01159912|5968345|P1|Overall Study|Lost to Follow-up|4
1710234|NCT01159912|5968343|P3|Overall Study|Protocol Violation|3
1710235|NCT01159912|5968344|P2|Overall Study|Protocol Violation|2
1710236|NCT01159912|5968345|P1|Overall Study|Protocol Violation|1
1710237|NCT01159912|5968343|P3|Overall Study|Lack of Efficacy|14
1710238|NCT01159912|5968344|P2|Overall Study|Lack of Efficacy|15
1710239|NCT01159912|5968345|P1|Overall Study|Lack of Efficacy|23
1710240|NCT01159912|5968343|P3|Overall Study|Adverse Event|3
1710241|NCT01159912|5968344|P2|Overall Study|Adverse Event|2
1710242|NCT01159912|5968345|P1|Overall Study|Adverse Event|2
1710243|NCT01159769|5968368|P1|Overall Study|Adverse Event|1
1710244|NCT01159691|5968388|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
1710245|NCT01159691|5968388|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
1710246|NCT01159691|5968388|P1|Overall Study|Disc. Neupro other & unknown reasons|7
1710247|NCT01159691|5968388|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
1710248|NCT01159691|5968388|P1|Overall Study|Discontinued Neupro due to other reasons|1
1710249|NCT01159691|5968388|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
1710250|NCT01159691|5968388|P1|Overall Study|Unknown reasons|1
1710251|NCT01159691|5968388|P1|Overall Study|Lost to Follow-up|2
1710252|NCT01159665|5968401|P6|Overall Study|Withdrawal by Subject|0
1710253|NCT01159665|5968402|P5|Overall Study|Withdrawal by Subject|0
1710254|NCT01159665|5968403|P4|Overall Study|Withdrawal by Subject|0
1710255|NCT01159665|5968404|P3|Overall Study|Withdrawal by Subject|0
1710256|NCT01159665|5968405|P2|Overall Study|Withdrawal by Subject|1
1710257|NCT01159665|5968406|P1|Overall Study|Withdrawal by Subject|0
1710258|NCT01159600|5968434|P8|Overall Study|Other reason not defined above|3
1710259|NCT01159600|5968435|P7|Overall Study|Other reason not defined above|3
1710260|NCT01159600|5968436|P6|Overall Study|Other reason not defined above|7
1710261|NCT01159600|5968437|P5|Overall Study|Other reason not defined above|5
1710262|NCT01159600|5968438|P4|Overall Study|Other reason not defined above|2
1710263|NCT01159600|5968439|P3|Overall Study|Other reason not defined above|4
1710264|NCT01159600|5968440|P2|Overall Study|Other reason not defined above|0
1710265|NCT01159600|5968441|P1|Overall Study|Other reason not defined above|3
1710266|NCT01159600|5968434|P8|Overall Study|Patient refusal to continue,not due toAE|5
1710267|NCT01159600|5968435|P7|Overall Study|Patient refusal to continue,not due toAE|2
1710268|NCT01159600|5968436|P6|Overall Study|Patient refusal to continue,not due toAE|4
1710269|NCT01159600|5968437|P5|Overall Study|Patient refusal to continue,not due toAE|4
1710270|NCT01159600|5968438|P4|Overall Study|Patient refusal to continue,not due toAE|5
1710271|NCT01159600|5968439|P3|Overall Study|Patient refusal to continue,not due toAE|4
1710272|NCT01159600|5968440|P2|Overall Study|Patient refusal to continue,not due toAE|2
1710273|NCT01159600|5968441|P1|Overall Study|Patient refusal to continue,not due toAE|7
1710274|NCT01159600|5968434|P8|Overall Study|Lost to Follow-up|2
1710275|NCT01159600|5968435|P7|Overall Study|Lost to Follow-up|3
1710276|NCT01159600|5968436|P6|Overall Study|Lost to Follow-up|0
1710277|NCT01159600|5968437|P5|Overall Study|Lost to Follow-up|3
1710278|NCT01159600|5968438|P4|Overall Study|Lost to Follow-up|3
1710279|NCT01159600|5968439|P3|Overall Study|Lost to Follow-up|4
1710280|NCT01159600|5968440|P2|Overall Study|Lost to Follow-up|3
1710281|NCT01159600|5968441|P1|Overall Study|Lost to Follow-up|2
1710282|NCT01159600|5968434|P8|Overall Study|Non compliant with protocol|0
1710283|NCT01159600|5968435|P7|Overall Study|Non compliant with protocol|2
1710284|NCT01159600|5968436|P6|Overall Study|Non compliant with protocol|0
1710285|NCT01159600|5968437|P5|Overall Study|Non compliant with protocol|2
1710286|NCT01159600|5968438|P4|Overall Study|Non compliant with protocol|0
1710287|NCT01159600|5968439|P3|Overall Study|Non compliant with protocol|0
1710288|NCT01159600|5968440|P2|Overall Study|Non compliant with protocol|1
1710289|NCT01159600|5968441|P1|Overall Study|Non compliant with protocol|2
1710290|NCT01159600|5968434|P8|Overall Study|Lack of Efficacy|1
1710291|NCT01159600|5968435|P7|Overall Study|Lack of Efficacy|0
1710292|NCT01159600|5968436|P6|Overall Study|Lack of Efficacy|0
1710293|NCT01159600|5968437|P5|Overall Study|Lack of Efficacy|2
1710294|NCT01159600|5968438|P4|Overall Study|Lack of Efficacy|0
1710295|NCT01159600|5968439|P3|Overall Study|Lack of Efficacy|0
1710296|NCT01159600|5968440|P2|Overall Study|Lack of Efficacy|0
1710297|NCT01159600|5968441|P1|Overall Study|Lack of Efficacy|0
1710298|NCT01159600|5968434|P8|Overall Study|Adverse Event|5
1710299|NCT01159600|5968435|P7|Overall Study|Adverse Event|7
1710300|NCT01159600|5968436|P6|Overall Study|Adverse Event|6
1710301|NCT01159600|5968437|P5|Overall Study|Adverse Event|8
1710302|NCT01159600|5968438|P4|Overall Study|Adverse Event|1
1710303|NCT01159600|5968439|P3|Overall Study|Adverse Event|5
1710304|NCT01159600|5968440|P2|Overall Study|Adverse Event|2
1710305|NCT01159600|5968441|P1|Overall Study|Adverse Event|7
1710306|NCT01159600|5968434|P8|Overall Study|Not treated|2
1710307|NCT01159600|5968435|P7|Overall Study|Not treated|2
1710308|NCT01159600|5968436|P6|Overall Study|Not treated|1
1710309|NCT01159600|5968437|P5|Overall Study|Not treated|0
1710310|NCT01159600|5968438|P4|Overall Study|Not treated|0
1710311|NCT01159600|5968439|P3|Overall Study|Not treated|1
1710312|NCT01159600|5968440|P2|Overall Study|Not treated|0
1710313|NCT01159600|5968441|P1|Overall Study|Not treated|0
1710314|NCT01159574|5968483|P1|Follow Up Phase|still being followed for overall surviva|18
1710315|NCT01159574|5968483|P1|Follow Up Phase|Lost to Follow-up|2
1710316|NCT01159574|5968483|P1|Treatment Phase|still on treatment|2
1710317|NCT01159574|5968483|P1|Treatment Phase|Withdrawal by Subject|7
1710318|NCT01159574|5968483|P1|Treatment Phase|Physician Decision|2
1710319|NCT01159574|5968483|P1|Treatment Phase|Death|6
1710320|NCT01159574|5968483|P1|Treatment Phase|Adverse Event|3
1710321|NCT01159574|5968483|P1|Treatment Phase|non-evaluable/not included in analysis|1
1710322|NCT01159431|5968504|P2|Overall Study|Lack of Efficacy|3
1710323|NCT01159431|5968505|P1|Overall Study|Lack of Efficacy|0
1710324|NCT01159431|5968504|P2|Overall Study|non-compliance|1
1710325|NCT01159431|5968505|P1|Overall Study|non-compliance|1
1710326|NCT01159431|5968504|P2|Overall Study|Adverse Event|2
1710327|NCT01159431|5968505|P1|Overall Study|Adverse Event|1
1710328|NCT01159171|5968558|P1|Overall Study|Death|1
1710329|NCT01159171|5968558|P1|Overall Study|Medical Decision|4
1710330|NCT01159171|5968558|P1|Overall Study|Need for Surgery|5
1710331|NCT01159171|5968558|P1|Overall Study|Protocol Violation|1
1710332|NCT01159171|5968558|P1|Overall Study|Progression of Disease|28
1710333|NCT01159171|5968558|P1|Overall Study|Adverse Event|11
1710334|NCT01158924|5968639|P2|Overall Study|Lost to Follow-up|1
1710335|NCT01158924|5968640|P1|Overall Study|Lost to Follow-up|0
1710336|NCT01158924|5968639|P2|Overall Study|Withdrawal by Subject|2
1710337|NCT01158924|5968640|P1|Overall Study|Withdrawal by Subject|1
1710338|NCT01158534|5968745|P1|Overall Study|Other|1
1710339|NCT01158534|5968745|P1|Overall Study|Death|1
1710340|NCT01158534|5968745|P1|Overall Study|Withdrawal by Subject|1
1710341|NCT01158404|5968770|P8|Overall Study|Progressive Disease|0
1710342|NCT01158404|5968771|P7|Overall Study|Progressive Disease|1
1710343|NCT01158404|5968772|P6|Overall Study|Progressive Disease|0
1710344|NCT01158404|5968773|P5|Overall Study|Progressive Disease|0
1710345|NCT01158404|5968774|P4|Overall Study|Progressive Disease|0
1710346|NCT01158404|5968775|P3|Overall Study|Progressive Disease|0
1710347|NCT01158404|5968776|P2|Overall Study|Progressive Disease|0
1710348|NCT01158404|5968777|P1|Overall Study|Progressive Disease|0
1710349|NCT01158404|5968770|P8|Overall Study|Physician Decision|1
1710350|NCT01158404|5968771|P7|Overall Study|Physician Decision|0
1710351|NCT01158404|5968772|P6|Overall Study|Physician Decision|0
1710352|NCT01158404|5968773|P5|Overall Study|Physician Decision|0
1710353|NCT01158404|5968774|P4|Overall Study|Physician Decision|0
1710354|NCT01158404|5968775|P3|Overall Study|Physician Decision|0
1710355|NCT01158404|5968776|P2|Overall Study|Physician Decision|0
1710356|NCT01158404|5968777|P1|Overall Study|Physician Decision|0
1710357|NCT01158404|5968770|P8|Overall Study|Withdrawal by Subject|1
1710358|NCT01158404|5968771|P7|Overall Study|Withdrawal by Subject|0
1710359|NCT01158404|5968772|P6|Overall Study|Withdrawal by Subject|1
1710360|NCT01158404|5968773|P5|Overall Study|Withdrawal by Subject|3
1710361|NCT01158404|5968774|P4|Overall Study|Withdrawal by Subject|0
1710362|NCT01158404|5968775|P3|Overall Study|Withdrawal by Subject|0
1710363|NCT01158404|5968776|P2|Overall Study|Withdrawal by Subject|1
1710364|NCT01158404|5968777|P1|Overall Study|Withdrawal by Subject|0
1710365|NCT01158378|5968819|P2|Overall Study|Withdrawal by Subject|0
1710366|NCT01158378|5968820|P1|Overall Study|Withdrawal by Subject|4
1710367|NCT01158378|5968819|P2|Overall Study|Lost to Follow-up|4
1710368|NCT01158378|5968820|P1|Overall Study|Lost to Follow-up|2
1710369|NCT01158378|5968819|P2|Overall Study|Death|5
1710370|NCT01158378|5968820|P1|Overall Study|Death|4
1710371|NCT01158261|5968832|P1|Overall Study|Withdrawal by Subject|1
1710372|NCT01158261|5968832|P1|Overall Study|Death|7
1710373|NCT01158261|5968832|P1|Overall Study|Lost to Follow-up|9
1710374|NCT01158222|5968836|P1|Overall Study|Not eligible for intermediate phase|17
1710375|NCT01158118|5968848|P2|Overall Study|Death|1
1710376|NCT01158118|5968849|P1|Overall Study|Death|0
1710377|NCT01158118|5968848|P2|Overall Study|Suffered stroke prior to transplant|1
1710378|NCT01158118|5968849|P1|Overall Study|Suffered stroke prior to transplant|0
1710379|NCT01158118|5968848|P2|Overall Study|Donor match was a screen failure|1
1710380|NCT01158118|5968849|P1|Overall Study|Donor match was a screen failure|0
1710381|NCT01158118|5968848|P2|Overall Study|Screen failure|0
1710382|NCT01158118|5968849|P1|Overall Study|Screen failure|1
1710383|NCT01157897|5968869|P4|Overall Study|Relocated|0
1710384|NCT01157897|5968870|P3|Overall Study|Relocated|0
1710385|NCT01157897|5968871|P2|Overall Study|Relocated|2
1710386|NCT01157897|5968872|P1|Overall Study|Relocated|0
1710387|NCT01157897|5968869|P4|Overall Study|Lost to Follow-up|1
1710388|NCT01157897|5968870|P3|Overall Study|Lost to Follow-up|0
1710389|NCT01157897|5968871|P2|Overall Study|Lost to Follow-up|0
1710390|NCT01157897|5968872|P1|Overall Study|Lost to Follow-up|2
1710391|NCT01157845|5968897|P1|Overall Study|Device malfunction|1
1710392|NCT01157845|5968897|P1|Overall Study|Study was ended|1
1710393|NCT01157845|5968897|P1|Overall Study|Protocol Violation|13
1710394|NCT01157845|5968897|P1|Overall Study|Physician Decision|3
1710395|NCT01157845|5968897|P1|Overall Study|Withdrawal by Subject|12
1710396|NCT01157845|5968897|P1|Overall Study|Lost to Follow-up|5
1710397|NCT01157676|5968904|P2|Surgery|underwent robotic cystectomy|0
1710398|NCT01157676|5968905|P1|Surgery|underwent robotic cystectomy|1
1710399|NCT01157676|5968904|P2|Surgery|converted to open procedure|5
1710400|NCT01157676|5968905|P1|Surgery|converted to open procedure|0
1710401|NCT01157676|5968904|P2|Surgery|underwent open cystectomy|4
1710402|NCT01157676|5968905|P1|Surgery|underwent open cystectomy|0
1710403|NCT01157676|5968904|P2|Randomization|Physician Decision|0
1710404|NCT01157676|5968905|P1|Randomization|Physician Decision|1
1710405|NCT01157676|5968904|P2|Randomization|Withdrawal by Subject|13
1710406|NCT01157676|5968905|P1|Randomization|Withdrawal by Subject|17
1710407|NCT01157676|5968904|P2|Randomization|unresectable|3
1710408|NCT01157676|5968905|P1|Randomization|unresectable|2
1710409|NCT01157676|5968904|P2|Randomization|Death|1
1710410|NCT01157676|5968905|P1|Randomization|Death|1
1710411|NCT01157377|5968980|P7|Overall Study|Other Miscellaneous Reasons|1
1710412|NCT01157377|5968981|P6|Overall Study|Other Miscellaneous Reasons|1
1710413|NCT01157377|5968982|P5|Overall Study|Other Miscellaneous Reasons|1
1710414|NCT01157377|5968983|P4|Overall Study|Other Miscellaneous Reasons|0
1710415|NCT01157377|5968984|P3|Overall Study|Other Miscellaneous Reasons|0
1710416|NCT01157377|5968985|P2|Overall Study|Other Miscellaneous Reasons|2
1710417|NCT01157377|5968986|P1|Overall Study|Other Miscellaneous Reasons|0
1710418|NCT01157377|5968980|P7|Overall Study|Lack of Efficacy|1
1710419|NCT01157377|5968981|P6|Overall Study|Lack of Efficacy|0
1710420|NCT01157377|5968982|P5|Overall Study|Lack of Efficacy|0
1710421|NCT01157377|5968983|P4|Overall Study|Lack of Efficacy|0
1710422|NCT01157377|5968984|P3|Overall Study|Lack of Efficacy|0
1710423|NCT01157377|5968985|P2|Overall Study|Lack of Efficacy|0
1710424|NCT01157377|5968986|P1|Overall Study|Lack of Efficacy|0
1710425|NCT01157377|5968980|P7|Overall Study|Protocol Violation|0
1710426|NCT01157377|5968981|P6|Overall Study|Protocol Violation|1
1710427|NCT01157377|5968982|P5|Overall Study|Protocol Violation|0
1710428|NCT01157377|5968983|P4|Overall Study|Protocol Violation|0
1710429|NCT01157377|5968984|P3|Overall Study|Protocol Violation|0
1710430|NCT01157377|5968985|P2|Overall Study|Protocol Violation|0
1710431|NCT01157377|5968986|P1|Overall Study|Protocol Violation|0
1710432|NCT01157377|5968980|P7|Overall Study|Personal Reasons|0
1710433|NCT01157377|5968981|P6|Overall Study|Personal Reasons|0
1710434|NCT01157377|5968982|P5|Overall Study|Personal Reasons|0
1710435|NCT01157377|5968983|P4|Overall Study|Personal Reasons|1
1710436|NCT01157377|5968984|P3|Overall Study|Personal Reasons|0
1710437|NCT01157377|5968985|P2|Overall Study|Personal Reasons|1
1710438|NCT01157377|5968986|P1|Overall Study|Personal Reasons|2
1710439|NCT01157377|5968980|P7|Overall Study|Lost to Follow-up|0
1710440|NCT01157377|5968981|P6|Overall Study|Lost to Follow-up|1
1710441|NCT01157377|5968982|P5|Overall Study|Lost to Follow-up|1
1710442|NCT01157377|5968983|P4|Overall Study|Lost to Follow-up|0
1710443|NCT01157377|5968984|P3|Overall Study|Lost to Follow-up|1
1710444|NCT01157377|5968985|P2|Overall Study|Lost to Follow-up|0
1710445|NCT01157377|5968986|P1|Overall Study|Lost to Follow-up|0
1710446|NCT01157351|5969004|P2|Overall Study|Randomized but not Treated|2
1710447|NCT01157351|5969005|P1|Overall Study|Randomized but not Treated|4
1710448|NCT01157351|5969004|P2|Overall Study|Noncompliance with Study Drug|3
1710449|NCT01157351|5969005|P1|Overall Study|Noncompliance with Study Drug|0
1710450|NCT01157351|5969004|P2|Overall Study|Other|36
1710451|NCT01157351|5969005|P1|Overall Study|Other|32
1710452|NCT01157351|5969004|P2|Overall Study|Protocol Violation|1
1710453|NCT01157351|5969005|P1|Overall Study|Protocol Violation|0
1710454|NCT01157351|5969004|P2|Overall Study|Physician Decision|4
1710455|NCT01157351|5969005|P1|Overall Study|Physician Decision|5
1710456|NCT01157351|5969004|P2|Overall Study|Withdrawal by Subject|27
1710457|NCT01157351|5969005|P1|Overall Study|Withdrawal by Subject|37
1710458|NCT01157351|5969004|P2|Overall Study|Lost to Follow-up|55
1710459|NCT01157351|5969005|P1|Overall Study|Lost to Follow-up|53
1710460|NCT01157351|5969004|P2|Overall Study|Death|0
1710461|NCT01157351|5969005|P1|Overall Study|Death|1
1710462|NCT01157351|5969004|P2|Overall Study|Adverse Event|4
1710463|NCT01157351|5969005|P1|Overall Study|Adverse Event|5
1710464|NCT01157234|5969023|P2|Overall Study|Withdrawal by Subject|0
1710465|NCT01157234|5969024|P1|Overall Study|Withdrawal by Subject|1
1710466|NCT01157182|5969056|P2|Washout of 28 Days|Adverse Event|0
1710467|NCT01157182|5969057|P1|Washout of 28 Days|Adverse Event|2
1710468|NCT01157169|5969105|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
1710469|NCT01157169|5969106|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
1710470|NCT01157169|5969105|P2|First Intervention|Emesis Within 4 hrs of Administration|2
1710471|NCT01157169|5969106|P1|First Intervention|Emesis Within 4 hrs of Administration|4
1710472|NCT01157117|5969125|P3|Overall Study|Unknown (Pending Final Form Submission)|13
1710473|NCT01157117|5969126|P2|Overall Study|Unknown (Pending Final Form Submission)|5
1710474|NCT01157117|5969127|P1|Overall Study|Unknown (Pending Final Form Submission)|4
1710475|NCT01157117|5969125|P3|Overall Study|Lost to Follow-up|1
1710476|NCT01157117|5969126|P2|Overall Study|Lost to Follow-up|0
1710477|NCT01157117|5969127|P1|Overall Study|Lost to Follow-up|0
1710478|NCT01157117|5969125|P3|Overall Study|Lack of Efficacy|0
1710479|NCT01157117|5969126|P2|Overall Study|Lack of Efficacy|1
1710480|NCT01157117|5969127|P1|Overall Study|Lack of Efficacy|1
1710481|NCT01157117|5969125|P3|Overall Study|Withdrawal by Subject|1
1710482|NCT01157117|5969126|P2|Overall Study|Withdrawal by Subject|1
1710483|NCT01157117|5969127|P1|Overall Study|Withdrawal by Subject|4
1710484|NCT01157117|5969125|P3|Overall Study|Dosing Symptoms|0
1710485|NCT01157117|5969126|P2|Overall Study|Dosing Symptoms|4
1710486|NCT01157117|5969127|P1|Overall Study|Dosing Symptoms|0
1710487|NCT01157078|5969168|P2|Overall Study|Other|4
1710488|NCT01157078|5969169|P1|Overall Study|Other|2
1710489|NCT01157078|5969168|P2|Overall Study|Lost to Follow-up|5
1710490|NCT01157078|5969169|P1|Overall Study|Lost to Follow-up|7
1710491|NCT01157078|5969168|P2|Overall Study|Study-specific withdrawal criteria|2
1710492|NCT01157078|5969169|P1|Overall Study|Study-specific withdrawal criteria|2
1710493|NCT01157078|5969168|P2|Overall Study|Lack of Efficacy|0
1710494|NCT01157078|5969169|P1|Overall Study|Lack of Efficacy|2
1710495|NCT01157078|5969168|P2|Overall Study|Condition under investigation worsened|1
1710496|NCT01157078|5969169|P1|Overall Study|Condition under investigation worsened|0
1710497|NCT01157078|5969168|P2|Overall Study|Severe non-compliance to protocol|4
1710498|NCT01157078|5969169|P1|Overall Study|Severe non-compliance to protocol|2
1710499|NCT01157078|5969168|P2|Overall Study|Adverse Event|6
1710500|NCT01157078|5969169|P1|Overall Study|Adverse Event|6
1710501|NCT01157078|5969168|P2|Overall Study|Eligibility criteria not fulfilled|0
1710502|NCT01157078|5969169|P1|Overall Study|Eligibility criteria not fulfilled|2
1710503|NCT01157078|5969168|P2|Overall Study|Withdrawal by Subject|14
1710504|NCT01157078|5969169|P1|Overall Study|Withdrawal by Subject|12
1710505|NCT01157065|5969219|P2|Overall Study|Death|1
1710506|NCT01157065|5969220|P1|Overall Study|Death|0
1710507|NCT01156844|5969241|P4|Overall Study|Protocol deviation|0
1710508|NCT01156844|5969242|P3|Overall Study|Protocol deviation|0
1710509|NCT01156844|5969243|P2|Overall Study|Protocol deviation|0
1710510|NCT01156844|5969244|P1|Overall Study|Protocol deviation|2
1710511|NCT01156844|5969241|P4|Overall Study|Administrative problems|1
1710512|NCT01156844|5969242|P3|Overall Study|Administrative problems|0
1710513|NCT01156844|5969243|P2|Overall Study|Administrative problems|1
1710514|NCT01156844|5969244|P1|Overall Study|Administrative problems|0
1710515|NCT01156844|5969241|P4|Overall Study|Lost to Follow-up|0
1710516|NCT01156844|5969242|P3|Overall Study|Lost to Follow-up|1
1710517|NCT01156844|5969243|P2|Overall Study|Lost to Follow-up|0
1710518|NCT01156844|5969244|P1|Overall Study|Lost to Follow-up|0
1710519|NCT01156844|5969241|P4|Overall Study|Withdrawal by Subject|2
1710520|NCT01156844|5969242|P3|Overall Study|Withdrawal by Subject|2
1710521|NCT01156844|5969243|P2|Overall Study|Withdrawal by Subject|0
1710522|NCT01156844|5969244|P1|Overall Study|Withdrawal by Subject|0
1710523|NCT01156844|5969241|P4|Overall Study|Abnormal test procedure result(s)|2
1710524|NCT01156844|5969242|P3|Overall Study|Abnormal test procedure result(s)|2
1710525|NCT01156844|5969243|P2|Overall Study|Abnormal test procedure result(s)|1
1710526|NCT01156844|5969244|P1|Overall Study|Abnormal test procedure result(s)|0
1710527|NCT01156844|5969241|P4|Overall Study|Adverse Event|1
1710528|NCT01156844|5969242|P3|Overall Study|Adverse Event|1
1710529|NCT01156844|5969243|P2|Overall Study|Adverse Event|0
1710530|NCT01156844|5969244|P1|Overall Study|Adverse Event|0
1710531|NCT01156792|5969278|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
1710532|NCT01156792|5969278|P1|Overall Study|Withdrawal by Subject|9
1710533|NCT01156792|5969278|P1|Overall Study|Physician Decision|3
1710534|NCT01156792|5969278|P1|Overall Study|Lost to Follow-up|3
1710535|NCT01156792|5969278|P1|Overall Study|Protocol Violation|6
1710536|NCT01156792|5969278|P1|Overall Study|Lack of Efficacy|36
1710537|NCT01156792|5969278|P1|Overall Study|Adverse Event|1
1710538|NCT01156714|5969346|P3|Overall Study|Withdrawal by Subject|3
1710539|NCT01156714|5969347|P2|Overall Study|Withdrawal by Subject|4
1710540|NCT01156714|5969348|P1|Overall Study|Withdrawal by Subject|9
1710541|NCT01156675|5969411|P3|Overall Study|No data|2
1710542|NCT01156675|5969412|P2|Overall Study|No data|22
1710543|NCT01156675|5969413|P1|Overall Study|No data|29
1710544|NCT01156675|5969411|P3|Overall Study|Death|0
1710545|NCT01156675|5969412|P2|Overall Study|Death|3
1710546|NCT01156675|5969413|P1|Overall Study|Death|5
1710547|NCT01156532|5969471|P1|Overall Study|Lost to Follow-up|1
1710548|NCT01156532|5969471|P1|Overall Study|Family Reasons|1
1710549|NCT01156480|5969483|P2|Overall Study|change in diagnosis|1
1710550|NCT01156480|5969484|P1|Overall Study|change in diagnosis|0
1710551|NCT01156376|5969513|P3|Overall Study|Withdrawal by Subject|3
1710552|NCT01156376|5969514|P2|Overall Study|Withdrawal by Subject|0
1710553|NCT01156376|5969515|P1|Overall Study|Withdrawal by Subject|0
1710554|NCT01156376|5969513|P3|Overall Study|Adverse Event|1
1710555|NCT01156376|5969514|P2|Overall Study|Adverse Event|0
1710556|NCT01156376|5969515|P1|Overall Study|Adverse Event|1
1710557|NCT01156363|5969736|P1|Overall Study|Other|6
1710558|NCT01156363|5969736|P1|Overall Study|Refused Treatment|4
1710559|NCT01156363|5969736|P1|Overall Study|Failure to Return|1
1710560|NCT01156363|5969736|P1|Overall Study|Insufficient Therapeutic Response|5
1710561|NCT01156363|5969736|P1|Overall Study|Adverse Event|6
1710562|NCT01156311|5969758|P4|6-month Add-on Therapy Period|Other|2
1710563|NCT01156311|5969759|P3|6-month Add-on Therapy Period|Other|1
1710564|NCT01156311|5969760|P2|6-month Add-on Therapy Period|Other|0
1710565|NCT01156311|5969761|P1|6-month Add-on Therapy Period|Other|0
1710566|NCT01156311|5969758|P4|6-month Add-on Therapy Period|Physician Decision|0
1710567|NCT01156311|5969759|P3|6-month Add-on Therapy Period|Physician Decision|1
1710568|NCT01156311|5969760|P2|6-month Add-on Therapy Period|Physician Decision|0
1710569|NCT01156311|5969761|P1|6-month Add-on Therapy Period|Physician Decision|0
1710570|NCT01156311|5969758|P4|6-month Add-on Therapy Period|Disease Activity|2
1710571|NCT01156311|5969759|P3|6-month Add-on Therapy Period|Disease Activity|1
1710572|NCT01156311|5969760|P2|6-month Add-on Therapy Period|Disease Activity|0
1710573|NCT01156311|5969761|P1|6-month Add-on Therapy Period|Disease Activity|0
1710574|NCT01156311|5969758|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
1710575|NCT01156311|5969759|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
1710576|NCT01156311|5969760|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
1710577|NCT01156311|5969761|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
1710578|NCT01156311|5969758|P4|6-month Add-on Therapy Period|Adverse Event|6
1710579|NCT01156311|5969759|P3|6-month Add-on Therapy Period|Adverse Event|7
1710580|NCT01156311|5969760|P2|6-month Add-on Therapy Period|Adverse Event|0
1710581|NCT01156311|5969761|P1|6-month Add-on Therapy Period|Adverse Event|0
1710582|NCT01156311|5969758|P4|2-Month Monotherapy Period|Other|0
1710583|NCT01156311|5969759|P3|2-Month Monotherapy Period|Other|0
1710584|NCT01156311|5969760|P2|2-Month Monotherapy Period|Other|0
1710585|NCT01156311|5969761|P1|2-Month Monotherapy Period|Other|1
1710586|NCT01156311|5969758|P4|2-Month Monotherapy Period|Physician Decision|0
1710587|NCT01156311|5969759|P3|2-Month Monotherapy Period|Physician Decision|0
1710588|NCT01156311|5969760|P2|2-Month Monotherapy Period|Physician Decision|1
1710589|NCT01156311|5969761|P1|2-Month Monotherapy Period|Physician Decision|0
1710590|NCT01156311|5969758|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
1710591|NCT01156311|5969759|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
1710592|NCT01156311|5969760|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
1710593|NCT01156311|5969761|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
1710594|NCT01156142|5969785|P2|Overall Study|Ineligible|1
1710595|NCT01156142|5969786|P1|Overall Study|Ineligible|0
1710596|NCT01156142|5969785|P2|Overall Study|Withdrawal by Subject|6
1710597|NCT01156142|5969786|P1|Overall Study|Withdrawal by Subject|8
1710598|NCT01156116|5969804|P2|Overall Study|CPAP intolerance|0
1710599|NCT01156116|5969805|P1|Overall Study|CPAP intolerance|2
1710600|NCT01156116|5969804|P2|Overall Study|Withdrawal by Subject|1
1710601|NCT01156116|5969805|P1|Overall Study|Withdrawal by Subject|3
1710602|NCT01156051|5969819|P2|Overall Study|patient not compliant with protocol|1
1710603|NCT01156051|5969820|P1|Overall Study|patient not compliant with protocol|0
1710604|NCT01156051|5969819|P2|Overall Study|Lost to Follow-up|0
1710605|NCT01156051|5969820|P1|Overall Study|Lost to Follow-up|1
1710606|NCT01156012|5969834|P2|Overall Study|Non respect of one of inclusion criteria|1
1710607|NCT01156012|5969835|P1|Overall Study|Non respect of one of inclusion criteria|2
1710608|NCT01156012|5969834|P2|Overall Study|use of commercial drug instead of study|1
1710609|NCT01156012|5969835|P1|Overall Study|use of commercial drug instead of study|0
1710610|NCT01156012|5969834|P2|Overall Study|Withdrawal by Subject|0
1710611|NCT01156012|5969835|P1|Overall Study|Withdrawal by Subject|1
1710612|NCT01156012|5969834|P2|Overall Study|Lost to Follow-up|0
1710613|NCT01156012|5969835|P1|Overall Study|Lost to Follow-up|1
1710614|NCT01156012|5969834|P2|Overall Study|Adverse Event|1
1710615|NCT01156012|5969835|P1|Overall Study|Adverse Event|3
1710616|NCT01155869|5969852|P2|Overall Study|Lost to Follow-up|1
1710617|NCT01155869|5969853|P1|Overall Study|Lost to Follow-up|3
1710618|NCT01155726|5969962|P4|Period 1, 3 Days (Masked)|Inconvenience|0
1710619|NCT01155726|5969963|P3|Period 1, 3 Days (Masked)|Inconvenience|2
1710620|NCT01155726|5969964|P2|Period 1, 3 Days (Masked)|Inconvenience|0
1710621|NCT01155726|5969965|P1|Period 1, 3 Days (Masked)|Inconvenience|1
1710622|NCT01155661|5969987|P1|Overall Study|Sponsor Decision|13
1710623|NCT01155661|5969987|P1|Overall Study|Withdrawal by Subject|73
1710624|NCT01155661|5969987|P1|Overall Study|Protocol Violation|35
1710625|NCT01155661|5969987|P1|Overall Study|Physician Decision|3
1710626|NCT01155661|5969987|P1|Overall Study|Lost to Follow-up|22
1710627|NCT01155661|5969987|P1|Overall Study|Lack of Efficacy|32
1710628|NCT01155661|5969987|P1|Overall Study|Death|1
1710629|NCT01155661|5969987|P1|Overall Study|Adverse Event|101
1710630|NCT01155570|5970013|P1|Overall Study|Other Reasons|23
1710631|NCT01155570|5970013|P1|Overall Study|Participant's Economic Reasons + Other|1
1710632|NCT01155570|5970013|P1|Overall Study|Adverse Event + Other Reasons|7
1710633|NCT01155570|5970013|P1|Overall Study|Adverse Event + Lack of Efficacy|2
1710634|NCT01155570|5970013|P1|Overall Study|No Hospital Visits|7
1710635|NCT01155570|5970013|P1|Overall Study|Participant's Economic Reasons|17
1710636|NCT01155570|5970013|P1|Overall Study|Lack of Efficacy|46
1710637|NCT01155570|5970013|P1|Overall Study|Adverse Event|39
1710638|NCT01155531|5970047|P4|Overall Study|Withdrawal by Subject|0
1710639|NCT01155531|5970048|P3|Overall Study|Withdrawal by Subject|1
1710640|NCT01155531|5970049|P2|Overall Study|Withdrawal by Subject|0
1710641|NCT01155531|5970050|P1|Overall Study|Withdrawal by Subject|1
1710642|NCT01155531|5970047|P4|Overall Study|Lost to Follow-up|1
1710643|NCT01155531|5970048|P3|Overall Study|Lost to Follow-up|0
1710644|NCT01155531|5970049|P2|Overall Study|Lost to Follow-up|0
1710645|NCT01155531|5970050|P1|Overall Study|Lost to Follow-up|0
1710646|NCT01155531|5970047|P4|Overall Study|Adverse Event|0
1710647|NCT01155531|5970048|P3|Overall Study|Adverse Event|1
1710648|NCT01155531|5970049|P2|Overall Study|Adverse Event|0
1710649|NCT01155531|5970050|P1|Overall Study|Adverse Event|0
1710650|NCT01155479|5970098|P5|Part II|Non-Compliance with Protocol|0
1710651|NCT01155479|5970099|P4|Part II|Non-Compliance with Protocol|2
1710652|NCT01155479|5970100|P3|Part II|Non-Compliance with Protocol|0
1710653|NCT01155479|5970101|P2|Part II|Non-Compliance with Protocol|1
1710654|NCT01155479|5970102|P1|Part II|Non-Compliance with Protocol|0
1710655|NCT01155479|5970098|P5|Part II|Treatment Failure|1
1710656|NCT01155479|5970099|P4|Part II|Treatment Failure|0
1710657|NCT01155479|5970100|P3|Part II|Treatment Failure|2
1710658|NCT01155479|5970101|P2|Part II|Treatment Failure|1
1710659|NCT01155479|5970102|P1|Part II|Treatment Failure|0
1710660|NCT01155479|5970098|P5|Part II|Lost to Follow-up|1
1710661|NCT01155479|5970099|P4|Part II|Lost to Follow-up|0
1710662|NCT01155479|5970100|P3|Part II|Lost to Follow-up|0
1710663|NCT01155479|5970101|P2|Part II|Lost to Follow-up|0
1710664|NCT01155479|5970102|P1|Part II|Lost to Follow-up|1
1710665|NCT01155479|5970098|P5|Part II|Withdrawal by Subject|3
1710666|NCT01155479|5970099|P4|Part II|Withdrawal by Subject|7
1710667|NCT01155479|5970100|P3|Part II|Withdrawal by Subject|12
1710668|NCT01155479|5970101|P2|Part II|Withdrawal by Subject|4
1710669|NCT01155479|5970102|P1|Part II|Withdrawal by Subject|8
1710670|NCT01155479|5970098|P5|Part II|Administrative|46
1710671|NCT01155479|5970099|P4|Part II|Administrative|38
1710672|NCT01155479|5970100|P3|Part II|Administrative|36
1710673|NCT01155479|5970101|P2|Part II|Administrative|49
1710674|NCT01155479|5970102|P1|Part II|Administrative|43
1710675|NCT01155479|5970098|P5|Part II|Adverse Event|4
1710676|NCT01155479|5970099|P4|Part II|Adverse Event|3
1710677|NCT01155479|5970100|P3|Part II|Adverse Event|8
1710678|NCT01155479|5970101|P2|Part II|Adverse Event|6
1710679|NCT01155479|5970102|P1|Part II|Adverse Event|7
1710680|NCT01155479|5970098|P5|Part I|Non-Compliance with Protocol|2
1710681|NCT01155479|5970099|P4|Part I|Non-Compliance with Protocol|3
1710682|NCT01155479|5970100|P3|Part I|Non-Compliance with Protocol|3
1710683|NCT01155479|5970101|P2|Part I|Non-Compliance with Protocol|1
1710684|NCT01155479|5970102|P1|Part I|Non-Compliance with Protocol|2
1710685|NCT01155479|5970098|P5|Part I|Did Not Receive Treatment|1
1710686|NCT01155479|5970099|P4|Part I|Did Not Receive Treatment|6
1710687|NCT01155479|5970100|P3|Part I|Did Not Receive Treatment|2
1710688|NCT01155479|5970101|P2|Part I|Did Not Receive Treatment|2
1710689|NCT01155479|5970102|P1|Part I|Did Not Receive Treatment|4
1710690|NCT01155479|5970098|P5|Part I|Treatment Failure|2
1710691|NCT01155479|5970099|P4|Part I|Treatment Failure|1
1710692|NCT01155479|5970100|P3|Part I|Treatment Failure|3
1710693|NCT01155479|5970101|P2|Part I|Treatment Failure|0
1710694|NCT01155479|5970102|P1|Part I|Treatment Failure|3
1710695|NCT01155479|5970098|P5|Part I|Lost to Follow-up|0
1710696|NCT01155479|5970099|P4|Part I|Lost to Follow-up|1
1710697|NCT01155479|5970100|P3|Part I|Lost to Follow-up|1
1710698|NCT01155479|5970101|P2|Part I|Lost to Follow-up|0
1710699|NCT01155479|5970102|P1|Part I|Lost to Follow-up|0
1710700|NCT01155479|5970098|P5|Part I|Withdrawal by Subject|9
1710701|NCT01155479|5970099|P4|Part I|Withdrawal by Subject|8
1710702|NCT01155479|5970100|P3|Part I|Withdrawal by Subject|8
1710703|NCT01155479|5970101|P2|Part I|Withdrawal by Subject|13
1710704|NCT01155479|5970102|P1|Part I|Withdrawal by Subject|11
1710705|NCT01155479|5970098|P5|Part I|Did Not Meet Protocol Eligibility|3
1710706|NCT01155479|5970099|P4|Part I|Did Not Meet Protocol Eligibility|1
1710707|NCT01155479|5970100|P3|Part I|Did Not Meet Protocol Eligibility|2
1710708|NCT01155479|5970101|P2|Part I|Did Not Meet Protocol Eligibility|1
1710709|NCT01155479|5970102|P1|Part I|Did Not Meet Protocol Eligibility|3
1710710|NCT01155479|5970098|P5|Part I|Administrative|0
1710711|NCT01155479|5970099|P4|Part I|Administrative|0
1710712|NCT01155479|5970100|P3|Part I|Administrative|2
1710713|NCT01155479|5970101|P2|Part I|Administrative|2
1710714|NCT01155479|5970102|P1|Part I|Administrative|2
1710715|NCT01155479|5970098|P5|Part I|Adverse Event|6
1710716|NCT01155479|5970099|P4|Part I|Adverse Event|7
1710717|NCT01155479|5970100|P3|Part I|Adverse Event|18
1710718|NCT01155479|5970101|P2|Part I|Adverse Event|8
1710719|NCT01155479|5970102|P1|Part I|Adverse Event|13
1710720|NCT01155466|5970154|P5|Overall Study|Randomized not treated|2
1710721|NCT01155466|5970155|P4|Overall Study|Randomized not treated|0
1710722|NCT01155466|5970156|P3|Overall Study|Randomized not treated|3
1710723|NCT01155466|5970157|P2|Overall Study|Randomized not treated|2
1710724|NCT01155466|5970158|P1|Overall Study|Randomized not treated|2
1710725|NCT01155466|5970154|P5|Overall Study|Administrative|0
1710726|NCT01155466|5970155|P4|Overall Study|Administrative|0
1710727|NCT01155466|5970156|P3|Overall Study|Administrative|0
1710728|NCT01155466|5970157|P2|Overall Study|Administrative|3
1710729|NCT01155466|5970158|P1|Overall Study|Administrative|0
1710730|NCT01155466|5970154|P5|Overall Study|Protocol Violation|1
1710731|NCT01155466|5970155|P4|Overall Study|Protocol Violation|0
1710732|NCT01155466|5970156|P3|Overall Study|Protocol Violation|2
1710733|NCT01155466|5970157|P2|Overall Study|Protocol Violation|0
1710734|NCT01155466|5970158|P1|Overall Study|Protocol Violation|0
1710735|NCT01155466|5970154|P5|Overall Study|Withdrawal by Subject|4
1710736|NCT01155466|5970155|P4|Overall Study|Withdrawal by Subject|4
1710737|NCT01155466|5970156|P3|Overall Study|Withdrawal by Subject|9
1710738|NCT01155466|5970157|P2|Overall Study|Withdrawal by Subject|5
1710739|NCT01155466|5970158|P1|Overall Study|Withdrawal by Subject|7
1710740|NCT01155466|5970154|P5|Overall Study|Lost to Follow-up|2
1710741|NCT01155466|5970155|P4|Overall Study|Lost to Follow-up|0
1710742|NCT01155466|5970156|P3|Overall Study|Lost to Follow-up|0
1710743|NCT01155466|5970157|P2|Overall Study|Lost to Follow-up|0
1710744|NCT01155466|5970158|P1|Overall Study|Lost to Follow-up|0
1710745|NCT01155466|5970154|P5|Overall Study|Adverse Event|18
1710746|NCT01155466|5970155|P4|Overall Study|Adverse Event|17
1710747|NCT01155466|5970156|P3|Overall Study|Adverse Event|6
1710748|NCT01155466|5970157|P2|Overall Study|Adverse Event|15
1710749|NCT01155466|5970158|P1|Overall Study|Adverse Event|13
1710750|NCT01155388|5970212|P2|Overall Study|Adverse Event|0
1710751|NCT01155388|5970213|P1|Overall Study|Adverse Event|1
1710752|NCT01155375|5970223|P2|Overall Study|Adverse Event|0
1710753|NCT01155375|5970224|P1|Overall Study|Adverse Event|1
1710754|NCT01155323|5970243|P2|Second Intervention|Lost to Follow-up|1
1710755|NCT01155323|5970244|P1|Second Intervention|Lost to Follow-up|1
1710756|NCT01155323|5970243|P2|First Intervention|exclusion criteria|1
1710757|NCT01155323|5970244|P1|First Intervention|exclusion criteria|1
1710758|NCT01155284|5970262|P2|Overall Study|Adverse Event|0
1710759|NCT01155284|5970263|P1|Overall Study|Adverse Event|1
1710760|NCT01155284|5970262|P2|Overall Study|Physician Decision|0
1710761|NCT01155284|5970263|P1|Overall Study|Physician Decision|1
1710762|NCT01155284|5970262|P2|Overall Study|Lost to Follow-up|2
1710763|NCT01155284|5970263|P1|Overall Study|Lost to Follow-up|1
1710764|NCT01155284|5970262|P2|Overall Study|Withdrawal by Subject|3
1710765|NCT01155284|5970263|P1|Overall Study|Withdrawal by Subject|4
1710766|NCT01155219|5970273|P2|Overall Study|non-medical reason|2
1710767|NCT01155219|5970274|P1|Overall Study|non-medical reason|1
1710768|NCT01155219|5970273|P2|Overall Study|Adverse Event|1
1710769|NCT01155219|5970274|P1|Overall Study|Adverse Event|3
1710770|NCT01155167|5970323|P2|Overall Study|Access site changed to femoral artery|0
1710771|NCT01155167|5970324|P1|Overall Study|Access site changed to femoral artery|1
1710772|NCT01155167|5970323|P2|Overall Study|Insufficient ultrasound data|0
1710773|NCT01155167|5970324|P1|Overall Study|Insufficient ultrasound data|2
1710774|NCT01155141|5970347|P1|Overall Study|Screen Failure|1
1710775|NCT01155141|5970347|P1|Overall Study|Withdrawal by Subject|1
1710776|NCT01155063|5970359|P1|Overall Study|Study terminated by sponsor|87
1710777|NCT01155063|5970359|P1|Overall Study|Withdrawal by Subject|1
1710778|NCT01155063|5970359|P1|Overall Study|Adverse Event|1
1710779|NCT01155024|5970369|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
1710780|NCT01155024|5970370|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
1710781|NCT01155024|5970369|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
1710782|NCT01155024|5970370|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
1710783|NCT01155024|5970369|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
1710784|NCT01155024|5970370|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
1710785|NCT01155011|5970380|P2|6 to 12 Months|Death|5
1710786|NCT01155011|5970381|P1|6 to 12 Months|Death|1
1710787|NCT01155011|5970380|P2|6 to 12 Months|Withdrawal by Subject|5
1710788|NCT01155011|5970381|P1|6 to 12 Months|Withdrawal by Subject|8
1710789|NCT01155011|5970380|P2|Baseline to 6 Months|Death|1
1710790|NCT01155011|5970381|P1|Baseline to 6 Months|Death|0
1710791|NCT01155011|5970380|P2|Baseline to 6 Months|investigator decision, moved|5
1710792|NCT01155011|5970381|P1|Baseline to 6 Months|investigator decision, moved|4
1710793|NCT01155011|5970380|P2|Baseline to 6 Months|Withdrawal by Subject|19
1710794|NCT01155011|5970381|P1|Baseline to 6 Months|Withdrawal by Subject|18
1710795|NCT01154816|5970422|P12|Overall Study|Adverse Event|0
1710796|NCT01154816|5970423|P11|Overall Study|Adverse Event|0
1710797|NCT01154816|5970424|P10|Overall Study|Adverse Event|0
1710798|NCT01154816|5970425|P9|Overall Study|Adverse Event|0
1710799|NCT01154816|5970426|P8|Overall Study|Adverse Event|1
1710800|NCT01154816|5970427|P7|Overall Study|Adverse Event|1
1710801|NCT01154816|5970428|P6|Overall Study|Adverse Event|0
1710802|NCT01154816|5970429|P5|Overall Study|Adverse Event|0
1710803|NCT01154816|5970430|P4|Overall Study|Adverse Event|0
1710804|NCT01154816|5970431|P3|Overall Study|Adverse Event|0
1710805|NCT01154816|5970432|P2|Overall Study|Adverse Event|2
1710806|NCT01154816|5970433|P1|Overall Study|Adverse Event|5
1710807|NCT01154816|5970422|P12|Overall Study|Physician Decision|1
1710808|NCT01154816|5970423|P11|Overall Study|Physician Decision|1
1710809|NCT01154816|5970424|P10|Overall Study|Physician Decision|1
1710810|NCT01154816|5970425|P9|Overall Study|Physician Decision|0
1710811|NCT01154816|5970426|P8|Overall Study|Physician Decision|0
1710812|NCT01154816|5970427|P7|Overall Study|Physician Decision|0
1710813|NCT01154816|5970428|P6|Overall Study|Physician Decision|0
1710814|NCT01154816|5970429|P5|Overall Study|Physician Decision|2
1710815|NCT01154816|5970430|P4|Overall Study|Physician Decision|0
1710816|NCT01154816|5970431|P3|Overall Study|Physician Decision|1
1710817|NCT01154816|5970432|P2|Overall Study|Physician Decision|0
1710818|NCT01154816|5970433|P1|Overall Study|Physician Decision|1
1710819|NCT01154816|5970422|P12|Overall Study|Progressive Disease|3
1710820|NCT01154816|5970423|P11|Overall Study|Progressive Disease|10
1710821|NCT01154816|5970424|P10|Overall Study|Progressive Disease|6
1710822|NCT01154816|5970425|P9|Overall Study|Progressive Disease|8
1710823|NCT01154816|5970426|P8|Overall Study|Progressive Disease|6
1710824|NCT01154816|5970427|P7|Overall Study|Progressive Disease|5
1710825|NCT01154816|5970428|P6|Overall Study|Progressive Disease|8
1710826|NCT01154816|5970429|P5|Overall Study|Progressive Disease|8
1710827|NCT01154816|5970430|P4|Overall Study|Progressive Disease|9
1710828|NCT01154816|5970431|P3|Overall Study|Progressive Disease|9
1710829|NCT01154816|5970432|P2|Overall Study|Progressive Disease|8
1710830|NCT01154816|5970433|P1|Overall Study|Progressive Disease|13
1710831|NCT01154816|5970422|P12|Overall Study|Withdrawal by Subject|0
1710832|NCT01154816|5970423|P11|Overall Study|Withdrawal by Subject|0
1710833|NCT01154816|5970424|P10|Overall Study|Withdrawal by Subject|3
1710834|NCT01154816|5970425|P9|Overall Study|Withdrawal by Subject|1
1710835|NCT01154816|5970426|P8|Overall Study|Withdrawal by Subject|0
1710836|NCT01154816|5970427|P7|Overall Study|Withdrawal by Subject|0
1710837|NCT01154816|5970428|P6|Overall Study|Withdrawal by Subject|0
1710838|NCT01154816|5970429|P5|Overall Study|Withdrawal by Subject|0
1710839|NCT01154816|5970430|P4|Overall Study|Withdrawal by Subject|1
1710840|NCT01154816|5970431|P3|Overall Study|Withdrawal by Subject|0
1710841|NCT01154816|5970432|P2|Overall Study|Withdrawal by Subject|0
1710842|NCT01154816|5970433|P1|Overall Study|Withdrawal by Subject|1
1710843|NCT01154673|5970510|P2|Overall Study|moved out of province|0
1710844|NCT01154673|5970511|P1|Overall Study|moved out of province|1
1710845|NCT01154673|5970510|P2|Overall Study|Lost to Follow-up|0
1710846|NCT01154673|5970511|P1|Overall Study|Lost to Follow-up|1
1710847|NCT01154452|5970566|P4|Phase II|Adverse Event|4
1710848|NCT01154452|5970567|P3|Phase II|Adverse Event|4
1710849|NCT01154452|5970568|P2|Phase II|Adverse Event|0
1710850|NCT01154452|5970569|P1|Phase II|Adverse Event|0
1710851|NCT01154452|5970566|P4|Phase II|Withdrawal by Subject|2
1710852|NCT01154452|5970567|P3|Phase II|Withdrawal by Subject|1
1710853|NCT01154452|5970568|P2|Phase II|Withdrawal by Subject|0
1710854|NCT01154452|5970569|P1|Phase II|Withdrawal by Subject|0
1710855|NCT01154452|5970566|P4|Phase Ib|Adverse Event|0
1710856|NCT01154452|5970567|P3|Phase Ib|Adverse Event|0
1710857|NCT01154452|5970568|P2|Phase Ib|Adverse Event|1
1710858|NCT01154452|5970569|P1|Phase Ib|Adverse Event|2
1710859|NCT01154452|5970566|P4|Phase Ib|Not Treated|0
1710860|NCT01154452|5970567|P3|Phase Ib|Not Treated|0
1710861|NCT01154452|5970568|P2|Phase Ib|Not Treated|0
1710862|NCT01154452|5970569|P1|Phase Ib|Not Treated|1
1710863|NCT01154296|5970601|P2|6-month Follow-up|Declined by Study Coordinator|4
1710864|NCT01154296|5970602|P1|6-month Follow-up|Declined by Study Coordinator|5
1710865|NCT01154296|5970601|P2|6-month Follow-up|Death|2
1710866|NCT01154296|5970602|P1|6-month Follow-up|Death|3
1710867|NCT01154296|5970601|P2|6-month Follow-up|Withdrew consent|15
1710868|NCT01154296|5970602|P1|6-month Follow-up|Withdrew consent|14
1710869|NCT01154296|5970601|P2|6-month Follow-up|Incarcerated|32
1710870|NCT01154296|5970602|P1|6-month Follow-up|Incarcerated|37
1710871|NCT01154296|5970601|P2|6-month Follow-up|Lost contact|275
1710872|NCT01154296|5970602|P1|6-month Follow-up|Lost contact|269
1710873|NCT01154296|5970601|P2|Randomization and Intervention|Left clinic early|0
1710874|NCT01154296|5970602|P1|Randomization and Intervention|Left clinic early|2
1710875|NCT01154296|5970601|P2|Randomization and Intervention|Left before test|1
1710876|NCT01154296|5970602|P1|Randomization and Intervention|Left before test|0
1710877|NCT01154296|5970601|P2|Randomization and Intervention|Did not return|0
1710878|NCT01154296|5970602|P1|Randomization and Intervention|Did not return|1
1710879|NCT01154296|5970601|P2|Randomization and Intervention|Declined by staff|0
1710880|NCT01154296|5970602|P1|Randomization and Intervention|Declined by staff|1
1710881|NCT01154296|5970601|P2|Randomization and Intervention|Decided to decline|1
1710882|NCT01154296|5970602|P1|Randomization and Intervention|Decided to decline|1
1710883|NCT01154283|5970620|P2|7-12 Weeks|Withdrawal by Subject|1
1710884|NCT01154283|5970621|P1|7-12 Weeks|Withdrawal by Subject|0
1710885|NCT01154283|5970620|P2|7-12 Weeks|Death|0
1710886|NCT01154283|5970621|P1|7-12 Weeks|Death|1
1710887|NCT01154283|5970620|P2|0-6 Weeks|Death|1
1710888|NCT01154283|5970621|P1|0-6 Weeks|Death|0
1710889|NCT01154283|5970620|P2|0-6 Weeks|Withdrawal by Subject|2
1710890|NCT01154283|5970621|P1|0-6 Weeks|Withdrawal by Subject|7
1710891|NCT01154231|5970633|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
1710892|NCT01154231|5970633|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
1710893|NCT01154218|5970639|P4|Fourth Intervention Period|Withdrawal by Subject|0
1710894|NCT01154218|5970640|P3|Fourth Intervention Period|Withdrawal by Subject|0
1710895|NCT01154218|5970641|P2|Fourth Intervention Period|Withdrawal by Subject|0
1710896|NCT01154218|5970642|P1|Fourth Intervention Period|Withdrawal by Subject|1
1710897|NCT01154218|5970639|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
1710898|NCT01154218|5970640|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1710899|NCT01154218|5970641|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1710900|NCT01154218|5970642|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
1710901|NCT01154218|5970639|P4|Third Intervention Period|Adverse Event|0
1710902|NCT01154218|5970640|P3|Third Intervention Period|Adverse Event|0
1710903|NCT01154218|5970641|P2|Third Intervention Period|Adverse Event|1
1710904|NCT01154218|5970642|P1|Third Intervention Period|Adverse Event|0
1710905|NCT01154166|5970716|P2|Overall Study|Poor Compliance|0
1710906|NCT01154166|5970717|P1|Overall Study|Poor Compliance|1
1710907|NCT01154166|5970716|P2|Overall Study|Disease Progression|0
1710908|NCT01154166|5970717|P1|Overall Study|Disease Progression|1
1710909|NCT01154166|5970716|P2|Overall Study|Lack of Efficacy|0
1710910|NCT01154166|5970717|P1|Overall Study|Lack of Efficacy|3
1710911|NCT01154166|5970716|P2|Overall Study|Withdrawal by Subject|1
1710912|NCT01154166|5970717|P1|Overall Study|Withdrawal by Subject|10
1710913|NCT01154166|5970716|P2|Overall Study|Protocol Violation|1
1710914|NCT01154166|5970717|P1|Overall Study|Protocol Violation|4
1710915|NCT01154166|5970716|P2|Overall Study|Lost to Follow-up|1
1710916|NCT01154166|5970717|P1|Overall Study|Lost to Follow-up|1
1710917|NCT01154166|5970716|P2|Overall Study|Adverse Event|9
1710918|NCT01154166|5970717|P1|Overall Study|Adverse Event|14
1710919|NCT01154153|5970749|P2|Overall Study|Withdrew consent|0
1710920|NCT01154153|5970750|P1|Overall Study|Withdrew consent|1
1710921|NCT01154153|5970749|P2|Overall Study|Unable to use labs|3
1710922|NCT01154153|5970750|P1|Overall Study|Unable to use labs|2
1710923|NCT01154153|5970749|P2|Overall Study|Poor compliance to protocol|0
1710924|NCT01154153|5970750|P1|Overall Study|Poor compliance to protocol|2
1710925|NCT01154140|5970768|P2|Overall Study|Randomized but not treated|2
1710926|NCT01154140|5970769|P1|Overall Study|Randomized but not treated|1
1710927|NCT01154140|5970768|P2|Overall Study|Other|1
1710928|NCT01154140|5970769|P1|Overall Study|Other|3
1710929|NCT01154140|5970768|P2|Overall Study|Withdrawal by Subject|13
1710930|NCT01154140|5970769|P1|Overall Study|Withdrawal by Subject|12
1710931|NCT01154140|5970768|P2|Overall Study|Lost to Follow-up|5
1710932|NCT01154140|5970769|P1|Overall Study|Lost to Follow-up|4
1710933|NCT01154140|5970768|P2|Overall Study|Death|81
1710934|NCT01154140|5970769|P1|Overall Study|Death|71
1710935|NCT01154127|5970822|P2|Period 2 (21 Days)|Protocol Deviation|1
1710936|NCT01154127|5970823|P1|Period 2 (21 Days)|Protocol Deviation|0
1710937|NCT01154127|5970822|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
1710938|NCT01154127|5970823|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
1710939|NCT01154127|5970822|P2|Washout (14 - 28 Days)|Adverse Event|0
1710940|NCT01154127|5970823|P1|Washout (14 - 28 Days)|Adverse Event|2
1710941|NCT01154127|5970822|P2|Period 1 (21 Days)|Withdrawal by Subject|2
1710942|NCT01154127|5970823|P1|Period 1 (21 Days)|Withdrawal by Subject|0
1710943|NCT01154127|5970822|P2|Period 1 (21 Days)|Adverse Event|4
1710944|NCT01154127|5970823|P1|Period 1 (21 Days)|Adverse Event|3
1710945|NCT01154101|5970850|P5|Overall Study|Withdrawal by Subject|1
1710946|NCT01154101|5970851|P4|Overall Study|Withdrawal by Subject|0
1710947|NCT01154101|5970852|P3|Overall Study|Withdrawal by Subject|2
1710948|NCT01154101|5970853|P2|Overall Study|Withdrawal by Subject|1
1710949|NCT01154101|5970854|P1|Overall Study|Withdrawal by Subject|0
1710950|NCT01154101|5970850|P5|Overall Study|Lost to Follow-up|0
1710951|NCT01154101|5970851|P4|Overall Study|Lost to Follow-up|1
1710952|NCT01154101|5970852|P3|Overall Study|Lost to Follow-up|0
1710953|NCT01154101|5970853|P2|Overall Study|Lost to Follow-up|1
1710954|NCT01154101|5970854|P1|Overall Study|Lost to Follow-up|0
1710955|NCT01154101|5970850|P5|Overall Study|Adverse Event|0
1710956|NCT01154101|5970851|P4|Overall Study|Adverse Event|1
1710957|NCT01154101|5970852|P3|Overall Study|Adverse Event|1
1710958|NCT01154101|5970853|P2|Overall Study|Adverse Event|2
1710959|NCT01154101|5970854|P1|Overall Study|Adverse Event|0
1710960|NCT01154088|5970909|P3|Overall Study|Lost to Follow-up|7
1710961|NCT01154088|5970910|P2|Overall Study|Lost to Follow-up|6
1710962|NCT01154088|5970911|P1|Overall Study|Lost to Follow-up|4
1710963|NCT01154036|5970951|P8|Phase II|Withdrawal by Subject|4
1710964|NCT01154036|5970952|P7|Phase II|Withdrawal by Subject|5
1710965|NCT01154036|5970953|P6|Phase II|Withdrawal by Subject|2
1710966|NCT01154036|5970954|P5|Phase II|Withdrawal by Subject|4
1710967|NCT01154036|5970955|P4|Phase II|Withdrawal by Subject|0
1710968|NCT01154036|5970956|P3|Phase II|Withdrawal by Subject|0
1710969|NCT01154036|5970957|P2|Phase II|Withdrawal by Subject|0
1710970|NCT01154036|5970958|P1|Phase II|Withdrawal by Subject|0
1710971|NCT01154036|5970951|P8|Phase II|Protocol Violation|0
1710972|NCT01154036|5970952|P7|Phase II|Protocol Violation|0
1710973|NCT01154036|5970953|P6|Phase II|Protocol Violation|2
1710974|NCT01154036|5970954|P5|Phase II|Protocol Violation|1
1710975|NCT01154036|5970955|P4|Phase II|Protocol Violation|0
1710976|NCT01154036|5970956|P3|Phase II|Protocol Violation|0
1710977|NCT01154036|5970957|P2|Phase II|Protocol Violation|0
1710978|NCT01154036|5970958|P1|Phase II|Protocol Violation|0
1710979|NCT01154036|5970951|P8|Phase II|Lost to Follow-up|1
1710980|NCT01154036|5970952|P7|Phase II|Lost to Follow-up|2
1710981|NCT01154036|5970953|P6|Phase II|Lost to Follow-up|0
1710982|NCT01154036|5970954|P5|Phase II|Lost to Follow-up|2
1710983|NCT01154036|5970955|P4|Phase II|Lost to Follow-up|1
1710984|NCT01154036|5970956|P3|Phase II|Lost to Follow-up|0
1710985|NCT01154036|5970957|P2|Phase II|Lost to Follow-up|0
1710986|NCT01154036|5970958|P1|Phase II|Lost to Follow-up|0
1710987|NCT01154036|5970951|P8|Phase II|Physician Decision|0
1710988|NCT01154036|5970952|P7|Phase II|Physician Decision|1
1710989|NCT01154036|5970953|P6|Phase II|Physician Decision|0
1710990|NCT01154036|5970954|P5|Phase II|Physician Decision|0
1710991|NCT01154036|5970955|P4|Phase II|Physician Decision|0
1710992|NCT01154036|5970956|P3|Phase II|Physician Decision|0
1710993|NCT01154036|5970957|P2|Phase II|Physician Decision|0
1710994|NCT01154036|5970958|P1|Phase II|Physician Decision|0
1710995|NCT01154036|5970951|P8|Phase II|Adverse Event|1
1710996|NCT01154036|5970952|P7|Phase II|Adverse Event|1
1710997|NCT01154036|5970953|P6|Phase II|Adverse Event|1
1710998|NCT01154036|5970954|P5|Phase II|Adverse Event|1
1710999|NCT01154036|5970955|P4|Phase II|Adverse Event|0
1711000|NCT01154036|5970956|P3|Phase II|Adverse Event|0
1711001|NCT01154036|5970957|P2|Phase II|Adverse Event|0
1711002|NCT01154036|5970958|P1|Phase II|Adverse Event|0
1711003|NCT01154036|5970951|P8|Phase I|Adverse Event|0
1711004|NCT01154036|5970952|P7|Phase I|Adverse Event|0
1711005|NCT01154036|5970953|P6|Phase I|Adverse Event|0
1711006|NCT01154036|5970954|P5|Phase I|Adverse Event|0
1711007|NCT01154036|5970955|P4|Phase I|Adverse Event|0
1711008|NCT01154036|5970956|P3|Phase I|Adverse Event|12
1711009|NCT01154036|5970957|P2|Phase I|Adverse Event|11
1711010|NCT01154036|5970958|P1|Phase I|Adverse Event|1
1711011|NCT01154036|5970951|P8|Phase I|Withdrawal by Subject|0
1711012|NCT01154036|5970952|P7|Phase I|Withdrawal by Subject|0
1711013|NCT01154036|5970953|P6|Phase I|Withdrawal by Subject|0
1711014|NCT01154036|5970954|P5|Phase I|Withdrawal by Subject|0
1711015|NCT01154036|5970955|P4|Phase I|Withdrawal by Subject|0
1711016|NCT01154036|5970956|P3|Phase I|Withdrawal by Subject|29
1711017|NCT01154036|5970957|P2|Phase I|Withdrawal by Subject|10
1711018|NCT01154036|5970958|P1|Phase I|Withdrawal by Subject|2
1711019|NCT01154036|5970951|P8|Phase I|Protocol Violation|0
1711020|NCT01154036|5970952|P7|Phase I|Protocol Violation|0
1711021|NCT01154036|5970953|P6|Phase I|Protocol Violation|0
1711022|NCT01154036|5970954|P5|Phase I|Protocol Violation|0
1711023|NCT01154036|5970955|P4|Phase I|Protocol Violation|0
1711024|NCT01154036|5970956|P3|Phase I|Protocol Violation|9
1711025|NCT01154036|5970957|P2|Phase I|Protocol Violation|3
1711026|NCT01154036|5970958|P1|Phase I|Protocol Violation|0
1711027|NCT01154036|5970951|P8|Phase I|Lost to Follow-up|0
1711028|NCT01154036|5970952|P7|Phase I|Lost to Follow-up|0
1711029|NCT01154036|5970953|P6|Phase I|Lost to Follow-up|0
1711030|NCT01154036|5970954|P5|Phase I|Lost to Follow-up|0
1711031|NCT01154036|5970955|P4|Phase I|Lost to Follow-up|0
1711032|NCT01154036|5970956|P3|Phase I|Lost to Follow-up|6
1711033|NCT01154036|5970957|P2|Phase I|Lost to Follow-up|3
1711034|NCT01154036|5970958|P1|Phase I|Lost to Follow-up|0
1711035|NCT01154036|5970951|P8|Phase I|Physician Decision|0
1711036|NCT01154036|5970952|P7|Phase I|Physician Decision|0
1711037|NCT01154036|5970953|P6|Phase I|Physician Decision|0
1711038|NCT01154036|5970954|P5|Phase I|Physician Decision|0
1711039|NCT01154036|5970955|P4|Phase I|Physician Decision|0
1711040|NCT01154036|5970956|P3|Phase I|Physician Decision|0
1711041|NCT01154036|5970957|P2|Phase I|Physician Decision|1
1711042|NCT01154036|5970958|P1|Phase I|Physician Decision|0
1711043|NCT01154010|5971082|P2|Overall Study|Lost to Follow-up|1
1711044|NCT01154010|5971083|P1|Overall Study|Lost to Follow-up|0
1711045|NCT01153984|5971089|P1|Overall Study|Adverse Event|1
1711046|NCT01153984|5971089|P1|Overall Study|Withdrawal by Subject|1
1711047|NCT01153971|5971100|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
1711048|NCT01153971|5971100|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
1711049|NCT01153971|5971100|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
1711050|NCT01153971|5971100|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
1711051|NCT01153971|5971100|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
1711052|NCT01153971|5971100|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
1711053|NCT01153971|5971100|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
1711054|NCT01153958|5971123|P2|Overall Study|Study Terminated|32
1711055|NCT01153958|5971124|P1|Overall Study|Study Terminated|36
1711056|NCT01153893|5971142|P2|Overall Study|Adverse Event|0
1711057|NCT01153893|5971143|P1|Overall Study|Adverse Event|1
1711058|NCT01153841|5971169|P2|Overall Study|Lost to Follow-up|0
1711059|NCT01153841|5971170|P1|Overall Study|Lost to Follow-up|2
1711060|NCT01153841|5971169|P2|Overall Study|Protocol Violation|0
1711061|NCT01153841|5971170|P1|Overall Study|Protocol Violation|2
1711062|NCT01153841|5971169|P2|Overall Study|Withdrawal by Subject|0
1711063|NCT01153841|5971170|P1|Overall Study|Withdrawal by Subject|1
1711064|NCT01153841|5971169|P2|Overall Study|Adverse Event|0
1711065|NCT01153841|5971170|P1|Overall Study|Adverse Event|1
1711066|NCT01153815|5971186|P2|Overall Study|Withdrawal by Subject|4
1711067|NCT01153815|5971187|P1|Overall Study|Withdrawal by Subject|6
1711068|NCT01153815|5971186|P2|Overall Study|Adverse Event|1
1711069|NCT01153815|5971187|P1|Overall Study|Adverse Event|3
1711070|NCT01153763|5971209|P1|Overall Study|Withdrawal by Subject|2
1711071|NCT01153763|5971209|P1|Overall Study|Physician Decision|2
1711072|NCT01153763|5971209|P1|Overall Study|Lost to Follow-up|1
1711073|NCT01153763|5971209|P1|Overall Study|Study Closed|16
1711074|NCT01153724|5971225|P1|Treatment Period 2|Other reason not defined above|1
1711075|NCT01153724|5971225|P1|Treatment Period 2|Adverse Event|1
1711076|NCT01153724|5971225|P1|Treatment Period 1|Withdrawal by Subject|1
1711077|NCT01153698|5971265|P1|Overall Study|Not treated with Pradaxa|5
1711078|NCT01153698|5971265|P1|Overall Study|Other|2
1711079|NCT01153698|5971265|P1|Overall Study|Switch to other anticoagulants|4
1711080|NCT01153698|5971265|P1|Overall Study|Withdrawal by Subject|2
1711081|NCT01153698|5971265|P1|Overall Study|Lost to Follow-up|4
1711082|NCT01153698|5971265|P1|Overall Study|Adverse Event|12
1711083|NCT01153633|5971316|P2|Overall Study|Therapeutic failure|3
1711084|NCT01153633|5971317|P1|Overall Study|Therapeutic failure|3
1711085|NCT01153633|5971316|P2|Overall Study|Protocol Violation|1
1711086|NCT01153633|5971317|P1|Overall Study|Protocol Violation|1
1711087|NCT01153516|5971354|P2|Overall Study|Both subjects refused surgery|0
1711088|NCT01153516|5971355|P1|Overall Study|Both subjects refused surgery|2
1711089|NCT01153425|5971380|P2|Overall Study|Withdrawal by Subject|3
1711090|NCT01153425|5971381|P1|Overall Study|Withdrawal by Subject|3
1711091|NCT01153347|5971393|P4|Overall Study|Death|0
1711092|NCT01153347|5971394|P3|Overall Study|Death|0
1711093|NCT01153347|5971395|P2|Overall Study|Death|0
1711094|NCT01153347|5971396|P1|Overall Study|Death|1
1711095|NCT01153347|5971393|P4|Overall Study|Other|0
1711096|NCT01153347|5971394|P3|Overall Study|Other|4
1711097|NCT01153347|5971395|P2|Overall Study|Other|5
1711098|NCT01153347|5971396|P1|Overall Study|Other|5
1711099|NCT01153347|5971393|P4|Overall Study|Lost to Follow-up|8
1711100|NCT01153347|5971394|P3|Overall Study|Lost to Follow-up|11
1711101|NCT01153347|5971395|P2|Overall Study|Lost to Follow-up|9
1711102|NCT01153347|5971396|P1|Overall Study|Lost to Follow-up|4
1711103|NCT01153347|5971393|P4|Overall Study|Study-specific withdrawal criteria|2
1711104|NCT01153347|5971394|P3|Overall Study|Study-specific withdrawal criteria|1
1711105|NCT01153347|5971395|P2|Overall Study|Study-specific withdrawal criteria|3
1711106|NCT01153347|5971396|P1|Overall Study|Study-specific withdrawal criteria|4
1711107|NCT01153347|5971393|P4|Overall Study|Lack of Efficacy|4
1711108|NCT01153347|5971394|P3|Overall Study|Lack of Efficacy|0
1711109|NCT01153347|5971395|P2|Overall Study|Lack of Efficacy|2
1711110|NCT01153347|5971396|P1|Overall Study|Lack of Efficacy|2
1711111|NCT01153347|5971393|P4|Overall Study|Condition under investigation worsened|0
1711112|NCT01153347|5971394|P3|Overall Study|Condition under investigation worsened|0
1711113|NCT01153347|5971395|P2|Overall Study|Condition under investigation worsened|1
1711114|NCT01153347|5971396|P1|Overall Study|Condition under investigation worsened|1
1711115|NCT01153347|5971393|P4|Overall Study|Severe non-compliance to protocol|3
1711116|NCT01153347|5971394|P3|Overall Study|Severe non-compliance to protocol|4
1711117|NCT01153347|5971395|P2|Overall Study|Severe non-compliance to protocol|7
1711118|NCT01153347|5971396|P1|Overall Study|Severe non-compliance to protocol|6
1711119|NCT01153347|5971393|P4|Overall Study|Adverse Event|7
1711120|NCT01153347|5971394|P3|Overall Study|Adverse Event|21
1711121|NCT01153347|5971395|P2|Overall Study|Adverse Event|9
1711122|NCT01153347|5971396|P1|Overall Study|Adverse Event|3
1711123|NCT01153347|5971393|P4|Overall Study|Eligibility criteria not fulfilled|1
1711124|NCT01153347|5971394|P3|Overall Study|Eligibility criteria not fulfilled|2
1711125|NCT01153347|5971395|P2|Overall Study|Eligibility criteria not fulfilled|1
1711126|NCT01153347|5971396|P1|Overall Study|Eligibility criteria not fulfilled|0
1711127|NCT01153347|5971393|P4|Overall Study|Withdrawal by Subject|7
1711128|NCT01153347|5971394|P3|Overall Study|Withdrawal by Subject|7
1711129|NCT01153347|5971395|P2|Overall Study|Withdrawal by Subject|7
1711130|NCT01153347|5971396|P1|Overall Study|Withdrawal by Subject|7
1711131|NCT01153321|5971496|P2|Overall Study|Adverse Event|1
1711132|NCT01153321|5971497|P1|Overall Study|Adverse Event|1
1711133|NCT01153321|5971496|P2|Overall Study|Withdrawal by Subject|1
1711134|NCT01153321|5971497|P1|Overall Study|Withdrawal by Subject|0
1711135|NCT01153321|5971496|P2|Overall Study|Development of study withdrawal criteria|1
1711136|NCT01153321|5971497|P1|Overall Study|Development of study withdrawal criteria|0
1711137|NCT01153269|5971609|P1|Overall Study|Antiretroviral therapy break|1
1711138|NCT01153269|5971609|P1|Overall Study|Withdrawal by Subject|1
1711139|NCT01153009|5971672|P4|Overall Study|Other|2
1711140|NCT01153009|5971673|P3|Overall Study|Other|3
1711141|NCT01153009|5971674|P2|Overall Study|Other|1
1711142|NCT01153009|5971675|P1|Overall Study|Other|1
1711143|NCT01153009|5971672|P4|Overall Study|Lost to Follow-up|15
1711144|NCT01153009|5971673|P3|Overall Study|Lost to Follow-up|11
1711145|NCT01153009|5971674|P2|Overall Study|Lost to Follow-up|8
1711146|NCT01153009|5971675|P1|Overall Study|Lost to Follow-up|8
1711147|NCT01153009|5971672|P4|Overall Study|Withdrawal of Consent|6
1711148|NCT01153009|5971673|P3|Overall Study|Withdrawal of Consent|4
1711149|NCT01153009|5971674|P2|Overall Study|Withdrawal of Consent|5
1711150|NCT01153009|5971675|P1|Overall Study|Withdrawal of Consent|5
1711151|NCT01153009|5971672|P4|Overall Study|Protocol Deviations|2
1711152|NCT01153009|5971673|P3|Overall Study|Protocol Deviations|3
1711153|NCT01153009|5971674|P2|Overall Study|Protocol Deviations|3
1711154|NCT01153009|5971675|P1|Overall Study|Protocol Deviations|4
1711155|NCT01153009|5971672|P4|Overall Study|Noncompliance with Study Medication|1
1711156|NCT01153009|5971673|P3|Overall Study|Noncompliance with Study Medication|4
1711157|NCT01153009|5971674|P2|Overall Study|Noncompliance with Study Medication|3
1711158|NCT01153009|5971675|P1|Overall Study|Noncompliance with Study Medication|1
1711159|NCT01153009|5971672|P4|Overall Study|Lack of Efficacy|1
1711160|NCT01153009|5971673|P3|Overall Study|Lack of Efficacy|2
1711161|NCT01153009|5971674|P2|Overall Study|Lack of Efficacy|0
1711162|NCT01153009|5971675|P1|Overall Study|Lack of Efficacy|9
1711163|NCT01153009|5971672|P4|Overall Study|Adverse Event|10
1711164|NCT01153009|5971673|P3|Overall Study|Adverse Event|14
1711165|NCT01153009|5971674|P2|Overall Study|Adverse Event|14
1711166|NCT01153009|5971675|P1|Overall Study|Adverse Event|4
1711167|NCT01152996|5971705|P1|Overall Study|Elevated liver enzymes|1
1711168|NCT01152996|5971705|P1|Overall Study|Protocol Violation|22
1711169|NCT01152996|5971705|P1|Overall Study|Other|36
1711170|NCT01152996|5971705|P1|Overall Study|Noncompliance|41
1711171|NCT01152996|5971705|P1|Overall Study|Lack of Efficacy|68
1711172|NCT01152996|5971705|P1|Overall Study|Lost to Follow-up|112
1711173|NCT01152996|5971705|P1|Overall Study|Adverse Event|115
1711174|NCT01152996|5971705|P1|Overall Study|Withdrawal by Subject|142
1711175|NCT01152814|5971718|P1|Overall Study|Lost to Follow-up|2
1711176|NCT01152788|5971727|P2|Overall Study|No treatment|1
1711177|NCT01152788|5971728|P1|Overall Study|No treatment|0
1711178|NCT01152788|5971727|P2|Overall Study|Withdrawal by Subject|3
1711179|NCT01152788|5971728|P1|Overall Study|Withdrawal by Subject|0
1711180|NCT01152580|5971765|P2|Overall Study|Withdrawal by Subject|1
1711181|NCT01152580|5971766|P1|Overall Study|Withdrawal by Subject|0
1711182|NCT01152554|5971788|P2|Overall Study|Death|1
1711183|NCT01152554|5971789|P1|Overall Study|Death|1
1711184|NCT01152554|5971788|P2|Overall Study|Other|8
1711185|NCT01152554|5971789|P1|Overall Study|Other|28
1711186|NCT01152554|5971788|P2|Overall Study|Lost to Follow-up|32
1711187|NCT01152554|5971789|P1|Overall Study|Lost to Follow-up|87
1711188|NCT01152554|5971788|P2|Overall Study|Study-specific withdrawal criteria|8
1711189|NCT01152554|5971789|P1|Overall Study|Study-specific withdrawal criteria|17
1711190|NCT01152554|5971788|P2|Overall Study|Lack of Efficacy|3
1711191|NCT01152554|5971789|P1|Overall Study|Lack of Efficacy|20
1711192|NCT01152554|5971788|P2|Overall Study|Condition under investigation worsened|2
1711193|NCT01152554|5971789|P1|Overall Study|Condition under investigation worsened|5
1711194|NCT01152554|5971788|P2|Overall Study|Severe non-compliance to protocol|14
1711195|NCT01152554|5971789|P1|Overall Study|Severe non-compliance to protocol|36
1711196|NCT01152554|5971788|P2|Overall Study|Adverse Event|14
1711197|NCT01152554|5971789|P1|Overall Study|Adverse Event|67
1711198|NCT01152554|5971788|P2|Overall Study|Eligiblity criteria not fulfilled|1
1711199|NCT01152554|5971789|P1|Overall Study|Eligiblity criteria not fulfilled|0
1711200|NCT01152554|5971788|P2|Overall Study|Withdrawal by Subject|28
1711201|NCT01152554|5971789|P1|Overall Study|Withdrawal by Subject|73
1711202|NCT01152450|5971811|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
1711203|NCT01152450|5971812|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
1711204|NCT01152450|5971813|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
1711205|NCT01152450|5971814|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
1711206|NCT01152450|5971815|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
1711207|NCT01152450|5971816|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
1711208|NCT01152450|5971811|P6|Period 1 (4 Weeks)|Protocol Violation|0
1711209|NCT01152450|5971812|P5|Period 1 (4 Weeks)|Protocol Violation|1
1711210|NCT01152450|5971813|P4|Period 1 (4 Weeks)|Protocol Violation|0
1711211|NCT01152450|5971814|P3|Period 1 (4 Weeks)|Protocol Violation|0
1711212|NCT01152450|5971815|P2|Period 1 (4 Weeks)|Protocol Violation|0
1711213|NCT01152450|5971816|P1|Period 1 (4 Weeks)|Protocol Violation|0
1711214|NCT01152450|5971811|P6|Period 1 (4 Weeks)|Adverse Event|1
1711215|NCT01152450|5971812|P5|Period 1 (4 Weeks)|Adverse Event|1
1711216|NCT01152450|5971813|P4|Period 1 (4 Weeks)|Adverse Event|0
1711217|NCT01152450|5971814|P3|Period 1 (4 Weeks)|Adverse Event|0
1711218|NCT01152450|5971815|P2|Period 1 (4 Weeks)|Adverse Event|0
1711219|NCT01152450|5971816|P1|Period 1 (4 Weeks)|Adverse Event|0
1711220|NCT01152437|5971887|P3|Overall Study|Refusal to continue taking trial medicat|2
1711221|NCT01152437|5971888|P2|Overall Study|Refusal to continue taking trial medicat|0
1711222|NCT01152437|5971889|P1|Overall Study|Refusal to continue taking trial medicat|1
1711223|NCT01152437|5971887|P3|Overall Study|Progressive disease|32
1711224|NCT01152437|5971888|P2|Overall Study|Progressive disease|13
1711225|NCT01152437|5971889|P1|Overall Study|Progressive disease|27
1711226|NCT01152437|5971887|P3|Overall Study|Not treated|2
1711227|NCT01152437|5971888|P2|Overall Study|Not treated|1
1711228|NCT01152437|5971889|P1|Overall Study|Not treated|0
1711229|NCT01152437|5971887|P3|Overall Study|Other Adverse Event|7
1711230|NCT01152437|5971888|P2|Overall Study|Other Adverse Event|1
1711231|NCT01152437|5971889|P1|Overall Study|Other Adverse Event|8
1711232|NCT01152385|5971909|P4|Overall Study|Other|3
1711233|NCT01152385|5971910|P3|Overall Study|Other|2
1711234|NCT01152385|5971911|P2|Overall Study|Other|3
1711235|NCT01152385|5971912|P1|Overall Study|Other|4
1711236|NCT01152385|5971909|P4|Overall Study|Study-specific withdrawal criteria|0
1711237|NCT01152385|5971910|P3|Overall Study|Study-specific withdrawal criteria|2
1711238|NCT01152385|5971911|P2|Overall Study|Study-specific withdrawal criteria|1
1711239|NCT01152385|5971912|P1|Overall Study|Study-specific withdrawal criteria|1
1711240|NCT01152385|5971909|P4|Overall Study|Adverse Event|0
1711241|NCT01152385|5971910|P3|Overall Study|Adverse Event|0
1711242|NCT01152385|5971911|P2|Overall Study|Adverse Event|1
1711243|NCT01152385|5971912|P1|Overall Study|Adverse Event|1
1711244|NCT01152385|5971909|P4|Overall Study|Protocol Violation|1
1711245|NCT01152385|5971910|P3|Overall Study|Protocol Violation|0
1711246|NCT01152385|5971911|P2|Overall Study|Protocol Violation|0
1711247|NCT01152385|5971912|P1|Overall Study|Protocol Violation|0
1711248|NCT01152385|5971909|P4|Overall Study|Withdrawal by Subject|1
1711249|NCT01152385|5971910|P3|Overall Study|Withdrawal by Subject|1
1711250|NCT01152385|5971911|P2|Overall Study|Withdrawal by Subject|1
1711251|NCT01152385|5971912|P1|Overall Study|Withdrawal by Subject|3
1711252|NCT01152190|5971983|P2|Overall Study|Withdrawal by Subject|3
1711253|NCT01152190|5971984|P1|Overall Study|Withdrawal by Subject|1
1711254|NCT01152190|5971983|P2|Overall Study|Protocol Violation|1
1711255|NCT01152190|5971984|P1|Overall Study|Protocol Violation|1
1711256|NCT01152190|5971983|P2|Overall Study|Death|0
1711257|NCT01152190|5971984|P1|Overall Study|Death|1
1711258|NCT01152190|5971983|P2|Overall Study|Adverse Event|4
1711259|NCT01152190|5971984|P1|Overall Study|Adverse Event|2
1711260|NCT01152021|5972007|P2|Overall Study|No access to study drug in Pharmacy|1
1711261|NCT01152021|5972008|P1|Overall Study|No access to study drug in Pharmacy|0
1711262|NCT01152021|5972007|P2|Overall Study|Physician Decision|1
1711263|NCT01152021|5972008|P1|Overall Study|Physician Decision|1
1711264|NCT01152021|5972007|P2|Overall Study|Study drug had expired|0
1711265|NCT01152021|5972008|P1|Overall Study|Study drug had expired|1
1711266|NCT01152021|5972007|P2|Overall Study|Adverse Event|4
1711267|NCT01152021|5972008|P1|Overall Study|Adverse Event|4
1711268|NCT01151618|5972052|P1|Overall Study|Withdrawal by Subject|7
1711269|NCT01151618|5972052|P1|Overall Study|Adverse Event|2
1711270|NCT01151579|5972060|P2|Overall Study|Not meet inclusion criteria|4
1711271|NCT01151579|5972061|P1|Overall Study|Not meet inclusion criteria|6
1711272|NCT01151579|5972060|P2|Overall Study|Withdrawal by Subject|2
1711273|NCT01151579|5972061|P1|Overall Study|Withdrawal by Subject|3
1711274|NCT01151579|5972060|P2|Overall Study|Physician Decision|1
1711275|NCT01151579|5972061|P1|Overall Study|Physician Decision|3
1711276|NCT01151540|5972075|P1|Overall Study|Withdrawal by Subject|7
1711277|NCT01151540|5972075|P1|Overall Study|Adverse event, non-fatal|4
1711278|NCT01151540|5972075|P1|Overall Study|Other|2
1711279|NCT01151423|5972124|P2|Overall Study|Participated in other clinical trial|0
1711280|NCT01151423|5972125|P1|Overall Study|Participated in other clinical trial|1
1711281|NCT01151423|5972124|P2|Overall Study|Diagnosed as non-TTP patient|1
1711282|NCT01151423|5972125|P1|Overall Study|Diagnosed as non-TTP patient|0
1711283|NCT01151423|5972124|P2|Overall Study|Lost to Follow-up|0
1711284|NCT01151423|5972125|P1|Overall Study|Lost to Follow-up|1
1711285|NCT01151423|5972124|P2|Overall Study|Withdrawal by Subject|3
1711286|NCT01151423|5972125|P1|Overall Study|Withdrawal by Subject|1
1711287|NCT01151423|5972124|P2|Overall Study|Adverse Event|0
1711288|NCT01151423|5972125|P1|Overall Study|Adverse Event|3
1711289|NCT01151423|5972124|P2|Overall Study|Death|1
1711290|NCT01151423|5972125|P1|Overall Study|Death|0
1711291|NCT01151423|5972124|P2|Overall Study|Pregnancy|1
1711292|NCT01151423|5972125|P1|Overall Study|Pregnancy|0
1711293|NCT01151423|5972124|P2|Overall Study|Physician Decision|1
1711294|NCT01151423|5972125|P1|Overall Study|Physician Decision|1
1711295|NCT01151423|5972124|P2|Overall Study|Protocol Violation|1
1711296|NCT01151423|5972125|P1|Overall Study|Protocol Violation|0
1711297|NCT01151423|5972124|P2|Overall Study|Study terminated by Sponsor|10
1711298|NCT01151423|5972125|P1|Overall Study|Study terminated by Sponsor|9
1711299|NCT01151410|5972173|P2|Overall Study|Abnormal laboratory value(s)|1
1711300|NCT01151410|5972174|P1|Overall Study|Abnormal laboratory value(s)|0
1711301|NCT01151410|5972173|P2|Overall Study|Unsatisfactory therapeutic effect|1
1711302|NCT01151410|5972174|P1|Overall Study|Unsatisfactory therapeutic effect|1
1711303|NCT01151410|5972173|P2|Overall Study|Administrative problems|1
1711304|NCT01151410|5972174|P1|Overall Study|Administrative problems|1
1711305|NCT01151410|5972173|P2|Overall Study|Protocol deviation|1
1711306|NCT01151410|5972174|P1|Overall Study|Protocol deviation|2
1711307|NCT01151410|5972173|P2|Overall Study|Adverse Event|2
1711308|NCT01151410|5972174|P1|Overall Study|Adverse Event|1
1711309|NCT01151410|5972173|P2|Overall Study|Lost to Follow-up|4
1711310|NCT01151410|5972174|P1|Overall Study|Lost to Follow-up|3
1711311|NCT01151410|5972173|P2|Overall Study|Withdrawal by Subject|5
1711312|NCT01151410|5972174|P1|Overall Study|Withdrawal by Subject|3
1711313|NCT01151345|5972218|P2|First Intervention Period|Protocol Violation|1
1711314|NCT01151345|5972219|P1|First Intervention Period|Protocol Violation|0
1711315|NCT01151280|5972233|P1|Overall Study|Lack of Efficacy|3
1711316|NCT01151280|5972233|P1|Overall Study|Adverse Event|1
1711317|NCT01151215|5972246|P3|Overall Study|Safety as judged by the investigator|1
1711318|NCT01151215|5972247|P2|Overall Study|Safety as judged by the investigator|0
1711319|NCT01151215|5972248|P1|Overall Study|Safety as judged by the investigator|0
1711320|NCT01151215|5972246|P3|Overall Study|Disease progression|1
1711321|NCT01151215|5972247|P2|Overall Study|Disease progression|1
1711322|NCT01151215|5972248|P1|Overall Study|Disease progression|0
1711323|NCT01151215|5972246|P3|Overall Study|Withdrawal by Subject|2
1711324|NCT01151215|5972247|P2|Overall Study|Withdrawal by Subject|1
1711325|NCT01151215|5972248|P1|Overall Study|Withdrawal by Subject|3
1711326|NCT01151215|5972246|P3|Overall Study|Lost to Follow-up|3
1711327|NCT01151215|5972247|P2|Overall Study|Lost to Follow-up|0
1711328|NCT01151215|5972248|P1|Overall Study|Lost to Follow-up|0
1711329|NCT01151215|5972246|P3|Overall Study|Death|11
1711330|NCT01151215|5972247|P2|Overall Study|Death|20
1711331|NCT01151215|5972248|P1|Overall Study|Death|16
1711332|NCT01151215|5972246|P3|Overall Study|Worsening of condition under study|1
1711333|NCT01151215|5972247|P2|Overall Study|Worsening of condition under study|1
1711334|NCT01151215|5972248|P1|Overall Study|Worsening of condition under study|1
1711335|NCT01151137|5972286|P2|Overall Study|Lost to Follow-up|1
1711336|NCT01151137|5972287|P1|Overall Study|Lost to Follow-up|1
1711337|NCT01151137|5972286|P2|Overall Study|Death|27
1711338|NCT01151137|5972287|P1|Overall Study|Death|15
1711339|NCT01151098|5972305|P1|Overall Study|Miscellaneous|13
1711340|NCT01151098|5972305|P1|Overall Study|Protocol Violation|1
1711341|NCT01151098|5972305|P1|Overall Study|Lack of Efficacy|15
1711342|NCT01151098|5972305|P1|Overall Study|Lost to Follow-up|6
1711343|NCT01151098|5972305|P1|Overall Study|Adverse Event|82
1711344|NCT01151085|5972309|P1|Overall Study|Protocol Violation|25
1711345|NCT01151085|5972309|P1|Overall Study|Lost to Follow-up|31
1711346|NCT01151020|5972340|P1|Overall Study|Still be eligible for follow-up|79
1711347|NCT01151020|5972340|P1|Overall Study|Patients did not receive the device|2
1711348|NCT01151020|5972340|P1|Overall Study|Withdrawal by Subject|12
1711349|NCT01151020|5972340|P1|Overall Study|Lost to Follow-up|1
1711350|NCT01151020|5972340|P1|Overall Study|Conversion to open repair|1
1711351|NCT01151020|5972340|P1|Overall Study|Death|15
1711352|NCT01150474|5972419|P2|Overall Study|Surgery Changed|0
1711353|NCT01150474|5972420|P1|Overall Study|Surgery Changed|1
1711354|NCT01150474|5972419|P2|Overall Study|Drug not administered|0
1711355|NCT01150474|5972420|P1|Overall Study|Drug not administered|1
1711356|NCT01150474|5972419|P2|Overall Study|Drug did not arrive in time|0
1711357|NCT01150474|5972420|P1|Overall Study|Drug did not arrive in time|1
1711358|NCT01150474|5972419|P2|Overall Study|Rectotomy|0
1711359|NCT01150474|5972420|P1|Overall Study|Rectotomy|1
1711360|NCT01150474|5972419|P2|Overall Study|Multiple Studies|1
1711361|NCT01150474|5972420|P1|Overall Study|Multiple Studies|0
1711362|NCT01150474|5972419|P2|Overall Study|Cancer found|0
1711363|NCT01150474|5972420|P1|Overall Study|Cancer found|1
1711364|NCT01150474|5972419|P2|Overall Study|Withdrawal by Subject|2
1711365|NCT01150474|5972420|P1|Overall Study|Withdrawal by Subject|5
1711366|NCT01150357|5972465|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
1711367|NCT01150357|5972466|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
1711368|NCT01150357|5972467|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
1711369|NCT01150357|5972465|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
1711370|NCT01150357|5972466|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
1711371|NCT01150357|5972467|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
1711372|NCT01150357|5972465|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
1711373|NCT01150357|5972466|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
1711374|NCT01150357|5972467|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
1711375|NCT01150357|5972465|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
1711376|NCT01150357|5972466|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
1711377|NCT01150357|5972467|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
1711378|NCT01150357|5972465|P3|Dose Response Phase (Phase 1)|Adverse Event|1
1711379|NCT01150357|5972466|P2|Dose Response Phase (Phase 1)|Adverse Event|0
1711380|NCT01150357|5972467|P1|Dose Response Phase (Phase 1)|Adverse Event|0
1711381|NCT01150357|5972465|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
1711382|NCT01150357|5972466|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
1711383|NCT01150357|5972467|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
1711384|NCT01150357|5972465|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
1711385|NCT01150357|5972466|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
1711386|NCT01150357|5972467|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
1711387|NCT01150123|5972547|P18|Overall Study|Lost to Follow-up|0
1711388|NCT01150123|5972548|P17|Overall Study|Lost to Follow-up|0
1711389|NCT01150123|5972549|P16|Overall Study|Lost to Follow-up|0
1711390|NCT01150123|5972550|P15|Overall Study|Lost to Follow-up|0
1711391|NCT01150123|5972551|P14|Overall Study|Lost to Follow-up|0
1711392|NCT01150123|5972552|P13|Overall Study|Lost to Follow-up|2
1711393|NCT01150123|5972553|P12|Overall Study|Lost to Follow-up|1
1711394|NCT01150123|5972554|P11|Overall Study|Lost to Follow-up|1
1711395|NCT01150123|5972555|P10|Overall Study|Lost to Follow-up|1
1711396|NCT01150123|5972556|P9|Overall Study|Lost to Follow-up|3
1711397|NCT01150123|5972557|P8|Overall Study|Lost to Follow-up|0
1711398|NCT01150123|5972558|P7|Overall Study|Lost to Follow-up|0
1711399|NCT01150123|5972559|P6|Overall Study|Lost to Follow-up|5
1711400|NCT01150123|5972560|P5|Overall Study|Lost to Follow-up|2
1711401|NCT01150123|5972561|P4|Overall Study|Lost to Follow-up|2
1711402|NCT01150123|5972562|P3|Overall Study|Lost to Follow-up|2
1711403|NCT01150123|5972563|P2|Overall Study|Lost to Follow-up|1
1711404|NCT01150123|5972564|P1|Overall Study|Lost to Follow-up|2
1711405|NCT01150123|5972547|P18|Overall Study|Withdrawal by Subject|1
1711406|NCT01150123|5972548|P17|Overall Study|Withdrawal by Subject|0
1711407|NCT01150123|5972549|P16|Overall Study|Withdrawal by Subject|1
1711408|NCT01150123|5972550|P15|Overall Study|Withdrawal by Subject|0
1711409|NCT01150123|5972551|P14|Overall Study|Withdrawal by Subject|0
1711410|NCT01150123|5972552|P13|Overall Study|Withdrawal by Subject|1
1711411|NCT01150123|5972553|P12|Overall Study|Withdrawal by Subject|0
1711412|NCT01150123|5972554|P11|Overall Study|Withdrawal by Subject|1
1711413|NCT01150123|5972555|P10|Overall Study|Withdrawal by Subject|0
1711414|NCT01150123|5972556|P9|Overall Study|Withdrawal by Subject|2
1711415|NCT01150123|5972557|P8|Overall Study|Withdrawal by Subject|3
1711416|NCT01150123|5972558|P7|Overall Study|Withdrawal by Subject|0
1711417|NCT01150123|5972559|P6|Overall Study|Withdrawal by Subject|1
1711418|NCT01150123|5972560|P5|Overall Study|Withdrawal by Subject|1
1711419|NCT01150123|5972561|P4|Overall Study|Withdrawal by Subject|1
1711420|NCT01150123|5972562|P3|Overall Study|Withdrawal by Subject|2
1711421|NCT01150123|5972563|P2|Overall Study|Withdrawal by Subject|1
1711422|NCT01150123|5972564|P1|Overall Study|Withdrawal by Subject|1
1711423|NCT01150097|5972740|P3|Months 24 to 48 Post-transplantation|Death|0
1711424|NCT01150097|5972741|P2|Months 24 to 48 Post-transplantation|Death|0
1711425|NCT01150097|5972742|P1|Months 24 to 48 Post-transplantation|Death|2
1711426|NCT01150097|5972740|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
1711427|NCT01150097|5972741|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
1711428|NCT01150097|5972742|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
1711429|NCT01150097|5972740|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
1711430|NCT01150097|5972741|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
1711431|NCT01150097|5972742|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
1711432|NCT01150097|5972740|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
1711433|NCT01150097|5972741|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
1711434|NCT01150097|5972742|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
1711435|NCT01150097|5972740|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
1711436|NCT01150097|5972741|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
1711437|NCT01150097|5972742|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
1711438|NCT01150097|5972740|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
1711513|NCT01149486|5972931|P2|First Intervention|Adverse Event|1
1711439|NCT01150097|5972741|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
1711440|NCT01150097|5972742|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
1711441|NCT01150097|5972740|P3|Months 24 to 36 Post-transplantation|Death|0
1711442|NCT01150097|5972741|P2|Months 24 to 36 Post-transplantation|Death|0
1711443|NCT01150097|5972742|P1|Months 24 to 36 Post-transplantation|Death|2
1711444|NCT01149863|5972786|P1|Overall Study|Missing data or Not receiveing studydrug|3
1711445|NCT01149655|5972863|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
1711446|NCT01149655|5972864|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
1711447|NCT01149655|5972865|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
1711448|NCT01149655|5972866|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
1711449|NCT01149655|5972863|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
1711450|NCT01149655|5972864|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
1711451|NCT01149655|5972865|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
1711452|NCT01149655|5972866|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
1711453|NCT01149655|5972863|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
1711454|NCT01149655|5972864|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
1711455|NCT01149655|5972865|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
1711456|NCT01149655|5972866|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
1711457|NCT01149655|5972863|P4|Period 3-DB Maintenance Phase|Physician Decision|0
1711458|NCT01149655|5972864|P3|Period 3-DB Maintenance Phase|Physician Decision|1
1711459|NCT01149655|5972865|P2|Period 3-DB Maintenance Phase|Physician Decision|0
1711460|NCT01149655|5972866|P1|Period 3-DB Maintenance Phase|Physician Decision|0
1711461|NCT01149655|5972863|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
1711462|NCT01149655|5972864|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
1711463|NCT01149655|5972865|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
1711464|NCT01149655|5972866|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
1711465|NCT01149655|5972863|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1711466|NCT01149655|5972864|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1711467|NCT01149655|5972865|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
1711468|NCT01149655|5972866|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
1711469|NCT01149655|5972863|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
1711470|NCT01149655|5972864|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
1711471|NCT01149655|5972865|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
1711472|NCT01149655|5972866|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
1711473|NCT01149655|5972863|P4|Period 2-Stabilization Phase|Physician Decision|0
1711474|NCT01149655|5972864|P3|Period 2-Stabilization Phase|Physician Decision|0
1711475|NCT01149655|5972865|P2|Period 2-Stabilization Phase|Physician Decision|3
1711476|NCT01149655|5972866|P1|Period 2-Stabilization Phase|Physician Decision|0
1711477|NCT01149655|5972863|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1711478|NCT01149655|5972864|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1711479|NCT01149655|5972865|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
1711480|NCT01149655|5972866|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
1711481|NCT01149655|5972863|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1711482|NCT01149655|5972864|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1711483|NCT01149655|5972865|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
1711484|NCT01149655|5972866|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
1711485|NCT01149655|5972863|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1711486|NCT01149655|5972864|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1711487|NCT01149655|5972865|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
1711488|NCT01149655|5972866|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
1711489|NCT01149655|5972863|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
1711490|NCT01149655|5972864|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
1711491|NCT01149655|5972865|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
1711492|NCT01149655|5972866|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
1711493|NCT01149655|5972863|P4|Period 1 - Conversion Phase|Physician Decision|0
1711494|NCT01149655|5972864|P3|Period 1 - Conversion Phase|Physician Decision|0
1711495|NCT01149655|5972865|P2|Period 1 - Conversion Phase|Physician Decision|0
1711496|NCT01149655|5972866|P1|Period 1 - Conversion Phase|Physician Decision|2
1711497|NCT01149655|5972863|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1711498|NCT01149655|5972864|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1711499|NCT01149655|5972865|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1711500|NCT01149655|5972866|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
1711501|NCT01149655|5972863|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1711502|NCT01149655|5972864|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1711503|NCT01149655|5972865|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
1711504|NCT01149655|5972866|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
1711505|NCT01149655|5972863|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
1711506|NCT01149655|5972864|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
1711507|NCT01149655|5972865|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
1711508|NCT01149655|5972866|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
1711509|NCT01149538|5972909|P2|Overall Study|Withdrawal by Subject|3
1711510|NCT01149538|5972910|P1|Overall Study|Withdrawal by Subject|5
1711511|NCT01149538|5972909|P2|Overall Study|Lost to Follow-up|1
1711512|NCT01149538|5972910|P1|Overall Study|Lost to Follow-up|0
1711514|NCT01149486|5972932|P1|First Intervention|Adverse Event|0
1711515|NCT01149473|5972956|P2|Washout of 7 Days|Withdrawal by Subject|1
1711516|NCT01149473|5972957|P1|Washout of 7 Days|Withdrawal by Subject|1
1711517|NCT01149473|5972956|P2|First Intervention|Adverse Event|1
1711518|NCT01149473|5972957|P1|First Intervention|Adverse Event|1
1711519|NCT01149460|5972975|P2|Overall Study|Withdrawal by Subject|2
1711520|NCT01149460|5972976|P1|Overall Study|Withdrawal by Subject|0
1711521|NCT01149421|5973009|P3|Overall Study|Protocol Violation|6
1711522|NCT01149421|5973010|P2|Overall Study|Protocol Violation|2
1711523|NCT01149421|5973011|P1|Overall Study|Protocol Violation|2
1711524|NCT01149421|5973009|P3|Overall Study|Entry Criteria Not Met|2
1711525|NCT01149421|5973010|P2|Overall Study|Entry Criteria Not Met|1
1711526|NCT01149421|5973011|P1|Overall Study|Entry Criteria Not Met|1
1711527|NCT01149421|5973009|P3|Overall Study|Physician Decision|6
1711528|NCT01149421|5973010|P2|Overall Study|Physician Decision|3
1711529|NCT01149421|5973011|P1|Overall Study|Physician Decision|5
1711530|NCT01149421|5973009|P3|Overall Study|Lost to Follow-up|5
1711531|NCT01149421|5973010|P2|Overall Study|Lost to Follow-up|4
1711532|NCT01149421|5973011|P1|Overall Study|Lost to Follow-up|2
1711533|NCT01149421|5973009|P3|Overall Study|Sponsor Decision|1
1711534|NCT01149421|5973010|P2|Overall Study|Sponsor Decision|1
1711535|NCT01149421|5973011|P1|Overall Study|Sponsor Decision|0
1711536|NCT01149421|5973009|P3|Overall Study|Withdrawal by Subject|13
1711537|NCT01149421|5973010|P2|Overall Study|Withdrawal by Subject|12
1711538|NCT01149421|5973011|P1|Overall Study|Withdrawal by Subject|20
1711539|NCT01149421|5973009|P3|Overall Study|Adverse Event|11
1711540|NCT01149421|5973010|P2|Overall Study|Adverse Event|6
1711541|NCT01149421|5973011|P1|Overall Study|Adverse Event|22
1711542|NCT01149369|5973092|P2|Overall Study|Adverse Event|3
1711543|NCT01149369|5973093|P1|Overall Study|Adverse Event|6
1711544|NCT01149343|5973261|P4|Overall Study|Recurrence / Progressive disease|0
1711545|NCT01149343|5973262|P3|Overall Study|Recurrence / Progressive disease|1
1711546|NCT01149343|5973263|P2|Overall Study|Recurrence / Progressive disease|0
1711547|NCT01149343|5973264|P1|Overall Study|Recurrence / Progressive disease|0
1711548|NCT01149343|5973261|P4|Overall Study|Sponsor study termination|2
1711549|NCT01149343|5973262|P3|Overall Study|Sponsor study termination|0
1711550|NCT01149343|5973263|P2|Overall Study|Sponsor study termination|0
1711551|NCT01149343|5973264|P1|Overall Study|Sponsor study termination|0
1711552|NCT01149343|5973261|P4|Overall Study|Other|14
1711553|NCT01149343|5973262|P3|Overall Study|Other|2
1711554|NCT01149343|5973263|P2|Overall Study|Other|10
1711555|NCT01149343|5973264|P1|Overall Study|Other|8
1711556|NCT01149343|5973261|P4|Overall Study|Lost to Follow-up|1
1711557|NCT01149343|5973262|P3|Overall Study|Lost to Follow-up|0
1711558|NCT01149343|5973263|P2|Overall Study|Lost to Follow-up|0
1711559|NCT01149343|5973264|P1|Overall Study|Lost to Follow-up|1
1711560|NCT01149343|5973261|P4|Overall Study|Death|18
1711561|NCT01149343|5973262|P3|Overall Study|Death|18
1711562|NCT01149343|5973263|P2|Overall Study|Death|13
1711563|NCT01149343|5973264|P1|Overall Study|Death|10
1711564|NCT01149343|5973261|P4|Overall Study|Withdrawal by Subject|5
1711565|NCT01149343|5973262|P3|Overall Study|Withdrawal by Subject|1
1711566|NCT01149343|5973263|P2|Overall Study|Withdrawal by Subject|1
1711567|NCT01149343|5973264|P1|Overall Study|Withdrawal by Subject|1
1711568|NCT01149148|5973349|P2|Overall Study|Death|0
1711569|NCT01149148|5973350|P1|Overall Study|Death|1
1711570|NCT01149148|5973349|P2|Overall Study|Lost to Follow-up|2
1711571|NCT01149148|5973350|P1|Overall Study|Lost to Follow-up|1
1711572|NCT01149057|5973358|P1|Overall Study|Other|6
1711573|NCT01149057|5973358|P1|Overall Study|High Parathyroid Hormone Value|1
1711574|NCT01149057|5973358|P1|Overall Study|Lost to Follow-up|1
1711575|NCT01149057|5973358|P1|Overall Study|Participant Non-Compliance|2
1711576|NCT01149057|5973358|P1|Overall Study|B Cell Depletion|4
1711577|NCT01149057|5973358|P1|Overall Study|Positive Hepatitis B Core Antibody|5
1711578|NCT01149057|5973358|P1|Overall Study|Withdrawal by Subject|9
1711579|NCT01149057|5973358|P1|Overall Study|Adverse Event|13
1711580|NCT01149057|5973358|P1|Overall Study|Lack of Efficacy|16
1711581|NCT01148979|5973385|P2|Overall Study|Lost to Follow-up|1
1711582|NCT01148979|5973386|P1|Overall Study|Lost to Follow-up|0
1711583|NCT01148862|5973404|P2|Second Intervention|Withdrawal by Subject|2
1711584|NCT01148862|5973405|P1|Second Intervention|Withdrawal by Subject|0
1711585|NCT01148810|5973437|P2|Overall Study|Protocol Violation|0
1711586|NCT01148810|5973438|P1|Overall Study|Protocol Violation|1
1711587|NCT01148810|5973437|P2|Overall Study|Withdrawal by Subject|2
1711588|NCT01148810|5973438|P1|Overall Study|Withdrawal by Subject|0
1711589|NCT01148810|5973437|P2|Overall Study|Lack of Efficacy|1
1711590|NCT01148810|5973438|P1|Overall Study|Lack of Efficacy|0
1711591|NCT01148810|5973437|P2|Overall Study|Adverse Event|2
1711592|NCT01148810|5973438|P1|Overall Study|Adverse Event|0
1711593|NCT01148771|5973465|P2|Washout Period|Withdrawal by Subject|1
1711594|NCT01148771|5973466|P1|Washout Period|Withdrawal by Subject|0
1711595|NCT01148693|5973486|P2|Overall Study|Attempts for cannulation were failed|10
1711596|NCT01148693|5973487|P1|Overall Study|Attempts for cannulation were failed|13
1711597|NCT01148537|5973507|P3|Overall Study|Adverse Event|1
1711598|NCT01148537|5973508|P2|Overall Study|Adverse Event|0
1711599|NCT01148537|5973509|P1|Overall Study|Adverse Event|2
1711600|NCT01148537|5973507|P3|Overall Study|Withdrawal by Subject|2
1711601|NCT01148537|5973508|P2|Overall Study|Withdrawal by Subject|0
1711602|NCT01148537|5973509|P1|Overall Study|Withdrawal by Subject|1
1711603|NCT01148511|5973595|P3|Randomized|Other|1
1711604|NCT01148511|5973596|P2|Randomized|Other|1
1711605|NCT01148511|5973597|P1|Randomized|Other|0
1711606|NCT01148511|5973595|P3|Randomized|Consent withdrawal|3
1711607|NCT01148511|5973596|P2|Randomized|Consent withdrawal|5
1711608|NCT01148511|5973597|P1|Randomized|Consent withdrawal|0
1711609|NCT01148511|5973595|P3|Randomized|Lost to Follow-up|1
1711610|NCT01148511|5973596|P2|Randomized|Lost to Follow-up|1
1711611|NCT01148511|5973597|P1|Randomized|Lost to Follow-up|0
1711612|NCT01148511|5973595|P3|Randomized|Protocol Violation|1
1711613|NCT01148511|5973596|P2|Randomized|Protocol Violation|2
1711614|NCT01148511|5973597|P1|Randomized|Protocol Violation|0
1711615|NCT01148511|5973595|P3|Randomized|Adverse Event|0
1711616|NCT01148511|5973596|P2|Randomized|Adverse Event|1
1711617|NCT01148511|5973597|P1|Randomized|Adverse Event|0
1711618|NCT01148511|5973595|P3|Exposed to Study Drug|Lost to Follow-up|0
1711619|NCT01148511|5973596|P2|Exposed to Study Drug|Lost to Follow-up|0
1711620|NCT01148511|5973597|P1|Exposed to Study Drug|Lost to Follow-up|4
1711621|NCT01148511|5973595|P3|Exposed to Study Drug|Protocol Violation|0
1711622|NCT01148511|5973596|P2|Exposed to Study Drug|Protocol Violation|0
1711623|NCT01148511|5973597|P1|Exposed to Study Drug|Protocol Violation|2
1711624|NCT01148459|5973618|P2|Overall Study|Failure to comply with study procedures|1
1711625|NCT01148459|5973619|P1|Overall Study|Failure to comply with study procedures|0
1711626|NCT01148459|5973618|P2|Overall Study|Refusal|0
1711627|NCT01148459|5973619|P1|Overall Study|Refusal|1
1711628|NCT01148459|5973618|P2|Overall Study|Lost to Follow-up|0
1711629|NCT01148459|5973619|P1|Overall Study|Lost to Follow-up|2
1711630|NCT01148459|5973618|P2|Overall Study|Migrated/moved from study area|6
1711631|NCT01148459|5973619|P1|Overall Study|Migrated/moved from study area|3
1711632|NCT01148459|5973618|P2|Overall Study|Withdrawal by Subject|0
1711633|NCT01148459|5973619|P1|Overall Study|Withdrawal by Subject|1
1711634|NCT01148459|5973618|P2|Overall Study|Serious Adverse Event|4
1711635|NCT01148459|5973619|P1|Overall Study|Serious Adverse Event|5
1711636|NCT01148225|5973667|P1|Overall Study|Other|185
1711637|NCT01148017|5973718|P4|Overall Study|Unable to classify|0
1711638|NCT01148017|5973719|P3|Overall Study|Unable to classify|0
1711639|NCT01148017|5973720|P2|Overall Study|Unable to classify|1
1711640|NCT01148017|5973721|P1|Overall Study|Unable to classify|3
1711641|NCT01148017|5973718|P4|Overall Study|Administrative reason|0
1711642|NCT01148017|5973719|P3|Overall Study|Administrative reason|0
1711643|NCT01148017|5973720|P2|Overall Study|Administrative reason|9
1711644|NCT01148017|5973721|P1|Overall Study|Administrative reason|22
1711645|NCT01148017|5973718|P4|Overall Study|Inappropriate enrollment|0
1711646|NCT01148017|5973719|P3|Overall Study|Inappropriate enrollment|0
1711647|NCT01148017|5973720|P2|Overall Study|Inappropriate enrollment|0
1711648|NCT01148017|5973721|P1|Overall Study|Inappropriate enrollment|1
1711649|NCT01148017|5973718|P4|Overall Study|Lost to Follow-up|0
1711650|NCT01148017|5973719|P3|Overall Study|Lost to Follow-up|0
1711651|NCT01148017|5973720|P2|Overall Study|Lost to Follow-up|10
1711652|NCT01148017|5973721|P1|Overall Study|Lost to Follow-up|23
1711653|NCT01148017|5973718|P4|Overall Study|Withdrawal by Subject|0
1711654|NCT01148017|5973719|P3|Overall Study|Withdrawal by Subject|0
1711655|NCT01148017|5973720|P2|Overall Study|Withdrawal by Subject|14
1711656|NCT01148017|5973721|P1|Overall Study|Withdrawal by Subject|31
1711657|NCT01147926|5973760|P2|Overall Study|Colonoscopy result|1
1711658|NCT01147926|5973761|P1|Overall Study|Colonoscopy result|0
1711659|NCT01147926|5973760|P2|Overall Study|Went on holiday|1
1711660|NCT01147926|5973761|P1|Overall Study|Went on holiday|0
1711661|NCT01147926|5973760|P2|Overall Study|Too busy, no time for study|0
1711662|NCT01147926|5973761|P1|Overall Study|Too busy, no time for study|1
1711663|NCT01147926|5973760|P2|Overall Study|Lack of Efficacy|0
1711664|NCT01147926|5973761|P1|Overall Study|Lack of Efficacy|1
1711665|NCT01147926|5973760|P2|Overall Study|Sponsor's Decision|1
1711666|NCT01147926|5973761|P1|Overall Study|Sponsor's Decision|0
1711667|NCT01147926|5973760|P2|Overall Study|Lost to Follow-up|2
1711668|NCT01147926|5973761|P1|Overall Study|Lost to Follow-up|0
1711669|NCT01147926|5973760|P2|Overall Study|Selection criteria not met|1
1711670|NCT01147926|5973761|P1|Overall Study|Selection criteria not met|3
1711671|NCT01147926|5973760|P2|Overall Study|Principal investigator left hospital|3
1711672|NCT01147926|5973761|P1|Overall Study|Principal investigator left hospital|1
1711673|NCT01147926|5973760|P2|Overall Study|Subject Non-Compliant|4
1711674|NCT01147926|5973761|P1|Overall Study|Subject Non-Compliant|5
1711675|NCT01147926|5973760|P2|Overall Study|Adverse Event|6
1711676|NCT01147926|5973761|P1|Overall Study|Adverse Event|7
1711677|NCT01147926|5973760|P2|Overall Study|Subject Withdrew Consent|10
1711678|NCT01147926|5973761|P1|Overall Study|Subject Withdrew Consent|9
1711679|NCT01147900|5973796|P3|At Year 10|Lost to Follow-up|0
1711680|NCT01147900|5973797|P2|At Year 10|Lost to Follow-up|1
1711681|NCT01147900|5973798|P1|At Year 10|Lost to Follow-up|0
1711682|NCT01147874|5973857|P1|Overall Study|Withdrawal by Subject|24
1711683|NCT01147874|5973857|P1|Overall Study|Sponsor's Decision|2
1711684|NCT01147874|5973857|P1|Overall Study|Protocol Violation|5
1711685|NCT01147874|5973857|P1|Overall Study|Other|5
1711686|NCT01147874|5973857|P1|Overall Study|Lost to Follow-up|25
1711687|NCT01147874|5973857|P1|Overall Study|Investigator’s Request|1
1711688|NCT01147874|5973857|P1|Overall Study|Adverse Event|5
1711689|NCT01147848|5973865|P3|Randomized Phase|Withdrawal by Subject|9
1711690|NCT01147848|5973866|P2|Randomized Phase|Withdrawal by Subject|7
1711691|NCT01147848|5973867|P1|Randomized Phase|Withdrawal by Subject|0
1711692|NCT01147848|5973865|P3|Randomized Phase|Physician Decision|1
1711693|NCT01147848|5973866|P2|Randomized Phase|Physician Decision|0
1711694|NCT01147848|5973867|P1|Randomized Phase|Physician Decision|0
1711695|NCT01147848|5973865|P3|Randomized Phase|Lost to Follow-up|7
1711696|NCT01147848|5973866|P2|Randomized Phase|Lost to Follow-up|5
1711697|NCT01147848|5973867|P1|Randomized Phase|Lost to Follow-up|0
1711698|NCT01147848|5973865|P3|Randomized Phase|Protocol Violation|10
1711699|NCT01147848|5973866|P2|Randomized Phase|Protocol Violation|7
1711700|NCT01147848|5973867|P1|Randomized Phase|Protocol Violation|0
1711701|NCT01147848|5973865|P3|Randomized Phase|Lack of Efficacy|11
1711702|NCT01147848|5973866|P2|Randomized Phase|Lack of Efficacy|20
1711703|NCT01147848|5973867|P1|Randomized Phase|Lack of Efficacy|0
1711704|NCT01147848|5973865|P3|Randomized Phase|Adverse Event|8
1711705|NCT01147848|5973866|P2|Randomized Phase|Adverse Event|6
1711706|NCT01147848|5973867|P1|Randomized Phase|Adverse Event|0
1711707|NCT01147848|5973865|P3|Run-in Period|Run-in Failure|0
1711708|NCT01147848|5973866|P2|Run-in Period|Run-in Failure|0
1711709|NCT01147848|5973867|P1|Run-in Period|Run-in Failure|135
1711710|NCT01147848|5973865|P3|Run-in Period|Screen Failure|0
1711711|NCT01147848|5973866|P2|Run-in Period|Screen Failure|0
1711712|NCT01147848|5973867|P1|Run-in Period|Screen Failure|623
1711713|NCT01147822|5973899|P2|Overall Study|Not Completed/Ongoing|102
1711714|NCT01147822|5973900|P1|Overall Study|Not Completed/Ongoing|111
1711715|NCT01147822|5973899|P2|Overall Study|Withdrawal by Subject|13
1711716|NCT01147822|5973900|P1|Overall Study|Withdrawal by Subject|8
1711717|NCT01147822|5973899|P2|Overall Study|Physician Decision|2
1711718|NCT01147822|5973900|P1|Overall Study|Physician Decision|0
1711719|NCT01147822|5973899|P2|Overall Study|Lost to Follow-up|2
1711720|NCT01147822|5973900|P1|Overall Study|Lost to Follow-up|3
1711721|NCT01147822|5973899|P2|Overall Study|Protocol Violation|1
1711722|NCT01147822|5973900|P1|Overall Study|Protocol Violation|0
1711723|NCT01147822|5973899|P2|Overall Study|Death|59
1711724|NCT01147822|5973900|P1|Overall Study|Death|66
1711725|NCT01147809|5973920|P6|Phase II (168 Days)|Ongoing|0
1711726|NCT01147809|5973921|P5|Phase II (168 Days)|Ongoing|1
1711727|NCT01147809|5973922|P4|Phase II (168 Days)|Ongoing|0
1711728|NCT01147809|5973923|P3|Phase II (168 Days)|Ongoing|0
1711729|NCT01147809|5973924|P2|Phase II (168 Days)|Ongoing|0
1711730|NCT01147809|5973925|P1|Phase II (168 Days)|Ongoing|0
1711731|NCT01147809|5973920|P6|Phase II (168 Days)|Withdrawal by Subject|15
1711732|NCT01147809|5973921|P5|Phase II (168 Days)|Withdrawal by Subject|7
1711733|NCT01147809|5973922|P4|Phase II (168 Days)|Withdrawal by Subject|0
1711734|NCT01147809|5973923|P3|Phase II (168 Days)|Withdrawal by Subject|0
1711735|NCT01147809|5973924|P2|Phase II (168 Days)|Withdrawal by Subject|0
1711736|NCT01147809|5973925|P1|Phase II (168 Days)|Withdrawal by Subject|0
1711737|NCT01147809|5973920|P6|Phase II (168 Days)|Physician Decision|11
1711738|NCT01147809|5973921|P5|Phase II (168 Days)|Physician Decision|5
1711739|NCT01147809|5973922|P4|Phase II (168 Days)|Physician Decision|0
1711740|NCT01147809|5973923|P3|Phase II (168 Days)|Physician Decision|0
1711741|NCT01147809|5973924|P2|Phase II (168 Days)|Physician Decision|0
1711742|NCT01147809|5973925|P1|Phase II (168 Days)|Physician Decision|0
1711743|NCT01147809|5973920|P6|Phase II (168 Days)|Protocol Violation|1
1711744|NCT01147809|5973921|P5|Phase II (168 Days)|Protocol Violation|0
1711745|NCT01147809|5973922|P4|Phase II (168 Days)|Protocol Violation|0
1711746|NCT01147809|5973923|P3|Phase II (168 Days)|Protocol Violation|0
1711747|NCT01147809|5973924|P2|Phase II (168 Days)|Protocol Violation|0
1711748|NCT01147809|5973925|P1|Phase II (168 Days)|Protocol Violation|0
1711749|NCT01147809|5973920|P6|Phase II (168 Days)|Adverse Event|6
1711750|NCT01147809|5973921|P5|Phase II (168 Days)|Adverse Event|3
1711751|NCT01147809|5973922|P4|Phase II (168 Days)|Adverse Event|0
1711752|NCT01147809|5973923|P3|Phase II (168 Days)|Adverse Event|0
1711753|NCT01147809|5973924|P2|Phase II (168 Days)|Adverse Event|0
1711754|NCT01147809|5973925|P1|Phase II (168 Days)|Adverse Event|0
1711755|NCT01147809|5973920|P6|Phase I (168 Days)|Withdrawal by Subject|0
1711756|NCT01147809|5973921|P5|Phase I (168 Days)|Withdrawal by Subject|0
1711757|NCT01147809|5973922|P4|Phase I (168 Days)|Withdrawal by Subject|3
1711758|NCT01147809|5973923|P3|Phase I (168 Days)|Withdrawal by Subject|0
1711759|NCT01147809|5973924|P2|Phase I (168 Days)|Withdrawal by Subject|0
1711760|NCT01147809|5973925|P1|Phase I (168 Days)|Withdrawal by Subject|0
1711761|NCT01147809|5973920|P6|Phase I (168 Days)|Physician Decision|0
1711762|NCT01147809|5973921|P5|Phase I (168 Days)|Physician Decision|0
1711763|NCT01147809|5973922|P4|Phase I (168 Days)|Physician Decision|0
1711764|NCT01147809|5973923|P3|Phase I (168 Days)|Physician Decision|2
1711765|NCT01147809|5973924|P2|Phase I (168 Days)|Physician Decision|1
1711766|NCT01147809|5973925|P1|Phase I (168 Days)|Physician Decision|0
1711767|NCT01147809|5973920|P6|Phase I (168 Days)|Lost to Follow-up|0
1711768|NCT01147809|5973921|P5|Phase I (168 Days)|Lost to Follow-up|0
1711769|NCT01147809|5973922|P4|Phase I (168 Days)|Lost to Follow-up|1
1711770|NCT01147809|5973923|P3|Phase I (168 Days)|Lost to Follow-up|0
1711771|NCT01147809|5973924|P2|Phase I (168 Days)|Lost to Follow-up|0
1711772|NCT01147809|5973925|P1|Phase I (168 Days)|Lost to Follow-up|1
1711773|NCT01147809|5973920|P6|Phase I (168 Days)|Adverse Event|0
1711774|NCT01147809|5973921|P5|Phase I (168 Days)|Adverse Event|0
1711775|NCT01147809|5973922|P4|Phase I (168 Days)|Adverse Event|1
1711776|NCT01147809|5973923|P3|Phase I (168 Days)|Adverse Event|0
1711777|NCT01147809|5973924|P2|Phase I (168 Days)|Adverse Event|0
1711778|NCT01147809|5973925|P1|Phase I (168 Days)|Adverse Event|0
1711779|NCT01147744|5974046|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
1711780|NCT01147744|5974047|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
1711781|NCT01147744|5974048|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
1711782|NCT01147744|5974049|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
1711783|NCT01147744|5974050|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
1711784|NCT01147744|5974051|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
1711785|NCT01147744|5974052|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
1711786|NCT01147744|5974046|P7|Overall Study|Sponsor decision to amend protocol|6
1711787|NCT01147744|5974047|P6|Overall Study|Sponsor decision to amend protocol|2
1711788|NCT01147744|5974048|P5|Overall Study|Sponsor decision to amend protocol|7
1711789|NCT01147744|5974049|P4|Overall Study|Sponsor decision to amend protocol|5
1711790|NCT01147744|5974050|P3|Overall Study|Sponsor decision to amend protocol|2
1711791|NCT01147744|5974051|P2|Overall Study|Sponsor decision to amend protocol|4
1711792|NCT01147744|5974052|P1|Overall Study|Sponsor decision to amend protocol|7
1711793|NCT01147744|5974046|P7|Overall Study|Lost to Follow-up|0
1711794|NCT01147744|5974047|P6|Overall Study|Lost to Follow-up|0
1711795|NCT01147744|5974048|P5|Overall Study|Lost to Follow-up|0
1711796|NCT01147744|5974049|P4|Overall Study|Lost to Follow-up|0
1711797|NCT01147744|5974050|P3|Overall Study|Lost to Follow-up|0
1711798|NCT01147744|5974051|P2|Overall Study|Lost to Follow-up|1
1711799|NCT01147744|5974052|P1|Overall Study|Lost to Follow-up|0
1711800|NCT01147744|5974046|P7|Overall Study|Withdrawal by Subject|2
1711801|NCT01147744|5974047|P6|Overall Study|Withdrawal by Subject|5
1711802|NCT01147744|5974048|P5|Overall Study|Withdrawal by Subject|2
1711803|NCT01147744|5974049|P4|Overall Study|Withdrawal by Subject|2
1711804|NCT01147744|5974050|P3|Overall Study|Withdrawal by Subject|2
1711805|NCT01147744|5974051|P2|Overall Study|Withdrawal by Subject|4
1711806|NCT01147744|5974052|P1|Overall Study|Withdrawal by Subject|8
1711807|NCT01147744|5974046|P7|Overall Study|Adverse Event|2
1711808|NCT01147744|5974047|P6|Overall Study|Adverse Event|1
1711809|NCT01147744|5974048|P5|Overall Study|Adverse Event|2
1711810|NCT01147744|5974049|P4|Overall Study|Adverse Event|0
1711811|NCT01147744|5974050|P3|Overall Study|Adverse Event|3
1711812|NCT01147744|5974051|P2|Overall Study|Adverse Event|2
1711813|NCT01147744|5974052|P1|Overall Study|Adverse Event|1
1711814|NCT01147744|5974046|P7|Overall Study|Lack of Efficacy|7
1711815|NCT01147744|5974047|P6|Overall Study|Lack of Efficacy|8
1711816|NCT01147744|5974048|P5|Overall Study|Lack of Efficacy|13
1711817|NCT01147744|5974049|P4|Overall Study|Lack of Efficacy|11
1711818|NCT01147744|5974050|P3|Overall Study|Lack of Efficacy|9
1711819|NCT01147744|5974051|P2|Overall Study|Lack of Efficacy|11
1711820|NCT01147744|5974052|P1|Overall Study|Lack of Efficacy|11
1711821|NCT01147744|5974046|P7|Overall Study|Physician Decision|1
1711822|NCT01147744|5974047|P6|Overall Study|Physician Decision|0
1711823|NCT01147744|5974048|P5|Overall Study|Physician Decision|0
1711824|NCT01147744|5974049|P4|Overall Study|Physician Decision|0
1711825|NCT01147744|5974050|P3|Overall Study|Physician Decision|1
1711826|NCT01147744|5974051|P2|Overall Study|Physician Decision|1
1711827|NCT01147744|5974052|P1|Overall Study|Physician Decision|0
1711828|NCT01147744|5974046|P7|Overall Study|Protocol Violation|1
1711829|NCT01147744|5974047|P6|Overall Study|Protocol Violation|3
1711830|NCT01147744|5974048|P5|Overall Study|Protocol Violation|1
1711831|NCT01147744|5974049|P4|Overall Study|Protocol Violation|0
1711832|NCT01147744|5974050|P3|Overall Study|Protocol Violation|1
1711833|NCT01147744|5974051|P2|Overall Study|Protocol Violation|0
1711834|NCT01147744|5974052|P1|Overall Study|Protocol Violation|1
1711835|NCT01147653|5974147|P2|Year 2|Withdrawal by Subject|3
1711836|NCT01147653|5974148|P1|Year 2|Withdrawal by Subject|2
1711837|NCT01147640|5974209|P2|Overall Study|Didn't meet eligibility criteria|0
1711838|NCT01147640|5974210|P1|Overall Study|Didn't meet eligibility criteria|1
1711839|NCT01147640|5974209|P2|Overall Study|Lost to Follow-up|1
1711840|NCT01147640|5974210|P1|Overall Study|Lost to Follow-up|0
1711841|NCT01147640|5974209|P2|Overall Study|Withdrawal by Subject|0
1711842|NCT01147640|5974210|P1|Overall Study|Withdrawal by Subject|1
1711843|NCT01147640|5974209|P2|Overall Study|Physician Decision|0
1711844|NCT01147640|5974210|P1|Overall Study|Physician Decision|1
1711845|NCT01147640|5974209|P2|Overall Study|Adverse Event|0
1711846|NCT01147640|5974210|P1|Overall Study|Adverse Event|2
1711847|NCT01147497|5974242|P2|Overall Study|failed insertion|0
1711848|NCT01147497|5974243|P1|Overall Study|failed insertion|2
1711849|NCT01147471|5974263|P2|6 Month Follow Up|Lost to Follow-up|2
1711850|NCT01147471|5974264|P1|6 Month Follow Up|Lost to Follow-up|4
1711851|NCT01147471|5974263|P2|3 Month Follow Up|Physician Decision|1
1711852|NCT01147471|5974264|P1|3 Month Follow Up|Physician Decision|0
1711853|NCT01147471|5974263|P2|3 Month Follow Up|Lost to Follow-up|1
1711854|NCT01147471|5974264|P1|3 Month Follow Up|Lost to Follow-up|1
1711855|NCT01147471|5974263|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
1711856|NCT01147471|5974264|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
1711857|NCT01147471|5974263|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
1711858|NCT01147471|5974264|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
1711859|NCT01147471|5974263|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
1711860|NCT01147471|5974264|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
1711861|NCT01147458|5974278|P4|Second Intervention|Other|0
1711862|NCT01147458|5974279|P3|Second Intervention|Other|1
1711863|NCT01147458|5974280|P2|Second Intervention|Other|0
1711864|NCT01147458|5974281|P1|Second Intervention|Other|0
1711865|NCT01147458|5974278|P4|Second Intervention|Adverse Event|1
1711866|NCT01147458|5974279|P3|Second Intervention|Adverse Event|1
1711867|NCT01147458|5974280|P2|Second Intervention|Adverse Event|0
1711868|NCT01147458|5974281|P1|Second Intervention|Adverse Event|2
1711869|NCT01147458|5974278|P4|Second Intervention|Withdrawal by Subject|0
1711870|NCT01147458|5974279|P3|Second Intervention|Withdrawal by Subject|0
1711871|NCT01147458|5974280|P2|Second Intervention|Withdrawal by Subject|1
1711872|NCT01147458|5974281|P1|Second Intervention|Withdrawal by Subject|0
1711873|NCT01147458|5974278|P4|Second Intervention|Protocol Violation|0
1711874|NCT01147458|5974279|P3|Second Intervention|Protocol Violation|1
1711875|NCT01147458|5974280|P2|Second Intervention|Protocol Violation|1
1711876|NCT01147458|5974281|P1|Second Intervention|Protocol Violation|0
1711877|NCT01147458|5974278|P4|Second Intervention|Study terminated by sponsor|3
1711878|NCT01147458|5974279|P3|Second Intervention|Study terminated by sponsor|5
1711879|NCT01147458|5974280|P2|Second Intervention|Study terminated by sponsor|5
1711880|NCT01147458|5974281|P1|Second Intervention|Study terminated by sponsor|7
1711881|NCT01147458|5974278|P4|First Intervention|Other|0
1711882|NCT01147458|5974279|P3|First Intervention|Other|0
1711883|NCT01147458|5974280|P2|First Intervention|Other|2
1711884|NCT01147458|5974281|P1|First Intervention|Other|1
1711885|NCT01147458|5974278|P4|First Intervention|Adverse Event|3
1711886|NCT01147458|5974279|P3|First Intervention|Adverse Event|2
1711887|NCT01147458|5974280|P2|First Intervention|Adverse Event|3
1711888|NCT01147458|5974281|P1|First Intervention|Adverse Event|0
1711889|NCT01147458|5974278|P4|First Intervention|Withdrawal by Subject|0
1711890|NCT01147458|5974279|P3|First Intervention|Withdrawal by Subject|1
1711891|NCT01147458|5974280|P2|First Intervention|Withdrawal by Subject|0
1711892|NCT01147458|5974281|P1|First Intervention|Withdrawal by Subject|3
1711893|NCT01147458|5974278|P4|First Intervention|Protocol Violation|3
1711894|NCT01147458|5974279|P3|First Intervention|Protocol Violation|2
1711895|NCT01147458|5974280|P2|First Intervention|Protocol Violation|3
1711896|NCT01147458|5974281|P1|First Intervention|Protocol Violation|2
1711897|NCT01147458|5974278|P4|First Intervention|Study terminated by sponsor|8
1711898|NCT01147458|5974279|P3|First Intervention|Study terminated by sponsor|7
1711899|NCT01147458|5974280|P2|First Intervention|Study terminated by sponsor|8
1711900|NCT01147458|5974281|P1|First Intervention|Study terminated by sponsor|8
1711901|NCT01147393|5974360|P1|Dose Level -1|Dose Limited Toxicity|1
1711902|NCT01147393|5974360|P1|Dose Level 1|Dose limiting Toxicity|2
1711903|NCT01147341|5974381|P2|Open Label Period|Subject moved|0
1711904|NCT01147341|5974382|P1|Open Label Period|Subject moved|1
1711905|NCT01147341|5974381|P2|Open Label Period|Lack of Efficacy|0
1711906|NCT01147341|5974382|P1|Open Label Period|Lack of Efficacy|3
1711907|NCT01147341|5974381|P2|Double Blind Period|Withdrawal by Subject|1
1711908|NCT01147341|5974382|P1|Double Blind Period|Withdrawal by Subject|0
1711909|NCT01147341|5974381|P2|Double Blind Period|Lack of Efficacy|1
1711910|NCT01147341|5974382|P1|Double Blind Period|Lack of Efficacy|1
1711911|NCT01147250|5974445|P2|Overall Study|Other than specified|1
1711912|NCT01147250|5974446|P1|Overall Study|Other than specified|0
1711913|NCT01147250|5974445|P2|Overall Study|Site termination by sponsor|5
1711914|NCT01147250|5974446|P1|Overall Study|Site termination by sponsor|13
1711915|NCT01147250|5974445|P2|Overall Study|Withdrawal by Subject|88
1711916|NCT01147250|5974446|P1|Overall Study|Withdrawal by Subject|83
1711917|NCT01147250|5974445|P2|Overall Study|Lost to Follow-up|11
1711918|NCT01147250|5974446|P1|Overall Study|Lost to Follow-up|14
1711919|NCT01147172|5974458|P1|Overall Study|Lost to Follow-up|2
1711920|NCT01147172|5974458|P1|Overall Study|Withdrawal by Subject|2
1711921|NCT01147068|5974476|P7|Subjects That Completed Safety Follow-up|Ineligible|0
1711922|NCT01147068|5974477|P6|Subjects That Completed Safety Follow-up|Ineligible|0
1711923|NCT01147068|5974478|P5|Subjects That Completed Safety Follow-up|Ineligible|0
1711924|NCT01147068|5974479|P4|Subjects That Completed Safety Follow-up|Ineligible|0
1711925|NCT01147068|5974480|P3|Subjects That Completed Safety Follow-up|Ineligible|0
1711926|NCT01147068|5974481|P2|Subjects That Completed Safety Follow-up|Ineligible|1
1711927|NCT01147068|5974482|P1|Subjects That Completed Safety Follow-up|Ineligible|0
1711928|NCT01147068|5974476|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1711929|NCT01147068|5974477|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1711930|NCT01147068|5974478|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1711931|NCT01147068|5974479|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
1711932|NCT01147068|5974480|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1711933|NCT01147068|5974481|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1711934|NCT01147068|5974482|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
1711935|NCT01147068|5974476|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1711936|NCT01147068|5974477|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1711937|NCT01147068|5974478|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1711938|NCT01147068|5974479|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1711939|NCT01147068|5974480|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1711940|NCT01147068|5974481|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
1711941|NCT01147068|5974482|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
1711942|NCT01147068|5974476|P7|Subjects That Received 2nd Dose|Other|0
1711943|NCT01147068|5974477|P6|Subjects That Received 2nd Dose|Other|0
1711944|NCT01147068|5974478|P5|Subjects That Received 2nd Dose|Other|1
1711945|NCT01147068|5974479|P4|Subjects That Received 2nd Dose|Other|0
1711946|NCT01147068|5974480|P3|Subjects That Received 2nd Dose|Other|3
1711947|NCT01147068|5974481|P2|Subjects That Received 2nd Dose|Other|3
1711948|NCT01147068|5974482|P1|Subjects That Received 2nd Dose|Other|0
1711949|NCT01147068|5974476|P7|Subjects That Received 2nd Dose|Did not complete the study|0
1711950|NCT01147068|5974477|P6|Subjects That Received 2nd Dose|Did not complete the study|1
1711951|NCT01147068|5974478|P5|Subjects That Received 2nd Dose|Did not complete the study|0
1711952|NCT01147068|5974479|P4|Subjects That Received 2nd Dose|Did not complete the study|0
1711953|NCT01147068|5974480|P3|Subjects That Received 2nd Dose|Did not complete the study|0
1711954|NCT01147068|5974481|P2|Subjects That Received 2nd Dose|Did not complete the study|1
1711955|NCT01147068|5974482|P1|Subjects That Received 2nd Dose|Did not complete the study|0
1711956|NCT01147068|5974476|P7|Subjects That Received 2nd Dose|Ineligible|0
1711957|NCT01147068|5974477|P6|Subjects That Received 2nd Dose|Ineligible|0
1711958|NCT01147068|5974478|P5|Subjects That Received 2nd Dose|Ineligible|0
1711959|NCT01147068|5974479|P4|Subjects That Received 2nd Dose|Ineligible|0
1711960|NCT01147068|5974480|P3|Subjects That Received 2nd Dose|Ineligible|0
1711961|NCT01147068|5974481|P2|Subjects That Received 2nd Dose|Ineligible|1
1711962|NCT01147068|5974482|P1|Subjects That Received 2nd Dose|Ineligible|0
1711963|NCT01147068|5974476|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
1711964|NCT01147068|5974477|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
1711965|NCT01147068|5974478|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
1711966|NCT01147068|5974479|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
1711967|NCT01147068|5974480|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
1711968|NCT01147068|5974481|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
1711969|NCT01147068|5974482|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
1711970|NCT01147055|5974512|P2|First Intervention Period|Lost to Follow-up|0
1711971|NCT01147055|5974513|P1|First Intervention Period|Lost to Follow-up|1
1711972|NCT01146951|5974555|P2|Overall Study|Adverse Event|1
1711973|NCT01146951|5974556|P1|Overall Study|Adverse Event|4
1711974|NCT01146912|5974577|P8|Overall Study|Duplicate patient|0
1711975|NCT01146912|5974578|P7|Overall Study|Duplicate patient|0
1711976|NCT01146912|5974579|P6|Overall Study|Duplicate patient|0
1711977|NCT01146912|5974580|P5|Overall Study|Duplicate patient|0
1711978|NCT01146912|5974581|P4|Overall Study|Duplicate patient|0
1711979|NCT01146912|5974582|P3|Overall Study|Duplicate patient|1
1711980|NCT01146912|5974583|P2|Overall Study|Duplicate patient|0
1711981|NCT01146912|5974584|P1|Overall Study|Duplicate patient|0
1711982|NCT01146912|5974577|P8|Overall Study|< 14 weeks gestational age|0
1711983|NCT01146912|5974578|P7|Overall Study|< 14 weeks gestational age|0
1711984|NCT01146912|5974579|P6|Overall Study|< 14 weeks gestational age|0
1711985|NCT01146912|5974580|P5|Overall Study|< 14 weeks gestational age|0
1711986|NCT01146912|5974581|P4|Overall Study|< 14 weeks gestational age|2
1711987|NCT01146912|5974582|P3|Overall Study|< 14 weeks gestational age|3
1711988|NCT01146912|5974583|P2|Overall Study|< 14 weeks gestational age|0
1711989|NCT01146912|5974584|P1|Overall Study|< 14 weeks gestational age|0
1711990|NCT01146912|5974577|P8|Overall Study|Already received influenza vaccination|0
1711991|NCT01146912|5974578|P7|Overall Study|Already received influenza vaccination|56
1711992|NCT01146912|5974579|P6|Overall Study|Already received influenza vaccination|61
1711993|NCT01146912|5974580|P5|Overall Study|Already received influenza vaccination|41
1711994|NCT01146912|5974581|P4|Overall Study|Already received influenza vaccination|15
1711995|NCT01146912|5974582|P3|Overall Study|Already received influenza vaccination|13
1711996|NCT01146912|5974583|P2|Overall Study|Already received influenza vaccination|822
1711997|NCT01146912|5974584|P1|Overall Study|Already received influenza vaccination|817
1711998|NCT01146873|5974606|P2|Overall Study|Transfer out|6
1711999|NCT01146873|5974607|P1|Overall Study|Transfer out|0
1712000|NCT01146860|5974623|P2|Overall Study|Withdrawal by Subject|1
1712001|NCT01146860|5974624|P1|Overall Study|Withdrawal by Subject|0
1712002|NCT01146782|5974675|P1|Primary Endpoint Cohort|Physician Decision|1
1712003|NCT01146782|5974675|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
1712004|NCT01146782|5974675|P1|Safety Cohort|TST <4 hrs|14
1712005|NCT01146782|5974675|P1|Safety Cohort|Control AHI <5|4
1712006|NCT01146782|5974675|P1|Safety Cohort|Withdrawal by Subject|4
1712007|NCT01146782|5974675|P1|Safety Cohort|Screen Failure|61
1712008|NCT01146782|5974675|P1|Screening Cohort|Withdrawal by Subject|29
1712009|NCT01146782|5974675|P1|Screening Cohort|Physician Decision|1
1712010|NCT01146782|5974675|P1|Screening Cohort|Lost to Follow-up|4
1712011|NCT01146782|5974675|P1|Screening Cohort|Screen Failure|187
1712012|NCT01146665|5974693|P2|Overall Study|Withdrawal by Subject|16
1712013|NCT01146665|5974694|P1|Overall Study|Withdrawal by Subject|10
1712014|NCT01146613|5974726|P2|Overall Study|Outpatient detox|0
1712015|NCT01146613|5974727|P1|Overall Study|Outpatient detox|1
1712016|NCT01146613|5974726|P2|Overall Study|schedule conflict|0
1712017|NCT01146613|5974727|P1|Overall Study|schedule conflict|1
1712018|NCT01146613|5974726|P2|Overall Study|Withdrawal by Subject|3
1712019|NCT01146613|5974727|P1|Overall Study|Withdrawal by Subject|0
1712020|NCT01146613|5974726|P2|Overall Study|Physician Decision|0
1712021|NCT01146613|5974727|P1|Overall Study|Physician Decision|1
1712022|NCT01146613|5974726|P2|Overall Study|Death|0
1712023|NCT01146613|5974727|P1|Overall Study|Death|1
1712024|NCT01146613|5974726|P2|Overall Study|Lack of Efficacy|1
1712025|NCT01146613|5974727|P1|Overall Study|Lack of Efficacy|0
1712026|NCT01146613|5974726|P2|Overall Study|Lost to Follow-up|8
1712027|NCT01146613|5974727|P1|Overall Study|Lost to Follow-up|3
1712028|NCT01146288|5974837|P2|First Intervention(1 Day)|Adverse Event|1
1712029|NCT01146288|5974838|P1|First Intervention(1 Day)|Adverse Event|0
1712030|NCT01146054|5974852|P1|Overall Study|Lost to Follow-up|1
1712031|NCT01146054|5974852|P1|Overall Study|Other illness precluded treatment|2
1712032|NCT01146054|5974852|P1|Overall Study|Rapid tumor progression|2
1712033|NCT01146054|5974852|P1|Overall Study|Did not meet dose constraints for SBRT|5
1712034|NCT01145898|5974862|P2|3-year Treatment|medication change by treating physician|16
1712035|NCT01145898|5974863|P1|3-year Treatment|medication change by treating physician|3
1712036|NCT01145885|5974894|P1|Overall Study|Progressive Disease|7
1712037|NCT01145755|5974929|P3|Overall Study|Positive urine ethanol|0
1712038|NCT01145755|5974930|P2|Overall Study|Positive urine ethanol|1
1712039|NCT01145755|5974931|P1|Overall Study|Positive urine ethanol|0
1712040|NCT01145755|5974929|P3|Overall Study|Withdrawal by Subject|1
1712041|NCT01145755|5974930|P2|Overall Study|Withdrawal by Subject|0
1712042|NCT01145755|5974931|P1|Overall Study|Withdrawal by Subject|0
1712043|NCT01145755|5974929|P3|Overall Study|Patient could not swollow medication|1
1712044|NCT01145755|5974930|P2|Overall Study|Patient could not swollow medication|0
1712045|NCT01145755|5974931|P1|Overall Study|Patient could not swollow medication|0
1712046|NCT01145755|5974929|P3|Overall Study|Lack of Efficacy|0
1712047|NCT01145755|5974930|P2|Overall Study|Lack of Efficacy|1
1712048|NCT01145755|5974931|P1|Overall Study|Lack of Efficacy|0
1712049|NCT01145755|5974929|P3|Overall Study|Study Closure|17
1712050|NCT01145755|5974930|P2|Overall Study|Study Closure|14
1712051|NCT01145755|5974931|P1|Overall Study|Study Closure|14
1712052|NCT01145755|5974929|P3|Overall Study|Protocol Violation|1
1712053|NCT01145755|5974930|P2|Overall Study|Protocol Violation|3
1712054|NCT01145755|5974931|P1|Overall Study|Protocol Violation|0
1712055|NCT01145755|5974929|P3|Overall Study|Lost to Follow-up|1
1712056|NCT01145755|5974930|P2|Overall Study|Lost to Follow-up|3
1712057|NCT01145755|5974931|P1|Overall Study|Lost to Follow-up|2
1712058|NCT01145755|5974929|P3|Overall Study|Withdrawal by Subject|2
1712059|NCT01145755|5974930|P2|Overall Study|Withdrawal by Subject|2
1712060|NCT01145755|5974931|P1|Overall Study|Withdrawal by Subject|2
1712061|NCT01145755|5974929|P3|Overall Study|Adverse Event|2
1712062|NCT01145755|5974930|P2|Overall Study|Adverse Event|4
1712063|NCT01145755|5974931|P1|Overall Study|Adverse Event|2
1712064|NCT01145625|5974958|P2|Overall Study|Pregnancy|1
1712065|NCT01145625|5974959|P1|Overall Study|Pregnancy|0
1712066|NCT01145625|5974958|P2|Overall Study|Withdrawal by Subject|16
1712067|NCT01145625|5974959|P1|Overall Study|Withdrawal by Subject|7
1712068|NCT01145625|5974958|P2|Overall Study|Protocol Violation|1
1712069|NCT01145625|5974959|P1|Overall Study|Protocol Violation|3
1712070|NCT01145625|5974958|P2|Overall Study|Adverse Event|4
1712071|NCT01145625|5974959|P1|Overall Study|Adverse Event|6
1712072|NCT01145625|5974958|P2|Overall Study|Lost to Follow-up|9
1712073|NCT01145625|5974959|P1|Overall Study|Lost to Follow-up|8
1712074|NCT01145560|5974972|P3|Overall Study|Withdrawal of therapy|1
1712075|NCT01145560|5974973|P2|Overall Study|Withdrawal of therapy|0
1712076|NCT01145560|5974974|P1|Overall Study|Withdrawal of therapy|0
1712077|NCT01145560|5974972|P3|Overall Study|False insurance information|0
1712078|NCT01145560|5974973|P2|Overall Study|False insurance information|1
1712079|NCT01145560|5974974|P1|Overall Study|False insurance information|0
1712080|NCT01145560|5974972|P3|Overall Study|Accidental unblinding of study treatment|0
1712081|NCT01145560|5974973|P2|Overall Study|Accidental unblinding of study treatment|1
1712082|NCT01145560|5974974|P1|Overall Study|Accidental unblinding of study treatment|0
1712083|NCT01145560|5974972|P3|Overall Study|No study drug by 24h after organ failure|0
1712084|NCT01145560|5974973|P2|Overall Study|No study drug by 24h after organ failure|0
1712085|NCT01145560|5974974|P1|Overall Study|No study drug by 24h after organ failure|1
1712086|NCT01145560|5974972|P3|Overall Study|Lost to Follow-up|1
1712087|NCT01145560|5974973|P2|Overall Study|Lost to Follow-up|1
1712088|NCT01145560|5974974|P1|Overall Study|Lost to Follow-up|1
1712089|NCT01145560|5974972|P3|Overall Study|Withdrawal by Subject|0
1712090|NCT01145560|5974973|P2|Overall Study|Withdrawal by Subject|1
1712091|NCT01145560|5974974|P1|Overall Study|Withdrawal by Subject|2
1712092|NCT01145508|5975000|P2|Overall Study|Never started treatment|1
1712093|NCT01145508|5975001|P1|Overall Study|Never started treatment|1
1712094|NCT01145508|5975000|P2|Overall Study|Physician Decision|1
1712095|NCT01145508|5975001|P1|Overall Study|Physician Decision|2
1712096|NCT01145508|5975000|P2|Overall Study|Death|0
1712097|NCT01145508|5975001|P1|Overall Study|Death|1
1712098|NCT01145508|5975000|P2|Overall Study|Adverse Event|0
1712099|NCT01145508|5975001|P1|Overall Study|Adverse Event|1
1712100|NCT01145495|5975007|P1|Overall Study|Disease progression after respone|1
1712101|NCT01145495|5975007|P1|Overall Study|Withdrawal by Subject|5
1712102|NCT01145495|5975007|P1|Overall Study|Adverse Event|6
1712103|NCT01145482|5975013|P2|First Intervention (1 Day)|Withdrawal by Subject|1
1712104|NCT01145482|5975014|P1|First Intervention (1 Day)|Withdrawal by Subject|0
1712105|NCT01145417|5975024|P2|Overall Study|Other|0
1712106|NCT01145417|5975025|P1|Overall Study|Other|1
1712107|NCT01145417|5975024|P2|Overall Study|Study terminated by sponsor|43
1712108|NCT01145417|5975025|P1|Overall Study|Study terminated by sponsor|35
1712109|NCT01145417|5975024|P2|Overall Study|Adverse Event|1
1712110|NCT01145417|5975025|P1|Overall Study|Adverse Event|0
1712111|NCT01145417|5975024|P2|Overall Study|Pregnancy|0
1712112|NCT01145417|5975025|P1|Overall Study|Pregnancy|1
1712113|NCT01145417|5975024|P2|Overall Study|Withdrawal by Subject|2
1712114|NCT01145417|5975025|P1|Overall Study|Withdrawal by Subject|1
1712115|NCT01145417|5975024|P2|Overall Study|Lost to Follow-up|1
1712116|NCT01145417|5975025|P1|Overall Study|Lost to Follow-up|2
1712117|NCT01145417|5975024|P2|Overall Study|Death|0
1712118|NCT01145417|5975025|P1|Overall Study|Death|1
1712119|NCT01145352|5975058|P1|Overall Study|Syringe formulation was used|1
1712120|NCT01145352|5975058|P1|Overall Study|Treated before marketing approval|4
1712121|NCT01145352|5975058|P1|Overall Study|Found to have been registered twice|6
1712122|NCT01145222|5975070|P4|Overall Study|Poor bowel preparation|1
1712123|NCT01145222|5975071|P3|Overall Study|Poor bowel preparation|0
1712124|NCT01145222|5975072|P2|Overall Study|Poor bowel preparation|0
1712125|NCT01145222|5975073|P1|Overall Study|Poor bowel preparation|0
1712126|NCT01145222|5975070|P4|Overall Study|Procedure not done (no anesthesiologist)|0
1712127|NCT01145222|5975071|P3|Overall Study|Procedure not done (no anesthesiologist)|1
1712128|NCT01145222|5975072|P2|Overall Study|Procedure not done (no anesthesiologist)|0
1712129|NCT01145222|5975073|P1|Overall Study|Procedure not done (no anesthesiologist)|0
1712130|NCT01145066|5975120|P3|Overall Study|Low platelet count|0
1712131|NCT01145066|5975121|P2|Overall Study|Low platelet count|1
1712132|NCT01145066|5975122|P1|Overall Study|Low platelet count|0
1712133|NCT01145066|5975120|P3|Overall Study|Abdominal discomfort|0
1712134|NCT01145066|5975121|P2|Overall Study|Abdominal discomfort|1
1712135|NCT01145066|5975122|P1|Overall Study|Abdominal discomfort|0
1712136|NCT01145066|5975120|P3|Overall Study|problems swallowing capsule|0
1712137|NCT01145066|5975121|P2|Overall Study|problems swallowing capsule|0
1712138|NCT01145066|5975122|P1|Overall Study|problems swallowing capsule|1
1712139|NCT01145066|5975120|P3|Overall Study|To start new med|0
1712140|NCT01145066|5975121|P2|Overall Study|To start new med|0
1712141|NCT01145066|5975122|P1|Overall Study|To start new med|1
1712142|NCT01145066|5975120|P3|Overall Study|Withdrawal by Subject|2
1712143|NCT01145066|5975121|P2|Overall Study|Withdrawal by Subject|0
1712144|NCT01145066|5975122|P1|Overall Study|Withdrawal by Subject|0
1712145|NCT01145066|5975120|P3|Overall Study|Non-related surgery|1
1712146|NCT01145066|5975121|P2|Overall Study|Non-related surgery|0
1712147|NCT01145066|5975122|P1|Overall Study|Non-related surgery|0
1712148|NCT01145066|5975120|P3|Overall Study|To resume NSAIDs|1
1712149|NCT01145066|5975121|P2|Overall Study|To resume NSAIDs|2
1712150|NCT01145066|5975122|P1|Overall Study|To resume NSAIDs|2
1712151|NCT01145053|5975190|P1|Overall Study|Other|18
1712152|NCT01145053|5975190|P1|Overall Study|Withdrawal by Subject|25
1712153|NCT01145053|5975190|P1|Overall Study|Lost to Follow-up|28
1712154|NCT01145053|5975190|P1|Overall Study|Adverse Event|22
1712155|NCT01144715|5975242|P2|Overall Study|Adverse Event|1
1712156|NCT01144715|5975243|P1|Overall Study|Adverse Event|0
1712157|NCT01144715|5975242|P2|Overall Study|Withdrawal by Subject|1
1712158|NCT01144715|5975243|P1|Overall Study|Withdrawal by Subject|2
1712159|NCT01144715|5975242|P2|Overall Study|Lost to Follow-up|1
1712160|NCT01144715|5975243|P1|Overall Study|Lost to Follow-up|2
1712161|NCT01144663|5975259|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
1712162|NCT01144663|5975260|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
1712163|NCT01144663|5975261|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
1712164|NCT01144663|5975262|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
1712165|NCT01144663|5975259|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
1712166|NCT01144663|5975260|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
1712167|NCT01144663|5975261|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
1712168|NCT01144663|5975262|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
1712169|NCT01144663|5975259|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
1712170|NCT01144663|5975260|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
1712171|NCT01144663|5975261|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
1712172|NCT01144663|5975262|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
1712173|NCT01144663|5975259|P4|Booster Vaccination Phase|Lost to Follow-up|0
1712174|NCT01144663|5975260|P3|Booster Vaccination Phase|Lost to Follow-up|3
1712175|NCT01144663|5975261|P2|Booster Vaccination Phase|Lost to Follow-up|1
1712176|NCT01144663|5975262|P1|Booster Vaccination Phase|Lost to Follow-up|2
1712177|NCT01144663|5975259|P4|Booster Vaccination Phase|Migrated/moved from study area|0
1712178|NCT01144663|5975260|P3|Booster Vaccination Phase|Migrated/moved from study area|1
1712179|NCT01144663|5975261|P2|Booster Vaccination Phase|Migrated/moved from study area|1
1712180|NCT01144663|5975262|P1|Booster Vaccination Phase|Migrated/moved from study area|1
1712181|NCT01144663|5975259|P4|Booster Vaccination Phase|Withdrawal by Subject|1
1712182|NCT01144663|5975260|P3|Booster Vaccination Phase|Withdrawal by Subject|1
1712183|NCT01144663|5975261|P2|Booster Vaccination Phase|Withdrawal by Subject|0
1712184|NCT01144663|5975262|P1|Booster Vaccination Phase|Withdrawal by Subject|0
1712185|NCT01144663|5975259|P4|Primary Vaccination Phase|Other|2
1712186|NCT01144663|5975260|P3|Primary Vaccination Phase|Other|0
1712187|NCT01144663|5975261|P2|Primary Vaccination Phase|Other|1
1712188|NCT01144663|5975262|P1|Primary Vaccination Phase|Other|0
1712189|NCT01144663|5975259|P4|Primary Vaccination Phase|Lost to Follow-up|2
1712190|NCT01144663|5975260|P3|Primary Vaccination Phase|Lost to Follow-up|1
1712191|NCT01144663|5975261|P2|Primary Vaccination Phase|Lost to Follow-up|0
1712192|NCT01144663|5975262|P1|Primary Vaccination Phase|Lost to Follow-up|2
1712193|NCT01144663|5975259|P4|Primary Vaccination Phase|Migrated/moved from study area|3
1712194|NCT01144663|5975260|P3|Primary Vaccination Phase|Migrated/moved from study area|2
1712195|NCT01144663|5975261|P2|Primary Vaccination Phase|Migrated/moved from study area|1
1712196|NCT01144663|5975262|P1|Primary Vaccination Phase|Migrated/moved from study area|4
1712197|NCT01144663|5975259|P4|Primary Vaccination Phase|Withdrawal by Subject|10
1712198|NCT01144663|5975260|P3|Primary Vaccination Phase|Withdrawal by Subject|3
1712199|NCT01144663|5975261|P2|Primary Vaccination Phase|Withdrawal by Subject|5
1712200|NCT01144663|5975262|P1|Primary Vaccination Phase|Withdrawal by Subject|9
1712201|NCT01144663|5975259|P4|Primary Vaccination Phase|Protocol Violation|0
1712202|NCT01144663|5975260|P3|Primary Vaccination Phase|Protocol Violation|1
1712203|NCT01144663|5975261|P2|Primary Vaccination Phase|Protocol Violation|0
1712204|NCT01144663|5975262|P1|Primary Vaccination Phase|Protocol Violation|2
1712205|NCT01144663|5975259|P4|Primary Vaccination Phase|Adverse Event|1
1712206|NCT01144663|5975260|P3|Primary Vaccination Phase|Adverse Event|0
1712207|NCT01144663|5975261|P2|Primary Vaccination Phase|Adverse Event|0
1712208|NCT01144663|5975262|P1|Primary Vaccination Phase|Adverse Event|1
1712209|NCT01144663|5975259|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
1712210|NCT01144663|5975260|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
1712211|NCT01144663|5975261|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
1712212|NCT01144663|5975262|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
1712213|NCT01144416|5975600|P2|Intervention Period|Other|5
1712214|NCT01144416|5975601|P1|Intervention Period|Other|7
1712215|NCT01144416|5975600|P2|Intervention Period|No/too few/bad quality embryos|3
1712216|NCT01144416|5975601|P1|Intervention Period|No/too few/bad quality embryos|3
1712217|NCT01144416|5975600|P2|Intervention Period|No or abnormal fertilization|10
1712218|NCT01144416|5975601|P1|Intervention Period|No or abnormal fertilization|25
1712219|NCT01144416|5975600|P2|Intervention Period|No/too few/bad oocytes|5
1712220|NCT01144416|5975601|P1|Intervention Period|No/too few/bad oocytes|7
1712221|NCT01144416|5975600|P2|Intervention Period|Too high ovarian response|2
1712222|NCT01144416|5975601|P1|Intervention Period|Too high ovarian response|4
1712223|NCT01144416|5975600|P2|Intervention Period|Risk of OHSS|1
1712224|NCT01144416|5975601|P1|Intervention Period|Risk of OHSS|0
1712225|NCT01144416|5975600|P2|Intervention Period|Insufficient ovarian response|17
1712226|NCT01144416|5975601|P1|Intervention Period|Insufficient ovarian response|11
1712227|NCT01144416|5975600|P2|Intervention Period|Adverse Event|6
1712228|NCT01144416|5975601|P1|Intervention Period|Adverse Event|5
1712229|NCT01144403|5975617|P1|Overall Study|Adverse Event|1
1712230|NCT01144403|5975617|P1|Overall Study|Death|1
1712231|NCT01144403|5975617|P1|Overall Study|Lost to Follow-up|3
1712232|NCT01144377|5975629|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1712233|NCT01144377|5975630|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1712234|NCT01144377|5975631|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1712235|NCT01144377|5975632|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
1712236|NCT01144377|5975633|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
1712237|NCT01144377|5975629|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
1712238|NCT01144377|5975630|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1712239|NCT01144377|5975631|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1712240|NCT01144377|5975632|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1712241|NCT01144377|5975633|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
1712242|NCT01144377|5975629|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
1712243|NCT01144377|5975630|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1712244|NCT01144377|5975631|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1712245|NCT01144377|5975632|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
1712246|NCT01144377|5975633|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
1712247|NCT01144377|5975629|P5|52 Week Treatment Period|Sponsor Decision|1
1712248|NCT01144377|5975630|P4|52 Week Treatment Period|Sponsor Decision|0
1712249|NCT01144377|5975631|P3|52 Week Treatment Period|Sponsor Decision|0
1712250|NCT01144377|5975632|P2|52 Week Treatment Period|Sponsor Decision|0
1712251|NCT01144377|5975633|P1|52 Week Treatment Period|Sponsor Decision|0
1712252|NCT01144377|5975629|P5|52 Week Treatment Period|Withdrawal by Subject|0
1712253|NCT01144377|5975630|P4|52 Week Treatment Period|Withdrawal by Subject|1
1712254|NCT01144377|5975631|P3|52 Week Treatment Period|Withdrawal by Subject|1
1712255|NCT01144377|5975632|P2|52 Week Treatment Period|Withdrawal by Subject|1
1712256|NCT01144377|5975633|P1|52 Week Treatment Period|Withdrawal by Subject|4
1712257|NCT01144377|5975629|P5|52 Week Treatment Period|Lost to Follow-up|0
1712258|NCT01144377|5975630|P4|52 Week Treatment Period|Lost to Follow-up|0
1712259|NCT01144377|5975631|P3|52 Week Treatment Period|Lost to Follow-up|0
1712260|NCT01144377|5975632|P2|52 Week Treatment Period|Lost to Follow-up|0
1712261|NCT01144377|5975633|P1|52 Week Treatment Period|Lost to Follow-up|1
1712262|NCT01144377|5975629|P5|52 Week Treatment Period|Protocol Violation|1
1712263|NCT01144377|5975630|P4|52 Week Treatment Period|Protocol Violation|0
1712264|NCT01144377|5975631|P3|52 Week Treatment Period|Protocol Violation|0
1712265|NCT01144377|5975632|P2|52 Week Treatment Period|Protocol Violation|0
1712266|NCT01144377|5975633|P1|52 Week Treatment Period|Protocol Violation|0
1712267|NCT01144377|5975629|P5|52 Week Treatment Period|Entry Criteria Not Met|0
1712268|NCT01144377|5975630|P4|52 Week Treatment Period|Entry Criteria Not Met|1
1712269|NCT01144377|5975631|P3|52 Week Treatment Period|Entry Criteria Not Met|1
1712270|NCT01144377|5975632|P2|52 Week Treatment Period|Entry Criteria Not Met|0
1712271|NCT01144377|5975633|P1|52 Week Treatment Period|Entry Criteria Not Met|0
1712272|NCT01144377|5975629|P5|52 Week Treatment Period|Adverse Event|1
1712273|NCT01144377|5975630|P4|52 Week Treatment Period|Adverse Event|2
1712274|NCT01144377|5975631|P3|52 Week Treatment Period|Adverse Event|3
1712275|NCT01144377|5975632|P2|52 Week Treatment Period|Adverse Event|0
1712276|NCT01144377|5975633|P1|52 Week Treatment Period|Adverse Event|0
1712277|NCT01144364|5975682|P3|Follow-Up/Maintenance Phase|Physician Decision|1
1712278|NCT01144364|5975683|P2|Follow-Up/Maintenance Phase|Physician Decision|0
1712279|NCT01144364|5975684|P1|Follow-Up/Maintenance Phase|Physician Decision|0
1712280|NCT01144364|5975682|P3|Follow-Up/Maintenance Phase|Relapse|5
1712281|NCT01144364|5975683|P2|Follow-Up/Maintenance Phase|Relapse|5
1712282|NCT01144364|5975684|P1|Follow-Up/Maintenance Phase|Relapse|0
1712283|NCT01144364|5975682|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
1712284|NCT01144364|5975683|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
1712285|NCT01144364|5975684|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
1712286|NCT01144364|5975682|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
1712287|NCT01144364|5975683|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
1712288|NCT01144364|5975684|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
1712289|NCT01144364|5975682|P3|Follow-Up/Maintenance Phase|Death|0
1712290|NCT01144364|5975683|P2|Follow-Up/Maintenance Phase|Death|2
1712291|NCT01144364|5975684|P1|Follow-Up/Maintenance Phase|Death|0
1712292|NCT01144364|5975682|P3|Follow-Up/Maintenance Phase|Adverse Event|1
1712293|NCT01144364|5975683|P2|Follow-Up/Maintenance Phase|Adverse Event|3
1712294|NCT01144364|5975684|P1|Follow-Up/Maintenance Phase|Adverse Event|0
1712295|NCT01144364|5975682|P3|Follow-Up/Maintenance Phase|Disease progression|29
1712296|NCT01144364|5975683|P2|Follow-Up/Maintenance Phase|Disease progression|23
1712297|NCT01144364|5975684|P1|Follow-Up/Maintenance Phase|Disease progression|0
1712298|NCT01144364|5975682|P3|Induction Phase|Protocol Violation|0
1712299|NCT01144364|5975683|P2|Induction Phase|Protocol Violation|0
1712300|NCT01144364|5975684|P1|Induction Phase|Protocol Violation|1
1712301|NCT01144364|5975682|P3|Induction Phase|Secondary neoplasia|0
1712302|NCT01144364|5975683|P2|Induction Phase|Secondary neoplasia|0
1712303|NCT01144364|5975684|P1|Induction Phase|Secondary neoplasia|1
1712304|NCT01144364|5975682|P3|Induction Phase|Stable disease|0
1712305|NCT01144364|5975683|P2|Induction Phase|Stable disease|0
1712306|NCT01144364|5975684|P1|Induction Phase|Stable disease|2
1712307|NCT01144364|5975682|P3|Induction Phase|Physician Decision|0
1712308|NCT01144364|5975683|P2|Induction Phase|Physician Decision|0
1712309|NCT01144364|5975684|P1|Induction Phase|Physician Decision|1
1712310|NCT01144364|5975682|P3|Induction Phase|Lost to Follow-up|0
1712311|NCT01144364|5975683|P2|Induction Phase|Lost to Follow-up|0
1712312|NCT01144364|5975684|P1|Induction Phase|Lost to Follow-up|2
1712313|NCT01144364|5975682|P3|Induction Phase|Withdrawal by Subject|0
1712314|NCT01144364|5975683|P2|Induction Phase|Withdrawal by Subject|0
1712315|NCT01144364|5975684|P1|Induction Phase|Withdrawal by Subject|1
1712316|NCT01144364|5975682|P3|Induction Phase|Death|0
1712317|NCT01144364|5975683|P2|Induction Phase|Death|0
1712318|NCT01144364|5975684|P1|Induction Phase|Death|1
1712319|NCT01144364|5975682|P3|Induction Phase|Adverse Event|0
1712320|NCT01144364|5975683|P2|Induction Phase|Adverse Event|0
1712321|NCT01144364|5975684|P1|Induction Phase|Adverse Event|9
1712322|NCT01144364|5975682|P3|Induction Phase|Disease progression|0
1712323|NCT01144364|5975683|P2|Induction Phase|Disease progression|0
1712324|NCT01144364|5975684|P1|Induction Phase|Disease progression|14
1712325|NCT01144299|5975733|P2|Overall Study|Withdrawal by Subject|0
1712326|NCT01144299|5975734|P1|Overall Study|Withdrawal by Subject|1
1712327|NCT01144299|5975733|P2|Overall Study|Lost to Follow-up|0
1712328|NCT01144299|5975734|P1|Overall Study|Lost to Follow-up|1
1712329|NCT01144182|5975779|P2|Overall Study|Lost to Follow-up|9
1712330|NCT01144182|5975780|P1|Overall Study|Lost to Follow-up|9
1712331|NCT01144182|5975779|P2|Overall Study|Withdrawal by Subject|6
1712332|NCT01144182|5975780|P1|Overall Study|Withdrawal by Subject|3
1712333|NCT01144182|5975779|P2|Overall Study|Death|6
1712334|NCT01144182|5975780|P1|Overall Study|Death|5
1712335|NCT01144052|5975840|P2|Overall Study|Withdrawal by Subject|1
1712336|NCT01144052|5975841|P1|Overall Study|Withdrawal by Subject|1
1712337|NCT01143896|5975872|P2|Overall Study|Death|3
1712338|NCT01143896|5975873|P1|Overall Study|Death|6
1712339|NCT01143896|5975872|P2|Overall Study|Withdrawal by Subject|5
1712340|NCT01143896|5975873|P1|Overall Study|Withdrawal by Subject|13
1712341|NCT01143896|5975872|P2|Overall Study|Lost to Follow-up|13
1712342|NCT01143896|5975873|P1|Overall Study|Lost to Follow-up|18
1712343|NCT01143896|5975872|P2|Overall Study|Did not complete Baseline Interview|4
1712344|NCT01143896|5975873|P1|Overall Study|Did not complete Baseline Interview|5
1712345|NCT01143714|5975985|P2|Overall Study|wound size increased|0
1712346|NCT01143714|5975986|P1|Overall Study|wound size increased|1
1712347|NCT01143714|5975985|P2|Overall Study|wound closed = deemed healed|0
1712348|NCT01143714|5975986|P1|Overall Study|wound closed = deemed healed|1
1712349|NCT01143714|5975985|P2|Overall Study|Subject non-compliance|1
1712350|NCT01143714|5975986|P1|Overall Study|Subject non-compliance|0
1712351|NCT01143714|5975985|P2|Overall Study|Withdrawal by Subject|0
1712352|NCT01143714|5975986|P1|Overall Study|Withdrawal by Subject|1
1712353|NCT01143714|5975985|P2|Overall Study|Adverse Event|2
1712354|NCT01143714|5975986|P1|Overall Study|Adverse Event|4
1712355|NCT01143402|5976091|P3|Overall Study|Not Treated|1
1712356|NCT01143402|5976092|P2|Overall Study|Not Treated|0
1712357|NCT01143402|5976093|P1|Overall Study|Not Treated|0
1712358|NCT01143402|5976091|P3|Overall Study|Rapid clinical decline|0
1712359|NCT01143402|5976092|P2|Overall Study|Rapid clinical decline|1
1712360|NCT01143402|5976093|P1|Overall Study|Rapid clinical decline|1
1712361|NCT01143389|5976104|P2|Overall Study|Lost to Follow-up|25
1712362|NCT01143389|5976105|P1|Overall Study|Lost to Follow-up|26
1712363|NCT01143337|5976119|P3|Overall Study|Other reason|5
1712364|NCT01143337|5976120|P2|Overall Study|Other reason|0
1712365|NCT01143337|5976121|P1|Overall Study|Other reason|0
1712366|NCT01143337|5976119|P3|Overall Study|Withdrawal by Subject|1
1712367|NCT01143337|5976120|P2|Overall Study|Withdrawal by Subject|0
1712368|NCT01143337|5976121|P1|Overall Study|Withdrawal by Subject|0
1712369|NCT01143337|5976119|P3|Overall Study|Protocol Violation|0
1712370|NCT01143337|5976120|P2|Overall Study|Protocol Violation|0
1712371|NCT01143337|5976121|P1|Overall Study|Protocol Violation|1
1712372|NCT01143337|5976119|P3|Overall Study|Lack of Efficacy|1
1712373|NCT01143337|5976120|P2|Overall Study|Lack of Efficacy|2
1712374|NCT01143337|5976121|P1|Overall Study|Lack of Efficacy|6
1712375|NCT01143337|5976119|P3|Overall Study|Adverse Event|5
1712376|NCT01143337|5976120|P2|Overall Study|Adverse Event|9
1712377|NCT01143337|5976121|P1|Overall Study|Adverse Event|3
1712378|NCT01143324|5976135|P1|Overall Study|Explant of the device|4
1712379|NCT01143324|5976135|P1|Overall Study|Withdrawal by Subject|4
1712380|NCT01143324|5976135|P1|Overall Study|Lost to Follow-up|11
1712381|NCT01143259|5976174|P2|Overall Study|Screen Failure|9
1712382|NCT01143259|5976175|P1|Overall Study|Screen Failure|7
1712383|NCT01143259|5976174|P2|Overall Study|Protocol Violation|9
1712384|NCT01143259|5976175|P1|Overall Study|Protocol Violation|13
1712385|NCT01143259|5976174|P2|Overall Study|Withdrawal by Subject|2
1712386|NCT01143259|5976175|P1|Overall Study|Withdrawal by Subject|3
1712387|NCT01143207|5976183|P1|Overall Study|Lost to Follow-up|2
1712388|NCT01143090|5976203|P1|Overall Study|Administrative|1
1712389|NCT01143090|5976203|P1|Overall Study|Failure to meet eligibility criteria|1
1712390|NCT01143090|5976203|P1|Overall Study|Non-compliance with study drug|1
1712391|NCT01143090|5976203|P1|Overall Study|Withdrawal by Subject|18
1712392|NCT01143090|5976203|P1|Overall Study|Protocol Violation|2
1712393|NCT01143090|5976203|P1|Overall Study|Lost to Follow-up|9
1712394|NCT01143090|5976203|P1|Overall Study|Adverse Event|17
1712395|NCT01143090|5976203|P1|Overall Study|Lack of Efficacy|2
1712396|NCT01143077|5976210|P3|Overall Study|Principal Investigator Decision|1
1712397|NCT01143077|5976211|P2|Overall Study|Principal Investigator Decision|0
1712398|NCT01143077|5976212|P1|Overall Study|Principal Investigator Decision|2
1712399|NCT01143077|5976210|P3|Overall Study|Administrative|0
1712400|NCT01143077|5976211|P2|Overall Study|Administrative|0
1712401|NCT01143077|5976212|P1|Overall Study|Administrative|1
1712402|NCT01143077|5976210|P3|Overall Study|Non-compliance with study drug|1
1712403|NCT01143077|5976211|P2|Overall Study|Non-compliance with study drug|1
1712404|NCT01143077|5976212|P1|Overall Study|Non-compliance with study drug|0
1712405|NCT01143077|5976210|P3|Overall Study|Withdrawal by Subject|3
1712406|NCT01143077|5976211|P2|Overall Study|Withdrawal by Subject|3
1712407|NCT01143077|5976212|P1|Overall Study|Withdrawal by Subject|4
1712408|NCT01143077|5976210|P3|Overall Study|Protocol Violation|0
1712409|NCT01143077|5976211|P2|Overall Study|Protocol Violation|0
1712410|NCT01143077|5976212|P1|Overall Study|Protocol Violation|2
1712411|NCT01143077|5976210|P3|Overall Study|Lost to Follow-up|4
1712412|NCT01143077|5976211|P2|Overall Study|Lost to Follow-up|3
1712413|NCT01143077|5976212|P1|Overall Study|Lost to Follow-up|2
1712414|NCT01143077|5976210|P3|Overall Study|Adverse Event|5
1712415|NCT01143077|5976211|P2|Overall Study|Adverse Event|6
1712416|NCT01143077|5976212|P1|Overall Study|Adverse Event|5
1712417|NCT01143077|5976210|P3|Overall Study|Lack of Efficacy|1
1712418|NCT01143077|5976211|P2|Overall Study|Lack of Efficacy|2
1712419|NCT01143077|5976212|P1|Overall Study|Lack of Efficacy|0
1712420|NCT01143051|5976229|P6|3-14 Day Washout|Withdrawal by Subject|1
1712421|NCT01143051|5976230|P5|3-14 Day Washout|Withdrawal by Subject|0
1712422|NCT01143051|5976231|P4|3-14 Day Washout|Withdrawal by Subject|0
1712423|NCT01143051|5976232|P3|3-14 Day Washout|Withdrawal by Subject|0
1712424|NCT01143051|5976233|P2|3-14 Day Washout|Withdrawal by Subject|0
1712425|NCT01143051|5976234|P1|3-14 Day Washout|Withdrawal by Subject|0
1712426|NCT01143051|5976229|P6|3-14 Day Washout|Withdrawal by Subject|0
1712427|NCT01143051|5976230|P5|3-14 Day Washout|Withdrawal by Subject|0
1712428|NCT01143051|5976231|P4|3-14 Day Washout|Withdrawal by Subject|0
1712429|NCT01143051|5976232|P3|3-14 Day Washout|Withdrawal by Subject|1
1712430|NCT01143051|5976233|P2|3-14 Day Washout|Withdrawal by Subject|0
1712431|NCT01143051|5976234|P1|3-14 Day Washout|Withdrawal by Subject|0
1712432|NCT01143038|5976283|P1|Overall Study|Death|1
1712433|NCT01143038|5976283|P1|Overall Study|Protocol Deviation|1
1712434|NCT01143038|5976283|P1|Overall Study|Lost to Follow-up|2
1712435|NCT01143038|5976283|P1|Overall Study|Adverse Event|3
1712436|NCT01143038|5976283|P1|Overall Study|Requirement for alternative therapy|5
1712437|NCT01143038|5976283|P1|Overall Study|Withdrawal by Subject|4
1712438|NCT01142908|5976297|P2|Overall Study|Withdrawal by Subject|0
1712439|NCT01142908|5976298|P1|Overall Study|Withdrawal by Subject|3
1712440|NCT01142908|5976297|P2|Overall Study|Excluded - did not meet criteria|5
1712441|NCT01142908|5976298|P1|Overall Study|Excluded - did not meet criteria|9
1712442|NCT01142908|5976297|P2|Overall Study|Death|4
1712443|NCT01142908|5976298|P1|Overall Study|Death|1
1712444|NCT01142908|5976297|P2|Overall Study|Lost to Follow-up|13
1712445|NCT01142908|5976298|P1|Overall Study|Lost to Follow-up|19
1712446|NCT01142791|5976344|P2|Overall Study|Received only 1 sonication|6
1712447|NCT01142791|5976345|P1|Overall Study|Received only 1 sonication|0
1712448|NCT01142791|5976344|P2|Overall Study|Withdrawal by Subject|0
1712449|NCT01142791|5976345|P1|Overall Study|Withdrawal by Subject|5
1712450|NCT01142791|5976344|P2|Overall Study|Lost to Follow-up|0
1712451|NCT01142791|5976345|P1|Overall Study|Lost to Follow-up|1
1712452|NCT01142791|5976344|P2|Overall Study|Alternative Treatment|0
1712453|NCT01142791|5976345|P1|Overall Study|Alternative Treatment|1
1712454|NCT01142726|5976352|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
1712455|NCT01142726|5976353|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
1712456|NCT01142726|5976354|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
1712457|NCT01142726|5976352|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
1712458|NCT01142726|5976353|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
1712459|NCT01142726|5976354|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
1712460|NCT01142726|5976352|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1712461|NCT01142726|5976353|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1712462|NCT01142726|5976354|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
1712463|NCT01142726|5976352|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
1712464|NCT01142726|5976353|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
1712465|NCT01142726|5976354|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
1712466|NCT01142726|5976352|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
1712467|NCT01142726|5976353|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
1712468|NCT01142726|5976354|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
1712469|NCT01142726|5976352|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
1712470|NCT01142726|5976353|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
1712471|NCT01142726|5976354|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
1712472|NCT01142726|5976352|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
1712473|NCT01142726|5976353|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
1712474|NCT01142726|5976354|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
1712475|NCT01142726|5976352|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
1712476|NCT01142726|5976353|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
1712477|NCT01142726|5976354|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
1712478|NCT01142726|5976352|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
1712479|NCT01142726|5976353|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
1712480|NCT01142726|5976354|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
1712481|NCT01142726|5976352|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
1712482|NCT01142726|5976353|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
1712483|NCT01142726|5976354|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
1712484|NCT01142726|5976352|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
1712485|NCT01142726|5976353|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
1712486|NCT01142726|5976354|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
1712487|NCT01142726|5976352|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
1712488|NCT01142726|5976353|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
1712489|NCT01142726|5976354|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
1712490|NCT01142726|5976352|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
1712491|NCT01142726|5976353|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
1712492|NCT01142726|5976354|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
1712493|NCT01142726|5976352|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
1712494|NCT01142726|5976353|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
1712495|NCT01142726|5976354|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
1712496|NCT01142726|5976352|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
1712497|NCT01142726|5976353|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
1712498|NCT01142726|5976354|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
1712499|NCT01142726|5976352|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
1712500|NCT01142726|5976353|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
1712501|NCT01142726|5976354|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
1712502|NCT01142661|5976417|P1|Overall Study|Physician Decision|1
1712503|NCT01142661|5976417|P1|Overall Study|Withdrawal by Subject|1
1712504|NCT01142661|5976417|P1|Overall Study|Adverse Event|2
1712505|NCT01142596|5976424|P2|Overall Study|Other reason (not specified)|4
1712506|NCT01142596|5976425|P1|Overall Study|Other reason (not specified)|5
1712507|NCT01142596|5976424|P2|Overall Study|Lost to Follow-up|3
1712508|NCT01142596|5976425|P1|Overall Study|Lost to Follow-up|2
1712509|NCT01142596|5976424|P2|Overall Study|Lack of Efficacy|9
1712510|NCT01142596|5976425|P1|Overall Study|Lack of Efficacy|5
1712511|NCT01142596|5976424|P2|Overall Study|Adverse Event|35
1712512|NCT01142596|5976425|P1|Overall Study|Adverse Event|8
1712513|NCT01142596|5976424|P2|Overall Study|Withdrawal by Subject|35
1712514|NCT01142596|5976425|P1|Overall Study|Withdrawal by Subject|9
1712515|NCT01142466|5976477|P2|Overall Study|Withdrawal by Subject|1
1712516|NCT01142466|5976478|P1|Overall Study|Withdrawal by Subject|1
1712517|NCT01142466|5976477|P2|Overall Study|Adverse Event|1
1712518|NCT01142466|5976478|P1|Overall Study|Adverse Event|2
1712519|NCT01142388|5976498|P2|Overall Study|Never started therapy|3
1712520|NCT01142388|5976499|P1|Overall Study|Never started therapy|7
1712521|NCT01142388|5976498|P2|Overall Study|Other|1
1712522|NCT01142388|5976499|P1|Overall Study|Other|1
1712523|NCT01142388|5976498|P2|Overall Study|Other complications|2
1712524|NCT01142388|5976499|P1|Overall Study|Other complications|0
1712525|NCT01142388|5976498|P2|Overall Study|Alternative therapy|0
1712526|NCT01142388|5976499|P1|Overall Study|Alternative therapy|1
1712527|NCT01142388|5976498|P2|Overall Study|Withdrawal by Subject|3
1712528|NCT01142388|5976499|P1|Overall Study|Withdrawal by Subject|5
1712529|NCT01142388|5976498|P2|Overall Study|Death|2
1712530|NCT01142388|5976499|P1|Overall Study|Death|3
1712531|NCT01142388|5976498|P2|Overall Study|Adverse Event|5
1712532|NCT01142388|5976499|P1|Overall Study|Adverse Event|9
1712533|NCT01142388|5976498|P2|Overall Study|Lack of Efficacy|31
1712534|NCT01142388|5976499|P1|Overall Study|Lack of Efficacy|21
1712535|NCT01142336|5976511|P2|Overall Study|Lost to Follow-up|1
1712536|NCT01142336|5976512|P1|Overall Study|Lost to Follow-up|0
1712537|NCT01142336|5976511|P2|Overall Study|Adverse Event|1
1712538|NCT01142336|5976512|P1|Overall Study|Adverse Event|1
1712539|NCT01142232|5976549|P5|Overall Study|Noncompliance|2
1712540|NCT01142232|5976550|P4|Overall Study|Noncompliance|0
1712541|NCT01142232|5976551|P3|Overall Study|Noncompliance|0
1712542|NCT01142232|5976552|P2|Overall Study|Noncompliance|0
1712543|NCT01142232|5976553|P1|Overall Study|Noncompliance|0
1712544|NCT01142232|5976549|P5|Overall Study|Off Trt for other complicating disease|1
1712545|NCT01142232|5976550|P4|Overall Study|Off Trt for other complicating disease|0
1712546|NCT01142232|5976551|P3|Overall Study|Off Trt for other complicating disease|0
1712547|NCT01142232|5976552|P2|Overall Study|Off Trt for other complicating disease|0
1712548|NCT01142232|5976553|P1|Overall Study|Off Trt for other complicating disease|0
1712549|NCT01142232|5976549|P5|Overall Study|Alternative Therapy|1
1712550|NCT01142232|5976550|P4|Overall Study|Alternative Therapy|0
1712551|NCT01142232|5976551|P3|Overall Study|Alternative Therapy|1
1712552|NCT01142232|5976552|P2|Overall Study|Alternative Therapy|1
1712553|NCT01142232|5976553|P1|Overall Study|Alternative Therapy|0
1712554|NCT01142232|5976549|P5|Overall Study|Physician Decision|10
1712555|NCT01142232|5976550|P4|Overall Study|Physician Decision|2
1712556|NCT01142232|5976551|P3|Overall Study|Physician Decision|0
1712557|NCT01142232|5976552|P2|Overall Study|Physician Decision|1
1712558|NCT01142232|5976553|P1|Overall Study|Physician Decision|0
1712559|NCT01142232|5976549|P5|Overall Study|Withdrawal by Subject|3
1712560|NCT01142232|5976550|P4|Overall Study|Withdrawal by Subject|1
1712561|NCT01142232|5976551|P3|Overall Study|Withdrawal by Subject|0
1712562|NCT01142232|5976552|P2|Overall Study|Withdrawal by Subject|0
1712563|NCT01142232|5976553|P1|Overall Study|Withdrawal by Subject|0
1712564|NCT01142232|5976549|P5|Overall Study|Disease Progression|12
1712565|NCT01142232|5976550|P4|Overall Study|Disease Progression|2
1712566|NCT01142232|5976551|P3|Overall Study|Disease Progression|1
1712567|NCT01142232|5976552|P2|Overall Study|Disease Progression|0
1712568|NCT01142232|5976553|P1|Overall Study|Disease Progression|2
1712569|NCT01142232|5976549|P5|Overall Study|Death|1
1712570|NCT01142232|5976550|P4|Overall Study|Death|0
1712571|NCT01142232|5976551|P3|Overall Study|Death|0
1712572|NCT01142232|5976552|P2|Overall Study|Death|0
1712573|NCT01142232|5976553|P1|Overall Study|Death|0
1712574|NCT01142232|5976549|P5|Overall Study|Adverse Event|4
1712575|NCT01142232|5976550|P4|Overall Study|Adverse Event|0
1712576|NCT01142232|5976551|P3|Overall Study|Adverse Event|1
1712577|NCT01142232|5976552|P2|Overall Study|Adverse Event|2
1712578|NCT01142232|5976553|P1|Overall Study|Adverse Event|1
1712579|NCT01142193|5976568|P2|Overall Study|Other|2
1712580|NCT01142193|5976569|P1|Overall Study|Other|1
1712581|NCT01142193|5976568|P2|Overall Study|Protocol Discontinuation Criterion Met|0
1712582|NCT01142193|5976569|P1|Overall Study|Protocol Discontinuation Criterion Met|1
1712583|NCT01142193|5976568|P2|Overall Study|Withdrawal by Subject|3
1712584|NCT01142193|5976569|P1|Overall Study|Withdrawal by Subject|4
1712585|NCT01142193|5976568|P2|Overall Study|Physician Decision|1
1712586|NCT01142193|5976569|P1|Overall Study|Physician Decision|1
1712587|NCT01142193|5976568|P2|Overall Study|Lack of Efficacy|1
1712588|NCT01142193|5976569|P1|Overall Study|Lack of Efficacy|2
1712589|NCT01142193|5976568|P2|Overall Study|Adverse Event|4
1712590|NCT01142193|5976569|P1|Overall Study|Adverse Event|12
1712591|NCT01142128|5976597|P1|Overall Study|Withdrawal by Subject|2
1712592|NCT01142128|5976597|P1|Overall Study|Lost to Follow-up|1
1712593|NCT01142128|5976597|P1|Overall Study|Physician Decision|1
1712594|NCT01142115|5976607|P2|First Intervention|Adverse Event|0
1712595|NCT01142115|5976608|P1|First Intervention|Adverse Event|1
1712596|NCT01142115|5976607|P2|First Intervention|Lack of Efficacy|1
1712597|NCT01142115|5976608|P1|First Intervention|Lack of Efficacy|1
1712598|NCT01142089|5976625|P2|Overall Study|Patient required rescue medication|17
1712599|NCT01142089|5976626|P1|Overall Study|Patient required rescue medication|8
1712600|NCT01142089|5976625|P2|Overall Study|Noncompliance with study procedures|1
1712601|NCT01142089|5976626|P1|Overall Study|Noncompliance with study procedures|2
1712602|NCT01142089|5976625|P2|Overall Study|Use of prohibited medications|1
1712603|NCT01142089|5976626|P1|Overall Study|Use of prohibited medications|0
1712604|NCT01142089|5976625|P2|Overall Study|Withdrawal by Subject|2
1712605|NCT01142089|5976626|P1|Overall Study|Withdrawal by Subject|1
1712606|NCT01142089|5976625|P2|Overall Study|Physician Decision|0
1712607|NCT01142089|5976626|P1|Overall Study|Physician Decision|1
1712608|NCT01141712|5976657|P1|Overall Study|Disease progression|3
1712609|NCT01141660|5976678|P2|Overall Study|Physician Decision|12
1712610|NCT01141660|5976679|P1|Overall Study|Physician Decision|0
1712611|NCT01141283|5976747|P1|Overall Study|Lack of Efficacy|10
1712612|NCT01141283|5976747|P1|Overall Study|Administrative|4
1712613|NCT01141283|5976747|P1|Overall Study|Withdrawal by Subject|14
1712614|NCT01141283|5976747|P1|Overall Study|Lost to Follow-up|4
1712615|NCT01141283|5976747|P1|Overall Study|Adverse Event|56
1712616|NCT01141205|5976753|P2|Overall Study|Withdrawal by Subject|1
1712617|NCT01141205|5976754|P1|Overall Study|Withdrawal by Subject|1
1712618|NCT01141205|5976753|P2|Overall Study|Lost to Follow-up|0
1712619|NCT01141205|5976754|P1|Overall Study|Lost to Follow-up|1
1712620|NCT01141205|5976753|P2|Overall Study|Physician Decision|1
1712621|NCT01141205|5976754|P1|Overall Study|Physician Decision|1
1712622|NCT01140906|5976781|P4|Overall Study|Administrative or other reason|2
1712623|NCT01140906|5976782|P3|Overall Study|Administrative or other reason|3
1712624|NCT01140906|5976783|P2|Overall Study|Administrative or other reason|5
1712625|NCT01140906|5976784|P1|Overall Study|Administrative or other reason|0
1712626|NCT01140906|5976781|P4|Overall Study|Lost to Follow-up|2
1712627|NCT01140906|5976782|P3|Overall Study|Lost to Follow-up|0
1712628|NCT01140906|5976783|P2|Overall Study|Lost to Follow-up|1
1712629|NCT01140906|5976784|P1|Overall Study|Lost to Follow-up|1
1712630|NCT01140906|5976781|P4|Overall Study|Withdrawal of consent|2
1712631|NCT01140906|5976782|P3|Overall Study|Withdrawal of consent|2
1712632|NCT01140906|5976783|P2|Overall Study|Withdrawal of consent|6
1712633|NCT01140906|5976784|P1|Overall Study|Withdrawal of consent|6
1712634|NCT01140906|5976781|P4|Overall Study|Protocol Violation|1
1712635|NCT01140906|5976782|P3|Overall Study|Protocol Violation|2
1712636|NCT01140906|5976783|P2|Overall Study|Protocol Violation|3
1712637|NCT01140906|5976784|P1|Overall Study|Protocol Violation|5
1712638|NCT01140906|5976781|P4|Overall Study|Non-compliance|1
1712639|NCT01140906|5976782|P3|Overall Study|Non-compliance|0
1712640|NCT01140906|5976783|P2|Overall Study|Non-compliance|1
1712641|NCT01140906|5976784|P1|Overall Study|Non-compliance|0
1712642|NCT01140906|5976781|P4|Overall Study|Lack of Efficacy|1
1712643|NCT01140906|5976782|P3|Overall Study|Lack of Efficacy|2
1712644|NCT01140906|5976783|P2|Overall Study|Lack of Efficacy|8
1712645|NCT01140906|5976784|P1|Overall Study|Lack of Efficacy|6
1712646|NCT01140906|5976781|P4|Overall Study|Adverse Event|7
1712647|NCT01140906|5976782|P3|Overall Study|Adverse Event|17
1712648|NCT01140906|5976783|P2|Overall Study|Adverse Event|10
1712649|NCT01140906|5976784|P1|Overall Study|Adverse Event|7
1712650|NCT01140880|5976824|P2|Overall Study|Protocol Violation|30
1712651|NCT01140880|5976825|P1|Overall Study|Protocol Violation|0
1712652|NCT01140880|5976824|P2|Overall Study|Lost to Follow-up|10
1712653|NCT01140880|5976825|P1|Overall Study|Lost to Follow-up|8
1712654|NCT01140880|5976824|P2|Overall Study|Withdrawal by Subject|3
1712655|NCT01140880|5976825|P1|Overall Study|Withdrawal by Subject|6
1712656|NCT01140880|5976824|P2|Overall Study|Death|1
1712657|NCT01140880|5976825|P1|Overall Study|Death|0
1712658|NCT01140867|5976837|P1|Overall Study|Medication Noncompliance|2
1712659|NCT01140867|5976837|P1|Overall Study|Uncooperative patient|2
1712660|NCT01140867|5976837|P1|Overall Study|Protocol Violation|1
1712661|NCT01140867|5976837|P1|Overall Study|Withdrawal by Subject|1
1712662|NCT01140867|5976837|P1|Overall Study|Lost to Follow-up|2
1712663|NCT01140867|5976837|P1|Overall Study|Lack of Efficacy|3
1712664|NCT01140867|5976837|P1|Overall Study|Adverse Event|22
1712665|NCT01140646|5976877|P1|Overall Study|Refused Further Treatment|5
1712666|NCT01140646|5976877|P1|Overall Study|Adverse Event|4
1712667|NCT01140503|5976885|P1|Overall Study|Withdrawal by Subject|1
1712668|NCT01140477|5976893|P2|Overall Study|Subject explanted|1
1712669|NCT01140477|5976894|P1|Overall Study|Subject explanted|0
1712670|NCT01140477|5976893|P2|Overall Study|Death|1
1712671|NCT01140477|5976894|P1|Overall Study|Death|1
1712672|NCT01140477|5976893|P2|Overall Study|Surgical complication preventing implant|0
1712673|NCT01140477|5976894|P1|Overall Study|Surgical complication preventing implant|2
1712674|NCT01140477|5976893|P2|Overall Study|Withdrawal by Subject|4
1712675|NCT01140477|5976894|P1|Overall Study|Withdrawal by Subject|1
1712676|NCT01140477|5976893|P2|Overall Study|Lost to Follow-up|0
1712677|NCT01140477|5976894|P1|Overall Study|Lost to Follow-up|4
1712678|NCT01140347|5976909|P2|Overall Study|Withdrawal by Subject|8
1712679|NCT01140347|5976910|P1|Overall Study|Withdrawal by Subject|13
1712680|NCT01140347|5976909|P2|Overall Study|Lost to Follow-up|6
1712681|NCT01140347|5976910|P1|Overall Study|Lost to Follow-up|5
1712682|NCT01140061|5976963|P10|Extension|Laboratory Adverse Event|1
1712683|NCT01140061|5976964|P9|Extension|Laboratory Adverse Event|0
1712684|NCT01140061|5976965|P8|Extension|Laboratory Adverse Event|0
1712685|NCT01140061|5976966|P7|Extension|Laboratory Adverse Event|0
1712686|NCT01140061|5976967|P6|Extension|Laboratory Adverse Event|0
1712687|NCT01140061|5976968|P5|Extension|Laboratory Adverse Event|0
1712688|NCT01140061|5976969|P4|Extension|Laboratory Adverse Event|0
1712689|NCT01140061|5976970|P3|Extension|Laboratory Adverse Event|0
1712690|NCT01140061|5976971|P2|Extension|Laboratory Adverse Event|0
1712691|NCT01140061|5976972|P1|Extension|Laboratory Adverse Event|0
1712692|NCT01140061|5976963|P10|Part I|Adverse Event|0
1712693|NCT01140061|5976964|P9|Part I|Adverse Event|0
1712694|NCT01140061|5976965|P8|Part I|Adverse Event|0
1712695|NCT01140061|5976966|P7|Part I|Adverse Event|0
1712696|NCT01140061|5976967|P6|Part I|Adverse Event|0
1712697|NCT01140061|5976968|P5|Part I|Adverse Event|0
1712698|NCT01140061|5976969|P4|Part I|Adverse Event|0
1712699|NCT01140061|5976970|P3|Part I|Adverse Event|0
1712700|NCT01140061|5976971|P2|Part I|Adverse Event|0
1712701|NCT01140061|5976972|P1|Part I|Adverse Event|1
1712702|NCT01140048|5976999|P1|Overall Study|Lost to Follow-up|31
1712703|NCT01140048|5976999|P1|Overall Study|Withdrawal by Subject|13
1712704|NCT01140048|5976999|P1|Overall Study|Physician Decision|1
1712705|NCT01139775|5977039|P3|Overall Study|Physician Decision|2
1712706|NCT01139775|5977040|P2|Overall Study|Physician Decision|2
1712707|NCT01139775|5977041|P1|Overall Study|Physician Decision|0
1712708|NCT01139775|5977039|P3|Overall Study|Withdrawal by Subject|2
1712709|NCT01139775|5977040|P2|Overall Study|Withdrawal by Subject|0
1712710|NCT01139775|5977041|P1|Overall Study|Withdrawal by Subject|1
1712711|NCT01139775|5977039|P3|Overall Study|Protocol Violation|0
1712712|NCT01139775|5977040|P2|Overall Study|Protocol Violation|5
1712713|NCT01139775|5977041|P1|Overall Study|Protocol Violation|0
1712714|NCT01139775|5977039|P3|Overall Study|Adverse Event|2
1712715|NCT01139775|5977040|P2|Overall Study|Adverse Event|6
1712716|NCT01139775|5977041|P1|Overall Study|Adverse Event|0
1712717|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
1712718|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
1712719|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
1712720|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
1712721|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
1712722|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
1712723|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
1712724|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
1712725|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
1712726|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
1712727|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
1712728|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
1712729|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
1712730|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
1712731|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
1712732|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
1712733|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
1712734|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
1712735|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
1712736|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
1712737|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
1712738|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Death|1
1712739|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Death|1
1712740|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Death|0
1712741|NCT01139762|5977073|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
1712742|NCT01139762|5977074|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
1712743|NCT01139762|5977075|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
1712744|NCT01139762|5977073|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
1712745|NCT01139762|5977074|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
1712746|NCT01139762|5977075|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
1712747|NCT01139762|5977073|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
1712748|NCT01139762|5977074|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
1712749|NCT01139762|5977075|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
1712750|NCT01139762|5977073|P3|Washout and Placebo Lead-In Period|Physician Decision|0
1712751|NCT01139762|5977074|P2|Washout and Placebo Lead-In Period|Physician Decision|0
1712752|NCT01139762|5977075|P1|Washout and Placebo Lead-In Period|Physician Decision|12
1712753|NCT01139762|5977073|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
1712754|NCT01139762|5977074|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
1712755|NCT01139762|5977075|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
1712756|NCT01139762|5977073|P3|Washout and Placebo Lead-In Period|Adverse Event|0
1712757|NCT01139762|5977074|P2|Washout and Placebo Lead-In Period|Adverse Event|0
1712758|NCT01139762|5977075|P1|Washout and Placebo Lead-In Period|Adverse Event|1
1712759|NCT01139762|5977073|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
1712760|NCT01139762|5977074|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
1712761|NCT01139762|5977075|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
1712762|NCT01139658|5977110|P2|Overall Study|Other|75
1712763|NCT01139658|5977111|P1|Overall Study|Other|28
1712764|NCT01139658|5977110|P2|Overall Study|No documentation of treatment|0
1712765|NCT01139658|5977111|P1|Overall Study|No documentation of treatment|1
1712766|NCT01139658|5977110|P2|Overall Study|Withdrawal by Subject|4
1712767|NCT01139658|5977111|P1|Overall Study|Withdrawal by Subject|2
1712768|NCT01139658|5977110|P2|Overall Study|Lack of Efficacy|7
1712769|NCT01139658|5977111|P1|Overall Study|Lack of Efficacy|15
1712770|NCT01139658|5977110|P2|Overall Study|Adverse Event|27
1712771|NCT01139658|5977111|P1|Overall Study|Adverse Event|10
1712772|NCT01139580|5977149|P2|Overall Study|Participant Randomization in Error|1
1712773|NCT01139580|5977150|P1|Overall Study|Participant Randomization in Error|0
1712774|NCT01139580|5977149|P2|Overall Study|Beginning Study Exclusion Treatment|1
1712775|NCT01139580|5977150|P1|Overall Study|Beginning Study Exclusion Treatment|0
1712776|NCT01139580|5977149|P2|Overall Study|Misrandomized|0
1712777|NCT01139580|5977150|P1|Overall Study|Misrandomized|1
1712778|NCT01139580|5977149|P2|Overall Study|Did Not Meet Exclusion Criteria|0
1712779|NCT01139580|5977150|P1|Overall Study|Did Not Meet Exclusion Criteria|1
1712780|NCT01139580|5977149|P2|Overall Study|Used Excluded Medicine After Enrollment|0
1712781|NCT01139580|5977150|P1|Overall Study|Used Excluded Medicine After Enrollment|1
1712782|NCT01139580|5977149|P2|Overall Study|Withdrawal by Subject|9
1712783|NCT01139580|5977150|P1|Overall Study|Withdrawal by Subject|6
1712784|NCT01139580|5977149|P2|Overall Study|Lack of Efficacy|2
1712785|NCT01139580|5977150|P1|Overall Study|Lack of Efficacy|0
1712786|NCT01139580|5977149|P2|Overall Study|Lost to Follow-up|1
1712787|NCT01139580|5977150|P1|Overall Study|Lost to Follow-up|9
1712788|NCT01139580|5977149|P2|Overall Study|Adverse Event|4
1712789|NCT01139580|5977150|P1|Overall Study|Adverse Event|5
1712790|NCT01139450|5977198|P3|Overall Study|Adverse Event|3
1712791|NCT01139450|5977199|P2|Overall Study|Adverse Event|2
1712792|NCT01139450|5977200|P1|Overall Study|Adverse Event|2
1712793|NCT01139450|5977198|P3|Overall Study|Administrative|1
1712794|NCT01139450|5977199|P2|Overall Study|Administrative|0
1712795|NCT01139450|5977200|P1|Overall Study|Administrative|0
1712796|NCT01139450|5977198|P3|Overall Study|Lost to Follow-up|11
1712797|NCT01139450|5977199|P2|Overall Study|Lost to Follow-up|7
1712798|NCT01139450|5977200|P1|Overall Study|Lost to Follow-up|9
1712799|NCT01139450|5977198|P3|Overall Study|Protocol Violation|2
1712800|NCT01139450|5977199|P2|Overall Study|Protocol Violation|5
1712801|NCT01139450|5977200|P1|Overall Study|Protocol Violation|6
1712802|NCT01139450|5977198|P3|Overall Study|Lack of Efficacy|8
1712803|NCT01139450|5977199|P2|Overall Study|Lack of Efficacy|1
1712804|NCT01139450|5977200|P1|Overall Study|Lack of Efficacy|3
1712805|NCT01139450|5977198|P3|Overall Study|Withdrawal by Subject|13
1712806|NCT01139450|5977199|P2|Overall Study|Withdrawal by Subject|10
1712807|NCT01139450|5977200|P1|Overall Study|Withdrawal by Subject|7
1712808|NCT01139164|5977252|P3|Overall Study|Withdrawn prior to study start|0
1712809|NCT01139164|5977253|P2|Overall Study|Withdrawn prior to study start|2
1712810|NCT01139164|5977254|P1|Overall Study|Withdrawn prior to study start|0
1712811|NCT01139125|5977268|P1|Overall Study|Withdrawal by Subject|1
1712812|NCT01139047|5977272|P1|Overall Study|Withdrawal by Subject|1
1712813|NCT01139021|5977287|P6|Overall Study|Withdrawal by Subject|0
1712814|NCT01139021|5977288|P5|Overall Study|Withdrawal by Subject|4
1712815|NCT01139021|5977289|P4|Overall Study|Withdrawal by Subject|1
1712816|NCT01139021|5977290|P3|Overall Study|Withdrawal by Subject|0
1712817|NCT01139021|5977291|P2|Overall Study|Withdrawal by Subject|0
1712818|NCT01139021|5977292|P1|Overall Study|Withdrawal by Subject|0
1712819|NCT01139021|5977287|P6|Overall Study|Protocol Violation|0
1712820|NCT01139021|5977288|P5|Overall Study|Protocol Violation|2
1712821|NCT01139021|5977289|P4|Overall Study|Protocol Violation|0
1712822|NCT01139021|5977290|P3|Overall Study|Protocol Violation|0
1712823|NCT01139021|5977291|P2|Overall Study|Protocol Violation|0
1712824|NCT01139021|5977292|P1|Overall Study|Protocol Violation|1
1712825|NCT01139021|5977287|P6|Overall Study|Lost to Follow-up|0
1712826|NCT01139021|5977288|P5|Overall Study|Lost to Follow-up|2
1712827|NCT01139021|5977289|P4|Overall Study|Lost to Follow-up|0
1712828|NCT01139021|5977290|P3|Overall Study|Lost to Follow-up|0
1712829|NCT01139021|5977291|P2|Overall Study|Lost to Follow-up|0
1712830|NCT01139021|5977292|P1|Overall Study|Lost to Follow-up|0
1712831|NCT01139021|5977287|P6|Overall Study|Adverse Event|0
1712832|NCT01139021|5977288|P5|Overall Study|Adverse Event|1
1712833|NCT01139021|5977289|P4|Overall Study|Adverse Event|0
1712834|NCT01139021|5977290|P3|Overall Study|Adverse Event|0
1712835|NCT01139021|5977291|P2|Overall Study|Adverse Event|0
1712836|NCT01139021|5977292|P1|Overall Study|Adverse Event|0
1712837|NCT01139008|5977328|P1|Overall Study|Non-compliant, lost product|1
1712838|NCT01139008|5977328|P1|Overall Study|Withdrawal by Subject|5
1712839|NCT01138826|5977375|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
1712840|NCT01138826|5977376|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
1712841|NCT01138826|5977377|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
1712842|NCT01138826|5977378|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
1712843|NCT01138826|5977379|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
1712844|NCT01138826|5977380|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
1712845|NCT01138657|5977417|P2|Overall Study|Miscellaneous Reasons|4
1712846|NCT01138657|5977418|P1|Overall Study|Miscellaneous Reasons|3
1712847|NCT01138657|5977417|P2|Overall Study|Lost to Follow-up|3
1712848|NCT01138657|5977418|P1|Overall Study|Lost to Follow-up|0
1712849|NCT01138657|5977417|P2|Overall Study|Lack of Efficacy|1
1712850|NCT01138657|5977418|P1|Overall Study|Lack of Efficacy|2
1712851|NCT01138657|5977417|P2|Overall Study|Adverse Event|10
1712852|NCT01138657|5977418|P1|Overall Study|Adverse Event|3
1712853|NCT01138501|5977481|P1|Overall Study|Withdrawal by Subject|3
1712854|NCT01138501|5977481|P1|Overall Study|Protocol Violation|2
1712855|NCT01138150|5977525|P2|Overall Study|Physician Decision|0
1712856|NCT01138150|5977526|P1|Overall Study|Physician Decision|1
1712857|NCT01138150|5977525|P2|Overall Study|blood unable to be processed|1
1712858|NCT01138150|5977526|P1|Overall Study|blood unable to be processed|0
1712859|NCT01138111|5977607|P1|Overall Study|Lost to Follow-up|2
1712860|NCT01138111|5977607|P1|Overall Study|Death|1
1712861|NCT01138111|5977607|P1|Overall Study|Adverse Event|1
1712862|NCT01138111|5977607|P1|Overall Study|Withdrawal by Subject|5
1712863|NCT01138046|5977661|P1|Overall Study|Withdrawal due to death|6
1712864|NCT01138007|5977681|P3|Overall Study|Withdrawal by Subject|15
1712865|NCT01138007|5977682|P2|Overall Study|Withdrawal by Subject|6
1712866|NCT01138007|5977683|P1|Overall Study|Withdrawal by Subject|5
1712867|NCT01138007|5977681|P3|Overall Study|Physician Decision|3
1712868|NCT01138007|5977682|P2|Overall Study|Physician Decision|5
1712869|NCT01138007|5977683|P1|Overall Study|Physician Decision|0
1712870|NCT01138007|5977681|P3|Overall Study|Lost to Follow-up|5
1712871|NCT01138007|5977682|P2|Overall Study|Lost to Follow-up|3
1712872|NCT01138007|5977683|P1|Overall Study|Lost to Follow-up|3
1712873|NCT01138007|5977681|P3|Overall Study|Protocol-Defined Stopping Criteria|8
1712874|NCT01138007|5977682|P2|Overall Study|Protocol-Defined Stopping Criteria|1
1712875|NCT01138007|5977683|P1|Overall Study|Protocol-Defined Stopping Criteria|6
1712876|NCT01138007|5977681|P3|Overall Study|Protocol Violation|2
1712877|NCT01138007|5977682|P2|Overall Study|Protocol Violation|3
1712878|NCT01138007|5977683|P1|Overall Study|Protocol Violation|2
1712879|NCT01138007|5977681|P3|Overall Study|Lack of Efficacy|6
1712880|NCT01138007|5977682|P2|Overall Study|Lack of Efficacy|0
1712881|NCT01138007|5977683|P1|Overall Study|Lack of Efficacy|2
1712882|NCT01138007|5977681|P3|Overall Study|Adverse Event|9
1712883|NCT01138007|5977682|P2|Overall Study|Adverse Event|12
1712884|NCT01138007|5977683|P1|Overall Study|Adverse Event|4
1712885|NCT01137812|5977790|P2|Overall Study|Other|27
1712886|NCT01137812|5977791|P1|Overall Study|Other|19
1712887|NCT01137812|5977790|P2|Overall Study|Patient met glycemic withdrawal criteria|85
1712888|NCT01137812|5977791|P1|Overall Study|Patient met glycemic withdrawal criteria|40
1712889|NCT01137812|5977790|P2|Overall Study|Death|0
1712890|NCT01137812|5977791|P1|Overall Study|Death|2
1712891|NCT01137812|5977790|P2|Overall Study|Withdrawal by Subject|13
1712892|NCT01137812|5977791|P1|Overall Study|Withdrawal by Subject|5
1712893|NCT01137812|5977790|P2|Overall Study|Protocol Violation|4
1712894|NCT01137812|5977791|P1|Overall Study|Protocol Violation|5
1712895|NCT01137812|5977790|P2|Overall Study|Physician Decision|17
1712896|NCT01137812|5977791|P1|Overall Study|Physician Decision|25
1712897|NCT01137812|5977790|P2|Overall Study|Lost to Follow-up|8
1712898|NCT01137812|5977791|P1|Overall Study|Lost to Follow-up|6
1712899|NCT01137812|5977790|P2|Overall Study|Adverse Event|14
1712900|NCT01137812|5977791|P1|Overall Study|Adverse Event|21
1712901|NCT01137786|5977811|P2|Overall Study|Withdrawal by Subject|1
1712902|NCT01137786|5977812|P1|Overall Study|Withdrawal by Subject|1
1712903|NCT01137786|5977811|P2|Overall Study|Lost to Follow-up|2
1712904|NCT01137786|5977812|P1|Overall Study|Lost to Follow-up|0
1712905|NCT01137773|5977822|P2|Overall Study|Lost to Follow-up|0
1712906|NCT01137773|5977823|P1|Overall Study|Lost to Follow-up|6
1712907|NCT01137773|5977822|P2|Overall Study|Death|3
1712908|NCT01137773|5977823|P1|Overall Study|Death|3
1712909|NCT01137682|5977834|P3|Overall Study|Did not receive treatment in extension|1
1712910|NCT01137682|5977835|P2|Overall Study|Did not receive treatment in extension|0
1712911|NCT01137682|5977836|P1|Overall Study|Did not receive treatment in extension|0
1712912|NCT01137682|5977834|P3|Overall Study|Did not enter extension|2
1712913|NCT01137682|5977835|P2|Overall Study|Did not enter extension|3
1712914|NCT01137682|5977836|P1|Overall Study|Did not enter extension|2
1712915|NCT01137682|5977834|P3|Overall Study|Protocol Violation-Extension|0
1712916|NCT01137682|5977835|P2|Overall Study|Protocol Violation-Extension|1
1712917|NCT01137682|5977836|P1|Overall Study|Protocol Violation-Extension|2
1712918|NCT01137682|5977834|P3|Overall Study|Death-Extension|0
1712919|NCT01137682|5977835|P2|Overall Study|Death-Extension|0
1712920|NCT01137682|5977836|P1|Overall Study|Death-Extension|2
1712921|NCT01137682|5977834|P3|Overall Study|Administrative problems-Extension|0
1712922|NCT01137682|5977835|P2|Overall Study|Administrative problems-Extension|2
1712923|NCT01137682|5977836|P1|Overall Study|Administrative problems-Extension|0
1712924|NCT01137682|5977834|P3|Overall Study|Lost to Follow Up-Extension|0
1712925|NCT01137682|5977835|P2|Overall Study|Lost to Follow Up-Extension|1
1712926|NCT01137682|5977836|P1|Overall Study|Lost to Follow Up-Extension|0
1712927|NCT01137682|5977834|P3|Overall Study|Withdrawal by Subject-Extension|8
1712928|NCT01137682|5977835|P2|Overall Study|Withdrawal by Subject-Extension|8
1712929|NCT01137682|5977836|P1|Overall Study|Withdrawal by Subject-Extension|6
1712930|NCT01137682|5977834|P3|Overall Study|Lack of Efficacy-Extension|13
1712931|NCT01137682|5977835|P2|Overall Study|Lack of Efficacy-Extension|9
1712932|NCT01137682|5977836|P1|Overall Study|Lack of Efficacy-Extension|15
1712933|NCT01137682|5977834|P3|Overall Study|Adverse Event-Extension|7
1712934|NCT01137682|5977835|P2|Overall Study|Adverse Event-Extension|8
1712935|NCT01137682|5977836|P1|Overall Study|Adverse Event-Extension|4
1712936|NCT01137682|5977834|P3|Overall Study|Protocol Violation-CORE|1
1712937|NCT01137682|5977835|P2|Overall Study|Protocol Violation-CORE|1
1712938|NCT01137682|5977836|P1|Overall Study|Protocol Violation-CORE|0
1712939|NCT01137682|5977834|P3|Overall Study|Administrative problems-CORE|0
1712940|NCT01137682|5977835|P2|Overall Study|Administrative problems-CORE|1
1712941|NCT01137682|5977836|P1|Overall Study|Administrative problems-CORE|2
1712942|NCT01137682|5977834|P3|Overall Study|Withdrawal by Subject-CORE|2
1712943|NCT01137682|5977835|P2|Overall Study|Withdrawal by Subject-CORE|2
1712944|NCT01137682|5977836|P1|Overall Study|Withdrawal by Subject-CORE|2
1712945|NCT01137682|5977834|P3|Overall Study|Adverse Event-CORE|0
1712946|NCT01137682|5977835|P2|Overall Study|Adverse Event-CORE|4
1712947|NCT01137682|5977836|P1|Overall Study|Adverse Event-CORE|2
1712948|NCT01137604|5977886|P4|Overall Study|Clinical Decline|1
1712949|NCT01137604|5977887|P3|Overall Study|Clinical Decline|1
1712950|NCT01137604|5977888|P2|Overall Study|Clinical Decline|0
1712951|NCT01137604|5977889|P1|Overall Study|Clinical Decline|0
1712952|NCT01137604|5977886|P4|Overall Study|Participant's Decision|0
1712953|NCT01137604|5977887|P3|Overall Study|Participant's Decision|0
1712954|NCT01137604|5977888|P2|Overall Study|Participant's Decision|0
1712955|NCT01137604|5977889|P1|Overall Study|Participant's Decision|1
1712956|NCT01137604|5977886|P4|Overall Study|Clinical Progression|0
1712957|NCT01137604|5977887|P3|Overall Study|Clinical Progression|1
1712958|NCT01137604|5977888|P2|Overall Study|Clinical Progression|2
1712959|NCT01137604|5977889|P1|Overall Study|Clinical Progression|0
1712960|NCT01137604|5977886|P4|Overall Study|Withdrawal by Subject|1
1712961|NCT01137604|5977887|P3|Overall Study|Withdrawal by Subject|2
1712962|NCT01137604|5977888|P2|Overall Study|Withdrawal by Subject|2
1712963|NCT01137604|5977889|P1|Overall Study|Withdrawal by Subject|0
1712964|NCT01137604|5977886|P4|Overall Study|Adverse Event|9
1712965|NCT01137604|5977887|P3|Overall Study|Adverse Event|9
1712966|NCT01137604|5977888|P2|Overall Study|Adverse Event|6
1712967|NCT01137604|5977889|P1|Overall Study|Adverse Event|1
1712968|NCT01137578|5977923|P3|Overall Study|Other|6
1712969|NCT01137578|5977924|P2|Overall Study|Other|2
1712970|NCT01137578|5977925|P1|Overall Study|Other|12
1712971|NCT01137578|5977923|P3|Overall Study|Withdrawal by Subject|0
1712972|NCT01137578|5977924|P2|Overall Study|Withdrawal by Subject|0
1712973|NCT01137578|5977925|P1|Overall Study|Withdrawal by Subject|1
1712974|NCT01137578|5977923|P3|Overall Study|Participant requested to Discontinue|0
1712975|NCT01137578|5977924|P2|Overall Study|Participant requested to Discontinue|0
1712976|NCT01137578|5977925|P1|Overall Study|Participant requested to Discontinue|3
1712977|NCT01137474|5977974|P4|Overall Study|Administrative reason by sponsor|0
1712978|NCT01137474|5977975|P3|Overall Study|Administrative reason by sponsor|0
1712979|NCT01137474|5977976|P2|Overall Study|Administrative reason by sponsor|1
1712980|NCT01137474|5977977|P1|Overall Study|Administrative reason by sponsor|0
1712981|NCT01137474|5977974|P4|Overall Study|Pregnancy|0
1712982|NCT01137474|5977975|P3|Overall Study|Pregnancy|0
1712983|NCT01137474|5977976|P2|Overall Study|Pregnancy|1
1712984|NCT01137474|5977977|P1|Overall Study|Pregnancy|0
1712985|NCT01137474|5977974|P4|Overall Study|Other|0
1712986|NCT01137474|5977975|P3|Overall Study|Other|0
1712987|NCT01137474|5977976|P2|Overall Study|Other|1
1712988|NCT01137474|5977977|P1|Overall Study|Other|3
1712989|NCT01137474|5977974|P4|Overall Study|Lack of Efficacy|2
1712990|NCT01137474|5977975|P3|Overall Study|Lack of Efficacy|0
1712991|NCT01137474|5977976|P2|Overall Study|Lack of Efficacy|0
1712992|NCT01137474|5977977|P1|Overall Study|Lack of Efficacy|0
1712993|NCT01137474|5977974|P4|Overall Study|Lost to Follow-up|2
1712994|NCT01137474|5977975|P3|Overall Study|Lost to Follow-up|0
1712995|NCT01137474|5977976|P2|Overall Study|Lost to Follow-up|1
1712996|NCT01137474|5977977|P1|Overall Study|Lost to Follow-up|5
1712997|NCT01137474|5977974|P4|Overall Study|No longer met study criteria|5
1712998|NCT01137474|5977975|P3|Overall Study|No longer met study criteria|0
1712999|NCT01137474|5977976|P2|Overall Study|No longer met study criteria|1
1713000|NCT01137474|5977977|P1|Overall Study|No longer met study criteria|6
1713001|NCT01137474|5977974|P4|Overall Study|Withdrawal by Subject|9
1713002|NCT01137474|5977975|P3|Overall Study|Withdrawal by Subject|6
1713003|NCT01137474|5977976|P2|Overall Study|Withdrawal by Subject|2
1713004|NCT01137474|5977977|P1|Overall Study|Withdrawal by Subject|7
1713005|NCT01137474|5977974|P4|Overall Study|Adverse Event|3
1713006|NCT01137474|5977975|P3|Overall Study|Adverse Event|1
1713007|NCT01137474|5977976|P2|Overall Study|Adverse Event|5
1713008|NCT01137474|5977977|P1|Overall Study|Adverse Event|3
1713009|NCT01137435|5977995|P1|Overall Study|Off label usage|4
1713010|NCT01137435|5977995|P1|Overall Study|Lost to Follow-up|24
1713011|NCT01137292|5978022|P1|Overall Study|Other|7
1713012|NCT01137292|5978022|P1|Overall Study|Lost to Follow-up|1
1713013|NCT01137292|5978022|P1|Overall Study|Lack of Efficacy|13
1713014|NCT01137292|5978022|P1|Overall Study|Adverse Event|3
1713015|NCT01137292|5978022|P1|Overall Study|Death|30
1713016|NCT01137110|5978031|P2|Overall Study|Protocol Violation|0
1713017|NCT01137110|5978032|P1|Overall Study|Protocol Violation|1
1713018|NCT01137071|5978038|P1|Overall Study|Wrongly Included|1
1713019|NCT01137071|5978038|P1|Overall Study|Withdrawal by Subject|2
1713020|NCT01137071|5978038|P1|Overall Study|Disease Progression|11
1713021|NCT01136967|5978194|P2|Overall Study|Diagnosis of Second Primary Cancer|1
1713022|NCT01136967|5978195|P1|Overall Study|Diagnosis of Second Primary Cancer|0
1713023|NCT01136967|5978194|P2|Overall Study|Increase in Lesion Size|2
1713024|NCT01136967|5978195|P1|Overall Study|Increase in Lesion Size|0
1713025|NCT01136967|5978194|P2|Overall Study|Investigator's Choice|1
1713026|NCT01136967|5978195|P1|Overall Study|Investigator's Choice|1
1713027|NCT01136967|5978194|P2|Overall Study|Non-compliance|0
1713028|NCT01136967|5978195|P1|Overall Study|Non-compliance|1
1713029|NCT01136967|5978194|P2|Overall Study|Radiation|0
1713030|NCT01136967|5978195|P1|Overall Study|Radiation|1
1713031|NCT01136967|5978194|P2|Overall Study|Clinical Progression|5
1713032|NCT01136967|5978195|P1|Overall Study|Clinical Progression|3
1713033|NCT01136967|5978194|P2|Overall Study|Withdrawal by Subject|2
1713034|NCT01136967|5978195|P1|Overall Study|Withdrawal by Subject|1
1713035|NCT01136967|5978194|P2|Overall Study|Lost to Follow-up|1
1713036|NCT01136967|5978195|P1|Overall Study|Lost to Follow-up|0
1713037|NCT01136967|5978194|P2|Overall Study|Participant Choice|3
1713038|NCT01136967|5978195|P1|Overall Study|Participant Choice|8
1713039|NCT01136967|5978194|P2|Overall Study|Adverse Event|12
1713040|NCT01136967|5978195|P1|Overall Study|Adverse Event|9
1713041|NCT01136954|5978217|P2|Overall Study|Other|3
1713042|NCT01136954|5978218|P1|Overall Study|Other|1
1713043|NCT01136954|5978217|P2|Overall Study|Physician Decision|1
1713044|NCT01136954|5978218|P1|Overall Study|Physician Decision|0
1713045|NCT01136954|5978217|P2|Overall Study|Lack of Efficacy|13
1713046|NCT01136954|5978218|P1|Overall Study|Lack of Efficacy|14
1713047|NCT01136954|5978217|P2|Overall Study|Withdrawal by Subject|2
1713048|NCT01136954|5978218|P1|Overall Study|Withdrawal by Subject|6
1713049|NCT01136954|5978217|P2|Overall Study|Adverse Event|2
1713050|NCT01136954|5978218|P1|Overall Study|Adverse Event|3
1713051|NCT01136915|5978232|P2|Overall Study|Exclusion criterion met|1
1713052|NCT01136915|5978233|P1|Overall Study|Exclusion criterion met|0
1713053|NCT01136915|5978232|P2|Overall Study|Lost to Follow-up|0
1713054|NCT01136915|5978233|P1|Overall Study|Lost to Follow-up|2
1713055|NCT01136876|5978243|P2|Overall Study|Physician Decision|5
1713056|NCT01136876|5978244|P1|Overall Study|Physician Decision|3
1713057|NCT01136876|5978243|P2|Overall Study|Lost to Follow-up|1
1713058|NCT01136876|5978244|P1|Overall Study|Lost to Follow-up|0
1713059|NCT01136785|5978273|P2|Overall Study|Protocol Violation|1
1713060|NCT01136785|5978274|P1|Overall Study|Protocol Violation|2
1713061|NCT01136772|5978289|P2|Overall Study|Did not follow up after first injection|2
1713062|NCT01136772|5978290|P1|Overall Study|Did not follow up after first injection|2
1713063|NCT01136772|5978289|P2|Overall Study|Did not receive injection|7
1713064|NCT01136772|5978290|P1|Overall Study|Did not receive injection|10
1713065|NCT01136772|5978289|P2|Overall Study|Withdrawal by Subject|36
1713066|NCT01136772|5978290|P1|Overall Study|Withdrawal by Subject|33
1713067|NCT01136772|5978289|P2|Overall Study|Administrative|12
1713068|NCT01136772|5978290|P1|Overall Study|Administrative|14
1713069|NCT01136772|5978289|P2|Overall Study|Lack of Efficacy|39
1713070|NCT01136772|5978290|P1|Overall Study|Lack of Efficacy|42
1713071|NCT01136772|5978289|P2|Overall Study|Adverse Event|14
1713072|NCT01136772|5978290|P1|Overall Study|Adverse Event|15
1713073|NCT01136746|5978300|P2|Overall Study|Death|0
1713074|NCT01136746|5978301|P1|Overall Study|Death|1
1713075|NCT01136746|5978300|P2|Overall Study|Protocol Violation|1
1713076|NCT01136746|5978301|P1|Overall Study|Protocol Violation|2
1713077|NCT01136746|5978300|P2|Overall Study|Lost to Follow-up|2
1713078|NCT01136746|5978301|P1|Overall Study|Lost to Follow-up|0
1713079|NCT01136733|5978368|P7|Phase 2|Other|6
1713080|NCT01136733|5978369|P6|Phase 2|Other|7
1713081|NCT01136733|5978370|P5|Phase 2|Other|6
1713082|NCT01136733|5978371|P4|Phase 2|Other|0
1713083|NCT01136733|5978372|P3|Phase 2|Other|0
1713084|NCT01136733|5978373|P2|Phase 2|Other|0
1713085|NCT01136733|5978374|P1|Phase 2|Other|0
1713086|NCT01136733|5978368|P7|Phase 2|Administrative-Withdrew Consent|0
1713087|NCT01136733|5978369|P6|Phase 2|Administrative-Withdrew Consent|0
1713088|NCT01136733|5978370|P5|Phase 2|Administrative-Withdrew Consent|1
1713089|NCT01136733|5978371|P4|Phase 2|Administrative-Withdrew Consent|0
1713090|NCT01136733|5978372|P3|Phase 2|Administrative-Withdrew Consent|0
1713091|NCT01136733|5978373|P2|Phase 2|Administrative-Withdrew Consent|0
1713092|NCT01136733|5978374|P1|Phase 2|Administrative-Withdrew Consent|0
1713093|NCT01136733|5978368|P7|Phase 2|Participant Choice|1
1713094|NCT01136733|5978369|P6|Phase 2|Participant Choice|0
1713095|NCT01136733|5978370|P5|Phase 2|Participant Choice|3
1713096|NCT01136733|5978371|P4|Phase 2|Participant Choice|0
1713097|NCT01136733|5978372|P3|Phase 2|Participant Choice|0
1713098|NCT01136733|5978373|P2|Phase 2|Participant Choice|0
1713099|NCT01136733|5978374|P1|Phase 2|Participant Choice|0
1713100|NCT01136733|5978368|P7|Phase 2|Adverse Event|5
1713101|NCT01136733|5978369|P6|Phase 2|Adverse Event|13
1713102|NCT01136733|5978370|P5|Phase 2|Adverse Event|11
1713103|NCT01136733|5978371|P4|Phase 2|Adverse Event|0
1713104|NCT01136733|5978372|P3|Phase 2|Adverse Event|0
1713105|NCT01136733|5978373|P2|Phase 2|Adverse Event|0
1713106|NCT01136733|5978374|P1|Phase 2|Adverse Event|0
1713107|NCT01136733|5978368|P7|Phase 2|Disease Progression|38
1713108|NCT01136733|5978369|P6|Phase 2|Disease Progression|32
1713109|NCT01136733|5978370|P5|Phase 2|Disease Progression|30
1713110|NCT01136733|5978371|P4|Phase 2|Disease Progression|0
1713111|NCT01136733|5978372|P3|Phase 2|Disease Progression|0
1713112|NCT01136733|5978373|P2|Phase 2|Disease Progression|0
1713113|NCT01136733|5978374|P1|Phase 2|Disease Progression|0
1713114|NCT01136733|5978368|P7|Phase 1b|Clinical Progression|0
1713115|NCT01136733|5978369|P6|Phase 1b|Clinical Progression|0
1713116|NCT01136733|5978370|P5|Phase 1b|Clinical Progression|0
1713117|NCT01136733|5978371|P4|Phase 1b|Clinical Progression|0
1713118|NCT01136733|5978372|P3|Phase 1b|Clinical Progression|0
1713119|NCT01136733|5978373|P2|Phase 1b|Clinical Progression|1
1713120|NCT01136733|5978374|P1|Phase 1b|Clinical Progression|1
1713121|NCT01136733|5978368|P7|Phase 1b|Administrative-Withdrew Consent|0
1713122|NCT01136733|5978369|P6|Phase 1b|Administrative-Withdrew Consent|0
1713123|NCT01136733|5978370|P5|Phase 1b|Administrative-Withdrew Consent|0
1713124|NCT01136733|5978371|P4|Phase 1b|Administrative-Withdrew Consent|0
1713125|NCT01136733|5978372|P3|Phase 1b|Administrative-Withdrew Consent|0
1713126|NCT01136733|5978373|P2|Phase 1b|Administrative-Withdrew Consent|1
1713127|NCT01136733|5978374|P1|Phase 1b|Administrative-Withdrew Consent|0
1713128|NCT01136733|5978368|P7|Phase 1b|Participant Choice|0
1713129|NCT01136733|5978369|P6|Phase 1b|Participant Choice|0
1713130|NCT01136733|5978370|P5|Phase 1b|Participant Choice|0
1713131|NCT01136733|5978371|P4|Phase 1b|Participant Choice|0
1713132|NCT01136733|5978372|P3|Phase 1b|Participant Choice|1
1713133|NCT01136733|5978373|P2|Phase 1b|Participant Choice|0
1713134|NCT01136733|5978374|P1|Phase 1b|Participant Choice|0
1713135|NCT01136733|5978368|P7|Phase 1b|Adverse Event|0
1713136|NCT01136733|5978369|P6|Phase 1b|Adverse Event|0
1713137|NCT01136733|5978370|P5|Phase 1b|Adverse Event|0
1713138|NCT01136733|5978371|P4|Phase 1b|Adverse Event|0
1713139|NCT01136733|5978372|P3|Phase 1b|Adverse Event|1
1713140|NCT01136733|5978373|P2|Phase 1b|Adverse Event|3
1713141|NCT01136733|5978374|P1|Phase 1b|Adverse Event|0
1713142|NCT01136655|5978457|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
1713143|NCT01136655|5978457|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
1713144|NCT01136655|5978457|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
1713145|NCT01136655|5978457|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
1713146|NCT01136408|5978490|P3|Overall Study|Protocol Violation|1
1713147|NCT01136408|5978491|P2|Overall Study|Protocol Violation|1
1713148|NCT01136408|5978492|P1|Overall Study|Protocol Violation|1
1713149|NCT01136408|5978490|P3|Overall Study|Adverse Event|4
1713150|NCT01136408|5978491|P2|Overall Study|Adverse Event|8
1713151|NCT01136408|5978492|P1|Overall Study|Adverse Event|4
1713152|NCT01136382|5978549|P2|Overall Study|Withdrawal by Subject|1
1713153|NCT01136382|5978550|P1|Overall Study|Withdrawal by Subject|4
1713154|NCT01136382|5978549|P2|Overall Study|Severe Non-Compliance to Protocol|2
1713155|NCT01136382|5978550|P1|Overall Study|Severe Non-Compliance to Protocol|0
1713156|NCT01136382|5978549|P2|Overall Study|Study-Specific Withdrawal Criteria|25
1713157|NCT01136382|5978550|P1|Overall Study|Study-Specific Withdrawal Criteria|48
1713158|NCT01136382|5978549|P2|Overall Study|Other|3
1713159|NCT01136382|5978550|P1|Overall Study|Other|8
1713160|NCT01136356|5978576|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
1713161|NCT01136356|5978577|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
1713162|NCT01136356|5978576|P2|First 18-day Withdrawal|Physician Decision|0
1713163|NCT01136356|5978577|P1|First 18-day Withdrawal|Physician Decision|1
1713164|NCT01136356|5978576|P2|First 18-day Withdrawal|Withdrawal by Subject|0
1713165|NCT01136356|5978577|P1|First 18-day Withdrawal|Withdrawal by Subject|3
1713166|NCT01136291|5978588|P2|Overall Study|Lost to Follow-up|1
1713167|NCT01136291|5978589|P1|Overall Study|Lost to Follow-up|1
1713168|NCT01136174|5978608|P4|Overall Study|Adverse Event|4
1713169|NCT01136174|5978609|P3|Overall Study|Adverse Event|0
1713170|NCT01136174|5978610|P2|Overall Study|Adverse Event|0
1713171|NCT01136174|5978611|P1|Overall Study|Adverse Event|0
1713172|NCT01135992|5978691|P1|Overall Study|Unclassified|7
1713173|NCT01135992|5978691|P1|Overall Study|Withdrawal criteria|10
1713174|NCT01135992|5978691|P1|Overall Study|Protocol Violation|2
1713175|NCT01135992|5978691|P1|Overall Study|Lack of Efficacy|1
1713176|NCT01135992|5978691|P1|Overall Study|Adverse Event|1
1713177|NCT01135914|5978703|P3|Overall Study|Adverse Event|2
1713178|NCT01135914|5978704|P2|Overall Study|Adverse Event|1
1713179|NCT01135914|5978705|P1|Overall Study|Adverse Event|0
1713180|NCT01135914|5978703|P3|Overall Study|Lack of Efficacy|10
1713181|NCT01135914|5978704|P2|Overall Study|Lack of Efficacy|1
1713182|NCT01135914|5978705|P1|Overall Study|Lack of Efficacy|2
1713183|NCT01135914|5978703|P3|Overall Study|Protocol Violation|3
1713184|NCT01135914|5978704|P2|Overall Study|Protocol Violation|0
1713185|NCT01135914|5978705|P1|Overall Study|Protocol Violation|0
1713186|NCT01135914|5978703|P3|Overall Study|Lost to Follow-up|1
1713187|NCT01135914|5978704|P2|Overall Study|Lost to Follow-up|0
1713188|NCT01135914|5978705|P1|Overall Study|Lost to Follow-up|1
1713189|NCT01135914|5978703|P3|Overall Study|Withdrawal by Subject|6
1713190|NCT01135914|5978704|P2|Overall Study|Withdrawal by Subject|3
1713191|NCT01135914|5978705|P1|Overall Study|Withdrawal by Subject|1
1713192|NCT01135524|5978738|P1|Overall Study|Lack of Efficacy|8
1713193|NCT01135524|5978738|P1|Overall Study|Administrative|151
1713194|NCT01135524|5978738|P1|Overall Study|Lost to Follow-up|3
1713195|NCT01135524|5978738|P1|Overall Study|Adverse Event|20
1713196|NCT01135524|5978738|P1|Overall Study|Withdrawal by Subject|14
1713197|NCT01135511|5978751|P9|Overall Study|Withdrawal by Subject|1
1713198|NCT01135511|5978752|P8|Overall Study|Withdrawal by Subject|0
1713199|NCT01135511|5978753|P7|Overall Study|Withdrawal by Subject|1
1713200|NCT01135511|5978754|P6|Overall Study|Withdrawal by Subject|0
1713201|NCT01135511|5978755|P5|Overall Study|Withdrawal by Subject|0
1713202|NCT01135511|5978756|P4|Overall Study|Withdrawal by Subject|0
1713203|NCT01135511|5978757|P3|Overall Study|Withdrawal by Subject|0
1713204|NCT01135511|5978758|P2|Overall Study|Withdrawal by Subject|0
1713205|NCT01135511|5978759|P1|Overall Study|Withdrawal by Subject|0
1713206|NCT01135511|5978751|P9|Overall Study|noncompliance with study drug taken|0
1713207|NCT01135511|5978752|P8|Overall Study|noncompliance with study drug taken|0
1713208|NCT01135511|5978753|P7|Overall Study|noncompliance with study drug taken|0
1713209|NCT01135511|5978754|P6|Overall Study|noncompliance with study drug taken|0
1713210|NCT01135511|5978755|P5|Overall Study|noncompliance with study drug taken|1
1713211|NCT01135511|5978756|P4|Overall Study|noncompliance with study drug taken|0
1713212|NCT01135511|5978757|P3|Overall Study|noncompliance with study drug taken|0
1713213|NCT01135511|5978758|P2|Overall Study|noncompliance with study drug taken|0
1713214|NCT01135511|5978759|P1|Overall Study|noncompliance with study drug taken|0
1713215|NCT01135511|5978751|P9|Overall Study|could not visit the clinic|0
1713216|NCT01135511|5978752|P8|Overall Study|could not visit the clinic|0
1713217|NCT01135511|5978753|P7|Overall Study|could not visit the clinic|0
1713218|NCT01135511|5978754|P6|Overall Study|could not visit the clinic|0
1713219|NCT01135511|5978755|P5|Overall Study|could not visit the clinic|0
1713220|NCT01135511|5978756|P4|Overall Study|could not visit the clinic|0
1713221|NCT01135511|5978757|P3|Overall Study|could not visit the clinic|2
1713222|NCT01135511|5978758|P2|Overall Study|could not visit the clinic|1
1713223|NCT01135511|5978759|P1|Overall Study|could not visit the clinic|0
1713224|NCT01135511|5978751|P9|Overall Study|Pregnancy|0
1713225|NCT01135511|5978752|P8|Overall Study|Pregnancy|0
1713226|NCT01135511|5978753|P7|Overall Study|Pregnancy|0
1713227|NCT01135511|5978754|P6|Overall Study|Pregnancy|0
1713228|NCT01135511|5978755|P5|Overall Study|Pregnancy|0
1713229|NCT01135511|5978756|P4|Overall Study|Pregnancy|1
1713230|NCT01135511|5978757|P3|Overall Study|Pregnancy|0
1713231|NCT01135511|5978758|P2|Overall Study|Pregnancy|0
1713232|NCT01135511|5978759|P1|Overall Study|Pregnancy|0
1713233|NCT01135511|5978751|P9|Overall Study|Protocol Violation|0
1713234|NCT01135511|5978752|P8|Overall Study|Protocol Violation|0
1713235|NCT01135511|5978753|P7|Overall Study|Protocol Violation|0
1713236|NCT01135511|5978754|P6|Overall Study|Protocol Violation|0
1713237|NCT01135511|5978755|P5|Overall Study|Protocol Violation|0
1713238|NCT01135511|5978756|P4|Overall Study|Protocol Violation|0
1713239|NCT01135511|5978757|P3|Overall Study|Protocol Violation|3
1713240|NCT01135511|5978758|P2|Overall Study|Protocol Violation|0
1713241|NCT01135511|5978759|P1|Overall Study|Protocol Violation|0
1713242|NCT01135511|5978751|P9|Overall Study|Lack of Efficacy|0
1713243|NCT01135511|5978752|P8|Overall Study|Lack of Efficacy|0
1713244|NCT01135511|5978753|P7|Overall Study|Lack of Efficacy|0
1713245|NCT01135511|5978754|P6|Overall Study|Lack of Efficacy|0
1713246|NCT01135511|5978755|P5|Overall Study|Lack of Efficacy|0
1713247|NCT01135511|5978756|P4|Overall Study|Lack of Efficacy|2
1713248|NCT01135511|5978757|P3|Overall Study|Lack of Efficacy|1
1713249|NCT01135511|5978758|P2|Overall Study|Lack of Efficacy|1
1713250|NCT01135511|5978759|P1|Overall Study|Lack of Efficacy|0
1713251|NCT01135511|5978751|P9|Overall Study|Adverse Event|0
1713252|NCT01135511|5978752|P8|Overall Study|Adverse Event|1
1713253|NCT01135511|5978753|P7|Overall Study|Adverse Event|0
1713254|NCT01135511|5978754|P6|Overall Study|Adverse Event|1
1713255|NCT01135511|5978755|P5|Overall Study|Adverse Event|0
1713256|NCT01135511|5978756|P4|Overall Study|Adverse Event|0
1713257|NCT01135511|5978757|P3|Overall Study|Adverse Event|2
1713258|NCT01135511|5978758|P2|Overall Study|Adverse Event|1
1713259|NCT01135511|5978759|P1|Overall Study|Adverse Event|0
1713260|NCT01135498|5979041|P1|Overall Study|Ongoing at time of analysis|2
1713261|NCT01135498|5979041|P1|Overall Study|Death|1
1713262|NCT01135498|5979041|P1|Overall Study|Withdrawal by Subject|4
1713263|NCT01135498|5979041|P1|Overall Study|Investigator judgement|25
1713264|NCT01135498|5979041|P1|Overall Study|Progressive disease|38
1713265|NCT01135498|5979041|P1|Overall Study|Adverse Event|20
1713266|NCT01135134|5979220|P2|Overall Study|Did not meet protocol eligibility|0
1713267|NCT01135134|5979221|P1|Overall Study|Did not meet protocol eligibility|1
1713268|NCT01135134|5979220|P2|Overall Study|Adverse Event|1
1713269|NCT01135134|5979221|P1|Overall Study|Adverse Event|1
1713270|NCT01135017|5979244|P2|Overall Study|Other than above|4
1713271|NCT01135017|5979245|P1|Overall Study|Other than above|3
1713272|NCT01135017|5979244|P2|Overall Study|Adverse Event|8
1713273|NCT01135017|5979245|P1|Overall Study|Adverse Event|3
1713274|NCT01134939|5979283|P8|Overall Study|Termination page not available|0
1713275|NCT01134939|5979284|P7|Overall Study|Termination page not available|7
1713276|NCT01134939|5979285|P6|Overall Study|Termination page not available|3
1713277|NCT01134939|5979286|P5|Overall Study|Termination page not available|0
1713278|NCT01134939|5979287|P4|Overall Study|Termination page not available|8
1713279|NCT01134939|5979288|P3|Overall Study|Termination page not available|5
1713280|NCT01134939|5979289|P2|Overall Study|Termination page not available|6
1713281|NCT01134939|5979290|P1|Overall Study|Termination page not available|4
1713282|NCT01134939|5979283|P8|Overall Study|Death|0
1713283|NCT01134939|5979284|P7|Overall Study|Death|0
1713284|NCT01134939|5979285|P6|Overall Study|Death|0
1713285|NCT01134939|5979286|P5|Overall Study|Death|0
1713286|NCT01134939|5979287|P4|Overall Study|Death|0
1713287|NCT01134939|5979288|P3|Overall Study|Death|0
1713288|NCT01134939|5979289|P2|Overall Study|Death|1
1713289|NCT01134939|5979290|P1|Overall Study|Death|0
1713290|NCT01134939|5979283|P8|Overall Study|Lost to Follow-up|0
1713291|NCT01134939|5979284|P7|Overall Study|Lost to Follow-up|0
1713292|NCT01134939|5979285|P6|Overall Study|Lost to Follow-up|1
1713293|NCT01134939|5979286|P5|Overall Study|Lost to Follow-up|2
1713294|NCT01134939|5979287|P4|Overall Study|Lost to Follow-up|1
1713295|NCT01134939|5979288|P3|Overall Study|Lost to Follow-up|0
1713296|NCT01134939|5979289|P2|Overall Study|Lost to Follow-up|3
1713297|NCT01134939|5979290|P1|Overall Study|Lost to Follow-up|2
1713298|NCT01134939|5979283|P8|Overall Study|Lack of Efficacy|0
1713299|NCT01134939|5979284|P7|Overall Study|Lack of Efficacy|1
1713300|NCT01134939|5979285|P6|Overall Study|Lack of Efficacy|0
1713301|NCT01134939|5979286|P5|Overall Study|Lack of Efficacy|3
1713302|NCT01134939|5979287|P4|Overall Study|Lack of Efficacy|0
1713303|NCT01134939|5979288|P3|Overall Study|Lack of Efficacy|1
1713304|NCT01134939|5979289|P2|Overall Study|Lack of Efficacy|5
1713305|NCT01134939|5979290|P1|Overall Study|Lack of Efficacy|2
1713306|NCT01134939|5979283|P8|Overall Study|Adverse Event|0
1713307|NCT01134939|5979284|P7|Overall Study|Adverse Event|1
1713308|NCT01134939|5979285|P6|Overall Study|Adverse Event|5
1713309|NCT01134939|5979286|P5|Overall Study|Adverse Event|5
1713310|NCT01134939|5979287|P4|Overall Study|Adverse Event|5
1713311|NCT01134939|5979288|P3|Overall Study|Adverse Event|4
1713312|NCT01134939|5979289|P2|Overall Study|Adverse Event|3
1713313|NCT01134939|5979290|P1|Overall Study|Adverse Event|9
1713314|NCT01134783|5979428|P2|Overall Study|Lost to Follow-up|20
1713315|NCT01134783|5979429|P1|Overall Study|Lost to Follow-up|5
1713316|NCT01134783|5979428|P2|Overall Study|Withdrawal by Subject|9
1713317|NCT01134783|5979429|P1|Overall Study|Withdrawal by Subject|15
1713318|NCT01134783|5979428|P2|Overall Study|Pregnancy|8
1713319|NCT01134783|5979429|P1|Overall Study|Pregnancy|16
1713320|NCT01134731|5979448|P3|Overall Study|Lost to Follow-up|3
1713321|NCT01134731|5979449|P2|Overall Study|Lost to Follow-up|4
1713322|NCT01134731|5979450|P1|Overall Study|Lost to Follow-up|5
1713323|NCT01134731|5979448|P3|Overall Study|Withdrawal by Subject|1
1713324|NCT01134731|5979449|P2|Overall Study|Withdrawal by Subject|3
1713325|NCT01134731|5979450|P1|Overall Study|Withdrawal by Subject|3
1713326|NCT01134731|5979448|P3|Overall Study|Lack of Efficacy|1
1713327|NCT01134731|5979449|P2|Overall Study|Lack of Efficacy|0
1713328|NCT01134731|5979450|P1|Overall Study|Lack of Efficacy|0
1713329|NCT01134731|5979448|P3|Overall Study|Physician Decision|2
1713330|NCT01134731|5979449|P2|Overall Study|Physician Decision|2
1713331|NCT01134731|5979450|P1|Overall Study|Physician Decision|2
1713332|NCT01134731|5979448|P3|Overall Study|Adverse Event|1
1713333|NCT01134731|5979449|P2|Overall Study|Adverse Event|2
1713334|NCT01134731|5979450|P1|Overall Study|Adverse Event|3
1713335|NCT01134705|5979463|P2|Overall Study|Other|6
1713336|NCT01134705|5979464|P1|Overall Study|Other|1
1713337|NCT01134705|5979463|P2|Overall Study|Protocol Violation|1
1713338|NCT01134705|5979464|P1|Overall Study|Protocol Violation|1
1713339|NCT01134705|5979463|P2|Overall Study|Lost to Follow-up|2
1713340|NCT01134705|5979464|P1|Overall Study|Lost to Follow-up|5
1713341|NCT01134705|5979463|P2|Overall Study|Pregnancy|0
1713342|NCT01134705|5979464|P1|Overall Study|Pregnancy|1
1713343|NCT01134705|5979463|P2|Overall Study|Withdrawal by Subject|6
1713344|NCT01134705|5979464|P1|Overall Study|Withdrawal by Subject|6
1713345|NCT01134705|5979463|P2|Overall Study|Adverse Event|7
1713346|NCT01134705|5979464|P1|Overall Study|Adverse Event|1
1713347|NCT01134627|5979476|P2|Overall Study|Other|14
1713348|NCT01134627|5979477|P1|Overall Study|Other|11
1713349|NCT01134627|5979476|P2|Overall Study|Planning to become pregnant/pregnancy|0
1713350|NCT01134627|5979477|P1|Overall Study|Planning to become pregnant/pregnancy|1
1713351|NCT01134627|5979476|P2|Overall Study|Withdrawal by Subject|3
1713352|NCT01134627|5979477|P1|Overall Study|Withdrawal by Subject|4
1713353|NCT01134627|5979476|P2|Overall Study|Lack of Efficacy|12
1713354|NCT01134627|5979477|P1|Overall Study|Lack of Efficacy|2
1713355|NCT01134627|5979476|P2|Overall Study|Protocol Violation|5
1713356|NCT01134627|5979477|P1|Overall Study|Protocol Violation|3
1713357|NCT01134627|5979476|P2|Overall Study|Lost to Follow-up|2
1713358|NCT01134627|5979477|P1|Overall Study|Lost to Follow-up|1
1713359|NCT01134627|5979476|P2|Overall Study|Adverse Event|31
1713360|NCT01134627|5979477|P1|Overall Study|Adverse Event|47
1713361|NCT01134614|5979507|P2|Overall Study|Patient in hospice care|1
1713362|NCT01134614|5979508|P1|Overall Study|Patient in hospice care|0
1713363|NCT01134614|5979507|P2|Overall Study|Symptomatic deterioration|1
1713364|NCT01134614|5979508|P1|Overall Study|Symptomatic deterioration|0
1713365|NCT01134614|5979507|P2|Overall Study|Pt received tx not allowed on study|1
1713366|NCT01134614|5979508|P1|Overall Study|Pt received tx not allowed on study|0
1713367|NCT01134614|5979507|P2|Overall Study|Never started treatment|1
1713368|NCT01134614|5979508|P1|Overall Study|Never started treatment|4
1713369|NCT01134614|5979507|P2|Overall Study|Physician's decision|1
1713370|NCT01134614|5979508|P1|Overall Study|Physician's decision|0
1713371|NCT01134614|5979507|P2|Overall Study|Complicating disease|1
1713372|NCT01134614|5979508|P1|Overall Study|Complicating disease|2
1713373|NCT01134614|5979507|P2|Overall Study|Alternative therapy|0
1713374|NCT01134614|5979508|P1|Overall Study|Alternative therapy|2
1713375|NCT01134614|5979507|P2|Overall Study|Withdrawal by Subject|2
1713376|NCT01134614|5979508|P1|Overall Study|Withdrawal by Subject|3
1713377|NCT01134614|5979507|P2|Overall Study|Death|8
1713378|NCT01134614|5979508|P1|Overall Study|Death|5
1713379|NCT01134614|5979507|P2|Overall Study|Adverse Event|39
1713380|NCT01134614|5979508|P1|Overall Study|Adverse Event|26
1713381|NCT01134614|5979507|P2|Overall Study|Progressive disease|54
1713382|NCT01134614|5979508|P1|Overall Study|Progressive disease|60
1713383|NCT01134614|5979507|P2|Overall Study|Still on treatment as of March 2013|13
1713384|NCT01134614|5979508|P1|Overall Study|Still on treatment as of March 2013|21
1713385|NCT01134562|5979536|P5|Overall Study|Adverse Event|0
1713386|NCT01134562|5979537|P4|Overall Study|Adverse Event|0
1713387|NCT01134562|5979538|P3|Overall Study|Adverse Event|0
1713388|NCT01134562|5979539|P2|Overall Study|Adverse Event|1
1713389|NCT01134562|5979540|P1|Overall Study|Adverse Event|0
1713390|NCT01134393|5979712|P1|Overall Study|Other|6
1713391|NCT01134393|5979712|P1|Overall Study|Withdrawal by Subject|11
1713392|NCT01134393|5979712|P1|Overall Study|Lost to Follow-up|3
1713393|NCT01134393|5979712|P1|Overall Study|Protocol Violation|12
1713394|NCT01134393|5979712|P1|Overall Study|Lack of Efficacy|2
1713395|NCT01134393|5979712|P1|Overall Study|Adverse Event|18
1713396|NCT01134315|5979833|P2|Overall Study|Other Reason|17
1713397|NCT01134315|5979834|P1|Overall Study|Other Reason|8
1713398|NCT01134315|5979833|P2|Overall Study|Adverse Event|2
1713399|NCT01134315|5979834|P1|Overall Study|Adverse Event|1
1713400|NCT01134263|5979872|P5|Overall Study|Enrolled, but not treated|0
1713401|NCT01134263|5979873|P4|Overall Study|Enrolled, but not treated|1
1713402|NCT01134263|5979874|P3|Overall Study|Enrolled, but not treated|0
1713403|NCT01134263|5979875|P2|Overall Study|Enrolled, but not treated|1
1713404|NCT01134263|5979876|P1|Overall Study|Enrolled, but not treated|1
1713405|NCT01134263|5979872|P5|Overall Study|Withdrawal by Subject|5
1713406|NCT01134263|5979873|P4|Overall Study|Withdrawal by Subject|7
1713407|NCT01134263|5979874|P3|Overall Study|Withdrawal by Subject|16
1713408|NCT01134263|5979875|P2|Overall Study|Withdrawal by Subject|6
1713409|NCT01134263|5979876|P1|Overall Study|Withdrawal by Subject|8
1713410|NCT01134263|5979872|P5|Overall Study|Lost to Follow-up|1
1713411|NCT01134263|5979873|P4|Overall Study|Lost to Follow-up|3
1713412|NCT01134263|5979874|P3|Overall Study|Lost to Follow-up|5
1713413|NCT01134263|5979875|P2|Overall Study|Lost to Follow-up|3
1713414|NCT01134263|5979876|P1|Overall Study|Lost to Follow-up|4
1713415|NCT01134263|5979872|P5|Overall Study|Protocol Violation|2
1713416|NCT01134263|5979873|P4|Overall Study|Protocol Violation|4
1713417|NCT01134263|5979874|P3|Overall Study|Protocol Violation|2
1713418|NCT01134263|5979875|P2|Overall Study|Protocol Violation|7
1713419|NCT01134263|5979876|P1|Overall Study|Protocol Violation|8
1713420|NCT01134263|5979872|P5|Overall Study|Other adverse event|0
1713421|NCT01134263|5979873|P4|Overall Study|Other adverse event|3
1713422|NCT01134263|5979874|P3|Overall Study|Other adverse event|5
1713423|NCT01134263|5979875|P2|Overall Study|Other adverse event|2
1713424|NCT01134263|5979876|P1|Overall Study|Other adverse event|1
1713425|NCT01134263|5979872|P5|Overall Study|Serious adverse event|1
1713426|NCT01134263|5979873|P4|Overall Study|Serious adverse event|1
1713427|NCT01134263|5979874|P3|Overall Study|Serious adverse event|1
1713428|NCT01134263|5979875|P2|Overall Study|Serious adverse event|1
1713429|NCT01134263|5979876|P1|Overall Study|Serious adverse event|2
1713430|NCT01134107|5979909|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
1713431|NCT01134107|5979910|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
1713432|NCT01134107|5979909|P2|Period 2-Second Treatment Intervention|Physician Decision|0
1713433|NCT01134107|5979910|P1|Period 2-Second Treatment Intervention|Physician Decision|1
1713434|NCT01134107|5979909|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
1713435|NCT01134107|5979910|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
1713436|NCT01134107|5979909|P2|Period 1-First Treatment Intervention|Physician Decision|0
1713437|NCT01134107|5979910|P1|Period 1-First Treatment Intervention|Physician Decision|1
1713438|NCT01134107|5979909|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
1713439|NCT01134107|5979910|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
1713440|NCT01134107|5979909|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
1713441|NCT01134107|5979910|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
1713442|NCT01134107|5979909|P2|Period 1-First Treatment Intervention|Adverse Event|0
1713443|NCT01134107|5979910|P1|Period 1-First Treatment Intervention|Adverse Event|1
1713444|NCT01134055|5979957|P7|Overall Study|Physician Decision|1
1713445|NCT01134055|5979958|P6|Overall Study|Physician Decision|0
1713446|NCT01134055|5979959|P5|Overall Study|Physician Decision|0
1713447|NCT01134055|5979960|P4|Overall Study|Physician Decision|0
1713448|NCT01134055|5979961|P3|Overall Study|Physician Decision|0
1713449|NCT01134055|5979962|P2|Overall Study|Physician Decision|0
1713450|NCT01134055|5979963|P1|Overall Study|Physician Decision|0
1713451|NCT01134055|5979957|P7|Overall Study|Protocol Violation|0
1713452|NCT01134055|5979958|P6|Overall Study|Protocol Violation|0
1713453|NCT01134055|5979959|P5|Overall Study|Protocol Violation|1
1713454|NCT01134055|5979960|P4|Overall Study|Protocol Violation|1
1713455|NCT01134055|5979961|P3|Overall Study|Protocol Violation|0
1713456|NCT01134055|5979962|P2|Overall Study|Protocol Violation|0
1713457|NCT01134055|5979963|P1|Overall Study|Protocol Violation|0
1713458|NCT01134055|5979957|P7|Overall Study|Withdrawal by Subject|8
1713459|NCT01134055|5979958|P6|Overall Study|Withdrawal by Subject|0
1713460|NCT01134055|5979959|P5|Overall Study|Withdrawal by Subject|0
1713461|NCT01134055|5979960|P4|Overall Study|Withdrawal by Subject|2
1713462|NCT01134055|5979961|P3|Overall Study|Withdrawal by Subject|1
1713463|NCT01134055|5979962|P2|Overall Study|Withdrawal by Subject|3
1713464|NCT01134055|5979963|P1|Overall Study|Withdrawal by Subject|3
1713465|NCT01134055|5979957|P7|Overall Study|Lost to Follow-up|0
1713466|NCT01134055|5979958|P6|Overall Study|Lost to Follow-up|0
1713467|NCT01134055|5979959|P5|Overall Study|Lost to Follow-up|0
1713468|NCT01134055|5979960|P4|Overall Study|Lost to Follow-up|1
1713469|NCT01134055|5979961|P3|Overall Study|Lost to Follow-up|0
1713470|NCT01134055|5979962|P2|Overall Study|Lost to Follow-up|1
1713471|NCT01134055|5979963|P1|Overall Study|Lost to Follow-up|0
1713472|NCT01134055|5979957|P7|Overall Study|Adverse Event|2
1713473|NCT01134055|5979958|P6|Overall Study|Adverse Event|7
1713474|NCT01134055|5979959|P5|Overall Study|Adverse Event|5
1713475|NCT01134055|5979960|P4|Overall Study|Adverse Event|2
1713476|NCT01134055|5979961|P3|Overall Study|Adverse Event|2
1713477|NCT01134055|5979962|P2|Overall Study|Adverse Event|2
1713478|NCT01134055|5979963|P1|Overall Study|Adverse Event|5
1713479|NCT01134042|5980097|P3|Overall Study|Withdrawal by Subject|7
1713480|NCT01134042|5980098|P2|Overall Study|Withdrawal by Subject|4
1713481|NCT01134042|5980099|P1|Overall Study|Withdrawal by Subject|13
1713482|NCT01134042|5980097|P3|Overall Study|Physician Decision|1
1713483|NCT01134042|5980098|P2|Overall Study|Physician Decision|8
1713484|NCT01134042|5980099|P1|Overall Study|Physician Decision|4
1713485|NCT01134042|5980097|P3|Overall Study|Lost to Follow-up|1
1713486|NCT01134042|5980098|P2|Overall Study|Lost to Follow-up|0
1713487|NCT01134042|5980099|P1|Overall Study|Lost to Follow-up|2
1713488|NCT01134042|5980097|P3|Overall Study|Protocol Violation|5
1713489|NCT01134042|5980098|P2|Overall Study|Protocol Violation|3
1713490|NCT01134042|5980099|P1|Overall Study|Protocol Violation|5
1713491|NCT01134042|5980097|P3|Overall Study|Lack of Efficacy|18
1713492|NCT01134042|5980098|P2|Overall Study|Lack of Efficacy|6
1713493|NCT01134042|5980099|P1|Overall Study|Lack of Efficacy|21
1713494|NCT01134042|5980097|P3|Overall Study|Adverse Event|2
1713495|NCT01134042|5980098|P2|Overall Study|Adverse Event|7
1713496|NCT01134042|5980099|P1|Overall Study|Adverse Event|3
1713497|NCT01133977|5980175|P5|Overall Study|Withdrawal by Subject|1
1713498|NCT01133977|5980176|P4|Overall Study|Withdrawal by Subject|5
1713499|NCT01133977|5980177|P3|Overall Study|Withdrawal by Subject|0
1713500|NCT01133977|5980178|P2|Overall Study|Withdrawal by Subject|0
1713501|NCT01133977|5980179|P1|Overall Study|Withdrawal by Subject|0
1713502|NCT01133977|5980175|P5|Overall Study|Lost to Follow-up|1
1713503|NCT01133977|5980176|P4|Overall Study|Lost to Follow-up|2
1713504|NCT01133977|5980177|P3|Overall Study|Lost to Follow-up|0
1713505|NCT01133977|5980178|P2|Overall Study|Lost to Follow-up|0
1713506|NCT01133977|5980179|P1|Overall Study|Lost to Follow-up|0
1713507|NCT01133977|5980175|P5|Overall Study|Started a New Line of Therapy|33
1713508|NCT01133977|5980176|P4|Overall Study|Started a New Line of Therapy|25
1713509|NCT01133977|5980177|P3|Overall Study|Started a New Line of Therapy|4
1713510|NCT01133977|5980178|P2|Overall Study|Started a New Line of Therapy|6
1713511|NCT01133977|5980179|P1|Overall Study|Started a New Line of Therapy|2
1713512|NCT01133977|5980175|P5|Overall Study|Death|3
1713513|NCT01133977|5980176|P4|Overall Study|Death|7
1713514|NCT01133977|5980177|P3|Overall Study|Death|1
1713515|NCT01133977|5980178|P2|Overall Study|Death|1
1713516|NCT01133977|5980179|P1|Overall Study|Death|1
1713517|NCT01133977|5980175|P5|Overall Study|Adverse Event|0
1713518|NCT01133977|5980176|P4|Overall Study|Adverse Event|0
1713519|NCT01133977|5980177|P3|Overall Study|Adverse Event|1
1713520|NCT01133977|5980178|P2|Overall Study|Adverse Event|0
1713521|NCT01133977|5980179|P1|Overall Study|Adverse Event|0
1713522|NCT01133847|5980206|P3|Follow-Up Phase|Lost to Follow-up|7
1713523|NCT01133847|5980207|P2|Follow-Up Phase|Lost to Follow-up|3
1713524|NCT01133847|5980208|P1|Follow-Up Phase|Lost to Follow-up|1
1713525|NCT01133847|5980206|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
1713526|NCT01133847|5980207|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
1713527|NCT01133847|5980208|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
1713528|NCT01133821|5980248|P2|Overall Study|Refused participation|3
1713529|NCT01133821|5980249|P1|Overall Study|Refused participation|1
1713530|NCT01133821|5980248|P2|Overall Study|Protocol Violation|1
1713531|NCT01133821|5980249|P1|Overall Study|Protocol Violation|0
1713532|NCT01133821|5980248|P2|Overall Study|preferred other treatment|1
1713533|NCT01133821|5980249|P1|Overall Study|preferred other treatment|1
1713534|NCT01133821|5980248|P2|Overall Study|Withdrawal by Subject|3
1713535|NCT01133821|5980249|P1|Overall Study|Withdrawal by Subject|8
1713536|NCT01133821|5980248|P2|Overall Study|Lost to Follow-up|11
1713537|NCT01133821|5980249|P1|Overall Study|Lost to Follow-up|8
1713538|NCT01133756|5980260|P3|Overall Study|Progression of Disease|1
1713539|NCT01133756|5980261|P2|Overall Study|Progression of Disease|0
1713540|NCT01133756|5980262|P1|Overall Study|Progression of Disease|0
1713541|NCT01133756|5980260|P3|Overall Study|Withdrawal by Subject|0
1713542|NCT01133756|5980261|P2|Overall Study|Withdrawal by Subject|1
1713543|NCT01133756|5980262|P1|Overall Study|Withdrawal by Subject|0
1713544|NCT01133756|5980260|P3|Overall Study|Investigator Decision|0
1713545|NCT01133756|5980261|P2|Overall Study|Investigator Decision|0
1713546|NCT01133756|5980262|P1|Overall Study|Investigator Decision|1
1713547|NCT01133756|5980260|P3|Overall Study|Adverse Event|1
1713548|NCT01133756|5980261|P2|Overall Study|Adverse Event|2
1713549|NCT01133756|5980262|P1|Overall Study|Adverse Event|1
1713550|NCT01133704|5980278|P2|Overall Study|Study Closure|0
1713551|NCT01133704|5980279|P1|Overall Study|Study Closure|1
1713552|NCT01133704|5980278|P2|Overall Study|Patient refused to continue|0
1713553|NCT01133704|5980279|P1|Overall Study|Patient refused to continue|4
1713554|NCT01133704|5980278|P2|Overall Study|Death|26
1713555|NCT01133704|5980279|P1|Overall Study|Death|44
1713556|NCT01133665|5980287|P1|Overall Study|Physician Decision|2
1713557|NCT01133626|5980347|P3|Overall Study|Other|0
1713558|NCT01133626|5980348|P2|Overall Study|Other|2
1713559|NCT01133626|5980349|P1|Overall Study|Other|0
1713560|NCT01133626|5980347|P3|Overall Study|Withdrawal by Subject|2
1713561|NCT01133626|5980348|P2|Overall Study|Withdrawal by Subject|2
1713562|NCT01133626|5980349|P1|Overall Study|Withdrawal by Subject|1
1713563|NCT01133626|5980347|P3|Overall Study|Adverse Event|0
1713564|NCT01133626|5980348|P2|Overall Study|Adverse Event|1
1713565|NCT01133626|5980349|P1|Overall Study|Adverse Event|0
1713566|NCT01133522|5980367|P10|Overall Study|Physician Decision|0
1713567|NCT01133522|5980368|P9|Overall Study|Physician Decision|0
1713568|NCT01133522|5980369|P8|Overall Study|Physician Decision|0
1713569|NCT01133522|5980370|P7|Overall Study|Physician Decision|0
1713570|NCT01133522|5980371|P6|Overall Study|Physician Decision|0
1713571|NCT01133522|5980372|P5|Overall Study|Physician Decision|1
1713572|NCT01133522|5980373|P4|Overall Study|Physician Decision|0
1713573|NCT01133522|5980374|P3|Overall Study|Physician Decision|0
1713574|NCT01133522|5980375|P2|Overall Study|Physician Decision|0
1713575|NCT01133522|5980376|P1|Overall Study|Physician Decision|0
1713576|NCT01133522|5980367|P10|Overall Study|Withdrawal by Subject|0
1713577|NCT01133522|5980368|P9|Overall Study|Withdrawal by Subject|0
1713578|NCT01133522|5980369|P8|Overall Study|Withdrawal by Subject|0
1713579|NCT01133522|5980370|P7|Overall Study|Withdrawal by Subject|0
1713580|NCT01133522|5980371|P6|Overall Study|Withdrawal by Subject|0
1713581|NCT01133522|5980372|P5|Overall Study|Withdrawal by Subject|0
1713582|NCT01133522|5980373|P4|Overall Study|Withdrawal by Subject|1
1713583|NCT01133522|5980374|P3|Overall Study|Withdrawal by Subject|0
1713584|NCT01133522|5980375|P2|Overall Study|Withdrawal by Subject|1
1713585|NCT01133522|5980376|P1|Overall Study|Withdrawal by Subject|0
1713586|NCT01133418|5980444|P2|Overall Study|Lost to Follow-up|6
1713587|NCT01133418|5980445|P1|Overall Study|Lost to Follow-up|5
1713588|NCT01133405|5980467|P10|Period 2|Physician Decision|0
1713589|NCT01133405|5980468|P9|Period 2|Physician Decision|0
1713590|NCT01133405|5980469|P8|Period 2|Physician Decision|0
1713591|NCT01133405|5980470|P7|Period 2|Physician Decision|0
1713592|NCT01133405|5980471|P6|Period 2|Physician Decision|1
1713593|NCT01133405|5980472|P5|Period 2|Physician Decision|0
1713594|NCT01133405|5980473|P4|Period 2|Physician Decision|0
1713595|NCT01133405|5980474|P3|Period 2|Physician Decision|0
1713596|NCT01133405|5980475|P2|Period 2|Physician Decision|0
1713597|NCT01133405|5980476|P1|Period 2|Physician Decision|0
1713598|NCT01133405|5980467|P10|Period 2|Entry Criteria Not Met|0
1713599|NCT01133405|5980468|P9|Period 2|Entry Criteria Not Met|0
1713600|NCT01133405|5980469|P8|Period 2|Entry Criteria Not Met|0
1713601|NCT01133405|5980470|P7|Period 2|Entry Criteria Not Met|0
1713602|NCT01133405|5980471|P6|Period 2|Entry Criteria Not Met|0
1713603|NCT01133405|5980472|P5|Period 2|Entry Criteria Not Met|0
1713604|NCT01133405|5980473|P4|Period 2|Entry Criteria Not Met|0
1713605|NCT01133405|5980474|P3|Period 2|Entry Criteria Not Met|0
1713606|NCT01133405|5980475|P2|Period 2|Entry Criteria Not Met|1
1713607|NCT01133405|5980476|P1|Period 2|Entry Criteria Not Met|0
1713608|NCT01133405|5980467|P10|Period 2|Withdrawal by Subject|0
1713609|NCT01133405|5980468|P9|Period 2|Withdrawal by Subject|0
1713610|NCT01133405|5980469|P8|Period 2|Withdrawal by Subject|0
1713611|NCT01133405|5980470|P7|Period 2|Withdrawal by Subject|0
1713612|NCT01133405|5980471|P6|Period 2|Withdrawal by Subject|1
1713613|NCT01133405|5980472|P5|Period 2|Withdrawal by Subject|0
1713614|NCT01133405|5980473|P4|Period 2|Withdrawal by Subject|1
1713615|NCT01133405|5980474|P3|Period 2|Withdrawal by Subject|0
1713616|NCT01133405|5980475|P2|Period 2|Withdrawal by Subject|0
1713617|NCT01133405|5980476|P1|Period 2|Withdrawal by Subject|0
1713618|NCT01133405|5980467|P10|Period 2|Adverse Event|0
1713619|NCT01133405|5980468|P9|Period 2|Adverse Event|0
1713620|NCT01133405|5980469|P8|Period 2|Adverse Event|0
1713621|NCT01133405|5980470|P7|Period 2|Adverse Event|0
1713622|NCT01133405|5980471|P6|Period 2|Adverse Event|0
1713623|NCT01133405|5980472|P5|Period 2|Adverse Event|0
1713624|NCT01133405|5980473|P4|Period 2|Adverse Event|0
1713625|NCT01133405|5980474|P3|Period 2|Adverse Event|1
1713626|NCT01133405|5980475|P2|Period 2|Adverse Event|0
1713627|NCT01133405|5980476|P1|Period 2|Adverse Event|0
1713628|NCT01133405|5980467|P10|Period 1|Received drug only in period 3|0
1713629|NCT01133405|5980468|P9|Period 1|Received drug only in period 3|0
1713630|NCT01133405|5980469|P8|Period 1|Received drug only in period 3|0
1713631|NCT01133405|5980470|P7|Period 1|Received drug only in period 3|0
1713632|NCT01133405|5980471|P6|Period 1|Received drug only in period 3|0
1713633|NCT01133405|5980472|P5|Period 1|Received drug only in period 3|0
1713634|NCT01133405|5980473|P4|Period 1|Received drug only in period 3|0
1713635|NCT01133405|5980474|P3|Period 1|Received drug only in period 3|1
1713636|NCT01133405|5980475|P2|Period 1|Received drug only in period 3|1
1713637|NCT01133405|5980476|P1|Period 1|Received drug only in period 3|0
1713638|NCT01133405|5980467|P10|Period 1|Received drug only in period 2|0
1713639|NCT01133405|5980468|P9|Period 1|Received drug only in period 2|0
1713640|NCT01133405|5980469|P8|Period 1|Received drug only in period 2|0
1713641|NCT01133405|5980470|P7|Period 1|Received drug only in period 2|0
1713642|NCT01133405|5980471|P6|Period 1|Received drug only in period 2|1
1713643|NCT01133405|5980472|P5|Period 1|Received drug only in period 2|0
1713644|NCT01133405|5980473|P4|Period 1|Received drug only in period 2|2
1713645|NCT01133405|5980474|P3|Period 1|Received drug only in period 2|0
1713646|NCT01133405|5980475|P2|Period 1|Received drug only in period 2|1
1713647|NCT01133405|5980476|P1|Period 1|Received drug only in period 2|0
1713648|NCT01133405|5980467|P10|Period 1|Discontinued after randomization|0
1713649|NCT01133405|5980468|P9|Period 1|Discontinued after randomization|0
1713650|NCT01133405|5980469|P8|Period 1|Discontinued after randomization|0
1713651|NCT01133405|5980470|P7|Period 1|Discontinued after randomization|1
1713652|NCT01133405|5980471|P6|Period 1|Discontinued after randomization|0
1713653|NCT01133405|5980472|P5|Period 1|Discontinued after randomization|0
1713654|NCT01133405|5980473|P4|Period 1|Discontinued after randomization|0
1713655|NCT01133405|5980474|P3|Period 1|Discontinued after randomization|0
1713656|NCT01133405|5980475|P2|Period 1|Discontinued after randomization|0
1713657|NCT01133405|5980476|P1|Period 1|Discontinued after randomization|1
1713658|NCT01133405|5980467|P10|Period 1|Physician Decision|0
1713659|NCT01133405|5980468|P9|Period 1|Physician Decision|0
1713660|NCT01133405|5980469|P8|Period 1|Physician Decision|0
1713661|NCT01133405|5980470|P7|Period 1|Physician Decision|0
1713662|NCT01133405|5980471|P6|Period 1|Physician Decision|0
1713663|NCT01133405|5980472|P5|Period 1|Physician Decision|0
1713664|NCT01133405|5980473|P4|Period 1|Physician Decision|1
1713665|NCT01133405|5980474|P3|Period 1|Physician Decision|0
1713666|NCT01133405|5980475|P2|Period 1|Physician Decision|0
1713667|NCT01133405|5980476|P1|Period 1|Physician Decision|0
1713668|NCT01133405|5980467|P10|Period 1|Withdrawal by Subject|0
1713669|NCT01133405|5980468|P9|Period 1|Withdrawal by Subject|0
1713670|NCT01133405|5980469|P8|Period 1|Withdrawal by Subject|0
1713671|NCT01133405|5980470|P7|Period 1|Withdrawal by Subject|0
1713672|NCT01133405|5980471|P6|Period 1|Withdrawal by Subject|1
1713673|NCT01133405|5980472|P5|Period 1|Withdrawal by Subject|0
1713674|NCT01133405|5980473|P4|Period 1|Withdrawal by Subject|1
1713675|NCT01133405|5980474|P3|Period 1|Withdrawal by Subject|0
1713676|NCT01133405|5980475|P2|Period 1|Withdrawal by Subject|1
1713677|NCT01133405|5980476|P1|Period 1|Withdrawal by Subject|0
1713678|NCT01133392|5980527|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
1713679|NCT01133392|5980528|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
1713680|NCT01133392|5980527|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
1713681|NCT01133392|5980528|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
1713682|NCT01133379|5980545|P3|Overall Study|Lost to Follow-up|1
1713683|NCT01133379|5980546|P2|Overall Study|Lost to Follow-up|1
1713684|NCT01133379|5980547|P1|Overall Study|Lost to Follow-up|1
1713685|NCT01133379|5980545|P3|Overall Study|Withdrawal by Subject|1
1713686|NCT01133379|5980546|P2|Overall Study|Withdrawal by Subject|1
1713687|NCT01133379|5980547|P1|Overall Study|Withdrawal by Subject|0
1713688|NCT01133288|5980600|P1|Intervention Allocation|study terminated|2
1713689|NCT01133288|5980600|P1|Eligibility Assessment|met exclusion criteria|5
1713690|NCT01133275|5980605|P1|Overall Study|Cerebrovascular accident (CVA)|1
1713691|NCT01133275|5980605|P1|Overall Study|Withdrawal by Subject|1
1713692|NCT01133171|5980613|P3|Overall Study|Withdrawal by Subject|0
1713693|NCT01133171|5980614|P2|Overall Study|Withdrawal by Subject|2
1713694|NCT01133171|5980615|P1|Overall Study|Withdrawal by Subject|1
1713695|NCT01133067|5980631|P1|Overall Study|Lost to Follow-up|3
1713696|NCT01133067|5980631|P1|Overall Study|Death|136
1713697|NCT01132820|5980691|P1|Overall Study|Inadequate data|1
1713698|NCT01132820|5980691|P1|Overall Study|Never treated|1
1713699|NCT01132820|5980691|P1|Overall Study|Ineligible:Inadequate pathology|1
1713700|NCT01132820|5980691|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
1713701|NCT01132820|5980691|P1|Overall Study|Ineligible: wrong cell type|1
1713702|NCT01132755|5980700|P1|Overall Study|Withdrawal by Subject|4
1713703|NCT01132755|5980700|P1|Overall Study|Protocol Violation|15
1713704|NCT01132755|5980700|P1|Overall Study|Procedure not done due to medical reason|23
1713705|NCT01132664|5980729|P5|BM Cohort|Withdrawal by Subject|1
1713706|NCT01132664|5980730|P4|BM Cohort|Withdrawal by Subject|0
1713707|NCT01132664|5980731|P3|BM Cohort|Withdrawal by Subject|0
1713708|NCT01132664|5980732|P2|BM Cohort|Withdrawal by Subject|0
1713709|NCT01132664|5980733|P1|BM Cohort|Withdrawal by Subject|0
1713710|NCT01132664|5980729|P5|BM Cohort|Adverse Event|1
1713711|NCT01132664|5980730|P4|BM Cohort|Adverse Event|0
1713712|NCT01132664|5980731|P3|BM Cohort|Adverse Event|0
1713713|NCT01132664|5980732|P2|BM Cohort|Adverse Event|0
1713714|NCT01132664|5980733|P1|BM Cohort|Adverse Event|0
1713715|NCT01132664|5980729|P5|BM Cohort|Disease progression|4
1713716|NCT01132664|5980730|P4|BM Cohort|Disease progression|3
1713717|NCT01132664|5980731|P3|BM Cohort|Disease progression|0
1713718|NCT01132664|5980732|P2|BM Cohort|Disease progression|0
1713719|NCT01132664|5980733|P1|BM Cohort|Disease progression|0
1713720|NCT01132664|5980729|P5|Phase ll|Disease progression|0
1713721|NCT01132664|5980730|P4|Phase ll|Disease progression|0
1713722|NCT01132664|5980731|P3|Phase ll|Disease progression|35
1713723|NCT01132664|5980732|P2|Phase ll|Disease progression|0
1713724|NCT01132664|5980733|P1|Phase ll|Disease progression|0
1713725|NCT01132664|5980729|P5|Phase ll|Withdrawal by Subject|0
1713726|NCT01132664|5980730|P4|Phase ll|Withdrawal by Subject|0
1713727|NCT01132664|5980731|P3|Phase ll|Withdrawal by Subject|3
1713728|NCT01132664|5980732|P2|Phase ll|Withdrawal by Subject|0
1713729|NCT01132664|5980733|P1|Phase ll|Withdrawal by Subject|0
1713730|NCT01132664|5980729|P5|Phase ll|Adverse Event|0
1713731|NCT01132664|5980730|P4|Phase ll|Adverse Event|0
1713732|NCT01132664|5980731|P3|Phase ll|Adverse Event|10
1713733|NCT01132664|5980732|P2|Phase ll|Adverse Event|0
1713734|NCT01132664|5980733|P1|Phase ll|Adverse Event|0
1713735|NCT01132664|5980729|P5|Phase ll|Death|0
1713736|NCT01132664|5980730|P4|Phase ll|Death|0
1713737|NCT01132664|5980731|P3|Phase ll|Death|2
1713738|NCT01132664|5980732|P2|Phase ll|Death|0
1713739|NCT01132664|5980733|P1|Phase ll|Death|0
1713740|NCT01132664|5980729|P5|Phase lb|Disease Progression|0
1713741|NCT01132664|5980730|P4|Phase lb|Disease Progression|0
1713742|NCT01132664|5980731|P3|Phase lb|Disease Progression|0
1713743|NCT01132664|5980732|P2|Phase lb|Disease Progression|9
1713744|NCT01132664|5980733|P1|Phase lb|Disease Progression|4
1713745|NCT01132664|5980729|P5|Phase lb|Withdrawal by Subject|0
1713746|NCT01132664|5980730|P4|Phase lb|Withdrawal by Subject|0
1713747|NCT01132664|5980731|P3|Phase lb|Withdrawal by Subject|0
1713748|NCT01132664|5980732|P2|Phase lb|Withdrawal by Subject|2
1713749|NCT01132664|5980733|P1|Phase lb|Withdrawal by Subject|1
1713750|NCT01132664|5980729|P5|Phase lb|Adverse Event|0
1713751|NCT01132664|5980730|P4|Phase lb|Adverse Event|0
1713752|NCT01132664|5980731|P3|Phase lb|Adverse Event|0
1713753|NCT01132664|5980732|P2|Phase lb|Adverse Event|1
1713754|NCT01132664|5980733|P1|Phase lb|Adverse Event|0
1713755|NCT01132651|5980767|P2|Overall Study|Lost to Follow-up|1
1713756|NCT01132651|5980768|P1|Overall Study|Lost to Follow-up|1
1713757|NCT01132612|5980779|P3|Overall Study|Lack of Efficacy|73
1713758|NCT01132612|5980780|P2|Overall Study|Lack of Efficacy|22
1713759|NCT01132612|5980781|P1|Overall Study|Lack of Efficacy|23
1713760|NCT01132612|5980779|P3|Overall Study|Administrative problems|52
1713761|NCT01132612|5980780|P2|Overall Study|Administrative problems|1
1713762|NCT01132612|5980781|P1|Overall Study|Administrative problems|5
1713763|NCT01132612|5980779|P3|Overall Study|Withdrawal by Subject|19
1713764|NCT01132612|5980780|P2|Overall Study|Withdrawal by Subject|8
1713765|NCT01132612|5980781|P1|Overall Study|Withdrawal by Subject|5
1713766|NCT01132612|5980779|P3|Overall Study|Adverse Event|15
1713767|NCT01132612|5980780|P2|Overall Study|Adverse Event|2
1713768|NCT01132612|5980781|P1|Overall Study|Adverse Event|5
1713769|NCT01132612|5980779|P3|Overall Study|Lost to Follow-up|7
1713770|NCT01132612|5980780|P2|Overall Study|Lost to Follow-up|2
1713771|NCT01132612|5980781|P1|Overall Study|Lost to Follow-up|2
1713772|NCT01132612|5980779|P3|Overall Study|Protocol deviation|3
1713773|NCT01132612|5980780|P2|Overall Study|Protocol deviation|0
1713774|NCT01132612|5980781|P1|Overall Study|Protocol deviation|0
1713775|NCT01132612|5980779|P3|Overall Study|Death|1
1713776|NCT01132612|5980780|P2|Overall Study|Death|0
1713777|NCT01132612|5980781|P1|Overall Study|Death|0
1713778|NCT01132547|5980797|P2|Overall Study|Death|0
1713779|NCT01132547|5980798|P1|Overall Study|Death|1
1713780|NCT01132547|5980797|P2|Overall Study|Withdrawal by Subject|1
1713781|NCT01132547|5980798|P1|Overall Study|Withdrawal by Subject|3
1713782|NCT01132495|5980868|P4|Overall Study|Various reasons|12
1713783|NCT01132495|5980869|P3|Overall Study|Various reasons|20
1713784|NCT01132495|5980870|P2|Overall Study|Various reasons|38
1713785|NCT01132495|5980871|P1|Overall Study|Various reasons|40
1713786|NCT01132482|5980884|P2|Overall Study|Adverse Event|0
1713787|NCT01132482|5980885|P1|Overall Study|Adverse Event|1
1713788|NCT01132326|5980908|P1|Overall Study|Subject Unable to Come To Visits|1
1713789|NCT01132326|5980908|P1|Overall Study|Death|5
1713790|NCT01132326|5980908|P1|Overall Study|Caregiver Withdrew Consent|1
1713791|NCT01132326|5980908|P1|Overall Study|Pregnancy|1
1713792|NCT01132326|5980908|P1|Overall Study|Declining Health|1
1713793|NCT01132326|5980908|P1|Overall Study|Study Termination|80
1713794|NCT01132326|5980908|P1|Overall Study|Physician Decision|10
1713795|NCT01132326|5980908|P1|Overall Study|Withdrawal by Subject|40
1713796|NCT01132326|5980908|P1|Overall Study|Lost to Follow-up|16
1713797|NCT01132326|5980908|P1|Overall Study|Protocol Violation|1
1713798|NCT01132326|5980908|P1|Overall Study|Adverse Event|37
1713799|NCT01132326|5980908|P1|Overall Study|Lack of Efficacy|25
1713800|NCT01132313|5980924|P12|Overall Study|Other reason not defined above|0
1713801|NCT01132313|5980925|P11|Overall Study|Other reason not defined above|0
1713802|NCT01132313|5980926|P10|Overall Study|Other reason not defined above|0
1713803|NCT01132313|5980927|P9|Overall Study|Other reason not defined above|0
1713804|NCT01132313|5980928|P8|Overall Study|Other reason not defined above|1
1713805|NCT01132313|5980929|P7|Overall Study|Other reason not defined above|0
1713806|NCT01132313|5980930|P6|Overall Study|Other reason not defined above|0
1713807|NCT01132313|5980931|P5|Overall Study|Other reason not defined above|0
1713808|NCT01132313|5980932|P4|Overall Study|Other reason not defined above|0
1713809|NCT01132313|5980933|P3|Overall Study|Other reason not defined above|0
1713810|NCT01132313|5980934|P2|Overall Study|Other reason not defined above|0
1713811|NCT01132313|5980935|P1|Overall Study|Other reason not defined above|0
1713812|NCT01132313|5980924|P12|Overall Study|Lack of antiviral response|0
1713813|NCT01132313|5980925|P11|Overall Study|Lack of antiviral response|1
1713814|NCT01132313|5980926|P10|Overall Study|Lack of antiviral response|0
1713815|NCT01132313|5980927|P9|Overall Study|Lack of antiviral response|0
1713816|NCT01132313|5980928|P8|Overall Study|Lack of antiviral response|0
1713817|NCT01132313|5980929|P7|Overall Study|Lack of antiviral response|21
1713818|NCT01132313|5980930|P6|Overall Study|Lack of antiviral response|18
1713819|NCT01132313|5980931|P5|Overall Study|Lack of antiviral response|18
1713820|NCT01132313|5980932|P4|Overall Study|Lack of antiviral response|18
1713821|NCT01132313|5980933|P3|Overall Study|Lack of antiviral response|12
1713822|NCT01132313|5980934|P2|Overall Study|Lack of antiviral response|0
1713823|NCT01132313|5980935|P1|Overall Study|Lack of antiviral response|0
1713824|NCT01132313|5980924|P12|Overall Study|Withdrawal by Subject|0
1713825|NCT01132313|5980925|P11|Overall Study|Withdrawal by Subject|0
1713826|NCT01132313|5980926|P10|Overall Study|Withdrawal by Subject|2
1713827|NCT01132313|5980927|P9|Overall Study|Withdrawal by Subject|0
1713828|NCT01132313|5980928|P8|Overall Study|Withdrawal by Subject|0
1713829|NCT01132313|5980929|P7|Overall Study|Withdrawal by Subject|1
1713830|NCT01132313|5980930|P6|Overall Study|Withdrawal by Subject|0
1713831|NCT01132313|5980931|P5|Overall Study|Withdrawal by Subject|6
1713832|NCT01132313|5980932|P4|Overall Study|Withdrawal by Subject|3
1713833|NCT01132313|5980933|P3|Overall Study|Withdrawal by Subject|3
1713834|NCT01132313|5980934|P2|Overall Study|Withdrawal by Subject|0
1713835|NCT01132313|5980935|P1|Overall Study|Withdrawal by Subject|0
1713836|NCT01132313|5980924|P12|Overall Study|Lost to Follow-up|0
1713837|NCT01132313|5980925|P11|Overall Study|Lost to Follow-up|0
1713838|NCT01132313|5980926|P10|Overall Study|Lost to Follow-up|0
1713839|NCT01132313|5980927|P9|Overall Study|Lost to Follow-up|0
1713840|NCT01132313|5980928|P8|Overall Study|Lost to Follow-up|1
1713841|NCT01132313|5980929|P7|Overall Study|Lost to Follow-up|0
1713842|NCT01132313|5980930|P6|Overall Study|Lost to Follow-up|0
1713843|NCT01132313|5980931|P5|Overall Study|Lost to Follow-up|0
1713844|NCT01132313|5980932|P4|Overall Study|Lost to Follow-up|0
1713845|NCT01132313|5980933|P3|Overall Study|Lost to Follow-up|1
1713846|NCT01132313|5980934|P2|Overall Study|Lost to Follow-up|0
1713847|NCT01132313|5980935|P1|Overall Study|Lost to Follow-up|0
1713848|NCT01132313|5980924|P12|Overall Study|Protocol Violation|0
1713849|NCT01132313|5980925|P11|Overall Study|Protocol Violation|0
1713850|NCT01132313|5980926|P10|Overall Study|Protocol Violation|0
1713851|NCT01132313|5980927|P9|Overall Study|Protocol Violation|0
1713852|NCT01132313|5980928|P8|Overall Study|Protocol Violation|0
1713853|NCT01132313|5980929|P7|Overall Study|Protocol Violation|0
1713854|NCT01132313|5980930|P6|Overall Study|Protocol Violation|0
1713855|NCT01132313|5980931|P5|Overall Study|Protocol Violation|0
1713856|NCT01132313|5980932|P4|Overall Study|Protocol Violation|1
1713857|NCT01132313|5980933|P3|Overall Study|Protocol Violation|0
1713858|NCT01132313|5980934|P2|Overall Study|Protocol Violation|0
1713859|NCT01132313|5980935|P1|Overall Study|Protocol Violation|0
1713860|NCT01132313|5980924|P12|Overall Study|Adverse Event|0
1713861|NCT01132313|5980925|P11|Overall Study|Adverse Event|0
1713862|NCT01132313|5980926|P10|Overall Study|Adverse Event|2
1713863|NCT01132313|5980927|P9|Overall Study|Adverse Event|7
1713864|NCT01132313|5980928|P8|Overall Study|Adverse Event|3
1713865|NCT01132313|5980929|P7|Overall Study|Adverse Event|5
1713866|NCT01132313|5980930|P6|Overall Study|Adverse Event|6
1713867|NCT01132313|5980931|P5|Overall Study|Adverse Event|19
1713868|NCT01132313|5980932|P4|Overall Study|Adverse Event|10
1713869|NCT01132313|5980933|P3|Overall Study|Adverse Event|4
1713870|NCT01132313|5980934|P2|Overall Study|Adverse Event|0
1713871|NCT01132313|5980935|P1|Overall Study|Adverse Event|0
1713872|NCT01132313|5980924|P12|Overall Study|Not treated|0
1713873|NCT01132313|5980925|P11|Overall Study|Not treated|0
1713874|NCT01132313|5980926|P10|Overall Study|Not treated|0
1713875|NCT01132313|5980927|P9|Overall Study|Not treated|0
1713876|NCT01132313|5980928|P8|Overall Study|Not treated|0
1713877|NCT01132313|5980929|P7|Overall Study|Not treated|3
1713878|NCT01132313|5980930|P6|Overall Study|Not treated|1
1713879|NCT01132313|5980931|P5|Overall Study|Not treated|2
1713880|NCT01132313|5980932|P4|Overall Study|Not treated|0
1713881|NCT01132313|5980933|P3|Overall Study|Not treated|0
1713882|NCT01132313|5980934|P2|Overall Study|Not treated|0
1713883|NCT01132313|5980935|P1|Overall Study|Not treated|2
1713884|NCT01132313|5980924|P12|Overall Study|Lack of Efficacy|0
1713885|NCT01132313|5980925|P11|Overall Study|Lack of Efficacy|0
1713886|NCT01132313|5980926|P10|Overall Study|Lack of Efficacy|16
1713887|NCT01132313|5980927|P9|Overall Study|Lack of Efficacy|14
1713888|NCT01132313|5980928|P8|Overall Study|Lack of Efficacy|3
1713889|NCT01132313|5980929|P7|Overall Study|Lack of Efficacy|0
1713890|NCT01132313|5980930|P6|Overall Study|Lack of Efficacy|0
1713891|NCT01132313|5980931|P5|Overall Study|Lack of Efficacy|0
1713892|NCT01132313|5980932|P4|Overall Study|Lack of Efficacy|0
1713893|NCT01132313|5980933|P3|Overall Study|Lack of Efficacy|0
1713894|NCT01132313|5980934|P2|Overall Study|Lack of Efficacy|0
1713895|NCT01132313|5980935|P1|Overall Study|Lack of Efficacy|1
1713896|NCT01132118|5981015|P2|Second Intervention (8 Weeks)|Adverse Event|1
1713897|NCT01132118|5981016|P1|Second Intervention (8 Weeks)|Adverse Event|0
1713898|NCT01132118|5981015|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
1713899|NCT01132118|5981016|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
1713900|NCT01132118|5981015|P2|First Intervention (8 Weeks)|Adverse Event|0
1713901|NCT01132118|5981016|P1|First Intervention (8 Weeks)|Adverse Event|1
1713902|NCT01131676|5981046|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
1713903|NCT01131676|5981047|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
1713904|NCT01131676|5981048|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
1713905|NCT01131676|5981046|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
1713906|NCT01131676|5981047|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
1713907|NCT01131676|5981048|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
1713908|NCT01131676|5981046|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
1713909|NCT01131676|5981047|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
1713910|NCT01131676|5981048|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
1713911|NCT01131676|5981046|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
1713912|NCT01131676|5981047|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
1713913|NCT01131676|5981048|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
1713914|NCT01131676|5981046|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
1713915|NCT01131676|5981047|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
1713916|NCT01131676|5981048|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
1713917|NCT01131676|5981046|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
1713918|NCT01131676|5981047|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
1713919|NCT01131676|5981048|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
1713920|NCT01131676|5981046|P3|Discontinuation From Treatment|Adverse Event|273
1713921|NCT01131676|5981047|P2|Discontinuation From Treatment|Adverse Event|267
1713922|NCT01131676|5981048|P1|Discontinuation From Treatment|Adverse Event|303
1713923|NCT01131676|5981046|P3|Discontinuation From Treatment|Other than those specified|125
1713924|NCT01131676|5981047|P2|Discontinuation From Treatment|Other than those specified|142
1713925|NCT01131676|5981048|P1|Discontinuation From Treatment|Other than those specified|162
1713926|NCT01131676|5981046|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
1713927|NCT01131676|5981047|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
1713928|NCT01131676|5981048|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
1713929|NCT01131676|5981046|P3|Discontinuation From Treatment|Lost to Follow-up|6
1713930|NCT01131676|5981047|P2|Discontinuation From Treatment|Lost to Follow-up|9
1713931|NCT01131676|5981048|P1|Discontinuation From Treatment|Lost to Follow-up|15
1713932|NCT01131676|5981046|P3|Discontinuation From Treatment|Non compliant with protocol|12
1713933|NCT01131676|5981047|P2|Discontinuation From Treatment|Non compliant with protocol|15
1713934|NCT01131676|5981048|P1|Discontinuation From Treatment|Non compliant with protocol|15
1713935|NCT01131676|5981046|P3|Discontinuation From Treatment|Lack of Efficacy|0
1713936|NCT01131676|5981047|P2|Discontinuation From Treatment|Lack of Efficacy|1
1713937|NCT01131676|5981048|P1|Discontinuation From Treatment|Lack of Efficacy|11
1713938|NCT01131676|5981046|P3|Discontinuation From Treatment|Not treated|2
1713939|NCT01131676|5981047|P2|Discontinuation From Treatment|Not treated|2
1713940|NCT01131676|5981048|P1|Discontinuation From Treatment|Not treated|4
1713941|NCT01131676|5981046|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
1713942|NCT01131676|5981047|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
1713943|NCT01131676|5981048|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
1713944|NCT01131585|5981083|P2|Overall Study|Study termination|32
1713945|NCT01131585|5981084|P1|Overall Study|Study termination|78
1713946|NCT01131585|5981083|P2|Overall Study|Administrative problems|1
1713947|NCT01131585|5981084|P1|Overall Study|Administrative problems|1
1713948|NCT01131585|5981083|P2|Overall Study|Lost to Follow-up|1
1713949|NCT01131585|5981084|P1|Overall Study|Lost to Follow-up|0
1713950|NCT01131585|5981083|P2|Overall Study|Withdrawal by Subject|3
1713951|NCT01131585|5981084|P1|Overall Study|Withdrawal by Subject|3
1713952|NCT01131585|5981083|P2|Overall Study|Protocol Violation|1
1713953|NCT01131585|5981084|P1|Overall Study|Protocol Violation|2
1713954|NCT01131585|5981083|P2|Overall Study|Unsatisfactory therapeutic effect|3
1713955|NCT01131585|5981084|P1|Overall Study|Unsatisfactory therapeutic effect|0
1713956|NCT01131585|5981083|P2|Overall Study|Abnormal laboratory value|0
1713957|NCT01131585|5981084|P1|Overall Study|Abnormal laboratory value|1
1713958|NCT01131585|5981083|P2|Overall Study|Adverse Event|2
1713959|NCT01131585|5981084|P1|Overall Study|Adverse Event|0
1713960|NCT01131520|5981092|P2|Overall Study|Subject changed history after enrollment|1
1713961|NCT01131520|5981093|P1|Overall Study|Subject changed history after enrollment|0
1713962|NCT01131520|5981092|P2|Overall Study|Counselor not available|3
1713963|NCT01131520|5981093|P1|Overall Study|Counselor not available|0
1713964|NCT01131520|5981092|P2|Overall Study|Computer problem|0
1713965|NCT01131520|5981093|P1|Overall Study|Computer problem|1
1713966|NCT01131507|5981115|P1|Overall Study|Withdrawal by Subject|1
1713967|NCT01131507|5981115|P1|Overall Study|Lost to Follow-up|1
1713968|NCT01131507|5981115|P1|Overall Study|Adverse Event|1
1713969|NCT01131494|5981120|P1|Overall Study|Withdrawal by Subject|2
1713970|NCT01131455|5981130|P3|Overall Study|Death of PI|0
1713971|NCT01131455|5981131|P2|Overall Study|Death of PI|4
1713972|NCT01131455|5981132|P1|Overall Study|Death of PI|6
1713973|NCT01131312|5981143|P3|Overall Study|Lost to Follow-up|351
1713974|NCT01131312|5981144|P2|Overall Study|Lost to Follow-up|229
1713975|NCT01131312|5981145|P1|Overall Study|Lost to Follow-up|425
1713976|NCT01131299|5981156|P2|Overall Study|Withdrawal by Subject|7
1713977|NCT01131299|5981157|P1|Overall Study|Withdrawal by Subject|4
1713978|NCT01131260|5981170|P2|Overall Study|Ineligible|2
1713979|NCT01131260|5981171|P1|Overall Study|Ineligible|0
1713980|NCT01131260|5981170|P2|Overall Study|Staff error|1
1713981|NCT01131260|5981171|P1|Overall Study|Staff error|2
1713982|NCT01131260|5981170|P2|Overall Study|Technical problems|6
1713983|NCT01131260|5981171|P1|Overall Study|Technical problems|7
1713984|NCT01131260|5981170|P2|Overall Study|Physician Decision|24
1713985|NCT01131260|5981171|P1|Overall Study|Physician Decision|22
1713986|NCT01131260|5981170|P2|Overall Study|Declined to continue participation|13
1713987|NCT01131260|5981171|P1|Overall Study|Declined to continue participation|8
1713988|NCT01131260|5981170|P2|Overall Study|Randomization error|1
1713989|NCT01131260|5981171|P1|Overall Study|Randomization error|5
1713990|NCT01131182|5981219|P2|Overall Study|Other Reason|0
1713991|NCT01131182|5981220|P1|Overall Study|Other Reason|1
1713992|NCT01131182|5981219|P2|Overall Study|Lost to Follow-up|15
1713993|NCT01131182|5981220|P1|Overall Study|Lost to Follow-up|14
1713994|NCT01131182|5981219|P2|Overall Study|Withdrawal by Subject|1
1713995|NCT01131182|5981220|P1|Overall Study|Withdrawal by Subject|1
1713996|NCT01131130|5981228|P1|Period 3- Crossover|+ Slit lamp finding|1
1713997|NCT01131130|5981228|P1|Period 1 - Baseline|Pregnancy|1
1713998|NCT01131104|5981241|P1|Overall Study|No Information on Index Date of Onset|1
1713999|NCT01131104|5981241|P1|Overall Study|Information Not Available|5
1714000|NCT01131104|5981241|P1|Overall Study|Physician Decision|4
1714001|NCT01131104|5981241|P1|Overall Study|Withdrawal by Subject|3
1714002|NCT01131078|5981248|P3|Overall Study|Other|0
1714003|NCT01131078|5981249|P2|Overall Study|Other|1
1714004|NCT01131078|5981250|P1|Overall Study|Other|0
1714005|NCT01131078|5981248|P3|Overall Study|Death|2
1714006|NCT01131078|5981249|P2|Overall Study|Death|0
1714007|NCT01131078|5981250|P1|Overall Study|Death|4
1714008|NCT01131078|5981248|P3|Overall Study|Physician Decision|8
1714009|NCT01131078|5981249|P2|Overall Study|Physician Decision|6
1714010|NCT01131078|5981250|P1|Overall Study|Physician Decision|10
1714011|NCT01131078|5981248|P3|Overall Study|Non-compliance|0
1714012|NCT01131078|5981249|P2|Overall Study|Non-compliance|0
1714013|NCT01131078|5981250|P1|Overall Study|Non-compliance|3
1714014|NCT01131078|5981248|P3|Overall Study|Withdrawal by Subject|3
1714015|NCT01131078|5981249|P2|Overall Study|Withdrawal by Subject|4
1714016|NCT01131078|5981250|P1|Overall Study|Withdrawal by Subject|2
1714017|NCT01131078|5981248|P3|Overall Study|Lost to Follow-up|1
1714018|NCT01131078|5981249|P2|Overall Study|Lost to Follow-up|1
1714019|NCT01131078|5981250|P1|Overall Study|Lost to Follow-up|1
1714020|NCT01131078|5981248|P3|Overall Study|Protocol Violation|0
1714021|NCT01131078|5981249|P2|Overall Study|Protocol Violation|0
1714022|NCT01131078|5981250|P1|Overall Study|Protocol Violation|1
1714023|NCT01131078|5981248|P3|Overall Study|Progressive Disease|71
1714024|NCT01131078|5981249|P2|Overall Study|Progressive Disease|77
1714025|NCT01131078|5981250|P1|Overall Study|Progressive Disease|58
1714026|NCT01131078|5981248|P3|Overall Study|Adverse Event|17
1714027|NCT01131078|5981249|P2|Overall Study|Adverse Event|12
1714028|NCT01131078|5981250|P1|Overall Study|Adverse Event|22
1714029|NCT01130974|5981337|P2|Overall Study|Ineligibility criteria|2
1714030|NCT01130974|5981338|P1|Overall Study|Ineligibility criteria|5
1714031|NCT01130974|5981337|P2|Overall Study|Withdrawal by Subject|1
1714032|NCT01130974|5981338|P1|Overall Study|Withdrawal by Subject|0
1714033|NCT01130974|5981337|P2|Overall Study|Protocol Violation|10
1714034|NCT01130974|5981338|P1|Overall Study|Protocol Violation|10
1714035|NCT01130883|5981364|P1|Overall Study|Adverse Event|3
1714036|NCT01130883|5981364|P1|Overall Study|Reason Unknown|1
1714037|NCT01130883|5981364|P1|Overall Study|Patient Noncompliance|6
1714038|NCT01130831|5981421|P1|Overall Study|Information was missing|3
1714039|NCT01130831|5981421|P1|Overall Study|Death|4
1714040|NCT01130831|5981421|P1|Overall Study|Withdrawal by Subject|7
1714041|NCT01130597|5981460|P1|Overall Study|Protocol Violation|1
1714042|NCT01130597|5981460|P1|Overall Study|Death|1
1714043|NCT01130597|5981460|P1|Overall Study|Adverse Event|4
1714044|NCT01130597|5981460|P1|Overall Study|Protocol-specified (High K+)|1
1714045|NCT01130532|5981485|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
1714046|NCT01130532|5981486|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1714047|NCT01130532|5981487|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1714048|NCT01130532|5981488|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
1714049|NCT01130532|5981485|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
1714050|NCT01130532|5981486|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
1714051|NCT01130532|5981487|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
1714052|NCT01130532|5981488|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
1714053|NCT01130532|5981485|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
1714054|NCT01130532|5981486|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1714055|NCT01130532|5981487|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1714056|NCT01130532|5981488|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
1714057|NCT01130532|5981485|P4|Period IV (Weeks 13-16)|Adverse Event|1
1714058|NCT01130532|5981486|P3|Period IV (Weeks 13-16)|Adverse Event|0
1714059|NCT01130532|5981487|P2|Period IV (Weeks 13-16)|Adverse Event|0
1714060|NCT01130532|5981488|P1|Period IV (Weeks 13-16)|Adverse Event|0
1714061|NCT01130532|5981485|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
1714062|NCT01130532|5981486|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
1714063|NCT01130532|5981487|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
1714064|NCT01130532|5981488|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
1714065|NCT01130532|5981485|P4|Period III (Weeks 0-12)|Sponsor Decision|0
1714066|NCT01130532|5981486|P3|Period III (Weeks 0-12)|Sponsor Decision|2
1714067|NCT01130532|5981487|P2|Period III (Weeks 0-12)|Sponsor Decision|4
1714068|NCT01130532|5981488|P1|Period III (Weeks 0-12)|Sponsor Decision|3
1714069|NCT01130532|5981485|P4|Period III (Weeks 0-12)|Protocol Violation|0
1714070|NCT01130532|5981486|P3|Period III (Weeks 0-12)|Protocol Violation|1
1714071|NCT01130532|5981487|P2|Period III (Weeks 0-12)|Protocol Violation|0
1714072|NCT01130532|5981488|P1|Period III (Weeks 0-12)|Protocol Violation|0
1714073|NCT01130532|5981485|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
1714074|NCT01130532|5981486|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
1714075|NCT01130532|5981487|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
1714076|NCT01130532|5981488|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
1714077|NCT01130532|5981485|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
1714078|NCT01130532|5981486|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
1714079|NCT01130532|5981487|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
1714080|NCT01130532|5981488|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
1714081|NCT01130532|5981485|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
1714082|NCT01130532|5981486|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
1714083|NCT01130532|5981487|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
1714084|NCT01130532|5981488|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
1714085|NCT01130532|5981485|P4|Period III (Weeks 0-12)|Adverse Event|0
1714086|NCT01130532|5981486|P3|Period III (Weeks 0-12)|Adverse Event|2
1714087|NCT01130532|5981487|P2|Period III (Weeks 0-12)|Adverse Event|3
1714088|NCT01130532|5981488|P1|Period III (Weeks 0-12)|Adverse Event|3
1714089|NCT01130493|5981533|P3|Part 2: OLE|Withdrawal by Subject|4
1714090|NCT01130493|5981534|P2|Part 2: OLE|Withdrawal by Subject|1
1714091|NCT01130493|5981535|P1|Part 2: OLE|Withdrawal by Subject|0
1714092|NCT01130493|5981533|P3|Part 2: OLE|Adverse Event|1
1714093|NCT01130493|5981534|P2|Part 2: OLE|Adverse Event|2
1714094|NCT01130493|5981535|P1|Part 2: OLE|Adverse Event|0
1714095|NCT01130493|5981533|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
1714096|NCT01130493|5981534|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
1714097|NCT01130493|5981535|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
1714098|NCT01130493|5981533|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
1714099|NCT01130493|5981534|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
1714100|NCT01130493|5981535|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
1714101|NCT01130493|5981533|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
1714102|NCT01130493|5981534|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
1714103|NCT01130493|5981535|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
1714104|NCT01130493|5981533|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
1714105|NCT01130493|5981534|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
1714106|NCT01130493|5981535|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
1714107|NCT01130493|5981533|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
1714108|NCT01130493|5981534|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
1714109|NCT01130493|5981535|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
1714110|NCT01130493|5981533|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
1714111|NCT01130493|5981534|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
1714112|NCT01130493|5981535|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
1714113|NCT01130493|5981533|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
1714114|NCT01130493|5981534|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
1714115|NCT01130493|5981535|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
1714116|NCT01130493|5981533|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
1714117|NCT01130493|5981534|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
1714118|NCT01130493|5981535|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
1714119|NCT01130493|5981533|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
1714120|NCT01130493|5981534|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
1714121|NCT01130493|5981535|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
1714122|NCT01130493|5981533|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
1714123|NCT01130493|5981534|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
1714124|NCT01130493|5981535|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
1714125|NCT01130493|5981533|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
1714126|NCT01130493|5981534|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
1714127|NCT01130493|5981535|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
1714128|NCT01130493|5981533|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
1714129|NCT01130493|5981534|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
1714130|NCT01130493|5981535|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
1714131|NCT01130337|5981552|P1|Overall Study|Surgical resection (R2)|1
1714132|NCT01130337|5981552|P1|Overall Study|Toxicity, AE/intercurrent disease|7
1714133|NCT01130337|5981552|P1|Overall Study|Disease progression|1
1714134|NCT01130337|5981552|P1|Overall Study|Death|1
1714135|NCT01130337|5981552|P1|Overall Study|Principal investigator decision|1
1714136|NCT01130337|5981552|P1|Overall Study|Withdrawal by Subject|3
1714137|NCT01130272|5981564|P5|Overall Study|Study arm discontinued|0
1714138|NCT01130272|5981565|P4|Overall Study|Study arm discontinued|0
1714139|NCT01130272|5981566|P3|Overall Study|Study arm discontinued|0
1714140|NCT01130272|5981567|P2|Overall Study|Study arm discontinued|0
1714141|NCT01130272|5981568|P1|Overall Study|Study arm discontinued|38
1714142|NCT01130272|5981564|P5|Overall Study|Sponsor decision|16
1714143|NCT01130272|5981565|P4|Overall Study|Sponsor decision|13
1714144|NCT01130272|5981566|P3|Overall Study|Sponsor decision|16
1714145|NCT01130272|5981567|P2|Overall Study|Sponsor decision|15
1714146|NCT01130272|5981568|P1|Overall Study|Sponsor decision|6
1714147|NCT01130272|5981564|P5|Overall Study|Physician Decision|2
1714148|NCT01130272|5981565|P4|Overall Study|Physician Decision|1
1714149|NCT01130272|5981566|P3|Overall Study|Physician Decision|0
1714150|NCT01130272|5981567|P2|Overall Study|Physician Decision|1
1714151|NCT01130272|5981568|P1|Overall Study|Physician Decision|1
1714152|NCT01130272|5981564|P5|Overall Study|Withdrawal by Subject|8
1714153|NCT01130272|5981565|P4|Overall Study|Withdrawal by Subject|9
1714154|NCT01130272|5981566|P3|Overall Study|Withdrawal by Subject|10
1714155|NCT01130272|5981567|P2|Overall Study|Withdrawal by Subject|11
1714156|NCT01130272|5981568|P1|Overall Study|Withdrawal by Subject|4
1714157|NCT01130272|5981564|P5|Overall Study|Lost to Follow-up|6
1714158|NCT01130272|5981565|P4|Overall Study|Lost to Follow-up|7
1714159|NCT01130272|5981566|P3|Overall Study|Lost to Follow-up|4
1714160|NCT01130272|5981567|P2|Overall Study|Lost to Follow-up|3
1714161|NCT01130272|5981568|P1|Overall Study|Lost to Follow-up|4
1714162|NCT01130272|5981564|P5|Overall Study|Protocol Violation|5
1714163|NCT01130272|5981565|P4|Overall Study|Protocol Violation|5
1714164|NCT01130272|5981566|P3|Overall Study|Protocol Violation|3
1714165|NCT01130272|5981567|P2|Overall Study|Protocol Violation|0
1714166|NCT01130272|5981568|P1|Overall Study|Protocol Violation|0
1714167|NCT01130272|5981564|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
1714168|NCT01130272|5981565|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
1714169|NCT01130272|5981566|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
1714170|NCT01130272|5981567|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
1714171|NCT01130272|5981568|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
1714172|NCT01130272|5981564|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
1714173|NCT01130272|5981565|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
1714174|NCT01130272|5981566|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
1714175|NCT01130272|5981567|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
1714176|NCT01130272|5981568|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
1714177|NCT01130272|5981564|P5|Overall Study|Rescue medications due to diarrhea|6
1714178|NCT01130272|5981565|P4|Overall Study|Rescue medications due to diarrhea|8
1714179|NCT01130272|5981566|P3|Overall Study|Rescue medications due to diarrhea|8
1714180|NCT01130272|5981567|P2|Overall Study|Rescue medications due to diarrhea|5
1714181|NCT01130272|5981568|P1|Overall Study|Rescue medications due to diarrhea|3
1714182|NCT01130272|5981564|P5|Overall Study|IVRS-confirmed constipation|0
1714183|NCT01130272|5981565|P4|Overall Study|IVRS-confirmed constipation|2
1714184|NCT01130272|5981566|P3|Overall Study|IVRS-confirmed constipation|1
1714185|NCT01130272|5981567|P2|Overall Study|IVRS-confirmed constipation|1
1714186|NCT01130272|5981568|P1|Overall Study|IVRS-confirmed constipation|0
1714187|NCT01130272|5981564|P5|Overall Study|Adverse Event|7
1714188|NCT01130272|5981565|P4|Overall Study|Adverse Event|22
1714189|NCT01130272|5981566|P3|Overall Study|Adverse Event|6
1714190|NCT01130272|5981567|P2|Overall Study|Adverse Event|5
1714191|NCT01130272|5981568|P1|Overall Study|Adverse Event|2
1714192|NCT01130168|5981605|P6|Period 1|Adverse Event|0
1714193|NCT01130168|5981606|P5|Period 1|Adverse Event|0
1714194|NCT01130168|5981607|P4|Period 1|Adverse Event|1
1714195|NCT01130168|5981608|P3|Period 1|Adverse Event|0
1714196|NCT01130168|5981609|P2|Period 1|Adverse Event|0
1714197|NCT01130168|5981610|P1|Period 1|Adverse Event|0
1714198|NCT01130168|5981605|P6|Period 1|Discontinued For Other Reason|0
1714199|NCT01130168|5981606|P5|Period 1|Discontinued For Other Reason|0
1714200|NCT01130168|5981607|P4|Period 1|Discontinued For Other Reason|1
1714201|NCT01130168|5981608|P3|Period 1|Discontinued For Other Reason|1
1714202|NCT01130168|5981609|P2|Period 1|Discontinued For Other Reason|0
1714203|NCT01130168|5981610|P1|Period 1|Discontinued For Other Reason|0
1714204|NCT01130168|5981605|P6|Period 1|Withdrawal by Subject|0
1714205|NCT01130168|5981606|P5|Period 1|Withdrawal by Subject|0
1714206|NCT01130168|5981607|P4|Period 1|Withdrawal by Subject|1
1714207|NCT01130168|5981608|P3|Period 1|Withdrawal by Subject|0
1714208|NCT01130168|5981609|P2|Period 1|Withdrawal by Subject|1
1714209|NCT01130168|5981610|P1|Period 1|Withdrawal by Subject|0
1714210|NCT01130103|5981647|P2|Maintenance Treatment|Withdrawal by Subject|0
1714211|NCT01130103|5981648|P1|Maintenance Treatment|Withdrawal by Subject|1
1714212|NCT01130103|5981647|P2|Maintenance Treatment|Lost to Follow-up|1
1714213|NCT01130103|5981648|P1|Maintenance Treatment|Lost to Follow-up|1
1714214|NCT01130103|5981647|P2|Maintenance Treatment|Lack of Efficacy|1
1714215|NCT01130103|5981648|P1|Maintenance Treatment|Lack of Efficacy|0
1714216|NCT01130103|5981647|P2|Randomized Treatment|Withdrawal by Subject|2
1714217|NCT01130103|5981648|P1|Randomized Treatment|Withdrawal by Subject|1
1714218|NCT01130103|5981647|P2|Randomized Treatment|Protocol Violation|2
1714219|NCT01130103|5981648|P1|Randomized Treatment|Protocol Violation|3
1714220|NCT01130103|5981647|P2|Randomized Treatment|Lost to Follow-up|0
1714221|NCT01130103|5981648|P1|Randomized Treatment|Lost to Follow-up|1
1714222|NCT01130103|5981647|P2|Randomized Treatment|Adverse Event|1
1714223|NCT01130103|5981648|P1|Randomized Treatment|Adverse Event|1
1714224|NCT01130051|5981662|P2|Washout Period of 14 Days|Protocol Violation|1
1714225|NCT01130051|5981663|P1|Washout Period of 14 Days|Protocol Violation|1
1714226|NCT01130051|5981662|P2|Washout Period of 14 Days|Withdrawal by Subject|1
1714227|NCT01130051|5981663|P1|Washout Period of 14 Days|Withdrawal by Subject|0
1714228|NCT01129960|5981677|P4|Overall Study|Pregnancy|0
1714229|NCT01129960|5981678|P3|Overall Study|Pregnancy|0
1714230|NCT01129960|5981679|P2|Overall Study|Pregnancy|0
1714231|NCT01129960|5981680|P1|Overall Study|Pregnancy|1
1714232|NCT01129960|5981677|P4|Overall Study|Physician Decision|0
1714233|NCT01129960|5981678|P3|Overall Study|Physician Decision|0
1714234|NCT01129960|5981679|P2|Overall Study|Physician Decision|0
1714235|NCT01129960|5981680|P1|Overall Study|Physician Decision|1
1714236|NCT01129960|5981677|P4|Overall Study|Discontinuation of the study by Sponsor|0
1714237|NCT01129960|5981678|P3|Overall Study|Discontinuation of the study by Sponsor|0
1714238|NCT01129960|5981679|P2|Overall Study|Discontinuation of the study by Sponsor|1
1714239|NCT01129960|5981680|P1|Overall Study|Discontinuation of the study by Sponsor|0
1714240|NCT01129960|5981677|P4|Overall Study|Lost to Follow-up|3
1714241|NCT01129960|5981678|P3|Overall Study|Lost to Follow-up|3
1714242|NCT01129960|5981679|P2|Overall Study|Lost to Follow-up|2
1714243|NCT01129960|5981680|P1|Overall Study|Lost to Follow-up|0
1714244|NCT01129960|5981677|P4|Overall Study|Protocol Violation|0
1714245|NCT01129960|5981678|P3|Overall Study|Protocol Violation|3
1714246|NCT01129960|5981679|P2|Overall Study|Protocol Violation|2
1714247|NCT01129960|5981680|P1|Overall Study|Protocol Violation|1
1714248|NCT01129960|5981677|P4|Overall Study|Adverse Event|7
1714249|NCT01129960|5981678|P3|Overall Study|Adverse Event|16
1714250|NCT01129960|5981679|P2|Overall Study|Adverse Event|16
1714251|NCT01129960|5981680|P1|Overall Study|Adverse Event|23
1714252|NCT01129960|5981677|P4|Overall Study|Lack of Efficacy|1
1714253|NCT01129960|5981678|P3|Overall Study|Lack of Efficacy|1
1714254|NCT01129960|5981679|P2|Overall Study|Lack of Efficacy|1
1714255|NCT01129960|5981680|P1|Overall Study|Lack of Efficacy|1
1714256|NCT01129960|5981677|P4|Overall Study|Withdrawal by Subject|2
1714257|NCT01129960|5981678|P3|Overall Study|Withdrawal by Subject|3
1714258|NCT01129960|5981679|P2|Overall Study|Withdrawal by Subject|0
1714259|NCT01129960|5981680|P1|Overall Study|Withdrawal by Subject|3
1714260|NCT01129921|5981692|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
1714261|NCT01129921|5981693|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
1714262|NCT01129921|5981692|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
1714263|NCT01129921|5981693|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
1714264|NCT01129921|5981692|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
1714265|NCT01129921|5981693|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
1714266|NCT01129921|5981692|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
1714267|NCT01129921|5981693|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
1714268|NCT01129882|5981703|P1|Overall Study|Withdrawal by Subject|160
1714269|NCT01129882|5981703|P1|Overall Study|Trial Termination by Sponsor|6
1714270|NCT01129882|5981703|P1|Overall Study|Withdrawal Criteria Met|19
1714271|NCT01129882|5981703|P1|Overall Study|Protocol Deviation|3
1714272|NCT01129882|5981703|P1|Overall Study|Physician Decision|27
1714273|NCT01129882|5981703|P1|Overall Study|Lost to Follow-up|13
1714274|NCT01129882|5981703|P1|Overall Study|Lack of Efficacy|5
1714275|NCT01129882|5981703|P1|Overall Study|Death|6
1714276|NCT01129882|5981703|P1|Overall Study|Adverse Event|39
1714277|NCT01129622|5981722|P1|Overall Study|Withdrawal by Subject|2
1714278|NCT01129583|5981733|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
1714279|NCT01129583|5981734|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
1714280|NCT01129583|5981733|P2|Overall Study|Lost to Follow-up|1
1714281|NCT01129583|5981734|P1|Overall Study|Lost to Follow-up|1
1714282|NCT01129583|5981733|P2|Overall Study|Death|0
1714283|NCT01129583|5981734|P1|Overall Study|Death|1
1714284|NCT01129557|5981747|P3|Overall Study|Novartis terminated study early|2
1714285|NCT01129557|5981748|P2|Overall Study|Novartis terminated study early|3
1714286|NCT01129557|5981749|P1|Overall Study|Novartis terminated study early|3
1714287|NCT01129557|5981747|P3|Overall Study|Adverse Event|2
1714288|NCT01129557|5981748|P2|Overall Study|Adverse Event|2
1714289|NCT01129557|5981749|P1|Overall Study|Adverse Event|1
1714290|NCT01129336|5981857|P2|Overall Study|Death|4
1714291|NCT01129336|5981858|P1|Overall Study|Death|0
1714292|NCT01129336|5981857|P2|Overall Study|Missing Study Completion Status|3
1714293|NCT01129336|5981858|P1|Overall Study|Missing Study Completion Status|2
1714294|NCT01129336|5981857|P2|Overall Study|Adverse Event|1
1714295|NCT01129336|5981858|P1|Overall Study|Adverse Event|0
1714296|NCT01129336|5981857|P2|Overall Study|Withdrawal by Subject|4
1714297|NCT01129336|5981858|P1|Overall Study|Withdrawal by Subject|7
1714298|NCT01129336|5981857|P2|Overall Study|Lost to Follow-up|0
1714299|NCT01129336|5981858|P1|Overall Study|Lost to Follow-up|1
1714300|NCT01129336|5981857|P2|Overall Study|Disease Progression|4
1714301|NCT01129336|5981858|P1|Overall Study|Disease Progression|1
1714302|NCT01129336|5981857|P2|Overall Study|Protocol Violation|0
1714303|NCT01129336|5981858|P1|Overall Study|Protocol Violation|1
1714304|NCT01129284|5981873|P3|Overall Study|Adverse Event|1
1714305|NCT01129284|5981874|P2|Overall Study|Adverse Event|0
1714306|NCT01129284|5981875|P1|Overall Study|Adverse Event|2
1714307|NCT01129128|5981923|P3|Overall Study|Physician Decision|0
1714308|NCT01129128|5981924|P2|Overall Study|Physician Decision|0
1714309|NCT01129128|5981925|P1|Overall Study|Physician Decision|1
1714310|NCT01129128|5981923|P3|Overall Study|Withdrawal by Subject|3
1714311|NCT01129128|5981924|P2|Overall Study|Withdrawal by Subject|1
1714312|NCT01129128|5981925|P1|Overall Study|Withdrawal by Subject|0
1714313|NCT01129128|5981923|P3|Overall Study|Protocol Violation|0
1714314|NCT01129128|5981924|P2|Overall Study|Protocol Violation|1
1714315|NCT01129128|5981925|P1|Overall Study|Protocol Violation|0
1714316|NCT01129128|5981923|P3|Overall Study|Lost to Follow-up|1
1714317|NCT01129128|5981924|P2|Overall Study|Lost to Follow-up|2
1714318|NCT01129128|5981925|P1|Overall Study|Lost to Follow-up|2
1714319|NCT01129115|5981949|P4|Overall Study|Protocol Violation|2
1714320|NCT01129115|5981950|P3|Overall Study|Protocol Violation|2
1714321|NCT01129115|5981951|P2|Overall Study|Protocol Violation|2
1714322|NCT01129115|5981952|P1|Overall Study|Protocol Violation|0
1714323|NCT01129115|5981949|P4|Overall Study|Withdrawal by Subject|4
1714324|NCT01129115|5981950|P3|Overall Study|Withdrawal by Subject|1
1714325|NCT01129115|5981951|P2|Overall Study|Withdrawal by Subject|3
1714326|NCT01129115|5981952|P1|Overall Study|Withdrawal by Subject|1
1714327|NCT01129115|5981949|P4|Overall Study|Adverse Event|3
1714328|NCT01129115|5981950|P3|Overall Study|Adverse Event|3
1714329|NCT01129115|5981951|P2|Overall Study|Adverse Event|2
1714330|NCT01129115|5981952|P1|Overall Study|Adverse Event|1
1714331|NCT01129102|5981989|P3|Overall Study|Lost to Follow-up|0
1714332|NCT01129102|5981990|P2|Overall Study|Lost to Follow-up|0
1714333|NCT01129102|5981991|P1|Overall Study|Lost to Follow-up|2
1714334|NCT01129102|5981989|P3|Overall Study|Adverse Event|1
1714335|NCT01129102|5981990|P2|Overall Study|Adverse Event|2
1714336|NCT01129102|5981991|P1|Overall Study|Adverse Event|2
1714337|NCT01129102|5981989|P3|Overall Study|Pregnancy|1
1714338|NCT01129102|5981990|P2|Overall Study|Pregnancy|0
1714339|NCT01129102|5981991|P1|Overall Study|Pregnancy|0
1714340|NCT01129102|5981989|P3|Overall Study|Protocol Violation|1
1714341|NCT01129102|5981990|P2|Overall Study|Protocol Violation|1
1714342|NCT01129102|5981991|P1|Overall Study|Protocol Violation|0
1714343|NCT01129102|5981989|P3|Overall Study|Withdrawal by Subject|3
1714344|NCT01129102|5981990|P2|Overall Study|Withdrawal by Subject|0
1714345|NCT01129102|5981991|P1|Overall Study|Withdrawal by Subject|2
1714346|NCT01129102|5981989|P3|Overall Study|No study drug treatment|1
1714347|NCT01129102|5981990|P2|Overall Study|No study drug treatment|3
1714348|NCT01129102|5981991|P1|Overall Study|No study drug treatment|2
1714349|NCT01129011|5982002|P2|Overall Study|misc|4
1714350|NCT01129011|5982003|P1|Overall Study|misc|7
1714351|NCT01129011|5982002|P2|Overall Study|Duodenal Ulcer|8
1714352|NCT01129011|5982003|P1|Overall Study|Duodenal Ulcer|2
1714353|NCT01129011|5982002|P2|Overall Study|Lost to Follow-up|7
1714354|NCT01129011|5982003|P1|Overall Study|Lost to Follow-up|6
1714355|NCT01129011|5982002|P2|Overall Study|Withdrawal by Subject|8
1714356|NCT01129011|5982003|P1|Overall Study|Withdrawal by Subject|24
1714357|NCT01129011|5982002|P2|Overall Study|Adverse Event|30
1714358|NCT01129011|5982003|P1|Overall Study|Adverse Event|20
1714359|NCT01128959|5982058|P1|Treatment Period|Withdrawal by Subject|1
1714360|NCT01128959|5982058|P1|Treatment Period|Adverse Event|3
1714361|NCT01128959|5982058|P1|Lead in Period|Adverse Event|3
1714362|NCT01128946|5982064|P4|Period III|Protocol Violation|0
1714363|NCT01128946|5982065|P3|Period III|Protocol Violation|0
1714364|NCT01128946|5982066|P2|Period III|Protocol Violation|0
1714365|NCT01128946|5982067|P1|Period III|Protocol Violation|1
1714366|NCT01128946|5982064|P4|Period II|Withdrawal by Subject|1
1714367|NCT01128946|5982065|P3|Period II|Withdrawal by Subject|0
1714368|NCT01128946|5982066|P2|Period II|Withdrawal by Subject|0
1714369|NCT01128946|5982067|P1|Period II|Withdrawal by Subject|0
1714370|NCT01128946|5982064|P4|Period II|Protocol Violation|0
1714371|NCT01128946|5982065|P3|Period II|Protocol Violation|0
1714372|NCT01128946|5982066|P2|Period II|Protocol Violation|1
1714373|NCT01128946|5982067|P1|Period II|Protocol Violation|0
1714374|NCT01128946|5982064|P4|Period I|Withdrawal by Subject|1
1714375|NCT01128946|5982065|P3|Period I|Withdrawal by Subject|1
1714376|NCT01128946|5982066|P2|Period I|Withdrawal by Subject|0
1714377|NCT01128946|5982067|P1|Period I|Withdrawal by Subject|0
1714378|NCT01128946|5982064|P4|Period I|Protocol Violation|0
1714379|NCT01128946|5982065|P3|Period I|Protocol Violation|0
1714380|NCT01128946|5982066|P2|Period I|Protocol Violation|1
1714381|NCT01128946|5982067|P1|Period I|Protocol Violation|0
1714382|NCT01128894|5982085|P2|Overall Study|Conflicting HbA1c Results at Screening|0
1714383|NCT01128894|5982086|P1|Overall Study|Conflicting HbA1c Results at Screening|1
1714384|NCT01128894|5982085|P2|Overall Study|Physician Decision|1
1714385|NCT01128894|5982086|P1|Overall Study|Physician Decision|2
1714386|NCT01128894|5982085|P2|Overall Study|Withdrawal by Subject|12
1714387|NCT01128894|5982086|P1|Overall Study|Withdrawal by Subject|10
1714388|NCT01128894|5982085|P2|Overall Study|Lost to Follow-up|8
1714389|NCT01128894|5982086|P1|Overall Study|Lost to Follow-up|8
1714390|NCT01128894|5982085|P2|Overall Study|Noncompliance|5
1714391|NCT01128894|5982086|P1|Overall Study|Noncompliance|4
1714392|NCT01128894|5982085|P2|Overall Study|Protocol Violation|1
1714393|NCT01128894|5982086|P1|Overall Study|Protocol Violation|2
1714394|NCT01128894|5982085|P2|Overall Study|Adverse Event|41
1714395|NCT01128894|5982086|P1|Overall Study|Adverse Event|31
1714396|NCT01128842|5982104|P1|Overall Study|Disease Progression|6
1714397|NCT01128842|5982104|P1|Overall Study|Adverse Event|1
1714398|NCT01128738|5982121|P2|Second TP|Withdrawal by Subject|2
1714399|NCT01128738|5982122|P1|Second TP|Withdrawal by Subject|0
1714400|NCT01128738|5982121|P2|Second TP|Lost to Follow-up|1
1714401|NCT01128738|5982122|P1|Second TP|Lost to Follow-up|0
1714402|NCT01128738|5982121|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
1714403|NCT01128738|5982122|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
1714404|NCT01128738|5982121|P2|First Treatment Phase (TP)|Lost to Follow-up|0
1714405|NCT01128738|5982122|P1|First Treatment Phase (TP)|Lost to Follow-up|1
1714406|NCT01128621|5982247|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
1714407|NCT01128621|5982248|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
1714408|NCT01128595|5982369|P4|Treatment Period 3|Withdrawal by Subject|0
1714409|NCT01128595|5982370|P3|Treatment Period 3|Withdrawal by Subject|0
1714410|NCT01128595|5982371|P2|Treatment Period 3|Withdrawal by Subject|1
1714411|NCT01128595|5982372|P1|Treatment Period 3|Withdrawal by Subject|0
1714412|NCT01128569|5982402|P6|Treatment Period 2|Withdrawal by Subject|0
1714413|NCT01128569|5982403|P5|Treatment Period 2|Withdrawal by Subject|0
1714414|NCT01128569|5982404|P4|Treatment Period 2|Withdrawal by Subject|0
1714415|NCT01128569|5982405|P3|Treatment Period 2|Withdrawal by Subject|0
1714416|NCT01128569|5982406|P2|Treatment Period 2|Withdrawal by Subject|1
1714417|NCT01128569|5982407|P1|Treatment Period 2|Withdrawal by Subject|0
1714418|NCT01128569|5982402|P6|Washout Period 1|Adverse Event|0
1714419|NCT01128569|5982403|P5|Washout Period 1|Adverse Event|0
1714420|NCT01128569|5982404|P4|Washout Period 1|Adverse Event|0
1714421|NCT01128569|5982405|P3|Washout Period 1|Adverse Event|1
1714422|NCT01128569|5982406|P2|Washout Period 1|Adverse Event|0
1714423|NCT01128569|5982407|P1|Washout Period 1|Adverse Event|0
1714424|NCT01128543|5982424|P1|Overall Study|Protocol Violation|1
1714425|NCT01128543|5982424|P1|Overall Study|Withdrawal by Subject|3
1714426|NCT01128413|5982450|P2|Overall Study|Pt made DNR|0
1714427|NCT01128413|5982451|P1|Overall Study|Pt made DNR|1
1714428|NCT01128413|5982450|P2|Overall Study|NICOM Monitor Problems|1
1714429|NCT01128413|5982451|P1|Overall Study|NICOM Monitor Problems|2
1714430|NCT01128413|5982450|P2|Overall Study|Withdrawal by Subject|0
1714431|NCT01128413|5982451|P1|Overall Study|Withdrawal by Subject|1
1714432|NCT01128400|5982460|P3|Overall Study|Excluded due to sinus problems|0
1714433|NCT01128400|5982461|P2|Overall Study|Excluded due to sinus problems|1
1714434|NCT01128400|5982462|P1|Overall Study|Excluded due to sinus problems|0
1714435|NCT01128400|5982460|P3|Overall Study|were not invited to participate on taste|15
1714436|NCT01128400|5982461|P2|Overall Study|were not invited to participate on taste|0
1714437|NCT01128400|5982462|P1|Overall Study|were not invited to participate on taste|0
1714438|NCT01128400|5982460|P3|Overall Study|Screening failure|0
1714439|NCT01128400|5982461|P2|Overall Study|Screening failure|0
1714440|NCT01128400|5982462|P1|Overall Study|Screening failure|1
1714441|NCT01128400|5982460|P3|Overall Study|Lost to Follow-up|1
1714442|NCT01128400|5982461|P2|Overall Study|Lost to Follow-up|0
1714443|NCT01128400|5982462|P1|Overall Study|Lost to Follow-up|1
1714444|NCT01128387|5982475|P2|Overall Study|Physician Decision|1
1714445|NCT01128387|5982476|P1|Overall Study|Physician Decision|0
1714446|NCT01128361|5982486|P2|Overall Study|Withdrawal by Subject|2
1714447|NCT01128361|5982487|P1|Overall Study|Withdrawal by Subject|5
1714448|NCT01128361|5982486|P2|Overall Study|Lost to Follow-up|1
1714449|NCT01128361|5982487|P1|Overall Study|Lost to Follow-up|0
1714450|NCT01128296|5982499|P6|Overall Study|Withdrawal by Subject|2
1714451|NCT01128296|5982500|P5|Overall Study|Withdrawal by Subject|0
1714452|NCT01128296|5982501|P4|Overall Study|Withdrawal by Subject|0
1714453|NCT01128296|5982502|P3|Overall Study|Withdrawal by Subject|0
1714454|NCT01128296|5982503|P2|Overall Study|Withdrawal by Subject|0
1714455|NCT01128296|5982504|P1|Overall Study|Withdrawal by Subject|0
1714456|NCT01128296|5982499|P6|Overall Study|Physician Decision|3
1714457|NCT01128296|5982500|P5|Overall Study|Physician Decision|0
1714458|NCT01128296|5982501|P4|Overall Study|Physician Decision|0
1714459|NCT01128296|5982502|P3|Overall Study|Physician Decision|0
1714460|NCT01128296|5982503|P2|Overall Study|Physician Decision|0
1714461|NCT01128296|5982504|P1|Overall Study|Physician Decision|0
1714462|NCT01128244|5982535|P1|Overall Study|Scheduling conflict|2
1714463|NCT01128244|5982535|P1|Overall Study|Adverse Event|1
1714464|NCT01128179|5982576|P2|Overall Study|Protocol Violation|0
1714465|NCT01128179|5982577|P1|Overall Study|Protocol Violation|1
1714466|NCT01128179|5982576|P2|Overall Study|Death|0
1714467|NCT01128179|5982577|P1|Overall Study|Death|1
1714468|NCT01128153|5982597|P2|Overall Study|Developed discontinuation criteria|1
1714469|NCT01128153|5982598|P1|Overall Study|Developed discontinuation criteria|1
1714470|NCT01128153|5982597|P2|Overall Study|Protocol Violation|0
1714471|NCT01128153|5982598|P1|Overall Study|Protocol Violation|2
1714472|NCT01128153|5982597|P2|Overall Study|Incorrect enrolment to study|1
1714473|NCT01128153|5982598|P1|Overall Study|Incorrect enrolment to study|2
1714474|NCT01128153|5982597|P2|Overall Study|Withdrawal by Subject|3
1714475|NCT01128153|5982598|P1|Overall Study|Withdrawal by Subject|2
1714476|NCT01128153|5982597|P2|Overall Study|Condition under investigation worsened|7
1714477|NCT01128153|5982598|P1|Overall Study|Condition under investigation worsened|8
1714478|NCT01128153|5982597|P2|Overall Study|Adverse Event|3
1714479|NCT01128153|5982598|P1|Overall Study|Adverse Event|1
1714480|NCT01128114|5982614|P1|Overall Study|Screening Failed|2
1714481|NCT01128114|5982614|P1|Overall Study|Treatment Withdrawn|6
1714482|NCT01127763|5982631|P1|Overall Study|Physician Decision|2
1714483|NCT01127763|5982631|P1|Overall Study|Withdrawal by Subject|1
1714484|NCT01127763|5982631|P1|Overall Study|Adverse Event|2
1714485|NCT01127646|5982676|P2|Overall Study|Protocol Violation|1
1714486|NCT01127646|5982677|P1|Overall Study|Protocol Violation|0
1714487|NCT01127646|5982676|P2|Overall Study|Entry Criteria Not Met|0
1714488|NCT01127646|5982677|P1|Overall Study|Entry Criteria Not Met|1
1714489|NCT01127633|5982711|P2|Overall Study|Not treated|0
1714490|NCT01127633|5982712|P1|Overall Study|Not treated|1
1714491|NCT01127633|5982711|P2|Overall Study|Abnormal Lab/ECG Result|1
1714492|NCT01127633|5982712|P1|Overall Study|Abnormal Lab/ECG Result|0
1714493|NCT01127633|5982711|P2|Overall Study|Protocol Violation|16
1714494|NCT01127633|5982712|P1|Overall Study|Protocol Violation|8
1714495|NCT01127633|5982711|P2|Overall Study|Sponsor Decision|195
1714496|NCT01127633|5982712|P1|Overall Study|Sponsor Decision|163
1714497|NCT01127633|5982711|P2|Overall Study|Withdrawal by Subject|72
1714498|NCT01127633|5982712|P1|Overall Study|Withdrawal by Subject|57
1714499|NCT01127633|5982711|P2|Overall Study|Physician Decision|45
1714500|NCT01127633|5982712|P1|Overall Study|Physician Decision|60
1714501|NCT01127633|5982711|P2|Overall Study|Parent/Caregiver Decision|228
1714502|NCT01127633|5982712|P1|Overall Study|Parent/Caregiver Decision|246
1714503|NCT01127633|5982711|P2|Overall Study|Lost to Follow-up|0
1714504|NCT01127633|5982712|P1|Overall Study|Lost to Follow-up|4
1714505|NCT01127633|5982711|P2|Overall Study|Death|43
1714506|NCT01127633|5982712|P1|Overall Study|Death|40
1714507|NCT01127633|5982711|P2|Overall Study|Adverse Event|73
1714508|NCT01127633|5982712|P1|Overall Study|Adverse Event|74
1714509|NCT01127607|5982744|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
1714510|NCT01127607|5982745|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
1714511|NCT01127607|5982744|P2|Phase II (Between Subjects)|Lost to Follow-up|2
1714512|NCT01127607|5982745|P1|Phase II (Between Subjects)|Lost to Follow-up|0
1714513|NCT01127256|5982922|P2|Overall Study|Protocol Violation|0
1714514|NCT01127256|5982923|P1|Overall Study|Protocol Violation|1
1714515|NCT01127256|5982922|P2|Overall Study|Withdrawal by Subject|9
1714516|NCT01127256|5982923|P1|Overall Study|Withdrawal by Subject|5
1714517|NCT01127256|5982922|P2|Overall Study|Lost to Follow-up|17
1714518|NCT01127256|5982923|P1|Overall Study|Lost to Follow-up|16
1714519|NCT01127256|5982922|P2|Overall Study|Lack of Efficacy|0
1714520|NCT01127256|5982923|P1|Overall Study|Lack of Efficacy|4
1714521|NCT01127256|5982922|P2|Overall Study|Adverse Event|13
1714522|NCT01127256|5982923|P1|Overall Study|Adverse Event|13
1714523|NCT01127165|5982935|P2|Overall Study|Protocol Violation|1
1714524|NCT01127165|5982936|P1|Overall Study|Protocol Violation|0
1714525|NCT01127165|5982935|P2|Overall Study|Withdrawal by Subject|3
1714526|NCT01127165|5982936|P1|Overall Study|Withdrawal by Subject|1
1714527|NCT01127165|5982935|P2|Overall Study|Lost to Follow-up|5
1714528|NCT01127165|5982936|P1|Overall Study|Lost to Follow-up|3
1714529|NCT01127165|5982935|P2|Overall Study|Lack of Efficacy|8
1714530|NCT01127165|5982936|P1|Overall Study|Lack of Efficacy|10
1714531|NCT01127165|5982935|P2|Overall Study|Adverse Event|2
1714532|NCT01127165|5982936|P1|Overall Study|Adverse Event|2
1714533|NCT01127139|5982948|P1|Overall Study|Reason not specified|1
1714534|NCT01127139|5982948|P1|Overall Study|Lack of Efficacy|4
1714535|NCT01127139|5982948|P1|Overall Study|Incompliance|12
1714536|NCT01127139|5982948|P1|Overall Study|Adverse Event|40
1714537|NCT01127061|5982976|P2|Overall Study|Physician Decision|3
1714538|NCT01127061|5982977|P1|Overall Study|Physician Decision|3
1714539|NCT01127061|5982976|P2|Overall Study|Lost to Follow-up|10
1714540|NCT01127061|5982977|P1|Overall Study|Lost to Follow-up|7
1714541|NCT01126879|5983014|P2|Overall Study|Physician Decision|0
1714542|NCT01126879|5983015|P1|Overall Study|Physician Decision|1
1714543|NCT01126879|5983014|P2|Overall Study|Adverse Event|1
1714544|NCT01126879|5983015|P1|Overall Study|Adverse Event|0
1714545|NCT01126879|5983014|P2|Overall Study|Withdrawal by Subject|0
1714546|NCT01126879|5983015|P1|Overall Study|Withdrawal by Subject|1
1714547|NCT01126879|5983014|P2|Overall Study|Progressive Disease|1
1714548|NCT01126879|5983015|P1|Overall Study|Progressive Disease|3
1714549|NCT01126619|5983062|P1|Overall Study|Non-compliance|1
1714550|NCT01126619|5983062|P1|Overall Study|Withdrawal by Subject|9
1714551|NCT01126619|5983062|P1|Overall Study|Serious adverse event|1
1714552|NCT01126619|5983062|P1|Overall Study|Investigator decision|4
1714553|NCT01126619|5983062|P1|Overall Study|Not eligible for the study|2
1714554|NCT01126580|5983090|P3|Overall Study|Treatment Non-compliance|3
1714555|NCT01126580|5983091|P2|Overall Study|Treatment Non-compliance|2
1714556|NCT01126580|5983092|P1|Overall Study|Treatment Non-compliance|0
1714557|NCT01126580|5983090|P3|Overall Study|Lost to Follow-up|9
1714558|NCT01126580|5983091|P2|Overall Study|Lost to Follow-up|13
1714559|NCT01126580|5983092|P1|Overall Study|Lost to Follow-up|15
1714560|NCT01126580|5983090|P3|Overall Study|Protocol Violation|2
1714561|NCT01126580|5983091|P2|Overall Study|Protocol Violation|1
1714562|NCT01126580|5983092|P1|Overall Study|Protocol Violation|0
1714563|NCT01126580|5983090|P3|Overall Study|Lack of Efficacy|4
1714564|NCT01126580|5983091|P2|Overall Study|Lack of Efficacy|3
1714565|NCT01126580|5983092|P1|Overall Study|Lack of Efficacy|2
1714566|NCT01126580|5983090|P3|Overall Study|Entry Criteria Not Met|2
1714567|NCT01126580|5983091|P2|Overall Study|Entry Criteria Not Met|1
1714568|NCT01126580|5983092|P1|Overall Study|Entry Criteria Not Met|1
1714569|NCT01126580|5983090|P3|Overall Study|Physician Decision|2
1714570|NCT01126580|5983091|P2|Overall Study|Physician Decision|1
1714571|NCT01126580|5983092|P1|Overall Study|Physician Decision|1
1714572|NCT01126580|5983090|P3|Overall Study|Sponsor Decision|7
1714573|NCT01126580|5983091|P2|Overall Study|Sponsor Decision|4
1714574|NCT01126580|5983092|P1|Overall Study|Sponsor Decision|5
1714575|NCT01126580|5983090|P3|Overall Study|Withdrawal by Subject|14
1714576|NCT01126580|5983091|P2|Overall Study|Withdrawal by Subject|19
1714577|NCT01126580|5983092|P1|Overall Study|Withdrawal by Subject|11
1714578|NCT01126580|5983090|P3|Overall Study|Adverse Event|12
1714579|NCT01126580|5983091|P2|Overall Study|Adverse Event|8
1714580|NCT01126580|5983092|P1|Overall Study|Adverse Event|14
1714581|NCT01126541|5983187|P3|Overall Study|Administrative reason or other|2
1714582|NCT01126541|5983188|P2|Overall Study|Administrative reason or other|1
1714583|NCT01126541|5983189|P1|Overall Study|Administrative reason or other|1
1714584|NCT01126541|5983187|P3|Overall Study|Protocol Violation|1
1714585|NCT01126541|5983188|P2|Overall Study|Protocol Violation|0
1714586|NCT01126541|5983189|P1|Overall Study|Protocol Violation|0
1714587|NCT01126541|5983187|P3|Overall Study|Withdrawal by Subject|6
1714588|NCT01126541|5983188|P2|Overall Study|Withdrawal by Subject|5
1714589|NCT01126541|5983189|P1|Overall Study|Withdrawal by Subject|2
1714590|NCT01126541|5983187|P3|Overall Study|Lost to Follow-up|2
1714591|NCT01126541|5983188|P2|Overall Study|Lost to Follow-up|2
1714592|NCT01126541|5983189|P1|Overall Study|Lost to Follow-up|1
1714593|NCT01126541|5983187|P3|Overall Study|Lack of Efficacy|11
1714594|NCT01126541|5983188|P2|Overall Study|Lack of Efficacy|1
1714595|NCT01126541|5983189|P1|Overall Study|Lack of Efficacy|6
1714596|NCT01126541|5983187|P3|Overall Study|Death|0
1714597|NCT01126541|5983188|P2|Overall Study|Death|1
1714598|NCT01126541|5983189|P1|Overall Study|Death|0
1714599|NCT01126541|5983187|P3|Overall Study|Adverse Event|4
1714600|NCT01126541|5983188|P2|Overall Study|Adverse Event|2
1714601|NCT01126541|5983189|P1|Overall Study|Adverse Event|0
1714602|NCT01126437|5983273|P3|Overall Study|Other reason not specified|178
1714603|NCT01126437|5983274|P2|Overall Study|Other reason not specified|176
1714604|NCT01126437|5983275|P1|Overall Study|Other reason not specified|210
1714605|NCT01126437|5983273|P3|Overall Study|Withdrawal by Subject|319
1714606|NCT01126437|5983274|P2|Overall Study|Withdrawal by Subject|335
1714607|NCT01126437|5983275|P1|Overall Study|Withdrawal by Subject|331
1714608|NCT01126437|5983273|P3|Overall Study|Lost to Follow-up|55
1714609|NCT01126437|5983274|P2|Overall Study|Lost to Follow-up|63
1714610|NCT01126437|5983275|P1|Overall Study|Lost to Follow-up|52
1714611|NCT01126437|5983273|P3|Overall Study|Protocol Violation|41
1714612|NCT01126437|5983274|P2|Overall Study|Protocol Violation|66
1714613|NCT01126437|5983275|P1|Overall Study|Protocol Violation|64
1714614|NCT01126437|5983273|P3|Overall Study|Lack of Efficacy|59
1714615|NCT01126437|5983274|P2|Overall Study|Lack of Efficacy|60
1714616|NCT01126437|5983275|P1|Overall Study|Lack of Efficacy|65
1714617|NCT01126437|5983273|P3|Overall Study|Adverse Event|635
1714618|NCT01126437|5983274|P2|Overall Study|Adverse Event|606
1714619|NCT01126437|5983275|P1|Overall Study|Adverse Event|602
1714620|NCT01126437|5983273|P3|Overall Study|Sites with data irregularities/fraud|7
1714621|NCT01126437|5983274|P2|Overall Study|Sites with data irregularities/fraud|6
1714622|NCT01126437|5983275|P1|Overall Study|Sites with data irregularities/fraud|6
1714623|NCT01126437|5983273|P3|Overall Study|Not treated|19
1714624|NCT01126437|5983274|P2|Overall Study|Not treated|18
1714625|NCT01126437|5983275|P1|Overall Study|Not treated|11
1714626|NCT01126424|5983313|P6|Overall Study|Withdrawal by Subject|0
1714627|NCT01126424|5983314|P5|Overall Study|Withdrawal by Subject|1
1714628|NCT01126424|5983315|P4|Overall Study|Withdrawal by Subject|3
1714629|NCT01126424|5983316|P3|Overall Study|Withdrawal by Subject|1
1714630|NCT01126424|5983317|P2|Overall Study|Withdrawal by Subject|0
1714631|NCT01126424|5983318|P1|Overall Study|Withdrawal by Subject|0
1714632|NCT01126424|5983313|P6|Overall Study|Adverse Event|0
1714633|NCT01126424|5983314|P5|Overall Study|Adverse Event|1
1714634|NCT01126424|5983315|P4|Overall Study|Adverse Event|0
1714635|NCT01126424|5983316|P3|Overall Study|Adverse Event|0
1714636|NCT01126424|5983317|P2|Overall Study|Adverse Event|0
1714637|NCT01126424|5983318|P1|Overall Study|Adverse Event|0
1714638|NCT01126359|5983341|P2|First Intervention (20-minutes)|Physician Decision|1
1714639|NCT01126359|5983342|P1|First Intervention (20-minutes)|Physician Decision|0
1714640|NCT01126268|5983354|P1|Overall Study|Adverse Event|1
1714641|NCT01126060|5983393|P2|Overall Study|Protocol Violation|2
1714642|NCT01126060|5983394|P1|Overall Study|Protocol Violation|0
1714643|NCT01125930|5983402|P2|Overall Study|Lost to Follow-up|2
1714644|NCT01125930|5983403|P1|Overall Study|Lost to Follow-up|0
1714645|NCT01125930|5983402|P2|Overall Study|Protocol Violation|1
1714646|NCT01125930|5983403|P1|Overall Study|Protocol Violation|0
1714647|NCT01125930|5983402|P2|Overall Study|Withdrawal by Subject|6
1714648|NCT01125930|5983403|P1|Overall Study|Withdrawal by Subject|1
1714649|NCT01125930|5983402|P2|Overall Study|Adverse Event|1
1714650|NCT01125930|5983403|P1|Overall Study|Adverse Event|0
1714651|NCT01125917|5983557|P1|Overall Study|Lack of Efficacy|19
1714652|NCT01125917|5983557|P1|Overall Study|Administrative|223
1714653|NCT01125917|5983557|P1|Overall Study|Withdrawal by Subject|31
1714654|NCT01125917|5983557|P1|Overall Study|Lost to Follow-up|23
1714655|NCT01125917|5983557|P1|Overall Study|Adverse Event|43
1714656|NCT01125813|5983561|P1|Overall Study|Screen Failures|4
1714657|NCT01125813|5983561|P1|Overall Study|Withdrawal by Subject|1
1714658|NCT01125813|5983561|P1|Overall Study|Death|1
1714659|NCT01125800|5983571|P5|Phase II|Disease progression|8
1714660|NCT01125800|5983572|P4|Phase II|Disease progression|1
1714661|NCT01125800|5983573|P3|Phase II|Disease progression|0
1714662|NCT01125800|5983574|P2|Phase II|Disease progression|0
1714663|NCT01125800|5983575|P1|Phase II|Disease progression|0
1714664|NCT01125800|5983571|P5|Phase II|Adverse Event|2
1714665|NCT01125800|5983572|P4|Phase II|Adverse Event|0
1714666|NCT01125800|5983573|P3|Phase II|Adverse Event|0
1714667|NCT01125800|5983574|P2|Phase II|Adverse Event|0
1714668|NCT01125800|5983575|P1|Phase II|Adverse Event|0
1714669|NCT01125800|5983571|P5|Phase II|Protocol Violation|1
1714670|NCT01125800|5983572|P4|Phase II|Protocol Violation|0
1714671|NCT01125800|5983573|P3|Phase II|Protocol Violation|0
1714672|NCT01125800|5983574|P2|Phase II|Protocol Violation|0
1714673|NCT01125800|5983575|P1|Phase II|Protocol Violation|0
1714674|NCT01125800|5983571|P5|Phase I|Disease progression|0
1714675|NCT01125800|5983572|P4|Phase I|Disease progression|3
1714676|NCT01125800|5983573|P3|Phase I|Disease progression|1
1714677|NCT01125800|5983574|P2|Phase I|Disease progression|4
1714678|NCT01125800|5983575|P1|Phase I|Disease progression|5
1714679|NCT01125800|5983571|P5|Phase I|Withdrawal by Subject|0
1714680|NCT01125800|5983572|P4|Phase I|Withdrawal by Subject|0
1714681|NCT01125800|5983573|P3|Phase I|Withdrawal by Subject|1
1714682|NCT01125800|5983574|P2|Phase I|Withdrawal by Subject|0
1714683|NCT01125800|5983575|P1|Phase I|Withdrawal by Subject|0
1714684|NCT01125800|5983571|P5|Phase I|Administrative problems|0
1714685|NCT01125800|5983572|P4|Phase I|Administrative problems|0
1714686|NCT01125800|5983573|P3|Phase I|Administrative problems|0
1714687|NCT01125800|5983574|P2|Phase I|Administrative problems|0
1714688|NCT01125800|5983575|P1|Phase I|Administrative problems|1
1714689|NCT01125800|5983571|P5|Phase I|Adverse Event|0
1714690|NCT01125800|5983572|P4|Phase I|Adverse Event|7
1714691|NCT01125800|5983573|P3|Phase I|Adverse Event|1
1714692|NCT01125800|5983574|P2|Phase I|Adverse Event|2
1714693|NCT01125800|5983575|P1|Phase I|Adverse Event|2
1714694|NCT01125800|5983571|P5|Phase I|Protocol Violation|0
1714695|NCT01125800|5983572|P4|Phase I|Protocol Violation|1
1714696|NCT01125800|5983573|P3|Phase I|Protocol Violation|1
1714697|NCT01125800|5983574|P2|Phase I|Protocol Violation|3
1714698|NCT01125800|5983575|P1|Phase I|Protocol Violation|0
1714699|NCT01125748|5983641|P2|Overall Study|Patient Decision to Withdraw|4
1714700|NCT01125748|5983642|P1|Overall Study|Patient Decision to Withdraw|2
1714701|NCT01125748|5983641|P2|Overall Study|Physician Decision|7
1714702|NCT01125748|5983642|P1|Overall Study|Physician Decision|8
1714703|NCT01125748|5983641|P2|Overall Study|Lost to Follow-up|1
1714704|NCT01125748|5983642|P1|Overall Study|Lost to Follow-up|0
1714705|NCT01125748|5983641|P2|Overall Study|Adverse Event|2
1714706|NCT01125748|5983642|P1|Overall Study|Adverse Event|0
1714707|NCT01125722|5983652|P2|Overall Study|Lost to Follow-up|0
1714708|NCT01125722|5983653|P1|Overall Study|Lost to Follow-up|1
1714709|NCT01125722|5983652|P2|Overall Study|Withdrawal by Subject|1
1714710|NCT01125722|5983653|P1|Overall Study|Withdrawal by Subject|2
1714711|NCT01125566|5983700|P3|Patients Who Switched From AV to TV|Other than listed above|4
1714712|NCT01125566|5983701|P2|Patients Who Switched From AV to TV|Other than listed above|0
1714713|NCT01125566|5983702|P1|Patients Who Switched From AV to TV|Other than listed above|0
1714714|NCT01125566|5983700|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
1714715|NCT01125566|5983701|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
1714716|NCT01125566|5983702|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
1714717|NCT01125566|5983700|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
1714718|NCT01125566|5983701|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
1714719|NCT01125566|5983702|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
1714720|NCT01125566|5983700|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
1714721|NCT01125566|5983701|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
1714722|NCT01125566|5983702|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
1714723|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
1714724|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
1714725|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
1714726|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
1714727|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
1714728|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
1714729|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Not treated|0
1714730|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Not treated|0
1714731|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Not treated|2
1714732|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
1714733|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
1714734|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
1714735|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
1714736|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
1714737|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
1714738|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
1714739|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
1714740|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
1714741|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
1714742|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
1714743|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
1714744|NCT01125566|5983700|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
1714745|NCT01125566|5983701|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
1714746|NCT01125566|5983702|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
1714747|NCT01125514|5983715|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
1714748|NCT01125514|5983715|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
1714749|NCT01125514|5983715|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
1714750|NCT01125514|5983715|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
1714751|NCT01125514|5983715|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
1714752|NCT01125514|5983715|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
1714753|NCT01125189|5983815|P3|Follow up Period|Other reasons|5
1714754|NCT01125189|5983816|P2|Follow up Period|Other reasons|4
1714755|NCT01125189|5983817|P1|Follow up Period|Other reasons|4
1714756|NCT01125189|5983815|P3|Follow up Period|Lost to Follow-up|6
1714757|NCT01125189|5983816|P2|Follow up Period|Lost to Follow-up|9
1714758|NCT01125189|5983817|P1|Follow up Period|Lost to Follow-up|12
1714759|NCT01125189|5983815|P3|Follow up Period|Death|0
1714760|NCT01125189|5983816|P2|Follow up Period|Death|0
1714761|NCT01125189|5983817|P1|Follow up Period|Death|1
1714762|NCT01125189|5983815|P3|Follow up Period|Withdrawal by Subject|5
1714763|NCT01125189|5983816|P2|Follow up Period|Withdrawal by Subject|2
1714764|NCT01125189|5983817|P1|Follow up Period|Withdrawal by Subject|3
1714765|NCT01125189|5983815|P3|Treatment Period|Completed 24 week treatment period only|2
1714766|NCT01125189|5983816|P2|Treatment Period|Completed 24 week treatment period only|1
1714767|NCT01125189|5983817|P1|Treatment Period|Completed 24 week treatment period only|2
1714768|NCT01125189|5983815|P3|Treatment Period|Other reasons|0
1714769|NCT01125189|5983816|P2|Treatment Period|Other reasons|1
1714770|NCT01125189|5983817|P1|Treatment Period|Other reasons|1
1714771|NCT01125189|5983815|P3|Treatment Period|Participants requested to discontinue|4
1714772|NCT01125189|5983816|P2|Treatment Period|Participants requested to discontinue|3
1714773|NCT01125189|5983817|P1|Treatment Period|Participants requested to discontinue|1
1714774|NCT01125189|5983815|P3|Treatment Period|Poor compliance/noncompliance|0
1714775|NCT01125189|5983816|P2|Treatment Period|Poor compliance/noncompliance|1
1714776|NCT01125189|5983817|P1|Treatment Period|Poor compliance/noncompliance|0
1714777|NCT01125189|5983815|P3|Treatment Period|Lost to Follow-up|1
1714778|NCT01125189|5983816|P2|Treatment Period|Lost to Follow-up|2
1714779|NCT01125189|5983817|P1|Treatment Period|Lost to Follow-up|1
1714780|NCT01125189|5983815|P3|Treatment Period|Death|0
1714781|NCT01125189|5983816|P2|Treatment Period|Death|0
1714782|NCT01125189|5983817|P1|Treatment Period|Death|1
1714783|NCT01125189|5983815|P3|Treatment Period|Withdrawal by Subject|1
1714784|NCT01125189|5983816|P2|Treatment Period|Withdrawal by Subject|1
1714785|NCT01125189|5983817|P1|Treatment Period|Withdrawal by Subject|3
1714786|NCT01125189|5983815|P3|Treatment Period|Adverse Event|8
1714787|NCT01125189|5983816|P2|Treatment Period|Adverse Event|8
1714788|NCT01125189|5983817|P1|Treatment Period|Adverse Event|7
1714789|NCT01125189|5983815|P3|Treatment Period|Lack of Efficacy|25
1714790|NCT01125189|5983816|P2|Treatment Period|Lack of Efficacy|18
1714791|NCT01125189|5983817|P1|Treatment Period|Lack of Efficacy|15
1714792|NCT01124916|5983886|P2|Overall Study|Lost to Follow-up|2
1714793|NCT01124916|5983887|P1|Overall Study|Lost to Follow-up|3
1714794|NCT01124864|5983901|P6|Overall Study|Protocol Violation|0
1714795|NCT01124864|5983902|P5|Overall Study|Protocol Violation|1
1714796|NCT01124864|5983903|P4|Overall Study|Protocol Violation|0
1714797|NCT01124864|5983904|P3|Overall Study|Protocol Violation|0
1714798|NCT01124864|5983905|P2|Overall Study|Protocol Violation|0
1714799|NCT01124864|5983906|P1|Overall Study|Protocol Violation|1
1714800|NCT01124864|5983901|P6|Overall Study|Lost to Follow-up|0
1714801|NCT01124864|5983902|P5|Overall Study|Lost to Follow-up|0
1714802|NCT01124864|5983903|P4|Overall Study|Lost to Follow-up|1
1714803|NCT01124864|5983904|P3|Overall Study|Lost to Follow-up|0
1714804|NCT01124864|5983905|P2|Overall Study|Lost to Follow-up|1
1714805|NCT01124864|5983906|P1|Overall Study|Lost to Follow-up|1
1714806|NCT01124864|5983901|P6|Overall Study|Withdrawal by Subject|1
1714807|NCT01124864|5983902|P5|Overall Study|Withdrawal by Subject|2
1714808|NCT01124864|5983903|P4|Overall Study|Withdrawal by Subject|0
1714809|NCT01124864|5983904|P3|Overall Study|Withdrawal by Subject|4
1714810|NCT01124864|5983905|P2|Overall Study|Withdrawal by Subject|3
1714811|NCT01124864|5983906|P1|Overall Study|Withdrawal by Subject|2
1714812|NCT01124864|5983901|P6|Overall Study|Death|0
1714813|NCT01124864|5983902|P5|Overall Study|Death|1
1714814|NCT01124864|5983903|P4|Overall Study|Death|2
1714815|NCT01124864|5983904|P3|Overall Study|Death|6
1714816|NCT01124864|5983905|P2|Overall Study|Death|9
1714817|NCT01124864|5983906|P1|Overall Study|Death|6
1714818|NCT01124864|5983901|P6|Overall Study|Follow up phase competed as per protocol|2
1714819|NCT01124864|5983902|P5|Overall Study|Follow up phase competed as per protocol|26
1714820|NCT01124864|5983903|P4|Overall Study|Follow up phase competed as per protocol|18
1714821|NCT01124864|5983904|P3|Overall Study|Follow up phase competed as per protocol|24
1714822|NCT01124864|5983905|P2|Overall Study|Follow up phase competed as per protocol|22
1714823|NCT01124864|5983906|P1|Overall Study|Follow up phase competed as per protocol|18
1714824|NCT01124838|5983940|P2|Overall Study|Lost to Follow-up|0
1714825|NCT01124838|5983941|P1|Overall Study|Lost to Follow-up|2
1714826|NCT01124838|5983940|P2|Overall Study|Withdrawal by Subject|2
1714827|NCT01124838|5983941|P1|Overall Study|Withdrawal by Subject|3
1714828|NCT01124838|5983940|P2|Overall Study|Lack of Efficacy|0
1714829|NCT01124838|5983941|P1|Overall Study|Lack of Efficacy|2
1714830|NCT01124838|5983940|P2|Overall Study|Adverse Event|11
1714831|NCT01124838|5983941|P1|Overall Study|Adverse Event|7
1714832|NCT01124838|5983940|P2|Overall Study|Miscellaneous|2
1714833|NCT01124838|5983941|P1|Overall Study|Miscellaneous|4
1714834|NCT01124734|5984008|P1|Overall Study|Elected for alternative treatment|2
1714835|NCT01124734|5984008|P1|Overall Study|Withdrawal by Subject|1
1714836|NCT01124734|5984008|P1|Overall Study|Adverse Event|1
1714837|NCT01124734|5984008|P1|Overall Study|Disease progression|13
1714838|NCT01124643|5984019|P1|Overall Study|Death|1
1714839|NCT01124617|5984033|P2|Overall Study|Other|1
1714840|NCT01124617|5984034|P1|Overall Study|Other|2
1714841|NCT01124617|5984033|P2|Overall Study|Withdrawal by Subject|1
1714842|NCT01124617|5984034|P1|Overall Study|Withdrawal by Subject|9
1714843|NCT01124617|5984033|P2|Overall Study|Protocol Violation|1
1714844|NCT01124617|5984034|P1|Overall Study|Protocol Violation|1
1714845|NCT01124617|5984033|P2|Overall Study|Lack of Efficacy|1
1714846|NCT01124617|5984034|P1|Overall Study|Lack of Efficacy|2
1714847|NCT01124617|5984033|P2|Overall Study|Adverse Event|2
1714848|NCT01124617|5984034|P1|Overall Study|Adverse Event|5
1714849|NCT01124604|5984066|P2|Overall Study|Disease Progression|1
1714850|NCT01124604|5984067|P1|Overall Study|Disease Progression|0
1714851|NCT01124604|5984066|P2|Overall Study|Withdrawal by Subject|0
1714852|NCT01124604|5984067|P1|Overall Study|Withdrawal by Subject|4
1714853|NCT01124604|5984066|P2|Overall Study|Lack of Efficacy|0
1714854|NCT01124604|5984067|P1|Overall Study|Lack of Efficacy|1
1714855|NCT01124604|5984066|P2|Overall Study|Adverse Event|1
1714856|NCT01124604|5984067|P1|Overall Study|Adverse Event|10
1714857|NCT01124448|5984106|P2|Overall Study|Protocol Violation|0
1714858|NCT01124448|5984107|P1|Overall Study|Protocol Violation|2
1714859|NCT01124448|5984106|P2|Overall Study|Lost to Follow-up|3
1714860|NCT01124448|5984107|P1|Overall Study|Lost to Follow-up|0
1714861|NCT01124422|5984115|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
1714862|NCT01124422|5984116|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
1714863|NCT01124422|5984117|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
1714864|NCT01124422|5984115|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
1714865|NCT01124422|5984116|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
1714866|NCT01124422|5984117|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
1714867|NCT01124422|5984115|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
1714868|NCT01124422|5984116|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
1714869|NCT01124422|5984117|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
1714870|NCT01124422|5984115|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
1714871|NCT01124422|5984116|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
1714872|NCT01124422|5984117|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
1714873|NCT01124422|5984115|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
1714874|NCT01124422|5984116|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
1714875|NCT01124422|5984117|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
1714876|NCT01124422|5984115|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
1714877|NCT01124422|5984116|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
1714878|NCT01124422|5984117|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
1714879|NCT01124422|5984115|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
1714880|NCT01124422|5984116|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
1714881|NCT01124422|5984117|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
1714882|NCT01124422|5984115|P3|4-Week Open-label Run-in Phase|Physician Decision|0
1714883|NCT01124422|5984116|P2|4-Week Open-label Run-in Phase|Physician Decision|0
1714884|NCT01124422|5984117|P1|4-Week Open-label Run-in Phase|Physician Decision|4
1714885|NCT01124422|5984115|P3|4-Week Open-label Run-in Phase|Adverse Event|0
1714886|NCT01124422|5984116|P2|4-Week Open-label Run-in Phase|Adverse Event|0
1714887|NCT01124422|5984117|P1|4-Week Open-label Run-in Phase|Adverse Event|7
1714888|NCT01124422|5984115|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
1714889|NCT01124422|5984116|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
1714890|NCT01124422|5984117|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
1714891|NCT01124292|5984187|P3|Overall Study|piercing track closed|1
1714892|NCT01124292|5984188|P2|Overall Study|piercing track closed|2
1714893|NCT01124292|5984189|P1|Overall Study|piercing track closed|0
1714894|NCT01124292|5984187|P3|Overall Study|medical issue unrelated to the study|2
1714895|NCT01124292|5984188|P2|Overall Study|medical issue unrelated to the study|0
1714896|NCT01124292|5984189|P1|Overall Study|medical issue unrelated to the study|0
1714897|NCT01124292|5984187|P3|Overall Study|Withdrawal by Subject|2
1714898|NCT01124292|5984188|P2|Overall Study|Withdrawal by Subject|6
1714899|NCT01124292|5984189|P1|Overall Study|Withdrawal by Subject|0
1714900|NCT01124292|5984187|P3|Overall Study|Physician Decision|2
1714901|NCT01124292|5984188|P2|Overall Study|Physician Decision|3
1714902|NCT01124292|5984189|P1|Overall Study|Physician Decision|0
1714903|NCT01124292|5984187|P3|Overall Study|Lost to Follow-up|3
1714904|NCT01124292|5984188|P2|Overall Study|Lost to Follow-up|4
1714905|NCT01124292|5984189|P1|Overall Study|Lost to Follow-up|2
1714906|NCT01124175|5984260|P2|Washout of 7 Days|Withdrawal by Subject|2
1714907|NCT01124175|5984261|P1|Washout of 7 Days|Withdrawal by Subject|0
1714908|NCT01124162|5984279|P2|Washout of 7 Days|Withdrawal by Subject|0
1714909|NCT01124162|5984280|P1|Washout of 7 Days|Withdrawal by Subject|1
1714910|NCT01124162|5984279|P2|First Intervention|Adverse Event|0
1714911|NCT01124162|5984280|P1|First Intervention|Adverse Event|2
1714912|NCT01124149|5984296|P1|Maintenance Phase|Non-compliance|1
1714913|NCT01124149|5984296|P1|Maintenance Phase|Coordinator error|1
1714914|NCT01124149|5984296|P1|Maintenance Phase|Protocol Violation|5
1714915|NCT01124149|5984296|P1|Maintenance Phase|Withdrawal by Subject|10
1714916|NCT01124149|5984296|P1|Maintenance Phase|Lost to Follow-up|15
1714917|NCT01124149|5984296|P1|Maintenance Phase|Adverse Event|24
1714918|NCT01124149|5984296|P1|Maintenance Phase|Lack of Efficacy|40
1714919|NCT01124149|5984296|P1|Acute Phase|Sponsor decision|1
1714920|NCT01124149|5984296|P1|Acute Phase|Travelling to another country|1
1714921|NCT01124149|5984296|P1|Acute Phase|Low hemoglobin|1
1714922|NCT01124149|5984296|P1|Acute Phase|Non-compliance|1
1714923|NCT01124149|5984296|P1|Acute Phase|UC symptoms not ameliorated|1
1714924|NCT01124149|5984296|P1|Acute Phase|Sponsor request|1
1714925|NCT01124149|5984296|P1|Acute Phase|Prolonged antibiotic therapy|1
1714926|NCT01124149|5984296|P1|Acute Phase|Lost to Follow-up|2
1714927|NCT01124149|5984296|P1|Acute Phase|Protocol Violation|14
1714928|NCT01124149|5984296|P1|Acute Phase|Lack of Efficacy|17
1714929|NCT01124149|5984296|P1|Acute Phase|Adverse Event|21
1714930|NCT01124149|5984296|P1|Acute Phase|Withdrawal by Subject|22
1714931|NCT01124097|5984316|P4|Overall Study|Physician Decision|0
1714932|NCT01124097|5984317|P3|Overall Study|Physician Decision|0
1714933|NCT01124097|5984318|P2|Overall Study|Physician Decision|1
1714934|NCT01124097|5984319|P1|Overall Study|Physician Decision|2
1714935|NCT01124097|5984316|P4|Overall Study|Protocol Violation|1
1714936|NCT01124097|5984317|P3|Overall Study|Protocol Violation|2
1714937|NCT01124097|5984318|P2|Overall Study|Protocol Violation|0
1714938|NCT01124097|5984319|P1|Overall Study|Protocol Violation|2
1714939|NCT01124097|5984316|P4|Overall Study|Adverse Event|7
1714940|NCT01124097|5984317|P3|Overall Study|Adverse Event|15
1714941|NCT01124097|5984318|P2|Overall Study|Adverse Event|15
1714942|NCT01124097|5984319|P1|Overall Study|Adverse Event|24
1714943|NCT01124097|5984316|P4|Overall Study|Lack of Efficacy|3
1714944|NCT01124097|5984317|P3|Overall Study|Lack of Efficacy|1
1714945|NCT01124097|5984318|P2|Overall Study|Lack of Efficacy|3
1714946|NCT01124097|5984319|P1|Overall Study|Lack of Efficacy|2
1714947|NCT01124097|5984316|P4|Overall Study|Withdrawal by Subject|3
1714948|NCT01124097|5984317|P3|Overall Study|Withdrawal by Subject|2
1714949|NCT01124097|5984318|P2|Overall Study|Withdrawal by Subject|3
1714950|NCT01124097|5984319|P1|Overall Study|Withdrawal by Subject|4
1714951|NCT01124045|5984331|P2|Overall Study|Physician Decision|2
1714952|NCT01124045|5984332|P1|Overall Study|Physician Decision|0
1714953|NCT01124045|5984331|P2|Overall Study|Lost to Follow-up|1
1714954|NCT01124045|5984332|P1|Overall Study|Lost to Follow-up|0
1714955|NCT01124006|5984365|P3|Overall Study|Other|1
1714956|NCT01124006|5984366|P2|Overall Study|Other|0
1714957|NCT01124006|5984367|P1|Overall Study|Other|0
1714958|NCT01124006|5984365|P3|Overall Study|Lost to Follow-up|1
1714959|NCT01124006|5984366|P2|Overall Study|Lost to Follow-up|0
1714960|NCT01124006|5984367|P1|Overall Study|Lost to Follow-up|1
1714961|NCT01124006|5984365|P3|Overall Study|Withdrawal by Subject|0
1714962|NCT01124006|5984366|P2|Overall Study|Withdrawal by Subject|2
1714963|NCT01124006|5984367|P1|Overall Study|Withdrawal by Subject|2
1714964|NCT01123980|5984395|P2|Overall Study|Unclassified|7
1714965|NCT01123980|5984396|P1|Overall Study|Unclassified|6
1714966|NCT01123980|5984395|P2|Overall Study|Withdrawal by Subject|3
1714967|NCT01123980|5984396|P1|Overall Study|Withdrawal by Subject|5
1714968|NCT01123980|5984395|P2|Overall Study|Protocol Violation|6
1714969|NCT01123980|5984396|P1|Overall Study|Protocol Violation|6
1714970|NCT01123980|5984395|P2|Overall Study|Lost to Follow-up|6
1714971|NCT01123980|5984396|P1|Overall Study|Lost to Follow-up|0
1714972|NCT01123980|5984395|P2|Overall Study|Physician Decision|1
1714973|NCT01123980|5984396|P1|Overall Study|Physician Decision|0
1714974|NCT01123980|5984395|P2|Overall Study|Lack of Efficacy|0
1714975|NCT01123980|5984396|P1|Overall Study|Lack of Efficacy|1
1714976|NCT01123980|5984395|P2|Overall Study|Adverse Event|1
1714977|NCT01123980|5984396|P1|Overall Study|Adverse Event|1
1714978|NCT01123941|5984416|P2|Overall Study|Lost to Follow-up|1
1714979|NCT01123941|5984417|P1|Overall Study|Lost to Follow-up|2
1714980|NCT01123889|5984452|P2|Overall Study|Lost to Follow-up|1
1714981|NCT01123889|5984453|P1|Overall Study|Lost to Follow-up|3
1714982|NCT01123850|5984463|P1|Overall Study|Slow enrollment|45
1714983|NCT01123655|5984470|P3|Overall Study|began prohibitive drug|1
1714984|NCT01123655|5984471|P2|Overall Study|began prohibitive drug|0
1714985|NCT01123655|5984472|P1|Overall Study|began prohibitive drug|0
1714986|NCT01123655|5984470|P3|Overall Study|new illness|0
1714987|NCT01123655|5984471|P2|Overall Study|new illness|1
1714988|NCT01123655|5984472|P1|Overall Study|new illness|0
1714989|NCT01123655|5984470|P3|Overall Study|Medication for RA had to be changed|0
1714990|NCT01123655|5984471|P2|Overall Study|Medication for RA had to be changed|0
1714991|NCT01123655|5984472|P1|Overall Study|Medication for RA had to be changed|1
1714992|NCT01123642|5984544|P1|Overall Study|ineligible at baseline assessment|36
1714993|NCT01123642|5984544|P1|Overall Study|Withdrawal by Subject|9
1714994|NCT01123642|5984544|P1|Overall Study|Lost to Follow-up|23
1714995|NCT01123395|5984560|P2|Washout Period of 14 Days|Withdrawal by Subject|1
1714996|NCT01123395|5984561|P1|Washout Period of 14 Days|Withdrawal by Subject|0
1714997|NCT01123382|5984573|P2|Overall Study|Lost to Follow-up|2
1714998|NCT01123382|5984574|P1|Overall Study|Lost to Follow-up|1
1714999|NCT01123382|5984573|P2|Overall Study|Withdrawal by Subject|4
1715000|NCT01123382|5984574|P1|Overall Study|Withdrawal by Subject|1
1715001|NCT01123356|5984596|P1|Overall Study|Withdrawal by Subject|1
1715002|NCT01123356|5984596|P1|Overall Study|Lack of Efficacy|4
1715003|NCT01123356|5984596|P1|Overall Study|Adverse Event|2
1715004|NCT01123200|5984604|P1|Overall Study|Withdrawal by Subject|1
1715005|NCT01123161|5984611|P2|Overall Study|Withdrawal by Subject|0
1715006|NCT01123161|5984612|P1|Overall Study|Withdrawal by Subject|1
1715007|NCT01123161|5984611|P2|Overall Study|Lost to Follow-up|0
1715008|NCT01123161|5984612|P1|Overall Study|Lost to Follow-up|1
1715009|NCT01123148|5984630|P1|Overall Study|Didn't meet milestone criteria|1
1715010|NCT01123148|5984630|P1|Overall Study|Coughing caused unacceptable EEG quality|1
1715011|NCT01123083|5984636|P2|Overall Study|Participant/legal representative request|3
1715012|NCT01123083|5984637|P1|Overall Study|Participant/legal representative request|7
1715013|NCT01123083|5984636|P2|Overall Study|Withdrew for another reason not covered|1
1715014|NCT01123083|5984637|P1|Overall Study|Withdrew for another reason not covered|0
1715015|NCT01123083|5984636|P2|Overall Study|Adverse Event|0
1715016|NCT01123083|5984637|P1|Overall Study|Adverse Event|1
1715017|NCT01123083|5984636|P2|Overall Study|Lost to Follow-up|6
1715018|NCT01123083|5984637|P1|Overall Study|Lost to Follow-up|2
1715019|NCT01123083|5984636|P2|Overall Study|Administrative reasons|4
1715020|NCT01123083|5984637|P1|Overall Study|Administrative reasons|0
1715021|NCT01123083|5984636|P2|Overall Study|Investigator recommendation|1
1715022|NCT01123083|5984637|P1|Overall Study|Investigator recommendation|1
1715023|NCT01122927|5984661|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
1715024|NCT01122927|5984662|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
1715025|NCT01122927|5984661|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
1715026|NCT01122927|5984662|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
1715027|NCT01122927|5984661|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
1715028|NCT01122927|5984662|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
1715029|NCT01122927|5984661|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
1715030|NCT01122927|5984662|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
1715031|NCT01122927|5984661|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
1715032|NCT01122927|5984662|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
1715033|NCT01122927|5984661|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
1715034|NCT01122927|5984662|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
1715035|NCT01122927|5984661|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
1715036|NCT01122927|5984662|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
1715037|NCT01122927|5984661|P2|Period 1 - Conversion Phase|Protocol Deviation|0
1715038|NCT01122927|5984662|P1|Period 1 - Conversion Phase|Protocol Deviation|1
1715039|NCT01122927|5984661|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
1715040|NCT01122927|5984662|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
1715041|NCT01122927|5984661|P2|Period 1 - Conversion Phase|Physician Decision|0
1715042|NCT01122927|5984662|P1|Period 1 - Conversion Phase|Physician Decision|2
1715043|NCT01122927|5984661|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
1715044|NCT01122927|5984662|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
1715045|NCT01122927|5984661|P2|Period 1 - Conversion Phase|Adverse Event|0
1715046|NCT01122927|5984662|P1|Period 1 - Conversion Phase|Adverse Event|3
1715047|NCT01122862|5984714|P3|Period 2|Adverse Event|1
1715048|NCT01122862|5984715|P2|Period 2|Adverse Event|0
1715049|NCT01122862|5984716|P1|Period 2|Adverse Event|0
1715050|NCT01122862|5984714|P3|Period 1|Protocol Violation|0
1715051|NCT01122862|5984715|P2|Period 1|Protocol Violation|1
1715052|NCT01122862|5984716|P1|Period 1|Protocol Violation|0
1715053|NCT01122680|5984822|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
1715054|NCT01122680|5984823|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
1715055|NCT01122680|5984824|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
1715056|NCT01122680|5984825|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
1715057|NCT01122680|5984822|P4|Period 3 (4 Weeks)|Adverse Event|0
1715058|NCT01122680|5984823|P3|Period 3 (4 Weeks)|Adverse Event|0
1715059|NCT01122680|5984824|P2|Period 3 (4 Weeks)|Adverse Event|0
1715060|NCT01122680|5984825|P1|Period 3 (4 Weeks)|Adverse Event|1
1715061|NCT01122680|5984822|P4|Period 2 (4 Weeks)|Other|0
1715062|NCT01122680|5984823|P3|Period 2 (4 Weeks)|Other|0
1715063|NCT01122680|5984824|P2|Period 2 (4 Weeks)|Other|0
1715064|NCT01122680|5984825|P1|Period 2 (4 Weeks)|Other|1
1715065|NCT01122680|5984822|P4|Period 2 (4 Weeks)|Protocol Violation|1
1715066|NCT01122680|5984823|P3|Period 2 (4 Weeks)|Protocol Violation|0
1715067|NCT01122680|5984824|P2|Period 2 (4 Weeks)|Protocol Violation|0
1715068|NCT01122680|5984825|P1|Period 2 (4 Weeks)|Protocol Violation|0
1715069|NCT01122680|5984822|P4|Period 1 (4 Weeks)|Other|0
1715070|NCT01122680|5984823|P3|Period 1 (4 Weeks)|Other|0
1715071|NCT01122680|5984824|P2|Period 1 (4 Weeks)|Other|1
1715072|NCT01122680|5984825|P1|Period 1 (4 Weeks)|Other|1
1715073|NCT01122680|5984822|P4|Period 1 (4 Weeks)|Protocol Violation|0
1715074|NCT01122680|5984823|P3|Period 1 (4 Weeks)|Protocol Violation|0
1715075|NCT01122680|5984824|P2|Period 1 (4 Weeks)|Protocol Violation|0
1715076|NCT01122680|5984825|P1|Period 1 (4 Weeks)|Protocol Violation|1
1715077|NCT01122680|5984822|P4|Period 1 (4 Weeks)|Adverse Event|0
1715078|NCT01122680|5984823|P3|Period 1 (4 Weeks)|Adverse Event|0
1715079|NCT01122680|5984824|P2|Period 1 (4 Weeks)|Adverse Event|0
1715080|NCT01122680|5984825|P1|Period 1 (4 Weeks)|Adverse Event|1
1715081|NCT01122576|5984890|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
1715082|NCT01122576|5984891|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
1715083|NCT01122576|5984892|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
1715084|NCT01122576|5984890|P3|Post-Cataract Surgery|Central Macular Edema|1
1715085|NCT01122576|5984891|P2|Post-Cataract Surgery|Central Macular Edema|0
1715086|NCT01122576|5984892|P1|Post-Cataract Surgery|Central Macular Edema|0
1715087|NCT01122576|5984890|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
1715088|NCT01122576|5984891|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
1715089|NCT01122576|5984892|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
1715090|NCT01122394|5985073|P2|Overall Study|Adverse Event|1
1715091|NCT01122394|5985074|P1|Overall Study|Adverse Event|0
1715092|NCT01122394|5985073|P2|Overall Study|Lost to Follow-up|2
1715093|NCT01122394|5985074|P1|Overall Study|Lost to Follow-up|2
1715094|NCT01122394|5985073|P2|Overall Study|Withdrawal by Subject|1
1715095|NCT01122394|5985074|P1|Overall Study|Withdrawal by Subject|1
1715096|NCT01122381|5985090|P2|Overall Study|study terminated early|1
1715097|NCT01122381|5985091|P1|Overall Study|study terminated early|0
1715098|NCT01122264|5985100|P3|Overall Study|Lack of Efficacy|1
1715099|NCT01122264|5985101|P2|Overall Study|Lack of Efficacy|1
1715100|NCT01122264|5985102|P1|Overall Study|Lack of Efficacy|3
1715101|NCT01122264|5985100|P3|Overall Study|Physician Decision|1
1715102|NCT01122264|5985101|P2|Overall Study|Physician Decision|1
1715103|NCT01122264|5985102|P1|Overall Study|Physician Decision|3
1715104|NCT01122264|5985100|P3|Overall Study|Withdrawal by Subject|16
1715105|NCT01122264|5985101|P2|Overall Study|Withdrawal by Subject|6
1715106|NCT01122264|5985102|P1|Overall Study|Withdrawal by Subject|6
1715107|NCT01122264|5985100|P3|Overall Study|Protocol Violation|9
1715108|NCT01122264|5985101|P2|Overall Study|Protocol Violation|7
1715109|NCT01122264|5985102|P1|Overall Study|Protocol Violation|7
1715110|NCT01122264|5985100|P3|Overall Study|Entry Criteria Not Met|0
1715111|NCT01122264|5985101|P2|Overall Study|Entry Criteria Not Met|0
1715112|NCT01122264|5985102|P1|Overall Study|Entry Criteria Not Met|1
1715113|NCT01122264|5985100|P3|Overall Study|Lost to Follow-up|13
1715114|NCT01122264|5985101|P2|Overall Study|Lost to Follow-up|9
1715115|NCT01122264|5985102|P1|Overall Study|Lost to Follow-up|5
1715116|NCT01122264|5985100|P3|Overall Study|Death|0
1715117|NCT01122264|5985101|P2|Overall Study|Death|0
1715118|NCT01122264|5985102|P1|Overall Study|Death|1
1715119|NCT01122264|5985100|P3|Overall Study|Adverse Event|7
1715120|NCT01122264|5985101|P2|Overall Study|Adverse Event|5
1715121|NCT01122264|5985102|P1|Overall Study|Adverse Event|6
1715122|NCT01122173|5985212|P1|Overall Study|Left study for other reasons|3
1715123|NCT01122173|5985212|P1|Overall Study|Withdrawal by Subject|3
1715124|NCT01122173|5985212|P1|Overall Study|Lost to Follow-up|3
1715125|NCT01121991|5985435|P1|Overall Study|No Fertilization|1
1715126|NCT01121991|5985435|P1|Overall Study|No Oocytes Retrieved|3
1715127|NCT01121991|5985435|P1|Overall Study|Lack of Ovarian Response|2
1715128|NCT01121926|5985460|P2|Washout Period|Positive pregnancy test|1
1715129|NCT01121926|5985461|P1|Washout Period|Positive pregnancy test|0
1715130|NCT01121926|5985460|P2|Washout Period|Adverse Event|1
1715131|NCT01121926|5985461|P1|Washout Period|Adverse Event|0
1715132|NCT01121926|5985460|P2|First Intervention Period|Adverse Event|0
1715133|NCT01121926|5985461|P1|First Intervention Period|Adverse Event|1
1715134|NCT01121913|5985479|P4|Third Washout Period|Adverse Event|0
1715135|NCT01121913|5985480|P3|Third Washout Period|Adverse Event|0
1715136|NCT01121913|5985481|P2|Third Washout Period|Adverse Event|0
1715137|NCT01121913|5985482|P1|Third Washout Period|Adverse Event|1
1715138|NCT01121913|5985479|P4|Second Washout Period|Withdrawal by Subject|0
1715139|NCT01121913|5985480|P3|Second Washout Period|Withdrawal by Subject|1
1715140|NCT01121913|5985481|P2|Second Washout Period|Withdrawal by Subject|0
1715141|NCT01121913|5985482|P1|Second Washout Period|Withdrawal by Subject|0
1715142|NCT01121913|5985479|P4|Second Intervention Period|Adverse Event|0
1715143|NCT01121913|5985480|P3|Second Intervention Period|Adverse Event|1
1715144|NCT01121913|5985481|P2|Second Intervention Period|Adverse Event|0
1715145|NCT01121913|5985482|P1|Second Intervention Period|Adverse Event|0
1715146|NCT01121913|5985479|P4|First Washout Period|Withdrawal by Subject|0
1715147|NCT01121913|5985480|P3|First Washout Period|Withdrawal by Subject|0
1715148|NCT01121913|5985481|P2|First Washout Period|Withdrawal by Subject|0
1715149|NCT01121913|5985482|P1|First Washout Period|Withdrawal by Subject|1
1715150|NCT01121913|5985479|P4|First Intervention Period|Adverse Event|0
1715151|NCT01121913|5985480|P3|First Intervention Period|Adverse Event|1
1715152|NCT01121913|5985481|P2|First Intervention Period|Adverse Event|0
1715153|NCT01121913|5985482|P1|First Intervention Period|Adverse Event|0
1715154|NCT01121900|5985512|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1715155|NCT01121900|5985513|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1715156|NCT01121900|5985512|P2|First Intervention Period|Adverse Event|1
1715157|NCT01121900|5985513|P1|First Intervention Period|Adverse Event|1
1715158|NCT01121757|5985533|P2|Combination|Disease Progression|0
1715159|NCT01121757|5985534|P1|Combination|Disease Progression|2
1715160|NCT01121757|5985533|P2|Combination|Physician Decision|1
1715161|NCT01121757|5985534|P1|Combination|Physician Decision|0
1715162|NCT01121757|5985533|P2|First Drug|Disease Progression|2
1715163|NCT01121757|5985534|P1|First Drug|Disease Progression|0
1715164|NCT01121757|5985533|P2|First Drug|Death|0
1715165|NCT01121757|5985534|P1|First Drug|Death|1
1715166|NCT01121666|5985550|P2|Overall Study|Protocol Violation|10
1715167|NCT01121666|5985551|P1|Overall Study|Protocol Violation|29
1715168|NCT01121575|5985607|P6|Overall Study|Death|1
1715169|NCT01121575|5985608|P5|Overall Study|Death|7
1715170|NCT01121575|5985609|P4|Overall Study|Death|1
1715171|NCT01121575|5985610|P3|Overall Study|Death|0
1715172|NCT01121575|5985611|P2|Overall Study|Death|0
1715173|NCT01121575|5985612|P1|Overall Study|Death|6
1715174|NCT01121575|5985607|P6|Overall Study|Unspecified Reasons|10
1715175|NCT01121575|5985608|P5|Overall Study|Unspecified Reasons|13
1715176|NCT01121575|5985609|P4|Overall Study|Unspecified Reasons|5
1715177|NCT01121575|5985610|P3|Overall Study|Unspecified Reasons|7
1715178|NCT01121575|5985611|P2|Overall Study|Unspecified Reasons|6
1715179|NCT01121575|5985612|P1|Overall Study|Unspecified Reasons|8
1715180|NCT01121575|5985607|P6|Overall Study|Participant Refused Further Follow-Up|1
1715181|NCT01121575|5985608|P5|Overall Study|Participant Refused Further Follow-Up|5
1715182|NCT01121575|5985609|P4|Overall Study|Participant Refused Further Follow-Up|0
1715183|NCT01121575|5985610|P3|Overall Study|Participant Refused Further Follow-Up|0
1715184|NCT01121575|5985611|P2|Overall Study|Participant Refused Further Follow-Up|0
1715185|NCT01121575|5985612|P1|Overall Study|Participant Refused Further Follow-Up|0
1715186|NCT01121562|5985736|P1|Overall Study|Met study discontinuation criteria|1
1715187|NCT01121562|5985736|P1|Overall Study|Sponsor Decision|1
1715188|NCT01121562|5985736|P1|Overall Study|Adverse Event|1
1715189|NCT01121562|5985736|P1|Overall Study|Withdrawal by Subject|1
1715190|NCT01121562|5985736|P1|Overall Study|Objective progression or relapse|8
1715191|NCT01121549|5985745|P1|Overall Study|Other|58
1715192|NCT01121549|5985745|P1|Overall Study|Withdrawal by Subject|16
1715193|NCT01121549|5985745|P1|Overall Study|Protocol Violation|33
1715194|NCT01121549|5985745|P1|Overall Study|Pregnancy|1
1715195|NCT01121549|5985745|P1|Overall Study|Study terminated by sponsor|197
1715196|NCT01121549|5985745|P1|Overall Study|Did not meet entrance criteria|9
1715197|NCT01121549|5985745|P1|Overall Study|Lost to Follow-up|12
1715198|NCT01121549|5985745|P1|Overall Study|Lack of Efficacy|11
1715199|NCT01121549|5985745|P1|Overall Study|Adverse Event|10
1715200|NCT01121536|5985756|P1|Overall Study|Other|118
1715201|NCT01121536|5985756|P1|Overall Study|Lost to Follow-up|39
1715202|NCT01121536|5985756|P1|Overall Study|Noncompliance with study procedures|9
1715203|NCT01121536|5985756|P1|Overall Study|Noncompliance with study medication|12
1715204|NCT01121536|5985756|P1|Overall Study|Protocol Violation|20
1715205|NCT01121536|5985756|P1|Overall Study|Withdrawal by Subject|65
1715206|NCT01121536|5985756|P1|Overall Study|Lack of Efficacy|35
1715207|NCT01121536|5985756|P1|Overall Study|Adverse Event|63
1715208|NCT01121484|5985777|P2|Overall Study|Randomized, not treated|4
1715209|NCT01121484|5985778|P1|Overall Study|Randomized, not treated|1
1715210|NCT01121484|5985777|P2|Overall Study|Other|3
1715211|NCT01121484|5985778|P1|Overall Study|Other|3
1715212|NCT01121484|5985777|P2|Overall Study|Discontinuation of study by sponsor|1
1715213|NCT01121484|5985778|P1|Overall Study|Discontinuation of study by sponsor|0
1715214|NCT01121484|5985777|P2|Overall Study|Withdrawal by Subject|7
1715215|NCT01121484|5985778|P1|Overall Study|Withdrawal by Subject|8
1715216|NCT01121484|5985777|P2|Overall Study|Protocol Violation|0
1715217|NCT01121484|5985778|P1|Overall Study|Protocol Violation|1
1715218|NCT01121484|5985777|P2|Overall Study|Physician Decision|3
1715219|NCT01121484|5985778|P1|Overall Study|Physician Decision|0
1715220|NCT01121484|5985777|P2|Overall Study|Lost to Follow-up|9
1715221|NCT01121484|5985778|P1|Overall Study|Lost to Follow-up|5
1715222|NCT01121484|5985777|P2|Overall Study|Lack of Efficacy|11
1715223|NCT01121484|5985778|P1|Overall Study|Lack of Efficacy|3
1715224|NCT01121484|5985777|P2|Overall Study|Adverse Event|5
1715225|NCT01121484|5985778|P1|Overall Study|Adverse Event|12
1715226|NCT01121406|5985796|P2|Overall Study|Not treated|0
1715227|NCT01121406|5985797|P1|Overall Study|Not treated|1
1715228|NCT01121406|5985796|P2|Overall Study|Reason other than specified above|6
1715229|NCT01121406|5985797|P1|Overall Study|Reason other than specified above|2
1715230|NCT01121406|5985796|P2|Overall Study|Refused continuation of study med.|2
1715231|NCT01121406|5985797|P1|Overall Study|Refused continuation of study med.|1
1715232|NCT01121406|5985796|P2|Overall Study|Lost to Follow-up|1
1715233|NCT01121406|5985797|P1|Overall Study|Lost to Follow-up|0
1715234|NCT01121406|5985796|P2|Overall Study|Non−compliant with protocol|2
1715235|NCT01121406|5985797|P1|Overall Study|Non−compliant with protocol|0
1715236|NCT01121406|5985796|P2|Overall Study|Other AE|10
1715237|NCT01121406|5985797|P1|Overall Study|Other AE|3
1715238|NCT01121406|5985796|P2|Overall Study|Wors. or AE of underlying cancer disease|6
1715239|NCT01121406|5985797|P1|Overall Study|Wors. or AE of underlying cancer disease|4
1715240|NCT01121406|5985796|P2|Overall Study|Progressive disease RECIST|28
1715241|NCT01121406|5985797|P1|Overall Study|Progressive disease RECIST|44
1715242|NCT01121393|5985847|P2|Overall Study|Other than listed|0
1715243|NCT01121393|5985848|P1|Overall Study|Other than listed|6
1715244|NCT01121393|5985847|P2|Overall Study|Not treated|9
1715245|NCT01121393|5985848|P1|Overall Study|Not treated|3
1715246|NCT01121393|5985847|P2|Overall Study|Refused cont. medication|7
1715247|NCT01121393|5985848|P1|Overall Study|Refused cont. medication|7
1715248|NCT01121393|5985847|P2|Overall Study|Lost to Follow-up|0
1715249|NCT01121393|5985848|P1|Overall Study|Lost to Follow-up|1
1715250|NCT01121393|5985847|P2|Overall Study|Non-compliant with protocol|3
1715251|NCT01121393|5985848|P1|Overall Study|Non-compliant with protocol|0
1715252|NCT01121393|5985847|P2|Overall Study|Other Adverse events|45
1715253|NCT01121393|5985848|P1|Overall Study|Other Adverse events|24
1715254|NCT01121393|5985847|P2|Overall Study|Progressive disease|20
1715255|NCT01121393|5985848|P1|Overall Study|Progressive disease|201
1715256|NCT01121263|5985893|P2|Overall Study|Withdrawal by Subject|1
1715257|NCT01121263|5985894|P1|Overall Study|Withdrawal by Subject|0
1715258|NCT01121263|5985893|P2|Overall Study|Lost to Follow-up|12
1715259|NCT01121263|5985894|P1|Overall Study|Lost to Follow-up|22
1715260|NCT01121263|5985893|P2|Overall Study|Death|2
1715261|NCT01121263|5985894|P1|Overall Study|Death|3
1715262|NCT01121185|5985985|P2|Overall Study|Not transplanted|0
1715263|NCT01121185|5985986|P1|Overall Study|Not transplanted|1
1715264|NCT01121185|5985985|P2|Overall Study|Not infused|1
1715265|NCT01121185|5985986|P1|Overall Study|Not infused|0
1715266|NCT01121146|5986020|P2|Overall Study|Lost to Follow-up|16
1715267|NCT01121146|5986021|P1|Overall Study|Lost to Follow-up|7
1715268|NCT01121146|5986020|P2|Overall Study|Adverse Event|11
1715269|NCT01121146|5986021|P1|Overall Study|Adverse Event|2
1715270|NCT01121146|5986020|P2|Overall Study|Death|15
1715271|NCT01121146|5986021|P1|Overall Study|Death|17
1715272|NCT01120899|5986042|P1|Overall Study|Withdrawal by Subject|3
1715273|NCT01120782|5986070|P1|Overall Study|Test article shipping error|11
1715274|NCT01120756|5986076|P2|Overall Study|Withdrawal by Subject|1
1715275|NCT01120756|5986077|P1|Overall Study|Withdrawal by Subject|1
1715276|NCT01120717|5986087|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1715277|NCT01120717|5986088|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1715278|NCT01120717|5986087|P2|Overall Study|Death|1
1715279|NCT01120717|5986088|P1|Overall Study|Death|3
1715280|NCT01120717|5986087|P2|Overall Study|Lost to Follow-up|3
1715281|NCT01120717|5986088|P1|Overall Study|Lost to Follow-up|2
1715282|NCT01120717|5986087|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
1715283|NCT01120717|5986088|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
1715284|NCT01120717|5986087|P2|Overall Study|Protocol Deviation|5
1715285|NCT01120717|5986088|P1|Overall Study|Protocol Deviation|2
1715286|NCT01120717|5986087|P2|Overall Study|Adverse Event|6
1715287|NCT01120717|5986088|P1|Overall Study|Adverse Event|10
1715288|NCT01120717|5986087|P2|Overall Study|Withdrawal by Subject|6
1715289|NCT01120717|5986088|P1|Overall Study|Withdrawal by Subject|11
1715290|NCT01120691|5986194|P3|Overall Study|Abnormal laboratory value(s)|4
1715291|NCT01120691|5986195|P2|Overall Study|Abnormal laboratory value(s)|3
1715292|NCT01120691|5986196|P1|Overall Study|Abnormal laboratory value(s)|1
1715293|NCT01120691|5986194|P3|Overall Study|Patient's inability to use the device|0
1715294|NCT01120691|5986195|P2|Overall Study|Patient's inability to use the device|1
1715295|NCT01120691|5986196|P1|Overall Study|Patient's inability to use the device|3
1715296|NCT01120691|5986194|P3|Overall Study|Abnormal test procedure result(s)|1
1715297|NCT01120691|5986195|P2|Overall Study|Abnormal test procedure result(s)|2
1715298|NCT01120691|5986196|P1|Overall Study|Abnormal test procedure result(s)|3
1715299|NCT01120691|5986194|P3|Overall Study|Lost to Follow-up|4
1715300|NCT01120691|5986195|P2|Overall Study|Lost to Follow-up|6
1715301|NCT01120691|5986196|P1|Overall Study|Lost to Follow-up|5
1715302|NCT01120691|5986194|P3|Overall Study|Protocol deviation|12
1715303|NCT01120691|5986195|P2|Overall Study|Protocol deviation|12
1715304|NCT01120691|5986196|P1|Overall Study|Protocol deviation|13
1715305|NCT01120691|5986194|P3|Overall Study|Administrative problems|9
1715306|NCT01120691|5986195|P2|Overall Study|Administrative problems|8
1715307|NCT01120691|5986196|P1|Overall Study|Administrative problems|15
1715308|NCT01120691|5986194|P3|Overall Study|Unsatisfactory therapeutic effect|38
1715309|NCT01120691|5986195|P2|Overall Study|Unsatisfactory therapeutic effect|32
1715310|NCT01120691|5986196|P1|Overall Study|Unsatisfactory therapeutic effect|18
1715311|NCT01120691|5986194|P3|Overall Study|Death|24
1715312|NCT01120691|5986195|P2|Overall Study|Death|22
1715313|NCT01120691|5986196|P1|Overall Study|Death|21
1715314|NCT01120691|5986194|P3|Overall Study|Subject withdrew consent|44
1715315|NCT01120691|5986195|P2|Overall Study|Subject withdrew consent|50
1715316|NCT01120691|5986196|P1|Overall Study|Subject withdrew consent|33
1715317|NCT01120691|5986194|P3|Overall Study|Adverse Event|47
1715318|NCT01120691|5986195|P2|Overall Study|Adverse Event|67
1715319|NCT01120691|5986196|P1|Overall Study|Adverse Event|59
1715320|NCT01120626|5986293|P2|Overall Study|Withdrawal by Subject|0
1715321|NCT01120626|5986294|P1|Overall Study|Withdrawal by Subject|1
1715322|NCT01120600|5986304|P2|Overall Study|Withdrawal by Subject|11
1715323|NCT01120600|5986305|P1|Overall Study|Withdrawal by Subject|10
1715324|NCT01120600|5986304|P2|Overall Study|Protocol Violation|4
1715325|NCT01120600|5986305|P1|Overall Study|Protocol Violation|0
1715326|NCT01120600|5986304|P2|Overall Study|Physician Decision|3
1715327|NCT01120600|5986305|P1|Overall Study|Physician Decision|1
1715328|NCT01120600|5986304|P2|Overall Study|Lost to Follow-up|3
1715329|NCT01120600|5986305|P1|Overall Study|Lost to Follow-up|1
1715330|NCT01120600|5986304|P2|Overall Study|Excessive Bone Loss|4
1715331|NCT01120600|5986305|P1|Overall Study|Excessive Bone Loss|0
1715332|NCT01120600|5986304|P2|Overall Study|Adverse Event|7
1715333|NCT01120600|5986305|P1|Overall Study|Adverse Event|7
1715334|NCT01120379|5986360|P1|Four Year Timepoint|Any other reason for early termination|217
1715335|NCT01120379|5986360|P1|Four Year Timepoint|Physician Decision|5
1715336|NCT01120379|5986360|P1|Four Year Timepoint|Death|131
1715337|NCT01120379|5986360|P1|Four Year Timepoint|Lost to Follow-up|10
1715338|NCT01120379|5986360|P1|Four Year Timepoint|Withdrawal by Subject|5
1715339|NCT01120379|5986360|P1|Three Year Timepoint|Any other reason for early termination|17
1715340|NCT01120379|5986360|P1|Three Year Timepoint|Physician Decision|9
1715341|NCT01120379|5986360|P1|Three Year Timepoint|Death|120
1715342|NCT01120379|5986360|P1|Three Year Timepoint|Lost to Follow-up|43
1715343|NCT01120379|5986360|P1|Three Year Timepoint|Withdrawal by Subject|25
1715344|NCT01120379|5986360|P1|Two Year Timepoint|Any other reason for early termination|4
1715345|NCT01120379|5986360|P1|Two Year Timepoint|Physician Decision|12
1715346|NCT01120379|5986360|P1|Two Year Timepoint|Death|123
1715347|NCT01120379|5986360|P1|Two Year Timepoint|Lost to Follow-up|87
1715348|NCT01120379|5986360|P1|Two Year Timepoint|Withdrawal by Subject|11
1715349|NCT01120379|5986360|P1|One Year Timepoint|Any other reason for early termination|5
1715350|NCT01120379|5986360|P1|One Year Timepoint|Physician Decision|9
1715351|NCT01120379|5986360|P1|One Year Timepoint|Death|108
1715352|NCT01120379|5986360|P1|One Year Timepoint|Lost to Follow-up|115
1715353|NCT01120379|5986360|P1|One Year Timepoint|Withdrawal by Subject|41
1715354|NCT01120275|5986396|P1|Overall Study|Not specific|1
1715355|NCT01120275|5986396|P1|Overall Study|Refusal|1
1715356|NCT01120275|5986396|P1|Overall Study|Withdrawal by Subject|1
1715357|NCT01120275|5986396|P1|Overall Study|Ineligible|3
1715358|NCT01120275|5986396|P1|Overall Study|Progression|27
1715359|NCT01120275|5986396|P1|Overall Study|Adverse Event|3
1715360|NCT01120210|5986463|P2|MAIN INFUSION|Withdrawal by Subject|1
1715361|NCT01120210|5986464|P1|MAIN INFUSION|Withdrawal by Subject|0
1715362|NCT01120210|5986463|P2|MAIN INFUSION|Adverse Event|0
1715363|NCT01120210|5986464|P1|MAIN INFUSION|Adverse Event|1
1715364|NCT01120184|5986514|P3|Overall Study|Death|169
1715365|NCT01120184|5986515|P2|Overall Study|Death|176
1715366|NCT01120184|5986516|P1|Overall Study|Death|170
1715367|NCT01120184|5986514|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
1715368|NCT01120184|5986515|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
1715369|NCT01120184|5986516|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
1715370|NCT01120184|5986514|P3|Overall Study|Sponsor Decision to Terminate Study|143
1715371|NCT01120184|5986515|P2|Overall Study|Sponsor Decision to Terminate Study|144
1715372|NCT01120184|5986516|P1|Overall Study|Sponsor Decision to Terminate Study|133
1715373|NCT01120184|5986514|P3|Overall Study|Reason not Specified|12
1715374|NCT01120184|5986515|P2|Overall Study|Reason not Specified|3
1715375|NCT01120184|5986516|P1|Overall Study|Reason not Specified|8
1715376|NCT01120184|5986514|P3|Overall Study|Physician Decision|3
1715377|NCT01120184|5986515|P2|Overall Study|Physician Decision|1
1715378|NCT01120184|5986516|P1|Overall Study|Physician Decision|9
1715379|NCT01120184|5986514|P3|Overall Study|Lost to Follow-up|11
1715380|NCT01120184|5986515|P2|Overall Study|Lost to Follow-up|13
1715381|NCT01120184|5986516|P1|Overall Study|Lost to Follow-up|13
1715382|NCT01120184|5986514|P3|Overall Study|Adverse Event|0
1715383|NCT01120184|5986515|P2|Overall Study|Adverse Event|1
1715384|NCT01120184|5986516|P1|Overall Study|Adverse Event|0
1715385|NCT01120093|5986638|P5|Treatment Period 5|Adverse Event|0
1715386|NCT01120093|5986639|P4|Treatment Period 5|Adverse Event|1
1715387|NCT01120093|5986640|P3|Treatment Period 5|Adverse Event|0
1715388|NCT01120093|5986641|P2|Treatment Period 5|Adverse Event|1
1715389|NCT01120093|5986642|P1|Treatment Period 5|Adverse Event|0
1715390|NCT01120093|5986638|P5|Treatment Period 4|Adverse Event|0
1715391|NCT01120093|5986639|P4|Treatment Period 4|Adverse Event|0
1715392|NCT01120093|5986640|P3|Treatment Period 4|Adverse Event|0
1715393|NCT01120093|5986641|P2|Treatment Period 4|Adverse Event|0
1715394|NCT01120093|5986642|P1|Treatment Period 4|Adverse Event|1
1715395|NCT01120093|5986638|P5|Treatment Period 3|Withdrawal by Subject|0
1715396|NCT01120093|5986639|P4|Treatment Period 3|Withdrawal by Subject|0
1715397|NCT01120093|5986640|P3|Treatment Period 3|Withdrawal by Subject|1
1715398|NCT01120093|5986641|P2|Treatment Period 3|Withdrawal by Subject|0
1715399|NCT01120093|5986642|P1|Treatment Period 3|Withdrawal by Subject|0
1715400|NCT01120093|5986638|P5|Treatment Period 3|Adverse Event|1
1715401|NCT01120093|5986639|P4|Treatment Period 3|Adverse Event|0
1715402|NCT01120093|5986640|P3|Treatment Period 3|Adverse Event|0
1715403|NCT01120093|5986641|P2|Treatment Period 3|Adverse Event|0
1715404|NCT01120093|5986642|P1|Treatment Period 3|Adverse Event|0
1715405|NCT01120093|5986638|P5|Treatment Period 3|Lack of Efficacy|0
1715406|NCT01120093|5986639|P4|Treatment Period 3|Lack of Efficacy|1
1715407|NCT01120093|5986640|P3|Treatment Period 3|Lack of Efficacy|0
1715408|NCT01120093|5986641|P2|Treatment Period 3|Lack of Efficacy|0
1715409|NCT01120093|5986642|P1|Treatment Period 3|Lack of Efficacy|0
1715410|NCT01120093|5986638|P5|Treatment Period 2|Withdrawal by Subject|1
1715411|NCT01120093|5986639|P4|Treatment Period 2|Withdrawal by Subject|0
1715412|NCT01120093|5986640|P3|Treatment Period 2|Withdrawal by Subject|0
1715413|NCT01120093|5986641|P2|Treatment Period 2|Withdrawal by Subject|0
1715414|NCT01120093|5986642|P1|Treatment Period 2|Withdrawal by Subject|0
1715415|NCT01120093|5986638|P5|Treatment Period 2|Adverse Event|0
1715416|NCT01120093|5986639|P4|Treatment Period 2|Adverse Event|1
1715417|NCT01120093|5986640|P3|Treatment Period 2|Adverse Event|0
1715418|NCT01120093|5986641|P2|Treatment Period 2|Adverse Event|0
1715419|NCT01120093|5986642|P1|Treatment Period 2|Adverse Event|0
1715420|NCT01120093|5986638|P5|Treatment Period 1|Withdrawal by Subject|0
1715421|NCT01120093|5986639|P4|Treatment Period 1|Withdrawal by Subject|0
1715422|NCT01120093|5986640|P3|Treatment Period 1|Withdrawal by Subject|0
1715423|NCT01120093|5986641|P2|Treatment Period 1|Withdrawal by Subject|1
1715424|NCT01120093|5986642|P1|Treatment Period 1|Withdrawal by Subject|0
1715425|NCT01120093|5986638|P5|Treatment Period 1|Adverse Event|1
1715426|NCT01120093|5986639|P4|Treatment Period 1|Adverse Event|0
1715427|NCT01120093|5986640|P3|Treatment Period 1|Adverse Event|1
1715428|NCT01120093|5986641|P2|Treatment Period 1|Adverse Event|0
1715429|NCT01120093|5986642|P1|Treatment Period 1|Adverse Event|0
1715430|NCT01120067|5986671|P2|Overall Study|fail to engage >3 sessions|0
1715431|NCT01120067|5986672|P1|Overall Study|fail to engage >3 sessions|2
1715432|NCT01120067|5986671|P2|Overall Study|Lost to Follow-up|1
1715433|NCT01120067|5986672|P1|Overall Study|Lost to Follow-up|3
1715434|NCT01120028|5986682|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
1715435|NCT01120028|5986683|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
1715436|NCT01120028|5986684|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
1715437|NCT01120028|5986685|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
1715438|NCT01120028|5986682|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
1715439|NCT01120028|5986683|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
1715440|NCT01120028|5986684|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
1715441|NCT01120028|5986685|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
1715442|NCT01119963|5986709|P2|Overall Study|Lost to Follow-up|1
1715443|NCT01119963|5986710|P1|Overall Study|Lost to Follow-up|1
1715444|NCT01119950|5986720|P1|Overall Study|Death|1
1715445|NCT01119950|5986720|P1|Overall Study|Abnormal lab value|1
1715446|NCT01119950|5986720|P1|Overall Study|Administrative|2
1715447|NCT01119950|5986720|P1|Overall Study|Lost to Follow-up|4
1715448|NCT01119950|5986720|P1|Overall Study|Protocol Violation|5
1715449|NCT01119950|5986720|P1|Overall Study|Withdrawal by Subject|9
1715450|NCT01119950|5986720|P1|Overall Study|Adverse Event|25
1715451|NCT01119937|5986967|P2|Overall Study|Withdrawal by Subject|1
1715452|NCT01119937|5986968|P1|Overall Study|Withdrawal by Subject|2
1715453|NCT01119937|5986967|P2|Overall Study|Unsatisfactory therapeutic effect|0
1715454|NCT01119937|5986968|P1|Overall Study|Unsatisfactory therapeutic effect|3
1715455|NCT01119937|5986967|P2|Overall Study|Protocol deviation|1
1715456|NCT01119937|5986968|P1|Overall Study|Protocol deviation|3
1715457|NCT01119937|5986967|P2|Overall Study|Adverse Event|5
1715458|NCT01119937|5986968|P1|Overall Study|Adverse Event|11
1715459|NCT01119898|5986996|P2|Overall Study|Randomized in error did not participate|0
1715460|NCT01119898|5986997|P1|Overall Study|Randomized in error did not participate|1
1715461|NCT01119898|5986996|P2|Overall Study|Medical procedure|0
1715462|NCT01119898|5986997|P1|Overall Study|Medical procedure|1
1715463|NCT01119898|5986996|P2|Overall Study|Protocol Violation|1
1715464|NCT01119898|5986997|P1|Overall Study|Protocol Violation|1
1715465|NCT01119898|5986996|P2|Overall Study|Lack of Efficacy|2
1715466|NCT01119898|5986997|P1|Overall Study|Lack of Efficacy|0
1715467|NCT01119898|5986996|P2|Overall Study|Withdrawal by Subject|4
1715468|NCT01119898|5986997|P1|Overall Study|Withdrawal by Subject|1
1715469|NCT01119898|5986996|P2|Overall Study|Adverse Event|5
1715470|NCT01119898|5986997|P1|Overall Study|Adverse Event|4
1715471|NCT01119859|5987023|P2|Overall Study|Failure to return|0
1715472|NCT01119859|5987024|P1|Overall Study|Failure to return|3
1715473|NCT01119859|5987023|P2|Overall Study|Refused treatment|6
1715474|NCT01119859|5987024|P1|Overall Study|Refused treatment|3
1715475|NCT01119859|5987023|P2|Overall Study|Insufficient therapeutic response|14
1715476|NCT01119859|5987024|P1|Overall Study|Insufficient therapeutic response|7
1715477|NCT01119859|5987023|P2|Overall Study|Death|0
1715478|NCT01119859|5987024|P1|Overall Study|Death|2
1715479|NCT01119859|5987023|P2|Overall Study|Adverse Event|10
1715480|NCT01119859|5987024|P1|Overall Study|Adverse Event|9
1715481|NCT01119846|5987043|P3|Overall Study|Withdrawal by Subject|4
1715482|NCT01119846|5987044|P2|Overall Study|Withdrawal by Subject|0
1715483|NCT01119846|5987045|P1|Overall Study|Withdrawal by Subject|0
1715484|NCT01119846|5987043|P3|Overall Study|Protocol Violation|1
1715485|NCT01119846|5987044|P2|Overall Study|Protocol Violation|0
1715486|NCT01119846|5987045|P1|Overall Study|Protocol Violation|0
1715487|NCT01119846|5987043|P3|Overall Study|Physician Decision|0
1715488|NCT01119846|5987044|P2|Overall Study|Physician Decision|0
1715489|NCT01119846|5987045|P1|Overall Study|Physician Decision|1
1715490|NCT01119846|5987043|P3|Overall Study|Adverse Event|6
1715491|NCT01119846|5987044|P2|Overall Study|Adverse Event|0
1715492|NCT01119846|5987045|P1|Overall Study|Adverse Event|1
1715493|NCT01119768|5987259|P2|Treatment Period|Lack of Efficacy|25
1715494|NCT01119768|5987260|P1|Treatment Period|Lack of Efficacy|18
1715495|NCT01119703|5987316|P2|Overall Study|Adverse Event|1
1715496|NCT01119703|5987317|P1|Overall Study|Adverse Event|0
1715497|NCT01119625|5987331|P2|Overall Study|Other|1
1715498|NCT01119625|5987332|P1|Overall Study|Other|0
1715499|NCT01119625|5987331|P2|Overall Study|Withdrawal by Subject|1
1715500|NCT01119625|5987332|P1|Overall Study|Withdrawal by Subject|2
1715501|NCT01119625|5987331|P2|Overall Study|Lost to Follow-up|2
1715502|NCT01119625|5987332|P1|Overall Study|Lost to Follow-up|1
1715503|NCT01119443|5987448|P2|Crossover Period 1 (5 Days)|Adverse Event|1
1715504|NCT01119443|5987449|P1|Crossover Period 1 (5 Days)|Adverse Event|0
1715505|NCT01119287|5987492|P6|Overall Study|Patient Decision, not related to AE|0
1715506|NCT01119287|5987493|P5|Overall Study|Patient Decision, not related to AE|1
1715507|NCT01119287|5987494|P4|Overall Study|Patient Decision, not related to AE|2
1715508|NCT01119287|5987495|P3|Overall Study|Patient Decision, not related to AE|2
1715509|NCT01119287|5987496|P2|Overall Study|Patient Decision, not related to AE|0
1715510|NCT01119287|5987497|P1|Overall Study|Patient Decision, not related to AE|0
1715511|NCT01119248|5987510|P1|Overall Study|Physician Decision|5
1715512|NCT01119131|5987560|P3|Overall Study|Physician Decision|1
1715513|NCT01119131|5987561|P2|Overall Study|Physician Decision|0
1715514|NCT01119131|5987562|P1|Overall Study|Physician Decision|0
1715515|NCT01119131|5987560|P3|Overall Study|Non-Compliance|4
1715516|NCT01119131|5987561|P2|Overall Study|Non-Compliance|0
1715517|NCT01119131|5987562|P1|Overall Study|Non-Compliance|1
1715518|NCT01119131|5987560|P3|Overall Study|Adverse Event|1
1715519|NCT01119131|5987561|P2|Overall Study|Adverse Event|1
1715520|NCT01119131|5987562|P1|Overall Study|Adverse Event|1
1715521|NCT01119118|5987591|P1|Overall Study|Adverse Event|1
1715522|NCT01119001|5987603|P1|Overall Study|Withdrawal by Subject|2
1715523|NCT01118975|5987647|P2|Overall Study|Adverse Event|1
1715524|NCT01118975|5987648|P1|Overall Study|Adverse Event|0
1715525|NCT01118962|5987654|P1|Overall Study|Non-compliance with Medicinal Product|1
1715526|NCT01118962|5987654|P1|Overall Study|Pregnancy|1
1715527|NCT01118962|5987654|P1|Overall Study|Withdrawal by Subject|4
1715528|NCT01118962|5987654|P1|Overall Study|Protocol Violation|1
1715529|NCT01118962|5987654|P1|Overall Study|Lack of Efficacy|1
1715530|NCT01118962|5987654|P1|Overall Study|Adverse Event|2
1715531|NCT01118949|5987659|P1|Overall Study|Withdrawal by Subject|4
1715532|NCT01118949|5987659|P1|Overall Study|Adverse Event|5
1715533|NCT01118780|5987689|P2|Overall Study|Withdrawal by Subject|8
1715534|NCT01118780|5987690|P1|Overall Study|Withdrawal by Subject|13
1715535|NCT01118780|5987689|P2|Overall Study|Protocol Violation|6
1715536|NCT01118780|5987690|P1|Overall Study|Protocol Violation|3
1715537|NCT01118780|5987689|P2|Overall Study|Physician Decision|0
1715538|NCT01118780|5987690|P1|Overall Study|Physician Decision|2
1715539|NCT01118780|5987689|P2|Overall Study|Lack of Efficacy|6
1715540|NCT01118780|5987690|P1|Overall Study|Lack of Efficacy|2
1715541|NCT01118780|5987689|P2|Overall Study|Death|0
1715542|NCT01118780|5987690|P1|Overall Study|Death|1
1715543|NCT01118780|5987689|P2|Overall Study|Adverse Event|15
1715544|NCT01118780|5987690|P1|Overall Study|Adverse Event|15
1715545|NCT01118728|5987748|P1|Overall Study|Lost to Follow-up|4
1715546|NCT01118728|5987748|P1|Overall Study|Withdrawal by Subject|3
1715547|NCT01118728|5987748|P1|Overall Study|Sponsor's decision to discontinue study|172
1715548|NCT01118728|5987748|P1|Overall Study|Lack of Efficacy|27
1715549|NCT01118728|5987748|P1|Overall Study|Adverse Event|17
1715550|NCT01118663|5987755|P2|Overall Study|Withdrawal by Subject|1
1715551|NCT01118663|5987756|P1|Overall Study|Withdrawal by Subject|0
1715552|NCT01118663|5987755|P2|Overall Study|Adverse Event|1
1715553|NCT01118663|5987756|P1|Overall Study|Adverse Event|2
1715554|NCT01118455|5987779|P2|Baseline [Visits 1 & 2]|Adverse Event|0
1715555|NCT01118455|5987780|P1|Baseline [Visits 1 & 2]|Adverse Event|1
1715556|NCT01118377|5987808|P1|Overall Study|Failure to Return|3
1715557|NCT01118377|5987808|P1|Overall Study|Death|38
1715558|NCT01118377|5987808|P1|Overall Study|Did Not Receive Study Medication|1
1715559|NCT01118351|5987814|P1|Overall Study|Withdrawal by Subject|1
1715560|NCT01118351|5987814|P1|Overall Study|Adverse Event|3
1715561|NCT01118325|5987825|P3|Overall Study|Adverse Event|1
1715562|NCT01118325|5987826|P2|Overall Study|Adverse Event|0
1715563|NCT01118325|5987827|P1|Overall Study|Adverse Event|1
1715564|NCT01118312|5987873|P2|Overall Study|Withdrawal by Subject|3
1715565|NCT01118312|5987874|P1|Overall Study|Withdrawal by Subject|1
1715566|NCT01118312|5987873|P2|Overall Study|Lost to Follow-up|32
1715567|NCT01118312|5987874|P1|Overall Study|Lost to Follow-up|33
1715568|NCT01118143|5988072|P2|Overall Study|Withdrawal by Subject|5
1715569|NCT01118143|5988073|P1|Overall Study|Withdrawal by Subject|2
1715570|NCT01118117|5988083|P2|Overall Study|Missed 12 Month Visit|0
1715571|NCT01118117|5988084|P1|Overall Study|Missed 12 Month Visit|7
1715572|NCT01118117|5988083|P2|Overall Study|Lost to Follow-up|0
1715573|NCT01118117|5988084|P1|Overall Study|Lost to Follow-up|6
1715574|NCT01118117|5988083|P2|Overall Study|Death|0
1715575|NCT01118117|5988084|P1|Overall Study|Death|8
1715576|NCT01118052|5988116|P1|Overall Study|Never treated|2
1715577|NCT01117987|5988139|P2|Overall Study|Administrative problems|22
1715578|NCT01117987|5988140|P1|Overall Study|Administrative problems|25
1715579|NCT01117987|5988139|P2|Overall Study|Adverse Event|26
1715580|NCT01117987|5988140|P1|Overall Study|Adverse Event|19
1715581|NCT01117987|5988139|P2|Overall Study|Withdrawal by Subject|10
1715582|NCT01117987|5988140|P1|Overall Study|Withdrawal by Subject|5
1715583|NCT01117987|5988139|P2|Overall Study|Death|10
1715584|NCT01117987|5988140|P1|Overall Study|Death|5
1715585|NCT01117987|5988139|P2|Overall Study|Lack of Efficacy|4
1715586|NCT01117987|5988140|P1|Overall Study|Lack of Efficacy|3
1715587|NCT01117987|5988139|P2|Overall Study|Abnormal test procedure result|0
1715588|NCT01117987|5988140|P1|Overall Study|Abnormal test procedure result|2
1715589|NCT01117987|5988139|P2|Overall Study|Lost to Follow-up|1
1715590|NCT01117987|5988140|P1|Overall Study|Lost to Follow-up|1
1715591|NCT01117987|5988139|P2|Overall Study|Subject no longer requires study drug|0
1715592|NCT01117987|5988140|P1|Overall Study|Subject no longer requires study drug|1
1715593|NCT01117987|5988139|P2|Overall Study|Protocol deviation|1
1715594|NCT01117987|5988140|P1|Overall Study|Protocol deviation|0
1715595|NCT01117870|5988161|P2|Overall Study|Inability to place needle|0
1715596|NCT01117870|5988162|P1|Overall Study|Inability to place needle|1
1715597|NCT01117857|5988176|P1|Overall Study|Physician Decision|1
1715598|NCT01117857|5988176|P1|Overall Study|Withdrawal by Subject|4
1715599|NCT01117857|5988176|P1|Overall Study|Lost to Follow-up|4
1715600|NCT01117766|5988184|P2|Second Intervention|Withdrawal by Subject|1
1715601|NCT01117766|5988185|P1|Second Intervention|Withdrawal by Subject|0
1715602|NCT01117766|5988184|P2|Second Intervention|Adverse Event|2
1715603|NCT01117766|5988185|P1|Second Intervention|Adverse Event|0
1715604|NCT01117766|5988184|P2|Second Intervention|Other|2
1715605|NCT01117766|5988185|P1|Second Intervention|Other|1
1715606|NCT01117766|5988184|P2|Second Intervention|Lost to Follow-up|0
1715607|NCT01117766|5988185|P1|Second Intervention|Lost to Follow-up|1
1715608|NCT01117766|5988184|P2|Washout Period|Protocol Violation|2
1715609|NCT01117766|5988185|P1|Washout Period|Protocol Violation|0
1715610|NCT01117766|5988184|P2|First Intervention|Protocol Violation|0
1715611|NCT01117766|5988185|P1|First Intervention|Protocol Violation|1
1715612|NCT01117766|5988184|P2|First Intervention|Adverse Event|1
1715613|NCT01117766|5988185|P1|First Intervention|Adverse Event|0
1715614|NCT01117623|5988222|P8|Overall Study|Invest. text: completed all planned txs|0
1715615|NCT01117623|5988223|P7|Overall Study|Invest. text: completed all planned txs|0
1715616|NCT01117623|5988224|P6|Overall Study|Invest. text: completed all planned txs|1
1715617|NCT01117623|5988225|P5|Overall Study|Invest. text: completed all planned txs|0
1715618|NCT01117623|5988226|P4|Overall Study|Invest. text: completed all planned txs|0
1715619|NCT01117623|5988227|P3|Overall Study|Invest. text: completed all planned txs|0
1715620|NCT01117623|5988228|P2|Overall Study|Invest. text: completed all planned txs|0
1715621|NCT01117623|5988229|P1|Overall Study|Invest. text: completed all planned txs|0
1715622|NCT01117623|5988222|P8|Overall Study|Non-compliance with study medication|1
1715623|NCT01117623|5988223|P7|Overall Study|Non-compliance with study medication|0
1715624|NCT01117623|5988224|P6|Overall Study|Non-compliance with study medication|0
1715625|NCT01117623|5988225|P5|Overall Study|Non-compliance with study medication|0
1715626|NCT01117623|5988226|P4|Overall Study|Non-compliance with study medication|0
1715627|NCT01117623|5988227|P3|Overall Study|Non-compliance with study medication|0
1715628|NCT01117623|5988228|P2|Overall Study|Non-compliance with study medication|0
1715629|NCT01117623|5988229|P1|Overall Study|Non-compliance with study medication|0
1715630|NCT01117623|5988222|P8|Overall Study|Withdrawal by Subject|1
1715631|NCT01117623|5988223|P7|Overall Study|Withdrawal by Subject|1
1715632|NCT01117623|5988224|P6|Overall Study|Withdrawal by Subject|1
1715633|NCT01117623|5988225|P5|Overall Study|Withdrawal by Subject|0
1715634|NCT01117623|5988226|P4|Overall Study|Withdrawal by Subject|0
1715635|NCT01117623|5988227|P3|Overall Study|Withdrawal by Subject|2
1715636|NCT01117623|5988228|P2|Overall Study|Withdrawal by Subject|0
1715637|NCT01117623|5988229|P1|Overall Study|Withdrawal by Subject|0
1715638|NCT01117623|5988222|P8|Overall Study|Disease progression, recurrence, relapse|22
1715639|NCT01117623|5988223|P7|Overall Study|Disease progression, recurrence, relapse|5
1715640|NCT01117623|5988224|P6|Overall Study|Disease progression, recurrence, relapse|14
1715641|NCT01117623|5988225|P5|Overall Study|Disease progression, recurrence, relapse|8
1715642|NCT01117623|5988226|P4|Overall Study|Disease progression, recurrence, relapse|6
1715643|NCT01117623|5988227|P3|Overall Study|Disease progression, recurrence, relapse|5
1715644|NCT01117623|5988228|P2|Overall Study|Disease progression, recurrence, relapse|6
1715645|NCT01117623|5988229|P1|Overall Study|Disease progression, recurrence, relapse|3
1715646|NCT01117623|5988222|P8|Overall Study|Adverse Event|2
1715647|NCT01117623|5988223|P7|Overall Study|Adverse Event|0
1715648|NCT01117623|5988224|P6|Overall Study|Adverse Event|0
1715649|NCT01117623|5988225|P5|Overall Study|Adverse Event|2
1715650|NCT01117623|5988226|P4|Overall Study|Adverse Event|0
1715651|NCT01117623|5988227|P3|Overall Study|Adverse Event|4
1715652|NCT01117623|5988228|P2|Overall Study|Adverse Event|2
1715653|NCT01117623|5988229|P1|Overall Study|Adverse Event|0
1715654|NCT01117480|5988381|P1|Overall Study|Did Not Start Adalimumab Therapy|20
1715655|NCT01117480|5988381|P1|Overall Study|Protocol Violation|8
1715656|NCT01117454|5988389|P2|Overall Study|Pregnancy|1
1715657|NCT01117454|5988390|P1|Overall Study|Pregnancy|0
1715658|NCT01117428|5988402|P6|Overall Study|Progressive disease|17
1715659|NCT01117428|5988403|P5|Overall Study|Progressive disease|16
1715660|NCT01117428|5988404|P4|Overall Study|Progressive disease|12
1715661|NCT01117428|5988405|P3|Overall Study|Progressive disease|10
1715662|NCT01117428|5988406|P2|Overall Study|Progressive disease|27
1715663|NCT01117428|5988407|P1|Overall Study|Progressive disease|15
1715664|NCT01117428|5988402|P6|Overall Study|Withdrawal by Subject|0
1715665|NCT01117428|5988403|P5|Overall Study|Withdrawal by Subject|0
1715666|NCT01117428|5988404|P4|Overall Study|Withdrawal by Subject|0
1715667|NCT01117428|5988405|P3|Overall Study|Withdrawal by Subject|1
1715668|NCT01117428|5988406|P2|Overall Study|Withdrawal by Subject|0
1715669|NCT01117428|5988407|P1|Overall Study|Withdrawal by Subject|0
1715670|NCT01117428|5988402|P6|Overall Study|Physician Decision|0
1715671|NCT01117428|5988403|P5|Overall Study|Physician Decision|0
1715672|NCT01117428|5988404|P4|Overall Study|Physician Decision|0
1715673|NCT01117428|5988405|P3|Overall Study|Physician Decision|0
1715674|NCT01117428|5988406|P2|Overall Study|Physician Decision|1
1715675|NCT01117428|5988407|P1|Overall Study|Physician Decision|0
1715676|NCT01117428|5988402|P6|Overall Study|Death|1
1715677|NCT01117428|5988403|P5|Overall Study|Death|0
1715678|NCT01117428|5988404|P4|Overall Study|Death|0
1715679|NCT01117428|5988405|P3|Overall Study|Death|2
1715680|NCT01117428|5988406|P2|Overall Study|Death|1
1715681|NCT01117428|5988407|P1|Overall Study|Death|0
1715682|NCT01117428|5988402|P6|Overall Study|Adverse Event|2
1715683|NCT01117428|5988403|P5|Overall Study|Adverse Event|1
1715684|NCT01117428|5988404|P4|Overall Study|Adverse Event|0
1715685|NCT01117428|5988405|P3|Overall Study|Adverse Event|0
1715686|NCT01117428|5988406|P2|Overall Study|Adverse Event|0
1715687|NCT01117428|5988407|P1|Overall Study|Adverse Event|4
1715688|NCT01117428|5988402|P6|Overall Study|Lack of Efficacy|0
1715689|NCT01117428|5988403|P5|Overall Study|Lack of Efficacy|0
1715690|NCT01117428|5988404|P4|Overall Study|Lack of Efficacy|0
1715691|NCT01117428|5988405|P3|Overall Study|Lack of Efficacy|0
1715692|NCT01117428|5988406|P2|Overall Study|Lack of Efficacy|0
1715693|NCT01117428|5988407|P1|Overall Study|Lack of Efficacy|1
1715694|NCT01117350|5988441|P2|Extension Period|Prohibited medication|1
1715695|NCT01117350|5988442|P1|Extension Period|Prohibited medication|0
1715696|NCT01117350|5988441|P2|Extension Period|Inclusion criteria not respected|1
1715697|NCT01117350|5988442|P1|Extension Period|Inclusion criteria not respected|0
1715698|NCT01117350|5988441|P2|Extension Period|Lack of Efficacy|2
1715699|NCT01117350|5988442|P1|Extension Period|Lack of Efficacy|0
1715700|NCT01117350|5988441|P2|Extension Period|Withdrawal by Subject|3
1715701|NCT01117350|5988442|P1|Extension Period|Withdrawal by Subject|0
1715702|NCT01117350|5988441|P2|Extension Period|Lost to Follow-up|2
1715703|NCT01117350|5988442|P1|Extension Period|Lost to Follow-up|0
1715704|NCT01117350|5988441|P2|Extension Period|Protocol Violation|2
1715705|NCT01117350|5988442|P1|Extension Period|Protocol Violation|0
1715706|NCT01117350|5988441|P2|Extension Period|Adverse Event|2
1715707|NCT01117350|5988442|P1|Extension Period|Adverse Event|0
1715708|NCT01117350|5988441|P2|Extension Period|Not included in extension, not treated|50
1715709|NCT01117350|5988442|P1|Extension Period|Not included in extension, not treated|0
1715710|NCT01117350|5988441|P2|Comparative Period|Move to another city/country|1
1715711|NCT01117350|5988442|P1|Comparative Period|Move to another city/country|2
1715712|NCT01117350|5988441|P2|Comparative Period|Physician Decision|1
1715713|NCT01117350|5988442|P1|Comparative Period|Physician Decision|0
1715714|NCT01117350|5988441|P2|Comparative Period|Lack of Efficacy|0
1715715|NCT01117350|5988442|P1|Comparative Period|Lack of Efficacy|1
1715716|NCT01117350|5988441|P2|Comparative Period|Protocol Violation|12
1715717|NCT01117350|5988442|P1|Comparative Period|Protocol Violation|8
1715718|NCT01117350|5988441|P2|Comparative Period|Withdrawal by Subject|13
1715719|NCT01117350|5988442|P1|Comparative Period|Withdrawal by Subject|9
1715720|NCT01117350|5988441|P2|Comparative Period|Lost to Follow-up|7
1715721|NCT01117350|5988442|P1|Comparative Period|Lost to Follow-up|11
1715722|NCT01117350|5988441|P2|Comparative Period|Adverse Event|33
1715723|NCT01117350|5988442|P1|Comparative Period|Adverse Event|6
1715724|NCT01117350|5988441|P2|Comparative Period|Not Treated|8
1715725|NCT01117350|5988442|P1|Comparative Period|Not Treated|5
1715726|NCT01117337|5988474|P2|Overall Study|Lost to Follow-up|0
1715727|NCT01117337|5988475|P1|Overall Study|Lost to Follow-up|4
1715728|NCT01117181|5988496|P2|Overall Study|Withdrawal by Subject|2
1715729|NCT01117181|5988497|P1|Overall Study|Withdrawal by Subject|0
1715730|NCT01117181|5988496|P2|Overall Study|Lost to Follow-up|0
1715731|NCT01117181|5988497|P1|Overall Study|Lost to Follow-up|1
1715732|NCT01117051|5988530|P2|Overall Study|Convenience issue|0
1715733|NCT01117051|5988531|P1|Overall Study|Convenience issue|1
1715734|NCT01117051|5988530|P2|Overall Study|Randomized by mistake|1
1715735|NCT01117051|5988531|P1|Overall Study|Randomized by mistake|0
1715736|NCT01117051|5988530|P2|Overall Study|Surgical procedure|1
1715737|NCT01117051|5988531|P1|Overall Study|Surgical procedure|0
1715738|NCT01117051|5988530|P2|Overall Study|Sponsor's decision|1
1715739|NCT01117051|5988531|P1|Overall Study|Sponsor's decision|3
1715740|NCT01117051|5988530|P2|Overall Study|Did not meet in-/exclusion criteria|1
1715741|NCT01117051|5988531|P1|Overall Study|Did not meet in-/exclusion criteria|0
1715742|NCT01117051|5988530|P2|Overall Study|Lost to Follow-up|1
1715743|NCT01117051|5988531|P1|Overall Study|Lost to Follow-up|0
1715744|NCT01117051|5988530|P2|Overall Study|Adverse Event|3
1715745|NCT01117051|5988531|P1|Overall Study|Adverse Event|4
1715746|NCT01117051|5988530|P2|Overall Study|Withdrawal by Subject|3
1715747|NCT01117051|5988531|P1|Overall Study|Withdrawal by Subject|5
1715748|NCT01117012|5988541|P2|Overall Study|Undefined|3
1715749|NCT01117012|5988542|P1|Overall Study|Undefined|4
1715750|NCT01117012|5988541|P2|Overall Study|Withdrawal by Subject|0
1715751|NCT01117012|5988542|P1|Overall Study|Withdrawal by Subject|3
1715752|NCT01117012|5988541|P2|Overall Study|Death|1
1715753|NCT01117012|5988542|P1|Overall Study|Death|1
1715754|NCT01117012|5988541|P2|Overall Study|Adverse Event|1
1715755|NCT01117012|5988542|P1|Overall Study|Adverse Event|0
1715756|NCT01116882|5988716|P2|12-month|Withdrawal by Subject|8
1715757|NCT01116882|5988717|P1|12-month|Withdrawal by Subject|5
1715758|NCT01116882|5988716|P2|12-month|Other Reasons|49
1715759|NCT01116882|5988717|P1|12-month|Other Reasons|151
1715760|NCT01116882|5988716|P2|12-month|Lost to Follow-up|42
1715761|NCT01116882|5988717|P1|12-month|Lost to Follow-up|111
1715762|NCT01116882|5988716|P2|30-day|Other Reasons|6
1715763|NCT01116882|5988717|P1|30-day|Other Reasons|16
1715764|NCT01116882|5988716|P2|30-day|Withdrawal by Subject|4
1715765|NCT01116882|5988717|P1|30-day|Withdrawal by Subject|2
1715766|NCT01116882|5988716|P2|30-day|Lost to Follow-up|21
1715767|NCT01116882|5988717|P1|30-day|Lost to Follow-up|50
1715768|NCT01116687|5988755|P1|Overall Study|Withdrawal by Subject|4
1715769|NCT01116544|5988769|P2|Overall Study|Withdrawal by Subject|1
1715770|NCT01116544|5988770|P1|Overall Study|Withdrawal by Subject|1
1715771|NCT01116544|5988769|P2|Overall Study|Protocol Violation|0
1715772|NCT01116544|5988770|P1|Overall Study|Protocol Violation|1
1715773|NCT01116427|5988796|P2|Extension Phase|Not using appropriate birth control|0
1715774|NCT01116427|5988797|P1|Extension Phase|Not using appropriate birth control|1
1715775|NCT01116427|5988796|P2|Extension Phase|Withdrawal by Subject|1
1715776|NCT01116427|5988797|P1|Extension Phase|Withdrawal by Subject|5
1715777|NCT01116427|5988796|P2|Extension Phase|Lost to Follow-up|0
1715778|NCT01116427|5988797|P1|Extension Phase|Lost to Follow-up|2
1715779|NCT01116427|5988796|P2|Extension Phase|Adverse Event|1
1715780|NCT01116427|5988797|P1|Extension Phase|Adverse Event|1
1715781|NCT01116427|5988796|P2|Core Phase|Worsening Multiple Sclerosis|0
1715782|NCT01116427|5988797|P1|Core Phase|Worsening Multiple Sclerosis|1
1715783|NCT01116427|5988796|P2|Core Phase|Withdrawal by Subject|0
1715784|NCT01116427|5988797|P1|Core Phase|Withdrawal by Subject|3
1715785|NCT01116427|5988796|P2|Core Phase|Lost to Follow-up|0
1715786|NCT01116427|5988797|P1|Core Phase|Lost to Follow-up|1
1715787|NCT01116427|5988796|P2|Core Phase|Adverse Event|1
1715788|NCT01116427|5988797|P1|Core Phase|Adverse Event|0
1715789|NCT01116232|5988838|P1|Overall Study|Progressive diease|4
1715790|NCT01115998|5988952|P2|Overall Study|Lost to Follow-up|6
1715791|NCT01115998|5988953|P1|Overall Study|Lost to Follow-up|6
1715792|NCT01115933|5988963|P1|Overall Study|Did not receive XIENCE PRIME SV|1
1715793|NCT01115855|5989060|P2|Overall Study|Other|6
1715794|NCT01115855|5989061|P1|Overall Study|Other|8
1715795|NCT01115855|5989060|P2|Overall Study|Withdrawal by Subject|5
1715796|NCT01115855|5989061|P1|Overall Study|Withdrawal by Subject|5
1715797|NCT01115855|5989060|P2|Overall Study|Protocol Violation|1
1715798|NCT01115855|5989061|P1|Overall Study|Protocol Violation|0
1715799|NCT01115855|5989060|P2|Overall Study|Lab Abnormality|1
1715800|NCT01115855|5989061|P1|Overall Study|Lab Abnormality|1
1715801|NCT01115855|5989060|P2|Overall Study|Death|5
1715802|NCT01115855|5989061|P1|Overall Study|Death|6
1715803|NCT01115855|5989060|P2|Overall Study|Adverse Event|18
1715804|NCT01115855|5989061|P1|Overall Study|Adverse Event|16
1715805|NCT01115803|5989116|P7|Overall Study|Progressive Disease during Cycle1|1
1715806|NCT01115803|5989117|P6|Overall Study|Progressive Disease during Cycle1|0
1715807|NCT01115803|5989118|P5|Overall Study|Progressive Disease during Cycle1|0
1715808|NCT01115803|5989119|P4|Overall Study|Progressive Disease during Cycle1|0
1715809|NCT01115803|5989120|P3|Overall Study|Progressive Disease during Cycle1|0
1715810|NCT01115803|5989121|P2|Overall Study|Progressive Disease during Cycle1|0
1715811|NCT01115803|5989122|P1|Overall Study|Progressive Disease during Cycle1|0
1715812|NCT01115803|5989116|P7|Overall Study|Lost to Follow-up|0
1715813|NCT01115803|5989117|P6|Overall Study|Lost to Follow-up|0
1715814|NCT01115803|5989118|P5|Overall Study|Lost to Follow-up|0
1715815|NCT01115803|5989119|P4|Overall Study|Lost to Follow-up|0
1715816|NCT01115803|5989120|P3|Overall Study|Lost to Follow-up|1
1715817|NCT01115803|5989121|P2|Overall Study|Lost to Follow-up|0
1715818|NCT01115803|5989122|P1|Overall Study|Lost to Follow-up|0
1715819|NCT01115803|5989116|P7|Overall Study|Withdrawal by Subject|1
1715820|NCT01115803|5989117|P6|Overall Study|Withdrawal by Subject|0
1715821|NCT01115803|5989118|P5|Overall Study|Withdrawal by Subject|0
1715822|NCT01115803|5989119|P4|Overall Study|Withdrawal by Subject|0
1715823|NCT01115803|5989120|P3|Overall Study|Withdrawal by Subject|0
1715824|NCT01115803|5989121|P2|Overall Study|Withdrawal by Subject|0
1715825|NCT01115803|5989122|P1|Overall Study|Withdrawal by Subject|0
1715826|NCT01115738|5989185|P3|Overall Study|Withdrawal by Subject|9
1715827|NCT01115738|5989186|P2|Overall Study|Withdrawal by Subject|6
1715828|NCT01115738|5989187|P1|Overall Study|Withdrawal by Subject|6
1715829|NCT01115738|5989185|P3|Overall Study|Physician Decision|17
1715830|NCT01115738|5989186|P2|Overall Study|Physician Decision|15
1715831|NCT01115738|5989187|P1|Overall Study|Physician Decision|18
1715832|NCT01115738|5989185|P3|Overall Study|Lost to Follow-up|1
1715833|NCT01115738|5989186|P2|Overall Study|Lost to Follow-up|0
1715834|NCT01115738|5989187|P1|Overall Study|Lost to Follow-up|0
1715835|NCT01115738|5989185|P3|Overall Study|Death|0
1715836|NCT01115738|5989186|P2|Overall Study|Death|0
1715837|NCT01115738|5989187|P1|Overall Study|Death|1
1715838|NCT01115569|5989385|P2|Maintenance Phase|Administrative|1
1715839|NCT01115569|5989386|P1|Maintenance Phase|Administrative|0
1715840|NCT01115569|5989385|P2|Maintenance Phase|Non-Compliance with Study Drug|48
1715841|NCT01115569|5989386|P1|Maintenance Phase|Non-Compliance with Study Drug|0
1715842|NCT01115569|5989385|P2|Maintenance Phase|Withdrawal by Subject|27
1715843|NCT01115569|5989386|P1|Maintenance Phase|Withdrawal by Subject|0
1715844|NCT01115569|5989385|P2|Maintenance Phase|Protocol Violation|9
1715845|NCT01115569|5989386|P1|Maintenance Phase|Protocol Violation|0
1715846|NCT01115569|5989385|P2|Maintenance Phase|Physician Decision|3
1715847|NCT01115569|5989386|P1|Maintenance Phase|Physician Decision|0
1715848|NCT01115569|5989385|P2|Maintenance Phase|Lost to Follow-up|8
1715849|NCT01115569|5989386|P1|Maintenance Phase|Lost to Follow-up|0
1715850|NCT01115569|5989385|P2|Maintenance Phase|Adverse Event|43
1715851|NCT01115569|5989386|P1|Maintenance Phase|Adverse Event|0
1715852|NCT01115569|5989385|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
1715853|NCT01115569|5989386|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
1715854|NCT01115569|5989385|P2|Conversion/Titration Phase|Withdrawal by Subject|0
1715855|NCT01115569|5989386|P1|Conversion/Titration Phase|Withdrawal by Subject|26
1715856|NCT01115569|5989385|P2|Conversion/Titration Phase|Protocol Violation|0
1715857|NCT01115569|5989386|P1|Conversion/Titration Phase|Protocol Violation|68
1715858|NCT01115569|5989385|P2|Conversion/Titration Phase|Physician Decision|0
1715859|NCT01115569|5989386|P1|Conversion/Titration Phase|Physician Decision|5
1715860|NCT01115569|5989385|P2|Conversion/Titration Phase|Lost to Follow-up|0
1715861|NCT01115569|5989386|P1|Conversion/Titration Phase|Lost to Follow-up|3
1715862|NCT01115569|5989385|P2|Conversion/Titration Phase|Adverse Event|0
1715863|NCT01115569|5989386|P1|Conversion/Titration Phase|Adverse Event|59
1715864|NCT01115491|5989415|P1|Overall Study|Physician Decision|1
1715865|NCT01115491|5989415|P1|Overall Study|Withdrawal by Subject|1
1715866|NCT01115491|5989415|P1|Overall Study|Lost to Follow-up|3
1715867|NCT01115491|5989415|P1|Overall Study|Adverse Event|3
1715868|NCT01115491|5989415|P1|Overall Study|Death|22
1715869|NCT01114880|5989633|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
1715870|NCT01114880|5989634|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
1715871|NCT01114880|5989633|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
1715872|NCT01114880|5989634|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
1715873|NCT01114880|5989633|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
1715874|NCT01114880|5989634|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
1715875|NCT01114880|5989633|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
1715876|NCT01114880|5989634|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
1715877|NCT01114880|5989633|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
1715878|NCT01114880|5989634|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
1715879|NCT01114880|5989633|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
1715880|NCT01114880|5989634|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
1715881|NCT01114828|5989686|P2|Overall Study|Withdrawal by Subject|1
1715882|NCT01114828|5989687|P1|Overall Study|Withdrawal by Subject|0
1715883|NCT01114828|5989686|P2|Overall Study|Protocol Violation|0
1715884|NCT01114828|5989687|P1|Overall Study|Protocol Violation|2
1715885|NCT01114828|5989686|P2|Overall Study|Lack of Efficacy|2
1715886|NCT01114828|5989687|P1|Overall Study|Lack of Efficacy|0
1715887|NCT01114828|5989686|P2|Overall Study|Adverse Event|1
1715888|NCT01114828|5989687|P1|Overall Study|Adverse Event|1
1715889|NCT01114737|5989697|P2|Open-Label Treatment Period|Difficult Personal Events|0
1715890|NCT01114737|5989698|P1|Open-Label Treatment Period|Difficult Personal Events|1
1715891|NCT01114737|5989697|P2|Open-Label Treatment Period|Lost to Follow-up|1
1715892|NCT01114737|5989698|P1|Open-Label Treatment Period|Lost to Follow-up|3
1715893|NCT01114737|5989697|P2|Open-Label Treatment Period|Withdrawal by Subject|1
1715894|NCT01114737|5989698|P1|Open-Label Treatment Period|Withdrawal by Subject|1
1715895|NCT01114737|5989697|P2|Randomized Treatment Period|Pregnancy|0
1715896|NCT01114737|5989698|P1|Randomized Treatment Period|Pregnancy|1
1715897|NCT01114737|5989697|P2|Randomized Treatment Period|Lost to Follow-up|1
1715898|NCT01114737|5989698|P1|Randomized Treatment Period|Lost to Follow-up|1
1715899|NCT01114737|5989697|P2|Randomized Treatment Period|Withdrawal by Subject|0
1715900|NCT01114737|5989698|P1|Randomized Treatment Period|Withdrawal by Subject|1
1715901|NCT01114724|5989746|P1|Overall Study|Withdrawal by Subject|1
1715902|NCT01114724|5989746|P1|Overall Study|Lost to Follow-up|1
1715903|NCT01114724|5989746|P1|Overall Study|Death|8
1715904|NCT01114672|5989766|P2|Overall Study|transplanted|0
1715905|NCT01114672|5989767|P1|Overall Study|transplanted|1
1715906|NCT01114672|5989766|P2|Overall Study|Lost to Follow-up|0
1715907|NCT01114672|5989767|P1|Overall Study|Lost to Follow-up|1
1715908|NCT01114672|5989766|P2|Overall Study|Withdrawal by Subject|1
1715909|NCT01114672|5989767|P1|Overall Study|Withdrawal by Subject|2
1715910|NCT01114672|5989766|P2|Overall Study|Death|1
1715911|NCT01114672|5989767|P1|Overall Study|Death|0
1715912|NCT01114646|5989775|P2|Overall Study|Withdrawal by Subject|2
1715913|NCT01114646|5989776|P1|Overall Study|Withdrawal by Subject|3
1715914|NCT01114529|5989836|P3|Completed Study Phase at Month 24|Missing|0
1715915|NCT01114529|5989837|P2|Completed Study Phase at Month 24|Missing|0
1715916|NCT01114529|5989838|P1|Completed Study Phase at Month 24|Missing|2
1715917|NCT01114529|5989836|P3|Completed Study Phase at Month 24|Other|0
1715918|NCT01114529|5989837|P2|Completed Study Phase at Month 24|Other|0
1715919|NCT01114529|5989838|P1|Completed Study Phase at Month 24|Other|2
1715920|NCT01114529|5989836|P3|Completed Study Phase at Month 24|Death|4
1715921|NCT01114529|5989837|P2|Completed Study Phase at Month 24|Death|5
1715922|NCT01114529|5989838|P1|Completed Study Phase at Month 24|Death|8
1715923|NCT01114529|5989836|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
1715924|NCT01114529|5989837|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
1715925|NCT01114529|5989838|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
1715926|NCT01114529|5989836|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
1715927|NCT01114529|5989837|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
1715928|NCT01114529|5989838|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
1715929|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Missing|0
1715930|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Missing|0
1715931|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Missing|2
1715932|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Protocol Violation|2
1715933|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Protocol Violation|5
1715934|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Protocol Violation|0
1715935|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Graft loss|0
1715936|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Graft loss|2
1715937|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Graft loss|0
1715938|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Death|2
1715939|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Death|1
1715940|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Death|2
1715941|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Administrative problems|2
1715942|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Administrative problems|1
1715943|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Administrative problems|2
1715944|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
1715945|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
1715946|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
1715947|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
1715948|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
1715949|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
1715950|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
1715951|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
1715952|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
1715953|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
1715954|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
1715955|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
1715956|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
1715957|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
1715958|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
1715959|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
1715960|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
1715961|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
1715962|NCT01114529|5989836|P3|Completed Study Medication at Month 24|Adverse Event|17
1715963|NCT01114529|5989837|P2|Completed Study Medication at Month 24|Adverse Event|18
1715964|NCT01114529|5989838|P1|Completed Study Medication at Month 24|Adverse Event|87
1715965|NCT01114516|5989857|P2|Overall Study|Lost to Follow-up|1
1715966|NCT01114516|5989858|P1|Overall Study|Lost to Follow-up|2
1715967|NCT01114438|5989893|P1|Overall Study|Withdrawal by Subject|2
1715968|NCT01114438|5989893|P1|Overall Study|Physician Decision|1
1715969|NCT01114438|5989893|P1|Overall Study|concomitant medication|1
1715970|NCT01114438|5989893|P1|Overall Study|Adverse Event|10
1715971|NCT01114373|5989903|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
1715972|NCT01114373|5989904|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
1715973|NCT01114373|5989903|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
1715974|NCT01114373|5989904|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
1715975|NCT01114373|5989903|P2|Intervention 1 (4 Weeks)|Incarceration|0
1715976|NCT01114373|5989904|P1|Intervention 1 (4 Weeks)|Incarceration|1
1715977|NCT01114373|5989903|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
1715978|NCT01114373|5989904|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
1715979|NCT01114360|5989936|P2|Intervention 1 (4 Weeks)|Physician Decision|1
1715980|NCT01114360|5989937|P1|Intervention 1 (4 Weeks)|Physician Decision|0
1715981|NCT01114217|5989988|P2|Overall Study|Other-Withdrawal by Subject|1
1715982|NCT01114217|5989989|P1|Overall Study|Other-Withdrawal by Subject|1
1715983|NCT01114217|5989988|P2|Overall Study|Other-Lost to Follow-up|0
1715984|NCT01114217|5989989|P1|Overall Study|Other-Lost to Follow-up|1
1715985|NCT01114217|5989988|P2|Overall Study|Other-Site Stopped Communicating|0
1715986|NCT01114217|5989989|P1|Overall Study|Other-Site Stopped Communicating|2
1715987|NCT01114217|5989988|P2|Overall Study|Other-Study Withdrawn|1
1715988|NCT01114217|5989989|P1|Overall Study|Other-Study Withdrawn|1
1715989|NCT01114217|5989988|P2|Overall Study|Other-Study Termination|1
1715990|NCT01114217|5989989|P1|Overall Study|Other-Study Termination|0
1715991|NCT01114217|5989988|P2|Overall Study|Other-Sponsor Decision|12
1715992|NCT01114217|5989989|P1|Overall Study|Other-Sponsor Decision|10
1715993|NCT01114217|5989988|P2|Overall Study|Other-Physician Decision|1
1715994|NCT01114217|5989989|P1|Overall Study|Other-Physician Decision|1
1715995|NCT01114217|5989988|P2|Overall Study|Other-Non Compliance|0
1715996|NCT01114217|5989989|P1|Overall Study|Other-Non Compliance|2
1715997|NCT01114217|5989988|P2|Overall Study|Other-Lack of Efficacy|0
1715998|NCT01114217|5989989|P1|Overall Study|Other-Lack of Efficacy|1
1715999|NCT01114217|5989988|P2|Overall Study|Other-Protocol Violation|3
1716000|NCT01114217|5989989|P1|Overall Study|Other-Protocol Violation|1
1716001|NCT01114217|5989988|P2|Overall Study|Other-Pregnancy|4
1716002|NCT01114217|5989989|P1|Overall Study|Other-Pregnancy|2
1716003|NCT01114217|5989988|P2|Overall Study|Other-Procedure|1
1716004|NCT01114217|5989989|P1|Overall Study|Other-Procedure|1
1716005|NCT01114217|5989988|P2|Overall Study|Other-Early termination|10
1716006|NCT01114217|5989989|P1|Overall Study|Other-Early termination|6
1716007|NCT01114217|5989988|P2|Overall Study|Other-Clerical Error|0
1716008|NCT01114217|5989989|P1|Overall Study|Other-Clerical Error|3
1716009|NCT01114217|5989988|P2|Overall Study|Withdrawal by Subject|28
1716010|NCT01114217|5989989|P1|Overall Study|Withdrawal by Subject|21
1716011|NCT01114217|5989988|P2|Overall Study|Lost to Follow-up|33
1716012|NCT01114217|5989989|P1|Overall Study|Lost to Follow-up|17
1716013|NCT01114217|5989988|P2|Overall Study|Adverse Event|3
1716014|NCT01114217|5989989|P1|Overall Study|Adverse Event|5
1716015|NCT01114204|5990001|P2|Overall Study|Other-Protocol Violation|0
1716016|NCT01114204|5990002|P1|Overall Study|Other-Protocol Violation|1
1716017|NCT01114204|5990001|P2|Overall Study|Other-Participant request|0
1716018|NCT01114204|5990002|P1|Overall Study|Other-Participant request|2
1716019|NCT01114204|5990001|P2|Overall Study|Other-Medical monitor request|0
1716020|NCT01114204|5990002|P1|Overall Study|Other-Medical monitor request|1
1716021|NCT01114204|5990001|P2|Overall Study|Other-Personal reasons|0
1716022|NCT01114204|5990002|P1|Overall Study|Other-Personal reasons|2
1716023|NCT01114204|5990001|P2|Overall Study|Death|0
1716024|NCT01114204|5990002|P1|Overall Study|Death|1
1716025|NCT01114204|5990001|P2|Overall Study|Withdrawal by Subject|6
1716026|NCT01114204|5990002|P1|Overall Study|Withdrawal by Subject|10
1716027|NCT01114204|5990001|P2|Overall Study|Lost to Follow-up|0
1716028|NCT01114204|5990002|P1|Overall Study|Lost to Follow-up|1
1716029|NCT01114204|5990001|P2|Overall Study|Adverse Event|2
1716030|NCT01114204|5990002|P1|Overall Study|Adverse Event|3
1716031|NCT01114139|5990020|P2|Overall Study|Other-Withdrew prior to receiving dose|3
1716032|NCT01114139|5990021|P1|Overall Study|Other-Withdrew prior to receiving dose|1
1716033|NCT01114139|5990020|P2|Overall Study|Other-Physician changed treatment|0
1716034|NCT01114139|5990021|P1|Overall Study|Other-Physician changed treatment|1
1716035|NCT01114139|5990020|P2|Overall Study|Other-Participant went on hospice|1
1716036|NCT01114139|5990021|P1|Overall Study|Other-Participant went on hospice|0
1716037|NCT01114139|5990020|P2|Overall Study|Other-Participant falsified records|1
1716038|NCT01114139|5990021|P1|Overall Study|Other-Participant falsified records|0
1716039|NCT01114139|5990020|P2|Overall Study|Other-Out of window for study drug dose|0
1716040|NCT01114139|5990021|P1|Overall Study|Other-Out of window for study drug dose|1
1716041|NCT01114139|5990020|P2|Overall Study|Other-Protocol Violation|0
1716042|NCT01114139|5990021|P1|Overall Study|Other-Protocol Violation|1
1716043|NCT01114139|5990020|P2|Overall Study|Other-Missed 1 visit|0
1716044|NCT01114139|5990021|P1|Overall Study|Other-Missed 1 visit|1
1716045|NCT01114139|5990020|P2|Overall Study|Withdrawal by Subject|6
1716046|NCT01114139|5990021|P1|Overall Study|Withdrawal by Subject|17
1716047|NCT01114139|5990020|P2|Overall Study|Lost to Follow-up|3
1716048|NCT01114139|5990021|P1|Overall Study|Lost to Follow-up|15
1716049|NCT01114139|5990020|P2|Overall Study|Adverse Event|2
1716050|NCT01114139|5990021|P1|Overall Study|Adverse Event|3
1716051|NCT01113931|5990039|P2|Overall Study|Withdrawal by Subject|0
1716052|NCT01113931|5990040|P1|Overall Study|Withdrawal by Subject|3
1716053|NCT01113931|5990039|P2|Overall Study|Various|4
1716054|NCT01113931|5990040|P1|Overall Study|Various|2
1716055|NCT01113931|5990039|P2|Overall Study|Lost to Follow-up|9
1716056|NCT01113931|5990040|P1|Overall Study|Lost to Follow-up|12
1716057|NCT01113931|5990039|P2|Overall Study|Physician Decision|2
1716058|NCT01113931|5990040|P1|Overall Study|Physician Decision|0
1716059|NCT01113931|5990039|P2|Overall Study|Adverse Event|2
1716060|NCT01113931|5990040|P1|Overall Study|Adverse Event|2
1716061|NCT01113879|5990054|P2|Period 1: Block 1|Withdrawal by Subject|0
1716062|NCT01113879|5990055|P1|Period 1: Block 1|Withdrawal by Subject|2
1716063|NCT01113801|5990067|P4|Overall Study|Clinical Endpoint (ESRD)|5
1716064|NCT01113801|5990068|P3|Overall Study|Clinical Endpoint (ESRD)|2
1716065|NCT01113801|5990069|P2|Overall Study|Clinical Endpoint (ESRD)|4
1716066|NCT01113801|5990070|P1|Overall Study|Clinical Endpoint (ESRD)|7
1716067|NCT01113801|5990067|P4|Overall Study|Sponsor Decision|15
1716068|NCT01113801|5990068|P3|Overall Study|Sponsor Decision|20
1716069|NCT01113801|5990069|P2|Overall Study|Sponsor Decision|21
1716070|NCT01113801|5990070|P1|Overall Study|Sponsor Decision|15
1716071|NCT01113801|5990067|P4|Overall Study|Physician Decision|3
1716072|NCT01113801|5990068|P3|Overall Study|Physician Decision|3
1716073|NCT01113801|5990069|P2|Overall Study|Physician Decision|2
1716074|NCT01113801|5990070|P1|Overall Study|Physician Decision|2
1716075|NCT01113801|5990067|P4|Overall Study|Withdrawal by Subject|8
1716076|NCT01113801|5990068|P3|Overall Study|Withdrawal by Subject|7
1716077|NCT01113801|5990069|P2|Overall Study|Withdrawal by Subject|7
1716078|NCT01113801|5990070|P1|Overall Study|Withdrawal by Subject|9
1716079|NCT01113801|5990067|P4|Overall Study|Protocol Violation|0
1716080|NCT01113801|5990068|P3|Overall Study|Protocol Violation|0
1716081|NCT01113801|5990069|P2|Overall Study|Protocol Violation|1
1716082|NCT01113801|5990070|P1|Overall Study|Protocol Violation|0
1716083|NCT01113801|5990067|P4|Overall Study|Death|4
1716084|NCT01113801|5990068|P3|Overall Study|Death|3
1716085|NCT01113801|5990069|P2|Overall Study|Death|5
1716086|NCT01113801|5990070|P1|Overall Study|Death|4
1716087|NCT01113801|5990067|P4|Overall Study|Adverse Event|6
1716088|NCT01113801|5990068|P3|Overall Study|Adverse Event|2
1716089|NCT01113801|5990069|P2|Overall Study|Adverse Event|0
1716090|NCT01113801|5990070|P1|Overall Study|Adverse Event|4
1716091|NCT01113749|5990098|P2|Overall Study|Lost to Follow-up|2
1716092|NCT01113749|5990099|P1|Overall Study|Lost to Follow-up|1
1716093|NCT01113710|5990122|P1|Overall Study|Subject Did Not Receive Neupro|3
1716094|NCT01113710|5990122|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
1716095|NCT01113710|5990122|P1|Overall Study|Lack of Patient's Compliance/Other|1
1716096|NCT01113710|5990122|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
1716097|NCT01113710|5990122|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
1716098|NCT01113710|5990122|P1|Overall Study|Compliance/Efficacy/AE/Other|1
1716099|NCT01113710|5990122|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
1716100|NCT01113710|5990122|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
1716101|NCT01113710|5990122|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
1716102|NCT01113710|5990122|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
1716103|NCT01113710|5990122|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
1716104|NCT01113710|5990122|P1|Overall Study|Lack of Efficacy/Adverse Event|3
1716105|NCT01113710|5990122|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
1716106|NCT01113710|5990122|P1|Overall Study|Lack of Efficacy/Other|4
1716107|NCT01113710|5990122|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
1716108|NCT01113710|5990122|P1|Overall Study|Adverse Event/Other|5
1716109|NCT01113710|5990122|P1|Overall Study|Other|7
1716110|NCT01113710|5990122|P1|Overall Study|Lack of Patient's Compliance|8
1716111|NCT01113710|5990122|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
1716112|NCT01113710|5990122|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
1716113|NCT01113710|5990122|P1|Overall Study|Lost to Follow-up|20
1716114|NCT01113710|5990122|P1|Overall Study|Withdrawal by Subject|28
1716115|NCT01113710|5990122|P1|Overall Study|No Information Available|40
1716116|NCT01113710|5990122|P1|Overall Study|Lack of Efficacy|41
1716117|NCT01113710|5990122|P1|Overall Study|Adverse Event|64
1716118|NCT01113580|5990150|P2|Overall Study|Protocol Violation|0
1716119|NCT01113580|5990151|P1|Overall Study|Protocol Violation|1
1716120|NCT01113541|5990165|P1|Overall Study|Adverse Event|4
1716121|NCT01113541|5990165|P1|Overall Study|Study Terminated by Sponsor|7
1716122|NCT01113541|5990165|P1|Overall Study|Protocol Violation|1
1716123|NCT01113541|5990165|P1|Overall Study|Withdrawal by Subject|1
1716124|NCT01113463|5990198|P1|Overall Study|Physician Decision|5
1716125|NCT01112982|5990228|P1|Overall Study|exceeded weight limit to complete MRI|1
1716126|NCT01112982|5990228|P1|Overall Study|Withdrawal by Subject|1
1716127|NCT01112917|5990240|P2|Overall Study|Unable to Convert Filter|0
1716128|NCT01112917|5990241|P1|Overall Study|Unable to Convert Filter|3
1716129|NCT01112917|5990240|P2|Overall Study|Withdrawal by Subject|3
1716130|NCT01112917|5990241|P1|Overall Study|Withdrawal by Subject|1
1716131|NCT01112917|5990240|P2|Overall Study|Lost to Follow-up|1
1716132|NCT01112917|5990241|P1|Overall Study|Lost to Follow-up|1
1716133|NCT01112917|5990240|P2|Overall Study|Death|11
1716134|NCT01112917|5990241|P1|Overall Study|Death|2
1716135|NCT01112579|5990345|P2|Overall Study|Death|2
1716136|NCT01112579|5990346|P1|Overall Study|Death|0
1716137|NCT01112579|5990345|P2|Overall Study|Missed Visit|1
1716138|NCT01112579|5990346|P1|Overall Study|Missed Visit|1
1716139|NCT01112514|5990356|P1|Overall Study|Lost to Follow-up|1
1716140|NCT01112267|5990401|P2|Overall Study|Participants not receive any study drug|2
1716141|NCT01112267|5990402|P1|Overall Study|Participants not receive any study drug|1
1716142|NCT01112267|5990401|P2|Overall Study|Participants not compliant|2
1716143|NCT01112267|5990402|P1|Overall Study|Participants not compliant|1
1716144|NCT01112267|5990401|P2|Overall Study|Protocol Violation|3
1716145|NCT01112267|5990402|P1|Overall Study|Protocol Violation|5
1716146|NCT01112267|5990401|P2|Overall Study|Withdrawal by Subject|5
1716147|NCT01112267|5990402|P1|Overall Study|Withdrawal by Subject|3
1716148|NCT01112267|5990401|P2|Overall Study|Adverse Event|6
1716149|NCT01112267|5990402|P1|Overall Study|Adverse Event|24
1716150|NCT01112059|5990435|P2|Overall Study|Withdrawal by Subject|0
1716151|NCT01112059|5990436|P1|Overall Study|Withdrawal by Subject|1
1716152|NCT01111851|5990450|P2|Overall Study|All planned PET scans were not obtained.|0
1716153|NCT01111851|5990451|P1|Overall Study|All planned PET scans were not obtained.|2
1716154|NCT01111838|5990463|P1|Overall Study|Other Complicating Disease|1
1716155|NCT01111838|5990463|P1|Overall Study|Clinical deterioration|1
1716156|NCT01111838|5990463|P1|Overall Study|Not Treated|3
1716157|NCT01111838|5990463|P1|Overall Study|Patient Ineligible|2
1716158|NCT01111825|5990471|P4|Overall Study|Discontinuation by Sponsor|20
1716159|NCT01111825|5990472|P3|Overall Study|Discontinuation by Sponsor|0
1716160|NCT01111825|5990473|P2|Overall Study|Discontinuation by Sponsor|0
1716161|NCT01111825|5990474|P1|Overall Study|Discontinuation by Sponsor|0
1716162|NCT01111825|5990471|P4|Overall Study|Disease Progression|0
1716163|NCT01111825|5990472|P3|Overall Study|Disease Progression|0
1716164|NCT01111825|5990473|P2|Overall Study|Disease Progression|0
1716165|NCT01111825|5990474|P1|Overall Study|Disease Progression|1
1716166|NCT01111825|5990471|P4|Overall Study|Adverse Event|0
1716167|NCT01111825|5990472|P3|Overall Study|Adverse Event|4
1716168|NCT01111825|5990473|P2|Overall Study|Adverse Event|1
1716169|NCT01111825|5990474|P1|Overall Study|Adverse Event|2
1716170|NCT01111825|5990471|P4|Overall Study|Lost to Follow-up|1
1716171|NCT01111825|5990472|P3|Overall Study|Lost to Follow-up|3
1716172|NCT01111825|5990473|P2|Overall Study|Lost to Follow-up|0
1716173|NCT01111825|5990474|P1|Overall Study|Lost to Follow-up|0
1716174|NCT01111825|5990471|P4|Overall Study|Withdrawal by Subject|0
1716175|NCT01111825|5990472|P3|Overall Study|Withdrawal by Subject|1
1716176|NCT01111825|5990473|P2|Overall Study|Withdrawal by Subject|0
1716177|NCT01111825|5990474|P1|Overall Study|Withdrawal by Subject|0
1716178|NCT01111604|5990496|P3|Overall Study|Met Exclusion Criteria|0
1716179|NCT01111604|5990497|P2|Overall Study|Met Exclusion Criteria|0
1716180|NCT01111604|5990498|P1|Overall Study|Met Exclusion Criteria|2
1716181|NCT01111604|5990496|P3|Overall Study|Death|0
1716182|NCT01111604|5990497|P2|Overall Study|Death|0
1716183|NCT01111604|5990498|P1|Overall Study|Death|1
1716184|NCT01111604|5990496|P3|Overall Study|Withdrawal by Subject|0
1716185|NCT01111604|5990497|P2|Overall Study|Withdrawal by Subject|0
1716186|NCT01111604|5990498|P1|Overall Study|Withdrawal by Subject|2
1716187|NCT01111604|5990496|P3|Overall Study|Withdrew Consent|2
1716188|NCT01111604|5990497|P2|Overall Study|Withdrew Consent|0
1716189|NCT01111604|5990498|P1|Overall Study|Withdrew Consent|3
1716190|NCT01111604|5990496|P3|Overall Study|Lost to Follow-up|1
1716191|NCT01111604|5990497|P2|Overall Study|Lost to Follow-up|0
1716192|NCT01111604|5990498|P1|Overall Study|Lost to Follow-up|0
1716193|NCT01111526|5990536|P3|Overall Study|GVHD Disease Progression|2
1716194|NCT01111526|5990537|P2|Overall Study|GVHD Disease Progression|1
1716195|NCT01111526|5990538|P1|Overall Study|GVHD Disease Progression|0
1716196|NCT01111461|5990550|P1|Overall Study|Other|6
1716197|NCT01111461|5990550|P1|Overall Study|Withdrawal by Subject|1
1716198|NCT01111461|5990550|P1|Overall Study|Lost to Follow-up|1
1716199|NCT01111461|5990550|P1|Overall Study|Participant choice|11
1716200|NCT01111461|5990550|P1|Overall Study|Adverse Event|32
1716201|NCT01111292|5990730|P2|Treatment|Physician Decision|1
1716202|NCT01111292|5990731|P1|Treatment|Physician Decision|1
1716203|NCT01111240|5990737|P1|Overall Study|Other|312
1716204|NCT01111240|5990737|P1|Overall Study|Lack of Efficacy and Adverse Event|19
1716205|NCT01111240|5990737|P1|Overall Study|Lack of Efficacy|545
1716206|NCT01111240|5990737|P1|Overall Study|Adverse Event|190
1716207|NCT01111149|5990767|P3|Overall Study|Withdrawal by Subject|2
1716208|NCT01111149|5990768|P2|Overall Study|Withdrawal by Subject|0
1716209|NCT01111149|5990769|P1|Overall Study|Withdrawal by Subject|1
1716210|NCT01111149|5990767|P3|Overall Study|Protocol Violation|2
1716211|NCT01111149|5990768|P2|Overall Study|Protocol Violation|1
1716212|NCT01111149|5990769|P1|Overall Study|Protocol Violation|1
1716213|NCT01111123|5990845|P2|Maintenance Phase|Lost to Follow-up|2
1716214|NCT01111123|5990846|P1|Maintenance Phase|Lost to Follow-up|0
1716215|NCT01111123|5990845|P2|Open- Label Phase|Failed to be clear or almost cleared|0
1716216|NCT01111123|5990846|P1|Open- Label Phase|Failed to be clear or almost cleared|14
1716217|NCT01111019|5990867|P1|Overall Study|Other|1
1716218|NCT01111019|5990867|P1|Overall Study|Withdrew Prematurely|2
1716219|NCT01110915|5990899|P2|Overall Study|Withdrawal by Subject|1
1716220|NCT01110915|5990900|P1|Overall Study|Withdrawal by Subject|7
1716221|NCT01110915|5990899|P2|Overall Study|Lost to Follow-up|0
1716222|NCT01110915|5990900|P1|Overall Study|Lost to Follow-up|1
1716223|NCT01110915|5990899|P2|Overall Study|Death|1
1716224|NCT01110915|5990900|P1|Overall Study|Death|2
1716225|NCT01110707|5990917|P2|Overall Study|Protocol Violation|3
1716226|NCT01110707|5990918|P1|Overall Study|Protocol Violation|0
1716227|NCT01110408|5991006|P2|Overall Study|Protocol Violation|0
1716228|NCT01110408|5991007|P1|Overall Study|Protocol Violation|1
1716229|NCT01110382|5991027|P2|Overall Study|Protocol Violation|1
1716230|NCT01110382|5991028|P1|Overall Study|Protocol Violation|0
1716231|NCT01110382|5991027|P2|Overall Study|Withdrawal by Subject|1
1716232|NCT01110382|5991028|P1|Overall Study|Withdrawal by Subject|0
1716233|NCT01110330|5991049|P3|Overall Study|Other|1
1716234|NCT01110330|5991050|P2|Overall Study|Other|1
1716235|NCT01110330|5991051|P1|Overall Study|Other|1
1716236|NCT01110330|5991049|P3|Overall Study|Withdrawal by Subject|2
1716237|NCT01110330|5991050|P2|Overall Study|Withdrawal by Subject|6
1716238|NCT01110330|5991051|P1|Overall Study|Withdrawal by Subject|0
1716239|NCT01110330|5991049|P3|Overall Study|Protocol Violation|4
1716240|NCT01110330|5991050|P2|Overall Study|Protocol Violation|0
1716241|NCT01110330|5991051|P1|Overall Study|Protocol Violation|2
1716242|NCT01110330|5991049|P3|Overall Study|Physician Decision|0
1716243|NCT01110330|5991050|P2|Overall Study|Physician Decision|1
1716244|NCT01110330|5991051|P1|Overall Study|Physician Decision|0
1716245|NCT01110330|5991049|P3|Overall Study|Lost to Follow-up|15
1716246|NCT01110330|5991050|P2|Overall Study|Lost to Follow-up|10
1716247|NCT01110330|5991051|P1|Overall Study|Lost to Follow-up|9
1716248|NCT01110330|5991049|P3|Overall Study|Lack of Efficacy|1
1716249|NCT01110330|5991050|P2|Overall Study|Lack of Efficacy|1
1716250|NCT01110330|5991051|P1|Overall Study|Lack of Efficacy|3
1716251|NCT01110330|5991049|P3|Overall Study|Adverse Event|3
1716252|NCT01110330|5991050|P2|Overall Study|Adverse Event|4
1716253|NCT01110330|5991051|P1|Overall Study|Adverse Event|0
1716254|NCT01110239|5991079|P4|7.5 Min Ischemia|Withdrawal by Subject|0
1716255|NCT01110239|5991080|P3|7.5 Min Ischemia|Withdrawal by Subject|1
1716256|NCT01110239|5991081|P2|7.5 Min Ischemia|Withdrawal by Subject|0
1716257|NCT01110239|5991082|P1|7.5 Min Ischemia|Withdrawal by Subject|0
1716258|NCT01110239|5991079|P4|Sham Preconditioning|Withdrawal by Subject|0
1716259|NCT01110239|5991080|P3|Sham Preconditioning|Withdrawal by Subject|1
1716260|NCT01110239|5991081|P2|Sham Preconditioning|Withdrawal by Subject|0
1716261|NCT01110239|5991082|P1|Sham Preconditioning|Withdrawal by Subject|0
1716262|NCT01110200|5991098|P2|Overall Study|Lost to Follow-up|7
1716263|NCT01110200|5991099|P1|Overall Study|Lost to Follow-up|10
1716264|NCT01110200|5991098|P2|Overall Study|Physician Decision|17
1716265|NCT01110200|5991099|P1|Overall Study|Physician Decision|13
1716266|NCT01110200|5991098|P2|Overall Study|Protocol Violation|12
1716267|NCT01110200|5991099|P1|Overall Study|Protocol Violation|14
1716268|NCT01110200|5991098|P2|Overall Study|Lack of Efficacy|25
1716269|NCT01110200|5991099|P1|Overall Study|Lack of Efficacy|16
1716270|NCT01110200|5991098|P2|Overall Study|Withdrawal by Subject|32
1716271|NCT01110200|5991099|P1|Overall Study|Withdrawal by Subject|25
1716272|NCT01110200|5991098|P2|Overall Study|Adverse Event|28
1716273|NCT01110200|5991099|P1|Overall Study|Adverse Event|28
1716274|NCT01110005|5991135|P2|Overall Study|Withdrawal by Subject|1
1716275|NCT01110005|5991136|P1|Overall Study|Withdrawal by Subject|0
1716276|NCT01110005|5991135|P2|Overall Study|missing consent|2
1716277|NCT01110005|5991136|P1|Overall Study|missing consent|3
1716278|NCT01110005|5991135|P2|Overall Study|ineligible|2
1716279|NCT01110005|5991136|P1|Overall Study|ineligible|1
1716280|NCT01109992|5991148|P2|Overall Study|Movement during rest scan.|1
1716281|NCT01109992|5991149|P1|Overall Study|Movement during rest scan.|0
1716282|NCT01109992|5991148|P2|Overall Study|Withdrawal by Subject|1
1716283|NCT01109992|5991149|P1|Overall Study|Withdrawal by Subject|0
1716284|NCT01109979|5991163|P2|Overall Study|Withdrawal by Subject|1
1716285|NCT01109979|5991164|P1|Overall Study|Withdrawal by Subject|0
1716286|NCT01109979|5991163|P2|Overall Study|Physician Decision|0
1716287|NCT01109979|5991164|P1|Overall Study|Physician Decision|2
1716288|NCT01109849|5991172|P5|Adaptive Randomization: Weight Recovery|moved away|0
1716289|NCT01109849|5991173|P4|Adaptive Randomization: Weight Recovery|moved away|2
1716290|NCT01109849|5991174|P3|Adaptive Randomization: Weight Recovery|moved away|0
1716291|NCT01109849|5991175|P2|Adaptive Randomization: Weight Recovery|moved away|0
1716292|NCT01109849|5991176|P1|Adaptive Randomization: Weight Recovery|moved away|0
1716293|NCT01109849|5991172|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1716294|NCT01109849|5991173|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1716295|NCT01109849|5991174|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
1716296|NCT01109849|5991175|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
1716297|NCT01109849|5991176|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
1716298|NCT01109849|5991172|P5|Initial Randomization: ADHD Treatment|move away|0
1716299|NCT01109849|5991173|P4|Initial Randomization: ADHD Treatment|move away|0
1716300|NCT01109849|5991174|P3|Initial Randomization: ADHD Treatment|move away|0
1716301|NCT01109849|5991175|P2|Initial Randomization: ADHD Treatment|move away|7
1716302|NCT01109849|5991176|P1|Initial Randomization: ADHD Treatment|move away|2
1716303|NCT01109849|5991172|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1716304|NCT01109849|5991173|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1716305|NCT01109849|5991174|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
1716306|NCT01109849|5991175|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
1716307|NCT01109849|5991176|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
1716308|NCT01109849|5991172|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
1716309|NCT01109849|5991173|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
1716310|NCT01109849|5991174|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
1716311|NCT01109849|5991175|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
1716312|NCT01109849|5991176|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
1716313|NCT01109849|5991172|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1716314|NCT01109849|5991173|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1716315|NCT01109849|5991174|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
1716316|NCT01109849|5991175|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
1716317|NCT01109849|5991176|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
1716318|NCT01109524|5991245|P1|Overall Study|Other|5
1716319|NCT01109524|5991245|P1|Overall Study|Participant requested to end treatment|4
1716320|NCT01109524|5991245|P1|Overall Study|No longer meets criteria|2
1716321|NCT01109524|5991245|P1|Overall Study|Death|2
1716322|NCT01109524|5991245|P1|Overall Study|Maximum clinical benefit|3
1716323|NCT01109524|5991245|P1|Overall Study|Withdrawal by Subject|2
1716324|NCT01109524|5991245|P1|Overall Study|Adverse Event|4
1716325|NCT01109524|5991245|P1|Overall Study|Study Drug toxicity|6
1716326|NCT01109524|5991245|P1|Overall Study|Disease Progression|29
1716327|NCT01109316|5991267|P6|Study Period 3|Withdrawal by Subject|0
1716328|NCT01109316|5991268|P5|Study Period 3|Withdrawal by Subject|1
1716329|NCT01109316|5991269|P4|Study Period 3|Withdrawal by Subject|0
1716330|NCT01109316|5991270|P3|Study Period 3|Withdrawal by Subject|0
1716331|NCT01109316|5991271|P2|Study Period 3|Withdrawal by Subject|0
1716332|NCT01109316|5991272|P1|Study Period 3|Withdrawal by Subject|1
1716333|NCT01109316|5991267|P6|Study Period 3|Lost to Follow-up|0
1716334|NCT01109316|5991268|P5|Study Period 3|Lost to Follow-up|1
1716335|NCT01109316|5991269|P4|Study Period 3|Lost to Follow-up|0
1716336|NCT01109316|5991270|P3|Study Period 3|Lost to Follow-up|0
1716337|NCT01109316|5991271|P2|Study Period 3|Lost to Follow-up|0
1716338|NCT01109316|5991272|P1|Study Period 3|Lost to Follow-up|0
1716339|NCT01109316|5991267|P6|Study Period 2|Withdrawal by Subject|1
1716340|NCT01109316|5991268|P5|Study Period 2|Withdrawal by Subject|0
1716341|NCT01109316|5991269|P4|Study Period 2|Withdrawal by Subject|0
1716342|NCT01109316|5991270|P3|Study Period 2|Withdrawal by Subject|1
1716343|NCT01109316|5991271|P2|Study Period 2|Withdrawal by Subject|0
1716344|NCT01109316|5991272|P1|Study Period 2|Withdrawal by Subject|0
1716345|NCT01109316|5991267|P6|Study Period 2|Protocol Violation|0
1716346|NCT01109316|5991268|P5|Study Period 2|Protocol Violation|0
1716347|NCT01109316|5991269|P4|Study Period 2|Protocol Violation|0
1716348|NCT01109316|5991270|P3|Study Period 2|Protocol Violation|0
1716349|NCT01109316|5991271|P2|Study Period 2|Protocol Violation|0
1716350|NCT01109316|5991272|P1|Study Period 2|Protocol Violation|1
1716351|NCT01109316|5991267|P6|Study Period 2|Physician Decision|0
1716352|NCT01109316|5991268|P5|Study Period 2|Physician Decision|0
1716353|NCT01109316|5991269|P4|Study Period 2|Physician Decision|1
1716354|NCT01109316|5991270|P3|Study Period 2|Physician Decision|0
1716355|NCT01109316|5991271|P2|Study Period 2|Physician Decision|0
1716356|NCT01109316|5991272|P1|Study Period 2|Physician Decision|0
1716357|NCT01109316|5991267|P6|Study Period 2|Entry Criteria Not Met|0
1716358|NCT01109316|5991268|P5|Study Period 2|Entry Criteria Not Met|0
1716359|NCT01109316|5991269|P4|Study Period 2|Entry Criteria Not Met|0
1716360|NCT01109316|5991270|P3|Study Period 2|Entry Criteria Not Met|0
1716361|NCT01109316|5991271|P2|Study Period 2|Entry Criteria Not Met|1
1716362|NCT01109316|5991272|P1|Study Period 2|Entry Criteria Not Met|0
1716363|NCT01109316|5991267|P6|Study Period 1|Sponsor Decision|2
1716364|NCT01109316|5991268|P5|Study Period 1|Sponsor Decision|0
1716365|NCT01109316|5991269|P4|Study Period 1|Sponsor Decision|0
1716366|NCT01109316|5991270|P3|Study Period 1|Sponsor Decision|0
1716367|NCT01109316|5991271|P2|Study Period 1|Sponsor Decision|0
1716368|NCT01109316|5991272|P1|Study Period 1|Sponsor Decision|0
1716369|NCT01109316|5991267|P6|Study Period 1|Withdrawal by Subject|0
1716370|NCT01109316|5991268|P5|Study Period 1|Withdrawal by Subject|2
1716371|NCT01109316|5991269|P4|Study Period 1|Withdrawal by Subject|0
1716372|NCT01109316|5991270|P3|Study Period 1|Withdrawal by Subject|1
1716373|NCT01109316|5991271|P2|Study Period 1|Withdrawal by Subject|0
1716374|NCT01109316|5991272|P1|Study Period 1|Withdrawal by Subject|0
1716375|NCT01109316|5991267|P6|Study Period 1|Lost to Follow-up|0
1716376|NCT01109316|5991268|P5|Study Period 1|Lost to Follow-up|0
1716377|NCT01109316|5991269|P4|Study Period 1|Lost to Follow-up|1
1716378|NCT01109316|5991270|P3|Study Period 1|Lost to Follow-up|1
1716379|NCT01109316|5991271|P2|Study Period 1|Lost to Follow-up|0
1716380|NCT01109316|5991272|P1|Study Period 1|Lost to Follow-up|0
1716381|NCT01109316|5991267|P6|Study Period 1|Adverse Event|0
1716382|NCT01109316|5991268|P5|Study Period 1|Adverse Event|0
1716383|NCT01109316|5991269|P4|Study Period 1|Adverse Event|0
1716384|NCT01109316|5991270|P3|Study Period 1|Adverse Event|1
1716385|NCT01109316|5991271|P2|Study Period 1|Adverse Event|0
1716386|NCT01109316|5991272|P1|Study Period 1|Adverse Event|0
1716387|NCT01109173|5991320|P4|Overall Study|Not Specifiied|14
1716388|NCT01109173|5991321|P3|Overall Study|Not Specifiied|9
1716389|NCT01109173|5991322|P2|Overall Study|Not Specifiied|4
1716390|NCT01109173|5991323|P1|Overall Study|Not Specifiied|5
1716391|NCT01109173|5991320|P4|Overall Study|Patient Did Not Use Study Medication|7
1716392|NCT01109173|5991321|P3|Overall Study|Patient Did Not Use Study Medication|11
1716393|NCT01109173|5991322|P2|Overall Study|Patient Did Not Use Study Medication|26
1716394|NCT01109173|5991323|P1|Overall Study|Patient Did Not Use Study Medication|34
1716395|NCT01109173|5991320|P4|Overall Study|Protocol Violation|2
1716396|NCT01109173|5991321|P3|Overall Study|Protocol Violation|1
1716397|NCT01109173|5991322|P2|Overall Study|Protocol Violation|5
1716398|NCT01109173|5991323|P1|Overall Study|Protocol Violation|4
1716399|NCT01109173|5991320|P4|Overall Study|Treatment Failure|64
1716400|NCT01109173|5991321|P3|Overall Study|Treatment Failure|69
1716401|NCT01109173|5991322|P2|Overall Study|Treatment Failure|32
1716402|NCT01109173|5991323|P1|Overall Study|Treatment Failure|25
1716403|NCT01109173|5991320|P4|Overall Study|Noncompliance|0
1716404|NCT01109173|5991321|P3|Overall Study|Noncompliance|0
1716405|NCT01109173|5991322|P2|Overall Study|Noncompliance|1
1716406|NCT01109173|5991323|P1|Overall Study|Noncompliance|0
1716407|NCT01109173|5991320|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
1716408|NCT01109173|5991321|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
1716409|NCT01109173|5991322|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
1716410|NCT01109173|5991323|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
1716411|NCT01109173|5991320|P4|Overall Study|Lost to Follow-up|0
1716412|NCT01109173|5991321|P3|Overall Study|Lost to Follow-up|0
1716413|NCT01109173|5991322|P2|Overall Study|Lost to Follow-up|1
1716414|NCT01109173|5991323|P1|Overall Study|Lost to Follow-up|0
1716415|NCT01109173|5991320|P4|Overall Study|Adverse Event|6
1716416|NCT01109173|5991321|P3|Overall Study|Adverse Event|9
1716417|NCT01109173|5991322|P2|Overall Study|Adverse Event|17
1716418|NCT01109173|5991323|P1|Overall Study|Adverse Event|15
1716419|NCT01108809|5991429|P1|Overall Study|Lost to Follow-up|1
1716420|NCT01108809|5991429|P1|Overall Study|Adverse Event|3
1716421|NCT01108796|5991446|P2|Overall Study|Lost to Follow-up|6
1716422|NCT01108796|5991447|P1|Overall Study|Lost to Follow-up|7
1716423|NCT01108796|5991446|P2|Overall Study|Adverse Event|1
1716424|NCT01108796|5991447|P1|Overall Study|Adverse Event|0
1716425|NCT01108731|5991490|P2|Overall Study|Adverse Event|3
1716426|NCT01108731|5991491|P1|Overall Study|Adverse Event|3
1716427|NCT01108731|5991490|P2|Overall Study|Withdrawal by Subject|1
1716428|NCT01108731|5991491|P1|Overall Study|Withdrawal by Subject|1
1716429|NCT01108718|5991503|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
1716430|NCT01108718|5991504|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
1716431|NCT01108523|5991509|P1|Overall Study|Protocol Violation|4
1716432|NCT01108510|5991516|P2|Overall Study|Death|1
1716433|NCT01108510|5991517|P1|Overall Study|Death|1
1716434|NCT01108510|5991516|P2|Overall Study|Pregnancy|3
1716435|NCT01108510|5991517|P1|Overall Study|Pregnancy|0
1716436|NCT01108510|5991516|P2|Overall Study|Lack of Efficacy|0
1716437|NCT01108510|5991517|P1|Overall Study|Lack of Efficacy|3
1716438|NCT01108510|5991516|P2|Overall Study|Participant Noncompliance|7
1716439|NCT01108510|5991517|P1|Overall Study|Participant Noncompliance|5
1716440|NCT01108510|5991516|P2|Overall Study|Investigator’s Discretion|10
1716441|NCT01108510|5991517|P1|Overall Study|Investigator’s Discretion|12
1716442|NCT01108510|5991516|P2|Overall Study|Withdrew Consent|15
1716443|NCT01108510|5991517|P1|Overall Study|Withdrew Consent|21
1716444|NCT01108510|5991516|P2|Overall Study|Lost to Follow-up|17
1716445|NCT01108510|5991517|P1|Overall Study|Lost to Follow-up|20
1716446|NCT01108510|5991516|P2|Overall Study|Adverse Event|19
1716447|NCT01108510|5991517|P1|Overall Study|Adverse Event|26
1716448|NCT01108510|5991516|P2|Overall Study|Joined Another Gilead-sponsored Study|195
1716449|NCT01108510|5991517|P1|Overall Study|Joined Another Gilead-sponsored Study|186
1716450|NCT01108510|5991516|P2|Overall Study|Randomized but Not Treated|1
1716451|NCT01108510|5991517|P1|Overall Study|Randomized but Not Treated|5
1716452|NCT01108458|5991537|P1|Overall Study|Withdrawal by Subject|1
1716453|NCT01108341|5991589|P1|Overall Study|Other|1
1716454|NCT01108341|5991589|P1|Overall Study|Lost to Follow-up|1
1716455|NCT01108341|5991589|P1|Overall Study|Withdrawal by Subject|1
1716456|NCT01108341|5991589|P1|Overall Study|Death|2
1716457|NCT01108263|5991596|P2|Overall Study|Adverse Event|1
1716458|NCT01108263|5991597|P1|Overall Study|Adverse Event|0
1716459|NCT01108237|5991607|P2|Overall Study|Did not meet criteria for analysis|0
1716460|NCT01108237|5991608|P1|Overall Study|Did not meet criteria for analysis|7
1716461|NCT01108237|5991607|P2|Overall Study|No alignment data|17
1716462|NCT01108237|5991608|P1|Overall Study|No alignment data|2
1716463|NCT01108185|5991614|P1|Overall Study|Lost to Follow-up|12
1716464|NCT01108185|5991614|P1|Overall Study|Non-compliance|15
1716465|NCT01108094|5991631|P4|Overall Study|Withdrawal by Subject|0
1716466|NCT01108094|5991632|P3|Overall Study|Withdrawal by Subject|0
1716467|NCT01108094|5991633|P2|Overall Study|Withdrawal by Subject|0
1716468|NCT01108094|5991634|P1|Overall Study|Withdrawal by Subject|1
1716469|NCT01108094|5991631|P4|Overall Study|Adverse Event|0
1716470|NCT01108094|5991632|P3|Overall Study|Adverse Event|0
1716471|NCT01108094|5991633|P2|Overall Study|Adverse Event|0
1716472|NCT01108094|5991634|P1|Overall Study|Adverse Event|2
1716473|NCT01108068|5991678|P2|Overall Study|5 not started, 1 stop due to side effect|0
1716474|NCT01108068|5991679|P1|Overall Study|5 not started, 1 stop due to side effect|6
1716475|NCT01108055|5991686|P1|Overall Study|Not evaluable- didn't complete treatment|4
1716476|NCT01108055|5991686|P1|Overall Study|Ineligible|11
1716477|NCT01107925|5991724|P6|Period 2|Withdrawal by Subject|1
1716478|NCT01107925|5991725|P5|Period 2|Withdrawal by Subject|0
1716479|NCT01107925|5991726|P4|Period 2|Withdrawal by Subject|0
1716480|NCT01107925|5991727|P3|Period 2|Withdrawal by Subject|0
1716481|NCT01107925|5991728|P2|Period 2|Withdrawal by Subject|1
1716482|NCT01107925|5991729|P1|Period 2|Withdrawal by Subject|0
1716483|NCT01107925|5991724|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1716484|NCT01107925|5991725|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
1716485|NCT01107925|5991726|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1716486|NCT01107925|5991727|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1716487|NCT01107925|5991728|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
1716488|NCT01107925|5991729|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
1716489|NCT01107912|5991767|P6|Period 3|Withdrawal by Subject|0
1716490|NCT01107912|5991768|P5|Period 3|Withdrawal by Subject|0
1716491|NCT01107912|5991769|P4|Period 3|Withdrawal by Subject|1
1716492|NCT01107912|5991770|P3|Period 3|Withdrawal by Subject|0
1716493|NCT01107912|5991771|P2|Period 3|Withdrawal by Subject|0
1716494|NCT01107912|5991772|P1|Period 3|Withdrawal by Subject|0
1716495|NCT01107912|5991767|P6|Period 3|Adverse Event|0
1716496|NCT01107912|5991768|P5|Period 3|Adverse Event|0
1716497|NCT01107912|5991769|P4|Period 3|Adverse Event|0
1716498|NCT01107912|5991770|P3|Period 3|Adverse Event|1
1716499|NCT01107912|5991771|P2|Period 3|Adverse Event|1
1716500|NCT01107912|5991772|P1|Period 3|Adverse Event|0
1716501|NCT01107912|5991767|P6|Period 2|Physician Decision|0
1716502|NCT01107912|5991768|P5|Period 2|Physician Decision|0
1716503|NCT01107912|5991769|P4|Period 2|Physician Decision|0
1716504|NCT01107912|5991770|P3|Period 2|Physician Decision|1
1716505|NCT01107912|5991771|P2|Period 2|Physician Decision|0
1716506|NCT01107912|5991772|P1|Period 2|Physician Decision|0
1716507|NCT01107912|5991767|P6|Period 1|Withdrawal by Subject|0
1716508|NCT01107912|5991768|P5|Period 1|Withdrawal by Subject|0
1716509|NCT01107912|5991769|P4|Period 1|Withdrawal by Subject|0
1716510|NCT01107912|5991770|P3|Period 1|Withdrawal by Subject|0
1716511|NCT01107912|5991771|P2|Period 1|Withdrawal by Subject|0
1716512|NCT01107912|5991772|P1|Period 1|Withdrawal by Subject|1
1716513|NCT01107912|5991767|P6|Period 1|Physician Decision|0
1716514|NCT01107912|5991768|P5|Period 1|Physician Decision|1
1716515|NCT01107912|5991769|P4|Period 1|Physician Decision|0
1716516|NCT01107912|5991770|P3|Period 1|Physician Decision|0
1716517|NCT01107912|5991771|P2|Period 1|Physician Decision|0
1716518|NCT01107912|5991772|P1|Period 1|Physician Decision|0
1716519|NCT01107912|5991767|P6|Period 1|Adverse Event|0
1716520|NCT01107912|5991768|P5|Period 1|Adverse Event|2
1716521|NCT01107912|5991769|P4|Period 1|Adverse Event|0
1716522|NCT01107912|5991770|P3|Period 1|Adverse Event|0
1716523|NCT01107912|5991771|P2|Period 1|Adverse Event|0
1716524|NCT01107912|5991772|P1|Period 1|Adverse Event|0
1716525|NCT01107899|5991809|P3|Overall Study|Withdrawal by Subject|1
1716526|NCT01107899|5991810|P2|Overall Study|Withdrawal by Subject|0
1716527|NCT01107899|5991811|P1|Overall Study|Withdrawal by Subject|0
1716528|NCT01107899|5991809|P3|Overall Study|Physician Decision|3
1716529|NCT01107899|5991810|P2|Overall Study|Physician Decision|0
1716530|NCT01107899|5991811|P1|Overall Study|Physician Decision|5
1716531|NCT01107886|5991857|P2|Overall Study|Administrative withdrawal of consent|5
1716532|NCT01107886|5991858|P1|Overall Study|Administrative withdrawal of consent|7
1716533|NCT01107886|5991857|P2|Overall Study|Withdrawal by Subject|196
1716534|NCT01107886|5991858|P1|Overall Study|Withdrawal by Subject|180
1716535|NCT01107886|5991857|P2|Overall Study|Lost to Follow-up|13
1716536|NCT01107886|5991858|P1|Overall Study|Lost to Follow-up|15
1716537|NCT01107743|5991891|P1|Overall Study|Protocol Violation|46
1716538|NCT01107535|5992005|P1|Overall Study|Death|5
1716539|NCT01107457|5992018|P6|Part B and C|Clinical Relapse|4
1716540|NCT01107457|5992019|P5|Part B and C|Clinical Relapse|0
1716541|NCT01107457|5992020|P4|Part B and C|Clinical Relapse|0
1716542|NCT01107457|5992021|P3|Part B and C|Clinical Relapse|0
1716543|NCT01107457|5992022|P2|Part B and C|Clinical Relapse|0
1716544|NCT01107457|5992023|P1|Part B and C|Clinical Relapse|0
1716545|NCT01107457|5992018|P6|Part B and C|Withdrawal by Subject|16
1716546|NCT01107457|5992019|P5|Part B and C|Withdrawal by Subject|0
1716547|NCT01107457|5992020|P4|Part B and C|Withdrawal by Subject|0
1716548|NCT01107457|5992021|P3|Part B and C|Withdrawal by Subject|0
1716549|NCT01107457|5992022|P2|Part B and C|Withdrawal by Subject|0
1716550|NCT01107457|5992023|P1|Part B and C|Withdrawal by Subject|0
1716551|NCT01107457|5992018|P6|Part B and C|Sponsor Decision|66
1716552|NCT01107457|5992019|P5|Part B and C|Sponsor Decision|0
1716553|NCT01107457|5992020|P4|Part B and C|Sponsor Decision|0
1716554|NCT01107457|5992021|P3|Part B and C|Sponsor Decision|0
1716555|NCT01107457|5992022|P2|Part B and C|Sponsor Decision|0
1716556|NCT01107457|5992023|P1|Part B and C|Sponsor Decision|0
1716557|NCT01107457|5992018|P6|Part B and C|Protocol Violation|1
1716558|NCT01107457|5992019|P5|Part B and C|Protocol Violation|0
1716559|NCT01107457|5992020|P4|Part B and C|Protocol Violation|0
1716560|NCT01107457|5992021|P3|Part B and C|Protocol Violation|0
1716561|NCT01107457|5992022|P2|Part B and C|Protocol Violation|0
1716562|NCT01107457|5992023|P1|Part B and C|Protocol Violation|0
1716563|NCT01107457|5992018|P6|Part B and C|Lost to Follow-up|10
1716564|NCT01107457|5992019|P5|Part B and C|Lost to Follow-up|0
1716565|NCT01107457|5992020|P4|Part B and C|Lost to Follow-up|0
1716566|NCT01107457|5992021|P3|Part B and C|Lost to Follow-up|0
1716567|NCT01107457|5992022|P2|Part B and C|Lost to Follow-up|0
1716568|NCT01107457|5992023|P1|Part B and C|Lost to Follow-up|0
1716569|NCT01107457|5992018|P6|Part B and C|Lack of Efficacy|7
1716570|NCT01107457|5992019|P5|Part B and C|Lack of Efficacy|0
1716571|NCT01107457|5992020|P4|Part B and C|Lack of Efficacy|0
1716572|NCT01107457|5992021|P3|Part B and C|Lack of Efficacy|0
1716573|NCT01107457|5992022|P2|Part B and C|Lack of Efficacy|0
1716574|NCT01107457|5992023|P1|Part B and C|Lack of Efficacy|0
1716575|NCT01107457|5992018|P6|Part B and C|Physician Decision|3
1716576|NCT01107457|5992019|P5|Part B and C|Physician Decision|0
1716577|NCT01107457|5992020|P4|Part B and C|Physician Decision|0
1716578|NCT01107457|5992021|P3|Part B and C|Physician Decision|0
1716579|NCT01107457|5992022|P2|Part B and C|Physician Decision|0
1716580|NCT01107457|5992023|P1|Part B and C|Physician Decision|0
1716581|NCT01107457|5992018|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
1716582|NCT01107457|5992019|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1716583|NCT01107457|5992020|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1716584|NCT01107457|5992021|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1716585|NCT01107457|5992022|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1716586|NCT01107457|5992023|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
1716587|NCT01107457|5992018|P6|Part B and C|Adverse Event|12
1716588|NCT01107457|5992019|P5|Part B and C|Adverse Event|0
1716589|NCT01107457|5992020|P4|Part B and C|Adverse Event|0
1716590|NCT01107457|5992021|P3|Part B and C|Adverse Event|0
1716591|NCT01107457|5992022|P2|Part B and C|Adverse Event|0
1716592|NCT01107457|5992023|P1|Part B and C|Adverse Event|0
1716593|NCT01107457|5992018|P6|Part A|Protocol Violation|0
1716594|NCT01107457|5992019|P5|Part A|Protocol Violation|0
1716595|NCT01107457|5992020|P4|Part A|Protocol Violation|0
1716596|NCT01107457|5992021|P3|Part A|Protocol Violation|0
1716597|NCT01107457|5992022|P2|Part A|Protocol Violation|1
1716598|NCT01107457|5992023|P1|Part A|Protocol Violation|0
1716599|NCT01107457|5992018|P6|Part A|Lack of Efficacy|0
1716600|NCT01107457|5992019|P5|Part A|Lack of Efficacy|0
1716601|NCT01107457|5992020|P4|Part A|Lack of Efficacy|0
1716602|NCT01107457|5992021|P3|Part A|Lack of Efficacy|0
1716603|NCT01107457|5992022|P2|Part A|Lack of Efficacy|0
1716604|NCT01107457|5992023|P1|Part A|Lack of Efficacy|1
1716605|NCT01107457|5992018|P6|Part A|Lost to Follow-up|0
1716606|NCT01107457|5992019|P5|Part A|Lost to Follow-up|0
1716607|NCT01107457|5992020|P4|Part A|Lost to Follow-up|0
1716608|NCT01107457|5992021|P3|Part A|Lost to Follow-up|0
1716609|NCT01107457|5992022|P2|Part A|Lost to Follow-up|1
1716610|NCT01107457|5992023|P1|Part A|Lost to Follow-up|0
1716611|NCT01107457|5992018|P6|Part A|Withdrawal by Subject|0
1716612|NCT01107457|5992019|P5|Part A|Withdrawal by Subject|1
1716613|NCT01107457|5992020|P4|Part A|Withdrawal by Subject|3
1716614|NCT01107457|5992021|P3|Part A|Withdrawal by Subject|0
1716615|NCT01107457|5992022|P2|Part A|Withdrawal by Subject|3
1716616|NCT01107457|5992023|P1|Part A|Withdrawal by Subject|3
1716617|NCT01107457|5992018|P6|Part A|Adverse Event|0
1716618|NCT01107457|5992019|P5|Part A|Adverse Event|0
1716619|NCT01107457|5992020|P4|Part A|Adverse Event|0
1716620|NCT01107457|5992021|P3|Part A|Adverse Event|1
1716621|NCT01107457|5992022|P2|Part A|Adverse Event|2
1716622|NCT01107457|5992023|P1|Part A|Adverse Event|1
1716623|NCT01107444|5992151|P2|Overall Study|Protocol Entry Criteria Not Met|1
1716624|NCT01107444|5992152|P1|Overall Study|Protocol Entry Criteria Not Met|0
1716625|NCT01107444|5992151|P2|Overall Study|Withdrawal by Subject|12
1716626|NCT01107444|5992152|P1|Overall Study|Withdrawal by Subject|8
1716627|NCT01107418|5992186|P1|Overall Study|Entered Extension Study|1
1716628|NCT01107418|5992186|P1|Overall Study|Started Other Therapy|1
1716629|NCT01107418|5992186|P1|Overall Study|Study Closing|1
1716630|NCT01107418|5992186|P1|Overall Study|Withdrawal by Subject|1
1716631|NCT01107418|5992186|P1|Overall Study|Adverse Event|3
1716632|NCT01107418|5992186|P1|Overall Study|Disease Progression|45
1716633|NCT01107405|5992259|P5|Overall Study|Protocol Violation|0
1716634|NCT01107405|5992260|P4|Overall Study|Protocol Violation|1
1716635|NCT01107405|5992261|P3|Overall Study|Protocol Violation|1
1716636|NCT01107405|5992262|P2|Overall Study|Protocol Violation|0
1716637|NCT01107405|5992263|P1|Overall Study|Protocol Violation|0
1716638|NCT01107405|5992259|P5|Overall Study|Withdrawal by Subject|1
1716639|NCT01107405|5992260|P4|Overall Study|Withdrawal by Subject|2
1716640|NCT01107405|5992261|P3|Overall Study|Withdrawal by Subject|1
1716641|NCT01107405|5992262|P2|Overall Study|Withdrawal by Subject|0
1716642|NCT01107405|5992263|P1|Overall Study|Withdrawal by Subject|1
1716643|NCT01107405|5992259|P5|Overall Study|Adverse Event|2
1716644|NCT01107405|5992260|P4|Overall Study|Adverse Event|0
1716645|NCT01107405|5992261|P3|Overall Study|Adverse Event|0
1716646|NCT01107405|5992262|P2|Overall Study|Adverse Event|1
1716647|NCT01107405|5992263|P1|Overall Study|Adverse Event|1
1716648|NCT01107392|5992302|P2|Overall Study|Administrative decision|0
1716649|NCT01107392|5992303|P1|Overall Study|Administrative decision|1
1716650|NCT01107392|5992302|P2|Overall Study|Personal Reasons|3
1716651|NCT01107392|5992303|P1|Overall Study|Personal Reasons|2
1716652|NCT01107392|5992302|P2|Overall Study|Adverse Event|0
1716653|NCT01107392|5992303|P1|Overall Study|Adverse Event|2
1716654|NCT01107379|5992315|P1|Overall Study|Lost to Follow-up|3
1716655|NCT01107379|5992315|P1|Overall Study|Withdrawal by Subject|18
1716656|NCT01107353|5992326|P2|Overall Study|Positive Drug Screen|0
1716657|NCT01107353|5992327|P1|Overall Study|Positive Drug Screen|1
1716658|NCT01107197|5992335|P2|Overall Study|Withdrawal by Subject|5
1716659|NCT01107197|5992336|P1|Overall Study|Withdrawal by Subject|3
1716660|NCT01107197|5992335|P2|Overall Study|Lost to Follow-up|8
1716661|NCT01107197|5992336|P1|Overall Study|Lost to Follow-up|5
1716662|NCT01107197|5992335|P2|Overall Study|Death|10
1716663|NCT01107197|5992336|P1|Overall Study|Death|12
1716664|NCT01106976|5992371|P1|Overall Study|Lost to Follow-up|8
1716665|NCT01106911|5992385|P1|Overall Study|deemed ineligible after screening|3
1716666|NCT01106911|5992385|P1|Overall Study|Physician Decision|2
1716667|NCT01106898|5992389|P1|Overall Study|Adverse Event|6
1716668|NCT01106846|5992434|P2|Overall Study|Change in surgical procedure|1
1716669|NCT01106846|5992435|P1|Overall Study|Change in surgical procedure|0
1716670|NCT01106690|5992485|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1716671|NCT01106690|5992486|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1716672|NCT01106690|5992487|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1716673|NCT01106690|5992485|P3|Extension Period: Week 26 to Week 52|Other|4
1716674|NCT01106690|5992486|P2|Extension Period: Week 26 to Week 52|Other|3
1716675|NCT01106690|5992487|P1|Extension Period: Week 26 to Week 52|Other|8
1716676|NCT01106690|5992485|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1716677|NCT01106690|5992486|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1716678|NCT01106690|5992487|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1716679|NCT01106690|5992485|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
1716680|NCT01106690|5992486|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1716681|NCT01106690|5992487|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1716682|NCT01106690|5992485|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
1716683|NCT01106690|5992486|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
1716684|NCT01106690|5992487|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
1716685|NCT01106690|5992485|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1716686|NCT01106690|5992486|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1716687|NCT01106690|5992487|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1716688|NCT01106690|5992485|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
1716689|NCT01106690|5992486|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1716690|NCT01106690|5992487|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1716691|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Other|6
1716692|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Other|2
1716693|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Other|10
1716694|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1716695|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1716696|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
1716697|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1716698|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1716699|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1716700|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1716701|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1716702|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1716703|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
1716704|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
1716705|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
1716706|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
1716707|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
1716708|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
1716709|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1716710|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Protocol Violation|0
1716711|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Protocol Violation|1
1716712|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
1716713|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
1716714|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
1716715|NCT01106690|5992485|P3|Core Period: Baseline to Week 26|Adverse Event|4
1716716|NCT01106690|5992486|P2|Core Period: Baseline to Week 26|Adverse Event|1
1716717|NCT01106690|5992487|P1|Core Period: Baseline to Week 26|Adverse Event|6
1716718|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Other|5
1716719|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Other|8
1716720|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Other|5
1716721|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Other|6
1716722|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1716723|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1716724|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1716725|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1716726|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1716727|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
1716728|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
1716729|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1716730|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1716731|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
1716732|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
1716733|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1716734|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
1716735|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1716736|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
1716737|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
1716738|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
1716739|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
1716740|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
1716741|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
1716742|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1716743|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1716744|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1716745|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1716746|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
1716747|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
1716748|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
1716749|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
1716750|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Death|1
1716751|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Death|0
1716752|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Death|0
1716753|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Death|0
1716754|NCT01106677|5992523|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
1716755|NCT01106677|5992524|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
1716756|NCT01106677|5992525|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1716757|NCT01106677|5992526|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1716758|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Pregnancy|0
1716759|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Pregnancy|0
1716760|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Pregnancy|1
1716761|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Pregnancy|0
1716762|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Other|23
1716763|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Other|8
1716764|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Other|14
1716765|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Other|8
1716766|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Product quality complaint|0
1716767|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Product quality complaint|1
1716768|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Product quality complaint|1
1716769|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Product quality complaint|0
1716770|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
1716771|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
1716772|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
1716773|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
1716774|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1716775|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1716776|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
1716777|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1716778|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
1716779|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
1716780|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
1716781|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
1716782|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
1716783|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
1716784|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1716785|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
1716786|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Protocol Violation|3
1716787|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1716788|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Protocol Violation|1
1716789|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Protocol Violation|0
1716790|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Physician Decision|1
1716791|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Physician Decision|3
1716792|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Physician Decision|1
1716793|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Physician Decision|2
1716794|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
1716795|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
1716796|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
1716797|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
1716798|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
1716799|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
1716800|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
1716801|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
1716802|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Death|0
1716803|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Death|1
1716804|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Death|0
1716805|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Death|0
1716806|NCT01106677|5992523|P4|Core Period: Baseline to Week 26|Adverse Event|8
1716807|NCT01106677|5992524|P3|Core Period: Baseline to Week 26|Adverse Event|6
1716808|NCT01106677|5992525|P2|Core Period: Baseline to Week 26|Adverse Event|18
1716809|NCT01106677|5992526|P1|Core Period: Baseline to Week 26|Adverse Event|7
1716810|NCT01106651|5992589|P3|Overall Study|Death|0
1716811|NCT01106651|5992590|P2|Overall Study|Death|3
1716812|NCT01106651|5992591|P1|Overall Study|Death|0
1716813|NCT01106651|5992589|P3|Overall Study|Other|21
1716814|NCT01106651|5992590|P2|Overall Study|Other|31
1716815|NCT01106651|5992591|P1|Overall Study|Other|34
1716816|NCT01106651|5992589|P3|Overall Study|Noncompliance with study drug|2
1716817|NCT01106651|5992590|P2|Overall Study|Noncompliance with study drug|0
1716818|NCT01106651|5992591|P1|Overall Study|Noncompliance with study drug|1
1716819|NCT01106651|5992589|P3|Overall Study|Withdrawal by Subject|4
1716820|NCT01106651|5992590|P2|Overall Study|Withdrawal by Subject|7
1716821|NCT01106651|5992591|P1|Overall Study|Withdrawal by Subject|14
1716822|NCT01106651|5992589|P3|Overall Study|Protocol Violation|1
1716823|NCT01106651|5992590|P2|Overall Study|Protocol Violation|2
1716824|NCT01106651|5992591|P1|Overall Study|Protocol Violation|1
1716825|NCT01106651|5992589|P3|Overall Study|Physician Decision|1
1716826|NCT01106651|5992590|P2|Overall Study|Physician Decision|3
1716827|NCT01106651|5992591|P1|Overall Study|Physician Decision|4
1716828|NCT01106651|5992589|P3|Overall Study|Lost to Follow-up|6
1716829|NCT01106651|5992590|P2|Overall Study|Lost to Follow-up|2
1716830|NCT01106651|5992591|P1|Overall Study|Lost to Follow-up|8
1716831|NCT01106651|5992589|P3|Overall Study|Adverse Event|23
1716832|NCT01106651|5992590|P2|Overall Study|Adverse Event|9
1716833|NCT01106651|5992591|P1|Overall Study|Adverse Event|17
1716834|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Other|4
1716835|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Other|5
1716836|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Other|5
1716837|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
1716838|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1716839|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1716840|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
1716841|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
1716842|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
1716843|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1716844|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1716845|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
1716846|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1716847|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1716848|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
1716849|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
1716850|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
1716851|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
1716852|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
1716853|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
1716854|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1716855|NCT01106625|5992644|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
1716856|NCT01106625|5992645|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
1716857|NCT01106625|5992646|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
1716858|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Other|4
1716859|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Other|7
1716860|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Other|8
1716861|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1716862|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1716863|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1716864|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
1716865|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
1716866|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
1716867|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1716868|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1716869|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
1716870|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
1716871|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
1716872|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
1716873|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Protocol Violation|3
1716874|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Protocol Violation|1
1716875|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Protocol Violation|2
1716876|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Physician Decision|0
1716877|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Physician Decision|0
1716878|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Physician Decision|1
1716879|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
1716880|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
1716881|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
1716882|NCT01106625|5992644|P3|Core Period: Baseline to Week 26|Adverse Event|8
1716883|NCT01106625|5992645|P2|Core Period: Baseline to Week 26|Adverse Event|8
1716884|NCT01106625|5992646|P1|Core Period: Baseline to Week 26|Adverse Event|6
1716885|NCT01106586|5992677|P2|Overall Study|Participant Transferred to Another Study|197
1716886|NCT01106586|5992678|P1|Overall Study|Participant Transferred to Another Study|212
1716887|NCT01106586|5992677|P2|Overall Study|Protocol Violation|0
1716888|NCT01106586|5992678|P1|Overall Study|Protocol Violation|1
1716889|NCT01106586|5992677|P2|Overall Study|Participant Noncompliance|10
1716890|NCT01106586|5992678|P1|Overall Study|Participant Noncompliance|12
1716891|NCT01106586|5992677|P2|Overall Study|Lost to Follow-up|20
1716892|NCT01106586|5992678|P1|Overall Study|Lost to Follow-up|24
1716893|NCT01106586|5992677|P2|Overall Study|Withdrew Consent|30
1716894|NCT01106586|5992678|P1|Overall Study|Withdrew Consent|18
1716895|NCT01106586|5992677|P2|Overall Study|Investigator's Discretion|8
1716896|NCT01106586|5992678|P1|Overall Study|Investigator's Discretion|5
1716897|NCT01106586|5992677|P2|Overall Study|Lack of Efficacy|0
1716898|NCT01106586|5992678|P1|Overall Study|Lack of Efficacy|1
1716899|NCT01106586|5992677|P2|Overall Study|Pregnancy|2
1716900|NCT01106586|5992678|P1|Overall Study|Pregnancy|2
1716901|NCT01106586|5992677|P2|Overall Study|Death|3
1716902|NCT01106586|5992678|P1|Overall Study|Death|1
1716903|NCT01106586|5992677|P2|Overall Study|Adverse Event|15
1716904|NCT01106586|5992678|P1|Overall Study|Adverse Event|9
1716905|NCT01106534|5992696|P1|Overall Study|Physician Decision|1
1716906|NCT01106534|5992696|P1|Overall Study|Death|16
1716907|NCT01106534|5992696|P1|Overall Study|Lost to Follow-up|2
1716908|NCT01106534|5992696|P1|Overall Study|Withdrawal by Subject|18
1716909|NCT01106430|5992728|P2|Overall Study|Withdrawal by Subject|4
1716910|NCT01106430|5992729|P1|Overall Study|Withdrawal by Subject|8
1716911|NCT01106430|5992728|P2|Overall Study|Protocol Violation|2
1716912|NCT01106430|5992729|P1|Overall Study|Protocol Violation|7
1716913|NCT01106430|5992728|P2|Overall Study|Previous Use Of Marijuana|0
1716914|NCT01106430|5992729|P1|Overall Study|Previous Use Of Marijuana|1
1716915|NCT01106430|5992728|P2|Overall Study|Hard Time Swallowing The Pills|0
1716916|NCT01106430|5992729|P1|Overall Study|Hard Time Swallowing The Pills|1
1716917|NCT01106430|5992728|P2|Overall Study|Noncompliance|1
1716918|NCT01106430|5992729|P1|Overall Study|Noncompliance|0
1716919|NCT01106430|5992728|P2|Overall Study|Refused To Take Medication|1
1716920|NCT01106430|5992729|P1|Overall Study|Refused To Take Medication|0
1716921|NCT01106430|5992728|P2|Overall Study|Moved Out Of State|1
1716922|NCT01106430|5992729|P1|Overall Study|Moved Out Of State|0
1716923|NCT01106430|5992728|P2|Overall Study|Early Termination Requested By Sponsor|0
1716924|NCT01106430|5992729|P1|Overall Study|Early Termination Requested By Sponsor|1
1716925|NCT01106430|5992728|P2|Overall Study|Lost to Follow-up|1
1716926|NCT01106430|5992729|P1|Overall Study|Lost to Follow-up|5
1716927|NCT01106430|5992728|P2|Overall Study|Lack of Efficacy|13
1716928|NCT01106430|5992729|P1|Overall Study|Lack of Efficacy|2
1716929|NCT01106430|5992728|P2|Overall Study|Adverse Event|10
1716930|NCT01106430|5992729|P1|Overall Study|Adverse Event|8
1716931|NCT01106404|5992751|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
1716932|NCT01106404|5992752|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
1716933|NCT01106404|5992751|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
1716934|NCT01106404|5992752|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
1716935|NCT01106404|5992751|P2|Period I (First 6 Weeks)|Physician Decision|0
1716936|NCT01106404|5992752|P1|Period I (First 6 Weeks)|Physician Decision|1
1716937|NCT01106404|5992751|P2|Period I (First 6 Weeks)|Adverse Event|0
1716938|NCT01106404|5992752|P1|Period I (First 6 Weeks)|Adverse Event|2
1716939|NCT01106352|5992775|P5|Overall Study|Home hospice since July 2013|0
1716940|NCT01106352|5992776|P4|Overall Study|Home hospice since July 2013|1
1716941|NCT01106352|5992777|P3|Overall Study|Home hospice since July 2013|0
1716942|NCT01106352|5992778|P2|Overall Study|Home hospice since July 2013|0
1716943|NCT01106352|5992779|P1|Overall Study|Home hospice since July 2013|0
1716944|NCT01106352|5992775|P5|Overall Study|Subject entered hospice|0
1716945|NCT01106352|5992776|P4|Overall Study|Subject entered hospice|1
1716946|NCT01106352|5992777|P3|Overall Study|Subject entered hospice|0
1716947|NCT01106352|5992778|P2|Overall Study|Subject entered hospice|0
1716948|NCT01106352|5992779|P1|Overall Study|Subject entered hospice|0
1716949|NCT01106352|5992775|P5|Overall Study|Went on hospice|0
1716950|NCT01106352|5992776|P4|Overall Study|Went on hospice|1
1716951|NCT01106352|5992777|P3|Overall Study|Went on hospice|0
1716952|NCT01106352|5992778|P2|Overall Study|Went on hospice|0
1716953|NCT01106352|5992779|P1|Overall Study|Went on hospice|0
1716954|NCT01106352|5992775|P5|Overall Study|Withdrawal by Subject|2
1716955|NCT01106352|5992776|P4|Overall Study|Withdrawal by Subject|3
1716956|NCT01106352|5992777|P3|Overall Study|Withdrawal by Subject|0
1716957|NCT01106352|5992778|P2|Overall Study|Withdrawal by Subject|0
1716958|NCT01106352|5992779|P1|Overall Study|Withdrawal by Subject|0
1716959|NCT01106352|5992775|P5|Overall Study|Disease progression|0
1716960|NCT01106352|5992776|P4|Overall Study|Disease progression|1
1716961|NCT01106352|5992777|P3|Overall Study|Disease progression|0
1716962|NCT01106352|5992778|P2|Overall Study|Disease progression|0
1716963|NCT01106352|5992779|P1|Overall Study|Disease progression|0
1716964|NCT01106352|5992775|P5|Overall Study|Death|1
1716965|NCT01106352|5992776|P4|Overall Study|Death|3
1716966|NCT01106352|5992777|P3|Overall Study|Death|1
1716967|NCT01106352|5992778|P2|Overall Study|Death|0
1716968|NCT01106352|5992779|P1|Overall Study|Death|0
1716969|NCT01106352|5992775|P5|Overall Study|Lost to Follow-up|1
1716970|NCT01106352|5992776|P4|Overall Study|Lost to Follow-up|0
1716971|NCT01106352|5992777|P3|Overall Study|Lost to Follow-up|0
1716972|NCT01106352|5992778|P2|Overall Study|Lost to Follow-up|0
1716973|NCT01106352|5992779|P1|Overall Study|Lost to Follow-up|0
1716974|NCT01106352|5992775|P5|Overall Study|Too ill to come in for the visit|0
1716975|NCT01106352|5992776|P4|Overall Study|Too ill to come in for the visit|0
1716976|NCT01106352|5992777|P3|Overall Study|Too ill to come in for the visit|1
1716977|NCT01106352|5992778|P2|Overall Study|Too ill to come in for the visit|0
1716978|NCT01106352|5992779|P1|Overall Study|Too ill to come in for the visit|0
1716979|NCT01106352|5992775|P5|Overall Study|Sponsor Decision|0
1716980|NCT01106352|5992776|P4|Overall Study|Sponsor Decision|0
1716981|NCT01106352|5992777|P3|Overall Study|Sponsor Decision|0
1716982|NCT01106352|5992778|P2|Overall Study|Sponsor Decision|0
1716983|NCT01106352|5992779|P1|Overall Study|Sponsor Decision|1
1716984|NCT01106352|5992775|P5|Overall Study|Subjects untreated|4
1716985|NCT01106352|5992776|P4|Overall Study|Subjects untreated|3
1716986|NCT01106352|5992777|P3|Overall Study|Subjects untreated|0
1716987|NCT01106352|5992778|P2|Overall Study|Subjects untreated|0
1716988|NCT01106352|5992779|P1|Overall Study|Subjects untreated|0
1716989|NCT01106287|5992875|P4|Overall Study|Adverse Event|0
1716990|NCT01106287|5992876|P3|Overall Study|Adverse Event|0
1716991|NCT01106287|5992877|P2|Overall Study|Adverse Event|0
1716992|NCT01106287|5992878|P1|Overall Study|Adverse Event|1
1716993|NCT01106248|5992898|P1|Overall Study|Administrative|2
1716994|NCT01106248|5992898|P1|Overall Study|Adverse Event|1
1716995|NCT01106157|5992906|P2|Overall Study|Withdrawal by Subject|0
1716996|NCT01106157|5992907|P1|Overall Study|Withdrawal by Subject|1
1716997|NCT01106092|5992935|P4|Overall Study|Withdrawal by Subject|1
1716998|NCT01106092|5992936|P3|Overall Study|Withdrawal by Subject|0
1716999|NCT01106092|5992937|P2|Overall Study|Withdrawal by Subject|0
1717000|NCT01106092|5992938|P1|Overall Study|Withdrawal by Subject|0
1717001|NCT01106027|5993021|P1|Overall Study|Lost graft early, discontinued|1
1717002|NCT01106014|5993027|P2|Overall Study|Lost to Follow-up|3
1717003|NCT01106014|5993028|P1|Overall Study|Lost to Follow-up|2
1717004|NCT01106014|5993027|P2|Overall Study|Administrative reason|6
1717005|NCT01106014|5993028|P1|Overall Study|Administrative reason|7
1717006|NCT01106014|5993027|P2|Overall Study|Withdrawal by Subject|37
1717007|NCT01106014|5993028|P1|Overall Study|Withdrawal by Subject|43
1717008|NCT01106014|5993027|P2|Overall Study|Adverse Event|42
1717009|NCT01106014|5993028|P1|Overall Study|Adverse Event|78
1717010|NCT01106014|5993027|P2|Overall Study|Morbidity or Mortality primary endpoint|242
1717011|NCT01106014|5993028|P1|Overall Study|Morbidity or Mortality primary endpoint|155
1717012|NCT01105975|5993048|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1717013|NCT01105975|5993049|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
1717014|NCT01105975|5993050|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1717015|NCT01105975|5993051|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1717016|NCT01105975|5993052|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
1717017|NCT01105975|5993053|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1717018|NCT01105975|5993054|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1717019|NCT01105975|5993055|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1717020|NCT01105975|5993056|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1717021|NCT01105975|5993057|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1717022|NCT01105975|5993048|P10|Overall Study|Protocol Violation|2
1717023|NCT01105975|5993049|P9|Overall Study|Protocol Violation|2
1717024|NCT01105975|5993050|P8|Overall Study|Protocol Violation|1
1717025|NCT01105975|5993051|P7|Overall Study|Protocol Violation|1
1717026|NCT01105975|5993052|P6|Overall Study|Protocol Violation|1
1717027|NCT01105975|5993053|P5|Overall Study|Protocol Violation|1
1717028|NCT01105975|5993054|P4|Overall Study|Protocol Violation|0
1717029|NCT01105975|5993055|P3|Overall Study|Protocol Violation|2
1717030|NCT01105975|5993056|P2|Overall Study|Protocol Violation|2
1717031|NCT01105975|5993057|P1|Overall Study|Protocol Violation|0
1717032|NCT01105975|5993048|P10|Overall Study|Physician Decision|0
1717033|NCT01105975|5993049|P9|Overall Study|Physician Decision|0
1717034|NCT01105975|5993050|P8|Overall Study|Physician Decision|0
1717035|NCT01105975|5993051|P7|Overall Study|Physician Decision|2
1717036|NCT01105975|5993052|P6|Overall Study|Physician Decision|0
1717037|NCT01105975|5993053|P5|Overall Study|Physician Decision|0
1717038|NCT01105975|5993054|P4|Overall Study|Physician Decision|0
1717039|NCT01105975|5993055|P3|Overall Study|Physician Decision|0
1717040|NCT01105975|5993056|P2|Overall Study|Physician Decision|0
1717041|NCT01105975|5993057|P1|Overall Study|Physician Decision|0
1717042|NCT01105975|5993048|P10|Overall Study|Lost to Follow-up|0
1717043|NCT01105975|5993049|P9|Overall Study|Lost to Follow-up|1
1717044|NCT01105975|5993050|P8|Overall Study|Lost to Follow-up|0
1717045|NCT01105975|5993051|P7|Overall Study|Lost to Follow-up|0
1717046|NCT01105975|5993052|P6|Overall Study|Lost to Follow-up|0
1717047|NCT01105975|5993053|P5|Overall Study|Lost to Follow-up|1
1717048|NCT01105975|5993054|P4|Overall Study|Lost to Follow-up|1
1717049|NCT01105975|5993055|P3|Overall Study|Lost to Follow-up|0
1717050|NCT01105975|5993056|P2|Overall Study|Lost to Follow-up|0
1717051|NCT01105975|5993057|P1|Overall Study|Lost to Follow-up|1
1717052|NCT01105975|5993048|P10|Overall Study|Withdrawal by Subject|3
1717053|NCT01105975|5993049|P9|Overall Study|Withdrawal by Subject|0
1717054|NCT01105975|5993050|P8|Overall Study|Withdrawal by Subject|1
1717055|NCT01105975|5993051|P7|Overall Study|Withdrawal by Subject|2
1717056|NCT01105975|5993052|P6|Overall Study|Withdrawal by Subject|1
1717057|NCT01105975|5993053|P5|Overall Study|Withdrawal by Subject|4
1717058|NCT01105975|5993054|P4|Overall Study|Withdrawal by Subject|0
1717059|NCT01105975|5993055|P3|Overall Study|Withdrawal by Subject|2
1717060|NCT01105975|5993056|P2|Overall Study|Withdrawal by Subject|2
1717061|NCT01105975|5993057|P1|Overall Study|Withdrawal by Subject|2
1717062|NCT01105975|5993048|P10|Overall Study|Adverse Event|4
1717063|NCT01105975|5993049|P9|Overall Study|Adverse Event|1
1717064|NCT01105975|5993050|P8|Overall Study|Adverse Event|4
1717065|NCT01105975|5993051|P7|Overall Study|Adverse Event|2
1717066|NCT01105975|5993052|P6|Overall Study|Adverse Event|1
1717067|NCT01105975|5993053|P5|Overall Study|Adverse Event|0
1717068|NCT01105975|5993054|P4|Overall Study|Adverse Event|1
1717069|NCT01105975|5993055|P3|Overall Study|Adverse Event|5
1717070|NCT01105975|5993056|P2|Overall Study|Adverse Event|1
1717071|NCT01105975|5993057|P1|Overall Study|Adverse Event|2
1717072|NCT01105936|5993205|P4|Period 3|Protocol Violation|0
1717073|NCT01105936|5993206|P3|Period 3|Protocol Violation|0
1717074|NCT01105936|5993207|P2|Period 3|Protocol Violation|2
1717075|NCT01105936|5993208|P1|Period 3|Protocol Violation|0
1717076|NCT01105936|5993205|P4|Period 2|Adverse Event|0
1717077|NCT01105936|5993206|P3|Period 2|Adverse Event|0
1717078|NCT01105936|5993207|P2|Period 2|Adverse Event|0
1717079|NCT01105936|5993208|P1|Period 2|Adverse Event|1
1717080|NCT01105936|5993205|P4|Period 1|Adverse Event|1
1717081|NCT01105936|5993206|P3|Period 1|Adverse Event|0
1717082|NCT01105936|5993207|P2|Period 1|Adverse Event|0
1717083|NCT01105936|5993208|P1|Period 1|Adverse Event|0
1717084|NCT01105767|5993237|P3|Overall Study|Lost to Follow-up|1184
1717085|NCT01105767|5993238|P2|Overall Study|Lost to Follow-up|1614
1717086|NCT01105767|5993239|P1|Overall Study|Lost to Follow-up|1160
1717087|NCT01105533|5993291|P9|Overall Study|Physician Decision|0
1717088|NCT01105533|5993292|P8|Overall Study|Physician Decision|1
1717089|NCT01105533|5993293|P7|Overall Study|Physician Decision|0
1717090|NCT01105533|5993294|P6|Overall Study|Physician Decision|0
1717091|NCT01105533|5993295|P5|Overall Study|Physician Decision|0
1717092|NCT01105533|5993296|P4|Overall Study|Physician Decision|0
1717093|NCT01105533|5993297|P3|Overall Study|Physician Decision|0
1717094|NCT01105533|5993298|P2|Overall Study|Physician Decision|0
1717095|NCT01105533|5993299|P1|Overall Study|Physician Decision|0
1717096|NCT01105533|5993291|P9|Overall Study|Other|2
1717097|NCT01105533|5993292|P8|Overall Study|Other|1
1717098|NCT01105533|5993293|P7|Overall Study|Other|3
1717099|NCT01105533|5993294|P6|Overall Study|Other|0
1717100|NCT01105533|5993295|P5|Overall Study|Other|1
1717101|NCT01105533|5993296|P4|Overall Study|Other|0
1717102|NCT01105533|5993297|P3|Overall Study|Other|0
1717103|NCT01105533|5993298|P2|Overall Study|Other|0
1717104|NCT01105533|5993299|P1|Overall Study|Other|0
1717105|NCT01105533|5993291|P9|Overall Study|Adverse Event|1
1717106|NCT01105533|5993292|P8|Overall Study|Adverse Event|0
1717107|NCT01105533|5993293|P7|Overall Study|Adverse Event|2
1717108|NCT01105533|5993294|P6|Overall Study|Adverse Event|2
1717109|NCT01105533|5993295|P5|Overall Study|Adverse Event|1
1717110|NCT01105533|5993296|P4|Overall Study|Adverse Event|0
1717111|NCT01105533|5993297|P3|Overall Study|Adverse Event|0
1717112|NCT01105533|5993298|P2|Overall Study|Adverse Event|0
1717113|NCT01105533|5993299|P1|Overall Study|Adverse Event|0
1717114|NCT01105533|5993291|P9|Overall Study|Lack of Efficacy|9
1717115|NCT01105533|5993292|P8|Overall Study|Lack of Efficacy|2
1717116|NCT01105533|5993293|P7|Overall Study|Lack of Efficacy|3
1717117|NCT01105533|5993294|P6|Overall Study|Lack of Efficacy|5
1717118|NCT01105533|5993295|P5|Overall Study|Lack of Efficacy|4
1717119|NCT01105533|5993296|P4|Overall Study|Lack of Efficacy|3
1717120|NCT01105533|5993297|P3|Overall Study|Lack of Efficacy|3
1717121|NCT01105533|5993298|P2|Overall Study|Lack of Efficacy|1
1717122|NCT01105533|5993299|P1|Overall Study|Lack of Efficacy|1
1717123|NCT01105533|5993291|P9|Overall Study|Death|0
1717124|NCT01105533|5993292|P8|Overall Study|Death|0
1717125|NCT01105533|5993293|P7|Overall Study|Death|0
1717126|NCT01105533|5993294|P6|Overall Study|Death|0
1717127|NCT01105533|5993295|P5|Overall Study|Death|1
1717128|NCT01105533|5993296|P4|Overall Study|Death|0
1717129|NCT01105533|5993297|P3|Overall Study|Death|0
1717130|NCT01105533|5993298|P2|Overall Study|Death|0
1717131|NCT01105533|5993299|P1|Overall Study|Death|0
1717132|NCT01105377|5993389|P2|Overall Study|Withdrawal by Subject|1
1717133|NCT01105377|5993390|P1|Overall Study|Withdrawal by Subject|0
1717134|NCT01105130|5993438|P3|Overall Study|Multiple Reasons|2
1717135|NCT01105130|5993439|P2|Overall Study|Multiple Reasons|0
1717136|NCT01105130|5993440|P1|Overall Study|Multiple Reasons|3
1717137|NCT01105130|5993438|P3|Overall Study|Toxicity|2
1717138|NCT01105130|5993439|P2|Overall Study|Toxicity|3
1717139|NCT01105130|5993440|P1|Overall Study|Toxicity|1
1717140|NCT01105130|5993438|P3|Overall Study|Never Started|4
1717141|NCT01105130|5993439|P2|Overall Study|Never Started|2
1717142|NCT01105130|5993440|P1|Overall Study|Never Started|2
1717143|NCT01105130|5993438|P3|Overall Study|Withdrawal by Subject|2
1717144|NCT01105130|5993439|P2|Overall Study|Withdrawal by Subject|6
1717145|NCT01105130|5993440|P1|Overall Study|Withdrawal by Subject|4
1717146|NCT01105091|5993470|P2|Overall Study|Death|0
1717147|NCT01105091|5993471|P1|Overall Study|Death|2
1717148|NCT01105065|5993495|P1|Overall Study|Technical Problems|1
1717149|NCT01105065|5993495|P1|Overall Study|Adverse Event|5
1717150|NCT01104870|5993504|P3|Overall Study|Withdrawal by Subject|1
1717151|NCT01104870|5993505|P2|Overall Study|Withdrawal by Subject|0
1717152|NCT01104870|5993506|P1|Overall Study|Withdrawal by Subject|0
1717153|NCT01104870|5993504|P3|Overall Study|Death|1
1717154|NCT01104870|5993505|P2|Overall Study|Death|0
1717155|NCT01104870|5993506|P1|Overall Study|Death|0
1717156|NCT01104870|5993504|P3|Overall Study|Adverse Event|0
1717157|NCT01104870|5993505|P2|Overall Study|Adverse Event|1
1717158|NCT01104870|5993506|P1|Overall Study|Adverse Event|1
1717159|NCT01104792|5993535|P1|Overall Study|Did Not Meet Eligibility Criteria|133
1717160|NCT01104792|5993535|P1|Overall Study|Reasons Not Specified|27
1717161|NCT01104792|5993535|P1|Overall Study|Lost to Follow-up|43
1717162|NCT01104792|5993535|P1|Overall Study|Withdrawal of Consent|179
1717163|NCT01104792|5993535|P1|Overall Study|Protocol Violation|45
1717164|NCT01104792|5993535|P1|Overall Study|Insufficient Therapeutic Response|22
1717165|NCT01104792|5993535|P1|Overall Study|Adverse Event|77
1717166|NCT01104779|5993543|P3|Overall Study|Withdrawal by Subject|32
1717167|NCT01104779|5993544|P2|Overall Study|Withdrawal by Subject|25
1717168|NCT01104779|5993545|P1|Overall Study|Withdrawal by Subject|16
1717169|NCT01104779|5993543|P3|Overall Study|Lost to Follow-up|1
1717170|NCT01104779|5993544|P2|Overall Study|Lost to Follow-up|0
1717171|NCT01104779|5993545|P1|Overall Study|Lost to Follow-up|2
1717172|NCT01104779|5993543|P3|Overall Study|Other reasons|0
1717173|NCT01104779|5993544|P2|Overall Study|Other reasons|1
1717174|NCT01104779|5993545|P1|Overall Study|Other reasons|0
1717175|NCT01104779|5993543|P3|Overall Study|Did not meet inc/exc criteria|1
1717176|NCT01104779|5993544|P2|Overall Study|Did not meet inc/exc criteria|1
1717177|NCT01104779|5993545|P1|Overall Study|Did not meet inc/exc criteria|1
1717178|NCT01104779|5993543|P3|Overall Study|Adverse Event|13
1717179|NCT01104779|5993544|P2|Overall Study|Adverse Event|14
1717180|NCT01104779|5993545|P1|Overall Study|Adverse Event|13
1717181|NCT01104779|5993543|P3|Overall Study|Lack of Efficacy|13
1717182|NCT01104779|5993544|P2|Overall Study|Lack of Efficacy|12
1717183|NCT01104779|5993545|P1|Overall Study|Lack of Efficacy|26
1717184|NCT01104779|5993543|P3|Overall Study|Protocol Violation|2
1717185|NCT01104779|5993544|P2|Overall Study|Protocol Violation|2
1717186|NCT01104779|5993545|P1|Overall Study|Protocol Violation|1
1717187|NCT01104766|5993560|P4|Overall Study|Lost to Follow-up|1
1717188|NCT01104766|5993561|P3|Overall Study|Lost to Follow-up|1
1717189|NCT01104766|5993562|P2|Overall Study|Lost to Follow-up|2
1717190|NCT01104766|5993563|P1|Overall Study|Lost to Follow-up|1
1717191|NCT01104766|5993560|P4|Overall Study|Withdrawal by Subject|15
1717192|NCT01104766|5993561|P3|Overall Study|Withdrawal by Subject|25
1717193|NCT01104766|5993562|P2|Overall Study|Withdrawal by Subject|19
1717194|NCT01104766|5993563|P1|Overall Study|Withdrawal by Subject|17
1717195|NCT01104766|5993560|P4|Overall Study|Protocol Violation|0
1717196|NCT01104766|5993561|P3|Overall Study|Protocol Violation|0
1717197|NCT01104766|5993562|P2|Overall Study|Protocol Violation|0
1717198|NCT01104766|5993563|P1|Overall Study|Protocol Violation|2
1717199|NCT01104766|5993560|P4|Overall Study|Lack of Efficacy|8
1717200|NCT01104766|5993561|P3|Overall Study|Lack of Efficacy|14
1717201|NCT01104766|5993562|P2|Overall Study|Lack of Efficacy|15
1717202|NCT01104766|5993563|P1|Overall Study|Lack of Efficacy|20
1717203|NCT01104766|5993560|P4|Overall Study|Adverse Event|14
1717204|NCT01104766|5993561|P3|Overall Study|Adverse Event|20
1717205|NCT01104766|5993562|P2|Overall Study|Adverse Event|15
1717206|NCT01104766|5993563|P1|Overall Study|Adverse Event|17
1717207|NCT01104766|5993560|P4|Overall Study|Did not meet inc/exc criteria|0
1717208|NCT01104766|5993561|P3|Overall Study|Did not meet inc/exc criteria|0
1717209|NCT01104766|5993562|P2|Overall Study|Did not meet inc/exc criteria|0
1717210|NCT01104766|5993563|P1|Overall Study|Did not meet inc/exc criteria|1
1717211|NCT01104701|5993581|P4|Overall Study|Physician Decision|0
1717212|NCT01104701|5993582|P3|Overall Study|Physician Decision|0
1717213|NCT01104701|5993583|P2|Overall Study|Physician Decision|2
1717214|NCT01104701|5993584|P1|Overall Study|Physician Decision|0
1717215|NCT01104701|5993581|P4|Overall Study|Adverse Event|1
1717216|NCT01104701|5993582|P3|Overall Study|Adverse Event|0
1717217|NCT01104701|5993583|P2|Overall Study|Adverse Event|0
1717218|NCT01104701|5993584|P1|Overall Study|Adverse Event|0
1717219|NCT01104701|5993581|P4|Overall Study|Withdrawal by Subject|1
1717220|NCT01104701|5993582|P3|Overall Study|Withdrawal by Subject|2
1717221|NCT01104701|5993583|P2|Overall Study|Withdrawal by Subject|1
1717222|NCT01104701|5993584|P1|Overall Study|Withdrawal by Subject|0
1717223|NCT01104662|5993646|P8|Overall Study|Randomized but not treated|0
1717224|NCT01104662|5993647|P7|Overall Study|Randomized but not treated|0
1717225|NCT01104662|5993648|P6|Overall Study|Randomized but not treated|1
1717226|NCT01104662|5993649|P5|Overall Study|Randomized but not treated|0
1717227|NCT01104662|5993650|P4|Overall Study|Randomized but not treated|0
1717228|NCT01104662|5993651|P3|Overall Study|Randomized but not treated|1
1717229|NCT01104662|5993652|P2|Overall Study|Randomized but not treated|4
1717230|NCT01104662|5993653|P1|Overall Study|Randomized but not treated|3
1717231|NCT01104662|5993646|P8|Overall Study|Reason not specified|0
1717232|NCT01104662|5993647|P7|Overall Study|Reason not specified|0
1717233|NCT01104662|5993648|P6|Overall Study|Reason not specified|1
1717234|NCT01104662|5993649|P5|Overall Study|Reason not specified|0
1717235|NCT01104662|5993650|P4|Overall Study|Reason not specified|0
1717236|NCT01104662|5993651|P3|Overall Study|Reason not specified|0
1717237|NCT01104662|5993652|P2|Overall Study|Reason not specified|3
1717238|NCT01104662|5993653|P1|Overall Study|Reason not specified|3
1717239|NCT01104662|5993646|P8|Overall Study|Participant left investigator’s care|0
1717240|NCT01104662|5993647|P7|Overall Study|Participant left investigator’s care|0
1717241|NCT01104662|5993648|P6|Overall Study|Participant left investigator’s care|0
1717242|NCT01104662|5993649|P5|Overall Study|Participant left investigator’s care|0
1717243|NCT01104662|5993650|P4|Overall Study|Participant left investigator’s care|0
1717244|NCT01104662|5993651|P3|Overall Study|Participant left investigator’s care|0
1717245|NCT01104662|5993652|P2|Overall Study|Participant left investigator’s care|1
1717246|NCT01104662|5993653|P1|Overall Study|Participant left investigator’s care|1
1717247|NCT01104662|5993646|P8|Overall Study|Clinical Failure|0
1717248|NCT01104662|5993647|P7|Overall Study|Clinical Failure|0
1717249|NCT01104662|5993648|P6|Overall Study|Clinical Failure|1
1717250|NCT01104662|5993649|P5|Overall Study|Clinical Failure|0
1717251|NCT01104662|5993650|P4|Overall Study|Clinical Failure|0
1717252|NCT01104662|5993651|P3|Overall Study|Clinical Failure|0
1717253|NCT01104662|5993652|P2|Overall Study|Clinical Failure|0
1717254|NCT01104662|5993653|P1|Overall Study|Clinical Failure|1
1717255|NCT01104662|5993646|P8|Overall Study|Adverse Event|0
1717256|NCT01104662|5993647|P7|Overall Study|Adverse Event|0
1717257|NCT01104662|5993648|P6|Overall Study|Adverse Event|1
1717258|NCT01104662|5993649|P5|Overall Study|Adverse Event|1
1717259|NCT01104662|5993650|P4|Overall Study|Adverse Event|1
1717260|NCT01104662|5993651|P3|Overall Study|Adverse Event|0
1717261|NCT01104662|5993652|P2|Overall Study|Adverse Event|2
1717262|NCT01104662|5993653|P1|Overall Study|Adverse Event|2
1717263|NCT01104636|5993679|P1|Overall Study|Ongoing|21
1717264|NCT01104636|5993679|P1|Overall Study|Adverse Event|40
1717265|NCT01104636|5993679|P1|Overall Study|Pregnancy|2
1717266|NCT01104636|5993679|P1|Overall Study|Study terminated by sponsor|1
1717267|NCT01104636|5993679|P1|Overall Study|Other|43
1717268|NCT01104636|5993679|P1|Overall Study|Withdrawal by Subject|4
1717269|NCT01104636|5993679|P1|Overall Study|Lost to Follow-up|24
1717270|NCT01104636|5993679|P1|Overall Study|Lack of Efficacy|43
1717271|NCT01104584|5993684|P1|Overall Study|Study prematurely discontinued|2
1717272|NCT01104584|5993684|P1|Overall Study|Study drug never administered|21
1717273|NCT01104558|5993754|P1|Overall Study|Missing of genetic analysis results|1
1717274|NCT01104558|5993754|P1|Overall Study|Missing of primary efficacy assessment|10
1717275|NCT01104558|5993754|P1|Overall Study|Protocol Violation|6
1717276|NCT01104545|5993798|P3|Overall Study|Adverse Event|2
1717277|NCT01104545|5993799|P2|Overall Study|Adverse Event|1
1717278|NCT01104545|5993800|P1|Overall Study|Adverse Event|0
1717279|NCT01104493|5993957|P2|Overall Study|Lost to Follow-up|2
1717280|NCT01104493|5993958|P1|Overall Study|Lost to Follow-up|0
1717281|NCT01104415|5993976|P2|Extension Period|Heart surgery/feeling miserable|1
1717282|NCT01104415|5993977|P1|Extension Period|Heart surgery/feeling miserable|0
1717283|NCT01104415|5993976|P2|Extension Period|Transition to Study LX1606.302|4
1717284|NCT01104415|5993977|P1|Extension Period|Transition to Study LX1606.302|0
1717285|NCT01104415|5993976|P2|Extension Period|Physician Decision|1
1717286|NCT01104415|5993977|P1|Extension Period|Physician Decision|0
1717287|NCT01104415|5993976|P2|Extension Period|Death|1
1717288|NCT01104415|5993977|P1|Extension Period|Death|0
1717289|NCT01104415|5993976|P2|Extension Period|Progressive disease|4
1717290|NCT01104415|5993977|P1|Extension Period|Progressive disease|0
1717291|NCT01104415|5993976|P2|Core Phase|Consent withdrawn by subjects|0
1717292|NCT01104415|5993977|P1|Core Phase|Consent withdrawn by subjects|1
1717293|NCT01104376|5994021|P1|Overall Study|Consented but excluded after labs|13
1717294|NCT01104376|5994021|P1|Overall Study|Withdrawal by Subject|15
1717295|NCT01104311|5994027|P2|Overall Study|Adverse Event|2
1717296|NCT01104311|5994028|P1|Overall Study|Adverse Event|1
1717297|NCT01104311|5994027|P2|Overall Study|low compliance|1
1717298|NCT01104311|5994028|P1|Overall Study|low compliance|1
1717299|NCT01104311|5994027|P2|Overall Study|Physician Decision|2
1717300|NCT01104311|5994028|P1|Overall Study|Physician Decision|2
1717301|NCT01104311|5994027|P2|Overall Study|Protocol Violation|1
1717302|NCT01104311|5994028|P1|Overall Study|Protocol Violation|0
1717303|NCT01104311|5994027|P2|Overall Study|Withdrawal by Subject|6
1717304|NCT01104311|5994028|P1|Overall Study|Withdrawal by Subject|6
1717305|NCT01104246|5994055|P1|Overall Study|did not meet inclusion criteria|4
1717306|NCT01104246|5994055|P1|Overall Study|Withdrawal by Subject|1
1717307|NCT01104155|5994070|P2|Overall Study|Other|4
1717308|NCT01104155|5994071|P1|Overall Study|Other|3
1717309|NCT01104155|5994070|P2|Overall Study|Withdrawal of consent|1
1717310|NCT01104155|5994071|P1|Overall Study|Withdrawal of consent|1
1717311|NCT01104155|5994070|P2|Overall Study|Participant choice|5
1717312|NCT01104155|5994071|P1|Overall Study|Participant choice|6
1717313|NCT01104155|5994070|P2|Overall Study|Adverse Event|8
1717314|NCT01104155|5994071|P1|Overall Study|Adverse Event|15
1717315|NCT01103960|5994114|P2|Overall Study|Other|0
1717316|NCT01103960|5994115|P1|Overall Study|Other|1
1717317|NCT01103960|5994114|P2|Overall Study|Withdrawal by Subject|1
1717318|NCT01103960|5994115|P1|Overall Study|Withdrawal by Subject|2
1717319|NCT01103960|5994114|P2|Overall Study|Adverse Event|1
1717320|NCT01103960|5994115|P1|Overall Study|Adverse Event|2
1717321|NCT01103778|5994150|P1|Overall Study|Screen failure|1
1717322|NCT01103778|5994150|P1|Overall Study|Proteinuria improved prior to enrollment|1
1717323|NCT01103778|5994150|P1|Overall Study|Lost to Follow-up|1
1717324|NCT01103713|5994157|P1|Overall Study|Other|1
1717325|NCT01103713|5994157|P1|Overall Study|Study terminated by sponsor|2
1717326|NCT01103713|5994157|P1|Overall Study|Withdrawal by Subject|8
1717327|NCT01103713|5994157|P1|Overall Study|Lost to Follow-up|2
1717328|NCT01103479|5994207|P3|Overall Study|Saw non-study physician|0
1717329|NCT01103479|5994208|P2|Overall Study|Saw non-study physician|0
1717330|NCT01103479|5994209|P1|Overall Study|Saw non-study physician|2
1717331|NCT01103479|5994207|P3|Overall Study|Active cancer|0
1717332|NCT01103479|5994208|P2|Overall Study|Active cancer|0
1717333|NCT01103479|5994209|P1|Overall Study|Active cancer|1
1717334|NCT01103479|5994207|P3|Overall Study|Family history of CRC|2
1717335|NCT01103479|5994208|P2|Overall Study|Family history of CRC|0
1717336|NCT01103479|5994209|P1|Overall Study|Family history of CRC|1
1717337|NCT01103479|5994207|P3|Overall Study|Up to date with CRC screening|12
1717338|NCT01103479|5994208|P2|Overall Study|Up to date with CRC screening|9
1717339|NCT01103479|5994209|P1|Overall Study|Up to date with CRC screening|1
1717340|NCT01103466|5994222|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
1717341|NCT01103466|5994223|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
1717342|NCT01103466|5994224|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
1717343|NCT01103466|5994222|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
1717344|NCT01103466|5994223|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
1717345|NCT01103466|5994224|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
1717346|NCT01103466|5994222|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
1717347|NCT01103466|5994223|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
1717348|NCT01103466|5994224|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
1717349|NCT01103466|5994222|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
1717350|NCT01103466|5994223|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
1717351|NCT01103466|5994224|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
1717352|NCT01103466|5994222|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
1717353|NCT01103466|5994223|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
1717354|NCT01103466|5994224|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
1717355|NCT01103466|5994222|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
1717356|NCT01103466|5994223|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
1717357|NCT01103466|5994224|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
1717358|NCT01103362|5994314|P1|Overall Study|study terminated|596
1717359|NCT01103323|5994320|P2|Switched From Placebo to Regorafenib|Adverse Event|1
1717360|NCT01103323|5994321|P1|Switched From Placebo to Regorafenib|Adverse Event|0
1717361|NCT01103323|5994320|P2|Without/Before Drug Switch|Switch to Regorafenib|4
1717362|NCT01103323|5994321|P1|Without/Before Drug Switch|Switch to Regorafenib|0
1717363|NCT01103323|5994320|P2|Without/Before Drug Switch|did not receive study treatment|2
1717364|NCT01103323|5994321|P1|Without/Before Drug Switch|did not receive study treatment|5
1717365|NCT01103323|5994320|P2|Without/Before Drug Switch|Physician Decision|0
1717366|NCT01103323|5994321|P1|Without/Before Drug Switch|Physician Decision|2
1717367|NCT01103323|5994320|P2|Without/Before Drug Switch|Protocol Violation|0
1717368|NCT01103323|5994321|P1|Without/Before Drug Switch|Protocol Violation|2
1717369|NCT01103323|5994320|P2|Without/Before Drug Switch|Withdrawal by Subject|5
1717370|NCT01103323|5994321|P1|Without/Before Drug Switch|Withdrawal by Subject|17
1717371|NCT01103323|5994320|P2|Without/Before Drug Switch|Adverse Event|7
1717372|NCT01103323|5994321|P1|Without/Before Drug Switch|Adverse Event|50
1717373|NCT01103284|5994338|P2|Overall Study|Missing CRF entries for study completion|2
1717374|NCT01103284|5994339|P1|Overall Study|Missing CRF entries for study completion|0
1717375|NCT01103284|5994338|P2|Overall Study|Not described|1
1717376|NCT01103284|5994339|P1|Overall Study|Not described|2
1717377|NCT01103284|5994338|P2|Overall Study|Termination by the Sponsor|1
1717378|NCT01103284|5994339|P1|Overall Study|Termination by the Sponsor|0
1717379|NCT01103284|5994338|P2|Overall Study|Dermal Hypersensitivity|1
1717380|NCT01103284|5994339|P1|Overall Study|Dermal Hypersensitivity|0
1717381|NCT01103284|5994338|P2|Overall Study|Withdrawal by Subject|18
1717382|NCT01103284|5994339|P1|Overall Study|Withdrawal by Subject|14
1717383|NCT01103284|5994338|P2|Overall Study|Adverse Event|5
1717384|NCT01103284|5994339|P1|Overall Study|Adverse Event|0
1717385|NCT01103284|5994338|P2|Overall Study|Protocol Violation|5
1717386|NCT01103284|5994339|P1|Overall Study|Protocol Violation|12
1717387|NCT01103284|5994338|P2|Overall Study|Pregnancy|1
1717388|NCT01103284|5994339|P1|Overall Study|Pregnancy|3
1717389|NCT01103284|5994338|P2|Overall Study|Lost to Follow-up|10
1717390|NCT01103284|5994339|P1|Overall Study|Lost to Follow-up|9
1717391|NCT01103284|5994338|P2|Overall Study|Death|0
1717392|NCT01103284|5994339|P1|Overall Study|Death|2
1717393|NCT01103245|5994367|P4|Overall Study|Physician Decision|0
1717394|NCT01103245|5994368|P3|Overall Study|Physician Decision|0
1717395|NCT01103245|5994369|P2|Overall Study|Physician Decision|0
1717396|NCT01103245|5994370|P1|Overall Study|Physician Decision|1
1717397|NCT01103245|5994367|P4|Overall Study|Adverse Event|0
1717398|NCT01103245|5994368|P3|Overall Study|Adverse Event|1
1717399|NCT01103245|5994369|P2|Overall Study|Adverse Event|2
1717400|NCT01103245|5994370|P1|Overall Study|Adverse Event|0
1717401|NCT01103245|5994367|P4|Overall Study|Inadequate IV access|0
1717402|NCT01103245|5994368|P3|Overall Study|Inadequate IV access|0
1717403|NCT01103245|5994369|P2|Overall Study|Inadequate IV access|0
1717404|NCT01103245|5994370|P1|Overall Study|Inadequate IV access|1
1717405|NCT01103245|5994367|P4|Overall Study|Withdrawal by Subject|0
1717406|NCT01103245|5994368|P3|Overall Study|Withdrawal by Subject|3
1717407|NCT01103245|5994369|P2|Overall Study|Withdrawal by Subject|0
1717408|NCT01103245|5994370|P1|Overall Study|Withdrawal by Subject|1
1717409|NCT01103232|5994386|P2|Overall Study|Protocol Violation|1
1717410|NCT01103232|5994387|P1|Overall Study|Protocol Violation|0
1717411|NCT01103232|5994386|P2|Overall Study|Withdrawal by Subject|1
1717412|NCT01103232|5994387|P1|Overall Study|Withdrawal by Subject|1
1717413|NCT01103180|5994395|P2|Overall Study|Protocol Violation|1
1717414|NCT01103180|5994396|P1|Overall Study|Protocol Violation|0
1717415|NCT01103180|5994395|P2|Overall Study|Physician Decision|0
1717416|NCT01103180|5994396|P1|Overall Study|Physician Decision|1
1717417|NCT01103180|5994395|P2|Overall Study|Lost to Follow-up|7
1717418|NCT01103180|5994396|P1|Overall Study|Lost to Follow-up|13
1717419|NCT01103180|5994395|P2|Overall Study|Withdrawal by Subject|13
1717420|NCT01103180|5994396|P1|Overall Study|Withdrawal by Subject|8
1717421|NCT01103141|5994406|P2|Overall Study|Lost to Follow-up|1
1717422|NCT01103141|5994407|P1|Overall Study|Lost to Follow-up|2
1717423|NCT01103141|5994406|P2|Overall Study|Death|1
1717424|NCT01103141|5994407|P1|Overall Study|Death|0
1717425|NCT01103063|5994415|P2|Overall Study|Death|1
1717426|NCT01103063|5994416|P1|Overall Study|Death|3
1717427|NCT01103063|5994415|P2|Overall Study|Study terminated by Sponsor|342
1717428|NCT01103063|5994416|P1|Overall Study|Study terminated by Sponsor|326
1717429|NCT01103063|5994415|P2|Overall Study|Protocol Violation|0
1717430|NCT01103063|5994416|P1|Overall Study|Protocol Violation|1
1717431|NCT01103063|5994415|P2|Overall Study|Other|11
1717432|NCT01103063|5994416|P1|Overall Study|Other|16
1717433|NCT01103063|5994415|P2|Overall Study|Withdrawal by Subject|15
1717434|NCT01103063|5994416|P1|Overall Study|Withdrawal by Subject|60
1717435|NCT01103063|5994415|P2|Overall Study|Lost to Follow-up|51
1717436|NCT01103063|5994416|P1|Overall Study|Lost to Follow-up|68
1717437|NCT01103063|5994415|P2|Overall Study|Adverse Event|1
1717438|NCT01103063|5994416|P1|Overall Study|Adverse Event|3
1717439|NCT01102972|5994484|P2|Overall Study|Withdrawal by Subject|6
1717440|NCT01102972|5994485|P1|Overall Study|Withdrawal by Subject|6
1717441|NCT01102972|5994484|P2|Overall Study|Investigator Discretion|0
1717442|NCT01102972|5994485|P1|Overall Study|Investigator Discretion|2
1717443|NCT01102972|5994484|P2|Overall Study|Lost to Follow-up|5
1717444|NCT01102972|5994485|P1|Overall Study|Lost to Follow-up|10
1717445|NCT01102972|5994484|P2|Overall Study|Protocol Violation|0
1717446|NCT01102972|5994485|P1|Overall Study|Protocol Violation|1
1717447|NCT01102972|5994484|P2|Overall Study|Lack of Efficacy|1
1717448|NCT01102972|5994485|P1|Overall Study|Lack of Efficacy|2
1717449|NCT01102972|5994484|P2|Overall Study|Adverse Event|2
1717450|NCT01102972|5994485|P1|Overall Study|Adverse Event|8
1717451|NCT01102803|5994549|P2|Post to Follow-Up|Lost to Follow-up|3
1717452|NCT01102803|5994550|P1|Post to Follow-Up|Lost to Follow-up|1
1717453|NCT01102803|5994549|P2|Baseline to Post-Treatment|Lost to Follow-up|0
1717454|NCT01102803|5994550|P1|Baseline to Post-Treatment|Lost to Follow-up|3
1717455|NCT01102777|5994564|P2|Overall Study|Lost to Follow-up|10
1717456|NCT01102777|5994565|P1|Overall Study|Lost to Follow-up|7
1717457|NCT01102777|5994564|P2|Overall Study|Death|6
1717458|NCT01102777|5994565|P1|Overall Study|Death|2
1717459|NCT01102491|5994620|P2|Overall Study|Protocol Violation|12
1717460|NCT01102491|5994621|P1|Overall Study|Protocol Violation|11
1717461|NCT01102374|5994640|P2|Overall Study|Lost to Follow-up|6
1717462|NCT01102374|5994641|P1|Overall Study|Lost to Follow-up|7
1717463|NCT01102374|5994640|P2|Overall Study|Death|13
1717464|NCT01102374|5994641|P1|Overall Study|Death|9
1717465|NCT01102257|5994690|P2|Overall Study|Adverse Event|0
1717466|NCT01102257|5994691|P1|Overall Study|Adverse Event|1
1717467|NCT01102257|5994690|P2|Overall Study|Adverse Event|0
1717468|NCT01102257|5994691|P1|Overall Study|Adverse Event|1
1717469|NCT01102140|5994708|P2|Overall Study|Investigator terminated study|2
1717470|NCT01102140|5994709|P1|Overall Study|Investigator terminated study|2
1717471|NCT01102140|5994708|P2|Overall Study|Lost to Follow-up|0
1717472|NCT01102140|5994709|P1|Overall Study|Lost to Follow-up|1
1717473|NCT01101841|5994764|P2|Overall Study|Eligibility Criteria|2
1717474|NCT01101841|5994765|P1|Overall Study|Eligibility Criteria|1
1717475|NCT01101841|5994764|P2|Overall Study|Suicidality Tracking Scale|1
1717476|NCT01101841|5994765|P1|Overall Study|Suicidality Tracking Scale|3
1717477|NCT01101841|5994764|P2|Overall Study|Other|1
1717478|NCT01101841|5994765|P1|Overall Study|Other|0
1717479|NCT01101841|5994764|P2|Overall Study|Lack of Efficacy|2
1717480|NCT01101841|5994765|P1|Overall Study|Lack of Efficacy|0
1717481|NCT01101841|5994764|P2|Overall Study|Physician Decision|2
1717482|NCT01101841|5994765|P1|Overall Study|Physician Decision|0
1717483|NCT01101841|5994764|P2|Overall Study|Protocol Violation|1
1717484|NCT01101841|5994765|P1|Overall Study|Protocol Violation|1
1717485|NCT01101841|5994764|P2|Overall Study|Withdrawal by Subject|40
1717486|NCT01101841|5994765|P1|Overall Study|Withdrawal by Subject|21
1717487|NCT01101841|5994764|P2|Overall Study|Lost to Follow-up|3
1717488|NCT01101841|5994765|P1|Overall Study|Lost to Follow-up|9
1717489|NCT01101841|5994764|P2|Overall Study|Adverse Event|15
1717490|NCT01101841|5994765|P1|Overall Study|Adverse Event|15
1717491|NCT01101542|5994803|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
1717492|NCT01101542|5994803|P1|Year 6 Surveillance Period|Pregnancy|1
1717493|NCT01101542|5994803|P1|Year 6 Surveillance Period|Lost to Follow-up|986
1717494|NCT01101542|5994803|P1|Year 5 Surveillance Period|Pregnancy|1
1717495|NCT01101542|5994803|P1|Year 5 Surveillance Period|Lost to Follow-up|140
1717496|NCT01101542|5994803|P1|Year 4 Surveillance Period|Other|287
1717497|NCT01101542|5994803|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
1717498|NCT01101542|5994803|P1|Year 3 Surveillance Period|Lost to Follow-up|7
1717499|NCT01101477|5994819|P3|Overall Study|Protocol Violation|1
1717500|NCT01101477|5994820|P2|Overall Study|Protocol Violation|3
1717501|NCT01101477|5994821|P1|Overall Study|Protocol Violation|5
1717502|NCT01101321|5994842|P2|Period 1|Adverse Event|3
1717503|NCT01101321|5994843|P1|Period 1|Adverse Event|3
1717504|NCT01101321|5994842|P2|Period 1|Withdrawal by Subject|1
1717505|NCT01101321|5994843|P1|Period 1|Withdrawal by Subject|1
1717506|NCT01101308|5994853|P2|Period 1|Positive for cotinine|0
1717507|NCT01101308|5994854|P1|Period 1|Positive for cotinine|1
1717508|NCT01101308|5994853|P2|Period 1|Adverse Event|1
1717509|NCT01101308|5994854|P1|Period 1|Adverse Event|2
1717510|NCT01101191|5994865|P2|Period 1|Adverse Event|2
1717511|NCT01101191|5994866|P1|Period 1|Adverse Event|1
1717512|NCT01101191|5994865|P2|Period 1|Withdrawal by Subject|0
1717513|NCT01101191|5994866|P1|Period 1|Withdrawal by Subject|1
1717514|NCT01101178|5994877|P2|Period 2|Withdrawal by Subject|1
1717515|NCT01101178|5994878|P1|Period 2|Withdrawal by Subject|0
1717516|NCT01101178|5994877|P2|Period 1|Adverse Event|1
1717517|NCT01101178|5994878|P1|Period 1|Adverse Event|2
1717518|NCT01101178|5994877|P2|Period 1|Positive drug screen|1
1717519|NCT01101178|5994878|P1|Period 1|Positive drug screen|1
1717520|NCT01101178|5994877|P2|Period 1|Withdrawal by Subject|2
1717521|NCT01101178|5994878|P1|Period 1|Withdrawal by Subject|1
1717522|NCT01101165|5994889|P2|Period 2|Adverse Event|0
1717523|NCT01101165|5994890|P1|Period 2|Adverse Event|1
1717524|NCT01101165|5994889|P2|Period 2|Withdrawal by Subject|1
1717525|NCT01101165|5994890|P1|Period 2|Withdrawal by Subject|3
1717526|NCT01101165|5994889|P2|Period 1|Lost to Follow-up|0
1717527|NCT01101165|5994890|P1|Period 1|Lost to Follow-up|1
1717528|NCT01101165|5994889|P2|Period 1|Positive Drug Screen|1
1717529|NCT01101165|5994890|P1|Period 1|Positive Drug Screen|0
1717530|NCT01101165|5994889|P2|Period 1|Withdrawal by Subject|2
1717531|NCT01101165|5994890|P1|Period 1|Withdrawal by Subject|0
1717532|NCT01101165|5994889|P2|Period 1|Adverse Event|2
1717533|NCT01101165|5994890|P1|Period 1|Adverse Event|1
1717534|NCT01101061|5994911|P6|Overall Study|Adverse Event|0
1717535|NCT01101061|5994912|P5|Overall Study|Adverse Event|0
1717536|NCT01101061|5994913|P4|Overall Study|Adverse Event|0
1717537|NCT01101061|5994914|P3|Overall Study|Adverse Event|1
1717538|NCT01101061|5994915|P2|Overall Study|Adverse Event|0
1717539|NCT01101061|5994916|P1|Overall Study|Adverse Event|0
1717540|NCT01101035|5994996|P2|Overall Study|Reason not Specified|363
1717541|NCT01101035|5994997|P1|Overall Study|Reason not Specified|333
1717542|NCT01101035|5994996|P2|Overall Study|Voluntary Withdrawal|587
1717543|NCT01101035|5994997|P1|Overall Study|Voluntary Withdrawal|595
1717544|NCT01101035|5994996|P2|Overall Study|Lost to Follow-up|223
1717545|NCT01101035|5994997|P1|Overall Study|Lost to Follow-up|226
1717546|NCT01101035|5994996|P2|Overall Study|Major Protocol Deviation|46
1717547|NCT01101035|5994997|P1|Overall Study|Major Protocol Deviation|52
1717548|NCT01101035|5994996|P2|Overall Study|Adverse Event|172
1717549|NCT01101035|5994997|P1|Overall Study|Adverse Event|191
1717550|NCT01101022|5995017|P2|Overall Study|Vacation|1
1717551|NCT01101022|5995018|P1|Overall Study|Vacation|0
1717552|NCT01101022|5995017|P2|Overall Study|Work schedule|1
1717553|NCT01101022|5995018|P1|Overall Study|Work schedule|1
1717554|NCT01101022|5995017|P2|Overall Study|Non-compliance|0
1717555|NCT01101022|5995018|P1|Overall Study|Non-compliance|1
1717556|NCT01101022|5995017|P2|Overall Study|Sponsor decision|1
1717557|NCT01101022|5995018|P1|Overall Study|Sponsor decision|1
1717558|NCT01101022|5995017|P2|Overall Study|Lack of Efficacy|7
1717559|NCT01101022|5995018|P1|Overall Study|Lack of Efficacy|0
1717560|NCT01101022|5995017|P2|Overall Study|Lost to Follow-up|4
1717561|NCT01101022|5995018|P1|Overall Study|Lost to Follow-up|1
1717562|NCT01101022|5995017|P2|Overall Study|Withdrawal by Subject|8
1717563|NCT01101022|5995018|P1|Overall Study|Withdrawal by Subject|3
1717564|NCT01101022|5995017|P2|Overall Study|Protocol Violation|3
1717565|NCT01101022|5995018|P1|Overall Study|Protocol Violation|4
1717566|NCT01101022|5995017|P2|Overall Study|Adverse Event|2
1717567|NCT01101022|5995018|P1|Overall Study|Adverse Event|6
1717568|NCT01100944|5995052|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
1717569|NCT01100944|5995053|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
1717570|NCT01100944|5995054|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
1717571|NCT01100944|5995052|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
1717572|NCT01100944|5995053|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
1717573|NCT01100944|5995054|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
1717574|NCT01100944|5995052|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
1717575|NCT01100944|5995053|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
1717576|NCT01100944|5995054|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
1717577|NCT01100944|5995052|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
1717578|NCT01100944|5995053|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
1717579|NCT01100944|5995054|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
1717580|NCT01100853|5995112|P2|Overall Study|Withdrawal by Subject|4
1717581|NCT01100853|5995113|P1|Overall Study|Withdrawal by Subject|6
1717582|NCT01100853|5995112|P2|Overall Study|Received <4 study injections|13
1717583|NCT01100853|5995113|P1|Overall Study|Received <4 study injections|10
1717584|NCT01100853|5995112|P2|Overall Study|Lost to Follow-up|6
1717585|NCT01100853|5995113|P1|Overall Study|Lost to Follow-up|11
1717586|NCT01100658|5995159|P1|Overall Study|Withdrawal by Subject|1
1717587|NCT01100567|5995191|P2|Overall Study|Deemed ineligible after consent|1
1717588|NCT01100567|5995192|P1|Overall Study|Deemed ineligible after consent|0
1717589|NCT01100567|5995191|P2|Overall Study|Physician Decision|1
1717590|NCT01100567|5995192|P1|Overall Study|Physician Decision|0
1717591|NCT01100567|5995191|P2|Overall Study|Lost to Follow-up|2
1717592|NCT01100567|5995192|P1|Overall Study|Lost to Follow-up|1
1717593|NCT01100567|5995191|P2|Overall Study|Early Hospital Discharge|4
1717594|NCT01100567|5995192|P1|Overall Study|Early Hospital Discharge|6
1717595|NCT01100567|5995191|P2|Overall Study|Withdrawal by Subject|8
1717596|NCT01100567|5995192|P1|Overall Study|Withdrawal by Subject|5
1717597|NCT01100528|5995200|P1|Overall Study|Withdrawal by Subject|2
1717598|NCT01100528|5995200|P1|Overall Study|Death|1
1717599|NCT01100502|5995208|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
1717600|NCT01100502|5995209|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
1717601|NCT01100502|5995208|P2|Long-Term Follow-up|Lost to Follow-up|2
1717602|NCT01100502|5995209|P1|Long-Term Follow-up|Lost to Follow-up|5
1717603|NCT01100502|5995208|P2|Long-Term Follow-up|Withdrawal by Subject|8
1717604|NCT01100502|5995209|P1|Long-Term Follow-up|Withdrawal by Subject|10
1717605|NCT01100502|5995208|P2|Treatment Period|Progressive Disease|69
1717606|NCT01100502|5995209|P1|Treatment Period|Progressive Disease|24
1717607|NCT01100502|5995208|P2|Treatment Period|Withdrawal by Subject|4
1717608|NCT01100502|5995209|P1|Treatment Period|Withdrawal by Subject|9
1717609|NCT01100502|5995208|P2|Treatment Period|Adverse Event|10
1717610|NCT01100502|5995209|P1|Treatment Period|Adverse Event|54
1717611|NCT01100437|5995219|P3|Maintenance|Sponsor termination of study|1
1717612|NCT01100437|5995220|P2|Maintenance|Sponsor termination of study|0
1717613|NCT01100437|5995221|P1|Maintenance|Sponsor termination of study|0
1717614|NCT01100437|5995219|P3|Maintenance|Withdrawal by Subject|1
1717615|NCT01100437|5995220|P2|Maintenance|Withdrawal by Subject|0
1717616|NCT01100437|5995221|P1|Maintenance|Withdrawal by Subject|0
1717617|NCT01100437|5995219|P3|Titration/Stabilization|Sponsor canceled study|1
1717618|NCT01100437|5995220|P2|Titration/Stabilization|Sponsor canceled study|0
1717619|NCT01100437|5995221|P1|Titration/Stabilization|Sponsor canceled study|0
1717620|NCT01100437|5995219|P3|Titration/Stabilization|Non-compliance|1
1717621|NCT01100437|5995220|P2|Titration/Stabilization|Non-compliance|0
1717622|NCT01100437|5995221|P1|Titration/Stabilization|Non-compliance|0
1717623|NCT01100437|5995219|P3|Titration/Stabilization|Adverse Event|4
1717624|NCT01100437|5995220|P2|Titration/Stabilization|Adverse Event|0
1717625|NCT01100437|5995221|P1|Titration/Stabilization|Adverse Event|0
1717626|NCT01100320|5995258|P2|Period 2|Withdrawal by Subject|1
1717627|NCT01100320|5995259|P1|Period 2|Withdrawal by Subject|1
1717628|NCT01100320|5995258|P2|Period 1|Adverse Event|2
1717629|NCT01100320|5995259|P1|Period 1|Adverse Event|2
1717630|NCT01100320|5995258|P2|Period 1|Positive Drug Screen|1
1717631|NCT01100320|5995259|P1|Period 1|Positive Drug Screen|1
1717632|NCT01100320|5995258|P2|Period 1|Withdrawal by Subject|4
1717633|NCT01100320|5995259|P1|Period 1|Withdrawal by Subject|2
1717634|NCT01100307|5995271|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
1717635|NCT01100307|5995272|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
1717636|NCT01100307|5995271|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
1717637|NCT01100307|5995272|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
1717638|NCT01100307|5995271|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
1717639|NCT01100307|5995272|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
1717640|NCT01100307|5995271|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
1717641|NCT01100307|5995272|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
1717642|NCT01100307|5995271|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
1717643|NCT01100307|5995272|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
1717644|NCT01100307|5995271|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
1717645|NCT01100307|5995272|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
1717646|NCT01100086|5995341|P2|Period 1|Withdrawal by Subject|0
1717647|NCT01100086|5995342|P1|Period 1|Withdrawal by Subject|1
1717648|NCT01100073|5995352|P1|Overall Study|Missing|5
1717649|NCT01100073|5995352|P1|Overall Study|Other|8
1717650|NCT01100073|5995352|P1|Overall Study|Insufficient tolerability +patients wish|8
1717651|NCT01100073|5995352|P1|Overall Study|Lack of effect + patient's wish|2
1717652|NCT01100073|5995352|P1|Overall Study|Lost to Follow-up|39
1717653|NCT01100073|5995352|P1|Overall Study|Withdrawal by Subject|13
1717654|NCT01100073|5995352|P1|Overall Study|Insufficient Tolerability|21
1717655|NCT01100073|5995352|P1|Overall Study|Lack of Efficacy|4
1717656|NCT01100034|5995367|P1|Overall Study|Site closed due to non-responsiveness|1
1717657|NCT01100034|5995367|P1|Overall Study|Participants moved to another hospital|4
1717658|NCT01100034|5995367|P1|Overall Study|Participated in another clinical trial|1
1717659|NCT01100034|5995367|P1|Overall Study|Sponsor decision|21
1717660|NCT01100034|5995367|P1|Overall Study|Withdrawal by Subject|4
1717661|NCT01100034|5995367|P1|Overall Study|Withdrawal of parent/guardian consent|1
1717662|NCT01100034|5995367|P1|Overall Study|Lost to Follow-up|11
1717663|NCT01099917|5995405|P1|Overall Study|Not Treated|24
1717664|NCT01099917|5995405|P1|Overall Study|Adverse Event|3
1717665|NCT01099709|5995467|P2|Period 1|Adverse Event|0
1717666|NCT01099709|5995468|P1|Period 1|Adverse Event|1
1717667|NCT01099709|5995467|P2|Period 1|Positive cotinine test|1
1717668|NCT01099709|5995468|P1|Period 1|Positive cotinine test|0
1717669|NCT01099709|5995467|P2|Period 1|Withdrawal by Subject|1
1717670|NCT01099709|5995468|P1|Period 1|Withdrawal by Subject|0
1717671|NCT01099579|5995494|P3|Stage 2 (ATV Capsule)|Adverse Event|0
1717672|NCT01099579|5995495|P2|Stage 2 (ATV Capsule)|Adverse Event|1
1717673|NCT01099579|5995496|P1|Stage 2 (ATV Capsule)|Adverse Event|0
1717674|NCT01099579|5995494|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
1717675|NCT01099579|5995495|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
1717676|NCT01099579|5995496|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
1717677|NCT01099579|5995494|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1717678|NCT01099579|5995495|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1717679|NCT01099579|5995496|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
1717680|NCT01099579|5995494|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
1717681|NCT01099579|5995495|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
1717682|NCT01099579|5995496|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
1717683|NCT01099579|5995494|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1717684|NCT01099579|5995495|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1717685|NCT01099579|5995496|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
1717686|NCT01099579|5995494|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
1717687|NCT01099579|5995495|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
1717688|NCT01099579|5995496|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
1717689|NCT01099579|5995494|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
1717690|NCT01099579|5995495|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
1717691|NCT01099579|5995496|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
1717692|NCT01099579|5995494|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
1717693|NCT01099579|5995495|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
1717694|NCT01099579|5995496|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
1717695|NCT01099579|5995494|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
1717696|NCT01099579|5995495|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
1717697|NCT01099579|5995496|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
1717698|NCT01099579|5995494|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
1717699|NCT01099579|5995495|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
1717700|NCT01099579|5995496|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
1717701|NCT01099397|5995605|P1|Overall Study|Withdrawal by Subject|5
1717702|NCT01099397|5995605|P1|Overall Study|Protocol Violation|4
1717703|NCT01099397|5995605|P1|Overall Study|Lost to Follow-up|4
1717704|NCT01099267|5995632|P1|MDS-003 Study|Secondary Malign Disease|1
1717705|NCT01099267|5995632|P1|MDS-003 Study|Loss of Response|1
1717706|NCT01099267|5995632|P1|MDS-003 Study|Non-Compliance|2
1717707|NCT01099267|5995632|P1|MDS-003 Study|Investigator Decision|2
1717708|NCT01099267|5995632|P1|MDS-003 Study|Disease Progression|7
1717709|NCT01099267|5995632|P1|MDS-003 Study|Study Closed by Sponsor|2
1717710|NCT01099267|5995632|P1|MDS-003 Study|Death|11
1717711|NCT01099267|5995632|P1|MDS-003 Study|Lost to Follow-up|1
1717712|NCT01099267|5995632|P1|MDS-003 Study|Withdrawal by Subject|8
1717713|NCT01099267|5995632|P1|MDS-003 Study|Lack of Efficacy|52
1717714|NCT01099267|5995632|P1|MDS-003 Study|Adverse Event|37
1717715|NCT01099215|5995642|P2|Overall Study|Adverse Event|1
1717716|NCT01099215|5995643|P1|Overall Study|Adverse Event|0
1717717|NCT01099215|5995642|P2|Overall Study|Withdrawal by Subject|0
1717718|NCT01099215|5995643|P1|Overall Study|Withdrawal by Subject|1
1717719|NCT01098851|5995713|P2|Overall Study|Equipment failure|0
1717720|NCT01098851|5995714|P1|Overall Study|Equipment failure|1
1717721|NCT01098812|5995725|P3|Overall Study|Lost to Follow-up|0
1717722|NCT01098812|5995726|P2|Overall Study|Lost to Follow-up|1
1717723|NCT01098812|5995727|P1|Overall Study|Lost to Follow-up|0
1717724|NCT01098812|5995725|P3|Overall Study|Death|1
1717725|NCT01098812|5995726|P2|Overall Study|Death|0
1717726|NCT01098812|5995727|P1|Overall Study|Death|2
1717727|NCT01098539|5995803|P2|Overall Study|Physician Decision|3
1717728|NCT01098539|5995804|P1|Overall Study|Physician Decision|5
1717729|NCT01098539|5995803|P2|Overall Study|Withdrawal by Subject|26
1717730|NCT01098539|5995804|P1|Overall Study|Withdrawal by Subject|12
1717731|NCT01098539|5995803|P2|Overall Study|Lost to Follow-up|4
1717732|NCT01098539|5995804|P1|Overall Study|Lost to Follow-up|4
1717733|NCT01098539|5995803|P2|Overall Study|Noncompliance|5
1717734|NCT01098539|5995804|P1|Overall Study|Noncompliance|3
1717735|NCT01098539|5995803|P2|Overall Study|Protocol Violation|4
1717736|NCT01098539|5995804|P1|Overall Study|Protocol Violation|1
1717737|NCT01098539|5995803|P2|Overall Study|Adverse Event|26
1717738|NCT01098539|5995804|P1|Overall Study|Adverse Event|26
1717739|NCT01098487|5995855|P1|Overall Study|Physician Decision|1
1717740|NCT01098487|5995855|P1|Overall Study|Lost to Follow-up|3
1717741|NCT01098487|5995855|P1|Overall Study|Withdrawal by Subject|7
1717742|NCT01098487|5995855|P1|Overall Study|Lack of Efficacy|11
1717743|NCT01098487|5995855|P1|Overall Study|Adverse Event|22
1717744|NCT01098474|5995873|P6|Follow Up Phase|Lost to Follow-up|0
1717745|NCT01098474|5995874|P5|Follow Up Phase|Lost to Follow-up|1
1717746|NCT01098474|5995875|P4|Follow Up Phase|Lost to Follow-up|0
1717747|NCT01098474|5995876|P3|Follow Up Phase|Lost to Follow-up|0
1717748|NCT01098474|5995877|P2|Follow Up Phase|Lost to Follow-up|0
1717749|NCT01098474|5995878|P1|Follow Up Phase|Lost to Follow-up|0
1717750|NCT01098474|5995873|P6|Follow Up Phase|Withdrawal by Subject|1
1717751|NCT01098474|5995874|P5|Follow Up Phase|Withdrawal by Subject|0
1717752|NCT01098474|5995875|P4|Follow Up Phase|Withdrawal by Subject|2
1717753|NCT01098474|5995876|P3|Follow Up Phase|Withdrawal by Subject|0
1717754|NCT01098474|5995877|P2|Follow Up Phase|Withdrawal by Subject|0
1717755|NCT01098474|5995878|P1|Follow Up Phase|Withdrawal by Subject|0
1717756|NCT01098474|5995873|P6|Follow Up Phase|Other|4
1717757|NCT01098474|5995874|P5|Follow Up Phase|Other|0
1717758|NCT01098474|5995875|P4|Follow Up Phase|Other|0
1717759|NCT01098474|5995876|P3|Follow Up Phase|Other|0
1717760|NCT01098474|5995877|P2|Follow Up Phase|Other|0
1717761|NCT01098474|5995878|P1|Follow Up Phase|Other|0
1717762|NCT01098474|5995873|P6|Follow Up Phase|Travelled out of study area|0
1717763|NCT01098474|5995874|P5|Follow Up Phase|Travelled out of study area|1
1717764|NCT01098474|5995875|P4|Follow Up Phase|Travelled out of study area|0
1717765|NCT01098474|5995876|P3|Follow Up Phase|Travelled out of study area|0
1717766|NCT01098474|5995877|P2|Follow Up Phase|Travelled out of study area|0
1717767|NCT01098474|5995878|P1|Follow Up Phase|Travelled out of study area|0
1717768|NCT01098474|5995873|P6|Active Phase|Lost to Follow-up|0
1717769|NCT01098474|5995874|P5|Active Phase|Lost to Follow-up|0
1717770|NCT01098474|5995875|P4|Active Phase|Lost to Follow-up|0
1717771|NCT01098474|5995876|P3|Active Phase|Lost to Follow-up|0
1717772|NCT01098474|5995877|P2|Active Phase|Lost to Follow-up|0
1717773|NCT01098474|5995878|P1|Active Phase|Lost to Follow-up|1
1717774|NCT01098474|5995873|P6|Active Phase|Withdrawal by Subject|0
1717775|NCT01098474|5995874|P5|Active Phase|Withdrawal by Subject|0
1717776|NCT01098474|5995875|P4|Active Phase|Withdrawal by Subject|0
1717777|NCT01098474|5995876|P3|Active Phase|Withdrawal by Subject|2
1717778|NCT01098474|5995877|P2|Active Phase|Withdrawal by Subject|1
1717779|NCT01098474|5995878|P1|Active Phase|Withdrawal by Subject|1
1717780|NCT01098474|5995873|P6|Active Phase|Other|0
1717781|NCT01098474|5995874|P5|Active Phase|Other|0
1717782|NCT01098474|5995875|P4|Active Phase|Other|0
1717783|NCT01098474|5995876|P3|Active Phase|Other|3
1717784|NCT01098474|5995877|P2|Active Phase|Other|0
1717785|NCT01098474|5995878|P1|Active Phase|Other|0
1717786|NCT01098461|5996112|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
1717787|NCT01098461|5996113|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
1717788|NCT01098461|5996114|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
1717789|NCT01098461|5996115|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
1717790|NCT01098461|5996112|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1717791|NCT01098461|5996113|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1717792|NCT01098461|5996114|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
1717793|NCT01098461|5996115|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
1717794|NCT01098461|5996112|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1717795|NCT01098461|5996113|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1717796|NCT01098461|5996114|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
1717797|NCT01098461|5996115|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
1717798|NCT01098461|5996112|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1717799|NCT01098461|5996113|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1717800|NCT01098461|5996114|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
1717801|NCT01098461|5996115|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
1717802|NCT01098461|5996112|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
1717803|NCT01098461|5996113|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
1717804|NCT01098461|5996114|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
1717805|NCT01098461|5996115|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
1717806|NCT01098461|5996112|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
1717807|NCT01098461|5996113|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
1717808|NCT01098461|5996114|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
1717809|NCT01098461|5996115|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
1717810|NCT01098461|5996112|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
1717811|NCT01098461|5996113|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
1717812|NCT01098461|5996114|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
1717813|NCT01098461|5996115|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
1717814|NCT01098305|5996175|P2|Overall Study|Lost to Follow-up|33
1717815|NCT01098305|5996176|P1|Overall Study|Lost to Follow-up|31
1717816|NCT01098266|5996186|P2|Overall Study|Withdrawal by Subject|5
1717817|NCT01098266|5996187|P1|Overall Study|Withdrawal by Subject|3
1717818|NCT01098266|5996186|P2|Overall Study|Death|2
1717819|NCT01098266|5996187|P1|Overall Study|Death|3
1717820|NCT01098266|5996186|P2|Overall Study|Physician Decision|0
1717821|NCT01098266|5996187|P1|Overall Study|Physician Decision|1
1717822|NCT01098240|5996216|P3|Double-Blind Phase|Adverse Event|3
1717823|NCT01098240|5996217|P2|Double-Blind Phase|Adverse Event|3
1717824|NCT01098240|5996218|P1|Double-Blind Phase|Adverse Event|0
1717825|NCT01098240|5996216|P3|Double-Blind Phase|Withdrawal by Subject|3
1717826|NCT01098240|5996217|P2|Double-Blind Phase|Withdrawal by Subject|1
1717827|NCT01098240|5996218|P1|Double-Blind Phase|Withdrawal by Subject|0
1717828|NCT01098240|5996216|P3|Double-Blind Phase|Insufficient Clinical Response|2
1717829|NCT01098240|5996217|P2|Double-Blind Phase|Insufficient Clinical Response|1
1717830|NCT01098240|5996218|P1|Double-Blind Phase|Insufficient Clinical Response|0
1717831|NCT01098240|5996216|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
1717832|NCT01098240|5996217|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
1717833|NCT01098240|5996218|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
1717834|NCT01098240|5996216|P3|Double-Blind Phase|Other|2
1717835|NCT01098240|5996217|P2|Double-Blind Phase|Other|2
1717836|NCT01098240|5996218|P1|Double-Blind Phase|Other|0
1717837|NCT01098240|5996216|P3|Double-Blind Phase|Lost to Follow-up|0
1717838|NCT01098240|5996217|P2|Double-Blind Phase|Lost to Follow-up|2
1717839|NCT01098240|5996218|P1|Double-Blind Phase|Lost to Follow-up|0
1717840|NCT01098240|5996216|P3|Double-Blind Phase|Protocol Violation|4
1717841|NCT01098240|5996217|P2|Double-Blind Phase|Protocol Violation|2
1717842|NCT01098240|5996218|P1|Double-Blind Phase|Protocol Violation|0
1717843|NCT01098240|5996216|P3|Double-Blind Phase|Study Terminated by Sponsor|8
1717844|NCT01098240|5996217|P2|Double-Blind Phase|Study Terminated by Sponsor|5
1717845|NCT01098240|5996218|P1|Double-Blind Phase|Study Terminated by Sponsor|0
1717846|NCT01098240|5996216|P3|Open-Label Phase|Adverse Event|0
1717847|NCT01098240|5996217|P2|Open-Label Phase|Adverse Event|0
1717848|NCT01098240|5996218|P1|Open-Label Phase|Adverse Event|12
1717849|NCT01098240|5996216|P3|Open-Label Phase|Withdrawal by Subject|0
1717850|NCT01098240|5996217|P2|Open-Label Phase|Withdrawal by Subject|0
1717851|NCT01098240|5996218|P1|Open-Label Phase|Withdrawal by Subject|9
1717852|NCT01098240|5996216|P3|Open-Label Phase|Pregnancy|0
1717853|NCT01098240|5996217|P2|Open-Label Phase|Pregnancy|0
1717854|NCT01098240|5996218|P1|Open-Label Phase|Pregnancy|1
1717855|NCT01098240|5996216|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
1717856|NCT01098240|5996217|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
1717857|NCT01098240|5996218|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
1717858|NCT01098240|5996216|P3|Open-Label Phase|Other|0
1717859|NCT01098240|5996217|P2|Open-Label Phase|Other|0
1717860|NCT01098240|5996218|P1|Open-Label Phase|Other|19
1717861|NCT01098240|5996216|P3|Open-Label Phase|Lost to Follow-up|0
1717862|NCT01098240|5996217|P2|Open-Label Phase|Lost to Follow-up|0
1717863|NCT01098240|5996218|P1|Open-Label Phase|Lost to Follow-up|13
1717864|NCT01098240|5996216|P3|Open-Label Phase|Protocol Violation|0
1717865|NCT01098240|5996217|P2|Open-Label Phase|Protocol Violation|0
1717866|NCT01098240|5996218|P1|Open-Label Phase|Protocol Violation|4
1717867|NCT01098240|5996216|P3|Open-Label Phase|Study Terminated by Sponsor|0
1717868|NCT01098240|5996217|P2|Open-Label Phase|Study Terminated by Sponsor|0
1717869|NCT01098240|5996218|P1|Open-Label Phase|Study Terminated by Sponsor|27
1717870|NCT01098162|5996248|P1|Overall Study|Reason Unknown|26
1717871|NCT01098162|5996248|P1|Overall Study|Other Reason|1
1717872|NCT01098162|5996248|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
1717873|NCT01098162|5996248|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
1717874|NCT01098162|5996248|P1|Overall Study|Adverse Event & Lost to Follow-up|2
1717875|NCT01098162|5996248|P1|Overall Study|Adverse Event & Wish of Patient|13
1717876|NCT01098162|5996248|P1|Overall Study|Adverse Event & Lack of Efficacy|6
1717877|NCT01098162|5996248|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
1717878|NCT01098162|5996248|P1|Overall Study|Lost to Follow-up|9
1717879|NCT01098162|5996248|P1|Overall Study|Wish of Patient|7
1717880|NCT01098162|5996248|P1|Overall Study|Lack of Efficacy|4
1717881|NCT01098162|5996248|P1|Overall Study|Adverse Event|37
1717882|NCT01098110|5996260|P3|Overall Study|Untreated|0
1717883|NCT01098110|5996261|P2|Overall Study|Untreated|1
1717884|NCT01098110|5996262|P1|Overall Study|Untreated|1
1717885|NCT01098110|5996260|P3|Overall Study|Other|5
1717886|NCT01098110|5996261|P2|Overall Study|Other|7
1717887|NCT01098110|5996262|P1|Overall Study|Other|4
1717888|NCT01098110|5996260|P3|Overall Study|Lack of Efficacy|27
1717889|NCT01098110|5996261|P2|Overall Study|Lack of Efficacy|9
1717890|NCT01098110|5996262|P1|Overall Study|Lack of Efficacy|13
1717891|NCT01098110|5996260|P3|Overall Study|Adverse Event|43
1717892|NCT01098110|5996261|P2|Overall Study|Adverse Event|32
1717893|NCT01098110|5996262|P1|Overall Study|Adverse Event|30
1717894|NCT01098110|5996260|P3|Overall Study|Withdrawal by Subject|19
1717895|NCT01098110|5996261|P2|Overall Study|Withdrawal by Subject|24
1717896|NCT01098110|5996262|P1|Overall Study|Withdrawal by Subject|14
1717897|NCT01098097|5996303|P1|Overall Study|No reason reported|31
1717898|NCT01098097|5996303|P1|Overall Study|Status unknown|16
1717899|NCT01098097|5996303|P1|Overall Study|Lost to Follow-up|18
1717900|NCT01098097|5996303|P1|Overall Study|Adverse Event|17
1717901|NCT01098071|5996312|P1|Overall Study|Lost to Follow-up|13
1717902|NCT01098071|5996312|P1|Overall Study|Surgery (adenoidectomy)|2
1717903|NCT01098032|5996325|P2|Overall Study|Withdrawal by Subject|1
1717904|NCT01098032|5996326|P1|Overall Study|Withdrawal by Subject|1
1717905|NCT01097863|5996443|P3|Overall Study|Did not return for final visit|1
1717906|NCT01097863|5996444|P2|Overall Study|Did not return for final visit|0
1717907|NCT01097863|5996445|P1|Overall Study|Did not return for final visit|0
1717908|NCT01097863|5996443|P3|Overall Study|Discomfort|1
1717909|NCT01097863|5996444|P2|Overall Study|Discomfort|0
1717910|NCT01097863|5996445|P1|Overall Study|Discomfort|1
1717911|NCT01097707|5996469|P5|Overall Study|Reason unknown|1
1717912|NCT01097707|5996470|P4|Overall Study|Reason unknown|0
1717913|NCT01097707|5996471|P3|Overall Study|Reason unknown|0
1717914|NCT01097707|5996472|P2|Overall Study|Reason unknown|0
1717915|NCT01097707|5996473|P1|Overall Study|Reason unknown|0
1717916|NCT01097707|5996469|P5|Overall Study|Withdrawal by Subject|3
1717917|NCT01097707|5996470|P4|Overall Study|Withdrawal by Subject|4
1717918|NCT01097707|5996471|P3|Overall Study|Withdrawal by Subject|1
1717919|NCT01097707|5996472|P2|Overall Study|Withdrawal by Subject|6
1717920|NCT01097707|5996473|P1|Overall Study|Withdrawal by Subject|3
1717921|NCT01097707|5996469|P5|Overall Study|Sponsor Decision|36
1717922|NCT01097707|5996470|P4|Overall Study|Sponsor Decision|35
1717923|NCT01097707|5996471|P3|Overall Study|Sponsor Decision|34
1717924|NCT01097707|5996472|P2|Overall Study|Sponsor Decision|31
1717925|NCT01097707|5996473|P1|Overall Study|Sponsor Decision|31
1717926|NCT01097707|5996469|P5|Overall Study|Protocol Violation|2
1717927|NCT01097707|5996470|P4|Overall Study|Protocol Violation|2
1717928|NCT01097707|5996471|P3|Overall Study|Protocol Violation|3
1717929|NCT01097707|5996472|P2|Overall Study|Protocol Violation|2
1717930|NCT01097707|5996473|P1|Overall Study|Protocol Violation|2
1717931|NCT01097707|5996469|P5|Overall Study|Lost to Follow-up|3
1717932|NCT01097707|5996470|P4|Overall Study|Lost to Follow-up|0
1717933|NCT01097707|5996471|P3|Overall Study|Lost to Follow-up|2
1717934|NCT01097707|5996472|P2|Overall Study|Lost to Follow-up|1
1717935|NCT01097707|5996473|P1|Overall Study|Lost to Follow-up|1
1717936|NCT01097707|5996469|P5|Overall Study|Lack of Efficacy|0
1717937|NCT01097707|5996470|P4|Overall Study|Lack of Efficacy|1
1717938|NCT01097707|5996471|P3|Overall Study|Lack of Efficacy|0
1717939|NCT01097707|5996472|P2|Overall Study|Lack of Efficacy|0
1717940|NCT01097707|5996473|P1|Overall Study|Lack of Efficacy|1
1717941|NCT01097707|5996469|P5|Overall Study|Entry Criteria Not Met|1
1717942|NCT01097707|5996470|P4|Overall Study|Entry Criteria Not Met|0
1717943|NCT01097707|5996471|P3|Overall Study|Entry Criteria Not Met|1
1717944|NCT01097707|5996472|P2|Overall Study|Entry Criteria Not Met|1
1717945|NCT01097707|5996473|P1|Overall Study|Entry Criteria Not Met|2
1717946|NCT01097707|5996469|P5|Overall Study|Adverse Event|3
1717947|NCT01097707|5996470|P4|Overall Study|Adverse Event|1
1717948|NCT01097707|5996471|P3|Overall Study|Adverse Event|3
1717949|NCT01097707|5996472|P2|Overall Study|Adverse Event|2
1717950|NCT01097707|5996473|P1|Overall Study|Adverse Event|4
1717951|NCT01097707|5996469|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1717952|NCT01097707|5996470|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1717953|NCT01097707|5996471|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
1717954|NCT01097707|5996472|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1717955|NCT01097707|5996473|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
1717956|NCT01097694|5996522|P2|Overall Study|Withdrawal by Subject|1
1717957|NCT01097694|5996523|P1|Overall Study|Withdrawal by Subject|3
1717958|NCT01097694|5996522|P2|Overall Study|Lost to Follow-up|3
1717959|NCT01097694|5996523|P1|Overall Study|Lost to Follow-up|0
1717960|NCT01097694|5996522|P2|Overall Study|Adverse Event|0
1717961|NCT01097694|5996523|P1|Overall Study|Adverse Event|5
1717962|NCT01097668|5996585|P2|Overall Study|Lost to Follow-up|0
1717963|NCT01097668|5996586|P1|Overall Study|Lost to Follow-up|1
1717964|NCT01097668|5996585|P2|Overall Study|Withdrawal by Subject|2
1717965|NCT01097668|5996586|P1|Overall Study|Withdrawal by Subject|1
1717966|NCT01097655|5996596|P1|Overall Study|Did Not Meet Inclusion Criteria|8
1717967|NCT01097655|5996596|P1|Overall Study|Subject Documented Twice|1
1717968|NCT01097655|5996596|P1|Overall Study|Withdrawal by Subject|1
1717969|NCT01097629|5996606|P8|DB RO Phase|Lost to Follow-up|0
1717970|NCT01097629|5996607|P7|DB RO Phase|Lost to Follow-up|2
1717971|NCT01097629|5996608|P6|DB RO Phase|Lost to Follow-up|0
1717972|NCT01097629|5996609|P5|DB RO Phase|Lost to Follow-up|0
1717973|NCT01097629|5996610|P4|DB RO Phase|Lost to Follow-up|0
1717974|NCT01097629|5996611|P3|DB RO Phase|Lost to Follow-up|0
1717975|NCT01097629|5996612|P2|DB RO Phase|Lost to Follow-up|0
1717976|NCT01097629|5996613|P1|DB RO Phase|Lost to Follow-up|0
1717977|NCT01097629|5996606|P8|DB RO Phase|Protocol Violation|0
1717978|NCT01097629|5996607|P7|DB RO Phase|Protocol Violation|1
1717979|NCT01097629|5996608|P6|DB RO Phase|Protocol Violation|1
1717980|NCT01097629|5996609|P5|DB RO Phase|Protocol Violation|0
1717981|NCT01097629|5996610|P4|DB RO Phase|Protocol Violation|1
1717982|NCT01097629|5996611|P3|DB RO Phase|Protocol Violation|0
1717983|NCT01097629|5996612|P2|DB RO Phase|Protocol Violation|0
1717984|NCT01097629|5996613|P1|DB RO Phase|Protocol Violation|0
1717985|NCT01097629|5996606|P8|DB RO Phase|Withdrawal by Subject|1
1717986|NCT01097629|5996607|P7|DB RO Phase|Withdrawal by Subject|0
1717987|NCT01097629|5996608|P6|DB RO Phase|Withdrawal by Subject|0
1717988|NCT01097629|5996609|P5|DB RO Phase|Withdrawal by Subject|0
1717989|NCT01097629|5996610|P4|DB RO Phase|Withdrawal by Subject|0
1717990|NCT01097629|5996611|P3|DB RO Phase|Withdrawal by Subject|0
1717991|NCT01097629|5996612|P2|DB RO Phase|Withdrawal by Subject|0
1717992|NCT01097629|5996613|P1|DB RO Phase|Withdrawal by Subject|0
1717993|NCT01097629|5996606|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1717994|NCT01097629|5996607|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1717995|NCT01097629|5996608|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1717996|NCT01097629|5996609|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1717997|NCT01097629|5996610|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1717998|NCT01097629|5996611|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
1717999|NCT01097629|5996612|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
1718000|NCT01097629|5996613|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
1718001|NCT01097629|5996606|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718002|NCT01097629|5996607|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718003|NCT01097629|5996608|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718004|NCT01097629|5996609|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718005|NCT01097629|5996610|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718006|NCT01097629|5996611|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718007|NCT01097629|5996612|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
1718008|NCT01097629|5996613|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
1718009|NCT01097629|5996606|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718010|NCT01097629|5996607|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718011|NCT01097629|5996608|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718012|NCT01097629|5996609|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718013|NCT01097629|5996610|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718014|NCT01097629|5996611|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
1718015|NCT01097629|5996612|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
1718016|NCT01097629|5996613|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
1718017|NCT01097629|5996606|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718018|NCT01097629|5996607|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718019|NCT01097629|5996608|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718020|NCT01097629|5996609|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718021|NCT01097629|5996610|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718022|NCT01097629|5996611|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1718023|NCT01097629|5996612|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
1718024|NCT01097629|5996613|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
1718025|NCT01097629|5996606|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718026|NCT01097629|5996607|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718027|NCT01097629|5996608|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718028|NCT01097629|5996609|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718029|NCT01097629|5996610|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718030|NCT01097629|5996611|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
1718031|NCT01097629|5996612|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
1718032|NCT01097629|5996613|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
1718033|NCT01097629|5996606|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718034|NCT01097629|5996607|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718035|NCT01097629|5996608|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718036|NCT01097629|5996609|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718037|NCT01097629|5996610|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718038|NCT01097629|5996611|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
1718039|NCT01097629|5996612|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
1718040|NCT01097629|5996613|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
1718041|NCT01097629|5996606|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718042|NCT01097629|5996607|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718043|NCT01097629|5996608|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718044|NCT01097629|5996609|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718045|NCT01097629|5996610|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718046|NCT01097629|5996611|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
1718047|NCT01097629|5996612|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
1718048|NCT01097629|5996613|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
1718049|NCT01097616|5996664|P8|DB RO Phase|Not Treated in RO|0
1718050|NCT01097616|5996665|P7|DB RO Phase|Not Treated in RO|0
1718051|NCT01097616|5996666|P6|DB RO Phase|Not Treated in RO|1
1718052|NCT01097616|5996667|P5|DB RO Phase|Not Treated in RO|0
1718053|NCT01097616|5996668|P4|DB RO Phase|Not Treated in RO|0
1718054|NCT01097616|5996669|P3|DB RO Phase|Not Treated in RO|0
1718055|NCT01097616|5996670|P2|DB RO Phase|Not Treated in RO|0
1718056|NCT01097616|5996671|P1|DB RO Phase|Not Treated in RO|0
1718057|NCT01097616|5996664|P8|DB RO Phase|Lost to Follow-up|1
1718058|NCT01097616|5996665|P7|DB RO Phase|Lost to Follow-up|0
1718059|NCT01097616|5996666|P6|DB RO Phase|Lost to Follow-up|0
1718060|NCT01097616|5996667|P5|DB RO Phase|Lost to Follow-up|1
1718061|NCT01097616|5996668|P4|DB RO Phase|Lost to Follow-up|1
1718062|NCT01097616|5996669|P3|DB RO Phase|Lost to Follow-up|0
1718063|NCT01097616|5996670|P2|DB RO Phase|Lost to Follow-up|0
1718064|NCT01097616|5996671|P1|DB RO Phase|Lost to Follow-up|0
1718065|NCT01097616|5996664|P8|DB RO Phase|Withdrawal by Subject|0
1718066|NCT01097616|5996665|P7|DB RO Phase|Withdrawal by Subject|0
1718067|NCT01097616|5996666|P6|DB RO Phase|Withdrawal by Subject|1
1718068|NCT01097616|5996667|P5|DB RO Phase|Withdrawal by Subject|0
1718069|NCT01097616|5996668|P4|DB RO Phase|Withdrawal by Subject|0
1718070|NCT01097616|5996669|P3|DB RO Phase|Withdrawal by Subject|0
1718071|NCT01097616|5996670|P2|DB RO Phase|Withdrawal by Subject|0
1718072|NCT01097616|5996671|P1|DB RO Phase|Withdrawal by Subject|0
1718073|NCT01097616|5996664|P8|DB RO Phase|Adverse Event|0
1718074|NCT01097616|5996665|P7|DB RO Phase|Adverse Event|1
1718075|NCT01097616|5996666|P6|DB RO Phase|Adverse Event|0
1718076|NCT01097616|5996667|P5|DB RO Phase|Adverse Event|0
1718077|NCT01097616|5996668|P4|DB RO Phase|Adverse Event|0
1718078|NCT01097616|5996669|P3|DB RO Phase|Adverse Event|0
1718079|NCT01097616|5996670|P2|DB RO Phase|Adverse Event|0
1718080|NCT01097616|5996671|P1|DB RO Phase|Adverse Event|0
1718081|NCT01097616|5996664|P8|Optional DB EXT Phase|Physician Decision|0
1718082|NCT01097616|5996665|P7|Optional DB EXT Phase|Physician Decision|0
1718083|NCT01097616|5996666|P6|Optional DB EXT Phase|Physician Decision|0
1718084|NCT01097616|5996667|P5|Optional DB EXT Phase|Physician Decision|0
1718085|NCT01097616|5996668|P4|Optional DB EXT Phase|Physician Decision|0
1718086|NCT01097616|5996669|P3|Optional DB EXT Phase|Physician Decision|0
1718087|NCT01097616|5996670|P2|Optional DB EXT Phase|Physician Decision|0
1718088|NCT01097616|5996671|P1|Optional DB EXT Phase|Physician Decision|1
1718089|NCT01097616|5996664|P8|Optional DB EXT Phase|Lack of Efficacy|0
1718090|NCT01097616|5996665|P7|Optional DB EXT Phase|Lack of Efficacy|0
1718091|NCT01097616|5996666|P6|Optional DB EXT Phase|Lack of Efficacy|0
1718092|NCT01097616|5996667|P5|Optional DB EXT Phase|Lack of Efficacy|0
1718093|NCT01097616|5996668|P4|Optional DB EXT Phase|Lack of Efficacy|0
1718094|NCT01097616|5996669|P3|Optional DB EXT Phase|Lack of Efficacy|1
1718095|NCT01097616|5996670|P2|Optional DB EXT Phase|Lack of Efficacy|1
1718096|NCT01097616|5996671|P1|Optional DB EXT Phase|Lack of Efficacy|1
1718097|NCT01097616|5996664|P8|Optional DB EXT Phase|Lost to Follow-up|0
1718098|NCT01097616|5996665|P7|Optional DB EXT Phase|Lost to Follow-up|0
1718099|NCT01097616|5996666|P6|Optional DB EXT Phase|Lost to Follow-up|0
1718100|NCT01097616|5996667|P5|Optional DB EXT Phase|Lost to Follow-up|0
1718101|NCT01097616|5996668|P4|Optional DB EXT Phase|Lost to Follow-up|0
1718102|NCT01097616|5996669|P3|Optional DB EXT Phase|Lost to Follow-up|1
1718103|NCT01097616|5996670|P2|Optional DB EXT Phase|Lost to Follow-up|5
1718104|NCT01097616|5996671|P1|Optional DB EXT Phase|Lost to Follow-up|1
1718105|NCT01097616|5996664|P8|Optional DB EXT Phase|Protocol Violation|0
1718106|NCT01097616|5996665|P7|Optional DB EXT Phase|Protocol Violation|0
1718107|NCT01097616|5996666|P6|Optional DB EXT Phase|Protocol Violation|0
1718108|NCT01097616|5996667|P5|Optional DB EXT Phase|Protocol Violation|0
1718109|NCT01097616|5996668|P4|Optional DB EXT Phase|Protocol Violation|0
1718110|NCT01097616|5996669|P3|Optional DB EXT Phase|Protocol Violation|3
1718111|NCT01097616|5996670|P2|Optional DB EXT Phase|Protocol Violation|2
1718112|NCT01097616|5996671|P1|Optional DB EXT Phase|Protocol Violation|0
1718113|NCT01097616|5996664|P8|Optional DB EXT Phase|Withdrawal by Subject|0
1718114|NCT01097616|5996665|P7|Optional DB EXT Phase|Withdrawal by Subject|0
1718115|NCT01097616|5996666|P6|Optional DB EXT Phase|Withdrawal by Subject|0
1718116|NCT01097616|5996667|P5|Optional DB EXT Phase|Withdrawal by Subject|0
1718117|NCT01097616|5996668|P4|Optional DB EXT Phase|Withdrawal by Subject|0
1718118|NCT01097616|5996669|P3|Optional DB EXT Phase|Withdrawal by Subject|3
1718119|NCT01097616|5996670|P2|Optional DB EXT Phase|Withdrawal by Subject|6
1718120|NCT01097616|5996671|P1|Optional DB EXT Phase|Withdrawal by Subject|12
1718121|NCT01097616|5996664|P8|Optional DB EXT Phase|Adverse Event|0
1718122|NCT01097616|5996665|P7|Optional DB EXT Phase|Adverse Event|0
1718123|NCT01097616|5996666|P6|Optional DB EXT Phase|Adverse Event|0
1718124|NCT01097616|5996667|P5|Optional DB EXT Phase|Adverse Event|0
1718125|NCT01097616|5996668|P4|Optional DB EXT Phase|Adverse Event|0
1718126|NCT01097616|5996669|P3|Optional DB EXT Phase|Adverse Event|2
1718127|NCT01097616|5996670|P2|Optional DB EXT Phase|Adverse Event|7
1718128|NCT01097616|5996671|P1|Optional DB EXT Phase|Adverse Event|0
1718129|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1718130|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1718131|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1718132|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1718133|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1718134|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
1718135|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1718136|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
1718137|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718138|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718139|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718140|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718141|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718142|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
1718143|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
1718144|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
1718145|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1718146|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1718147|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1718148|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1718149|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1718150|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
1718151|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
1718152|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
1718153|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718154|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718155|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718156|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718157|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
1718158|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
1718159|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
1718160|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
1718161|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718162|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718163|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718164|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718165|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718166|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
1718167|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1718168|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
1718169|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718170|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718171|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718172|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718173|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
1718174|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
1718175|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
1718176|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
1718177|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718178|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718179|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718180|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718181|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
1718182|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
1718183|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
1718184|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
1718185|NCT01097616|5996664|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718186|NCT01097616|5996665|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718187|NCT01097616|5996666|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718188|NCT01097616|5996667|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718189|NCT01097616|5996668|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
1718190|NCT01097616|5996669|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
1718191|NCT01097616|5996670|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
1718192|NCT01097616|5996671|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
1718193|NCT01097421|5996746|P1|Overall Study|Withdrawal by Subject|3
1718194|NCT01097421|5996746|P1|Overall Study|Lost to Follow-up|1
1718195|NCT01097421|5996746|P1|Overall Study|Protocol Violation|2
1718196|NCT01097421|5996746|P1|Overall Study|Adverse Event|8
1718197|NCT01097330|5996765|P2|Overall Study|Study terminated early|5
1718198|NCT01097330|5996766|P1|Overall Study|Study terminated early|7
1718199|NCT01097057|5996783|P1|Overall Study|Physician Decision|3
1718200|NCT01097044|5996792|P2|Overall Study|Withdrawal by Sponsor|1
1718201|NCT01097044|5996793|P1|Overall Study|Withdrawal by Sponsor|0
1718202|NCT01097044|5996792|P2|Overall Study|Lost to Follow-up|0
1718203|NCT01097044|5996793|P1|Overall Study|Lost to Follow-up|1
1718204|NCT01097044|5996792|P2|Overall Study|Withdrawal by Subject|4
1718205|NCT01097044|5996793|P1|Overall Study|Withdrawal by Subject|4
1718206|NCT01097005|5996811|P1|Overall Study|Discontinuance by complication|50
1718207|NCT01097005|5996811|P1|Overall Study|Adverse Event|14
1718208|NCT01097005|5996811|P1|Overall Study|Deviation from exclusion criteria|37
1718209|NCT01097005|5996811|P1|Overall Study|No examination data available|244
1718210|NCT01097005|5996811|P1|Overall Study|Poor medication compliance|1
1718211|NCT01097005|5996811|P1|Overall Study|Subjects cannot visit the hospital|1
1718212|NCT01097005|5996811|P1|Overall Study|Case Report Form not collected|18
1718213|NCT01096849|5996857|P3|Overall Study|Lost to Follow-up|1
1718214|NCT01096849|5996858|P2|Overall Study|Lost to Follow-up|3
1718215|NCT01096849|5996859|P1|Overall Study|Lost to Follow-up|1
1718216|NCT01096849|5996857|P3|Overall Study|Administrative Reasons|2
1718217|NCT01096849|5996858|P2|Overall Study|Administrative Reasons|1
1718218|NCT01096849|5996859|P1|Overall Study|Administrative Reasons|0
1718219|NCT01096849|5996857|P3|Overall Study|Investigator or Medical Monitor Decision|0
1718220|NCT01096849|5996858|P2|Overall Study|Investigator or Medical Monitor Decision|1
1718221|NCT01096849|5996859|P1|Overall Study|Investigator or Medical Monitor Decision|0
1718222|NCT01096849|5996857|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
1718223|NCT01096849|5996858|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
1718224|NCT01096849|5996859|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
1718225|NCT01096849|5996857|P3|Overall Study|Lack of Efficacy|0
1718226|NCT01096849|5996858|P2|Overall Study|Lack of Efficacy|2
1718227|NCT01096849|5996859|P1|Overall Study|Lack of Efficacy|0
1718228|NCT01096849|5996857|P3|Overall Study|Consent Withdrawn|2
1718229|NCT01096849|5996858|P2|Overall Study|Consent Withdrawn|4
1718230|NCT01096849|5996859|P1|Overall Study|Consent Withdrawn|1
1718231|NCT01096784|5996935|P2|Overall Study|Other Unspecified|1
1718232|NCT01096784|5996936|P1|Overall Study|Other Unspecified|0
1718233|NCT01096784|5996935|P2|Overall Study|Administrative Decision|1
1718234|NCT01096784|5996936|P1|Overall Study|Administrative Decision|0
1718235|NCT01096784|5996935|P2|Overall Study|Protocol Deviation|2
1718236|NCT01096784|5996936|P1|Overall Study|Protocol Deviation|2
1718237|NCT01096784|5996935|P2|Overall Study|Adverse Event|9
1718238|NCT01096784|5996936|P1|Overall Study|Adverse Event|11
1718239|NCT01096784|5996935|P2|Overall Study|Withdrawal by Subject|1
1718240|NCT01096784|5996936|P1|Overall Study|Withdrawal by Subject|2
1718241|NCT01096667|5997041|P5|Overall Study|Not treated|0
1718242|NCT01096667|5997042|P4|Overall Study|Not treated|0
1718243|NCT01096667|5997043|P3|Overall Study|Not treated|0
1718244|NCT01096667|5997044|P2|Overall Study|Not treated|0
1718245|NCT01096667|5997045|P1|Overall Study|Not treated|1
1718246|NCT01096667|5997041|P5|Overall Study|Protocol Violation|0
1718247|NCT01096667|5997042|P4|Overall Study|Protocol Violation|1
1718248|NCT01096667|5997043|P3|Overall Study|Protocol Violation|0
1718249|NCT01096667|5997044|P2|Overall Study|Protocol Violation|0
1718250|NCT01096667|5997045|P1|Overall Study|Protocol Violation|0
1718251|NCT01096667|5997041|P5|Overall Study|Reason not available|0
1718252|NCT01096667|5997042|P4|Overall Study|Reason not available|1
1718253|NCT01096667|5997043|P3|Overall Study|Reason not available|1
1718254|NCT01096667|5997044|P2|Overall Study|Reason not available|1
1718255|NCT01096667|5997045|P1|Overall Study|Reason not available|0
1718256|NCT01096667|5997041|P5|Overall Study|Withdrawal by Subject|0
1718257|NCT01096667|5997042|P4|Overall Study|Withdrawal by Subject|1
1718258|NCT01096667|5997043|P3|Overall Study|Withdrawal by Subject|0
1718259|NCT01096667|5997044|P2|Overall Study|Withdrawal by Subject|0
1718260|NCT01096667|5997045|P1|Overall Study|Withdrawal by Subject|1
1718261|NCT01096667|5997041|P5|Overall Study|Lost to Follow-up|0
1718262|NCT01096667|5997042|P4|Overall Study|Lost to Follow-up|0
1718263|NCT01096667|5997043|P3|Overall Study|Lost to Follow-up|1
1718264|NCT01096667|5997044|P2|Overall Study|Lost to Follow-up|1
1718265|NCT01096667|5997045|P1|Overall Study|Lost to Follow-up|1
1718266|NCT01096589|5997187|P4|Overall Study|found treatment exhausting|1
1718267|NCT01096589|5997188|P3|Overall Study|found treatment exhausting|0
1718268|NCT01096589|5997189|P2|Overall Study|found treatment exhausting|0
1718269|NCT01096589|5997190|P1|Overall Study|found treatment exhausting|0
1718270|NCT01096589|5997187|P4|Overall Study|Compliance with protocol|0
1718271|NCT01096589|5997188|P3|Overall Study|Compliance with protocol|1
1718272|NCT01096589|5997189|P2|Overall Study|Compliance with protocol|0
1718273|NCT01096589|5997190|P1|Overall Study|Compliance with protocol|0
1718274|NCT01096589|5997187|P4|Overall Study|Withdrawal by Subject|1
1718275|NCT01096589|5997188|P3|Overall Study|Withdrawal by Subject|1
1718276|NCT01096589|5997189|P2|Overall Study|Withdrawal by Subject|1
1718277|NCT01096589|5997190|P1|Overall Study|Withdrawal by Subject|2
1718278|NCT01096589|5997187|P4|Overall Study|Adverse Event|1
1718279|NCT01096589|5997188|P3|Overall Study|Adverse Event|2
1718280|NCT01096589|5997189|P2|Overall Study|Adverse Event|1
1718281|NCT01096589|5997190|P1|Overall Study|Adverse Event|2
1718294|NCT01096446|5997215|P2|Overall Study|Protocol Violation|0
1718295|NCT01096446|5997216|P1|Overall Study|Protocol Violation|2
1718296|NCT01096446|5997215|P2|Overall Study|Death|0
1718297|NCT01096446|5997216|P1|Overall Study|Death|1
1718298|NCT01096342|5997221|P1|Overall Study|Protocol Violation|1
1718299|NCT01096316|5997229|P2|Overall Study|Lost to Follow-up|9
1718300|NCT01096316|5997230|P1|Overall Study|Lost to Follow-up|15
1718301|NCT01096186|5997240|P1|Overall Study|Noncompliance with study drug|1
1718302|NCT01096186|5997240|P1|Overall Study|Physician Decision|1
1718303|NCT01096186|5997240|P1|Overall Study|Withdrawal by Subject|22
1718304|NCT01096186|5997240|P1|Overall Study|Lost to Follow-up|2
1718305|NCT01096186|5997240|P1|Overall Study|Lack of Efficacy|4
1718306|NCT01096186|5997240|P1|Overall Study|Death|4
1718307|NCT01096186|5997240|P1|Overall Study|Adverse Event|16
1718308|NCT01096160|5997256|P10|Overall Study|Met stopping criteria per protocol|0
1718309|NCT01096160|5997257|P9|Overall Study|Met stopping criteria per protocol|2
1718310|NCT01096160|5997258|P8|Overall Study|Met stopping criteria per protocol|0
1718311|NCT01096160|5997259|P7|Overall Study|Met stopping criteria per protocol|2
1718312|NCT01096160|5997260|P6|Overall Study|Met stopping criteria per protocol|0
1718313|NCT01096160|5997261|P5|Overall Study|Met stopping criteria per protocol|1
1718314|NCT01096160|5997262|P4|Overall Study|Met stopping criteria per protocol|0
1718315|NCT01096160|5997263|P3|Overall Study|Met stopping criteria per protocol|0
1718316|NCT01096160|5997264|P2|Overall Study|Met stopping criteria per protocol|0
1718317|NCT01096160|5997265|P1|Overall Study|Met stopping criteria per protocol|0
1718318|NCT01096160|5997256|P10|Overall Study|Adverse Event|1
1718319|NCT01096160|5997257|P9|Overall Study|Adverse Event|0
1718320|NCT01096160|5997258|P8|Overall Study|Adverse Event|0
1718321|NCT01096160|5997259|P7|Overall Study|Adverse Event|0
1718322|NCT01096160|5997260|P6|Overall Study|Adverse Event|0
1718323|NCT01096160|5997261|P5|Overall Study|Adverse Event|0
1718324|NCT01096160|5997262|P4|Overall Study|Adverse Event|0
1718325|NCT01096160|5997263|P3|Overall Study|Adverse Event|1
1718326|NCT01096160|5997264|P2|Overall Study|Adverse Event|0
1718327|NCT01096160|5997265|P1|Overall Study|Adverse Event|0
1718328|NCT01096056|5997323|P2|Overall Study|Lost to Follow-up|1
1718329|NCT01096056|5997324|P1|Overall Study|Lost to Follow-up|0
1718330|NCT01096017|5997356|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
1718331|NCT01096017|5997357|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
1718332|NCT01095978|5997385|P1|Overall Study|Adverse Event|1
1718333|NCT01095978|5997385|P1|Overall Study|Did not take Klacid SR|2
1718334|NCT01095835|5997419|P3|Overall Study|Protocol Violation|0
1718335|NCT01095835|5997420|P2|Overall Study|Protocol Violation|2
1718336|NCT01095835|5997421|P1|Overall Study|Protocol Violation|1
1718337|NCT01095835|5997419|P3|Overall Study|Non study compliance|1
1718338|NCT01095835|5997420|P2|Overall Study|Non study compliance|0
1718339|NCT01095835|5997421|P1|Overall Study|Non study compliance|0
1718340|NCT01095835|5997419|P3|Overall Study|Withdrawal by Subject|0
1718341|NCT01095835|5997420|P2|Overall Study|Withdrawal by Subject|3
1718342|NCT01095835|5997421|P1|Overall Study|Withdrawal by Subject|1
1718343|NCT01095835|5997419|P3|Overall Study|Physician Decision|1
1718344|NCT01095835|5997420|P2|Overall Study|Physician Decision|0
1718345|NCT01095835|5997421|P1|Overall Study|Physician Decision|0
1718346|NCT01095835|5997419|P3|Overall Study|Lack of Efficacy|0
1718347|NCT01095835|5997420|P2|Overall Study|Lack of Efficacy|1
1718348|NCT01095835|5997421|P1|Overall Study|Lack of Efficacy|0
1718349|NCT01095835|5997419|P3|Overall Study|Adverse Event|6
1718350|NCT01095835|5997420|P2|Overall Study|Adverse Event|6
1718351|NCT01095835|5997421|P1|Overall Study|Adverse Event|8
1718352|NCT01095796|5997459|P2|Overall Study|Participant Transferred to Another Study|200
1718353|NCT01095796|5997460|P1|Overall Study|Participant Transferred to Another Study|215
1718354|NCT01095796|5997459|P2|Overall Study|Protocol Violation|0
1718355|NCT01095796|5997460|P1|Overall Study|Protocol Violation|1
1718356|NCT01095796|5997459|P2|Overall Study|Participant Noncompliance|10
1718357|NCT01095796|5997460|P1|Overall Study|Participant Noncompliance|5
1718358|NCT01095796|5997459|P2|Overall Study|Lost to Follow-up|29
1718359|NCT01095796|5997460|P1|Overall Study|Lost to Follow-up|27
1718360|NCT01095796|5997459|P2|Overall Study|Withdrew Consent|22
1718361|NCT01095796|5997460|P1|Overall Study|Withdrew Consent|16
1718362|NCT01095796|5997459|P2|Overall Study|Investigator's Discretion|2
1718363|NCT01095796|5997460|P1|Overall Study|Investigator's Discretion|7
1718364|NCT01095796|5997459|P2|Overall Study|Lack of Efficacy|3
1718365|NCT01095796|5997460|P1|Overall Study|Lack of Efficacy|5
1718366|NCT01095796|5997459|P2|Overall Study|Pregnancy|0
1718367|NCT01095796|5997460|P1|Overall Study|Pregnancy|2
1718368|NCT01095796|5997459|P2|Overall Study|Death|2
1718369|NCT01095796|5997460|P1|Overall Study|Death|3
1718370|NCT01095796|5997459|P2|Overall Study|Adverse Event|19
1718371|NCT01095796|5997460|P1|Overall Study|Adverse Event|9
1718372|NCT01095796|5997459|P2|Overall Study|Randomized but Not Treated|2
1718373|NCT01095796|5997460|P1|Overall Study|Randomized but Not Treated|5
1718374|NCT01095666|5997490|P3|Overall Study|Non-compliance, not met criteria etc.|2
1718375|NCT01095666|5997491|P2|Overall Study|Non-compliance, not met criteria etc.|2
1718376|NCT01095666|5997492|P1|Overall Study|Non-compliance, not met criteria etc.|7
1718377|NCT01095666|5997490|P3|Overall Study|Withdrawal by Subject|1
1718378|NCT01095666|5997491|P2|Overall Study|Withdrawal by Subject|6
1718379|NCT01095666|5997492|P1|Overall Study|Withdrawal by Subject|6
1718380|NCT01095666|5997490|P3|Overall Study|Lost to Follow-up|0
1718381|NCT01095666|5997491|P2|Overall Study|Lost to Follow-up|2
1718382|NCT01095666|5997492|P1|Overall Study|Lost to Follow-up|2
1718383|NCT01095666|5997490|P3|Overall Study|Adverse Event|3
1718384|NCT01095666|5997491|P2|Overall Study|Adverse Event|1
1718385|NCT01095666|5997492|P1|Overall Study|Adverse Event|2
1718386|NCT01095666|5997490|P3|Overall Study|Lack of Efficacy|1
1718387|NCT01095666|5997491|P2|Overall Study|Lack of Efficacy|0
1718388|NCT01095666|5997492|P1|Overall Study|Lack of Efficacy|0
1718389|NCT01095653|5997515|P3|Overall Study|non-compliance, not met criteria, etc.|5
1718390|NCT01095653|5997516|P2|Overall Study|non-compliance, not met criteria, etc.|6
1718391|NCT01095653|5997517|P1|Overall Study|non-compliance, not met criteria, etc.|10
1718392|NCT01095653|5997515|P3|Overall Study|Withdrawal by Subject|3
1718393|NCT01095653|5997516|P2|Overall Study|Withdrawal by Subject|5
1718394|NCT01095653|5997517|P1|Overall Study|Withdrawal by Subject|4
1718395|NCT01095653|5997515|P3|Overall Study|Lost to Follow-up|4
1718396|NCT01095653|5997516|P2|Overall Study|Lost to Follow-up|0
1718397|NCT01095653|5997517|P1|Overall Study|Lost to Follow-up|1
1718398|NCT01095653|5997515|P3|Overall Study|Adverse Event|4
1718399|NCT01095653|5997516|P2|Overall Study|Adverse Event|4
1718400|NCT01095653|5997517|P1|Overall Study|Adverse Event|1
1718401|NCT01095653|5997515|P3|Overall Study|Lack of Efficacy|0
1718402|NCT01095653|5997516|P2|Overall Study|Lack of Efficacy|0
1718403|NCT01095653|5997517|P1|Overall Study|Lack of Efficacy|3
1718404|NCT01095250|5997575|P4|Overall Study|Withdrawal by Subject|0
1718405|NCT01095250|5997576|P3|Overall Study|Withdrawal by Subject|1
1718406|NCT01095250|5997577|P2|Overall Study|Withdrawal by Subject|0
1718407|NCT01095250|5997578|P1|Overall Study|Withdrawal by Subject|0
1718408|NCT01095250|5997575|P4|Overall Study|administrative reasons|5
1718409|NCT01095250|5997576|P3|Overall Study|administrative reasons|7
1718410|NCT01095250|5997577|P2|Overall Study|administrative reasons|10
1718411|NCT01095250|5997578|P1|Overall Study|administrative reasons|8
1718412|NCT01095094|5997608|P1|Overall Study|Physician Decision|1
1718413|NCT01095094|5997608|P1|Overall Study|Death|1
1718414|NCT01095094|5997608|P1|Overall Study|Withdrawal by Subject|1
1718415|NCT01094886|5997630|P1|Overall Study|Withdrawal by Subject|5
1718416|NCT01094886|5997630|P1|Overall Study|Adverse Event|2
1718417|NCT01094808|5997640|P3|Overall Study|Withdrawal by Subject|0
1718418|NCT01094808|5997641|P2|Overall Study|Withdrawal by Subject|1
1718419|NCT01094808|5997642|P1|Overall Study|Withdrawal by Subject|1
1718486|NCT01094743|5997732|P1|Period 1|Unsatisfactory comfort at lens fitting|2
1718487|NCT01094730|5997749|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
1718488|NCT01094730|5997750|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
1718489|NCT01094730|5997749|P2|Period 2 (14 Days)|Adverse Event|1
1718490|NCT01094730|5997750|P1|Period 2 (14 Days)|Adverse Event|0
1718491|NCT01094730|5997749|P2|Period 2 (14 Days)|No time for the follow-up visit|0
1718492|NCT01094730|5997750|P1|Period 2 (14 Days)|No time for the follow-up visit|1
1718493|NCT01094730|5997749|P2|Period 2 (14 Days)|Protocol Violation|0
1718494|NCT01094730|5997750|P1|Period 2 (14 Days)|Protocol Violation|2
1718495|NCT01094730|5997749|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
1718496|NCT01094730|5997750|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
1718497|NCT01094730|5997749|P2|Period 1 (14 Days)|No time for the follow-up visit|0
1718498|NCT01094730|5997750|P1|Period 1 (14 Days)|No time for the follow-up visit|1
1718499|NCT01094730|5997749|P2|Period 1 (14 Days)|Withdrawal by Subject|1
1718500|NCT01094730|5997750|P1|Period 1 (14 Days)|Withdrawal by Subject|0
1718501|NCT01094730|5997749|P2|Period 1 (14 Days)|Lost to Follow-up|1
1718502|NCT01094730|5997750|P1|Period 1 (14 Days)|Lost to Follow-up|0
1718503|NCT01094301|5997886|P1|Implant Stage|No return of pain|4
1718504|NCT01094301|5997886|P1|Implant Stage|Withdrawal by Subject|2
1718505|NCT01094301|5997886|P1|Implant Stage|Protocol Violation|1
1718506|NCT01094301|5997886|P1|Implant Stage|Adverse Event|1
1718507|NCT01094301|5997886|P1|Trial Stage|Withdrawal by Subject|1
1718508|NCT01094288|5997916|P8|Overall Study|Ongoing Participants|0
1718509|NCT01094288|5997917|P7|Overall Study|Ongoing Participants|0
1718510|NCT01094288|5997918|P6|Overall Study|Ongoing Participants|0
1718511|NCT01094288|5997919|P5|Overall Study|Ongoing Participants|0
1718512|NCT01094288|5997920|P4|Overall Study|Ongoing Participants|0
1718513|NCT01094288|5997921|P3|Overall Study|Ongoing Participants|0
1718514|NCT01094288|5997922|P2|Overall Study|Ongoing Participants|3
1718515|NCT01094288|5997923|P1|Overall Study|Ongoing Participants|0
1718516|NCT01094288|5997916|P8|Overall Study|Reason not Specified|0
1718517|NCT01094288|5997917|P7|Overall Study|Reason not Specified|0
1718518|NCT01094288|5997918|P6|Overall Study|Reason not Specified|0
1718519|NCT01094288|5997919|P5|Overall Study|Reason not Specified|0
1718520|NCT01094288|5997920|P4|Overall Study|Reason not Specified|1
1718521|NCT01094288|5997921|P3|Overall Study|Reason not Specified|0
1718522|NCT01094288|5997922|P2|Overall Study|Reason not Specified|3
1718523|NCT01094288|5997923|P1|Overall Study|Reason not Specified|2
1718524|NCT01094288|5997916|P8|Overall Study|Initiation of Alternative Therapy|0
1718525|NCT01094288|5997917|P7|Overall Study|Initiation of Alternative Therapy|0
1718526|NCT01094288|5997918|P6|Overall Study|Initiation of Alternative Therapy|0
1718527|NCT01094288|5997919|P5|Overall Study|Initiation of Alternative Therapy|0
1718528|NCT01094288|5997920|P4|Overall Study|Initiation of Alternative Therapy|0
1718529|NCT01094288|5997921|P3|Overall Study|Initiation of Alternative Therapy|1
1718530|NCT01094288|5997922|P2|Overall Study|Initiation of Alternative Therapy|0
1718531|NCT01094288|5997923|P1|Overall Study|Initiation of Alternative Therapy|0
1718532|NCT01094288|5997916|P8|Overall Study|Withdrawal by Subject|2
1718533|NCT01094288|5997917|P7|Overall Study|Withdrawal by Subject|0
1718534|NCT01094288|5997918|P6|Overall Study|Withdrawal by Subject|0
1718535|NCT01094288|5997919|P5|Overall Study|Withdrawal by Subject|0
1718536|NCT01094288|5997920|P4|Overall Study|Withdrawal by Subject|0
1718537|NCT01094288|5997921|P3|Overall Study|Withdrawal by Subject|2
1718538|NCT01094288|5997922|P2|Overall Study|Withdrawal by Subject|1
1718539|NCT01094288|5997923|P1|Overall Study|Withdrawal by Subject|0
1718540|NCT01094288|5997916|P8|Overall Study|Adverse Event|0
1718541|NCT01094288|5997917|P7|Overall Study|Adverse Event|0
1718542|NCT01094288|5997918|P6|Overall Study|Adverse Event|0
1718543|NCT01094288|5997919|P5|Overall Study|Adverse Event|0
1718544|NCT01094288|5997920|P4|Overall Study|Adverse Event|1
1718545|NCT01094288|5997921|P3|Overall Study|Adverse Event|1
1718546|NCT01094288|5997922|P2|Overall Study|Adverse Event|3
1718547|NCT01094288|5997923|P1|Overall Study|Adverse Event|0
1718548|NCT01094184|5998035|P2|Overall Study|Death|11
1718549|NCT01094184|5998036|P1|Overall Study|Death|35
1718550|NCT01094171|5998270|P1|Overall Study|Other|1
1718551|NCT01094171|5998270|P1|Overall Study|Migration from the study area|3
1718552|NCT01094171|5998270|P1|Overall Study|Informed consent withdrawal|4
1718553|NCT01094171|5998270|P1|Overall Study|Lost to Follow-up|2
1718554|NCT01094119|5998279|P2|Overall Study|Lack of Efficacy|4
1718555|NCT01094119|5998280|P1|Overall Study|Lack of Efficacy|2
1718556|NCT01093885|5998292|P1|Overall Study|Lost to Follow-up|1
1718557|NCT01093885|5998292|P1|Overall Study|Adverse Event|4
1718558|NCT01093846|5998300|P3|Overall Study|Administrative Problems|15
1718559|NCT01093846|5998301|P2|Overall Study|Administrative Problems|17
1718560|NCT01093846|5998302|P1|Overall Study|Administrative Problems|18
1718561|NCT01093846|5998300|P3|Overall Study|Condition no longer required study drug|1
1718562|NCT01093846|5998301|P2|Overall Study|Condition no longer required study drug|1
1718563|NCT01093846|5998302|P1|Overall Study|Condition no longer required study drug|1
1718564|NCT01093846|5998300|P3|Overall Study|Lack of Efficacy|4
1718565|NCT01093846|5998301|P2|Overall Study|Lack of Efficacy|0
1718566|NCT01093846|5998302|P1|Overall Study|Lack of Efficacy|0
1718567|NCT01093846|5998300|P3|Overall Study|Adverse Event|1
1718568|NCT01093846|5998301|P2|Overall Study|Adverse Event|0
1718569|NCT01093846|5998302|P1|Overall Study|Adverse Event|0
1718570|NCT01093755|5998327|P2|Overall Study|Withdrawal by Subject|4
1718571|NCT01093755|5998328|P1|Overall Study|Withdrawal by Subject|3
1718572|NCT01093625|5998368|P2|1-Year Visit|Lost to Follow-up|3
1718573|NCT01093625|5998369|P1|1-Year Visit|Lost to Follow-up|5
1718574|NCT01093625|5998368|P2|6-Month Visit|Lost to Follow-up|2
1718575|NCT01093625|5998369|P1|6-Month Visit|Lost to Follow-up|2
1718576|NCT01093625|5998368|P2|6-Month Visit|Withdrawal by Subject|7
1718577|NCT01093625|5998369|P1|6-Month Visit|Withdrawal by Subject|6
1718578|NCT01093625|5998368|P2|3-Month Visit|Lost to Follow-up|0
1718579|NCT01093625|5998369|P1|3-Month Visit|Lost to Follow-up|2
1718580|NCT01093625|5998368|P2|1-Month Visit|Lost to Follow-up|0
1718581|NCT01093625|5998369|P1|1-Month Visit|Lost to Follow-up|2
1718582|NCT01093625|5998368|P2|2-Week Visit|Withdrawal by Subject|0
1718583|NCT01093625|5998369|P1|2-Week Visit|Withdrawal by Subject|1
1718584|NCT01093625|5998368|P2|Baseline and Dispensed|Withdrawal by Subject|0
1718585|NCT01093625|5998369|P1|Baseline and Dispensed|Withdrawal by Subject|2
1718586|NCT01093599|5998389|P2|Overall Study|Lost to Follow-up|46
1718587|NCT01093599|5998390|P1|Overall Study|Lost to Follow-up|32
1718588|NCT01093586|5998396|P1|Overall Study|Failed to engraft|3
1718589|NCT01093534|5998417|P3|Overall Study|Other|4
1718590|NCT01093534|5998418|P2|Overall Study|Other|3
1718591|NCT01093534|5998419|P1|Overall Study|Other|1
1718592|NCT01093534|5998417|P3|Overall Study|Withdrawal by Subject|2
1718593|NCT01093534|5998418|P2|Overall Study|Withdrawal by Subject|7
1718594|NCT01093534|5998419|P1|Overall Study|Withdrawal by Subject|5
1718595|NCT01093534|5998417|P3|Overall Study|Lack of Efficacy|1
1718596|NCT01093534|5998418|P2|Overall Study|Lack of Efficacy|1
1718597|NCT01093534|5998419|P1|Overall Study|Lack of Efficacy|2
1718598|NCT01093534|5998417|P3|Overall Study|Adverse Event|2
1718599|NCT01093534|5998418|P2|Overall Study|Adverse Event|5
1718600|NCT01093534|5998419|P1|Overall Study|Adverse Event|2
1718601|NCT01093222|5998567|P1|Overall Study|Not protocol specified|1
1718602|NCT01093222|5998567|P1|Overall Study|Death|2
1718603|NCT01093222|5998567|P1|Overall Study|Progression/relapse|24
1718604|NCT01093222|5998567|P1|Overall Study|Adverse Event|7
1718605|NCT01093222|5998567|P1|Overall Study|Ineligible|6
1718606|NCT01092832|5998643|P2|Overall Study|Other|0
1718607|NCT01092832|5998644|P1|Overall Study|Other|1
1718608|NCT01092780|5998656|P4|Washout Period 2|Adverse Event|0
1718609|NCT01092780|5998657|P3|Washout Period 2|Adverse Event|1
1718610|NCT01092780|5998658|P2|Washout Period 2|Adverse Event|1
1718611|NCT01092780|5998659|P1|Washout Period 2|Adverse Event|0
1718612|NCT01092780|5998656|P4|Washout Period 1|Noncompliance with nCPAP|0
1718613|NCT01092780|5998657|P3|Washout Period 1|Noncompliance with nCPAP|0
1718614|NCT01092780|5998658|P2|Washout Period 1|Noncompliance with nCPAP|0
1718615|NCT01092780|5998659|P1|Washout Period 1|Noncompliance with nCPAP|1
1718616|NCT01092780|5998656|P4|Washout Period 1|Adverse Event|0
1718617|NCT01092780|5998657|P3|Washout Period 1|Adverse Event|0
1718618|NCT01092780|5998658|P2|Washout Period 1|Adverse Event|1
1718619|NCT01092780|5998659|P1|Washout Period 1|Adverse Event|0
1718620|NCT01092728|5998695|P2|Overall Study|Prohibited Concomitant Medications|0
1718621|NCT01092728|5998696|P1|Overall Study|Prohibited Concomitant Medications|1
1718622|NCT01092728|5998695|P2|Overall Study|Disease Progression|13
1718623|NCT01092728|5998696|P1|Overall Study|Disease Progression|1
1718624|NCT01092728|5998695|P2|Overall Study|Adverse Event|1
1718625|NCT01092728|5998696|P1|Overall Study|Adverse Event|0
1718626|NCT01092728|5998695|P2|Overall Study|Withdrawal by Subject|0
1718627|NCT01092728|5998696|P1|Overall Study|Withdrawal by Subject|2
1718628|NCT01092702|5998704|P1|Overall Study|Lost to Follow-up|2
1718629|NCT01092702|5998704|P1|Overall Study|Withdrawal by Subject|7
1718630|NCT01092663|5998721|P2|Overall Study|Protocol Violation|1
1718631|NCT01092663|5998722|P1|Overall Study|Protocol Violation|0
1718632|NCT01092663|5998721|P2|Overall Study|Adverse Event|1
1718633|NCT01092663|5998722|P1|Overall Study|Adverse Event|1
1718634|NCT01092663|5998721|P2|Overall Study|High fasting triglyceride|0
1718635|NCT01092663|5998722|P1|Overall Study|High fasting triglyceride|2
1718636|NCT01092663|5998721|P2|Overall Study|Glucose >300mg/dL|0
1718637|NCT01092663|5998722|P1|Overall Study|Glucose >300mg/dL|1
1718638|NCT01092663|5998721|P2|Overall Study|Withdrawal by Subject|2
1718639|NCT01092663|5998722|P1|Overall Study|Withdrawal by Subject|3
1718640|NCT01092637|5998770|P2|Overall Study|Death|49
1718641|NCT01092637|5998771|P1|Overall Study|Death|47
1718642|NCT01092546|5998786|P1|Overall Study|Subjects withdrawn prior to dosing|4
1718643|NCT01092507|5998793|P2|Overall Study|Withdrawal by Subject|0
1718644|NCT01092507|5998794|P1|Overall Study|Withdrawal by Subject|2
1718645|NCT01092416|5998829|P1|12-Month Follow-up|Data collected after close of 1Y window|2
1718646|NCT01092416|5998829|P1|12-Month Follow-up|Missed 1-year follow-up|1
1718647|NCT01092416|5998829|P1|12-Month Follow-up|Withdrawal by Subject|2
1718648|NCT01092416|5998829|P1|12-Month Follow-up|Lost to Follow-up|4
1718649|NCT01092416|5998829|P1|12-Month Follow-up|Death|16
1718650|NCT01092416|5998829|P1|30-Day Follow-up|Data collected after close of 30D window|5
1718651|NCT01092416|5998829|P1|30-Day Follow-up|Missed 30-day follow-up|3
1718652|NCT01092416|5998829|P1|30-Day Follow-up|Death|2
1718653|NCT01092416|5998829|P1|Enrollment|Atherectomy device not inserted|3
1718654|NCT01091974|5998879|P4|Overall Study|side-effects|2
1718655|NCT01091974|5998880|P3|Overall Study|side-effects|0
1718656|NCT01091974|5998881|P2|Overall Study|side-effects|1
1718657|NCT01091974|5998882|P1|Overall Study|side-effects|1
1718658|NCT01091974|5998879|P4|Overall Study|Withdrawal by Subject|2
1718659|NCT01091974|5998880|P3|Overall Study|Withdrawal by Subject|2
1718660|NCT01091974|5998881|P2|Overall Study|Withdrawal by Subject|3
1718661|NCT01091974|5998882|P1|Overall Study|Withdrawal by Subject|1
1718662|NCT01091974|5998879|P4|Overall Study|resumed sleep medication|2
1718663|NCT01091974|5998880|P3|Overall Study|resumed sleep medication|1
1718664|NCT01091974|5998881|P2|Overall Study|resumed sleep medication|0
1718665|NCT01091974|5998882|P1|Overall Study|resumed sleep medication|0
1718666|NCT01091974|5998879|P4|Overall Study|Did not start intervention|1
1718667|NCT01091974|5998880|P3|Overall Study|Did not start intervention|3
1718668|NCT01091974|5998881|P2|Overall Study|Did not start intervention|1
1718669|NCT01091974|5998882|P1|Overall Study|Did not start intervention|3
1718670|NCT01091675|5998917|P1|Overall Study|Lack of Efficacy|27
1718671|NCT01091675|5998917|P1|Overall Study|Adverse Event|7
1718672|NCT01091662|5998923|P2|Overall Study|unable to swallow capsule|1
1718673|NCT01091662|5998924|P1|Overall Study|unable to swallow capsule|0
1718674|NCT01091662|5998923|P2|Overall Study|Protocol Violation|2
1718675|NCT01091662|5998924|P1|Overall Study|Protocol Violation|0
1718676|NCT01091662|5998923|P2|Overall Study|Pregnancy|1
1718677|NCT01091662|5998924|P1|Overall Study|Pregnancy|0
1718678|NCT01091662|5998923|P2|Overall Study|Lost to Follow-up|1
1718679|NCT01091662|5998924|P1|Overall Study|Lost to Follow-up|0
1718680|NCT01091662|5998923|P2|Overall Study|met exclusion criteria|0
1718681|NCT01091662|5998924|P1|Overall Study|met exclusion criteria|1
1718682|NCT01091662|5998923|P2|Overall Study|met exit criteria|13
1718683|NCT01091662|5998924|P1|Overall Study|met exit criteria|7
1718684|NCT01091662|5998923|P2|Overall Study|Withdrawal by Subject|6
1718685|NCT01091662|5998924|P1|Overall Study|Withdrawal by Subject|7
1718686|NCT01091662|5998923|P2|Overall Study|Physician Decision|1
1718687|NCT01091662|5998924|P1|Overall Study|Physician Decision|1
1718688|NCT01091662|5998923|P2|Overall Study|Adverse Event|9
1718689|NCT01091662|5998924|P1|Overall Study|Adverse Event|1
1718690|NCT01091519|5998962|P2|Overall Study|Randomized not treated|4
1718691|NCT01091519|5998963|P1|Overall Study|Randomized not treated|4
1718692|NCT01091519|5998962|P2|Overall Study|Other|8
1718693|NCT01091519|5998963|P1|Overall Study|Other|6
1718694|NCT01091519|5998962|P2|Overall Study|Withdrawal by Subject|2
1718695|NCT01091519|5998963|P1|Overall Study|Withdrawal by Subject|2
1718696|NCT01091519|5998962|P2|Overall Study|Lost to Follow-up|24
1718697|NCT01091519|5998963|P1|Overall Study|Lost to Follow-up|14
1718698|NCT01091519|5998962|P2|Overall Study|Lack of Efficacy|19
1718699|NCT01091519|5998963|P1|Overall Study|Lack of Efficacy|16
1718700|NCT01091519|5998962|P2|Overall Study|Death|0
1718701|NCT01091519|5998963|P1|Overall Study|Death|1
1718702|NCT01091519|5998962|P2|Overall Study|Adverse Event|16
1718703|NCT01091519|5998963|P1|Overall Study|Adverse Event|12
1718704|NCT01091454|5998975|P1|Overall Study|Ineligible|1
1718705|NCT01091428|5998988|P4|Phase 2|Physician Decision|0
1718706|NCT01091428|5998989|P3|Phase 2|Physician Decision|2
1718707|NCT01091428|5998990|P2|Phase 2|Physician Decision|0
1718708|NCT01091428|5998991|P1|Phase 2|Physician Decision|0
1718709|NCT01091428|5998988|P4|Phase 2|Reason not specified|3
1718710|NCT01091428|5998989|P3|Phase 2|Reason not specified|4
1718711|NCT01091428|5998990|P2|Phase 2|Reason not specified|0
1718712|NCT01091428|5998991|P1|Phase 2|Reason not specified|0
1718713|NCT01091428|5998988|P4|Phase 2|Unsatisfactory Therapeutic Response|1
1718714|NCT01091428|5998989|P3|Phase 2|Unsatisfactory Therapeutic Response|1
1718715|NCT01091428|5998990|P2|Phase 2|Unsatisfactory Therapeutic Response|0
1718716|NCT01091428|5998991|P1|Phase 2|Unsatisfactory Therapeutic Response|0
1718717|NCT01091428|5998988|P4|Phase 2|Withdrawal by Subject|8
1718718|NCT01091428|5998989|P3|Phase 2|Withdrawal by Subject|9
1718719|NCT01091428|5998990|P2|Phase 2|Withdrawal by Subject|0
1718720|NCT01091428|5998991|P1|Phase 2|Withdrawal by Subject|0
1718721|NCT01091428|5998988|P4|Phase 2|Adverse Event|5
1718722|NCT01091428|5998989|P3|Phase 2|Adverse Event|12
1718723|NCT01091428|5998990|P2|Phase 2|Adverse Event|0
1718724|NCT01091428|5998991|P1|Phase 2|Adverse Event|0
1718725|NCT01091428|5998988|P4|Phase 2|Symptomatic Deterioration|6
1718726|NCT01091428|5998989|P3|Phase 2|Symptomatic Deterioration|1
1718727|NCT01091428|5998990|P2|Phase 2|Symptomatic Deterioration|0
1718728|NCT01091428|5998991|P1|Phase 2|Symptomatic Deterioration|0
1718729|NCT01091428|5998988|P4|Phase 2|Progressive Disease|46
1718730|NCT01091428|5998989|P3|Phase 2|Progressive Disease|44
1718731|NCT01091428|5998990|P2|Phase 2|Progressive Disease|0
1718732|NCT01091428|5998991|P1|Phase 2|Progressive Disease|0
1718733|NCT01091428|5998988|P4|Phase 1|Single-Patient IND|0
1718734|NCT01091428|5998989|P3|Phase 1|Single-Patient IND|0
1718735|NCT01091428|5998990|P2|Phase 1|Single-Patient IND|0
1718736|NCT01091428|5998991|P1|Phase 1|Single-Patient IND|2
1718737|NCT01091428|5998988|P4|Phase 1|Reason not specified|0
1718738|NCT01091428|5998989|P3|Phase 1|Reason not specified|0
1718739|NCT01091428|5998990|P2|Phase 1|Reason not specified|1
1718740|NCT01091428|5998991|P1|Phase 1|Reason not specified|0
1718741|NCT01091428|5998988|P4|Phase 1|Withdrawal by Subject|0
1718742|NCT01091428|5998989|P3|Phase 1|Withdrawal by Subject|0
1718743|NCT01091428|5998990|P2|Phase 1|Withdrawal by Subject|0
1718744|NCT01091428|5998991|P1|Phase 1|Withdrawal by Subject|7
1718745|NCT01091428|5998988|P4|Phase 1|Adverse Event|0
1718746|NCT01091428|5998989|P3|Phase 1|Adverse Event|0
1718747|NCT01091428|5998990|P2|Phase 1|Adverse Event|0
1718748|NCT01091428|5998991|P1|Phase 1|Adverse Event|2
1718749|NCT01091428|5998988|P4|Phase 1|Symptomatic Deterioration|0
1718750|NCT01091428|5998989|P3|Phase 1|Symptomatic Deterioration|0
1718751|NCT01091428|5998990|P2|Phase 1|Symptomatic Deterioration|2
1718752|NCT01091428|5998991|P1|Phase 1|Symptomatic Deterioration|3
1718753|NCT01091428|5998988|P4|Phase 1|Progressive Disease|0
1718754|NCT01091428|5998989|P3|Phase 1|Progressive Disease|0
1718755|NCT01091428|5998990|P2|Phase 1|Progressive Disease|8
1718756|NCT01091428|5998991|P1|Phase 1|Progressive Disease|24
1718757|NCT01091363|5999094|P2|Overall Study|Lost to Follow-up|2
1718758|NCT01091363|5999095|P1|Overall Study|Lost to Follow-up|2
1718759|NCT01091363|5999094|P2|Overall Study|Withdrawal by Subject|15
1718760|NCT01091363|5999095|P1|Overall Study|Withdrawal by Subject|11
1718761|NCT01091259|5999105|P1|Overall Study|Lack of Efficacy|2
1718762|NCT01091259|5999105|P1|Overall Study|Adverse Event|3
1718763|NCT01091246|5999116|P3|Overall Study|Subject not dosed|1
1718764|NCT01091246|5999117|P2|Overall Study|Subject not dosed|0
1718765|NCT01091246|5999118|P1|Overall Study|Subject not dosed|2
1718766|NCT01091246|5999116|P3|Overall Study|Withdrawal by Subject|4
1718767|NCT01091246|5999117|P2|Overall Study|Withdrawal by Subject|5
1718768|NCT01091246|5999118|P1|Overall Study|Withdrawal by Subject|9
1718769|NCT01091246|5999116|P3|Overall Study|Adverse Event|1
1718770|NCT01091246|5999117|P2|Overall Study|Adverse Event|0
1718771|NCT01091246|5999118|P1|Overall Study|Adverse Event|1
1718772|NCT01091246|5999116|P3|Overall Study|Lost to Follow-up|7
1718773|NCT01091246|5999117|P2|Overall Study|Lost to Follow-up|11
1718774|NCT01091246|5999118|P1|Overall Study|Lost to Follow-up|23
1718775|NCT01091168|5999194|P2|Overall Study|Physician, patient's decision, other|37
1718776|NCT01091168|5999195|P1|Overall Study|Physician, patient's decision, other|27
1718777|NCT01091168|5999194|P2|Overall Study|Lost to Follow-up|1
1718778|NCT01091168|5999195|P1|Overall Study|Lost to Follow-up|0
1718779|NCT01091168|5999194|P2|Overall Study|Adverse Event|24
1718780|NCT01091168|5999195|P1|Overall Study|Adverse Event|21
1718781|NCT01091168|5999194|P2|Overall Study|Progressive disease|234
1718782|NCT01091168|5999195|P1|Overall Study|Progressive disease|250
1718783|NCT01091103|5999270|P1|Overall Study|Progressive Disease|3
1718784|NCT01091103|5999270|P1|Overall Study|Adverse Event|1
1718785|NCT01090973|5999290|P1|Overall Study|Disease progression|1
1718786|NCT01090765|5999306|P6|Overall Study|Vasovagal reaction with first infusion|0
1718787|NCT01090765|5999307|P5|Overall Study|Vasovagal reaction with first infusion|1
1718788|NCT01090765|5999308|P4|Overall Study|Vasovagal reaction with first infusion|0
1718789|NCT01090765|5999309|P3|Overall Study|Vasovagal reaction with first infusion|0
1718790|NCT01090765|5999310|P2|Overall Study|Vasovagal reaction with first infusion|0
1718791|NCT01090765|5999311|P1|Overall Study|Vasovagal reaction with first infusion|0
1718792|NCT01090765|5999306|P6|Overall Study|Developed a DVT, needed anticoagulation|0
1718793|NCT01090765|5999307|P5|Overall Study|Developed a DVT, needed anticoagulation|0
1718794|NCT01090765|5999308|P4|Overall Study|Developed a DVT, needed anticoagulation|1
1718795|NCT01090765|5999309|P3|Overall Study|Developed a DVT, needed anticoagulation|0
1718796|NCT01090765|5999310|P2|Overall Study|Developed a DVT, needed anticoagulation|0
1718797|NCT01090765|5999311|P1|Overall Study|Developed a DVT, needed anticoagulation|0
1718798|NCT01090765|5999306|P6|Overall Study|Patient withdrew consent|1
1718799|NCT01090765|5999307|P5|Overall Study|Patient withdrew consent|1
1718800|NCT01090765|5999308|P4|Overall Study|Patient withdrew consent|0
1718801|NCT01090765|5999309|P3|Overall Study|Patient withdrew consent|0
1718802|NCT01090765|5999310|P2|Overall Study|Patient withdrew consent|0
1718803|NCT01090765|5999311|P1|Overall Study|Patient withdrew consent|0
1718804|NCT01090739|5999357|P1|36 Month Follow-up|Visit still pending|17
1718805|NCT01090739|5999357|P1|36 Month Follow-up|Withdrawal by Subject|6
1718806|NCT01090739|5999357|P1|24 Month Follow-up|Death|1
1718807|NCT01090739|5999357|P1|24 Month Follow-up|Lost to Follow-up|1
1718808|NCT01090739|5999357|P1|24 Month Follow-up|Withdrawal by Subject|7
1718809|NCT01090739|5999357|P1|12 Month Follow-up|Death|1
1718810|NCT01090739|5999357|P1|12 Month Follow-up|Physician Decision|1
1718811|NCT01090739|5999357|P1|12 Month Follow-up|Lost to Follow-up|1
1718812|NCT01090739|5999357|P1|12 Month Follow-up|Withdrawal by Subject|2
1718813|NCT01090739|5999357|P1|Enrollment|Adverse Event|1
1718814|NCT01090739|5999357|P1|Enrollment|Study implant limit reached|2
1718815|NCT01090739|5999357|P1|Enrollment|Sponsor termination of site|4
1718816|NCT01090739|5999357|P1|Enrollment|Physician Decision|5
1718817|NCT01090739|5999357|P1|Enrollment|Lost to Follow-up|5
1718818|NCT01090739|5999357|P1|Enrollment|Protocol Violation|14
1718819|NCT01090739|5999357|P1|Enrollment|Withdrawal by Subject|24
1718820|NCT01090492|5999382|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1718821|NCT01090492|5999383|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
1718822|NCT01090492|5999384|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1718823|NCT01090492|5999385|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1718824|NCT01090492|5999386|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1718825|NCT01090492|5999387|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1718826|NCT01090492|5999388|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1718827|NCT01090492|5999389|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
1718828|NCT01090492|5999382|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
1718829|NCT01090492|5999383|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
1718830|NCT01090492|5999384|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
1718831|NCT01090492|5999385|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
1718832|NCT01090492|5999386|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
1718833|NCT01090492|5999387|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
1718834|NCT01090492|5999388|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
1718835|NCT01090492|5999389|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
1718836|NCT01090492|5999382|P8|Second Intervention Period (4 Weeks)|Other|0
1718837|NCT01090492|5999383|P7|Second Intervention Period (4 Weeks)|Other|0
1718838|NCT01090492|5999384|P6|Second Intervention Period (4 Weeks)|Other|0
1718839|NCT01090492|5999385|P5|Second Intervention Period (4 Weeks)|Other|0
1718840|NCT01090492|5999386|P4|Second Intervention Period (4 Weeks)|Other|0
1718841|NCT01090492|5999387|P3|Second Intervention Period (4 Weeks)|Other|1
1718842|NCT01090492|5999388|P2|Second Intervention Period (4 Weeks)|Other|1
1718843|NCT01090492|5999389|P1|Second Intervention Period (4 Weeks)|Other|0
1718844|NCT01090492|5999382|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
1718845|NCT01090492|5999383|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
1718846|NCT01090492|5999384|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
1718847|NCT01090492|5999385|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
1718848|NCT01090492|5999386|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
1718849|NCT01090492|5999387|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
1718850|NCT01090492|5999388|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
1718851|NCT01090492|5999389|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
1718852|NCT01090492|5999382|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
1718853|NCT01090492|5999383|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
1718854|NCT01090492|5999384|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
1718855|NCT01090492|5999385|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
1718856|NCT01090492|5999386|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
1718857|NCT01090492|5999387|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
1718858|NCT01090492|5999388|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
1718859|NCT01090492|5999389|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
1718860|NCT01090492|5999382|P8|First Intervention Period (4 Weeks)|Adverse Event|5
1718861|NCT01090492|5999383|P7|First Intervention Period (4 Weeks)|Adverse Event|0
1718862|NCT01090492|5999384|P6|First Intervention Period (4 Weeks)|Adverse Event|2
1718863|NCT01090492|5999385|P5|First Intervention Period (4 Weeks)|Adverse Event|1
1718864|NCT01090492|5999386|P4|First Intervention Period (4 Weeks)|Adverse Event|3
1718865|NCT01090492|5999387|P3|First Intervention Period (4 Weeks)|Adverse Event|0
1718866|NCT01090492|5999388|P2|First Intervention Period (4 Weeks)|Adverse Event|2
1718867|NCT01090492|5999389|P1|First Intervention Period (4 Weeks)|Adverse Event|0
1718868|NCT01090492|5999382|P8|First Intervention Period (4 Weeks)|Pregnancy|0
1718869|NCT01090492|5999383|P7|First Intervention Period (4 Weeks)|Pregnancy|0
1718870|NCT01090492|5999384|P6|First Intervention Period (4 Weeks)|Pregnancy|0
1718871|NCT01090492|5999385|P5|First Intervention Period (4 Weeks)|Pregnancy|1
1718872|NCT01090492|5999386|P4|First Intervention Period (4 Weeks)|Pregnancy|0
1718873|NCT01090492|5999387|P3|First Intervention Period (4 Weeks)|Pregnancy|0
1718874|NCT01090492|5999388|P2|First Intervention Period (4 Weeks)|Pregnancy|0
1718875|NCT01090492|5999389|P1|First Intervention Period (4 Weeks)|Pregnancy|0
1718876|NCT01090492|5999382|P8|First Intervention Period (4 Weeks)|Other|0
1718877|NCT01090492|5999383|P7|First Intervention Period (4 Weeks)|Other|0
1718878|NCT01090492|5999384|P6|First Intervention Period (4 Weeks)|Other|0
1718879|NCT01090492|5999385|P5|First Intervention Period (4 Weeks)|Other|2
1718880|NCT01090492|5999386|P4|First Intervention Period (4 Weeks)|Other|1
1718881|NCT01090492|5999387|P3|First Intervention Period (4 Weeks)|Other|1
1718882|NCT01090492|5999388|P2|First Intervention Period (4 Weeks)|Other|0
1718883|NCT01090492|5999389|P1|First Intervention Period (4 Weeks)|Other|0
1718884|NCT01090492|5999382|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1718885|NCT01090492|5999383|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1718886|NCT01090492|5999384|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1718887|NCT01090492|5999385|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1718888|NCT01090492|5999386|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1718889|NCT01090492|5999387|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
1718890|NCT01090492|5999388|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1718891|NCT01090492|5999389|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
1718892|NCT01090492|5999382|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
1718893|NCT01090492|5999383|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1718894|NCT01090492|5999384|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1718895|NCT01090492|5999385|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1718896|NCT01090492|5999386|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1718897|NCT01090492|5999387|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1718898|NCT01090492|5999388|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
1718899|NCT01090492|5999389|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
1718900|NCT01090492|5999382|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
1718901|NCT01090492|5999383|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
1718902|NCT01090492|5999384|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
1718903|NCT01090492|5999385|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
1718904|NCT01090492|5999386|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
1718905|NCT01090492|5999387|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
1718906|NCT01090492|5999388|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
1718907|NCT01090492|5999389|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
1718908|NCT01090453|5999457|P2|Overall Study|Eligibility Criteria|1
1718909|NCT01090453|5999458|P1|Overall Study|Eligibility Criteria|0
1718910|NCT01090453|5999457|P2|Overall Study|Other|4
1718911|NCT01090453|5999458|P1|Overall Study|Other|2
1718912|NCT01090453|5999457|P2|Overall Study|Protocol Violation|0
1718913|NCT01090453|5999458|P1|Overall Study|Protocol Violation|2
1718914|NCT01090453|5999457|P2|Overall Study|Non serious AEs|0
1718915|NCT01090453|5999458|P1|Overall Study|Non serious AEs|1
1718916|NCT01090453|5999457|P2|Overall Study|Lost to Follow-up|7
1718917|NCT01090453|5999458|P1|Overall Study|Lost to Follow-up|7
1718918|NCT01090453|5999457|P2|Overall Study|Withdrawal by Subject|2
1718919|NCT01090453|5999458|P1|Overall Study|Withdrawal by Subject|1
1718920|NCT01090427|5999509|P7|After Controlled Period|Adverse Event|0
1718921|NCT01090427|5999510|P6|After Controlled Period|Adverse Event|1
1718922|NCT01090427|5999511|P5|After Controlled Period|Adverse Event|0
1718923|NCT01090427|5999512|P4|After Controlled Period|Adverse Event|2
1718924|NCT01090427|5999513|P3|After Controlled Period|Adverse Event|0
1718925|NCT01090427|5999514|P2|After Controlled Period|Adverse Event|0
1718926|NCT01090427|5999515|P1|After Controlled Period|Adverse Event|0
1718927|NCT01090427|5999509|P7|After Controlled Period|Lack of Efficacy|2
1718928|NCT01090427|5999510|P6|After Controlled Period|Lack of Efficacy|3
1718929|NCT01090427|5999511|P5|After Controlled Period|Lack of Efficacy|0
1718930|NCT01090427|5999512|P4|After Controlled Period|Lack of Efficacy|0
1718931|NCT01090427|5999513|P3|After Controlled Period|Lack of Efficacy|0
1718932|NCT01090427|5999514|P2|After Controlled Period|Lack of Efficacy|0
1718933|NCT01090427|5999515|P1|After Controlled Period|Lack of Efficacy|0
1718934|NCT01090427|5999509|P7|After Controlled Period|Death|0
1718935|NCT01090427|5999510|P6|After Controlled Period|Death|1
1718936|NCT01090427|5999511|P5|After Controlled Period|Death|0
1718937|NCT01090427|5999512|P4|After Controlled Period|Death|0
1718938|NCT01090427|5999513|P3|After Controlled Period|Death|0
1718939|NCT01090427|5999514|P2|After Controlled Period|Death|0
1718940|NCT01090427|5999515|P1|After Controlled Period|Death|0
1718941|NCT01090414|5999552|P4|Study 101-99|Participant Request|0
1718942|NCT01090414|5999553|P3|Study 101-99|Participant Request|0
1718943|NCT01090414|5999554|P2|Study 101-99|Participant Request|1
1718944|NCT01090414|5999555|P1|Study 101-99|Participant Request|3
1718945|NCT01090414|5999552|P4|Study 101-99|Withdrew Consent|1
1718946|NCT01090414|5999553|P3|Study 101-99|Withdrew Consent|3
1718947|NCT01090414|5999554|P2|Study 101-99|Withdrew Consent|2
1718948|NCT01090414|5999555|P1|Study 101-99|Withdrew Consent|0
1718949|NCT01090414|5999552|P4|Study 101-99|Other (Unknown Reasons)|0
1718950|NCT01090414|5999553|P3|Study 101-99|Other (Unknown Reasons)|0
1718951|NCT01090414|5999554|P2|Study 101-99|Other (Unknown Reasons)|3
1718952|NCT01090414|5999555|P1|Study 101-99|Other (Unknown Reasons)|3
1718953|NCT01090414|5999552|P4|Study 101-99|Sponsor Discontinued Study|0
1718954|NCT01090414|5999553|P3|Study 101-99|Sponsor Discontinued Study|5
1718955|NCT01090414|5999554|P2|Study 101-99|Sponsor Discontinued Study|7
1718956|NCT01090414|5999555|P1|Study 101-99|Sponsor Discontinued Study|0
1718957|NCT01090414|5999552|P4|Study 101-99|Death|0
1718958|NCT01090414|5999553|P3|Study 101-99|Death|1
1718959|NCT01090414|5999554|P2|Study 101-99|Death|8
1718960|NCT01090414|5999555|P1|Study 101-99|Death|3
1718961|NCT01090414|5999552|P4|Study 101-99|Investigator Request|0
1718962|NCT01090414|5999553|P3|Study 101-99|Investigator Request|4
1718963|NCT01090414|5999554|P2|Study 101-99|Investigator Request|11
1718964|NCT01090414|5999555|P1|Study 101-99|Investigator Request|1
1718965|NCT01090414|5999552|P4|Study 101-99|Adverse Event|0
1718966|NCT01090414|5999553|P3|Study 101-99|Adverse Event|18
1718967|NCT01090414|5999554|P2|Study 101-99|Adverse Event|28
1718968|NCT01090414|5999555|P1|Study 101-99|Adverse Event|10
1718969|NCT01090414|5999552|P4|Study 101-99|Progressive Disease|4
1718970|NCT01090414|5999553|P3|Study 101-99|Progressive Disease|10
1718971|NCT01090414|5999554|P2|Study 101-99|Progressive Disease|48
1718972|NCT01090414|5999555|P1|Study 101-99|Progressive Disease|28
1718973|NCT01090323|5999622|P2|Overall Study|Stopped end of extension 1#|1
1718974|NCT01090323|5999623|P1|Overall Study|Stopped end of extension 1#|3
1718975|NCT01090323|5999622|P2|Overall Study|Stopped end of core|0
1718976|NCT01090323|5999623|P1|Overall Study|Stopped end of core|7
1718977|NCT01090323|5999622|P2|Overall Study|Death|2
1718978|NCT01090323|5999623|P1|Overall Study|Death|1
1718979|NCT01090323|5999622|P2|Overall Study|Administrative problems|4
1718980|NCT01090323|5999623|P1|Overall Study|Administrative problems|6
1718981|NCT01090323|5999622|P2|Overall Study|Lost to Follow-up|6
1718982|NCT01090323|5999623|P1|Overall Study|Lost to Follow-up|11
1718983|NCT01090323|5999622|P2|Overall Study|Withdrew consent|11
1718984|NCT01090323|5999623|P1|Overall Study|Withdrew consent|33
1718985|NCT01090323|5999622|P2|Overall Study|Protocol Violation|1
1718986|NCT01090323|5999623|P1|Overall Study|Protocol Violation|2
1718987|NCT01090323|5999622|P2|Overall Study|Condition no longer requires drug|4
1718988|NCT01090323|5999623|P1|Overall Study|Condition no longer requires drug|5
1718989|NCT01090323|5999622|P2|Overall Study|Unsatisfactory therapeutic effect|2
1718990|NCT01090323|5999623|P1|Overall Study|Unsatisfactory therapeutic effect|4
1718991|NCT01090323|5999622|P2|Overall Study|Abnormal Test Procedure Results|0
1718992|NCT01090323|5999623|P1|Overall Study|Abnormal Test Procedure Results|2
1718993|NCT01090323|5999622|P2|Overall Study|Abnormal Lab Values|1
1718994|NCT01090323|5999623|P1|Overall Study|Abnormal Lab Values|3
1718995|NCT01090323|5999622|P2|Overall Study|Adverse Event|2
1718996|NCT01090323|5999623|P1|Overall Study|Adverse Event|12
1718997|NCT01090310|5999635|P4|Extension Study|Subject withdrew consent|0
1718998|NCT01090310|5999636|P3|Extension Study|Subject withdrew consent|0
1718999|NCT01090310|5999637|P2|Extension Study|Subject withdrew consent|1
1719000|NCT01090310|5999638|P1|Extension Study|Subject withdrew consent|0
1719001|NCT01090310|5999635|P4|Extension Study|Unsatisfactory therapeutic effect|1
1719002|NCT01090310|5999636|P3|Extension Study|Unsatisfactory therapeutic effect|1
1719003|NCT01090310|5999637|P2|Extension Study|Unsatisfactory therapeutic effect|0
1719004|NCT01090310|5999638|P1|Extension Study|Unsatisfactory therapeutic effect|1
1719005|NCT01090310|5999635|P4|Extension Study|Adverse Event|1
1719006|NCT01090310|5999636|P3|Extension Study|Adverse Event|0
1719007|NCT01090310|5999637|P2|Extension Study|Adverse Event|0
1719008|NCT01090310|5999638|P1|Extension Study|Adverse Event|0
1719009|NCT01090310|5999635|P4|Extension Study|Aministrative problems|18
1719010|NCT01090310|5999636|P3|Extension Study|Aministrative problems|14
1719011|NCT01090310|5999637|P2|Extension Study|Aministrative problems|15
1719012|NCT01090310|5999638|P1|Extension Study|Aministrative problems|13
1719013|NCT01090310|5999635|P4|Core Study|Protocol deviation|1
1719014|NCT01090310|5999636|P3|Core Study|Protocol deviation|0
1719015|NCT01090310|5999637|P2|Core Study|Protocol deviation|0
1719016|NCT01090310|5999638|P1|Core Study|Protocol deviation|1
1719017|NCT01090310|5999635|P4|Core Study|Administrative reasons|4
1719018|NCT01090310|5999636|P3|Core Study|Administrative reasons|4
1719019|NCT01090310|5999637|P2|Core Study|Administrative reasons|6
1719020|NCT01090310|5999638|P1|Core Study|Administrative reasons|5
1719021|NCT01090310|5999635|P4|Core Study|Abnormal test procedure result|0
1719022|NCT01090310|5999636|P3|Core Study|Abnormal test procedure result|1
1719023|NCT01090310|5999637|P2|Core Study|Abnormal test procedure result|0
1719024|NCT01090310|5999638|P1|Core Study|Abnormal test procedure result|0
1719025|NCT01090310|5999635|P4|Core Study|Subject withdrew consent|1
1719026|NCT01090310|5999636|P3|Core Study|Subject withdrew consent|1
1719027|NCT01090310|5999637|P2|Core Study|Subject withdrew consent|3
1719028|NCT01090310|5999638|P1|Core Study|Subject withdrew consent|0
1719029|NCT01090310|5999635|P4|Core Study|Adverse Event|1
1719030|NCT01090310|5999636|P3|Core Study|Adverse Event|1
1719031|NCT01090310|5999637|P2|Core Study|Adverse Event|2
1719032|NCT01090310|5999638|P1|Core Study|Adverse Event|2
1719033|NCT01090102|5999677|P2|Second 12 Weeks|Withdrawal by Subject|1
1719034|NCT01090102|5999678|P1|Second 12 Weeks|Withdrawal by Subject|0
1719035|NCT01090102|5999677|P2|First 12 Weeks|Death|1
1719036|NCT01090102|5999678|P1|First 12 Weeks|Death|1
1719037|NCT01090102|5999677|P2|First 12 Weeks|Adverse Event|0
1719038|NCT01090102|5999678|P1|First 12 Weeks|Adverse Event|2
1719039|NCT01090102|5999677|P2|First 12 Weeks|Withdrawal by Subject|1
1719040|NCT01090102|5999678|P1|First 12 Weeks|Withdrawal by Subject|1
1719041|NCT01090076|5999688|P2|Overall Study|Withdrawal by Subject|1
1719042|NCT01090076|5999689|P1|Overall Study|Withdrawal by Subject|0
1719043|NCT01090076|5999688|P2|Overall Study|Death|1
1719044|NCT01090076|5999689|P1|Overall Study|Death|1
1719045|NCT01090063|5999699|P1|Treatment|Withdrawal by Subject|4
1719046|NCT01090063|5999699|P1|Screen|Screen Failed|4
1719047|NCT01090050|5999715|P2|Overall Study|Physician Decision|1
1719048|NCT01090050|5999716|P1|Overall Study|Physician Decision|0
1719049|NCT01090050|5999715|P2|Overall Study|Lack of Efficacy|5
1719050|NCT01090050|5999716|P1|Overall Study|Lack of Efficacy|1
1719051|NCT01090050|5999715|P2|Overall Study|Lost to Follow-up|1
1719052|NCT01090050|5999716|P1|Overall Study|Lost to Follow-up|0
1719053|NCT01090011|5999736|P1|Overall Study|Other reason not defined above|5
1719054|NCT01090011|5999736|P1|Overall Study|Refusal to start/continue medication|5
1719055|NCT01090011|5999736|P1|Overall Study|Protocol Violation|1
1719056|NCT01090011|5999736|P1|Overall Study|Adverse Event|32
1719057|NCT01090011|5999736|P1|Overall Study|Progressive disease|128
1719058|NCT01089647|5999829|P2|Overall Study|Adverse Event|1
1719059|NCT01089647|5999830|P1|Overall Study|Adverse Event|0
1719060|NCT01089647|5999829|P2|Overall Study|Withdrawal by Subject|1
1719061|NCT01089647|5999830|P1|Overall Study|Withdrawal by Subject|2
1719062|NCT01089647|5999829|P2|Overall Study|Lost to Follow-up|2
1719063|NCT01089647|5999830|P1|Overall Study|Lost to Follow-up|2
1719064|NCT01089608|5999838|P2|Overall Study|Lost to Follow-up|2
1719065|NCT01089608|5999839|P1|Overall Study|Lost to Follow-up|0
1719066|NCT01089608|5999838|P2|Overall Study|Adverse Event|4
1719067|NCT01089608|5999839|P1|Overall Study|Adverse Event|0
1719068|NCT01089582|5999856|P1|Overall Study|Withdrawal by Subject|1
1719069|NCT01089582|5999856|P1|Overall Study|Other|4
1719070|NCT01089582|5999856|P1|Overall Study|Lost to Follow-up|8
1719071|NCT01089582|5999856|P1|Overall Study|Adverse Event|15
1719072|NCT01089582|5999856|P1|Overall Study|Death|2
1719073|NCT01089556|5999899|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
1719074|NCT01089556|5999900|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
1719075|NCT01089556|5999901|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1719076|NCT01089556|5999902|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
1719077|NCT01089556|5999903|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1719078|NCT01089556|5999904|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
1719079|NCT01089556|5999899|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
1719080|NCT01089556|5999900|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
1719081|NCT01089556|5999901|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
1719082|NCT01089556|5999902|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
1719083|NCT01089556|5999903|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
1719084|NCT01089556|5999904|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
1719085|NCT01089556|5999899|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
1719086|NCT01089556|5999900|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
1719087|NCT01089556|5999901|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
1719088|NCT01089556|5999902|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
1719089|NCT01089556|5999903|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
1719090|NCT01089556|5999904|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
1719091|NCT01089556|5999899|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1719092|NCT01089556|5999900|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1719093|NCT01089556|5999901|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1719094|NCT01089556|5999902|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
1719095|NCT01089556|5999903|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1719096|NCT01089556|5999904|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
1719097|NCT01089556|5999899|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1719098|NCT01089556|5999900|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
1719099|NCT01089556|5999901|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
1719100|NCT01089556|5999902|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1719101|NCT01089556|5999903|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1719102|NCT01089556|5999904|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
1719103|NCT01089556|5999899|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1719104|NCT01089556|5999900|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1719105|NCT01089556|5999901|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1719106|NCT01089556|5999902|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
1719107|NCT01089556|5999903|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
1719108|NCT01089556|5999904|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
1719109|NCT01089556|5999899|P6|Study Period III (Weeks 9-16)|Adverse Event|3
1719110|NCT01089556|5999900|P5|Study Period III (Weeks 9-16)|Adverse Event|4
1719111|NCT01089556|5999901|P4|Study Period III (Weeks 9-16)|Adverse Event|2
1719112|NCT01089556|5999902|P3|Study Period III (Weeks 9-16)|Adverse Event|4
1719113|NCT01089556|5999903|P2|Study Period III (Weeks 9-16)|Adverse Event|0
1719114|NCT01089556|5999904|P1|Study Period III (Weeks 9-16)|Adverse Event|0
1719115|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
1719116|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
1719117|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
1719118|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
1719119|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
1719120|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
1719121|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1719122|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1719123|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1719124|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
1719125|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
1719126|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
1719127|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
1719128|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
1719129|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
1719130|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
1719131|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
1719132|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
1719133|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Physician Decision|0
1719134|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Physician Decision|0
1719135|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Physician Decision|0
1719136|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Physician Decision|0
1719137|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Physician Decision|0
1719138|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Physician Decision|4
1719139|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1719140|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1719141|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1719142|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1719143|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
1719144|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
1719145|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1719146|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1719147|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1719148|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
1719149|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
1719150|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
1719151|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1719152|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1719153|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1719154|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
1719155|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
1719156|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
1719157|NCT01089556|5999899|P6|Study Period II (Weeks 1-8)|Adverse Event|0
1719158|NCT01089556|5999900|P5|Study Period II (Weeks 1-8)|Adverse Event|0
1719159|NCT01089556|5999901|P4|Study Period II (Weeks 1-8)|Adverse Event|0
1719160|NCT01089556|5999902|P3|Study Period II (Weeks 1-8)|Adverse Event|0
1719161|NCT01089556|5999903|P2|Study Period II (Weeks 1-8)|Adverse Event|39
1719162|NCT01089556|5999904|P1|Study Period II (Weeks 1-8)|Adverse Event|35
1719163|NCT01089543|5999978|P4|Overall Study|Adverse Event|0
1719164|NCT01089543|5999979|P3|Overall Study|Adverse Event|0
1719165|NCT01089543|5999980|P2|Overall Study|Adverse Event|1
1719166|NCT01089543|5999981|P1|Overall Study|Adverse Event|0
1719167|NCT01089543|5999978|P4|Overall Study|Physician Decision|1
1719168|NCT01089543|5999979|P3|Overall Study|Physician Decision|0
1719169|NCT01089543|5999980|P2|Overall Study|Physician Decision|0
1719170|NCT01089543|5999981|P1|Overall Study|Physician Decision|1
1719171|NCT01089543|5999978|P4|Overall Study|Withdrawal by Subject|1
1719172|NCT01089543|5999979|P3|Overall Study|Withdrawal by Subject|3
1719173|NCT01089543|5999980|P2|Overall Study|Withdrawal by Subject|3
1719174|NCT01089543|5999981|P1|Overall Study|Withdrawal by Subject|2
1719175|NCT01089504|6000016|P2|Overall Study|Withdrawal by Subject|0
1719176|NCT01089504|6000017|P1|Overall Study|Withdrawal by Subject|2
1719177|NCT01089504|6000016|P2|Overall Study|Lost to Follow-up|1
1719178|NCT01089504|6000017|P1|Overall Study|Lost to Follow-up|1
1719179|NCT01089413|6000030|P1|Overall Study|Other|71
1719180|NCT01089413|6000030|P1|Overall Study|Metastasectomy|13
1719181|NCT01089413|6000030|P1|Overall Study|Death|10
1719182|NCT01089413|6000030|P1|Overall Study|Unacceptable Toxicity|12
1719183|NCT01089413|6000030|P1|Overall Study|Participant Withdrew Consent|1
1719184|NCT01089413|6000030|P1|Overall Study|Progressive Disease|93
1719185|NCT01089413|6000030|P1|Overall Study|Lost to Follow-up|1
1719186|NCT01089361|6000049|P2|Overall Study|Death|0
1719187|NCT01089361|6000050|P1|Overall Study|Death|1
1719188|NCT01089127|6000099|P6|Overall Study|Protocol deviation|0
1719189|NCT01089127|6000100|P5|Overall Study|Protocol deviation|1
1719190|NCT01089127|6000101|P4|Overall Study|Protocol deviation|0
1719191|NCT01089127|6000102|P3|Overall Study|Protocol deviation|0
1719192|NCT01089127|6000103|P2|Overall Study|Protocol deviation|1
1719193|NCT01089127|6000104|P1|Overall Study|Protocol deviation|0
1719194|NCT01089127|6000099|P6|Overall Study|Lost to Follow-up|0
1719195|NCT01089127|6000100|P5|Overall Study|Lost to Follow-up|1
1719196|NCT01089127|6000101|P4|Overall Study|Lost to Follow-up|0
1719197|NCT01089127|6000102|P3|Overall Study|Lost to Follow-up|0
1719198|NCT01089127|6000103|P2|Overall Study|Lost to Follow-up|1
1719199|NCT01089127|6000104|P1|Overall Study|Lost to Follow-up|1
1719200|NCT01089127|6000099|P6|Overall Study|Abnormal test procedure result(s)|0
1719201|NCT01089127|6000100|P5|Overall Study|Abnormal test procedure result(s)|0
1719202|NCT01089127|6000101|P4|Overall Study|Abnormal test procedure result(s)|0
1719203|NCT01089127|6000102|P3|Overall Study|Abnormal test procedure result(s)|0
1719204|NCT01089127|6000103|P2|Overall Study|Abnormal test procedure result(s)|1
1719205|NCT01089127|6000104|P1|Overall Study|Abnormal test procedure result(s)|2
1719206|NCT01089127|6000099|P6|Overall Study|Subject withdrew consent|2
1719207|NCT01089127|6000100|P5|Overall Study|Subject withdrew consent|0
1719208|NCT01089127|6000101|P4|Overall Study|Subject withdrew consent|1
1719209|NCT01089127|6000102|P3|Overall Study|Subject withdrew consent|1
1719210|NCT01089127|6000103|P2|Overall Study|Subject withdrew consent|1
1719211|NCT01089127|6000104|P1|Overall Study|Subject withdrew consent|0
1719212|NCT01089127|6000099|P6|Overall Study|Adverse Event|1
1719213|NCT01089127|6000100|P5|Overall Study|Adverse Event|0
1719214|NCT01089127|6000101|P4|Overall Study|Adverse Event|0
1719215|NCT01089127|6000102|P3|Overall Study|Adverse Event|1
1719216|NCT01089127|6000103|P2|Overall Study|Adverse Event|1
1719217|NCT01089127|6000104|P1|Overall Study|Adverse Event|5
1719218|NCT01089023|6000158|P1|Overall Study|Lack of Efficacy|1
1719219|NCT01089023|6000158|P1|Overall Study|Protocol Violation|1
1719220|NCT01089023|6000158|P1|Overall Study|Withdrawal by Subject|1
1719221|NCT01089023|6000158|P1|Overall Study|Adverse Event|1
1719222|NCT01089023|6000158|P1|Overall Study|Lost to Follow-up|3
1719223|NCT01088997|6000172|P2|Overall Study|Excluded prior to receiving drug|1
1719224|NCT01088997|6000173|P1|Overall Study|Excluded prior to receiving drug|1
1719225|NCT01088997|6000172|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
1719226|NCT01088997|6000173|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
1719227|NCT01088997|6000172|P2|Overall Study|Physician Decision|1
1719228|NCT01088997|6000173|P1|Overall Study|Physician Decision|1
1719229|NCT01088984|6000184|P2|Phase 2|Other|1
1719230|NCT01088984|6000185|P1|Phase 2|Other|0
1719231|NCT01088984|6000184|P2|Phase 2|DIsease Progression|25
1719232|NCT01088984|6000185|P1|Phase 2|DIsease Progression|0
1719233|NCT01088984|6000184|P2|Phase 2|Withdrawal by Subject|1
1719234|NCT01088984|6000185|P1|Phase 2|Withdrawal by Subject|0
1719235|NCT01088984|6000184|P2|Phase 2|Death|5
1719236|NCT01088984|6000185|P1|Phase 2|Death|0
1719237|NCT01088984|6000184|P2|Phase 1|Other|1
1719238|NCT01088984|6000185|P1|Phase 1|Other|1
1719239|NCT01088984|6000184|P2|Phase 1|Disease Progression|4
1719240|NCT01088984|6000185|P1|Phase 1|Disease Progression|2
1719241|NCT01088984|6000184|P2|Phase 1|Death|1
1719242|NCT01088984|6000185|P1|Phase 1|Death|2
1719243|NCT01088529|6000255|P2|Overall Study|Did not receive study treatment|1
1719244|NCT01088529|6000256|P1|Overall Study|Did not receive study treatment|0
1719245|NCT01088503|6000269|P3|Overall Study|Death|7
1719246|NCT01088503|6000270|P2|Overall Study|Death|358
1719247|NCT01088503|6000271|P1|Overall Study|Death|64
1719248|NCT01088503|6000269|P3|Overall Study|Withdrawal by Subject|10
1719249|NCT01088503|6000270|P2|Overall Study|Withdrawal by Subject|327
1719250|NCT01088503|6000271|P1|Overall Study|Withdrawal by Subject|118
1719251|NCT01088438|6000349|P2|Overall Study|Lost to Follow-up|30
1719252|NCT01088438|6000350|P1|Overall Study|Lost to Follow-up|18
1719253|NCT01088438|6000349|P2|Overall Study|Withdrawal by Subject|6
1719254|NCT01088438|6000350|P1|Overall Study|Withdrawal by Subject|11
1719255|NCT01088412|6000363|P3|Overall Study|Study Summary Not Completed|22
1719256|NCT01088412|6000364|P2|Overall Study|Study Summary Not Completed|64
1719257|NCT01088412|6000365|P1|Overall Study|Study Summary Not Completed|4360
1719258|NCT01088412|6000363|P3|Overall Study|Lost to Follow-up|11
1719259|NCT01088412|6000364|P2|Overall Study|Lost to Follow-up|130
1719260|NCT01088412|6000365|P1|Overall Study|Lost to Follow-up|3052
1719261|NCT01088412|6000363|P3|Overall Study|Third Party Required to Change Brand|0
1719262|NCT01088412|6000364|P2|Overall Study|Third Party Required to Change Brand|0
1719263|NCT01088412|6000365|P1|Overall Study|Third Party Required to Change Brand|487
1719264|NCT01088412|6000363|P3|Overall Study|Sponsor Decision|23
1719265|NCT01088412|6000364|P2|Overall Study|Sponsor Decision|79
1719266|NCT01088412|6000365|P1|Overall Study|Sponsor Decision|4467
1719267|NCT01088412|6000363|P3|Overall Study|Physician Decision|4
1719268|NCT01088412|6000364|P2|Overall Study|Physician Decision|8
1719269|NCT01088412|6000365|P1|Overall Study|Physician Decision|1041
1719270|NCT01088412|6000363|P3|Overall Study|Participant Moved|2
1719271|NCT01088412|6000364|P2|Overall Study|Participant Moved|21
1719272|NCT01088412|6000365|P1|Overall Study|Participant Moved|601
1719273|NCT01088412|6000363|P3|Overall Study|Received Another GH Product|0
1719274|NCT01088412|6000364|P2|Overall Study|Received Another GH Product|0
1719275|NCT01088412|6000365|P1|Overall Study|Received Another GH Product|79
1719276|NCT01088412|6000363|P3|Overall Study|Withdrawal by Subject|1
1719277|NCT01088412|6000364|P2|Overall Study|Withdrawal by Subject|25
1719278|NCT01088412|6000365|P1|Overall Study|Withdrawal by Subject|1761
1719279|NCT01088412|6000363|P3|Overall Study|Other Reason per Case Report Form|9
1719280|NCT01088412|6000364|P2|Overall Study|Other Reason per Case Report Form|103
1719281|NCT01088412|6000365|P1|Overall Study|Other Reason per Case Report Form|2089
1719282|NCT01088412|6000363|P3|Overall Study|Death|0
1719283|NCT01088412|6000364|P2|Overall Study|Death|6
1719284|NCT01088412|6000365|P1|Overall Study|Death|42
1719285|NCT01088412|6000363|P3|Overall Study|Adverse Event|0
1719286|NCT01088412|6000364|P2|Overall Study|Adverse Event|0
1719287|NCT01088412|6000365|P1|Overall Study|Adverse Event|38
1719288|NCT01088399|6000384|P3|Overall Study|Study summary visit not completed|80
1719289|NCT01088399|6000385|P2|Overall Study|Study summary visit not completed|283
1719290|NCT01088399|6000386|P1|Overall Study|Study summary visit not completed|2398
1719291|NCT01088399|6000384|P3|Overall Study|Enrollment criteria not met|70
1719292|NCT01088399|6000385|P2|Overall Study|Enrollment criteria not met|119
1719293|NCT01088399|6000386|P1|Overall Study|Enrollment criteria not met|48
1719294|NCT01088399|6000384|P3|Overall Study|Protocol Violation|0
1719295|NCT01088399|6000385|P2|Overall Study|Protocol Violation|1
1719296|NCT01088399|6000386|P1|Overall Study|Protocol Violation|10
1719297|NCT01088399|6000384|P3|Overall Study|Sponsor decision|7
1719298|NCT01088399|6000385|P2|Overall Study|Sponsor decision|298
1719299|NCT01088399|6000386|P1|Overall Study|Sponsor decision|1573
1719300|NCT01088399|6000384|P3|Overall Study|Change to or start of somatropin therapy|12
1719301|NCT01088399|6000385|P2|Overall Study|Change to or start of somatropin therapy|17
1719302|NCT01088399|6000386|P1|Overall Study|Change to or start of somatropin therapy|234
1719303|NCT01088399|6000384|P3|Overall Study|Withdrawal by Subject|33
1719304|NCT01088399|6000385|P2|Overall Study|Withdrawal by Subject|195
1719305|NCT01088399|6000386|P1|Overall Study|Withdrawal by Subject|544
1719306|NCT01088399|6000384|P3|Overall Study|Physician Decision|16
1719307|NCT01088399|6000385|P2|Overall Study|Physician Decision|88
1719308|NCT01088399|6000386|P1|Overall Study|Physician Decision|531
1719309|NCT01088399|6000384|P3|Overall Study|Lost to Follow-up|58
1719310|NCT01088399|6000385|P2|Overall Study|Lost to Follow-up|278
1719311|NCT01088399|6000386|P1|Overall Study|Lost to Follow-up|1070
1719312|NCT01088399|6000384|P3|Overall Study|Lack of Efficacy|5
1719313|NCT01088399|6000385|P2|Overall Study|Lack of Efficacy|7
1719314|NCT01088399|6000386|P1|Overall Study|Lack of Efficacy|298
1719315|NCT01088399|6000384|P3|Overall Study|Death|0
1719316|NCT01088399|6000385|P2|Overall Study|Death|45
1719317|NCT01088399|6000386|P1|Overall Study|Death|204
1719318|NCT01088399|6000384|P3|Overall Study|Adverse Event|0
1719319|NCT01088399|6000385|P2|Overall Study|Adverse Event|16
1719320|NCT01088399|6000386|P1|Overall Study|Adverse Event|211
1719321|NCT01088243|6000415|P2|Overall Study|Adverse Event|0
1719322|NCT01088243|6000416|P1|Overall Study|Adverse Event|1
1719323|NCT01087970|6000457|P1|Overall Study|Protocol Violation|2
1719324|NCT01087957|6000469|P2|Overall Study|Physician Decision|9
1719325|NCT01087957|6000470|P1|Overall Study|Physician Decision|5
1719326|NCT01087957|6000469|P2|Overall Study|Withdrawal by Subject|15
1719327|NCT01087957|6000470|P1|Overall Study|Withdrawal by Subject|18
1719328|NCT01087957|6000469|P2|Overall Study|Protocol Violation|25
1719329|NCT01087957|6000470|P1|Overall Study|Protocol Violation|13
1719330|NCT01087957|6000469|P2|Overall Study|Lost to Follow-up|4
1719331|NCT01087957|6000470|P1|Overall Study|Lost to Follow-up|3
1719332|NCT01087957|6000469|P2|Overall Study|Death|2
1719333|NCT01087957|6000470|P1|Overall Study|Death|2
1719334|NCT01087944|6000496|P2|Period 2 (Week 4-6)|Adverse Event|2
1719335|NCT01087944|6000497|P1|Period 2 (Week 4-6)|Adverse Event|0
1719336|NCT01087944|6000496|P2|Period 1 (Week 1-3)|Adverse Event|0
1719337|NCT01087944|6000497|P1|Period 1 (Week 1-3)|Adverse Event|1
1719338|NCT01087905|6000577|P8|Overall Study|Withdrawal by Subject|5
1719339|NCT01087905|6000578|P7|Overall Study|Withdrawal by Subject|3
1719340|NCT01087905|6000579|P6|Overall Study|Withdrawal by Subject|3
1719341|NCT01087905|6000580|P5|Overall Study|Withdrawal by Subject|4
1719342|NCT01087905|6000581|P4|Overall Study|Withdrawal by Subject|5
1719343|NCT01087905|6000582|P3|Overall Study|Withdrawal by Subject|4
1719344|NCT01087905|6000583|P2|Overall Study|Withdrawal by Subject|4
1719345|NCT01087905|6000584|P1|Overall Study|Withdrawal by Subject|5
1719346|NCT01087905|6000577|P8|Overall Study|Lost to Follow-up|24
1719347|NCT01087905|6000578|P7|Overall Study|Lost to Follow-up|20
1719348|NCT01087905|6000579|P6|Overall Study|Lost to Follow-up|25
1719349|NCT01087905|6000580|P5|Overall Study|Lost to Follow-up|27
1719350|NCT01087905|6000581|P4|Overall Study|Lost to Follow-up|31
1719351|NCT01087905|6000582|P3|Overall Study|Lost to Follow-up|18
1719352|NCT01087905|6000583|P2|Overall Study|Lost to Follow-up|28
1719353|NCT01087905|6000584|P1|Overall Study|Lost to Follow-up|24
1719354|NCT01087814|6000606|P2|Second Intervention (5 Days)|Physician Decision|0
1719355|NCT01087814|6000607|P1|Second Intervention (5 Days)|Physician Decision|1
1719356|NCT01087814|6000606|P2|First Intervention (5 Days)|Withdrawal by Subject|1
1719357|NCT01087814|6000607|P1|First Intervention (5 Days)|Withdrawal by Subject|3
1719358|NCT01087788|6000625|P3|Open-Label Period (OL-P)|Personal reasons|1
1719359|NCT01087788|6000626|P2|Open-Label Period (OL-P)|Personal reasons|0
1719360|NCT01087788|6000627|P1|Open-Label Period (OL-P)|Personal reasons|0
1719361|NCT01087788|6000625|P3|Open-Label Period (OL-P)|No participation in study extension|1
1719362|NCT01087788|6000626|P2|Open-Label Period (OL-P)|No participation in study extension|0
1719363|NCT01087788|6000627|P1|Open-Label Period (OL-P)|No participation in study extension|0
1719364|NCT01087788|6000625|P3|Open-Label Period (OL-P)|Principal investigator decision|2
1719365|NCT01087788|6000626|P2|Open-Label Period (OL-P)|Principal investigator decision|1
1719366|NCT01087788|6000627|P1|Open-Label Period (OL-P)|Principal investigator decision|0
1719367|NCT01087788|6000625|P3|Open-Label Period (OL-P)|Sponsor request|0
1719368|NCT01087788|6000626|P2|Open-Label Period (OL-P)|Sponsor request|0
1719369|NCT01087788|6000627|P1|Open-Label Period (OL-P)|Sponsor request|1
1719370|NCT01087788|6000625|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
1719371|NCT01087788|6000626|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
1719372|NCT01087788|6000627|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
1719373|NCT01087788|6000625|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
1719374|NCT01087788|6000626|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
1719375|NCT01087788|6000627|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
1719376|NCT01087788|6000625|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
1719377|NCT01087788|6000626|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
1719378|NCT01087788|6000627|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
1719379|NCT01087788|6000625|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
1719380|NCT01087788|6000626|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
1719381|NCT01087788|6000627|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
1719382|NCT01087788|6000625|P3|Open-Label Period (OL-P)|AE, serious fatal|1
1719383|NCT01087788|6000626|P2|Open-Label Period (OL-P)|AE, serious fatal|0
1719384|NCT01087788|6000627|P1|Open-Label Period (OL-P)|AE, serious fatal|2
1719385|NCT01087788|6000625|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
1719386|NCT01087788|6000626|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
1719387|NCT01087788|6000627|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
1719388|NCT01087788|6000625|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
1719389|NCT01087788|6000626|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
1719390|NCT01087788|6000627|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
1719391|NCT01087788|6000625|P3|Open-Label Period (OL-P)|Protocol Violation|0
1719392|NCT01087788|6000626|P2|Open-Label Period (OL-P)|Protocol Violation|1
1719393|NCT01087788|6000627|P1|Open-Label Period (OL-P)|Protocol Violation|2
1719394|NCT01087788|6000625|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
1719395|NCT01087788|6000626|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
1719396|NCT01087788|6000627|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
1719397|NCT01087788|6000625|P3|24-weeks Dose-blind Period|Patient moved|1
1719398|NCT01087788|6000626|P2|24-weeks Dose-blind Period|Patient moved|0
1719399|NCT01087788|6000627|P1|24-weeks Dose-blind Period|Patient moved|0
1719400|NCT01087788|6000625|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
1719401|NCT01087788|6000626|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
1719402|NCT01087788|6000627|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
1719403|NCT01087788|6000625|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
1719404|NCT01087788|6000626|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
1719405|NCT01087788|6000627|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
1719406|NCT01087788|6000625|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
1719407|NCT01087788|6000626|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
1719408|NCT01087788|6000627|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
1719409|NCT01087788|6000625|P3|24-weeks Dose-blind Period|AE, serious fatal|0
1719410|NCT01087788|6000626|P2|24-weeks Dose-blind Period|AE, serious fatal|1
1719411|NCT01087788|6000627|P1|24-weeks Dose-blind Period|AE, serious fatal|0
1719412|NCT01087788|6000625|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
1719413|NCT01087788|6000626|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
1719414|NCT01087788|6000627|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
1719415|NCT01087788|6000625|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
1719416|NCT01087788|6000626|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
1719417|NCT01087788|6000627|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
1719418|NCT01087788|6000625|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
1719419|NCT01087788|6000626|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
1719420|NCT01087788|6000627|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
1719421|NCT01087788|6000625|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
1719422|NCT01087788|6000626|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
1719423|NCT01087788|6000627|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
1719424|NCT01087788|6000625|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
1719425|NCT01087788|6000626|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
1719426|NCT01087788|6000627|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
1719427|NCT01087788|6000625|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
1719428|NCT01087788|6000626|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
1719429|NCT01087788|6000627|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
1719430|NCT01087788|6000625|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
1719431|NCT01087788|6000626|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
1719432|NCT01087788|6000627|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
1719433|NCT01087788|6000625|P3|24-weeks Double-blind Period|AE, unknown type|1
1719434|NCT01087788|6000626|P2|24-weeks Double-blind Period|AE, unknown type|0
1719435|NCT01087788|6000627|P1|24-weeks Double-blind Period|AE, unknown type|0
1719436|NCT01087788|6000625|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
1719437|NCT01087788|6000626|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
1719438|NCT01087788|6000627|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
1719439|NCT01087788|6000625|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
1719440|NCT01087788|6000626|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
1719441|NCT01087788|6000627|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
1719442|NCT01087788|6000625|P3|24-weeks Double-blind Period|AE, serious fatal|1
1719443|NCT01087788|6000626|P2|24-weeks Double-blind Period|AE, serious fatal|1
1719444|NCT01087788|6000627|P1|24-weeks Double-blind Period|AE, serious fatal|0
1719445|NCT01087788|6000625|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
1719446|NCT01087788|6000626|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
1719447|NCT01087788|6000627|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
1719448|NCT01087788|6000625|P3|24-weeks Double-blind Period|Lost to Follow-up|1
1719449|NCT01087788|6000626|P2|24-weeks Double-blind Period|Lost to Follow-up|1
1719450|NCT01087788|6000627|P1|24-weeks Double-blind Period|Lost to Follow-up|4
1719451|NCT01087788|6000625|P3|24-weeks Double-blind Period|Protocol Violation|0
1719452|NCT01087788|6000626|P2|24-weeks Double-blind Period|Protocol Violation|1
1719453|NCT01087788|6000627|P1|24-weeks Double-blind Period|Protocol Violation|0
1719454|NCT01087788|6000625|P3|24-weeks Double-blind Period|Lack of Efficacy|1
1719455|NCT01087788|6000626|P2|24-weeks Double-blind Period|Lack of Efficacy|0
1719456|NCT01087788|6000627|P1|24-weeks Double-blind Period|Lack of Efficacy|2
1719457|NCT01087775|6000654|P1|Overall Study|failed inclusion criteria|2
1719458|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
1719459|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
1719460|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1719461|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1719462|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
1719463|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
1719464|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
1719465|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1719466|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1719467|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
1719468|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
1719469|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
1719470|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1719471|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1719472|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
1719473|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|Other|4
1719474|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|Other|2
1719475|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|Other|0
1719476|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|Other|0
1719477|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|Other|0
1719478|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
1719479|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
1719480|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1719481|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1719482|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
1719483|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
1719484|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
1719485|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1719486|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1719487|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
1719488|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
1719489|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
1719490|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1719491|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1719492|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
1719493|NCT01087762|6000662|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
1719494|NCT01087762|6000663|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
1719495|NCT01087762|6000664|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1719496|NCT01087762|6000665|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1719497|NCT01087762|6000666|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
1719498|NCT01087762|6000662|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
1719499|NCT01087762|6000663|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
1719500|NCT01087762|6000664|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
1719501|NCT01087762|6000665|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
1719502|NCT01087762|6000666|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
1719503|NCT01087762|6000662|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
1719504|NCT01087762|6000663|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
1719505|NCT01087762|6000664|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
1719506|NCT01087762|6000665|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
1719507|NCT01087762|6000666|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
1719508|NCT01087762|6000662|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
1719509|NCT01087762|6000663|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
1719510|NCT01087762|6000664|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
1719511|NCT01087762|6000665|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
1719512|NCT01087762|6000666|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
1719513|NCT01087762|6000662|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1719514|NCT01087762|6000663|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1719515|NCT01087762|6000664|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
1719516|NCT01087762|6000665|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
1719517|NCT01087762|6000666|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
1719518|NCT01087762|6000662|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1719519|NCT01087762|6000663|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1719520|NCT01087762|6000664|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
1719521|NCT01087762|6000665|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
1719522|NCT01087762|6000666|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
1719523|NCT01087736|6000714|P2|Overall Study|Withdrawal by Subject|1
1719524|NCT01087736|6000715|P1|Overall Study|Withdrawal by Subject|0
1719525|NCT01087736|6000714|P2|Overall Study|Death|1
1719526|NCT01087736|6000715|P1|Overall Study|Death|0
1719527|NCT01087736|6000714|P2|Overall Study|Lost to Follow-up|0
1719528|NCT01087736|6000715|P1|Overall Study|Lost to Follow-up|1
1719529|NCT01087723|6000725|P2|Overall Study|Reason Not Specified|2
1719530|NCT01087723|6000726|P1|Overall Study|Reason Not Specified|1
1719531|NCT01087723|6000725|P2|Overall Study|Lost to Follow-up|4
1719532|NCT01087723|6000726|P1|Overall Study|Lost to Follow-up|1
1719533|NCT01087723|6000725|P2|Overall Study|Physician Decision|0
1719534|NCT01087723|6000726|P1|Overall Study|Physician Decision|2
1719535|NCT01087723|6000725|P2|Overall Study|Withdrawal by Subject|13
1719536|NCT01087723|6000726|P1|Overall Study|Withdrawal by Subject|10
1719537|NCT01087723|6000725|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
1719538|NCT01087723|6000726|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
1719539|NCT01087528|6000767|P1|Overall Study|Incomplete CE procedure|6
1719540|NCT01087528|6000767|P1|Overall Study|Withdrawal by Subject|1
1719541|NCT01087502|6000773|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
1719542|NCT01087502|6000774|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
1719543|NCT01087502|6000773|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
1719544|NCT01087502|6000774|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
1719545|NCT01087502|6000773|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
1719546|NCT01087502|6000774|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
1719547|NCT01087502|6000773|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
1719548|NCT01087502|6000774|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
1719549|NCT01087502|6000773|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
1719550|NCT01087502|6000774|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
1719551|NCT01087502|6000773|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
1719552|NCT01087502|6000774|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
1719553|NCT01087502|6000773|P2|Up to Final Analysis (Week 52)|Adverse Event|10
1719554|NCT01087502|6000774|P1|Up to Final Analysis (Week 52)|Adverse Event|17
1719555|NCT01087502|6000773|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
1719556|NCT01087502|6000774|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
1719557|NCT01087502|6000773|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
1719558|NCT01087502|6000774|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
1719559|NCT01087502|6000773|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
1719560|NCT01087502|6000774|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
1719561|NCT01087502|6000773|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
1719562|NCT01087502|6000774|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
1719563|NCT01087502|6000773|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
1719649|NCT01086384|6001067|P1|2-week Run-in Period|Physician Decision|6
1719564|NCT01087502|6000774|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
1719565|NCT01087489|6000793|P2|Overall Study|unable to survey by telephone|1
1719566|NCT01087489|6000794|P1|Overall Study|unable to survey by telephone|0
1719567|NCT01087489|6000793|P2|Overall Study|Death|1
1719568|NCT01087489|6000794|P1|Overall Study|Death|0
1719569|NCT01087489|6000793|P2|Overall Study|enrolled in another VA study|1
1719570|NCT01087489|6000794|P1|Overall Study|enrolled in another VA study|0
1719571|NCT01086969|6000807|P3|Overall Study|Withdrawal by Subject|0
1719572|NCT01086969|6000808|P2|Overall Study|Withdrawal by Subject|2
1719573|NCT01086969|6000809|P1|Overall Study|Withdrawal by Subject|1
1719574|NCT01086423|6000919|P3|Overall Study|Lost to Follow-up|1
1719575|NCT01086423|6000920|P2|Overall Study|Lost to Follow-up|0
1719576|NCT01086423|6000921|P1|Overall Study|Lost to Follow-up|0
1719577|NCT01086423|6000919|P3|Overall Study|Withdrawal by Subject|3
1719578|NCT01086423|6000920|P2|Overall Study|Withdrawal by Subject|1
1719579|NCT01086423|6000921|P1|Overall Study|Withdrawal by Subject|5
1719580|NCT01086423|6000919|P3|Overall Study|Adverse event, non-fatal|0
1719581|NCT01086423|6000920|P2|Overall Study|Adverse event, non-fatal|1
1719582|NCT01086423|6000921|P1|Overall Study|Adverse event, non-fatal|2
1719583|NCT01086423|6000919|P3|Overall Study|Adverse event, fatal|0
1719584|NCT01086423|6000920|P2|Overall Study|Adverse event, fatal|1
1719585|NCT01086423|6000921|P1|Overall Study|Adverse event, fatal|1
1719586|NCT01086423|6000919|P3|Overall Study|Migrated/moved from study area|4
1719587|NCT01086423|6000920|P2|Overall Study|Migrated/moved from study area|0
1719588|NCT01086423|6000921|P1|Overall Study|Migrated/moved from study area|2
1719589|NCT01086423|6000919|P3|Overall Study|Protocol Violation|1
1719590|NCT01086423|6000920|P2|Overall Study|Protocol Violation|0
1719591|NCT01086423|6000921|P1|Overall Study|Protocol Violation|0
1719592|NCT01086410|6000966|P4|Overall Study|Lost to Follow-up|0
1719593|NCT01086410|6000967|P3|Overall Study|Lost to Follow-up|1
1719594|NCT01086410|6000968|P2|Overall Study|Lost to Follow-up|0
1719595|NCT01086410|6000969|P1|Overall Study|Lost to Follow-up|0
1719596|NCT01086410|6000966|P4|Overall Study|Protocol Violation|0
1719597|NCT01086410|6000967|P3|Overall Study|Protocol Violation|0
1719598|NCT01086410|6000968|P2|Overall Study|Protocol Violation|1
1719599|NCT01086410|6000969|P1|Overall Study|Protocol Violation|1
1719600|NCT01086410|6000966|P4|Overall Study|Lack of Efficacy|0
1719601|NCT01086410|6000967|P3|Overall Study|Lack of Efficacy|0
1719602|NCT01086410|6000968|P2|Overall Study|Lack of Efficacy|1
1719603|NCT01086410|6000969|P1|Overall Study|Lack of Efficacy|1
1719604|NCT01086410|6000966|P4|Overall Study|Adverse Event|2
1719605|NCT01086410|6000967|P3|Overall Study|Adverse Event|0
1719606|NCT01086410|6000968|P2|Overall Study|Adverse Event|0
1719607|NCT01086410|6000969|P1|Overall Study|Adverse Event|1
1719608|NCT01086384|6001065|P3|Treatment Period|Received Treatment in Error|0
1719609|NCT01086384|6001066|P2|Treatment Period|Received Treatment in Error|1
1719610|NCT01086384|6001067|P1|Treatment Period|Received Treatment in Error|0
1719611|NCT01086384|6001065|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
1719612|NCT01086384|6001066|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
1719613|NCT01086384|6001067|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
1719614|NCT01086384|6001065|P3|Treatment Period|Study Closed/Terminated|8
1719615|NCT01086384|6001066|P2|Treatment Period|Study Closed/Terminated|7
1719616|NCT01086384|6001067|P1|Treatment Period|Study Closed/Terminated|0
1719617|NCT01086384|6001065|P3|Treatment Period|Physician Decision|6
1719618|NCT01086384|6001066|P2|Treatment Period|Physician Decision|9
1719619|NCT01086384|6001067|P1|Treatment Period|Physician Decision|0
1719620|NCT01086384|6001065|P3|Treatment Period|Lost to Follow-up|9
1719621|NCT01086384|6001066|P2|Treatment Period|Lost to Follow-up|11
1719622|NCT01086384|6001067|P1|Treatment Period|Lost to Follow-up|0
1719623|NCT01086384|6001065|P3|Treatment Period|Adverse Event|15
1719624|NCT01086384|6001066|P2|Treatment Period|Adverse Event|19
1719625|NCT01086384|6001067|P1|Treatment Period|Adverse Event|0
1719626|NCT01086384|6001065|P3|Treatment Period|Lack of Efficacy|13
1719627|NCT01086384|6001066|P2|Treatment Period|Lack of Efficacy|22
1719628|NCT01086384|6001067|P1|Treatment Period|Lack of Efficacy|0
1719629|NCT01086384|6001065|P3|Treatment Period|Protocol Violation|17
1719630|NCT01086384|6001066|P2|Treatment Period|Protocol Violation|26
1719631|NCT01086384|6001067|P1|Treatment Period|Protocol Violation|0
1719632|NCT01086384|6001065|P3|Treatment Period|Withdrawal by Subject|55
1719633|NCT01086384|6001066|P2|Treatment Period|Withdrawal by Subject|53
1719634|NCT01086384|6001067|P1|Treatment Period|Withdrawal by Subject|0
1719635|NCT01086384|6001065|P3|2-week Run-in Period|Randomized in Error|0
1719636|NCT01086384|6001066|P2|2-week Run-in Period|Randomized in Error|0
1719637|NCT01086384|6001067|P1|2-week Run-in Period|Randomized in Error|1
1719638|NCT01086384|6001065|P3|2-week Run-in Period|Continuation Criteria Not Met|0
1719639|NCT01086384|6001066|P2|2-week Run-in Period|Continuation Criteria Not Met|0
1719640|NCT01086384|6001067|P1|2-week Run-in Period|Continuation Criteria Not Met|92
1719641|NCT01086384|6001065|P3|2-week Run-in Period|Study Closed/Terminated|0
1719642|NCT01086384|6001066|P2|2-week Run-in Period|Study Closed/Terminated|0
1719643|NCT01086384|6001067|P1|2-week Run-in Period|Study Closed/Terminated|42
1719644|NCT01086384|6001065|P3|2-week Run-in Period|Withdrawal by Subject|0
1719645|NCT01086384|6001066|P2|2-week Run-in Period|Withdrawal by Subject|0
1719646|NCT01086384|6001067|P1|2-week Run-in Period|Withdrawal by Subject|19
1719647|NCT01086384|6001065|P3|2-week Run-in Period|Physician Decision|0
1719648|NCT01086384|6001066|P2|2-week Run-in Period|Physician Decision|0
1719650|NCT01086384|6001065|P3|2-week Run-in Period|Lost to Follow-up|0
1719651|NCT01086384|6001066|P2|2-week Run-in Period|Lost to Follow-up|0
1719652|NCT01086384|6001067|P1|2-week Run-in Period|Lost to Follow-up|1
1719653|NCT01086384|6001065|P3|2-week Run-in Period|Protocol Violation|0
1719654|NCT01086384|6001066|P2|2-week Run-in Period|Protocol Violation|0
1719655|NCT01086384|6001067|P1|2-week Run-in Period|Protocol Violation|1
1719656|NCT01086384|6001065|P3|2-week Run-in Period|Adverse Event|0
1719657|NCT01086384|6001066|P2|2-week Run-in Period|Adverse Event|0
1719658|NCT01086384|6001067|P1|2-week Run-in Period|Adverse Event|1
1719659|NCT01086358|6001077|P2|Second Intervention|Lost to Follow-up|4
1719660|NCT01086358|6001078|P1|Second Intervention|Lost to Follow-up|4
1719661|NCT01086358|6001077|P2|First Intervention|Withdrawal by Subject|1
1719662|NCT01086358|6001078|P1|First Intervention|Withdrawal by Subject|0
1719663|NCT01086358|6001077|P2|First Intervention|Lost to Follow-up|4
1719664|NCT01086358|6001078|P1|First Intervention|Lost to Follow-up|9
1719665|NCT01086215|6001148|P4|Overall Study|Lost to Follow-up|2
1719666|NCT01086215|6001149|P3|Overall Study|Lost to Follow-up|18
1719667|NCT01086215|6001150|P2|Overall Study|Lost to Follow-up|39
1719668|NCT01086215|6001151|P1|Overall Study|Lost to Follow-up|22
1719669|NCT01086215|6001148|P4|Overall Study|Death|1
1719670|NCT01086215|6001149|P3|Overall Study|Death|8
1719671|NCT01086215|6001150|P2|Overall Study|Death|8
1719672|NCT01086215|6001151|P1|Overall Study|Death|14
1719673|NCT01086033|6001169|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
1719674|NCT01086033|6001169|P1|Overall Study|AE and Other Reason|1
1719675|NCT01086033|6001169|P1|Overall Study|AE and Lost to Follow-up|1
1719676|NCT01086033|6001169|P1|Overall Study|Death|1
1719677|NCT01086033|6001169|P1|Overall Study|AE and Lack of Efficacy|4
1719678|NCT01086033|6001169|P1|Overall Study|Withdrew consent and Other Reason|4
1719679|NCT01086033|6001169|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
1719680|NCT01086033|6001169|P1|Overall Study|AE and Withdrew Consent|5
1719681|NCT01086033|6001169|P1|Overall Study|Other|13
1719682|NCT01086033|6001169|P1|Overall Study|Other|14
1719683|NCT01086033|6001169|P1|Overall Study|Withdrawal by Subject|41
1719684|NCT01086033|6001169|P1|Overall Study|Adverse Event|42
1719685|NCT01086033|6001169|P1|Overall Study|Lost to Follow-up|86
1719686|NCT01086033|6001169|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
1719687|NCT01085812|6001235|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
1719688|NCT01085812|6001236|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
1719689|NCT01085812|6001235|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
1719690|NCT01085812|6001236|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
1719691|NCT01085812|6001235|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
1719692|NCT01085812|6001236|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
1719693|NCT01085812|6001235|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
1719694|NCT01085812|6001236|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
1719695|NCT01085812|6001235|P2|Double-blind Intent-to-treat Population|Adverse Event|8
1719696|NCT01085812|6001236|P1|Double-blind Intent-to-treat Population|Adverse Event|3
1719697|NCT01085812|6001235|P2|Double-Blind Period|Other Reasons|2
1719698|NCT01085812|6001236|P1|Double-Blind Period|Other Reasons|0
1719699|NCT01085812|6001235|P2|Double-Blind Period|Lost to Follow-up|17
1719700|NCT01085812|6001236|P1|Double-Blind Period|Lost to Follow-up|5
1719701|NCT01085812|6001235|P2|Double-Blind Period|Withdrawal by Subject|24
1719702|NCT01085812|6001236|P1|Double-Blind Period|Withdrawal by Subject|11
1719703|NCT01085812|6001235|P2|Double-Blind Period|Protocol Violation|7
1719704|NCT01085812|6001236|P1|Double-Blind Period|Protocol Violation|2
1719705|NCT01085812|6001235|P2|Double-Blind Period|Adverse Event|8
1719706|NCT01085812|6001236|P1|Double-Blind Period|Adverse Event|3
1719707|NCT01085812|6001235|P2|Open-Label Period|Lost to Follow-up|42
1719708|NCT01085812|6001236|P1|Open-Label Period|Lost to Follow-up|0
1719709|NCT01085812|6001235|P2|Open-Label Period|Withdrawal by Subject|53
1719710|NCT01085812|6001236|P1|Open-Label Period|Withdrawal by Subject|0
1719711|NCT01085812|6001235|P2|Open-Label Period|Protocol Violation|39
1719712|NCT01085812|6001236|P1|Open-Label Period|Protocol Violation|0
1719713|NCT01085812|6001235|P2|Open-Label Period|Lack of Efficacy|26
1719714|NCT01085812|6001236|P1|Open-Label Period|Lack of Efficacy|0
1719715|NCT01085812|6001235|P2|Open-Label Period|Adverse Event|80
1719716|NCT01085812|6001236|P1|Open-Label Period|Adverse Event|0
1719717|NCT01085734|6001283|P2|Overall Study|Withdrawal by Subject|1
1719718|NCT01085734|6001284|P1|Overall Study|Withdrawal by Subject|0
1719719|NCT01085734|6001283|P2|Overall Study|Lost to Follow-up|1
1719720|NCT01085734|6001284|P1|Overall Study|Lost to Follow-up|0
1719721|NCT01085734|6001283|P2|Overall Study|Death|0
1719722|NCT01085734|6001284|P1|Overall Study|Death|1
1719723|NCT01085734|6001283|P2|Overall Study|Adverse Event|2
1719724|NCT01085734|6001284|P1|Overall Study|Adverse Event|0
1719725|NCT01085682|6001296|P2|Overall Study|Withdrawal by Subject|25
1719726|NCT01085682|6001297|P1|Overall Study|Withdrawal by Subject|25
1719727|NCT01085630|6001314|P2|Overall Study|Ineligible|0
1719728|NCT01085630|6001315|P1|Overall Study|Ineligible|3
1719729|NCT01085630|6001314|P2|Overall Study|Insufficient data|0
1719730|NCT01085630|6001315|P1|Overall Study|Insufficient data|1
1719731|NCT01085591|6001328|P3|Overall Study|Not Properly Consented|0
1719732|NCT01085591|6001329|P2|Overall Study|Not Properly Consented|0
1719733|NCT01085591|6001330|P1|Overall Study|Not Properly Consented|1
1719734|NCT01085591|6001328|P3|Overall Study|Other|0
1719735|NCT01085591|6001329|P2|Overall Study|Other|1
1719736|NCT01085591|6001330|P1|Overall Study|Other|0
1719737|NCT01085591|6001328|P3|Overall Study|Protocol Violation|1
1719738|NCT01085591|6001329|P2|Overall Study|Protocol Violation|1
1719739|NCT01085591|6001330|P1|Overall Study|Protocol Violation|1
1719740|NCT01085591|6001328|P3|Overall Study|Lost to Follow-up|1
1719741|NCT01085591|6001329|P2|Overall Study|Lost to Follow-up|1
1719742|NCT01085591|6001330|P1|Overall Study|Lost to Follow-up|0
1719743|NCT01085591|6001328|P3|Overall Study|Withdrawal by Subject|1
1719744|NCT01085591|6001329|P2|Overall Study|Withdrawal by Subject|2
1719745|NCT01085591|6001330|P1|Overall Study|Withdrawal by Subject|0
1719746|NCT01085591|6001328|P3|Overall Study|Physician Decision|1
1719747|NCT01085591|6001329|P2|Overall Study|Physician Decision|0
1719748|NCT01085591|6001330|P1|Overall Study|Physician Decision|1
1719749|NCT01085591|6001328|P3|Overall Study|Adverse Event|3
1719750|NCT01085591|6001329|P2|Overall Study|Adverse Event|1
1719751|NCT01085591|6001330|P1|Overall Study|Adverse Event|0
1719752|NCT01085357|6001381|P2|Overall Study|Lost to Follow-up|0
1719753|NCT01085357|6001382|P1|Overall Study|Lost to Follow-up|2
1719754|NCT01085357|6001381|P2|Overall Study|Death|1
1719755|NCT01085357|6001382|P1|Overall Study|Death|11
1719756|NCT01085357|6001381|P2|Overall Study|Investigator Decision|1
1719757|NCT01085357|6001382|P1|Overall Study|Investigator Decision|1
1719758|NCT01085357|6001381|P2|Overall Study|Subject Decision|3
1719759|NCT01085357|6001382|P1|Overall Study|Subject Decision|4
1719760|NCT01085357|6001381|P2|Overall Study|Adverse Event|1
1719761|NCT01085357|6001382|P1|Overall Study|Adverse Event|1
1719762|NCT01085214|6001455|P1|Overall Study|Alternate treatment required|1
1719763|NCT01085201|6001467|P5|Overall Study|Fond ineligible after consent|0
1719764|NCT01085201|6001468|P4|Overall Study|Fond ineligible after consent|0
1719765|NCT01085201|6001469|P3|Overall Study|Fond ineligible after consent|1
1719766|NCT01085201|6001470|P2|Overall Study|Fond ineligible after consent|1
1719767|NCT01085201|6001471|P1|Overall Study|Fond ineligible after consent|0
1719768|NCT01085201|6001467|P5|Overall Study|Unknown- no study drug|0
1719769|NCT01085201|6001468|P4|Overall Study|Unknown- no study drug|0
1719770|NCT01085201|6001469|P3|Overall Study|Unknown- no study drug|0
1719771|NCT01085201|6001470|P2|Overall Study|Unknown- no study drug|0
1719772|NCT01085201|6001471|P1|Overall Study|Unknown- no study drug|2
1719773|NCT01085201|6001467|P5|Overall Study|Scheduling conflict|0
1719774|NCT01085201|6001468|P4|Overall Study|Scheduling conflict|0
1719775|NCT01085201|6001469|P3|Overall Study|Scheduling conflict|1
1719776|NCT01085201|6001470|P2|Overall Study|Scheduling conflict|0
1719777|NCT01085201|6001471|P1|Overall Study|Scheduling conflict|1
1719778|NCT01085136|6001493|P3|Part B|Other reason not defined above|3
1719779|NCT01085136|6001494|P2|Part B|Other reason not defined above|6
1719780|NCT01085136|6001495|P1|Part B|Other reason not defined above|0
1719781|NCT01085136|6001493|P3|Part B|Not treated|8
1719782|NCT01085136|6001494|P2|Part B|Not treated|4
1719783|NCT01085136|6001495|P1|Part B|Not treated|0
1719784|NCT01085136|6001493|P3|Part B|Refusal to continue trial medication|7
1719785|NCT01085136|6001494|P2|Part B|Refusal to continue trial medication|12
1719786|NCT01085136|6001495|P1|Part B|Refusal to continue trial medication|0
1719787|NCT01085136|6001493|P3|Part B|Other AE|8
1719788|NCT01085136|6001494|P2|Part B|Other AE|29
1719789|NCT01085136|6001495|P1|Part B|Other AE|0
1719790|NCT01085136|6001493|P3|Part A|Other reason not defined above|0
1719791|NCT01085136|6001494|P2|Part A|Other reason not defined above|0
1719792|NCT01085136|6001495|P1|Part A|Other reason not defined above|30
1719793|NCT01085136|6001493|P3|Part A|Refusal to continue trial medication|0
1719794|NCT01085136|6001494|P2|Part A|Refusal to continue trial medication|0
1719795|NCT01085136|6001495|P1|Part A|Refusal to continue trial medication|64
1719796|NCT01085136|6001493|P3|Part A|Lost to Follow-up|0
1719797|NCT01085136|6001494|P2|Part A|Lost to Follow-up|0
1719798|NCT01085136|6001495|P1|Part A|Lost to Follow-up|3
1719799|NCT01085136|6001493|P3|Part A|Protocol Violation|0
1719800|NCT01085136|6001494|P2|Part A|Protocol Violation|0
1719801|NCT01085136|6001495|P1|Part A|Protocol Violation|3
1719802|NCT01085136|6001493|P3|Part A|Other Adverse event|0
1719803|NCT01085136|6001494|P2|Part A|Other Adverse event|0
1719804|NCT01085136|6001495|P1|Part A|Other Adverse event|223
1719805|NCT01085045|6001511|P1|Part B|Adverse Event|6
1719806|NCT01085045|6001511|P1|Part B|Lost to Follow-up|1
1719807|NCT01085045|6001511|P1|Part B|Protocol Specified Criteria|6
1719808|NCT01085045|6001511|P1|Part B|Withdrawal by Subject|2
1719809|NCT01085045|6001511|P1|Part A|Protocol Specified Criteria|7
1719810|NCT01085045|6001511|P1|Part A|Protocol Violation|1
1719811|NCT01085045|6001511|P1|Part A|Adverse Event|6
1719812|NCT01085045|6001511|P1|Part A|Withdrawal by Subject|4
1719813|NCT01084707|6001626|P1|Overall Study|Withdrawal by Subject|6
1719814|NCT01084694|6001662|P2|Overall Study|eligibility not maintained|7
1719815|NCT01084694|6001663|P1|Overall Study|eligibility not maintained|2
1719816|NCT01084694|6001662|P2|Overall Study|Death|12
1719817|NCT01084694|6001663|P1|Overall Study|Death|2
1719818|NCT01084694|6001662|P2|Overall Study|Withdrawal by Subject|1
1719819|NCT01084694|6001663|P1|Overall Study|Withdrawal by Subject|2
1719820|NCT01084668|6001679|P1|Overall Study|Non-compliance|1
1719821|NCT01084668|6001679|P1|Overall Study|Pregnancy|1
1719822|NCT01084668|6001679|P1|Overall Study|Withdrawal by Subject|2
1719823|NCT01084668|6001679|P1|Overall Study|Lack of Efficacy|5
1719824|NCT01084655|6001691|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
1719825|NCT01084655|6001692|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
1719826|NCT01084655|6001693|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
1719827|NCT01084655|6001691|P3|Overall Study|Symptomatic deterioration|2
1719828|NCT01084655|6001692|P2|Overall Study|Symptomatic deterioration|0
1719829|NCT01084655|6001693|P1|Overall Study|Symptomatic deterioration|0
1719830|NCT01084655|6001691|P3|Overall Study|Other|2
1719831|NCT01084655|6001692|P2|Overall Study|Other|3
1719832|NCT01084655|6001693|P1|Overall Study|Other|0
1719833|NCT01084655|6001691|P3|Overall Study|Adverse Event|2
1719834|NCT01084655|6001692|P2|Overall Study|Adverse Event|1
1719835|NCT01084655|6001693|P1|Overall Study|Adverse Event|2
1719836|NCT01084655|6001691|P3|Overall Study|Withdrawal by Subject|4
1719837|NCT01084655|6001692|P2|Overall Study|Withdrawal by Subject|0
1719838|NCT01084655|6001693|P1|Overall Study|Withdrawal by Subject|1
1719839|NCT01084655|6001691|P3|Overall Study|Radiographic disease progression|8
1719840|NCT01084655|6001692|P2|Overall Study|Radiographic disease progression|2
1719841|NCT01084655|6001693|P1|Overall Study|Radiographic disease progression|3
1719842|NCT01084603|6001728|P1|Washout Period 4|Adverse Event|1
1719843|NCT01084603|6001728|P1|Oral Nicotine 1|Withdrawal by Subject|1
1719844|NCT01084603|6001728|P1|Nicorette® Gum|Withdrawal by Subject|1
1719845|NCT01084603|6001728|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
1719846|NCT01084603|6001728|P1|Baseline|Withdrawal by Subject|2
1719847|NCT01084551|6001764|P3|Overall Study|Physician Decision|0
1719848|NCT01084551|6001765|P2|Overall Study|Physician Decision|0
1719849|NCT01084551|6001766|P1|Overall Study|Physician Decision|1
1719850|NCT01084551|6001764|P3|Overall Study|Lost to Follow-up|3
1719851|NCT01084551|6001765|P2|Overall Study|Lost to Follow-up|0
1719852|NCT01084551|6001766|P1|Overall Study|Lost to Follow-up|0
1719853|NCT01084551|6001764|P3|Overall Study|Protocol Violation|0
1719854|NCT01084551|6001765|P2|Overall Study|Protocol Violation|4
1719855|NCT01084551|6001766|P1|Overall Study|Protocol Violation|2
1719856|NCT01084551|6001764|P3|Overall Study|Withdrawal by Subject|0
1719857|NCT01084551|6001765|P2|Overall Study|Withdrawal by Subject|1
1719858|NCT01084551|6001766|P1|Overall Study|Withdrawal by Subject|2
1719859|NCT01084551|6001764|P3|Overall Study|Lack of Efficacy|1
1719860|NCT01084551|6001765|P2|Overall Study|Lack of Efficacy|0
1719861|NCT01084551|6001766|P1|Overall Study|Lack of Efficacy|2
1719862|NCT01084551|6001764|P3|Overall Study|Adverse Event|4
1719863|NCT01084551|6001765|P2|Overall Study|Adverse Event|9
1719864|NCT01084551|6001766|P1|Overall Study|Adverse Event|2
1719865|NCT01084538|6001804|P1|Overall Study|Reason unknown|8
1719866|NCT01084538|6001804|P1|Overall Study|Over-suppression of parathyroid gland|2
1719867|NCT01084538|6001804|P1|Overall Study|Change of residence|2
1719868|NCT01084538|6001804|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
1719869|NCT01084538|6001804|P1|Overall Study|Hyperphosphatemia|2
1719870|NCT01084538|6001804|P1|Overall Study|Patient noncompliance|2
1719871|NCT01084538|6001804|P1|Overall Study|Lack of effectiveness|2
1719872|NCT01084538|6001804|P1|Overall Study|Serious Adverse Event|3
1719873|NCT01084538|6001804|P1|Overall Study|Kidney transplant|6
1719874|NCT01084538|6001804|P1|Overall Study|Adverse Event|9
1719875|NCT01084538|6001804|P1|Overall Study|Drug not available|30
1719876|NCT01084239|6001926|P2|28-Day Follow-up|Lost to Follow-up|9
1719877|NCT01084239|6001927|P1|28-Day Follow-up|Lost to Follow-up|4
1719878|NCT01084174|6001945|P2|Overall Study|Participant noncompliance|1
1719879|NCT01084174|6001946|P1|Overall Study|Participant noncompliance|0
1719880|NCT01084174|6001945|P2|Overall Study|Anaphylaxis|1
1719881|NCT01084174|6001946|P1|Overall Study|Anaphylaxis|0
1719882|NCT01084174|6001945|P2|Overall Study|Eosinophilic esophagitis|1
1719883|NCT01084174|6001946|P1|Overall Study|Eosinophilic esophagitis|0
1719884|NCT01084174|6001945|P2|Overall Study|gastrointestinal symptoms|1
1719885|NCT01084174|6001946|P1|Overall Study|gastrointestinal symptoms|1
1719886|NCT01084135|6001979|P2|20 Week|Physician Decision|1
1719887|NCT01084135|6001980|P1|20 Week|Physician Decision|0
1719888|NCT01084083|6001990|P1|Overall Study|Never started assigned therapy|1
1719889|NCT01084083|6001990|P1|Overall Study|Other|2
1719890|NCT01084083|6001990|P1|Overall Study|Complicating disease|1
1719891|NCT01084083|6001990|P1|Overall Study|Withdrawal by Subject|2
1719892|NCT01084083|6001990|P1|Overall Study|Death|1
1719893|NCT01084083|6001990|P1|Overall Study|Adverse Event|5
1719894|NCT01084005|6001998|P2|Overall Study|Withdrawal by Subject|1
1719895|NCT01084005|6001999|P1|Overall Study|Withdrawal by Subject|1
1719896|NCT01084005|6001998|P2|Overall Study|Protocol Violation|7
1719897|NCT01084005|6001999|P1|Overall Study|Protocol Violation|3
1719898|NCT01084005|6001998|P2|Overall Study|Adverse Event|8
1719899|NCT01084005|6001999|P1|Overall Study|Adverse Event|1
1719900|NCT01083810|6002080|P3|Overall Study|Virologic failure|0
1719901|NCT01083810|6002081|P2|Overall Study|Virologic failure|8
1719902|NCT01083810|6002082|P1|Overall Study|Virologic failure|1
1719903|NCT01083810|6002080|P3|Overall Study|Therapy break|2
1719904|NCT01083810|6002081|P2|Overall Study|Therapy break|2
1719905|NCT01083810|6002082|P1|Overall Study|Therapy break|1
1719906|NCT01083810|6002080|P3|Overall Study|Participation in study|0
1719907|NCT01083810|6002081|P2|Overall Study|Participation in study|0
1719908|NCT01083810|6002082|P1|Overall Study|Participation in study|1
1719909|NCT01083810|6002080|P3|Overall Study|Co-morbidities|0
1719910|NCT01083810|6002081|P2|Overall Study|Co-morbidities|0
1719911|NCT01083810|6002082|P1|Overall Study|Co-morbidities|1
1719912|NCT01083810|6002080|P3|Overall Study|Death|3
1719913|NCT01083810|6002081|P2|Overall Study|Death|2
1719914|NCT01083810|6002082|P1|Overall Study|Death|2
1719915|NCT01083810|6002080|P3|Overall Study|Simplification|0
1719916|NCT01083810|6002081|P2|Overall Study|Simplification|1
1719917|NCT01083810|6002082|P1|Overall Study|Simplification|4
1719918|NCT01083810|6002080|P3|Overall Study|Non-compliance|2
1719919|NCT01083810|6002081|P2|Overall Study|Non-compliance|7
1719920|NCT01083810|6002082|P1|Overall Study|Non-compliance|4
1719921|NCT01083810|6002080|P3|Overall Study|Reason not reported|1
1719922|NCT01083810|6002081|P2|Overall Study|Reason not reported|1
1719923|NCT01083810|6002082|P1|Overall Study|Reason not reported|6
1719924|NCT01083810|6002080|P3|Overall Study|Withdrawal by Subject|4
1719925|NCT01083810|6002081|P2|Overall Study|Withdrawal by Subject|2
1719926|NCT01083810|6002082|P1|Overall Study|Withdrawal by Subject|7
1719927|NCT01083810|6002080|P3|Overall Study|Adverse Event|4
1719928|NCT01083810|6002081|P2|Overall Study|Adverse Event|11
1719929|NCT01083810|6002082|P1|Overall Study|Adverse Event|15
1719930|NCT01083810|6002080|P3|Overall Study|Lost to Follow-up|4
1719931|NCT01083810|6002081|P2|Overall Study|Lost to Follow-up|11
1719932|NCT01083810|6002082|P1|Overall Study|Lost to Follow-up|23
1719933|NCT01083771|6002103|P1|Overall Study|Withdrawal by Subject|3
1719934|NCT01083771|6002103|P1|Overall Study|non-compliant|2
1719935|NCT01083693|6002204|P3|Overall Study|Reason unknown|1
1719936|NCT01083693|6002205|P2|Overall Study|Reason unknown|0
1719937|NCT01083693|6002206|P1|Overall Study|Reason unknown|0
1719938|NCT01083693|6002204|P3|Overall Study|Withdrawal by Subject|2
1719939|NCT01083693|6002205|P2|Overall Study|Withdrawal by Subject|0
1719940|NCT01083693|6002206|P1|Overall Study|Withdrawal by Subject|3
1719941|NCT01083693|6002204|P3|Overall Study|Other medical condition/surgery|0
1719942|NCT01083693|6002205|P2|Overall Study|Other medical condition/surgery|1
1719943|NCT01083693|6002206|P1|Overall Study|Other medical condition/surgery|1
1719944|NCT01083693|6002204|P3|Overall Study|Complete remission|0
1719945|NCT01083693|6002205|P2|Overall Study|Complete remission|1
1719946|NCT01083693|6002206|P1|Overall Study|Complete remission|0
1719947|NCT01083693|6002204|P3|Overall Study|Patient Moved|0
1719948|NCT01083693|6002205|P2|Overall Study|Patient Moved|1
1719949|NCT01083693|6002206|P1|Overall Study|Patient Moved|0
1719950|NCT01083693|6002204|P3|Overall Study|Lack of effectiveness|2
1719951|NCT01083693|6002205|P2|Overall Study|Lack of effectiveness|2
1719952|NCT01083693|6002206|P1|Overall Study|Lack of effectiveness|13
1719953|NCT01083693|6002204|P3|Overall Study|Lost to Follow-up|2
1719954|NCT01083693|6002205|P2|Overall Study|Lost to Follow-up|0
1719955|NCT01083693|6002206|P1|Overall Study|Lost to Follow-up|2
1719956|NCT01083693|6002204|P3|Overall Study|Adverse Event|0
1719957|NCT01083693|6002205|P2|Overall Study|Adverse Event|1
1719958|NCT01083693|6002206|P1|Overall Study|Adverse Event|1
1719959|NCT01083680|6002241|P1|Overall Study|Withdrawal by Subject|1086
1719960|NCT01083680|6002241|P1|Overall Study|Lost to Follow-up|2758
1719961|NCT01083641|6002264|P1|Overall Study|Withdrawal by Subject|2
1719962|NCT01083602|6002284|P1|Overall Study|Lack of Efficacy|36
1719963|NCT01083602|6002284|P1|Overall Study|Withdrawal by Subject|5
1719964|NCT01083602|6002284|P1|Overall Study|Death|1
1719965|NCT01083602|6002284|P1|Overall Study|New Cancer Therapy|2
1719966|NCT01083602|6002284|P1|Overall Study|Adverse Event|11
1719967|NCT01083576|6002295|P2|Overall Study|Treatment Failure|1
1719968|NCT01083576|6002296|P1|Overall Study|Treatment Failure|6
1719969|NCT01083485|6002326|P2|Overall Study|Other|0
1719970|NCT01083485|6002327|P1|Overall Study|Other|1
1719971|NCT01083485|6002326|P2|Overall Study|Withdrawal by Subject|2
1719972|NCT01083485|6002327|P1|Overall Study|Withdrawal by Subject|5
1719973|NCT01083485|6002326|P2|Overall Study|Protocol Violation|0
1719974|NCT01083485|6002327|P1|Overall Study|Protocol Violation|1
1719975|NCT01083485|6002326|P2|Overall Study|Adverse Event|1
1719976|NCT01083485|6002327|P1|Overall Study|Adverse Event|0
1719977|NCT01083316|6002359|P1|Overall Study|Withdrawal by Subject|1
1719978|NCT01083316|6002359|P1|Overall Study|Adverse Event|2
1719979|NCT01083186|6002371|P1|Overall Study|Non-compliance to Study Treatment|1
1719980|NCT01083186|6002371|P1|Overall Study|Administrative Reasons|2
1719981|NCT01083186|6002371|P1|Overall Study|Hemodialysis Initiation|28
1719982|NCT01083186|6002371|P1|Overall Study|Lack of Efficacy|2
1719983|NCT01083186|6002371|P1|Overall Study|Adverse Event|3
1719984|NCT01083186|6002371|P1|Overall Study|Death|3
1719985|NCT01083186|6002371|P1|Overall Study|Consent Withdrawal|7
1719986|NCT01083186|6002371|P1|Overall Study|Lost to Follow-up|48
1719987|NCT01083173|6002412|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
1719988|NCT01083173|6002413|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
1719989|NCT01083173|6002412|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
1719990|NCT01083173|6002413|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
1719991|NCT01083173|6002412|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
1719992|NCT01083173|6002413|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
1719993|NCT01083173|6002412|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
1719994|NCT01083173|6002413|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
1719995|NCT01083173|6002412|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
1719996|NCT01083173|6002413|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
1719997|NCT01083173|6002412|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
1719998|NCT01083173|6002413|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
1720083|NCT01081912|6002715|P2|Maintenance Treatment|Withdrawal by Subject|5
1719999|NCT01083173|6002412|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
1720000|NCT01083173|6002413|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
1720001|NCT01083173|6002412|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
1720002|NCT01083173|6002413|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
1720003|NCT01083173|6002412|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
1720004|NCT01083173|6002413|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
1720005|NCT01083173|6002412|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
1720006|NCT01083173|6002413|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
1720007|NCT01083173|6002412|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
1720008|NCT01083173|6002413|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
1720009|NCT01083160|6002431|P1|Overall Study|Adverse Event|1
1720010|NCT01083121|6002438|P1|Overall Study|Use of Humira outside the approved label|81
1720011|NCT01082965|6002448|P2|Overall Study|Other|1
1720012|NCT01082965|6002449|P1|Overall Study|Other|1
1720013|NCT01082965|6002448|P2|Overall Study|Protocol Violation|1
1720014|NCT01082965|6002449|P1|Overall Study|Protocol Violation|0
1720015|NCT01082874|6002486|P4|Overall Study|Withdrawal by Subject|3
1720016|NCT01082874|6002487|P3|Overall Study|Withdrawal by Subject|5
1720017|NCT01082874|6002488|P2|Overall Study|Withdrawal by Subject|2
1720018|NCT01082874|6002489|P1|Overall Study|Withdrawal by Subject|1
1720019|NCT01082874|6002486|P4|Overall Study|Lost to Follow-up|10
1720020|NCT01082874|6002487|P3|Overall Study|Lost to Follow-up|6
1720021|NCT01082874|6002488|P2|Overall Study|Lost to Follow-up|10
1720022|NCT01082874|6002489|P1|Overall Study|Lost to Follow-up|10
1720023|NCT01082640|6002502|P3|Overall Study|Other|3
1720024|NCT01082640|6002503|P2|Overall Study|Other|1
1720025|NCT01082640|6002504|P1|Overall Study|Other|2
1720026|NCT01082640|6002502|P3|Overall Study|Lost to Follow-up|0
1720027|NCT01082640|6002503|P2|Overall Study|Lost to Follow-up|3
1720028|NCT01082640|6002504|P1|Overall Study|Lost to Follow-up|0
1720029|NCT01082640|6002502|P3|Overall Study|Major protocol deviation|0
1720030|NCT01082640|6002503|P2|Overall Study|Major protocol deviation|3
1720031|NCT01082640|6002504|P1|Overall Study|Major protocol deviation|3
1720032|NCT01082640|6002502|P3|Overall Study|Withdrawal by Subject|2
1720033|NCT01082640|6002503|P2|Overall Study|Withdrawal by Subject|3
1720034|NCT01082640|6002504|P1|Overall Study|Withdrawal by Subject|3
1720035|NCT01082640|6002502|P3|Overall Study|Adverse Event|3
1720036|NCT01082640|6002503|P2|Overall Study|Adverse Event|5
1720037|NCT01082640|6002504|P1|Overall Study|Adverse Event|9
1720038|NCT01082614|6002526|P2|Overall Study|Physician Decision|0
1720039|NCT01082614|6002527|P1|Overall Study|Physician Decision|2
1720040|NCT01082614|6002526|P2|Overall Study|Equipment Malfunction|1
1720041|NCT01082614|6002527|P1|Overall Study|Equipment Malfunction|0
1720042|NCT01082614|6002526|P2|Overall Study|Adverse Event|4
1720043|NCT01082614|6002527|P1|Overall Study|Adverse Event|1
1720044|NCT01082367|6002598|P2|Follow-up (F-U) Period|Adverse Event|1
1720045|NCT01082367|6002599|P1|Follow-up (F-U) Period|Adverse Event|0
1720046|NCT01082367|6002598|P2|Follow-up (F-U) Period|Abnormal lab values|0
1720047|NCT01082367|6002599|P1|Follow-up (F-U) Period|Abnormal lab values|1
1720048|NCT01082367|6002598|P2|Follow-up (F-U) Period|Administrative problems|0
1720049|NCT01082367|6002599|P1|Follow-up (F-U) Period|Administrative problems|1
1720050|NCT01082367|6002598|P2|Double-blind Period|Adverse Event|1
1720051|NCT01082367|6002599|P1|Double-blind Period|Adverse Event|0
1720052|NCT01082367|6002598|P2|Double-blind Period|Lack of Efficacy|11
1720053|NCT01082367|6002599|P1|Double-blind Period|Lack of Efficacy|5
1720054|NCT01082367|6002598|P2|Double-blind Period|Administrative problems|1
1720055|NCT01082367|6002599|P1|Double-blind Period|Administrative problems|0
1720056|NCT01082328|6002613|P1|Overall Study|Adverse Event|1
1720057|NCT01082211|6002622|P1|Overall Study|No protocol treatment received|3
1720058|NCT01082211|6002622|P1|Overall Study|Protocol Violation|4
1720059|NCT01082081|6002649|P3|Overall Study|Other Reason|0
1720060|NCT01082081|6002650|P2|Overall Study|Other Reason|1
1720061|NCT01082081|6002651|P1|Overall Study|Other Reason|0
1720062|NCT01082081|6002649|P3|Overall Study|Withdrawal by Subject|1
1720063|NCT01082081|6002650|P2|Overall Study|Withdrawal by Subject|0
1720064|NCT01082081|6002651|P1|Overall Study|Withdrawal by Subject|0
1720065|NCT01082081|6002649|P3|Overall Study|Lost to Follow-up|1
1720066|NCT01082081|6002650|P2|Overall Study|Lost to Follow-up|0
1720067|NCT01082081|6002651|P1|Overall Study|Lost to Follow-up|0
1720068|NCT01081951|6002703|P2|Overall Study|Lost to Follow-up|1
1720069|NCT01081951|6002704|P1|Overall Study|Lost to Follow-up|0
1720070|NCT01081951|6002703|P2|Overall Study|Allocated treatment but did not take it|1
1720071|NCT01081951|6002704|P1|Overall Study|Allocated treatment but did not take it|0
1720072|NCT01081951|6002703|P2|Overall Study|Withdrawal by Subject|6
1720073|NCT01081951|6002704|P1|Overall Study|Withdrawal by Subject|2
1720074|NCT01081951|6002703|P2|Overall Study|Death|47
1720075|NCT01081951|6002704|P1|Overall Study|Death|54
1720076|NCT01081912|6002714|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
1720077|NCT01081912|6002715|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
1720078|NCT01081912|6002716|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
1720079|NCT01081912|6002714|P3|Maintenance Treatment|Non-Compliance|7
1720080|NCT01081912|6002715|P2|Maintenance Treatment|Non-Compliance|4
1720081|NCT01081912|6002716|P1|Maintenance Treatment|Non-Compliance|0
1720082|NCT01081912|6002714|P3|Maintenance Treatment|Withdrawal by Subject|5
1720084|NCT01081912|6002716|P1|Maintenance Treatment|Withdrawal by Subject|0
1720085|NCT01081912|6002714|P3|Maintenance Treatment|Protocol Violation|2
1720086|NCT01081912|6002715|P2|Maintenance Treatment|Protocol Violation|1
1720087|NCT01081912|6002716|P1|Maintenance Treatment|Protocol Violation|0
1720088|NCT01081912|6002714|P3|Maintenance Treatment|Physician Decision|1
1720089|NCT01081912|6002715|P2|Maintenance Treatment|Physician Decision|0
1720090|NCT01081912|6002716|P1|Maintenance Treatment|Physician Decision|0
1720091|NCT01081912|6002714|P3|Maintenance Treatment|Lost to Follow-up|0
1720092|NCT01081912|6002715|P2|Maintenance Treatment|Lost to Follow-up|1
1720093|NCT01081912|6002716|P1|Maintenance Treatment|Lost to Follow-up|0
1720094|NCT01081912|6002714|P3|Maintenance Treatment|Lack of Efficacy|64
1720095|NCT01081912|6002715|P2|Maintenance Treatment|Lack of Efficacy|14
1720096|NCT01081912|6002716|P1|Maintenance Treatment|Lack of Efficacy|0
1720097|NCT01081912|6002714|P3|Maintenance Treatment|Adverse Event|12
1720098|NCT01081912|6002715|P2|Maintenance Treatment|Adverse Event|2
1720099|NCT01081912|6002716|P1|Maintenance Treatment|Adverse Event|0
1720100|NCT01081912|6002714|P3|Conversion/Titration|Non-Compliance|0
1720101|NCT01081912|6002715|P2|Conversion/Titration|Non-Compliance|0
1720102|NCT01081912|6002716|P1|Conversion/Titration|Non-Compliance|47
1720103|NCT01081912|6002714|P3|Conversion/Titration|Withdrawal by Subject|0
1720104|NCT01081912|6002715|P2|Conversion/Titration|Withdrawal by Subject|0
1720105|NCT01081912|6002716|P1|Conversion/Titration|Withdrawal by Subject|23
1720106|NCT01081912|6002714|P3|Conversion/Titration|Protocol Violation|0
1720107|NCT01081912|6002715|P2|Conversion/Titration|Protocol Violation|0
1720108|NCT01081912|6002716|P1|Conversion/Titration|Protocol Violation|67
1720109|NCT01081912|6002714|P3|Conversion/Titration|Physician Decision|0
1720110|NCT01081912|6002715|P2|Conversion/Titration|Physician Decision|0
1720111|NCT01081912|6002716|P1|Conversion/Titration|Physician Decision|2
1720112|NCT01081912|6002714|P3|Conversion/Titration|Lost to Follow-up|0
1720113|NCT01081912|6002715|P2|Conversion/Titration|Lost to Follow-up|0
1720114|NCT01081912|6002716|P1|Conversion/Titration|Lost to Follow-up|5
1720115|NCT01081912|6002714|P3|Conversion/Titration|Lack of Efficacy|0
1720116|NCT01081912|6002715|P2|Conversion/Titration|Lack of Efficacy|0
1720117|NCT01081912|6002716|P1|Conversion/Titration|Lack of Efficacy|17
1720118|NCT01081912|6002714|P3|Conversion/Titration|Adverse Event|0
1720119|NCT01081912|6002715|P2|Conversion/Titration|Adverse Event|0
1720120|NCT01081912|6002716|P1|Conversion/Titration|Adverse Event|47
1720121|NCT01081886|6002725|P2|Overall Study|Study termination|13
1720122|NCT01081886|6002726|P1|Overall Study|Study termination|11
1720123|NCT01081873|6002734|P1|Overall Study|Other|47
1720124|NCT01081873|6002734|P1|Overall Study|Progression of prostate cancer|13
1720125|NCT01081873|6002734|P1|Overall Study|Lost to Follow-up|142
1720126|NCT01081873|6002734|P1|Overall Study|Withdrawal by Subject|10
1720127|NCT01081873|6002734|P1|Overall Study|Death|86
1720128|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
1720129|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
1720130|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
1720131|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
1720132|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
1720133|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1720134|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1720135|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
1720136|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
1720137|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
1720138|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Other|0
1720139|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Other|0
1720140|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Other|4
1720141|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Other|5
1720142|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Other|4
1720143|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1720144|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1720145|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
1720146|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
1720147|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
1720148|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1720149|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1720150|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1720151|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
1720152|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
1720153|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1720154|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1720155|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1720156|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
1720157|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1720158|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
1720159|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
1720160|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
1720161|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1720162|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
1720163|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1720164|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1720165|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1720166|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
1720167|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
1720168|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Death|0
1720169|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Death|0
1720170|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Death|0
1720171|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Death|0
1720172|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Death|1
1720173|NCT01081834|6002806|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
1720174|NCT01081834|6002807|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
1720175|NCT01081834|6002808|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
1720176|NCT01081834|6002809|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
1720177|NCT01081834|6002810|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
1720178|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1720179|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1720180|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
1720181|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
1720182|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
1720183|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Other|0
1720184|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Other|1
1720185|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Other|3
1720186|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Other|4
1720187|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Other|4
1720188|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1720189|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1720190|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1720191|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
1720192|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
1720193|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1720194|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
1720195|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
1720196|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
1720197|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
1720198|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
1720199|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1720200|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
1720201|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
1720202|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
1720203|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Protocol Violation|2
1720204|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Protocol Violation|0
1720205|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Protocol Violation|0
1720206|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Protocol Violation|4
1720207|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Protocol Violation|0
1720208|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
1720209|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
1720210|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
1720211|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
1720212|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
1720213|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Death|0
1720214|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Death|0
1720215|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Death|0
1720216|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Death|0
1720217|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Death|1
1720218|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Adverse Event|1
1720219|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Adverse Event|1
1720220|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Adverse Event|3
1720221|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Adverse Event|5
1720222|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Adverse Event|2
1720223|NCT01081834|6002806|P5|Core Period: Baseline to Week 26|Pregnancy|0
1720224|NCT01081834|6002807|P4|Core Period: Baseline to Week 26|Pregnancy|0
1720225|NCT01081834|6002808|P3|Core Period: Baseline to Week 26|Pregnancy|0
1720226|NCT01081834|6002809|P2|Core Period: Baseline to Week 26|Pregnancy|0
1720227|NCT01081834|6002810|P1|Core Period: Baseline to Week 26|Pregnancy|1
1720228|NCT01081795|6002871|P3|Overall Study|Other|0
1720229|NCT01081795|6002872|P2|Overall Study|Other|2
1720230|NCT01081795|6002873|P1|Overall Study|Other|1
1720231|NCT01081795|6002871|P3|Overall Study|Using drug with restricted days of use|2
1720232|NCT01081795|6002872|P2|Overall Study|Using drug with restricted days of use|3
1720233|NCT01081795|6002873|P1|Overall Study|Using drug with restricted days of use|2
1720234|NCT01081795|6002871|P3|Overall Study|Use of a prohibited concomitant drug|1
1720235|NCT01081795|6002872|P2|Overall Study|Use of a prohibited concomitant drug|1
1720236|NCT01081795|6002873|P1|Overall Study|Use of a prohibited concomitant drug|1
1720237|NCT01081795|6002871|P3|Overall Study|Ineligible for participation|0
1720238|NCT01081795|6002872|P2|Overall Study|Ineligible for participation|0
1720239|NCT01081795|6002873|P1|Overall Study|Ineligible for participation|1
1720240|NCT01081795|6002871|P3|Overall Study|Revocation of informed consent|0
1720241|NCT01081795|6002872|P2|Overall Study|Revocation of informed consent|0
1720242|NCT01081795|6002873|P1|Overall Study|Revocation of informed consent|2
1720243|NCT01081795|6002871|P3|Overall Study|Subject’s schedule|2
1720244|NCT01081795|6002872|P2|Overall Study|Subject’s schedule|1
1720245|NCT01081795|6002873|P1|Overall Study|Subject’s schedule|1
1720246|NCT01081795|6002871|P3|Overall Study|Lack of Efficacy|19
1720247|NCT01081795|6002872|P2|Overall Study|Lack of Efficacy|5
1720248|NCT01081795|6002873|P1|Overall Study|Lack of Efficacy|7
1720249|NCT01081795|6002871|P3|Overall Study|Adverse Event|6
1720250|NCT01081795|6002872|P2|Overall Study|Adverse Event|23
1720251|NCT01081795|6002873|P1|Overall Study|Adverse Event|18
1720252|NCT01081769|6002910|P2|CORE Intent-To-Treat|Patient Moved|2
1720253|NCT01081769|6002911|P1|CORE Intent-To-Treat|Patient Moved|2
1720254|NCT01081769|6002910|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
1720255|NCT01081769|6002911|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
1720256|NCT01081769|6002910|P2|CORE Intent-To-Treat|Ineligibility|4
1720257|NCT01081769|6002911|P1|CORE Intent-To-Treat|Ineligibility|3
1720258|NCT01081769|6002910|P2|CORE Intent-To-Treat|Other|1
1720259|NCT01081769|6002911|P1|CORE Intent-To-Treat|Other|0
1720260|NCT01081769|6002910|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
1720261|NCT01081769|6002911|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
1720262|NCT01081769|6002910|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
1720263|NCT01081769|6002911|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
1720264|NCT01081769|6002910|P2|CORE Intent-To-Treat|Pregnancy|0
1720265|NCT01081769|6002911|P1|CORE Intent-To-Treat|Pregnancy|1
1720266|NCT01081769|6002910|P2|CORE Intent-To-Treat|Lost to Follow-up|5
1720267|NCT01081769|6002911|P1|CORE Intent-To-Treat|Lost to Follow-up|4
1720268|NCT01081769|6002910|P2|CORE Intent-To-Treat|Lack of Efficacy|6
1720269|NCT01081769|6002911|P1|CORE Intent-To-Treat|Lack of Efficacy|2
1720270|NCT01081769|6002910|P2|CORE Intent-To-Treat|Death|1
1720271|NCT01081769|6002911|P1|CORE Intent-To-Treat|Death|1
1720272|NCT01081769|6002910|P2|CORE Intent-To-Treat|Adverse Event|11
1720273|NCT01081769|6002911|P1|CORE Intent-To-Treat|Adverse Event|14
1720274|NCT01081769|6002910|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
1720275|NCT01081769|6002911|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
1720276|NCT01081769|6002910|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
1720277|NCT01081769|6002911|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
1720278|NCT01081769|6002910|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
1720279|NCT01081769|6002911|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
1720280|NCT01081769|6002910|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
1720281|NCT01081769|6002911|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
1720282|NCT01081678|6002949|P4|Overall Study|Other|0
1720283|NCT01081678|6002950|P3|Overall Study|Other|0
1720284|NCT01081678|6002951|P2|Overall Study|Other|1
1720285|NCT01081678|6002952|P1|Overall Study|Other|0
1720286|NCT01081678|6002949|P4|Overall Study|Death|6
1720287|NCT01081678|6002950|P3|Overall Study|Death|2
1720288|NCT01081678|6002951|P2|Overall Study|Death|2
1720289|NCT01081678|6002952|P1|Overall Study|Death|2
1720290|NCT01081678|6002949|P4|Overall Study|Lost to Follow-up|3
1720291|NCT01081678|6002950|P3|Overall Study|Lost to Follow-up|4
1720292|NCT01081678|6002951|P2|Overall Study|Lost to Follow-up|1
1720293|NCT01081678|6002952|P1|Overall Study|Lost to Follow-up|4
1720294|NCT01081678|6002949|P4|Overall Study|Administrative Decision|1
1720295|NCT01081678|6002950|P3|Overall Study|Administrative Decision|0
1720296|NCT01081678|6002951|P2|Overall Study|Administrative Decision|0
1720297|NCT01081678|6002952|P1|Overall Study|Administrative Decision|1
1720298|NCT01081678|6002949|P4|Overall Study|Withdrawal by Subject|14
1720299|NCT01081678|6002950|P3|Overall Study|Withdrawal by Subject|17
1720300|NCT01081678|6002951|P2|Overall Study|Withdrawal by Subject|7
1720301|NCT01081678|6002952|P1|Overall Study|Withdrawal by Subject|15
1720302|NCT01081678|6002949|P4|Overall Study|Adverse Event|2
1720303|NCT01081678|6002950|P3|Overall Study|Adverse Event|2
1720304|NCT01081678|6002951|P2|Overall Study|Adverse Event|1
1720305|NCT01081678|6002952|P1|Overall Study|Adverse Event|2
1720306|NCT01081678|6002949|P4|Overall Study|Noncompliance|2
1720307|NCT01081678|6002950|P3|Overall Study|Noncompliance|5
1720308|NCT01081678|6002951|P2|Overall Study|Noncompliance|4
1720309|NCT01081678|6002952|P1|Overall Study|Noncompliance|3
1720310|NCT01081678|6002949|P4|Overall Study|Ineligibility Determined|1
1720311|NCT01081678|6002950|P3|Overall Study|Ineligibility Determined|1
1720312|NCT01081678|6002951|P2|Overall Study|Ineligibility Determined|0
1720313|NCT01081678|6002952|P1|Overall Study|Ineligibility Determined|0
1720314|NCT01081665|6002982|P1|Overall Study|Lack of Efficacy|1
1720315|NCT01081665|6002982|P1|Overall Study|Adverse Event|1
1720316|NCT01081665|6002982|P1|Overall Study|Change in renal replacement therapy|2
1720317|NCT01081665|6002982|P1|Overall Study|Regulation of iPTH|5
1720318|NCT01081665|6002982|P1|Overall Study|Change of dialysis unit|10
1720319|NCT01081665|6002982|P1|Overall Study|Withdrawal by Subject|17
1720320|NCT01081665|6002982|P1|Overall Study|Lost to Follow-up|18
1720321|NCT01081665|6002982|P1|Overall Study|Death|41
1720322|NCT01081626|6002994|P2|Overall Study|Other|30
1720323|NCT01081626|6002995|P1|Overall Study|Other|33
1720324|NCT01081626|6002994|P2|Overall Study|Lost to Follow-up|1
1720325|NCT01081626|6002995|P1|Overall Study|Lost to Follow-up|0
1720326|NCT01081626|6002994|P2|Overall Study|Overstimulation|1
1720327|NCT01081626|6002995|P1|Overall Study|Overstimulation|0
1720328|NCT01081626|6002994|P2|Overall Study|Low antral follicle count|0
1720329|NCT01081626|6002995|P1|Overall Study|Low antral follicle count|1
1720330|NCT01081626|6002994|P2|Overall Study|Missing Estradiol|28
1720331|NCT01081626|6002995|P1|Overall Study|Missing Estradiol|25
1720332|NCT01081626|6002994|P2|Overall Study|Dosing error|1
1720333|NCT01081626|6002995|P1|Overall Study|Dosing error|1
1720334|NCT01081301|6003021|P1|Overall Study|Lost to Follow-up|4
1720335|NCT01081301|6003021|P1|Overall Study|Patient too ill|2
1720336|NCT01081301|6003021|P1|Overall Study|Too busy|5
1720337|NCT01081301|6003021|P1|Overall Study|Bereaved|3
1720338|NCT01081249|6003096|P2|Overall Study|Diagnosed with Bipolar Disorder|1
1720339|NCT01081249|6003097|P1|Overall Study|Diagnosed with Bipolar Disorder|0
1720340|NCT01081145|6003103|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
1720341|NCT01081145|6003104|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
1720342|NCT01081145|6003103|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
1720343|NCT01081145|6003104|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
1720344|NCT01081145|6003103|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
1720345|NCT01081145|6003104|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
1720346|NCT01081145|6003103|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
1720347|NCT01081145|6003104|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
1720348|NCT01081145|6003103|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
1720349|NCT01081145|6003104|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
1720350|NCT01081145|6003103|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
1720351|NCT01081145|6003104|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
1720352|NCT01081145|6003103|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
1720353|NCT01081145|6003104|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
1720354|NCT01081145|6003103|P2|Open-Label Phase|Protocol Violation|0
1720355|NCT01081145|6003104|P1|Open-Label Phase|Protocol Violation|4
1720356|NCT01081145|6003103|P2|Open-Label Phase|Lost to Follow-up|0
1720357|NCT01081145|6003104|P1|Open-Label Phase|Lost to Follow-up|11
1720358|NCT01081145|6003103|P2|Open-Label Phase|Other|0
1720359|NCT01081145|6003104|P1|Open-Label Phase|Other|12
1720360|NCT01081145|6003103|P2|Open-Label Phase|Withdrawal by Subject|0
1720361|NCT01081145|6003104|P1|Open-Label Phase|Withdrawal by Subject|41
1720362|NCT01081145|6003103|P2|Open-Label Phase|Adverse Event|0
1720363|NCT01081145|6003104|P1|Open-Label Phase|Adverse Event|42
1720364|NCT01081145|6003103|P2|Open-Label Phase|Response criteria not met|0
1720365|NCT01081145|6003104|P1|Open-Label Phase|Response criteria not met|46
1720366|NCT01081145|6003103|P2|Open-Label Phase|Lack of Efficacy|0
1720367|NCT01081145|6003104|P1|Open-Label Phase|Lack of Efficacy|56
1720368|NCT01081132|6003132|P2|Overall Study|Protocol Violation|1
1720369|NCT01081132|6003133|P1|Overall Study|Protocol Violation|3
1720370|NCT01081132|6003132|P2|Overall Study|Declined Taper Phase|1
1720371|NCT01081132|6003133|P1|Overall Study|Declined Taper Phase|0
1720372|NCT01081132|6003132|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
1720373|NCT01081132|6003133|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
1720374|NCT01081132|6003132|P2|Overall Study|Stopped Taking Meds|0
1720375|NCT01081132|6003133|P1|Overall Study|Stopped Taking Meds|2
1720376|NCT01081132|6003132|P2|Overall Study|Missed Visits|1
1720377|NCT01081132|6003133|P1|Overall Study|Missed Visits|1
1720378|NCT01081132|6003132|P2|Overall Study|Lack Of Compliance|1
1720379|NCT01081132|6003133|P1|Overall Study|Lack Of Compliance|0
1720380|NCT01081132|6003132|P2|Overall Study|Non Compliance|2
1720381|NCT01081132|6003133|P1|Overall Study|Non Compliance|4
1720382|NCT01081132|6003132|P2|Overall Study|Adverse Event|9
1720383|NCT01081132|6003133|P1|Overall Study|Adverse Event|3
1720384|NCT01081132|6003132|P2|Overall Study|Lost to Follow-up|11
1720385|NCT01081132|6003133|P1|Overall Study|Lost to Follow-up|4
1720386|NCT01081132|6003132|P2|Overall Study|Withdrawal by Subject|16
1720387|NCT01081132|6003133|P1|Overall Study|Withdrawal by Subject|13
1720388|NCT01081132|6003132|P2|Overall Study|Lack of Efficacy|9
1720389|NCT01081132|6003133|P1|Overall Study|Lack of Efficacy|25
1720390|NCT01080807|6003217|P2|Overall Study|Moved away without notifying center|0
1720391|NCT01080807|6003218|P1|Overall Study|Moved away without notifying center|1
1720392|NCT01080807|6003217|P2|Overall Study|Switched to first shift|0
1720393|NCT01080807|6003218|P1|Overall Study|Switched to first shift|1
1720394|NCT01080807|6003217|P2|Overall Study|Work schedule and travel|1
1720395|NCT01080807|6003218|P1|Overall Study|Work schedule and travel|0
1720396|NCT01080807|6003217|P2|Overall Study|Work schedule changing|1
1720397|NCT01080807|6003218|P1|Overall Study|Work schedule changing|1
1720398|NCT01080807|6003217|P2|Overall Study|Stopped working consistent night shifts|1
1720399|NCT01080807|6003218|P1|Overall Study|Stopped working consistent night shifts|0
1720400|NCT01080807|6003217|P2|Overall Study|Laid off or terminated from job|2
1720401|NCT01080807|6003218|P1|Overall Study|Laid off or terminated from job|1
1720402|NCT01080807|6003217|P2|Overall Study|Began working day shift|2
1720403|NCT01080807|6003218|P1|Overall Study|Began working day shift|0
1720404|NCT01080807|6003217|P2|Overall Study|Noncompliance to study procedures|1
1720405|NCT01080807|6003218|P1|Overall Study|Noncompliance to study procedures|1
1720406|NCT01080807|6003217|P2|Overall Study|Noncompliance with drug administration|1
1720407|NCT01080807|6003218|P1|Overall Study|Noncompliance with drug administration|1
1720408|NCT01080807|6003217|P2|Overall Study|Lost to Follow-up|4
1720409|NCT01080807|6003218|P1|Overall Study|Lost to Follow-up|6
1720410|NCT01080807|6003217|P2|Overall Study|Protocol Violation|6
1720411|NCT01080807|6003218|P1|Overall Study|Protocol Violation|7
1720412|NCT01080807|6003217|P2|Overall Study|Withdrawal by Subject|2
1720413|NCT01080807|6003218|P1|Overall Study|Withdrawal by Subject|7
1720414|NCT01080807|6003217|P2|Overall Study|Lack of Efficacy|1
1720415|NCT01080807|6003218|P1|Overall Study|Lack of Efficacy|0
1720416|NCT01080807|6003217|P2|Overall Study|Adverse Event|1
1720417|NCT01080807|6003218|P1|Overall Study|Adverse Event|9
1720418|NCT01080768|6003327|P2|Overall Study|Protocol Deviation|1
1720419|NCT01080768|6003328|P1|Overall Study|Protocol Deviation|2
1720420|NCT01080716|6003338|P4|Part 1|Physician Decision|0
1720421|NCT01080716|6003339|P3|Part 1|Physician Decision|0
1720422|NCT01080716|6003340|P2|Part 1|Physician Decision|0
1720423|NCT01080716|6003341|P1|Part 1|Physician Decision|1
1720424|NCT01080625|6003380|P3|Overall Study|Physician Decision|1
1720425|NCT01080625|6003381|P2|Overall Study|Physician Decision|2
1720426|NCT01080625|6003382|P1|Overall Study|Physician Decision|0
1720427|NCT01080391|6003392|P2|Overall Study|Randomized but not treated|4
1720428|NCT01080391|6003393|P1|Overall Study|Randomized but not treated|7
1720429|NCT01080326|6003411|P1|Overall Study|Surgeon decision|1
1720430|NCT01080326|6003411|P1|Overall Study|Patient deterioration prior to procedure|3
1720431|NCT01080300|6003417|P2|Overall Study|Reasons not specified|6
1720432|NCT01080300|6003418|P1|Overall Study|Reasons not specified|4
1720433|NCT01080300|6003417|P2|Overall Study|Withdrawal by Subject|28
1720434|NCT01080300|6003418|P1|Overall Study|Withdrawal by Subject|12
1720435|NCT01080300|6003417|P2|Overall Study|Death|1
1720436|NCT01080300|6003418|P1|Overall Study|Death|0
1720437|NCT01080300|6003417|P2|Overall Study|Lost to Follow-up|6
1720438|NCT01080300|6003418|P1|Overall Study|Lost to Follow-up|10
1720439|NCT01080300|6003417|P2|Overall Study|Protocol Violation|13
1720440|NCT01080300|6003418|P1|Overall Study|Protocol Violation|7
1720441|NCT01080300|6003417|P2|Overall Study|Lack of Efficacy|15
1720442|NCT01080300|6003418|P1|Overall Study|Lack of Efficacy|12
1720443|NCT01080300|6003417|P2|Overall Study|Adverse Event|35
1720444|NCT01080300|6003418|P1|Overall Study|Adverse Event|49
1720445|NCT01080131|6003503|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
1720446|NCT01080131|6003504|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
1720447|NCT01080131|6003503|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
1720448|NCT01080131|6003504|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
1720449|NCT01080131|6003503|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
1720450|NCT01080131|6003504|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
1720451|NCT01080131|6003503|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
1720452|NCT01080131|6003504|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
1720453|NCT01080131|6003503|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
1720454|NCT01080131|6003504|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
1720455|NCT01080131|6003503|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
1720456|NCT01080131|6003504|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
1720457|NCT01080131|6003503|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
1720458|NCT01080131|6003504|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
1720459|NCT01080131|6003503|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
1720460|NCT01080131|6003504|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
1720461|NCT01080131|6003503|P2|Core Study (0- 12 Weeks)|Death|0
1720462|NCT01080131|6003504|P1|Core Study (0- 12 Weeks)|Death|1
1720463|NCT01080131|6003503|P2|Core Study (0- 12 Weeks)|Administrative problems|1
1720464|NCT01080131|6003504|P1|Core Study (0- 12 Weeks)|Administrative problems|0
1720465|NCT01080131|6003503|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
1720466|NCT01080131|6003504|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
1720467|NCT01080131|6003503|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
1720468|NCT01080131|6003504|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
1720469|NCT01080131|6003503|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
1720470|NCT01080131|6003504|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
1720471|NCT01079988|6003599|P5|Overall Study|Other|1
1720472|NCT01079988|6003600|P4|Overall Study|Other|2
1720473|NCT01079988|6003601|P3|Overall Study|Other|0
1720474|NCT01079988|6003602|P2|Overall Study|Other|0
1720475|NCT01079988|6003603|P1|Overall Study|Other|0
1720476|NCT01079988|6003599|P5|Overall Study|Lack of Efficacy|0
1720477|NCT01079988|6003600|P4|Overall Study|Lack of Efficacy|0
1720478|NCT01079988|6003601|P3|Overall Study|Lack of Efficacy|0
1720479|NCT01079988|6003602|P2|Overall Study|Lack of Efficacy|0
1720480|NCT01079988|6003603|P1|Overall Study|Lack of Efficacy|1
1720481|NCT01079988|6003599|P5|Overall Study|Lost to Follow-up|0
1720482|NCT01079988|6003600|P4|Overall Study|Lost to Follow-up|1
1720483|NCT01079988|6003601|P3|Overall Study|Lost to Follow-up|0
1720484|NCT01079988|6003602|P2|Overall Study|Lost to Follow-up|0
1720485|NCT01079988|6003603|P1|Overall Study|Lost to Follow-up|0
1720486|NCT01079962|6003622|P2|Overall Study|Due to arrhythmia/bradycardia|1
1720487|NCT01079962|6003623|P1|Overall Study|Due to arrhythmia/bradycardia|1
1720488|NCT01079962|6003622|P2|Overall Study|Participant not returning for next visit|0
1720489|NCT01079962|6003623|P1|Overall Study|Participant not returning for next visit|1
1720490|NCT01079962|6003622|P2|Overall Study|Inclusion/exclusion criteria|3
1720491|NCT01079962|6003623|P1|Overall Study|Inclusion/exclusion criteria|1
1720492|NCT01079962|6003622|P2|Overall Study|No blood pressure (BP) control|0
1720493|NCT01079962|6003623|P1|Overall Study|No blood pressure (BP) control|3
1720494|NCT01079962|6003622|P2|Overall Study|Protocol Violation|2
1720495|NCT01079962|6003623|P1|Overall Study|Protocol Violation|2
1720496|NCT01079962|6003622|P2|Overall Study|Withdrawal by Subject|7
1720497|NCT01079962|6003623|P1|Overall Study|Withdrawal by Subject|5
1720498|NCT01079962|6003622|P2|Overall Study|Adverse Event|2
1720499|NCT01079962|6003623|P1|Overall Study|Adverse Event|2
1720500|NCT01079949|6003651|P2|Overall Study|Randomized but not treated|0
1720501|NCT01079949|6003652|P1|Overall Study|Randomized but not treated|1
1720502|NCT01079949|6003651|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
1720503|NCT01079949|6003652|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
1720504|NCT01079949|6003651|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
1720505|NCT01079949|6003652|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
1720506|NCT01079949|6003651|P2|Overall Study|Withdrawal before r-hCG administration|3
1720507|NCT01079949|6003652|P1|Overall Study|Withdrawal before r-hCG administration|2
1720508|NCT01079936|6003698|P5|Phase II|Insurance Issue|1
1720509|NCT01079936|6003699|P4|Phase II|Insurance Issue|0
1720510|NCT01079936|6003700|P3|Phase II|Insurance Issue|0
1720511|NCT01079936|6003701|P2|Phase II|Insurance Issue|0
1720512|NCT01079936|6003702|P1|Phase II|Insurance Issue|0
1720513|NCT01079936|6003698|P5|Phase II|Adverse Event|0
1720514|NCT01079936|6003699|P4|Phase II|Adverse Event|0
1720515|NCT01079936|6003700|P3|Phase II|Adverse Event|1
1720516|NCT01079936|6003701|P2|Phase II|Adverse Event|0
1720517|NCT01079936|6003702|P1|Phase II|Adverse Event|0
1720518|NCT01079936|6003698|P5|Phase I: MTD|No Stem Cell Transplantation|0
1720519|NCT01079936|6003699|P4|Phase I: MTD|No Stem Cell Transplantation|0
1720520|NCT01079936|6003700|P3|Phase I: MTD|No Stem Cell Transplantation|0
1720521|NCT01079936|6003701|P2|Phase I: MTD|No Stem Cell Transplantation|0
1720522|NCT01079936|6003702|P1|Phase I: MTD|No Stem Cell Transplantation|2
1720523|NCT01079936|6003698|P5|Phase I: MTD|First Remission Status|0
1720524|NCT01079936|6003699|P4|Phase I: MTD|First Remission Status|0
1720525|NCT01079936|6003700|P3|Phase I: MTD|First Remission Status|0
1720526|NCT01079936|6003701|P2|Phase I: MTD|First Remission Status|0
1720527|NCT01079936|6003702|P1|Phase I: MTD|First Remission Status|2
1720528|NCT01079832|6003721|P1|Overall Study|Withdrawal by Subject|1
1720529|NCT01079806|6003731|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
1720530|NCT01079806|6003732|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
1720531|NCT01079806|6003731|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
1720532|NCT01079806|6003732|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
1720533|NCT01079806|6003731|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
1720534|NCT01079806|6003732|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
1720535|NCT01079806|6003731|P2|Day 1 to Week 96|Removal by Medical Monitor|1
1720536|NCT01079806|6003732|P1|Day 1 to Week 96|Removal by Medical Monitor|0
1720537|NCT01079806|6003731|P2|Day 1 to Week 96|Subject request to stop study treatment|0
1720538|NCT01079806|6003732|P1|Day 1 to Week 96|Subject request to stop study treatment|1
1720539|NCT01079806|6003731|P2|Day 1 to Week 96|Lost to Follow-up|0
1720540|NCT01079806|6003732|P1|Day 1 to Week 96|Lost to Follow-up|1
1720541|NCT01079806|6003731|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
1720542|NCT01079806|6003732|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
1720543|NCT01079806|6003731|P2|Day 1 to Week 96|Pregnancy|1
1720544|NCT01079806|6003732|P1|Day 1 to Week 96|Pregnancy|0
1720545|NCT01079806|6003731|P2|Day 1 to Week 96|Withdrawal by Subject|2
1720546|NCT01079806|6003732|P1|Day 1 to Week 96|Withdrawal by Subject|3
1720547|NCT01079806|6003731|P2|Day 1 to Week 96|Adverse Event|3
1720548|NCT01079806|6003732|P1|Day 1 to Week 96|Adverse Event|0
1720549|NCT01079741|6003767|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
1720550|NCT01079741|6003768|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1720551|NCT01079741|6003769|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1720552|NCT01079741|6003770|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1720553|NCT01079741|6003771|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
1720554|NCT01079741|6003767|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1720555|NCT01079741|6003768|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1720556|NCT01079741|6003769|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1720557|NCT01079741|6003770|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
1720558|NCT01079741|6003771|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
1720559|NCT01079234|6003819|P4|Extension: Week 27 to 52|Unclassified|7
1720560|NCT01079234|6003820|P3|Extension: Week 27 to 52|Unclassified|4
1720561|NCT01079234|6003821|P2|Extension: Week 27 to 52|Unclassified|0
1720562|NCT01079234|6003822|P1|Extension: Week 27 to 52|Unclassified|0
1720563|NCT01079234|6003819|P4|Extension: Week 27 to 52|Withdrawal criteria|2
1720564|NCT01079234|6003820|P3|Extension: Week 27 to 52|Withdrawal criteria|4
1720565|NCT01079234|6003821|P2|Extension: Week 27 to 52|Withdrawal criteria|0
1720566|NCT01079234|6003822|P1|Extension: Week 27 to 52|Withdrawal criteria|0
1720567|NCT01079234|6003819|P4|Extension: Week 27 to 52|Protocol Violation|5
1720568|NCT01079234|6003820|P3|Extension: Week 27 to 52|Protocol Violation|2
1720569|NCT01079234|6003821|P2|Extension: Week 27 to 52|Protocol Violation|0
1720570|NCT01079234|6003822|P1|Extension: Week 27 to 52|Protocol Violation|0
1720571|NCT01079234|6003819|P4|Extension: Week 27 to 52|Lack of Efficacy|2
1720572|NCT01079234|6003820|P3|Extension: Week 27 to 52|Lack of Efficacy|0
1720573|NCT01079234|6003821|P2|Extension: Week 27 to 52|Lack of Efficacy|0
1720574|NCT01079234|6003822|P1|Extension: Week 27 to 52|Lack of Efficacy|0
1720575|NCT01079234|6003819|P4|Extension: Week 27 to 52|Adverse Event|0
1720576|NCT01079234|6003820|P3|Extension: Week 27 to 52|Adverse Event|1
1720577|NCT01079234|6003821|P2|Extension: Week 27 to 52|Adverse Event|0
1720578|NCT01079234|6003822|P1|Extension: Week 27 to 52|Adverse Event|0
1720579|NCT01079234|6003819|P4|Main: Week 0 to 26|Unclassified|0
1720580|NCT01079234|6003820|P3|Main: Week 0 to 26|Unclassified|4
1720581|NCT01079234|6003821|P2|Main: Week 0 to 26|Unclassified|13
1720582|NCT01079234|6003822|P1|Main: Week 0 to 26|Unclassified|7
1720583|NCT01079234|6003819|P4|Main: Week 0 to 26|Withdrawal criteria|0
1720584|NCT01079234|6003820|P3|Main: Week 0 to 26|Withdrawal criteria|2
1720585|NCT01079234|6003821|P2|Main: Week 0 to 26|Withdrawal criteria|6
1720586|NCT01079234|6003822|P1|Main: Week 0 to 26|Withdrawal criteria|6
1720587|NCT01079234|6003819|P4|Main: Week 0 to 26|Protocol Violation|0
1720588|NCT01079234|6003820|P3|Main: Week 0 to 26|Protocol Violation|4
1720589|NCT01079234|6003821|P2|Main: Week 0 to 26|Protocol Violation|2
1720590|NCT01079234|6003822|P1|Main: Week 0 to 26|Protocol Violation|6
1720591|NCT01079234|6003819|P4|Main: Week 0 to 26|Lack of Efficacy|0
1720592|NCT01079234|6003820|P3|Main: Week 0 to 26|Lack of Efficacy|1
1720593|NCT01079234|6003821|P2|Main: Week 0 to 26|Lack of Efficacy|1
1720594|NCT01079234|6003822|P1|Main: Week 0 to 26|Lack of Efficacy|2
1720595|NCT01079234|6003819|P4|Main: Week 0 to 26|Adverse Event|0
1720596|NCT01079234|6003820|P3|Main: Week 0 to 26|Adverse Event|1
1720597|NCT01079234|6003821|P2|Main: Week 0 to 26|Adverse Event|4
1720598|NCT01079234|6003822|P1|Main: Week 0 to 26|Adverse Event|5
1720599|NCT01079195|6003840|P1|Overall Study|Non-compliance|2
1720600|NCT01079195|6003840|P1|Overall Study|No Follow-up Documentation Available|4
1720601|NCT01079195|6003840|P1|Overall Study|Improved Status of Participant|4
1720602|NCT01079195|6003840|P1|Overall Study|Physician Decision|4
1720603|NCT01079195|6003840|P1|Overall Study|Lack of Effectiveness|12
1720604|NCT01079195|6003840|P1|Overall Study|Financial Reasons|15
1720605|NCT01079195|6003840|P1|Overall Study|Withdrawal by Subject|18
1720606|NCT01079195|6003840|P1|Overall Study|Reason Unknown|39
1720607|NCT01079195|6003840|P1|Overall Study|Adverse Event|157
1720608|NCT01079195|6003840|P1|Overall Study|No Documentation Available|437
1720609|NCT01079195|6003840|P1|Overall Study|No Documentation of Tarka Therapy|739
1720610|NCT01079182|6003846|P1|Overall Study|Reasons not Evaluated|271
1720611|NCT01079182|6003846|P1|Overall Study|ADR and Lack of Effectiveness|39
1720612|NCT01079182|6003846|P1|Overall Study|Lack of Efficacy|514
1720613|NCT01079182|6003846|P1|Overall Study|Adverse Drug Reaction (ADR)|261
1720614|NCT01079182|6003846|P1|Overall Study|Lost to Follow-up|1634
1720615|NCT01079130|6003954|P6|Overall Study|Lost to Follow-up|0
1720616|NCT01079130|6003955|P5|Overall Study|Lost to Follow-up|1
1720617|NCT01079130|6003956|P4|Overall Study|Lost to Follow-up|0
1720618|NCT01079130|6003957|P3|Overall Study|Lost to Follow-up|0
1720619|NCT01079130|6003958|P2|Overall Study|Lost to Follow-up|0
1720620|NCT01079130|6003959|P1|Overall Study|Lost to Follow-up|0
1720621|NCT01079130|6003954|P6|Overall Study|Unsatisfactory therapeutic effect|0
1720622|NCT01079130|6003955|P5|Overall Study|Unsatisfactory therapeutic effect|0
1720623|NCT01079130|6003956|P4|Overall Study|Unsatisfactory therapeutic effect|2
1720624|NCT01079130|6003957|P3|Overall Study|Unsatisfactory therapeutic effect|0
1720625|NCT01079130|6003958|P2|Overall Study|Unsatisfactory therapeutic effect|0
1720626|NCT01079130|6003959|P1|Overall Study|Unsatisfactory therapeutic effect|0
1720627|NCT01079130|6003954|P6|Overall Study|Abnormal test procedure result(s)|0
1720628|NCT01079130|6003955|P5|Overall Study|Abnormal test procedure result(s)|1
1720629|NCT01079130|6003956|P4|Overall Study|Abnormal test procedure result(s)|0
1720630|NCT01079130|6003957|P3|Overall Study|Abnormal test procedure result(s)|0
1720631|NCT01079130|6003958|P2|Overall Study|Abnormal test procedure result(s)|0
1720632|NCT01079130|6003959|P1|Overall Study|Abnormal test procedure result(s)|0
1720633|NCT01079130|6003954|P6|Overall Study|Protocol deviation|0
1720634|NCT01079130|6003955|P5|Overall Study|Protocol deviation|0
1720635|NCT01079130|6003956|P4|Overall Study|Protocol deviation|2
1720636|NCT01079130|6003957|P3|Overall Study|Protocol deviation|1
1720637|NCT01079130|6003958|P2|Overall Study|Protocol deviation|2
1720638|NCT01079130|6003959|P1|Overall Study|Protocol deviation|0
1720639|NCT01079130|6003954|P6|Overall Study|Withdrawal by Subject|3
1720640|NCT01079130|6003955|P5|Overall Study|Withdrawal by Subject|1
1720641|NCT01079130|6003956|P4|Overall Study|Withdrawal by Subject|0
1720642|NCT01079130|6003957|P3|Overall Study|Withdrawal by Subject|0
1720643|NCT01079130|6003958|P2|Overall Study|Withdrawal by Subject|1
1720644|NCT01079130|6003959|P1|Overall Study|Withdrawal by Subject|0
1720645|NCT01079130|6003954|P6|Overall Study|Administrative problems|1
1720646|NCT01079130|6003955|P5|Overall Study|Administrative problems|0
1720647|NCT01079130|6003956|P4|Overall Study|Administrative problems|0
1720648|NCT01079130|6003957|P3|Overall Study|Administrative problems|0
1720649|NCT01079130|6003958|P2|Overall Study|Administrative problems|3
1720650|NCT01079130|6003959|P1|Overall Study|Administrative problems|1
1720651|NCT01079130|6003954|P6|Overall Study|Adverse Event|1
1720652|NCT01079130|6003955|P5|Overall Study|Adverse Event|5
1720653|NCT01079130|6003956|P4|Overall Study|Adverse Event|1
1720654|NCT01079130|6003957|P3|Overall Study|Adverse Event|0
1720655|NCT01079130|6003958|P2|Overall Study|Adverse Event|1
1720656|NCT01079130|6003959|P1|Overall Study|Adverse Event|1
1720657|NCT01078974|6003979|P1|Overall Study|Adverse Event|3
1720658|NCT01078922|6003984|P1|Overall Study|Adverse Event|1
1720659|NCT01078805|6004025|P1|Overall Study|Didn't take study drug|82
1720660|NCT01078805|6004025|P1|Overall Study|Other|173
1720661|NCT01078805|6004025|P1|Overall Study|Withdrawal by Subject|739
1720662|NCT01078805|6004025|P1|Overall Study|Sponsor decision|46
1720663|NCT01078805|6004025|P1|Overall Study|Serious adverse event|26
1720664|NCT01078805|6004025|P1|Overall Study|Physician Decision|169
1720665|NCT01078805|6004025|P1|Overall Study|Lost to Follow-up|676
1720666|NCT01078805|6004025|P1|Overall Study|Death|134
1720667|NCT01078805|6004025|P1|Overall Study|Clinically significant abnormal lab|5
1720668|NCT01078675|6004052|P2|Overall Study|Adverse Event|0
1720669|NCT01078675|6004053|P1|Overall Study|Adverse Event|3
1720670|NCT01078675|6004052|P2|Overall Study|Provided in CRF for specific reasons|3
1720671|NCT01078675|6004053|P1|Overall Study|Provided in CRF for specific reasons|2
1720672|NCT01078675|6004052|P2|Overall Study|Protocol Violation|0
1720673|NCT01078675|6004053|P1|Overall Study|Protocol Violation|56
1720674|NCT01078675|6004052|P2|Overall Study|Withdrawal by Subject|3
1720675|NCT01078675|6004053|P1|Overall Study|Withdrawal by Subject|7
1720676|NCT01078662|6004075|P5|Overall Study|Lost to Follow-up|0
1720677|NCT01078662|6004076|P4|Overall Study|Lost to Follow-up|0
1720678|NCT01078662|6004077|P3|Overall Study|Lost to Follow-up|0
1720679|NCT01078662|6004078|P2|Overall Study|Lost to Follow-up|0
1720680|NCT01078662|6004079|P1|Overall Study|Lost to Follow-up|1
1720681|NCT01078662|6004075|P5|Overall Study|Protocol Violation|0
1720682|NCT01078662|6004076|P4|Overall Study|Protocol Violation|0
1720683|NCT01078662|6004077|P3|Overall Study|Protocol Violation|0
1720684|NCT01078662|6004078|P2|Overall Study|Protocol Violation|1
1720685|NCT01078662|6004079|P1|Overall Study|Protocol Violation|0
1720686|NCT01078662|6004075|P5|Overall Study|Withdrawal by Subject|0
1720687|NCT01078662|6004076|P4|Overall Study|Withdrawal by Subject|0
1720688|NCT01078662|6004077|P3|Overall Study|Withdrawal by Subject|1
1720689|NCT01078662|6004078|P2|Overall Study|Withdrawal by Subject|11
1720690|NCT01078662|6004079|P1|Overall Study|Withdrawal by Subject|4
1720691|NCT01078662|6004075|P5|Overall Study|Patients reached data cut-off|3
1720692|NCT01078662|6004076|P4|Overall Study|Patients reached data cut-off|2
1720693|NCT01078662|6004077|P3|Overall Study|Patients reached data cut-off|2
1720694|NCT01078662|6004078|P2|Overall Study|Patients reached data cut-off|53
1720695|NCT01078662|6004079|P1|Overall Study|Patients reached data cut-off|12
1720696|NCT01078662|6004075|P5|Overall Study|Death|8
1720697|NCT01078662|6004076|P4|Overall Study|Death|5
1720698|NCT01078662|6004077|P3|Overall Study|Death|18
1720699|NCT01078662|6004078|P2|Overall Study|Death|103
1720700|NCT01078662|6004079|P1|Overall Study|Death|41
1720701|NCT01078623|6004118|P20|Treatment Period 4|Withdrawal by Subject|0
1720702|NCT01078623|6004119|P19|Treatment Period 4|Withdrawal by Subject|0
1720703|NCT01078623|6004120|P18|Treatment Period 4|Withdrawal by Subject|0
1720704|NCT01078623|6004121|P17|Treatment Period 4|Withdrawal by Subject|0
1720705|NCT01078623|6004122|P16|Treatment Period 4|Withdrawal by Subject|1
1720706|NCT01078623|6004123|P15|Treatment Period 4|Withdrawal by Subject|0
1720707|NCT01078623|6004124|P14|Treatment Period 4|Withdrawal by Subject|0
1720708|NCT01078623|6004125|P13|Treatment Period 4|Withdrawal by Subject|0
1720709|NCT01078623|6004126|P12|Treatment Period 4|Withdrawal by Subject|0
1720710|NCT01078623|6004127|P11|Treatment Period 4|Withdrawal by Subject|0
1720711|NCT01078623|6004128|P10|Treatment Period 4|Withdrawal by Subject|0
1720712|NCT01078623|6004129|P9|Treatment Period 4|Withdrawal by Subject|0
1720713|NCT01078623|6004130|P8|Treatment Period 4|Withdrawal by Subject|0
1720714|NCT01078623|6004131|P7|Treatment Period 4|Withdrawal by Subject|0
1720715|NCT01078623|6004132|P6|Treatment Period 4|Withdrawal by Subject|0
1720716|NCT01078623|6004133|P5|Treatment Period 4|Withdrawal by Subject|0
1720717|NCT01078623|6004134|P4|Treatment Period 4|Withdrawal by Subject|0
1720718|NCT01078623|6004135|P3|Treatment Period 4|Withdrawal by Subject|0
1720719|NCT01078623|6004136|P2|Treatment Period 4|Withdrawal by Subject|0
1720720|NCT01078623|6004137|P1|Treatment Period 4|Withdrawal by Subject|0
1720721|NCT01078623|6004118|P20|Treatment Period 4|Adverse Event|0
1720722|NCT01078623|6004119|P19|Treatment Period 4|Adverse Event|0
1720723|NCT01078623|6004120|P18|Treatment Period 4|Adverse Event|0
1720724|NCT01078623|6004121|P17|Treatment Period 4|Adverse Event|0
1720725|NCT01078623|6004122|P16|Treatment Period 4|Adverse Event|0
1720726|NCT01078623|6004123|P15|Treatment Period 4|Adverse Event|0
1720727|NCT01078623|6004124|P14|Treatment Period 4|Adverse Event|0
1720728|NCT01078623|6004125|P13|Treatment Period 4|Adverse Event|0
1720729|NCT01078623|6004126|P12|Treatment Period 4|Adverse Event|0
1720730|NCT01078623|6004127|P11|Treatment Period 4|Adverse Event|0
1720731|NCT01078623|6004128|P10|Treatment Period 4|Adverse Event|0
1720732|NCT01078623|6004129|P9|Treatment Period 4|Adverse Event|0
1720733|NCT01078623|6004130|P8|Treatment Period 4|Adverse Event|0
1720734|NCT01078623|6004131|P7|Treatment Period 4|Adverse Event|0
1720735|NCT01078623|6004132|P6|Treatment Period 4|Adverse Event|0
1720736|NCT01078623|6004133|P5|Treatment Period 4|Adverse Event|0
1720737|NCT01078623|6004134|P4|Treatment Period 4|Adverse Event|0
1720738|NCT01078623|6004135|P3|Treatment Period 4|Adverse Event|1
1720739|NCT01078623|6004136|P2|Treatment Period 4|Adverse Event|0
1720740|NCT01078623|6004137|P1|Treatment Period 4|Adverse Event|0
1720741|NCT01078623|6004118|P20|Treatment Period 3|Adverse Event|0
1720742|NCT01078623|6004119|P19|Treatment Period 3|Adverse Event|0
1720743|NCT01078623|6004120|P18|Treatment Period 3|Adverse Event|0
1720744|NCT01078623|6004121|P17|Treatment Period 3|Adverse Event|0
1720745|NCT01078623|6004122|P16|Treatment Period 3|Adverse Event|0
1720746|NCT01078623|6004123|P15|Treatment Period 3|Adverse Event|0
1720747|NCT01078623|6004124|P14|Treatment Period 3|Adverse Event|1
1720748|NCT01078623|6004125|P13|Treatment Period 3|Adverse Event|0
1720749|NCT01078623|6004126|P12|Treatment Period 3|Adverse Event|0
1720750|NCT01078623|6004127|P11|Treatment Period 3|Adverse Event|0
1720751|NCT01078623|6004128|P10|Treatment Period 3|Adverse Event|0
1720752|NCT01078623|6004129|P9|Treatment Period 3|Adverse Event|0
1720753|NCT01078623|6004130|P8|Treatment Period 3|Adverse Event|0
1720754|NCT01078623|6004131|P7|Treatment Period 3|Adverse Event|0
1720755|NCT01078623|6004132|P6|Treatment Period 3|Adverse Event|0
1720756|NCT01078623|6004133|P5|Treatment Period 3|Adverse Event|1
1720757|NCT01078623|6004134|P4|Treatment Period 3|Adverse Event|0
1720758|NCT01078623|6004135|P3|Treatment Period 3|Adverse Event|0
1720759|NCT01078623|6004136|P2|Treatment Period 3|Adverse Event|0
1720760|NCT01078623|6004137|P1|Treatment Period 3|Adverse Event|0
1720761|NCT01078623|6004118|P20|Treatment Period 2|Withdrawal by Subject|0
1720762|NCT01078623|6004119|P19|Treatment Period 2|Withdrawal by Subject|0
1720763|NCT01078623|6004120|P18|Treatment Period 2|Withdrawal by Subject|0
1720764|NCT01078623|6004121|P17|Treatment Period 2|Withdrawal by Subject|0
1720765|NCT01078623|6004122|P16|Treatment Period 2|Withdrawal by Subject|0
1720766|NCT01078623|6004123|P15|Treatment Period 2|Withdrawal by Subject|0
1720767|NCT01078623|6004124|P14|Treatment Period 2|Withdrawal by Subject|0
1720768|NCT01078623|6004125|P13|Treatment Period 2|Withdrawal by Subject|0
1720769|NCT01078623|6004126|P12|Treatment Period 2|Withdrawal by Subject|0
1720770|NCT01078623|6004127|P11|Treatment Period 2|Withdrawal by Subject|0
1720771|NCT01078623|6004128|P10|Treatment Period 2|Withdrawal by Subject|0
1720772|NCT01078623|6004129|P9|Treatment Period 2|Withdrawal by Subject|0
1720773|NCT01078623|6004130|P8|Treatment Period 2|Withdrawal by Subject|0
1720774|NCT01078623|6004131|P7|Treatment Period 2|Withdrawal by Subject|0
1720775|NCT01078623|6004132|P6|Treatment Period 2|Withdrawal by Subject|1
1720776|NCT01078623|6004133|P5|Treatment Period 2|Withdrawal by Subject|0
1720777|NCT01078623|6004134|P4|Treatment Period 2|Withdrawal by Subject|0
1720778|NCT01078623|6004135|P3|Treatment Period 2|Withdrawal by Subject|0
1720779|NCT01078623|6004136|P2|Treatment Period 2|Withdrawal by Subject|0
1720780|NCT01078623|6004137|P1|Treatment Period 2|Withdrawal by Subject|0
1720781|NCT01078623|6004118|P20|Treatment Period 2|Adverse Event|0
1720782|NCT01078623|6004119|P19|Treatment Period 2|Adverse Event|1
1720783|NCT01078623|6004120|P18|Treatment Period 2|Adverse Event|0
1720784|NCT01078623|6004121|P17|Treatment Period 2|Adverse Event|0
1720785|NCT01078623|6004122|P16|Treatment Period 2|Adverse Event|0
1720786|NCT01078623|6004123|P15|Treatment Period 2|Adverse Event|0
1720787|NCT01078623|6004124|P14|Treatment Period 2|Adverse Event|0
1720788|NCT01078623|6004125|P13|Treatment Period 2|Adverse Event|0
1720789|NCT01078623|6004126|P12|Treatment Period 2|Adverse Event|0
1720790|NCT01078623|6004127|P11|Treatment Period 2|Adverse Event|0
1720791|NCT01078623|6004128|P10|Treatment Period 2|Adverse Event|0
1720792|NCT01078623|6004129|P9|Treatment Period 2|Adverse Event|0
1720793|NCT01078623|6004130|P8|Treatment Period 2|Adverse Event|0
1720794|NCT01078623|6004131|P7|Treatment Period 2|Adverse Event|1
1720795|NCT01078623|6004132|P6|Treatment Period 2|Adverse Event|0
1720796|NCT01078623|6004133|P5|Treatment Period 2|Adverse Event|0
1720797|NCT01078623|6004134|P4|Treatment Period 2|Adverse Event|0
1720798|NCT01078623|6004135|P3|Treatment Period 2|Adverse Event|0
1720799|NCT01078623|6004136|P2|Treatment Period 2|Adverse Event|0
1720800|NCT01078623|6004137|P1|Treatment Period 2|Adverse Event|0
1720801|NCT01078623|6004118|P20|Treatment Period 1|Protocol Violation|0
1720802|NCT01078623|6004119|P19|Treatment Period 1|Protocol Violation|0
1720803|NCT01078623|6004120|P18|Treatment Period 1|Protocol Violation|0
1720804|NCT01078623|6004121|P17|Treatment Period 1|Protocol Violation|0
1720805|NCT01078623|6004122|P16|Treatment Period 1|Protocol Violation|0
1720806|NCT01078623|6004123|P15|Treatment Period 1|Protocol Violation|0
1720807|NCT01078623|6004124|P14|Treatment Period 1|Protocol Violation|0
1720808|NCT01078623|6004125|P13|Treatment Period 1|Protocol Violation|0
1720809|NCT01078623|6004126|P12|Treatment Period 1|Protocol Violation|0
1720810|NCT01078623|6004127|P11|Treatment Period 1|Protocol Violation|0
1720811|NCT01078623|6004128|P10|Treatment Period 1|Protocol Violation|0
1720812|NCT01078623|6004129|P9|Treatment Period 1|Protocol Violation|0
1720813|NCT01078623|6004130|P8|Treatment Period 1|Protocol Violation|0
1720814|NCT01078623|6004131|P7|Treatment Period 1|Protocol Violation|0
1720815|NCT01078623|6004132|P6|Treatment Period 1|Protocol Violation|1
1720816|NCT01078623|6004133|P5|Treatment Period 1|Protocol Violation|0
1720817|NCT01078623|6004134|P4|Treatment Period 1|Protocol Violation|0
1720818|NCT01078623|6004135|P3|Treatment Period 1|Protocol Violation|0
1720819|NCT01078623|6004136|P2|Treatment Period 1|Protocol Violation|0
1720820|NCT01078623|6004137|P1|Treatment Period 1|Protocol Violation|0
1720821|NCT01078623|6004118|P20|Treatment Period 1|Withdrawal by Subject|0
1720822|NCT01078623|6004119|P19|Treatment Period 1|Withdrawal by Subject|0
1720823|NCT01078623|6004120|P18|Treatment Period 1|Withdrawal by Subject|0
1720824|NCT01078623|6004121|P17|Treatment Period 1|Withdrawal by Subject|0
1720825|NCT01078623|6004122|P16|Treatment Period 1|Withdrawal by Subject|0
1720826|NCT01078623|6004123|P15|Treatment Period 1|Withdrawal by Subject|0
1720827|NCT01078623|6004124|P14|Treatment Period 1|Withdrawal by Subject|0
1720828|NCT01078623|6004125|P13|Treatment Period 1|Withdrawal by Subject|0
1720829|NCT01078623|6004126|P12|Treatment Period 1|Withdrawal by Subject|0
1720830|NCT01078623|6004127|P11|Treatment Period 1|Withdrawal by Subject|1
1720831|NCT01078623|6004128|P10|Treatment Period 1|Withdrawal by Subject|0
1720832|NCT01078623|6004129|P9|Treatment Period 1|Withdrawal by Subject|0
1720833|NCT01078623|6004130|P8|Treatment Period 1|Withdrawal by Subject|1
1720834|NCT01078623|6004131|P7|Treatment Period 1|Withdrawal by Subject|0
1720835|NCT01078623|6004132|P6|Treatment Period 1|Withdrawal by Subject|0
1720836|NCT01078623|6004133|P5|Treatment Period 1|Withdrawal by Subject|0
1720837|NCT01078623|6004134|P4|Treatment Period 1|Withdrawal by Subject|0
1720838|NCT01078623|6004135|P3|Treatment Period 1|Withdrawal by Subject|0
1720839|NCT01078623|6004136|P2|Treatment Period 1|Withdrawal by Subject|0
1720840|NCT01078623|6004137|P1|Treatment Period 1|Withdrawal by Subject|0
1720841|NCT01078623|6004118|P20|Treatment Period 1|Adverse Event|0
1720842|NCT01078623|6004119|P19|Treatment Period 1|Adverse Event|0
1720843|NCT01078623|6004120|P18|Treatment Period 1|Adverse Event|0
1720844|NCT01078623|6004121|P17|Treatment Period 1|Adverse Event|0
1720845|NCT01078623|6004122|P16|Treatment Period 1|Adverse Event|0
1720846|NCT01078623|6004123|P15|Treatment Period 1|Adverse Event|0
1720847|NCT01078623|6004124|P14|Treatment Period 1|Adverse Event|0
1720848|NCT01078623|6004125|P13|Treatment Period 1|Adverse Event|0
1720849|NCT01078623|6004126|P12|Treatment Period 1|Adverse Event|0
1720850|NCT01078623|6004127|P11|Treatment Period 1|Adverse Event|0
1720851|NCT01078623|6004128|P10|Treatment Period 1|Adverse Event|1
1720852|NCT01078623|6004129|P9|Treatment Period 1|Adverse Event|1
1720853|NCT01078623|6004130|P8|Treatment Period 1|Adverse Event|0
1720854|NCT01078623|6004131|P7|Treatment Period 1|Adverse Event|1
1720855|NCT01078623|6004132|P6|Treatment Period 1|Adverse Event|0
1720856|NCT01078623|6004133|P5|Treatment Period 1|Adverse Event|0
1720857|NCT01078623|6004134|P4|Treatment Period 1|Adverse Event|0
1720858|NCT01078623|6004135|P3|Treatment Period 1|Adverse Event|1
1720859|NCT01078623|6004136|P2|Treatment Period 1|Adverse Event|1
1720860|NCT01078623|6004137|P1|Treatment Period 1|Adverse Event|1
1720861|NCT01078584|6004159|P1|Overall Study|Multiple Reasons|2
1720862|NCT01078584|6004159|P1|Overall Study|Serious Adverse Event|27
1720863|NCT01078584|6004159|P1|Overall Study|Protocol Violation|75
1720864|NCT01078584|6004159|P1|Overall Study|Lack of Efficacy|98
1720865|NCT01078584|6004159|P1|Overall Study|Physician Discontinued Patient|12
1720866|NCT01078584|6004159|P1|Overall Study|Physician Switched Medication|26
1720867|NCT01078584|6004159|P1|Overall Study|Blood Pressure Controlled|49
1720868|NCT01078584|6004159|P1|Overall Study|Non-compliance|67
1720869|NCT01078584|6004159|P1|Overall Study|Physician Withdrew from Study|90
1720870|NCT01078584|6004159|P1|Overall Study|Withdrawal of Consent|244
1720871|NCT01078584|6004159|P1|Overall Study|Non-serious Adverse Event|577
1720872|NCT01078584|6004159|P1|Overall Study|Lost to Follow-up|670
1720873|NCT01078584|6004159|P1|Overall Study|Final Status Unknown|1073
1720874|NCT01078571|6004240|P1|Overall Study|Protocol Violation|2
1720875|NCT01078571|6004240|P1|Overall Study|Lost to Follow-up|8
1720876|NCT01078571|6004240|P1|Overall Study|Withdrawal by Subject|12
1720877|NCT01078571|6004240|P1|Overall Study|Reason not reported|21
1720878|NCT01078571|6004240|P1|Overall Study|Lack of effectiveness|36
1720879|NCT01078571|6004240|P1|Overall Study|Adverse Event|36
1720880|NCT01078545|6004291|P1|Overall Study|Participant moved to another physician|1
1720881|NCT01078545|6004291|P1|Overall Study|Death|3
1720882|NCT01078545|6004291|P1|Overall Study|Withdrawal by Subject|3
1720883|NCT01078545|6004291|P1|Overall Study|Physician Decision|6
1720884|NCT01078545|6004291|P1|Overall Study|Lost to Follow-up|13
1720885|NCT01078454|6004301|P2|Overall Study|Death|1
1720886|NCT01078454|6004302|P1|Overall Study|Death|0
1720887|NCT01078454|6004301|P2|Overall Study|Adverse Event|1
1720888|NCT01078454|6004302|P1|Overall Study|Adverse Event|1
1720889|NCT01078441|6004308|P1|Overall Study|Withdrawal by Subject|1
1720890|NCT01078389|6004348|P2|Overall Study|Other|2
1720891|NCT01078389|6004349|P1|Overall Study|Other|9
1720892|NCT01078389|6004348|P2|Overall Study|Voluntary Withdrawal|36
1720893|NCT01078389|6004349|P1|Overall Study|Voluntary Withdrawal|20
1720894|NCT01078389|6004348|P2|Overall Study|Lost to Follow-up|23
1720895|NCT01078389|6004349|P1|Overall Study|Lost to Follow-up|23
1720896|NCT01078389|6004348|P2|Overall Study|Major Protocol Deviation|0
1720897|NCT01078389|6004349|P1|Overall Study|Major Protocol Deviation|2
1720898|NCT01078389|6004348|P2|Overall Study|Adverse Event|6
1720899|NCT01078389|6004349|P1|Overall Study|Adverse Event|10
1720900|NCT01078298|6004510|P2|Overall Study|Other|32
1720901|NCT01078298|6004511|P1|Overall Study|Other|24
1720902|NCT01078298|6004510|P2|Overall Study|Did not meet entrance criteria|1
1720903|NCT01078298|6004511|P1|Overall Study|Did not meet entrance criteria|0
1720904|NCT01078298|6004510|P2|Overall Study|Death|0
1720905|NCT01078298|6004511|P1|Overall Study|Death|2
1720906|NCT01078298|6004510|P2|Overall Study|Adverse Event|5
1720907|NCT01078298|6004511|P1|Overall Study|Adverse Event|6
1720908|NCT01078298|6004510|P2|Overall Study|Protocol Violation|6
1720909|NCT01078298|6004511|P1|Overall Study|Protocol Violation|6
1720910|NCT01078298|6004510|P2|Overall Study|Withdrawal by Subject|33
1720911|NCT01078298|6004511|P1|Overall Study|Withdrawal by Subject|31
1720912|NCT01078298|6004510|P2|Overall Study|Lost to Follow-up|13
1720913|NCT01078298|6004511|P1|Overall Study|Lost to Follow-up|12
1720914|NCT01078168|6004621|P2|Overall Study|Physician Decision|1
1720915|NCT01078168|6004622|P1|Overall Study|Physician Decision|0
1720916|NCT01078155|6004628|P1|Overall Study|Lost to Follow-up|15
1720917|NCT01078155|6004628|P1|Overall Study|Participant's Decision|6
1720918|NCT01078155|6004628|P1|Overall Study|Lack of Efficacy|16
1720919|NCT01078155|6004628|P1|Overall Study|Adverse Event|7
1720920|NCT01078116|6004644|P1|Overall Study|Case report form not completed|3
1720921|NCT01078116|6004644|P1|Overall Study|Lack of effectiveness|15
1720922|NCT01078116|6004644|P1|Overall Study|Withdrawal by Subject|8
1720923|NCT01078116|6004644|P1|Overall Study|Adverse Event|5
1720924|NCT01078116|6004644|P1|Overall Study|Lost to Follow-up|17
1720925|NCT01078090|6004652|P1|Overall Study|Other|523
1720926|NCT01078090|6004652|P1|Overall Study|ADR and lack of efficacy|61
1720927|NCT01078090|6004652|P1|Overall Study|Lack of Efficacy|1193
1720928|NCT01078090|6004652|P1|Overall Study|Adverse drug reaction (ADR)|453
1720929|NCT01078090|6004652|P1|Overall Study|Lost to Follow-up|2363
1720930|NCT01077960|6004746|P1|Overall Study|Reason unspecified|1
1720931|NCT01077960|6004746|P1|Overall Study|Subject decision|1
1720932|NCT01077960|6004746|P1|Overall Study|Lost to Follow-up|5
1720933|NCT01077960|6004746|P1|Overall Study|Protocol Violation|3
1720934|NCT01077960|6004746|P1|Overall Study|Adverse Event|6
1720935|NCT01077804|6004996|P1|Overall Study|Other|18
1720936|NCT01077804|6004996|P1|Overall Study|Refused to continue|79
1720937|NCT01077804|6004996|P1|Overall Study|Unreachable|102
1720938|NCT01077739|6005005|P2|Overall Study|Other|2
1720939|NCT01077739|6005006|P1|Overall Study|Other|2
1720940|NCT01077739|6005005|P2|Overall Study|Unacceptable toxicity|2
1720941|NCT01077739|6005006|P1|Overall Study|Unacceptable toxicity|1
1720942|NCT01077739|6005005|P2|Overall Study|Death|3
1720943|NCT01077739|6005006|P1|Overall Study|Death|0
1720944|NCT01077739|6005005|P2|Overall Study|Withdrawal by Subject|0
1720945|NCT01077739|6005006|P1|Overall Study|Withdrawal by Subject|1
1720946|NCT01077739|6005005|P2|Overall Study|Premature withdrawal|3
1720947|NCT01077739|6005006|P1|Overall Study|Premature withdrawal|1
1720948|NCT01077713|6005020|P2|Overall Study|Other|2
1720949|NCT01077713|6005021|P1|Overall Study|Other|4
1720950|NCT01077713|6005020|P2|Overall Study|Adverse Event|1
1720951|NCT01077713|6005021|P1|Overall Study|Adverse Event|2
1720952|NCT01077713|6005020|P2|Overall Study|Lost to Follow-up|1
1720953|NCT01077713|6005021|P1|Overall Study|Lost to Follow-up|1
1720954|NCT01077713|6005020|P2|Overall Study|Death|29
1720955|NCT01077713|6005021|P1|Overall Study|Death|28
1720956|NCT01077713|6005020|P2|Overall Study|Progressive Disease (PD)|1
1720957|NCT01077713|6005021|P1|Overall Study|Progressive Disease (PD)|0
1720958|NCT01077713|6005020|P2|Overall Study|Withdrawal by Subject|2
1720959|NCT01077713|6005021|P1|Overall Study|Withdrawal by Subject|1
1720960|NCT01077622|6005045|P1|Overall Study|Withdrawal by Subject|1
1720961|NCT01077622|6005045|P1|Overall Study|Physician Decision|2
1720962|NCT01077544|6005165|P2|Overall Study|Disease Progression|1
1720963|NCT01077544|6005166|P1|Overall Study|Disease Progression|0
1720964|NCT01077544|6005165|P2|Overall Study|Adverse Event|1
1720965|NCT01077544|6005166|P1|Overall Study|Adverse Event|0
1720966|NCT01077544|6005165|P2|Overall Study|New Cancer Therapy|3
1720967|NCT01077544|6005166|P1|Overall Study|New Cancer Therapy|3
1720968|NCT01077375|6005207|P2|Overall Study|Other Reason|1
1720969|NCT01077375|6005208|P1|Overall Study|Other Reason|0
1720970|NCT01077375|6005207|P2|Overall Study|Lost to Follow-up|5
1720971|NCT01077375|6005208|P1|Overall Study|Lost to Follow-up|2
1720972|NCT01077375|6005207|P2|Overall Study|Withdrawal by Subject|6
1720973|NCT01077375|6005208|P1|Overall Study|Withdrawal by Subject|0
1720974|NCT01077375|6005207|P2|Overall Study|Lack of Efficacy|8
1720975|NCT01077375|6005208|P1|Overall Study|Lack of Efficacy|6
1720976|NCT01077375|6005207|P2|Overall Study|Adverse Event|15
1720977|NCT01077375|6005208|P1|Overall Study|Adverse Event|2
1720978|NCT01077362|6005219|P3|Overall Study|Other|2
1720979|NCT01077362|6005220|P2|Overall Study|Other|1
1720980|NCT01077362|6005221|P1|Overall Study|Other|0
1720981|NCT01077362|6005219|P3|Overall Study|Withdrawal by Subject|5
1720982|NCT01077362|6005220|P2|Overall Study|Withdrawal by Subject|3
1720983|NCT01077362|6005221|P1|Overall Study|Withdrawal by Subject|5
1720984|NCT01077362|6005219|P3|Overall Study|Adverse Event|4
1720985|NCT01077362|6005220|P2|Overall Study|Adverse Event|7
1720986|NCT01077362|6005221|P1|Overall Study|Adverse Event|12
1720987|NCT01077362|6005219|P3|Overall Study|Lost to Follow-up|3
1720988|NCT01077362|6005220|P2|Overall Study|Lost to Follow-up|0
1720989|NCT01077362|6005221|P1|Overall Study|Lost to Follow-up|1
1720990|NCT01077362|6005219|P3|Overall Study|Lack of Efficacy|10
1720991|NCT01077362|6005220|P2|Overall Study|Lack of Efficacy|8
1720992|NCT01077362|6005221|P1|Overall Study|Lack of Efficacy|13
1720993|NCT01077323|6005257|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
1720994|NCT01077323|6005258|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
1720995|NCT01077323|6005259|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
1720996|NCT01077323|6005257|P3|Overall Study|Dispensing of drug in baseline period|256446
1720997|NCT01077323|6005258|P2|Overall Study|Dispensing of drug in baseline period|120229
1720998|NCT01077323|6005259|P1|Overall Study|Dispensing of drug in baseline period|0
1720999|NCT01077323|6005257|P3|Overall Study|<9 months enroll before drug dispensed|11655523
1721000|NCT01077323|6005258|P2|Overall Study|<9 months enroll before drug dispensed|263954
1721001|NCT01077323|6005259|P1|Overall Study|<9 months enroll before drug dispensed|11226
1721002|NCT01077284|6005302|P3|Overall Study|Other|1
1721003|NCT01077284|6005303|P2|Overall Study|Other|0
1721004|NCT01077284|6005304|P1|Overall Study|Other|0
1721005|NCT01077284|6005302|P3|Overall Study|Withdrawal by Subject|1
1721006|NCT01077284|6005303|P2|Overall Study|Withdrawal by Subject|3
1721007|NCT01077284|6005304|P1|Overall Study|Withdrawal by Subject|2
1721008|NCT01077284|6005302|P3|Overall Study|Lost to Follow-up|0
1721009|NCT01077284|6005303|P2|Overall Study|Lost to Follow-up|2
1721010|NCT01077284|6005304|P1|Overall Study|Lost to Follow-up|1
1721011|NCT01077284|6005302|P3|Overall Study|Adverse Event|1
1721012|NCT01077284|6005303|P2|Overall Study|Adverse Event|0
1721013|NCT01077284|6005304|P1|Overall Study|Adverse Event|2
1721014|NCT01077271|6005325|P1|Overall Study|Mother unconvinced of the necessity|1
1721015|NCT01077271|6005325|P1|Overall Study|End of RSV season nearly reached|1
1721016|NCT01077271|6005325|P1|Overall Study|Parents thought too many injections|2
1721017|NCT01077271|6005325|P1|Overall Study|Changed doctors|2
1721018|NCT01077271|6005325|P1|Overall Study|Quota used up (insurance reimb issue)|2
1721019|NCT01077271|6005325|P1|Overall Study|Noncompliance|2
1721020|NCT01077271|6005325|P1|Overall Study|Screen failure, did not take palivizumab|4
1721021|NCT01077271|6005325|P1|Overall Study|Parental desire|8
1721022|NCT01077258|6005363|P1|Overall Study|Other reasons|260
1721023|NCT01077258|6005363|P1|Overall Study|Clinical remission|37
1721024|NCT01077258|6005363|P1|Overall Study|Lack of Efficacy|663
1721025|NCT01077258|6005363|P1|Overall Study|Adverse drug reaction|218
1721026|NCT01077258|6005363|P1|Overall Study|Lost to Follow-up|1390
1721027|NCT01077193|6005399|P1|Overall Study|Study Terminated by Sponsor|40
1721028|NCT01077193|6005399|P1|Overall Study|Lack of Efficacy|1
1721029|NCT01077193|6005399|P1|Overall Study|Withdrawal by Subject|2
1721030|NCT01077193|6005399|P1|Overall Study|Lost to Follow-up|1
1721031|NCT01077154|6005405|P2|Overall Study|Protocol Deviation|0
1721032|NCT01077154|6005406|P1|Overall Study|Protocol Deviation|1
1721033|NCT01077154|6005405|P2|Overall Study|Administrative Decision|6
1721034|NCT01077154|6005406|P1|Overall Study|Administrative Decision|1
1721035|NCT01077154|6005405|P2|Overall Study|Adverse Event|9
1721036|NCT01077154|6005406|P1|Overall Study|Adverse Event|9
1721037|NCT01077154|6005405|P2|Overall Study|Other|11
1721038|NCT01077154|6005406|P1|Overall Study|Other|14
1721039|NCT01077154|6005405|P2|Overall Study|Ineligibility Determined|14
1721040|NCT01077154|6005406|P1|Overall Study|Ineligibility Determined|10
1721041|NCT01077154|6005405|P2|Overall Study|Disease Progression|20
1721042|NCT01077154|6005406|P1|Overall Study|Disease Progression|18
1721043|NCT01077154|6005405|P2|Overall Study|Noncompliance|20
1721044|NCT01077154|6005406|P1|Overall Study|Noncompliance|22
1721045|NCT01077154|6005405|P2|Overall Study|Lost to Follow-up|35
1721046|NCT01077154|6005406|P1|Overall Study|Lost to Follow-up|43
1721047|NCT01077154|6005405|P2|Overall Study|Death|214
1721048|NCT01077154|6005406|P1|Overall Study|Death|215
1721049|NCT01077154|6005405|P2|Overall Study|Withdrawal by Subject|385
1721050|NCT01077154|6005406|P1|Overall Study|Withdrawal by Subject|369
1721051|NCT01077154|6005405|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
1721052|NCT01077154|6005406|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
1721053|NCT01077128|6005420|P1|Overall Study|Other|54
1721054|NCT01077128|6005420|P1|Overall Study|Lack of efficacy/disease exacerbation|1
1721055|NCT01077128|6005420|P1|Overall Study|Adverse event and disease exacerbation|1
1721056|NCT01077128|6005420|P1|Overall Study|Adverse event and consent withdrawal|1
1721057|NCT01077128|6005420|P1|Overall Study|Disease exacerbation|1
1721058|NCT01077128|6005420|P1|Overall Study|Lack of Efficacy|1
1721059|NCT01077128|6005420|P1|Overall Study|Adverse Event|8
1721060|NCT01077076|6005478|P6|Third Intervention|Death in the participant's family|1
1721061|NCT01077076|6005479|P5|Third Intervention|Death in the participant's family|0
1721062|NCT01077076|6005480|P4|Third Intervention|Death in the participant's family|0
1721063|NCT01077076|6005481|P3|Third Intervention|Death in the participant's family|0
1721064|NCT01077076|6005482|P2|Third Intervention|Death in the participant's family|0
1721065|NCT01077076|6005483|P1|Third Intervention|Death in the participant's family|0
1721066|NCT01077076|6005478|P6|First Intervention|Withdrawal by Subject|0
1721067|NCT01077076|6005479|P5|First Intervention|Withdrawal by Subject|0
1721068|NCT01077076|6005480|P4|First Intervention|Withdrawal by Subject|0
1721069|NCT01077076|6005481|P3|First Intervention|Withdrawal by Subject|0
1721070|NCT01077076|6005482|P2|First Intervention|Withdrawal by Subject|0
1721071|NCT01077076|6005483|P1|First Intervention|Withdrawal by Subject|1
1721072|NCT01077063|6005493|P2|Overall Study|Withdrawal by Subject|2
1721073|NCT01077063|6005494|P1|Overall Study|Withdrawal by Subject|0
1721074|NCT01077063|6005493|P2|Overall Study|Death|1
1721075|NCT01077063|6005494|P1|Overall Study|Death|1
1721076|NCT01077063|6005493|P2|Overall Study|Adverse Event|0
1721077|NCT01077063|6005494|P1|Overall Study|Adverse Event|3
1721078|NCT01077050|6005500|P1|Overall Study|Screen failure|8
1721079|NCT01077050|6005500|P1|Overall Study|Subjects signed ICF could not be located|1
1721080|NCT01077024|6005506|P2|Overall Study|Other|4
1721081|NCT01077024|6005507|P1|Overall Study|Other|4
1721082|NCT01077024|6005506|P2|Overall Study|Incarcerated|8
1721083|NCT01077024|6005507|P1|Overall Study|Incarcerated|7
1721084|NCT01077024|6005506|P2|Overall Study|Withdrawal by Subject|2
1721085|NCT01077024|6005507|P1|Overall Study|Withdrawal by Subject|0
1721086|NCT01077024|6005506|P2|Overall Study|Lost to Follow-up|14
1721087|NCT01077024|6005507|P1|Overall Study|Lost to Follow-up|20
1721088|NCT01076959|6005546|P1|Overall Study|Other|119
1721089|NCT01076959|6005546|P1|Overall Study|Lost to Follow-up|241
1721090|NCT01076959|6005546|P1|Overall Study|Non-compliance|274
1721091|NCT01076959|6005546|P1|Overall Study|Lack of Efficacy|849
1721092|NCT01076959|6005546|P1|Overall Study|Adverse Event|767
1721093|NCT01076647|6005582|P2|Overall Study|Unclassified|12
1721094|NCT01076647|6005583|P1|Overall Study|Unclassified|12
1721095|NCT01076647|6005582|P2|Overall Study|Withdrawal criteria|2
1721096|NCT01076647|6005583|P1|Overall Study|Withdrawal criteria|2
1721097|NCT01076647|6005582|P2|Overall Study|Protocol Violation|9
1721098|NCT01076647|6005583|P1|Overall Study|Protocol Violation|7
1721099|NCT01076647|6005582|P2|Overall Study|Lack of Efficacy|1
1721100|NCT01076647|6005583|P1|Overall Study|Lack of Efficacy|0
1721101|NCT01076647|6005582|P2|Overall Study|Adverse Event|1
1721102|NCT01076647|6005583|P1|Overall Study|Adverse Event|4
1721103|NCT01076543|6005597|P6|Overall Study|Withdrawal by Subject|0
1721104|NCT01076543|6005598|P5|Overall Study|Withdrawal by Subject|0
1721105|NCT01076543|6005599|P4|Overall Study|Withdrawal by Subject|0
1721106|NCT01076543|6005600|P3|Overall Study|Withdrawal by Subject|0
1721107|NCT01076543|6005601|P2|Overall Study|Withdrawal by Subject|0
1721108|NCT01076543|6005602|P1|Overall Study|Withdrawal by Subject|2
1721109|NCT01076400|6005663|P3|Overall Study|Progressive Disease|0
1721110|NCT01076400|6005664|P2|Overall Study|Progressive Disease|0
1721111|NCT01076400|6005665|P1|Overall Study|Progressive Disease|5
1721112|NCT01076400|6005663|P3|Overall Study|Adverse Event|0
1721113|NCT01076400|6005664|P2|Overall Study|Adverse Event|0
1721114|NCT01076400|6005665|P1|Overall Study|Adverse Event|2
1721115|NCT01076361|6005671|P1|Overall Study|22 leads were excluded from analysis|21
1721116|NCT01076335|6005679|P1|Overall Study|Withdrawal without treatment|1
1721117|NCT01076335|6005679|P1|Overall Study|Withdrawal by Subject|3
1721118|NCT01076205|6005731|P1|Overall Study|Lost to Follow-up|3151
1721119|NCT01076205|6005731|P1|Overall Study|Unknown Reason|71
1721120|NCT01076205|6005731|P1|Overall Study|Other Reason|1075
1721121|NCT01076205|6005731|P1|Overall Study|Lack of Effectiveness|1423
1721122|NCT01076205|6005731|P1|Overall Study|Adverse Drug Reaction|299
1721123|NCT01076192|6005784|P1|Overall Study|Other|197
1721124|NCT01076179|6005799|P1|Overall Study|Withdrawal by Subject|1
1721125|NCT01076166|6005822|P1|Overall Study|Symptoms improved/resolved|6
1721126|NCT01076166|6005822|P1|Overall Study|Adverse Event|3
1721127|NCT01076153|6005829|P1|Overall Study|Adverse Event|1
1721128|NCT01076153|6005829|P1|Overall Study|Symptoms improved/resolved|10
1721129|NCT01076088|6005843|P6|Overall Study|Other protocol specified criteria|1
1721130|NCT01076088|6005844|P5|Overall Study|Other protocol specified criteria|0
1721131|NCT01076088|6005845|P4|Overall Study|Other protocol specified criteria|0
1721132|NCT01076088|6005846|P3|Overall Study|Other protocol specified criteria|0
1721133|NCT01076088|6005847|P2|Overall Study|Other protocol specified criteria|0
1721134|NCT01076088|6005848|P1|Overall Study|Other protocol specified criteria|0
1721135|NCT01076088|6005843|P6|Overall Study|Withdrawal by Subject|17
1721136|NCT01076088|6005844|P5|Overall Study|Withdrawal by Subject|11
1721137|NCT01076088|6005845|P4|Overall Study|Withdrawal by Subject|10
1721138|NCT01076088|6005846|P3|Overall Study|Withdrawal by Subject|14
1721139|NCT01076088|6005847|P2|Overall Study|Withdrawal by Subject|8
1721140|NCT01076088|6005848|P1|Overall Study|Withdrawal by Subject|8
1721141|NCT01076088|6005843|P6|Overall Study|Physician Decision|0
1721142|NCT01076088|6005844|P5|Overall Study|Physician Decision|1
1721143|NCT01076088|6005845|P4|Overall Study|Physician Decision|1
1721144|NCT01076088|6005846|P3|Overall Study|Physician Decision|0
1721145|NCT01076088|6005847|P2|Overall Study|Physician Decision|3
1721146|NCT01076088|6005848|P1|Overall Study|Physician Decision|1
1721147|NCT01076088|6005843|P6|Overall Study|Non-compliance with study drug|0
1721148|NCT01076088|6005844|P5|Overall Study|Non-compliance with study drug|0
1721149|NCT01076088|6005845|P4|Overall Study|Non-compliance with study drug|1
1721150|NCT01076088|6005846|P3|Overall Study|Non-compliance with study drug|0
1721151|NCT01076088|6005847|P2|Overall Study|Non-compliance with study drug|0
1721152|NCT01076088|6005848|P1|Overall Study|Non-compliance with study drug|0
1721153|NCT01076088|6005843|P6|Overall Study|Lost to Follow-up|2
1721154|NCT01076088|6005844|P5|Overall Study|Lost to Follow-up|1
1721155|NCT01076088|6005845|P4|Overall Study|Lost to Follow-up|1
1721156|NCT01076088|6005846|P3|Overall Study|Lost to Follow-up|0
1721157|NCT01076088|6005847|P2|Overall Study|Lost to Follow-up|1
1721158|NCT01076088|6005848|P1|Overall Study|Lost to Follow-up|1
1721159|NCT01076088|6005843|P6|Overall Study|Adverse Event|3
1721160|NCT01076088|6005844|P5|Overall Study|Adverse Event|3
1721161|NCT01076088|6005845|P4|Overall Study|Adverse Event|2
1721162|NCT01076088|6005846|P3|Overall Study|Adverse Event|3
1721163|NCT01076088|6005847|P2|Overall Study|Adverse Event|6
1721164|NCT01076088|6005848|P1|Overall Study|Adverse Event|1
1721165|NCT01076075|6005876|P2|Overall Study|Withdrawal by Subject|19
1721166|NCT01076075|6005877|P1|Overall Study|Withdrawal by Subject|8
1721167|NCT01076075|6005876|P2|Overall Study|Protocol Violation|1
1721168|NCT01076075|6005877|P1|Overall Study|Protocol Violation|0
1721169|NCT01076075|6005876|P2|Overall Study|other|9
1721170|NCT01076075|6005877|P1|Overall Study|other|19
1721171|NCT01076075|6005876|P2|Overall Study|Lost to Follow-up|5
1721172|NCT01076075|6005877|P1|Overall Study|Lost to Follow-up|6
1721173|NCT01076075|6005876|P2|Overall Study|Lack of Efficacy|4
1721174|NCT01076075|6005877|P1|Overall Study|Lack of Efficacy|5
1721175|NCT01076075|6005876|P2|Overall Study|Adverse Event|9
1721176|NCT01076075|6005877|P1|Overall Study|Adverse Event|3
1721177|NCT01076036|6005891|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
1721178|NCT01075984|6005901|P5|Follow-up Phase|Treatment failure|4
1721179|NCT01075984|6005902|P4|Follow-up Phase|Treatment failure|0
1721180|NCT01075984|6005903|P3|Follow-up Phase|Treatment failure|0
1721181|NCT01075984|6005904|P2|Follow-up Phase|Treatment failure|0
1721182|NCT01075984|6005905|P1|Follow-up Phase|Treatment failure|0
1721183|NCT01075984|6005901|P5|Follow-up Phase|Progression of disease|2
1721184|NCT01075984|6005902|P4|Follow-up Phase|Progression of disease|0
1721185|NCT01075984|6005903|P3|Follow-up Phase|Progression of disease|0
1721186|NCT01075984|6005904|P2|Follow-up Phase|Progression of disease|0
1721187|NCT01075984|6005905|P1|Follow-up Phase|Progression of disease|0
1721188|NCT01075984|6005901|P5|Follow-up Phase|Withdrawal by Subject|10
1721189|NCT01075984|6005902|P4|Follow-up Phase|Withdrawal by Subject|0
1721190|NCT01075984|6005903|P3|Follow-up Phase|Withdrawal by Subject|0
1721191|NCT01075984|6005904|P2|Follow-up Phase|Withdrawal by Subject|0
1721192|NCT01075984|6005905|P1|Follow-up Phase|Withdrawal by Subject|0
1721193|NCT01075984|6005901|P5|Follow-up Phase|Administrative|1
1721194|NCT01075984|6005902|P4|Follow-up Phase|Administrative|0
1721195|NCT01075984|6005903|P3|Follow-up Phase|Administrative|0
1721196|NCT01075984|6005904|P2|Follow-up Phase|Administrative|0
1721197|NCT01075984|6005905|P1|Follow-up Phase|Administrative|0
1721198|NCT01075984|6005901|P5|Follow-up Phase|Adverse Event|27
1721199|NCT01075984|6005902|P4|Follow-up Phase|Adverse Event|2
1721200|NCT01075984|6005903|P3|Follow-up Phase|Adverse Event|0
1721201|NCT01075984|6005904|P2|Follow-up Phase|Adverse Event|0
1721202|NCT01075984|6005905|P1|Follow-up Phase|Adverse Event|0
1721203|NCT01075984|6005901|P5|Follow-up Phase|Protocol Violation|3
1721204|NCT01075984|6005902|P4|Follow-up Phase|Protocol Violation|0
1721205|NCT01075984|6005903|P3|Follow-up Phase|Protocol Violation|1
1721206|NCT01075984|6005904|P2|Follow-up Phase|Protocol Violation|0
1721207|NCT01075984|6005905|P1|Follow-up Phase|Protocol Violation|0
1721208|NCT01075984|6005901|P5|Treatment Phase|Progression of disease|2
1721209|NCT01075984|6005902|P4|Treatment Phase|Progression of disease|0
1721210|NCT01075984|6005903|P3|Treatment Phase|Progression of disease|0
1721211|NCT01075984|6005904|P2|Treatment Phase|Progression of disease|0
1721212|NCT01075984|6005905|P1|Treatment Phase|Progression of disease|0
1721213|NCT01075984|6005901|P5|Treatment Phase|Treatment Failure|5
1721214|NCT01075984|6005902|P4|Treatment Phase|Treatment Failure|0
1721215|NCT01075984|6005903|P3|Treatment Phase|Treatment Failure|1
1721216|NCT01075984|6005904|P2|Treatment Phase|Treatment Failure|0
1721217|NCT01075984|6005905|P1|Treatment Phase|Treatment Failure|0
1721218|NCT01075984|6005901|P5|Treatment Phase|Withdrawal by Subject|15
1721219|NCT01075984|6005902|P4|Treatment Phase|Withdrawal by Subject|0
1721220|NCT01075984|6005903|P3|Treatment Phase|Withdrawal by Subject|2
1721221|NCT01075984|6005904|P2|Treatment Phase|Withdrawal by Subject|0
1721222|NCT01075984|6005905|P1|Treatment Phase|Withdrawal by Subject|0
1721223|NCT01075984|6005901|P5|Treatment Phase|Protocol Violation|3
1721224|NCT01075984|6005902|P4|Treatment Phase|Protocol Violation|0
1721225|NCT01075984|6005903|P3|Treatment Phase|Protocol Violation|1
1721226|NCT01075984|6005904|P2|Treatment Phase|Protocol Violation|0
1721227|NCT01075984|6005905|P1|Treatment Phase|Protocol Violation|0
1721228|NCT01075984|6005901|P5|Treatment Phase|Adverse Event|35
1721229|NCT01075984|6005902|P4|Treatment Phase|Adverse Event|7
1721230|NCT01075984|6005903|P3|Treatment Phase|Adverse Event|3
1721231|NCT01075984|6005904|P2|Treatment Phase|Adverse Event|1
1721232|NCT01075984|6005905|P1|Treatment Phase|Adverse Event|0
1721233|NCT01075958|6005963|P1|Overall Study|Blood sample could not be obtained|44
1721234|NCT01075815|6005979|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
1721235|NCT01075815|6005980|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
1721236|NCT01075815|6005979|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
1721237|NCT01075815|6005980|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
1721238|NCT01075815|6005979|P2|Overall Study|Withdrawal before r-hCG administration|1
1721239|NCT01075815|6005980|P1|Overall Study|Withdrawal before r-hCG administration|6
1721240|NCT01075763|6006018|P2|Overall Study|Withdrawal by Subject|2
1721241|NCT01075763|6006019|P1|Overall Study|Withdrawal by Subject|2
1721242|NCT01075763|6006018|P2|Overall Study|Lack of Efficacy|1
1721243|NCT01075763|6006019|P1|Overall Study|Lack of Efficacy|0
1721244|NCT01075763|6006018|P2|Overall Study|Lost to Follow-up|1
1721245|NCT01075763|6006019|P1|Overall Study|Lost to Follow-up|2
1721246|NCT01075685|6006043|P2|Overall Study|Lost to Follow-up|220
1721247|NCT01075685|6006044|P1|Overall Study|Lost to Follow-up|563
1721248|NCT01075685|6006043|P2|Overall Study|Withdrawal by Subject|5
1721249|NCT01075685|6006044|P1|Overall Study|Withdrawal by Subject|20
1721250|NCT01075685|6006043|P2|Overall Study|Protocol Violation|1
1721251|NCT01075685|6006044|P1|Overall Study|Protocol Violation|9
1721252|NCT01075646|6006060|P4|Overall Study|Lost to Follow-up|2
1721253|NCT01075646|6006061|P3|Overall Study|Lost to Follow-up|1
1721254|NCT01075646|6006062|P2|Overall Study|Lost to Follow-up|3
1721255|NCT01075646|6006063|P1|Overall Study|Lost to Follow-up|4
1721256|NCT01075412|6006095|P2|Overall Study|Withdrawal by Subject|1
1721257|NCT01075412|6006096|P1|Overall Study|Withdrawal by Subject|0
1721258|NCT01075282|6006124|P3|Overall Study|Death|2
1721259|NCT01075282|6006125|P2|Overall Study|Death|1
1721260|NCT01075282|6006126|P1|Overall Study|Death|0
1721261|NCT01075282|6006124|P3|Overall Study|Protocol Violation|1
1721262|NCT01075282|6006125|P2|Overall Study|Protocol Violation|2
1721263|NCT01075282|6006126|P1|Overall Study|Protocol Violation|0
1721264|NCT01075282|6006124|P3|Overall Study|Treatment Non-compliance|2
1721265|NCT01075282|6006125|P2|Overall Study|Treatment Non-compliance|2
1721266|NCT01075282|6006126|P1|Overall Study|Treatment Non-compliance|1
1721267|NCT01075282|6006124|P3|Overall Study|Lack of Efficacy|0
1721268|NCT01075282|6006125|P2|Overall Study|Lack of Efficacy|1
1721269|NCT01075282|6006126|P1|Overall Study|Lack of Efficacy|1
1721270|NCT01075282|6006124|P3|Overall Study|Physician Decision|3
1721271|NCT01075282|6006125|P2|Overall Study|Physician Decision|3
1721272|NCT01075282|6006126|P1|Overall Study|Physician Decision|3
1721273|NCT01075282|6006124|P3|Overall Study|Lost to Follow-up|3
1721274|NCT01075282|6006125|P2|Overall Study|Lost to Follow-up|3
1721275|NCT01075282|6006126|P1|Overall Study|Lost to Follow-up|3
1721276|NCT01075282|6006124|P3|Overall Study|Entry Criteria Not Met|0
1721277|NCT01075282|6006125|P2|Overall Study|Entry Criteria Not Met|2
1721278|NCT01075282|6006126|P1|Overall Study|Entry Criteria Not Met|3
1721279|NCT01075282|6006124|P3|Overall Study|Adverse Event|5
1721280|NCT01075282|6006125|P2|Overall Study|Adverse Event|8
1721281|NCT01075282|6006126|P1|Overall Study|Adverse Event|9
1721282|NCT01075282|6006124|P3|Overall Study|Withdrawal by Subject|11
1721283|NCT01075282|6006125|P2|Overall Study|Withdrawal by Subject|7
1721284|NCT01075282|6006126|P1|Overall Study|Withdrawal by Subject|11
1721285|NCT01075256|6006209|P3|Overall Study|Withdrawal by Subject|0
1721286|NCT01075256|6006210|P2|Overall Study|Withdrawal by Subject|0
1721287|NCT01075256|6006211|P1|Overall Study|Withdrawal by Subject|1
1721288|NCT01075243|6006243|P3|Overall Study|Withdrawal by Subject|0
1721289|NCT01075243|6006244|P2|Overall Study|Withdrawal by Subject|1
1721290|NCT01075243|6006245|P1|Overall Study|Withdrawal by Subject|1
1721291|NCT01075243|6006243|P3|Overall Study|Lost to Follow-up|0
1721292|NCT01075243|6006244|P2|Overall Study|Lost to Follow-up|2
1721293|NCT01075243|6006245|P1|Overall Study|Lost to Follow-up|5
1721294|NCT01075217|6006297|P2|Overall Study|Physician Decision|0
1721295|NCT01075217|6006298|P1|Overall Study|Physician Decision|1
1721296|NCT01075217|6006297|P2|Overall Study|Adverse Event|1
1721297|NCT01075217|6006298|P1|Overall Study|Adverse Event|1
1721298|NCT01075191|6006331|P1|Overall Study|Unknown Reasons|1
1721299|NCT01075191|6006331|P1|Overall Study|Patient's Wish|2
1721300|NCT01075191|6006331|P1|Overall Study|Therapy Break|3
1721301|NCT01075191|6006331|P1|Overall Study|Noncompliance|3
1721302|NCT01075191|6006331|P1|Overall Study|Adverse Event|4
1721303|NCT01075191|6006331|P1|Overall Study|Co-morbidities|1
1721304|NCT01075191|6006331|P1|Overall Study|Intensification|3
1721305|NCT01075191|6006331|P1|Overall Study|Death|1
1721306|NCT01075178|6006342|P2|Subject Chart Review|matched partner excluded (reasons above)|3
1721307|NCT01075178|6006343|P1|Subject Chart Review|matched partner excluded (reasons above)|6
1721308|NCT01075178|6006342|P2|Subject Chart Review|no data collected due to site closure|4
1721309|NCT01075178|6006343|P1|Subject Chart Review|no data collected due to site closure|3
1721310|NCT01075178|6006342|P2|Subject Chart Review|died before chart review period|2
1721311|NCT01075178|6006343|P1|Subject Chart Review|died before chart review period|0
1721312|NCT01075178|6006342|P2|Subject Matching|eligible but not matched|403
1721313|NCT01075178|6006343|P1|Subject Matching|eligible but not matched|130
1721314|NCT01075152|6006357|P2|Overall Study|Withdrawal by Subject|0
1721315|NCT01075152|6006358|P1|Overall Study|Withdrawal by Subject|1
1721316|NCT01075100|6006384|P2|Overall Study|Other|1
1721317|NCT01075100|6006385|P1|Overall Study|Other|3
1721318|NCT01075100|6006384|P2|Overall Study|Disease Progression|29
1721319|NCT01075100|6006385|P1|Overall Study|Disease Progression|25
1721320|NCT01075100|6006384|P2|Overall Study|Investigator Request|1
1721321|NCT01075100|6006385|P1|Overall Study|Investigator Request|2
1721322|NCT01075100|6006384|P2|Overall Study|Patient Request|4
1721323|NCT01075100|6006385|P1|Overall Study|Patient Request|4
1721324|NCT01075100|6006384|P2|Overall Study|Adverse Event|18
1721325|NCT01075100|6006385|P1|Overall Study|Adverse Event|15
1721326|NCT01075074|6006415|P3|Overall Study|Surgeon changed to open incisional case|2
1721327|NCT01075074|6006416|P2|Overall Study|Surgeon changed to open incisional case|2
1721328|NCT01075074|6006417|P1|Overall Study|Surgeon changed to open incisional case|1
1721329|NCT01074944|6006434|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
1721330|NCT01074944|6006435|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1721331|NCT01074944|6006436|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1721332|NCT01074944|6006437|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1721333|NCT01074944|6006438|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
1721334|NCT01074944|6006434|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
1721335|NCT01074944|6006435|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
1721336|NCT01074944|6006436|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
1721337|NCT01074944|6006437|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
1721338|NCT01074944|6006438|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
1721339|NCT01074944|6006434|P5|Long Term Treatment|Withdrawal by Subject|0
1721340|NCT01074944|6006435|P4|Long Term Treatment|Withdrawal by Subject|2
1721341|NCT01074944|6006436|P3|Long Term Treatment|Withdrawal by Subject|0
1721342|NCT01074944|6006437|P2|Long Term Treatment|Withdrawal by Subject|0
1721343|NCT01074944|6006438|P1|Long Term Treatment|Withdrawal by Subject|0
1721344|NCT01074944|6006434|P5|Long Term Treatment|Entered in Period, But Not Treated|0
1721345|NCT01074944|6006435|P4|Long Term Treatment|Entered in Period, But Not Treated|1
1721346|NCT01074944|6006436|P3|Long Term Treatment|Entered in Period, But Not Treated|0
1721347|NCT01074944|6006437|P2|Long Term Treatment|Entered in Period, But Not Treated|0
1721348|NCT01074944|6006438|P1|Long Term Treatment|Entered in Period, But Not Treated|0
1721349|NCT01074944|6006434|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1721350|NCT01074944|6006435|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
1721351|NCT01074944|6006436|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1721352|NCT01074944|6006437|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1721353|NCT01074944|6006438|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
1721354|NCT01074944|6006434|P5|Long Term Treatment|Lost to Follow-up|0
1721355|NCT01074944|6006435|P4|Long Term Treatment|Lost to Follow-up|2
1721356|NCT01074944|6006436|P3|Long Term Treatment|Lost to Follow-up|0
1721357|NCT01074944|6006437|P2|Long Term Treatment|Lost to Follow-up|0
1721358|NCT01074944|6006438|P1|Long Term Treatment|Lost to Follow-up|0
1721359|NCT01074944|6006434|P5|Long Term Treatment|Adverse Event|0
1721360|NCT01074944|6006435|P4|Long Term Treatment|Adverse Event|3
1721361|NCT01074944|6006436|P3|Long Term Treatment|Adverse Event|0
1721362|NCT01074944|6006437|P2|Long Term Treatment|Adverse Event|0
1721363|NCT01074944|6006438|P1|Long Term Treatment|Adverse Event|0
1721364|NCT01074944|6006434|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1721365|NCT01074944|6006435|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1721366|NCT01074944|6006436|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
1721367|NCT01074944|6006437|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
1721368|NCT01074944|6006438|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
1721369|NCT01074944|6006434|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1721370|NCT01074944|6006435|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1721371|NCT01074944|6006436|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1721372|NCT01074944|6006437|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
1721373|NCT01074944|6006438|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
1721374|NCT01074944|6006434|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1721375|NCT01074944|6006435|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1721376|NCT01074944|6006436|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
1721377|NCT01074944|6006437|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
1721378|NCT01074944|6006438|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
1721379|NCT01074944|6006434|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1721380|NCT01074944|6006435|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1721381|NCT01074944|6006436|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
1721382|NCT01074944|6006437|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
1721383|NCT01074944|6006438|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
1721384|NCT01074944|6006434|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1721385|NCT01074944|6006435|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1721386|NCT01074944|6006436|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
1721387|NCT01074944|6006437|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
1721388|NCT01074944|6006438|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
1721389|NCT01074944|6006434|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1721390|NCT01074944|6006435|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1721391|NCT01074944|6006436|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1721392|NCT01074944|6006437|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
1721393|NCT01074944|6006438|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
1721394|NCT01074944|6006434|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1721395|NCT01074944|6006435|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1721396|NCT01074944|6006436|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1721397|NCT01074944|6006437|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
1721398|NCT01074944|6006438|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
1721399|NCT01074944|6006434|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1721400|NCT01074944|6006435|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1721401|NCT01074944|6006436|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1721402|NCT01074944|6006437|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
1721403|NCT01074944|6006438|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
1721404|NCT01074944|6006434|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1721405|NCT01074944|6006435|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1721406|NCT01074944|6006436|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1721407|NCT01074944|6006437|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
1721408|NCT01074944|6006438|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
1721409|NCT01074931|6006492|P1|Overall Study|Death|5
1721410|NCT01074931|6006492|P1|Overall Study|Economic reasons|1
1721411|NCT01074658|6006504|P1|Overall Study|No implant attempted|19
1721412|NCT01074554|6006512|P2|Overall Study|Lost to Follow-up|1
1721413|NCT01074554|6006513|P1|Overall Study|Lost to Follow-up|0
1721414|NCT01074554|6006512|P2|Overall Study|Adverse Event|3
1721415|NCT01074554|6006513|P1|Overall Study|Adverse Event|3
1721416|NCT01074502|6006523|P1|Overall Study|Withdrawal by Subject|1
1721417|NCT01074450|6006547|P2|Second Intervention|Physician Decision|1
1721418|NCT01074450|6006548|P1|Second Intervention|Physician Decision|0
1721419|NCT01074450|6006547|P2|Second Intervention|Protocol Violation|0
1721420|NCT01074450|6006548|P1|Second Intervention|Protocol Violation|1
1721421|NCT01074450|6006547|P2|First Intervention|Emesis in Dosing Interval|2
1721422|NCT01074450|6006548|P1|First Intervention|Emesis in Dosing Interval|0
1721423|NCT01074307|6006577|P2|Overall Study|Protocol Violation|5
1721424|NCT01074307|6006578|P1|Overall Study|Protocol Violation|8
1721425|NCT01074307|6006577|P2|Overall Study|Exclusion criterion|1
1721426|NCT01074307|6006578|P1|Overall Study|Exclusion criterion|0
1721427|NCT01074307|6006577|P2|Overall Study|No primary endpoint evaluation|6
1721428|NCT01074307|6006578|P1|Overall Study|No primary endpoint evaluation|14
1721429|NCT01074268|6006600|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
1721430|NCT01074268|6006601|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
1721431|NCT01074268|6006600|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
1721432|NCT01074268|6006601|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
1721433|NCT01074268|6006600|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
1721434|NCT01074268|6006601|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
1721435|NCT01074268|6006600|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
1721436|NCT01074268|6006601|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
1721437|NCT01074268|6006600|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
1721438|NCT01074268|6006601|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
1721439|NCT01074268|6006600|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
1721440|NCT01074268|6006601|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
1721441|NCT01074268|6006600|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
1721442|NCT01074268|6006601|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
1721443|NCT01074268|6006600|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
1721444|NCT01074268|6006601|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
1721445|NCT01074268|6006600|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
1721446|NCT01074268|6006601|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
1721447|NCT01074255|6006627|P1|Overall Study|Did not receive EMEND|2
1721448|NCT01074242|6006631|P1|Overall Study|Duplicate Case Report Form|5
1721449|NCT01074242|6006631|P1|Overall Study|Violation of vaccine dose or dosage|351
1721450|NCT01074242|6006631|P1|Overall Study|Case report unclear|6
1721451|NCT01074242|6006631|P1|Overall Study|Lost to Follow-up|1
1721452|NCT01074242|6006631|P1|Overall Study|Case report before date of contract|40
1721453|NCT01074229|6006639|P3|Overall Study|Change to open surgical procedure|4
1721454|NCT01074229|6006640|P2|Overall Study|Change to open surgical procedure|3
1721455|NCT01074229|6006641|P1|Overall Study|Change to open surgical procedure|1
1721456|NCT01074229|6006639|P3|Overall Study|Lost to Follow-up|0
1721457|NCT01074229|6006640|P2|Overall Study|Lost to Follow-up|0
1721458|NCT01074229|6006641|P1|Overall Study|Lost to Follow-up|1
1721459|NCT01074216|6006652|P1|Overall Study|Not Treated|12
1721460|NCT01074216|6006652|P1|Overall Study|Physician Decision|1
1721461|NCT01074047|6006716|P2|Extension Phase|Death|0
1721462|NCT01074047|6006717|P1|Extension Phase|Death|5
1721463|NCT01074047|6006716|P2|Extension Phase|Withdrawal by Subject|0
1721464|NCT01074047|6006717|P1|Extension Phase|Withdrawal by Subject|2
1721465|NCT01074047|6006716|P2|Extension Phase|Disease Progression|0
1721466|NCT01074047|6006717|P1|Extension Phase|Disease Progression|9
1721467|NCT01074047|6006716|P2|Extension Phase|Adverse Event|0
1721468|NCT01074047|6006717|P1|Extension Phase|Adverse Event|5
1721469|NCT01074047|6006716|P2|Extension Phase|Physician Decision|0
1721470|NCT01074047|6006717|P1|Extension Phase|Physician Decision|1
1721471|NCT01074047|6006716|P2|Survival Follow-Up Phase|Alive at study closure|3
1721472|NCT01074047|6006717|P1|Survival Follow-Up Phase|Alive at study closure|1
1721473|NCT01074047|6006716|P2|Survival Follow-Up Phase|Death|124
1721474|NCT01074047|6006717|P1|Survival Follow-Up Phase|Death|116
1721475|NCT01074047|6006716|P2|Survival Follow-Up Phase|Lost to Follow-up|1
1721476|NCT01074047|6006717|P1|Survival Follow-Up Phase|Lost to Follow-up|2
1721477|NCT01074047|6006716|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
1721478|NCT01074047|6006717|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
1721479|NCT01074047|6006716|P2|Treatment Phase|Miscellaneous|39
1721480|NCT01074047|6006717|P1|Treatment Phase|Miscellaneous|32
1721481|NCT01074047|6006716|P2|Treatment Phase|Protocol Violation|1
1721482|NCT01074047|6006717|P1|Treatment Phase|Protocol Violation|0
1721483|NCT01074047|6006716|P2|Treatment Phase|Lost to Follow-up|1
1721484|NCT01074047|6006717|P1|Treatment Phase|Lost to Follow-up|0
1721485|NCT01074047|6006716|P2|Treatment Phase|Death|58
1721486|NCT01074047|6006717|P1|Treatment Phase|Death|53
1721487|NCT01074047|6006716|P2|Treatment Phase|Withdrawal by Subject|48
1721488|NCT01074047|6006717|P1|Treatment Phase|Withdrawal by Subject|27
1721489|NCT01074047|6006716|P2|Treatment Phase|Disease Progression|21
1721490|NCT01074047|6006717|P1|Treatment Phase|Disease Progression|16
1721491|NCT01074047|6006716|P2|Treatment Phase|Adverse Event|66
1721492|NCT01074047|6006717|P1|Treatment Phase|Adverse Event|89
1721493|NCT01074008|6006805|P9|Overall Study|Lost to Follow-up|4
1721494|NCT01074008|6006806|P8|Overall Study|Lost to Follow-up|0
1721495|NCT01074008|6006807|P7|Overall Study|Lost to Follow-up|1
1721496|NCT01074008|6006808|P6|Overall Study|Lost to Follow-up|0
1721497|NCT01074008|6006809|P5|Overall Study|Lost to Follow-up|1
1721498|NCT01074008|6006810|P4|Overall Study|Lost to Follow-up|1
1721499|NCT01074008|6006811|P3|Overall Study|Lost to Follow-up|1
1721500|NCT01074008|6006812|P2|Overall Study|Lost to Follow-up|1
1721501|NCT01074008|6006813|P1|Overall Study|Lost to Follow-up|0
1721502|NCT01074008|6006805|P9|Overall Study|Withdrawal by Subject|0
1721503|NCT01074008|6006806|P8|Overall Study|Withdrawal by Subject|0
1721504|NCT01074008|6006807|P7|Overall Study|Withdrawal by Subject|0
1721505|NCT01074008|6006808|P6|Overall Study|Withdrawal by Subject|0
1721506|NCT01074008|6006809|P5|Overall Study|Withdrawal by Subject|1
1721507|NCT01074008|6006810|P4|Overall Study|Withdrawal by Subject|0
1721508|NCT01074008|6006811|P3|Overall Study|Withdrawal by Subject|1
1721509|NCT01074008|6006812|P2|Overall Study|Withdrawal by Subject|1
1721510|NCT01074008|6006813|P1|Overall Study|Withdrawal by Subject|1
1721511|NCT01074008|6006805|P9|Overall Study|Adverse Event|0
1721512|NCT01074008|6006806|P8|Overall Study|Adverse Event|0
1721513|NCT01074008|6006807|P7|Overall Study|Adverse Event|0
1721514|NCT01074008|6006808|P6|Overall Study|Adverse Event|0
1721515|NCT01074008|6006809|P5|Overall Study|Adverse Event|0
1721516|NCT01074008|6006810|P4|Overall Study|Adverse Event|0
1721517|NCT01074008|6006811|P3|Overall Study|Adverse Event|0
1721518|NCT01074008|6006812|P2|Overall Study|Adverse Event|1
1721519|NCT01074008|6006813|P1|Overall Study|Adverse Event|0
1721520|NCT01073943|6006923|P2|Overall Study|Could not tolerate prep|0
1721521|NCT01073943|6006924|P1|Overall Study|Could not tolerate prep|1
1721522|NCT01073943|6006923|P2|Overall Study|Unable to return for follow-up|1
1721523|NCT01073943|6006924|P1|Overall Study|Unable to return for follow-up|0
1721524|NCT01073943|6006923|P2|Overall Study|Subject forgot|1
1721525|NCT01073943|6006924|P1|Overall Study|Subject forgot|0
1721526|NCT01073943|6006923|P2|Overall Study|Power outage; colonoscopy not done|0
1721527|NCT01073943|6006924|P1|Overall Study|Power outage; colonoscopy not done|1
1721528|NCT01073943|6006923|P2|Overall Study|Lost to Follow-up|2
1721529|NCT01073943|6006924|P1|Overall Study|Lost to Follow-up|0
1721530|NCT01073943|6006923|P2|Overall Study|Adverse Event|1
1721531|NCT01073943|6006924|P1|Overall Study|Adverse Event|1
1721532|NCT01073943|6006923|P2|Overall Study|Protocol Violation|1
1721533|NCT01073943|6006924|P1|Overall Study|Protocol Violation|2
1721534|NCT01073943|6006923|P2|Overall Study|Withdrawal by Subject|2
1721535|NCT01073943|6006924|P1|Overall Study|Withdrawal by Subject|8
1721536|NCT01073930|6006950|P2|Overall Study|Inadequate prep; unable to do procedure|1
1721537|NCT01073930|6006951|P1|Overall Study|Inadequate prep; unable to do procedure|0
1721538|NCT01073930|6006950|P2|Overall Study|Noncompliance with study drug|1
1721539|NCT01073930|6006951|P1|Overall Study|Noncompliance with study drug|0
1721540|NCT01073930|6006950|P2|Overall Study|Adverse Event|1
1721541|NCT01073930|6006951|P1|Overall Study|Adverse Event|0
1721542|NCT01073930|6006950|P2|Overall Study|Lost to Follow-up|1
1721543|NCT01073930|6006951|P1|Overall Study|Lost to Follow-up|0
1721544|NCT01073930|6006950|P2|Overall Study|Withdrawal by Subject|2
1721545|NCT01073930|6006951|P1|Overall Study|Withdrawal by Subject|3
1721546|NCT01073865|6006975|P2|Overall Study|Withdrawal by Subject|5
1721547|NCT01073865|6006976|P1|Overall Study|Withdrawal by Subject|5
1721548|NCT01073865|6006975|P2|Overall Study|Death|2
1721549|NCT01073865|6006976|P1|Overall Study|Death|3
1721550|NCT01073865|6006975|P2|Overall Study|Lost to Follow-up|1
1721551|NCT01073865|6006976|P1|Overall Study|Lost to Follow-up|1
1721552|NCT01073865|6006975|P2|Overall Study|Reasons other than below|31
1721553|NCT01073865|6006976|P1|Overall Study|Reasons other than below|19
1721554|NCT01073631|6006995|P1|Overall Study|Other|63
1721555|NCT01073631|6006995|P1|Overall Study|Adverse Event|24
1721556|NCT01073631|6006995|P1|Overall Study|Death|82
1721557|NCT01073618|6007000|P1|Overall Study|Other|80
1721558|NCT01073618|6007000|P1|Overall Study|Adverse Event|19
1721559|NCT01073618|6007000|P1|Overall Study|Death|208
1721560|NCT01073605|6007008|P3|Overall Study|Randomized But Not Treated|1
1721561|NCT01073605|6007009|P2|Overall Study|Randomized But Not Treated|1
1721562|NCT01073605|6007010|P1|Overall Study|Randomized But Not Treated|0
1721563|NCT01073605|6007008|P3|Overall Study|Withdrawal by Subject|22
1721564|NCT01073605|6007009|P2|Overall Study|Withdrawal by Subject|39
1721565|NCT01073605|6007010|P1|Overall Study|Withdrawal by Subject|31
1721566|NCT01073605|6007008|P3|Overall Study|Other|29
1721567|NCT01073605|6007009|P2|Overall Study|Other|21
1721568|NCT01073605|6007010|P1|Overall Study|Other|25
1721569|NCT01073605|6007008|P3|Overall Study|Lost to Follow-up|9
1721570|NCT01073605|6007009|P2|Overall Study|Lost to Follow-up|4
1721571|NCT01073605|6007010|P1|Overall Study|Lost to Follow-up|3
1721572|NCT01073605|6007008|P3|Overall Study|Adverse Event|0
1721573|NCT01073605|6007009|P2|Overall Study|Adverse Event|1
1721574|NCT01073605|6007010|P1|Overall Study|Adverse Event|2
1721575|NCT01073605|6007008|P3|Overall Study|Ongoing at Cutoff Date|0
1721576|NCT01073605|6007009|P2|Overall Study|Ongoing at Cutoff Date|1
1721577|NCT01073605|6007010|P1|Overall Study|Ongoing at Cutoff Date|1
1721578|NCT01073566|6007056|P2|Period 2 (6 Weeks)|Adverse Event|0
1721579|NCT01073566|6007057|P1|Period 2 (6 Weeks)|Adverse Event|1
1721580|NCT01073462|6007069|P1|Overall Study|Lost to Follow-up|7
1721581|NCT01073462|6007069|P1|Overall Study|Serious adverse event|2
1721582|NCT01073462|6007069|P1|Overall Study|Low parathyroid hormone levels|8
1721583|NCT01073462|6007069|P1|Overall Study|Kidney transplant|10
1721584|NCT01073462|6007069|P1|Overall Study|Death|14
1721585|NCT01073293|6007088|P2|Overall Study|Withdrawal by Subject|10
1721586|NCT01073293|6007089|P1|Overall Study|Withdrawal by Subject|5
1721587|NCT01073293|6007088|P2|Overall Study|Lost to Follow-up|1
1721588|NCT01073293|6007089|P1|Overall Study|Lost to Follow-up|0
1721589|NCT01073267|6007111|P1|Overall Study|Disease Progression|3
1721590|NCT01073163|6007115|P1|Overall Study|Early termination|1
1721591|NCT01073163|6007115|P1|Overall Study|Disease Progression|1
1721592|NCT01073163|6007115|P1|Overall Study|Adverse Event|1
1721593|NCT01072929|6007138|P3|Overall Study|Other|0
1721594|NCT01072929|6007139|P2|Overall Study|Other|3
1721595|NCT01072929|6007140|P1|Overall Study|Other|0
1721596|NCT01072929|6007138|P3|Overall Study|Noncompliance with study procedures|1
1721597|NCT01072929|6007139|P2|Overall Study|Noncompliance with study procedures|0
1721598|NCT01072929|6007140|P1|Overall Study|Noncompliance with study procedures|1
1721599|NCT01072929|6007138|P3|Overall Study|Noncompliance with study medication|0
1721600|NCT01072929|6007139|P2|Overall Study|Noncompliance with study medication|3
1721601|NCT01072929|6007140|P1|Overall Study|Noncompliance with study medication|0
1721602|NCT01072929|6007138|P3|Overall Study|Lost to Follow-up|1
1721603|NCT01072929|6007139|P2|Overall Study|Lost to Follow-up|4
1721604|NCT01072929|6007140|P1|Overall Study|Lost to Follow-up|8
1721605|NCT01072929|6007138|P3|Overall Study|Protocol Violation|2
1721606|NCT01072929|6007139|P2|Overall Study|Protocol Violation|11
1721607|NCT01072929|6007140|P1|Overall Study|Protocol Violation|13
1721608|NCT01072929|6007138|P3|Overall Study|Withdrawal by Subject|3
1721609|NCT01072929|6007139|P2|Overall Study|Withdrawal by Subject|15
1721610|NCT01072929|6007140|P1|Overall Study|Withdrawal by Subject|7
1721611|NCT01072929|6007138|P3|Overall Study|Lack of Efficacy|0
1721612|NCT01072929|6007139|P2|Overall Study|Lack of Efficacy|4
1721613|NCT01072929|6007140|P1|Overall Study|Lack of Efficacy|7
1721614|NCT01072929|6007138|P3|Overall Study|Adverse Event|2
1721615|NCT01072929|6007139|P2|Overall Study|Adverse Event|11
1721616|NCT01072929|6007140|P1|Overall Study|Adverse Event|8
1721617|NCT01072877|6007219|P5|Overall Study|Lost to Follow-up|0
1721618|NCT01072877|6007220|P4|Overall Study|Lost to Follow-up|2
1721619|NCT01072877|6007221|P3|Overall Study|Lost to Follow-up|0
1721620|NCT01072877|6007222|P2|Overall Study|Lost to Follow-up|1
1721621|NCT01072877|6007223|P1|Overall Study|Lost to Follow-up|1
1721622|NCT01072630|6007302|P3|Overall Study|Other|1
1721623|NCT01072630|6007303|P2|Overall Study|Other|2
1721624|NCT01072630|6007304|P1|Overall Study|Other|3
1721625|NCT01072630|6007302|P3|Overall Study|Noncompliance with study procedures|1
1721626|NCT01072630|6007303|P2|Overall Study|Noncompliance with study procedures|2
1721627|NCT01072630|6007304|P1|Overall Study|Noncompliance with study procedures|1
1721628|NCT01072630|6007302|P3|Overall Study|Noncompliance with study medication|1
1721629|NCT01072630|6007303|P2|Overall Study|Noncompliance with study medication|1
1721630|NCT01072630|6007304|P1|Overall Study|Noncompliance with study medication|1
1721631|NCT01072630|6007302|P3|Overall Study|Lost to Follow-up|1
1721632|NCT01072630|6007303|P2|Overall Study|Lost to Follow-up|11
1721633|NCT01072630|6007304|P1|Overall Study|Lost to Follow-up|11
1721634|NCT01072630|6007302|P3|Overall Study|Protocol Violation|4
1721635|NCT01072630|6007303|P2|Overall Study|Protocol Violation|8
1721636|NCT01072630|6007304|P1|Overall Study|Protocol Violation|10
1721637|NCT01072630|6007302|P3|Overall Study|Withdrawal by Subject|2
1721638|NCT01072630|6007303|P2|Overall Study|Withdrawal by Subject|7
1721639|NCT01072630|6007304|P1|Overall Study|Withdrawal by Subject|8
1721640|NCT01072630|6007302|P3|Overall Study|Lack of Efficacy|1
1721641|NCT01072630|6007303|P2|Overall Study|Lack of Efficacy|10
1721642|NCT01072630|6007304|P1|Overall Study|Lack of Efficacy|10
1721643|NCT01072630|6007302|P3|Overall Study|Adverse Event|2
1721644|NCT01072630|6007303|P2|Overall Study|Adverse Event|19
1721645|NCT01072630|6007304|P1|Overall Study|Adverse Event|11
1721646|NCT01072539|6007385|P1|Overall Study|Protocol Violation|2
1721647|NCT01072539|6007385|P1|Overall Study|Treated prior to the Site Initiation|1
1721648|NCT01072500|6007409|P2|Overall Study|Withdrawal by Subject|10
1721649|NCT01072500|6007410|P1|Overall Study|Withdrawal by Subject|17
1721650|NCT01072500|6007409|P2|Overall Study|Lost to Follow-up|2
1721651|NCT01072500|6007410|P1|Overall Study|Lost to Follow-up|5
1721652|NCT01072500|6007409|P2|Overall Study|Death|2
1721653|NCT01072500|6007410|P1|Overall Study|Death|2
1721654|NCT01072448|6007420|P2|Overall Study|Death|2
1721655|NCT01072448|6007421|P1|Overall Study|Death|0
1721656|NCT01072448|6007420|P2|Overall Study|Abnormal laboratory value(s)|1
1721657|NCT01072448|6007421|P1|Overall Study|Abnormal laboratory value(s)|0
1721658|NCT01072448|6007420|P2|Overall Study|Lost to Follow-up|1
1721659|NCT01072448|6007421|P1|Overall Study|Lost to Follow-up|1
1721660|NCT01072448|6007420|P2|Overall Study|Unsatisfactory therapeutic effect|3
1721661|NCT01072448|6007421|P1|Overall Study|Unsatisfactory therapeutic effect|1
1721662|NCT01072448|6007420|P2|Overall Study|Abnormal test procedure result(s)|0
1721663|NCT01072448|6007421|P1|Overall Study|Abnormal test procedure result(s)|1
1721664|NCT01072448|6007420|P2|Overall Study|Protocol deviation|4
1721665|NCT01072448|6007421|P1|Overall Study|Protocol deviation|3
1721666|NCT01072448|6007420|P2|Overall Study|Subject withdrew consent|9
1721667|NCT01072448|6007421|P1|Overall Study|Subject withdrew consent|4
1721668|NCT01072448|6007420|P2|Overall Study|Adverse Event|10
1721669|NCT01072448|6007421|P1|Overall Study|Adverse Event|9
1721670|NCT01072396|6007435|P2|Period Two|Lost to Follow-up|0
1721671|NCT01072396|6007436|P1|Period Two|Lost to Follow-up|1
1721672|NCT01072396|6007435|P2|Period Two|Adverse Event|3
1721673|NCT01072396|6007436|P1|Period Two|Adverse Event|0
1721674|NCT01072396|6007435|P2|Washout Period|Missing termination information|1
1721675|NCT01072396|6007436|P1|Washout Period|Missing termination information|0
1721676|NCT01072396|6007435|P2|Period One|Withdrawal by Subject|0
1721677|NCT01072396|6007436|P1|Period One|Withdrawal by Subject|2
1721678|NCT01072396|6007435|P2|Period One|Protocol Violation|1
1721679|NCT01072396|6007436|P1|Period One|Protocol Violation|2
1721680|NCT01072396|6007435|P2|Period One|Adverse Event|1
1721681|NCT01072396|6007436|P1|Period One|Adverse Event|1
1721682|NCT01072357|6007448|P2|Overall Study|Lost to Follow-up|1
1721683|NCT01072357|6007449|P1|Overall Study|Lost to Follow-up|0
1721684|NCT01072344|6007459|P2|Overall Study|Lost to Follow-up|4
1721685|NCT01072344|6007460|P1|Overall Study|Lost to Follow-up|3
1721686|NCT01072344|6007459|P2|Overall Study|Protocol Violation|2
1721687|NCT01072344|6007460|P1|Overall Study|Protocol Violation|1
1721688|NCT01072344|6007459|P2|Overall Study|Relasped-reached end point|12
1721689|NCT01072344|6007460|P1|Overall Study|Relasped-reached end point|7
1721690|NCT01072201|6007498|P2|Overall Study|Lost to Follow-up|1
1721691|NCT01072201|6007499|P1|Overall Study|Lost to Follow-up|0
1721692|NCT01072175|6007532|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721693|NCT01072175|6007533|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
1721694|NCT01072175|6007534|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
1721695|NCT01072175|6007535|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721696|NCT01072175|6007536|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721697|NCT01072175|6007537|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721698|NCT01072175|6007538|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721699|NCT01072175|6007539|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721700|NCT01072175|6007540|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721701|NCT01072175|6007541|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721702|NCT01072175|6007542|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721703|NCT01072175|6007543|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721704|NCT01072175|6007544|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
1721705|NCT01072175|6007532|P13|Part D (HPMC Capsules)|Study closed/terminated|9
1721706|NCT01072175|6007533|P12|Part D (HPMC Capsules)|Study closed/terminated|10
1721707|NCT01072175|6007534|P11|Part D (HPMC Capsules)|Study closed/terminated|1
1721708|NCT01072175|6007535|P10|Part D (HPMC Capsules)|Study closed/terminated|2
1721709|NCT01072175|6007536|P9|Part D (HPMC Capsules)|Study closed/terminated|0
1721710|NCT01072175|6007537|P8|Part D (HPMC Capsules)|Study closed/terminated|0
1721711|NCT01072175|6007538|P7|Part D (HPMC Capsules)|Study closed/terminated|0
1721712|NCT01072175|6007539|P6|Part D (HPMC Capsules)|Study closed/terminated|0
1721713|NCT01072175|6007540|P5|Part D (HPMC Capsules)|Study closed/terminated|0
1721714|NCT01072175|6007541|P4|Part D (HPMC Capsules)|Study closed/terminated|0
1721715|NCT01072175|6007542|P3|Part D (HPMC Capsules)|Study closed/terminated|0
1721716|NCT01072175|6007543|P2|Part D (HPMC Capsules)|Study closed/terminated|0
1721717|NCT01072175|6007544|P1|Part D (HPMC Capsules)|Study closed/terminated|0
1721718|NCT01072175|6007532|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
1721719|NCT01072175|6007533|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
1721720|NCT01072175|6007534|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
1721721|NCT01072175|6007535|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
1721722|NCT01072175|6007536|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
1721723|NCT01072175|6007537|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
1721724|NCT01072175|6007538|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
1721725|NCT01072175|6007539|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
1721726|NCT01072175|6007540|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
1721727|NCT01072175|6007541|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
1721728|NCT01072175|6007542|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
1721729|NCT01072175|6007543|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
1721730|NCT01072175|6007544|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
1721731|NCT01072175|6007532|P13|Part D (HPMC Capsules)|Physician Decision|1
1721732|NCT01072175|6007533|P12|Part D (HPMC Capsules)|Physician Decision|1
1721733|NCT01072175|6007534|P11|Part D (HPMC Capsules)|Physician Decision|1
1721734|NCT01072175|6007535|P10|Part D (HPMC Capsules)|Physician Decision|0
1721735|NCT01072175|6007536|P9|Part D (HPMC Capsules)|Physician Decision|0
1721736|NCT01072175|6007537|P8|Part D (HPMC Capsules)|Physician Decision|0
1721737|NCT01072175|6007538|P7|Part D (HPMC Capsules)|Physician Decision|0
1721738|NCT01072175|6007539|P6|Part D (HPMC Capsules)|Physician Decision|0
1721739|NCT01072175|6007540|P5|Part D (HPMC Capsules)|Physician Decision|0
1721740|NCT01072175|6007541|P4|Part D (HPMC Capsules)|Physician Decision|0
1721741|NCT01072175|6007542|P3|Part D (HPMC Capsules)|Physician Decision|0
1721742|NCT01072175|6007543|P2|Part D (HPMC Capsules)|Physician Decision|0
1721743|NCT01072175|6007544|P1|Part D (HPMC Capsules)|Physician Decision|0
1721744|NCT01072175|6007532|P13|Part D (HPMC Capsules)|Death|26
1721745|NCT01072175|6007533|P12|Part D (HPMC Capsules)|Death|28
1721746|NCT01072175|6007534|P11|Part D (HPMC Capsules)|Death|12
1721747|NCT01072175|6007535|P10|Part D (HPMC Capsules)|Death|10
1721748|NCT01072175|6007536|P9|Part D (HPMC Capsules)|Death|0
1721749|NCT01072175|6007537|P8|Part D (HPMC Capsules)|Death|0
1721750|NCT01072175|6007538|P7|Part D (HPMC Capsules)|Death|0
1721751|NCT01072175|6007539|P6|Part D (HPMC Capsules)|Death|0
1721752|NCT01072175|6007540|P5|Part D (HPMC Capsules)|Death|0
1721753|NCT01072175|6007541|P4|Part D (HPMC Capsules)|Death|0
1721754|NCT01072175|6007542|P3|Part D (HPMC Capsules)|Death|0
1721755|NCT01072175|6007543|P2|Part D (HPMC Capsules)|Death|0
1721756|NCT01072175|6007544|P1|Part D (HPMC Capsules)|Death|0
1721757|NCT01072175|6007532|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721758|NCT01072175|6007533|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721759|NCT01072175|6007534|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721760|NCT01072175|6007535|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721761|NCT01072175|6007536|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
1721762|NCT01072175|6007537|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721763|NCT01072175|6007538|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721764|NCT01072175|6007539|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721765|NCT01072175|6007540|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721766|NCT01072175|6007541|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721767|NCT01072175|6007542|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721768|NCT01072175|6007543|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721769|NCT01072175|6007544|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
1721770|NCT01072175|6007532|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721771|NCT01072175|6007533|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721772|NCT01072175|6007534|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721773|NCT01072175|6007535|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721774|NCT01072175|6007536|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
1721775|NCT01072175|6007537|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721776|NCT01072175|6007538|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721777|NCT01072175|6007539|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721778|NCT01072175|6007540|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721779|NCT01072175|6007541|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721780|NCT01072175|6007542|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721781|NCT01072175|6007543|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721782|NCT01072175|6007544|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
1721783|NCT01072175|6007532|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721784|NCT01072175|6007533|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721785|NCT01072175|6007534|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721786|NCT01072175|6007535|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721787|NCT01072175|6007536|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
1721788|NCT01072175|6007537|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721789|NCT01072175|6007538|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721790|NCT01072175|6007539|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721791|NCT01072175|6007540|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721792|NCT01072175|6007541|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721793|NCT01072175|6007542|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721794|NCT01072175|6007543|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721795|NCT01072175|6007544|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
1721796|NCT01072175|6007532|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
1721797|NCT01072175|6007533|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
1721798|NCT01072175|6007534|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
1721799|NCT01072175|6007535|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
1721800|NCT01072175|6007536|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
1721801|NCT01072175|6007537|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
1721802|NCT01072175|6007538|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
1721803|NCT01072175|6007539|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
1721804|NCT01072175|6007540|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
1721805|NCT01072175|6007541|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
1721806|NCT01072175|6007542|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
1721807|NCT01072175|6007543|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
1721808|NCT01072175|6007544|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
1721809|NCT01072175|6007532|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721810|NCT01072175|6007533|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721811|NCT01072175|6007534|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721812|NCT01072175|6007535|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721813|NCT01072175|6007536|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721814|NCT01072175|6007537|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721815|NCT01072175|6007538|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
1721816|NCT01072175|6007539|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
1721817|NCT01072175|6007540|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721818|NCT01072175|6007541|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721819|NCT01072175|6007542|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721820|NCT01072175|6007543|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721821|NCT01072175|6007544|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
1721822|NCT01072175|6007532|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721823|NCT01072175|6007533|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721824|NCT01072175|6007534|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721825|NCT01072175|6007535|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721826|NCT01072175|6007536|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721827|NCT01072175|6007537|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
1721828|NCT01072175|6007538|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
1721829|NCT01072175|6007539|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
1721830|NCT01072175|6007540|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721831|NCT01072175|6007541|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1722209|NCT01071252|6007964|P3|Overall Study|Death|0
1721832|NCT01072175|6007542|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721833|NCT01072175|6007543|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721834|NCT01072175|6007544|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
1721835|NCT01072175|6007532|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721836|NCT01072175|6007533|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721837|NCT01072175|6007534|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721838|NCT01072175|6007535|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721839|NCT01072175|6007536|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721840|NCT01072175|6007537|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
1721841|NCT01072175|6007538|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
1721842|NCT01072175|6007539|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721843|NCT01072175|6007540|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721844|NCT01072175|6007541|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721845|NCT01072175|6007542|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721846|NCT01072175|6007543|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721847|NCT01072175|6007544|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
1721848|NCT01072175|6007532|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721849|NCT01072175|6007533|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721850|NCT01072175|6007534|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721851|NCT01072175|6007535|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721852|NCT01072175|6007536|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721853|NCT01072175|6007537|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
1721854|NCT01072175|6007538|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
1721855|NCT01072175|6007539|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
1721856|NCT01072175|6007540|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721857|NCT01072175|6007541|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721858|NCT01072175|6007542|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721859|NCT01072175|6007543|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721860|NCT01072175|6007544|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
1721861|NCT01072175|6007532|P13|Part C (Phase II: Randomized Phase)|Death|0
1721862|NCT01072175|6007533|P12|Part C (Phase II: Randomized Phase)|Death|0
1721863|NCT01072175|6007534|P11|Part C (Phase II: Randomized Phase)|Death|0
1721864|NCT01072175|6007535|P10|Part C (Phase II: Randomized Phase)|Death|0
1721865|NCT01072175|6007536|P9|Part C (Phase II: Randomized Phase)|Death|0
1721866|NCT01072175|6007537|P8|Part C (Phase II: Randomized Phase)|Death|39
1721867|NCT01072175|6007538|P7|Part C (Phase II: Randomized Phase)|Death|34
1721868|NCT01072175|6007539|P6|Part C (Phase II: Randomized Phase)|Death|44
1721869|NCT01072175|6007540|P5|Part C (Phase II: Randomized Phase)|Death|0
1721870|NCT01072175|6007541|P4|Part C (Phase II: Randomized Phase)|Death|0
1721871|NCT01072175|6007542|P3|Part C (Phase II: Randomized Phase)|Death|0
1721872|NCT01072175|6007543|P2|Part C (Phase II: Randomized Phase)|Death|0
1721873|NCT01072175|6007544|P1|Part C (Phase II: Randomized Phase)|Death|0
1721874|NCT01072175|6007532|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721875|NCT01072175|6007533|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721876|NCT01072175|6007534|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721877|NCT01072175|6007535|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721878|NCT01072175|6007536|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721879|NCT01072175|6007537|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721880|NCT01072175|6007538|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721881|NCT01072175|6007539|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721882|NCT01072175|6007540|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
1721883|NCT01072175|6007541|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
1721884|NCT01072175|6007542|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721885|NCT01072175|6007543|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
1721886|NCT01072175|6007544|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
1721887|NCT01072175|6007532|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721888|NCT01072175|6007533|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721889|NCT01072175|6007534|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721890|NCT01072175|6007535|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721891|NCT01072175|6007536|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721892|NCT01072175|6007537|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721893|NCT01072175|6007538|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721894|NCT01072175|6007539|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721895|NCT01072175|6007540|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
1721896|NCT01072175|6007541|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
1721897|NCT01072175|6007542|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
1721898|NCT01072175|6007543|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721899|NCT01072175|6007544|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
1721900|NCT01072175|6007532|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721901|NCT01072175|6007533|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721902|NCT01072175|6007534|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721903|NCT01072175|6007535|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721904|NCT01072175|6007536|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721905|NCT01072175|6007537|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721906|NCT01072175|6007538|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721907|NCT01072175|6007539|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721908|NCT01072175|6007540|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
1721909|NCT01072175|6007541|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
1721910|NCT01072175|6007542|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721911|NCT01072175|6007543|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
1721912|NCT01072175|6007544|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
1721913|NCT01072175|6007532|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721914|NCT01072175|6007533|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721915|NCT01072175|6007534|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721916|NCT01072175|6007535|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721917|NCT01072175|6007536|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721918|NCT01072175|6007537|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721919|NCT01072175|6007538|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721920|NCT01072175|6007539|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721921|NCT01072175|6007540|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
1721922|NCT01072175|6007541|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721923|NCT01072175|6007542|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
1721924|NCT01072175|6007543|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721925|NCT01072175|6007544|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
1721926|NCT01072175|6007532|P13|Part B (Dose Escalation and Expansion)|Death|0
1721927|NCT01072175|6007533|P12|Part B (Dose Escalation and Expansion)|Death|0
1721928|NCT01072175|6007534|P11|Part B (Dose Escalation and Expansion)|Death|0
1721929|NCT01072175|6007535|P10|Part B (Dose Escalation and Expansion)|Death|0
1721930|NCT01072175|6007536|P9|Part B (Dose Escalation and Expansion)|Death|0
1721931|NCT01072175|6007537|P8|Part B (Dose Escalation and Expansion)|Death|0
1721932|NCT01072175|6007538|P7|Part B (Dose Escalation and Expansion)|Death|0
1721933|NCT01072175|6007539|P6|Part B (Dose Escalation and Expansion)|Death|0
1721934|NCT01072175|6007540|P5|Part B (Dose Escalation and Expansion)|Death|68
1721935|NCT01072175|6007541|P4|Part B (Dose Escalation and Expansion)|Death|21
1721936|NCT01072175|6007542|P3|Part B (Dose Escalation and Expansion)|Death|18
1721937|NCT01072175|6007543|P2|Part B (Dose Escalation and Expansion)|Death|4
1721938|NCT01072175|6007544|P1|Part B (Dose Escalation and Expansion)|Death|0
1721939|NCT01072175|6007532|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721940|NCT01072175|6007533|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721941|NCT01072175|6007534|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721942|NCT01072175|6007535|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721943|NCT01072175|6007536|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721944|NCT01072175|6007537|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721945|NCT01072175|6007538|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721946|NCT01072175|6007539|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721947|NCT01072175|6007540|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721948|NCT01072175|6007541|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721949|NCT01072175|6007542|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721950|NCT01072175|6007543|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
1721951|NCT01072175|6007544|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
1721952|NCT01072175|6007532|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
1721953|NCT01072175|6007533|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
1721954|NCT01072175|6007534|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
1721955|NCT01072175|6007535|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
1721956|NCT01072175|6007536|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
1721957|NCT01072175|6007537|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
1721958|NCT01072175|6007538|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
1721959|NCT01072175|6007539|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
1721960|NCT01072175|6007540|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
1721961|NCT01072175|6007541|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
1721962|NCT01072175|6007542|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
1721963|NCT01072175|6007543|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
1721964|NCT01072175|6007544|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
1721965|NCT01072175|6007532|P13|Part A (Drug-Drug Interaction)|Death|0
1721966|NCT01072175|6007533|P12|Part A (Drug-Drug Interaction)|Death|0
1721967|NCT01072175|6007534|P11|Part A (Drug-Drug Interaction)|Death|0
1721968|NCT01072175|6007535|P10|Part A (Drug-Drug Interaction)|Death|0
1721969|NCT01072175|6007536|P9|Part A (Drug-Drug Interaction)|Death|0
1721970|NCT01072175|6007537|P8|Part A (Drug-Drug Interaction)|Death|0
1721971|NCT01072175|6007538|P7|Part A (Drug-Drug Interaction)|Death|0
1721972|NCT01072175|6007539|P6|Part A (Drug-Drug Interaction)|Death|0
1721973|NCT01072175|6007540|P5|Part A (Drug-Drug Interaction)|Death|0
1721974|NCT01072175|6007541|P4|Part A (Drug-Drug Interaction)|Death|0
1721975|NCT01072175|6007542|P3|Part A (Drug-Drug Interaction)|Death|0
1721976|NCT01072175|6007543|P2|Part A (Drug-Drug Interaction)|Death|0
1721977|NCT01072175|6007544|P1|Part A (Drug-Drug Interaction)|Death|1
1722210|NCT01071252|6007965|P2|Overall Study|Death|0
1721978|NCT01072149|6007753|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721979|NCT01072149|6007754|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721980|NCT01072149|6007755|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721981|NCT01072149|6007756|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721982|NCT01072149|6007757|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
1721983|NCT01072149|6007758|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721984|NCT01072149|6007759|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721985|NCT01072149|6007760|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721986|NCT01072149|6007761|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721987|NCT01072149|6007762|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721988|NCT01072149|6007763|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721989|NCT01072149|6007764|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721990|NCT01072149|6007765|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721991|NCT01072149|6007766|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721992|NCT01072149|6007767|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721993|NCT01072149|6007768|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
1721994|NCT01072149|6007769|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721995|NCT01072149|6007770|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
1721996|NCT01072149|6007753|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
1721997|NCT01072149|6007754|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
1721998|NCT01072149|6007755|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
1721999|NCT01072149|6007756|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722000|NCT01072149|6007757|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722001|NCT01072149|6007758|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
1722002|NCT01072149|6007759|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722003|NCT01072149|6007760|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722004|NCT01072149|6007761|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722005|NCT01072149|6007762|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722006|NCT01072149|6007763|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722007|NCT01072149|6007764|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722008|NCT01072149|6007765|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722009|NCT01072149|6007766|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722010|NCT01072149|6007767|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722011|NCT01072149|6007768|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722012|NCT01072149|6007769|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722013|NCT01072149|6007770|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
1722014|NCT01072149|6007753|P18|Washout Period 2 (14 Days)|Adverse Event|0
1722015|NCT01072149|6007754|P17|Washout Period 2 (14 Days)|Adverse Event|0
1722016|NCT01072149|6007755|P16|Washout Period 2 (14 Days)|Adverse Event|1
1722017|NCT01072149|6007756|P15|Washout Period 2 (14 Days)|Adverse Event|0
1722018|NCT01072149|6007757|P14|Washout Period 2 (14 Days)|Adverse Event|0
1722019|NCT01072149|6007758|P13|Washout Period 2 (14 Days)|Adverse Event|0
1722020|NCT01072149|6007759|P12|Washout Period 2 (14 Days)|Adverse Event|0
1722021|NCT01072149|6007760|P11|Washout Period 2 (14 Days)|Adverse Event|0
1722022|NCT01072149|6007761|P10|Washout Period 2 (14 Days)|Adverse Event|0
1722023|NCT01072149|6007762|P9|Washout Period 2 (14 Days)|Adverse Event|0
1722024|NCT01072149|6007763|P8|Washout Period 2 (14 Days)|Adverse Event|0
1722025|NCT01072149|6007764|P7|Washout Period 2 (14 Days)|Adverse Event|0
1722026|NCT01072149|6007765|P6|Washout Period 2 (14 Days)|Adverse Event|0
1722027|NCT01072149|6007766|P5|Washout Period 2 (14 Days)|Adverse Event|0
1722028|NCT01072149|6007767|P4|Washout Period 2 (14 Days)|Adverse Event|0
1722029|NCT01072149|6007768|P3|Washout Period 2 (14 Days)|Adverse Event|0
1722030|NCT01072149|6007769|P2|Washout Period 2 (14 Days)|Adverse Event|0
1722031|NCT01072149|6007770|P1|Washout Period 2 (14 Days)|Adverse Event|0
1722032|NCT01072149|6007753|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722033|NCT01072149|6007754|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722034|NCT01072149|6007755|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
1722035|NCT01072149|6007756|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722036|NCT01072149|6007757|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722037|NCT01072149|6007758|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722038|NCT01072149|6007759|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722039|NCT01072149|6007760|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722040|NCT01072149|6007761|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722041|NCT01072149|6007762|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722042|NCT01072149|6007763|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722043|NCT01072149|6007764|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722044|NCT01072149|6007765|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722045|NCT01072149|6007766|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722046|NCT01072149|6007767|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722047|NCT01072149|6007768|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722048|NCT01072149|6007769|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722049|NCT01072149|6007770|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
1722050|NCT01072149|6007753|P18|Washout Period 2 (14 Days)|Physician Decision|0
1722051|NCT01072149|6007754|P17|Washout Period 2 (14 Days)|Physician Decision|0
1722052|NCT01072149|6007755|P16|Washout Period 2 (14 Days)|Physician Decision|0
1722053|NCT01072149|6007756|P15|Washout Period 2 (14 Days)|Physician Decision|0
1722054|NCT01072149|6007757|P14|Washout Period 2 (14 Days)|Physician Decision|0
1722055|NCT01072149|6007758|P13|Washout Period 2 (14 Days)|Physician Decision|0
1722056|NCT01072149|6007759|P12|Washout Period 2 (14 Days)|Physician Decision|0
1722057|NCT01072149|6007760|P11|Washout Period 2 (14 Days)|Physician Decision|0
1722058|NCT01072149|6007761|P10|Washout Period 2 (14 Days)|Physician Decision|0
1722059|NCT01072149|6007762|P9|Washout Period 2 (14 Days)|Physician Decision|0
1722060|NCT01072149|6007763|P8|Washout Period 2 (14 Days)|Physician Decision|0
1722061|NCT01072149|6007764|P7|Washout Period 2 (14 Days)|Physician Decision|0
1722062|NCT01072149|6007765|P6|Washout Period 2 (14 Days)|Physician Decision|0
1722063|NCT01072149|6007766|P5|Washout Period 2 (14 Days)|Physician Decision|0
1722064|NCT01072149|6007767|P4|Washout Period 2 (14 Days)|Physician Decision|0
1722065|NCT01072149|6007768|P3|Washout Period 2 (14 Days)|Physician Decision|0
1722066|NCT01072149|6007769|P2|Washout Period 2 (14 Days)|Physician Decision|0
1722067|NCT01072149|6007770|P1|Washout Period 2 (14 Days)|Physician Decision|1
1722068|NCT01072149|6007753|P18|Treatment Period 2 (28 Days)|Physician Decision|0
1722069|NCT01072149|6007754|P17|Treatment Period 2 (28 Days)|Physician Decision|0
1722070|NCT01072149|6007755|P16|Treatment Period 2 (28 Days)|Physician Decision|0
1722071|NCT01072149|6007756|P15|Treatment Period 2 (28 Days)|Physician Decision|0
1722072|NCT01072149|6007757|P14|Treatment Period 2 (28 Days)|Physician Decision|0
1722073|NCT01072149|6007758|P13|Treatment Period 2 (28 Days)|Physician Decision|0
1722074|NCT01072149|6007759|P12|Treatment Period 2 (28 Days)|Physician Decision|0
1722075|NCT01072149|6007760|P11|Treatment Period 2 (28 Days)|Physician Decision|0
1722076|NCT01072149|6007761|P10|Treatment Period 2 (28 Days)|Physician Decision|0
1722077|NCT01072149|6007762|P9|Treatment Period 2 (28 Days)|Physician Decision|0
1722078|NCT01072149|6007763|P8|Treatment Period 2 (28 Days)|Physician Decision|1
1722079|NCT01072149|6007764|P7|Treatment Period 2 (28 Days)|Physician Decision|0
1722080|NCT01072149|6007765|P6|Treatment Period 2 (28 Days)|Physician Decision|0
1722081|NCT01072149|6007766|P5|Treatment Period 2 (28 Days)|Physician Decision|0
1722082|NCT01072149|6007767|P4|Treatment Period 2 (28 Days)|Physician Decision|0
1722083|NCT01072149|6007768|P3|Treatment Period 2 (28 Days)|Physician Decision|0
1722084|NCT01072149|6007769|P2|Treatment Period 2 (28 Days)|Physician Decision|0
1722085|NCT01072149|6007770|P1|Treatment Period 2 (28 Days)|Physician Decision|0
1722086|NCT01072149|6007753|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722087|NCT01072149|6007754|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722088|NCT01072149|6007755|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722089|NCT01072149|6007756|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722090|NCT01072149|6007757|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722091|NCT01072149|6007758|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722092|NCT01072149|6007759|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722093|NCT01072149|6007760|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722094|NCT01072149|6007761|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722095|NCT01072149|6007762|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722096|NCT01072149|6007763|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722097|NCT01072149|6007764|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722098|NCT01072149|6007765|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722099|NCT01072149|6007766|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722100|NCT01072149|6007767|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722101|NCT01072149|6007768|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
1722102|NCT01072149|6007769|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722103|NCT01072149|6007770|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
1722104|NCT01072149|6007753|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722105|NCT01072149|6007754|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722106|NCT01072149|6007755|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722107|NCT01072149|6007756|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722108|NCT01072149|6007757|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722109|NCT01072149|6007758|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722110|NCT01072149|6007759|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722111|NCT01072149|6007760|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722112|NCT01072149|6007761|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722113|NCT01072149|6007762|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722114|NCT01072149|6007763|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722115|NCT01072149|6007764|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722116|NCT01072149|6007765|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722117|NCT01072149|6007766|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722118|NCT01072149|6007767|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722119|NCT01072149|6007768|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722120|NCT01072149|6007769|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
1722121|NCT01072149|6007770|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1722122|NCT01072149|6007753|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722123|NCT01072149|6007754|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722124|NCT01072149|6007755|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722125|NCT01072149|6007756|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722126|NCT01072149|6007757|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722127|NCT01072149|6007758|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722128|NCT01072149|6007759|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722129|NCT01072149|6007760|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
1722130|NCT01072149|6007761|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722131|NCT01072149|6007762|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722132|NCT01072149|6007763|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722133|NCT01072149|6007764|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722134|NCT01072149|6007765|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722135|NCT01072149|6007766|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722136|NCT01072149|6007767|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722137|NCT01072149|6007768|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722138|NCT01072149|6007769|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722139|NCT01072149|6007770|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1722140|NCT01072149|6007753|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
1722141|NCT01072149|6007754|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
1722142|NCT01072149|6007755|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
1722143|NCT01072149|6007756|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
1722144|NCT01072149|6007757|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
1722145|NCT01072149|6007758|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
1722146|NCT01072149|6007759|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
1722147|NCT01072149|6007760|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
1722148|NCT01072149|6007761|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
1722149|NCT01072149|6007762|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
1722150|NCT01072149|6007763|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
1722151|NCT01072149|6007764|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
1722152|NCT01072149|6007765|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
1722153|NCT01072149|6007766|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
1722154|NCT01072149|6007767|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
1722155|NCT01072149|6007768|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
1722156|NCT01072149|6007769|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
1722157|NCT01072149|6007770|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
1722158|NCT01072149|6007753|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722159|NCT01072149|6007754|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722160|NCT01072149|6007755|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722161|NCT01072149|6007756|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722162|NCT01072149|6007757|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722163|NCT01072149|6007758|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722164|NCT01072149|6007759|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722165|NCT01072149|6007760|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722166|NCT01072149|6007761|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722167|NCT01072149|6007762|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722168|NCT01072149|6007763|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722169|NCT01072149|6007764|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722170|NCT01072149|6007765|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722171|NCT01072149|6007766|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722172|NCT01072149|6007767|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722173|NCT01072149|6007768|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1722174|NCT01072149|6007769|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722175|NCT01072149|6007770|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1722176|NCT01071954|6007859|P1|Overall Study|Protocol Specified Criteria|1
1722177|NCT01071954|6007859|P1|Overall Study|Administrative Decision|5
1722178|NCT01071954|6007859|P1|Overall Study|Requirement for Alternative Therapy|5
1722179|NCT01071954|6007859|P1|Overall Study|Withdrawal by Subject|11
1722180|NCT01071954|6007859|P1|Overall Study|Adverse Event|1
1722181|NCT01071954|6007859|P1|Overall Study|Noncompliance|4
1722182|NCT01071915|6007868|P1|Overall Study|Miscellaneous Reasons|2
1722183|NCT01071915|6007868|P1|Overall Study|Withdrawal by Subject|2
1722184|NCT01071915|6007868|P1|Overall Study|Physician Decision|2
1722185|NCT01071915|6007868|P1|Overall Study|Adverse Event|3
1722186|NCT01071798|6007878|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
1722187|NCT01071798|6007878|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
1722188|NCT01071798|6007878|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
1722189|NCT01071798|6007878|P1|Subpopulation Who Received Two Cycles|Remission|1
1722190|NCT01071798|6007878|P1|Participants Who Received One Cycle|Severe concomitant disease|2
1722191|NCT01071798|6007878|P1|Participants Who Received One Cycle|Change of therapy|6
1722192|NCT01071798|6007878|P1|Participants Who Received One Cycle|Death|5
1722193|NCT01071798|6007878|P1|Participants Who Received One Cycle|Patient requirement|20
1722194|NCT01071798|6007878|P1|Participants Who Received One Cycle|Lack of tolerability|14
1722195|NCT01071798|6007878|P1|Participants Who Received One Cycle|Lack of Efficacy|18
1722196|NCT01071512|6007908|P1|Overall Study|positive anti-JC virus antibody test|2
1722197|NCT01071512|6007908|P1|Overall Study|Development of antibodies to drug|2
1722198|NCT01071512|6007908|P1|Overall Study|Adverse Event|1
1722199|NCT01071395|6007918|P2|Overall Study|Adverse Event|1
1722200|NCT01071395|6007919|P1|Overall Study|Adverse Event|3
1722201|NCT01071395|6007918|P2|Overall Study|Withdrawal by Subject|1
1722202|NCT01071395|6007919|P1|Overall Study|Withdrawal by Subject|2
1722203|NCT01071317|6007938|P2|Overall Study|Lost to Follow-up|2
1722204|NCT01071317|6007939|P1|Overall Study|Lost to Follow-up|2
1722205|NCT01071278|6007951|P1|Overall Study|Completion Status Unknown|459
1722206|NCT01071278|6007951|P1|Overall Study|Premature Discontinuation|254
1722207|NCT01071252|6007962|P5|Overall Study|Death|1
1722208|NCT01071252|6007963|P4|Overall Study|Death|0
1722211|NCT01071252|6007966|P1|Overall Study|Death|0
1722212|NCT01071252|6007962|P5|Overall Study|Adverse Event|0
1722213|NCT01071252|6007963|P4|Overall Study|Adverse Event|1
1722214|NCT01071252|6007964|P3|Overall Study|Adverse Event|0
1722215|NCT01071252|6007965|P2|Overall Study|Adverse Event|1
1722216|NCT01071252|6007966|P1|Overall Study|Adverse Event|1
1722217|NCT01071252|6007962|P5|Overall Study|Lost to Follow-up|0
1722218|NCT01071252|6007963|P4|Overall Study|Lost to Follow-up|2
1722219|NCT01071252|6007964|P3|Overall Study|Lost to Follow-up|1
1722220|NCT01071252|6007965|P2|Overall Study|Lost to Follow-up|0
1722221|NCT01071252|6007966|P1|Overall Study|Lost to Follow-up|1
1722222|NCT01071252|6007962|P5|Overall Study|administrative problems|1
1722223|NCT01071252|6007963|P4|Overall Study|administrative problems|2
1722224|NCT01071252|6007964|P3|Overall Study|administrative problems|0
1722225|NCT01071252|6007965|P2|Overall Study|administrative problems|1
1722226|NCT01071252|6007966|P1|Overall Study|administrative problems|1
1722227|NCT01071252|6007962|P5|Overall Study|Withdrawal by Subject|3
1722228|NCT01071252|6007963|P4|Overall Study|Withdrawal by Subject|2
1722229|NCT01071252|6007964|P3|Overall Study|Withdrawal by Subject|1
1722230|NCT01071252|6007965|P2|Overall Study|Withdrawal by Subject|2
1722231|NCT01071252|6007966|P1|Overall Study|Withdrawal by Subject|8
1722232|NCT01071252|6007962|P5|Overall Study|unsatisfactory therapeutic effect|6
1722233|NCT01071252|6007963|P4|Overall Study|unsatisfactory therapeutic effect|0
1722234|NCT01071252|6007964|P3|Overall Study|unsatisfactory therapeutic effect|2
1722235|NCT01071252|6007965|P2|Overall Study|unsatisfactory therapeutic effect|6
1722236|NCT01071252|6007966|P1|Overall Study|unsatisfactory therapeutic effect|4
1722237|NCT01071200|6007994|P2|Overall Study|No viable embryos|1
1722238|NCT01071200|6007995|P1|Overall Study|No viable embryos|0
1722239|NCT01071200|6007994|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
1722240|NCT01071200|6007995|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
1722241|NCT01071200|6007994|P2|Overall Study|No oocytes retrieved|1
1722242|NCT01071200|6007995|P1|Overall Study|No oocytes retrieved|1
1722243|NCT01071200|6007994|P2|Overall Study|No fertilization|0
1722244|NCT01071200|6007995|P1|Overall Study|No fertilization|4
1722245|NCT01071200|6007994|P2|Overall Study|Lack of ovarian response|1
1722246|NCT01071200|6007995|P1|Overall Study|Lack of ovarian response|1
1722247|NCT01071096|6008027|P2|First Intervention (90 Days)|Lost to Follow-up|0
1722248|NCT01071096|6008028|P1|First Intervention (90 Days)|Lost to Follow-up|1
1722249|NCT01071083|6008052|P5|Overall Study|Subject Refused to Continue|0
1722250|NCT01071083|6008053|P4|Overall Study|Subject Refused to Continue|0
1722251|NCT01071083|6008054|P3|Overall Study|Subject Refused to Continue|0
1722252|NCT01071083|6008055|P2|Overall Study|Subject Refused to Continue|0
1722253|NCT01071083|6008056|P1|Overall Study|Subject Refused to Continue|1
1722254|NCT01071083|6008052|P5|Overall Study|Did Not Want Per Protocol Treatment|1
1722255|NCT01071083|6008053|P4|Overall Study|Did Not Want Per Protocol Treatment|0
1722256|NCT01071083|6008054|P3|Overall Study|Did Not Want Per Protocol Treatment|1
1722257|NCT01071083|6008055|P2|Overall Study|Did Not Want Per Protocol Treatment|0
1722258|NCT01071083|6008056|P1|Overall Study|Did Not Want Per Protocol Treatment|0
1722259|NCT01071083|6008052|P5|Overall Study|Did Not Meet Eligibility Criteria|1
1722260|NCT01071083|6008053|P4|Overall Study|Did Not Meet Eligibility Criteria|1
1722261|NCT01071083|6008054|P3|Overall Study|Did Not Meet Eligibility Criteria|1
1722262|NCT01071083|6008055|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1722263|NCT01071083|6008056|P1|Overall Study|Did Not Meet Eligibility Criteria|0
1722264|NCT01071083|6008052|P5|Overall Study|Images Not Usable (Motion)|0
1722265|NCT01071083|6008053|P4|Overall Study|Images Not Usable (Motion)|0
1722266|NCT01071083|6008054|P3|Overall Study|Images Not Usable (Motion)|0
1722267|NCT01071083|6008055|P2|Overall Study|Images Not Usable (Motion)|1
1722268|NCT01071083|6008056|P1|Overall Study|Images Not Usable (Motion)|0
1722269|NCT01071083|6008052|P5|Overall Study|Subject Moved|0
1722270|NCT01071083|6008053|P4|Overall Study|Subject Moved|0
1722271|NCT01071083|6008054|P3|Overall Study|Subject Moved|0
1722272|NCT01071083|6008055|P2|Overall Study|Subject Moved|1
1722273|NCT01071083|6008056|P1|Overall Study|Subject Moved|0
1722274|NCT01071083|6008052|P5|Overall Study|Early Rescue|1
1722275|NCT01071083|6008053|P4|Overall Study|Early Rescue|0
1722276|NCT01071083|6008054|P3|Overall Study|Early Rescue|0
1722277|NCT01071083|6008055|P2|Overall Study|Early Rescue|0
1722278|NCT01071083|6008056|P1|Overall Study|Early Rescue|1
1722279|NCT01071083|6008052|P5|Overall Study|Physician Decision|1
1722280|NCT01071083|6008053|P4|Overall Study|Physician Decision|1
1722281|NCT01071083|6008054|P3|Overall Study|Physician Decision|0
1722282|NCT01071083|6008055|P2|Overall Study|Physician Decision|0
1722283|NCT01071083|6008056|P1|Overall Study|Physician Decision|1
1722284|NCT01071083|6008052|P5|Overall Study|Withdrawal by Subject|3
1722285|NCT01071083|6008053|P4|Overall Study|Withdrawal by Subject|0
1722286|NCT01071083|6008054|P3|Overall Study|Withdrawal by Subject|2
1722287|NCT01071083|6008055|P2|Overall Study|Withdrawal by Subject|0
1722288|NCT01071083|6008056|P1|Overall Study|Withdrawal by Subject|3
1722289|NCT01071083|6008052|P5|Overall Study|Adverse Event|1
1722290|NCT01071083|6008053|P4|Overall Study|Adverse Event|0
1722291|NCT01071083|6008054|P3|Overall Study|Adverse Event|1
1722292|NCT01071083|6008055|P2|Overall Study|Adverse Event|0
1722293|NCT01071083|6008056|P1|Overall Study|Adverse Event|1
1722294|NCT01071070|6008075|P2|Overall Study|Hypercalcemia|0
1722295|NCT01071070|6008076|P1|Overall Study|Hypercalcemia|1
1722378|NCT01070550|6008313|P2|Overall Study|Treatment stopped|0
1722296|NCT01071070|6008075|P2|Overall Study|Missed 3 consecutive doses of study drug|0
1722297|NCT01071070|6008076|P1|Overall Study|Missed 3 consecutive doses of study drug|2
1722298|NCT01071070|6008075|P2|Overall Study|Withdrawal by Subject|0
1722299|NCT01071070|6008076|P1|Overall Study|Withdrawal by Subject|1
1722300|NCT01071070|6008075|P2|Overall Study|Adverse Event|3
1722301|NCT01071070|6008076|P1|Overall Study|Adverse Event|0
1722302|NCT01070979|6008122|P3|Overall Study|No study drug taken|0
1722303|NCT01070979|6008123|P2|Overall Study|No study drug taken|1
1722304|NCT01070979|6008124|P1|Overall Study|No study drug taken|0
1722305|NCT01070979|6008122|P3|Overall Study|Withdrawal by Subject|1
1722306|NCT01070979|6008123|P2|Overall Study|Withdrawal by Subject|1
1722307|NCT01070979|6008124|P1|Overall Study|Withdrawal by Subject|3
1722308|NCT01070979|6008122|P3|Overall Study|Surgery, moving, personal, abn. labs|2
1722309|NCT01070979|6008123|P2|Overall Study|Surgery, moving, personal, abn. labs|4
1722310|NCT01070979|6008124|P1|Overall Study|Surgery, moving, personal, abn. labs|4
1722311|NCT01070979|6008122|P3|Overall Study|Protocol Violation|6
1722312|NCT01070979|6008123|P2|Overall Study|Protocol Violation|2
1722313|NCT01070979|6008124|P1|Overall Study|Protocol Violation|0
1722314|NCT01070979|6008122|P3|Overall Study|Lost to Follow-up|1
1722315|NCT01070979|6008123|P2|Overall Study|Lost to Follow-up|1
1722316|NCT01070979|6008124|P1|Overall Study|Lost to Follow-up|2
1722317|NCT01070979|6008122|P3|Overall Study|Adverse Event|3
1722318|NCT01070979|6008123|P2|Overall Study|Adverse Event|3
1722319|NCT01070979|6008124|P1|Overall Study|Adverse Event|2
1722320|NCT01070966|6008150|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
1722321|NCT01070966|6008150|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
1722322|NCT01070966|6008150|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
1722323|NCT01070966|6008150|P1|Participants for Safety Evaluation|TMT given before date of contract|3
1722324|NCT01070966|6008150|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
1722325|NCT01070966|6008150|P1|Participants for Safety Evaluation|Duplicate Participants|4
1722326|NCT01070966|6008150|P1|Participants for Safety Evaluation|Off-label use|9
1722327|NCT01070966|6008150|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
1722328|NCT01070953|6008161|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
1722329|NCT01070953|6008161|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
1722330|NCT01070953|6008161|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
1722331|NCT01070953|6008161|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
1722332|NCT01070953|6008161|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
1722333|NCT01070953|6008161|P1|Participants for Safety Evaluation|Uncontracted participants|4
1722334|NCT01070953|6008161|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
1722335|NCT01070953|6008161|P1|Participants for Safety Evaluation|Duplicated participants|22
1722336|NCT01070953|6008161|P1|Participants for Safety Evaluation|Off-label use|283
1722337|NCT01070953|6008161|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
1722338|NCT01070888|6008174|P2|Washout (14 Days)|Physician Decision|0
1722339|NCT01070888|6008175|P1|Washout (14 Days)|Physician Decision|1
1722340|NCT01070888|6008174|P2|First Intervention (14 Days)|Lost to Follow-up|1
1722341|NCT01070888|6008175|P1|First Intervention (14 Days)|Lost to Follow-up|0
1722342|NCT01070888|6008174|P2|First Intervention (14 Days)|Adverse Event|1
1722343|NCT01070888|6008175|P1|First Intervention (14 Days)|Adverse Event|0
1722344|NCT01070784|6008200|P2|Overall Study|Adverse Event|9
1722345|NCT01070784|6008201|P1|Overall Study|Adverse Event|14
1722346|NCT01070784|6008200|P2|Overall Study|Withdrawal by Subject|9
1722347|NCT01070784|6008201|P1|Overall Study|Withdrawal by Subject|6
1722348|NCT01070771|6008289|P1|Overall Study|Protocol Violation|1
1722349|NCT01070771|6008289|P1|Overall Study|Adverse Event|2
1722350|NCT01070550|6008309|P6|Overall Study|Withdrawal by Subject|0
1722351|NCT01070550|6008310|P5|Overall Study|Withdrawal by Subject|0
1722352|NCT01070550|6008311|P4|Overall Study|Withdrawal by Subject|0
1722353|NCT01070550|6008312|P3|Overall Study|Withdrawal by Subject|3
1722354|NCT01070550|6008313|P2|Overall Study|Withdrawal by Subject|0
1722355|NCT01070550|6008314|P1|Overall Study|Withdrawal by Subject|35
1722356|NCT01070550|6008309|P6|Overall Study|Other|0
1722357|NCT01070550|6008310|P5|Overall Study|Other|0
1722358|NCT01070550|6008311|P4|Overall Study|Other|1
1722359|NCT01070550|6008312|P3|Overall Study|Other|0
1722360|NCT01070550|6008313|P2|Overall Study|Other|0
1722361|NCT01070550|6008314|P1|Overall Study|Other|5
1722362|NCT01070550|6008309|P6|Overall Study|Treatment was stopped early|0
1722363|NCT01070550|6008310|P5|Overall Study|Treatment was stopped early|0
1722364|NCT01070550|6008311|P4|Overall Study|Treatment was stopped early|0
1722365|NCT01070550|6008312|P3|Overall Study|Treatment was stopped early|0
1722366|NCT01070550|6008313|P2|Overall Study|Treatment was stopped early|0
1722367|NCT01070550|6008314|P1|Overall Study|Treatment was stopped early|7
1722368|NCT01070550|6008309|P6|Overall Study|Treatment unavailable|0
1722369|NCT01070550|6008310|P5|Overall Study|Treatment unavailable|0
1722370|NCT01070550|6008311|P4|Overall Study|Treatment unavailable|0
1722371|NCT01070550|6008312|P3|Overall Study|Treatment unavailable|0
1722372|NCT01070550|6008313|P2|Overall Study|Treatment unavailable|0
1722373|NCT01070550|6008314|P1|Overall Study|Treatment unavailable|1
1722374|NCT01070550|6008309|P6|Overall Study|Treatment stopped|0
1722375|NCT01070550|6008310|P5|Overall Study|Treatment stopped|0
1722376|NCT01070550|6008311|P4|Overall Study|Treatment stopped|0
1722377|NCT01070550|6008312|P3|Overall Study|Treatment stopped|0
1722379|NCT01070550|6008314|P1|Overall Study|Treatment stopped|3
1722380|NCT01070550|6008309|P6|Overall Study|Treatment restarted|0
1722381|NCT01070550|6008310|P5|Overall Study|Treatment restarted|0
1722382|NCT01070550|6008311|P4|Overall Study|Treatment restarted|0
1722383|NCT01070550|6008312|P3|Overall Study|Treatment restarted|0
1722384|NCT01070550|6008313|P2|Overall Study|Treatment restarted|1
1722385|NCT01070550|6008314|P1|Overall Study|Treatment restarted|0
1722386|NCT01070550|6008309|P6|Overall Study|Treatment not started|0
1722387|NCT01070550|6008310|P5|Overall Study|Treatment not started|0
1722388|NCT01070550|6008311|P4|Overall Study|Treatment not started|0
1722389|NCT01070550|6008312|P3|Overall Study|Treatment not started|4
1722390|NCT01070550|6008313|P2|Overall Study|Treatment not started|2
1722391|NCT01070550|6008314|P1|Overall Study|Treatment not started|14
1722392|NCT01070550|6008309|P6|Overall Study|Treatment interrupted|0
1722393|NCT01070550|6008310|P5|Overall Study|Treatment interrupted|0
1722394|NCT01070550|6008311|P4|Overall Study|Treatment interrupted|1
1722395|NCT01070550|6008312|P3|Overall Study|Treatment interrupted|1
1722396|NCT01070550|6008313|P2|Overall Study|Treatment interrupted|0
1722397|NCT01070550|6008314|P1|Overall Study|Treatment interrupted|7
1722398|NCT01070550|6008309|P6|Overall Study|Treatment duration shortened|0
1722399|NCT01070550|6008310|P5|Overall Study|Treatment duration shortened|0
1722400|NCT01070550|6008311|P4|Overall Study|Treatment duration shortened|0
1722401|NCT01070550|6008312|P3|Overall Study|Treatment duration shortened|0
1722402|NCT01070550|6008313|P2|Overall Study|Treatment duration shortened|0
1722403|NCT01070550|6008314|P1|Overall Study|Treatment duration shortened|1
1722404|NCT01070550|6008309|P6|Overall Study|Sponsor decision|0
1722405|NCT01070550|6008310|P5|Overall Study|Sponsor decision|0
1722406|NCT01070550|6008311|P4|Overall Study|Sponsor decision|0
1722407|NCT01070550|6008312|P3|Overall Study|Sponsor decision|0
1722408|NCT01070550|6008313|P2|Overall Study|Sponsor decision|0
1722409|NCT01070550|6008314|P1|Overall Study|Sponsor decision|1
1722410|NCT01070550|6008309|P6|Overall Study|Screen failure|0
1722411|NCT01070550|6008310|P5|Overall Study|Screen failure|0
1722412|NCT01070550|6008311|P4|Overall Study|Screen failure|0
1722413|NCT01070550|6008312|P3|Overall Study|Screen failure|0
1722414|NCT01070550|6008313|P2|Overall Study|Screen failure|0
1722415|NCT01070550|6008314|P1|Overall Study|Screen failure|1
1722416|NCT01070550|6008309|P6|Overall Study|Result not available|0
1722417|NCT01070550|6008310|P5|Overall Study|Result not available|0
1722418|NCT01070550|6008311|P4|Overall Study|Result not available|0
1722419|NCT01070550|6008312|P3|Overall Study|Result not available|3
1722420|NCT01070550|6008313|P2|Overall Study|Result not available|1
1722421|NCT01070550|6008314|P1|Overall Study|Result not available|3
1722422|NCT01070550|6008309|P6|Overall Study|Relapse|0
1722423|NCT01070550|6008310|P5|Overall Study|Relapse|0
1722424|NCT01070550|6008311|P4|Overall Study|Relapse|4
1722425|NCT01070550|6008312|P3|Overall Study|Relapse|14
1722426|NCT01070550|6008313|P2|Overall Study|Relapse|5
1722427|NCT01070550|6008314|P1|Overall Study|Relapse|44
1722428|NCT01070550|6008309|P6|Overall Study|Protocol Violation|0
1722429|NCT01070550|6008310|P5|Overall Study|Protocol Violation|0
1722430|NCT01070550|6008311|P4|Overall Study|Protocol Violation|1
1722431|NCT01070550|6008312|P3|Overall Study|Protocol Violation|1
1722432|NCT01070550|6008313|P2|Overall Study|Protocol Violation|1
1722433|NCT01070550|6008314|P1|Overall Study|Protocol Violation|15
1722434|NCT01070550|6008309|P6|Overall Study|Not categorized|1
1722435|NCT01070550|6008310|P5|Overall Study|Not categorized|0
1722436|NCT01070550|6008311|P4|Overall Study|Not categorized|1
1722437|NCT01070550|6008312|P3|Overall Study|Not categorized|6
1722438|NCT01070550|6008313|P2|Overall Study|Not categorized|2
1722439|NCT01070550|6008314|P1|Overall Study|Not categorized|33
1722440|NCT01070550|6008309|P6|Overall Study|Non-responders|2
1722441|NCT01070550|6008310|P5|Overall Study|Non-responders|0
1722442|NCT01070550|6008311|P4|Overall Study|Non-responders|20
1722443|NCT01070550|6008312|P3|Overall Study|Non-responders|21
1722444|NCT01070550|6008313|P2|Overall Study|Non-responders|4
1722445|NCT01070550|6008314|P1|Overall Study|Non-responders|493
1722446|NCT01070550|6008309|P6|Overall Study|New treatment started|0
1722447|NCT01070550|6008310|P5|Overall Study|New treatment started|0
1722448|NCT01070550|6008311|P4|Overall Study|New treatment started|2
1722449|NCT01070550|6008312|P3|Overall Study|New treatment started|0
1722450|NCT01070550|6008313|P2|Overall Study|New treatment started|1
1722451|NCT01070550|6008314|P1|Overall Study|New treatment started|3
1722452|NCT01070550|6008309|P6|Overall Study|Miscellaneous|0
1722453|NCT01070550|6008310|P5|Overall Study|Miscellaneous|0
1722454|NCT01070550|6008311|P4|Overall Study|Miscellaneous|1
1722455|NCT01070550|6008312|P3|Overall Study|Miscellaneous|3
1722456|NCT01070550|6008313|P2|Overall Study|Miscellaneous|2
1722457|NCT01070550|6008314|P1|Overall Study|Miscellaneous|12
1722458|NCT01070550|6008309|P6|Overall Study|Lack of Efficacy|1
1722459|NCT01070550|6008310|P5|Overall Study|Lack of Efficacy|0
1722460|NCT01070550|6008311|P4|Overall Study|Lack of Efficacy|5
1722461|NCT01070550|6008312|P3|Overall Study|Lack of Efficacy|5
1722462|NCT01070550|6008313|P2|Overall Study|Lack of Efficacy|1
1722463|NCT01070550|6008314|P1|Overall Study|Lack of Efficacy|65
1722464|NCT01070550|6008309|P6|Overall Study|Lab test not done|1
1722465|NCT01070550|6008310|P5|Overall Study|Lab test not done|0
1722466|NCT01070550|6008311|P4|Overall Study|Lab test not done|1
1722467|NCT01070550|6008312|P3|Overall Study|Lab test not done|4
1722468|NCT01070550|6008313|P2|Overall Study|Lab test not done|3
1722469|NCT01070550|6008314|P1|Overall Study|Lab test not done|22
1722470|NCT01070550|6008309|P6|Overall Study|Incomplete treatment|0
1722471|NCT01070550|6008310|P5|Overall Study|Incomplete treatment|0
1722472|NCT01070550|6008311|P4|Overall Study|Incomplete treatment|0
1722473|NCT01070550|6008312|P3|Overall Study|Incomplete treatment|0
1722474|NCT01070550|6008313|P2|Overall Study|Incomplete treatment|0
1722475|NCT01070550|6008314|P1|Overall Study|Incomplete treatment|2
1722476|NCT01070550|6008309|P6|Overall Study|Failed to return|2
1722477|NCT01070550|6008310|P5|Overall Study|Failed to return|1
1722478|NCT01070550|6008311|P4|Overall Study|Failed to return|40
1722479|NCT01070550|6008312|P3|Overall Study|Failed to return|144
1722480|NCT01070550|6008313|P2|Overall Study|Failed to return|33
1722481|NCT01070550|6008314|P1|Overall Study|Failed to return|450
1722482|NCT01070550|6008309|P6|Overall Study|Early termination|0
1722483|NCT01070550|6008310|P5|Overall Study|Early termination|0
1722484|NCT01070550|6008311|P4|Overall Study|Early termination|0
1722485|NCT01070550|6008312|P3|Overall Study|Early termination|0
1722486|NCT01070550|6008313|P2|Overall Study|Early termination|0
1722487|NCT01070550|6008314|P1|Overall Study|Early termination|3
1722488|NCT01070550|6008309|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
1722489|NCT01070550|6008310|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
1722490|NCT01070550|6008311|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
1722491|NCT01070550|6008312|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
1722492|NCT01070550|6008313|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
1722493|NCT01070550|6008314|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
1722494|NCT01070550|6008309|P6|Overall Study|Death|0
1722495|NCT01070550|6008310|P5|Overall Study|Death|0
1722496|NCT01070550|6008311|P4|Overall Study|Death|0
1722497|NCT01070550|6008312|P3|Overall Study|Death|3
1722498|NCT01070550|6008313|P2|Overall Study|Death|4
1722499|NCT01070550|6008314|P1|Overall Study|Death|20
1722500|NCT01070550|6008309|P6|Overall Study|Adverse Event|0
1722501|NCT01070550|6008310|P5|Overall Study|Adverse Event|0
1722502|NCT01070550|6008311|P4|Overall Study|Adverse Event|0
1722503|NCT01070550|6008312|P3|Overall Study|Adverse Event|3
1722504|NCT01070550|6008313|P2|Overall Study|Adverse Event|1
1722505|NCT01070550|6008314|P1|Overall Study|Adverse Event|43
1722506|NCT01070394|6008454|P1|Overall Study|Withdrawal by Subject|1
1722507|NCT01070394|6008454|P1|Overall Study|Adverse Event|6
1722508|NCT01070381|6008465|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
1722509|NCT01070381|6008466|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
1722510|NCT01070381|6008465|P2|Period 2, 1 Week of Wear|Handling|1
1722511|NCT01070381|6008466|P1|Period 2, 1 Week of Wear|Handling|0
1722512|NCT01070329|6008474|P2|Overall Study|Sponsor Decision|1
1722513|NCT01070329|6008475|P1|Overall Study|Sponsor Decision|0
1722514|NCT01070329|6008474|P2|Overall Study|Entry Criteria Not Met|0
1722515|NCT01070329|6008475|P1|Overall Study|Entry Criteria Not Met|1
1722516|NCT01070329|6008474|P2|Overall Study|Physician Decision|1
1722517|NCT01070329|6008475|P1|Overall Study|Physician Decision|2
1722518|NCT01070329|6008474|P2|Overall Study|Lack of Efficacy|6
1722519|NCT01070329|6008475|P1|Overall Study|Lack of Efficacy|2
1722520|NCT01070329|6008474|P2|Overall Study|Protocol Violation|8
1722521|NCT01070329|6008475|P1|Overall Study|Protocol Violation|3
1722522|NCT01070329|6008474|P2|Overall Study|Withdrawal by Subject|11
1722523|NCT01070329|6008475|P1|Overall Study|Withdrawal by Subject|9
1722524|NCT01070329|6008474|P2|Overall Study|Lost to Follow-up|12
1722525|NCT01070329|6008475|P1|Overall Study|Lost to Follow-up|22
1722526|NCT01070329|6008474|P2|Overall Study|Adverse Event|10
1722527|NCT01070329|6008475|P1|Overall Study|Adverse Event|13
1722528|NCT01070316|6008507|P1|Extension Phase|Withdrawal by Subject|1
1722529|NCT01070316|6008507|P1|Extension Phase|Lack of Efficacy|3
1722530|NCT01070303|6008514|P1|Overall Study|Other|18
1722531|NCT01070303|6008514|P1|Overall Study|Administrative Reason|1
1722532|NCT01070303|6008514|P1|Overall Study|Lack of Efficacy|2
1722533|NCT01070303|6008514|P1|Overall Study|Protocol Violation|0
1722534|NCT01070303|6008514|P1|Overall Study|Lost to Follow-up|9
1722535|NCT01070303|6008514|P1|Overall Study|Withdrawal by Subject|20
1722536|NCT01070303|6008514|P1|Overall Study|Adverse Event|39
1722537|NCT01070043|6008609|P3|Double-Blind Treatment|Adverse Event|2
1722538|NCT01070043|6008610|P2|Double-Blind Treatment|Adverse Event|0
1722539|NCT01070043|6008611|P1|Double-Blind Treatment|Adverse Event|0
1722540|NCT01070043|6008609|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
1722541|NCT01070043|6008610|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
1722542|NCT01070043|6008611|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
1722543|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Removal|0
1722544|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Removal|1
1722545|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Physician Decision|2
1722546|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Physician Decision|0
1722547|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
1722548|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
1722549|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
1722550|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
1722551|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
1722552|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
1722553|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
1722554|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
1722555|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Protocol Violation|1
1722556|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Protocol Violation|0
1722557|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
1722558|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
1722559|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
1722560|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
1722561|NCT01069939|6008627|P2|Randomised and Included in the Analyses|Adverse Event|22
1722562|NCT01069939|6008628|P1|Randomised and Included in the Analyses|Adverse Event|17
1722563|NCT01069900|6008654|P2|Overall Study|Insufficient Therapeutic effect|0
1722564|NCT01069900|6008655|P1|Overall Study|Insufficient Therapeutic effect|1
1722565|NCT01069900|6008654|P2|Overall Study|Protocol Violation|1
1722566|NCT01069900|6008655|P1|Overall Study|Protocol Violation|4
1722567|NCT01069900|6008654|P2|Overall Study|Withdrawal by Subject|1
1722568|NCT01069900|6008655|P1|Overall Study|Withdrawal by Subject|6
1722569|NCT01069900|6008654|P2|Overall Study|Lost to Follow-up|1
1722570|NCT01069900|6008655|P1|Overall Study|Lost to Follow-up|7
1722571|NCT01069900|6008654|P2|Overall Study|Technical problems|1
1722572|NCT01069900|6008655|P1|Overall Study|Technical problems|0
1722573|NCT01069861|6008699|P1|Overall Study|Did not meet entrance criteria|1
1722574|NCT01069861|6008699|P1|Overall Study|Adverse Event|1
1722575|NCT01069861|6008699|P1|Overall Study|Death|1
1722576|NCT01069627|6008712|P1|Overall Study|Protocol Violation|1
1722577|NCT01069627|6008712|P1|Overall Study|Adverse Event|12
1722578|NCT01069627|6008712|P1|Overall Study|Disease progression|7
1722579|NCT01069523|6008762|P2|Overall Study|Withdrawal by Subject|7
1722580|NCT01069523|6008763|P1|Overall Study|Withdrawal by Subject|4
1722581|NCT01069484|6008786|P2|Overall Study|Illness mother or child|1
1722582|NCT01069484|6008787|P1|Overall Study|Illness mother or child|3
1722583|NCT01069484|6008786|P2|Overall Study|No specific reason|2
1722584|NCT01069484|6008787|P1|Overall Study|No specific reason|8
1722585|NCT01069484|6008786|P2|Overall Study|Death-in-near-family|0
1722586|NCT01069484|6008787|P1|Overall Study|Death-in-near-family|1
1722587|NCT01069419|6008795|P1|Overall Study|Missing termination information|13
1722588|NCT01069419|6008795|P1|Overall Study|Other Reason|43
1722589|NCT01069419|6008795|P1|Overall Study|Withdrawal by Subject|34
1722590|NCT01069419|6008795|P1|Overall Study|Remission of disease|11
1722591|NCT01069419|6008795|P1|Overall Study|Lost to Follow-up|49
1722592|NCT01069419|6008795|P1|Overall Study|Lack of Efficacy|332
1722593|NCT01069419|6008795|P1|Overall Study|Adverse Event|233
1722594|NCT01069341|6008824|P1|Overall Study|Lost to Follow-up|1
1722595|NCT01069289|6008866|P2|Overall Study|Due to deteriorating health condition|0
1722596|NCT01069289|6008867|P1|Overall Study|Due to deteriorating health condition|1
1722597|NCT01069289|6008866|P2|Overall Study|Severe non-compliance to protocol|2
1722598|NCT01069289|6008867|P1|Overall Study|Severe non-compliance to protocol|3
1722599|NCT01069289|6008866|P2|Overall Study|Eligibility criteria not fulfilled|0
1722600|NCT01069289|6008867|P1|Overall Study|Eligibility criteria not fulfilled|2
1722601|NCT01069289|6008866|P2|Overall Study|Adverse Event|28
1722602|NCT01069289|6008867|P1|Overall Study|Adverse Event|21
1722603|NCT01069289|6008866|P2|Overall Study|Withdrawal by Subject|26
1722604|NCT01069289|6008867|P1|Overall Study|Withdrawal by Subject|15
1722605|NCT01069172|6008916|P2|Overall Study|Withdrawal by Subject|0
1722606|NCT01069172|6008917|P1|Overall Study|Withdrawal by Subject|1
1722607|NCT01069120|6008927|P1|Overall Study|Study prematurely terminated|27
1722608|NCT01068912|6008964|P3|Overall Study|other underlying illness|3
1722609|NCT01068912|6008965|P2|Overall Study|other underlying illness|3
1722610|NCT01068912|6008966|P1|Overall Study|other underlying illness|0
1722611|NCT01068912|6008964|P3|Overall Study|aggravation influenza|1
1722612|NCT01068912|6008965|P2|Overall Study|aggravation influenza|1
1722613|NCT01068912|6008966|P1|Overall Study|aggravation influenza|1
1722614|NCT01068912|6008964|P3|Overall Study|Protocol Violation|0
1722615|NCT01068912|6008965|P2|Overall Study|Protocol Violation|2
1722616|NCT01068912|6008966|P1|Overall Study|Protocol Violation|0
1722617|NCT01068912|6008964|P3|Overall Study|Lost to Follow-up|3
1722618|NCT01068912|6008965|P2|Overall Study|Lost to Follow-up|7
1722619|NCT01068912|6008966|P1|Overall Study|Lost to Follow-up|3
1722620|NCT01068912|6008964|P3|Overall Study|Withdrawal by Subject|6
1722621|NCT01068912|6008965|P2|Overall Study|Withdrawal by Subject|6
1722622|NCT01068912|6008966|P1|Overall Study|Withdrawal by Subject|5
1722623|NCT01068912|6008964|P3|Overall Study|Adverse Event|2
1722624|NCT01068912|6008965|P2|Overall Study|Adverse Event|3
1722625|NCT01068912|6008966|P1|Overall Study|Adverse Event|2
1722626|NCT01068860|6008984|P10|Overall Study|Lost to Follow-up|0
1722627|NCT01068860|6008985|P9|Overall Study|Lost to Follow-up|0
1722628|NCT01068860|6008986|P8|Overall Study|Lost to Follow-up|0
1722629|NCT01068860|6008987|P7|Overall Study|Lost to Follow-up|0
1722630|NCT01068860|6008988|P6|Overall Study|Lost to Follow-up|0
1722631|NCT01068860|6008989|P5|Overall Study|Lost to Follow-up|0
1722632|NCT01068860|6008990|P4|Overall Study|Lost to Follow-up|0
1722633|NCT01068860|6008991|P3|Overall Study|Lost to Follow-up|0
1722634|NCT01068860|6008992|P2|Overall Study|Lost to Follow-up|1
1722635|NCT01068860|6008993|P1|Overall Study|Lost to Follow-up|0
1722636|NCT01068860|6008984|P10|Overall Study|Administrative problems; misrandomized|1
1722637|NCT01068860|6008985|P9|Overall Study|Administrative problems; misrandomized|0
1722638|NCT01068860|6008986|P8|Overall Study|Administrative problems; misrandomized|0
1722639|NCT01068860|6008987|P7|Overall Study|Administrative problems; misrandomized|0
1722640|NCT01068860|6008988|P6|Overall Study|Administrative problems; misrandomized|0
1722641|NCT01068860|6008989|P5|Overall Study|Administrative problems; misrandomized|0
1722642|NCT01068860|6008990|P4|Overall Study|Administrative problems; misrandomized|1
1722643|NCT01068860|6008991|P3|Overall Study|Administrative problems; misrandomized|0
1722644|NCT01068860|6008992|P2|Overall Study|Administrative problems; misrandomized|0
1722645|NCT01068860|6008993|P1|Overall Study|Administrative problems; misrandomized|0
1722646|NCT01068860|6008984|P10|Overall Study|Withdrawal by Subject|3
1722647|NCT01068860|6008985|P9|Overall Study|Withdrawal by Subject|0
1722648|NCT01068860|6008986|P8|Overall Study|Withdrawal by Subject|0
1722649|NCT01068860|6008987|P7|Overall Study|Withdrawal by Subject|0
1722650|NCT01068860|6008988|P6|Overall Study|Withdrawal by Subject|2
1722651|NCT01068860|6008989|P5|Overall Study|Withdrawal by Subject|0
1722652|NCT01068860|6008990|P4|Overall Study|Withdrawal by Subject|0
1722653|NCT01068860|6008991|P3|Overall Study|Withdrawal by Subject|0
1722654|NCT01068860|6008992|P2|Overall Study|Withdrawal by Subject|0
1722655|NCT01068860|6008993|P1|Overall Study|Withdrawal by Subject|0
1722656|NCT01068769|6009176|P1|Overall Study|Ineligible|1
1722657|NCT01068743|6009181|P4|Period 3|Adverse Event|0
1722658|NCT01068743|6009182|P3|Period 3|Adverse Event|0
1722659|NCT01068743|6009183|P2|Period 3|Adverse Event|1
1722660|NCT01068743|6009184|P1|Period 3|Adverse Event|0
1722661|NCT01068730|6009258|P4|Period 4|Family emergency|0
1722662|NCT01068730|6009259|P3|Period 4|Family emergency|0
1722663|NCT01068730|6009260|P2|Period 4|Family emergency|1
1722664|NCT01068730|6009261|P1|Period 4|Family emergency|0
1722665|NCT01068730|6009258|P4|Period 3|Personal reason|0
1722666|NCT01068730|6009259|P3|Period 3|Personal reason|0
1722667|NCT01068730|6009260|P2|Period 3|Personal reason|0
1722668|NCT01068730|6009261|P1|Period 3|Personal reason|1
1722669|NCT01068717|6009315|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1722670|NCT01068717|6009316|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1722671|NCT01068717|6009317|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
1722672|NCT01068717|6009318|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
1722673|NCT01068678|6009374|P2|Overall Study|Unclassified|15
1722674|NCT01068678|6009375|P1|Overall Study|Unclassified|18
1722675|NCT01068678|6009374|P2|Overall Study|Withdrawal criteria|6
1722676|NCT01068678|6009375|P1|Overall Study|Withdrawal criteria|12
1722677|NCT01068678|6009374|P2|Overall Study|Protocol Violation|1
1722678|NCT01068678|6009375|P1|Overall Study|Protocol Violation|5
1722679|NCT01068678|6009374|P2|Overall Study|Lack of Efficacy|2
1722680|NCT01068678|6009375|P1|Overall Study|Lack of Efficacy|3
1722681|NCT01068665|6009385|P2|Overall Study|Other|12
1722682|NCT01068665|6009386|P1|Overall Study|Other|17
1722683|NCT01068665|6009385|P2|Overall Study|Withdrawal Criteria|9
1722684|NCT01068665|6009386|P1|Overall Study|Withdrawal Criteria|3
1722685|NCT01068665|6009385|P2|Overall Study|Protocol Violation|2
1722686|NCT01068665|6009386|P1|Overall Study|Protocol Violation|5
1722687|NCT01068665|6009385|P2|Overall Study|Lack of Efficacy|2
1722688|NCT01068665|6009386|P1|Overall Study|Lack of Efficacy|0
1722689|NCT01068665|6009385|P2|Overall Study|Adverse Event|4
1722690|NCT01068665|6009386|P1|Overall Study|Adverse Event|5
1722691|NCT01068652|6009396|P2|Overall Study|Unclassified|4
1722692|NCT01068652|6009397|P1|Overall Study|Unclassified|7
1722693|NCT01068652|6009396|P2|Overall Study|Patient was not eligible|0
1722694|NCT01068652|6009397|P1|Overall Study|Patient was not eligible|1
1722695|NCT01068652|6009396|P2|Overall Study|Withdrawal criteria|2
1722696|NCT01068652|6009397|P1|Overall Study|Withdrawal criteria|1
1722697|NCT01068652|6009396|P2|Overall Study|Protocol Violation|6
1722698|NCT01068652|6009397|P1|Overall Study|Protocol Violation|3
1722699|NCT01068652|6009396|P2|Overall Study|Lost to Follow-up|1
1722700|NCT01068652|6009397|P1|Overall Study|Lost to Follow-up|2
1722701|NCT01068652|6009396|P2|Overall Study|Lack of Efficacy|2
1722702|NCT01068652|6009397|P1|Overall Study|Lack of Efficacy|0
1722703|NCT01068652|6009396|P2|Overall Study|Adverse Event|0
1722704|NCT01068652|6009397|P1|Overall Study|Adverse Event|4
1722705|NCT01068626|6009437|P2|Overall Study|Withdrawal by Subject|2
1722706|NCT01068626|6009438|P1|Overall Study|Withdrawal by Subject|0
1722707|NCT01068626|6009437|P2|Overall Study|Adverse Event|0
1722708|NCT01068626|6009438|P1|Overall Study|Adverse Event|3
1722709|NCT01068600|6009456|P2|Overall Study|Administrative problems|1
1722710|NCT01068600|6009457|P1|Overall Study|Administrative problems|0
1722711|NCT01068600|6009456|P2|Overall Study|Unsatisfactory therapeutic effect|4
1722712|NCT01068600|6009457|P1|Overall Study|Unsatisfactory therapeutic effect|0
1722713|NCT01068600|6009456|P2|Overall Study|Protocol deviation|1
1722714|NCT01068600|6009457|P1|Overall Study|Protocol deviation|1
1722715|NCT01068600|6009456|P2|Overall Study|Lost to Follow-up|2
1722716|NCT01068600|6009457|P1|Overall Study|Lost to Follow-up|1
1722717|NCT01068600|6009456|P2|Overall Study|Abnormal laboratory value(s)|0
1722718|NCT01068600|6009457|P1|Overall Study|Abnormal laboratory value(s)|1
1722719|NCT01068600|6009456|P2|Overall Study|Adverse Event|3
1722720|NCT01068600|6009457|P1|Overall Study|Adverse Event|3
1722721|NCT01068600|6009456|P2|Overall Study|Withdrawal by Subject|6
1722722|NCT01068600|6009457|P1|Overall Study|Withdrawal by Subject|5
1722723|NCT01068509|6009479|P3|Overall Study|Reason Not Specified|0
1722724|NCT01068509|6009480|P2|Overall Study|Reason Not Specified|1
1722725|NCT01068509|6009481|P1|Overall Study|Reason Not Specified|0
1722726|NCT01068509|6009479|P3|Overall Study|Withdrew Consent|2
1722727|NCT01068509|6009480|P2|Overall Study|Withdrew Consent|1
1722728|NCT01068509|6009481|P1|Overall Study|Withdrew Consent|0
1722729|NCT01068509|6009479|P3|Overall Study|Lost to Follow-up|0
1722730|NCT01068509|6009480|P2|Overall Study|Lost to Follow-up|0
1722731|NCT01068509|6009481|P1|Overall Study|Lost to Follow-up|1
1722732|NCT01068509|6009479|P3|Overall Study|Disease Progression|18
1722733|NCT01068509|6009480|P2|Overall Study|Disease Progression|20
1722734|NCT01068509|6009481|P1|Overall Study|Disease Progression|5
1722735|NCT01068509|6009479|P3|Overall Study|Death|1
1722736|NCT01068509|6009480|P2|Overall Study|Death|0
1722737|NCT01068509|6009481|P1|Overall Study|Death|0
1722738|NCT01068418|6009494|P1|Overall Study|Physician Decision|12
1722739|NCT01068262|6009503|P4|Overall Study|Withdrawal by Subject|0
1722740|NCT01068262|6009504|P3|Overall Study|Withdrawal by Subject|0
1722741|NCT01068262|6009505|P2|Overall Study|Withdrawal by Subject|1
1722742|NCT01068262|6009506|P1|Overall Study|Withdrawal by Subject|0
1722743|NCT01068262|6009503|P4|Overall Study|Protocol Violation|0
1722744|NCT01068262|6009504|P3|Overall Study|Protocol Violation|0
1722745|NCT01068262|6009505|P2|Overall Study|Protocol Violation|0
1722746|NCT01068262|6009506|P1|Overall Study|Protocol Violation|1
1722747|NCT01068262|6009503|P4|Overall Study|Adverse Event|0
1722748|NCT01068262|6009504|P3|Overall Study|Adverse Event|1
1722749|NCT01068262|6009505|P2|Overall Study|Adverse Event|0
1722750|NCT01068262|6009506|P1|Overall Study|Adverse Event|2
1722751|NCT01068158|6009536|P2|Overall Study|Protocol Violation|2
1722752|NCT01068158|6009537|P1|Overall Study|Protocol Violation|0
1722753|NCT01068158|6009536|P2|Overall Study|Lost to Follow-up|0
1722754|NCT01068158|6009537|P1|Overall Study|Lost to Follow-up|7
1722755|NCT01068158|6009536|P2|Overall Study|Withdrawal by Subject|2
1722756|NCT01068158|6009537|P1|Overall Study|Withdrawal by Subject|1
1722757|NCT01067976|6009549|P1|Overall Study|Study prematurely discontinued|2
1722758|NCT01067976|6009549|P1|Overall Study|Study drug never administered|20
1722759|NCT01067846|6009610|P2|Overall Study|participation in other tx study|0
1722760|NCT01067846|6009611|P1|Overall Study|participation in other tx study|1
1722761|NCT01067846|6009610|P2|Overall Study|Withdrawal by Subject|0
1722762|NCT01067846|6009611|P1|Overall Study|Withdrawal by Subject|1
1722763|NCT01067846|6009610|P2|Overall Study|Lost to Follow-up|19
1722764|NCT01067846|6009611|P1|Overall Study|Lost to Follow-up|17
1722765|NCT01067521|6009681|P2|Open-Label Period|Lost to Follow-up|20
1722766|NCT01067521|6009682|P1|Open-Label Period|Lost to Follow-up|21
1722767|NCT01067521|6009681|P2|Open-Label Period|Teva requested subject to be withdrawn|2
1722768|NCT01067521|6009682|P1|Open-Label Period|Teva requested subject to be withdrawn|5
1722769|NCT01067521|6009681|P2|Open-Label Period|Pregnancy|8
1722770|NCT01067521|6009682|P1|Open-Label Period|Pregnancy|14
1722771|NCT01067521|6009681|P2|Open-Label Period|Protocol Violation|0
1722772|NCT01067521|6009682|P1|Open-Label Period|Protocol Violation|3
1722773|NCT01067521|6009681|P2|Open-Label Period|Non-compliance with study drug|0
1722774|NCT01067521|6009682|P1|Open-Label Period|Non-compliance with study drug|5
1722775|NCT01067521|6009681|P2|Open-Label Period|Physician Decision|11
1722776|NCT01067521|6009682|P1|Open-Label Period|Physician Decision|13
1722777|NCT01067521|6009681|P2|Open-Label Period|Withdrawal by Subject|88
1722778|NCT01067521|6009682|P1|Open-Label Period|Withdrawal by Subject|160
1722779|NCT01067521|6009681|P2|Open-Label Period|Adverse Event|28
1722780|NCT01067521|6009682|P1|Open-Label Period|Adverse Event|30
1722781|NCT01067521|6009681|P2|Open-Label Period|Death|1
1722782|NCT01067521|6009682|P1|Open-Label Period|Death|3
1722783|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
1722784|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
1722785|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
1722786|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
1722787|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
1722788|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
1722789|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
1722790|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
1722791|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
1722792|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
1722793|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
1722794|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
1722795|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
1722796|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
1722797|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
1722798|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
1722799|NCT01067521|6009681|P2|Double-Blind Placebo-Controlled Period|Death|1
1722800|NCT01067521|6009682|P1|Double-Blind Placebo-Controlled Period|Death|0
1722801|NCT01067508|6009708|P2|Overall Study|Withdrawal by Subject|1
1722802|NCT01067508|6009709|P1|Overall Study|Withdrawal by Subject|0
1722803|NCT01067508|6009708|P2|Overall Study|Physician Decision|1
1722804|NCT01067508|6009709|P1|Overall Study|Physician Decision|0
1722805|NCT01067352|6009731|P3|Overall Study|Physician Decision|0
1722806|NCT01067352|6009732|P2|Overall Study|Physician Decision|1
1722807|NCT01067352|6009733|P1|Overall Study|Physician Decision|0
1722808|NCT01067352|6009731|P3|Overall Study|Withdrawal by Subject|1
1722809|NCT01067352|6009732|P2|Overall Study|Withdrawal by Subject|2
1722810|NCT01067352|6009733|P1|Overall Study|Withdrawal by Subject|1
1722811|NCT01067339|6009749|P2|Overall Study|Withdrawal by Subject|5
1722812|NCT01067339|6009750|P1|Overall Study|Withdrawal by Subject|6
1722813|NCT01067326|6009760|P2|Overall Study|Early Study Termination|1
1722814|NCT01067326|6009761|P1|Overall Study|Early Study Termination|1
1722815|NCT01067326|6009760|P2|Overall Study|Withdrawal by Subject|0
1722816|NCT01067326|6009761|P1|Overall Study|Withdrawal by Subject|1
1722817|NCT01067326|6009760|P2|Overall Study|Adverse Event|2
1722818|NCT01067326|6009761|P1|Overall Study|Adverse Event|0
1722819|NCT01067144|6009775|P2|Follow-up|Death|1
1722820|NCT01067144|6009776|P1|Follow-up|Death|0
1722821|NCT01067144|6009775|P2|Follow-up|Surgery cancelled|1
1722822|NCT01067144|6009776|P1|Follow-up|Surgery cancelled|0
1722823|NCT01067144|6009775|P2|Follow-up|Withdrawal by Subject|14
1722824|NCT01067144|6009776|P1|Follow-up|Withdrawal by Subject|18
1722825|NCT01067144|6009775|P2|Follow-up|Censored owing to second surgery|28
1722826|NCT01067144|6009776|P1|Follow-up|Censored owing to second surgery|19
1722827|NCT01067144|6009775|P2|Follow-up|Lost to Follow-up|12
1722828|NCT01067144|6009776|P1|Follow-up|Lost to Follow-up|22
1722829|NCT01067144|6009775|P2|Treatment|Did not receive allocated intervention|7
1722830|NCT01067144|6009776|P1|Treatment|Did not receive allocated intervention|4
1722831|NCT01067105|6009792|P1|Overall Study|Other|31
1722832|NCT01067105|6009792|P1|Overall Study|Physician Decision|6
1722833|NCT01067105|6009792|P1|Overall Study|Lost to Follow-up|6
1722834|NCT01067105|6009792|P1|Overall Study|Withdrawal by Subject|36
1722835|NCT01067105|6009792|P1|Overall Study|Protocol Violation|48
1722836|NCT01067105|6009792|P1|Overall Study|Adverse Event|14
1722837|NCT01066923|6009813|P4|Overall Study|Withdrawal by Subject|8
1722838|NCT01066923|6009814|P3|Overall Study|Withdrawal by Subject|8
1722839|NCT01066923|6009815|P2|Overall Study|Withdrawal by Subject|3
1722840|NCT01066923|6009816|P1|Overall Study|Withdrawal by Subject|3
1722841|NCT01066897|6009840|P2|Overall Study|stopped study after developing the flu.|0
1722842|NCT01066897|6009841|P1|Overall Study|stopped study after developing the flu.|1
1722843|NCT01066897|6009840|P2|Overall Study|Withdrawal by Subject|0
1722844|NCT01066897|6009841|P1|Overall Study|Withdrawal by Subject|1
1722845|NCT01066871|6009855|P4|Overall Study|Other|2
1722846|NCT01066871|6009856|P3|Overall Study|Other|1
1722847|NCT01066871|6009857|P2|Overall Study|Other|2
1722848|NCT01066871|6009858|P1|Overall Study|Other|0
1722849|NCT01066871|6009855|P4|Overall Study|Withdrawal by Subject|0
1722850|NCT01066871|6009856|P3|Overall Study|Withdrawal by Subject|0
1722851|NCT01066871|6009857|P2|Overall Study|Withdrawal by Subject|1
1722852|NCT01066871|6009858|P1|Overall Study|Withdrawal by Subject|3
1722853|NCT01066871|6009855|P4|Overall Study|Lack of Efficacy|1
1722854|NCT01066871|6009856|P3|Overall Study|Lack of Efficacy|0
1722855|NCT01066871|6009857|P2|Overall Study|Lack of Efficacy|0
1722856|NCT01066871|6009858|P1|Overall Study|Lack of Efficacy|0
1722857|NCT01066871|6009855|P4|Overall Study|Protocol Violation|2
1722858|NCT01066871|6009856|P3|Overall Study|Protocol Violation|3
1722859|NCT01066871|6009857|P2|Overall Study|Protocol Violation|0
1722860|NCT01066871|6009858|P1|Overall Study|Protocol Violation|1
1722861|NCT01066871|6009855|P4|Overall Study|Lost to Follow-up|0
1722862|NCT01066871|6009856|P3|Overall Study|Lost to Follow-up|2
1722863|NCT01066871|6009857|P2|Overall Study|Lost to Follow-up|2
1722864|NCT01066871|6009858|P1|Overall Study|Lost to Follow-up|0
1722865|NCT01066819|6009922|P6|Overall Study|Other|0
1722866|NCT01066819|6009923|P5|Overall Study|Other|0
1722867|NCT01066819|6009924|P4|Overall Study|Other|0
1722868|NCT01066819|6009925|P3|Overall Study|Other|1
1722869|NCT01066819|6009926|P2|Overall Study|Other|1
1722870|NCT01066819|6009927|P1|Overall Study|Other|5
1722871|NCT01066819|6009922|P6|Overall Study|Treatment stopped|0
1722872|NCT01066819|6009923|P5|Overall Study|Treatment stopped|0
1722873|NCT01066819|6009924|P4|Overall Study|Treatment stopped|1
1722874|NCT01066819|6009925|P3|Overall Study|Treatment stopped|2
1722875|NCT01066819|6009926|P2|Overall Study|Treatment stopped|1
1722876|NCT01066819|6009927|P1|Overall Study|Treatment stopped|12
1722877|NCT01066819|6009922|P6|Overall Study|Treatment never started|2
1722878|NCT01066819|6009923|P5|Overall Study|Treatment never started|2
1722879|NCT01066819|6009924|P4|Overall Study|Treatment never started|3
1722880|NCT01066819|6009925|P3|Overall Study|Treatment never started|19
1722881|NCT01066819|6009926|P2|Overall Study|Treatment never started|19
1722882|NCT01066819|6009927|P1|Overall Study|Treatment never started|85
1722883|NCT01066819|6009922|P6|Overall Study|Spontaneous cure|0
1722884|NCT01066819|6009923|P5|Overall Study|Spontaneous cure|0
1722885|NCT01066819|6009924|P4|Overall Study|Spontaneous cure|0
1722886|NCT01066819|6009925|P3|Overall Study|Spontaneous cure|0
1722887|NCT01066819|6009926|P2|Overall Study|Spontaneous cure|0
1722888|NCT01066819|6009927|P1|Overall Study|Spontaneous cure|1
1722889|NCT01066819|6009922|P6|Overall Study|Screen failure|0
1722890|NCT01066819|6009923|P5|Overall Study|Screen failure|0
1722891|NCT01066819|6009924|P4|Overall Study|Screen failure|0
1722892|NCT01066819|6009925|P3|Overall Study|Screen failure|0
1722893|NCT01066819|6009926|P2|Overall Study|Screen failure|0
1722894|NCT01066819|6009927|P1|Overall Study|Screen failure|1
1722895|NCT01066819|6009922|P6|Overall Study|Results not available|0
1722896|NCT01066819|6009923|P5|Overall Study|Results not available|0
1722897|NCT01066819|6009924|P4|Overall Study|Results not available|0
1722898|NCT01066819|6009925|P3|Overall Study|Results not available|0
1722899|NCT01066819|6009926|P2|Overall Study|Results not available|0
1722900|NCT01066819|6009927|P1|Overall Study|Results not available|1
1722901|NCT01066819|6009922|P6|Overall Study|Relapse|0
1722902|NCT01066819|6009923|P5|Overall Study|Relapse|0
1722903|NCT01066819|6009924|P4|Overall Study|Relapse|0
1722904|NCT01066819|6009925|P3|Overall Study|Relapse|3
1722905|NCT01066819|6009926|P2|Overall Study|Relapse|4
1722906|NCT01066819|6009927|P1|Overall Study|Relapse|16
1722907|NCT01066819|6009922|P6|Overall Study|Not categorised|0
1722908|NCT01066819|6009923|P5|Overall Study|Not categorised|0
1722909|NCT01066819|6009924|P4|Overall Study|Not categorised|1
1722910|NCT01066819|6009925|P3|Overall Study|Not categorised|6
1722911|NCT01066819|6009926|P2|Overall Study|Not categorised|2
1722912|NCT01066819|6009927|P1|Overall Study|Not categorised|9
1722913|NCT01066819|6009922|P6|Overall Study|Non responders|1
1722914|NCT01066819|6009923|P5|Overall Study|Non responders|0
1722915|NCT01066819|6009924|P4|Overall Study|Non responders|2
1722916|NCT01066819|6009925|P3|Overall Study|Non responders|7
1722917|NCT01066819|6009926|P2|Overall Study|Non responders|2
1722918|NCT01066819|6009927|P1|Overall Study|Non responders|123
1722919|NCT01066819|6009922|P6|Overall Study|Miscellaneous|0
1722920|NCT01066819|6009923|P5|Overall Study|Miscellaneous|0
1722921|NCT01066819|6009924|P4|Overall Study|Miscellaneous|1
1722922|NCT01066819|6009925|P3|Overall Study|Miscellaneous|18
1722923|NCT01066819|6009926|P2|Overall Study|Miscellaneous|10
1722924|NCT01066819|6009927|P1|Overall Study|Miscellaneous|28
1722925|NCT01066819|6009922|P6|Overall Study|Lab test not done|0
1722926|NCT01066819|6009923|P5|Overall Study|Lab test not done|0
1722927|NCT01066819|6009924|P4|Overall Study|Lab test not done|1
1722928|NCT01066819|6009925|P3|Overall Study|Lab test not done|2
1722929|NCT01066819|6009926|P2|Overall Study|Lab test not done|0
1722930|NCT01066819|6009927|P1|Overall Study|Lab test not done|9
1722931|NCT01066819|6009922|P6|Overall Study|Failed to return|3
1722932|NCT01066819|6009923|P5|Overall Study|Failed to return|2
1722933|NCT01066819|6009924|P4|Overall Study|Failed to return|7
1722934|NCT01066819|6009925|P3|Overall Study|Failed to return|68
1722935|NCT01066819|6009926|P2|Overall Study|Failed to return|107
1722936|NCT01066819|6009927|P1|Overall Study|Failed to return|298
1722937|NCT01066819|6009922|P6|Overall Study|Early termination|0
1722938|NCT01066819|6009923|P5|Overall Study|Early termination|0
1722939|NCT01066819|6009924|P4|Overall Study|Early termination|0
1722940|NCT01066819|6009925|P3|Overall Study|Early termination|0
1722941|NCT01066819|6009926|P2|Overall Study|Early termination|0
1722942|NCT01066819|6009927|P1|Overall Study|Early termination|2
1722943|NCT01066819|6009922|P6|Overall Study|Not met inclusion/exclusion criteria|0
1722944|NCT01066819|6009923|P5|Overall Study|Not met inclusion/exclusion criteria|0
1722945|NCT01066819|6009924|P4|Overall Study|Not met inclusion/exclusion criteria|0
1722946|NCT01066819|6009925|P3|Overall Study|Not met inclusion/exclusion criteria|0
1722947|NCT01066819|6009926|P2|Overall Study|Not met inclusion/exclusion criteria|0
1722948|NCT01066819|6009927|P1|Overall Study|Not met inclusion/exclusion criteria|1
1722949|NCT01066819|6009922|P6|Overall Study|Administrative|0
1722950|NCT01066819|6009923|P5|Overall Study|Administrative|0
1722951|NCT01066819|6009924|P4|Overall Study|Administrative|0
1722952|NCT01066819|6009925|P3|Overall Study|Administrative|2
1722953|NCT01066819|6009926|P2|Overall Study|Administrative|4
1722954|NCT01066819|6009927|P1|Overall Study|Administrative|6
1722955|NCT01066819|6009922|P6|Overall Study|Withdrawal by Subject|0
1722956|NCT01066819|6009923|P5|Overall Study|Withdrawal by Subject|0
1722957|NCT01066819|6009924|P4|Overall Study|Withdrawal by Subject|0
1722958|NCT01066819|6009925|P3|Overall Study|Withdrawal by Subject|6
1722959|NCT01066819|6009926|P2|Overall Study|Withdrawal by Subject|11
1722960|NCT01066819|6009927|P1|Overall Study|Withdrawal by Subject|29
1722961|NCT01066819|6009922|P6|Overall Study|Protocol Violation|0
1722962|NCT01066819|6009923|P5|Overall Study|Protocol Violation|0
1722963|NCT01066819|6009924|P4|Overall Study|Protocol Violation|0
1722964|NCT01066819|6009925|P3|Overall Study|Protocol Violation|0
1722965|NCT01066819|6009926|P2|Overall Study|Protocol Violation|6
1722966|NCT01066819|6009927|P1|Overall Study|Protocol Violation|12
1722967|NCT01066819|6009922|P6|Overall Study|Physician Decision|0
1722968|NCT01066819|6009923|P5|Overall Study|Physician Decision|0
1722969|NCT01066819|6009924|P4|Overall Study|Physician Decision|0
1722970|NCT01066819|6009925|P3|Overall Study|Physician Decision|3
1722971|NCT01066819|6009926|P2|Overall Study|Physician Decision|2
1722972|NCT01066819|6009927|P1|Overall Study|Physician Decision|6
1722973|NCT01066819|6009922|P6|Overall Study|Lack of Efficacy|0
1722974|NCT01066819|6009923|P5|Overall Study|Lack of Efficacy|0
1722975|NCT01066819|6009924|P4|Overall Study|Lack of Efficacy|1
1722976|NCT01066819|6009925|P3|Overall Study|Lack of Efficacy|2
1722977|NCT01066819|6009926|P2|Overall Study|Lack of Efficacy|1
1722978|NCT01066819|6009927|P1|Overall Study|Lack of Efficacy|22
1722979|NCT01066819|6009922|P6|Overall Study|Death|0
1722980|NCT01066819|6009923|P5|Overall Study|Death|0
1722981|NCT01066819|6009924|P4|Overall Study|Death|0
1722982|NCT01066819|6009925|P3|Overall Study|Death|1
1722983|NCT01066819|6009926|P2|Overall Study|Death|0
1722984|NCT01066819|6009927|P1|Overall Study|Death|5
1722985|NCT01066819|6009922|P6|Overall Study|Adverse Event|0
1722986|NCT01066819|6009923|P5|Overall Study|Adverse Event|0
1722987|NCT01066819|6009924|P4|Overall Study|Adverse Event|0
1722988|NCT01066819|6009925|P3|Overall Study|Adverse Event|6
1722989|NCT01066819|6009926|P2|Overall Study|Adverse Event|1
1722990|NCT01066819|6009927|P1|Overall Study|Adverse Event|18
1722991|NCT01066793|6010068|P6|Overall Study|Treatment Stopped|0
1722992|NCT01066793|6010069|P5|Overall Study|Treatment Stopped|0
1722993|NCT01066793|6010070|P4|Overall Study|Treatment Stopped|1
1722994|NCT01066793|6010071|P3|Overall Study|Treatment Stopped|0
1722995|NCT01066793|6010072|P2|Overall Study|Treatment Stopped|1
1722996|NCT01066793|6010073|P1|Overall Study|Treatment Stopped|2
1722997|NCT01066793|6010068|P6|Overall Study|Treatment Never Started|0
1722998|NCT01066793|6010069|P5|Overall Study|Treatment Never Started|0
1722999|NCT01066793|6010070|P4|Overall Study|Treatment Never Started|1
1723000|NCT01066793|6010071|P3|Overall Study|Treatment Never Started|4
1723001|NCT01066793|6010072|P2|Overall Study|Treatment Never Started|5
1723002|NCT01066793|6010073|P1|Overall Study|Treatment Never Started|18
1723003|NCT01066793|6010068|P6|Overall Study|Treatment Interrupted|0
1723004|NCT01066793|6010069|P5|Overall Study|Treatment Interrupted|0
1723005|NCT01066793|6010070|P4|Overall Study|Treatment Interrupted|0
1723006|NCT01066793|6010071|P3|Overall Study|Treatment Interrupted|0
1723007|NCT01066793|6010072|P2|Overall Study|Treatment Interrupted|1
1723008|NCT01066793|6010073|P1|Overall Study|Treatment Interrupted|1
1723009|NCT01066793|6010068|P6|Overall Study|Result Not Available|0
1723010|NCT01066793|6010069|P5|Overall Study|Result Not Available|0
1723011|NCT01066793|6010070|P4|Overall Study|Result Not Available|0
1723012|NCT01066793|6010071|P3|Overall Study|Result Not Available|0
1723013|NCT01066793|6010072|P2|Overall Study|Result Not Available|0
1723014|NCT01066793|6010073|P1|Overall Study|Result Not Available|1
1723015|NCT01066793|6010068|P6|Overall Study|Relapse|0
1723016|NCT01066793|6010069|P5|Overall Study|Relapse|0
1723017|NCT01066793|6010070|P4|Overall Study|Relapse|3
1723018|NCT01066793|6010071|P3|Overall Study|Relapse|2
1723019|NCT01066793|6010072|P2|Overall Study|Relapse|8
1723020|NCT01066793|6010073|P1|Overall Study|Relapse|20
1723021|NCT01066793|6010068|P6|Overall Study|Other|0
1723022|NCT01066793|6010069|P5|Overall Study|Other|0
1723023|NCT01066793|6010070|P4|Overall Study|Other|2
1723024|NCT01066793|6010071|P3|Overall Study|Other|6
1723025|NCT01066793|6010072|P2|Overall Study|Other|5
1723026|NCT01066793|6010073|P1|Overall Study|Other|15
1723027|NCT01066793|6010068|P6|Overall Study|Non-responders|0
1723028|NCT01066793|6010069|P5|Overall Study|Non-responders|0
1723029|NCT01066793|6010070|P4|Overall Study|Non-responders|25
1723030|NCT01066793|6010071|P3|Overall Study|Non-responders|11
1723031|NCT01066793|6010072|P2|Overall Study|Non-responders|5
1723032|NCT01066793|6010073|P1|Overall Study|Non-responders|104
1723033|NCT01066793|6010068|P6|Overall Study|Miscellaneous|0
1723034|NCT01066793|6010069|P5|Overall Study|Miscellaneous|0
1723035|NCT01066793|6010070|P4|Overall Study|Miscellaneous|0
1723036|NCT01066793|6010071|P3|Overall Study|Miscellaneous|6
1723037|NCT01066793|6010072|P2|Overall Study|Miscellaneous|5
1723038|NCT01066793|6010073|P1|Overall Study|Miscellaneous|4
1723039|NCT01066793|6010068|P6|Overall Study|Lab test not done|0
1723040|NCT01066793|6010069|P5|Overall Study|Lab test not done|0
1723041|NCT01066793|6010070|P4|Overall Study|Lab test not done|1
1723042|NCT01066793|6010071|P3|Overall Study|Lab test not done|0
1723043|NCT01066793|6010072|P2|Overall Study|Lab test not done|0
1723044|NCT01066793|6010073|P1|Overall Study|Lab test not done|7
1723045|NCT01066793|6010068|P6|Overall Study|Early Termination|0
1723046|NCT01066793|6010069|P5|Overall Study|Early Termination|0
1723047|NCT01066793|6010070|P4|Overall Study|Early Termination|0
1723048|NCT01066793|6010071|P3|Overall Study|Early Termination|0
1723049|NCT01066793|6010072|P2|Overall Study|Early Termination|0
1723050|NCT01066793|6010073|P1|Overall Study|Early Termination|3
1723051|NCT01066793|6010068|P6|Overall Study|Withdrawal by Subject|0
1723052|NCT01066793|6010069|P5|Overall Study|Withdrawal by Subject|0
1723053|NCT01066793|6010070|P4|Overall Study|Withdrawal by Subject|0
1723054|NCT01066793|6010071|P3|Overall Study|Withdrawal by Subject|1
1723055|NCT01066793|6010072|P2|Overall Study|Withdrawal by Subject|4
1723056|NCT01066793|6010073|P1|Overall Study|Withdrawal by Subject|7
1723057|NCT01066793|6010068|P6|Overall Study|Protocol Violation|0
1723058|NCT01066793|6010069|P5|Overall Study|Protocol Violation|0
1723059|NCT01066793|6010070|P4|Overall Study|Protocol Violation|0
1723060|NCT01066793|6010071|P3|Overall Study|Protocol Violation|2
1723061|NCT01066793|6010072|P2|Overall Study|Protocol Violation|2
1723062|NCT01066793|6010073|P1|Overall Study|Protocol Violation|3
1723063|NCT01066793|6010068|P6|Overall Study|Physician Decision|0
1723064|NCT01066793|6010069|P5|Overall Study|Physician Decision|0
1723065|NCT01066793|6010070|P4|Overall Study|Physician Decision|0
1723066|NCT01066793|6010071|P3|Overall Study|Physician Decision|0
1723067|NCT01066793|6010072|P2|Overall Study|Physician Decision|0
1723068|NCT01066793|6010073|P1|Overall Study|Physician Decision|3
1723069|NCT01066793|6010068|P6|Overall Study|Lost to Follow-up|1
1723070|NCT01066793|6010069|P5|Overall Study|Lost to Follow-up|0
1723071|NCT01066793|6010070|P4|Overall Study|Lost to Follow-up|16
1723072|NCT01066793|6010071|P3|Overall Study|Lost to Follow-up|82
1723073|NCT01066793|6010072|P2|Overall Study|Lost to Follow-up|39
1723074|NCT01066793|6010073|P1|Overall Study|Lost to Follow-up|180
1723075|NCT01066793|6010068|P6|Overall Study|Lack of Efficacy|0
1723076|NCT01066793|6010069|P5|Overall Study|Lack of Efficacy|0
1723077|NCT01066793|6010070|P4|Overall Study|Lack of Efficacy|0
1723078|NCT01066793|6010071|P3|Overall Study|Lack of Efficacy|0
1723079|NCT01066793|6010072|P2|Overall Study|Lack of Efficacy|1
1723080|NCT01066793|6010073|P1|Overall Study|Lack of Efficacy|2
1723081|NCT01066793|6010068|P6|Overall Study|Death|0
1723082|NCT01066793|6010069|P5|Overall Study|Death|0
1723083|NCT01066793|6010070|P4|Overall Study|Death|0
1723084|NCT01066793|6010071|P3|Overall Study|Death|1
1723085|NCT01066793|6010072|P2|Overall Study|Death|1
1723086|NCT01066793|6010073|P1|Overall Study|Death|4
1723087|NCT01066780|6010213|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
1723088|NCT01066780|6010214|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
1723089|NCT01066585|6010233|P2|Overall Study|Withdrawal by Subject|3
1723090|NCT01066585|6010234|P1|Overall Study|Withdrawal by Subject|0
1723091|NCT01066585|6010233|P2|Overall Study|Protocol Violation|0
1723092|NCT01066585|6010234|P1|Overall Study|Protocol Violation|1
1723093|NCT01066546|6010246|P1|Overall Study|Study terminated by sponsor|5
1723094|NCT01066156|6010276|P1|Overall Study|Withdrawal by Subject|1
1723095|NCT01066156|6010276|P1|Overall Study|Lost to Follow-up|7
1723096|NCT01066156|6010276|P1|Overall Study|ineligible|2
1723097|NCT01066143|6010280|P1|Overall Study|ineligible for the study|8
1723098|NCT01066104|6010286|P2|Overall Study|Protocol Violation|0
1723099|NCT01066104|6010287|P1|Overall Study|Protocol Violation|1
1723100|NCT01066104|6010286|P2|Overall Study|Adverse Event|1
1723101|NCT01066104|6010287|P1|Overall Study|Adverse Event|1
1723102|NCT01066052|6010297|P2|Overall Study|Enrolled But Not Treated|0
1723103|NCT01066052|6010298|P1|Overall Study|Enrolled But Not Treated|3
1723104|NCT01066039|6010309|P1|Overall Study|Drug/Dose Adjustment Required|1
1723105|NCT01066039|6010309|P1|Overall Study|Failure to Control Blood Pressure|1
1723106|NCT01066039|6010309|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
1723107|NCT01066039|6010309|P1|Overall Study|Additional Antihypertensive Required|4
1723108|NCT01066039|6010309|P1|Overall Study|Dropout due to Insulin Administration|1
1723109|NCT01066039|6010309|P1|Overall Study|Investigator’s Request|1
1723110|NCT01066039|6010309|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
1723111|NCT01066039|6010309|P1|Overall Study|Protocol Violation|2
1723112|NCT01066039|6010309|P1|Overall Study|Withdrawal by Subject|17
1723113|NCT01066039|6010309|P1|Overall Study|Adverse Event|6
1723114|NCT01066000|6010322|P1|Overall Study|Adverse Event|1
1723115|NCT01066000|6010322|P1|Overall Study|Withdrawal by Subject|1
1723116|NCT01066000|6010322|P1|Overall Study|Death|3
1723117|NCT01066000|6010322|P1|Overall Study|Protocol Violation|4
1723118|NCT01065844|6010333|P1|Overall Study|Adverse Event|5
1723119|NCT01065818|6010337|P1|Overall Study|Not a candidate for surgery|1
1723120|NCT01065818|6010337|P1|Overall Study|Withdrawal by Subject|1
1723121|NCT01065779|6010341|P1|Overall Study|Inclusion Criteria Violation|7
1723122|NCT01065779|6010341|P1|Overall Study|Failed to Follow-up|10
1723123|NCT01065779|6010341|P1|Overall Study|Not Administered With Study Drug|17
1723124|NCT01065779|6010341|P1|Overall Study|Non-enrollment Period Administration|10
1723125|NCT01065779|6010341|P1|Overall Study|Investigation Before Contract Date|37
1723126|NCT01065779|6010341|P1|Overall Study|Duplicate Investigation|1
1723127|NCT01065766|6010352|P1|Overall Study|Violated dosage/administration|25
1723128|NCT01065766|6010352|P1|Overall Study|Contraindication to administration|6
1723129|NCT01065766|6010352|P1|Overall Study|Assessed before the contracted date|1
1723130|NCT01065597|6010371|P1|Overall Study|Adverse Event|1
1723179|NCT01065350|6010544|P2|Overall Study|Received incorrect drug allocation|1
1723180|NCT01065350|6010545|P1|Overall Study|Received incorrect drug allocation|0
1723181|NCT01064947|6010606|P1|Overall Study|negative culture|41
1723182|NCT01064856|6010647|P4|Open-label (OL) Period|Other|7
1723183|NCT01064856|6010648|P3|Open-label (OL) Period|Other|7
1723184|NCT01064856|6010649|P2|Open-label (OL) Period|Other|0
1723185|NCT01064856|6010650|P1|Open-label (OL) Period|Other|0
1723186|NCT01064856|6010647|P4|Open-label (OL) Period|Lost to Follow-up|1
1723187|NCT01064856|6010648|P3|Open-label (OL) Period|Lost to Follow-up|2
1723188|NCT01064856|6010649|P2|Open-label (OL) Period|Lost to Follow-up|0
1723189|NCT01064856|6010650|P1|Open-label (OL) Period|Lost to Follow-up|0
1723190|NCT01064856|6010647|P4|Open-label (OL) Period|Consent withdrawn by participant|6
1723191|NCT01064856|6010648|P3|Open-label (OL) Period|Consent withdrawn by participant|5
1723192|NCT01064856|6010649|P2|Open-label (OL) Period|Consent withdrawn by participant|0
1723193|NCT01064856|6010650|P1|Open-label (OL) Period|Consent withdrawn by participant|0
1723194|NCT01064856|6010647|P4|Open-label (OL) Period|Adverse Event|6
1723195|NCT01064856|6010648|P3|Open-label (OL) Period|Adverse Event|12
1723196|NCT01064856|6010649|P2|Open-label (OL) Period|Adverse Event|0
1723197|NCT01064856|6010650|P1|Open-label (OL) Period|Adverse Event|0
1723198|NCT01064856|6010647|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
1723199|NCT01064856|6010648|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
1723200|NCT01064856|6010649|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
1723201|NCT01064856|6010650|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
1723202|NCT01064856|6010647|P4|Double-blind (DB) Period|Adverse Event|0
1723203|NCT01064856|6010648|P3|Double-blind (DB) Period|Adverse Event|0
1723204|NCT01064856|6010649|P2|Double-blind (DB) Period|Adverse Event|0
1723205|NCT01064856|6010650|P1|Double-blind (DB) Period|Adverse Event|1
1723206|NCT01064817|6010694|P2|Study Completion|Withdrawal by Subject|0
1723207|NCT01064817|6010695|P1|Study Completion|Withdrawal by Subject|1
1723208|NCT01064817|6010694|P2|Study Completion|Physician Decision|0
1723209|NCT01064817|6010695|P1|Study Completion|Physician Decision|1
1723210|NCT01064739|6010707|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
1723211|NCT01064687|6010778|P4|Overall Study|Treatment Noncompliance|0
1723212|NCT01064687|6010779|P3|Overall Study|Treatment Noncompliance|1
1723213|NCT01064687|6010780|P2|Overall Study|Treatment Noncompliance|1
1723214|NCT01064687|6010781|P1|Overall Study|Treatment Noncompliance|1
1723215|NCT01064687|6010778|P4|Overall Study|Withdrawal by Subject|5
1723216|NCT01064687|6010779|P3|Overall Study|Withdrawal by Subject|12
1723217|NCT01064687|6010780|P2|Overall Study|Withdrawal by Subject|7
1723218|NCT01064687|6010781|P1|Overall Study|Withdrawal by Subject|9
1723219|NCT01064687|6010778|P4|Overall Study|Sponsor Decision|0
1723220|NCT01064687|6010779|P3|Overall Study|Sponsor Decision|3
1723221|NCT01064687|6010780|P2|Overall Study|Sponsor Decision|0
1723222|NCT01064687|6010781|P1|Overall Study|Sponsor Decision|0
1723223|NCT01064687|6010778|P4|Overall Study|Protocol Violation|1
1723224|NCT01064687|6010779|P3|Overall Study|Protocol Violation|0
1723225|NCT01064687|6010780|P2|Overall Study|Protocol Violation|1
1723226|NCT01064687|6010781|P1|Overall Study|Protocol Violation|1
1723227|NCT01064687|6010778|P4|Overall Study|Physician Decision|0
1723228|NCT01064687|6010779|P3|Overall Study|Physician Decision|0
1723229|NCT01064687|6010780|P2|Overall Study|Physician Decision|2
1723230|NCT01064687|6010781|P1|Overall Study|Physician Decision|2
1723231|NCT01064687|6010778|P4|Overall Study|Lost to Follow-up|5
1723232|NCT01064687|6010779|P3|Overall Study|Lost to Follow-up|13
1723233|NCT01064687|6010780|P2|Overall Study|Lost to Follow-up|10
1723234|NCT01064687|6010781|P1|Overall Study|Lost to Follow-up|7
1723235|NCT01064687|6010778|P4|Overall Study|Lack of Efficacy|3
1723236|NCT01064687|6010779|P3|Overall Study|Lack of Efficacy|2
1723237|NCT01064687|6010780|P2|Overall Study|Lack of Efficacy|0
1723238|NCT01064687|6010781|P1|Overall Study|Lack of Efficacy|1
1723239|NCT01064687|6010778|P4|Overall Study|Entry Criteria Not Met|0
1723240|NCT01064687|6010779|P3|Overall Study|Entry Criteria Not Met|0
1723241|NCT01064687|6010780|P2|Overall Study|Entry Criteria Not Met|0
1723242|NCT01064687|6010781|P1|Overall Study|Entry Criteria Not Met|3
1723243|NCT01064687|6010778|P4|Overall Study|Death|0
1723244|NCT01064687|6010779|P3|Overall Study|Death|0
1723245|NCT01064687|6010780|P2|Overall Study|Death|1
1723246|NCT01064687|6010781|P1|Overall Study|Death|1
1723247|NCT01064687|6010778|P4|Overall Study|Adverse Event|3
1723248|NCT01064687|6010779|P3|Overall Study|Adverse Event|10
1723249|NCT01064687|6010780|P2|Overall Study|Adverse Event|4
1723250|NCT01064687|6010781|P1|Overall Study|Adverse Event|9
1723299|NCT01064622|6010990|P2|Randomized Phase II|Protocol Violation|1
1723300|NCT01064622|6010991|P1|Randomized Phase II|Protocol Violation|0
1723301|NCT01064622|6010990|P2|Randomized Phase II|Withdrawal by Subject|2
1723302|NCT01064622|6010991|P1|Randomized Phase II|Withdrawal by Subject|2
1723303|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Other|1
1723304|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Other|2
1723305|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Other|5
1723306|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
1723307|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
1723308|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
1723309|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1723310|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
1723311|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
1723312|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1723313|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
1723314|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
1723315|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
1723316|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
1723317|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
1723318|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1723319|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
1723320|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
1723321|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Death|0
1723322|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Death|1
1723323|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Death|0
1723324|NCT01064414|6011015|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
1723325|NCT01064414|6011016|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
1723326|NCT01064414|6011017|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
1723327|NCT01064414|6011015|P3|Core Period: Baseline to Week 26|Other|2
1723328|NCT01064414|6011016|P2|Core Period: Baseline to Week 26|Other|7
1723329|NCT01064414|6011017|P1|Core Period: Baseline to Week 26|Other|4
1723330|NCT01064414|6011015|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1723331|NCT01064414|6011016|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
1723332|NCT01064414|6011017|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
1723333|NCT01064414|6011015|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
1723334|NCT01064414|6011016|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
1723335|NCT01064414|6011017|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
1723336|NCT01064414|6011015|P3|Core Period: Baseline to Week 26|Protocol Violation|1
1723337|NCT01064414|6011016|P2|Core Period: Baseline to Week 26|Protocol Violation|0
1723338|NCT01064414|6011017|P1|Core Period: Baseline to Week 26|Protocol Violation|1
1723339|NCT01064414|6011015|P3|Core Period: Baseline to Week 26|Death|0
1723340|NCT01064414|6011016|P2|Core Period: Baseline to Week 26|Death|1
1723341|NCT01064414|6011017|P1|Core Period: Baseline to Week 26|Death|0
1723342|NCT01064414|6011015|P3|Core Period: Baseline to Week 26|Adverse Event|2
1723343|NCT01064414|6011016|P2|Core Period: Baseline to Week 26|Adverse Event|4
1723344|NCT01064414|6011017|P1|Core Period: Baseline to Week 26|Adverse Event|4
1723345|NCT01064401|6011036|P2|Overall Study|Other|1
1723346|NCT01064401|6011037|P1|Overall Study|Other|2
1723347|NCT01064401|6011036|P2|Overall Study|Site Closure|5
1723348|NCT01064401|6011037|P1|Overall Study|Site Closure|4
1723349|NCT01064401|6011036|P2|Overall Study|Noncompliance|8
1723350|NCT01064401|6011037|P1|Overall Study|Noncompliance|7
1723351|NCT01064401|6011036|P2|Overall Study|Pregnancy|7
1723352|NCT01064401|6011037|P1|Overall Study|Pregnancy|4
1723353|NCT01064401|6011036|P2|Overall Study|Death|0
1723354|NCT01064401|6011037|P1|Overall Study|Death|4
1723355|NCT01064401|6011036|P2|Overall Study|Investigator Decision|6
1723356|NCT01064401|6011037|P1|Overall Study|Investigator Decision|4
1723357|NCT01064401|6011036|P2|Overall Study|Consent Withdrawn|80
1723358|NCT01064401|6011037|P1|Overall Study|Consent Withdrawn|98
1723359|NCT01064401|6011036|P2|Overall Study|Lost to Follow-up|9
1723360|NCT01064401|6011037|P1|Overall Study|Lost to Follow-up|12
1723361|NCT01064401|6011036|P2|Overall Study|Lack of Efficacy|23
1723362|NCT01064401|6011037|P1|Overall Study|Lack of Efficacy|46
1723363|NCT01064401|6011036|P2|Overall Study|Adverse Event|56
1723364|NCT01064401|6011037|P1|Overall Study|Adverse Event|47
1723365|NCT01064310|6011086|P3|Open Label Pazopinib|Physician Decision|20
1723366|NCT01064310|6011087|P2|Open Label Pazopinib|Physician Decision|0
1723367|NCT01064310|6011088|P1|Open Label Pazopinib|Physician Decision|0
1723368|NCT01064310|6011086|P3|Open Label Pazopinib|Lack of Efficacy|51
1723369|NCT01064310|6011087|P2|Open Label Pazopinib|Lack of Efficacy|0
1723370|NCT01064310|6011088|P1|Open Label Pazopinib|Lack of Efficacy|0
1723371|NCT01064310|6011086|P3|Open Label Pazopinib|Adverse Event|12
1723372|NCT01064310|6011087|P2|Open Label Pazopinib|Adverse Event|0
1723373|NCT01064310|6011088|P1|Open Label Pazopinib|Adverse Event|0
1723374|NCT01064310|6011086|P3|Open Label Pazopinib|Withdrawal by Subject|1
1723375|NCT01064310|6011087|P2|Open Label Pazopinib|Withdrawal by Subject|0
1723376|NCT01064310|6011088|P1|Open Label Pazopinib|Withdrawal by Subject|0
1723377|NCT01064310|6011086|P3|Period 2|Lack of Efficacy|0
1723378|NCT01064310|6011087|P2|Period 2|Lack of Efficacy|4
1723379|NCT01064310|6011088|P1|Period 2|Lack of Efficacy|1
1723380|NCT01064310|6011086|P3|Period 2|Entered Open-label Period|0
1723381|NCT01064310|6011087|P2|Period 2|Entered Open-label Period|0
1723382|NCT01064310|6011088|P1|Period 2|Entered Open-label Period|1
1723383|NCT01064310|6011086|P3|Period 2|Physician Decision|0
1723384|NCT01064310|6011087|P2|Period 2|Physician Decision|1
1723385|NCT01064310|6011088|P1|Period 2|Physician Decision|0
1723386|NCT01064310|6011086|P3|Period 2|Adverse Event|0
1723387|NCT01064310|6011087|P2|Period 2|Adverse Event|1
1723388|NCT01064310|6011088|P1|Period 2|Adverse Event|2
1723389|NCT01064310|6011086|P3|Period 1|Entered Open-label Period|0
1723390|NCT01064310|6011087|P2|Period 1|Entered Open-label Period|1
1723391|NCT01064310|6011088|P1|Period 1|Entered Open-label Period|1
1723392|NCT01064310|6011086|P3|Period 1|Lack of Efficacy|0
1723393|NCT01064310|6011087|P2|Period 1|Lack of Efficacy|5
1723394|NCT01064310|6011088|P1|Period 1|Lack of Efficacy|3
1723395|NCT01064310|6011086|P3|Period 1|Withdrawal by Subject|0
1723396|NCT01064310|6011087|P2|Period 1|Withdrawal by Subject|2
1723397|NCT01064310|6011088|P1|Period 1|Withdrawal by Subject|2
1723398|NCT01064310|6011086|P3|Period 1|Physician Decision|0
1723399|NCT01064310|6011087|P2|Period 1|Physician Decision|0
1723400|NCT01064310|6011088|P1|Period 1|Physician Decision|1
1723401|NCT01064310|6011086|P3|Period 1|Adverse Event|0
1723402|NCT01064310|6011087|P2|Period 1|Adverse Event|10
1723403|NCT01064310|6011088|P1|Period 1|Adverse Event|7
1723404|NCT01064297|6011118|P3|Overall Study|Lost to Follow-up|133
1723405|NCT01064297|6011119|P2|Overall Study|Lost to Follow-up|48
1723406|NCT01064297|6011120|P1|Overall Study|Lost to Follow-up|791
1723407|NCT01064167|6011189|P2|Overall Study|Protocol Violation|15
1723408|NCT01064167|6011190|P1|Overall Study|Protocol Violation|14
1723409|NCT01063972|6011205|P2|Overall Study|Incarcerated|1
1723410|NCT01063972|6011206|P1|Overall Study|Incarcerated|2
1723411|NCT01063972|6011205|P2|Overall Study|Death|11
1723412|NCT01063972|6011206|P1|Overall Study|Death|12
1723413|NCT01063881|6011256|P3|Overall Study|Reason for not completed not specified|0
1723414|NCT01063881|6011257|P2|Overall Study|Reason for not completed not specified|1
1723415|NCT01063881|6011258|P1|Overall Study|Reason for not completed not specified|5
1723416|NCT01063881|6011256|P3|Overall Study|Withdrawal by Subject|0
1723417|NCT01063881|6011257|P2|Overall Study|Withdrawal by Subject|1
1723418|NCT01063881|6011258|P1|Overall Study|Withdrawal by Subject|25
1723419|NCT01063881|6011256|P3|Overall Study|Lost to Follow-up|1
1723420|NCT01063881|6011257|P2|Overall Study|Lost to Follow-up|7
1723421|NCT01063881|6011258|P1|Overall Study|Lost to Follow-up|13
1723422|NCT01063881|6011256|P3|Overall Study|Adverse Event|0
1723423|NCT01063881|6011257|P2|Overall Study|Adverse Event|2
1723424|NCT01063881|6011258|P1|Overall Study|Adverse Event|12
1723425|NCT01063868|6011282|P2|Overall Study|Study Terminated By Sponsor|4
1723426|NCT01063868|6011283|P1|Overall Study|Study Terminated By Sponsor|23
1723427|NCT01063868|6011282|P2|Overall Study|Withdrawal by Subject|1
1723428|NCT01063868|6011283|P1|Overall Study|Withdrawal by Subject|3
1723429|NCT01063868|6011282|P2|Overall Study|Adverse Event|7
1723430|NCT01063868|6011283|P1|Overall Study|Adverse Event|9
1723431|NCT01063855|6011291|P2|Overall Study|Reason not specified|11
1723432|NCT01063855|6011292|P1|Overall Study|Reason not specified|13
1723433|NCT01063855|6011291|P2|Overall Study|Withdrawal by Subject|8
1723434|NCT01063855|6011292|P1|Overall Study|Withdrawal by Subject|11
1723435|NCT01063855|6011291|P2|Overall Study|Lack of Efficacy|1
1723436|NCT01063855|6011292|P1|Overall Study|Lack of Efficacy|0
1723437|NCT01063855|6011291|P2|Overall Study|Pregnancy|0
1723438|NCT01063855|6011292|P1|Overall Study|Pregnancy|1
1723439|NCT01063855|6011291|P2|Overall Study|Lost to Follow-up|4
1723440|NCT01063855|6011292|P1|Overall Study|Lost to Follow-up|8
1723441|NCT01063855|6011291|P2|Overall Study|Death|1
1723442|NCT01063855|6011292|P1|Overall Study|Death|0
1723443|NCT01063855|6011291|P2|Overall Study|Adverse Event|4
1723444|NCT01063855|6011292|P1|Overall Study|Adverse Event|4
1723445|NCT01063764|6011339|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
1723446|NCT01063764|6011339|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
1723447|NCT01063764|6011339|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
1723448|NCT01063764|6011339|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
1723449|NCT01063764|6011339|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
1723450|NCT01063764|6011339|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
1723451|NCT01063764|6011339|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
1723452|NCT01063595|6011358|P2|First Intervention|Reason not Specified|1
1723453|NCT01063595|6011359|P1|First Intervention|Reason not Specified|0
1723454|NCT01063595|6011358|P2|First Intervention|Withdrawal by Subject|0
1723455|NCT01063595|6011359|P1|First Intervention|Withdrawal by Subject|1
1723456|NCT01063595|6011358|P2|First Intervention|Adverse Event|4
1723457|NCT01063595|6011359|P1|First Intervention|Adverse Event|1
1723458|NCT01063595|6011358|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
1723459|NCT01063595|6011359|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
1723460|NCT01063595|6011358|P2|Enrolled in Study and Randomized|Adverse Event|1
1723461|NCT01063595|6011359|P1|Enrolled in Study and Randomized|Adverse Event|0
1723462|NCT01063595|6011358|P2|Enrolled in Study and Randomized|Reason not Specified|0
1723463|NCT01063595|6011359|P1|Enrolled in Study and Randomized|Reason not Specified|1
1723474|NCT01063348|6011412|P2|Overall Study|Lost to Follow-up|10
1723475|NCT01063348|6011413|P1|Overall Study|Lost to Follow-up|3
1723476|NCT01063283|6011423|P3|Cycle 1|Technical failure in data collection|0
1723477|NCT01063283|6011424|P2|Cycle 1|Technical failure in data collection|0
1723478|NCT01063283|6011425|P1|Cycle 1|Technical failure in data collection|1
1723479|NCT01063283|6011423|P3|Cycle 1|Adverse Event|0
1723480|NCT01063283|6011424|P2|Cycle 1|Adverse Event|0
1723481|NCT01063283|6011425|P1|Cycle 1|Adverse Event|2
1723482|NCT01063153|6011439|P2|Overall Study|Physician Decision|4
1723483|NCT01063153|6011440|P1|Overall Study|Physician Decision|0
1723484|NCT01063153|6011439|P2|Overall Study|Withdrawal by Subject|1
1723485|NCT01063153|6011440|P1|Overall Study|Withdrawal by Subject|0
1723486|NCT01063153|6011439|P2|Overall Study|Lost to Follow-up|7
1723487|NCT01063153|6011440|P1|Overall Study|Lost to Follow-up|0
1723488|NCT01063153|6011439|P2|Overall Study|Found Ineligible During Screening|0
1723489|NCT01063153|6011440|P1|Overall Study|Found Ineligible During Screening|2
1723490|NCT01063062|6011471|P2|Overall Study|Miscellaneous reason|1
1723491|NCT01063062|6011472|P1|Overall Study|Miscellaneous reason|0
1723492|NCT01063062|6011471|P2|Overall Study|Lost to Follow-up|2
1723493|NCT01063062|6011472|P1|Overall Study|Lost to Follow-up|0
1723494|NCT01063062|6011471|P2|Overall Study|Investigator's request|0
1723495|NCT01063062|6011472|P1|Overall Study|Investigator's request|1
1723496|NCT01063062|6011471|P2|Overall Study|Protocol Violation|4
1723497|NCT01063062|6011472|P1|Overall Study|Protocol Violation|5
1723498|NCT01063062|6011471|P2|Overall Study|Adverse Event|4
1723499|NCT01063062|6011472|P1|Overall Study|Adverse Event|2
1723500|NCT01063062|6011471|P2|Overall Study|Patient withdrew consent|1
1723501|NCT01063062|6011472|P1|Overall Study|Patient withdrew consent|0
1723502|NCT01063036|6011526|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
1723503|NCT01063036|6011526|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
1723504|NCT01063036|6011526|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
1723505|NCT01063036|6011526|P1|Participants Treated With Study Drug|Pregnancy|1
1723506|NCT01063036|6011526|P1|Participants Treated With Study Drug|Lost to Follow-up|1
1723507|NCT01063036|6011526|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
1723596|NCT01061736|6011829|P3|Overall Study|Lack of Efficacy|1
1723508|NCT01063036|6011526|P1|Participants Treated With Study Drug|Protocol Violation|1
1723509|NCT01063036|6011526|P1|Participants Treated With Study Drug|Adverse Event|1
1723510|NCT01062971|6011542|P2|Overall Study|Lost to Follow-up|4
1723511|NCT01062971|6011543|P1|Overall Study|Lost to Follow-up|3
1723512|NCT01062971|6011542|P2|Overall Study|Protocol Violation|3
1723513|NCT01062971|6011543|P1|Overall Study|Protocol Violation|1
1723514|NCT01062841|6011582|P2|Overall Study|Withdrawal by Study|0
1723515|NCT01062841|6011583|P1|Overall Study|Withdrawal by Study|3
1723516|NCT01062841|6011582|P2|Overall Study|Withdrawal by Subject|0
1723517|NCT01062841|6011583|P1|Overall Study|Withdrawal by Subject|2
1723518|NCT01062841|6011582|P2|Overall Study|Death|5
1723519|NCT01062841|6011583|P1|Overall Study|Death|3
1723520|NCT01062841|6011582|P2|Overall Study|Indwelling Device Removed|48
1723521|NCT01062841|6011583|P1|Overall Study|Indwelling Device Removed|41
1723522|NCT01062763|6011613|P2|Overall Study|Adverse Event|4
1723523|NCT01062763|6011614|P1|Overall Study|Adverse Event|3
1723524|NCT01062425|6011640|P2|Overall Study|Protocol Violation|6
1723525|NCT01062425|6011641|P1|Overall Study|Protocol Violation|3
1723526|NCT01062399|6011658|P5|Overall Study|Protocol Violation|4
1723527|NCT01062399|6011659|P4|Overall Study|Protocol Violation|6
1723528|NCT01062399|6011660|P3|Overall Study|Protocol Violation|0
1723529|NCT01062399|6011661|P2|Overall Study|Protocol Violation|1
1723530|NCT01062399|6011662|P1|Overall Study|Protocol Violation|0
1723531|NCT01062256|6011706|P3|Overall Study|Administrative|0
1723532|NCT01062256|6011707|P2|Overall Study|Administrative|2
1723533|NCT01062256|6011708|P1|Overall Study|Administrative|0
1723534|NCT01062256|6011706|P3|Overall Study|Ineligible|3
1723535|NCT01062256|6011707|P2|Overall Study|Ineligible|4
1723536|NCT01062256|6011708|P1|Overall Study|Ineligible|1
1723537|NCT01062256|6011706|P3|Overall Study|Withdrawal by Subject|1
1723538|NCT01062256|6011707|P2|Overall Study|Withdrawal by Subject|1
1723539|NCT01062256|6011708|P1|Overall Study|Withdrawal by Subject|1
1723540|NCT01062256|6011706|P3|Overall Study|Adverse Event|0
1723541|NCT01062256|6011707|P2|Overall Study|Adverse Event|0
1723542|NCT01062256|6011708|P1|Overall Study|Adverse Event|1
1723543|NCT01062113|6011742|P3|Overall Study|Withdrawal by Subject|0
1723544|NCT01062113|6011743|P2|Overall Study|Withdrawal by Subject|0
1723545|NCT01062113|6011744|P1|Overall Study|Withdrawal by Subject|1
1723546|NCT01062113|6011742|P3|Overall Study|Lack of Efficacy|31
1723547|NCT01062113|6011743|P2|Overall Study|Lack of Efficacy|22
1723548|NCT01062113|6011744|P1|Overall Study|Lack of Efficacy|38
1723549|NCT01062113|6011742|P3|Overall Study|Adverse Event|0
1723550|NCT01062113|6011743|P2|Overall Study|Adverse Event|0
1723551|NCT01062113|6011744|P1|Overall Study|Adverse Event|1
1723552|NCT01062061|6011762|P1|Overall Study|Failed to meet inclusion criteria|2
1723553|NCT01062061|6011762|P1|Overall Study|Outside chief indications|10
1723554|NCT01062061|6011762|P1|Overall Study|Investigated before study start|13
1723555|NCT01062061|6011762|P1|Overall Study|Enrolled more than once|2
1723556|NCT01061866|6011801|P1|Overall Study|Adverse Event|2
1723557|NCT01061775|6011805|P1|Overall Study|Lost to Follow-up|1
1723558|NCT01061775|6011805|P1|Overall Study|Physician Decision|2
1723559|NCT01061736|6011822|P10|Overall Study|Other than specified above|21
1723560|NCT01061736|6011823|P9|Overall Study|Other than specified above|15
1723561|NCT01061736|6011824|P8|Overall Study|Other than specified above|18
1723562|NCT01061736|6011825|P7|Overall Study|Other than specified above|0
1723563|NCT01061736|6011826|P6|Overall Study|Other than specified above|0
1723564|NCT01061736|6011827|P5|Overall Study|Other than specified above|1
1723565|NCT01061736|6011828|P4|Overall Study|Other than specified above|0
1723566|NCT01061736|6011829|P3|Overall Study|Other than specified above|2
1723567|NCT01061736|6011830|P2|Overall Study|Other than specified above|1
1723568|NCT01061736|6011831|P1|Overall Study|Other than specified above|0
1723569|NCT01061736|6011822|P10|Overall Study|Not treated|0
1723570|NCT01061736|6011823|P9|Overall Study|Not treated|1
1723571|NCT01061736|6011824|P8|Overall Study|Not treated|2
1723572|NCT01061736|6011825|P7|Overall Study|Not treated|0
1723573|NCT01061736|6011826|P6|Overall Study|Not treated|0
1723574|NCT01061736|6011827|P5|Overall Study|Not treated|1
1723575|NCT01061736|6011828|P4|Overall Study|Not treated|0
1723576|NCT01061736|6011829|P3|Overall Study|Not treated|0
1723577|NCT01061736|6011830|P2|Overall Study|Not treated|0
1723578|NCT01061736|6011831|P1|Overall Study|Not treated|0
1723579|NCT01061736|6011822|P10|Overall Study|Poor compliance to protocol|9
1723580|NCT01061736|6011823|P9|Overall Study|Poor compliance to protocol|5
1723581|NCT01061736|6011824|P8|Overall Study|Poor compliance to protocol|2
1723582|NCT01061736|6011825|P7|Overall Study|Poor compliance to protocol|0
1723583|NCT01061736|6011826|P6|Overall Study|Poor compliance to protocol|0
1723584|NCT01061736|6011827|P5|Overall Study|Poor compliance to protocol|0
1723585|NCT01061736|6011828|P4|Overall Study|Poor compliance to protocol|0
1723586|NCT01061736|6011829|P3|Overall Study|Poor compliance to protocol|0
1723587|NCT01061736|6011830|P2|Overall Study|Poor compliance to protocol|0
1723588|NCT01061736|6011831|P1|Overall Study|Poor compliance to protocol|0
1723589|NCT01061736|6011822|P10|Overall Study|Lack of Efficacy|10
1723590|NCT01061736|6011823|P9|Overall Study|Lack of Efficacy|9
1723591|NCT01061736|6011824|P8|Overall Study|Lack of Efficacy|9
1723592|NCT01061736|6011825|P7|Overall Study|Lack of Efficacy|1
1723593|NCT01061736|6011826|P6|Overall Study|Lack of Efficacy|2
1723594|NCT01061736|6011827|P5|Overall Study|Lack of Efficacy|1
1723595|NCT01061736|6011828|P4|Overall Study|Lack of Efficacy|1
1723597|NCT01061736|6011830|P2|Overall Study|Lack of Efficacy|2
1723598|NCT01061736|6011831|P1|Overall Study|Lack of Efficacy|0
1723599|NCT01061736|6011822|P10|Overall Study|Adverse Event|34
1723600|NCT01061736|6011823|P9|Overall Study|Adverse Event|67
1723601|NCT01061736|6011824|P8|Overall Study|Adverse Event|63
1723602|NCT01061736|6011825|P7|Overall Study|Adverse Event|4
1723603|NCT01061736|6011826|P6|Overall Study|Adverse Event|1
1723604|NCT01061736|6011827|P5|Overall Study|Adverse Event|4
1723605|NCT01061736|6011828|P4|Overall Study|Adverse Event|2
1723606|NCT01061736|6011829|P3|Overall Study|Adverse Event|3
1723607|NCT01061736|6011830|P2|Overall Study|Adverse Event|1
1723608|NCT01061736|6011831|P1|Overall Study|Adverse Event|13
1723609|NCT01061736|6011822|P10|Overall Study|Dose regimen not selected|0
1723610|NCT01061736|6011823|P9|Overall Study|Dose regimen not selected|0
1723611|NCT01061736|6011824|P8|Overall Study|Dose regimen not selected|0
1723612|NCT01061736|6011825|P7|Overall Study|Dose regimen not selected|79
1723613|NCT01061736|6011826|P6|Overall Study|Dose regimen not selected|0
1723614|NCT01061736|6011827|P5|Overall Study|Dose regimen not selected|0
1723615|NCT01061736|6011828|P4|Overall Study|Dose regimen not selected|0
1723616|NCT01061736|6011829|P3|Overall Study|Dose regimen not selected|0
1723617|NCT01061736|6011830|P2|Overall Study|Dose regimen not selected|0
1723618|NCT01061736|6011831|P1|Overall Study|Dose regimen not selected|0
1723619|NCT01061723|6011870|P6|Overall Study|Other than specified above|1
1723620|NCT01061723|6011871|P5|Overall Study|Other than specified above|0
1723621|NCT01061723|6011872|P4|Overall Study|Other than specified above|1
1723622|NCT01061723|6011873|P3|Overall Study|Other than specified above|1
1723623|NCT01061723|6011874|P2|Overall Study|Other than specified above|1
1723624|NCT01061723|6011875|P1|Overall Study|Other than specified above|2
1723625|NCT01061723|6011870|P6|Overall Study|Randomized but not treated|1
1723626|NCT01061723|6011871|P5|Overall Study|Randomized but not treated|0
1723627|NCT01061723|6011872|P4|Overall Study|Randomized but not treated|0
1723628|NCT01061723|6011873|P3|Overall Study|Randomized but not treated|0
1723629|NCT01061723|6011874|P2|Overall Study|Randomized but not treated|0
1723630|NCT01061723|6011875|P1|Overall Study|Randomized but not treated|0
1723631|NCT01061723|6011870|P6|Overall Study|Lack of Efficacy|1
1723632|NCT01061723|6011871|P5|Overall Study|Lack of Efficacy|1
1723633|NCT01061723|6011872|P4|Overall Study|Lack of Efficacy|2
1723634|NCT01061723|6011873|P3|Overall Study|Lack of Efficacy|4
1723635|NCT01061723|6011874|P2|Overall Study|Lack of Efficacy|3
1723636|NCT01061723|6011875|P1|Overall Study|Lack of Efficacy|2
1723637|NCT01061723|6011870|P6|Overall Study|Adverse Event|6
1723638|NCT01061723|6011871|P5|Overall Study|Adverse Event|2
1723639|NCT01061723|6011872|P4|Overall Study|Adverse Event|5
1723640|NCT01061723|6011873|P3|Overall Study|Adverse Event|5
1723641|NCT01061723|6011874|P2|Overall Study|Adverse Event|2
1723642|NCT01061723|6011875|P1|Overall Study|Adverse Event|0
1723643|NCT01061710|6011955|P1|Overall Study|Protocol Violation|14
1723644|NCT01061671|6011965|P2|Overall Study|Death|30
1723645|NCT01061671|6011966|P1|Overall Study|Death|28
1723646|NCT01061671|6011965|P2|Overall Study|Lost to Follow-up|5
1723647|NCT01061671|6011966|P1|Overall Study|Lost to Follow-up|3
1723648|NCT01061671|6011965|P2|Overall Study|Withdrawal by Subject|20
1723649|NCT01061671|6011966|P1|Overall Study|Withdrawal by Subject|16
1723650|NCT01061606|6011978|P1|Overall Study|alternative therapy|2
1723651|NCT01061606|6011978|P1|Overall Study|Disease Progression|4
1723652|NCT01061606|6011978|P1|Overall Study|Death|1
1723653|NCT01061606|6011978|P1|Overall Study|Adverse Event|1
1723654|NCT01061567|6011987|P1|Overall Study|Other reason than stated above|3
1723655|NCT01061567|6011987|P1|Overall Study|Withdrawal by Subject|11
1723656|NCT01061567|6011987|P1|Overall Study|Protocol Violation|1
1723657|NCT01061567|6011987|P1|Overall Study|Lost to Follow-up|24
1723658|NCT01061567|6011987|P1|Overall Study|Lack of Efficacy|3
1723659|NCT01061567|6011987|P1|Overall Study|Death|2
1723660|NCT01061567|6011987|P1|Overall Study|Adverse Event|32
1723661|NCT01061385|6012011|P2|Overall Study|subject decision not related to AE|1
1723662|NCT01061385|6012012|P1|Overall Study|subject decision not related to AE|0
1723663|NCT01061385|6012011|P2|Overall Study|Lost to Follow-up|0
1723664|NCT01061385|6012012|P1|Overall Study|Lost to Follow-up|1
1723665|NCT01061359|6012020|P1|Overall Study|Secondary neoplasm|11
1723666|NCT01061359|6012020|P1|Overall Study|Relapse|187
1723667|NCT01061359|6012020|P1|Overall Study|Lost to Follow-up|1072
1723668|NCT01061359|6012020|P1|Overall Study|Death|32
1723669|NCT01061333|6012026|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
1723670|NCT01061333|6012027|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
1723671|NCT01061177|6012065|P1|Overall Study|Death|4
1723672|NCT01061177|6012065|P1|Overall Study|Administratie problems|4
1723673|NCT01061177|6012065|P1|Overall Study|Abnormal test procedure results|4
1723674|NCT01061177|6012065|P1|Overall Study|Abnormal laboratory values|6
1723675|NCT01061177|6012065|P1|Overall Study|New cancer therapy|9
1723676|NCT01061177|6012065|P1|Overall Study|Lost to Follow-up|9
1723677|NCT01061177|6012065|P1|Overall Study|Protocol Violation|11
1723678|NCT01061177|6012065|P1|Overall Study|Disease progression|17
1723679|NCT01061177|6012065|P1|Overall Study|Withdrawal by Subject|27
1723680|NCT01061177|6012065|P1|Overall Study|Adverse Event|117
1723681|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
1723682|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
1723683|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
1723759|NCT01060540|6012203|P2|Overall Study|Physician Decision|1
1723684|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
1723685|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
1723686|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
1723687|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
1723688|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
1723689|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
1723690|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
1723691|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
1723692|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
1723693|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
1723694|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
1723695|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
1723696|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
1723697|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
1723698|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
1723699|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
1723700|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
1723701|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
1723702|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
1723703|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
1723704|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
1723705|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1723706|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1723707|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
1723708|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
1723709|NCT01061151|6012088|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
1723710|NCT01061151|6012089|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
1723711|NCT01061151|6012090|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
1723712|NCT01061151|6012091|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
1723713|NCT01061151|6012088|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
1723714|NCT01061151|6012089|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
1723715|NCT01061151|6012090|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
1723716|NCT01061151|6012091|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
1723717|NCT01061151|6012088|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
1723718|NCT01061151|6012089|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
1723719|NCT01061151|6012090|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
1723720|NCT01061151|6012091|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
1723721|NCT01061151|6012088|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
1723722|NCT01061151|6012089|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
1723723|NCT01061151|6012090|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
1723724|NCT01061151|6012091|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
1723725|NCT01061151|6012088|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
1723726|NCT01061151|6012089|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
1723727|NCT01061151|6012090|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
1723728|NCT01061151|6012091|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
1723729|NCT01061151|6012088|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
1723730|NCT01061151|6012089|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
1723731|NCT01061151|6012090|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
1723732|NCT01061151|6012091|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
1723733|NCT01061151|6012088|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
1723734|NCT01061151|6012089|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
1723735|NCT01061151|6012090|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
1723736|NCT01061151|6012091|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
1723737|NCT01061151|6012088|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
1723738|NCT01061151|6012089|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
1723739|NCT01061151|6012090|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
1723740|NCT01061151|6012091|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
1723741|NCT01061008|6012150|P2|Overall Study|Adverse Event|1
1723742|NCT01061008|6012151|P1|Overall Study|Adverse Event|0
1723743|NCT01061008|6012150|P2|Overall Study|Unable to exercise following surgery|0
1723744|NCT01061008|6012151|P1|Overall Study|Unable to exercise following surgery|1
1723745|NCT01061008|6012150|P2|Overall Study|Withdrawal by Subject|3
1723746|NCT01061008|6012151|P1|Overall Study|Withdrawal by Subject|1
1723747|NCT01061008|6012150|P2|Overall Study|Death|0
1723748|NCT01061008|6012151|P1|Overall Study|Death|1
1723749|NCT01061008|6012150|P2|Overall Study|Badiocephalic fistula failed|2
1723750|NCT01061008|6012151|P1|Overall Study|Badiocephalic fistula failed|3
1723751|NCT01060670|6012159|P2|Run In|screen failure|238
1723752|NCT01060670|6012160|P1|Run In|screen failure|0
1723753|NCT01060553|6012195|P2|Overall Study|Lack of Efficacy|0
1723754|NCT01060553|6012196|P1|Overall Study|Lack of Efficacy|1
1723755|NCT01060553|6012195|P2|Overall Study|Withdrawal by Subject|5
1723756|NCT01060553|6012196|P1|Overall Study|Withdrawal by Subject|5
1723757|NCT01060553|6012195|P2|Overall Study|Lost to Follow-up|5
1723758|NCT01060553|6012196|P1|Overall Study|Lost to Follow-up|3
1723760|NCT01060540|6012204|P1|Overall Study|Physician Decision|0
1723761|NCT01060540|6012203|P2|Overall Study|Death|1
1723762|NCT01060540|6012204|P1|Overall Study|Death|2
1723763|NCT01060540|6012203|P2|Overall Study|Lost to Follow-up|43
1723764|NCT01060540|6012204|P1|Overall Study|Lost to Follow-up|52
1723765|NCT01060540|6012203|P2|Overall Study|Withdrawal by Subject|20
1723766|NCT01060540|6012204|P1|Overall Study|Withdrawal by Subject|10
1723767|NCT01060384|6012218|P5|Overall Study|Intercurrent illness|1
1723768|NCT01060384|6012219|P4|Overall Study|Intercurrent illness|0
1723769|NCT01060384|6012220|P3|Overall Study|Intercurrent illness|0
1723770|NCT01060384|6012221|P2|Overall Study|Intercurrent illness|0
1723771|NCT01060384|6012222|P1|Overall Study|Intercurrent illness|0
1723772|NCT01060384|6012218|P5|Overall Study|Death|1
1723773|NCT01060384|6012219|P4|Overall Study|Death|0
1723774|NCT01060384|6012220|P3|Overall Study|Death|0
1723775|NCT01060384|6012221|P2|Overall Study|Death|0
1723776|NCT01060384|6012222|P1|Overall Study|Death|0
1723777|NCT01060384|6012218|P5|Overall Study|Withdrawal by Subject|0
1723778|NCT01060384|6012219|P4|Overall Study|Withdrawal by Subject|0
1723779|NCT01060384|6012220|P3|Overall Study|Withdrawal by Subject|0
1723780|NCT01060384|6012221|P2|Overall Study|Withdrawal by Subject|1
1723781|NCT01060384|6012222|P1|Overall Study|Withdrawal by Subject|0
1723782|NCT01060150|6012231|P1|Overall Study|Enrolled, but not treated|2
1723783|NCT01060150|6012231|P1|Overall Study|Withdrawal by Subject|8
1723784|NCT01060150|6012231|P1|Overall Study|Protocol Violation|6
1723785|NCT01060150|6012231|P1|Overall Study|Lost to Follow-up|1
1723786|NCT01060150|6012231|P1|Overall Study|Adverse Event|6
1723787|NCT01060124|6012246|P1|Overall Study|Withdrawal by Subject|7
1723788|NCT01060124|6012246|P1|Overall Study|Adverse Event|14
1723789|NCT01060124|6012246|P1|Overall Study|Other|16
1723790|NCT01060111|6012257|P3|Overall Study|Other|4
1723791|NCT01060111|6012258|P2|Overall Study|Other|3
1723792|NCT01060111|6012259|P1|Overall Study|Other|2
1723793|NCT01060111|6012257|P3|Overall Study|Participants' non-cooperation|0
1723794|NCT01060111|6012258|P2|Overall Study|Participants' non-cooperation|0
1723795|NCT01060111|6012259|P1|Overall Study|Participants' non-cooperation|1
1723796|NCT01060111|6012257|P3|Overall Study|Adverse event and insufficient effect|0
1723797|NCT01060111|6012258|P2|Overall Study|Adverse event and insufficient effect|1
1723798|NCT01060111|6012259|P1|Overall Study|Adverse event and insufficient effect|0
1723799|NCT01060111|6012257|P3|Overall Study|Participants' non-cooperation|6
1723800|NCT01060111|6012258|P2|Overall Study|Participants' non-cooperation|6
1723801|NCT01060111|6012259|P1|Overall Study|Participants' non-cooperation|8
1723802|NCT01060111|6012257|P3|Overall Study|Participants' evasion for hospital visit|2
1723803|NCT01060111|6012258|P2|Overall Study|Participants' evasion for hospital visit|3
1723804|NCT01060111|6012259|P1|Overall Study|Participants' evasion for hospital visit|0
1723805|NCT01060111|6012257|P3|Overall Study|Inappropriate participant|5
1723806|NCT01060111|6012258|P2|Overall Study|Inappropriate participant|4
1723807|NCT01060111|6012259|P1|Overall Study|Inappropriate participant|5
1723808|NCT01060111|6012257|P3|Overall Study|Lack of Efficacy|0
1723809|NCT01060111|6012258|P2|Overall Study|Lack of Efficacy|1
1723810|NCT01060111|6012259|P1|Overall Study|Lack of Efficacy|2
1723811|NCT01060111|6012257|P3|Overall Study|Adverse Event|18
1723812|NCT01060111|6012258|P2|Overall Study|Adverse Event|5
1723813|NCT01060111|6012259|P1|Overall Study|Adverse Event|9
1723814|NCT01060072|6012291|P2|Overall Study|Excluded Medications|1
1723815|NCT01060072|6012292|P1|Overall Study|Excluded Medications|0
1723816|NCT01060072|6012291|P2|Overall Study|Acute cholecystitis|0
1723817|NCT01060072|6012292|P1|Overall Study|Acute cholecystitis|1
1723818|NCT01060072|6012291|P2|Overall Study|Protocol Violation|1
1723819|NCT01060072|6012292|P1|Overall Study|Protocol Violation|0
1723820|NCT01060072|6012291|P2|Overall Study|Physician Decision|2
1723821|NCT01060072|6012292|P1|Overall Study|Physician Decision|0
1723822|NCT01060072|6012291|P2|Overall Study|Adverse Event|1
1723823|NCT01060072|6012292|P1|Overall Study|Adverse Event|1
1723824|NCT01060059|6012308|P2|Overall Study|lack of compliance|2
1723825|NCT01060059|6012309|P1|Overall Study|lack of compliance|5
1723826|NCT01060059|6012308|P2|Overall Study|lack of glycemic control|1
1723827|NCT01060059|6012309|P1|Overall Study|lack of glycemic control|2
1723828|NCT01060059|6012308|P2|Overall Study|Withdrawal by Subject|23
1723829|NCT01060059|6012309|P1|Overall Study|Withdrawal by Subject|35
1723830|NCT01060059|6012308|P2|Overall Study|entry criteria not met|3
1723831|NCT01060059|6012309|P1|Overall Study|entry criteria not met|4
1723832|NCT01060059|6012308|P2|Overall Study|Lost to Follow-up|34
1723833|NCT01060059|6012309|P1|Overall Study|Lost to Follow-up|18
1723834|NCT01060059|6012308|P2|Overall Study|Death|3
1723835|NCT01060059|6012309|P1|Overall Study|Death|2
1723836|NCT01060059|6012308|P2|Overall Study|Adverse Event|1
1723837|NCT01060059|6012309|P1|Overall Study|Adverse Event|1
1723838|NCT01060007|6012367|P1|Overall Study|Inevaluable for response at surgery|3
1723839|NCT01060007|6012367|P1|Overall Study|Withdrawal by Subject|1
1723840|NCT01059903|6012435|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
1723841|NCT01059903|6012436|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
1723842|NCT01059864|6012479|P3|Double-Blind Treatment Phase|Adverse Event|3
1723843|NCT01059864|6012480|P2|Double-Blind Treatment Phase|Adverse Event|3
1723844|NCT01059864|6012481|P1|Double-Blind Treatment Phase|Adverse Event|0
1723845|NCT01059864|6012479|P3|Open-Label Run-In Phase|Protocol Violation|0
1723846|NCT01059864|6012480|P2|Open-Label Run-In Phase|Protocol Violation|0
1723847|NCT01059864|6012481|P1|Open-Label Run-In Phase|Protocol Violation|2
1723848|NCT01059864|6012479|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
1723849|NCT01059864|6012480|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
1723850|NCT01059864|6012481|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
1723851|NCT01059864|6012479|P3|Open-Label Run-In Phase|Lost to Follow-up|0
1723852|NCT01059864|6012480|P2|Open-Label Run-In Phase|Lost to Follow-up|0
1723853|NCT01059864|6012481|P1|Open-Label Run-In Phase|Lost to Follow-up|2
1723854|NCT01059864|6012479|P3|Open-Label Run-In Phase|Lack of Efficacy|0
1723855|NCT01059864|6012480|P2|Open-Label Run-In Phase|Lack of Efficacy|0
1723856|NCT01059864|6012481|P1|Open-Label Run-In Phase|Lack of Efficacy|1
1723857|NCT01059864|6012479|P3|Open-Label Run-In Phase|Adverse Event|0
1723858|NCT01059864|6012480|P2|Open-Label Run-In Phase|Adverse Event|0
1723859|NCT01059864|6012481|P1|Open-Label Run-In Phase|Adverse Event|7
1723860|NCT01059825|6012555|P7|Treatment Period|Adverse event not related to study drug|0
1723861|NCT01059825|6012556|P6|Treatment Period|Adverse event not related to study drug|1
1723862|NCT01059825|6012557|P5|Treatment Period|Adverse event not related to study drug|1
1723863|NCT01059825|6012558|P4|Treatment Period|Adverse event not related to study drug|1
1723864|NCT01059825|6012559|P3|Treatment Period|Adverse event not related to study drug|2
1723865|NCT01059825|6012560|P2|Treatment Period|Adverse event not related to study drug|1
1723866|NCT01059825|6012561|P1|Treatment Period|Adverse event not related to study drug|0
1723867|NCT01059825|6012555|P7|Treatment Period|Insufficient clinical response|0
1723868|NCT01059825|6012556|P6|Treatment Period|Insufficient clinical response|0
1723869|NCT01059825|6012557|P5|Treatment Period|Insufficient clinical response|0
1723870|NCT01059825|6012558|P4|Treatment Period|Insufficient clinical response|0
1723871|NCT01059825|6012559|P3|Treatment Period|Insufficient clinical response|0
1723872|NCT01059825|6012560|P2|Treatment Period|Insufficient clinical response|0
1723873|NCT01059825|6012561|P1|Treatment Period|Insufficient clinical response|3
1723874|NCT01059825|6012555|P7|Treatment Period|Adverse event related to study drug|0
1723875|NCT01059825|6012556|P6|Treatment Period|Adverse event related to study drug|0
1723876|NCT01059825|6012557|P5|Treatment Period|Adverse event related to study drug|0
1723877|NCT01059825|6012558|P4|Treatment Period|Adverse event related to study drug|1
1723878|NCT01059825|6012559|P3|Treatment Period|Adverse event related to study drug|1
1723879|NCT01059825|6012560|P2|Treatment Period|Adverse event related to study drug|0
1723880|NCT01059825|6012561|P1|Treatment Period|Adverse event related to study drug|1
1723881|NCT01059825|6012555|P7|Treatment Period|Protocol Violation|0
1723882|NCT01059825|6012556|P6|Treatment Period|Protocol Violation|1
1723883|NCT01059825|6012557|P5|Treatment Period|Protocol Violation|1
1723884|NCT01059825|6012558|P4|Treatment Period|Protocol Violation|1
1723885|NCT01059825|6012559|P3|Treatment Period|Protocol Violation|1
1723886|NCT01059825|6012560|P2|Treatment Period|Protocol Violation|0
1723887|NCT01059825|6012561|P1|Treatment Period|Protocol Violation|0
1723888|NCT01059825|6012555|P7|Treatment Period|Other reason not specified|0
1723889|NCT01059825|6012556|P6|Treatment Period|Other reason not specified|0
1723890|NCT01059825|6012557|P5|Treatment Period|Other reason not specified|0
1723891|NCT01059825|6012558|P4|Treatment Period|Other reason not specified|2
1723892|NCT01059825|6012559|P3|Treatment Period|Other reason not specified|1
1723893|NCT01059825|6012560|P2|Treatment Period|Other reason not specified|2
1723894|NCT01059825|6012561|P1|Treatment Period|Other reason not specified|1
1723895|NCT01059825|6012555|P7|Treatment Period|Withdrawal by Subject|0
1723896|NCT01059825|6012556|P6|Treatment Period|Withdrawal by Subject|1
1723897|NCT01059825|6012557|P5|Treatment Period|Withdrawal by Subject|4
1723898|NCT01059825|6012558|P4|Treatment Period|Withdrawal by Subject|5
1723899|NCT01059825|6012559|P3|Treatment Period|Withdrawal by Subject|1
1723900|NCT01059825|6012560|P2|Treatment Period|Withdrawal by Subject|0
1723901|NCT01059825|6012561|P1|Treatment Period|Withdrawal by Subject|3
1723902|NCT01059825|6012555|P7|Treatment Period|Lost to Follow-up|0
1723903|NCT01059825|6012556|P6|Treatment Period|Lost to Follow-up|0
1723904|NCT01059825|6012557|P5|Treatment Period|Lost to Follow-up|2
1723905|NCT01059825|6012558|P4|Treatment Period|Lost to Follow-up|1
1723906|NCT01059825|6012559|P3|Treatment Period|Lost to Follow-up|0
1723907|NCT01059825|6012560|P2|Treatment Period|Lost to Follow-up|1
1723908|NCT01059825|6012561|P1|Treatment Period|Lost to Follow-up|2
1723909|NCT01059825|6012555|P7|Enrolled, Run-in Period|Protocol Violation|5
1723910|NCT01059825|6012556|P6|Enrolled, Run-in Period|Protocol Violation|0
1723911|NCT01059825|6012557|P5|Enrolled, Run-in Period|Protocol Violation|0
1723912|NCT01059825|6012558|P4|Enrolled, Run-in Period|Protocol Violation|0
1723913|NCT01059825|6012559|P3|Enrolled, Run-in Period|Protocol Violation|0
1723914|NCT01059825|6012560|P2|Enrolled, Run-in Period|Protocol Violation|0
1723915|NCT01059825|6012561|P1|Enrolled, Run-in Period|Protocol Violation|0
1723916|NCT01059825|6012555|P7|Enrolled, Run-in Period|Other reason not specified|7
1723917|NCT01059825|6012556|P6|Enrolled, Run-in Period|Other reason not specified|0
1723918|NCT01059825|6012557|P5|Enrolled, Run-in Period|Other reason not specified|0
1723919|NCT01059825|6012558|P4|Enrolled, Run-in Period|Other reason not specified|0
1723920|NCT01059825|6012559|P3|Enrolled, Run-in Period|Other reason not specified|0
1723921|NCT01059825|6012560|P2|Enrolled, Run-in Period|Other reason not specified|0
1723922|NCT01059825|6012561|P1|Enrolled, Run-in Period|Other reason not specified|0
1723923|NCT01059825|6012555|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
1723924|NCT01059825|6012556|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
1723925|NCT01059825|6012557|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
1723926|NCT01059825|6012558|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
1723927|NCT01059825|6012559|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
1723928|NCT01059825|6012560|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
1723929|NCT01059825|6012561|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
1723930|NCT01059825|6012555|P7|Enrolled, Run-in Period|Lost to Follow-up|5
1723931|NCT01059825|6012556|P6|Enrolled, Run-in Period|Lost to Follow-up|0
1723932|NCT01059825|6012557|P5|Enrolled, Run-in Period|Lost to Follow-up|0
1723933|NCT01059825|6012558|P4|Enrolled, Run-in Period|Lost to Follow-up|0
1723934|NCT01059825|6012559|P3|Enrolled, Run-in Period|Lost to Follow-up|0
1723935|NCT01059825|6012560|P2|Enrolled, Run-in Period|Lost to Follow-up|0
1723936|NCT01059825|6012561|P1|Enrolled, Run-in Period|Lost to Follow-up|0
1723937|NCT01059825|6012555|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
1723938|NCT01059825|6012556|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
1723939|NCT01059825|6012557|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
1723940|NCT01059825|6012558|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
1723941|NCT01059825|6012559|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
1723942|NCT01059825|6012560|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
1723943|NCT01059825|6012561|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
1723944|NCT01059825|6012555|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
1723945|NCT01059825|6012556|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
1723946|NCT01059825|6012557|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
1723947|NCT01059825|6012558|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
1723948|NCT01059825|6012559|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
1723949|NCT01059825|6012560|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
1723950|NCT01059825|6012561|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
1723951|NCT01059812|6012748|P2|Overall Study|Unclassified|4
1723952|NCT01059812|6012749|P1|Overall Study|Unclassified|14
1723953|NCT01059812|6012748|P2|Overall Study|Withdrawal Criteria|4
1723954|NCT01059812|6012749|P1|Overall Study|Withdrawal Criteria|9
1723955|NCT01059812|6012748|P2|Overall Study|Protocol Violation|1
1723956|NCT01059812|6012749|P1|Overall Study|Protocol Violation|3
1723957|NCT01059812|6012748|P2|Overall Study|Lack of Efficacy|2
1723958|NCT01059812|6012749|P1|Overall Study|Lack of Efficacy|2
1723959|NCT01059812|6012748|P2|Overall Study|Adverse Event|5
1723960|NCT01059812|6012749|P1|Overall Study|Adverse Event|9
1723961|NCT01059799|6012765|P2|Overall Study|Other|3
1723962|NCT01059799|6012766|P1|Overall Study|Other|12
1723963|NCT01059799|6012765|P2|Overall Study|Withdrawal criteria|2
1723964|NCT01059799|6012766|P1|Overall Study|Withdrawal criteria|13
1723965|NCT01059799|6012765|P2|Overall Study|Protocol Violation|2
1723966|NCT01059799|6012766|P1|Overall Study|Protocol Violation|3
1723967|NCT01059799|6012765|P2|Overall Study|Lack of Efficacy|0
1723968|NCT01059799|6012766|P1|Overall Study|Lack of Efficacy|1
1723969|NCT01059799|6012765|P2|Overall Study|Adverse Event|3
1723970|NCT01059799|6012766|P1|Overall Study|Adverse Event|2
1723971|NCT01059773|6012780|P2|Overall Study|Other|3
1723972|NCT01059773|6012781|P1|Overall Study|Other|1
1723973|NCT01059773|6012780|P2|Overall Study|Ineligible follow TB screening criteria|1
1723974|NCT01059773|6012781|P1|Overall Study|Ineligible follow TB screening criteria|0
1723975|NCT01059773|6012780|P2|Overall Study|Malignancy including squamous cell skin|1
1723976|NCT01059773|6012781|P1|Overall Study|Malignancy including squamous cell skin|0
1723977|NCT01059773|6012780|P2|Overall Study|Death|1
1723978|NCT01059773|6012781|P1|Overall Study|Death|0
1723979|NCT01059773|6012780|P2|Overall Study|Lack of Efficacy|3
1723980|NCT01059773|6012781|P1|Overall Study|Lack of Efficacy|3
1723981|NCT01059773|6012780|P2|Overall Study|Physician Decision|4
1723982|NCT01059773|6012781|P1|Overall Study|Physician Decision|5
1723983|NCT01059773|6012780|P2|Overall Study|Protocol Violation|2
1723984|NCT01059773|6012781|P1|Overall Study|Protocol Violation|6
1723985|NCT01059773|6012780|P2|Overall Study|Pregnancy|1
1723986|NCT01059773|6012781|P1|Overall Study|Pregnancy|1
1723987|NCT01059773|6012780|P2|Overall Study|Lost to Follow-up|1
1723988|NCT01059773|6012781|P1|Overall Study|Lost to Follow-up|1
1723989|NCT01059773|6012780|P2|Overall Study|Withdrawal by Subject|5
1723990|NCT01059773|6012781|P1|Overall Study|Withdrawal by Subject|1
1723991|NCT01059773|6012780|P2|Overall Study|Adverse Event|2
1723992|NCT01059773|6012781|P1|Overall Study|Adverse Event|2
1723993|NCT01059643|6012920|P1|Overall Study|Physician Decision|1
1723994|NCT01059643|6012920|P1|Overall Study|Withdrawal by Subject|2
1723995|NCT01059643|6012920|P1|Overall Study|Adverse Event|3
1723996|NCT01059630|6012935|P2|Overall Study|Withdrawal by Subject|14
1723997|NCT01059630|6012936|P1|Overall Study|Withdrawal by Subject|21
1723998|NCT01059630|6012935|P2|Overall Study|Physician Decision|4
1723999|NCT01059630|6012936|P1|Overall Study|Physician Decision|2
1724000|NCT01059630|6012935|P2|Overall Study|Lost to Follow-up|1
1724001|NCT01059630|6012936|P1|Overall Study|Lost to Follow-up|4
1724002|NCT01059630|6012935|P2|Overall Study|Death|84
1724003|NCT01059630|6012936|P1|Overall Study|Death|100
1724004|NCT01059617|6013010|P4|Overall Study|Other|6
1724005|NCT01059617|6013011|P3|Overall Study|Other|8
1724006|NCT01059617|6013012|P2|Overall Study|Other|1
1724007|NCT01059617|6013013|P1|Overall Study|Other|7
1724008|NCT01059565|6013183|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
1724009|NCT01059565|6013184|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
1724010|NCT01059565|6013183|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
1724011|NCT01059565|6013184|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
1724012|NCT01059565|6013183|P2|24-Week Open-Label Phase|Subject noncompliance|0
1724013|NCT01059565|6013184|P1|24-Week Open-Label Phase|Subject noncompliance|1
1724014|NCT01059565|6013183|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
1724015|NCT01059565|6013184|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
1724016|NCT01059565|6013183|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
1724017|NCT01059565|6013184|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
1724018|NCT01059565|6013183|P2|24-Week Open-Label Phase|Adverse Event|0
1724019|NCT01059565|6013184|P1|24-Week Open-Label Phase|Adverse Event|2
1724020|NCT01059565|6013183|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
1724021|NCT01059565|6013184|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
1724022|NCT01059565|6013183|P2|24-Week Randomized Phase|Lost to Follow-up|1
1724023|NCT01059565|6013184|P1|24-Week Randomized Phase|Lost to Follow-up|0
1724024|NCT01059565|6013183|P2|24-Week Randomized Phase|Withdrawal by Subject|1
1724025|NCT01059565|6013184|P1|24-Week Randomized Phase|Withdrawal by Subject|3
1724026|NCT01059565|6013183|P2|24-Week Randomized Phase|Adverse Event|0
1724027|NCT01059565|6013184|P1|24-Week Randomized Phase|Adverse Event|5
1724028|NCT01059565|6013183|P2|24-Week Randomized Phase|Randomized but not treated|0
1724029|NCT01059565|6013184|P1|24-Week Randomized Phase|Randomized but not treated|1
1724030|NCT01059539|6013218|P1|Overall Study|Reason Not Specified|2
1724031|NCT01059539|6013218|P1|Overall Study|Lost to Follow-up|42
1724032|NCT01059539|6013218|P1|Overall Study|Withdrawal of Consent|80
1724033|NCT01059539|6013218|P1|Overall Study|Protocol Violation|55
1724034|NCT01059539|6013218|P1|Overall Study|Insufficient Therapeutic Response|26
1724035|NCT01059539|6013218|P1|Overall Study|Adverse Event|66
1724036|NCT01059526|6013225|P2|Overall Study|Patient found to be dermatographic|0
1724037|NCT01059526|6013226|P1|Overall Study|Patient found to be dermatographic|1
1724038|NCT01059526|6013225|P2|Overall Study|Lost to Follow-up|1
1724039|NCT01059526|6013226|P1|Overall Study|Lost to Follow-up|4
1724040|NCT01059526|6013225|P2|Overall Study|Withdrawal by Subject|1
1724041|NCT01059526|6013226|P1|Overall Study|Withdrawal by Subject|3
1724042|NCT01059526|6013225|P2|Overall Study|Protocol Violation|1
1724043|NCT01059526|6013226|P1|Overall Study|Protocol Violation|0
1724044|NCT01059526|6013225|P2|Overall Study|Adverse Event|2
1724045|NCT01059526|6013226|P1|Overall Study|Adverse Event|2
1724046|NCT01059526|6013225|P2|Overall Study|Patient enrolled but not treated|17
1724047|NCT01059526|6013226|P1|Overall Study|Patient enrolled but not treated|20
1724048|NCT01059344|6013572|P2|Overall Study|Other|6
1724049|NCT01059344|6013573|P1|Overall Study|Other|3
1724050|NCT01059344|6013572|P2|Overall Study|Lost to Follow-up|1
1724051|NCT01059344|6013573|P1|Overall Study|Lost to Follow-up|1
1724052|NCT01059344|6013572|P2|Overall Study|Withdrawal by Subject|9
1724053|NCT01059344|6013573|P1|Overall Study|Withdrawal by Subject|6
1724054|NCT01059344|6013572|P2|Overall Study|Adverse Event|30
1724055|NCT01059344|6013573|P1|Overall Study|Adverse Event|12
1724056|NCT01059175|6013597|P2|Overall Study|Lost to Follow-up|1
1724057|NCT01059175|6013598|P1|Overall Study|Lost to Follow-up|0
1724058|NCT01059175|6013597|P2|Overall Study|Adverse Event|2
1724059|NCT01059175|6013598|P1|Overall Study|Adverse Event|4
1724060|NCT01059175|6013597|P2|Overall Study|Death|17
1724061|NCT01059175|6013598|P1|Overall Study|Death|17
1724062|NCT01059071|6013620|P4|Overall Study|Physician Decision|1
1724063|NCT01059071|6013621|P3|Overall Study|Physician Decision|0
1724064|NCT01059071|6013622|P2|Overall Study|Physician Decision|0
1724065|NCT01059071|6013623|P1|Overall Study|Physician Decision|0
1724066|NCT01059071|6013620|P4|Overall Study|Withdrawal by Subject|2
1724067|NCT01059071|6013621|P3|Overall Study|Withdrawal by Subject|0
1724068|NCT01059071|6013622|P2|Overall Study|Withdrawal by Subject|0
1724069|NCT01059071|6013623|P1|Overall Study|Withdrawal by Subject|1
1724070|NCT01059071|6013620|P4|Overall Study|Lack of Efficacy|3
1724071|NCT01059071|6013621|P3|Overall Study|Lack of Efficacy|2
1724072|NCT01059071|6013622|P2|Overall Study|Lack of Efficacy|4
1724073|NCT01059071|6013623|P1|Overall Study|Lack of Efficacy|1
1724074|NCT01058863|6013650|P1|Overall Study|Randomized in error|1
1724075|NCT01058863|6013650|P1|Overall Study|Sponsor requested withdrawal|1
1724076|NCT01058863|6013650|P1|Overall Study|Withdrawal by Subject|1
1724077|NCT01058863|6013650|P1|Overall Study|Lost to Follow-up|1
1724078|NCT01058668|6013671|P3|Double-blind Treatment Phase|Other Unspecified|0
1724079|NCT01058668|6013672|P2|Double-blind Treatment Phase|Other Unspecified|1
1724080|NCT01058668|6013673|P1|Double-blind Treatment Phase|Other Unspecified|1
1724081|NCT01058668|6013671|P3|Double-blind Treatment Phase|Lost to Follow-up|1
1724082|NCT01058668|6013672|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1724083|NCT01058668|6013673|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1724084|NCT01058668|6013671|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
1724085|NCT01058668|6013672|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
1724086|NCT01058668|6013673|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
1724087|NCT01058668|6013671|P3|Double-blind Treatment Phase|Protocol Violation|2
1724088|NCT01058668|6013672|P2|Double-blind Treatment Phase|Protocol Violation|1
1724089|NCT01058668|6013673|P1|Double-blind Treatment Phase|Protocol Violation|1
1724090|NCT01058668|6013671|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
1724091|NCT01058668|6013672|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
1724092|NCT01058668|6013673|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
1724093|NCT01058668|6013671|P3|Double-blind Treatment Phase|Adverse Event|25
1724094|NCT01058668|6013672|P2|Double-blind Treatment Phase|Adverse Event|15
1724095|NCT01058668|6013673|P1|Double-blind Treatment Phase|Adverse Event|8
1724096|NCT01058655|6013688|P4|Overall Study|Other|4
1724097|NCT01058655|6013689|P3|Overall Study|Other|0
1724098|NCT01058655|6013690|P2|Overall Study|Other|0
1724099|NCT01058655|6013691|P1|Overall Study|Other|0
1724100|NCT01058655|6013688|P4|Overall Study|Disease Progression|24
1724101|NCT01058655|6013689|P3|Overall Study|Disease Progression|4
1724102|NCT01058655|6013690|P2|Overall Study|Disease Progression|2
1724103|NCT01058655|6013691|P1|Overall Study|Disease Progression|1
1724104|NCT01058655|6013688|P4|Overall Study|Death|0
1724105|NCT01058655|6013689|P3|Overall Study|Death|1
1724106|NCT01058655|6013690|P2|Overall Study|Death|1
1724107|NCT01058655|6013691|P1|Overall Study|Death|0
1724108|NCT01058655|6013688|P4|Overall Study|Clinical Progression (non-RECIST)|7
1724109|NCT01058655|6013689|P3|Overall Study|Clinical Progression (non-RECIST)|0
1724110|NCT01058655|6013690|P2|Overall Study|Clinical Progression (non-RECIST)|0
1724111|NCT01058655|6013691|P1|Overall Study|Clinical Progression (non-RECIST)|1
1724112|NCT01058655|6013688|P4|Overall Study|Symptomatic Deterioration|1
1724113|NCT01058655|6013689|P3|Overall Study|Symptomatic Deterioration|0
1724114|NCT01058655|6013690|P2|Overall Study|Symptomatic Deterioration|0
1724115|NCT01058655|6013691|P1|Overall Study|Symptomatic Deterioration|0
1724116|NCT01058655|6013688|P4|Overall Study|Prolonged Treatment Delay|2
1724117|NCT01058655|6013689|P3|Overall Study|Prolonged Treatment Delay|0
1724118|NCT01058655|6013690|P2|Overall Study|Prolonged Treatment Delay|0
1724119|NCT01058655|6013691|P1|Overall Study|Prolonged Treatment Delay|0
1724120|NCT01058655|6013688|P4|Overall Study|Withdrawal by Subject|4
1724121|NCT01058655|6013689|P3|Overall Study|Withdrawal by Subject|3
1724122|NCT01058655|6013690|P2|Overall Study|Withdrawal by Subject|0
1724123|NCT01058655|6013691|P1|Overall Study|Withdrawal by Subject|1
1724124|NCT01058642|6013709|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
1724125|NCT01058642|6013710|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
1724126|NCT01058642|6013711|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
1724127|NCT01058642|6013712|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
1724128|NCT01058642|6013709|P4|Treatment Period 1|Protocol Violation|1
1724129|NCT01058642|6013710|P3|Treatment Period 1|Protocol Violation|0
1724130|NCT01058642|6013711|P2|Treatment Period 1|Protocol Violation|0
1724131|NCT01058642|6013712|P1|Treatment Period 1|Protocol Violation|0
1724132|NCT01058642|6013709|P4|Treatment Period 1|Lack of Efficacy|1
1724133|NCT01058642|6013710|P3|Treatment Period 1|Lack of Efficacy|0
1724134|NCT01058642|6013711|P2|Treatment Period 1|Lack of Efficacy|0
1724135|NCT01058642|6013712|P1|Treatment Period 1|Lack of Efficacy|0
1724136|NCT01058642|6013709|P4|Treatment Period 1|Withdrawal by Subject|0
1724137|NCT01058642|6013710|P3|Treatment Period 1|Withdrawal by Subject|0
1724138|NCT01058642|6013711|P2|Treatment Period 1|Withdrawal by Subject|0
1724139|NCT01058642|6013712|P1|Treatment Period 1|Withdrawal by Subject|1
1724140|NCT01058642|6013709|P4|Treatment Period 1|Physician Decision|0
1724141|NCT01058642|6013710|P3|Treatment Period 1|Physician Decision|1
1724142|NCT01058642|6013711|P2|Treatment Period 1|Physician Decision|0
1724143|NCT01058642|6013712|P1|Treatment Period 1|Physician Decision|0
1724144|NCT01058642|6013709|P4|Treatment Period 1|Adverse Event|0
1724145|NCT01058642|6013710|P3|Treatment Period 1|Adverse Event|1
1724146|NCT01058642|6013711|P2|Treatment Period 1|Adverse Event|1
1724147|NCT01058642|6013712|P1|Treatment Period 1|Adverse Event|0
1724148|NCT01058421|6013722|P2|6 Month Outcomes|Remained in Other Facility|3
1724149|NCT01058421|6013723|P1|6 Month Outcomes|Remained in Other Facility|1
1724150|NCT01058421|6013722|P2|6 Month Outcomes|Lost to Follow-up|21
1724151|NCT01058421|6013723|P1|6 Month Outcomes|Lost to Follow-up|16
1724152|NCT01058421|6013722|P2|6 Month Outcomes|Death|2
1724153|NCT01058421|6013723|P1|6 Month Outcomes|Death|2
1724154|NCT01058421|6013722|P2|3 Month Outcomes|Remained in Other Facility|8
1724155|NCT01058421|6013723|P1|3 Month Outcomes|Remained in Other Facility|5
1724156|NCT01058421|6013722|P2|3 Month Outcomes|Remained in Hospital|2
1724157|NCT01058421|6013723|P1|3 Month Outcomes|Remained in Hospital|0
1724158|NCT01058421|6013722|P2|3 Month Outcomes|Lost to Follow-up|11
1724159|NCT01058421|6013723|P1|3 Month Outcomes|Lost to Follow-up|12
1724160|NCT01058421|6013722|P2|3 Month Outcomes|Death|5
1724161|NCT01058421|6013723|P1|3 Month Outcomes|Death|3
1724162|NCT01058421|6013722|P2|1 Month Outcomes|Remained in Other Facility|17
1724163|NCT01058421|6013723|P1|1 Month Outcomes|Remained in Other Facility|16
1724164|NCT01058421|6013722|P2|1 Month Outcomes|Remained in Hospital|12
1724165|NCT01058421|6013723|P1|1 Month Outcomes|Remained in Hospital|5
1724166|NCT01058421|6013722|P2|1 Month Outcomes|Lost to Follow-up|7
1724167|NCT01058421|6013723|P1|1 Month Outcomes|Lost to Follow-up|8
1724168|NCT01058421|6013722|P2|1 Month Outcomes|Death|6
1724169|NCT01058421|6013723|P1|1 Month Outcomes|Death|10
1724170|NCT01058395|6013747|P2|Overall Study|Lost to Follow-up|0
1724171|NCT01058395|6013748|P1|Overall Study|Lost to Follow-up|1
1724172|NCT01058395|6013747|P2|Overall Study|Death|1
1724173|NCT01058395|6013748|P1|Overall Study|Death|2
1724174|NCT01058356|6013757|P1|Overall Study|Lost to Follow-up|4
1724175|NCT01058356|6013757|P1|Overall Study|Withdrawal by Subject|21
1724176|NCT01058356|6013757|P1|Overall Study|Administration of contraindicated drugs|12
1724177|NCT01058356|6013757|P1|Overall Study|Adverse Event|5
1724178|NCT01058304|6013764|P2|Overall Study|Developed exclusion criterion|12
1724179|NCT01058304|6013765|P1|Overall Study|Developed exclusion criterion|6
1724180|NCT01058304|6013764|P2|Overall Study|Lost to Follow-up|16
1724181|NCT01058304|6013765|P1|Overall Study|Lost to Follow-up|13
1724182|NCT01058304|6013764|P2|Overall Study|Withdrawal by Subject|5
1724183|NCT01058304|6013765|P1|Overall Study|Withdrawal by Subject|8
1724184|NCT01058265|6013775|P2|Overall Study|Lost to Follow-up|12
1724185|NCT01058265|6013776|P1|Overall Study|Lost to Follow-up|11
1724186|NCT01058096|6013795|P2|Double-blind Treatment Phase|Other Unspecified|0
1724187|NCT01058096|6013796|P1|Double-blind Treatment Phase|Other Unspecified|2
1724188|NCT01058096|6013795|P2|Double-blind Treatment Phase|Lost to Follow-up|1
1724189|NCT01058096|6013796|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1724190|NCT01058096|6013795|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
1724191|NCT01058096|6013796|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
1724192|NCT01058096|6013795|P2|Double-blind Treatment Phase|Protocol Violation|1
1724193|NCT01058096|6013796|P1|Double-blind Treatment Phase|Protocol Violation|2
1724194|NCT01058096|6013795|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
1724195|NCT01058096|6013796|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
1724196|NCT01058096|6013795|P2|Double-blind Treatment Phase|Adverse Event|15
1724197|NCT01058096|6013796|P1|Double-blind Treatment Phase|Adverse Event|11
1724198|NCT01058005|6013812|P3|Overall Study|Reason Missing|1
1724199|NCT01058005|6013813|P2|Overall Study|Reason Missing|3
1724200|NCT01058005|6013814|P1|Overall Study|Reason Missing|5
1724201|NCT01058005|6013812|P3|Overall Study|Withdrawn Due to Study Termination|7
1724202|NCT01058005|6013813|P2|Overall Study|Withdrawn Due to Study Termination|13
1724203|NCT01058005|6013814|P1|Overall Study|Withdrawn Due to Study Termination|27
1724204|NCT01058005|6013812|P3|Overall Study|Withdrawal by Subject|11
1724205|NCT01058005|6013813|P2|Overall Study|Withdrawal by Subject|5
1724206|NCT01058005|6013814|P1|Overall Study|Withdrawal by Subject|4
1724207|NCT01058005|6013812|P3|Overall Study|Physician Decision|0
1724208|NCT01058005|6013813|P2|Overall Study|Physician Decision|2
1724209|NCT01058005|6013814|P1|Overall Study|Physician Decision|2
1724210|NCT01058005|6013812|P3|Overall Study|Adverse Event|1
1724211|NCT01058005|6013813|P2|Overall Study|Adverse Event|2
1724212|NCT01058005|6013814|P1|Overall Study|Adverse Event|0
1724213|NCT01057862|6013849|P2|Overall Study|Withdrawal by Subject|2
1724214|NCT01057862|6013850|P1|Overall Study|Withdrawal by Subject|1
1724215|NCT01057810|6013860|P2|Overall Study|Other|14
1724216|NCT01057810|6013861|P1|Overall Study|Other|7
1724217|NCT01057810|6013860|P2|Overall Study|No longer met study criteria|1
1724218|NCT01057810|6013861|P1|Overall Study|No longer met study criteria|0
1724219|NCT01057810|6013860|P2|Overall Study|Poor/non-compliance|1
1724220|NCT01057810|6013861|P1|Overall Study|Poor/non-compliance|0
1724221|NCT01057810|6013860|P2|Overall Study|Maximum clinical benefit|5
1724222|NCT01057810|6013861|P1|Overall Study|Maximum clinical benefit|5
1724223|NCT01057810|6013860|P2|Overall Study|Death|12
1724224|NCT01057810|6013861|P1|Overall Study|Death|2
1724225|NCT01057810|6013860|P2|Overall Study|Withdrawal by Subject|25
1724226|NCT01057810|6013861|P1|Overall Study|Withdrawal by Subject|10
1724227|NCT01057810|6013860|P2|Overall Study|Adverse event unrelated to study drug|29
1724228|NCT01057810|6013861|P1|Overall Study|Adverse event unrelated to study drug|13
1724229|NCT01057810|6013860|P2|Overall Study|Study drug toxicity|114
1724230|NCT01057810|6013861|P1|Overall Study|Study drug toxicity|5
1724231|NCT01057810|6013860|P2|Overall Study|Disease progression|197
1724232|NCT01057810|6013861|P1|Overall Study|Disease progression|156
1724233|NCT01057693|6013877|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
1724234|NCT01057693|6013878|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
1724235|NCT01057693|6013879|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
1724236|NCT01057693|6013877|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
1724237|NCT01057693|6013878|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
1724238|NCT01057693|6013879|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
1724239|NCT01057693|6013877|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
1724240|NCT01057693|6013878|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
1724241|NCT01057693|6013879|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
1724242|NCT01057693|6013877|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
1724243|NCT01057693|6013878|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
1724244|NCT01057693|6013879|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
1724245|NCT01057693|6013877|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
1724246|NCT01057693|6013878|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
1724247|NCT01057693|6013879|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
1724248|NCT01057693|6013877|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
1724249|NCT01057693|6013878|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
1724250|NCT01057693|6013879|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
1724251|NCT01057693|6013877|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
1724252|NCT01057693|6013878|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
1724253|NCT01057693|6013879|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
1724254|NCT01057693|6013877|P3|Between Single-Blind and Double-Blind|Other|0
1724255|NCT01057693|6013878|P2|Between Single-Blind and Double-Blind|Other|0
1724256|NCT01057693|6013879|P1|Between Single-Blind and Double-Blind|Other|6
1724257|NCT01057693|6013877|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
1724258|NCT01057693|6013878|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
1724259|NCT01057693|6013879|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
1724260|NCT01057693|6013877|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
1724261|NCT01057693|6013878|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
1724262|NCT01057693|6013879|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
1724263|NCT01057693|6013877|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
1724264|NCT01057693|6013878|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
1724265|NCT01057693|6013879|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
1724266|NCT01057693|6013877|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
1724267|NCT01057693|6013878|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
1724268|NCT01057693|6013879|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
1724269|NCT01057693|6013877|P3|Between Single-Blind and Double-Blind|Adverse Event|0
1724270|NCT01057693|6013878|P2|Between Single-Blind and Double-Blind|Adverse Event|0
1724271|NCT01057693|6013879|P1|Between Single-Blind and Double-Blind|Adverse Event|5
1724272|NCT01057693|6013877|P3|Single-Blind Phase (Up to Week 6)|Other|0
1724273|NCT01057693|6013878|P2|Single-Blind Phase (Up to Week 6)|Other|0
1724274|NCT01057693|6013879|P1|Single-Blind Phase (Up to Week 6)|Other|2
1724275|NCT01057693|6013877|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
1724276|NCT01057693|6013878|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
1724277|NCT01057693|6013879|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
1724278|NCT01057693|6013877|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
1724279|NCT01057693|6013878|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
1724280|NCT01057693|6013879|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
1724281|NCT01057693|6013877|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
1724282|NCT01057693|6013878|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
1724283|NCT01057693|6013879|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
1724284|NCT01057693|6013877|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
1724285|NCT01057693|6013878|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
1724286|NCT01057693|6013879|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
1724287|NCT01057693|6013877|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
1724288|NCT01057693|6013878|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
1724289|NCT01057693|6013879|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
1724290|NCT01057589|6013925|P1|Overall Study|Lost to Follow-up|1
1724291|NCT01057589|6013925|P1|Overall Study|Death|8
1724292|NCT01057589|6013925|P1|Overall Study|Sponsor Decision|1
1724293|NCT01057589|6013925|P1|Overall Study|Withdrawal by Subject|3
1724294|NCT01057589|6013925|P1|Overall Study|Physician Decision|8
1724295|NCT01057589|6013925|P1|Overall Study|Adverse Event|10
1724296|NCT01057589|6013925|P1|Overall Study|Disease Progression|35
1724297|NCT01057433|6013934|P1|Overall Study|Adverse Event|1
1724298|NCT01057394|6013938|P2|Overall Study|Not eligible|2
1724299|NCT01057394|6013939|P1|Overall Study|Not eligible|0
1724300|NCT01057251|6013949|P2|Overall Study|Other Reason|1
1724301|NCT01057251|6013950|P1|Overall Study|Other Reason|1
1724302|NCT01057251|6013949|P2|Overall Study|Lost to Follow-up|6
1724303|NCT01057251|6013950|P1|Overall Study|Lost to Follow-up|7
1724304|NCT01057251|6013949|P2|Overall Study|Withdrawal by Subject|5
1724305|NCT01057251|6013950|P1|Overall Study|Withdrawal by Subject|4
1724306|NCT01057251|6013949|P2|Overall Study|Protocol Violation|2
1724307|NCT01057251|6013950|P1|Overall Study|Protocol Violation|6
1724308|NCT01057251|6013949|P2|Overall Study|Lack of Efficacy|11
1724309|NCT01057251|6013950|P1|Overall Study|Lack of Efficacy|2
1724310|NCT01057251|6013949|P2|Overall Study|Adverse Event|2
1724311|NCT01057251|6013950|P1|Overall Study|Adverse Event|4
1724312|NCT01057251|6013949|P2|Overall Study|Did not meet InclusionExclusion criteria|2
1724313|NCT01057251|6013950|P1|Overall Study|Did not meet InclusionExclusion criteria|4
1724314|NCT01056822|6014028|P2|Overall Study|Lost to Follow-up|0
1724315|NCT01056822|6014029|P1|Overall Study|Lost to Follow-up|1
1724316|NCT01056822|6014028|P2|Overall Study|Withdrawal by Subject|1
1724317|NCT01056822|6014029|P1|Overall Study|Withdrawal by Subject|1
1724318|NCT01056822|6014028|P2|Overall Study|Protocol Violation|5
1724319|NCT01056822|6014029|P1|Overall Study|Protocol Violation|6
1724320|NCT01056822|6014028|P2|Overall Study|Adverse Event|1
1724321|NCT01056822|6014029|P1|Overall Study|Adverse Event|0
1724322|NCT01056718|6014078|P1|Overall Study|Ischemia on baseline stress test|1
1724323|NCT01056718|6014078|P1|Overall Study|Withdrawal by Subject|2
1724324|NCT01056653|6014111|P3|Overall Study|Lost to Follow-up|2
1724325|NCT01056653|6014112|P2|Overall Study|Lost to Follow-up|0
1724326|NCT01056653|6014113|P1|Overall Study|Lost to Follow-up|0
1724327|NCT01056640|6014129|P2|Overall Study|Death|4
1724328|NCT01056640|6014130|P1|Overall Study|Death|15
1724329|NCT01056640|6014129|P2|Overall Study|Withdrawal by Subject|8
1724330|NCT01056640|6014130|P1|Overall Study|Withdrawal by Subject|11
1724331|NCT01056523|6014142|P7|Overall Study|Death|1
1724332|NCT01056523|6014143|P6|Overall Study|Death|0
1724333|NCT01056523|6014144|P5|Overall Study|Death|0
1724334|NCT01056523|6014145|P4|Overall Study|Death|3
1724335|NCT01056523|6014146|P3|Overall Study|Death|2
1724336|NCT01056523|6014147|P2|Overall Study|Death|0
1724337|NCT01056523|6014148|P1|Overall Study|Death|1
1724338|NCT01056510|6014158|P2|Overall Study|Missing|1
1724339|NCT01056510|6014159|P1|Overall Study|Missing|0
1724340|NCT01056510|6014158|P2|Overall Study|Other|12
1724341|NCT01056510|6014159|P1|Overall Study|Other|10
1724342|NCT01056510|6014158|P2|Overall Study|Lost to Follow-up|6
1724343|NCT01056510|6014159|P1|Overall Study|Lost to Follow-up|5
1724344|NCT01056510|6014158|P2|Overall Study|Physician Decision|5
1724345|NCT01056510|6014159|P1|Overall Study|Physician Decision|4
1724346|NCT01056510|6014158|P2|Overall Study|Noncompliance|3
1724347|NCT01056510|6014159|P1|Overall Study|Noncompliance|1
1724348|NCT01056510|6014158|P2|Overall Study|Death|34
1724349|NCT01056510|6014159|P1|Overall Study|Death|29
1724350|NCT01056510|6014158|P2|Overall Study|Withdrawal by Subject|2
1724351|NCT01056510|6014159|P1|Overall Study|Withdrawal by Subject|4
1724352|NCT01056510|6014158|P2|Overall Study|Dropout Before Start of Treatment|1
1724353|NCT01056510|6014159|P1|Overall Study|Dropout Before Start of Treatment|1
1724354|NCT01056484|6014205|P2|Follow up - Non-randomized|Withdrawal by Subject|2
1724355|NCT01056484|6014206|P1|Follow up - Non-randomized|Withdrawal by Subject|0
1724356|NCT01056484|6014205|P2|Randomized Controlled Trial|Physician Decision|0
1724357|NCT01056484|6014206|P1|Randomized Controlled Trial|Physician Decision|1
1724358|NCT01056484|6014205|P2|Randomized Controlled Trial|Withdrawal by Subject|1
1724359|NCT01056484|6014206|P1|Randomized Controlled Trial|Withdrawal by Subject|6
1724360|NCT01056380|6014222|P2|Overall Study|Lost to Follow-up|3
1724361|NCT01056380|6014223|P1|Overall Study|Lost to Follow-up|2
1724362|NCT01056341|6014250|P5|Overall Study|Other reasons|5
1724363|NCT01056341|6014251|P4|Overall Study|Other reasons|9
1724364|NCT01056341|6014252|P3|Overall Study|Other reasons|8
1724365|NCT01056341|6014253|P2|Overall Study|Other reasons|4
1724366|NCT01056341|6014254|P1|Overall Study|Other reasons|4
1724367|NCT01056341|6014250|P5|Overall Study|Lack of Efficacy|9
1724368|NCT01056341|6014251|P4|Overall Study|Lack of Efficacy|25
1724369|NCT01056341|6014252|P3|Overall Study|Lack of Efficacy|7
1724370|NCT01056341|6014253|P2|Overall Study|Lack of Efficacy|30
1724371|NCT01056341|6014254|P1|Overall Study|Lack of Efficacy|32
1724372|NCT01056341|6014250|P5|Overall Study|Treatment Intolerance|0
1724373|NCT01056341|6014251|P4|Overall Study|Treatment Intolerance|2
1724374|NCT01056341|6014252|P3|Overall Study|Treatment Intolerance|0
1724375|NCT01056341|6014253|P2|Overall Study|Treatment Intolerance|2
1724376|NCT01056341|6014254|P1|Overall Study|Treatment Intolerance|0
1724377|NCT01056289|6014327|P4|Double-blind Phase|Physician Decision|0
1724378|NCT01056289|6014328|P3|Double-blind Phase|Physician Decision|1
1724379|NCT01056289|6014329|P2|Double-blind Phase|Physician Decision|0
1724380|NCT01056289|6014330|P1|Double-blind Phase|Physician Decision|0
1724381|NCT01056289|6014327|P4|Double-blind Phase|Discontinuation symptom|2
1724382|NCT01056289|6014328|P3|Double-blind Phase|Discontinuation symptom|2
1724383|NCT01056289|6014329|P2|Double-blind Phase|Discontinuation symptom|1
1724384|NCT01056289|6014330|P1|Double-blind Phase|Discontinuation symptom|0
1724385|NCT01056289|6014327|P4|Double-blind Phase|Withdrawal by Subject|2
1724386|NCT01056289|6014328|P3|Double-blind Phase|Withdrawal by Subject|4
1724387|NCT01056289|6014329|P2|Double-blind Phase|Withdrawal by Subject|0
1724388|NCT01056289|6014330|P1|Double-blind Phase|Withdrawal by Subject|0
1724389|NCT01056289|6014327|P4|Double-blind Phase|Protocol Violation|1
1724390|NCT01056289|6014328|P3|Double-blind Phase|Protocol Violation|1
1724391|NCT01056289|6014329|P2|Double-blind Phase|Protocol Violation|0
1724392|NCT01056289|6014330|P1|Double-blind Phase|Protocol Violation|0
1724393|NCT01056289|6014327|P4|Double-blind Phase|Other|2
1724394|NCT01056289|6014328|P3|Double-blind Phase|Other|1
1724395|NCT01056289|6014329|P2|Double-blind Phase|Other|0
1724396|NCT01056289|6014330|P1|Double-blind Phase|Other|0
1724397|NCT01056289|6014327|P4|Double-blind Phase|Lost to Follow-up|2
1724398|NCT01056289|6014328|P3|Double-blind Phase|Lost to Follow-up|2
1724399|NCT01056289|6014329|P2|Double-blind Phase|Lost to Follow-up|2
1724400|NCT01056289|6014330|P1|Double-blind Phase|Lost to Follow-up|0
1724401|NCT01056289|6014327|P4|Double-blind Phase|Adverse Event|1
1724402|NCT01056289|6014328|P3|Double-blind Phase|Adverse Event|2
1724403|NCT01056289|6014329|P2|Double-blind Phase|Adverse Event|1
1724404|NCT01056289|6014330|P1|Double-blind Phase|Adverse Event|0
1724405|NCT01056289|6014327|P4|Open-label Phase|Not randomized to Double-blind phase|0
1724406|NCT01056289|6014328|P3|Open-label Phase|Not randomized to Double-blind phase|0
1724407|NCT01056289|6014329|P2|Open-label Phase|Not randomized to Double-blind phase|0
1724408|NCT01056289|6014330|P1|Open-label Phase|Not randomized to Double-blind phase|1
1724409|NCT01056289|6014327|P4|Open-label Phase|Lack of Efficacy|0
1724410|NCT01056289|6014328|P3|Open-label Phase|Lack of Efficacy|0
1724411|NCT01056289|6014329|P2|Open-label Phase|Lack of Efficacy|0
1724412|NCT01056289|6014330|P1|Open-label Phase|Lack of Efficacy|18
1724413|NCT01056289|6014327|P4|Open-label Phase|Withdrawal by Subject|0
1724414|NCT01056289|6014328|P3|Open-label Phase|Withdrawal by Subject|0
1724415|NCT01056289|6014329|P2|Open-label Phase|Withdrawal by Subject|0
1724416|NCT01056289|6014330|P1|Open-label Phase|Withdrawal by Subject|26
1724417|NCT01056289|6014327|P4|Open-label Phase|Protocol Violation|0
1724418|NCT01056289|6014328|P3|Open-label Phase|Protocol Violation|0
1724419|NCT01056289|6014329|P2|Open-label Phase|Protocol Violation|0
1724420|NCT01056289|6014330|P1|Open-label Phase|Protocol Violation|6
1724421|NCT01056289|6014327|P4|Open-label Phase|Other|0
1724422|NCT01056289|6014328|P3|Open-label Phase|Other|0
1724423|NCT01056289|6014329|P2|Open-label Phase|Other|0
1724424|NCT01056289|6014330|P1|Open-label Phase|Other|9
1724425|NCT01056289|6014327|P4|Open-label Phase|Lost to Follow-up|0
1724426|NCT01056289|6014328|P3|Open-label Phase|Lost to Follow-up|0
1724427|NCT01056289|6014329|P2|Open-label Phase|Lost to Follow-up|0
1724428|NCT01056289|6014330|P1|Open-label Phase|Lost to Follow-up|30
1724429|NCT01056289|6014327|P4|Open-label Phase|Adverse Event|0
1724430|NCT01056289|6014328|P3|Open-label Phase|Adverse Event|0
1724431|NCT01056289|6014329|P2|Open-label Phase|Adverse Event|0
1724432|NCT01056289|6014330|P1|Open-label Phase|Adverse Event|29
1724433|NCT01056276|6014347|P2|Maintenance Therapy|Continuing maintenance therapy|14
1724434|NCT01056276|6014348|P1|Maintenance Therapy|Continuing maintenance therapy|0
1724435|NCT01056276|6014347|P2|Maintenance Therapy|Intercurrent Illness|1
1724436|NCT01056276|6014348|P1|Maintenance Therapy|Intercurrent Illness|0
1724437|NCT01056276|6014347|P2|Maintenance Therapy|Withdrawal by Subject|1
1724438|NCT01056276|6014348|P1|Maintenance Therapy|Withdrawal by Subject|0
1724439|NCT01056276|6014347|P2|Maintenance Therapy|Physician Decision|1
1724440|NCT01056276|6014348|P1|Maintenance Therapy|Physician Decision|0
1724441|NCT01056276|6014347|P2|Maintenance Therapy|Progressive Disease|9
1724442|NCT01056276|6014348|P1|Maintenance Therapy|Progressive Disease|0
1724443|NCT01056276|6014347|P2|Maintenance Therapy|Toxicity|2
1724444|NCT01056276|6014348|P1|Maintenance Therapy|Toxicity|0
1724445|NCT01056276|6014347|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
1724446|NCT01056276|6014348|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
1724447|NCT01056276|6014347|P2|Treatment Period-Cycles 1-8|Death|1
1724448|NCT01056276|6014348|P1|Treatment Period-Cycles 1-8|Death|3
1724449|NCT01056276|6014347|P2|Treatment Period-Cycles 1-8|Physician Decision|0
1724450|NCT01056276|6014348|P1|Treatment Period-Cycles 1-8|Physician Decision|3
1724451|NCT01056276|6014347|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
1724452|NCT01056276|6014348|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
1724453|NCT01056276|6014347|P2|Treatment Period-Cycles 1-8|Disease Progression|2
1724454|NCT01056276|6014348|P1|Treatment Period-Cycles 1-8|Disease Progression|2
1724455|NCT01056276|6014347|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
1724456|NCT01056276|6014348|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
1724457|NCT01056276|6014347|P2|Treatment Period-Cycles 1-8|Toxicity|1
1724458|NCT01056276|6014348|P1|Treatment Period-Cycles 1-8|Toxicity|2
1724459|NCT01056263|6014362|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
1724460|NCT01056263|6014362|P1|Overall Study|Objective progression or relapse|1
1724461|NCT01056263|6014362|P1|Overall Study|Neoplasm progression|1
1724462|NCT01056263|6014362|P1|Overall Study|Progressive disease|2
1724463|NCT01056263|6014362|P1|Overall Study|Lack of Efficacy|29
1724464|NCT01056263|6014362|P1|Overall Study|Withdrawal by Subject|1
1724465|NCT01056263|6014362|P1|Overall Study|Death|1
1724466|NCT01056263|6014362|P1|Overall Study|Adverse Event|12
1724467|NCT01056107|6014385|P4|Overall Study|Withdrawal by Subject|0
1724468|NCT01056107|6014386|P3|Overall Study|Withdrawal by Subject|3
1724469|NCT01056107|6014387|P2|Overall Study|Withdrawal by Subject|1
1724470|NCT01056107|6014388|P1|Overall Study|Withdrawal by Subject|0
1724471|NCT01055886|6014445|P2|Overall Study|Withdrawal by PI|1
1724472|NCT01055886|6014446|P1|Overall Study|Withdrawal by PI|0
1724473|NCT01055886|6014445|P2|Overall Study|Lost to Follow-up|1
1724474|NCT01055886|6014446|P1|Overall Study|Lost to Follow-up|1
1724475|NCT01055886|6014445|P2|Overall Study|Withdrawal by Subject|9
1724476|NCT01055886|6014446|P1|Overall Study|Withdrawal by Subject|4
1724477|NCT01055834|6014458|P2|Treatment Period I|Adverse Event|0
1724478|NCT01055834|6014459|P1|Treatment Period I|Adverse Event|1
1724479|NCT01055639|6014544|P2|Overall Study|Withdrawal by Subject|11
1724480|NCT01055639|6014545|P1|Overall Study|Withdrawal by Subject|8
1724481|NCT01055639|6014544|P2|Overall Study|Protocol Violation|5
1724482|NCT01055639|6014545|P1|Overall Study|Protocol Violation|5
1724483|NCT01055639|6014544|P2|Overall Study|Lost to Follow-up|11
1724484|NCT01055639|6014545|P1|Overall Study|Lost to Follow-up|8
1724485|NCT01055639|6014544|P2|Overall Study|Lack of Efficacy|1
1724486|NCT01055639|6014545|P1|Overall Study|Lack of Efficacy|0
1724487|NCT01055639|6014544|P2|Overall Study|Adverse Event|1
1724488|NCT01055639|6014545|P1|Overall Study|Adverse Event|0
1724489|NCT01055613|6014569|P2|Overall Study|Subject Disinterest|1
1724490|NCT01055613|6014570|P1|Overall Study|Subject Disinterest|1
1724491|NCT01055613|6014569|P2|Overall Study|Protocol Violation|1
1724492|NCT01055613|6014570|P1|Overall Study|Protocol Violation|1
1724493|NCT01055613|6014569|P2|Overall Study|Lost to Follow-up|1
1724494|NCT01055613|6014570|P1|Overall Study|Lost to Follow-up|1
1724495|NCT01055613|6014569|P2|Overall Study|Discomfort|1
1724496|NCT01055613|6014570|P1|Overall Study|Discomfort|2
1724497|NCT01055613|6014569|P2|Overall Study|Unacceptable lens fit|0
1724498|NCT01055613|6014570|P1|Overall Study|Unacceptable lens fit|1
1724499|NCT01055613|6014569|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1724500|NCT01055613|6014570|P1|Overall Study|No Longer Meets Eligibility Criteria|3
1724501|NCT01055496|6014580|P2|Overall Study|Other - Unspecified|1
1724502|NCT01055496|6014581|P1|Overall Study|Other - Unspecified|0
1724503|NCT01055496|6014580|P2|Overall Study|Lost to Follow-up|2
1724504|NCT01055496|6014581|P1|Overall Study|Lost to Follow-up|0
1724505|NCT01055496|6014580|P2|Overall Study|Death|23
1724506|NCT01055496|6014581|P1|Overall Study|Death|13
1724507|NCT01055496|6014580|P2|Overall Study|Withdrawal by Subject|4
1724508|NCT01055496|6014581|P1|Overall Study|Withdrawal by Subject|2
1724509|NCT01055457|6014638|P10|Overall Study|Adverse Event|0
1724510|NCT01055457|6014639|P9|Overall Study|Adverse Event|0
1724511|NCT01055457|6014640|P8|Overall Study|Adverse Event|0
1724512|NCT01055457|6014641|P7|Overall Study|Adverse Event|0
1724513|NCT01055457|6014642|P6|Overall Study|Adverse Event|0
1724514|NCT01055457|6014643|P5|Overall Study|Adverse Event|0
1724515|NCT01055457|6014644|P4|Overall Study|Adverse Event|1
1724516|NCT01055457|6014645|P3|Overall Study|Adverse Event|0
1724517|NCT01055457|6014646|P2|Overall Study|Adverse Event|0
1724518|NCT01055457|6014647|P1|Overall Study|Adverse Event|0
1724519|NCT01055457|6014638|P10|Overall Study|Pregnancy|0
1724520|NCT01055457|6014639|P9|Overall Study|Pregnancy|0
1724521|NCT01055457|6014640|P8|Overall Study|Pregnancy|0
1724522|NCT01055457|6014641|P7|Overall Study|Pregnancy|0
1724523|NCT01055457|6014642|P6|Overall Study|Pregnancy|0
1724524|NCT01055457|6014643|P5|Overall Study|Pregnancy|0
1724525|NCT01055457|6014644|P4|Overall Study|Pregnancy|1
1724526|NCT01055457|6014645|P3|Overall Study|Pregnancy|0
1724527|NCT01055457|6014646|P2|Overall Study|Pregnancy|0
1724528|NCT01055457|6014647|P1|Overall Study|Pregnancy|0
1724529|NCT01055457|6014638|P10|Overall Study|Discomfort|0
1724530|NCT01055457|6014639|P9|Overall Study|Discomfort|0
1724531|NCT01055457|6014640|P8|Overall Study|Discomfort|0
1724532|NCT01055457|6014641|P7|Overall Study|Discomfort|0
1724533|NCT01055457|6014642|P6|Overall Study|Discomfort|0
1724534|NCT01055457|6014643|P5|Overall Study|Discomfort|1
1724535|NCT01055457|6014644|P4|Overall Study|Discomfort|0
1724536|NCT01055457|6014645|P3|Overall Study|Discomfort|0
1724537|NCT01055457|6014646|P2|Overall Study|Discomfort|0
1724538|NCT01055457|6014647|P1|Overall Study|Discomfort|0
1724539|NCT01055457|6014638|P10|Overall Study|Subject Ineligible|0
1724540|NCT01055457|6014639|P9|Overall Study|Subject Ineligible|0
1724541|NCT01055457|6014640|P8|Overall Study|Subject Ineligible|0
1724542|NCT01055457|6014641|P7|Overall Study|Subject Ineligible|0
1724543|NCT01055457|6014642|P6|Overall Study|Subject Ineligible|0
1724544|NCT01055457|6014643|P5|Overall Study|Subject Ineligible|1
1724545|NCT01055457|6014644|P4|Overall Study|Subject Ineligible|0
1724546|NCT01055457|6014645|P3|Overall Study|Subject Ineligible|1
1724547|NCT01055457|6014646|P2|Overall Study|Subject Ineligible|0
1724548|NCT01055457|6014647|P1|Overall Study|Subject Ineligible|1
1724549|NCT01055457|6014638|P10|Overall Study|Subject Disinterest|0
1724550|NCT01055457|6014639|P9|Overall Study|Subject Disinterest|0
1724551|NCT01055457|6014640|P8|Overall Study|Subject Disinterest|1
1724552|NCT01055457|6014641|P7|Overall Study|Subject Disinterest|0
1724553|NCT01055457|6014642|P6|Overall Study|Subject Disinterest|0
1724554|NCT01055457|6014643|P5|Overall Study|Subject Disinterest|0
1724555|NCT01055457|6014644|P4|Overall Study|Subject Disinterest|0
1724556|NCT01055457|6014645|P3|Overall Study|Subject Disinterest|0
1724557|NCT01055457|6014646|P2|Overall Study|Subject Disinterest|0
1724558|NCT01055457|6014647|P1|Overall Study|Subject Disinterest|0
1724559|NCT01055457|6014638|P10|Overall Study|Protocol Violation|1
1724560|NCT01055457|6014639|P9|Overall Study|Protocol Violation|0
1724561|NCT01055457|6014640|P8|Overall Study|Protocol Violation|0
1724562|NCT01055457|6014641|P7|Overall Study|Protocol Violation|1
1724563|NCT01055457|6014642|P6|Overall Study|Protocol Violation|2
1724564|NCT01055457|6014643|P5|Overall Study|Protocol Violation|1
1724565|NCT01055457|6014644|P4|Overall Study|Protocol Violation|1
1724566|NCT01055457|6014645|P3|Overall Study|Protocol Violation|1
1724567|NCT01055457|6014646|P2|Overall Study|Protocol Violation|0
1724568|NCT01055457|6014647|P1|Overall Study|Protocol Violation|0
1724569|NCT01055457|6014638|P10|Overall Study|Lost to Follow-up|0
1724570|NCT01055457|6014639|P9|Overall Study|Lost to Follow-up|0
1724571|NCT01055457|6014640|P8|Overall Study|Lost to Follow-up|0
1724572|NCT01055457|6014641|P7|Overall Study|Lost to Follow-up|0
1724573|NCT01055457|6014642|P6|Overall Study|Lost to Follow-up|1
1724574|NCT01055457|6014643|P5|Overall Study|Lost to Follow-up|0
1724575|NCT01055457|6014644|P4|Overall Study|Lost to Follow-up|0
1724576|NCT01055457|6014645|P3|Overall Study|Lost to Follow-up|0
1724577|NCT01055457|6014646|P2|Overall Study|Lost to Follow-up|1
1724578|NCT01055457|6014647|P1|Overall Study|Lost to Follow-up|0
1724579|NCT01055314|6014681|P2|Overall Study|No treatment|0
1724580|NCT01055314|6014682|P1|Overall Study|No treatment|1
1724581|NCT01055314|6014681|P2|Overall Study|Refusal of further protocol therapy|4
1724582|NCT01055314|6014682|P1|Overall Study|Refusal of further protocol therapy|10
1724583|NCT01055314|6014681|P2|Overall Study|Ineligible|5
1724584|NCT01055314|6014682|P1|Overall Study|Ineligible|3
1724585|NCT01055314|6014681|P2|Overall Study|Withdrawal by Subject|0
1724586|NCT01055314|6014682|P1|Overall Study|Withdrawal by Subject|1
1724587|NCT01055314|6014681|P2|Overall Study|Physician Decision|5
1724588|NCT01055314|6014682|P1|Overall Study|Physician Decision|10
1724589|NCT01055314|6014681|P2|Overall Study|Lack of Efficacy|19
1724590|NCT01055314|6014682|P1|Overall Study|Lack of Efficacy|11
1724591|NCT01055314|6014681|P2|Overall Study|Death|1
1724592|NCT01055314|6014682|P1|Overall Study|Death|2
1724593|NCT01055314|6014681|P2|Overall Study|Adverse Event|4
1724594|NCT01055314|6014682|P1|Overall Study|Adverse Event|7
1724595|NCT01055262|6014694|P1|Overall Study|Uncooperativeness|1
1724596|NCT01055262|6014694|P1|Overall Study|Protocol Violation|3
1724597|NCT01055262|6014694|P1|Overall Study|Adverse Event|5
1724598|NCT01055197|6014735|P2|Overall Study|Withdrawal by Subject|0
1724599|NCT01055197|6014736|P1|Overall Study|Withdrawal by Subject|2
1724600|NCT01055197|6014735|P2|Overall Study|Protocol Violation|2
1724601|NCT01055197|6014736|P1|Overall Study|Protocol Violation|7
1724602|NCT01055132|6014771|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
1724603|NCT01055132|6014772|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
1724604|NCT01055132|6014771|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
1724605|NCT01055132|6014772|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
1724606|NCT01055028|6014785|P2|Inter-treatment Period|Did not start Cycle 4|3
1724607|NCT01055028|6014786|P1|Inter-treatment Period|Did not start Cycle 4|0
1724608|NCT01055028|6014785|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
1724609|NCT01055028|6014786|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
1724610|NCT01055028|6014785|P2|Treatment Cycles 1 to 3|Adverse Event|1
1724611|NCT01055028|6014786|P1|Treatment Cycles 1 to 3|Adverse Event|0
1724612|NCT01055028|6014785|P2|Screening|Screen Failure|1
1724613|NCT01055028|6014786|P1|Screening|Screen Failure|1
1724614|NCT01054976|6014800|P1|Overall Study|Other|8
1724615|NCT01054976|6014800|P1|Overall Study|Withdrawal by Subject|4
1724616|NCT01054976|6014800|P1|Overall Study|Uncooperative participations to study|7
1724617|NCT01054976|6014800|P1|Overall Study|Adverse Event|16
1724618|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
1724619|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1724620|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
1724621|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1724622|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1724623|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
1724624|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1724625|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Physician Decision|1
1724626|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Physician Decision|1
1724627|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Physician Decision|3
1724628|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Physician Decision|6
1724629|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Physician Decision|1
1724630|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Physician Decision|4
1724631|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1724632|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1724633|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1724634|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1724635|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1724636|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1724637|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1724638|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1724639|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
1724640|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1724641|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1724642|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1724643|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
1724644|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1724645|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
1724646|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
1724647|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
1724648|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1724649|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1724650|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
1724651|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
1724652|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
1724653|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
1724654|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
1724655|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
1724656|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1724657|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
1724658|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
1724659|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1724660|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
1724661|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
1724662|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
1724663|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
1724664|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
1724665|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
1724666|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1724667|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1724668|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
1724669|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1724670|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
1724671|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1724672|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1724673|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1724674|NCT01054885|6014821|P7|24-week, Double-blind Treatment Period|Adverse Event|19
1724675|NCT01054885|6014822|P6|24-week, Double-blind Treatment Period|Adverse Event|17
1724676|NCT01054885|6014823|P5|24-week, Double-blind Treatment Period|Adverse Event|15
1724677|NCT01054885|6014824|P4|24-week, Double-blind Treatment Period|Adverse Event|15
1724678|NCT01054885|6014825|P3|24-week, Double-blind Treatment Period|Adverse Event|12
1724679|NCT01054885|6014826|P2|24-week, Double-blind Treatment Period|Adverse Event|18
1724680|NCT01054885|6014827|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1724681|NCT01054885|6014821|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724682|NCT01054885|6014822|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724683|NCT01054885|6014823|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724684|NCT01054885|6014824|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724685|NCT01054885|6014825|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724686|NCT01054885|6014826|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724687|NCT01054885|6014827|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
1724688|NCT01054885|6014821|P7|2-week, Single-blind Run-In Period|Adverse Event|0
1724689|NCT01054885|6014822|P6|2-week, Single-blind Run-In Period|Adverse Event|0
1724690|NCT01054885|6014823|P5|2-week, Single-blind Run-In Period|Adverse Event|0
1724691|NCT01054885|6014824|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1724692|NCT01054885|6014825|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1724693|NCT01054885|6014826|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1724694|NCT01054885|6014827|P1|2-week, Single-blind Run-In Period|Adverse Event|7
1724695|NCT01054885|6014821|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724696|NCT01054885|6014822|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724697|NCT01054885|6014823|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724698|NCT01054885|6014824|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724699|NCT01054885|6014825|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724700|NCT01054885|6014826|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724701|NCT01054885|6014827|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
1724702|NCT01054885|6014821|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724703|NCT01054885|6014822|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724704|NCT01054885|6014823|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724705|NCT01054885|6014824|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724706|NCT01054885|6014825|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724707|NCT01054885|6014826|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724708|NCT01054885|6014827|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
1724709|NCT01054885|6014821|P7|2-week, Single-blind Run-In Period|Physician Decision|0
1724710|NCT01054885|6014822|P6|2-week, Single-blind Run-In Period|Physician Decision|0
1724711|NCT01054885|6014823|P5|2-week, Single-blind Run-In Period|Physician Decision|0
1724712|NCT01054885|6014824|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1724713|NCT01054885|6014825|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1724714|NCT01054885|6014826|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1724715|NCT01054885|6014827|P1|2-week, Single-blind Run-In Period|Physician Decision|6
1724716|NCT01054885|6014821|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724717|NCT01054885|6014822|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724718|NCT01054885|6014823|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724719|NCT01054885|6014824|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724720|NCT01054885|6014825|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724721|NCT01054885|6014826|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724722|NCT01054885|6014827|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
1724723|NCT01054846|6014867|P2|Overall Study|Lost to Follow-up|17
1724724|NCT01054846|6014868|P1|Overall Study|Lost to Follow-up|76
1724725|NCT01054820|6014875|P1|Overall Study|Withdrawal by Subject|2
1724726|NCT01054729|6014897|P4|Overall Study|Lack of Efficacy|1
1724727|NCT01054729|6014898|P3|Overall Study|Lack of Efficacy|0
1724728|NCT01054729|6014899|P2|Overall Study|Lack of Efficacy|0
1724729|NCT01054729|6014900|P1|Overall Study|Lack of Efficacy|0
1724730|NCT01054729|6014897|P4|Overall Study|Subject moved|0
1724731|NCT01054729|6014898|P3|Overall Study|Subject moved|1
1724732|NCT01054729|6014899|P2|Overall Study|Subject moved|0
1724733|NCT01054729|6014900|P1|Overall Study|Subject moved|0
1724734|NCT01054729|6014897|P4|Overall Study|Personal/Obligations|0
1724735|NCT01054729|6014898|P3|Overall Study|Personal/Obligations|0
1724736|NCT01054729|6014899|P2|Overall Study|Personal/Obligations|1
1724737|NCT01054729|6014900|P1|Overall Study|Personal/Obligations|0
1724738|NCT01054729|6014897|P4|Overall Study|PEG/RBV Non-responder|0
1724739|NCT01054729|6014898|P3|Overall Study|PEG/RBV Non-responder|1
1724740|NCT01054729|6014899|P2|Overall Study|PEG/RBV Non-responder|0
1724741|NCT01054729|6014900|P1|Overall Study|PEG/RBV Non-responder|1
1724742|NCT01054729|6014897|P4|Overall Study|Non-responder|1
1724743|NCT01054729|6014898|P3|Overall Study|Non-responder|1
1724744|NCT01054729|6014899|P2|Overall Study|Non-responder|0
1724745|NCT01054729|6014900|P1|Overall Study|Non-responder|1
1724746|NCT01054729|6014897|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
1724747|NCT01054729|6014898|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
1724748|NCT01054729|6014899|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
1724749|NCT01054729|6014900|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
1724750|NCT01054729|6014897|P4|Overall Study|Lost to Follow-up|0
1724751|NCT01054729|6014898|P3|Overall Study|Lost to Follow-up|0
1724752|NCT01054729|6014899|P2|Overall Study|Lost to Follow-up|1
1724753|NCT01054729|6014900|P1|Overall Study|Lost to Follow-up|0
1724754|NCT01054729|6014897|P4|Overall Study|Withdrawal by Subject|0
1724755|NCT01054729|6014898|P3|Overall Study|Withdrawal by Subject|1
1724756|NCT01054729|6014899|P2|Overall Study|Withdrawal by Subject|0
1724757|NCT01054729|6014900|P1|Overall Study|Withdrawal by Subject|1
1724758|NCT01054729|6014897|P4|Overall Study|Adverse Event|1
1724759|NCT01054729|6014898|P3|Overall Study|Adverse Event|2
1724760|NCT01054729|6014899|P2|Overall Study|Adverse Event|1
1724761|NCT01054729|6014900|P1|Overall Study|Adverse Event|1
1724762|NCT01054729|6014897|P4|Overall Study|Randomized but Not Treated|0
1724763|NCT01054729|6014898|P3|Overall Study|Randomized but Not Treated|0
1724764|NCT01054729|6014899|P2|Overall Study|Randomized but Not Treated|1
1724765|NCT01054729|6014900|P1|Overall Study|Randomized but Not Treated|0
1724766|NCT01054599|6014998|P2|Overall Study|Withdrawal by Subject|1
1724767|NCT01054599|6014999|P1|Overall Study|Withdrawal by Subject|0
1724768|NCT01054599|6014998|P2|Overall Study|Adverse Event|1
1724769|NCT01054599|6014999|P1|Overall Study|Adverse Event|0
1724770|NCT01054599|6014998|P2|Overall Study|Lost to Follow-up|2
1724771|NCT01054599|6014999|P1|Overall Study|Lost to Follow-up|0
1724772|NCT01054599|6014998|P2|Overall Study|Visual impairment, WTAR <80|1
1724773|NCT01054599|6014999|P1|Overall Study|Visual impairment, WTAR <80|0
1724774|NCT01054599|6014998|P2|Overall Study|Timing/scheduling difficulties|1
1724775|NCT01054599|6014999|P1|Overall Study|Timing/scheduling difficulties|1
1724776|NCT01054599|6014998|P2|Overall Study|Spells/seizure-like episodes|1
1724777|NCT01054599|6014999|P1|Overall Study|Spells/seizure-like episodes|1
1724778|NCT01054599|6014998|P2|Overall Study|Protocol Violation|0
1724779|NCT01054599|6014999|P1|Overall Study|Protocol Violation|1
1724780|NCT01054599|6014998|P2|Overall Study|Dizziness due to phenytoin toxicity|0
1724781|NCT01054599|6014999|P1|Overall Study|Dizziness due to phenytoin toxicity|1
1724782|NCT01054573|6015106|P4|Overall Study|Withdrawal by Subject|1
1724783|NCT01054573|6015107|P3|Overall Study|Withdrawal by Subject|2
1724784|NCT01054573|6015108|P2|Overall Study|Withdrawal by Subject|2
1724785|NCT01054573|6015109|P1|Overall Study|Withdrawal by Subject|0
1724786|NCT01054573|6015106|P4|Overall Study|Lost to Follow-up|0
1724787|NCT01054573|6015107|P3|Overall Study|Lost to Follow-up|0
1724788|NCT01054573|6015108|P2|Overall Study|Lost to Follow-up|2
1724789|NCT01054573|6015109|P1|Overall Study|Lost to Follow-up|0
1724790|NCT01054573|6015106|P4|Overall Study|Adverse Event|1
1724791|NCT01054573|6015107|P3|Overall Study|Adverse Event|1
1724792|NCT01054573|6015108|P2|Overall Study|Adverse Event|0
1724793|NCT01054573|6015109|P1|Overall Study|Adverse Event|1
1724794|NCT01054560|6015155|P2|Overall Study|Physician Decision|0
1724795|NCT01054560|6015156|P1|Overall Study|Physician Decision|1
1724796|NCT01054560|6015155|P2|Overall Study|Withdrawal by Subject|2
1724797|NCT01054560|6015156|P1|Overall Study|Withdrawal by Subject|0
1724798|NCT01054560|6015155|P2|Overall Study|Lost to Follow-up|5
1724799|NCT01054560|6015156|P1|Overall Study|Lost to Follow-up|2
1724800|NCT01054560|6015155|P2|Overall Study|Death|21
1724801|NCT01054560|6015156|P1|Overall Study|Death|10
1724802|NCT01054300|6015208|P4|Period 2|Withdrawal by Subject|0
1724803|NCT01054300|6015209|P3|Period 2|Withdrawal by Subject|1
1724804|NCT01054300|6015210|P2|Period 2|Withdrawal by Subject|0
1724805|NCT01054300|6015211|P1|Period 2|Withdrawal by Subject|0
1724806|NCT01054300|6015208|P4|Period 1|Adverse Event|0
1724807|NCT01054300|6015209|P3|Period 1|Adverse Event|0
1724808|NCT01054300|6015210|P2|Period 1|Adverse Event|0
1724809|NCT01054300|6015211|P1|Period 1|Adverse Event|1
1724810|NCT01054222|6015261|P1|Overall Study|Withdrawal by Subject|6
1724811|NCT01054222|6015261|P1|Overall Study|Lost to Follow-up|4
1724812|NCT01054222|6015261|P1|Overall Study|Lack of Efficacy|1
1724813|NCT01054170|6015302|P2|Overall Study|Adverse Event|4
1724814|NCT01054170|6015303|P1|Overall Study|Adverse Event|0
1724815|NCT01054170|6015302|P2|Overall Study|Withdrawal by Subject|2
1724816|NCT01054170|6015303|P1|Overall Study|Withdrawal by Subject|3
1724817|NCT01054170|6015302|P2|Overall Study|Protocol Violation|0
1724818|NCT01054170|6015303|P1|Overall Study|Protocol Violation|1
1724819|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1724820|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
1724821|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
1724822|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
1724823|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
1724824|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
1724825|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Physician Decision|4
1724826|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Physician Decision|5
1724827|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Physician Decision|5
1724828|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Physician Decision|2
1724829|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Physician Decision|5
1724830|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Physician Decision|0
1724831|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
1724832|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
1724833|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
1724834|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1724835|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
1724836|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
1724837|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
1724838|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1724839|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
1724840|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
1724841|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
1724842|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1724843|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
1724844|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
1724845|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
1724846|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
1724847|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
1724848|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
1724849|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
1724850|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
1724851|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
1724852|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
1724853|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
1724854|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
1724855|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1724856|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1724857|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1724858|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
1724859|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
1724860|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
1724861|NCT01053988|6015368|P6|24-week, Double-blind Treatment Period|Adverse Event|14
1724862|NCT01053988|6015369|P5|24-week, Double-blind Treatment Period|Adverse Event|17
1724863|NCT01053988|6015370|P4|24-week, Double-blind Treatment Period|Adverse Event|24
1724864|NCT01053988|6015371|P3|24-week, Double-blind Treatment Period|Adverse Event|23
1724865|NCT01053988|6015372|P2|24-week, Double-blind Treatment Period|Adverse Event|15
1724866|NCT01053988|6015373|P1|24-week, Double-blind Treatment Period|Adverse Event|0
1724867|NCT01053988|6015368|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724868|NCT01053988|6015369|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724869|NCT01053988|6015370|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724870|NCT01053988|6015371|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724871|NCT01053988|6015372|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
1724872|NCT01053988|6015373|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
1724873|NCT01053988|6015368|P6|2-week, Single-blind Run-In Period|Physician Decision|0
1724874|NCT01053988|6015369|P5|2-week, Single-blind Run-In Period|Physician Decision|0
1724875|NCT01053988|6015370|P4|2-week, Single-blind Run-In Period|Physician Decision|0
1724876|NCT01053988|6015371|P3|2-week, Single-blind Run-In Period|Physician Decision|0
1724877|NCT01053988|6015372|P2|2-week, Single-blind Run-In Period|Physician Decision|0
1724878|NCT01053988|6015373|P1|2-week, Single-blind Run-In Period|Physician Decision|5
1724879|NCT01053988|6015368|P6|2-week, Single-blind Run-In Period|Adverse Event|0
1724880|NCT01053988|6015369|P5|2-week, Single-blind Run-In Period|Adverse Event|0
1724881|NCT01053988|6015370|P4|2-week, Single-blind Run-In Period|Adverse Event|0
1724882|NCT01053988|6015371|P3|2-week, Single-blind Run-In Period|Adverse Event|0
1724883|NCT01053988|6015372|P2|2-week, Single-blind Run-In Period|Adverse Event|0
1724884|NCT01053988|6015373|P1|2-week, Single-blind Run-In Period|Adverse Event|6
1724885|NCT01053988|6015368|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724886|NCT01053988|6015369|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724887|NCT01053988|6015370|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724888|NCT01053988|6015371|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724889|NCT01053988|6015372|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
1724890|NCT01053988|6015373|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
1724891|NCT01053988|6015368|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724892|NCT01053988|6015369|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724893|NCT01053988|6015370|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724894|NCT01053988|6015371|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724895|NCT01053988|6015372|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
1724896|NCT01053988|6015373|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
1724897|NCT01053988|6015368|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724898|NCT01053988|6015369|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724899|NCT01053988|6015370|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724900|NCT01053988|6015371|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724901|NCT01053988|6015372|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
1724902|NCT01053988|6015373|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
1724903|NCT01053962|6015410|P5|Treatment Period|Noncompliance with protocol|0
1724904|NCT01053962|6015411|P4|Treatment Period|Noncompliance with protocol|0
1724905|NCT01053962|6015412|P3|Treatment Period|Noncompliance with protocol|0
1724906|NCT01053962|6015413|P2|Treatment Period|Noncompliance with protocol|0
1724907|NCT01053962|6015414|P1|Treatment Period|Noncompliance with protocol|1
1724908|NCT01053962|6015410|P5|Treatment Period|Withdrawal by Subject|1
1724909|NCT01053962|6015411|P4|Treatment Period|Withdrawal by Subject|0
1724910|NCT01053962|6015412|P3|Treatment Period|Withdrawal by Subject|0
1724911|NCT01053962|6015413|P2|Treatment Period|Withdrawal by Subject|0
1724912|NCT01053962|6015414|P1|Treatment Period|Withdrawal by Subject|0
1724913|NCT01053962|6015410|P5|Treatment Period|Adverse Event|1
1724914|NCT01053962|6015411|P4|Treatment Period|Adverse Event|0
1724915|NCT01053962|6015412|P3|Treatment Period|Adverse Event|0
1724916|NCT01053962|6015413|P2|Treatment Period|Adverse Event|0
1724917|NCT01053962|6015414|P1|Treatment Period|Adverse Event|0
1724918|NCT01053962|6015410|P5|Treatment Period|Lack of Efficacy|1
1724919|NCT01053962|6015411|P4|Treatment Period|Lack of Efficacy|0
1724920|NCT01053962|6015412|P3|Treatment Period|Lack of Efficacy|0
1724921|NCT01053962|6015413|P2|Treatment Period|Lack of Efficacy|0
1724922|NCT01053962|6015414|P1|Treatment Period|Lack of Efficacy|0
1724923|NCT01053962|6015410|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
1724924|NCT01053962|6015411|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
1724925|NCT01053962|6015412|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
1724926|NCT01053962|6015413|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
1724927|NCT01053962|6015414|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
1724928|NCT01053962|6015410|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
1724929|NCT01053962|6015411|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
1724930|NCT01053962|6015412|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
1724931|NCT01053962|6015413|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
1724932|NCT01053962|6015414|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
1724933|NCT01053962|6015410|P5|Pretreatment Period|Venipuncture Failure|0
1724934|NCT01053962|6015411|P4|Pretreatment Period|Venipuncture Failure|0
1724935|NCT01053962|6015412|P3|Pretreatment Period|Venipuncture Failure|1
1724936|NCT01053962|6015413|P2|Pretreatment Period|Venipuncture Failure|0
1724937|NCT01053962|6015414|P1|Pretreatment Period|Venipuncture Failure|0
1724938|NCT01053962|6015410|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
1724939|NCT01053962|6015411|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
1724940|NCT01053962|6015412|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
1724941|NCT01053962|6015413|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
1724942|NCT01053962|6015414|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
1724943|NCT01053741|6015465|P2|2nd Study Intervention|Physician Decision|1
1724944|NCT01053741|6015466|P1|2nd Study Intervention|Physician Decision|0
1724945|NCT01053663|6015475|P1|Overall Study|Negative Influenza Diagnosis|1
1724946|NCT01053663|6015475|P1|Overall Study|Transferred to Another Hospital|1
1724947|NCT01053663|6015475|P1|Overall Study|Poor IV Access|1
1724948|NCT01053663|6015475|P1|Overall Study|Lost to Follow-up|1
1724949|NCT01053663|6015475|P1|Overall Study|Death|2
1724950|NCT01053429|6015533|P1|Overall Study|Other|309
1724951|NCT01053429|6015533|P1|Overall Study|Adverse Event|64
1724952|NCT01053247|6015563|P3|Overall Study|Adverse Event|3
1724953|NCT01053247|6015564|P2|Overall Study|Adverse Event|9
1724954|NCT01053247|6015565|P1|Overall Study|Adverse Event|0
1724955|NCT01053247|6015563|P3|Overall Study|Lost to Follow-up|7
1724956|NCT01053247|6015564|P2|Overall Study|Lost to Follow-up|5
1724957|NCT01053247|6015565|P1|Overall Study|Lost to Follow-up|8
1724958|NCT01053247|6015563|P3|Overall Study|Protocol Violation|2
1724959|NCT01053247|6015564|P2|Overall Study|Protocol Violation|1
1724960|NCT01053247|6015565|P1|Overall Study|Protocol Violation|2
1724961|NCT01053247|6015563|P3|Overall Study|Lack of Efficacy|1
1724962|NCT01053247|6015564|P2|Overall Study|Lack of Efficacy|0
1724963|NCT01053247|6015565|P1|Overall Study|Lack of Efficacy|1
1724964|NCT01053247|6015563|P3|Overall Study|Withdrawal by Subject|15
1724965|NCT01053247|6015564|P2|Overall Study|Withdrawal by Subject|4
1724966|NCT01053247|6015565|P1|Overall Study|Withdrawal by Subject|9
1724967|NCT01053221|6015575|P2|Overall Study|The study was closed prematurely|9
1724968|NCT01053221|6015576|P1|Overall Study|The study was closed prematurely|5
1724969|NCT01052844|6015678|P2|Overall Study|Adverse Event|1
1724970|NCT01052844|6015679|P1|Overall Study|Adverse Event|0
1724971|NCT01052779|6015700|P2|Overall Study|Other-Missed Week 5 Visit|0
1724972|NCT01052779|6015701|P1|Overall Study|Other-Missed Week 5 Visit|2
1724973|NCT01052779|6015700|P2|Overall Study|Other-Surgery|2
1724974|NCT01052779|6015701|P1|Overall Study|Other-Surgery|0
1724975|NCT01052779|6015700|P2|Overall Study|Other-Protocol Violation|1
1724976|NCT01052779|6015701|P1|Overall Study|Other-Protocol Violation|1
1724977|NCT01052779|6015700|P2|Overall Study|Withdrawal by Subject|2
1724978|NCT01052779|6015701|P1|Overall Study|Withdrawal by Subject|1
1724979|NCT01052779|6015700|P2|Overall Study|Adverse Event|4
1724980|NCT01052779|6015701|P1|Overall Study|Adverse Event|1
1724981|NCT01052714|6015711|P3|Overall Study|Withdrawal by Subject|1
1724982|NCT01052714|6015712|P2|Overall Study|Withdrawal by Subject|12
1724983|NCT01052714|6015713|P1|Overall Study|Withdrawal by Subject|7
1724984|NCT01052714|6015711|P3|Overall Study|Physician Decision|1
1724985|NCT01052714|6015712|P2|Overall Study|Physician Decision|9
1724986|NCT01052714|6015713|P1|Overall Study|Physician Decision|9
1724987|NCT01052714|6015711|P3|Overall Study|Lost to Follow-up|0
1724988|NCT01052714|6015712|P2|Overall Study|Lost to Follow-up|3
1724989|NCT01052714|6015713|P1|Overall Study|Lost to Follow-up|2
1724990|NCT01052714|6015711|P3|Overall Study|Death|0
1724991|NCT01052714|6015712|P2|Overall Study|Death|2
1724992|NCT01052714|6015713|P1|Overall Study|Death|1
1724993|NCT01052714|6015711|P3|Overall Study|Adverse Event|0
1724994|NCT01052714|6015712|P2|Overall Study|Adverse Event|3
1724995|NCT01052714|6015713|P1|Overall Study|Adverse Event|6
1724996|NCT01052662|6015767|P3|Overall Study|Administrative|0
1724997|NCT01052662|6015768|P2|Overall Study|Administrative|3
1724998|NCT01052662|6015769|P1|Overall Study|Administrative|0
1724999|NCT01052662|6015767|P3|Overall Study|Legal Problem|0
1725000|NCT01052662|6015768|P2|Overall Study|Legal Problem|0
1725001|NCT01052662|6015769|P1|Overall Study|Legal Problem|2
1725002|NCT01052662|6015767|P3|Overall Study|Adverse Event|0
1725003|NCT01052662|6015768|P2|Overall Study|Adverse Event|1
1725004|NCT01052662|6015769|P1|Overall Study|Adverse Event|1
1725005|NCT01052662|6015767|P3|Overall Study|Pharmacy issue|3
1725006|NCT01052662|6015768|P2|Overall Study|Pharmacy issue|3
1725007|NCT01052662|6015769|P1|Overall Study|Pharmacy issue|1
1725008|NCT01052662|6015767|P3|Overall Study|Withdrawal by Subject|1
1725009|NCT01052662|6015768|P2|Overall Study|Withdrawal by Subject|2
1725010|NCT01052662|6015769|P1|Overall Study|Withdrawal by Subject|3
1725011|NCT01052662|6015767|P3|Overall Study|Lost to Follow-up|18
1725012|NCT01052662|6015768|P2|Overall Study|Lost to Follow-up|13
1725013|NCT01052662|6015769|P1|Overall Study|Lost to Follow-up|15
1725014|NCT01052480|6015810|P2|Overall Study|Death|5
1725015|NCT01052480|6015811|P1|Overall Study|Death|1
1725016|NCT01052480|6015810|P2|Overall Study|Physician Decision|2
1725017|NCT01052480|6015811|P1|Overall Study|Physician Decision|0
1725018|NCT01052480|6015810|P2|Overall Study|Withdrawal by Subject|7
1725019|NCT01052480|6015811|P1|Overall Study|Withdrawal by Subject|3
1725020|NCT01052480|6015810|P2|Overall Study|Protocol Violation|0
1725021|NCT01052480|6015811|P1|Overall Study|Protocol Violation|1
1725022|NCT01052480|6015810|P2|Overall Study|Lost to Follow-up|3
1725023|NCT01052480|6015811|P1|Overall Study|Lost to Follow-up|3
1725024|NCT01052428|6015861|P2|Overall Study|Withdrawal by Subject|1
1725025|NCT01052428|6015862|P1|Overall Study|Withdrawal by Subject|0
1725026|NCT01052428|6015861|P2|Overall Study|Death|0
1725027|NCT01052428|6015862|P1|Overall Study|Death|1
1725028|NCT01052272|6015884|P4|Overall Study|decline in health|0
1725029|NCT01052272|6015885|P3|Overall Study|decline in health|1
1725030|NCT01052272|6015886|P2|Overall Study|decline in health|0
1725031|NCT01052272|6015887|P1|Overall Study|decline in health|0
1725032|NCT01052272|6015884|P4|Overall Study|placed in long-term care|0
1725033|NCT01052272|6015885|P3|Overall Study|placed in long-term care|1
1725034|NCT01052272|6015886|P2|Overall Study|placed in long-term care|0
1725035|NCT01052272|6015887|P1|Overall Study|placed in long-term care|0
1725036|NCT01052272|6015884|P4|Overall Study|Withdrawal by Subject|2
1725037|NCT01052272|6015885|P3|Overall Study|Withdrawal by Subject|3
1725038|NCT01052272|6015886|P2|Overall Study|Withdrawal by Subject|2
1725039|NCT01052272|6015887|P1|Overall Study|Withdrawal by Subject|0
1725040|NCT01052272|6015884|P4|Overall Study|patient refuses follow-up|4
1725041|NCT01052272|6015885|P3|Overall Study|patient refuses follow-up|2
1725042|NCT01052272|6015886|P2|Overall Study|patient refuses follow-up|4
1725043|NCT01052272|6015887|P1|Overall Study|patient refuses follow-up|5
1725044|NCT01052272|6015884|P4|Overall Study|Physician Decision|0
1725045|NCT01052272|6015885|P3|Overall Study|Physician Decision|0
1725046|NCT01052272|6015886|P2|Overall Study|Physician Decision|1
1725047|NCT01052272|6015887|P1|Overall Study|Physician Decision|0
1725048|NCT01052272|6015884|P4|Overall Study|Death|1
1725049|NCT01052272|6015885|P3|Overall Study|Death|1
1725050|NCT01052272|6015886|P2|Overall Study|Death|0
1725051|NCT01052272|6015887|P1|Overall Study|Death|0
1725052|NCT01052116|6015932|P2|Overall Study|Spirometry not performed|4
1725053|NCT01052116|6015933|P1|Overall Study|Spirometry not performed|0
1725054|NCT01052116|6015932|P2|Overall Study|Withdrawal by Subject|6
1725055|NCT01052116|6015933|P1|Overall Study|Withdrawal by Subject|3
1725056|NCT01052116|6015932|P2|Overall Study|Lost to Follow-up|17
1725057|NCT01052116|6015933|P1|Overall Study|Lost to Follow-up|11
1725058|NCT01052077|6015941|P4|Phase A+|Withdrawal by Subject|7
1725059|NCT01052077|6015942|P3|Phase A+|Withdrawal by Subject|0
1725060|NCT01052077|6015943|P2|Phase A+|Withdrawal by Subject|0
1725061|NCT01052077|6015944|P1|Phase A+|Withdrawal by Subject|0
1725062|NCT01052077|6015941|P4|Phase A+|Met Withdrawal Criteria|2
1725063|NCT01052077|6015942|P3|Phase A+|Met Withdrawal Criteria|0
1725064|NCT01052077|6015943|P2|Phase A+|Met Withdrawal Criteria|0
1725065|NCT01052077|6015944|P1|Phase A+|Met Withdrawal Criteria|0
1725066|NCT01052077|6015941|P4|Phase A+|Adverse Event|4
1725067|NCT01052077|6015942|P3|Phase A+|Adverse Event|0
1725068|NCT01052077|6015943|P2|Phase A+|Adverse Event|0
1725069|NCT01052077|6015944|P1|Phase A+|Adverse Event|0
1725070|NCT01052077|6015941|P4|Phase A+|Lost to Follow-up|8
1725071|NCT01052077|6015942|P3|Phase A+|Lost to Follow-up|0
1725072|NCT01052077|6015943|P2|Phase A+|Lost to Follow-up|0
1725073|NCT01052077|6015944|P1|Phase A+|Lost to Follow-up|0
1725074|NCT01052077|6015941|P4|Phase B|Lack of Efficacy|0
1725075|NCT01052077|6015942|P3|Phase B|Lack of Efficacy|0
1725076|NCT01052077|6015943|P2|Phase B|Lack of Efficacy|1
1725077|NCT01052077|6015944|P1|Phase B|Lack of Efficacy|0
1725078|NCT01052077|6015941|P4|Phase B|Protocol Deviation|0
1725079|NCT01052077|6015942|P3|Phase B|Protocol Deviation|4
1725080|NCT01052077|6015943|P2|Phase B|Protocol Deviation|3
1725081|NCT01052077|6015944|P1|Phase B|Protocol Deviation|0
1725082|NCT01052077|6015941|P4|Phase B|Withdrawal by Subject|0
1725083|NCT01052077|6015942|P3|Phase B|Withdrawal by Subject|5
1725084|NCT01052077|6015943|P2|Phase B|Withdrawal by Subject|0
1725085|NCT01052077|6015944|P1|Phase B|Withdrawal by Subject|0
1725086|NCT01052077|6015941|P4|Phase B|Physician Decision|0
1725087|NCT01052077|6015942|P3|Phase B|Physician Decision|1
1725088|NCT01052077|6015943|P2|Phase B|Physician Decision|1
1725089|NCT01052077|6015944|P1|Phase B|Physician Decision|0
1725090|NCT01052077|6015941|P4|Phase B|Met Withdrawal Criteria|0
1725091|NCT01052077|6015942|P3|Phase B|Met Withdrawal Criteria|1
1725092|NCT01052077|6015943|P2|Phase B|Met Withdrawal Criteria|2
1725093|NCT01052077|6015944|P1|Phase B|Met Withdrawal Criteria|0
1725094|NCT01052077|6015941|P4|Phase B|Adverse Event|0
1725095|NCT01052077|6015942|P3|Phase B|Adverse Event|2
1725096|NCT01052077|6015943|P2|Phase B|Adverse Event|9
1725097|NCT01052077|6015944|P1|Phase B|Adverse Event|0
1725098|NCT01052077|6015941|P4|Phase B|Lost to Follow-up|0
1725099|NCT01052077|6015942|P3|Phase B|Lost to Follow-up|3
1725100|NCT01052077|6015943|P2|Phase B|Lost to Follow-up|2
1725101|NCT01052077|6015944|P1|Phase B|Lost to Follow-up|0
1725102|NCT01052077|6015941|P4|Phase A|Protocol Deviation|0
1725103|NCT01052077|6015942|P3|Phase A|Protocol Deviation|0
1725104|NCT01052077|6015943|P2|Phase A|Protocol Deviation|0
1725105|NCT01052077|6015944|P1|Phase A|Protocol Deviation|27
1725106|NCT01052077|6015941|P4|Phase A|Withdrawal by Subject|0
1725107|NCT01052077|6015942|P3|Phase A|Withdrawal by Subject|0
1725108|NCT01052077|6015943|P2|Phase A|Withdrawal by Subject|0
1725109|NCT01052077|6015944|P1|Phase A|Withdrawal by Subject|29
1725110|NCT01052077|6015941|P4|Phase A|Physician Decision|0
1725111|NCT01052077|6015942|P3|Phase A|Physician Decision|0
1725112|NCT01052077|6015943|P2|Phase A|Physician Decision|0
1725113|NCT01052077|6015944|P1|Phase A|Physician Decision|10
1725114|NCT01052077|6015941|P4|Phase A|Met Withdrawal Criteria|0
1725115|NCT01052077|6015942|P3|Phase A|Met Withdrawal Criteria|0
1725116|NCT01052077|6015943|P2|Phase A|Met Withdrawal Criteria|0
1725117|NCT01052077|6015944|P1|Phase A|Met Withdrawal Criteria|26
1725118|NCT01052077|6015941|P4|Phase A|Adverse Event|0
1725119|NCT01052077|6015942|P3|Phase A|Adverse Event|0
1725120|NCT01052077|6015943|P2|Phase A|Adverse Event|0
1725121|NCT01052077|6015944|P1|Phase A|Adverse Event|32
1725122|NCT01052077|6015941|P4|Phase A|Lost to Follow-up|0
1725123|NCT01052077|6015942|P3|Phase A|Lost to Follow-up|0
1725124|NCT01052077|6015943|P2|Phase A|Lost to Follow-up|0
1725125|NCT01052077|6015944|P1|Phase A|Lost to Follow-up|22
1725126|NCT01052038|6015971|P3|Overall Study|Protocol Violation|3
1725127|NCT01052038|6015972|P2|Overall Study|Protocol Violation|3
1725128|NCT01052038|6015973|P1|Overall Study|Protocol Violation|2
1725129|NCT01052038|6015971|P3|Overall Study|Lost to Follow-up|1
1725130|NCT01052038|6015972|P2|Overall Study|Lost to Follow-up|3
1725131|NCT01052038|6015973|P1|Overall Study|Lost to Follow-up|2
1725132|NCT01051986|6015995|P2|Overall Study|Protocol Violation|3
1725133|NCT01051986|6015996|P1|Overall Study|Protocol Violation|2
1725134|NCT01051986|6015995|P2|Overall Study|Withdrawal by Subject|1
1725135|NCT01051986|6015996|P1|Overall Study|Withdrawal by Subject|2
1725136|NCT01051986|6015995|P2|Overall Study|Death|0
1725137|NCT01051986|6015996|P1|Overall Study|Death|1
1725138|NCT01051921|6016010|P1|Overall Study|patient moved|1
1725139|NCT01051921|6016010|P1|Overall Study|virological failure|1
1725140|NCT01051921|6016010|P1|Overall Study|Lost to Follow-up|4
1725141|NCT01051921|6016010|P1|Overall Study|Withdrawal by Subject|7
1725142|NCT01051921|6016010|P1|Overall Study|Adverse Event|8
1725143|NCT01051921|6016010|P1|Overall Study|Physician Decision|9
1725144|NCT01051856|6016017|P2|Overall Study|Withdrawal by Subject|0
1725145|NCT01051856|6016018|P1|Overall Study|Withdrawal by Subject|1
1725146|NCT01051817|6016028|P2|Overall Study|Protocol Violation|1
1725147|NCT01051817|6016029|P1|Overall Study|Protocol Violation|0
1725148|NCT01051817|6016028|P2|Overall Study|Withdrawal by Subject|5
1725149|NCT01051817|6016029|P1|Overall Study|Withdrawal by Subject|3
1725150|NCT01051817|6016028|P2|Overall Study|Abnormal Test Proceedure reults|1
1725151|NCT01051817|6016029|P1|Overall Study|Abnormal Test Proceedure reults|0
1725152|NCT01051817|6016028|P2|Overall Study|Adverse Event|2
1725153|NCT01051817|6016029|P1|Overall Study|Adverse Event|0
1725154|NCT01051791|6016039|P1|Overall Study|Withdrawal by Subject|1
1725155|NCT01051791|6016039|P1|Overall Study|Failed screening|3
1725156|NCT01051739|6016057|P2|Overall Study|Withdrawal by Subject|10
1725157|NCT01051739|6016058|P1|Overall Study|Withdrawal by Subject|25
1725158|NCT01051739|6016057|P2|Overall Study|Death|3
1725159|NCT01051739|6016058|P1|Overall Study|Death|3
1725160|NCT01051557|6016082|P7|Overall Study|Adverse Event|4
1725161|NCT01051557|6016083|P6|Overall Study|Adverse Event|3
1725162|NCT01051557|6016084|P5|Overall Study|Adverse Event|1
1725163|NCT01051557|6016085|P4|Overall Study|Adverse Event|1
1725164|NCT01051557|6016086|P3|Overall Study|Adverse Event|0
1725165|NCT01051557|6016087|P2|Overall Study|Adverse Event|0
1725166|NCT01051557|6016088|P1|Overall Study|Adverse Event|0
1725167|NCT01051557|6016082|P7|Overall Study|Withdrawal by Subject|1
1725168|NCT01051557|6016083|P6|Overall Study|Withdrawal by Subject|0
1725169|NCT01051557|6016084|P5|Overall Study|Withdrawal by Subject|2
1725170|NCT01051557|6016085|P4|Overall Study|Withdrawal by Subject|0
1725171|NCT01051557|6016086|P3|Overall Study|Withdrawal by Subject|1
1725172|NCT01051557|6016087|P2|Overall Study|Withdrawal by Subject|0
1725173|NCT01051557|6016088|P1|Overall Study|Withdrawal by Subject|0
1725174|NCT01051557|6016082|P7|Overall Study|disease progression|1
1725175|NCT01051557|6016083|P6|Overall Study|disease progression|3
1725176|NCT01051557|6016084|P5|Overall Study|disease progression|4
1725177|NCT01051557|6016085|P4|Overall Study|disease progression|2
1725178|NCT01051557|6016086|P3|Overall Study|disease progression|5
1725179|NCT01051557|6016087|P2|Overall Study|disease progression|3
1725180|NCT01051557|6016088|P1|Overall Study|disease progression|3
1725181|NCT01051557|6016082|P7|Overall Study|Physician Decision|0
1725182|NCT01051557|6016083|P6|Overall Study|Physician Decision|0
1725183|NCT01051557|6016084|P5|Overall Study|Physician Decision|0
1725184|NCT01051557|6016085|P4|Overall Study|Physician Decision|0
1725185|NCT01051557|6016086|P3|Overall Study|Physician Decision|0
1725186|NCT01051557|6016087|P2|Overall Study|Physician Decision|0
1725187|NCT01051557|6016088|P1|Overall Study|Physician Decision|1
1725188|NCT01051466|6016119|P2|Overall Study|Physician Decision|0
1725189|NCT01051466|6016120|P1|Overall Study|Physician Decision|1
1725190|NCT01051466|6016119|P2|Overall Study|Entry Criteria Not Met|3
1725191|NCT01051466|6016120|P1|Overall Study|Entry Criteria Not Met|0
1725192|NCT01051466|6016119|P2|Overall Study|Withdrawal by Subject|1
1725193|NCT01051466|6016120|P1|Overall Study|Withdrawal by Subject|5
1725194|NCT01051466|6016119|P2|Overall Study|Lost to Follow-up|1
1725195|NCT01051466|6016120|P1|Overall Study|Lost to Follow-up|1
1725196|NCT01051466|6016119|P2|Overall Study|Adverse Event|0
1725197|NCT01051466|6016120|P1|Overall Study|Adverse Event|1
1725198|NCT01051349|6016165|P1|Overall Study|Reason not Specified|12
1725199|NCT01051349|6016165|P1|Overall Study|Subject non-compliance|7
1725200|NCT01051349|6016165|P1|Overall Study|Lost to Follow-up|6
1725201|NCT01051349|6016165|P1|Overall Study|Investigator Decision|6
1725202|NCT01051349|6016165|P1|Overall Study|Consent Withdrawn|54
1725203|NCT01051349|6016165|P1|Overall Study|Adverse Event|88
1725204|NCT01051323|6016194|P1|Overall Study|Missing|37
1725205|NCT01051323|6016194|P1|Overall Study|Other|148
1725206|NCT01051323|6016194|P1|Overall Study|Hospitalization|28
1725207|NCT01051323|6016194|P1|Overall Study|Death|129
1725208|NCT01051323|6016194|P1|Overall Study|Lost to Follow-up|31
1725209|NCT01051323|6016194|P1|Overall Study|Withdrawal by Subject|13
1725210|NCT01051323|6016194|P1|Overall Study|Dialysis dependency|22
1725211|NCT01051323|6016194|P1|Overall Study|Transplantation|28
1725212|NCT01051323|6016194|P1|Overall Study|Discontinuation of treatment|103
1725213|NCT01051063|6016223|P2|Overall Study|Lost to Follow-up|1
1725214|NCT01051063|6016224|P1|Overall Study|Lost to Follow-up|0
1725215|NCT01051063|6016223|P2|Overall Study|Other|0
1725216|NCT01051063|6016224|P1|Overall Study|Other|1
1725217|NCT01051063|6016223|P2|Overall Study|Moved from the study site area|0
1725218|NCT01051063|6016224|P1|Overall Study|Moved from the study site area|1
1725219|NCT01051063|6016223|P2|Overall Study|Termination of the study|0
1725220|NCT01051063|6016224|P1|Overall Study|Termination of the study|5
1725221|NCT01051063|6016223|P2|Overall Study|Withdrawal by Subject|1
1725222|NCT01051063|6016224|P1|Overall Study|Withdrawal by Subject|1
1725223|NCT01051063|6016223|P2|Overall Study|Death|2
1725224|NCT01051063|6016224|P1|Overall Study|Death|2
1725225|NCT01050998|6016244|P5|Overall Study|Data integrity issues|4
1725226|NCT01050998|6016245|P4|Overall Study|Data integrity issues|1
1725227|NCT01050998|6016246|P3|Overall Study|Data integrity issues|1
1725228|NCT01050998|6016247|P2|Overall Study|Data integrity issues|0
1725229|NCT01050998|6016248|P1|Overall Study|Data integrity issues|0
1725230|NCT01050998|6016244|P5|Overall Study|Other|5
1725231|NCT01050998|6016245|P4|Overall Study|Other|1
1725232|NCT01050998|6016246|P3|Overall Study|Other|1
1725233|NCT01050998|6016247|P2|Overall Study|Other|2
1725234|NCT01050998|6016248|P1|Overall Study|Other|3
1725235|NCT01050998|6016244|P5|Overall Study|Withdrawal by Subject|3
1725236|NCT01050998|6016245|P4|Overall Study|Withdrawal by Subject|1
1725237|NCT01050998|6016246|P3|Overall Study|Withdrawal by Subject|0
1725238|NCT01050998|6016247|P2|Overall Study|Withdrawal by Subject|0
1725239|NCT01050998|6016248|P1|Overall Study|Withdrawal by Subject|0
1725240|NCT01050998|6016244|P5|Overall Study|Adverse Event|2
1725241|NCT01050998|6016245|P4|Overall Study|Adverse Event|0
1725242|NCT01050998|6016246|P3|Overall Study|Adverse Event|1
1725243|NCT01050998|6016247|P2|Overall Study|Adverse Event|0
1725244|NCT01050998|6016248|P1|Overall Study|Adverse Event|1
1725245|NCT01050816|6016582|P1|Overall Study|patient's refusal|2
1725246|NCT01050816|6016582|P1|Overall Study|Lost to Follow-up|2
1725247|NCT01050790|6016588|P1|Overall Study|Adverse Event|1
1725248|NCT01050764|6016598|P1|Overall Study|Death after HSCT, before T-cell infusion|1
1725249|NCT01050764|6016598|P1|Overall Study|Donor mobilization failure, death|1
1725250|NCT01050764|6016598|P1|Overall Study|Death, before HSCT|1
1725251|NCT01050673|6016609|P2|Overall Study|Physician Decision|5
1725252|NCT01050673|6016610|P1|Overall Study|Physician Decision|4
1725253|NCT01050634|6016678|P1|Overall Study|Ongoing at Date of Cut-Off|5
1725254|NCT01050634|6016678|P1|Overall Study|Other|21
1725255|NCT01050634|6016678|P1|Overall Study|Lost to Follow-up|2
1725256|NCT01050634|6016678|P1|Overall Study|Adverse Event|42
1725257|NCT01050634|6016678|P1|Overall Study|Death|2
1725258|NCT01050634|6016678|P1|Overall Study|Enrolled, but Not Treated|56
1725259|NCT01050569|6016702|P3|Overall Study|Physician Decision|3
1725260|NCT01050569|6016703|P2|Overall Study|Physician Decision|3
1725261|NCT01050569|6016704|P1|Overall Study|Physician Decision|3
1725262|NCT01050569|6016702|P3|Overall Study|Adverse Event|0
1725263|NCT01050569|6016703|P2|Overall Study|Adverse Event|0
1725264|NCT01050569|6016704|P1|Overall Study|Adverse Event|1
1725265|NCT01050569|6016702|P3|Overall Study|Lack of Efficacy|3
1725266|NCT01050569|6016703|P2|Overall Study|Lack of Efficacy|4
1725267|NCT01050569|6016704|P1|Overall Study|Lack of Efficacy|5
1725268|NCT01050569|6016702|P3|Overall Study|Withdrawal by Subject|11
1725269|NCT01050569|6016703|P2|Overall Study|Withdrawal by Subject|3
1725270|NCT01050569|6016704|P1|Overall Study|Withdrawal by Subject|9
1725271|NCT01050569|6016702|P3|Overall Study|Lost to Follow-up|16
1725272|NCT01050569|6016703|P2|Overall Study|Lost to Follow-up|14
1725273|NCT01050569|6016704|P1|Overall Study|Lost to Follow-up|20
1725274|NCT01050543|6016723|P2|Overall Study|Administrative|1
1725275|NCT01050543|6016724|P1|Overall Study|Administrative|4
1725276|NCT01050543|6016723|P2|Overall Study|Protocol Violation|1
1725277|NCT01050543|6016724|P1|Overall Study|Protocol Violation|0
1725278|NCT01050543|6016723|P2|Overall Study|Withdrawal by Subject|2
1725279|NCT01050543|6016724|P1|Overall Study|Withdrawal by Subject|0
1725280|NCT01050530|6016732|P2|Overall Study|Protocol Violation|0
1725281|NCT01050530|6016733|P1|Overall Study|Protocol Violation|1
1725282|NCT01050530|6016732|P2|Overall Study|Withdrawal by Subject|3
1725283|NCT01050530|6016733|P1|Overall Study|Withdrawal by Subject|0
1725284|NCT01050530|6016732|P2|Overall Study|Lack of Efficacy|4
1725285|NCT01050530|6016733|P1|Overall Study|Lack of Efficacy|1
1725286|NCT01050530|6016732|P2|Overall Study|Adverse Event|3
1725287|NCT01050530|6016733|P1|Overall Study|Adverse Event|6
1725288|NCT01050257|6016744|P3|Overall Study|Death|1
1725289|NCT01050257|6016745|P2|Overall Study|Death|0
1725290|NCT01050257|6016746|P1|Overall Study|Death|0
1725291|NCT01050257|6016744|P3|Overall Study|Failure to return|0
1725292|NCT01050257|6016745|P2|Overall Study|Failure to return|2
1725293|NCT01050257|6016746|P1|Overall Study|Failure to return|0
1725294|NCT01050257|6016744|P3|Overall Study|Violation criteria|0
1725295|NCT01050257|6016745|P2|Overall Study|Violation criteria|1
1725296|NCT01050257|6016746|P1|Overall Study|Violation criteria|0
1725297|NCT01050257|6016744|P3|Overall Study|Refused treatment/ Did not Cooperate|0
1725298|NCT01050257|6016745|P2|Overall Study|Refused treatment/ Did not Cooperate|1
1725299|NCT01050257|6016746|P1|Overall Study|Refused treatment/ Did not Cooperate|1
1725300|NCT01050257|6016744|P3|Overall Study|No reason specified|2
1725301|NCT01050257|6016745|P2|Overall Study|No reason specified|0
1725302|NCT01050257|6016746|P1|Overall Study|No reason specified|0
1725303|NCT01050257|6016744|P3|Overall Study|Withdrawal by Subject|0
1725304|NCT01050257|6016745|P2|Overall Study|Withdrawal by Subject|3
1725305|NCT01050257|6016746|P1|Overall Study|Withdrawal by Subject|0
1725306|NCT01050257|6016744|P3|Overall Study|Admin/Other (did not switch to oral)|2
1725307|NCT01050257|6016745|P2|Overall Study|Admin/Other (did not switch to oral)|2
1725308|NCT01050257|6016746|P1|Overall Study|Admin/Other (did not switch to oral)|6
1725309|NCT01050257|6016744|P3|Overall Study|Adverse Event|2
1725310|NCT01050257|6016745|P2|Overall Study|Adverse Event|4
1725311|NCT01050257|6016746|P1|Overall Study|Adverse Event|4
1725312|NCT01050218|6016781|P1|Overall Study|Family emergency|1
1725313|NCT01050218|6016781|P1|Overall Study|Serious Adverse Event|1
1725314|NCT01050218|6016781|P1|Overall Study|Failed to return|7
1725315|NCT01050218|6016781|P1|Overall Study|Compliance|2
1725316|NCT01050218|6016781|P1|Overall Study|Discontinued by sponsor|18
1725317|NCT01050218|6016781|P1|Overall Study|Withdrawal by Subject|18
1725318|NCT01050218|6016781|P1|Overall Study|Protocol Violation|3
1725319|NCT01050218|6016781|P1|Overall Study|Lack of Efficacy|8
1725320|NCT01050218|6016781|P1|Overall Study|Adverse Event|37
1725321|NCT01050205|6016787|P2|Overall Study|Discontinued Intervention|0
1725322|NCT01050205|6016788|P1|Overall Study|Discontinued Intervention|2
1725323|NCT01050205|6016787|P2|Overall Study|Relocated from area|2
1725324|NCT01050205|6016788|P1|Overall Study|Relocated from area|1
1725325|NCT01050205|6016787|P2|Overall Study|Withdrawal by Subject|1
1725326|NCT01050205|6016788|P1|Overall Study|Withdrawal by Subject|1
1725327|NCT01050205|6016787|P2|Overall Study|Lost to Follow-up|1
1725328|NCT01050205|6016788|P1|Overall Study|Lost to Follow-up|7
1725329|NCT01050062|6016845|P2|Overall Study|Others|11
1725330|NCT01050062|6016846|P1|Overall Study|Others|17
1725331|NCT01050062|6016845|P2|Overall Study|Physician Decision|9
1725332|NCT01050062|6016846|P1|Overall Study|Physician Decision|74
1725333|NCT01050062|6016845|P2|Overall Study|Lack of Efficacy|35
1725334|NCT01050062|6016846|P1|Overall Study|Lack of Efficacy|22
1725335|NCT01050062|6016845|P2|Overall Study|Lost to Follow-up|35
1725336|NCT01050062|6016846|P1|Overall Study|Lost to Follow-up|83
1725337|NCT01050062|6016845|P2|Overall Study|Adverse Event|22
1725338|NCT01050062|6016846|P1|Overall Study|Adverse Event|75
1725339|NCT01049984|6016868|P2|Overall Study|Treatment failure|2
1725340|NCT01049984|6016869|P1|Overall Study|Treatment failure|0
1725341|NCT01049984|6016868|P2|Overall Study|Adverse Event|7
1725342|NCT01049984|6016869|P1|Overall Study|Adverse Event|13
1725343|NCT01049984|6016868|P2|Overall Study|Lost to Follow-up|1
1725344|NCT01049984|6016869|P1|Overall Study|Lost to Follow-up|2
1725345|NCT01049984|6016868|P2|Overall Study|Protocol Violation|4
1725346|NCT01049984|6016869|P1|Overall Study|Protocol Violation|3
1725347|NCT01049984|6016868|P2|Overall Study|Withdrawal by Subject|5
1725348|NCT01049984|6016869|P1|Overall Study|Withdrawal by Subject|1
1725349|NCT01049581|6016933|P2|Overall Study|Lost to Follow-up|1
1725350|NCT01049581|6016934|P1|Overall Study|Lost to Follow-up|2
1725351|NCT01049503|6016949|P6|Overall Study|Lost to Follow-up|8
1725352|NCT01049503|6016950|P5|Overall Study|Lost to Follow-up|27
1725353|NCT01049503|6016951|P4|Overall Study|Lost to Follow-up|26
1725354|NCT01049503|6016952|P3|Overall Study|Lost to Follow-up|24
1725355|NCT01049503|6016953|P2|Overall Study|Lost to Follow-up|12
1725356|NCT01049503|6016954|P1|Overall Study|Lost to Follow-up|11
1725357|NCT01049412|6016985|P2|Period II|Lost to Follow-up|0
1725358|NCT01049412|6016986|P1|Period II|Lost to Follow-up|1
1725359|NCT01049412|6016985|P2|Period II|Adverse Event|0
1725360|NCT01049412|6016986|P1|Period II|Adverse Event|1
1725361|NCT01049412|6016985|P2|Period II|Withdrawal by Subject|3
1725362|NCT01049412|6016986|P1|Period II|Withdrawal by Subject|2
1725363|NCT01049412|6016985|P2|Period I|Adverse Event|0
1725364|NCT01049412|6016986|P1|Period I|Adverse Event|1
1725365|NCT01049412|6016985|P2|Period I|Protocol Violation|2
1725366|NCT01049412|6016986|P1|Period I|Protocol Violation|1
1725367|NCT01049412|6016985|P2|Period I|Physician Decision|3
1725368|NCT01049412|6016986|P1|Period I|Physician Decision|0
1725369|NCT01049412|6016985|P2|Period I|Lost to Follow-up|2
1725370|NCT01049412|6016986|P1|Period I|Lost to Follow-up|2
1725371|NCT01049412|6016985|P2|Period I|Withdrawal by Subject|6
1725372|NCT01049412|6016986|P1|Period I|Withdrawal by Subject|4
1725373|NCT01049373|6017015|P2|Overall Study|Non-cooperation|1
1725374|NCT01049373|6017016|P1|Overall Study|Non-cooperation|0
1725375|NCT01049373|6017015|P2|Overall Study|Other|1
1725376|NCT01049373|6017016|P1|Overall Study|Other|1
1725377|NCT01049373|6017015|P2|Overall Study|no evaluable study values|21
1725378|NCT01049373|6017016|P1|Overall Study|no evaluable study values|9
1725379|NCT01049373|6017015|P2|Overall Study|Lost to Follow-up|4
1725380|NCT01049373|6017016|P1|Overall Study|Lost to Follow-up|9
1725381|NCT01049373|6017015|P2|Overall Study|Adverse Event|3
1725382|NCT01049373|6017016|P1|Overall Study|Adverse Event|3
1725383|NCT01049373|6017015|P2|Overall Study|Withdrawal by Subject|5
1725384|NCT01049373|6017016|P1|Overall Study|Withdrawal by Subject|8
1725385|NCT01049373|6017015|P2|Overall Study|Protocol Violation|9
1725386|NCT01049373|6017016|P1|Overall Study|Protocol Violation|9
1725387|NCT01049360|6017030|P20|Period 4|Withdrawal by Subject|0
1725388|NCT01049360|6017031|P19|Period 4|Withdrawal by Subject|0
1725389|NCT01049360|6017032|P18|Period 4|Withdrawal by Subject|0
1725390|NCT01049360|6017033|P17|Period 4|Withdrawal by Subject|0
1725391|NCT01049360|6017034|P16|Period 4|Withdrawal by Subject|0
1725392|NCT01049360|6017035|P15|Period 4|Withdrawal by Subject|0
1725393|NCT01049360|6017036|P14|Period 4|Withdrawal by Subject|0
1725394|NCT01049360|6017037|P13|Period 4|Withdrawal by Subject|0
1725395|NCT01049360|6017038|P12|Period 4|Withdrawal by Subject|0
1725396|NCT01049360|6017039|P11|Period 4|Withdrawal by Subject|0
1725397|NCT01049360|6017040|P10|Period 4|Withdrawal by Subject|0
1725398|NCT01049360|6017041|P9|Period 4|Withdrawal by Subject|0
1725399|NCT01049360|6017042|P8|Period 4|Withdrawal by Subject|0
1725400|NCT01049360|6017043|P7|Period 4|Withdrawal by Subject|0
1725401|NCT01049360|6017044|P6|Period 4|Withdrawal by Subject|0
1725402|NCT01049360|6017045|P5|Period 4|Withdrawal by Subject|0
1725403|NCT01049360|6017046|P4|Period 4|Withdrawal by Subject|1
1725404|NCT01049360|6017047|P3|Period 4|Withdrawal by Subject|0
1725405|NCT01049360|6017048|P2|Period 4|Withdrawal by Subject|0
1725406|NCT01049360|6017049|P1|Period 4|Withdrawal by Subject|0
1725407|NCT01049360|6017030|P20|Period 4|Protocol Violation|0
1725408|NCT01049360|6017031|P19|Period 4|Protocol Violation|0
1725409|NCT01049360|6017032|P18|Period 4|Protocol Violation|1
1725410|NCT01049360|6017033|P17|Period 4|Protocol Violation|0
1725411|NCT01049360|6017034|P16|Period 4|Protocol Violation|0
1725412|NCT01049360|6017035|P15|Period 4|Protocol Violation|0
1725413|NCT01049360|6017036|P14|Period 4|Protocol Violation|0
1725414|NCT01049360|6017037|P13|Period 4|Protocol Violation|0
1725415|NCT01049360|6017038|P12|Period 4|Protocol Violation|0
1725416|NCT01049360|6017039|P11|Period 4|Protocol Violation|0
1725417|NCT01049360|6017040|P10|Period 4|Protocol Violation|0
1725418|NCT01049360|6017041|P9|Period 4|Protocol Violation|0
1725419|NCT01049360|6017042|P8|Period 4|Protocol Violation|0
1725420|NCT01049360|6017043|P7|Period 4|Protocol Violation|0
1725421|NCT01049360|6017044|P6|Period 4|Protocol Violation|0
1725422|NCT01049360|6017045|P5|Period 4|Protocol Violation|0
1725423|NCT01049360|6017046|P4|Period 4|Protocol Violation|0
1725424|NCT01049360|6017047|P3|Period 4|Protocol Violation|0
1725425|NCT01049360|6017048|P2|Period 4|Protocol Violation|0
1725426|NCT01049360|6017049|P1|Period 4|Protocol Violation|0
1725427|NCT01049360|6017030|P20|Period 2|Lack of Efficacy|0
1725428|NCT01049360|6017031|P19|Period 2|Lack of Efficacy|0
1725429|NCT01049360|6017032|P18|Period 2|Lack of Efficacy|0
1725430|NCT01049360|6017033|P17|Period 2|Lack of Efficacy|0
1725431|NCT01049360|6017034|P16|Period 2|Lack of Efficacy|0
1725432|NCT01049360|6017035|P15|Period 2|Lack of Efficacy|0
1725433|NCT01049360|6017036|P14|Period 2|Lack of Efficacy|0
1725434|NCT01049360|6017037|P13|Period 2|Lack of Efficacy|0
1725435|NCT01049360|6017038|P12|Period 2|Lack of Efficacy|0
1725436|NCT01049360|6017039|P11|Period 2|Lack of Efficacy|0
1725437|NCT01049360|6017040|P10|Period 2|Lack of Efficacy|0
1725438|NCT01049360|6017041|P9|Period 2|Lack of Efficacy|0
1725439|NCT01049360|6017042|P8|Period 2|Lack of Efficacy|0
1725440|NCT01049360|6017043|P7|Period 2|Lack of Efficacy|0
1725441|NCT01049360|6017044|P6|Period 2|Lack of Efficacy|1
1725442|NCT01049360|6017045|P5|Period 2|Lack of Efficacy|0
1725443|NCT01049360|6017046|P4|Period 2|Lack of Efficacy|0
1725444|NCT01049360|6017047|P3|Period 2|Lack of Efficacy|0
1725445|NCT01049360|6017048|P2|Period 2|Lack of Efficacy|0
1725446|NCT01049360|6017049|P1|Period 2|Lack of Efficacy|0
1725447|NCT01049360|6017030|P20|Period 2|Withdrawal by Subject|1
1725448|NCT01049360|6017031|P19|Period 2|Withdrawal by Subject|0
1725449|NCT01049360|6017032|P18|Period 2|Withdrawal by Subject|0
1725450|NCT01049360|6017033|P17|Period 2|Withdrawal by Subject|0
1725451|NCT01049360|6017034|P16|Period 2|Withdrawal by Subject|0
1725452|NCT01049360|6017035|P15|Period 2|Withdrawal by Subject|1
1725453|NCT01049360|6017036|P14|Period 2|Withdrawal by Subject|0
1725454|NCT01049360|6017037|P13|Period 2|Withdrawal by Subject|0
1725455|NCT01049360|6017038|P12|Period 2|Withdrawal by Subject|0
1725456|NCT01049360|6017039|P11|Period 2|Withdrawal by Subject|0
1725457|NCT01049360|6017040|P10|Period 2|Withdrawal by Subject|0
1725458|NCT01049360|6017041|P9|Period 2|Withdrawal by Subject|0
1725459|NCT01049360|6017042|P8|Period 2|Withdrawal by Subject|0
1725460|NCT01049360|6017043|P7|Period 2|Withdrawal by Subject|0
1725461|NCT01049360|6017044|P6|Period 2|Withdrawal by Subject|0
1725462|NCT01049360|6017045|P5|Period 2|Withdrawal by Subject|0
1725463|NCT01049360|6017046|P4|Period 2|Withdrawal by Subject|1
1725464|NCT01049360|6017047|P3|Period 2|Withdrawal by Subject|0
1725465|NCT01049360|6017048|P2|Period 2|Withdrawal by Subject|0
1725466|NCT01049360|6017049|P1|Period 2|Withdrawal by Subject|0
1725467|NCT01049360|6017030|P20|Period 2|Adverse Event|1
1725468|NCT01049360|6017031|P19|Period 2|Adverse Event|0
1725469|NCT01049360|6017032|P18|Period 2|Adverse Event|0
1725470|NCT01049360|6017033|P17|Period 2|Adverse Event|0
1725471|NCT01049360|6017034|P16|Period 2|Adverse Event|0
1725472|NCT01049360|6017035|P15|Period 2|Adverse Event|0
1725473|NCT01049360|6017036|P14|Period 2|Adverse Event|0
1725474|NCT01049360|6017037|P13|Period 2|Adverse Event|0
1725475|NCT01049360|6017038|P12|Period 2|Adverse Event|0
1725476|NCT01049360|6017039|P11|Period 2|Adverse Event|0
1725477|NCT01049360|6017040|P10|Period 2|Adverse Event|0
1725478|NCT01049360|6017041|P9|Period 2|Adverse Event|1
1725479|NCT01049360|6017042|P8|Period 2|Adverse Event|0
1725480|NCT01049360|6017043|P7|Period 2|Adverse Event|0
1725481|NCT01049360|6017044|P6|Period 2|Adverse Event|0
1725482|NCT01049360|6017045|P5|Period 2|Adverse Event|0
1725483|NCT01049360|6017046|P4|Period 2|Adverse Event|0
1725484|NCT01049360|6017047|P3|Period 2|Adverse Event|0
1725485|NCT01049360|6017048|P2|Period 2|Adverse Event|1
1725486|NCT01049360|6017049|P1|Period 2|Adverse Event|0
1725487|NCT01049360|6017030|P20|Period 2|Protocol Violation|0
1725488|NCT01049360|6017031|P19|Period 2|Protocol Violation|0
1725489|NCT01049360|6017032|P18|Period 2|Protocol Violation|0
1725490|NCT01049360|6017033|P17|Period 2|Protocol Violation|0
1725491|NCT01049360|6017034|P16|Period 2|Protocol Violation|1
1725492|NCT01049360|6017035|P15|Period 2|Protocol Violation|1
1725493|NCT01049360|6017036|P14|Period 2|Protocol Violation|0
1725494|NCT01049360|6017037|P13|Period 2|Protocol Violation|0
1725495|NCT01049360|6017038|P12|Period 2|Protocol Violation|0
1725496|NCT01049360|6017039|P11|Period 2|Protocol Violation|0
1725497|NCT01049360|6017040|P10|Period 2|Protocol Violation|0
1725498|NCT01049360|6017041|P9|Period 2|Protocol Violation|0
1725499|NCT01049360|6017042|P8|Period 2|Protocol Violation|0
1725500|NCT01049360|6017043|P7|Period 2|Protocol Violation|0
1725501|NCT01049360|6017044|P6|Period 2|Protocol Violation|0
1725502|NCT01049360|6017045|P5|Period 2|Protocol Violation|0
1725503|NCT01049360|6017046|P4|Period 2|Protocol Violation|1
1725504|NCT01049360|6017047|P3|Period 2|Protocol Violation|0
1725505|NCT01049360|6017048|P2|Period 2|Protocol Violation|0
1725506|NCT01049360|6017049|P1|Period 2|Protocol Violation|0
1725507|NCT01049360|6017030|P20|Period 1|Withdrawal by Subject|0
1725508|NCT01049360|6017031|P19|Period 1|Withdrawal by Subject|0
1725509|NCT01049360|6017032|P18|Period 1|Withdrawal by Subject|0
1725510|NCT01049360|6017033|P17|Period 1|Withdrawal by Subject|0
1725511|NCT01049360|6017034|P16|Period 1|Withdrawal by Subject|0
1725512|NCT01049360|6017035|P15|Period 1|Withdrawal by Subject|0
1725513|NCT01049360|6017036|P14|Period 1|Withdrawal by Subject|0
1725514|NCT01049360|6017037|P13|Period 1|Withdrawal by Subject|1
1725515|NCT01049360|6017038|P12|Period 1|Withdrawal by Subject|0
1725516|NCT01049360|6017039|P11|Period 1|Withdrawal by Subject|1
1725517|NCT01049360|6017040|P10|Period 1|Withdrawal by Subject|0
1725518|NCT01049360|6017041|P9|Period 1|Withdrawal by Subject|1
1725519|NCT01049360|6017042|P8|Period 1|Withdrawal by Subject|0
1725520|NCT01049360|6017043|P7|Period 1|Withdrawal by Subject|0
1725521|NCT01049360|6017044|P6|Period 1|Withdrawal by Subject|0
1725522|NCT01049360|6017045|P5|Period 1|Withdrawal by Subject|0
1725523|NCT01049360|6017046|P4|Period 1|Withdrawal by Subject|0
1725524|NCT01049360|6017047|P3|Period 1|Withdrawal by Subject|0
1725525|NCT01049360|6017048|P2|Period 1|Withdrawal by Subject|0
1725526|NCT01049360|6017049|P1|Period 1|Withdrawal by Subject|0
1725527|NCT01049360|6017030|P20|Period 1|Did not meet inc/exc criteria|0
1725528|NCT01049360|6017031|P19|Period 1|Did not meet inc/exc criteria|0
1725529|NCT01049360|6017032|P18|Period 1|Did not meet inc/exc criteria|0
1725530|NCT01049360|6017033|P17|Period 1|Did not meet inc/exc criteria|0
1725531|NCT01049360|6017034|P16|Period 1|Did not meet inc/exc criteria|0
1725532|NCT01049360|6017035|P15|Period 1|Did not meet inc/exc criteria|0
1725533|NCT01049360|6017036|P14|Period 1|Did not meet inc/exc criteria|0
1725534|NCT01049360|6017037|P13|Period 1|Did not meet inc/exc criteria|0
1725535|NCT01049360|6017038|P12|Period 1|Did not meet inc/exc criteria|0
1725536|NCT01049360|6017039|P11|Period 1|Did not meet inc/exc criteria|0
1725537|NCT01049360|6017040|P10|Period 1|Did not meet inc/exc criteria|0
1725538|NCT01049360|6017041|P9|Period 1|Did not meet inc/exc criteria|1
1725539|NCT01049360|6017042|P8|Period 1|Did not meet inc/exc criteria|1
1725540|NCT01049360|6017043|P7|Period 1|Did not meet inc/exc criteria|0
1725541|NCT01049360|6017044|P6|Period 1|Did not meet inc/exc criteria|0
1725542|NCT01049360|6017045|P5|Period 1|Did not meet inc/exc criteria|0
1725543|NCT01049360|6017046|P4|Period 1|Did not meet inc/exc criteria|0
1725544|NCT01049360|6017047|P3|Period 1|Did not meet inc/exc criteria|0
1725545|NCT01049360|6017048|P2|Period 1|Did not meet inc/exc criteria|0
1725546|NCT01049360|6017049|P1|Period 1|Did not meet inc/exc criteria|0
1725547|NCT01049360|6017030|P20|Period 1|Adverse Event|0
1725548|NCT01049360|6017031|P19|Period 1|Adverse Event|1
1725549|NCT01049360|6017032|P18|Period 1|Adverse Event|0
1725550|NCT01049360|6017033|P17|Period 1|Adverse Event|1
1725551|NCT01049360|6017034|P16|Period 1|Adverse Event|0
1725552|NCT01049360|6017035|P15|Period 1|Adverse Event|0
1725553|NCT01049360|6017036|P14|Period 1|Adverse Event|1
1725554|NCT01049360|6017037|P13|Period 1|Adverse Event|1
1725555|NCT01049360|6017038|P12|Period 1|Adverse Event|0
1725556|NCT01049360|6017039|P11|Period 1|Adverse Event|0
1725557|NCT01049360|6017040|P10|Period 1|Adverse Event|0
1725558|NCT01049360|6017041|P9|Period 1|Adverse Event|0
1725559|NCT01049360|6017042|P8|Period 1|Adverse Event|1
1725560|NCT01049360|6017043|P7|Period 1|Adverse Event|0
1725561|NCT01049360|6017044|P6|Period 1|Adverse Event|0
1725562|NCT01049360|6017045|P5|Period 1|Adverse Event|0
1725563|NCT01049360|6017046|P4|Period 1|Adverse Event|1
1725564|NCT01049360|6017047|P3|Period 1|Adverse Event|0
1725565|NCT01049360|6017048|P2|Period 1|Adverse Event|1
1725566|NCT01049360|6017049|P1|Period 1|Adverse Event|0
1725567|NCT01049334|6017073|P2|Overall Study|Protocol Violation|1
1725568|NCT01049334|6017074|P1|Overall Study|Protocol Violation|0
1725569|NCT01049334|6017073|P2|Overall Study|Physician Decision|0
1725570|NCT01049334|6017074|P1|Overall Study|Physician Decision|2
1725571|NCT01049334|6017073|P2|Overall Study|Adverse Event|3
1725572|NCT01049334|6017074|P1|Overall Study|Adverse Event|2
1725573|NCT01049334|6017073|P2|Overall Study|Withdrawal by Subject|3
1725574|NCT01049334|6017074|P1|Overall Study|Withdrawal by Subject|5
1725575|NCT01049308|6017110|P1|Pill Counts|Withdrawal by Subject|83
1725576|NCT01049217|6017124|P2|Overall Study|Randomized but not Treated|2
1725577|NCT01049217|6017125|P1|Overall Study|Randomized but not Treated|0
1725578|NCT01049217|6017124|P2|Overall Study|Other|2
1725579|NCT01049217|6017125|P1|Overall Study|Other|1
1725580|NCT01049217|6017124|P2|Overall Study|Study Terminated by Sponsor|43
1725581|NCT01049217|6017125|P1|Overall Study|Study Terminated by Sponsor|43
1725582|NCT01049217|6017124|P2|Overall Study|Pregnancy|0
1725583|NCT01049217|6017125|P1|Overall Study|Pregnancy|1
1725584|NCT01049217|6017124|P2|Overall Study|Protocol Violation|3
1725585|NCT01049217|6017125|P1|Overall Study|Protocol Violation|1
1725586|NCT01049217|6017124|P2|Overall Study|Withdrawal by Subject|3
1725587|NCT01049217|6017125|P1|Overall Study|Withdrawal by Subject|4
1725588|NCT01049217|6017124|P2|Overall Study|Lost to Follow-up|8
1725589|NCT01049217|6017125|P1|Overall Study|Lost to Follow-up|3
1725590|NCT01049217|6017124|P2|Overall Study|Lack of Efficacy|1
1725591|NCT01049217|6017125|P1|Overall Study|Lack of Efficacy|1
1725592|NCT01049217|6017124|P2|Overall Study|Adverse Event|1
1725593|NCT01049217|6017125|P1|Overall Study|Adverse Event|2
1725594|NCT01049009|6017197|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
1725595|NCT01049009|6017198|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
1725596|NCT01049009|6017197|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
1725597|NCT01049009|6017198|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
1725598|NCT01049009|6017197|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
1725599|NCT01049009|6017198|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
1725600|NCT01049009|6017197|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1725601|NCT01049009|6017198|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
1725602|NCT01048944|6017210|P4|Overall Study|Protocol Violation|2
1725603|NCT01048944|6017211|P3|Overall Study|Protocol Violation|10
1725604|NCT01048944|6017212|P2|Overall Study|Protocol Violation|10
1725605|NCT01048944|6017213|P1|Overall Study|Protocol Violation|8
1725606|NCT01048866|6017245|P2|Overall Study|Other|1
1725607|NCT01048866|6017246|P1|Overall Study|Other|1
1725608|NCT01048866|6017245|P2|Overall Study|Lost to Follow-up|2
1725609|NCT01048866|6017246|P1|Overall Study|Lost to Follow-up|0
1725610|NCT01048866|6017245|P2|Overall Study|Withdrawal by Subject|2
1725611|NCT01048866|6017246|P1|Overall Study|Withdrawal by Subject|0
1725612|NCT01048866|6017245|P2|Overall Study|Physician Decision|0
1725613|NCT01048866|6017246|P1|Overall Study|Physician Decision|1
1725614|NCT01048866|6017245|P2|Overall Study|Protocol Violation|0
1725615|NCT01048866|6017246|P1|Overall Study|Protocol Violation|1
1725616|NCT01048866|6017245|P2|Overall Study|Adverse Event|0
1725617|NCT01048866|6017246|P1|Overall Study|Adverse Event|1
1725618|NCT01048788|6017291|P3|Overall Study|Withdrawal by Subject|0
1725619|NCT01048788|6017292|P2|Overall Study|Withdrawal by Subject|1
1725620|NCT01048788|6017293|P1|Overall Study|Withdrawal by Subject|0
1725621|NCT01048788|6017291|P3|Overall Study|Lack of Efficacy|1
1725622|NCT01048788|6017292|P2|Overall Study|Lack of Efficacy|0
1725623|NCT01048788|6017293|P1|Overall Study|Lack of Efficacy|0
1725624|NCT01048788|6017291|P3|Overall Study|Adverse Event|1
1725625|NCT01048788|6017292|P2|Overall Study|Adverse Event|1
1725626|NCT01048788|6017293|P1|Overall Study|Adverse Event|5
1725627|NCT01048671|6017315|P3|Overall Study|Protocol Violation|1
1725628|NCT01048671|6017316|P2|Overall Study|Protocol Violation|1
1725629|NCT01048671|6017317|P1|Overall Study|Protocol Violation|0
1725630|NCT01048541|6017397|P2|Overall Study|Withdrawal by Subject|0
1725631|NCT01048541|6017398|P1|Overall Study|Withdrawal by Subject|1
1725632|NCT01048502|6017408|P4|Overall Study|Physician Decision|1
1725633|NCT01048502|6017409|P3|Overall Study|Physician Decision|0
1725634|NCT01048502|6017410|P2|Overall Study|Physician Decision|3
1725635|NCT01048502|6017411|P1|Overall Study|Physician Decision|0
1725636|NCT01048502|6017408|P4|Overall Study|Withdrawal by Subject|3
1725637|NCT01048502|6017409|P3|Overall Study|Withdrawal by Subject|5
1725638|NCT01048502|6017410|P2|Overall Study|Withdrawal by Subject|4
1725639|NCT01048502|6017411|P1|Overall Study|Withdrawal by Subject|1
1725640|NCT01048502|6017408|P4|Overall Study|Adverse Event|0
1725641|NCT01048502|6017409|P3|Overall Study|Adverse Event|0
1725642|NCT01048502|6017410|P2|Overall Study|Adverse Event|0
1725643|NCT01048502|6017411|P1|Overall Study|Adverse Event|1
1725644|NCT01048502|6017408|P4|Overall Study|Lost to Follow-up|0
1725645|NCT01048502|6017409|P3|Overall Study|Lost to Follow-up|0
1725646|NCT01048502|6017410|P2|Overall Study|Lost to Follow-up|0
1725647|NCT01048502|6017411|P1|Overall Study|Lost to Follow-up|2
1725648|NCT01048333|6017447|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1725649|NCT01048333|6017448|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1725650|NCT01048333|6017449|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1725651|NCT01048333|6017450|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1725652|NCT01048333|6017451|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
1725653|NCT01048333|6017452|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
1725654|NCT01048242|6017474|P2|Overall Study|See study flow chart|2
1725655|NCT01048242|6017475|P1|Overall Study|See study flow chart|4
1725656|NCT01048099|6017490|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
1725657|NCT01048099|6017490|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
1725658|NCT01047553|6017520|P2|Overall Study|PI's decision|1
1725659|NCT01047553|6017521|P1|Overall Study|PI's decision|0
1725660|NCT01047553|6017520|P2|Overall Study|Sever Non-Compliance to Protocol|0
1725661|NCT01047553|6017521|P1|Overall Study|Sever Non-Compliance to Protocol|1
1725662|NCT01047553|6017520|P2|Overall Study|Lost to Follow-up|0
1725663|NCT01047553|6017521|P1|Overall Study|Lost to Follow-up|1
1725664|NCT01047553|6017520|P2|Overall Study|Development of Study-Specific Withdrawal|1
1725665|NCT01047553|6017521|P1|Overall Study|Development of Study-Specific Withdrawal|1
1725666|NCT01047553|6017520|P2|Overall Study|Withdrawal by Subject|2
1725667|NCT01047553|6017521|P1|Overall Study|Withdrawal by Subject|4
1725668|NCT01047553|6017520|P2|Overall Study|Adverse Event|5
1725669|NCT01047553|6017521|P1|Overall Study|Adverse Event|10
1725670|NCT01047436|6017628|P2|Overall Study|Protocol Violation|0
1725671|NCT01047436|6017629|P1|Overall Study|Protocol Violation|1
1725672|NCT01047345|6017654|P3|Extension|Lost to Follow-up|5
1725673|NCT01047345|6017655|P2|Extension|Lost to Follow-up|0
1725674|NCT01047345|6017656|P1|Extension|Lost to Follow-up|0
1725675|NCT01047345|6017654|P3|Extension|Withdrawal by Subject|1
1725676|NCT01047345|6017655|P2|Extension|Withdrawal by Subject|0
1725677|NCT01047345|6017656|P1|Extension|Withdrawal by Subject|0
1725678|NCT01047345|6017654|P3|Base Study|Withdrawal by Subject|0
1725679|NCT01047345|6017655|P2|Base Study|Withdrawal by Subject|4
1725680|NCT01047345|6017656|P1|Base Study|Withdrawal by Subject|12
1725681|NCT01047345|6017654|P3|Base Study|Protocol Violation|0
1725682|NCT01047345|6017655|P2|Base Study|Protocol Violation|1
1725683|NCT01047345|6017656|P1|Base Study|Protocol Violation|3
1725684|NCT01047345|6017654|P3|Base Study|Lost to Follow-up|0
1725685|NCT01047345|6017655|P2|Base Study|Lost to Follow-up|1
1725686|NCT01047345|6017656|P1|Base Study|Lost to Follow-up|4
1725687|NCT01047345|6017654|P3|Base Study|Adverse Event|0
1725688|NCT01047345|6017655|P2|Base Study|Adverse Event|0
1725689|NCT01047345|6017656|P1|Base Study|Adverse Event|3
1725690|NCT01047332|6017678|P2|Overall Study|Lost to Follow-up|3
1725691|NCT01047332|6017679|P1|Overall Study|Lost to Follow-up|8
1725692|NCT01047332|6017678|P2|Overall Study|Died Unobstructed|41
1725693|NCT01047332|6017679|P1|Overall Study|Died Unobstructed|38
1725694|NCT01047332|6017678|P2|Overall Study|SEMS Obstruction|20
1725695|NCT01047332|6017679|P1|Overall Study|SEMS Obstruction|11
1725696|NCT01047319|6017694|P3|Overall Study|Study terminated by Sponsor|203
1725697|NCT01047319|6017695|P2|Overall Study|Study terminated by Sponsor|215
1725698|NCT01047319|6017696|P1|Overall Study|Study terminated by Sponsor|198
1725699|NCT01047319|6017694|P3|Overall Study|Withdrawal by Subject|87
1725700|NCT01047319|6017695|P2|Overall Study|Withdrawal by Subject|75
1725701|NCT01047319|6017696|P1|Overall Study|Withdrawal by Subject|77
1725702|NCT01047319|6017694|P3|Overall Study|Adverse Event|21
1725703|NCT01047319|6017695|P2|Overall Study|Adverse Event|27
1725704|NCT01047319|6017696|P1|Overall Study|Adverse Event|16
1725705|NCT01047319|6017694|P3|Overall Study|Lost to Follow-up|10
1725706|NCT01047319|6017695|P2|Overall Study|Lost to Follow-up|10
1725707|NCT01047319|6017696|P1|Overall Study|Lost to Follow-up|14
1725708|NCT01047319|6017694|P3|Overall Study|Physician Decision|10
1725709|NCT01047319|6017695|P2|Overall Study|Physician Decision|9
1725710|NCT01047319|6017696|P1|Overall Study|Physician Decision|12
1725711|NCT01047319|6017694|P3|Overall Study|Pregnancy|8
1725712|NCT01047319|6017695|P2|Overall Study|Pregnancy|8
1725713|NCT01047319|6017696|P1|Overall Study|Pregnancy|13
1725714|NCT01047319|6017694|P3|Overall Study|Death|5
1725715|NCT01047319|6017695|P2|Overall Study|Death|1
1725716|NCT01047319|6017696|P1|Overall Study|Death|5
1725717|NCT01047319|6017694|P3|Overall Study|Lack of Efficacy|3
1725718|NCT01047319|6017695|P2|Overall Study|Lack of Efficacy|3
1725719|NCT01047319|6017696|P1|Overall Study|Lack of Efficacy|4
1725720|NCT01047319|6017694|P3|Overall Study|Protocol Violation|4
1725721|NCT01047319|6017695|P2|Overall Study|Protocol Violation|2
1725722|NCT01047319|6017696|P1|Overall Study|Protocol Violation|3
1725723|NCT01047319|6017694|P3|Overall Study|Teva requested participant withdrawal|1
1725724|NCT01047319|6017695|P2|Overall Study|Teva requested participant withdrawal|0
1725725|NCT01047319|6017696|P1|Overall Study|Teva requested participant withdrawal|3
1725726|NCT01047306|6017718|P2|Overall Study|Lost to Follow-up|0
1725727|NCT01047306|6017719|P1|Overall Study|Lost to Follow-up|1
1725728|NCT01047306|6017718|P2|Overall Study|Withdrawal by Subject|0
1725729|NCT01047306|6017719|P1|Overall Study|Withdrawal by Subject|2
1725730|NCT01047293|6017793|P4|Overall Study|DLT criteria not fulfilled|0
1725731|NCT01047293|6017794|P3|Overall Study|DLT criteria not fulfilled|0
1725732|NCT01047293|6017795|P2|Overall Study|DLT criteria not fulfilled|1
1725733|NCT01047293|6017796|P1|Overall Study|DLT criteria not fulfilled|1
1725734|NCT01047007|6017827|P4|Overall Study|Progressive Disease|0
1725735|NCT01047007|6017828|P3|Overall Study|Progressive Disease|1
1725736|NCT01047007|6017829|P2|Overall Study|Progressive Disease|4
1725737|NCT01047007|6017830|P1|Overall Study|Progressive Disease|2
1725738|NCT01047007|6017827|P4|Overall Study|Adverse Event|0
1725739|NCT01047007|6017828|P3|Overall Study|Adverse Event|1
1725740|NCT01047007|6017829|P2|Overall Study|Adverse Event|2
1725741|NCT01047007|6017830|P1|Overall Study|Adverse Event|0
1725742|NCT01046903|6017841|P1|Overall Study|Other|5
1725743|NCT01046903|6017841|P1|Overall Study|Withdrawal by Subject|3
1725744|NCT01046903|6017841|P1|Overall Study|Adverse Event|4
1725745|NCT01046903|6017841|P1|Overall Study|Lost to Follow-up|16
1725746|NCT01046877|6017854|P1|Overall Study|Exited voluntarily after tube extrusion|11
1725747|NCT01046877|6017854|P1|Overall Study|Exited voluntarily before tube extrusion|7
1725748|NCT01046695|6017870|P2|Overall Study|TENS interfered with the cardiac monitor|1
1725749|NCT01046695|6017871|P1|Overall Study|TENS interfered with the cardiac monitor|0
1725750|NCT01046695|6017870|P2|Overall Study|Subject had a pacemaker|1
1725751|NCT01046695|6017871|P1|Overall Study|Subject had a pacemaker|0
1725752|NCT01046682|6017883|P2|Overall Study|Adverse Event|0
1725753|NCT01046682|6017884|P1|Overall Study|Adverse Event|2
1725754|NCT01046643|6017901|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
1725755|NCT01046643|6017902|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
1725756|NCT01046643|6017903|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
1725757|NCT01046643|6017904|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
1725758|NCT01046565|6017926|P1|Overall Study|Withdrawal by Subject|7
1725759|NCT01046565|6017926|P1|Overall Study|Adverse Event|2
1725760|NCT01046396|6017935|P1|Overall Study|Withdrawal by Subject|5
1725761|NCT01046253|6017946|P2|Second Intervention|Protocol Violation|1
1725762|NCT01046253|6017947|P1|Second Intervention|Protocol Violation|0
1725763|NCT01046253|6017946|P2|Second Intervention|Adverse Event|1
1725764|NCT01046253|6017947|P1|Second Intervention|Adverse Event|0
1725765|NCT01046136|6017959|P2|Overall Study|Lost to Follow-up|3
1725766|NCT01046136|6017960|P1|Overall Study|Lost to Follow-up|3
1725767|NCT01046136|6017959|P2|Overall Study|Physician Decision|1
1725768|NCT01046136|6017960|P1|Overall Study|Physician Decision|1
1725769|NCT01046136|6017959|P2|Overall Study|Withdrawal by Subject|4
1725770|NCT01046136|6017960|P1|Overall Study|Withdrawal by Subject|0
1725771|NCT01046110|6017972|P2|Overall Study|Unclassified|35
1725772|NCT01046110|6017973|P1|Overall Study|Unclassified|36
1725773|NCT01046110|6017972|P2|Overall Study|Withdrawal Criteria|5
1725774|NCT01046110|6017973|P1|Overall Study|Withdrawal Criteria|3
1725775|NCT01046110|6017972|P2|Overall Study|Protocol Violation|12
1725776|NCT01046110|6017973|P1|Overall Study|Protocol Violation|7
1725777|NCT01046110|6017972|P2|Overall Study|Lack of Efficacy|1
1725778|NCT01046110|6017973|P1|Overall Study|Lack of Efficacy|0
1725779|NCT01046110|6017972|P2|Overall Study|Adverse Event|2
1725780|NCT01046110|6017973|P1|Overall Study|Adverse Event|9
1725781|NCT01046084|6017983|P2|Third Washout of 7 Days|Withdrawal by Subject|0
1725782|NCT01046084|6017984|P1|Third Washout of 7 Days|Withdrawal by Subject|2
1725783|NCT01045993|6017998|P4|Overall Study|Treated-later found eligibility not met|0
1725784|NCT01045993|6017999|P3|Overall Study|Treated-later found eligibility not met|0
1725785|NCT01045993|6018000|P2|Overall Study|Treated-later found eligibility not met|1
1725786|NCT01045993|6018001|P1|Overall Study|Treated-later found eligibility not met|0
1725787|NCT01045967|6018077|P2|Second Intervention|Protocol Violation|1
1725788|NCT01045967|6018078|P1|Second Intervention|Protocol Violation|0
1725789|NCT01045798|6018090|P2|Overall Study|Received Systemic Antifungal Prestudy|1
1725790|NCT01045798|6018091|P1|Overall Study|Received Systemic Antifungal Prestudy|0
1725791|NCT01045798|6018090|P2|Overall Study|Changed to Other Antifungal Therapy|2
1725792|NCT01045798|6018091|P1|Overall Study|Changed to Other Antifungal Therapy|1
1725793|NCT01045798|6018090|P2|Overall Study|Invasive Fungal Infection at Baseline|1
1725794|NCT01045798|6018091|P1|Overall Study|Invasive Fungal Infection at Baseline|0
1725795|NCT01045798|6018090|P2|Overall Study|Changed to Open-Label Caspofungin|0
1725796|NCT01045798|6018091|P1|Overall Study|Changed to Open-Label Caspofungin|1
1725797|NCT01045707|6018099|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
1725798|NCT01045707|6018100|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
1725799|NCT01045707|6018099|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
1725800|NCT01045707|6018100|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
1725801|NCT01045707|6018099|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
1725802|NCT01045707|6018100|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
1725803|NCT01045707|6018099|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
1725804|NCT01045707|6018100|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
1725805|NCT01045707|6018099|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
1725806|NCT01045707|6018100|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
1725807|NCT01045707|6018099|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
1725808|NCT01045707|6018100|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
1725809|NCT01045707|6018099|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
1725810|NCT01045707|6018100|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
1725811|NCT01045707|6018099|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
1725812|NCT01045707|6018100|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
1725813|NCT01045707|6018099|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
1725814|NCT01045707|6018100|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
1725815|NCT01045694|6018116|P1|Overall Study|Withdrawal by Subject|2
1725816|NCT01045460|6018132|P2|Overall Study|Lack of Efficacy|0
1725817|NCT01045460|6018133|P1|Overall Study|Lack of Efficacy|3
1725818|NCT01045460|6018132|P2|Overall Study|Lost to Follow-up|1
1725819|NCT01045460|6018133|P1|Overall Study|Lost to Follow-up|0
1725820|NCT01045460|6018132|P2|Overall Study|Physician Decision|2
1725821|NCT01045460|6018133|P1|Overall Study|Physician Decision|3
1725822|NCT01045447|6018145|P2|Overall Study|Unclassified|13
1725823|NCT01045447|6018146|P1|Overall Study|Unclassified|17
1725824|NCT01045447|6018145|P2|Overall Study|Withdrawal Criteria|10
1725825|NCT01045447|6018146|P1|Overall Study|Withdrawal Criteria|10
1725826|NCT01045447|6018145|P2|Overall Study|Protocol Violation|3
1725827|NCT01045447|6018146|P1|Overall Study|Protocol Violation|6
1725828|NCT01045447|6018145|P2|Overall Study|Lack of Efficacy|1
1725829|NCT01045447|6018146|P1|Overall Study|Lack of Efficacy|3
1725830|NCT01045447|6018145|P2|Overall Study|Adverse Event|1
1725831|NCT01045447|6018146|P1|Overall Study|Adverse Event|0
1725832|NCT01045421|6018160|P11|Phase 2|Other|1
1725833|NCT01045421|6018161|P10|Phase 2|Other|0
1725834|NCT01045421|6018162|P9|Phase 2|Other|0
1725835|NCT01045421|6018163|P8|Phase 2|Other|3
1725836|NCT01045421|6018164|P7|Phase 2|Other|0
1725837|NCT01045421|6018165|P6|Phase 2|Other|0
1725838|NCT01045421|6018166|P5|Phase 2|Other|0
1725839|NCT01045421|6018167|P4|Phase 2|Other|0
1725840|NCT01045421|6018168|P3|Phase 2|Other|0
1725841|NCT01045421|6018169|P2|Phase 2|Other|0
1725842|NCT01045421|6018170|P1|Phase 2|Other|0
1725843|NCT01045421|6018160|P11|Phase 2|Death|0
1725844|NCT01045421|6018161|P10|Phase 2|Death|2
1725845|NCT01045421|6018162|P9|Phase 2|Death|1
1725846|NCT01045421|6018163|P8|Phase 2|Death|1
1725847|NCT01045421|6018164|P7|Phase 2|Death|0
1725848|NCT01045421|6018165|P6|Phase 2|Death|0
1725849|NCT01045421|6018166|P5|Phase 2|Death|0
1725850|NCT01045421|6018167|P4|Phase 2|Death|0
1725851|NCT01045421|6018168|P3|Phase 2|Death|0
1725852|NCT01045421|6018169|P2|Phase 2|Death|0
1725853|NCT01045421|6018170|P1|Phase 2|Death|0
1725854|NCT01045421|6018160|P11|Phase 2|Progressive Disease|1
1725855|NCT01045421|6018161|P10|Phase 2|Progressive Disease|1
1725856|NCT01045421|6018162|P9|Phase 2|Progressive Disease|1
1725857|NCT01045421|6018163|P8|Phase 2|Progressive Disease|1
1725858|NCT01045421|6018164|P7|Phase 2|Progressive Disease|0
1725859|NCT01045421|6018165|P6|Phase 2|Progressive Disease|0
1725860|NCT01045421|6018166|P5|Phase 2|Progressive Disease|0
1725861|NCT01045421|6018167|P4|Phase 2|Progressive Disease|0
1725862|NCT01045421|6018168|P3|Phase 2|Progressive Disease|0
1725863|NCT01045421|6018169|P2|Phase 2|Progressive Disease|0
1725864|NCT01045421|6018170|P1|Phase 2|Progressive Disease|0
1725865|NCT01045421|6018160|P11|Phase 1|Withdrawal by Subject|0
1725866|NCT01045421|6018161|P10|Phase 1|Withdrawal by Subject|0
1725867|NCT01045421|6018162|P9|Phase 1|Withdrawal by Subject|0
1725868|NCT01045421|6018163|P8|Phase 1|Withdrawal by Subject|0
1725869|NCT01045421|6018164|P7|Phase 1|Withdrawal by Subject|0
1725870|NCT01045421|6018165|P6|Phase 1|Withdrawal by Subject|0
1725871|NCT01045421|6018166|P5|Phase 1|Withdrawal by Subject|0
1725872|NCT01045421|6018167|P4|Phase 1|Withdrawal by Subject|1
1725873|NCT01045421|6018168|P3|Phase 1|Withdrawal by Subject|0
1725874|NCT01045421|6018169|P2|Phase 1|Withdrawal by Subject|0
1725875|NCT01045421|6018170|P1|Phase 1|Withdrawal by Subject|0
1725876|NCT01045421|6018160|P11|Phase 1|Progressive Disease|0
1725877|NCT01045421|6018161|P10|Phase 1|Progressive Disease|0
1725878|NCT01045421|6018162|P9|Phase 1|Progressive Disease|0
1725879|NCT01045421|6018163|P8|Phase 1|Progressive Disease|0
1725880|NCT01045421|6018164|P7|Phase 1|Progressive Disease|0
1725881|NCT01045421|6018165|P6|Phase 1|Progressive Disease|0
1725882|NCT01045421|6018166|P5|Phase 1|Progressive Disease|1
1725883|NCT01045421|6018167|P4|Phase 1|Progressive Disease|0
1725884|NCT01045421|6018168|P3|Phase 1|Progressive Disease|0
1725885|NCT01045421|6018169|P2|Phase 1|Progressive Disease|0
1725886|NCT01045421|6018170|P1|Phase 1|Progressive Disease|0
1725887|NCT01045161|6018264|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
1725888|NCT01045161|6018265|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
1725889|NCT01045161|6018266|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
1725890|NCT01045161|6018264|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
1725891|NCT01045161|6018265|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
1725892|NCT01045161|6018266|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
1725893|NCT01045161|6018264|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
1725894|NCT01045161|6018265|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
1725895|NCT01045161|6018266|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
1725896|NCT01045161|6018264|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
1725897|NCT01045161|6018265|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
1725898|NCT01045161|6018266|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
1725899|NCT01045161|6018264|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
1725900|NCT01045161|6018265|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
1725901|NCT01045161|6018266|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
1725902|NCT01045161|6018264|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
1725903|NCT01045161|6018265|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
1725904|NCT01045161|6018266|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
1725905|NCT01045161|6018264|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
1725906|NCT01045161|6018265|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
1725907|NCT01045161|6018266|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
1725908|NCT01045161|6018264|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
1725909|NCT01045161|6018265|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
1725910|NCT01045161|6018266|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
1725911|NCT01045161|6018264|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
1725912|NCT01045161|6018265|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
1725913|NCT01045161|6018266|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
1725914|NCT01045161|6018264|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1725915|NCT01045161|6018265|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1725916|NCT01045161|6018266|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
1725917|NCT01045161|6018264|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
1725918|NCT01045161|6018265|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
1725919|NCT01045161|6018266|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
1725920|NCT01045161|6018264|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
1725921|NCT01045161|6018265|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
1725922|NCT01045161|6018266|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
1725923|NCT01045161|6018264|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
1725924|NCT01045161|6018265|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
1725925|NCT01045161|6018266|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
1725926|NCT01045161|6018264|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
1725927|NCT01045161|6018265|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
1725928|NCT01045161|6018266|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
1725929|NCT01045096|6018303|P3|Overall Study|Other|0
1725930|NCT01045096|6018304|P2|Overall Study|Other|0
1725931|NCT01045096|6018305|P1|Overall Study|Other|1
1725932|NCT01045096|6018303|P3|Overall Study|Withdrawal by Subject|0
1725933|NCT01045096|6018304|P2|Overall Study|Withdrawal by Subject|0
1725934|NCT01045096|6018305|P1|Overall Study|Withdrawal by Subject|2
1725935|NCT01044745|6018422|P1|Overall Study|Ineiligible|2
1725936|NCT01044732|6018431|P2|Overall Study|Technical error or malfunction|14
1725937|NCT01044732|6018432|P1|Overall Study|Technical error or malfunction|15
1725938|NCT01044732|6018431|P2|Overall Study|Inability to reach cecum|2
1725939|NCT01044732|6018432|P1|Overall Study|Inability to reach cecum|5
1725940|NCT01044732|6018431|P2|Overall Study|Inadequate bowel preparation|17
1725941|NCT01044732|6018432|P1|Overall Study|Inadequate bowel preparation|11
1725942|NCT01044732|6018431|P2|Overall Study|Withdrawal by Subject|1
1725943|NCT01044732|6018432|P1|Overall Study|Withdrawal by Subject|0
1725944|NCT01044732|6018431|P2|Overall Study|Protocol Violation|12
1725945|NCT01044732|6018432|P1|Overall Study|Protocol Violation|11
1725946|NCT01044732|6018431|P2|Overall Study|Physician Decision|3
1725947|NCT01044732|6018432|P1|Overall Study|Physician Decision|5
1725948|NCT01044732|6018431|P2|Overall Study|Lost to Follow-up|1
1725949|NCT01044732|6018432|P1|Overall Study|Lost to Follow-up|2
1725950|NCT01044498|6018621|P2|Overall Study|Other|0
1725951|NCT01044498|6018622|P1|Overall Study|Other|1
1725952|NCT01044498|6018621|P2|Overall Study|Adverse Event|1
1725953|NCT01044498|6018622|P1|Overall Study|Adverse Event|1
1725954|NCT01044498|6018621|P2|Overall Study|Withdrew consent|1
1725955|NCT01044498|6018622|P1|Overall Study|Withdrew consent|1
1725956|NCT01044459|6018648|P2|Overall Study|Lost to Follow-up|12
1725957|NCT01044459|6018649|P1|Overall Study|Lost to Follow-up|18
1725958|NCT01044459|6018648|P2|Overall Study|COPD exacerbation|8
1725959|NCT01044459|6018649|P1|Overall Study|COPD exacerbation|9
1725960|NCT01044459|6018648|P2|Overall Study|Other Reason|14
1725961|NCT01044459|6018649|P1|Overall Study|Other Reason|7
1725962|NCT01044459|6018648|P2|Overall Study|Protocol Violation|16
1725963|NCT01044459|6018649|P1|Overall Study|Protocol Violation|11
1725964|NCT01044459|6018648|P2|Overall Study|Lack of Efficacy|12
1725965|NCT01044459|6018649|P1|Overall Study|Lack of Efficacy|23
1725966|NCT01044459|6018648|P2|Overall Study|Adverse Event|20
1725967|NCT01044459|6018649|P1|Overall Study|Adverse Event|22
1725968|NCT01044459|6018648|P2|Overall Study|Terminated by Sponsor|21
1725969|NCT01044459|6018649|P1|Overall Study|Terminated by Sponsor|22
1725970|NCT01044459|6018648|P2|Overall Study|Withdrawal by Subject|28
1725971|NCT01044459|6018649|P1|Overall Study|Withdrawal by Subject|21
1725972|NCT01044303|6018657|P1|Overall Study|Lost to Follow-up|2
1725973|NCT01044290|6018667|P3|Follow-Up 2|Withdrawal by Subject|1
1725974|NCT01044290|6018668|P2|Follow-Up 2|Withdrawal by Subject|1
1725975|NCT01044290|6018669|P1|Follow-Up 2|Withdrawal by Subject|0
1725976|NCT01044290|6018667|P3|Follow-Up 2|Death|1
1725977|NCT01044290|6018668|P2|Follow-Up 2|Death|1
1725978|NCT01044290|6018669|P1|Follow-Up 2|Death|0
1725979|NCT01044290|6018667|P3|Follow-up 1|Withdrawal by Subject|0
1725980|NCT01044290|6018668|P2|Follow-up 1|Withdrawal by Subject|2
1725981|NCT01044290|6018669|P1|Follow-up 1|Withdrawal by Subject|2
1725982|NCT01044290|6018667|P3|Follow-up 1|Death|1
1725983|NCT01044290|6018668|P2|Follow-up 1|Death|3
1725984|NCT01044290|6018669|P1|Follow-up 1|Death|3
1725985|NCT01043874|6018789|P1|Overall Study|Administrative Problems|1
1725986|NCT01043874|6018789|P1|Overall Study|Lack of Efficacy|1
1725987|NCT01043874|6018789|P1|Overall Study|Withdrawal by Subject|1
1725988|NCT01043874|6018789|P1|Overall Study|Adverse Event|3
1725989|NCT01043705|6018799|P3|Overall Study|Other|25
1725990|NCT01043705|6018800|P2|Overall Study|Other|19
1725991|NCT01043705|6018801|P1|Overall Study|Other|0
1725992|NCT01043705|6018799|P3|Overall Study|Screen Fail|0
1725993|NCT01043705|6018800|P2|Overall Study|Screen Fail|0
1725994|NCT01043705|6018801|P1|Overall Study|Screen Fail|21
1725995|NCT01043705|6018799|P3|Overall Study|Adverse Event|0
1725996|NCT01043705|6018800|P2|Overall Study|Adverse Event|2
1725997|NCT01043705|6018801|P1|Overall Study|Adverse Event|0
1725998|NCT01043705|6018799|P3|Overall Study|Subsequent Procedure|29
1725999|NCT01043705|6018800|P2|Overall Study|Subsequent Procedure|24
1726000|NCT01043705|6018801|P1|Overall Study|Subsequent Procedure|9
1726001|NCT01043705|6018799|P3|Overall Study|Site Closure|0
1726002|NCT01043705|6018800|P2|Overall Study|Site Closure|0
1726003|NCT01043705|6018801|P1|Overall Study|Site Closure|8
1726004|NCT01043705|6018799|P3|Overall Study|Withdrawal by Subject|0
1726005|NCT01043705|6018800|P2|Overall Study|Withdrawal by Subject|6
1726006|NCT01043705|6018801|P1|Overall Study|Withdrawal by Subject|8
1726007|NCT01043705|6018799|P3|Overall Study|Protocol Violation|0
1726008|NCT01043705|6018800|P2|Overall Study|Protocol Violation|1
1726009|NCT01043705|6018801|P1|Overall Study|Protocol Violation|2
1726010|NCT01043705|6018799|P3|Overall Study|Multiple Reasons|0
1726011|NCT01043705|6018800|P2|Overall Study|Multiple Reasons|7
1726012|NCT01043705|6018801|P1|Overall Study|Multiple Reasons|4
1726013|NCT01043705|6018799|P3|Overall Study|Lost to Follow-up|0
1726014|NCT01043705|6018800|P2|Overall Study|Lost to Follow-up|12
1726015|NCT01043705|6018801|P1|Overall Study|Lost to Follow-up|27
1726016|NCT01043705|6018799|P3|Overall Study|Death|26
1726017|NCT01043705|6018800|P2|Overall Study|Death|60
1726018|NCT01043705|6018801|P1|Overall Study|Death|28
1726019|NCT01043185|6018890|P10|Period 6 - Third Washout Period|Protocol Violation|0
1726020|NCT01043185|6018891|P9|Period 6 - Third Washout Period|Protocol Violation|1
1726021|NCT01043185|6018892|P8|Period 6 - Third Washout Period|Protocol Violation|0
1726022|NCT01043185|6018893|P7|Period 6 - Third Washout Period|Protocol Violation|0
1726023|NCT01043185|6018894|P6|Period 6 - Third Washout Period|Protocol Violation|0
1726024|NCT01043185|6018895|P5|Period 6 - Third Washout Period|Protocol Violation|0
1726025|NCT01043185|6018896|P4|Period 6 - Third Washout Period|Protocol Violation|0
1726026|NCT01043185|6018897|P3|Period 6 - Third Washout Period|Protocol Violation|0
1726027|NCT01043185|6018898|P2|Period 6 - Third Washout Period|Protocol Violation|0
1726028|NCT01043185|6018899|P1|Period 6 - Third Washout Period|Protocol Violation|0
1726029|NCT01042977|6018975|P2|Overall Study|Various|0
1726030|NCT01042977|6018976|P1|Overall Study|Various|3
1726031|NCT01042977|6018975|P2|Overall Study|Administrative reason by sponsor|1
1726032|NCT01042977|6018976|P1|Overall Study|Administrative reason by sponsor|0
1726033|NCT01042977|6018975|P2|Overall Study|Safety|2
1726034|NCT01042977|6018976|P1|Overall Study|Safety|0
1726035|NCT01042977|6018975|P2|Overall Study|Incorrect enrollment|4
1726036|NCT01042977|6018976|P1|Overall Study|Incorrect enrollment|6
1726037|NCT01042977|6018975|P2|Overall Study|Subject no longer meets study criteria|13
1726038|NCT01042977|6018976|P1|Overall Study|Subject no longer meets study criteria|15
1726039|NCT01042977|6018975|P2|Overall Study|Poor/non-compliance|4
1726040|NCT01042977|6018976|P1|Overall Study|Poor/non-compliance|3
1726041|NCT01042977|6018975|P2|Overall Study|Lost to Follow-up|2
1726042|NCT01042977|6018976|P1|Overall Study|Lost to Follow-up|0
1726043|NCT01042977|6018975|P2|Overall Study|Withdrawal by Subject|16
1726044|NCT01042977|6018976|P1|Overall Study|Withdrawal by Subject|8
1726045|NCT01042977|6018975|P2|Overall Study|Death|1
1726046|NCT01042977|6018976|P1|Overall Study|Death|2
1726047|NCT01042977|6018975|P2|Overall Study|Adverse Event|12
1726048|NCT01042977|6018976|P1|Overall Study|Adverse Event|4
1726049|NCT01042938|6018996|P2|Overall Study|Ineligible: RTOG study conflict|0
1726050|NCT01042938|6018997|P1|Overall Study|Ineligible: RTOG study conflict|1
1726051|NCT01042938|6018996|P2|Overall Study|Protocol Violation|1
1726052|NCT01042938|6018997|P1|Overall Study|Protocol Violation|1
1726053|NCT01042938|6018996|P2|Overall Study|Withdrawal by Subject|1
1726054|NCT01042938|6018997|P1|Overall Study|Withdrawal by Subject|1
1726055|NCT01042678|6019016|P6|Overall Study|Physician Decision|0
1726056|NCT01042678|6019017|P5|Overall Study|Physician Decision|0
1726057|NCT01042678|6019018|P4|Overall Study|Physician Decision|0
1726058|NCT01042678|6019019|P3|Overall Study|Physician Decision|0
1726059|NCT01042678|6019020|P2|Overall Study|Physician Decision|0
1726060|NCT01042678|6019021|P1|Overall Study|Physician Decision|1
1726061|NCT01042600|6019059|P2|Overall Study|Ineligible|0
1726062|NCT01042600|6019060|P1|Overall Study|Ineligible|1
1726063|NCT01042535|6019080|P1|Overall Study|complications from other disease|2
1726064|NCT01042535|6019080|P1|Overall Study|disease progression during treatment|3
1726065|NCT01042535|6019080|P1|Overall Study|disease progression prior to treatment|3
1726066|NCT01042392|6019114|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1726067|NCT01042392|6019115|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1726068|NCT01042392|6019116|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
1726069|NCT01042392|6019117|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
1726070|NCT01042392|6019114|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1726071|NCT01042392|6019115|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
1726072|NCT01042392|6019116|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1726073|NCT01042392|6019117|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
1726074|NCT01042392|6019114|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1726075|NCT01042392|6019115|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1726076|NCT01042392|6019116|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
1726077|NCT01042392|6019117|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
1726078|NCT01042392|6019114|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1726079|NCT01042392|6019115|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
1726080|NCT01042392|6019116|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1726081|NCT01042392|6019117|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
1726082|NCT01042392|6019114|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1726083|NCT01042392|6019115|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1726084|NCT01042392|6019116|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
1726085|NCT01042392|6019117|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
1726086|NCT01042392|6019114|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1726087|NCT01042392|6019115|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
1726088|NCT01042392|6019116|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1726089|NCT01042392|6019117|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
1726090|NCT01042392|6019114|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
1726091|NCT01042392|6019115|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
1726092|NCT01042392|6019116|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
1726093|NCT01042392|6019117|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
1726094|NCT01042392|6019114|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1726095|NCT01042392|6019115|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1726096|NCT01042392|6019116|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
1726097|NCT01042392|6019117|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
1726098|NCT01042392|6019114|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
1726099|NCT01042392|6019115|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
1726100|NCT01042392|6019116|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
1726101|NCT01042392|6019117|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
1726102|NCT01042236|6019165|P6|Treatment Period 3|Protocol Violation|0
1726103|NCT01042236|6019166|P5|Treatment Period 3|Protocol Violation|0
1726104|NCT01042236|6019167|P4|Treatment Period 3|Protocol Violation|1
1726105|NCT01042236|6019168|P3|Treatment Period 3|Protocol Violation|0
1726106|NCT01042236|6019169|P2|Treatment Period 3|Protocol Violation|0
1726107|NCT01042236|6019170|P1|Treatment Period 3|Protocol Violation|0
1726108|NCT01042236|6019165|P6|Treatment Period 3|Adverse Event|0
1726109|NCT01042236|6019166|P5|Treatment Period 3|Adverse Event|0
1726110|NCT01042236|6019167|P4|Treatment Period 3|Adverse Event|1
1726111|NCT01042236|6019168|P3|Treatment Period 3|Adverse Event|0
1726112|NCT01042236|6019169|P2|Treatment Period 3|Adverse Event|0
1726113|NCT01042236|6019170|P1|Treatment Period 3|Adverse Event|0
1726114|NCT01042236|6019165|P6|Treatment Period 1|Adverse Event|0
1726115|NCT01042236|6019166|P5|Treatment Period 1|Adverse Event|1
1726116|NCT01042236|6019167|P4|Treatment Period 1|Adverse Event|0
1726117|NCT01042236|6019168|P3|Treatment Period 1|Adverse Event|0
1726118|NCT01042236|6019169|P2|Treatment Period 1|Adverse Event|1
1726119|NCT01042236|6019170|P1|Treatment Period 1|Adverse Event|0
1726120|NCT01042158|6019207|P1|Overall Study|Physician Decision|1
1726121|NCT01042093|6019237|P4|Overall Study|Withdrawal by Subject|1
1726122|NCT01042093|6019238|P3|Overall Study|Withdrawal by Subject|0
1726123|NCT01042093|6019239|P2|Overall Study|Withdrawal by Subject|0
1726124|NCT01042093|6019240|P1|Overall Study|Withdrawal by Subject|0
1726125|NCT01042093|6019237|P4|Overall Study|Protocol Violation|3
1726126|NCT01042093|6019238|P3|Overall Study|Protocol Violation|2
1726127|NCT01042093|6019239|P2|Overall Study|Protocol Violation|2
1726128|NCT01042093|6019240|P1|Overall Study|Protocol Violation|2
1726129|NCT01041976|6019260|P2|Overall Study|Death|4
1726130|NCT01041976|6019261|P1|Overall Study|Death|0
1726131|NCT01041976|6019260|P2|Overall Study|Incarceration|0
1726132|NCT01041976|6019261|P1|Overall Study|Incarceration|2
1726133|NCT01041976|6019260|P2|Overall Study|Withdrawal by Subject|0
1726134|NCT01041976|6019261|P1|Overall Study|Withdrawal by Subject|3
1726135|NCT01041859|6019271|P3|Double-Blind Maintenance|Withdrawal by Subject|9
1726136|NCT01041859|6019272|P2|Double-Blind Maintenance|Withdrawal by Subject|8
1726137|NCT01041859|6019273|P1|Double-Blind Maintenance|Withdrawal by Subject|0
1726138|NCT01041859|6019271|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
1726139|NCT01041859|6019272|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
1726140|NCT01041859|6019273|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
1726141|NCT01041859|6019271|P3|Double-Blind Maintenance|Other|2
1726142|NCT01041859|6019272|P2|Double-Blind Maintenance|Other|6
1726143|NCT01041859|6019273|P1|Double-Blind Maintenance|Other|0
1726144|NCT01041859|6019271|P3|Double-Blind Maintenance|Protocol Violation|3
1726145|NCT01041859|6019272|P2|Double-Blind Maintenance|Protocol Violation|1
1726146|NCT01041859|6019273|P1|Double-Blind Maintenance|Protocol Violation|0
1726147|NCT01041859|6019271|P3|Double-Blind Maintenance|Physician Decision|1
1726148|NCT01041859|6019272|P2|Double-Blind Maintenance|Physician Decision|2
1726149|NCT01041859|6019273|P1|Double-Blind Maintenance|Physician Decision|0
1726150|NCT01041859|6019271|P3|Double-Blind Maintenance|Lost to Follow-up|0
1726151|NCT01041859|6019272|P2|Double-Blind Maintenance|Lost to Follow-up|1
1726152|NCT01041859|6019273|P1|Double-Blind Maintenance|Lost to Follow-up|0
1726153|NCT01041859|6019271|P3|Double-Blind Maintenance|Lack of Efficacy|11
1726154|NCT01041859|6019272|P2|Double-Blind Maintenance|Lack of Efficacy|3
1726155|NCT01041859|6019273|P1|Double-Blind Maintenance|Lack of Efficacy|0
1726156|NCT01041859|6019271|P3|Double-Blind Maintenance|Adverse Event|13
1726157|NCT01041859|6019272|P2|Double-Blind Maintenance|Adverse Event|23
1726158|NCT01041859|6019273|P1|Double-Blind Maintenance|Adverse Event|0
1726159|NCT01041859|6019271|P3|Open-Label Titration|Withdrawal by Subject|0
1726160|NCT01041859|6019272|P2|Open-Label Titration|Withdrawal by Subject|0
1726161|NCT01041859|6019273|P1|Open-Label Titration|Withdrawal by Subject|11
1726162|NCT01041859|6019271|P3|Open-Label Titration|Noncompliance With Study Drug|0
1726163|NCT01041859|6019272|P2|Open-Label Titration|Noncompliance With Study Drug|0
1726164|NCT01041859|6019273|P1|Open-Label Titration|Noncompliance With Study Drug|8
1726165|NCT01041859|6019271|P3|Open-Label Titration|Other|0
1726166|NCT01041859|6019272|P2|Open-Label Titration|Other|0
1726167|NCT01041859|6019273|P1|Open-Label Titration|Other|7
1726168|NCT01041859|6019271|P3|Open-Label Titration|Protocol Violation|0
1726169|NCT01041859|6019272|P2|Open-Label Titration|Protocol Violation|0
1726170|NCT01041859|6019273|P1|Open-Label Titration|Protocol Violation|1
1726171|NCT01041859|6019271|P3|Open-Label Titration|Physician Decision|0
1726172|NCT01041859|6019272|P2|Open-Label Titration|Physician Decision|0
1726173|NCT01041859|6019273|P1|Open-Label Titration|Physician Decision|1
1726174|NCT01041859|6019271|P3|Open-Label Titration|Lost to Follow-up|0
1726175|NCT01041859|6019272|P2|Open-Label Titration|Lost to Follow-up|0
1726176|NCT01041859|6019273|P1|Open-Label Titration|Lost to Follow-up|1
1726177|NCT01041859|6019271|P3|Open-Label Titration|Lack of Efficacy|0
1726178|NCT01041859|6019272|P2|Open-Label Titration|Lack of Efficacy|0
1726179|NCT01041859|6019273|P1|Open-Label Titration|Lack of Efficacy|3
1726180|NCT01041859|6019271|P3|Open-Label Titration|Adverse Event|0
1726181|NCT01041859|6019272|P2|Open-Label Titration|Adverse Event|0
1726182|NCT01041859|6019273|P1|Open-Label Titration|Adverse Event|69
1726183|NCT01041638|6019309|P1|Overall Study|Withdrawal by Subject|11
1726184|NCT01041638|6019309|P1|Overall Study|Physician Decision|4
1726185|NCT01041638|6019309|P1|Overall Study|Lack of Efficacy|7
1726186|NCT01041638|6019309|P1|Overall Study|Death|1
1726187|NCT01041638|6019309|P1|Overall Study|Adverse Event|4
1726188|NCT01041573|6019319|P4|Overall Study|positive to anti-HCV|0
1726189|NCT01041573|6019320|P3|Overall Study|positive to anti-HCV|0
1726190|NCT01041573|6019321|P2|Overall Study|positive to anti-HCV|0
1726191|NCT01041573|6019322|P1|Overall Study|positive to anti-HCV|1
1726192|NCT01041573|6019319|P4|Overall Study|further blood extraction|0
1726193|NCT01041573|6019320|P3|Overall Study|further blood extraction|0
1726194|NCT01041573|6019321|P2|Overall Study|further blood extraction|1
1726195|NCT01041573|6019322|P1|Overall Study|further blood extraction|0
1726196|NCT01041573|6019319|P4|Overall Study|relocation|1
1726197|NCT01041573|6019320|P3|Overall Study|relocation|3
1726198|NCT01041573|6019321|P2|Overall Study|relocation|4
1726199|NCT01041573|6019322|P1|Overall Study|relocation|1
1726200|NCT01041573|6019319|P4|Overall Study|Adverse Event|0
1726201|NCT01041573|6019320|P3|Overall Study|Adverse Event|0
1726202|NCT01041573|6019321|P2|Overall Study|Adverse Event|2
1726203|NCT01041573|6019322|P1|Overall Study|Adverse Event|0
1726204|NCT01041573|6019319|P4|Overall Study|Lost to Follow-up|1
1726205|NCT01041573|6019320|P3|Overall Study|Lost to Follow-up|2
1726206|NCT01041573|6019321|P2|Overall Study|Lost to Follow-up|1
1726207|NCT01041573|6019322|P1|Overall Study|Lost to Follow-up|0
1726208|NCT01041573|6019319|P4|Overall Study|Death|0
1726209|NCT01041573|6019320|P3|Overall Study|Death|0
1726210|NCT01041573|6019321|P2|Overall Study|Death|0
1726211|NCT01041573|6019322|P1|Overall Study|Death|1
1726212|NCT01041573|6019319|P4|Overall Study|Withdrawal by Subject|0
1726213|NCT01041573|6019320|P3|Overall Study|Withdrawal by Subject|2
1726214|NCT01041573|6019321|P2|Overall Study|Withdrawal by Subject|5
1726215|NCT01041573|6019322|P1|Overall Study|Withdrawal by Subject|2
1726216|NCT01041417|6019345|P2|Overall Study|Death|0
1726217|NCT01041417|6019346|P1|Overall Study|Death|1
1726218|NCT01041417|6019345|P2|Overall Study|Lost to Follow-up|1
1726219|NCT01041417|6019346|P1|Overall Study|Lost to Follow-up|1
1726220|NCT01041417|6019345|P2|Overall Study|Adverse Event|2
1726221|NCT01041417|6019346|P1|Overall Study|Adverse Event|5
1726222|NCT01041404|6019384|P2|Overall Study|Other|23
1726223|NCT01041404|6019385|P1|Overall Study|Other|11
1726224|NCT01041404|6019384|P2|Overall Study|Failure to Return|2
1726225|NCT01041404|6019385|P1|Overall Study|Failure to Return|1
1726226|NCT01041404|6019384|P2|Overall Study|Withdrawal by Subject|23
1726227|NCT01041404|6019385|P1|Overall Study|Withdrawal by Subject|29
1726228|NCT01041404|6019384|P2|Overall Study|Protocol Violation|0
1726229|NCT01041404|6019385|P1|Overall Study|Protocol Violation|4
1726230|NCT01041404|6019384|P2|Overall Study|Violation of Selection Criteria|1
1726231|NCT01041404|6019385|P1|Overall Study|Violation of Selection Criteria|0
1726232|NCT01041404|6019384|P2|Overall Study|Lack of Efficacy|210
1726233|NCT01041404|6019385|P1|Overall Study|Lack of Efficacy|200
1726234|NCT01041404|6019384|P2|Overall Study|Adverse Event|35
1726235|NCT01041404|6019385|P1|Overall Study|Adverse Event|45
1726236|NCT01041287|6019426|P2|Treatment Period 2 (3 Months)|Adverse Event|2
1726237|NCT01041287|6019427|P1|Treatment Period 2 (3 Months)|Adverse Event|0
1726238|NCT01041287|6019426|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
1726239|NCT01041287|6019427|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
1726240|NCT01040871|6019467|P2|Overall Study|Randomized and Not Treated|1
1726241|NCT01040871|6019468|P1|Overall Study|Randomized and Not Treated|2
1726242|NCT01040871|6019467|P2|Overall Study|drug supply issue|0
1726243|NCT01040871|6019468|P1|Overall Study|drug supply issue|1
1726244|NCT01040871|6019467|P2|Overall Study|Lack of Efficacy|1
1726245|NCT01040871|6019468|P1|Overall Study|Lack of Efficacy|1
1726246|NCT01040871|6019467|P2|Overall Study|Death|3
1726247|NCT01040871|6019468|P1|Overall Study|Death|1
1726248|NCT01040871|6019467|P2|Overall Study|Withdrawal by Subject|0
1726249|NCT01040871|6019468|P1|Overall Study|Withdrawal by Subject|2
1726250|NCT01040871|6019467|P2|Overall Study|Adverse Event|2
1726251|NCT01040871|6019468|P1|Overall Study|Adverse Event|6
1726252|NCT01040845|6019519|P2|Overall Study|Physician Decision|0
1726253|NCT01040845|6019520|P1|Overall Study|Physician Decision|1
1726254|NCT01040845|6019519|P2|Overall Study|Withdrawal by Subject|1
1726255|NCT01040845|6019520|P1|Overall Study|Withdrawal by Subject|1
1726256|NCT01040832|6019535|P2|Overall Study|Other|1
1726257|NCT01040832|6019536|P1|Overall Study|Other|2
1726258|NCT01040832|6019535|P2|Overall Study|Symptomatic deterioration|5
1726259|NCT01040832|6019536|P1|Overall Study|Symptomatic deterioration|2
1726260|NCT01040832|6019535|P2|Overall Study|Progressive disease|17
1726261|NCT01040832|6019536|P1|Overall Study|Progressive disease|32
1726262|NCT01040832|6019535|P2|Overall Study|Withdrawal by Subject|3
1726263|NCT01040832|6019536|P1|Overall Study|Withdrawal by Subject|2
1726264|NCT01040832|6019535|P2|Overall Study|Death|6
1726265|NCT01040832|6019536|P1|Overall Study|Death|4
1726266|NCT01040832|6019535|P2|Overall Study|Adverse Event|5
1726267|NCT01040832|6019536|P1|Overall Study|Adverse Event|4
1726268|NCT01040793|6019559|P6|Overall Study|Other reasons not listed above|0
1726269|NCT01040793|6019560|P5|Overall Study|Other reasons not listed above|1
1726270|NCT01040793|6019561|P4|Overall Study|Other reasons not listed above|0
1726271|NCT01040793|6019562|P3|Overall Study|Other reasons not listed above|1
1726272|NCT01040793|6019563|P2|Overall Study|Other reasons not listed above|0
1726273|NCT01040793|6019564|P1|Overall Study|Other reasons not listed above|0
1726274|NCT01040793|6019559|P6|Overall Study|Withdrawal by Subject|0
1726275|NCT01040793|6019560|P5|Overall Study|Withdrawal by Subject|0
1726276|NCT01040793|6019561|P4|Overall Study|Withdrawal by Subject|2
1726277|NCT01040793|6019562|P3|Overall Study|Withdrawal by Subject|0
1726278|NCT01040793|6019563|P2|Overall Study|Withdrawal by Subject|0
1726279|NCT01040793|6019564|P1|Overall Study|Withdrawal by Subject|0
1726280|NCT01040793|6019559|P6|Overall Study|Lost to Follow-up|0
1726281|NCT01040793|6019560|P5|Overall Study|Lost to Follow-up|0
1726282|NCT01040793|6019561|P4|Overall Study|Lost to Follow-up|0
1726283|NCT01040793|6019562|P3|Overall Study|Lost to Follow-up|1
1726284|NCT01040793|6019563|P2|Overall Study|Lost to Follow-up|1
1726285|NCT01040793|6019564|P1|Overall Study|Lost to Follow-up|0
1726286|NCT01040793|6019559|P6|Overall Study|Protocol Violation|0
1726287|NCT01040793|6019560|P5|Overall Study|Protocol Violation|1
1726288|NCT01040793|6019561|P4|Overall Study|Protocol Violation|0
1726289|NCT01040793|6019562|P3|Overall Study|Protocol Violation|1
1726290|NCT01040793|6019563|P2|Overall Study|Protocol Violation|1
1726291|NCT01040793|6019564|P1|Overall Study|Protocol Violation|1
1726292|NCT01040793|6019559|P6|Overall Study|Adverse Event|1
1726293|NCT01040793|6019560|P5|Overall Study|Adverse Event|2
1726294|NCT01040793|6019561|P4|Overall Study|Adverse Event|2
1726295|NCT01040793|6019562|P3|Overall Study|Adverse Event|0
1726296|NCT01040793|6019563|P2|Overall Study|Adverse Event|3
1726297|NCT01040793|6019564|P1|Overall Study|Adverse Event|5
1726298|NCT01040780|6019643|P2|Overall Study|Protocol Violation|3
1726299|NCT01040780|6019644|P1|Overall Study|Protocol Violation|1
1726300|NCT01040728|6019658|P4|Overall Study|Other reasons not listed above|0
1726301|NCT01040728|6019659|P3|Overall Study|Other reasons not listed above|0
1726302|NCT01040728|6019660|P2|Overall Study|Other reasons not listed above|1
1726303|NCT01040728|6019661|P1|Overall Study|Other reasons not listed above|0
1726304|NCT01040728|6019658|P4|Overall Study|Lack of Efficacy|1
1726305|NCT01040728|6019659|P3|Overall Study|Lack of Efficacy|0
1726306|NCT01040728|6019660|P2|Overall Study|Lack of Efficacy|1
1726307|NCT01040728|6019661|P1|Overall Study|Lack of Efficacy|0
1726308|NCT01040728|6019658|P4|Overall Study|Protocol Violation|1
1726309|NCT01040728|6019659|P3|Overall Study|Protocol Violation|0
1726310|NCT01040728|6019660|P2|Overall Study|Protocol Violation|0
1726311|NCT01040728|6019661|P1|Overall Study|Protocol Violation|0
1726312|NCT01040728|6019658|P4|Overall Study|Withdrawal by Subject|0
1726313|NCT01040728|6019659|P3|Overall Study|Withdrawal by Subject|1
1726314|NCT01040728|6019660|P2|Overall Study|Withdrawal by Subject|1
1726315|NCT01040728|6019661|P1|Overall Study|Withdrawal by Subject|0
1726316|NCT01040728|6019658|P4|Overall Study|Adverse Event|4
1726317|NCT01040728|6019659|P3|Overall Study|Adverse Event|0
1726318|NCT01040728|6019660|P2|Overall Study|Adverse Event|8
1726319|NCT01040728|6019661|P1|Overall Study|Adverse Event|4
1726320|NCT01040689|6019731|P4|Overall Study|Other reasons not listed above|0
1726321|NCT01040689|6019732|P3|Overall Study|Other reasons not listed above|0
1726322|NCT01040689|6019733|P2|Overall Study|Other reasons not listed above|1
1726323|NCT01040689|6019734|P1|Overall Study|Other reasons not listed above|0
1726324|NCT01040689|6019731|P4|Overall Study|Withdrawal by Subject|0
1726325|NCT01040689|6019732|P3|Overall Study|Withdrawal by Subject|1
1726326|NCT01040689|6019733|P2|Overall Study|Withdrawal by Subject|1
1726327|NCT01040689|6019734|P1|Overall Study|Withdrawal by Subject|2
1726328|NCT01040689|6019731|P4|Overall Study|Lost to Follow-up|0
1726329|NCT01040689|6019732|P3|Overall Study|Lost to Follow-up|0
1726330|NCT01040689|6019733|P2|Overall Study|Lost to Follow-up|0
1726331|NCT01040689|6019734|P1|Overall Study|Lost to Follow-up|1
1726332|NCT01040689|6019731|P4|Overall Study|Lack of Efficacy|0
1726333|NCT01040689|6019732|P3|Overall Study|Lack of Efficacy|1
1726334|NCT01040689|6019733|P2|Overall Study|Lack of Efficacy|0
1726335|NCT01040689|6019734|P1|Overall Study|Lack of Efficacy|0
1726336|NCT01040689|6019731|P4|Overall Study|Adverse Event|4
1726337|NCT01040689|6019732|P3|Overall Study|Adverse Event|2
1726338|NCT01040689|6019733|P2|Overall Study|Adverse Event|0
1726339|NCT01040689|6019734|P1|Overall Study|Adverse Event|0
1726340|NCT01040403|6019813|P1|Overall Study|Other reason not defined above|6
1726341|NCT01040403|6019813|P1|Overall Study|Not treated|1
1726342|NCT01040403|6019813|P1|Overall Study|Lost to Follow-up|1
1726343|NCT01040403|6019813|P1|Overall Study|Protocol Violation|2
1726344|NCT01040403|6019813|P1|Overall Study|Adverse Event|10
1726345|NCT01040351|6020001|P2|Overall Study|poor ovarian response|2
1726346|NCT01040351|6020002|P1|Overall Study|poor ovarian response|1
1726347|NCT01040260|6020012|P2|Overall Study|Lost to Follow-up|5
1726348|NCT01040260|6020013|P1|Overall Study|Lost to Follow-up|3
1726349|NCT01040260|6020012|P2|Overall Study|Withdrawal by Subject|6
1726350|NCT01040260|6020013|P1|Overall Study|Withdrawal by Subject|12
1726351|NCT01040169|6020040|P2|Overall Study|Lost to Follow-up|8
1726352|NCT01040169|6020041|P1|Overall Study|Lost to Follow-up|3
1726353|NCT01040130|6020049|P6|Overall Study|Other reasons not listed above|0
1726354|NCT01040130|6020050|P5|Overall Study|Other reasons not listed above|0
1726355|NCT01040130|6020051|P4|Overall Study|Other reasons not listed above|0
1726356|NCT01040130|6020052|P3|Overall Study|Other reasons not listed above|0
1726357|NCT01040130|6020053|P2|Overall Study|Other reasons not listed above|0
1726358|NCT01040130|6020054|P1|Overall Study|Other reasons not listed above|2
1726359|NCT01040130|6020049|P6|Overall Study|Withdrawal by Subject|1
1726360|NCT01040130|6020050|P5|Overall Study|Withdrawal by Subject|0
1726361|NCT01040130|6020051|P4|Overall Study|Withdrawal by Subject|0
1726362|NCT01040130|6020052|P3|Overall Study|Withdrawal by Subject|0
1726363|NCT01040130|6020053|P2|Overall Study|Withdrawal by Subject|2
1726364|NCT01040130|6020054|P1|Overall Study|Withdrawal by Subject|0
1726365|NCT01040130|6020049|P6|Overall Study|Protocol Violation|0
1726366|NCT01040130|6020050|P5|Overall Study|Protocol Violation|0
1726367|NCT01040130|6020051|P4|Overall Study|Protocol Violation|0
1726368|NCT01040130|6020052|P3|Overall Study|Protocol Violation|2
1726369|NCT01040130|6020053|P2|Overall Study|Protocol Violation|0
1726370|NCT01040130|6020054|P1|Overall Study|Protocol Violation|0
1726371|NCT01040130|6020049|P6|Overall Study|Adverse Event|3
1726372|NCT01040130|6020050|P5|Overall Study|Adverse Event|0
1726373|NCT01040130|6020051|P4|Overall Study|Adverse Event|5
1726374|NCT01040130|6020052|P3|Overall Study|Adverse Event|0
1726375|NCT01040130|6020053|P2|Overall Study|Adverse Event|1
1726376|NCT01040130|6020054|P1|Overall Study|Adverse Event|1
1726377|NCT01039688|6020147|P3|Overall Study|Death|0
1726378|NCT01039688|6020148|P2|Overall Study|Death|0
1726379|NCT01039688|6020149|P1|Overall Study|Death|2
1726380|NCT01039688|6020147|P3|Overall Study|Withdrawal by Subject|13
1726381|NCT01039688|6020148|P2|Overall Study|Withdrawal by Subject|27
1726382|NCT01039688|6020149|P1|Overall Study|Withdrawal by Subject|23
1726383|NCT01039688|6020147|P3|Overall Study|Other|12
1726384|NCT01039688|6020148|P2|Overall Study|Other|25
1726385|NCT01039688|6020149|P1|Overall Study|Other|13
1726386|NCT01039688|6020147|P3|Overall Study|Lost to Follow-up|5
1726387|NCT01039688|6020148|P2|Overall Study|Lost to Follow-up|9
1726388|NCT01039688|6020149|P1|Overall Study|Lost to Follow-up|11
1726389|NCT01039688|6020147|P3|Overall Study|Lack of Efficacy|26
1726390|NCT01039688|6020148|P2|Overall Study|Lack of Efficacy|11
1726391|NCT01039688|6020149|P1|Overall Study|Lack of Efficacy|20
1726392|NCT01039688|6020147|P3|Overall Study|Adverse Event|24
1726393|NCT01039688|6020148|P2|Overall Study|Adverse Event|39
1726394|NCT01039688|6020149|P1|Overall Study|Adverse Event|38
1726395|NCT01039675|6020420|P2|Overall Study|Physician Decision|1
1726396|NCT01039675|6020421|P1|Overall Study|Physician Decision|0
1726397|NCT01039675|6020420|P2|Overall Study|Lost to Follow-up|1
1726398|NCT01039675|6020421|P1|Overall Study|Lost to Follow-up|0
1726399|NCT01039675|6020420|P2|Overall Study|Withdrawal by Subject|1
1726400|NCT01039675|6020421|P1|Overall Study|Withdrawal by Subject|0
1726401|NCT01039675|6020420|P2|Overall Study|Lack of Efficacy|2
1726402|NCT01039675|6020421|P1|Overall Study|Lack of Efficacy|0
1726403|NCT01039675|6020420|P2|Overall Study|Adverse Event|2
1726404|NCT01039675|6020421|P1|Overall Study|Adverse Event|0
1726405|NCT01039584|6020434|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
1726406|NCT01039584|6020435|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
1726407|NCT01039584|6020436|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
1726408|NCT01039584|6020434|P3|Overall Study|Pap smear with significant pathology|3
1726409|NCT01039584|6020435|P2|Overall Study|Pap smear with significant pathology|10
1726410|NCT01039584|6020436|P1|Overall Study|Pap smear with significant pathology|10
1726411|NCT01039584|6020434|P3|Overall Study|other|1
1726412|NCT01039584|6020435|P2|Overall Study|other|3
1726413|NCT01039584|6020436|P1|Overall Study|other|1
1726414|NCT01039584|6020434|P3|Overall Study|Lack of Efficacy|10
1726415|NCT01039584|6020435|P2|Overall Study|Lack of Efficacy|6
1726416|NCT01039584|6020436|P1|Overall Study|Lack of Efficacy|7
1726417|NCT01039584|6020434|P3|Overall Study|Negative Baseline culture for Candida|24
1726418|NCT01039584|6020435|P2|Overall Study|Negative Baseline culture for Candida|59
1726419|NCT01039584|6020436|P1|Overall Study|Negative Baseline culture for Candida|59
1726420|NCT01039584|6020434|P3|Overall Study|Lost to Follow-up|4
1726421|NCT01039584|6020435|P2|Overall Study|Lost to Follow-up|3
1726422|NCT01039584|6020436|P1|Overall Study|Lost to Follow-up|5
1726423|NCT01039584|6020434|P3|Overall Study|Protocol Violation|6
1726424|NCT01039584|6020435|P2|Overall Study|Protocol Violation|4
1726425|NCT01039584|6020436|P1|Overall Study|Protocol Violation|10
1726426|NCT01039584|6020434|P3|Overall Study|Withdrawal by Subject|1
1726427|NCT01039584|6020435|P2|Overall Study|Withdrawal by Subject|2
1726428|NCT01039584|6020436|P1|Overall Study|Withdrawal by Subject|4
1726429|NCT01039519|6020450|P1|Survival Follow-up|Sponsor decision|4
1726430|NCT01039519|6020450|P1|Survival Follow-up|Death|23
1726431|NCT01039519|6020450|P1|Treatment|Physician Decision|2
1726432|NCT01039519|6020450|P1|Treatment|Adverse Event|3
1726433|NCT01039519|6020450|P1|Treatment|Treatment failure|2
1726434|NCT01039519|6020450|P1|Treatment|Progressive disease|20
1726435|NCT01039428|6020486|P2|Overall Study|Withdrawal by Subject|0
1726436|NCT01039428|6020487|P1|Overall Study|Withdrawal by Subject|1
1726437|NCT01039428|6020486|P2|Overall Study|Protocol Violation|0
1726438|NCT01039428|6020487|P1|Overall Study|Protocol Violation|1
1726439|NCT01039376|6020511|P2|Overall Study|Study terminated by Sponsor|72
1726440|NCT01039376|6020512|P1|Overall Study|Study terminated by Sponsor|90
1726441|NCT01039376|6020511|P2|Overall Study|Withdrawal by Subject|32
1726442|NCT01039376|6020512|P1|Overall Study|Withdrawal by Subject|20
1726443|NCT01039376|6020511|P2|Overall Study|Physician Decision|10
1726444|NCT01039376|6020512|P1|Overall Study|Physician Decision|15
1726445|NCT01039376|6020511|P2|Overall Study|Lost to Follow-up|12
1726446|NCT01039376|6020512|P1|Overall Study|Lost to Follow-up|5
1726447|NCT01038921|6020581|P2|Overall Study|Physician Decision|0
1726448|NCT01038921|6020582|P1|Overall Study|Physician Decision|1
1726449|NCT01038921|6020581|P2|Overall Study|Withdrawal by Subject|0
1726450|NCT01038921|6020582|P1|Overall Study|Withdrawal by Subject|1
1726451|NCT01038869|6020588|P1|Overall Study|Lost to Follow-up|6
1726452|NCT01038869|6020588|P1|Overall Study|Withdrawal by Subject|1
1726453|NCT01038856|6020596|P1|Overall Study|Adverse Event|2
1726454|NCT01038752|6020605|P2|Overall Study|Lost to Follow-up|3
1726455|NCT01038752|6020606|P1|Overall Study|Lost to Follow-up|3
1726456|NCT01038752|6020605|P2|Overall Study|Tumor Progression|2
1726457|NCT01038752|6020606|P1|Overall Study|Tumor Progression|2
1726458|NCT01038713|6020629|P3|Overall Study|Autoimmune Pancreatitis|0
1726459|NCT01038713|6020630|P2|Overall Study|Autoimmune Pancreatitis|0
1726460|NCT01038713|6020631|P1|Overall Study|Autoimmune Pancreatitis|1
1726461|NCT01038713|6020629|P3|Overall Study|died from PEP|0
1726462|NCT01038713|6020630|P2|Overall Study|died from PEP|1
1726463|NCT01038713|6020631|P1|Overall Study|died from PEP|0
1726464|NCT01038713|6020629|P3|Overall Study|Neuroendocrine Tumor|0
1726465|NCT01038713|6020630|P2|Overall Study|Neuroendocrine Tumor|1
1726466|NCT01038713|6020631|P1|Overall Study|Neuroendocrine Tumor|0
1726467|NCT01038713|6020629|P3|Overall Study|Lost to Follow-up|0
1726468|NCT01038713|6020630|P2|Overall Study|Lost to Follow-up|0
1726469|NCT01038713|6020631|P1|Overall Study|Lost to Follow-up|3
1726470|NCT01038713|6020629|P3|Overall Study|Patient to hospice|1
1726471|NCT01038713|6020630|P2|Overall Study|Patient to hospice|1
1726472|NCT01038713|6020631|P1|Overall Study|Patient to hospice|1
1726473|NCT01038635|6020660|P9|Overall Study|Death|2
1726474|NCT01038635|6020661|P8|Overall Study|Death|1
1726475|NCT01038635|6020662|P7|Overall Study|Death|1
1726476|NCT01038635|6020663|P6|Overall Study|Death|0
1726477|NCT01038635|6020664|P5|Overall Study|Death|1
1726478|NCT01038635|6020665|P4|Overall Study|Death|0
1726479|NCT01038635|6020666|P3|Overall Study|Death|0
1726480|NCT01038635|6020667|P2|Overall Study|Death|0
1726481|NCT01038635|6020668|P1|Overall Study|Death|0
1726482|NCT01038635|6020660|P9|Overall Study|Disease Progression|0
1726483|NCT01038635|6020661|P8|Overall Study|Disease Progression|4
1726484|NCT01038635|6020662|P7|Overall Study|Disease Progression|1
1726485|NCT01038635|6020663|P6|Overall Study|Disease Progression|0
1726486|NCT01038635|6020664|P5|Overall Study|Disease Progression|0
1726487|NCT01038635|6020665|P4|Overall Study|Disease Progression|0
1726488|NCT01038635|6020666|P3|Overall Study|Disease Progression|0
1726489|NCT01038635|6020667|P2|Overall Study|Disease Progression|0
1726490|NCT01038635|6020668|P1|Overall Study|Disease Progression|2
1726491|NCT01038609|6020694|P5|Overall Study|Refusal of Blood Draws|0
1726492|NCT01038609|6020695|P4|Overall Study|Refusal of Blood Draws|0
1726493|NCT01038609|6020696|P3|Overall Study|Refusal of Blood Draws|0
1726494|NCT01038609|6020697|P2|Overall Study|Refusal of Blood Draws|1
1726495|NCT01038609|6020698|P1|Overall Study|Refusal of Blood Draws|0
1726496|NCT01038609|6020694|P5|Overall Study|Death in the Family|0
1726497|NCT01038609|6020695|P4|Overall Study|Death in the Family|0
1726498|NCT01038609|6020696|P3|Overall Study|Death in the Family|0
1726499|NCT01038609|6020697|P2|Overall Study|Death in the Family|0
1726500|NCT01038609|6020698|P1|Overall Study|Death in the Family|1
1726501|NCT01038609|6020694|P5|Overall Study|Dosing Error|1
1726502|NCT01038609|6020695|P4|Overall Study|Dosing Error|1
1726503|NCT01038609|6020696|P3|Overall Study|Dosing Error|0
1726504|NCT01038609|6020697|P2|Overall Study|Dosing Error|0
1726505|NCT01038609|6020698|P1|Overall Study|Dosing Error|0
1726506|NCT01038609|6020694|P5|Overall Study|Adverse Event|0
1726507|NCT01038609|6020695|P4|Overall Study|Adverse Event|0
1726508|NCT01038609|6020696|P3|Overall Study|Adverse Event|1
1726509|NCT01038609|6020697|P2|Overall Study|Adverse Event|0
1726510|NCT01038609|6020698|P1|Overall Study|Adverse Event|0
1726511|NCT01038323|6020817|P3|Overall Study|Withdrawal by Subject|4
1726512|NCT01038323|6020818|P2|Overall Study|Withdrawal by Subject|2
1726513|NCT01038323|6020819|P1|Overall Study|Withdrawal by Subject|3
1726514|NCT01038128|6020833|P1|Overall Study|Withdrawal by Subject|2
1726515|NCT01038128|6020833|P1|Overall Study|Lost to Follow-up|1
1726516|NCT01038128|6020833|P1|Overall Study|Lack of Efficacy|1
1726517|NCT01037244|6020997|P4|Overall Study|Various|1
1726518|NCT01037244|6020998|P3|Overall Study|Various|1
1726519|NCT01037244|6020999|P2|Overall Study|Various|2
1726520|NCT01037244|6021000|P1|Overall Study|Various|3
1726521|NCT01037244|6020997|P4|Overall Study|Partner Withdrew Consent|0
1726522|NCT01037244|6020998|P3|Overall Study|Partner Withdrew Consent|0
1726523|NCT01037244|6020999|P2|Overall Study|Partner Withdrew Consent|1
1726524|NCT01037244|6021000|P1|Overall Study|Partner Withdrew Consent|2
1726525|NCT01037244|6020997|P4|Overall Study|Withdrawal by Subject|5
1726526|NCT01037244|6020998|P3|Overall Study|Withdrawal by Subject|3
1726527|NCT01037244|6020999|P2|Overall Study|Withdrawal by Subject|5
1726528|NCT01037244|6021000|P1|Overall Study|Withdrawal by Subject|1
1726529|NCT01037244|6020997|P4|Overall Study|Lost to Follow-up|4
1726530|NCT01037244|6020998|P3|Overall Study|Lost to Follow-up|4
1726531|NCT01037244|6020999|P2|Overall Study|Lost to Follow-up|3
1726532|NCT01037244|6021000|P1|Overall Study|Lost to Follow-up|3
1726533|NCT01037244|6020997|P4|Overall Study|Lack of Efficacy|1
1726534|NCT01037244|6020998|P3|Overall Study|Lack of Efficacy|0
1726535|NCT01037244|6020999|P2|Overall Study|Lack of Efficacy|1
1726536|NCT01037244|6021000|P1|Overall Study|Lack of Efficacy|1
1726537|NCT01037244|6020997|P4|Overall Study|Adverse Event|3
1726538|NCT01037244|6020998|P3|Overall Study|Adverse Event|6
1726539|NCT01037244|6020999|P2|Overall Study|Adverse Event|2
1726540|NCT01037244|6021000|P1|Overall Study|Adverse Event|3
1726541|NCT01037218|6021062|P4|Overall Study|Various|1
1726542|NCT01037218|6021063|P3|Overall Study|Various|3
1726543|NCT01037218|6021064|P2|Overall Study|Various|2
1726544|NCT01037218|6021065|P1|Overall Study|Various|3
1726545|NCT01037218|6021062|P4|Overall Study|Protocol Violation|2
1726546|NCT01037218|6021063|P3|Overall Study|Protocol Violation|2
1726547|NCT01037218|6021064|P2|Overall Study|Protocol Violation|0
1726548|NCT01037218|6021065|P1|Overall Study|Protocol Violation|0
1726549|NCT01037218|6021062|P4|Overall Study|Partner Withdrew Consent|1
1726550|NCT01037218|6021063|P3|Overall Study|Partner Withdrew Consent|2
1726551|NCT01037218|6021064|P2|Overall Study|Partner Withdrew Consent|3
1726552|NCT01037218|6021065|P1|Overall Study|Partner Withdrew Consent|0
1726553|NCT01037218|6021062|P4|Overall Study|Withdrawal by Subject|4
1726554|NCT01037218|6021063|P3|Overall Study|Withdrawal by Subject|7
1726555|NCT01037218|6021064|P2|Overall Study|Withdrawal by Subject|7
1726556|NCT01037218|6021065|P1|Overall Study|Withdrawal by Subject|6
1726557|NCT01037218|6021062|P4|Overall Study|Lost to Follow-up|2
1726558|NCT01037218|6021063|P3|Overall Study|Lost to Follow-up|4
1726559|NCT01037218|6021064|P2|Overall Study|Lost to Follow-up|5
1726560|NCT01037218|6021065|P1|Overall Study|Lost to Follow-up|3
1726561|NCT01037218|6021062|P4|Overall Study|Lack of Efficacy|5
1726562|NCT01037218|6021063|P3|Overall Study|Lack of Efficacy|1
1726563|NCT01037218|6021064|P2|Overall Study|Lack of Efficacy|2
1726564|NCT01037218|6021065|P1|Overall Study|Lack of Efficacy|0
1726565|NCT01037218|6021062|P4|Overall Study|Adverse Event|1
1726566|NCT01037218|6021063|P3|Overall Study|Adverse Event|2
1726567|NCT01037218|6021064|P2|Overall Study|Adverse Event|2
1726568|NCT01037218|6021065|P1|Overall Study|Adverse Event|4
1726569|NCT01037127|6021136|P2|Overall Study|Study Closed Terminated|17
1726570|NCT01037127|6021137|P1|Overall Study|Study Closed Terminated|2
1726571|NCT01037127|6021136|P2|Overall Study|Physician Decision|0
1726572|NCT01037127|6021137|P1|Overall Study|Physician Decision|1
1726573|NCT01037127|6021136|P2|Overall Study|Lost to Follow-up|4
1726574|NCT01037127|6021137|P1|Overall Study|Lost to Follow-up|2
1726575|NCT01037114|6021169|P1|Year 20|Others|1
1726576|NCT01037088|6021182|P1|Overall Study|Withdrawal by Subject|3
1726577|NCT01036763|6021214|P1|Overall Study|Other reason (not specified)|40
1726578|NCT01036763|6021214|P1|Overall Study|Lost to Follow-up|28
1726579|NCT01036763|6021214|P1|Overall Study|Adverse Event|25
1726580|NCT01036724|6021226|P2|Overall Study|Protocol Violation|5
1726581|NCT01036724|6021227|P1|Overall Study|Protocol Violation|4
1726582|NCT01036724|6021226|P2|Overall Study|Lack of Efficacy|1
1726583|NCT01036724|6021227|P1|Overall Study|Lack of Efficacy|1
1726584|NCT01036724|6021226|P2|Overall Study|Adverse Event|2
1726585|NCT01036724|6021227|P1|Overall Study|Adverse Event|1
1726586|NCT01036529|6021237|P2|Overall Study|Sponsor study termination|12
1726587|NCT01036529|6021238|P1|Overall Study|Sponsor study termination|11
1726588|NCT01036529|6021237|P2|Overall Study|Withdrawal by Subject|1
1726589|NCT01036529|6021238|P1|Overall Study|Withdrawal by Subject|1
1726590|NCT01036529|6021237|P2|Overall Study|Physician Decision|0
1726591|NCT01036529|6021238|P1|Overall Study|Physician Decision|1
1726592|NCT01036529|6021237|P2|Overall Study|Lost to Follow-up|1
1726593|NCT01036529|6021238|P1|Overall Study|Lost to Follow-up|0
1726594|NCT01036529|6021237|P2|Overall Study|Adverse Event|1
1726595|NCT01036529|6021238|P1|Overall Study|Adverse Event|0
1726596|NCT01036438|6021265|P2|Overall Study|No effect of study treatment|1
1726597|NCT01036438|6021266|P1|Overall Study|No effect of study treatment|3
1726598|NCT01036438|6021265|P2|Overall Study|Death|1
1726599|NCT01036438|6021266|P1|Overall Study|Death|0
1726600|NCT01036438|6021265|P2|Overall Study|Adverse Event|8
1726601|NCT01036438|6021266|P1|Overall Study|Adverse Event|7
1726602|NCT01036321|6021274|P2|Overall Study|Adverse Event|1
1726603|NCT01036321|6021275|P1|Overall Study|Adverse Event|2
1726604|NCT01036321|6021274|P2|Overall Study|Withdrawal by Subject|2
1726605|NCT01036321|6021275|P1|Overall Study|Withdrawal by Subject|3
1726606|NCT01036321|6021274|P2|Overall Study|Ineligible after randomization|1
1726607|NCT01036321|6021275|P1|Overall Study|Ineligible after randomization|0
1726608|NCT01036165|6021299|P1|Overall Study|Problems finding proper area to inject|1
1726609|NCT01036165|6021299|P1|Overall Study|Device Related Issues|3
1726610|NCT01036165|6021299|P1|Overall Study|Withdrawal by Subject|3
1726611|NCT01036165|6021299|P1|Overall Study|Lost to Follow-up|2
1726612|NCT01036165|6021299|P1|Overall Study|Adverse Event|6
1726613|NCT01036022|6021310|P6|Overall Study|Withdrawal by Subject|0
1726614|NCT01036022|6021311|P5|Overall Study|Withdrawal by Subject|2
1726615|NCT01036022|6021312|P4|Overall Study|Withdrawal by Subject|1
1726616|NCT01036022|6021313|P3|Overall Study|Withdrawal by Subject|0
1726617|NCT01036022|6021314|P2|Overall Study|Withdrawal by Subject|0
1726618|NCT01036022|6021315|P1|Overall Study|Withdrawal by Subject|0
1726619|NCT01036022|6021310|P6|Overall Study|Physician Decision|0
1726620|NCT01036022|6021311|P5|Overall Study|Physician Decision|0
1726621|NCT01036022|6021312|P4|Overall Study|Physician Decision|0
1726622|NCT01036022|6021313|P3|Overall Study|Physician Decision|1
1726623|NCT01036022|6021314|P2|Overall Study|Physician Decision|0
1726624|NCT01036022|6021315|P1|Overall Study|Physician Decision|0
1726625|NCT01036022|6021310|P6|Overall Study|Lack of Efficacy|1
1726626|NCT01036022|6021311|P5|Overall Study|Lack of Efficacy|1
1726627|NCT01036022|6021312|P4|Overall Study|Lack of Efficacy|0
1726628|NCT01036022|6021313|P3|Overall Study|Lack of Efficacy|1
1726629|NCT01036022|6021314|P2|Overall Study|Lack of Efficacy|1
1726630|NCT01036022|6021315|P1|Overall Study|Lack of Efficacy|1
1726631|NCT01036022|6021310|P6|Overall Study|Adverse Event|2
1726632|NCT01036022|6021311|P5|Overall Study|Adverse Event|0
1726633|NCT01036022|6021312|P4|Overall Study|Adverse Event|1
1726634|NCT01036022|6021313|P3|Overall Study|Adverse Event|2
1726635|NCT01036022|6021314|P2|Overall Study|Adverse Event|3
1726636|NCT01036022|6021315|P1|Overall Study|Adverse Event|1
1726637|NCT01035905|6021451|P2|Overall Study|Lack of Efficacy|1
1726638|NCT01035905|6021452|P1|Overall Study|Lack of Efficacy|1
1726639|NCT01035606|6021625|P3|Overall Study|change in health, job demands,family|4
1726640|NCT01035606|6021626|P2|Overall Study|change in health, job demands,family|3
1726641|NCT01035606|6021627|P1|Overall Study|change in health, job demands,family|3
1726642|NCT01035463|6021643|P6|Overall Study|Other|2
1726643|NCT01035463|6021644|P5|Overall Study|Other|0
1726644|NCT01035463|6021645|P4|Overall Study|Other|1
1726645|NCT01035463|6021646|P3|Overall Study|Other|0
1726646|NCT01035463|6021647|P2|Overall Study|Other|0
1726647|NCT01035463|6021648|P1|Overall Study|Other|0
1726648|NCT01035463|6021643|P6|Overall Study|Other Malignancy|2
1726649|NCT01035463|6021644|P5|Overall Study|Other Malignancy|0
1726650|NCT01035463|6021645|P4|Overall Study|Other Malignancy|0
1726651|NCT01035463|6021646|P3|Overall Study|Other Malignancy|0
1726652|NCT01035463|6021647|P2|Overall Study|Other Malignancy|0
1726653|NCT01035463|6021648|P1|Overall Study|Other Malignancy|0
1726654|NCT01035463|6021643|P6|Overall Study|Disease progression|3
1726655|NCT01035463|6021644|P5|Overall Study|Disease progression|0
1726656|NCT01035463|6021645|P4|Overall Study|Disease progression|0
1726657|NCT01035463|6021646|P3|Overall Study|Disease progression|0
1726658|NCT01035463|6021647|P2|Overall Study|Disease progression|0
1726659|NCT01035463|6021648|P1|Overall Study|Disease progression|0
1726660|NCT01035463|6021643|P6|Overall Study|Withdrawal by Subject|4
1726661|NCT01035463|6021644|P5|Overall Study|Withdrawal by Subject|1
1726662|NCT01035463|6021645|P4|Overall Study|Withdrawal by Subject|0
1726663|NCT01035463|6021646|P3|Overall Study|Withdrawal by Subject|1
1726664|NCT01035463|6021647|P2|Overall Study|Withdrawal by Subject|2
1726665|NCT01035463|6021648|P1|Overall Study|Withdrawal by Subject|0
1726666|NCT01035463|6021643|P6|Overall Study|Adverse Event|7
1726667|NCT01035463|6021644|P5|Overall Study|Adverse Event|5
1726668|NCT01035463|6021645|P4|Overall Study|Adverse Event|1
1726669|NCT01035463|6021646|P3|Overall Study|Adverse Event|4
1726670|NCT01035463|6021647|P2|Overall Study|Adverse Event|0
1726671|NCT01035463|6021648|P1|Overall Study|Adverse Event|0
1726672|NCT01035255|6021685|P2|Overall Study|patient's request|13
1726673|NCT01035255|6021686|P1|Overall Study|patient's request|15
1726674|NCT01035255|6021685|P2|Overall Study|Lost to Follow-up|5
1726675|NCT01035255|6021686|P1|Overall Study|Lost to Follow-up|2
1726676|NCT01035255|6021685|P2|Overall Study|Death|844
1726677|NCT01035255|6021686|P1|Overall Study|Death|724
1726678|NCT01035229|6021704|P2|Overall Study|Disease Progression|152
1726679|NCT01035229|6021705|P1|Overall Study|Disease Progression|261
1726680|NCT01035229|6021704|P2|Overall Study|Sponsor's decision to end study|3
1726681|NCT01035229|6021705|P1|Overall Study|Sponsor's decision to end study|3
1726682|NCT01035229|6021704|P2|Overall Study|Protocol Violation|2
1726683|NCT01035229|6021705|P1|Overall Study|Protocol Violation|0
1726684|NCT01035229|6021704|P2|Overall Study|New cancer therapy|0
1726685|NCT01035229|6021705|P1|Overall Study|New cancer therapy|2
1726686|NCT01035229|6021704|P2|Overall Study|Death|5
1726687|NCT01035229|6021705|P1|Overall Study|Death|13
1726688|NCT01035229|6021704|P2|Overall Study|Administrative problems|1
1726689|NCT01035229|6021705|P1|Overall Study|Administrative problems|1
1726690|NCT01035229|6021704|P2|Overall Study|Lost to Follow-up|0
1726691|NCT01035229|6021705|P1|Overall Study|Lost to Follow-up|1
1726692|NCT01035229|6021704|P2|Overall Study|Withdrawal by Subject|7
1726693|NCT01035229|6021705|P1|Overall Study|Withdrawal by Subject|20
1726694|NCT01035229|6021704|P2|Overall Study|Adverse Event|14
1726695|NCT01035229|6021705|P1|Overall Study|Adverse Event|61
1726696|NCT01035138|6021735|P3|Overall Study|Lost to Follow-up|1
1726697|NCT01035138|6021736|P2|Overall Study|Lost to Follow-up|0
1726698|NCT01035138|6021737|P1|Overall Study|Lost to Follow-up|0
1726699|NCT01035138|6021735|P3|Overall Study|Sponsor Decision|42
1726700|NCT01035138|6021736|P2|Overall Study|Sponsor Decision|60
1726701|NCT01035138|6021737|P1|Overall Study|Sponsor Decision|66
1726702|NCT01035138|6021735|P3|Overall Study|Physician Decision|1
1726703|NCT01035138|6021736|P2|Overall Study|Physician Decision|0
1726704|NCT01035138|6021737|P1|Overall Study|Physician Decision|0
1726705|NCT01035138|6021735|P3|Overall Study|Withdrawal by Subject|0
1726706|NCT01035138|6021736|P2|Overall Study|Withdrawal by Subject|0
1726707|NCT01035138|6021737|P1|Overall Study|Withdrawal by Subject|1
1726708|NCT01035138|6021735|P3|Overall Study|Caregiver Decision|1
1726709|NCT01035138|6021736|P2|Overall Study|Caregiver Decision|0
1726710|NCT01035138|6021737|P1|Overall Study|Caregiver Decision|2
1726711|NCT01035138|6021735|P3|Overall Study|Adverse Event|2
1726712|NCT01035138|6021736|P2|Overall Study|Adverse Event|0
1726713|NCT01035138|6021737|P1|Overall Study|Adverse Event|4
1726714|NCT01035060|6021793|P2|Overall Study|Physician Decision|0
1726715|NCT01035060|6021794|P1|Overall Study|Physician Decision|2
1726716|NCT01035060|6021793|P2|Overall Study|Withdrawal by Subject|6
1726717|NCT01035060|6021794|P1|Overall Study|Withdrawal by Subject|8
1726718|NCT01035060|6021793|P2|Overall Study|Did not quality after 2nd screening|1
1726719|NCT01035060|6021794|P1|Overall Study|Did not quality after 2nd screening|14
1726720|NCT01035060|6021793|P2|Overall Study|Lost to Follow-up|7
1726721|NCT01035060|6021794|P1|Overall Study|Lost to Follow-up|0
1726722|NCT01034709|6021819|P2|Overall Study|Protocol Violation|16
1726723|NCT01034709|6021820|P1|Overall Study|Protocol Violation|9
1726724|NCT01034657|6021826|P3|Randomized Phase|Adverse Event|1
1726725|NCT01034657|6021827|P2|Randomized Phase|Adverse Event|2
1726726|NCT01034657|6021828|P1|Randomized Phase|Adverse Event|0
1726727|NCT01034657|6021826|P3|Randomized Phase|Abnormal laboratory value|0
1726728|NCT01034657|6021827|P2|Randomized Phase|Abnormal laboratory value|1
1726729|NCT01034657|6021828|P1|Randomized Phase|Abnormal laboratory value|0
1726730|NCT01034657|6021826|P3|Randomized Phase|Lack of Efficacy|0
1726731|NCT01034657|6021827|P2|Randomized Phase|Lack of Efficacy|1
1726732|NCT01034657|6021828|P1|Randomized Phase|Lack of Efficacy|5
1726733|NCT01034657|6021826|P3|Randomized Phase|Withdrawal by Subject|0
1726734|NCT01034657|6021827|P2|Randomized Phase|Withdrawal by Subject|2
1726735|NCT01034657|6021828|P1|Randomized Phase|Withdrawal by Subject|0
1726736|NCT01034657|6021826|P3|Core Phase|Protocol Violation|0
1726737|NCT01034657|6021827|P2|Core Phase|Protocol Violation|0
1726738|NCT01034657|6021828|P1|Core Phase|Protocol Violation|2
1726739|NCT01034657|6021826|P3|Core Phase|Adverse Event|0
1726740|NCT01034657|6021827|P2|Core Phase|Adverse Event|0
1726741|NCT01034657|6021828|P1|Core Phase|Adverse Event|8
1726742|NCT01034657|6021826|P3|Core Phase|Abnormal laboratory value|0
1726743|NCT01034657|6021827|P2|Core Phase|Abnormal laboratory value|0
1726744|NCT01034657|6021828|P1|Core Phase|Abnormal laboratory value|1
1726745|NCT01034657|6021826|P3|Core Phase|Lack of Efficacy|0
1726746|NCT01034657|6021827|P2|Core Phase|Lack of Efficacy|0
1726747|NCT01034657|6021828|P1|Core Phase|Lack of Efficacy|2
1726748|NCT01034657|6021826|P3|Core Phase|Withdrawal by Subject|0
1726749|NCT01034657|6021827|P2|Core Phase|Withdrawal by Subject|0
1726750|NCT01034657|6021828|P1|Core Phase|Withdrawal by Subject|1
1726751|NCT01034631|6021869|P3|Phase II|Determined Ineligible per protocol|0
1726752|NCT01034631|6021870|P2|Phase II|Determined Ineligible per protocol|1
1726753|NCT01034631|6021871|P1|Phase II|Determined Ineligible per protocol|0
1726754|NCT01034631|6021869|P3|Phase II|Not Evaluable per protocol|2
1726755|NCT01034631|6021870|P2|Phase II|Not Evaluable per protocol|0
1726756|NCT01034631|6021871|P1|Phase II|Not Evaluable per protocol|0
1726757|NCT01034631|6021869|P3|Phase I|Symptomatic Deterioration before Treatme|0
1726758|NCT01034631|6021870|P2|Phase I|Symptomatic Deterioration before Treatme|0
1726759|NCT01034631|6021871|P1|Phase I|Symptomatic Deterioration before Treatme|3
1726760|NCT01034540|6021938|P2|Overall Study|Adverse Event|1
1726761|NCT01034540|6021939|P1|Overall Study|Adverse Event|0
1726762|NCT01034462|6021958|P2|Overall Study|Other reasons|2
1726763|NCT01034462|6021959|P1|Overall Study|Other reasons|1
1726764|NCT01034462|6021958|P2|Overall Study|Lost to Follow-up|16
1726765|NCT01034462|6021959|P1|Overall Study|Lost to Follow-up|14
1726766|NCT01034462|6021958|P2|Overall Study|Withdrawal by Subject|8
1726767|NCT01034462|6021959|P1|Overall Study|Withdrawal by Subject|9
1726768|NCT01034462|6021958|P2|Overall Study|Protocol Violation|7
1726769|NCT01034462|6021959|P1|Overall Study|Protocol Violation|10
1726770|NCT01034462|6021958|P2|Overall Study|Lack of Efficacy|4
1726771|NCT01034462|6021959|P1|Overall Study|Lack of Efficacy|4
1726772|NCT01034462|6021958|P2|Overall Study|Adverse Event|17
1726773|NCT01034462|6021959|P1|Overall Study|Adverse Event|7
1726774|NCT01034397|6021969|P2|Overall Study|Other|1
1726775|NCT01034397|6021970|P1|Overall Study|Other|0
1726776|NCT01034397|6021969|P2|Overall Study|Adverse Event|0
1726777|NCT01034397|6021970|P1|Overall Study|Adverse Event|4
1726778|NCT01034397|6021969|P2|Overall Study|Lack of Efficacy|0
1726779|NCT01034397|6021970|P1|Overall Study|Lack of Efficacy|3
1726780|NCT01034397|6021969|P2|Overall Study|Lack of compliance|1
1726781|NCT01034397|6021970|P1|Overall Study|Lack of compliance|0
1726782|NCT01034358|6022119|P1|Overall Study|Protocol Violation|1
1726783|NCT01034358|6022119|P1|Overall Study|Withdrawal by Subject|1
1726784|NCT01034306|6022125|P2|Overall Study|Noncomplience|0
1726785|NCT01034306|6022126|P1|Overall Study|Noncomplience|1
1726786|NCT01034306|6022125|P2|Overall Study|hospitalized and decided to stop|0
1726787|NCT01034306|6022126|P1|Overall Study|hospitalized and decided to stop|1
1726788|NCT01034306|6022125|P2|Overall Study|Withdrawal by Subject|2
1726789|NCT01034306|6022126|P1|Overall Study|Withdrawal by Subject|2
1726790|NCT01034306|6022125|P2|Overall Study|Lost to Follow-up|1
1726791|NCT01034306|6022126|P1|Overall Study|Lost to Follow-up|0
1726792|NCT01034306|6022125|P2|Overall Study|Adverse Event|0
1726793|NCT01034306|6022126|P1|Overall Study|Adverse Event|1
1726794|NCT01034176|6022134|P2|Overall Study|Lost to Follow-up|1
1726795|NCT01034176|6022135|P1|Overall Study|Lost to Follow-up|0
1726796|NCT01034176|6022134|P2|Overall Study|Withdrawal by Subject|1
1726797|NCT01034176|6022135|P1|Overall Study|Withdrawal by Subject|0
1726798|NCT01034176|6022134|P2|Overall Study|Physician Decision|0
1726799|NCT01034176|6022135|P1|Overall Study|Physician Decision|2
1726800|NCT01034163|6022145|P2|Overall Study|Abnormal laboratory value|0
1726801|NCT01034163|6022146|P1|Overall Study|Abnormal laboratory value|1
1726802|NCT01034163|6022145|P2|Overall Study|Administrative problems|1
1726803|NCT01034163|6022146|P1|Overall Study|Administrative problems|0
1726804|NCT01034163|6022145|P2|Overall Study|Adverse Event|0
1726805|NCT01034163|6022146|P1|Overall Study|Adverse Event|6
1726806|NCT01034163|6022145|P2|Overall Study|Disease progression|4
1726807|NCT01034163|6022146|P1|Overall Study|Disease progression|3
1726808|NCT01034163|6022145|P2|Overall Study|Protocol deviation|0
1726809|NCT01034163|6022146|P1|Overall Study|Protocol deviation|1
1726810|NCT01034163|6022145|P2|Overall Study|Withdrawal by Subject|2
1726811|NCT01034163|6022146|P1|Overall Study|Withdrawal by Subject|8
1726812|NCT01034163|6022145|P2|Overall Study|Treatment completed as per protocol|7
1726813|NCT01034163|6022146|P1|Overall Study|Treatment completed as per protocol|8
1726814|NCT01034137|6022155|P3|Overall Study|Administrative or other|4
1726815|NCT01034137|6022156|P2|Overall Study|Administrative or other|3
1726816|NCT01034137|6022157|P1|Overall Study|Administrative or other|2
1726817|NCT01034137|6022155|P3|Overall Study|Refused treatment or did not cooperate|1
1726818|NCT01034137|6022156|P2|Overall Study|Refused treatment or did not cooperate|0
1726819|NCT01034137|6022157|P1|Overall Study|Refused treatment or did not cooperate|2
1726820|NCT01034137|6022155|P3|Overall Study|Protocol Violation|1
1726821|NCT01034137|6022156|P2|Overall Study|Protocol Violation|2
1726822|NCT01034137|6022157|P1|Overall Study|Protocol Violation|2
1726823|NCT01034137|6022155|P3|Overall Study|Lack of Efficacy|13
1726824|NCT01034137|6022156|P2|Overall Study|Lack of Efficacy|4
1726825|NCT01034137|6022157|P1|Overall Study|Lack of Efficacy|9
1726826|NCT01034137|6022155|P3|Overall Study|Withdrawal by Subject|3
1726827|NCT01034137|6022156|P2|Overall Study|Withdrawal by Subject|3
1726828|NCT01034137|6022157|P1|Overall Study|Withdrawal by Subject|4
1726829|NCT01034137|6022155|P3|Overall Study|Adverse Event|8
1726830|NCT01034137|6022156|P2|Overall Study|Adverse Event|10
1726831|NCT01034137|6022157|P1|Overall Study|Adverse Event|9
1726832|NCT01033942|6022296|P3|Overall Study|Enrolled in Extension Study|0
1726833|NCT01033942|6022297|P2|Overall Study|Enrolled in Extension Study|3
1726834|NCT01033942|6022298|P1|Overall Study|Enrolled in Extension Study|0
1726835|NCT01033942|6022296|P3|Overall Study|Lost to Follow-up|0
1726836|NCT01033942|6022297|P2|Overall Study|Lost to Follow-up|0
1726837|NCT01033942|6022298|P1|Overall Study|Lost to Follow-up|1
1726838|NCT01033942|6022296|P3|Overall Study|Withdrawal by Subject|1
1726839|NCT01033942|6022297|P2|Overall Study|Withdrawal by Subject|1
1726840|NCT01033942|6022298|P1|Overall Study|Withdrawal by Subject|1
1726841|NCT01033851|6022596|P2|Overall Study|Withdrawal by Subject|7
1726842|NCT01033851|6022597|P1|Overall Study|Withdrawal by Subject|3
1726843|NCT01033825|6022612|P7|Overall Study|Other|0
1726844|NCT01033825|6022613|P6|Overall Study|Other|0
1726845|NCT01033825|6022614|P5|Overall Study|Other|1
1726846|NCT01033825|6022615|P4|Overall Study|Other|0
1726847|NCT01033825|6022616|P3|Overall Study|Other|0
1726848|NCT01033825|6022617|P2|Overall Study|Other|0
1726849|NCT01033825|6022618|P1|Overall Study|Other|0
1726850|NCT01033825|6022612|P7|Overall Study|Protocol Violation|0
1726851|NCT01033825|6022613|P6|Overall Study|Protocol Violation|0
1726852|NCT01033825|6022614|P5|Overall Study|Protocol Violation|0
1726853|NCT01033825|6022615|P4|Overall Study|Protocol Violation|0
1726854|NCT01033825|6022616|P3|Overall Study|Protocol Violation|0
1726855|NCT01033825|6022617|P2|Overall Study|Protocol Violation|0
1726856|NCT01033825|6022618|P1|Overall Study|Protocol Violation|1
1726857|NCT01033825|6022612|P7|Overall Study|Adverse Event|0
1726858|NCT01033825|6022613|P6|Overall Study|Adverse Event|0
1726859|NCT01033825|6022614|P5|Overall Study|Adverse Event|0
1726860|NCT01033825|6022615|P4|Overall Study|Adverse Event|1
1726861|NCT01033825|6022616|P3|Overall Study|Adverse Event|0
1726862|NCT01033825|6022617|P2|Overall Study|Adverse Event|0
1726863|NCT01033825|6022618|P1|Overall Study|Adverse Event|0
1726864|NCT01033825|6022612|P7|Overall Study|Withdrawal by Subject|0
1726865|NCT01033825|6022613|P6|Overall Study|Withdrawal by Subject|0
1726866|NCT01033825|6022614|P5|Overall Study|Withdrawal by Subject|1
1726867|NCT01033825|6022615|P4|Overall Study|Withdrawal by Subject|1
1726868|NCT01033825|6022616|P3|Overall Study|Withdrawal by Subject|2
1726869|NCT01033825|6022617|P2|Overall Study|Withdrawal by Subject|3
1726870|NCT01033825|6022618|P1|Overall Study|Withdrawal by Subject|2
1726871|NCT01033747|6022839|P2|Overall Study|Stopped at end of Extension 1|0
1726872|NCT01033747|6022840|P1|Overall Study|Stopped at end of Extension 1|2
1726873|NCT01033747|6022839|P2|Overall Study|Stopped at end of prolongation visit 1|0
1726874|NCT01033747|6022840|P1|Overall Study|Stopped at end of prolongation visit 1|1
1726875|NCT01033747|6022839|P2|Overall Study|Withdrawal by Subject|6
1726876|NCT01033747|6022840|P1|Overall Study|Withdrawal by Subject|9
1726877|NCT01033747|6022839|P2|Overall Study|Protocol Violation|0
1726878|NCT01033747|6022840|P1|Overall Study|Protocol Violation|1
1726879|NCT01033747|6022839|P2|Overall Study|Unsatisfactory therapeutic effect|4
1726880|NCT01033747|6022840|P1|Overall Study|Unsatisfactory therapeutic effect|14
1726881|NCT01033747|6022839|P2|Overall Study|Abnormal test procedure|1
1726882|NCT01033747|6022840|P1|Overall Study|Abnormal test procedure|0
1726883|NCT01033747|6022839|P2|Overall Study|Abnormal Laboratory Value|0
1726884|NCT01033747|6022840|P1|Overall Study|Abnormal Laboratory Value|1
1726885|NCT01033747|6022839|P2|Overall Study|Adverse Event|4
1726886|NCT01033747|6022840|P1|Overall Study|Adverse Event|9
1726887|NCT01033734|6022848|P1|Overall Study|Withdrawal by Subject|1
1726888|NCT01033487|6022904|P10|Fourth Intervention Period|Adverse Event|0
1726889|NCT01033487|6022905|P9|Fourth Intervention Period|Adverse Event|1
1726890|NCT01033487|6022906|P8|Fourth Intervention Period|Adverse Event|0
1726891|NCT01033487|6022907|P7|Fourth Intervention Period|Adverse Event|0
1726892|NCT01033487|6022908|P6|Fourth Intervention Period|Adverse Event|0
1726893|NCT01033487|6022909|P5|Fourth Intervention Period|Adverse Event|0
1726894|NCT01033487|6022910|P4|Fourth Intervention Period|Adverse Event|0
1726895|NCT01033487|6022911|P3|Fourth Intervention Period|Adverse Event|0
1726896|NCT01033487|6022912|P2|Fourth Intervention Period|Adverse Event|0
1726897|NCT01033487|6022913|P1|Fourth Intervention Period|Adverse Event|0
1726898|NCT01033448|6022967|P1|Overall Study|Unknown disposition|1
1726899|NCT01033448|6022967|P1|Overall Study|Withdrew due to other reasons|3
1726900|NCT01033448|6022967|P1|Overall Study|Lost to Follow-up|3
1726901|NCT01033448|6022967|P1|Overall Study|Positive HCV-RNA at week 48|1
1726902|NCT01033448|6022967|P1|Overall Study|Withdrawal by Subject|4
1726903|NCT01033136|6023026|P2|Follow-Up (3 Month)|Lost to Follow-up|2
1726904|NCT01033136|6023027|P1|Follow-Up (3 Month)|Lost to Follow-up|2
1726905|NCT01033071|6023038|P3|Overall Study|Other|3
1726906|NCT01033071|6023039|P2|Overall Study|Other|4
1726907|NCT01033071|6023040|P1|Overall Study|Other|6
1726908|NCT01033071|6023038|P3|Overall Study|Lack of Efficacy|1
1726909|NCT01033071|6023039|P2|Overall Study|Lack of Efficacy|1
1726910|NCT01033071|6023040|P1|Overall Study|Lack of Efficacy|0
1726911|NCT01033071|6023038|P3|Overall Study|Withdrawal by Subject|11
1726912|NCT01033071|6023039|P2|Overall Study|Withdrawal by Subject|14
1726913|NCT01033071|6023040|P1|Overall Study|Withdrawal by Subject|17
1726914|NCT01033071|6023038|P3|Overall Study|Lost to Follow-up|5
1726915|NCT01033071|6023039|P2|Overall Study|Lost to Follow-up|5
1726916|NCT01033071|6023040|P1|Overall Study|Lost to Follow-up|4
1726917|NCT01033071|6023038|P3|Overall Study|Protocol Violation|1
1726918|NCT01033071|6023039|P2|Overall Study|Protocol Violation|2
1726919|NCT01033071|6023040|P1|Overall Study|Protocol Violation|0
1726920|NCT01033071|6023038|P3|Overall Study|Adverse Event|26
1726921|NCT01033071|6023039|P2|Overall Study|Adverse Event|51
1726922|NCT01033071|6023040|P1|Overall Study|Adverse Event|28
1726923|NCT01033019|6023111|P2|Overall Study|Withdrawal by Subject|0
1726924|NCT01033019|6023112|P1|Overall Study|Withdrawal by Subject|1
1726925|NCT01032915|6023150|P4|Overall Study|Protocol Violation|1
1726926|NCT01032915|6023151|P3|Overall Study|Protocol Violation|0
1726927|NCT01032915|6023152|P2|Overall Study|Protocol Violation|0
1726928|NCT01032915|6023153|P1|Overall Study|Protocol Violation|1
1726929|NCT01032915|6023150|P4|Overall Study|Administrative reasons|4
1726930|NCT01032915|6023151|P3|Overall Study|Administrative reasons|4
1726931|NCT01032915|6023152|P2|Overall Study|Administrative reasons|6
1726932|NCT01032915|6023153|P1|Overall Study|Administrative reasons|5
1726933|NCT01032915|6023150|P4|Overall Study|Withdrawal by Subject|1
1726934|NCT01032915|6023151|P3|Overall Study|Withdrawal by Subject|1
1726935|NCT01032915|6023152|P2|Overall Study|Withdrawal by Subject|3
1726936|NCT01032915|6023153|P1|Overall Study|Withdrawal by Subject|0
1726937|NCT01032915|6023150|P4|Overall Study|Abnormal test procedure result|0
1726938|NCT01032915|6023151|P3|Overall Study|Abnormal test procedure result|1
1726939|NCT01032915|6023152|P2|Overall Study|Abnormal test procedure result|0
1726940|NCT01032915|6023153|P1|Overall Study|Abnormal test procedure result|0
1726941|NCT01032915|6023150|P4|Overall Study|Adverse Event|1
1726942|NCT01032915|6023151|P3|Overall Study|Adverse Event|1
1726943|NCT01032915|6023152|P2|Overall Study|Adverse Event|2
1726944|NCT01032915|6023153|P1|Overall Study|Adverse Event|2
1726945|NCT01032889|6023178|P3|Overall Study|Miscellaneous Reasons|1
1726946|NCT01032889|6023179|P2|Overall Study|Miscellaneous Reasons|1
1726947|NCT01032889|6023180|P1|Overall Study|Miscellaneous Reasons|2
1726948|NCT01032889|6023178|P3|Overall Study|Lack of Submental Fat|1
1726949|NCT01032889|6023179|P2|Overall Study|Lack of Submental Fat|8
1726950|NCT01032889|6023180|P1|Overall Study|Lack of Submental Fat|2
1726951|NCT01032889|6023178|P3|Overall Study|Lost to Follow-up|0
1726952|NCT01032889|6023179|P2|Overall Study|Lost to Follow-up|1
1726953|NCT01032889|6023180|P1|Overall Study|Lost to Follow-up|1
1726954|NCT01032889|6023178|P3|Overall Study|Patient Request|0
1726955|NCT01032889|6023179|P2|Overall Study|Patient Request|1
1726956|NCT01032889|6023180|P1|Overall Study|Patient Request|0
1726957|NCT01032889|6023178|P3|Overall Study|Withdrawal of Consent|1
1726958|NCT01032889|6023179|P2|Overall Study|Withdrawal of Consent|2
1726959|NCT01032889|6023180|P1|Overall Study|Withdrawal of Consent|1
1726960|NCT01032889|6023178|P3|Overall Study|Adverse Event|0
1726961|NCT01032889|6023179|P2|Overall Study|Adverse Event|2
1726962|NCT01032889|6023180|P1|Overall Study|Adverse Event|2
1726963|NCT01032837|6023211|P4|Overall Study|Refused treatment|1
1726964|NCT01032837|6023212|P3|Overall Study|Refused treatment|0
1726965|NCT01032837|6023213|P2|Overall Study|Refused treatment|0
1726966|NCT01032837|6023214|P1|Overall Study|Refused treatment|0
1726967|NCT01032837|6023211|P4|Overall Study|Failed to return|0
1726968|NCT01032837|6023212|P3|Overall Study|Failed to return|1
1726969|NCT01032837|6023213|P2|Overall Study|Failed to return|0
1726970|NCT01032837|6023214|P1|Overall Study|Failed to return|0
1726971|NCT01032837|6023211|P4|Overall Study|Withdrew consent|1
1726972|NCT01032837|6023212|P3|Overall Study|Withdrew consent|0
1726973|NCT01032837|6023213|P2|Overall Study|Withdrew consent|2
1726974|NCT01032837|6023214|P1|Overall Study|Withdrew consent|0
1726975|NCT01032837|6023211|P4|Overall Study|Adverse event/internal illness|1
1726976|NCT01032837|6023212|P3|Overall Study|Adverse event/internal illness|0
1726977|NCT01032837|6023213|P2|Overall Study|Adverse event/internal illness|1
1726978|NCT01032837|6023214|P1|Overall Study|Adverse event/internal illness|0
1726979|NCT01032629|6023314|P3|Overall Study|Lost to Follow-up|37
1726980|NCT01032629|6023315|P2|Overall Study|Lost to Follow-up|47
1726981|NCT01032629|6023316|P1|Overall Study|Lost to Follow-up|74
1726982|NCT01032629|6023314|P3|Overall Study|Withdrawal by Subject|35
1726983|NCT01032629|6023315|P2|Overall Study|Withdrawal by Subject|36
1726984|NCT01032629|6023316|P1|Overall Study|Withdrawal by Subject|50
1726985|NCT01032629|6023314|P3|Overall Study|Closed Site|16
1726986|NCT01032629|6023315|P2|Overall Study|Closed Site|18
1726987|NCT01032629|6023316|P1|Overall Study|Closed Site|21
1726988|NCT01032382|6023428|P2|Overall Study|Index lesion relapse|3
1726989|NCT01032382|6023429|P1|Overall Study|Index lesion relapse|1
1726990|NCT01032382|6023428|P2|Overall Study|Treatment failure|1
1726991|NCT01032382|6023429|P1|Overall Study|Treatment failure|3
1726992|NCT01032382|6023428|P2|Overall Study|Disease dissemination|1
1726993|NCT01032382|6023429|P1|Overall Study|Disease dissemination|1
1726994|NCT01032291|6023517|P3|Proof of Concept|Never Received Study Drug|0
1726995|NCT01032291|6023518|P2|Proof of Concept|Never Received Study Drug|1
1726996|NCT01032291|6023519|P1|Proof of Concept|Never Received Study Drug|0
1726997|NCT01032291|6023517|P3|Proof of Concept|Lack of Efficacy|0
1726998|NCT01032291|6023518|P2|Proof of Concept|Lack of Efficacy|1
1726999|NCT01032291|6023519|P1|Proof of Concept|Lack of Efficacy|0
1727000|NCT01032291|6023517|P3|Proof of Concept|Death|2
1727001|NCT01032291|6023518|P2|Proof of Concept|Death|1
1727002|NCT01032291|6023519|P1|Proof of Concept|Death|0
1727003|NCT01032291|6023517|P3|Proof of Concept|Adverse Event|1
1727004|NCT01032291|6023518|P2|Proof of Concept|Adverse Event|5
1727005|NCT01032291|6023519|P1|Proof of Concept|Adverse Event|0
1727006|NCT01032291|6023517|P3|Safety Lead-in|Death|0
1727007|NCT01032291|6023518|P2|Safety Lead-in|Death|0
1727008|NCT01032291|6023519|P1|Safety Lead-in|Death|1
1727009|NCT01032291|6023517|P3|Safety Lead-in|Adverse Event|0
1727010|NCT01032291|6023518|P2|Safety Lead-in|Adverse Event|0
1727011|NCT01032291|6023519|P1|Safety Lead-in|Adverse Event|1
1727012|NCT01032239|6023566|P2|Overall Study|Protocol Violation|0
1727013|NCT01032239|6023567|P1|Overall Study|Protocol Violation|1
1727014|NCT01032239|6023566|P2|Overall Study|Death|0
1727015|NCT01032239|6023567|P1|Overall Study|Death|1
1727016|NCT01032239|6023566|P2|Overall Study|Withdrawal by Subject|3
1727017|NCT01032239|6023567|P1|Overall Study|Withdrawal by Subject|2
1727018|NCT01032239|6023566|P2|Overall Study|Lost to Follow-up|2
1727019|NCT01032239|6023567|P1|Overall Study|Lost to Follow-up|3
1727020|NCT01032200|6023597|P2|Overall Study|Multiple|1
1727021|NCT01032200|6023598|P1|Overall Study|Multiple|1
1727022|NCT01032200|6023597|P2|Overall Study|Progression|0
1727023|NCT01032200|6023598|P1|Overall Study|Progression|1
1727024|NCT01032200|6023597|P2|Overall Study|Toxicity|2
1727025|NCT01032200|6023598|P1|Overall Study|Toxicity|0
1727026|NCT01032200|6023597|P2|Overall Study|Withdrawal by Subject|3
1727027|NCT01032200|6023598|P1|Overall Study|Withdrawal by Subject|1
1727028|NCT01032200|6023597|P2|Overall Study|Death|1
1727029|NCT01032200|6023598|P1|Overall Study|Death|1
1727030|NCT01032174|6023614|P2|Overall Study|Adverse Event|1
1727031|NCT01032174|6023615|P1|Overall Study|Adverse Event|0
1727032|NCT01032070|6023855|P2|Overall Study|Withdrawal by Subject|2
1727033|NCT01032070|6023856|P1|Overall Study|Withdrawal by Subject|0
1727034|NCT01032070|6023855|P2|Overall Study|Medical or ethical reasons|2
1727035|NCT01032070|6023856|P1|Overall Study|Medical or ethical reasons|0
1727036|NCT01032070|6023855|P2|Overall Study|Disease progression|8
1727037|NCT01032070|6023856|P1|Overall Study|Disease progression|13
1727038|NCT01032044|6023885|P2|Overall Study|Lost to Follow-up|11
1727039|NCT01032044|6023886|P1|Overall Study|Lost to Follow-up|11
1727040|NCT01032044|6023885|P2|Overall Study|Adverse Event|1
1727041|NCT01032044|6023886|P1|Overall Study|Adverse Event|0
1727042|NCT01032044|6023885|P2|Overall Study|Protocol Violation|8
1727043|NCT01032044|6023886|P1|Overall Study|Protocol Violation|14
1727044|NCT01032018|6023894|P2|Overall Study|Death|1
1727045|NCT01032018|6023895|P1|Overall Study|Death|0
1727046|NCT01032018|6023894|P2|Overall Study|Lost to Follow-up|5
1727047|NCT01032018|6023895|P1|Overall Study|Lost to Follow-up|6
1727048|NCT01031979|6023905|P2|Overall Study|Lost to Follow-up|4
1727049|NCT01031979|6023906|P1|Overall Study|Lost to Follow-up|5
1727050|NCT01031836|6023939|P6|Stage II|Other|0
1727051|NCT01031836|6023940|P5|Stage II|Other|1
1727052|NCT01031836|6023941|P4|Stage II|Other|1
1727053|NCT01031836|6023942|P3|Stage II|Other|0
1727054|NCT01031836|6023943|P2|Stage II|Other|0
1727055|NCT01031836|6023944|P1|Stage II|Other|2
1727056|NCT01031836|6023939|P6|Stage II|Adverse Event|1
1727057|NCT01031836|6023940|P5|Stage II|Adverse Event|1
1727058|NCT01031836|6023941|P4|Stage II|Adverse Event|2
1727059|NCT01031836|6023942|P3|Stage II|Adverse Event|2
1727060|NCT01031836|6023943|P2|Stage II|Adverse Event|0
1727061|NCT01031836|6023944|P1|Stage II|Adverse Event|0
1727062|NCT01031836|6023939|P6|Stage I|Other|1
1727063|NCT01031836|6023940|P5|Stage I|Other|0
1727064|NCT01031836|6023941|P4|Stage I|Other|0
1727065|NCT01031836|6023942|P3|Stage I|Other|0
1727066|NCT01031836|6023943|P2|Stage I|Other|1
1727067|NCT01031836|6023944|P1|Stage I|Other|0
1727068|NCT01031836|6023939|P6|Stage I|Adverse Event|0
1727069|NCT01031836|6023940|P5|Stage I|Adverse Event|0
1727070|NCT01031836|6023941|P4|Stage I|Adverse Event|0
1727071|NCT01031836|6023942|P3|Stage I|Adverse Event|0
1727072|NCT01031836|6023943|P2|Stage I|Adverse Event|1
1727073|NCT01031836|6023944|P1|Stage I|Adverse Event|1
1727074|NCT01031706|6024005|P2|Overall Study|Withdrawal by Subject|1
1727075|NCT01031706|6024006|P1|Overall Study|Withdrawal by Subject|1
1727076|NCT01031706|6024005|P2|Overall Study|Adverse Event|0
1727077|NCT01031706|6024006|P1|Overall Study|Adverse Event|1
1727078|NCT01031680|6024016|P2|Overall Study|Various|2
1727079|NCT01031680|6024017|P1|Overall Study|Various|0
1727080|NCT01031680|6024016|P2|Overall Study|Administrative Reason by Sponsor|1
1727081|NCT01031680|6024017|P1|Overall Study|Administrative Reason by Sponsor|0
1727082|NCT01031680|6024016|P2|Overall Study|Incorrect Enrolment|2
1727083|NCT01031680|6024017|P1|Overall Study|Incorrect Enrolment|1
1727084|NCT01031680|6024016|P2|Overall Study|Safety|0
1727085|NCT01031680|6024017|P1|Overall Study|Safety|1
1727086|NCT01031680|6024016|P2|Overall Study|Poor/Non-compliance|6
1727087|NCT01031680|6024017|P1|Overall Study|Poor/Non-compliance|5
1727088|NCT01031680|6024016|P2|Overall Study|Subject No Longer Meets Study Criteria|17
1727089|NCT01031680|6024017|P1|Overall Study|Subject No Longer Meets Study Criteria|26
1727090|NCT01031680|6024016|P2|Overall Study|Death|1
1727091|NCT01031680|6024017|P1|Overall Study|Death|2
1727092|NCT01031680|6024016|P2|Overall Study|Withdrawal by Subject|16
1727093|NCT01031680|6024017|P1|Overall Study|Withdrawal by Subject|12
1727094|NCT01031680|6024016|P2|Overall Study|Lost to Follow-up|10
1727095|NCT01031680|6024017|P1|Overall Study|Lost to Follow-up|2
1727096|NCT01031680|6024016|P2|Overall Study|Adverse Event|3
1727097|NCT01031680|6024017|P1|Overall Study|Adverse Event|8
1727098|NCT01031628|6024037|P4|Overall Study|Study terminated early|0
1727099|NCT01031628|6024038|P3|Overall Study|Study terminated early|3
1727100|NCT01031628|6024039|P2|Overall Study|Study terminated early|1
1727101|NCT01031628|6024040|P1|Overall Study|Study terminated early|0
1727102|NCT01031537|6024065|P1|Overall Study|PI removal, no longer met eligibility|12
1727103|NCT01031537|6024065|P1|Overall Study|Withdrawal by Subject|5
1727104|NCT01031537|6024065|P1|Overall Study|moved, met exclusion criteria|10
1727105|NCT01031537|6024065|P1|Overall Study|retired from NIH, met exclusion criteria|1
1727106|NCT01031537|6024065|P1|Overall Study|Lack of Efficacy|1
1727107|NCT01031537|6024065|P1|Overall Study|medical reasons not related to study|3
1727108|NCT01031446|6024083|P1|Overall Study|Still on treatment|1
1727109|NCT01031446|6024083|P1|Overall Study|Withdrawal by Subject|3
1727110|NCT01031446|6024083|P1|Overall Study|Physician Decision|4
1727111|NCT01031446|6024083|P1|Overall Study|Adverse Event|9
1727112|NCT01031446|6024083|P1|Overall Study|Disease Progression|38
1727113|NCT01031381|6024097|P1|Overall Study|Withdrawal by Subject|6
1727114|NCT01031381|6024097|P1|Overall Study|Physician Decision|3
1727115|NCT01031069|6024126|P4|Overall Study|Other|0
1727116|NCT01031069|6024127|P3|Overall Study|Other|1
1727117|NCT01031069|6024128|P2|Overall Study|Other|0
1727118|NCT01031069|6024129|P1|Overall Study|Other|0
1727119|NCT01031069|6024126|P4|Overall Study|Lost to Follow-up|15
1727120|NCT01031069|6024127|P3|Overall Study|Lost to Follow-up|21
1727121|NCT01031069|6024128|P2|Overall Study|Lost to Follow-up|5
1727122|NCT01031069|6024129|P1|Overall Study|Lost to Follow-up|9
1727123|NCT01031069|6024126|P4|Overall Study|Migrated/moved from study area|1
1727124|NCT01031069|6024127|P3|Overall Study|Migrated/moved from study area|1
1727125|NCT01031069|6024128|P2|Overall Study|Migrated/moved from study area|2
1727126|NCT01031069|6024129|P1|Overall Study|Migrated/moved from study area|1
1727127|NCT01031069|6024126|P4|Overall Study|Withdrawal by Subject|18
1727128|NCT01031069|6024127|P3|Overall Study|Withdrawal by Subject|18
1727129|NCT01031069|6024128|P2|Overall Study|Withdrawal by Subject|3
1727130|NCT01031069|6024129|P1|Overall Study|Withdrawal by Subject|2
1727131|NCT01031069|6024126|P4|Overall Study|Serious Adverse Event|0
1727132|NCT01031069|6024127|P3|Overall Study|Serious Adverse Event|0
1727133|NCT01031069|6024128|P2|Overall Study|Serious Adverse Event|1
1727134|NCT01031069|6024129|P1|Overall Study|Serious Adverse Event|0
1727135|NCT01031004|6024231|P2|Overall Study|Lost to Follow-up|0
1727136|NCT01031004|6024232|P1|Overall Study|Lost to Follow-up|1
1727137|NCT01031004|6024231|P2|Overall Study|Protocol Violation|1
1727138|NCT01031004|6024232|P1|Overall Study|Protocol Violation|0
1727139|NCT01030965|6024276|P4|Overall Study|Withdrawal by Subject|2
1727140|NCT01030965|6024277|P3|Overall Study|Withdrawal by Subject|0
1727141|NCT01030965|6024278|P2|Overall Study|Withdrawal by Subject|1
1727142|NCT01030965|6024279|P1|Overall Study|Withdrawal by Subject|0
1727143|NCT01030965|6024276|P4|Overall Study|Protocol-defined Stopping Criteria|0
1727144|NCT01030965|6024277|P3|Overall Study|Protocol-defined Stopping Criteria|1
1727145|NCT01030965|6024278|P2|Overall Study|Protocol-defined Stopping Criteria|1
1727146|NCT01030965|6024279|P1|Overall Study|Protocol-defined Stopping Criteria|0
1727147|NCT01030965|6024276|P4|Overall Study|Adverse Event|1
1727148|NCT01030965|6024277|P3|Overall Study|Adverse Event|2
1727149|NCT01030965|6024278|P2|Overall Study|Adverse Event|1
1727150|NCT01030965|6024279|P1|Overall Study|Adverse Event|0
1727151|NCT01030965|6024276|P4|Overall Study|Protocol Violation|1
1727152|NCT01030965|6024277|P3|Overall Study|Protocol Violation|1
1727153|NCT01030965|6024278|P2|Overall Study|Protocol Violation|1
1727154|NCT01030965|6024279|P1|Overall Study|Protocol Violation|1
1727155|NCT01030965|6024276|P4|Overall Study|Lack of Efficacy|3
1727156|NCT01030965|6024277|P3|Overall Study|Lack of Efficacy|0
1727157|NCT01030965|6024278|P2|Overall Study|Lack of Efficacy|2
1727158|NCT01030965|6024279|P1|Overall Study|Lack of Efficacy|3
1727159|NCT01030952|6024299|P2|Overall Study|Unexplained|1
1727160|NCT01030952|6024300|P1|Overall Study|Unexplained|1
1727161|NCT01030952|6024299|P2|Overall Study|Lost to Follow-up|1
1727162|NCT01030952|6024300|P1|Overall Study|Lost to Follow-up|0
1727163|NCT01030952|6024299|P2|Overall Study|Informed consent withdrawal|0
1727164|NCT01030952|6024300|P1|Overall Study|Informed consent withdrawal|1
1727165|NCT01030952|6024299|P2|Overall Study|Protocol Violation|1
1727166|NCT01030952|6024300|P1|Overall Study|Protocol Violation|0
1727167|NCT01030822|6024337|P3|Overall Study|Lost to Follow-up|7
1727168|NCT01030822|6024338|P2|Overall Study|Lost to Follow-up|4
1727169|NCT01030822|6024339|P1|Overall Study|Lost to Follow-up|9
1727170|NCT01030822|6024337|P3|Overall Study|Withdrawal by Subject|16
1727171|NCT01030822|6024338|P2|Overall Study|Withdrawal by Subject|13
1727172|NCT01030822|6024339|P1|Overall Study|Withdrawal by Subject|16
1727173|NCT01030822|6024337|P3|Overall Study|Moved/migrated from study area|3
1727174|NCT01030822|6024338|P2|Overall Study|Moved/migrated from study area|7
1727175|NCT01030822|6024339|P1|Overall Study|Moved/migrated from study area|6
1727176|NCT01030718|6024414|P3|Study CA180-036 Only|Other Reasons|0
1727177|NCT01030718|6024415|P2|Study CA180-036 Only|Other Reasons|2
1727178|NCT01030718|6024416|P1|Study CA180-036 Only|Other Reasons|0
1727179|NCT01030718|6024414|P3|Study CA180-036 Only|Death|0
1727180|NCT01030718|6024415|P2|Study CA180-036 Only|Death|1
1727181|NCT01030718|6024416|P1|Study CA180-036 Only|Death|0
1727182|NCT01030718|6024414|P3|Study CA180-036 Only|Adverse Event|0
1727183|NCT01030718|6024415|P2|Study CA180-036 Only|Adverse Event|3
1727184|NCT01030718|6024416|P1|Study CA180-036 Only|Adverse Event|2
1727185|NCT01030718|6024414|P3|Study CA180-036 Only|insufficient effect|5
1727186|NCT01030718|6024415|P2|Study CA180-036 Only|insufficient effect|1
1727187|NCT01030718|6024416|P1|Study CA180-036 Only|insufficient effect|1
1727188|NCT01030718|6024414|P3|Studies CA180-031 and -036 Combined|other reasons|0
1727189|NCT01030718|6024415|P2|Studies CA180-031 and -036 Combined|other reasons|2
1727190|NCT01030718|6024416|P1|Studies CA180-031 and -036 Combined|other reasons|0
1727191|NCT01030718|6024414|P3|Studies CA180-031 and -036 Combined|Death|0
1727192|NCT01030718|6024415|P2|Studies CA180-031 and -036 Combined|Death|1
1727193|NCT01030718|6024416|P1|Studies CA180-031 and -036 Combined|Death|0
1727194|NCT01030718|6024414|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
1727195|NCT01030718|6024415|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
1727196|NCT01030718|6024416|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
1727197|NCT01030718|6024414|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
1727198|NCT01030718|6024415|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
1727199|NCT01030718|6024416|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
1727200|NCT01030666|6024477|P2|Overall Study|Lost to Follow-up|2
1727201|NCT01030666|6024478|P1|Overall Study|Lost to Follow-up|3
1727202|NCT01030536|6024503|P5|Overall Study|Death|0
1727203|NCT01030536|6024504|P4|Overall Study|Death|0
1727204|NCT01030536|6024505|P3|Overall Study|Death|0
1727205|NCT01030536|6024506|P2|Overall Study|Death|1
1727206|NCT01030536|6024507|P1|Overall Study|Death|0
1727207|NCT01030536|6024503|P5|Overall Study|Progressive disease|0
1727208|NCT01030536|6024504|P4|Overall Study|Progressive disease|2
1727209|NCT01030536|6024505|P3|Overall Study|Progressive disease|3
1727210|NCT01030536|6024506|P2|Overall Study|Progressive disease|2
1727211|NCT01030536|6024507|P1|Overall Study|Progressive disease|6
1727212|NCT01030536|6024503|P5|Overall Study|Adverse Event|1
1727213|NCT01030536|6024504|P4|Overall Study|Adverse Event|0
1727214|NCT01030536|6024505|P3|Overall Study|Adverse Event|1
1727215|NCT01030536|6024506|P2|Overall Study|Adverse Event|3
1727216|NCT01030536|6024507|P1|Overall Study|Adverse Event|0
1727217|NCT01030536|6024503|P5|Overall Study|undefined|0
1727218|NCT01030536|6024504|P4|Overall Study|undefined|1
1727219|NCT01030536|6024505|P3|Overall Study|undefined|1
1727220|NCT01030536|6024506|P2|Overall Study|undefined|0
1727221|NCT01030536|6024507|P1|Overall Study|undefined|1
1727222|NCT01030536|6024503|P5|Overall Study|Withdrawal by Subject|0
1727223|NCT01030536|6024504|P4|Overall Study|Withdrawal by Subject|0
1727224|NCT01030536|6024505|P3|Overall Study|Withdrawal by Subject|1
1727225|NCT01030536|6024506|P2|Overall Study|Withdrawal by Subject|0
1727226|NCT01030536|6024507|P1|Overall Study|Withdrawal by Subject|0
1727227|NCT01030458|6024612|P2|Overall Study|Side effect of medication|1
1727228|NCT01030458|6024613|P1|Overall Study|Side effect of medication|1
1727229|NCT01030458|6024612|P2|Overall Study|Moved or changed job|13
1727230|NCT01030458|6024613|P1|Overall Study|Moved or changed job|6
1727231|NCT01030458|6024612|P2|Overall Study|Logistical reasons|5
1727232|NCT01030458|6024613|P1|Overall Study|Logistical reasons|9
1727233|NCT01030458|6024612|P2|Overall Study|Withdrawal by Subject|3
1727234|NCT01030458|6024613|P1|Overall Study|Withdrawal by Subject|2
1727235|NCT01030458|6024612|P2|Overall Study|Lost to Follow-up|10
1727236|NCT01030458|6024613|P1|Overall Study|Lost to Follow-up|9
1727237|NCT01030341|6024646|P1|Overall Study|Lost to Follow-up|2
1727238|NCT01030341|6024646|P1|Overall Study|Withdrawal by Subject|1
1727239|NCT01030133|6024669|P2|Overall Study|failed to experience pain at level 7/10|2
1727240|NCT01030133|6024670|P1|Overall Study|failed to experience pain at level 7/10|2
1727241|NCT01029925|6024682|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
1727242|NCT01029925|6024682|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
1727243|NCT01029925|6024682|P1|Completion of Cycle 1 (28 Days)|Death|2
1727244|NCT01029886|6024701|P2|Overall Study|Loss Glucose Control|1
1727245|NCT01029886|6024702|P1|Overall Study|Loss Glucose Control|7
1727246|NCT01029886|6024701|P2|Overall Study|Sponsor Decision|0
1727247|NCT01029886|6024702|P1|Overall Study|Sponsor Decision|1
1727248|NCT01029886|6024701|P2|Overall Study|Entry Criteria Not Met|5
1727249|NCT01029886|6024702|P1|Overall Study|Entry Criteria Not Met|13
1727250|NCT01029886|6024701|P2|Overall Study|Withdrawal by Subject|18
1727251|NCT01029886|6024702|P1|Overall Study|Withdrawal by Subject|8
1727252|NCT01029886|6024701|P2|Overall Study|Protocol Violation|5
1727253|NCT01029886|6024702|P1|Overall Study|Protocol Violation|17
1727254|NCT01029886|6024701|P2|Overall Study|Physician Decision|6
1727255|NCT01029886|6024702|P1|Overall Study|Physician Decision|2
1727256|NCT01029886|6024701|P2|Overall Study|Lost to Follow-up|0
1727257|NCT01029886|6024702|P1|Overall Study|Lost to Follow-up|1
1727258|NCT01029886|6024701|P2|Overall Study|Adverse Event|25
1727259|NCT01029886|6024702|P1|Overall Study|Adverse Event|12
1727260|NCT01029795|6024730|P2|Overall Study|Withdrawal by Subject|3
1727261|NCT01029795|6024731|P1|Overall Study|Withdrawal by Subject|1
1727262|NCT01029795|6024730|P2|Overall Study|Sponsor Decision|17
1727263|NCT01029795|6024731|P1|Overall Study|Sponsor Decision|11
1727264|NCT01029795|6024730|P2|Overall Study|Physician Decision|1
1727265|NCT01029795|6024731|P1|Overall Study|Physician Decision|2
1727266|NCT01029795|6024730|P2|Overall Study|Entry Criteria Not Met|1
1727267|NCT01029795|6024731|P1|Overall Study|Entry Criteria Not Met|2
1727268|NCT01029782|6024785|P2|Overall Study|Withdrawal by Subject|1
1727269|NCT01029782|6024786|P1|Overall Study|Withdrawal by Subject|0
1727270|NCT01029782|6024785|P2|Overall Study|Protocol Violation|2
1727271|NCT01029782|6024786|P1|Overall Study|Protocol Violation|0
1727272|NCT01029782|6024785|P2|Overall Study|Physician Decision|1
1727273|NCT01029782|6024786|P1|Overall Study|Physician Decision|0
1727274|NCT01029782|6024785|P2|Overall Study|Adverse Event|1
1727275|NCT01029782|6024786|P1|Overall Study|Adverse Event|0
1727276|NCT01029782|6024785|P2|Overall Study|Diagnosis changed|1
1727277|NCT01029782|6024786|P1|Overall Study|Diagnosis changed|1
1727278|NCT01029782|6024785|P2|Overall Study|Lost to Follow-up|2
1727279|NCT01029782|6024786|P1|Overall Study|Lost to Follow-up|2
1727280|NCT01029691|6024838|P3|Continued APAP to Delivery|Death|1
1727281|NCT01029691|6024839|P2|Continued APAP to Delivery|Death|0
1727282|NCT01029691|6024840|P1|Continued APAP to Delivery|Death|0
1727283|NCT01029652|6024865|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
1727284|NCT01029652|6024866|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
1727285|NCT01029652|6024865|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
1727286|NCT01029652|6024866|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
1727287|NCT01029652|6024865|P2|Extension Study 2 (25-72 Weeks)|Death|1
1727288|NCT01029652|6024866|P1|Extension Study 2 (25-72 Weeks)|Death|1
1727289|NCT01029652|6024865|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
1727290|NCT01029652|6024866|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
1727291|NCT01029652|6024865|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
1727292|NCT01029652|6024866|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
1727293|NCT01029652|6024865|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
1727294|NCT01029652|6024866|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
1727295|NCT01029652|6024865|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
1727296|NCT01029652|6024866|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
1727297|NCT01029652|6024865|P2|Core Study (0-12 Weeks)|Death|1
1727298|NCT01029652|6024866|P1|Core Study (0-12 Weeks)|Death|0
1727299|NCT01029652|6024865|P2|Core Study (0-12 Weeks)|Administrative problems|1
1727300|NCT01029652|6024866|P1|Core Study (0-12 Weeks)|Administrative problems|2
1727301|NCT01029652|6024865|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
1727302|NCT01029652|6024866|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
1727303|NCT01029652|6024865|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
1727304|NCT01029652|6024866|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
1727305|NCT01029652|6024865|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
1727306|NCT01029652|6024866|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
1727307|NCT01029535|6024944|P1|Overall Study|Death|1
1727308|NCT01029535|6024944|P1|Overall Study|Use of Another Treatment|1
1727309|NCT01029535|6024944|P1|Overall Study|Adverse Event|1
1727310|NCT01029535|6024944|P1|Overall Study|Participant Withdrew Consent|2
1727311|NCT01029535|6024944|P1|Overall Study|Protocol Violation|2
1727312|NCT01029535|6024944|P1|Overall Study|Lost to Follow-up|24
1727313|NCT01029405|6024973|P4|Overall Study|Other|1
1727314|NCT01029405|6024974|P3|Overall Study|Other|0
1727315|NCT01029405|6024975|P2|Overall Study|Other|1
1727316|NCT01029405|6024976|P1|Overall Study|Other|0
1727317|NCT01029405|6024973|P4|Overall Study|Lost to Follow-up|2
1727318|NCT01029405|6024974|P3|Overall Study|Lost to Follow-up|1
1727319|NCT01029405|6024975|P2|Overall Study|Lost to Follow-up|1
1727320|NCT01029405|6024976|P1|Overall Study|Lost to Follow-up|2
1727321|NCT01029405|6024973|P4|Overall Study|Adverse Event|1
1727322|NCT01029405|6024974|P3|Overall Study|Adverse Event|1
1727323|NCT01029405|6024975|P2|Overall Study|Adverse Event|0
1727324|NCT01029405|6024976|P1|Overall Study|Adverse Event|0
1727325|NCT01029405|6024973|P4|Overall Study|Protocol Violation|1
1727326|NCT01029405|6024974|P3|Overall Study|Protocol Violation|0
1727327|NCT01029405|6024975|P2|Overall Study|Protocol Violation|0
1727328|NCT01029405|6024976|P1|Overall Study|Protocol Violation|0
1727329|NCT01029405|6024973|P4|Overall Study|Withdrawal by Subject|0
1727330|NCT01029405|6024974|P3|Overall Study|Withdrawal by Subject|2
1727331|NCT01029405|6024975|P2|Overall Study|Withdrawal by Subject|1
1727332|NCT01029405|6024976|P1|Overall Study|Withdrawal by Subject|0
1727333|NCT01029392|6024988|P2|Overall Study|Physician Decision|0
1727334|NCT01029392|6024989|P1|Overall Study|Physician Decision|2
1727335|NCT01029392|6024988|P2|Overall Study|Withdrawal by Subject|11
1727336|NCT01029392|6024989|P1|Overall Study|Withdrawal by Subject|18
1727337|NCT01029366|6024999|P2|Overall Study|manufacturing failure|1
1727338|NCT01029366|6025000|P1|Overall Study|manufacturing failure|0
1727339|NCT01029366|6024999|P2|Overall Study|disease progression|0
1727340|NCT01029366|6025000|P1|Overall Study|disease progression|2
1727341|NCT01029366|6024999|P2|Overall Study|Death|1
1727342|NCT01029366|6025000|P1|Overall Study|Death|1
1727343|NCT01029366|6024999|P2|Overall Study|Withdrawal by Subject|0
1727344|NCT01029366|6025000|P1|Overall Study|Withdrawal by Subject|1
1727345|NCT01029340|6025012|P6|Extension Period|Physician Decision|1
1727346|NCT01029340|6025013|P5|Extension Period|Physician Decision|0
1727347|NCT01029340|6025014|P4|Extension Period|Physician Decision|0
1727348|NCT01029340|6025015|P3|Extension Period|Physician Decision|0
1727349|NCT01029340|6025016|P2|Extension Period|Physician Decision|0
1727350|NCT01029340|6025017|P1|Extension Period|Physician Decision|0
1727351|NCT01029340|6025012|P6|Extension Period|Withdrawal by Subject|1
1727352|NCT01029340|6025013|P5|Extension Period|Withdrawal by Subject|0
1727353|NCT01029340|6025014|P4|Extension Period|Withdrawal by Subject|0
1727354|NCT01029340|6025015|P3|Extension Period|Withdrawal by Subject|0
1727355|NCT01029340|6025016|P2|Extension Period|Withdrawal by Subject|0
1727356|NCT01029340|6025017|P1|Extension Period|Withdrawal by Subject|0
1727357|NCT01029340|6025012|P6|Extension Period|non-compliance|1
1727358|NCT01029340|6025013|P5|Extension Period|non-compliance|0
1727359|NCT01029340|6025014|P4|Extension Period|non-compliance|0
1727360|NCT01029340|6025015|P3|Extension Period|non-compliance|0
1727361|NCT01029340|6025016|P2|Extension Period|non-compliance|0
1727362|NCT01029340|6025017|P1|Extension Period|non-compliance|0
1727363|NCT01029340|6025012|P6|Extension Period|starting another study|8
1727364|NCT01029340|6025013|P5|Extension Period|starting another study|0
1727365|NCT01029340|6025014|P4|Extension Period|starting another study|0
1727366|NCT01029340|6025015|P3|Extension Period|starting another study|0
1727367|NCT01029340|6025016|P2|Extension Period|starting another study|0
1727368|NCT01029340|6025017|P1|Extension Period|starting another study|0
1727369|NCT01029340|6025012|P6|Extension Period|Adverse Event|1
1727370|NCT01029340|6025013|P5|Extension Period|Adverse Event|0
1727371|NCT01029340|6025014|P4|Extension Period|Adverse Event|0
1727372|NCT01029340|6025015|P3|Extension Period|Adverse Event|0
1727373|NCT01029340|6025016|P2|Extension Period|Adverse Event|0
1727374|NCT01029340|6025017|P1|Extension Period|Adverse Event|0
1727375|NCT01029340|6025012|P6|Part B Treatment Period|Protocol Violation|0
1727376|NCT01029340|6025013|P5|Part B Treatment Period|Protocol Violation|0
1727377|NCT01029340|6025014|P4|Part B Treatment Period|Protocol Violation|0
1727378|NCT01029340|6025015|P3|Part B Treatment Period|Protocol Violation|1
1727379|NCT01029340|6025016|P2|Part B Treatment Period|Protocol Violation|0
1727380|NCT01029340|6025017|P1|Part B Treatment Period|Protocol Violation|0
1727381|NCT01029340|6025012|P6|Part B Treatment Period|Withdrawal by Subject|0
1727382|NCT01029340|6025013|P5|Part B Treatment Period|Withdrawal by Subject|0
1727383|NCT01029340|6025014|P4|Part B Treatment Period|Withdrawal by Subject|0
1727384|NCT01029340|6025015|P3|Part B Treatment Period|Withdrawal by Subject|1
1727385|NCT01029340|6025016|P2|Part B Treatment Period|Withdrawal by Subject|0
1727386|NCT01029340|6025017|P1|Part B Treatment Period|Withdrawal by Subject|0
1727387|NCT01029262|6025048|P2|Overall Study|Death|3
1727388|NCT01029262|6025049|P1|Overall Study|Death|0
1727389|NCT01029262|6025048|P2|Overall Study|Miscellaneous|9
1727390|NCT01029262|6025049|P1|Overall Study|Miscellaneous|1
1727391|NCT01029262|6025048|P2|Overall Study|Protocol Violation|3
1727392|NCT01029262|6025049|P1|Overall Study|Protocol Violation|2
1727393|NCT01029262|6025048|P2|Overall Study|Withdrawal by Subject|17
1727394|NCT01029262|6025049|P1|Overall Study|Withdrawal by Subject|10
1727395|NCT01029262|6025048|P2|Overall Study|Lack of therapeutic effect|76
1727396|NCT01029262|6025049|P1|Overall Study|Lack of therapeutic effect|57
1727397|NCT01029262|6025048|P2|Overall Study|Adverse Event|52
1727398|NCT01029262|6025049|P1|Overall Study|Adverse Event|9
1727399|NCT01028651|6025218|P1|Overall Study|Adverse Event|1
1727400|NCT01028651|6025218|P1|Overall Study|Death|2
1727401|NCT01028560|6025241|P2|Overall Study|Withdrawal by Subject|12
1727402|NCT01028560|6025242|P1|Overall Study|Withdrawal by Subject|7
1727403|NCT01028560|6025241|P2|Overall Study|Lack of Efficacy|6
1727404|NCT01028560|6025242|P1|Overall Study|Lack of Efficacy|3
1727405|NCT01028391|6025256|P2|Overall Study|Needed excluded medication|1
1727406|NCT01028391|6025257|P1|Overall Study|Needed excluded medication|1
1727407|NCT01028391|6025256|P2|Overall Study|Withdrawal by Subject|3
1727408|NCT01028391|6025257|P1|Overall Study|Withdrawal by Subject|6
1727409|NCT01028391|6025256|P2|Overall Study|Physician Decision|1
1727410|NCT01028391|6025257|P1|Overall Study|Physician Decision|0
1727411|NCT01028391|6025256|P2|Overall Study|Lost to Follow-up|4
1727412|NCT01028391|6025257|P1|Overall Study|Lost to Follow-up|3
1727413|NCT01028391|6025256|P2|Overall Study|Lack of Efficacy|2
1727414|NCT01028391|6025257|P1|Overall Study|Lack of Efficacy|0
1727415|NCT01028391|6025256|P2|Overall Study|Adverse Event|0
1727416|NCT01028391|6025257|P1|Overall Study|Adverse Event|4
1727417|NCT01028378|6025265|P1|Overall Study|Adminstrative Reasons|4
1727418|NCT01028378|6025265|P1|Overall Study|Withdrawal by Subject|1
1727419|NCT01028378|6025265|P1|Overall Study|Lost to Follow-up|12
1727420|NCT01028352|6025277|P1|Overall Study|Withdrawal by Subject|1
1727421|NCT01028352|6025277|P1|Overall Study|Ineligible due to baseline average pain|5
1727422|NCT01028300|6025282|P1|Overall Study|Study Terminated|4
1727423|NCT01028222|6025291|P2|Overall Study|Adverse Event|0
1727424|NCT01028222|6025292|P1|Overall Study|Adverse Event|2
1727425|NCT01028222|6025291|P2|Overall Study|Crossover to nilotinib w/out progression|2
1727426|NCT01028222|6025292|P1|Overall Study|Crossover to nilotinib w/out progression|0
1727427|NCT01028222|6025291|P2|Overall Study|Withdrawal by Subject|0
1727428|NCT01028222|6025292|P1|Overall Study|Withdrawal by Subject|1
1727429|NCT01028222|6025291|P2|Overall Study|Lost to Follow-up|1
1727430|NCT01028222|6025292|P1|Overall Study|Lost to Follow-up|0
1727431|NCT01028222|6025291|P2|Overall Study|Administrative problems|1
1727432|NCT01028222|6025292|P1|Overall Study|Administrative problems|1
1727433|NCT01028222|6025291|P2|Overall Study|Disease progression|9
1727434|NCT01028222|6025292|P1|Overall Study|Disease progression|33
1727435|NCT01028222|6025291|P2|Overall Study|Protocol deviation|0
1727436|NCT01028222|6025292|P1|Overall Study|Protocol deviation|1
1727437|NCT01028053|6025334|P1|Overall Study|Various reasons|4
1727438|NCT01028053|6025334|P1|Overall Study|Terminated by Sponsor|1
1727439|NCT01028053|6025334|P1|Overall Study|Technical Problem|1
1727440|NCT01028053|6025334|P1|Overall Study|Physician Decision|2
1727441|NCT01028053|6025334|P1|Overall Study|Protocol Violation|1
1727442|NCT01028053|6025334|P1|Overall Study|Patient Request|11
1727443|NCT01028053|6025334|P1|Overall Study|Screen Failure|113
1727444|NCT01028027|6025342|P2|Overall Study|Lack of Efficacy|1
1727445|NCT01028027|6025343|P1|Overall Study|Lack of Efficacy|0
1727446|NCT01028027|6025342|P2|Overall Study|Protocol Violation|1
1727447|NCT01028027|6025343|P1|Overall Study|Protocol Violation|3
1727448|NCT01028027|6025342|P2|Overall Study|Adverse Event|7
1727449|NCT01028027|6025343|P1|Overall Study|Adverse Event|4
1727450|NCT01028027|6025342|P2|Overall Study|Withdrawal by Subject|3
1727451|NCT01028027|6025343|P1|Overall Study|Withdrawal by Subject|5
1727452|NCT01028027|6025342|P2|Overall Study|Lost to Follow-up|1
1727453|NCT01028027|6025343|P1|Overall Study|Lost to Follow-up|4
1727454|NCT01028014|6025365|P6|Overall Study|Lost to Follow-up|2
1727455|NCT01028014|6025366|P5|Overall Study|Lost to Follow-up|1
1727456|NCT01028014|6025367|P4|Overall Study|Lost to Follow-up|1
1727457|NCT01028014|6025368|P3|Overall Study|Lost to Follow-up|0
1727458|NCT01028014|6025369|P2|Overall Study|Lost to Follow-up|2
1727459|NCT01028014|6025370|P1|Overall Study|Lost to Follow-up|1
1727460|NCT01027897|6025411|P1|Overall Study|Withdrawal by Subject|1
1727461|NCT01027897|6025411|P1|Overall Study|Protocol Violation|1
1727462|NCT01027884|6025419|P2|Overall Study|Spinal fixation surgery|3
1727463|NCT01027884|6025420|P1|Overall Study|Spinal fixation surgery|0
1727464|NCT01027884|6025419|P2|Overall Study|Lost to Follow-up|1
1727465|NCT01027884|6025420|P1|Overall Study|Lost to Follow-up|0
1727466|NCT01027884|6025419|P2|Overall Study|Withdrawal by Subject|1
1727467|NCT01027884|6025420|P1|Overall Study|Withdrawal by Subject|0
1727468|NCT01027884|6025419|P2|Overall Study|Non-compliance|1
1727469|NCT01027884|6025420|P1|Overall Study|Non-compliance|1
1727470|NCT01027884|6025419|P2|Overall Study|Protocol Violation|0
1727471|NCT01027884|6025420|P1|Overall Study|Protocol Violation|1
1727472|NCT01027884|6025419|P2|Overall Study|Adverse Event|1
1727473|NCT01027884|6025420|P1|Overall Study|Adverse Event|2
1727474|NCT01027871|6025437|P3|Overall Study|Discontinued Prior to Treatment|1
1727475|NCT01027871|6025438|P2|Overall Study|Discontinued Prior to Treatment|0
1727476|NCT01027871|6025439|P1|Overall Study|Discontinued Prior to Treatment|0
1727477|NCT01027871|6025437|P3|Overall Study|Sponsor Decision|0
1727478|NCT01027871|6025438|P2|Overall Study|Sponsor Decision|2
1727479|NCT01027871|6025439|P1|Overall Study|Sponsor Decision|0
1727480|NCT01027871|6025437|P3|Overall Study|Adverse Event|2
1727481|NCT01027871|6025438|P2|Overall Study|Adverse Event|2
1727482|NCT01027871|6025439|P1|Overall Study|Adverse Event|0
1727483|NCT01027871|6025437|P3|Overall Study|Withdrawal by Subject|2
1727484|NCT01027871|6025438|P2|Overall Study|Withdrawal by Subject|2
1727485|NCT01027871|6025439|P1|Overall Study|Withdrawal by Subject|1
1727486|NCT01027871|6025437|P3|Overall Study|Protocol Violation|2
1727487|NCT01027871|6025438|P2|Overall Study|Protocol Violation|2
1727488|NCT01027871|6025439|P1|Overall Study|Protocol Violation|0
1727489|NCT01027871|6025437|P3|Overall Study|Physician Decision|0
1727490|NCT01027871|6025438|P2|Overall Study|Physician Decision|5
1727491|NCT01027871|6025439|P1|Overall Study|Physician Decision|1
1727492|NCT01027845|6025498|P4|Booster Vaccination Phase|Migrated/moved from study area|0
1727493|NCT01027845|6025499|P3|Booster Vaccination Phase|Migrated/moved from study area|0
1727494|NCT01027845|6025500|P2|Booster Vaccination Phase|Migrated/moved from study area|0
1727495|NCT01027845|6025501|P1|Booster Vaccination Phase|Migrated/moved from study area|1
1727496|NCT01027845|6025498|P4|Booster Vaccination Phase|Withdrawal by Subject|0
1727497|NCT01027845|6025499|P3|Booster Vaccination Phase|Withdrawal by Subject|0
1727498|NCT01027845|6025500|P2|Booster Vaccination Phase|Withdrawal by Subject|0
1727499|NCT01027845|6025501|P1|Booster Vaccination Phase|Withdrawal by Subject|1
1727500|NCT01027845|6025498|P4|Primary Vaccination Phase|Migrated/moved from study area|0
1727501|NCT01027845|6025499|P3|Primary Vaccination Phase|Migrated/moved from study area|0
1727502|NCT01027845|6025500|P2|Primary Vaccination Phase|Migrated/moved from study area|1
1727503|NCT01027845|6025501|P1|Primary Vaccination Phase|Migrated/moved from study area|0
1727504|NCT01027845|6025498|P4|Primary Vaccination Phase|Protocol Violation|0
1727505|NCT01027845|6025499|P3|Primary Vaccination Phase|Protocol Violation|0
1727506|NCT01027845|6025500|P2|Primary Vaccination Phase|Protocol Violation|0
1727507|NCT01027845|6025501|P1|Primary Vaccination Phase|Protocol Violation|1
1727508|NCT01027845|6025498|P4|Primary Vaccination Phase|Adverse Event|0
1727509|NCT01027845|6025499|P3|Primary Vaccination Phase|Adverse Event|0
1727510|NCT01027845|6025500|P2|Primary Vaccination Phase|Adverse Event|0
1727511|NCT01027845|6025501|P1|Primary Vaccination Phase|Adverse Event|1
1727512|NCT01027845|6025498|P4|Primary Vaccination Phase|Serious Adverse Event|0
1727513|NCT01027845|6025499|P3|Primary Vaccination Phase|Serious Adverse Event|0
1727514|NCT01027845|6025500|P2|Primary Vaccination Phase|Serious Adverse Event|0
1727515|NCT01027845|6025501|P1|Primary Vaccination Phase|Serious Adverse Event|2
1727516|NCT01027754|6025584|P2|Overall Study|Withdrawal by Subject|5
1727517|NCT01027754|6025585|P1|Overall Study|Withdrawal by Subject|0
1727518|NCT01027754|6025584|P2|Overall Study|withdrew/lost to follow-up after interve|3
1727519|NCT01027754|6025585|P1|Overall Study|withdrew/lost to follow-up after interve|2
1727520|NCT01027702|6025619|P7|Overall Study|Death|0
1727521|NCT01027702|6025620|P6|Overall Study|Death|0
1727522|NCT01027702|6025621|P5|Overall Study|Death|0
1727523|NCT01027702|6025622|P4|Overall Study|Death|0
1727524|NCT01027702|6025623|P3|Overall Study|Death|1
1727525|NCT01027702|6025624|P2|Overall Study|Death|0
1727526|NCT01027702|6025625|P1|Overall Study|Death|0
1727527|NCT01027702|6025619|P7|Overall Study|Received subsequent therapy|1
1727528|NCT01027702|6025620|P6|Overall Study|Received subsequent therapy|0
1727529|NCT01027702|6025621|P5|Overall Study|Received subsequent therapy|1
1727530|NCT01027702|6025622|P4|Overall Study|Received subsequent therapy|4
1727531|NCT01027702|6025623|P3|Overall Study|Received subsequent therapy|0
1727532|NCT01027702|6025624|P2|Overall Study|Received subsequent therapy|2
1727533|NCT01027702|6025625|P1|Overall Study|Received subsequent therapy|1
1727534|NCT01027650|6025651|P8|Overall Study|Lack of Efficacy|0
1727535|NCT01027650|6025652|P7|Overall Study|Lack of Efficacy|0
1727536|NCT01027650|6025653|P6|Overall Study|Lack of Efficacy|1
1727537|NCT01027650|6025654|P5|Overall Study|Lack of Efficacy|0
1727538|NCT01027650|6025655|P4|Overall Study|Lack of Efficacy|0
1727539|NCT01027650|6025656|P3|Overall Study|Lack of Efficacy|0
1727540|NCT01027650|6025657|P2|Overall Study|Lack of Efficacy|0
1727541|NCT01027650|6025658|P1|Overall Study|Lack of Efficacy|0
1727542|NCT01027650|6025651|P8|Overall Study|Lost to Follow-up|0
1727543|NCT01027650|6025652|P7|Overall Study|Lost to Follow-up|1
1727544|NCT01027650|6025653|P6|Overall Study|Lost to Follow-up|0
1727545|NCT01027650|6025654|P5|Overall Study|Lost to Follow-up|0
1727546|NCT01027650|6025655|P4|Overall Study|Lost to Follow-up|0
1727547|NCT01027650|6025656|P3|Overall Study|Lost to Follow-up|0
1727548|NCT01027650|6025657|P2|Overall Study|Lost to Follow-up|0
1727549|NCT01027650|6025658|P1|Overall Study|Lost to Follow-up|0
1727550|NCT01027650|6025651|P8|Overall Study|Personal Reasons|0
1727551|NCT01027650|6025652|P7|Overall Study|Personal Reasons|0
1727552|NCT01027650|6025653|P6|Overall Study|Personal Reasons|1
1727553|NCT01027650|6025654|P5|Overall Study|Personal Reasons|2
1727554|NCT01027650|6025655|P4|Overall Study|Personal Reasons|0
1727555|NCT01027650|6025656|P3|Overall Study|Personal Reasons|0
1727556|NCT01027650|6025657|P2|Overall Study|Personal Reasons|0
1727557|NCT01027650|6025658|P1|Overall Study|Personal Reasons|0
1727558|NCT01027416|6025736|P2|Overall Study|Physician Decision|4
1727559|NCT01027416|6025737|P1|Overall Study|Physician Decision|1
1727560|NCT01027416|6025736|P2|Overall Study|Withdrawal by Subject|1
1727561|NCT01027416|6025737|P1|Overall Study|Withdrawal by Subject|0
1727562|NCT01027364|6025749|P4|Overall Study|Withdrawal by Subject|0
1727563|NCT01027364|6025750|P3|Overall Study|Withdrawal by Subject|0
1727564|NCT01027364|6025751|P2|Overall Study|Withdrawal by Subject|2
1727565|NCT01027364|6025752|P1|Overall Study|Withdrawal by Subject|1
1727566|NCT01027364|6025749|P4|Overall Study|Protocol Violation|1
1727567|NCT01027364|6025750|P3|Overall Study|Protocol Violation|0
1727568|NCT01027364|6025751|P2|Overall Study|Protocol Violation|0
1727569|NCT01027364|6025752|P1|Overall Study|Protocol Violation|1
1727570|NCT01027364|6025749|P4|Overall Study|Lost to Follow-up|0
1727571|NCT01027364|6025750|P3|Overall Study|Lost to Follow-up|0
1727572|NCT01027364|6025751|P2|Overall Study|Lost to Follow-up|0
1727573|NCT01027364|6025752|P1|Overall Study|Lost to Follow-up|1
1727574|NCT01027364|6025749|P4|Overall Study|Adverse Event|0
1727575|NCT01027364|6025750|P3|Overall Study|Adverse Event|1
1727576|NCT01027364|6025751|P2|Overall Study|Adverse Event|0
1727577|NCT01027364|6025752|P1|Overall Study|Adverse Event|1
1727578|NCT01027351|6025847|P6|Overall Study|Protocol Violation|0
1727579|NCT01027351|6025848|P5|Overall Study|Protocol Violation|1
1727580|NCT01027351|6025849|P4|Overall Study|Protocol Violation|1
1727581|NCT01027351|6025850|P3|Overall Study|Protocol Violation|0
1727582|NCT01027351|6025851|P2|Overall Study|Protocol Violation|0
1727583|NCT01027351|6025852|P1|Overall Study|Protocol Violation|1
1727584|NCT01027351|6025847|P6|Overall Study|Inappropriate enrollment|0
1727585|NCT01027351|6025848|P5|Overall Study|Inappropriate enrollment|1
1727586|NCT01027351|6025849|P4|Overall Study|Inappropriate enrollment|0
1727587|NCT01027351|6025850|P3|Overall Study|Inappropriate enrollment|0
1727588|NCT01027351|6025851|P2|Overall Study|Inappropriate enrollment|0
1727589|NCT01027351|6025852|P1|Overall Study|Inappropriate enrollment|0
1727590|NCT01027351|6025847|P6|Overall Study|Lost to Follow-up|0
1727591|NCT01027351|6025848|P5|Overall Study|Lost to Follow-up|6
1727592|NCT01027351|6025849|P4|Overall Study|Lost to Follow-up|1
1727593|NCT01027351|6025850|P3|Overall Study|Lost to Follow-up|0
1727594|NCT01027351|6025851|P2|Overall Study|Lost to Follow-up|1
1727595|NCT01027351|6025852|P1|Overall Study|Lost to Follow-up|1
1727596|NCT01027351|6025847|P6|Overall Study|Withdrawal by Subject|5
1727597|NCT01027351|6025848|P5|Overall Study|Withdrawal by Subject|3
1727598|NCT01027351|6025849|P4|Overall Study|Withdrawal by Subject|0
1727599|NCT01027351|6025850|P3|Overall Study|Withdrawal by Subject|1
1727600|NCT01027351|6025851|P2|Overall Study|Withdrawal by Subject|0
1727601|NCT01027351|6025852|P1|Overall Study|Withdrawal by Subject|1
1727602|NCT01027286|6025936|P2|Overall Study|Lost to Follow-up|1
1727603|NCT01027286|6025937|P1|Overall Study|Lost to Follow-up|0
1727604|NCT01027286|6025936|P2|Overall Study|Unable to Obtain Required Blood Volume|0
1727605|NCT01027286|6025937|P1|Overall Study|Unable to Obtain Required Blood Volume|1
1727606|NCT01027273|6025957|P2|Overall Study|Death|2
1727607|NCT01027273|6025958|P1|Overall Study|Death|2
1727608|NCT01027273|6025957|P2|Overall Study|Lost to Follow-up|31
1727609|NCT01027273|6025958|P1|Overall Study|Lost to Follow-up|57
1727610|NCT01026974|6026005|P4|Overall Study|Inappropriate enrollment|0
1727611|NCT01026974|6026006|P3|Overall Study|Inappropriate enrollment|1
1727612|NCT01026974|6026007|P2|Overall Study|Inappropriate enrollment|0
1727613|NCT01026974|6026008|P1|Overall Study|Inappropriate enrollment|0
1727614|NCT01026974|6026005|P4|Overall Study|Adverse Event|1
1727615|NCT01026974|6026006|P3|Overall Study|Adverse Event|0
1727616|NCT01026974|6026007|P2|Overall Study|Adverse Event|0
1727617|NCT01026974|6026008|P1|Overall Study|Adverse Event|0
1727618|NCT01026974|6026005|P4|Overall Study|Lost to Follow-up|0
1727619|NCT01026974|6026006|P3|Overall Study|Lost to Follow-up|4
1727620|NCT01026974|6026007|P2|Overall Study|Lost to Follow-up|1
1727621|NCT01026974|6026008|P1|Overall Study|Lost to Follow-up|1
1727622|NCT01026974|6026005|P4|Overall Study|Withdrawal by Subject|2
1727623|NCT01026974|6026006|P3|Overall Study|Withdrawal by Subject|7
1727624|NCT01026974|6026007|P2|Overall Study|Withdrawal by Subject|1
1727625|NCT01026974|6026008|P1|Overall Study|Withdrawal by Subject|0
1727626|NCT01026948|6026065|P1|Overall Study|Physician Decision|8
1727627|NCT01026831|6026098|P2|Overall Study|Withdrawal by Subject|5
1727628|NCT01026831|6026099|P1|Overall Study|Withdrawal by Subject|7
1727629|NCT01026831|6026098|P2|Overall Study|Protocol Violation|2
1727630|NCT01026831|6026099|P1|Overall Study|Protocol Violation|0
1727631|NCT01026831|6026098|P2|Overall Study|Physician Decision|1
1727632|NCT01026831|6026099|P1|Overall Study|Physician Decision|1
1727633|NCT01026831|6026098|P2|Overall Study|Lost to Follow-up|0
1727634|NCT01026831|6026099|P1|Overall Study|Lost to Follow-up|2
1727635|NCT01026831|6026098|P2|Overall Study|Adverse Event|3
1727636|NCT01026831|6026099|P1|Overall Study|Adverse Event|4
1727637|NCT01026818|6026110|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
1727638|NCT01026818|6026111|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
1727639|NCT01026818|6026112|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
1727640|NCT01026818|6026113|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
1727641|NCT01026818|6026110|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
1727642|NCT01026818|6026111|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
1727643|NCT01026818|6026112|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
1727644|NCT01026818|6026113|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
1727645|NCT01026818|6026110|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
1727646|NCT01026818|6026111|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
1727647|NCT01026818|6026112|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
1727648|NCT01026818|6026113|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
1727649|NCT01026818|6026110|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1727650|NCT01026818|6026111|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1727651|NCT01026818|6026112|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
1727652|NCT01026818|6026113|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
1727653|NCT01026818|6026110|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1727654|NCT01026818|6026111|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1727655|NCT01026818|6026112|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
1727656|NCT01026818|6026113|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
1727657|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
1727658|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
1727659|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
1727660|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
1727661|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
1727662|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
1727663|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
1727664|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
1727665|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1727666|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1727667|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
1727668|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
1727669|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
1727670|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
1727671|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
1727672|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
1727673|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
1727674|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
1727675|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
1727676|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
1727677|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1727678|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1727679|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
1727680|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
1727681|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
1727682|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
1727683|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
1727684|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
1727685|NCT01026818|6026110|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
1727686|NCT01026818|6026111|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
1727687|NCT01026818|6026112|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
1727688|NCT01026818|6026113|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
1727689|NCT01026818|6026110|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
1727690|NCT01026818|6026111|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
1727691|NCT01026818|6026112|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
1727692|NCT01026818|6026113|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
1727693|NCT01026818|6026110|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
1727694|NCT01026818|6026111|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
1727695|NCT01026818|6026112|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
1727696|NCT01026818|6026113|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
1727697|NCT01026818|6026110|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
1727698|NCT01026818|6026111|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
1727699|NCT01026818|6026112|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
1727700|NCT01026818|6026113|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
1727701|NCT01026818|6026110|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
1727702|NCT01026818|6026111|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
1727703|NCT01026818|6026112|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
1727704|NCT01026818|6026113|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
1727705|NCT01026818|6026110|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
1727706|NCT01026818|6026111|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
1727707|NCT01026818|6026112|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
1727708|NCT01026818|6026113|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
1727709|NCT01026818|6026110|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
1727710|NCT01026818|6026111|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
1727711|NCT01026818|6026112|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
1727712|NCT01026818|6026113|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
1727713|NCT01026818|6026110|P4|Screening Period|Physician Decision|0
1727714|NCT01026818|6026111|P3|Screening Period|Physician Decision|0
1727715|NCT01026818|6026112|P2|Screening Period|Physician Decision|0
1727716|NCT01026818|6026113|P1|Screening Period|Physician Decision|1
1727717|NCT01026818|6026110|P4|Screening Period|Adverse Event|0
1727718|NCT01026818|6026111|P3|Screening Period|Adverse Event|0
1727719|NCT01026818|6026112|P2|Screening Period|Adverse Event|0
1727720|NCT01026818|6026113|P1|Screening Period|Adverse Event|2
1727721|NCT01026818|6026110|P4|Screening Period|Protocol Deviation|0
1727722|NCT01026818|6026111|P3|Screening Period|Protocol Deviation|0
1727723|NCT01026818|6026112|P2|Screening Period|Protocol Deviation|0
1727724|NCT01026818|6026113|P1|Screening Period|Protocol Deviation|3
1727725|NCT01026818|6026110|P4|Screening Period|Withdrawal by Subject|0
1727726|NCT01026818|6026111|P3|Screening Period|Withdrawal by Subject|0
1727727|NCT01026818|6026112|P2|Screening Period|Withdrawal by Subject|0
1727728|NCT01026818|6026113|P1|Screening Period|Withdrawal by Subject|49
1727729|NCT01026818|6026110|P4|Screening Period|Entry Criteria Not Met|0
1727730|NCT01026818|6026111|P3|Screening Period|Entry Criteria Not Met|0
1727731|NCT01026818|6026112|P2|Screening Period|Entry Criteria Not Met|0
1727732|NCT01026818|6026113|P1|Screening Period|Entry Criteria Not Met|105
1727733|NCT01026792|6026201|P1|Overall Study|Protocol Violation|1
1727734|NCT01026493|6026244|P8|Overall Study|Protocol Violation|1
1727735|NCT01026493|6026245|P7|Overall Study|Protocol Violation|4
1727736|NCT01026493|6026246|P6|Overall Study|Protocol Violation|3
1727737|NCT01026493|6026247|P5|Overall Study|Protocol Violation|2
1727738|NCT01026493|6026248|P4|Overall Study|Protocol Violation|0
1727739|NCT01026493|6026249|P3|Overall Study|Protocol Violation|0
1727740|NCT01026493|6026250|P2|Overall Study|Protocol Violation|1
1727741|NCT01026493|6026251|P1|Overall Study|Protocol Violation|0
1727742|NCT01026454|6026279|P2|Second Intervention|Pregnancy|1
1727743|NCT01026454|6026280|P1|Second Intervention|Pregnancy|1
1727744|NCT01026389|6026629|P2|Overall Study|change of treatment, patient moved|2
1727745|NCT01026389|6026630|P1|Overall Study|change of treatment, patient moved|4
1727746|NCT01026389|6026629|P2|Overall Study|Withdrawal by Subject|3
1727747|NCT01026389|6026630|P1|Overall Study|Withdrawal by Subject|1
1727748|NCT01026324|6026645|P3|Follow up/Survival|Withdrawal by Subject|0
1727749|NCT01026324|6026646|P2|Follow up/Survival|Withdrawal by Subject|0
1727750|NCT01026324|6026647|P1|Follow up/Survival|Withdrawal by Subject|1
1727751|NCT01026220|6026657|P3|Consolidation Maintenance|Withdrawal by Subject|6
1727752|NCT01026220|6026658|P2|Consolidation Maintenance|Withdrawal by Subject|2
1727753|NCT01026220|6026659|P1|Consolidation Maintenance|Withdrawal by Subject|0
1727754|NCT01026220|6026657|P3|Consolidation Maintenance|Physician Decision|7
1727755|NCT01026220|6026658|P2|Consolidation Maintenance|Physician Decision|2
1727756|NCT01026220|6026659|P1|Consolidation Maintenance|Physician Decision|0
1727757|NCT01026220|6026657|P3|Consolidation Maintenance|Lack of Efficacy|1
1727758|NCT01026220|6026658|P2|Consolidation Maintenance|Lack of Efficacy|1
1727759|NCT01026220|6026659|P1|Consolidation Maintenance|Lack of Efficacy|0
1727760|NCT01026220|6026657|P3|Consolidation Maintenance|Death|0
1727761|NCT01026220|6026658|P2|Consolidation Maintenance|Death|1
1727762|NCT01026220|6026659|P1|Consolidation Maintenance|Death|0
1727763|NCT01026220|6026657|P3|Induction|Ineligible|0
1727764|NCT01026220|6026658|P2|Induction|Ineligible|0
1727765|NCT01026220|6026659|P1|Induction|Ineligible|1
1727766|NCT01026220|6026657|P3|Induction|Withdrawal by Subject|0
1727767|NCT01026220|6026658|P2|Induction|Withdrawal by Subject|0
1727768|NCT01026220|6026659|P1|Induction|Withdrawal by Subject|9
1727769|NCT01026220|6026657|P3|Induction|Physician Decision|0
1727770|NCT01026220|6026658|P2|Induction|Physician Decision|0
1727771|NCT01026220|6026659|P1|Induction|Physician Decision|12
1727772|NCT01026220|6026657|P3|Induction|Lack of Efficacy|0
1727773|NCT01026220|6026658|P2|Induction|Lack of Efficacy|0
1727774|NCT01026220|6026659|P1|Induction|Lack of Efficacy|2
1727775|NCT01026220|6026657|P3|Induction|Death|0
1727776|NCT01026220|6026658|P2|Induction|Death|0
1727777|NCT01026220|6026659|P1|Induction|Death|1
1727778|NCT01026194|6026683|P2|Period 2：Open-label Period|Withdrawal by Subject|4
1727779|NCT01026194|6026684|P1|Period 2：Open-label Period|Withdrawal by Subject|0
1727780|NCT01026194|6026683|P2|Period 2：Open-label Period|Physician Decision|1
1727781|NCT01026194|6026684|P1|Period 2：Open-label Period|Physician Decision|3
1727782|NCT01026194|6026683|P2|Period 2：Open-label Period|Adverse Event|5
1727783|NCT01026194|6026684|P1|Period 2：Open-label Period|Adverse Event|4
1727784|NCT01026194|6026683|P2|Period 1：Double Blind Period|Physician Decision|4
1727785|NCT01026194|6026684|P1|Period 1：Double Blind Period|Physician Decision|0
1727786|NCT01026194|6026683|P2|Period 1：Double Blind Period|Lack of Efficacy|0
1727787|NCT01026194|6026684|P1|Period 1：Double Blind Period|Lack of Efficacy|1
1727788|NCT01026194|6026683|P2|Period 1：Double Blind Period|Adverse Event|1
1727789|NCT01026194|6026684|P1|Period 1：Double Blind Period|Adverse Event|2
1727790|NCT01026142|6026716|P2|Overall Study|Withdrew consent or lost to follow-up|29
1727791|NCT01026142|6026717|P1|Overall Study|Withdrew consent or lost to follow-up|36
1727792|NCT01026142|6026716|P2|Overall Study|Death|134
1727793|NCT01026142|6026717|P1|Overall Study|Death|136
1727794|NCT01026103|6026739|P1|Overall Study|did not receive study device bc of error|1
1727795|NCT01026103|6026739|P1|Overall Study|Physician Decision|1
1727796|NCT01026038|6026749|P3|Overall Study|Lost to Follow-up|0
1727797|NCT01026038|6026750|P2|Overall Study|Lost to Follow-up|1
1727798|NCT01026038|6026751|P1|Overall Study|Lost to Follow-up|1
1727799|NCT01025843|6026800|P10|Washout 4|Withdrawal by Subject|0
1727800|NCT01025843|6026801|P9|Washout 4|Withdrawal by Subject|0
1727801|NCT01025843|6026802|P8|Washout 4|Withdrawal by Subject|0
1727802|NCT01025843|6026803|P7|Washout 4|Withdrawal by Subject|0
1727803|NCT01025843|6026804|P6|Washout 4|Withdrawal by Subject|0
1727804|NCT01025843|6026805|P5|Washout 4|Withdrawal by Subject|0
1727805|NCT01025843|6026806|P4|Washout 4|Withdrawal by Subject|1
1727806|NCT01025843|6026807|P3|Washout 4|Withdrawal by Subject|1
1727807|NCT01025843|6026808|P2|Washout 4|Withdrawal by Subject|0
1727808|NCT01025843|6026809|P1|Washout 4|Withdrawal by Subject|0
1727809|NCT01025817|6026903|P2|Completed Study|Lost to Follow-up|1
1727810|NCT01025817|6026904|P1|Completed Study|Lost to Follow-up|0
1727811|NCT01025817|6026903|P2|Completed Study|Missing|0
1727812|NCT01025817|6026904|P1|Completed Study|Missing|2
1727813|NCT01025817|6026903|P2|Completed Study|Death|5
1727814|NCT01025817|6026904|P1|Completed Study|Death|6
1727815|NCT01025817|6026903|P2|Completed Study|Withdrawal by Subject|16
1727816|NCT01025817|6026904|P1|Completed Study|Withdrawal by Subject|8
1727817|NCT01025817|6026903|P2|Completed Study Medication|Lost to Follow-up|1
1727818|NCT01025817|6026904|P1|Completed Study Medication|Lost to Follow-up|0
1727819|NCT01025817|6026903|P2|Completed Study Medication|Subject no longer required study drug|1
1727820|NCT01025817|6026904|P1|Completed Study Medication|Subject no longer required study drug|0
1727821|NCT01025817|6026903|P2|Completed Study Medication|Abnormal lab values|2
1727822|NCT01025817|6026904|P1|Completed Study Medication|Abnormal lab values|0
1727823|NCT01025817|6026903|P2|Completed Study Medication|Death|2
1727824|NCT01025817|6026904|P1|Completed Study Medication|Death|2
1727825|NCT01025817|6026903|P2|Completed Study Medication|Graft loss|5
1727826|NCT01025817|6026904|P1|Completed Study Medication|Graft loss|2
1727827|NCT01025817|6026903|P2|Completed Study Medication|Abnormal test procedure|0
1727828|NCT01025817|6026904|P1|Completed Study Medication|Abnormal test procedure|4
1727829|NCT01025817|6026903|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
1727830|NCT01025817|6026904|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
1727831|NCT01025817|6026903|P2|Completed Study Medication|Administrative problems|5
1727832|NCT01025817|6026904|P1|Completed Study Medication|Administrative problems|7
1727833|NCT01025817|6026903|P2|Completed Study Medication|Withdrawal by Subject|9
1727834|NCT01025817|6026904|P1|Completed Study Medication|Withdrawal by Subject|8
1727835|NCT01025817|6026903|P2|Completed Study Medication|Protocol Deviation|8
1727836|NCT01025817|6026904|P1|Completed Study Medication|Protocol Deviation|9
1727837|NCT01025817|6026903|P2|Completed Study Medication|Adverse Event|39
1727838|NCT01025817|6026904|P1|Completed Study Medication|Adverse Event|66
1727839|NCT01025752|6027070|P2|Overall Study|Physician Decision|3
1727840|NCT01025752|6027071|P1|Overall Study|Physician Decision|1
1727841|NCT01025752|6027070|P2|Overall Study|Lost to Follow-up|10
1727842|NCT01025752|6027071|P1|Overall Study|Lost to Follow-up|7
1727843|NCT01025635|6027091|P2|Overall Study|Reason not known|2
1727844|NCT01025635|6027092|P1|Overall Study|Reason not known|4
1727845|NCT01025635|6027091|P2|Overall Study|Lost to Follow-up|13
1727846|NCT01025635|6027092|P1|Overall Study|Lost to Follow-up|9
1727847|NCT01025635|6027091|P2|Overall Study|Lack of Efficacy|1
1727848|NCT01025635|6027092|P1|Overall Study|Lack of Efficacy|0
1727849|NCT01025635|6027091|P2|Overall Study|Protocol Violation|2
1727850|NCT01025635|6027092|P1|Overall Study|Protocol Violation|4
1727851|NCT01025635|6027091|P2|Overall Study|Withdrawal by Subject|7
1727852|NCT01025635|6027092|P1|Overall Study|Withdrawal by Subject|6
1727853|NCT01025336|6027120|P5|Overall Study|Protocol Violation|0
1727854|NCT01025336|6027121|P4|Overall Study|Protocol Violation|2
1727855|NCT01025336|6027122|P3|Overall Study|Protocol Violation|0
1727856|NCT01025336|6027123|P2|Overall Study|Protocol Violation|0
1727857|NCT01025336|6027124|P1|Overall Study|Protocol Violation|0
1727858|NCT01025284|6027179|P3|Overall Study|Withdrawal by Subject|0
1727859|NCT01025284|6027180|P2|Overall Study|Withdrawal by Subject|1
1727860|NCT01025284|6027181|P1|Overall Study|Withdrawal by Subject|0
1727861|NCT01025284|6027179|P3|Overall Study|Investigator Decision|0
1727862|NCT01025284|6027180|P2|Overall Study|Investigator Decision|1
1727863|NCT01025284|6027181|P1|Overall Study|Investigator Decision|0
1727864|NCT01025232|6027206|P2|Overall Study|Study drug no longer available|6
1727865|NCT01025232|6027207|P1|Overall Study|Study drug no longer available|3
1727866|NCT01025193|6027225|P1|Overall Study|Adverse Event|3
1727867|NCT01025193|6027225|P1|Overall Study|Protocol Violation|1
1727868|NCT01025154|6027235|P1|Overall Study|Withdrawal by Subject|1
1727869|NCT01025154|6027235|P1|Overall Study|Lost to Follow-up|1
1727870|NCT01025037|6027244|P1|Overall Study|Withdrawal by Subject|1
1727871|NCT01025037|6027244|P1|Overall Study|Lost to Follow-up|7
1727872|NCT01025037|6027244|P1|Overall Study|Adverse Event|3
1727873|NCT01024959|6027266|P1|Overall Study|missing results required for analysis|17
1727874|NCT01024959|6027266|P1|Overall Study|results not evaluable|12
1727875|NCT01024959|6027266|P1|Overall Study|ineligible|12
1727876|NCT01024946|6027275|P1|Overall Study|Adverse Event|1
1727877|NCT01024946|6027275|P1|Overall Study|Withdrawal by Subject|1
1727878|NCT01024946|6027275|P1|Overall Study|Screen Failure|3
1727879|NCT01024855|6027279|P1|Overall Study|Inclusion/exclusion criteria|1
1727880|NCT01024751|6027286|P2|Eligible Participants|Ineligible|1
1727881|NCT01024751|6027287|P1|Eligible Participants|Ineligible|0
1727882|NCT01024751|6027286|P2|Eligible Participants|Lost to Follow-up|1
1727883|NCT01024751|6027287|P1|Eligible Participants|Lost to Follow-up|0
1727884|NCT01024751|6027286|P2|Eligible Participants|Withdrawal by Subject|1
1727885|NCT01024751|6027287|P1|Eligible Participants|Withdrawal by Subject|0
1727886|NCT01024751|6027286|P2|Enrolled Participants|Ineligible at baseline|4
1727887|NCT01024751|6027287|P1|Enrolled Participants|Ineligible at baseline|3
1727888|NCT01024608|6027344|P2|Overall Study|Never received study treatment|0
1727889|NCT01024608|6027345|P1|Overall Study|Never received study treatment|2
1727890|NCT01024608|6027344|P2|Overall Study|Protocol Violation|3
1727891|NCT01024608|6027345|P1|Overall Study|Protocol Violation|0
1727892|NCT01024608|6027344|P2|Overall Study|Lost to Follow-up|1
1727893|NCT01024608|6027345|P1|Overall Study|Lost to Follow-up|0
1727894|NCT01024608|6027344|P2|Overall Study|Withdrawal by Subject|0
1727895|NCT01024608|6027345|P1|Overall Study|Withdrawal by Subject|1
1727896|NCT01024608|6027344|P2|Overall Study|Adverse Event|0
1727897|NCT01024608|6027345|P1|Overall Study|Adverse Event|1
1727898|NCT01024465|6027374|P1|Overall Study|Physician Decision|1
1727899|NCT01024465|6027374|P1|Overall Study|Adverse Event|2
1727900|NCT01024387|6027378|P1|Overall Study|Other|5
1727901|NCT01024387|6027378|P1|Overall Study|Adverse Event|3
1727902|NCT01024387|6027378|P1|Overall Study|Prolonged Treatment Delay|1
1727903|NCT01024387|6027378|P1|Overall Study|Death|2
1727904|NCT01024387|6027378|P1|Overall Study|Withdrawal by Subject|5
1727905|NCT01024387|6027378|P1|Overall Study|Physician Decision|5
1727906|NCT01024387|6027378|P1|Overall Study|Symptomatic Progression|10
1727907|NCT01024387|6027378|P1|Overall Study|Radiographic Progression|29
1727908|NCT01024309|6027399|P2|Overall Study|Withdrawal by Subject|4
1727909|NCT01024309|6027400|P1|Overall Study|Withdrawal by Subject|4
1727910|NCT01024309|6027399|P2|Overall Study|Physician Decision|0
1727911|NCT01024309|6027400|P1|Overall Study|Physician Decision|4
1727912|NCT01024244|6027432|P5|Overall Study|Withdrawal by Subject|0
1727913|NCT01024244|6027433|P4|Overall Study|Withdrawal by Subject|0
1727914|NCT01024244|6027434|P3|Overall Study|Withdrawal by Subject|0
1727915|NCT01024244|6027435|P2|Overall Study|Withdrawal by Subject|1
1727916|NCT01024244|6027436|P1|Overall Study|Withdrawal by Subject|0
1727917|NCT01024244|6027432|P5|Overall Study|Sponsor Decision|10
1727918|NCT01024244|6027433|P4|Overall Study|Sponsor Decision|12
1727919|NCT01024244|6027434|P3|Overall Study|Sponsor Decision|14
1727920|NCT01024244|6027435|P2|Overall Study|Sponsor Decision|7
1727921|NCT01024244|6027436|P1|Overall Study|Sponsor Decision|14
1727922|NCT01024244|6027432|P5|Overall Study|Protocol Violation|2
1727923|NCT01024244|6027433|P4|Overall Study|Protocol Violation|0
1727924|NCT01024244|6027434|P3|Overall Study|Protocol Violation|0
1727925|NCT01024244|6027435|P2|Overall Study|Protocol Violation|0
1727926|NCT01024244|6027436|P1|Overall Study|Protocol Violation|1
1727927|NCT01024244|6027432|P5|Overall Study|Lack of Efficacy|0
1727928|NCT01024244|6027433|P4|Overall Study|Lack of Efficacy|0
1727929|NCT01024244|6027434|P3|Overall Study|Lack of Efficacy|0
1727930|NCT01024244|6027435|P2|Overall Study|Lack of Efficacy|0
1727931|NCT01024244|6027436|P1|Overall Study|Lack of Efficacy|1
1727932|NCT01024244|6027432|P5|Overall Study|Entry Criteria Not Met|0
1727933|NCT01024244|6027433|P4|Overall Study|Entry Criteria Not Met|0
1727934|NCT01024244|6027434|P3|Overall Study|Entry Criteria Not Met|0
1727935|NCT01024244|6027435|P2|Overall Study|Entry Criteria Not Met|1
1727936|NCT01024244|6027436|P1|Overall Study|Entry Criteria Not Met|0
1727937|NCT01024244|6027432|P5|Overall Study|Adverse Event|2
1727938|NCT01024244|6027433|P4|Overall Study|Adverse Event|1
1727939|NCT01024244|6027434|P3|Overall Study|Adverse Event|0
1727940|NCT01024244|6027435|P2|Overall Study|Adverse Event|2
1727941|NCT01024244|6027436|P1|Overall Study|Adverse Event|1
1727942|NCT01024036|6027550|P2|Follow-Up Period|Adverse Event|1
1727943|NCT01024036|6027551|P1|Follow-Up Period|Adverse Event|4
1727944|NCT01024036|6027550|P2|Follow-Up Period|Withdrawal by Subject|1
1727945|NCT01024036|6027551|P1|Follow-Up Period|Withdrawal by Subject|0
1727946|NCT01024036|6027550|P2|Follow-Up Period|Lost to Follow-up|1
1727947|NCT01024036|6027551|P1|Follow-Up Period|Lost to Follow-up|1
1727948|NCT01024036|6027550|P2|Unblinded Treatment|Lack of Efficacy|2
1727949|NCT01024036|6027551|P1|Unblinded Treatment|Lack of Efficacy|0
1727950|NCT01024036|6027550|P2|Unblinded Treatment|Adverse Event|1
1727951|NCT01024036|6027551|P1|Unblinded Treatment|Adverse Event|0
1727952|NCT01024036|6027550|P2|Blinded Treatment|Withdrawal by Subject|3
1727953|NCT01024036|6027551|P1|Blinded Treatment|Withdrawal by Subject|4
1727954|NCT01024036|6027550|P2|Blinded Treatment|Death|2
1727955|NCT01024036|6027551|P1|Blinded Treatment|Death|0
1727956|NCT01024036|6027550|P2|Blinded Treatment|Physician Decision|0
1727957|NCT01024036|6027551|P1|Blinded Treatment|Physician Decision|1
1727958|NCT01024036|6027550|P2|Blinded Treatment|Lack of Efficacy|14
1727959|NCT01024036|6027551|P1|Blinded Treatment|Lack of Efficacy|16
1727960|NCT01024036|6027550|P2|Blinded Treatment|Adverse Event|1
1727961|NCT01024036|6027551|P1|Blinded Treatment|Adverse Event|1
1727962|NCT01023958|6027598|P1|Overall Study|Refused to continue medication|1
1727963|NCT01023958|6027598|P1|Overall Study|Other adverse event|1
1727964|NCT01023958|6027598|P1|Overall Study|Progressive disease|48
1727965|NCT01023815|6027646|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1727966|NCT01023815|6027647|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1727967|NCT01023815|6027648|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
1727968|NCT01023815|6027649|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
1727969|NCT01023815|6027646|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
1727970|NCT01023815|6027647|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
1727971|NCT01023815|6027648|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
1727972|NCT01023815|6027649|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
1727973|NCT01023815|6027646|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
1727974|NCT01023815|6027647|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
1727975|NCT01023815|6027648|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
1727976|NCT01023815|6027649|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
1727977|NCT01023815|6027646|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
1727978|NCT01023815|6027647|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
1727979|NCT01023815|6027648|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
1727980|NCT01023815|6027649|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
1727981|NCT01023815|6027646|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1727982|NCT01023815|6027647|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1727983|NCT01023815|6027648|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
1727984|NCT01023815|6027649|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
1727985|NCT01023789|6027668|P1|3 - Year Visit|Lost to Follow-up|13
1727986|NCT01023789|6027668|P1|3 - Year Visit|Withdrawal of consent|1
1727987|NCT01023789|6027668|P1|3 - Year Visit|Death|29
1727988|NCT01023672|6027754|P1|Overall Study|Death|1
1727989|NCT01023672|6027754|P1|Overall Study|Worsening disease|2
1727990|NCT01023659|6027761|P3|Overall Study|Lost to Follow-up|99
1727991|NCT01023659|6027762|P2|Overall Study|Lost to Follow-up|228
1727992|NCT01023659|6027763|P1|Overall Study|Lost to Follow-up|73
1727993|NCT01023581|6027790|P7|Overall Study|Other|0
1727994|NCT01023581|6027791|P6|Overall Study|Other|0
1727995|NCT01023581|6027792|P5|Overall Study|Other|1
1727996|NCT01023581|6027793|P4|Overall Study|Other|0
1727997|NCT01023581|6027794|P3|Overall Study|Other|1
1727998|NCT01023581|6027795|P2|Overall Study|Other|0
1727999|NCT01023581|6027796|P1|Overall Study|Other|1
1728000|NCT01023581|6027790|P7|Overall Study|Physician Decision|1
1728001|NCT01023581|6027791|P6|Overall Study|Physician Decision|1
1728002|NCT01023581|6027792|P5|Overall Study|Physician Decision|1
1728003|NCT01023581|6027793|P4|Overall Study|Physician Decision|1
1728004|NCT01023581|6027794|P3|Overall Study|Physician Decision|2
1728005|NCT01023581|6027795|P2|Overall Study|Physician Decision|0
1728006|NCT01023581|6027796|P1|Overall Study|Physician Decision|2
1728007|NCT01023581|6027790|P7|Overall Study|Lack of Efficacy|1
1728008|NCT01023581|6027791|P6|Overall Study|Lack of Efficacy|2
1728009|NCT01023581|6027792|P5|Overall Study|Lack of Efficacy|1
1728010|NCT01023581|6027793|P4|Overall Study|Lack of Efficacy|2
1728011|NCT01023581|6027794|P3|Overall Study|Lack of Efficacy|6
1728012|NCT01023581|6027795|P2|Overall Study|Lack of Efficacy|3
1728013|NCT01023581|6027796|P1|Overall Study|Lack of Efficacy|9
1728014|NCT01023581|6027790|P7|Overall Study|Pregnancy|0
1728015|NCT01023581|6027791|P6|Overall Study|Pregnancy|1
1728016|NCT01023581|6027792|P5|Overall Study|Pregnancy|0
1728017|NCT01023581|6027793|P4|Overall Study|Pregnancy|2
1728018|NCT01023581|6027794|P3|Overall Study|Pregnancy|0
1728019|NCT01023581|6027795|P2|Overall Study|Pregnancy|0
1728020|NCT01023581|6027796|P1|Overall Study|Pregnancy|0
1728021|NCT01023581|6027790|P7|Overall Study|Withdrawal by Subject|5
1728022|NCT01023581|6027791|P6|Overall Study|Withdrawal by Subject|8
1728023|NCT01023581|6027792|P5|Overall Study|Withdrawal by Subject|6
1728024|NCT01023581|6027793|P4|Overall Study|Withdrawal by Subject|10
1728025|NCT01023581|6027794|P3|Overall Study|Withdrawal by Subject|16
1728026|NCT01023581|6027795|P2|Overall Study|Withdrawal by Subject|8
1728027|NCT01023581|6027796|P1|Overall Study|Withdrawal by Subject|13
1728028|NCT01023581|6027790|P7|Overall Study|Lost to Follow-up|2
1728029|NCT01023581|6027791|P6|Overall Study|Lost to Follow-up|2
1728030|NCT01023581|6027792|P5|Overall Study|Lost to Follow-up|5
1728031|NCT01023581|6027793|P4|Overall Study|Lost to Follow-up|2
1728032|NCT01023581|6027794|P3|Overall Study|Lost to Follow-up|7
1728033|NCT01023581|6027795|P2|Overall Study|Lost to Follow-up|8
1728034|NCT01023581|6027796|P1|Overall Study|Lost to Follow-up|4
1728035|NCT01023581|6027790|P7|Overall Study|Major protocol deviation|0
1728036|NCT01023581|6027791|P6|Overall Study|Major protocol deviation|0
1728037|NCT01023581|6027792|P5|Overall Study|Major protocol deviation|0
1728038|NCT01023581|6027793|P4|Overall Study|Major protocol deviation|0
1728039|NCT01023581|6027794|P3|Overall Study|Major protocol deviation|3
1728040|NCT01023581|6027795|P2|Overall Study|Major protocol deviation|0
1728041|NCT01023581|6027796|P1|Overall Study|Major protocol deviation|2
1728042|NCT01023581|6027790|P7|Overall Study|Adverse Event|11
1728043|NCT01023581|6027791|P6|Overall Study|Adverse Event|5
1728044|NCT01023581|6027792|P5|Overall Study|Adverse Event|2
1728045|NCT01023581|6027793|P4|Overall Study|Adverse Event|3
1728046|NCT01023581|6027794|P3|Overall Study|Adverse Event|7
1728047|NCT01023581|6027795|P2|Overall Study|Adverse Event|4
1728048|NCT01023581|6027796|P1|Overall Study|Adverse Event|4
1728049|NCT01023516|6027853|P2|Overall Study|Incorrect enrolment|2
1728050|NCT01023516|6027854|P1|Overall Study|Incorrect enrolment|4
1728051|NCT01023516|6027853|P2|Overall Study|Study-specific criteria|2
1728052|NCT01023516|6027854|P1|Overall Study|Study-specific criteria|4
1728053|NCT01023516|6027853|P2|Overall Study|Safety reason|3
1728054|NCT01023516|6027854|P1|Overall Study|Safety reason|0
1728055|NCT01023516|6027853|P2|Overall Study|Adverse Event|6
1728056|NCT01023516|6027854|P1|Overall Study|Adverse Event|9
1728057|NCT01023516|6027853|P2|Overall Study|Voluntary discontinuation|5
1728058|NCT01023516|6027854|P1|Overall Study|Voluntary discontinuation|7
1728059|NCT01023308|6027936|P2|Overall Study|Withdrawal by Subject|18
1728060|NCT01023308|6027937|P1|Overall Study|Withdrawal by Subject|34
1728061|NCT01023308|6027936|P2|Overall Study|Lost to Follow-up|0
1728062|NCT01023308|6027937|P1|Overall Study|Lost to Follow-up|1
1728063|NCT01023308|6027936|P2|Overall Study|Untreated|5
1728064|NCT01023308|6027937|P1|Overall Study|Untreated|5
1728065|NCT01023308|6027936|P2|Overall Study|Protocol Violation|4
1728066|NCT01023308|6027937|P1|Overall Study|Protocol Violation|3
1728067|NCT01023308|6027936|P2|Overall Study|New Cancer therapy|7
1728068|NCT01023308|6027937|P1|Overall Study|New Cancer therapy|4
1728069|NCT01023308|6027936|P2|Overall Study|Disease progression|153
1728070|NCT01023308|6027937|P1|Overall Study|Disease progression|82
1728071|NCT01023308|6027936|P2|Overall Study|Death|17
1728072|NCT01023308|6027937|P1|Overall Study|Death|21
1728073|NCT01023308|6027936|P2|Overall Study|Adverse Event|66
1728074|NCT01023308|6027937|P1|Overall Study|Adverse Event|130
1728075|NCT01023308|6027936|P2|Overall Study|Administrative problems|1
1728076|NCT01023308|6027937|P1|Overall Study|Administrative problems|2
1728077|NCT01023308|6027936|P2|Overall Study|Abnormal test proceedure results|8
1728078|NCT01023308|6027937|P1|Overall Study|Abnormal test proceedure results|3
1728079|NCT01023269|6027963|P2|Overall Study|early termination of the study|0
1728080|NCT01023269|6027964|P1|Overall Study|early termination of the study|2
1728081|NCT01023256|6027972|P4|Overall Study|Withdrawal by Subject|2
1728082|NCT01023256|6027973|P3|Overall Study|Withdrawal by Subject|0
1728083|NCT01023256|6027974|P2|Overall Study|Withdrawal by Subject|0
1728084|NCT01023256|6027975|P1|Overall Study|Withdrawal by Subject|0
1728085|NCT01023256|6027972|P4|Overall Study|Adverse Event|1
1728086|NCT01023256|6027973|P3|Overall Study|Adverse Event|0
1728087|NCT01023256|6027974|P2|Overall Study|Adverse Event|0
1728088|NCT01023256|6027975|P1|Overall Study|Adverse Event|0
1728089|NCT01023256|6027972|P4|Overall Study|Other|2
1728090|NCT01023256|6027973|P3|Overall Study|Other|0
1728091|NCT01023256|6027974|P2|Overall Study|Other|0
1728092|NCT01023256|6027975|P1|Overall Study|Other|1
1728093|NCT01023256|6027972|P4|Overall Study|Randomized but not treated|0
1728094|NCT01023256|6027973|P3|Overall Study|Randomized but not treated|1
1728095|NCT01023256|6027974|P2|Overall Study|Randomized but not treated|0
1728096|NCT01023256|6027975|P1|Overall Study|Randomized but not treated|1
1728097|NCT01023256|6027972|P4|Overall Study|Protocol Violation|0
1728098|NCT01023256|6027973|P3|Overall Study|Protocol Violation|0
1728099|NCT01023256|6027974|P2|Overall Study|Protocol Violation|3
1728100|NCT01023256|6027975|P1|Overall Study|Protocol Violation|2
1728101|NCT01023217|6028017|P2|Overall Study|Withdrawal by Subject|0
1728102|NCT01023217|6028018|P1|Overall Study|Withdrawal by Subject|1
1728103|NCT01023061|6028056|P1|Overall Study|Withdrawal prior to treatment|2
1728104|NCT01023035|6028065|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
1728105|NCT01023035|6028066|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
1728106|NCT01023035|6028067|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
1728107|NCT01023035|6028065|P3|Follow-up Period (up to Week 72)|Adverse Event|1
1728108|NCT01023035|6028066|P2|Follow-up Period (up to Week 72)|Adverse Event|0
1728109|NCT01023035|6028067|P1|Follow-up Period (up to Week 72)|Adverse Event|2
1728110|NCT01023035|6028065|P3|Treatment Period|Treatment Failure|24
1728111|NCT01023035|6028066|P2|Treatment Period|Treatment Failure|31
1728112|NCT01023035|6028067|P1|Treatment Period|Treatment Failure|26
1728113|NCT01023035|6028065|P3|Treatment Period|Non-Medical Reasons|44
1728114|NCT01023035|6028066|P2|Treatment Period|Non-Medical Reasons|22
1728115|NCT01023035|6028067|P1|Treatment Period|Non-Medical Reasons|19
1728116|NCT01023035|6028065|P3|Treatment Period|Adverse Event|50
1728117|NCT01023035|6028066|P2|Treatment Period|Adverse Event|32
1728118|NCT01023035|6028067|P1|Treatment Period|Adverse Event|27
1728119|NCT01023022|6028077|P1|Overall Study|due to technical issues|2
1728120|NCT01023022|6028077|P1|Overall Study|Lost to Follow-up|7
1728121|NCT01023022|6028077|P1|Overall Study|Death|5
1728122|NCT01022996|6028083|P1|Overall Study|Protocol Violation|1
1728123|NCT01022996|6028083|P1|Overall Study|Disease Progression|32
1728124|NCT01022996|6028083|P1|Overall Study|Administrative problems|6
1728125|NCT01022996|6028083|P1|Overall Study|Lost to Follow-up|1
1728126|NCT01022996|6028083|P1|Overall Study|Withdrawal by Subject|3
1728127|NCT01022996|6028083|P1|Overall Study|Adverse Event|14
1728128|NCT01022853|6028097|P5|Overall Study|Other not stated above|0
1728129|NCT01022853|6028098|P4|Overall Study|Other not stated above|0
1728130|NCT01022853|6028099|P3|Overall Study|Other not stated above|1
1728131|NCT01022853|6028100|P2|Overall Study|Other not stated above|0
1728132|NCT01022853|6028101|P1|Overall Study|Other not stated above|1
1728133|NCT01022853|6028097|P5|Overall Study|Withdrawal by Subject|0
1728134|NCT01022853|6028098|P4|Overall Study|Withdrawal by Subject|1
1728135|NCT01022853|6028099|P3|Overall Study|Withdrawal by Subject|1
1728136|NCT01022853|6028100|P2|Overall Study|Withdrawal by Subject|1
1728137|NCT01022853|6028101|P1|Overall Study|Withdrawal by Subject|0
1728138|NCT01022853|6028097|P5|Overall Study|Dose-limiting toxicity|1
1728139|NCT01022853|6028098|P4|Overall Study|Dose-limiting toxicity|0
1728140|NCT01022853|6028099|P3|Overall Study|Dose-limiting toxicity|0
1728141|NCT01022853|6028100|P2|Overall Study|Dose-limiting toxicity|0
1728142|NCT01022853|6028101|P1|Overall Study|Dose-limiting toxicity|0
1728143|NCT01022853|6028097|P5|Overall Study|Progressive disease|1
1728144|NCT01022853|6028098|P4|Overall Study|Progressive disease|7
1728145|NCT01022853|6028099|P3|Overall Study|Progressive disease|11
1728146|NCT01022853|6028100|P2|Overall Study|Progressive disease|3
1728147|NCT01022853|6028101|P1|Overall Study|Progressive disease|2
1728148|NCT01022762|6028180|P2|Overall Study|Unclassified|20
1728149|NCT01022762|6028181|P1|Overall Study|Unclassified|12
1728150|NCT01022762|6028180|P2|Overall Study|Protocol Violation|6
1728151|NCT01022762|6028181|P1|Overall Study|Protocol Violation|7
1728152|NCT01022762|6028180|P2|Overall Study|Lack of Efficacy|1
1728153|NCT01022762|6028181|P1|Overall Study|Lack of Efficacy|0
1728154|NCT01022762|6028180|P2|Overall Study|Adverse Event|1
1728155|NCT01022762|6028181|P1|Overall Study|Adverse Event|3
1728156|NCT01022502|6028216|P1|Overall Study|Withdrawal by Subject|1
1728157|NCT01022502|6028216|P1|Overall Study|employment related reasons|1
1728158|NCT01022502|6028216|P1|Overall Study|Adverse Event|1
1728159|NCT01022424|6028230|P1|Overall Study|eGFR under the withdrawal criteria|2
1728160|NCT01022424|6028230|P1|Overall Study|Physician Decision|1
1728161|NCT01022424|6028230|P1|Overall Study|Adverse Event|1
1728162|NCT01022398|6028245|P2|Overall Study|Study terminated|2
1728163|NCT01022398|6028246|P1|Overall Study|Study terminated|2
1728164|NCT01022203|6028271|P2|Follow-Up Assessment|Lost to Follow-up|2
1728165|NCT01022203|6028272|P1|Follow-Up Assessment|Lost to Follow-up|2
1728166|NCT01022203|6028271|P2|Post Treatment Assessment|Adverse Event|2
1728167|NCT01022203|6028272|P1|Post Treatment Assessment|Adverse Event|0
1728168|NCT01022203|6028271|P2|Post Treatment Assessment|Physician Decision|0
1728169|NCT01022203|6028272|P1|Post Treatment Assessment|Physician Decision|2
1728170|NCT01022203|6028271|P2|Post Treatment Assessment|Withdrawal by Subject|12
1728171|NCT01022203|6028272|P1|Post Treatment Assessment|Withdrawal by Subject|12
1728172|NCT01022112|6028291|P5|Overall Study|Fasting plasma glucose level increased|7
1728173|NCT01022112|6028292|P4|Overall Study|Fasting plasma glucose level increased|0
1728174|NCT01022112|6028293|P3|Overall Study|Fasting plasma glucose level increased|0
1728175|NCT01022112|6028294|P2|Overall Study|Fasting plasma glucose level increased|0
1728176|NCT01022112|6028295|P1|Overall Study|Fasting plasma glucose level increased|1
1728177|NCT01022112|6028291|P5|Overall Study|Withdrawal by Subject|1
1728178|NCT01022112|6028292|P4|Overall Study|Withdrawal by Subject|2
1728179|NCT01022112|6028293|P3|Overall Study|Withdrawal by Subject|2
1728180|NCT01022112|6028294|P2|Overall Study|Withdrawal by Subject|1
1728181|NCT01022112|6028295|P1|Overall Study|Withdrawal by Subject|0
1728182|NCT01022112|6028291|P5|Overall Study|Physician Decision|1
1728183|NCT01022112|6028292|P4|Overall Study|Physician Decision|0
1728184|NCT01022112|6028293|P3|Overall Study|Physician Decision|1
1728185|NCT01022112|6028294|P2|Overall Study|Physician Decision|0
1728186|NCT01022112|6028295|P1|Overall Study|Physician Decision|0
1728187|NCT01022112|6028291|P5|Overall Study|Lack of Efficacy|1
1728188|NCT01022112|6028292|P4|Overall Study|Lack of Efficacy|0
1728189|NCT01022112|6028293|P3|Overall Study|Lack of Efficacy|0
1728190|NCT01022112|6028294|P2|Overall Study|Lack of Efficacy|0
1728191|NCT01022112|6028295|P1|Overall Study|Lack of Efficacy|1
1728192|NCT01022112|6028291|P5|Overall Study|Adverse Event|0
1728193|NCT01022112|6028292|P4|Overall Study|Adverse Event|1
1728194|NCT01022112|6028293|P3|Overall Study|Adverse Event|0
1728195|NCT01022112|6028294|P2|Overall Study|Adverse Event|2
1728196|NCT01022112|6028295|P1|Overall Study|Adverse Event|1
1728197|NCT01021878|6028344|P2|Overall Study|Transplantation|1
1728198|NCT01021878|6028345|P1|Overall Study|Transplantation|6
1728199|NCT01021878|6028344|P2|Overall Study|Adverse Event|5
1728200|NCT01021878|6028345|P1|Overall Study|Adverse Event|6
1728201|NCT01021878|6028344|P2|Overall Study|Death|1
1728202|NCT01021878|6028345|P1|Overall Study|Death|0
1728203|NCT01021878|6028344|P2|Overall Study|Lost to Follow-up|3
1728204|NCT01021878|6028345|P1|Overall Study|Lost to Follow-up|4
1728205|NCT01021852|6028367|P8|Treatment Period 2|Withdrawal by Subject|2
1728206|NCT01021852|6028368|P7|Treatment Period 2|Withdrawal by Subject|1
1728207|NCT01021852|6028369|P6|Treatment Period 2|Withdrawal by Subject|0
1728208|NCT01021852|6028370|P5|Treatment Period 2|Withdrawal by Subject|0
1728209|NCT01021852|6028371|P4|Treatment Period 2|Withdrawal by Subject|0
1728210|NCT01021852|6028372|P3|Treatment Period 2|Withdrawal by Subject|0
1728211|NCT01021852|6028373|P2|Treatment Period 2|Withdrawal by Subject|0
1728212|NCT01021852|6028374|P1|Treatment Period 2|Withdrawal by Subject|0
1728213|NCT01021852|6028367|P8|Treatment Period 2|Protocol Violation|0
1728214|NCT01021852|6028368|P7|Treatment Period 2|Protocol Violation|1
1728215|NCT01021852|6028369|P6|Treatment Period 2|Protocol Violation|0
1728216|NCT01021852|6028370|P5|Treatment Period 2|Protocol Violation|1
1728217|NCT01021852|6028371|P4|Treatment Period 2|Protocol Violation|0
1728218|NCT01021852|6028372|P3|Treatment Period 2|Protocol Violation|0
1728219|NCT01021852|6028373|P2|Treatment Period 2|Protocol Violation|0
1728220|NCT01021852|6028374|P1|Treatment Period 2|Protocol Violation|0
1728221|NCT01021852|6028367|P8|Treatment Period 2|Physician Decision|0
1728222|NCT01021852|6028368|P7|Treatment Period 2|Physician Decision|0
1728223|NCT01021852|6028369|P6|Treatment Period 2|Physician Decision|0
1728224|NCT01021852|6028370|P5|Treatment Period 2|Physician Decision|0
1728225|NCT01021852|6028371|P4|Treatment Period 2|Physician Decision|0
1728226|NCT01021852|6028372|P3|Treatment Period 2|Physician Decision|1
1728227|NCT01021852|6028373|P2|Treatment Period 2|Physician Decision|0
1728228|NCT01021852|6028374|P1|Treatment Period 2|Physician Decision|0
1728229|NCT01021852|6028367|P8|Treatment Period 2|Lack of Efficacy|0
1728230|NCT01021852|6028368|P7|Treatment Period 2|Lack of Efficacy|0
1728231|NCT01021852|6028369|P6|Treatment Period 2|Lack of Efficacy|1
1728232|NCT01021852|6028370|P5|Treatment Period 2|Lack of Efficacy|0
1728233|NCT01021852|6028371|P4|Treatment Period 2|Lack of Efficacy|0
1728234|NCT01021852|6028372|P3|Treatment Period 2|Lack of Efficacy|0
1728235|NCT01021852|6028373|P2|Treatment Period 2|Lack of Efficacy|0
1728236|NCT01021852|6028374|P1|Treatment Period 2|Lack of Efficacy|0
1728237|NCT01021852|6028367|P8|Treatment Period 2|Adverse Event|0
1728238|NCT01021852|6028368|P7|Treatment Period 2|Adverse Event|1
1728239|NCT01021852|6028369|P6|Treatment Period 2|Adverse Event|0
1728240|NCT01021852|6028370|P5|Treatment Period 2|Adverse Event|1
1728241|NCT01021852|6028371|P4|Treatment Period 2|Adverse Event|0
1728242|NCT01021852|6028372|P3|Treatment Period 2|Adverse Event|0
1728243|NCT01021852|6028373|P2|Treatment Period 2|Adverse Event|1
1728244|NCT01021852|6028374|P1|Treatment Period 2|Adverse Event|0
1728245|NCT01021852|6028367|P8|Washout Period-No Drug|Adverse Event|0
1728246|NCT01021852|6028368|P7|Washout Period-No Drug|Adverse Event|0
1728247|NCT01021852|6028369|P6|Washout Period-No Drug|Adverse Event|1
1728248|NCT01021852|6028370|P5|Washout Period-No Drug|Adverse Event|0
1728249|NCT01021852|6028371|P4|Washout Period-No Drug|Adverse Event|0
1728250|NCT01021852|6028372|P3|Washout Period-No Drug|Adverse Event|0
1728251|NCT01021852|6028373|P2|Washout Period-No Drug|Adverse Event|0
1728252|NCT01021852|6028374|P1|Washout Period-No Drug|Adverse Event|1
1728253|NCT01021852|6028367|P8|Washout Period-Placebo|Protocol Violation|0
1728254|NCT01021852|6028368|P7|Washout Period-Placebo|Protocol Violation|1
1728255|NCT01021852|6028369|P6|Washout Period-Placebo|Protocol Violation|0
1728256|NCT01021852|6028370|P5|Washout Period-Placebo|Protocol Violation|0
1728257|NCT01021852|6028371|P4|Washout Period-Placebo|Protocol Violation|0
1728258|NCT01021852|6028372|P3|Washout Period-Placebo|Protocol Violation|0
1728259|NCT01021852|6028373|P2|Washout Period-Placebo|Protocol Violation|0
1728260|NCT01021852|6028374|P1|Washout Period-Placebo|Protocol Violation|0
1728261|NCT01021852|6028367|P8|Washout Period-Placebo|Lost to Follow-up|0
1728262|NCT01021852|6028368|P7|Washout Period-Placebo|Lost to Follow-up|0
1728263|NCT01021852|6028369|P6|Washout Period-Placebo|Lost to Follow-up|0
1728264|NCT01021852|6028370|P5|Washout Period-Placebo|Lost to Follow-up|1
1728265|NCT01021852|6028371|P4|Washout Period-Placebo|Lost to Follow-up|0
1728266|NCT01021852|6028372|P3|Washout Period-Placebo|Lost to Follow-up|0
1728267|NCT01021852|6028373|P2|Washout Period-Placebo|Lost to Follow-up|0
1728268|NCT01021852|6028374|P1|Washout Period-Placebo|Lost to Follow-up|0
1728269|NCT01021852|6028367|P8|Washout Period-Placebo|Adverse Event|0
1728270|NCT01021852|6028368|P7|Washout Period-Placebo|Adverse Event|0
1728271|NCT01021852|6028369|P6|Washout Period-Placebo|Adverse Event|1
1728272|NCT01021852|6028370|P5|Washout Period-Placebo|Adverse Event|0
1728273|NCT01021852|6028371|P4|Washout Period-Placebo|Adverse Event|1
1728274|NCT01021852|6028372|P3|Washout Period-Placebo|Adverse Event|0
1728275|NCT01021852|6028373|P2|Washout Period-Placebo|Adverse Event|0
1728276|NCT01021852|6028374|P1|Washout Period-Placebo|Adverse Event|0
1728277|NCT01021852|6028367|P8|Treatment Period 1|Not Treated|0
1728278|NCT01021852|6028368|P7|Treatment Period 1|Not Treated|0
1728279|NCT01021852|6028369|P6|Treatment Period 1|Not Treated|0
1728280|NCT01021852|6028370|P5|Treatment Period 1|Not Treated|0
1728281|NCT01021852|6028371|P4|Treatment Period 1|Not Treated|2
1728282|NCT01021852|6028372|P3|Treatment Period 1|Not Treated|0
1728283|NCT01021852|6028373|P2|Treatment Period 1|Not Treated|0
1728284|NCT01021852|6028374|P1|Treatment Period 1|Not Treated|0
1728285|NCT01021852|6028367|P8|Treatment Period 1|Withdrawal by Subject|1
1728286|NCT01021852|6028368|P7|Treatment Period 1|Withdrawal by Subject|0
1728287|NCT01021852|6028369|P6|Treatment Period 1|Withdrawal by Subject|0
1728288|NCT01021852|6028370|P5|Treatment Period 1|Withdrawal by Subject|1
1728289|NCT01021852|6028371|P4|Treatment Period 1|Withdrawal by Subject|0
1728290|NCT01021852|6028372|P3|Treatment Period 1|Withdrawal by Subject|0
1728291|NCT01021852|6028373|P2|Treatment Period 1|Withdrawal by Subject|0
1728292|NCT01021852|6028374|P1|Treatment Period 1|Withdrawal by Subject|0
1728293|NCT01021852|6028367|P8|Treatment Period 1|Pregnancy|0
1728294|NCT01021852|6028368|P7|Treatment Period 1|Pregnancy|0
1728295|NCT01021852|6028369|P6|Treatment Period 1|Pregnancy|0
1728296|NCT01021852|6028370|P5|Treatment Period 1|Pregnancy|0
1728297|NCT01021852|6028371|P4|Treatment Period 1|Pregnancy|0
1728298|NCT01021852|6028372|P3|Treatment Period 1|Pregnancy|1
1728299|NCT01021852|6028373|P2|Treatment Period 1|Pregnancy|0
1728300|NCT01021852|6028374|P1|Treatment Period 1|Pregnancy|0
1728301|NCT01021852|6028367|P8|Treatment Period 1|Adverse Event|0
1728302|NCT01021852|6028368|P7|Treatment Period 1|Adverse Event|0
1728303|NCT01021852|6028369|P6|Treatment Period 1|Adverse Event|2
1728304|NCT01021852|6028370|P5|Treatment Period 1|Adverse Event|2
1728305|NCT01021852|6028371|P4|Treatment Period 1|Adverse Event|0
1728306|NCT01021852|6028372|P3|Treatment Period 1|Adverse Event|1
1728307|NCT01021852|6028373|P2|Treatment Period 1|Adverse Event|1
1728308|NCT01021852|6028374|P1|Treatment Period 1|Adverse Event|3
1728309|NCT01021813|6028410|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
1728310|NCT01021813|6028411|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
1728311|NCT01021813|6028412|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
1728312|NCT01021813|6028413|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
1728313|NCT01021813|6028414|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
1728314|NCT01021813|6028410|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
1728315|NCT01021813|6028411|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
1728316|NCT01021813|6028412|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
1728317|NCT01021813|6028413|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
1728318|NCT01021813|6028414|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
1728319|NCT01021813|6028410|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
1728320|NCT01021813|6028411|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1728321|NCT01021813|6028412|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1728322|NCT01021813|6028413|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1728323|NCT01021813|6028414|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
1728324|NCT01021813|6028410|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1728325|NCT01021813|6028411|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
1728326|NCT01021813|6028412|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1728327|NCT01021813|6028413|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1728328|NCT01021813|6028414|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
1728329|NCT01021813|6028410|P5|DB Randomized Discontinuation Phase|Adverse Event|1
1728330|NCT01021813|6028411|P4|DB Randomized Discontinuation Phase|Adverse Event|3
1728331|NCT01021813|6028412|P3|DB Randomized Discontinuation Phase|Adverse Event|0
1728332|NCT01021813|6028413|P2|DB Randomized Discontinuation Phase|Adverse Event|0
1728333|NCT01021813|6028414|P1|DB Randomized Discontinuation Phase|Adverse Event|0
1728334|NCT01021813|6028410|P5|DB Treatment Phase|Withdrawal by Subject|0
1728335|NCT01021813|6028411|P4|DB Treatment Phase|Withdrawal by Subject|0
1728336|NCT01021813|6028412|P3|DB Treatment Phase|Withdrawal by Subject|0
1728337|NCT01021813|6028413|P2|DB Treatment Phase|Withdrawal by Subject|24
1728338|NCT01021813|6028414|P1|DB Treatment Phase|Withdrawal by Subject|60
1728339|NCT01021813|6028410|P5|DB Treatment Phase|Protocol Violation|0
1728340|NCT01021813|6028411|P4|DB Treatment Phase|Protocol Violation|0
1728341|NCT01021813|6028412|P3|DB Treatment Phase|Protocol Violation|0
1728342|NCT01021813|6028413|P2|DB Treatment Phase|Protocol Violation|3
1728343|NCT01021813|6028414|P1|DB Treatment Phase|Protocol Violation|4
1728344|NCT01021813|6028410|P5|DB Treatment Phase|Pregnancy|0
1728345|NCT01021813|6028411|P4|DB Treatment Phase|Pregnancy|0
1728346|NCT01021813|6028412|P3|DB Treatment Phase|Pregnancy|0
1728347|NCT01021813|6028413|P2|DB Treatment Phase|Pregnancy|0
1728348|NCT01021813|6028414|P1|DB Treatment Phase|Pregnancy|1
1728349|NCT01021813|6028410|P5|DB Treatment Phase|Physician Decision|0
1728350|NCT01021813|6028411|P4|DB Treatment Phase|Physician Decision|0
1728351|NCT01021813|6028412|P3|DB Treatment Phase|Physician Decision|0
1728352|NCT01021813|6028413|P2|DB Treatment Phase|Physician Decision|8
1728353|NCT01021813|6028414|P1|DB Treatment Phase|Physician Decision|17
1728354|NCT01021813|6028410|P5|DB Treatment Phase|Lost to Follow-up|0
1728355|NCT01021813|6028411|P4|DB Treatment Phase|Lost to Follow-up|0
1728356|NCT01021813|6028412|P3|DB Treatment Phase|Lost to Follow-up|0
1728357|NCT01021813|6028413|P2|DB Treatment Phase|Lost to Follow-up|12
1728358|NCT01021813|6028414|P1|DB Treatment Phase|Lost to Follow-up|14
1728359|NCT01021813|6028410|P5|DB Treatment Phase|Lack of Efficacy|0
1728360|NCT01021813|6028411|P4|DB Treatment Phase|Lack of Efficacy|0
1728361|NCT01021813|6028412|P3|DB Treatment Phase|Lack of Efficacy|0
1728362|NCT01021813|6028413|P2|DB Treatment Phase|Lack of Efficacy|28
1728363|NCT01021813|6028414|P1|DB Treatment Phase|Lack of Efficacy|44
1728364|NCT01021813|6028410|P5|DB Treatment Phase|Adverse Event|0
1728365|NCT01021813|6028411|P4|DB Treatment Phase|Adverse Event|0
1728366|NCT01021813|6028412|P3|DB Treatment Phase|Adverse Event|0
1728367|NCT01021813|6028413|P2|DB Treatment Phase|Adverse Event|22
1728368|NCT01021813|6028414|P1|DB Treatment Phase|Adverse Event|60
1728369|NCT01021748|6028475|P9|Overall Study|Not Treated|0
1728370|NCT01021748|6028476|P8|Overall Study|Not Treated|0
1728371|NCT01021748|6028477|P7|Overall Study|Not Treated|0
1728372|NCT01021748|6028478|P6|Overall Study|Not Treated|0
1728373|NCT01021748|6028479|P5|Overall Study|Not Treated|0
1728374|NCT01021748|6028480|P4|Overall Study|Not Treated|0
1728375|NCT01021748|6028481|P3|Overall Study|Not Treated|0
1728376|NCT01021748|6028482|P2|Overall Study|Not Treated|1
1728377|NCT01021748|6028483|P1|Overall Study|Not Treated|0
1728378|NCT01021748|6028475|P9|Overall Study|Withdrawal by Subject|1
1728379|NCT01021748|6028476|P8|Overall Study|Withdrawal by Subject|0
1728380|NCT01021748|6028477|P7|Overall Study|Withdrawal by Subject|1
1728381|NCT01021748|6028478|P6|Overall Study|Withdrawal by Subject|0
1728382|NCT01021748|6028479|P5|Overall Study|Withdrawal by Subject|0
1728383|NCT01021748|6028480|P4|Overall Study|Withdrawal by Subject|0
1728384|NCT01021748|6028481|P3|Overall Study|Withdrawal by Subject|0
1728385|NCT01021748|6028482|P2|Overall Study|Withdrawal by Subject|0
1728386|NCT01021748|6028483|P1|Overall Study|Withdrawal by Subject|0
1728387|NCT01021748|6028475|P9|Overall Study|Progressive Disease|6
1728388|NCT01021748|6028476|P8|Overall Study|Progressive Disease|5
1728389|NCT01021748|6028477|P7|Overall Study|Progressive Disease|0
1728390|NCT01021748|6028478|P6|Overall Study|Progressive Disease|3
1728391|NCT01021748|6028479|P5|Overall Study|Progressive Disease|7
1728392|NCT01021748|6028480|P4|Overall Study|Progressive Disease|6
1728393|NCT01021748|6028481|P3|Overall Study|Progressive Disease|4
1728394|NCT01021748|6028482|P2|Overall Study|Progressive Disease|3
1728395|NCT01021748|6028483|P1|Overall Study|Progressive Disease|3
1728396|NCT01021748|6028475|P9|Overall Study|Physician Decision|2
1728397|NCT01021748|6028476|P8|Overall Study|Physician Decision|1
1728398|NCT01021748|6028477|P7|Overall Study|Physician Decision|1
1728399|NCT01021748|6028478|P6|Overall Study|Physician Decision|0
1728400|NCT01021748|6028479|P5|Overall Study|Physician Decision|0
1728401|NCT01021748|6028480|P4|Overall Study|Physician Decision|1
1728402|NCT01021748|6028481|P3|Overall Study|Physician Decision|1
1728403|NCT01021748|6028482|P2|Overall Study|Physician Decision|0
1728404|NCT01021748|6028483|P1|Overall Study|Physician Decision|1
1728405|NCT01021748|6028475|P9|Overall Study|Adverse Event|7
1728406|NCT01021748|6028476|P8|Overall Study|Adverse Event|0
1728407|NCT01021748|6028477|P7|Overall Study|Adverse Event|1
1728408|NCT01021748|6028478|P6|Overall Study|Adverse Event|0
1728409|NCT01021748|6028479|P5|Overall Study|Adverse Event|2
1728410|NCT01021748|6028480|P4|Overall Study|Adverse Event|0
1728411|NCT01021748|6028481|P3|Overall Study|Adverse Event|2
1728412|NCT01021748|6028482|P2|Overall Study|Adverse Event|1
1728413|NCT01021748|6028483|P1|Overall Study|Adverse Event|2
1728414|NCT01021683|6028530|P1|Overall Study|Other|8
1728415|NCT01021683|6028530|P1|Overall Study|Recovery of neutrophil count|51
1728416|NCT01021683|6028530|P1|Overall Study|Lack of Efficacy|12
1728417|NCT01021553|6028556|P3|Overall Study|Withdrawal by Subject|0
1728418|NCT01021553|6028557|P2|Overall Study|Withdrawal by Subject|1
1728419|NCT01021553|6028558|P1|Overall Study|Withdrawal by Subject|1
1728420|NCT01021553|6028556|P3|Overall Study|Lost to Follow-up|1
1728421|NCT01021553|6028557|P2|Overall Study|Lost to Follow-up|0
1728422|NCT01021553|6028558|P1|Overall Study|Lost to Follow-up|0
1728423|NCT01021553|6028556|P3|Overall Study|Protocol Violation|2
1728424|NCT01021553|6028557|P2|Overall Study|Protocol Violation|2
1728425|NCT01021553|6028558|P1|Overall Study|Protocol Violation|0
1728426|NCT01021553|6028556|P3|Overall Study|Lack of Efficacy|0
1728427|NCT01021553|6028557|P2|Overall Study|Lack of Efficacy|2
1728428|NCT01021553|6028558|P1|Overall Study|Lack of Efficacy|2
1728429|NCT01021553|6028556|P3|Overall Study|Adverse Event|0
1728430|NCT01021553|6028557|P2|Overall Study|Adverse Event|0
1728431|NCT01021553|6028558|P1|Overall Study|Adverse Event|1
1728432|NCT01021423|6028612|P2|Overall Study|Study terminated|5
1728433|NCT01021423|6028613|P1|Overall Study|Study terminated|4
1728434|NCT01021332|6028629|P1|Overall Study|Miscellaneous|3
1728435|NCT01021332|6028629|P1|Overall Study|Protocol Violation|9
1728436|NCT01021332|6028629|P1|Overall Study|Lost to Follow-up|4
1728437|NCT01021332|6028629|P1|Overall Study|Withdrawal of Consent|23
1728438|NCT01021332|6028629|P1|Overall Study|Lack of Efficacy|19
1728439|NCT01021332|6028629|P1|Overall Study|Adverse Event|43
1728440|NCT01021332|6028629|P1|Overall Study|Not fulfilling incl./excl.criteria|5
1728441|NCT01021293|6028690|P2|Overall Study|Lost to Follow-up|1
1728442|NCT01021293|6028691|P1|Overall Study|Lost to Follow-up|1
1728443|NCT01021293|6028690|P2|Overall Study|Migrated/moved from study area|18
1728444|NCT01021293|6028691|P1|Overall Study|Migrated/moved from study area|6
1728445|NCT01021293|6028690|P2|Overall Study|Withdrawal by Subject|3
1728446|NCT01021293|6028691|P1|Overall Study|Withdrawal by Subject|1
1728447|NCT01021293|6028690|P2|Overall Study|Adverse Event|1
1728448|NCT01021293|6028691|P1|Overall Study|Adverse Event|2
1728449|NCT01021293|6028690|P2|Overall Study|Serious Adverse Event|1
1728450|NCT01021293|6028691|P1|Overall Study|Serious Adverse Event|2
1728451|NCT01021215|6028710|P2|Overall Study|Lost to Follow-up|0
1728452|NCT01021215|6028711|P1|Overall Study|Lost to Follow-up|3
1728453|NCT01021137|6028725|P4|Overall Study|Withdrawal by Subject|3
1728454|NCT01021137|6028726|P3|Overall Study|Withdrawal by Subject|0
1728455|NCT01021137|6028727|P2|Overall Study|Withdrawal by Subject|0
1728456|NCT01021137|6028728|P1|Overall Study|Withdrawal by Subject|1
1728457|NCT01021137|6028725|P4|Overall Study|Lost to Follow-up|6
1728458|NCT01021137|6028726|P3|Overall Study|Lost to Follow-up|2
1728459|NCT01021137|6028727|P2|Overall Study|Lost to Follow-up|4
1728460|NCT01021137|6028728|P1|Overall Study|Lost to Follow-up|9
1728461|NCT01021020|6028771|P1|14 Day Washout Period A|Physician Decision|1
1728462|NCT01021020|6028771|P1|Period I|Withdrawal by Subject|1
1728463|NCT01021020|6028771|P1|Period I|Protocol Violation|1
1728464|NCT01021007|6028787|P2|Overall Study|Adverse Event|3
1728465|NCT01021007|6028788|P1|Overall Study|Adverse Event|1
1728466|NCT01021007|6028787|P2|Overall Study|Lost to Follow-up|1
1728467|NCT01021007|6028788|P1|Overall Study|Lost to Follow-up|1
1728468|NCT01020981|6028800|P2|Overall Study|Participant declined to complete survey|0
1728469|NCT01020981|6028801|P1|Overall Study|Participant declined to complete survey|2
1728470|NCT01020981|6028800|P2|Overall Study|Survey returned undeliverable|32
1728471|NCT01020981|6028801|P1|Overall Study|Survey returned undeliverable|8
1728472|NCT01020981|6028800|P2|Overall Study|Did not return mailed survey|58
1728473|NCT01020981|6028801|P1|Overall Study|Did not return mailed survey|74
1728474|NCT01020877|6028822|P2|Second Intervention|Withdrawal by Subject|0
1728475|NCT01020877|6028823|P1|Second Intervention|Withdrawal by Subject|1
1728476|NCT01020838|6028833|P1|Overall Study|Most common: Study ended by sponsor|77
1728477|NCT01020838|6028833|P1|Overall Study|Lost to Follow-up|6
1728478|NCT01020838|6028833|P1|Overall Study|Withdrawal by Subject|9
1728479|NCT01020838|6028833|P1|Overall Study|Adverse Event|1
1728480|NCT01020838|6028833|P1|Overall Study|Death|90
1728481|NCT01020812|6028848|P1|Overall Study|Protocol Violation|1
1728482|NCT01020812|6028848|P1|Overall Study|Withdrawal by Subject|1
1728483|NCT01020812|6028848|P1|Overall Study|Physician Decision|1
1728484|NCT01020799|6028858|P3|Overall Study|Lost to Follow-up|2
1728485|NCT01020799|6028859|P2|Overall Study|Lost to Follow-up|4
1728486|NCT01020799|6028860|P1|Overall Study|Lost to Follow-up|6
1728487|NCT01020799|6028858|P3|Overall Study|Withdrawal by Subject|3
1728488|NCT01020799|6028859|P2|Overall Study|Withdrawal by Subject|2
1728489|NCT01020799|6028860|P1|Overall Study|Withdrawal by Subject|2
1728490|NCT01020799|6028858|P3|Overall Study|Protocol Violation|0
1728491|NCT01020799|6028859|P2|Overall Study|Protocol Violation|2
1728492|NCT01020799|6028860|P1|Overall Study|Protocol Violation|3
1728493|NCT01020799|6028858|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
1728494|NCT01020799|6028859|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
1728495|NCT01020799|6028860|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
1728496|NCT01020799|6028858|P3|Overall Study|Adverse Event|2
1728497|NCT01020799|6028859|P2|Overall Study|Adverse Event|3
1728498|NCT01020799|6028860|P1|Overall Study|Adverse Event|4
1728499|NCT01020786|6028883|P1|Maintenance Period|Sponsor Decision|1
1728500|NCT01020786|6028883|P1|Maintenance Period|Withdrawal by Subject|8
1728501|NCT01020786|6028883|P1|Maintenance Period|Progressive Disease|43
1728502|NCT01020786|6028883|P1|Maintenance Period|Adverse Event|8
1728503|NCT01020786|6028883|P1|Induction Period|Withdrawal by Subject|3
1728504|NCT01020786|6028883|P1|Induction Period|Investigator Decision|3
1728505|NCT01020786|6028883|P1|Induction Period|Progressive Disease|31
1728506|NCT01020786|6028883|P1|Induction Period|Adverse Event|10
1728507|NCT01020786|6028883|P1|Induction Period|Entry Criteria Not Met|2
1728508|NCT01020773|6028897|P2|Overall Study|Withdrawal by Subject|3
1728509|NCT01020773|6028898|P1|Overall Study|Withdrawal by Subject|4
1728510|NCT01020747|6028904|P1|Overall Study|Withdrawal by Subject|1
1728511|NCT01020526|6028920|P1|Overall Study|Adverse Event|2
1728512|NCT01020526|6028920|P1|Overall Study|Lost to Follow-up|1
1728513|NCT01020526|6028920|P1|Overall Study|Insufficient clinical response|3
1728514|NCT01020526|6028920|P1|Overall Study|Other reasons|3
1728515|NCT01020526|6028920|P1|Overall Study|Withdrawal by Subject|5
1728516|NCT01020474|6028926|P2|Overall Study|Insufficient Clinical Response|3
1728517|NCT01020474|6028927|P1|Overall Study|Insufficient Clinical Response|0
1728518|NCT01020474|6028926|P2|Overall Study|Other Reasons|1
1728519|NCT01020474|6028927|P1|Overall Study|Other Reasons|1
1728520|NCT01020474|6028926|P2|Overall Study|Withdrawal by Subject|7
1728521|NCT01020474|6028927|P1|Overall Study|Withdrawal by Subject|5
1728522|NCT01020474|6028926|P2|Overall Study|Protocol Violation|2
1728523|NCT01020474|6028927|P1|Overall Study|Protocol Violation|0
1728524|NCT01020474|6028926|P2|Overall Study|Adverse Event|4
1728525|NCT01020474|6028927|P1|Overall Study|Adverse Event|4
1728526|NCT01020448|6028947|P1|Treatment|Lost to Follow-up|2
1728527|NCT01020448|6028947|P1|Treatment|Lack of Efficacy|8
1728528|NCT01020448|6028947|P1|Treatment|Disease Progression|2
1728529|NCT01020448|6028947|P1|Treatment|Consent Withdrawn|3
1728530|NCT01020448|6028947|P1|Treatment|Adverse Event|11
1728531|NCT01020448|6028947|P1|Pre-assignment|Does Not Meet Entry Criteria|2
1728532|NCT01020448|6028947|P1|Pre-assignment|Withdrawal by Subject|5
1728533|NCT01020448|6028947|P1|Pre-assignment|Adverse Event|6
1728534|NCT01020435|6028958|P2|Overall Study|Lost to Follow-up|1
1728535|NCT01020435|6028959|P1|Overall Study|Lost to Follow-up|0
1728536|NCT01020305|6028967|P1|Overall Study|Adverse Event|2
1728537|NCT01020123|6028978|P7|Extention Period|Lost to Follow-up|0
1728538|NCT01020123|6028979|P6|Extention Period|Lost to Follow-up|2
1728539|NCT01020123|6028980|P5|Extention Period|Lost to Follow-up|0
1728540|NCT01020123|6028981|P4|Extention Period|Lost to Follow-up|0
1728541|NCT01020123|6028982|P3|Extention Period|Lost to Follow-up|0
1728542|NCT01020123|6028983|P2|Extention Period|Lost to Follow-up|0
1728543|NCT01020123|6028984|P1|Extention Period|Lost to Follow-up|0
1728544|NCT01020123|6028978|P7|Extention Period|Protocol Violation|1
1728545|NCT01020123|6028979|P6|Extention Period|Protocol Violation|0
1728546|NCT01020123|6028980|P5|Extention Period|Protocol Violation|0
1728547|NCT01020123|6028981|P4|Extention Period|Protocol Violation|0
1728548|NCT01020123|6028982|P3|Extention Period|Protocol Violation|1
1728549|NCT01020123|6028983|P2|Extention Period|Protocol Violation|1
1728550|NCT01020123|6028984|P1|Extention Period|Protocol Violation|1
1728551|NCT01020123|6028978|P7|Extention Period|Adverse Event|0
1728552|NCT01020123|6028979|P6|Extention Period|Adverse Event|0
1728553|NCT01020123|6028980|P5|Extention Period|Adverse Event|0
1728554|NCT01020123|6028981|P4|Extention Period|Adverse Event|1
1728555|NCT01020123|6028982|P3|Extention Period|Adverse Event|0
1728556|NCT01020123|6028983|P2|Extention Period|Adverse Event|0
1728557|NCT01020123|6028984|P1|Extention Period|Adverse Event|0
1728558|NCT01020123|6028978|P7|Extention Period|Withdrawal by Subject|0
1728559|NCT01020123|6028979|P6|Extention Period|Withdrawal by Subject|0
1728560|NCT01020123|6028980|P5|Extention Period|Withdrawal by Subject|0
1728561|NCT01020123|6028981|P4|Extention Period|Withdrawal by Subject|0
1728562|NCT01020123|6028982|P3|Extention Period|Withdrawal by Subject|1
1728563|NCT01020123|6028983|P2|Extention Period|Withdrawal by Subject|1
1728564|NCT01020123|6028984|P1|Extention Period|Withdrawal by Subject|2
1728565|NCT01020123|6028978|P7|Main Period|Unclasified|6
1728566|NCT01020123|6028979|P6|Main Period|Unclasified|3
1728567|NCT01020123|6028980|P5|Main Period|Unclasified|1
1728568|NCT01020123|6028981|P4|Main Period|Unclasified|0
1728569|NCT01020123|6028982|P3|Main Period|Unclasified|1
1728570|NCT01020123|6028983|P2|Main Period|Unclasified|0
1728571|NCT01020123|6028984|P1|Main Period|Unclasified|2
1728572|NCT01020123|6028978|P7|Main Period|Lost to Follow-up|0
1728573|NCT01020123|6028979|P6|Main Period|Lost to Follow-up|0
1728574|NCT01020123|6028980|P5|Main Period|Lost to Follow-up|0
1728575|NCT01020123|6028981|P4|Main Period|Lost to Follow-up|0
1728576|NCT01020123|6028982|P3|Main Period|Lost to Follow-up|0
1728577|NCT01020123|6028983|P2|Main Period|Lost to Follow-up|2
1728578|NCT01020123|6028984|P1|Main Period|Lost to Follow-up|0
1728579|NCT01020123|6028978|P7|Main Period|Protocol Violation|2
1728580|NCT01020123|6028979|P6|Main Period|Protocol Violation|3
1728581|NCT01020123|6028980|P5|Main Period|Protocol Violation|2
1728582|NCT01020123|6028981|P4|Main Period|Protocol Violation|5
1728583|NCT01020123|6028982|P3|Main Period|Protocol Violation|2
1728584|NCT01020123|6028983|P2|Main Period|Protocol Violation|4
1728585|NCT01020123|6028984|P1|Main Period|Protocol Violation|4
1728586|NCT01020123|6028978|P7|Main Period|Adverse Event|1
1728587|NCT01020123|6028979|P6|Main Period|Adverse Event|2
1728588|NCT01020123|6028980|P5|Main Period|Adverse Event|1
1728589|NCT01020123|6028981|P4|Main Period|Adverse Event|1
1728590|NCT01020123|6028982|P3|Main Period|Adverse Event|2
1728591|NCT01020123|6028983|P2|Main Period|Adverse Event|2
1728592|NCT01020123|6028984|P1|Main Period|Adverse Event|5
1728593|NCT01020123|6028978|P7|Main Period|Eligibility Criteria not fullfilled|0
1728594|NCT01020123|6028979|P6|Main Period|Eligibility Criteria not fullfilled|0
1728595|NCT01020123|6028980|P5|Main Period|Eligibility Criteria not fullfilled|1
1728596|NCT01020123|6028981|P4|Main Period|Eligibility Criteria not fullfilled|0
1728597|NCT01020123|6028982|P3|Main Period|Eligibility Criteria not fullfilled|0
1728598|NCT01020123|6028983|P2|Main Period|Eligibility Criteria not fullfilled|1
1728599|NCT01020123|6028984|P1|Main Period|Eligibility Criteria not fullfilled|0
1728600|NCT01020123|6028978|P7|Main Period|Withdrawal by Subject|2
1728601|NCT01020123|6028979|P6|Main Period|Withdrawal by Subject|3
1728602|NCT01020123|6028980|P5|Main Period|Withdrawal by Subject|6
1728603|NCT01020123|6028981|P4|Main Period|Withdrawal by Subject|1
1728604|NCT01020123|6028982|P3|Main Period|Withdrawal by Subject|3
1728605|NCT01020123|6028983|P2|Main Period|Withdrawal by Subject|5
1728606|NCT01020123|6028984|P1|Main Period|Withdrawal by Subject|6
1728607|NCT01020019|6029179|P2|Overall Study|moving|2
1728608|NCT01020019|6029180|P1|Overall Study|moving|0
1728609|NCT01020019|6029179|P2|Overall Study|not interested in treatment|4
1728610|NCT01020019|6029180|P1|Overall Study|not interested in treatment|4
1728611|NCT01020019|6029179|P2|Overall Study|Adverse Event|5
1728612|NCT01020019|6029180|P1|Overall Study|Adverse Event|1
1728613|NCT01020019|6029179|P2|Overall Study|Lost to Follow-up|18
1728614|NCT01020019|6029180|P1|Overall Study|Lost to Follow-up|21
1728615|NCT01019980|6029201|P2|Overall Study|Drug not available.|0
1728616|NCT01019980|6029202|P1|Overall Study|Drug not available.|2
1728617|NCT01019694|6029265|P3|Overall Study|Other reason (not specified)|6
1728618|NCT01019694|6029266|P2|Overall Study|Other reason (not specified)|5
1728619|NCT01019694|6029267|P1|Overall Study|Other reason (not specified)|1
1728620|NCT01019694|6029265|P3|Overall Study|Not treated|3
1728621|NCT01019694|6029266|P2|Overall Study|Not treated|2
1728622|NCT01019694|6029267|P1|Overall Study|Not treated|0
1728623|NCT01019694|6029265|P3|Overall Study|Withdrawal by Subject|12
1728624|NCT01019694|6029266|P2|Overall Study|Withdrawal by Subject|6
1728625|NCT01019694|6029267|P1|Overall Study|Withdrawal by Subject|4
1728626|NCT01019694|6029265|P3|Overall Study|Lost to Follow-up|3
1728627|NCT01019694|6029266|P2|Overall Study|Lost to Follow-up|3
1728628|NCT01019694|6029267|P1|Overall Study|Lost to Follow-up|5
1728629|NCT01019694|6029265|P3|Overall Study|Protocol Violation|4
1728630|NCT01019694|6029266|P2|Overall Study|Protocol Violation|6
1728631|NCT01019694|6029267|P1|Overall Study|Protocol Violation|2
1728632|NCT01019694|6029265|P3|Overall Study|Adverse Event|19
1728633|NCT01019694|6029266|P2|Overall Study|Adverse Event|16
1728634|NCT01019694|6029267|P1|Overall Study|Adverse Event|12
1728635|NCT01019486|6029392|P3|Overall Study|Withdrawal by Subject|1
1728636|NCT01019486|6029393|P2|Overall Study|Withdrawal by Subject|1
1728637|NCT01019486|6029394|P1|Overall Study|Withdrawal by Subject|1
1728638|NCT01019369|6029408|P2|Overall Study|Withdrawal by Subject|1
1728639|NCT01019369|6029409|P1|Overall Study|Withdrawal by Subject|0
1728640|NCT01019369|6029408|P2|Overall Study|Lost to Follow-up|6
1728641|NCT01019369|6029409|P1|Overall Study|Lost to Follow-up|10
1728642|NCT01019317|6029425|P1|Overall Study|Not Eligible|4
1728643|NCT01019252|6029431|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
1728644|NCT01019252|6029432|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
1728645|NCT01019252|6029431|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
1728646|NCT01019252|6029432|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
1728647|NCT01019252|6029431|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
1728648|NCT01019252|6029432|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
1728649|NCT01019252|6029431|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
1728650|NCT01019252|6029432|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
1728651|NCT01019135|6029445|P3|Overall Study|Did not attend CR|6
1728652|NCT01019135|6029446|P2|Overall Study|Did not attend CR|13
1728653|NCT01019135|6029447|P1|Overall Study|Did not attend CR|8
1728654|NCT01019135|6029445|P3|Overall Study|Did not receive allocated intervention|25
1728655|NCT01019135|6029446|P2|Overall Study|Did not receive allocated intervention|6
1728656|NCT01019135|6029447|P1|Overall Study|Did not receive allocated intervention|12
1728657|NCT01018992|6029475|P2|Overall Study|Lost to Follow-up|1
1728658|NCT01018992|6029476|P1|Overall Study|Lost to Follow-up|5
1728659|NCT01018992|6029475|P2|Overall Study|Protocol Violation|4
1728660|NCT01018992|6029476|P1|Overall Study|Protocol Violation|0
1728661|NCT01018992|6029475|P2|Overall Study|Withdrawal by Subject|8
1728662|NCT01018992|6029476|P1|Overall Study|Withdrawal by Subject|3
1728663|NCT01018992|6029475|P2|Overall Study|Adverse Event|3
1728664|NCT01018992|6029476|P1|Overall Study|Adverse Event|8
1728665|NCT01018979|6029490|P2|Overall Study|Not received at least one dose|1
1728666|NCT01018979|6029491|P1|Overall Study|Not received at least one dose|0
1728667|NCT01018979|6029490|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
1728668|NCT01018979|6029491|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
1728669|NCT01018953|6029521|P1|Overall Study|Study termination by sponsor|5
1728670|NCT01018953|6029521|P1|Overall Study|Withdrawal by Subject|1
1728671|NCT01018953|6029521|P1|Overall Study|Adverse Event|2
1728672|NCT01018862|6029534|P3|Overall Study|administrative problems|4
1728673|NCT01018862|6029535|P2|Overall Study|administrative problems|4
1728674|NCT01018862|6029536|P1|Overall Study|administrative problems|5
1728675|NCT01018862|6029534|P3|Overall Study|Withdrawal by Subject|1
1728676|NCT01018862|6029535|P2|Overall Study|Withdrawal by Subject|2
1728677|NCT01018862|6029536|P1|Overall Study|Withdrawal by Subject|1
1728678|NCT01018862|6029534|P3|Overall Study|Protocol Violation|3
1728679|NCT01018862|6029535|P2|Overall Study|Protocol Violation|3
1728680|NCT01018862|6029536|P1|Overall Study|Protocol Violation|1
1728681|NCT01018862|6029534|P3|Overall Study|Lost to Follow-up|0
1728682|NCT01018862|6029535|P2|Overall Study|Lost to Follow-up|1
1728683|NCT01018862|6029536|P1|Overall Study|Lost to Follow-up|3
1728684|NCT01018862|6029534|P3|Overall Study|Lack of Efficacy|2
1728685|NCT01018862|6029535|P2|Overall Study|Lack of Efficacy|0
1728686|NCT01018862|6029536|P1|Overall Study|Lack of Efficacy|1
1728687|NCT01018862|6029534|P3|Overall Study|Adverse Event|6
1728688|NCT01018862|6029535|P2|Overall Study|Adverse Event|0
1728689|NCT01018862|6029536|P1|Overall Study|Adverse Event|2
1728690|NCT01018810|6029558|P5|Overall Study|Sponsor Decision|1
1728691|NCT01018810|6029559|P4|Overall Study|Sponsor Decision|1
1728692|NCT01018810|6029560|P3|Overall Study|Sponsor Decision|1
1728693|NCT01018810|6029561|P2|Overall Study|Sponsor Decision|0
1728694|NCT01018810|6029562|P1|Overall Study|Sponsor Decision|2
1728695|NCT01018810|6029558|P5|Overall Study|Withdrawal by Subject|0
1728696|NCT01018810|6029559|P4|Overall Study|Withdrawal by Subject|0
1728697|NCT01018810|6029560|P3|Overall Study|Withdrawal by Subject|0
1728698|NCT01018810|6029561|P2|Overall Study|Withdrawal by Subject|1
1728699|NCT01018810|6029562|P1|Overall Study|Withdrawal by Subject|0
1728700|NCT01018732|6029622|P3|Overall Study|Unable to Classify|1
1728701|NCT01018732|6029623|P2|Overall Study|Unable to Classify|0
1728702|NCT01018732|6029624|P1|Overall Study|Unable to Classify|0
1728703|NCT01018732|6029622|P3|Overall Study|Inappropriate Enrollment|0
1728704|NCT01018732|6029623|P2|Overall Study|Inappropriate Enrollment|1
1728705|NCT01018732|6029624|P1|Overall Study|Inappropriate Enrollment|0
1728706|NCT01018732|6029622|P3|Overall Study|Protocol Violation|0
1728707|NCT01018732|6029623|P2|Overall Study|Protocol Violation|1
1728708|NCT01018732|6029624|P1|Overall Study|Protocol Violation|1
1728709|NCT01018732|6029622|P3|Overall Study|Lost to Follow-up|3
1728710|NCT01018732|6029623|P2|Overall Study|Lost to Follow-up|0
1728711|NCT01018732|6029624|P1|Overall Study|Lost to Follow-up|0
1728712|NCT01018680|6029658|P2|Overall Study|Physician Decision|1
1728713|NCT01018680|6029659|P1|Overall Study|Physician Decision|3
1728714|NCT01018680|6029658|P2|Overall Study|Entry Criteria Not Met|4
1728715|NCT01018680|6029659|P1|Overall Study|Entry Criteria Not Met|1
1728716|NCT01018680|6029658|P2|Overall Study|Lost to Follow-up|3
1728717|NCT01018680|6029659|P1|Overall Study|Lost to Follow-up|5
1728718|NCT01018680|6029658|P2|Overall Study|Lack of Efficacy|2
1728719|NCT01018680|6029659|P1|Overall Study|Lack of Efficacy|8
1728720|NCT01018680|6029658|P2|Overall Study|Sponsor Decision|7
1728721|NCT01018680|6029659|P1|Overall Study|Sponsor Decision|6
1728722|NCT01018680|6029658|P2|Overall Study|Protocol Violation|8
1728723|NCT01018680|6029659|P1|Overall Study|Protocol Violation|5
1728724|NCT01018680|6029658|P2|Overall Study|Withdrawal by Subject|10
1728725|NCT01018680|6029659|P1|Overall Study|Withdrawal by Subject|10
1728726|NCT01018680|6029658|P2|Overall Study|Adverse Event|40
1728727|NCT01018680|6029659|P1|Overall Study|Adverse Event|23
1728728|NCT01020487|6029702|P3|Part 2 Open-label Period|Adverse Event|1
1728729|NCT01020487|6029703|P2|Part 2 Open-label Period|Adverse Event|4
1728730|NCT01020487|6029704|P1|Part 2 Open-label Period|Adverse Event|0
1728731|NCT01020487|6029702|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
1728732|NCT01020487|6029703|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
1728733|NCT01020487|6029704|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
1728734|NCT01020487|6029702|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
1728735|NCT01020487|6029703|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
1728736|NCT01020487|6029704|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
1728737|NCT01020487|6029702|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
1728738|NCT01020487|6029703|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
1728739|NCT01020487|6029704|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
1728740|NCT01020487|6029702|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
1728741|NCT01020487|6029703|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
1728742|NCT01020487|6029704|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
1728743|NCT01018511|6029729|P4|Overall Study|Miscellaneous|0
1728744|NCT01018511|6029730|P3|Overall Study|Miscellaneous|0
1728745|NCT01018511|6029731|P2|Overall Study|Miscellaneous|2
1728746|NCT01018511|6029732|P1|Overall Study|Miscellaneous|0
1728747|NCT01018511|6029729|P4|Overall Study|Protocol Violation|9
1728748|NCT01018511|6029730|P3|Overall Study|Protocol Violation|7
1728749|NCT01018511|6029731|P2|Overall Study|Protocol Violation|8
1728750|NCT01018511|6029732|P1|Overall Study|Protocol Violation|5
1728751|NCT01018511|6029729|P4|Overall Study|Lost to Follow-up|0
1728752|NCT01018511|6029730|P3|Overall Study|Lost to Follow-up|1
1728753|NCT01018511|6029731|P2|Overall Study|Lost to Follow-up|0
1728754|NCT01018511|6029732|P1|Overall Study|Lost to Follow-up|0
1728755|NCT01018511|6029729|P4|Overall Study|Withdrawal by Subject|9
1728756|NCT01018511|6029730|P3|Overall Study|Withdrawal by Subject|11
1728757|NCT01018511|6029731|P2|Overall Study|Withdrawal by Subject|5
1728758|NCT01018511|6029732|P1|Overall Study|Withdrawal by Subject|6
1728759|NCT01018511|6029729|P4|Overall Study|Lack of Efficacy|2
1728760|NCT01018511|6029730|P3|Overall Study|Lack of Efficacy|1
1728761|NCT01018511|6029731|P2|Overall Study|Lack of Efficacy|1
1728762|NCT01018511|6029732|P1|Overall Study|Lack of Efficacy|4
1728763|NCT01018511|6029729|P4|Overall Study|Adverse Event|10
1728764|NCT01018511|6029730|P3|Overall Study|Adverse Event|13
1728765|NCT01018511|6029731|P2|Overall Study|Adverse Event|9
1728766|NCT01018511|6029732|P1|Overall Study|Adverse Event|5
1728767|NCT01018511|6029729|P4|Overall Study|Not fulfilling eligibility criteria|3
1728768|NCT01018511|6029730|P3|Overall Study|Not fulfilling eligibility criteria|7
1728769|NCT01018511|6029731|P2|Overall Study|Not fulfilling eligibility criteria|7
1728770|NCT01018511|6029732|P1|Overall Study|Not fulfilling eligibility criteria|6
1728771|NCT01018394|6029929|P2|Overall Study|Lost to Follow-up|3
1728772|NCT01018394|6029930|P1|Overall Study|Lost to Follow-up|4
1728773|NCT01018394|6029929|P2|Overall Study|Withdrawal by Subject|5
1728774|NCT01018394|6029930|P1|Overall Study|Withdrawal by Subject|5
1728775|NCT01018264|6029940|P2|Overall Study|Lost to Follow-up|1
1728776|NCT01018264|6029941|P1|Overall Study|Lost to Follow-up|0
1728777|NCT01018264|6029940|P2|Overall Study|Withdrawal by Subject|0
1728778|NCT01018264|6029941|P1|Overall Study|Withdrawal by Subject|1
1728779|NCT01018186|6029958|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
1728780|NCT01018186|6029959|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
1728781|NCT01018186|6029960|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
1728782|NCT01018186|6029961|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
1728783|NCT01018186|6029958|P4|52-week Double-blind Treatment Period|Physician Decision|3
1728784|NCT01018186|6029959|P3|52-week Double-blind Treatment Period|Physician Decision|0
1728785|NCT01018186|6029960|P2|52-week Double-blind Treatment Period|Physician Decision|1
1728786|NCT01018186|6029961|P1|52-week Double-blind Treatment Period|Physician Decision|0
1728787|NCT01018186|6029958|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
1728788|NCT01018186|6029959|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
1728789|NCT01018186|6029960|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
1728790|NCT01018186|6029961|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
1728791|NCT01018186|6029958|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
1728792|NCT01018186|6029959|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
1728793|NCT01018186|6029960|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
1728794|NCT01018186|6029961|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
1728795|NCT01018186|6029958|P4|52-week Double-blind Treatment Period|Protocol Violation|2
1728796|NCT01018186|6029959|P3|52-week Double-blind Treatment Period|Protocol Violation|8
1728797|NCT01018186|6029960|P2|52-week Double-blind Treatment Period|Protocol Violation|8
1728798|NCT01018186|6029961|P1|52-week Double-blind Treatment Period|Protocol Violation|0
1728799|NCT01018186|6029958|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
1728800|NCT01018186|6029959|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
1728801|NCT01018186|6029960|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
1728802|NCT01018186|6029961|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
1728803|NCT01018186|6029958|P4|52-week Double-blind Treatment Period|Adverse Event|6
1728804|NCT01018186|6029959|P3|52-week Double-blind Treatment Period|Adverse Event|3
1728805|NCT01018186|6029960|P2|52-week Double-blind Treatment Period|Adverse Event|5
1728806|NCT01018186|6029961|P1|52-week Double-blind Treatment Period|Adverse Event|0
1728807|NCT01018186|6029958|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1728808|NCT01018186|6029959|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1728809|NCT01018186|6029960|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1728810|NCT01018186|6029961|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
1728811|NCT01018186|6029958|P4|2-week Run-in Period|Withdrawal by Subject|0
1728812|NCT01018186|6029959|P3|2-week Run-in Period|Withdrawal by Subject|0
1728813|NCT01018186|6029960|P2|2-week Run-in Period|Withdrawal by Subject|0
1728814|NCT01018186|6029961|P1|2-week Run-in Period|Withdrawal by Subject|11
1728815|NCT01018186|6029958|P4|2-week Run-in Period|Physician Decision|0
1728816|NCT01018186|6029959|P3|2-week Run-in Period|Physician Decision|0
1728817|NCT01018186|6029960|P2|2-week Run-in Period|Physician Decision|0
1728818|NCT01018186|6029961|P1|2-week Run-in Period|Physician Decision|3
1728819|NCT01018186|6029958|P4|2-week Run-in Period|Lost to Follow-up|0
1728820|NCT01018186|6029959|P3|2-week Run-in Period|Lost to Follow-up|0
1728821|NCT01018186|6029960|P2|2-week Run-in Period|Lost to Follow-up|0
1728822|NCT01018186|6029961|P1|2-week Run-in Period|Lost to Follow-up|2
1728823|NCT01018186|6029958|P4|2-week Run-in Period|Protocol Violation|0
1728824|NCT01018186|6029959|P3|2-week Run-in Period|Protocol Violation|0
1728825|NCT01018186|6029960|P2|2-week Run-in Period|Protocol Violation|0
1728826|NCT01018186|6029961|P1|2-week Run-in Period|Protocol Violation|1
1728827|NCT01018030|6030162|P3|Overall Study|Did Not Receive Study Drug|0
1728828|NCT01018030|6030163|P2|Overall Study|Did Not Receive Study Drug|3
1728829|NCT01018030|6030164|P1|Overall Study|Did Not Receive Study Drug|1
1728830|NCT01018030|6030162|P3|Overall Study|Lack of Efficacy|0
1728831|NCT01018030|6030163|P2|Overall Study|Lack of Efficacy|0
1728832|NCT01018030|6030164|P1|Overall Study|Lack of Efficacy|1
1728833|NCT01018030|6030162|P3|Overall Study|Physician Decision|1
1728834|NCT01018030|6030163|P2|Overall Study|Physician Decision|0
1728835|NCT01018030|6030164|P1|Overall Study|Physician Decision|1
1728836|NCT01018030|6030162|P3|Overall Study|Protocol Violation|0
1728837|NCT01018030|6030163|P2|Overall Study|Protocol Violation|1
1728838|NCT01018030|6030164|P1|Overall Study|Protocol Violation|2
1728839|NCT01018030|6030162|P3|Overall Study|Lost to Follow-up|3
1728840|NCT01018030|6030163|P2|Overall Study|Lost to Follow-up|0
1728841|NCT01018030|6030164|P1|Overall Study|Lost to Follow-up|2
1728842|NCT01018030|6030162|P3|Overall Study|Withdrawal by Subject|4
1728843|NCT01018030|6030163|P2|Overall Study|Withdrawal by Subject|2
1728844|NCT01018030|6030164|P1|Overall Study|Withdrawal by Subject|2
1728845|NCT01018030|6030162|P3|Overall Study|Adverse Event|5
1728846|NCT01018030|6030163|P2|Overall Study|Adverse Event|5
1728847|NCT01018030|6030164|P1|Overall Study|Adverse Event|10
1728848|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Physician Decision|7
1728849|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Physician Decision|9
1728850|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Physician Decision|8
1728851|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Physician Decision|10
1728852|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Physician Decision|0
1728853|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
1728854|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1728855|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
1728856|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1728857|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
1728858|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1728859|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1728860|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1728861|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1728862|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1728863|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
1728864|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
1728865|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1728866|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
1728867|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1728868|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
1728869|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
1728870|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
1728871|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
1728872|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
1728873|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
1728874|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
1728875|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
1728876|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
1728877|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
1728878|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
1728879|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
1728880|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
1728881|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
1728882|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
1728883|NCT01017952|6030215|P5|52-week, Double-blind Treatment Period|Adverse Event|30
1728884|NCT01017952|6030216|P4|52-week, Double-blind Treatment Period|Adverse Event|35
1728885|NCT01017952|6030217|P3|52-week, Double-blind Treatment Period|Adverse Event|32
1728886|NCT01017952|6030218|P2|52-week, Double-blind Treatment Period|Adverse Event|25
1728887|NCT01017952|6030219|P1|52-week, Double-blind Treatment Period|Adverse Event|0
1728888|NCT01017952|6030215|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1728889|NCT01017952|6030216|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1728890|NCT01017952|6030217|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1728891|NCT01017952|6030218|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1728892|NCT01017952|6030219|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
1728893|NCT01017952|6030215|P5|4-week, Open-label Run-In Period|Physician Decision|0
1728894|NCT01017952|6030216|P4|4-week, Open-label Run-In Period|Physician Decision|0
1728895|NCT01017952|6030217|P3|4-week, Open-label Run-In Period|Physician Decision|0
1728896|NCT01017952|6030218|P2|4-week, Open-label Run-In Period|Physician Decision|0
1728897|NCT01017952|6030219|P1|4-week, Open-label Run-In Period|Physician Decision|10
1728898|NCT01017952|6030215|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
1728899|NCT01017952|6030216|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
1728900|NCT01017952|6030217|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
1728901|NCT01017952|6030218|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
1728902|NCT01017952|6030219|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
1728903|NCT01017952|6030215|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1728904|NCT01017952|6030216|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1728905|NCT01017952|6030217|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1728906|NCT01017952|6030218|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
1728907|NCT01017952|6030219|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
1728908|NCT01017952|6030215|P5|4-week, Open-label Run-In Period|Adverse Event|0
1728909|NCT01017952|6030216|P4|4-week, Open-label Run-In Period|Adverse Event|0
1728910|NCT01017952|6030217|P3|4-week, Open-label Run-In Period|Adverse Event|0
1728911|NCT01017952|6030218|P2|4-week, Open-label Run-In Period|Adverse Event|0
1728912|NCT01017952|6030219|P1|4-week, Open-label Run-In Period|Adverse Event|23
1728913|NCT01017952|6030215|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1728914|NCT01017952|6030216|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1728915|NCT01017952|6030217|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1728916|NCT01017952|6030218|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1728917|NCT01017952|6030219|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
1728918|NCT01017874|6030243|P2|Overall Study|Physician Decision|3
1728919|NCT01017874|6030244|P1|Overall Study|Physician Decision|1
1728920|NCT01017874|6030243|P2|Overall Study|Lost to Follow-up|2
1728921|NCT01017874|6030244|P1|Overall Study|Lost to Follow-up|3
1728922|NCT01017874|6030243|P2|Overall Study|Sponsor decision|1
1728923|NCT01017874|6030244|P1|Overall Study|Sponsor decision|3
1728924|NCT01017874|6030243|P2|Overall Study|Withdrawal by Subject|20
1728925|NCT01017874|6030244|P1|Overall Study|Withdrawal by Subject|23
1728926|NCT01017731|6030262|P1|Overall Study|Adverse Event|1
1728927|NCT01017731|6030262|P1|Overall Study|Physician Decision|2
1728928|NCT01017731|6030262|P1|Overall Study|Withdrawal by Subject|3
1728929|NCT01017731|6030262|P1|Overall Study|Lost to Follow-up|2
1728930|NCT01017601|6030291|P2|Overall Study|Withdrawal by Subject|1
1728931|NCT01017601|6030292|P1|Overall Study|Withdrawal by Subject|0
1728932|NCT01017601|6030291|P2|Overall Study|Disease Progression|12
1728933|NCT01017601|6030292|P1|Overall Study|Disease Progression|12
1728934|NCT01017575|6030319|P5|Overall Study|Withdrawal by Subject|0
1728935|NCT01017575|6030320|P4|Overall Study|Withdrawal by Subject|0
1728936|NCT01017575|6030321|P3|Overall Study|Withdrawal by Subject|0
1728937|NCT01017575|6030322|P2|Overall Study|Withdrawal by Subject|0
1728938|NCT01017575|6030323|P1|Overall Study|Withdrawal by Subject|1
1728939|NCT01017575|6030319|P5|Overall Study|Adverse Event|2
1728940|NCT01017575|6030320|P4|Overall Study|Adverse Event|0
1728941|NCT01017575|6030321|P3|Overall Study|Adverse Event|0
1728942|NCT01017575|6030322|P2|Overall Study|Adverse Event|1
1728943|NCT01017575|6030323|P1|Overall Study|Adverse Event|0
1728944|NCT01017575|6030319|P5|Overall Study|Lack of Efficacy|1
1728945|NCT01017575|6030320|P4|Overall Study|Lack of Efficacy|1
1728946|NCT01017575|6030321|P3|Overall Study|Lack of Efficacy|0
1728947|NCT01017575|6030322|P2|Overall Study|Lack of Efficacy|1
1728948|NCT01017575|6030323|P1|Overall Study|Lack of Efficacy|0
1728949|NCT01017549|6030360|P1|One-year Follow-up|Withdrawal by Subject|5
1728950|NCT01017549|6030360|P1|One-year Follow-up|Lost to Follow-up|2
1728951|NCT01017549|6030360|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
1728952|NCT01017263|6030391|P1|Overall Study|not eligible|12
1728953|NCT01017146|6030472|P2|Overall Study|Change in Work Situation|0
1728954|NCT01017146|6030473|P1|Overall Study|Change in Work Situation|1
1728955|NCT01017146|6030472|P2|Overall Study|Did Not Meet Eligibility Criteria|2
1728956|NCT01017146|6030473|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1728957|NCT01017146|6030472|P2|Overall Study|Took Excluded Medication|0
1728958|NCT01017146|6030473|P1|Overall Study|Took Excluded Medication|2
1728959|NCT01017146|6030472|P2|Overall Study|Protocol Violation|0
1728960|NCT01017146|6030473|P1|Overall Study|Protocol Violation|2
1728961|NCT01017146|6030472|P2|Overall Study|Pregnancy|1
1728962|NCT01017146|6030473|P1|Overall Study|Pregnancy|2
1728963|NCT01017146|6030472|P2|Overall Study|Relocation|4
1728964|NCT01017146|6030473|P1|Overall Study|Relocation|0
1728965|NCT01017146|6030472|P2|Overall Study|Withdrawal by Subject|16
1728966|NCT01017146|6030473|P1|Overall Study|Withdrawal by Subject|32
1728967|NCT01017146|6030472|P2|Overall Study|Noncompliance with Study Product|1
1728968|NCT01017146|6030473|P1|Overall Study|Noncompliance with Study Product|1
1728969|NCT01017146|6030472|P2|Overall Study|Lost to Follow-up|14
1728970|NCT01017146|6030473|P1|Overall Study|Lost to Follow-up|14
1728971|NCT01017146|6030472|P2|Overall Study|Adverse Event|1
1728972|NCT01017146|6030473|P1|Overall Study|Adverse Event|11
1728973|NCT01017120|6030511|P2|Overall Study|Parent Unable to Provide Transportation|0
1728974|NCT01017120|6030512|P1|Overall Study|Parent Unable to Provide Transportation|1
1728975|NCT01017120|6030511|P2|Overall Study|Protocol Violation|0
1728976|NCT01017120|6030512|P1|Overall Study|Protocol Violation|1
1728977|NCT01017120|6030511|P2|Overall Study|Relocated Out of Town|2
1728978|NCT01017120|6030512|P1|Overall Study|Relocated Out of Town|0
1728979|NCT01017120|6030511|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1728980|NCT01017120|6030512|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1728981|NCT01017120|6030511|P2|Overall Study|Pregnancy|1
1728982|NCT01017120|6030512|P1|Overall Study|Pregnancy|1
1728983|NCT01017120|6030511|P2|Overall Study|Withdrawal by Subject|21
1728984|NCT01017120|6030512|P1|Overall Study|Withdrawal by Subject|39
1728985|NCT01017120|6030511|P2|Overall Study|Lack of Efficacy|0
1728986|NCT01017120|6030512|P1|Overall Study|Lack of Efficacy|1
1728987|NCT01017120|6030511|P2|Overall Study|Lost to Follow-up|11
1728988|NCT01017120|6030512|P1|Overall Study|Lost to Follow-up|13
1728989|NCT01017120|6030511|P2|Overall Study|Adverse Event|0
1728990|NCT01017120|6030512|P1|Overall Study|Adverse Event|9
1728991|NCT01017029|6030573|P2|Overall Study|Death|1
1728992|NCT01017029|6030574|P1|Overall Study|Death|3
1728993|NCT01017029|6030573|P2|Overall Study|Administrative problem|1
1728994|NCT01017029|6030574|P1|Overall Study|Administrative problem|0
1728995|NCT01017029|6030573|P2|Overall Study|Lost to Follow-up|0
1728996|NCT01017029|6030574|P1|Overall Study|Lost to Follow-up|1
1728997|NCT01016977|6030602|P2|Overall Study|Withdrawal by Subject|2
1728998|NCT01016977|6030603|P1|Overall Study|Withdrawal by Subject|2
1728999|NCT01016977|6030602|P2|Overall Study|Lost to Follow-up|0
1729000|NCT01016977|6030603|P1|Overall Study|Lost to Follow-up|1
1729001|NCT01016964|6030639|P2|Overall Study|Lost to Follow-up|3
1729002|NCT01016964|6030640|P1|Overall Study|Lost to Follow-up|3
1729003|NCT01016912|6030656|P5|Follow-up Period|Other reason|0
1729004|NCT01016912|6030657|P4|Follow-up Period|Other reason|1
1729005|NCT01016912|6030658|P3|Follow-up Period|Other reason|1
1729006|NCT01016912|6030659|P2|Follow-up Period|Other reason|0
1729007|NCT01016912|6030660|P1|Follow-up Period|Other reason|0
1729008|NCT01016912|6030656|P5|End of Treatment Period|Completed double-blind period only|0
1729009|NCT01016912|6030657|P4|End of Treatment Period|Completed double-blind period only|0
1729010|NCT01016912|6030658|P3|End of Treatment Period|Completed double-blind period only|0
1729011|NCT01016912|6030659|P2|End of Treatment Period|Completed double-blind period only|1
1729012|NCT01016912|6030660|P1|End of Treatment Period|Completed double-blind period only|0
1729013|NCT01016912|6030656|P5|End of Treatment Period|Adverse Event|0
1729014|NCT01016912|6030657|P4|End of Treatment Period|Adverse Event|0
1729015|NCT01016912|6030658|P3|End of Treatment Period|Adverse Event|1
1729016|NCT01016912|6030659|P2|End of Treatment Period|Adverse Event|1
1729017|NCT01016912|6030660|P1|End of Treatment Period|Adverse Event|0
1729018|NCT01016912|6030656|P5|End of Treatment Period|Lack of Efficacy|4
1729019|NCT01016912|6030657|P4|End of Treatment Period|Lack of Efficacy|4
1729020|NCT01016912|6030658|P3|End of Treatment Period|Lack of Efficacy|0
1729021|NCT01016912|6030659|P2|End of Treatment Period|Lack of Efficacy|1
1729022|NCT01016912|6030660|P1|End of Treatment Period|Lack of Efficacy|0
1729023|NCT01016600|6030839|P4|Overall Study|Did not start treatment|0
1729024|NCT01016600|6030840|P3|Overall Study|Did not start treatment|0
1729025|NCT01016600|6030841|P2|Overall Study|Did not start treatment|0
1729026|NCT01016600|6030842|P1|Overall Study|Did not start treatment|1
1729027|NCT01016262|6031030|P6|Open-Label Phase|Withdrawal of Informed Consent|0
1729028|NCT01016262|6031031|P5|Open-Label Phase|Withdrawal of Informed Consent|1
1729029|NCT01016262|6031032|P4|Open-Label Phase|Withdrawal of Informed Consent|0
1729030|NCT01016262|6031033|P3|Open-Label Phase|Withdrawal of Informed Consent|0
1729031|NCT01016262|6031034|P2|Open-Label Phase|Withdrawal of Informed Consent|0
1729032|NCT01016262|6031035|P1|Open-Label Phase|Withdrawal of Informed Consent|0
1729033|NCT01016262|6031030|P6|Open-Label Phase|Lack of Efficacy|0
1729034|NCT01016262|6031031|P5|Open-Label Phase|Lack of Efficacy|0
1729035|NCT01016262|6031032|P4|Open-Label Phase|Lack of Efficacy|1
1729036|NCT01016262|6031033|P3|Open-Label Phase|Lack of Efficacy|0
1729037|NCT01016262|6031034|P2|Open-Label Phase|Lack of Efficacy|0
1729038|NCT01016262|6031035|P1|Open-Label Phase|Lack of Efficacy|0
1729039|NCT01016262|6031030|P6|Open-Label Phase|Lost to Follow-up|0
1729040|NCT01016262|6031031|P5|Open-Label Phase|Lost to Follow-up|1
1729041|NCT01016262|6031032|P4|Open-Label Phase|Lost to Follow-up|0
1729042|NCT01016262|6031033|P3|Open-Label Phase|Lost to Follow-up|0
1729043|NCT01016262|6031034|P2|Open-Label Phase|Lost to Follow-up|0
1729044|NCT01016262|6031035|P1|Open-Label Phase|Lost to Follow-up|0
1729045|NCT01016262|6031030|P6|Open-Label Phase|Adverse Event|0
1729046|NCT01016262|6031031|P5|Open-Label Phase|Adverse Event|0
1729047|NCT01016262|6031032|P4|Open-Label Phase|Adverse Event|1
1729048|NCT01016262|6031033|P3|Open-Label Phase|Adverse Event|0
1729049|NCT01016262|6031034|P2|Open-Label Phase|Adverse Event|0
1729050|NCT01016262|6031035|P1|Open-Label Phase|Adverse Event|0
1729051|NCT01016262|6031030|P6|Double-blind Phase|Withdrawal of Informed Consent|0
1729052|NCT01016262|6031031|P5|Double-blind Phase|Withdrawal of Informed Consent|0
1729053|NCT01016262|6031032|P4|Double-blind Phase|Withdrawal of Informed Consent|0
1729054|NCT01016262|6031033|P3|Double-blind Phase|Withdrawal of Informed Consent|1
1729055|NCT01016262|6031034|P2|Double-blind Phase|Withdrawal of Informed Consent|0
1729056|NCT01016262|6031035|P1|Double-blind Phase|Withdrawal of Informed Consent|0
1729057|NCT01016262|6031030|P6|Double-blind Phase|Disease Progression|0
1729058|NCT01016262|6031031|P5|Double-blind Phase|Disease Progression|0
1729059|NCT01016262|6031032|P4|Double-blind Phase|Disease Progression|0
1729060|NCT01016262|6031033|P3|Double-blind Phase|Disease Progression|2
1729061|NCT01016262|6031034|P2|Double-blind Phase|Disease Progression|1
1729062|NCT01016262|6031035|P1|Double-blind Phase|Disease Progression|0
1729063|NCT01016262|6031030|P6|Double-blind Phase|Lack of Efficacy|0
1729064|NCT01016262|6031031|P5|Double-blind Phase|Lack of Efficacy|0
1729065|NCT01016262|6031032|P4|Double-blind Phase|Lack of Efficacy|0
1729066|NCT01016262|6031033|P3|Double-blind Phase|Lack of Efficacy|5
1729067|NCT01016262|6031034|P2|Double-blind Phase|Lack of Efficacy|0
1729068|NCT01016262|6031035|P1|Double-blind Phase|Lack of Efficacy|1
1729069|NCT01016262|6031030|P6|Double-blind Phase|Adverse Event|0
1729070|NCT01016262|6031031|P5|Double-blind Phase|Adverse Event|0
1729071|NCT01016262|6031032|P4|Double-blind Phase|Adverse Event|0
1729072|NCT01016262|6031033|P3|Double-blind Phase|Adverse Event|1
1729073|NCT01016262|6031034|P2|Double-blind Phase|Adverse Event|0
1729074|NCT01016262|6031035|P1|Double-blind Phase|Adverse Event|0
1729075|NCT01016132|6031058|P1|Overall Study|Discomfort|1
1729076|NCT01016067|6031073|P2|Overall Study|Withdrew due to Relocation|1
1729077|NCT01016067|6031074|P1|Overall Study|Withdrew due to Relocation|0
1729078|NCT01016067|6031073|P2|Overall Study|Physician Decision|1
1729079|NCT01016067|6031074|P1|Overall Study|Physician Decision|1
1729080|NCT01016067|6031073|P2|Overall Study|Lost to Follow-up|2
1729081|NCT01016067|6031074|P1|Overall Study|Lost to Follow-up|1
1729082|NCT01016015|6031092|P1|Overall Study|Adverse Event|15
1729083|NCT01016015|6031092|P1|Overall Study|Withdrawal by Subject|1
1729084|NCT01016015|6031092|P1|Overall Study|Not Treated|3
1729101|NCT01015820|6031120|P2|Overall Study|Suboptimal measurements|0
1729102|NCT01015820|6031121|P1|Overall Study|Suboptimal measurements|1
1729103|NCT01015703|6031156|P5|Overall Study|Protocol Violation|0
1729104|NCT01015703|6031157|P4|Overall Study|Protocol Violation|0
1729105|NCT01015703|6031158|P3|Overall Study|Protocol Violation|0
1729106|NCT01015703|6031159|P2|Overall Study|Protocol Violation|0
1729107|NCT01015703|6031160|P1|Overall Study|Protocol Violation|1
1729108|NCT01015703|6031156|P5|Overall Study|Adverse Event|0
1729109|NCT01015703|6031157|P4|Overall Study|Adverse Event|0
1729110|NCT01015703|6031158|P3|Overall Study|Adverse Event|0
1729111|NCT01015703|6031159|P2|Overall Study|Adverse Event|0
1729112|NCT01015703|6031160|P1|Overall Study|Adverse Event|1
1729113|NCT01015703|6031156|P5|Overall Study|Withdrawal by Subject|0
1729114|NCT01015703|6031157|P4|Overall Study|Withdrawal by Subject|0
1729115|NCT01015703|6031158|P3|Overall Study|Withdrawal by Subject|0
1729116|NCT01015703|6031159|P2|Overall Study|Withdrawal by Subject|1
1729117|NCT01015703|6031160|P1|Overall Study|Withdrawal by Subject|0
1729118|NCT01015677|6031175|P3|Overall Study|Withdrawal by Subject|0
1729119|NCT01015677|6031176|P2|Overall Study|Withdrawal by Subject|1
1729120|NCT01015677|6031177|P1|Overall Study|Withdrawal by Subject|1
1729121|NCT01015677|6031175|P3|Overall Study|Protocol Violation|0
1729122|NCT01015677|6031176|P2|Overall Study|Protocol Violation|1
1729123|NCT01015677|6031177|P1|Overall Study|Protocol Violation|0
1729124|NCT01015677|6031175|P3|Overall Study|Lack of Efficacy|0
1729125|NCT01015677|6031176|P2|Overall Study|Lack of Efficacy|1
1729126|NCT01015677|6031177|P1|Overall Study|Lack of Efficacy|0
1729127|NCT01015677|6031175|P3|Overall Study|Adverse Event|0
1729128|NCT01015677|6031176|P2|Overall Study|Adverse Event|1
1729129|NCT01015677|6031177|P1|Overall Study|Adverse Event|0
1729130|NCT01015638|6031199|P2|Overall Study|Withdrawal by Subject|0
1729131|NCT01015638|6031200|P1|Overall Study|Withdrawal by Subject|1
1729132|NCT01015612|6031228|P1|Overall Study|Withdrawal by Subject|40
1729133|NCT01015612|6031228|P1|Overall Study|Death|113
1729134|NCT01015560|6031259|P1|Overall Study|Withdrawal by Subject|1
1729135|NCT01015560|6031259|P1|Overall Study|Not protocol specified|1
1729136|NCT01015560|6031259|P1|Overall Study|Adverse Event|1
1729137|NCT01015287|6031308|P2|Overall Study|Protocol Violation|1
1729138|NCT01015287|6031309|P1|Overall Study|Protocol Violation|1
1729139|NCT01015287|6031308|P2|Overall Study|Lost to Follow-up|1
1729140|NCT01015287|6031309|P1|Overall Study|Lost to Follow-up|2
1729141|NCT01015287|6031308|P2|Overall Study|Entry Criteria not Met|14
1729142|NCT01015287|6031309|P1|Overall Study|Entry Criteria not Met|11
1729143|NCT01015287|6031308|P2|Overall Study|Withdrawal by Subject|19
1729144|NCT01015287|6031309|P1|Overall Study|Withdrawal by Subject|14
1729145|NCT01015287|6031308|P2|Overall Study|Physician Decision|21
1729146|NCT01015287|6031309|P1|Overall Study|Physician Decision|19
1729147|NCT01015287|6031308|P2|Overall Study|Sponsor Decision|7
1729148|NCT01015287|6031309|P1|Overall Study|Sponsor Decision|3
1729149|NCT01015287|6031308|P2|Overall Study|Adverse Event|0
1729150|NCT01015287|6031309|P1|Overall Study|Adverse Event|1
1729151|NCT01015287|6031308|P2|Overall Study|Death|16
1729152|NCT01015287|6031309|P1|Overall Study|Death|21
1729153|NCT01015131|6031341|P1|Overall Study|Other Protocol Specified Criteria|4
1729154|NCT01015131|6031341|P1|Overall Study|Withdrawal by Subject|2
1729155|NCT01015131|6031341|P1|Overall Study|Protocol Violation|1
1729156|NCT01015131|6031341|P1|Overall Study|Physician Decision|1
1729157|NCT01015118|6031357|P2|Overall Study|Other than stated above|23
1729158|NCT01015118|6031358|P1|Overall Study|Other than stated above|42
1729159|NCT01015118|6031357|P2|Overall Study|Not treated|5
1729160|NCT01015118|6031358|P1|Overall Study|Not treated|9
1729161|NCT01015118|6031357|P2|Overall Study|Progressive disease|229
1729162|NCT01015118|6031358|P1|Overall Study|Progressive disease|364
1729163|NCT01015118|6031357|P2|Overall Study|Worsening or AE of underlying disease|4
1729164|NCT01015118|6031358|P1|Overall Study|Worsening or AE of underlying disease|5
1729165|NCT01015118|6031357|P2|Overall Study|Other Adverse Event (AE)|33
1729166|NCT01015118|6031358|P1|Overall Study|Other Adverse Event (AE)|141
1729167|NCT01015118|6031357|P2|Overall Study|Withdrawal by Subject|27
1729168|NCT01015118|6031358|P1|Overall Study|Withdrawal by Subject|103
1729169|NCT01015118|6031357|P2|Overall Study|Protocol Violation|6
1729170|NCT01015118|6031358|P1|Overall Study|Protocol Violation|5
1729171|NCT01014988|6031386|P6|Overall Study|Withdrawal by Subject|0
1729172|NCT01014988|6031387|P5|Overall Study|Withdrawal by Subject|0
1729173|NCT01014988|6031388|P4|Overall Study|Withdrawal by Subject|0
1729174|NCT01014988|6031389|P3|Overall Study|Withdrawal by Subject|0
1729175|NCT01014988|6031390|P2|Overall Study|Withdrawal by Subject|0
1729176|NCT01014988|6031391|P1|Overall Study|Withdrawal by Subject|1
1729177|NCT01014988|6031386|P6|Overall Study|Physician Decision|0
1729178|NCT01014988|6031387|P5|Overall Study|Physician Decision|0
1729179|NCT01014988|6031388|P4|Overall Study|Physician Decision|0
1729180|NCT01014988|6031389|P3|Overall Study|Physician Decision|0
1729181|NCT01014988|6031390|P2|Overall Study|Physician Decision|0
1729182|NCT01014988|6031391|P1|Overall Study|Physician Decision|1
1729183|NCT01014988|6031386|P6|Overall Study|Lost to Follow-up|0
1729184|NCT01014988|6031387|P5|Overall Study|Lost to Follow-up|0
1729185|NCT01014988|6031388|P4|Overall Study|Lost to Follow-up|0
1729186|NCT01014988|6031389|P3|Overall Study|Lost to Follow-up|1
1729187|NCT01014988|6031390|P2|Overall Study|Lost to Follow-up|0
1729188|NCT01014988|6031391|P1|Overall Study|Lost to Follow-up|1
1729189|NCT01014988|6031386|P6|Overall Study|Adverse Event|3
1729190|NCT01014988|6031387|P5|Overall Study|Adverse Event|1
1729191|NCT01014988|6031388|P4|Overall Study|Adverse Event|0
1729192|NCT01014988|6031389|P3|Overall Study|Adverse Event|1
1729193|NCT01014988|6031390|P2|Overall Study|Adverse Event|0
1729194|NCT01014988|6031391|P1|Overall Study|Adverse Event|20
1729195|NCT01014975|6031563|P3|Overall Study|Lost to Follow-up|1
1729196|NCT01014975|6031564|P2|Overall Study|Lost to Follow-up|0
1729197|NCT01014975|6031565|P1|Overall Study|Lost to Follow-up|0
1729198|NCT01014975|6031563|P3|Overall Study|Death|4
1729199|NCT01014975|6031564|P2|Overall Study|Death|3
1729200|NCT01014975|6031565|P1|Overall Study|Death|3
1729201|NCT01014975|6031563|P3|Overall Study|Withdrawal by Subject|1
1729202|NCT01014975|6031564|P2|Overall Study|Withdrawal by Subject|0
1729203|NCT01014975|6031565|P1|Overall Study|Withdrawal by Subject|1
1729204|NCT01014910|6032070|P2|Overall Study|Withdrawal by Subject|2
1729205|NCT01014910|6032071|P1|Overall Study|Withdrawal by Subject|0
1729206|NCT01014767|6032089|P4|Overall Study|PI left institution, data unavailable|1
1729207|NCT01014767|6032090|P3|Overall Study|PI left institution, data unavailable|4
1729208|NCT01014767|6032091|P2|Overall Study|PI left institution, data unavailable|1
1729209|NCT01014767|6032092|P1|Overall Study|PI left institution, data unavailable|12
1729210|NCT01014689|6032136|P2|Overall Study|Pregnancy|0
1729211|NCT01014689|6032137|P1|Overall Study|Pregnancy|1
1729212|NCT01014689|6032136|P2|Overall Study|Lost to Follow-up|7
1729213|NCT01014689|6032137|P1|Overall Study|Lost to Follow-up|3
1729214|NCT01014689|6032136|P2|Overall Study|Protocol Violation|1
1729215|NCT01014689|6032137|P1|Overall Study|Protocol Violation|1
1729216|NCT01014689|6032136|P2|Overall Study|Withdrawal by Subject|4
1729217|NCT01014689|6032137|P1|Overall Study|Withdrawal by Subject|5
1729218|NCT01014689|6032136|P2|Overall Study|Adverse Event|0
1729219|NCT01014689|6032137|P1|Overall Study|Adverse Event|3
1729220|NCT01014689|6032136|P2|Overall Study|Lack of Efficacy|1
1729221|NCT01014689|6032137|P1|Overall Study|Lack of Efficacy|0
1729222|NCT01014585|6032172|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
1729223|NCT01014585|6032173|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
1729224|NCT01014585|6032174|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
1729225|NCT01014585|6032175|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
1729226|NCT01014585|6032172|P4|Overall Study|Lost to Follow-up|2
1729227|NCT01014585|6032173|P3|Overall Study|Lost to Follow-up|0
1729228|NCT01014585|6032174|P2|Overall Study|Lost to Follow-up|0
1729229|NCT01014585|6032175|P1|Overall Study|Lost to Follow-up|0
1729230|NCT01014585|6032172|P4|Overall Study|Withdrawal by Subject|3
1729231|NCT01014585|6032173|P3|Overall Study|Withdrawal by Subject|1
1729232|NCT01014585|6032174|P2|Overall Study|Withdrawal by Subject|0
1729233|NCT01014585|6032175|P1|Overall Study|Withdrawal by Subject|2
1729234|NCT01014585|6032172|P4|Overall Study|Adverse Event|3
1729235|NCT01014585|6032173|P3|Overall Study|Adverse Event|0
1729236|NCT01014585|6032174|P2|Overall Study|Adverse Event|2
1729237|NCT01014585|6032175|P1|Overall Study|Adverse Event|0
1729238|NCT01014533|6032195|P2|Overall Study|unable to come to appointment|3
1729239|NCT01014533|6032196|P1|Overall Study|unable to come to appointment|0
1729240|NCT01014533|6032195|P2|Overall Study|Withdrawal by Subject|0
1729241|NCT01014533|6032196|P1|Overall Study|Withdrawal by Subject|2
1729242|NCT01014533|6032195|P2|Overall Study|Protocol Violation|2
1729243|NCT01014533|6032196|P1|Overall Study|Protocol Violation|3
1729244|NCT01014442|6032217|P2|Overall Study|Unspecified Reason|1
1729245|NCT01014442|6032218|P1|Overall Study|Unspecified Reason|1
1729246|NCT01014442|6032217|P2|Overall Study|Lack of Compliance|1
1729247|NCT01014442|6032218|P1|Overall Study|Lack of Compliance|0
1729248|NCT01014442|6032217|P2|Overall Study|Protocol Violation|5
1729249|NCT01014442|6032218|P1|Overall Study|Protocol Violation|2
1729250|NCT01014442|6032217|P2|Overall Study|Withdrawal by Subject|4
1729251|NCT01014442|6032218|P1|Overall Study|Withdrawal by Subject|4
1729252|NCT01014442|6032217|P2|Overall Study|Adverse Event|8
1729253|NCT01014442|6032218|P1|Overall Study|Adverse Event|0
1729254|NCT01014208|6032342|P2|Overall Study|Study Closed/terminated|83
1729255|NCT01014208|6032343|P1|Overall Study|Study Closed/terminated|78
1729256|NCT01014208|6032342|P2|Overall Study|Did Not Receive Study Drug|0
1729257|NCT01014208|6032343|P1|Overall Study|Did Not Receive Study Drug|2
1729258|NCT01014208|6032342|P2|Overall Study|Participant Withdrew Consent|12
1729259|NCT01014208|6032343|P1|Overall Study|Participant Withdrew Consent|12
1729260|NCT01014208|6032342|P2|Overall Study|Lost to Follow-up|5
1729261|NCT01014208|6032343|P1|Overall Study|Lost to Follow-up|2
1729262|NCT01014143|6032385|P3|Second Intervention|Lost to Follow-up|0
1729263|NCT01014143|6032386|P2|Second Intervention|Lost to Follow-up|0
1729264|NCT01014143|6032387|P1|Second Intervention|Lost to Follow-up|2
1729265|NCT01014013|6032482|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
1729266|NCT01014013|6032483|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
1729267|NCT01014013|6032482|P2|Overall Study|Appendectomy|0
1729268|NCT01014013|6032483|P1|Overall Study|Appendectomy|1
1729269|NCT01014013|6032482|P2|Overall Study|Another antibiotic therapy required|1
1729270|NCT01014013|6032483|P1|Overall Study|Another antibiotic therapy required|0
1729271|NCT01014013|6032482|P2|Overall Study|Physician Decision|1
1729272|NCT01014013|6032483|P1|Overall Study|Physician Decision|0
1729273|NCT01014013|6032482|P2|Overall Study|Pathogen resistant|4
1729274|NCT01014013|6032483|P1|Overall Study|Pathogen resistant|7
1729275|NCT01014013|6032482|P2|Overall Study|Negative urine culture|0
1729276|NCT01014013|6032483|P1|Overall Study|Negative urine culture|2
1729277|NCT01014013|6032482|P2|Overall Study|Pathogen culture = no growth|34
1729278|NCT01014013|6032483|P1|Overall Study|Pathogen culture = no growth|26
1729279|NCT01014013|6032482|P2|Overall Study|Clinical/microbiologic failure|2
1729280|NCT01014013|6032483|P1|Overall Study|Clinical/microbiologic failure|1
1729281|NCT01014013|6032482|P2|Overall Study|Withdrawal by Subject|4
1729282|NCT01014013|6032483|P1|Overall Study|Withdrawal by Subject|7
1729283|NCT01014013|6032482|P2|Overall Study|Protocol Violation|3
1729284|NCT01014013|6032483|P1|Overall Study|Protocol Violation|1
1729285|NCT01014013|6032482|P2|Overall Study|Laboratory adverse experience|1
1729286|NCT01014013|6032483|P1|Overall Study|Laboratory adverse experience|1
1729287|NCT01014013|6032482|P2|Overall Study|Clinical adverse experience|2
1729288|NCT01014013|6032483|P1|Overall Study|Clinical adverse experience|4
1729289|NCT01014013|6032482|P2|Overall Study|Inclusion/Exclusion criteria not met|3
1729290|NCT01014013|6032483|P1|Overall Study|Inclusion/Exclusion criteria not met|1
1729291|NCT01013961|6032495|P2|Overall Study|Physician Decision|1
1729292|NCT01013961|6032496|P1|Overall Study|Physician Decision|0
1729293|NCT01013961|6032495|P2|Overall Study|Withdrawal by Subject|0
1729294|NCT01013961|6032496|P1|Overall Study|Withdrawal by Subject|1
1729295|NCT01013961|6032495|P2|Overall Study|Adverse Event|2
1729296|NCT01013961|6032496|P1|Overall Study|Adverse Event|2
1729297|NCT01013883|6032514|P2|Overall Study|Lost to Follow-up|2
1729298|NCT01013883|6032515|P1|Overall Study|Lost to Follow-up|2
1729299|NCT01013870|6032527|P2|Overall Study|Lost to Follow-up|3
1729300|NCT01013870|6032528|P1|Overall Study|Lost to Follow-up|1
1729301|NCT01013792|6032577|P2|Overall Study|Lost to Follow-up|1
1729302|NCT01013792|6032578|P1|Overall Study|Lost to Follow-up|0
1729303|NCT01013792|6032577|P2|Overall Study|Adverse Event|3
1729304|NCT01013792|6032578|P1|Overall Study|Adverse Event|0
1729305|NCT01013792|6032577|P2|Overall Study|Study suspended|1
1729306|NCT01013792|6032578|P1|Overall Study|Study suspended|2
1729307|NCT01013753|6032584|P1|Overall Study|Other|2
1729308|NCT01013753|6032584|P1|Overall Study|Withdrawal by Subject|2
1729309|NCT01013753|6032584|P1|Overall Study|Lost to Follow-up|1
1729310|NCT01013753|6032584|P1|Overall Study|Protocol Violation|3
1729311|NCT01013753|6032584|P1|Overall Study|Adverse Event|8
1729312|NCT01013740|6032780|P2|Overall Study|Ongoing: Study records not completed|2
1729313|NCT01013740|6032781|P1|Overall Study|Ongoing: Study records not completed|0
1729314|NCT01013740|6032780|P2|Overall Study|Missing|1
1729315|NCT01013740|6032781|P1|Overall Study|Missing|2
1729316|NCT01013740|6032780|P2|Overall Study|study close / terminated : done in error|1
1729317|NCT01013740|6032781|P1|Overall Study|study close / terminated : done in error|2
1729318|NCT01013740|6032780|P2|Overall Study|Withdrawal by Subject|10
1729319|NCT01013740|6032781|P1|Overall Study|Withdrawal by Subject|2
1729320|NCT01013740|6032780|P2|Overall Study|Physician Decision|0
1729321|NCT01013740|6032781|P1|Overall Study|Physician Decision|2
1729322|NCT01013740|6032780|P2|Overall Study|Lost to Follow-up|5
1729323|NCT01013740|6032781|P1|Overall Study|Lost to Follow-up|3
1729324|NCT01013701|6032805|P1|Overall Study|study prematurely terminated|7
1729325|NCT01013597|6032812|P1|Overall Study|Withdrawal by Subject|1
1729326|NCT01013350|6032824|P2|Overall Study|Other|25
1729327|NCT01013350|6032825|P1|Overall Study|Other|1
1729328|NCT01013350|6032824|P2|Overall Study|Participant entered interventional study|8
1729329|NCT01013350|6032825|P1|Overall Study|Participant entered interventional study|0
1729330|NCT01013350|6032824|P2|Overall Study|Death|5
1729331|NCT01013350|6032825|P1|Overall Study|Death|3
1729332|NCT01013350|6032824|P2|Overall Study|Withdrawal by Subject|38
1729333|NCT01013350|6032825|P1|Overall Study|Withdrawal by Subject|15
1729334|NCT01013350|6032824|P2|Overall Study|Physician Decision|20
1729335|NCT01013350|6032825|P1|Overall Study|Physician Decision|4
1729336|NCT01013350|6032824|P2|Overall Study|Adverse Event|1
1729337|NCT01013350|6032825|P1|Overall Study|Adverse Event|0
1729338|NCT01013350|6032824|P2|Overall Study|Lost to Follow-up|95
1729339|NCT01013350|6032825|P1|Overall Study|Lost to Follow-up|15
1729340|NCT01013207|6032836|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
1729341|NCT01012999|6032854|P1|Overall Study|Protocol Violation|1
1729342|NCT01012973|6032860|P2|Overall Study|Withdrawal by Subject|6
1729343|NCT01012973|6032861|P1|Overall Study|Withdrawal by Subject|4
1729344|NCT01012973|6032860|P2|Overall Study|Protocol Violation|2
1729345|NCT01012973|6032861|P1|Overall Study|Protocol Violation|5
1729346|NCT01012973|6032860|P2|Overall Study|Increase in vis. acuity, never injected|1
1729347|NCT01012973|6032861|P1|Overall Study|Increase in vis. acuity, never injected|0
1729348|NCT01012973|6032860|P2|Overall Study|(Overseas travel - indefinite period)|0
1729349|NCT01012973|6032861|P1|Overall Study|(Overseas travel - indefinite period)|1
1729350|NCT01012973|6032860|P2|Overall Study|Lost to Follow-up|0
1729351|NCT01012973|6032861|P1|Overall Study|Lost to Follow-up|1
1729352|NCT01012973|6032860|P2|Overall Study|Lack of Efficacy|5
1729353|NCT01012973|6032861|P1|Overall Study|Lack of Efficacy|0
1729354|NCT01012973|6032860|P2|Overall Study|Adverse Event|5
1729355|NCT01012973|6032861|P1|Overall Study|Adverse Event|5
1729356|NCT01012947|6032886|P5|Overall Study|Lost to Follow-up|142
1729357|NCT01012947|6032887|P4|Overall Study|Lost to Follow-up|118
1729358|NCT01012947|6032888|P3|Overall Study|Lost to Follow-up|130
1729359|NCT01012947|6032889|P2|Overall Study|Lost to Follow-up|135
1729360|NCT01012947|6032890|P1|Overall Study|Lost to Follow-up|131
1729361|NCT01012765|6032911|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
1729362|NCT01012765|6032912|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
1729363|NCT01012765|6032913|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
1729364|NCT01012765|6032914|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
1729365|NCT01012765|6032915|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
1729366|NCT01012765|6032916|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
1729367|NCT01012765|6032911|P6|Treatment Period 2|Adverse Event|0
1729368|NCT01012765|6032912|P5|Treatment Period 2|Adverse Event|0
1729369|NCT01012765|6032913|P4|Treatment Period 2|Adverse Event|0
1729370|NCT01012765|6032914|P3|Treatment Period 2|Adverse Event|1
1729371|NCT01012765|6032915|P2|Treatment Period 2|Adverse Event|1
1729372|NCT01012765|6032916|P1|Treatment Period 2|Adverse Event|0
1729373|NCT01012765|6032911|P6|Treatment Period 2|Abnormal laboratory value(s)|1
1729374|NCT01012765|6032912|P5|Treatment Period 2|Abnormal laboratory value(s)|0
1729375|NCT01012765|6032913|P4|Treatment Period 2|Abnormal laboratory value(s)|0
1729376|NCT01012765|6032914|P3|Treatment Period 2|Abnormal laboratory value(s)|0
1729377|NCT01012765|6032915|P2|Treatment Period 2|Abnormal laboratory value(s)|0
1729378|NCT01012765|6032916|P1|Treatment Period 2|Abnormal laboratory value(s)|0
1729379|NCT01012765|6032911|P6|Treatment Period 2|Withdrawal by Subject|0
1729380|NCT01012765|6032912|P5|Treatment Period 2|Withdrawal by Subject|1
1729381|NCT01012765|6032913|P4|Treatment Period 2|Withdrawal by Subject|0
1729382|NCT01012765|6032914|P3|Treatment Period 2|Withdrawal by Subject|1
1729383|NCT01012765|6032915|P2|Treatment Period 2|Withdrawal by Subject|0
1729384|NCT01012765|6032916|P1|Treatment Period 2|Withdrawal by Subject|1
1729385|NCT01012765|6032911|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
1729386|NCT01012765|6032912|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
1729387|NCT01012765|6032913|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
1729388|NCT01012765|6032914|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
1729389|NCT01012765|6032915|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
1729390|NCT01012765|6032916|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
1729391|NCT01012765|6032911|P6|Treatment Period 1|Protocol Violation|0
1729392|NCT01012765|6032912|P5|Treatment Period 1|Protocol Violation|1
1729393|NCT01012765|6032913|P4|Treatment Period 1|Protocol Violation|2
1729394|NCT01012765|6032914|P3|Treatment Period 1|Protocol Violation|0
1729395|NCT01012765|6032915|P2|Treatment Period 1|Protocol Violation|0
1729396|NCT01012765|6032916|P1|Treatment Period 1|Protocol Violation|0
1729397|NCT01012765|6032911|P6|Treatment Period 1|Administrative problems|0
1729398|NCT01012765|6032912|P5|Treatment Period 1|Administrative problems|1
1729399|NCT01012765|6032913|P4|Treatment Period 1|Administrative problems|1
1729400|NCT01012765|6032914|P3|Treatment Period 1|Administrative problems|1
1729401|NCT01012765|6032915|P2|Treatment Period 1|Administrative problems|0
1729402|NCT01012765|6032916|P1|Treatment Period 1|Administrative problems|0
1729403|NCT01012765|6032911|P6|Treatment Period 1|Withdrawal by Subject|0
1729404|NCT01012765|6032912|P5|Treatment Period 1|Withdrawal by Subject|0
1729405|NCT01012765|6032913|P4|Treatment Period 1|Withdrawal by Subject|0
1729406|NCT01012765|6032914|P3|Treatment Period 1|Withdrawal by Subject|0
1729407|NCT01012765|6032915|P2|Treatment Period 1|Withdrawal by Subject|0
1729408|NCT01012765|6032916|P1|Treatment Period 1|Withdrawal by Subject|2
1729409|NCT01012765|6032911|P6|Treatment Period 1|Adverse Event|0
1729410|NCT01012765|6032912|P5|Treatment Period 1|Adverse Event|0
1729411|NCT01012765|6032913|P4|Treatment Period 1|Adverse Event|0
1729412|NCT01012765|6032914|P3|Treatment Period 1|Adverse Event|1
1729413|NCT01012765|6032915|P2|Treatment Period 1|Adverse Event|0
1729414|NCT01012765|6032916|P1|Treatment Period 1|Adverse Event|1
1729415|NCT01012739|6032945|P4|Treatment Period 2|Abnormal test procedure results|1
1729416|NCT01012739|6032946|P3|Treatment Period 2|Abnormal test procedure results|0
1729417|NCT01012739|6032947|P2|Treatment Period 2|Abnormal test procedure results|0
1729418|NCT01012739|6032948|P1|Treatment Period 2|Abnormal test procedure results|0
1729419|NCT01012739|6032945|P4|Treatment Period 1|Adverse Event|1
1729420|NCT01012739|6032946|P3|Treatment Period 1|Adverse Event|0
1729421|NCT01012739|6032947|P2|Treatment Period 1|Adverse Event|0
1729422|NCT01012739|6032948|P1|Treatment Period 1|Adverse Event|0
1729423|NCT01012713|6032976|P1|Overall Study|Lack of Efficacy|3
1729424|NCT01012622|6033002|P1|Overall Study|withdrawal of consent by a parent|2
1729425|NCT01012622|6033002|P1|Overall Study|screening failure|1
1729426|NCT01012622|6033002|P1|Overall Study|Other|1
1729427|NCT01012622|6033002|P1|Overall Study|non-compliance with the drug|9
1729428|NCT01012622|6033002|P1|Overall Study|Adverse Event|7
1729429|NCT01012622|6033002|P1|Overall Study|Lost to Follow-up|5
1729430|NCT01012622|6033002|P1|Overall Study|Withdrawal by Subject|6
1729431|NCT01012440|6033028|P1|Overall Study|Withdrawal by Subject|2
1729432|NCT01012414|6033032|P1|Overall Study|Trial was stopped before completed|7
1729433|NCT01012414|6033032|P1|Overall Study|Lost to Follow-up|1
1729434|NCT01012414|6033032|P1|Overall Study|Withdrawal by Subject|2
1729435|NCT01012323|6033073|P1|Overall Study|Investigator Judgment|1
1729436|NCT01012258|6033110|P1|Overall Study|Ongoing|29
1729437|NCT01012258|6033110|P1|Overall Study|Another Tumor Discovered|1
1729438|NCT01012258|6033110|P1|Overall Study|Another Anti-cancer Drug Received|1
1729439|NCT01012258|6033110|P1|Overall Study|Symptomatic Deterioration|1
1729440|NCT01012258|6033110|P1|Overall Study|Progressive Disease (PD)|18
1729441|NCT01012258|6033110|P1|Overall Study|Adverse Event|1
1729442|NCT01012258|6033110|P1|Overall Study|Lost to Follow-up|1
1729443|NCT01012258|6033110|P1|Overall Study|Death|14
1729444|NCT01012219|6033157|P1|Period 2|Withdrawal by Subject|1
1729445|NCT01012219|6033157|P1|Period 1|Withdrawal by Subject|1
1729446|NCT01012037|6033448|P3|Overall Study|Other reason (not specified)|1
1729447|NCT01012037|6033449|P2|Overall Study|Other reason (not specified)|1
1729448|NCT01012037|6033450|P1|Overall Study|Other reason (not specified)|1
1729449|NCT01012037|6033448|P3|Overall Study|Withdrawal by Subject|1
1729450|NCT01012037|6033449|P2|Overall Study|Withdrawal by Subject|4
1729451|NCT01012037|6033450|P1|Overall Study|Withdrawal by Subject|0
1729452|NCT01012037|6033448|P3|Overall Study|Protocol Violation|5
1729453|NCT01012037|6033449|P2|Overall Study|Protocol Violation|3
1729454|NCT01012037|6033450|P1|Overall Study|Protocol Violation|0
1729455|NCT01012037|6033448|P3|Overall Study|Adverse Event|3
1729456|NCT01012037|6033449|P2|Overall Study|Adverse Event|8
1729457|NCT01012037|6033450|P1|Overall Study|Adverse Event|0
1729458|NCT01011946|6033485|P1|Overall Study|No pathological lab value|1
1729459|NCT01011946|6033485|P1|Overall Study|Transferred to another hospital|2
1729460|NCT01011933|6033489|P1|Overall Study|Never treated|1
1729461|NCT01011933|6033489|P1|Overall Study|Inadequate pathology|1
1729462|NCT01011933|6033489|P1|Overall Study|Improper pre-protocol Rx|1
1729463|NCT01011933|6033489|P1|Overall Study|Wrong cell type|1
1729464|NCT01011907|6033506|P2|Overall Study|Adverse Event|4
1729465|NCT01011907|6033507|P1|Overall Study|Adverse Event|1
1729466|NCT01011907|6033506|P2|Overall Study|Withdrawal by Subject|11
1729467|NCT01011907|6033507|P1|Overall Study|Withdrawal by Subject|13
1729468|NCT01011868|6033524|P3|After Week 78 Follow-up|Other reason not defined above|16
1729469|NCT01011868|6033525|P2|After Week 78 Follow-up|Other reason not defined above|5
1729470|NCT01011868|6033526|P1|After Week 78 Follow-up|Other reason not defined above|5
1729471|NCT01011868|6033524|P3|After Week 78 Follow-up|Withdrawal by Subject|1
1729472|NCT01011868|6033525|P2|After Week 78 Follow-up|Withdrawal by Subject|8
1729473|NCT01011868|6033526|P1|After Week 78 Follow-up|Withdrawal by Subject|9
1729474|NCT01011868|6033524|P3|After Week 78 Follow-up|Lost to Follow-up|4
1729475|NCT01011868|6033525|P2|After Week 78 Follow-up|Lost to Follow-up|6
1729476|NCT01011868|6033526|P1|After Week 78 Follow-up|Lost to Follow-up|11
1729477|NCT01011868|6033524|P3|After Week 78 Follow-up|Protocol Violation|2
1729478|NCT01011868|6033525|P2|After Week 78 Follow-up|Protocol Violation|1
1729479|NCT01011868|6033526|P1|After Week 78 Follow-up|Protocol Violation|9
1729480|NCT01011868|6033524|P3|After Week 78 Follow-up|Lack of Efficacy|0
1729481|NCT01011868|6033525|P2|After Week 78 Follow-up|Lack of Efficacy|0
1729482|NCT01011868|6033526|P1|After Week 78 Follow-up|Lack of Efficacy|4
1729483|NCT01011868|6033524|P3|After Week 78 Follow-up|Adverse Event|21
1729484|NCT01011868|6033525|P2|After Week 78 Follow-up|Adverse Event|18
1729485|NCT01011868|6033526|P1|After Week 78 Follow-up|Adverse Event|14
1729486|NCT01011868|6033524|P3|After Week 18 Follow-up|Other reason not defined above|12
1729487|NCT01011868|6033525|P2|After Week 18 Follow-up|Other reason not defined above|3
1729488|NCT01011868|6033526|P1|After Week 18 Follow-up|Other reason not defined above|2
1729489|NCT01011868|6033524|P3|After Week 18 Follow-up|Withdrawal by Subject|0
1729490|NCT01011868|6033525|P2|After Week 18 Follow-up|Withdrawal by Subject|3
1729491|NCT01011868|6033526|P1|After Week 18 Follow-up|Withdrawal by Subject|6
1729492|NCT01011868|6033524|P3|After Week 18 Follow-up|Lost to Follow-up|0
1729493|NCT01011868|6033525|P2|After Week 18 Follow-up|Lost to Follow-up|3
1729494|NCT01011868|6033526|P1|After Week 18 Follow-up|Lost to Follow-up|5
1729495|NCT01011868|6033524|P3|After Week 18 Follow-up|Protocol Violation|1
1729496|NCT01011868|6033525|P2|After Week 18 Follow-up|Protocol Violation|1
1729497|NCT01011868|6033526|P1|After Week 18 Follow-up|Protocol Violation|1
1729498|NCT01011868|6033524|P3|After Week 18 Follow-up|Lack of Efficacy|0
1729499|NCT01011868|6033525|P2|After Week 18 Follow-up|Lack of Efficacy|0
1729500|NCT01011868|6033526|P1|After Week 18 Follow-up|Lack of Efficacy|1
1729501|NCT01011868|6033524|P3|After Week 18 Follow-up|Adverse Event|13
1729502|NCT01011868|6033525|P2|After Week 18 Follow-up|Adverse Event|6
1729503|NCT01011868|6033526|P1|After Week 18 Follow-up|Adverse Event|8
1729504|NCT01011738|6033588|P3|Overall Study|Unknown reasons|17
1729505|NCT01011738|6033589|P2|Overall Study|Unknown reasons|291
1729506|NCT01011738|6033590|P1|Overall Study|Unknown reasons|312
1729507|NCT01011738|6033588|P3|Overall Study|Death|0
1729508|NCT01011738|6033589|P2|Overall Study|Death|3
1729509|NCT01011738|6033590|P1|Overall Study|Death|12
1729510|NCT01011673|6033630|P2|24 Hour Follow-up|Lost to Follow-up|3
1729511|NCT01011673|6033631|P1|24 Hour Follow-up|Lost to Follow-up|3
1729512|NCT01011673|6033630|P2|Randomized|Secondary headache|1
1729513|NCT01011673|6033631|P1|Randomized|Secondary headache|2
1729514|NCT01011556|6033654|P4|Overall Study|Inclusion/exclusion criteria not met|5
1729515|NCT01011556|6033655|P3|Overall Study|Inclusion/exclusion criteria not met|3
1729516|NCT01011556|6033656|P2|Overall Study|Inclusion/exclusion criteria not met|1
1729517|NCT01011556|6033657|P1|Overall Study|Inclusion/exclusion criteria not met|2
1729518|NCT01011556|6033654|P4|Overall Study|Sponsor decision|2
1729519|NCT01011556|6033655|P3|Overall Study|Sponsor decision|1
1729520|NCT01011556|6033656|P2|Overall Study|Sponsor decision|1
1729521|NCT01011556|6033657|P1|Overall Study|Sponsor decision|0
1729522|NCT01011556|6033654|P4|Overall Study|Withdrawal by Subject|4
1729523|NCT01011556|6033655|P3|Overall Study|Withdrawal by Subject|4
1729524|NCT01011556|6033656|P2|Overall Study|Withdrawal by Subject|2
1729525|NCT01011556|6033657|P1|Overall Study|Withdrawal by Subject|1
1729526|NCT01011556|6033654|P4|Overall Study|Protocol Violation|0
1729527|NCT01011556|6033655|P3|Overall Study|Protocol Violation|0
1729528|NCT01011556|6033656|P2|Overall Study|Protocol Violation|1
1729529|NCT01011556|6033657|P1|Overall Study|Protocol Violation|0
1729530|NCT01011556|6033654|P4|Overall Study|Physician Decision|1
1729531|NCT01011556|6033655|P3|Overall Study|Physician Decision|0
1729532|NCT01011556|6033656|P2|Overall Study|Physician Decision|0
1729533|NCT01011556|6033657|P1|Overall Study|Physician Decision|1
1729534|NCT01011556|6033654|P4|Overall Study|Lost to Follow-up|0
1729535|NCT01011556|6033655|P3|Overall Study|Lost to Follow-up|0
1729536|NCT01011556|6033656|P2|Overall Study|Lost to Follow-up|0
1729537|NCT01011556|6033657|P1|Overall Study|Lost to Follow-up|1
1729538|NCT01011556|6033654|P4|Overall Study|Adverse Event|1
1729539|NCT01011556|6033655|P3|Overall Study|Adverse Event|2
1729540|NCT01011556|6033656|P2|Overall Study|Adverse Event|3
1729541|NCT01011556|6033657|P1|Overall Study|Adverse Event|1
1729542|NCT01011465|6033735|P8|Overall Study|Withdrawal by Subject|0
1729543|NCT01011465|6033736|P7|Overall Study|Withdrawal by Subject|1
1729544|NCT01011465|6033737|P6|Overall Study|Withdrawal by Subject|0
1729545|NCT01011465|6033738|P5|Overall Study|Withdrawal by Subject|1
1729546|NCT01011465|6033739|P4|Overall Study|Withdrawal by Subject|0
1729547|NCT01011465|6033740|P3|Overall Study|Withdrawal by Subject|0
1729548|NCT01011465|6033741|P2|Overall Study|Withdrawal by Subject|1
1729549|NCT01011465|6033742|P1|Overall Study|Withdrawal by Subject|2
1729550|NCT01011439|6033770|P1|Overall Study|Sponsor's decision|15
1729551|NCT01011439|6033770|P1|Overall Study|Withdrawal by Subject|1
1729552|NCT01011439|6033770|P1|Overall Study|Lost to Follow-up|4
1729553|NCT01011439|6033770|P1|Overall Study|Death|37
1729554|NCT01011387|6033807|P1|Overall Study|Protocol Violation|1
1729555|NCT01011387|6033807|P1|Overall Study|Adverse Event|2
1729556|NCT01011387|6033807|P1|Overall Study|Withdrawal by Subject|3
1729557|NCT01011335|6033815|P13|Overall Study|Adverse Event|1
1729558|NCT01011335|6033816|P12|Overall Study|Adverse Event|0
1729559|NCT01011335|6033817|P11|Overall Study|Adverse Event|4
1729560|NCT01011335|6033818|P10|Overall Study|Adverse Event|0
1729561|NCT01011335|6033819|P9|Overall Study|Adverse Event|0
1729562|NCT01011335|6033820|P8|Overall Study|Adverse Event|0
1729563|NCT01011335|6033821|P7|Overall Study|Adverse Event|0
1729564|NCT01011335|6033822|P6|Overall Study|Adverse Event|0
1729565|NCT01011335|6033823|P5|Overall Study|Adverse Event|0
1729566|NCT01011335|6033824|P4|Overall Study|Adverse Event|0
1729567|NCT01011335|6033825|P3|Overall Study|Adverse Event|0
1729568|NCT01011335|6033826|P2|Overall Study|Adverse Event|0
1729569|NCT01011335|6033827|P1|Overall Study|Adverse Event|0
1729570|NCT01011335|6033815|P13|Overall Study|Moved/deployed or no booster|0
1729571|NCT01011335|6033816|P12|Overall Study|Moved/deployed or no booster|0
1729572|NCT01011335|6033817|P11|Overall Study|Moved/deployed or no booster|2
1729573|NCT01011335|6033818|P10|Overall Study|Moved/deployed or no booster|0
1729574|NCT01011335|6033819|P9|Overall Study|Moved/deployed or no booster|1
1729575|NCT01011335|6033820|P8|Overall Study|Moved/deployed or no booster|0
1729576|NCT01011335|6033821|P7|Overall Study|Moved/deployed or no booster|1
1729577|NCT01011335|6033822|P6|Overall Study|Moved/deployed or no booster|0
1729578|NCT01011335|6033823|P5|Overall Study|Moved/deployed or no booster|0
1729579|NCT01011335|6033824|P4|Overall Study|Moved/deployed or no booster|1
1729580|NCT01011335|6033825|P3|Overall Study|Moved/deployed or no booster|0
1729581|NCT01011335|6033826|P2|Overall Study|Moved/deployed or no booster|0
1729582|NCT01011335|6033827|P1|Overall Study|Moved/deployed or no booster|1
1729583|NCT01011335|6033815|P13|Overall Study|Protocol Violation|0
1729584|NCT01011335|6033816|P12|Overall Study|Protocol Violation|0
1729585|NCT01011335|6033817|P11|Overall Study|Protocol Violation|0
1729586|NCT01011335|6033818|P10|Overall Study|Protocol Violation|0
1729587|NCT01011335|6033819|P9|Overall Study|Protocol Violation|0
1729588|NCT01011335|6033820|P8|Overall Study|Protocol Violation|0
1729589|NCT01011335|6033821|P7|Overall Study|Protocol Violation|0
1729590|NCT01011335|6033822|P6|Overall Study|Protocol Violation|0
1729591|NCT01011335|6033823|P5|Overall Study|Protocol Violation|0
1729592|NCT01011335|6033824|P4|Overall Study|Protocol Violation|0
1729593|NCT01011335|6033825|P3|Overall Study|Protocol Violation|0
1729594|NCT01011335|6033826|P2|Overall Study|Protocol Violation|1
1729595|NCT01011335|6033827|P1|Overall Study|Protocol Violation|0
1729596|NCT01011335|6033815|P13|Overall Study|Lost to Follow-up|2
1729597|NCT01011335|6033816|P12|Overall Study|Lost to Follow-up|1
1729598|NCT01011335|6033817|P11|Overall Study|Lost to Follow-up|0
1729599|NCT01011335|6033818|P10|Overall Study|Lost to Follow-up|0
1729600|NCT01011335|6033819|P9|Overall Study|Lost to Follow-up|1
1729601|NCT01011335|6033820|P8|Overall Study|Lost to Follow-up|2
1729602|NCT01011335|6033821|P7|Overall Study|Lost to Follow-up|2
1729603|NCT01011335|6033822|P6|Overall Study|Lost to Follow-up|1
1729604|NCT01011335|6033823|P5|Overall Study|Lost to Follow-up|1
1729605|NCT01011335|6033824|P4|Overall Study|Lost to Follow-up|1
1729606|NCT01011335|6033825|P3|Overall Study|Lost to Follow-up|1
1729607|NCT01011335|6033826|P2|Overall Study|Lost to Follow-up|0
1729608|NCT01011335|6033827|P1|Overall Study|Lost to Follow-up|0
1729609|NCT01011309|6033867|P3|Overall Study|Protocol Violation|3
1729610|NCT01011309|6033868|P2|Overall Study|Protocol Violation|1
1729611|NCT01011309|6033869|P1|Overall Study|Protocol Violation|0
1729612|NCT01011309|6033867|P3|Overall Study|Lack of Efficacy|0
1729613|NCT01011309|6033868|P2|Overall Study|Lack of Efficacy|1
1729614|NCT01011309|6033869|P1|Overall Study|Lack of Efficacy|0
1729615|NCT01011309|6033867|P3|Overall Study|Adverse Event|2
1729616|NCT01011309|6033868|P2|Overall Study|Adverse Event|1
1729617|NCT01011309|6033869|P1|Overall Study|Adverse Event|2
1729618|NCT01011283|6033885|P2|Overall Study|Other|2
1729619|NCT01011283|6033886|P1|Overall Study|Other|2
1729620|NCT01011283|6033885|P2|Overall Study|Terminated by Sponsor|5
1729621|NCT01011283|6033886|P1|Overall Study|Terminated by Sponsor|5
1729622|NCT01011283|6033885|P2|Overall Study|Progressive Disease|2
1729623|NCT01011283|6033886|P1|Overall Study|Progressive Disease|0
1729624|NCT01011283|6033885|P2|Overall Study|Adverse Event|2
1729625|NCT01011283|6033886|P1|Overall Study|Adverse Event|4
1729626|NCT01011153|6033935|P3|Overall Study|Less than 78 cases completed|9
1729627|NCT01011153|6033936|P2|Overall Study|Less than 78 cases completed|11
1729628|NCT01011153|6033937|P1|Overall Study|Less than 78 cases completed|8
1729629|NCT01011049|6033966|P4|Overall Study|Withdrawal by Subject|0
1729630|NCT01011049|6033967|P3|Overall Study|Withdrawal by Subject|1
1729631|NCT01011049|6033968|P2|Overall Study|Withdrawal by Subject|0
1729632|NCT01011049|6033969|P1|Overall Study|Withdrawal by Subject|0
1729633|NCT01011049|6033966|P4|Overall Study|Lost to Follow-up|0
1729634|NCT01011049|6033967|P3|Overall Study|Lost to Follow-up|1
1729635|NCT01011049|6033968|P2|Overall Study|Lost to Follow-up|2
1729636|NCT01011049|6033969|P1|Overall Study|Lost to Follow-up|1
1729637|NCT01011049|6033966|P4|Overall Study|Protocol Violation|0
1729638|NCT01011049|6033967|P3|Overall Study|Protocol Violation|2
1729639|NCT01011049|6033968|P2|Overall Study|Protocol Violation|0
1729640|NCT01011049|6033969|P1|Overall Study|Protocol Violation|0
1729641|NCT01010971|6033999|P3|Overall Study|Other|2
1729642|NCT01010971|6034000|P2|Overall Study|Other|0
1729643|NCT01010971|6034001|P1|Overall Study|Other|1
1729644|NCT01010971|6033999|P3|Overall Study|Lost to Follow-up|3
1729645|NCT01010971|6034000|P2|Overall Study|Lost to Follow-up|2
1729646|NCT01010971|6034001|P1|Overall Study|Lost to Follow-up|0
1729647|NCT01010971|6033999|P3|Overall Study|Withdrawal by Subject|5
1729648|NCT01010971|6034000|P2|Overall Study|Withdrawal by Subject|2
1729649|NCT01010971|6034001|P1|Overall Study|Withdrawal by Subject|0
1729650|NCT01010971|6033999|P3|Overall Study|Adverse Event|3
1729651|NCT01010971|6034000|P2|Overall Study|Adverse Event|4
1729652|NCT01010971|6034001|P1|Overall Study|Adverse Event|2
1729653|NCT01010867|6034129|P1|Overall Study|< 50% adherence to probiotic|1
1729654|NCT01010776|6034141|P1|Extension Phase|Other|3
1729655|NCT01010776|6034141|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
1729656|NCT01010776|6034141|P1|Main Phase|Did not received study medication|5
1729657|NCT01010776|6034141|P1|Main Phase|Other|1
1729658|NCT01010776|6034141|P1|Main Phase|Inform consent withdrawal|1
1729659|NCT01010776|6034141|P1|Main Phase|Selection failure|2
1729660|NCT01010776|6034141|P1|Main Phase|Non-compliance to study medication|5
1729661|NCT01010776|6034141|P1|Main Phase|Lost to Follow-up|6
1729662|NCT01010776|6034141|P1|Main Phase|Adverse Event|7
1729663|NCT01010776|6034141|P1|Main Phase|Lack of Efficacy|8
1729664|NCT01010776|6034141|P1|Main Phase|Withdrawal by Subject|14
1729665|NCT01010750|6034198|P6|Second Intervention|Adverse Event|0
1729666|NCT01010750|6034199|P5|Second Intervention|Adverse Event|0
1729667|NCT01010750|6034200|P4|Second Intervention|Adverse Event|0
1729668|NCT01010750|6034201|P3|Second Intervention|Adverse Event|0
1729669|NCT01010750|6034202|P2|Second Intervention|Adverse Event|1
1729670|NCT01010750|6034203|P1|Second Intervention|Adverse Event|0
1729671|NCT01010633|6034228|P2|Overall Study|Investigator decision|1
1729672|NCT01010633|6034229|P1|Overall Study|Investigator decision|0
1729673|NCT01010633|6034228|P2|Overall Study|Withdrawal by Subject|1
1729674|NCT01010633|6034229|P1|Overall Study|Withdrawal by Subject|2
1729675|NCT01010633|6034228|P2|Overall Study|Protocol Violation|2
1729676|NCT01010633|6034229|P1|Overall Study|Protocol Violation|1
1729677|NCT01010633|6034228|P2|Overall Study|Adverse Event|1
1729678|NCT01010633|6034229|P1|Overall Study|Adverse Event|1
1729679|NCT01010503|6034256|P1|Overall Study|Death|1
1729680|NCT01010503|6034256|P1|Overall Study|Adverse Event|1
1729681|NCT01010230|6034315|P2|Overall Study|Lost to Follow-up|2
1729682|NCT01010230|6034316|P1|Overall Study|Lost to Follow-up|4
1729683|NCT01010230|6034315|P2|Overall Study|Withdrawal by Subject|5
1729684|NCT01010230|6034316|P1|Overall Study|Withdrawal by Subject|6
1729685|NCT01010217|6034351|P5|Overall Study|Physician Decision|3
1729686|NCT01010217|6034352|P4|Overall Study|Physician Decision|6
1729687|NCT01010217|6034353|P3|Overall Study|Physician Decision|0
1729688|NCT01010217|6034354|P2|Overall Study|Physician Decision|0
1729689|NCT01010217|6034355|P1|Overall Study|Physician Decision|0
1729690|NCT01010217|6034351|P5|Overall Study|Withdrawal by Subject|0
1729691|NCT01010217|6034352|P4|Overall Study|Withdrawal by Subject|0
1729692|NCT01010217|6034353|P3|Overall Study|Withdrawal by Subject|0
1729693|NCT01010217|6034354|P2|Overall Study|Withdrawal by Subject|0
1729694|NCT01010217|6034355|P1|Overall Study|Withdrawal by Subject|1
1729695|NCT01010217|6034351|P5|Overall Study|Lost to Follow-up|0
1729696|NCT01010217|6034352|P4|Overall Study|Lost to Follow-up|0
1729697|NCT01010217|6034353|P3|Overall Study|Lost to Follow-up|1
1729698|NCT01010217|6034354|P2|Overall Study|Lost to Follow-up|5
1729699|NCT01010217|6034355|P1|Overall Study|Lost to Follow-up|4
1729700|NCT01010204|6034394|P2|Overall Study|psychiatric hospitalization|1
1729701|NCT01010204|6034395|P1|Overall Study|psychiatric hospitalization|2
1729702|NCT01010204|6034394|P2|Overall Study|Withdrawal by Subject|3
1729703|NCT01010204|6034395|P1|Overall Study|Withdrawal by Subject|2
1729704|NCT01010204|6034394|P2|Overall Study|Adverse Event|3
1729705|NCT01010204|6034395|P1|Overall Study|Adverse Event|1
1729706|NCT01010204|6034394|P2|Overall Study|Lost to Follow-up|2
1729707|NCT01010204|6034395|P1|Overall Study|Lost to Follow-up|2
1729708|NCT01010126|6034411|P6|Overall Study|Withdrawal by Subject|0
1729709|NCT01010126|6034412|P5|Overall Study|Withdrawal by Subject|3
1729710|NCT01010126|6034413|P4|Overall Study|Withdrawal by Subject|0
1729711|NCT01010126|6034414|P3|Overall Study|Withdrawal by Subject|1
1729712|NCT01010126|6034415|P2|Overall Study|Withdrawal by Subject|0
1729713|NCT01010126|6034416|P1|Overall Study|Withdrawal by Subject|1
1729714|NCT01010061|6034468|P2|Overall Study|Did Not Receive Treatment|2
1729715|NCT01010061|6034469|P1|Overall Study|Did Not Receive Treatment|2
1729716|NCT01010061|6034468|P2|Overall Study|Violation of Selection Criteria|1
1729717|NCT01010061|6034469|P1|Overall Study|Violation of Selection Criteria|0
1729718|NCT01010061|6034468|P2|Overall Study|Insufficient Therapeutic Response|5
1729719|NCT01010061|6034469|P1|Overall Study|Insufficient Therapeutic Response|1
1729720|NCT01010061|6034468|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1729721|NCT01010061|6034469|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
1729722|NCT01010061|6034468|P2|Overall Study|Administrative/Other|1
1729723|NCT01010061|6034469|P1|Overall Study|Administrative/Other|0
1729724|NCT01010061|6034468|P2|Overall Study|Death|6
1729725|NCT01010061|6034469|P1|Overall Study|Death|3
1729726|NCT01010061|6034468|P2|Overall Study|Withdrew Consent|1
1729727|NCT01010061|6034469|P1|Overall Study|Withdrew Consent|5
1729728|NCT01010061|6034468|P2|Overall Study|Disease Progression|8
1729729|NCT01010061|6034469|P1|Overall Study|Disease Progression|2
1729730|NCT01010061|6034468|P2|Overall Study|Adverse Events or Intercurrent Illness|16
1729731|NCT01010061|6034469|P1|Overall Study|Adverse Events or Intercurrent Illness|33
1729732|NCT01009983|6034520|P1|Overall Study|necessary scans not completed|1
1729733|NCT01009840|6034533|P1|Overall Study|Subject Withdrew Consent to Participate|1
1729734|NCT01009840|6034533|P1|Overall Study|Subject was Withdrawn by Investigator|1
1729735|NCT01009840|6034533|P1|Overall Study|Subject Met Withdrawal Criteria|7
1729736|NCT01009840|6034533|P1|Overall Study|Adverse Event|4
1729737|NCT01009840|6034533|P1|Overall Study|Lost to Follow-up|1
1729738|NCT01009814|6034551|P5|Overall Study|No longer met study criteria|0
1729739|NCT01009814|6034552|P4|Overall Study|No longer met study criteria|0
1729740|NCT01009814|6034553|P3|Overall Study|No longer met study criteria|0
1729741|NCT01009814|6034554|P2|Overall Study|No longer met study criteria|1
1729742|NCT01009814|6034555|P1|Overall Study|No longer met study criteria|1
1729743|NCT01009645|6034679|P4|Overall Study|Lost to Follow-up|5
1729744|NCT01009645|6034680|P3|Overall Study|Lost to Follow-up|4
1729745|NCT01009645|6034681|P2|Overall Study|Lost to Follow-up|8
1729746|NCT01009645|6034682|P1|Overall Study|Lost to Follow-up|2
1729747|NCT01009580|6034719|P2|Overall Study|Unclassified|21
1729748|NCT01009580|6034720|P1|Overall Study|Unclassified|17
1729749|NCT01009580|6034719|P2|Overall Study|Withdrawal Criteria|6
1729750|NCT01009580|6034720|P1|Overall Study|Withdrawal Criteria|4
1729751|NCT01009580|6034719|P2|Overall Study|Protocol Violation|3
1729752|NCT01009580|6034720|P1|Overall Study|Protocol Violation|2
1729753|NCT01009580|6034719|P2|Overall Study|Lack of Efficacy|1
1729754|NCT01009580|6034720|P1|Overall Study|Lack of Efficacy|0
1729755|NCT01009580|6034719|P2|Overall Study|Adverse Event|4
1729756|NCT01009580|6034720|P1|Overall Study|Adverse Event|4
1729757|NCT01009554|6034734|P2|Overall Study|Noncompliant with Study Product|3
1729758|NCT01009554|6034735|P1|Overall Study|Noncompliant with Study Product|0
1729759|NCT01009554|6034734|P2|Overall Study|Withdrawal by Subject|3
1729760|NCT01009554|6034735|P1|Overall Study|Withdrawal by Subject|1
1729761|NCT01009554|6034734|P2|Overall Study|Adverse Event|1
1729762|NCT01009554|6034735|P1|Overall Study|Adverse Event|1
1729763|NCT01009515|6034867|P1|Overall Study|Withdrawal by Subject|3
1729764|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Physician Decision|8
1729765|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Physician Decision|6
1729766|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Physician Decision|6
1729767|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Physician Decision|4
1729768|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Physician Decision|0
1729769|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
1729770|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
1729771|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
1729772|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
1729773|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
1729774|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1729775|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
1729776|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1729777|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
1729778|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
1729779|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
1729780|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
1729781|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
1729782|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
1729783|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
1729784|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
1729785|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
1729786|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
1729787|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
1729788|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
1729789|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
1729790|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
1729791|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
1729792|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
1729793|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
1729794|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
1729795|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
1729796|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
1729797|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
1729798|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
1729799|NCT01009463|6034878|P5|52-week, Double-blind Treatment Period|Adverse Event|31
1729800|NCT01009463|6034879|P4|52-week, Double-blind Treatment Period|Adverse Event|29
1729801|NCT01009463|6034880|P3|52-week, Double-blind Treatment Period|Adverse Event|25
1729802|NCT01009463|6034881|P2|52-week, Double-blind Treatment Period|Adverse Event|22
1729803|NCT01009463|6034882|P1|52-week, Double-blind Treatment Period|Adverse Event|0
1729804|NCT01009463|6034878|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1729805|NCT01009463|6034879|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1729806|NCT01009463|6034880|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1729807|NCT01009463|6034881|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
1729808|NCT01009463|6034882|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
1729809|NCT01009463|6034878|P5|4-week, Open-label Run-In Period|Physician Decision|0
1729810|NCT01009463|6034879|P4|4-week, Open-label Run-In Period|Physician Decision|0
1729811|NCT01009463|6034880|P3|4-week, Open-label Run-In Period|Physician Decision|0
1729812|NCT01009463|6034881|P2|4-week, Open-label Run-In Period|Physician Decision|0
1729813|NCT01009463|6034882|P1|4-week, Open-label Run-In Period|Physician Decision|10
1729814|NCT01009463|6034878|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
1729815|NCT01009463|6034879|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
1729816|NCT01009463|6034880|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
1729817|NCT01009463|6034881|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
1729818|NCT01009463|6034882|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
1729819|NCT01009463|6034878|P5|4-week, Open-label Run-In Period|Adverse Event|0
1729820|NCT01009463|6034879|P4|4-week, Open-label Run-In Period|Adverse Event|0
1729821|NCT01009463|6034880|P3|4-week, Open-label Run-In Period|Adverse Event|0
1729822|NCT01009463|6034881|P2|4-week, Open-label Run-In Period|Adverse Event|0
1729823|NCT01009463|6034882|P1|4-week, Open-label Run-In Period|Adverse Event|10
1729824|NCT01009463|6034878|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1729825|NCT01009463|6034879|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1729826|NCT01009463|6034880|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1729827|NCT01009463|6034881|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
1729828|NCT01009463|6034882|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
1729829|NCT01009346|6034904|P1|Overall Study|Adverse Event|4
1729830|NCT01009203|6034928|P1|Overall Study|Treatment-unrelated death|1
1729831|NCT01009203|6034928|P1|Overall Study|Adverse Event|5
1729832|NCT01009203|6034928|P1|Overall Study|Withdrawal by Subject|1
1729833|NCT01009099|6034968|P2|Overall Study|Death|1
1729834|NCT01009099|6034969|P1|Overall Study|Death|0
1729835|NCT01009099|6034968|P2|Overall Study|Withdrawal by Subject|1
1729836|NCT01009099|6034969|P1|Overall Study|Withdrawal by Subject|1
1729837|NCT01009099|6034968|P2|Overall Study|Physician Decision|2
1729838|NCT01009099|6034969|P1|Overall Study|Physician Decision|3
1729839|NCT01009099|6034968|P2|Overall Study|Lost to Follow-up|0
1729840|NCT01009099|6034969|P1|Overall Study|Lost to Follow-up|1
1729841|NCT01009086|6034978|P3|Overall Study|Other|1
1729842|NCT01009086|6034979|P2|Overall Study|Other|5
1729843|NCT01009086|6034980|P1|Overall Study|Other|3
1729844|NCT01009086|6034978|P3|Overall Study|Withdrawal by Subject|13
1729845|NCT01009086|6034979|P2|Overall Study|Withdrawal by Subject|11
1729846|NCT01009086|6034980|P1|Overall Study|Withdrawal by Subject|9
1729847|NCT01009086|6034978|P3|Overall Study|Adverse Event|8
1729848|NCT01009086|6034979|P2|Overall Study|Adverse Event|11
1729849|NCT01009086|6034980|P1|Overall Study|Adverse Event|12
1729850|NCT01009086|6034978|P3|Overall Study|Lost to Follow-up|3
1729851|NCT01009086|6034979|P2|Overall Study|Lost to Follow-up|5
1729852|NCT01009086|6034980|P1|Overall Study|Lost to Follow-up|4
1729853|NCT01009086|6034978|P3|Overall Study|Lack of Efficacy|9
1729854|NCT01009086|6034979|P2|Overall Study|Lack of Efficacy|15
1729855|NCT01009086|6034980|P1|Overall Study|Lack of Efficacy|16
1729856|NCT01009060|6035015|P2|Overall Study|Withdrawal by Subject|1
1729857|NCT01009060|6035016|P1|Overall Study|Withdrawal by Subject|1
1729858|NCT01009060|6035015|P2|Overall Study|Physician Decision|1
1729859|NCT01009060|6035016|P1|Overall Study|Physician Decision|1
1729860|NCT01009060|6035015|P2|Overall Study|Lost to Follow-up|0
1729861|NCT01009060|6035016|P1|Overall Study|Lost to Follow-up|1
1729862|NCT01009060|6035015|P2|Overall Study|Protocol Violation|1
1729863|NCT01009060|6035016|P1|Overall Study|Protocol Violation|0
1729864|NCT01009060|6035015|P2|Overall Study|Adverse Event|2
1729865|NCT01009060|6035016|P1|Overall Study|Adverse Event|1
1729866|NCT01009047|6035054|P2|Overall Study|Other|2
1729867|NCT01009047|6035055|P1|Overall Study|Other|3
1729868|NCT01009047|6035054|P2|Overall Study|Withdrawal by consent|11
1729869|NCT01009047|6035055|P1|Overall Study|Withdrawal by consent|16
1729870|NCT01009047|6035054|P2|Overall Study|Lack of Efficacy|11
1729871|NCT01009047|6035055|P1|Overall Study|Lack of Efficacy|4
1729872|NCT01009047|6035054|P2|Overall Study|Lost to Follow-up|2
1729873|NCT01009047|6035055|P1|Overall Study|Lost to Follow-up|0
1729874|NCT01009047|6035054|P2|Overall Study|Adverse Event|0
1729875|NCT01009047|6035055|P1|Overall Study|Adverse Event|5
1729876|NCT01009034|6035077|P1|Overall Study|Withdrawal by Subject|2
1729877|NCT01009034|6035077|P1|Overall Study|Lost to Follow-up|2
1729878|NCT01008995|6035085|P4|After Controlled Period|Other|0
1729879|NCT01008995|6035086|P3|After Controlled Period|Other|1
1729880|NCT01008995|6035087|P2|After Controlled Period|Other|0
1729881|NCT01008995|6035088|P1|After Controlled Period|Other|0
1729882|NCT01008995|6035085|P4|After Controlled Period|Adverse Event|1
1729883|NCT01008995|6035086|P3|After Controlled Period|Adverse Event|1
1729884|NCT01008995|6035087|P2|After Controlled Period|Adverse Event|0
1729885|NCT01008995|6035088|P1|After Controlled Period|Adverse Event|0
1729886|NCT01008995|6035085|P4|Controlled Period|Other|0
1729887|NCT01008995|6035086|P3|Controlled Period|Other|0
1729888|NCT01008995|6035087|P2|Controlled Period|Other|1
1729889|NCT01008995|6035088|P1|Controlled Period|Other|2
1729890|NCT01008995|6035085|P4|Controlled Period|Adverse Event|0
1729891|NCT01008995|6035086|P3|Controlled Period|Adverse Event|0
1729892|NCT01008995|6035087|P2|Controlled Period|Adverse Event|2
1729893|NCT01008995|6035088|P1|Controlled Period|Adverse Event|1
1729894|NCT01008943|6035105|P1|Overall Study|Withdrawal by Subject|1
1729895|NCT01008904|6035112|P1|Overall Study|unexpected unrelated surgery|1
1729896|NCT01008904|6035112|P1|Overall Study|Adverse Event|2
1729897|NCT01008904|6035112|P1|Overall Study|Lost to Follow-up|1
1729898|NCT01008696|6035130|P2|Overall Study|Other|2
1729899|NCT01008696|6035131|P1|Overall Study|Other|0
1729900|NCT01008696|6035130|P2|Overall Study|Other|3
1729901|NCT01008696|6035131|P1|Overall Study|Other|2
1729902|NCT01008696|6035130|P2|Overall Study|Participants' non-cooperation|3
1729903|NCT01008696|6035131|P1|Overall Study|Participants' non-cooperation|2
1729904|NCT01008696|6035130|P2|Overall Study|Adverse Event|0
1729905|NCT01008696|6035131|P1|Overall Study|Adverse Event|1
1729906|NCT01008696|6035130|P2|Overall Study|Physician Decision|1
1729907|NCT01008696|6035131|P1|Overall Study|Physician Decision|5
1729908|NCT01008696|6035130|P2|Overall Study|Withdrawal by Subject|4
1729909|NCT01008696|6035131|P1|Overall Study|Withdrawal by Subject|2
1729910|NCT01008696|6035130|P2|Overall Study|Participant's evasion of hospital visit|4
1729911|NCT01008696|6035131|P1|Overall Study|Participant's evasion of hospital visit|5
1729912|NCT01008618|6035141|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
1729913|NCT01008618|6035142|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
1729914|NCT01008618|6035143|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
1729915|NCT01008618|6035141|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
1729916|NCT01008618|6035142|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
1729917|NCT01008618|6035143|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
1729918|NCT01008618|6035141|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
1729919|NCT01008618|6035142|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1729920|NCT01008618|6035143|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1729921|NCT01008618|6035141|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
1729922|NCT01008618|6035142|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1729923|NCT01008618|6035143|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1729924|NCT01008618|6035141|P3|Period 2 (Double-Blind Period)|Physician Decision|0
1729925|NCT01008618|6035142|P2|Period 2 (Double-Blind Period)|Physician Decision|1
1729926|NCT01008618|6035143|P1|Period 2 (Double-Blind Period)|Physician Decision|0
1729927|NCT01008618|6035141|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1729928|NCT01008618|6035142|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
1729929|NCT01008618|6035143|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
1729930|NCT01008618|6035141|P3|Period 2 (Double-Blind Period)|Adverse Event|2
1729931|NCT01008618|6035142|P2|Period 2 (Double-Blind Period)|Adverse Event|11
1729932|NCT01008618|6035143|P1|Period 2 (Double-Blind Period)|Adverse Event|0
1729933|NCT01008618|6035141|P3|Period 1 (Titration Period)|Aggravated symptom|0
1729934|NCT01008618|6035142|P2|Period 1 (Titration Period)|Aggravated symptom|0
1729935|NCT01008618|6035143|P1|Period 1 (Titration Period)|Aggravated symptom|2
1729936|NCT01008618|6035141|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1729937|NCT01008618|6035142|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1729938|NCT01008618|6035143|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
1729939|NCT01008618|6035141|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
1729940|NCT01008618|6035142|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
1729941|NCT01008618|6035143|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
1729942|NCT01008618|6035141|P3|Period 1 (Titration Period)|Adverse Event|0
1729943|NCT01008618|6035142|P2|Period 1 (Titration Period)|Adverse Event|0
1729944|NCT01008618|6035143|P1|Period 1 (Titration Period)|Adverse Event|33
1729945|NCT01008618|6035141|P3|Period 1 (Titration Period)|Physician Decision|0
1729946|NCT01008618|6035142|P2|Period 1 (Titration Period)|Physician Decision|0
1729947|NCT01008618|6035143|P1|Period 1 (Titration Period)|Physician Decision|2
1729948|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
1729949|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
1729950|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
1729951|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
1729952|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1729953|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
1729954|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
1729955|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
1729956|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
1729957|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
1729958|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
1729959|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
1729960|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
1729961|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
1729962|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
1729963|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1729964|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
1729965|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
1729966|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|Adverse Event|4
1729967|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|Adverse Event|14
1729968|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|Adverse Event|0
1729969|NCT01008553|6035192|P3|Period 2 (Double-Blind Period)|Physician Decision|2
1729970|NCT01008553|6035193|P2|Period 2 (Double-Blind Period)|Physician Decision|1
1729971|NCT01008553|6035194|P1|Period 2 (Double-Blind Period)|Physician Decision|0
1729972|NCT01008553|6035192|P3|Period 1 (Titration Period)|Not appropriate for this study|0
1729973|NCT01008553|6035193|P2|Period 1 (Titration Period)|Not appropriate for this study|0
1729974|NCT01008553|6035194|P1|Period 1 (Titration Period)|Not appropriate for this study|1
1729975|NCT01008553|6035192|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1729976|NCT01008553|6035193|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
1730061|NCT01007838|6035464|P4|Overall Study|Physician Decision|0
1729977|NCT01008553|6035194|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
1729978|NCT01008553|6035192|P3|Period 1 (Titration Period)|Determined to increase dosage|0
1729979|NCT01008553|6035193|P2|Period 1 (Titration Period)|Determined to increase dosage|0
1729980|NCT01008553|6035194|P1|Period 1 (Titration Period)|Determined to increase dosage|3
1729981|NCT01008553|6035192|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
1729982|NCT01008553|6035193|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
1729983|NCT01008553|6035194|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
1729984|NCT01008553|6035192|P3|Period 1 (Titration Period)|Adverse Event|0
1729985|NCT01008553|6035193|P2|Period 1 (Titration Period)|Adverse Event|0
1729986|NCT01008553|6035194|P1|Period 1 (Titration Period)|Adverse Event|33
1729987|NCT01008553|6035192|P3|Period 1 (Titration Period)|Physician Decision|0
1729988|NCT01008553|6035193|P2|Period 1 (Titration Period)|Physician Decision|0
1729989|NCT01008553|6035194|P1|Period 1 (Titration Period)|Physician Decision|2
1729990|NCT01008475|6035226|P7|Overall Study|Ongoing treatment at data cut-off date|4
1729991|NCT01008475|6035227|P6|Overall Study|Ongoing treatment at data cut-off date|6
1729992|NCT01008475|6035228|P5|Overall Study|Ongoing treatment at data cut-off date|5
1729993|NCT01008475|6035229|P4|Overall Study|Ongoing treatment at data cut-off date|0
1729994|NCT01008475|6035230|P3|Overall Study|Ongoing treatment at data cut-off date|0
1729995|NCT01008475|6035231|P2|Overall Study|Ongoing treatment at data cut-off date|0
1729996|NCT01008475|6035232|P1|Overall Study|Ongoing treatment at data cut-off date|0
1729997|NCT01008449|6035272|P2|Overall Study|Lost to Follow-up|19
1729998|NCT01008449|6035273|P1|Overall Study|Lost to Follow-up|29
1729999|NCT01008423|6035295|P2|Overall Study|Other|1
1730000|NCT01008423|6035296|P1|Overall Study|Other|0
1730001|NCT01008423|6035295|P2|Overall Study|Personal Conflict|0
1730002|NCT01008423|6035296|P1|Overall Study|Personal Conflict|1
1730003|NCT01008423|6035295|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
1730004|NCT01008423|6035296|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
1730005|NCT01008423|6035295|P2|Overall Study|Lack of Efficacy|5
1730006|NCT01008423|6035296|P1|Overall Study|Lack of Efficacy|0
1730007|NCT01008423|6035295|P2|Overall Study|Low Cortisol|1
1730008|NCT01008423|6035296|P1|Overall Study|Low Cortisol|0
1730009|NCT01008423|6035295|P2|Overall Study|Lost to Follow-up|2
1730010|NCT01008423|6035296|P1|Overall Study|Lost to Follow-up|0
1730011|NCT01008423|6035295|P2|Overall Study|Withdrawal by Subject|7
1730012|NCT01008423|6035296|P1|Overall Study|Withdrawal by Subject|4
1730013|NCT01008423|6035295|P2|Overall Study|Adverse Event|6
1730014|NCT01008423|6035296|P1|Overall Study|Adverse Event|13
1730015|NCT01008410|6035322|P2|Overall Study|Met Exclusion Criterion|1
1730016|NCT01008410|6035323|P1|Overall Study|Met Exclusion Criterion|0
1730017|NCT01008410|6035322|P2|Overall Study|Lack of Efficacy|6
1730018|NCT01008410|6035323|P1|Overall Study|Lack of Efficacy|2
1730019|NCT01008410|6035322|P2|Overall Study|Low Cortisol|0
1730020|NCT01008410|6035323|P1|Overall Study|Low Cortisol|2
1730021|NCT01008410|6035322|P2|Overall Study|Noncompliance|0
1730022|NCT01008410|6035323|P1|Overall Study|Noncompliance|1
1730023|NCT01008410|6035322|P2|Overall Study|Lost to Follow-up|0
1730024|NCT01008410|6035323|P1|Overall Study|Lost to Follow-up|1
1730025|NCT01008410|6035322|P2|Overall Study|Withdrawal by Subject|2
1730026|NCT01008410|6035323|P1|Overall Study|Withdrawal by Subject|6
1730027|NCT01008410|6035322|P2|Overall Study|Adverse Event|7
1730028|NCT01008410|6035323|P1|Overall Study|Adverse Event|13
1730029|NCT01008150|6035377|P4|Overall Study|did not receive study drug|0
1730030|NCT01008150|6035378|P3|Overall Study|did not receive study drug|1
1730031|NCT01008150|6035379|P2|Overall Study|did not receive study drug|1
1730032|NCT01008150|6035380|P1|Overall Study|did not receive study drug|1
1730033|NCT01007916|6035428|P2|Period 2, 4 Weeks of Wear|Relocation|0
1730034|NCT01007916|6035429|P1|Period 2, 4 Weeks of Wear|Relocation|1
1730035|NCT01007916|6035428|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
1730036|NCT01007916|6035429|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
1730037|NCT01007942|6035437|P2|Overall Study|Patients untreated|3
1730038|NCT01007942|6035438|P1|Overall Study|Patients untreated|4
1730039|NCT01007942|6035437|P2|Overall Study|Death|2
1730040|NCT01007942|6035438|P1|Overall Study|Death|3
1730041|NCT01007942|6035437|P2|Overall Study|Administrative problems|0
1730042|NCT01007942|6035438|P1|Overall Study|Administrative problems|2
1730043|NCT01007942|6035437|P2|Overall Study|Lost to Follow-up|0
1730044|NCT01007942|6035438|P1|Overall Study|Lost to Follow-up|1
1730045|NCT01007942|6035437|P2|Overall Study|Withdrawal by Subject|14
1730046|NCT01007942|6035438|P1|Overall Study|Withdrawal by Subject|19
1730047|NCT01007942|6035437|P2|Overall Study|Protocol Violation|1
1730048|NCT01007942|6035438|P1|Overall Study|Protocol Violation|1
1730049|NCT01007942|6035437|P2|Overall Study|New cancer therapy|1
1730050|NCT01007942|6035438|P1|Overall Study|New cancer therapy|5
1730051|NCT01007942|6035437|P2|Overall Study|Disease progression|242
1730052|NCT01007942|6035438|P1|Overall Study|Disease progression|217
1730053|NCT01007942|6035437|P2|Overall Study|Abnormal test procedure|1
1730054|NCT01007942|6035438|P1|Overall Study|Abnormal test procedure|0
1730055|NCT01007942|6035437|P2|Overall Study|Adverse Event|14
1730056|NCT01007942|6035438|P1|Overall Study|Adverse Event|29
1730057|NCT01007838|6035464|P4|Overall Study|Started home haemodialysis|0
1730058|NCT01007838|6035465|P3|Overall Study|Started home haemodialysis|0
1730059|NCT01007838|6035466|P2|Overall Study|Started home haemodialysis|0
1730060|NCT01007838|6035467|P1|Overall Study|Started home haemodialysis|1
1730062|NCT01007838|6035465|P3|Overall Study|Physician Decision|0
1730063|NCT01007838|6035466|P2|Overall Study|Physician Decision|0
1730064|NCT01007838|6035467|P1|Overall Study|Physician Decision|1
1730065|NCT01007838|6035464|P4|Overall Study|Withdrawal by Subject|0
1730066|NCT01007838|6035465|P3|Overall Study|Withdrawal by Subject|0
1730067|NCT01007838|6035466|P2|Overall Study|Withdrawal by Subject|0
1730068|NCT01007838|6035467|P1|Overall Study|Withdrawal by Subject|1
1730069|NCT01007812|6035477|P2|Period 1, One Week|Discomfort|0
1730070|NCT01007812|6035478|P1|Period 1, One Week|Discomfort|1
1730071|NCT01007812|6035477|P2|Period 1, One Week|Lost to Follow-up|1
1730072|NCT01007812|6035478|P1|Period 1, One Week|Lost to Follow-up|0
1730073|NCT01007552|6035528|P1|Overall Study|Withdrawal by Subject|1
1730074|NCT01007448|6035544|P2|Overall Study|Adverse Event|4
1730075|NCT01007448|6035545|P1|Overall Study|Adverse Event|1
1730076|NCT01007448|6035544|P2|Overall Study|Withdrawal by Subject|3
1730077|NCT01007448|6035545|P1|Overall Study|Withdrawal by Subject|2
1730078|NCT01007448|6035544|P2|Overall Study|Lack of Efficacy|0
1730079|NCT01007448|6035545|P1|Overall Study|Lack of Efficacy|2
1730080|NCT01007448|6035544|P2|Overall Study|Progressive Disease|2
1730081|NCT01007448|6035545|P1|Overall Study|Progressive Disease|1
1730082|NCT01007448|6035544|P2|Overall Study|Participant Given Prohibited Medication|0
1730083|NCT01007448|6035545|P1|Overall Study|Participant Given Prohibited Medication|1
1730084|NCT01007448|6035544|P2|Overall Study|Participant Leaving the Country|0
1730085|NCT01007448|6035545|P1|Overall Study|Participant Leaving the Country|1
1730086|NCT01007448|6035544|P2|Overall Study|Staph Skin Infection Flare|0
1730087|NCT01007448|6035545|P1|Overall Study|Staph Skin Infection Flare|1
1730088|NCT01007448|6035544|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
1730089|NCT01007448|6035545|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
1730090|NCT01007435|6035577|P4|Overall Study|Reason not Specified|1
1730091|NCT01007435|6035578|P3|Overall Study|Reason not Specified|2
1730092|NCT01007435|6035579|P2|Overall Study|Reason not Specified|1
1730093|NCT01007435|6035580|P1|Overall Study|Reason not Specified|1
1730094|NCT01007435|6035577|P4|Overall Study|Failure to Return|6
1730095|NCT01007435|6035578|P3|Overall Study|Failure to Return|3
1730096|NCT01007435|6035579|P2|Overall Study|Failure to Return|4
1730097|NCT01007435|6035580|P1|Overall Study|Failure to Return|5
1730098|NCT01007435|6035577|P4|Overall Study|Refused Treatment|8
1730099|NCT01007435|6035578|P3|Overall Study|Refused Treatment|5
1730100|NCT01007435|6035579|P2|Overall Study|Refused Treatment|13
1730101|NCT01007435|6035580|P1|Overall Study|Refused Treatment|13
1730102|NCT01007435|6035577|P4|Overall Study|Other Protocol Violation|0
1730103|NCT01007435|6035578|P3|Overall Study|Other Protocol Violation|1
1730104|NCT01007435|6035579|P2|Overall Study|Other Protocol Violation|0
1730105|NCT01007435|6035580|P1|Overall Study|Other Protocol Violation|2
1730106|NCT01007435|6035577|P4|Overall Study|Violation of Selection Criteria at Entry|0
1730107|NCT01007435|6035578|P3|Overall Study|Violation of Selection Criteria at Entry|2
1730108|NCT01007435|6035579|P2|Overall Study|Violation of Selection Criteria at Entry|5
1730109|NCT01007435|6035580|P1|Overall Study|Violation of Selection Criteria at Entry|3
1730110|NCT01007435|6035577|P4|Overall Study|Insufficient Therapeutic Response|9
1730111|NCT01007435|6035578|P3|Overall Study|Insufficient Therapeutic Response|2
1730112|NCT01007435|6035579|P2|Overall Study|Insufficient Therapeutic Response|7
1730113|NCT01007435|6035580|P1|Overall Study|Insufficient Therapeutic Response|21
1730114|NCT01007435|6035577|P4|Overall Study|Death|1
1730115|NCT01007435|6035578|P3|Overall Study|Death|2
1730116|NCT01007435|6035579|P2|Overall Study|Death|4
1730117|NCT01007435|6035580|P1|Overall Study|Death|2
1730118|NCT01007435|6035577|P4|Overall Study|Adverse Event|31
1730119|NCT01007435|6035578|P3|Overall Study|Adverse Event|47
1730120|NCT01007435|6035579|P2|Overall Study|Adverse Event|25
1730121|NCT01007435|6035580|P1|Overall Study|Adverse Event|16
1730122|NCT01007396|6035622|P1|Overall Study|Lost to Follow-up|47
1730123|NCT01007253|6035627|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
1730124|NCT01007253|6035628|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
1730125|NCT01007253|6035629|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
1730126|NCT01007253|6035630|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
1730127|NCT01007149|6035662|P2|Overall Study|Administrative problems|1
1730128|NCT01007149|6035663|P1|Overall Study|Administrative problems|0
1730129|NCT01007123|6035689|P4|Overall Study|Lost to Follow-up|0
1730130|NCT01007123|6035690|P3|Overall Study|Lost to Follow-up|0
1730131|NCT01007123|6035691|P2|Overall Study|Lost to Follow-up|1
1730132|NCT01007123|6035692|P1|Overall Study|Lost to Follow-up|0
1730133|NCT01007123|6035689|P4|Overall Study|Withdrawal by Subject|0
1730134|NCT01007123|6035690|P3|Overall Study|Withdrawal by Subject|1
1730135|NCT01007123|6035691|P2|Overall Study|Withdrawal by Subject|0
1730136|NCT01007123|6035692|P1|Overall Study|Withdrawal by Subject|1
1730137|NCT01007123|6035689|P4|Overall Study|Protocol Violation|1
1730138|NCT01007123|6035690|P3|Overall Study|Protocol Violation|2
1730139|NCT01007123|6035691|P2|Overall Study|Protocol Violation|1
1730140|NCT01007123|6035692|P1|Overall Study|Protocol Violation|1
1730141|NCT01007123|6035689|P4|Overall Study|Lack of Efficacy|4
1730142|NCT01007123|6035690|P3|Overall Study|Lack of Efficacy|1
1730143|NCT01007123|6035691|P2|Overall Study|Lack of Efficacy|0
1730144|NCT01007123|6035692|P1|Overall Study|Lack of Efficacy|1
1730145|NCT01007123|6035689|P4|Overall Study|Adverse Event|1
1730146|NCT01007123|6035690|P3|Overall Study|Adverse Event|7
1730147|NCT01007123|6035691|P2|Overall Study|Adverse Event|4
1730148|NCT01007123|6035692|P1|Overall Study|Adverse Event|3
1730149|NCT01007032|6035753|P4|Overall Study|Withdrawal by Subject|1
1730150|NCT01007032|6035754|P3|Overall Study|Withdrawal by Subject|0
1730151|NCT01007032|6035755|P2|Overall Study|Withdrawal by Subject|0
1730152|NCT01007032|6035756|P1|Overall Study|Withdrawal by Subject|0
1730153|NCT01007032|6035753|P4|Overall Study|On Study Treatment at Cut-off Date|0
1730154|NCT01007032|6035754|P3|Overall Study|On Study Treatment at Cut-off Date|1
1730155|NCT01007032|6035755|P2|Overall Study|On Study Treatment at Cut-off Date|1
1730156|NCT01007032|6035756|P1|Overall Study|On Study Treatment at Cut-off Date|0
1730157|NCT01006980|6035800|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
1730158|NCT01006980|6035801|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
1730159|NCT01006980|6035800|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
1730160|NCT01006980|6035801|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
1730161|NCT01006980|6035800|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
1730162|NCT01006980|6035801|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
1730163|NCT01006980|6035800|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
1730164|NCT01006980|6035801|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
1730165|NCT01006980|6035800|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
1730166|NCT01006980|6035801|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
1730167|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
1730168|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
1730169|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
1730170|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
1730171|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
1730172|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
1730173|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
1730174|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
1730175|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Progression|218
1730176|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Progression|257
1730177|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Death|12
1730178|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Death|13
1730179|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Adverse Event|5
1730180|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Adverse Event|25
1730181|NCT01006980|6035800|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
1730182|NCT01006980|6035801|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
1730183|NCT01006889|6035840|P1|Overall Study|Withdrawal by Subject|3
1730184|NCT01006707|6035851|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
1730185|NCT01006707|6035852|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
1730186|NCT01006707|6035853|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
1730187|NCT01006707|6035851|P3|Study Session 1|Lost to Follow-up|0
1730188|NCT01006707|6035852|P2|Study Session 1|Lost to Follow-up|0
1730189|NCT01006707|6035853|P1|Study Session 1|Lost to Follow-up|2
1730190|NCT01006629|6035873|P1|Overall Study|Parent unable to perform site visit|4
1730191|NCT01006629|6035873|P1|Overall Study|Parent refused to continue participation|1
1730192|NCT01006629|6035873|P1|Overall Study|Adverse Event|1
1730193|NCT01006616|6035888|P4|Period 2 (18 Months)|Study Terminated|70
1730194|NCT01006616|6035889|P3|Period 2 (18 Months)|Study Terminated|44
1730195|NCT01006616|6035890|P2|Period 2 (18 Months)|Study Terminated|46
1730196|NCT01006616|6035891|P1|Period 2 (18 Months)|Study Terminated|63
1730197|NCT01006616|6035888|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
1730198|NCT01006616|6035889|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
1730199|NCT01006616|6035890|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
1730200|NCT01006616|6035891|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
1730201|NCT01006616|6035888|P4|Period 2 (18 Months)|Withdrawal by Subject|1
1730202|NCT01006616|6035889|P3|Period 2 (18 Months)|Withdrawal by Subject|0
1730203|NCT01006616|6035890|P2|Period 2 (18 Months)|Withdrawal by Subject|4
1730204|NCT01006616|6035891|P1|Period 2 (18 Months)|Withdrawal by Subject|1
1730205|NCT01006616|6035888|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
1730206|NCT01006616|6035889|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
1730207|NCT01006616|6035890|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
1730208|NCT01006616|6035891|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
1730209|NCT01006616|6035888|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
1730210|NCT01006616|6035889|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
1730211|NCT01006616|6035890|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
1730212|NCT01006616|6035891|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
1730213|NCT01006616|6035888|P4|Period 2 (18 Months)|Lost to Follow-up|0
1730214|NCT01006616|6035889|P3|Period 2 (18 Months)|Lost to Follow-up|0
1730215|NCT01006616|6035890|P2|Period 2 (18 Months)|Lost to Follow-up|0
1730216|NCT01006616|6035891|P1|Period 2 (18 Months)|Lost to Follow-up|2
1730217|NCT01006616|6035888|P4|Period 2 (18 Months)|Lack of Efficacy|2
1730218|NCT01006616|6035889|P3|Period 2 (18 Months)|Lack of Efficacy|1
1730219|NCT01006616|6035890|P2|Period 2 (18 Months)|Lack of Efficacy|0
1730220|NCT01006616|6035891|P1|Period 2 (18 Months)|Lack of Efficacy|0
1730221|NCT01006616|6035888|P4|Period 2 (18 Months)|Adverse Event|4
1730222|NCT01006616|6035889|P3|Period 2 (18 Months)|Adverse Event|6
1730223|NCT01006616|6035890|P2|Period 2 (18 Months)|Adverse Event|6
1730224|NCT01006616|6035891|P1|Period 2 (18 Months)|Adverse Event|6
1730225|NCT01006616|6035888|P4|Period 1 (6 Months)|Not Treated|1
1730226|NCT01006616|6035889|P3|Period 1 (6 Months)|Not Treated|1
1730227|NCT01006616|6035890|P2|Period 1 (6 Months)|Not Treated|0
1730228|NCT01006616|6035891|P1|Period 1 (6 Months)|Not Treated|0
1730229|NCT01006616|6035888|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
1730230|NCT01006616|6035889|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
1730231|NCT01006616|6035890|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
1730232|NCT01006616|6035891|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
1730233|NCT01006616|6035888|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1730234|NCT01006616|6035889|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1730235|NCT01006616|6035890|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
1730236|NCT01006616|6035891|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
1730237|NCT01006616|6035888|P4|Period 1 (6 Months)|Withdrawal by Subject|0
1730238|NCT01006616|6035889|P3|Period 1 (6 Months)|Withdrawal by Subject|2
1730239|NCT01006616|6035890|P2|Period 1 (6 Months)|Withdrawal by Subject|2
1730240|NCT01006616|6035891|P1|Period 1 (6 Months)|Withdrawal by Subject|2
1730241|NCT01006616|6035888|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
1730242|NCT01006616|6035889|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
1730243|NCT01006616|6035890|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
1730244|NCT01006616|6035891|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
1730245|NCT01006616|6035888|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
1730246|NCT01006616|6035889|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
1730247|NCT01006616|6035890|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
1730248|NCT01006616|6035891|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
1730249|NCT01006616|6035888|P4|Period 1 (6 Months)|Lost to Follow-up|0
1730250|NCT01006616|6035889|P3|Period 1 (6 Months)|Lost to Follow-up|1
1730251|NCT01006616|6035890|P2|Period 1 (6 Months)|Lost to Follow-up|0
1730252|NCT01006616|6035891|P1|Period 1 (6 Months)|Lost to Follow-up|0
1730253|NCT01006616|6035888|P4|Period 1 (6 Months)|Lack of Efficacy|4
1730254|NCT01006616|6035889|P3|Period 1 (6 Months)|Lack of Efficacy|0
1730255|NCT01006616|6035890|P2|Period 1 (6 Months)|Lack of Efficacy|4
1730256|NCT01006616|6035891|P1|Period 1 (6 Months)|Lack of Efficacy|3
1730257|NCT01006616|6035888|P4|Period 1 (6 Months)|Adverse Event|9
1730258|NCT01006616|6035889|P3|Period 1 (6 Months)|Adverse Event|37
1730259|NCT01006616|6035890|P2|Period 1 (6 Months)|Adverse Event|31
1730260|NCT01006616|6035891|P1|Period 1 (6 Months)|Adverse Event|10
1730261|NCT01006603|6036027|P2|Overall Study|Other|7
1730262|NCT01006603|6036028|P1|Overall Study|Other|3
1730263|NCT01006603|6036027|P2|Overall Study|Study specific discontinuation criteria|34
1730264|NCT01006603|6036028|P1|Overall Study|Study specific discontinuation criteria|33
1730265|NCT01006603|6036027|P2|Overall Study|Death|1
1730266|NCT01006603|6036028|P1|Overall Study|Death|1
1730267|NCT01006603|6036027|P2|Overall Study|Adverse Event|7
1730268|NCT01006603|6036028|P1|Overall Study|Adverse Event|15
1730269|NCT01006603|6036027|P2|Overall Study|Incorrect enrolment|2
1730270|NCT01006603|6036028|P1|Overall Study|Incorrect enrolment|0
1730271|NCT01006603|6036027|P2|Overall Study|Protocol Violation|3
1730272|NCT01006603|6036028|P1|Overall Study|Protocol Violation|1
1730273|NCT01006603|6036027|P2|Overall Study|Safety reason|1
1730274|NCT01006603|6036028|P1|Overall Study|Safety reason|1
1730275|NCT01006603|6036027|P2|Overall Study|Lost to Follow-up|1
1730276|NCT01006603|6036028|P1|Overall Study|Lost to Follow-up|0
1730277|NCT01006603|6036027|P2|Overall Study|Withdrawal by Subject|19
1730278|NCT01006603|6036028|P1|Overall Study|Withdrawal by Subject|17
1730279|NCT01006590|6036048|P2|Overall Study|Other|2
1730280|NCT01006590|6036049|P1|Overall Study|Other|3
1730281|NCT01006590|6036048|P2|Overall Study|Study specific discontinuation criteria|23
1730282|NCT01006590|6036049|P1|Overall Study|Study specific discontinuation criteria|16
1730283|NCT01006590|6036048|P2|Overall Study|Withdrawal by Subject|2
1730284|NCT01006590|6036049|P1|Overall Study|Withdrawal by Subject|4
1730285|NCT01006590|6036048|P2|Overall Study|Protocol Violation|0
1730286|NCT01006590|6036049|P1|Overall Study|Protocol Violation|1
1730287|NCT01006590|6036048|P2|Overall Study|Lost to Follow-up|1
1730288|NCT01006590|6036049|P1|Overall Study|Lost to Follow-up|1
1730289|NCT01006590|6036048|P2|Overall Study|Death|1
1730290|NCT01006590|6036049|P1|Overall Study|Death|1
1730291|NCT01006590|6036048|P2|Overall Study|Adverse Event|3
1730292|NCT01006590|6036049|P1|Overall Study|Adverse Event|2
1730293|NCT01006356|6036088|P1|Overall Study|Other|23
1730294|NCT01006356|6036088|P1|Overall Study|Protocol Violation|3
1730295|NCT01006356|6036088|P1|Overall Study|Choice by participants|2
1730296|NCT01006356|6036088|P1|Overall Study|Withdrawal by Subject|1
1730297|NCT01006356|6036088|P1|Overall Study|Paticipants did not cooperate|6
1730298|NCT01006356|6036088|P1|Overall Study|Physician Decision|1
1730299|NCT01006356|6036088|P1|Overall Study|Adverse Event|6
1730300|NCT01006291|6036103|P3|Overall Study|Other|17
1730301|NCT01006291|6036104|P2|Overall Study|Other|14
1730302|NCT01006291|6036105|P1|Overall Study|Other|14
1730303|NCT01006291|6036103|P3|Overall Study|Withdrawal criteria|4
1730304|NCT01006291|6036104|P2|Overall Study|Withdrawal criteria|4
1730305|NCT01006291|6036105|P1|Overall Study|Withdrawal criteria|5
1730306|NCT01006291|6036103|P3|Overall Study|Protocol Violation|3
1730307|NCT01006291|6036104|P2|Overall Study|Protocol Violation|3
1730308|NCT01006291|6036105|P1|Overall Study|Protocol Violation|3
1730309|NCT01006291|6036103|P3|Overall Study|Lack of Efficacy|1
1730310|NCT01006291|6036104|P2|Overall Study|Lack of Efficacy|2
1730311|NCT01006291|6036105|P1|Overall Study|Lack of Efficacy|2
1730312|NCT01006291|6036103|P3|Overall Study|Adverse Event|2
1730313|NCT01006291|6036104|P2|Overall Study|Adverse Event|1
1730314|NCT01006291|6036105|P1|Overall Study|Adverse Event|2
1730315|NCT01006135|6036155|P1|Overall Study|Other|72
1730316|NCT01006135|6036155|P1|Overall Study|Lost to Follow-up|32
1730317|NCT01006135|6036155|P1|Overall Study|Protocol Violation|14
1730318|NCT01006135|6036155|P1|Overall Study|Adverse Event|22
1730319|NCT01006122|6036162|P2|Second Double-blind Intervention Period|Death|1
1730320|NCT01006122|6036163|P1|Second Double-blind Intervention Period|Death|0
1730321|NCT01006122|6036162|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
1730322|NCT01006122|6036163|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
1730323|NCT01006122|6036162|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
1730324|NCT01006122|6036163|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
1730325|NCT01006122|6036162|P2|Second Double-blind Intervention Period|Protocol Violation|0
1730326|NCT01006122|6036163|P1|Second Double-blind Intervention Period|Protocol Violation|1
1730327|NCT01006122|6036162|P2|Second Double-blind Intervention Period|Adverse Event|1
1730328|NCT01006122|6036163|P1|Second Double-blind Intervention Period|Adverse Event|1
1730329|NCT01006122|6036162|P2|First Double-blind Intervention Period|Adverse Event|4
1730330|NCT01006122|6036163|P1|First Double-blind Intervention Period|Adverse Event|0
1730331|NCT01006122|6036162|P2|First Double-blind Intervention Period|Other|0
1730332|NCT01006122|6036163|P1|First Double-blind Intervention Period|Other|3
1730333|NCT01006122|6036162|P2|First Double-blind Intervention Period|Lack of Efficacy|1
1730334|NCT01006122|6036163|P1|First Double-blind Intervention Period|Lack of Efficacy|2
1730335|NCT01006122|6036162|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
1730336|NCT01006122|6036163|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
1730337|NCT01006122|6036162|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
1730338|NCT01006122|6036163|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
1730339|NCT01006122|6036162|P2|First Double-blind Intervention Period|Pregnancy|1
1730340|NCT01006122|6036163|P1|First Double-blind Intervention Period|Pregnancy|0
1730341|NCT01006122|6036162|P2|First Double-blind Intervention Period|Protocol Violation|1
1730342|NCT01006122|6036163|P1|First Double-blind Intervention Period|Protocol Violation|1
1730343|NCT01006122|6036162|P2|First Double-blind Intervention Period|Lost to Follow-up|2
1730344|NCT01006122|6036163|P1|First Double-blind Intervention Period|Lost to Follow-up|0
1730345|NCT01005966|6036214|P5|Treatment Period 4 (14 Days)|Other Reason|1
1730346|NCT01005966|6036215|P4|Treatment Period 4 (14 Days)|Other Reason|0
1730347|NCT01005966|6036216|P3|Treatment Period 4 (14 Days)|Other Reason|0
1730348|NCT01005966|6036217|P2|Treatment Period 4 (14 Days)|Other Reason|0
1730349|NCT01005966|6036218|P1|Treatment Period 4 (14 Days)|Other Reason|0
1730350|NCT01005966|6036214|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
1730351|NCT01005966|6036215|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
1730352|NCT01005966|6036216|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
1730353|NCT01005966|6036217|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
1730354|NCT01005966|6036218|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
1730355|NCT01005966|6036214|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
1730356|NCT01005966|6036215|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
1730357|NCT01005966|6036216|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
1730358|NCT01005966|6036217|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
1730359|NCT01005966|6036218|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
1730360|NCT01005966|6036214|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1730361|NCT01005966|6036215|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1730362|NCT01005966|6036216|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
1730363|NCT01005966|6036217|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1730364|NCT01005966|6036218|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
1730365|NCT01005966|6036214|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
1730366|NCT01005966|6036215|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
1730367|NCT01005966|6036216|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
1730368|NCT01005966|6036217|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
1730369|NCT01005966|6036218|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
1730370|NCT01005966|6036214|P5|Treatment Period 2 (14 Days)|Adverse Event|0
1730371|NCT01005966|6036215|P4|Treatment Period 2 (14 Days)|Adverse Event|0
1730372|NCT01005966|6036216|P3|Treatment Period 2 (14 Days)|Adverse Event|1
1730373|NCT01005966|6036217|P2|Treatment Period 2 (14 Days)|Adverse Event|1
1730374|NCT01005966|6036218|P1|Treatment Period 2 (14 Days)|Adverse Event|0
1730375|NCT01005966|6036214|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1730376|NCT01005966|6036215|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
1730377|NCT01005966|6036216|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1730378|NCT01005966|6036217|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1730379|NCT01005966|6036218|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
1730380|NCT01005966|6036214|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
1730381|NCT01005966|6036215|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
1730382|NCT01005966|6036216|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
1730383|NCT01005966|6036217|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
1730384|NCT01005966|6036218|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
1730385|NCT01005966|6036214|P5|Treatment Period 1 (14 Days)|Adverse Event|0
1730386|NCT01005966|6036215|P4|Treatment Period 1 (14 Days)|Adverse Event|0
1730387|NCT01005966|6036216|P3|Treatment Period 1 (14 Days)|Adverse Event|0
1730388|NCT01005966|6036217|P2|Treatment Period 1 (14 Days)|Adverse Event|0
1730389|NCT01005966|6036218|P1|Treatment Period 1 (14 Days)|Adverse Event|1
1730390|NCT01005914|6036238|P1|Overall Study|Withdrawal by Subject|1
1730391|NCT01005914|6036238|P1|Overall Study|Lack of Efficacy|1
1730392|NCT01005914|6036238|P1|Overall Study|Death|4
1730393|NCT01005914|6036238|P1|Overall Study|Adverse Event|4
1730394|NCT01005901|6036244|P2|Overall Study|No longer requires study drug|1
1730395|NCT01005901|6036245|P1|Overall Study|No longer requires study drug|0
1730396|NCT01005901|6036244|P2|Overall Study|Patient's inability to use the device|1
1730397|NCT01005901|6036245|P1|Overall Study|Patient's inability to use the device|1
1730398|NCT01005901|6036244|P2|Overall Study|Lost to Follow-up|2
1730399|NCT01005901|6036245|P1|Overall Study|Lost to Follow-up|1
1730400|NCT01005901|6036244|P2|Overall Study|Death|3
1730401|NCT01005901|6036245|P1|Overall Study|Death|2
1730402|NCT01005901|6036244|P2|Overall Study|Protocol Violation|3
1730403|NCT01005901|6036245|P1|Overall Study|Protocol Violation|4
1730404|NCT01005901|6036244|P2|Overall Study|Unsatisfactory therapeutic effect|5
1730405|NCT01005901|6036245|P1|Overall Study|Unsatisfactory therapeutic effect|5
1730406|NCT01005901|6036244|P2|Overall Study|Administrative problems|13
1730407|NCT01005901|6036245|P1|Overall Study|Administrative problems|21
1730408|NCT01005901|6036244|P2|Overall Study|Adverse Event|16
1730409|NCT01005901|6036245|P1|Overall Study|Adverse Event|30
1730410|NCT01005901|6036244|P2|Overall Study|Withdrawal by Subject|14
1730411|NCT01005901|6036245|P1|Overall Study|Withdrawal by Subject|38
1730412|NCT01005875|6036308|P1|Overall Study|Death|3
1730417|NCT01005732|6036330|P1|Overall Study|Death|1
1730418|NCT01005732|6036330|P1|Overall Study|Lost to Follow-up|10
1730419|NCT01005719|6036346|P6|Period 2|Adverse Event|1
1730420|NCT01005719|6036347|P5|Period 2|Adverse Event|1
1730421|NCT01005719|6036348|P4|Period 2|Adverse Event|0
1730422|NCT01005719|6036349|P3|Period 2|Adverse Event|0
1730423|NCT01005719|6036350|P2|Period 2|Adverse Event|0
1730424|NCT01005719|6036351|P1|Period 2|Adverse Event|0
1730425|NCT01005719|6036346|P6|Period 1|Delay in completing study procedures|1
1730426|NCT01005719|6036347|P5|Period 1|Delay in completing study procedures|0
1730427|NCT01005719|6036348|P4|Period 1|Delay in completing study procedures|0
1730428|NCT01005719|6036349|P3|Period 1|Delay in completing study procedures|0
1730429|NCT01005719|6036350|P2|Period 1|Delay in completing study procedures|0
1730430|NCT01005719|6036351|P1|Period 1|Delay in completing study procedures|0
1730431|NCT01005719|6036346|P6|Period 1|Adverse Event|0
1730432|NCT01005719|6036347|P5|Period 1|Adverse Event|0
1730433|NCT01005719|6036348|P4|Period 1|Adverse Event|1
1730434|NCT01005719|6036349|P3|Period 1|Adverse Event|0
1730435|NCT01005719|6036350|P2|Period 1|Adverse Event|0
1730436|NCT01005719|6036351|P1|Period 1|Adverse Event|0
1730437|NCT01005680|6036418|P2|Overall Study|Physician Decision|1
1730438|NCT01005680|6036419|P1|Overall Study|Physician Decision|1
1730439|NCT01005680|6036418|P2|Overall Study|Withdrawal by Subject|4
1730440|NCT01005680|6036419|P1|Overall Study|Withdrawal by Subject|1
1730441|NCT01005680|6036418|P2|Overall Study|Lost to Follow-up|6
1730442|NCT01005680|6036419|P1|Overall Study|Lost to Follow-up|4
1730443|NCT01005602|6036443|P2|Overall Study|Excluded due to unreliable clinical data|0
1730444|NCT01005602|6036444|P1|Overall Study|Excluded due to unreliable clinical data|1
1730445|NCT01005329|6036532|P1|Overall Study|Ineligible or received no protocol trt.|4
1730446|NCT01005316|6036545|P4|Overall Study|Retransplanted|0
1730447|NCT01005316|6036546|P3|Overall Study|Retransplanted|0
1730448|NCT01005316|6036547|P2|Overall Study|Retransplanted|1
1730449|NCT01005316|6036548|P1|Overall Study|Retransplanted|0
1730450|NCT01005316|6036545|P4|Overall Study|Transferred Care|3
1730451|NCT01005316|6036546|P3|Overall Study|Transferred Care|1
1730452|NCT01005316|6036547|P2|Overall Study|Transferred Care|0
1730453|NCT01005316|6036548|P1|Overall Study|Transferred Care|1
1730454|NCT01005316|6036545|P4|Overall Study|Delisted|0
1730455|NCT01005316|6036546|P3|Overall Study|Delisted|0
1730456|NCT01005316|6036547|P2|Overall Study|Delisted|0
1730457|NCT01005316|6036548|P1|Overall Study|Delisted|8
1730458|NCT01005316|6036545|P4|Overall Study|Consented to Another Study|0
1730459|NCT01005316|6036546|P3|Overall Study|Consented to Another Study|0
1730460|NCT01005316|6036547|P2|Overall Study|Consented to Another Study|0
1730461|NCT01005316|6036548|P1|Overall Study|Consented to Another Study|2
1730462|NCT01005316|6036545|P4|Overall Study|Withdrawal by Subject|2
1730463|NCT01005316|6036546|P3|Overall Study|Withdrawal by Subject|0
1730464|NCT01005316|6036547|P2|Overall Study|Withdrawal by Subject|1
1730465|NCT01005316|6036548|P1|Overall Study|Withdrawal by Subject|1
1730466|NCT01005316|6036545|P4|Overall Study|Sponsor Decision|0
1730467|NCT01005316|6036546|P3|Overall Study|Sponsor Decision|0
1730468|NCT01005316|6036547|P2|Overall Study|Sponsor Decision|3
1730469|NCT01005316|6036548|P1|Overall Study|Sponsor Decision|6
1730470|NCT01005316|6036545|P4|Overall Study|Physician Decision|0
1730471|NCT01005316|6036546|P3|Overall Study|Physician Decision|0
1730472|NCT01005316|6036547|P2|Overall Study|Physician Decision|0
1730473|NCT01005316|6036548|P1|Overall Study|Physician Decision|6
1730474|NCT01005316|6036545|P4|Overall Study|Lost to Follow-up|2
1730475|NCT01005316|6036546|P3|Overall Study|Lost to Follow-up|0
1730476|NCT01005316|6036547|P2|Overall Study|Lost to Follow-up|3
1730477|NCT01005316|6036548|P1|Overall Study|Lost to Follow-up|1
1730478|NCT01005316|6036545|P4|Overall Study|Study Termination|85
1730479|NCT01005316|6036546|P3|Overall Study|Study Termination|9
1730480|NCT01005316|6036547|P2|Overall Study|Study Termination|63
1730481|NCT01005316|6036548|P1|Overall Study|Study Termination|5
1730482|NCT01005316|6036545|P4|Overall Study|Death|15
1730483|NCT01005316|6036546|P3|Overall Study|Death|1
1730484|NCT01005316|6036547|P2|Overall Study|Death|5
1730485|NCT01005316|6036548|P1|Overall Study|Death|20
1730486|NCT01005316|6036545|P4|Overall Study|Adverse Event|1
1730487|NCT01005316|6036546|P3|Overall Study|Adverse Event|0
1730488|NCT01005316|6036547|P2|Overall Study|Adverse Event|0
1730489|NCT01005316|6036548|P1|Overall Study|Adverse Event|0
1730490|NCT01005251|6036615|P5|Overall Study|Lack of Efficacy|0
1730491|NCT01005251|6036616|P4|Overall Study|Lack of Efficacy|1
1730492|NCT01005251|6036617|P3|Overall Study|Lack of Efficacy|1
1730493|NCT01005251|6036618|P2|Overall Study|Lack of Efficacy|0
1730494|NCT01005251|6036619|P1|Overall Study|Lack of Efficacy|0
1730495|NCT01005251|6036615|P5|Overall Study|Randomized in error|0
1730496|NCT01005251|6036616|P4|Overall Study|Randomized in error|1
1730497|NCT01005251|6036617|P3|Overall Study|Randomized in error|1
1730498|NCT01005251|6036618|P2|Overall Study|Randomized in error|0
1730499|NCT01005251|6036619|P1|Overall Study|Randomized in error|0
1730500|NCT01005251|6036615|P5|Overall Study|Wrong drug dispensed|0
1730501|NCT01005251|6036616|P4|Overall Study|Wrong drug dispensed|0
1730502|NCT01005251|6036617|P3|Overall Study|Wrong drug dispensed|0
1730503|NCT01005251|6036618|P2|Overall Study|Wrong drug dispensed|1
1730504|NCT01005251|6036619|P1|Overall Study|Wrong drug dispensed|0
1730505|NCT01005251|6036615|P5|Overall Study|Patient moved|0
1730506|NCT01005251|6036616|P4|Overall Study|Patient moved|0
1730507|NCT01005251|6036617|P3|Overall Study|Patient moved|0
1730508|NCT01005251|6036618|P2|Overall Study|Patient moved|0
1730509|NCT01005251|6036619|P1|Overall Study|Patient moved|1
1730510|NCT01005251|6036615|P5|Overall Study|Physician Decision|2
1730511|NCT01005251|6036616|P4|Overall Study|Physician Decision|0
1730512|NCT01005251|6036617|P3|Overall Study|Physician Decision|0
1730513|NCT01005251|6036618|P2|Overall Study|Physician Decision|0
1730514|NCT01005251|6036619|P1|Overall Study|Physician Decision|0
1730515|NCT01005251|6036615|P5|Overall Study|Lost to Follow-up|0
1730516|NCT01005251|6036616|P4|Overall Study|Lost to Follow-up|0
1730517|NCT01005251|6036617|P3|Overall Study|Lost to Follow-up|2
1730518|NCT01005251|6036618|P2|Overall Study|Lost to Follow-up|4
1730519|NCT01005251|6036619|P1|Overall Study|Lost to Follow-up|1
1730520|NCT01005251|6036615|P5|Overall Study|Developed study-specific withdrawal crit|1
1730521|NCT01005251|6036616|P4|Overall Study|Developed study-specific withdrawal crit|0
1730522|NCT01005251|6036617|P3|Overall Study|Developed study-specific withdrawal crit|3
1730523|NCT01005251|6036618|P2|Overall Study|Developed study-specific withdrawal crit|0
1730524|NCT01005251|6036619|P1|Overall Study|Developed study-specific withdrawal crit|2
1730525|NCT01005251|6036615|P5|Overall Study|Protocol Violation|2
1730526|NCT01005251|6036616|P4|Overall Study|Protocol Violation|0
1730527|NCT01005251|6036617|P3|Overall Study|Protocol Violation|0
1730528|NCT01005251|6036618|P2|Overall Study|Protocol Violation|0
1730529|NCT01005251|6036619|P1|Overall Study|Protocol Violation|1
1730530|NCT01005251|6036615|P5|Overall Study|Adverse Event|4
1730531|NCT01005251|6036616|P4|Overall Study|Adverse Event|5
1730532|NCT01005251|6036617|P3|Overall Study|Adverse Event|8
1730533|NCT01005251|6036618|P2|Overall Study|Adverse Event|6
1730534|NCT01005251|6036619|P1|Overall Study|Adverse Event|2
1730535|NCT01005251|6036615|P5|Overall Study|Eligibility criteria not fulfilled|0
1730536|NCT01005251|6036616|P4|Overall Study|Eligibility criteria not fulfilled|1
1730537|NCT01005251|6036617|P3|Overall Study|Eligibility criteria not fulfilled|4
1730538|NCT01005251|6036618|P2|Overall Study|Eligibility criteria not fulfilled|0
1730539|NCT01005251|6036619|P1|Overall Study|Eligibility criteria not fulfilled|4
1730540|NCT01005251|6036615|P5|Overall Study|Withdrawal by Subject|9
1730541|NCT01005251|6036616|P4|Overall Study|Withdrawal by Subject|4
1730542|NCT01005251|6036617|P3|Overall Study|Withdrawal by Subject|3
1730543|NCT01005251|6036618|P2|Overall Study|Withdrawal by Subject|5
1730544|NCT01005251|6036619|P1|Overall Study|Withdrawal by Subject|2
1730545|NCT01004848|6036692|P2|Overall Study|Lost to Follow-up|45
1730546|NCT01004848|6036693|P1|Overall Study|Lost to Follow-up|55
1730547|NCT01004822|6036731|P8|Overall Study|Other|0
1730548|NCT01004822|6036732|P7|Overall Study|Other|0
1730549|NCT01004822|6036733|P6|Overall Study|Other|1
1730550|NCT01004822|6036734|P5|Overall Study|Other|0
1730551|NCT01004822|6036735|P4|Overall Study|Other|1
1730552|NCT01004822|6036736|P3|Overall Study|Other|4
1730553|NCT01004822|6036737|P2|Overall Study|Other|0
1730554|NCT01004822|6036738|P1|Overall Study|Other|0
1730555|NCT01004822|6036731|P8|Overall Study|Adverse Event|1
1730556|NCT01004822|6036732|P7|Overall Study|Adverse Event|1
1730557|NCT01004822|6036733|P6|Overall Study|Adverse Event|0
1730558|NCT01004822|6036734|P5|Overall Study|Adverse Event|0
1730559|NCT01004822|6036735|P4|Overall Study|Adverse Event|0
1730560|NCT01004822|6036736|P3|Overall Study|Adverse Event|0
1730561|NCT01004822|6036737|P2|Overall Study|Adverse Event|0
1730562|NCT01004822|6036738|P1|Overall Study|Adverse Event|0
1730563|NCT01004822|6036731|P8|Overall Study|No longer willing to continue|0
1730564|NCT01004822|6036732|P7|Overall Study|No longer willing to continue|1
1730565|NCT01004822|6036733|P6|Overall Study|No longer willing to continue|1
1730566|NCT01004822|6036734|P5|Overall Study|No longer willing to continue|2
1730567|NCT01004822|6036735|P4|Overall Study|No longer willing to continue|1
1730568|NCT01004822|6036736|P3|Overall Study|No longer willing to continue|0
1730569|NCT01004822|6036737|P2|Overall Study|No longer willing to continue|0
1730570|NCT01004822|6036738|P1|Overall Study|No longer willing to continue|0
1730571|NCT01004822|6036731|P8|Overall Study|Global deterioration of health status|0
1730572|NCT01004822|6036732|P7|Overall Study|Global deterioration of health status|1
1730573|NCT01004822|6036733|P6|Overall Study|Global deterioration of health status|0
1730574|NCT01004822|6036734|P5|Overall Study|Global deterioration of health status|0
1730575|NCT01004822|6036735|P4|Overall Study|Global deterioration of health status|1
1730576|NCT01004822|6036736|P3|Overall Study|Global deterioration of health status|0
1730577|NCT01004822|6036737|P2|Overall Study|Global deterioration of health status|0
1730578|NCT01004822|6036738|P1|Overall Study|Global deterioration of health status|0
1730579|NCT01004822|6036731|P8|Overall Study|Objective progression or relapse|4
1730580|NCT01004822|6036732|P7|Overall Study|Objective progression or relapse|1
1730581|NCT01004822|6036733|P6|Overall Study|Objective progression or relapse|2
1730582|NCT01004822|6036734|P5|Overall Study|Objective progression or relapse|2
1730583|NCT01004822|6036735|P4|Overall Study|Objective progression or relapse|1
1730584|NCT01004822|6036736|P3|Overall Study|Objective progression or relapse|0
1730585|NCT01004822|6036737|P2|Overall Study|Objective progression or relapse|3
1730586|NCT01004822|6036738|P1|Overall Study|Objective progression or relapse|3
1730587|NCT01004614|6036903|P4|Washout|Withdrawal by Subject|0
1730588|NCT01004614|6036904|P3|Washout|Withdrawal by Subject|0
1730589|NCT01004614|6036905|P2|Washout|Withdrawal by Subject|1
1730590|NCT01004614|6036906|P1|Washout|Withdrawal by Subject|0
1730591|NCT01004510|6036940|P1|Overall Study|Adverse Event|1
1730592|NCT01004432|6036944|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
1730593|NCT01004432|6036945|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1730594|NCT01004432|6036946|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1730595|NCT01004432|6036947|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1730596|NCT01004432|6036948|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
1730597|NCT01004432|6036944|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
1730598|NCT01004432|6036945|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1730599|NCT01004432|6036946|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1730600|NCT01004432|6036947|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1730601|NCT01004432|6036948|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
1730602|NCT01004432|6036944|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
1730603|NCT01004432|6036945|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1730604|NCT01004432|6036946|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1730605|NCT01004432|6036947|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1730606|NCT01004432|6036948|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
1730607|NCT01004432|6036944|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
1730608|NCT01004432|6036945|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
1730609|NCT01004432|6036946|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
1730610|NCT01004432|6036947|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
1730611|NCT01004432|6036948|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
1730612|NCT01004432|6036944|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
1730613|NCT01004432|6036945|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
1730614|NCT01004432|6036946|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
1730615|NCT01004432|6036947|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
1730616|NCT01004432|6036948|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
1730617|NCT01004432|6036944|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
1730618|NCT01004432|6036945|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
1730619|NCT01004432|6036946|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
1730620|NCT01004432|6036947|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
1730621|NCT01004432|6036948|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
1730622|NCT01004432|6036944|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1730623|NCT01004432|6036945|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
1730624|NCT01004432|6036946|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1730625|NCT01004432|6036947|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1730626|NCT01004432|6036948|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
1730627|NCT01004432|6036944|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
1730628|NCT01004432|6036945|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
1730629|NCT01004432|6036946|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
1730630|NCT01004432|6036947|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
1730631|NCT01004432|6036948|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
1730632|NCT01004432|6036944|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
1730633|NCT01004432|6036945|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
1730634|NCT01004432|6036946|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
1730635|NCT01004432|6036947|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
1730636|NCT01004432|6036948|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
1730637|NCT01004432|6036944|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
1730638|NCT01004432|6036945|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
1730639|NCT01004432|6036946|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
1730640|NCT01004432|6036947|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
1730641|NCT01004432|6036948|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
1730642|NCT01004432|6036944|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1730643|NCT01004432|6036945|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1730644|NCT01004432|6036946|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1730645|NCT01004432|6036947|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
1730646|NCT01004432|6036948|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
1730647|NCT01004432|6036944|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1730648|NCT01004432|6036945|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1730649|NCT01004432|6036946|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1730650|NCT01004432|6036947|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
1730651|NCT01004432|6036948|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
1730652|NCT01004432|6036944|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1730653|NCT01004432|6036945|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1730654|NCT01004432|6036946|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1730655|NCT01004432|6036947|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
1730656|NCT01004432|6036948|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
1730657|NCT01004432|6036944|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1730658|NCT01004432|6036945|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1730659|NCT01004432|6036946|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1730660|NCT01004432|6036947|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
1730661|NCT01004432|6036948|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
1730662|NCT01004432|6036944|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1730663|NCT01004432|6036945|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1730664|NCT01004432|6036946|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1730665|NCT01004432|6036947|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
1730666|NCT01004432|6036948|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
1730667|NCT01004406|6036970|P2|Overall Study|Lost to Follow-up|0
1730668|NCT01004406|6036971|P1|Overall Study|Lost to Follow-up|1
1730669|NCT01004406|6036970|P2|Overall Study|Withdrawal by Subject|0
1730670|NCT01004406|6036971|P1|Overall Study|Withdrawal by Subject|2
1730671|NCT01004263|6037006|P1|Overall Study|Lack of Qualifying Event|2
1730672|NCT01004263|6037006|P1|Overall Study|Physician Decision|15
1730673|NCT01004263|6037006|P1|Overall Study|Pregnancy|2
1730674|NCT01004263|6037006|P1|Overall Study|Lack of Efficacy|13
1730675|NCT01004263|6037006|P1|Overall Study|Lost to Follow-up|64
1730676|NCT01004263|6037006|P1|Overall Study|Protocol Violation|10
1730677|NCT01004263|6037006|P1|Overall Study|Withdrawal by Subject|58
1730678|NCT01004263|6037006|P1|Overall Study|Adverse Event|15
1730679|NCT01004250|6037014|P1|Follow-Up (FU) Period|Lost to Follow-up|1
1730680|NCT01004250|6037014|P1|Maintenance Therapy Period|Physician Decision|4
1730681|NCT01004250|6037014|P1|Maintenance Therapy Period|Withdrawal by Subject|5
1730682|NCT01004250|6037014|P1|Maintenance Therapy Period|Protocol Violation|1
1730683|NCT01004250|6037014|P1|Maintenance Therapy Period|Lost to Follow-up|1
1730684|NCT01004250|6037014|P1|Maintenance Therapy Period|Adverse Event|15
1730685|NCT01004250|6037014|P1|Induction Therapy Period|Physician Decision|2
1730686|NCT01004250|6037014|P1|Induction Therapy Period|Withdrawal by Subject|2
1730687|NCT01004250|6037014|P1|Induction Therapy Period|Entry Criteria Not Met|1
1730688|NCT01004250|6037014|P1|Induction Therapy Period|Adverse Event|10
1730689|NCT01004185|6037026|P2|Overall Study|Withdrawal by Subject|1
1730690|NCT01004185|6037027|P1|Overall Study|Withdrawal by Subject|2
1730691|NCT01004185|6037026|P2|Overall Study|Sponsor Terminated Study|5
1730692|NCT01004185|6037027|P1|Overall Study|Sponsor Terminated Study|4
1730693|NCT01004185|6037026|P2|Overall Study|Lack of Efficacy|1
1730694|NCT01004185|6037027|P1|Overall Study|Lack of Efficacy|2
1730695|NCT01004185|6037026|P2|Overall Study|Lost to Follow-up|1
1730696|NCT01004185|6037027|P1|Overall Study|Lost to Follow-up|0
1730697|NCT01004185|6037026|P2|Overall Study|Adverse Event|1
1730698|NCT01004185|6037027|P1|Overall Study|Adverse Event|1
1730699|NCT01004172|6037035|P1|Overall Study|Symptomatic Deterioration|2
1730700|NCT01004172|6037035|P1|Overall Study|Physician Decision|1
1730701|NCT01004172|6037035|P1|Overall Study|Adverse Event|1
1730702|NCT01004172|6037035|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
1730703|NCT01004172|6037035|P1|Overall Study|Progressive Disease in Non-CNS Only|16
1730704|NCT01004172|6037035|P1|Overall Study|Progressive Disease in CNS Only|16
1730705|NCT01004159|6037043|P1|Overall Study|Disease Progression|18
1730706|NCT01004159|6037043|P1|Overall Study|Adverse Event|2
1730707|NCT01004146|6037050|P2|Overall Study|Withdrawal by Subject|5
1730708|NCT01004146|6037051|P1|Overall Study|Withdrawal by Subject|4
1730709|NCT01004003|6037145|P9|Overall Study|Other|0
1730710|NCT01004003|6037146|P8|Overall Study|Other|0
1730711|NCT01004003|6037147|P7|Overall Study|Other|0
1730712|NCT01004003|6037148|P6|Overall Study|Other|1
1730713|NCT01004003|6037149|P5|Overall Study|Other|0
1730714|NCT01004003|6037150|P4|Overall Study|Other|0
1730715|NCT01004003|6037151|P3|Overall Study|Other|0
1730716|NCT01004003|6037152|P2|Overall Study|Other|0
1730717|NCT01004003|6037153|P1|Overall Study|Other|0
1730718|NCT01004003|6037145|P9|Overall Study|Refused to continue taking trial med.|2
1730719|NCT01004003|6037146|P8|Overall Study|Refused to continue taking trial med.|0
1730720|NCT01004003|6037147|P7|Overall Study|Refused to continue taking trial med.|0
1730721|NCT01004003|6037148|P6|Overall Study|Refused to continue taking trial med.|0
1730722|NCT01004003|6037149|P5|Overall Study|Refused to continue taking trial med.|0
1730723|NCT01004003|6037150|P4|Overall Study|Refused to continue taking trial med.|0
1730724|NCT01004003|6037151|P3|Overall Study|Refused to continue taking trial med.|0
1730725|NCT01004003|6037152|P2|Overall Study|Refused to continue taking trial med.|0
1730726|NCT01004003|6037153|P1|Overall Study|Refused to continue taking trial med.|0
1730727|NCT01004003|6037145|P9|Overall Study|Adverse Event|6
1730728|NCT01004003|6037146|P8|Overall Study|Adverse Event|21
1730729|NCT01004003|6037147|P7|Overall Study|Adverse Event|7
1730730|NCT01004003|6037148|P6|Overall Study|Adverse Event|2
1730731|NCT01004003|6037149|P5|Overall Study|Adverse Event|2
1730732|NCT01004003|6037150|P4|Overall Study|Adverse Event|3
1730733|NCT01004003|6037151|P3|Overall Study|Adverse Event|3
1730734|NCT01004003|6037152|P2|Overall Study|Adverse Event|2
1730735|NCT01004003|6037153|P1|Overall Study|Adverse Event|4
1730736|NCT01004003|6037145|P9|Overall Study|Progressive disease|22
1730737|NCT01004003|6037146|P8|Overall Study|Progressive disease|39
1730738|NCT01004003|6037147|P7|Overall Study|Progressive disease|1
1730739|NCT01004003|6037148|P6|Overall Study|Progressive disease|1
1730740|NCT01004003|6037149|P5|Overall Study|Progressive disease|2
1730741|NCT01004003|6037150|P4|Overall Study|Progressive disease|0
1730742|NCT01004003|6037151|P3|Overall Study|Progressive disease|1
1730743|NCT01004003|6037152|P2|Overall Study|Progressive disease|1
1730744|NCT01004003|6037153|P1|Overall Study|Progressive disease|2
1730745|NCT01003990|6037184|P3|Overall Study|Subject Withdrew Consent|7
1730746|NCT01003990|6037185|P2|Overall Study|Subject Withdrew Consent|5
1730747|NCT01003990|6037186|P1|Overall Study|Subject Withdrew Consent|12
1730748|NCT01003990|6037184|P3|Overall Study|No Longer Met Study Criteria|0
1730749|NCT01003990|6037185|P2|Overall Study|No Longer Met Study Criteria|1
1730750|NCT01003990|6037186|P1|Overall Study|No Longer Met Study Criteria|4
1730751|NCT01003990|6037184|P3|Overall Study|Pregnancy|4
1730752|NCT01003990|6037185|P2|Overall Study|Pregnancy|2
1730753|NCT01003990|6037186|P1|Overall Study|Pregnancy|10
1730754|NCT01003990|6037184|P3|Overall Study|Poor/Non-compliance|2
1730755|NCT01003990|6037185|P2|Overall Study|Poor/Non-compliance|3
1730756|NCT01003990|6037186|P1|Overall Study|Poor/Non-compliance|4
1730757|NCT01003990|6037184|P3|Overall Study|Reasons Not Identified|8
1730758|NCT01003990|6037185|P2|Overall Study|Reasons Not Identified|13
1730759|NCT01003990|6037186|P1|Overall Study|Reasons Not Identified|14
1730760|NCT01003990|6037184|P3|Overall Study|Lost to Follow-up|7
1730761|NCT01003990|6037185|P2|Overall Study|Lost to Follow-up|12
1730762|NCT01003990|6037186|P1|Overall Study|Lost to Follow-up|30
1730763|NCT01003990|6037184|P3|Overall Study|Lack of Efficacy|3
1730764|NCT01003990|6037185|P2|Overall Study|Lack of Efficacy|2
1730765|NCT01003990|6037186|P1|Overall Study|Lack of Efficacy|10
1730766|NCT01003990|6037184|P3|Overall Study|Death|1
1730767|NCT01003990|6037185|P2|Overall Study|Death|8
1730768|NCT01003990|6037186|P1|Overall Study|Death|0
1730769|NCT01003990|6037184|P3|Overall Study|Adverse Event|11
1730770|NCT01003990|6037185|P2|Overall Study|Adverse Event|5
1730771|NCT01003990|6037186|P1|Overall Study|Adverse Event|8
1730772|NCT01003899|6037203|P1|Overall Study|Progressive disease|34
1730773|NCT01003899|6037203|P1|Overall Study|Not treated|1
1730774|NCT01003899|6037203|P1|Overall Study|Not entered|4
1730775|NCT01003899|6037203|P1|Overall Study|Other Adverse Event|8
1730776|NCT01003886|6037212|P1|Overall Study|Adverse Event|3
1730777|NCT01003886|6037212|P1|Overall Study|Other|14
1730778|NCT01003886|6037212|P1|Overall Study|Withdrawal by Subject|39
1730779|NCT01003886|6037212|P1|Overall Study|Lost to Follow-up|169
1730780|NCT01003886|6037212|P1|Overall Study|Lack of Efficacy|5
1730781|NCT01003639|6037223|P2|Overall Study|Physician Decision|0
1730782|NCT01003639|6037224|P1|Overall Study|Physician Decision|1
1730783|NCT01003639|6037223|P2|Overall Study|Protocol Violation|1
1730784|NCT01003639|6037224|P1|Overall Study|Protocol Violation|0
1730785|NCT01003639|6037223|P2|Overall Study|Adverse Event|1
1730786|NCT01003639|6037224|P1|Overall Study|Adverse Event|0
1730787|NCT01003639|6037223|P2|Overall Study|Lack of Efficacy|6
1730788|NCT01003639|6037224|P1|Overall Study|Lack of Efficacy|1
1730789|NCT01003639|6037223|P2|Overall Study|Withdrawal by Subject|5
1730790|NCT01003639|6037224|P1|Overall Study|Withdrawal by Subject|9
1730791|NCT01003639|6037223|P2|Overall Study|Lost to Follow-up|9
1730792|NCT01003639|6037224|P1|Overall Study|Lost to Follow-up|6
1730793|NCT01003249|6037280|P2|Second Intervention (4 Weeks)|Adverse Event|0
1730794|NCT01003249|6037281|P1|Second Intervention (4 Weeks)|Adverse Event|1
1730795|NCT01003249|6037280|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1730796|NCT01003249|6037281|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1730797|NCT01003249|6037280|P2|First Intervention (4 Weeks)|Non-Serious Event|1
1730798|NCT01003249|6037281|P1|First Intervention (4 Weeks)|Non-Serious Event|1
1730799|NCT01003249|6037280|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
1730800|NCT01003249|6037281|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
1730801|NCT01003210|6037299|P2|Overall Study|Lost to Follow-up|3
1730802|NCT01003210|6037300|P1|Overall Study|Lost to Follow-up|1
1730803|NCT01003184|6037312|P2|Overall Study|Physician Decision|0
1730804|NCT01003184|6037313|P1|Overall Study|Physician Decision|1
1730805|NCT01003184|6037312|P2|Overall Study|Withdrawal by Subject|6
1730806|NCT01003184|6037313|P1|Overall Study|Withdrawal by Subject|1
1730807|NCT01003184|6037312|P2|Overall Study|Protocol Violation|0
1730808|NCT01003184|6037313|P1|Overall Study|Protocol Violation|3
1730809|NCT01003184|6037312|P2|Overall Study|Loss of glucose control|1
1730810|NCT01003184|6037313|P1|Overall Study|Loss of glucose control|1
1730811|NCT01003184|6037312|P2|Overall Study|Lost to Follow-up|0
1730812|NCT01003184|6037313|P1|Overall Study|Lost to Follow-up|1
1730813|NCT01003184|6037312|P2|Overall Study|Adverse Event|5
1730814|NCT01003184|6037313|P1|Overall Study|Adverse Event|12
1730815|NCT01002989|6037396|P1|Overall Study|exclusion criteria, no consent|5
1730816|NCT01002742|6037411|P2|Overall Study|Determined to be ineligible|1
1730817|NCT01002742|6037412|P1|Overall Study|Determined to be ineligible|0
1730818|NCT01002573|6037448|P2|Overall Study|Subject did not receive at least 1 dose|7
1730819|NCT01002573|6037449|P1|Overall Study|Subject did not receive at least 1 dose|11
1730820|NCT01002547|6037470|P3|Overall Study|Adverse Event|0
1730821|NCT01002547|6037471|P2|Overall Study|Adverse Event|0
1730822|NCT01002547|6037472|P1|Overall Study|Adverse Event|1
1730823|NCT01002547|6037470|P3|Overall Study|Death|2
1730824|NCT01002547|6037471|P2|Overall Study|Death|2
1730825|NCT01002547|6037472|P1|Overall Study|Death|0
1730826|NCT01002547|6037470|P3|Overall Study|Physician Decision|0
1730827|NCT01002547|6037471|P2|Overall Study|Physician Decision|0
1730828|NCT01002547|6037472|P1|Overall Study|Physician Decision|1
1730829|NCT01002547|6037470|P3|Overall Study|Lost to Follow-up|1
1730830|NCT01002547|6037471|P2|Overall Study|Lost to Follow-up|1
1730831|NCT01002547|6037472|P1|Overall Study|Lost to Follow-up|2
1730832|NCT01002547|6037470|P3|Overall Study|Withdrawal by Subject|5
1730833|NCT01002547|6037471|P2|Overall Study|Withdrawal by Subject|0
1730834|NCT01002547|6037472|P1|Overall Study|Withdrawal by Subject|4
1730835|NCT01002482|6037530|P2|Overall Study|Included twice|0
1730836|NCT01002482|6037531|P1|Overall Study|Included twice|1
1730837|NCT01002482|6037530|P2|Overall Study|Withdrawal by Subject|21
1730838|NCT01002482|6037531|P1|Overall Study|Withdrawal by Subject|14
1730839|NCT01002339|6037565|P3|Overall Study|Randomized. Not transplanted|1
1730840|NCT01002339|6037566|P2|Overall Study|Randomized. Not transplanted|0
1730841|NCT01002339|6037567|P1|Overall Study|Randomized. Not transplanted|0
1730842|NCT01002339|6037565|P3|Overall Study|Lung cancer detected before transplant|1
1730843|NCT01002339|6037566|P2|Overall Study|Lung cancer detected before transplant|0
1730844|NCT01002339|6037567|P1|Overall Study|Lung cancer detected before transplant|0
1730845|NCT01002339|6037565|P3|Overall Study|Protocol Violation|2
1730846|NCT01002339|6037566|P2|Overall Study|Protocol Violation|0
1730847|NCT01002339|6037567|P1|Overall Study|Protocol Violation|0
1730848|NCT01002339|6037565|P3|Overall Study|Incorrect treatment assignment|1
1730849|NCT01002339|6037566|P2|Overall Study|Incorrect treatment assignment|0
1730850|NCT01002339|6037567|P1|Overall Study|Incorrect treatment assignment|0
1730851|NCT01002339|6037565|P3|Overall Study|Withdrawal by Subject|0
1730852|NCT01002339|6037566|P2|Overall Study|Withdrawal by Subject|1
1730853|NCT01002339|6037567|P1|Overall Study|Withdrawal by Subject|0
1730854|NCT01002105|6037643|P2|Overall Study|condition worsened|2
1730855|NCT01002105|6037644|P1|Overall Study|condition worsened|4
1730856|NCT01002105|6037643|P2|Overall Study|non compliance|3
1730857|NCT01002105|6037644|P1|Overall Study|non compliance|5
1730858|NCT01002105|6037643|P2|Overall Study|Lost to Follow-up|16
1730859|NCT01002105|6037644|P1|Overall Study|Lost to Follow-up|10
1730860|NCT01001988|6037660|P1|Overall Study|Lost to Follow-up|15
1730861|NCT01001988|6037660|P1|Overall Study|Withdrawal by Subject|18
1730862|NCT01001988|6037660|P1|Overall Study|Protocol Violation|84
1730863|NCT01001832|6037678|P2|Follow-up Period|Other|1
1730864|NCT01001832|6037679|P1|Follow-up Period|Other|2
1730865|NCT01001832|6037678|P2|Follow-up Period|Follow-up no longer required /protocol|20
1730866|NCT01001832|6037679|P1|Follow-up Period|Follow-up no longer required /protocol|15
1730867|NCT01001832|6037678|P2|Follow-up Period|Withdrawal by Subject|0
1730868|NCT01001832|6037679|P1|Follow-up Period|Withdrawal by Subject|1
1730869|NCT01001832|6037678|P2|Long-term Period|Other|2
1730870|NCT01001832|6037679|P1|Long-term Period|Other|1
1730871|NCT01001832|6037678|P2|Long-term Period|Lack of Efficacy|2
1730872|NCT01001832|6037679|P1|Long-term Period|Lack of Efficacy|0
1730873|NCT01001832|6037678|P2|Long-term Period|Withdrawal by Subject|0
1730874|NCT01001832|6037679|P1|Long-term Period|Withdrawal by Subject|1
1730875|NCT01001832|6037678|P2|Long-term Period|Adverse Event|1
1730876|NCT01001832|6037679|P1|Long-term Period|Adverse Event|2
1730877|NCT01001832|6037678|P2|Short-term Period|Adverse Event|3
1730878|NCT01001832|6037679|P1|Short-term Period|Adverse Event|2
1730879|NCT01001767|6037737|P2|Overall Study|Physician Decision|0
1730880|NCT01001767|6037738|P1|Overall Study|Physician Decision|1
1730881|NCT01001767|6037737|P2|Overall Study|Lost to Follow-up|0
1730882|NCT01001767|6037738|P1|Overall Study|Lost to Follow-up|1
1730883|NCT01001767|6037737|P2|Overall Study|Protocol Violation|0
1730884|NCT01001767|6037738|P1|Overall Study|Protocol Violation|1
1730885|NCT01001767|6037737|P2|Overall Study|no baseline study performed|0
1730886|NCT01001767|6037738|P1|Overall Study|no baseline study performed|1
1730887|NCT01001702|6037744|P1|Overall Study|Lack of Efficacy per Investigator|3
1730888|NCT01001702|6037744|P1|Overall Study|Withdrawal by Subject|19
1730889|NCT01001702|6037744|P1|Overall Study|Investigator withdrew Subject|10
1730890|NCT01001702|6037744|P1|Overall Study|Subject met Withdrawal Criteria|22
1730891|NCT01001702|6037744|P1|Overall Study|Sponsor Discontinued Study|4
1730892|NCT01001702|6037744|P1|Overall Study|Adverse Event|7
1730893|NCT01001702|6037744|P1|Overall Study|Lost to Follow-up|7
1730894|NCT01001598|6037755|P1|Overall Study|Adverse Event|1
1730895|NCT01001598|6037755|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
1730896|NCT01001572|6037763|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
1730897|NCT01001572|6037764|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
1730898|NCT01001572|6037765|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
1730899|NCT01001572|6037763|P3|Double-Blind Treatment Phase|Protocol deviation|1
1730900|NCT01001572|6037764|P2|Double-Blind Treatment Phase|Protocol deviation|0
1730901|NCT01001572|6037765|P1|Double-Blind Treatment Phase|Protocol deviation|0
1730902|NCT01001572|6037763|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
1730903|NCT01001572|6037764|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1730904|NCT01001572|6037765|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1730905|NCT01001572|6037763|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
1730906|NCT01001572|6037764|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
1730907|NCT01001572|6037765|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
1730908|NCT01001572|6037763|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
1730909|NCT01001572|6037764|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
1730910|NCT01001572|6037765|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
1730911|NCT01001572|6037763|P3|Double-Blind Treatment Phase|Adverse Event|2
1730912|NCT01001572|6037764|P2|Double-Blind Treatment Phase|Adverse Event|2
1730913|NCT01001572|6037765|P1|Double-Blind Treatment Phase|Adverse Event|0
1730914|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
1730915|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
1730916|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
1730917|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
1730918|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
1730919|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
1730920|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
1730921|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
1730922|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
1730923|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
1730924|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
1730925|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
1730926|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
1730927|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
1730928|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
1730929|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
1730930|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
1730931|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
1730932|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
1730933|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
1730934|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
1730935|NCT01001572|6037763|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
1730936|NCT01001572|6037764|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
1730937|NCT01001572|6037765|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
1730938|NCT01001520|6037803|P2|Medication Period 2|Withdrawal by Subject|3
1730939|NCT01001520|6037804|P1|Medication Period 2|Withdrawal by Subject|0
1730940|NCT01001520|6037803|P2|Washout Period|Withdrawal by Subject|1
1730941|NCT01001520|6037804|P1|Washout Period|Withdrawal by Subject|2
1730942|NCT01001520|6037803|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
1730943|NCT01001520|6037804|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
1730944|NCT01001520|6037803|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
1730945|NCT01001520|6037804|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
1730946|NCT01001520|6037803|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
1730947|NCT01001520|6037804|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
1730948|NCT01001520|6037803|P2|Medication Period 1|Withdrawal by Subject|2
1730949|NCT01001520|6037804|P1|Medication Period 1|Withdrawal by Subject|2
1730950|NCT01001494|6037831|P3|Overall Study|Other|3
1730951|NCT01001494|6037832|P2|Overall Study|Other|1
1730952|NCT01001494|6037833|P1|Overall Study|Other|0
1730953|NCT01001494|6037831|P3|Overall Study|Lack of Efficacy|8
1730954|NCT01001494|6037832|P2|Overall Study|Lack of Efficacy|0
1730955|NCT01001494|6037833|P1|Overall Study|Lack of Efficacy|2
1730956|NCT01001494|6037831|P3|Overall Study|COPD exacerbation|5
1730957|NCT01001494|6037832|P2|Overall Study|COPD exacerbation|4
1730958|NCT01001494|6037833|P1|Overall Study|COPD exacerbation|3
1730959|NCT01001494|6037831|P3|Overall Study|Withdrawal by Subject|17
1730960|NCT01001494|6037832|P2|Overall Study|Withdrawal by Subject|7
1730961|NCT01001494|6037833|P1|Overall Study|Withdrawal by Subject|9
1730962|NCT01001494|6037831|P3|Overall Study|Lost to Follow-up|1
1730963|NCT01001494|6037832|P2|Overall Study|Lost to Follow-up|0
1730964|NCT01001494|6037833|P1|Overall Study|Lost to Follow-up|2
1730965|NCT01001494|6037831|P3|Overall Study|Protocol Violation|1
1730966|NCT01001494|6037832|P2|Overall Study|Protocol Violation|1
1730967|NCT01001494|6037833|P1|Overall Study|Protocol Violation|0
1730968|NCT01001494|6037831|P3|Overall Study|Adverse Event|6
1730969|NCT01001494|6037832|P2|Overall Study|Adverse Event|4
1730970|NCT01001494|6037833|P1|Overall Study|Adverse Event|8
1730971|NCT01001429|6037918|P2|Overall Study|surgery cancelled|1
1730972|NCT01001429|6037919|P1|Overall Study|surgery cancelled|0
1730973|NCT01001390|6037958|P2|Overall Study|Failure to wear AFO device|0
1730974|NCT01001390|6037959|P1|Overall Study|Failure to wear AFO device|2
1730975|NCT01001377|6037967|P2|Overall Study|Death|384
1730976|NCT01001377|6037968|P1|Overall Study|Death|391
1730977|NCT01001377|6037967|P2|Overall Study|Lost to Follow-up|17
1730978|NCT01001377|6037968|P1|Overall Study|Lost to Follow-up|14
1730979|NCT01001377|6037967|P2|Overall Study|Withdrawal by Subject|20
1730980|NCT01001377|6037968|P1|Overall Study|Withdrawal by Subject|19
1730981|NCT01001377|6037967|P2|Overall Study|Ineligibility determined|0
1730982|NCT01001377|6037968|P1|Overall Study|Ineligibility determined|2
1730983|NCT01001325|6037998|P2|Overall Study|Protocol Violation|0
1730984|NCT01001325|6037999|P1|Overall Study|Protocol Violation|2
1730985|NCT01001325|6037998|P2|Overall Study|Lost to Follow-up|10
1730986|NCT01001325|6037999|P1|Overall Study|Lost to Follow-up|16
1730987|NCT01001299|6038005|P1|Overall Study|Withdrew Consent|1
1730988|NCT01001299|6038005|P1|Overall Study|Began Taking Commercially Available Drug|2
1730989|NCT01001299|6038005|P1|Overall Study|Death|1
1730990|NCT01001299|6038005|P1|Overall Study|Adverse event or Intercurrent Illness|1
1730991|NCT01001299|6038005|P1|Overall Study|Insufficient Therapeutic Response|20
1730992|NCT01001234|6038034|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
1730993|NCT01001234|6038035|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
1730994|NCT01001234|6038036|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
1730995|NCT01001234|6038037|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
1730996|NCT01001234|6038038|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
1730997|NCT01001234|6038034|P5|Overall Study|Not Treated: Physician Decision|0
1730998|NCT01001234|6038035|P4|Overall Study|Not Treated: Physician Decision|0
1730999|NCT01001234|6038036|P3|Overall Study|Not Treated: Physician Decision|0
1731000|NCT01001234|6038037|P2|Overall Study|Not Treated: Physician Decision|4
1731001|NCT01001234|6038038|P1|Overall Study|Not Treated: Physician Decision|37
1731002|NCT01001234|6038034|P5|Overall Study|Not Treated: Pregnancy|0
1731003|NCT01001234|6038035|P4|Overall Study|Not Treated: Pregnancy|0
1731004|NCT01001234|6038036|P3|Overall Study|Not Treated: Pregnancy|0
1731005|NCT01001234|6038037|P2|Overall Study|Not Treated: Pregnancy|0
1731006|NCT01001234|6038038|P1|Overall Study|Not Treated: Pregnancy|3
1731007|NCT01001234|6038034|P5|Overall Study|Not Treated: Lost to Follow-up|0
1731008|NCT01001234|6038035|P4|Overall Study|Not Treated: Lost to Follow-up|5
1731009|NCT01001234|6038036|P3|Overall Study|Not Treated: Lost to Follow-up|7
1731010|NCT01001234|6038037|P2|Overall Study|Not Treated: Lost to Follow-up|4
1731011|NCT01001234|6038038|P1|Overall Study|Not Treated: Lost to Follow-up|53
1731012|NCT01001234|6038034|P5|Overall Study|Not Treated: Protocol Violation|0
1731013|NCT01001234|6038035|P4|Overall Study|Not Treated: Protocol Violation|0
1731014|NCT01001234|6038036|P3|Overall Study|Not Treated: Protocol Violation|0
1731015|NCT01001234|6038037|P2|Overall Study|Not Treated: Protocol Violation|0
1731016|NCT01001234|6038038|P1|Overall Study|Not Treated: Protocol Violation|3
1731017|NCT01001234|6038034|P5|Overall Study|Not Treated: Withdrawal by Subject|0
1731018|NCT01001234|6038035|P4|Overall Study|Not Treated: Withdrawal by Subject|0
1731019|NCT01001234|6038036|P3|Overall Study|Not Treated: Withdrawal by Subject|2
1731020|NCT01001234|6038037|P2|Overall Study|Not Treated: Withdrawal by Subject|2
1731021|NCT01001234|6038038|P1|Overall Study|Not Treated: Withdrawal by Subject|23
1731022|NCT01001234|6038034|P5|Overall Study|Not Treated: Adverse Event|0
1731023|NCT01001234|6038035|P4|Overall Study|Not Treated: Adverse Event|0
1731024|NCT01001234|6038036|P3|Overall Study|Not Treated: Adverse Event|0
1731025|NCT01001234|6038037|P2|Overall Study|Not Treated: Adverse Event|0
1731026|NCT01001234|6038038|P1|Overall Study|Not Treated: Adverse Event|1
1731027|NCT01001234|6038034|P5|Overall Study|Physician Decision|0
1731028|NCT01001234|6038035|P4|Overall Study|Physician Decision|0
1731029|NCT01001234|6038036|P3|Overall Study|Physician Decision|0
1731030|NCT01001234|6038037|P2|Overall Study|Physician Decision|0
1731031|NCT01001234|6038038|P1|Overall Study|Physician Decision|1
1731032|NCT01001234|6038034|P5|Overall Study|Lost to Follow-up|0
1731033|NCT01001234|6038035|P4|Overall Study|Lost to Follow-up|2
1731034|NCT01001234|6038036|P3|Overall Study|Lost to Follow-up|1
1731035|NCT01001234|6038037|P2|Overall Study|Lost to Follow-up|0
1731036|NCT01001234|6038038|P1|Overall Study|Lost to Follow-up|0
1731037|NCT01001234|6038034|P5|Overall Study|Protocol Violation|0
1731038|NCT01001234|6038035|P4|Overall Study|Protocol Violation|18
1731039|NCT01001234|6038036|P3|Overall Study|Protocol Violation|19
1731040|NCT01001234|6038037|P2|Overall Study|Protocol Violation|3
1731041|NCT01001234|6038038|P1|Overall Study|Protocol Violation|34
1731042|NCT01001234|6038034|P5|Overall Study|Withdrawal by Subject|0
1731043|NCT01001234|6038035|P4|Overall Study|Withdrawal by Subject|0
1731044|NCT01001234|6038036|P3|Overall Study|Withdrawal by Subject|3
1731045|NCT01001234|6038037|P2|Overall Study|Withdrawal by Subject|0
1731046|NCT01001234|6038038|P1|Overall Study|Withdrawal by Subject|2
1731047|NCT01001221|6038054|P5|Overall Study|Not treated; protocol exclusion|0
1731048|NCT01001221|6038055|P4|Overall Study|Not treated; protocol exclusion|0
1731049|NCT01001221|6038056|P3|Overall Study|Not treated; protocol exclusion|1
1731050|NCT01001221|6038057|P2|Overall Study|Not treated; protocol exclusion|0
1731051|NCT01001221|6038058|P1|Overall Study|Not treated; protocol exclusion|0
1731052|NCT01001221|6038054|P5|Overall Study|Other|0
1731053|NCT01001221|6038055|P4|Overall Study|Other|0
1731054|NCT01001221|6038056|P3|Overall Study|Other|0
1731055|NCT01001221|6038057|P2|Overall Study|Other|1
1731056|NCT01001221|6038058|P1|Overall Study|Other|1
1731057|NCT01001221|6038054|P5|Overall Study|Disease progression|0
1731058|NCT01001221|6038055|P4|Overall Study|Disease progression|4
1731059|NCT01001221|6038056|P3|Overall Study|Disease progression|2
1731060|NCT01001221|6038057|P2|Overall Study|Disease progression|2
1731061|NCT01001221|6038058|P1|Overall Study|Disease progression|3
1731062|NCT01001221|6038054|P5|Overall Study|Adverse Event|0
1731063|NCT01001221|6038055|P4|Overall Study|Adverse Event|2
1731064|NCT01001221|6038056|P3|Overall Study|Adverse Event|0
1731065|NCT01001221|6038057|P2|Overall Study|Adverse Event|2
1731066|NCT01001221|6038058|P1|Overall Study|Adverse Event|1
1731067|NCT01001208|6038233|P2|Overall Study|Other|2
1731068|NCT01001208|6038234|P1|Overall Study|Other|0
1731069|NCT01001208|6038233|P2|Overall Study|Disease Progression|3
1731070|NCT01001208|6038234|P1|Overall Study|Disease Progression|0
1731071|NCT01001208|6038233|P2|Overall Study|Noncompliance|7
1731072|NCT01001208|6038234|P1|Overall Study|Noncompliance|4
1731073|NCT01001208|6038233|P2|Overall Study|Ineligibility Determined|2
1731074|NCT01001208|6038234|P1|Overall Study|Ineligibility Determined|4
1731075|NCT01001208|6038233|P2|Overall Study|Withdrawal by Subject|5
1731076|NCT01001208|6038234|P1|Overall Study|Withdrawal by Subject|4
1731077|NCT01001208|6038233|P2|Overall Study|Physician Decision|0
1731078|NCT01001208|6038234|P1|Overall Study|Physician Decision|1
1731079|NCT01001208|6038233|P2|Overall Study|Lost to Follow-up|9
1731080|NCT01001208|6038234|P1|Overall Study|Lost to Follow-up|5
1731081|NCT01001208|6038233|P2|Overall Study|Adverse Event|5
1731082|NCT01001208|6038234|P1|Overall Study|Adverse Event|10
1731083|NCT01001169|6038277|P2|Overall Study|Withdrawal by Subject|1
1731084|NCT01001169|6038278|P1|Overall Study|Withdrawal by Subject|2
1731085|NCT01001104|6038386|P4|Overall Study|Withdrawal by Subject|2
1731086|NCT01001104|6038387|P3|Overall Study|Withdrawal by Subject|0
1731087|NCT01001104|6038388|P2|Overall Study|Withdrawal by Subject|0
1731088|NCT01001104|6038389|P1|Overall Study|Withdrawal by Subject|0
1731089|NCT01001104|6038386|P4|Overall Study|Entry Criteria Not Met|1
1731090|NCT01001104|6038387|P3|Overall Study|Entry Criteria Not Met|0
1731091|NCT01001104|6038388|P2|Overall Study|Entry Criteria Not Met|0
1731092|NCT01001104|6038389|P1|Overall Study|Entry Criteria Not Met|0
1731093|NCT01001104|6038386|P4|Overall Study|Lost to Follow-up|0
1731094|NCT01001104|6038387|P3|Overall Study|Lost to Follow-up|1
1731095|NCT01001104|6038388|P2|Overall Study|Lost to Follow-up|0
1731096|NCT01001104|6038389|P1|Overall Study|Lost to Follow-up|0
1731097|NCT01001104|6038386|P4|Overall Study|Adverse Event|0
1731098|NCT01001104|6038387|P3|Overall Study|Adverse Event|0
1731099|NCT01001104|6038388|P2|Overall Study|Adverse Event|1
1731100|NCT01001104|6038389|P1|Overall Study|Adverse Event|2
1731101|NCT01000974|6038480|P3|Booster Vaccination Phase|Other|4
1731102|NCT01000974|6038481|P2|Booster Vaccination Phase|Other|6
1731103|NCT01000974|6038482|P1|Booster Vaccination Phase|Other|24
1731104|NCT01000974|6038480|P3|Booster Vaccination Phase|Lost to Follow-up|7
1731105|NCT01000974|6038481|P2|Booster Vaccination Phase|Lost to Follow-up|5
1731106|NCT01000974|6038482|P1|Booster Vaccination Phase|Lost to Follow-up|40
1731107|NCT01000974|6038480|P3|Booster Vaccination Phase|Withdrawal by Subject|1
1731108|NCT01000974|6038481|P2|Booster Vaccination Phase|Withdrawal by Subject|1
1731109|NCT01000974|6038482|P1|Booster Vaccination Phase|Withdrawal by Subject|3
1731110|NCT01000974|6038480|P3|Booster Vaccination Phase|Protocol Violation|2
1731111|NCT01000974|6038481|P2|Booster Vaccination Phase|Protocol Violation|0
1731112|NCT01000974|6038482|P1|Booster Vaccination Phase|Protocol Violation|0
1731113|NCT01000974|6038480|P3|Primary Vaccination Phase|Other|12
1731114|NCT01000974|6038481|P2|Primary Vaccination Phase|Other|9
1731115|NCT01000974|6038482|P1|Primary Vaccination Phase|Other|4
1731116|NCT01000974|6038480|P3|Primary Vaccination Phase|Adverse Event|2
1731117|NCT01000974|6038481|P2|Primary Vaccination Phase|Adverse Event|2
1731118|NCT01000974|6038482|P1|Primary Vaccination Phase|Adverse Event|14
1731119|NCT01000974|6038480|P3|Primary Vaccination Phase|Protocol Violation|2
1731120|NCT01000974|6038481|P2|Primary Vaccination Phase|Protocol Violation|3
1731121|NCT01000974|6038482|P1|Primary Vaccination Phase|Protocol Violation|40
1731122|NCT01000974|6038480|P3|Primary Vaccination Phase|Lost to Follow-up|26
1731123|NCT01000974|6038481|P2|Primary Vaccination Phase|Lost to Follow-up|19
1731124|NCT01000974|6038482|P1|Primary Vaccination Phase|Lost to Follow-up|171
1731125|NCT01000974|6038480|P3|Primary Vaccination Phase|Withdrawal by Subject|21
1731126|NCT01000974|6038481|P2|Primary Vaccination Phase|Withdrawal by Subject|17
1731127|NCT01000974|6038482|P1|Primary Vaccination Phase|Withdrawal by Subject|109
1731128|NCT01000961|6038589|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
1731129|NCT01000961|6038590|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
1731130|NCT01000961|6038589|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
1731131|NCT01000961|6038590|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
1731132|NCT01000805|6038613|P2|Overall Study|Sponsor Decision|1
1731133|NCT01000805|6038614|P1|Overall Study|Sponsor Decision|0
1731134|NCT01000805|6038613|P2|Overall Study|Withdrawal by Subject|6
1731135|NCT01000805|6038614|P1|Overall Study|Withdrawal by Subject|16
1731136|NCT01000805|6038613|P2|Overall Study|Protocol Violation|8
1731137|NCT01000805|6038614|P1|Overall Study|Protocol Violation|12
1731138|NCT01000805|6038613|P2|Overall Study|Physician Decision|1
1731139|NCT01000805|6038614|P1|Overall Study|Physician Decision|0
1731140|NCT01000805|6038613|P2|Overall Study|Lost to Follow-up|21
1731141|NCT01000805|6038614|P1|Overall Study|Lost to Follow-up|16
1731142|NCT01000805|6038613|P2|Overall Study|Lack of Efficacy|16
1731143|NCT01000805|6038614|P1|Overall Study|Lack of Efficacy|5
1731144|NCT01000805|6038613|P2|Overall Study|Adverse Event|9
1731145|NCT01000805|6038614|P1|Overall Study|Adverse Event|21
1731146|NCT01000727|6038648|P2|Overall Study|Study closed/terminated|24
1731147|NCT01000727|6038649|P1|Overall Study|Study closed/terminated|23
1731148|NCT01000727|6038648|P2|Overall Study|Withdrawal by Subject|109
1731149|NCT01000727|6038649|P1|Overall Study|Withdrawal by Subject|111
1731150|NCT01000727|6038648|P2|Overall Study|Lost to Follow-up|43
1731151|NCT01000727|6038649|P1|Overall Study|Lost to Follow-up|41
1731152|NCT01000649|6038690|P4|Overall Study|Lost to Follow-up|2
1731153|NCT01000649|6038691|P3|Overall Study|Lost to Follow-up|0
1731154|NCT01000649|6038692|P2|Overall Study|Lost to Follow-up|2
1731155|NCT01000649|6038693|P1|Overall Study|Lost to Follow-up|0
1731156|NCT01000649|6038690|P4|Overall Study|Adverse Event|4
1731157|NCT01000649|6038691|P3|Overall Study|Adverse Event|2
1731158|NCT01000649|6038692|P2|Overall Study|Adverse Event|1
1731159|NCT01000649|6038693|P1|Overall Study|Adverse Event|5
1731160|NCT01000610|6038774|P1|Overall Study|Treatment failure|1
1731161|NCT01000610|6038774|P1|Overall Study|Lost to Follow-up|4
1731162|NCT01000610|6038774|P1|Overall Study|Adverse Event|1
1731163|NCT01000506|6038785|P4|Overall Study|Withdrawal by Subject|7
1731164|NCT01000506|6038786|P3|Overall Study|Withdrawal by Subject|2
1731165|NCT01000506|6038787|P2|Overall Study|Withdrawal by Subject|8
1731166|NCT01000506|6038788|P1|Overall Study|Withdrawal by Subject|11
1731167|NCT01000506|6038785|P4|Overall Study|Physician Decision|3
1731168|NCT01000506|6038786|P3|Overall Study|Physician Decision|3
1731169|NCT01000506|6038787|P2|Overall Study|Physician Decision|3
1731170|NCT01000506|6038788|P1|Overall Study|Physician Decision|1
1731171|NCT01000506|6038785|P4|Overall Study|Lost to Follow-up|0
1731172|NCT01000506|6038786|P3|Overall Study|Lost to Follow-up|4
1731173|NCT01000506|6038787|P2|Overall Study|Lost to Follow-up|1
1731174|NCT01000506|6038788|P1|Overall Study|Lost to Follow-up|1
1731175|NCT01000506|6038785|P4|Overall Study|Protocol Violation|0
1731176|NCT01000506|6038786|P3|Overall Study|Protocol Violation|0
1731177|NCT01000506|6038787|P2|Overall Study|Protocol Violation|1
1731178|NCT01000506|6038788|P1|Overall Study|Protocol Violation|1
1731179|NCT01000506|6038785|P4|Overall Study|Lack of Efficacy|4
1731180|NCT01000506|6038786|P3|Overall Study|Lack of Efficacy|4
1731181|NCT01000506|6038787|P2|Overall Study|Lack of Efficacy|6
1731182|NCT01000506|6038788|P1|Overall Study|Lack of Efficacy|8
1731183|NCT01000506|6038785|P4|Overall Study|Adverse Event|9
1731184|NCT01000506|6038786|P3|Overall Study|Adverse Event|8
1731185|NCT01000506|6038787|P2|Overall Study|Adverse Event|5
1731186|NCT01000506|6038788|P1|Overall Study|Adverse Event|6
1731187|NCT01000493|6038832|P2|Overall Study|Withdrawal by Subject|7
1731188|NCT01000493|6038833|P1|Overall Study|Withdrawal by Subject|3
1731189|NCT01000493|6038832|P2|Overall Study|Physician Decision|1
1731190|NCT01000493|6038833|P1|Overall Study|Physician Decision|1
1731191|NCT01000493|6038832|P2|Overall Study|Lost to Follow-up|9
1731192|NCT01000493|6038833|P1|Overall Study|Lost to Follow-up|5
1731193|NCT01000493|6038832|P2|Overall Study|Study closed/terminated|23
1731194|NCT01000493|6038833|P1|Overall Study|Study closed/terminated|25
1731195|NCT01000493|6038832|P2|Overall Study|Protocol Violation|8
1731196|NCT01000493|6038833|P1|Overall Study|Protocol Violation|1
1731197|NCT01000493|6038832|P2|Overall Study|Lack of Efficacy|1
1731198|NCT01000493|6038833|P1|Overall Study|Lack of Efficacy|1
1731199|NCT01000493|6038832|P2|Overall Study|Adverse Event|6
1731200|NCT01000493|6038833|P1|Overall Study|Adverse Event|3
1731201|NCT01000480|6038883|P1|Concurrent Therapy Phase|Physician Decision|1
1731202|NCT01000480|6038883|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
1731203|NCT01000480|6038883|P1|Concurrent Therapy Phase|Protocol Violation|2
1731204|NCT01000480|6038883|P1|Concurrent Therapy Phase|Adverse Event|4
1731205|NCT01000480|6038883|P1|Induction Phase|Entry Criteria Not Met|3
1731206|NCT01000480|6038883|P1|Induction Phase|Physician Decision|1
1731207|NCT01000480|6038883|P1|Induction Phase|Lost to Follow-up|1
1731208|NCT01000480|6038883|P1|Induction Phase|Adverse Event|2
1731209|NCT01000376|6038891|P2|Cycle 1 Day 1|Progressive Disease|0
1731210|NCT01000376|6038892|P1|Cycle 1 Day 1|Progressive Disease|1
1731211|NCT01000376|6038891|P2|Cycle 1 Day 1|Adverse Event|0
1731212|NCT01000376|6038892|P1|Cycle 1 Day 1|Adverse Event|1
1731213|NCT01000337|6038902|P2|Overall Study|Lost to Follow-up|3
1731214|NCT01000337|6038903|P1|Overall Study|Lost to Follow-up|4
1731215|NCT01000311|6038921|P2|Overall Study|Administrative reason|15
1731216|NCT01000311|6038922|P1|Overall Study|Administrative reason|9
1731217|NCT01000311|6038921|P2|Overall Study|Inappropriate enrollment|0
1731218|NCT01000311|6038922|P1|Overall Study|Inappropriate enrollment|2
1731219|NCT01000311|6038921|P2|Overall Study|Protocol Violation|2
1731220|NCT01000311|6038922|P1|Overall Study|Protocol Violation|1
1731221|NCT01000311|6038921|P2|Overall Study|Lost to Follow-up|24
1731222|NCT01000311|6038922|P1|Overall Study|Lost to Follow-up|15
1731223|NCT01000311|6038921|P2|Overall Study|Withdrawal by Subject|24
1731224|NCT01000311|6038922|P1|Overall Study|Withdrawal by Subject|16
1731225|NCT01000311|6038921|P2|Overall Study|Adverse Event|5
1731226|NCT01000311|6038922|P1|Overall Study|Adverse Event|2
1731227|NCT01000155|6038972|P1|Overall Study|Adverse Event|1
1731228|NCT01000155|6038972|P1|Overall Study|Withdrawal by Subject|1
1731229|NCT01000064|6038978|P2|Overall Study|Withdrawal by Subject|1
1731230|NCT01000064|6038979|P1|Overall Study|Withdrawal by Subject|1
1731231|NCT01000051|6039002|P2|Overall Study|Serious noncompliance|0
1731232|NCT01000051|6039003|P1|Overall Study|Serious noncompliance|1
1731233|NCT01000051|6039002|P2|Overall Study|Disease Progression|0
1731234|NCT01000051|6039003|P1|Overall Study|Disease Progression|1
1731235|NCT01000051|6039002|P2|Overall Study|Withdrawal by Subject|1
1731236|NCT01000051|6039003|P1|Overall Study|Withdrawal by Subject|1
1731237|NCT01000025|6039011|P2|Overall Study|Intercurrent Illness|7
1731238|NCT01000025|6039012|P1|Overall Study|Intercurrent Illness|26
1731239|NCT01000025|6039011|P2|Overall Study|Lack of Efficacy|208
1731240|NCT01000025|6039012|P1|Overall Study|Lack of Efficacy|363
1731241|NCT01000025|6039011|P2|Overall Study|Death|13
1731242|NCT01000025|6039012|P1|Overall Study|Death|23
1731243|NCT01000025|6039011|P2|Overall Study|Withdrawal by Subject|8
1731244|NCT01000025|6039012|P1|Overall Study|Withdrawal by Subject|13
1731245|NCT01000025|6039011|P2|Overall Study|Adverse Event|2
1731246|NCT01000025|6039012|P1|Overall Study|Adverse Event|43
1731247|NCT00999921|6039030|P2|Overall Study|Lost to Follow-up|19
1731248|NCT00999921|6039031|P1|Overall Study|Lost to Follow-up|10
1731249|NCT00999908|6039041|P3|Treatment Period 2|Protocol Violation|0
1731250|NCT00999908|6039042|P2|Treatment Period 2|Protocol Violation|0
1731251|NCT00999908|6039043|P1|Treatment Period 2|Protocol Violation|1
1731252|NCT00999908|6039041|P3|Treatment Period 1|Subject withdrew consent|0
1731253|NCT00999908|6039042|P2|Treatment Period 1|Subject withdrew consent|0
1731254|NCT00999908|6039043|P1|Treatment Period 1|Subject withdrew consent|2
1731255|NCT00999804|6039072|P2|Overall Study|Ineligible|0
1731256|NCT00999804|6039073|P1|Overall Study|Ineligible|3
1731257|NCT00999804|6039072|P2|Overall Study|Death|0
1731258|NCT00999804|6039073|P1|Overall Study|Death|1
1731259|NCT00999804|6039072|P2|Overall Study|Withdrawal by Subject|0
1731260|NCT00999804|6039073|P1|Overall Study|Withdrawal by Subject|4
1731261|NCT00999804|6039072|P2|Overall Study|Adverse Event|3
1731262|NCT00999804|6039073|P1|Overall Study|Adverse Event|4
1731263|NCT00999804|6039072|P2|Overall Study|Lack of Efficacy|2
1731264|NCT00999804|6039073|P1|Overall Study|Lack of Efficacy|9
1731265|NCT00999713|6039087|P2|Overall Study|Physician Decision|0
1731266|NCT00999713|6039088|P1|Overall Study|Physician Decision|2
1731267|NCT00999687|6039102|P1|Second Intervention|Lack of Efficacy|1
1731268|NCT00999687|6039102|P1|Second Intervention|Withdrawal by Subject|2
1731269|NCT00999687|6039102|P1|First Intervention|Withdrawal by Subject|1
1731270|NCT00999661|6039109|P1|Overall Study|Not meeting eligibility criteria|9
1731271|NCT00999661|6039109|P1|Overall Study|Withdrawal by Subject|1
1731272|NCT00999661|6039109|P1|Overall Study|Adverse Event|1
1731273|NCT00999661|6039109|P1|Overall Study|Lost to Follow-up|59
1731274|NCT00999596|6039130|P1|Overall Study|Statistical population not required|101
1731275|NCT00999544|6039135|P1|Overall Study|Withdrawal by Subject|1
1731276|NCT00999466|6039171|P3|Main Part|Adverse Event|2
1731277|NCT00999466|6039172|P2|Main Part|Adverse Event|4
1731278|NCT00999466|6039173|P1|Main Part|Adverse Event|0
1731279|NCT00999466|6039171|P3|Main Part|Withdrawal by Subject|2
1731280|NCT00999466|6039172|P2|Main Part|Withdrawal by Subject|0
1731281|NCT00999466|6039173|P1|Main Part|Withdrawal by Subject|0
1731282|NCT00999167|6039450|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
1731283|NCT00999167|6039451|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
1731284|NCT00999167|6039452|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
1731285|NCT00999167|6039450|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
1731286|NCT00999167|6039451|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
1731287|NCT00999167|6039452|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
1731288|NCT00999167|6039450|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
1731289|NCT00999167|6039451|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
1731290|NCT00999167|6039452|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
1731291|NCT00999167|6039450|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
1731292|NCT00999167|6039451|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
1731293|NCT00999167|6039452|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
1731294|NCT00999167|6039450|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
1731295|NCT00999167|6039451|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
1731296|NCT00999167|6039452|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
1731297|NCT00999167|6039450|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
1731298|NCT00999167|6039451|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
1731299|NCT00999167|6039452|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
1731300|NCT00999167|6039450|P3|Part A: Open Label Safety run-in|Adverse Event|0
1731301|NCT00999167|6039451|P2|Part A: Open Label Safety run-in|Adverse Event|0
1731302|NCT00999167|6039452|P1|Part A: Open Label Safety run-in|Adverse Event|3
1731303|NCT00999167|6039450|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
1731304|NCT00999167|6039451|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
1731305|NCT00999167|6039452|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
1731306|NCT00998985|6039590|P14|Overall Study|Protocol Violation|0
1731307|NCT00998985|6039591|P13|Overall Study|Protocol Violation|0
1731308|NCT00998985|6039592|P12|Overall Study|Protocol Violation|0
1731309|NCT00998985|6039593|P11|Overall Study|Protocol Violation|0
1731310|NCT00998985|6039594|P10|Overall Study|Protocol Violation|0
1731311|NCT00998985|6039595|P9|Overall Study|Protocol Violation|0
1731312|NCT00998985|6039596|P8|Overall Study|Protocol Violation|0
1731313|NCT00998985|6039597|P7|Overall Study|Protocol Violation|0
1731314|NCT00998985|6039598|P6|Overall Study|Protocol Violation|1
1731315|NCT00998985|6039599|P5|Overall Study|Protocol Violation|0
1731316|NCT00998985|6039600|P4|Overall Study|Protocol Violation|0
1731317|NCT00998985|6039601|P3|Overall Study|Protocol Violation|0
1731318|NCT00998985|6039602|P2|Overall Study|Protocol Violation|0
1731319|NCT00998985|6039603|P1|Overall Study|Protocol Violation|0
1731320|NCT00998985|6039590|P14|Overall Study|Withdrawal by Subject|0
1731321|NCT00998985|6039591|P13|Overall Study|Withdrawal by Subject|0
1731322|NCT00998985|6039592|P12|Overall Study|Withdrawal by Subject|0
1731323|NCT00998985|6039593|P11|Overall Study|Withdrawal by Subject|0
1731324|NCT00998985|6039594|P10|Overall Study|Withdrawal by Subject|0
1731325|NCT00998985|6039595|P9|Overall Study|Withdrawal by Subject|1
1731326|NCT00998985|6039596|P8|Overall Study|Withdrawal by Subject|0
1731327|NCT00998985|6039597|P7|Overall Study|Withdrawal by Subject|0
1731328|NCT00998985|6039598|P6|Overall Study|Withdrawal by Subject|0
1731329|NCT00998985|6039599|P5|Overall Study|Withdrawal by Subject|0
1731330|NCT00998985|6039600|P4|Overall Study|Withdrawal by Subject|0
1731331|NCT00998985|6039601|P3|Overall Study|Withdrawal by Subject|0
1731332|NCT00998985|6039602|P2|Overall Study|Withdrawal by Subject|0
1731333|NCT00998985|6039603|P1|Overall Study|Withdrawal by Subject|0
1731334|NCT00998881|6039671|P2|Overall Study|Personal matter|0
1731335|NCT00998881|6039672|P1|Overall Study|Personal matter|1
1731336|NCT00998881|6039671|P2|Overall Study|Withdrawal by Subject|0
1731337|NCT00998881|6039672|P1|Overall Study|Withdrawal by Subject|1
1731338|NCT00998881|6039671|P2|Overall Study|Physician Decision|0
1731339|NCT00998881|6039672|P1|Overall Study|Physician Decision|3
1731340|NCT00998881|6039671|P2|Overall Study|Lack of Efficacy|0
1731341|NCT00998881|6039672|P1|Overall Study|Lack of Efficacy|1
1731342|NCT00998881|6039671|P2|Overall Study|Adverse Event|2
1731343|NCT00998881|6039672|P1|Overall Study|Adverse Event|2
1731344|NCT00998790|6039691|P1|Overall Study|Withdrawal by Subject|21
1731345|NCT00998764|6039701|P2|Overall Study|Recurrent Episode of vasogenic edema|0
1731346|NCT00998764|6039702|P1|Overall Study|Recurrent Episode of vasogenic edema|1
1731347|NCT00998764|6039701|P2|Overall Study|Other|4
1731348|NCT00998764|6039702|P1|Overall Study|Other|4
1731349|NCT00998764|6039701|P2|Overall Study|Loss of Caregiver|3
1731350|NCT00998764|6039702|P1|Overall Study|Loss of Caregiver|0
1731351|NCT00998764|6039701|P2|Overall Study|Lost to Follow-up|1
1731352|NCT00998764|6039702|P1|Overall Study|Lost to Follow-up|1
1731353|NCT00998764|6039701|P2|Overall Study|Failed to Return|1
1731354|NCT00998764|6039702|P1|Overall Study|Failed to Return|1
1731355|NCT00998764|6039701|P2|Overall Study|Protocol Violation|1
1731356|NCT00998764|6039702|P1|Overall Study|Protocol Violation|0
1731357|NCT00998764|6039701|P2|Overall Study|Discontinuation of Study by Sponsor|217
1731358|NCT00998764|6039702|P1|Overall Study|Discontinuation of Study by Sponsor|164
1731359|NCT00998764|6039701|P2|Overall Study|Death|1
1731360|NCT00998764|6039702|P1|Overall Study|Death|3
1731361|NCT00998764|6039701|P2|Overall Study|Physician Decision|3
1731362|NCT00998764|6039702|P1|Overall Study|Physician Decision|3
1731363|NCT00998764|6039701|P2|Overall Study|Withdrawal by Subject|25
1731364|NCT00998764|6039702|P1|Overall Study|Withdrawal by Subject|19
1731365|NCT00998764|6039701|P2|Overall Study|Adverse Event|12
1731366|NCT00998764|6039702|P1|Overall Study|Adverse Event|17
1731367|NCT00998764|6039701|P2|Overall Study|Lack of Efficacy|6
1731368|NCT00998764|6039702|P1|Overall Study|Lack of Efficacy|3
1731369|NCT00998738|6039724|P1|Overall Study|Uknown|1
1731370|NCT00998400|6039792|P2|Overall Study|Logistical problems|0
1731371|NCT00998400|6039793|P1|Overall Study|Logistical problems|1
1731372|NCT00998400|6039792|P2|Overall Study|Lack of interest/motivation|2
1731373|NCT00998400|6039793|P1|Overall Study|Lack of interest/motivation|1
1731374|NCT00998335|6039838|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
1731375|NCT00998335|6039839|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
1731376|NCT00998309|6039867|P1|Overall Study|Protocol Violation|4
1731377|NCT00998296|6039934|P11|Overall Study|Reason other than those specified above|0
1731378|NCT00998296|6039935|P10|Overall Study|Reason other than those specified above|1
1731379|NCT00998296|6039936|P9|Overall Study|Reason other than those specified above|0
1731380|NCT00998296|6039937|P8|Overall Study|Reason other than those specified above|0
1731381|NCT00998296|6039938|P7|Overall Study|Reason other than those specified above|0
1731382|NCT00998296|6039939|P6|Overall Study|Reason other than those specified above|0
1731383|NCT00998296|6039940|P5|Overall Study|Reason other than those specified above|0
1731384|NCT00998296|6039941|P4|Overall Study|Reason other than those specified above|0
1731385|NCT00998296|6039942|P3|Overall Study|Reason other than those specified above|0
1731386|NCT00998296|6039943|P2|Overall Study|Reason other than those specified above|0
1731387|NCT00998296|6039944|P1|Overall Study|Reason other than those specified above|0
1731388|NCT00998296|6039934|P11|Overall Study|Refused to continue taking trial med.|0
1731389|NCT00998296|6039935|P10|Overall Study|Refused to continue taking trial med.|2
1731390|NCT00998296|6039936|P9|Overall Study|Refused to continue taking trial med.|0
1731391|NCT00998296|6039937|P8|Overall Study|Refused to continue taking trial med.|0
1731392|NCT00998296|6039938|P7|Overall Study|Refused to continue taking trial med.|0
1731393|NCT00998296|6039939|P6|Overall Study|Refused to continue taking trial med.|0
1731394|NCT00998296|6039940|P5|Overall Study|Refused to continue taking trial med.|0
1731395|NCT00998296|6039941|P4|Overall Study|Refused to continue taking trial med.|0
1731396|NCT00998296|6039942|P3|Overall Study|Refused to continue taking trial med.|0
1731397|NCT00998296|6039943|P2|Overall Study|Refused to continue taking trial med.|0
1731398|NCT00998296|6039944|P1|Overall Study|Refused to continue taking trial med.|0
1731399|NCT00998296|6039934|P11|Overall Study|Other adverse event|2
1731400|NCT00998296|6039935|P10|Overall Study|Other adverse event|1
1731401|NCT00998296|6039936|P9|Overall Study|Other adverse event|0
1731402|NCT00998296|6039937|P8|Overall Study|Other adverse event|0
1731403|NCT00998296|6039938|P7|Overall Study|Other adverse event|0
1731404|NCT00998296|6039939|P6|Overall Study|Other adverse event|0
1731405|NCT00998296|6039940|P5|Overall Study|Other adverse event|1
1731406|NCT00998296|6039941|P4|Overall Study|Other adverse event|0
1731407|NCT00998296|6039942|P3|Overall Study|Other adverse event|0
1731408|NCT00998296|6039943|P2|Overall Study|Other adverse event|0
1731409|NCT00998296|6039944|P1|Overall Study|Other adverse event|0
1731410|NCT00998296|6039934|P11|Overall Study|Dose limiting or dose reducing toxicity|0
1731411|NCT00998296|6039935|P10|Overall Study|Dose limiting or dose reducing toxicity|0
1731412|NCT00998296|6039936|P9|Overall Study|Dose limiting or dose reducing toxicity|2
1731413|NCT00998296|6039937|P8|Overall Study|Dose limiting or dose reducing toxicity|2
1731414|NCT00998296|6039938|P7|Overall Study|Dose limiting or dose reducing toxicity|0
1731415|NCT00998296|6039939|P6|Overall Study|Dose limiting or dose reducing toxicity|0
1731416|NCT00998296|6039940|P5|Overall Study|Dose limiting or dose reducing toxicity|1
1731417|NCT00998296|6039941|P4|Overall Study|Dose limiting or dose reducing toxicity|0
1731418|NCT00998296|6039942|P3|Overall Study|Dose limiting or dose reducing toxicity|0
1731419|NCT00998296|6039943|P2|Overall Study|Dose limiting or dose reducing toxicity|0
1731420|NCT00998296|6039944|P1|Overall Study|Dose limiting or dose reducing toxicity|0
1731421|NCT00998296|6039934|P11|Overall Study|Progressive disease|5
1731422|NCT00998296|6039935|P10|Overall Study|Progressive disease|14
1731423|NCT00998296|6039936|P9|Overall Study|Progressive disease|0
1731424|NCT00998296|6039937|P8|Overall Study|Progressive disease|0
1731425|NCT00998296|6039938|P7|Overall Study|Progressive disease|1
1731426|NCT00998296|6039939|P6|Overall Study|Progressive disease|0
1731427|NCT00998296|6039940|P5|Overall Study|Progressive disease|0
1731428|NCT00998296|6039941|P4|Overall Study|Progressive disease|0
1731429|NCT00998296|6039942|P3|Overall Study|Progressive disease|0
1731430|NCT00998296|6039943|P2|Overall Study|Progressive disease|1
1731431|NCT00998296|6039944|P1|Overall Study|Progressive disease|0
1731432|NCT00997984|6040039|P3|Overall Study|Work schedule|2
1731433|NCT00997984|6040040|P2|Overall Study|Work schedule|0
1731434|NCT00997984|6040041|P1|Overall Study|Work schedule|0
1731435|NCT00997984|6040039|P3|Overall Study|Suicidal ideation|1
1731436|NCT00997984|6040040|P2|Overall Study|Suicidal ideation|0
1731437|NCT00997984|6040041|P1|Overall Study|Suicidal ideation|0
1731438|NCT00997984|6040039|P3|Overall Study|Wrong medication dispensed|0
1731439|NCT00997984|6040040|P2|Overall Study|Wrong medication dispensed|1
1731440|NCT00997984|6040041|P1|Overall Study|Wrong medication dispensed|0
1731441|NCT00997984|6040039|P3|Overall Study|non-compliance|3
1731442|NCT00997984|6040040|P2|Overall Study|non-compliance|2
1731443|NCT00997984|6040041|P1|Overall Study|non-compliance|0
1731444|NCT00997984|6040039|P3|Overall Study|Met exclusion criteria|0
1731445|NCT00997984|6040040|P2|Overall Study|Met exclusion criteria|0
1731446|NCT00997984|6040041|P1|Overall Study|Met exclusion criteria|1
1731447|NCT00997984|6040039|P3|Overall Study|Lack of Efficacy|3
1731448|NCT00997984|6040040|P2|Overall Study|Lack of Efficacy|6
1731449|NCT00997984|6040041|P1|Overall Study|Lack of Efficacy|20
1731450|NCT00997984|6040039|P3|Overall Study|Lost to Follow-up|4
1731451|NCT00997984|6040040|P2|Overall Study|Lost to Follow-up|5
1731452|NCT00997984|6040041|P1|Overall Study|Lost to Follow-up|8
1731453|NCT00997984|6040039|P3|Overall Study|Withdrawal by Subject|5
1731454|NCT00997984|6040040|P2|Overall Study|Withdrawal by Subject|9
1731455|NCT00997984|6040041|P1|Overall Study|Withdrawal by Subject|6
1731456|NCT00997984|6040039|P3|Overall Study|Protocol Violation|0
1731457|NCT00997984|6040040|P2|Overall Study|Protocol Violation|3
1731458|NCT00997984|6040041|P1|Overall Study|Protocol Violation|1
1731459|NCT00997984|6040039|P3|Overall Study|Adverse Event|8
1731460|NCT00997984|6040040|P2|Overall Study|Adverse Event|8
1731461|NCT00997984|6040041|P1|Overall Study|Adverse Event|1
1731462|NCT00997503|6040199|P1|Overall Study|Other reason|13
1731463|NCT00997503|6040199|P1|Overall Study|Missed 12-month follow-up|85
1731464|NCT00997503|6040199|P1|Overall Study|Physician Decision|10
1731465|NCT00997503|6040199|P1|Overall Study|Adverse Event|3
1731466|NCT00997503|6040199|P1|Overall Study|Lost to Follow-up|33
1731467|NCT00997503|6040199|P1|Overall Study|Withdrawal by Subject|76
1731468|NCT00997503|6040199|P1|Overall Study|Death|53
1731469|NCT00997438|6040242|P3|Overall Study|Exclusion criteria at visit 1|3
1731470|NCT00997438|6040243|P2|Overall Study|Exclusion criteria at visit 1|2
1731471|NCT00997438|6040244|P1|Overall Study|Exclusion criteria at visit 1|2
1731472|NCT00997438|6040242|P3|Overall Study|Withdrawal by Subject|0
1731473|NCT00997438|6040243|P2|Overall Study|Withdrawal by Subject|1
1731474|NCT00997438|6040244|P1|Overall Study|Withdrawal by Subject|1
1731475|NCT00997438|6040242|P3|Overall Study|Blood draw difficulty|1
1731476|NCT00997438|6040243|P2|Overall Study|Blood draw difficulty|0
1731477|NCT00997438|6040244|P1|Overall Study|Blood draw difficulty|2
1731478|NCT00997386|6040284|P1|Overall Study|Death|7
1731479|NCT00997373|6040293|P2|Overall Study|could not have hysterectomy|0
1731480|NCT00997373|6040294|P1|Overall Study|could not have hysterectomy|6
1731481|NCT00997373|6040293|P2|Overall Study|wrong tumor type|0
1731482|NCT00997373|6040294|P1|Overall Study|wrong tumor type|4
1731483|NCT00997373|6040293|P2|Overall Study|Withdrawal by Subject|0
1731484|NCT00997373|6040294|P1|Overall Study|Withdrawal by Subject|5
1731485|NCT00997334|6040300|P1|Overall Study|Ineligible|1
1731486|NCT00997334|6040300|P1|Overall Study|No lesion amenable|1
1731487|NCT00997334|6040300|P1|Overall Study|Urgent Palliative Care|2
1731488|NCT00997334|6040300|P1|Overall Study|Death|2
1731489|NCT00997334|6040300|P1|Overall Study|Withdrawal by Subject|3
1731490|NCT00997334|6040300|P1|Overall Study|Patient non-compliance|1
1731491|NCT00997334|6040300|P1|Overall Study|Adverse Event|3
1731492|NCT00997334|6040300|P1|Overall Study|still on therapy|12
1731493|NCT00997321|6040309|P2|Overall Study|did not undergo sedation after enrollmen|3
1731494|NCT00997321|6040310|P1|Overall Study|did not undergo sedation after enrollmen|0
1731495|NCT00997243|6040322|P1|Overall Study|Early termination of study by sponsor|7
1731496|NCT00997126|6040354|P2|Overall Study|Physician Decision|11
1731497|NCT00997126|6040355|P1|Overall Study|Physician Decision|7
1731498|NCT00997035|6040384|P2|3-month Follow-up Visit|Lost to Follow-up|6
1731499|NCT00997035|6040385|P1|3-month Follow-up Visit|Lost to Follow-up|12
1731500|NCT00997035|6040384|P2|3-week Followup Visit|Lost to Follow-up|6
1731501|NCT00997035|6040385|P1|3-week Followup Visit|Lost to Follow-up|9
1731502|NCT00996996|6040409|P1|Overall Study|Did Not Receive Study Medications|1
1731503|NCT00996996|6040409|P1|Overall Study|Death|5
1731504|NCT00996996|6040409|P1|Overall Study|Lost to Follow-up|9
1731505|NCT00996996|6040409|P1|Overall Study|Non-compliance|8
1731506|NCT00996996|6040409|P1|Overall Study|Progressive Disease|10
1731507|NCT00996944|6040443|P2|Long-term Treatment Period|Study Closed/Terminated|5
1731508|NCT00996944|6040444|P1|Long-term Treatment Period|Study Closed/Terminated|12
1731509|NCT00996944|6040443|P2|Double-blind Treatment Period|Withdrawal by Subject|1
1731510|NCT00996944|6040444|P1|Double-blind Treatment Period|Withdrawal by Subject|1
1731511|NCT00996944|6040443|P2|Double-blind Treatment Period|Study Closed/Terminated|5
1731512|NCT00996944|6040444|P1|Double-blind Treatment Period|Study Closed/Terminated|6
1731513|NCT00996944|6040443|P2|Double-blind Treatment Period|Protocol Violation|0
1731514|NCT00996944|6040444|P1|Double-blind Treatment Period|Protocol Violation|1
1731515|NCT00996944|6040443|P2|Double-blind Treatment Period|Adverse Event|1
1731516|NCT00996944|6040444|P1|Double-blind Treatment Period|Adverse Event|2
1731517|NCT00996918|6040496|P5|Overall Study|Other|0
1731518|NCT00996918|6040497|P4|Overall Study|Other|0
1731519|NCT00996918|6040498|P3|Overall Study|Other|0
1731520|NCT00996918|6040499|P2|Overall Study|Other|1
1731521|NCT00996918|6040500|P1|Overall Study|Other|3
1731522|NCT00996918|6040496|P5|Overall Study|Loss of Caregiver|0
1731523|NCT00996918|6040497|P4|Overall Study|Loss of Caregiver|0
1731524|NCT00996918|6040498|P3|Overall Study|Loss of Caregiver|0
1731525|NCT00996918|6040499|P2|Overall Study|Loss of Caregiver|1
1731526|NCT00996918|6040500|P1|Overall Study|Loss of Caregiver|0
1731527|NCT00996918|6040496|P5|Overall Study|Discontinuation of Study by Sponsor|2
1731528|NCT00996918|6040497|P4|Overall Study|Discontinuation of Study by Sponsor|45
1731529|NCT00996918|6040498|P3|Overall Study|Discontinuation of Study by Sponsor|30
1731530|NCT00996918|6040499|P2|Overall Study|Discontinuation of Study by Sponsor|54
1731531|NCT00996918|6040500|P1|Overall Study|Discontinuation of Study by Sponsor|31
1731532|NCT00996918|6040496|P5|Overall Study|Physician Decision|0
1731533|NCT00996918|6040497|P4|Overall Study|Physician Decision|0
1731534|NCT00996918|6040498|P3|Overall Study|Physician Decision|0
1731535|NCT00996918|6040499|P2|Overall Study|Physician Decision|0
1731536|NCT00996918|6040500|P1|Overall Study|Physician Decision|1
1731537|NCT00996918|6040496|P5|Overall Study|Withdrawal by Subject|2
1731538|NCT00996918|6040497|P4|Overall Study|Withdrawal by Subject|3
1731539|NCT00996918|6040498|P3|Overall Study|Withdrawal by Subject|3
1731540|NCT00996918|6040499|P2|Overall Study|Withdrawal by Subject|4
1731541|NCT00996918|6040500|P1|Overall Study|Withdrawal by Subject|1
1731542|NCT00996918|6040496|P5|Overall Study|Adverse Event|0
1731543|NCT00996918|6040497|P4|Overall Study|Adverse Event|6
1731544|NCT00996918|6040498|P3|Overall Study|Adverse Event|2
1731545|NCT00996918|6040499|P2|Overall Study|Adverse Event|5
1731546|NCT00996918|6040500|P1|Overall Study|Adverse Event|2
1731547|NCT00996918|6040496|P5|Overall Study|Lack of Efficacy|0
1731548|NCT00996918|6040497|P4|Overall Study|Lack of Efficacy|2
1731549|NCT00996918|6040498|P3|Overall Study|Lack of Efficacy|2
1731550|NCT00996918|6040499|P2|Overall Study|Lack of Efficacy|1
1731551|NCT00996918|6040500|P1|Overall Study|Lack of Efficacy|1
1731552|NCT00996892|6040544|P20|Expansion Stage 2A|Disease Progression|31
1731553|NCT00996892|6040545|P19|Expansion Stage 2A|Disease Progression|0
1731554|NCT00996892|6040546|P18|Expansion Stage 2A|Disease Progression|0
1731555|NCT00996892|6040547|P17|Expansion Stage 2A|Disease Progression|0
1731556|NCT00996892|6040548|P16|Expansion Stage 2A|Disease Progression|0
1731557|NCT00996892|6040549|P15|Expansion Stage 2A|Disease Progression|0
1731558|NCT00996892|6040550|P14|Expansion Stage 2A|Disease Progression|0
1731559|NCT00996892|6040551|P13|Expansion Stage 2A|Disease Progression|0
1731560|NCT00996892|6040552|P12|Expansion Stage 2A|Disease Progression|0
1731561|NCT00996892|6040553|P11|Expansion Stage 2A|Disease Progression|0
1731562|NCT00996892|6040554|P10|Expansion Stage 2A|Disease Progression|0
1731563|NCT00996892|6040555|P9|Expansion Stage 2A|Disease Progression|0
1731564|NCT00996892|6040556|P8|Expansion Stage 2A|Disease Progression|0
1731565|NCT00996892|6040557|P7|Expansion Stage 2A|Disease Progression|0
1731566|NCT00996892|6040558|P6|Expansion Stage 2A|Disease Progression|0
1731567|NCT00996892|6040559|P5|Expansion Stage 2A|Disease Progression|0
1731568|NCT00996892|6040560|P4|Expansion Stage 2A|Disease Progression|0
1731569|NCT00996892|6040561|P3|Expansion Stage 2A|Disease Progression|0
1731570|NCT00996892|6040562|P2|Expansion Stage 2A|Disease Progression|0
1731571|NCT00996892|6040563|P1|Expansion Stage 2A|Disease Progression|0
1731572|NCT00996892|6040544|P20|Expansion Stage 2A|Withdrawal by Subject|4
1731573|NCT00996892|6040545|P19|Expansion Stage 2A|Withdrawal by Subject|0
1731574|NCT00996892|6040546|P18|Expansion Stage 2A|Withdrawal by Subject|0
1731575|NCT00996892|6040547|P17|Expansion Stage 2A|Withdrawal by Subject|0
1731576|NCT00996892|6040548|P16|Expansion Stage 2A|Withdrawal by Subject|0
1731577|NCT00996892|6040549|P15|Expansion Stage 2A|Withdrawal by Subject|0
1731578|NCT00996892|6040550|P14|Expansion Stage 2A|Withdrawal by Subject|0
1731579|NCT00996892|6040551|P13|Expansion Stage 2A|Withdrawal by Subject|0
1731580|NCT00996892|6040552|P12|Expansion Stage 2A|Withdrawal by Subject|0
1731581|NCT00996892|6040553|P11|Expansion Stage 2A|Withdrawal by Subject|0
1731582|NCT00996892|6040554|P10|Expansion Stage 2A|Withdrawal by Subject|0
1731583|NCT00996892|6040555|P9|Expansion Stage 2A|Withdrawal by Subject|0
1731584|NCT00996892|6040556|P8|Expansion Stage 2A|Withdrawal by Subject|0
1731585|NCT00996892|6040557|P7|Expansion Stage 2A|Withdrawal by Subject|0
1731586|NCT00996892|6040558|P6|Expansion Stage 2A|Withdrawal by Subject|0
1731587|NCT00996892|6040559|P5|Expansion Stage 2A|Withdrawal by Subject|0
1731588|NCT00996892|6040560|P4|Expansion Stage 2A|Withdrawal by Subject|0
1731589|NCT00996892|6040561|P3|Expansion Stage 2A|Withdrawal by Subject|0
1731590|NCT00996892|6040562|P2|Expansion Stage 2A|Withdrawal by Subject|0
1731591|NCT00996892|6040563|P1|Expansion Stage 2A|Withdrawal by Subject|0
1731592|NCT00996892|6040544|P20|Expansion Stage 2A|Physician Decision|2
1731593|NCT00996892|6040545|P19|Expansion Stage 2A|Physician Decision|0
1731594|NCT00996892|6040546|P18|Expansion Stage 2A|Physician Decision|0
1731595|NCT00996892|6040547|P17|Expansion Stage 2A|Physician Decision|0
1731596|NCT00996892|6040548|P16|Expansion Stage 2A|Physician Decision|0
1731597|NCT00996892|6040549|P15|Expansion Stage 2A|Physician Decision|0
1731598|NCT00996892|6040550|P14|Expansion Stage 2A|Physician Decision|0
1731599|NCT00996892|6040551|P13|Expansion Stage 2A|Physician Decision|0
1731600|NCT00996892|6040552|P12|Expansion Stage 2A|Physician Decision|0
1731601|NCT00996892|6040553|P11|Expansion Stage 2A|Physician Decision|0
1731602|NCT00996892|6040554|P10|Expansion Stage 2A|Physician Decision|0
1731603|NCT00996892|6040555|P9|Expansion Stage 2A|Physician Decision|0
1731604|NCT00996892|6040556|P8|Expansion Stage 2A|Physician Decision|0
1731605|NCT00996892|6040557|P7|Expansion Stage 2A|Physician Decision|0
1731606|NCT00996892|6040558|P6|Expansion Stage 2A|Physician Decision|0
1731607|NCT00996892|6040559|P5|Expansion Stage 2A|Physician Decision|0
1731608|NCT00996892|6040560|P4|Expansion Stage 2A|Physician Decision|0
1731609|NCT00996892|6040561|P3|Expansion Stage 2A|Physician Decision|0
1731610|NCT00996892|6040562|P2|Expansion Stage 2A|Physician Decision|0
1731611|NCT00996892|6040563|P1|Expansion Stage 2A|Physician Decision|0
1731612|NCT00996892|6040544|P20|Expansion Stage 2A|Adverse Event|8
1731613|NCT00996892|6040545|P19|Expansion Stage 2A|Adverse Event|0
1731614|NCT00996892|6040546|P18|Expansion Stage 2A|Adverse Event|0
1731615|NCT00996892|6040547|P17|Expansion Stage 2A|Adverse Event|0
1731616|NCT00996892|6040548|P16|Expansion Stage 2A|Adverse Event|0
1731617|NCT00996892|6040549|P15|Expansion Stage 2A|Adverse Event|0
1731618|NCT00996892|6040550|P14|Expansion Stage 2A|Adverse Event|0
1731619|NCT00996892|6040551|P13|Expansion Stage 2A|Adverse Event|0
1731620|NCT00996892|6040552|P12|Expansion Stage 2A|Adverse Event|0
1731621|NCT00996892|6040553|P11|Expansion Stage 2A|Adverse Event|0
1731622|NCT00996892|6040554|P10|Expansion Stage 2A|Adverse Event|0
1731623|NCT00996892|6040555|P9|Expansion Stage 2A|Adverse Event|0
1731624|NCT00996892|6040556|P8|Expansion Stage 2A|Adverse Event|0
1731625|NCT00996892|6040557|P7|Expansion Stage 2A|Adverse Event|0
1731626|NCT00996892|6040558|P6|Expansion Stage 2A|Adverse Event|0
1731627|NCT00996892|6040559|P5|Expansion Stage 2A|Adverse Event|0
1731628|NCT00996892|6040560|P4|Expansion Stage 2A|Adverse Event|0
1731629|NCT00996892|6040561|P3|Expansion Stage 2A|Adverse Event|0
1731630|NCT00996892|6040562|P2|Expansion Stage 2A|Adverse Event|0
1731631|NCT00996892|6040563|P1|Expansion Stage 2A|Adverse Event|0
1731632|NCT00996892|6040544|P20|Expansion Stage 2|Disease Progression|0
1731633|NCT00996892|6040545|P19|Expansion Stage 2|Disease Progression|28
1731634|NCT00996892|6040546|P18|Expansion Stage 2|Disease Progression|0
1731635|NCT00996892|6040547|P17|Expansion Stage 2|Disease Progression|0
1731636|NCT00996892|6040548|P16|Expansion Stage 2|Disease Progression|0
1731637|NCT00996892|6040549|P15|Expansion Stage 2|Disease Progression|0
1731638|NCT00996892|6040550|P14|Expansion Stage 2|Disease Progression|0
1731639|NCT00996892|6040551|P13|Expansion Stage 2|Disease Progression|0
1731640|NCT00996892|6040552|P12|Expansion Stage 2|Disease Progression|0
1731641|NCT00996892|6040553|P11|Expansion Stage 2|Disease Progression|0
1731642|NCT00996892|6040554|P10|Expansion Stage 2|Disease Progression|0
1731643|NCT00996892|6040555|P9|Expansion Stage 2|Disease Progression|0
1731644|NCT00996892|6040556|P8|Expansion Stage 2|Disease Progression|0
1731645|NCT00996892|6040557|P7|Expansion Stage 2|Disease Progression|0
1731646|NCT00996892|6040558|P6|Expansion Stage 2|Disease Progression|0
1731647|NCT00996892|6040559|P5|Expansion Stage 2|Disease Progression|0
1731648|NCT00996892|6040560|P4|Expansion Stage 2|Disease Progression|0
1731649|NCT00996892|6040561|P3|Expansion Stage 2|Disease Progression|0
1731650|NCT00996892|6040562|P2|Expansion Stage 2|Disease Progression|0
1731651|NCT00996892|6040563|P1|Expansion Stage 2|Disease Progression|0
1731652|NCT00996892|6040544|P20|Expansion Stage 2|Withdrawal by Subject|0
1731653|NCT00996892|6040545|P19|Expansion Stage 2|Withdrawal by Subject|1
1731654|NCT00996892|6040546|P18|Expansion Stage 2|Withdrawal by Subject|0
1731655|NCT00996892|6040547|P17|Expansion Stage 2|Withdrawal by Subject|0
1731656|NCT00996892|6040548|P16|Expansion Stage 2|Withdrawal by Subject|0
1731657|NCT00996892|6040549|P15|Expansion Stage 2|Withdrawal by Subject|0
1731658|NCT00996892|6040550|P14|Expansion Stage 2|Withdrawal by Subject|0
1731659|NCT00996892|6040551|P13|Expansion Stage 2|Withdrawal by Subject|0
1731660|NCT00996892|6040552|P12|Expansion Stage 2|Withdrawal by Subject|0
1731661|NCT00996892|6040553|P11|Expansion Stage 2|Withdrawal by Subject|0
1731662|NCT00996892|6040554|P10|Expansion Stage 2|Withdrawal by Subject|0
1731663|NCT00996892|6040555|P9|Expansion Stage 2|Withdrawal by Subject|0
1731664|NCT00996892|6040556|P8|Expansion Stage 2|Withdrawal by Subject|0
1731665|NCT00996892|6040557|P7|Expansion Stage 2|Withdrawal by Subject|0
1731666|NCT00996892|6040558|P6|Expansion Stage 2|Withdrawal by Subject|0
1731667|NCT00996892|6040559|P5|Expansion Stage 2|Withdrawal by Subject|0
1731668|NCT00996892|6040560|P4|Expansion Stage 2|Withdrawal by Subject|0
1731669|NCT00996892|6040561|P3|Expansion Stage 2|Withdrawal by Subject|0
1731670|NCT00996892|6040562|P2|Expansion Stage 2|Withdrawal by Subject|0
1731671|NCT00996892|6040563|P1|Expansion Stage 2|Withdrawal by Subject|0
1731672|NCT00996892|6040544|P20|Expansion Stage 2|Physician Decision|0
1731673|NCT00996892|6040545|P19|Expansion Stage 2|Physician Decision|1
1731674|NCT00996892|6040546|P18|Expansion Stage 2|Physician Decision|0
1731675|NCT00996892|6040547|P17|Expansion Stage 2|Physician Decision|0
1731676|NCT00996892|6040548|P16|Expansion Stage 2|Physician Decision|0
1731677|NCT00996892|6040549|P15|Expansion Stage 2|Physician Decision|0
1731678|NCT00996892|6040550|P14|Expansion Stage 2|Physician Decision|0
1731679|NCT00996892|6040551|P13|Expansion Stage 2|Physician Decision|0
1731680|NCT00996892|6040552|P12|Expansion Stage 2|Physician Decision|0
1731681|NCT00996892|6040553|P11|Expansion Stage 2|Physician Decision|0
1731682|NCT00996892|6040554|P10|Expansion Stage 2|Physician Decision|0
1731683|NCT00996892|6040555|P9|Expansion Stage 2|Physician Decision|0
1731684|NCT00996892|6040556|P8|Expansion Stage 2|Physician Decision|0
1731685|NCT00996892|6040557|P7|Expansion Stage 2|Physician Decision|0
1731686|NCT00996892|6040558|P6|Expansion Stage 2|Physician Decision|0
1731687|NCT00996892|6040559|P5|Expansion Stage 2|Physician Decision|0
1731688|NCT00996892|6040560|P4|Expansion Stage 2|Physician Decision|0
1731689|NCT00996892|6040561|P3|Expansion Stage 2|Physician Decision|0
1731690|NCT00996892|6040562|P2|Expansion Stage 2|Physician Decision|0
1731691|NCT00996892|6040563|P1|Expansion Stage 2|Physician Decision|0
1731692|NCT00996892|6040544|P20|Expansion Stage 2|Death|0
1731693|NCT00996892|6040545|P19|Expansion Stage 2|Death|2
1731694|NCT00996892|6040546|P18|Expansion Stage 2|Death|0
1731695|NCT00996892|6040547|P17|Expansion Stage 2|Death|0
1731696|NCT00996892|6040548|P16|Expansion Stage 2|Death|0
1731697|NCT00996892|6040549|P15|Expansion Stage 2|Death|0
1731698|NCT00996892|6040550|P14|Expansion Stage 2|Death|0
1731699|NCT00996892|6040551|P13|Expansion Stage 2|Death|0
1731700|NCT00996892|6040552|P12|Expansion Stage 2|Death|0
1731701|NCT00996892|6040553|P11|Expansion Stage 2|Death|0
1731702|NCT00996892|6040554|P10|Expansion Stage 2|Death|0
1731703|NCT00996892|6040555|P9|Expansion Stage 2|Death|0
1731704|NCT00996892|6040556|P8|Expansion Stage 2|Death|0
1731705|NCT00996892|6040557|P7|Expansion Stage 2|Death|0
1731706|NCT00996892|6040558|P6|Expansion Stage 2|Death|0
1731707|NCT00996892|6040559|P5|Expansion Stage 2|Death|0
1731708|NCT00996892|6040560|P4|Expansion Stage 2|Death|0
1731709|NCT00996892|6040561|P3|Expansion Stage 2|Death|0
1731710|NCT00996892|6040562|P2|Expansion Stage 2|Death|0
1731711|NCT00996892|6040563|P1|Expansion Stage 2|Death|0
1731712|NCT00996892|6040544|P20|Expansion Stage 2|Adverse Event|0
1731713|NCT00996892|6040545|P19|Expansion Stage 2|Adverse Event|3
1731714|NCT00996892|6040546|P18|Expansion Stage 2|Adverse Event|0
1731715|NCT00996892|6040547|P17|Expansion Stage 2|Adverse Event|0
1731716|NCT00996892|6040548|P16|Expansion Stage 2|Adverse Event|0
1731717|NCT00996892|6040549|P15|Expansion Stage 2|Adverse Event|0
1731718|NCT00996892|6040550|P14|Expansion Stage 2|Adverse Event|0
1731719|NCT00996892|6040551|P13|Expansion Stage 2|Adverse Event|0
1731720|NCT00996892|6040552|P12|Expansion Stage 2|Adverse Event|0
1731721|NCT00996892|6040553|P11|Expansion Stage 2|Adverse Event|0
1731722|NCT00996892|6040554|P10|Expansion Stage 2|Adverse Event|0
1731723|NCT00996892|6040555|P9|Expansion Stage 2|Adverse Event|0
1731724|NCT00996892|6040556|P8|Expansion Stage 2|Adverse Event|0
1731725|NCT00996892|6040557|P7|Expansion Stage 2|Adverse Event|0
1731726|NCT00996892|6040558|P6|Expansion Stage 2|Adverse Event|0
1731727|NCT00996892|6040559|P5|Expansion Stage 2|Adverse Event|0
1731728|NCT00996892|6040560|P4|Expansion Stage 2|Adverse Event|0
1731729|NCT00996892|6040561|P3|Expansion Stage 2|Adverse Event|0
1731730|NCT00996892|6040562|P2|Expansion Stage 2|Adverse Event|0
1731731|NCT00996892|6040563|P1|Expansion Stage 2|Adverse Event|0
1731732|NCT00996892|6040544|P20|Dose-Escalation Stage 1B|Disease Progression|0
1731733|NCT00996892|6040545|P19|Dose-Escalation Stage 1B|Disease Progression|0
1731734|NCT00996892|6040546|P18|Dose-Escalation Stage 1B|Disease Progression|3
1731735|NCT00996892|6040547|P17|Dose-Escalation Stage 1B|Disease Progression|3
1731736|NCT00996892|6040548|P16|Dose-Escalation Stage 1B|Disease Progression|3
1731737|NCT00996892|6040549|P15|Dose-Escalation Stage 1B|Disease Progression|4
1731738|NCT00996892|6040550|P14|Dose-Escalation Stage 1B|Disease Progression|0
1731739|NCT00996892|6040551|P13|Dose-Escalation Stage 1B|Disease Progression|0
1731740|NCT00996892|6040552|P12|Dose-Escalation Stage 1B|Disease Progression|0
1731741|NCT00996892|6040553|P11|Dose-Escalation Stage 1B|Disease Progression|0
1731742|NCT00996892|6040554|P10|Dose-Escalation Stage 1B|Disease Progression|0
1731743|NCT00996892|6040555|P9|Dose-Escalation Stage 1B|Disease Progression|0
1731744|NCT00996892|6040556|P8|Dose-Escalation Stage 1B|Disease Progression|0
1731745|NCT00996892|6040557|P7|Dose-Escalation Stage 1B|Disease Progression|0
1731746|NCT00996892|6040558|P6|Dose-Escalation Stage 1B|Disease Progression|0
1731747|NCT00996892|6040559|P5|Dose-Escalation Stage 1B|Disease Progression|0
1731748|NCT00996892|6040560|P4|Dose-Escalation Stage 1B|Disease Progression|0
1731749|NCT00996892|6040561|P3|Dose-Escalation Stage 1B|Disease Progression|0
1731750|NCT00996892|6040562|P2|Dose-Escalation Stage 1B|Disease Progression|0
1731751|NCT00996892|6040563|P1|Dose-Escalation Stage 1B|Disease Progression|0
1731752|NCT00996892|6040544|P20|Dose-Escalation Stage 1B|Physician Decision|0
1731753|NCT00996892|6040545|P19|Dose-Escalation Stage 1B|Physician Decision|0
1731754|NCT00996892|6040546|P18|Dose-Escalation Stage 1B|Physician Decision|2
1731755|NCT00996892|6040547|P17|Dose-Escalation Stage 1B|Physician Decision|0
1731756|NCT00996892|6040548|P16|Dose-Escalation Stage 1B|Physician Decision|0
1731757|NCT00996892|6040549|P15|Dose-Escalation Stage 1B|Physician Decision|0
1731758|NCT00996892|6040550|P14|Dose-Escalation Stage 1B|Physician Decision|0
1731759|NCT00996892|6040551|P13|Dose-Escalation Stage 1B|Physician Decision|0
1731760|NCT00996892|6040552|P12|Dose-Escalation Stage 1B|Physician Decision|0
1731761|NCT00996892|6040553|P11|Dose-Escalation Stage 1B|Physician Decision|0
1731762|NCT00996892|6040554|P10|Dose-Escalation Stage 1B|Physician Decision|0
1731763|NCT00996892|6040555|P9|Dose-Escalation Stage 1B|Physician Decision|0
1731764|NCT00996892|6040556|P8|Dose-Escalation Stage 1B|Physician Decision|0
1731765|NCT00996892|6040557|P7|Dose-Escalation Stage 1B|Physician Decision|0
1731766|NCT00996892|6040558|P6|Dose-Escalation Stage 1B|Physician Decision|0
1731767|NCT00996892|6040559|P5|Dose-Escalation Stage 1B|Physician Decision|0
1731768|NCT00996892|6040560|P4|Dose-Escalation Stage 1B|Physician Decision|0
1731769|NCT00996892|6040561|P3|Dose-Escalation Stage 1B|Physician Decision|0
1731770|NCT00996892|6040562|P2|Dose-Escalation Stage 1B|Physician Decision|0
1731771|NCT00996892|6040563|P1|Dose-Escalation Stage 1B|Physician Decision|0
1731772|NCT00996892|6040544|P20|Dose-Escalation Stage 1A|Disease Progression|0
1731773|NCT00996892|6040545|P19|Dose-Escalation Stage 1A|Disease Progression|0
1731774|NCT00996892|6040546|P18|Dose-Escalation Stage 1A|Disease Progression|0
1731775|NCT00996892|6040547|P17|Dose-Escalation Stage 1A|Disease Progression|0
1731776|NCT00996892|6040548|P16|Dose-Escalation Stage 1A|Disease Progression|0
1731777|NCT00996892|6040549|P15|Dose-Escalation Stage 1A|Disease Progression|0
1731778|NCT00996892|6040550|P14|Dose-Escalation Stage 1A|Disease Progression|4
1731779|NCT00996892|6040551|P13|Dose-Escalation Stage 1A|Disease Progression|6
1731780|NCT00996892|6040552|P12|Dose-Escalation Stage 1A|Disease Progression|7
1731781|NCT00996892|6040553|P11|Dose-Escalation Stage 1A|Disease Progression|5
1731782|NCT00996892|6040554|P10|Dose-Escalation Stage 1A|Disease Progression|1
1731783|NCT00996892|6040555|P9|Dose-Escalation Stage 1A|Disease Progression|3
1731784|NCT00996892|6040556|P8|Dose-Escalation Stage 1A|Disease Progression|2
1731785|NCT00996892|6040557|P7|Dose-Escalation Stage 1A|Disease Progression|0
1731786|NCT00996892|6040558|P6|Dose-Escalation Stage 1A|Disease Progression|0
1731787|NCT00996892|6040559|P5|Dose-Escalation Stage 1A|Disease Progression|0
1731788|NCT00996892|6040560|P4|Dose-Escalation Stage 1A|Disease Progression|0
1731789|NCT00996892|6040561|P3|Dose-Escalation Stage 1A|Disease Progression|0
1731790|NCT00996892|6040562|P2|Dose-Escalation Stage 1A|Disease Progression|0
1731791|NCT00996892|6040563|P1|Dose-Escalation Stage 1A|Disease Progression|0
1731792|NCT00996892|6040544|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731793|NCT00996892|6040545|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731794|NCT00996892|6040546|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731795|NCT00996892|6040547|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731796|NCT00996892|6040548|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731797|NCT00996892|6040549|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731798|NCT00996892|6040550|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731799|NCT00996892|6040551|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1731800|NCT00996892|6040552|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1731801|NCT00996892|6040553|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1731802|NCT00996892|6040554|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
1731803|NCT00996892|6040555|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731804|NCT00996892|6040556|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731805|NCT00996892|6040557|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731806|NCT00996892|6040558|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731807|NCT00996892|6040559|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731808|NCT00996892|6040560|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731809|NCT00996892|6040561|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731810|NCT00996892|6040562|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731811|NCT00996892|6040563|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
1731812|NCT00996892|6040544|P20|Dose-Escalation Stage 1A|Physician Decision|0
1731813|NCT00996892|6040545|P19|Dose-Escalation Stage 1A|Physician Decision|0
1731814|NCT00996892|6040546|P18|Dose-Escalation Stage 1A|Physician Decision|0
1731815|NCT00996892|6040547|P17|Dose-Escalation Stage 1A|Physician Decision|0
1731816|NCT00996892|6040548|P16|Dose-Escalation Stage 1A|Physician Decision|0
1731817|NCT00996892|6040549|P15|Dose-Escalation Stage 1A|Physician Decision|0
1731818|NCT00996892|6040550|P14|Dose-Escalation Stage 1A|Physician Decision|0
1731819|NCT00996892|6040551|P13|Dose-Escalation Stage 1A|Physician Decision|0
1731820|NCT00996892|6040552|P12|Dose-Escalation Stage 1A|Physician Decision|0
1731821|NCT00996892|6040553|P11|Dose-Escalation Stage 1A|Physician Decision|0
1731822|NCT00996892|6040554|P10|Dose-Escalation Stage 1A|Physician Decision|0
1731823|NCT00996892|6040555|P9|Dose-Escalation Stage 1A|Physician Decision|0
1731824|NCT00996892|6040556|P8|Dose-Escalation Stage 1A|Physician Decision|1
1731825|NCT00996892|6040557|P7|Dose-Escalation Stage 1A|Physician Decision|0
1731826|NCT00996892|6040558|P6|Dose-Escalation Stage 1A|Physician Decision|0
1731827|NCT00996892|6040559|P5|Dose-Escalation Stage 1A|Physician Decision|0
1731828|NCT00996892|6040560|P4|Dose-Escalation Stage 1A|Physician Decision|0
1731829|NCT00996892|6040561|P3|Dose-Escalation Stage 1A|Physician Decision|0
1731830|NCT00996892|6040562|P2|Dose-Escalation Stage 1A|Physician Decision|0
1731831|NCT00996892|6040563|P1|Dose-Escalation Stage 1A|Physician Decision|0
1731832|NCT00996892|6040544|P20|Dose-Escalation Stage 1A|Death|0
1731833|NCT00996892|6040545|P19|Dose-Escalation Stage 1A|Death|0
1731834|NCT00996892|6040546|P18|Dose-Escalation Stage 1A|Death|0
1731835|NCT00996892|6040547|P17|Dose-Escalation Stage 1A|Death|0
1731836|NCT00996892|6040548|P16|Dose-Escalation Stage 1A|Death|0
1731837|NCT00996892|6040549|P15|Dose-Escalation Stage 1A|Death|0
1731838|NCT00996892|6040550|P14|Dose-Escalation Stage 1A|Death|0
1731839|NCT00996892|6040551|P13|Dose-Escalation Stage 1A|Death|1
1731840|NCT00996892|6040552|P12|Dose-Escalation Stage 1A|Death|1
1731841|NCT00996892|6040553|P11|Dose-Escalation Stage 1A|Death|0
1731842|NCT00996892|6040554|P10|Dose-Escalation Stage 1A|Death|2
1731843|NCT00996892|6040555|P9|Dose-Escalation Stage 1A|Death|0
1731844|NCT00996892|6040556|P8|Dose-Escalation Stage 1A|Death|0
1731845|NCT00996892|6040557|P7|Dose-Escalation Stage 1A|Death|0
1731846|NCT00996892|6040558|P6|Dose-Escalation Stage 1A|Death|0
1731847|NCT00996892|6040559|P5|Dose-Escalation Stage 1A|Death|0
1731848|NCT00996892|6040560|P4|Dose-Escalation Stage 1A|Death|0
1731849|NCT00996892|6040561|P3|Dose-Escalation Stage 1A|Death|0
1731850|NCT00996892|6040562|P2|Dose-Escalation Stage 1A|Death|0
1731851|NCT00996892|6040563|P1|Dose-Escalation Stage 1A|Death|0
1731852|NCT00996892|6040544|P20|Dose-Escalation Stage 1A|Adverse Event|0
1731853|NCT00996892|6040545|P19|Dose-Escalation Stage 1A|Adverse Event|0
1731854|NCT00996892|6040546|P18|Dose-Escalation Stage 1A|Adverse Event|0
1731855|NCT00996892|6040547|P17|Dose-Escalation Stage 1A|Adverse Event|0
1731856|NCT00996892|6040548|P16|Dose-Escalation Stage 1A|Adverse Event|0
1731857|NCT00996892|6040549|P15|Dose-Escalation Stage 1A|Adverse Event|0
1731858|NCT00996892|6040550|P14|Dose-Escalation Stage 1A|Adverse Event|1
1731859|NCT00996892|6040551|P13|Dose-Escalation Stage 1A|Adverse Event|0
1731860|NCT00996892|6040552|P12|Dose-Escalation Stage 1A|Adverse Event|0
1731861|NCT00996892|6040553|P11|Dose-Escalation Stage 1A|Adverse Event|1
1731862|NCT00996892|6040554|P10|Dose-Escalation Stage 1A|Adverse Event|0
1731863|NCT00996892|6040555|P9|Dose-Escalation Stage 1A|Adverse Event|0
1731864|NCT00996892|6040556|P8|Dose-Escalation Stage 1A|Adverse Event|0
1731865|NCT00996892|6040557|P7|Dose-Escalation Stage 1A|Adverse Event|0
1731866|NCT00996892|6040558|P6|Dose-Escalation Stage 1A|Adverse Event|0
1731867|NCT00996892|6040559|P5|Dose-Escalation Stage 1A|Adverse Event|0
1731868|NCT00996892|6040560|P4|Dose-Escalation Stage 1A|Adverse Event|0
1731869|NCT00996892|6040561|P3|Dose-Escalation Stage 1A|Adverse Event|0
1731870|NCT00996892|6040562|P2|Dose-Escalation Stage 1A|Adverse Event|0
1731871|NCT00996892|6040563|P1|Dose-Escalation Stage 1A|Adverse Event|0
1731872|NCT00996892|6040544|P20|Dose-Escalation Stage 1|Disease Progression|0
1731873|NCT00996892|6040545|P19|Dose-Escalation Stage 1|Disease Progression|0
1731874|NCT00996892|6040546|P18|Dose-Escalation Stage 1|Disease Progression|0
1731875|NCT00996892|6040547|P17|Dose-Escalation Stage 1|Disease Progression|0
1731876|NCT00996892|6040548|P16|Dose-Escalation Stage 1|Disease Progression|0
1731877|NCT00996892|6040549|P15|Dose-Escalation Stage 1|Disease Progression|0
1731878|NCT00996892|6040550|P14|Dose-Escalation Stage 1|Disease Progression|0
1731879|NCT00996892|6040551|P13|Dose-Escalation Stage 1|Disease Progression|0
1731880|NCT00996892|6040552|P12|Dose-Escalation Stage 1|Disease Progression|0
1731881|NCT00996892|6040553|P11|Dose-Escalation Stage 1|Disease Progression|0
1731882|NCT00996892|6040554|P10|Dose-Escalation Stage 1|Disease Progression|0
1731883|NCT00996892|6040555|P9|Dose-Escalation Stage 1|Disease Progression|0
1731884|NCT00996892|6040556|P8|Dose-Escalation Stage 1|Disease Progression|0
1731885|NCT00996892|6040557|P7|Dose-Escalation Stage 1|Disease Progression|0
1731886|NCT00996892|6040558|P6|Dose-Escalation Stage 1|Disease Progression|7
1731887|NCT00996892|6040559|P5|Dose-Escalation Stage 1|Disease Progression|10
1731888|NCT00996892|6040560|P4|Dose-Escalation Stage 1|Disease Progression|4
1731889|NCT00996892|6040561|P3|Dose-Escalation Stage 1|Disease Progression|3
1731890|NCT00996892|6040562|P2|Dose-Escalation Stage 1|Disease Progression|2
1731891|NCT00996892|6040563|P1|Dose-Escalation Stage 1|Disease Progression|2
1731892|NCT00996892|6040544|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731893|NCT00996892|6040545|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731894|NCT00996892|6040546|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731895|NCT00996892|6040547|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731896|NCT00996892|6040548|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731897|NCT00996892|6040549|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731898|NCT00996892|6040550|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731899|NCT00996892|6040551|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731900|NCT00996892|6040552|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731901|NCT00996892|6040553|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731902|NCT00996892|6040554|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731903|NCT00996892|6040555|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731904|NCT00996892|6040556|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731905|NCT00996892|6040557|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
1731906|NCT00996892|6040558|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
1731907|NCT00996892|6040559|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
1731908|NCT00996892|6040560|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
1731909|NCT00996892|6040561|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731910|NCT00996892|6040562|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
1731911|NCT00996892|6040563|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
1731912|NCT00996892|6040544|P20|Dose-Escalation Stage 1|Physician Decision|0
1731913|NCT00996892|6040545|P19|Dose-Escalation Stage 1|Physician Decision|0
1731914|NCT00996892|6040546|P18|Dose-Escalation Stage 1|Physician Decision|0
1731915|NCT00996892|6040547|P17|Dose-Escalation Stage 1|Physician Decision|0
1731916|NCT00996892|6040548|P16|Dose-Escalation Stage 1|Physician Decision|0
1731917|NCT00996892|6040549|P15|Dose-Escalation Stage 1|Physician Decision|0
1731918|NCT00996892|6040550|P14|Dose-Escalation Stage 1|Physician Decision|0
1731919|NCT00996892|6040551|P13|Dose-Escalation Stage 1|Physician Decision|0
1731920|NCT00996892|6040552|P12|Dose-Escalation Stage 1|Physician Decision|0
1731921|NCT00996892|6040553|P11|Dose-Escalation Stage 1|Physician Decision|0
1731922|NCT00996892|6040554|P10|Dose-Escalation Stage 1|Physician Decision|0
1731923|NCT00996892|6040555|P9|Dose-Escalation Stage 1|Physician Decision|0
1731924|NCT00996892|6040556|P8|Dose-Escalation Stage 1|Physician Decision|0
1731925|NCT00996892|6040557|P7|Dose-Escalation Stage 1|Physician Decision|2
1731926|NCT00996892|6040558|P6|Dose-Escalation Stage 1|Physician Decision|1
1731927|NCT00996892|6040559|P5|Dose-Escalation Stage 1|Physician Decision|0
1731928|NCT00996892|6040560|P4|Dose-Escalation Stage 1|Physician Decision|1
1731929|NCT00996892|6040561|P3|Dose-Escalation Stage 1|Physician Decision|0
1731930|NCT00996892|6040562|P2|Dose-Escalation Stage 1|Physician Decision|0
1731931|NCT00996892|6040563|P1|Dose-Escalation Stage 1|Physician Decision|1
1731932|NCT00996892|6040544|P20|Dose-Escalation Stage 1|Death|0
1731933|NCT00996892|6040545|P19|Dose-Escalation Stage 1|Death|0
1731934|NCT00996892|6040546|P18|Dose-Escalation Stage 1|Death|0
1731935|NCT00996892|6040547|P17|Dose-Escalation Stage 1|Death|0
1731936|NCT00996892|6040548|P16|Dose-Escalation Stage 1|Death|0
1731937|NCT00996892|6040549|P15|Dose-Escalation Stage 1|Death|0
1731938|NCT00996892|6040550|P14|Dose-Escalation Stage 1|Death|0
1731939|NCT00996892|6040551|P13|Dose-Escalation Stage 1|Death|0
1731940|NCT00996892|6040552|P12|Dose-Escalation Stage 1|Death|0
1731941|NCT00996892|6040553|P11|Dose-Escalation Stage 1|Death|0
1731942|NCT00996892|6040554|P10|Dose-Escalation Stage 1|Death|0
1731943|NCT00996892|6040555|P9|Dose-Escalation Stage 1|Death|0
1731944|NCT00996892|6040556|P8|Dose-Escalation Stage 1|Death|0
1731945|NCT00996892|6040557|P7|Dose-Escalation Stage 1|Death|0
1731946|NCT00996892|6040558|P6|Dose-Escalation Stage 1|Death|1
1731947|NCT00996892|6040559|P5|Dose-Escalation Stage 1|Death|0
1731948|NCT00996892|6040560|P4|Dose-Escalation Stage 1|Death|0
1731949|NCT00996892|6040561|P3|Dose-Escalation Stage 1|Death|0
1731950|NCT00996892|6040562|P2|Dose-Escalation Stage 1|Death|0
1731951|NCT00996892|6040563|P1|Dose-Escalation Stage 1|Death|1
1731952|NCT00996892|6040544|P20|Dose-Escalation Stage 1|Adverse Event|0
1731953|NCT00996892|6040545|P19|Dose-Escalation Stage 1|Adverse Event|0
1731954|NCT00996892|6040546|P18|Dose-Escalation Stage 1|Adverse Event|0
1731955|NCT00996892|6040547|P17|Dose-Escalation Stage 1|Adverse Event|0
1731956|NCT00996892|6040548|P16|Dose-Escalation Stage 1|Adverse Event|0
1731957|NCT00996892|6040549|P15|Dose-Escalation Stage 1|Adverse Event|0
1731958|NCT00996892|6040550|P14|Dose-Escalation Stage 1|Adverse Event|0
1731959|NCT00996892|6040551|P13|Dose-Escalation Stage 1|Adverse Event|0
1731960|NCT00996892|6040552|P12|Dose-Escalation Stage 1|Adverse Event|0
1731961|NCT00996892|6040553|P11|Dose-Escalation Stage 1|Adverse Event|0
1731962|NCT00996892|6040554|P10|Dose-Escalation Stage 1|Adverse Event|0
1731963|NCT00996892|6040555|P9|Dose-Escalation Stage 1|Adverse Event|0
1731964|NCT00996892|6040556|P8|Dose-Escalation Stage 1|Adverse Event|0
1731965|NCT00996892|6040557|P7|Dose-Escalation Stage 1|Adverse Event|1
1731966|NCT00996892|6040558|P6|Dose-Escalation Stage 1|Adverse Event|0
1731967|NCT00996892|6040559|P5|Dose-Escalation Stage 1|Adverse Event|0
1731968|NCT00996892|6040560|P4|Dose-Escalation Stage 1|Adverse Event|2
1731969|NCT00996892|6040561|P3|Dose-Escalation Stage 1|Adverse Event|0
1731970|NCT00996892|6040562|P2|Dose-Escalation Stage 1|Adverse Event|0
1731971|NCT00996892|6040563|P1|Dose-Escalation Stage 1|Adverse Event|0
1731972|NCT00996840|6041157|P5|Overall Study|Withdrawal by Subject|0
1731973|NCT00996840|6041158|P4|Overall Study|Withdrawal by Subject|0
1731974|NCT00996840|6041159|P3|Overall Study|Withdrawal by Subject|0
1731975|NCT00996840|6041160|P2|Overall Study|Withdrawal by Subject|1
1731976|NCT00996840|6041161|P1|Overall Study|Withdrawal by Subject|1
1731977|NCT00996840|6041157|P5|Overall Study|Physician Decision|2
1731978|NCT00996840|6041158|P4|Overall Study|Physician Decision|1
1731979|NCT00996840|6041159|P3|Overall Study|Physician Decision|1
1731980|NCT00996840|6041160|P2|Overall Study|Physician Decision|0
1731981|NCT00996840|6041161|P1|Overall Study|Physician Decision|0
1731982|NCT00996840|6041157|P5|Overall Study|Adverse Event|0
1731983|NCT00996840|6041158|P4|Overall Study|Adverse Event|0
1731984|NCT00996840|6041159|P3|Overall Study|Adverse Event|0
1731985|NCT00996840|6041160|P2|Overall Study|Adverse Event|1
1731986|NCT00996840|6041161|P1|Overall Study|Adverse Event|0
1731987|NCT00996801|6041311|P6|Overall Study|Withdrawal by Subject|9
1731988|NCT00996801|6041312|P5|Overall Study|Withdrawal by Subject|5
1731989|NCT00996801|6041313|P4|Overall Study|Withdrawal by Subject|5
1731990|NCT00996801|6041314|P3|Overall Study|Withdrawal by Subject|9
1731991|NCT00996801|6041315|P2|Overall Study|Withdrawal by Subject|6
1731992|NCT00996801|6041316|P1|Overall Study|Withdrawal by Subject|8
1731993|NCT00996801|6041311|P6|Overall Study|Study Terminated by Sponsor|0
1731994|NCT00996801|6041312|P5|Overall Study|Study Terminated by Sponsor|46
1731995|NCT00996801|6041313|P4|Overall Study|Study Terminated by Sponsor|0
1731996|NCT00996801|6041314|P3|Overall Study|Study Terminated by Sponsor|0
1731997|NCT00996801|6041315|P2|Overall Study|Study Terminated by Sponsor|1
1731998|NCT00996801|6041316|P1|Overall Study|Study Terminated by Sponsor|0
1731999|NCT00996801|6041311|P6|Overall Study|Protocol Violation|4
1732000|NCT00996801|6041312|P5|Overall Study|Protocol Violation|3
1732001|NCT00996801|6041313|P4|Overall Study|Protocol Violation|2
1732002|NCT00996801|6041314|P3|Overall Study|Protocol Violation|1
1732003|NCT00996801|6041315|P2|Overall Study|Protocol Violation|4
1732004|NCT00996801|6041316|P1|Overall Study|Protocol Violation|3
1732005|NCT00996801|6041311|P6|Overall Study|Progressive Disease|0
1732006|NCT00996801|6041312|P5|Overall Study|Progressive Disease|0
1732007|NCT00996801|6041313|P4|Overall Study|Progressive Disease|0
1732008|NCT00996801|6041314|P3|Overall Study|Progressive Disease|0
1732009|NCT00996801|6041315|P2|Overall Study|Progressive Disease|1
1732010|NCT00996801|6041316|P1|Overall Study|Progressive Disease|0
1732011|NCT00996801|6041311|P6|Overall Study|Physician Decision|0
1732012|NCT00996801|6041312|P5|Overall Study|Physician Decision|0
1732013|NCT00996801|6041313|P4|Overall Study|Physician Decision|1
1732014|NCT00996801|6041314|P3|Overall Study|Physician Decision|0
1732015|NCT00996801|6041315|P2|Overall Study|Physician Decision|0
1732016|NCT00996801|6041316|P1|Overall Study|Physician Decision|0
1732017|NCT00996801|6041311|P6|Overall Study|Lost to Follow-up|2
1732018|NCT00996801|6041312|P5|Overall Study|Lost to Follow-up|3
1732019|NCT00996801|6041313|P4|Overall Study|Lost to Follow-up|3
1732020|NCT00996801|6041314|P3|Overall Study|Lost to Follow-up|0
1732021|NCT00996801|6041315|P2|Overall Study|Lost to Follow-up|0
1732022|NCT00996801|6041316|P1|Overall Study|Lost to Follow-up|0
1732023|NCT00996801|6041311|P6|Overall Study|Lack of Efficacy|1
1732024|NCT00996801|6041312|P5|Overall Study|Lack of Efficacy|0
1732025|NCT00996801|6041313|P4|Overall Study|Lack of Efficacy|3
1732026|NCT00996801|6041314|P3|Overall Study|Lack of Efficacy|1
1732027|NCT00996801|6041315|P2|Overall Study|Lack of Efficacy|0
1732028|NCT00996801|6041316|P1|Overall Study|Lack of Efficacy|3
1732029|NCT00996801|6041311|P6|Overall Study|Adverse Event|3
1732030|NCT00996801|6041312|P5|Overall Study|Adverse Event|31
1732031|NCT00996801|6041313|P4|Overall Study|Adverse Event|17
1732032|NCT00996801|6041314|P3|Overall Study|Adverse Event|12
1732033|NCT00996801|6041315|P2|Overall Study|Adverse Event|4
1732034|NCT00996801|6041316|P1|Overall Study|Adverse Event|6
1732035|NCT00996736|6041428|P2|Overall Study|Visit not within 3-month window|3
1732036|NCT00996736|6041429|P1|Overall Study|Visit not within 3-month window|5
1732037|NCT00996736|6041428|P2|Overall Study|Lost to Follow-up|14
1732038|NCT00996736|6041429|P1|Overall Study|Lost to Follow-up|15
1732039|NCT00996736|6041428|P2|Overall Study|Death|1
1732040|NCT00996736|6041429|P1|Overall Study|Death|1
1732041|NCT00996658|6041449|P2|Overall Study|Other|7
1732042|NCT00996658|6041450|P1|Overall Study|Other|9
1732043|NCT00996658|6041449|P2|Overall Study|Non-compliance issues|3
1732044|NCT00996658|6041450|P1|Overall Study|Non-compliance issues|3
1732045|NCT00996658|6041449|P2|Overall Study|Lost to Follow-up|5
1732046|NCT00996658|6041450|P1|Overall Study|Lost to Follow-up|2
1732047|NCT00996658|6041449|P2|Overall Study|Protocol Violation|1
1732048|NCT00996658|6041450|P1|Overall Study|Protocol Violation|0
1732049|NCT00996658|6041449|P2|Overall Study|Adverse Event|5
1732050|NCT00996658|6041450|P1|Overall Study|Adverse Event|2
1732051|NCT00996632|6041478|P2|Overall Study|Physician Decision|0
1732052|NCT00996632|6041479|P1|Overall Study|Physician Decision|0
1732053|NCT00996606|6041487|P1|Overall Study|Withdrawal by Subject|3
1732054|NCT00996606|6041487|P1|Overall Study|Protocol Violation|1
1732055|NCT00996606|6041487|P1|Overall Study|Insufficient Therapeutic Response|2
1732056|NCT00996606|6041487|P1|Overall Study|Adverse Event or Intercurrent Illness|2
1732057|NCT00996593|6041581|P1|Long-Term Follow-Up|Site Closed|1
1732058|NCT00996593|6041581|P1|Long-Term Follow-Up|Withdrawal by Subject|2
1732059|NCT00996593|6041581|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
1732060|NCT00996593|6041581|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
1732061|NCT00996593|6041581|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
1732062|NCT00996593|6041581|P1|Dosimetric and Therapeutic Treatment|Death|1
1732063|NCT00996593|6041581|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
1732064|NCT00996593|6041581|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
1732065|NCT00996593|6041581|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
1732066|NCT00996580|6041609|P1|Overall Study|Other|29
1732067|NCT00996580|6041609|P1|Overall Study|Withdrawal by Subject|217
1732068|NCT00996580|6041609|P1|Overall Study|Sponsor requested participant withdrawal|35
1732069|NCT00996580|6041609|P1|Overall Study|Protocol Violation|16
1732070|NCT00996580|6041609|P1|Overall Study|Pregnancy|68
1732071|NCT00996580|6041609|P1|Overall Study|Physician Decision|5
1732072|NCT00996580|6041609|P1|Overall Study|Noncompliance with the protocol|137
1732073|NCT00996580|6041609|P1|Overall Study|Lost to Follow-up|480
1732074|NCT00996580|6041609|P1|Overall Study|Adverse Event|466
1732075|NCT00996489|6041644|P1|Overall Study|Discontinued|116
1732076|NCT00996489|6041644|P1|Overall Study|Device failure|45
1732077|NCT00996476|6041664|P5|Overall Study|Adverse Event|1
1732078|NCT00996476|6041665|P4|Overall Study|Adverse Event|0
1732079|NCT00996476|6041666|P3|Overall Study|Adverse Event|0
1732080|NCT00996476|6041667|P2|Overall Study|Adverse Event|1
1732081|NCT00996476|6041668|P1|Overall Study|Adverse Event|0
1732082|NCT00996476|6041664|P5|Overall Study|Withdrawal by Subject|1
1732083|NCT00996476|6041665|P4|Overall Study|Withdrawal by Subject|0
1732084|NCT00996476|6041666|P3|Overall Study|Withdrawal by Subject|1
1732085|NCT00996476|6041667|P2|Overall Study|Withdrawal by Subject|2
1732086|NCT00996476|6041668|P1|Overall Study|Withdrawal by Subject|1
1732087|NCT00996437|6041736|P2|Overall Study|Missed|5
1732088|NCT00996437|6041737|P1|Overall Study|Missed|2
1732089|NCT00996437|6041736|P2|Overall Study|Dropped|2
1732090|NCT00996437|6041737|P1|Overall Study|Dropped|2
1732091|NCT00996437|6041736|P2|Overall Study|Death|0
1732092|NCT00996437|6041737|P1|Overall Study|Death|1
1732093|NCT00996333|6041782|P1|Overall Study|Other|5
1732094|NCT00996333|6041782|P1|Overall Study|Physician Decision|1
1732095|NCT00996333|6041782|P1|Overall Study|Adverse Event|1
1732096|NCT00996333|6041782|P1|Overall Study|Death|4
1732097|NCT00996333|6041782|P1|Overall Study|Withdrawal by Subject|1
1732098|NCT00996333|6041782|P1|Overall Study|Screen failure|1
1732099|NCT00996307|6041792|P4|Overall Study|Unable to classify|1
1732100|NCT00996307|6041793|P3|Overall Study|Unable to classify|2
1732101|NCT00996307|6041794|P2|Overall Study|Unable to classify|0
1732102|NCT00996307|6041795|P1|Overall Study|Unable to classify|4
1732103|NCT00996307|6041792|P4|Overall Study|Administrative reason|0
1732104|NCT00996307|6041793|P3|Overall Study|Administrative reason|0
1732105|NCT00996307|6041794|P2|Overall Study|Administrative reason|1
1732106|NCT00996307|6041795|P1|Overall Study|Administrative reason|0
1732107|NCT00996307|6041792|P4|Overall Study|Lost to Follow-up|15
1732108|NCT00996307|6041793|P3|Overall Study|Lost to Follow-up|7
1732109|NCT00996307|6041794|P2|Overall Study|Lost to Follow-up|13
1732110|NCT00996307|6041795|P1|Overall Study|Lost to Follow-up|13
1732111|NCT00996307|6041792|P4|Overall Study|Withdrawal by Subject|5
1732112|NCT00996307|6041793|P3|Overall Study|Withdrawal by Subject|5
1732113|NCT00996307|6041794|P2|Overall Study|Withdrawal by Subject|2
1732114|NCT00996307|6041795|P1|Overall Study|Withdrawal by Subject|3
1732115|NCT00996307|6041792|P4|Overall Study|Adverse Event|0
1732116|NCT00996307|6041793|P3|Overall Study|Adverse Event|0
1732117|NCT00996307|6041794|P2|Overall Study|Adverse Event|1
1732118|NCT00996307|6041795|P1|Overall Study|Adverse Event|0
1732119|NCT00996281|6041855|P2|Overall Study|Other|7
1732120|NCT00996281|6041856|P1|Overall Study|Other|5
1732121|NCT00996281|6041855|P2|Overall Study|Lack of Efficacy|2
1732122|NCT00996281|6041856|P1|Overall Study|Lack of Efficacy|0
1732123|NCT00996281|6041855|P2|Overall Study|Withdrawal by Subject|20
1732124|NCT00996281|6041856|P1|Overall Study|Withdrawal by Subject|31
1732125|NCT00996281|6041855|P2|Overall Study|Lost to Follow-up|16
1732126|NCT00996281|6041856|P1|Overall Study|Lost to Follow-up|14
1732127|NCT00996281|6041855|P2|Overall Study|Major Protocol Deviation|7
1732128|NCT00996281|6041856|P1|Overall Study|Major Protocol Deviation|6
1732129|NCT00996281|6041855|P2|Overall Study|Adverse Event|37
1732130|NCT00996281|6041856|P1|Overall Study|Adverse Event|75
1732131|NCT00996216|6041864|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
1732132|NCT00996216|6041864|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
1732133|NCT00996216|6041864|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
1732134|NCT00996203|6041880|P1|Overall Study|Protocol Violation|2
1732135|NCT00996203|6041880|P1|Overall Study|Lack of Efficacy|1
1732136|NCT00996203|6041880|P1|Overall Study|Lost to Follow-up|1
1732137|NCT00996203|6041880|P1|Overall Study|Adverse Event|3
1732138|NCT00996125|6041912|P2|Overall Study|Withdrawal by Subject|3
1732139|NCT00996125|6041913|P1|Overall Study|Withdrawal by Subject|4
1732140|NCT00996125|6041912|P2|Overall Study|Lost to Follow-up|6
1732141|NCT00996125|6041913|P1|Overall Study|Lost to Follow-up|1
1732142|NCT00996125|6041912|P2|Overall Study|Adverse Event|2
1732143|NCT00996125|6041913|P1|Overall Study|Adverse Event|0
1732144|NCT00996034|6041933|P1|Overall Study|withdrawn by PI|1
1732145|NCT00996034|6041933|P1|Overall Study|Lost to Follow-up|2
1732146|NCT00995930|6041939|P2|Overall Study|Adverse Event|14
1732147|NCT00995930|6041940|P1|Overall Study|Adverse Event|11
1732148|NCT00995930|6041939|P2|Overall Study|Withdrawal by Subject|4
1732149|NCT00995930|6041940|P1|Overall Study|Withdrawal by Subject|3
1732150|NCT00995930|6041939|P2|Overall Study|Lost to Follow-up|2
1732151|NCT00995930|6041940|P1|Overall Study|Lost to Follow-up|1
1732152|NCT00995930|6041939|P2|Overall Study|Administrative problems|2
1732153|NCT00995930|6041940|P1|Overall Study|Administrative problems|4
1732154|NCT00995930|6041939|P2|Overall Study|Death|1
1732155|NCT00995930|6041940|P1|Overall Study|Death|0
1732156|NCT00995930|6041939|P2|Overall Study|Protocol deviation|5
1732157|NCT00995930|6041940|P1|Overall Study|Protocol deviation|2
1732158|NCT00995865|6041991|P3|Overall Study|Lost to Follow-up|1
1732159|NCT00995865|6041992|P2|Overall Study|Lost to Follow-up|0
1732160|NCT00995865|6041993|P1|Overall Study|Lost to Follow-up|0
1732161|NCT00995865|6041991|P3|Overall Study|Protocol Violation|0
1732162|NCT00995865|6041992|P2|Overall Study|Protocol Violation|0
1732163|NCT00995865|6041993|P1|Overall Study|Protocol Violation|2
1732164|NCT00995774|6042015|P2|Training Period 2|Withdrawal by Subject|0
1732165|NCT00995774|6042016|P1|Training Period 2|Withdrawal by Subject|2
1732166|NCT00995709|6042050|P3|Overall Study|Protocol Violation|0
1732167|NCT00995709|6042051|P2|Overall Study|Protocol Violation|1
1732168|NCT00995709|6042052|P1|Overall Study|Protocol Violation|2
1732169|NCT00995709|6042050|P3|Overall Study|Death|0
1732170|NCT00995709|6042051|P2|Overall Study|Death|1
1732171|NCT00995709|6042052|P1|Overall Study|Death|0
1732172|NCT00995709|6042050|P3|Overall Study|Lost to Follow-up|0
1732173|NCT00995709|6042051|P2|Overall Study|Lost to Follow-up|0
1732174|NCT00995709|6042052|P1|Overall Study|Lost to Follow-up|1
1732175|NCT00995709|6042050|P3|Overall Study|Withdrawal by Subject|1
1732176|NCT00995709|6042051|P2|Overall Study|Withdrawal by Subject|4
1732177|NCT00995709|6042052|P1|Overall Study|Withdrawal by Subject|0
1732178|NCT00995709|6042050|P3|Overall Study|Lack of Efficacy|4
1732179|NCT00995709|6042051|P2|Overall Study|Lack of Efficacy|1
1732180|NCT00995709|6042052|P1|Overall Study|Lack of Efficacy|0
1732181|NCT00995709|6042050|P3|Overall Study|Adverse Event|0
1732182|NCT00995709|6042051|P2|Overall Study|Adverse Event|2
1732183|NCT00995709|6042052|P1|Overall Study|Adverse Event|4
1732184|NCT00995670|6042078|P3|Overall Study|Failed arterial cannulation|3
1732185|NCT00995670|6042079|P2|Overall Study|Failed arterial cannulation|0
1732186|NCT00995670|6042080|P1|Overall Study|Failed arterial cannulation|1
1732187|NCT00995566|6042088|P1|Overall Study|Early study termination|52
1732188|NCT00995566|6042088|P1|Overall Study|Adverse Event|2
1732189|NCT00995553|6042102|P2|Overall Study|Withdrawal by Subject|6
1732190|NCT00995553|6042103|P1|Overall Study|Withdrawal by Subject|2
1732191|NCT00995488|6042152|P1|Overall Study|Withdrawal by Subject|1
1732192|NCT00995436|6042186|P3|Overall Study|Withdrawal by Subject|0
1732193|NCT00995436|6042187|P2|Overall Study|Withdrawal by Subject|5
1732194|NCT00995436|6042188|P1|Overall Study|Withdrawal by Subject|2
1732195|NCT00995410|6042196|P1|Overall Study|Misc|28
1732196|NCT00995410|6042196|P1|Overall Study|Lost to Follow-up|2
1732197|NCT00995410|6042196|P1|Overall Study|Withdrawal by Subject|7
1732198|NCT00995410|6042196|P1|Overall Study|Adverse Event|51
1732199|NCT00995371|6042203|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
1732200|NCT00995371|6042204|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
1732201|NCT00995345|6042222|P5|Overall Study|all other reasons combined|3
1732202|NCT00995345|6042223|P4|Overall Study|all other reasons combined|1
1732203|NCT00995345|6042224|P3|Overall Study|all other reasons combined|2
1732204|NCT00995345|6042225|P2|Overall Study|all other reasons combined|2
1732205|NCT00995345|6042226|P1|Overall Study|all other reasons combined|2
1732206|NCT00995345|6042222|P5|Overall Study|Lost to Follow-up|0
1732207|NCT00995345|6042223|P4|Overall Study|Lost to Follow-up|1
1732208|NCT00995345|6042224|P3|Overall Study|Lost to Follow-up|2
1732209|NCT00995345|6042225|P2|Overall Study|Lost to Follow-up|2
1732210|NCT00995345|6042226|P1|Overall Study|Lost to Follow-up|2
1732211|NCT00995345|6042222|P5|Overall Study|Adverse Event|1
1732212|NCT00995345|6042223|P4|Overall Study|Adverse Event|0
1732213|NCT00995345|6042224|P3|Overall Study|Adverse Event|2
1732214|NCT00995345|6042225|P2|Overall Study|Adverse Event|1
1732215|NCT00995345|6042226|P1|Overall Study|Adverse Event|3
1732216|NCT00995345|6042222|P5|Overall Study|Withdrawal by Subject|1
1732217|NCT00995345|6042223|P4|Overall Study|Withdrawal by Subject|3
1732218|NCT00995345|6042224|P3|Overall Study|Withdrawal by Subject|1
1732219|NCT00995345|6042225|P2|Overall Study|Withdrawal by Subject|2
1732220|NCT00995345|6042226|P1|Overall Study|Withdrawal by Subject|4
1732221|NCT00995085|6042253|P1|Overall Study|Withdrawal by Subject|5
1732222|NCT00995020|6042270|P2|Overall Study|specimen fragmentation, thermal damage|2
1732223|NCT00995020|6042271|P1|Overall Study|specimen fragmentation, thermal damage|1
1732224|NCT00995020|6042270|P2|Overall Study|margin analysis not performed|5
1732225|NCT00995020|6042271|P1|Overall Study|margin analysis not performed|2
1732226|NCT00995007|6042281|P2|Overall Study|Toxicity|0
1732227|NCT00995007|6042282|P1|Overall Study|Toxicity|8
1732228|NCT00995007|6042281|P2|Overall Study|Refused further treatment|2
1732229|NCT00995007|6042282|P1|Overall Study|Refused further treatment|8
1732230|NCT00995007|6042281|P2|Overall Study|Withdrew consent|0
1732231|NCT00995007|6042282|P1|Overall Study|Withdrew consent|1
1732232|NCT00994682|6042345|P2|Pioglitazone Open Label|Physician Decision|1
1732233|NCT00994682|6042346|P1|Pioglitazone Open Label|Physician Decision|6
1732234|NCT00994682|6042345|P2|Pioglitazone Open Label|Lost to Follow-up|2
1732235|NCT00994682|6042346|P1|Pioglitazone Open Label|Lost to Follow-up|3
1732236|NCT00994682|6042345|P2|Pioglitazone Open Label|Withdrawal by Subject|4
1732237|NCT00994682|6042346|P1|Pioglitazone Open Label|Withdrawal by Subject|4
1732238|NCT00994682|6042345|P2|Double Bilnd|Adverse Event|0
1732239|NCT00994682|6042346|P1|Double Bilnd|Adverse Event|1
1732240|NCT00994682|6042345|P2|Double Bilnd|Lost to Follow-up|3
1732241|NCT00994682|6042346|P1|Double Bilnd|Lost to Follow-up|3
1732242|NCT00994682|6042345|P2|Double Bilnd|Withdrawal by Subject|6
1732243|NCT00994682|6042346|P1|Double Bilnd|Withdrawal by Subject|5
1732244|NCT00994643|6042390|P1|Overall Study|Withdrawal by Subject|1
1732245|NCT00994461|6042404|P3|Overall Study|Adverse Event|0
1732246|NCT00994461|6042405|P2|Overall Study|Adverse Event|1
1732247|NCT00994461|6042406|P1|Overall Study|Adverse Event|2
1732248|NCT00994448|6042434|P2|Overall Study|Physician Decision|0
1732249|NCT00994448|6042435|P1|Overall Study|Physician Decision|1
1732250|NCT00994448|6042434|P2|Overall Study|Withdrawal by Subject|1
1732251|NCT00994448|6042435|P1|Overall Study|Withdrawal by Subject|1
1732252|NCT00994448|6042434|P2|Overall Study|Lost to Follow-up|1
1732253|NCT00994448|6042435|P1|Overall Study|Lost to Follow-up|5
1732254|NCT00994448|6042434|P2|Overall Study|Adverse Event|0
1732255|NCT00994448|6042435|P1|Overall Study|Adverse Event|1
1732256|NCT00994422|6042443|P2|Overall Study|Lost to Follow-up|1
1732257|NCT00994422|6042444|P1|Overall Study|Lost to Follow-up|7
1732258|NCT00994279|6042469|P2|Overall Study|Multiple reasons|3
1732259|NCT00994279|6042470|P1|Overall Study|Multiple reasons|1
1732260|NCT00994279|6042469|P2|Overall Study|Toxicity|0
1732261|NCT00994279|6042470|P1|Overall Study|Toxicity|1
1732262|NCT00994279|6042469|P2|Overall Study|Withdrawal by Subject|2
1732263|NCT00994279|6042470|P1|Overall Study|Withdrawal by Subject|2
1732264|NCT00994240|6042480|P2|Overall Study|study termination|3
1732265|NCT00994240|6042481|P1|Overall Study|study termination|2
1732266|NCT00994240|6042480|P2|Overall Study|Withdrawal by Subject|0
1732267|NCT00994240|6042481|P1|Overall Study|Withdrawal by Subject|1
1732268|NCT00994240|6042480|P2|Overall Study|Lost to Follow-up|2
1732269|NCT00994240|6042481|P1|Overall Study|Lost to Follow-up|3
1732270|NCT00994214|6042491|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
1732271|NCT00994214|6042492|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
1732272|NCT00994214|6042493|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
1732273|NCT00994214|6042494|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
1732274|NCT00994214|6042491|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
1732275|NCT00994214|6042492|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1732276|NCT00994214|6042493|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1732277|NCT00994214|6042494|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
1732278|NCT00994214|6042491|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
1732279|NCT00994214|6042492|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
1732280|NCT00994214|6042493|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
1732281|NCT00994214|6042494|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
1732282|NCT00994214|6042491|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1732283|NCT00994214|6042492|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1732284|NCT00994214|6042493|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
1732285|NCT00994214|6042494|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
1732286|NCT00994214|6042491|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
1732287|NCT00994214|6042492|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1732288|NCT00994214|6042493|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1732289|NCT00994214|6042494|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
1732290|NCT00994214|6042491|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1732291|NCT00994214|6042492|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1732292|NCT00994214|6042493|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
1732293|NCT00994214|6042494|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
1732294|NCT00994110|6042573|P2|Overall Study|Pt not eligible|5
1732295|NCT00994110|6042574|P1|Overall Study|Pt not eligible|10
1732296|NCT00994110|6042573|P2|Overall Study|Patient not resected|52
1732297|NCT00994110|6042574|P1|Overall Study|Patient not resected|41
1732298|NCT00994110|6042573|P2|Overall Study|Adverse Event|0
1732299|NCT00994110|6042574|P1|Overall Study|Adverse Event|1
1732300|NCT00994110|6042573|P2|Overall Study|Not Treated|8
1732301|NCT00994110|6042574|P1|Overall Study|Not Treated|4
1732302|NCT00994110|6042573|P2|Overall Study|Withdrawal by Subject|9
1732303|NCT00994110|6042574|P1|Overall Study|Withdrawal by Subject|9
1732304|NCT00993967|6042580|P1|Overall Study|Protocol Violation|2
1732305|NCT00993967|6042580|P1|Overall Study|Withdrawal by Subject|36
1732306|NCT00993967|6042580|P1|Overall Study|Lost to Follow-up|14
1732307|NCT00993967|6042580|P1|Overall Study|Death|1
1732308|NCT00993967|6042580|P1|Overall Study|Adverse Event|8
1732309|NCT00993954|6042587|P2|Overall Study|Protocol Violation|2
1732310|NCT00993954|6042588|P1|Overall Study|Protocol Violation|21
1732311|NCT00993928|6042601|P2|Overall Study|ineligible|0
1732312|NCT00993928|6042602|P1|Overall Study|ineligible|1
1732313|NCT00993928|6042601|P2|Overall Study|Withdrawal by Subject|7
1732314|NCT00993928|6042602|P1|Overall Study|Withdrawal by Subject|4
1732315|NCT00993915|6042616|P1|Overall Study|Ongoing|3
1732316|NCT00993915|6042616|P1|Overall Study|Other|1
1732317|NCT00993915|6042616|P1|Overall Study|Withdrawal by Subject|2
1732318|NCT00993915|6042616|P1|Overall Study|Insufficient clinical response|3
1732319|NCT00993668|6042642|P2|Open-Label Period|Lost to Follow-up|1
1732320|NCT00993668|6042643|P1|Open-Label Period|Lost to Follow-up|6
1732321|NCT00993668|6042642|P2|Open-Label Period|Withdrawal by Subject|3
1732322|NCT00993668|6042643|P1|Open-Label Period|Withdrawal by Subject|4
1732323|NCT00993668|6042642|P2|Open-Label Period|Lack of Efficacy|3
1732324|NCT00993668|6042643|P1|Open-Label Period|Lack of Efficacy|4
1732325|NCT00993668|6042642|P2|Open-Label Period|Adverse Event|8
1732326|NCT00993668|6042643|P1|Open-Label Period|Adverse Event|9
1732327|NCT00993668|6042642|P2|Single-Blind Period|Lost to Follow-up|1
1732328|NCT00993668|6042643|P1|Single-Blind Period|Lost to Follow-up|3
1732329|NCT00993668|6042642|P2|Single-Blind Period|Lack of Efficacy|1
1732330|NCT00993668|6042643|P1|Single-Blind Period|Lack of Efficacy|0
1732331|NCT00993668|6042642|P2|Single-Blind Period|Adverse Event|1
1732332|NCT00993668|6042643|P1|Single-Blind Period|Adverse Event|1
1732333|NCT00993616|6042687|P1|Overall Study|Never treated|1
1732334|NCT00993616|6042687|P1|Overall Study|No tumor at entry|1
1732335|NCT00993499|6042705|P6|Discontinued After Starting Course 3|Other adverse event|0
1732336|NCT00993499|6042706|P5|Discontinued After Starting Course 3|Other adverse event|0
1732337|NCT00993499|6042707|P4|Discontinued After Starting Course 3|Other adverse event|0
1732338|NCT00993499|6042708|P3|Discontinued After Starting Course 3|Other adverse event|1
1732339|NCT00993499|6042709|P2|Discontinued After Starting Course 3|Other adverse event|0
1732340|NCT00993499|6042710|P1|Discontinued After Starting Course 3|Other adverse event|1
1732341|NCT00993499|6042705|P6|Discontinued After Starting Course 3|DLT|0
1732342|NCT00993499|6042706|P5|Discontinued After Starting Course 3|DLT|0
1732343|NCT00993499|6042707|P4|Discontinued After Starting Course 3|DLT|1
1732344|NCT00993499|6042708|P3|Discontinued After Starting Course 3|DLT|2
1732345|NCT00993499|6042709|P2|Discontinued After Starting Course 3|DLT|0
1732346|NCT00993499|6042710|P1|Discontinued After Starting Course 3|DLT|1
1732347|NCT00993499|6042705|P6|Discontinued After Starting Course 3|Progressive Disease|3
1732348|NCT00993499|6042706|P5|Discontinued After Starting Course 3|Progressive Disease|3
1732349|NCT00993499|6042707|P4|Discontinued After Starting Course 3|Progressive Disease|1
1732350|NCT00993499|6042708|P3|Discontinued After Starting Course 3|Progressive Disease|3
1732351|NCT00993499|6042709|P2|Discontinued After Starting Course 3|Progressive Disease|4
1732352|NCT00993499|6042710|P1|Discontinued After Starting Course 3|Progressive Disease|6
1732353|NCT00993499|6042705|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
1732354|NCT00993499|6042706|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
1732355|NCT00993499|6042707|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
1732356|NCT00993499|6042708|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
1732357|NCT00993499|6042709|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
1732358|NCT00993499|6042710|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
1732359|NCT00993499|6042705|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1732360|NCT00993499|6042706|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1732361|NCT00993499|6042707|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1732362|NCT00993499|6042708|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
1732363|NCT00993499|6042709|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1732364|NCT00993499|6042710|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
1732365|NCT00993499|6042705|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1732366|NCT00993499|6042706|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1732367|NCT00993499|6042707|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
1732368|NCT00993499|6042708|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
1732369|NCT00993499|6042709|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1732370|NCT00993499|6042710|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
1732371|NCT00993499|6042705|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1732372|NCT00993499|6042706|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1732373|NCT00993499|6042707|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1732374|NCT00993499|6042708|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
1732375|NCT00993499|6042709|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
1732376|NCT00993499|6042710|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
1732377|NCT00993499|6042705|P6|Discontinued Before Starting Course 3|Progressive Disease|0
1732378|NCT00993499|6042706|P5|Discontinued Before Starting Course 3|Progressive Disease|0
1732379|NCT00993499|6042707|P4|Discontinued Before Starting Course 3|Progressive Disease|0
1732380|NCT00993499|6042708|P3|Discontinued Before Starting Course 3|Progressive Disease|0
1732381|NCT00993499|6042709|P2|Discontinued Before Starting Course 3|Progressive Disease|2
1732382|NCT00993499|6042710|P1|Discontinued Before Starting Course 3|Progressive Disease|2
1732383|NCT00993499|6042705|P6|Run-in Period (8 Days)|Progressive disease|0
1732384|NCT00993499|6042706|P5|Run-in Period (8 Days)|Progressive disease|0
1732385|NCT00993499|6042707|P4|Run-in Period (8 Days)|Progressive disease|0
1732386|NCT00993499|6042708|P3|Run-in Period (8 Days)|Progressive disease|1
1732387|NCT00993499|6042709|P2|Run-in Period (8 Days)|Progressive disease|1
1732388|NCT00993499|6042710|P1|Run-in Period (8 Days)|Progressive disease|0
1732389|NCT00993499|6042705|P6|Run-in Period (8 Days)|Consent withdrawn|0
1732390|NCT00993499|6042706|P5|Run-in Period (8 Days)|Consent withdrawn|0
1732391|NCT00993499|6042707|P4|Run-in Period (8 Days)|Consent withdrawn|0
1732392|NCT00993499|6042708|P3|Run-in Period (8 Days)|Consent withdrawn|0
1732393|NCT00993499|6042709|P2|Run-in Period (8 Days)|Consent withdrawn|1
1732394|NCT00993499|6042710|P1|Run-in Period (8 Days)|Consent withdrawn|0
1732395|NCT00993499|6042705|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1732396|NCT00993499|6042706|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1732397|NCT00993499|6042707|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1732398|NCT00993499|6042708|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1732399|NCT00993499|6042709|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
1732400|NCT00993499|6042710|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
1732401|NCT00993499|6042705|P6|Run-in Period (8 Days)|Adverse Event|0
1732402|NCT00993499|6042706|P5|Run-in Period (8 Days)|Adverse Event|0
1732403|NCT00993499|6042707|P4|Run-in Period (8 Days)|Adverse Event|0
1732404|NCT00993499|6042708|P3|Run-in Period (8 Days)|Adverse Event|0
1732405|NCT00993499|6042709|P2|Run-in Period (8 Days)|Adverse Event|1
1732406|NCT00993499|6042710|P1|Run-in Period (8 Days)|Adverse Event|0
1732407|NCT00993473|6042792|P2|Overall Study|Family event|0
1732408|NCT00993473|6042793|P1|Overall Study|Family event|1
1732409|NCT00993473|6042792|P2|Overall Study|Technical problem with CGM device|1
1732410|NCT00993473|6042793|P1|Overall Study|Technical problem with CGM device|0
1732411|NCT00993473|6042792|P2|Overall Study|Withdrawal by Subject|5
1732412|NCT00993473|6042793|P1|Overall Study|Withdrawal by Subject|1
1732413|NCT00993473|6042792|P2|Overall Study|Lost to Follow-up|0
1732414|NCT00993473|6042793|P1|Overall Study|Lost to Follow-up|1
1732415|NCT00993473|6042792|P2|Overall Study|Protocol Violation|2
1732416|NCT00993473|6042793|P1|Overall Study|Protocol Violation|1
1732417|NCT00993473|6042792|P2|Overall Study|Adverse Event|2
1732418|NCT00993473|6042793|P1|Overall Study|Adverse Event|0
1732419|NCT00993447|6042831|P2|Overall Study|Adverse Event|0
1732420|NCT00993447|6042832|P1|Overall Study|Adverse Event|1
1732421|NCT00993447|6042831|P2|Overall Study|Lost to Follow-up|3
1732422|NCT00993447|6042832|P1|Overall Study|Lost to Follow-up|1
1732423|NCT00993447|6042831|P2|Overall Study|Protocol Violation|8
1732424|NCT00993447|6042832|P1|Overall Study|Protocol Violation|12
1732425|NCT00993447|6042831|P2|Overall Study|Withdrawal by Subject|8
1732426|NCT00993447|6042832|P1|Overall Study|Withdrawal by Subject|23
1732427|NCT00993421|6042869|P7|Overall Study|Protocol Violation|1
1732428|NCT00993421|6042870|P6|Overall Study|Protocol Violation|2
1732429|NCT00993421|6042871|P5|Overall Study|Protocol Violation|0
1732430|NCT00993421|6042872|P4|Overall Study|Protocol Violation|0
1732431|NCT00993421|6042873|P3|Overall Study|Protocol Violation|0
1732432|NCT00993421|6042874|P2|Overall Study|Protocol Violation|0
1732433|NCT00993421|6042875|P1|Overall Study|Protocol Violation|0
1732434|NCT00993421|6042869|P7|Overall Study|Physician Decision|1
1732435|NCT00993421|6042870|P6|Overall Study|Physician Decision|1
1732436|NCT00993421|6042871|P5|Overall Study|Physician Decision|0
1732437|NCT00993421|6042872|P4|Overall Study|Physician Decision|0
1732438|NCT00993421|6042873|P3|Overall Study|Physician Decision|0
1732439|NCT00993421|6042874|P2|Overall Study|Physician Decision|0
1732440|NCT00993421|6042875|P1|Overall Study|Physician Decision|0
1732441|NCT00993421|6042869|P7|Overall Study|Entry Criteria Exclusion|0
1732442|NCT00993421|6042870|P6|Overall Study|Entry Criteria Exclusion|1
1732443|NCT00993421|6042871|P5|Overall Study|Entry Criteria Exclusion|0
1732444|NCT00993421|6042872|P4|Overall Study|Entry Criteria Exclusion|3
1732445|NCT00993421|6042873|P3|Overall Study|Entry Criteria Exclusion|1
1732446|NCT00993421|6042874|P2|Overall Study|Entry Criteria Exclusion|0
1732447|NCT00993421|6042875|P1|Overall Study|Entry Criteria Exclusion|0
1732448|NCT00993421|6042869|P7|Overall Study|Death|1
1732449|NCT00993421|6042870|P6|Overall Study|Death|0
1732450|NCT00993421|6042871|P5|Overall Study|Death|0
1732451|NCT00993421|6042872|P4|Overall Study|Death|0
1732452|NCT00993421|6042873|P3|Overall Study|Death|0
1732453|NCT00993421|6042874|P2|Overall Study|Death|0
1732454|NCT00993421|6042875|P1|Overall Study|Death|0
1732455|NCT00993421|6042869|P7|Overall Study|Withdrawal by Subject|3
1732456|NCT00993421|6042870|P6|Overall Study|Withdrawal by Subject|5
1732457|NCT00993421|6042871|P5|Overall Study|Withdrawal by Subject|3
1732458|NCT00993421|6042872|P4|Overall Study|Withdrawal by Subject|3
1732459|NCT00993421|6042873|P3|Overall Study|Withdrawal by Subject|3
1732460|NCT00993421|6042874|P2|Overall Study|Withdrawal by Subject|2
1732461|NCT00993421|6042875|P1|Overall Study|Withdrawal by Subject|3
1732462|NCT00993421|6042869|P7|Overall Study|Lost to Follow-up|6
1732463|NCT00993421|6042870|P6|Overall Study|Lost to Follow-up|0
1732464|NCT00993421|6042871|P5|Overall Study|Lost to Follow-up|0
1732465|NCT00993421|6042872|P4|Overall Study|Lost to Follow-up|0
1732466|NCT00993421|6042873|P3|Overall Study|Lost to Follow-up|5
1732467|NCT00993421|6042874|P2|Overall Study|Lost to Follow-up|5
1732468|NCT00993421|6042875|P1|Overall Study|Lost to Follow-up|3
1732469|NCT00993421|6042869|P7|Overall Study|Sponsor Decision|29
1732470|NCT00993421|6042870|P6|Overall Study|Sponsor Decision|30
1732471|NCT00993421|6042871|P5|Overall Study|Sponsor Decision|38
1732472|NCT00993421|6042872|P4|Overall Study|Sponsor Decision|30
1732473|NCT00993421|6042873|P3|Overall Study|Sponsor Decision|28
1732474|NCT00993421|6042874|P2|Overall Study|Sponsor Decision|31
1732475|NCT00993421|6042875|P1|Overall Study|Sponsor Decision|36
1732476|NCT00993421|6042869|P7|Overall Study|Adverse Event|1
1732477|NCT00993421|6042870|P6|Overall Study|Adverse Event|7
1732478|NCT00993421|6042871|P5|Overall Study|Adverse Event|5
1732479|NCT00993421|6042872|P4|Overall Study|Adverse Event|9
1732480|NCT00993421|6042873|P3|Overall Study|Adverse Event|6
1732481|NCT00993421|6042874|P2|Overall Study|Adverse Event|7
1732482|NCT00993421|6042875|P1|Overall Study|Adverse Event|2
1732483|NCT00993317|6043026|P2|Overall Study|Early study termination at the site|0
1732484|NCT00993317|6043027|P1|Overall Study|Early study termination at the site|1
1732485|NCT00993317|6043026|P2|Overall Study|Investigator's opinion|1
1732486|NCT00993317|6043027|P1|Overall Study|Investigator's opinion|0
1732487|NCT00993317|6043026|P2|Overall Study|Withdrawal by Subject|2
1732488|NCT00993317|6043027|P1|Overall Study|Withdrawal by Subject|0
1732489|NCT00993317|6043026|P2|Overall Study|Lack of Efficacy|18
1732490|NCT00993317|6043027|P1|Overall Study|Lack of Efficacy|18
1732491|NCT00993317|6043026|P2|Overall Study|Adverse Event|4
1732492|NCT00993317|6043027|P1|Overall Study|Adverse Event|2
1732493|NCT00993291|6043045|P1|Overall Study|Withdrawal by Subject|1
1732494|NCT00993265|6043051|P2|Overall Study|Non-compliant with study medication|0
1732495|NCT00993265|6043052|P1|Overall Study|Non-compliant with study medication|1
1732496|NCT00993265|6043051|P2|Overall Study|Changed dose of concomitant drug|0
1732497|NCT00993265|6043052|P1|Overall Study|Changed dose of concomitant drug|2
1732498|NCT00993265|6043051|P2|Overall Study|Adverse Event|0
1732499|NCT00993265|6043052|P1|Overall Study|Adverse Event|1
1732500|NCT00993148|6043104|P1|Overall Study|never initiated treatment|1
1732501|NCT00993148|6043104|P1|Overall Study|Lost to Follow-up|2
1732502|NCT00993044|6043116|P1|Irinotecan 50 mg|Physician Decision|1
1732503|NCT00993031|6043123|P2|Overall Study|Lost to Follow-up|13
1732504|NCT00993031|6043124|P1|Overall Study|Lost to Follow-up|19
1732505|NCT00993031|6043123|P2|Overall Study|Withdrawal by Subject|3
1732506|NCT00993031|6043124|P1|Overall Study|Withdrawal by Subject|3
1732507|NCT00993031|6043123|P2|Overall Study|Physician Decision|2
1732508|NCT00993031|6043124|P1|Overall Study|Physician Decision|0
1732509|NCT00993031|6043123|P2|Overall Study|Death|1
1732510|NCT00993031|6043124|P1|Overall Study|Death|0
1732511|NCT00992992|6043156|P1|Overall Study|Sponsor Closed the Study|4
1732512|NCT00992992|6043156|P1|Overall Study|GlaxoSmithKline Closed the Study|2
1732513|NCT00992992|6043156|P1|Overall Study|Death|16
1732514|NCT00992992|6043156|P1|Overall Study|Lost to Follow-up|3
1732515|NCT00992836|6043187|P1|Overall Study|Protocol Violation|2
1732516|NCT00992836|6043187|P1|Overall Study|Withdrawal by Subject|2
1732517|NCT00992836|6043187|P1|Overall Study|Lost to Follow-up|1
1732518|NCT00992784|6043202|P3|Overall Study|Withdrawal by Subject|1
1732519|NCT00992784|6043203|P2|Overall Study|Withdrawal by Subject|1
1732520|NCT00992784|6043204|P1|Overall Study|Withdrawal by Subject|1
1732521|NCT00992784|6043202|P3|Overall Study|Adverse Event|0
1732522|NCT00992784|6043203|P2|Overall Study|Adverse Event|1
1732523|NCT00992784|6043204|P1|Overall Study|Adverse Event|2
1732524|NCT00992589|6043316|P4|Double-Blind Phase|Other|3
1732525|NCT00992589|6043317|P3|Double-Blind Phase|Other|6
1732526|NCT00992589|6043318|P2|Double-Blind Phase|Other|1
1732527|NCT00992589|6043319|P1|Double-Blind Phase|Other|0
1732528|NCT00992589|6043316|P4|Double-Blind Phase|Lost to Follow-up|2
1732529|NCT00992589|6043317|P3|Double-Blind Phase|Lost to Follow-up|0
1732530|NCT00992589|6043318|P2|Double-Blind Phase|Lost to Follow-up|0
1732531|NCT00992589|6043319|P1|Double-Blind Phase|Lost to Follow-up|0
1732532|NCT00992589|6043316|P4|Double-Blind Phase|Withdrawal by Subject|2
1732533|NCT00992589|6043317|P3|Double-Blind Phase|Withdrawal by Subject|5
1732534|NCT00992589|6043318|P2|Double-Blind Phase|Withdrawal by Subject|6
1732535|NCT00992589|6043319|P1|Double-Blind Phase|Withdrawal by Subject|0
1732536|NCT00992589|6043316|P4|Double-Blind Phase|Adverse Event|3
1732537|NCT00992589|6043317|P3|Double-Blind Phase|Adverse Event|2
1732538|NCT00992589|6043318|P2|Double-Blind Phase|Adverse Event|6
1732539|NCT00992589|6043319|P1|Double-Blind Phase|Adverse Event|0
1732540|NCT00992589|6043316|P4|Open-Label Phase|Other|0
1732541|NCT00992589|6043317|P3|Open-Label Phase|Other|0
1732542|NCT00992589|6043318|P2|Open-Label Phase|Other|0
1732543|NCT00992589|6043319|P1|Open-Label Phase|Other|45
1732544|NCT00992589|6043316|P4|Open-Label Phase|Physician Decision|0
1732545|NCT00992589|6043317|P3|Open-Label Phase|Physician Decision|0
1732546|NCT00992589|6043318|P2|Open-Label Phase|Physician Decision|0
1732547|NCT00992589|6043319|P1|Open-Label Phase|Physician Decision|4
1732548|NCT00992589|6043316|P4|Open-Label Phase|Protocol Violation|0
1732549|NCT00992589|6043317|P3|Open-Label Phase|Protocol Violation|0
1732550|NCT00992589|6043318|P2|Open-Label Phase|Protocol Violation|0
1732551|NCT00992589|6043319|P1|Open-Label Phase|Protocol Violation|3
1732552|NCT00992589|6043316|P4|Open-Label Phase|Lost to Follow-up|0
1732553|NCT00992589|6043317|P3|Open-Label Phase|Lost to Follow-up|0
1732554|NCT00992589|6043318|P2|Open-Label Phase|Lost to Follow-up|0
1732555|NCT00992589|6043319|P1|Open-Label Phase|Lost to Follow-up|1
1732556|NCT00992589|6043316|P4|Open-Label Phase|Withdrawal by Subject|0
1732557|NCT00992589|6043317|P3|Open-Label Phase|Withdrawal by Subject|0
1732558|NCT00992589|6043318|P2|Open-Label Phase|Withdrawal by Subject|0
1732559|NCT00992589|6043319|P1|Open-Label Phase|Withdrawal by Subject|20
1732560|NCT00992589|6043316|P4|Open-Label Phase|Adverse Event|0
1732561|NCT00992589|6043317|P3|Open-Label Phase|Adverse Event|0
1732562|NCT00992589|6043318|P2|Open-Label Phase|Adverse Event|0
1732563|NCT00992589|6043319|P1|Open-Label Phase|Adverse Event|4
1732564|NCT00992511|6043365|P4|Overall Study|Withdrawal by Subject|1
1732565|NCT00992511|6043366|P3|Overall Study|Withdrawal by Subject|1
1732566|NCT00992511|6043367|P2|Overall Study|Withdrawal by Subject|0
1732567|NCT00992511|6043368|P1|Overall Study|Withdrawal by Subject|0
1732568|NCT00992511|6043365|P4|Overall Study|Lost to Follow-up|2
1732569|NCT00992511|6043366|P3|Overall Study|Lost to Follow-up|0
1732570|NCT00992511|6043367|P2|Overall Study|Lost to Follow-up|0
1732571|NCT00992511|6043368|P1|Overall Study|Lost to Follow-up|1
1732572|NCT00992511|6043365|P4|Overall Study|Migrated/moved from study area|2
1732573|NCT00992511|6043366|P3|Overall Study|Migrated/moved from study area|1
1732574|NCT00992511|6043367|P2|Overall Study|Migrated/moved from study area|0
1732575|NCT00992511|6043368|P1|Overall Study|Migrated/moved from study area|1
1732576|NCT00992459|6043452|P2|Overall Study|Adverse Event|0
1732577|NCT00992459|6043453|P1|Overall Study|Adverse Event|1
1732578|NCT00992459|6043452|P2|Overall Study|Withdrawal by Subject|1
1732579|NCT00992459|6043453|P1|Overall Study|Withdrawal by Subject|0
1732580|NCT00992446|6043477|P1|Overall Study|Maintenance Therapy Screen Fail|5
1732581|NCT00992446|6043477|P1|Overall Study|Withdrawal by Subject|2
1732582|NCT00992446|6043477|P1|Overall Study|Disease Progression|1
1732583|NCT00992407|6043549|P2|Overall Study|Study medication not administered|13
1732584|NCT00992407|6043550|P1|Overall Study|Study medication not administered|17
1732585|NCT00992407|6043549|P2|Overall Study|Loss of follow-up & Adverse events|1
1732586|NCT00992407|6043550|P1|Overall Study|Loss of follow-up & Adverse events|2
1732587|NCT00992407|6043549|P2|Overall Study|Other|0
1732588|NCT00992407|6043550|P1|Overall Study|Other|2
1732589|NCT00992407|6043549|P2|Overall Study|protocol Violation & Adverse events|4
1732590|NCT00992407|6043550|P1|Overall Study|protocol Violation & Adverse events|2
1732591|NCT00992407|6043549|P2|Overall Study|Adverse Event|2
1732592|NCT00992407|6043550|P1|Overall Study|Adverse Event|3
1732593|NCT00992407|6043549|P2|Overall Study|Lost to Follow-up|3
1732594|NCT00992407|6043550|P1|Overall Study|Lost to Follow-up|3
1732595|NCT00992407|6043549|P2|Overall Study|Protocol Violation|1
1732596|NCT00992407|6043550|P1|Overall Study|Protocol Violation|2
1732597|NCT00992394|6043600|P2|Overall Study|Other event|0
1732598|NCT00992394|6043601|P1|Overall Study|Other event|1
1732599|NCT00992394|6043600|P2|Overall Study|Lost to Follow-up|0
1732600|NCT00992394|6043601|P1|Overall Study|Lost to Follow-up|2
1732601|NCT00992394|6043600|P2|Overall Study|Protocol Violation|4
1732602|NCT00992394|6043601|P1|Overall Study|Protocol Violation|2
1732603|NCT00992394|6043600|P2|Overall Study|Physician Decision|0
1732604|NCT00992394|6043601|P1|Overall Study|Physician Decision|1
1732605|NCT00992394|6043600|P2|Overall Study|Withdrawal by Subject|2
1732606|NCT00992394|6043601|P1|Overall Study|Withdrawal by Subject|8
1732607|NCT00992394|6043600|P2|Overall Study|Adverse Event|5
1732608|NCT00992394|6043601|P1|Overall Study|Adverse Event|4
1732609|NCT00992394|6043600|P2|Overall Study|Lack of Efficacy|3
1732610|NCT00992394|6043601|P1|Overall Study|Lack of Efficacy|6
1732611|NCT00992225|6043688|P1|Overall Study|Adverse Event|2
1732612|NCT00992225|6043688|P1|Overall Study|Entry Criteria Not Met|8
1732613|NCT00992186|6043698|P1|Overall Study|Refusal To Receive Study Agent|3
1732614|NCT00992186|6043698|P1|Overall Study|Progressive Disease|30
1732615|NCT00992186|6043698|P1|Overall Study|Adverse Event|9
1732616|NCT00992186|6043698|P1|Overall Study|Physician Decision|1
1732617|NCT00992186|6043698|P1|Overall Study|Protocol Violation|1
1732618|NCT00992186|6043698|P1|Overall Study|Withdrawal by Subject|2
1732619|NCT00992108|6043717|P2|Overall Study|Lost to Follow-up|1
1732620|NCT00992108|6043718|P1|Overall Study|Lost to Follow-up|0
1732621|NCT00992056|6043732|P2|Washout Period (2 Weeks)|Physician Decision|0
1732622|NCT00992056|6043733|P1|Washout Period (2 Weeks)|Physician Decision|1
1732623|NCT00992056|6043732|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
1732624|NCT00992056|6043733|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
1732625|NCT00992017|6043739|P1|Overall Study|Not adhere to study requirements|1
1732626|NCT00992017|6043739|P1|Overall Study|Unable to get to clinic|5
1732627|NCT00992017|6043739|P1|Overall Study|Withdrawal by Subject|2
1732628|NCT00992017|6043739|P1|Overall Study|Lost to Follow-up|2
1732629|NCT00991952|6043754|P2|Overall Study|Adverse Event|1
1732630|NCT00991952|6043755|P1|Overall Study|Adverse Event|0
1732631|NCT00991939|6043763|P2|Overall Study|Entire study terminated|1
1732632|NCT00991939|6043764|P1|Overall Study|Entire study terminated|4
1732633|NCT00991939|6043763|P2|Overall Study|Withdrawal by Subject|0
1732634|NCT00991939|6043764|P1|Overall Study|Withdrawal by Subject|1
1732635|NCT00991939|6043763|P2|Overall Study|Lost to Follow-up|1
1732636|NCT00991939|6043764|P1|Overall Study|Lost to Follow-up|0
1732637|NCT00991887|6043798|P2|Overall Study|Lost to Follow-up|1
1732638|NCT00991887|6043799|P1|Overall Study|Lost to Follow-up|2
1732639|NCT00991510|6043818|P2|Period III (Days 29-112)|Adverse Event|1
1732640|NCT00991510|6043819|P1|Period III (Days 29-112)|Adverse Event|1
1732641|NCT00991510|6043818|P2|Period I (Days 1-14)|Adverse Event|0
1732642|NCT00991510|6043819|P1|Period I (Days 1-14)|Adverse Event|1
1732643|NCT00991406|6043863|P1|Overall Study|One participant did not respond to FES.|1
1732644|NCT00991341|6043872|P2|Overall Study|Withdrawal by Subject|4
1732645|NCT00991341|6043873|P1|Overall Study|Withdrawal by Subject|3
1732646|NCT00991341|6043872|P2|Overall Study|Physician Decision|2
1732647|NCT00991341|6043873|P1|Overall Study|Physician Decision|1
1732648|NCT00991341|6043872|P2|Overall Study|no RBCs received 96hrs after randomized|155
1732649|NCT00991341|6043873|P1|Overall Study|no RBCs received 96hrs after randomized|186
1732650|NCT00991341|6043872|P2|Overall Study|Death|0
1732651|NCT00991341|6043873|P1|Overall Study|Death|3
1732652|NCT00991341|6043872|P2|Overall Study|no surgery w/in 30 days of randomization|18
1732653|NCT00991341|6043873|P1|Overall Study|no surgery w/in 30 days of randomization|11
1732654|NCT00991302|6043911|P2|Overall Study|Lost to Follow-up|12
1732655|NCT00991302|6043912|P1|Overall Study|Lost to Follow-up|14
1732656|NCT00991302|6043911|P2|Overall Study|Death|1
1732657|NCT00991302|6043912|P1|Overall Study|Death|0
1732658|NCT00991289|6043928|P1|Overall Study|Protocol Violation|2
1732659|NCT00991289|6043928|P1|Overall Study|Lost to Follow-up|4
1732660|NCT00991289|6043928|P1|Overall Study|Withdrawal by Subject|3
1732661|NCT00991289|6043928|P1|Overall Study|Physician Decision|2
1732662|NCT00991289|6043928|P1|Overall Study|Adverse Event|1
1732663|NCT00991276|6043948|P6|Third Intervention Period|Withdrawal by Subject|0
1732664|NCT00991276|6043949|P5|Third Intervention Period|Withdrawal by Subject|0
1732665|NCT00991276|6043950|P4|Third Intervention Period|Withdrawal by Subject|1
1732666|NCT00991276|6043951|P3|Third Intervention Period|Withdrawal by Subject|0
1732667|NCT00991276|6043952|P2|Third Intervention Period|Withdrawal by Subject|0
1732668|NCT00991276|6043953|P1|Third Intervention Period|Withdrawal by Subject|0
1732669|NCT00991276|6043948|P6|Third Intervention Period|Adverse Event|0
1732670|NCT00991276|6043949|P5|Third Intervention Period|Adverse Event|0
1732671|NCT00991276|6043950|P4|Third Intervention Period|Adverse Event|0
1732672|NCT00991276|6043951|P3|Third Intervention Period|Adverse Event|1
1732673|NCT00991276|6043952|P2|Third Intervention Period|Adverse Event|0
1732674|NCT00991276|6043953|P1|Third Intervention Period|Adverse Event|0
1732675|NCT00991276|6043948|P6|Third Intervention Period|Other|1
1732676|NCT00991276|6043949|P5|Third Intervention Period|Other|0
1732677|NCT00991276|6043950|P4|Third Intervention Period|Other|0
1732678|NCT00991276|6043951|P3|Third Intervention Period|Other|0
1732679|NCT00991276|6043952|P2|Third Intervention Period|Other|0
1732680|NCT00991276|6043953|P1|Third Intervention Period|Other|0
1732681|NCT00991276|6043948|P6|Third Intervention Period|Protocol Violation|0
1732682|NCT00991276|6043949|P5|Third Intervention Period|Protocol Violation|0
1732683|NCT00991276|6043950|P4|Third Intervention Period|Protocol Violation|0
1732684|NCT00991276|6043951|P3|Third Intervention Period|Protocol Violation|0
1732685|NCT00991276|6043952|P2|Third Intervention Period|Protocol Violation|0
1732686|NCT00991276|6043953|P1|Third Intervention Period|Protocol Violation|1
1732687|NCT00991276|6043948|P6|Second Intervention Period|Other|1
1732688|NCT00991276|6043949|P5|Second Intervention Period|Other|0
1732689|NCT00991276|6043950|P4|Second Intervention Period|Other|1
1732690|NCT00991276|6043951|P3|Second Intervention Period|Other|0
1732691|NCT00991276|6043952|P2|Second Intervention Period|Other|0
1732692|NCT00991276|6043953|P1|Second Intervention Period|Other|0
1732693|NCT00991276|6043948|P6|Second Intervention Period|Protocol Violation|0
1732694|NCT00991276|6043949|P5|Second Intervention Period|Protocol Violation|0
1732695|NCT00991276|6043950|P4|Second Intervention Period|Protocol Violation|0
1732696|NCT00991276|6043951|P3|Second Intervention Period|Protocol Violation|0
1732697|NCT00991276|6043952|P2|Second Intervention Period|Protocol Violation|0
1732698|NCT00991276|6043953|P1|Second Intervention Period|Protocol Violation|1
1732699|NCT00991276|6043948|P6|Second Intervention Period|Adverse Event|0
1732700|NCT00991276|6043949|P5|Second Intervention Period|Adverse Event|1
1732701|NCT00991276|6043950|P4|Second Intervention Period|Adverse Event|1
1732702|NCT00991276|6043951|P3|Second Intervention Period|Adverse Event|0
1732703|NCT00991276|6043952|P2|Second Intervention Period|Adverse Event|2
1732704|NCT00991276|6043953|P1|Second Intervention Period|Adverse Event|0
1732705|NCT00991276|6043948|P6|First Intervention Period|Lost to Follow-up|0
1732706|NCT00991276|6043949|P5|First Intervention Period|Lost to Follow-up|0
1732707|NCT00991276|6043950|P4|First Intervention Period|Lost to Follow-up|1
1732708|NCT00991276|6043951|P3|First Intervention Period|Lost to Follow-up|0
1732709|NCT00991276|6043952|P2|First Intervention Period|Lost to Follow-up|1
1732710|NCT00991276|6043953|P1|First Intervention Period|Lost to Follow-up|0
1732711|NCT00991276|6043948|P6|First Intervention Period|Withdrawal by Subject|1
1732712|NCT00991276|6043949|P5|First Intervention Period|Withdrawal by Subject|0
1732713|NCT00991276|6043950|P4|First Intervention Period|Withdrawal by Subject|1
1732714|NCT00991276|6043951|P3|First Intervention Period|Withdrawal by Subject|0
1732715|NCT00991276|6043952|P2|First Intervention Period|Withdrawal by Subject|1
1732716|NCT00991276|6043953|P1|First Intervention Period|Withdrawal by Subject|0
1732717|NCT00991276|6043948|P6|First Intervention Period|Other|0
1732718|NCT00991276|6043949|P5|First Intervention Period|Other|1
1732719|NCT00991276|6043950|P4|First Intervention Period|Other|1
1732720|NCT00991276|6043951|P3|First Intervention Period|Other|0
1732721|NCT00991276|6043952|P2|First Intervention Period|Other|0
1732722|NCT00991276|6043953|P1|First Intervention Period|Other|0
1732723|NCT00991276|6043948|P6|First Intervention Period|Insufficient clinical response|0
1732724|NCT00991276|6043949|P5|First Intervention Period|Insufficient clinical response|1
1732725|NCT00991276|6043950|P4|First Intervention Period|Insufficient clinical response|0
1732726|NCT00991276|6043951|P3|First Intervention Period|Insufficient clinical response|0
1732727|NCT00991276|6043952|P2|First Intervention Period|Insufficient clinical response|0
1732728|NCT00991276|6043953|P1|First Intervention Period|Insufficient clinical response|0
1732729|NCT00991276|6043948|P6|First Intervention Period|Protocol Violation|0
1732730|NCT00991276|6043949|P5|First Intervention Period|Protocol Violation|2
1732731|NCT00991276|6043950|P4|First Intervention Period|Protocol Violation|0
1732732|NCT00991276|6043951|P3|First Intervention Period|Protocol Violation|0
1732733|NCT00991276|6043952|P2|First Intervention Period|Protocol Violation|0
1732734|NCT00991276|6043953|P1|First Intervention Period|Protocol Violation|0
1732735|NCT00991276|6043948|P6|First Intervention Period|Adverse Event|0
1732736|NCT00991276|6043949|P5|First Intervention Period|Adverse Event|0
1732737|NCT00991276|6043950|P4|First Intervention Period|Adverse Event|1
1732738|NCT00991276|6043951|P3|First Intervention Period|Adverse Event|0
1732739|NCT00991276|6043952|P2|First Intervention Period|Adverse Event|1
1732740|NCT00991276|6043953|P1|First Intervention Period|Adverse Event|0
1732741|NCT00990821|6044168|P14|Overall Study|Withdrawal by Subject|1
1732742|NCT00990821|6044169|P13|Overall Study|Withdrawal by Subject|2
1732743|NCT00990821|6044170|P12|Overall Study|Withdrawal by Subject|5
1732744|NCT00990821|6044171|P11|Overall Study|Withdrawal by Subject|3
1732745|NCT00990821|6044172|P10|Overall Study|Withdrawal by Subject|1
1732746|NCT00990821|6044173|P9|Overall Study|Withdrawal by Subject|0
1732747|NCT00990821|6044174|P8|Overall Study|Withdrawal by Subject|0
1732748|NCT00990821|6044175|P7|Overall Study|Withdrawal by Subject|1
1732749|NCT00990821|6044176|P6|Overall Study|Withdrawal by Subject|3
1732750|NCT00990821|6044177|P5|Overall Study|Withdrawal by Subject|3
1732751|NCT00990821|6044178|P4|Overall Study|Withdrawal by Subject|0
1732752|NCT00990821|6044179|P3|Overall Study|Withdrawal by Subject|0
1732753|NCT00990821|6044180|P2|Overall Study|Withdrawal by Subject|2
1732754|NCT00990821|6044181|P1|Overall Study|Withdrawal by Subject|0
1732755|NCT00990704|6044218|P2|Overall Study|Physician Decision|1
1732756|NCT00990704|6044219|P1|Overall Study|Physician Decision|0
1732757|NCT00990704|6044218|P2|Overall Study|Adverse Event|1
1732758|NCT00990704|6044219|P1|Overall Study|Adverse Event|1
1732759|NCT00990665|6044239|P1|Overall Study|System Explant|3
1732760|NCT00990665|6044239|P1|Overall Study|Lost to Follow-up|1
1732761|NCT00990665|6044239|P1|Overall Study|Withdrawal by Subject|6
1732762|NCT00990665|6044239|P1|Overall Study|Heart Transplant|1
1732763|NCT00990665|6044239|P1|Overall Study|Death|29
1732764|NCT00990665|6044239|P1|Overall Study|Unsuccessful Implant|8
1732765|NCT00990652|6044246|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
1732766|NCT00990652|6044246|P1|Pre-surgical Bortezomib|Adverse Event|1
1732767|NCT00990340|6044280|P2|First 14-day Treatment|Protocol Violation|2
1732768|NCT00990340|6044281|P1|First 14-day Treatment|Protocol Violation|2
1732769|NCT00990340|6044280|P2|First 14-day Treatment|Lost to Follow-up|1
1732770|NCT00990340|6044281|P1|First 14-day Treatment|Lost to Follow-up|2
1732771|NCT00990340|6044280|P2|First 14-day Treatment|Not Compliant|1
1732772|NCT00990340|6044281|P1|First 14-day Treatment|Not Compliant|2
1732773|NCT00990314|6044295|P1|Overall Study|Lack of Efficacy|1
1732774|NCT00990314|6044295|P1|Overall Study|Physician Decision|3
1732775|NCT00990314|6044295|P1|Overall Study|Non-Compliance|1
1732776|NCT00990314|6044295|P1|Overall Study|Withdrawal by Subject|3
1732777|NCT00990314|6044295|P1|Overall Study|Adverse Event|2
1732778|NCT00990314|6044295|P1|Overall Study|Death|2
1732779|NCT00990249|6044337|P1|Overall Study|Not treated|2
1732780|NCT00990249|6044337|P1|Overall Study|Death|2
1732781|NCT00990249|6044337|P1|Overall Study|Non-Compliance|1
1732782|NCT00990249|6044337|P1|Overall Study|Disease Progression|8
1732783|NCT00990184|6044341|P1|Overall Study|Physician Decision|1
1732784|NCT00990106|6044349|P2|Overall Study|scheduling conflicts|2
1732785|NCT00990106|6044350|P1|Overall Study|scheduling conflicts|0
1732786|NCT00990106|6044349|P2|Overall Study|planned major surgery|1
1732787|NCT00990106|6044350|P1|Overall Study|planned major surgery|0
1732788|NCT00990106|6044349|P2|Overall Study|started exclusionary medication|1
1732789|NCT00990106|6044350|P1|Overall Study|started exclusionary medication|0
1732790|NCT00990106|6044349|P2|Overall Study|relocation/deployment|1
1732791|NCT00990106|6044350|P1|Overall Study|relocation/deployment|4
1732792|NCT00990106|6044349|P2|Overall Study|opted for open label prazosin|1
1732793|NCT00990106|6044350|P1|Overall Study|opted for open label prazosin|1
1732794|NCT00990106|6044349|P2|Overall Study|Withdrawal by Subject|1
1732795|NCT00990106|6044350|P1|Overall Study|Withdrawal by Subject|2
1732796|NCT00990106|6044349|P2|Overall Study|Lost to Follow-up|3
1732797|NCT00990106|6044350|P1|Overall Study|Lost to Follow-up|1
1732798|NCT00990106|6044349|P2|Overall Study|"too busy to continue"|2
1732799|NCT00990106|6044350|P1|Overall Study|"too busy to continue"|1
1732800|NCT00990093|6044360|P2|Test Period 2 (15-28 Days)|Other|1
1732801|NCT00990093|6044361|P1|Test Period 2 (15-28 Days)|Other|0
1732802|NCT00990093|6044360|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
1732803|NCT00990093|6044361|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
1732804|NCT00990093|6044360|P2|Test Period 2 (15-28 Days)|Adverse Event|0
1732805|NCT00990093|6044361|P1|Test Period 2 (15-28 Days)|Adverse Event|1
1732806|NCT00990093|6044360|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
1732807|NCT00990093|6044361|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
1732808|NCT00990093|6044360|P2|Test Period 1 (1-14 Days)|Other|0
1732809|NCT00990093|6044361|P1|Test Period 1 (1-14 Days)|Other|1
1732810|NCT00990093|6044360|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
1732811|NCT00990093|6044361|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
1732812|NCT00990093|6044360|P2|Test Period 1 (1-14 Days)|Adverse Event|0
1732813|NCT00990093|6044361|P1|Test Period 1 (1-14 Days)|Adverse Event|1
1732814|NCT00989950|6044414|P4|Randomized Phase|Adverse Event|0
1732815|NCT00989950|6044415|P3|Randomized Phase|Adverse Event|0
1732816|NCT00989950|6044416|P2|Randomized Phase|Adverse Event|1
1732817|NCT00989950|6044417|P1|Randomized Phase|Adverse Event|0
1732818|NCT00989950|6044414|P4|Randomized Phase|Protocol Violation|0
1732819|NCT00989950|6044415|P3|Randomized Phase|Protocol Violation|0
1732820|NCT00989950|6044416|P2|Randomized Phase|Protocol Violation|0
1732821|NCT00989950|6044417|P1|Randomized Phase|Protocol Violation|1
1732822|NCT00989833|6044449|P3|Overall Study|Incorrectly randomized|0
1732823|NCT00989833|6044450|P2|Overall Study|Incorrectly randomized|0
1732824|NCT00989833|6044451|P1|Overall Study|Incorrectly randomized|1
1732825|NCT00989833|6044449|P3|Overall Study|Withdrawal by Subject|1
1732826|NCT00989833|6044450|P2|Overall Study|Withdrawal by Subject|0
1732827|NCT00989833|6044451|P1|Overall Study|Withdrawal by Subject|0
1732828|NCT00989833|6044449|P3|Overall Study|Protocol Violation|1
1732829|NCT00989833|6044450|P2|Overall Study|Protocol Violation|2
1732830|NCT00989833|6044451|P1|Overall Study|Protocol Violation|1
1732831|NCT00989833|6044449|P3|Overall Study|Lost to Follow-up|0
1732832|NCT00989833|6044450|P2|Overall Study|Lost to Follow-up|1
1732833|NCT00989833|6044451|P1|Overall Study|Lost to Follow-up|0
1732834|NCT00989781|6044482|P2|Ovarian Response to hCG|Lost to Follow-up|2
1732835|NCT00989781|6044483|P1|Ovarian Response to hCG|Lost to Follow-up|3
1732836|NCT00989664|6044513|P1|Long-Term Follow-Up|Death|3
1732837|NCT00989664|6044513|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
1732838|NCT00989664|6044513|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
1732839|NCT00989664|6044513|P1|Dosimetric and Therapeutic Treatment|Death|1
1732840|NCT00989664|6044513|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
1732841|NCT00989664|6044513|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
1732842|NCT00989664|6044513|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
1732843|NCT00989287|6044598|P2|Overall Study|Lost to Follow-up|1
1732844|NCT00989287|6044599|P1|Overall Study|Lost to Follow-up|0
1732845|NCT00989287|6044598|P2|Overall Study|Adverse Event|0
1732846|NCT00989287|6044599|P1|Overall Study|Adverse Event|1
1732847|NCT00989261|6044701|P2|Overall Study|Lost to Follow-up|0
1732848|NCT00989261|6044702|P1|Overall Study|Lost to Follow-up|3
1732849|NCT00989261|6044701|P2|Overall Study|Withdrawal by Subject|1
1732850|NCT00989261|6044702|P1|Overall Study|Withdrawal by Subject|0
1732851|NCT00989261|6044701|P2|Overall Study|Still in follow up|21
1732852|NCT00989261|6044702|P1|Overall Study|Still in follow up|12
1732853|NCT00989235|6044732|P2|Overall Study|Lost to Follow-up|1
1732854|NCT00989235|6044733|P1|Overall Study|Lost to Follow-up|0
1732855|NCT00989235|6044732|P2|Overall Study|Randomized by Mistake|2
1732856|NCT00989235|6044733|P1|Overall Study|Randomized by Mistake|0
1732857|NCT00989235|6044732|P2|Overall Study|Desire to Become Pregnant|0
1732858|NCT00989235|6044733|P1|Overall Study|Desire to Become Pregnant|1
1732859|NCT00989235|6044732|P2|Overall Study|Withdrawal of Consent|1
1732860|NCT00989235|6044733|P1|Overall Study|Withdrawal of Consent|1
1732861|NCT00989235|6044732|P2|Overall Study|Lack of Efficacy|0
1732862|NCT00989235|6044733|P1|Overall Study|Lack of Efficacy|1
1732863|NCT00989235|6044732|P2|Overall Study|Adverse Event|1
1732864|NCT00989235|6044733|P1|Overall Study|Adverse Event|0
1732865|NCT00989235|6044732|P2|Overall Study|Death|1
1732866|NCT00989235|6044733|P1|Overall Study|Death|0
1732867|NCT00989196|6044778|P2|Treatment Period|Lost to Follow-up|0
1732868|NCT00989196|6044779|P1|Treatment Period|Lost to Follow-up|1
1732869|NCT00989092|6044817|P2|Overall Study|Did not receive study drug|0
1732870|NCT00989092|6044818|P1|Overall Study|Did not receive study drug|2
1732871|NCT00989092|6044817|P2|Overall Study|Erythropoietin therapy initiated|0
1732872|NCT00989092|6044818|P1|Overall Study|Erythropoietin therapy initiated|2
1732873|NCT00989092|6044817|P2|Overall Study|Protocol deviation|0
1732874|NCT00989092|6044818|P1|Overall Study|Protocol deviation|2
1732875|NCT00989092|6044817|P2|Overall Study|Other|1
1732876|NCT00989092|6044818|P1|Overall Study|Other|3
1732877|NCT00989092|6044817|P2|Overall Study|Lost to Follow-up|2
1732878|NCT00989092|6044818|P1|Overall Study|Lost to Follow-up|6
1732879|NCT00989092|6044817|P2|Overall Study|Ineligibility determined|3
1732880|NCT00989092|6044818|P1|Overall Study|Ineligibility determined|3
1732881|NCT00989092|6044817|P2|Overall Study|Death|2
1732882|NCT00989092|6044818|P1|Overall Study|Death|14
1732883|NCT00989092|6044817|P2|Overall Study|Withdrawal by Subject|9
1732884|NCT00989092|6044818|P1|Overall Study|Withdrawal by Subject|17
1732885|NCT00989092|6044817|P2|Overall Study|Chemotherapy initiated|4
1732886|NCT00989092|6044818|P1|Overall Study|Chemotherapy initiated|12
1732887|NCT00989092|6044817|P2|Overall Study|Adverse Event|1
1732888|NCT00989092|6044818|P1|Overall Study|Adverse Event|20
1732889|NCT00989092|6044817|P2|Overall Study|Physician Decision|6
1732890|NCT00989092|6044818|P1|Overall Study|Physician Decision|9
1732891|NCT00988884|6044870|P2|Overall Study|Withdrawal by Subject|18
1732892|NCT00988884|6044871|P1|Overall Study|Withdrawal by Subject|15
1732893|NCT00988884|6044870|P2|Overall Study|Protocol Violation|1
1732894|NCT00988884|6044871|P1|Overall Study|Protocol Violation|0
1732895|NCT00988884|6044870|P2|Overall Study|Lost to Follow-up|16
1732896|NCT00988884|6044871|P1|Overall Study|Lost to Follow-up|20
1732897|NCT00988884|6044870|P2|Overall Study|Adverse Event|1
1732898|NCT00988884|6044871|P1|Overall Study|Adverse Event|0
1732899|NCT00988858|6044893|P1|Overall Study|Sponsor Decision|1
1732900|NCT00988858|6044893|P1|Overall Study|Physician Decision|1
1732901|NCT00988858|6044893|P1|Overall Study|Death|1
1732902|NCT00988858|6044893|P1|Overall Study|Adverse Event|7
1732903|NCT00988637|6044942|P2|Overall Study|non-compliance with study drug|1
1732904|NCT00988637|6044943|P1|Overall Study|non-compliance with study drug|0
1732905|NCT00988637|6044942|P2|Overall Study|Withdrawal by Subject|1
1732906|NCT00988637|6044943|P1|Overall Study|Withdrawal by Subject|1
1732907|NCT00988637|6044942|P2|Overall Study|Lost to Follow-up|1
1732908|NCT00988637|6044943|P1|Overall Study|Lost to Follow-up|2
1732909|NCT00988559|6044977|P4|Overall Study|Lost to Follow-up|0
1732910|NCT00988559|6044978|P3|Overall Study|Lost to Follow-up|1
1732911|NCT00988559|6044979|P2|Overall Study|Lost to Follow-up|0
1732912|NCT00988559|6044980|P1|Overall Study|Lost to Follow-up|0
1732913|NCT00988559|6044977|P4|Overall Study|Pregnancy|0
1732914|NCT00988559|6044978|P3|Overall Study|Pregnancy|1
1732915|NCT00988559|6044979|P2|Overall Study|Pregnancy|1
1732916|NCT00988559|6044980|P1|Overall Study|Pregnancy|0
1732917|NCT00988559|6044977|P4|Overall Study|Withdrawal by Subject|1
1732918|NCT00988559|6044978|P3|Overall Study|Withdrawal by Subject|0
1732919|NCT00988559|6044979|P2|Overall Study|Withdrawal by Subject|1
1732920|NCT00988559|6044980|P1|Overall Study|Withdrawal by Subject|1
1732921|NCT00988533|6044994|P1|Overall Study|Lost to Follow-up|3
1732922|NCT00988442|6045008|P2|Overall Study|Early Study Closure|25
1732923|NCT00988442|6045009|P1|Overall Study|Early Study Closure|29
1732924|NCT00988442|6045008|P2|Overall Study|Lost to Follow-up|1
1732925|NCT00988442|6045009|P1|Overall Study|Lost to Follow-up|0
1732926|NCT00988442|6045008|P2|Overall Study|Death|2
1732927|NCT00988442|6045009|P1|Overall Study|Death|1
1732928|NCT00988429|6045072|P3|Overall Study|other reasons|1
1732929|NCT00988429|6045073|P2|Overall Study|other reasons|8
1732930|NCT00988429|6045074|P1|Overall Study|other reasons|8
1732931|NCT00988429|6045072|P3|Overall Study|Administrative Reasons|1
1732932|NCT00988429|6045073|P2|Overall Study|Administrative Reasons|2
1732933|NCT00988429|6045074|P1|Overall Study|Administrative Reasons|1
1732934|NCT00988429|6045072|P3|Overall Study|Withdrawal by Subject|12
1732935|NCT00988429|6045073|P2|Overall Study|Withdrawal by Subject|7
1732936|NCT00988429|6045074|P1|Overall Study|Withdrawal by Subject|7
1732937|NCT00988429|6045072|P3|Overall Study|Protocol Violation|3
1732938|NCT00988429|6045073|P2|Overall Study|Protocol Violation|3
1732939|NCT00988429|6045074|P1|Overall Study|Protocol Violation|4
1732940|NCT00988429|6045072|P3|Overall Study|Pregnancy|0
1732941|NCT00988429|6045073|P2|Overall Study|Pregnancy|1
1732942|NCT00988429|6045074|P1|Overall Study|Pregnancy|2
1732943|NCT00988429|6045072|P3|Overall Study|Physician Decision|3
1732944|NCT00988429|6045073|P2|Overall Study|Physician Decision|0
1732945|NCT00988429|6045074|P1|Overall Study|Physician Decision|1
1732946|NCT00988429|6045072|P3|Overall Study|Non-Compliance with Study Drug|3
1732947|NCT00988429|6045073|P2|Overall Study|Non-Compliance with Study Drug|1
1732948|NCT00988429|6045074|P1|Overall Study|Non-Compliance with Study Drug|5
1732949|NCT00988429|6045072|P3|Overall Study|Lack of Efficacy|1
1732950|NCT00988429|6045073|P2|Overall Study|Lack of Efficacy|0
1732951|NCT00988429|6045074|P1|Overall Study|Lack of Efficacy|0
1732952|NCT00988429|6045072|P3|Overall Study|Adverse Event|45
1732953|NCT00988429|6045073|P2|Overall Study|Adverse Event|21
1732954|NCT00988429|6045074|P1|Overall Study|Adverse Event|9
1732955|NCT00988351|6045087|P2|Overall Study|not using CPAP|3
1732956|NCT00988351|6045088|P1|Overall Study|not using CPAP|5
1732957|NCT00988351|6045087|P2|Overall Study|Lost to Follow-up|9
1732958|NCT00988351|6045088|P1|Overall Study|Lost to Follow-up|6
1732959|NCT00988351|6045087|P2|Overall Study|Withdrawal by Subject|0
1732960|NCT00988351|6045088|P1|Overall Study|Withdrawal by Subject|8
1732961|NCT00988247|6045165|P2|Overall Study|Other|0
1732962|NCT00988247|6045166|P1|Overall Study|Other|3
1732963|NCT00988247|6045165|P2|Overall Study|Sponsor requested withdrawal|1
1732964|NCT00988247|6045166|P1|Overall Study|Sponsor requested withdrawal|3
1732965|NCT00988247|6045165|P2|Overall Study|Protocol Violation|5
1732966|NCT00988247|6045166|P1|Overall Study|Protocol Violation|4
1732967|NCT00988247|6045165|P2|Overall Study|Lost to Follow-up|2
1732968|NCT00988247|6045166|P1|Overall Study|Lost to Follow-up|11
1732969|NCT00988247|6045165|P2|Overall Study|Pregnancy|2
1732970|NCT00988247|6045166|P1|Overall Study|Pregnancy|1
1732971|NCT00988247|6045165|P2|Overall Study|Withdrawal by Subject|13
1732972|NCT00988247|6045166|P1|Overall Study|Withdrawal by Subject|44
1732973|NCT00988247|6045165|P2|Overall Study|Adverse Event|3
1732974|NCT00988247|6045166|P1|Overall Study|Adverse Event|17
1732975|NCT00988221|6045185|P4|Part III|Refused Treatment|0
1732976|NCT00988221|6045186|P3|Part III|Refused Treatment|1
1732977|NCT00988221|6045187|P2|Part III|Refused Treatment|0
1732978|NCT00988221|6045188|P1|Part III|Refused Treatment|0
1732979|NCT00988221|6045185|P4|Part III|Insufficient Therapeutic Response|0
1732980|NCT00988221|6045186|P3|Part III|Insufficient Therapeutic Response|1
1732981|NCT00988221|6045187|P2|Part III|Insufficient Therapeutic Response|1
1732982|NCT00988221|6045188|P1|Part III|Insufficient Therapeutic Response|0
1732983|NCT00988221|6045185|P4|Part III|Adverse Event|0
1732984|NCT00988221|6045186|P3|Part III|Adverse Event|1
1732985|NCT00988221|6045187|P2|Part III|Adverse Event|0
1732986|NCT00988221|6045188|P1|Part III|Adverse Event|1
1732987|NCT00988221|6045185|P4|Part II|Reason not Specified|0
1732988|NCT00988221|6045186|P3|Part II|Reason not Specified|1
1732989|NCT00988221|6045187|P2|Part II|Reason not Specified|0
1732990|NCT00988221|6045188|P1|Part II|Reason not Specified|0
1732991|NCT00988221|6045185|P4|Part II|Withdrawal by Subject|2
1732992|NCT00988221|6045186|P3|Part II|Withdrawal by Subject|2
1732993|NCT00988221|6045187|P2|Part II|Withdrawal by Subject|0
1732994|NCT00988221|6045188|P1|Part II|Withdrawal by Subject|0
1732995|NCT00988221|6045185|P4|Part II|Adverse Event|1
1732996|NCT00988221|6045186|P3|Part II|Adverse Event|0
1732997|NCT00988221|6045187|P2|Part II|Adverse Event|0
1732998|NCT00988221|6045188|P1|Part II|Adverse Event|1
1732999|NCT00988221|6045185|P4|Part I|Lost to Follow-up|0
1733000|NCT00988221|6045186|P3|Part I|Lost to Follow-up|0
1733001|NCT00988221|6045187|P2|Part I|Lost to Follow-up|1
1733002|NCT00988221|6045188|P1|Part I|Lost to Follow-up|0
1733003|NCT00988221|6045185|P4|Part I|Refused Treatment|0
1733004|NCT00988221|6045186|P3|Part I|Refused Treatment|1
1733005|NCT00988221|6045187|P2|Part I|Refused Treatment|2
1733006|NCT00988221|6045188|P1|Part I|Refused Treatment|0
1733007|NCT00988221|6045185|P4|Part I|Insufficient Therapeutic Response|0
1733008|NCT00988221|6045186|P3|Part I|Insufficient Therapeutic Response|5
1733009|NCT00988221|6045187|P2|Part I|Insufficient Therapeutic Response|6
1733010|NCT00988221|6045188|P1|Part I|Insufficient Therapeutic Response|4
1733011|NCT00988221|6045185|P4|Part I|Adverse Event|0
1733012|NCT00988221|6045186|P3|Part I|Adverse Event|2
1733013|NCT00988221|6045187|P2|Part I|Adverse Event|1
1733014|NCT00988221|6045188|P1|Part I|Adverse Event|0
1733015|NCT00988208|6045361|P2|Overall Study|Other|3
1733016|NCT00988208|6045362|P1|Overall Study|Other|8
1733017|NCT00988208|6045361|P2|Overall Study|Subject Decision/Investigator Discretion|32
1733018|NCT00988208|6045362|P1|Overall Study|Subject Decision/Investigator Discretion|32
1733019|NCT00988208|6045361|P2|Overall Study|Clinical Deterioration|14
1733020|NCT00988208|6045362|P1|Overall Study|Clinical Deterioration|7
1733021|NCT00988208|6045361|P2|Overall Study|Biochemical Progression|7
1733022|NCT00988208|6045362|P1|Overall Study|Biochemical Progression|21
1733023|NCT00988208|6045361|P2|Overall Study|Clinical Progression|16
1733024|NCT00988208|6045362|P1|Overall Study|Clinical Progression|17
1733025|NCT00988208|6045361|P2|Overall Study|Sponsor Decision|78
1733026|NCT00988208|6045362|P1|Overall Study|Sponsor Decision|102
1733027|NCT00988208|6045361|P2|Overall Study|Protocol Violation|2
1733028|NCT00988208|6045362|P1|Overall Study|Protocol Violation|9
1733029|NCT00988208|6045361|P2|Overall Study|Lost to Follow-up|3
1733030|NCT00988208|6045362|P1|Overall Study|Lost to Follow-up|2
1733031|NCT00988208|6045361|P2|Overall Study|Death|15
1733032|NCT00988208|6045362|P1|Overall Study|Death|9
1733033|NCT00988208|6045361|P2|Overall Study|Withdrawal by Subject|57
1733034|NCT00988208|6045362|P1|Overall Study|Withdrawal by Subject|50
1733035|NCT00988208|6045361|P2|Overall Study|Disease Progression|89
1733036|NCT00988208|6045362|P1|Overall Study|Disease Progression|103
1733037|NCT00988208|6045361|P2|Overall Study|Adverse Event|122
1733038|NCT00988208|6045362|P1|Overall Study|Adverse Event|71
1733039|NCT00988169|6045380|P1|Overall Study|Withdrawal by Subject|1
1733040|NCT00988117|6045432|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
1733041|NCT00988117|6045432|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
1733042|NCT00988091|6045441|P2|Open-label Period|Other|3
1733043|NCT00988091|6045442|P1|Open-label Period|Other|2
1733044|NCT00988091|6045441|P2|Open-label Period|Lost to Follow-up|5
1733045|NCT00988091|6045442|P1|Open-label Period|Lost to Follow-up|3
1733046|NCT00988091|6045441|P2|Open-label Period|Withdrawal by Subject|16
1733047|NCT00988091|6045442|P1|Open-label Period|Withdrawal by Subject|10
1733048|NCT00988091|6045441|P2|Open-label Period|Protocol Violation|1
1733049|NCT00988091|6045442|P1|Open-label Period|Protocol Violation|1
1733050|NCT00988091|6045441|P2|Open-label Period|Use of exclusionary medication|1
1733051|NCT00988091|6045442|P1|Open-label Period|Use of exclusionary medication|1
1733052|NCT00988091|6045441|P2|Open-label Period|Adverse Event|7
1733053|NCT00988091|6045442|P1|Open-label Period|Adverse Event|4
1733054|NCT00988091|6045441|P2|Double-blind Period|Use of exclusionary medication|3
1733055|NCT00988091|6045442|P1|Double-blind Period|Use of exclusionary medication|2
1733056|NCT00988091|6045441|P2|Double-blind Period|Adverse Event|9
1733057|NCT00988091|6045442|P1|Double-blind Period|Adverse Event|6
1733058|NCT00988091|6045441|P2|Double-blind Period|Other|8
1733059|NCT00988091|6045442|P1|Double-blind Period|Other|8
1733060|NCT00988091|6045441|P2|Double-blind Period|Lost to Follow-up|14
1733061|NCT00988091|6045442|P1|Double-blind Period|Lost to Follow-up|12
1733062|NCT00988091|6045441|P2|Double-blind Period|Withdrawal by Subject|13
1733063|NCT00988091|6045442|P1|Double-blind Period|Withdrawal by Subject|15
1733064|NCT00988065|6045464|P3|Overall Study|Noncompliance with protocol|9
1733065|NCT00988065|6045465|P2|Overall Study|Noncompliance with protocol|6
1733066|NCT00988065|6045466|P1|Overall Study|Noncompliance with protocol|5
1733067|NCT00988065|6045464|P3|Overall Study|Subject withdrew consent|2
1733068|NCT00988065|6045465|P2|Overall Study|Subject withdrew consent|5
1733069|NCT00988065|6045466|P1|Overall Study|Subject withdrew consent|3
1733070|NCT00988065|6045464|P3|Overall Study|Lost to Follow-up|2
1733071|NCT00988065|6045465|P2|Overall Study|Lost to Follow-up|2
1733072|NCT00988065|6045466|P1|Overall Study|Lost to Follow-up|1
1733073|NCT00988065|6045464|P3|Overall Study|Adverse Event|2
1733074|NCT00988065|6045465|P2|Overall Study|Adverse Event|10
1733075|NCT00988065|6045466|P1|Overall Study|Adverse Event|4
1733076|NCT00988052|6045488|P2|Overall Study|Study terminated by sponsor|236
1733077|NCT00988052|6045489|P1|Overall Study|Study terminated by sponsor|240
1733078|NCT00988052|6045488|P2|Overall Study|Withdrawal by Subject|91
1733079|NCT00988052|6045489|P1|Overall Study|Withdrawal by Subject|90
1733080|NCT00988052|6045488|P2|Overall Study|Adverse Event|28
1733081|NCT00988052|6045489|P1|Overall Study|Adverse Event|35
1733082|NCT00988052|6045488|P2|Overall Study|Physician Decision|28
1733083|NCT00988052|6045489|P1|Overall Study|Physician Decision|27
1733084|NCT00988052|6045488|P2|Overall Study|Lost to Follow-up|11
1733085|NCT00988052|6045489|P1|Overall Study|Lost to Follow-up|6
1733086|NCT00988052|6045488|P2|Overall Study|Lack of Efficacy|7
1733087|NCT00988052|6045489|P1|Overall Study|Lack of Efficacy|8
1733088|NCT00988052|6045488|P2|Overall Study|Pregnancy|6
1733089|NCT00988052|6045489|P1|Overall Study|Pregnancy|6
1733090|NCT00988052|6045488|P2|Overall Study|Protocol Violation|5
1733091|NCT00988052|6045489|P1|Overall Study|Protocol Violation|6
1733092|NCT00988052|6045488|P2|Overall Study|Death|3
1733093|NCT00988052|6045489|P1|Overall Study|Death|1
1733094|NCT00988052|6045488|P2|Overall Study|Teva requested subject withdrawal|1
1733095|NCT00988052|6045489|P1|Overall Study|Teva requested subject withdrawal|3
1733096|NCT00988052|6045488|P2|Overall Study|Missing|0
1733097|NCT00988052|6045489|P1|Overall Study|Missing|1
1733098|NCT00987935|6045533|P9|Overall Study|Reason other than those specified above|1
1733099|NCT00987935|6045534|P8|Overall Study|Reason other than those specified above|0
1733100|NCT00987935|6045535|P7|Overall Study|Reason other than those specified above|0
1733101|NCT00987935|6045536|P6|Overall Study|Reason other than those specified above|0
1733102|NCT00987935|6045537|P5|Overall Study|Reason other than those specified above|0
1733103|NCT00987935|6045538|P4|Overall Study|Reason other than those specified above|0
1733104|NCT00987935|6045539|P3|Overall Study|Reason other than those specified above|0
1733105|NCT00987935|6045540|P2|Overall Study|Reason other than those specified above|0
1733106|NCT00987935|6045541|P1|Overall Study|Reason other than those specified above|0
1733107|NCT00987935|6045533|P9|Overall Study|Refused to continue taking trial med.|2
1733108|NCT00987935|6045534|P8|Overall Study|Refused to continue taking trial med.|4
1733109|NCT00987935|6045535|P7|Overall Study|Refused to continue taking trial med.|4
1733110|NCT00987935|6045536|P6|Overall Study|Refused to continue taking trial med.|0
1733111|NCT00987935|6045537|P5|Overall Study|Refused to continue taking trial med.|1
1733112|NCT00987935|6045538|P4|Overall Study|Refused to continue taking trial med.|0
1733113|NCT00987935|6045539|P3|Overall Study|Refused to continue taking trial med.|0
1733114|NCT00987935|6045540|P2|Overall Study|Refused to continue taking trial med.|0
1733115|NCT00987935|6045541|P1|Overall Study|Refused to continue taking trial med.|1
1733116|NCT00987935|6045533|P9|Overall Study|Adverse Event|6
1733117|NCT00987935|6045534|P8|Overall Study|Adverse Event|10
1733118|NCT00987935|6045535|P7|Overall Study|Adverse Event|2
1733119|NCT00987935|6045536|P6|Overall Study|Adverse Event|0
1733120|NCT00987935|6045537|P5|Overall Study|Adverse Event|1
1733121|NCT00987935|6045538|P4|Overall Study|Adverse Event|1
1733122|NCT00987935|6045539|P3|Overall Study|Adverse Event|0
1733123|NCT00987935|6045540|P2|Overall Study|Adverse Event|1
1733124|NCT00987935|6045541|P1|Overall Study|Adverse Event|0
1733125|NCT00987935|6045533|P9|Overall Study|Progressive disease|23
1733126|NCT00987935|6045534|P8|Overall Study|Progressive disease|48
1733127|NCT00987935|6045535|P7|Overall Study|Progressive disease|9
1733128|NCT00987935|6045536|P6|Overall Study|Progressive disease|3
1733129|NCT00987935|6045537|P5|Overall Study|Progressive disease|5
1733130|NCT00987935|6045538|P4|Overall Study|Progressive disease|2
1733131|NCT00987935|6045539|P3|Overall Study|Progressive disease|3
1733132|NCT00987935|6045540|P2|Overall Study|Progressive disease|2
1733133|NCT00987935|6045541|P1|Overall Study|Progressive disease|3
1733134|NCT00987831|6045597|P3|Overall Study|Lost to Follow-up|0
1733135|NCT00987831|6045598|P2|Overall Study|Lost to Follow-up|3
1733136|NCT00987831|6045599|P1|Overall Study|Lost to Follow-up|0
1733137|NCT00987831|6045597|P3|Overall Study|Never flared in 12 months|0
1733138|NCT00987831|6045598|P2|Overall Study|Never flared in 12 months|0
1733139|NCT00987831|6045599|P1|Overall Study|Never flared in 12 months|1
1733140|NCT00987623|6045621|P2|Overall Study|Influenza|1
1733141|NCT00987623|6045622|P1|Overall Study|Influenza|0
1733142|NCT00987623|6045621|P2|Overall Study|Biomicroscopy|1
1733143|NCT00987623|6045622|P1|Overall Study|Biomicroscopy|0
1733144|NCT00987623|6045621|P2|Overall Study|Discomfort|0
1733145|NCT00987623|6045622|P1|Overall Study|Discomfort|1
1733146|NCT00987623|6045621|P2|Overall Study|Time/job conflict|0
1733147|NCT00987623|6045622|P1|Overall Study|Time/job conflict|2
1733148|NCT00987623|6045621|P2|Overall Study|Lost to Follow-up|1
1733149|NCT00987623|6045622|P1|Overall Study|Lost to Follow-up|2
1733150|NCT00987467|6045651|P1|Overall Study|Lost to Follow-up|2
1733151|NCT00987402|6045675|P2|Overall Study|Insufficient data entry|98
1733152|NCT00987402|6045676|P1|Overall Study|Insufficient data entry|86
1733153|NCT00987337|6045685|P3|Overall Study|Participant Relapsed|5
1733154|NCT00987337|6045686|P2|Overall Study|Participant Relapsed|20
1733155|NCT00987337|6045687|P1|Overall Study|Participant Relapsed|18
1733156|NCT00987337|6045685|P3|Overall Study|Protocol Violation|2
1733157|NCT00987337|6045686|P2|Overall Study|Protocol Violation|0
1733158|NCT00987337|6045687|P1|Overall Study|Protocol Violation|1
1733159|NCT00987337|6045685|P3|Overall Study|Other|5
1733160|NCT00987337|6045686|P2|Overall Study|Other|2
1733161|NCT00987337|6045687|P1|Overall Study|Other|0
1733162|NCT00987337|6045685|P3|Overall Study|Withdrawal by Subject|9
1733163|NCT00987337|6045686|P2|Overall Study|Withdrawal by Subject|9
1733164|NCT00987337|6045687|P1|Overall Study|Withdrawal by Subject|6
1733165|NCT00987337|6045685|P3|Overall Study|Lost to Follow-up|2
1733166|NCT00987337|6045686|P2|Overall Study|Lost to Follow-up|6
1733167|NCT00987337|6045687|P1|Overall Study|Lost to Follow-up|10
1733168|NCT00987337|6045685|P3|Overall Study|Virologic Breakthrough|8
1733169|NCT00987337|6045686|P2|Overall Study|Virologic Breakthrough|2
1733170|NCT00987337|6045687|P1|Overall Study|Virologic Breakthrough|2
1733171|NCT00987337|6045685|P3|Overall Study|Insufficient Virologic Response|12
1733172|NCT00987337|6045686|P2|Overall Study|Insufficient Virologic Response|7
1733173|NCT00987337|6045687|P1|Overall Study|Insufficient Virologic Response|10
1733174|NCT00987337|6045685|P3|Overall Study|Adverse Event|8
1733175|NCT00987337|6045686|P2|Overall Study|Adverse Event|9
1733176|NCT00987337|6045687|P1|Overall Study|Adverse Event|10
1733177|NCT00986986|6045742|P2|Overall Study|Lost to Follow-up|1
1733178|NCT00986986|6045743|P1|Overall Study|Lost to Follow-up|0
1733179|NCT00986973|6045753|P1|Overall Study|Withdrawn by study team|1
1733180|NCT00986921|6045779|P2|Overall Study|Physician Decision|0
1733181|NCT00986921|6045780|P1|Overall Study|Physician Decision|1
1733182|NCT00986674|6045816|P3|Overall Study|unknown/not specify|9
1733183|NCT00986674|6045817|P2|Overall Study|unknown/not specify|7
1733184|NCT00986674|6045818|P1|Overall Study|unknown/not specify|0
1733185|NCT00986674|6045816|P3|Overall Study|not start protocol therapy|1
1733186|NCT00986674|6045817|P2|Overall Study|not start protocol therapy|3
1733187|NCT00986674|6045818|P1|Overall Study|not start protocol therapy|4
1733188|NCT00986674|6045816|P3|Overall Study|alternative therapy|1
1733189|NCT00986674|6045817|P2|Overall Study|alternative therapy|0
1733190|NCT00986674|6045818|P1|Overall Study|alternative therapy|0
1733191|NCT00986674|6045816|P3|Overall Study|Withdrawal by Subject|1
1733192|NCT00986674|6045817|P2|Overall Study|Withdrawal by Subject|2
1733193|NCT00986674|6045818|P1|Overall Study|Withdrawal by Subject|6
1733194|NCT00986674|6045816|P3|Overall Study|Death|4
1733195|NCT00986674|6045817|P2|Overall Study|Death|0
1733196|NCT00986674|6045818|P1|Overall Study|Death|5
1733197|NCT00986674|6045816|P3|Overall Study|Adverse Event|9
1733198|NCT00986674|6045817|P2|Overall Study|Adverse Event|8
1733199|NCT00986674|6045818|P1|Overall Study|Adverse Event|4
1733200|NCT00986674|6045816|P3|Overall Study|Lack of Efficacy|23
1733201|NCT00986674|6045817|P2|Overall Study|Lack of Efficacy|25
1733202|NCT00986674|6045818|P1|Overall Study|Lack of Efficacy|28
1733203|NCT00986570|6045851|P1|Overall Study|Potential bias for objective assessment|1
1733204|NCT00986570|6045851|P1|Overall Study|Lost to Follow-up|6
1733205|NCT00986479|6045868|P2|Period 1|Administrative reasons|0
1733206|NCT00986479|6045869|P1|Period 1|Administrative reasons|1
1733207|NCT00986479|6045868|P2|Period 1|Improved mood|0
1733208|NCT00986479|6045869|P1|Period 1|Improved mood|1
1733209|NCT00986427|6045915|P2|Overall Study|Withdrawal by Subject|0
1733210|NCT00986427|6045916|P1|Overall Study|Withdrawal by Subject|1
1733211|NCT00986427|6045915|P2|Overall Study|Lack of Efficacy|0
1733212|NCT00986427|6045916|P1|Overall Study|Lack of Efficacy|1
1733213|NCT00986427|6045915|P2|Overall Study|Lost to Follow-up|0
1733214|NCT00986427|6045916|P1|Overall Study|Lost to Follow-up|2
1733215|NCT00986362|6045944|P2|Overall Study|Lost to Follow-up|1
1733216|NCT00986362|6045945|P1|Overall Study|Lost to Follow-up|0
1733217|NCT00986362|6045944|P2|Overall Study|Death|0
1733218|NCT00986362|6045945|P1|Overall Study|Death|2
1733219|NCT00986349|6045951|P1|Overall Study|device migration|1
1733220|NCT00986349|6045951|P1|Overall Study|Physician Decision|1
1733221|NCT00986349|6045951|P1|Overall Study|Adverse Event|2
1733222|NCT00986349|6045951|P1|Overall Study|Unsuccessful implant procedure|3
1733223|NCT00986258|6045975|P1|Maintenance Period|Withdrawal by Subject|2
1733224|NCT00986258|6045975|P1|Maintenance Period|Lack of Efficacy|2
1733225|NCT00986258|6045975|P1|Maintenance Period|Adverse Event|5
1733226|NCT00986258|6045975|P1|Titration and Optimal Dose Period|Other|1
1733227|NCT00986258|6045975|P1|Titration and Optimal Dose Period|Non-Compliance|1
1733228|NCT00986258|6045975|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
1733229|NCT00986258|6045975|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
1733230|NCT00986258|6045975|P1|Titration and Optimal Dose Period|Adverse Event|15
1733231|NCT00986258|6045975|P1|Observation Period|Not eligible to be dosed|11
1733232|NCT00986245|6046003|P2|Second Intervention|Protocol Violation|1
1733233|NCT00986245|6046004|P1|Second Intervention|Protocol Violation|0
1733234|NCT00986245|6046003|P2|Second Intervention|Lost to Follow-up|0
1733235|NCT00986245|6046004|P1|Second Intervention|Lost to Follow-up|1
1733236|NCT00986245|6046003|P2|Second Intervention|Poor compliance|0
1733237|NCT00986245|6046004|P1|Second Intervention|Poor compliance|1
1733238|NCT00986245|6046003|P2|First Intervention|Out of indication|0
1733239|NCT00986245|6046004|P1|First Intervention|Out of indication|1
1733240|NCT00986245|6046003|P2|First Intervention|Protocol Violation|1
1733241|NCT00986245|6046004|P1|First Intervention|Protocol Violation|0
1733242|NCT00986245|6046003|P2|First Intervention|Withdrawal by Subject|1
1733243|NCT00986245|6046004|P1|First Intervention|Withdrawal by Subject|0
1733244|NCT00986245|6046003|P2|First Intervention|Lack of Efficacy|2
1733245|NCT00986245|6046004|P1|First Intervention|Lack of Efficacy|1
1733246|NCT00986245|6046003|P2|First Intervention|Poor compliance|4
1733247|NCT00986245|6046004|P1|First Intervention|Poor compliance|8
1733248|NCT00986232|6046041|P4|Overall Study|Incomplete safety follow-up|2
1733249|NCT00986232|6046042|P3|Overall Study|Incomplete safety follow-up|2
1733250|NCT00986232|6046043|P2|Overall Study|Incomplete safety follow-up|7
1733251|NCT00986232|6046044|P1|Overall Study|Incomplete safety follow-up|3
1733252|NCT00986232|6046041|P4|Overall Study|Missed one or more bleeds|7
1733253|NCT00986232|6046042|P3|Overall Study|Missed one or more bleeds|6
1733254|NCT00986232|6046043|P2|Overall Study|Missed one or more bleeds|10
1733255|NCT00986232|6046044|P1|Overall Study|Missed one or more bleeds|13
1733256|NCT00986232|6046041|P4|Overall Study|Withdrawal by Subject|3
1733257|NCT00986232|6046042|P3|Overall Study|Withdrawal by Subject|12
1733258|NCT00986232|6046043|P2|Overall Study|Withdrawal by Subject|16
1733259|NCT00986232|6046044|P1|Overall Study|Withdrawal by Subject|13
1733260|NCT00986232|6046041|P4|Overall Study|Protocol Violation|1
1733261|NCT00986232|6046042|P3|Overall Study|Protocol Violation|0
1733262|NCT00986232|6046043|P2|Overall Study|Protocol Violation|3
1733263|NCT00986232|6046044|P1|Overall Study|Protocol Violation|2
1733264|NCT00986232|6046041|P4|Overall Study|Lost to Follow-up|7
1733265|NCT00986232|6046042|P3|Overall Study|Lost to Follow-up|12
1733266|NCT00986232|6046043|P2|Overall Study|Lost to Follow-up|12
1733267|NCT00986232|6046044|P1|Overall Study|Lost to Follow-up|19
1733268|NCT00986232|6046041|P4|Overall Study|Adverse Event|0
1733269|NCT00986232|6046042|P3|Overall Study|Adverse Event|3
1733270|NCT00986232|6046043|P2|Overall Study|Adverse Event|2
1733271|NCT00986232|6046044|P1|Overall Study|Adverse Event|1
1733272|NCT00986180|6046118|P2|Overall Study|Miscellanies|11
1733273|NCT00986180|6046119|P1|Overall Study|Miscellanies|10
1733274|NCT00986180|6046118|P2|Overall Study|Withdrawal by Subject|9
1733275|NCT00986180|6046119|P1|Overall Study|Withdrawal by Subject|1
1733276|NCT00986180|6046118|P2|Overall Study|Protocol Violation|0
1733277|NCT00986180|6046119|P1|Overall Study|Protocol Violation|2
1733278|NCT00986180|6046118|P2|Overall Study|Physician Decision|3
1733279|NCT00986180|6046119|P1|Overall Study|Physician Decision|1
1733280|NCT00986180|6046118|P2|Overall Study|Lost to Follow-up|7
1733281|NCT00986180|6046119|P1|Overall Study|Lost to Follow-up|5
1733282|NCT00986180|6046118|P2|Overall Study|Lack of Efficacy|3
1733283|NCT00986180|6046119|P1|Overall Study|Lack of Efficacy|4
1733284|NCT00986180|6046118|P2|Overall Study|Adverse Event|23
1733285|NCT00986180|6046119|P1|Overall Study|Adverse Event|21
1733286|NCT00986154|6046197|P2|Overall Study|never received study drug|27
1733287|NCT00986154|6046198|P1|Overall Study|never received study drug|25
1733288|NCT00986154|6046197|P2|Overall Study|investigator/subject decide not continue|3
1733289|NCT00986154|6046198|P1|Overall Study|investigator/subject decide not continue|6
1733290|NCT00986154|6046197|P2|Overall Study|Withdrawal by Subject|33
1733291|NCT00986154|6046198|P1|Overall Study|Withdrawal by Subject|32
1733292|NCT00986154|6046197|P2|Overall Study|Lost to Follow-up|4
1733293|NCT00986154|6046198|P1|Overall Study|Lost to Follow-up|7
1733294|NCT00986154|6046197|P2|Overall Study|Death|127
1733295|NCT00986154|6046198|P1|Overall Study|Death|136
1733296|NCT00986102|6046212|P4|Overall Study|Withdrawal by Subject|0
1733297|NCT00986102|6046213|P3|Overall Study|Withdrawal by Subject|0
1733298|NCT00986102|6046214|P2|Overall Study|Withdrawal by Subject|1
1733299|NCT00986102|6046215|P1|Overall Study|Withdrawal by Subject|1
1733300|NCT00986102|6046212|P4|Overall Study|Lost to Follow-up|1
1733301|NCT00986102|6046213|P3|Overall Study|Lost to Follow-up|0
1733302|NCT00986102|6046214|P2|Overall Study|Lost to Follow-up|1
1733303|NCT00986102|6046215|P1|Overall Study|Lost to Follow-up|0
1733304|NCT00985985|6046265|P4|Overall Study|Other Reason|2
1733305|NCT00985985|6046266|P3|Overall Study|Other Reason|4
1733306|NCT00985985|6046267|P2|Overall Study|Other Reason|1
1733307|NCT00985985|6046268|P1|Overall Study|Other Reason|6
1733308|NCT00985985|6046265|P4|Overall Study|Withdrawal by Subject|2
1733309|NCT00985985|6046266|P3|Overall Study|Withdrawal by Subject|2
1733310|NCT00985985|6046267|P2|Overall Study|Withdrawal by Subject|2
1733311|NCT00985985|6046268|P1|Overall Study|Withdrawal by Subject|4
1733312|NCT00985985|6046265|P4|Overall Study|Lack of Efficacy|3
1733313|NCT00985985|6046266|P3|Overall Study|Lack of Efficacy|1
1733314|NCT00985985|6046267|P2|Overall Study|Lack of Efficacy|6
1733315|NCT00985985|6046268|P1|Overall Study|Lack of Efficacy|5
1733316|NCT00985985|6046265|P4|Overall Study|Protocol Violation|1
1733317|NCT00985985|6046266|P3|Overall Study|Protocol Violation|0
1733318|NCT00985985|6046267|P2|Overall Study|Protocol Violation|2
1733319|NCT00985985|6046268|P1|Overall Study|Protocol Violation|1
1733320|NCT00985985|6046265|P4|Overall Study|Lost to Follow-up|3
1733321|NCT00985985|6046266|P3|Overall Study|Lost to Follow-up|2
1733322|NCT00985985|6046267|P2|Overall Study|Lost to Follow-up|11
1733323|NCT00985985|6046268|P1|Overall Study|Lost to Follow-up|4
1733324|NCT00985985|6046265|P4|Overall Study|Adverse Event|2
1733325|NCT00985985|6046266|P3|Overall Study|Adverse Event|2
1733326|NCT00985985|6046267|P2|Overall Study|Adverse Event|2
1733327|NCT00985985|6046268|P1|Overall Study|Adverse Event|4
1733328|NCT00985959|6046309|P3|Overall Study|Other|11
1733329|NCT00985959|6046310|P2|Overall Study|Other|0
1733330|NCT00985959|6046311|P1|Overall Study|Other|0
1733331|NCT00985959|6046309|P3|Overall Study|Complete response observed over 2 cycles|4
1733332|NCT00985959|6046310|P2|Overall Study|Complete response observed over 2 cycles|1
1733333|NCT00985959|6046311|P1|Overall Study|Complete response observed over 2 cycles|0
1733334|NCT00985959|6046309|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
1733335|NCT00985959|6046310|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
1733336|NCT00985959|6046311|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
1733337|NCT00985959|6046309|P3|Overall Study|Unrecovered toxicity|7
1733338|NCT00985959|6046310|P2|Overall Study|Unrecovered toxicity|0
1733339|NCT00985959|6046311|P1|Overall Study|Unrecovered toxicity|0
1733340|NCT00985959|6046309|P3|Overall Study|Progressive disease|8
1733341|NCT00985959|6046310|P2|Overall Study|Progressive disease|2
1733342|NCT00985959|6046311|P1|Overall Study|Progressive disease|1
1733343|NCT00985959|6046309|P3|Overall Study|Withdrawal by Subject|8
1733344|NCT00985959|6046310|P2|Overall Study|Withdrawal by Subject|0
1733345|NCT00985959|6046311|P1|Overall Study|Withdrawal by Subject|0
1733346|NCT00985959|6046309|P3|Overall Study|Adverse Event|19
1733347|NCT00985959|6046310|P2|Overall Study|Adverse Event|0
1733348|NCT00985959|6046311|P1|Overall Study|Adverse Event|0
1733349|NCT00985946|6046334|P1|Overall Study|Withdrawal by Subject|1
1733350|NCT00985946|6046334|P1|Overall Study|Lost to Follow-up|6
1733351|NCT00985790|6046353|P2|Overall Study|Lost to Follow-up|7
1733352|NCT00985790|6046354|P1|Overall Study|Lost to Follow-up|6
1733353|NCT00985790|6046353|P2|Overall Study|Withdrawal by Subject|1
1733354|NCT00985790|6046354|P1|Overall Study|Withdrawal by Subject|1
1733355|NCT00985751|6046395|P5|Overall Study|Adverse Event|1
1733356|NCT00985751|6046396|P4|Overall Study|Adverse Event|0
1733357|NCT00985751|6046397|P3|Overall Study|Adverse Event|0
1733358|NCT00985751|6046398|P2|Overall Study|Adverse Event|0
1733359|NCT00985751|6046399|P1|Overall Study|Adverse Event|0
1733360|NCT00985738|6046462|P2|Overall Study|Study closed prematurely|8
1733361|NCT00985738|6046463|P1|Overall Study|Study closed prematurely|8
1733362|NCT00985725|6046471|P2|Overall Study|Out-of-window visits|1
1733363|NCT00985725|6046472|P1|Overall Study|Out-of-window visits|0
1733364|NCT00985725|6046471|P2|Overall Study|Non-compliance|2
1733365|NCT00985725|6046472|P1|Overall Study|Non-compliance|1
1733366|NCT00985725|6046471|P2|Overall Study|Lack of Efficacy|1
1733367|NCT00985725|6046472|P1|Overall Study|Lack of Efficacy|0
1733368|NCT00985725|6046471|P2|Overall Study|Lost to Follow-up|1
1733369|NCT00985725|6046472|P1|Overall Study|Lost to Follow-up|1
1733370|NCT00985725|6046471|P2|Overall Study|Withdrawal by Subject|4
1733371|NCT00985725|6046472|P1|Overall Study|Withdrawal by Subject|4
1733372|NCT00985725|6046471|P2|Overall Study|Protocol Violation|3
1733373|NCT00985725|6046472|P1|Overall Study|Protocol Violation|1
1733374|NCT00985725|6046471|P2|Overall Study|Adverse Event|1
1733375|NCT00985725|6046472|P1|Overall Study|Adverse Event|4
1733376|NCT00985712|6046508|P2|Overall Study|Sponsor decision|2
1733377|NCT00985712|6046509|P1|Overall Study|Sponsor decision|0
1733378|NCT00985712|6046508|P2|Overall Study|Withdrawal by Subject|1
1733379|NCT00985712|6046509|P1|Overall Study|Withdrawal by Subject|4
1733380|NCT00985712|6046508|P2|Overall Study|Protocol Violation|1
1733381|NCT00985712|6046509|P1|Overall Study|Protocol Violation|0
1733382|NCT00985712|6046508|P2|Overall Study|Lost to Follow-up|2
1733383|NCT00985712|6046509|P1|Overall Study|Lost to Follow-up|2
1733384|NCT00985712|6046508|P2|Overall Study|Adverse Event|1
1733385|NCT00985712|6046509|P1|Overall Study|Adverse Event|0
1733386|NCT00985686|6046527|P4|Overall Study|Lost to Follow-up|2
1733387|NCT00985686|6046528|P3|Overall Study|Lost to Follow-up|0
1733388|NCT00985686|6046529|P2|Overall Study|Lost to Follow-up|1
1733389|NCT00985686|6046530|P1|Overall Study|Lost to Follow-up|1
1733390|NCT00985673|6046544|P6|Overall Study|Other|0
1733391|NCT00985673|6046545|P5|Overall Study|Other|1
1733392|NCT00985673|6046546|P4|Overall Study|Other|0
1733393|NCT00985673|6046547|P3|Overall Study|Other|1
1733394|NCT00985673|6046548|P2|Overall Study|Other|0
1733395|NCT00985673|6046549|P1|Overall Study|Other|1
1733396|NCT00985673|6046544|P6|Overall Study|Withdrawal by Subject|3
1733397|NCT00985673|6046545|P5|Overall Study|Withdrawal by Subject|2
1733398|NCT00985673|6046546|P4|Overall Study|Withdrawal by Subject|2
1733399|NCT00985673|6046547|P3|Overall Study|Withdrawal by Subject|5
1733400|NCT00985673|6046548|P2|Overall Study|Withdrawal by Subject|4
1733401|NCT00985673|6046549|P1|Overall Study|Withdrawal by Subject|0
1733402|NCT00985673|6046544|P6|Overall Study|Lost to Follow-up|3
1733403|NCT00985673|6046545|P5|Overall Study|Lost to Follow-up|5
1733404|NCT00985673|6046546|P4|Overall Study|Lost to Follow-up|10
1733405|NCT00985673|6046547|P3|Overall Study|Lost to Follow-up|6
1733406|NCT00985673|6046548|P2|Overall Study|Lost to Follow-up|7
1733407|NCT00985673|6046549|P1|Overall Study|Lost to Follow-up|6
1733408|NCT00985504|6046811|P2|Optimization Period|Withdrawal by Subject|8
1733409|NCT00985504|6046812|P1|Optimization Period|Withdrawal by Subject|10
1733410|NCT00985504|6046811|P2|Optimization Period|Protocol Violation|1
1733411|NCT00985504|6046812|P1|Optimization Period|Protocol Violation|3
1733412|NCT00985504|6046811|P2|Optimization Period|Physician Decision|0
1733413|NCT00985504|6046812|P1|Optimization Period|Physician Decision|1
1733414|NCT00985504|6046811|P2|Optimization Period|Lost to Follow-up|1
1733415|NCT00985504|6046812|P1|Optimization Period|Lost to Follow-up|0
1733416|NCT00985504|6046811|P2|Optimization Period|Lack of Efficacy|3
1733417|NCT00985504|6046812|P1|Optimization Period|Lack of Efficacy|5
1733418|NCT00985504|6046811|P2|Optimization Period|Death|1
1733419|NCT00985504|6046812|P1|Optimization Period|Death|0
1733420|NCT00985504|6046811|P2|Optimization Period|Adverse Event|9
1733421|NCT00985504|6046812|P1|Optimization Period|Adverse Event|7
1733422|NCT00985504|6046811|P2|Acute Treatment Period|Withdrawal by Subject|5
1733423|NCT00985504|6046812|P1|Acute Treatment Period|Withdrawal by Subject|9
1733424|NCT00985504|6046811|P2|Acute Treatment Period|Sponsor Decision|1
1733425|NCT00985504|6046812|P1|Acute Treatment Period|Sponsor Decision|0
1733426|NCT00985504|6046811|P2|Acute Treatment Period|Protocol Violation|0
1733427|NCT00985504|6046812|P1|Acute Treatment Period|Protocol Violation|2
1733428|NCT00985504|6046811|P2|Acute Treatment Period|Entry Criteria Not Met|2
1733429|NCT00985504|6046812|P1|Acute Treatment Period|Entry Criteria Not Met|1
1733430|NCT00985504|6046811|P2|Acute Treatment Period|Adverse Event|4
1733431|NCT00985504|6046812|P1|Acute Treatment Period|Adverse Event|3
1733432|NCT00985491|6046838|P1|Overall Study|implant failure|3
1733433|NCT00985491|6046838|P1|Overall Study|Withdrawal by Subject|1
1733434|NCT00985491|6046838|P1|Overall Study|device migration|7
1733435|NCT00985491|6046838|P1|Overall Study|Adverse Event|8
1733436|NCT00985465|6046845|P2|Overall Study|Considered to be part of the other group|1
1733437|NCT00985465|6046846|P1|Overall Study|Considered to be part of the other group|0
1733438|NCT00985465|6046845|P2|Overall Study|Withdrawal by Subject|2
1733439|NCT00985465|6046846|P1|Overall Study|Withdrawal by Subject|1
1733440|NCT00985439|6046873|P4|Overall Study|Adverse Event|0
1733441|NCT00985439|6046874|P3|Overall Study|Adverse Event|1
1733442|NCT00985439|6046875|P2|Overall Study|Adverse Event|0
1733443|NCT00985439|6046876|P1|Overall Study|Adverse Event|0
1733444|NCT00985231|6046892|P2|Overall Study|Study related symptoms & complaints|2
1733445|NCT00985231|6046893|P1|Overall Study|Study related symptoms & complaints|0
1733446|NCT00985231|6046892|P2|Overall Study|Lost to Follow-up|1
1733447|NCT00985231|6046893|P1|Overall Study|Lost to Follow-up|0
1733448|NCT00985231|6046892|P2|Overall Study|Withdrawal by Subject|0
1733449|NCT00985231|6046893|P1|Overall Study|Withdrawal by Subject|1
1733450|NCT00985231|6046892|P2|Overall Study|Protocol Violation|0
1733451|NCT00985231|6046893|P1|Overall Study|Protocol Violation|1
1733452|NCT00985231|6046892|P2|Overall Study|ineligible|0
1733453|NCT00985231|6046893|P1|Overall Study|ineligible|1
1733454|NCT00985192|6046901|P1|Overall Study|Determined to be Ineligible During Trial|2
1733455|NCT00985192|6046901|P1|Overall Study|Disease Progression|1
1733456|NCT00985192|6046901|P1|Overall Study|Withdrawal by Subject|1
1733457|NCT00985166|6046913|P3|Overall Study|Other|1
1733458|NCT00985166|6046914|P2|Overall Study|Other|0
1733459|NCT00985166|6046915|P1|Overall Study|Other|1
1733460|NCT00985166|6046913|P3|Overall Study|Test not done|4
1733461|NCT00985166|6046914|P2|Overall Study|Test not done|0
1733462|NCT00985166|6046915|P1|Overall Study|Test not done|2
1733463|NCT00985166|6046913|P3|Overall Study|Withdrawal by Subject|0
1733464|NCT00985166|6046914|P2|Overall Study|Withdrawal by Subject|2
1733465|NCT00985166|6046915|P1|Overall Study|Withdrawal by Subject|3
1733466|NCT00985166|6046913|P3|Overall Study|Lost to Follow-up|2
1733467|NCT00985166|6046914|P2|Overall Study|Lost to Follow-up|2
1733468|NCT00985166|6046915|P1|Overall Study|Lost to Follow-up|3
1733469|NCT00985153|6046935|P4|Overall Study|Incomplete Safety Follow-up|4
1733470|NCT00985153|6046936|P3|Overall Study|Incomplete Safety Follow-up|4
1733471|NCT00985153|6046937|P2|Overall Study|Incomplete Safety Follow-up|5
1733472|NCT00985153|6046938|P1|Overall Study|Incomplete Safety Follow-up|3
1733473|NCT00985153|6046935|P4|Overall Study|Missed One or More Bleeds|10
1733474|NCT00985153|6046936|P3|Overall Study|Missed One or More Bleeds|8
1733475|NCT00985153|6046937|P2|Overall Study|Missed One or More Bleeds|7
1733476|NCT00985153|6046938|P1|Overall Study|Missed One or More Bleeds|7
1733477|NCT00985153|6046935|P4|Overall Study|Withdrawal by Subject|10
1733478|NCT00985153|6046936|P3|Overall Study|Withdrawal by Subject|11
1733479|NCT00985153|6046937|P2|Overall Study|Withdrawal by Subject|11
1733480|NCT00985153|6046938|P1|Overall Study|Withdrawal by Subject|6
1733481|NCT00985153|6046935|P4|Overall Study|Protocol Violation|3
1733482|NCT00985153|6046936|P3|Overall Study|Protocol Violation|4
1733483|NCT00985153|6046937|P2|Overall Study|Protocol Violation|2
1733484|NCT00985153|6046938|P1|Overall Study|Protocol Violation|3
1733485|NCT00985153|6046935|P4|Overall Study|Lost to Follow-up|20
1733486|NCT00985153|6046936|P3|Overall Study|Lost to Follow-up|17
1733487|NCT00985153|6046937|P2|Overall Study|Lost to Follow-up|19
1733488|NCT00985153|6046938|P1|Overall Study|Lost to Follow-up|16
1733489|NCT00985114|6046986|P2|Overall Study|Withdrawal by Subject|2
1733490|NCT00985114|6046987|P1|Overall Study|Withdrawal by Subject|0
1733491|NCT00985114|6046986|P2|Overall Study|Adverse Event|0
1733492|NCT00985114|6046987|P1|Overall Study|Adverse Event|1
1733493|NCT00985088|6047001|P8|Overall Study|Lost to Follow-up|2
1733494|NCT00985088|6047002|P7|Overall Study|Lost to Follow-up|3
1733495|NCT00985088|6047003|P6|Overall Study|Lost to Follow-up|5
1733496|NCT00985088|6047004|P5|Overall Study|Lost to Follow-up|6
1733497|NCT00985088|6047005|P4|Overall Study|Lost to Follow-up|6
1733498|NCT00985088|6047006|P3|Overall Study|Lost to Follow-up|2
1733499|NCT00985088|6047007|P2|Overall Study|Lost to Follow-up|1
1733500|NCT00985088|6047008|P1|Overall Study|Lost to Follow-up|6
1733501|NCT00985088|6047001|P8|Overall Study|Migrated/moved from study area|1
1733502|NCT00985088|6047002|P7|Overall Study|Migrated/moved from study area|0
1733503|NCT00985088|6047003|P6|Overall Study|Migrated/moved from study area|0
1733504|NCT00985088|6047004|P5|Overall Study|Migrated/moved from study area|0
1733505|NCT00985088|6047005|P4|Overall Study|Migrated/moved from study area|0
1733506|NCT00985088|6047006|P3|Overall Study|Migrated/moved from study area|1
1733507|NCT00985088|6047007|P2|Overall Study|Migrated/moved from study area|0
1733508|NCT00985088|6047008|P1|Overall Study|Migrated/moved from study area|0
1733509|NCT00985088|6047001|P8|Overall Study|Withdrawal by Subject|2
1733510|NCT00985088|6047002|P7|Overall Study|Withdrawal by Subject|1
1733511|NCT00985088|6047003|P6|Overall Study|Withdrawal by Subject|2
1733512|NCT00985088|6047004|P5|Overall Study|Withdrawal by Subject|3
1733513|NCT00985088|6047005|P4|Overall Study|Withdrawal by Subject|1
1733514|NCT00985088|6047006|P3|Overall Study|Withdrawal by Subject|0
1733515|NCT00985088|6047007|P2|Overall Study|Withdrawal by Subject|0
1733516|NCT00985088|6047008|P1|Overall Study|Withdrawal by Subject|4
1733517|NCT00985088|6047001|P8|Overall Study|Adverse Event|0
1733518|NCT00985088|6047002|P7|Overall Study|Adverse Event|0
1733519|NCT00985088|6047003|P6|Overall Study|Adverse Event|0
1733520|NCT00985088|6047004|P5|Overall Study|Adverse Event|0
1733521|NCT00985088|6047005|P4|Overall Study|Adverse Event|0
1733522|NCT00985088|6047006|P3|Overall Study|Adverse Event|1
1733523|NCT00985088|6047007|P2|Overall Study|Adverse Event|0
1733524|NCT00985088|6047008|P1|Overall Study|Adverse Event|0
1733525|NCT00985088|6047001|P8|Overall Study|Serious Adverse Event|1
1733526|NCT00985088|6047002|P7|Overall Study|Serious Adverse Event|0
1733527|NCT00985088|6047003|P6|Overall Study|Serious Adverse Event|0
1733528|NCT00985088|6047004|P5|Overall Study|Serious Adverse Event|0
1733529|NCT00985088|6047005|P4|Overall Study|Serious Adverse Event|0
1733530|NCT00985088|6047006|P3|Overall Study|Serious Adverse Event|0
1733531|NCT00985088|6047007|P2|Overall Study|Serious Adverse Event|1
1733532|NCT00985088|6047008|P1|Overall Study|Serious Adverse Event|1
1733533|NCT00984867|6047277|P2|Overall Study|lack of efficacy and subject compliance|0
1733534|NCT00984867|6047278|P1|Overall Study|lack of efficacy and subject compliance|1
1733535|NCT00984867|6047277|P2|Overall Study|site closing|0
1733536|NCT00984867|6047278|P1|Overall Study|site closing|1
1733537|NCT00984867|6047277|P2|Overall Study|Subject no longer meets study criteria|1
1733538|NCT00984867|6047278|P1|Overall Study|Subject no longer meets study criteria|1
1733539|NCT00984867|6047277|P2|Overall Study|Poor/non-compliance|1
1733540|NCT00984867|6047278|P1|Overall Study|Poor/non-compliance|0
1733541|NCT00984867|6047277|P2|Overall Study|Lost to Follow-up|4
1733542|NCT00984867|6047278|P1|Overall Study|Lost to Follow-up|3
1733543|NCT00984867|6047277|P2|Overall Study|Withdrawal by Subject|4
1733544|NCT00984867|6047278|P1|Overall Study|Withdrawal by Subject|13
1733545|NCT00984867|6047277|P2|Overall Study|Death|0
1733546|NCT00984867|6047278|P1|Overall Study|Death|1
1733547|NCT00984867|6047277|P2|Overall Study|Adverse Event|7
1733548|NCT00984867|6047278|P1|Overall Study|Adverse Event|3
1733549|NCT00984659|6047318|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
1733550|NCT00984659|6047319|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
1733551|NCT00984659|6047320|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
1733552|NCT00984659|6047321|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
1733553|NCT00984659|6047318|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1733554|NCT00984659|6047319|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
1733555|NCT00984659|6047320|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1733556|NCT00984659|6047321|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
1733557|NCT00984659|6047318|P4|6-week Double-blind Treatment Period|Protocol Violation|4
1733558|NCT00984659|6047319|P3|6-week Double-blind Treatment Period|Protocol Violation|0
1733559|NCT00984659|6047320|P2|6-week Double-blind Treatment Period|Protocol Violation|0
1733560|NCT00984659|6047321|P1|6-week Double-blind Treatment Period|Protocol Violation|0
1733561|NCT00984659|6047318|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
1733562|NCT00984659|6047319|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
1733563|NCT00984659|6047320|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
1733564|NCT00984659|6047321|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
1733565|NCT00984659|6047318|P4|6-week Double-blind Treatment Period|Adverse Event|7
1733566|NCT00984659|6047319|P3|6-week Double-blind Treatment Period|Adverse Event|3
1733567|NCT00984659|6047320|P2|6-week Double-blind Treatment Period|Adverse Event|3
1733568|NCT00984659|6047321|P1|6-week Double-blind Treatment Period|Adverse Event|0
1733569|NCT00984659|6047318|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1733570|NCT00984659|6047319|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1733571|NCT00984659|6047320|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
1733572|NCT00984659|6047321|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
1733573|NCT00984659|6047318|P4|2-week Run-in Period|Withdrawal by Subject|0
1733574|NCT00984659|6047319|P3|2-week Run-in Period|Withdrawal by Subject|0
1733575|NCT00984659|6047320|P2|2-week Run-in Period|Withdrawal by Subject|0
1733576|NCT00984659|6047321|P1|2-week Run-in Period|Withdrawal by Subject|10
1733577|NCT00984659|6047318|P4|2-week Run-in Period|Physician Decision|0
1733578|NCT00984659|6047319|P3|2-week Run-in Period|Physician Decision|0
1733579|NCT00984659|6047320|P2|2-week Run-in Period|Physician Decision|0
1733580|NCT00984659|6047321|P1|2-week Run-in Period|Physician Decision|10
1733581|NCT00984659|6047318|P4|2-week Run-in Period|Lost to Follow-up|0
1733582|NCT00984659|6047319|P3|2-week Run-in Period|Lost to Follow-up|0
1733583|NCT00984659|6047320|P2|2-week Run-in Period|Lost to Follow-up|0
1733584|NCT00984659|6047321|P1|2-week Run-in Period|Lost to Follow-up|3
1733585|NCT00984659|6047318|P4|2-week Run-in Period|Study Closed/Terminated|0
1733586|NCT00984659|6047319|P3|2-week Run-in Period|Study Closed/Terminated|0
1733587|NCT00984659|6047320|P2|2-week Run-in Period|Study Closed/Terminated|0
1733588|NCT00984659|6047321|P1|2-week Run-in Period|Study Closed/Terminated|2
1733589|NCT00984659|6047318|P4|2-week Run-in Period|Protocol Violation|0
1733590|NCT00984659|6047319|P3|2-week Run-in Period|Protocol Violation|0
1733591|NCT00984659|6047320|P2|2-week Run-in Period|Protocol Violation|0
1733592|NCT00984659|6047321|P1|2-week Run-in Period|Protocol Violation|5
1733593|NCT00984659|6047318|P4|2-week Run-in Period|Adverse Event|0
1733594|NCT00984659|6047319|P3|2-week Run-in Period|Adverse Event|0
1733595|NCT00984659|6047320|P2|2-week Run-in Period|Adverse Event|0
1733596|NCT00984659|6047321|P1|2-week Run-in Period|Adverse Event|8
1733597|NCT00984620|6047348|P2|Overall Study|reason other than listed above|4
1733598|NCT00984620|6047349|P1|Overall Study|reason other than listed above|0
1733599|NCT00984620|6047348|P2|Overall Study|Withdrawal by Subject|2
1733600|NCT00984620|6047349|P1|Overall Study|Withdrawal by Subject|0
1733601|NCT00984620|6047348|P2|Overall Study|Lost to Follow-up|1
1733602|NCT00984620|6047349|P1|Overall Study|Lost to Follow-up|1
1733603|NCT00984620|6047348|P2|Overall Study|Adverse Event|5
1733604|NCT00984620|6047349|P1|Overall Study|Adverse Event|5
1733605|NCT00984594|6047387|P2|Overall Study|Withdrawal by Subject|1
1733606|NCT00984594|6047388|P1|Overall Study|Withdrawal by Subject|0
1733607|NCT00984594|6047387|P2|Overall Study|Lost to Follow-up|0
1733608|NCT00984594|6047388|P1|Overall Study|Lost to Follow-up|1
1733609|NCT00984568|6047404|P2|Overall Study|Unknown Reason|3
1733610|NCT00984568|6047405|P1|Overall Study|Unknown Reason|1
1733611|NCT00984568|6047404|P2|Overall Study|Opportunistic Infection|0
1733612|NCT00984568|6047405|P1|Overall Study|Opportunistic Infection|1
1733613|NCT00984568|6047404|P2|Overall Study|Lost to Follow-up|1
1733614|NCT00984568|6047405|P1|Overall Study|Lost to Follow-up|0
1733615|NCT00984568|6047404|P2|Overall Study|Did Not Meet Randomization Criteria|0
1733616|NCT00984568|6047405|P1|Overall Study|Did Not Meet Randomization Criteria|1
1733617|NCT00984568|6047404|P2|Overall Study|Adverse Event|0
1733618|NCT00984568|6047405|P1|Overall Study|Adverse Event|2
1733619|NCT00984568|6047404|P2|Overall Study|Lack of Efficacy|0
1733620|NCT00984568|6047405|P1|Overall Study|Lack of Efficacy|2
1733621|NCT00984568|6047404|P2|Overall Study|Withdrawal by Subject|2
1733622|NCT00984568|6047405|P1|Overall Study|Withdrawal by Subject|1
1733623|NCT00984542|6047413|P1|Overall Study|clinical deterioration|2
1733624|NCT00984542|6047413|P1|Overall Study|Withdrawal by Subject|3
1733625|NCT00984542|6047413|P1|Overall Study|complicating disease|3
1733626|NCT00984542|6047413|P1|Overall Study|Death|7
1733627|NCT00984542|6047413|P1|Overall Study|toxicity|7
1733628|NCT00984542|6047413|P1|Overall Study|disease progression|19
1733629|NCT00984295|6047463|P3|Overall Study|Incomplete safety follow-up|3
1733630|NCT00984295|6047464|P2|Overall Study|Incomplete safety follow-up|2
1733631|NCT00984295|6047465|P1|Overall Study|Incomplete safety follow-up|11
1733632|NCT00984295|6047463|P3|Overall Study|Missed one or more blood samplings|2
1733633|NCT00984295|6047464|P2|Overall Study|Missed one or more blood samplings|7
1733634|NCT00984295|6047465|P1|Overall Study|Missed one or more blood samplings|3
1733635|NCT00984295|6047463|P3|Overall Study|CAE – discontinued test vaccine|3
1733636|NCT00984295|6047464|P2|Overall Study|CAE – discontinued test vaccine|1
1733637|NCT00984295|6047465|P1|Overall Study|CAE – discontinued test vaccine|0
1733638|NCT00984295|6047463|P3|Overall Study|Withdrawal by Subject|12
1733639|NCT00984295|6047464|P2|Overall Study|Withdrawal by Subject|9
1733640|NCT00984295|6047465|P1|Overall Study|Withdrawal by Subject|18
1733641|NCT00984295|6047463|P3|Overall Study|Protocol Violation|4
1733642|NCT00984295|6047464|P2|Overall Study|Protocol Violation|1
1733643|NCT00984295|6047465|P1|Overall Study|Protocol Violation|2
1733644|NCT00984295|6047463|P3|Overall Study|Lost to Follow-up|13
1733645|NCT00984295|6047464|P2|Overall Study|Lost to Follow-up|12
1733646|NCT00984295|6047465|P1|Overall Study|Lost to Follow-up|31
1733647|NCT00984282|6047532|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
1733648|NCT00984282|6047533|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
1733649|NCT00984282|6047532|P2|Long Term Follow-up|Switched to commercial drug|2
1733650|NCT00984282|6047533|P1|Long Term Follow-up|Switched to commercial drug|4
1733651|NCT00984282|6047532|P2|Long Term Follow-up|Transferred to treat. continuation study|3
1733652|NCT00984282|6047533|P1|Long Term Follow-up|Transferred to treat. continuation study|2
1733653|NCT00984282|6047532|P2|Long Term Follow-up|Protocol driven decision point|26
1733654|NCT00984282|6047533|P1|Long Term Follow-up|Protocol driven decision point|25
1733655|NCT00984282|6047532|P2|Long Term Follow-up|Lost to Follow-up|6
1733656|NCT00984282|6047533|P1|Long Term Follow-up|Lost to Follow-up|3
1733657|NCT00984282|6047532|P2|Long Term Follow-up|Death|68
1733658|NCT00984282|6047533|P1|Long Term Follow-up|Death|27
1733659|NCT00984282|6047532|P2|Long Term Follow-up|Withdrawal by Subject|14
1733660|NCT00984282|6047533|P1|Long Term Follow-up|Withdrawal by Subject|8
1733661|NCT00984282|6047532|P2|Open-label Treatment|Physician Decision|0
1733662|NCT00984282|6047533|P1|Open-label Treatment|Physician Decision|1
1733663|NCT00984282|6047532|P2|Open-label Treatment|Switched to commercial drug|7
1733664|NCT00984282|6047533|P1|Open-label Treatment|Switched to commercial drug|6
1733665|NCT00984282|6047532|P2|Open-label Treatment|Transferred to treat. continuation study|3
1733666|NCT00984282|6047533|P1|Open-label Treatment|Transferred to treat. continuation study|2
1733667|NCT00984282|6047532|P2|Open-label Treatment|Protocol driven decision point|1
1733668|NCT00984282|6047533|P1|Open-label Treatment|Protocol driven decision point|1
1733669|NCT00984282|6047532|P2|Open-label Treatment|Target lesion removed|1
1733670|NCT00984282|6047533|P1|Open-label Treatment|Target lesion removed|0
1733671|NCT00984282|6047532|P2|Open-label Treatment|Non-compliant with study medication|0
1733672|NCT00984282|6047533|P1|Open-label Treatment|Non-compliant with study medication|1
1733673|NCT00984282|6047532|P2|Open-label Treatment|Patient convenience|0
1733674|NCT00984282|6047533|P1|Open-label Treatment|Patient convenience|1
1733675|NCT00984282|6047532|P2|Open-label Treatment|Lost to Follow-up|1
1733676|NCT00984282|6047533|P1|Open-label Treatment|Lost to Follow-up|1
1733677|NCT00984282|6047532|P2|Open-label Treatment|Progression, recurrence or relapse|82
1733678|NCT00984282|6047533|P1|Open-label Treatment|Progression, recurrence or relapse|40
1733679|NCT00984282|6047532|P2|Open-label Treatment|Death|15
1733680|NCT00984282|6047533|P1|Open-label Treatment|Death|7
1733681|NCT00984282|6047532|P2|Open-label Treatment|Withdrawal by Subject|21
1733682|NCT00984282|6047533|P1|Open-label Treatment|Withdrawal by Subject|6
1733683|NCT00984282|6047532|P2|Open-label Treatment|Adverse Event|30
1733684|NCT00984282|6047533|P1|Open-label Treatment|Adverse Event|20
1733685|NCT00984282|6047532|P2|Double Blind Treatment|Transferred to treat. continuation study|1
1733686|NCT00984282|6047533|P1|Double Blind Treatment|Transferred to treat. continuation study|2
1733687|NCT00984282|6047532|P2|Double Blind Treatment|Radiological and clinical progression|1
1733688|NCT00984282|6047533|P1|Double Blind Treatment|Radiological and clinical progression|0
1733689|NCT00984282|6047532|P2|Double Blind Treatment|protocol driven decision point|1
1733690|NCT00984282|6047533|P1|Double Blind Treatment|protocol driven decision point|1
1733691|NCT00984282|6047532|P2|Double Blind Treatment|Switched to commercial drug|1
1733692|NCT00984282|6047533|P1|Double Blind Treatment|Switched to commercial drug|6
1733693|NCT00984282|6047532|P2|Double Blind Treatment|Not treated|1
1733694|NCT00984282|6047533|P1|Double Blind Treatment|Not treated|0
1733695|NCT00984282|6047532|P2|Double Blind Treatment|Death|4
1733696|NCT00984282|6047533|P1|Double Blind Treatment|Death|8
1733697|NCT00984282|6047532|P2|Double Blind Treatment|Lost to Follow-up|0
1733698|NCT00984282|6047533|P1|Double Blind Treatment|Lost to Follow-up|3
1733699|NCT00984282|6047532|P2|Double Blind Treatment|Withdrawal by Subject|18
1733700|NCT00984282|6047533|P1|Double Blind Treatment|Withdrawal by Subject|13
1733701|NCT00984282|6047532|P2|Double Blind Treatment|Progression by clinical judgment|0
1733702|NCT00984282|6047533|P1|Double Blind Treatment|Progression by clinical judgment|2
1733703|NCT00984282|6047532|P2|Double Blind Treatment|Noncompliance with study medication|0
1733704|NCT00984282|6047533|P1|Double Blind Treatment|Noncompliance with study medication|3
1733705|NCT00984282|6047532|P2|Double Blind Treatment|Physician Decision|2
1733706|NCT00984282|6047533|P1|Double Blind Treatment|Physician Decision|1
1733707|NCT00984282|6047532|P2|Double Blind Treatment|Progression, recurrence or relapse|3
1733708|NCT00984282|6047533|P1|Double Blind Treatment|Progression, recurrence or relapse|25
1733709|NCT00984282|6047532|P2|Double Blind Treatment|Adverse Event|6
1733710|NCT00984282|6047533|P1|Double Blind Treatment|Adverse Event|40
1733711|NCT00984256|6047556|P2|Overall Study|Withdrawal by Subject|1
1733712|NCT00984256|6047557|P1|Overall Study|Withdrawal by Subject|0
1733713|NCT00984204|6047577|P1|Overall Study|Lack of Efficacy|10
1733714|NCT00984204|6047577|P1|Overall Study|Lost to Follow-up|4
1733715|NCT00984204|6047577|P1|Overall Study|Death|1
1733716|NCT00984165|6047587|P4|Overall Study|removed with a pair recipient|1
1733717|NCT00984165|6047588|P3|Overall Study|removed with a pair recipient|0
1733718|NCT00984165|6047589|P2|Overall Study|removed with a pair recipient|0
1733719|NCT00984165|6047590|P1|Overall Study|removed with a pair recipient|0
1733720|NCT00984165|6047587|P4|Overall Study|P+/donor pair removed from protocol|1
1733721|NCT00984165|6047588|P3|Overall Study|P+/donor pair removed from protocol|0
1733722|NCT00984165|6047589|P2|Overall Study|P+/donor pair removed from protocol|0
1733723|NCT00984165|6047590|P1|Overall Study|P+/donor pair removed from protocol|0
1733724|NCT00984165|6047587|P4|Overall Study|New protocol|1
1733725|NCT00984165|6047588|P3|Overall Study|New protocol|0
1733726|NCT00984165|6047589|P2|Overall Study|New protocol|0
1733727|NCT00984165|6047590|P1|Overall Study|New protocol|0
1733728|NCT00984165|6047587|P4|Overall Study|Death of recipient|1
1733729|NCT00984165|6047588|P3|Overall Study|Death of recipient|0
1733730|NCT00984165|6047589|P2|Overall Study|Death of recipient|0
1733731|NCT00984165|6047590|P1|Overall Study|Death of recipient|0
1733732|NCT00984165|6047587|P4|Overall Study|Disease progression on study|0
1733733|NCT00984165|6047588|P3|Overall Study|Disease progression on study|0
1733734|NCT00984165|6047589|P2|Overall Study|Disease progression on study|1
1733735|NCT00984165|6047590|P1|Overall Study|Disease progression on study|5
1733736|NCT00984165|6047587|P4|Overall Study|Death on study|0
1733737|NCT00984165|6047588|P3|Overall Study|Death on study|0
1733738|NCT00984165|6047589|P2|Overall Study|Death on study|0
1733739|NCT00984165|6047590|P1|Overall Study|Death on study|2
1733740|NCT00984126|6047619|P4|Overall Study|Withdrawal criteria|9
1733741|NCT00984126|6047620|P3|Overall Study|Withdrawal criteria|3
1733742|NCT00984126|6047621|P2|Overall Study|Withdrawal criteria|1
1733743|NCT00984126|6047622|P1|Overall Study|Withdrawal criteria|0
1733744|NCT00984126|6047619|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
1733745|NCT00984126|6047620|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
1733746|NCT00984126|6047621|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
1733747|NCT00984126|6047622|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
1733748|NCT00984126|6047619|P4|Overall Study|Adverse Event|2
1733749|NCT00984126|6047620|P3|Overall Study|Adverse Event|0
1733750|NCT00984126|6047621|P2|Overall Study|Adverse Event|0
1733751|NCT00984126|6047622|P1|Overall Study|Adverse Event|0
1733752|NCT00984126|6047619|P4|Overall Study|Protocol Violation|2
1733753|NCT00984126|6047620|P3|Overall Study|Protocol Violation|1
1733754|NCT00984126|6047621|P2|Overall Study|Protocol Violation|0
1733755|NCT00984126|6047622|P1|Overall Study|Protocol Violation|0
1733756|NCT00984061|6047647|P1|Clarithromycin Alone|Protocol Violation|1
1733757|NCT00984022|6047660|P2|Overall Study|Lost to Follow-up|14
1733758|NCT00984022|6047661|P1|Overall Study|Lost to Follow-up|10
1733759|NCT00984009|6047671|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
1733760|NCT00983957|6047704|P1|Overall Study|Personal Reasons|1
1733761|NCT00983957|6047704|P1|Overall Study|Adverse Event|1
1733762|NCT00983931|6047738|P1|14 Day Washout Period|Physician Decision|1
1733763|NCT00983918|6047752|P4|Overall Study|conversion to open cholecystectomy|2
1733764|NCT00983918|6047753|P3|Overall Study|conversion to open cholecystectomy|2
1733765|NCT00983918|6047754|P2|Overall Study|conversion to open cholecystectomy|2
1733766|NCT00983918|6047755|P1|Overall Study|conversion to open cholecystectomy|0
1733767|NCT00983905|6047765|P1|Colchicine Alone|Adverse Event|2
1733768|NCT00983905|6047765|P1|Theophylline Alone|Adverse Event|1
1733769|NCT00983892|6047778|P2|Overall Study|Withdrawal by Subject|12
1733770|NCT00983892|6047779|P1|Overall Study|Withdrawal by Subject|10
1733771|NCT00983853|6047791|P6|Overall Study|Unable to come to study follow-up visits|0
1733772|NCT00983853|6047792|P5|Overall Study|Unable to come to study follow-up visits|0
1733773|NCT00983853|6047793|P4|Overall Study|Unable to come to study follow-up visits|0
1733774|NCT00983853|6047794|P3|Overall Study|Unable to come to study follow-up visits|0
1733775|NCT00983853|6047795|P2|Overall Study|Unable to come to study follow-up visits|1
1733776|NCT00983853|6047796|P1|Overall Study|Unable to come to study follow-up visits|0
1733777|NCT00983853|6047791|P6|Overall Study|Withdrawal by Subject|0
1733778|NCT00983853|6047792|P5|Overall Study|Withdrawal by Subject|1
1733779|NCT00983853|6047793|P4|Overall Study|Withdrawal by Subject|0
1733780|NCT00983853|6047794|P3|Overall Study|Withdrawal by Subject|1
1733781|NCT00983853|6047795|P2|Overall Study|Withdrawal by Subject|0
1733782|NCT00983853|6047796|P1|Overall Study|Withdrawal by Subject|0
1733783|NCT00983853|6047791|P6|Overall Study|Lost to Follow-up|1
1733784|NCT00983853|6047792|P5|Overall Study|Lost to Follow-up|2
1733785|NCT00983853|6047793|P4|Overall Study|Lost to Follow-up|2
1733786|NCT00983853|6047794|P3|Overall Study|Lost to Follow-up|2
1733787|NCT00983853|6047795|P2|Overall Study|Lost to Follow-up|1
1733788|NCT00983853|6047796|P1|Overall Study|Lost to Follow-up|1
1733789|NCT00983827|6047824|P1|Overall Study|Withdrawal by Subject|1
1733790|NCT00983749|6047842|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
1733791|NCT00983749|6047843|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
1733792|NCT00983580|6047868|P2|Overall Study|Ineligible|0
1733793|NCT00983580|6047869|P1|Overall Study|Ineligible|3
1733794|NCT00983580|6047868|P2|Overall Study|Protocol Violation|1
1733795|NCT00983580|6047869|P1|Overall Study|Protocol Violation|1
1733796|NCT00983580|6047868|P2|Overall Study|Cancel Prior to treatment|3
1733797|NCT00983580|6047869|P1|Overall Study|Cancel Prior to treatment|1
1733798|NCT00983515|6047895|P1|Colchicine With Ritonavir|Lost to Follow-up|1
1733799|NCT00983515|6047895|P1|Ritonavir Alone|liver panel out of range|6
1733800|NCT00983476|6047922|P3|Overall Study|Did not receive intervention|0
1733801|NCT00983476|6047923|P2|Overall Study|Did not receive intervention|22
1733802|NCT00983476|6047924|P1|Overall Study|Did not receive intervention|17
1733803|NCT00983437|6047956|P1|Overall Study|Other Reason|26
1733804|NCT00983437|6047956|P1|Overall Study|Lost to Follow-up|2
1733805|NCT00983437|6047956|P1|Overall Study|Noncompliance to Study Procedures|1
1733806|NCT00983437|6047956|P1|Overall Study|Withdrawal by Subject|8
1733807|NCT00983437|6047956|P1|Overall Study|Lack of Efficacy|1
1733808|NCT00983437|6047956|P1|Overall Study|Adverse Event|9
1733809|NCT00983385|6047975|P1|Observation Period|Not Evaluable due to Non Compliance|12
1733810|NCT00983385|6047975|P1|Observation Period|Not eligible to be dosed|20
1733811|NCT00983372|6048020|P1|Diltiazem ER Alone|Adverse Event|1
1733812|NCT00983372|6048020|P1|Diltiazem ER Alone|missed diltiazem dose|2
1733813|NCT00983372|6048020|P1|14 Day Washout Period|Withdrawal by Subject|1
1733814|NCT00983294|6048047|P1|Colchicine With Azithromycin|Adverse Event|1
1733815|NCT00983294|6048047|P1|14 Day Washout Period|Withdrawal by Subject|2
1733816|NCT00983073|6048089|P1|Maintenance Period|Other Reason|7
1733817|NCT00983073|6048089|P1|Maintenance Period|Lack of Efficacy|2
1733818|NCT00983073|6048089|P1|Maintenance Period|Withdrawal by Subject|2
1733819|NCT00983073|6048089|P1|Maintenance Period|Adverse Event|5
1733820|NCT00983073|6048089|P1|Titration and Optimal Dose Period|Other reason|4
1733821|NCT00983073|6048089|P1|Titration and Optimal Dose Period|Non-Compliance|1
1733822|NCT00983073|6048089|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
1733823|NCT00983073|6048089|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
1733824|NCT00983073|6048089|P1|Titration and Optimal Dose Period|Adverse Event|19
1733825|NCT00982878|6048115|P1|Overall Study|Physician Decision|1
1733826|NCT00982735|6048413|P1|Overall Study|Patient ineligible for trial|224
1733827|NCT00982735|6048413|P1|Overall Study|Lost to Follow-up|6
1733828|NCT00982657|6048423|P4|Overall Study|On going at date of cut-off|1
1733829|NCT00982657|6048424|P3|Overall Study|On going at date of cut-off|0
1733830|NCT00982657|6048425|P2|Overall Study|On going at date of cut-off|0
1733831|NCT00982657|6048426|P1|Overall Study|On going at date of cut-off|0
1733832|NCT00982657|6048423|P4|Overall Study|Other|4
1733833|NCT00982657|6048424|P3|Overall Study|Other|0
1733834|NCT00982657|6048425|P2|Overall Study|Other|0
1733835|NCT00982657|6048426|P1|Overall Study|Other|0
1733836|NCT00982657|6048423|P4|Overall Study|Withdrawal by Subject|3
1733837|NCT00982657|6048424|P3|Overall Study|Withdrawal by Subject|1
1733838|NCT00982657|6048425|P2|Overall Study|Withdrawal by Subject|0
1733839|NCT00982657|6048426|P1|Overall Study|Withdrawal by Subject|0
1733840|NCT00982657|6048423|P4|Overall Study|Death|1
1733841|NCT00982657|6048424|P3|Overall Study|Death|1
1733842|NCT00982657|6048425|P2|Overall Study|Death|0
1733843|NCT00982657|6048426|P1|Overall Study|Death|1
1733844|NCT00982644|6048467|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
1733845|NCT00982644|6048468|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
1733846|NCT00982644|6048467|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
1733847|NCT00982644|6048468|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
1733848|NCT00982644|6048467|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
1733849|NCT00982644|6048468|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
1733850|NCT00982644|6048467|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
1733851|NCT00982644|6048468|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
1733852|NCT00982644|6048467|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
1733853|NCT00982644|6048468|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
1733854|NCT00982644|6048467|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
1733855|NCT00982644|6048468|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
1733856|NCT00982644|6048467|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
1733857|NCT00982644|6048468|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
1733858|NCT00982644|6048467|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
1733859|NCT00982644|6048468|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
1733860|NCT00982644|6048467|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
1733861|NCT00982644|6048468|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
1733862|NCT00982644|6048467|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
1733863|NCT00982644|6048468|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
1733864|NCT00982488|6048523|P5|Overall Study|Withdrawal by Subject|0
1733865|NCT00982488|6048524|P4|Overall Study|Withdrawal by Subject|0
1733866|NCT00982488|6048525|P3|Overall Study|Withdrawal by Subject|1
1733867|NCT00982488|6048526|P2|Overall Study|Withdrawal by Subject|1
1733868|NCT00982488|6048527|P1|Overall Study|Withdrawal by Subject|5
1733869|NCT00982488|6048523|P5|Overall Study|Study drug toxicity|0
1733870|NCT00982488|6048524|P4|Overall Study|Study drug toxicity|0
1733871|NCT00982488|6048525|P3|Overall Study|Study drug toxicity|6
1733872|NCT00982488|6048526|P2|Overall Study|Study drug toxicity|1
1733873|NCT00982488|6048527|P1|Overall Study|Study drug toxicity|34
1733874|NCT00982488|6048523|P5|Overall Study|Stem cell transplant|0
1733875|NCT00982488|6048524|P4|Overall Study|Stem cell transplant|1
1733876|NCT00982488|6048525|P3|Overall Study|Stem cell transplant|0
1733877|NCT00982488|6048526|P2|Overall Study|Stem cell transplant|0
1733878|NCT00982488|6048527|P1|Overall Study|Stem cell transplant|2
1733879|NCT00982488|6048523|P5|Overall Study|Poor compliance/noncompliance|0
1733880|NCT00982488|6048524|P4|Overall Study|Poor compliance/noncompliance|0
1733881|NCT00982488|6048525|P3|Overall Study|Poor compliance/noncompliance|0
1733882|NCT00982488|6048526|P2|Overall Study|Poor compliance/noncompliance|1
1733883|NCT00982488|6048527|P1|Overall Study|Poor compliance/noncompliance|0
1733884|NCT00982488|6048523|P5|Overall Study|Other|0
1733885|NCT00982488|6048524|P4|Overall Study|Other|1
1733886|NCT00982488|6048525|P3|Overall Study|Other|3
1733887|NCT00982488|6048526|P2|Overall Study|Other|1
1733888|NCT00982488|6048527|P1|Overall Study|Other|15
1733889|NCT00982488|6048523|P5|Overall Study|Maximum clinical benefit|0
1733890|NCT00982488|6048524|P4|Overall Study|Maximum clinical benefit|0
1733891|NCT00982488|6048525|P3|Overall Study|Maximum clinical benefit|1
1733892|NCT00982488|6048526|P2|Overall Study|Maximum clinical benefit|1
1733893|NCT00982488|6048527|P1|Overall Study|Maximum clinical benefit|1
1733894|NCT00982488|6048523|P5|Overall Study|Lost to Follow-up|0
1733895|NCT00982488|6048524|P4|Overall Study|Lost to Follow-up|0
1733896|NCT00982488|6048525|P3|Overall Study|Lost to Follow-up|0
1733897|NCT00982488|6048526|P2|Overall Study|Lost to Follow-up|0
1733898|NCT00982488|6048527|P1|Overall Study|Lost to Follow-up|1
1733899|NCT00982488|6048523|P5|Overall Study|Disease progression|1
1733900|NCT00982488|6048524|P4|Overall Study|Disease progression|1
1733901|NCT00982488|6048525|P3|Overall Study|Disease progression|10
1733902|NCT00982488|6048526|P2|Overall Study|Disease progression|5
1733903|NCT00982488|6048527|P1|Overall Study|Disease progression|30
1733904|NCT00982488|6048523|P5|Overall Study|Death|0
1733905|NCT00982488|6048524|P4|Overall Study|Death|0
1733906|NCT00982488|6048525|P3|Overall Study|Death|2
1733907|NCT00982488|6048526|P2|Overall Study|Death|0
1733908|NCT00982488|6048527|P1|Overall Study|Death|11
1733909|NCT00982488|6048523|P5|Overall Study|Adverse event unrelated to study drug|0
1733910|NCT00982488|6048524|P4|Overall Study|Adverse event unrelated to study drug|0
1733911|NCT00982488|6048525|P3|Overall Study|Adverse event unrelated to study drug|0
1733912|NCT00982488|6048526|P2|Overall Study|Adverse event unrelated to study drug|1
1733913|NCT00982488|6048527|P1|Overall Study|Adverse event unrelated to study drug|5
1733914|NCT00982488|6048523|P5|Overall Study|Administrative reason by sponsor|0
1733915|NCT00982488|6048524|P4|Overall Study|Administrative reason by sponsor|0
1733916|NCT00982488|6048525|P3|Overall Study|Administrative reason by sponsor|11
1733917|NCT00982488|6048526|P2|Overall Study|Administrative reason by sponsor|3
1733918|NCT00982488|6048527|P1|Overall Study|Administrative reason by sponsor|81
1733919|NCT00982410|6048560|P2|12-month Follow-up Assessment|scheduled, no-show|0
1733920|NCT00982410|6048561|P1|12-month Follow-up Assessment|scheduled, no-show|1
1733921|NCT00982410|6048560|P2|12-month Follow-up Assessment|incarceration|1
1733922|NCT00982410|6048561|P1|12-month Follow-up Assessment|incarceration|2
1733923|NCT00982410|6048560|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
1733924|NCT00982410|6048561|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
1733925|NCT00982410|6048560|P2|12-month Follow-up Assessment|could not reach to schedule|5
1733926|NCT00982410|6048561|P1|12-month Follow-up Assessment|could not reach to schedule|6
1733927|NCT00982410|6048560|P2|12-month Follow-up Assessment|Death|2
1733928|NCT00982410|6048561|P1|12-month Follow-up Assessment|Death|0
1733929|NCT00982410|6048560|P2|6-month Follow-up Assessment|scheduled, no-show|1
1733930|NCT00982410|6048561|P1|6-month Follow-up Assessment|scheduled, no-show|0
1733931|NCT00982410|6048560|P2|6-month Follow-up Assessment|patent surgery|1
1733932|NCT00982410|6048561|P1|6-month Follow-up Assessment|patent surgery|0
1733933|NCT00982410|6048560|P2|6-month Follow-up Assessment|incarceration|2
1733934|NCT00982410|6048561|P1|6-month Follow-up Assessment|incarceration|0
1733935|NCT00982410|6048560|P2|6-month Follow-up Assessment|participant no transportation|0
1733936|NCT00982410|6048561|P1|6-month Follow-up Assessment|participant no transportation|1
1733937|NCT00982410|6048560|P2|6-month Follow-up Assessment|Could not reach to schedule|7
1733938|NCT00982410|6048561|P1|6-month Follow-up Assessment|Could not reach to schedule|5
1733939|NCT00982410|6048560|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
1733940|NCT00982410|6048561|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
1733941|NCT00982410|6048560|P2|3-month Follow-up Assessment|Scheduled, no-show|2
1733942|NCT00982410|6048561|P1|3-month Follow-up Assessment|Scheduled, no-show|1
1733943|NCT00982410|6048560|P2|3-month Follow-up Assessment|Could not reach to schedule|9
1733944|NCT00982410|6048561|P1|3-month Follow-up Assessment|Could not reach to schedule|8
1733945|NCT00982319|6048602|P2|Overall Study|Pregnancy|1
1733946|NCT00982319|6048603|P1|Overall Study|Pregnancy|0
1733947|NCT00982319|6048602|P2|Overall Study|Preop values out of acceptable range|1
1733948|NCT00982319|6048603|P1|Overall Study|Preop values out of acceptable range|1
1733949|NCT00982319|6048602|P2|Overall Study|Surgery date change|0
1733950|NCT00982319|6048603|P1|Overall Study|Surgery date change|1
1733951|NCT00982280|6048611|P1|Maintenance Period|Adverse Event|1
1733952|NCT00982280|6048611|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
1733953|NCT00982280|6048611|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
1733954|NCT00982280|6048611|P1|Titration and Optimal Dose Period|Adverse Event|5
1733955|NCT00982280|6048611|P1|Observation Period|Not eligible to be dosed|19
1733956|NCT00982228|6048636|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
1733957|NCT00982228|6048637|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
1733958|NCT00982228|6048636|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
1733959|NCT00982228|6048637|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
1733960|NCT00982228|6048636|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
1733961|NCT00982228|6048637|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
1733962|NCT00982228|6048636|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
1733963|NCT00982228|6048637|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
1733964|NCT00982228|6048636|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
1733965|NCT00982228|6048637|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
1733966|NCT00982228|6048636|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
1733967|NCT00982228|6048637|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
1733968|NCT00982228|6048636|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
1733969|NCT00982228|6048637|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
1733970|NCT00982228|6048636|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
1733971|NCT00982228|6048637|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
1733972|NCT00982228|6048636|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
1733973|NCT00982228|6048637|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
1733974|NCT00982228|6048636|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
1733975|NCT00982228|6048637|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
1733976|NCT00982137|6048696|P4|Overall Study|Withdrawal by Subject|0
1733977|NCT00982137|6048697|P3|Overall Study|Withdrawal by Subject|0
1733978|NCT00982137|6048698|P2|Overall Study|Withdrawal by Subject|1
1733979|NCT00982137|6048699|P1|Overall Study|Withdrawal by Subject|0
1733980|NCT00982137|6048696|P4|Overall Study|Lost to Follow-up|1
1733981|NCT00982137|6048697|P3|Overall Study|Lost to Follow-up|0
1733982|NCT00982137|6048698|P2|Overall Study|Lost to Follow-up|0
1733983|NCT00982137|6048699|P1|Overall Study|Lost to Follow-up|0
1733984|NCT00982111|6048731|P2|Overall Study|Withdrawal by Subject|17
1733985|NCT00982111|6048732|P1|Overall Study|Withdrawal by Subject|16
1733986|NCT00982111|6048731|P2|Overall Study|On Study Treatment at Conclusion|0
1733987|NCT00982111|6048732|P1|Overall Study|On Study Treatment at Conclusion|7
1733988|NCT00982111|6048731|P2|Overall Study|New Anti-Cancer Therapy|5
1733989|NCT00982111|6048732|P1|Overall Study|New Anti-Cancer Therapy|5
1733990|NCT00982111|6048731|P2|Overall Study|Lost to Follow-up|6
1733991|NCT00982111|6048732|P1|Overall Study|Lost to Follow-up|9
1733992|NCT00982111|6048731|P2|Overall Study|Progressive Disease|37
1733993|NCT00982111|6048732|P1|Overall Study|Progressive Disease|37
1733994|NCT00982111|6048731|P2|Overall Study|Adverse Event|1
1733995|NCT00982111|6048732|P1|Overall Study|Adverse Event|1
1733996|NCT00982020|6048765|P2|Overall Study|Clinical Relapse|1
1733997|NCT00982020|6048766|P1|Overall Study|Clinical Relapse|0
1733998|NCT00982020|6048765|P2|Overall Study|Protocol Violation|2
1733999|NCT00982020|6048766|P1|Overall Study|Protocol Violation|0
1734000|NCT00982020|6048765|P2|Overall Study|Entry Criteria Not Met|1
1734001|NCT00982020|6048766|P1|Overall Study|Entry Criteria Not Met|2
1734002|NCT00982020|6048765|P2|Overall Study|Physician Decision|5
1734003|NCT00982020|6048766|P1|Overall Study|Physician Decision|2
1734004|NCT00982020|6048765|P2|Overall Study|Treatment Non-compliance|6
1734005|NCT00982020|6048766|P1|Overall Study|Treatment Non-compliance|3
1734006|NCT00982020|6048765|P2|Overall Study|Parent/Caregiver Decision|5
1734007|NCT00982020|6048766|P1|Overall Study|Parent/Caregiver Decision|5
1734008|NCT00982020|6048765|P2|Overall Study|Lack of Efficacy|4
1734009|NCT00982020|6048766|P1|Overall Study|Lack of Efficacy|10
1734010|NCT00982020|6048765|P2|Overall Study|Lost to Follow-up|11
1734011|NCT00982020|6048766|P1|Overall Study|Lost to Follow-up|5
1734012|NCT00982020|6048765|P2|Overall Study|Withdrawal by Subject|14
1734013|NCT00982020|6048766|P1|Overall Study|Withdrawal by Subject|11
1734014|NCT00982020|6048765|P2|Overall Study|Adverse Event|15
1734015|NCT00982020|6048766|P1|Overall Study|Adverse Event|19
1734016|NCT00981747|6048816|P1|Placebo Oral Tablet|Withdrawal by Subject|1
1734017|NCT00981747|6048816|P1|Losartan|Death|1
1734018|NCT00981747|6048816|P1|Losartan|Withdrawal by Subject|1
1734019|NCT00981526|6048884|P2|Overall Study|Physician Decision|4
1734020|NCT00981526|6048885|P1|Overall Study|Physician Decision|4
1734021|NCT00981526|6048884|P2|Overall Study|Withdrawal by Subject|2
1734022|NCT00981526|6048885|P1|Overall Study|Withdrawal by Subject|0
1734023|NCT00981461|6048903|P2|Overall Study|Lost to Follow-up|2
1734024|NCT00981461|6048904|P1|Overall Study|Lost to Follow-up|5
1734025|NCT00981409|6048928|P2|Overall Study|Prostate Cancer Treatment before Trial|0
1734026|NCT00981409|6048929|P1|Overall Study|Prostate Cancer Treatment before Trial|2
1734027|NCT00981409|6048928|P2|Overall Study|Protocol Violation|1
1734028|NCT00981409|6048929|P1|Overall Study|Protocol Violation|0
1734029|NCT00981409|6048928|P2|Overall Study|Adverse Event|0
1734030|NCT00981409|6048929|P1|Overall Study|Adverse Event|4
1734031|NCT00981292|6048968|P6|Day 3|Protocol Violation|1
1734032|NCT00981292|6048969|P5|Day 3|Protocol Violation|0
1734033|NCT00981292|6048970|P4|Day 3|Protocol Violation|0
1734034|NCT00981292|6048971|P3|Day 3|Protocol Violation|0
1734035|NCT00981292|6048972|P2|Day 3|Protocol Violation|0
1734036|NCT00981292|6048973|P1|Day 3|Protocol Violation|0
1734037|NCT00981292|6048968|P6|Day 2|Protocol Violation|0
1734038|NCT00981292|6048969|P5|Day 2|Protocol Violation|0
1734039|NCT00981292|6048970|P4|Day 2|Protocol Violation|0
1734040|NCT00981292|6048971|P3|Day 2|Protocol Violation|0
1734041|NCT00981292|6048972|P2|Day 2|Protocol Violation|0
1734042|NCT00981292|6048973|P1|Day 2|Protocol Violation|2
1734043|NCT00981292|6048968|P6|Day 1|Protocol Violation|2
1734044|NCT00981292|6048969|P5|Day 1|Protocol Violation|0
1734045|NCT00981292|6048970|P4|Day 1|Protocol Violation|0
1734046|NCT00981292|6048971|P3|Day 1|Protocol Violation|0
1734047|NCT00981292|6048972|P2|Day 1|Protocol Violation|0
1734048|NCT00981292|6048973|P1|Day 1|Protocol Violation|1
1734049|NCT00981175|6049057|P2|Booster Dose Vaccination|Lost to Follow-up|3
1734050|NCT00981175|6049058|P1|Booster Dose Vaccination|Lost to Follow-up|2
1734051|NCT00981175|6049057|P2|Primary Dose Vaccination|Lost to Follow-up|1
1734052|NCT00981175|6049058|P1|Primary Dose Vaccination|Lost to Follow-up|2
1734053|NCT00981175|6049057|P2|Primary Dose Vaccination|Protocol Violation|1
1734054|NCT00981175|6049058|P1|Primary Dose Vaccination|Protocol Violation|0
1734055|NCT00981175|6049057|P2|Primary Dose Vaccination|Adverse Event|0
1734056|NCT00981175|6049058|P1|Primary Dose Vaccination|Adverse Event|1
1734057|NCT00981149|6049083|P2|Overall Study|Withdrawal by Subject|1
1734058|NCT00981149|6049084|P1|Overall Study|Withdrawal by Subject|1
1734059|NCT00981149|6049083|P2|Overall Study|Lost to Follow-up|2
1734060|NCT00981149|6049084|P1|Overall Study|Lost to Follow-up|1
1734061|NCT00981084|6049094|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
1734062|NCT00981084|6049095|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
1734063|NCT00981084|6049094|P2|Post Intervention (Data Analysis)|poor effort|1
1734064|NCT00981084|6049095|P1|Post Intervention (Data Analysis)|poor effort|1
1734065|NCT00981058|6049111|P2|Overall Study|On study treatment at conclusion|0
1734066|NCT00981058|6049112|P1|Overall Study|On study treatment at conclusion|9
1734067|NCT00981058|6049111|P2|Overall Study|Withdrawal by Subject|23
1734068|NCT00981058|6049112|P1|Overall Study|Withdrawal by Subject|25
1734069|NCT00981058|6049111|P2|Overall Study|Randomization Error|2
1734070|NCT00981058|6049112|P1|Overall Study|Randomization Error|1
1734071|NCT00981058|6049111|P2|Overall Study|Radiologist Error|1
1734072|NCT00981058|6049112|P1|Overall Study|Radiologist Error|0
1734073|NCT00981058|6049111|P2|Overall Study|Noncompliance|0
1734074|NCT00981058|6049112|P1|Overall Study|Noncompliance|1
1734075|NCT00981058|6049111|P2|Overall Study|New Anticancer Therapy|6
1734076|NCT00981058|6049112|P1|Overall Study|New Anticancer Therapy|6
1734077|NCT00981058|6049111|P2|Overall Study|Lost to Follow-up|15
1734078|NCT00981058|6049112|P1|Overall Study|Lost to Follow-up|16
1734079|NCT00981058|6049111|P2|Overall Study|Progressive Disease|49
1734080|NCT00981058|6049112|P1|Overall Study|Progressive Disease|61
1734081|NCT00981058|6049111|P2|Overall Study|Adverse Event|1
1734082|NCT00981058|6049112|P1|Overall Study|Adverse Event|1
1734083|NCT00981019|6049143|P1|Overall Study|Hit the survey after closure|79
1734084|NCT00981019|6049143|P1|Overall Study|Inadvertent exclusion|239
1734085|NCT00981019|6049143|P1|Overall Study|Did not match target population|94
1734086|NCT00981019|6049143|P1|Overall Study|Did not respond|65
1734087|NCT00980980|6049150|P3|Overall Study|Withdrawal by Hospital|0
1734088|NCT00980980|6049151|P2|Overall Study|Withdrawal by Hospital|1
1734089|NCT00980980|6049152|P1|Overall Study|Withdrawal by Hospital|0
1734090|NCT00980798|6049183|P2|Overall Study|Other|1
1734091|NCT00980798|6049184|P1|Overall Study|Other|0
1734092|NCT00980798|6049183|P2|Overall Study|Withdrawal by Subject|11
1734093|NCT00980798|6049184|P1|Overall Study|Withdrawal by Subject|8
1734094|NCT00980798|6049183|P2|Overall Study|Physician Decision|1
1734095|NCT00980798|6049184|P1|Overall Study|Physician Decision|2
1734096|NCT00980798|6049183|P2|Overall Study|Lost to Follow-up|1
1734097|NCT00980798|6049184|P1|Overall Study|Lost to Follow-up|0
1734098|NCT00980798|6049183|P2|Overall Study|Lack of Efficacy|5
1734099|NCT00980798|6049184|P1|Overall Study|Lack of Efficacy|16
1734100|NCT00980798|6049183|P2|Overall Study|Adverse Event|36
1734101|NCT00980798|6049184|P1|Overall Study|Adverse Event|7
1734102|NCT00980655|6049225|P2|Overall Study|Other|1
1734103|NCT00980655|6049226|P1|Overall Study|Other|0
1734104|NCT00980655|6049225|P2|Overall Study|Parent/legal guardian request|0
1734105|NCT00980655|6049226|P1|Overall Study|Parent/legal guardian request|1
1734106|NCT00980655|6049225|P2|Overall Study|Lost to Follow-up|1
1734107|NCT00980655|6049226|P1|Overall Study|Lost to Follow-up|0
1734108|NCT00980655|6049225|P2|Overall Study|Withdrawal by Subject|4
1734109|NCT00980655|6049226|P1|Overall Study|Withdrawal by Subject|0
1734110|NCT00980655|6049225|P2|Overall Study|Protocol Violation|7
1734111|NCT00980655|6049226|P1|Overall Study|Protocol Violation|2
1734112|NCT00980655|6049225|P2|Overall Study|Death|7
1734113|NCT00980655|6049226|P1|Overall Study|Death|0
1734114|NCT00980655|6049225|P2|Overall Study|Adverse Event|31
1734115|NCT00980655|6049226|P1|Overall Study|Adverse Event|13
1734116|NCT00980343|6049309|P2|Overall Study|no tumor at surgery - treatment effect|3
1734117|NCT00980343|6049310|P1|Overall Study|no tumor at surgery - treatment effect|1
1734118|NCT00980330|6049334|P7|Overall Study|(not specified)|0
1734119|NCT00980330|6049335|P6|Overall Study|(not specified)|1
1734120|NCT00980330|6049336|P5|Overall Study|(not specified)|1
1734121|NCT00980330|6049337|P4|Overall Study|(not specified)|1
1734122|NCT00980330|6049338|P3|Overall Study|(not specified)|0
1734123|NCT00980330|6049339|P2|Overall Study|(not specified)|0
1734124|NCT00980330|6049340|P1|Overall Study|(not specified)|2
1734125|NCT00980330|6049334|P7|Overall Study|Withdrawal by Subject|5
1734126|NCT00980330|6049335|P6|Overall Study|Withdrawal by Subject|2
1734127|NCT00980330|6049336|P5|Overall Study|Withdrawal by Subject|3
1734128|NCT00980330|6049337|P4|Overall Study|Withdrawal by Subject|1
1734129|NCT00980330|6049338|P3|Overall Study|Withdrawal by Subject|4
1734130|NCT00980330|6049339|P2|Overall Study|Withdrawal by Subject|4
1734131|NCT00980330|6049340|P1|Overall Study|Withdrawal by Subject|2
1734132|NCT00980330|6049334|P7|Overall Study|Lost to Follow-up|2
1734133|NCT00980330|6049335|P6|Overall Study|Lost to Follow-up|1
1734134|NCT00980330|6049336|P5|Overall Study|Lost to Follow-up|1
1734135|NCT00980330|6049337|P4|Overall Study|Lost to Follow-up|2
1734136|NCT00980330|6049338|P3|Overall Study|Lost to Follow-up|4
1734137|NCT00980330|6049339|P2|Overall Study|Lost to Follow-up|1
1734138|NCT00980330|6049340|P1|Overall Study|Lost to Follow-up|1
1734139|NCT00980330|6049334|P7|Overall Study|Adverse Event|0
1734140|NCT00980330|6049335|P6|Overall Study|Adverse Event|0
1734141|NCT00980330|6049336|P5|Overall Study|Adverse Event|0
1734142|NCT00980330|6049337|P4|Overall Study|Adverse Event|1
1734143|NCT00980330|6049338|P3|Overall Study|Adverse Event|0
1734144|NCT00980330|6049339|P2|Overall Study|Adverse Event|0
1734145|NCT00980330|6049340|P1|Overall Study|Adverse Event|0
1734146|NCT00980200|6049455|P5|7-day Treatment Period 3|Lack of Efficacy|1
1734147|NCT00980200|6049456|P4|7-day Treatment Period 3|Lack of Efficacy|0
1734148|NCT00980200|6049457|P3|7-day Treatment Period 3|Lack of Efficacy|0
1734149|NCT00980200|6049458|P2|7-day Treatment Period 3|Lack of Efficacy|1
1734150|NCT00980200|6049459|P1|7-day Treatment Period 3|Lack of Efficacy|0
1734151|NCT00980200|6049455|P5|7-day Treatment Period 1|Withdrawal by Subject|0
1734152|NCT00980200|6049456|P4|7-day Treatment Period 1|Withdrawal by Subject|0
1734153|NCT00980200|6049457|P3|7-day Treatment Period 1|Withdrawal by Subject|0
1734154|NCT00980200|6049458|P2|7-day Treatment Period 1|Withdrawal by Subject|1
1734155|NCT00980200|6049459|P1|7-day Treatment Period 1|Withdrawal by Subject|0
1734156|NCT00980174|6049478|P2|Overall Study|Other|1
1734157|NCT00980174|6049479|P1|Overall Study|Other|0
1734158|NCT00980174|6049478|P2|Overall Study|Death|1
1734159|NCT00980174|6049479|P1|Overall Study|Death|1
1734160|NCT00980174|6049478|P2|Overall Study|Ineligibility determined|1
1734161|NCT00980174|6049479|P1|Overall Study|Ineligibility determined|2
1734162|NCT00980174|6049478|P2|Overall Study|Adverse Event|3
1734163|NCT00980174|6049479|P1|Overall Study|Adverse Event|0
1734164|NCT00980174|6049478|P2|Overall Study|Withdrawal by Subject|4
1734165|NCT00980174|6049479|P1|Overall Study|Withdrawal by Subject|1
1734166|NCT00980148|6049497|P2|Overall Study|Various other reasons|9
1734167|NCT00980148|6049498|P1|Overall Study|Various other reasons|8
1734168|NCT00980148|6049497|P2|Overall Study|Negative for chlamydia at enrollment|9
1734169|NCT00980148|6049498|P1|Overall Study|Negative for chlamydia at enrollment|12
1734170|NCT00980148|6049497|P2|Overall Study|Received other antichlamydia treatment|14
1734171|NCT00980148|6049498|P1|Overall Study|Received other antichlamydia treatment|20
1734172|NCT00980148|6049497|P2|Overall Study|Discharged from facility|96
1734173|NCT00980148|6049498|P1|Overall Study|Discharged from facility|89
1734174|NCT00980057|6049506|P2|Overall Study|Withdrawal by Subject|1
1734175|NCT00980057|6049507|P1|Overall Study|Withdrawal by Subject|1
1734176|NCT00980057|6049506|P2|Overall Study|Lost to Follow-up|0
1734177|NCT00980057|6049507|P1|Overall Study|Lost to Follow-up|1
1734178|NCT00980057|6049506|P2|Overall Study|Physician Decision|0
1734179|NCT00980057|6049507|P1|Overall Study|Physician Decision|4
1734180|NCT00980057|6049506|P2|Overall Study|Adverse Event|1
1734181|NCT00980057|6049507|P1|Overall Study|Adverse Event|0
1734182|NCT00980057|6049506|P2|Overall Study|Death|3
1734183|NCT00980057|6049507|P1|Overall Study|Death|13
1734184|NCT00980044|6049530|P3|Overall Study|Protocol Violation|2
1734185|NCT00980044|6049531|P2|Overall Study|Protocol Violation|0
1734186|NCT00980044|6049532|P1|Overall Study|Protocol Violation|0
1734187|NCT00980044|6049530|P3|Overall Study|Withdrawal by Subject|3
1734188|NCT00980044|6049531|P2|Overall Study|Withdrawal by Subject|7
1734189|NCT00980044|6049532|P1|Overall Study|Withdrawal by Subject|5
1734190|NCT00980005|6049551|P2|Overall Study|Other|3
1734191|NCT00980005|6049552|P1|Overall Study|Other|4
1734192|NCT00980005|6049551|P2|Overall Study|Lost to Follow-up|43
1734193|NCT00980005|6049552|P1|Overall Study|Lost to Follow-up|37
1734194|NCT00980005|6049551|P2|Overall Study|Withdrawal by Subject|17
1734195|NCT00980005|6049552|P1|Overall Study|Withdrawal by Subject|6
1734199|NCT00979953|6049604|P4|Overall Study|Protocol Violation|2
1734200|NCT00979953|6049605|P3|Overall Study|Protocol Violation|2
1734201|NCT00979953|6049606|P2|Overall Study|Protocol Violation|0
1734202|NCT00979953|6049607|P1|Overall Study|Protocol Violation|1
1734203|NCT00979953|6049604|P4|Overall Study|Withdrawal by Subject|1
1734204|NCT00979953|6049605|P3|Overall Study|Withdrawal by Subject|2
1734205|NCT00979953|6049606|P2|Overall Study|Withdrawal by Subject|0
1734206|NCT00979953|6049607|P1|Overall Study|Withdrawal by Subject|0
1734207|NCT00979953|6049604|P4|Overall Study|Lost to Follow-up|0
1734208|NCT00979953|6049605|P3|Overall Study|Lost to Follow-up|1
1734209|NCT00979953|6049606|P2|Overall Study|Lost to Follow-up|1
1734210|NCT00979953|6049607|P1|Overall Study|Lost to Follow-up|1
1734211|NCT00979953|6049604|P4|Overall Study|Lack of Efficacy|0
1734212|NCT00979953|6049605|P3|Overall Study|Lack of Efficacy|0
1734213|NCT00979953|6049606|P2|Overall Study|Lack of Efficacy|2
1734214|NCT00979953|6049607|P1|Overall Study|Lack of Efficacy|1
1734215|NCT00979953|6049604|P4|Overall Study|Adverse Event|4
1734216|NCT00979953|6049605|P3|Overall Study|Adverse Event|17
1734217|NCT00979953|6049606|P2|Overall Study|Adverse Event|2
1734218|NCT00979953|6049607|P1|Overall Study|Adverse Event|5
1734219|NCT00979901|6049630|P4|Overall Study|Treatment Group Terminated by Sponsor|112
1734220|NCT00979901|6049631|P3|Overall Study|Treatment Group Terminated by Sponsor|0
1734221|NCT00979901|6049632|P2|Overall Study|Treatment Group Terminated by Sponsor|0
1734222|NCT00979901|6049633|P1|Overall Study|Treatment Group Terminated by Sponsor|0
1734223|NCT00979901|6049630|P4|Overall Study|Left Country|0
1734224|NCT00979901|6049631|P3|Overall Study|Left Country|1
1734225|NCT00979901|6049632|P2|Overall Study|Left Country|0
1734226|NCT00979901|6049633|P1|Overall Study|Left Country|0
1734227|NCT00979901|6049630|P4|Overall Study|Discontinued in Error|0
1734228|NCT00979901|6049631|P3|Overall Study|Discontinued in Error|0
1734229|NCT00979901|6049632|P2|Overall Study|Discontinued in Error|1
1734230|NCT00979901|6049633|P1|Overall Study|Discontinued in Error|0
1734231|NCT00979901|6049630|P4|Overall Study|elevated lab values pre-randomization|0
1734232|NCT00979901|6049631|P3|Overall Study|elevated lab values pre-randomization|0
1734233|NCT00979901|6049632|P2|Overall Study|elevated lab values pre-randomization|0
1734234|NCT00979901|6049633|P1|Overall Study|elevated lab values pre-randomization|1
1734235|NCT00979901|6049630|P4|Overall Study|vacation|0
1734236|NCT00979901|6049631|P3|Overall Study|vacation|0
1734237|NCT00979901|6049632|P2|Overall Study|vacation|0
1734238|NCT00979901|6049633|P1|Overall Study|vacation|1
1734239|NCT00979901|6049630|P4|Overall Study|out-of-state|0
1734240|NCT00979901|6049631|P3|Overall Study|out-of-state|0
1734241|NCT00979901|6049632|P2|Overall Study|out-of-state|0
1734242|NCT00979901|6049633|P1|Overall Study|out-of-state|1
1734243|NCT00979901|6049630|P4|Overall Study|Noncompliance|0
1734244|NCT00979901|6049631|P3|Overall Study|Noncompliance|0
1734245|NCT00979901|6049632|P2|Overall Study|Noncompliance|0
1734246|NCT00979901|6049633|P1|Overall Study|Noncompliance|1
1734247|NCT00979901|6049630|P4|Overall Study|Withdrawal by Subject|1
1734248|NCT00979901|6049631|P3|Overall Study|Withdrawal by Subject|1
1734249|NCT00979901|6049632|P2|Overall Study|Withdrawal by Subject|1
1734250|NCT00979901|6049633|P1|Overall Study|Withdrawal by Subject|2
1734251|NCT00979901|6049630|P4|Overall Study|Protocol Violation|1
1734252|NCT00979901|6049631|P3|Overall Study|Protocol Violation|7
1734253|NCT00979901|6049632|P2|Overall Study|Protocol Violation|2
1734254|NCT00979901|6049633|P1|Overall Study|Protocol Violation|2
1734255|NCT00979901|6049630|P4|Overall Study|Lost to Follow-up|0
1734256|NCT00979901|6049631|P3|Overall Study|Lost to Follow-up|2
1734257|NCT00979901|6049632|P2|Overall Study|Lost to Follow-up|1
1734258|NCT00979901|6049633|P1|Overall Study|Lost to Follow-up|1
1734259|NCT00979901|6049630|P4|Overall Study|Lack of Efficacy|0
1734260|NCT00979901|6049631|P3|Overall Study|Lack of Efficacy|9
1734261|NCT00979901|6049632|P2|Overall Study|Lack of Efficacy|4
1734262|NCT00979901|6049633|P1|Overall Study|Lack of Efficacy|8
1734263|NCT00979901|6049630|P4|Overall Study|Adverse Event|2
1734264|NCT00979901|6049631|P3|Overall Study|Adverse Event|9
1734265|NCT00979901|6049632|P2|Overall Study|Adverse Event|3
1734266|NCT00979901|6049633|P1|Overall Study|Adverse Event|1
1734267|NCT00979654|6049706|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
1734268|NCT00979654|6049706|P1|Overall Study|Serious Adverse Event|1
1734269|NCT00979654|6049706|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
1734270|NCT00979654|6049706|P1|Overall Study|Per Principal Investigator’s Discretion|1
1734271|NCT00979654|6049706|P1|Overall Study|Adverse Event of Diverticulitis|1
1734272|NCT00979654|6049706|P1|Overall Study|Adverse Event|1
1734273|NCT00979654|6049706|P1|Overall Study|Lack of Efficacy|6
1734274|NCT00979654|6049706|P1|Overall Study|Death|1
1734275|NCT00979654|6049706|P1|Overall Study|Withdrawal by Subject|22
1734276|NCT00979654|6049706|P1|Overall Study|Lost to Follow-up|1
1734277|NCT00979628|6049721|P3|Overall Study|transferred to ICU|1
1734278|NCT00979628|6049722|P2|Overall Study|transferred to ICU|2
1734279|NCT00979628|6049723|P1|Overall Study|transferred to ICU|1
1734280|NCT00979628|6049721|P3|Overall Study|received steroids|0
1734281|NCT00979628|6049722|P2|Overall Study|received steroids|1
1734282|NCT00979628|6049723|P1|Overall Study|received steroids|1
1734283|NCT00979628|6049721|P3|Overall Study|received regimen < 24 hours|5
1734284|NCT00979628|6049722|P2|Overall Study|received regimen < 24 hours|6
1734285|NCT00979628|6049723|P1|Overall Study|received regimen < 24 hours|7
1734286|NCT00979602|6049753|P2|Overall Study|Others|3
1734287|NCT00979602|6049754|P1|Overall Study|Others|3
1734288|NCT00979602|6049753|P2|Overall Study|Migrated/moved from study area|6
1734289|NCT00979602|6049754|P1|Overall Study|Migrated/moved from study area|3
1734290|NCT00979602|6049753|P2|Overall Study|Lost to Follow-up|96
1734291|NCT00979602|6049754|P1|Overall Study|Lost to Follow-up|100
1734292|NCT00979602|6049753|P2|Overall Study|Withdrawal by Subject|25
1734293|NCT00979602|6049754|P1|Overall Study|Withdrawal by Subject|31
1734294|NCT00979602|6049753|P2|Overall Study|Protocol Violation|0
1734295|NCT00979602|6049754|P1|Overall Study|Protocol Violation|3
1734296|NCT00979602|6049753|P2|Overall Study|Serious Adverse Event|3
1734297|NCT00979602|6049754|P1|Overall Study|Serious Adverse Event|5
1734298|NCT00979576|6049925|P3|Combination Followed by Monotherapy|Progressive Disease|1
1734299|NCT00979576|6049926|P2|Combination Followed by Monotherapy|Progressive Disease|2
1734300|NCT00979576|6049927|P1|Combination Followed by Monotherapy|Progressive Disease|0
1734301|NCT00979576|6049925|P3|Combination Treatment Phase|Adverse Event|2
1734302|NCT00979576|6049926|P2|Combination Treatment Phase|Adverse Event|2
1734303|NCT00979576|6049927|P1|Combination Treatment Phase|Adverse Event|0
1734304|NCT00979576|6049925|P3|Combination Treatment Phase|Dose limiting toxicity|2
1734305|NCT00979576|6049926|P2|Combination Treatment Phase|Dose limiting toxicity|3
1734306|NCT00979576|6049927|P1|Combination Treatment Phase|Dose limiting toxicity|0
1734307|NCT00979576|6049925|P3|Combination Treatment Phase|Progressive disease|5
1734308|NCT00979576|6049926|P2|Combination Treatment Phase|Progressive disease|1
1734309|NCT00979576|6049927|P1|Combination Treatment Phase|Progressive disease|3
1734310|NCT00979420|6049984|P4|Overall Study|Other reasons not related to Viramune|1
1734311|NCT00979420|6049985|P3|Overall Study|Other reasons not related to Viramune|0
1734312|NCT00979420|6049986|P2|Overall Study|Other reasons not related to Viramune|0
1734313|NCT00979420|6049987|P1|Overall Study|Other reasons not related to Viramune|3
1734314|NCT00979420|6049984|P4|Overall Study|Lack of Efficacy|1
1734315|NCT00979420|6049985|P3|Overall Study|Lack of Efficacy|1
1734316|NCT00979420|6049986|P2|Overall Study|Lack of Efficacy|0
1734317|NCT00979420|6049987|P1|Overall Study|Lack of Efficacy|3
1734318|NCT00979420|6049984|P4|Overall Study|Adverse Event|0
1734319|NCT00979420|6049985|P3|Overall Study|Adverse Event|0
1734320|NCT00979420|6049986|P2|Overall Study|Adverse Event|0
1734321|NCT00979420|6049987|P1|Overall Study|Adverse Event|1
1734322|NCT00979407|6050057|P2|Overall Study|Lost to Follow-up|3
1734323|NCT00979407|6050058|P1|Overall Study|Lost to Follow-up|3
1734324|NCT00979407|6050057|P2|Overall Study|Withdrawal by Subject|4
1734325|NCT00979407|6050058|P1|Overall Study|Withdrawal by Subject|3
1734326|NCT00979212|6050111|P2|Overall Study|No protocol therapy received|0
1734327|NCT00979212|6050112|P1|Overall Study|No protocol therapy received|1
1734328|NCT00979212|6050111|P2|Overall Study|Protocol Violation|8
1734329|NCT00979212|6050112|P1|Overall Study|Protocol Violation|1
1734330|NCT00979134|6050138|P3|Overall Study|Other|5
1734331|NCT00979134|6050139|P2|Overall Study|Other|1
1734332|NCT00979134|6050140|P1|Overall Study|Other|8
1734333|NCT00979134|6050138|P3|Overall Study|Death|26
1734334|NCT00979134|6050139|P2|Overall Study|Death|0
1734335|NCT00979134|6050140|P1|Overall Study|Death|4
1734336|NCT00979134|6050138|P3|Overall Study|Lost to Follow-up|0
1734337|NCT00979134|6050139|P2|Overall Study|Lost to Follow-up|2
1734338|NCT00979134|6050140|P1|Overall Study|Lost to Follow-up|2
1734339|NCT00979134|6050138|P3|Overall Study|Withdrawal by Subject|2
1734340|NCT00979134|6050139|P2|Overall Study|Withdrawal by Subject|1
1734341|NCT00979134|6050140|P1|Overall Study|Withdrawal by Subject|1
1734342|NCT00979134|6050138|P3|Overall Study|Adverse Event|2
1734343|NCT00979134|6050139|P2|Overall Study|Adverse Event|0
1734344|NCT00979134|6050140|P1|Overall Study|Adverse Event|0
1734345|NCT00979134|6050138|P3|Overall Study|Disease progression|5
1734346|NCT00979134|6050139|P2|Overall Study|Disease progression|2
1734347|NCT00979134|6050140|P1|Overall Study|Disease progression|18
1734348|NCT00978757|6050228|P2|Overall Study|Physician Decision|3
1734349|NCT00978757|6050229|P1|Overall Study|Physician Decision|1
1734350|NCT00978731|6050239|P4|Overall Study|No response|0
1734351|NCT00978731|6050240|P3|Overall Study|No response|0
1734352|NCT00978731|6050241|P2|Overall Study|No response|0
1734353|NCT00978731|6050242|P1|Overall Study|No response|1
1734354|NCT00978731|6050239|P4|Overall Study|Study closure|1
1734355|NCT00978731|6050240|P3|Overall Study|Study closure|1
1734356|NCT00978731|6050241|P2|Overall Study|Study closure|4
1734357|NCT00978731|6050242|P1|Overall Study|Study closure|3
1734358|NCT00978731|6050239|P4|Overall Study|Disease progression/relapse|2
1734359|NCT00978731|6050240|P3|Overall Study|Disease progression/relapse|2
1734360|NCT00978731|6050241|P2|Overall Study|Disease progression/relapse|4
1734361|NCT00978731|6050242|P1|Overall Study|Disease progression/relapse|5
1734362|NCT00978731|6050239|P4|Overall Study|Deterioration without progression|0
1734363|NCT00978731|6050240|P3|Overall Study|Deterioration without progression|0
1734364|NCT00978731|6050241|P2|Overall Study|Deterioration without progression|1
1734365|NCT00978731|6050242|P1|Overall Study|Deterioration without progression|0
1734366|NCT00978731|6050239|P4|Overall Study|Administrative reason|0
1734367|NCT00978731|6050240|P3|Overall Study|Administrative reason|1
1734368|NCT00978731|6050241|P2|Overall Study|Administrative reason|3
1734369|NCT00978731|6050242|P1|Overall Study|Administrative reason|3
1734370|NCT00978731|6050239|P4|Overall Study|Participant's request|0
1734371|NCT00978731|6050240|P3|Overall Study|Participant's request|0
1734372|NCT00978731|6050241|P2|Overall Study|Participant's request|0
1734373|NCT00978731|6050242|P1|Overall Study|Participant's request|1
1734374|NCT00978731|6050239|P4|Overall Study|Adverse Event|0
1734375|NCT00978731|6050240|P3|Overall Study|Adverse Event|0
1734376|NCT00978731|6050241|P2|Overall Study|Adverse Event|2
1734377|NCT00978731|6050242|P1|Overall Study|Adverse Event|5
1734378|NCT00978731|6050239|P4|Overall Study|Lost to Follow-up|1
1734379|NCT00978731|6050240|P3|Overall Study|Lost to Follow-up|0
1734380|NCT00978731|6050241|P2|Overall Study|Lost to Follow-up|0
1734381|NCT00978731|6050242|P1|Overall Study|Lost to Follow-up|0
1734382|NCT00978731|6050239|P4|Overall Study|Death|0
1734383|NCT00978731|6050240|P3|Overall Study|Death|1
1734384|NCT00978731|6050241|P2|Overall Study|Death|1
1734385|NCT00978731|6050242|P1|Overall Study|Death|4
1734386|NCT00978627|6050282|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
1734387|NCT00978627|6050283|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
1734388|NCT00978627|6050282|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
1734389|NCT00978627|6050283|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
1734390|NCT00978627|6050282|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
1734391|NCT00978627|6050283|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
1734392|NCT00978627|6050282|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
1734393|NCT00978627|6050283|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
1734394|NCT00978627|6050282|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
1734395|NCT00978627|6050283|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
1734396|NCT00978627|6050282|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
1734397|NCT00978627|6050283|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
1734398|NCT00978627|6050282|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
1734399|NCT00978627|6050283|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
1734400|NCT00978627|6050282|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
1734401|NCT00978627|6050283|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
1734402|NCT00978627|6050282|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
1734403|NCT00978627|6050283|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
1734404|NCT00978432|6050321|P3|Overall Study|Adverse Event|1
1734405|NCT00978432|6050322|P2|Overall Study|Adverse Event|0
1734406|NCT00978432|6050323|P1|Overall Study|Adverse Event|2
1734407|NCT00978432|6050321|P3|Overall Study|Lack of Efficacy|3
1734408|NCT00978432|6050322|P2|Overall Study|Lack of Efficacy|1
1734409|NCT00978432|6050323|P1|Overall Study|Lack of Efficacy|1
1734410|NCT00978432|6050321|P3|Overall Study|Withdrawal by Subject|1
1734411|NCT00978432|6050322|P2|Overall Study|Withdrawal by Subject|0
1734412|NCT00978432|6050323|P1|Overall Study|Withdrawal by Subject|0
1734413|NCT00978380|6050374|P1|Overall Study|Unclassified|8
1734414|NCT00978380|6050374|P1|Overall Study|Withdrawal criteria|9
1734415|NCT00978380|6050374|P1|Overall Study|Protocol Violation|2
1734416|NCT00978341|6050380|P2|Washout Period of 2 Weeks|Adverse Event|0
1734417|NCT00978341|6050381|P1|Washout Period of 2 Weeks|Adverse Event|1
1734418|NCT00978250|6050403|P4|Overall Study|Late determination of ineligibility|1
1734419|NCT00978250|6050404|P3|Overall Study|Late determination of ineligibility|0
1734420|NCT00978250|6050405|P2|Overall Study|Late determination of ineligibility|1
1734421|NCT00978250|6050406|P1|Overall Study|Late determination of ineligibility|0
1734422|NCT00978120|6050422|P4|Overall Study|Moved out of state|1
1734423|NCT00978120|6050423|P3|Overall Study|Moved out of state|0
1734424|NCT00978120|6050424|P2|Overall Study|Moved out of state|0
1734425|NCT00978120|6050425|P1|Overall Study|Moved out of state|0
1734426|NCT00978120|6050422|P4|Overall Study|Withdrawal by Subject|0
1734427|NCT00978120|6050423|P3|Overall Study|Withdrawal by Subject|0
1734428|NCT00978120|6050424|P2|Overall Study|Withdrawal by Subject|0
1734429|NCT00978120|6050425|P1|Overall Study|Withdrawal by Subject|2
1734430|NCT00978120|6050422|P4|Overall Study|Lost to Follow-up|0
1734431|NCT00978120|6050423|P3|Overall Study|Lost to Follow-up|3
1734432|NCT00978120|6050424|P2|Overall Study|Lost to Follow-up|0
1734433|NCT00978120|6050425|P1|Overall Study|Lost to Follow-up|0
1734434|NCT00978120|6050422|P4|Overall Study|Death|1
1734435|NCT00978120|6050423|P3|Overall Study|Death|0
1734436|NCT00978120|6050424|P2|Overall Study|Death|0
1734437|NCT00978120|6050425|P1|Overall Study|Death|0
1734438|NCT00978068|6050477|P2|Overall Study|Unable to Comply with Study|2
1734439|NCT00978068|6050478|P1|Overall Study|Unable to Comply with Study|0
1734440|NCT00978068|6050477|P2|Overall Study|Physician Decision|1
1734441|NCT00978068|6050478|P1|Overall Study|Physician Decision|0
1734442|NCT00978068|6050477|P2|Overall Study|Lost to Follow-up|2
1734443|NCT00978068|6050478|P1|Overall Study|Lost to Follow-up|1
1734444|NCT00978068|6050477|P2|Overall Study|Death|2
1734445|NCT00978068|6050478|P1|Overall Study|Death|1
1734446|NCT00978068|6050477|P2|Overall Study|Were Awaiting Initiation of ART|2
1734447|NCT00978068|6050478|P1|Overall Study|Were Awaiting Initiation of ART|2
1734448|NCT00978042|6050496|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
1734449|NCT00978042|6050497|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
1734450|NCT00978042|6050496|P2|Initial Treatment Period|Consent withdrawn|9
1734451|NCT00978042|6050497|P1|Initial Treatment Period|Consent withdrawn|22
1734452|NCT00978042|6050496|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
1734453|NCT00978042|6050497|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
1734454|NCT00978042|6050496|P2|Initial Treatment Period|Adverse Event|0
1734455|NCT00978042|6050497|P1|Initial Treatment Period|Adverse Event|2
1734456|NCT00978042|6050496|P2|Initial Treatment Period|Lost to Follow-up|3
1734457|NCT00978042|6050497|P1|Initial Treatment Period|Lost to Follow-up|21
1734458|NCT00978042|6050496|P2|Initial Treatment Period|Ineligibility|0
1734459|NCT00978042|6050497|P1|Initial Treatment Period|Ineligibility|1
1734460|NCT00978042|6050496|P2|Initial Treatment Period|Treated in Error|3
1734461|NCT00978042|6050497|P1|Initial Treatment Period|Treated in Error|0
1734462|NCT00978029|6050510|P3|Overall Study|Protocol Violation|0
1734463|NCT00978029|6050511|P2|Overall Study|Protocol Violation|1
1734464|NCT00978029|6050512|P1|Overall Study|Protocol Violation|0
1734465|NCT00978029|6050510|P3|Overall Study|Withdrawal by Subject|1
1734466|NCT00978029|6050511|P2|Overall Study|Withdrawal by Subject|0
1734467|NCT00978029|6050512|P1|Overall Study|Withdrawal by Subject|0
1734468|NCT00978029|6050510|P3|Overall Study|Adverse Event|5
1734469|NCT00978029|6050511|P2|Overall Study|Adverse Event|2
1734470|NCT00978029|6050512|P1|Overall Study|Adverse Event|1
1734471|NCT00977938|6050539|P4|Observation (30-33 mo. Post Procedure)|Other|0
1734472|NCT00977938|6050540|P3|Observation (30-33 mo. Post Procedure)|Other|0
1734473|NCT00977938|6050541|P2|Observation (30-33 mo. Post Procedure)|Other|4
1734474|NCT00977938|6050542|P1|Observation (30-33 mo. Post Procedure)|Other|8
1734475|NCT00977938|6050539|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
1734476|NCT00977938|6050540|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
1734477|NCT00977938|6050541|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
1734478|NCT00977938|6050542|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
1734479|NCT00977938|6050539|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
1734480|NCT00977938|6050540|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
1734481|NCT00977938|6050541|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
1734482|NCT00977938|6050542|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
1734483|NCT00977938|6050539|P4|Treatment (12-30 mo. Post Procedure)|Other|4
1734484|NCT00977938|6050540|P3|Treatment (12-30 mo. Post Procedure)|Other|3
1734485|NCT00977938|6050541|P2|Treatment (12-30 mo. Post Procedure)|Other|18
1734486|NCT00977938|6050542|P1|Treatment (12-30 mo. Post Procedure)|Other|17
1734487|NCT00977938|6050539|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
1734488|NCT00977938|6050540|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
1734489|NCT00977938|6050541|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
1734490|NCT00977938|6050542|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
1734491|NCT00977938|6050539|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
1734492|NCT00977938|6050540|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
1734493|NCT00977938|6050541|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
1734494|NCT00977938|6050542|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
1734495|NCT00977665|6050619|P2|Overall Study|Treatment failure|1
1734496|NCT00977665|6050620|P1|Overall Study|Treatment failure|0
1734497|NCT00977665|6050619|P2|Overall Study|Adverse Event|7
1734498|NCT00977665|6050620|P1|Overall Study|Adverse Event|14
1734499|NCT00977665|6050619|P2|Overall Study|Death|2
1734500|NCT00977665|6050620|P1|Overall Study|Death|3
1734501|NCT00977665|6050619|P2|Overall Study|Lost to Follow-up|0
1734502|NCT00977665|6050620|P1|Overall Study|Lost to Follow-up|1
1734503|NCT00977665|6050619|P2|Overall Study|Sponsor requested withdrawal|1
1734504|NCT00977665|6050620|P1|Overall Study|Sponsor requested withdrawal|0
1734505|NCT00977665|6050619|P2|Overall Study|Physician Decision|1
1734506|NCT00977665|6050620|P1|Overall Study|Physician Decision|2
1734507|NCT00977665|6050619|P2|Overall Study|Withdrawal by Subject|3
1734508|NCT00977665|6050620|P1|Overall Study|Withdrawal by Subject|1
1734509|NCT00977613|6050652|P1|Overall Study|Lost to Follow-up|16
1734510|NCT00977574|6050659|P3|Overall Study|Never Treated|4
1734511|NCT00977574|6050660|P2|Overall Study|Never Treated|2
1734512|NCT00977574|6050661|P1|Overall Study|Never Treated|4
1734513|NCT00977561|6050680|P2|Overall Study|Other|0
1734514|NCT00977561|6050681|P1|Overall Study|Other|2
1734515|NCT00977561|6050680|P2|Overall Study|Study terminated|2
1734516|NCT00977561|6050681|P1|Overall Study|Study terminated|0
1734517|NCT00977561|6050680|P2|Overall Study|Death|2
1734518|NCT00977561|6050681|P1|Overall Study|Death|3
1734519|NCT00977548|6050708|P1|Overall Study|Withdrawal by Subject|1
1734520|NCT00977548|6050708|P1|Overall Study|Adverse Event|8
1734521|NCT00977548|6050708|P1|Overall Study|Ineligible|4
1734522|NCT00977470|6050717|P2|Overall Study|Still on-study|0
1734523|NCT00977470|6050718|P1|Overall Study|Still on-study|2
1734524|NCT00977470|6050717|P2|Overall Study|prolonged recovery post-surgery|1
1734525|NCT00977470|6050718|P1|Overall Study|prolonged recovery post-surgery|0
1734526|NCT00977470|6050717|P2|Overall Study|clinical decline|1
1734527|NCT00977470|6050718|P1|Overall Study|clinical decline|0
1734528|NCT00977470|6050717|P2|Overall Study|Death|2
1734529|NCT00977470|6050718|P1|Overall Study|Death|0
1734530|NCT00977470|6050717|P2|Overall Study|Withdrawal by Subject|2
1734531|NCT00977470|6050718|P1|Overall Study|Withdrawal by Subject|0
1734532|NCT00977470|6050717|P2|Overall Study|Protocol Violation|0
1734533|NCT00977470|6050718|P1|Overall Study|Protocol Violation|1
1734534|NCT00977470|6050717|P2|Overall Study|Adverse Event|2
1734535|NCT00977470|6050718|P1|Overall Study|Adverse Event|1
1734536|NCT00977470|6050717|P2|Overall Study|Physician Decision|0
1734537|NCT00977470|6050718|P1|Overall Study|Physician Decision|2
1734538|NCT00977470|6050717|P2|Overall Study|Lack of Efficacy|30
1734539|NCT00977470|6050718|P1|Overall Study|Lack of Efficacy|32
1734540|NCT00977431|6050741|P5|Overall Study|Progressive disease|5
1734541|NCT00977431|6050742|P4|Overall Study|Progressive disease|3
1734542|NCT00977431|6050743|P3|Overall Study|Progressive disease|1
1734543|NCT00977431|6050744|P2|Overall Study|Progressive disease|6
1734544|NCT00977431|6050745|P1|Overall Study|Progressive disease|2
1734545|NCT00977431|6050741|P5|Overall Study|Dose-limiting toxicity (DLT)|0
1734546|NCT00977431|6050742|P4|Overall Study|Dose-limiting toxicity (DLT)|0
1734547|NCT00977431|6050743|P3|Overall Study|Dose-limiting toxicity (DLT)|1
1734548|NCT00977431|6050744|P2|Overall Study|Dose-limiting toxicity (DLT)|0
1734549|NCT00977431|6050745|P1|Overall Study|Dose-limiting toxicity (DLT)|1
1734550|NCT00977431|6050741|P5|Overall Study|Adverse Event|6
1734551|NCT00977431|6050742|P4|Overall Study|Adverse Event|0
1734552|NCT00977431|6050743|P3|Overall Study|Adverse Event|4
1734553|NCT00977431|6050744|P2|Overall Study|Adverse Event|0
1734554|NCT00977431|6050745|P1|Overall Study|Adverse Event|3
1734555|NCT00977431|6050741|P5|Overall Study|Protocol Violation|0
1734556|NCT00977431|6050742|P4|Overall Study|Protocol Violation|0
1734557|NCT00977431|6050743|P3|Overall Study|Protocol Violation|1
1734558|NCT00977431|6050744|P2|Overall Study|Protocol Violation|0
1734559|NCT00977431|6050745|P1|Overall Study|Protocol Violation|0
1734560|NCT00977431|6050741|P5|Overall Study|Other than listed|2
1734561|NCT00977431|6050742|P4|Overall Study|Other than listed|0
1734562|NCT00977431|6050743|P3|Overall Study|Other than listed|0
1734563|NCT00977431|6050744|P2|Overall Study|Other than listed|0
1734564|NCT00977431|6050745|P1|Overall Study|Other than listed|1
1734565|NCT00977379|6050778|P2|Overall Study|Randomization Error|1
1734566|NCT00977379|6050779|P1|Overall Study|Randomization Error|0
1734567|NCT00977379|6050778|P2|Overall Study|Participant Moving House|1
1734568|NCT00977379|6050779|P1|Overall Study|Participant Moving House|0
1734569|NCT00977379|6050778|P2|Overall Study|Premature Study Termination|0
1734570|NCT00977379|6050779|P1|Overall Study|Premature Study Termination|4
1734571|NCT00977379|6050778|P2|Overall Study|Death|9
1734572|NCT00977379|6050779|P1|Overall Study|Death|7
1734573|NCT00977379|6050778|P2|Overall Study|Withdrawal by Subject|1
1734574|NCT00977379|6050779|P1|Overall Study|Withdrawal by Subject|1
1734575|NCT00977314|6050815|P2|Overall Study|Physician Decision|0
1734576|NCT00977314|6050816|P1|Overall Study|Physician Decision|1
1734577|NCT00977314|6050815|P2|Overall Study|Withdrawal by Subject|0
1734578|NCT00977314|6050816|P1|Overall Study|Withdrawal by Subject|1
1734579|NCT00977197|6050824|P2|Overall Study|Nonadherence|1
1734580|NCT00977197|6050825|P1|Overall Study|Nonadherence|1
1734581|NCT00977197|6050824|P2|Overall Study|Lost to Follow-up|3
1734582|NCT00977197|6050825|P1|Overall Study|Lost to Follow-up|1
1734583|NCT00977197|6050824|P2|Overall Study|Lack of Efficacy|0
1734584|NCT00977197|6050825|P1|Overall Study|Lack of Efficacy|1
1734585|NCT00977197|6050824|P2|Overall Study|Adverse Event|1
1734586|NCT00977197|6050825|P1|Overall Study|Adverse Event|3
1734587|NCT00977197|6050824|P2|Overall Study|Withdrawal by Subject|4
1734588|NCT00977197|6050825|P1|Overall Study|Withdrawal by Subject|3
1734589|NCT00977106|6050888|P2|Overall Study|Other|0
1734590|NCT00977106|6050889|P1|Overall Study|Other|1
1734591|NCT00977106|6050888|P2|Overall Study|Protocol Violation|1
1734592|NCT00977106|6050889|P1|Overall Study|Protocol Violation|0
1734593|NCT00977106|6050888|P2|Overall Study|Lack of Efficacy|2
1734594|NCT00977106|6050889|P1|Overall Study|Lack of Efficacy|2
1734595|NCT00977106|6050888|P2|Overall Study|Withdrawal by Subject|2
1734596|NCT00977106|6050889|P1|Overall Study|Withdrawal by Subject|2
1734597|NCT00977106|6050888|P2|Overall Study|Adverse Event|6
1734598|NCT00977106|6050889|P1|Overall Study|Adverse Event|5
1734599|NCT00977080|6050981|P4|Overall Study|Travel for family reasons|0
1734600|NCT00977080|6050982|P3|Overall Study|Travel for family reasons|0
1734601|NCT00977080|6050983|P2|Overall Study|Travel for family reasons|0
1734602|NCT00977080|6050984|P1|Overall Study|Travel for family reasons|1
1734603|NCT00977080|6050981|P4|Overall Study|Required kidney transplantation|1
1734604|NCT00977080|6050982|P3|Overall Study|Required kidney transplantation|3
1734605|NCT00977080|6050983|P2|Overall Study|Required kidney transplantation|3
1734606|NCT00977080|6050984|P1|Overall Study|Required kidney transplantation|1
1734607|NCT00977080|6050981|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
1734608|NCT00977080|6050982|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1734609|NCT00977080|6050983|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1734610|NCT00977080|6050984|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
1734611|NCT00977080|6050981|P4|Overall Study|Noncompliance|0
1734612|NCT00977080|6050982|P3|Overall Study|Noncompliance|1
1734613|NCT00977080|6050983|P2|Overall Study|Noncompliance|2
1734614|NCT00977080|6050984|P1|Overall Study|Noncompliance|0
1734615|NCT00977080|6050981|P4|Overall Study|Protocol Violation|3
1734616|NCT00977080|6050982|P3|Overall Study|Protocol Violation|4
1734617|NCT00977080|6050983|P2|Overall Study|Protocol Violation|3
1734618|NCT00977080|6050984|P1|Overall Study|Protocol Violation|7
1734619|NCT00977080|6050981|P4|Overall Study|Withdrawal by Subject|5
1734620|NCT00977080|6050982|P3|Overall Study|Withdrawal by Subject|1
1734621|NCT00977080|6050983|P2|Overall Study|Withdrawal by Subject|5
1734622|NCT00977080|6050984|P1|Overall Study|Withdrawal by Subject|1
1734623|NCT00977080|6050981|P4|Overall Study|Adverse Event|7
1734624|NCT00977080|6050982|P3|Overall Study|Adverse Event|7
1734625|NCT00977080|6050983|P2|Overall Study|Adverse Event|7
1734626|NCT00977080|6050984|P1|Overall Study|Adverse Event|2
1734627|NCT00976989|6051017|P3|Overall Study|Other|1
1734628|NCT00976989|6051018|P2|Overall Study|Other|0
1734629|NCT00976989|6051019|P1|Overall Study|Other|1
1734630|NCT00976989|6051017|P3|Overall Study|Recurrence of Disease|0
1734631|NCT00976989|6051018|P2|Overall Study|Recurrence of Disease|1
1734632|NCT00976989|6051019|P1|Overall Study|Recurrence of Disease|0
1734633|NCT00976989|6051017|P3|Overall Study|Failure to Return|0
1734634|NCT00976989|6051018|P2|Overall Study|Failure to Return|1
1734635|NCT00976989|6051019|P1|Overall Study|Failure to Return|2
1734636|NCT00976989|6051017|P3|Overall Study|Refused Treatment|5
1734637|NCT00976989|6051018|P2|Overall Study|Refused Treatment|3
1734638|NCT00976989|6051019|P1|Overall Study|Refused Treatment|4
1734639|NCT00976989|6051017|P3|Overall Study|Death|10
1734640|NCT00976989|6051018|P2|Overall Study|Death|7
1734641|NCT00976989|6051019|P1|Overall Study|Death|5
1734642|NCT00976989|6051017|P3|Overall Study|Violation of Selection Criteria at Entry|1
1734643|NCT00976989|6051018|P2|Overall Study|Violation of Selection Criteria at Entry|0
1734644|NCT00976989|6051019|P1|Overall Study|Violation of Selection Criteria at Entry|1
1734645|NCT00976950|6051060|P1|Overall Study|Events with no relationship to Aptivus|3
1734646|NCT00976950|6051060|P1|Overall Study|Adverse Event|3
1734647|NCT00976937|6051068|P2|Overall Study|Personal and Familial Reason|2
1734648|NCT00976937|6051069|P1|Overall Study|Personal and Familial Reason|2
1734649|NCT00976937|6051068|P2|Overall Study|Poor compliance to protocol|0
1734650|NCT00976937|6051069|P1|Overall Study|Poor compliance to protocol|3
1734651|NCT00976937|6051068|P2|Overall Study|Withdrawal by Subject|3
1734652|NCT00976937|6051069|P1|Overall Study|Withdrawal by Subject|5
1734653|NCT00976937|6051068|P2|Overall Study|Lost to Follow-up|1
1734654|NCT00976937|6051069|P1|Overall Study|Lost to Follow-up|2
1734655|NCT00976937|6051068|P2|Overall Study|Adverse Event|5
1734656|NCT00976937|6051069|P1|Overall Study|Adverse Event|4
1734657|NCT00976911|6051111|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
1734658|NCT00976911|6051112|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
1734659|NCT00976911|6051111|P2|Overall Study|Other|9
1734660|NCT00976911|6051112|P1|Overall Study|Other|8
1734661|NCT00976911|6051111|P2|Overall Study|Protocol Violation|0
1734662|NCT00976911|6051112|P1|Overall Study|Protocol Violation|2
1734663|NCT00976911|6051111|P2|Overall Study|Adverse Event|1
1734664|NCT00976911|6051112|P1|Overall Study|Adverse Event|0
1734665|NCT00976911|6051111|P2|Overall Study|Death|126
1734666|NCT00976911|6051112|P1|Overall Study|Death|138
1734667|NCT00976911|6051111|P2|Overall Study|Withdrawal by Subject|6
1734668|NCT00976911|6051112|P1|Overall Study|Withdrawal by Subject|4
1734669|NCT00976898|6051130|P1|Overall Study|Progressive Disease|1
1734670|NCT00976898|6051130|P1|Overall Study|Liver Transplant|1
1734671|NCT00976898|6051130|P1|Overall Study|Physician Decision|1
1734672|NCT00976898|6051130|P1|Overall Study|Adverse Event|1
1734673|NCT00976898|6051130|P1|Overall Study|Protocol Violation|1
1734674|NCT00976820|6051141|P4|Overall Study|Withdrawal by Subject|4
1734675|NCT00976820|6051142|P3|Overall Study|Withdrawal by Subject|1
1734676|NCT00976820|6051143|P2|Overall Study|Withdrawal by Subject|4
1734677|NCT00976820|6051144|P1|Overall Study|Withdrawal by Subject|2
1734678|NCT00976820|6051141|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
1734679|NCT00976820|6051142|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
1734680|NCT00976820|6051143|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
1734681|NCT00976820|6051144|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
1734682|NCT00976820|6051141|P4|Overall Study|Lost to Follow-up|3
1734683|NCT00976820|6051142|P3|Overall Study|Lost to Follow-up|2
1734684|NCT00976820|6051143|P2|Overall Study|Lost to Follow-up|16
1734685|NCT00976820|6051144|P1|Overall Study|Lost to Follow-up|5
1734686|NCT00976716|6051480|P1|Overall Study|Adverse Event|1
1734687|NCT00976703|6051498|P2|Overall Study|ineligible for study|2
1734688|NCT00976703|6051499|P1|Overall Study|ineligible for study|2
1734689|NCT00976703|6051498|P2|Overall Study|Physician Decision|1
1734690|NCT00976703|6051499|P1|Overall Study|Physician Decision|1
1734691|NCT00976677|6051513|P2|Overall Study|Unknown/Missing|0
1734692|NCT00976677|6051514|P1|Overall Study|Unknown/Missing|1
1734693|NCT00976677|6051513|P2|Overall Study|Trial unblinded|2
1734694|NCT00976677|6051514|P1|Overall Study|Trial unblinded|2
1734695|NCT00976677|6051513|P2|Overall Study|Disease progression|1
1734696|NCT00976677|6051514|P1|Overall Study|Disease progression|1
1734697|NCT00976677|6051513|P2|Overall Study|Withdrawal by Subject|2
1734698|NCT00976677|6051514|P1|Overall Study|Withdrawal by Subject|0
1734699|NCT00976677|6051513|P2|Overall Study|Adverse Event|0
1734700|NCT00976677|6051514|P1|Overall Study|Adverse Event|1
1734701|NCT00976573|6051722|P2|Overall Study|Cancel prior to receiving treatment|2
1734702|NCT00976573|6051723|P1|Overall Study|Cancel prior to receiving treatment|4
1734703|NCT00976573|6051722|P2|Overall Study|Ineligible|1
1734704|NCT00976573|6051723|P1|Overall Study|Ineligible|0
1734705|NCT00976560|6051737|P2|Overall Study|Withdrawal by Subject|3
1734706|NCT00976560|6051738|P1|Overall Study|Withdrawal by Subject|2
1734707|NCT00976560|6051737|P2|Overall Study|Physician Decision|0
1734708|NCT00976560|6051738|P1|Overall Study|Physician Decision|2
1734709|NCT00976560|6051737|P2|Overall Study|Lost to Follow-up|0
1734710|NCT00976560|6051738|P1|Overall Study|Lost to Follow-up|1
1734711|NCT00976560|6051737|P2|Overall Study|Protocol Violation|0
1734712|NCT00976560|6051738|P1|Overall Study|Protocol Violation|1
1734713|NCT00976560|6051737|P2|Overall Study|Lack of Efficacy|5
1734714|NCT00976560|6051738|P1|Overall Study|Lack of Efficacy|3
1734715|NCT00976560|6051737|P2|Overall Study|Adverse Event|5
1734716|NCT00976560|6051738|P1|Overall Study|Adverse Event|5
1734717|NCT00976508|6051807|P2|Overall Study|Terminated by the Sponsor|1
1734718|NCT00976508|6051808|P1|Overall Study|Terminated by the Sponsor|0
1734719|NCT00976508|6051807|P2|Overall Study|Subject Enrolled in Hospice|0
1734720|NCT00976508|6051808|P1|Overall Study|Subject Enrolled in Hospice|1
1734721|NCT00976508|6051807|P2|Overall Study|Disease Progression|4
1734722|NCT00976508|6051808|P1|Overall Study|Disease Progression|4
1734723|NCT00976508|6051807|P2|Overall Study|Withdrawal by Subject|0
1734724|NCT00976508|6051808|P1|Overall Study|Withdrawal by Subject|1
1734725|NCT00976508|6051807|P2|Overall Study|Lost to Follow-up|0
1734726|NCT00976508|6051808|P1|Overall Study|Lost to Follow-up|1
1734727|NCT00976508|6051807|P2|Overall Study|Death|1
1734728|NCT00976508|6051808|P1|Overall Study|Death|7
1734729|NCT00976495|6051841|P3|Overall Study|Withdrawal by Subject|0
1734730|NCT00976495|6051842|P2|Overall Study|Withdrawal by Subject|1
1734731|NCT00976495|6051843|P1|Overall Study|Withdrawal by Subject|0
1734732|NCT00976482|6051860|P1|Overall Study|Protocol Violation|5
1734733|NCT00976482|6051860|P1|Overall Study|Center terminated|1
1734734|NCT00976482|6051860|P1|Overall Study|Withdrawal by Subject|45
1734735|NCT00976482|6051860|P1|Overall Study|Death|208
1734736|NCT00976456|6051866|P2|Overall Study|screening failure, unknown|4
1734737|NCT00976456|6051867|P1|Overall Study|screening failure, unknown|11
1734738|NCT00976456|6051866|P2|Overall Study|Withdrawal by Subject|1
1734739|NCT00976456|6051867|P1|Overall Study|Withdrawal by Subject|3
1734740|NCT00976456|6051866|P2|Overall Study|Lack of Efficacy|2
1734741|NCT00976456|6051867|P1|Overall Study|Lack of Efficacy|5
1734742|NCT00976456|6051866|P2|Overall Study|Death|9
1734743|NCT00976456|6051867|P1|Overall Study|Death|7
1734744|NCT00976456|6051866|P2|Overall Study|Adverse Event|22
1734745|NCT00976456|6051867|P1|Overall Study|Adverse Event|17
1734746|NCT00976391|6051894|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1734747|NCT00976391|6051895|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
1734748|NCT00976391|6051894|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
1734749|NCT00976391|6051895|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
1734750|NCT00976391|6051894|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
1734751|NCT00976391|6051895|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
1734752|NCT00976391|6051894|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
1734753|NCT00976391|6051895|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
1734754|NCT00976391|6051894|P2|Follow-up Period (8 Weeks)|Noncompliance|2
1734755|NCT00976391|6051895|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1734756|NCT00976391|6051894|P2|Follow-up Period (8 Weeks)|Adverse Event|1
1734757|NCT00976391|6051895|P1|Follow-up Period (8 Weeks)|Adverse Event|3
1734758|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Pregnancy|0
1734759|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Pregnancy|1
1734760|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
1734761|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
1734762|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Physician Decision|1
1734763|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Physician Decision|1
1734764|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
1734765|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
1734766|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
1734767|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
1734768|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Noncompliance|4
1734769|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Noncompliance|4
1734770|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Protocol Violation|1
1734771|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Protocol Violation|1
1734772|NCT00976391|6051894|P2|Treatment Period (52 Weeks)|Adverse Event|2
1734773|NCT00976391|6051895|P1|Treatment Period (52 Weeks)|Adverse Event|16
1734774|NCT00976274|6051943|P2|Overall Study|Physician Decision|2
1734775|NCT00976274|6051944|P1|Overall Study|Physician Decision|1
1734776|NCT00976274|6051943|P2|Overall Study|Withdrawal by Subject|1
1734777|NCT00976274|6051944|P1|Overall Study|Withdrawal by Subject|1
1734778|NCT00976274|6051943|P2|Overall Study|Lost to Follow-up|5
1734779|NCT00976274|6051944|P1|Overall Study|Lost to Follow-up|5
1734780|NCT00976209|6051960|P2|Treatment Period 2|Lost to Follow-up|1
1734781|NCT00976209|6051961|P1|Treatment Period 2|Lost to Follow-up|0
1734782|NCT00976209|6051960|P2|Treatment Period 2|Withdrawal by Subject|1
1734783|NCT00976209|6051961|P1|Treatment Period 2|Withdrawal by Subject|0
1734784|NCT00976209|6051960|P2|Wash-out Period|Other|0
1734785|NCT00976209|6051961|P1|Wash-out Period|Other|1
1734786|NCT00976209|6051960|P2|Wash-out Period|Protocol Violation|0
1734787|NCT00976209|6051961|P1|Wash-out Period|Protocol Violation|1
1734788|NCT00976209|6051960|P2|Wash-out Period|Lost to Follow-up|0
1734789|NCT00976209|6051961|P1|Wash-out Period|Lost to Follow-up|1
1734790|NCT00976209|6051960|P2|Wash-out Period|Adverse Event|2
1734791|NCT00976209|6051961|P1|Wash-out Period|Adverse Event|1
1734792|NCT00976209|6051960|P2|Treatment Period 1|Other|1
1734793|NCT00976209|6051961|P1|Treatment Period 1|Other|0
1734794|NCT00976209|6051960|P2|Treatment Period 1|Lost to Follow-up|0
1734795|NCT00976209|6051961|P1|Treatment Period 1|Lost to Follow-up|2
1734796|NCT00976209|6051960|P2|Treatment Period 1|Protocol Violation|0
1734797|NCT00976209|6051961|P1|Treatment Period 1|Protocol Violation|1
1734798|NCT00976027|6051974|P2|Overall Study|Withdrawal by Subject|66
1734799|NCT00976027|6051975|P1|Overall Study|Withdrawal by Subject|107
1734800|NCT00976027|6051974|P2|Overall Study|Lost to Follow-up|103
1734801|NCT00976027|6051975|P1|Overall Study|Lost to Follow-up|208
1734802|NCT00976027|6051974|P2|Overall Study|Protocol Violation|27
1734803|NCT00976027|6051975|P1|Overall Study|Protocol Violation|60
1734804|NCT00976027|6051974|P2|Overall Study|Adverse Event|2
1734805|NCT00976027|6051975|P1|Overall Study|Adverse Event|0
1734806|NCT00976027|6051974|P2|Overall Study|Serious Adverse Event|17
1734807|NCT00976027|6051975|P1|Overall Study|Serious Adverse Event|36
1734808|NCT00975975|6051987|P1|Overall Study|Death|6
1734809|NCT00975923|6051995|P2|Overall Study|Withdrawal by Subject|1
1734810|NCT00975923|6051996|P1|Overall Study|Withdrawal by Subject|0
1734811|NCT00975884|6052006|P2|Overall Study|Other|3
1734812|NCT00975884|6052007|P1|Overall Study|Other|1
1734813|NCT00975884|6052006|P2|Overall Study|Withdrawal by Subject|9
1734814|NCT00975884|6052007|P1|Overall Study|Withdrawal by Subject|9
1734815|NCT00975884|6052006|P2|Overall Study|Lost to Follow-up|3
1734816|NCT00975884|6052007|P1|Overall Study|Lost to Follow-up|5
1734817|NCT00975884|6052006|P2|Overall Study|Adverse Event|0
1734818|NCT00975884|6052007|P1|Overall Study|Adverse Event|1
1734819|NCT00975806|6052164|P3|Overall Study|Physician decision and disease related|1
1734820|NCT00975806|6052165|P2|Overall Study|Physician decision and disease related|0
1734821|NCT00975806|6052166|P1|Overall Study|Physician decision and disease related|1
1734822|NCT00975806|6052164|P3|Overall Study|Death|0
1734823|NCT00975806|6052165|P2|Overall Study|Death|1
1734824|NCT00975806|6052166|P1|Overall Study|Death|0
1734825|NCT00975806|6052164|P3|Overall Study|Withdrawal by Subject|0
1734826|NCT00975806|6052165|P2|Overall Study|Withdrawal by Subject|0
1734827|NCT00975806|6052166|P1|Overall Study|Withdrawal by Subject|1
1734828|NCT00975806|6052164|P3|Overall Study|Disease Progression|1
1734829|NCT00975806|6052165|P2|Overall Study|Disease Progression|5
1734830|NCT00975806|6052166|P1|Overall Study|Disease Progression|1
1734831|NCT00975806|6052164|P3|Overall Study|Adverse Event|2
1734832|NCT00975806|6052165|P2|Overall Study|Adverse Event|1
1734833|NCT00975806|6052166|P1|Overall Study|Adverse Event|2
1734834|NCT00975780|6052190|P2|Follow Up|Discharged from Facility|12
1734835|NCT00975780|6052191|P1|Follow Up|Discharged from Facility|7
1734836|NCT00975780|6052190|P2|Follow Up|Facility Withdrawal|23
1734837|NCT00975780|6052191|P1|Follow Up|Facility Withdrawal|7
1734838|NCT00975780|6052190|P2|Follow Up|Death|122
1734839|NCT00975780|6052191|P1|Follow Up|Death|88
1734840|NCT00975715|6052201|P2|Maintenance Period|Adverse Event|1
1734841|NCT00975715|6052202|P1|Maintenance Period|Adverse Event|2
1734842|NCT00975715|6052201|P2|Titration Period|Protocol Violation|0
1734843|NCT00975715|6052202|P1|Titration Period|Protocol Violation|1
1734844|NCT00975715|6052201|P2|Titration Period|Adverse Event|0
1734845|NCT00975715|6052202|P1|Titration Period|Adverse Event|6
1734846|NCT00975689|6052218|P2|Overall Study|Physician Decision|0
1734847|NCT00975689|6052219|P1|Overall Study|Physician Decision|1
1734848|NCT00975689|6052218|P2|Overall Study|Withdrawal by Subject|0
1734849|NCT00975689|6052219|P1|Overall Study|Withdrawal by Subject|1
1734850|NCT00975689|6052218|P2|Overall Study|Adverse Event|3
1734851|NCT00975689|6052219|P1|Overall Study|Adverse Event|0
1734852|NCT00975611|6052288|P1|Overall Study|Physician Decision|1
1734853|NCT00975611|6052288|P1|Overall Study|Screen Fail|16
1734854|NCT00975585|6052294|P2|Overall Study|Lens issue|2
1734855|NCT00975585|6052295|P1|Overall Study|Lens issue|2
1734856|NCT00975585|6052294|P2|Overall Study|Withdrawal by Subject|1
1734857|NCT00975585|6052295|P1|Overall Study|Withdrawal by Subject|2
1734858|NCT00975585|6052294|P2|Overall Study|Lost to Follow-up|5
1734859|NCT00975585|6052295|P1|Overall Study|Lost to Follow-up|3
1734860|NCT00975585|6052294|P2|Overall Study|Adverse Event|4
1734861|NCT00975585|6052295|P1|Overall Study|Adverse Event|0
1734862|NCT00975507|6052315|P2|Overall Study|Withdrawal by Subject|3
1734863|NCT00975507|6052316|P1|Overall Study|Withdrawal by Subject|10
1734864|NCT00975507|6052315|P2|Overall Study|Protocol Violation|0
1734865|NCT00975507|6052316|P1|Overall Study|Protocol Violation|2
1734866|NCT00975507|6052315|P2|Overall Study|Lost to Follow-up|1
1734867|NCT00975507|6052316|P1|Overall Study|Lost to Follow-up|7
1734868|NCT00975507|6052315|P2|Overall Study|Adverse Event|0
1734869|NCT00975507|6052316|P1|Overall Study|Adverse Event|1
1734870|NCT00975481|6052336|P6|Fifth Intervention Period|Withdrawal by Subject|0
1734871|NCT00975481|6052337|P5|Fifth Intervention Period|Withdrawal by Subject|1
1734872|NCT00975481|6052338|P4|Fifth Intervention Period|Withdrawal by Subject|0
1734873|NCT00975481|6052339|P3|Fifth Intervention Period|Withdrawal by Subject|0
1734874|NCT00975481|6052340|P2|Fifth Intervention Period|Withdrawal by Subject|0
1734875|NCT00975481|6052341|P1|Fifth Intervention Period|Withdrawal by Subject|0
1734876|NCT00975481|6052336|P6|Fourth Intervention Period|Withdrawal by Subject|0
1734877|NCT00975481|6052337|P5|Fourth Intervention Period|Withdrawal by Subject|0
1734878|NCT00975481|6052338|P4|Fourth Intervention Period|Withdrawal by Subject|1
1734879|NCT00975481|6052339|P3|Fourth Intervention Period|Withdrawal by Subject|1
1734880|NCT00975481|6052340|P2|Fourth Intervention Period|Withdrawal by Subject|0
1734881|NCT00975481|6052341|P1|Fourth Intervention Period|Withdrawal by Subject|0
1734882|NCT00975481|6052336|P6|Second Intervention Period|Withdrawal by Subject|0
1734883|NCT00975481|6052337|P5|Second Intervention Period|Withdrawal by Subject|0
1734884|NCT00975481|6052338|P4|Second Intervention Period|Withdrawal by Subject|0
1734885|NCT00975481|6052339|P3|Second Intervention Period|Withdrawal by Subject|1
1734886|NCT00975481|6052340|P2|Second Intervention Period|Withdrawal by Subject|0
1734887|NCT00975481|6052341|P1|Second Intervention Period|Withdrawal by Subject|0
1734888|NCT00975481|6052336|P6|Second Intervention Period|Adverse Event|0
1734889|NCT00975481|6052337|P5|Second Intervention Period|Adverse Event|0
1734890|NCT00975481|6052338|P4|Second Intervention Period|Adverse Event|0
1734891|NCT00975481|6052339|P3|Second Intervention Period|Adverse Event|0
1734892|NCT00975481|6052340|P2|Second Intervention Period|Adverse Event|1
1734893|NCT00975481|6052341|P1|Second Intervention Period|Adverse Event|2
1734894|NCT00975416|6052441|P2|Overall Study|early discharge from tx|5
1734895|NCT00975416|6052442|P1|Overall Study|early discharge from tx|3
1734896|NCT00975286|6052451|P2|Overall Study|Sponsor Decision|2
1734897|NCT00975286|6052452|P1|Overall Study|Sponsor Decision|0
1734898|NCT00975286|6052451|P2|Overall Study|Poor Compliance to Protocol|2
1734899|NCT00975286|6052452|P1|Overall Study|Poor Compliance to Protocol|0
1734900|NCT00975286|6052451|P2|Overall Study|Familial and Personal Reasons|2
1734901|NCT00975286|6052452|P1|Overall Study|Familial and Personal Reasons|2
1734902|NCT00975286|6052451|P2|Overall Study|Withdrawal by Subject|2
1734903|NCT00975286|6052452|P1|Overall Study|Withdrawal by Subject|0
1734904|NCT00975286|6052451|P2|Overall Study|Protocol Violation|2
1734905|NCT00975286|6052452|P1|Overall Study|Protocol Violation|1
1734906|NCT00975286|6052451|P2|Overall Study|Adverse Event|19
1734907|NCT00975286|6052452|P1|Overall Study|Adverse Event|9
1734908|NCT00975221|6052484|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
1734909|NCT00975221|6052485|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
1734910|NCT00975221|6052484|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
1734911|NCT00975221|6052485|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
1734912|NCT00975221|6052484|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
1734913|NCT00975221|6052485|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
1734914|NCT00975221|6052484|P2|Titration Phase (Weeks 1-12)|Other|1
1734915|NCT00975221|6052485|P1|Titration Phase (Weeks 1-12)|Other|0
1734916|NCT00975221|6052484|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
1734917|NCT00975221|6052485|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
1734918|NCT00975221|6052484|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
1734919|NCT00975221|6052485|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
1734920|NCT00975195|6052501|P2|Overall Study|Not treated|2
1734921|NCT00975195|6052502|P1|Overall Study|Not treated|1
1734922|NCT00975195|6052501|P2|Overall Study|Other reason not defined above|33
1734923|NCT00975195|6052502|P1|Overall Study|Other reason not defined above|29
1734924|NCT00975195|6052501|P2|Overall Study|Withdrawal by Subject|61
1734925|NCT00975195|6052502|P1|Overall Study|Withdrawal by Subject|48
1734926|NCT00975195|6052501|P2|Overall Study|Lost to Follow-up|7
1734927|NCT00975195|6052502|P1|Overall Study|Lost to Follow-up|9
1734928|NCT00975195|6052501|P2|Overall Study|Protocol Violation|23
1734929|NCT00975195|6052502|P1|Overall Study|Protocol Violation|27
1734930|NCT00975195|6052501|P2|Overall Study|Lack of Efficacy|6
1734931|NCT00975195|6052502|P1|Overall Study|Lack of Efficacy|6
1734932|NCT00975195|6052501|P2|Overall Study|Adverse Event|101
1734933|NCT00975195|6052502|P1|Overall Study|Adverse Event|108
1734934|NCT00975156|6052562|P2|Overall Study|Protocol Violation|1
1734935|NCT00975156|6052563|P1|Overall Study|Protocol Violation|0
1734936|NCT00975143|6052575|P2|Overall Study|Details not available|4
1734937|NCT00975143|6052576|P1|Overall Study|Details not available|10
1734938|NCT00975143|6052575|P2|Overall Study|Physician Decision|2
1734939|NCT00975143|6052576|P1|Overall Study|Physician Decision|1
1734940|NCT00975143|6052575|P2|Overall Study|Non-compliance|8
1734941|NCT00975143|6052576|P1|Overall Study|Non-compliance|5
1734942|NCT00975143|6052575|P2|Overall Study|Lost to Follow-up|16
1734943|NCT00975143|6052576|P1|Overall Study|Lost to Follow-up|20
1734944|NCT00975143|6052575|P2|Overall Study|Withdrawal by Subject|15
1734945|NCT00975143|6052576|P1|Overall Study|Withdrawal by Subject|15
1734946|NCT00975143|6052575|P2|Overall Study|Adverse Event|15
1734947|NCT00975143|6052576|P1|Overall Study|Adverse Event|19
1734948|NCT00975130|6052586|P3|Study Part 2|Protocol Violation|1
1734949|NCT00975130|6052587|P2|Study Part 2|Protocol Violation|0
1734950|NCT00975130|6052588|P1|Study Part 2|Protocol Violation|0
1734951|NCT00975130|6052586|P3|Study Part 2|Administrative|0
1734952|NCT00975130|6052587|P2|Study Part 2|Administrative|1
1734953|NCT00975130|6052588|P1|Study Part 2|Administrative|0
1734954|NCT00975130|6052586|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
1734955|NCT00975130|6052587|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
1734956|NCT00975130|6052588|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
1734957|NCT00975130|6052586|P3|Study Part 2|Withdrew Consent|2
1734958|NCT00975130|6052587|P2|Study Part 2|Withdrew Consent|6
1734959|NCT00975130|6052588|P1|Study Part 2|Withdrew Consent|0
1734960|NCT00975130|6052586|P3|Study Part 2|Withdrawal by Subject|5
1734961|NCT00975130|6052587|P2|Study Part 2|Withdrawal by Subject|13
1734962|NCT00975130|6052588|P1|Study Part 2|Withdrawal by Subject|0
1734963|NCT00975130|6052586|P3|Study Part 2|Lost to Follow-up|1
1734964|NCT00975130|6052587|P2|Study Part 2|Lost to Follow-up|0
1734965|NCT00975130|6052588|P1|Study Part 2|Lost to Follow-up|0
1734966|NCT00975130|6052586|P3|Study Part 2|Adverse Event|7
1734967|NCT00975130|6052587|P2|Study Part 2|Adverse Event|14
1734968|NCT00975130|6052588|P1|Study Part 2|Adverse Event|0
1734969|NCT00975130|6052586|P3|Study Part 1|Withdrew Consent|0
1734970|NCT00975130|6052587|P2|Study Part 1|Withdrew Consent|0
1734971|NCT00975130|6052588|P1|Study Part 1|Withdrew Consent|24
1734972|NCT00975130|6052586|P3|Study Part 1|Administrative|0
1734973|NCT00975130|6052587|P2|Study Part 1|Administrative|0
1734974|NCT00975130|6052588|P1|Study Part 1|Administrative|4
1734975|NCT00975130|6052586|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
1734976|NCT00975130|6052587|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
1734977|NCT00975130|6052588|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
1734978|NCT00975130|6052586|P3|Study Part 1|Protocol Violation|0
1734979|NCT00975130|6052587|P2|Study Part 1|Protocol Violation|0
1734980|NCT00975130|6052588|P1|Study Part 1|Protocol Violation|13
1734981|NCT00975130|6052586|P3|Study Part 1|Withdrawal by Subject|0
1734982|NCT00975130|6052587|P2|Study Part 1|Withdrawal by Subject|0
1734983|NCT00975130|6052588|P1|Study Part 1|Withdrawal by Subject|61
1734984|NCT00975130|6052586|P3|Study Part 1|Lost to Follow-up|0
1734985|NCT00975130|6052587|P2|Study Part 1|Lost to Follow-up|0
1734986|NCT00975130|6052588|P1|Study Part 1|Lost to Follow-up|19
1734987|NCT00975130|6052586|P3|Study Part 1|Adverse Event|0
1734988|NCT00975130|6052587|P2|Study Part 1|Adverse Event|0
1734989|NCT00975130|6052588|P1|Study Part 1|Adverse Event|150
1734990|NCT00975000|6052772|P2|Overall Study|Non-compliance|1
1734991|NCT00975000|6052773|P1|Overall Study|Non-compliance|0
1734992|NCT00975000|6052772|P2|Overall Study|Protocol-specified Criteria|0
1734993|NCT00975000|6052773|P1|Overall Study|Protocol-specified Criteria|1
1734994|NCT00975000|6052772|P2|Overall Study|Lost to Follow-up|1
1734995|NCT00975000|6052773|P1|Overall Study|Lost to Follow-up|0
1734996|NCT00975000|6052772|P2|Overall Study|Withdrawal by Subject|2
1734997|NCT00975000|6052773|P1|Overall Study|Withdrawal by Subject|2
1734998|NCT00975000|6052772|P2|Overall Study|Adverse Event|1
1734999|NCT00975000|6052773|P1|Overall Study|Adverse Event|1
1735000|NCT00975000|6052772|P2|Overall Study|Other|0
1735001|NCT00975000|6052773|P1|Overall Study|Other|1
1735002|NCT00974974|6052797|P2|Maintenance - Double Blind Treatment|Various|0
1735003|NCT00974974|6052798|P1|Maintenance - Double Blind Treatment|Various|4
1735004|NCT00974974|6052797|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
1735005|NCT00974974|6052798|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
1735006|NCT00974974|6052797|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
1735007|NCT00974974|6052798|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
1735008|NCT00974974|6052797|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
1735009|NCT00974974|6052798|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
1735010|NCT00974974|6052797|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
1735011|NCT00974974|6052798|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
1735012|NCT00974974|6052797|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
1735013|NCT00974974|6052798|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
1735014|NCT00974974|6052797|P2|Maintenance - Double Blind Treatment|Adverse Event|3
1735015|NCT00974974|6052798|P1|Maintenance - Double Blind Treatment|Adverse Event|3
1735016|NCT00974974|6052797|P2|IPX066 Dose Conversion|Protocol Violation|0
1735017|NCT00974974|6052798|P1|IPX066 Dose Conversion|Protocol Violation|4
1735018|NCT00974974|6052797|P2|IPX066 Dose Conversion|Various|0
1735019|NCT00974974|6052798|P1|IPX066 Dose Conversion|Various|3
1735020|NCT00974974|6052797|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
1735021|NCT00974974|6052798|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
1735022|NCT00974974|6052797|P2|IPX066 Dose Conversion|Lack of Efficacy|0
1735023|NCT00974974|6052798|P1|IPX066 Dose Conversion|Lack of Efficacy|13
1735024|NCT00974974|6052797|P2|IPX066 Dose Conversion|Death|0
1735025|NCT00974974|6052798|P1|IPX066 Dose Conversion|Death|2
1735026|NCT00974974|6052797|P2|IPX066 Dose Conversion|Adverse Event|0
1735027|NCT00974974|6052798|P1|IPX066 Dose Conversion|Adverse Event|23
1735028|NCT00974974|6052797|P2|IR CD-LD Dose Adjustment|Various|9
1735029|NCT00974974|6052798|P1|IR CD-LD Dose Adjustment|Various|0
1735030|NCT00974974|6052797|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
1735031|NCT00974974|6052798|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
1735032|NCT00974974|6052797|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
1735033|NCT00974974|6052798|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
1735034|NCT00974974|6052797|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
1735035|NCT00974974|6052798|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
1735036|NCT00974974|6052797|P2|IR CD-LD Dose Adjustment|Adverse Event|3
1735037|NCT00974974|6052798|P1|IR CD-LD Dose Adjustment|Adverse Event|0
1735038|NCT00974922|6052808|P1|Overall Study|study terminated|24
1735039|NCT00974675|6052826|P4|Overall Study|Participant on holiday; unable to attend|1
1735040|NCT00974675|6052827|P3|Overall Study|Participant on holiday; unable to attend|0
1735041|NCT00974675|6052828|P2|Overall Study|Participant on holiday; unable to attend|0
1735042|NCT00974675|6052829|P1|Overall Study|Participant on holiday; unable to attend|0
1735043|NCT00974675|6052826|P4|Overall Study|Physician Decision|0
1735044|NCT00974675|6052827|P3|Overall Study|Physician Decision|1
1735045|NCT00974675|6052828|P2|Overall Study|Physician Decision|0
1735046|NCT00974675|6052829|P1|Overall Study|Physician Decision|0
1735047|NCT00974675|6052826|P4|Overall Study|Adverse Event|1
1735048|NCT00974675|6052827|P3|Overall Study|Adverse Event|1
1735049|NCT00974675|6052828|P2|Overall Study|Adverse Event|1
1735050|NCT00974675|6052829|P1|Overall Study|Adverse Event|2
1735051|NCT00974571|6052878|P3|Overall Study|Other|10
1735052|NCT00974571|6052879|P2|Overall Study|Other|0
1735053|NCT00974571|6052880|P1|Overall Study|Other|4
1735054|NCT00974571|6052878|P3|Overall Study|Patient Moved|1
1735055|NCT00974571|6052879|P2|Overall Study|Patient Moved|0
1735056|NCT00974571|6052880|P1|Overall Study|Patient Moved|1
1735057|NCT00974571|6052878|P3|Overall Study|Withdrawal by Subject|16
1735058|NCT00974571|6052879|P2|Overall Study|Withdrawal by Subject|5
1735059|NCT00974571|6052880|P1|Overall Study|Withdrawal by Subject|14
1735060|NCT00974571|6052878|P3|Overall Study|Protocol Violation|18
1735061|NCT00974571|6052879|P2|Overall Study|Protocol Violation|4
1735062|NCT00974571|6052880|P1|Overall Study|Protocol Violation|13
1735063|NCT00974571|6052878|P3|Overall Study|Lost to Follow-up|2
1735064|NCT00974571|6052879|P2|Overall Study|Lost to Follow-up|1
1735065|NCT00974571|6052880|P1|Overall Study|Lost to Follow-up|2
1735066|NCT00974571|6052878|P3|Overall Study|Lack of Efficacy|9
1735067|NCT00974571|6052879|P2|Overall Study|Lack of Efficacy|2
1735068|NCT00974571|6052880|P1|Overall Study|Lack of Efficacy|3
1735069|NCT00974571|6052878|P3|Overall Study|Adverse Event|27
1735070|NCT00974571|6052879|P2|Overall Study|Adverse Event|4
1735071|NCT00974571|6052880|P1|Overall Study|Adverse Event|31
1735072|NCT00974311|6052977|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
1735073|NCT00974311|6052978|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
1735074|NCT00974311|6052977|P2|OLE Phase (up to 77 Months)|Other|2
1735075|NCT00974311|6052978|P1|OLE Phase (up to 77 Months)|Other|15
1735076|NCT00974311|6052977|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
1735077|NCT00974311|6052978|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
1735078|NCT00974311|6052977|P2|OLE Phase (up to 77 Months)|Death|21
1735079|NCT00974311|6052978|P1|OLE Phase (up to 77 Months)|Death|14
1735080|NCT00974311|6052977|P2|DB Phase (up to 24 Months)|Other|0
1735081|NCT00974311|6052978|P1|DB Phase (up to 24 Months)|Other|1
1735082|NCT00974311|6052977|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
1735083|NCT00974311|6052978|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
1735084|NCT00974311|6052977|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
1735085|NCT00974311|6052978|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
1735086|NCT00974311|6052977|P2|DB Phase (up to 24 Months)|Death|298
1735087|NCT00974311|6052978|P1|DB Phase (up to 24 Months)|Death|561
1735088|NCT00974311|6052977|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
1735089|NCT00974311|6052978|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
1735090|NCT00974259|6053016|P2|Overall Study|Technically inadequate PbtO2 recordings|1
1735091|NCT00974259|6053017|P1|Overall Study|Technically inadequate PbtO2 recordings|2
1735092|NCT00974233|6053035|P1|Maintenance Lenalidomide|Adverse Event|8
1735093|NCT00974233|6053035|P1|Maintenance Lenalidomide|Lack of Efficacy|5
1735094|NCT00974233|6053035|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
1735095|NCT00974233|6053035|P1|Induction Chemoimmunotherapy|Adverse Event|7
1735096|NCT00974233|6053035|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
1735097|NCT00974233|6053035|P1|Induction Chemoimmunotherapy|Death|2
1735098|NCT00974220|6053050|P2|Treatment Period 1|noncompliant subjects|1
1735099|NCT00974220|6053051|P1|Treatment Period 1|noncompliant subjects|0
1735100|NCT00974220|6053050|P2|Treatment Period 1|Adverse Event|1
1735101|NCT00974220|6053051|P1|Treatment Period 1|Adverse Event|2
1735102|NCT00974090|6053096|P2|Period 2: Open-label Period|Withdrawal by Subject|0
1735103|NCT00974090|6053097|P1|Period 2: Open-label Period|Withdrawal by Subject|1
1735104|NCT00974090|6053096|P2|Period 2: Open-label Period|Physician Decision|3
1735105|NCT00974090|6053097|P1|Period 2: Open-label Period|Physician Decision|0
1735106|NCT00974090|6053096|P2|Period 2: Open-label Period|Lack of Efficacy|1
1735107|NCT00974090|6053097|P1|Period 2: Open-label Period|Lack of Efficacy|3
1735108|NCT00974090|6053096|P2|Period 2: Open-label Period|Adverse Event|6
1735109|NCT00974090|6053097|P1|Period 2: Open-label Period|Adverse Event|4
1735110|NCT00974090|6053096|P2|Period 1: Double Blind Period|Physician Decision|0
1735111|NCT00974090|6053097|P1|Period 1: Double Blind Period|Physician Decision|1
1735112|NCT00974090|6053096|P2|Period 1: Double Blind Period|Adverse Event|1
1735113|NCT00974090|6053097|P1|Period 1: Double Blind Period|Adverse Event|2
1735114|NCT00973973|6053133|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
1735115|NCT00973973|6053134|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
1735116|NCT00973973|6053133|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
1735117|NCT00973973|6053134|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
1735118|NCT00973973|6053133|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
1735119|NCT00973973|6053134|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
1735120|NCT00973973|6053133|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
1735121|NCT00973973|6053134|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
1735122|NCT00973973|6053133|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
1735123|NCT00973973|6053134|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
1735124|NCT00973973|6053133|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
1735125|NCT00973973|6053134|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
1735126|NCT00973973|6053133|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
1735127|NCT00973973|6053134|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
1735128|NCT00973973|6053133|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
1735129|NCT00973973|6053134|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
1735130|NCT00973973|6053133|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
1735131|NCT00973973|6053134|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
1735132|NCT00973973|6053133|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
1735133|NCT00973973|6053134|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
1735134|NCT00973973|6053133|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
1735135|NCT00973973|6053134|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
1735136|NCT00973973|6053133|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
1735137|NCT00973973|6053134|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
1735138|NCT00973921|6053194|P1|Overall Study|IVUS results were not available|9
1735139|NCT00973765|6053211|P2|Overall Study|Lost to Follow-up|14
1735140|NCT00973765|6053212|P1|Overall Study|Lost to Follow-up|8
1735141|NCT00973700|6053234|P5|Overall Study|Unable to Classify|1
1735142|NCT00973700|6053235|P4|Overall Study|Unable to Classify|2
1735143|NCT00973700|6053236|P3|Overall Study|Unable to Classify|1
1735144|NCT00973700|6053237|P2|Overall Study|Unable to Classify|0
1735145|NCT00973700|6053238|P1|Overall Study|Unable to Classify|0
1735146|NCT00973700|6053234|P5|Overall Study|Inappropriate enrolment|0
1735147|NCT00973700|6053235|P4|Overall Study|Inappropriate enrolment|4
1735148|NCT00973700|6053236|P3|Overall Study|Inappropriate enrolment|0
1735149|NCT00973700|6053237|P2|Overall Study|Inappropriate enrolment|0
1735150|NCT00973700|6053238|P1|Overall Study|Inappropriate enrolment|0
1735151|NCT00973700|6053234|P5|Overall Study|Lost to Follow-up|5
1735152|NCT00973700|6053235|P4|Overall Study|Lost to Follow-up|8
1735153|NCT00973700|6053236|P3|Overall Study|Lost to Follow-up|1
1735154|NCT00973700|6053237|P2|Overall Study|Lost to Follow-up|0
1735155|NCT00973700|6053238|P1|Overall Study|Lost to Follow-up|5
1735156|NCT00973700|6053234|P5|Overall Study|Withdrawal by Subject|4
1735157|NCT00973700|6053235|P4|Overall Study|Withdrawal by Subject|4
1735158|NCT00973700|6053236|P3|Overall Study|Withdrawal by Subject|8
1735159|NCT00973700|6053237|P2|Overall Study|Withdrawal by Subject|2
1735160|NCT00973700|6053238|P1|Overall Study|Withdrawal by Subject|2
1735161|NCT00973674|6053287|P2|Overall Study|Protocol Violation|0
1735162|NCT00973674|6053288|P1|Overall Study|Protocol Violation|2
1735163|NCT00973622|6053302|P2|Overall Study|did not complete rTMS sessions|2
1735164|NCT00973622|6053303|P1|Overall Study|did not complete rTMS sessions|11
1735165|NCT00973622|6053302|P2|Overall Study|did not pass MRI screen|0
1735166|NCT00973622|6053303|P1|Overall Study|did not pass MRI screen|6
1735167|NCT00973622|6053302|P2|Overall Study|did not attend MRI|3
1735168|NCT00973622|6053303|P1|Overall Study|did not attend MRI|14
1735169|NCT00973479|6053311|P2|Overall Study|Other|7
1735170|NCT00973479|6053312|P1|Overall Study|Other|1
1735171|NCT00973479|6053311|P2|Overall Study|Protocol Violation|2
1735172|NCT00973479|6053312|P1|Overall Study|Protocol Violation|2
1735173|NCT00973479|6053311|P2|Overall Study|Adverse Event|32
1735174|NCT00973479|6053312|P1|Overall Study|Adverse Event|12
1735175|NCT00973479|6053311|P2|Overall Study|Lack of Efficacy|7
1735176|NCT00973479|6053312|P1|Overall Study|Lack of Efficacy|5
1735177|NCT00973479|6053311|P2|Overall Study|Withdrawal by Subject|16
1735178|NCT00973479|6053312|P1|Overall Study|Withdrawal by Subject|15
1735179|NCT00973479|6053311|P2|Overall Study|Death|2
1735180|NCT00973479|6053312|P1|Overall Study|Death|2
1735181|NCT00973479|6053311|P2|Overall Study|Lost to Follow-up|3
1735182|NCT00973479|6053312|P1|Overall Study|Lost to Follow-up|0
1735183|NCT00973362|6053330|P2|3-Year Follow-up|Lost to Follow-up|0
1735184|NCT00973362|6053331|P1|3-Year Follow-up|Lost to Follow-up|17
1735185|NCT00973362|6053330|P2|Baseline Evaluation|Inevaluable|223
1735186|NCT00973362|6053331|P1|Baseline Evaluation|Inevaluable|686
1735187|NCT00973362|6053330|P2|Baseline Evaluation|No colposcopy visit|0
1735188|NCT00973362|6053331|P1|Baseline Evaluation|No colposcopy visit|62
1735189|NCT00973362|6053330|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
1735190|NCT00973362|6053331|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
1735191|NCT00973349|6053356|P16|Overall Study|Unable to classify|0
1735192|NCT00973349|6053357|P15|Overall Study|Unable to classify|0
1735193|NCT00973349|6053358|P14|Overall Study|Unable to classify|0
1735194|NCT00973349|6053359|P13|Overall Study|Unable to classify|0
1735195|NCT00973349|6053360|P12|Overall Study|Unable to classify|0
1735196|NCT00973349|6053361|P11|Overall Study|Unable to classify|0
1735197|NCT00973349|6053362|P10|Overall Study|Unable to classify|1
1735198|NCT00973349|6053363|P9|Overall Study|Unable to classify|0
1735199|NCT00973349|6053364|P8|Overall Study|Unable to classify|0
1735200|NCT00973349|6053365|P7|Overall Study|Unable to classify|0
1735201|NCT00973349|6053366|P6|Overall Study|Unable to classify|1
1735202|NCT00973349|6053367|P5|Overall Study|Unable to classify|1
1735203|NCT00973349|6053368|P4|Overall Study|Unable to classify|0
1735204|NCT00973349|6053369|P3|Overall Study|Unable to classify|0
1735205|NCT00973349|6053370|P2|Overall Study|Unable to classify|0
1735206|NCT00973349|6053371|P1|Overall Study|Unable to classify|0
1735207|NCT00973349|6053356|P16|Overall Study|Protocol Violation|0
1735208|NCT00973349|6053357|P15|Overall Study|Protocol Violation|0
1735209|NCT00973349|6053358|P14|Overall Study|Protocol Violation|0
1735210|NCT00973349|6053359|P13|Overall Study|Protocol Violation|0
1735211|NCT00973349|6053360|P12|Overall Study|Protocol Violation|0
1735212|NCT00973349|6053361|P11|Overall Study|Protocol Violation|0
1735213|NCT00973349|6053362|P10|Overall Study|Protocol Violation|0
1735214|NCT00973349|6053363|P9|Overall Study|Protocol Violation|1
1735215|NCT00973349|6053364|P8|Overall Study|Protocol Violation|0
1735216|NCT00973349|6053365|P7|Overall Study|Protocol Violation|0
1735217|NCT00973349|6053366|P6|Overall Study|Protocol Violation|0
1735218|NCT00973349|6053367|P5|Overall Study|Protocol Violation|0
1735219|NCT00973349|6053368|P4|Overall Study|Protocol Violation|0
1735220|NCT00973349|6053369|P3|Overall Study|Protocol Violation|0
1735221|NCT00973349|6053370|P2|Overall Study|Protocol Violation|0
1735222|NCT00973349|6053371|P1|Overall Study|Protocol Violation|0
1735223|NCT00973349|6053356|P16|Overall Study|Inappropriate enrolment|1
1735224|NCT00973349|6053357|P15|Overall Study|Inappropriate enrolment|1
1735225|NCT00973349|6053358|P14|Overall Study|Inappropriate enrolment|0
1735226|NCT00973349|6053359|P13|Overall Study|Inappropriate enrolment|1
1735227|NCT00973349|6053360|P12|Overall Study|Inappropriate enrolment|0
1735228|NCT00973349|6053361|P11|Overall Study|Inappropriate enrolment|0
1735229|NCT00973349|6053362|P10|Overall Study|Inappropriate enrolment|2
1735230|NCT00973349|6053363|P9|Overall Study|Inappropriate enrolment|0
1735231|NCT00973349|6053364|P8|Overall Study|Inappropriate enrolment|0
1735232|NCT00973349|6053365|P7|Overall Study|Inappropriate enrolment|0
1735233|NCT00973349|6053366|P6|Overall Study|Inappropriate enrolment|0
1735234|NCT00973349|6053367|P5|Overall Study|Inappropriate enrolment|0
1735235|NCT00973349|6053368|P4|Overall Study|Inappropriate enrolment|0
1735236|NCT00973349|6053369|P3|Overall Study|Inappropriate enrolment|1
1735237|NCT00973349|6053370|P2|Overall Study|Inappropriate enrolment|0
1735238|NCT00973349|6053371|P1|Overall Study|Inappropriate enrolment|0
1735239|NCT00973349|6053356|P16|Overall Study|Lost to Follow-up|1
1735240|NCT00973349|6053357|P15|Overall Study|Lost to Follow-up|0
1735241|NCT00973349|6053358|P14|Overall Study|Lost to Follow-up|0
1735242|NCT00973349|6053359|P13|Overall Study|Lost to Follow-up|0
1735243|NCT00973349|6053360|P12|Overall Study|Lost to Follow-up|1
1735244|NCT00973349|6053361|P11|Overall Study|Lost to Follow-up|0
1735245|NCT00973349|6053362|P10|Overall Study|Lost to Follow-up|1
1735246|NCT00973349|6053363|P9|Overall Study|Lost to Follow-up|2
1735247|NCT00973349|6053364|P8|Overall Study|Lost to Follow-up|1
1735248|NCT00973349|6053365|P7|Overall Study|Lost to Follow-up|0
1735249|NCT00973349|6053366|P6|Overall Study|Lost to Follow-up|3
1735250|NCT00973349|6053367|P5|Overall Study|Lost to Follow-up|1
1735251|NCT00973349|6053368|P4|Overall Study|Lost to Follow-up|2
1735252|NCT00973349|6053369|P3|Overall Study|Lost to Follow-up|2
1735253|NCT00973349|6053370|P2|Overall Study|Lost to Follow-up|1
1735254|NCT00973349|6053371|P1|Overall Study|Lost to Follow-up|3
1735255|NCT00973349|6053356|P16|Overall Study|Withdrawal by Subject|0
1735256|NCT00973349|6053357|P15|Overall Study|Withdrawal by Subject|0
1735257|NCT00973349|6053358|P14|Overall Study|Withdrawal by Subject|0
1735258|NCT00973349|6053359|P13|Overall Study|Withdrawal by Subject|0
1735259|NCT00973349|6053360|P12|Overall Study|Withdrawal by Subject|1
1735260|NCT00973349|6053361|P11|Overall Study|Withdrawal by Subject|0
1735261|NCT00973349|6053362|P10|Overall Study|Withdrawal by Subject|2
1735262|NCT00973349|6053363|P9|Overall Study|Withdrawal by Subject|0
1735263|NCT00973349|6053364|P8|Overall Study|Withdrawal by Subject|2
1735264|NCT00973349|6053365|P7|Overall Study|Withdrawal by Subject|2
1735265|NCT00973349|6053366|P6|Overall Study|Withdrawal by Subject|0
1735266|NCT00973349|6053367|P5|Overall Study|Withdrawal by Subject|2
1735267|NCT00973349|6053368|P4|Overall Study|Withdrawal by Subject|3
1735268|NCT00973349|6053369|P3|Overall Study|Withdrawal by Subject|2
1735269|NCT00973349|6053370|P2|Overall Study|Withdrawal by Subject|2
1735270|NCT00973349|6053371|P1|Overall Study|Withdrawal by Subject|1
1735271|NCT00973349|6053356|P16|Overall Study|Adverse Event|0
1735272|NCT00973349|6053357|P15|Overall Study|Adverse Event|1
1735273|NCT00973349|6053358|P14|Overall Study|Adverse Event|0
1735274|NCT00973349|6053359|P13|Overall Study|Adverse Event|0
1735275|NCT00973349|6053360|P12|Overall Study|Adverse Event|0
1735276|NCT00973349|6053361|P11|Overall Study|Adverse Event|0
1735277|NCT00973349|6053362|P10|Overall Study|Adverse Event|0
1735278|NCT00973349|6053363|P9|Overall Study|Adverse Event|1
1735279|NCT00973349|6053364|P8|Overall Study|Adverse Event|0
1735280|NCT00973349|6053365|P7|Overall Study|Adverse Event|0
1735281|NCT00973349|6053366|P6|Overall Study|Adverse Event|0
1735282|NCT00973349|6053367|P5|Overall Study|Adverse Event|1
1735283|NCT00973349|6053368|P4|Overall Study|Adverse Event|0
1735284|NCT00973349|6053369|P3|Overall Study|Adverse Event|0
1735285|NCT00973349|6053370|P2|Overall Study|Adverse Event|0
1735286|NCT00973349|6053371|P1|Overall Study|Adverse Event|0
1735287|NCT00972816|6053492|P8|Overall Study|Unable to classify|0
1735288|NCT00972816|6053493|P7|Overall Study|Unable to classify|0
1735289|NCT00972816|6053494|P6|Overall Study|Unable to classify|0
1735290|NCT00972816|6053495|P5|Overall Study|Unable to classify|1
1735291|NCT00972816|6053496|P4|Overall Study|Unable to classify|0
1735292|NCT00972816|6053497|P3|Overall Study|Unable to classify|0
1735293|NCT00972816|6053498|P2|Overall Study|Unable to classify|0
1735294|NCT00972816|6053499|P1|Overall Study|Unable to classify|2
1735295|NCT00972816|6053492|P8|Overall Study|Inappropriate enrolment|0
1735296|NCT00972816|6053493|P7|Overall Study|Inappropriate enrolment|2
1735297|NCT00972816|6053494|P6|Overall Study|Inappropriate enrolment|0
1735298|NCT00972816|6053495|P5|Overall Study|Inappropriate enrolment|0
1735299|NCT00972816|6053496|P4|Overall Study|Inappropriate enrolment|0
1735300|NCT00972816|6053497|P3|Overall Study|Inappropriate enrolment|0
1735301|NCT00972816|6053498|P2|Overall Study|Inappropriate enrolment|0
1735302|NCT00972816|6053499|P1|Overall Study|Inappropriate enrolment|0
1735303|NCT00972816|6053492|P8|Overall Study|Lost to Follow-up|7
1735304|NCT00972816|6053493|P7|Overall Study|Lost to Follow-up|7
1735305|NCT00972816|6053494|P6|Overall Study|Lost to Follow-up|10
1735306|NCT00972816|6053495|P5|Overall Study|Lost to Follow-up|11
1735307|NCT00972816|6053496|P4|Overall Study|Lost to Follow-up|5
1735308|NCT00972816|6053497|P3|Overall Study|Lost to Follow-up|7
1735309|NCT00972816|6053498|P2|Overall Study|Lost to Follow-up|9
1735310|NCT00972816|6053499|P1|Overall Study|Lost to Follow-up|11
1735311|NCT00972816|6053492|P8|Overall Study|Withdrawal by Subject|2
1735312|NCT00972816|6053493|P7|Overall Study|Withdrawal by Subject|1
1735313|NCT00972816|6053494|P6|Overall Study|Withdrawal by Subject|1
1735314|NCT00972816|6053495|P5|Overall Study|Withdrawal by Subject|0
1735315|NCT00972816|6053496|P4|Overall Study|Withdrawal by Subject|3
1735316|NCT00972816|6053497|P3|Overall Study|Withdrawal by Subject|1
1735317|NCT00972816|6053498|P2|Overall Study|Withdrawal by Subject|2
1735318|NCT00972816|6053499|P1|Overall Study|Withdrawal by Subject|4
1735319|NCT00972816|6053492|P8|Overall Study|Adverse Event|0
1735320|NCT00972816|6053493|P7|Overall Study|Adverse Event|0
1735321|NCT00972816|6053494|P6|Overall Study|Adverse Event|0
1735322|NCT00972816|6053495|P5|Overall Study|Adverse Event|0
1735323|NCT00972816|6053496|P4|Overall Study|Adverse Event|0
1735324|NCT00972816|6053497|P3|Overall Study|Adverse Event|1
1735325|NCT00972816|6053498|P2|Overall Study|Adverse Event|0
1735326|NCT00972816|6053499|P1|Overall Study|Adverse Event|0
1735327|NCT00972777|6053583|P2|Overall Study|Missed visit|0
1735328|NCT00972777|6053584|P1|Overall Study|Missed visit|1
1735329|NCT00972777|6053583|P2|Overall Study|Screening Failure|1
1735330|NCT00972777|6053584|P1|Overall Study|Screening Failure|2
1735331|NCT00972777|6053583|P2|Overall Study|Protocol Violation|2
1735332|NCT00972777|6053584|P1|Overall Study|Protocol Violation|0
1735333|NCT00972777|6053583|P2|Overall Study|Physician Decision|0
1735334|NCT00972777|6053584|P1|Overall Study|Physician Decision|4
1735335|NCT00972777|6053583|P2|Overall Study|Withdrawal by Subject|5
1735336|NCT00972777|6053584|P1|Overall Study|Withdrawal by Subject|4
1735337|NCT00972777|6053583|P2|Overall Study|Lost to Follow-up|4
1735338|NCT00972777|6053584|P1|Overall Study|Lost to Follow-up|0
1735339|NCT00972777|6053583|P2|Overall Study|Adverse Event|2
1735340|NCT00972777|6053584|P1|Overall Study|Adverse Event|3
1735341|NCT00972738|6053599|P3|Overall Study|Other|1
1735342|NCT00972738|6053600|P2|Overall Study|Other|2
1735343|NCT00972738|6053601|P1|Overall Study|Other|1
1735344|NCT00972738|6053599|P3|Overall Study|Moved|1
1735345|NCT00972738|6053600|P2|Overall Study|Moved|0
1735346|NCT00972738|6053601|P1|Overall Study|Moved|0
1735347|NCT00972738|6053599|P3|Overall Study|Withdrawal by Subject|4
1735348|NCT00972738|6053600|P2|Overall Study|Withdrawal by Subject|1
1735349|NCT00972738|6053601|P1|Overall Study|Withdrawal by Subject|5
1735350|NCT00972738|6053599|P3|Overall Study|Lack of Efficacy|11
1735351|NCT00972738|6053600|P2|Overall Study|Lack of Efficacy|1
1735352|NCT00972738|6053601|P1|Overall Study|Lack of Efficacy|5
1735353|NCT00972738|6053599|P3|Overall Study|Lost to Follow-up|1
1735354|NCT00972738|6053600|P2|Overall Study|Lost to Follow-up|0
1735355|NCT00972738|6053601|P1|Overall Study|Lost to Follow-up|1
1735356|NCT00972738|6053599|P3|Overall Study|Protocol Violation|3
1735357|NCT00972738|6053600|P2|Overall Study|Protocol Violation|1
1735358|NCT00972738|6053601|P1|Overall Study|Protocol Violation|2
1735359|NCT00972738|6053599|P3|Overall Study|Adverse Event|8
1735360|NCT00972738|6053600|P2|Overall Study|Adverse Event|1
1735361|NCT00972738|6053601|P1|Overall Study|Adverse Event|7
1735362|NCT00972595|6053718|P2|Period 1|Adverse Event|0
1735363|NCT00972595|6053719|P1|Period 1|Adverse Event|1
1735364|NCT00972543|6053729|P2|Overall Study|Early study termination by sponsor|1
1735365|NCT00972543|6053730|P1|Overall Study|Early study termination by sponsor|4
1735366|NCT00972543|6053729|P2|Overall Study|Adverse Event|0
1735367|NCT00972543|6053730|P1|Overall Study|Adverse Event|1
1735368|NCT00972517|6053813|P6|Overall Study|Withdrawal by Subject|0
1735369|NCT00972517|6053814|P5|Overall Study|Withdrawal by Subject|1
1735370|NCT00972517|6053815|P4|Overall Study|Withdrawal by Subject|2
1735371|NCT00972517|6053816|P3|Overall Study|Withdrawal by Subject|0
1735372|NCT00972517|6053817|P2|Overall Study|Withdrawal by Subject|1
1735373|NCT00972517|6053818|P1|Overall Study|Withdrawal by Subject|0
1735374|NCT00972517|6053813|P6|Overall Study|Adverse Event|0
1735375|NCT00972517|6053814|P5|Overall Study|Adverse Event|0
1735376|NCT00972517|6053815|P4|Overall Study|Adverse Event|1
1735377|NCT00972517|6053816|P3|Overall Study|Adverse Event|0
1735378|NCT00972517|6053817|P2|Overall Study|Adverse Event|0
1735379|NCT00972517|6053818|P1|Overall Study|Adverse Event|0
1735380|NCT00972504|6053913|P1|Overall Study|Investigator discretion|1
1735381|NCT00972504|6053913|P1|Overall Study|Adverse Event|2
1735396|NCT00972322|6053991|P2|Overall Study|Consistently high glucose values|0
1735397|NCT00972322|6053992|P1|Overall Study|Consistently high glucose values|1
1735398|NCT00972322|6053991|P2|Overall Study|Lost to Follow-up|1
1735399|NCT00972322|6053992|P1|Overall Study|Lost to Follow-up|0
1735400|NCT00972322|6053991|P2|Overall Study|Positive drug screen|1
1735401|NCT00972322|6053992|P1|Overall Study|Positive drug screen|0
1735402|NCT00972322|6053991|P2|Overall Study|Adverse Event|1
1735403|NCT00972322|6053992|P1|Overall Study|Adverse Event|2
1735404|NCT00972283|6054004|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
1735405|NCT00972283|6054005|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
1735406|NCT00972283|6054004|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
1735407|NCT00972283|6054005|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
1735408|NCT00972283|6054004|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
1735409|NCT00972283|6054005|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
1735410|NCT00972283|6054004|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
1735411|NCT00972283|6054005|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
1735412|NCT00972283|6054004|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
1735413|NCT00972283|6054005|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
1735414|NCT00972283|6054004|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
1735415|NCT00972283|6054005|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
1735416|NCT00972283|6054004|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
1735417|NCT00972283|6054005|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
1735418|NCT00972283|6054004|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
1735419|NCT00972283|6054005|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
1735420|NCT00972283|6054004|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
1735421|NCT00972283|6054005|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
1735422|NCT00972283|6054004|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
1735423|NCT00972283|6054005|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
1735424|NCT00972244|6054032|P5|Overall Study|Various|2
1735425|NCT00972244|6054033|P4|Overall Study|Various|0
1735426|NCT00972244|6054034|P3|Overall Study|Various|0
1735427|NCT00972244|6054035|P2|Overall Study|Various|0
1735428|NCT00972244|6054036|P1|Overall Study|Various|0
1735429|NCT00972244|6054032|P5|Overall Study|Death|0
1735430|NCT00972244|6054033|P4|Overall Study|Death|0
1735431|NCT00972244|6054034|P3|Overall Study|Death|0
1735432|NCT00972244|6054035|P2|Overall Study|Death|0
1735433|NCT00972244|6054036|P1|Overall Study|Death|1
1735434|NCT00972244|6054032|P5|Overall Study|Safety|1
1735435|NCT00972244|6054033|P4|Overall Study|Safety|0
1735436|NCT00972244|6054034|P3|Overall Study|Safety|0
1735437|NCT00972244|6054035|P2|Overall Study|Safety|0
1735438|NCT00972244|6054036|P1|Overall Study|Safety|0
1735439|NCT00972244|6054032|P5|Overall Study|Withdrawal by Subject|1
1735440|NCT00972244|6054033|P4|Overall Study|Withdrawal by Subject|0
1735441|NCT00972244|6054034|P3|Overall Study|Withdrawal by Subject|1
1735442|NCT00972244|6054035|P2|Overall Study|Withdrawal by Subject|2
1735443|NCT00972244|6054036|P1|Overall Study|Withdrawal by Subject|1
1735444|NCT00972244|6054032|P5|Overall Study|Subject No Longer Meets Study Criteria|5
1735445|NCT00972244|6054033|P4|Overall Study|Subject No Longer Meets Study Criteria|0
1735446|NCT00972244|6054034|P3|Overall Study|Subject No Longer Meets Study Criteria|0
1735447|NCT00972244|6054035|P2|Overall Study|Subject No Longer Meets Study Criteria|2
1735448|NCT00972244|6054036|P1|Overall Study|Subject No Longer Meets Study Criteria|2
1735449|NCT00972244|6054032|P5|Overall Study|Adverse Event|0
1735450|NCT00972244|6054033|P4|Overall Study|Adverse Event|0
1735451|NCT00972244|6054034|P3|Overall Study|Adverse Event|1
1735452|NCT00972244|6054035|P2|Overall Study|Adverse Event|1
1735453|NCT00972244|6054036|P1|Overall Study|Adverse Event|0
1735454|NCT00972244|6054032|P5|Overall Study|Incorrect Enrolment|0
1735455|NCT00972244|6054033|P4|Overall Study|Incorrect Enrolment|0
1735456|NCT00972244|6054034|P3|Overall Study|Incorrect Enrolment|0
1735457|NCT00972244|6054035|P2|Overall Study|Incorrect Enrolment|0
1735458|NCT00972244|6054036|P1|Overall Study|Incorrect Enrolment|1
1735459|NCT00972153|6054068|P3|Overall Study|Equipment malfunction during case|0
1735460|NCT00972153|6054069|P2|Overall Study|Equipment malfunction during case|1
1735461|NCT00972153|6054070|P1|Overall Study|Equipment malfunction during case|0
1735462|NCT00972023|6054085|P1|Overall Study|Withdrawal by Subject|1
1735463|NCT00971997|6054092|P1|Overall Study|Physician Decision|7
1735464|NCT00971997|6054092|P1|Overall Study|Withdrawal by Subject|5
1735465|NCT00971997|6054092|P1|Overall Study|Protocol Violation|4
1735466|NCT00971997|6054092|P1|Overall Study|Death|1
1735467|NCT00971997|6054092|P1|Overall Study|Adverse Event|2
1735468|NCT00971932|6054110|P1|Overall Study|Ongoing|4
1735469|NCT00971932|6054110|P1|Overall Study|Investigator's decision|2
1735470|NCT00971932|6054110|P1|Overall Study|Withdrawal by Subject|1
1735471|NCT00971425|6054211|P2|Overall Study|Withdrawal by Subject|1
1735472|NCT00971425|6054212|P1|Overall Study|Withdrawal by Subject|0
1735473|NCT00971425|6054211|P2|Overall Study|Adverse Event|1
1735474|NCT00971425|6054212|P1|Overall Study|Adverse Event|1
1735475|NCT00971321|6054248|P2|Up to Month 11-12|Lost to Follow-up|0
1735476|NCT00971321|6054249|P1|Up to Month 11-12|Lost to Follow-up|1
1735477|NCT00971321|6054248|P2|Up to Month 11-12|Migrated/moved from study area|2
1735478|NCT00971321|6054249|P1|Up to Month 11-12|Migrated/moved from study area|2
1735479|NCT00971321|6054248|P2|Up to Month 11-12|Withdrawal by Subject|1
1735480|NCT00971321|6054249|P1|Up to Month 11-12|Withdrawal by Subject|2
1735481|NCT00971321|6054248|P2|Up to Month 7|Migrated/moved from study area|2
1735482|NCT00971321|6054249|P1|Up to Month 7|Migrated/moved from study area|3
1735483|NCT00971321|6054248|P2|Up to Month 7|Withdrawal by Subject|0
1735484|NCT00971321|6054249|P1|Up to Month 7|Withdrawal by Subject|1
1735485|NCT00971243|6054329|P5|Open-label Period|Other reason|2
1735486|NCT00971243|6054330|P4|Open-label Period|Other reason|0
1735487|NCT00971243|6054331|P3|Open-label Period|Other reason|0
1735488|NCT00971243|6054332|P2|Open-label Period|Other reason|0
1735489|NCT00971243|6054333|P1|Open-label Period|Other reason|0
1735490|NCT00971243|6054329|P5|Open-label Period|Withdrawal by Subject|1
1735491|NCT00971243|6054330|P4|Open-label Period|Withdrawal by Subject|2
1735492|NCT00971243|6054331|P3|Open-label Period|Withdrawal by Subject|0
1735493|NCT00971243|6054332|P2|Open-label Period|Withdrawal by Subject|0
1735494|NCT00971243|6054333|P1|Open-label Period|Withdrawal by Subject|1
1735495|NCT00971243|6054329|P5|Open-label Period|Protocol Violation|1
1735496|NCT00971243|6054330|P4|Open-label Period|Protocol Violation|0
1735497|NCT00971243|6054331|P3|Open-label Period|Protocol Violation|1
1735498|NCT00971243|6054332|P2|Open-label Period|Protocol Violation|1
1735499|NCT00971243|6054333|P1|Open-label Period|Protocol Violation|1
1735500|NCT00971243|6054329|P5|Open-label Period|Physician Decision|2
1735501|NCT00971243|6054330|P4|Open-label Period|Physician Decision|7
1735502|NCT00971243|6054331|P3|Open-label Period|Physician Decision|3
1735503|NCT00971243|6054332|P2|Open-label Period|Physician Decision|9
1735504|NCT00971243|6054333|P1|Open-label Period|Physician Decision|5
1735505|NCT00971243|6054329|P5|Open-label Period|Adverse Event|0
1735506|NCT00971243|6054330|P4|Open-label Period|Adverse Event|1
1735507|NCT00971243|6054331|P3|Open-label Period|Adverse Event|1
1735508|NCT00971243|6054332|P2|Open-label Period|Adverse Event|0
1735509|NCT00971243|6054333|P1|Open-label Period|Adverse Event|1
1735510|NCT00971243|6054329|P5|Double Blind Period|Other reasons|1
1735511|NCT00971243|6054330|P4|Double Blind Period|Other reasons|0
1735512|NCT00971243|6054331|P3|Double Blind Period|Other reasons|2
1735513|NCT00971243|6054332|P2|Double Blind Period|Other reasons|0
1735514|NCT00971243|6054333|P1|Double Blind Period|Other reasons|1
1735515|NCT00971243|6054329|P5|Double Blind Period|Withdrawal by Subject|4
1735516|NCT00971243|6054330|P4|Double Blind Period|Withdrawal by Subject|4
1735517|NCT00971243|6054331|P3|Double Blind Period|Withdrawal by Subject|4
1735518|NCT00971243|6054332|P2|Double Blind Period|Withdrawal by Subject|1
1735519|NCT00971243|6054333|P1|Double Blind Period|Withdrawal by Subject|4
1735520|NCT00971243|6054329|P5|Double Blind Period|Protocol Violation|2
1735521|NCT00971243|6054330|P4|Double Blind Period|Protocol Violation|2
1735522|NCT00971243|6054331|P3|Double Blind Period|Protocol Violation|3
1735523|NCT00971243|6054332|P2|Double Blind Period|Protocol Violation|0
1735524|NCT00971243|6054333|P1|Double Blind Period|Protocol Violation|2
1735525|NCT00971243|6054329|P5|Double Blind Period|Physician Decision|7
1735526|NCT00971243|6054330|P4|Double Blind Period|Physician Decision|6
1735527|NCT00971243|6054331|P3|Double Blind Period|Physician Decision|7
1735528|NCT00971243|6054332|P2|Double Blind Period|Physician Decision|6
1735529|NCT00971243|6054333|P1|Double Blind Period|Physician Decision|10
1735530|NCT00971243|6054329|P5|Double Blind Period|Lost to Follow-up|1
1735531|NCT00971243|6054330|P4|Double Blind Period|Lost to Follow-up|0
1735532|NCT00971243|6054331|P3|Double Blind Period|Lost to Follow-up|1
1735533|NCT00971243|6054332|P2|Double Blind Period|Lost to Follow-up|1
1735534|NCT00971243|6054333|P1|Double Blind Period|Lost to Follow-up|0
1735535|NCT00971243|6054329|P5|Double Blind Period|Adverse Event|3
1735536|NCT00971243|6054330|P4|Double Blind Period|Adverse Event|2
1735537|NCT00971243|6054331|P3|Double Blind Period|Adverse Event|2
1735538|NCT00971243|6054332|P2|Double Blind Period|Adverse Event|3
1735539|NCT00971243|6054333|P1|Double Blind Period|Adverse Event|2
1735540|NCT00971204|6054350|P1|Overall Study|Lost to Follow-up|10
1735541|NCT00971204|6054350|P1|Overall Study|Did not meet all criteria-not treated|14
1735542|NCT00971048|6054358|P4|Overall Study|Physician Decision|1
1735543|NCT00971048|6054359|P3|Overall Study|Physician Decision|0
1735544|NCT00971048|6054360|P2|Overall Study|Physician Decision|0
1735545|NCT00971048|6054361|P1|Overall Study|Physician Decision|0
1735546|NCT00971048|6054358|P4|Overall Study|Adverse Event|0
1735547|NCT00971048|6054359|P3|Overall Study|Adverse Event|1
1735548|NCT00971048|6054360|P2|Overall Study|Adverse Event|0
1735549|NCT00971048|6054361|P1|Overall Study|Adverse Event|0
1735550|NCT00971048|6054358|P4|Overall Study|Protocol Violation|1
1735551|NCT00971048|6054359|P3|Overall Study|Protocol Violation|0
1735552|NCT00971048|6054360|P2|Overall Study|Protocol Violation|2
1735553|NCT00971048|6054361|P1|Overall Study|Protocol Violation|1
1735554|NCT00970944|6054385|P2|Overall Study|Physician Decision|2
1735555|NCT00970944|6054386|P1|Overall Study|Physician Decision|0
1735556|NCT00970944|6054385|P2|Overall Study|Death|0
1735557|NCT00970944|6054386|P1|Overall Study|Death|1
1735558|NCT00970684|6054438|P1|Overall Study|Withdrawal by Subject|1
1735559|NCT00970684|6054438|P1|Overall Study|Adverse Event|4
1735560|NCT00970684|6054438|P1|Overall Study|Lack of Efficacy|5
1735561|NCT00970632|6054447|P3|Overall Study|Sponsor decision|1
1735562|NCT00970632|6054448|P2|Overall Study|Sponsor decision|0
1735563|NCT00970632|6054449|P1|Overall Study|Sponsor decision|1
1735564|NCT00970632|6054447|P3|Overall Study|Entry criteria not met|2
1735565|NCT00970632|6054448|P2|Overall Study|Entry criteria not met|2
1735566|NCT00970632|6054449|P1|Overall Study|Entry criteria not met|0
1735567|NCT00970632|6054447|P3|Overall Study|Withdrawal by Subject|4
1735568|NCT00970632|6054448|P2|Overall Study|Withdrawal by Subject|6
1735569|NCT00970632|6054449|P1|Overall Study|Withdrawal by Subject|7
1735570|NCT00970632|6054447|P3|Overall Study|Protocol Violation|8
1735571|NCT00970632|6054448|P2|Overall Study|Protocol Violation|5
1735572|NCT00970632|6054449|P1|Overall Study|Protocol Violation|8
1735573|NCT00970632|6054447|P3|Overall Study|Lost to Follow-up|2
1735574|NCT00970632|6054448|P2|Overall Study|Lost to Follow-up|0
1735575|NCT00970632|6054449|P1|Overall Study|Lost to Follow-up|3
1735576|NCT00970632|6054447|P3|Overall Study|Lack of Efficacy|0
1735577|NCT00970632|6054448|P2|Overall Study|Lack of Efficacy|0
1735578|NCT00970632|6054449|P1|Overall Study|Lack of Efficacy|3
1735579|NCT00970632|6054447|P3|Overall Study|Adverse Event|1
1735580|NCT00970632|6054448|P2|Overall Study|Adverse Event|2
1735581|NCT00970632|6054449|P1|Overall Study|Adverse Event|2
1735582|NCT00970502|6054514|P1|Overall Study|Withdrawal by Subject|1
1735583|NCT00970489|6054525|P2|Overall Study|Death/Withdrew/Criteria Violation|41
1735584|NCT00970489|6054526|P1|Overall Study|Death/Withdrew/Criteria Violation|54
1735585|NCT00970359|6054538|P1|Overall Study|Not Treated|4
1735586|NCT00970307|6054568|P3|Overall Study|Withdrawal by Subject|2
1735587|NCT00970307|6054569|P2|Overall Study|Withdrawal by Subject|3
1735588|NCT00970307|6054570|P1|Overall Study|Withdrawal by Subject|2
1735589|NCT00970307|6054568|P3|Overall Study|Serious Adverse Event|0
1735590|NCT00970307|6054569|P2|Overall Study|Serious Adverse Event|0
1735591|NCT00970307|6054570|P1|Overall Study|Serious Adverse Event|1
1735592|NCT00970294|6054644|P1|Overall Study|Withdrawal by Subject|1
1735593|NCT00970294|6054644|P1|Overall Study|Physician Decision|4
1735594|NCT00970281|6054652|P2|Overall Study|Physician Decision|1
1735595|NCT00970281|6054653|P1|Overall Study|Physician Decision|1
1735596|NCT00970281|6054652|P2|Overall Study|Withdrawal by Subject|1
1735597|NCT00970281|6054653|P1|Overall Study|Withdrawal by Subject|0
1735598|NCT00970281|6054652|P2|Overall Study|Lack of Efficacy|14
1735599|NCT00970281|6054653|P1|Overall Study|Lack of Efficacy|1
1735600|NCT00970268|6054671|P2|Overall Study|Inclusion/Exclusion Criteria|0
1735601|NCT00970268|6054672|P1|Overall Study|Inclusion/Exclusion Criteria|1
1735602|NCT00970268|6054671|P2|Overall Study|Lost to Follow-up|2
1735603|NCT00970268|6054672|P1|Overall Study|Lost to Follow-up|1
1735604|NCT00970268|6054671|P2|Overall Study|COPD Exacerbation|2
1735605|NCT00970268|6054672|P1|Overall Study|COPD Exacerbation|4
1735606|NCT00970268|6054671|P2|Overall Study|Other Reason|1
1735607|NCT00970268|6054672|P1|Overall Study|Other Reason|3
1735608|NCT00970268|6054671|P2|Overall Study|Protocol Violation|7
1735609|NCT00970268|6054672|P1|Overall Study|Protocol Violation|4
1735610|NCT00970268|6054671|P2|Overall Study|Lack of Efficacy|6
1735611|NCT00970268|6054672|P1|Overall Study|Lack of Efficacy|3
1735612|NCT00970268|6054671|P2|Overall Study|Adverse Event|12
1735613|NCT00970268|6054672|P1|Overall Study|Adverse Event|15
1735614|NCT00970268|6054671|P2|Overall Study|Withdrawal by Subject|19
1735615|NCT00970268|6054672|P1|Overall Study|Withdrawal by Subject|12
1735616|NCT00969761|6054735|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735617|NCT00969761|6054736|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735618|NCT00969761|6054737|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735619|NCT00969761|6054738|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
1735620|NCT00969761|6054739|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735621|NCT00969761|6054740|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735622|NCT00969761|6054741|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735623|NCT00969761|6054742|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
1735624|NCT00969761|6054743|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
1735625|NCT00969761|6054744|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735626|NCT00969761|6054745|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735627|NCT00969761|6054746|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
1735628|NCT00969761|6054735|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
1735629|NCT00969761|6054736|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
1735630|NCT00969761|6054737|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
1735631|NCT00969761|6054738|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
1735632|NCT00969761|6054739|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
1735633|NCT00969761|6054740|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
1735634|NCT00969761|6054741|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
1735635|NCT00969761|6054742|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
1735636|NCT00969761|6054743|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
1735637|NCT00969761|6054744|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
1735638|NCT00969761|6054745|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
1735639|NCT00969761|6054746|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
1735640|NCT00969761|6054735|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735641|NCT00969761|6054736|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735642|NCT00969761|6054737|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735643|NCT00969761|6054738|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
1735644|NCT00969761|6054739|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735645|NCT00969761|6054740|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735646|NCT00969761|6054741|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735647|NCT00969761|6054742|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735648|NCT00969761|6054743|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735649|NCT00969761|6054744|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735650|NCT00969761|6054745|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735651|NCT00969761|6054746|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
1735652|NCT00969761|6054735|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735653|NCT00969761|6054736|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735654|NCT00969761|6054737|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735655|NCT00969761|6054738|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735735|NCT00969553|6055096|P2|Overall Study|Refused cont. medication|1
1735656|NCT00969761|6054739|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735657|NCT00969761|6054740|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735658|NCT00969761|6054741|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735659|NCT00969761|6054742|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735660|NCT00969761|6054743|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735661|NCT00969761|6054744|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
1735662|NCT00969761|6054745|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735663|NCT00969761|6054746|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
1735664|NCT00969761|6054735|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735665|NCT00969761|6054736|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735666|NCT00969761|6054737|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735667|NCT00969761|6054738|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735668|NCT00969761|6054739|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735669|NCT00969761|6054740|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735670|NCT00969761|6054741|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735671|NCT00969761|6054742|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735672|NCT00969761|6054743|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735673|NCT00969761|6054744|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
1735674|NCT00969761|6054745|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735675|NCT00969761|6054746|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
1735676|NCT00969761|6054735|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735677|NCT00969761|6054736|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735678|NCT00969761|6054737|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
1735679|NCT00969761|6054738|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
1735680|NCT00969761|6054739|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735681|NCT00969761|6054740|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735682|NCT00969761|6054741|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735683|NCT00969761|6054742|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735684|NCT00969761|6054743|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
1735685|NCT00969761|6054744|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735686|NCT00969761|6054745|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
1735687|NCT00969761|6054746|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
1735688|NCT00969709|6055052|P4|Overall Study|Other reasons|0
1735689|NCT00969709|6055053|P3|Overall Study|Other reasons|3
1735690|NCT00969709|6055054|P2|Overall Study|Other reasons|0
1735691|NCT00969709|6055055|P1|Overall Study|Other reasons|0
1735692|NCT00969709|6055052|P4|Overall Study|Lost to Follow-up|15
1735693|NCT00969709|6055053|P3|Overall Study|Lost to Follow-up|8
1735694|NCT00969709|6055054|P2|Overall Study|Lost to Follow-up|14
1735695|NCT00969709|6055055|P1|Overall Study|Lost to Follow-up|10
1735696|NCT00969709|6055052|P4|Overall Study|Withdrawal by Subject|23
1735697|NCT00969709|6055053|P3|Overall Study|Withdrawal by Subject|11
1735698|NCT00969709|6055054|P2|Overall Study|Withdrawal by Subject|12
1735699|NCT00969709|6055055|P1|Overall Study|Withdrawal by Subject|9
1735700|NCT00969709|6055052|P4|Overall Study|Protocol Violation|10
1735701|NCT00969709|6055053|P3|Overall Study|Protocol Violation|9
1735702|NCT00969709|6055054|P2|Overall Study|Protocol Violation|5
1735703|NCT00969709|6055055|P1|Overall Study|Protocol Violation|9
1735704|NCT00969709|6055052|P4|Overall Study|Lack of Efficacy|3
1735705|NCT00969709|6055053|P3|Overall Study|Lack of Efficacy|1
1735706|NCT00969709|6055054|P2|Overall Study|Lack of Efficacy|4
1735707|NCT00969709|6055055|P1|Overall Study|Lack of Efficacy|7
1735708|NCT00969709|6055052|P4|Overall Study|Adverse Event|12
1735709|NCT00969709|6055053|P3|Overall Study|Adverse Event|26
1735710|NCT00969709|6055054|P2|Overall Study|Adverse Event|13
1735711|NCT00969709|6055055|P1|Overall Study|Adverse Event|3
1735712|NCT00969618|6055069|P1|Overall Study|Withdrawal by Subject|27
1735713|NCT00969618|6055069|P1|Overall Study|Protocol Violation|9
1735714|NCT00969618|6055069|P1|Overall Study|Physician Decision|1
1735715|NCT00969618|6055069|P1|Overall Study|Lost to Follow-up|7
1735716|NCT00969618|6055069|P1|Overall Study|Lack of Efficacy|2
1735717|NCT00969618|6055069|P1|Overall Study|Entry Criteria Not Met|3
1735718|NCT00969618|6055069|P1|Overall Study|Adverse Event|29
1735719|NCT00969553|6055089|P9|Overall Study|Not specified above|0
1735720|NCT00969553|6055090|P8|Overall Study|Not specified above|1
1735721|NCT00969553|6055091|P7|Overall Study|Not specified above|1
1735722|NCT00969553|6055092|P6|Overall Study|Not specified above|0
1735723|NCT00969553|6055093|P5|Overall Study|Not specified above|0
1735724|NCT00969553|6055094|P4|Overall Study|Not specified above|4
1735725|NCT00969553|6055095|P3|Overall Study|Not specified above|0
1735726|NCT00969553|6055096|P2|Overall Study|Not specified above|0
1735727|NCT00969553|6055097|P1|Overall Study|Not specified above|0
1735728|NCT00969553|6055089|P9|Overall Study|Refused cont. medication|0
1735729|NCT00969553|6055090|P8|Overall Study|Refused cont. medication|1
1735730|NCT00969553|6055091|P7|Overall Study|Refused cont. medication|0
1735731|NCT00969553|6055092|P6|Overall Study|Refused cont. medication|0
1735732|NCT00969553|6055093|P5|Overall Study|Refused cont. medication|0
1735733|NCT00969553|6055094|P4|Overall Study|Refused cont. medication|2
1735734|NCT00969553|6055095|P3|Overall Study|Refused cont. medication|0
1735736|NCT00969553|6055097|P1|Overall Study|Refused cont. medication|1
1735737|NCT00969553|6055089|P9|Overall Study|Other Adverse Event|0
1735738|NCT00969553|6055090|P8|Overall Study|Other Adverse Event|0
1735739|NCT00969553|6055091|P7|Overall Study|Other Adverse Event|1
1735740|NCT00969553|6055092|P6|Overall Study|Other Adverse Event|0
1735741|NCT00969553|6055093|P5|Overall Study|Other Adverse Event|0
1735742|NCT00969553|6055094|P4|Overall Study|Other Adverse Event|1
1735743|NCT00969553|6055095|P3|Overall Study|Other Adverse Event|0
1735744|NCT00969553|6055096|P2|Overall Study|Other Adverse Event|0
1735745|NCT00969553|6055097|P1|Overall Study|Other Adverse Event|0
1735746|NCT00969553|6055089|P9|Overall Study|Dose limiting Toxicity (DLT)|0
1735747|NCT00969553|6055090|P8|Overall Study|Dose limiting Toxicity (DLT)|0
1735748|NCT00969553|6055091|P7|Overall Study|Dose limiting Toxicity (DLT)|0
1735749|NCT00969553|6055092|P6|Overall Study|Dose limiting Toxicity (DLT)|0
1735750|NCT00969553|6055093|P5|Overall Study|Dose limiting Toxicity (DLT)|1
1735751|NCT00969553|6055094|P4|Overall Study|Dose limiting Toxicity (DLT)|0
1735752|NCT00969553|6055095|P3|Overall Study|Dose limiting Toxicity (DLT)|0
1735753|NCT00969553|6055096|P2|Overall Study|Dose limiting Toxicity (DLT)|0
1735754|NCT00969553|6055097|P1|Overall Study|Dose limiting Toxicity (DLT)|0
1735755|NCT00969553|6055089|P9|Overall Study|Progressive disease (PD)|3
1735756|NCT00969553|6055090|P8|Overall Study|Progressive disease (PD)|12
1735757|NCT00969553|6055091|P7|Overall Study|Progressive disease (PD)|2
1735758|NCT00969553|6055092|P6|Overall Study|Progressive disease (PD)|4
1735759|NCT00969553|6055093|P5|Overall Study|Progressive disease (PD)|2
1735760|NCT00969553|6055094|P4|Overall Study|Progressive disease (PD)|9
1735761|NCT00969553|6055095|P3|Overall Study|Progressive disease (PD)|6
1735762|NCT00969553|6055096|P2|Overall Study|Progressive disease (PD)|2
1735763|NCT00969553|6055097|P1|Overall Study|Progressive disease (PD)|2
1735764|NCT00969540|6055240|P2|Overall Study|Lost to Follow-up|1
1735765|NCT00969540|6055241|P1|Overall Study|Lost to Follow-up|1
1735766|NCT00969436|6055266|P3|Overall Study|Lost to Follow-up|5
1735767|NCT00969436|6055267|P2|Overall Study|Lost to Follow-up|8
1735768|NCT00969436|6055268|P1|Overall Study|Lost to Follow-up|8
1735769|NCT00969436|6055266|P3|Overall Study|Withdrawal by Subject|2
1735770|NCT00969436|6055267|P2|Overall Study|Withdrawal by Subject|0
1735771|NCT00969436|6055268|P1|Overall Study|Withdrawal by Subject|3
1735772|NCT00969436|6055266|P3|Overall Study|Subject eliminated (other vaccine)|0
1735773|NCT00969436|6055267|P2|Overall Study|Subject eliminated (other vaccine)|0
1735774|NCT00969436|6055268|P1|Overall Study|Subject eliminated (other vaccine)|1
1735775|NCT00969436|6055266|P3|Overall Study|Parents personal problem|1
1735776|NCT00969436|6055267|P2|Overall Study|Parents personal problem|0
1735777|NCT00969436|6055268|P1|Overall Study|Parents personal problem|0
1735778|NCT00969436|6055266|P3|Overall Study|Father - serious health problem|1
1735779|NCT00969436|6055267|P2|Overall Study|Father - serious health problem|0
1735780|NCT00969436|6055268|P1|Overall Study|Father - serious health problem|0
1735781|NCT00969436|6055266|P3|Overall Study|Migrated/moved from study area|2
1735782|NCT00969436|6055267|P2|Overall Study|Migrated/moved from study area|10
1735783|NCT00969436|6055268|P1|Overall Study|Migrated/moved from study area|12
1735784|NCT00969436|6055266|P3|Overall Study|Protocol Violation|0
1735785|NCT00969436|6055267|P2|Overall Study|Protocol Violation|3
1735786|NCT00969436|6055268|P1|Overall Study|Protocol Violation|1
1735789|NCT00969280|6055316|P2|Overall Study|infection of influenza A(H1N1)|1
1735790|NCT00969280|6055317|P1|Overall Study|infection of influenza A(H1N1)|0
1735791|NCT00969280|6055316|P2|Overall Study|Withdrawal by Subject|1
1735792|NCT00969280|6055317|P1|Overall Study|Withdrawal by Subject|0
1735793|NCT00969280|6055316|P2|Overall Study|Protocol Violation|1
1735794|NCT00969280|6055317|P1|Overall Study|Protocol Violation|2
1735795|NCT00969228|6055325|P2|Overall Study|Porcine circovirus detection in vaccine|14
1735796|NCT00969228|6055326|P1|Overall Study|Porcine circovirus detection in vaccine|38
1735797|NCT00969228|6055325|P2|Overall Study|Withdrawal by Subject|0
1735798|NCT00969228|6055326|P1|Overall Study|Withdrawal by Subject|4
1735799|NCT00969228|6055325|P2|Overall Study|Adverse Event|0
1735800|NCT00969228|6055326|P1|Overall Study|Adverse Event|1
1735801|NCT00969150|6055344|P2|Overall Study|Other reasons|0
1735802|NCT00969150|6055345|P1|Overall Study|Other reasons|1
1735803|NCT00969150|6055344|P2|Overall Study|Lost to Follow-up|4
1735804|NCT00969150|6055345|P1|Overall Study|Lost to Follow-up|5
1735805|NCT00969150|6055344|P2|Overall Study|Withdrawal by Subject|9
1735806|NCT00969150|6055345|P1|Overall Study|Withdrawal by Subject|13
1735807|NCT00969150|6055344|P2|Overall Study|Protocol Violation|12
1735808|NCT00969150|6055345|P1|Overall Study|Protocol Violation|9
1735809|NCT00969150|6055344|P2|Overall Study|Lack of Efficacy|1
1735810|NCT00969150|6055345|P1|Overall Study|Lack of Efficacy|1
1735811|NCT00969150|6055344|P2|Overall Study|Adverse Event|14
1735812|NCT00969150|6055345|P1|Overall Study|Adverse Event|4
1735813|NCT00969124|6055353|P1|Overall Study|Technical error|1
1735814|NCT00969124|6055353|P1|Overall Study|Previously unrecognized disease|3
1735815|NCT00969124|6055353|P1|Overall Study|Inability to reach cecum|9
1735816|NCT00969124|6055353|P1|Overall Study|Inadequate bowel preparation|15
1735817|NCT00969124|6055353|P1|Overall Study|Protocol Violation|2
1735818|NCT00968981|6055362|P3|Overall Study|Withdrawal by Subject|3
1735819|NCT00968981|6055363|P2|Overall Study|Withdrawal by Subject|3
1735820|NCT00968981|6055364|P1|Overall Study|Withdrawal by Subject|1
1735821|NCT00968981|6055362|P3|Overall Study|Physician Decision|5
1735822|NCT00968981|6055363|P2|Overall Study|Physician Decision|3
1735823|NCT00968981|6055364|P1|Overall Study|Physician Decision|5
1735824|NCT00968981|6055362|P3|Overall Study|Lost to Follow-up|1
1735825|NCT00968981|6055363|P2|Overall Study|Lost to Follow-up|0
1735826|NCT00968981|6055364|P1|Overall Study|Lost to Follow-up|0
1735827|NCT00968981|6055362|P3|Overall Study|Disease Progression|13
1735828|NCT00968981|6055363|P2|Overall Study|Disease Progression|16
1735829|NCT00968981|6055364|P1|Overall Study|Disease Progression|14
1735830|NCT00968981|6055362|P3|Overall Study|Adverse Event|0
1735831|NCT00968981|6055363|P2|Overall Study|Adverse Event|0
1735832|NCT00968981|6055364|P1|Overall Study|Adverse Event|2
1735833|NCT00968968|6055402|P2|Overall Study|Lost to Follow-up|1
1735834|NCT00968968|6055403|P1|Overall Study|Lost to Follow-up|0
1735835|NCT00968968|6055402|P2|Overall Study|Physician Decision|2
1735836|NCT00968968|6055403|P1|Overall Study|Physician Decision|1
1735837|NCT00968968|6055402|P2|Overall Study|Withdrawal by Subject|0
1735838|NCT00968968|6055403|P1|Overall Study|Withdrawal by Subject|2
1735839|NCT00968968|6055402|P2|Overall Study|Protocol defined stopping criteria|1
1735840|NCT00968968|6055403|P1|Overall Study|Protocol defined stopping criteria|3
1735841|NCT00968968|6055402|P2|Overall Study|Study closed/terminated|10
1735842|NCT00968968|6055403|P1|Overall Study|Study closed/terminated|10
1735843|NCT00968864|6055449|P1|Overall Study|Protocol exception/ not evaluable|1
1735844|NCT00968812|6055477|P3|Overall Study|Other|40
1735845|NCT00968812|6055478|P2|Overall Study|Other|37
1735846|NCT00968812|6055479|P1|Overall Study|Other|25
1735847|NCT00968812|6055477|P3|Overall Study|Unable to take rescue therapy|17
1735848|NCT00968812|6055478|P2|Overall Study|Unable to take rescue therapy|12
1735849|NCT00968812|6055479|P1|Overall Study|Unable to take rescue therapy|12
1735850|NCT00968812|6055477|P3|Overall Study|Noncompliance with study drug|6
1735851|NCT00968812|6055478|P2|Overall Study|Noncompliance with study drug|1
1735852|NCT00968812|6055479|P1|Overall Study|Noncompliance with study drug|4
1735853|NCT00968812|6055477|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
1735854|NCT00968812|6055478|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
1735855|NCT00968812|6055479|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
1735856|NCT00968812|6055477|P3|Overall Study|Withdrawal by Subject|25
1735857|NCT00968812|6055478|P2|Overall Study|Withdrawal by Subject|23
1735858|NCT00968812|6055479|P1|Overall Study|Withdrawal by Subject|17
1735859|NCT00968812|6055477|P3|Overall Study|Protocol Violation|3
1735860|NCT00968812|6055478|P2|Overall Study|Protocol Violation|4
1735861|NCT00968812|6055479|P1|Overall Study|Protocol Violation|7
1735862|NCT00968812|6055477|P3|Overall Study|Physician Decision|9
1735863|NCT00968812|6055478|P2|Overall Study|Physician Decision|5
1735864|NCT00968812|6055479|P1|Overall Study|Physician Decision|8
1735865|NCT00968812|6055477|P3|Overall Study|Lost to Follow-up|11
1735866|NCT00968812|6055478|P2|Overall Study|Lost to Follow-up|12
1735867|NCT00968812|6055479|P1|Overall Study|Lost to Follow-up|17
1735868|NCT00968812|6055477|P3|Overall Study|Lack of Efficacy|16
1735869|NCT00968812|6055478|P2|Overall Study|Lack of Efficacy|7
1735870|NCT00968812|6055479|P1|Overall Study|Lack of Efficacy|9
1735871|NCT00968812|6055477|P3|Overall Study|Death|1
1735872|NCT00968812|6055478|P2|Overall Study|Death|2
1735873|NCT00968812|6055479|P1|Overall Study|Death|2
1735874|NCT00968812|6055477|P3|Overall Study|Adverse Event|33
1735875|NCT00968812|6055478|P2|Overall Study|Adverse Event|46
1735876|NCT00968812|6055479|P1|Overall Study|Adverse Event|30
1735877|NCT00968799|6055499|P1|Overall Study|Advanced disease, HIPEC not applicable|2
1735878|NCT00968708|6055509|P2|Overall Study|Other|34
1735879|NCT00968708|6055510|P1|Overall Study|Other|26
1735880|NCT00968708|6055509|P2|Overall Study|Investigator Discretion|1
1735881|NCT00968708|6055510|P1|Overall Study|Investigator Discretion|0
1735882|NCT00968708|6055509|P2|Overall Study|Voluntary Withdrawal|101
1735883|NCT00968708|6055510|P1|Overall Study|Voluntary Withdrawal|104
1735884|NCT00968708|6055509|P2|Overall Study|Lost to Follow-up|11
1735885|NCT00968708|6055510|P1|Overall Study|Lost to Follow-up|19
1735886|NCT00968708|6055509|P2|Overall Study|Major Protocol Deviation|1
1735887|NCT00968708|6055510|P1|Overall Study|Major Protocol Deviation|0
1735888|NCT00968708|6055509|P2|Overall Study|Adverse Event|150
1735889|NCT00968708|6055510|P1|Overall Study|Adverse Event|169
1735890|NCT00968669|6055522|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
1735891|NCT00968669|6055523|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1735892|NCT00968669|6055524|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1735893|NCT00968669|6055525|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
1735894|NCT00968669|6055522|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1735895|NCT00968669|6055523|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1735896|NCT00968669|6055524|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
1735897|NCT00968669|6055525|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
1735898|NCT00968669|6055522|P4|Overall Study|SUBJECT INCARCERATED|0
1735899|NCT00968669|6055523|P3|Overall Study|SUBJECT INCARCERATED|0
1735900|NCT00968669|6055524|P2|Overall Study|SUBJECT INCARCERATED|1
1735901|NCT00968669|6055525|P1|Overall Study|SUBJECT INCARCERATED|0
1735902|NCT00968669|6055522|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1735903|NCT00968669|6055523|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1735904|NCT00968669|6055524|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
1735905|NCT00968669|6055525|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
1735906|NCT00968669|6055522|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1735907|NCT00968669|6055523|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
1735908|NCT00968669|6055524|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1735909|NCT00968669|6055525|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
1735910|NCT00968669|6055522|P4|Overall Study|SPONSOR DECISION|0
1735911|NCT00968669|6055523|P3|Overall Study|SPONSOR DECISION|0
1735912|NCT00968669|6055524|P2|Overall Study|SPONSOR DECISION|1
1735913|NCT00968669|6055525|P1|Overall Study|SPONSOR DECISION|0
1735914|NCT00968669|6055522|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1735915|NCT00968669|6055523|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1735916|NCT00968669|6055524|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
1735917|NCT00968669|6055525|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
1735918|NCT00968669|6055522|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1735919|NCT00968669|6055523|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1735920|NCT00968669|6055524|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
1735921|NCT00968669|6055525|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
1735922|NCT00968669|6055522|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1735923|NCT00968669|6055523|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1735924|NCT00968669|6055524|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
1735925|NCT00968669|6055525|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
1735926|NCT00968669|6055522|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1735927|NCT00968669|6055523|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1735928|NCT00968669|6055524|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
1735929|NCT00968669|6055525|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
1735930|NCT00968669|6055522|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1735931|NCT00968669|6055523|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1735932|NCT00968669|6055524|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
1735933|NCT00968669|6055525|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
1735934|NCT00968669|6055522|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
1735935|NCT00968669|6055523|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
1735936|NCT00968669|6055524|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
1735937|NCT00968669|6055525|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
1735938|NCT00968669|6055522|P4|Overall Study|EARLY WITHDRAWAL|0
1735939|NCT00968669|6055523|P3|Overall Study|EARLY WITHDRAWAL|0
1735940|NCT00968669|6055524|P2|Overall Study|EARLY WITHDRAWAL|1
1735941|NCT00968669|6055525|P1|Overall Study|EARLY WITHDRAWAL|0
1735942|NCT00968669|6055522|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1735943|NCT00968669|6055523|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
1735944|NCT00968669|6055524|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1735945|NCT00968669|6055525|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
1735946|NCT00968669|6055522|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1735947|NCT00968669|6055523|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1735948|NCT00968669|6055524|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
1735949|NCT00968669|6055525|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
1735950|NCT00968669|6055522|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1735951|NCT00968669|6055523|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1735952|NCT00968669|6055524|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
1735953|NCT00968669|6055525|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
1735954|NCT00968669|6055522|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
1735955|NCT00968669|6055523|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1735956|NCT00968669|6055524|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1735957|NCT00968669|6055525|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
1735958|NCT00968669|6055522|P4|Overall Study|AE|0
1735959|NCT00968669|6055523|P3|Overall Study|AE|0
1735960|NCT00968669|6055524|P2|Overall Study|AE|0
1735961|NCT00968669|6055525|P1|Overall Study|AE|1
1735962|NCT00968669|6055522|P4|Overall Study|Pregnancy|0
1735963|NCT00968669|6055523|P3|Overall Study|Pregnancy|2
1735964|NCT00968669|6055524|P2|Overall Study|Pregnancy|0
1735965|NCT00968669|6055525|P1|Overall Study|Pregnancy|0
1735966|NCT00968669|6055522|P4|Overall Study|Withdrawal by Subject|3
1735967|NCT00968669|6055523|P3|Overall Study|Withdrawal by Subject|5
1735968|NCT00968669|6055524|P2|Overall Study|Withdrawal by Subject|7
1735969|NCT00968669|6055525|P1|Overall Study|Withdrawal by Subject|9
1735970|NCT00968669|6055522|P4|Overall Study|Lost to Follow-up|4
1735971|NCT00968669|6055523|P3|Overall Study|Lost to Follow-up|1
1735972|NCT00968669|6055524|P2|Overall Study|Lost to Follow-up|2
1735973|NCT00968669|6055525|P1|Overall Study|Lost to Follow-up|5
1735974|NCT00968617|6055615|P1|Overall Study|Study terminated by sponsor|6
1735975|NCT00968539|6055629|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
1735976|NCT00968539|6055630|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
1735977|NCT00968526|6055690|P2|Overall Study|Migrated/moved from study area|0
1735978|NCT00968526|6055691|P1|Overall Study|Migrated/moved from study area|1
1735979|NCT00968526|6055690|P2|Overall Study|Adverse Event|0
1735980|NCT00968526|6055691|P1|Overall Study|Adverse Event|2
1735981|NCT00968253|6055793|P3|Overall Study|Adverse Event|1
1735982|NCT00968253|6055794|P2|Overall Study|Adverse Event|0
1735983|NCT00968253|6055795|P1|Overall Study|Adverse Event|0
1735984|NCT00968253|6055793|P3|Overall Study|Disease Progression|3
1735985|NCT00968253|6055794|P2|Overall Study|Disease Progression|3
1735986|NCT00968253|6055795|P1|Overall Study|Disease Progression|0
1735987|NCT00968253|6055793|P3|Overall Study|Withdrawal by Subject|1
1735988|NCT00968253|6055794|P2|Overall Study|Withdrawal by Subject|0
1735989|NCT00968253|6055795|P1|Overall Study|Withdrawal by Subject|0
1735990|NCT00968253|6055793|P3|Overall Study|Death|2
1735991|NCT00968253|6055794|P2|Overall Study|Death|0
1735992|NCT00968253|6055795|P1|Overall Study|Death|0
1735993|NCT00968201|6055816|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
1735994|NCT00968201|6055817|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
1735995|NCT00968201|6055818|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
1735996|NCT00968201|6055816|P3|Extension Study - (Period III)|Other|2
1735997|NCT00968201|6055817|P2|Extension Study - (Period III)|Other|0
1735998|NCT00968201|6055818|P1|Extension Study - (Period III)|Other|0
1735999|NCT00968201|6055816|P3|Extension Study - (Period III)|Noncompliance|3
1736000|NCT00968201|6055817|P2|Extension Study - (Period III)|Noncompliance|0
1736001|NCT00968201|6055818|P1|Extension Study - (Period III)|Noncompliance|0
1736002|NCT00968201|6055816|P3|Extension Study - (Period III)|Patient Relocated|1
1736003|NCT00968201|6055817|P2|Extension Study - (Period III)|Patient Relocated|1
1736004|NCT00968201|6055818|P1|Extension Study - (Period III)|Patient Relocated|0
1736005|NCT00968201|6055816|P3|Extension Study - (Period III)|Withdrawal by Subject|40
1736006|NCT00968201|6055817|P2|Extension Study - (Period III)|Withdrawal by Subject|20
1736007|NCT00968201|6055818|P1|Extension Study - (Period III)|Withdrawal by Subject|0
1736008|NCT00968201|6055816|P3|Extension Study - (Period III)|Protocol Violation|14
1736009|NCT00968201|6055817|P2|Extension Study - (Period III)|Protocol Violation|17
1736010|NCT00968201|6055818|P1|Extension Study - (Period III)|Protocol Violation|0
1736011|NCT00968201|6055816|P3|Extension Study - (Period III)|Lost to Follow-up|13
1736012|NCT00968201|6055817|P2|Extension Study - (Period III)|Lost to Follow-up|7
1736013|NCT00968201|6055818|P1|Extension Study - (Period III)|Lost to Follow-up|0
1736014|NCT00968201|6055816|P3|Extension Study - (Period III)|Adverse Event|22
1736015|NCT00968201|6055817|P2|Extension Study - (Period III)|Adverse Event|5
1736016|NCT00968201|6055818|P1|Extension Study - (Period III)|Adverse Event|0
1736017|NCT00968201|6055816|P3|Base Study - (Period II)|Site Error|1
1736018|NCT00968201|6055817|P2|Base Study - (Period II)|Site Error|0
1736019|NCT00968201|6055818|P1|Base Study - (Period II)|Site Error|0
1736020|NCT00968201|6055816|P3|Base Study - (Period II)|Withdrawal by Subject|8
1736021|NCT00968201|6055817|P2|Base Study - (Period II)|Withdrawal by Subject|0
1736022|NCT00968201|6055818|P1|Base Study - (Period II)|Withdrawal by Subject|4
1736023|NCT00968201|6055816|P3|Base Study - (Period II)|Protocol Violation|12
1736024|NCT00968201|6055817|P2|Base Study - (Period II)|Protocol Violation|0
1736025|NCT00968201|6055818|P1|Base Study - (Period II)|Protocol Violation|12
1736026|NCT00968201|6055816|P3|Base Study - (Period II)|Lost to Follow-up|7
1736027|NCT00968201|6055817|P2|Base Study - (Period II)|Lost to Follow-up|0
1736028|NCT00968201|6055818|P1|Base Study - (Period II)|Lost to Follow-up|2
1736029|NCT00968201|6055816|P3|Base Study - (Period II)|Lack of Efficacy|1
1736030|NCT00968201|6055817|P2|Base Study - (Period II)|Lack of Efficacy|0
1736031|NCT00968201|6055818|P1|Base Study - (Period II)|Lack of Efficacy|0
1736032|NCT00968201|6055816|P3|Base Study - (Period II)|Adverse Event|16
1736033|NCT00968201|6055817|P2|Base Study - (Period II)|Adverse Event|0
1736034|NCT00968201|6055818|P1|Base Study - (Period II)|Adverse Event|8
1736035|NCT00968149|6055879|P2|Overall Study|Withdrawal by Subject|0
1736036|NCT00968149|6055880|P1|Overall Study|Withdrawal by Subject|2
1736037|NCT00968149|6055879|P2|Overall Study|Protocol Violation|0
1736038|NCT00968149|6055880|P1|Overall Study|Protocol Violation|4
1736039|NCT00968149|6055879|P2|Overall Study|Lost to Follow-up|1
1736040|NCT00968149|6055880|P1|Overall Study|Lost to Follow-up|0
1736041|NCT00968149|6055879|P2|Overall Study|Lack of Efficacy|4
1736042|NCT00968149|6055880|P1|Overall Study|Lack of Efficacy|0
1736043|NCT00968149|6055879|P2|Overall Study|Adverse Event|1
1736044|NCT00968149|6055880|P1|Overall Study|Adverse Event|5
1736045|NCT00967798|6055935|P2|Overall Study|Lost to Follow-up|1
1736046|NCT00967798|6055936|P1|Overall Study|Lost to Follow-up|4
1736047|NCT00967798|6055935|P2|Overall Study|Withdrawal by Subject|2
1736048|NCT00967798|6055936|P1|Overall Study|Withdrawal by Subject|5
1736049|NCT00967694|6055950|P1|Overall Study|Withdrawal by Subject|6
1736050|NCT00967668|6055957|P3|Overall Study|Pregnancy|0
1736051|NCT00967668|6055958|P2|Overall Study|Pregnancy|0
1736052|NCT00967668|6055959|P1|Overall Study|Pregnancy|1
1736053|NCT00967668|6055957|P3|Overall Study|Refused 12-mo assessment|9
1736054|NCT00967668|6055958|P2|Overall Study|Refused 12-mo assessment|1
1736055|NCT00967668|6055959|P1|Overall Study|Refused 12-mo assessment|3
1736056|NCT00967668|6055957|P3|Overall Study|Lost to Follow-up|16
1736057|NCT00967668|6055958|P2|Overall Study|Lost to Follow-up|9
1736058|NCT00967668|6055959|P1|Overall Study|Lost to Follow-up|15
1736059|NCT00967668|6055957|P3|Overall Study|Lost to follow-up at 12-mo|26
1736060|NCT00967668|6055958|P2|Overall Study|Lost to follow-up at 12-mo|29
1736061|NCT00967668|6055959|P1|Overall Study|Lost to follow-up at 12-mo|27
1736062|NCT00967668|6055957|P3|Overall Study|Refused Year 2|4
1736063|NCT00967668|6055958|P2|Overall Study|Refused Year 2|6
1736064|NCT00967668|6055959|P1|Overall Study|Refused Year 2|11
1736065|NCT00967668|6055957|P3|Overall Study|Removed due to behavior|2
1736066|NCT00967668|6055958|P2|Overall Study|Removed due to behavior|1
1736067|NCT00967668|6055959|P1|Overall Study|Removed due to behavior|1
1736068|NCT00967668|6055957|P3|Overall Study|Death|4
1736069|NCT00967668|6055958|P2|Overall Study|Death|2
1736070|NCT00967668|6055959|P1|Overall Study|Death|0
1736071|NCT00967668|6055957|P3|Overall Study|Withdrawal by Subject|8
1736072|NCT00967668|6055958|P2|Overall Study|Withdrawal by Subject|8
1736073|NCT00967668|6055959|P1|Overall Study|Withdrawal by Subject|13
1736074|NCT00967330|6056005|P2|Overall Study|Severe protocol deviation|1
1736075|NCT00967330|6056006|P1|Overall Study|Severe protocol deviation|0
1736076|NCT00967330|6056005|P2|Overall Study|Death|51
1736077|NCT00967330|6056006|P1|Overall Study|Death|102
1736078|NCT00967330|6056005|P2|Overall Study|Lost to Follow-up|1
1736079|NCT00967330|6056006|P1|Overall Study|Lost to Follow-up|1
1736080|NCT00967330|6056005|P2|Overall Study|Withdrawal by Subject|0
1736081|NCT00967330|6056006|P1|Overall Study|Withdrawal by Subject|6
1736082|NCT00967330|6056005|P2|Overall Study|Regular|3
1736083|NCT00967330|6056006|P1|Overall Study|Regular|10
1736084|NCT00967330|6056005|P2|Overall Study|Protocol Violation|4
1736085|NCT00967330|6056006|P1|Overall Study|Protocol Violation|3
1736086|NCT00967226|6056036|P2|Overall Study|Physician Decision|1
1736087|NCT00967226|6056037|P1|Overall Study|Physician Decision|0
1736088|NCT00967226|6056036|P2|Overall Study|Protocol Violation|0
1736089|NCT00967226|6056037|P1|Overall Study|Protocol Violation|2
1736090|NCT00967226|6056036|P2|Overall Study|Adverse Event|5
1736091|NCT00967226|6056037|P1|Overall Study|Adverse Event|0
1736092|NCT00967018|6056071|P1|Overall Study|Miscellaneous Reasons|9
1736093|NCT00967018|6056071|P1|Overall Study|Withdrawal by Subject|1
1736094|NCT00967018|6056071|P1|Overall Study|Lost to Follow-up|2
1736095|NCT00967018|6056071|P1|Overall Study|Physician Decision|7
1736096|NCT00967018|6056071|P1|Overall Study|Adverse Event|2
1736097|NCT00967005|6056080|P2|Overall Study|Lost to Follow-up|10
1736098|NCT00967005|6056081|P1|Overall Study|Lost to Follow-up|7
1736099|NCT00966940|6056167|P2|Period 1, First 6 Weeks|Protocol Violation|0
1736100|NCT00966940|6056168|P1|Period 1, First 6 Weeks|Protocol Violation|1
1736101|NCT00966940|6056167|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
1736102|NCT00966940|6056168|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
1736103|NCT00966875|6056195|P9|Part B|Entry Criteria|1
1736104|NCT00966875|6056196|P8|Part B|Entry Criteria|0
1736105|NCT00966875|6056197|P7|Part B|Entry Criteria|1
1736106|NCT00966875|6056198|P6|Part B|Entry Criteria|0
1736107|NCT00966875|6056199|P5|Part B|Entry Criteria|0
1736108|NCT00966875|6056200|P4|Part B|Entry Criteria|0
1736109|NCT00966875|6056201|P3|Part B|Entry Criteria|0
1736110|NCT00966875|6056202|P2|Part B|Entry Criteria|0
1736111|NCT00966875|6056203|P1|Part B|Entry Criteria|0
1736112|NCT00966875|6056195|P9|Part B|Withdrawal by Subject|5
1736113|NCT00966875|6056196|P8|Part B|Withdrawal by Subject|5
1736114|NCT00966875|6056197|P7|Part B|Withdrawal by Subject|4
1736115|NCT00966875|6056198|P6|Part B|Withdrawal by Subject|1
1736116|NCT00966875|6056199|P5|Part B|Withdrawal by Subject|2
1736117|NCT00966875|6056200|P4|Part B|Withdrawal by Subject|1
1736118|NCT00966875|6056201|P3|Part B|Withdrawal by Subject|2
1736119|NCT00966875|6056202|P2|Part B|Withdrawal by Subject|1
1736120|NCT00966875|6056203|P1|Part B|Withdrawal by Subject|2
1736121|NCT00966875|6056195|P9|Part B|Sponsor Decision|1
1736122|NCT00966875|6056196|P8|Part B|Sponsor Decision|2
1736123|NCT00966875|6056197|P7|Part B|Sponsor Decision|0
1736124|NCT00966875|6056198|P6|Part B|Sponsor Decision|1
1736125|NCT00966875|6056199|P5|Part B|Sponsor Decision|0
1736126|NCT00966875|6056200|P4|Part B|Sponsor Decision|0
1736127|NCT00966875|6056201|P3|Part B|Sponsor Decision|0
1736128|NCT00966875|6056202|P2|Part B|Sponsor Decision|0
1736129|NCT00966875|6056203|P1|Part B|Sponsor Decision|1
1736130|NCT00966875|6056195|P9|Part B|Physician Decision|2
1736131|NCT00966875|6056196|P8|Part B|Physician Decision|0
1736132|NCT00966875|6056197|P7|Part B|Physician Decision|0
1736133|NCT00966875|6056198|P6|Part B|Physician Decision|1
1736134|NCT00966875|6056199|P5|Part B|Physician Decision|2
1736135|NCT00966875|6056200|P4|Part B|Physician Decision|0
1736136|NCT00966875|6056201|P3|Part B|Physician Decision|1
1736137|NCT00966875|6056202|P2|Part B|Physician Decision|0
1736138|NCT00966875|6056203|P1|Part B|Physician Decision|0
1736139|NCT00966875|6056195|P9|Part B|Lost to Follow-up|1
1736140|NCT00966875|6056196|P8|Part B|Lost to Follow-up|0
1736141|NCT00966875|6056197|P7|Part B|Lost to Follow-up|0
1736142|NCT00966875|6056198|P6|Part B|Lost to Follow-up|0
1736143|NCT00966875|6056199|P5|Part B|Lost to Follow-up|0
1736144|NCT00966875|6056200|P4|Part B|Lost to Follow-up|1
1736145|NCT00966875|6056201|P3|Part B|Lost to Follow-up|0
1736146|NCT00966875|6056202|P2|Part B|Lost to Follow-up|0
1736147|NCT00966875|6056203|P1|Part B|Lost to Follow-up|0
1736148|NCT00966875|6056195|P9|Part B|Lack of Efficacy|6
1736149|NCT00966875|6056196|P8|Part B|Lack of Efficacy|9
1736150|NCT00966875|6056197|P7|Part B|Lack of Efficacy|12
1736151|NCT00966875|6056198|P6|Part B|Lack of Efficacy|3
1736152|NCT00966875|6056199|P5|Part B|Lack of Efficacy|2
1736153|NCT00966875|6056200|P4|Part B|Lack of Efficacy|1
1736154|NCT00966875|6056201|P3|Part B|Lack of Efficacy|1
1736155|NCT00966875|6056202|P2|Part B|Lack of Efficacy|1
1736156|NCT00966875|6056203|P1|Part B|Lack of Efficacy|2
1736157|NCT00966875|6056195|P9|Part B|Death|0
1736158|NCT00966875|6056196|P8|Part B|Death|1
1736159|NCT00966875|6056197|P7|Part B|Death|0
1736160|NCT00966875|6056198|P6|Part B|Death|0
1736161|NCT00966875|6056199|P5|Part B|Death|0
1736162|NCT00966875|6056200|P4|Part B|Death|0
1736163|NCT00966875|6056201|P3|Part B|Death|1
1736164|NCT00966875|6056202|P2|Part B|Death|0
1736165|NCT00966875|6056203|P1|Part B|Death|0
1736166|NCT00966875|6056195|P9|Part B|Adverse Event|2
1736167|NCT00966875|6056196|P8|Part B|Adverse Event|2
1736168|NCT00966875|6056197|P7|Part B|Adverse Event|5
1736169|NCT00966875|6056198|P6|Part B|Adverse Event|0
1736170|NCT00966875|6056199|P5|Part B|Adverse Event|1
1736171|NCT00966875|6056200|P4|Part B|Adverse Event|0
1736172|NCT00966875|6056201|P3|Part B|Adverse Event|1
1736173|NCT00966875|6056202|P2|Part B|Adverse Event|1
1736174|NCT00966875|6056203|P1|Part B|Adverse Event|0
1736175|NCT00966875|6056195|P9|Part A|Protocol Violation|1
1736176|NCT00966875|6056196|P8|Part A|Protocol Violation|1
1736177|NCT00966875|6056197|P7|Part A|Protocol Violation|2
1736178|NCT00966875|6056198|P6|Part A|Protocol Violation|0
1736179|NCT00966875|6056199|P5|Part A|Protocol Violation|0
1736180|NCT00966875|6056200|P4|Part A|Protocol Violation|0
1736181|NCT00966875|6056201|P3|Part A|Protocol Violation|0
1736182|NCT00966875|6056202|P2|Part A|Protocol Violation|0
1736183|NCT00966875|6056203|P1|Part A|Protocol Violation|0
1736184|NCT00966875|6056195|P9|Part A|Withdrawal by Subject|1
1736185|NCT00966875|6056196|P8|Part A|Withdrawal by Subject|1
1736186|NCT00966875|6056197|P7|Part A|Withdrawal by Subject|5
1736187|NCT00966875|6056198|P6|Part A|Withdrawal by Subject|0
1736188|NCT00966875|6056199|P5|Part A|Withdrawal by Subject|3
1736189|NCT00966875|6056200|P4|Part A|Withdrawal by Subject|1
1736190|NCT00966875|6056201|P3|Part A|Withdrawal by Subject|1
1736191|NCT00966875|6056202|P2|Part A|Withdrawal by Subject|2
1736192|NCT00966875|6056203|P1|Part A|Withdrawal by Subject|2
1736193|NCT00966875|6056195|P9|Part A|Sponsor Decision|1
1736194|NCT00966875|6056196|P8|Part A|Sponsor Decision|2
1736195|NCT00966875|6056197|P7|Part A|Sponsor Decision|0
1736196|NCT00966875|6056198|P6|Part A|Sponsor Decision|0
1736197|NCT00966875|6056199|P5|Part A|Sponsor Decision|1
1736198|NCT00966875|6056200|P4|Part A|Sponsor Decision|0
1736199|NCT00966875|6056201|P3|Part A|Sponsor Decision|1
1736200|NCT00966875|6056202|P2|Part A|Sponsor Decision|0
1736201|NCT00966875|6056203|P1|Part A|Sponsor Decision|0
1736202|NCT00966875|6056195|P9|Part A|Physician Decision|2
1736203|NCT00966875|6056196|P8|Part A|Physician Decision|0
1736204|NCT00966875|6056197|P7|Part A|Physician Decision|1
1736205|NCT00966875|6056198|P6|Part A|Physician Decision|0
1736206|NCT00966875|6056199|P5|Part A|Physician Decision|1
1736207|NCT00966875|6056200|P4|Part A|Physician Decision|0
1736208|NCT00966875|6056201|P3|Part A|Physician Decision|0
1736209|NCT00966875|6056202|P2|Part A|Physician Decision|0
1736210|NCT00966875|6056203|P1|Part A|Physician Decision|0
1736211|NCT00966875|6056195|P9|Part A|Parent/Caregiver Decision|0
1736212|NCT00966875|6056196|P8|Part A|Parent/Caregiver Decision|0
1736213|NCT00966875|6056197|P7|Part A|Parent/Caregiver Decision|0
1736214|NCT00966875|6056198|P6|Part A|Parent/Caregiver Decision|0
1736215|NCT00966875|6056199|P5|Part A|Parent/Caregiver Decision|0
1736216|NCT00966875|6056200|P4|Part A|Parent/Caregiver Decision|1
1736217|NCT00966875|6056201|P3|Part A|Parent/Caregiver Decision|0
1736218|NCT00966875|6056202|P2|Part A|Parent/Caregiver Decision|0
1736219|NCT00966875|6056203|P1|Part A|Parent/Caregiver Decision|0
1736220|NCT00966875|6056195|P9|Part A|Lost to Follow-up|0
1736221|NCT00966875|6056196|P8|Part A|Lost to Follow-up|0
1736222|NCT00966875|6056197|P7|Part A|Lost to Follow-up|0
1736223|NCT00966875|6056198|P6|Part A|Lost to Follow-up|1
1736224|NCT00966875|6056199|P5|Part A|Lost to Follow-up|0
1736225|NCT00966875|6056200|P4|Part A|Lost to Follow-up|0
1736226|NCT00966875|6056201|P3|Part A|Lost to Follow-up|0
1736227|NCT00966875|6056202|P2|Part A|Lost to Follow-up|0
1736228|NCT00966875|6056203|P1|Part A|Lost to Follow-up|2
1736229|NCT00966875|6056195|P9|Part A|Lack of Efficacy|0
1736230|NCT00966875|6056196|P8|Part A|Lack of Efficacy|0
1736231|NCT00966875|6056197|P7|Part A|Lack of Efficacy|4
1736232|NCT00966875|6056198|P6|Part A|Lack of Efficacy|0
1736233|NCT00966875|6056199|P5|Part A|Lack of Efficacy|0
1736234|NCT00966875|6056200|P4|Part A|Lack of Efficacy|0
1736235|NCT00966875|6056201|P3|Part A|Lack of Efficacy|0
1736236|NCT00966875|6056202|P2|Part A|Lack of Efficacy|1
1736237|NCT00966875|6056203|P1|Part A|Lack of Efficacy|0
1736238|NCT00966875|6056195|P9|Part A|Entry Criteria|0
1736239|NCT00966875|6056196|P8|Part A|Entry Criteria|0
1736240|NCT00966875|6056197|P7|Part A|Entry Criteria|0
1736241|NCT00966875|6056198|P6|Part A|Entry Criteria|2
1736242|NCT00966875|6056199|P5|Part A|Entry Criteria|0
1736243|NCT00966875|6056200|P4|Part A|Entry Criteria|0
1736244|NCT00966875|6056201|P3|Part A|Entry Criteria|0
1736245|NCT00966875|6056202|P2|Part A|Entry Criteria|0
1736246|NCT00966875|6056203|P1|Part A|Entry Criteria|0
1736247|NCT00966875|6056195|P9|Part A|Adverse Event|3
1736248|NCT00966875|6056196|P8|Part A|Adverse Event|3
1736249|NCT00966875|6056197|P7|Part A|Adverse Event|0
1736250|NCT00966875|6056198|P6|Part A|Adverse Event|1
1736251|NCT00966875|6056199|P5|Part A|Adverse Event|0
1736252|NCT00966875|6056200|P4|Part A|Adverse Event|1
1736253|NCT00966875|6056201|P3|Part A|Adverse Event|0
1736254|NCT00966875|6056202|P2|Part A|Adverse Event|1
1736255|NCT00966875|6056203|P1|Part A|Adverse Event|2
1736256|NCT00966719|6056554|P2|Overall Study|Lost to Follow-up|11
1736257|NCT00966719|6056555|P1|Overall Study|Lost to Follow-up|6
1736258|NCT00966654|6056575|P1|Overall Study|Study was terminated,PI left institution|12
1736259|NCT00966355|6056649|P3|Overall Study|Lost to Follow-up|3
1736260|NCT00966355|6056650|P2|Overall Study|Lost to Follow-up|4
1736261|NCT00966355|6056651|P1|Overall Study|Lost to Follow-up|5
1736262|NCT00966355|6056649|P3|Overall Study|newly diagnosed advanced HCC|10
1736263|NCT00966355|6056650|P2|Overall Study|newly diagnosed advanced HCC|12
1736264|NCT00966355|6056651|P1|Overall Study|newly diagnosed advanced HCC|11
1736265|NCT00966355|6056649|P3|Overall Study|non-variceal bleeding on endoscopy|71
1736266|NCT00966355|6056650|P2|Overall Study|non-variceal bleeding on endoscopy|70
1736267|NCT00966355|6056651|P1|Overall Study|non-variceal bleeding on endoscopy|68
1736268|NCT00966277|6056664|P2|Overall Study|Treatment Plan Changed|1
1736269|NCT00966277|6056665|P1|Overall Study|Treatment Plan Changed|0
1736270|NCT00966277|6056664|P2|Overall Study|Ineligible|3
1736271|NCT00966277|6056665|P1|Overall Study|Ineligible|1
1736272|NCT00966277|6056664|P2|Overall Study|Withdrawal by Subject|0
1736273|NCT00966277|6056665|P1|Overall Study|Withdrawal by Subject|3
1736274|NCT00966264|6056673|P2|Overall Study|Lost to Follow-up|3
1736275|NCT00966264|6056674|P1|Overall Study|Lost to Follow-up|4
1736276|NCT00965848|6056720|P3|Overall Study|Other|1
1736277|NCT00965848|6056721|P2|Overall Study|Other|0
1736278|NCT00965848|6056722|P1|Overall Study|Other|5
1736279|NCT00965848|6056720|P3|Overall Study|Not Clinically Evaluable|1
1736280|NCT00965848|6056721|P2|Overall Study|Not Clinically Evaluable|1
1736281|NCT00965848|6056722|P1|Overall Study|Not Clinically Evaluable|7
1736282|NCT00965848|6056720|P3|Overall Study|Indeterminate Clinical Outcome|1
1736283|NCT00965848|6056721|P2|Overall Study|Indeterminate Clinical Outcome|0
1736284|NCT00965848|6056722|P1|Overall Study|Indeterminate Clinical Outcome|2
1736285|NCT00965848|6056720|P3|Overall Study|Withdrawal by Subject|0
1736286|NCT00965848|6056721|P2|Overall Study|Withdrawal by Subject|0
1736287|NCT00965848|6056722|P1|Overall Study|Withdrawal by Subject|1
1736288|NCT00965848|6056720|P3|Overall Study|Lost to Follow-up|1
1736289|NCT00965848|6056721|P2|Overall Study|Lost to Follow-up|0
1736290|NCT00965848|6056722|P1|Overall Study|Lost to Follow-up|0
1736291|NCT00965848|6056720|P3|Overall Study|Death|5
1736292|NCT00965848|6056721|P2|Overall Study|Death|1
1736293|NCT00965848|6056722|P1|Overall Study|Death|11
1736294|NCT00965848|6056720|P3|Overall Study|Protocol Violation|1
1736295|NCT00965848|6056721|P2|Overall Study|Protocol Violation|0
1736296|NCT00965848|6056722|P1|Overall Study|Protocol Violation|3
1736297|NCT00965757|6056741|P4|Extension Phase|Other|1
1736298|NCT00965757|6056742|P3|Extension Phase|Other|2
1736299|NCT00965757|6056743|P2|Extension Phase|Other|0
1736300|NCT00965757|6056744|P1|Extension Phase|Other|0
1736301|NCT00965757|6056741|P4|Extension Phase|Protocol Violation|1
1736302|NCT00965757|6056742|P3|Extension Phase|Protocol Violation|0
1736303|NCT00965757|6056743|P2|Extension Phase|Protocol Violation|0
1736304|NCT00965757|6056744|P1|Extension Phase|Protocol Violation|0
1736305|NCT00965757|6056741|P4|Extension Phase|Ineligible after Taking Study Drug|3
1736306|NCT00965757|6056742|P3|Extension Phase|Ineligible after Taking Study Drug|3
1736307|NCT00965757|6056743|P2|Extension Phase|Ineligible after Taking Study Drug|0
1736308|NCT00965757|6056744|P1|Extension Phase|Ineligible after Taking Study Drug|0
1736309|NCT00965757|6056741|P4|Extension Phase|Lost to Follow-up|1
1736310|NCT00965757|6056742|P3|Extension Phase|Lost to Follow-up|0
1736311|NCT00965757|6056743|P2|Extension Phase|Lost to Follow-up|0
1736312|NCT00965757|6056744|P1|Extension Phase|Lost to Follow-up|0
1736313|NCT00965757|6056741|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
1736314|NCT00965757|6056742|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
1736315|NCT00965757|6056743|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
1736316|NCT00965757|6056744|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
1736317|NCT00965757|6056741|P4|Extension Phase|Lack of Efficacy|12
1736318|NCT00965757|6056742|P3|Extension Phase|Lack of Efficacy|8
1736319|NCT00965757|6056743|P2|Extension Phase|Lack of Efficacy|0
1736320|NCT00965757|6056744|P1|Extension Phase|Lack of Efficacy|0
1736321|NCT00965757|6056741|P4|Extension Phase|Abnormal Laboratory Value|1
1736322|NCT00965757|6056742|P3|Extension Phase|Abnormal Laboratory Value|6
1736323|NCT00965757|6056743|P2|Extension Phase|Abnormal Laboratory Value|0
1736324|NCT00965757|6056744|P1|Extension Phase|Abnormal Laboratory Value|0
1736325|NCT00965757|6056741|P4|Extension Phase|Adverse drug reaction|3
1736326|NCT00965757|6056742|P3|Extension Phase|Adverse drug reaction|6
1736327|NCT00965757|6056743|P2|Extension Phase|Adverse drug reaction|0
1736328|NCT00965757|6056744|P1|Extension Phase|Adverse drug reaction|0
1736329|NCT00965757|6056741|P4|Extension Phase|Progression of concomitant disease|2
1736330|NCT00965757|6056742|P3|Extension Phase|Progression of concomitant disease|4
1736331|NCT00965757|6056743|P2|Extension Phase|Progression of concomitant disease|0
1736332|NCT00965757|6056744|P1|Extension Phase|Progression of concomitant disease|0
1736333|NCT00965757|6056741|P4|Double-blind Phase|Other|0
1736334|NCT00965757|6056742|P3|Double-blind Phase|Other|0
1736335|NCT00965757|6056743|P2|Double-blind Phase|Other|0
1736336|NCT00965757|6056744|P1|Double-blind Phase|Other|1
1736337|NCT00965757|6056741|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
1736338|NCT00965757|6056742|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
1736339|NCT00965757|6056743|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
1736340|NCT00965757|6056744|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
1736341|NCT00965757|6056741|P4|Double-blind Phase|Lost to Follow-up|0
1736342|NCT00965757|6056742|P3|Double-blind Phase|Lost to Follow-up|0
1736343|NCT00965757|6056743|P2|Double-blind Phase|Lost to Follow-up|1
1736344|NCT00965757|6056744|P1|Double-blind Phase|Lost to Follow-up|0
1736345|NCT00965757|6056741|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1736346|NCT00965757|6056742|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1736347|NCT00965757|6056743|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
1736348|NCT00965757|6056744|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
1736349|NCT00965757|6056741|P4|Double-blind Phase|Lack of Efficacy|0
1736350|NCT00965757|6056742|P3|Double-blind Phase|Lack of Efficacy|0
1736351|NCT00965757|6056743|P2|Double-blind Phase|Lack of Efficacy|11
1736352|NCT00965757|6056744|P1|Double-blind Phase|Lack of Efficacy|7
1736353|NCT00965757|6056741|P4|Double-blind Phase|Abnormal Laboratory Value|0
1736354|NCT00965757|6056742|P3|Double-blind Phase|Abnormal Laboratory Value|0
1736355|NCT00965757|6056743|P2|Double-blind Phase|Abnormal Laboratory Value|0
1736356|NCT00965757|6056744|P1|Double-blind Phase|Abnormal Laboratory Value|2
1736357|NCT00965757|6056741|P4|Double-blind Phase|Adverse drug reaction|0
1736358|NCT00965757|6056742|P3|Double-blind Phase|Adverse drug reaction|0
1736359|NCT00965757|6056743|P2|Double-blind Phase|Adverse drug reaction|1
1736360|NCT00965757|6056744|P1|Double-blind Phase|Adverse drug reaction|2
1736361|NCT00965757|6056741|P4|Double-blind Phase|Progression of concomitant disease|0
1736362|NCT00965757|6056742|P3|Double-blind Phase|Progression of concomitant disease|0
1736363|NCT00965757|6056743|P2|Double-blind Phase|Progression of concomitant disease|2
1736364|NCT00965757|6056744|P1|Double-blind Phase|Progression of concomitant disease|1
1736365|NCT00965731|6056778|P2|Overall Study|Other|15
1736366|NCT00965731|6056779|P1|Overall Study|Other|7
1736367|NCT00965731|6056778|P2|Overall Study|Withdrawal by Subject|1
1736368|NCT00965731|6056779|P1|Overall Study|Withdrawal by Subject|0
1736369|NCT00965731|6056778|P2|Overall Study|Death|4
1736370|NCT00965731|6056779|P1|Overall Study|Death|0
1736371|NCT00965718|6056843|P1|Overall Study|Withdrawal by Subject|4
1736372|NCT00965562|6056856|P3|Overall Study|Withdrawal by Subject|0
1736373|NCT00965562|6056857|P2|Overall Study|Withdrawal by Subject|2
1736374|NCT00965562|6056858|P1|Overall Study|Withdrawal by Subject|2
1736375|NCT00965562|6056856|P3|Overall Study|Lost to Follow-up|3
1736376|NCT00965562|6056857|P2|Overall Study|Lost to Follow-up|2
1736377|NCT00965562|6056858|P1|Overall Study|Lost to Follow-up|1
1736378|NCT00965523|6056896|P1|Study 224|Physician Decision|1
1736379|NCT00965523|6056896|P1|Study 224|Progressive Disease|5
1736380|NCT00965523|6056896|P1|Study 221|Physician Decision|3
1736381|NCT00965523|6056896|P1|Study 221|Progressive Disease|4
1736382|NCT00965497|6056901|P1|Overall Study|Physician Decision|1
1736383|NCT00965484|6056906|P1|Overall Study|Withdrawal by Subject|1
1736384|NCT00965484|6056906|P1|Overall Study|Protocol Violation|1
1736385|NCT00965458|6056915|P2|Overall Study|Withdrawal by Subject|1
1736386|NCT00965458|6056916|P1|Overall Study|Withdrawal by Subject|0
1736387|NCT00965458|6056915|P2|Overall Study|Lost to Follow-up|3
1736388|NCT00965458|6056916|P1|Overall Study|Lost to Follow-up|1
1736389|NCT00965458|6056915|P2|Overall Study|Adverse Event|0
1736390|NCT00965458|6056916|P1|Overall Study|Adverse Event|1
1736391|NCT00965419|6056932|P1|Follow-up Phase|Lack of Efficacy|28
1736392|NCT00965419|6056932|P1|Follow-up Phase|Parent/Caregiver Decision|9
1736393|NCT00965419|6056932|P1|Follow-up Phase|Physician Decision|4
1736394|NCT00965419|6056932|P1|Follow-up Phase|Withdrawal by Subject|8
1736395|NCT00965419|6056932|P1|Follow-up Phase|Protocol Violation|4
1736396|NCT00965419|6056932|P1|Follow-up Phase|Adverse Event|9
1736397|NCT00965419|6056932|P1|Open Label Treatment for Responders|Lost to Follow-up|46
1736398|NCT00965419|6056932|P1|Open Label Treatment for Responders|Lack of Efficacy|67
1736399|NCT00965419|6056932|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
1736400|NCT00965419|6056932|P1|Open Label Treatment for Responders|Sponsor Decision|5
1736401|NCT00965419|6056932|P1|Open Label Treatment for Responders|Physician Decision|6
1736402|NCT00965419|6056932|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
1736403|NCT00965419|6056932|P1|Open Label Treatment for Responders|Protocol Violation|21
1736404|NCT00965419|6056932|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
1736405|NCT00965419|6056932|P1|Open Label Treatment for Responders|Adverse Event|33
1736406|NCT00965341|6056978|P2|Overall Study|Transportation issues|3
1736407|NCT00965341|6056979|P1|Overall Study|Transportation issues|4
1736408|NCT00965341|6056978|P2|Overall Study|Lost to Follow-up|0
1736409|NCT00965341|6056979|P1|Overall Study|Lost to Follow-up|1
1736410|NCT00965341|6056978|P2|Overall Study|Withdrew consent|5
1736411|NCT00965341|6056979|P1|Overall Study|Withdrew consent|1
1736412|NCT00965263|6056989|P2|Overall Study|Protocol Violation|2
1736413|NCT00965263|6056990|P1|Overall Study|Protocol Violation|0
1736414|NCT00965263|6056989|P2|Overall Study|Family emergency|1
1736415|NCT00965263|6056990|P1|Overall Study|Family emergency|0
1736416|NCT00965263|6056989|P2|Overall Study|Physician Decision|0
1736417|NCT00965263|6056990|P1|Overall Study|Physician Decision|2
1736418|NCT00965185|6057050|P2|Overall Study|Withdrawal by Subject|1
1736419|NCT00965185|6057051|P1|Overall Study|Withdrawal by Subject|0
1736420|NCT00965185|6057050|P2|Overall Study|Lost to Follow-up|0
1736421|NCT00965185|6057051|P1|Overall Study|Lost to Follow-up|2
1736422|NCT00965146|6057071|P1|Overall Study|Overall Study Termination|145
1736423|NCT00965146|6057071|P1|Overall Study|Revision / Removal of Study Implant|6
1736424|NCT00965146|6057071|P1|Overall Study|Intercurrent illness|1
1736425|NCT00965146|6057071|P1|Overall Study|Unwilling to return|11
1736426|NCT00965146|6057071|P1|Overall Study|Unable to return|1
1736427|NCT00965146|6057071|P1|Overall Study|Withdrawal by Subject|17
1736428|NCT00965146|6057071|P1|Overall Study|Lost to Follow-up|22
1736429|NCT00965146|6057071|P1|Overall Study|Death|7
1736430|NCT00965094|6057078|P2|Overall Study|Lost to Follow-up|1
1736431|NCT00965094|6057079|P1|Overall Study|Lost to Follow-up|0
1736432|NCT00965094|6057078|P2|Overall Study|Adverse Event|0
1736433|NCT00965094|6057079|P1|Overall Study|Adverse Event|5
1736434|NCT00965081|6057095|P2|Overall Study|Switched to Rescue Arm|12
1736435|NCT00965081|6057096|P1|Overall Study|Switched to Rescue Arm|5
1736436|NCT00965081|6057095|P2|Overall Study|Withdrawal by Subject|7
1736437|NCT00965081|6057096|P1|Overall Study|Withdrawal by Subject|4
1736438|NCT00965081|6057095|P2|Overall Study|Sponsor Decision|0
1736439|NCT00965081|6057096|P1|Overall Study|Sponsor Decision|1
1736440|NCT00965081|6057095|P2|Overall Study|Protocol Violation|5
1736441|NCT00965081|6057096|P1|Overall Study|Protocol Violation|2
1736442|NCT00965081|6057095|P2|Overall Study|Physician Decision|0
1736443|NCT00965081|6057096|P1|Overall Study|Physician Decision|2
1736444|NCT00965081|6057095|P2|Overall Study|Lost to Follow-up|5
1736445|NCT00965081|6057096|P1|Overall Study|Lost to Follow-up|4
1736446|NCT00965081|6057095|P2|Overall Study|Lack of Efficacy|5
1736447|NCT00965081|6057096|P1|Overall Study|Lack of Efficacy|2
1736448|NCT00965081|6057095|P2|Overall Study|Adverse Event|9
1736449|NCT00965081|6057096|P1|Overall Study|Adverse Event|14
1736450|NCT00964886|6057128|P4|Overall Study|Protocol Violation|0
1736451|NCT00964886|6057129|P3|Overall Study|Protocol Violation|0
1736452|NCT00964886|6057130|P2|Overall Study|Protocol Violation|2
1736453|NCT00964886|6057131|P1|Overall Study|Protocol Violation|0
1736454|NCT00964886|6057128|P4|Overall Study|Adverse Event|2
1736455|NCT00964886|6057129|P3|Overall Study|Adverse Event|5
1736456|NCT00964886|6057130|P2|Overall Study|Adverse Event|1
1736457|NCT00964886|6057131|P1|Overall Study|Adverse Event|3
1736458|NCT00964886|6057128|P4|Overall Study|Withdrawal by Subject|3
1736459|NCT00964886|6057129|P3|Overall Study|Withdrawal by Subject|5
1736460|NCT00964886|6057130|P2|Overall Study|Withdrawal by Subject|2
1736461|NCT00964886|6057131|P1|Overall Study|Withdrawal by Subject|6
1736462|NCT00964886|6057128|P4|Overall Study|Lost to Follow-up|4
1736463|NCT00964886|6057129|P3|Overall Study|Lost to Follow-up|6
1736464|NCT00964886|6057130|P2|Overall Study|Lost to Follow-up|2
1736465|NCT00964886|6057131|P1|Overall Study|Lost to Follow-up|2
1736466|NCT00964860|6057147|P2|Overall Study|Withdrawal by Subject|1
1736467|NCT00964860|6057148|P1|Overall Study|Withdrawal by Subject|0
1736468|NCT00964795|6057156|P1|Overall Study|Other|23
1736469|NCT00964795|6057156|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
1736470|NCT00964795|6057156|P1|Overall Study|Termination of Study by Sponsor|169
1736471|NCT00964795|6057156|P1|Overall Study|Lost to Follow-up|7
1736472|NCT00964795|6057156|P1|Overall Study|Death|14
1736473|NCT00964795|6057156|P1|Overall Study|Adverse Event|12
1736474|NCT00964795|6057156|P1|Overall Study|Withdrawal by Subject|79
1736475|NCT00964782|6057165|P2|Overall Study|Lost to Follow-up|0
1736476|NCT00964782|6057166|P1|Overall Study|Lost to Follow-up|1
1736477|NCT00964743|6057180|P1|Overall Study|Neither patient completed 8 weeks of tre|2
1736478|NCT00964678|6057188|P1|Overall Study|Physician Decision|4
1736479|NCT00964392|6057252|P2|Overall Study|Not completed|168
1736480|NCT00964392|6057253|P1|Overall Study|Not completed|44
1736481|NCT00964392|6057252|P2|Overall Study|Early Termination, non-study arrhythmia|6
1736482|NCT00964392|6057253|P1|Overall Study|Early Termination, non-study arrhythmia|1
1736483|NCT00964392|6057252|P2|Overall Study|Lost to Follow-up|10
1736484|NCT00964392|6057253|P1|Overall Study|Lost to Follow-up|4
1736485|NCT00964392|6057252|P2|Overall Study|Withdrawal by Subject|6
1736486|NCT00964392|6057253|P1|Overall Study|Withdrawal by Subject|4
1736487|NCT00964366|6057263|P2|Overall Study|Withdrawal by Subject|1
1736488|NCT00964366|6057264|P1|Overall Study|Withdrawal by Subject|0
1736489|NCT00964366|6057263|P2|Overall Study|Did not qualify at Day 1|0
1736490|NCT00964366|6057264|P1|Overall Study|Did not qualify at Day 1|1
1736491|NCT00964223|6057289|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
1736492|NCT00964158|6057357|P3|Overall Study|Withdrawal by Subject|6
1736493|NCT00964158|6057358|P2|Overall Study|Withdrawal by Subject|0
1736494|NCT00964158|6057359|P1|Overall Study|Withdrawal by Subject|0
1736495|NCT00964158|6057357|P3|Overall Study|Lost to Follow-up|2
1736496|NCT00964158|6057358|P2|Overall Study|Lost to Follow-up|1
1736497|NCT00964158|6057359|P1|Overall Study|Lost to Follow-up|0
1736498|NCT00964028|6057434|P2|Overall Study|Withdrawal by Subject|1
1736499|NCT00964028|6057435|P1|Overall Study|Withdrawal by Subject|0
1736500|NCT00963937|6057450|P3|Overall Study|Physician Decision|4
1736501|NCT00963937|6057451|P2|Overall Study|Physician Decision|10
1736502|NCT00963937|6057452|P1|Overall Study|Physician Decision|18
1736503|NCT00963937|6057450|P3|Overall Study|Protocol Violation|0
1736504|NCT00963937|6057451|P2|Overall Study|Protocol Violation|1
1736505|NCT00963937|6057452|P1|Overall Study|Protocol Violation|1
1736506|NCT00963924|6057490|P2|Overall Study|Lost to Follow-up|1
1736507|NCT00963924|6057491|P1|Overall Study|Lost to Follow-up|0
1736508|NCT00963924|6057490|P2|Overall Study|Changed antipsychotic|1
1736509|NCT00963924|6057491|P1|Overall Study|Changed antipsychotic|0
1736510|NCT00963924|6057490|P2|Overall Study|Withdrawal by Subject|1
1736511|NCT00963924|6057491|P1|Overall Study|Withdrawal by Subject|0
1736512|NCT00963924|6057490|P2|Overall Study|Adverse Event|0
1736513|NCT00963924|6057491|P1|Overall Study|Adverse Event|1
1736514|NCT00963820|6057565|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
1736515|NCT00963820|6057566|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736516|NCT00963820|6057567|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736517|NCT00963820|6057568|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736518|NCT00963820|6057569|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736519|NCT00963820|6057570|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736520|NCT00963820|6057571|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736521|NCT00963820|6057572|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736604|NCT00963820|6057571|P6|Dose Escalation Phase|Progressive Disease|3
1736522|NCT00963820|6057573|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736523|NCT00963820|6057574|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736524|NCT00963820|6057575|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736525|NCT00963820|6057576|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
1736526|NCT00963820|6057565|P12|Expansion Phase|Withdrawal by Subject|1
1736527|NCT00963820|6057566|P11|Expansion Phase|Withdrawal by Subject|1
1736528|NCT00963820|6057567|P10|Expansion Phase|Withdrawal by Subject|0
1736529|NCT00963820|6057568|P9|Expansion Phase|Withdrawal by Subject|1
1736530|NCT00963820|6057569|P8|Expansion Phase|Withdrawal by Subject|0
1736531|NCT00963820|6057570|P7|Expansion Phase|Withdrawal by Subject|0
1736532|NCT00963820|6057571|P6|Expansion Phase|Withdrawal by Subject|0
1736533|NCT00963820|6057572|P5|Expansion Phase|Withdrawal by Subject|0
1736534|NCT00963820|6057573|P4|Expansion Phase|Withdrawal by Subject|0
1736535|NCT00963820|6057574|P3|Expansion Phase|Withdrawal by Subject|0
1736536|NCT00963820|6057575|P2|Expansion Phase|Withdrawal by Subject|0
1736537|NCT00963820|6057576|P1|Expansion Phase|Withdrawal by Subject|0
1736538|NCT00963820|6057565|P12|Expansion Phase|Adverse Event|0
1736539|NCT00963820|6057566|P11|Expansion Phase|Adverse Event|0
1736540|NCT00963820|6057567|P10|Expansion Phase|Adverse Event|3
1736541|NCT00963820|6057568|P9|Expansion Phase|Adverse Event|1
1736542|NCT00963820|6057569|P8|Expansion Phase|Adverse Event|0
1736543|NCT00963820|6057570|P7|Expansion Phase|Adverse Event|0
1736544|NCT00963820|6057571|P6|Expansion Phase|Adverse Event|0
1736545|NCT00963820|6057572|P5|Expansion Phase|Adverse Event|0
1736546|NCT00963820|6057573|P4|Expansion Phase|Adverse Event|0
1736547|NCT00963820|6057574|P3|Expansion Phase|Adverse Event|0
1736548|NCT00963820|6057575|P2|Expansion Phase|Adverse Event|0
1736549|NCT00963820|6057576|P1|Expansion Phase|Adverse Event|0
1736550|NCT00963820|6057565|P12|Expansion Phase|Progressive Disease|2
1736551|NCT00963820|6057566|P11|Expansion Phase|Progressive Disease|4
1736552|NCT00963820|6057567|P10|Expansion Phase|Progressive Disease|6
1736553|NCT00963820|6057568|P9|Expansion Phase|Progressive Disease|8
1736554|NCT00963820|6057569|P8|Expansion Phase|Progressive Disease|0
1736555|NCT00963820|6057570|P7|Expansion Phase|Progressive Disease|0
1736556|NCT00963820|6057571|P6|Expansion Phase|Progressive Disease|0
1736557|NCT00963820|6057572|P5|Expansion Phase|Progressive Disease|0
1736558|NCT00963820|6057573|P4|Expansion Phase|Progressive Disease|0
1736559|NCT00963820|6057574|P3|Expansion Phase|Progressive Disease|0
1736560|NCT00963820|6057575|P2|Expansion Phase|Progressive Disease|0
1736561|NCT00963820|6057576|P1|Expansion Phase|Progressive Disease|0
1736562|NCT00963820|6057565|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736563|NCT00963820|6057566|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736564|NCT00963820|6057567|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736565|NCT00963820|6057568|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736566|NCT00963820|6057569|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736567|NCT00963820|6057570|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
1736568|NCT00963820|6057571|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736569|NCT00963820|6057572|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736570|NCT00963820|6057573|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736571|NCT00963820|6057574|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736572|NCT00963820|6057575|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736573|NCT00963820|6057576|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
1736574|NCT00963820|6057565|P12|Dose Escalation Phase|Withdrawal by Subject|0
1736575|NCT00963820|6057566|P11|Dose Escalation Phase|Withdrawal by Subject|0
1736576|NCT00963820|6057567|P10|Dose Escalation Phase|Withdrawal by Subject|0
1736577|NCT00963820|6057568|P9|Dose Escalation Phase|Withdrawal by Subject|0
1736578|NCT00963820|6057569|P8|Dose Escalation Phase|Withdrawal by Subject|2
1736579|NCT00963820|6057570|P7|Dose Escalation Phase|Withdrawal by Subject|1
1736580|NCT00963820|6057571|P6|Dose Escalation Phase|Withdrawal by Subject|0
1736581|NCT00963820|6057572|P5|Dose Escalation Phase|Withdrawal by Subject|0
1736582|NCT00963820|6057573|P4|Dose Escalation Phase|Withdrawal by Subject|0
1736583|NCT00963820|6057574|P3|Dose Escalation Phase|Withdrawal by Subject|0
1736584|NCT00963820|6057575|P2|Dose Escalation Phase|Withdrawal by Subject|0
1736585|NCT00963820|6057576|P1|Dose Escalation Phase|Withdrawal by Subject|0
1736586|NCT00963820|6057565|P12|Dose Escalation Phase|Adverse Event|0
1736587|NCT00963820|6057566|P11|Dose Escalation Phase|Adverse Event|0
1736588|NCT00963820|6057567|P10|Dose Escalation Phase|Adverse Event|0
1736589|NCT00963820|6057568|P9|Dose Escalation Phase|Adverse Event|0
1736590|NCT00963820|6057569|P8|Dose Escalation Phase|Adverse Event|1
1736591|NCT00963820|6057570|P7|Dose Escalation Phase|Adverse Event|3
1736592|NCT00963820|6057571|P6|Dose Escalation Phase|Adverse Event|0
1736593|NCT00963820|6057572|P5|Dose Escalation Phase|Adverse Event|0
1736594|NCT00963820|6057573|P4|Dose Escalation Phase|Adverse Event|0
1736595|NCT00963820|6057574|P3|Dose Escalation Phase|Adverse Event|0
1736596|NCT00963820|6057575|P2|Dose Escalation Phase|Adverse Event|0
1736597|NCT00963820|6057576|P1|Dose Escalation Phase|Adverse Event|0
1736598|NCT00963820|6057565|P12|Dose Escalation Phase|Progressive Disease|0
1736599|NCT00963820|6057566|P11|Dose Escalation Phase|Progressive Disease|0
1736600|NCT00963820|6057567|P10|Dose Escalation Phase|Progressive Disease|0
1736601|NCT00963820|6057568|P9|Dose Escalation Phase|Progressive Disease|0
1736602|NCT00963820|6057569|P8|Dose Escalation Phase|Progressive Disease|2
1736603|NCT00963820|6057570|P7|Dose Escalation Phase|Progressive Disease|3
1736605|NCT00963820|6057572|P5|Dose Escalation Phase|Progressive Disease|4
1736606|NCT00963820|6057573|P4|Dose Escalation Phase|Progressive Disease|3
1736607|NCT00963820|6057574|P3|Dose Escalation Phase|Progressive Disease|3
1736608|NCT00963820|6057575|P2|Dose Escalation Phase|Progressive Disease|3
1736609|NCT00963820|6057576|P1|Dose Escalation Phase|Progressive Disease|3
1736610|NCT00963807|6057712|P1|Overall Study|Disease progression|15
1736611|NCT00963807|6057712|P1|Overall Study|Reaction to study chemotherapy regimen|1
1736612|NCT00963807|6057712|P1|Overall Study|Physician Decision|2
1736613|NCT00963599|6057745|P4|Overall Study|Withdrawal by Subject|3
1736614|NCT00963599|6057746|P3|Overall Study|Withdrawal by Subject|3
1736615|NCT00963599|6057747|P2|Overall Study|Withdrawal by Subject|1
1736616|NCT00963599|6057748|P1|Overall Study|Withdrawal by Subject|2
1736617|NCT00963599|6057745|P4|Overall Study|Protocol Violation|4
1736618|NCT00963599|6057746|P3|Overall Study|Protocol Violation|3
1736619|NCT00963599|6057747|P2|Overall Study|Protocol Violation|2
1736620|NCT00963599|6057748|P1|Overall Study|Protocol Violation|2
1736621|NCT00963599|6057745|P4|Overall Study|Lost to Follow-up|1
1736622|NCT00963599|6057746|P3|Overall Study|Lost to Follow-up|1
1736623|NCT00963599|6057747|P2|Overall Study|Lost to Follow-up|1
1736624|NCT00963599|6057748|P1|Overall Study|Lost to Follow-up|0
1736625|NCT00963599|6057745|P4|Overall Study|Lack of Efficacy|4
1736626|NCT00963599|6057746|P3|Overall Study|Lack of Efficacy|1
1736627|NCT00963599|6057747|P2|Overall Study|Lack of Efficacy|2
1736628|NCT00963599|6057748|P1|Overall Study|Lack of Efficacy|0
1736629|NCT00963599|6057745|P4|Overall Study|Adverse Event|2
1736630|NCT00963599|6057746|P3|Overall Study|Adverse Event|1
1736631|NCT00963599|6057747|P2|Overall Study|Adverse Event|0
1736632|NCT00963599|6057748|P1|Overall Study|Adverse Event|2
1736633|NCT00963547|6057819|P7|Overall Study|Reason Unknown|0
1736634|NCT00963547|6057820|P6|Overall Study|Reason Unknown|0
1736635|NCT00963547|6057821|P5|Overall Study|Reason Unknown|0
1736636|NCT00963547|6057822|P4|Overall Study|Reason Unknown|0
1736637|NCT00963547|6057823|P3|Overall Study|Reason Unknown|0
1736638|NCT00963547|6057824|P2|Overall Study|Reason Unknown|1
1736639|NCT00963547|6057825|P1|Overall Study|Reason Unknown|0
1736640|NCT00963547|6057819|P7|Overall Study|Withdrawal by Subject|0
1736641|NCT00963547|6057820|P6|Overall Study|Withdrawal by Subject|0
1736642|NCT00963547|6057821|P5|Overall Study|Withdrawal by Subject|0
1736643|NCT00963547|6057822|P4|Overall Study|Withdrawal by Subject|0
1736644|NCT00963547|6057823|P3|Overall Study|Withdrawal by Subject|3
1736645|NCT00963547|6057824|P2|Overall Study|Withdrawal by Subject|0
1736646|NCT00963547|6057825|P1|Overall Study|Withdrawal by Subject|0
1736647|NCT00963547|6057819|P7|Overall Study|Progressive Disease|0
1736648|NCT00963547|6057820|P6|Overall Study|Progressive Disease|0
1736649|NCT00963547|6057821|P5|Overall Study|Progressive Disease|0
1736650|NCT00963547|6057822|P4|Overall Study|Progressive Disease|5
1736651|NCT00963547|6057823|P3|Overall Study|Progressive Disease|9
1736652|NCT00963547|6057824|P2|Overall Study|Progressive Disease|8
1736653|NCT00963547|6057825|P1|Overall Study|Progressive Disease|3
1736654|NCT00963547|6057819|P7|Overall Study|Physician Decision|0
1736655|NCT00963547|6057820|P6|Overall Study|Physician Decision|0
1736656|NCT00963547|6057821|P5|Overall Study|Physician Decision|0
1736657|NCT00963547|6057822|P4|Overall Study|Physician Decision|0
1736658|NCT00963547|6057823|P3|Overall Study|Physician Decision|0
1736659|NCT00963547|6057824|P2|Overall Study|Physician Decision|1
1736660|NCT00963547|6057825|P1|Overall Study|Physician Decision|1
1736661|NCT00963547|6057819|P7|Overall Study|Adverse Event|0
1736662|NCT00963547|6057820|P6|Overall Study|Adverse Event|0
1736663|NCT00963547|6057821|P5|Overall Study|Adverse Event|0
1736664|NCT00963547|6057822|P4|Overall Study|Adverse Event|1
1736665|NCT00963547|6057823|P3|Overall Study|Adverse Event|0
1736666|NCT00963547|6057824|P2|Overall Study|Adverse Event|1
1736667|NCT00963547|6057825|P1|Overall Study|Adverse Event|0
1736668|NCT00963469|6057872|P3|Overall Study|Site closed (local pollen Season ended)|3
1736669|NCT00963469|6057873|P2|Overall Study|Site closed (local pollen Season ended)|1
1736670|NCT00963469|6057874|P1|Overall Study|Site closed (local pollen Season ended)|4
1736671|NCT00963469|6057872|P3|Overall Study|Moved|0
1736672|NCT00963469|6057873|P2|Overall Study|Moved|0
1736673|NCT00963469|6057874|P1|Overall Study|Moved|1
1736674|NCT00963469|6057872|P3|Overall Study|Pre-randomization Adverse Event|0
1736675|NCT00963469|6057873|P2|Overall Study|Pre-randomization Adverse Event|2
1736676|NCT00963469|6057874|P1|Overall Study|Pre-randomization Adverse Event|1
1736677|NCT00963469|6057872|P3|Overall Study|Withdrawal by Subject|1
1736678|NCT00963469|6057873|P2|Overall Study|Withdrawal by Subject|1
1736679|NCT00963469|6057874|P1|Overall Study|Withdrawal by Subject|4
1736680|NCT00963469|6057872|P3|Overall Study|Protocol Violation|3
1736681|NCT00963469|6057873|P2|Overall Study|Protocol Violation|5
1736682|NCT00963469|6057874|P1|Overall Study|Protocol Violation|5
1736683|NCT00963469|6057872|P3|Overall Study|Lost to Follow-up|0
1736684|NCT00963469|6057873|P2|Overall Study|Lost to Follow-up|1
1736685|NCT00963469|6057874|P1|Overall Study|Lost to Follow-up|1
1736686|NCT00963469|6057872|P3|Overall Study|Lack of Efficacy|2
1736687|NCT00963469|6057873|P2|Overall Study|Lack of Efficacy|7
1736688|NCT00963469|6057874|P1|Overall Study|Lack of Efficacy|10
1736689|NCT00963469|6057872|P3|Overall Study|Adverse Event|1
1736690|NCT00963469|6057873|P2|Overall Study|Adverse Event|11
1736691|NCT00963469|6057874|P1|Overall Study|Adverse Event|15
1736692|NCT00963235|6057941|P1|Overall Study|Other|1
1736693|NCT00963235|6057941|P1|Overall Study|Physician Decision|2
1736694|NCT00963235|6057941|P1|Overall Study|Adverse Event|5
1736695|NCT00963235|6057941|P1|Overall Study|Protocol Violation|7
1736696|NCT00963235|6057941|P1|Overall Study|Failed to return|9
1736697|NCT00963235|6057941|P1|Overall Study|Lost to Follow-up|14
1736698|NCT00963235|6057941|P1|Overall Study|Withdrawal by Subject|22
1736699|NCT00962780|6058233|P2|Overall Study|Other|1
1736700|NCT00962780|6058234|P1|Overall Study|Other|0
1736701|NCT00962780|6058233|P2|Overall Study|Withdrawal by Subject|8
1736702|NCT00962780|6058234|P1|Overall Study|Withdrawal by Subject|1
1736703|NCT00962780|6058233|P2|Overall Study|Protocol Violation|4
1736704|NCT00962780|6058234|P1|Overall Study|Protocol Violation|9
1736705|NCT00962780|6058233|P2|Overall Study|Death|1
1736706|NCT00962780|6058234|P1|Overall Study|Death|0
1736707|NCT00962741|6058309|P1|Overall Study|drug ineffective+prohibited drug taken|1
1736708|NCT00962741|6058309|P1|Overall Study|Lack of Efficacy|1
1736709|NCT00962741|6058309|P1|Overall Study|Withdrawal by Subject|1
1736710|NCT00962741|6058309|P1|Overall Study|Lost to Follow-up|2
1736711|NCT00962741|6058309|P1|Overall Study|Failed to return|3
1736712|NCT00962650|6058400|P1|Overall Study|Transgastric DP was not completed|2
1736713|NCT00962585|6058419|P4|Overall Study|Withdrew Consent|0
1736714|NCT00962585|6058420|P3|Overall Study|Withdrew Consent|0
1736715|NCT00962585|6058421|P2|Overall Study|Withdrew Consent|0
1736716|NCT00962585|6058422|P1|Overall Study|Withdrew Consent|2
1736717|NCT00962585|6058419|P4|Overall Study|Withdrawal by Subject|0
1736718|NCT00962585|6058420|P3|Overall Study|Withdrawal by Subject|0
1736719|NCT00962585|6058421|P2|Overall Study|Withdrawal by Subject|0
1736720|NCT00962585|6058422|P1|Overall Study|Withdrawal by Subject|1
1736721|NCT00962585|6058419|P4|Overall Study|Protocol Violation|0
1736722|NCT00962585|6058420|P3|Overall Study|Protocol Violation|1
1736723|NCT00962585|6058421|P2|Overall Study|Protocol Violation|0
1736724|NCT00962585|6058422|P1|Overall Study|Protocol Violation|0
1736725|NCT00962585|6058419|P4|Overall Study|Lost to Follow-up|0
1736726|NCT00962585|6058420|P3|Overall Study|Lost to Follow-up|1
1736727|NCT00962585|6058421|P2|Overall Study|Lost to Follow-up|0
1736728|NCT00962585|6058422|P1|Overall Study|Lost to Follow-up|3
1736729|NCT00962585|6058419|P4|Overall Study|Adverse Event|0
1736730|NCT00962585|6058420|P3|Overall Study|Adverse Event|1
1736731|NCT00962585|6058421|P2|Overall Study|Adverse Event|2
1736732|NCT00962585|6058422|P1|Overall Study|Adverse Event|0
1736733|NCT00962390|6058484|P4|Overall Study|Withdrawal by Subject|0
1736734|NCT00962390|6058485|P3|Overall Study|Withdrawal by Subject|1
1736735|NCT00962390|6058486|P2|Overall Study|Withdrawal by Subject|1
1736736|NCT00962390|6058487|P1|Overall Study|Withdrawal by Subject|1
1736737|NCT00962390|6058484|P4|Overall Study|Protocol Violation|0
1736738|NCT00962390|6058485|P3|Overall Study|Protocol Violation|0
1736739|NCT00962390|6058486|P2|Overall Study|Protocol Violation|0
1736740|NCT00962390|6058487|P1|Overall Study|Protocol Violation|1
1736741|NCT00962390|6058484|P4|Overall Study|Lost to Follow-up|0
1736742|NCT00962390|6058485|P3|Overall Study|Lost to Follow-up|0
1736743|NCT00962390|6058486|P2|Overall Study|Lost to Follow-up|2
1736744|NCT00962390|6058487|P1|Overall Study|Lost to Follow-up|2
1736745|NCT00962390|6058484|P4|Overall Study|Adverse Event|1
1736746|NCT00962390|6058485|P3|Overall Study|Adverse Event|3
1736747|NCT00962390|6058486|P2|Overall Study|Adverse Event|0
1736748|NCT00962390|6058487|P1|Overall Study|Adverse Event|0
1736749|NCT00962247|6058549|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
1736750|NCT00962247|6058549|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
1736751|NCT00962208|6058560|P2|Overall Study|Lost to Follow-up|9
1736752|NCT00962208|6058561|P1|Overall Study|Lost to Follow-up|0
1736753|NCT00962208|6058560|P2|Overall Study|Contraindicated to continue study|1
1736754|NCT00962208|6058561|P1|Overall Study|Contraindicated to continue study|5
1736755|NCT00962208|6058560|P2|Overall Study|Could not achieve good vision|0
1736756|NCT00962208|6058561|P1|Overall Study|Could not achieve good vision|9
1736757|NCT00962104|6058569|P2|Overall Study|Other|0
1736758|NCT00962104|6058570|P1|Overall Study|Other|2
1736759|NCT00962104|6058569|P2|Overall Study|Withdrawal by Subject|6
1736760|NCT00962104|6058570|P1|Overall Study|Withdrawal by Subject|10
1736761|NCT00962104|6058569|P2|Overall Study|Sponsor Decision|1
1736762|NCT00962104|6058570|P1|Overall Study|Sponsor Decision|0
1736763|NCT00962104|6058569|P2|Overall Study|Protocol Violation|8
1736764|NCT00962104|6058570|P1|Overall Study|Protocol Violation|6
1736765|NCT00962104|6058569|P2|Overall Study|Physician Decision|0
1736766|NCT00962104|6058570|P1|Overall Study|Physician Decision|1
1736767|NCT00962104|6058569|P2|Overall Study|Lost to Follow-up|4
1736768|NCT00962104|6058570|P1|Overall Study|Lost to Follow-up|10
1736769|NCT00962104|6058569|P2|Overall Study|Lack of Efficacy|1
1736770|NCT00962104|6058570|P1|Overall Study|Lack of Efficacy|0
1736771|NCT00962104|6058569|P2|Overall Study|Entry Criteria Not Met|2
1736772|NCT00962104|6058570|P1|Overall Study|Entry Criteria Not Met|1
1736773|NCT00962104|6058569|P2|Overall Study|Adverse Event|3
1736774|NCT00962104|6058570|P1|Overall Study|Adverse Event|10
1736775|NCT00962091|6058603|P7|Overall Study|Adverse Event|1
1736776|NCT00962091|6058604|P6|Overall Study|Adverse Event|0
1736777|NCT00962091|6058605|P5|Overall Study|Adverse Event|0
1736778|NCT00962091|6058606|P4|Overall Study|Adverse Event|0
1736779|NCT00962091|6058607|P3|Overall Study|Adverse Event|0
1736780|NCT00962091|6058608|P2|Overall Study|Adverse Event|0
1736781|NCT00962091|6058609|P1|Overall Study|Adverse Event|0
1736782|NCT00962091|6058603|P7|Overall Study|Withdrawal by Subject|0
1736783|NCT00962091|6058604|P6|Overall Study|Withdrawal by Subject|1
1736784|NCT00962091|6058605|P5|Overall Study|Withdrawal by Subject|0
1736785|NCT00962091|6058606|P4|Overall Study|Withdrawal by Subject|1
1736786|NCT00962091|6058607|P3|Overall Study|Withdrawal by Subject|1
1736787|NCT00962091|6058608|P2|Overall Study|Withdrawal by Subject|2
1736788|NCT00962091|6058609|P1|Overall Study|Withdrawal by Subject|1
1736789|NCT00962013|6058693|P1|Overall Study|No 5 year evaluation|6
1736790|NCT00962013|6058693|P1|Overall Study|Site Termination|24
1736791|NCT00962013|6058693|P1|Overall Study|Removal of study device|3
1736792|NCT00962013|6058693|P1|Overall Study|Withdrawal by Subject|8
1736793|NCT00962013|6058693|P1|Overall Study|Unable/Unwilling to return|6
1736794|NCT00962013|6058693|P1|Overall Study|Lost to Follow-up|12
1736795|NCT00962013|6058693|P1|Overall Study|Death|8
1736796|NCT00962013|6058693|P1|Overall Study|Did not have surgery|1
1736797|NCT00961896|6058716|P3|Overall Study|Abnormal laboratory value|1
1736798|NCT00961896|6058717|P2|Overall Study|Abnormal laboratory value|0
1736799|NCT00961896|6058718|P1|Overall Study|Abnormal laboratory value|0
1736800|NCT00961649|6058785|P4|Overall Study|Study terminated by sponsor|1
1736801|NCT00961649|6058786|P3|Overall Study|Study terminated by sponsor|4
1736802|NCT00961649|6058787|P2|Overall Study|Study terminated by sponsor|4
1736803|NCT00961649|6058788|P1|Overall Study|Study terminated by sponsor|4
1736804|NCT00961649|6058785|P4|Overall Study|Patient left to Mexico-family emergency|0
1736805|NCT00961649|6058786|P3|Overall Study|Patient left to Mexico-family emergency|0
1736806|NCT00961649|6058787|P2|Overall Study|Patient left to Mexico-family emergency|0
1736807|NCT00961649|6058788|P1|Overall Study|Patient left to Mexico-family emergency|1
1736808|NCT00961649|6058785|P4|Overall Study|Patient has travel plans during holidays|0
1736809|NCT00961649|6058786|P3|Overall Study|Patient has travel plans during holidays|1
1736810|NCT00961649|6058787|P2|Overall Study|Patient has travel plans during holidays|0
1736811|NCT00961649|6058788|P1|Overall Study|Patient has travel plans during holidays|0
1736812|NCT00961649|6058785|P4|Overall Study|Inadequate control of IOP|1
1736813|NCT00961649|6058786|P3|Overall Study|Inadequate control of IOP|0
1736814|NCT00961649|6058787|P2|Overall Study|Inadequate control of IOP|0
1736815|NCT00961649|6058788|P1|Overall Study|Inadequate control of IOP|0
1736816|NCT00961649|6058785|P4|Overall Study|Adverse Event|2
1736817|NCT00961649|6058786|P3|Overall Study|Adverse Event|0
1736818|NCT00961649|6058787|P2|Overall Study|Adverse Event|0
1736819|NCT00961649|6058788|P1|Overall Study|Adverse Event|4
1736820|NCT00961636|6058802|P3|Overall Study|Withdrawal by Subject|13
1736821|NCT00961636|6058803|P2|Overall Study|Withdrawal by Subject|22
1736822|NCT00961636|6058804|P1|Overall Study|Withdrawal by Subject|29
1736823|NCT00961636|6058802|P3|Overall Study|Protocol Violation|1
1736824|NCT00961636|6058803|P2|Overall Study|Protocol Violation|5
1736825|NCT00961636|6058804|P1|Overall Study|Protocol Violation|9
1736826|NCT00961636|6058802|P3|Overall Study|Physician Decision|1
1736827|NCT00961636|6058803|P2|Overall Study|Physician Decision|1
1736828|NCT00961636|6058804|P1|Overall Study|Physician Decision|3
1736829|NCT00961636|6058802|P3|Overall Study|Lost to Follow-up|1
1736830|NCT00961636|6058803|P2|Overall Study|Lost to Follow-up|3
1736831|NCT00961636|6058804|P1|Overall Study|Lost to Follow-up|2
1736832|NCT00961636|6058802|P3|Overall Study|Flushing Symptoms|3
1736833|NCT00961636|6058803|P2|Overall Study|Flushing Symptoms|46
1736834|NCT00961636|6058804|P1|Overall Study|Flushing Symptoms|29
1736835|NCT00961636|6058802|P3|Overall Study|Adverse Event|13
1736836|NCT00961636|6058803|P2|Overall Study|Adverse Event|54
1736837|NCT00961636|6058804|P1|Overall Study|Adverse Event|35
1736838|NCT00961571|6058815|P1|Overall Study|Physician Decision|39
1736839|NCT00961415|6058843|P3|Maintenance Treatment Phase|Other reason|3
1736840|NCT00961415|6058844|P2|Maintenance Treatment Phase|Other reason|1
1736841|NCT00961415|6058845|P1|Maintenance Treatment Phase|Other reason|0
1736842|NCT00961415|6058843|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
1736843|NCT00961415|6058844|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
1736844|NCT00961415|6058845|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
1736845|NCT00961415|6058843|P3|Maintenance Treatment Phase|Investigators decision|0
1736846|NCT00961415|6058844|P2|Maintenance Treatment Phase|Investigators decision|2
1736847|NCT00961415|6058845|P1|Maintenance Treatment Phase|Investigators decision|0
1736848|NCT00961415|6058843|P3|Maintenance Treatment Phase|Death|34
1736849|NCT00961415|6058844|P2|Maintenance Treatment Phase|Death|42
1736850|NCT00961415|6058845|P1|Maintenance Treatment Phase|Death|0
1736851|NCT00961415|6058843|P3|Induction Treatment Phase|Other Reason|0
1736852|NCT00961415|6058844|P2|Induction Treatment Phase|Other Reason|0
1736853|NCT00961415|6058845|P1|Induction Treatment Phase|Other Reason|5
1736854|NCT00961415|6058843|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
1736855|NCT00961415|6058844|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
1736856|NCT00961415|6058845|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
1736857|NCT00961415|6058843|P3|Induction Treatment Phase|Physician Decision|0
1736858|NCT00961415|6058844|P2|Induction Treatment Phase|Physician Decision|0
1736859|NCT00961415|6058845|P1|Induction Treatment Phase|Physician Decision|2
1736860|NCT00961415|6058843|P3|Induction Treatment Phase|Protocol Violation|0
1736861|NCT00961415|6058844|P2|Induction Treatment Phase|Protocol Violation|0
1736862|NCT00961415|6058845|P1|Induction Treatment Phase|Protocol Violation|1
1736863|NCT00961415|6058843|P3|Induction Treatment Phase|Death|0
1736864|NCT00961415|6058844|P2|Induction Treatment Phase|Death|0
1736865|NCT00961415|6058845|P1|Induction Treatment Phase|Death|77
1736866|NCT00961415|6058843|P3|Induction Treatment Phase|Withdrawal by Subject|0
1736867|NCT00961415|6058844|P2|Induction Treatment Phase|Withdrawal by Subject|0
1736868|NCT00961415|6058845|P1|Induction Treatment Phase|Withdrawal by Subject|11
1736869|NCT00961350|6058885|P2|Overall Study|Misc|21
1736870|NCT00961350|6058886|P1|Overall Study|Misc|16
1736871|NCT00961350|6058885|P2|Overall Study|Lost to Follow-up|3
1736872|NCT00961350|6058886|P1|Overall Study|Lost to Follow-up|3
1736873|NCT00961350|6058885|P2|Overall Study|Withdrawal by Subject|10
1736874|NCT00961350|6058886|P1|Overall Study|Withdrawal by Subject|10
1736875|NCT00961350|6058885|P2|Overall Study|Adverse Event|33
1736876|NCT00961350|6058886|P1|Overall Study|Adverse Event|18
1736877|NCT00961298|6058907|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
1736878|NCT00961298|6058907|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
1736879|NCT00961298|6058907|P1|Two Week Placebo Run in|Withdrawal by Subject|1
1736880|NCT00961259|6058914|P3|Washout Period of 7 Days|due to concomitant medication used|0
1736881|NCT00961259|6058915|P2|Washout Period of 7 Days|due to concomitant medication used|1
1736882|NCT00961259|6058916|P1|Washout Period of 7 Days|due to concomitant medication used|0
1736883|NCT00961220|6058944|P1|Overall Study|Complete Response prior to 12 courses|1
1736884|NCT00961220|6058944|P1|Overall Study|O6BG no longer supplied|1
1736885|NCT00961220|6058944|P1|Overall Study|No IV access for O6BG|1
1736886|NCT00961220|6058944|P1|Overall Study|Lack of Efficacy|1
1736887|NCT00961220|6058944|P1|Overall Study|Adverse Event|3
1736888|NCT00961181|6058960|P1|Overall Study|Lost to Follow-up|1
1736889|NCT00961181|6058960|P1|Overall Study|Withdrawal by Subject|2
1736890|NCT00961181|6058960|P1|Overall Study|Death|2
1736891|NCT00961116|6058973|P2|Washout Period of 7 Days|Protocol Violation|1
1736892|NCT00961116|6058974|P1|Washout Period of 7 Days|Protocol Violation|0
1736893|NCT00961116|6058973|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1736894|NCT00961116|6058974|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1736895|NCT00961116|6058973|P2|Washout Period of 7 Days|Adverse Event|1
1736896|NCT00961116|6058974|P1|Washout Period of 7 Days|Adverse Event|1
1736897|NCT00960999|6059001|P2|Overall Study|RT dose constraints not met|0
1736898|NCT00960999|6059002|P1|Overall Study|RT dose constraints not met|2
1736899|NCT00960999|6059001|P2|Overall Study|Protocol Violation|2
1736900|NCT00960999|6059002|P1|Overall Study|Protocol Violation|5
1736901|NCT00960999|6059001|P2|Overall Study|Withdrawal by Subject|0
1736902|NCT00960999|6059002|P1|Overall Study|Withdrawal by Subject|1
1736903|NCT00960986|6059012|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
1736904|NCT00960986|6059013|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
1736905|NCT00960986|6059014|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
1736906|NCT00960986|6059015|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
1736907|NCT00960986|6059012|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1736908|NCT00960986|6059013|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
1736909|NCT00960986|6059014|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1736910|NCT00960986|6059015|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
1736911|NCT00960986|6059012|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
1736912|NCT00960986|6059013|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
1736913|NCT00960986|6059014|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
1736914|NCT00960986|6059015|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
1736915|NCT00960986|6059012|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1736916|NCT00960986|6059013|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
1736917|NCT00960986|6059014|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1736918|NCT00960986|6059015|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
1736919|NCT00960986|6059012|P4|Period 3 (7-week Therapy Period)|Death|0
1736920|NCT00960986|6059013|P3|Period 3 (7-week Therapy Period)|Death|1
1736921|NCT00960986|6059014|P2|Period 3 (7-week Therapy Period)|Death|0
1736922|NCT00960986|6059015|P1|Period 3 (7-week Therapy Period)|Death|0
1736923|NCT00960986|6059012|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
1736924|NCT00960986|6059013|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
1736925|NCT00960986|6059014|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
1736926|NCT00960986|6059015|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
1736927|NCT00960986|6059012|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1736928|NCT00960986|6059013|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1736929|NCT00960986|6059014|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
1736930|NCT00960986|6059015|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
1736931|NCT00960986|6059012|P4|Period 1 (Screening and Washout)|Protocol Violation|0
1736932|NCT00960986|6059013|P3|Period 1 (Screening and Washout)|Protocol Violation|0
1736933|NCT00960986|6059014|P2|Period 1 (Screening and Washout)|Protocol Violation|0
1736934|NCT00960986|6059015|P1|Period 1 (Screening and Washout)|Protocol Violation|1
1736935|NCT00960986|6059012|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
1736936|NCT00960986|6059013|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
1736937|NCT00960986|6059014|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
1736938|NCT00960986|6059015|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
1736939|NCT00960986|6059012|P4|Period 1 (Screening and Washout)|Adverse Event|1
1736940|NCT00960986|6059013|P3|Period 1 (Screening and Washout)|Adverse Event|1
1736941|NCT00960986|6059014|P2|Period 1 (Screening and Washout)|Adverse Event|2
1736942|NCT00960986|6059015|P1|Period 1 (Screening and Washout)|Adverse Event|1
1736943|NCT00960934|6059091|P6|Overall Study|Study Terminated by Sponsor|49
1736944|NCT00960934|6059092|P5|Overall Study|Study Terminated by Sponsor|49
1736945|NCT00960934|6059093|P4|Overall Study|Study Terminated by Sponsor|50
1736946|NCT00960934|6059094|P3|Overall Study|Study Terminated by Sponsor|52
1736947|NCT00960934|6059095|P2|Overall Study|Study Terminated by Sponsor|46
1736948|NCT00960934|6059096|P1|Overall Study|Study Terminated by Sponsor|50
1736949|NCT00960934|6059091|P6|Overall Study|Withdrawal by Subject|7
1736950|NCT00960934|6059092|P5|Overall Study|Withdrawal by Subject|5
1736951|NCT00960934|6059093|P4|Overall Study|Withdrawal by Subject|5
1736952|NCT00960934|6059094|P3|Overall Study|Withdrawal by Subject|4
1736953|NCT00960934|6059095|P2|Overall Study|Withdrawal by Subject|6
1736954|NCT00960934|6059096|P1|Overall Study|Withdrawal by Subject|5
1736955|NCT00960934|6059091|P6|Overall Study|Protocol Violation|2
1736956|NCT00960934|6059092|P5|Overall Study|Protocol Violation|3
1736957|NCT00960934|6059093|P4|Overall Study|Protocol Violation|3
1736958|NCT00960934|6059094|P3|Overall Study|Protocol Violation|0
1736959|NCT00960934|6059095|P2|Overall Study|Protocol Violation|4
1736960|NCT00960934|6059096|P1|Overall Study|Protocol Violation|3
1736961|NCT00960934|6059091|P6|Overall Study|Progressive Disease|1
1736962|NCT00960934|6059092|P5|Overall Study|Progressive Disease|1
1736963|NCT00960934|6059093|P4|Overall Study|Progressive Disease|0
1736964|NCT00960934|6059094|P3|Overall Study|Progressive Disease|0
1736965|NCT00960934|6059095|P2|Overall Study|Progressive Disease|1
1736966|NCT00960934|6059096|P1|Overall Study|Progressive Disease|1
1736967|NCT00960934|6059091|P6|Overall Study|Physician Decision|0
1736968|NCT00960934|6059092|P5|Overall Study|Physician Decision|0
1736969|NCT00960934|6059093|P4|Overall Study|Physician Decision|0
1736970|NCT00960934|6059094|P3|Overall Study|Physician Decision|0
1736971|NCT00960934|6059095|P2|Overall Study|Physician Decision|1
1736972|NCT00960934|6059096|P1|Overall Study|Physician Decision|0
1736973|NCT00960934|6059091|P6|Overall Study|Other|2
1736974|NCT00960934|6059092|P5|Overall Study|Other|2
1736975|NCT00960934|6059093|P4|Overall Study|Other|4
1736976|NCT00960934|6059094|P3|Overall Study|Other|5
1736977|NCT00960934|6059095|P2|Overall Study|Other|1
1736978|NCT00960934|6059096|P1|Overall Study|Other|2
1736979|NCT00960934|6059091|P6|Overall Study|Lost to Follow-up|0
1736980|NCT00960934|6059092|P5|Overall Study|Lost to Follow-up|0
1736981|NCT00960934|6059093|P4|Overall Study|Lost to Follow-up|0
1736982|NCT00960934|6059094|P3|Overall Study|Lost to Follow-up|0
1736983|NCT00960934|6059095|P2|Overall Study|Lost to Follow-up|1
1736984|NCT00960934|6059096|P1|Overall Study|Lost to Follow-up|0
1736985|NCT00960934|6059091|P6|Overall Study|Lack of Efficacy|0
1736986|NCT00960934|6059092|P5|Overall Study|Lack of Efficacy|0
1736987|NCT00960934|6059093|P4|Overall Study|Lack of Efficacy|0
1736988|NCT00960934|6059094|P3|Overall Study|Lack of Efficacy|0
1736989|NCT00960934|6059095|P2|Overall Study|Lack of Efficacy|0
1736990|NCT00960934|6059096|P1|Overall Study|Lack of Efficacy|1
1736991|NCT00960934|6059091|P6|Overall Study|Adverse Event|3
1736992|NCT00960934|6059092|P5|Overall Study|Adverse Event|4
1736993|NCT00960934|6059093|P4|Overall Study|Adverse Event|2
1736994|NCT00960934|6059094|P3|Overall Study|Adverse Event|3
1736995|NCT00960934|6059095|P2|Overall Study|Adverse Event|3
1736996|NCT00960934|6059096|P1|Overall Study|Adverse Event|2
1736997|NCT00960869|6059208|P2|Overall Study|Misc|18
1736998|NCT00960869|6059209|P1|Overall Study|Misc|19
1736999|NCT00960869|6059208|P2|Overall Study|Lost to Follow-up|4
1737000|NCT00960869|6059209|P1|Overall Study|Lost to Follow-up|1
1737001|NCT00960869|6059208|P2|Overall Study|Withdrawal by Subject|14
1737002|NCT00960869|6059209|P1|Overall Study|Withdrawal by Subject|16
1737003|NCT00960869|6059208|P2|Overall Study|Adverse Event|26
1737004|NCT00960869|6059209|P1|Overall Study|Adverse Event|17
1737005|NCT00960856|6059223|P4|Washout Period of 7 Days|Adverse Event|0
1737006|NCT00960856|6059224|P3|Washout Period of 7 Days|Adverse Event|1
1737007|NCT00960856|6059225|P2|Washout Period of 7 Days|Adverse Event|0
1737008|NCT00960856|6059226|P1|Washout Period of 7 Days|Adverse Event|0
1737009|NCT00960856|6059223|P4|Washout Period of 7 Days|Withdrawal by Subject|0
1737010|NCT00960856|6059224|P3|Washout Period of 7 Days|Withdrawal by Subject|0
1737011|NCT00960856|6059225|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1737012|NCT00960856|6059226|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1737013|NCT00960843|6059246|P2|Overall Study|Repeated needle dislodgment|1
1737014|NCT00960843|6059247|P1|Overall Study|Repeated needle dislodgment|0
1737015|NCT00960843|6059246|P2|Overall Study|Protocol Violation|4
1737016|NCT00960843|6059247|P1|Overall Study|Protocol Violation|0
1737017|NCT00960843|6059246|P2|Overall Study|Lost to Follow-up|0
1737018|NCT00960843|6059247|P1|Overall Study|Lost to Follow-up|2
1737019|NCT00960687|6059268|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1737020|NCT00960687|6059269|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1737021|NCT00960687|6059268|P2|Washout Period of 7 Days|Adverse Event|2
1737022|NCT00960687|6059269|P1|Washout Period of 7 Days|Adverse Event|3
1737023|NCT00960661|6059281|P3|Interventional Phase|Lack of Efficacy|0
1737024|NCT00960661|6059282|P2|Interventional Phase|Lack of Efficacy|2
1737025|NCT00960661|6059283|P1|Interventional Phase|Lack of Efficacy|0
1737026|NCT00960661|6059281|P3|Interventional Phase|sponsor decision|0
1737027|NCT00960661|6059282|P2|Interventional Phase|sponsor decision|1
1737028|NCT00960661|6059283|P1|Interventional Phase|sponsor decision|0
1737029|NCT00960661|6059281|P3|Interventional Phase|Physician Decision|5
1737030|NCT00960661|6059282|P2|Interventional Phase|Physician Decision|3
1737031|NCT00960661|6059283|P1|Interventional Phase|Physician Decision|0
1737032|NCT00960661|6059281|P3|Interventional Phase|Withdrawal by Subject|29
1737033|NCT00960661|6059282|P2|Interventional Phase|Withdrawal by Subject|18
1737034|NCT00960661|6059283|P1|Interventional Phase|Withdrawal by Subject|0
1737035|NCT00960661|6059281|P3|Interventional Phase|Protocol Violation|2
1737036|NCT00960661|6059282|P2|Interventional Phase|Protocol Violation|7
1737037|NCT00960661|6059283|P1|Interventional Phase|Protocol Violation|0
1737038|NCT00960661|6059281|P3|Interventional Phase|entry criteria not met|0
1737039|NCT00960661|6059282|P2|Interventional Phase|entry criteria not met|3
1737040|NCT00960661|6059283|P1|Interventional Phase|entry criteria not met|0
1737041|NCT00960661|6059281|P3|Interventional Phase|Lost to Follow-up|2
1737042|NCT00960661|6059282|P2|Interventional Phase|Lost to Follow-up|0
1737043|NCT00960661|6059283|P1|Interventional Phase|Lost to Follow-up|0
1737044|NCT00960661|6059281|P3|Interventional Phase|Death|0
1737045|NCT00960661|6059282|P2|Interventional Phase|Death|1
1737046|NCT00960661|6059283|P1|Interventional Phase|Death|0
1737047|NCT00960661|6059281|P3|Interventional Phase|Adverse Event|8
1737048|NCT00960661|6059282|P2|Interventional Phase|Adverse Event|17
1737049|NCT00960661|6059283|P1|Interventional Phase|Adverse Event|0
1737050|NCT00960661|6059281|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
1737051|NCT00960661|6059282|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
1737052|NCT00960661|6059283|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
1737053|NCT00960661|6059281|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
1737054|NCT00960661|6059282|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
1737055|NCT00960661|6059283|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
1737056|NCT00960661|6059281|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
1737057|NCT00960661|6059282|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
1737058|NCT00960661|6059283|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
1737059|NCT00960661|6059281|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
1737060|NCT00960661|6059282|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
1737061|NCT00960661|6059283|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
1737062|NCT00960661|6059281|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
1737063|NCT00960661|6059282|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
1737064|NCT00960661|6059283|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
1737065|NCT00960661|6059281|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
1737066|NCT00960661|6059282|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
1737067|NCT00960661|6059283|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
1737068|NCT00960570|6059322|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
1737069|NCT00960570|6059322|P1|1 Day Period Between Dosing|Adverse Event|2
1737070|NCT00960570|6059322|P1|21 Day Washout Period|Withdrawal by Subject|1
1737071|NCT00960570|6059322|P1|21 Day Washout Period|Adverse Event|1
1737072|NCT00960531|6059343|P10|Overall Study|Reason not Specified|1
1737073|NCT00960531|6059344|P9|Overall Study|Reason not Specified|8
1737074|NCT00960531|6059345|P8|Overall Study|Reason not Specified|0
1737075|NCT00960531|6059346|P7|Overall Study|Reason not Specified|16
1737076|NCT00960531|6059347|P6|Overall Study|Reason not Specified|0
1737077|NCT00960531|6059348|P5|Overall Study|Reason not Specified|2
1737078|NCT00960531|6059349|P4|Overall Study|Reason not Specified|1
1737079|NCT00960531|6059350|P3|Overall Study|Reason not Specified|13
1737080|NCT00960531|6059351|P2|Overall Study|Reason not Specified|1
1737081|NCT00960531|6059352|P1|Overall Study|Reason not Specified|2
1737082|NCT00960531|6059343|P10|Overall Study|Adverse Event (AE)|0
1737083|NCT00960531|6059344|P9|Overall Study|Adverse Event (AE)|2
1737084|NCT00960531|6059345|P8|Overall Study|Adverse Event (AE)|0
1737085|NCT00960531|6059346|P7|Overall Study|Adverse Event (AE)|2
1737086|NCT00960531|6059347|P6|Overall Study|Adverse Event (AE)|1
1737087|NCT00960531|6059348|P5|Overall Study|Adverse Event (AE)|0
1737088|NCT00960531|6059349|P4|Overall Study|Adverse Event (AE)|0
1737089|NCT00960531|6059350|P3|Overall Study|Adverse Event (AE)|0
1737090|NCT00960531|6059351|P2|Overall Study|Adverse Event (AE)|0
1737091|NCT00960531|6059352|P1|Overall Study|Adverse Event (AE)|2
1737092|NCT00960531|6059343|P10|Overall Study|Failed to Return|0
1737093|NCT00960531|6059344|P9|Overall Study|Failed to Return|0
1737094|NCT00960531|6059345|P8|Overall Study|Failed to Return|2
1737095|NCT00960531|6059346|P7|Overall Study|Failed to Return|0
1737096|NCT00960531|6059347|P6|Overall Study|Failed to Return|0
1737097|NCT00960531|6059348|P5|Overall Study|Failed to Return|0
1737098|NCT00960531|6059349|P4|Overall Study|Failed to Return|0
1737099|NCT00960531|6059350|P3|Overall Study|Failed to Return|0
1737100|NCT00960531|6059351|P2|Overall Study|Failed to Return|0
1737101|NCT00960531|6059352|P1|Overall Study|Failed to Return|2
1737102|NCT00960531|6059343|P10|Overall Study|Lost to Follow-up|0
1737103|NCT00960531|6059344|P9|Overall Study|Lost to Follow-up|0
1737104|NCT00960531|6059345|P8|Overall Study|Lost to Follow-up|0
1737105|NCT00960531|6059346|P7|Overall Study|Lost to Follow-up|1
1737106|NCT00960531|6059347|P6|Overall Study|Lost to Follow-up|0
1737107|NCT00960531|6059348|P5|Overall Study|Lost to Follow-up|0
1737108|NCT00960531|6059349|P4|Overall Study|Lost to Follow-up|0
1737109|NCT00960531|6059350|P3|Overall Study|Lost to Follow-up|1
1737110|NCT00960531|6059351|P2|Overall Study|Lost to Follow-up|0
1737111|NCT00960531|6059352|P1|Overall Study|Lost to Follow-up|0
1737112|NCT00960531|6059343|P10|Overall Study|Discontinuation of Study by Sponsor|0
1737113|NCT00960531|6059344|P9|Overall Study|Discontinuation of Study by Sponsor|0
1737114|NCT00960531|6059345|P8|Overall Study|Discontinuation of Study by Sponsor|1
1737115|NCT00960531|6059346|P7|Overall Study|Discontinuation of Study by Sponsor|0
1737116|NCT00960531|6059347|P6|Overall Study|Discontinuation of Study by Sponsor|0
1737117|NCT00960531|6059348|P5|Overall Study|Discontinuation of Study by Sponsor|0
1737118|NCT00960531|6059349|P4|Overall Study|Discontinuation of Study by Sponsor|0
1737119|NCT00960531|6059350|P3|Overall Study|Discontinuation of Study by Sponsor|0
1737120|NCT00960531|6059351|P2|Overall Study|Discontinuation of Study by Sponsor|0
1737121|NCT00960531|6059352|P1|Overall Study|Discontinuation of Study by Sponsor|0
1737122|NCT00960531|6059343|P10|Overall Study|Investigator Request|0
1737123|NCT00960531|6059344|P9|Overall Study|Investigator Request|0
1737124|NCT00960531|6059345|P8|Overall Study|Investigator Request|0
1737125|NCT00960531|6059346|P7|Overall Study|Investigator Request|0
1737126|NCT00960531|6059347|P6|Overall Study|Investigator Request|0
1737127|NCT00960531|6059348|P5|Overall Study|Investigator Request|0
1737128|NCT00960531|6059349|P4|Overall Study|Investigator Request|0
1737129|NCT00960531|6059350|P3|Overall Study|Investigator Request|1
1737130|NCT00960531|6059351|P2|Overall Study|Investigator Request|0
1737131|NCT00960531|6059352|P1|Overall Study|Investigator Request|0
1737132|NCT00960531|6059343|P10|Overall Study|Caregiver Request|0
1737133|NCT00960531|6059344|P9|Overall Study|Caregiver Request|3
1737134|NCT00960531|6059345|P8|Overall Study|Caregiver Request|1
1737135|NCT00960531|6059346|P7|Overall Study|Caregiver Request|3
1737136|NCT00960531|6059347|P6|Overall Study|Caregiver Request|2
1737137|NCT00960531|6059348|P5|Overall Study|Caregiver Request|0
1737138|NCT00960531|6059349|P4|Overall Study|Caregiver Request|5
1737139|NCT00960531|6059350|P3|Overall Study|Caregiver Request|6
1737140|NCT00960531|6059351|P2|Overall Study|Caregiver Request|0
1737141|NCT00960531|6059352|P1|Overall Study|Caregiver Request|2
1737142|NCT00960531|6059343|P10|Overall Study|Withdrawal by Subject|0
1737143|NCT00960531|6059344|P9|Overall Study|Withdrawal by Subject|1
1737144|NCT00960531|6059345|P8|Overall Study|Withdrawal by Subject|0
1737145|NCT00960531|6059346|P7|Overall Study|Withdrawal by Subject|2
1737146|NCT00960531|6059347|P6|Overall Study|Withdrawal by Subject|0
1737147|NCT00960531|6059348|P5|Overall Study|Withdrawal by Subject|0
1737148|NCT00960531|6059349|P4|Overall Study|Withdrawal by Subject|2
1737149|NCT00960531|6059350|P3|Overall Study|Withdrawal by Subject|5
1737150|NCT00960531|6059351|P2|Overall Study|Withdrawal by Subject|0
1737151|NCT00960531|6059352|P1|Overall Study|Withdrawal by Subject|1
1737152|NCT00960531|6059343|P10|Overall Study|Lack of Efficacy|0
1737153|NCT00960531|6059344|P9|Overall Study|Lack of Efficacy|0
1737154|NCT00960531|6059345|P8|Overall Study|Lack of Efficacy|0
1737155|NCT00960531|6059346|P7|Overall Study|Lack of Efficacy|0
1737156|NCT00960531|6059347|P6|Overall Study|Lack of Efficacy|0
1737157|NCT00960531|6059348|P5|Overall Study|Lack of Efficacy|0
1737158|NCT00960531|6059349|P4|Overall Study|Lack of Efficacy|0
1737159|NCT00960531|6059350|P3|Overall Study|Lack of Efficacy|0
1737160|NCT00960531|6059351|P2|Overall Study|Lack of Efficacy|0
1737161|NCT00960531|6059352|P1|Overall Study|Lack of Efficacy|1
1737162|NCT00960440|6059400|P4|Overall Study|Other|0
1737163|NCT00960440|6059401|P3|Overall Study|Other|1
1737164|NCT00960440|6059402|P2|Overall Study|Other|1
1737165|NCT00960440|6059403|P1|Overall Study|Other|1
1737166|NCT00960440|6059400|P4|Overall Study|Withdrawal by Subject|1
1737167|NCT00960440|6059401|P3|Overall Study|Withdrawal by Subject|2
1737168|NCT00960440|6059402|P2|Overall Study|Withdrawal by Subject|5
1737169|NCT00960440|6059403|P1|Overall Study|Withdrawal by Subject|9
1737170|NCT00960440|6059400|P4|Overall Study|Protocol Violation|4
1737171|NCT00960440|6059401|P3|Overall Study|Protocol Violation|3
1737172|NCT00960440|6059402|P2|Overall Study|Protocol Violation|8
1737173|NCT00960440|6059403|P1|Overall Study|Protocol Violation|2
1737174|NCT00960440|6059400|P4|Overall Study|Lack of Efficacy|8
1737175|NCT00960440|6059401|P3|Overall Study|Lack of Efficacy|3
1737176|NCT00960440|6059402|P2|Overall Study|Lack of Efficacy|5
1737177|NCT00960440|6059403|P1|Overall Study|Lack of Efficacy|2
1737178|NCT00960440|6059400|P4|Overall Study|Adverse Event|4
1737179|NCT00960440|6059401|P3|Overall Study|Adverse Event|4
1737180|NCT00960440|6059402|P2|Overall Study|Adverse Event|12
1737181|NCT00960440|6059403|P1|Overall Study|Adverse Event|12
1737182|NCT00960440|6059400|P4|Overall Study|Death|1
1737183|NCT00960440|6059401|P3|Overall Study|Death|0
1737184|NCT00960440|6059402|P2|Overall Study|Death|0
1737185|NCT00960440|6059403|P1|Overall Study|Death|0
1737186|NCT00960375|6059575|P2|Overall Study|Lost to Follow-up|22
1737187|NCT00960375|6059576|P1|Overall Study|Lost to Follow-up|20
1737188|NCT00960323|6059584|P1|Atorvastatin Alone|Withdrawal by Subject|1
1737189|NCT00960297|6059595|P1|Overall Study|Disease progression|1
1737190|NCT00960297|6059595|P1|Overall Study|Venous port infection|1
1737191|NCT00960297|6059595|P1|Overall Study|Physician Decision|1
1737192|NCT00960206|6059602|P3|Overall Study|Missing 10 year data|1
1737193|NCT00960206|6059603|P2|Overall Study|Missing 10 year data|1
1737194|NCT00960206|6059604|P1|Overall Study|Missing 10 year data|20
1737195|NCT00960206|6059602|P3|Overall Study|Revision of study component|2
1737196|NCT00960206|6059603|P2|Overall Study|Revision of study component|2
1737197|NCT00960206|6059604|P1|Overall Study|Revision of study component|2
1737198|NCT00960206|6059602|P3|Overall Study|Withdrawal by Subject|0
1737199|NCT00960206|6059603|P2|Overall Study|Withdrawal by Subject|4
1737200|NCT00960206|6059604|P1|Overall Study|Withdrawal by Subject|2
1737201|NCT00960206|6059602|P3|Overall Study|Lost to Follow-up|8
1737202|NCT00960206|6059603|P2|Overall Study|Lost to Follow-up|14
1737203|NCT00960206|6059604|P1|Overall Study|Lost to Follow-up|8
1737204|NCT00960206|6059602|P3|Overall Study|Unwilling/Unable to return|0
1737205|NCT00960206|6059603|P2|Overall Study|Unwilling/Unable to return|2
1737206|NCT00960206|6059604|P1|Overall Study|Unwilling/Unable to return|1
1737207|NCT00960206|6059602|P3|Overall Study|Death|1
1737208|NCT00960206|6059603|P2|Overall Study|Death|4
1737209|NCT00960206|6059604|P1|Overall Study|Death|7
1737210|NCT00960193|6059622|P1|14 Day Washout Period|Withdrawal by Subject|1
1737211|NCT00960154|6059635|P2|Overall Study|Study termination|25
1737212|NCT00960154|6059636|P1|Overall Study|Study termination|25
1737213|NCT00960141|6059647|P3|Overall Study|Withdrawal by Subject|1
1737214|NCT00960141|6059648|P2|Overall Study|Withdrawal by Subject|2
1737215|NCT00960141|6059649|P1|Overall Study|Withdrawal by Subject|1
1737216|NCT00960141|6059647|P3|Overall Study|Protocol Violation|2
1737217|NCT00960141|6059648|P2|Overall Study|Protocol Violation|3
1737218|NCT00960141|6059649|P1|Overall Study|Protocol Violation|1
1737219|NCT00960141|6059647|P3|Overall Study|Lost to Follow-up|0
1737220|NCT00960141|6059648|P2|Overall Study|Lost to Follow-up|0
1737221|NCT00960141|6059649|P1|Overall Study|Lost to Follow-up|1
1737222|NCT00960141|6059647|P3|Overall Study|Lack of Efficacy|2
1737223|NCT00960141|6059648|P2|Overall Study|Lack of Efficacy|4
1737224|NCT00960141|6059649|P1|Overall Study|Lack of Efficacy|3
1737225|NCT00960141|6059647|P3|Overall Study|Adverse Event|2
1737226|NCT00960141|6059648|P2|Overall Study|Adverse Event|8
1737227|NCT00960141|6059649|P1|Overall Study|Adverse Event|4
1737228|NCT00960115|6059674|P2|Overall Study|Ongoing treatment at data cut-off date|15
1737229|NCT00960115|6059675|P1|Overall Study|Ongoing treatment at data cut-off date|19
1737230|NCT00960076|6059689|P2|Overall Study|Did not attend the termination visit|1
1737231|NCT00960076|6059690|P1|Overall Study|Did not attend the termination visit|0
1737232|NCT00960076|6059689|P2|Overall Study|Hyperglycemia|5
1737233|NCT00960076|6059690|P1|Overall Study|Hyperglycemia|1
1737234|NCT00960076|6059689|P2|Overall Study|Severe non-compliance to protocol|2
1737235|NCT00960076|6059690|P1|Overall Study|Severe non-compliance to protocol|1
1737236|NCT00960076|6059689|P2|Overall Study|Lost to Follow-up|3
1737237|NCT00960076|6059690|P1|Overall Study|Lost to Follow-up|3
1737238|NCT00960076|6059689|P2|Overall Study|Withdrawal by Subject|2
1737239|NCT00960076|6059690|P1|Overall Study|Withdrawal by Subject|1
1737240|NCT00960076|6059689|P2|Overall Study|No longer met study criteria|5
1737241|NCT00960076|6059690|P1|Overall Study|No longer met study criteria|1
1737242|NCT00960076|6059689|P2|Overall Study|Adverse Event|7
1737243|NCT00960076|6059690|P1|Overall Study|Adverse Event|1
1737244|NCT00960063|6059705|P3|Overall Study|Progression of Disease|3
1737245|NCT00960063|6059706|P2|Overall Study|Progression of Disease|0
1737246|NCT00960063|6059707|P1|Overall Study|Progression of Disease|0
1737247|NCT00960063|6059705|P3|Overall Study|Adverse Event|0
1737248|NCT00960063|6059706|P2|Overall Study|Adverse Event|0
1737249|NCT00960063|6059707|P1|Overall Study|Adverse Event|1
1737250|NCT00959946|6059798|P8|Overall Study|Withdrawal by Subject|0
1737251|NCT00959946|6059799|P7|Overall Study|Withdrawal by Subject|0
1737252|NCT00959946|6059800|P6|Overall Study|Withdrawal by Subject|1
1737253|NCT00959946|6059801|P5|Overall Study|Withdrawal by Subject|0
1737254|NCT00959946|6059802|P4|Overall Study|Withdrawal by Subject|0
1737255|NCT00959946|6059803|P3|Overall Study|Withdrawal by Subject|0
1737256|NCT00959946|6059804|P2|Overall Study|Withdrawal by Subject|0
1737257|NCT00959946|6059805|P1|Overall Study|Withdrawal by Subject|0
1737258|NCT00959946|6059798|P8|Overall Study|Disease Progression|2
1737259|NCT00959946|6059799|P7|Overall Study|Disease Progression|2
1737260|NCT00959946|6059800|P6|Overall Study|Disease Progression|6
1737261|NCT00959946|6059801|P5|Overall Study|Disease Progression|4
1737262|NCT00959946|6059802|P4|Overall Study|Disease Progression|4
1737263|NCT00959946|6059803|P3|Overall Study|Disease Progression|2
1737264|NCT00959946|6059804|P2|Overall Study|Disease Progression|4
1737265|NCT00959946|6059805|P1|Overall Study|Disease Progression|2
1737266|NCT00959946|6059798|P8|Overall Study|Death|0
1737267|NCT00959946|6059799|P7|Overall Study|Death|0
1737268|NCT00959946|6059800|P6|Overall Study|Death|1
1737269|NCT00959946|6059801|P5|Overall Study|Death|0
1737270|NCT00959946|6059802|P4|Overall Study|Death|0
1737271|NCT00959946|6059803|P3|Overall Study|Death|0
1737272|NCT00959946|6059804|P2|Overall Study|Death|0
1737273|NCT00959946|6059805|P1|Overall Study|Death|0
1737274|NCT00959946|6059798|P8|Overall Study|Adverse Event|0
1737275|NCT00959946|6059799|P7|Overall Study|Adverse Event|0
1737276|NCT00959946|6059800|P6|Overall Study|Adverse Event|1
1737277|NCT00959946|6059801|P5|Overall Study|Adverse Event|0
1737278|NCT00959946|6059802|P4|Overall Study|Adverse Event|1
1737279|NCT00959946|6059803|P3|Overall Study|Adverse Event|2
1737280|NCT00959946|6059804|P2|Overall Study|Adverse Event|0
1737281|NCT00959946|6059805|P1|Overall Study|Adverse Event|0
1737282|NCT00959907|6059869|P2|Overall Study|Withdrawal by Subject|0
1737283|NCT00959907|6059870|P1|Overall Study|Withdrawal by Subject|2
1737284|NCT00959907|6059869|P2|Overall Study|Adverse Event|0
1737285|NCT00959907|6059870|P1|Overall Study|Adverse Event|1
1737286|NCT00959907|6059869|P2|Overall Study|Protocol Violation|1
1737287|NCT00959907|6059870|P1|Overall Study|Protocol Violation|0
1737288|NCT00959894|6059880|P1|Overall Study|Subject moved out of town|1
1737289|NCT00959894|6059880|P1|Overall Study|Need for contraindicated medication|1
1737290|NCT00959894|6059880|P1|Overall Study|Withdrawal by Subject|1
1737291|NCT00959894|6059880|P1|Overall Study|Adverse Event|3
1737292|NCT00959894|6059880|P1|Overall Study|Lost to Follow-up|10
1737293|NCT00959751|6059929|P2|Overall Study|No migraine headache without aura|7
1737294|NCT00959751|6059930|P1|Overall Study|No migraine headache without aura|7
1737295|NCT00959751|6059929|P2|Overall Study|Non-compliance to Study Procedures|1
1737296|NCT00959751|6059930|P1|Overall Study|Non-compliance to Study Procedures|0
1737297|NCT00959751|6059929|P2|Overall Study|Consent Withdrawn|1
1737298|NCT00959751|6059930|P1|Overall Study|Consent Withdrawn|0
1737299|NCT00959751|6059929|P2|Overall Study|Lost to Follow-up|3
1737300|NCT00959751|6059930|P1|Overall Study|Lost to Follow-up|2
1737301|NCT00959699|6059952|P2|Follow-up Period|Withdrawal by Subject|4
1737302|NCT00959699|6059953|P1|Follow-up Period|Withdrawal by Subject|3
1737303|NCT00959699|6059952|P2|Follow-up Period|Lost to Follow-up|2
1737304|NCT00959699|6059953|P1|Follow-up Period|Lost to Follow-up|3
1737305|NCT00959699|6059952|P2|Treatment Period|Futility/crossover to boceprevir|0
1737306|NCT00959699|6059953|P1|Treatment Period|Futility/crossover to boceprevir|4
1737307|NCT00959699|6059952|P2|Treatment Period|Did not receive treatment|1
1737308|NCT00959699|6059953|P1|Treatment Period|Did not receive treatment|0
1737309|NCT00959699|6059952|P2|Treatment Period|Non-Compliance with Protocol|1
1737310|NCT00959699|6059953|P1|Treatment Period|Non-Compliance with Protocol|0
1737311|NCT00959699|6059952|P2|Treatment Period|Withdrawal by Subject|3
1737312|NCT00959699|6059953|P1|Treatment Period|Withdrawal by Subject|1
1737313|NCT00959699|6059952|P2|Treatment Period|Lost to Follow-up|1
1737314|NCT00959699|6059953|P1|Treatment Period|Lost to Follow-up|0
1737315|NCT00959699|6059952|P2|Treatment Period|Lack of Efficacy|6
1737316|NCT00959699|6059953|P1|Treatment Period|Lack of Efficacy|15
1737317|NCT00959699|6059952|P2|Treatment Period|Adverse Event|13
1737318|NCT00959699|6059953|P1|Treatment Period|Adverse Event|3
1737319|NCT00959647|6059999|P1|Overall Study|Withdrawal by Subject|7
1737320|NCT00959647|6059999|P1|Overall Study|Study terminated by sponsor|4
1737321|NCT00959647|6059999|P1|Overall Study|Progressive disease|6
1737322|NCT00959647|6059999|P1|Overall Study|Adverse Event|2
1737323|NCT00959374|6060004|P1|Overall Study|Physician Decision|1
1737324|NCT00959374|6060004|P1|Overall Study|Implant Removed/Not Replaced|4
1737325|NCT00959374|6060004|P1|Overall Study|Protocol Violation|1
1737326|NCT00959374|6060004|P1|Overall Study|Death|1
1737327|NCT00959374|6060004|P1|Overall Study|Lost to Follow-up|14
1737328|NCT00959374|6060004|P1|Overall Study|Withdrawal by Subject|2
1737329|NCT00959192|6060018|P4|Overall Study|Caregiver Request|1
1737330|NCT00959192|6060019|P3|Overall Study|Caregiver Request|2
1737331|NCT00959192|6060020|P2|Overall Study|Caregiver Request|0
1737332|NCT00959192|6060021|P1|Overall Study|Caregiver Request|0
1737333|NCT00959192|6060018|P4|Overall Study|Investigator Request|0
1737334|NCT00959192|6060019|P3|Overall Study|Investigator Request|0
1737335|NCT00959192|6060020|P2|Overall Study|Investigator Request|0
1737336|NCT00959192|6060021|P1|Overall Study|Investigator Request|1
1737337|NCT00959192|6060018|P4|Overall Study|Adverse Event|0
1737338|NCT00959192|6060019|P3|Overall Study|Adverse Event|1
1737339|NCT00959192|6060020|P2|Overall Study|Adverse Event|1
1737340|NCT00959192|6060021|P1|Overall Study|Adverse Event|1
1737341|NCT00959049|6060080|P6|Overall Study|Withdrawal by Subject|0
1737342|NCT00959049|6060081|P5|Overall Study|Withdrawal by Subject|0
1737343|NCT00959049|6060082|P4|Overall Study|Withdrawal by Subject|0
1737344|NCT00959049|6060083|P3|Overall Study|Withdrawal by Subject|0
1737345|NCT00959049|6060084|P2|Overall Study|Withdrawal by Subject|2
1737346|NCT00959049|6060085|P1|Overall Study|Withdrawal by Subject|0
1737347|NCT00959049|6060080|P6|Overall Study|Contraindicated medication|0
1737348|NCT00959049|6060081|P5|Overall Study|Contraindicated medication|0
1737349|NCT00959049|6060082|P4|Overall Study|Contraindicated medication|1
1737350|NCT00959049|6060083|P3|Overall Study|Contraindicated medication|0
1737351|NCT00959049|6060084|P2|Overall Study|Contraindicated medication|0
1737352|NCT00959049|6060085|P1|Overall Study|Contraindicated medication|0
1737353|NCT00959049|6060080|P6|Overall Study|Lost to Follow-up|1
1737354|NCT00959049|6060081|P5|Overall Study|Lost to Follow-up|9
1737355|NCT00959049|6060082|P4|Overall Study|Lost to Follow-up|10
1737356|NCT00959049|6060083|P3|Overall Study|Lost to Follow-up|1
1737357|NCT00959049|6060084|P2|Overall Study|Lost to Follow-up|5
1737358|NCT00959049|6060085|P1|Overall Study|Lost to Follow-up|17
1737359|NCT00959049|6060080|P6|Overall Study|Adverse Event|0
1737360|NCT00959049|6060081|P5|Overall Study|Adverse Event|0
1737361|NCT00959049|6060082|P4|Overall Study|Adverse Event|0
1737362|NCT00959049|6060083|P3|Overall Study|Adverse Event|0
1737363|NCT00959049|6060084|P2|Overall Study|Adverse Event|0
1737364|NCT00959049|6060085|P1|Overall Study|Adverse Event|1
1737365|NCT00958893|6060150|P1|Overall Study|Study prematurely terminated|4
1737366|NCT00958880|6060156|P2|Overall Study|Lost to Follow-up|2
1737367|NCT00958880|6060157|P1|Overall Study|Lost to Follow-up|2
1737368|NCT00958841|6060165|P1|Overall Study|Discontinued prior to M*|28
1737369|NCT00958841|6060165|P1|Overall Study|Completed M6/did not enter extension|27
1737370|NCT00958841|6060165|P1|Overall Study|Unsatisfactory therapeutic effect|22
1737371|NCT00958841|6060165|P1|Overall Study|Withdrawal by Subject|1
1737372|NCT00958841|6060165|P1|Overall Study|New cancer therapy|5
1737373|NCT00958841|6060165|P1|Overall Study|Adverse Event|8
1737374|NCT00958841|6060165|P1|Overall Study|Administrative problems|1
1737375|NCT00958841|6060165|P1|Overall Study|Abnormal test procedure result(s)|3
1737376|NCT00958841|6060165|P1|Overall Study|Abnormal laboratory value(s)|1
1737377|NCT00958828|6060183|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
1737378|NCT00958828|6060184|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
1737379|NCT00958828|6060183|P2|Period 1, 1 Week of Wear|Randomization break|1
1737380|NCT00958828|6060184|P1|Period 1, 1 Week of Wear|Randomization break|0
1737381|NCT00958789|6060190|P1|Overall Study|Revision|7
1737382|NCT00958789|6060190|P1|Overall Study|Subject terminated|2
1737383|NCT00958789|6060190|P1|Overall Study|2 yr. Knee Society Score not calculable|1
1737384|NCT00958789|6060190|P1|Overall Study|No 2 yr. Knee Society Score data|4
1737385|NCT00958789|6060190|P1|Overall Study|Withdrawal by Subject|17
1737386|NCT00958789|6060190|P1|Overall Study|Lost to Follow-up|14
1737387|NCT00958789|6060190|P1|Overall Study|Death|5
1737388|NCT00958776|6060197|P2|Overall Study|Missing|1
1737389|NCT00958776|6060198|P1|Overall Study|Missing|1
1737390|NCT00958776|6060197|P2|Overall Study|Noncompliance; Protocol Deviations|3
1737391|NCT00958776|6060198|P1|Overall Study|Noncompliance; Protocol Deviations|2
1737392|NCT00958776|6060197|P2|Overall Study|Death|1
1737393|NCT00958776|6060198|P1|Overall Study|Death|2
1737394|NCT00958776|6060197|P2|Overall Study|Protocol Violation|1
1737395|NCT00958776|6060198|P1|Overall Study|Protocol Violation|1
1737396|NCT00958776|6060197|P2|Overall Study|Withdrawal by Subject|16
1737397|NCT00958776|6060198|P1|Overall Study|Withdrawal by Subject|7
1737398|NCT00958776|6060197|P2|Overall Study|Lost to Follow-up|6
1737399|NCT00958776|6060198|P1|Overall Study|Lost to Follow-up|2
1737400|NCT00958776|6060197|P2|Overall Study|Physician Decision|0
1737401|NCT00958776|6060198|P1|Overall Study|Physician Decision|1
1737402|NCT00958776|6060197|P2|Overall Study|Adverse Event|1
1737403|NCT00958776|6060198|P1|Overall Study|Adverse Event|0
1737404|NCT00958724|6060228|P1|Overall Study|Disease Progression|6
1737405|NCT00958711|6060240|P2|Overall Study|Adverse Event|2
1737406|NCT00958711|6060241|P1|Overall Study|Adverse Event|1
1737407|NCT00958711|6060240|P2|Overall Study|Death|2
1737408|NCT00958711|6060241|P1|Overall Study|Death|1
1737409|NCT00958711|6060240|P2|Overall Study|Other|5
1737410|NCT00958711|6060241|P1|Overall Study|Other|2
1737411|NCT00958711|6060240|P2|Overall Study|Lost to Follow-up|1
1737412|NCT00958711|6060241|P1|Overall Study|Lost to Follow-up|4
1737413|NCT00958711|6060240|P2|Overall Study|Physician Decision|7
1737414|NCT00958711|6060241|P1|Overall Study|Physician Decision|5
1737415|NCT00958711|6060240|P2|Overall Study|Withdrawal by Subject|4
1737416|NCT00958711|6060241|P1|Overall Study|Withdrawal by Subject|0
1737417|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1737418|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
1737419|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1737420|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
1737421|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1737422|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
1737423|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1737424|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
1737425|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
1737426|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
1737427|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
1737428|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
1737429|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
1737430|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
1737431|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
1737432|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
1737433|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
1737434|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
1737435|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
1737436|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
1737437|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
1737438|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
1737439|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
1737440|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
1737441|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
1737442|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
1737443|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
1737444|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
1737445|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
1737446|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
1737447|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
1737448|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
1737449|NCT00958568|6060286|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
1737450|NCT00958568|6060287|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
1737451|NCT00958568|6060288|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
1737452|NCT00958568|6060289|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
1737453|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1737454|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1737455|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
1737456|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
1737613|NCT00958126|6060731|P5|Overall Study|Lost to Follow-up|0
1737457|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1737458|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1737459|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
1737460|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
1737461|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1737462|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1737463|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
1737464|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
1737465|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1737466|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1737467|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
1737468|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
1737469|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1737470|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1737471|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
1737472|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
1737473|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1737474|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1737475|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
1737476|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
1737477|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1737478|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1737479|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
1737480|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
1737481|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1737482|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1737483|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
1737484|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
1737485|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1737486|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1737487|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
1737488|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
1737489|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1737490|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1737491|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
1737492|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
1737493|NCT00958568|6060286|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1737494|NCT00958568|6060287|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1737495|NCT00958568|6060288|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
1737496|NCT00958568|6060289|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
1737497|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1737498|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1737499|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
1737500|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
1737501|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1737502|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1737503|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
1737504|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
1737505|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1737506|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1737507|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
1737508|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
1737509|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1737510|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1737511|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
1737512|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
1737513|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1737514|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1737515|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
1737516|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
1737517|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1737518|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1737519|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
1737520|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
1737521|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1737522|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1737523|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
1737524|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
1737525|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1737526|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1737527|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
1737528|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
1737529|NCT00958568|6060286|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1737530|NCT00958568|6060287|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1737531|NCT00958568|6060288|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
1737532|NCT00958568|6060289|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
1737533|NCT00958438|6060526|P3|Overall Study|Other than specified above|2
1737534|NCT00958438|6060527|P2|Overall Study|Other than specified above|3
1737535|NCT00958438|6060528|P1|Overall Study|Other than specified above|2
1737536|NCT00958438|6060526|P3|Overall Study|Physician Decision|1
1737537|NCT00958438|6060527|P2|Overall Study|Physician Decision|0
1737538|NCT00958438|6060528|P1|Overall Study|Physician Decision|1
1737539|NCT00958438|6060526|P3|Overall Study|Adverse Event|0
1737540|NCT00958438|6060527|P2|Overall Study|Adverse Event|3
1737541|NCT00958438|6060528|P1|Overall Study|Adverse Event|0
1737542|NCT00958438|6060526|P3|Overall Study|Withdrawal by Subject|1
1737543|NCT00958438|6060527|P2|Overall Study|Withdrawal by Subject|2
1737544|NCT00958438|6060528|P1|Overall Study|Withdrawal by Subject|4
1737545|NCT00958438|6060526|P3|Overall Study|Protocol Violation|2
1737546|NCT00958438|6060527|P2|Overall Study|Protocol Violation|2
1737547|NCT00958438|6060528|P1|Overall Study|Protocol Violation|3
1737548|NCT00958412|6060551|P1|Overall Study|Study prematurely terminated|18
1737549|NCT00958360|6060557|P2|Overall Study|Lost to Follow-up|1
1737550|NCT00958360|6060558|P1|Overall Study|Lost to Follow-up|0
1737551|NCT00958360|6060557|P2|Overall Study|Physician Decision|1
1737552|NCT00958360|6060558|P1|Overall Study|Physician Decision|2
1737553|NCT00958360|6060557|P2|Overall Study|Death|7
1737554|NCT00958360|6060558|P1|Overall Study|Death|6
1737555|NCT00958360|6060557|P2|Overall Study|Withdrawal by Subject|1
1737556|NCT00958360|6060558|P1|Overall Study|Withdrawal by Subject|3
1737557|NCT00958347|6060572|P1|Overall Study|study termination|135
1737558|NCT00958347|6060572|P1|Overall Study|revision/removal|10
1737559|NCT00958347|6060572|P1|Overall Study|Lost to Follow-up|15
1737560|NCT00958347|6060572|P1|Overall Study|Withdrawal by Subject|23
1737561|NCT00958347|6060572|P1|Overall Study|Death|43
1737562|NCT00958256|6060616|P1|Overall Study|Adverse Event|3
1737563|NCT00958243|6060626|P6|Overall Study|Lost to Follow-up|5
1737564|NCT00958243|6060627|P5|Overall Study|Lost to Follow-up|8
1737565|NCT00958243|6060628|P4|Overall Study|Lost to Follow-up|2
1737566|NCT00958243|6060629|P3|Overall Study|Lost to Follow-up|11
1737567|NCT00958243|6060630|P2|Overall Study|Lost to Follow-up|5
1737568|NCT00958243|6060631|P1|Overall Study|Lost to Follow-up|2
1737569|NCT00958243|6060626|P6|Overall Study|Withdrawal by Subject|5
1737570|NCT00958243|6060627|P5|Overall Study|Withdrawal by Subject|1
1737571|NCT00958243|6060628|P4|Overall Study|Withdrawal by Subject|1
1737572|NCT00958243|6060629|P3|Overall Study|Withdrawal by Subject|3
1737573|NCT00958243|6060630|P2|Overall Study|Withdrawal by Subject|1
1737574|NCT00958243|6060631|P1|Overall Study|Withdrawal by Subject|0
1737575|NCT00958217|6060689|P2|Overall Study|Inpatient hospitalization|1
1737576|NCT00958217|6060690|P1|Overall Study|Inpatient hospitalization|0
1737577|NCT00958217|6060689|P2|Overall Study|Moved out of area|1
1737578|NCT00958217|6060690|P1|Overall Study|Moved out of area|1
1737579|NCT00958217|6060689|P2|Overall Study|Lost to Follow-up|19
1737580|NCT00958217|6060690|P1|Overall Study|Lost to Follow-up|17
1737581|NCT00958217|6060689|P2|Overall Study|Withdrawal by Subject|3
1737582|NCT00958217|6060690|P1|Overall Study|Withdrawal by Subject|4
1737583|NCT00958217|6060689|P2|Overall Study|Death|1
1737584|NCT00958217|6060690|P1|Overall Study|Death|2
1737585|NCT00958191|6060701|P1|Overall Study|No 5 yr x-rays|56
1737586|NCT00958191|6060701|P1|Overall Study|Site termination|11
1737587|NCT00958191|6060701|P1|Overall Study|Revision of study device|4
1737588|NCT00958191|6060701|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
1737589|NCT00958191|6060701|P1|Overall Study|Inadequate 5 yr x-ray quality|10
1737590|NCT00958191|6060701|P1|Overall Study|Lost to Follow-up|5
1737591|NCT00958191|6060701|P1|Overall Study|Death|4
1737592|NCT00958165|6060716|P1|Overall Study|Not eligible|9
1737593|NCT00958165|6060716|P1|Overall Study|Lost to Follow-up|5
1737594|NCT00958126|6060728|P8|Overall Study|Other Reason|0
1737595|NCT00958126|6060729|P7|Overall Study|Other Reason|0
1737596|NCT00958126|6060730|P6|Overall Study|Other Reason|1
1737597|NCT00958126|6060731|P5|Overall Study|Other Reason|0
1737598|NCT00958126|6060732|P4|Overall Study|Other Reason|1
1737599|NCT00958126|6060733|P3|Overall Study|Other Reason|0
1737600|NCT00958126|6060734|P2|Overall Study|Other Reason|0
1737601|NCT00958126|6060735|P1|Overall Study|Other Reason|0
1737602|NCT00958126|6060728|P8|Overall Study|Sponsor/Investigator decision|0
1737603|NCT00958126|6060729|P7|Overall Study|Sponsor/Investigator decision|0
1737604|NCT00958126|6060730|P6|Overall Study|Sponsor/Investigator decision|0
1737605|NCT00958126|6060731|P5|Overall Study|Sponsor/Investigator decision|0
1737606|NCT00958126|6060732|P4|Overall Study|Sponsor/Investigator decision|1
1737607|NCT00958126|6060733|P3|Overall Study|Sponsor/Investigator decision|0
1737608|NCT00958126|6060734|P2|Overall Study|Sponsor/Investigator decision|0
1737609|NCT00958126|6060735|P1|Overall Study|Sponsor/Investigator decision|0
1737610|NCT00958126|6060728|P8|Overall Study|Lost to Follow-up|0
1737611|NCT00958126|6060729|P7|Overall Study|Lost to Follow-up|0
1737612|NCT00958126|6060730|P6|Overall Study|Lost to Follow-up|0
1737614|NCT00958126|6060732|P4|Overall Study|Lost to Follow-up|8
1737615|NCT00958126|6060733|P3|Overall Study|Lost to Follow-up|9
1737616|NCT00958126|6060734|P2|Overall Study|Lost to Follow-up|5
1737617|NCT00958126|6060735|P1|Overall Study|Lost to Follow-up|1
1737618|NCT00958126|6060728|P8|Overall Study|Moved away from study area|0
1737619|NCT00958126|6060729|P7|Overall Study|Moved away from study area|0
1737620|NCT00958126|6060730|P6|Overall Study|Moved away from study area|0
1737621|NCT00958126|6060731|P5|Overall Study|Moved away from study area|0
1737622|NCT00958126|6060732|P4|Overall Study|Moved away from study area|1
1737623|NCT00958126|6060733|P3|Overall Study|Moved away from study area|1
1737624|NCT00958126|6060734|P2|Overall Study|Moved away from study area|0
1737625|NCT00958126|6060735|P1|Overall Study|Moved away from study area|0
1737626|NCT00958126|6060728|P8|Overall Study|Withdrawal by Subject|0
1737627|NCT00958126|6060729|P7|Overall Study|Withdrawal by Subject|0
1737628|NCT00958126|6060730|P6|Overall Study|Withdrawal by Subject|0
1737629|NCT00958126|6060731|P5|Overall Study|Withdrawal by Subject|0
1737630|NCT00958126|6060732|P4|Overall Study|Withdrawal by Subject|0
1737631|NCT00958126|6060733|P3|Overall Study|Withdrawal by Subject|0
1737632|NCT00958126|6060734|P2|Overall Study|Withdrawal by Subject|2
1737633|NCT00958126|6060735|P1|Overall Study|Withdrawal by Subject|0
1737634|NCT00958126|6060728|P8|Overall Study|Serious Adverse Event|0
1737635|NCT00958126|6060729|P7|Overall Study|Serious Adverse Event|1
1737636|NCT00958126|6060730|P6|Overall Study|Serious Adverse Event|0
1737637|NCT00958126|6060731|P5|Overall Study|Serious Adverse Event|0
1737638|NCT00958126|6060732|P4|Overall Study|Serious Adverse Event|0
1737639|NCT00958126|6060733|P3|Overall Study|Serious Adverse Event|0
1737640|NCT00958126|6060734|P2|Overall Study|Serious Adverse Event|2
1737641|NCT00958126|6060735|P1|Overall Study|Serious Adverse Event|0
1737642|NCT00958074|6060807|P2|Overall Study|Withdrawal by Subject|1
1737643|NCT00958074|6060808|P1|Overall Study|Withdrawal by Subject|0
1737644|NCT00958009|6060831|P1|Overall Study|Subject found device difficult to use|1
1737645|NCT00958009|6060831|P1|Overall Study|Adverse Event|1
1737646|NCT00957996|6060838|P2|Overall Study|Noncompliance; Protocol Deviations|6
1737647|NCT00957996|6060839|P1|Overall Study|Noncompliance; Protocol Deviations|5
1737648|NCT00957996|6060838|P2|Overall Study|Missing|0
1737649|NCT00957996|6060839|P1|Overall Study|Missing|1
1737650|NCT00957996|6060838|P2|Overall Study|Influenza-related complication|1
1737651|NCT00957996|6060839|P1|Overall Study|Influenza-related complication|0
1737652|NCT00957996|6060838|P2|Overall Study|Physician Decision|1
1737653|NCT00957996|6060839|P1|Overall Study|Physician Decision|1
1737654|NCT00957996|6060838|P2|Overall Study|Adverse Event|1
1737655|NCT00957996|6060839|P1|Overall Study|Adverse Event|2
1737656|NCT00957996|6060838|P2|Overall Study|Withdrawal by Subject|2
1737657|NCT00957996|6060839|P1|Overall Study|Withdrawal by Subject|9
1737658|NCT00957996|6060838|P2|Overall Study|Lost to Follow-up|7
1737659|NCT00957996|6060839|P1|Overall Study|Lost to Follow-up|4
1737660|NCT00957996|6060838|P2|Overall Study|Death|10
1737661|NCT00957996|6060839|P1|Overall Study|Death|4
1737662|NCT00957944|6060871|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
1737663|NCT00957944|6060872|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
1737664|NCT00957931|6060906|P1|Overall Study|Death|4
1737665|NCT00957905|6060916|P2|Part B|Protocol Violation|1
1737666|NCT00957905|6060917|P1|Part B|Protocol Violation|0
1737667|NCT00957905|6060916|P2|Part B|Death|1
1737668|NCT00957905|6060917|P1|Part B|Death|0
1737669|NCT00957905|6060916|P2|Part B|Physician Decision|1
1737670|NCT00957905|6060917|P1|Part B|Physician Decision|0
1737671|NCT00957905|6060916|P2|Part B|Not Treated|1
1737672|NCT00957905|6060917|P1|Part B|Not Treated|0
1737673|NCT00957801|6060936|P4|Overall Study|Withdrawal by Subject|1
1737674|NCT00957801|6060937|P3|Overall Study|Withdrawal by Subject|0
1737675|NCT00957801|6060938|P2|Overall Study|Withdrawal by Subject|0
1737676|NCT00957801|6060939|P1|Overall Study|Withdrawal by Subject|0
1737677|NCT00957723|6061105|P1|Overall Study|2yr ROM Data Not Evaluable|12
1737678|NCT00957723|6061105|P1|Overall Study|Intercurrent Illness|2
1737679|NCT00957723|6061105|P1|Overall Study|Investigative Site Terminated|61
1737680|NCT00957723|6061105|P1|Overall Study|Withdrawal by Subject|24
1737681|NCT00957723|6061105|P1|Overall Study|Lost to Follow-up|8
1737682|NCT00957723|6061105|P1|Overall Study|Revision/ Removal of Study Implant|3
1737683|NCT00957723|6061105|P1|Overall Study|Death|3
1737684|NCT00957658|6061194|P1|Overall Study|Protocol Violation|5
1737685|NCT00957658|6061194|P1|Overall Study|surgery cancelled|2
1737686|NCT00957658|6061194|P1|Overall Study|unwilling/unable to return|2
1737687|NCT00957658|6061194|P1|Overall Study|Site termination|10
1737688|NCT00957658|6061194|P1|Overall Study|Incomplete 2 yr data|28
1737689|NCT00957658|6061194|P1|Overall Study|Revision|1
1737690|NCT00957658|6061194|P1|Overall Study|Withdrawal by Subject|12
1737691|NCT00957658|6061194|P1|Overall Study|Lost to Follow-up|4
1737692|NCT00957658|6061194|P1|Overall Study|Death|1
1737693|NCT00957580|6061221|P3|Overall Study|Enrolled but not treated|0
1737694|NCT00957580|6061222|P2|Overall Study|Enrolled but not treated|1
1737695|NCT00957580|6061223|P1|Overall Study|Enrolled but not treated|0
1737696|NCT00957580|6061221|P3|Overall Study|Ongoing at data cut-off|0
1737697|NCT00957580|6061222|P2|Overall Study|Ongoing at data cut-off|1
1737698|NCT00957580|6061223|P1|Overall Study|Ongoing at data cut-off|0
1737699|NCT00957528|6061370|P3|Overall Study|Withdrawal by Subject|1
1737700|NCT00957528|6061371|P2|Overall Study|Withdrawal by Subject|0
1737701|NCT00957528|6061372|P1|Overall Study|Withdrawal by Subject|0
1737702|NCT00957528|6061370|P3|Overall Study|Protocol Violation|0
1737703|NCT00957528|6061371|P2|Overall Study|Protocol Violation|1
1737704|NCT00957528|6061372|P1|Overall Study|Protocol Violation|0
1737705|NCT00957424|6061395|P1|Overall Study|Withdrawal by Subject|1
1737706|NCT00957424|6061395|P1|Overall Study|Protocol Violation|3
1737707|NCT00957424|6061395|P1|Overall Study|Lost to Follow-up|19
1737708|NCT00957372|6061405|P4|PART II|Patient non-compliance|4
1737709|NCT00957372|6061406|P3|PART II|Patient non-compliance|0
1737710|NCT00957372|6061407|P2|PART II|Patient non-compliance|0
1737711|NCT00957372|6061408|P1|PART II|Patient non-compliance|0
1737712|NCT00957372|6061405|P4|PART II|Adverse Event|10
1737713|NCT00957372|6061406|P3|PART II|Adverse Event|0
1737714|NCT00957372|6061407|P2|PART II|Adverse Event|0
1737715|NCT00957372|6061408|P1|PART II|Adverse Event|0
1737716|NCT00957372|6061405|P4|PART II|Not Know|20
1737717|NCT00957372|6061406|P3|PART II|Not Know|0
1737718|NCT00957372|6061407|P2|PART II|Not Know|0
1737719|NCT00957372|6061408|P1|PART II|Not Know|0
1737720|NCT00957372|6061405|P4|PART II|Pregnancy|1
1737721|NCT00957372|6061406|P3|PART II|Pregnancy|0
1737722|NCT00957372|6061407|P2|PART II|Pregnancy|0
1737723|NCT00957372|6061408|P1|PART II|Pregnancy|0
1737724|NCT00957372|6061405|P4|PART II|Physician Decision|1
1737725|NCT00957372|6061406|P3|PART II|Physician Decision|0
1737726|NCT00957372|6061407|P2|PART II|Physician Decision|0
1737727|NCT00957372|6061408|P1|PART II|Physician Decision|0
1737728|NCT00957372|6061405|P4|PART II|Withdrawal by Subject|8
1737729|NCT00957372|6061406|P3|PART II|Withdrawal by Subject|0
1737730|NCT00957372|6061407|P2|PART II|Withdrawal by Subject|0
1737731|NCT00957372|6061408|P1|PART II|Withdrawal by Subject|0
1737732|NCT00957372|6061405|P4|PART I|Lost to Follow-up|0
1737733|NCT00957372|6061406|P3|PART I|Lost to Follow-up|1
1737734|NCT00957372|6061407|P2|PART I|Lost to Follow-up|0
1737735|NCT00957372|6061408|P1|PART I|Lost to Follow-up|0
1737736|NCT00957268|6061548|P5|Overall Study|Voluntary Withdrawal|0
1737737|NCT00957268|6061549|P4|Overall Study|Voluntary Withdrawal|0
1737738|NCT00957268|6061550|P3|Overall Study|Voluntary Withdrawal|1
1737739|NCT00957268|6061551|P2|Overall Study|Voluntary Withdrawal|0
1737740|NCT00957268|6061552|P1|Overall Study|Voluntary Withdrawal|0
1737741|NCT00957034|6061674|P3|Overall Study|Withdrawal by Subject|0
1737742|NCT00957034|6061675|P2|Overall Study|Withdrawal by Subject|2
1737743|NCT00957034|6061676|P1|Overall Study|Withdrawal by Subject|0
1737744|NCT00957034|6061674|P3|Overall Study|Sponsor Terminated Study|5
1737745|NCT00957034|6061675|P2|Overall Study|Sponsor Terminated Study|1
1737746|NCT00957034|6061676|P1|Overall Study|Sponsor Terminated Study|6
1737747|NCT00957034|6061674|P3|Overall Study|Adverse Event|1
1737748|NCT00957034|6061675|P2|Overall Study|Adverse Event|1
1737749|NCT00957034|6061676|P1|Overall Study|Adverse Event|0
1737750|NCT00957021|6061699|P1|Overall Study|Termination due to language issue|2
1737751|NCT00957021|6061699|P1|Overall Study|Surgery Cancelled|9
1737752|NCT00957021|6061699|P1|Overall Study|Site Termination by the 2 yr visit|16
1737753|NCT00957021|6061699|P1|Overall Study|Revised study component by 2 yr visit|8
1737754|NCT00957021|6061699|P1|Overall Study|No 2 yr ROM data|35
1737755|NCT00957021|6061699|P1|Overall Study|Withdrawal by Subject|34
1737756|NCT00957021|6061699|P1|Overall Study|Lost to Follow-up|8
1737757|NCT00957021|6061699|P1|Overall Study|Death|5
1737758|NCT00957008|6061712|P4|Overall Study|Relocated; Family conflict|3
1737759|NCT00957008|6061713|P3|Overall Study|Relocated; Family conflict|1
1737760|NCT00957008|6061714|P2|Overall Study|Relocated; Family conflict|1
1737761|NCT00957008|6061715|P1|Overall Study|Relocated; Family conflict|4
1737762|NCT00957008|6061712|P4|Overall Study|Physician Decision|1
1737763|NCT00957008|6061713|P3|Overall Study|Physician Decision|1
1737764|NCT00957008|6061714|P2|Overall Study|Physician Decision|0
1737765|NCT00957008|6061715|P1|Overall Study|Physician Decision|1
1737766|NCT00957008|6061712|P4|Overall Study|Lost to Follow-up|4
1737767|NCT00957008|6061713|P3|Overall Study|Lost to Follow-up|3
1737768|NCT00957008|6061714|P2|Overall Study|Lost to Follow-up|1
1737769|NCT00957008|6061715|P1|Overall Study|Lost to Follow-up|3
1737770|NCT00957008|6061712|P4|Overall Study|Withdrawal by Subject|16
1737771|NCT00957008|6061713|P3|Overall Study|Withdrawal by Subject|12
1737772|NCT00957008|6061714|P2|Overall Study|Withdrawal by Subject|10
1737773|NCT00957008|6061715|P1|Overall Study|Withdrawal by Subject|13
1737774|NCT00956943|6061743|P2|Overall Study|Lost to Follow-up|10
1737775|NCT00956943|6061744|P1|Overall Study|Lost to Follow-up|9
1737776|NCT00956839|6061768|P3|Overall Study|Lost to Follow-up|3
1737777|NCT00956839|6061769|P2|Overall Study|Lost to Follow-up|0
1737778|NCT00956839|6061770|P1|Overall Study|Lost to Follow-up|3
1737779|NCT00956813|6061783|P2|Flaxseed and Placebo|Ineligible|1
1737780|NCT00956813|6061784|P1|Flaxseed and Placebo|Ineligible|3
1737781|NCT00956813|6061783|P2|Flaxseed and Placebo|Withdrawal by Subject|4
1737782|NCT00956813|6061784|P1|Flaxseed and Placebo|Withdrawal by Subject|5
1737783|NCT00956592|6061836|P2|Overall Study|Protocol Violation|3
1737784|NCT00956592|6061837|P1|Overall Study|Protocol Violation|1
1737785|NCT00956293|6061872|P3|Follow-up Period|Follow-up period was terminated.|0
1737786|NCT00956293|6061873|P2|Follow-up Period|Follow-up period was terminated.|32
1737787|NCT00956293|6061874|P1|Follow-up Period|Follow-up period was terminated.|20
1737788|NCT00956293|6061872|P3|Main Period (Randomization)|Adverse Event|0
1737789|NCT00956293|6061873|P2|Main Period (Randomization)|Adverse Event|15
1737790|NCT00956293|6061874|P1|Main Period (Randomization)|Adverse Event|0
1737791|NCT00956293|6061872|P3|Main Period (Randomization)|Lack of Efficacy|0
1737792|NCT00956293|6061873|P2|Main Period (Randomization)|Lack of Efficacy|10
1737793|NCT00956293|6061874|P1|Main Period (Randomization)|Lack of Efficacy|1
1737794|NCT00956293|6061872|P3|Main Period (Randomization)|Abnormal laboratory value|0
1737795|NCT00956293|6061873|P2|Main Period (Randomization)|Abnormal laboratory value|2
1737796|NCT00956293|6061874|P1|Main Period (Randomization)|Abnormal laboratory value|0
1737797|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
1737798|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
1737799|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
1737800|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Adverse Event|36
1737801|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Adverse Event|0
1737802|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Adverse Event|0
1737803|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
1737804|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
1737805|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
1737806|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
1737807|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
1737808|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
1737809|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Graft loss|7
1737810|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Graft loss|0
1737811|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Graft loss|0
1737812|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Administrative problems|6
1737813|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Administrative problems|0
1737814|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Administrative problems|0
1737815|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
1737816|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
1737817|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
1737818|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Protocol Violation|1
1737819|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Protocol Violation|0
1737820|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Protocol Violation|0
1737821|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Death|1
1737822|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Death|0
1737823|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Death|0
1737824|NCT00956293|6061872|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
1737825|NCT00956293|6061873|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
1737826|NCT00956293|6061874|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
1737827|NCT00955968|6061929|P2|Overall Study|Site closed|52
1737828|NCT00955968|6061930|P1|Overall Study|Site closed|55
1737829|NCT00955968|6061929|P2|Overall Study|Lost to Follow-up|39
1737830|NCT00955968|6061930|P1|Overall Study|Lost to Follow-up|45
1737831|NCT00955968|6061929|P2|Overall Study|Withdrawal by Subject|31
1737832|NCT00955968|6061930|P1|Overall Study|Withdrawal by Subject|35
1737833|NCT00955968|6061929|P2|Overall Study|Death|4
1737834|NCT00955968|6061930|P1|Overall Study|Death|2
1737835|NCT00955955|6061968|P3|Overall Study|Lost to Follow-up|0
1737836|NCT00955955|6061969|P2|Overall Study|Lost to Follow-up|0
1737837|NCT00955955|6061970|P1|Overall Study|Lost to Follow-up|2
1737838|NCT00955825|6062054|P2|Overall Study|Any other reason not above-mentioned|9
1737839|NCT00955825|6062055|P1|Overall Study|Any other reason not above-mentioned|7
1737840|NCT00955825|6062054|P2|Overall Study|Withdrawal by Subject|6
1737841|NCT00955825|6062055|P1|Overall Study|Withdrawal by Subject|4
1737842|NCT00955825|6062054|P2|Overall Study|Adverse Event|2
1737843|NCT00955825|6062055|P1|Overall Study|Adverse Event|15
1737844|NCT00955721|6062072|P2|Overall Study|Withdrawal by Subject|0
1737845|NCT00955721|6062073|P1|Overall Study|Withdrawal by Subject|1
1737846|NCT00955721|6062072|P2|Overall Study|Death|0
1737847|NCT00955721|6062073|P1|Overall Study|Death|1
1737848|NCT00955721|6062072|P2|Overall Study|Physician Decision|0
1737849|NCT00955721|6062073|P1|Overall Study|Physician Decision|1
1737850|NCT00955708|6062083|P1|Overall Study|Patient changed care provider/moved|91
1737851|NCT00955708|6062083|P1|Overall Study|Closure of study location|60
1737852|NCT00955708|6062083|P1|Overall Study|Patient Refused to participate further|116
1737853|NCT00955708|6062083|P1|Overall Study|Product removed from service|94
1737854|NCT00955708|6062083|P1|Overall Study|Registry Conclusion|186
1737855|NCT00955708|6062083|P1|Overall Study|Protocol Violation|134
1737856|NCT00955708|6062083|P1|Overall Study|Physician Decision|36
1737857|NCT00955708|6062083|P1|Overall Study|Lost to Follow-up|72
1737858|NCT00955708|6062083|P1|Overall Study|Death|269
1737859|NCT00955682|6062089|P2|Booster Period (Month 49)|Lost to Follow-up|1
1737860|NCT00955682|6062090|P1|Booster Period (Month 49)|Lost to Follow-up|1
1737861|NCT00955617|6062200|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
1737862|NCT00955617|6062201|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
1737863|NCT00955617|6062200|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
1737864|NCT00955617|6062201|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
1737865|NCT00955617|6062200|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
1737866|NCT00955617|6062201|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
1737867|NCT00955617|6062200|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
1737868|NCT00955617|6062201|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
1737869|NCT00955474|6062265|P2|Overall Study|Physician Decision|5
1737870|NCT00955474|6062266|P1|Overall Study|Physician Decision|7
1737871|NCT00955357|6062302|P2|Maintenance Phase|Non compliance to study procedures|0
1737872|NCT00955357|6062303|P1|Maintenance Phase|Non compliance to study procedures|1
1737873|NCT00955357|6062302|P2|Maintenance Phase|Patient moving out of area|1
1737874|NCT00955357|6062303|P1|Maintenance Phase|Patient moving out of area|0
1737875|NCT00955357|6062302|P2|Maintenance Phase|Withdrawal by Subject|4
1737876|NCT00955357|6062303|P1|Maintenance Phase|Withdrawal by Subject|4
1737877|NCT00955357|6062302|P2|Maintenance Phase|Lost to Follow-up|7
1737878|NCT00955357|6062303|P1|Maintenance Phase|Lost to Follow-up|2
1737879|NCT00955357|6062302|P2|Maintenance Phase|Protocol Violation|6
1737880|NCT00955357|6062303|P1|Maintenance Phase|Protocol Violation|2
1737881|NCT00955357|6062302|P2|Maintenance Phase|Lack of Efficacy|4
1737882|NCT00955357|6062303|P1|Maintenance Phase|Lack of Efficacy|0
1737883|NCT00955357|6062302|P2|Maintenance Phase|Adverse Event|23
1737884|NCT00955357|6062303|P1|Maintenance Phase|Adverse Event|3
1737885|NCT00955357|6062302|P2|Titration Phase|Non compliance to study procedures|1
1737886|NCT00955357|6062303|P1|Titration Phase|Non compliance to study procedures|0
1737887|NCT00955357|6062302|P2|Titration Phase|Study medication not tolerated|1
1737888|NCT00955357|6062303|P1|Titration Phase|Study medication not tolerated|0
1737889|NCT00955357|6062302|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
1737890|NCT00955357|6062303|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
1737891|NCT00955357|6062302|P2|Titration Phase|Withdrawal by Subject|5
1737892|NCT00955357|6062303|P1|Titration Phase|Withdrawal by Subject|3
1737893|NCT00955357|6062302|P2|Titration Phase|Lost to Follow-up|3
1737894|NCT00955357|6062303|P1|Titration Phase|Lost to Follow-up|1
1737895|NCT00955357|6062302|P2|Titration Phase|Protocol Violation|7
1737896|NCT00955357|6062303|P1|Titration Phase|Protocol Violation|3
1737897|NCT00955357|6062302|P2|Titration Phase|Lack of Efficacy|2
1737898|NCT00955357|6062303|P1|Titration Phase|Lack of Efficacy|0
1737899|NCT00955357|6062302|P2|Titration Phase|Adverse Event|46
1737900|NCT00955357|6062303|P1|Titration Phase|Adverse Event|9
1737901|NCT00955305|6062311|P2|Overall Study|Ineligible|7
1737902|NCT00955305|6062312|P1|Overall Study|Ineligible|5
1737903|NCT00955305|6062311|P2|Overall Study|Never started protocol treatment|5
1737904|NCT00955305|6062312|P1|Overall Study|Never started protocol treatment|5
1737905|NCT00955305|6062311|P2|Overall Study|No off-treatment reason submitted|0
1737906|NCT00955305|6062312|P1|Overall Study|No off-treatment reason submitted|1
1737907|NCT00955305|6062311|P2|Overall Study|Lost to Follow-up|1
1737908|NCT00955305|6062312|P1|Overall Study|Lost to Follow-up|0
1737909|NCT00955305|6062311|P2|Overall Study|Maximum response achieved|1
1737910|NCT00955305|6062312|P1|Overall Study|Maximum response achieved|0
1737911|NCT00955305|6062311|P2|Overall Study|Functional decline|0
1737912|NCT00955305|6062312|P1|Overall Study|Functional decline|2
1737913|NCT00955305|6062311|P2|Overall Study|Continued presence of residual disease|1
1737914|NCT00955305|6062312|P1|Overall Study|Continued presence of residual disease|0
1737915|NCT00955305|6062311|P2|Overall Study|Physician Decision|0
1737916|NCT00955305|6062312|P1|Overall Study|Physician Decision|1
1737917|NCT00955305|6062311|P2|Overall Study|Other complicating disease|4
1737918|NCT00955305|6062312|P1|Overall Study|Other complicating disease|2
1737919|NCT00955305|6062311|P2|Overall Study|Alternative therapy|0
1737920|NCT00955305|6062312|P1|Overall Study|Alternative therapy|4
1737921|NCT00955305|6062311|P2|Overall Study|Withdrawal by Subject|4
1737922|NCT00955305|6062312|P1|Overall Study|Withdrawal by Subject|5
1737923|NCT00955305|6062311|P2|Overall Study|Death|1
1737924|NCT00955305|6062312|P1|Overall Study|Death|2
1737925|NCT00955305|6062311|P2|Overall Study|Adverse Event|22
1737926|NCT00955305|6062312|P1|Overall Study|Adverse Event|22
1737927|NCT00955305|6062311|P2|Overall Study|Disease progression|41
1737928|NCT00955305|6062312|P1|Overall Study|Disease progression|39
1737929|NCT00955279|6062325|P3|Overall Study|Withdrawal by Subject|3
1737930|NCT00955279|6062326|P2|Overall Study|Withdrawal by Subject|0
1737931|NCT00955279|6062327|P1|Overall Study|Withdrawal by Subject|2
1737932|NCT00955279|6062325|P3|Overall Study|Lost to Follow-up|1
1737933|NCT00955279|6062326|P2|Overall Study|Lost to Follow-up|3
1737934|NCT00955279|6062327|P1|Overall Study|Lost to Follow-up|0
1737935|NCT00955279|6062325|P3|Overall Study|Death|1
1737936|NCT00955279|6062326|P2|Overall Study|Death|1
1737937|NCT00955279|6062327|P1|Overall Study|Death|1
1737938|NCT00955279|6062325|P3|Overall Study|Other|3
1737939|NCT00955279|6062326|P2|Overall Study|Other|0
1737940|NCT00955279|6062327|P1|Overall Study|Other|0
1737941|NCT00955110|6062535|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
1737942|NCT00955110|6062535|P1|Treatment Phase|Non-compliance with study restrictions|1
1737943|NCT00955110|6062535|P1|Treatment Phase|Administrative reasons|2
1737944|NCT00955110|6062535|P1|Treatment Phase|Adverse Event|2
1737945|NCT00955110|6062535|P1|Qualification Phase|Did not meet eligibility criteria|24
1737946|NCT00954941|6062582|P2|Overall Study|Adverse Event|1
1737947|NCT00954941|6062583|P1|Overall Study|Adverse Event|0
1737948|NCT00954941|6062582|P2|Overall Study|Ineligible|2
1737949|NCT00954941|6062583|P1|Overall Study|Ineligible|2
1737950|NCT00954941|6062582|P2|Overall Study|Physician Decision|2
1737951|NCT00954941|6062583|P1|Overall Study|Physician Decision|2
1737952|NCT00954941|6062582|P2|Overall Study|Insurance Denial|2
1737953|NCT00954941|6062583|P1|Overall Study|Insurance Denial|2
1737954|NCT00954941|6062582|P2|Overall Study|Withdrawal by Subject|0
1737955|NCT00954941|6062583|P1|Overall Study|Withdrawal by Subject|1
1737956|NCT00954941|6062582|P2|Overall Study|Received treatment at home|0
1737957|NCT00954941|6062583|P1|Overall Study|Received treatment at home|1
1737958|NCT00954733|6062599|P1|Overall Study|blood gas machine did not work|1
1737959|NCT00954707|6062603|P1|Overall Study|Lost to Follow-up|33
1737960|NCT00954707|6062603|P1|Overall Study|Withdrawal by Subject|100
1737961|NCT00954707|6062603|P1|Overall Study|Death|34
1737962|NCT00954538|6062625|P6|Part III|Withdrawal by Subject|0
1737963|NCT00954538|6062626|P5|Part III|Withdrawal by Subject|1
1737964|NCT00954538|6062627|P4|Part III|Withdrawal by Subject|0
1737965|NCT00954538|6062628|P3|Part III|Withdrawal by Subject|0
1737966|NCT00954538|6062629|P2|Part III|Withdrawal by Subject|0
1737967|NCT00954538|6062630|P1|Part III|Withdrawal by Subject|0
1737968|NCT00954512|6062647|P6|Overall Study|Progression of Disease|1
1737969|NCT00954512|6062648|P5|Overall Study|Progression of Disease|1
1737970|NCT00954512|6062649|P4|Overall Study|Progression of Disease|1
1737971|NCT00954512|6062650|P3|Overall Study|Progression of Disease|0
1737972|NCT00954512|6062651|P2|Overall Study|Progression of Disease|1
1737973|NCT00954512|6062652|P1|Overall Study|Progression of Disease|2
1737974|NCT00954512|6062647|P6|Overall Study|Symptomatic Deterioration|0
1737975|NCT00954512|6062648|P5|Overall Study|Symptomatic Deterioration|2
1737976|NCT00954512|6062649|P4|Overall Study|Symptomatic Deterioration|0
1737977|NCT00954512|6062650|P3|Overall Study|Symptomatic Deterioration|0
1737978|NCT00954512|6062651|P2|Overall Study|Symptomatic Deterioration|1
1737979|NCT00954512|6062652|P1|Overall Study|Symptomatic Deterioration|0
1737980|NCT00954512|6062647|P6|Overall Study|Physician Decision|0
1737981|NCT00954512|6062648|P5|Overall Study|Physician Decision|0
1737982|NCT00954512|6062649|P4|Overall Study|Physician Decision|1
1737983|NCT00954512|6062650|P3|Overall Study|Physician Decision|0
1737984|NCT00954512|6062651|P2|Overall Study|Physician Decision|1
1737985|NCT00954512|6062652|P1|Overall Study|Physician Decision|0
1737986|NCT00954512|6062647|P6|Overall Study|Adverse Event|2
1737987|NCT00954512|6062648|P5|Overall Study|Adverse Event|1
1737988|NCT00954512|6062649|P4|Overall Study|Adverse Event|0
1737989|NCT00954512|6062650|P3|Overall Study|Adverse Event|0
1737990|NCT00954512|6062651|P2|Overall Study|Adverse Event|0
1737991|NCT00954512|6062652|P1|Overall Study|Adverse Event|0
1737992|NCT00954512|6062647|P6|Overall Study|Withdrawal by Subject|1
1737993|NCT00954512|6062648|P5|Overall Study|Withdrawal by Subject|0
1737994|NCT00954512|6062649|P4|Overall Study|Withdrawal by Subject|0
1737995|NCT00954512|6062650|P3|Overall Study|Withdrawal by Subject|0
1737996|NCT00954512|6062651|P2|Overall Study|Withdrawal by Subject|0
1737997|NCT00954512|6062652|P1|Overall Study|Withdrawal by Subject|0
1737998|NCT00954447|6062673|P2|Overall Study|Other|18
1737999|NCT00954447|6062674|P1|Overall Study|Other|21
1738000|NCT00954447|6062673|P2|Overall Study|Withdrawal by Subject|21
1738001|NCT00954447|6062674|P1|Overall Study|Withdrawal by Subject|26
1738002|NCT00954447|6062673|P2|Overall Study|Lost to Follow-up|14
1738003|NCT00954447|6062674|P1|Overall Study|Lost to Follow-up|8
1738004|NCT00954447|6062673|P2|Overall Study|Protocol Violation|7
1738005|NCT00954447|6062674|P1|Overall Study|Protocol Violation|5
1738006|NCT00954447|6062673|P2|Overall Study|Lack of Efficacy|3
1738007|NCT00954447|6062674|P1|Overall Study|Lack of Efficacy|17
1738008|NCT00954447|6062673|P2|Overall Study|Adverse Event|25
1738009|NCT00954447|6062674|P1|Overall Study|Adverse Event|33
1738010|NCT00954421|6062710|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
1738011|NCT00954421|6062710|P1|6 Months of DBS|Withdrawal by Subject|1
1738012|NCT00954421|6062710|P1|Screening|screen failures|3
1738013|NCT00954122|6062756|P1|Overall Study|Safety Reason|1
1738014|NCT00954122|6062756|P1|Overall Study|Adverse Event|1
1738015|NCT00954122|6062756|P1|Overall Study|Withdrawal by Subject|5
1738016|NCT00953927|6062773|P2|Overall Study|Other study discontinuation|1
1738017|NCT00953927|6062774|P1|Overall Study|Other study discontinuation|1
1738018|NCT00953927|6062773|P2|Overall Study|Death|4
1738019|NCT00953927|6062774|P1|Overall Study|Death|7
1738020|NCT00953927|6062773|P2|Overall Study|Withdrawal by Subject|25
1738021|NCT00953927|6062774|P1|Overall Study|Withdrawal by Subject|36
1738022|NCT00953927|6062773|P2|Overall Study|Lost to Follow-up|65
1738023|NCT00953927|6062774|P1|Overall Study|Lost to Follow-up|61
1738024|NCT00953745|6062829|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
1738025|NCT00953745|6062830|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
1738026|NCT00953745|6062829|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
1738027|NCT00953745|6062830|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
1738028|NCT00953745|6062829|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
1738029|NCT00953745|6062830|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
1738030|NCT00953745|6062829|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
1738031|NCT00953745|6062830|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
1738032|NCT00953745|6062829|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
1738033|NCT00953745|6062830|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
1738034|NCT00953745|6062829|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
1738035|NCT00953745|6062830|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
1738036|NCT00953706|6062863|P4|Part B (96-Week Open-Label Extension)|Other|2
1738037|NCT00953706|6062864|P3|Part B (96-Week Open-Label Extension)|Other|0
1738038|NCT00953706|6062865|P2|Part B (96-Week Open-Label Extension)|Other|0
1738039|NCT00953706|6062866|P1|Part B (96-Week Open-Label Extension)|Other|0
1738040|NCT00953706|6062863|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
1738041|NCT00953706|6062864|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
1738042|NCT00953706|6062865|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
1738043|NCT00953706|6062866|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
1738044|NCT00953706|6062863|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
1738045|NCT00953706|6062864|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
1738046|NCT00953706|6062865|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
1738047|NCT00953706|6062866|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
1738048|NCT00953706|6062863|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
1738049|NCT00953706|6062864|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1738050|NCT00953706|6062865|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1738051|NCT00953706|6062866|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
1738052|NCT00953706|6062863|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
1738053|NCT00953706|6062864|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1738054|NCT00953706|6062865|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1738055|NCT00953706|6062866|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
1738056|NCT00953706|6062863|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
1738057|NCT00953706|6062864|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
1738058|NCT00953706|6062865|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
1738059|NCT00953706|6062866|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
1738060|NCT00953706|6062863|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1738061|NCT00953706|6062864|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1738062|NCT00953706|6062865|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
1738063|NCT00953706|6062866|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
1738064|NCT00953706|6062863|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1738065|NCT00953706|6062864|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1738066|NCT00953706|6062865|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
1738067|NCT00953706|6062866|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
1738068|NCT00953706|6062863|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1738069|NCT00953706|6062864|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1738070|NCT00953706|6062865|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
1738071|NCT00953706|6062866|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
1738072|NCT00953706|6062863|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1738073|NCT00953706|6062864|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1738074|NCT00953706|6062865|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
1738075|NCT00953706|6062866|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
1738076|NCT00953706|6062863|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
1738077|NCT00953706|6062864|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
1738078|NCT00953706|6062865|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
1738079|NCT00953706|6062866|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
1738080|NCT00953680|6062898|P2|Period 1|Withdrawal by Subject|1
1738081|NCT00953680|6062899|P1|Period 1|Withdrawal by Subject|0
1738082|NCT00953667|6062911|P1|Overall Study|poor venous access,unable to draw blood|4
1738083|NCT00953667|6062911|P1|Overall Study|Adverse Event|10
1738084|NCT00953667|6062911|P1|Overall Study|Withdrawal by Subject|63
1738085|NCT00953667|6062911|P1|Overall Study|Physician Decision|35
1738086|NCT00953667|6062911|P1|Overall Study|Lost to Follow-up|11
1738087|NCT00953615|6062932|P1|Overall Study|Adverse Event|1
1738088|NCT00953576|6062941|P2|Overall Study|Ineligible after Consent|0
1738089|NCT00953576|6062942|P1|Overall Study|Ineligible after Consent|2
1738090|NCT00953576|6062941|P2|Overall Study|Adverse Event|1
1738091|NCT00953576|6062942|P1|Overall Study|Adverse Event|0
1738092|NCT00953524|6062957|P4|Overall Study|Withdrawal by Subject|0
1738093|NCT00953524|6062958|P3|Overall Study|Withdrawal by Subject|1
1738094|NCT00953524|6062959|P2|Overall Study|Withdrawal by Subject|4
1738095|NCT00953524|6062960|P1|Overall Study|Withdrawal by Subject|2
1738096|NCT00953524|6062957|P4|Overall Study|Lost to Follow-up|0
1738097|NCT00953524|6062958|P3|Overall Study|Lost to Follow-up|1
1738098|NCT00953524|6062959|P2|Overall Study|Lost to Follow-up|1
1738099|NCT00953524|6062960|P1|Overall Study|Lost to Follow-up|0
1738100|NCT00953524|6062957|P4|Overall Study|Protocol Violation|6
1738101|NCT00953524|6062958|P3|Overall Study|Protocol Violation|11
1738102|NCT00953524|6062959|P2|Overall Study|Protocol Violation|10
1738103|NCT00953524|6062960|P1|Overall Study|Protocol Violation|18
1738104|NCT00953524|6062957|P4|Overall Study|Adverse Event|2
1738105|NCT00953524|6062958|P3|Overall Study|Adverse Event|1
1738106|NCT00953524|6062959|P2|Overall Study|Adverse Event|0
1738107|NCT00953524|6062960|P1|Overall Study|Adverse Event|2
1738108|NCT00953407|6063003|P5|Overall Study|Lost to Follow-up|0
1738109|NCT00953407|6063004|P4|Overall Study|Lost to Follow-up|1
1738110|NCT00953407|6063005|P3|Overall Study|Lost to Follow-up|0
1738111|NCT00953407|6063006|P2|Overall Study|Lost to Follow-up|0
1738112|NCT00953407|6063007|P1|Overall Study|Lost to Follow-up|0
1738113|NCT00953407|6063003|P5|Overall Study|Failed inclusion criteria|1
1738114|NCT00953407|6063004|P4|Overall Study|Failed inclusion criteria|1
1738115|NCT00953407|6063005|P3|Overall Study|Failed inclusion criteria|1
1738116|NCT00953407|6063006|P2|Overall Study|Failed inclusion criteria|1
1738117|NCT00953407|6063007|P1|Overall Study|Failed inclusion criteria|1
1738118|NCT00953329|6063019|P1|Overall Study|Lack of Efficacy|1
1738119|NCT00953225|6063032|P2|Overall Study|Withdrawal by Subject|0
1738120|NCT00953225|6063033|P1|Overall Study|Withdrawal by Subject|2
1738121|NCT00953160|6063117|P1|Overall Study|Withdrawal by Subject|4
1738122|NCT00953160|6063117|P1|Overall Study|Lost to Follow-up|23
1738123|NCT00953147|6063126|P3|Overall Study|Other|13
1738124|NCT00953147|6063127|P2|Overall Study|Other|11
1738125|NCT00953147|6063128|P1|Overall Study|Other|4
1738126|NCT00953147|6063126|P3|Overall Study|Physician Decision|3
1738127|NCT00953147|6063127|P2|Overall Study|Physician Decision|7
1738128|NCT00953147|6063128|P1|Overall Study|Physician Decision|2
1738129|NCT00953147|6063126|P3|Overall Study|Lost to Follow-up|4
1738130|NCT00953147|6063127|P2|Overall Study|Lost to Follow-up|9
1738131|NCT00953147|6063128|P1|Overall Study|Lost to Follow-up|8
1738132|NCT00953147|6063126|P3|Overall Study|Withdrawal by Subject|12
1738133|NCT00953147|6063127|P2|Overall Study|Withdrawal by Subject|15
1738134|NCT00953147|6063128|P1|Overall Study|Withdrawal by Subject|13
1738135|NCT00953147|6063126|P3|Overall Study|Protocol Violation|4
1738136|NCT00953147|6063127|P2|Overall Study|Protocol Violation|8
1738137|NCT00953147|6063128|P1|Overall Study|Protocol Violation|2
1738138|NCT00953147|6063126|P3|Overall Study|Adverse Event|6
1738139|NCT00953147|6063127|P2|Overall Study|Adverse Event|16
1738140|NCT00953147|6063128|P1|Overall Study|Adverse Event|8
1738141|NCT00953056|6063206|P6|Overall Study|Serious Adverse Event|1
1738142|NCT00953056|6063207|P5|Overall Study|Serious Adverse Event|0
1738143|NCT00953056|6063208|P4|Overall Study|Serious Adverse Event|0
1738144|NCT00953056|6063209|P3|Overall Study|Serious Adverse Event|0
1738145|NCT00953056|6063210|P2|Overall Study|Serious Adverse Event|0
1738146|NCT00953056|6063211|P1|Overall Study|Serious Adverse Event|0
1738147|NCT00953056|6063206|P6|Overall Study|Withdrew Consent|3
1738148|NCT00953056|6063207|P5|Overall Study|Withdrew Consent|2
1738149|NCT00953056|6063208|P4|Overall Study|Withdrew Consent|0
1738150|NCT00953056|6063209|P3|Overall Study|Withdrew Consent|0
1738151|NCT00953056|6063210|P2|Overall Study|Withdrew Consent|0
1738152|NCT00953056|6063211|P1|Overall Study|Withdrew Consent|0
1738153|NCT00953043|6063235|P2|Overall Study|Physician Decision|2
1738154|NCT00953043|6063236|P1|Overall Study|Physician Decision|0
1738155|NCT00953043|6063235|P2|Overall Study|Withdrawal by Subject|0
1738156|NCT00953043|6063236|P1|Overall Study|Withdrawal by Subject|4
1738157|NCT00953017|6063260|P4|Overall Study|Brown stool prior to procedure|0
1738158|NCT00953017|6063261|P3|Overall Study|Brown stool prior to procedure|1
1738159|NCT00953017|6063262|P2|Overall Study|Brown stool prior to procedure|0
1738160|NCT00953017|6063263|P1|Overall Study|Brown stool prior to procedure|0
1738161|NCT00953017|6063260|P4|Overall Study|Procedure incomplete due to pain/looping|1
1738162|NCT00953017|6063261|P3|Overall Study|Procedure incomplete due to pain/looping|0
1738163|NCT00953017|6063262|P2|Overall Study|Procedure incomplete due to pain/looping|1
1738164|NCT00953017|6063263|P1|Overall Study|Procedure incomplete due to pain/looping|0
1738165|NCT00953017|6063260|P4|Overall Study|Incomplete data|0
1738166|NCT00953017|6063261|P3|Overall Study|Incomplete data|0
1738167|NCT00953017|6063262|P2|Overall Study|Incomplete data|1
1738168|NCT00953017|6063263|P1|Overall Study|Incomplete data|1
1738169|NCT00953017|6063260|P4|Overall Study|DId not show up for colonoscopy|4
1738170|NCT00953017|6063261|P3|Overall Study|DId not show up for colonoscopy|5
1738171|NCT00953017|6063262|P2|Overall Study|DId not show up for colonoscopy|4
1738172|NCT00953017|6063263|P1|Overall Study|DId not show up for colonoscopy|4
1738173|NCT00952848|6063285|P1|Overall Study|Withdrawal by Subject|4
1738174|NCT00952822|6063292|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1738175|NCT00952822|6063293|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
1738176|NCT00952822|6063294|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1738177|NCT00952822|6063295|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
1738178|NCT00952822|6063292|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1738179|NCT00952822|6063293|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1738180|NCT00952822|6063294|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
1738181|NCT00952822|6063295|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
1738182|NCT00952731|6063327|P2|Overall Study|Drug supply expired|0
1738183|NCT00952731|6063328|P1|Overall Study|Drug supply expired|1
1738184|NCT00952705|6063360|P3|Overall Study|Exclusion criteria not met pre dose|0
1738185|NCT00952705|6063361|P2|Overall Study|Exclusion criteria not met pre dose|1
1738186|NCT00952705|6063362|P1|Overall Study|Exclusion criteria not met pre dose|0
1738187|NCT00952705|6063360|P3|Overall Study|Incarcerated post dose|0
1738188|NCT00952705|6063361|P2|Overall Study|Incarcerated post dose|0
1738189|NCT00952705|6063362|P1|Overall Study|Incarcerated post dose|5
1738190|NCT00952705|6063360|P3|Overall Study|Death|0
1738191|NCT00952705|6063361|P2|Overall Study|Death|0
1738192|NCT00952705|6063362|P1|Overall Study|Death|2
1738193|NCT00952705|6063360|P3|Overall Study|Withdrawal by Subject|1
1738194|NCT00952705|6063361|P2|Overall Study|Withdrawal by Subject|1
1738195|NCT00952705|6063362|P1|Overall Study|Withdrawal by Subject|2
1738196|NCT00952705|6063360|P3|Overall Study|Lost to Follow-up|9
1738197|NCT00952705|6063361|P2|Overall Study|Lost to Follow-up|8
1738198|NCT00952705|6063362|P1|Overall Study|Lost to Follow-up|24
1738199|NCT00952614|6063449|P1|Overall Study|other reason|1
1738200|NCT00952614|6063449|P1|Overall Study|Lost to Follow-up|3
1738201|NCT00952614|6063449|P1|Overall Study|Death|3
1738214|NCT00952523|6063475|P1|Overall Study|Withdrawal by Subject|7
1738215|NCT00952484|6063484|P3|Overall Study|Withdrawal by Subject|0
1738216|NCT00952484|6063485|P2|Overall Study|Withdrawal by Subject|1
1738217|NCT00952484|6063486|P1|Overall Study|Withdrawal by Subject|0
1738218|NCT00952419|6063513|P3|Overall Study|Withdrawal by Subject|0
1738219|NCT00952419|6063514|P2|Overall Study|Withdrawal by Subject|3
1738220|NCT00952419|6063515|P1|Overall Study|Withdrawal by Subject|1
1738221|NCT00952419|6063513|P3|Overall Study|Protocol Violation|0
1738222|NCT00952419|6063514|P2|Overall Study|Protocol Violation|7
1738223|NCT00952419|6063515|P1|Overall Study|Protocol Violation|3
1738224|NCT00952419|6063513|P3|Overall Study|Adverse Event|0
1738225|NCT00952419|6063514|P2|Overall Study|Adverse Event|0
1738226|NCT00952419|6063515|P1|Overall Study|Adverse Event|2
1738227|NCT00952380|6063556|P5|Overall Study|Non-compliant to protocol|0
1738228|NCT00952380|6063557|P4|Overall Study|Non-compliant to protocol|1
1738229|NCT00952380|6063558|P3|Overall Study|Non-compliant to protocol|0
1738230|NCT00952380|6063559|P2|Overall Study|Non-compliant to protocol|0
1738231|NCT00952380|6063560|P1|Overall Study|Non-compliant to protocol|0
1738232|NCT00952380|6063556|P5|Overall Study|Physician Decision|0
1738233|NCT00952380|6063557|P4|Overall Study|Physician Decision|2
1738234|NCT00952380|6063558|P3|Overall Study|Physician Decision|1
1738235|NCT00952380|6063559|P2|Overall Study|Physician Decision|0
1738236|NCT00952380|6063560|P1|Overall Study|Physician Decision|0
1738237|NCT00952380|6063556|P5|Overall Study|Adverse Event|3
1738238|NCT00952380|6063557|P4|Overall Study|Adverse Event|0
1738239|NCT00952380|6063558|P3|Overall Study|Adverse Event|0
1738240|NCT00952380|6063559|P2|Overall Study|Adverse Event|1
1738241|NCT00952380|6063560|P1|Overall Study|Adverse Event|0
1738242|NCT00952380|6063556|P5|Overall Study|Withdrawal by Subject|2
1738243|NCT00952380|6063557|P4|Overall Study|Withdrawal by Subject|0
1738244|NCT00952380|6063558|P3|Overall Study|Withdrawal by Subject|1
1738245|NCT00952380|6063559|P2|Overall Study|Withdrawal by Subject|0
1738246|NCT00952380|6063560|P1|Overall Study|Withdrawal by Subject|0
1738247|NCT00952380|6063556|P5|Overall Study|Other|1
1738248|NCT00952380|6063557|P4|Overall Study|Other|0
1738249|NCT00952380|6063558|P3|Overall Study|Other|0
1738250|NCT00952380|6063559|P2|Overall Study|Other|0
1738251|NCT00952380|6063560|P1|Overall Study|Other|0
1738252|NCT00952367|6063661|P1|Overall Study|Protocol Violation|3
1738253|NCT00952367|6063661|P1|Overall Study|Noncoordination|1
1738254|NCT00952367|6063661|P1|Overall Study|Withdrawal by Subject|2
1738255|NCT00952341|6063676|P2|Cycle 2|Progressive Disease|1
1738256|NCT00952341|6063677|P1|Cycle 2|Progressive Disease|0
1738257|NCT00952341|6063676|P2|Cycle 2|Physician Decision|1
1738258|NCT00952341|6063677|P1|Cycle 2|Physician Decision|1
1738259|NCT00952341|6063676|P2|Cycle 2|Lost to Follow-up|9
1738260|NCT00952341|6063677|P1|Cycle 2|Lost to Follow-up|6
1738261|NCT00952341|6063676|P2|Cycle 2|Protocol Violation|0
1738262|NCT00952341|6063677|P1|Cycle 2|Protocol Violation|1
1738263|NCT00952341|6063676|P2|Cycle 2|Withdrawal by Subject|1
1738264|NCT00952341|6063677|P1|Cycle 2|Withdrawal by Subject|1
1738265|NCT00952341|6063676|P2|Cycle 1|Physician Decision|1
1738266|NCT00952341|6063677|P1|Cycle 1|Physician Decision|0
1738267|NCT00952341|6063676|P2|Cycle 1|Lost to Follow-up|2
1738268|NCT00952341|6063677|P1|Cycle 1|Lost to Follow-up|11
1738269|NCT00952341|6063676|P2|Cycle 1|Protocol Violation|1
1738270|NCT00952341|6063677|P1|Cycle 1|Protocol Violation|2
1738271|NCT00952341|6063676|P2|Cycle 1|Withdrawal by Subject|8
1738272|NCT00952341|6063677|P1|Cycle 1|Withdrawal by Subject|3
1738273|NCT00952341|6063676|P2|Cycle 1|Adverse Event|1
1738274|NCT00952341|6063677|P1|Cycle 1|Adverse Event|4
1738275|NCT00952289|6063739|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
1738276|NCT00952289|6063740|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
1738277|NCT00952289|6063739|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
1738278|NCT00952289|6063740|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
1738279|NCT00952289|6063739|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
1738280|NCT00952289|6063740|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
1738281|NCT00952289|6063739|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
1738282|NCT00952289|6063740|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
1738283|NCT00952289|6063739|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
1738284|NCT00952289|6063740|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
1738285|NCT00952289|6063739|P2|All Participants|Data lost during site relocation|1
1738286|NCT00952289|6063740|P1|All Participants|Data lost during site relocation|0
1738287|NCT00952289|6063739|P2|All Participants|Withdrawal by Subject|10
1738288|NCT00952289|6063740|P1|All Participants|Withdrawal by Subject|1
1738289|NCT00952289|6063739|P2|All Participants|Disease progression|12
1738290|NCT00952289|6063740|P1|All Participants|Disease progression|3
1738291|NCT00952289|6063739|P2|All Participants|Adverse Event|8
1738292|NCT00952289|6063740|P1|All Participants|Adverse Event|8
1738293|NCT00952289|6063739|P2|All Participants|Death|9
1738294|NCT00952289|6063740|P1|All Participants|Death|9
1738295|NCT00952276|6063769|P5|Overall Study|Withdrawal by Subject|0
1738296|NCT00952276|6063770|P4|Overall Study|Withdrawal by Subject|1
1738297|NCT00952276|6063771|P3|Overall Study|Withdrawal by Subject|0
1738298|NCT00952276|6063772|P2|Overall Study|Withdrawal by Subject|0
1738299|NCT00952276|6063773|P1|Overall Study|Withdrawal by Subject|1
1738300|NCT00952068|6063859|P1|Overall Study|Withdrawal by Subject|4
1738301|NCT00952068|6063859|P1|Overall Study|Adverse Event|3
1738302|NCT00951912|6063870|P3|Overall Study|Other: Stroke|0
1738303|NCT00951912|6063871|P2|Overall Study|Other: Stroke|1
1738304|NCT00951912|6063872|P1|Overall Study|Other: Stroke|0
1738305|NCT00951912|6063870|P3|Overall Study|Other: Colon cancer|0
1738306|NCT00951912|6063871|P2|Overall Study|Other: Colon cancer|0
1738307|NCT00951912|6063872|P1|Overall Study|Other: Colon cancer|1
1738308|NCT00951912|6063870|P3|Overall Study|Other:Depression|0
1738309|NCT00951912|6063871|P2|Overall Study|Other:Depression|0
1738310|NCT00951912|6063872|P1|Overall Study|Other:Depression|1
1738311|NCT00951912|6063870|P3|Overall Study|Withdrawal by Subject|0
1738312|NCT00951912|6063871|P2|Overall Study|Withdrawal by Subject|1
1738313|NCT00951912|6063872|P1|Overall Study|Withdrawal by Subject|1
1738314|NCT00951912|6063870|P3|Overall Study|Physician Decision|1
1738315|NCT00951912|6063871|P2|Overall Study|Physician Decision|0
1738316|NCT00951912|6063872|P1|Overall Study|Physician Decision|1
1738317|NCT00951912|6063870|P3|Overall Study|Lost to Follow-up|0
1738318|NCT00951912|6063871|P2|Overall Study|Lost to Follow-up|2
1738319|NCT00951912|6063872|P1|Overall Study|Lost to Follow-up|2
1738320|NCT00951912|6063870|P3|Overall Study|Adverse Event|1
1738321|NCT00951912|6063871|P2|Overall Study|Adverse Event|1
1738322|NCT00951912|6063872|P1|Overall Study|Adverse Event|0
1738323|NCT00951912|6063870|P3|Overall Study|Lack of Efficacy|0
1738324|NCT00951912|6063871|P2|Overall Study|Lack of Efficacy|0
1738325|NCT00951912|6063872|P1|Overall Study|Lack of Efficacy|1
1738326|NCT00951665|6063972|P6|Phase 2a|Disease Progression|5
1738327|NCT00951665|6063973|P5|Phase 2a|Disease Progression|6
1738328|NCT00951665|6063974|P4|Phase 2a|Disease Progression|0
1738329|NCT00951665|6063975|P3|Phase 2a|Disease Progression|0
1738330|NCT00951665|6063976|P2|Phase 2a|Disease Progression|0
1738331|NCT00951665|6063977|P1|Phase 2a|Disease Progression|0
1738332|NCT00951665|6063972|P6|Phase 2a|Withdrawal by Subject|0
1738333|NCT00951665|6063973|P5|Phase 2a|Withdrawal by Subject|2
1738334|NCT00951665|6063974|P4|Phase 2a|Withdrawal by Subject|0
1738335|NCT00951665|6063975|P3|Phase 2a|Withdrawal by Subject|0
1738336|NCT00951665|6063976|P2|Phase 2a|Withdrawal by Subject|0
1738337|NCT00951665|6063977|P1|Phase 2a|Withdrawal by Subject|0
1738338|NCT00951665|6063972|P6|Phase 2a|Physician Decision|1
1738339|NCT00951665|6063973|P5|Phase 2a|Physician Decision|0
1738340|NCT00951665|6063974|P4|Phase 2a|Physician Decision|0
1738341|NCT00951665|6063975|P3|Phase 2a|Physician Decision|0
1738342|NCT00951665|6063976|P2|Phase 2a|Physician Decision|0
1738343|NCT00951665|6063977|P1|Phase 2a|Physician Decision|0
1738344|NCT00951665|6063972|P6|Phase 2a|Lost to Follow-up|0
1738345|NCT00951665|6063973|P5|Phase 2a|Lost to Follow-up|1
1738346|NCT00951665|6063974|P4|Phase 2a|Lost to Follow-up|0
1738347|NCT00951665|6063975|P3|Phase 2a|Lost to Follow-up|0
1738348|NCT00951665|6063976|P2|Phase 2a|Lost to Follow-up|0
1738349|NCT00951665|6063977|P1|Phase 2a|Lost to Follow-up|0
1738350|NCT00951665|6063972|P6|Phase 2a|Death|1
1738351|NCT00951665|6063973|P5|Phase 2a|Death|1
1738352|NCT00951665|6063974|P4|Phase 2a|Death|0
1738353|NCT00951665|6063975|P3|Phase 2a|Death|0
1738354|NCT00951665|6063976|P2|Phase 2a|Death|0
1738355|NCT00951665|6063977|P1|Phase 2a|Death|0
1738356|NCT00951665|6063972|P6|Phase 2a|Adverse Event|0
1738357|NCT00951665|6063973|P5|Phase 2a|Adverse Event|2
1738358|NCT00951665|6063974|P4|Phase 2a|Adverse Event|0
1738359|NCT00951665|6063975|P3|Phase 2a|Adverse Event|0
1738360|NCT00951665|6063976|P2|Phase 2a|Adverse Event|0
1738361|NCT00951665|6063977|P1|Phase 2a|Adverse Event|0
1738362|NCT00951665|6063972|P6|Phase 1b|Protocol Violation|0
1738363|NCT00951665|6063973|P5|Phase 1b|Protocol Violation|0
1738364|NCT00951665|6063974|P4|Phase 1b|Protocol Violation|0
1738365|NCT00951665|6063975|P3|Phase 1b|Protocol Violation|0
1738366|NCT00951665|6063976|P2|Phase 1b|Protocol Violation|0
1738367|NCT00951665|6063977|P1|Phase 1b|Protocol Violation|2
1738368|NCT00951665|6063972|P6|Phase 1b|Disease Progression|0
1738369|NCT00951665|6063973|P5|Phase 1b|Disease Progression|0
1738370|NCT00951665|6063974|P4|Phase 1b|Disease Progression|0
1738371|NCT00951665|6063975|P3|Phase 1b|Disease Progression|14
1738372|NCT00951665|6063976|P2|Phase 1b|Disease Progression|2
1738373|NCT00951665|6063977|P1|Phase 1b|Disease Progression|13
1738374|NCT00951665|6063972|P6|Phase 1b|Withdrawal by Subject|0
1738375|NCT00951665|6063973|P5|Phase 1b|Withdrawal by Subject|0
1738376|NCT00951665|6063974|P4|Phase 1b|Withdrawal by Subject|0
1738377|NCT00951665|6063975|P3|Phase 1b|Withdrawal by Subject|0
1738378|NCT00951665|6063976|P2|Phase 1b|Withdrawal by Subject|1
1738379|NCT00951665|6063977|P1|Phase 1b|Withdrawal by Subject|0
1738380|NCT00951665|6063972|P6|Phase 1b|Physician Decision|0
1738381|NCT00951665|6063973|P5|Phase 1b|Physician Decision|0
1738382|NCT00951665|6063974|P4|Phase 1b|Physician Decision|0
1738383|NCT00951665|6063975|P3|Phase 1b|Physician Decision|1
1738384|NCT00951665|6063976|P2|Phase 1b|Physician Decision|0
1738385|NCT00951665|6063977|P1|Phase 1b|Physician Decision|4
1738386|NCT00951665|6063972|P6|Phase 1b|Death|0
1738387|NCT00951665|6063973|P5|Phase 1b|Death|0
1738388|NCT00951665|6063974|P4|Phase 1b|Death|0
1738389|NCT00951665|6063975|P3|Phase 1b|Death|2
1738390|NCT00951665|6063976|P2|Phase 1b|Death|0
1738391|NCT00951665|6063977|P1|Phase 1b|Death|1
1738392|NCT00951665|6063972|P6|Phase 1b|Adverse Event|0
1738393|NCT00951665|6063973|P5|Phase 1b|Adverse Event|0
1738394|NCT00951665|6063974|P4|Phase 1b|Adverse Event|1
1738395|NCT00951665|6063975|P3|Phase 1b|Adverse Event|0
1738396|NCT00951665|6063976|P2|Phase 1b|Adverse Event|1
1738397|NCT00951665|6063977|P1|Phase 1b|Adverse Event|2
1738398|NCT00951509|6064086|P1|Overall Study|Withdrawal by Subject|2
1738402|NCT00951483|6064127|P2|Overall Study|Withdrawal by Subject|0
1738403|NCT00951483|6064128|P1|Overall Study|Withdrawal by Subject|15
1738404|NCT00951483|6064127|P2|Overall Study|Physician Decision|0
1738405|NCT00951483|6064128|P1|Overall Study|Physician Decision|4
1738406|NCT00951379|6064148|P2|Overall Study|Disease Progression|1
1738407|NCT00951379|6064149|P1|Overall Study|Disease Progression|0
1738408|NCT00951379|6064148|P2|Overall Study|Noncompliance|0
1738409|NCT00951379|6064149|P1|Overall Study|Noncompliance|1
1738410|NCT00951379|6064148|P2|Overall Study|Withdrawal by Subject|0
1738411|NCT00951379|6064149|P1|Overall Study|Withdrawal by Subject|1
1738412|NCT00951379|6064148|P2|Overall Study|Adverse Event|1
1738413|NCT00951379|6064149|P1|Overall Study|Adverse Event|4
1738414|NCT00951275|6064191|P1|Overall Study|Protocol Violation|1
1738415|NCT00951275|6064191|P1|Overall Study|Withdrawal by Subject|4
1738416|NCT00951275|6064191|P1|Overall Study|Adverse Event|7
1738417|NCT00951275|6064191|P1|Overall Study|Administrative Reason|1
1738418|NCT00951171|6064223|P2|Overall Study|Adverse Event|0
1738419|NCT00951171|6064224|P1|Overall Study|Adverse Event|2
1738420|NCT00951041|6064256|P2|Overall Study|Other|0
1738421|NCT00951041|6064257|P1|Overall Study|Other|3
1738422|NCT00951041|6064256|P2|Overall Study|Lost to Follow-up|0
1738423|NCT00951041|6064257|P1|Overall Study|Lost to Follow-up|1
1738424|NCT00951041|6064256|P2|Overall Study|Withdrawal by Subject|1
1738425|NCT00951041|6064257|P1|Overall Study|Withdrawal by Subject|1
1738426|NCT00951015|6064312|P5|Open-label Phase|Physician Decision|8
1738427|NCT00951015|6064313|P4|Open-label Phase|Physician Decision|0
1738428|NCT00951015|6064314|P3|Open-label Phase|Physician Decision|0
1738429|NCT00951015|6064315|P2|Open-label Phase|Physician Decision|0
1738430|NCT00951015|6064316|P1|Open-label Phase|Physician Decision|0
1738431|NCT00951015|6064312|P5|Open-label Phase|Withdrawal by Subject|14
1738432|NCT00951015|6064313|P4|Open-label Phase|Withdrawal by Subject|0
1738433|NCT00951015|6064314|P3|Open-label Phase|Withdrawal by Subject|0
1738434|NCT00951015|6064315|P2|Open-label Phase|Withdrawal by Subject|0
1738435|NCT00951015|6064316|P1|Open-label Phase|Withdrawal by Subject|0
1738436|NCT00951015|6064312|P5|Open-label Phase|Lost to Follow-up|12
1738437|NCT00951015|6064313|P4|Open-label Phase|Lost to Follow-up|0
1738438|NCT00951015|6064314|P3|Open-label Phase|Lost to Follow-up|0
1738439|NCT00951015|6064315|P2|Open-label Phase|Lost to Follow-up|0
1738440|NCT00951015|6064316|P1|Open-label Phase|Lost to Follow-up|0
1738441|NCT00951015|6064312|P5|Open-label Phase|Protocol Violation|12
1738442|NCT00951015|6064313|P4|Open-label Phase|Protocol Violation|0
1738443|NCT00951015|6064314|P3|Open-label Phase|Protocol Violation|0
1738444|NCT00951015|6064315|P2|Open-label Phase|Protocol Violation|0
1738445|NCT00951015|6064316|P1|Open-label Phase|Protocol Violation|0
1738446|NCT00951015|6064312|P5|Open-label Phase|Lack of Efficacy|1
1738447|NCT00951015|6064313|P4|Open-label Phase|Lack of Efficacy|0
1738448|NCT00951015|6064314|P3|Open-label Phase|Lack of Efficacy|0
1738449|NCT00951015|6064315|P2|Open-label Phase|Lack of Efficacy|0
1738450|NCT00951015|6064316|P1|Open-label Phase|Lack of Efficacy|0
1738451|NCT00951015|6064312|P5|Open-label Phase|Adverse Event|3
1738452|NCT00951015|6064313|P4|Open-label Phase|Adverse Event|0
1738453|NCT00951015|6064314|P3|Open-label Phase|Adverse Event|0
1738454|NCT00951015|6064315|P2|Open-label Phase|Adverse Event|0
1738455|NCT00951015|6064316|P1|Open-label Phase|Adverse Event|0
1738456|NCT00951015|6064312|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
1738457|NCT00951015|6064313|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
1738458|NCT00951015|6064314|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
1738459|NCT00951015|6064315|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
1738460|NCT00951015|6064316|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
1738461|NCT00951015|6064312|P5|Randomization Phase 96 Week|Lost to Follow-up|0
1738462|NCT00951015|6064313|P4|Randomization Phase 96 Week|Lost to Follow-up|2
1738463|NCT00951015|6064314|P3|Randomization Phase 96 Week|Lost to Follow-up|1
1738464|NCT00951015|6064315|P2|Randomization Phase 96 Week|Lost to Follow-up|3
1738465|NCT00951015|6064316|P1|Randomization Phase 96 Week|Lost to Follow-up|0
1738466|NCT00951015|6064312|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1738467|NCT00951015|6064313|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
1738468|NCT00951015|6064314|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1738469|NCT00951015|6064315|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1738470|NCT00951015|6064316|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
1738471|NCT00951015|6064312|P5|Randomization Phase 96 Week|Protocol Violation|0
1738472|NCT00951015|6064313|P4|Randomization Phase 96 Week|Protocol Violation|0
1738473|NCT00951015|6064314|P3|Randomization Phase 96 Week|Protocol Violation|1
1738474|NCT00951015|6064315|P2|Randomization Phase 96 Week|Protocol Violation|1
1738475|NCT00951015|6064316|P1|Randomization Phase 96 Week|Protocol Violation|1
1738476|NCT00951015|6064312|P5|Randomization Phase 96 Week|Lack of Efficacy|0
1738477|NCT00951015|6064313|P4|Randomization Phase 96 Week|Lack of Efficacy|0
1738478|NCT00951015|6064314|P3|Randomization Phase 96 Week|Lack of Efficacy|0
1738479|NCT00951015|6064315|P2|Randomization Phase 96 Week|Lack of Efficacy|1
1738480|NCT00951015|6064316|P1|Randomization Phase 96 Week|Lack of Efficacy|1
1738481|NCT00951015|6064312|P5|Randomization Phase 96 Week|Adverse Event|0
1738482|NCT00951015|6064313|P4|Randomization Phase 96 Week|Adverse Event|5
1738483|NCT00951015|6064314|P3|Randomization Phase 96 Week|Adverse Event|2
1738484|NCT00951015|6064315|P2|Randomization Phase 96 Week|Adverse Event|1
1738485|NCT00951015|6064316|P1|Randomization Phase 96 Week|Adverse Event|1
1738486|NCT00950963|6064413|P2|Overall Study|Lost to Follow-up|24
1738487|NCT00950963|6064414|P1|Overall Study|Lost to Follow-up|29
1738488|NCT00950950|6064430|P2|Overall Study|Withdrawal by Subject|1
1738489|NCT00950950|6064431|P1|Overall Study|Withdrawal by Subject|0
1738490|NCT00950950|6064430|P2|Overall Study|Adverse Event|0
1738491|NCT00950950|6064431|P1|Overall Study|Adverse Event|1
1738492|NCT00950911|6064513|P2|Overall Study|Poor performance status|1
1738493|NCT00950911|6064514|P1|Overall Study|Poor performance status|0
1738494|NCT00950911|6064513|P2|Overall Study|Noncompliance|0
1738495|NCT00950911|6064514|P1|Overall Study|Noncompliance|1
1738496|NCT00950911|6064513|P2|Overall Study|Ineligibility determined|0
1738497|NCT00950911|6064514|P1|Overall Study|Ineligibility determined|1
1738498|NCT00950911|6064513|P2|Overall Study|Administrative decision|1
1738499|NCT00950911|6064514|P1|Overall Study|Administrative decision|3
1738500|NCT00950911|6064513|P2|Overall Study|Consent withdrawn|3
1738501|NCT00950911|6064514|P1|Overall Study|Consent withdrawn|1
1738502|NCT00950911|6064513|P2|Overall Study|Disease progression|2
1738503|NCT00950911|6064514|P1|Overall Study|Disease progression|2
1738504|NCT00950911|6064513|P2|Overall Study|Death|6
1738505|NCT00950911|6064514|P1|Overall Study|Death|4
1738506|NCT00950911|6064513|P2|Overall Study|Adverse Event|2
1738507|NCT00950911|6064514|P1|Overall Study|Adverse Event|0
1738508|NCT00950872|6064520|P1|Overall Study|Did not have surgery|2
1738509|NCT00950872|6064520|P1|Overall Study|Withdrawal by Subject|1
1738510|NCT00950859|6064529|P2|Overall Study|Lost to Follow-up|3
1738511|NCT00950859|6064530|P1|Overall Study|Lost to Follow-up|0
1738512|NCT00950859|6064529|P2|Overall Study|Protocol Violation|1
1738513|NCT00950859|6064530|P1|Overall Study|Protocol Violation|1
1738514|NCT00950859|6064529|P2|Overall Study|Insufficient Viral Load Response|3
1738515|NCT00950859|6064530|P1|Overall Study|Insufficient Viral Load Response|12
1738516|NCT00950859|6064529|P2|Overall Study|Adverse Event|3
1738517|NCT00950859|6064530|P1|Overall Study|Adverse Event|3
1738518|NCT00950807|6064629|P10|Treatment Period 3|Adverse Event|0
1738519|NCT00950807|6064630|P9|Treatment Period 3|Adverse Event|0
1738520|NCT00950807|6064631|P8|Treatment Period 3|Adverse Event|0
1738521|NCT00950807|6064632|P7|Treatment Period 3|Adverse Event|1
1738522|NCT00950807|6064633|P6|Treatment Period 3|Adverse Event|0
1738523|NCT00950807|6064634|P5|Treatment Period 3|Adverse Event|0
1738524|NCT00950807|6064635|P4|Treatment Period 3|Adverse Event|0
1738525|NCT00950807|6064636|P3|Treatment Period 3|Adverse Event|0
1738526|NCT00950807|6064637|P2|Treatment Period 3|Adverse Event|0
1738527|NCT00950807|6064638|P1|Treatment Period 3|Adverse Event|0
1738528|NCT00950807|6064629|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738529|NCT00950807|6064630|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738530|NCT00950807|6064631|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
1738531|NCT00950807|6064632|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738532|NCT00950807|6064633|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738533|NCT00950807|6064634|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738534|NCT00950807|6064635|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738535|NCT00950807|6064636|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738536|NCT00950807|6064637|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
1738537|NCT00950807|6064638|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
1738538|NCT00950807|6064629|P10|Treatment Period 3|Withdrawal by Subject|1
1738539|NCT00950807|6064630|P9|Treatment Period 3|Withdrawal by Subject|0
1738540|NCT00950807|6064631|P8|Treatment Period 3|Withdrawal by Subject|0
1738541|NCT00950807|6064632|P7|Treatment Period 3|Withdrawal by Subject|0
1738542|NCT00950807|6064633|P6|Treatment Period 3|Withdrawal by Subject|0
1738543|NCT00950807|6064634|P5|Treatment Period 3|Withdrawal by Subject|0
1738544|NCT00950807|6064635|P4|Treatment Period 3|Withdrawal by Subject|0
1738545|NCT00950807|6064636|P3|Treatment Period 3|Withdrawal by Subject|0
1738546|NCT00950807|6064637|P2|Treatment Period 3|Withdrawal by Subject|0
1738547|NCT00950807|6064638|P1|Treatment Period 3|Withdrawal by Subject|0
1738548|NCT00950807|6064629|P10|Washout Period 2|Adverse Event|0
1738549|NCT00950807|6064630|P9|Washout Period 2|Adverse Event|0
1738550|NCT00950807|6064631|P8|Washout Period 2|Adverse Event|0
1738551|NCT00950807|6064632|P7|Washout Period 2|Adverse Event|0
1738552|NCT00950807|6064633|P6|Washout Period 2|Adverse Event|0
1738553|NCT00950807|6064634|P5|Washout Period 2|Adverse Event|0
1738554|NCT00950807|6064635|P4|Washout Period 2|Adverse Event|1
1738555|NCT00950807|6064636|P3|Washout Period 2|Adverse Event|0
1738556|NCT00950807|6064637|P2|Washout Period 2|Adverse Event|0
1738557|NCT00950807|6064638|P1|Washout Period 2|Adverse Event|3
1738558|NCT00950807|6064629|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
1738559|NCT00950807|6064630|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
1738560|NCT00950807|6064631|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
1738561|NCT00950807|6064632|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
1738562|NCT00950807|6064633|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
1738563|NCT00950807|6064634|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
1738564|NCT00950807|6064635|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
1738565|NCT00950807|6064636|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
1738566|NCT00950807|6064637|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
1738567|NCT00950807|6064638|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
1738568|NCT00950807|6064629|P10|Washout Period 2|Lack of Efficacy|0
1738569|NCT00950807|6064630|P9|Washout Period 2|Lack of Efficacy|0
1738570|NCT00950807|6064631|P8|Washout Period 2|Lack of Efficacy|0
1738571|NCT00950807|6064632|P7|Washout Period 2|Lack of Efficacy|0
1738572|NCT00950807|6064633|P6|Washout Period 2|Lack of Efficacy|0
1738573|NCT00950807|6064634|P5|Washout Period 2|Lack of Efficacy|0
1738574|NCT00950807|6064635|P4|Washout Period 2|Lack of Efficacy|0
1738575|NCT00950807|6064636|P3|Washout Period 2|Lack of Efficacy|0
1738576|NCT00950807|6064637|P2|Washout Period 2|Lack of Efficacy|0
1738577|NCT00950807|6064638|P1|Washout Period 2|Lack of Efficacy|1
1738578|NCT00950807|6064629|P10|Treatment Period 2|Adverse Event|0
1738579|NCT00950807|6064630|P9|Treatment Period 2|Adverse Event|0
1738580|NCT00950807|6064631|P8|Treatment Period 2|Adverse Event|1
1738581|NCT00950807|6064632|P7|Treatment Period 2|Adverse Event|0
1738582|NCT00950807|6064633|P6|Treatment Period 2|Adverse Event|1
1738583|NCT00950807|6064634|P5|Treatment Period 2|Adverse Event|0
1738584|NCT00950807|6064635|P4|Treatment Period 2|Adverse Event|1
1738585|NCT00950807|6064636|P3|Treatment Period 2|Adverse Event|0
1738586|NCT00950807|6064637|P2|Treatment Period 2|Adverse Event|1
1738587|NCT00950807|6064638|P1|Treatment Period 2|Adverse Event|0
1738588|NCT00950807|6064629|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738589|NCT00950807|6064630|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738590|NCT00950807|6064631|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738591|NCT00950807|6064632|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738592|NCT00950807|6064633|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738593|NCT00950807|6064634|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738594|NCT00950807|6064635|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738595|NCT00950807|6064636|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738596|NCT00950807|6064637|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
1738597|NCT00950807|6064638|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
1738598|NCT00950807|6064629|P10|Treatment Period 2|Withdrawal by Subject|0
1738599|NCT00950807|6064630|P9|Treatment Period 2|Withdrawal by Subject|0
1738600|NCT00950807|6064631|P8|Treatment Period 2|Withdrawal by Subject|2
1738601|NCT00950807|6064632|P7|Treatment Period 2|Withdrawal by Subject|1
1738602|NCT00950807|6064633|P6|Treatment Period 2|Withdrawal by Subject|0
1738603|NCT00950807|6064634|P5|Treatment Period 2|Withdrawal by Subject|0
1738604|NCT00950807|6064635|P4|Treatment Period 2|Withdrawal by Subject|0
1738605|NCT00950807|6064636|P3|Treatment Period 2|Withdrawal by Subject|0
1738606|NCT00950807|6064637|P2|Treatment Period 2|Withdrawal by Subject|0
1738607|NCT00950807|6064638|P1|Treatment Period 2|Withdrawal by Subject|0
1738608|NCT00950807|6064629|P10|Treatment Period 2|Lack of Efficacy|0
1738609|NCT00950807|6064630|P9|Treatment Period 2|Lack of Efficacy|0
1738610|NCT00950807|6064631|P8|Treatment Period 2|Lack of Efficacy|0
1738611|NCT00950807|6064632|P7|Treatment Period 2|Lack of Efficacy|0
1738612|NCT00950807|6064633|P6|Treatment Period 2|Lack of Efficacy|0
1738613|NCT00950807|6064634|P5|Treatment Period 2|Lack of Efficacy|0
1738614|NCT00950807|6064635|P4|Treatment Period 2|Lack of Efficacy|0
1738615|NCT00950807|6064636|P3|Treatment Period 2|Lack of Efficacy|0
1738616|NCT00950807|6064637|P2|Treatment Period 2|Lack of Efficacy|0
1738617|NCT00950807|6064638|P1|Treatment Period 2|Lack of Efficacy|1
1738618|NCT00950807|6064629|P10|Washout Period 1|Adverse Event|0
1738619|NCT00950807|6064630|P9|Washout Period 1|Adverse Event|0
1738620|NCT00950807|6064631|P8|Washout Period 1|Adverse Event|0
1738621|NCT00950807|6064632|P7|Washout Period 1|Adverse Event|0
1738622|NCT00950807|6064633|P6|Washout Period 1|Adverse Event|0
1738623|NCT00950807|6064634|P5|Washout Period 1|Adverse Event|1
1738624|NCT00950807|6064635|P4|Washout Period 1|Adverse Event|1
1738625|NCT00950807|6064636|P3|Washout Period 1|Adverse Event|0
1738626|NCT00950807|6064637|P2|Washout Period 1|Adverse Event|0
1738627|NCT00950807|6064638|P1|Washout Period 1|Adverse Event|2
1738628|NCT00950807|6064629|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
1738629|NCT00950807|6064630|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
1738630|NCT00950807|6064631|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
1738631|NCT00950807|6064632|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
1738632|NCT00950807|6064633|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
1738633|NCT00950807|6064634|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
1738634|NCT00950807|6064635|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
1738635|NCT00950807|6064636|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
1738636|NCT00950807|6064637|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
1738637|NCT00950807|6064638|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
1738638|NCT00950807|6064629|P10|Washout Period 1|Withdrawal by Subject|0
1738639|NCT00950807|6064630|P9|Washout Period 1|Withdrawal by Subject|1
1738640|NCT00950807|6064631|P8|Washout Period 1|Withdrawal by Subject|0
1738641|NCT00950807|6064632|P7|Washout Period 1|Withdrawal by Subject|0
1738642|NCT00950807|6064633|P6|Washout Period 1|Withdrawal by Subject|0
1738643|NCT00950807|6064634|P5|Washout Period 1|Withdrawal by Subject|0
1738644|NCT00950807|6064635|P4|Washout Period 1|Withdrawal by Subject|0
1738645|NCT00950807|6064636|P3|Washout Period 1|Withdrawal by Subject|0
1738646|NCT00950807|6064637|P2|Washout Period 1|Withdrawal by Subject|0
1738647|NCT00950807|6064638|P1|Washout Period 1|Withdrawal by Subject|0
1738648|NCT00950807|6064629|P10|Washout Period 1|Lack of Efficacy|0
1738649|NCT00950807|6064630|P9|Washout Period 1|Lack of Efficacy|0
1738650|NCT00950807|6064631|P8|Washout Period 1|Lack of Efficacy|0
1738651|NCT00950807|6064632|P7|Washout Period 1|Lack of Efficacy|1
1738652|NCT00950807|6064633|P6|Washout Period 1|Lack of Efficacy|0
1738653|NCT00950807|6064634|P5|Washout Period 1|Lack of Efficacy|0
1738654|NCT00950807|6064635|P4|Washout Period 1|Lack of Efficacy|0
1738655|NCT00950807|6064636|P3|Washout Period 1|Lack of Efficacy|0
1738656|NCT00950807|6064637|P2|Washout Period 1|Lack of Efficacy|0
1738657|NCT00950807|6064638|P1|Washout Period 1|Lack of Efficacy|0
1738658|NCT00950807|6064629|P10|Treatment Period 1|Adverse Event|0
1738659|NCT00950807|6064630|P9|Treatment Period 1|Adverse Event|0
1738660|NCT00950807|6064631|P8|Treatment Period 1|Adverse Event|0
1738661|NCT00950807|6064632|P7|Treatment Period 1|Adverse Event|0
1738662|NCT00950807|6064633|P6|Treatment Period 1|Adverse Event|1
1738663|NCT00950807|6064634|P5|Treatment Period 1|Adverse Event|0
1738664|NCT00950807|6064635|P4|Treatment Period 1|Adverse Event|0
1738665|NCT00950807|6064636|P3|Treatment Period 1|Adverse Event|0
1738666|NCT00950807|6064637|P2|Treatment Period 1|Adverse Event|0
1738667|NCT00950807|6064638|P1|Treatment Period 1|Adverse Event|0
1738668|NCT00950807|6064629|P10|Treatment Period 1|Withdrawal by Subject|0
1738669|NCT00950807|6064630|P9|Treatment Period 1|Withdrawal by Subject|1
1738670|NCT00950807|6064631|P8|Treatment Period 1|Withdrawal by Subject|0
1738671|NCT00950807|6064632|P7|Treatment Period 1|Withdrawal by Subject|0
1738672|NCT00950807|6064633|P6|Treatment Period 1|Withdrawal by Subject|0
1738673|NCT00950807|6064634|P5|Treatment Period 1|Withdrawal by Subject|1
1738674|NCT00950807|6064635|P4|Treatment Period 1|Withdrawal by Subject|0
1738675|NCT00950807|6064636|P3|Treatment Period 1|Withdrawal by Subject|0
1738676|NCT00950807|6064637|P2|Treatment Period 1|Withdrawal by Subject|0
1738677|NCT00950807|6064638|P1|Treatment Period 1|Withdrawal by Subject|1
1738678|NCT00950807|6064629|P10|Treatment Period 1|Lost to Follow-up|0
1738679|NCT00950807|6064630|P9|Treatment Period 1|Lost to Follow-up|0
1738680|NCT00950807|6064631|P8|Treatment Period 1|Lost to Follow-up|0
1738681|NCT00950807|6064632|P7|Treatment Period 1|Lost to Follow-up|0
1738682|NCT00950807|6064633|P6|Treatment Period 1|Lost to Follow-up|0
1738683|NCT00950807|6064634|P5|Treatment Period 1|Lost to Follow-up|0
1738684|NCT00950807|6064635|P4|Treatment Period 1|Lost to Follow-up|0
1738685|NCT00950807|6064636|P3|Treatment Period 1|Lost to Follow-up|1
1738686|NCT00950807|6064637|P2|Treatment Period 1|Lost to Follow-up|0
1738687|NCT00950807|6064638|P1|Treatment Period 1|Lost to Follow-up|0
1738688|NCT00950807|6064629|P10|Treatment Period 1|Protocol Violation|0
1738689|NCT00950807|6064630|P9|Treatment Period 1|Protocol Violation|0
1738690|NCT00950807|6064631|P8|Treatment Period 1|Protocol Violation|0
1738691|NCT00950807|6064632|P7|Treatment Period 1|Protocol Violation|0
1738692|NCT00950807|6064633|P6|Treatment Period 1|Protocol Violation|0
1738693|NCT00950807|6064634|P5|Treatment Period 1|Protocol Violation|0
1738694|NCT00950807|6064635|P4|Treatment Period 1|Protocol Violation|0
1738695|NCT00950807|6064636|P3|Treatment Period 1|Protocol Violation|0
1738696|NCT00950807|6064637|P2|Treatment Period 1|Protocol Violation|0
1738697|NCT00950807|6064638|P1|Treatment Period 1|Protocol Violation|1
1738698|NCT00950807|6064629|P10|Treatment Period 1|Lack of Efficacy|0
1738699|NCT00950807|6064630|P9|Treatment Period 1|Lack of Efficacy|0
1738700|NCT00950807|6064631|P8|Treatment Period 1|Lack of Efficacy|0
1738701|NCT00950807|6064632|P7|Treatment Period 1|Lack of Efficacy|0
1738702|NCT00950807|6064633|P6|Treatment Period 1|Lack of Efficacy|1
1738703|NCT00950807|6064634|P5|Treatment Period 1|Lack of Efficacy|0
1738704|NCT00950807|6064635|P4|Treatment Period 1|Lack of Efficacy|0
1738705|NCT00950807|6064636|P3|Treatment Period 1|Lack of Efficacy|0
1738706|NCT00950807|6064637|P2|Treatment Period 1|Lack of Efficacy|0
1738707|NCT00950807|6064638|P1|Treatment Period 1|Lack of Efficacy|1
1738708|NCT00950755|6064680|P1|Long-Term Follow-Up|Death|8
1738709|NCT00950755|6064680|P1|Long-Term Follow-Up|Lost to Follow-up|1
1738710|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
1738711|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
1738712|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
1738713|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
1738714|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Death|1
1738715|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
1738716|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
1738717|NCT00950755|6064680|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
1738718|NCT00950742|6064706|P2|Overall Study|Dose limiting toxicity|0
1738719|NCT00950742|6064707|P1|Overall Study|Dose limiting toxicity|6
1738720|NCT00950742|6064706|P2|Overall Study|Progressive Disease|2
1738721|NCT00950742|6064707|P1|Overall Study|Progressive Disease|6
1738722|NCT00950742|6064706|P2|Overall Study|Withdrawal by Subject|0
1738723|NCT00950742|6064707|P1|Overall Study|Withdrawal by Subject|3
1738724|NCT00950742|6064706|P2|Overall Study|Other Adverse Event|0
1738725|NCT00950742|6064707|P1|Overall Study|Other Adverse Event|1
1738726|NCT00950690|6064728|P1|Overall Study|Other|163
1738727|NCT00950690|6064728|P1|Overall Study|Lost to Follow-up|40
1738728|NCT00950690|6064728|P1|Overall Study|Lack of Efficacy|22
1738729|NCT00950690|6064728|P1|Overall Study|Adverse Event|15
1738730|NCT00950690|6064728|P1|Overall Study|Death|4
1738731|NCT00950664|6064735|P2|First Intervention|Withdrawal by Subject|2
1738732|NCT00950664|6064736|P1|First Intervention|Withdrawal by Subject|2
1738733|NCT00950664|6064735|P2|First Intervention|Lost to Follow-up|3
1738734|NCT00950664|6064736|P1|First Intervention|Lost to Follow-up|1
1738735|NCT00950651|6064756|P2|Overall Study|Withdrawal by Subject|9
1738736|NCT00950651|6064757|P1|Overall Study|Withdrawal by Subject|8
1738737|NCT00950651|6064756|P2|Overall Study|Protocol Violation|4
1738738|NCT00950651|6064757|P1|Overall Study|Protocol Violation|3
1738739|NCT00950651|6064756|P2|Overall Study|Lack of Efficacy|2
1738740|NCT00950651|6064757|P1|Overall Study|Lack of Efficacy|2
1738741|NCT00950651|6064756|P2|Overall Study|Death|0
1738742|NCT00950651|6064757|P1|Overall Study|Death|1
1738743|NCT00950651|6064756|P2|Overall Study|Adverse Event|20
1738744|NCT00950651|6064757|P1|Overall Study|Adverse Event|17
1738745|NCT00950599|6064850|P10|Follow-Up Period|Subject withdrew Consent|1
1738746|NCT00950599|6064851|P9|Follow-Up Period|Subject withdrew Consent|2
1738747|NCT00950599|6064852|P8|Follow-Up Period|Subject withdrew Consent|0
1738748|NCT00950599|6064853|P7|Follow-Up Period|Subject withdrew Consent|0
1738749|NCT00950599|6064854|P6|Follow-Up Period|Subject withdrew Consent|0
1738750|NCT00950599|6064855|P5|Follow-Up Period|Subject withdrew Consent|0
1738751|NCT00950599|6064856|P4|Follow-Up Period|Subject withdrew Consent|0
1738752|NCT00950599|6064857|P3|Follow-Up Period|Subject withdrew Consent|0
1738753|NCT00950599|6064858|P2|Follow-Up Period|Subject withdrew Consent|0
1738754|NCT00950599|6064859|P1|Follow-Up Period|Subject withdrew Consent|0
1738755|NCT00950599|6064850|P10|Follow-Up Period|Poor/Noncompliance|0
1738756|NCT00950599|6064851|P9|Follow-Up Period|Poor/Noncompliance|1
1738757|NCT00950599|6064852|P8|Follow-Up Period|Poor/Noncompliance|0
1738758|NCT00950599|6064853|P7|Follow-Up Period|Poor/Noncompliance|0
1738759|NCT00950599|6064854|P6|Follow-Up Period|Poor/Noncompliance|0
1738760|NCT00950599|6064855|P5|Follow-Up Period|Poor/Noncompliance|0
1738761|NCT00950599|6064856|P4|Follow-Up Period|Poor/Noncompliance|0
1738762|NCT00950599|6064857|P3|Follow-Up Period|Poor/Noncompliance|0
1738763|NCT00950599|6064858|P2|Follow-Up Period|Poor/Noncompliance|0
1738764|NCT00950599|6064859|P1|Follow-Up Period|Poor/Noncompliance|0
1738765|NCT00950599|6064850|P10|Follow-Up Period|Physician Decision|0
1738766|NCT00950599|6064851|P9|Follow-Up Period|Physician Decision|1
1738767|NCT00950599|6064852|P8|Follow-Up Period|Physician Decision|0
1738768|NCT00950599|6064853|P7|Follow-Up Period|Physician Decision|0
1738769|NCT00950599|6064854|P6|Follow-Up Period|Physician Decision|0
1738770|NCT00950599|6064855|P5|Follow-Up Period|Physician Decision|0
1738771|NCT00950599|6064856|P4|Follow-Up Period|Physician Decision|0
1738772|NCT00950599|6064857|P3|Follow-Up Period|Physician Decision|0
1738773|NCT00950599|6064858|P2|Follow-Up Period|Physician Decision|0
1738774|NCT00950599|6064859|P1|Follow-Up Period|Physician Decision|0
1738775|NCT00950599|6064850|P10|Follow-Up Period|Lost to Follow-up|1
1738776|NCT00950599|6064851|P9|Follow-Up Period|Lost to Follow-up|5
1738777|NCT00950599|6064852|P8|Follow-Up Period|Lost to Follow-up|0
1738778|NCT00950599|6064853|P7|Follow-Up Period|Lost to Follow-up|0
1738779|NCT00950599|6064854|P6|Follow-Up Period|Lost to Follow-up|0
1738780|NCT00950599|6064855|P5|Follow-Up Period|Lost to Follow-up|0
1738781|NCT00950599|6064856|P4|Follow-Up Period|Lost to Follow-up|0
1738782|NCT00950599|6064857|P3|Follow-Up Period|Lost to Follow-up|0
1738783|NCT00950599|6064858|P2|Follow-Up Period|Lost to Follow-up|0
1738784|NCT00950599|6064859|P1|Follow-Up Period|Lost to Follow-up|0
1738785|NCT00950599|6064850|P10|Follow-Up Period|Lack of Efficacy|0
1738786|NCT00950599|6064851|P9|Follow-Up Period|Lack of Efficacy|3
1738787|NCT00950599|6064852|P8|Follow-Up Period|Lack of Efficacy|0
1738788|NCT00950599|6064853|P7|Follow-Up Period|Lack of Efficacy|0
1738789|NCT00950599|6064854|P6|Follow-Up Period|Lack of Efficacy|0
1738790|NCT00950599|6064855|P5|Follow-Up Period|Lack of Efficacy|0
1738791|NCT00950599|6064856|P4|Follow-Up Period|Lack of Efficacy|0
1738792|NCT00950599|6064857|P3|Follow-Up Period|Lack of Efficacy|0
1738793|NCT00950599|6064858|P2|Follow-Up Period|Lack of Efficacy|0
1738794|NCT00950599|6064859|P1|Follow-Up Period|Lack of Efficacy|0
1738795|NCT00950599|6064850|P10|Follow-Up Period|Adverse Event|0
1738796|NCT00950599|6064851|P9|Follow-Up Period|Adverse Event|1
1738797|NCT00950599|6064852|P8|Follow-Up Period|Adverse Event|0
1738798|NCT00950599|6064853|P7|Follow-Up Period|Adverse Event|0
1738799|NCT00950599|6064854|P6|Follow-Up Period|Adverse Event|0
1738800|NCT00950599|6064855|P5|Follow-Up Period|Adverse Event|0
1738801|NCT00950599|6064856|P4|Follow-Up Period|Adverse Event|0
1738802|NCT00950599|6064857|P3|Follow-Up Period|Adverse Event|0
1738803|NCT00950599|6064858|P2|Follow-Up Period|Adverse Event|0
1738804|NCT00950599|6064859|P1|Follow-Up Period|Adverse Event|0
1738805|NCT00950599|6064850|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
1738806|NCT00950599|6064851|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
1738807|NCT00950599|6064852|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
1738808|NCT00950599|6064853|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
1738809|NCT00950599|6064854|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
1738810|NCT00950599|6064855|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
1738811|NCT00950599|6064856|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
1738812|NCT00950599|6064857|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
1738813|NCT00950599|6064858|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
1738814|NCT00950599|6064859|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
1738815|NCT00950599|6064850|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738816|NCT00950599|6064851|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738817|NCT00950599|6064852|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738818|NCT00950599|6064853|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738819|NCT00950599|6064854|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
1738820|NCT00950599|6064855|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
1738821|NCT00950599|6064856|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738822|NCT00950599|6064857|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738823|NCT00950599|6064858|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738824|NCT00950599|6064859|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
1738825|NCT00950599|6064850|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
1738826|NCT00950599|6064851|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
1738827|NCT00950599|6064852|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
1738828|NCT00950599|6064853|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
1738829|NCT00950599|6064854|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
1738830|NCT00950599|6064855|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
1738831|NCT00950599|6064856|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
1738832|NCT00950599|6064857|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
1738833|NCT00950599|6064858|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
1738834|NCT00950599|6064859|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
1738835|NCT00950599|6064850|P10|Double-Blind Treatment Period|Lost to Follow-up|0
1738836|NCT00950599|6064851|P9|Double-Blind Treatment Period|Lost to Follow-up|0
1738837|NCT00950599|6064852|P8|Double-Blind Treatment Period|Lost to Follow-up|1
1738838|NCT00950599|6064853|P7|Double-Blind Treatment Period|Lost to Follow-up|0
1738839|NCT00950599|6064854|P6|Double-Blind Treatment Period|Lost to Follow-up|2
1738840|NCT00950599|6064855|P5|Double-Blind Treatment Period|Lost to Follow-up|1
1738841|NCT00950599|6064856|P4|Double-Blind Treatment Period|Lost to Follow-up|1
1738842|NCT00950599|6064857|P3|Double-Blind Treatment Period|Lost to Follow-up|0
1738843|NCT00950599|6064858|P2|Double-Blind Treatment Period|Lost to Follow-up|0
1738844|NCT00950599|6064859|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1738845|NCT00950599|6064850|P10|Double-Blind Treatment Period|Lack of Efficacy|0
1738846|NCT00950599|6064851|P9|Double-Blind Treatment Period|Lack of Efficacy|0
1738847|NCT00950599|6064852|P8|Double-Blind Treatment Period|Lack of Efficacy|1
1738848|NCT00950599|6064853|P7|Double-Blind Treatment Period|Lack of Efficacy|0
1738849|NCT00950599|6064854|P6|Double-Blind Treatment Period|Lack of Efficacy|6
1738850|NCT00950599|6064855|P5|Double-Blind Treatment Period|Lack of Efficacy|3
1738851|NCT00950599|6064856|P4|Double-Blind Treatment Period|Lack of Efficacy|7
1738852|NCT00950599|6064857|P3|Double-Blind Treatment Period|Lack of Efficacy|5
1738853|NCT00950599|6064858|P2|Double-Blind Treatment Period|Lack of Efficacy|5
1738854|NCT00950599|6064859|P1|Double-Blind Treatment Period|Lack of Efficacy|2
1738855|NCT00950599|6064850|P10|Double-Blind Treatment Period|Adverse Event|0
1738856|NCT00950599|6064851|P9|Double-Blind Treatment Period|Adverse Event|0
1738857|NCT00950599|6064852|P8|Double-Blind Treatment Period|Adverse Event|0
1738858|NCT00950599|6064853|P7|Double-Blind Treatment Period|Adverse Event|0
1738859|NCT00950599|6064854|P6|Double-Blind Treatment Period|Adverse Event|1
1738860|NCT00950599|6064855|P5|Double-Blind Treatment Period|Adverse Event|1
1738861|NCT00950599|6064856|P4|Double-Blind Treatment Period|Adverse Event|1
1738862|NCT00950599|6064857|P3|Double-Blind Treatment Period|Adverse Event|1
1738863|NCT00950599|6064858|P2|Double-Blind Treatment Period|Adverse Event|1
1738864|NCT00950599|6064859|P1|Double-Blind Treatment Period|Adverse Event|0
1738865|NCT00950599|6064850|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738866|NCT00950599|6064851|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738867|NCT00950599|6064852|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738868|NCT00950599|6064853|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738869|NCT00950599|6064854|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738870|NCT00950599|6064855|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738871|NCT00950599|6064856|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
1738872|NCT00950599|6064857|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738873|NCT00950599|6064858|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738874|NCT00950599|6064859|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
1738875|NCT00950300|6065432|P2|SFU Period|Withdrawal by Subject|8
1738876|NCT00950300|6065433|P1|SFU Period|Withdrawal by Subject|4
1738877|NCT00950300|6065432|P2|SFU Period|Lost to Follow-up|28
1738878|NCT00950300|6065433|P1|SFU Period|Lost to Follow-up|30
1738879|NCT00950300|6065432|P2|SFU Period|Death|42
1738880|NCT00950300|6065433|P1|SFU Period|Death|44
1738881|NCT00950300|6065432|P2|TFFU Period|Other|3
1738882|NCT00950300|6065433|P1|TFFU Period|Other|4
1738883|NCT00950300|6065432|P2|TFFU Period|Recurrence of Disease|72
1738884|NCT00950300|6065433|P1|TFFU Period|Recurrence of Disease|63
1738885|NCT00950300|6065432|P2|TFFU Period|Failure to Return|16
1738886|NCT00950300|6065433|P1|TFFU Period|Failure to Return|16
1738887|NCT00950300|6065432|P2|TFFU Period|Refused Treatment|11
1738888|NCT00950300|6065433|P1|TFFU Period|Refused Treatment|10
1738889|NCT00950300|6065432|P2|TFFU Period|Death|1
1738890|NCT00950300|6065433|P1|TFFU Period|Death|4
1738891|NCT00950300|6065432|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
1738892|NCT00950300|6065433|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
1738893|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
1738894|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
1738895|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
1738896|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
1738897|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
1738898|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
1738899|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
1738900|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
1738901|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
1738902|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
1738903|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
1738904|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
1738905|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
1738906|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
1738907|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
1738908|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
1738909|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
1738910|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
1738911|NCT00950300|6065432|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
1738912|NCT00950300|6065433|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
1738913|NCT00950248|6065482|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
1738914|NCT00950248|6065483|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
1738915|NCT00950248|6065484|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
1738916|NCT00950248|6065482|P3|Year 2&3 Treatment Randomization|Death|1
1738917|NCT00950248|6065483|P2|Year 2&3 Treatment Randomization|Death|0
1738918|NCT00950248|6065484|P1|Year 2&3 Treatment Randomization|Death|0
1738919|NCT00950248|6065482|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
1738920|NCT00950248|6065483|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
1738921|NCT00950248|6065484|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
1738922|NCT00950248|6065482|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
1738923|NCT00950248|6065483|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
1738924|NCT00950248|6065484|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
1738925|NCT00950248|6065482|P3|Year 1: Baseline|worsening of symptoms|0
1738926|NCT00950248|6065483|P2|Year 1: Baseline|worsening of symptoms|0
1738927|NCT00950248|6065484|P1|Year 1: Baseline|worsening of symptoms|2
1738928|NCT00950248|6065482|P3|Year 1: Baseline|Withdrawal by Subject|0
1738929|NCT00950248|6065483|P2|Year 1: Baseline|Withdrawal by Subject|0
1738930|NCT00950248|6065484|P1|Year 1: Baseline|Withdrawal by Subject|6
1738931|NCT00950170|6065524|P1|Overall Study|Discontinuation of Study by Sponsor|1
1738932|NCT00950170|6065524|P1|Overall Study|Adverse Event|2
1738933|NCT00950170|6065524|P1|Overall Study|Parent/Legal Guardian Request|1
1738934|NCT00949988|6065575|P1|Overall Study|Withdrawal by Subject|3
1738935|NCT00949975|6065590|P4|Overall Study|Other|0
1738936|NCT00949975|6065591|P3|Overall Study|Other|0
1738937|NCT00949975|6065592|P2|Overall Study|Other|0
1738938|NCT00949975|6065593|P1|Overall Study|Other|1
1738939|NCT00949975|6065590|P4|Overall Study|Lost to Follow-up|3
1738940|NCT00949975|6065591|P3|Overall Study|Lost to Follow-up|1
1738941|NCT00949975|6065592|P2|Overall Study|Lost to Follow-up|0
1738942|NCT00949975|6065593|P1|Overall Study|Lost to Follow-up|1
1738943|NCT00949975|6065590|P4|Overall Study|Severe non-compliance|2
1738944|NCT00949975|6065591|P3|Overall Study|Severe non-compliance|0
1738945|NCT00949975|6065592|P2|Overall Study|Severe non-compliance|1
1738946|NCT00949975|6065593|P1|Overall Study|Severe non-compliance|3
1738947|NCT00949975|6065590|P4|Overall Study|Incorrect enrolment|7
1738948|NCT00949975|6065591|P3|Overall Study|Incorrect enrolment|4
1738949|NCT00949975|6065592|P2|Overall Study|Incorrect enrolment|10
1738950|NCT00949975|6065593|P1|Overall Study|Incorrect enrolment|5
1738951|NCT00949975|6065590|P4|Overall Study|Study-specific criteria|0
1738952|NCT00949975|6065591|P3|Overall Study|Study-specific criteria|1
1738953|NCT00949975|6065592|P2|Overall Study|Study-specific criteria|1
1738954|NCT00949975|6065593|P1|Overall Study|Study-specific criteria|0
1738955|NCT00949975|6065590|P4|Overall Study|Safety reason|0
1738956|NCT00949975|6065591|P3|Overall Study|Safety reason|0
1738957|NCT00949975|6065592|P2|Overall Study|Safety reason|1
1738958|NCT00949975|6065593|P1|Overall Study|Safety reason|0
1738959|NCT00949975|6065590|P4|Overall Study|Adverse Event|10
1738960|NCT00949975|6065591|P3|Overall Study|Adverse Event|10
1738961|NCT00949975|6065592|P2|Overall Study|Adverse Event|11
1738962|NCT00949975|6065593|P1|Overall Study|Adverse Event|11
1738963|NCT00949975|6065590|P4|Overall Study|Voluntary discontinuation|6
1738964|NCT00949975|6065591|P3|Overall Study|Voluntary discontinuation|3
1738965|NCT00949975|6065592|P2|Overall Study|Voluntary discontinuation|5
1738966|NCT00949975|6065593|P1|Overall Study|Voluntary discontinuation|6
1738967|NCT00949910|6065711|P1|Overall Study|No Data|9
1738968|NCT00949910|6065711|P1|Overall Study|Other|4
1738969|NCT00949910|6065711|P1|Overall Study|Physician/Participant Decision|7
1738970|NCT00949910|6065711|P1|Overall Study|Serious Adverse Event|6
1738971|NCT00949910|6065711|P1|Overall Study|Adverse Event|83
1738972|NCT00949910|6065711|P1|Overall Study|Prolonged Dosing Interruption|4
1738973|NCT00949910|6065711|P1|Overall Study|Non-Compliance|10
1738974|NCT00949910|6065711|P1|Overall Study|Logistical Reasons|13
1738975|NCT00949910|6065711|P1|Overall Study|Violation of Eligibility|23
1738976|NCT00949910|6065711|P1|Overall Study|Switched to Commercial Treatment|4
1738977|NCT00949910|6065711|P1|Overall Study|Switched to Compassionate/Other Use|174
1738978|NCT00949910|6065711|P1|Overall Study|Unspecified Progression/Deterioration|13
1738979|NCT00949910|6065711|P1|Overall Study|Death from Unknown Cause|5
1738980|NCT00949910|6065711|P1|Overall Study|Death Due to Toxicity|3
1738981|NCT00949910|6065711|P1|Overall Study|Death Due to Adverse Event|115
1738982|NCT00949910|6065711|P1|Overall Study|Death Due to Progression/Deterioration|4
1738983|NCT00949910|6065711|P1|Overall Study|Death Due to Malignant Disease|456
1738984|NCT00949910|6065711|P1|Overall Study|Participant Refusal|390
1738985|NCT00949910|6065711|P1|Overall Study|Study Drug-Related Adverse Event|315
1738986|NCT00949910|6065711|P1|Overall Study|Lost to Follow-up|100
1738987|NCT00949910|6065711|P1|Overall Study|Symptomatic Deterioration|1088
1738988|NCT00949910|6065711|P1|Overall Study|Progressive Disease|3750
1738989|NCT00949884|6065724|P3|Overall Study|Study terminated by sponsor|1
1738990|NCT00949884|6065725|P2|Overall Study|Study terminated by sponsor|0
1738991|NCT00949884|6065726|P1|Overall Study|Study terminated by sponsor|0
1738992|NCT00949884|6065724|P3|Overall Study|Lack of Efficacy|7
1738993|NCT00949884|6065725|P2|Overall Study|Lack of Efficacy|2
1738994|NCT00949884|6065726|P1|Overall Study|Lack of Efficacy|4
1738995|NCT00949884|6065724|P3|Overall Study|Withdrawal by Subject|16
1738996|NCT00949884|6065725|P2|Overall Study|Withdrawal by Subject|4
1738997|NCT00949884|6065726|P1|Overall Study|Withdrawal by Subject|13
1738998|NCT00949884|6065724|P3|Overall Study|Treatment non-compliance|8
1738999|NCT00949884|6065725|P2|Overall Study|Treatment non-compliance|0
1739000|NCT00949884|6065726|P1|Overall Study|Treatment non-compliance|5
1739001|NCT00949884|6065724|P3|Overall Study|Physician Decision|6
1739002|NCT00949884|6065725|P2|Overall Study|Physician Decision|0
1739003|NCT00949884|6065726|P1|Overall Study|Physician Decision|5
1739004|NCT00949884|6065724|P3|Overall Study|Lost to Follow-up|5
1739005|NCT00949884|6065725|P2|Overall Study|Lost to Follow-up|5
1739006|NCT00949884|6065726|P1|Overall Study|Lost to Follow-up|7
1739007|NCT00949884|6065724|P3|Overall Study|Did not meet inclusion/exclusion|3
1739008|NCT00949884|6065725|P2|Overall Study|Did not meet inclusion/exclusion|1
1739009|NCT00949884|6065726|P1|Overall Study|Did not meet inclusion/exclusion|2
1739010|NCT00949884|6065724|P3|Overall Study|Adverse Event|12
1739011|NCT00949884|6065725|P2|Overall Study|Adverse Event|3
1739012|NCT00949884|6065726|P1|Overall Study|Adverse Event|14
1739013|NCT00949715|6065781|P2|Overall Study|Missing 24 month LVEF measurement|0
1739014|NCT00949715|6065782|P1|Overall Study|Missing 24 month LVEF measurement|2
1739015|NCT00949715|6065781|P2|Overall Study|Lost to Follow-up|0
1739016|NCT00949715|6065782|P1|Overall Study|Lost to Follow-up|1
1739017|NCT00949715|6065781|P2|Overall Study|Physician Decision|0
1739018|NCT00949715|6065782|P1|Overall Study|Physician Decision|1
1739019|NCT00949702|6065793|P1|Overall Study|Withdrawal of consent|1
1739020|NCT00949702|6065793|P1|Overall Study|Disease progression|7
1739021|NCT00949702|6065793|P1|Overall Study|Death|40
1739022|NCT00949650|6065810|P2|Overall Study|Other not specified above|0
1739023|NCT00949650|6065811|P1|Overall Study|Other not specified above|5
1739024|NCT00949650|6065810|P2|Overall Study|Not treated|4
1739025|NCT00949650|6065811|P1|Overall Study|Not treated|1
1739026|NCT00949650|6065810|P2|Overall Study|Refusal to continue medication|11
1739027|NCT00949650|6065811|P1|Overall Study|Refusal to continue medication|7
1739028|NCT00949650|6065810|P2|Overall Study|Protocol Violation|4
1739029|NCT00949650|6065811|P1|Overall Study|Protocol Violation|1
1739030|NCT00949650|6065810|P2|Overall Study|Other Adverse Event (AE)|17
1739031|NCT00949650|6065811|P1|Overall Study|Other Adverse Event (AE)|28
1739032|NCT00949650|6065810|P2|Overall Study|Completed 6 courses of chemotherapy|60
1739033|NCT00949650|6065811|P1|Overall Study|Completed 6 courses of chemotherapy|0
1739034|NCT00949650|6065810|P2|Overall Study|Progressive disease|19
1739035|NCT00949650|6065811|P1|Overall Study|Progressive disease|188
1739036|NCT00949533|6065849|P2|Overall Study|Lost to Follow-up|1
1739037|NCT00949533|6065850|P1|Overall Study|Lost to Follow-up|0
1739038|NCT00949325|6065862|P3|Overall Study|Adverse Event|0
1739039|NCT00949325|6065863|P2|Overall Study|Adverse Event|2
1739040|NCT00949325|6065864|P1|Overall Study|Adverse Event|0
1739041|NCT00949117|6065888|P2|Overall Study|Adverse Event|1
1739042|NCT00949117|6065889|P1|Overall Study|Adverse Event|0
1739043|NCT00949117|6065888|P2|Overall Study|Protocol Violation|1
1739044|NCT00949117|6065889|P1|Overall Study|Protocol Violation|1
1739045|NCT00949117|6065888|P2|Overall Study|Lack of Efficacy|3
1739046|NCT00949117|6065889|P1|Overall Study|Lack of Efficacy|2
1739047|NCT00948974|6065930|P2|Overall Study|Lost to Follow-up|20
1739048|NCT00948974|6065931|P1|Overall Study|Lost to Follow-up|23
1739049|NCT00948922|6065949|P3|Overall Study|Not evaluable at time of analysis|0
1739050|NCT00948922|6065950|P2|Overall Study|Not evaluable at time of analysis|3
1739051|NCT00948922|6065951|P1|Overall Study|Not evaluable at time of analysis|0
1739052|NCT00948922|6065949|P3|Overall Study|Transplant eligibility issues|0
1739053|NCT00948922|6065950|P2|Overall Study|Transplant eligibility issues|3
1739054|NCT00948922|6065951|P1|Overall Study|Transplant eligibility issues|2
1739055|NCT00948922|6065949|P3|Overall Study|Insurance issues|0
1739056|NCT00948922|6065950|P2|Overall Study|Insurance issues|0
1739057|NCT00948922|6065951|P1|Overall Study|Insurance issues|1
1739058|NCT00948922|6065949|P3|Overall Study|Disease progression|0
1739059|NCT00948922|6065950|P2|Overall Study|Disease progression|1
1739060|NCT00948922|6065951|P1|Overall Study|Disease progression|0
1739061|NCT00948922|6065949|P3|Overall Study|Death|0
1739062|NCT00948922|6065950|P2|Overall Study|Death|0
1739063|NCT00948922|6065951|P1|Overall Study|Death|3
1739064|NCT00948922|6065949|P3|Overall Study|Withdrawal by Subject|1
1739065|NCT00948922|6065950|P2|Overall Study|Withdrawal by Subject|2
1739066|NCT00948922|6065951|P1|Overall Study|Withdrawal by Subject|0
1739067|NCT00948922|6065949|P3|Overall Study|Did not start study treatment|0
1739068|NCT00948922|6065950|P2|Overall Study|Did not start study treatment|5
1739069|NCT00948922|6065951|P1|Overall Study|Did not start study treatment|2
1739070|NCT00948896|6065974|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1739071|NCT00948896|6065975|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1739072|NCT00948896|6065976|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1739073|NCT00948896|6065977|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1739074|NCT00948896|6065978|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
1739075|NCT00948896|6065979|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1739076|NCT00948896|6065980|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1739077|NCT00948896|6065981|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
1739078|NCT00948896|6065974|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
1739079|NCT00948896|6065975|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
1739080|NCT00948896|6065976|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
1739081|NCT00948896|6065977|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
1739082|NCT00948896|6065978|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
1739083|NCT00948896|6065979|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
1739084|NCT00948896|6065980|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
1739085|NCT00948896|6065981|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
1739086|NCT00948896|6065974|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1739087|NCT00948896|6065975|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1739088|NCT00948896|6065976|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1739089|NCT00948896|6065977|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
1739090|NCT00948896|6065978|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1739091|NCT00948896|6065979|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
1739092|NCT00948896|6065980|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
1739093|NCT00948896|6065981|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
1739094|NCT00948896|6065974|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1739095|NCT00948896|6065975|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1739096|NCT00948896|6065976|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1739097|NCT00948896|6065977|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1739098|NCT00948896|6065978|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1739099|NCT00948896|6065979|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1739100|NCT00948896|6065980|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
1739101|NCT00948896|6065981|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
1739102|NCT00948896|6065974|P8|24 Months of Age to 36 Months of Age|Death|0
1739103|NCT00948896|6065975|P7|24 Months of Age to 36 Months of Age|Death|0
1739104|NCT00948896|6065976|P6|24 Months of Age to 36 Months of Age|Death|1
1739105|NCT00948896|6065977|P5|24 Months of Age to 36 Months of Age|Death|0
1739106|NCT00948896|6065978|P4|24 Months of Age to 36 Months of Age|Death|0
1739107|NCT00948896|6065979|P3|24 Months of Age to 36 Months of Age|Death|2
1739108|NCT00948896|6065980|P2|24 Months of Age to 36 Months of Age|Death|2
1739109|NCT00948896|6065981|P1|24 Months of Age to 36 Months of Age|Death|0
1739110|NCT00948896|6065974|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
1739111|NCT00948896|6065975|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
1739112|NCT00948896|6065976|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
1739113|NCT00948896|6065977|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
1739114|NCT00948896|6065978|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
1739115|NCT00948896|6065979|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
1739116|NCT00948896|6065980|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
1739117|NCT00948896|6065981|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
1739118|NCT00948896|6065974|P8|Randomization to 24 Months of Age|Protocol Violation|1
1739119|NCT00948896|6065975|P7|Randomization to 24 Months of Age|Protocol Violation|1
1739120|NCT00948896|6065976|P6|Randomization to 24 Months of Age|Protocol Violation|0
1739121|NCT00948896|6065977|P5|Randomization to 24 Months of Age|Protocol Violation|0
1739122|NCT00948896|6065978|P4|Randomization to 24 Months of Age|Protocol Violation|1
1739123|NCT00948896|6065979|P3|Randomization to 24 Months of Age|Protocol Violation|0
1739124|NCT00948896|6065980|P2|Randomization to 24 Months of Age|Protocol Violation|1
1739125|NCT00948896|6065981|P1|Randomization to 24 Months of Age|Protocol Violation|0
1739126|NCT00948896|6065974|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
1739127|NCT00948896|6065975|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
1739128|NCT00948896|6065976|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
1739129|NCT00948896|6065977|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
1739130|NCT00948896|6065978|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
1739131|NCT00948896|6065979|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
1739132|NCT00948896|6065980|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
1739133|NCT00948896|6065981|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
1739134|NCT00948896|6065974|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
1739135|NCT00948896|6065975|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
1739136|NCT00948896|6065976|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
1739137|NCT00948896|6065977|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
1739138|NCT00948896|6065978|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
1739139|NCT00948896|6065979|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
1739140|NCT00948896|6065980|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
1739141|NCT00948896|6065981|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
1739142|NCT00948896|6065974|P8|Randomization to 24 Months of Age|Death|1
1739143|NCT00948896|6065975|P7|Randomization to 24 Months of Age|Death|2
1739144|NCT00948896|6065976|P6|Randomization to 24 Months of Age|Death|1
1739145|NCT00948896|6065977|P5|Randomization to 24 Months of Age|Death|2
1739146|NCT00948896|6065978|P4|Randomization to 24 Months of Age|Death|0
1739147|NCT00948896|6065979|P3|Randomization to 24 Months of Age|Death|0
1739148|NCT00948896|6065980|P2|Randomization to 24 Months of Age|Death|0
1739149|NCT00948896|6065981|P1|Randomization to 24 Months of Age|Death|1
1739150|NCT00948857|6066017|P2|Overall Study|Lost to Follow-up|0
1739151|NCT00948857|6066018|P1|Overall Study|Lost to Follow-up|1
1739152|NCT00948818|6066026|P2|Overall Study|Other Reason|5
1739153|NCT00948818|6066027|P1|Overall Study|Other Reason|4
1739154|NCT00948818|6066026|P2|Overall Study|Lack of Efficacy|5
1739155|NCT00948818|6066027|P1|Overall Study|Lack of Efficacy|4
1739156|NCT00948818|6066026|P2|Overall Study|Lost to Follow-up|17
1739157|NCT00948818|6066027|P1|Overall Study|Lost to Follow-up|10
1739158|NCT00948818|6066026|P2|Overall Study|Withdrawal by Subject|25
1739159|NCT00948818|6066027|P1|Overall Study|Withdrawal by Subject|25
1739160|NCT00948818|6066026|P2|Overall Study|Protocol Violation|10
1739161|NCT00948818|6066027|P1|Overall Study|Protocol Violation|9
1739162|NCT00948818|6066026|P2|Overall Study|Adverse Event|32
1739163|NCT00948818|6066027|P1|Overall Study|Adverse Event|10
1739164|NCT00948766|6066074|P2|Extension Study|Death|0
1739165|NCT00948766|6066075|P1|Extension Study|Death|4
1739166|NCT00948766|6066074|P2|Extension Study|Administrative Problems|0
1739167|NCT00948766|6066075|P1|Extension Study|Administrative Problems|1
1739168|NCT00948766|6066074|P2|Extension Study|Lost to Follow-up|0
1739169|NCT00948766|6066075|P1|Extension Study|Lost to Follow-up|8
1739170|NCT00948766|6066074|P2|Extension Study|Patient Withdrew Consent|0
1739171|NCT00948766|6066075|P1|Extension Study|Patient Withdrew Consent|32
1739172|NCT00948766|6066074|P2|Extension Study|Study Drug No Longer Required|0
1739173|NCT00948766|6066075|P1|Extension Study|Study Drug No Longer Required|1
1739174|NCT00948766|6066074|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
1739175|NCT00948766|6066075|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
1739176|NCT00948766|6066074|P2|Extension Study|Adverse Event|0
1739177|NCT00948766|6066075|P1|Extension Study|Adverse Event|43
1739178|NCT00948766|6066074|P2|Core Study|Protocol Deviation|10
1739179|NCT00948766|6066075|P1|Core Study|Protocol Deviation|8
1739180|NCT00948766|6066074|P2|Core Study|Death|1
1739181|NCT00948766|6066075|P1|Core Study|Death|1
1739182|NCT00948766|6066074|P2|Core Study|Administrative Problems|2
1739183|NCT00948766|6066075|P1|Core Study|Administrative Problems|2
1739184|NCT00948766|6066074|P2|Core Study|Lost to Follow-up|2
1739185|NCT00948766|6066075|P1|Core Study|Lost to Follow-up|3
1739186|NCT00948766|6066074|P2|Core Study|Patient Withdrew Consent|46
1739187|NCT00948766|6066075|P1|Core Study|Patient Withdrew Consent|27
1739188|NCT00948766|6066074|P2|Core Study|Unsatisfactory Therapeutic Effect|14
1739189|NCT00948766|6066075|P1|Core Study|Unsatisfactory Therapeutic Effect|13
1739190|NCT00948766|6066074|P2|Core Study|Adverse Event|51
1739191|NCT00948766|6066075|P1|Core Study|Adverse Event|73
1739192|NCT00948688|6066091|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
1739193|NCT00948688|6066092|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
1739194|NCT00948688|6066091|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
1739195|NCT00948688|6066092|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
1739196|NCT00948688|6066091|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
1739197|NCT00948688|6066092|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
1739198|NCT00948675|6066106|P2|Overall Study|Treatment ongoing|4
1739199|NCT00948675|6066107|P1|Overall Study|Treatment ongoing|5
1739200|NCT00948675|6066106|P2|Overall Study|Lost to Follow-up|0
1739201|NCT00948675|6066107|P1|Overall Study|Lost to Follow-up|2
1739202|NCT00948506|6066134|P2|Overall Study|Withdrawal by Subject|1
1739203|NCT00948506|6066135|P1|Overall Study|Withdrawal by Subject|3
1739204|NCT00948441|6066146|P2|Overall Study|no longer meet inclusion criteria|4
1739205|NCT00948441|6066147|P1|Overall Study|no longer meet inclusion criteria|1
1739206|NCT00948389|6066160|P5|Overall Study|Both Progression and Toxicity|0
1739207|NCT00948389|6066161|P4|Overall Study|Both Progression and Toxicity|0
1739208|NCT00948389|6066162|P3|Overall Study|Both Progression and Toxicity|0
1739209|NCT00948389|6066163|P2|Overall Study|Both Progression and Toxicity|0
1739210|NCT00948389|6066164|P1|Overall Study|Both Progression and Toxicity|1
1739211|NCT00948389|6066160|P5|Overall Study|Thrombocytopenia, Grade 4|0
1739212|NCT00948389|6066161|P4|Overall Study|Thrombocytopenia, Grade 4|1
1739213|NCT00948389|6066162|P3|Overall Study|Thrombocytopenia, Grade 4|0
1739214|NCT00948389|6066163|P2|Overall Study|Thrombocytopenia, Grade 4|0
1739215|NCT00948389|6066164|P1|Overall Study|Thrombocytopenia, Grade 4|2
1739216|NCT00948389|6066160|P5|Overall Study|Disease Progression/Relapse/Death|1
1739217|NCT00948389|6066161|P4|Overall Study|Disease Progression/Relapse/Death|8
1739218|NCT00948389|6066162|P3|Overall Study|Disease Progression/Relapse/Death|7
1739219|NCT00948389|6066163|P2|Overall Study|Disease Progression/Relapse/Death|3
1739220|NCT00948389|6066164|P1|Overall Study|Disease Progression/Relapse/Death|3
1739221|NCT00948246|6066212|P1|Overall Study|Withdrawal by Subject|1
1739222|NCT00948246|6066212|P1|Overall Study|Death|1
1739223|NCT00948246|6066212|P1|Overall Study|Adverse Event|11
1739224|NCT00948246|6066212|P1|Overall Study|Lost to Follow-up|11
1739225|NCT00948155|6066221|P2|Washout 14 Days|Lost to Follow-up|2
1739226|NCT00948155|6066222|P1|Washout 14 Days|Lost to Follow-up|1
1739227|NCT00948155|6066221|P2|First Intervention 21 Days|Lost to Follow-up|2
1739228|NCT00948155|6066222|P1|First Intervention 21 Days|Lost to Follow-up|2
1739238|NCT00947882|6066286|P4|Overall Study|Trial Terminated by Sponsor|70
1739239|NCT00947882|6066287|P3|Overall Study|Trial Terminated by Sponsor|62
1739240|NCT00947882|6066288|P2|Overall Study|Trial Terminated by Sponsor|61
1739241|NCT00947882|6066289|P1|Overall Study|Trial Terminated by Sponsor|62
1739242|NCT00947882|6066286|P4|Overall Study|Other/Unknown|6
1739243|NCT00947882|6066287|P3|Overall Study|Other/Unknown|3
1739244|NCT00947882|6066288|P2|Overall Study|Other/Unknown|13
1739245|NCT00947882|6066289|P1|Overall Study|Other/Unknown|10
1739246|NCT00947882|6066286|P4|Overall Study|Lost to Follow-up|0
1739247|NCT00947882|6066287|P3|Overall Study|Lost to Follow-up|1
1739248|NCT00947882|6066288|P2|Overall Study|Lost to Follow-up|2
1739249|NCT00947882|6066289|P1|Overall Study|Lost to Follow-up|0
1739250|NCT00947882|6066286|P4|Overall Study|Protocol Violation|0
1739251|NCT00947882|6066287|P3|Overall Study|Protocol Violation|1
1739252|NCT00947882|6066288|P2|Overall Study|Protocol Violation|0
1739253|NCT00947882|6066289|P1|Overall Study|Protocol Violation|0
1739254|NCT00947882|6066286|P4|Overall Study|Withdrawal by Subject|2
1739255|NCT00947882|6066287|P3|Overall Study|Withdrawal by Subject|8
1739256|NCT00947882|6066288|P2|Overall Study|Withdrawal by Subject|0
1739257|NCT00947882|6066289|P1|Overall Study|Withdrawal by Subject|2
1739258|NCT00947882|6066286|P4|Overall Study|Adverse Event|4
1739259|NCT00947882|6066287|P3|Overall Study|Adverse Event|4
1739260|NCT00947882|6066288|P2|Overall Study|Adverse Event|1
1739261|NCT00947882|6066289|P1|Overall Study|Adverse Event|0
1739262|NCT00947856|6066317|P2|Follow-up Period|Withdrawal by Subject|0
1739263|NCT00947856|6066318|P1|Follow-up Period|Withdrawal by Subject|1
1739264|NCT00947856|6066317|P2|Follow-up Period|Patient unavailable for site visits|0
1739265|NCT00947856|6066318|P1|Follow-up Period|Patient unavailable for site visits|1
1739266|NCT00947856|6066317|P2|Follow-up Period|Lost to Follow-up|0
1739267|NCT00947856|6066318|P1|Follow-up Period|Lost to Follow-up|7
1739268|NCT00947856|6066317|P2|Follow-up Period|Re-enrolled for Retreatment|3
1739269|NCT00947856|6066318|P1|Follow-up Period|Re-enrolled for Retreatment|2
1739270|NCT00947856|6066317|P2|Follow-up Period|Study Stopped by Sponsor|20
1739271|NCT00947856|6066318|P1|Follow-up Period|Study Stopped by Sponsor|40
1739272|NCT00947856|6066317|P2|Treatment Period|Withdrawal by Subject|1
1739273|NCT00947856|6066318|P1|Treatment Period|Withdrawal by Subject|12
1739274|NCT00947856|6066317|P2|Treatment Period|Study Stopped by Sponsor|4
1739275|NCT00947856|6066318|P1|Treatment Period|Study Stopped by Sponsor|4
1739276|NCT00947856|6066317|P2|Treatment Period|Physician Decision|6
1739277|NCT00947856|6066318|P1|Treatment Period|Physician Decision|14
1739278|NCT00947856|6066317|P2|Treatment Period|Adverse Event|9
1739279|NCT00947856|6066318|P1|Treatment Period|Adverse Event|15
1739280|NCT00947856|6066317|P2|Treatment Period|Progressive Disease|12
1739281|NCT00947856|6066318|P1|Treatment Period|Progressive Disease|33
1739282|NCT00947544|6066407|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
1739283|NCT00947544|6066408|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
1739284|NCT00947531|6066434|P2|Overall Study|Other|1
1739285|NCT00947531|6066435|P1|Overall Study|Other|1
1739286|NCT00947531|6066434|P2|Overall Study|Lack of Efficacy|0
1739287|NCT00947531|6066435|P1|Overall Study|Lack of Efficacy|1
1739288|NCT00947531|6066434|P2|Overall Study|Adverse Event|2
1739289|NCT00947531|6066435|P1|Overall Study|Adverse Event|2
1739290|NCT00947531|6066434|P2|Overall Study|Administrative Reason|1
1739291|NCT00947531|6066435|P1|Overall Study|Administrative Reason|0
1739292|NCT00947531|6066434|P2|Overall Study|Withdrawal by Subject|7
1739293|NCT00947531|6066435|P1|Overall Study|Withdrawal by Subject|10
1739294|NCT00947427|6066471|P2|Overall Study|Protocol Violation|1
1739295|NCT00947427|6066472|P1|Overall Study|Protocol Violation|0
1739296|NCT00947427|6066471|P2|Overall Study|Withdrawal by Subject|3
1739297|NCT00947427|6066472|P1|Overall Study|Withdrawal by Subject|1
1739298|NCT00947349|6066482|P4|Overall Study Standard of Care|Other|1
1739299|NCT00947349|6066483|P3|Overall Study Standard of Care|Other|0
1739300|NCT00947349|6066484|P2|Overall Study Standard of Care|Other|0
1739301|NCT00947349|6066485|P1|Overall Study Standard of Care|Other|0
1739302|NCT00947349|6066482|P4|Overall Study Standard of Care|Withdrawal by Subject|0
1739303|NCT00947349|6066483|P3|Overall Study Standard of Care|Withdrawal by Subject|1
1739304|NCT00947349|6066484|P2|Overall Study Standard of Care|Withdrawal by Subject|0
1739305|NCT00947349|6066485|P1|Overall Study Standard of Care|Withdrawal by Subject|0
1739306|NCT00947349|6066482|P4|Overall Study Standard of Care|Lack of Efficacy|1
1739307|NCT00947349|6066483|P3|Overall Study Standard of Care|Lack of Efficacy|1
1739308|NCT00947349|6066484|P2|Overall Study Standard of Care|Lack of Efficacy|0
1739309|NCT00947349|6066485|P1|Overall Study Standard of Care|Lack of Efficacy|0
1739310|NCT00947349|6066482|P4|Triple Treatment Combination Period|Adverse Event|0
1739311|NCT00947349|6066483|P3|Triple Treatment Combination Period|Adverse Event|0
1739312|NCT00947349|6066484|P2|Triple Treatment Combination Period|Adverse Event|1
1739313|NCT00947349|6066485|P1|Triple Treatment Combination Period|Adverse Event|0
1739314|NCT00947154|6066699|P1|Overall Study|Lost to Follow-up|1
1739315|NCT00947115|6066709|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
1739316|NCT00947115|6066710|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
1739317|NCT00947115|6066711|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
1739318|NCT00947115|6066709|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
1739319|NCT00947115|6066710|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
1739320|NCT00947115|6066711|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
1739321|NCT00947115|6066709|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
1739322|NCT00947115|6066710|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
1739323|NCT00947115|6066711|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
1739324|NCT00947115|6066709|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
1739325|NCT00947115|6066710|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
1739326|NCT00947115|6066711|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
1739327|NCT00947115|6066709|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
1739328|NCT00947115|6066710|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
1739329|NCT00947115|6066711|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
1739330|NCT00947115|6066709|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
1739331|NCT00947115|6066710|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
1739332|NCT00947115|6066711|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
1739333|NCT00947011|6066773|P1|Overall Study|Study was terminated,PI left institution|12
1739334|NCT00946998|6066783|P2|Overall Study|Exited prior to first outcome assessment|3
1739335|NCT00946998|6066784|P1|Overall Study|Exited prior to first outcome assessment|5
1739336|NCT00946985|6066798|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
1739337|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
1739338|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
1739339|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
1739340|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
1739341|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
1739342|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
1739343|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
1739344|NCT00946985|6066798|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
1739345|NCT00946920|6066804|P2|Overall Study|Miscellaneous reasons|3
1739346|NCT00946920|6066805|P1|Overall Study|Miscellaneous reasons|18
1739347|NCT00946920|6066804|P2|Overall Study|Protocol Violation|8
1739348|NCT00946920|6066805|P1|Overall Study|Protocol Violation|16
1739349|NCT00946920|6066804|P2|Overall Study|Adverse Event|14
1739350|NCT00946920|6066805|P1|Overall Study|Adverse Event|41
1739351|NCT00946920|6066804|P2|Overall Study|Physician Decision|2
1739352|NCT00946920|6066805|P1|Overall Study|Physician Decision|5
1739353|NCT00946920|6066804|P2|Overall Study|Lost to Follow-up|2
1739354|NCT00946920|6066805|P1|Overall Study|Lost to Follow-up|2
1739355|NCT00946920|6066804|P2|Overall Study|Withdrawal by Subject|15
1739356|NCT00946920|6066805|P1|Overall Study|Withdrawal by Subject|28
1739357|NCT00946881|6066820|P1|Retreatment|Withdrawal by Subject|1
1739358|NCT00946881|6066820|P1|First Treatment|Patient relocated to another state|1
1739359|NCT00946881|6066820|P1|First Treatment|Withdrawal by Subject|1
1739360|NCT00946712|6066851|P2|Overall Study|Ineligible|6
1739361|NCT00946712|6066852|P1|Overall Study|Ineligible|14
1739362|NCT00946712|6066851|P2|Overall Study|On Treatment|4
1739363|NCT00946712|6066852|P1|Overall Study|On Treatment|0
1739364|NCT00946712|6066851|P2|Overall Study|Other reasons|73
1739365|NCT00946712|6066852|P1|Overall Study|Other reasons|61
1739366|NCT00946712|6066851|P2|Overall Study|No treatment given|29
1739367|NCT00946712|6066852|P1|Overall Study|No treatment given|25
1739368|NCT00946712|6066851|P2|Overall Study|Death|22
1739369|NCT00946712|6066852|P1|Overall Study|Death|21
1739370|NCT00946712|6066851|P2|Overall Study|Disease progression|404
1739371|NCT00946712|6066852|P1|Overall Study|Disease progression|308
1739372|NCT00946712|6066851|P2|Overall Study|Adverse Event|124
1739373|NCT00946712|6066852|P1|Overall Study|Adverse Event|118
1739374|NCT00946530|6066876|P4|Overall Study|Physician Decision|1
1739375|NCT00946530|6066877|P3|Overall Study|Physician Decision|1
1739376|NCT00946530|6066878|P2|Overall Study|Physician Decision|1
1739377|NCT00946530|6066879|P1|Overall Study|Physician Decision|1
1739378|NCT00946530|6066876|P4|Overall Study|Withdrawal by Subject|3
1739379|NCT00946530|6066877|P3|Overall Study|Withdrawal by Subject|0
1739380|NCT00946530|6066878|P2|Overall Study|Withdrawal by Subject|3
1739381|NCT00946530|6066879|P1|Overall Study|Withdrawal by Subject|0
1739382|NCT00946322|6066911|P1|Post-treatment|participant failure to follow up|2
1739383|NCT00946322|6066911|P1|Pre-treatment|participant failure to follow up|1
1739384|NCT00946309|6066924|P2|Overall Study|Procedure cancelled/discontinued|3
1739385|NCT00946309|6066925|P1|Overall Study|Procedure cancelled/discontinued|0
1739386|NCT00946309|6066924|P2|Overall Study|Lost to Follow-up|1
1739387|NCT00946309|6066925|P1|Overall Study|Lost to Follow-up|0
1739388|NCT00946309|6066924|P2|Overall Study|Protocol Violation|0
1739389|NCT00946309|6066925|P1|Overall Study|Protocol Violation|1
1739390|NCT00946296|6066943|P2|Overall Study|Physician Decision|0
1739391|NCT00946296|6066944|P1|Overall Study|Physician Decision|3
1739392|NCT00946153|6066968|P5|Phase 2|14 days washout for recovery due to AE|4
1739393|NCT00946153|6066969|P4|Phase 2|14 days washout for recovery due to AE|0
1739394|NCT00946153|6066970|P3|Phase 2|14 days washout for recovery due to AE|0
1739395|NCT00946153|6066971|P2|Phase 2|14 days washout for recovery due to AE|0
1739396|NCT00946153|6066972|P1|Phase 2|14 days washout for recovery due to AE|0
1739397|NCT00946153|6066968|P5|Phase 2|Physician Decision|1
1739398|NCT00946153|6066969|P4|Phase 2|Physician Decision|0
1739399|NCT00946153|6066970|P3|Phase 2|Physician Decision|0
1739400|NCT00946153|6066971|P2|Phase 2|Physician Decision|0
1739401|NCT00946153|6066972|P1|Phase 2|Physician Decision|0
1739402|NCT00946153|6066968|P5|Phase 2|Need more reduction of dose|2
1739403|NCT00946153|6066969|P4|Phase 2|Need more reduction of dose|0
1739404|NCT00946153|6066970|P3|Phase 2|Need more reduction of dose|0
1739405|NCT00946153|6066971|P2|Phase 2|Need more reduction of dose|0
1739406|NCT00946153|6066972|P1|Phase 2|Need more reduction of dose|0
1739407|NCT00946153|6066968|P5|Phase 2|Adverse Event|6
1739408|NCT00946153|6066969|P4|Phase 2|Adverse Event|0
1739409|NCT00946153|6066970|P3|Phase 2|Adverse Event|0
1739410|NCT00946153|6066971|P2|Phase 2|Adverse Event|0
1739411|NCT00946153|6066972|P1|Phase 2|Adverse Event|0
1739412|NCT00946114|6067000|P2|Overall Study|Withdrawal by Subject|0
1739413|NCT00946114|6067001|P1|Overall Study|Withdrawal by Subject|2
1739414|NCT00946114|6067000|P2|Overall Study|Other|0
1739415|NCT00946114|6067001|P1|Overall Study|Other|1
1739416|NCT00946114|6067000|P2|Overall Study|Death|2
1739417|NCT00946114|6067001|P1|Overall Study|Death|5
1739418|NCT00946101|6067009|P2|Overall Study|Physician Decision|1
1739419|NCT00946101|6067010|P1|Overall Study|Physician Decision|0
1739420|NCT00946101|6067009|P2|Overall Study|Withdrawal of consent|0
1739421|NCT00946101|6067010|P1|Overall Study|Withdrawal of consent|2
1739422|NCT00946101|6067009|P2|Overall Study|Lost to Follow-up|1
1739423|NCT00946101|6067010|P1|Overall Study|Lost to Follow-up|2
1739424|NCT00946088|6067076|P2|Overall Study|Withdrawal by Subject|1
1739425|NCT00946088|6067077|P1|Overall Study|Withdrawal by Subject|0
1739426|NCT00945945|6067121|P2|Overall Study|Entry Criteria Not Met|1
1739427|NCT00945945|6067122|P1|Overall Study|Entry Criteria Not Met|0
1739428|NCT00945945|6067121|P2|Overall Study|Protocol Violation|2
1739429|NCT00945945|6067122|P1|Overall Study|Protocol Violation|4
1739430|NCT00945945|6067121|P2|Overall Study|Lack of Efficacy|2
1739431|NCT00945945|6067122|P1|Overall Study|Lack of Efficacy|6
1739432|NCT00945945|6067121|P2|Overall Study|Lost to Follow-up|5
1739433|NCT00945945|6067122|P1|Overall Study|Lost to Follow-up|4
1739434|NCT00945945|6067121|P2|Overall Study|Withdrawal by Subject|10
1739435|NCT00945945|6067122|P1|Overall Study|Withdrawal by Subject|7
1739436|NCT00945945|6067121|P2|Overall Study|Adverse Event|35
1739437|NCT00945945|6067122|P1|Overall Study|Adverse Event|15
1739438|NCT00945906|6067148|P1|Overall Study|Moved to another country|2
1739439|NCT00945906|6067148|P1|Overall Study|Unable to return for last visit|2
1739440|NCT00945906|6067148|P1|Overall Study|Did not want to return for last visit|2
1739441|NCT00945906|6067148|P1|Overall Study|Withdrawal by Subject|1
1739442|NCT00945893|6067159|P2|Overall Study|Withdrawal of consent|2
1739443|NCT00945893|6067160|P1|Overall Study|Withdrawal of consent|1
1739444|NCT00945893|6067159|P2|Overall Study|Lost to Follow-up|8
1739445|NCT00945893|6067160|P1|Overall Study|Lost to Follow-up|2
1739446|NCT00945815|6067237|P1|Overall Study|Did not begin protocol therapy|1
1739447|NCT00945815|6067237|P1|Overall Study|Ineligible|3
1739448|NCT00945815|6067237|P1|Overall Study|Not protocol specified|1
1739449|NCT00945815|6067237|P1|Overall Study|Death|3
1739450|NCT00945659|6067269|P3|Overall Study|Lost to Follow-up|17
1739451|NCT00945659|6067270|P2|Overall Study|Lost to Follow-up|20
1739452|NCT00945659|6067271|P1|Overall Study|Lost to Follow-up|7
1739453|NCT00945555|6067328|P1|Overall Study|Other|1
1739454|NCT00945555|6067328|P1|Overall Study|Death|18
1739455|NCT00945555|6067328|P1|Overall Study|Participant continued treatment at home|1
1739456|NCT00945555|6067328|P1|Overall Study|Withdrawal by Subject|2
1739457|NCT00945555|6067328|P1|Overall Study|Worsening condition, intensive care unit|1
1739458|NCT00945555|6067328|P1|Overall Study|Referred to another hospital|5
1739459|NCT00945477|6067339|P1|Overall Study|Withdrawal by Subject|1
1739460|NCT00945477|6067339|P1|Overall Study|Lack of Efficacy|2
1739461|NCT00945477|6067339|P1|Overall Study|Adverse Event|3
1739462|NCT00945321|6067355|P6|Period 4|Lost to Follow-up|1
1739463|NCT00945321|6067356|P5|Period 4|Lost to Follow-up|0
1739464|NCT00945321|6067357|P4|Period 4|Lost to Follow-up|0
1739465|NCT00945321|6067358|P3|Period 4|Lost to Follow-up|0
1739466|NCT00945321|6067359|P2|Period 4|Lost to Follow-up|0
1739467|NCT00945321|6067360|P1|Period 4|Lost to Follow-up|0
1739468|NCT00945321|6067355|P6|Period 1|Adverse Event|0
1739469|NCT00945321|6067356|P5|Period 1|Adverse Event|1
1739470|NCT00945321|6067357|P4|Period 1|Adverse Event|0
1739471|NCT00945321|6067358|P3|Period 1|Adverse Event|0
1739472|NCT00945321|6067359|P2|Period 1|Adverse Event|0
1739473|NCT00945321|6067360|P1|Period 1|Adverse Event|0
1739474|NCT00945243|6067493|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
1739475|NCT00945009|6067587|P3|Overall Study|Refusal of further protocol|0
1739476|NCT00945009|6067588|P2|Overall Study|Refusal of further protocol|0
1739477|NCT00945009|6067589|P1|Overall Study|Refusal of further protocol|1
1739478|NCT00945009|6067587|P3|Overall Study|Inevaluable|0
1739479|NCT00945009|6067588|P2|Overall Study|Inevaluable|1
1739480|NCT00945009|6067589|P1|Overall Study|Inevaluable|0
1739481|NCT00945009|6067587|P3|Overall Study|Ineligible|0
1739482|NCT00945009|6067588|P2|Overall Study|Ineligible|1
1739483|NCT00945009|6067589|P1|Overall Study|Ineligible|6
1739484|NCT00945009|6067587|P3|Overall Study|Withdrawal by Subject|0
1739485|NCT00945009|6067588|P2|Overall Study|Withdrawal by Subject|0
1739486|NCT00945009|6067589|P1|Overall Study|Withdrawal by Subject|1
1739487|NCT00945009|6067587|P3|Overall Study|Protocol Violation|0
1739488|NCT00945009|6067588|P2|Overall Study|Protocol Violation|1
1739489|NCT00945009|6067589|P1|Overall Study|Protocol Violation|6
1739490|NCT00945009|6067587|P3|Overall Study|Physician Decision|3
1739491|NCT00945009|6067588|P2|Overall Study|Physician Decision|4
1739492|NCT00945009|6067589|P1|Overall Study|Physician Decision|21
1739493|NCT00945009|6067587|P3|Overall Study|Lack of Efficacy|0
1739494|NCT00945009|6067588|P2|Overall Study|Lack of Efficacy|0
1739495|NCT00945009|6067589|P1|Overall Study|Lack of Efficacy|10
1739496|NCT00944697|6067665|P2|Overall Study|Administrative|1
1739497|NCT00944697|6067666|P1|Overall Study|Administrative|1
1739498|NCT00944697|6067665|P2|Overall Study|Adverse Event|3
1739499|NCT00944697|6067666|P1|Overall Study|Adverse Event|0
1739500|NCT00944697|6067665|P2|Overall Study|Withdrawal by Subject|1
1739501|NCT00944697|6067666|P1|Overall Study|Withdrawal by Subject|1
1739502|NCT00944658|6067698|P2|Treatment 12 Weeks|Adverse Event|2
1739503|NCT00944658|6067699|P1|Treatment 12 Weeks|Adverse Event|0
1739504|NCT00944645|6067711|P2|Period 2|Withdrawal by Subject|6
1739505|NCT00944645|6067712|P1|Period 2|Withdrawal by Subject|7
1739506|NCT00944645|6067711|P2|Period 2|Lost to Follow-up|3
1739507|NCT00944645|6067712|P1|Period 2|Lost to Follow-up|0
1739508|NCT00944645|6067711|P2|Period 2|Adverse Event|0
1739509|NCT00944645|6067712|P1|Period 2|Adverse Event|1
1739510|NCT00944229|6067759|P1|Overall Study|Physician Decision|14
1739511|NCT00944229|6067759|P1|Overall Study|Withdrawal by Subject|11
1739512|NCT00944125|6067765|P2|6 Months to Study Completion|Withdrawal by Subject|2
1739513|NCT00944125|6067766|P1|6 Months to Study Completion|Withdrawal by Subject|0
1739514|NCT00944125|6067765|P2|3 to 6 Months|Withdrawal by Subject|2
1739515|NCT00944125|6067766|P1|3 to 6 Months|Withdrawal by Subject|0
1739516|NCT00944034|6067869|P12|Overall Study|Administrative reason|0
1739517|NCT00944034|6067870|P11|Overall Study|Administrative reason|0
1739518|NCT00944034|6067871|P10|Overall Study|Administrative reason|0
1739519|NCT00944034|6067872|P9|Overall Study|Administrative reason|0
1739520|NCT00944034|6067873|P8|Overall Study|Administrative reason|0
1739521|NCT00944034|6067874|P7|Overall Study|Administrative reason|1
1739522|NCT00944034|6067875|P6|Overall Study|Administrative reason|0
1739523|NCT00944034|6067876|P5|Overall Study|Administrative reason|0
1739524|NCT00944034|6067877|P4|Overall Study|Administrative reason|0
1739525|NCT00944034|6067878|P3|Overall Study|Administrative reason|0
1739526|NCT00944034|6067879|P2|Overall Study|Administrative reason|0
1739527|NCT00944034|6067880|P1|Overall Study|Administrative reason|0
1739528|NCT00944034|6067869|P12|Overall Study|Unable to classify|0
1739529|NCT00944034|6067870|P11|Overall Study|Unable to classify|0
1739530|NCT00944034|6067871|P10|Overall Study|Unable to classify|0
1739531|NCT00944034|6067872|P9|Overall Study|Unable to classify|0
1739532|NCT00944034|6067873|P8|Overall Study|Unable to classify|1
1739533|NCT00944034|6067874|P7|Overall Study|Unable to classify|1
1739534|NCT00944034|6067875|P6|Overall Study|Unable to classify|1
1739535|NCT00944034|6067876|P5|Overall Study|Unable to classify|0
1739536|NCT00944034|6067877|P4|Overall Study|Unable to classify|0
1739537|NCT00944034|6067878|P3|Overall Study|Unable to classify|0
1739538|NCT00944034|6067879|P2|Overall Study|Unable to classify|0
1739539|NCT00944034|6067880|P1|Overall Study|Unable to classify|0
1739540|NCT00944034|6067869|P12|Overall Study|Protocol Violation|0
1739541|NCT00944034|6067870|P11|Overall Study|Protocol Violation|0
1739542|NCT00944034|6067871|P10|Overall Study|Protocol Violation|4
1739543|NCT00944034|6067872|P9|Overall Study|Protocol Violation|1
1739544|NCT00944034|6067873|P8|Overall Study|Protocol Violation|1
1739545|NCT00944034|6067874|P7|Overall Study|Protocol Violation|0
1739546|NCT00944034|6067875|P6|Overall Study|Protocol Violation|3
1739547|NCT00944034|6067876|P5|Overall Study|Protocol Violation|2
1739548|NCT00944034|6067877|P4|Overall Study|Protocol Violation|1
1739549|NCT00944034|6067878|P3|Overall Study|Protocol Violation|0
1739550|NCT00944034|6067879|P2|Overall Study|Protocol Violation|0
1739551|NCT00944034|6067880|P1|Overall Study|Protocol Violation|2
1739552|NCT00944034|6067869|P12|Overall Study|Death|0
1739553|NCT00944034|6067870|P11|Overall Study|Death|0
1739554|NCT00944034|6067871|P10|Overall Study|Death|0
1739555|NCT00944034|6067872|P9|Overall Study|Death|0
1739556|NCT00944034|6067873|P8|Overall Study|Death|0
1739557|NCT00944034|6067874|P7|Overall Study|Death|0
1739558|NCT00944034|6067875|P6|Overall Study|Death|0
1739559|NCT00944034|6067876|P5|Overall Study|Death|0
1739560|NCT00944034|6067877|P4|Overall Study|Death|0
1739561|NCT00944034|6067878|P3|Overall Study|Death|1
1739562|NCT00944034|6067879|P2|Overall Study|Death|0
1739563|NCT00944034|6067880|P1|Overall Study|Death|0
1739564|NCT00944034|6067869|P12|Overall Study|Lost to Follow-up|0
1739565|NCT00944034|6067870|P11|Overall Study|Lost to Follow-up|1
1739566|NCT00944034|6067871|P10|Overall Study|Lost to Follow-up|1
1739567|NCT00944034|6067872|P9|Overall Study|Lost to Follow-up|5
1739568|NCT00944034|6067873|P8|Overall Study|Lost to Follow-up|1
1739569|NCT00944034|6067874|P7|Overall Study|Lost to Follow-up|0
1739570|NCT00944034|6067875|P6|Overall Study|Lost to Follow-up|7
1739571|NCT00944034|6067876|P5|Overall Study|Lost to Follow-up|5
1739572|NCT00944034|6067877|P4|Overall Study|Lost to Follow-up|0
1739573|NCT00944034|6067878|P3|Overall Study|Lost to Follow-up|2
1739574|NCT00944034|6067879|P2|Overall Study|Lost to Follow-up|4
1739575|NCT00944034|6067880|P1|Overall Study|Lost to Follow-up|0
1739576|NCT00944034|6067869|P12|Overall Study|Withdrawal by Subject|4
1739577|NCT00944034|6067870|P11|Overall Study|Withdrawal by Subject|0
1739578|NCT00944034|6067871|P10|Overall Study|Withdrawal by Subject|4
1739579|NCT00944034|6067872|P9|Overall Study|Withdrawal by Subject|3
1739580|NCT00944034|6067873|P8|Overall Study|Withdrawal by Subject|2
1739581|NCT00944034|6067874|P7|Overall Study|Withdrawal by Subject|2
1739582|NCT00944034|6067875|P6|Overall Study|Withdrawal by Subject|8
1739583|NCT00944034|6067876|P5|Overall Study|Withdrawal by Subject|5
1739584|NCT00944034|6067877|P4|Overall Study|Withdrawal by Subject|2
1739585|NCT00944034|6067878|P3|Overall Study|Withdrawal by Subject|6
1739586|NCT00944034|6067879|P2|Overall Study|Withdrawal by Subject|2
1739587|NCT00944034|6067880|P1|Overall Study|Withdrawal by Subject|3
1739588|NCT00944034|6067869|P12|Overall Study|Inappropriate enrollment|0
1739589|NCT00944034|6067870|P11|Overall Study|Inappropriate enrollment|0
1739590|NCT00944034|6067871|P10|Overall Study|Inappropriate enrollment|1
1739591|NCT00944034|6067872|P9|Overall Study|Inappropriate enrollment|1
1739592|NCT00944034|6067873|P8|Overall Study|Inappropriate enrollment|0
1739593|NCT00944034|6067874|P7|Overall Study|Inappropriate enrollment|0
1739594|NCT00944034|6067875|P6|Overall Study|Inappropriate enrollment|1
1739595|NCT00944034|6067876|P5|Overall Study|Inappropriate enrollment|2
1739596|NCT00944034|6067877|P4|Overall Study|Inappropriate enrollment|1
1739597|NCT00944034|6067878|P3|Overall Study|Inappropriate enrollment|0
1739598|NCT00944034|6067879|P2|Overall Study|Inappropriate enrollment|1
1739599|NCT00944034|6067880|P1|Overall Study|Inappropriate enrollment|0
1739600|NCT00943917|6068026|P15|Stage II Continuation|A1C elevation|0
1739601|NCT00943917|6068027|P14|Stage II Continuation|A1C elevation|1
1739602|NCT00943917|6068028|P13|Stage II Continuation|A1C elevation|0
1739603|NCT00943917|6068029|P12|Stage II Continuation|A1C elevation|0
1739604|NCT00943917|6068030|P11|Stage II Continuation|A1C elevation|0
1739605|NCT00943917|6068031|P10|Stage II Continuation|A1C elevation|0
1739606|NCT00943917|6068032|P9|Stage II Continuation|A1C elevation|0
1739607|NCT00943917|6068033|P8|Stage II Continuation|A1C elevation|0
1739608|NCT00943917|6068034|P7|Stage II Continuation|A1C elevation|0
1739609|NCT00943917|6068035|P6|Stage II Continuation|A1C elevation|0
1739610|NCT00943917|6068036|P5|Stage II Continuation|A1C elevation|0
1739611|NCT00943917|6068037|P4|Stage II Continuation|A1C elevation|0
1739612|NCT00943917|6068038|P3|Stage II Continuation|A1C elevation|0
1739613|NCT00943917|6068039|P2|Stage II Continuation|A1C elevation|0
1739614|NCT00943917|6068040|P1|Stage II Continuation|A1C elevation|0
1739615|NCT00943917|6068026|P15|Stage II Continuation|hypoglycemia|0
1739616|NCT00943917|6068027|P14|Stage II Continuation|hypoglycemia|0
1739617|NCT00943917|6068028|P13|Stage II Continuation|hypoglycemia|1
1739618|NCT00943917|6068029|P12|Stage II Continuation|hypoglycemia|0
1739619|NCT00943917|6068030|P11|Stage II Continuation|hypoglycemia|0
1739620|NCT00943917|6068031|P10|Stage II Continuation|hypoglycemia|0
1739621|NCT00943917|6068032|P9|Stage II Continuation|hypoglycemia|0
1739622|NCT00943917|6068033|P8|Stage II Continuation|hypoglycemia|0
1739623|NCT00943917|6068034|P7|Stage II Continuation|hypoglycemia|0
1739624|NCT00943917|6068035|P6|Stage II Continuation|hypoglycemia|0
1739625|NCT00943917|6068036|P5|Stage II Continuation|hypoglycemia|0
1739626|NCT00943917|6068037|P4|Stage II Continuation|hypoglycemia|0
1739627|NCT00943917|6068038|P3|Stage II Continuation|hypoglycemia|0
1739628|NCT00943917|6068039|P2|Stage II Continuation|hypoglycemia|0
1739629|NCT00943917|6068040|P1|Stage II Continuation|hypoglycemia|0
1739630|NCT00943917|6068026|P15|Stage II Continuation|Protocol Violation|0
1739631|NCT00943917|6068027|P14|Stage II Continuation|Protocol Violation|0
1739632|NCT00943917|6068028|P13|Stage II Continuation|Protocol Violation|0
1739633|NCT00943917|6068029|P12|Stage II Continuation|Protocol Violation|1
1739634|NCT00943917|6068030|P11|Stage II Continuation|Protocol Violation|0
1739635|NCT00943917|6068031|P10|Stage II Continuation|Protocol Violation|1
1739636|NCT00943917|6068032|P9|Stage II Continuation|Protocol Violation|0
1739637|NCT00943917|6068033|P8|Stage II Continuation|Protocol Violation|0
1739638|NCT00943917|6068034|P7|Stage II Continuation|Protocol Violation|0
1739639|NCT00943917|6068035|P6|Stage II Continuation|Protocol Violation|0
1739640|NCT00943917|6068036|P5|Stage II Continuation|Protocol Violation|0
1739641|NCT00943917|6068037|P4|Stage II Continuation|Protocol Violation|0
1739642|NCT00943917|6068038|P3|Stage II Continuation|Protocol Violation|0
1739643|NCT00943917|6068039|P2|Stage II Continuation|Protocol Violation|0
1739644|NCT00943917|6068040|P1|Stage II Continuation|Protocol Violation|0
1739645|NCT00943917|6068026|P15|Stage II Continuation|Withdrawal by Subject|3
1739646|NCT00943917|6068027|P14|Stage II Continuation|Withdrawal by Subject|1
1739647|NCT00943917|6068028|P13|Stage II Continuation|Withdrawal by Subject|0
1739648|NCT00943917|6068029|P12|Stage II Continuation|Withdrawal by Subject|0
1739649|NCT00943917|6068030|P11|Stage II Continuation|Withdrawal by Subject|0
1739650|NCT00943917|6068031|P10|Stage II Continuation|Withdrawal by Subject|0
1739651|NCT00943917|6068032|P9|Stage II Continuation|Withdrawal by Subject|0
1739652|NCT00943917|6068033|P8|Stage II Continuation|Withdrawal by Subject|0
1739653|NCT00943917|6068034|P7|Stage II Continuation|Withdrawal by Subject|0
1739654|NCT00943917|6068035|P6|Stage II Continuation|Withdrawal by Subject|0
1739655|NCT00943917|6068036|P5|Stage II Continuation|Withdrawal by Subject|0
1739656|NCT00943917|6068037|P4|Stage II Continuation|Withdrawal by Subject|0
1739657|NCT00943917|6068038|P3|Stage II Continuation|Withdrawal by Subject|0
1739658|NCT00943917|6068039|P2|Stage II Continuation|Withdrawal by Subject|0
1739659|NCT00943917|6068040|P1|Stage II Continuation|Withdrawal by Subject|0
1739660|NCT00943917|6068026|P15|Stage II Continuation|Adverse Event|1
1739661|NCT00943917|6068027|P14|Stage II Continuation|Adverse Event|1
1739662|NCT00943917|6068028|P13|Stage II Continuation|Adverse Event|2
1739663|NCT00943917|6068029|P12|Stage II Continuation|Adverse Event|1
1739664|NCT00943917|6068030|P11|Stage II Continuation|Adverse Event|0
1739665|NCT00943917|6068031|P10|Stage II Continuation|Adverse Event|0
1739666|NCT00943917|6068032|P9|Stage II Continuation|Adverse Event|0
1739667|NCT00943917|6068033|P8|Stage II Continuation|Adverse Event|0
1739668|NCT00943917|6068034|P7|Stage II Continuation|Adverse Event|0
1739669|NCT00943917|6068035|P6|Stage II Continuation|Adverse Event|0
1739670|NCT00943917|6068036|P5|Stage II Continuation|Adverse Event|0
1739671|NCT00943917|6068037|P4|Stage II Continuation|Adverse Event|0
1739672|NCT00943917|6068038|P3|Stage II Continuation|Adverse Event|0
1739673|NCT00943917|6068039|P2|Stage II Continuation|Adverse Event|0
1739674|NCT00943917|6068040|P1|Stage II Continuation|Adverse Event|0
1739675|NCT00943917|6068026|P15|Stage II|Pregnancy|0
1739676|NCT00943917|6068027|P14|Stage II|Pregnancy|0
1739677|NCT00943917|6068028|P13|Stage II|Pregnancy|0
1739678|NCT00943917|6068029|P12|Stage II|Pregnancy|0
1739679|NCT00943917|6068030|P11|Stage II|Pregnancy|0
1739680|NCT00943917|6068031|P10|Stage II|Pregnancy|0
1739681|NCT00943917|6068032|P9|Stage II|Pregnancy|0
1739682|NCT00943917|6068033|P8|Stage II|Pregnancy|0
1739683|NCT00943917|6068034|P7|Stage II|Pregnancy|0
1739684|NCT00943917|6068035|P6|Stage II|Pregnancy|1
1739685|NCT00943917|6068036|P5|Stage II|Pregnancy|0
1739686|NCT00943917|6068037|P4|Stage II|Pregnancy|0
1739687|NCT00943917|6068038|P3|Stage II|Pregnancy|0
1739688|NCT00943917|6068039|P2|Stage II|Pregnancy|0
1739689|NCT00943917|6068040|P1|Stage II|Pregnancy|0
1739690|NCT00943917|6068026|P15|Stage II|Withdrawal by Subject|0
1739691|NCT00943917|6068027|P14|Stage II|Withdrawal by Subject|0
1739692|NCT00943917|6068028|P13|Stage II|Withdrawal by Subject|0
1739693|NCT00943917|6068029|P12|Stage II|Withdrawal by Subject|0
1739694|NCT00943917|6068030|P11|Stage II|Withdrawal by Subject|0
1739695|NCT00943917|6068031|P10|Stage II|Withdrawal by Subject|0
1739696|NCT00943917|6068032|P9|Stage II|Withdrawal by Subject|0
1739697|NCT00943917|6068033|P8|Stage II|Withdrawal by Subject|0
1739698|NCT00943917|6068034|P7|Stage II|Withdrawal by Subject|0
1739699|NCT00943917|6068035|P6|Stage II|Withdrawal by Subject|1
1739700|NCT00943917|6068036|P5|Stage II|Withdrawal by Subject|0
1739701|NCT00943917|6068037|P4|Stage II|Withdrawal by Subject|0
1739702|NCT00943917|6068038|P3|Stage II|Withdrawal by Subject|0
1739703|NCT00943917|6068039|P2|Stage II|Withdrawal by Subject|0
1739704|NCT00943917|6068040|P1|Stage II|Withdrawal by Subject|0
1739705|NCT00943917|6068026|P15|Stage II|Adverse Event|0
1739706|NCT00943917|6068027|P14|Stage II|Adverse Event|0
1739707|NCT00943917|6068028|P13|Stage II|Adverse Event|0
1739708|NCT00943917|6068029|P12|Stage II|Adverse Event|0
1739709|NCT00943917|6068030|P11|Stage II|Adverse Event|0
1739710|NCT00943917|6068031|P10|Stage II|Adverse Event|0
1739711|NCT00943917|6068032|P9|Stage II|Adverse Event|1
1739712|NCT00943917|6068033|P8|Stage II|Adverse Event|0
1739713|NCT00943917|6068034|P7|Stage II|Adverse Event|3
1739714|NCT00943917|6068035|P6|Stage II|Adverse Event|1
1739715|NCT00943917|6068036|P5|Stage II|Adverse Event|0
1739716|NCT00943917|6068037|P4|Stage II|Adverse Event|0
1739717|NCT00943917|6068038|P3|Stage II|Adverse Event|0
1739718|NCT00943917|6068039|P2|Stage II|Adverse Event|0
1739719|NCT00943917|6068040|P1|Stage II|Adverse Event|0
1739720|NCT00943917|6068026|P15|Stage I|Withdrawal by Subject|0
1739721|NCT00943917|6068027|P14|Stage I|Withdrawal by Subject|0
1739722|NCT00943917|6068028|P13|Stage I|Withdrawal by Subject|0
1739723|NCT00943917|6068029|P12|Stage I|Withdrawal by Subject|0
1739724|NCT00943917|6068030|P11|Stage I|Withdrawal by Subject|0
1739725|NCT00943917|6068031|P10|Stage I|Withdrawal by Subject|0
1739726|NCT00943917|6068032|P9|Stage I|Withdrawal by Subject|0
1739727|NCT00943917|6068033|P8|Stage I|Withdrawal by Subject|0
1739728|NCT00943917|6068034|P7|Stage I|Withdrawal by Subject|0
1739729|NCT00943917|6068035|P6|Stage I|Withdrawal by Subject|0
1739730|NCT00943917|6068036|P5|Stage I|Withdrawal by Subject|0
1739731|NCT00943917|6068037|P4|Stage I|Withdrawal by Subject|0
1739732|NCT00943917|6068038|P3|Stage I|Withdrawal by Subject|2
1739733|NCT00943917|6068039|P2|Stage I|Withdrawal by Subject|1
1739734|NCT00943917|6068040|P1|Stage I|Withdrawal by Subject|2
1739735|NCT00943917|6068026|P15|Stage I|A1C elevation|0
1739736|NCT00943917|6068027|P14|Stage I|A1C elevation|0
1739737|NCT00943917|6068028|P13|Stage I|A1C elevation|0
1739738|NCT00943917|6068029|P12|Stage I|A1C elevation|0
1739739|NCT00943917|6068030|P11|Stage I|A1C elevation|0
1739740|NCT00943917|6068031|P10|Stage I|A1C elevation|0
1739741|NCT00943917|6068032|P9|Stage I|A1C elevation|0
1739742|NCT00943917|6068033|P8|Stage I|A1C elevation|0
1739743|NCT00943917|6068034|P7|Stage I|A1C elevation|0
1739744|NCT00943917|6068035|P6|Stage I|A1C elevation|0
1739745|NCT00943917|6068036|P5|Stage I|A1C elevation|0
1739746|NCT00943917|6068037|P4|Stage I|A1C elevation|0
1739747|NCT00943917|6068038|P3|Stage I|A1C elevation|0
1739748|NCT00943917|6068039|P2|Stage I|A1C elevation|0
1739749|NCT00943917|6068040|P1|Stage I|A1C elevation|1
1739750|NCT00943917|6068026|P15|Stage I|hyperglycemia|0
1739751|NCT00943917|6068027|P14|Stage I|hyperglycemia|0
1739752|NCT00943917|6068028|P13|Stage I|hyperglycemia|0
1739753|NCT00943917|6068029|P12|Stage I|hyperglycemia|0
1739754|NCT00943917|6068030|P11|Stage I|hyperglycemia|0
1739755|NCT00943917|6068031|P10|Stage I|hyperglycemia|0
1739756|NCT00943917|6068032|P9|Stage I|hyperglycemia|0
1739757|NCT00943917|6068033|P8|Stage I|hyperglycemia|0
1739758|NCT00943917|6068034|P7|Stage I|hyperglycemia|0
1739759|NCT00943917|6068035|P6|Stage I|hyperglycemia|0
1739760|NCT00943917|6068036|P5|Stage I|hyperglycemia|0
1739761|NCT00943917|6068037|P4|Stage I|hyperglycemia|0
1739762|NCT00943917|6068038|P3|Stage I|hyperglycemia|1
1739763|NCT00943917|6068039|P2|Stage I|hyperglycemia|0
1739764|NCT00943917|6068040|P1|Stage I|hyperglycemia|0
1739765|NCT00943917|6068026|P15|Stage I|Lost to Follow-up|0
1739766|NCT00943917|6068027|P14|Stage I|Lost to Follow-up|0
1739767|NCT00943917|6068028|P13|Stage I|Lost to Follow-up|0
1739768|NCT00943917|6068029|P12|Stage I|Lost to Follow-up|0
1739769|NCT00943917|6068030|P11|Stage I|Lost to Follow-up|0
1739770|NCT00943917|6068031|P10|Stage I|Lost to Follow-up|0
1739771|NCT00943917|6068032|P9|Stage I|Lost to Follow-up|0
1739772|NCT00943917|6068033|P8|Stage I|Lost to Follow-up|0
1739773|NCT00943917|6068034|P7|Stage I|Lost to Follow-up|0
1739774|NCT00943917|6068035|P6|Stage I|Lost to Follow-up|0
1739775|NCT00943917|6068036|P5|Stage I|Lost to Follow-up|0
1739776|NCT00943917|6068037|P4|Stage I|Lost to Follow-up|0
1739777|NCT00943917|6068038|P3|Stage I|Lost to Follow-up|1
1739778|NCT00943917|6068039|P2|Stage I|Lost to Follow-up|0
1739779|NCT00943917|6068040|P1|Stage I|Lost to Follow-up|0
1739780|NCT00943917|6068026|P15|Stage I|Adverse Event|0
1739781|NCT00943917|6068027|P14|Stage I|Adverse Event|0
1739782|NCT00943917|6068028|P13|Stage I|Adverse Event|0
1739783|NCT00943917|6068029|P12|Stage I|Adverse Event|0
1739784|NCT00943917|6068030|P11|Stage I|Adverse Event|0
1739785|NCT00943917|6068031|P10|Stage I|Adverse Event|0
1739786|NCT00943917|6068032|P9|Stage I|Adverse Event|0
1739787|NCT00943917|6068033|P8|Stage I|Adverse Event|0
1739788|NCT00943917|6068034|P7|Stage I|Adverse Event|0
1739789|NCT00943917|6068035|P6|Stage I|Adverse Event|0
1739790|NCT00943917|6068036|P5|Stage I|Adverse Event|0
1739791|NCT00943917|6068037|P4|Stage I|Adverse Event|0
1739792|NCT00943917|6068038|P3|Stage I|Adverse Event|2
1739793|NCT00943917|6068039|P2|Stage I|Adverse Event|2
1739794|NCT00943917|6068040|P1|Stage I|Adverse Event|1
1739795|NCT00943852|6068216|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
1739796|NCT00943852|6068217|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
1739797|NCT00943852|6068218|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
1739798|NCT00943852|6068219|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
1739799|NCT00943852|6068220|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
1739800|NCT00943852|6068221|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
1739801|NCT00943852|6068222|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
1739802|NCT00943852|6068223|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
1739803|NCT00943852|6068224|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
1739804|NCT00943852|6068225|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
1739805|NCT00943852|6068216|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739806|NCT00943852|6068217|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739807|NCT00943852|6068218|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
1739808|NCT00943852|6068219|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739809|NCT00943852|6068220|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739810|NCT00943852|6068221|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739811|NCT00943852|6068222|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739812|NCT00943852|6068223|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739813|NCT00943852|6068224|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739814|NCT00943852|6068225|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
1739815|NCT00943852|6068216|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739816|NCT00943852|6068217|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739817|NCT00943852|6068218|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739818|NCT00943852|6068219|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
1739819|NCT00943852|6068220|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739820|NCT00943852|6068221|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739821|NCT00943852|6068222|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739822|NCT00943852|6068223|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739823|NCT00943852|6068224|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739824|NCT00943852|6068225|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
1739825|NCT00943852|6068216|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
1739826|NCT00943852|6068217|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
1739827|NCT00943852|6068218|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
1739828|NCT00943852|6068219|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
1739829|NCT00943852|6068220|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
1739830|NCT00943852|6068221|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
1739831|NCT00943852|6068222|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
1739832|NCT00943852|6068223|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
1739833|NCT00943852|6068224|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
1739834|NCT00943852|6068225|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
1739835|NCT00943852|6068216|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739836|NCT00943852|6068217|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739837|NCT00943852|6068218|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739838|NCT00943852|6068219|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739839|NCT00943852|6068220|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739840|NCT00943852|6068221|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739841|NCT00943852|6068222|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
1739842|NCT00943852|6068223|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739843|NCT00943852|6068224|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739844|NCT00943852|6068225|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
1739845|NCT00943826|6068238|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
1739846|NCT00943826|6068239|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
1739847|NCT00943826|6068238|P2|After Primary Overall Survival Analysis|Progression of Disease|4
1739848|NCT00943826|6068239|P1|After Primary Overall Survival Analysis|Progression of Disease|2
1739849|NCT00943826|6068238|P2|After Primary Overall Survival Analysis|Administrative reasons|16
1739850|NCT00943826|6068239|P1|After Primary Overall Survival Analysis|Administrative reasons|10
1739851|NCT00943826|6068238|P2|After Primary Overall Survival Analysis|Adverse Event|0
1739852|NCT00943826|6068239|P1|After Primary Overall Survival Analysis|Adverse Event|11
1739853|NCT00943826|6068238|P2|Monotherapy Phase|Failure to return|1
1739854|NCT00943826|6068239|P1|Monotherapy Phase|Failure to return|2
1739855|NCT00943826|6068238|P2|Monotherapy Phase|Withdrew Consent|3
1739856|NCT00943826|6068239|P1|Monotherapy Phase|Withdrew Consent|2
1739857|NCT00943826|6068238|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
1739858|NCT00943826|6068239|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
1739859|NCT00943826|6068238|P2|Monotherapy Phase|Administrative reasons|5
1739860|NCT00943826|6068239|P1|Monotherapy Phase|Administrative reasons|11
1739861|NCT00943826|6068238|P2|Monotherapy Phase|Adverse Event|5
1739862|NCT00943826|6068239|P1|Monotherapy Phase|Adverse Event|42
1739863|NCT00943826|6068238|P2|Maintenance Phase|Failure to return|1
1739864|NCT00943826|6068239|P1|Maintenance Phase|Failure to return|0
1739865|NCT00943826|6068238|P2|Maintenance Phase|Administrative reasons|1
1739866|NCT00943826|6068239|P1|Maintenance Phase|Administrative reasons|4
1739867|NCT00943826|6068238|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
1739868|NCT00943826|6068239|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
1739869|NCT00943826|6068238|P2|Maintenance Phase|Withdrew consent|4
1739870|NCT00943826|6068239|P1|Maintenance Phase|Withdrew consent|2
1739871|NCT00943826|6068238|P2|Maintenance Phase|Adverse Event|30
1739872|NCT00943826|6068239|P1|Maintenance Phase|Adverse Event|31
1739873|NCT00943826|6068238|P2|Concurrent Phase|Protocol Violation|0
1739874|NCT00943826|6068239|P1|Concurrent Phase|Protocol Violation|1
1739875|NCT00943826|6068238|P2|Concurrent Phase|Administrative reasons|1
1739876|NCT00943826|6068239|P1|Concurrent Phase|Administrative reasons|2
1739877|NCT00943826|6068238|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
1739878|NCT00943826|6068239|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
1739879|NCT00943826|6068238|P2|Concurrent Phase|Withdrew consent|7
1739880|NCT00943826|6068239|P1|Concurrent Phase|Withdrew consent|3
1739881|NCT00943826|6068238|P2|Concurrent Phase|Adverse Event|27
1739882|NCT00943826|6068239|P1|Concurrent Phase|Adverse Event|50
1739883|NCT00943787|6068257|P1|Overall Study|Withdrawal by Subject|3
1739884|NCT00943787|6068257|P1|Overall Study|Physician Decision|4
1739885|NCT00943761|6068264|P2|Overall Study|Withdrawal by Subject|1
1739886|NCT00943761|6068265|P1|Overall Study|Withdrawal by Subject|2
1739887|NCT00943761|6068264|P2|Overall Study|Lost to Follow-up|0
1739888|NCT00943761|6068265|P1|Overall Study|Lost to Follow-up|2
1739889|NCT00943735|6068277|P1|Overall Study|Other|3
1739890|NCT00943735|6068277|P1|Overall Study|Other|8
1739891|NCT00943735|6068277|P1|Overall Study|Death|1
1739892|NCT00943735|6068277|P1|Overall Study|Withdrawal by Subject|8
1739893|NCT00943735|6068277|P1|Overall Study|Adverse Event|12
1739894|NCT00943722|6068315|P5|Overall Study|Withdrawal by Subject|8
1739895|NCT00943722|6068316|P4|Overall Study|Withdrawal by Subject|13
1739896|NCT00943722|6068317|P3|Overall Study|Withdrawal by Subject|2
1739897|NCT00943722|6068318|P2|Overall Study|Withdrawal by Subject|13
1739898|NCT00943722|6068319|P1|Overall Study|Withdrawal by Subject|12
1739899|NCT00943722|6068315|P5|Overall Study|Protocol Violation|2
1739900|NCT00943722|6068316|P4|Overall Study|Protocol Violation|0
1739901|NCT00943722|6068317|P3|Overall Study|Protocol Violation|0
1739902|NCT00943722|6068318|P2|Overall Study|Protocol Violation|1
1739903|NCT00943722|6068319|P1|Overall Study|Protocol Violation|0
1739904|NCT00943722|6068315|P5|Overall Study|Pregnancy|0
1739905|NCT00943722|6068316|P4|Overall Study|Pregnancy|0
1739906|NCT00943722|6068317|P3|Overall Study|Pregnancy|1
1739907|NCT00943722|6068318|P2|Overall Study|Pregnancy|0
1739908|NCT00943722|6068319|P1|Overall Study|Pregnancy|0
1739909|NCT00943722|6068315|P5|Overall Study|Physician Decision|1
1739910|NCT00943722|6068316|P4|Overall Study|Physician Decision|0
1739911|NCT00943722|6068317|P3|Overall Study|Physician Decision|0
1739912|NCT00943722|6068318|P2|Overall Study|Physician Decision|0
1739913|NCT00943722|6068319|P1|Overall Study|Physician Decision|1
1739914|NCT00943722|6068315|P5|Overall Study|Lost to Follow-up|11
1739915|NCT00943722|6068316|P4|Overall Study|Lost to Follow-up|8
1739916|NCT00943722|6068317|P3|Overall Study|Lost to Follow-up|10
1739917|NCT00943722|6068318|P2|Overall Study|Lost to Follow-up|8
1739918|NCT00943722|6068319|P1|Overall Study|Lost to Follow-up|12
1739919|NCT00943722|6068315|P5|Overall Study|Adverse Event|0
1739920|NCT00943722|6068316|P4|Overall Study|Adverse Event|1
1739921|NCT00943722|6068317|P3|Overall Study|Adverse Event|0
1739922|NCT00943722|6068318|P2|Overall Study|Adverse Event|0
1739923|NCT00943722|6068319|P1|Overall Study|Adverse Event|0
1739924|NCT00943683|6068349|P2|Overall Study|Patient Moved|0
1739925|NCT00943683|6068350|P1|Overall Study|Patient Moved|1
1739926|NCT00943683|6068349|P2|Overall Study|Withdrawal by Subject|0
1739927|NCT00943683|6068350|P1|Overall Study|Withdrawal by Subject|1
1739928|NCT00943683|6068349|P2|Overall Study|Protocol Violation|2
1739929|NCT00943683|6068350|P1|Overall Study|Protocol Violation|1
1739930|NCT00943683|6068349|P2|Overall Study|Lost to Follow-up|1
1739931|NCT00943683|6068350|P1|Overall Study|Lost to Follow-up|1
1739932|NCT00943683|6068349|P2|Overall Study|Adverse Event|3
1739933|NCT00943683|6068350|P1|Overall Study|Adverse Event|3
1739934|NCT00943670|6068356|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
1739935|NCT00943670|6068356|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
1739936|NCT00943670|6068356|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
1739937|NCT00943670|6068356|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
1739938|NCT00943670|6068356|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
1739939|NCT00943670|6068356|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
1739940|NCT00943670|6068356|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
1739941|NCT00943670|6068356|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
1739942|NCT00943670|6068356|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
1739943|NCT00943670|6068356|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
1739944|NCT00943605|6068445|P2|Overall Study|Study termination|30
1739945|NCT00943605|6068446|P1|Overall Study|Study termination|30
1739946|NCT00943592|6068456|P1|Overall Study|Death|3
1739947|NCT00943579|6068469|P2|Overall Study|Lack of Efficacy|2
1739948|NCT00943579|6068470|P1|Overall Study|Lack of Efficacy|2
1739949|NCT00943579|6068469|P2|Overall Study|Adverse Event|3
1739950|NCT00943579|6068470|P1|Overall Study|Adverse Event|4
1739951|NCT00943397|6068571|P2|Overall Study|Site terminated and other|56
1739952|NCT00943397|6068572|P1|Overall Study|Site terminated and other|12
1739953|NCT00943397|6068571|P2|Overall Study|Withdrawal by Subject|1
1739954|NCT00943397|6068572|P1|Overall Study|Withdrawal by Subject|1
1739955|NCT00943397|6068571|P2|Overall Study|Protocol Violation|5
1739956|NCT00943397|6068572|P1|Overall Study|Protocol Violation|2
1739957|NCT00943397|6068571|P2|Overall Study|Lost to Follow-up|4
1739958|NCT00943397|6068572|P1|Overall Study|Lost to Follow-up|0
1739959|NCT00943397|6068571|P2|Overall Study|Adverse Event|6
1739960|NCT00943397|6068572|P1|Overall Study|Adverse Event|0
1739961|NCT00943384|6068578|P1|Overall Study|Withdrawal by Subject|5
1739962|NCT00943384|6068578|P1|Overall Study|Lost to Follow-up|16
1739963|NCT00943384|6068578|P1|Overall Study|Treated off protocol-protocol violation|5
1739964|NCT00943384|6068578|P1|Overall Study|Dispositioned prior to treatment|23
1739965|NCT00943319|6068592|P1|Overall Study|Death|1
1739966|NCT00943306|6068598|P1|Overall Study|Sponsor decision due to non-compliance|1
1739967|NCT00943306|6068598|P1|Overall Study|Death|1
1739968|NCT00943306|6068598|P1|Overall Study|Physician Decision|1
1739969|NCT00943124|6068900|P2|Period 1|Personal Reasons|1
1739970|NCT00943124|6068901|P1|Period 1|Personal Reasons|0
1739971|NCT00943124|6068900|P2|Period 1|Did Not Follow Study Procedures|0
1739972|NCT00943124|6068901|P1|Period 1|Did Not Follow Study Procedures|1
1739973|NCT00943124|6068900|P2|Period 1|Withdrawal by Subject|1
1739974|NCT00943124|6068901|P1|Period 1|Withdrawal by Subject|1
1739975|NCT00943111|6068923|P3|5 Years Long-term Treatment Period|Other than specified above|2
1739976|NCT00943111|6068924|P2|5 Years Long-term Treatment Period|Other than specified above|0
1739977|NCT00943111|6068925|P1|5 Years Long-term Treatment Period|Other than specified above|0
1739978|NCT00943111|6068923|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
1739979|NCT00943111|6068924|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
1739980|NCT00943111|6068925|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
1739981|NCT00943111|6068923|P3|5 Years Long-term Treatment Period|Pregnancy|4
1739982|NCT00943111|6068924|P2|5 Years Long-term Treatment Period|Pregnancy|0
1739983|NCT00943111|6068925|P1|5 Years Long-term Treatment Period|Pregnancy|0
1739984|NCT00943111|6068923|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
1739985|NCT00943111|6068924|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
1739986|NCT00943111|6068925|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
1739987|NCT00943111|6068923|P3|5 Years Long-term Treatment Period|Adverse Event|9
1739988|NCT00943111|6068924|P2|5 Years Long-term Treatment Period|Adverse Event|0
1739989|NCT00943111|6068925|P1|5 Years Long-term Treatment Period|Adverse Event|0
1739990|NCT00943111|6068923|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
1739991|NCT00943111|6068924|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
1739992|NCT00943111|6068925|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
1739993|NCT00943111|6068923|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
1739994|NCT00943111|6068924|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
1739995|NCT00943111|6068925|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
1739996|NCT00943111|6068923|P3|52-Weeks Primary Analysis Period|Adverse Event|0
1739997|NCT00943111|6068924|P2|52-Weeks Primary Analysis Period|Adverse Event|1
1739998|NCT00943111|6068925|P1|52-Weeks Primary Analysis Period|Adverse Event|2
1739999|NCT00943072|6068993|P2|Overall Study|Other|1
1740000|NCT00943072|6068994|P1|Overall Study|Other|1
1740001|NCT00943072|6068993|P2|Overall Study|Lack of Efficacy|4
1740002|NCT00943072|6068994|P1|Overall Study|Lack of Efficacy|0
1740003|NCT00943072|6068993|P2|Overall Study|Lost to Follow-up|2
1740004|NCT00943072|6068994|P1|Overall Study|Lost to Follow-up|1
1740005|NCT00943072|6068993|P2|Overall Study|Protocol Violation|1
1740006|NCT00943072|6068994|P1|Overall Study|Protocol Violation|0
1740007|NCT00943072|6068993|P2|Overall Study|Withdrawal by Subject|1
1740008|NCT00943072|6068994|P1|Overall Study|Withdrawal by Subject|3
1740009|NCT00943072|6068993|P2|Overall Study|Death|2
1740010|NCT00943072|6068994|P1|Overall Study|Death|0
1740011|NCT00943072|6068993|P2|Overall Study|Adverse Event|3
1740012|NCT00943072|6068994|P1|Overall Study|Adverse Event|0
1740013|NCT00942994|6069012|P2|Overall Study|Protocol deviation|2
1740014|NCT00942994|6069013|P1|Overall Study|Protocol deviation|1
1740015|NCT00942994|6069012|P2|Overall Study|Lost to Follow-up|4
1740016|NCT00942994|6069013|P1|Overall Study|Lost to Follow-up|1
1740017|NCT00942994|6069012|P2|Overall Study|Patient withdrew consent|8
1740018|NCT00942994|6069013|P1|Overall Study|Patient withdrew consent|5
1740019|NCT00942994|6069012|P2|Overall Study|Unsatisfactory therapeutic effect|1
1740020|NCT00942994|6069013|P1|Overall Study|Unsatisfactory therapeutic effect|1
1740021|NCT00942994|6069012|P2|Overall Study|Abnormal laboratory value(s)|0
1740022|NCT00942994|6069013|P1|Overall Study|Abnormal laboratory value(s)|1
1740023|NCT00942994|6069012|P2|Overall Study|Adverse Event|4
1740024|NCT00942994|6069013|P1|Overall Study|Adverse Event|7
1740025|NCT00942968|6069029|P1|Overall Study|Deep vein thrombosis (DVT)|2
1740026|NCT00942968|6069029|P1|Overall Study|Participant required pancreatic biopsy|1
1740027|NCT00942968|6069029|P1|Overall Study|Pulmonary embolism (PE)|1
1740028|NCT00942968|6069029|P1|Overall Study|Inferior vena cava filter placement|4
1740029|NCT00942968|6069029|P1|Overall Study|Progression of disease|12
1740030|NCT00942968|6069029|P1|Overall Study|Physician Decision|11
1740031|NCT00942968|6069029|P1|Overall Study|Sponsor request|5
1740032|NCT00942968|6069029|P1|Overall Study|Withdrawal by Subject|44
1740033|NCT00942968|6069029|P1|Overall Study|Lost to Follow-up|4
1740034|NCT00942968|6069029|P1|Overall Study|Protocol Violation|9
1740035|NCT00942968|6069029|P1|Overall Study|Death|76
1740036|NCT00942968|6069029|P1|Overall Study|Adverse Event|60
1740037|NCT00942734|6069107|P1|Overall Study|Physician Decision|1
1740038|NCT00942734|6069107|P1|Overall Study|Disease Progression|2
1740039|NCT00942734|6069107|P1|Overall Study|Protocol Violation|3
1740040|NCT00942734|6069107|P1|Overall Study|Adverse Event|2
1740041|NCT00942708|6069111|P1|Overall Study|Withdrawal by Subject|1
1740042|NCT00942604|6069119|P2|Overall Study|Patient relocation|1
1740043|NCT00942604|6069120|P1|Overall Study|Patient relocation|1
1740044|NCT00942604|6069119|P2|Overall Study|Withdrawal by Subject|1
1740045|NCT00942604|6069120|P1|Overall Study|Withdrawal by Subject|0
1740046|NCT00942604|6069119|P2|Overall Study|Adverse Event|1
1740047|NCT00942604|6069120|P1|Overall Study|Adverse Event|0
1740048|NCT00942604|6069119|P2|Overall Study|Protocol Violation|1
1740049|NCT00942604|6069120|P1|Overall Study|Protocol Violation|1
1740050|NCT00942422|6069228|P1|Overall Study|Progressive diease|1
1740051|NCT00942422|6069228|P1|Overall Study|Death|1
1740052|NCT00942422|6069228|P1|Overall Study|Withdrawal by Subject|1
1740053|NCT00942409|6069232|P1|Overall Study|study drug unavailable|2
1740054|NCT00942409|6069232|P1|Overall Study|Lack of Efficacy|1
1740055|NCT00942357|6069238|P2|Overall Study|Ineligible|40
1740056|NCT00942357|6069239|P1|Overall Study|Ineligible|37
1740059|NCT00942266|6069266|P2|Overall Study|medical deterioration (pneumonia)|1
1740060|NCT00942266|6069267|P1|Overall Study|medical deterioration (pneumonia)|0
1740061|NCT00942266|6069266|P2|Overall Study|Physician Decision|0
1740062|NCT00942266|6069267|P1|Overall Study|Physician Decision|2
1740063|NCT00942266|6069266|P2|Overall Study|Intercurrent illness|1
1740064|NCT00942266|6069267|P1|Overall Study|Intercurrent illness|0
1740065|NCT00942266|6069266|P2|Overall Study|Failure to thrive and pt withdrawal|1
1740066|NCT00942266|6069267|P1|Overall Study|Failure to thrive and pt withdrawal|0
1740067|NCT00942266|6069266|P2|Overall Study|Disease Progression|11
1740068|NCT00942266|6069267|P1|Overall Study|Disease Progression|38
1740069|NCT00942266|6069266|P2|Overall Study|Adverse Event|1
1740070|NCT00942266|6069267|P1|Overall Study|Adverse Event|2
1740071|NCT00942266|6069266|P2|Overall Study|Withdrawal by Subject|0
1740072|NCT00942266|6069267|P1|Overall Study|Withdrawal by Subject|1
1740073|NCT00942188|6069289|P4|Overall Study|Sponsor Decision|1
1740074|NCT00942188|6069290|P3|Overall Study|Sponsor Decision|0
1740075|NCT00942188|6069291|P2|Overall Study|Sponsor Decision|2
1740076|NCT00942188|6069292|P1|Overall Study|Sponsor Decision|0
1740077|NCT00942188|6069289|P4|Overall Study|Physician Decision|0
1740078|NCT00942188|6069290|P3|Overall Study|Physician Decision|1
1740079|NCT00942188|6069291|P2|Overall Study|Physician Decision|0
1740080|NCT00942188|6069292|P1|Overall Study|Physician Decision|0
1740081|NCT00942188|6069289|P4|Overall Study|Withdrawal by Subject|2
1740082|NCT00942188|6069290|P3|Overall Study|Withdrawal by Subject|4
1740083|NCT00942188|6069291|P2|Overall Study|Withdrawal by Subject|3
1740084|NCT00942188|6069292|P1|Overall Study|Withdrawal by Subject|1
1740085|NCT00942188|6069289|P4|Overall Study|Lost to Follow-up|0
1740086|NCT00942188|6069290|P3|Overall Study|Lost to Follow-up|2
1740087|NCT00942188|6069291|P2|Overall Study|Lost to Follow-up|1
1740088|NCT00942188|6069292|P1|Overall Study|Lost to Follow-up|2
1740089|NCT00942188|6069289|P4|Overall Study|Protocol Violation|0
1740090|NCT00942188|6069290|P3|Overall Study|Protocol Violation|0
1740091|NCT00942188|6069291|P2|Overall Study|Protocol Violation|1
1740092|NCT00942188|6069292|P1|Overall Study|Protocol Violation|1
1740093|NCT00942188|6069289|P4|Overall Study|Lack of Efficacy|1
1740094|NCT00942188|6069290|P3|Overall Study|Lack of Efficacy|0
1740095|NCT00942188|6069291|P2|Overall Study|Lack of Efficacy|0
1740096|NCT00942188|6069292|P1|Overall Study|Lack of Efficacy|0
1740097|NCT00942188|6069289|P4|Overall Study|Adverse Event|0
1740098|NCT00942188|6069290|P3|Overall Study|Adverse Event|2
1740099|NCT00942188|6069291|P2|Overall Study|Adverse Event|3
1740100|NCT00942188|6069292|P1|Overall Study|Adverse Event|0
1740101|NCT00942175|6069331|P4|Overall Study|Low Platelet Count|0
1740102|NCT00942175|6069332|P3|Overall Study|Low Platelet Count|0
1740103|NCT00942175|6069333|P2|Overall Study|Low Platelet Count|2
1740104|NCT00942175|6069334|P1|Overall Study|Low Platelet Count|0
1740105|NCT00942175|6069331|P4|Overall Study|Elevated Alanine Amino Transferase|1
1740106|NCT00942175|6069332|P3|Overall Study|Elevated Alanine Amino Transferase|0
1740107|NCT00942175|6069333|P2|Overall Study|Elevated Alanine Amino Transferase|0
1740108|NCT00942175|6069334|P1|Overall Study|Elevated Alanine Amino Transferase|0
1740109|NCT00942175|6069331|P4|Overall Study|Pregnancy|1
1740110|NCT00942175|6069332|P3|Overall Study|Pregnancy|0
1740111|NCT00942175|6069333|P2|Overall Study|Pregnancy|0
1740112|NCT00942175|6069334|P1|Overall Study|Pregnancy|0
1740113|NCT00942175|6069331|P4|Overall Study|Protocol Violation|0
1740114|NCT00942175|6069332|P3|Overall Study|Protocol Violation|2
1740115|NCT00942175|6069333|P2|Overall Study|Protocol Violation|1
1740116|NCT00942175|6069334|P1|Overall Study|Protocol Violation|0
1740117|NCT00942175|6069331|P4|Overall Study|Adverse Event|0
1740118|NCT00942175|6069332|P3|Overall Study|Adverse Event|0
1740119|NCT00942175|6069333|P2|Overall Study|Adverse Event|1
1740120|NCT00942175|6069334|P1|Overall Study|Adverse Event|2
1740121|NCT00942162|6069387|P3|Overall Study|Other|0
1740122|NCT00942162|6069388|P2|Overall Study|Other|2
1740123|NCT00942162|6069389|P1|Overall Study|Other|8
1740124|NCT00942162|6069387|P3|Overall Study|Withdrawal by Subject|0
1740125|NCT00942162|6069388|P2|Overall Study|Withdrawal by Subject|2
1740126|NCT00942162|6069389|P1|Overall Study|Withdrawal by Subject|4
1740127|NCT00942162|6069387|P3|Overall Study|Protocol Violation|0
1740128|NCT00942162|6069388|P2|Overall Study|Protocol Violation|0
1740129|NCT00942162|6069389|P1|Overall Study|Protocol Violation|1
1740130|NCT00942162|6069387|P3|Overall Study|Adverse Event|0
1740131|NCT00942162|6069388|P2|Overall Study|Adverse Event|0
1740132|NCT00942162|6069389|P1|Overall Study|Adverse Event|2
1740133|NCT00942162|6069387|P3|Overall Study|Disease progression|1
1740134|NCT00942162|6069388|P2|Overall Study|Disease progression|43
1740135|NCT00942162|6069389|P1|Overall Study|Disease progression|53
1740136|NCT00942084|6069458|P1|Overall Study|Death|2
1740137|NCT00941928|6069475|P1|Overall Study|Disease Progression|1
1740138|NCT00941928|6069475|P1|Overall Study|Withdrawal by Subject|1
1740139|NCT00941863|6069493|P5|Continued After PCD|Disease progression, recurrence, relapse|18
1740140|NCT00941863|6069494|P4|Continued After PCD|Disease progression, recurrence, relapse|0
1740141|NCT00941863|6069495|P3|Continued After PCD|Disease progression, recurrence, relapse|0
1740142|NCT00941863|6069496|P2|Continued After PCD|Disease progression, recurrence, relapse|0
1740143|NCT00941863|6069497|P1|Continued After PCD|Disease progression, recurrence, relapse|0
1740144|NCT00941863|6069493|P5|Continued After PCD|Withdrawal by Subject|1
1740145|NCT00941863|6069494|P4|Continued After PCD|Withdrawal by Subject|0
1740146|NCT00941863|6069495|P3|Continued After PCD|Withdrawal by Subject|0
1740147|NCT00941863|6069496|P2|Continued After PCD|Withdrawal by Subject|0
1740148|NCT00941863|6069497|P1|Continued After PCD|Withdrawal by Subject|0
1740149|NCT00941863|6069493|P5|Until Primary Completion Date (PCD)|Disease progression|73
1740150|NCT00941863|6069494|P4|Until Primary Completion Date (PCD)|Disease progression|14
1740151|NCT00941863|6069495|P3|Until Primary Completion Date (PCD)|Disease progression|8
1740152|NCT00941863|6069496|P2|Until Primary Completion Date (PCD)|Disease progression|1
1740153|NCT00941863|6069497|P1|Until Primary Completion Date (PCD)|Disease progression|6
1740154|NCT00941863|6069493|P5|Until Primary Completion Date (PCD)|Death|7
1740155|NCT00941863|6069494|P4|Until Primary Completion Date (PCD)|Death|2
1740156|NCT00941863|6069495|P3|Until Primary Completion Date (PCD)|Death|1
1740157|NCT00941863|6069496|P2|Until Primary Completion Date (PCD)|Death|0
1740158|NCT00941863|6069497|P1|Until Primary Completion Date (PCD)|Death|0
1740159|NCT00941863|6069493|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
1740160|NCT00941863|6069494|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1740161|NCT00941863|6069495|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
1740162|NCT00941863|6069496|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1740163|NCT00941863|6069497|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
1740164|NCT00941863|6069493|P5|Until Primary Completion Date (PCD)|Physician Decision|1
1740165|NCT00941863|6069494|P4|Until Primary Completion Date (PCD)|Physician Decision|0
1740166|NCT00941863|6069495|P3|Until Primary Completion Date (PCD)|Physician Decision|0
1740167|NCT00941863|6069496|P2|Until Primary Completion Date (PCD)|Physician Decision|0
1740168|NCT00941863|6069497|P1|Until Primary Completion Date (PCD)|Physician Decision|0
1740169|NCT00941863|6069493|P5|Until Primary Completion Date (PCD)|Adverse Event|5
1740170|NCT00941863|6069494|P4|Until Primary Completion Date (PCD)|Adverse Event|1
1740171|NCT00941863|6069495|P3|Until Primary Completion Date (PCD)|Adverse Event|2
1740172|NCT00941863|6069496|P2|Until Primary Completion Date (PCD)|Adverse Event|2
1740173|NCT00941863|6069497|P1|Until Primary Completion Date (PCD)|Adverse Event|1
1740174|NCT00941798|6069524|P2|Overall Study|Death|1
1740175|NCT00941798|6069525|P1|Overall Study|Death|0
1740176|NCT00941798|6069524|P2|Overall Study|Abnormal laboratory values|2
1740177|NCT00941798|6069525|P1|Overall Study|Abnormal laboratory values|1
1740178|NCT00941798|6069524|P2|Overall Study|Abnormal test procedure results|1
1740179|NCT00941798|6069525|P1|Overall Study|Abnormal test procedure results|3
1740180|NCT00941798|6069524|P2|Overall Study|Patient's inability to use device|1
1740181|NCT00941798|6069525|P1|Overall Study|Patient's inability to use device|6
1740182|NCT00941798|6069524|P2|Overall Study|Lack of Efficacy|17
1740183|NCT00941798|6069525|P1|Overall Study|Lack of Efficacy|10
1740184|NCT00941798|6069524|P2|Overall Study|Administrative problems|23
1740185|NCT00941798|6069525|P1|Overall Study|Administrative problems|13
1740186|NCT00941798|6069524|P2|Overall Study|Protocol Violation|20
1740187|NCT00941798|6069525|P1|Overall Study|Protocol Violation|17
1740188|NCT00941798|6069524|P2|Overall Study|Lost to Follow-up|23
1740189|NCT00941798|6069525|P1|Overall Study|Lost to Follow-up|29
1740190|NCT00941798|6069524|P2|Overall Study|Adverse Event|23
1740191|NCT00941798|6069525|P1|Overall Study|Adverse Event|43
1740192|NCT00941798|6069524|P2|Overall Study|Withdrawal by Subject|74
1740193|NCT00941798|6069525|P1|Overall Study|Withdrawal by Subject|72
1740194|NCT00941733|6069555|P2|Overall Study|Protocol Violation|6
1740195|NCT00941733|6069556|P1|Overall Study|Protocol Violation|15
1740196|NCT00941733|6069555|P2|Overall Study|Lost to Follow-up|2
1740197|NCT00941733|6069556|P1|Overall Study|Lost to Follow-up|1
1740198|NCT00941733|6069555|P2|Overall Study|Adverse Event|4
1740199|NCT00941733|6069556|P1|Overall Study|Adverse Event|20
1740200|NCT00941733|6069555|P2|Overall Study|Withdrawal by Subject|6
1740201|NCT00941733|6069556|P1|Overall Study|Withdrawal by Subject|14
1740202|NCT00941733|6069555|P2|Overall Study|Death|10
1740203|NCT00941733|6069556|P1|Overall Study|Death|24
1740204|NCT00941720|6069596|P1|Overall Study|ineligible|2
1740205|NCT00941720|6069596|P1|Overall Study|Insurance denied participation|11
1740206|NCT00941720|6069596|P1|Overall Study|Withdrawal by Subject|1
1740207|NCT00941655|6069643|P2|Overall Study|non-compliant|1
1740208|NCT00941655|6069644|P1|Overall Study|non-compliant|0
1740209|NCT00941655|6069643|P2|Overall Study|withdrew consent|1
1740210|NCT00941655|6069644|P1|Overall Study|withdrew consent|0
1740211|NCT00941655|6069643|P2|Overall Study|refused further treatment|1
1740212|NCT00941655|6069644|P1|Overall Study|refused further treatment|0
1740213|NCT00941655|6069643|P2|Overall Study|progressed while on chemo|2
1740214|NCT00941655|6069644|P1|Overall Study|progressed while on chemo|0
1740215|NCT00941655|6069643|P2|Overall Study|not meet criteria for chemo foll surgery|0
1740216|NCT00941655|6069644|P1|Overall Study|not meet criteria for chemo foll surgery|4
1740217|NCT00941655|6069643|P2|Overall Study|received some chemo, 4 and 9 cycles|0
1740218|NCT00941655|6069644|P1|Overall Study|received some chemo, 4 and 9 cycles|1
1740219|NCT00941603|6069669|P6|Overall Study|Did not meet protocol eligibility|0
1740220|NCT00941603|6069670|P5|Overall Study|Did not meet protocol eligibility|0
1740221|NCT00941603|6069671|P4|Overall Study|Did not meet protocol eligibility|0
1740222|NCT00941603|6069672|P3|Overall Study|Did not meet protocol eligibility|0
1740223|NCT00941603|6069673|P2|Overall Study|Did not meet protocol eligibility|0
1740224|NCT00941603|6069674|P1|Overall Study|Did not meet protocol eligibility|1
1740225|NCT00941603|6069669|P6|Overall Study|Protocol Violation|0
1740226|NCT00941603|6069670|P5|Overall Study|Protocol Violation|0
1740227|NCT00941603|6069671|P4|Overall Study|Protocol Violation|0
1740228|NCT00941603|6069672|P3|Overall Study|Protocol Violation|0
1740229|NCT00941603|6069673|P2|Overall Study|Protocol Violation|1
1740230|NCT00941603|6069674|P1|Overall Study|Protocol Violation|0
1740231|NCT00941603|6069669|P6|Overall Study|Withdrawal by Subject|1
1740232|NCT00941603|6069670|P5|Overall Study|Withdrawal by Subject|0
1740233|NCT00941603|6069671|P4|Overall Study|Withdrawal by Subject|2
1740234|NCT00941603|6069672|P3|Overall Study|Withdrawal by Subject|0
1740235|NCT00941603|6069673|P2|Overall Study|Withdrawal by Subject|0
1740236|NCT00941603|6069674|P1|Overall Study|Withdrawal by Subject|0
1740237|NCT00941603|6069669|P6|Overall Study|Lost to Follow-up|2
1740238|NCT00941603|6069670|P5|Overall Study|Lost to Follow-up|0
1740239|NCT00941603|6069671|P4|Overall Study|Lost to Follow-up|1
1740240|NCT00941603|6069672|P3|Overall Study|Lost to Follow-up|0
1740241|NCT00941603|6069673|P2|Overall Study|Lost to Follow-up|0
1740242|NCT00941603|6069674|P1|Overall Study|Lost to Follow-up|0
1740243|NCT00941603|6069669|P6|Overall Study|Adverse Event|0
1740244|NCT00941603|6069670|P5|Overall Study|Adverse Event|4
1740245|NCT00941603|6069671|P4|Overall Study|Adverse Event|1
1740246|NCT00941603|6069672|P3|Overall Study|Adverse Event|5
1740247|NCT00941603|6069673|P2|Overall Study|Adverse Event|15
1740248|NCT00941603|6069674|P1|Overall Study|Adverse Event|10
1740249|NCT00941330|6069696|P2|Overall Study|Physician Decision|2
1740250|NCT00941330|6069697|P1|Overall Study|Physician Decision|0
1740251|NCT00941330|6069696|P2|Overall Study|Other|0
1740252|NCT00941330|6069697|P1|Overall Study|Other|1
1740253|NCT00941304|6069710|P5|Overall Study|Lost to Follow-up|0
1740254|NCT00941304|6069711|P4|Overall Study|Lost to Follow-up|0
1740255|NCT00941304|6069712|P3|Overall Study|Lost to Follow-up|0
1740256|NCT00941304|6069713|P2|Overall Study|Lost to Follow-up|0
1740257|NCT00941304|6069714|P1|Overall Study|Lost to Follow-up|1
1740258|NCT00941070|6069776|P1|Overall Study|Patient non-compliant|1
1740259|NCT00941031|6069796|P7|Maintenance Period|Lack of Efficacy|13
1740260|NCT00941031|6069797|P6|Maintenance Period|Lack of Efficacy|0
1740261|NCT00941031|6069798|P5|Maintenance Period|Lack of Efficacy|0
1740262|NCT00941031|6069799|P4|Maintenance Period|Lack of Efficacy|0
1740263|NCT00941031|6069800|P3|Maintenance Period|Lack of Efficacy|0
1740264|NCT00941031|6069801|P2|Maintenance Period|Lack of Efficacy|0
1740265|NCT00941031|6069802|P1|Maintenance Period|Lack of Efficacy|0
1740266|NCT00941031|6069796|P7|Maintenance Period|Lost to Follow-up|7
1740267|NCT00941031|6069797|P6|Maintenance Period|Lost to Follow-up|2
1740268|NCT00941031|6069798|P5|Maintenance Period|Lost to Follow-up|2
1740269|NCT00941031|6069799|P4|Maintenance Period|Lost to Follow-up|0
1740270|NCT00941031|6069800|P3|Maintenance Period|Lost to Follow-up|0
1740271|NCT00941031|6069801|P2|Maintenance Period|Lost to Follow-up|0
1740272|NCT00941031|6069802|P1|Maintenance Period|Lost to Follow-up|0
1740273|NCT00941031|6069796|P7|Maintenance Period|Adverse Event|8
1740274|NCT00941031|6069797|P6|Maintenance Period|Adverse Event|2
1740275|NCT00941031|6069798|P5|Maintenance Period|Adverse Event|0
1740276|NCT00941031|6069799|P4|Maintenance Period|Adverse Event|0
1740277|NCT00941031|6069800|P3|Maintenance Period|Adverse Event|0
1740278|NCT00941031|6069801|P2|Maintenance Period|Adverse Event|0
1740279|NCT00941031|6069802|P1|Maintenance Period|Adverse Event|0
1740280|NCT00941031|6069796|P7|Maintenance Period|Protocol Violation|1
1740281|NCT00941031|6069797|P6|Maintenance Period|Protocol Violation|0
1740282|NCT00941031|6069798|P5|Maintenance Period|Protocol Violation|0
1740283|NCT00941031|6069799|P4|Maintenance Period|Protocol Violation|0
1740284|NCT00941031|6069800|P3|Maintenance Period|Protocol Violation|0
1740285|NCT00941031|6069801|P2|Maintenance Period|Protocol Violation|0
1740286|NCT00941031|6069802|P1|Maintenance Period|Protocol Violation|0
1740287|NCT00941031|6069796|P7|Maintenance Period|Administrative Problems|1
1740288|NCT00941031|6069797|P6|Maintenance Period|Administrative Problems|0
1740289|NCT00941031|6069798|P5|Maintenance Period|Administrative Problems|1
1740290|NCT00941031|6069799|P4|Maintenance Period|Administrative Problems|0
1740291|NCT00941031|6069800|P3|Maintenance Period|Administrative Problems|0
1740292|NCT00941031|6069801|P2|Maintenance Period|Administrative Problems|0
1740293|NCT00941031|6069802|P1|Maintenance Period|Administrative Problems|0
1740294|NCT00941031|6069796|P7|Maintenance Period|Withdrawal by Subject|13
1740295|NCT00941031|6069797|P6|Maintenance Period|Withdrawal by Subject|2
1740296|NCT00941031|6069798|P5|Maintenance Period|Withdrawal by Subject|6
1740297|NCT00941031|6069799|P4|Maintenance Period|Withdrawal by Subject|0
1740298|NCT00941031|6069800|P3|Maintenance Period|Withdrawal by Subject|0
1740299|NCT00941031|6069801|P2|Maintenance Period|Withdrawal by Subject|0
1740300|NCT00941031|6069802|P1|Maintenance Period|Withdrawal by Subject|0
1740301|NCT00941031|6069796|P7|Induction Period|Adverse Event|0
1740302|NCT00941031|6069797|P6|Induction Period|Adverse Event|0
1740303|NCT00941031|6069798|P5|Induction Period|Adverse Event|0
1740304|NCT00941031|6069799|P4|Induction Period|Adverse Event|2
1740305|NCT00941031|6069800|P3|Induction Period|Adverse Event|3
1740306|NCT00941031|6069801|P2|Induction Period|Adverse Event|0
1740307|NCT00941031|6069802|P1|Induction Period|Adverse Event|1
1740308|NCT00941031|6069796|P7|Induction Period|Adminstative Problems|0
1740309|NCT00941031|6069797|P6|Induction Period|Adminstative Problems|0
1740310|NCT00941031|6069798|P5|Induction Period|Adminstative Problems|0
1740311|NCT00941031|6069799|P4|Induction Period|Adminstative Problems|0
1740312|NCT00941031|6069800|P3|Induction Period|Adminstative Problems|1
1740313|NCT00941031|6069801|P2|Induction Period|Adminstative Problems|1
1740314|NCT00941031|6069802|P1|Induction Period|Adminstative Problems|1
1740315|NCT00941031|6069796|P7|Induction Period|Withdrawal by Subject|0
1740316|NCT00941031|6069797|P6|Induction Period|Withdrawal by Subject|0
1740317|NCT00941031|6069798|P5|Induction Period|Withdrawal by Subject|0
1740318|NCT00941031|6069799|P4|Induction Period|Withdrawal by Subject|2
1740319|NCT00941031|6069800|P3|Induction Period|Withdrawal by Subject|2
1740320|NCT00941031|6069801|P2|Induction Period|Withdrawal by Subject|2
1740321|NCT00941031|6069802|P1|Induction Period|Withdrawal by Subject|1
1740322|NCT00941031|6069796|P7|Induction Period|Lack of Efficacy|0
1740323|NCT00941031|6069797|P6|Induction Period|Lack of Efficacy|0
1740324|NCT00941031|6069798|P5|Induction Period|Lack of Efficacy|0
1740325|NCT00941031|6069799|P4|Induction Period|Lack of Efficacy|5
1740326|NCT00941031|6069800|P3|Induction Period|Lack of Efficacy|0
1740327|NCT00941031|6069801|P2|Induction Period|Lack of Efficacy|1
1740328|NCT00941031|6069802|P1|Induction Period|Lack of Efficacy|2
1740329|NCT00940992|6069828|P3|Overall Study|Lost to Follow-up|1
1740330|NCT00940992|6069829|P2|Overall Study|Lost to Follow-up|1
1740331|NCT00940992|6069830|P1|Overall Study|Lost to Follow-up|0
1740332|NCT00940992|6069828|P3|Overall Study|subject request|0
1740333|NCT00940992|6069829|P2|Overall Study|subject request|1
1740334|NCT00940992|6069830|P1|Overall Study|subject request|2
1740335|NCT00940992|6069828|P3|Overall Study|Adverse Event|1
1740336|NCT00940992|6069829|P2|Overall Study|Adverse Event|0
1740337|NCT00940992|6069830|P1|Overall Study|Adverse Event|2
1740338|NCT00940888|6069859|P1|Overall Study|Lost to Follow-up|6
1740339|NCT00940888|6069859|P1|Overall Study|Withdrawn - Non-Death|364
1740340|NCT00940888|6069859|P1|Overall Study|Death|461
1740341|NCT00940888|6069859|P1|Overall Study|Unsuccessful Implant|4
1740342|NCT00940875|6069866|P2|Post-Study Treatment|Disease Progression|2
1740343|NCT00940875|6069867|P1|Post-Study Treatment|Disease Progression|0
1740344|NCT00940875|6069866|P2|Post-Study Treatment|Death|1
1740345|NCT00940875|6069867|P1|Post-Study Treatment|Death|0
1740346|NCT00940875|6069866|P2|Treatment Phase|Physician Decision|0
1740347|NCT00940875|6069867|P1|Treatment Phase|Physician Decision|1
1740348|NCT00940875|6069866|P2|Treatment Phase|Disease progression|11
1740349|NCT00940875|6069867|P1|Treatment Phase|Disease progression|9
1740350|NCT00940875|6069866|P2|Treatment Phase|Withdrawal by Subject|0
1740351|NCT00940875|6069867|P1|Treatment Phase|Withdrawal by Subject|3
1740352|NCT00940875|6069866|P2|Treatment Phase|Lack of Efficacy|0
1740353|NCT00940875|6069867|P1|Treatment Phase|Lack of Efficacy|1
1740354|NCT00940875|6069866|P2|Treatment Phase|Death|5
1740355|NCT00940875|6069867|P1|Treatment Phase|Death|3
1740356|NCT00940875|6069866|P2|Treatment Phase|Adverse Event|3
1740357|NCT00940875|6069867|P1|Treatment Phase|Adverse Event|9
1740358|NCT00940823|6069887|P2|Overall Study|Lost to Follow-up|20
1740359|NCT00940823|6069888|P1|Overall Study|Lost to Follow-up|27
1740360|NCT00940823|6069887|P2|Overall Study|Death|12
1740361|NCT00940823|6069888|P1|Overall Study|Death|8
1740362|NCT00940498|6069945|P8|Overall Study|Not treated due to disease related pain|0
1740363|NCT00940498|6069946|P7|Overall Study|Not treated due to disease related pain|0
1740364|NCT00940498|6069947|P6|Overall Study|Not treated due to disease related pain|0
1740365|NCT00940498|6069948|P5|Overall Study|Not treated due to disease related pain|1
1740366|NCT00940498|6069949|P4|Overall Study|Not treated due to disease related pain|0
1740367|NCT00940498|6069950|P3|Overall Study|Not treated due to disease related pain|0
1740368|NCT00940498|6069951|P2|Overall Study|Not treated due to disease related pain|0
1740369|NCT00940498|6069952|P1|Overall Study|Not treated due to disease related pain|0
1740370|NCT00940498|6069945|P8|Overall Study|Physician Decision|0
1740371|NCT00940498|6069946|P7|Overall Study|Physician Decision|0
1740372|NCT00940498|6069947|P6|Overall Study|Physician Decision|0
1740373|NCT00940498|6069948|P5|Overall Study|Physician Decision|2
1740374|NCT00940498|6069949|P4|Overall Study|Physician Decision|0
1740375|NCT00940498|6069950|P3|Overall Study|Physician Decision|0
1740376|NCT00940498|6069951|P2|Overall Study|Physician Decision|0
1740377|NCT00940498|6069952|P1|Overall Study|Physician Decision|0
1740378|NCT00940498|6069945|P8|Overall Study|Disease Progression|0
1740379|NCT00940498|6069946|P7|Overall Study|Disease Progression|0
1740380|NCT00940498|6069947|P6|Overall Study|Disease Progression|1
1740381|NCT00940498|6069948|P5|Overall Study|Disease Progression|0
1740382|NCT00940498|6069949|P4|Overall Study|Disease Progression|1
1740383|NCT00940498|6069950|P3|Overall Study|Disease Progression|1
1740384|NCT00940498|6069951|P2|Overall Study|Disease Progression|0
1740385|NCT00940498|6069952|P1|Overall Study|Disease Progression|0
1740386|NCT00940498|6069945|P8|Overall Study|Lost to Follow-up|1
1740387|NCT00940498|6069946|P7|Overall Study|Lost to Follow-up|0
1740388|NCT00940498|6069947|P6|Overall Study|Lost to Follow-up|0
1740389|NCT00940498|6069948|P5|Overall Study|Lost to Follow-up|1
1740390|NCT00940498|6069949|P4|Overall Study|Lost to Follow-up|0
1740391|NCT00940498|6069950|P3|Overall Study|Lost to Follow-up|2
1740392|NCT00940498|6069951|P2|Overall Study|Lost to Follow-up|1
1740393|NCT00940498|6069952|P1|Overall Study|Lost to Follow-up|1
1740394|NCT00940498|6069945|P8|Overall Study|Death|0
1740395|NCT00940498|6069946|P7|Overall Study|Death|1
1740396|NCT00940498|6069947|P6|Overall Study|Death|0
1740397|NCT00940498|6069948|P5|Overall Study|Death|5
1740398|NCT00940498|6069949|P4|Overall Study|Death|1
1740399|NCT00940498|6069950|P3|Overall Study|Death|0
1740400|NCT00940498|6069951|P2|Overall Study|Death|0
1740401|NCT00940498|6069952|P1|Overall Study|Death|2
1740402|NCT00940485|6070070|P2|Overall Study|Others|1
1740403|NCT00940485|6070071|P1|Overall Study|Others|1
1740404|NCT00940485|6070070|P2|Overall Study|Withdrawal by Subject|1
1740405|NCT00940485|6070071|P1|Overall Study|Withdrawal by Subject|1
1740406|NCT00940485|6070070|P2|Overall Study|Adverse Event|0
1740407|NCT00940485|6070071|P1|Overall Study|Adverse Event|8
1740408|NCT00940485|6070070|P2|Overall Study|Lost to Follow-up|3
1740409|NCT00940485|6070071|P1|Overall Study|Lost to Follow-up|2
1740410|NCT00940485|6070070|P2|Overall Study|HBeAb positive at Baseline|2
1740411|NCT00940485|6070071|P1|Overall Study|HBeAb positive at Baseline|3
1740412|NCT00940342|6070109|P3|Overall Study|Adverse Event|1
1740413|NCT00940342|6070110|P2|Overall Study|Adverse Event|2
1740414|NCT00940342|6070111|P1|Overall Study|Adverse Event|0
1740415|NCT00940316|6070122|P3|Treated After Cycle 5|Progressive disease|0
1740416|NCT00940316|6070123|P2|Treated After Cycle 5|Progressive disease|1
1740417|NCT00940316|6070124|P1|Treated After Cycle 5|Progressive disease|0
1740418|NCT00940316|6070122|P3|Treated After Cycle 5|Adverse Event|1
1740419|NCT00940316|6070123|P2|Treated After Cycle 5|Adverse Event|0
1740420|NCT00940316|6070124|P1|Treated After Cycle 5|Adverse Event|0
1740421|NCT00940316|6070122|P3|Moved on to be Treated Cycle 5|Adverse Event|0
1740422|NCT00940316|6070123|P2|Moved on to be Treated Cycle 5|Adverse Event|0
1740423|NCT00940316|6070124|P1|Moved on to be Treated Cycle 5|Adverse Event|2
1740424|NCT00940316|6070122|P3|Reached First Response at 8 Weeks|Progressive disease|0
1740425|NCT00940316|6070123|P2|Reached First Response at 8 Weeks|Progressive disease|3
1740426|NCT00940316|6070124|P1|Reached First Response at 8 Weeks|Progressive disease|1
1740427|NCT00940316|6070122|P3|Reached First Response at 8 Weeks|Adverse Event|0
1740428|NCT00940316|6070123|P2|Reached First Response at 8 Weeks|Adverse Event|1
1740429|NCT00940316|6070124|P1|Reached First Response at 8 Weeks|Adverse Event|2
1740430|NCT00940108|6070167|P4|Overall Study|Diagnosed with H1N1|1
1740431|NCT00940108|6070168|P3|Overall Study|Diagnosed with H1N1|0
1740432|NCT00940108|6070169|P2|Overall Study|Diagnosed with H1N1|0
1740433|NCT00940108|6070170|P1|Overall Study|Diagnosed with H1N1|0
1740434|NCT00940108|6070167|P4|Overall Study|Viral illness after Dose 1|0
1740435|NCT00940108|6070168|P3|Overall Study|Viral illness after Dose 1|0
1740436|NCT00940108|6070169|P2|Overall Study|Viral illness after Dose 1|1
1740437|NCT00940108|6070170|P1|Overall Study|Viral illness after Dose 1|0
1740438|NCT00940108|6070167|P4|Overall Study|Refused - pyrexia after Dose 1|0
1740439|NCT00940108|6070168|P3|Overall Study|Refused - pyrexia after Dose 1|0
1740440|NCT00940108|6070169|P2|Overall Study|Refused - pyrexia after Dose 1|1
1740441|NCT00940108|6070170|P1|Overall Study|Refused - pyrexia after Dose 1|0
1740442|NCT00940108|6070167|P4|Overall Study|Declined further vaccination|0
1740443|NCT00940108|6070168|P3|Overall Study|Declined further vaccination|3
1740444|NCT00940108|6070169|P2|Overall Study|Declined further vaccination|1
1740445|NCT00940108|6070170|P1|Overall Study|Declined further vaccination|0
1740446|NCT00940108|6070167|P4|Overall Study|Dose 2 contraindicated|1
1740447|NCT00940108|6070168|P3|Overall Study|Dose 2 contraindicated|0
1740448|NCT00940108|6070169|P2|Overall Study|Dose 2 contraindicated|1
1740449|NCT00940108|6070170|P1|Overall Study|Dose 2 contraindicated|1
1740450|NCT00940108|6070167|P4|Overall Study|Withdrew Consent|1
1740451|NCT00940108|6070168|P3|Overall Study|Withdrew Consent|0
1740452|NCT00940108|6070169|P2|Overall Study|Withdrew Consent|1
1740453|NCT00940108|6070170|P1|Overall Study|Withdrew Consent|2
1740454|NCT00940108|6070167|P4|Overall Study|Adverse Event|2
1740455|NCT00940108|6070168|P3|Overall Study|Adverse Event|0
1740456|NCT00940108|6070169|P2|Overall Study|Adverse Event|4
1740457|NCT00940108|6070170|P1|Overall Study|Adverse Event|2
1740458|NCT00940017|6070220|P1|Overall Study|Adverse Event|1
1740459|NCT00940017|6070220|P1|Overall Study|did not meet entrance criteria|3
1740460|NCT00939822|6070278|P2|Overall Study|Mental health issues|2
1740461|NCT00939822|6070279|P1|Overall Study|Mental health issues|0
1740462|NCT00939822|6070278|P2|Overall Study|withdrew from study due to busy schedule|1
1740463|NCT00939822|6070279|P1|Overall Study|withdrew from study due to busy schedule|1
1740464|NCT00939822|6070278|P2|Overall Study|Lost to Follow-up|0
1740465|NCT00939822|6070279|P1|Overall Study|Lost to Follow-up|1
1740466|NCT00939809|6070291|P1|Overall Study|Death|1
1740467|NCT00939809|6070291|P1|Overall Study|Adverse Event|2
1740468|NCT00939783|6070306|P1|Overall Study|Enrolled but not treated|1
1740469|NCT00939783|6070306|P1|Overall Study|Protocol Violation|3
1740470|NCT00939783|6070306|P1|Overall Study|Lost to Follow-up|8
1740471|NCT00939783|6070306|P1|Overall Study|Other|16
1740472|NCT00939783|6070306|P1|Overall Study|Withdrawal by Subject|78
1740473|NCT00939783|6070306|P1|Overall Study|Study Terminated by Sponsor|498
1740474|NCT00939783|6070306|P1|Overall Study|Adverse Event|39
1740475|NCT00939783|6070306|P1|Overall Study|Death|6
1740476|NCT00939692|6070347|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
1740477|NCT00939692|6070348|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
1740478|NCT00939692|6070347|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
1740479|NCT00939692|6070348|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
1740480|NCT00939640|6070363|P1|Overall Study|Physician Decision|1
1740481|NCT00939627|6070384|P3|Overall Study|No off-tx reason given|0
1740482|NCT00939627|6070385|P2|Overall Study|No off-tx reason given|2
1740483|NCT00939627|6070386|P1|Overall Study|No off-tx reason given|0
1740484|NCT00939627|6070384|P3|Overall Study|Not compliant|0
1740485|NCT00939627|6070385|P2|Overall Study|Not compliant|0
1740486|NCT00939627|6070386|P1|Overall Study|Not compliant|2
1740487|NCT00939627|6070384|P3|Overall Study|Other complicating disease|0
1740488|NCT00939627|6070385|P2|Overall Study|Other complicating disease|1
1740489|NCT00939627|6070386|P1|Overall Study|Other complicating disease|1
1740490|NCT00939627|6070384|P3|Overall Study|Withdrawal by Subject|0
1740491|NCT00939627|6070385|P2|Overall Study|Withdrawal by Subject|4
1740492|NCT00939627|6070386|P1|Overall Study|Withdrawal by Subject|2
1740493|NCT00939627|6070384|P3|Overall Study|Death|0
1740494|NCT00939627|6070385|P2|Overall Study|Death|2
1740495|NCT00939627|6070386|P1|Overall Study|Death|0
1740496|NCT00939627|6070384|P3|Overall Study|Adverse Event|0
1740497|NCT00939627|6070385|P2|Overall Study|Adverse Event|7
1740498|NCT00939627|6070386|P1|Overall Study|Adverse Event|6
1740499|NCT00939627|6070384|P3|Overall Study|Disease Progression|0
1740500|NCT00939627|6070385|P2|Overall Study|Disease Progression|12
1740501|NCT00939627|6070386|P1|Overall Study|Disease Progression|16
1740502|NCT00939523|6070426|P1|Overall Study|Physician Decision|2
1740503|NCT00939523|6070426|P1|Overall Study|Lack of Efficacy|1
1740504|NCT00939510|6070433|P1|Overall Study|Withdrawal by Subject|1
1740505|NCT00939484|6070442|P3|Overall Study|Progression/Relapse|3
1740506|NCT00939484|6070443|P2|Overall Study|Progression/Relapse|20
1740507|NCT00939484|6070444|P1|Overall Study|Progression/Relapse|8
1740508|NCT00939393|6070470|P2|Overall Study|Lost to Follow-up|0
1740509|NCT00939393|6070471|P1|Overall Study|Lost to Follow-up|3
1740510|NCT00939393|6070470|P2|Overall Study|Withdrawal by Subject|0
1740511|NCT00939393|6070471|P1|Overall Study|Withdrawal by Subject|1
1740512|NCT00939341|6070502|P1|Overall Study|Incorrect enrolment|8
1740513|NCT00939341|6070502|P1|Overall Study|Protocol Violation|6
1740514|NCT00939341|6070502|P1|Overall Study|Withdrawal by Subject|13
1740515|NCT00939341|6070502|P1|Overall Study|Lost to Follow-up|23
1740516|NCT00939341|6070502|P1|Overall Study|Pregnancy|1
1740517|NCT00939341|6070502|P1|Overall Study|Adverse Event|15
1740518|NCT00939185|6070589|P1|Overall Study|Randomized But Did Not Receive Treatment|10
1740519|NCT00939185|6070589|P1|Overall Study|Withdrawal by Subject|2
1740520|NCT00939185|6070589|P1|Overall Study|Other|3
1740521|NCT00939185|6070589|P1|Overall Study|Lost to Follow-up|6
1740522|NCT00939185|6070589|P1|Overall Study|Lack of Efficacy|1
1740523|NCT00939185|6070589|P1|Overall Study|Adverse Event|3
1740524|NCT00939107|6070627|P2|Overall Study|Lost to Follow-up|12
1740525|NCT00939107|6070628|P1|Overall Study|Lost to Follow-up|14
1740526|NCT00939094|6070642|P2|Overall Study|Abnormal ECG findings|0
1740527|NCT00939094|6070643|P1|Overall Study|Abnormal ECG findings|1
1740528|NCT00939094|6070642|P2|Overall Study|Study stopped by sponsor|2
1740529|NCT00939094|6070643|P1|Overall Study|Study stopped by sponsor|0
1740530|NCT00939094|6070642|P2|Overall Study|Severe non-compliance to protocol|1
1740531|NCT00939094|6070643|P1|Overall Study|Severe non-compliance to protocol|0
1740532|NCT00939094|6070642|P2|Overall Study|Eligibility criteria not fulfilled|0
1740533|NCT00939094|6070643|P1|Overall Study|Eligibility criteria not fulfilled|2
1740534|NCT00939094|6070642|P2|Overall Study|Lost to Follow-up|1
1740535|NCT00939094|6070643|P1|Overall Study|Lost to Follow-up|1
1740536|NCT00939094|6070642|P2|Overall Study|Withdrawal by Subject|6
1740537|NCT00939094|6070643|P1|Overall Study|Withdrawal by Subject|1
1740538|NCT00939094|6070642|P2|Overall Study|Adverse Event|0
1740539|NCT00939094|6070643|P1|Overall Study|Adverse Event|9
1740540|NCT00939055|6070665|P2|Overall Study|Discontinuation prior to procedure|0
1740541|NCT00939055|6070666|P1|Overall Study|Discontinuation prior to procedure|4
1740542|NCT00939029|6070676|P2|Overall Study|Adverse Event|1
1740543|NCT00939029|6070677|P1|Overall Study|Adverse Event|0
1740544|NCT00939029|6070676|P2|Overall Study|Lost to Follow-up|4
1740545|NCT00939029|6070677|P1|Overall Study|Lost to Follow-up|3
1740546|NCT00939029|6070676|P2|Overall Study|Withdrawal by Subject|7
1740547|NCT00939029|6070677|P1|Overall Study|Withdrawal by Subject|3
1740548|NCT00939003|6070689|P2|Open-label Treatment Period|Site Closure|4
1740549|NCT00939003|6070690|P1|Open-label Treatment Period|Site Closure|3
1740550|NCT00939003|6070689|P2|Open-label Treatment Period|Exclusion Criteria|0
1740551|NCT00939003|6070690|P1|Open-label Treatment Period|Exclusion Criteria|1
1740552|NCT00939003|6070689|P2|Open-label Treatment Period|Pregnancy|1
1740553|NCT00939003|6070690|P1|Open-label Treatment Period|Pregnancy|1
1740554|NCT00939003|6070689|P2|Open-label Treatment Period|Lack of Efficacy|9
1740555|NCT00939003|6070690|P1|Open-label Treatment Period|Lack of Efficacy|6
1740556|NCT00939003|6070689|P2|Open-label Treatment Period|Withdrawal by Subject|7
1740557|NCT00939003|6070690|P1|Open-label Treatment Period|Withdrawal by Subject|14
1740558|NCT00939003|6070689|P2|Open-label Treatment Period|Adverse Event|8
1740559|NCT00939003|6070690|P1|Open-label Treatment Period|Adverse Event|4
1740560|NCT00939003|6070689|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
1740561|NCT00939003|6070690|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
1740562|NCT00939003|6070689|P2|Double-blind Treatment Period|Pregnancy|1
1740563|NCT00939003|6070690|P1|Double-blind Treatment Period|Pregnancy|0
1740564|NCT00939003|6070689|P2|Double-blind Treatment Period|Lack of Efficacy|1
1740565|NCT00939003|6070690|P1|Double-blind Treatment Period|Lack of Efficacy|0
1740566|NCT00939003|6070689|P2|Double-blind Treatment Period|Adverse Event|1
1740567|NCT00939003|6070690|P1|Double-blind Treatment Period|Adverse Event|1
1740568|NCT00938964|6070727|P2|Overall Study|Found to Meet Exclusion Criteria|4
1740569|NCT00938964|6070728|P1|Overall Study|Found to Meet Exclusion Criteria|3
1740570|NCT00938964|6070727|P2|Overall Study|Withdrawal by Subject|18
1740571|NCT00938964|6070728|P1|Overall Study|Withdrawal by Subject|22
1740572|NCT00938964|6070727|P2|Overall Study|Lost to Follow-up|3
1740573|NCT00938964|6070728|P1|Overall Study|Lost to Follow-up|2
1740574|NCT00938964|6070727|P2|Overall Study|Death|3
1740575|NCT00938964|6070728|P1|Overall Study|Death|3
1740576|NCT00938886|6070792|P2|Overall Study|Lost to Follow-up|2
1740577|NCT00938886|6070793|P1|Overall Study|Lost to Follow-up|3
1740578|NCT00938886|6070792|P2|Overall Study|Withdrawal by Subject|7
1740579|NCT00938886|6070793|P1|Overall Study|Withdrawal by Subject|4
1740580|NCT00938886|6070792|P2|Overall Study|Death|1
1740581|NCT00938886|6070793|P1|Overall Study|Death|0
1740582|NCT00938860|6070803|P2|Overall Study|Protocol Violation|1
1740583|NCT00938860|6070804|P1|Overall Study|Protocol Violation|3
1740584|NCT00938860|6070803|P2|Overall Study|Death|1
1740585|NCT00938860|6070804|P1|Overall Study|Death|1
1740586|NCT00938860|6070803|P2|Overall Study|Administration problems|0
1740587|NCT00938860|6070804|P1|Overall Study|Administration problems|2
1740588|NCT00938860|6070803|P2|Overall Study|Lost to Follow-up|4
1740589|NCT00938860|6070804|P1|Overall Study|Lost to Follow-up|4
1740590|NCT00938860|6070803|P2|Overall Study|Withdrawal by Subject|8
1740591|NCT00938860|6070804|P1|Overall Study|Withdrawal by Subject|11
1740592|NCT00938860|6070803|P2|Overall Study|Abnormal laboratory values|2
1740593|NCT00938860|6070804|P1|Overall Study|Abnormal laboratory values|2
1740594|NCT00938860|6070803|P2|Overall Study|Adverse Event|1
1740595|NCT00938860|6070804|P1|Overall Study|Adverse Event|2
1740596|NCT00938717|6070837|P2|Overall Study|Other reason|2
1740597|NCT00938717|6070838|P1|Overall Study|Other reason|5
1740598|NCT00938717|6070837|P2|Overall Study|Lack of Efficacy|15
1740599|NCT00938717|6070838|P1|Overall Study|Lack of Efficacy|33
1740600|NCT00938717|6070837|P2|Overall Study|Lost to Follow-up|18
1740601|NCT00938717|6070838|P1|Overall Study|Lost to Follow-up|13
1740602|NCT00938717|6070837|P2|Overall Study|Withdrawal by Subject|24
1740603|NCT00938717|6070838|P1|Overall Study|Withdrawal by Subject|26
1740604|NCT00938717|6070837|P2|Overall Study|Protocol Violation|8
1740605|NCT00938717|6070838|P1|Overall Study|Protocol Violation|11
1740606|NCT00938717|6070837|P2|Overall Study|Adverse Event|41
1740607|NCT00938717|6070838|P1|Overall Study|Adverse Event|10
1740608|NCT00938639|6070889|P2|Overall Study|Participant noncompliance|0
1740609|NCT00938639|6070890|P1|Overall Study|Participant noncompliance|1
1740610|NCT00938639|6070889|P2|Overall Study|Family issues|1
1740611|NCT00938639|6070890|P1|Overall Study|Family issues|1
1740612|NCT00938639|6070889|P2|Overall Study|Lost to Follow-up|2
1740613|NCT00938639|6070890|P1|Overall Study|Lost to Follow-up|1
1740614|NCT00938639|6070889|P2|Overall Study|Moved away from study area|1
1740615|NCT00938639|6070890|P1|Overall Study|Moved away from study area|0
1740616|NCT00938470|6070973|P2|Overall Study|Other Reason|1
1740617|NCT00938470|6070974|P1|Overall Study|Other Reason|0
1740618|NCT00938470|6070973|P2|Overall Study|Death|2
1740619|NCT00938470|6070974|P1|Overall Study|Death|3
1740620|NCT00938470|6070973|P2|Overall Study|Alternate Treatment|0
1740621|NCT00938470|6070974|P1|Overall Study|Alternate Treatment|1
1740622|NCT00938470|6070973|P2|Overall Study|Disease Progression|0
1740623|NCT00938470|6070974|P1|Overall Study|Disease Progression|3
1740624|NCT00938431|6071004|P3|Overall Study|Reached maximum dose early|1
1740625|NCT00938431|6071005|P2|Overall Study|Reached maximum dose early|0
1740626|NCT00938431|6071006|P1|Overall Study|Reached maximum dose early|0
1740627|NCT00938431|6071004|P3|Overall Study|Dosing compliance issue|1
1740628|NCT00938431|6071005|P2|Overall Study|Dosing compliance issue|0
1740629|NCT00938431|6071006|P1|Overall Study|Dosing compliance issue|0
1740630|NCT00938431|6071004|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
1740631|NCT00938431|6071005|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
1740632|NCT00938431|6071006|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
1740633|NCT00938431|6071004|P3|Overall Study|Lack of Efficacy|0
1740634|NCT00938431|6071005|P2|Overall Study|Lack of Efficacy|1
1740635|NCT00938431|6071006|P1|Overall Study|Lack of Efficacy|0
1740636|NCT00938431|6071004|P3|Overall Study|Adverse Event|6
1740637|NCT00938431|6071005|P2|Overall Study|Adverse Event|8
1740638|NCT00938431|6071006|P1|Overall Study|Adverse Event|5
1740639|NCT00938392|6071033|P2|Overall Study|Lost to Follow-up|2
1740640|NCT00938392|6071034|P1|Overall Study|Lost to Follow-up|2
1740641|NCT00938392|6071033|P2|Overall Study|Withdrawal by Subject|1
1740642|NCT00938392|6071034|P1|Overall Study|Withdrawal by Subject|0
1740643|NCT00938392|6071033|P2|Overall Study|Adverse Event|1
1740644|NCT00938392|6071034|P1|Overall Study|Adverse Event|0
1740645|NCT00938366|6071060|P2|Overall Study|Withdrawal by Subject|0
1740646|NCT00938366|6071061|P1|Overall Study|Withdrawal by Subject|1
1740647|NCT00938340|6071081|P1|Overall Study|Adverse Event|1
1740648|NCT00938340|6071081|P1|Overall Study|Protocol Violation|1
1740649|NCT00938340|6071081|P1|Overall Study|Withdrawal by Subject|3
1740650|NCT00938327|6071211|P1|Overall Study|Vaccine not received as out of stock|9
1740651|NCT00938327|6071211|P1|Overall Study|2nd dose received outside of the study|7
1740652|NCT00938327|6071211|P1|Overall Study|Lost to Follow-up|37
1740653|NCT00938327|6071211|P1|Overall Study|Withdrawal by Subject|4
1740654|NCT00938327|6071211|P1|Overall Study|Protocol Violation|1
1740655|NCT00938327|6071211|P1|Overall Study|Adverse Event|2
1740656|NCT00938041|6071279|P1|Overall Study|Adrenal Insufficiency|3
1740657|NCT00938041|6071279|P1|Overall Study|Death|12
1740658|NCT00938041|6071279|P1|Overall Study|Progressive Disease|5
1740659|NCT00938041|6071279|P1|Overall Study|Received Alternative Therapy|1
1740660|NCT00938041|6071279|P1|Overall Study|Lost to Follow-up|6
1740661|NCT00938015|6071288|P1|Overall Study|Reason not related to Etanercept|29
1740662|NCT00938015|6071288|P1|Overall Study|Non-responder|52
1740663|NCT00938015|6071288|P1|Overall Study|Adverse Event|32
1740664|NCT00938015|6071288|P1|Overall Study|Lost to Follow-up|32
1740665|NCT00938015|6071288|P1|Overall Study|Death|2
1740666|NCT00937950|6071304|P1|Overall Study|Other|18
1740667|NCT00937950|6071304|P1|Overall Study|Missing confirmed|4
1740668|NCT00937950|6071304|P1|Overall Study|Lost to Follow-up|144
1740669|NCT00937950|6071304|P1|Overall Study|Migrated/moved from study area|27
1740670|NCT00937950|6071304|P1|Overall Study|Withdrawal by Subject|23
1740671|NCT00937937|6071320|P1|Overall Study|Other|2
1740672|NCT00937937|6071320|P1|Overall Study|Death|1
1740673|NCT00937937|6071320|P1|Overall Study|Progression/relapse|61
1740674|NCT00937937|6071320|P1|Overall Study|Withdrawal by Subject|2
1740675|NCT00937937|6071320|P1|Overall Study|Adverse Event|6
1740676|NCT00937833|6071329|P2|Overall Study|Withdrawal by Subject|6
1740677|NCT00937833|6071330|P1|Overall Study|Withdrawal by Subject|4
1740678|NCT00937833|6071329|P2|Overall Study|Lost to Follow-up|8
1740679|NCT00937833|6071330|P1|Overall Study|Lost to Follow-up|10
1740680|NCT00937833|6071329|P2|Overall Study|Procedure delayed; enrollment closed|1
1740681|NCT00937833|6071330|P1|Overall Study|Procedure delayed; enrollment closed|0
1740682|NCT00937833|6071329|P2|Overall Study|Protocol Violation|2
1740683|NCT00937833|6071330|P1|Overall Study|Protocol Violation|1
1740684|NCT00937768|6071343|P2|Overall Study|No Further Funding|4
1740685|NCT00937768|6071344|P1|Overall Study|No Further Funding|4
1740686|NCT00937768|6071343|P2|Overall Study|Alternate Treatment|1
1740687|NCT00937768|6071344|P1|Overall Study|Alternate Treatment|0
1740688|NCT00937768|6071343|P2|Overall Study|Disease Progression|1
1740689|NCT00937768|6071344|P1|Overall Study|Disease Progression|1
1740690|NCT00937768|6071343|P2|Overall Study|Refused Further Treatment|2
1740691|NCT00937768|6071344|P1|Overall Study|Refused Further Treatment|3
1740692|NCT00937560|6071364|P1|Maintenance Treatment|According to protocol|1
1740693|NCT00937560|6071364|P1|Maintenance Treatment|Withdraw consent|5
1740694|NCT00937560|6071364|P1|Maintenance Treatment|Death|12
1740695|NCT00937560|6071364|P1|Initial Treatment|No end of study page|10
1740696|NCT00937560|6071364|P1|Initial Treatment|Lost to Follow-up|1
1740697|NCT00937560|6071364|P1|Initial Treatment|Adverse Event|1
1740698|NCT00937560|6071364|P1|Initial Treatment|Withdraw consent|3
1740699|NCT00937560|6071364|P1|Initial Treatment|Death|6
1740700|NCT00937547|6071375|P3|Overall Study|misdiagnosis|7
1740701|NCT00937547|6071376|P2|Overall Study|misdiagnosis|6
1740702|NCT00937547|6071377|P1|Overall Study|misdiagnosis|1
1740703|NCT00937521|6071414|P8|Booster Phase|Protocol Deviation|0
1740704|NCT00937521|6071415|P7|Booster Phase|Protocol Deviation|1
1740705|NCT00937521|6071416|P6|Booster Phase|Protocol Deviation|0
1740706|NCT00937521|6071417|P5|Booster Phase|Protocol Deviation|0
1740707|NCT00937521|6071418|P4|Booster Phase|Protocol Deviation|0
1740708|NCT00937521|6071419|P3|Booster Phase|Protocol Deviation|0
1740709|NCT00937521|6071420|P2|Booster Phase|Protocol Deviation|0
1740710|NCT00937521|6071421|P1|Booster Phase|Protocol Deviation|0
1740711|NCT00937521|6071414|P8|Booster Phase|Administrative Reason|0
1740712|NCT00937521|6071415|P7|Booster Phase|Administrative Reason|0
1740713|NCT00937521|6071416|P6|Booster Phase|Administrative Reason|1
1740714|NCT00937521|6071417|P5|Booster Phase|Administrative Reason|1
1740715|NCT00937521|6071418|P4|Booster Phase|Administrative Reason|0
1740716|NCT00937521|6071419|P3|Booster Phase|Administrative Reason|1
1740717|NCT00937521|6071420|P2|Booster Phase|Administrative Reason|0
1740718|NCT00937521|6071421|P1|Booster Phase|Administrative Reason|0
1740719|NCT00937521|6071414|P8|Booster Phase|Lost to Follow-up|0
1740720|NCT00937521|6071415|P7|Booster Phase|Lost to Follow-up|3
1740721|NCT00937521|6071416|P6|Booster Phase|Lost to Follow-up|4
1740722|NCT00937521|6071417|P5|Booster Phase|Lost to Follow-up|4
1740723|NCT00937521|6071418|P4|Booster Phase|Lost to Follow-up|2
1740724|NCT00937521|6071419|P3|Booster Phase|Lost to Follow-up|4
1740725|NCT00937521|6071420|P2|Booster Phase|Lost to Follow-up|2
1740726|NCT00937521|6071421|P1|Booster Phase|Lost to Follow-up|2
1740727|NCT00937521|6071414|P8|Booster Phase|Withdrawal by Subject|2
1740728|NCT00937521|6071415|P7|Booster Phase|Withdrawal by Subject|0
1740729|NCT00937521|6071416|P6|Booster Phase|Withdrawal by Subject|0
1740730|NCT00937521|6071417|P5|Booster Phase|Withdrawal by Subject|0
1740731|NCT00937521|6071418|P4|Booster Phase|Withdrawal by Subject|1
1740732|NCT00937521|6071419|P3|Booster Phase|Withdrawal by Subject|0
1740733|NCT00937521|6071420|P2|Booster Phase|Withdrawal by Subject|0
1740734|NCT00937521|6071421|P1|Booster Phase|Withdrawal by Subject|1
1740735|NCT00937521|6071414|P8|Booster Phase|Adverse Event|0
1740736|NCT00937521|6071415|P7|Booster Phase|Adverse Event|1
1740737|NCT00937521|6071416|P6|Booster Phase|Adverse Event|0
1740738|NCT00937521|6071417|P5|Booster Phase|Adverse Event|0
1740739|NCT00937521|6071418|P4|Booster Phase|Adverse Event|0
1740740|NCT00937521|6071419|P3|Booster Phase|Adverse Event|0
1740741|NCT00937521|6071420|P2|Booster Phase|Adverse Event|0
1740742|NCT00937521|6071421|P1|Booster Phase|Adverse Event|0
1740743|NCT00937521|6071414|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1740744|NCT00937521|6071415|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
1740745|NCT00937521|6071416|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1740746|NCT00937521|6071417|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1740747|NCT00937521|6071418|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1740748|NCT00937521|6071419|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1740749|NCT00937521|6071420|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
1740750|NCT00937521|6071421|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
1740751|NCT00937521|6071414|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1740752|NCT00937521|6071415|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
1740753|NCT00937521|6071416|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
1740754|NCT00937521|6071417|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
1740755|NCT00937521|6071418|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1740756|NCT00937521|6071419|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1740757|NCT00937521|6071420|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
1740758|NCT00937521|6071421|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
1740759|NCT00937521|6071414|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1740760|NCT00937521|6071415|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1740761|NCT00937521|6071416|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1740762|NCT00937521|6071417|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1740763|NCT00937521|6071418|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
1740764|NCT00937521|6071419|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
1740765|NCT00937521|6071420|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1740766|NCT00937521|6071421|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
1740767|NCT00937521|6071414|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1740768|NCT00937521|6071415|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
1740769|NCT00937521|6071416|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
1740770|NCT00937521|6071417|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1740771|NCT00937521|6071418|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
1740772|NCT00937521|6071419|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
1740773|NCT00937521|6071420|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
1740774|NCT00937521|6071421|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
1740775|NCT00937521|6071414|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
1740776|NCT00937521|6071415|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
1740777|NCT00937521|6071416|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
1740778|NCT00937521|6071417|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
1740779|NCT00937521|6071418|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
1740780|NCT00937521|6071419|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
1740781|NCT00937521|6071420|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
1740782|NCT00937521|6071421|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
1740783|NCT00937495|6071527|P1|Overall Study|Protocol Violation|2
1740784|NCT00937404|6071533|P1|Overall Study|Withdrawal by Subject|1
1740785|NCT00937404|6071533|P1|Overall Study|Protocol Violation|1
1740786|NCT00937391|6071542|P1|Stage 2|Withdrawal by Subject|1
1740787|NCT00937326|6071598|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
1740788|NCT00937326|6071599|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
1740789|NCT00937326|6071600|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
1740790|NCT00937326|6071601|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
1740791|NCT00937326|6071602|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
1740792|NCT00937326|6071598|P5|Overall Study|Withdrawal by Subject|3
1740793|NCT00937326|6071599|P4|Overall Study|Withdrawal by Subject|4
1740794|NCT00937326|6071600|P3|Overall Study|Withdrawal by Subject|1
1740795|NCT00937326|6071601|P2|Overall Study|Withdrawal by Subject|4
1740796|NCT00937326|6071602|P1|Overall Study|Withdrawal by Subject|3
1740797|NCT00937326|6071598|P5|Overall Study|Death|0
1740798|NCT00937326|6071599|P4|Overall Study|Death|0
1740799|NCT00937326|6071600|P3|Overall Study|Death|1
1740800|NCT00937326|6071601|P2|Overall Study|Death|0
1740801|NCT00937326|6071602|P1|Overall Study|Death|0
1740802|NCT00937326|6071598|P5|Overall Study|Adverse Event|2
1740803|NCT00937326|6071599|P4|Overall Study|Adverse Event|1
1740804|NCT00937326|6071600|P3|Overall Study|Adverse Event|1
1740805|NCT00937326|6071601|P2|Overall Study|Adverse Event|3
1740806|NCT00937326|6071602|P1|Overall Study|Adverse Event|0
1740807|NCT00937157|6071851|P1|Overall Study|Lost to Follow-up|3
1740808|NCT00937157|6071851|P1|Overall Study|Pregnancy|1
1740809|NCT00937040|6071882|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
1740810|NCT00937040|6071883|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
1740811|NCT00937040|6071882|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
1740812|NCT00937040|6071883|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
1740813|NCT00937040|6071882|P2|Overall Study|Withdrawal by Subject|7
1740814|NCT00937040|6071883|P1|Overall Study|Withdrawal by Subject|13
1740815|NCT00937040|6071882|P2|Overall Study|Protocol Violation|0
1740816|NCT00937040|6071883|P1|Overall Study|Protocol Violation|3
1740817|NCT00937040|6071882|P2|Overall Study|Lost to Follow-up|12
1740818|NCT00937040|6071883|P1|Overall Study|Lost to Follow-up|12
1740819|NCT00937040|6071882|P2|Overall Study|Adverse Event|8
1740820|NCT00937040|6071883|P1|Overall Study|Adverse Event|5
1740821|NCT00936975|6071925|P1|Overall Study|Post-Tx scan uninterpretable|2
1740822|NCT00936975|6071925|P1|Overall Study|Disease progression|3
1740823|NCT00936975|6071925|P1|Overall Study|Withdrawal by Subject|1
1740824|NCT00936910|6071934|P1|Overall Study|Lack of Efficacy|3
1740825|NCT00936897|6071943|P2|Overall Study|Death|1
1740826|NCT00936897|6071944|P1|Overall Study|Death|0
1740827|NCT00936897|6071943|P2|Overall Study|Noncompliance|2
1740828|NCT00936897|6071944|P1|Overall Study|Noncompliance|0
1740829|NCT00936897|6071943|P2|Overall Study|Ineligibility Determined|3
1740830|NCT00936897|6071944|P1|Overall Study|Ineligibility Determined|0
1740831|NCT00936897|6071943|P2|Overall Study|Protocol Violation|1
1740832|NCT00936897|6071944|P1|Overall Study|Protocol Violation|1
1740833|NCT00936897|6071943|P2|Overall Study|Administrative Decision|2
1740834|NCT00936897|6071944|P1|Overall Study|Administrative Decision|1
1740835|NCT00936897|6071943|P2|Overall Study|Lost to Follow-up|10
1740836|NCT00936897|6071944|P1|Overall Study|Lost to Follow-up|1
1740837|NCT00936897|6071943|P2|Overall Study|Other|9
1740838|NCT00936897|6071944|P1|Overall Study|Other|3
1740839|NCT00936897|6071943|P2|Overall Study|Adverse Event|13
1740840|NCT00936897|6071944|P1|Overall Study|Adverse Event|4
1740841|NCT00936897|6071943|P2|Overall Study|Withdrawal by Subject|19
1740842|NCT00936897|6071944|P1|Overall Study|Withdrawal by Subject|9
1740843|NCT00936884|6071958|P3|Double-blind|Did not receive study drug|0
1740844|NCT00936884|6071959|P2|Double-blind|Did not receive study drug|1
1740845|NCT00936884|6071960|P1|Double-blind|Did not receive study drug|0
1740846|NCT00936884|6071958|P3|Double-blind|No post baseline diary entry|0
1740847|NCT00936884|6071959|P2|Double-blind|No post baseline diary entry|0
1740848|NCT00936884|6071960|P1|Double-blind|No post baseline diary entry|1
1740849|NCT00936884|6071958|P3|Double-blind|Physician Decision|0
1740850|NCT00936884|6071959|P2|Double-blind|Physician Decision|0
1740851|NCT00936884|6071960|P1|Double-blind|Physician Decision|1
1740852|NCT00936884|6071958|P3|Double-blind|Adverse Event|0
1740853|NCT00936884|6071959|P2|Double-blind|Adverse Event|0
1740854|NCT00936884|6071960|P1|Double-blind|Adverse Event|1
1740855|NCT00936884|6071958|P3|Double-blind|Lack of Efficacy|0
1740856|NCT00936884|6071959|P2|Double-blind|Lack of Efficacy|1
1740857|NCT00936884|6071960|P1|Double-blind|Lack of Efficacy|1
1740858|NCT00936884|6071958|P3|Double-blind|Death|0
1740859|NCT00936884|6071959|P2|Double-blind|Death|1
1740860|NCT00936884|6071960|P1|Double-blind|Death|2
1740861|NCT00936884|6071958|P3|Double-blind|Withdrawal by Subject|0
1740862|NCT00936884|6071959|P2|Double-blind|Withdrawal by Subject|4
1740863|NCT00936884|6071960|P1|Double-blind|Withdrawal by Subject|6
1740864|NCT00936715|6071976|P1|Overall Study|Safety or Tolerability Reasons|4
1740865|NCT00936715|6071976|P1|Overall Study|Protocol Violation|1
1740866|NCT00936715|6071976|P1|Overall Study|Investigators Discretion|1
1740867|NCT00936702|6071980|P1|Overall Study|Other|1
1740868|NCT00936702|6071980|P1|Overall Study|Alternative Treatment|1
1740869|NCT00936702|6071980|P1|Overall Study|Withdrawal by Subject|2
1740870|NCT00936702|6071980|P1|Overall Study|Adverse Event|8
1740871|NCT00936702|6071980|P1|Overall Study|Disease progression|34
1740872|NCT00936598|6072013|P2|Overall Study|Ineligible after consent|0
1740873|NCT00936598|6072014|P1|Overall Study|Ineligible after consent|1
1740874|NCT00936598|6072013|P2|Overall Study|Withdrawal by Subject|0
1740875|NCT00936598|6072014|P1|Overall Study|Withdrawal by Subject|1
1740876|NCT00936221|6072116|P2|Overall Study|Withdrawal by Subject|1
1740877|NCT00936221|6072117|P1|Overall Study|Withdrawal by Subject|1
1740878|NCT00936208|6072131|P2|Overall Study|Protocol Violation|22
1740879|NCT00936208|6072132|P1|Overall Study|Protocol Violation|37
1740880|NCT00936117|6072150|P1|Overall Study|Unable to continue oral medication|3
1740881|NCT00936117|6072150|P1|Overall Study|Adverse Event|7
1740882|NCT00936065|6072158|P3|Overall Study|Withdrawal by Subject|4
1740883|NCT00936065|6072159|P2|Overall Study|Withdrawal by Subject|2
1740884|NCT00936065|6072160|P1|Overall Study|Withdrawal by Subject|0
1740885|NCT00936065|6072158|P3|Overall Study|Protocol Violation|1
1740886|NCT00936065|6072159|P2|Overall Study|Protocol Violation|2
1740887|NCT00936065|6072160|P1|Overall Study|Protocol Violation|1
1740888|NCT00936065|6072158|P3|Overall Study|Lost to Follow-up|0
1740889|NCT00936065|6072159|P2|Overall Study|Lost to Follow-up|0
1740890|NCT00936065|6072160|P1|Overall Study|Lost to Follow-up|1
1740891|NCT00936065|6072158|P3|Overall Study|Lack of Efficacy|1
1740892|NCT00936065|6072159|P2|Overall Study|Lack of Efficacy|0
1740893|NCT00936065|6072160|P1|Overall Study|Lack of Efficacy|1
1740894|NCT00936065|6072158|P3|Overall Study|Adverse Event|1
1740895|NCT00936065|6072159|P2|Overall Study|Adverse Event|0
1740896|NCT00936065|6072160|P1|Overall Study|Adverse Event|1
1740897|NCT00935883|6072266|P2|Treatment Period|Withdrawal by Subject|2
1740898|NCT00935883|6072267|P1|Treatment Period|Withdrawal by Subject|0
1740899|NCT00935883|6072266|P2|Treatment Period|Physician Decision|0
1740900|NCT00935883|6072267|P1|Treatment Period|Physician Decision|1
1740901|NCT00935818|6072294|P2|Overall Study|Physician Decision|1
1740902|NCT00935818|6072295|P1|Overall Study|Physician Decision|0
1740903|NCT00935818|6072294|P2|Overall Study|Adverse Event|7
1740904|NCT00935818|6072295|P1|Overall Study|Adverse Event|6
1740905|NCT00935818|6072294|P2|Overall Study|Lost to Follow-up|42
1740906|NCT00935818|6072295|P1|Overall Study|Lost to Follow-up|40
1740907|NCT00935818|6072294|P2|Overall Study|Withdrawal by Subject|50
1740908|NCT00935818|6072295|P1|Overall Study|Withdrawal by Subject|45
1740909|NCT00935701|6072346|P1|Overall Study|Failure to Transition to Acupuncture|1
1740910|NCT00935584|6072363|P2|Overall Study|Provider dropped out of study|4
1740911|NCT00935584|6072364|P1|Overall Study|Provider dropped out of study|14
1740912|NCT00935584|6072363|P2|Overall Study|Patient changed provider|0
1740913|NCT00935584|6072364|P1|Overall Study|Patient changed provider|3
1740914|NCT00935584|6072363|P2|Overall Study|Relocated|0
1740915|NCT00935584|6072364|P1|Overall Study|Relocated|3
1740916|NCT00935584|6072363|P2|Overall Study|No show|0
1740917|NCT00935584|6072364|P1|Overall Study|No show|9
1740918|NCT00935584|6072363|P2|Overall Study|Lost to Follow-up|0
1740919|NCT00935584|6072364|P1|Overall Study|Lost to Follow-up|8
1740920|NCT00935584|6072363|P2|Overall Study|Death|0
1740921|NCT00935584|6072364|P1|Overall Study|Death|3
1740922|NCT00935584|6072363|P2|Overall Study|Withdrawal by Subject|0
1740923|NCT00935584|6072364|P1|Overall Study|Withdrawal by Subject|9
1740924|NCT00935532|6072376|P2|Overall Study|Loss Glucose Control|0
1740925|NCT00935532|6072377|P1|Overall Study|Loss Glucose Control|4
1740926|NCT00935532|6072376|P2|Overall Study|Sponsor Decision|1
1740927|NCT00935532|6072377|P1|Overall Study|Sponsor Decision|0
1740928|NCT00935532|6072376|P2|Overall Study|Subject Decision|1
1740929|NCT00935532|6072377|P1|Overall Study|Subject Decision|2
1740930|NCT00935532|6072376|P2|Overall Study|Protocol Violation|1
1740931|NCT00935532|6072377|P1|Overall Study|Protocol Violation|2
1740932|NCT00935532|6072376|P2|Overall Study|Physician Decision|2
1740933|NCT00935532|6072377|P1|Overall Study|Physician Decision|1
1740934|NCT00935532|6072376|P2|Overall Study|Lost to Follow-up|0
1740935|NCT00935532|6072377|P1|Overall Study|Lost to Follow-up|1
1740936|NCT00935532|6072376|P2|Overall Study|Death|0
1740937|NCT00935532|6072377|P1|Overall Study|Death|1
1740938|NCT00935532|6072376|P2|Overall Study|Adverse Event|6
1740939|NCT00935532|6072377|P1|Overall Study|Adverse Event|11
1740940|NCT00935493|6072406|P3|Overall Study|Treatment Discontinued|0
1740941|NCT00935493|6072407|P2|Overall Study|Treatment Discontinued|1
1740942|NCT00935493|6072408|P1|Overall Study|Treatment Discontinued|0
1740943|NCT00935493|6072406|P3|Overall Study|Lost to Follow-up|1
1740944|NCT00935493|6072407|P2|Overall Study|Lost to Follow-up|1
1740945|NCT00935493|6072408|P1|Overall Study|Lost to Follow-up|1
1740946|NCT00935272|6072457|P2|Overall Study|Protocol Violation|1
1740947|NCT00935272|6072458|P1|Overall Study|Protocol Violation|0
1740948|NCT00935272|6072457|P2|Overall Study|Physician Decision|0
1740949|NCT00935272|6072458|P1|Overall Study|Physician Decision|1
1740950|NCT00935272|6072457|P2|Overall Study|Withdrawal by Subject|2
1740951|NCT00935272|6072458|P1|Overall Study|Withdrawal by Subject|8
1740952|NCT00935272|6072457|P2|Overall Study|Lost to Follow-up|3
1740953|NCT00935272|6072458|P1|Overall Study|Lost to Follow-up|10
1740954|NCT00935259|6072467|P2|Period 1|Administrative (scheduling conflict)|1
1740955|NCT00935259|6072468|P1|Period 1|Administrative (scheduling conflict)|1
1740956|NCT00935220|6072482|P1|Overall Study|Other reason (not specified)|1
1740957|NCT00935220|6072482|P1|Overall Study|Adverse Event|1
1740958|NCT00934947|6072513|P2|Overall Study|Adverse Event|2
1740959|NCT00934947|6072514|P1|Overall Study|Adverse Event|0
1740960|NCT00934856|6072543|P6|Extension Part|Non-compliance with drug|1
1740961|NCT00934856|6072544|P5|Extension Part|Non-compliance with drug|0
1740962|NCT00934856|6072545|P4|Extension Part|Non-compliance with drug|0
1740963|NCT00934856|6072546|P3|Extension Part|Non-compliance with drug|0
1740964|NCT00934856|6072547|P2|Extension Part|Non-compliance with drug|0
1740965|NCT00934856|6072548|P1|Extension Part|Non-compliance with drug|0
1740966|NCT00934856|6072543|P6|Extension Part|Progressive disease|0
1740967|NCT00934856|6072544|P5|Extension Part|Progressive disease|0
1740968|NCT00934856|6072545|P4|Extension Part|Progressive disease|1
1740969|NCT00934856|6072546|P3|Extension Part|Progressive disease|0
1740970|NCT00934856|6072547|P2|Extension Part|Progressive disease|0
1740971|NCT00934856|6072548|P1|Extension Part|Progressive disease|0
1740972|NCT00934856|6072543|P6|Extension Part|Adverse Event|4
1740973|NCT00934856|6072544|P5|Extension Part|Adverse Event|4
1740974|NCT00934856|6072545|P4|Extension Part|Adverse Event|1
1740975|NCT00934856|6072546|P3|Extension Part|Adverse Event|0
1740976|NCT00934856|6072547|P2|Extension Part|Adverse Event|0
1740977|NCT00934856|6072548|P1|Extension Part|Adverse Event|0
1740978|NCT00934856|6072543|P6|Feasibility Part|Withdrawal by Subject|1
1740979|NCT00934856|6072544|P5|Feasibility Part|Withdrawal by Subject|0
1740980|NCT00934856|6072545|P4|Feasibility Part|Withdrawal by Subject|1
1740981|NCT00934856|6072546|P3|Feasibility Part|Withdrawal by Subject|0
1740982|NCT00934856|6072547|P2|Feasibility Part|Withdrawal by Subject|0
1740983|NCT00934856|6072548|P1|Feasibility Part|Withdrawal by Subject|0
1740984|NCT00934856|6072543|P6|Feasibility Part|Adverse Event|2
1740985|NCT00934856|6072544|P5|Feasibility Part|Adverse Event|0
1740986|NCT00934856|6072545|P4|Feasibility Part|Adverse Event|1
1740987|NCT00934856|6072546|P3|Feasibility Part|Adverse Event|0
1740988|NCT00934856|6072547|P2|Feasibility Part|Adverse Event|1
1740989|NCT00934856|6072548|P1|Feasibility Part|Adverse Event|1
1740990|NCT00934856|6072543|P6|Feasibility Part|Physician Decision|0
1740991|NCT00934856|6072544|P5|Feasibility Part|Physician Decision|0
1740992|NCT00934856|6072545|P4|Feasibility Part|Physician Decision|0
1740993|NCT00934856|6072546|P3|Feasibility Part|Physician Decision|1
1740994|NCT00934856|6072547|P2|Feasibility Part|Physician Decision|0
1740995|NCT00934856|6072548|P1|Feasibility Part|Physician Decision|0
1740996|NCT00934856|6072543|P6|Feasibility Part|Progressive disease|0
1740997|NCT00934856|6072544|P5|Feasibility Part|Progressive disease|0
1740998|NCT00934856|6072545|P4|Feasibility Part|Progressive disease|3
1740999|NCT00934856|6072546|P3|Feasibility Part|Progressive disease|2
1741000|NCT00934856|6072547|P2|Feasibility Part|Progressive disease|4
1741001|NCT00934856|6072548|P1|Feasibility Part|Progressive disease|4
1741002|NCT00934843|6072646|P2|Overall Study|Protocol Violation|1
1741003|NCT00934843|6072647|P1|Overall Study|Protocol Violation|0
1741004|NCT00934791|6072663|P2|Overall Study|Withdrawal by Subject|0
1741005|NCT00934791|6072664|P1|Overall Study|Withdrawal by Subject|1
1741006|NCT00934661|6072672|P2|Overall Study|Failure of Combined/Spinal Epidural|0
1741007|NCT00934661|6072673|P1|Overall Study|Failure of Combined/Spinal Epidural|1
1741008|NCT00934648|6072693|P1|Overall Study|Withdrawal by Subject|1
1741009|NCT00934648|6072693|P1|Overall Study|Failure to return|8
1741010|NCT00934622|6072737|P1|Overall Study|2nd Intraoperative exclusion criteria|1
1741011|NCT00934622|6072737|P1|Overall Study|Lost to Follow-up|7
1741012|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
1741013|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
1741014|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
1741015|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
1741016|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
1741017|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
1741018|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
1741019|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
1741020|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
1741021|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
1741022|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
1741023|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
1741024|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
1741025|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
1741026|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
1741027|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
1741028|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
1741029|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
1741030|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
1741031|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
1741032|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
1741033|NCT00934544|6072775|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
1741034|NCT00934544|6072776|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
1741035|NCT00934544|6072777|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
1741036|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
1741037|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
1741038|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
1741039|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
1741040|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
1741041|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
1741042|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
1741043|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
1741044|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
1741045|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
1741046|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
1741047|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
1741048|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
1741049|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
1741050|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
1741051|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
1741052|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
1741053|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
1741054|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
1741055|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
1741056|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
1741057|NCT00934544|6072775|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
1741058|NCT00934544|6072776|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
1741059|NCT00934544|6072777|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
1741060|NCT00934440|6072813|P1|Overall Study|Lost to Follow-up|1
1741061|NCT00934362|6072829|P2|Overall Study|Adverse Event|0
1741062|NCT00934362|6072830|P1|Overall Study|Adverse Event|1
1741063|NCT00934128|6072880|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
1741064|NCT00934128|6072881|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
1741065|NCT00934128|6072880|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
1741066|NCT00934128|6072881|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
1741067|NCT00934128|6072880|P2|Washout Period (1 Hour)|Too tired|0
1741068|NCT00934128|6072881|P1|Washout Period (1 Hour)|Too tired|1
1741069|NCT00934128|6072880|P2|Washout Period (1 Hour)|Pain|0
1741070|NCT00934128|6072881|P1|Washout Period (1 Hour)|Pain|1
1741071|NCT00934128|6072880|P2|Washout Period (1 Hour)|Patient preference|3
1741072|NCT00934128|6072881|P1|Washout Period (1 Hour)|Patient preference|1
1741073|NCT00934128|6072880|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
1741074|NCT00934128|6072881|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
1741075|NCT00934128|6072880|P2|First Intervention (2 Hours)|Adverse Event|1
1741076|NCT00934128|6072881|P1|First Intervention (2 Hours)|Adverse Event|4
1741077|NCT00934128|6072880|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
1741078|NCT00934128|6072881|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
1741079|NCT00934102|6072889|P3|Period 1, One Night of Wear|Personal Reasons|0
1741080|NCT00934102|6072890|P2|Period 1, One Night of Wear|Personal Reasons|0
1741081|NCT00934102|6072891|P1|Period 1, One Night of Wear|Personal Reasons|1
1741082|NCT00934050|6072905|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
1741083|NCT00934050|6072906|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
1741084|NCT00934050|6072907|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1741085|NCT00934050|6072908|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1741086|NCT00934050|6072909|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1741087|NCT00934050|6072910|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
1741088|NCT00934050|6072905|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
1741089|NCT00934050|6072906|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1741090|NCT00934050|6072907|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1741091|NCT00934050|6072908|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1741092|NCT00934050|6072909|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1741093|NCT00934050|6072910|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
1741094|NCT00934050|6072905|P6|Enrolled After 15 Dec 2009|Death|1
1741095|NCT00934050|6072906|P5|Enrolled After 15 Dec 2009|Death|0
1741096|NCT00934050|6072907|P4|Enrolled After 15 Dec 2009|Death|0
1741097|NCT00934050|6072908|P3|Enrolled After 15 Dec 2009|Death|0
1741098|NCT00934050|6072909|P2|Enrolled After 15 Dec 2009|Death|0
1741099|NCT00934050|6072910|P1|Enrolled After 15 Dec 2009|Death|0
1741100|NCT00934050|6072905|P6|Enrolled After 15 Dec 2009|Adverse Event|0
1741101|NCT00934050|6072906|P5|Enrolled After 15 Dec 2009|Adverse Event|3
1741102|NCT00934050|6072907|P4|Enrolled After 15 Dec 2009|Adverse Event|0
1741103|NCT00934050|6072908|P3|Enrolled After 15 Dec 2009|Adverse Event|0
1741104|NCT00934050|6072909|P2|Enrolled After 15 Dec 2009|Adverse Event|0
1741105|NCT00934050|6072910|P1|Enrolled After 15 Dec 2009|Adverse Event|0
1741106|NCT00934050|6072905|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1741107|NCT00934050|6072906|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1741108|NCT00934050|6072907|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1741109|NCT00934050|6072908|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
1741110|NCT00934050|6072909|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1741111|NCT00934050|6072910|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
1741112|NCT00934050|6072905|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
1741113|NCT00934050|6072906|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
1741114|NCT00934050|6072907|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
1741115|NCT00934050|6072908|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
1741116|NCT00934050|6072909|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
1741117|NCT00934050|6072910|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
1741118|NCT00934050|6072905|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1741119|NCT00934050|6072906|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1741120|NCT00934050|6072907|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
1741121|NCT00934050|6072908|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1741122|NCT00934050|6072909|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
1741123|NCT00934050|6072910|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
1741124|NCT00933933|6072933|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
1741125|NCT00933933|6072934|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
1741126|NCT00933933|6072935|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
1741127|NCT00933933|6072933|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
1741128|NCT00933933|6072934|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
1741129|NCT00933933|6072935|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
1741130|NCT00933686|6072953|P2|Overall Study|Failure to show up at endpoint visits|2
1741131|NCT00933686|6072954|P1|Overall Study|Failure to show up at endpoint visits|0
1741132|NCT00933686|6072953|P2|Overall Study|Physician Decision|0
1741133|NCT00933686|6072954|P1|Overall Study|Physician Decision|1
1741134|NCT00933686|6072953|P2|Overall Study|Adverse Event|1
1741135|NCT00933686|6072954|P1|Overall Study|Adverse Event|1
1741136|NCT00933686|6072953|P2|Overall Study|Withdrawal by Subject|5
1741137|NCT00933686|6072954|P1|Overall Study|Withdrawal by Subject|6
1741138|NCT00933686|6072953|P2|Overall Study|Lost to Follow-up|2
1741139|NCT00933686|6072954|P1|Overall Study|Lost to Follow-up|2
1741140|NCT00933686|6072953|P2|Overall Study|Protocol Violation|1
1741141|NCT00933686|6072954|P1|Overall Study|Protocol Violation|0
1741142|NCT00933608|6072974|P2|Overall Study|Physician Decision|0
1741143|NCT00933608|6072975|P1|Overall Study|Physician Decision|1
1741144|NCT00933608|6072974|P2|Overall Study|Adverse Event|2
1741145|NCT00933608|6072975|P1|Overall Study|Adverse Event|4
1741146|NCT00933543|6072983|P2|Overall Study|Other|1
1741147|NCT00933543|6072984|P1|Overall Study|Other|1
1741148|NCT00933543|6072983|P2|Overall Study|Lack of Efficacy|3
1741149|NCT00933543|6072984|P1|Overall Study|Lack of Efficacy|0
1741150|NCT00933543|6072983|P2|Overall Study|Withdrawal by Subject|1
1741151|NCT00933543|6072984|P1|Overall Study|Withdrawal by Subject|0
1741152|NCT00933543|6072983|P2|Overall Study|Lost to Follow-up|1
1741153|NCT00933543|6072984|P1|Overall Study|Lost to Follow-up|0
1741154|NCT00933543|6072983|P2|Overall Study|Adverse Event|1
1741155|NCT00933543|6072984|P1|Overall Study|Adverse Event|2
1741156|NCT00933335|6073053|P2|Overall Study|Co-morbid Illness|0
1741157|NCT00933335|6073054|P1|Overall Study|Co-morbid Illness|1
1741158|NCT00933335|6073053|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
1741159|NCT00933335|6073054|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
1741160|NCT00933335|6073053|P2|Overall Study|Progressive Disease|11
1741161|NCT00933335|6073054|P1|Overall Study|Progressive Disease|0
1741162|NCT00933335|6073053|P2|Overall Study|Withdrawal by Subject|1
1741163|NCT00933335|6073054|P1|Overall Study|Withdrawal by Subject|0
1741164|NCT00933335|6073053|P2|Overall Study|Lost to Follow-up|3
1741165|NCT00933335|6073054|P1|Overall Study|Lost to Follow-up|1
1741166|NCT00933270|6073124|P1|Overall Study|Moved or would not return|10
1741167|NCT00933270|6073124|P1|Overall Study|Death|24
1741168|NCT00933270|6073124|P1|Overall Study|Missed Visit|2
1741169|NCT00933270|6073124|P1|Overall Study|Adverse Event|1
1741170|NCT00933270|6073124|P1|Overall Study|Lost to Follow-up|14
1741171|NCT00933270|6073124|P1|Overall Study|Insufficient Follow-up|10
1741172|NCT00933270|6073124|P1|Overall Study|Withdrawal by Subject|26
1741173|NCT00933244|6073218|P3|Overall Study|Withdrawal by Subject|3
1741174|NCT00933244|6073219|P2|Overall Study|Withdrawal by Subject|1
1741175|NCT00933244|6073220|P1|Overall Study|Withdrawal by Subject|5
1741176|NCT00933166|6073237|P1|Overall Study|Withdrawal by Subject|1
1741177|NCT00933166|6073237|P1|Overall Study|Unavailable|4
1741178|NCT00933166|6073237|P1|Overall Study|Lack of Efficacy|9
1741179|NCT00933166|6073237|P1|Overall Study|Lost to Follow-up|4
1741180|NCT00932893|6073243|P2|Overall Study|Other|144
1741181|NCT00932893|6073244|P1|Overall Study|Other|5
1741182|NCT00932893|6073243|P2|Overall Study|Withdrawal by Subject|2
1741183|NCT00932893|6073244|P1|Overall Study|Withdrawal by Subject|5
1741184|NCT00932893|6073243|P2|Overall Study|Lost to Follow-up|0
1741185|NCT00932893|6073244|P1|Overall Study|Lost to Follow-up|8
1741186|NCT00932893|6073243|P2|Overall Study|Death|24
1741187|NCT00932893|6073244|P1|Overall Study|Death|115
1741188|NCT00932698|6073292|P11|Part 2 (Dose Expansion)|Adverse Event|0
1741189|NCT00932698|6073293|P10|Part 2 (Dose Expansion)|Adverse Event|1
1741190|NCT00932698|6073294|P9|Part 2 (Dose Expansion)|Adverse Event|1
1741191|NCT00932698|6073295|P8|Part 2 (Dose Expansion)|Adverse Event|5
1741192|NCT00932698|6073296|P7|Part 2 (Dose Expansion)|Adverse Event|0
1741193|NCT00932698|6073297|P6|Part 2 (Dose Expansion)|Adverse Event|0
1741194|NCT00932698|6073298|P5|Part 2 (Dose Expansion)|Adverse Event|0
1741195|NCT00932698|6073299|P4|Part 2 (Dose Expansion)|Adverse Event|0
1741196|NCT00932698|6073300|P3|Part 2 (Dose Expansion)|Adverse Event|0
1741197|NCT00932698|6073301|P2|Part 2 (Dose Expansion)|Adverse Event|0
1741198|NCT00932698|6073302|P1|Part 2 (Dose Expansion)|Adverse Event|0
1741199|NCT00932698|6073292|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741200|NCT00932698|6073293|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
1741201|NCT00932698|6073294|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
1741202|NCT00932698|6073295|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
1741203|NCT00932698|6073296|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741204|NCT00932698|6073297|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741205|NCT00932698|6073298|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741206|NCT00932698|6073299|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741207|NCT00932698|6073300|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741208|NCT00932698|6073301|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741209|NCT00932698|6073302|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
1741210|NCT00932698|6073292|P11|Part 2 (Dose Expansion)|Progressive Disease|2
1741211|NCT00932698|6073293|P10|Part 2 (Dose Expansion)|Progressive Disease|3
1741212|NCT00932698|6073294|P9|Part 2 (Dose Expansion)|Progressive Disease|8
1741213|NCT00932698|6073295|P8|Part 2 (Dose Expansion)|Progressive Disease|14
1741214|NCT00932698|6073296|P7|Part 2 (Dose Expansion)|Progressive Disease|0
1741215|NCT00932698|6073297|P6|Part 2 (Dose Expansion)|Progressive Disease|0
1741216|NCT00932698|6073298|P5|Part 2 (Dose Expansion)|Progressive Disease|0
1741217|NCT00932698|6073299|P4|Part 2 (Dose Expansion)|Progressive Disease|0
1741218|NCT00932698|6073300|P3|Part 2 (Dose Expansion)|Progressive Disease|0
1741219|NCT00932698|6073301|P2|Part 2 (Dose Expansion)|Progressive Disease|0
1741220|NCT00932698|6073302|P1|Part 2 (Dose Expansion)|Progressive Disease|0
1741221|NCT00932698|6073292|P11|Part 1 (Dose Escalation)|Other|0
1741222|NCT00932698|6073293|P10|Part 1 (Dose Escalation)|Other|0
1741223|NCT00932698|6073294|P9|Part 1 (Dose Escalation)|Other|0
1741224|NCT00932698|6073295|P8|Part 1 (Dose Escalation)|Other|0
1741225|NCT00932698|6073296|P7|Part 1 (Dose Escalation)|Other|1
1741226|NCT00932698|6073297|P6|Part 1 (Dose Escalation)|Other|0
1741227|NCT00932698|6073298|P5|Part 1 (Dose Escalation)|Other|0
1741228|NCT00932698|6073299|P4|Part 1 (Dose Escalation)|Other|0
1741229|NCT00932698|6073300|P3|Part 1 (Dose Escalation)|Other|1
1741230|NCT00932698|6073301|P2|Part 1 (Dose Escalation)|Other|0
1741231|NCT00932698|6073302|P1|Part 1 (Dose Escalation)|Other|0
1741232|NCT00932698|6073292|P11|Part 1 (Dose Escalation)|Adverse Event|0
1741233|NCT00932698|6073293|P10|Part 1 (Dose Escalation)|Adverse Event|0
1741234|NCT00932698|6073294|P9|Part 1 (Dose Escalation)|Adverse Event|0
1741235|NCT00932698|6073295|P8|Part 1 (Dose Escalation)|Adverse Event|0
1741236|NCT00932698|6073296|P7|Part 1 (Dose Escalation)|Adverse Event|0
1741237|NCT00932698|6073297|P6|Part 1 (Dose Escalation)|Adverse Event|1
1741238|NCT00932698|6073298|P5|Part 1 (Dose Escalation)|Adverse Event|0
1741239|NCT00932698|6073299|P4|Part 1 (Dose Escalation)|Adverse Event|0
1741240|NCT00932698|6073300|P3|Part 1 (Dose Escalation)|Adverse Event|0
1741241|NCT00932698|6073301|P2|Part 1 (Dose Escalation)|Adverse Event|0
1741242|NCT00932698|6073302|P1|Part 1 (Dose Escalation)|Adverse Event|0
1741243|NCT00932698|6073292|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
1741244|NCT00932698|6073293|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
1741245|NCT00932698|6073294|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
1741246|NCT00932698|6073295|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
1741247|NCT00932698|6073296|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
1741248|NCT00932698|6073297|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
1741249|NCT00932698|6073298|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
1741250|NCT00932698|6073299|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
1741251|NCT00932698|6073300|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
1741252|NCT00932698|6073301|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
1741253|NCT00932698|6073302|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
1741254|NCT00932698|6073292|P11|Part 1 (Dose Escalation)|Progressive Disease|0
1741255|NCT00932698|6073293|P10|Part 1 (Dose Escalation)|Progressive Disease|0
1741256|NCT00932698|6073294|P9|Part 1 (Dose Escalation)|Progressive Disease|0
1741257|NCT00932698|6073295|P8|Part 1 (Dose Escalation)|Progressive Disease|0
1741258|NCT00932698|6073296|P7|Part 1 (Dose Escalation)|Progressive Disease|2
1741259|NCT00932698|6073297|P6|Part 1 (Dose Escalation)|Progressive Disease|5
1741260|NCT00932698|6073298|P5|Part 1 (Dose Escalation)|Progressive Disease|3
1741261|NCT00932698|6073299|P4|Part 1 (Dose Escalation)|Progressive Disease|2
1741262|NCT00932698|6073300|P3|Part 1 (Dose Escalation)|Progressive Disease|2
1741263|NCT00932698|6073301|P2|Part 1 (Dose Escalation)|Progressive Disease|2
1741264|NCT00932698|6073302|P1|Part 1 (Dose Escalation)|Progressive Disease|3
1741265|NCT00932646|6073476|P4|Overall Study|Withdrawal by Subject|0
1741266|NCT00932646|6073477|P3|Overall Study|Withdrawal by Subject|3
1741267|NCT00932646|6073478|P2|Overall Study|Withdrawal by Subject|1
1741268|NCT00932646|6073479|P1|Overall Study|Withdrawal by Subject|1
1741269|NCT00932646|6073476|P4|Overall Study|Lost to Follow-up|0
1741270|NCT00932646|6073477|P3|Overall Study|Lost to Follow-up|0
1741271|NCT00932646|6073478|P2|Overall Study|Lost to Follow-up|1
1741272|NCT00932646|6073479|P1|Overall Study|Lost to Follow-up|2
1741273|NCT00932646|6073476|P4|Overall Study|Adverse Event|1
1741274|NCT00932646|6073477|P3|Overall Study|Adverse Event|1
1741275|NCT00932646|6073478|P2|Overall Study|Adverse Event|1
1741276|NCT00932646|6073479|P1|Overall Study|Adverse Event|2
1741277|NCT00932451|6073566|P1|Overall Study|Other reasons|5
1741278|NCT00932451|6073566|P1|Overall Study|Death|726
1741279|NCT00932451|6073566|P1|Overall Study|Lost to Follow-up|22
1741280|NCT00932451|6073566|P1|Overall Study|Withdrawal by Subject|69
1741281|NCT00932425|6073590|P2|Overall Study|Withdrawal by Subject|1
1741282|NCT00932425|6073591|P1|Overall Study|Withdrawal by Subject|0
1741283|NCT00932425|6073590|P2|Overall Study|Lost to Follow-up|1
1741284|NCT00932425|6073591|P1|Overall Study|Lost to Follow-up|0
1741285|NCT00932373|6073624|P11|Overall Study|Lack of Efficacy|0
1741286|NCT00932373|6073625|P10|Overall Study|Lack of Efficacy|1
1741287|NCT00932373|6073626|P9|Overall Study|Lack of Efficacy|0
1741288|NCT00932373|6073627|P8|Overall Study|Lack of Efficacy|0
1741289|NCT00932373|6073628|P7|Overall Study|Lack of Efficacy|0
1741290|NCT00932373|6073629|P6|Overall Study|Lack of Efficacy|0
1741291|NCT00932373|6073630|P5|Overall Study|Lack of Efficacy|0
1741292|NCT00932373|6073631|P4|Overall Study|Lack of Efficacy|0
1741293|NCT00932373|6073632|P3|Overall Study|Lack of Efficacy|0
1741294|NCT00932373|6073633|P2|Overall Study|Lack of Efficacy|0
1741295|NCT00932373|6073634|P1|Overall Study|Lack of Efficacy|0
1741296|NCT00932373|6073624|P11|Overall Study|Clinical progression|0
1741297|NCT00932373|6073625|P10|Overall Study|Clinical progression|0
1741298|NCT00932373|6073626|P9|Overall Study|Clinical progression|0
1741299|NCT00932373|6073627|P8|Overall Study|Clinical progression|0
1741300|NCT00932373|6073628|P7|Overall Study|Clinical progression|1
1741301|NCT00932373|6073629|P6|Overall Study|Clinical progression|0
1741302|NCT00932373|6073630|P5|Overall Study|Clinical progression|0
1741303|NCT00932373|6073631|P4|Overall Study|Clinical progression|0
1741304|NCT00932373|6073632|P3|Overall Study|Clinical progression|0
1741305|NCT00932373|6073633|P2|Overall Study|Clinical progression|0
1741306|NCT00932373|6073634|P1|Overall Study|Clinical progression|0
1741307|NCT00932373|6073624|P11|Overall Study|Withdrawal by Subject|0
1741308|NCT00932373|6073625|P10|Overall Study|Withdrawal by Subject|0
1741309|NCT00932373|6073626|P9|Overall Study|Withdrawal by Subject|1
1741310|NCT00932373|6073627|P8|Overall Study|Withdrawal by Subject|0
1741311|NCT00932373|6073628|P7|Overall Study|Withdrawal by Subject|0
1741312|NCT00932373|6073629|P6|Overall Study|Withdrawal by Subject|0
1741313|NCT00932373|6073630|P5|Overall Study|Withdrawal by Subject|0
1741314|NCT00932373|6073631|P4|Overall Study|Withdrawal by Subject|0
1741315|NCT00932373|6073632|P3|Overall Study|Withdrawal by Subject|0
1741316|NCT00932373|6073633|P2|Overall Study|Withdrawal by Subject|0
1741317|NCT00932373|6073634|P1|Overall Study|Withdrawal by Subject|0
1741318|NCT00932373|6073624|P11|Overall Study|Dose limiting toxicity|0
1741319|NCT00932373|6073625|P10|Overall Study|Dose limiting toxicity|0
1741320|NCT00932373|6073626|P9|Overall Study|Dose limiting toxicity|0
1741321|NCT00932373|6073627|P8|Overall Study|Dose limiting toxicity|0
1741322|NCT00932373|6073628|P7|Overall Study|Dose limiting toxicity|0
1741323|NCT00932373|6073629|P6|Overall Study|Dose limiting toxicity|1
1741324|NCT00932373|6073630|P5|Overall Study|Dose limiting toxicity|0
1741325|NCT00932373|6073631|P4|Overall Study|Dose limiting toxicity|0
1741326|NCT00932373|6073632|P3|Overall Study|Dose limiting toxicity|0
1741327|NCT00932373|6073633|P2|Overall Study|Dose limiting toxicity|0
1741328|NCT00932373|6073634|P1|Overall Study|Dose limiting toxicity|0
1741329|NCT00932373|6073624|P11|Overall Study|Physician Decision|0
1741330|NCT00932373|6073625|P10|Overall Study|Physician Decision|1
1741331|NCT00932373|6073626|P9|Overall Study|Physician Decision|0
1741332|NCT00932373|6073627|P8|Overall Study|Physician Decision|0
1741333|NCT00932373|6073628|P7|Overall Study|Physician Decision|0
1741334|NCT00932373|6073629|P6|Overall Study|Physician Decision|0
1741335|NCT00932373|6073630|P5|Overall Study|Physician Decision|2
1741336|NCT00932373|6073631|P4|Overall Study|Physician Decision|0
1741337|NCT00932373|6073632|P3|Overall Study|Physician Decision|1
1741338|NCT00932373|6073633|P2|Overall Study|Physician Decision|0
1741339|NCT00932373|6073634|P1|Overall Study|Physician Decision|0
1741340|NCT00932373|6073624|P11|Overall Study|Adverse Event|1
1741341|NCT00932373|6073625|P10|Overall Study|Adverse Event|2
1741342|NCT00932373|6073626|P9|Overall Study|Adverse Event|0
1741343|NCT00932373|6073627|P8|Overall Study|Adverse Event|1
1741344|NCT00932373|6073628|P7|Overall Study|Adverse Event|0
1741345|NCT00932373|6073629|P6|Overall Study|Adverse Event|1
1741346|NCT00932373|6073630|P5|Overall Study|Adverse Event|2
1741347|NCT00932373|6073631|P4|Overall Study|Adverse Event|0
1741348|NCT00932373|6073632|P3|Overall Study|Adverse Event|0
1741349|NCT00932373|6073633|P2|Overall Study|Adverse Event|0
1741350|NCT00932373|6073634|P1|Overall Study|Adverse Event|0
1741351|NCT00932373|6073624|P11|Overall Study|Progressive disease|2
1741352|NCT00932373|6073625|P10|Overall Study|Progressive disease|9
1741353|NCT00932373|6073626|P9|Overall Study|Progressive disease|1
1741354|NCT00932373|6073627|P8|Overall Study|Progressive disease|2
1741355|NCT00932373|6073628|P7|Overall Study|Progressive disease|0
1741356|NCT00932373|6073629|P6|Overall Study|Progressive disease|1
1741357|NCT00932373|6073630|P5|Overall Study|Progressive disease|10
1741358|NCT00932373|6073631|P4|Overall Study|Progressive disease|0
1741359|NCT00932373|6073632|P3|Overall Study|Progressive disease|0
1741360|NCT00932373|6073633|P2|Overall Study|Progressive disease|1
1741361|NCT00932373|6073634|P1|Overall Study|Progressive disease|3
1741362|NCT00932360|6073734|P6|Washout (One Week)|Withdrawal by Subject|0
1741363|NCT00932360|6073735|P5|Washout (One Week)|Withdrawal by Subject|2
1741364|NCT00932360|6073736|P4|Washout (One Week)|Withdrawal by Subject|0
1741365|NCT00932360|6073737|P3|Washout (One Week)|Withdrawal by Subject|0
1741366|NCT00932360|6073738|P2|Washout (One Week)|Withdrawal by Subject|0
1741367|NCT00932360|6073739|P1|Washout (One Week)|Withdrawal by Subject|0
1741368|NCT00932165|6073796|P1|Overall Study|Lost to Follow-up|1
1741369|NCT00932126|6073820|P8|Overall Study|Other|2
1741370|NCT00932126|6073821|P7|Overall Study|Other|1
1741371|NCT00932126|6073822|P6|Overall Study|Other|0
1741372|NCT00932126|6073823|P5|Overall Study|Other|1
1741373|NCT00932126|6073824|P4|Overall Study|Other|0
1741374|NCT00932126|6073825|P3|Overall Study|Other|0
1741375|NCT00932126|6073826|P2|Overall Study|Other|0
1741376|NCT00932126|6073827|P1|Overall Study|Other|0
1741377|NCT00932126|6073820|P8|Overall Study|Objective progression or relapse|5
1741378|NCT00932126|6073821|P7|Overall Study|Objective progression or relapse|3
1741379|NCT00932126|6073822|P6|Overall Study|Objective progression or relapse|3
1741380|NCT00932126|6073823|P5|Overall Study|Objective progression or relapse|3
1741381|NCT00932126|6073824|P4|Overall Study|Objective progression or relapse|3
1741382|NCT00932126|6073825|P3|Overall Study|Objective progression or relapse|2
1741383|NCT00932126|6073826|P2|Overall Study|Objective progression or relapse|3
1741384|NCT00932126|6073827|P1|Overall Study|Objective progression or relapse|3
1741385|NCT00932126|6073820|P8|Overall Study|Withdrawal by Subject|1
1741386|NCT00932126|6073821|P7|Overall Study|Withdrawal by Subject|0
1741387|NCT00932126|6073822|P6|Overall Study|Withdrawal by Subject|0
1741388|NCT00932126|6073823|P5|Overall Study|Withdrawal by Subject|0
1741389|NCT00932126|6073824|P4|Overall Study|Withdrawal by Subject|0
1741390|NCT00932126|6073825|P3|Overall Study|Withdrawal by Subject|1
1741391|NCT00932126|6073826|P2|Overall Study|Withdrawal by Subject|0
1741392|NCT00932126|6073827|P1|Overall Study|Withdrawal by Subject|0
1741393|NCT00932126|6073820|P8|Overall Study|Protocol Violation|0
1741394|NCT00932126|6073821|P7|Overall Study|Protocol Violation|0
1741395|NCT00932126|6073822|P6|Overall Study|Protocol Violation|0
1741396|NCT00932126|6073823|P5|Overall Study|Protocol Violation|1
1741397|NCT00932126|6073824|P4|Overall Study|Protocol Violation|0
1741398|NCT00932126|6073825|P3|Overall Study|Protocol Violation|0
1741399|NCT00932126|6073826|P2|Overall Study|Protocol Violation|0
1741400|NCT00932126|6073827|P1|Overall Study|Protocol Violation|0
1741401|NCT00932126|6073820|P8|Overall Study|Adverse Event|2
1741402|NCT00932126|6073821|P7|Overall Study|Adverse Event|1
1741403|NCT00932126|6073822|P6|Overall Study|Adverse Event|0
1741404|NCT00932126|6073823|P5|Overall Study|Adverse Event|0
1741405|NCT00932126|6073824|P4|Overall Study|Adverse Event|0
1741406|NCT00932126|6073825|P3|Overall Study|Adverse Event|0
1741407|NCT00932126|6073826|P2|Overall Study|Adverse Event|0
1741408|NCT00932126|6073827|P1|Overall Study|Adverse Event|0
1741409|NCT00932113|6073865|P2|Overall Study|Lost to Follow-up|0
1741410|NCT00932113|6073866|P1|Overall Study|Lost to Follow-up|1
1741411|NCT00931918|6073918|P2|Overall Study|Did not receive study drug|2
1741412|NCT00931918|6073919|P1|Overall Study|Did not receive study drug|3
1741413|NCT00931918|6073918|P2|Overall Study|Other Reason not Specified|4
1741414|NCT00931918|6073919|P1|Overall Study|Other Reason not Specified|4
1741415|NCT00931918|6073918|P2|Overall Study|Withdrawal by Patient|4
1741416|NCT00931918|6073919|P1|Overall Study|Withdrawal by Patient|3
1741417|NCT00931918|6073918|P2|Overall Study|Symptomatic Deterioration|0
1741418|NCT00931918|6073919|P1|Overall Study|Symptomatic Deterioration|1
1741419|NCT00931918|6073918|P2|Overall Study|Progressive Disease|1
1741420|NCT00931918|6073919|P1|Overall Study|Progressive Disease|2
1741421|NCT00931918|6073918|P2|Overall Study|Adverse Event|6
1741422|NCT00931918|6073919|P1|Overall Study|Adverse Event|4
1741423|NCT00931801|6073971|P3|Overall Study|Confirmed Virologic Failure|3
1741424|NCT00931801|6073972|P2|Overall Study|Confirmed Virologic Failure|0
1741425|NCT00931801|6073973|P1|Overall Study|Confirmed Virologic Failure|0
1741426|NCT00931801|6073971|P3|Overall Study|Withdrawal by Subject|0
1741427|NCT00931801|6073972|P2|Overall Study|Withdrawal by Subject|0
1741428|NCT00931801|6073973|P1|Overall Study|Withdrawal by Subject|1
1741429|NCT00931801|6073971|P3|Overall Study|Lost to Follow-up|0
1741430|NCT00931801|6073972|P2|Overall Study|Lost to Follow-up|1
1741431|NCT00931801|6073973|P1|Overall Study|Lost to Follow-up|0
1741432|NCT00931801|6073971|P3|Overall Study|Adverse Event|1
1741433|NCT00931801|6073972|P2|Overall Study|Adverse Event|0
1741434|NCT00931801|6073973|P1|Overall Study|Adverse Event|0
1741435|NCT00931723|6073996|P2|Overall Study|Late hospital discharge|0
1741436|NCT00931723|6073997|P1|Overall Study|Late hospital discharge|1
1741437|NCT00931723|6073996|P2|Overall Study|Sponsor decision|0
1741438|NCT00931723|6073997|P1|Overall Study|Sponsor decision|1
1741439|NCT00931723|6073996|P2|Overall Study|Lack or insufficient theraputic response|5
1741440|NCT00931723|6073997|P1|Overall Study|Lack or insufficient theraputic response|2
1741441|NCT00931723|6073996|P2|Overall Study|Took prohibited concomitant medication|1
1741442|NCT00931723|6073997|P1|Overall Study|Took prohibited concomitant medication|0
1741443|NCT00931723|6073996|P2|Overall Study|Safety reasons|1
1741444|NCT00931723|6073997|P1|Overall Study|Safety reasons|0
1741445|NCT00931723|6073996|P2|Overall Study|Severe non-compliance to protocol|0
1741446|NCT00931723|6073997|P1|Overall Study|Severe non-compliance to protocol|2
1741447|NCT00931723|6073996|P2|Overall Study|Study-specific discontinuation criteria|1
1741448|NCT00931723|6073997|P1|Overall Study|Study-specific discontinuation criteria|1
1741449|NCT00931723|6073996|P2|Overall Study|Lost to Follow-up|2
1741450|NCT00931723|6073997|P1|Overall Study|Lost to Follow-up|1
1741451|NCT00931723|6073996|P2|Overall Study|Condition under investigation worsened|2
1741452|NCT00931723|6073997|P1|Overall Study|Condition under investigation worsened|1
1741453|NCT00931723|6073996|P2|Overall Study|Lithium found in blood|1
1741454|NCT00931723|6073997|P1|Overall Study|Lithium found in blood|0
1741455|NCT00931723|6073996|P2|Overall Study|Adverse Event|13
1741456|NCT00931723|6073997|P1|Overall Study|Adverse Event|6
1741457|NCT00931723|6073996|P2|Overall Study|Withdrawal by Subject|13
1741458|NCT00931723|6073997|P1|Overall Study|Withdrawal by Subject|11
1741459|NCT00931710|6074045|P2|Overall Study|Protocol deviation|2
1741460|NCT00931710|6074046|P1|Overall Study|Protocol deviation|1
1741461|NCT00931710|6074045|P2|Overall Study|Lost to Follow-up|5
1741462|NCT00931710|6074046|P1|Overall Study|Lost to Follow-up|6
1741463|NCT00931710|6074045|P2|Overall Study|Patient withdrew consent|9
1741464|NCT00931710|6074046|P1|Overall Study|Patient withdrew consent|4
1741465|NCT00931710|6074045|P2|Overall Study|Unsatisfactory therapeutic effects|12
1741466|NCT00931710|6074046|P1|Overall Study|Unsatisfactory therapeutic effects|5
1741467|NCT00931710|6074045|P2|Overall Study|Abnormal test procedure results|0
1741468|NCT00931710|6074046|P1|Overall Study|Abnormal test procedure results|2
1741469|NCT00931710|6074045|P2|Overall Study|Adverse Event|10
1741470|NCT00931710|6074046|P1|Overall Study|Adverse Event|16
1741471|NCT00931632|6074064|P2|Overall Study|Adverse Event|15
1741472|NCT00931632|6074065|P1|Overall Study|Adverse Event|19
1741473|NCT00931632|6074064|P2|Overall Study|Withdrawal by Subject|3
1741474|NCT00931632|6074065|P1|Overall Study|Withdrawal by Subject|2
1741475|NCT00931528|6074087|P2|Overall Study|Assessment outside of Time Frame|23
1741476|NCT00931528|6074088|P1|Overall Study|Assessment outside of Time Frame|22
1741477|NCT00931528|6074087|P2|Overall Study|Lost to Follow-up|13
1741478|NCT00931528|6074088|P1|Overall Study|Lost to Follow-up|6
1741479|NCT00931528|6074087|P2|Overall Study|Withdrawal by Subject|12
1741480|NCT00931528|6074088|P1|Overall Study|Withdrawal by Subject|4
1741481|NCT00931528|6074087|P2|Overall Study|Protocol Violation|12
1741482|NCT00931528|6074088|P1|Overall Study|Protocol Violation|9
1741483|NCT00931515|6074108|P2|Overall Study|Lost to Follow-up|5
1741484|NCT00931515|6074109|P1|Overall Study|Lost to Follow-up|2
1741485|NCT00931463|6074139|P2|Overall Study|Lost to Follow-up|1
1741486|NCT00931463|6074140|P1|Overall Study|Lost to Follow-up|4
1741487|NCT00931463|6074139|P2|Overall Study|Withdrawal by Subject|0
1741488|NCT00931463|6074140|P1|Overall Study|Withdrawal by Subject|5
1741489|NCT00931463|6074139|P2|Overall Study|Death|4
1741490|NCT00931463|6074140|P1|Overall Study|Death|8
1741491|NCT00931411|6074156|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
1741492|NCT00931411|6074157|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
1741493|NCT00931411|6074156|P2|First Intervention - 42 Days|Lost to Follow-up|0
1741494|NCT00931411|6074157|P1|First Intervention - 42 Days|Lost to Follow-up|2
1741495|NCT00931411|6074156|P2|First Intervention - 42 Days|Adverse Event|3
1741496|NCT00931411|6074157|P1|First Intervention - 42 Days|Adverse Event|2
1741497|NCT00931385|6074178|P4|Overall Study|Lost to Follow-up|1
1741498|NCT00931385|6074179|P3|Overall Study|Lost to Follow-up|0
1741499|NCT00931385|6074180|P2|Overall Study|Lost to Follow-up|0
1741500|NCT00931385|6074181|P1|Overall Study|Lost to Follow-up|0
1741501|NCT00931385|6074178|P4|Overall Study|Withdrawal by Subject|1
1741502|NCT00931385|6074179|P3|Overall Study|Withdrawal by Subject|0
1741503|NCT00931385|6074180|P2|Overall Study|Withdrawal by Subject|1
1741504|NCT00931385|6074181|P1|Overall Study|Withdrawal by Subject|0
1741505|NCT00931385|6074178|P4|Overall Study|Protocol Violation|0
1741506|NCT00931385|6074179|P3|Overall Study|Protocol Violation|1
1741507|NCT00931385|6074180|P2|Overall Study|Protocol Violation|0
1741508|NCT00931385|6074181|P1|Overall Study|Protocol Violation|0
1741509|NCT00931385|6074178|P4|Overall Study|Adverse Event|3
1741510|NCT00931385|6074179|P3|Overall Study|Adverse Event|0
1741511|NCT00931385|6074180|P2|Overall Study|Adverse Event|1
1741512|NCT00931385|6074181|P1|Overall Study|Adverse Event|2
1741513|NCT00931307|6074250|P1|Overall Study|Biomicroscopy|1
1741514|NCT00931307|6074250|P1|Overall Study|Lack of Efficacy|12
1741515|NCT00931268|6074254|P1|Overall Study|Lost to Follow-up|6
1741516|NCT00931255|6074266|P2|Overall Study|Follow up biopsy not done|3
1741517|NCT00931255|6074267|P1|Overall Study|Follow up biopsy not done|2
1741518|NCT00930982|6074304|P2|Overall Study|Withdrawal by Subject|1
1741519|NCT00930982|6074305|P1|Overall Study|Withdrawal by Subject|1
1741520|NCT00930982|6074304|P2|Overall Study|Protocol Violation|5
1741521|NCT00930982|6074305|P1|Overall Study|Protocol Violation|1
1741522|NCT00930982|6074304|P2|Overall Study|Adverse Event|23
1741523|NCT00930982|6074305|P1|Overall Study|Adverse Event|19
1741524|NCT00930969|6074339|P1|Overall Study|Withdrawal by Subject|19
1741525|NCT00930969|6074339|P1|Overall Study|Physician Decision|13
1741526|NCT00930969|6074339|P1|Overall Study|Lost to Follow-up|1
1741527|NCT00930969|6074339|P1|Overall Study|Death|5
1741528|NCT00930930|6074349|P2|Overall Study|patients not compliant|1
1741529|NCT00930930|6074350|P1|Overall Study|patients not compliant|1
1741530|NCT00930930|6074349|P2|Overall Study|excessive lapse btw txs, not eligible|1
1741531|NCT00930930|6074350|P1|Overall Study|excessive lapse btw txs, not eligible|0
1741532|NCT00930930|6074349|P2|Overall Study|Disease progression|3
1741533|NCT00930930|6074350|P1|Overall Study|Disease progression|2
1741534|NCT00930930|6074349|P2|Overall Study|Withdrawal by Subject|1
1741535|NCT00930930|6074350|P1|Overall Study|Withdrawal by Subject|3
1741536|NCT00930930|6074349|P2|Overall Study|Adverse Event|3
1741537|NCT00930930|6074350|P1|Overall Study|Adverse Event|13
1741538|NCT00930930|6074349|P2|Overall Study|Physician Decision|0
1741539|NCT00930930|6074350|P1|Overall Study|Physician Decision|1
1741540|NCT00930930|6074349|P2|Overall Study|Death|0
1741541|NCT00930930|6074350|P1|Overall Study|Death|1
1741542|NCT00930813|6074364|P2|Overall Study|Lost to Follow-up|4
1741543|NCT00930813|6074365|P1|Overall Study|Lost to Follow-up|2
1741544|NCT00930813|6074364|P2|Overall Study|Withdrawal by Subject|5
1741545|NCT00930813|6074365|P1|Overall Study|Withdrawal by Subject|2
1741546|NCT00930813|6074364|P2|Overall Study|Death|5
1741547|NCT00930813|6074365|P1|Overall Study|Death|4
1741548|NCT00930774|6074386|P4|Overall Study|Withdrawal by Subject|0
1741549|NCT00930774|6074387|P3|Overall Study|Withdrawal by Subject|2
1741550|NCT00930774|6074388|P2|Overall Study|Withdrawal by Subject|9
1741551|NCT00930774|6074389|P1|Overall Study|Withdrawal by Subject|1
1741552|NCT00930761|6074429|P2|Overall Study|less than 3 music therapy sessions|3
1741553|NCT00930761|6074430|P1|Overall Study|less than 3 music therapy sessions|0
1741554|NCT00930761|6074429|P2|Overall Study|3 newborns died; 1 mother quit the study|0
1741555|NCT00930761|6074430|P1|Overall Study|3 newborns died; 1 mother quit the study|4
1741556|NCT00930722|6074442|P1|Overall Study|Study terminated by sponsor|2
1741557|NCT00930722|6074442|P1|Overall Study|No longer willing to participate|9
1741558|NCT00930722|6074442|P1|Overall Study|Lost to Follow-up|16
1741559|NCT00930644|6074457|P1|Overall Study|Adverse Event|16
1741560|NCT00930644|6074457|P1|Overall Study|Death|1
1741561|NCT00930644|6074457|P1|Overall Study|Physician Decision|2
1741562|NCT00930644|6074457|P1|Overall Study|Withdrawal by Subject|4
1741563|NCT00930553|6074470|P1|Overall Study|Other than specified above|28
1741564|NCT00930553|6074470|P1|Overall Study|Study terminated by sponsor|24
1741565|NCT00930553|6074470|P1|Overall Study|Death|9
1741566|NCT00930553|6074470|P1|Overall Study|Lost to Follow-up|25
1741567|NCT00930553|6074470|P1|Overall Study|Withdrawal by Subject|88
1741568|NCT00930553|6074470|P1|Overall Study|Pregnancy|1
1741569|NCT00930553|6074470|P1|Overall Study|Protocol Violation|1
1741570|NCT00930553|6074470|P1|Overall Study|Physician Decision|39
1741571|NCT00930553|6074470|P1|Overall Study|Lack of Efficacy|7
1741572|NCT00930553|6074470|P1|Overall Study|Adverse Event|1
1741573|NCT00930176|6074547|P1|Overall Study|Death|1
1741574|NCT00929994|6074552|P1|Overall Study|employment|1
1741575|NCT00929994|6074552|P1|Overall Study|medical issue unrelated to intervention|4
1741576|NCT00929994|6074552|P1|Overall Study|Withdrawal by Subject|1
1741577|NCT00929864|6074571|P2|Overall Study|Non-specified|7
1741578|NCT00929864|6074572|P1|Overall Study|Non-specified|2
1741579|NCT00929864|6074571|P2|Overall Study|Administrative reason by Sponsor|1
1741580|NCT00929864|6074572|P1|Overall Study|Administrative reason by Sponsor|1
1741581|NCT00929864|6074571|P2|Overall Study|Pregnancy|3
1741582|NCT00929864|6074572|P1|Overall Study|Pregnancy|0
1741583|NCT00929864|6074571|P2|Overall Study|Poor or non-compliance|3
1741584|NCT00929864|6074572|P1|Overall Study|Poor or non-compliance|3
1741585|NCT00929864|6074571|P2|Overall Study|No longer met criteria|1
1741586|NCT00929864|6074572|P1|Overall Study|No longer met criteria|2
1741587|NCT00929864|6074571|P2|Overall Study|Withdrawal by Subject|9
1741588|NCT00929864|6074572|P1|Overall Study|Withdrawal by Subject|20
1741589|NCT00929864|6074571|P2|Overall Study|Lost to Follow-up|12
1741590|NCT00929864|6074572|P1|Overall Study|Lost to Follow-up|7
1741591|NCT00929864|6074571|P2|Overall Study|Lack of Efficacy|16
1741592|NCT00929864|6074572|P1|Overall Study|Lack of Efficacy|19
1741593|NCT00929864|6074571|P2|Overall Study|Adverse Event|30
1741594|NCT00929864|6074572|P1|Overall Study|Adverse Event|11
1741595|NCT00929864|6074571|P2|Overall Study|Death|1
1741596|NCT00929864|6074572|P1|Overall Study|Death|1
1741597|NCT00929734|6074628|P2|Overall Study|Withdrawal by Subject|2
1741598|NCT00929734|6074629|P1|Overall Study|Withdrawal by Subject|0
1741599|NCT00929734|6074628|P2|Overall Study|Lost to Follow-up|1
1741600|NCT00929734|6074629|P1|Overall Study|Lost to Follow-up|2
1741601|NCT00929708|6074646|P5|Overall Study|Lost to Follow-up|0
1741602|NCT00929708|6074647|P4|Overall Study|Lost to Follow-up|1
1741603|NCT00929708|6074648|P3|Overall Study|Lost to Follow-up|0
1741604|NCT00929708|6074649|P2|Overall Study|Lost to Follow-up|0
1741605|NCT00929708|6074650|P1|Overall Study|Lost to Follow-up|0
1741606|NCT00929708|6074646|P5|Overall Study|Physician Decision|1
1741607|NCT00929708|6074647|P4|Overall Study|Physician Decision|2
1741608|NCT00929708|6074648|P3|Overall Study|Physician Decision|2
1741609|NCT00929708|6074649|P2|Overall Study|Physician Decision|2
1741610|NCT00929708|6074650|P1|Overall Study|Physician Decision|0
1741611|NCT00929708|6074646|P5|Overall Study|Adverse Event|3
1741612|NCT00929708|6074647|P4|Overall Study|Adverse Event|0
1741613|NCT00929708|6074648|P3|Overall Study|Adverse Event|0
1741614|NCT00929708|6074649|P2|Overall Study|Adverse Event|0
1741615|NCT00929708|6074650|P1|Overall Study|Adverse Event|0
1741616|NCT00929708|6074646|P5|Overall Study|Withdrawal by Subject|1
1741617|NCT00929708|6074647|P4|Overall Study|Withdrawal by Subject|2
1741618|NCT00929708|6074648|P3|Overall Study|Withdrawal by Subject|0
1741619|NCT00929708|6074649|P2|Overall Study|Withdrawal by Subject|0
1741620|NCT00929708|6074650|P1|Overall Study|Withdrawal by Subject|2
1741621|NCT00929708|6074646|P5|Overall Study|Protocol Violation|1
1741622|NCT00929708|6074647|P4|Overall Study|Protocol Violation|1
1741623|NCT00929708|6074648|P3|Overall Study|Protocol Violation|1
1741624|NCT00929708|6074649|P2|Overall Study|Protocol Violation|1
1741625|NCT00929708|6074650|P1|Overall Study|Protocol Violation|2
1741626|NCT00929695|6074704|P2|Overall Study|incorrect stratification|0
1741627|NCT00929695|6074705|P1|Overall Study|incorrect stratification|2
1741628|NCT00929695|6074704|P2|Overall Study|discharge home|3
1741629|NCT00929695|6074705|P1|Overall Study|discharge home|4
1741630|NCT00929695|6074704|P2|Overall Study|Withdrawal by Subject|2
1741631|NCT00929695|6074705|P1|Overall Study|Withdrawal by Subject|0
1741632|NCT00929695|6074704|P2|Overall Study|Death|1
1741633|NCT00929695|6074705|P1|Overall Study|Death|2
1741634|NCT00929669|6074735|P1|Overall Study|elevated glucose levels|1
1741635|NCT00929656|6074742|P2|Overall Study|Lost to Follow-up|1
1741636|NCT00929656|6074743|P1|Overall Study|Lost to Follow-up|0
1741637|NCT00929643|6074757|P1|Overall Study|Protocol Violation|2
1741638|NCT00929526|6074779|P2|Overall Study|Other|6
1741639|NCT00929526|6074780|P1|Overall Study|Other|8
1741640|NCT00929526|6074779|P2|Overall Study|Lost to Follow-up|12
1741641|NCT00929526|6074780|P1|Overall Study|Lost to Follow-up|8
1741642|NCT00929526|6074779|P2|Overall Study|Withdrawal by Subject|11
1741643|NCT00929526|6074780|P1|Overall Study|Withdrawal by Subject|1
1741644|NCT00929240|6074934|P3|Maintenance Phase|Participant not treated|0
1741645|NCT00929240|6074935|P2|Maintenance Phase|Participant not treated|2
1741646|NCT00929240|6074936|P1|Maintenance Phase|Participant not treated|0
1741647|NCT00929240|6074934|P3|Maintenance Phase|Treatment ongoing at study closure|10
1741648|NCT00929240|6074935|P2|Maintenance Phase|Treatment ongoing at study closure|0
1741649|NCT00929240|6074936|P1|Maintenance Phase|Treatment ongoing at study closure|0
1741650|NCT00929240|6074934|P3|Maintenance Phase|Change of treatment|0
1741651|NCT00929240|6074935|P2|Maintenance Phase|Change of treatment|4
1741652|NCT00929240|6074936|P1|Maintenance Phase|Change of treatment|0
1741653|NCT00929240|6074934|P3|Maintenance Phase|Physician Decision|1
1741654|NCT00929240|6074935|P2|Maintenance Phase|Physician Decision|2
1741655|NCT00929240|6074936|P1|Maintenance Phase|Physician Decision|0
1741656|NCT00929240|6074934|P3|Maintenance Phase|Health authority/Study termination|2
1741657|NCT00929240|6074935|P2|Maintenance Phase|Health authority/Study termination|1
1741658|NCT00929240|6074936|P1|Maintenance Phase|Health authority/Study termination|0
1741659|NCT00929240|6074934|P3|Maintenance Phase|Protocol Violation|0
1741660|NCT00929240|6074935|P2|Maintenance Phase|Protocol Violation|1
1741661|NCT00929240|6074936|P1|Maintenance Phase|Protocol Violation|0
1741662|NCT00929240|6074934|P3|Maintenance Phase|Withdrawal by Subject|6
1741663|NCT00929240|6074935|P2|Maintenance Phase|Withdrawal by Subject|2
1741664|NCT00929240|6074936|P1|Maintenance Phase|Withdrawal by Subject|0
1741665|NCT00929240|6074934|P3|Maintenance Phase|Adverse Event|12
1741666|NCT00929240|6074935|P2|Maintenance Phase|Adverse Event|9
1741667|NCT00929240|6074936|P1|Maintenance Phase|Adverse Event|0
1741668|NCT00929240|6074934|P3|Maintenance Phase|Disease progression|60
1741669|NCT00929240|6074935|P2|Maintenance Phase|Disease progression|73
1741670|NCT00929240|6074936|P1|Maintenance Phase|Disease progression|0
1741671|NCT00929240|6074934|P3|Initial Treatment Phase|Physician Decision|0
1741672|NCT00929240|6074935|P2|Initial Treatment Phase|Physician Decision|0
1741673|NCT00929240|6074936|P1|Initial Treatment Phase|Physician Decision|4
1741674|NCT00929240|6074934|P3|Initial Treatment Phase|Health authority/Study termination|0
1741675|NCT00929240|6074935|P2|Initial Treatment Phase|Health authority/Study termination|0
1741676|NCT00929240|6074936|P1|Initial Treatment Phase|Health authority/Study termination|3
1741677|NCT00929240|6074934|P3|Initial Treatment Phase|Death|0
1741678|NCT00929240|6074935|P2|Initial Treatment Phase|Death|0
1741679|NCT00929240|6074936|P1|Initial Treatment Phase|Death|2
1741680|NCT00929240|6074934|P3|Initial Treatment Phase|Protocol Violation|0
1741681|NCT00929240|6074935|P2|Initial Treatment Phase|Protocol Violation|0
1741682|NCT00929240|6074936|P1|Initial Treatment Phase|Protocol Violation|5
1741683|NCT00929240|6074934|P3|Initial Treatment Phase|Withdrawal by Subject|0
1741684|NCT00929240|6074935|P2|Initial Treatment Phase|Withdrawal by Subject|0
1741685|NCT00929240|6074936|P1|Initial Treatment Phase|Withdrawal by Subject|13
1741686|NCT00929240|6074934|P3|Initial Treatment Phase|Disease progression|0
1741687|NCT00929240|6074935|P2|Initial Treatment Phase|Disease progression|0
1741688|NCT00929240|6074936|P1|Initial Treatment Phase|Disease progression|41
1741689|NCT00929240|6074934|P3|Initial Treatment Phase|Adverse Event|0
1741690|NCT00929240|6074935|P2|Initial Treatment Phase|Adverse Event|0
1741691|NCT00929240|6074936|P1|Initial Treatment Phase|Adverse Event|31
1741692|NCT00929201|6074963|P2|Period 1|Withdrawal by Subject|1
1741693|NCT00929201|6074964|P1|Period 1|Withdrawal by Subject|0
1741694|NCT00929162|6074974|P2|Overall Study|Other termination reason|6
1741695|NCT00929162|6074975|P1|Overall Study|Other termination reason|5
1741696|NCT00929162|6074974|P2|Overall Study|Protocol Violation|30
1741697|NCT00929162|6074975|P1|Overall Study|Protocol Violation|32
1741698|NCT00929162|6074974|P2|Overall Study|Withdrawal by Subject|1
1741699|NCT00929162|6074975|P1|Overall Study|Withdrawal by Subject|3
1741700|NCT00929162|6074974|P2|Overall Study|Adverse Event|5
1741701|NCT00929162|6074975|P1|Overall Study|Adverse Event|8
1741702|NCT00929110|6074988|P3|Overall Study|Patient inability to use the device|0
1741703|NCT00929110|6074989|P2|Overall Study|Patient inability to use the device|1
1741704|NCT00929110|6074990|P1|Overall Study|Patient inability to use the device|0
1741705|NCT00929110|6074988|P3|Overall Study|Abnormal test procedure result(s)|1
1741706|NCT00929110|6074989|P2|Overall Study|Abnormal test procedure result(s)|1
1741707|NCT00929110|6074990|P1|Overall Study|Abnormal test procedure result(s)|0
1741708|NCT00929110|6074988|P3|Overall Study|Abnormal laboratory value(s)|0
1741709|NCT00929110|6074989|P2|Overall Study|Abnormal laboratory value(s)|1
1741710|NCT00929110|6074990|P1|Overall Study|Abnormal laboratory value(s)|0
1741711|NCT00929110|6074988|P3|Overall Study|Death|2
1741712|NCT00929110|6074989|P2|Overall Study|Death|2
1741713|NCT00929110|6074990|P1|Overall Study|Death|2
1741714|NCT00929110|6074988|P3|Overall Study|Administrative problems|2
1741715|NCT00929110|6074989|P2|Overall Study|Administrative problems|1
1741716|NCT00929110|6074990|P1|Overall Study|Administrative problems|4
1741717|NCT00929110|6074988|P3|Overall Study|Protocol deviation|4
1741718|NCT00929110|6074989|P2|Overall Study|Protocol deviation|2
1741719|NCT00929110|6074990|P1|Overall Study|Protocol deviation|5
1741720|NCT00929110|6074988|P3|Overall Study|Lost to Follow-up|3
1741721|NCT00929110|6074989|P2|Overall Study|Lost to Follow-up|7
1741722|NCT00929110|6074990|P1|Overall Study|Lost to Follow-up|7
1741723|NCT00929110|6074988|P3|Overall Study|Unsatisfactory therapeutic effect|6
1741724|NCT00929110|6074989|P2|Overall Study|Unsatisfactory therapeutic effect|9
1741725|NCT00929110|6074990|P1|Overall Study|Unsatisfactory therapeutic effect|20
1741726|NCT00929110|6074988|P3|Overall Study|Subject withdrew consent|26
1741727|NCT00929110|6074989|P2|Overall Study|Subject withdrew consent|23
1741728|NCT00929110|6074990|P1|Overall Study|Subject withdrew consent|40
1741729|NCT00929110|6074988|P3|Overall Study|Adverse Event|18
1741730|NCT00929110|6074989|P2|Overall Study|Adverse Event|29
1741731|NCT00929110|6074990|P1|Overall Study|Adverse Event|40
1741732|NCT00928889|6075073|P2|Overall Study|Other|0
1741733|NCT00928889|6075074|P1|Overall Study|Other|1
1741734|NCT00928889|6075073|P2|Overall Study|Adverse Event|0
1741735|NCT00928889|6075074|P1|Overall Study|Adverse Event|1
1741736|NCT00928889|6075073|P2|Overall Study|Protocol Violation|1
1741737|NCT00928889|6075074|P1|Overall Study|Protocol Violation|0
1741738|NCT00928889|6075073|P2|Overall Study|Lost to Follow-up|1
1741739|NCT00928889|6075074|P1|Overall Study|Lost to Follow-up|3
1741740|NCT00928746|6075120|P1|Overall Study|Other|2
1741741|NCT00928746|6075120|P1|Overall Study|Withdrawal by Subject|1
1741742|NCT00928746|6075120|P1|Overall Study|Protocol Violation|1
1741743|NCT00928746|6075120|P1|Overall Study|Adverse Event|2
1741744|NCT00928707|6075170|P2|Overall Study|Protocol Violation|0
1741745|NCT00928707|6075171|P1|Overall Study|Protocol Violation|1
1741746|NCT00928668|6075192|P5|Overall Study|Other reasons not listed above|0
1741747|NCT00928668|6075193|P4|Overall Study|Other reasons not listed above|1
1741748|NCT00928668|6075194|P3|Overall Study|Other reasons not listed above|0
1741749|NCT00928668|6075195|P2|Overall Study|Other reasons not listed above|0
1741750|NCT00928668|6075196|P1|Overall Study|Other reasons not listed above|0
1741751|NCT00928668|6075192|P5|Overall Study|Withdrawal by Subject|0
1741752|NCT00928668|6075193|P4|Overall Study|Withdrawal by Subject|0
1741753|NCT00928668|6075194|P3|Overall Study|Withdrawal by Subject|1
1741754|NCT00928668|6075195|P2|Overall Study|Withdrawal by Subject|1
1741755|NCT00928668|6075196|P1|Overall Study|Withdrawal by Subject|0
1741756|NCT00928668|6075192|P5|Overall Study|Protocol Violation|1
1741757|NCT00928668|6075193|P4|Overall Study|Protocol Violation|0
1741758|NCT00928668|6075194|P3|Overall Study|Protocol Violation|0
1741759|NCT00928668|6075195|P2|Overall Study|Protocol Violation|0
1741760|NCT00928668|6075196|P1|Overall Study|Protocol Violation|0
1741761|NCT00928668|6075192|P5|Overall Study|Adverse Event|0
1741762|NCT00928668|6075193|P4|Overall Study|Adverse Event|0
1741763|NCT00928668|6075194|P3|Overall Study|Adverse Event|0
1741764|NCT00928668|6075195|P2|Overall Study|Adverse Event|0
1741765|NCT00928668|6075196|P1|Overall Study|Adverse Event|1
1741766|NCT00928512|6075252|P5|Overall Study|Administrative Problems|0
1741767|NCT00928512|6075253|P4|Overall Study|Administrative Problems|0
1741768|NCT00928512|6075254|P3|Overall Study|Administrative Problems|0
1741769|NCT00928512|6075255|P2|Overall Study|Administrative Problems|1
1741770|NCT00928512|6075256|P1|Overall Study|Administrative Problems|0
1741771|NCT00928512|6075252|P5|Overall Study|Lost to Follow-up|3
1741772|NCT00928512|6075253|P4|Overall Study|Lost to Follow-up|1
1741773|NCT00928512|6075254|P3|Overall Study|Lost to Follow-up|2
1741774|NCT00928512|6075255|P2|Overall Study|Lost to Follow-up|1
1741775|NCT00928512|6075256|P1|Overall Study|Lost to Follow-up|1
1741776|NCT00928512|6075252|P5|Overall Study|Withdrawal by Subject|0
1741777|NCT00928512|6075253|P4|Overall Study|Withdrawal by Subject|4
1741778|NCT00928512|6075254|P3|Overall Study|Withdrawal by Subject|3
1741779|NCT00928512|6075255|P2|Overall Study|Withdrawal by Subject|0
1741780|NCT00928512|6075256|P1|Overall Study|Withdrawal by Subject|3
1741781|NCT00928512|6075252|P5|Overall Study|Protocol Violation|3
1741782|NCT00928512|6075253|P4|Overall Study|Protocol Violation|1
1741783|NCT00928512|6075254|P3|Overall Study|Protocol Violation|0
1741784|NCT00928512|6075255|P2|Overall Study|Protocol Violation|1
1741785|NCT00928512|6075256|P1|Overall Study|Protocol Violation|0
1741786|NCT00928512|6075252|P5|Overall Study|Lack of Efficacy|3
1741787|NCT00928512|6075253|P4|Overall Study|Lack of Efficacy|7
1741788|NCT00928512|6075254|P3|Overall Study|Lack of Efficacy|4
1741789|NCT00928512|6075255|P2|Overall Study|Lack of Efficacy|0
1741790|NCT00928512|6075256|P1|Overall Study|Lack of Efficacy|2
1741791|NCT00928512|6075252|P5|Overall Study|Adverse Event|6
1741792|NCT00928512|6075253|P4|Overall Study|Adverse Event|8
1741793|NCT00928512|6075254|P3|Overall Study|Adverse Event|2
1741794|NCT00928512|6075255|P2|Overall Study|Adverse Event|3
1741795|NCT00928512|6075256|P1|Overall Study|Adverse Event|4
1741796|NCT00928486|6075357|P1|Overall Study|Withdrawal by Subject|1
1741797|NCT00928486|6075357|P1|Overall Study|Disease Progression|7
1741798|NCT00928486|6075357|P1|Overall Study|Adverse Event|2
1741799|NCT00928434|6075366|P3|Overall Study|Other (not meeting above criteria)|2
1741800|NCT00928434|6075367|P2|Overall Study|Other (not meeting above criteria)|1
1741801|NCT00928434|6075368|P1|Overall Study|Other (not meeting above criteria)|5
1741802|NCT00928434|6075366|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
1741803|NCT00928434|6075367|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
1741804|NCT00928434|6075368|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
1741805|NCT00928434|6075366|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
1741806|NCT00928434|6075367|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
1741807|NCT00928434|6075368|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
1741808|NCT00928434|6075366|P3|Overall Study|Withdrawal by Subject|2
1741809|NCT00928434|6075367|P2|Overall Study|Withdrawal by Subject|3
1741810|NCT00928434|6075368|P1|Overall Study|Withdrawal by Subject|5
1741811|NCT00928434|6075366|P3|Overall Study|Lost to Follow-up|3
1741812|NCT00928434|6075367|P2|Overall Study|Lost to Follow-up|0
1741813|NCT00928434|6075368|P1|Overall Study|Lost to Follow-up|1
1741814|NCT00928434|6075366|P3|Overall Study|Physician Decision|3
1741815|NCT00928434|6075367|P2|Overall Study|Physician Decision|0
1741816|NCT00928434|6075368|P1|Overall Study|Physician Decision|2
1741817|NCT00928434|6075366|P3|Overall Study|Protocol Violation|8
1741818|NCT00928434|6075367|P2|Overall Study|Protocol Violation|0
1741819|NCT00928434|6075368|P1|Overall Study|Protocol Violation|5
1741820|NCT00928434|6075366|P3|Overall Study|Adverse Event|18
1741821|NCT00928434|6075367|P2|Overall Study|Adverse Event|5
1741822|NCT00928434|6075368|P1|Overall Study|Adverse Event|14
1741823|NCT00928408|6075444|P1|Overall Study|Lost to Follow-up|12
1741824|NCT00928408|6075444|P1|Overall Study|Death|5
1741825|NCT00928408|6075444|P1|Overall Study|Withdrawal by Subject|4
1741826|NCT00928408|6075444|P1|Overall Study|Other|2
1741827|NCT00928252|6075490|P1|Overall Study|Physician Decision|3
1741828|NCT00928187|6075550|P3|Overall Study|Protocol Violation|0
1741829|NCT00928187|6075551|P2|Overall Study|Protocol Violation|1
1741830|NCT00928187|6075552|P1|Overall Study|Protocol Violation|0
1741831|NCT00928187|6075550|P3|Overall Study|Withdrawal by Subject|1
1741832|NCT00928187|6075551|P2|Overall Study|Withdrawal by Subject|1
1741833|NCT00928187|6075552|P1|Overall Study|Withdrawal by Subject|0
1741834|NCT00928187|6075550|P3|Overall Study|Lost to Follow-up|1
1741835|NCT00928187|6075551|P2|Overall Study|Lost to Follow-up|2
1741836|NCT00928187|6075552|P1|Overall Study|Lost to Follow-up|1
1741837|NCT00928187|6075550|P3|Overall Study|Death|3
1741838|NCT00928187|6075551|P2|Overall Study|Death|2
1741839|NCT00928187|6075552|P1|Overall Study|Death|1
1741840|NCT00928070|6075722|P2|Overall Study|Other|5
1741841|NCT00928070|6075723|P1|Overall Study|Other|5
1741842|NCT00928070|6075722|P2|Overall Study|Randomized but not treated|2
1741843|NCT00928070|6075723|P1|Overall Study|Randomized but not treated|2
1741844|NCT00928070|6075722|P2|Overall Study|Protocol Violation|5
1741845|NCT00928070|6075723|P1|Overall Study|Protocol Violation|6
1741846|NCT00928070|6075722|P2|Overall Study|Did not meet entrance criteria|9
1741847|NCT00928070|6075723|P1|Overall Study|Did not meet entrance criteria|16
1741848|NCT00928070|6075722|P2|Overall Study|Lack of Efficacy|5
1741849|NCT00928070|6075723|P1|Overall Study|Lack of Efficacy|9
1741850|NCT00928070|6075722|P2|Overall Study|Adverse Event|26
1741851|NCT00928070|6075723|P1|Overall Study|Adverse Event|14
1741852|NCT00928070|6075722|P2|Overall Study|Withdrawal by Subject|3
1741853|NCT00928070|6075723|P1|Overall Study|Withdrawal by Subject|10
1741854|NCT00928070|6075722|P2|Overall Study|Lost to Follow-up|2
1741855|NCT00928070|6075723|P1|Overall Study|Lost to Follow-up|1
1741856|NCT00928057|6075781|P2|Overall Study|Protocol Violation|1
1741857|NCT00928057|6075782|P1|Overall Study|Protocol Violation|0
1741858|NCT00928057|6075781|P2|Overall Study|Lost to Follow-up|1
1741859|NCT00928057|6075782|P1|Overall Study|Lost to Follow-up|0
1741860|NCT00928057|6075781|P2|Overall Study|Withdrawal by Subject|0
1741861|NCT00928057|6075782|P1|Overall Study|Withdrawal by Subject|1
1741862|NCT00928057|6075781|P2|Overall Study|Adverse Event|2
1741863|NCT00928057|6075782|P1|Overall Study|Adverse Event|1
1741864|NCT00928018|6075807|P2|Overall Study|Withdrawal by Subject|0
1741865|NCT00928018|6075808|P1|Overall Study|Withdrawal by Subject|1
1741866|NCT00927953|6075838|P2|Overall Study|Death|1
1741867|NCT00927953|6075839|P1|Overall Study|Death|2
1741868|NCT00927940|6075853|P1|Overall Study|Death|1
1741869|NCT00927927|6075873|P15|Overall Study|Withdrawal by Subject|0
1741870|NCT00927927|6075874|P14|Overall Study|Withdrawal by Subject|0
1741871|NCT00927927|6075875|P13|Overall Study|Withdrawal by Subject|0
1741872|NCT00927927|6075876|P12|Overall Study|Withdrawal by Subject|2
1741873|NCT00927927|6075877|P11|Overall Study|Withdrawal by Subject|0
1741874|NCT00927927|6075878|P10|Overall Study|Withdrawal by Subject|0
1741875|NCT00927927|6075879|P9|Overall Study|Withdrawal by Subject|0
1741876|NCT00927927|6075880|P8|Overall Study|Withdrawal by Subject|2
1741877|NCT00927927|6075881|P7|Overall Study|Withdrawal by Subject|0
1741878|NCT00927927|6075882|P6|Overall Study|Withdrawal by Subject|0
1741879|NCT00927927|6075883|P5|Overall Study|Withdrawal by Subject|0
1741880|NCT00927927|6075884|P4|Overall Study|Withdrawal by Subject|0
1741881|NCT00927927|6075885|P3|Overall Study|Withdrawal by Subject|0
1741882|NCT00927927|6075886|P2|Overall Study|Withdrawal by Subject|0
1741883|NCT00927927|6075887|P1|Overall Study|Withdrawal by Subject|0
1741884|NCT00927901|6075934|P4|Treatment Period 4|Subject withdrew consent|0
1741885|NCT00927901|6075935|P3|Treatment Period 4|Subject withdrew consent|1
1741886|NCT00927901|6075936|P2|Treatment Period 4|Subject withdrew consent|0
1741887|NCT00927901|6075937|P1|Treatment Period 4|Subject withdrew consent|0
1741888|NCT00927901|6075934|P4|Treatment Period 4|Adverse Event|1
1741889|NCT00927901|6075935|P3|Treatment Period 4|Adverse Event|0
1741890|NCT00927901|6075936|P2|Treatment Period 4|Adverse Event|0
1741891|NCT00927901|6075937|P1|Treatment Period 4|Adverse Event|0
1741892|NCT00927901|6075934|P4|Treatment Period 1|Subject withdrew consent|0
1741893|NCT00927901|6075935|P3|Treatment Period 1|Subject withdrew consent|1
1741894|NCT00927901|6075936|P2|Treatment Period 1|Subject withdrew consent|0
1741895|NCT00927901|6075937|P1|Treatment Period 1|Subject withdrew consent|0
1741896|NCT00927862|6075978|P2|Overall Study|Missing data needed for endpt analyses|45
1741897|NCT00927862|6075979|P1|Overall Study|Missing data needed for endpt analyses|27
1741898|NCT00927823|6076014|P4|Continuous Dosing Period|Other|3
1741899|NCT00927823|6076015|P3|Continuous Dosing Period|Other|9
1741900|NCT00927823|6076016|P2|Continuous Dosing Period|Other|2
1741901|NCT00927823|6076017|P1|Continuous Dosing Period|Other|1
1741902|NCT00927823|6076014|P4|Continuous Dosing Period|Withdrawal by Subject|2
1741903|NCT00927823|6076015|P3|Continuous Dosing Period|Withdrawal by Subject|2
1741904|NCT00927823|6076016|P2|Continuous Dosing Period|Withdrawal by Subject|0
1741905|NCT00927823|6076017|P1|Continuous Dosing Period|Withdrawal by Subject|1
1741906|NCT00927823|6076014|P4|Continuous Dosing Period|Lost to Follow-up|0
1741907|NCT00927823|6076015|P3|Continuous Dosing Period|Lost to Follow-up|9
1741908|NCT00927823|6076016|P2|Continuous Dosing Period|Lost to Follow-up|1
1741909|NCT00927823|6076017|P1|Continuous Dosing Period|Lost to Follow-up|1
1741910|NCT00927823|6076014|P4|Continuous Dosing Period|Death|0
1741911|NCT00927823|6076015|P3|Continuous Dosing Period|Death|6
1741912|NCT00927823|6076016|P2|Continuous Dosing Period|Death|0
1741913|NCT00927823|6076017|P1|Continuous Dosing Period|Death|0
1741914|NCT00927784|6076083|P2|Overall Study|Withdrawal by Subject|0
1741915|NCT00927784|6076084|P1|Overall Study|Withdrawal by Subject|1
1741916|NCT00927784|6076083|P2|Overall Study|Death|0
1741917|NCT00927784|6076084|P1|Overall Study|Death|1
1741918|NCT00927758|6076114|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1741919|NCT00927758|6076115|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1741920|NCT00927758|6076116|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1741921|NCT00927758|6076117|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
1741922|NCT00927758|6076118|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1741923|NCT00927758|6076119|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
1741924|NCT00927758|6076114|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
1741925|NCT00927758|6076115|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1741926|NCT00927758|6076116|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
1741927|NCT00927758|6076117|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1741928|NCT00927758|6076118|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1741929|NCT00927758|6076119|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
1741930|NCT00927589|6076127|P1|Overall Study|Non-compliance|1
1741931|NCT00927589|6076127|P1|Overall Study|Disease Progression|8
1741932|NCT00927589|6076127|P1|Overall Study|Adverse Event|2
1741933|NCT00927589|6076127|P1|Overall Study|Withdrawal by Subject|3
1741934|NCT00927589|6076127|P1|Overall Study|Physician Decision|1
1741935|NCT00927589|6076127|P1|Overall Study|Death|1
1741936|NCT00927563|6076157|P1|Overall Study|Withdrawal by Subject|1
1741937|NCT00927563|6076157|P1|Overall Study|Lost to Follow-up|1
1741938|NCT00927472|6076165|P2|Overall Study|Post treatment Assessment out of window|4
1741939|NCT00927472|6076166|P1|Overall Study|Post treatment Assessment out of window|0
1741940|NCT00927472|6076165|P2|Overall Study|Protocol Violation|1
1741941|NCT00927472|6076166|P1|Overall Study|Protocol Violation|0
1741942|NCT00927472|6076165|P2|Overall Study|Lost to Follow-up|6
1741943|NCT00927472|6076166|P1|Overall Study|Lost to Follow-up|1
1741944|NCT00927472|6076165|P2|Overall Study|Withdrawal by Subject|11
1741945|NCT00927472|6076166|P1|Overall Study|Withdrawal by Subject|10
1741946|NCT00927394|6076192|P2|Overall Study|Randomized in error|1
1741947|NCT00927394|6076193|P1|Overall Study|Randomized in error|0
1741948|NCT00927394|6076192|P2|Overall Study|Protocol deviation|13
1741949|NCT00927394|6076193|P1|Overall Study|Protocol deviation|16
1741950|NCT00927394|6076192|P2|Overall Study|Death|1
1741951|NCT00927394|6076193|P1|Overall Study|Death|1
1741952|NCT00927394|6076192|P2|Overall Study|Administrative Problem|0
1741953|NCT00927394|6076193|P1|Overall Study|Administrative Problem|1
1741954|NCT00927394|6076192|P2|Overall Study|Lost to Follow-up|14
1741955|NCT00927394|6076193|P1|Overall Study|Lost to Follow-up|8
1741956|NCT00927394|6076192|P2|Overall Study|Withdrawal by Subject|24
1741957|NCT00927394|6076193|P1|Overall Study|Withdrawal by Subject|20
1741958|NCT00927394|6076192|P2|Overall Study|Unsatisfactory therapeutic effect|23
1741959|NCT00927394|6076193|P1|Overall Study|Unsatisfactory therapeutic effect|17
1741960|NCT00927394|6076192|P2|Overall Study|Adverse Event|9
1741961|NCT00927394|6076193|P1|Overall Study|Adverse Event|14
1741962|NCT00927368|6076224|P3|Overall Study|cancellation of surgery|2
1741963|NCT00927368|6076225|P2|Overall Study|cancellation of surgery|1
1741964|NCT00927368|6076226|P1|Overall Study|cancellation of surgery|0
1741965|NCT00927368|6076224|P3|Overall Study|ineligible post randomization|1
1741966|NCT00927368|6076225|P2|Overall Study|ineligible post randomization|3
1741967|NCT00927368|6076226|P1|Overall Study|ineligible post randomization|0
1741968|NCT00927368|6076224|P3|Overall Study|equipment failure|0
1741969|NCT00927368|6076225|P2|Overall Study|equipment failure|0
1741970|NCT00927368|6076226|P1|Overall Study|equipment failure|1
1741971|NCT00927368|6076224|P3|Overall Study|Lost to Follow-up|0
1741972|NCT00927368|6076225|P2|Overall Study|Lost to Follow-up|0
1741973|NCT00927368|6076226|P1|Overall Study|Lost to Follow-up|4
1741974|NCT00927368|6076224|P3|Overall Study|enrollment in another study|2
1741975|NCT00927368|6076225|P2|Overall Study|enrollment in another study|1
1741976|NCT00927368|6076226|P1|Overall Study|enrollment in another study|1
1741977|NCT00927355|6076245|P2|Overall Study|Adverse Event|1
1741978|NCT00927355|6076246|P1|Overall Study|Adverse Event|1
1741979|NCT00927251|6076281|P1|Overall Study|Patients not implanted with 4296 lead|8
1741980|NCT00927186|6076287|P2|12 Months Primary Study|Withdrawal by Subject|1
1741981|NCT00927186|6076288|P1|12 Months Primary Study|Withdrawal by Subject|1
1741982|NCT00927186|6076287|P2|12 Months Primary Study|Protocol Violation|1
1741983|NCT00927186|6076288|P1|12 Months Primary Study|Protocol Violation|0
1741984|NCT00927186|6076287|P2|12 Months Primary Study|Lost to Follow-up|0
1741985|NCT00927186|6076288|P1|12 Months Primary Study|Lost to Follow-up|1
1741986|NCT00927186|6076287|P2|12 Months Primary Study|Adverse Event|2
1741987|NCT00927186|6076288|P1|12 Months Primary Study|Adverse Event|5
1741988|NCT00927095|6076418|P3|Overall Study|Physician Decision|1
1741989|NCT00927095|6076419|P2|Overall Study|Physician Decision|2
1741990|NCT00927095|6076420|P1|Overall Study|Physician Decision|1
1741991|NCT00927095|6076418|P3|Overall Study|Withdrawal by Subject|1
1741992|NCT00927095|6076419|P2|Overall Study|Withdrawal by Subject|1
1741993|NCT00927095|6076420|P1|Overall Study|Withdrawal by Subject|2
1741994|NCT00927095|6076418|P3|Overall Study|Adverse Event|0
1741995|NCT00927095|6076419|P2|Overall Study|Adverse Event|1
1741996|NCT00927095|6076420|P1|Overall Study|Adverse Event|3
1741997|NCT00927082|6076432|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
1741998|NCT00927082|6076433|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
1741999|NCT00927082|6076434|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
1742000|NCT00927082|6076435|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
1742001|NCT00927082|6076432|P4|Overall Study|Death|0
1742002|NCT00927082|6076433|P3|Overall Study|Death|1
1742003|NCT00927082|6076434|P2|Overall Study|Death|0
1742004|NCT00927082|6076435|P1|Overall Study|Death|0
1742005|NCT00927082|6076432|P4|Overall Study|Withdrawal by Subject|2
1742006|NCT00927082|6076433|P3|Overall Study|Withdrawal by Subject|7
1742007|NCT00927082|6076434|P2|Overall Study|Withdrawal by Subject|2
1742008|NCT00927082|6076435|P1|Overall Study|Withdrawal by Subject|3
1742009|NCT00927082|6076432|P4|Overall Study|Lost to Follow-up|16
1742010|NCT00927082|6076433|P3|Overall Study|Lost to Follow-up|12
1742011|NCT00927082|6076434|P2|Overall Study|Lost to Follow-up|8
1742012|NCT00927082|6076435|P1|Overall Study|Lost to Follow-up|9
1742013|NCT00927069|6076499|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
1742014|NCT00927069|6076500|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
1742015|NCT00927069|6076501|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
1742016|NCT00927069|6076502|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
1742017|NCT00927069|6076499|P4|Week 12 to Week 24|Withdrawal by Subject|0
1742018|NCT00927069|6076500|P3|Week 12 to Week 24|Withdrawal by Subject|0
1742019|NCT00927069|6076501|P2|Week 12 to Week 24|Withdrawal by Subject|0
1742020|NCT00927069|6076502|P1|Week 12 to Week 24|Withdrawal by Subject|1
1742021|NCT00927069|6076499|P4|Week 12 to Week 24|Lost to Follow-up|0
1742022|NCT00927069|6076500|P3|Week 12 to Week 24|Lost to Follow-up|1
1742023|NCT00927069|6076501|P2|Week 12 to Week 24|Lost to Follow-up|0
1742024|NCT00927069|6076502|P1|Week 12 to Week 24|Lost to Follow-up|0
1742025|NCT00927069|6076499|P4|Week 12 to Week 24|Lack of Efficacy|3
1742026|NCT00927069|6076500|P3|Week 12 to Week 24|Lack of Efficacy|2
1742027|NCT00927069|6076501|P2|Week 12 to Week 24|Lack of Efficacy|0
1742028|NCT00927069|6076502|P1|Week 12 to Week 24|Lack of Efficacy|0
1742029|NCT00927069|6076499|P4|Week 0 to Week 12|Worsening of psoriasis|0
1742030|NCT00927069|6076500|P3|Week 0 to Week 12|Worsening of psoriasis|0
1742031|NCT00927069|6076501|P2|Week 0 to Week 12|Worsening of psoriasis|1
1742032|NCT00927069|6076502|P1|Week 0 to Week 12|Worsening of psoriasis|1
1742033|NCT00926796|6076558|P2|Overall Study|Withdrawal by Subject|0
1742034|NCT00926796|6076559|P1|Overall Study|Withdrawal by Subject|1
1742035|NCT00926796|6076558|P2|Overall Study|Protocol Violation|11
1742036|NCT00926796|6076559|P1|Overall Study|Protocol Violation|15
1742037|NCT00926796|6076558|P2|Overall Study|Lost to Follow-up|13
1742038|NCT00926796|6076559|P1|Overall Study|Lost to Follow-up|22
1742039|NCT00926796|6076558|P2|Overall Study|Adverse Event|14
1742040|NCT00926796|6076559|P1|Overall Study|Adverse Event|7
1742041|NCT00926796|6076558|P2|Overall Study|Ineligible, but positive for gonorrhea|1
1742042|NCT00926796|6076559|P1|Overall Study|Ineligible, but positive for gonorrhea|1
1742043|NCT00926796|6076558|P2|Overall Study|Ineligible, negative for gonorrhea|60
1742044|NCT00926796|6076559|P1|Overall Study|Ineligible, negative for gonorrhea|57
1742045|NCT00926796|6076558|P2|Overall Study|Did not receive randomized treatment|7
1742046|NCT00926796|6076559|P1|Overall Study|Did not receive randomized treatment|4
1742047|NCT00926783|6076580|P2|Overall Study|Incomplete CFAE Procedures|3
1742048|NCT00926783|6076581|P1|Overall Study|Incomplete CFAE Procedures|3
1742049|NCT00926575|6076608|P2|Overall Study|Withdrawal by Subject|9
1742050|NCT00926575|6076609|P1|Overall Study|Withdrawal by Subject|8
1742051|NCT00926575|6076608|P2|Overall Study|Protocol Violation|0
1742052|NCT00926575|6076609|P1|Overall Study|Protocol Violation|1
1742053|NCT00926575|6076608|P2|Overall Study|Physician Decision|2
1742054|NCT00926575|6076609|P1|Overall Study|Physician Decision|1
1742055|NCT00926575|6076608|P2|Overall Study|Lost to Follow-up|1
1742056|NCT00926575|6076609|P1|Overall Study|Lost to Follow-up|1
1742057|NCT00926575|6076608|P2|Overall Study|Death|4
1742058|NCT00926575|6076609|P1|Overall Study|Death|4
1742059|NCT00926575|6076608|P2|Overall Study|Adverse Event|1
1742060|NCT00926575|6076609|P1|Overall Study|Adverse Event|1
1742061|NCT00926536|6076621|P2|Overall Study|Physician Decision|2
1742062|NCT00926536|6076622|P1|Overall Study|Physician Decision|1
1742063|NCT00926393|6076643|P2|Overall Study|Adverse Event|1
1742064|NCT00926393|6076644|P1|Overall Study|Adverse Event|1
1742065|NCT00926393|6076643|P2|Overall Study|Withdrawal by Subject|2
1742066|NCT00926393|6076644|P1|Overall Study|Withdrawal by Subject|1
1742067|NCT00926367|6076689|P2|Overall Study|Skin Irritation|2
1742068|NCT00926367|6076690|P1|Overall Study|Skin Irritation|1
1742069|NCT00926367|6076689|P2|Overall Study|Lost to Follow-up|0
1742070|NCT00926367|6076690|P1|Overall Study|Lost to Follow-up|1
1742071|NCT00926367|6076689|P2|Overall Study|Withdrawal by Subject|1
1742072|NCT00926367|6076690|P1|Overall Study|Withdrawal by Subject|0
1742073|NCT00926328|6076732|P2|Overall Study|Lost to Follow-up|14
1742074|NCT00926328|6076733|P1|Overall Study|Lost to Follow-up|12
1742075|NCT00926289|6076743|P2|Overall Study|Other|3
1742076|NCT00926289|6076744|P1|Overall Study|Other|1
1742077|NCT00926289|6076743|P2|Overall Study|Withdrawal by Subject|4
1742078|NCT00926289|6076744|P1|Overall Study|Withdrawal by Subject|4
1742079|NCT00926289|6076743|P2|Overall Study|Lost to Follow-up|6
1742080|NCT00926289|6076744|P1|Overall Study|Lost to Follow-up|3
1742081|NCT00926289|6076743|P2|Overall Study|Protocol Violation|12
1742082|NCT00926289|6076744|P1|Overall Study|Protocol Violation|8
1742083|NCT00926289|6076743|P2|Overall Study|Adverse Event|11
1742084|NCT00926289|6076744|P1|Overall Study|Adverse Event|9
1742085|NCT00926211|6076812|P1|Overall Study|Lost to Follow-up|1
1742086|NCT00926029|6076843|P3|Overall Study|Lost to Follow-up|1
1742087|NCT00926029|6076844|P2|Overall Study|Lost to Follow-up|1
1742088|NCT00926029|6076845|P1|Overall Study|Lost to Follow-up|2
1742089|NCT00926003|6076859|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
1742090|NCT00926003|6076860|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
1742091|NCT00926003|6076861|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
1742092|NCT00926003|6076859|P3|Post-Training Evaluation|Withdrawal by Subject|0
1742093|NCT00926003|6076860|P2|Post-Training Evaluation|Withdrawal by Subject|0
1742094|NCT00926003|6076861|P1|Post-Training Evaluation|Withdrawal by Subject|1
1742095|NCT00925990|6076874|P2|Overall Study|moved out of state, missed medication|2
1742096|NCT00925990|6076875|P1|Overall Study|moved out of state, missed medication|0
1742097|NCT00925990|6076874|P2|Overall Study|Physician Decision|1
1742098|NCT00925990|6076875|P1|Overall Study|Physician Decision|1
1742099|NCT00925990|6076874|P2|Overall Study|Lost to Follow-up|3
1742100|NCT00925990|6076875|P1|Overall Study|Lost to Follow-up|1
1742101|NCT00925990|6076874|P2|Overall Study|Withdrawal by Subject|2
1742102|NCT00925990|6076875|P1|Overall Study|Withdrawal by Subject|2
1742103|NCT00925990|6076874|P2|Overall Study|Adverse Event|3
1742104|NCT00925990|6076875|P1|Overall Study|Adverse Event|1
1742105|NCT00925899|6076910|P2|Part 1|Withdrawal by Subject|9
1742106|NCT00925899|6076911|P1|Part 1|Withdrawal by Subject|10
1742107|NCT00925899|6076910|P2|Part 1|Death|2
1742108|NCT00925899|6076911|P1|Part 1|Death|1
1742109|NCT00925769|6076939|P6|Overall Study|Adverse Event|0
1742110|NCT00925769|6076940|P5|Overall Study|Adverse Event|1
1742111|NCT00925769|6076941|P4|Overall Study|Adverse Event|0
1742112|NCT00925769|6076942|P3|Overall Study|Adverse Event|0
1742113|NCT00925769|6076943|P2|Overall Study|Adverse Event|0
1742114|NCT00925769|6076944|P1|Overall Study|Adverse Event|0
1742115|NCT00925769|6076939|P6|Overall Study|Participant is unable to swallow drug|0
1742116|NCT00925769|6076940|P5|Overall Study|Participant is unable to swallow drug|0
1742117|NCT00925769|6076941|P4|Overall Study|Participant is unable to swallow drug|1
1742118|NCT00925769|6076942|P3|Overall Study|Participant is unable to swallow drug|0
1742119|NCT00925769|6076943|P2|Overall Study|Participant is unable to swallow drug|0
1742120|NCT00925769|6076944|P1|Overall Study|Participant is unable to swallow drug|0
1742121|NCT00925769|6076939|P6|Overall Study|End of study visit not done|0
1742122|NCT00925769|6076940|P5|Overall Study|End of study visit not done|0
1742123|NCT00925769|6076941|P4|Overall Study|End of study visit not done|0
1742124|NCT00925769|6076942|P3|Overall Study|End of study visit not done|1
1742125|NCT00925769|6076943|P2|Overall Study|End of study visit not done|0
1742126|NCT00925769|6076944|P1|Overall Study|End of study visit not done|0
1742127|NCT00925769|6076939|P6|Overall Study|Missing documentation|0
1742128|NCT00925769|6076940|P5|Overall Study|Missing documentation|0
1742129|NCT00925769|6076941|P4|Overall Study|Missing documentation|0
1742130|NCT00925769|6076942|P3|Overall Study|Missing documentation|0
1742131|NCT00925769|6076943|P2|Overall Study|Missing documentation|1
1742132|NCT00925769|6076944|P1|Overall Study|Missing documentation|0
1742133|NCT00925769|6076939|P6|Overall Study|Physician Decision|0
1742134|NCT00925769|6076940|P5|Overall Study|Physician Decision|0
1742135|NCT00925769|6076941|P4|Overall Study|Physician Decision|0
1742136|NCT00925769|6076942|P3|Overall Study|Physician Decision|0
1742137|NCT00925769|6076943|P2|Overall Study|Physician Decision|0
1742138|NCT00925769|6076944|P1|Overall Study|Physician Decision|1
1742139|NCT00925769|6076939|P6|Overall Study|Death|0
1742140|NCT00925769|6076940|P5|Overall Study|Death|0
1742141|NCT00925769|6076941|P4|Overall Study|Death|0
1742142|NCT00925769|6076942|P3|Overall Study|Death|1
1742143|NCT00925769|6076943|P2|Overall Study|Death|0
1742144|NCT00925769|6076944|P1|Overall Study|Death|0
1742145|NCT00925769|6076939|P6|Overall Study|Disease progression|3
1742146|NCT00925769|6076940|P5|Overall Study|Disease progression|2
1742147|NCT00925769|6076941|P4|Overall Study|Disease progression|4
1742148|NCT00925769|6076942|P3|Overall Study|Disease progression|3
1742149|NCT00925769|6076943|P2|Overall Study|Disease progression|5
1742150|NCT00925769|6076944|P1|Overall Study|Disease progression|4
1742151|NCT00925769|6076939|P6|Overall Study|Major toxicity|0
1742152|NCT00925769|6076940|P5|Overall Study|Major toxicity|0
1742153|NCT00925769|6076941|P4|Overall Study|Major toxicity|1
1742154|NCT00925769|6076942|P3|Overall Study|Major toxicity|1
1742155|NCT00925769|6076943|P2|Overall Study|Major toxicity|0
1742156|NCT00925769|6076944|P1|Overall Study|Major toxicity|1
1742157|NCT00925704|6077012|P6|Third Intervention|Withdrew consent|1
1742158|NCT00925704|6077013|P5|Third Intervention|Withdrew consent|0
1742159|NCT00925704|6077014|P4|Third Intervention|Withdrew consent|0
1742160|NCT00925704|6077015|P3|Third Intervention|Withdrew consent|0
1742161|NCT00925704|6077016|P2|Third Intervention|Withdrew consent|0
1742162|NCT00925704|6077017|P1|Third Intervention|Withdrew consent|0
1742163|NCT00925704|6077012|P6|Second Intervention|Withdrawal by Subject|0
1742164|NCT00925704|6077013|P5|Second Intervention|Withdrawal by Subject|1
1742165|NCT00925704|6077014|P4|Second Intervention|Withdrawal by Subject|0
1742166|NCT00925704|6077015|P3|Second Intervention|Withdrawal by Subject|0
1742167|NCT00925704|6077016|P2|Second Intervention|Withdrawal by Subject|0
1742168|NCT00925704|6077017|P1|Second Intervention|Withdrawal by Subject|1
1742169|NCT00925704|6077012|P6|First Intervention|Withdrew consent|0
1742170|NCT00925704|6077013|P5|First Intervention|Withdrew consent|1
1742171|NCT00925704|6077014|P4|First Intervention|Withdrew consent|1
1742172|NCT00925704|6077015|P3|First Intervention|Withdrew consent|0
1742173|NCT00925704|6077016|P2|First Intervention|Withdrew consent|0
1742174|NCT00925704|6077017|P1|First Intervention|Withdrew consent|0
1742175|NCT00925600|6077030|P2|Overall Study|Adverse Event|2
1742176|NCT00925600|6077031|P1|Overall Study|Adverse Event|1
1742177|NCT00925600|6077030|P2|Overall Study|Other|1
1742178|NCT00925600|6077031|P1|Overall Study|Other|3
1742179|NCT00925600|6077030|P2|Overall Study|Requirement for Alternative Therapy|1
1742180|NCT00925600|6077031|P1|Overall Study|Requirement for Alternative Therapy|0
1742181|NCT00925600|6077030|P2|Overall Study|Protocol Deviation|1
1742182|NCT00925600|6077031|P1|Overall Study|Protocol Deviation|0
1742183|NCT00925600|6077030|P2|Overall Study|Ineligibility Determined|0
1742184|NCT00925600|6077031|P1|Overall Study|Ineligibility Determined|2
1742185|NCT00925600|6077030|P2|Overall Study|Noncompliance|0
1742186|NCT00925600|6077031|P1|Overall Study|Noncompliance|2
1742187|NCT00925600|6077030|P2|Overall Study|Administrative Decision|1
1742188|NCT00925600|6077031|P1|Overall Study|Administrative Decision|1
1742189|NCT00925600|6077030|P2|Overall Study|Disease Progression|3
1742190|NCT00925600|6077031|P1|Overall Study|Disease Progression|1
1742191|NCT00925600|6077030|P2|Overall Study|Lost to Follow-up|2
1742192|NCT00925600|6077031|P1|Overall Study|Lost to Follow-up|2
1742193|NCT00925600|6077030|P2|Overall Study|Death|3
1742194|NCT00925600|6077031|P1|Overall Study|Death|4
1742195|NCT00925600|6077030|P2|Overall Study|Withdrawal by Subject|14
1742196|NCT00925600|6077031|P1|Overall Study|Withdrawal by Subject|16
1742197|NCT00925587|6077053|P2|Overall Study|Lost to Follow-up|1
1742198|NCT00925587|6077054|P1|Overall Study|Lost to Follow-up|0
1742199|NCT00925587|6077053|P2|Overall Study|Adverse Event|2
1742200|NCT00925587|6077054|P1|Overall Study|Adverse Event|6
1742201|NCT00925587|6077053|P2|Overall Study|Death|5
1742202|NCT00925587|6077054|P1|Overall Study|Death|5
1742203|NCT00925587|6077053|P2|Overall Study|Withdrawal by Subject|6
1742204|NCT00925587|6077054|P1|Overall Study|Withdrawal by Subject|9
1742205|NCT00925587|6077053|P2|Overall Study|Protocol Violation|4
1742206|NCT00925587|6077054|P1|Overall Study|Protocol Violation|6
1742207|NCT00925587|6077053|P2|Overall Study|Physician Decision|1
1742208|NCT00925587|6077054|P1|Overall Study|Physician Decision|4
1742209|NCT00925587|6077053|P2|Overall Study|Protocol Specified Criteria|6
1742210|NCT00925587|6077054|P1|Overall Study|Protocol Specified Criteria|6
1742211|NCT00925548|6077168|P2|Overall Study|Discontinuation of trial by sponsor|5
1742212|NCT00925548|6077169|P1|Overall Study|Discontinuation of trial by sponsor|10
1742213|NCT00925522|6077195|P1|Overall Study|study closed -- business decision|20
1742214|NCT00925353|6077199|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
1742215|NCT00925301|6077205|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
1742216|NCT00925301|6077206|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
1742217|NCT00925301|6077207|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
1742218|NCT00925301|6077208|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
1742219|NCT00925301|6077205|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
1742220|NCT00925301|6077206|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
1742221|NCT00925301|6077207|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
1742222|NCT00925301|6077208|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
1742223|NCT00925301|6077205|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
1742224|NCT00925301|6077206|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
1742225|NCT00925301|6077207|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
1742226|NCT00925301|6077208|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
1742227|NCT00925301|6077205|P4|6-Month Open-label (Stage 2)|Adverse Event|0
1742228|NCT00925301|6077206|P3|6-Month Open-label (Stage 2)|Adverse Event|2
1742229|NCT00925301|6077207|P2|6-Month Open-label (Stage 2)|Adverse Event|0
1742230|NCT00925301|6077208|P1|6-Month Open-label (Stage 2)|Adverse Event|0
1742231|NCT00925301|6077205|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
1742232|NCT00925301|6077206|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
1742233|NCT00925301|6077207|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
1742234|NCT00925301|6077208|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
1742235|NCT00925301|6077205|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
1742236|NCT00925301|6077206|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
1742237|NCT00925301|6077207|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
1742238|NCT00925301|6077208|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
1742239|NCT00925301|6077205|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
1742240|NCT00925301|6077206|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
1742241|NCT00925301|6077207|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
1742242|NCT00925301|6077208|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
1742243|NCT00925288|6077224|P2|Overall Study|Lost to Follow-up|7
1742244|NCT00925288|6077225|P1|Overall Study|Lost to Follow-up|9
1742245|NCT00925132|6077237|P5|Overall Study|Removed due to disease progression|4
1742246|NCT00925132|6077238|P4|Overall Study|Removed due to disease progression|0
1742247|NCT00925132|6077239|P3|Overall Study|Removed due to disease progression|0
1742248|NCT00925132|6077240|P2|Overall Study|Removed due to disease progression|0
1742249|NCT00925132|6077241|P1|Overall Study|Removed due to disease progression|0
1742250|NCT00925132|6077237|P5|Overall Study|Withdrawal by Subject|1
1742251|NCT00925132|6077238|P4|Overall Study|Withdrawal by Subject|0
1742252|NCT00925132|6077239|P3|Overall Study|Withdrawal by Subject|0
1742253|NCT00925132|6077240|P2|Overall Study|Withdrawal by Subject|0
1742254|NCT00925132|6077241|P1|Overall Study|Withdrawal by Subject|2
1742255|NCT00925015|6077336|P3|Overall Study|Withdrawal by Subject|1
1742256|NCT00925015|6077337|P2|Overall Study|Withdrawal by Subject|0
1742257|NCT00925015|6077338|P1|Overall Study|Withdrawal by Subject|0
1742258|NCT00925015|6077336|P3|Overall Study|Progressive Disease|4
1742259|NCT00925015|6077337|P2|Overall Study|Progressive Disease|3
1742260|NCT00925015|6077338|P1|Overall Study|Progressive Disease|7
1742261|NCT00925015|6077336|P3|Overall Study|Physician Decision|0
1742262|NCT00925015|6077337|P2|Overall Study|Physician Decision|1
1742263|NCT00925015|6077338|P1|Overall Study|Physician Decision|0
1742264|NCT00925015|6077336|P3|Overall Study|Adverse Event|1
1742265|NCT00925015|6077337|P2|Overall Study|Adverse Event|2
1742266|NCT00925015|6077338|P1|Overall Study|Adverse Event|1
1742267|NCT00924950|6077394|P1|Overall Study|Lost to Follow-up|2
1742268|NCT00924898|6077401|P1|Overall Study|Withdrawal by Subject|2
1742269|NCT00924781|6077438|P2|Overall Study|Study terminated by sponsor|10
1742270|NCT00924781|6077439|P1|Overall Study|Study terminated by sponsor|12
1742271|NCT00924729|6077473|P2|Overall Study|Protocol Violation|0
1742272|NCT00924729|6077474|P1|Overall Study|Protocol Violation|1
1742273|NCT00924729|6077473|P2|Overall Study|insufficient volume for analysis|0
1742274|NCT00924729|6077474|P1|Overall Study|insufficient volume for analysis|1
1742275|NCT00924651|6077484|P2|Overall Study|Incomplete Form|1
1742276|NCT00924651|6077485|P1|Overall Study|Incomplete Form|2
1742277|NCT00924651|6077484|P2|Overall Study|Changed Mind|1
1742278|NCT00924651|6077485|P1|Overall Study|Changed Mind|10
1742279|NCT00924651|6077484|P2|Overall Study|Medical|3
1742280|NCT00924651|6077485|P1|Overall Study|Medical|1
1742281|NCT00924651|6077484|P2|Overall Study|Noncompliant|4
1742282|NCT00924651|6077485|P1|Overall Study|Noncompliant|1
1742283|NCT00924651|6077484|P2|Overall Study|Overwhelmed|6
1742284|NCT00924651|6077485|P1|Overall Study|Overwhelmed|6
1742285|NCT00924651|6077484|P2|Overall Study|No Reason|7
1742286|NCT00924651|6077485|P1|Overall Study|No Reason|3
1742287|NCT00924651|6077484|P2|Overall Study|Chemo started too soon|3
1742288|NCT00924651|6077485|P1|Overall Study|Chemo started too soon|2
1742289|NCT00924638|6077493|P2|Overall Study|Physician Decision|3
1742290|NCT00924638|6077494|P1|Overall Study|Physician Decision|3
1742291|NCT00924638|6077493|P2|Overall Study|Withdrawal by Subject|7
1742292|NCT00924638|6077494|P1|Overall Study|Withdrawal by Subject|5
1742293|NCT00924638|6077493|P2|Overall Study|Lost to Follow-up|1
1742294|NCT00924638|6077494|P1|Overall Study|Lost to Follow-up|1
1742295|NCT00924638|6077493|P2|Overall Study|Death|2
1742296|NCT00924638|6077494|P1|Overall Study|Death|3
1742297|NCT00924560|6077516|P3|Overall Study|Miscellaneous Reasons|10
1742298|NCT00924560|6077517|P2|Overall Study|Miscellaneous Reasons|10
1742299|NCT00924560|6077518|P1|Overall Study|Miscellaneous Reasons|13
1742300|NCT00924560|6077516|P3|Overall Study|Lost to Follow-up|45
1742301|NCT00924560|6077517|P2|Overall Study|Lost to Follow-up|94
1742302|NCT00924560|6077518|P1|Overall Study|Lost to Follow-up|78
1742303|NCT00924560|6077516|P3|Overall Study|Pregnancy|1
1742304|NCT00924560|6077517|P2|Overall Study|Pregnancy|7
1742305|NCT00924560|6077518|P1|Overall Study|Pregnancy|5
1742306|NCT00924560|6077516|P3|Overall Study|Adverse Event|0
1742307|NCT00924560|6077517|P2|Overall Study|Adverse Event|33
1742308|NCT00924560|6077518|P1|Overall Study|Adverse Event|39
1742309|NCT00924560|6077516|P3|Overall Study|Withdrawal by Subject|18
1742310|NCT00924560|6077517|P2|Overall Study|Withdrawal by Subject|44
1742311|NCT00924560|6077518|P1|Overall Study|Withdrawal by Subject|50
1742312|NCT00924560|6077516|P3|Overall Study|Physician Decision|4
1742313|NCT00924560|6077517|P2|Overall Study|Physician Decision|3
1742314|NCT00924560|6077518|P1|Overall Study|Physician Decision|2
1742315|NCT00924560|6077516|P3|Overall Study|Non Compliance with the Protocol|4
1742316|NCT00924560|6077517|P2|Overall Study|Non Compliance with the Protocol|15
1742317|NCT00924560|6077518|P1|Overall Study|Non Compliance with the Protocol|20
1742318|NCT00924560|6077516|P3|Overall Study|Did Not Meet Protocol Requirements|1
1742319|NCT00924560|6077517|P2|Overall Study|Did Not Meet Protocol Requirements|2
1742320|NCT00924560|6077518|P1|Overall Study|Did Not Meet Protocol Requirements|4
1742321|NCT00924508|6077562|P1|Overall Study|Withdrawal by Subject|3
1742322|NCT00924469|6077576|P2|Overall Study|Lost to Follow-up|1
1742323|NCT00924469|6077577|P1|Overall Study|Lost to Follow-up|0
1742324|NCT00924469|6077576|P2|Overall Study|Withdrawal by Subject|1
1742325|NCT00924469|6077577|P1|Overall Study|Withdrawal by Subject|0
1742326|NCT00924469|6077576|P2|Overall Study|Adverse Event|0
1742327|NCT00924469|6077577|P1|Overall Study|Adverse Event|2
1742328|NCT00924443|6077599|P1|Overall Study|Protocol Violation|1
1742329|NCT00924443|6077599|P1|Overall Study|Physician Decision|2
1742330|NCT00924404|6077609|P2|Overall Study|Lost to Follow-up|4
1742331|NCT00924404|6077610|P1|Overall Study|Lost to Follow-up|6
1742332|NCT00924313|6077681|P1|Overall Study|not imaged due to failed tracer imaging|1
1742333|NCT00924287|6077693|P1|Overall Study|Death|1
1742334|NCT00924170|6077709|P2|Overall Study|Death|0
1742335|NCT00924170|6077710|P1|Overall Study|Death|1
1742336|NCT00924170|6077709|P2|Overall Study|Stopped due to neutralizing antibodies|0
1742337|NCT00924170|6077710|P1|Overall Study|Stopped due to neutralizing antibodies|3
1742338|NCT00924170|6077709|P2|Overall Study|Progressive disease|6
1742339|NCT00924170|6077710|P1|Overall Study|Progressive disease|3
1742340|NCT00924170|6077709|P2|Overall Study|Physician Decision|1
1742341|NCT00924170|6077710|P1|Overall Study|Physician Decision|0
1742342|NCT00924170|6077709|P2|Overall Study|Refused further treatment|1
1742343|NCT00924170|6077710|P1|Overall Study|Refused further treatment|0
1742344|NCT00923975|6077835|P1|Overall Study|Did not meet inclusion criteria|1
1742345|NCT00923936|6077854|P2|Overall Study|Continuing in follow up period|1
1742346|NCT00923936|6077855|P1|Overall Study|Continuing in follow up period|2
1742347|NCT00923936|6077854|P2|Overall Study|Lost to follow up|0
1742348|NCT00923936|6077855|P1|Overall Study|Lost to follow up|2
1742349|NCT00923936|6077854|P2|Overall Study|Adverse Event|1
1742350|NCT00923936|6077855|P1|Overall Study|Adverse Event|2
1742351|NCT00923936|6077854|P2|Overall Study|progressive disease on study|1
1742352|NCT00923936|6077855|P1|Overall Study|progressive disease on study|2
1742353|NCT00923845|6077884|P2|Induction Therapy|Poor performance status|2
1742354|NCT00923845|6077885|P1|Induction Therapy|Poor performance status|0
1742355|NCT00923364|6077920|P2|Overall Study|Did not go to transplant|0
1742356|NCT00923364|6077921|P1|Overall Study|Did not go to transplant|1
1742357|NCT00923364|6077920|P2|Overall Study|Death|0
1742358|NCT00923364|6077921|P1|Overall Study|Death|3
1742359|NCT00923351|6077933|P3|Overall Study|no apheresis/adequate tumor sample|12
1742360|NCT00923351|6077934|P2|Overall Study|no apheresis/adequate tumor sample|0
1742361|NCT00923351|6077935|P1|Overall Study|no apheresis/adequate tumor sample|0
1742362|NCT00923273|6077950|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1742363|NCT00923273|6077951|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
1742364|NCT00923273|6077952|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1742365|NCT00923273|6077953|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1742366|NCT00923273|6077954|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
1742367|NCT00923273|6077950|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1742368|NCT00923273|6077951|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
1742369|NCT00923273|6077952|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1742370|NCT00923273|6077953|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1742371|NCT00923273|6077954|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
1742372|NCT00923260|6077979|P2|Overall Study|Lost to Follow-up|1
1742373|NCT00923260|6077980|P1|Overall Study|Lost to Follow-up|1
1742374|NCT00923195|6078143|P2|Overall Study|Death|1
1742375|NCT00923195|6078144|P1|Overall Study|Death|0
1742376|NCT00923156|6078155|P3|Overall Study|Lack of Efficacy|1
1742377|NCT00923156|6078156|P2|Overall Study|Lack of Efficacy|0
1742378|NCT00923156|6078157|P1|Overall Study|Lack of Efficacy|0
1742379|NCT00923156|6078155|P3|Overall Study|Death|0
1742380|NCT00923156|6078156|P2|Overall Study|Death|1
1742381|NCT00923156|6078157|P1|Overall Study|Death|0
1742382|NCT00923156|6078155|P3|Overall Study|Withdrawal by Subject|0
1742383|NCT00923156|6078156|P2|Overall Study|Withdrawal by Subject|1
1742384|NCT00923156|6078157|P1|Overall Study|Withdrawal by Subject|0
1742385|NCT00923156|6078155|P3|Overall Study|Abnormal laboratory values|1
1742386|NCT00923156|6078156|P2|Overall Study|Abnormal laboratory values|0
1742387|NCT00923156|6078157|P1|Overall Study|Abnormal laboratory values|0
1742388|NCT00923156|6078155|P3|Overall Study|Adverse Event|1
1742389|NCT00923156|6078156|P2|Overall Study|Adverse Event|2
1742390|NCT00923156|6078157|P1|Overall Study|Adverse Event|0
1742391|NCT00923130|6078183|P1|Overall Study|Refused further treatment|2
1742392|NCT00923130|6078183|P1|Overall Study|Switched to alternative treatment|2
1742393|NCT00923130|6078183|P1|Overall Study|Discontinued treatment due to toxicities|3
1742394|NCT00923130|6078183|P1|Overall Study|Death|1
1742395|NCT00923130|6078183|P1|Overall Study|Stopped treatment due to progression|17
1742396|NCT00923091|6078218|P13|Period VI (Open-Label)|Other Reason|0
1742397|NCT00923091|6078219|P12|Period VI (Open-Label)|Other Reason|0
1742398|NCT00923091|6078220|P11|Period VI (Open-Label)|Other Reason|0
1742399|NCT00923091|6078221|P10|Period VI (Open-Label)|Other Reason|0
1742400|NCT00923091|6078222|P9|Period VI (Open-Label)|Other Reason|0
1742401|NCT00923091|6078223|P8|Period VI (Open-Label)|Other Reason|0
1742402|NCT00923091|6078224|P7|Period VI (Open-Label)|Other Reason|0
1742403|NCT00923091|6078225|P6|Period VI (Open-Label)|Other Reason|0
1742404|NCT00923091|6078226|P5|Period VI (Open-Label)|Other Reason|1
1742405|NCT00923091|6078227|P4|Period VI (Open-Label)|Other Reason|1
1742406|NCT00923091|6078228|P3|Period VI (Open-Label)|Other Reason|0
1742407|NCT00923091|6078229|P2|Period VI (Open-Label)|Other Reason|0
1742408|NCT00923091|6078230|P1|Period VI (Open-Label)|Other Reason|0
1742409|NCT00923091|6078218|P13|Period VI (Open-Label)|Lost to Follow-up|0
1742410|NCT00923091|6078219|P12|Period VI (Open-Label)|Lost to Follow-up|0
1742411|NCT00923091|6078220|P11|Period VI (Open-Label)|Lost to Follow-up|0
1742412|NCT00923091|6078221|P10|Period VI (Open-Label)|Lost to Follow-up|0
1742413|NCT00923091|6078222|P9|Period VI (Open-Label)|Lost to Follow-up|0
1742414|NCT00923091|6078223|P8|Period VI (Open-Label)|Lost to Follow-up|0
1742415|NCT00923091|6078224|P7|Period VI (Open-Label)|Lost to Follow-up|0
1742416|NCT00923091|6078225|P6|Period VI (Open-Label)|Lost to Follow-up|0
1742417|NCT00923091|6078226|P5|Period VI (Open-Label)|Lost to Follow-up|0
1742418|NCT00923091|6078227|P4|Period VI (Open-Label)|Lost to Follow-up|0
1742419|NCT00923091|6078228|P3|Period VI (Open-Label)|Lost to Follow-up|1
1742420|NCT00923091|6078229|P2|Period VI (Open-Label)|Lost to Follow-up|0
1742421|NCT00923091|6078230|P1|Period VI (Open-Label)|Lost to Follow-up|1
1742422|NCT00923091|6078218|P13|Period VI (Open-Label)|Protocol Violation|0
1742423|NCT00923091|6078219|P12|Period VI (Open-Label)|Protocol Violation|0
1742424|NCT00923091|6078220|P11|Period VI (Open-Label)|Protocol Violation|0
1742425|NCT00923091|6078221|P10|Period VI (Open-Label)|Protocol Violation|0
1742426|NCT00923091|6078222|P9|Period VI (Open-Label)|Protocol Violation|0
1742427|NCT00923091|6078223|P8|Period VI (Open-Label)|Protocol Violation|0
1742428|NCT00923091|6078224|P7|Period VI (Open-Label)|Protocol Violation|0
1742429|NCT00923091|6078225|P6|Period VI (Open-Label)|Protocol Violation|0
1742430|NCT00923091|6078226|P5|Period VI (Open-Label)|Protocol Violation|4
1742431|NCT00923091|6078227|P4|Period VI (Open-Label)|Protocol Violation|1
1742432|NCT00923091|6078228|P3|Period VI (Open-Label)|Protocol Violation|3
1742433|NCT00923091|6078229|P2|Period VI (Open-Label)|Protocol Violation|1
1742434|NCT00923091|6078230|P1|Period VI (Open-Label)|Protocol Violation|6
1742435|NCT00923091|6078218|P13|Period VI (Open-Label)|Withdrawal by Subject|0
1742436|NCT00923091|6078219|P12|Period VI (Open-Label)|Withdrawal by Subject|0
1742437|NCT00923091|6078220|P11|Period VI (Open-Label)|Withdrawal by Subject|0
1742438|NCT00923091|6078221|P10|Period VI (Open-Label)|Withdrawal by Subject|0
1742439|NCT00923091|6078222|P9|Period VI (Open-Label)|Withdrawal by Subject|0
1742440|NCT00923091|6078223|P8|Period VI (Open-Label)|Withdrawal by Subject|0
1742441|NCT00923091|6078224|P7|Period VI (Open-Label)|Withdrawal by Subject|0
1742442|NCT00923091|6078225|P6|Period VI (Open-Label)|Withdrawal by Subject|0
1742443|NCT00923091|6078226|P5|Period VI (Open-Label)|Withdrawal by Subject|1
1742444|NCT00923091|6078227|P4|Period VI (Open-Label)|Withdrawal by Subject|0
1742445|NCT00923091|6078228|P3|Period VI (Open-Label)|Withdrawal by Subject|5
1742446|NCT00923091|6078229|P2|Period VI (Open-Label)|Withdrawal by Subject|7
1742447|NCT00923091|6078230|P1|Period VI (Open-Label)|Withdrawal by Subject|15
1742448|NCT00923091|6078218|P13|Period VI (Open-Label)|Adverse Event|0
1742449|NCT00923091|6078219|P12|Period VI (Open-Label)|Adverse Event|0
1742450|NCT00923091|6078220|P11|Period VI (Open-Label)|Adverse Event|0
1742451|NCT00923091|6078221|P10|Period VI (Open-Label)|Adverse Event|0
1742452|NCT00923091|6078222|P9|Period VI (Open-Label)|Adverse Event|0
1742453|NCT00923091|6078223|P8|Period VI (Open-Label)|Adverse Event|0
1742454|NCT00923091|6078224|P7|Period VI (Open-Label)|Adverse Event|0
1742455|NCT00923091|6078225|P6|Period VI (Open-Label)|Adverse Event|0
1742456|NCT00923091|6078226|P5|Period VI (Open-Label)|Adverse Event|1
1742457|NCT00923091|6078227|P4|Period VI (Open-Label)|Adverse Event|1
1742458|NCT00923091|6078228|P3|Period VI (Open-Label)|Adverse Event|4
1742459|NCT00923091|6078229|P2|Period VI (Open-Label)|Adverse Event|0
1742460|NCT00923091|6078230|P1|Period VI (Open-Label)|Adverse Event|17
1742461|NCT00923091|6078218|P13|Period V (Double -Blind)|Lost to Follow-up|0
1742462|NCT00923091|6078219|P12|Period V (Double -Blind)|Lost to Follow-up|0
1742463|NCT00923091|6078220|P11|Period V (Double -Blind)|Lost to Follow-up|1
1742464|NCT00923091|6078221|P10|Period V (Double -Blind)|Lost to Follow-up|0
1742465|NCT00923091|6078222|P9|Period V (Double -Blind)|Lost to Follow-up|0
1742466|NCT00923091|6078223|P8|Period V (Double -Blind)|Lost to Follow-up|0
1742467|NCT00923091|6078224|P7|Period V (Double -Blind)|Lost to Follow-up|0
1742468|NCT00923091|6078225|P6|Period V (Double -Blind)|Lost to Follow-up|0
1742469|NCT00923091|6078226|P5|Period V (Double -Blind)|Lost to Follow-up|0
1742470|NCT00923091|6078227|P4|Period V (Double -Blind)|Lost to Follow-up|0
1742471|NCT00923091|6078228|P3|Period V (Double -Blind)|Lost to Follow-up|0
1742472|NCT00923091|6078229|P2|Period V (Double -Blind)|Lost to Follow-up|0
1742473|NCT00923091|6078230|P1|Period V (Double -Blind)|Lost to Follow-up|0
1742474|NCT00923091|6078218|P13|Period V (Double -Blind)|Protocol Violation|1
1742475|NCT00923091|6078219|P12|Period V (Double -Blind)|Protocol Violation|0
1742476|NCT00923091|6078220|P11|Period V (Double -Blind)|Protocol Violation|0
1742477|NCT00923091|6078221|P10|Period V (Double -Blind)|Protocol Violation|0
1742478|NCT00923091|6078222|P9|Period V (Double -Blind)|Protocol Violation|0
1742479|NCT00923091|6078223|P8|Period V (Double -Blind)|Protocol Violation|0
1742480|NCT00923091|6078224|P7|Period V (Double -Blind)|Protocol Violation|0
1742481|NCT00923091|6078225|P6|Period V (Double -Blind)|Protocol Violation|0
1742482|NCT00923091|6078226|P5|Period V (Double -Blind)|Protocol Violation|0
1742483|NCT00923091|6078227|P4|Period V (Double -Blind)|Protocol Violation|0
1742484|NCT00923091|6078228|P3|Period V (Double -Blind)|Protocol Violation|0
1742485|NCT00923091|6078229|P2|Period V (Double -Blind)|Protocol Violation|0
1742486|NCT00923091|6078230|P1|Period V (Double -Blind)|Protocol Violation|0
1742487|NCT00923091|6078218|P13|Period V (Double -Blind)|Withdrawal by Subject|1
1742488|NCT00923091|6078219|P12|Period V (Double -Blind)|Withdrawal by Subject|0
1742489|NCT00923091|6078220|P11|Period V (Double -Blind)|Withdrawal by Subject|0
1742490|NCT00923091|6078221|P10|Period V (Double -Blind)|Withdrawal by Subject|0
1742491|NCT00923091|6078222|P9|Period V (Double -Blind)|Withdrawal by Subject|1
1742492|NCT00923091|6078223|P8|Period V (Double -Blind)|Withdrawal by Subject|0
1742493|NCT00923091|6078224|P7|Period V (Double -Blind)|Withdrawal by Subject|0
1742494|NCT00923091|6078225|P6|Period V (Double -Blind)|Withdrawal by Subject|0
1742495|NCT00923091|6078226|P5|Period V (Double -Blind)|Withdrawal by Subject|0
1742496|NCT00923091|6078227|P4|Period V (Double -Blind)|Withdrawal by Subject|0
1742497|NCT00923091|6078228|P3|Period V (Double -Blind)|Withdrawal by Subject|0
1742498|NCT00923091|6078229|P2|Period V (Double -Blind)|Withdrawal by Subject|0
1742499|NCT00923091|6078230|P1|Period V (Double -Blind)|Withdrawal by Subject|0
1742500|NCT00923091|6078218|P13|Period IV (Double-Blind)|Protocol Violation|0
1742501|NCT00923091|6078219|P12|Period IV (Double-Blind)|Protocol Violation|0
1742502|NCT00923091|6078220|P11|Period IV (Double-Blind)|Protocol Violation|0
1742503|NCT00923091|6078221|P10|Period IV (Double-Blind)|Protocol Violation|0
1742504|NCT00923091|6078222|P9|Period IV (Double-Blind)|Protocol Violation|0
1742505|NCT00923091|6078223|P8|Period IV (Double-Blind)|Protocol Violation|0
1742506|NCT00923091|6078224|P7|Period IV (Double-Blind)|Protocol Violation|0
1742507|NCT00923091|6078225|P6|Period IV (Double-Blind)|Protocol Violation|0
1742508|NCT00923091|6078226|P5|Period IV (Double-Blind)|Protocol Violation|0
1742509|NCT00923091|6078227|P4|Period IV (Double-Blind)|Protocol Violation|0
1742510|NCT00923091|6078228|P3|Period IV (Double-Blind)|Protocol Violation|0
1742511|NCT00923091|6078229|P2|Period IV (Double-Blind)|Protocol Violation|1
1742512|NCT00923091|6078230|P1|Period IV (Double-Blind)|Protocol Violation|0
1742513|NCT00923091|6078218|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
1742514|NCT00923091|6078219|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
1742515|NCT00923091|6078220|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
1742516|NCT00923091|6078221|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
1742517|NCT00923091|6078222|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
1742518|NCT00923091|6078223|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
1742519|NCT00923091|6078224|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
1742520|NCT00923091|6078225|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
1742521|NCT00923091|6078226|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
1742522|NCT00923091|6078227|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
1742523|NCT00923091|6078228|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
1742524|NCT00923091|6078229|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
1742525|NCT00923091|6078230|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
1742526|NCT00923091|6078218|P13|Period IV (Double-Blind)|Adverse Event|0
1742527|NCT00923091|6078219|P12|Period IV (Double-Blind)|Adverse Event|0
1742528|NCT00923091|6078220|P11|Period IV (Double-Blind)|Adverse Event|0
1742529|NCT00923091|6078221|P10|Period IV (Double-Blind)|Adverse Event|0
1742530|NCT00923091|6078222|P9|Period IV (Double-Blind)|Adverse Event|0
1742531|NCT00923091|6078223|P8|Period IV (Double-Blind)|Adverse Event|0
1742532|NCT00923091|6078224|P7|Period IV (Double-Blind)|Adverse Event|0
1742533|NCT00923091|6078225|P6|Period IV (Double-Blind)|Adverse Event|0
1742534|NCT00923091|6078226|P5|Period IV (Double-Blind)|Adverse Event|0
1742535|NCT00923091|6078227|P4|Period IV (Double-Blind)|Adverse Event|0
1742536|NCT00923091|6078228|P3|Period IV (Double-Blind)|Adverse Event|0
1742537|NCT00923091|6078229|P2|Period IV (Double-Blind)|Adverse Event|0
1742538|NCT00923091|6078230|P1|Period IV (Double-Blind)|Adverse Event|2
1742539|NCT00923091|6078218|P13|Period III (Single-Blind)|Lost to Follow-up|0
1742540|NCT00923091|6078219|P12|Period III (Single-Blind)|Lost to Follow-up|0
1742541|NCT00923091|6078220|P11|Period III (Single-Blind)|Lost to Follow-up|0
1742542|NCT00923091|6078221|P10|Period III (Single-Blind)|Lost to Follow-up|0
1742543|NCT00923091|6078222|P9|Period III (Single-Blind)|Lost to Follow-up|0
1742544|NCT00923091|6078223|P8|Period III (Single-Blind)|Lost to Follow-up|0
1742545|NCT00923091|6078224|P7|Period III (Single-Blind)|Lost to Follow-up|0
1742546|NCT00923091|6078225|P6|Period III (Single-Blind)|Lost to Follow-up|0
1742547|NCT00923091|6078226|P5|Period III (Single-Blind)|Lost to Follow-up|0
1742548|NCT00923091|6078227|P4|Period III (Single-Blind)|Lost to Follow-up|0
1742549|NCT00923091|6078228|P3|Period III (Single-Blind)|Lost to Follow-up|0
1742550|NCT00923091|6078229|P2|Period III (Single-Blind)|Lost to Follow-up|0
1742551|NCT00923091|6078230|P1|Period III (Single-Blind)|Lost to Follow-up|2
1742552|NCT00923091|6078218|P13|Period III (Single-Blind)|Protocol Violation|0
1742553|NCT00923091|6078219|P12|Period III (Single-Blind)|Protocol Violation|0
1742554|NCT00923091|6078220|P11|Period III (Single-Blind)|Protocol Violation|0
1742555|NCT00923091|6078221|P10|Period III (Single-Blind)|Protocol Violation|0
1742556|NCT00923091|6078222|P9|Period III (Single-Blind)|Protocol Violation|0
1742557|NCT00923091|6078223|P8|Period III (Single-Blind)|Protocol Violation|0
1742558|NCT00923091|6078224|P7|Period III (Single-Blind)|Protocol Violation|0
1742559|NCT00923091|6078225|P6|Period III (Single-Blind)|Protocol Violation|0
1742560|NCT00923091|6078226|P5|Period III (Single-Blind)|Protocol Violation|0
1742561|NCT00923091|6078227|P4|Period III (Single-Blind)|Protocol Violation|0
1742562|NCT00923091|6078228|P3|Period III (Single-Blind)|Protocol Violation|0
1742563|NCT00923091|6078229|P2|Period III (Single-Blind)|Protocol Violation|0
1742564|NCT00923091|6078230|P1|Period III (Single-Blind)|Protocol Violation|3
1742565|NCT00923091|6078218|P13|Period III (Single-Blind)|Withdrawal by Subject|0
1742566|NCT00923091|6078219|P12|Period III (Single-Blind)|Withdrawal by Subject|0
1742567|NCT00923091|6078220|P11|Period III (Single-Blind)|Withdrawal by Subject|0
1742568|NCT00923091|6078221|P10|Period III (Single-Blind)|Withdrawal by Subject|0
1742569|NCT00923091|6078222|P9|Period III (Single-Blind)|Withdrawal by Subject|0
1742570|NCT00923091|6078223|P8|Period III (Single-Blind)|Withdrawal by Subject|0
1742571|NCT00923091|6078224|P7|Period III (Single-Blind)|Withdrawal by Subject|0
1742572|NCT00923091|6078225|P6|Period III (Single-Blind)|Withdrawal by Subject|0
1742573|NCT00923091|6078226|P5|Period III (Single-Blind)|Withdrawal by Subject|0
1742574|NCT00923091|6078227|P4|Period III (Single-Blind)|Withdrawal by Subject|0
1742575|NCT00923091|6078228|P3|Period III (Single-Blind)|Withdrawal by Subject|0
1742576|NCT00923091|6078229|P2|Period III (Single-Blind)|Withdrawal by Subject|0
1742577|NCT00923091|6078230|P1|Period III (Single-Blind)|Withdrawal by Subject|10
1742578|NCT00923091|6078218|P13|Period III (Single-Blind)|Adverse Event|0
1742579|NCT00923091|6078219|P12|Period III (Single-Blind)|Adverse Event|0
1742580|NCT00923091|6078220|P11|Period III (Single-Blind)|Adverse Event|0
1742581|NCT00923091|6078221|P10|Period III (Single-Blind)|Adverse Event|0
1742582|NCT00923091|6078222|P9|Period III (Single-Blind)|Adverse Event|0
1742583|NCT00923091|6078223|P8|Period III (Single-Blind)|Adverse Event|0
1742584|NCT00923091|6078224|P7|Period III (Single-Blind)|Adverse Event|0
1742585|NCT00923091|6078225|P6|Period III (Single-Blind)|Adverse Event|0
1742586|NCT00923091|6078226|P5|Period III (Single-Blind)|Adverse Event|0
1742587|NCT00923091|6078227|P4|Period III (Single-Blind)|Adverse Event|0
1742588|NCT00923091|6078228|P3|Period III (Single-Blind)|Adverse Event|0
1742589|NCT00923091|6078229|P2|Period III (Single-Blind)|Adverse Event|0
1742590|NCT00923091|6078230|P1|Period III (Single-Blind)|Adverse Event|5
1742591|NCT00923091|6078218|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742592|NCT00923091|6078219|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742593|NCT00923091|6078220|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742594|NCT00923091|6078221|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742595|NCT00923091|6078222|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742596|NCT00923091|6078223|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742597|NCT00923091|6078224|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742598|NCT00923091|6078225|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1742599|NCT00923091|6078226|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742600|NCT00923091|6078227|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1742601|NCT00923091|6078228|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742602|NCT00923091|6078229|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
1742603|NCT00923091|6078230|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
1742604|NCT00923091|6078218|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742605|NCT00923091|6078219|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742606|NCT00923091|6078220|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742607|NCT00923091|6078221|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742608|NCT00923091|6078222|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742609|NCT00923091|6078223|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742610|NCT00923091|6078224|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742611|NCT00923091|6078225|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
1742612|NCT00923091|6078226|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742613|NCT00923091|6078227|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742614|NCT00923091|6078228|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742615|NCT00923091|6078229|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742616|NCT00923091|6078230|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
1742617|NCT00923091|6078218|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1742618|NCT00923091|6078219|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1742619|NCT00923091|6078220|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1742620|NCT00923091|6078221|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1742621|NCT00923091|6078222|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
1742622|NCT00923091|6078223|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
1742623|NCT00923091|6078224|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
1742624|NCT00923091|6078225|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
1742625|NCT00923091|6078226|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
1742626|NCT00923091|6078227|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
1742627|NCT00923091|6078228|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1742628|NCT00923091|6078229|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1742629|NCT00923091|6078230|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
1742630|NCT00923091|6078218|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1742631|NCT00923091|6078219|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1742632|NCT00923091|6078220|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1742633|NCT00923091|6078221|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1742634|NCT00923091|6078222|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
1742635|NCT00923091|6078223|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1742636|NCT00923091|6078224|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1742637|NCT00923091|6078225|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
1742638|NCT00923091|6078226|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
1742639|NCT00923091|6078227|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
1742640|NCT00923091|6078228|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
1742641|NCT00923091|6078229|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
1742642|NCT00923091|6078230|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
1742643|NCT00923091|6078218|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1742644|NCT00923091|6078219|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1742645|NCT00923091|6078220|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1742646|NCT00923091|6078221|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1742647|NCT00923091|6078222|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
1742648|NCT00923091|6078223|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
1742649|NCT00923091|6078224|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
1742650|NCT00923091|6078225|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
1742651|NCT00923091|6078226|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
1742652|NCT00923091|6078227|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
1742653|NCT00923091|6078228|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
1742654|NCT00923091|6078229|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
1742655|NCT00923091|6078230|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
1742656|NCT00923078|6078280|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
1742657|NCT00923078|6078281|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
1742658|NCT00923078|6078282|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
1742659|NCT00923078|6078280|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
1742660|NCT00923078|6078281|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
1742661|NCT00923078|6078282|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
1742662|NCT00922987|6078301|P1|Overall Study|Adverse Event|1
1742663|NCT00922987|6078301|P1|Overall Study|Protocol Violation|2
1742664|NCT00922987|6078301|P1|Overall Study|Insufficient clinical response|1
1742665|NCT00922974|6078316|P2|Phase III Component|Protocol Violation|6
1742666|NCT00922974|6078317|P1|Phase III Component|Protocol Violation|8
1742667|NCT00922974|6078316|P2|Phase II Component|Not evaluable for treatment review|0
1742668|NCT00922974|6078317|P1|Phase II Component|Not evaluable for treatment review|5
1742669|NCT00922974|6078316|P2|Phase II Component|Protocol Violation|0
1742670|NCT00922974|6078317|P1|Phase II Component|Protocol Violation|2
1742671|NCT00922935|6078332|P3|Overall Study|Lost to Follow-up|0
1742672|NCT00922935|6078333|P2|Overall Study|Lost to Follow-up|1
1742673|NCT00922935|6078334|P1|Overall Study|Lost to Follow-up|0
1742674|NCT00922935|6078332|P3|Overall Study|Physician Decision|0
1742675|NCT00922935|6078333|P2|Overall Study|Physician Decision|1
1742676|NCT00922935|6078334|P1|Overall Study|Physician Decision|1
1742677|NCT00922935|6078332|P3|Overall Study|Protocol Violation|0
1742678|NCT00922935|6078333|P2|Overall Study|Protocol Violation|3
1742679|NCT00922935|6078334|P1|Overall Study|Protocol Violation|0
1742680|NCT00922779|6078346|P1|Overall Study|Missing|1874
1742681|NCT00922779|6078346|P1|Overall Study|Other|27
1742682|NCT00922779|6078346|P1|Overall Study|Lost to Follow-up|44
1742683|NCT00922779|6078346|P1|Overall Study|Withdrawal by Subject|308
1742684|NCT00922779|6078346|P1|Overall Study|Pregnancy|7
1742685|NCT00922779|6078346|P1|Overall Study|Adverse Event|67
1742686|NCT00922766|6078353|P1|Overall Study|Adverse Event|1
1742687|NCT00922766|6078353|P1|Overall Study|Other|1
1742688|NCT00922766|6078353|P1|Overall Study|Withdrawal by Subject|2
1742689|NCT00922766|6078353|P1|Overall Study|Death|3
1742690|NCT00922636|6078371|P5|Overall Study|Lost to Follow-up|4
1742691|NCT00922636|6078372|P4|Overall Study|Lost to Follow-up|2
1742692|NCT00922636|6078373|P3|Overall Study|Lost to Follow-up|2
1742693|NCT00922636|6078374|P2|Overall Study|Lost to Follow-up|2
1742694|NCT00922636|6078375|P1|Overall Study|Lost to Follow-up|1
1742695|NCT00922636|6078371|P5|Overall Study|Parent/Caregiver Decision|2
1742696|NCT00922636|6078372|P4|Overall Study|Parent/Caregiver Decision|5
1742697|NCT00922636|6078373|P3|Overall Study|Parent/Caregiver Decision|3
1742698|NCT00922636|6078374|P2|Overall Study|Parent/Caregiver Decision|4
1742699|NCT00922636|6078375|P1|Overall Study|Parent/Caregiver Decision|2
1742700|NCT00922636|6078371|P5|Overall Study|Entry Criteria Not Met|0
1742701|NCT00922636|6078372|P4|Overall Study|Entry Criteria Not Met|1
1742702|NCT00922636|6078373|P3|Overall Study|Entry Criteria Not Met|1
1742703|NCT00922636|6078374|P2|Overall Study|Entry Criteria Not Met|0
1742704|NCT00922636|6078375|P1|Overall Study|Entry Criteria Not Met|0
1742705|NCT00922636|6078371|P5|Overall Study|Protocol Violation|0
1742706|NCT00922636|6078372|P4|Overall Study|Protocol Violation|2
1742707|NCT00922636|6078373|P3|Overall Study|Protocol Violation|2
1742708|NCT00922636|6078374|P2|Overall Study|Protocol Violation|0
1742709|NCT00922636|6078375|P1|Overall Study|Protocol Violation|0
1742710|NCT00922636|6078371|P5|Overall Study|Withdrawal by Subject|4
1742711|NCT00922636|6078372|P4|Overall Study|Withdrawal by Subject|2
1742712|NCT00922636|6078373|P3|Overall Study|Withdrawal by Subject|5
1742713|NCT00922636|6078374|P2|Overall Study|Withdrawal by Subject|0
1742714|NCT00922636|6078375|P1|Overall Study|Withdrawal by Subject|0
1742715|NCT00922636|6078371|P5|Overall Study|Sponsor Decision|0
1742716|NCT00922636|6078372|P4|Overall Study|Sponsor Decision|0
1742717|NCT00922636|6078373|P3|Overall Study|Sponsor Decision|2
1742718|NCT00922636|6078374|P2|Overall Study|Sponsor Decision|0
1742719|NCT00922636|6078375|P1|Overall Study|Sponsor Decision|0
1742720|NCT00922636|6078371|P5|Overall Study|Lack of Efficacy|4
1742721|NCT00922636|6078372|P4|Overall Study|Lack of Efficacy|2
1742722|NCT00922636|6078373|P3|Overall Study|Lack of Efficacy|3
1742723|NCT00922636|6078374|P2|Overall Study|Lack of Efficacy|7
1742724|NCT00922636|6078375|P1|Overall Study|Lack of Efficacy|1
1742725|NCT00922636|6078371|P5|Overall Study|Adverse Event|2
1742726|NCT00922636|6078372|P4|Overall Study|Adverse Event|3
1742727|NCT00922636|6078373|P3|Overall Study|Adverse Event|2
1742728|NCT00922636|6078374|P2|Overall Study|Adverse Event|3
1742729|NCT00922636|6078375|P1|Overall Study|Adverse Event|3
1742730|NCT00922623|6078522|P1|Overall Study|Lost to Follow-up|1
1742731|NCT00922623|6078522|P1|Overall Study|Other|4
1742732|NCT00922480|6078530|P2|Extension Study|Others|1
1742733|NCT00922480|6078531|P1|Extension Study|Others|0
1742734|NCT00922480|6078530|P2|Extension Study|Withdrawal by Subject|1
1742735|NCT00922480|6078531|P1|Extension Study|Withdrawal by Subject|1
1742736|NCT00922480|6078530|P2|Extension Study|Adverse Event|1
1742737|NCT00922480|6078531|P1|Extension Study|Adverse Event|1
1742738|NCT00922480|6078530|P2|Extension Study|Protocol Violation|0
1742739|NCT00922480|6078531|P1|Extension Study|Protocol Violation|3
1742740|NCT00922480|6078530|P2|Main Study|Physician Decision|1
1742741|NCT00922480|6078531|P1|Main Study|Physician Decision|0
1742742|NCT00922480|6078530|P2|Main Study|Lost to Follow-up|0
1742743|NCT00922480|6078531|P1|Main Study|Lost to Follow-up|5
1742744|NCT00922480|6078530|P2|Main Study|Withdrawal by Subject|15
1742745|NCT00922480|6078531|P1|Main Study|Withdrawal by Subject|20
1742746|NCT00922480|6078530|P2|Main Study|Lack of Efficacy|0
1742747|NCT00922480|6078531|P1|Main Study|Lack of Efficacy|3
1742748|NCT00922480|6078530|P2|Main Study|Adverse Event|7
1742749|NCT00922480|6078531|P1|Main Study|Adverse Event|6
1742750|NCT00922480|6078530|P2|Main Study|Protocol Violation|6
1742751|NCT00922480|6078531|P1|Main Study|Protocol Violation|3
1742752|NCT00922441|6078542|P3|Overall Study|Withdrawal by Subject|1
1742753|NCT00922441|6078543|P2|Overall Study|Withdrawal by Subject|0
1742754|NCT00922441|6078544|P1|Overall Study|Withdrawal by Subject|0
1742755|NCT00922441|6078542|P3|Overall Study|Protocol Violation|2
1742756|NCT00922441|6078543|P2|Overall Study|Protocol Violation|0
1742757|NCT00922441|6078544|P1|Overall Study|Protocol Violation|0
1742758|NCT00922428|6078552|P1|Overall Study|no medication use or questionable use|13
1742759|NCT00922428|6078552|P1|Overall Study|retrospective/extremely implausible data|2
1742760|NCT00922272|6078581|P2|Double-blind Phase|Positive urine drug screen|1
1742761|NCT00922272|6078582|P1|Double-blind Phase|Positive urine drug screen|1
1742762|NCT00922272|6078581|P2|Double-blind Phase|Noncompliance|1
1742763|NCT00922272|6078582|P1|Double-blind Phase|Noncompliance|1
1742764|NCT00922272|6078581|P2|Double-blind Phase|Withdrawal criteria met|1
1742765|NCT00922272|6078582|P1|Double-blind Phase|Withdrawal criteria met|1
1742766|NCT00922272|6078581|P2|Double-blind Phase|Lost to Follow-up|1
1742767|NCT00922272|6078582|P1|Double-blind Phase|Lost to Follow-up|2
1742768|NCT00922272|6078581|P2|Double-blind Phase|Withdrawal by Subject|1
1742769|NCT00922272|6078582|P1|Double-blind Phase|Withdrawal by Subject|1
1742770|NCT00922272|6078581|P2|Double-blind Phase|Adverse Event|1
1742771|NCT00922272|6078582|P1|Double-blind Phase|Adverse Event|1
1742772|NCT00922272|6078581|P2|Open-label Phase|Withdrawal criteria met|0
1742773|NCT00922272|6078582|P1|Open-label Phase|Withdrawal criteria met|5
1742774|NCT00922272|6078581|P2|Open-label Phase|Failure to meet randomization criteria|0
1742775|NCT00922272|6078582|P1|Open-label Phase|Failure to meet randomization criteria|1
1742776|NCT00922272|6078581|P2|Open-label Phase|Withdrawal by Subject|0
1742777|NCT00922272|6078582|P1|Open-label Phase|Withdrawal by Subject|11
1742778|NCT00922272|6078581|P2|Open-label Phase|Protocol Violation|0
1742779|NCT00922272|6078582|P1|Open-label Phase|Protocol Violation|1
1742780|NCT00922272|6078581|P2|Open-label Phase|Adverse Event|0
1742781|NCT00922272|6078582|P1|Open-label Phase|Adverse Event|5
1742782|NCT00922207|6078647|P3|Overall Study|Abnormality of Laboratory Test|1
1742783|NCT00922207|6078648|P2|Overall Study|Abnormality of Laboratory Test|1
1742784|NCT00922207|6078649|P1|Overall Study|Abnormality of Laboratory Test|0
1742785|NCT00922207|6078647|P3|Overall Study|Withdrew Consent|2
1742786|NCT00922207|6078648|P2|Overall Study|Withdrew Consent|5
1742787|NCT00922207|6078649|P1|Overall Study|Withdrew Consent|2
1742788|NCT00922207|6078647|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
1742789|NCT00922207|6078648|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
1742790|NCT00922207|6078649|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
1742791|NCT00922207|6078647|P3|Overall Study|Violation of Selection Criteria at Entry|0
1742792|NCT00922207|6078648|P2|Overall Study|Violation of Selection Criteria at Entry|1
1742793|NCT00922207|6078649|P1|Overall Study|Violation of Selection Criteria at Entry|0
1742794|NCT00922207|6078647|P3|Overall Study|Insufficient Therapeutic Response|1
1742795|NCT00922207|6078648|P2|Overall Study|Insufficient Therapeutic Response|0
1742796|NCT00922207|6078649|P1|Overall Study|Insufficient Therapeutic Response|0
1742797|NCT00922207|6078647|P3|Overall Study|Adverse Event/Intercurrent Illness|0
1742798|NCT00922207|6078648|P2|Overall Study|Adverse Event/Intercurrent Illness|0
1742799|NCT00922207|6078649|P1|Overall Study|Adverse Event/Intercurrent Illness|3
1742800|NCT00922116|6078685|P1|Overall Study|Other|5
1742801|NCT00922116|6078685|P1|Overall Study|Withdrawal by Subject|4
1742802|NCT00922116|6078685|P1|Overall Study|Lost to Follow-up|1
1742803|NCT00922116|6078685|P1|Overall Study|Death|1
1742804|NCT00922116|6078685|P1|Overall Study|Adverse Event|4
1742805|NCT00921557|6078747|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
1742806|NCT00921557|6078748|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
1742807|NCT00921557|6078749|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
1742808|NCT00921557|6078747|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
1742809|NCT00921557|6078748|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
1742810|NCT00921557|6078749|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
1742811|NCT00921557|6078747|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
1742812|NCT00921557|6078748|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
1742813|NCT00921557|6078749|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
1742814|NCT00921557|6078747|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
1742815|NCT00921557|6078748|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
1742816|NCT00921557|6078749|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
1742817|NCT00921557|6078747|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
1742818|NCT00921557|6078748|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
1742819|NCT00921557|6078749|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
1742820|NCT00921024|6078851|P2|Overall Study|Withdrawal by Subject|3
1742821|NCT00921024|6078852|P1|Overall Study|Withdrawal by Subject|0
1742822|NCT00921024|6078851|P2|Overall Study|Received concomittant therapy|0
1742823|NCT00921024|6078852|P1|Overall Study|Received concomittant therapy|2
1742824|NCT00921024|6078851|P2|Overall Study|Lost to Follow-up|0
1742825|NCT00921024|6078852|P1|Overall Study|Lost to Follow-up|2
1742826|NCT00920907|6078862|P2|Maintenance Period|Adverse Event|1
1742827|NCT00920907|6078863|P1|Maintenance Period|Adverse Event|0
1742828|NCT00920907|6078862|P2|Maintenance Period|Withdrawal by Subject|0
1742829|NCT00920907|6078863|P1|Maintenance Period|Withdrawal by Subject|1
1742830|NCT00920907|6078862|P2|Maintenance Period|Death|1
1742831|NCT00920907|6078863|P1|Maintenance Period|Death|1
1742832|NCT00920907|6078862|P2|Maintenance Period|Study Drug Toxicity|2
1742833|NCT00920907|6078863|P1|Maintenance Period|Study Drug Toxicity|0
1742834|NCT00920907|6078862|P2|Maintenance Period|Administrative (study closure)|2
1742835|NCT00920907|6078863|P1|Maintenance Period|Administrative (study closure)|7
1742836|NCT00920907|6078862|P2|Maintenance Period|Disease Progression|7
1742837|NCT00920907|6078863|P1|Maintenance Period|Disease Progression|3
1742838|NCT00920907|6078862|P2|Induction Period|Withdrawal by Subject|1
1742839|NCT00920907|6078863|P1|Induction Period|Withdrawal by Subject|1
1742840|NCT00920907|6078862|P2|Induction Period|No longer meets study criteria|1
1742841|NCT00920907|6078863|P1|Induction Period|No longer meets study criteria|0
1742842|NCT00920907|6078862|P2|Induction Period|Study Drug Toxicity|6
1742843|NCT00920907|6078863|P1|Induction Period|Study Drug Toxicity|8
1742844|NCT00920907|6078862|P2|Induction Period|Disease Progression|11
1742845|NCT00920907|6078863|P1|Induction Period|Disease Progression|12
1742846|NCT00920907|6078862|P2|Induction Period|Death|1
1742847|NCT00920907|6078863|P1|Induction Period|Death|1
1742848|NCT00920907|6078862|P2|Induction Period|Adverse Event|2
1742849|NCT00920907|6078863|P1|Induction Period|Adverse Event|0
1742935|NCT00920621|6079104|P2|Overall Study|Blood sample not collected|14
1742850|NCT00920855|6078904|P3|Overall Study|Response plateau; started maintenance|1
1742851|NCT00920855|6078905|P2|Overall Study|Response plateau; started maintenance|0
1742852|NCT00920855|6078906|P1|Overall Study|Response plateau; started maintenance|0
1742853|NCT00920855|6078904|P3|Overall Study|Noncompliance to study medication|1
1742854|NCT00920855|6078905|P2|Overall Study|Noncompliance to study medication|0
1742855|NCT00920855|6078906|P1|Overall Study|Noncompliance to study medication|0
1742856|NCT00920855|6078904|P3|Overall Study|Disease progression|10
1742857|NCT00920855|6078905|P2|Overall Study|Disease progression|1
1742858|NCT00920855|6078906|P1|Overall Study|Disease progression|2
1742859|NCT00920855|6078904|P3|Overall Study|Withdrawal by Subject|6
1742860|NCT00920855|6078905|P2|Overall Study|Withdrawal by Subject|1
1742861|NCT00920855|6078906|P1|Overall Study|Withdrawal by Subject|2
1742862|NCT00920855|6078904|P3|Overall Study|Adverse Event|4
1742863|NCT00920855|6078905|P2|Overall Study|Adverse Event|1
1742864|NCT00920855|6078906|P1|Overall Study|Adverse Event|1
1742865|NCT00920829|6078932|P4|Available for Analysis|Required more treatment|1
1742866|NCT00920829|6078933|P3|Available for Analysis|Required more treatment|0
1742867|NCT00920829|6078934|P2|Available for Analysis|Required more treatment|2
1742868|NCT00920829|6078935|P1|Available for Analysis|Required more treatment|0
1742869|NCT00920829|6078932|P4|Available for Analysis|Protocol Violation|0
1742870|NCT00920829|6078933|P3|Available for Analysis|Protocol Violation|1
1742871|NCT00920829|6078934|P2|Available for Analysis|Protocol Violation|0
1742872|NCT00920829|6078935|P1|Available for Analysis|Protocol Violation|0
1742873|NCT00920829|6078932|P4|Available for Analysis|Death|0
1742874|NCT00920829|6078933|P3|Available for Analysis|Death|0
1742875|NCT00920829|6078934|P2|Available for Analysis|Death|0
1742876|NCT00920829|6078935|P1|Available for Analysis|Death|1
1742877|NCT00920829|6078932|P4|Available for Analysis|Adverse Event|0
1742878|NCT00920829|6078933|P3|Available for Analysis|Adverse Event|1
1742879|NCT00920829|6078934|P2|Available for Analysis|Adverse Event|2
1742880|NCT00920829|6078935|P1|Available for Analysis|Adverse Event|1
1742881|NCT00920829|6078932|P4|Available for Analysis|Required Medical Treatment|0
1742882|NCT00920829|6078933|P3|Available for Analysis|Required Medical Treatment|2
1742883|NCT00920829|6078934|P2|Available for Analysis|Required Medical Treatment|1
1742884|NCT00920829|6078935|P1|Available for Analysis|Required Medical Treatment|0
1742885|NCT00920829|6078932|P4|Available for Analysis|Withdrawal by Subject|10
1742886|NCT00920829|6078933|P3|Available for Analysis|Withdrawal by Subject|6
1742887|NCT00920829|6078934|P2|Available for Analysis|Withdrawal by Subject|6
1742888|NCT00920829|6078935|P1|Available for Analysis|Withdrawal by Subject|6
1742889|NCT00920829|6078932|P4|Allocation|No post randomization data|2
1742890|NCT00920829|6078933|P3|Allocation|No post randomization data|0
1742891|NCT00920829|6078934|P2|Allocation|No post randomization data|1
1742892|NCT00920829|6078935|P1|Allocation|No post randomization data|3
1742893|NCT00920816|6078949|P4|Overall Study|Ongoing|36
1742894|NCT00920816|6078950|P3|Overall Study|Ongoing|70
1742895|NCT00920816|6078951|P2|Overall Study|Ongoing|56
1742896|NCT00920816|6078952|P1|Overall Study|Ongoing|106
1742897|NCT00920816|6078949|P4|Overall Study|Withdrawal by Subject|1
1742898|NCT00920816|6078950|P3|Overall Study|Withdrawal by Subject|1
1742899|NCT00920816|6078951|P2|Overall Study|Withdrawal by Subject|2
1742900|NCT00920816|6078952|P1|Overall Study|Withdrawal by Subject|7
1742901|NCT00920816|6078949|P4|Overall Study|Objective progression or relapse|0
1742902|NCT00920816|6078950|P3|Overall Study|Objective progression or relapse|2
1742903|NCT00920816|6078951|P2|Overall Study|Objective progression or relapse|0
1742904|NCT00920816|6078952|P1|Overall Study|Objective progression or relapse|0
1742905|NCT00920816|6078949|P4|Overall Study|Lost to Follow-up|4
1742906|NCT00920816|6078950|P3|Overall Study|Lost to Follow-up|3
1742907|NCT00920816|6078951|P2|Overall Study|Lost to Follow-up|2
1742908|NCT00920816|6078952|P1|Overall Study|Lost to Follow-up|1
1742909|NCT00920816|6078949|P4|Overall Study|Adverse Event|0
1742910|NCT00920816|6078950|P3|Overall Study|Adverse Event|1
1742911|NCT00920816|6078951|P2|Overall Study|Adverse Event|0
1742912|NCT00920816|6078952|P1|Overall Study|Adverse Event|1
1742913|NCT00920816|6078949|P4|Overall Study|Death|28
1742914|NCT00920816|6078950|P3|Overall Study|Death|58
1742915|NCT00920816|6078951|P2|Overall Study|Death|36
1742916|NCT00920816|6078952|P1|Overall Study|Death|77
1742917|NCT00920790|6078990|P1|Overall Study|aggravation of general condition|14
1742918|NCT00920699|6079002|P3|Overall Study|Lost to Follow-up|2
1742919|NCT00920699|6079003|P2|Overall Study|Lost to Follow-up|0
1742920|NCT00920699|6079004|P1|Overall Study|Lost to Follow-up|0
1742921|NCT00920699|6079002|P3|Overall Study|no longer met eligibility|0
1742922|NCT00920699|6079003|P2|Overall Study|no longer met eligibility|1
1742923|NCT00920699|6079004|P1|Overall Study|no longer met eligibility|0
1742924|NCT00920699|6079002|P3|Overall Study|Withdrawal by Subject|2
1742925|NCT00920699|6079003|P2|Overall Study|Withdrawal by Subject|0
1742926|NCT00920699|6079004|P1|Overall Study|Withdrawal by Subject|2
1742927|NCT00920686|6079021|P3|Overall Study|Study drug dosing criteria not met|12
1742928|NCT00920686|6079022|P2|Overall Study|Study drug dosing criteria not met|19
1742929|NCT00920686|6079023|P1|Overall Study|Study drug dosing criteria not met|17
1742930|NCT00920686|6079021|P3|Overall Study|Lost to Follow-up|1
1742931|NCT00920686|6079022|P2|Overall Study|Lost to Follow-up|3
1742932|NCT00920686|6079023|P1|Overall Study|Lost to Follow-up|2
1742933|NCT00920621|6079102|P4|Overall Study|Blood sample not collected|0
1742934|NCT00920621|6079103|P3|Overall Study|Blood sample not collected|0
1742936|NCT00920621|6079105|P1|Overall Study|Blood sample not collected|22
1742937|NCT00920621|6079102|P4|Overall Study|Fetal/neonatal deaths|14
1742938|NCT00920621|6079103|P3|Overall Study|Fetal/neonatal deaths|16
1742939|NCT00920621|6079104|P2|Overall Study|Fetal/neonatal deaths|14
1742940|NCT00920621|6079105|P1|Overall Study|Fetal/neonatal deaths|16
1742941|NCT00920621|6079102|P4|Overall Study|Lost to Follow-up|21
1742942|NCT00920621|6079103|P3|Overall Study|Lost to Follow-up|19
1742943|NCT00920621|6079104|P2|Overall Study|Lost to Follow-up|17
1742944|NCT00920621|6079105|P1|Overall Study|Lost to Follow-up|16
1742945|NCT00920556|6079135|P1|Overall Study|Withdrawal by Subject|1
1742946|NCT00920556|6079135|P1|Overall Study|Physician Decision|7
1742947|NCT00920556|6079135|P1|Overall Study|Adverse Event|16
1742948|NCT00920426|6079184|P4|ITZ111451|Adverse Event|0
1742949|NCT00920426|6079185|P3|ITZ111451|Adverse Event|0
1742950|NCT00920426|6079186|P2|ITZ111451|Adverse Event|0
1742951|NCT00920426|6079187|P1|ITZ111451|Adverse Event|1
1742952|NCT00920218|6079307|P4|Overall Study|Other|0
1742953|NCT00920218|6079308|P3|Overall Study|Other|1
1742954|NCT00920218|6079309|P2|Overall Study|Other|0
1742955|NCT00920218|6079310|P1|Overall Study|Other|0
1742956|NCT00920218|6079307|P4|Overall Study|Transplant failed/malignancy recurrence|3
1742957|NCT00920218|6079308|P3|Overall Study|Transplant failed/malignancy recurrence|2
1742958|NCT00920218|6079309|P2|Overall Study|Transplant failed/malignancy recurrence|1
1742959|NCT00920218|6079310|P1|Overall Study|Transplant failed/malignancy recurrence|0
1742960|NCT00920218|6079307|P4|Overall Study|Lost to Follow-up|3
1742961|NCT00920218|6079308|P3|Overall Study|Lost to Follow-up|0
1742962|NCT00920218|6079309|P2|Overall Study|Lost to Follow-up|1
1742963|NCT00920218|6079310|P1|Overall Study|Lost to Follow-up|0
1742964|NCT00920218|6079307|P4|Overall Study|Migrated/moved from study area|0
1742965|NCT00920218|6079308|P3|Overall Study|Migrated/moved from study area|1
1742966|NCT00920218|6079309|P2|Overall Study|Migrated/moved from study area|0
1742967|NCT00920218|6079310|P1|Overall Study|Migrated/moved from study area|0
1742968|NCT00920218|6079307|P4|Overall Study|Withdrawal by Subject|0
1742969|NCT00920218|6079308|P3|Overall Study|Withdrawal by Subject|2
1742970|NCT00920218|6079309|P2|Overall Study|Withdrawal by Subject|3
1742971|NCT00920218|6079310|P1|Overall Study|Withdrawal by Subject|0
1742972|NCT00920218|6079307|P4|Overall Study|Serious Adverse Event|1
1742973|NCT00920218|6079308|P3|Overall Study|Serious Adverse Event|2
1742974|NCT00920218|6079309|P2|Overall Study|Serious Adverse Event|0
1742975|NCT00920218|6079310|P1|Overall Study|Serious Adverse Event|2
1742976|NCT00920140|6079413|P5|Phase 2|Withdrawal by Subject|1
1742977|NCT00920140|6079414|P4|Phase 2|Withdrawal by Subject|2
1742978|NCT00920140|6079415|P3|Phase 2|Withdrawal by Subject|4
1742979|NCT00920140|6079416|P2|Phase 2|Withdrawal by Subject|0
1742980|NCT00920140|6079417|P1|Phase 2|Withdrawal by Subject|0
1742981|NCT00920140|6079413|P5|Phase 2|Physician Decision|2
1742982|NCT00920140|6079414|P4|Phase 2|Physician Decision|3
1742983|NCT00920140|6079415|P3|Phase 2|Physician Decision|3
1742984|NCT00920140|6079416|P2|Phase 2|Physician Decision|0
1742985|NCT00920140|6079417|P1|Phase 2|Physician Decision|0
1742986|NCT00920140|6079413|P5|Phase 2|Lost to Follow-up|0
1742987|NCT00920140|6079414|P4|Phase 2|Lost to Follow-up|1
1742988|NCT00920140|6079415|P3|Phase 2|Lost to Follow-up|0
1742989|NCT00920140|6079416|P2|Phase 2|Lost to Follow-up|0
1742990|NCT00920140|6079417|P1|Phase 2|Lost to Follow-up|0
1742991|NCT00920140|6079413|P5|Phase 2|Lack of Efficacy|5
1742992|NCT00920140|6079414|P4|Phase 2|Lack of Efficacy|14
1742993|NCT00920140|6079415|P3|Phase 2|Lack of Efficacy|29
1742994|NCT00920140|6079416|P2|Phase 2|Lack of Efficacy|0
1742995|NCT00920140|6079417|P1|Phase 2|Lack of Efficacy|0
1742996|NCT00920140|6079413|P5|Phase 2|Adverse Event|3
1742997|NCT00920140|6079414|P4|Phase 2|Adverse Event|2
1742998|NCT00920140|6079415|P3|Phase 2|Adverse Event|14
1742999|NCT00920140|6079416|P2|Phase 2|Adverse Event|0
1743000|NCT00920140|6079417|P1|Phase 2|Adverse Event|0
1743001|NCT00920140|6079413|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1743002|NCT00920140|6079414|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1743003|NCT00920140|6079415|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1743004|NCT00920140|6079416|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
1743005|NCT00920140|6079417|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
1743006|NCT00920140|6079413|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1743007|NCT00920140|6079414|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1743008|NCT00920140|6079415|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
1743009|NCT00920140|6079416|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
1743010|NCT00920140|6079417|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
1743011|NCT00920140|6079413|P5|Phase 1 (Dose Escalation)|Adverse Event|0
1743012|NCT00920140|6079414|P4|Phase 1 (Dose Escalation)|Adverse Event|0
1743013|NCT00920140|6079415|P3|Phase 1 (Dose Escalation)|Adverse Event|0
1743014|NCT00920140|6079416|P2|Phase 1 (Dose Escalation)|Adverse Event|3
1743015|NCT00920140|6079417|P1|Phase 1 (Dose Escalation)|Adverse Event|3
1743016|NCT00919893|6079479|P2|Overall Study|Protocol Violation|9
1743017|NCT00919893|6079480|P1|Overall Study|Protocol Violation|19
1743018|NCT00919867|6079492|P6|First Intervention|Physician Decision|1
1743019|NCT00919867|6079493|P5|First Intervention|Physician Decision|0
1743020|NCT00919867|6079494|P4|First Intervention|Physician Decision|0
1743021|NCT00919867|6079495|P3|First Intervention|Physician Decision|0
1743022|NCT00919867|6079496|P2|First Intervention|Physician Decision|0
1743023|NCT00919867|6079497|P1|First Intervention|Physician Decision|0
1743024|NCT00919867|6079492|P6|First Intervention|Withdrawal by Subject|0
1743025|NCT00919867|6079493|P5|First Intervention|Withdrawal by Subject|0
1743026|NCT00919867|6079494|P4|First Intervention|Withdrawal by Subject|0
1743027|NCT00919867|6079495|P3|First Intervention|Withdrawal by Subject|1
1743028|NCT00919867|6079496|P2|First Intervention|Withdrawal by Subject|0
1743029|NCT00919867|6079497|P1|First Intervention|Withdrawal by Subject|0
1743030|NCT00919854|6079518|P1|Overall Study|Adverse Event|1
1743031|NCT00919711|6079556|P2|Overall Study|Noncompliance|0
1743032|NCT00919711|6079557|P1|Overall Study|Noncompliance|1
1743033|NCT00919711|6079556|P2|Overall Study|Death|0
1743034|NCT00919711|6079557|P1|Overall Study|Death|1
1743035|NCT00919711|6079556|P2|Overall Study|Lost to Follow-up|0
1743036|NCT00919711|6079557|P1|Overall Study|Lost to Follow-up|2
1743037|NCT00919711|6079556|P2|Overall Study|Administrative Decision|1
1743038|NCT00919711|6079557|P1|Overall Study|Administrative Decision|0
1743039|NCT00919711|6079556|P2|Overall Study|Other|2
1743040|NCT00919711|6079557|P1|Overall Study|Other|1
1743041|NCT00919711|6079556|P2|Overall Study|Adverse Event|3
1743042|NCT00919711|6079557|P1|Overall Study|Adverse Event|13
1743043|NCT00919711|6079556|P2|Overall Study|Withdrawal by Subject|7
1743044|NCT00919711|6079557|P1|Overall Study|Withdrawal by Subject|15
1743045|NCT00919633|6079573|P4|Overall Study|Viral rebound outside protocol timepoint|0
1743046|NCT00919633|6079574|P3|Overall Study|Viral rebound outside protocol timepoint|1
1743047|NCT00919633|6079575|P2|Overall Study|Viral rebound outside protocol timepoint|0
1743048|NCT00919633|6079576|P1|Overall Study|Viral rebound outside protocol timepoint|0
1743049|NCT00919633|6079573|P4|Overall Study|Request of withdrawal w/o future contact|0
1743050|NCT00919633|6079574|P3|Overall Study|Request of withdrawal w/o future contact|1
1743051|NCT00919633|6079575|P2|Overall Study|Request of withdrawal w/o future contact|0
1743052|NCT00919633|6079576|P1|Overall Study|Request of withdrawal w/o future contact|0
1743053|NCT00919633|6079573|P4|Overall Study|Physician Decision|1
1743054|NCT00919633|6079574|P3|Overall Study|Physician Decision|0
1743055|NCT00919633|6079575|P2|Overall Study|Physician Decision|0
1743056|NCT00919633|6079576|P1|Overall Study|Physician Decision|0
1743057|NCT00919633|6079573|P4|Overall Study|Protocol Violation|1
1743058|NCT00919633|6079574|P3|Overall Study|Protocol Violation|0
1743059|NCT00919633|6079575|P2|Overall Study|Protocol Violation|0
1743060|NCT00919633|6079576|P1|Overall Study|Protocol Violation|0
1743061|NCT00919633|6079573|P4|Overall Study|Withdraw consent post transition to SOC|1
1743062|NCT00919633|6079574|P3|Overall Study|Withdraw consent post transition to SOC|1
1743063|NCT00919633|6079575|P2|Overall Study|Withdraw consent post transition to SOC|0
1743064|NCT00919633|6079576|P1|Overall Study|Withdraw consent post transition to SOC|0
1743065|NCT00919633|6079573|P4|Overall Study|Lost to Follow-up|2
1743066|NCT00919633|6079574|P3|Overall Study|Lost to Follow-up|0
1743067|NCT00919633|6079575|P2|Overall Study|Lost to Follow-up|1
1743068|NCT00919633|6079576|P1|Overall Study|Lost to Follow-up|3
1743069|NCT00919633|6079573|P4|Overall Study|Withdrawal by Subject|3
1743070|NCT00919633|6079574|P3|Overall Study|Withdrawal by Subject|4
1743071|NCT00919633|6079575|P2|Overall Study|Withdrawal by Subject|2
1743072|NCT00919633|6079576|P1|Overall Study|Withdrawal by Subject|1
1743073|NCT00919633|6079573|P4|Overall Study|Lack of Efficacy|3
1743074|NCT00919633|6079574|P3|Overall Study|Lack of Efficacy|2
1743075|NCT00919633|6079575|P2|Overall Study|Lack of Efficacy|3
1743076|NCT00919633|6079576|P1|Overall Study|Lack of Efficacy|17
1743077|NCT00919633|6079573|P4|Overall Study|Death|0
1743078|NCT00919633|6079574|P3|Overall Study|Death|2
1743079|NCT00919633|6079575|P2|Overall Study|Death|0
1743080|NCT00919633|6079576|P1|Overall Study|Death|0
1743081|NCT00919633|6079573|P4|Overall Study|Adverse Event|10
1743082|NCT00919633|6079574|P3|Overall Study|Adverse Event|12
1743083|NCT00919633|6079575|P2|Overall Study|Adverse Event|9
1743084|NCT00919633|6079576|P1|Overall Study|Adverse Event|1
1743085|NCT00919061|6079674|P1|Overall Study|Withdrawal by Subject|1
1743086|NCT00919061|6079674|P1|Overall Study|Adverse Event|1
1743087|NCT00918957|6079687|P2|Overall Study|Withdrawal by Subject|0
1743088|NCT00918957|6079688|P1|Overall Study|Withdrawal by Subject|1
1743089|NCT00918957|6079687|P2|Overall Study|Adverse Event|0
1743090|NCT00918957|6079688|P1|Overall Study|Adverse Event|2
1743091|NCT00918879|6079721|P2|Overall Study|Severe non-compliance to protocol|1
1743092|NCT00918879|6079722|P1|Overall Study|Severe non-compliance to protocol|1
1743093|NCT00918879|6079721|P2|Overall Study|Lost to Follow-up|1
1743094|NCT00918879|6079722|P1|Overall Study|Lost to Follow-up|1
1743095|NCT00918879|6079721|P2|Overall Study|Withdrawal by Subject|4
1743096|NCT00918879|6079722|P1|Overall Study|Withdrawal by Subject|4
1743097|NCT00918749|6079754|P3|Overall Study|No Study Medication Taken|0
1743098|NCT00918749|6079755|P2|Overall Study|No Study Medication Taken|0
1743099|NCT00918749|6079756|P1|Overall Study|No Study Medication Taken|1
1743100|NCT00918749|6079754|P3|Overall Study|Withdrawal by Subject|5
1743101|NCT00918749|6079755|P2|Overall Study|Withdrawal by Subject|3
1743102|NCT00918749|6079756|P1|Overall Study|Withdrawal by Subject|5
1743103|NCT00918749|6079754|P3|Overall Study|Lost to Follow-up|1
1743104|NCT00918749|6079755|P2|Overall Study|Lost to Follow-up|0
1743105|NCT00918749|6079756|P1|Overall Study|Lost to Follow-up|0
1743106|NCT00918749|6079754|P3|Overall Study|Adverse Event|1
1743107|NCT00918749|6079755|P2|Overall Study|Adverse Event|0
1743108|NCT00918749|6079756|P1|Overall Study|Adverse Event|1
1743109|NCT00918736|6079788|P1|Overall Study|Withdrawal by Subject|4
1743110|NCT00918684|6079801|P1|Treatment Phase|Withdrawal by Subject|8
1743111|NCT00918684|6079801|P1|Treatment Phase|Protocol Violation|1
1743112|NCT00918684|6079801|P1|Treatment Phase|Physician Decision|8
1743113|NCT00918684|6079801|P1|Treatment Phase|Lost to Follow-up|2
1743114|NCT00918684|6079801|P1|Treatment Phase|Lack of Efficacy|6
1743115|NCT00918684|6079801|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
1743116|NCT00918645|6079812|P1|Overall Study|Withdrawal by Subject|1
1743117|NCT00918580|6079818|P1|After 6-month FU to 1-year FU|Failed to Return|2
1743118|NCT00918580|6079818|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
1743119|NCT00918580|6079818|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
1743120|NCT00918580|6079818|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
1743121|NCT00918580|6079818|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
1743122|NCT00918580|6079818|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
1743123|NCT00918580|6079818|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
1743124|NCT00918463|6079836|P1|Overall Study|Lack of Efficacy|1
1743125|NCT00918463|6079836|P1|Overall Study|Death|1
1743126|NCT00918385|6079844|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
1743127|NCT00918385|6079845|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
1743128|NCT00918385|6079844|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
1743129|NCT00918385|6079845|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
1743130|NCT00918385|6079844|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
1743131|NCT00918385|6079845|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
1743132|NCT00918385|6079844|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
1743133|NCT00918385|6079845|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
1743134|NCT00918385|6079844|P2|Monotherapy|Complicating illness|0
1743135|NCT00918385|6079845|P1|Monotherapy|Complicating illness|1
1743136|NCT00918385|6079844|P2|Monotherapy|Adverse Event|6
1743137|NCT00918385|6079845|P1|Monotherapy|Adverse Event|1
1743138|NCT00918346|6079854|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
1743139|NCT00918346|6079855|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
1743148|NCT00918281|6079892|P1|Overall Study|Physician Decision|29
1743149|NCT00918255|6079902|P3|Overall Study|Investigator discretion|0
1743150|NCT00918255|6079903|P2|Overall Study|Investigator discretion|0
1743151|NCT00918255|6079904|P1|Overall Study|Investigator discretion|1
1743152|NCT00918255|6079902|P3|Overall Study|Non-compliance|0
1743153|NCT00918255|6079903|P2|Overall Study|Non-compliance|0
1743154|NCT00918255|6079904|P1|Overall Study|Non-compliance|1
1743155|NCT00918255|6079902|P3|Overall Study|Exceeded allowed number of interventions|1
1743156|NCT00918255|6079903|P2|Overall Study|Exceeded allowed number of interventions|0
1743157|NCT00918255|6079904|P1|Overall Study|Exceeded allowed number of interventions|0
1743158|NCT00918255|6079902|P3|Overall Study|Lost to Follow-up|2
1743159|NCT00918255|6079903|P2|Overall Study|Lost to Follow-up|0
1743160|NCT00918255|6079904|P1|Overall Study|Lost to Follow-up|1
1743161|NCT00918255|6079902|P3|Overall Study|Lack of Efficacy|0
1743162|NCT00918255|6079903|P2|Overall Study|Lack of Efficacy|0
1743163|NCT00918255|6079904|P1|Overall Study|Lack of Efficacy|1
1743164|NCT00918255|6079902|P3|Overall Study|Withdrawal by Subject|2
1743165|NCT00918255|6079903|P2|Overall Study|Withdrawal by Subject|0
1743166|NCT00918255|6079904|P1|Overall Study|Withdrawal by Subject|1
1743167|NCT00918255|6079902|P3|Overall Study|Adverse Event|0
1743168|NCT00918255|6079903|P2|Overall Study|Adverse Event|0
1743169|NCT00918255|6079904|P1|Overall Study|Adverse Event|1
1743170|NCT00918203|6079937|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
1743171|NCT00918203|6079938|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
1743172|NCT00918203|6079939|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
1743173|NCT00918203|6079937|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
1743174|NCT00918203|6079938|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
1743175|NCT00918203|6079939|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
1743176|NCT00918203|6079937|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
1743177|NCT00918203|6079938|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
1743178|NCT00918203|6079939|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
1743179|NCT00918203|6079937|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
1743180|NCT00918203|6079938|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
1743181|NCT00918203|6079939|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
1743182|NCT00918138|6079970|P2|Overall Study|Death|0
1743183|NCT00918138|6079971|P1|Overall Study|Death|1
1743184|NCT00918138|6079970|P2|Overall Study|Subject withdrew consent|1
1743185|NCT00918138|6079971|P1|Overall Study|Subject withdrew consent|1
1743186|NCT00917852|6080010|P1|Overall Study|Death|6
1743187|NCT00917644|6080028|P2|Period 2: Second Intervention|family emergency|0
1743188|NCT00917644|6080029|P1|Period 2: Second Intervention|family emergency|1
1743275|NCT00916617|6080195|P3|Overall Study|Caregiver Request|1
1743189|NCT00917644|6080028|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
1743190|NCT00917644|6080029|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
1743191|NCT00917644|6080028|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
1743192|NCT00917644|6080029|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
1743193|NCT00917579|6080043|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
1743194|NCT00917579|6080044|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
1743195|NCT00917579|6080043|P2|Washout >= 2 Weeks|Adverse Event|0
1743196|NCT00917579|6080044|P1|Washout >= 2 Weeks|Adverse Event|1
1743197|NCT00917553|6080060|P2|Overall Study|Lost to Follow-up|1
1743198|NCT00917553|6080061|P1|Overall Study|Lost to Follow-up|2
1743199|NCT00917501|6080077|P2|Overall Study|trouble swollowing capsules|1
1743200|NCT00917501|6080078|P1|Overall Study|trouble swollowing capsules|0
1743201|NCT00917501|6080077|P2|Overall Study|Lack of Efficacy|2
1743202|NCT00917501|6080078|P1|Overall Study|Lack of Efficacy|1
1743203|NCT00917501|6080077|P2|Overall Study|Withdrawal by Subject|1
1743204|NCT00917501|6080078|P1|Overall Study|Withdrawal by Subject|3
1743205|NCT00917501|6080077|P2|Overall Study|Lost to Follow-up|1
1743206|NCT00917501|6080078|P1|Overall Study|Lost to Follow-up|4
1743207|NCT00917462|6080084|P1|Overall Study|Clinical Deterioration|1
1743208|NCT00917384|6080094|P2|Overall Study|Withdrawal by Subject|2
1743209|NCT00917384|6080095|P1|Overall Study|Withdrawal by Subject|10
1743210|NCT00917384|6080094|P2|Overall Study|Lost to Follow-up|2
1743211|NCT00917384|6080095|P1|Overall Study|Lost to Follow-up|4
1743212|NCT00917267|6080119|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
1743213|NCT00917267|6080120|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
1743214|NCT00917267|6080119|P2|Overall Study|Sponsor Decision|5
1743215|NCT00917267|6080120|P1|Overall Study|Sponsor Decision|5
1743216|NCT00917267|6080119|P2|Overall Study|Entry Criteria Not Met|0
1743217|NCT00917267|6080120|P1|Overall Study|Entry Criteria Not Met|1
1743218|NCT00917267|6080119|P2|Overall Study|Lost to follow up|2
1743219|NCT00917267|6080120|P1|Overall Study|Lost to follow up|0
1743220|NCT00917267|6080119|P2|Overall Study|Withdrawal by Subject|12
1743221|NCT00917267|6080120|P1|Overall Study|Withdrawal by Subject|5
1743222|NCT00917267|6080119|P2|Overall Study|Protocol Violation|18
1743223|NCT00917267|6080120|P1|Overall Study|Protocol Violation|9
1743224|NCT00917267|6080119|P2|Overall Study|Physician Decision|4
1743225|NCT00917267|6080120|P1|Overall Study|Physician Decision|2
1743226|NCT00917267|6080119|P2|Overall Study|Adverse Event|36
1743227|NCT00917267|6080120|P1|Overall Study|Adverse Event|15
1743228|NCT00917124|6080148|P2|Overall Study|Protocol Violation|6
1743229|NCT00917124|6080149|P1|Overall Study|Protocol Violation|4
1743230|NCT00916929|6080159|P2|Overall Study|Device unable to process impedance data|7
1743231|NCT00916929|6080160|P1|Overall Study|Device unable to process impedance data|0
1743232|NCT00916929|6080159|P2|Overall Study|Moved to another state|1
1743233|NCT00916929|6080160|P1|Overall Study|Moved to another state|0
1743234|NCT00916929|6080159|P2|Overall Study|System explant|0
1743235|NCT00916929|6080160|P1|Overall Study|System explant|1
1743236|NCT00916929|6080159|P2|Overall Study|Transferred to hospice care|1
1743237|NCT00916929|6080160|P1|Overall Study|Transferred to hospice care|1
1743238|NCT00916929|6080159|P2|Overall Study|Left ventricular epicardial lead|2
1743239|NCT00916929|6080160|P1|Overall Study|Left ventricular epicardial lead|1
1743240|NCT00916929|6080159|P2|Overall Study|Withdrawal by Subject|5
1743241|NCT00916929|6080160|P1|Overall Study|Withdrawal by Subject|1
1743242|NCT00916929|6080159|P2|Overall Study|Death|10
1743243|NCT00916929|6080160|P1|Overall Study|Death|5
1743244|NCT00916929|6080159|P2|Overall Study|Lost to Follow-up|3
1743245|NCT00916929|6080160|P1|Overall Study|Lost to Follow-up|1
1743246|NCT00916721|6080170|P2|Overall Study|Protocol Violation|4
1743247|NCT00916721|6080171|P1|Overall Study|Protocol Violation|2
1743248|NCT00916721|6080170|P2|Overall Study|Withdrawal by Subject|2
1743249|NCT00916721|6080171|P1|Overall Study|Withdrawal by Subject|2
1743250|NCT00916721|6080170|P2|Overall Study|Adverse Event|3
1743251|NCT00916721|6080171|P1|Overall Study|Adverse Event|6
1743252|NCT00916721|6080170|P2|Overall Study|Lost to Follow-up|1
1743253|NCT00916721|6080171|P1|Overall Study|Lost to Follow-up|0
1743254|NCT00916617|6080194|P4|Overall Study|Other|2
1743255|NCT00916617|6080195|P3|Overall Study|Other|0
1743256|NCT00916617|6080196|P2|Overall Study|Other|0
1743257|NCT00916617|6080197|P1|Overall Study|Other|2
1743258|NCT00916617|6080194|P4|Overall Study|Lack of Efficacy|0
1743259|NCT00916617|6080195|P3|Overall Study|Lack of Efficacy|0
1743260|NCT00916617|6080196|P2|Overall Study|Lack of Efficacy|0
1743261|NCT00916617|6080197|P1|Overall Study|Lack of Efficacy|1
1743262|NCT00916617|6080194|P4|Overall Study|Lost to Follow-up|0
1743263|NCT00916617|6080195|P3|Overall Study|Lost to Follow-up|0
1743264|NCT00916617|6080196|P2|Overall Study|Lost to Follow-up|1
1743265|NCT00916617|6080197|P1|Overall Study|Lost to Follow-up|2
1743266|NCT00916617|6080194|P4|Overall Study|Discontinuation of Study by Sponsor|1
1743267|NCT00916617|6080195|P3|Overall Study|Discontinuation of Study by Sponsor|3
1743268|NCT00916617|6080196|P2|Overall Study|Discontinuation of Study by Sponsor|13
1743269|NCT00916617|6080197|P1|Overall Study|Discontinuation of Study by Sponsor|8
1743270|NCT00916617|6080194|P4|Overall Study|Physician Decision|0
1743271|NCT00916617|6080195|P3|Overall Study|Physician Decision|0
1743272|NCT00916617|6080196|P2|Overall Study|Physician Decision|1
1743273|NCT00916617|6080197|P1|Overall Study|Physician Decision|1
1743274|NCT00916617|6080194|P4|Overall Study|Caregiver Request|0
1743276|NCT00916617|6080196|P2|Overall Study|Caregiver Request|2
1743277|NCT00916617|6080197|P1|Overall Study|Caregiver Request|3
1743278|NCT00916617|6080194|P4|Overall Study|Withdrawal by Subject|1
1743279|NCT00916617|6080195|P3|Overall Study|Withdrawal by Subject|0
1743280|NCT00916617|6080196|P2|Overall Study|Withdrawal by Subject|2
1743281|NCT00916617|6080197|P1|Overall Study|Withdrawal by Subject|3
1743282|NCT00916617|6080194|P4|Overall Study|Adverse Event|3
1743283|NCT00916617|6080195|P3|Overall Study|Adverse Event|6
1743284|NCT00916617|6080196|P2|Overall Study|Adverse Event|2
1743285|NCT00916617|6080197|P1|Overall Study|Adverse Event|3
1743286|NCT00916578|6080211|P1|Overall Study|Insurance Denial|2
1743287|NCT00916578|6080211|P1|Overall Study|Withdrawal by Subject|3
1743288|NCT00916578|6080211|P1|Overall Study|Physician Decision|2
1743289|NCT00916383|6080240|P1|Overall Study|Protocol Violation|1
1743290|NCT00916383|6080240|P1|Overall Study|Death|1
1743291|NCT00916383|6080240|P1|Overall Study|Adverse Event|1
1743292|NCT00916370|6080268|P2|Overall Study|Physician Decision|1
1743293|NCT00916370|6080269|P1|Overall Study|Physician Decision|0
1743294|NCT00916370|6080268|P2|Overall Study|Withdrawal by Subject|0
1743295|NCT00916370|6080269|P1|Overall Study|Withdrawal by Subject|2
1743296|NCT00916370|6080268|P2|Overall Study|Death|1
1743297|NCT00916370|6080269|P1|Overall Study|Death|3
1743298|NCT00916357|6080443|P6|Period 2|Weight loss > 3 kilograms (kg)|0
1743299|NCT00916357|6080444|P5|Period 2|Weight loss > 3 kilograms (kg)|0
1743300|NCT00916357|6080445|P4|Period 2|Weight loss > 3 kilograms (kg)|1
1743301|NCT00916357|6080446|P3|Period 2|Weight loss > 3 kilograms (kg)|0
1743302|NCT00916357|6080447|P2|Period 2|Weight loss > 3 kilograms (kg)|0
1743303|NCT00916357|6080448|P1|Period 2|Weight loss > 3 kilograms (kg)|0
1743304|NCT00916357|6080443|P6|Period 1|Withdrawal by Subject|0
1743305|NCT00916357|6080444|P5|Period 1|Withdrawal by Subject|0
1743306|NCT00916357|6080445|P4|Period 1|Withdrawal by Subject|0
1743307|NCT00916357|6080446|P3|Period 1|Withdrawal by Subject|0
1743308|NCT00916357|6080447|P2|Period 1|Withdrawal by Subject|0
1743309|NCT00916357|6080448|P1|Period 1|Withdrawal by Subject|1
1743310|NCT00916344|6080486|P1|Overall Study|Drop-out|5
1743311|NCT00916344|6080486|P1|Overall Study|ICD upgrade|1
1743312|NCT00916344|6080486|P1|Overall Study|Death|2
1743313|NCT00916305|6080493|P2|Overall Study|Withdrawal by Subject|1
1743314|NCT00916305|6080494|P1|Overall Study|Withdrawal by Subject|0
1743315|NCT00916305|6080493|P2|Overall Study|Lost to Follow-up|27
1743316|NCT00916305|6080494|P1|Overall Study|Lost to Follow-up|21
1743317|NCT00916279|6080502|P1|Overall Study|Lost to Follow-up|2
1743318|NCT00916279|6080502|P1|Overall Study|Death|2
1743319|NCT00916149|6080513|P3|Overall Study|Unable to place scalp EEG leads|0
1743320|NCT00916149|6080514|P2|Overall Study|Unable to place scalp EEG leads|0
1743321|NCT00916149|6080515|P1|Overall Study|Unable to place scalp EEG leads|1
1743322|NCT00916149|6080513|P3|Overall Study|Lost to Follow-up|0
1743323|NCT00916149|6080514|P2|Overall Study|Lost to Follow-up|2
1743324|NCT00916149|6080515|P1|Overall Study|Lost to Follow-up|3
1743325|NCT00916058|6080602|P7|Phase 2|Screen Failure|3
1743326|NCT00916058|6080603|P6|Phase 2|Screen Failure|0
1743327|NCT00916058|6080604|P5|Phase 2|Screen Failure|0
1743328|NCT00916058|6080605|P4|Phase 2|Screen Failure|0
1743329|NCT00916058|6080606|P3|Phase 2|Screen Failure|0
1743330|NCT00916058|6080607|P2|Phase 2|Screen Failure|0
1743331|NCT00916058|6080608|P1|Phase 2|Screen Failure|0
1743332|NCT00916058|6080602|P7|Phase 1|Screen Failure|0
1743333|NCT00916058|6080603|P6|Phase 1|Screen Failure|1
1743334|NCT00916058|6080604|P5|Phase 1|Screen Failure|0
1743335|NCT00916058|6080605|P4|Phase 1|Screen Failure|0
1743336|NCT00916058|6080606|P3|Phase 1|Screen Failure|0
1743337|NCT00916058|6080607|P2|Phase 1|Screen Failure|0
1743338|NCT00916058|6080608|P1|Phase 1|Screen Failure|0
1743339|NCT00916006|6080671|P2|Overall Study|Protocol Violation|1
1743340|NCT00916006|6080672|P1|Overall Study|Protocol Violation|0
1743341|NCT00916006|6080671|P2|Overall Study|Withdrawal by Subject|5
1743342|NCT00916006|6080672|P1|Overall Study|Withdrawal by Subject|2
1743343|NCT00916006|6080671|P2|Overall Study|Adverse Event|1
1743344|NCT00916006|6080672|P1|Overall Study|Adverse Event|1
1743345|NCT00915876|6080724|P2|Overall Study|Adverse Event|1
1743346|NCT00915876|6080725|P1|Overall Study|Adverse Event|0
1743347|NCT00915772|6080761|P3|Overall Study|Any other reason|7
1743348|NCT00915772|6080762|P2|Overall Study|Any other reason|7
1743349|NCT00915772|6080763|P1|Overall Study|Any other reason|4
1743350|NCT00915772|6080761|P3|Overall Study|Refused to continue trial medication|4
1743351|NCT00915772|6080762|P2|Overall Study|Refused to continue trial medication|8
1743352|NCT00915772|6080763|P1|Overall Study|Refused to continue trial medication|6
1743353|NCT00915772|6080761|P3|Overall Study|Lack of Efficacy|3
1743354|NCT00915772|6080762|P2|Overall Study|Lack of Efficacy|15
1743355|NCT00915772|6080763|P1|Overall Study|Lack of Efficacy|9
1743356|NCT00915772|6080761|P3|Overall Study|Lost to Follow-up|2
1743357|NCT00915772|6080762|P2|Overall Study|Lost to Follow-up|2
1743358|NCT00915772|6080763|P1|Overall Study|Lost to Follow-up|1
1743359|NCT00915772|6080761|P3|Overall Study|Protocol Violation|2
1743360|NCT00915772|6080762|P2|Overall Study|Protocol Violation|1
1743361|NCT00915772|6080763|P1|Overall Study|Protocol Violation|4
1743362|NCT00915772|6080761|P3|Overall Study|Adverse Event|11
1743363|NCT00915772|6080762|P2|Overall Study|Adverse Event|13
1743364|NCT00915772|6080763|P1|Overall Study|Adverse Event|12
1743365|NCT00915551|6080862|P2|Overall Study|Withdrawal by Subject|1
1743366|NCT00915551|6080863|P1|Overall Study|Withdrawal by Subject|0
1743367|NCT00915525|6080873|P2|Overall Study|Patient Moved|9
1743368|NCT00915525|6080874|P1|Overall Study|Patient Moved|15
1743369|NCT00915525|6080873|P2|Overall Study|Non-Compliance|1
1743370|NCT00915525|6080874|P1|Overall Study|Non-Compliance|3
1743371|NCT00915525|6080873|P2|Overall Study|Study Burden|12
1743372|NCT00915525|6080874|P1|Overall Study|Study Burden|28
1743373|NCT00915525|6080873|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
1743374|NCT00915525|6080874|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
1743375|NCT00915525|6080873|P2|Overall Study|Site Closed|9
1743376|NCT00915525|6080874|P1|Overall Study|Site Closed|27
1743377|NCT00915525|6080873|P2|Overall Study|Other Reason|12
1743378|NCT00915525|6080874|P1|Overall Study|Other Reason|35
1743379|NCT00915525|6080873|P2|Overall Study|Missing|1
1743380|NCT00915525|6080874|P1|Overall Study|Missing|12
1743381|NCT00915525|6080873|P2|Overall Study|Adverse Event|13
1743382|NCT00915525|6080874|P1|Overall Study|Adverse Event|29
1743383|NCT00915525|6080873|P2|Overall Study|Lack of Efficacy|32
1743384|NCT00915525|6080874|P1|Overall Study|Lack of Efficacy|15
1743385|NCT00915525|6080873|P2|Overall Study|Pregnancy|0
1743386|NCT00915525|6080874|P1|Overall Study|Pregnancy|2
1743387|NCT00915525|6080873|P2|Overall Study|Lost to Follow-up|16
1743388|NCT00915525|6080874|P1|Overall Study|Lost to Follow-up|27
1743389|NCT00915525|6080873|P2|Overall Study|Withdrawal by Subject|21
1743390|NCT00915525|6080874|P1|Overall Study|Withdrawal by Subject|59
1743391|NCT00915525|6080873|P2|Overall Study|Protocol Violation|4
1743392|NCT00915525|6080874|P1|Overall Study|Protocol Violation|9
1743393|NCT00915473|6080988|P2|4-week Follow Up|Lost to Follow-up|5
1743394|NCT00915473|6080989|P1|4-week Follow Up|Lost to Follow-up|1
1743395|NCT00915473|6080988|P2|Screening|Withdrawal by Subject|0
1743396|NCT00915473|6080989|P1|Screening|Withdrawal by Subject|1
1743397|NCT00915356|6081006|P5|Overall Study|Withdrawal by Subject|0
1743398|NCT00915356|6081007|P4|Overall Study|Withdrawal by Subject|0
1743399|NCT00915356|6081008|P3|Overall Study|Withdrawal by Subject|0
1743400|NCT00915356|6081009|P2|Overall Study|Withdrawal by Subject|0
1743401|NCT00915356|6081010|P1|Overall Study|Withdrawal by Subject|1
1743402|NCT00915343|6081072|P3|Part B - Open Label Period|Did not attend the last visit|1
1743403|NCT00915343|6081073|P2|Part B - Open Label Period|Did not attend the last visit|0
1743404|NCT00915343|6081074|P1|Part B - Open Label Period|Did not attend the last visit|0
1743405|NCT00915343|6081072|P3|Part B - Open Label Period|Treatment switch|1
1743406|NCT00915343|6081073|P2|Part B - Open Label Period|Treatment switch|0
1743407|NCT00915343|6081074|P1|Part B - Open Label Period|Treatment switch|0
1743408|NCT00915278|6081159|P6|Overall Study|Admission to hospice|0
1743409|NCT00915278|6081160|P5|Overall Study|Admission to hospice|0
1743410|NCT00915278|6081161|P4|Overall Study|Admission to hospice|0
1743411|NCT00915278|6081162|P3|Overall Study|Admission to hospice|1
1743412|NCT00915278|6081163|P2|Overall Study|Admission to hospice|0
1743413|NCT00915278|6081164|P1|Overall Study|Admission to hospice|0
1743414|NCT00915278|6081159|P6|Overall Study|Infusion related AEs|2
1743415|NCT00915278|6081160|P5|Overall Study|Infusion related AEs|0
1743416|NCT00915278|6081161|P4|Overall Study|Infusion related AEs|0
1743417|NCT00915278|6081162|P3|Overall Study|Infusion related AEs|0
1743418|NCT00915278|6081163|P2|Overall Study|Infusion related AEs|0
1743419|NCT00915278|6081164|P1|Overall Study|Infusion related AEs|0
1743420|NCT00915278|6081159|P6|Overall Study|Progressive disease/clinical progression|2
1743421|NCT00915278|6081160|P5|Overall Study|Progressive disease/clinical progression|1
1743422|NCT00915278|6081161|P4|Overall Study|Progressive disease/clinical progression|3
1743423|NCT00915278|6081162|P3|Overall Study|Progressive disease/clinical progression|0
1743424|NCT00915278|6081163|P2|Overall Study|Progressive disease/clinical progression|0
1743425|NCT00915278|6081164|P1|Overall Study|Progressive disease/clinical progression|0
1743426|NCT00915278|6081159|P6|Overall Study|Adverse Event|0
1743427|NCT00915278|6081160|P5|Overall Study|Adverse Event|0
1743428|NCT00915278|6081161|P4|Overall Study|Adverse Event|0
1743429|NCT00915278|6081162|P3|Overall Study|Adverse Event|0
1743430|NCT00915278|6081163|P2|Overall Study|Adverse Event|1
1743431|NCT00915278|6081164|P1|Overall Study|Adverse Event|4
1743432|NCT00915278|6081159|P6|Overall Study|Withdrawal by Subject|4
1743433|NCT00915278|6081160|P5|Overall Study|Withdrawal by Subject|1
1743434|NCT00915278|6081161|P4|Overall Study|Withdrawal by Subject|0
1743435|NCT00915278|6081162|P3|Overall Study|Withdrawal by Subject|0
1743436|NCT00915278|6081163|P2|Overall Study|Withdrawal by Subject|1
1743437|NCT00915278|6081164|P1|Overall Study|Withdrawal by Subject|0
1743438|NCT00915278|6081159|P6|Overall Study|Lost to Follow-up|0
1743439|NCT00915278|6081160|P5|Overall Study|Lost to Follow-up|0
1743440|NCT00915278|6081161|P4|Overall Study|Lost to Follow-up|0
1743441|NCT00915278|6081162|P3|Overall Study|Lost to Follow-up|0
1743442|NCT00915278|6081163|P2|Overall Study|Lost to Follow-up|1
1743443|NCT00915278|6081164|P1|Overall Study|Lost to Follow-up|0
1743444|NCT00915278|6081159|P6|Overall Study|Death|0
1743445|NCT00915278|6081160|P5|Overall Study|Death|0
1743446|NCT00915278|6081161|P4|Overall Study|Death|0
1743447|NCT00915278|6081162|P3|Overall Study|Death|0
1743448|NCT00915278|6081163|P2|Overall Study|Death|0
1743449|NCT00915278|6081164|P1|Overall Study|Death|1
1743450|NCT00915018|6081325|P2|Overall Study|By Sponsor due to Protocol Amendment|105
1743451|NCT00915018|6081326|P1|Overall Study|By Sponsor due to Protocol Amendment|92
1743452|NCT00915018|6081325|P2|Overall Study|Withdrawal by Subject|27
1743453|NCT00915018|6081326|P1|Overall Study|Withdrawal by Subject|38
1743454|NCT00915018|6081325|P2|Overall Study|Lost to Follow-up|5
1743455|NCT00915018|6081326|P1|Overall Study|Lost to Follow-up|10
1743456|NCT00915018|6081325|P2|Overall Study|Death|70
1743457|NCT00915018|6081326|P1|Overall Study|Death|75
1743458|NCT00914966|6081340|P1|Step 2: 2000 Units|Withdrawal by Subject|1
1743459|NCT00914966|6081340|P1|Step 1: 1500 Units|Physician Decision|1
1743460|NCT00914966|6081340|P1|Step 1: 1500 Units|Withdrawal by Subject|1
1743461|NCT00914927|6081359|P7|Overall Study|Administrative/Other|0
1743462|NCT00914927|6081360|P6|Overall Study|Administrative/Other|0
1743463|NCT00914927|6081361|P5|Overall Study|Administrative/Other|1
1743464|NCT00914927|6081362|P4|Overall Study|Administrative/Other|0
1743465|NCT00914927|6081363|P3|Overall Study|Administrative/Other|0
1743466|NCT00914927|6081364|P2|Overall Study|Administrative/Other|1
1743467|NCT00914927|6081365|P1|Overall Study|Administrative/Other|2
1743468|NCT00914927|6081359|P7|Overall Study|Lost to Follow-up|0
1743469|NCT00914927|6081360|P6|Overall Study|Lost to Follow-up|0
1743470|NCT00914927|6081361|P5|Overall Study|Lost to Follow-up|0
1743471|NCT00914927|6081362|P4|Overall Study|Lost to Follow-up|1
1743472|NCT00914927|6081363|P3|Overall Study|Lost to Follow-up|0
1743473|NCT00914927|6081364|P2|Overall Study|Lost to Follow-up|0
1743474|NCT00914927|6081365|P1|Overall Study|Lost to Follow-up|0
1743475|NCT00914927|6081359|P7|Overall Study|Withdrawal by Subject|0
1743476|NCT00914927|6081360|P6|Overall Study|Withdrawal by Subject|0
1743477|NCT00914927|6081361|P5|Overall Study|Withdrawal by Subject|0
1743478|NCT00914927|6081362|P4|Overall Study|Withdrawal by Subject|1
1743479|NCT00914927|6081363|P3|Overall Study|Withdrawal by Subject|0
1743480|NCT00914927|6081364|P2|Overall Study|Withdrawal by Subject|1
1743481|NCT00914927|6081365|P1|Overall Study|Withdrawal by Subject|0
1743482|NCT00914927|6081359|P7|Overall Study|Adverse Event|0
1743483|NCT00914927|6081360|P6|Overall Study|Adverse Event|0
1743484|NCT00914927|6081361|P5|Overall Study|Adverse Event|1
1743485|NCT00914927|6081362|P4|Overall Study|Adverse Event|0
1743486|NCT00914927|6081363|P3|Overall Study|Adverse Event|0
1743487|NCT00914927|6081364|P2|Overall Study|Adverse Event|0
1743488|NCT00914927|6081365|P1|Overall Study|Adverse Event|0
1743489|NCT00914849|6081492|P2|Overall Study|Not eligible|1
1743490|NCT00914849|6081493|P1|Overall Study|Not eligible|0
1743491|NCT00914849|6081492|P2|Overall Study|Withdrawal by Subject|0
1743492|NCT00914849|6081493|P1|Overall Study|Withdrawal by Subject|1
1743493|NCT00914810|6081527|P2|Overall Study|Hospitalized and unable to follow up.|1
1743494|NCT00914810|6081528|P1|Overall Study|Hospitalized and unable to follow up.|0
1743495|NCT00914810|6081527|P2|Overall Study|Relocated out of state|0
1743496|NCT00914810|6081528|P1|Overall Study|Relocated out of state|1
1743497|NCT00914810|6081527|P2|Overall Study|Withdrawal by Subject|0
1743498|NCT00914810|6081528|P1|Overall Study|Withdrawal by Subject|1
1743499|NCT00914589|6081539|P3|Overall Study|Death|1
1743500|NCT00914589|6081540|P2|Overall Study|Death|1
1743501|NCT00914589|6081541|P1|Overall Study|Death|0
1743502|NCT00914589|6081539|P3|Overall Study|unclassified|7
1743503|NCT00914589|6081540|P2|Overall Study|unclassified|9
1743504|NCT00914589|6081541|P1|Overall Study|unclassified|16
1743505|NCT00914589|6081539|P3|Overall Study|Protocol Violation|3
1743506|NCT00914589|6081540|P2|Overall Study|Protocol Violation|6
1743507|NCT00914589|6081541|P1|Overall Study|Protocol Violation|8
1743508|NCT00914589|6081539|P3|Overall Study|Adverse Event|1
1743509|NCT00914589|6081540|P2|Overall Study|Adverse Event|0
1743510|NCT00914589|6081541|P1|Overall Study|Adverse Event|1
1743511|NCT00914459|6081567|P2|Overall Study|Parent/Legal guardian request|0
1743512|NCT00914459|6081568|P1|Overall Study|Parent/Legal guardian request|1
1743513|NCT00914459|6081567|P2|Overall Study|Protocol Violation|1
1743514|NCT00914459|6081568|P1|Overall Study|Protocol Violation|0
1743515|NCT00914316|6081598|P4|Phase 2|Withdrawal by Subject|0
1743516|NCT00914316|6081599|P3|Phase 2|Withdrawal by Subject|1
1743517|NCT00914316|6081600|P2|Phase 2|Withdrawal by Subject|0
1743518|NCT00914316|6081601|P1|Phase 2|Withdrawal by Subject|1
1743519|NCT00914316|6081598|P4|Phase 1|Adverse Event|0
1743520|NCT00914316|6081599|P3|Phase 1|Adverse Event|0
1743521|NCT00914316|6081600|P2|Phase 1|Adverse Event|0
1743522|NCT00914316|6081601|P1|Phase 1|Adverse Event|1
1743523|NCT00914316|6081598|P4|Phase 1|Withdrawal by Subject|0
1743524|NCT00914316|6081599|P3|Phase 1|Withdrawal by Subject|4
1743525|NCT00914316|6081600|P2|Phase 1|Withdrawal by Subject|2
1743526|NCT00914316|6081601|P1|Phase 1|Withdrawal by Subject|0
1743527|NCT00914316|6081598|P4|Phase 1|Physician Decision|2
1743528|NCT00914316|6081599|P3|Phase 1|Physician Decision|1
1743529|NCT00914316|6081600|P2|Phase 1|Physician Decision|0
1743530|NCT00914316|6081601|P1|Phase 1|Physician Decision|4
1743531|NCT00913978|6081673|P2|Overall Study|Surgeon choice|3
1743532|NCT00913978|6081674|P1|Overall Study|Surgeon choice|1
1743533|NCT00913835|6081691|P2|Lip Dox: Olaratumab Monotherapy|Other|3
1743534|NCT00913835|6081692|P1|Lip Dox: Olaratumab Monotherapy|Other|0
1743535|NCT00913835|6081691|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
1743536|NCT00913835|6081692|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
1743537|NCT00913835|6081691|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
1743538|NCT00913835|6081692|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
1743539|NCT00913835|6081691|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
1743540|NCT00913835|6081692|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
1743541|NCT00913835|6081691|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
1743631|NCT00913458|6081887|P1|Phase 2|Lost to Follow-up|0
1743542|NCT00913835|6081692|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
1743543|NCT00913770|6081731|P3|Overall Study|Refused|8
1743544|NCT00913770|6081732|P2|Overall Study|Refused|10
1743545|NCT00913770|6081733|P1|Overall Study|Refused|11
1743546|NCT00913770|6081731|P3|Overall Study|Unable to contact|13
1743547|NCT00913770|6081732|P2|Overall Study|Unable to contact|19
1743548|NCT00913770|6081733|P1|Overall Study|Unable to contact|24
1743549|NCT00913744|6081746|P2|Overall Study|Death|0
1743550|NCT00913744|6081747|P1|Overall Study|Death|1
1743551|NCT00913744|6081746|P2|Overall Study|Withdrawal by Subject|1
1743552|NCT00913744|6081747|P1|Overall Study|Withdrawal by Subject|2
1743553|NCT00913744|6081746|P2|Overall Study|Adverse Event|0
1743554|NCT00913744|6081747|P1|Overall Study|Adverse Event|2
1743555|NCT00913692|6081753|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
1743556|NCT00913692|6081753|P1|Screening (4 Months)|Not eligible after screening phase.|6
1743557|NCT00913692|6081753|P1|Screening (4 Months)|Physician Decision|3
1743558|NCT00913523|6081847|P3|Overall Study|Inadequate Number of Tampons Used|3
1743559|NCT00913523|6081848|P2|Overall Study|Inadequate Number of Tampons Used|2
1743560|NCT00913523|6081849|P1|Overall Study|Inadequate Number of Tampons Used|7
1743561|NCT00913523|6081847|P3|Overall Study|Pregnancy|0
1743562|NCT00913523|6081848|P2|Overall Study|Pregnancy|3
1743563|NCT00913523|6081849|P1|Overall Study|Pregnancy|1
1743564|NCT00913523|6081847|P3|Overall Study|Protocol Violation|8
1743565|NCT00913523|6081848|P2|Overall Study|Protocol Violation|8
1743566|NCT00913523|6081849|P1|Overall Study|Protocol Violation|5
1743567|NCT00913523|6081847|P3|Overall Study|Adverse Event|0
1743568|NCT00913523|6081848|P2|Overall Study|Adverse Event|0
1743569|NCT00913523|6081849|P1|Overall Study|Adverse Event|1
1743570|NCT00913523|6081847|P3|Overall Study|Lost to Follow-up|1
1743571|NCT00913523|6081848|P2|Overall Study|Lost to Follow-up|1
1743572|NCT00913523|6081849|P1|Overall Study|Lost to Follow-up|1
1743573|NCT00913523|6081847|P3|Overall Study|Withdrawal by Subject|2
1743574|NCT00913523|6081848|P2|Overall Study|Withdrawal by Subject|2
1743575|NCT00913523|6081849|P1|Overall Study|Withdrawal by Subject|3
1743576|NCT00913458|6081881|P7|Phase 3|Unsatisfactory Response per Investigator|4
1743577|NCT00913458|6081882|P6|Phase 3|Unsatisfactory Response per Investigator|11
1743578|NCT00913458|6081883|P5|Phase 3|Unsatisfactory Response per Investigator|14
1743579|NCT00913458|6081884|P4|Phase 3|Unsatisfactory Response per Investigator|0
1743580|NCT00913458|6081885|P3|Phase 3|Unsatisfactory Response per Investigator|0
1743581|NCT00913458|6081886|P2|Phase 3|Unsatisfactory Response per Investigator|0
1743582|NCT00913458|6081887|P1|Phase 3|Unsatisfactory Response per Investigator|0
1743583|NCT00913458|6081881|P7|Phase 3|Withdrawal by Subject|0
1743584|NCT00913458|6081882|P6|Phase 3|Withdrawal by Subject|2
1743585|NCT00913458|6081883|P5|Phase 3|Withdrawal by Subject|1
1743586|NCT00913458|6081884|P4|Phase 3|Withdrawal by Subject|0
1743587|NCT00913458|6081885|P3|Phase 3|Withdrawal by Subject|0
1743588|NCT00913458|6081886|P2|Phase 3|Withdrawal by Subject|0
1743589|NCT00913458|6081887|P1|Phase 3|Withdrawal by Subject|0
1743590|NCT00913458|6081881|P7|Phase 3|Non-Responder|3
1743591|NCT00913458|6081882|P6|Phase 3|Non-Responder|1
1743592|NCT00913458|6081883|P5|Phase 3|Non-Responder|0
1743593|NCT00913458|6081884|P4|Phase 3|Non-Responder|0
1743594|NCT00913458|6081885|P3|Phase 3|Non-Responder|0
1743595|NCT00913458|6081886|P2|Phase 3|Non-Responder|0
1743596|NCT00913458|6081887|P1|Phase 3|Non-Responder|0
1743597|NCT00913458|6081881|P7|Phase 3|Lost to Follow-up|0
1743598|NCT00913458|6081882|P6|Phase 3|Lost to Follow-up|0
1743599|NCT00913458|6081883|P5|Phase 3|Lost to Follow-up|2
1743600|NCT00913458|6081884|P4|Phase 3|Lost to Follow-up|0
1743601|NCT00913458|6081885|P3|Phase 3|Lost to Follow-up|0
1743602|NCT00913458|6081886|P2|Phase 3|Lost to Follow-up|0
1743603|NCT00913458|6081887|P1|Phase 3|Lost to Follow-up|0
1743604|NCT00913458|6081881|P7|Phase 3|Adverse Event|1
1743605|NCT00913458|6081882|P6|Phase 3|Adverse Event|4
1743606|NCT00913458|6081883|P5|Phase 3|Adverse Event|5
1743607|NCT00913458|6081884|P4|Phase 3|Adverse Event|0
1743608|NCT00913458|6081885|P3|Phase 3|Adverse Event|0
1743609|NCT00913458|6081886|P2|Phase 3|Adverse Event|0
1743610|NCT00913458|6081887|P1|Phase 3|Adverse Event|0
1743611|NCT00913458|6081881|P7|Phase 2|Unsatisfactory Response per Investigator|0
1743612|NCT00913458|6081882|P6|Phase 2|Unsatisfactory Response per Investigator|0
1743613|NCT00913458|6081883|P5|Phase 2|Unsatisfactory Response per Investigator|0
1743614|NCT00913458|6081884|P4|Phase 2|Unsatisfactory Response per Investigator|17
1743615|NCT00913458|6081885|P3|Phase 2|Unsatisfactory Response per Investigator|11
1743616|NCT00913458|6081886|P2|Phase 2|Unsatisfactory Response per Investigator|0
1743617|NCT00913458|6081887|P1|Phase 2|Unsatisfactory Response per Investigator|0
1743618|NCT00913458|6081881|P7|Phase 2|Protocol Violation|0
1743619|NCT00913458|6081882|P6|Phase 2|Protocol Violation|0
1743620|NCT00913458|6081883|P5|Phase 2|Protocol Violation|0
1743621|NCT00913458|6081884|P4|Phase 2|Protocol Violation|0
1743622|NCT00913458|6081885|P3|Phase 2|Protocol Violation|0
1743623|NCT00913458|6081886|P2|Phase 2|Protocol Violation|2
1743624|NCT00913458|6081887|P1|Phase 2|Protocol Violation|0
1743625|NCT00913458|6081881|P7|Phase 2|Lost to Follow-up|0
1743626|NCT00913458|6081882|P6|Phase 2|Lost to Follow-up|0
1743627|NCT00913458|6081883|P5|Phase 2|Lost to Follow-up|0
1743628|NCT00913458|6081884|P4|Phase 2|Lost to Follow-up|1
1743629|NCT00913458|6081885|P3|Phase 2|Lost to Follow-up|0
1743630|NCT00913458|6081886|P2|Phase 2|Lost to Follow-up|0
1743632|NCT00913458|6081881|P7|Phase 2|Adverse Event|0
1743633|NCT00913458|6081882|P6|Phase 2|Adverse Event|0
1743634|NCT00913458|6081883|P5|Phase 2|Adverse Event|0
1743635|NCT00913458|6081884|P4|Phase 2|Adverse Event|1
1743636|NCT00913458|6081885|P3|Phase 2|Adverse Event|0
1743637|NCT00913458|6081886|P2|Phase 2|Adverse Event|3
1743638|NCT00913458|6081887|P1|Phase 2|Adverse Event|0
1743639|NCT00913458|6081881|P7|Phase 2|Subject Request|0
1743640|NCT00913458|6081882|P6|Phase 2|Subject Request|0
1743641|NCT00913458|6081883|P5|Phase 2|Subject Request|0
1743642|NCT00913458|6081884|P4|Phase 2|Subject Request|2
1743643|NCT00913458|6081885|P3|Phase 2|Subject Request|1
1743644|NCT00913458|6081886|P2|Phase 2|Subject Request|0
1743645|NCT00913458|6081887|P1|Phase 2|Subject Request|0
1743646|NCT00913458|6081881|P7|Phase 2|Non-Responder|0
1743647|NCT00913458|6081882|P6|Phase 2|Non-Responder|0
1743648|NCT00913458|6081883|P5|Phase 2|Non-Responder|0
1743649|NCT00913458|6081884|P4|Phase 2|Non-Responder|12
1743650|NCT00913458|6081885|P3|Phase 2|Non-Responder|7
1743651|NCT00913458|6081886|P2|Phase 2|Non-Responder|5
1743652|NCT00913458|6081887|P1|Phase 2|Non-Responder|0
1743653|NCT00913458|6081881|P7|Phase 1|Unsatisfactory Response per Investigator|0
1743654|NCT00913458|6081882|P6|Phase 1|Unsatisfactory Response per Investigator|0
1743655|NCT00913458|6081883|P5|Phase 1|Unsatisfactory Response per Investigator|0
1743656|NCT00913458|6081884|P4|Phase 1|Unsatisfactory Response per Investigator|0
1743657|NCT00913458|6081885|P3|Phase 1|Unsatisfactory Response per Investigator|0
1743658|NCT00913458|6081886|P2|Phase 1|Unsatisfactory Response per Investigator|0
1743659|NCT00913458|6081887|P1|Phase 1|Unsatisfactory Response per Investigator|7
1743660|NCT00913458|6081881|P7|Phase 1|Sponsor|0
1743661|NCT00913458|6081882|P6|Phase 1|Sponsor|0
1743662|NCT00913458|6081883|P5|Phase 1|Sponsor|0
1743663|NCT00913458|6081884|P4|Phase 1|Sponsor|0
1743664|NCT00913458|6081885|P3|Phase 1|Sponsor|0
1743665|NCT00913458|6081886|P2|Phase 1|Sponsor|0
1743666|NCT00913458|6081887|P1|Phase 1|Sponsor|2
1743667|NCT00913458|6081881|P7|Phase 1|Protocol Violation|0
1743668|NCT00913458|6081882|P6|Phase 1|Protocol Violation|0
1743669|NCT00913458|6081883|P5|Phase 1|Protocol Violation|0
1743670|NCT00913458|6081884|P4|Phase 1|Protocol Violation|0
1743671|NCT00913458|6081885|P3|Phase 1|Protocol Violation|0
1743672|NCT00913458|6081886|P2|Phase 1|Protocol Violation|0
1743673|NCT00913458|6081887|P1|Phase 1|Protocol Violation|10
1743674|NCT00913458|6081881|P7|Phase 1|Lost to Follow-up|0
1743675|NCT00913458|6081882|P6|Phase 1|Lost to Follow-up|0
1743676|NCT00913458|6081883|P5|Phase 1|Lost to Follow-up|0
1743677|NCT00913458|6081884|P4|Phase 1|Lost to Follow-up|0
1743678|NCT00913458|6081885|P3|Phase 1|Lost to Follow-up|0
1743679|NCT00913458|6081886|P2|Phase 1|Lost to Follow-up|0
1743680|NCT00913458|6081887|P1|Phase 1|Lost to Follow-up|2
1743681|NCT00913458|6081881|P7|Phase 1|Adverse Event|0
1743682|NCT00913458|6081882|P6|Phase 1|Adverse Event|0
1743683|NCT00913458|6081883|P5|Phase 1|Adverse Event|0
1743684|NCT00913458|6081884|P4|Phase 1|Adverse Event|0
1743685|NCT00913458|6081885|P3|Phase 1|Adverse Event|0
1743686|NCT00913458|6081886|P2|Phase 1|Adverse Event|0
1743687|NCT00913458|6081887|P1|Phase 1|Adverse Event|20
1743688|NCT00913458|6081881|P7|Phase 1|Subject Request|0
1743689|NCT00913458|6081882|P6|Phase 1|Subject Request|0
1743690|NCT00913458|6081883|P5|Phase 1|Subject Request|0
1743691|NCT00913458|6081884|P4|Phase 1|Subject Request|0
1743692|NCT00913458|6081885|P3|Phase 1|Subject Request|0
1743693|NCT00913458|6081886|P2|Phase 1|Subject Request|0
1743694|NCT00913458|6081887|P1|Phase 1|Subject Request|17
1743695|NCT00913458|6081881|P7|Phase 1|Non-Responder|0
1743696|NCT00913458|6081882|P6|Phase 1|Non-Responder|0
1743697|NCT00913458|6081883|P5|Phase 1|Non-Responder|0
1743698|NCT00913458|6081884|P4|Phase 1|Non-Responder|0
1743699|NCT00913458|6081885|P3|Phase 1|Non-Responder|0
1743700|NCT00913458|6081886|P2|Phase 1|Non-Responder|0
1743701|NCT00913458|6081887|P1|Phase 1|Non-Responder|54
1743702|NCT00913380|6081980|P2|Clinical Outcomes|Lost to Follow-up|6
1743703|NCT00913380|6081981|P1|Clinical Outcomes|Lost to Follow-up|6
1743704|NCT00912964|6082047|P3|Overall Study|Randomized but never received study drug|0
1743705|NCT00912964|6082048|P2|Overall Study|Randomized but never received study drug|1
1743706|NCT00912964|6082049|P1|Overall Study|Randomized but never received study drug|0
1743707|NCT00912964|6082047|P3|Overall Study|Violation of exclusion criterion|2
1743708|NCT00912964|6082048|P2|Overall Study|Violation of exclusion criterion|0
1743709|NCT00912964|6082049|P1|Overall Study|Violation of exclusion criterion|0
1743710|NCT00912964|6082047|P3|Overall Study|Non-compliance with study procedures|0
1743711|NCT00912964|6082048|P2|Overall Study|Non-compliance with study procedures|0
1743712|NCT00912964|6082049|P1|Overall Study|Non-compliance with study procedures|2
1743713|NCT00912964|6082047|P3|Overall Study|Medical History|0
1743714|NCT00912964|6082048|P2|Overall Study|Medical History|0
1743715|NCT00912964|6082049|P1|Overall Study|Medical History|1
1743716|NCT00912964|6082047|P3|Overall Study|Taking exclusionary medications|8
1743717|NCT00912964|6082048|P2|Overall Study|Taking exclusionary medications|4
1743718|NCT00912964|6082049|P1|Overall Study|Taking exclusionary medications|7
1743719|NCT00912964|6082047|P3|Overall Study|Protocol Violation|8
1743720|NCT00912964|6082048|P2|Overall Study|Protocol Violation|3
1743721|NCT00912964|6082049|P1|Overall Study|Protocol Violation|5
1743722|NCT00912964|6082047|P3|Overall Study|Lost to Follow-up|3
1743723|NCT00912964|6082048|P2|Overall Study|Lost to Follow-up|3
1743724|NCT00912964|6082049|P1|Overall Study|Lost to Follow-up|4
1743725|NCT00912964|6082047|P3|Overall Study|Withdrawal by Subject|18
1743726|NCT00912964|6082048|P2|Overall Study|Withdrawal by Subject|12
1743727|NCT00912964|6082049|P1|Overall Study|Withdrawal by Subject|20
1743728|NCT00912964|6082047|P3|Overall Study|Lack of Efficacy|3
1743729|NCT00912964|6082048|P2|Overall Study|Lack of Efficacy|4
1743730|NCT00912964|6082049|P1|Overall Study|Lack of Efficacy|11
1743731|NCT00912964|6082047|P3|Overall Study|Adverse Event|12
1743732|NCT00912964|6082048|P2|Overall Study|Adverse Event|18
1743733|NCT00912964|6082049|P1|Overall Study|Adverse Event|15
1743734|NCT00912964|6082047|P3|Overall Study|Eligibility criterion not met|0
1743735|NCT00912964|6082048|P2|Overall Study|Eligibility criterion not met|1
1743736|NCT00912964|6082049|P1|Overall Study|Eligibility criterion not met|1
1743737|NCT00912912|6082192|P1|Overall Study|Disease Progression|3
1743738|NCT00912912|6082192|P1|Overall Study|Withdrawal by Subject|1
1743739|NCT00912808|6082198|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
1743740|NCT00912808|6082199|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
1743741|NCT00912808|6082198|P2|Second Intervention (6 Weeks)|Adverse Event|1
1743742|NCT00912808|6082199|P1|Second Intervention (6 Weeks)|Adverse Event|0
1743743|NCT00912808|6082198|P2|Washout|Withdrawal by Subject|1
1743744|NCT00912808|6082199|P1|Washout|Withdrawal by Subject|0
1743745|NCT00912808|6082198|P2|First Intervention (6 Weeks)|Adverse Event|1
1743746|NCT00912808|6082199|P1|First Intervention (6 Weeks)|Adverse Event|2
1743747|NCT00912782|6082224|P2|Overall Study|Relocated before study completion|1
1743748|NCT00912782|6082225|P1|Overall Study|Relocated before study completion|0
1743749|NCT00912782|6082224|P2|Overall Study|Did not receive vascular access type|2
1743750|NCT00912782|6082225|P1|Overall Study|Did not receive vascular access type|1
1743751|NCT00912782|6082224|P2|Overall Study|Lost to Follow-up|1
1743752|NCT00912782|6082225|P1|Overall Study|Lost to Follow-up|0
1743753|NCT00912782|6082224|P2|Overall Study|Death|1
1743754|NCT00912782|6082225|P1|Overall Study|Death|2
1743755|NCT00912743|6082235|P2|Overall Study|End of treatment form was not collected|0
1743756|NCT00912743|6082236|P1|Overall Study|End of treatment form was not collected|1
1743757|NCT00912743|6082235|P2|Overall Study|Toxicity|1
1743758|NCT00912743|6082236|P1|Overall Study|Toxicity|0
1743759|NCT00912743|6082235|P2|Overall Study|Lack of Efficacy|18
1743760|NCT00912743|6082236|P1|Overall Study|Lack of Efficacy|9
1743761|NCT00912743|6082235|P2|Overall Study|Adverse Event|1
1743762|NCT00912743|6082236|P1|Overall Study|Adverse Event|3
1743763|NCT00912509|6082248|P2|Overall Study|Lack of Efficacy|3
1743764|NCT00912509|6082249|P1|Overall Study|Lack of Efficacy|4
1743765|NCT00912509|6082248|P2|Overall Study|Lost to Follow-up|0
1743766|NCT00912509|6082249|P1|Overall Study|Lost to Follow-up|1
1743767|NCT00912405|6082257|P1|Overall Study|Lost to Follow-up|5
1743768|NCT00912340|6082267|P3|Overall Study|Protocol revised to remove arm|4
1743769|NCT00912340|6082268|P2|Overall Study|Protocol revised to remove arm|0
1743770|NCT00912340|6082269|P1|Overall Study|Protocol revised to remove arm|0
1743771|NCT00912340|6082267|P3|Overall Study|Adverse Event|0
1743772|NCT00912340|6082268|P2|Overall Study|Adverse Event|4
1743773|NCT00912340|6082269|P1|Overall Study|Adverse Event|2
1743774|NCT00912288|6082307|P2|Overall Study|Other|0
1743775|NCT00912288|6082308|P1|Overall Study|Other|1
1743776|NCT00912288|6082307|P2|Overall Study|Study terminated by sponsor|35
1743777|NCT00912288|6082308|P1|Overall Study|Study terminated by sponsor|34
1743778|NCT00912288|6082307|P2|Overall Study|Withdrawal by Subject|3
1743779|NCT00912288|6082308|P1|Overall Study|Withdrawal by Subject|3
1743780|NCT00912288|6082307|P2|Overall Study|Protocol Violation|0
1743781|NCT00912288|6082308|P1|Overall Study|Protocol Violation|1
1743782|NCT00912288|6082307|P2|Overall Study|Lost to Follow-up|0
1743783|NCT00912288|6082308|P1|Overall Study|Lost to Follow-up|1
1743784|NCT00912288|6082307|P2|Overall Study|Adverse Event|1
1743785|NCT00912288|6082308|P1|Overall Study|Adverse Event|1
1743786|NCT00912288|6082307|P2|Overall Study|Death|1
1743787|NCT00912288|6082308|P1|Overall Study|Death|0
1743788|NCT00912223|6082330|P1|Overall Study|Transformed disease|1
1743789|NCT00912223|6082330|P1|Overall Study|Not transplanted|1
1743790|NCT00912223|6082330|P1|Overall Study|Withdrawal by Subject|1
1743791|NCT00912093|6082361|P5|The Controlled Phase|Lost to Follow-up|1
1743792|NCT00912093|6082362|P4|The Controlled Phase|Lost to Follow-up|0
1743793|NCT00912093|6082363|P3|The Controlled Phase|Lost to Follow-up|0
1743794|NCT00912093|6082364|P2|The Controlled Phase|Lost to Follow-up|0
1743795|NCT00912093|6082365|P1|The Controlled Phase|Lost to Follow-up|0
1743796|NCT00912093|6082361|P5|The Controlled Phase|Medical Condition|0
1743797|NCT00912093|6082362|P4|The Controlled Phase|Medical Condition|0
1743798|NCT00912093|6082363|P3|The Controlled Phase|Medical Condition|0
1743799|NCT00912093|6082364|P2|The Controlled Phase|Medical Condition|1
1743800|NCT00912093|6082365|P1|The Controlled Phase|Medical Condition|0
1743801|NCT00912093|6082361|P5|The Controlled Phase|Death|0
1743802|NCT00912093|6082362|P4|The Controlled Phase|Death|0
1743803|NCT00912093|6082363|P3|The Controlled Phase|Death|0
1743804|NCT00912093|6082364|P2|The Controlled Phase|Death|1
1743805|NCT00912093|6082365|P1|The Controlled Phase|Death|0
1743806|NCT00912028|6082384|P5|Overall Study|Withdrawal by Subject|0
1743807|NCT00912028|6082385|P4|Overall Study|Withdrawal by Subject|0
1743808|NCT00912028|6082386|P3|Overall Study|Withdrawal by Subject|0
1743809|NCT00912028|6082387|P2|Overall Study|Withdrawal by Subject|0
1743810|NCT00912028|6082388|P1|Overall Study|Withdrawal by Subject|3
1743811|NCT00912028|6082384|P5|Overall Study|Lost to Follow-up|3
1743812|NCT00912028|6082385|P4|Overall Study|Lost to Follow-up|1
1743813|NCT00912028|6082386|P3|Overall Study|Lost to Follow-up|0
1743814|NCT00912028|6082387|P2|Overall Study|Lost to Follow-up|3
1743815|NCT00912028|6082388|P1|Overall Study|Lost to Follow-up|2
1743816|NCT00912015|6082417|P4|Overall Study|Adverse Event|1
1743817|NCT00912015|6082418|P3|Overall Study|Adverse Event|0
1743818|NCT00912015|6082419|P2|Overall Study|Adverse Event|0
1743819|NCT00912015|6082420|P1|Overall Study|Adverse Event|6
1743820|NCT00912015|6082417|P4|Overall Study|Protocol Violation|1
1743821|NCT00912015|6082418|P3|Overall Study|Protocol Violation|0
1743822|NCT00912015|6082419|P2|Overall Study|Protocol Violation|0
1743823|NCT00912015|6082420|P1|Overall Study|Protocol Violation|1
1743824|NCT00912015|6082417|P4|Overall Study|Withdrawal by Subject|0
1743825|NCT00912015|6082418|P3|Overall Study|Withdrawal by Subject|3
1743826|NCT00912015|6082419|P2|Overall Study|Withdrawal by Subject|8
1743827|NCT00912015|6082420|P1|Overall Study|Withdrawal by Subject|8
1743828|NCT00912015|6082417|P4|Overall Study|Lack of Efficacy|0
1743829|NCT00912015|6082418|P3|Overall Study|Lack of Efficacy|0
1743830|NCT00912015|6082419|P2|Overall Study|Lack of Efficacy|0
1743831|NCT00912015|6082420|P1|Overall Study|Lack of Efficacy|1
1743832|NCT00911989|6082436|P1|Overall Study|Adverse Event|1
1743833|NCT00911937|6082442|P2|Overall Study|Other|5
1743834|NCT00911937|6082443|P1|Overall Study|Other|9
1743835|NCT00911937|6082442|P2|Overall Study|Randomized but not treated|13
1743836|NCT00911937|6082443|P1|Overall Study|Randomized but not treated|13
1743837|NCT00911937|6082442|P2|Overall Study|Protocol Violation|23
1743838|NCT00911937|6082443|P1|Overall Study|Protocol Violation|14
1743839|NCT00911937|6082442|P2|Overall Study|Did not meet inclusion criteria|11
1743840|NCT00911937|6082443|P1|Overall Study|Did not meet inclusion criteria|9
1743841|NCT00911937|6082442|P2|Overall Study|Lack of Efficacy|6
1743842|NCT00911937|6082443|P1|Overall Study|Lack of Efficacy|11
1743843|NCT00911937|6082442|P2|Overall Study|Adverse Event|25
1743844|NCT00911937|6082443|P1|Overall Study|Adverse Event|11
1743845|NCT00911937|6082442|P2|Overall Study|Withdrawn due to pregnancy|0
1743846|NCT00911937|6082443|P1|Overall Study|Withdrawn due to pregnancy|1
1743847|NCT00911937|6082442|P2|Overall Study|Withdrawal by Subject|7
1743848|NCT00911937|6082443|P1|Overall Study|Withdrawal by Subject|10
1743849|NCT00911937|6082442|P2|Overall Study|Lost to Follow-up|5
1743850|NCT00911937|6082443|P1|Overall Study|Lost to Follow-up|8
1743851|NCT00911937|6082442|P2|Overall Study|Death|0
1743852|NCT00911937|6082443|P1|Overall Study|Death|1
1743853|NCT00911859|6082510|P3|Follow-up Period|Study terminated by sponsor|27
1743854|NCT00911859|6082511|P2|Follow-up Period|Study terminated by sponsor|33
1743855|NCT00911859|6082512|P1|Follow-up Period|Study terminated by sponsor|5
1743856|NCT00911859|6082510|P3|Follow-up Period|Withdrawal by Subject|4
1743857|NCT00911859|6082511|P2|Follow-up Period|Withdrawal by Subject|4
1743858|NCT00911859|6082512|P1|Follow-up Period|Withdrawal by Subject|0
1743859|NCT00911859|6082510|P3|Follow-up Period|Lost to Follow-up|0
1743860|NCT00911859|6082511|P2|Follow-up Period|Lost to Follow-up|1
1743861|NCT00911859|6082512|P1|Follow-up Period|Lost to Follow-up|1
1743862|NCT00911859|6082510|P3|Follow-up Period|Death|10
1743863|NCT00911859|6082511|P2|Follow-up Period|Death|8
1743864|NCT00911859|6082512|P1|Follow-up Period|Death|5
1743865|NCT00911859|6082510|P3|Maintainance Period|Withdrawal by Subject|3
1743866|NCT00911859|6082511|P2|Maintainance Period|Withdrawal by Subject|0
1743867|NCT00911859|6082512|P1|Maintainance Period|Withdrawal by Subject|0
1743868|NCT00911859|6082510|P3|Maintainance Period|Physician Decision|9
1743869|NCT00911859|6082511|P2|Maintainance Period|Physician Decision|0
1743870|NCT00911859|6082512|P1|Maintainance Period|Physician Decision|0
1743871|NCT00911859|6082510|P3|Maintainance Period|Lack of Efficacy|9
1743872|NCT00911859|6082511|P2|Maintainance Period|Lack of Efficacy|0
1743873|NCT00911859|6082512|P1|Maintainance Period|Lack of Efficacy|0
1743874|NCT00911859|6082510|P3|Treatment Period|Did not receive study treatment|0
1743875|NCT00911859|6082511|P2|Treatment Period|Did not receive study treatment|1
1743876|NCT00911859|6082512|P1|Treatment Period|Did not receive study treatment|0
1743877|NCT00911859|6082510|P3|Treatment Period|Withdrawal by Subject|5
1743878|NCT00911859|6082511|P2|Treatment Period|Withdrawal by Subject|4
1743879|NCT00911859|6082512|P1|Treatment Period|Withdrawal by Subject|0
1743880|NCT00911859|6082510|P3|Treatment Period|Physician Decision|3
1743881|NCT00911859|6082511|P2|Treatment Period|Physician Decision|3
1743882|NCT00911859|6082512|P1|Treatment Period|Physician Decision|3
1743883|NCT00911859|6082510|P3|Treatment Period|Lack of Efficacy|5
1743884|NCT00911859|6082511|P2|Treatment Period|Lack of Efficacy|7
1743885|NCT00911859|6082512|P1|Treatment Period|Lack of Efficacy|1
1743886|NCT00911859|6082510|P3|Treatment Period|Death|5
1743887|NCT00911859|6082511|P2|Treatment Period|Death|3
1743888|NCT00911859|6082512|P1|Treatment Period|Death|1
1743889|NCT00911859|6082510|P3|Treatment Period|Adverse Event|7
1743890|NCT00911859|6082511|P2|Treatment Period|Adverse Event|3
1743891|NCT00911859|6082512|P1|Treatment Period|Adverse Event|3
1743892|NCT00911820|6082538|P2|Overall Study|Withdraw before Receive Treatment|2
1743893|NCT00911820|6082539|P1|Overall Study|Withdraw before Receive Treatment|0
1743894|NCT00911820|6082538|P2|Overall Study|Pathology Not Confirmed|0
1743895|NCT00911820|6082539|P1|Overall Study|Pathology Not Confirmed|1
1743896|NCT00911820|6082538|P2|Overall Study|Still on Therapy|2
1743897|NCT00911820|6082539|P1|Overall Study|Still on Therapy|2
1743898|NCT00911820|6082538|P2|Overall Study|Pursue Radiation|0
1743899|NCT00911820|6082539|P1|Overall Study|Pursue Radiation|1
1743900|NCT00911820|6082538|P2|Overall Study|Pursue surgery|1
1743901|NCT00911820|6082539|P1|Overall Study|Pursue surgery|1
1743902|NCT00911820|6082538|P2|Overall Study|Death|2
1743903|NCT00911820|6082539|P1|Overall Study|Death|1
1743904|NCT00911820|6082538|P2|Overall Study|Withdrawal by Subject|4
1743905|NCT00911820|6082539|P1|Overall Study|Withdrawal by Subject|3
1743906|NCT00911820|6082538|P2|Overall Study|Decline in Performance Status|2
1743907|NCT00911820|6082539|P1|Overall Study|Decline in Performance Status|4
1743908|NCT00911820|6082538|P2|Overall Study|Physician Decision|9
1743909|NCT00911820|6082539|P1|Overall Study|Physician Decision|5
1743910|NCT00911820|6082538|P2|Overall Study|Clinical Progression|5
1743911|NCT00911820|6082539|P1|Overall Study|Clinical Progression|7
1743912|NCT00911820|6082538|P2|Overall Study|Adverse Event|8
1743913|NCT00911820|6082539|P1|Overall Study|Adverse Event|8
1743914|NCT00911820|6082538|P2|Overall Study|RECIST progression|8
1743915|NCT00911820|6082539|P1|Overall Study|RECIST progression|12
1743916|NCT00911807|6082556|P3|Overall Study|Organizational reasons|1
1743917|NCT00911807|6082557|P2|Overall Study|Organizational reasons|3
1743918|NCT00911807|6082558|P1|Overall Study|Organizational reasons|1
1743919|NCT00911807|6082556|P3|Overall Study|Withdrawal by Subject|7
1743920|NCT00911807|6082557|P2|Overall Study|Withdrawal by Subject|10
1743921|NCT00911807|6082558|P1|Overall Study|Withdrawal by Subject|8
1743922|NCT00911807|6082556|P3|Overall Study|Protocol Violation|9
1743923|NCT00911807|6082557|P2|Overall Study|Protocol Violation|4
1743924|NCT00911807|6082558|P1|Overall Study|Protocol Violation|6
1743925|NCT00911807|6082556|P3|Overall Study|Death|1
1743926|NCT00911807|6082557|P2|Overall Study|Death|0
1743927|NCT00911807|6082558|P1|Overall Study|Death|0
1743928|NCT00911807|6082556|P3|Overall Study|Adverse Event|5
1743929|NCT00911807|6082557|P2|Overall Study|Adverse Event|1
1743930|NCT00911807|6082558|P1|Overall Study|Adverse Event|2
1743931|NCT00911768|6082568|P2|Overall Study|Withdrawal by Subject|0
1743932|NCT00911768|6082569|P1|Overall Study|Withdrawal by Subject|1
1743933|NCT00911768|6082568|P2|Overall Study|Protocol Violation|4
1743934|NCT00911768|6082569|P1|Overall Study|Protocol Violation|5
1743935|NCT00911625|6082598|P2|Overall Study|Lost to Follow-up|0
1743936|NCT00911625|6082599|P1|Overall Study|Lost to Follow-up|7
1743937|NCT00911547|6082628|P4|Overall Study|Withdrawal by Subject|8
1743938|NCT00911547|6082629|P3|Overall Study|Withdrawal by Subject|4
1743939|NCT00911547|6082630|P2|Overall Study|Withdrawal by Subject|10
1743940|NCT00911547|6082631|P1|Overall Study|Withdrawal by Subject|3
1743941|NCT00911547|6082628|P4|Overall Study|Protocol Violation|1
1743942|NCT00911547|6082629|P3|Overall Study|Protocol Violation|5
1743943|NCT00911547|6082630|P2|Overall Study|Protocol Violation|5
1743944|NCT00911547|6082631|P1|Overall Study|Protocol Violation|0
1743945|NCT00911547|6082628|P4|Overall Study|Lost to Follow-up|1
1743946|NCT00911547|6082629|P3|Overall Study|Lost to Follow-up|2
1743947|NCT00911547|6082630|P2|Overall Study|Lost to Follow-up|0
1743948|NCT00911547|6082631|P1|Overall Study|Lost to Follow-up|0
1743949|NCT00911547|6082628|P4|Overall Study|Adverse Event|6
1743950|NCT00911547|6082629|P3|Overall Study|Adverse Event|11
1743951|NCT00911547|6082630|P2|Overall Study|Adverse Event|27
1743952|NCT00911547|6082631|P1|Overall Study|Adverse Event|8
1743953|NCT00911534|6082659|P2|Overall Study|Other|2
1743954|NCT00911534|6082660|P1|Overall Study|Other|2
1743955|NCT00911534|6082659|P2|Overall Study|Withdrawal of consent|4
1743956|NCT00911534|6082660|P1|Overall Study|Withdrawal of consent|1
1743957|NCT00911534|6082659|P2|Overall Study|Lack of Efficacy|1
1743958|NCT00911534|6082660|P1|Overall Study|Lack of Efficacy|4
1743959|NCT00911534|6082659|P2|Overall Study|Withdrawal by Subject|1
1743960|NCT00911534|6082660|P1|Overall Study|Withdrawal by Subject|2
1743961|NCT00911534|6082659|P2|Overall Study|Lost to Follow-up|4
1743962|NCT00911534|6082660|P1|Overall Study|Lost to Follow-up|2
1743963|NCT00911534|6082659|P2|Overall Study|Adverse Event|4
1743964|NCT00911534|6082660|P1|Overall Study|Adverse Event|4
1743965|NCT00911508|6082674|P2|Overall Study|Withdrawal by Subject|112
1743966|NCT00911508|6082675|P1|Overall Study|Withdrawal by Subject|79
1743967|NCT00911508|6082674|P2|Overall Study|Lost to Follow-up|18
1743968|NCT00911508|6082675|P1|Overall Study|Lost to Follow-up|27
1743969|NCT00911300|6082750|P2|Overall Study|Randomized; No Study Medication Received|2
1743970|NCT00911300|6082751|P1|Overall Study|Randomized; No Study Medication Received|0
1743971|NCT00911300|6082750|P2|Overall Study|Treatment Stopped by Mistake|1
1743972|NCT00911300|6082751|P1|Overall Study|Treatment Stopped by Mistake|0
1743973|NCT00911300|6082750|P2|Overall Study|Physician Decision|1
1743974|NCT00911300|6082751|P1|Overall Study|Physician Decision|0
1743975|NCT00911300|6082750|P2|Overall Study|Underlying Disease (Myocarditis)|1
1743976|NCT00911300|6082751|P1|Overall Study|Underlying Disease (Myocarditis)|0
1743977|NCT00911300|6082750|P2|Overall Study|Participant Refused Hospital Consulation|1
1743978|NCT00911300|6082751|P1|Overall Study|Participant Refused Hospital Consulation|0
1743979|NCT00911300|6082750|P2|Overall Study|International Normalized Ratio Too High|1
1743980|NCT00911300|6082751|P1|Overall Study|International Normalized Ratio Too High|0
1743981|NCT00911300|6082750|P2|Overall Study|Investigator's Decision; New AF Episode|1
1743982|NCT00911300|6082751|P1|Overall Study|Investigator's Decision; New AF Episode|0
1743983|NCT00911300|6082750|P2|Overall Study|Participant Could Not Stay in Hospital|1
1743984|NCT00911300|6082751|P1|Overall Study|Participant Could Not Stay in Hospital|0
1743985|NCT00911300|6082750|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
1743986|NCT00911300|6082751|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
1743987|NCT00911300|6082750|P2|Overall Study|Nurse Unavailable in Participant's City|0
1743988|NCT00911300|6082751|P1|Overall Study|Nurse Unavailable in Participant's City|1
1743989|NCT00911300|6082750|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
1743990|NCT00911300|6082751|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
1743991|NCT00911300|6082750|P2|Overall Study|Recurrent Tachyarrhythmia|1
1743992|NCT00911300|6082751|P1|Overall Study|Recurrent Tachyarrhythmia|1
1743993|NCT00911300|6082750|P2|Overall Study|Received Commercial Treatment|0
1743994|NCT00911300|6082751|P1|Overall Study|Received Commercial Treatment|1
1743995|NCT00911300|6082750|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
1743996|NCT00911300|6082751|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
1743997|NCT00911300|6082750|P2|Overall Study|Coronary Angiography Performed|0
1743998|NCT00911300|6082751|P1|Overall Study|Coronary Angiography Performed|1
1743999|NCT00911300|6082750|P2|Overall Study|Consent Withdrawn|12
1744000|NCT00911300|6082751|P1|Overall Study|Consent Withdrawn|4
1744001|NCT00911300|6082750|P2|Overall Study|Protocol Violation|2
1744002|NCT00911300|6082751|P1|Overall Study|Protocol Violation|3
1744003|NCT00911300|6082750|P2|Overall Study|Adverse Event|6
1744004|NCT00911300|6082751|P1|Overall Study|Adverse Event|14
1744005|NCT00911300|6082750|P2|Overall Study|Thrombus Persistant in Second TEE|7
1744006|NCT00911300|6082751|P1|Overall Study|Thrombus Persistant in Second TEE|3
1744007|NCT00911300|6082750|P2|Overall Study|Death|0
1744008|NCT00911300|6082751|P1|Overall Study|Death|1
1744009|NCT00911300|6082750|P2|Overall Study|Primary Endpoint Component Occurred|2
1744010|NCT00911300|6082751|P1|Overall Study|Primary Endpoint Component Occurred|1
1744011|NCT00911170|6082788|P2|Long Term Follow-Up|Death|121
1744012|NCT00911170|6082789|P1|Long Term Follow-Up|Death|116
1744013|NCT00911170|6082788|P2|Long Term Follow-Up|Lost to Follow-up|7
1744014|NCT00911170|6082789|P1|Long Term Follow-Up|Lost to Follow-up|8
1744015|NCT00911170|6082788|P2|Long Term Follow-Up|Physician Decision|4
1744016|NCT00911170|6082789|P1|Long Term Follow-Up|Physician Decision|5
1744017|NCT00911170|6082788|P2|Long Term Follow-Up|Withdrawal by Subject|21
1744018|NCT00911170|6082789|P1|Long Term Follow-Up|Withdrawal by Subject|20
1744019|NCT00911170|6082788|P2|Long Term Follow-Up|Continuing in study|269
1744020|NCT00911170|6082789|P1|Long Term Follow-Up|Continuing in study|274
1744021|NCT00911170|6082788|P2|Treatment Period|Death|9
1744022|NCT00911170|6082789|P1|Treatment Period|Death|6
1744023|NCT00911170|6082788|P2|Treatment Period|Lost to Follow-up|1
1744024|NCT00911170|6082789|P1|Treatment Period|Lost to Follow-up|0
1744025|NCT00911170|6082788|P2|Treatment Period|Physician Decision|5
1744026|NCT00911170|6082789|P1|Treatment Period|Physician Decision|5
1744027|NCT00911170|6082788|P2|Treatment Period|Disease progression|2
1744028|NCT00911170|6082789|P1|Treatment Period|Disease progression|0
1744029|NCT00911170|6082788|P2|Treatment Period|Withdrawal by Subject|4
1744030|NCT00911170|6082789|P1|Treatment Period|Withdrawal by Subject|4
1744031|NCT00911170|6082788|P2|Treatment Period|Adverse Event|10
1744032|NCT00911170|6082789|P1|Treatment Period|Adverse Event|9
1744033|NCT00911170|6082788|P2|Treatment Period|Protocol deviation|2
1744034|NCT00911170|6082789|P1|Treatment Period|Protocol deviation|1
1744035|NCT00911170|6082788|P2|Treatment Period|Ineligibility determined|3
1744036|NCT00911170|6082789|P1|Treatment Period|Ineligibility determined|1
1744037|NCT00911170|6082788|P2|Treatment Period|Randomized in error|1
1744038|NCT00911170|6082789|P1|Treatment Period|Randomized in error|1
1744039|NCT00911157|6082813|P2|Overall Study|Need to treat for lung cancer|0
1744040|NCT00911157|6082814|P1|Overall Study|Need to treat for lung cancer|1
1744041|NCT00911157|6082813|P2|Overall Study|Need for prohibited drug (heparin)|0
1744042|NCT00911157|6082814|P1|Overall Study|Need for prohibited drug (heparin)|1
1744043|NCT00911157|6082813|P2|Overall Study|Withdrawal by Subject|1
1744044|NCT00911157|6082814|P1|Overall Study|Withdrawal by Subject|1
1744045|NCT00911157|6082813|P2|Overall Study|Adverse Event|1
1744046|NCT00911157|6082814|P1|Overall Study|Adverse Event|4
1744047|NCT00911144|6082830|P2|Overall Study|Withdrawal by Subject|5
1744048|NCT00911144|6082831|P1|Overall Study|Withdrawal by Subject|16
1744049|NCT00910988|6082885|P4|Overall Study|Lost to Follow-up|0
1744050|NCT00910988|6082886|P3|Overall Study|Lost to Follow-up|3
1744051|NCT00910988|6082887|P2|Overall Study|Lost to Follow-up|4
1744052|NCT00910988|6082888|P1|Overall Study|Lost to Follow-up|2
1744053|NCT00910962|6082933|P3|Overall Study|Reached defined stopping criteria|17
1744054|NCT00910962|6082934|P2|Overall Study|Reached defined stopping criteria|14
1744055|NCT00910962|6082935|P1|Overall Study|Reached defined stopping criteria|12
1744056|NCT00910962|6082933|P3|Overall Study|Withdrawal by Subject|32
1744057|NCT00910962|6082934|P2|Overall Study|Withdrawal by Subject|32
1744058|NCT00910962|6082935|P1|Overall Study|Withdrawal by Subject|25
1744059|NCT00910962|6082933|P3|Overall Study|Physician Decision|6
1744060|NCT00910962|6082934|P2|Overall Study|Physician Decision|6
1744061|NCT00910962|6082935|P1|Overall Study|Physician Decision|0
1744062|NCT00910962|6082933|P3|Overall Study|Lost to Follow-up|1
1744063|NCT00910962|6082934|P2|Overall Study|Lost to Follow-up|3
1744064|NCT00910962|6082935|P1|Overall Study|Lost to Follow-up|0
1744065|NCT00910962|6082933|P3|Overall Study|Protocol Violation|3
1744066|NCT00910962|6082934|P2|Overall Study|Protocol Violation|3
1744067|NCT00910962|6082935|P1|Overall Study|Protocol Violation|1
1744068|NCT00910962|6082933|P3|Overall Study|Adverse Event|17
1744069|NCT00910962|6082934|P2|Overall Study|Adverse Event|20
1744070|NCT00910962|6082935|P1|Overall Study|Adverse Event|5
1744071|NCT00910910|6083027|P2|Overall Study|Untreated before cycle 1|2
1744072|NCT00910910|6083028|P1|Overall Study|Untreated before cycle 1|1
1744073|NCT00910910|6083027|P2|Overall Study|Other|32
1744074|NCT00910910|6083028|P1|Overall Study|Other|114
1744075|NCT00910910|6083027|P2|Overall Study|Completed 13 cycles of treatment|118
1744076|NCT00910910|6083028|P1|Overall Study|Completed 13 cycles of treatment|0
1744077|NCT00910910|6083027|P2|Overall Study|Protocol Violation|2
1744078|NCT00910910|6083028|P1|Overall Study|Protocol Violation|2
1744079|NCT00910910|6083027|P2|Overall Study|Death|3
1744080|NCT00910910|6083028|P1|Overall Study|Death|9
1744081|NCT00910910|6083027|P2|Overall Study|Lost to Follow-up|2
1744082|NCT00910910|6083028|P1|Overall Study|Lost to Follow-up|2
1744083|NCT00910910|6083027|P2|Overall Study|Withdrawal by Subject|5
1744084|NCT00910910|6083028|P1|Overall Study|Withdrawal by Subject|7
1744085|NCT00910910|6083027|P2|Overall Study|PD with histologic change|2
1744086|NCT00910910|6083028|P1|Overall Study|PD with histologic change|0
1744087|NCT00910910|6083027|P2|Overall Study|PD without histologic change|23
1744088|NCT00910910|6083028|P1|Overall Study|PD without histologic change|27
1744089|NCT00910910|6083027|P2|Overall Study|Adverse Event|35
1744090|NCT00910910|6083028|P1|Overall Study|Adverse Event|63
1744091|NCT00910871|6083064|P1|Overall Study|Undefined|1
1744092|NCT00910871|6083064|P1|Overall Study|Subject didn’t meet eligibility criteria|5
1744093|NCT00910871|6083064|P1|Overall Study|Withdrawal by Subject|12
1744094|NCT00910871|6083064|P1|Overall Study|Protocol Violation|11
1744095|NCT00910871|6083064|P1|Overall Study|Lost to Follow-up|8
1744096|NCT00910871|6083064|P1|Overall Study|Death|12
1744097|NCT00910871|6083064|P1|Overall Study|Adverse Event|5
1744098|NCT00910858|6083072|P3|Combined Treatment Phase|Other|1
1744099|NCT00910858|6083073|P2|Combined Treatment Phase|Other|2
1744100|NCT00910858|6083074|P1|Combined Treatment Phase|Other|0
1744101|NCT00910858|6083072|P3|Combined Treatment Phase|Protocol Violation|0
1744102|NCT00910858|6083073|P2|Combined Treatment Phase|Protocol Violation|0
1744103|NCT00910858|6083074|P1|Combined Treatment Phase|Protocol Violation|1
1744104|NCT00910858|6083072|P3|Combined Treatment Phase|Withdrawal by Subject|0
1744105|NCT00910858|6083073|P2|Combined Treatment Phase|Withdrawal by Subject|2
1744106|NCT00910858|6083074|P1|Combined Treatment Phase|Withdrawal by Subject|0
1744107|NCT00910858|6083072|P3|Combined Treatment Phase|Lack of therapeutic effect|3
1744108|NCT00910858|6083073|P2|Combined Treatment Phase|Lack of therapeutic effect|6
1744109|NCT00910858|6083074|P1|Combined Treatment Phase|Lack of therapeutic effect|8
1744110|NCT00910858|6083072|P3|Monotherapy Phase|Other|2
1744111|NCT00910858|6083073|P2|Monotherapy Phase|Other|4
1744112|NCT00910858|6083074|P1|Monotherapy Phase|Other|3
1744113|NCT00910858|6083072|P3|Monotherapy Phase|Protocol Violation|0
1744114|NCT00910858|6083073|P2|Monotherapy Phase|Protocol Violation|0
1744115|NCT00910858|6083074|P1|Monotherapy Phase|Protocol Violation|1
1744116|NCT00910858|6083072|P3|Monotherapy Phase|Withdrawal by Subject|1
1744117|NCT00910858|6083073|P2|Monotherapy Phase|Withdrawal by Subject|3
1744118|NCT00910858|6083074|P1|Monotherapy Phase|Withdrawal by Subject|1
1744119|NCT00910858|6083072|P3|Monotherapy Phase|Lack of therapeutic effect|4
1744120|NCT00910858|6083073|P2|Monotherapy Phase|Lack of therapeutic effect|6
1744121|NCT00910858|6083074|P1|Monotherapy Phase|Lack of therapeutic effect|9
1744122|NCT00910858|6083072|P3|Monotherapy Phase|Adverse Event|0
1744123|NCT00910858|6083073|P2|Monotherapy Phase|Adverse Event|2
1744124|NCT00910858|6083074|P1|Monotherapy Phase|Adverse Event|3
1744125|NCT00910858|6083072|P3|Pharmacokinetic Phase|Adverse Event|0
1744126|NCT00910858|6083073|P2|Pharmacokinetic Phase|Adverse Event|0
1744127|NCT00910858|6083074|P1|Pharmacokinetic Phase|Adverse Event|1
1744128|NCT00910728|6083119|P9|Overall Study|Adverse Event|1
1744129|NCT00910728|6083120|P8|Overall Study|Adverse Event|1
1744130|NCT00910728|6083121|P7|Overall Study|Adverse Event|2
1744131|NCT00910728|6083122|P6|Overall Study|Adverse Event|0
1744132|NCT00910728|6083123|P5|Overall Study|Adverse Event|0
1744133|NCT00910728|6083124|P4|Overall Study|Adverse Event|1
1744134|NCT00910728|6083125|P3|Overall Study|Adverse Event|1
1744135|NCT00910728|6083126|P2|Overall Study|Adverse Event|0
1744136|NCT00910728|6083127|P1|Overall Study|Adverse Event|2
1744137|NCT00910728|6083119|P9|Overall Study|(not specified)|0
1744138|NCT00910728|6083120|P8|Overall Study|(not specified)|0
1744139|NCT00910728|6083121|P7|Overall Study|(not specified)|0
1744140|NCT00910728|6083122|P6|Overall Study|(not specified)|0
1744141|NCT00910728|6083123|P5|Overall Study|(not specified)|1
1744142|NCT00910728|6083124|P4|Overall Study|(not specified)|0
1744143|NCT00910728|6083125|P3|Overall Study|(not specified)|1
1744144|NCT00910728|6083126|P2|Overall Study|(not specified)|0
1744145|NCT00910728|6083127|P1|Overall Study|(not specified)|2
1744146|NCT00910728|6083119|P9|Overall Study|Withdrawal by Subject|0
1744147|NCT00910728|6083120|P8|Overall Study|Withdrawal by Subject|0
1744148|NCT00910728|6083121|P7|Overall Study|Withdrawal by Subject|2
1744149|NCT00910728|6083122|P6|Overall Study|Withdrawal by Subject|1
1744150|NCT00910728|6083123|P5|Overall Study|Withdrawal by Subject|3
1744151|NCT00910728|6083124|P4|Overall Study|Withdrawal by Subject|0
1744152|NCT00910728|6083125|P3|Overall Study|Withdrawal by Subject|0
1744153|NCT00910728|6083126|P2|Overall Study|Withdrawal by Subject|0
1744154|NCT00910728|6083127|P1|Overall Study|Withdrawal by Subject|0
1744155|NCT00910728|6083119|P9|Overall Study|Lack of Efficacy|2
1744156|NCT00910728|6083120|P8|Overall Study|Lack of Efficacy|2
1744157|NCT00910728|6083121|P7|Overall Study|Lack of Efficacy|2
1744158|NCT00910728|6083122|P6|Overall Study|Lack of Efficacy|0
1744159|NCT00910728|6083123|P5|Overall Study|Lack of Efficacy|1
1744160|NCT00910728|6083124|P4|Overall Study|Lack of Efficacy|2
1744161|NCT00910728|6083125|P3|Overall Study|Lack of Efficacy|1
1744162|NCT00910728|6083126|P2|Overall Study|Lack of Efficacy|3
1744163|NCT00910728|6083127|P1|Overall Study|Lack of Efficacy|2
1744164|NCT00910715|6083249|P3|Overall Study|Lost to Follow-up|0
1744165|NCT00910715|6083250|P2|Overall Study|Lost to Follow-up|26
1744166|NCT00910715|6083251|P1|Overall Study|Lost to Follow-up|22
1744167|NCT00910689|6083265|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
1744168|NCT00910689|6083266|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
1744169|NCT00910689|6083267|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
1744170|NCT00910689|6083268|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
1744171|NCT00910689|6083265|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
1744172|NCT00910689|6083266|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1744173|NCT00910689|6083267|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1744174|NCT00910689|6083268|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
1744175|NCT00910689|6083265|P4|Months 11- 16: Evaluation Period II|Time Demands|0
1744176|NCT00910689|6083266|P3|Months 11- 16: Evaluation Period II|Time Demands|0
1744177|NCT00910689|6083267|P2|Months 11- 16: Evaluation Period II|Time Demands|1
1744178|NCT00910689|6083268|P1|Months 11- 16: Evaluation Period II|Time Demands|2
1744179|NCT00910689|6083265|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
1744180|NCT00910689|6083266|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
1744181|NCT00910689|6083267|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
1744182|NCT00910689|6083268|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
1744183|NCT00910689|6083265|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
1744184|NCT00910689|6083266|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
1744185|NCT00910689|6083267|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
1744186|NCT00910689|6083268|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
1744187|NCT00910689|6083265|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
1744188|NCT00910689|6083266|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
1744189|NCT00910689|6083267|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
1744190|NCT00910689|6083268|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
1744191|NCT00910689|6083265|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
1744192|NCT00910689|6083266|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
1744193|NCT00910689|6083267|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
1744194|NCT00910689|6083268|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
1744195|NCT00910689|6083265|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
1744196|NCT00910689|6083266|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
1744197|NCT00910689|6083267|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
1744198|NCT00910689|6083268|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
1744199|NCT00910689|6083265|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
1744200|NCT00910689|6083266|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
1744201|NCT00910689|6083267|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
1744202|NCT00910689|6083268|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
1744203|NCT00910689|6083265|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
1744204|NCT00910689|6083266|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
1744205|NCT00910689|6083267|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
1744206|NCT00910689|6083268|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
1744207|NCT00910689|6083265|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1744208|NCT00910689|6083266|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1744209|NCT00910689|6083267|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
1744210|NCT00910689|6083268|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
1744211|NCT00910689|6083265|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
1744212|NCT00910689|6083266|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
1744213|NCT00910689|6083267|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
1744214|NCT00910689|6083268|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
1744215|NCT00910689|6083265|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
1744216|NCT00910689|6083266|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
1744217|NCT00910689|6083267|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
1744218|NCT00910689|6083268|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
1744219|NCT00910689|6083265|P4|Month 2- 4: Treatment Period|Protocol Violation|0
1744220|NCT00910689|6083266|P3|Month 2- 4: Treatment Period|Protocol Violation|0
1744221|NCT00910689|6083267|P2|Month 2- 4: Treatment Period|Protocol Violation|0
1744222|NCT00910689|6083268|P1|Month 2- 4: Treatment Period|Protocol Violation|1
1744223|NCT00910689|6083265|P4|Month 2- 4: Treatment Period|Pregnancy|0
1744224|NCT00910689|6083266|P3|Month 2- 4: Treatment Period|Pregnancy|0
1744225|NCT00910689|6083267|P2|Month 2- 4: Treatment Period|Pregnancy|2
1744226|NCT00910689|6083268|P1|Month 2- 4: Treatment Period|Pregnancy|0
1744227|NCT00910689|6083265|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
1744228|NCT00910689|6083266|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
1744229|NCT00910689|6083267|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
1744230|NCT00910689|6083268|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
1744231|NCT00910689|6083265|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
1744232|NCT00910689|6083266|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
1744233|NCT00910689|6083267|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
1744234|NCT00910689|6083268|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
1744235|NCT00910689|6083265|P4|Month 2- 4: Treatment Period|Time Demands|8
1744236|NCT00910689|6083266|P3|Month 2- 4: Treatment Period|Time Demands|4
1744237|NCT00910689|6083267|P2|Month 2- 4: Treatment Period|Time Demands|0
1744238|NCT00910689|6083268|P1|Month 2- 4: Treatment Period|Time Demands|1
1744239|NCT00910689|6083265|P4|Month 2- 4: Treatment Period|Adverse Event|0
1744240|NCT00910689|6083266|P3|Month 2- 4: Treatment Period|Adverse Event|2
1744241|NCT00910689|6083267|P2|Month 2- 4: Treatment Period|Adverse Event|3
1744242|NCT00910689|6083268|P1|Month 2- 4: Treatment Period|Adverse Event|2
1744243|NCT00910689|6083265|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
1744244|NCT00910689|6083266|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
1744245|NCT00910689|6083267|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
1744246|NCT00910689|6083268|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
1744247|NCT00910689|6083265|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
1744248|NCT00910689|6083266|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
1744249|NCT00910689|6083267|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
1744250|NCT00910689|6083268|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
1744251|NCT00910663|6083300|P2|Period 1|Withdrawal by Subject|1
1744252|NCT00910663|6083301|P1|Period 1|Withdrawal by Subject|0
1744253|NCT00910624|6083315|P4|Follow-Up Phase|Administrative|0
1744254|NCT00910624|6083316|P3|Follow-Up Phase|Administrative|1
1744255|NCT00910624|6083317|P2|Follow-Up Phase|Administrative|1
1744256|NCT00910624|6083318|P1|Follow-Up Phase|Administrative|0
1744257|NCT00910624|6083315|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1744258|NCT00910624|6083316|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1744259|NCT00910624|6083317|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
1744260|NCT00910624|6083318|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
1744261|NCT00910624|6083315|P4|Follow-Up Phase|Withdrawal by Subject|0
1744262|NCT00910624|6083316|P3|Follow-Up Phase|Withdrawal by Subject|0
1744263|NCT00910624|6083317|P2|Follow-Up Phase|Withdrawal by Subject|0
1744264|NCT00910624|6083318|P1|Follow-Up Phase|Withdrawal by Subject|1
1744265|NCT00910624|6083315|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
1744266|NCT00910624|6083316|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
1744267|NCT00910624|6083317|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
1744268|NCT00910624|6083318|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
1744269|NCT00910624|6083315|P4|Follow-Up Phase|Lost to Follow-up|0
1744270|NCT00910624|6083316|P3|Follow-Up Phase|Lost to Follow-up|2
1744271|NCT00910624|6083317|P2|Follow-Up Phase|Lost to Follow-up|1
1744272|NCT00910624|6083318|P1|Follow-Up Phase|Lost to Follow-up|3
1744273|NCT00910624|6083315|P4|Follow-Up Phase|Adverse Event|0
1744274|NCT00910624|6083316|P3|Follow-Up Phase|Adverse Event|1
1744275|NCT00910624|6083317|P2|Follow-Up Phase|Adverse Event|0
1744276|NCT00910624|6083318|P1|Follow-Up Phase|Adverse Event|0
1744277|NCT00910624|6083315|P4|Treatment Phase|Non-Compliance With Protocol|0
1744278|NCT00910624|6083316|P3|Treatment Phase|Non-Compliance With Protocol|1
1744279|NCT00910624|6083317|P2|Treatment Phase|Non-Compliance With Protocol|1
1744280|NCT00910624|6083318|P1|Treatment Phase|Non-Compliance With Protocol|0
1744281|NCT00910624|6083315|P4|Treatment Phase|Withdrawal by Subject|0
1744282|NCT00910624|6083316|P3|Treatment Phase|Withdrawal by Subject|0
1744283|NCT00910624|6083317|P2|Treatment Phase|Withdrawal by Subject|1
1744284|NCT00910624|6083318|P1|Treatment Phase|Withdrawal by Subject|2
1744285|NCT00910624|6083315|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
1744286|NCT00910624|6083316|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
1744287|NCT00910624|6083317|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
1744288|NCT00910624|6083318|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
1744289|NCT00910624|6083315|P4|Treatment Phase|Lost to Follow-up|0
1744290|NCT00910624|6083316|P3|Treatment Phase|Lost to Follow-up|1
1744291|NCT00910624|6083317|P2|Treatment Phase|Lost to Follow-up|0
1744292|NCT00910624|6083318|P1|Treatment Phase|Lost to Follow-up|0
1744293|NCT00910624|6083315|P4|Treatment Phase|Treatment Failure|0
1744294|NCT00910624|6083316|P3|Treatment Phase|Treatment Failure|0
1744295|NCT00910624|6083317|P2|Treatment Phase|Treatment Failure|10
1744296|NCT00910624|6083318|P1|Treatment Phase|Treatment Failure|23
1744297|NCT00910624|6083315|P4|Treatment Phase|Adverse Event|0
1744298|NCT00910624|6083316|P3|Treatment Phase|Adverse Event|6
1744299|NCT00910624|6083317|P2|Treatment Phase|Adverse Event|6
1744300|NCT00910624|6083318|P1|Treatment Phase|Adverse Event|2
1744301|NCT00910299|6083345|P2|Overall Study|Didn't receive any study drug|1
1744302|NCT00910299|6083346|P1|Overall Study|Didn't receive any study drug|2
1744303|NCT00910299|6083345|P2|Overall Study|Sponsor Decision|60
1744304|NCT00910299|6083346|P1|Overall Study|Sponsor Decision|58
1744305|NCT00910299|6083345|P2|Overall Study|Withdrawal by Subject|13
1744306|NCT00910299|6083346|P1|Overall Study|Withdrawal by Subject|16
1744307|NCT00910273|6083358|P2|Overall Study|Lost to Follow-up|1
1744308|NCT00910273|6083359|P1|Overall Study|Lost to Follow-up|1
1744309|NCT00910273|6083358|P2|Overall Study|Protocol Violation|0
1744310|NCT00910273|6083359|P1|Overall Study|Protocol Violation|1
1744311|NCT00910273|6083358|P2|Overall Study|Discontinuation of study by sponsor|2
1744312|NCT00910273|6083359|P1|Overall Study|Discontinuation of study by sponsor|8
1744313|NCT00910273|6083358|P2|Overall Study|Withdrawal by Subject|0
1744314|NCT00910273|6083359|P1|Overall Study|Withdrawal by Subject|1
1744315|NCT00910273|6083358|P2|Overall Study|Adverse Event|1
1744316|NCT00910273|6083359|P1|Overall Study|Adverse Event|1
1744317|NCT00910273|6083358|P2|Overall Study|Lack of Efficacy|9
1744318|NCT00910273|6083359|P1|Overall Study|Lack of Efficacy|6
1744319|NCT00910247|6083409|P1|Overall Study|Not collected|4
1744320|NCT00910247|6083409|P1|Overall Study|Withdrawal by Subject|25
1744321|NCT00910247|6083409|P1|Overall Study|Protocol Violation|10
1744322|NCT00910247|6083409|P1|Overall Study|Physician Decision|3
1744323|NCT00910247|6083409|P1|Overall Study|Lost to Follow-up|10
1744324|NCT00910247|6083409|P1|Overall Study|Death|2
1744325|NCT00910247|6083409|P1|Overall Study|Adverse Event|15
1744326|NCT00910091|6083459|P2|Treatment and Survival|Adverse Event|0
1744327|NCT00910091|6083460|P1|Treatment and Survival|Adverse Event|1
1744328|NCT00910091|6083459|P2|Treatment and Survival|Withdrawal by Subject|4
1744329|NCT00910091|6083460|P1|Treatment and Survival|Withdrawal by Subject|3
1744330|NCT00910091|6083459|P2|Pre-assignment|Withdrawal by Subject|2
1744331|NCT00910091|6083460|P1|Pre-assignment|Withdrawal by Subject|0
1744332|NCT00910039|6083488|P1|Overall Study|Physician Decision|1
1744333|NCT00910000|6083505|P6|Overall Study|Withdrawal by Subject|0
1744334|NCT00910000|6083506|P5|Overall Study|Withdrawal by Subject|1
1744335|NCT00910000|6083507|P4|Overall Study|Withdrawal by Subject|0
1744336|NCT00910000|6083508|P3|Overall Study|Withdrawal by Subject|1
1744337|NCT00910000|6083509|P2|Overall Study|Withdrawal by Subject|0
1744338|NCT00910000|6083510|P1|Overall Study|Withdrawal by Subject|0
1744339|NCT00910000|6083505|P6|Overall Study|Adverse Event|1
1744340|NCT00910000|6083506|P5|Overall Study|Adverse Event|0
1744341|NCT00910000|6083507|P4|Overall Study|Adverse Event|2
1744342|NCT00910000|6083508|P3|Overall Study|Adverse Event|2
1744343|NCT00910000|6083509|P2|Overall Study|Adverse Event|3
1744344|NCT00910000|6083510|P1|Overall Study|Adverse Event|0
1744345|NCT00909870|6083528|P2|Overall Study|Other|5
1744346|NCT00909870|6083529|P1|Overall Study|Other|1
1744347|NCT00909870|6083528|P2|Overall Study|Physician Decision|2
1744348|NCT00909870|6083529|P1|Overall Study|Physician Decision|0
1744349|NCT00909870|6083528|P2|Overall Study|Lost to Follow-up|3
1744350|NCT00909870|6083529|P1|Overall Study|Lost to Follow-up|3
1744351|NCT00909870|6083528|P2|Overall Study|Withdrawal by Subject|8
1744352|NCT00909870|6083529|P1|Overall Study|Withdrawal by Subject|5
1744353|NCT00909870|6083528|P2|Overall Study|Protocol Violation|2
1744354|NCT00909870|6083529|P1|Overall Study|Protocol Violation|1
1744355|NCT00909870|6083528|P2|Overall Study|Adverse Event|7
1744356|NCT00909870|6083529|P1|Overall Study|Adverse Event|13
1744357|NCT00909857|6083541|P2|Overall Study|Did not receive study medication|24
1744358|NCT00909857|6083542|P1|Overall Study|Did not receive study medication|19
1744359|NCT00909857|6083541|P2|Overall Study|Other|0
1744360|NCT00909857|6083542|P1|Overall Study|Other|1
1744361|NCT00909857|6083541|P2|Overall Study|Pregnancy|0
1744362|NCT00909857|6083542|P1|Overall Study|Pregnancy|1
1744363|NCT00909857|6083541|P2|Overall Study|Protocol Violation|1
1744364|NCT00909857|6083542|P1|Overall Study|Protocol Violation|2
1744365|NCT00909857|6083541|P2|Overall Study|Lost to Follow-up|5
1744366|NCT00909857|6083542|P1|Overall Study|Lost to Follow-up|2
1744367|NCT00909857|6083541|P2|Overall Study|Adverse Event|5
1744368|NCT00909857|6083542|P1|Overall Study|Adverse Event|5
1744369|NCT00909857|6083541|P2|Overall Study|Withdrawal by Subject|10
1744370|NCT00909857|6083542|P1|Overall Study|Withdrawal by Subject|6
1744371|NCT00909844|6083682|P1|Overall Study|Lost to Follow-up|2
1744372|NCT00909844|6083682|P1|Overall Study|Withdrawal by Subject|1
1744373|NCT00909844|6083682|P1|Overall Study|Adverse Event|1
1744374|NCT00909792|6083700|P2|Period 2|Lost to Follow-up|1
1744375|NCT00909792|6083701|P1|Period 2|Lost to Follow-up|0
1744376|NCT00909792|6083700|P2|Period 2|Biomicroscopy|0
1744377|NCT00909792|6083701|P1|Period 2|Biomicroscopy|1
1744378|NCT00909792|6083700|P2|Period 1|Did not meet inclusion criteria|1
1744379|NCT00909792|6083701|P1|Period 1|Did not meet inclusion criteria|0
1744380|NCT00909779|6083709|P2|Overall Study|Randomized in error|1
1744381|NCT00909779|6083710|P1|Overall Study|Randomized in error|1
1744382|NCT00909779|6083709|P2|Overall Study|Noncompliance|1
1744383|NCT00909779|6083710|P1|Overall Study|Noncompliance|1
1744384|NCT00909779|6083709|P2|Overall Study|Medical Monitor Decision|0
1744385|NCT00909779|6083710|P1|Overall Study|Medical Monitor Decision|1
1744386|NCT00909779|6083709|P2|Overall Study|Site Ceasing Operation|2
1744387|NCT00909779|6083710|P1|Overall Study|Site Ceasing Operation|2
1744388|NCT00909779|6083709|P2|Overall Study|Withdrawal by Subject|80
1744389|NCT00909779|6083710|P1|Overall Study|Withdrawal by Subject|116
1744390|NCT00909779|6083709|P2|Overall Study|Protocol Violation|5
1744391|NCT00909779|6083710|P1|Overall Study|Protocol Violation|2
1744392|NCT00909779|6083709|P2|Overall Study|Physician Decision|2
1744393|NCT00909779|6083710|P1|Overall Study|Physician Decision|8
1744394|NCT00909779|6083709|P2|Overall Study|Lost to Follow-up|15
1744395|NCT00909779|6083710|P1|Overall Study|Lost to Follow-up|19
1744396|NCT00909779|6083709|P2|Overall Study|Lack of Efficacy|4
1744397|NCT00909779|6083710|P1|Overall Study|Lack of Efficacy|7
1744398|NCT00909779|6083709|P2|Overall Study|Adverse Event|55
1744399|NCT00909779|6083710|P1|Overall Study|Adverse Event|53
1744400|NCT00909753|6083734|P2|Period: Second Intervention|Protocol Violation|0
1744401|NCT00909753|6083735|P1|Period: Second Intervention|Protocol Violation|1
1744402|NCT00909753|6083734|P2|Period: Washout of 28 Days|Protocol Violation|3
1744403|NCT00909753|6083735|P1|Period: Washout of 28 Days|Protocol Violation|2
1744404|NCT00909727|6083755|P2|Overall Study|Prohibited Medication|0
1744405|NCT00909727|6083756|P1|Overall Study|Prohibited Medication|1
1744406|NCT00909727|6083755|P2|Overall Study|Withdrawal of Consent|0
1744407|NCT00909727|6083756|P1|Overall Study|Withdrawal of Consent|1
1744408|NCT00909727|6083755|P2|Overall Study|Wrong Genotype|0
1744409|NCT00909727|6083756|P1|Overall Study|Wrong Genotype|1
1744410|NCT00909727|6083755|P2|Overall Study|Adverse Event|0
1744411|NCT00909727|6083756|P1|Overall Study|Adverse Event|1
1744412|NCT00909610|6083779|P2|Period: Second Intervention|Adverse Event|0
1744413|NCT00909610|6083780|P1|Period: Second Intervention|Adverse Event|1
1744414|NCT00909610|6083779|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
1744415|NCT00909610|6083780|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
1744416|NCT00909610|6083779|P2|Period: First Intervention|Adverse Event|1
1744417|NCT00909610|6083780|P1|Period: First Intervention|Adverse Event|0
1744418|NCT00909532|6083941|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
1744419|NCT00909532|6083942|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
1744420|NCT00909532|6083941|P2|Overall Study|Wrong Genotype|0
1744421|NCT00909532|6083942|P1|Overall Study|Wrong Genotype|1
1744422|NCT00909532|6083941|P2|Overall Study|Physician Decision|0
1744423|NCT00909532|6083942|P1|Overall Study|Physician Decision|1
1744424|NCT00909532|6083941|P2|Overall Study|Noncompliance with Study Requirements|2
1744425|NCT00909532|6083942|P1|Overall Study|Noncompliance with Study Requirements|0
1744426|NCT00909532|6083941|P2|Overall Study|Withdrawal of Consent|1
1744427|NCT00909532|6083942|P1|Overall Study|Withdrawal of Consent|1
1744428|NCT00909532|6083941|P2|Overall Study|Prohibited Medication|1
1744429|NCT00909532|6083942|P1|Overall Study|Prohibited Medication|2
1744430|NCT00909532|6083941|P2|Overall Study|Pregnancy|1
1744431|NCT00909532|6083942|P1|Overall Study|Pregnancy|0
1744432|NCT00909532|6083941|P2|Overall Study|Adverse Event|1
1744433|NCT00909532|6083942|P1|Overall Study|Adverse Event|4
1744434|NCT00909480|6083960|P2|Overall Study|Unclassified|19
1744435|NCT00909480|6083961|P1|Overall Study|Unclassified|18
1744436|NCT00909480|6083960|P2|Overall Study|Withdrawal criteria|11
1744437|NCT00909480|6083961|P1|Overall Study|Withdrawal criteria|9
1744438|NCT00909480|6083960|P2|Overall Study|Protocol Violation|8
1744439|NCT00909480|6083961|P1|Overall Study|Protocol Violation|6
1744440|NCT00909480|6083960|P2|Overall Study|Adverse Event|3
1744441|NCT00909480|6083961|P1|Overall Study|Adverse Event|5
1744442|NCT00909428|6083996|P3|Overall Study|Lost to Follow-up|9
1744443|NCT00909428|6083997|P2|Overall Study|Lost to Follow-up|10
1744444|NCT00909428|6083998|P1|Overall Study|Lost to Follow-up|13
1744445|NCT00909389|6084005|P1|Overall Study|No Information|103
1744446|NCT00909389|6084005|P1|Overall Study|Lost to Follow-up|4
1744447|NCT00909389|6084005|P1|Overall Study|Poor Compliance|16
1744448|NCT00909389|6084005|P1|Overall Study|Death|4
1744449|NCT00909389|6084005|P1|Overall Study|Adverse Event|6
1744450|NCT00909363|6084012|P3|Overall Study|Lack of Efficacy|0
1744451|NCT00909363|6084013|P2|Overall Study|Lack of Efficacy|0
1744452|NCT00909363|6084014|P1|Overall Study|Lack of Efficacy|1
1744453|NCT00909363|6084012|P3|Overall Study|Withdrawal by Subject|0
1744454|NCT00909363|6084013|P2|Overall Study|Withdrawal by Subject|0
1744455|NCT00909363|6084014|P1|Overall Study|Withdrawal by Subject|1
1744456|NCT00909181|6084061|P3|Overall Study|Lost to Follow-up|33
1744457|NCT00909181|6084062|P2|Overall Study|Lost to Follow-up|18
1744458|NCT00909181|6084063|P1|Overall Study|Lost to Follow-up|39
1744459|NCT00909038|6084093|P1|Overall Study|Non-evaluable Subjects|230
1744460|NCT00909038|6084093|P1|Overall Study|Protocol Violation|187
1744461|NCT00908960|6084105|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
1744462|NCT00908960|6084106|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
1744463|NCT00908960|6084107|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
1744464|NCT00908895|6084151|P2|Overall Study|Adverse Event|1
1744465|NCT00908895|6084152|P1|Overall Study|Adverse Event|1
1744466|NCT00908895|6084151|P2|Overall Study|algodystrophy|2
1744467|NCT00908895|6084152|P1|Overall Study|algodystrophy|2
1744468|NCT00908895|6084151|P2|Overall Study|Lost to Follow-up|3
1744469|NCT00908895|6084152|P1|Overall Study|Lost to Follow-up|1
1744470|NCT00908596|6084253|P4|Overall Study|Withdrawal by Subject|1
1744471|NCT00908596|6084254|P3|Overall Study|Withdrawal by Subject|3
1744472|NCT00908596|6084255|P2|Overall Study|Withdrawal by Subject|1
1744473|NCT00908596|6084256|P1|Overall Study|Withdrawal by Subject|0
1744474|NCT00908596|6084253|P4|Overall Study|Protocol Violation|0
1744475|NCT00908596|6084254|P3|Overall Study|Protocol Violation|0
1744476|NCT00908596|6084255|P2|Overall Study|Protocol Violation|0
1744477|NCT00908596|6084256|P1|Overall Study|Protocol Violation|1
1744478|NCT00908596|6084253|P4|Overall Study|Death|32
1744479|NCT00908596|6084254|P3|Overall Study|Death|57
1744480|NCT00908596|6084255|P2|Overall Study|Death|5
1744481|NCT00908596|6084256|P1|Overall Study|Death|0
1744482|NCT00908596|6084253|P4|Overall Study|Lost to Follow-up|4
1744483|NCT00908596|6084254|P3|Overall Study|Lost to Follow-up|12
1744484|NCT00908596|6084255|P2|Overall Study|Lost to Follow-up|1
1744485|NCT00908596|6084256|P1|Overall Study|Lost to Follow-up|0
1744486|NCT00908596|6084253|P4|Overall Study|Other reasons|0
1744487|NCT00908596|6084254|P3|Overall Study|Other reasons|2
1744488|NCT00908596|6084255|P2|Overall Study|Other reasons|6
1744489|NCT00908596|6084256|P1|Overall Study|Other reasons|46
1744490|NCT00908583|6084286|P1|Phase 5|Adverse Event|3
1744491|NCT00908583|6084286|P1|Phase 4|Physician Decision|1
1744492|NCT00908583|6084286|P1|Phase 4|Adverse Event|1
1744493|NCT00908583|6084286|P1|Phase 3|Adverse Event|2
1744494|NCT00908583|6084286|P1|Phase 2|Adverse Event|1
1744495|NCT00908583|6084286|P1|Phase 2|Physician Decision|1
1744496|NCT00908583|6084286|P1|Phase 1|Adverse Event|4
1744497|NCT00908583|6084286|P1|Phase 1|Withdrawal by Subject|1
1744498|NCT00908544|6084306|P2|Overall Study|Unable to visit sutdy center|0
1744499|NCT00908544|6084307|P1|Overall Study|Unable to visit sutdy center|1
1744500|NCT00908544|6084306|P2|Overall Study|Relocation abroad|1
1744501|NCT00908544|6084307|P1|Overall Study|Relocation abroad|1
1744502|NCT00908544|6084306|P2|Overall Study|Pregnancy|0
1744503|NCT00908544|6084307|P1|Overall Study|Pregnancy|1
1744504|NCT00908544|6084306|P2|Overall Study|Lack of Efficacy|1
1744505|NCT00908544|6084307|P1|Overall Study|Lack of Efficacy|0
1744506|NCT00908544|6084306|P2|Overall Study|Withdrawal by Subject|4
1744507|NCT00908544|6084307|P1|Overall Study|Withdrawal by Subject|2
1744508|NCT00908375|6084366|P2|Overall Study|Lost to Follow-up|6
1744509|NCT00908375|6084367|P1|Overall Study|Lost to Follow-up|8
1744510|NCT00908375|6084366|P2|Overall Study|Withdrawal by Subject|4
1744511|NCT00908375|6084367|P1|Overall Study|Withdrawal by Subject|2
1744512|NCT00908349|6084377|P1|Overall Study|Various|6
1744513|NCT00908349|6084377|P1|Overall Study|Lost to Follow-up|5
1744514|NCT00908349|6084377|P1|Overall Study|Physician Decision|5
1744515|NCT00908349|6084377|P1|Overall Study|Withdrawal by Subject|9
1744516|NCT00908349|6084377|P1|Overall Study|Adverse Event|10
1744517|NCT00908310|6084381|P1|Overall Study|Other reasons|4
1744518|NCT00908310|6084381|P1|Overall Study|Screening failure|5
1744519|NCT00908310|6084381|P1|Overall Study|Lost to Follow-up|7
1744520|NCT00908310|6084381|P1|Overall Study|Withdrawal by Subject|7
1744521|NCT00908310|6084381|P1|Overall Study|Death|37
1744522|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1744523|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1744524|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
1744525|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
1744526|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Other|0
1744527|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Other|0
1744528|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Other|1
1744529|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Other|3
1744530|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1744531|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1744532|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
1744533|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
1744534|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
1744535|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
1744536|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
1744537|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
1744538|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
1744539|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
1744540|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
1744541|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
1744542|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Death|0
1744543|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Death|0
1744544|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Death|0
1744545|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Death|2
1744546|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1744547|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1744548|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
1744549|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
1744550|NCT00908232|6084385|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1744551|NCT00908232|6084386|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1744552|NCT00908232|6084387|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
1744553|NCT00908232|6084388|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
1744554|NCT00908232|6084385|P4|Cycle 1 to 4|Other|0
1744555|NCT00908232|6084386|P3|Cycle 1 to 4|Other|0
1744556|NCT00908232|6084387|P2|Cycle 1 to 4|Other|0
1744557|NCT00908232|6084388|P1|Cycle 1 to 4|Other|1
1744558|NCT00908232|6084385|P4|Cycle 1 to 4|Adverse Event|0
1744559|NCT00908232|6084386|P3|Cycle 1 to 4|Adverse Event|0
1744560|NCT00908232|6084387|P2|Cycle 1 to 4|Adverse Event|0
1744561|NCT00908232|6084388|P1|Cycle 1 to 4|Adverse Event|12
1744562|NCT00908232|6084385|P4|Cycle 1 to 4|Progressive Disease|0
1744563|NCT00908232|6084386|P3|Cycle 1 to 4|Progressive Disease|0
1744564|NCT00908232|6084387|P2|Cycle 1 to 4|Progressive Disease|0
1744565|NCT00908232|6084388|P1|Cycle 1 to 4|Progressive Disease|6
1744566|NCT00908232|6084385|P4|Cycle 1 to 4|Withdrawal by Subject|0
1744567|NCT00908232|6084386|P3|Cycle 1 to 4|Withdrawal by Subject|0
1744568|NCT00908232|6084387|P2|Cycle 1 to 4|Withdrawal by Subject|0
1744569|NCT00908232|6084388|P1|Cycle 1 to 4|Withdrawal by Subject|4
1744570|NCT00908232|6084385|P4|Cycle 1 to 4|Death|0
1744571|NCT00908232|6084386|P3|Cycle 1 to 4|Death|0
1744572|NCT00908232|6084387|P2|Cycle 1 to 4|Death|0
1744573|NCT00908232|6084388|P1|Cycle 1 to 4|Death|5
1744574|NCT00908141|6084406|P2|Overall Study|Withdrawal by Subject|1
1744575|NCT00908141|6084407|P1|Overall Study|Withdrawal by Subject|0
1744576|NCT00908115|6084424|P1|Overall Study|Other|14
1744577|NCT00908076|6084432|P2|Overall Study|Lack of Efficacy|1
1744578|NCT00908076|6084433|P1|Overall Study|Lack of Efficacy|1
1744579|NCT00908037|6084446|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744580|NCT00908037|6084447|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
1744581|NCT00908037|6084448|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744582|NCT00908037|6084449|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744583|NCT00908037|6084450|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744584|NCT00908037|6084451|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744585|NCT00908037|6084452|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744586|NCT00908037|6084453|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744587|NCT00908037|6084454|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744588|NCT00908037|6084455|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744589|NCT00908037|6084456|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744590|NCT00908037|6084457|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
1744591|NCT00908037|6084446|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744592|NCT00908037|6084447|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744593|NCT00908037|6084448|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
1744594|NCT00908037|6084449|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744595|NCT00908037|6084450|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744596|NCT00908037|6084451|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744597|NCT00908037|6084452|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744598|NCT00908037|6084453|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744599|NCT00908037|6084454|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744600|NCT00908037|6084455|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744601|NCT00908037|6084456|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744602|NCT00908037|6084457|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
1744603|NCT00908037|6084446|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744604|NCT00908037|6084447|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
1744605|NCT00908037|6084448|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744606|NCT00908037|6084449|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744607|NCT00908037|6084450|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744608|NCT00908037|6084451|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744609|NCT00908037|6084452|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744610|NCT00908037|6084453|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744611|NCT00908037|6084454|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744612|NCT00908037|6084455|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744613|NCT00908037|6084456|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744614|NCT00908037|6084457|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
1744615|NCT00908037|6084446|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744616|NCT00908037|6084447|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744617|NCT00908037|6084448|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
1744618|NCT00908037|6084449|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744619|NCT00908037|6084450|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744620|NCT00908037|6084451|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744621|NCT00908037|6084452|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744622|NCT00908037|6084453|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744623|NCT00908037|6084454|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744624|NCT00908037|6084455|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744625|NCT00908037|6084456|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744626|NCT00908037|6084457|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
1744627|NCT00908037|6084446|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
1744628|NCT00908037|6084447|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744629|NCT00908037|6084448|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
1744630|NCT00908037|6084449|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744631|NCT00908037|6084450|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744632|NCT00908037|6084451|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744633|NCT00908037|6084452|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744634|NCT00908037|6084453|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744635|NCT00908037|6084454|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744636|NCT00908037|6084455|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744637|NCT00908037|6084456|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744638|NCT00908037|6084457|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
1744639|NCT00908037|6084446|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
1744640|NCT00908037|6084447|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744641|NCT00908037|6084448|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744642|NCT00908037|6084449|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744643|NCT00908037|6084450|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744644|NCT00908037|6084451|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744645|NCT00908037|6084452|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744646|NCT00908037|6084453|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744647|NCT00908037|6084454|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744648|NCT00908037|6084455|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744649|NCT00908037|6084456|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744650|NCT00908037|6084457|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
1744651|NCT00908037|6084446|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744652|NCT00908037|6084447|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744653|NCT00908037|6084448|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744654|NCT00908037|6084449|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744655|NCT00908037|6084450|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744656|NCT00908037|6084451|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
1744657|NCT00908037|6084452|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744658|NCT00908037|6084453|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744659|NCT00908037|6084454|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
1744660|NCT00908037|6084455|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744661|NCT00908037|6084456|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744662|NCT00908037|6084457|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
1744663|NCT00908037|6084446|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744664|NCT00908037|6084447|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744665|NCT00908037|6084448|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744666|NCT00908037|6084449|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
1744667|NCT00908037|6084450|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744668|NCT00908037|6084451|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744669|NCT00908037|6084452|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744670|NCT00908037|6084453|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
1744671|NCT00908037|6084454|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744672|NCT00908037|6084455|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744673|NCT00908037|6084456|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744674|NCT00908037|6084457|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
1744675|NCT00908037|6084446|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744676|NCT00908037|6084447|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744677|NCT00908037|6084448|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744678|NCT00908037|6084449|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
1744679|NCT00908037|6084450|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744680|NCT00908037|6084451|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
1744681|NCT00908037|6084452|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744682|NCT00908037|6084453|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
1744683|NCT00908037|6084454|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744684|NCT00908037|6084455|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744685|NCT00908037|6084456|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744686|NCT00908037|6084457|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
1744687|NCT00908011|6084606|P2|Overall Study|Withdrawal by Subject|2
1744688|NCT00908011|6084607|P1|Overall Study|Withdrawal by Subject|2
1744689|NCT00907881|6084624|P1|Overall Study|Missing discontinuation information|15
1744690|NCT00907881|6084624|P1|Overall Study|Protocol Violation|1
1744691|NCT00907881|6084624|P1|Overall Study|Withdrawal by Subject|5
1744692|NCT00907881|6084624|P1|Overall Study|Noncompliance|5
1744693|NCT00907881|6084624|P1|Overall Study|Lost to Follow-up|59
1744694|NCT00907803|6084634|P3|Overall Study|Protocol Violation|0
1744695|NCT00907803|6084635|P2|Overall Study|Protocol Violation|1
1744696|NCT00907803|6084636|P1|Overall Study|Protocol Violation|0
1744697|NCT00907803|6084634|P3|Overall Study|Lost to Follow-up|0
1744698|NCT00907803|6084635|P2|Overall Study|Lost to Follow-up|1
1744699|NCT00907803|6084636|P1|Overall Study|Lost to Follow-up|0
1744700|NCT00907803|6084634|P3|Overall Study|Withdrawal by Subject|0
1744701|NCT00907803|6084635|P2|Overall Study|Withdrawal by Subject|1
1744702|NCT00907803|6084636|P1|Overall Study|Withdrawal by Subject|0
1744703|NCT00907803|6084634|P3|Overall Study|Adverse Event|0
1744704|NCT00907803|6084635|P2|Overall Study|Adverse Event|0
1744705|NCT00907803|6084636|P1|Overall Study|Adverse Event|2
1744706|NCT00907803|6084634|P3|Overall Study|Withdrawal of consent - long commute|0
1744707|NCT00907803|6084635|P2|Overall Study|Withdrawal of consent - long commute|0
1744708|NCT00907803|6084636|P1|Overall Study|Withdrawal of consent - long commute|1
1744709|NCT00907777|6084667|P2|Overall Study|Withdrawal by Subject|1
1744710|NCT00907777|6084668|P1|Overall Study|Withdrawal by Subject|0
1744711|NCT00907738|6084695|P5|Overall Study|Disease progression|2
1744712|NCT00907738|6084696|P4|Overall Study|Disease progression|4
1744713|NCT00907738|6084697|P3|Overall Study|Disease progression|6
1744714|NCT00907738|6084698|P2|Overall Study|Disease progression|1
1744715|NCT00907738|6084699|P1|Overall Study|Disease progression|8
1744716|NCT00907738|6084695|P5|Overall Study|not specified or withdrew consent|0
1744717|NCT00907738|6084696|P4|Overall Study|not specified or withdrew consent|0
1744718|NCT00907738|6084697|P3|Overall Study|not specified or withdrew consent|0
1744719|NCT00907738|6084698|P2|Overall Study|not specified or withdrew consent|0
1744720|NCT00907738|6084699|P1|Overall Study|not specified or withdrew consent|3
1744721|NCT00907738|6084695|P5|Overall Study|Adverse Event|0
1744722|NCT00907738|6084696|P4|Overall Study|Adverse Event|0
1744723|NCT00907738|6084697|P3|Overall Study|Adverse Event|1
1744724|NCT00907738|6084698|P2|Overall Study|Adverse Event|0
1744725|NCT00907738|6084699|P1|Overall Study|Adverse Event|2
1744726|NCT00907621|6084717|P2|Overall Study|intercurrent febrile illness|1
1744727|NCT00907621|6084718|P1|Overall Study|intercurrent febrile illness|1
1744728|NCT00907621|6084717|P2|Overall Study|Lost to Follow-up|3
1744729|NCT00907621|6084718|P1|Overall Study|Lost to Follow-up|6
1744730|NCT00907517|6084731|P5|Overall Study|Symptomatic Deterioration|1
1744731|NCT00907517|6084732|P4|Overall Study|Symptomatic Deterioration|0
1744732|NCT00907517|6084733|P3|Overall Study|Symptomatic Deterioration|0
1744733|NCT00907517|6084734|P2|Overall Study|Symptomatic Deterioration|0
1744734|NCT00907517|6084735|P1|Overall Study|Symptomatic Deterioration|0
1744735|NCT00907517|6084731|P5|Overall Study|Progressive Disease|4
1744736|NCT00907517|6084732|P4|Overall Study|Progressive Disease|4
1744737|NCT00907517|6084733|P3|Overall Study|Progressive Disease|4
1744738|NCT00907517|6084734|P2|Overall Study|Progressive Disease|3
1744739|NCT00907517|6084735|P1|Overall Study|Progressive Disease|3
1744740|NCT00907478|6084760|P3|Overall Study|Other|1
1744741|NCT00907478|6084761|P2|Overall Study|Other|0
1744742|NCT00907478|6084762|P1|Overall Study|Other|3
1744743|NCT00907478|6084760|P3|Overall Study|Lost to Follow-up|0
1744744|NCT00907478|6084761|P2|Overall Study|Lost to Follow-up|0
1744745|NCT00907478|6084762|P1|Overall Study|Lost to Follow-up|1
1744746|NCT00907478|6084760|P3|Overall Study|Pregnancy|1
1744747|NCT00907478|6084761|P2|Overall Study|Pregnancy|1
1744748|NCT00907478|6084762|P1|Overall Study|Pregnancy|0
1744749|NCT00907478|6084760|P3|Overall Study|Protocol-specified criteria|3
1744750|NCT00907478|6084761|P2|Overall Study|Protocol-specified criteria|2
1744751|NCT00907478|6084762|P1|Overall Study|Protocol-specified criteria|5
1744752|NCT00907478|6084760|P3|Overall Study|Death|1
1744753|NCT00907478|6084761|P2|Overall Study|Death|2
1744754|NCT00907478|6084762|P1|Overall Study|Death|4
1744755|NCT00907478|6084760|P3|Overall Study|Physician Decision|3
1744756|NCT00907478|6084761|P2|Overall Study|Physician Decision|0
1744757|NCT00907478|6084762|P1|Overall Study|Physician Decision|2
1744758|NCT00907478|6084760|P3|Overall Study|Requirement for alternative therapy|3
1744759|NCT00907478|6084761|P2|Overall Study|Requirement for alternative therapy|2
1744760|NCT00907478|6084762|P1|Overall Study|Requirement for alternative therapy|1
1744761|NCT00907478|6084760|P3|Overall Study|Withdrawal by Subject|6
1744762|NCT00907478|6084761|P2|Overall Study|Withdrawal by Subject|9
1744763|NCT00907478|6084762|P1|Overall Study|Withdrawal by Subject|8
1744764|NCT00907478|6084760|P3|Overall Study|Adverse Event|2
1744765|NCT00907478|6084761|P2|Overall Study|Adverse Event|1
1744766|NCT00907478|6084762|P1|Overall Study|Adverse Event|3
1744767|NCT00907478|6084760|P3|Overall Study|Noncompliance|1
1744768|NCT00907478|6084761|P2|Overall Study|Noncompliance|0
1744769|NCT00907478|6084762|P1|Overall Study|Noncompliance|0
1744770|NCT00907478|6084760|P3|Overall Study|Ineligibility determined|1
1744771|NCT00907478|6084761|P2|Overall Study|Ineligibility determined|0
1744772|NCT00907478|6084762|P1|Overall Study|Ineligibility determined|0
1744773|NCT00907374|6084812|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
1744774|NCT00907374|6084813|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
1744775|NCT00907335|6084827|P2|Overall Study|Lost to Follow-up|0
1744776|NCT00907335|6084828|P1|Overall Study|Lost to Follow-up|2
1744777|NCT00907335|6084827|P2|Overall Study|Adverse Event|1
1744778|NCT00907335|6084828|P1|Overall Study|Adverse Event|4
1744779|NCT00907335|6084827|P2|Overall Study|Withdrawal by Subject|0
1744780|NCT00907335|6084828|P1|Overall Study|Withdrawal by Subject|2
1744781|NCT00907296|6084854|P10|Overall Study|Lost to Follow-up|4
1744782|NCT00907296|6084855|P9|Overall Study|Lost to Follow-up|0
1744783|NCT00907296|6084856|P8|Overall Study|Lost to Follow-up|2
1744784|NCT00907296|6084857|P7|Overall Study|Lost to Follow-up|2
1744785|NCT00907296|6084858|P6|Overall Study|Lost to Follow-up|3
1744786|NCT00907296|6084859|P5|Overall Study|Lost to Follow-up|0
1744787|NCT00907296|6084860|P4|Overall Study|Lost to Follow-up|2
1744788|NCT00907296|6084861|P3|Overall Study|Lost to Follow-up|0
1744789|NCT00907296|6084862|P2|Overall Study|Lost to Follow-up|1
1744790|NCT00907296|6084863|P1|Overall Study|Lost to Follow-up|9
1744791|NCT00907296|6084854|P10|Overall Study|Withdrawal by Subject|2
1744792|NCT00907296|6084855|P9|Overall Study|Withdrawal by Subject|4
1744793|NCT00907296|6084856|P8|Overall Study|Withdrawal by Subject|2
1744794|NCT00907296|6084857|P7|Overall Study|Withdrawal by Subject|3
1744795|NCT00907296|6084858|P6|Overall Study|Withdrawal by Subject|5
1744796|NCT00907296|6084859|P5|Overall Study|Withdrawal by Subject|1
1744797|NCT00907296|6084860|P4|Overall Study|Withdrawal by Subject|1
1744798|NCT00907296|6084861|P3|Overall Study|Withdrawal by Subject|1
1744799|NCT00907296|6084862|P2|Overall Study|Withdrawal by Subject|2
1744800|NCT00907296|6084863|P1|Overall Study|Withdrawal by Subject|7
1744801|NCT00907296|6084854|P10|Overall Study|Adverse Event|1
1744802|NCT00907296|6084855|P9|Overall Study|Adverse Event|0
1744803|NCT00907296|6084856|P8|Overall Study|Adverse Event|0
1744804|NCT00907296|6084857|P7|Overall Study|Adverse Event|1
1744805|NCT00907296|6084858|P6|Overall Study|Adverse Event|0
1744806|NCT00907296|6084859|P5|Overall Study|Adverse Event|0
1744807|NCT00907296|6084860|P4|Overall Study|Adverse Event|0
1744808|NCT00907296|6084861|P3|Overall Study|Adverse Event|0
1744809|NCT00907296|6084862|P2|Overall Study|Adverse Event|0
1744810|NCT00907296|6084863|P1|Overall Study|Adverse Event|2
1744811|NCT00907296|6084854|P10|Overall Study|Noncompliance|0
1744812|NCT00907296|6084855|P9|Overall Study|Noncompliance|0
1744813|NCT00907296|6084856|P8|Overall Study|Noncompliance|2
1744814|NCT00907296|6084857|P7|Overall Study|Noncompliance|0
1744815|NCT00907296|6084858|P6|Overall Study|Noncompliance|1
1744816|NCT00907296|6084859|P5|Overall Study|Noncompliance|0
1744817|NCT00907296|6084860|P4|Overall Study|Noncompliance|0
1744818|NCT00907296|6084861|P3|Overall Study|Noncompliance|1
1744819|NCT00907296|6084862|P2|Overall Study|Noncompliance|1
1744820|NCT00907296|6084863|P1|Overall Study|Noncompliance|1
1744821|NCT00907296|6084854|P10|Overall Study|Protocol Deviation|0
1744822|NCT00907296|6084855|P9|Overall Study|Protocol Deviation|0
1744823|NCT00907296|6084856|P8|Overall Study|Protocol Deviation|0
1744824|NCT00907296|6084857|P7|Overall Study|Protocol Deviation|0
1744825|NCT00907296|6084858|P6|Overall Study|Protocol Deviation|0
1744826|NCT00907296|6084859|P5|Overall Study|Protocol Deviation|0
1744827|NCT00907296|6084860|P4|Overall Study|Protocol Deviation|0
1744828|NCT00907296|6084861|P3|Overall Study|Protocol Deviation|0
1744829|NCT00907296|6084862|P2|Overall Study|Protocol Deviation|1
1744830|NCT00907296|6084863|P1|Overall Study|Protocol Deviation|0
1744831|NCT00907296|6084854|P10|Overall Study|Ineligibility Determined|0
1744832|NCT00907296|6084855|P9|Overall Study|Ineligibility Determined|0
1744833|NCT00907296|6084856|P8|Overall Study|Ineligibility Determined|1
1744834|NCT00907296|6084857|P7|Overall Study|Ineligibility Determined|0
1744835|NCT00907296|6084858|P6|Overall Study|Ineligibility Determined|0
1744836|NCT00907296|6084859|P5|Overall Study|Ineligibility Determined|0
1744837|NCT00907296|6084860|P4|Overall Study|Ineligibility Determined|1
1744838|NCT00907296|6084861|P3|Overall Study|Ineligibility Determined|0
1744839|NCT00907296|6084862|P2|Overall Study|Ineligibility Determined|0
1744840|NCT00907296|6084863|P1|Overall Study|Ineligibility Determined|1
1744841|NCT00907257|6084917|P2|Overall Study|Personal Reasons|1
1744842|NCT00907257|6084918|P1|Overall Study|Personal Reasons|6
1744843|NCT00907257|6084917|P2|Overall Study|Moved|0
1744844|NCT00907257|6084918|P1|Overall Study|Moved|1
1744845|NCT00907257|6084917|P2|Overall Study|Per IRB-Subject became vulnerable|0
1744846|NCT00907257|6084918|P1|Overall Study|Per IRB-Subject became vulnerable|1
1744847|NCT00907257|6084917|P2|Overall Study|Withdrawal by Subject|2
1744848|NCT00907257|6084918|P1|Overall Study|Withdrawal by Subject|1
1744849|NCT00907257|6084917|P2|Overall Study|Lost to Follow-up|3
1744850|NCT00907257|6084918|P1|Overall Study|Lost to Follow-up|3
1744851|NCT00907257|6084917|P2|Overall Study|Protocol Violation|2
1744852|NCT00907257|6084918|P1|Overall Study|Protocol Violation|1
1744853|NCT00907257|6084917|P2|Overall Study|Adverse Event|4
1744854|NCT00907257|6084918|P1|Overall Study|Adverse Event|0
1744855|NCT00907153|6084940|P2|Overall Study|Withdrawal by Subject|3
1744856|NCT00907153|6084941|P1|Overall Study|Withdrawal by Subject|1
1744857|NCT00907153|6084940|P2|Overall Study|Lost to Follow-up|1
1744858|NCT00907153|6084941|P1|Overall Study|Lost to Follow-up|1
1744859|NCT00906971|6085002|P2|Overall Study|Lost to Follow-up|1
1744860|NCT00906971|6085003|P1|Overall Study|Lost to Follow-up|0
1744861|NCT00906971|6085002|P2|Overall Study|Withdrawal by Subject|2
1744862|NCT00906971|6085003|P1|Overall Study|Withdrawal by Subject|8
1744863|NCT00906945|6085016|P6|Overall Study|Physician Decision|1
1744864|NCT00906945|6085017|P5|Overall Study|Physician Decision|0
1744865|NCT00906945|6085018|P4|Overall Study|Physician Decision|0
1744866|NCT00906945|6085019|P3|Overall Study|Physician Decision|0
1744867|NCT00906945|6085020|P2|Overall Study|Physician Decision|0
1744868|NCT00906945|6085021|P1|Overall Study|Physician Decision|0
1744869|NCT00906945|6085016|P6|Overall Study|Found to be not eligible|1
1744870|NCT00906945|6085017|P5|Overall Study|Found to be not eligible|1
1744871|NCT00906945|6085018|P4|Overall Study|Found to be not eligible|1
1744872|NCT00906945|6085019|P3|Overall Study|Found to be not eligible|0
1744873|NCT00906945|6085020|P2|Overall Study|Found to be not eligible|0
1744874|NCT00906945|6085021|P1|Overall Study|Found to be not eligible|0
1744875|NCT00906698|6085081|P6|Overall Study|incl. non compliance, lost to follow-up|0
1744876|NCT00906698|6085082|P5|Overall Study|incl. non compliance, lost to follow-up|0
1744877|NCT00906698|6085083|P4|Overall Study|incl. non compliance, lost to follow-up|0
1744878|NCT00906698|6085084|P3|Overall Study|incl. non compliance, lost to follow-up|0
1744879|NCT00906698|6085085|P2|Overall Study|incl. non compliance, lost to follow-up|1
1744880|NCT00906698|6085086|P1|Overall Study|incl. non compliance, lost to follow-up|0
1744881|NCT00906698|6085081|P6|Overall Study|Withdrawal by Subject|0
1744882|NCT00906698|6085082|P5|Overall Study|Withdrawal by Subject|1
1744883|NCT00906698|6085083|P4|Overall Study|Withdrawal by Subject|0
1744884|NCT00906698|6085084|P3|Overall Study|Withdrawal by Subject|0
1744885|NCT00906698|6085085|P2|Overall Study|Withdrawal by Subject|0
1744886|NCT00906698|6085086|P1|Overall Study|Withdrawal by Subject|0
1744887|NCT00906698|6085081|P6|Overall Study|Disease progression|4
1744888|NCT00906698|6085082|P5|Overall Study|Disease progression|12
1744889|NCT00906698|6085083|P4|Overall Study|Disease progression|4
1744890|NCT00906698|6085084|P3|Overall Study|Disease progression|4
1744891|NCT00906698|6085085|P2|Overall Study|Disease progression|12
1744892|NCT00906698|6085086|P1|Overall Study|Disease progression|3
1744893|NCT00906698|6085081|P6|Overall Study|Adverse Event|1
1744894|NCT00906698|6085082|P5|Overall Study|Adverse Event|4
1744895|NCT00906698|6085083|P4|Overall Study|Adverse Event|0
1744896|NCT00906698|6085084|P3|Overall Study|Adverse Event|2
1744897|NCT00906698|6085085|P2|Overall Study|Adverse Event|0
1744898|NCT00906698|6085086|P1|Overall Study|Adverse Event|0
1744899|NCT00906698|6085081|P6|Overall Study|Dose-limiting toxicity (DLT)|0
1744900|NCT00906698|6085082|P5|Overall Study|Dose-limiting toxicity (DLT)|1
1744901|NCT00906698|6085083|P4|Overall Study|Dose-limiting toxicity (DLT)|0
1744902|NCT00906698|6085084|P3|Overall Study|Dose-limiting toxicity (DLT)|0
1744903|NCT00906698|6085085|P2|Overall Study|Dose-limiting toxicity (DLT)|6
1744904|NCT00906698|6085086|P1|Overall Study|Dose-limiting toxicity (DLT)|0
1744905|NCT00906399|6085188|P7|Year 2|Other|0
1744906|NCT00906399|6085189|P6|Year 2|Other|1
1744907|NCT00906399|6085190|P5|Year 2|Other|3
1744908|NCT00906399|6085191|P4|Year 2|Other|2
1744909|NCT00906399|6085192|P3|Year 2|Other|0
1744910|NCT00906399|6085193|P2|Year 2|Other|0
1744911|NCT00906399|6085194|P1|Year 2|Other|0
1744912|NCT00906399|6085188|P7|Year 2|Death|3
1744913|NCT00906399|6085189|P6|Year 2|Death|0
1744914|NCT00906399|6085190|P5|Year 2|Death|0
1744915|NCT00906399|6085191|P4|Year 2|Death|1
1744916|NCT00906399|6085192|P3|Year 2|Death|0
1744917|NCT00906399|6085193|P2|Year 2|Death|0
1744918|NCT00906399|6085194|P1|Year 2|Death|0
1744919|NCT00906399|6085188|P7|Year 2|Physician Decision|3
1744920|NCT00906399|6085189|P6|Year 2|Physician Decision|6
1744921|NCT00906399|6085190|P5|Year 2|Physician Decision|2
1744922|NCT00906399|6085191|P4|Year 2|Physician Decision|0
1744923|NCT00906399|6085192|P3|Year 2|Physician Decision|0
1744924|NCT00906399|6085193|P2|Year 2|Physician Decision|0
1744925|NCT00906399|6085194|P1|Year 2|Physician Decision|0
1744926|NCT00906399|6085188|P7|Year 2|Withdrawal by Subject|13
1744927|NCT00906399|6085189|P6|Year 2|Withdrawal by Subject|27
1744928|NCT00906399|6085190|P5|Year 2|Withdrawal by Subject|18
1744929|NCT00906399|6085191|P4|Year 2|Withdrawal by Subject|17
1744930|NCT00906399|6085192|P3|Year 2|Withdrawal by Subject|0
1744931|NCT00906399|6085193|P2|Year 2|Withdrawal by Subject|0
1744932|NCT00906399|6085194|P1|Year 2|Withdrawal by Subject|0
1744933|NCT00906399|6085188|P7|Year 2|Lost to Follow-up|4
1744934|NCT00906399|6085189|P6|Year 2|Lost to Follow-up|2
1744935|NCT00906399|6085190|P5|Year 2|Lost to Follow-up|4
1744936|NCT00906399|6085191|P4|Year 2|Lost to Follow-up|1
1744937|NCT00906399|6085192|P3|Year 2|Lost to Follow-up|0
1744938|NCT00906399|6085193|P2|Year 2|Lost to Follow-up|0
1744939|NCT00906399|6085194|P1|Year 2|Lost to Follow-up|0
1744940|NCT00906399|6085188|P7|Year 2|Adverse Event|6
1744941|NCT00906399|6085189|P6|Year 2|Adverse Event|11
1744942|NCT00906399|6085190|P5|Year 2|Adverse Event|8
1744943|NCT00906399|6085191|P4|Year 2|Adverse Event|9
1744944|NCT00906399|6085192|P3|Year 2|Adverse Event|0
1744945|NCT00906399|6085193|P2|Year 2|Adverse Event|0
1744946|NCT00906399|6085194|P1|Year 2|Adverse Event|0
1744947|NCT00906399|6085188|P7|Year 1|Other|0
1744948|NCT00906399|6085189|P6|Year 1|Other|0
1744949|NCT00906399|6085190|P5|Year 1|Other|0
1744950|NCT00906399|6085191|P4|Year 1|Other|0
1744951|NCT00906399|6085192|P3|Year 1|Other|7
1744952|NCT00906399|6085193|P2|Year 1|Other|2
1744953|NCT00906399|6085194|P1|Year 1|Other|4
1744954|NCT00906399|6085188|P7|Year 1|Death|0
1744955|NCT00906399|6085189|P6|Year 1|Death|0
1744956|NCT00906399|6085190|P5|Year 1|Death|0
1744957|NCT00906399|6085191|P4|Year 1|Death|0
1744958|NCT00906399|6085192|P3|Year 1|Death|1
1744959|NCT00906399|6085193|P2|Year 1|Death|1
1744960|NCT00906399|6085194|P1|Year 1|Death|2
1744961|NCT00906399|6085188|P7|Year 1|Physician Decision|0
1744962|NCT00906399|6085189|P6|Year 1|Physician Decision|0
1744963|NCT00906399|6085190|P5|Year 1|Physician Decision|0
1744964|NCT00906399|6085191|P4|Year 1|Physician Decision|0
1744965|NCT00906399|6085192|P3|Year 1|Physician Decision|3
1744966|NCT00906399|6085193|P2|Year 1|Physician Decision|1
1744967|NCT00906399|6085194|P1|Year 1|Physician Decision|0
1744968|NCT00906399|6085188|P7|Year 1|Withdrawal by Subject|0
1744969|NCT00906399|6085189|P6|Year 1|Withdrawal by Subject|0
1744970|NCT00906399|6085190|P5|Year 1|Withdrawal by Subject|0
1744971|NCT00906399|6085191|P4|Year 1|Withdrawal by Subject|0
1744972|NCT00906399|6085192|P3|Year 1|Withdrawal by Subject|36
1744973|NCT00906399|6085193|P2|Year 1|Withdrawal by Subject|32
1744974|NCT00906399|6085194|P1|Year 1|Withdrawal by Subject|30
1744975|NCT00906399|6085188|P7|Year 1|Lost to Follow-up|0
1744976|NCT00906399|6085189|P6|Year 1|Lost to Follow-up|0
1744977|NCT00906399|6085190|P5|Year 1|Lost to Follow-up|0
1744978|NCT00906399|6085191|P4|Year 1|Lost to Follow-up|0
1744979|NCT00906399|6085192|P3|Year 1|Lost to Follow-up|2
1744980|NCT00906399|6085193|P2|Year 1|Lost to Follow-up|4
1744981|NCT00906399|6085194|P1|Year 1|Lost to Follow-up|4
1744982|NCT00906399|6085188|P7|Year 1|Adverse Event|0
1744983|NCT00906399|6085189|P6|Year 1|Adverse Event|0
1744984|NCT00906399|6085190|P5|Year 1|Adverse Event|0
1744985|NCT00906399|6085191|P4|Year 1|Adverse Event|0
1744986|NCT00906399|6085192|P3|Year 1|Adverse Event|24
1744987|NCT00906399|6085193|P2|Year 1|Adverse Event|22
1744988|NCT00906399|6085194|P1|Year 1|Adverse Event|4
1744989|NCT00906399|6085188|P7|Year 1|Randomized But Not Treated|0
1744990|NCT00906399|6085189|P6|Year 1|Randomized But Not Treated|0
1744991|NCT00906399|6085190|P5|Year 1|Randomized But Not Treated|0
1744992|NCT00906399|6085191|P4|Year 1|Randomized But Not Treated|0
1744993|NCT00906399|6085192|P3|Year 1|Randomized But Not Treated|3
1744994|NCT00906399|6085193|P2|Year 1|Randomized But Not Treated|1
1744995|NCT00906399|6085194|P1|Year 1|Randomized But Not Treated|0
1744996|NCT00906373|6085217|P2|Overall Study|Still on treatment at cutoff date|2
1744997|NCT00906373|6085218|P1|Overall Study|Still on treatment at cutoff date|0
1744998|NCT00906373|6085217|P2|Overall Study|Other|1
1744999|NCT00906373|6085218|P1|Overall Study|Other|0
1745000|NCT00906373|6085217|P2|Overall Study|Withdrawal by Subject|5
1745001|NCT00906373|6085218|P1|Overall Study|Withdrawal by Subject|0
1745002|NCT00906347|6085257|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
1745003|NCT00906347|6085258|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
1745004|NCT00906347|6085257|P2|Received Study Drug|Refused study drug|0
1745005|NCT00906347|6085258|P1|Received Study Drug|Refused study drug|1
1745006|NCT00906347|6085257|P2|Received Study Drug|Nonreassuring fetal heart rate|1
1745007|NCT00906347|6085258|P1|Received Study Drug|Nonreassuring fetal heart rate|13
1745008|NCT00906347|6085257|P2|Received Study Drug|8 cm prior to initiation of study drug|30
1745009|NCT00906347|6085258|P1|Received Study Drug|8 cm prior to initiation of study drug|18
1745010|NCT00906282|6085278|P1|Preoperative Chemotherapy|Toxicity|1
1745011|NCT00906282|6085278|P1|Preoperative Chemotherapy|Progressive disease|6
1745012|NCT00906282|6085278|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
1745013|NCT00906282|6085278|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
1745014|NCT00906204|6085292|P2|Secondary Endpoints (Long-term Safety)|Death|1
1745015|NCT00906204|6085293|P1|Secondary Endpoints (Long-term Safety)|Death|0
1745016|NCT00906204|6085292|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
1745017|NCT00906204|6085293|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
1745018|NCT00906204|6085292|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
1745019|NCT00906204|6085293|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
1745020|NCT00906204|6085292|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
1745021|NCT00906204|6085293|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
1745022|NCT00906204|6085292|P2|Primary Endpoint (Early Safety)|Physician Decision|0
1745023|NCT00906204|6085293|P1|Primary Endpoint (Early Safety)|Physician Decision|1
1745024|NCT00906087|6085347|P1|Initial Washout|Physician Decision|1
1745025|NCT00906087|6085347|P1|Initial Washout|Withdrawal by Subject|1
1745026|NCT00906035|6085384|P3|Overall Study|Withdrawal by Subject|0
1745027|NCT00906035|6085385|P2|Overall Study|Withdrawal by Subject|3
1745028|NCT00906035|6085386|P1|Overall Study|Withdrawal by Subject|2
1745029|NCT00905840|6085400|P1|Overall Study|Adverse Event|1
1745030|NCT00905840|6085400|P1|Overall Study|Withdrawal by Subject|1
1745031|NCT00905840|6085400|P1|Overall Study|Death|3
1745032|NCT00905840|6085400|P1|Overall Study|Lost to Follow-up|11
1745033|NCT00905632|6085431|P7|Overall Study|Adverse Event|4
1745034|NCT00905632|6085432|P6|Overall Study|Adverse Event|1
1745035|NCT00905632|6085433|P5|Overall Study|Adverse Event|0
1745036|NCT00905632|6085434|P4|Overall Study|Adverse Event|0
1745037|NCT00905632|6085435|P3|Overall Study|Adverse Event|0
1745038|NCT00905632|6085436|P2|Overall Study|Adverse Event|0
1745039|NCT00905632|6085437|P1|Overall Study|Adverse Event|0
1745040|NCT00905606|6085575|P2|Washout|Withdrawal by Subject|0
1745041|NCT00905606|6085576|P1|Washout|Withdrawal by Subject|1
1745042|NCT00905606|6085575|P2|Period 1|Adverse Event|1
1745043|NCT00905606|6085576|P1|Period 1|Adverse Event|0
1745044|NCT00905567|6085601|P2|Washout|Withdrawal by Subject|1
1745045|NCT00905567|6085602|P1|Washout|Withdrawal by Subject|0
1745046|NCT00905489|6085634|P1|Optional Extension Phase (OEP)|Adverse Event|1
1745047|NCT00905489|6085634|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
1745048|NCT00905489|6085634|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
1745049|NCT00905437|6085683|P2|Overall Study|Other|6
1745050|NCT00905437|6085684|P1|Overall Study|Other|5
1745051|NCT00905437|6085683|P2|Overall Study|Withdrawal by Subject|1
1745052|NCT00905437|6085684|P1|Overall Study|Withdrawal by Subject|0
1745053|NCT00905437|6085683|P2|Overall Study|Lost to Follow-up|1
1745054|NCT00905437|6085684|P1|Overall Study|Lost to Follow-up|0
1745055|NCT00905437|6085683|P2|Overall Study|Adverse Event|2
1745056|NCT00905437|6085684|P1|Overall Study|Adverse Event|3
1745057|NCT00905424|6085704|P2|Overall Study|Non-adherence to visit schedule|1
1745058|NCT00905424|6085705|P1|Overall Study|Non-adherence to visit schedule|0
1745059|NCT00905424|6085704|P2|Overall Study|Positive urine drug screen|1
1745060|NCT00905424|6085705|P1|Overall Study|Positive urine drug screen|0
1745061|NCT00905424|6085704|P2|Overall Study|Sponsor decision|0
1745062|NCT00905424|6085705|P1|Overall Study|Sponsor decision|1
1745063|NCT00905424|6085704|P2|Overall Study|Non-compliance with study medication|0
1745064|NCT00905424|6085705|P1|Overall Study|Non-compliance with study medication|2
1745065|NCT00905424|6085704|P2|Overall Study|Adverse Event|2
1745066|NCT00905424|6085705|P1|Overall Study|Adverse Event|4
1745067|NCT00905424|6085704|P2|Overall Study|Withdrawal by Subject|2
1745068|NCT00905424|6085705|P1|Overall Study|Withdrawal by Subject|1
1745069|NCT00905424|6085704|P2|Overall Study|Lost to Follow-up|3
1745070|NCT00905424|6085705|P1|Overall Study|Lost to Follow-up|3
1745071|NCT00905359|6085747|P2|Overall Study|Withdrawal consent|6
1745072|NCT00905359|6085748|P1|Overall Study|Withdrawal consent|5
1745073|NCT00905359|6085747|P2|Overall Study|Death|0
1745074|NCT00905359|6085748|P1|Overall Study|Death|2
1745075|NCT00905359|6085747|P2|Overall Study|Lost to Follow-up|10
1745076|NCT00905359|6085748|P1|Overall Study|Lost to Follow-up|17
1745077|NCT00905346|6085784|P2|Period 1|Withdrawal by Subject|0
1745078|NCT00905346|6085785|P1|Period 1|Withdrawal by Subject|1
1745079|NCT00905307|6085799|P6|Overall Study|Lack of Efficacy|8
1745080|NCT00905307|6085800|P5|Overall Study|Lack of Efficacy|4
1745081|NCT00905307|6085801|P4|Overall Study|Lack of Efficacy|4
1745082|NCT00905307|6085802|P3|Overall Study|Lack of Efficacy|5
1745083|NCT00905307|6085803|P2|Overall Study|Lack of Efficacy|3
1745084|NCT00905307|6085804|P1|Overall Study|Lack of Efficacy|6
1745085|NCT00905307|6085799|P6|Overall Study|Protocol Violation|0
1745086|NCT00905307|6085800|P5|Overall Study|Protocol Violation|0
1745087|NCT00905307|6085801|P4|Overall Study|Protocol Violation|0
1745088|NCT00905307|6085802|P3|Overall Study|Protocol Violation|1
1745089|NCT00905307|6085803|P2|Overall Study|Protocol Violation|0
1745090|NCT00905307|6085804|P1|Overall Study|Protocol Violation|1
1745091|NCT00905307|6085799|P6|Overall Study|Withdrawal by Subject|13
1745092|NCT00905307|6085800|P5|Overall Study|Withdrawal by Subject|4
1745093|NCT00905307|6085801|P4|Overall Study|Withdrawal by Subject|11
1745094|NCT00905307|6085802|P3|Overall Study|Withdrawal by Subject|15
1745095|NCT00905307|6085803|P2|Overall Study|Withdrawal by Subject|13
1745096|NCT00905307|6085804|P1|Overall Study|Withdrawal by Subject|5
1745097|NCT00905307|6085799|P6|Overall Study|Adverse Event|5
1745098|NCT00905307|6085800|P5|Overall Study|Adverse Event|3
1745099|NCT00905307|6085801|P4|Overall Study|Adverse Event|11
1745100|NCT00905307|6085802|P3|Overall Study|Adverse Event|5
1745101|NCT00905307|6085803|P2|Overall Study|Adverse Event|4
1745102|NCT00905307|6085804|P1|Overall Study|Adverse Event|3
1745103|NCT00905307|6085799|P6|Overall Study|Lost to Follow-up|1
1745104|NCT00905307|6085800|P5|Overall Study|Lost to Follow-up|1
1745105|NCT00905307|6085801|P4|Overall Study|Lost to Follow-up|0
1745106|NCT00905307|6085802|P3|Overall Study|Lost to Follow-up|0
1745107|NCT00905307|6085803|P2|Overall Study|Lost to Follow-up|0
1745108|NCT00905307|6085804|P1|Overall Study|Lost to Follow-up|0
1745109|NCT00905307|6085799|P6|Overall Study|Switched to Open Label Rescue|15
1745110|NCT00905307|6085800|P5|Overall Study|Switched to Open Label Rescue|4
1745111|NCT00905307|6085801|P4|Overall Study|Switched to Open Label Rescue|11
1745112|NCT00905307|6085802|P3|Overall Study|Switched to Open Label Rescue|11
1745113|NCT00905307|6085803|P2|Overall Study|Switched to Open Label Rescue|17
1745114|NCT00905307|6085804|P1|Overall Study|Switched to Open Label Rescue|7
1745115|NCT00905255|6085899|P2|Overall Study|Familial and Personal Reasons|0
1745116|NCT00905255|6085900|P1|Overall Study|Familial and Personal Reasons|1
1745117|NCT00905255|6085899|P2|Overall Study|Withdrawal by Subject|4
1745118|NCT00905255|6085900|P1|Overall Study|Withdrawal by Subject|5
1745119|NCT00905255|6085899|P2|Overall Study|Adverse Event|5
1745120|NCT00905255|6085900|P1|Overall Study|Adverse Event|7
1745121|NCT00905164|6085918|P2|Period 1|Protocol Violation|1
1745122|NCT00905164|6085919|P1|Period 1|Protocol Violation|0
1745123|NCT00905034|6085966|P1|Overall Study|Withdrawal by Subject|1
1745124|NCT00905021|6085970|P1|Overall Study|Adverse Event|2
1745125|NCT00904982|6085988|P4|Overall Study|Withdrawal by Subject|0
1745126|NCT00904982|6085989|P3|Overall Study|Withdrawal by Subject|0
1745127|NCT00904982|6085990|P2|Overall Study|Withdrawal by Subject|0
1745128|NCT00904982|6085991|P1|Overall Study|Withdrawal by Subject|2
1745129|NCT00904969|6086001|P1|Overall Study|Case Aborted; Subject Exited|1
1745130|NCT00904969|6086001|P1|Overall Study|Additional Treatments|11
1745131|NCT00904969|6086001|P1|Overall Study|Withdrawal by Subject|3
1745132|NCT00904969|6086001|P1|Overall Study|Lost to Follow-up|4
1745133|NCT00904917|6086066|P4|Overall Study|Lost to Follow-up|2
1745134|NCT00904917|6086067|P3|Overall Study|Lost to Follow-up|2
1745135|NCT00904917|6086068|P2|Overall Study|Lost to Follow-up|2
1745136|NCT00904917|6086069|P1|Overall Study|Lost to Follow-up|2
1745137|NCT00904839|6086087|P3|Overall Study|Other than above|7
1745138|NCT00904839|6086088|P2|Overall Study|Other than above|9
1745139|NCT00904839|6086089|P1|Overall Study|Other than above|0
1745140|NCT00904839|6086087|P3|Overall Study|Not treated|1
1745141|NCT00904839|6086088|P2|Overall Study|Not treated|0
1745142|NCT00904839|6086089|P1|Overall Study|Not treated|1
1745143|NCT00904839|6086087|P3|Overall Study|Withdrawal by Subject|0
1745144|NCT00904839|6086088|P2|Overall Study|Withdrawal by Subject|2
1745145|NCT00904839|6086089|P1|Overall Study|Withdrawal by Subject|0
1745146|NCT00904839|6086087|P3|Overall Study|Lost to Follow-up|2
1745147|NCT00904839|6086088|P2|Overall Study|Lost to Follow-up|1
1745148|NCT00904839|6086089|P1|Overall Study|Lost to Follow-up|0
1745149|NCT00904839|6086087|P3|Overall Study|Protocol Violation|1
1745150|NCT00904839|6086088|P2|Overall Study|Protocol Violation|1
1745151|NCT00904839|6086089|P1|Overall Study|Protocol Violation|0
1745152|NCT00904839|6086087|P3|Overall Study|Adverse Event|4
1745153|NCT00904839|6086088|P2|Overall Study|Adverse Event|5
1745154|NCT00904839|6086089|P1|Overall Study|Adverse Event|0
1745155|NCT00904748|6086135|P6|Overall Study|Adverse Event|0
1745156|NCT00904748|6086136|P5|Overall Study|Adverse Event|1
1745157|NCT00904748|6086137|P4|Overall Study|Adverse Event|0
1745158|NCT00904748|6086138|P3|Overall Study|Adverse Event|0
1745159|NCT00904748|6086139|P2|Overall Study|Adverse Event|0
1745160|NCT00904748|6086140|P1|Overall Study|Adverse Event|0
1745161|NCT00904748|6086135|P6|Overall Study|Withdrawal by Subject|0
1745162|NCT00904748|6086136|P5|Overall Study|Withdrawal by Subject|0
1745163|NCT00904748|6086137|P4|Overall Study|Withdrawal by Subject|2
1745164|NCT00904748|6086138|P3|Overall Study|Withdrawal by Subject|1
1745165|NCT00904748|6086139|P2|Overall Study|Withdrawal by Subject|1
1745166|NCT00904748|6086140|P1|Overall Study|Withdrawal by Subject|1
1745167|NCT00904722|6086164|P1|Overall Study|Physician Decision|1
1745168|NCT00904670|6086169|P2|Open Label Phase|Lost to Follow-up|0
1745169|NCT00904670|6086170|P1|Open Label Phase|Lost to Follow-up|1
1745170|NCT00904670|6086169|P2|Open Label Phase|Lack of Efficacy|0
1745171|NCT00904670|6086170|P1|Open Label Phase|Lack of Efficacy|1
1745172|NCT00904670|6086169|P2|Open Label Phase|Adverse Event|0
1745173|NCT00904670|6086170|P1|Open Label Phase|Adverse Event|2
1745174|NCT00904670|6086169|P2|Open Label Phase|Withdrawal by Subject|0
1745175|NCT00904670|6086170|P1|Open Label Phase|Withdrawal by Subject|2
1745176|NCT00904371|6086240|P1|Overall Study|Continued with Tritace|1
1745177|NCT00904371|6086240|P1|Overall Study|Discontinued at target blood pressure|2
1745178|NCT00904371|6086240|P1|Overall Study|Lost to Follow-up|4
1745179|NCT00904371|6086240|P1|Overall Study|Adverse Event|2
1745180|NCT00904215|6086254|P1|Overall Study|Other|28
1745181|NCT00904215|6086254|P1|Overall Study|Withdrawal by Subject|9
1745182|NCT00904215|6086254|P1|Overall Study|Lost to Follow-up|63
1745183|NCT00904215|6086254|P1|Overall Study|Protocol Violation|10
1745184|NCT00904215|6086254|P1|Overall Study|Adverse Event|25
1745185|NCT00904150|6086268|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
1745186|NCT00904150|6086269|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
1745187|NCT00904150|6086268|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
1745188|NCT00904150|6086269|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
1745189|NCT00904033|6086291|P4|Overall Study|Unable to obtain final blood draw|2
1745190|NCT00904033|6086292|P3|Overall Study|Unable to obtain final blood draw|0
1745191|NCT00904033|6086293|P2|Overall Study|Unable to obtain final blood draw|0
1745192|NCT00904033|6086294|P1|Overall Study|Unable to obtain final blood draw|0
1745193|NCT00904033|6086291|P4|Overall Study|Physician Decision|0
1745194|NCT00904033|6086292|P3|Overall Study|Physician Decision|1
1745195|NCT00904033|6086293|P2|Overall Study|Physician Decision|0
1745196|NCT00904033|6086294|P1|Overall Study|Physician Decision|0
1745197|NCT00904033|6086291|P4|Overall Study|Withdrawal by Subject|0
1745198|NCT00904033|6086292|P3|Overall Study|Withdrawal by Subject|0
1745199|NCT00904033|6086293|P2|Overall Study|Withdrawal by Subject|1
1745200|NCT00904033|6086294|P1|Overall Study|Withdrawal by Subject|1
1745201|NCT00903968|6086359|P8|Overall Study|Lack of Efficacy|3
1745202|NCT00903968|6086360|P7|Overall Study|Lack of Efficacy|0
1745203|NCT00903968|6086361|P6|Overall Study|Lack of Efficacy|0
1745204|NCT00903968|6086362|P5|Overall Study|Lack of Efficacy|0
1745205|NCT00903968|6086363|P4|Overall Study|Lack of Efficacy|0
1745206|NCT00903968|6086364|P3|Overall Study|Lack of Efficacy|0
1745207|NCT00903968|6086365|P2|Overall Study|Lack of Efficacy|0
1745208|NCT00903968|6086366|P1|Overall Study|Lack of Efficacy|0
1745209|NCT00903968|6086359|P8|Overall Study|Progressive Disease|18
1745210|NCT00903968|6086360|P7|Overall Study|Progressive Disease|0
1745211|NCT00903968|6086361|P6|Overall Study|Progressive Disease|3
1745212|NCT00903968|6086362|P5|Overall Study|Progressive Disease|3
1745213|NCT00903968|6086363|P4|Overall Study|Progressive Disease|3
1745214|NCT00903968|6086364|P3|Overall Study|Progressive Disease|2
1745215|NCT00903968|6086365|P2|Overall Study|Progressive Disease|3
1745216|NCT00903968|6086366|P1|Overall Study|Progressive Disease|2
1745217|NCT00903968|6086359|P8|Overall Study|Physician Decision|0
1745218|NCT00903968|6086360|P7|Overall Study|Physician Decision|0
1745219|NCT00903968|6086361|P6|Overall Study|Physician Decision|1
1745220|NCT00903968|6086362|P5|Overall Study|Physician Decision|0
1745221|NCT00903968|6086363|P4|Overall Study|Physician Decision|0
1745222|NCT00903968|6086364|P3|Overall Study|Physician Decision|0
1745223|NCT00903968|6086365|P2|Overall Study|Physician Decision|0
1745224|NCT00903968|6086366|P1|Overall Study|Physician Decision|0
1745225|NCT00903968|6086359|P8|Overall Study|Non-Compliance|0
1745226|NCT00903968|6086360|P7|Overall Study|Non-Compliance|0
1745227|NCT00903968|6086361|P6|Overall Study|Non-Compliance|1
1745228|NCT00903968|6086362|P5|Overall Study|Non-Compliance|0
1745229|NCT00903968|6086363|P4|Overall Study|Non-Compliance|0
1745230|NCT00903968|6086364|P3|Overall Study|Non-Compliance|0
1745231|NCT00903968|6086365|P2|Overall Study|Non-Compliance|0
1745232|NCT00903968|6086366|P1|Overall Study|Non-Compliance|0
1745233|NCT00903968|6086359|P8|Overall Study|Withdrawal by Subject|4
1745234|NCT00903968|6086360|P7|Overall Study|Withdrawal by Subject|0
1745235|NCT00903968|6086361|P6|Overall Study|Withdrawal by Subject|1
1745236|NCT00903968|6086362|P5|Overall Study|Withdrawal by Subject|1
1745237|NCT00903968|6086363|P4|Overall Study|Withdrawal by Subject|0
1745238|NCT00903968|6086364|P3|Overall Study|Withdrawal by Subject|1
1745239|NCT00903968|6086365|P2|Overall Study|Withdrawal by Subject|0
1745240|NCT00903968|6086366|P1|Overall Study|Withdrawal by Subject|1
1745241|NCT00903968|6086359|P8|Overall Study|DLT|0
1745242|NCT00903968|6086360|P7|Overall Study|DLT|2
1745243|NCT00903968|6086361|P6|Overall Study|DLT|0
1745244|NCT00903968|6086362|P5|Overall Study|DLT|0
1745245|NCT00903968|6086363|P4|Overall Study|DLT|0
1745246|NCT00903968|6086364|P3|Overall Study|DLT|0
1745247|NCT00903968|6086365|P2|Overall Study|DLT|0
1745248|NCT00903968|6086366|P1|Overall Study|DLT|0
1745249|NCT00903968|6086359|P8|Overall Study|Adverse Event|8
1745250|NCT00903968|6086360|P7|Overall Study|Adverse Event|1
1745251|NCT00903968|6086361|P6|Overall Study|Adverse Event|0
1745252|NCT00903968|6086362|P5|Overall Study|Adverse Event|0
1745253|NCT00903968|6086363|P4|Overall Study|Adverse Event|0
1745254|NCT00903968|6086364|P3|Overall Study|Adverse Event|0
1745255|NCT00903968|6086365|P2|Overall Study|Adverse Event|0
1745256|NCT00903968|6086366|P1|Overall Study|Adverse Event|0
1745257|NCT00903929|6086396|P4|Overall Study|Adverse Event|1
1745258|NCT00903929|6086397|P3|Overall Study|Adverse Event|0
1745259|NCT00903929|6086398|P2|Overall Study|Adverse Event|0
1745260|NCT00903929|6086399|P1|Overall Study|Adverse Event|0
1745261|NCT00903929|6086396|P4|Overall Study|Withdrawal by Subject|2
1745262|NCT00903929|6086397|P3|Overall Study|Withdrawal by Subject|1
1745263|NCT00903929|6086398|P2|Overall Study|Withdrawal by Subject|0
1745264|NCT00903929|6086399|P1|Overall Study|Withdrawal by Subject|0
1745265|NCT00903877|6086405|P1|Overall Study|Participation put on hold|4
1745266|NCT00903877|6086405|P1|Overall Study|Lost to Follow-up|1
1745267|NCT00903877|6086405|P1|Overall Study|Adverse Event|2
1745268|NCT00903877|6086405|P1|Overall Study|Withdrawal by Subject|3
1745269|NCT00903877|6086405|P1|Overall Study|Did not meet study criteria|33
1745270|NCT00903786|6086409|P1|Overall Study|Reason other than lack of efficacy|4
1745271|NCT00903786|6086409|P1|Overall Study|Lack of Efficacy|5
1745272|NCT00903786|6086409|P1|Overall Study|Physician Decision|6
1745273|NCT00903760|6086419|P2|Overall Study|Off treatment for long period|1
1745274|NCT00903760|6086420|P1|Overall Study|Off treatment for long period|0
1745275|NCT00903760|6086419|P2|Overall Study|Withdrawal by Subject|2
1745276|NCT00903760|6086420|P1|Overall Study|Withdrawal by Subject|1
1745277|NCT00903760|6086419|P2|Overall Study|Lost to Follow-up|0
1745278|NCT00903760|6086420|P1|Overall Study|Lost to Follow-up|1
1745279|NCT00903760|6086419|P2|Overall Study|Death|1
1745280|NCT00903760|6086420|P1|Overall Study|Death|0
1745281|NCT00903760|6086419|P2|Overall Study|Physician Decision|2
1745282|NCT00903760|6086420|P1|Overall Study|Physician Decision|1
1745283|NCT00903760|6086419|P2|Overall Study|Stem Cell Transplant|4
1745284|NCT00903760|6086420|P1|Overall Study|Stem Cell Transplant|8
1745285|NCT00903760|6086419|P2|Overall Study|Disease Progression/Death|6
1745286|NCT00903760|6086420|P1|Overall Study|Disease Progression/Death|8
1745287|NCT00903695|6086430|P2|Overall Study|lung cancer|0
1745288|NCT00903695|6086431|P1|Overall Study|lung cancer|1
1745289|NCT00903695|6086430|P2|Overall Study|medical exclusion after 1st testing|0
1745290|NCT00903695|6086431|P1|Overall Study|medical exclusion after 1st testing|1
1745291|NCT00903682|6086453|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
1745292|NCT00903682|6086454|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
1745293|NCT00903682|6086453|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
1745294|NCT00903682|6086454|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
1745295|NCT00903682|6086453|P2|Overall Study|Subject Non-Compliant|0
1745296|NCT00903682|6086454|P1|Overall Study|Subject Non-Compliant|1
1745297|NCT00903682|6086453|P2|Overall Study|Subject Reached A Virologic Endpoint|1
1745298|NCT00903682|6086454|P1|Overall Study|Subject Reached A Virologic Endpoint|1
1745299|NCT00903682|6086453|P2|Overall Study|Pregnancy|1
1745300|NCT00903682|6086454|P1|Overall Study|Pregnancy|0
1745301|NCT00903682|6086453|P2|Overall Study|Withdrawal by Subject|0
1745302|NCT00903682|6086454|P1|Overall Study|Withdrawal by Subject|5
1745303|NCT00903682|6086453|P2|Overall Study|Lost to Follow-up|0
1745304|NCT00903682|6086454|P1|Overall Study|Lost to Follow-up|1
1745305|NCT00903682|6086453|P2|Overall Study|Adverse Event|13
1745306|NCT00903682|6086454|P1|Overall Study|Adverse Event|6
1745307|NCT00903630|6086475|P3|Phase 2|Adverse Event|1
1745308|NCT00903630|6086476|P2|Phase 2|Adverse Event|0
1745309|NCT00903630|6086477|P1|Phase 2|Adverse Event|0
1745310|NCT00903617|6086495|P4|Overall Study|Withdrawal by Subject|0
1745311|NCT00903617|6086496|P3|Overall Study|Withdrawal by Subject|3
1745312|NCT00903617|6086497|P2|Overall Study|Withdrawal by Subject|2
1745313|NCT00903617|6086498|P1|Overall Study|Withdrawal by Subject|1
1745314|NCT00903617|6086495|P4|Overall Study|Lost to Follow-up|1
1745315|NCT00903617|6086496|P3|Overall Study|Lost to Follow-up|1
1745316|NCT00903617|6086497|P2|Overall Study|Lost to Follow-up|0
1745317|NCT00903617|6086498|P1|Overall Study|Lost to Follow-up|2
1745318|NCT00903617|6086495|P4|Overall Study|Protocol-defined stopping criteria|0
1745319|NCT00903617|6086496|P3|Overall Study|Protocol-defined stopping criteria|0
1745320|NCT00903617|6086497|P2|Overall Study|Protocol-defined stopping criteria|2
1745321|NCT00903617|6086498|P1|Overall Study|Protocol-defined stopping criteria|0
1745322|NCT00903617|6086495|P4|Overall Study|Adverse Event|0
1745323|NCT00903617|6086496|P3|Overall Study|Adverse Event|1
1745324|NCT00903617|6086497|P2|Overall Study|Adverse Event|1
1745325|NCT00903617|6086498|P1|Overall Study|Adverse Event|0
1745326|NCT00903409|6086601|P2|Overall Study|Lost to Follow-up|6
1745327|NCT00903409|6086602|P1|Overall Study|Lost to Follow-up|2
1745328|NCT00903409|6086601|P2|Overall Study|Other|3
1745329|NCT00903409|6086602|P1|Overall Study|Other|2
1745330|NCT00903409|6086601|P2|Overall Study|Withdrawal by Subject|8
1745331|NCT00903409|6086602|P1|Overall Study|Withdrawal by Subject|8
1745332|NCT00903409|6086601|P2|Overall Study|Laboratory Abnormality|0
1745333|NCT00903409|6086602|P1|Overall Study|Laboratory Abnormality|2
1745334|NCT00903409|6086601|P2|Overall Study|Non-compliance with Protocol|1
1745335|NCT00903409|6086602|P1|Overall Study|Non-compliance with Protocol|1
1745336|NCT00903409|6086601|P2|Overall Study|Adverse Event|9
1745337|NCT00903409|6086602|P1|Overall Study|Adverse Event|11
1745338|NCT00903383|6086653|P4|Overall Study|Patient Decision|1
1745339|NCT00903383|6086654|P3|Overall Study|Patient Decision|0
1745340|NCT00903383|6086655|P2|Overall Study|Patient Decision|0
1745341|NCT00903383|6086656|P1|Overall Study|Patient Decision|0
1745342|NCT00903383|6086653|P4|Overall Study|Patient Decision - Lack of Efficacy|0
1745343|NCT00903383|6086654|P3|Overall Study|Patient Decision - Lack of Efficacy|0
1745344|NCT00903383|6086655|P2|Overall Study|Patient Decision - Lack of Efficacy|1
1745345|NCT00903383|6086656|P1|Overall Study|Patient Decision - Lack of Efficacy|0
1745346|NCT00903383|6086653|P4|Overall Study|Withdrawal by Subject|2
1745347|NCT00903383|6086654|P3|Overall Study|Withdrawal by Subject|0
1745348|NCT00903383|6086655|P2|Overall Study|Withdrawal by Subject|1
1745349|NCT00903383|6086656|P1|Overall Study|Withdrawal by Subject|4
1745350|NCT00903383|6086653|P4|Overall Study|Decision of Sponsor|0
1745351|NCT00903383|6086654|P3|Overall Study|Decision of Sponsor|0
1745352|NCT00903383|6086655|P2|Overall Study|Decision of Sponsor|0
1745353|NCT00903383|6086656|P1|Overall Study|Decision of Sponsor|1
1745354|NCT00903383|6086653|P4|Overall Study|Lost to Follow-up|1
1745355|NCT00903383|6086654|P3|Overall Study|Lost to Follow-up|0
1745356|NCT00903383|6086655|P2|Overall Study|Lost to Follow-up|0
1745357|NCT00903383|6086656|P1|Overall Study|Lost to Follow-up|0
1745358|NCT00903383|6086653|P4|Overall Study|Physician Decision|0
1745359|NCT00903383|6086654|P3|Overall Study|Physician Decision|0
1745360|NCT00903383|6086655|P2|Overall Study|Physician Decision|2
1745361|NCT00903383|6086656|P1|Overall Study|Physician Decision|1
1745362|NCT00903383|6086653|P4|Overall Study|Adverse Event|1
1745363|NCT00903383|6086654|P3|Overall Study|Adverse Event|3
1745364|NCT00903383|6086655|P2|Overall Study|Adverse Event|2
1745365|NCT00903383|6086656|P1|Overall Study|Adverse Event|1
1745366|NCT00903370|6086688|P2|Overall Study|Lost to Follow-up|8
1745367|NCT00903370|6086689|P1|Overall Study|Lost to Follow-up|6
1745368|NCT00903370|6086688|P2|Overall Study|Withdrawal by Subject|6
1745369|NCT00903370|6086689|P1|Overall Study|Withdrawal by Subject|9
1745370|NCT00903370|6086688|P2|Overall Study|Death|10
1745371|NCT00903370|6086689|P1|Overall Study|Death|13
1745372|NCT00903357|6086697|P2|Second Intervention|Lost to Follow-up|0
1745373|NCT00903357|6086698|P1|Second Intervention|Lost to Follow-up|1
1745374|NCT00903357|6086697|P2|Wash Out Period of 2 Weeks|Flu|1
1745375|NCT00903357|6086698|P1|Wash Out Period of 2 Weeks|Flu|0
1745376|NCT00903357|6086697|P2|First Intervention|Flu|1
1745377|NCT00903357|6086698|P1|First Intervention|Flu|0
1745378|NCT00903357|6086697|P2|First Intervention|Withdrawal by Subject|3
1745379|NCT00903357|6086698|P1|First Intervention|Withdrawal by Subject|5
1745380|NCT00903344|6086710|P2|Overall Study|Lost to Follow-up|0
1745381|NCT00903344|6086711|P1|Overall Study|Lost to Follow-up|3
1745382|NCT00903344|6086710|P2|Overall Study|Pregnancy|3
1745383|NCT00903344|6086711|P1|Overall Study|Pregnancy|2
1745384|NCT00903331|6086729|P2|Overall Study|Lung transplant|2
1745385|NCT00903331|6086730|P1|Overall Study|Lung transplant|0
1745386|NCT00903331|6086729|P2|Overall Study|Withdrawal of consent|8
1745387|NCT00903331|6086730|P1|Overall Study|Withdrawal of consent|1
1745388|NCT00903331|6086729|P2|Overall Study|Death|8
1745389|NCT00903331|6086730|P1|Overall Study|Death|4
1745390|NCT00903201|6086741|P3|Overall Study|Withdrawal by Subject|1
1745391|NCT00903201|6086742|P2|Overall Study|Withdrawal by Subject|0
1745392|NCT00903201|6086743|P1|Overall Study|Withdrawal by Subject|1
1745393|NCT00903201|6086741|P3|Overall Study|Physician Decision|1
1745394|NCT00903201|6086742|P2|Overall Study|Physician Decision|0
1745395|NCT00903201|6086743|P1|Overall Study|Physician Decision|1
1745396|NCT00903201|6086741|P3|Overall Study|Lost to Follow-up|0
1745397|NCT00903201|6086742|P2|Overall Study|Lost to Follow-up|1
1745398|NCT00903201|6086743|P1|Overall Study|Lost to Follow-up|0
1745399|NCT00903201|6086741|P3|Overall Study|Protocol Violation|0
1745400|NCT00903201|6086742|P2|Overall Study|Protocol Violation|1
1745401|NCT00903201|6086743|P1|Overall Study|Protocol Violation|2
1745402|NCT00903201|6086741|P3|Overall Study|Adverse Event|0
1745403|NCT00903201|6086742|P2|Overall Study|Adverse Event|4
1745404|NCT00903201|6086743|P1|Overall Study|Adverse Event|1
1745405|NCT00903175|6086801|P2|Period 2 - Second Line|Death|2
1745406|NCT00903175|6086802|P1|Period 2 - Second Line|Death|5
1745407|NCT00903175|6086801|P2|Period 2 - Second Line|Administrative problems|9
1745408|NCT00903175|6086802|P1|Period 2 - Second Line|Administrative problems|19
1745409|NCT00903175|6086801|P2|Period 2 - Second Line|Lost to Follow-up|0
1745410|NCT00903175|6086802|P1|Period 2 - Second Line|Lost to Follow-up|1
1745411|NCT00903175|6086801|P2|Period 2 - Second Line|Withdrawal by Subject|5
1745412|NCT00903175|6086802|P1|Period 2 - Second Line|Withdrawal by Subject|7
1745413|NCT00903175|6086801|P2|Period 2 - Second Line|Adverse Event|20
1745414|NCT00903175|6086802|P1|Period 2 - Second Line|Adverse Event|16
1745415|NCT00903175|6086801|P2|Period 2 - Second Line|Missing|0
1745416|NCT00903175|6086802|P1|Period 2 - Second Line|Missing|1
1745417|NCT00903175|6086801|P2|Period 1 - First Line|Death|10
1745418|NCT00903175|6086802|P1|Period 1 - First Line|Death|17
1745419|NCT00903175|6086801|P2|Period 1 - First Line|Administrative problems|13
1745420|NCT00903175|6086802|P1|Period 1 - First Line|Administrative problems|12
1745421|NCT00903175|6086801|P2|Period 1 - First Line|Withdrawal by Subject|12
1745422|NCT00903175|6086802|P1|Period 1 - First Line|Withdrawal by Subject|8
1745423|NCT00903175|6086801|P2|Period 1 - First Line|Protocol Violation|3
1745424|NCT00903175|6086802|P1|Period 1 - First Line|Protocol Violation|3
1745425|NCT00903175|6086801|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
1745426|NCT00903175|6086802|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
1745427|NCT00903175|6086801|P2|Period 1 - First Line|Abnormal lab value(s)|1
1745428|NCT00903175|6086802|P1|Period 1 - First Line|Abnormal lab value(s)|0
1745429|NCT00903175|6086801|P2|Period 1 - First Line|Adverse Event|50
1745430|NCT00903175|6086802|P1|Period 1 - First Line|Adverse Event|36
1745431|NCT00903032|6086840|P2|Overall Study|Lost to Follow-up|2
1745432|NCT00903032|6086841|P1|Overall Study|Lost to Follow-up|2
1745433|NCT00903032|6086840|P2|Overall Study|Withdrawal by Subject|3
1745434|NCT00903032|6086841|P1|Overall Study|Withdrawal by Subject|5
1745435|NCT00903006|6086851|P4|Overall Study|Progressive Disease|0
1745436|NCT00903006|6086852|P3|Overall Study|Progressive Disease|1
1745437|NCT00903006|6086853|P2|Overall Study|Progressive Disease|3
1745438|NCT00903006|6086854|P1|Overall Study|Progressive Disease|0
1745439|NCT00903006|6086851|P4|Overall Study|Withdrawal by Subject|0
1745440|NCT00903006|6086852|P3|Overall Study|Withdrawal by Subject|0
1745441|NCT00903006|6086853|P2|Overall Study|Withdrawal by Subject|0
1745442|NCT00903006|6086854|P1|Overall Study|Withdrawal by Subject|2
1745443|NCT00902850|6086866|P2|Overall Study|Physician Decision|2
1745444|NCT00902850|6086867|P1|Overall Study|Physician Decision|2
1745445|NCT00902746|6086873|P1|Overall Study|Physician Decision|2
1745446|NCT00902746|6086873|P1|Overall Study|Lost to Follow-up|3
1745447|NCT00902746|6086873|P1|Overall Study|Adverse Event|8
1745448|NCT00902746|6086873|P1|Overall Study|Withdrawal by Subject|16
1745449|NCT00902746|6086873|P1|Overall Study|Protocol Violation|7
1745450|NCT00902668|6086878|P1|Overall Study|Protocol stopped due to slow accrual.|3
1745451|NCT00902577|6086882|P1|Overall Study|FMISO production failure|2
1745452|NCT00902577|6086882|P1|Overall Study|Withdrawal by Subject|6
1745453|NCT00902564|6086911|P1|Overall Study|Withdrawal by Subject|2
1745454|NCT00902538|6086926|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1745455|NCT00902538|6086927|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1745456|NCT00902538|6086928|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
1745457|NCT00902538|6086929|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1745458|NCT00902538|6086930|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1745459|NCT00902538|6086931|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
1745460|NCT00902538|6086926|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1745461|NCT00902538|6086927|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
1745462|NCT00902538|6086928|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
1745463|NCT00902538|6086929|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1745464|NCT00902538|6086930|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1745465|NCT00902538|6086931|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
1745466|NCT00902538|6086926|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
1745467|NCT00902538|6086927|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
1745468|NCT00902538|6086928|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
1745469|NCT00902538|6086929|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1745470|NCT00902538|6086930|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1745471|NCT00902538|6086931|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
1745472|NCT00902538|6086926|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
1745473|NCT00902538|6086927|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
1745474|NCT00902538|6086928|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
1745475|NCT00902538|6086929|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
1745476|NCT00902538|6086930|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
1745477|NCT00902538|6086931|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
1745478|NCT00902538|6086926|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1745479|NCT00902538|6086927|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1745480|NCT00902538|6086928|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1745481|NCT00902538|6086929|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1745482|NCT00902538|6086930|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
1745483|NCT00902538|6086931|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
1745484|NCT00902538|6086926|P6|3-Single-blind, Single Treatment|Protocol Violation|0
1745485|NCT00902538|6086927|P5|3-Single-blind, Single Treatment|Protocol Violation|0
1745486|NCT00902538|6086928|P4|3-Single-blind, Single Treatment|Protocol Violation|0
1745487|NCT00902538|6086929|P3|3-Single-blind, Single Treatment|Protocol Violation|0
1745488|NCT00902538|6086930|P2|3-Single-blind, Single Treatment|Protocol Violation|5
1745489|NCT00902538|6086931|P1|3-Single-blind, Single Treatment|Protocol Violation|0
1745490|NCT00902538|6086926|P6|3-Single-blind, Single Treatment|Adverse Event|0
1745491|NCT00902538|6086927|P5|3-Single-blind, Single Treatment|Adverse Event|0
1745492|NCT00902538|6086928|P4|3-Single-blind, Single Treatment|Adverse Event|0
1745493|NCT00902538|6086929|P3|3-Single-blind, Single Treatment|Adverse Event|0
1745494|NCT00902538|6086930|P2|3-Single-blind, Single Treatment|Adverse Event|5
1745495|NCT00902538|6086931|P1|3-Single-blind, Single Treatment|Adverse Event|0
1745496|NCT00902538|6086926|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1745497|NCT00902538|6086927|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1745498|NCT00902538|6086928|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
1745499|NCT00902538|6086929|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
1745500|NCT00902538|6086930|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
1745501|NCT00902538|6086931|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
1745502|NCT00902538|6086926|P6|2-Randomized Double-blind 3 Treatments|Other|0
1745503|NCT00902538|6086927|P5|2-Randomized Double-blind 3 Treatments|Other|0
1745504|NCT00902538|6086928|P4|2-Randomized Double-blind 3 Treatments|Other|0
1745505|NCT00902538|6086929|P3|2-Randomized Double-blind 3 Treatments|Other|0
1745506|NCT00902538|6086930|P2|2-Randomized Double-blind 3 Treatments|Other|1
1745507|NCT00902538|6086931|P1|2-Randomized Double-blind 3 Treatments|Other|2
1745508|NCT00902538|6086926|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1745509|NCT00902538|6086927|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1745510|NCT00902538|6086928|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1745511|NCT00902538|6086929|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
1745512|NCT00902538|6086930|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
1745513|NCT00902538|6086931|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
1745514|NCT00902538|6086926|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1745515|NCT00902538|6086927|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1745516|NCT00902538|6086928|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
1745517|NCT00902538|6086929|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
1745518|NCT00902538|6086930|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
1745519|NCT00902538|6086931|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
1745520|NCT00902538|6086926|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1745521|NCT00902538|6086927|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1745522|NCT00902538|6086928|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
1745523|NCT00902538|6086929|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
1745524|NCT00902538|6086930|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
1745525|NCT00902538|6086931|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
1745526|NCT00902538|6086926|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1745527|NCT00902538|6086927|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1745528|NCT00902538|6086928|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1745529|NCT00902538|6086929|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1745530|NCT00902538|6086930|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
1745531|NCT00902538|6086931|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
1745532|NCT00902538|6086926|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1745533|NCT00902538|6086927|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1745534|NCT00902538|6086928|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1745535|NCT00902538|6086929|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1745536|NCT00902538|6086930|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
1745537|NCT00902538|6086931|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
1745538|NCT00902538|6086926|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1745539|NCT00902538|6086927|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1745540|NCT00902538|6086928|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1745541|NCT00902538|6086929|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1745542|NCT00902538|6086930|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
1745543|NCT00902538|6086931|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
1745544|NCT00902538|6086926|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1745545|NCT00902538|6086927|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1745546|NCT00902538|6086928|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1745547|NCT00902538|6086929|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1745548|NCT00902538|6086930|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
1745549|NCT00902538|6086931|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
1745550|NCT00902538|6086926|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1745551|NCT00902538|6086927|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1745552|NCT00902538|6086928|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1745553|NCT00902538|6086929|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1745554|NCT00902538|6086930|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
1745555|NCT00902538|6086931|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
1745556|NCT00902486|6086965|P6|Follow-up (After Week 24)|Lost to Follow-up|0
1745557|NCT00902486|6086966|P5|Follow-up (After Week 24)|Lost to Follow-up|0
1745558|NCT00902486|6086967|P4|Follow-up (After Week 24)|Lost to Follow-up|1
1745559|NCT00902486|6086968|P3|Follow-up (After Week 24)|Lost to Follow-up|0
1745560|NCT00902486|6086969|P2|Follow-up (After Week 24)|Lost to Follow-up|0
1745561|NCT00902486|6086970|P1|Follow-up (After Week 24)|Lost to Follow-up|0
1745562|NCT00902486|6086965|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1745563|NCT00902486|6086966|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1745564|NCT00902486|6086967|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1745565|NCT00902486|6086968|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
1745566|NCT00902486|6086969|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1745567|NCT00902486|6086970|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
1745568|NCT00902486|6086965|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1745569|NCT00902486|6086966|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1745570|NCT00902486|6086967|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
1745571|NCT00902486|6086968|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1745572|NCT00902486|6086969|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1745573|NCT00902486|6086970|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
1745574|NCT00902486|6086965|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
1745575|NCT00902486|6086966|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1745576|NCT00902486|6086967|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1745577|NCT00902486|6086968|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1745578|NCT00902486|6086969|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1745579|NCT00902486|6086970|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
1745580|NCT00902486|6086965|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1745581|NCT00902486|6086966|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1745582|NCT00902486|6086967|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
1745583|NCT00902486|6086968|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
1745584|NCT00902486|6086969|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1745585|NCT00902486|6086970|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
1745586|NCT00902486|6086965|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
1745587|NCT00902486|6086966|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
1745588|NCT00902486|6086967|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1745589|NCT00902486|6086968|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1745590|NCT00902486|6086969|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1745591|NCT00902486|6086970|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
1745592|NCT00902486|6086965|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1745593|NCT00902486|6086966|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1745594|NCT00902486|6086967|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
1745595|NCT00902486|6086968|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1745596|NCT00902486|6086969|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1745597|NCT00902486|6086970|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
1745598|NCT00902486|6086965|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1745599|NCT00902486|6086966|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1745600|NCT00902486|6086967|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
1745601|NCT00902486|6086968|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1745602|NCT00902486|6086969|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1745603|NCT00902486|6086970|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
1745604|NCT00902486|6086965|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
1745605|NCT00902486|6086966|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
1745606|NCT00902486|6086967|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1745607|NCT00902486|6086968|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1745608|NCT00902486|6086969|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1745609|NCT00902486|6086970|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
1745610|NCT00902486|6086965|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
1745611|NCT00902486|6086966|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1745612|NCT00902486|6086967|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1745613|NCT00902486|6086968|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1745614|NCT00902486|6086969|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
1745615|NCT00902486|6086970|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
1745616|NCT00902486|6086965|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
1745617|NCT00902486|6086966|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
1745618|NCT00902486|6086967|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
1745619|NCT00902486|6086968|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
1745620|NCT00902486|6086969|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
1745621|NCT00902486|6086970|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
1745622|NCT00902330|6087108|P2|Overall Study|No post baseline data|0
1745623|NCT00902330|6087109|P1|Overall Study|No post baseline data|1
1745624|NCT00902330|6087108|P2|Overall Study|Adverse Event|0
1745625|NCT00902330|6087109|P1|Overall Study|Adverse Event|1
1745626|NCT00902330|6087108|P2|Overall Study|Too overwhelmed by treatment|5
1745627|NCT00902330|6087109|P1|Overall Study|Too overwhelmed by treatment|2
1745628|NCT00902304|6087146|P3|Overall Study|includes pregnancy|2
1745629|NCT00902304|6087147|P2|Overall Study|includes pregnancy|9
1745630|NCT00902304|6087148|P1|Overall Study|includes pregnancy|3
1745631|NCT00902304|6087146|P3|Overall Study|Withdrawal by Subject|43
1745632|NCT00902304|6087147|P2|Overall Study|Withdrawal by Subject|22
1745633|NCT00902304|6087148|P1|Overall Study|Withdrawal by Subject|32
1745634|NCT00902304|6087146|P3|Overall Study|Protocol Violation|20
1745635|NCT00902304|6087147|P2|Overall Study|Protocol Violation|18
1745636|NCT00902304|6087148|P1|Overall Study|Protocol Violation|9
1745637|NCT00902304|6087146|P3|Overall Study|Lost to Follow-up|7
1745638|NCT00902304|6087147|P2|Overall Study|Lost to Follow-up|7
1745639|NCT00902304|6087148|P1|Overall Study|Lost to Follow-up|7
1745640|NCT00902304|6087146|P3|Overall Study|Investigator discretion|13
1745641|NCT00902304|6087147|P2|Overall Study|Investigator discretion|5
1745642|NCT00902304|6087148|P1|Overall Study|Investigator discretion|3
1745643|NCT00902304|6087146|P3|Overall Study|Adverse Event|25
1745644|NCT00902304|6087147|P2|Overall Study|Adverse Event|10
1745645|NCT00902304|6087148|P1|Overall Study|Adverse Event|4
1745646|NCT00902278|6087198|P5|Overall Study|Lost to Follow-up|1
1745647|NCT00902278|6087199|P4|Overall Study|Lost to Follow-up|0
1745648|NCT00902278|6087200|P3|Overall Study|Lost to Follow-up|3
1745649|NCT00902278|6087201|P2|Overall Study|Lost to Follow-up|2
1745650|NCT00902278|6087202|P1|Overall Study|Lost to Follow-up|3
1745651|NCT00902278|6087198|P5|Overall Study|Physician Decision|1
1745652|NCT00902278|6087199|P4|Overall Study|Physician Decision|0
1745653|NCT00902278|6087200|P3|Overall Study|Physician Decision|2
1745654|NCT00902278|6087201|P2|Overall Study|Physician Decision|0
1745655|NCT00902278|6087202|P1|Overall Study|Physician Decision|1
1745656|NCT00902265|6087219|P1|Overall Study|Protocol Violation|1
1745657|NCT00902265|6087219|P1|Overall Study|Lack of Efficacy|2
1745658|NCT00902265|6087219|P1|Overall Study|Adverse Event|2
1745659|NCT00902265|6087219|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
1745660|NCT00902174|6087243|P2|Overall Study|Administration problem|1
1745661|NCT00902174|6087244|P1|Overall Study|Administration problem|0
1745662|NCT00902174|6087243|P2|Overall Study|Protocol Violation|1
1745663|NCT00902174|6087244|P1|Overall Study|Protocol Violation|1
1745664|NCT00902174|6087243|P2|Overall Study|Abnormal labs|1
1745665|NCT00902174|6087244|P1|Overall Study|Abnormal labs|1
1745666|NCT00902174|6087243|P2|Overall Study|Withdrawal by Subject|1
1745667|NCT00902174|6087244|P1|Overall Study|Withdrawal by Subject|2
1745668|NCT00902174|6087243|P2|Overall Study|Death|2
1745669|NCT00902174|6087244|P1|Overall Study|Death|2
1745670|NCT00902174|6087243|P2|Overall Study|Lack of Efficacy|5
1745671|NCT00902174|6087244|P1|Overall Study|Lack of Efficacy|1
1745672|NCT00902174|6087243|P2|Overall Study|Adverse Event|7
1745673|NCT00902174|6087244|P1|Overall Study|Adverse Event|27
1745674|NCT00901901|6087321|P2|Follow-up Period|Missing|80
1745675|NCT00901901|6087322|P1|Follow-up Period|Missing|94
1745676|NCT00901901|6087321|P2|Follow-up Period|Lost to Follow-up|8
1745677|NCT00901901|6087322|P1|Follow-up Period|Lost to Follow-up|12
1745678|NCT00901901|6087321|P2|Follow-up Period|Withdrawal by Subject|9
1745679|NCT00901901|6087322|P1|Follow-up Period|Withdrawal by Subject|6
1745680|NCT00901901|6087321|P2|Follow-up Period|Protocol driven decision point|36
1745681|NCT00901901|6087322|P1|Follow-up Period|Protocol driven decision point|47
1745682|NCT00901901|6087321|P2|Follow-up Period|Death|208
1745683|NCT00901901|6087322|P1|Follow-up Period|Death|181
1745684|NCT00901901|6087321|P2|Treatment Period|Transfer to treatment continuation study|2
1745685|NCT00901901|6087322|P1|Treatment Period|Transfer to treatment continuation study|5
1745686|NCT00901901|6087321|P2|Treatment Period|Switch to commercial drug|1
1745687|NCT00901901|6087322|P1|Treatment Period|Switch to commercial drug|1
1745688|NCT00901901|6087321|P2|Treatment Period|Protocol Violation|9
1745689|NCT00901901|6087322|P1|Treatment Period|Protocol Violation|5
1745690|NCT00901901|6087321|P2|Treatment Period|Study terminated by sponsor|0
1745691|NCT00901901|6087322|P1|Treatment Period|Study terminated by sponsor|2
1745692|NCT00901901|6087321|P2|Treatment Period|Protocol driven decision point|2
1745693|NCT00901901|6087322|P1|Treatment Period|Protocol driven decision point|0
1745694|NCT00901901|6087321|P2|Treatment Period|Never treated|3
1745695|NCT00901901|6087322|P1|Treatment Period|Never treated|0
1745696|NCT00901901|6087321|P2|Treatment Period|Missing|0
1745697|NCT00901901|6087322|P1|Treatment Period|Missing|1
1745698|NCT00901901|6087321|P2|Treatment Period|Noncompliance with study medication|1
1745699|NCT00901901|6087322|P1|Treatment Period|Noncompliance with study medication|4
1745700|NCT00901901|6087321|P2|Treatment Period|Lost to Follow-up|5
1745701|NCT00901901|6087322|P1|Treatment Period|Lost to Follow-up|3
1745702|NCT00901901|6087321|P2|Treatment Period|Physician Decision|2
1745703|NCT00901901|6087322|P1|Treatment Period|Physician Decision|2
1745704|NCT00901901|6087321|P2|Treatment Period|Withdrawal by Subject|24
1745705|NCT00901901|6087322|P1|Treatment Period|Withdrawal by Subject|26
1745706|NCT00901901|6087321|P2|Treatment Period|Adverse Event|128
1745707|NCT00901901|6087322|P1|Treatment Period|Adverse Event|120
1745708|NCT00901628|6087344|P2|Overall Study|peroneal nerve palsy|1
1745709|NCT00901628|6087345|P1|Overall Study|peroneal nerve palsy|0
1745710|NCT00901628|6087344|P2|Overall Study|disconnection of drain|1
1745711|NCT00901628|6087345|P1|Overall Study|disconnection of drain|0
1745712|NCT00901628|6087344|P2|Overall Study|disconnection of catheter|8
1745713|NCT00901628|6087345|P1|Overall Study|disconnection of catheter|4
1745714|NCT00901576|6087367|P6|Second Intervention|Physician Decision|0
1745715|NCT00901576|6087368|P5|Second Intervention|Physician Decision|0
1745716|NCT00901576|6087369|P4|Second Intervention|Physician Decision|0
1745717|NCT00901576|6087370|P3|Second Intervention|Physician Decision|0
1745718|NCT00901576|6087371|P2|Second Intervention|Physician Decision|0
1745719|NCT00901576|6087372|P1|Second Intervention|Physician Decision|1
1745720|NCT00901576|6087367|P6|Second Intervention|Withdrawal by Subject|1
1745721|NCT00901576|6087368|P5|Second Intervention|Withdrawal by Subject|0
1745722|NCT00901576|6087369|P4|Second Intervention|Withdrawal by Subject|1
1745723|NCT00901576|6087370|P3|Second Intervention|Withdrawal by Subject|0
1745724|NCT00901576|6087371|P2|Second Intervention|Withdrawal by Subject|0
1745725|NCT00901576|6087372|P1|Second Intervention|Withdrawal by Subject|0
1745726|NCT00901459|6087393|P1|Overall Study|Withdrawal by Subject|6
1745727|NCT00901342|6087404|P1|Overall Study|Withdrawal by Subject|9
1745728|NCT00901342|6087404|P1|Overall Study|Disease progression|1
1745729|NCT00901342|6087404|P1|Overall Study|Death|4
1745730|NCT00901342|6087404|P1|Overall Study|Adverse Event|1
1745731|NCT00901186|6087437|P2|Overall Study|Protocol deviations|4
1745732|NCT00901186|6087438|P1|Overall Study|Protocol deviations|5
1745733|NCT00901186|6087437|P2|Overall Study|Administration problems|1
1745734|NCT00901186|6087438|P1|Overall Study|Administration problems|0
1745735|NCT00901186|6087437|P2|Overall Study|Adverse Event|4
1745736|NCT00901186|6087438|P1|Overall Study|Adverse Event|2
1745737|NCT00901186|6087437|P2|Overall Study|Lost to Follow-up|0
1745738|NCT00901186|6087438|P1|Overall Study|Lost to Follow-up|2
1745739|NCT00901186|6087437|P2|Overall Study|Abnormal laboratory values|1
1745740|NCT00901186|6087438|P1|Overall Study|Abnormal laboratory values|0
1745741|NCT00901186|6087437|P2|Overall Study|Lack of Efficacy|1
1745742|NCT00901186|6087438|P1|Overall Study|Lack of Efficacy|0
1745743|NCT00900796|6087478|P1|Phase 2|Lost to Follow-up|5
1745744|NCT00900796|6087478|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
1745745|NCT00900796|6087478|P1|Phase 1|Missing information at Week 16|7
1745746|NCT00900796|6087478|P1|Phase 1|Lacked sufficient information|4
1745747|NCT00900757|6087488|P1|Overall Study|screen failure|19
1745748|NCT00900731|6087498|P2|Overall Study|Death|2
1745749|NCT00900731|6087499|P1|Overall Study|Death|0
1745750|NCT00900731|6087498|P2|Overall Study|Lack of Efficacy|3
1745751|NCT00900731|6087499|P1|Overall Study|Lack of Efficacy|1
1745752|NCT00900731|6087498|P2|Overall Study|Lost to Follow-up|3
1745753|NCT00900731|6087499|P1|Overall Study|Lost to Follow-up|2
1745754|NCT00900731|6087498|P2|Overall Study|Abnormal Laboratory Value(s)|4
1745755|NCT00900731|6087499|P1|Overall Study|Abnormal Laboratory Value(s)|2
1745756|NCT00900731|6087498|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1745757|NCT00900731|6087499|P1|Overall Study|Abnormal Test Procedure Result(s)|3
1745758|NCT00900731|6087498|P2|Overall Study|Administrative Problems|4
1745759|NCT00900731|6087499|P1|Overall Study|Administrative Problems|5
1745760|NCT00900731|6087498|P2|Overall Study|Protocol Deviation|11
1745761|NCT00900731|6087499|P1|Overall Study|Protocol Deviation|8
1745762|NCT00900731|6087498|P2|Overall Study|Withdrawal by Subject|7
1745763|NCT00900731|6087499|P1|Overall Study|Withdrawal by Subject|8
1745764|NCT00900731|6087498|P2|Overall Study|Adverse Event|27
1745765|NCT00900731|6087499|P1|Overall Study|Adverse Event|31
1745766|NCT00900627|6087536|P6|Overall Study|Death|24
1745767|NCT00900627|6087537|P5|Overall Study|Death|28
1745768|NCT00900627|6087538|P4|Overall Study|Death|0
1745769|NCT00900627|6087539|P3|Overall Study|Death|0
1745770|NCT00900627|6087540|P2|Overall Study|Death|0
1745771|NCT00900627|6087541|P1|Overall Study|Death|0
1745772|NCT00900627|6087536|P6|Overall Study|Adverse Event|0
1745773|NCT00900627|6087537|P5|Overall Study|Adverse Event|0
1745774|NCT00900627|6087538|P4|Overall Study|Adverse Event|3
1745775|NCT00900627|6087539|P3|Overall Study|Adverse Event|0
1745776|NCT00900627|6087540|P2|Overall Study|Adverse Event|2
1745777|NCT00900627|6087541|P1|Overall Study|Adverse Event|1
1745778|NCT00900627|6087536|P6|Overall Study|Withdrawal by Subject|2
1745779|NCT00900627|6087537|P5|Overall Study|Withdrawal by Subject|1
1745780|NCT00900627|6087538|P4|Overall Study|Withdrawal by Subject|0
1745781|NCT00900627|6087539|P3|Overall Study|Withdrawal by Subject|1
1745782|NCT00900627|6087540|P2|Overall Study|Withdrawal by Subject|0
1745783|NCT00900627|6087541|P1|Overall Study|Withdrawal by Subject|1
1745784|NCT00900627|6087536|P6|Overall Study|Condition under investigation worsened|0
1745785|NCT00900627|6087537|P5|Overall Study|Condition under investigation worsened|0
1745786|NCT00900627|6087538|P4|Overall Study|Condition under investigation worsened|3
1745787|NCT00900627|6087539|P3|Overall Study|Condition under investigation worsened|5
1745788|NCT00900627|6087540|P2|Overall Study|Condition under investigation worsened|0
1745789|NCT00900627|6087541|P1|Overall Study|Condition under investigation worsened|4
1745790|NCT00900601|6087559|P1|Overall Study|Physician Decision|1
1745791|NCT00900159|6087578|P2|Second Intervention|disempanelled for inappropriate behavior|0
1745792|NCT00900159|6087579|P1|Second Intervention|disempanelled for inappropriate behavior|1
1745793|NCT00900146|6087598|P5|Intermediate: Period III|Administrative problems|163
1745794|NCT00900146|6087599|P4|Intermediate: Period III|Administrative problems|90
1745795|NCT00900146|6087600|P3|Intermediate: Period III|Administrative problems|84
1745796|NCT00900146|6087601|P2|Intermediate: Period III|Administrative problems|92
1745797|NCT00900146|6087602|P1|Intermediate: Period III|Administrative problems|85
1745798|NCT00900146|6087598|P5|Intermediate: Period III|Lost to Follow-up|1
1745799|NCT00900146|6087599|P4|Intermediate: Period III|Lost to Follow-up|0
1745800|NCT00900146|6087600|P3|Intermediate: Period III|Lost to Follow-up|0
1745801|NCT00900146|6087601|P2|Intermediate: Period III|Lost to Follow-up|0
1745802|NCT00900146|6087602|P1|Intermediate: Period III|Lost to Follow-up|2
1745803|NCT00900146|6087598|P5|Intermediate: Period III|Withdrawal by Subject|3
1745804|NCT00900146|6087599|P4|Intermediate: Period III|Withdrawal by Subject|0
1745805|NCT00900146|6087600|P3|Intermediate: Period III|Withdrawal by Subject|0
1745806|NCT00900146|6087601|P2|Intermediate: Period III|Withdrawal by Subject|1
1745807|NCT00900146|6087602|P1|Intermediate: Period III|Withdrawal by Subject|0
1745808|NCT00900146|6087598|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
1745809|NCT00900146|6087599|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
1745810|NCT00900146|6087600|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
1745811|NCT00900146|6087601|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
1745812|NCT00900146|6087602|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
1745813|NCT00900146|6087598|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
1745814|NCT00900146|6087599|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
1745815|NCT00900146|6087600|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
1745816|NCT00900146|6087601|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
1745817|NCT00900146|6087602|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
1745818|NCT00900146|6087598|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
1745819|NCT00900146|6087599|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
1745820|NCT00900146|6087600|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
1745821|NCT00900146|6087601|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
1745822|NCT00900146|6087602|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
1745823|NCT00900029|6087719|P5|Overall Study|Death|0
1745824|NCT00900029|6087720|P4|Overall Study|Death|1
1745825|NCT00900029|6087721|P3|Overall Study|Death|0
1745826|NCT00900029|6087722|P2|Overall Study|Death|0
1745827|NCT00900029|6087723|P1|Overall Study|Death|1
1745828|NCT00900029|6087719|P5|Overall Study|Adverse Event|1
1745829|NCT00900029|6087720|P4|Overall Study|Adverse Event|1
1745830|NCT00900029|6087721|P3|Overall Study|Adverse Event|1
1745831|NCT00900029|6087722|P2|Overall Study|Adverse Event|0
1745832|NCT00900029|6087723|P1|Overall Study|Adverse Event|0
1745833|NCT00900029|6087719|P5|Overall Study|Withdrawal by Subject|1
1745834|NCT00900029|6087720|P4|Overall Study|Withdrawal by Subject|1
1745835|NCT00900029|6087721|P3|Overall Study|Withdrawal by Subject|1
1745836|NCT00900029|6087722|P2|Overall Study|Withdrawal by Subject|2
1745837|NCT00900029|6087723|P1|Overall Study|Withdrawal by Subject|2
1745838|NCT00900029|6087719|P5|Overall Study|Lost to Follow-up|4
1745839|NCT00900029|6087720|P4|Overall Study|Lost to Follow-up|4
1745840|NCT00900029|6087721|P3|Overall Study|Lost to Follow-up|1
1745841|NCT00900029|6087722|P2|Overall Study|Lost to Follow-up|2
1745842|NCT00900029|6087723|P1|Overall Study|Lost to Follow-up|0
1745843|NCT00899847|6087740|P1|Overall Study|Lack of suitable allogeneic donor|2
1745844|NCT00899678|6087771|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
1745845|NCT00899678|6087772|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
1745846|NCT00899678|6087773|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
1745847|NCT00899678|6087771|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
1745848|NCT00899678|6087772|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
1745849|NCT00899678|6087773|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
1745850|NCT00899678|6087771|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
1745851|NCT00899678|6087772|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
1745852|NCT00899678|6087773|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
1745853|NCT00899678|6087771|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
1745854|NCT00899678|6087772|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
1745855|NCT00899678|6087773|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
1745856|NCT00899678|6087771|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
1745857|NCT00899678|6087772|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
1745858|NCT00899678|6087773|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
1745859|NCT00899678|6087771|P3|Induction Period (Weeks 0 to 6)|Other reason|0
1745860|NCT00899678|6087772|P2|Induction Period (Weeks 0 to 6)|Other reason|0
1745861|NCT00899678|6087773|P1|Induction Period (Weeks 0 to 6)|Other reason|1
1745862|NCT00899678|6087771|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
1745863|NCT00899678|6087772|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
1745864|NCT00899678|6087773|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
1745865|NCT00899678|6087771|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
1745866|NCT00899678|6087772|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
1745867|NCT00899678|6087773|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
1745868|NCT00899678|6087771|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
1745869|NCT00899678|6087772|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
1745870|NCT00899678|6087773|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
1745871|NCT00899548|6087823|P1|Overall Study|Physician Decision|3
1745872|NCT00899431|6087917|P3|Overall Study|Physician Decision|0
1745873|NCT00899431|6087918|P2|Overall Study|Physician Decision|0
1745874|NCT00899431|6087919|P1|Overall Study|Physician Decision|1
1745875|NCT00899392|6087932|P2|Overall Study|Subject didn't finish/partial pilot data|24
1745876|NCT00899392|6087933|P1|Overall Study|Subject didn't finish/partial pilot data|21
1745877|NCT00899379|6087950|P5|Overall Study|Inc/Exc Criteria Not Met|0
1745878|NCT00899379|6087951|P4|Overall Study|Inc/Exc Criteria Not Met|0
1745879|NCT00899379|6087952|P3|Overall Study|Inc/Exc Criteria Not Met|1
1745880|NCT00899379|6087953|P2|Overall Study|Inc/Exc Criteria Not Met|0
1745881|NCT00899379|6087954|P1|Overall Study|Inc/Exc Criteria Not Met|0
1745882|NCT00899379|6087950|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
1745883|NCT00899379|6087951|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
1745884|NCT00899379|6087952|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
1745885|NCT00899379|6087953|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
1745886|NCT00899379|6087954|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1745887|NCT00899379|6087950|P5|Overall Study|No Attack Pretreatment|4
1745888|NCT00899379|6087951|P4|Overall Study|No Attack Pretreatment|6
1745889|NCT00899379|6087952|P3|Overall Study|No Attack Pretreatment|5
1745890|NCT00899379|6087953|P2|Overall Study|No Attack Pretreatment|5
1745891|NCT00899379|6087954|P1|Overall Study|No Attack Pretreatment|3
1745892|NCT00899379|6087950|P5|Overall Study|Abnormal Baseline ECG|0
1745893|NCT00899379|6087951|P4|Overall Study|Abnormal Baseline ECG|1
1745894|NCT00899379|6087952|P3|Overall Study|Abnormal Baseline ECG|1
1745895|NCT00899379|6087953|P2|Overall Study|Abnormal Baseline ECG|0
1745896|NCT00899379|6087954|P1|Overall Study|Abnormal Baseline ECG|0
1745897|NCT00899379|6087950|P5|Overall Study|Abnormal Prestudy Labs|2
1745898|NCT00899379|6087951|P4|Overall Study|Abnormal Prestudy Labs|0
1745899|NCT00899379|6087952|P3|Overall Study|Abnormal Prestudy Labs|0
1745900|NCT00899379|6087953|P2|Overall Study|Abnormal Prestudy Labs|0
1745901|NCT00899379|6087954|P1|Overall Study|Abnormal Prestudy Labs|0
1745902|NCT00899379|6087950|P5|Overall Study|Patient Uncooperative|0
1745903|NCT00899379|6087951|P4|Overall Study|Patient Uncooperative|1
1745904|NCT00899379|6087952|P3|Overall Study|Patient Uncooperative|0
1745905|NCT00899379|6087953|P2|Overall Study|Patient Uncooperative|0
1745906|NCT00899379|6087954|P1|Overall Study|Patient Uncooperative|0
1745907|NCT00899379|6087950|P5|Overall Study|Pregnancy|0
1745908|NCT00899379|6087951|P4|Overall Study|Pregnancy|0
1745909|NCT00899379|6087952|P3|Overall Study|Pregnancy|0
1745910|NCT00899379|6087953|P2|Overall Study|Pregnancy|0
1745911|NCT00899379|6087954|P1|Overall Study|Pregnancy|1
1745912|NCT00899379|6087950|P5|Overall Study|Withdrawal by Subject|2
1745913|NCT00899379|6087951|P4|Overall Study|Withdrawal by Subject|7
1745914|NCT00899379|6087952|P3|Overall Study|Withdrawal by Subject|4
1745915|NCT00899379|6087953|P2|Overall Study|Withdrawal by Subject|7
1745916|NCT00899379|6087954|P1|Overall Study|Withdrawal by Subject|4
1745917|NCT00899379|6087950|P5|Overall Study|Lost to Follow-up|5
1745918|NCT00899379|6087951|P4|Overall Study|Lost to Follow-up|2
1745919|NCT00899379|6087952|P3|Overall Study|Lost to Follow-up|0
1745920|NCT00899379|6087953|P2|Overall Study|Lost to Follow-up|1
1745921|NCT00899379|6087954|P1|Overall Study|Lost to Follow-up|3
1745922|NCT00899379|6087950|P5|Overall Study|Study Terminated|1
1745923|NCT00899379|6087951|P4|Overall Study|Study Terminated|3
1745924|NCT00899379|6087952|P3|Overall Study|Study Terminated|3
1745925|NCT00899379|6087953|P2|Overall Study|Study Terminated|0
1745926|NCT00899379|6087954|P1|Overall Study|Study Terminated|3
1745927|NCT00899379|6087950|P5|Overall Study|Not Completed/Entered Extn|3
1745928|NCT00899379|6087951|P4|Overall Study|Not Completed/Entered Extn|4
1745929|NCT00899379|6087952|P3|Overall Study|Not Completed/Entered Extn|6
1745930|NCT00899379|6087953|P2|Overall Study|Not Completed/Entered Extn|1
1745931|NCT00899379|6087954|P1|Overall Study|Not Completed/Entered Extn|5
1745932|NCT00899379|6087950|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
1745933|NCT00899379|6087951|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
1745934|NCT00899379|6087952|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
1745935|NCT00899379|6087953|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
1745936|NCT00899379|6087954|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1745937|NCT00899379|6087950|P5|Overall Study|Abnormal Baseline ECG|0
1745938|NCT00899379|6087951|P4|Overall Study|Abnormal Baseline ECG|1
1745939|NCT00899379|6087952|P3|Overall Study|Abnormal Baseline ECG|0
1745940|NCT00899379|6087953|P2|Overall Study|Abnormal Baseline ECG|0
1745941|NCT00899379|6087954|P1|Overall Study|Abnormal Baseline ECG|0
1745942|NCT00899379|6087950|P5|Overall Study|Patient Uncooperative|2
1745943|NCT00899379|6087951|P4|Overall Study|Patient Uncooperative|1
1745944|NCT00899379|6087952|P3|Overall Study|Patient Uncooperative|0
1745945|NCT00899379|6087953|P2|Overall Study|Patient Uncooperative|1
1745946|NCT00899379|6087954|P1|Overall Study|Patient Uncooperative|0
1745947|NCT00899379|6087950|P5|Overall Study|Pregnancy|1
1745948|NCT00899379|6087951|P4|Overall Study|Pregnancy|0
1745949|NCT00899379|6087952|P3|Overall Study|Pregnancy|1
1745950|NCT00899379|6087953|P2|Overall Study|Pregnancy|0
1745951|NCT00899379|6087954|P1|Overall Study|Pregnancy|0
1745952|NCT00899379|6087950|P5|Overall Study|Withdrawal by Subject|6
1745953|NCT00899379|6087951|P4|Overall Study|Withdrawal by Subject|3
1745954|NCT00899379|6087952|P3|Overall Study|Withdrawal by Subject|2
1745955|NCT00899379|6087953|P2|Overall Study|Withdrawal by Subject|4
1745956|NCT00899379|6087954|P1|Overall Study|Withdrawal by Subject|2
1745957|NCT00899379|6087950|P5|Overall Study|Protocol Violation|0
1745958|NCT00899379|6087951|P4|Overall Study|Protocol Violation|1
1745959|NCT00899379|6087952|P3|Overall Study|Protocol Violation|1
1745960|NCT00899379|6087953|P2|Overall Study|Protocol Violation|0
1745961|NCT00899379|6087954|P1|Overall Study|Protocol Violation|0
1745962|NCT00899379|6087950|P5|Overall Study|Lost to Follow-up|2
1745963|NCT00899379|6087951|P4|Overall Study|Lost to Follow-up|6
1745964|NCT00899379|6087952|P3|Overall Study|Lost to Follow-up|0
1745965|NCT00899379|6087953|P2|Overall Study|Lost to Follow-up|3
1745966|NCT00899379|6087954|P1|Overall Study|Lost to Follow-up|9
1745967|NCT00899379|6087950|P5|Overall Study|Lack of Efficacy|1
1745968|NCT00899379|6087951|P4|Overall Study|Lack of Efficacy|0
1745969|NCT00899379|6087952|P3|Overall Study|Lack of Efficacy|3
1745970|NCT00899379|6087953|P2|Overall Study|Lack of Efficacy|4
1745971|NCT00899379|6087954|P1|Overall Study|Lack of Efficacy|0
1745972|NCT00899379|6087950|P5|Overall Study|Adverse Event|2
1745973|NCT00899379|6087951|P4|Overall Study|Adverse Event|1
1745974|NCT00899379|6087952|P3|Overall Study|Adverse Event|1
1745975|NCT00899379|6087953|P2|Overall Study|Adverse Event|2
1745976|NCT00899379|6087954|P1|Overall Study|Adverse Event|2
1745977|NCT00899353|6087966|P1|Overall Study|Withdrawal by Subject|2
1745978|NCT00899353|6087966|P1|Overall Study|Lost to Follow-up|1
1745979|NCT00899353|6087966|P1|Overall Study|Adverse Event|2
1745980|NCT00898807|6088002|P2|Overall Study|Death|1
1745981|NCT00898807|6088003|P1|Overall Study|Death|0
1745982|NCT00898807|6088002|P2|Overall Study|Lost to Follow-up|3
1745983|NCT00898807|6088003|P1|Overall Study|Lost to Follow-up|1
1745984|NCT00898807|6088002|P2|Overall Study|Family pressure to discontinue|2
1745985|NCT00898807|6088003|P1|Overall Study|Family pressure to discontinue|2
1745986|NCT00898807|6088002|P2|Overall Study|Withdrawal by Subject|3
1745987|NCT00898807|6088003|P1|Overall Study|Withdrawal by Subject|5
1745988|NCT00898677|6088019|P4|Overall Study|Not Treated: Other (Not Specified)|0
1745989|NCT00898677|6088020|P3|Overall Study|Not Treated: Other (Not Specified)|2
1745990|NCT00898677|6088021|P2|Overall Study|Not Treated: Other (Not Specified)|0
1745991|NCT00898677|6088022|P1|Overall Study|Not Treated: Other (Not Specified)|0
1745992|NCT00898677|6088019|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
1745993|NCT00898677|6088020|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
1745994|NCT00898677|6088021|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
1745995|NCT00898677|6088022|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
1745996|NCT00898677|6088019|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1745997|NCT00898677|6088020|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
1745998|NCT00898677|6088021|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
1745999|NCT00898677|6088022|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
1746000|NCT00898677|6088019|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
1746001|NCT00898677|6088020|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
1746002|NCT00898677|6088021|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
1746003|NCT00898677|6088022|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
1746004|NCT00898677|6088019|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
1746005|NCT00898677|6088020|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1746006|NCT00898677|6088021|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1746007|NCT00898677|6088022|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
1746008|NCT00898677|6088019|P4|Overall Study|Not Treated: Patient uncooperative|0
1746009|NCT00898677|6088020|P3|Overall Study|Not Treated: Patient uncooperative|1
1746010|NCT00898677|6088021|P2|Overall Study|Not Treated: Patient uncooperative|3
1746011|NCT00898677|6088022|P1|Overall Study|Not Treated: Patient uncooperative|2
1746012|NCT00898677|6088019|P4|Overall Study|Not Treated: Withdraw by Subject|3
1746013|NCT00898677|6088020|P3|Overall Study|Not Treated: Withdraw by Subject|11
1746014|NCT00898677|6088021|P2|Overall Study|Not Treated: Withdraw by Subject|16
1746015|NCT00898677|6088022|P1|Overall Study|Not Treated: Withdraw by Subject|2
1746016|NCT00898677|6088019|P4|Overall Study|Not Treated: Protocol Violation|0
1746017|NCT00898677|6088020|P3|Overall Study|Not Treated: Protocol Violation|2
1746018|NCT00898677|6088021|P2|Overall Study|Not Treated: Protocol Violation|0
1746019|NCT00898677|6088022|P1|Overall Study|Not Treated: Protocol Violation|2
1746020|NCT00898677|6088019|P4|Overall Study|Not Treated: Pregnancy|0
1746021|NCT00898677|6088020|P3|Overall Study|Not Treated: Pregnancy|1
1746022|NCT00898677|6088021|P2|Overall Study|Not Treated: Pregnancy|0
1746023|NCT00898677|6088022|P1|Overall Study|Not Treated: Pregnancy|0
1746024|NCT00898677|6088019|P4|Overall Study|Not Treated: Lost to Follow-Up|2
1746025|NCT00898677|6088020|P3|Overall Study|Not Treated: Lost to Follow-Up|5
1746026|NCT00898677|6088021|P2|Overall Study|Not Treated: Lost to Follow-Up|5
1746027|NCT00898677|6088022|P1|Overall Study|Not Treated: Lost to Follow-Up|0
1746028|NCT00898677|6088019|P4|Overall Study|Not Treated: Adverse Event|0
1746029|NCT00898677|6088020|P3|Overall Study|Not Treated: Adverse Event|1
1746030|NCT00898677|6088021|P2|Overall Study|Not Treated: Adverse Event|2
1746031|NCT00898677|6088022|P1|Overall Study|Not Treated: Adverse Event|0
1746032|NCT00898677|6088019|P4|Overall Study|Withdrawal by Subject|1
1746033|NCT00898677|6088020|P3|Overall Study|Withdrawal by Subject|0
1746034|NCT00898677|6088021|P2|Overall Study|Withdrawal by Subject|0
1746035|NCT00898677|6088022|P1|Overall Study|Withdrawal by Subject|0
1746036|NCT00898677|6088019|P4|Overall Study|Protocol Violation|0
1746037|NCT00898677|6088020|P3|Overall Study|Protocol Violation|2
1746038|NCT00898677|6088021|P2|Overall Study|Protocol Violation|1
1746039|NCT00898677|6088022|P1|Overall Study|Protocol Violation|1
1746040|NCT00898677|6088019|P4|Overall Study|Lost to Follow-up|0
1746041|NCT00898677|6088020|P3|Overall Study|Lost to Follow-up|2
1746042|NCT00898677|6088021|P2|Overall Study|Lost to Follow-up|0
1746043|NCT00898677|6088022|P1|Overall Study|Lost to Follow-up|0
1746044|NCT00898677|6088019|P4|Overall Study|Adverse Event|0
1746045|NCT00898677|6088020|P3|Overall Study|Adverse Event|1
1746046|NCT00898677|6088021|P2|Overall Study|Adverse Event|0
1746047|NCT00898677|6088022|P1|Overall Study|Adverse Event|0
1746048|NCT00898443|6088060|P2|Overall Study|Withdrawal by Subject|0
1746049|NCT00898443|6088061|P1|Overall Study|Withdrawal by Subject|1
1746050|NCT00897949|6088076|P3|Overall Study|Did not take study drug|4
1746051|NCT00897949|6088077|P2|Overall Study|Did not take study drug|3
1746052|NCT00897949|6088078|P1|Overall Study|Did not take study drug|9
1746053|NCT00897949|6088076|P3|Overall Study|Lack of Migraine Attack|19
1746054|NCT00897949|6088077|P2|Overall Study|Lack of Migraine Attack|30
1746055|NCT00897949|6088078|P1|Overall Study|Lack of Migraine Attack|29
1746056|NCT00897949|6088076|P3|Overall Study|Need for Concom. Med.|1
1746057|NCT00897949|6088077|P2|Overall Study|Need for Concom. Med.|1
1746058|NCT00897949|6088078|P1|Overall Study|Need for Concom. Med.|0
1746059|NCT00897949|6088076|P3|Overall Study|Abnormal Baseline ECG|4
1746060|NCT00897949|6088077|P2|Overall Study|Abnormal Baseline ECG|2
1746061|NCT00897949|6088078|P1|Overall Study|Abnormal Baseline ECG|2
1746062|NCT00897949|6088076|P3|Overall Study|Abnormal Prestudy Labs|4
1746063|NCT00897949|6088077|P2|Overall Study|Abnormal Prestudy Labs|3
1746064|NCT00897949|6088078|P1|Overall Study|Abnormal Prestudy Labs|2
1746065|NCT00897949|6088076|P3|Overall Study|Withdrawal by Subject|17
1746066|NCT00897949|6088077|P2|Overall Study|Withdrawal by Subject|31
1746067|NCT00897949|6088078|P1|Overall Study|Withdrawal by Subject|24
1746068|NCT00897949|6088076|P3|Overall Study|Lost to Follow-up|17
1746069|NCT00897949|6088077|P2|Overall Study|Lost to Follow-up|23
1746070|NCT00897949|6088078|P1|Overall Study|Lost to Follow-up|30
1746071|NCT00897949|6088076|P3|Overall Study|Patient Uncoorperative|1
1746072|NCT00897949|6088077|P2|Overall Study|Patient Uncoorperative|2
1746073|NCT00897949|6088078|P1|Overall Study|Patient Uncoorperative|0
1746074|NCT00897949|6088076|P3|Overall Study|Withdrawal by Subject|0
1746075|NCT00897949|6088077|P2|Overall Study|Withdrawal by Subject|2
1746076|NCT00897949|6088078|P1|Overall Study|Withdrawal by Subject|1
1746077|NCT00897949|6088076|P3|Overall Study|Protocol Violation|1
1746078|NCT00897949|6088077|P2|Overall Study|Protocol Violation|3
1746079|NCT00897949|6088078|P1|Overall Study|Protocol Violation|6
1746080|NCT00897949|6088076|P3|Overall Study|Lost to Follow-up|1
1746081|NCT00897949|6088077|P2|Overall Study|Lost to Follow-up|2
1746082|NCT00897949|6088078|P1|Overall Study|Lost to Follow-up|0
1746083|NCT00897949|6088076|P3|Overall Study|Adverse Event|0
1746084|NCT00897949|6088077|P2|Overall Study|Adverse Event|1
1746085|NCT00897949|6088078|P1|Overall Study|Adverse Event|1
1746086|NCT00897715|6088112|P2|Overall Study|increased risk of infection|0
1746087|NCT00897715|6088113|P1|Overall Study|increased risk of infection|1
1746088|NCT00897715|6088112|P2|Overall Study|Physician Decision|0
1746089|NCT00897715|6088113|P1|Overall Study|Physician Decision|1
1746090|NCT00897715|6088112|P2|Overall Study|Lost to Follow-up|1
1746091|NCT00897715|6088113|P1|Overall Study|Lost to Follow-up|0
1746092|NCT00897390|6088138|P1|Overall Study|Did not Return for the Clinic Visit|2
1746093|NCT00897390|6088138|P1|Overall Study|Personal Reasons|1
1746094|NCT00897390|6088138|P1|Overall Study|No Longer Met Study Criteria|1
1746095|NCT00897390|6088138|P1|Overall Study|Adverse Event|2
1746096|NCT00897104|6088228|P3|Overall Study|Withdrawal by Subject|1
1746097|NCT00897104|6088229|P2|Overall Study|Withdrawal by Subject|0
1746098|NCT00897104|6088230|P1|Overall Study|Withdrawal by Subject|0
1746099|NCT00897104|6088228|P3|Overall Study|Protocol Violation|0
1746100|NCT00897104|6088229|P2|Overall Study|Protocol Violation|0
1746101|NCT00897104|6088230|P1|Overall Study|Protocol Violation|1
1746102|NCT00897104|6088228|P3|Overall Study|Other|0
1746103|NCT00897104|6088229|P2|Overall Study|Other|0
1746104|NCT00897104|6088230|P1|Overall Study|Other|3
1746105|NCT00897104|6088228|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
1746106|NCT00897104|6088229|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
1746107|NCT00897104|6088230|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
1746108|NCT00897104|6088228|P3|Overall Study|Lack of Migraine Attack|1
1746109|NCT00897104|6088229|P2|Overall Study|Lack of Migraine Attack|22
1746110|NCT00897104|6088230|P1|Overall Study|Lack of Migraine Attack|20
1746111|NCT00897104|6088228|P3|Overall Study|Need for Concom. Med.|1
1746112|NCT00897104|6088229|P2|Overall Study|Need for Concom. Med.|1
1746113|NCT00897104|6088230|P1|Overall Study|Need for Concom. Med.|0
1746114|NCT00897104|6088228|P3|Overall Study|Abnormal Baseline ECG|0
1746115|NCT00897104|6088229|P2|Overall Study|Abnormal Baseline ECG|2
1746116|NCT00897104|6088230|P1|Overall Study|Abnormal Baseline ECG|2
1746117|NCT00897104|6088228|P3|Overall Study|Abnormal Prestudy Labs|0
1746118|NCT00897104|6088229|P2|Overall Study|Abnormal Prestudy Labs|0
1746119|NCT00897104|6088230|P1|Overall Study|Abnormal Prestudy Labs|2
1746120|NCT00897104|6088228|P3|Overall Study|Withdrawal by Subject|3
1746121|NCT00897104|6088229|P2|Overall Study|Withdrawal by Subject|27
1746122|NCT00897104|6088230|P1|Overall Study|Withdrawal by Subject|23
1746123|NCT00897104|6088228|P3|Overall Study|Protocol Violation|0
1746124|NCT00897104|6088229|P2|Overall Study|Protocol Violation|1
1746125|NCT00897104|6088230|P1|Overall Study|Protocol Violation|0
1746126|NCT00897104|6088228|P3|Overall Study|Pregnancy|0
1746127|NCT00897104|6088229|P2|Overall Study|Pregnancy|1
1746128|NCT00897104|6088230|P1|Overall Study|Pregnancy|0
1746129|NCT00897104|6088228|P3|Overall Study|Lost to Follow-up|2
1746130|NCT00897104|6088229|P2|Overall Study|Lost to Follow-up|17
1746131|NCT00897104|6088230|P1|Overall Study|Lost to Follow-up|12
1746132|NCT00896649|6088265|P1|Overall Study|technical difficulties|2
1746133|NCT00896649|6088265|P1|Overall Study|missing documentation|1
1746134|NCT00896649|6088265|P1|Overall Study|Pregnancy|1
1746135|NCT00896649|6088265|P1|Overall Study|Physician Decision|1
1746136|NCT00896532|6088278|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746137|NCT00896532|6088279|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
1746138|NCT00896532|6088280|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746139|NCT00896532|6088281|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746140|NCT00896532|6088282|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746141|NCT00896532|6088283|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746142|NCT00896532|6088284|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746143|NCT00896532|6088285|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746144|NCT00896532|6088286|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746145|NCT00896532|6088287|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746146|NCT00896532|6088288|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746147|NCT00896532|6088289|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746148|NCT00896532|6088290|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746149|NCT00896532|6088291|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746150|NCT00896532|6088292|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746151|NCT00896532|6088293|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746152|NCT00896532|6088294|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746153|NCT00896532|6088295|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746154|NCT00896532|6088296|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746155|NCT00896532|6088297|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746156|NCT00896532|6088298|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746157|NCT00896532|6088299|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746158|NCT00896532|6088300|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
1746159|NCT00896532|6088278|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746160|NCT00896532|6088279|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
1746161|NCT00896532|6088280|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746162|NCT00896532|6088281|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746163|NCT00896532|6088282|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746164|NCT00896532|6088283|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746165|NCT00896532|6088284|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746166|NCT00896532|6088285|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746167|NCT00896532|6088286|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746168|NCT00896532|6088287|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746169|NCT00896532|6088288|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746170|NCT00896532|6088289|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746171|NCT00896532|6088290|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746172|NCT00896532|6088291|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746173|NCT00896532|6088292|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746174|NCT00896532|6088293|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746175|NCT00896532|6088294|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746176|NCT00896532|6088295|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746177|NCT00896532|6088296|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746178|NCT00896532|6088297|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746179|NCT00896532|6088298|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746180|NCT00896532|6088299|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746181|NCT00896532|6088300|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
1746182|NCT00896532|6088278|P23|Months 48-72: Follow-on Phase|Death|0
1746183|NCT00896532|6088279|P22|Months 48-72: Follow-on Phase|Death|0
1746184|NCT00896532|6088280|P21|Months 48-72: Follow-on Phase|Death|0
1746185|NCT00896532|6088281|P20|Months 48-72: Follow-on Phase|Death|0
1746186|NCT00896532|6088282|P19|Months 48-72: Follow-on Phase|Death|1
1746187|NCT00896532|6088283|P18|Months 48-72: Follow-on Phase|Death|0
1746188|NCT00896532|6088284|P17|Months 48-72: Follow-on Phase|Death|0
1746189|NCT00896532|6088285|P16|Months 48-72: Follow-on Phase|Death|0
1746190|NCT00896532|6088286|P15|Months 48-72: Follow-on Phase|Death|0
1746191|NCT00896532|6088287|P14|Months 48-72: Follow-on Phase|Death|0
1746192|NCT00896532|6088288|P13|Months 48-72: Follow-on Phase|Death|0
1746193|NCT00896532|6088289|P12|Months 48-72: Follow-on Phase|Death|0
1746194|NCT00896532|6088290|P11|Months 48-72: Follow-on Phase|Death|0
1746195|NCT00896532|6088291|P10|Months 48-72: Follow-on Phase|Death|0
1746196|NCT00896532|6088292|P9|Months 48-72: Follow-on Phase|Death|0
1746197|NCT00896532|6088293|P8|Months 48-72: Follow-on Phase|Death|0
1746198|NCT00896532|6088294|P7|Months 48-72: Follow-on Phase|Death|0
1746199|NCT00896532|6088295|P6|Months 48-72: Follow-on Phase|Death|0
1746200|NCT00896532|6088296|P5|Months 48-72: Follow-on Phase|Death|0
1746201|NCT00896532|6088297|P4|Months 48-72: Follow-on Phase|Death|0
1746202|NCT00896532|6088298|P3|Months 48-72: Follow-on Phase|Death|0
1746203|NCT00896532|6088299|P2|Months 48-72: Follow-on Phase|Death|0
1746204|NCT00896532|6088300|P1|Months 48-72: Follow-on Phase|Death|0
1746205|NCT00896532|6088278|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746206|NCT00896532|6088279|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746207|NCT00896532|6088280|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746208|NCT00896532|6088281|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746209|NCT00896532|6088282|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746210|NCT00896532|6088283|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746211|NCT00896532|6088284|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
1746212|NCT00896532|6088285|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746213|NCT00896532|6088286|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746214|NCT00896532|6088287|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746215|NCT00896532|6088288|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746216|NCT00896532|6088289|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746217|NCT00896532|6088290|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746218|NCT00896532|6088291|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746219|NCT00896532|6088292|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746220|NCT00896532|6088293|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746221|NCT00896532|6088294|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746222|NCT00896532|6088295|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746223|NCT00896532|6088296|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746224|NCT00896532|6088297|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746225|NCT00896532|6088298|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746226|NCT00896532|6088299|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746227|NCT00896532|6088300|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
1746228|NCT00896532|6088278|P23|Months 36-48: Romosozumab Retreatment|Other|0
1746229|NCT00896532|6088279|P22|Months 36-48: Romosozumab Retreatment|Other|0
1746230|NCT00896532|6088280|P21|Months 36-48: Romosozumab Retreatment|Other|0
1746231|NCT00896532|6088281|P20|Months 36-48: Romosozumab Retreatment|Other|0
1746232|NCT00896532|6088282|P19|Months 36-48: Romosozumab Retreatment|Other|0
1746233|NCT00896532|6088283|P18|Months 36-48: Romosozumab Retreatment|Other|1
1746234|NCT00896532|6088284|P17|Months 36-48: Romosozumab Retreatment|Other|0
1746235|NCT00896532|6088285|P16|Months 36-48: Romosozumab Retreatment|Other|0
1746236|NCT00896532|6088286|P15|Months 36-48: Romosozumab Retreatment|Other|0
1746237|NCT00896532|6088287|P14|Months 36-48: Romosozumab Retreatment|Other|0
1746238|NCT00896532|6088288|P13|Months 36-48: Romosozumab Retreatment|Other|0
1746239|NCT00896532|6088289|P12|Months 36-48: Romosozumab Retreatment|Other|0
1746240|NCT00896532|6088290|P11|Months 36-48: Romosozumab Retreatment|Other|0
1746241|NCT00896532|6088291|P10|Months 36-48: Romosozumab Retreatment|Other|0
1746242|NCT00896532|6088292|P9|Months 36-48: Romosozumab Retreatment|Other|0
1746243|NCT00896532|6088293|P8|Months 36-48: Romosozumab Retreatment|Other|0
1746244|NCT00896532|6088294|P7|Months 36-48: Romosozumab Retreatment|Other|0
1746245|NCT00896532|6088295|P6|Months 36-48: Romosozumab Retreatment|Other|0
1746246|NCT00896532|6088296|P5|Months 36-48: Romosozumab Retreatment|Other|0
1746247|NCT00896532|6088297|P4|Months 36-48: Romosozumab Retreatment|Other|0
1746248|NCT00896532|6088298|P3|Months 36-48: Romosozumab Retreatment|Other|0
1746249|NCT00896532|6088299|P2|Months 36-48: Romosozumab Retreatment|Other|0
1746250|NCT00896532|6088300|P1|Months 36-48: Romosozumab Retreatment|Other|0
1746251|NCT00896532|6088278|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746252|NCT00896532|6088279|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746253|NCT00896532|6088280|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746254|NCT00896532|6088281|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746255|NCT00896532|6088282|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746256|NCT00896532|6088283|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746257|NCT00896532|6088284|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
1746258|NCT00896532|6088285|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746259|NCT00896532|6088286|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746260|NCT00896532|6088287|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746261|NCT00896532|6088288|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746262|NCT00896532|6088289|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746263|NCT00896532|6088290|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746264|NCT00896532|6088291|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746265|NCT00896532|6088292|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746266|NCT00896532|6088293|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746267|NCT00896532|6088294|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746268|NCT00896532|6088295|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746269|NCT00896532|6088296|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746270|NCT00896532|6088297|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746271|NCT00896532|6088298|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746272|NCT00896532|6088299|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746273|NCT00896532|6088300|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
1746274|NCT00896532|6088278|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746275|NCT00896532|6088279|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746276|NCT00896532|6088280|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746277|NCT00896532|6088281|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746278|NCT00896532|6088282|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746279|NCT00896532|6088283|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
1746280|NCT00896532|6088284|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
1746281|NCT00896532|6088285|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
1746282|NCT00896532|6088286|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746283|NCT00896532|6088287|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746284|NCT00896532|6088288|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746285|NCT00896532|6088289|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746286|NCT00896532|6088290|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746287|NCT00896532|6088291|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746288|NCT00896532|6088292|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746289|NCT00896532|6088293|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746290|NCT00896532|6088294|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746291|NCT00896532|6088295|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746292|NCT00896532|6088296|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746293|NCT00896532|6088297|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746294|NCT00896532|6088298|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746295|NCT00896532|6088299|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746296|NCT00896532|6088300|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
1746297|NCT00896532|6088278|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746298|NCT00896532|6088279|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746299|NCT00896532|6088280|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746300|NCT00896532|6088281|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746301|NCT00896532|6088282|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746302|NCT00896532|6088283|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746303|NCT00896532|6088284|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
1746304|NCT00896532|6088285|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
1746305|NCT00896532|6088286|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746306|NCT00896532|6088287|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746307|NCT00896532|6088288|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746308|NCT00896532|6088289|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746309|NCT00896532|6088290|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746310|NCT00896532|6088291|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746311|NCT00896532|6088292|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746312|NCT00896532|6088293|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746313|NCT00896532|6088294|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746314|NCT00896532|6088295|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746315|NCT00896532|6088296|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746316|NCT00896532|6088297|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746317|NCT00896532|6088298|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746318|NCT00896532|6088299|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746319|NCT00896532|6088300|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
1746320|NCT00896532|6088278|P23|Months 24-36: Denosumab Extension Phase|Other|0
1746321|NCT00896532|6088279|P22|Months 24-36: Denosumab Extension Phase|Other|0
1746322|NCT00896532|6088280|P21|Months 24-36: Denosumab Extension Phase|Other|0
1746323|NCT00896532|6088281|P20|Months 24-36: Denosumab Extension Phase|Other|0
1746324|NCT00896532|6088282|P19|Months 24-36: Denosumab Extension Phase|Other|0
1746325|NCT00896532|6088283|P18|Months 24-36: Denosumab Extension Phase|Other|0
1746326|NCT00896532|6088284|P17|Months 24-36: Denosumab Extension Phase|Other|0
1746327|NCT00896532|6088285|P16|Months 24-36: Denosumab Extension Phase|Other|0
1746328|NCT00896532|6088286|P15|Months 24-36: Denosumab Extension Phase|Other|0
1746329|NCT00896532|6088287|P14|Months 24-36: Denosumab Extension Phase|Other|1
1746330|NCT00896532|6088288|P13|Months 24-36: Denosumab Extension Phase|Other|2
1746331|NCT00896532|6088289|P12|Months 24-36: Denosumab Extension Phase|Other|2
1746332|NCT00896532|6088290|P11|Months 24-36: Denosumab Extension Phase|Other|1
1746333|NCT00896532|6088291|P10|Months 24-36: Denosumab Extension Phase|Other|0
1746334|NCT00896532|6088292|P9|Months 24-36: Denosumab Extension Phase|Other|0
1746335|NCT00896532|6088293|P8|Months 24-36: Denosumab Extension Phase|Other|0
1746336|NCT00896532|6088294|P7|Months 24-36: Denosumab Extension Phase|Other|0
1746337|NCT00896532|6088295|P6|Months 24-36: Denosumab Extension Phase|Other|0
1746338|NCT00896532|6088296|P5|Months 24-36: Denosumab Extension Phase|Other|0
1746339|NCT00896532|6088297|P4|Months 24-36: Denosumab Extension Phase|Other|0
1746340|NCT00896532|6088298|P3|Months 24-36: Denosumab Extension Phase|Other|0
1746341|NCT00896532|6088299|P2|Months 24-36: Denosumab Extension Phase|Other|0
1746342|NCT00896532|6088300|P1|Months 24-36: Denosumab Extension Phase|Other|0
1746343|NCT00896532|6088278|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746344|NCT00896532|6088279|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746345|NCT00896532|6088280|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746346|NCT00896532|6088281|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746347|NCT00896532|6088282|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746348|NCT00896532|6088283|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746349|NCT00896532|6088284|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746350|NCT00896532|6088285|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746351|NCT00896532|6088286|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746352|NCT00896532|6088287|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
1746353|NCT00896532|6088288|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
1746354|NCT00896532|6088289|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746355|NCT00896532|6088290|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746356|NCT00896532|6088291|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746357|NCT00896532|6088292|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746358|NCT00896532|6088293|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746359|NCT00896532|6088294|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746360|NCT00896532|6088295|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746361|NCT00896532|6088296|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746362|NCT00896532|6088297|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746363|NCT00896532|6088298|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746364|NCT00896532|6088299|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746365|NCT00896532|6088300|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
1746366|NCT00896532|6088278|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746367|NCT00896532|6088279|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746368|NCT00896532|6088280|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746369|NCT00896532|6088281|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746370|NCT00896532|6088282|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746371|NCT00896532|6088283|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746372|NCT00896532|6088284|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746373|NCT00896532|6088285|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746374|NCT00896532|6088286|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746375|NCT00896532|6088287|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746376|NCT00896532|6088288|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
1746377|NCT00896532|6088289|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746378|NCT00896532|6088290|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
1746379|NCT00896532|6088291|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746380|NCT00896532|6088292|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746381|NCT00896532|6088293|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746664|NCT00896168|6088664|P1|Overall Study|Other|1
1746382|NCT00896532|6088294|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746383|NCT00896532|6088295|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746384|NCT00896532|6088296|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746385|NCT00896532|6088297|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746386|NCT00896532|6088298|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746387|NCT00896532|6088299|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746388|NCT00896532|6088300|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
1746389|NCT00896532|6088278|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746390|NCT00896532|6088279|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746391|NCT00896532|6088280|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746392|NCT00896532|6088281|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746393|NCT00896532|6088282|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746394|NCT00896532|6088283|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746395|NCT00896532|6088284|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746396|NCT00896532|6088285|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746397|NCT00896532|6088286|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746398|NCT00896532|6088287|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746399|NCT00896532|6088288|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
1746400|NCT00896532|6088289|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746401|NCT00896532|6088290|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746402|NCT00896532|6088291|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746403|NCT00896532|6088292|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746404|NCT00896532|6088293|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746405|NCT00896532|6088294|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746406|NCT00896532|6088295|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746407|NCT00896532|6088296|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746408|NCT00896532|6088297|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746409|NCT00896532|6088298|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746410|NCT00896532|6088299|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746411|NCT00896532|6088300|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
1746412|NCT00896532|6088278|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746413|NCT00896532|6088279|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746414|NCT00896532|6088280|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746415|NCT00896532|6088281|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746416|NCT00896532|6088282|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746417|NCT00896532|6088283|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746418|NCT00896532|6088284|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746419|NCT00896532|6088285|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746420|NCT00896532|6088286|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746421|NCT00896532|6088287|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746422|NCT00896532|6088288|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746423|NCT00896532|6088289|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746424|NCT00896532|6088290|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746425|NCT00896532|6088291|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746426|NCT00896532|6088292|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
1746427|NCT00896532|6088293|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746428|NCT00896532|6088294|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746429|NCT00896532|6088295|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746430|NCT00896532|6088296|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746431|NCT00896532|6088297|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746432|NCT00896532|6088298|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746433|NCT00896532|6088299|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746434|NCT00896532|6088300|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
1746435|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
1746436|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
1746437|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
1746438|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
1746439|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
1746440|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
1746441|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
1746442|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
1746443|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
1746444|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
1746445|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
1746446|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
1746447|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
1746448|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
1746449|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
1746450|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
1746451|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
1746452|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
1746453|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
1746454|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
1746455|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
1746456|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
1746457|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
1746458|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746459|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746460|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746461|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746462|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746463|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746464|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746465|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746466|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746467|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746468|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746469|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746470|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746471|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746472|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746473|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746474|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746475|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746476|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746477|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
1746478|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746479|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746480|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
1746481|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746482|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746483|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746484|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746485|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746486|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746487|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746488|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746489|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746490|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746491|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746492|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746493|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746494|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746495|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746496|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746497|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746498|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746499|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746500|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746501|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
1746502|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746503|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
1746504|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746505|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746506|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746507|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746508|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746509|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746510|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746511|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746512|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746513|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746514|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746515|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746516|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746517|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746518|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746519|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746520|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746521|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746522|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746523|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746524|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
1746525|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746526|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
1746527|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
1746528|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
1746529|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
1746530|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
1746531|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
1746532|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
1746533|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
1746534|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
1746535|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
1746536|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
1746537|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
1746538|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
1746539|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
1746540|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
1746541|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
1746542|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
1746543|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
1746544|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
1746545|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
1746546|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
1746547|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
1746548|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
1746549|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
1746550|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746551|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746552|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746553|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746554|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746555|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746556|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746557|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746558|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746559|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746560|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746561|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746562|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746563|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746564|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746565|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746566|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746567|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746568|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
1746569|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746570|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
1746571|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746572|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
1746573|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746574|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746575|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746576|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746577|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746578|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746579|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746580|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746581|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746582|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746583|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746584|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746585|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746586|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746587|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
1746588|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1746589|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1746590|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
1746591|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
1746592|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
1746593|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1746594|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
1746595|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
1746596|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746597|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746598|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746599|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746600|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746601|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746602|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746603|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746604|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746605|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746606|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746607|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746608|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746609|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746610|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746611|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
1746612|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1746613|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1746614|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1746615|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
1746616|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1746617|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
1746618|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
1746619|NCT00896532|6088278|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746620|NCT00896532|6088279|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746621|NCT00896532|6088280|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746622|NCT00896532|6088281|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746623|NCT00896532|6088282|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746624|NCT00896532|6088283|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746625|NCT00896532|6088284|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746626|NCT00896532|6088285|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746627|NCT00896532|6088286|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746628|NCT00896532|6088287|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746629|NCT00896532|6088288|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746630|NCT00896532|6088289|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746631|NCT00896532|6088290|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746632|NCT00896532|6088291|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746633|NCT00896532|6088292|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746634|NCT00896532|6088293|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746635|NCT00896532|6088294|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746636|NCT00896532|6088295|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
1746637|NCT00896532|6088296|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746638|NCT00896532|6088297|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
1746639|NCT00896532|6088298|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746640|NCT00896532|6088299|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746641|NCT00896532|6088300|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
1746642|NCT00896480|6088427|P1|Overall Study|Disease progression/recurrence|21
1746643|NCT00896454|6088475|P1|Overall Study|Withdrawal by Subject|1
1746644|NCT00896454|6088475|P1|Overall Study|Ongoing in study|2
1746645|NCT00896454|6088475|P1|Overall Study|Requirement for alternative therapy|3
1746646|NCT00896454|6088475|P1|Overall Study|Other|4
1746647|NCT00896454|6088475|P1|Overall Study|Disease Progression|5
1746648|NCT00896454|6088475|P1|Overall Study|Adverse Event|8
1746649|NCT00896454|6088475|P1|Overall Study|Death|10
1746650|NCT00896363|6088514|P3|Overall Study|Withdrawal by Subject|5
1746651|NCT00896363|6088515|P2|Overall Study|Withdrawal by Subject|5
1746652|NCT00896363|6088516|P1|Overall Study|Withdrawal by Subject|3
1746653|NCT00896363|6088514|P3|Overall Study|Lack of Efficacy|1
1746654|NCT00896363|6088515|P2|Overall Study|Lack of Efficacy|2
1746655|NCT00896363|6088516|P1|Overall Study|Lack of Efficacy|0
1746656|NCT00896363|6088514|P3|Overall Study|Adverse Event|2
1746657|NCT00896363|6088515|P2|Overall Study|Adverse Event|4
1746658|NCT00896363|6088516|P1|Overall Study|Adverse Event|3
1746659|NCT00896337|6088568|P1|Overall Study|Lost to Follow-up|11
1746660|NCT00896337|6088568|P1|Overall Study|Withdrawal by Subject|7
1746661|NCT00896337|6088568|P1|Overall Study|Death|7
1746662|NCT00896233|6088650|P1|Overall Study|Claustrophobia during MRI|1
1746663|NCT00896168|6088663|P2|Overall Study|Other|1
1746665|NCT00896168|6088663|P2|Overall Study|Lost to Follow-up|1
1746666|NCT00896168|6088664|P1|Overall Study|Lost to Follow-up|1
1746667|NCT00896168|6088663|P2|Overall Study|Treatment failure|10
1746668|NCT00896168|6088664|P1|Overall Study|Treatment failure|8
1746669|NCT00896168|6088663|P2|Overall Study|Adverse Event|7
1746670|NCT00896168|6088664|P1|Overall Study|Adverse Event|4
1746671|NCT00896051|6088725|P2|Overall Study|Other|1
1746672|NCT00896051|6088726|P1|Overall Study|Other|1
1746673|NCT00896051|6088725|P2|Overall Study|Subject noncompliant|3
1746674|NCT00896051|6088726|P1|Overall Study|Subject noncompliant|1
1746675|NCT00896051|6088725|P2|Overall Study|Withdrawal by Subject|2
1746676|NCT00896051|6088726|P1|Overall Study|Withdrawal by Subject|3
1746677|NCT00896051|6088725|P2|Overall Study|Lost to Follow-up|2
1746678|NCT00896051|6088726|P1|Overall Study|Lost to Follow-up|3
1746679|NCT00896051|6088725|P2|Overall Study|Adverse Event|1
1746680|NCT00896051|6088726|P1|Overall Study|Adverse Event|2
1746681|NCT00895947|6088821|P2|Overall Study|Withdrawal by Subject|0
1746682|NCT00895947|6088822|P1|Overall Study|Withdrawal by Subject|2
1746683|NCT00895947|6088821|P2|Overall Study|Protocol Violation|2
1746684|NCT00895947|6088822|P1|Overall Study|Protocol Violation|4
1746685|NCT00895947|6088821|P2|Overall Study|Lost to Follow-up|4
1746686|NCT00895947|6088822|P1|Overall Study|Lost to Follow-up|3
1746687|NCT00895947|6088821|P2|Overall Study|Adverse Event|4
1746688|NCT00895947|6088822|P1|Overall Study|Adverse Event|3
1746689|NCT00895895|6088860|P5|Period 2|unsatisfactory response-efficacy|0
1746690|NCT00895895|6088861|P4|Period 2|unsatisfactory response-efficacy|0
1746691|NCT00895895|6088862|P3|Period 2|unsatisfactory response-efficacy|0
1746692|NCT00895895|6088863|P2|Period 2|unsatisfactory response-efficacy|1
1746693|NCT00895895|6088864|P1|Period 2|unsatisfactory response-efficacy|2
1746694|NCT00895895|6088860|P5|Period 2|Withdrawal by Subject|5
1746695|NCT00895895|6088861|P4|Period 2|Withdrawal by Subject|3
1746696|NCT00895895|6088862|P3|Period 2|Withdrawal by Subject|0
1746697|NCT00895895|6088863|P2|Period 2|Withdrawal by Subject|2
1746698|NCT00895895|6088864|P1|Period 2|Withdrawal by Subject|0
1746699|NCT00895895|6088860|P5|Period 2|Protocol Violation|1
1746700|NCT00895895|6088861|P4|Period 2|Protocol Violation|1
1746701|NCT00895895|6088862|P3|Period 2|Protocol Violation|1
1746702|NCT00895895|6088863|P2|Period 2|Protocol Violation|0
1746703|NCT00895895|6088864|P1|Period 2|Protocol Violation|1
1746704|NCT00895895|6088860|P5|Period 2|Other|1
1746705|NCT00895895|6088861|P4|Period 2|Other|1
1746706|NCT00895895|6088862|P3|Period 2|Other|3
1746707|NCT00895895|6088863|P2|Period 2|Other|1
1746708|NCT00895895|6088864|P1|Period 2|Other|1
1746709|NCT00895895|6088860|P5|Period 2|Lost to Follow-up|0
1746710|NCT00895895|6088861|P4|Period 2|Lost to Follow-up|1
1746711|NCT00895895|6088862|P3|Period 2|Lost to Follow-up|1
1746712|NCT00895895|6088863|P2|Period 2|Lost to Follow-up|2
1746713|NCT00895895|6088864|P1|Period 2|Lost to Follow-up|1
1746714|NCT00895895|6088860|P5|Period 2|investigator request|0
1746715|NCT00895895|6088861|P4|Period 2|investigator request|0
1746716|NCT00895895|6088862|P3|Period 2|investigator request|0
1746717|NCT00895895|6088863|P2|Period 2|investigator request|0
1746718|NCT00895895|6088864|P1|Period 2|investigator request|2
1746719|NCT00895895|6088860|P5|Period 2|failed to return|0
1746720|NCT00895895|6088861|P4|Period 2|failed to return|0
1746721|NCT00895895|6088862|P3|Period 2|failed to return|0
1746722|NCT00895895|6088863|P2|Period 2|failed to return|0
1746723|NCT00895895|6088864|P1|Period 2|failed to return|2
1746724|NCT00895895|6088860|P5|Period 2|discontinued by sponsor|37
1746725|NCT00895895|6088861|P4|Period 2|discontinued by sponsor|46
1746726|NCT00895895|6088862|P3|Period 2|discontinued by sponsor|38
1746727|NCT00895895|6088863|P2|Period 2|discontinued by sponsor|44
1746728|NCT00895895|6088864|P1|Period 2|discontinued by sponsor|44
1746729|NCT00895895|6088860|P5|Period 2|Death|0
1746730|NCT00895895|6088861|P4|Period 2|Death|0
1746731|NCT00895895|6088862|P3|Period 2|Death|1
1746732|NCT00895895|6088863|P2|Period 2|Death|0
1746733|NCT00895895|6088864|P1|Period 2|Death|0
1746734|NCT00895895|6088860|P5|Period 2|Adverse Event|5
1746735|NCT00895895|6088861|P4|Period 2|Adverse Event|2
1746736|NCT00895895|6088862|P3|Period 2|Adverse Event|5
1746737|NCT00895895|6088863|P2|Period 2|Adverse Event|3
1746738|NCT00895895|6088864|P1|Period 2|Adverse Event|3
1746739|NCT00895895|6088860|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
1746740|NCT00895895|6088861|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1746741|NCT00895895|6088862|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1746742|NCT00895895|6088863|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1746743|NCT00895895|6088864|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
1746744|NCT00895895|6088860|P5|After Period 1, Prior to Period 2|Protocol Violation|1
1746745|NCT00895895|6088861|P4|After Period 1, Prior to Period 2|Protocol Violation|0
1746746|NCT00895895|6088862|P3|After Period 1, Prior to Period 2|Protocol Violation|0
1746747|NCT00895895|6088863|P2|After Period 1, Prior to Period 2|Protocol Violation|0
1746748|NCT00895895|6088864|P1|After Period 1, Prior to Period 2|Protocol Violation|0
1746749|NCT00895895|6088860|P5|After Period 1, Prior to Period 2|Other|0
1746750|NCT00895895|6088861|P4|After Period 1, Prior to Period 2|Other|0
1746751|NCT00895895|6088862|P3|After Period 1, Prior to Period 2|Other|1
1746752|NCT00895895|6088863|P2|After Period 1, Prior to Period 2|Other|0
1746753|NCT00895895|6088864|P1|After Period 1, Prior to Period 2|Other|0
1746845|NCT00895245|6089189|P1|Overall Study|Lack of Efficacy|6
1746754|NCT00895895|6088860|P5|After Period 1, Prior to Period 2|Adverse Event|0
1746755|NCT00895895|6088861|P4|After Period 1, Prior to Period 2|Adverse Event|0
1746756|NCT00895895|6088862|P3|After Period 1, Prior to Period 2|Adverse Event|1
1746757|NCT00895895|6088863|P2|After Period 1, Prior to Period 2|Adverse Event|0
1746758|NCT00895895|6088864|P1|After Period 1, Prior to Period 2|Adverse Event|0
1746759|NCT00895895|6088860|P5|Period 1|randomized and not treated|2
1746760|NCT00895895|6088861|P4|Period 1|randomized and not treated|1
1746761|NCT00895895|6088862|P3|Period 1|randomized and not treated|1
1746762|NCT00895895|6088863|P2|Period 1|randomized and not treated|3
1746763|NCT00895895|6088864|P1|Period 1|randomized and not treated|1
1746764|NCT00895895|6088860|P5|Period 1|unsatisfactory response-efficacy|0
1746765|NCT00895895|6088861|P4|Period 1|unsatisfactory response-efficacy|0
1746766|NCT00895895|6088862|P3|Period 1|unsatisfactory response-efficacy|0
1746767|NCT00895895|6088863|P2|Period 1|unsatisfactory response-efficacy|0
1746768|NCT00895895|6088864|P1|Period 1|unsatisfactory response-efficacy|2
1746769|NCT00895895|6088860|P5|Period 1|Withdrawal by Subject|4
1746770|NCT00895895|6088861|P4|Period 1|Withdrawal by Subject|2
1746771|NCT00895895|6088862|P3|Period 1|Withdrawal by Subject|8
1746772|NCT00895895|6088863|P2|Period 1|Withdrawal by Subject|6
1746773|NCT00895895|6088864|P1|Period 1|Withdrawal by Subject|6
1746774|NCT00895895|6088860|P5|Period 1|Protocol Violation|0
1746775|NCT00895895|6088861|P4|Period 1|Protocol Violation|0
1746776|NCT00895895|6088862|P3|Period 1|Protocol Violation|0
1746777|NCT00895895|6088863|P2|Period 1|Protocol Violation|1
1746778|NCT00895895|6088864|P1|Period 1|Protocol Violation|0
1746779|NCT00895895|6088860|P5|Period 1|Other|1
1746780|NCT00895895|6088861|P4|Period 1|Other|1
1746781|NCT00895895|6088862|P3|Period 1|Other|1
1746782|NCT00895895|6088863|P2|Period 1|Other|2
1746783|NCT00895895|6088864|P1|Period 1|Other|1
1746784|NCT00895895|6088860|P5|Period 1|Lost to Follow-up|3
1746785|NCT00895895|6088861|P4|Period 1|Lost to Follow-up|2
1746786|NCT00895895|6088862|P3|Period 1|Lost to Follow-up|3
1746787|NCT00895895|6088863|P2|Period 1|Lost to Follow-up|1
1746788|NCT00895895|6088864|P1|Period 1|Lost to Follow-up|2
1746789|NCT00895895|6088860|P5|Period 1|investigator request|0
1746790|NCT00895895|6088861|P4|Period 1|investigator request|0
1746791|NCT00895895|6088862|P3|Period 1|investigator request|0
1746792|NCT00895895|6088863|P2|Period 1|investigator request|1
1746793|NCT00895895|6088864|P1|Period 1|investigator request|0
1746794|NCT00895895|6088860|P5|Period 1|failed to return|1
1746795|NCT00895895|6088861|P4|Period 1|failed to return|0
1746796|NCT00895895|6088862|P3|Period 1|failed to return|1
1746797|NCT00895895|6088863|P2|Period 1|failed to return|0
1746798|NCT00895895|6088864|P1|Period 1|failed to return|0
1746799|NCT00895895|6088860|P5|Period 1|discontinued by sponsor|1
1746800|NCT00895895|6088861|P4|Period 1|discontinued by sponsor|1
1746801|NCT00895895|6088862|P3|Period 1|discontinued by sponsor|2
1746802|NCT00895895|6088863|P2|Period 1|discontinued by sponsor|1
1746803|NCT00895895|6088864|P1|Period 1|discontinued by sponsor|2
1746804|NCT00895895|6088860|P5|Period 1|Death|1
1746805|NCT00895895|6088861|P4|Period 1|Death|0
1746806|NCT00895895|6088862|P3|Period 1|Death|0
1746807|NCT00895895|6088863|P2|Period 1|Death|0
1746808|NCT00895895|6088864|P1|Period 1|Death|0
1746809|NCT00895895|6088860|P5|Period 1|Adverse Event|7
1746810|NCT00895895|6088861|P4|Period 1|Adverse Event|6
1746811|NCT00895895|6088862|P3|Period 1|Adverse Event|4
1746812|NCT00895895|6088863|P2|Period 1|Adverse Event|6
1746813|NCT00895895|6088864|P1|Period 1|Adverse Event|7
1746814|NCT00895843|6088978|P2|Overall Study|Protocol Violation|12
1746815|NCT00895843|6088979|P1|Overall Study|Protocol Violation|12
1746816|NCT00895661|6089026|P1|Overall Study|reason unknown|2
1746817|NCT00895661|6089026|P1|Overall Study|Death|1
1746818|NCT00895622|6089036|P3|Overall Study|Protocol Violation|4
1746819|NCT00895622|6089037|P2|Overall Study|Protocol Violation|4
1746820|NCT00895622|6089038|P1|Overall Study|Protocol Violation|5
1746821|NCT00895583|6089061|P2|Overall Study|Other|1
1746822|NCT00895583|6089062|P1|Overall Study|Other|0
1746823|NCT00895583|6089061|P2|Overall Study|Lack of Efficacy|0
1746824|NCT00895583|6089062|P1|Overall Study|Lack of Efficacy|5
1746825|NCT00895583|6089061|P2|Overall Study|Withdrawal by Subject|2
1746826|NCT00895583|6089062|P1|Overall Study|Withdrawal by Subject|4
1746827|NCT00895583|6089061|P2|Overall Study|Protocol Violation|0
1746828|NCT00895583|6089062|P1|Overall Study|Protocol Violation|1
1746829|NCT00895583|6089061|P2|Overall Study|Lost to Follow-up|3
1746830|NCT00895583|6089062|P1|Overall Study|Lost to Follow-up|1
1746831|NCT00895583|6089061|P2|Overall Study|Physician Decision|1
1746832|NCT00895583|6089062|P1|Overall Study|Physician Decision|3
1746833|NCT00895583|6089061|P2|Overall Study|Death|1
1746834|NCT00895583|6089062|P1|Overall Study|Death|2
1746835|NCT00895583|6089061|P2|Overall Study|Adverse Event|4
1746836|NCT00895583|6089062|P1|Overall Study|Adverse Event|28
1746837|NCT00895453|6089152|P3|Overall Study|Lost to Follow-up|23
1746838|NCT00895453|6089153|P2|Overall Study|Lost to Follow-up|25
1746839|NCT00895453|6089154|P1|Overall Study|Lost to Follow-up|25
1746840|NCT00895414|6089162|P2|First Intervention (14 Days)|Physician Decision|1
1746841|NCT00895414|6089163|P1|First Intervention (14 Days)|Physician Decision|0
1746842|NCT00895414|6089162|P2|First Intervention (14 Days)|Withdrawal by Subject|0
1746843|NCT00895414|6089163|P1|First Intervention (14 Days)|Withdrawal by Subject|1
1746844|NCT00895310|6089173|P1|Overall Study|Withdrawal by Subject|1
1746846|NCT00895154|6089267|P2|Overall Study|Withdrawal by Subject|1
1746847|NCT00895154|6089268|P1|Overall Study|Withdrawal by Subject|0
1746848|NCT00895154|6089267|P2|Overall Study|Lost to Follow-up|1
1746849|NCT00895154|6089268|P1|Overall Study|Lost to Follow-up|1
1746850|NCT00895037|6089303|P3|Overall Study|Death|1
1746851|NCT00895037|6089304|P2|Overall Study|Death|2
1746852|NCT00895037|6089305|P1|Overall Study|Death|0
1746853|NCT00895011|6089336|P3|Overall Study|schedule conflict|0
1746854|NCT00895011|6089337|P2|Overall Study|schedule conflict|0
1746855|NCT00895011|6089338|P1|Overall Study|schedule conflict|1
1746856|NCT00895011|6089336|P3|Overall Study|Adverse Event|2
1746857|NCT00895011|6089337|P2|Overall Study|Adverse Event|2
1746858|NCT00895011|6089338|P1|Overall Study|Adverse Event|1
1746859|NCT00895011|6089336|P3|Overall Study|Protocol Violation|3
1746860|NCT00895011|6089337|P2|Overall Study|Protocol Violation|1
1746861|NCT00895011|6089338|P1|Overall Study|Protocol Violation|3
1746862|NCT00895011|6089336|P3|Overall Study|Lost to Follow-up|1
1746863|NCT00895011|6089337|P2|Overall Study|Lost to Follow-up|4
1746864|NCT00895011|6089338|P1|Overall Study|Lost to Follow-up|5
1746865|NCT00895011|6089336|P3|Overall Study|Withdrawal by Subject|2
1746866|NCT00895011|6089337|P2|Overall Study|Withdrawal by Subject|7
1746867|NCT00895011|6089338|P1|Overall Study|Withdrawal by Subject|14
1746868|NCT00894933|6089352|P1|Overall Study|Did not meeting incl/excl criteria|1
1746869|NCT00894933|6089352|P1|Overall Study|Cancelled Procedure|1
1746870|NCT00894933|6089352|P1|Overall Study|Lost to Follow-up|2
1746871|NCT00894803|6089370|P2|Overall Study|Lost to Follow-up|1
1746872|NCT00894803|6089371|P1|Overall Study|Lost to Follow-up|0
1746873|NCT00894803|6089370|P2|Overall Study|Death|4
1746874|NCT00894803|6089371|P1|Overall Study|Death|20
1746875|NCT00894790|6089407|P2|Overall Study|Did not meet entrance criteria|0
1746876|NCT00894790|6089408|P1|Overall Study|Did not meet entrance criteria|1
1746877|NCT00894790|6089407|P2|Overall Study|Lost to Follow-up|1
1746878|NCT00894790|6089408|P1|Overall Study|Lost to Follow-up|0
1746879|NCT00894790|6089407|P2|Overall Study|Protocol Violation|1
1746880|NCT00894790|6089408|P1|Overall Study|Protocol Violation|0
1746881|NCT00894686|6089450|P1|Overall Study|Other|5
1746882|NCT00894686|6089450|P1|Overall Study|Physician Decision|1
1746883|NCT00894686|6089450|P1|Overall Study|Withdrawal by Subject|50
1746884|NCT00894647|6089474|P2|Overall Study|Other, not due to AE|2
1746885|NCT00894647|6089475|P1|Overall Study|Other, not due to AE|1
1746886|NCT00894647|6089474|P2|Overall Study|Non-compliance with study procedures|2
1746887|NCT00894647|6089475|P1|Overall Study|Non-compliance with study procedures|0
1746888|NCT00894647|6089474|P2|Overall Study|Lost to Follow-up|2
1746889|NCT00894647|6089475|P1|Overall Study|Lost to Follow-up|0
1746890|NCT00894647|6089474|P2|Overall Study|Withdrawal by Subject|4
1746891|NCT00894647|6089475|P1|Overall Study|Withdrawal by Subject|4
1746892|NCT00894647|6089474|P2|Overall Study|Adverse Event|4
1746893|NCT00894647|6089475|P1|Overall Study|Adverse Event|5
1746894|NCT00894556|6089488|P4|Treatment Phase|Lack of Qualifying Event|0
1746895|NCT00894556|6089489|P3|Treatment Phase|Lack of Qualifying Event|0
1746896|NCT00894556|6089490|P2|Treatment Phase|Lack of Qualifying Event|1
1746897|NCT00894556|6089491|P1|Treatment Phase|Lack of Qualifying Event|2
1746898|NCT00894556|6089488|P4|Treatment Phase|Lost to Follow-up|0
1746899|NCT00894556|6089489|P3|Treatment Phase|Lost to Follow-up|1
1746900|NCT00894556|6089490|P2|Treatment Phase|Lost to Follow-up|3
1746901|NCT00894556|6089491|P1|Treatment Phase|Lost to Follow-up|2
1746902|NCT00894556|6089488|P4|Baseline Phase|Did not meet Randomization Criteria|85
1746903|NCT00894556|6089489|P3|Baseline Phase|Did not meet Randomization Criteria|0
1746904|NCT00894556|6089490|P2|Baseline Phase|Did not meet Randomization Criteria|0
1746905|NCT00894556|6089491|P1|Baseline Phase|Did not meet Randomization Criteria|0
1746906|NCT00894543|6089502|P2|Week 4 to Week 8|No diary or lost or withdrew|2
1746907|NCT00894543|6089503|P1|Week 4 to Week 8|No diary or lost or withdrew|4
1746908|NCT00894543|6089502|P2|Baseline to Week 4|No diary or lost or withdrew|2
1746909|NCT00894543|6089503|P1|Baseline to Week 4|No diary or lost or withdrew|3
1746910|NCT00894413|6089569|P2|Overall Study|Withdrawal by Subject|4
1746911|NCT00894413|6089570|P1|Overall Study|Withdrawal by Subject|0
1746912|NCT00894413|6089569|P2|Overall Study|Adverse Event|2
1746913|NCT00894413|6089570|P1|Overall Study|Adverse Event|0
1746914|NCT00894413|6089569|P2|Overall Study|Physician Decision|2
1746915|NCT00894413|6089570|P1|Overall Study|Physician Decision|0
1746916|NCT00894387|6089578|P2|Overall Study|GCP non-compliance|2
1746917|NCT00894387|6089579|P1|Overall Study|GCP non-compliance|0
1746918|NCT00894387|6089578|P2|Overall Study|Mis-randomized|9
1746919|NCT00894387|6089579|P1|Overall Study|Mis-randomized|13
1746920|NCT00894387|6089578|P2|Overall Study|Other (Missing)|3
1746921|NCT00894387|6089579|P1|Overall Study|Other (Missing)|5
1746922|NCT00894387|6089578|P2|Overall Study|Patient's request|30
1746923|NCT00894387|6089579|P1|Overall Study|Patient's request|25
1746924|NCT00894387|6089578|P2|Overall Study|Protocol Deviation|0
1746925|NCT00894387|6089579|P1|Overall Study|Protocol Deviation|4
1746926|NCT00894387|6089578|P2|Overall Study|Death|76
1746927|NCT00894387|6089579|P1|Overall Study|Death|77
1746928|NCT00894387|6089578|P2|Overall Study|Administrative problems|2
1746929|NCT00894387|6089579|P1|Overall Study|Administrative problems|2
1746930|NCT00894387|6089578|P2|Overall Study|Lost to Follow-up|5
1746931|NCT00894387|6089579|P1|Overall Study|Lost to Follow-up|3
1746932|NCT00894387|6089578|P2|Overall Study|Unsatisfactory therapeutic effect|1
1746933|NCT00894387|6089579|P1|Overall Study|Unsatisfactory therapeutic effect|0
1746934|NCT00894387|6089578|P2|Overall Study|Abnormal Laboratory values|2
1746935|NCT00894387|6089579|P1|Overall Study|Abnormal Laboratory values|2
1746936|NCT00894387|6089578|P2|Overall Study|Adverse Event|45
1746937|NCT00894387|6089579|P1|Overall Study|Adverse Event|44
1746938|NCT00894361|6089599|P2|Overall Study|deaths and less than 2 yr followup|64
1746939|NCT00894361|6089600|P1|Overall Study|deaths and less than 2 yr followup|24
1746940|NCT00894322|6089609|P3|Overall Study|Withdrawal by Subject|0
1746941|NCT00894322|6089610|P2|Overall Study|Withdrawal by Subject|0
1746942|NCT00894322|6089611|P1|Overall Study|Withdrawal by Subject|1
1746943|NCT00894166|6089662|P8|Overall Study|Death|0
1746944|NCT00894166|6089663|P7|Overall Study|Death|0
1746945|NCT00894166|6089664|P6|Overall Study|Death|0
1746946|NCT00894166|6089665|P5|Overall Study|Death|0
1746947|NCT00894166|6089666|P4|Overall Study|Death|1
1746948|NCT00894166|6089667|P3|Overall Study|Death|0
1746949|NCT00894166|6089668|P2|Overall Study|Death|0
1746950|NCT00894166|6089669|P1|Overall Study|Death|0
1746951|NCT00894166|6089662|P8|Overall Study|Withdrew or Lost to Follow-Up|34
1746952|NCT00894166|6089663|P7|Overall Study|Withdrew or Lost to Follow-Up|16
1746953|NCT00894166|6089664|P6|Overall Study|Withdrew or Lost to Follow-Up|16
1746954|NCT00894166|6089665|P5|Overall Study|Withdrew or Lost to Follow-Up|24
1746955|NCT00894166|6089666|P4|Overall Study|Withdrew or Lost to Follow-Up|68
1746956|NCT00894166|6089667|P3|Overall Study|Withdrew or Lost to Follow-Up|62
1746957|NCT00894166|6089668|P2|Overall Study|Withdrew or Lost to Follow-Up|63
1746958|NCT00894166|6089669|P1|Overall Study|Withdrew or Lost to Follow-Up|61
1746959|NCT00893971|6089715|P1|Overall Study|Physician Decision|3
1746960|NCT00893789|6089833|P4|Overall Study|Lost to Follow-up|1
1746961|NCT00893789|6089834|P3|Overall Study|Lost to Follow-up|0
1746962|NCT00893789|6089835|P2|Overall Study|Lost to Follow-up|0
1746963|NCT00893789|6089836|P1|Overall Study|Lost to Follow-up|0
1746964|NCT00893789|6089833|P4|Overall Study|Protocol Violation|4
1746965|NCT00893789|6089834|P3|Overall Study|Protocol Violation|1
1746966|NCT00893789|6089835|P2|Overall Study|Protocol Violation|1
1746967|NCT00893789|6089836|P1|Overall Study|Protocol Violation|0
1746968|NCT00893789|6089833|P4|Overall Study|Adverse Event|5
1746969|NCT00893789|6089834|P3|Overall Study|Adverse Event|1
1746970|NCT00893789|6089835|P2|Overall Study|Adverse Event|2
1746971|NCT00893789|6089836|P1|Overall Study|Adverse Event|0
1746972|NCT00893789|6089833|P4|Overall Study|Taking Excluded Concomitant Medication|0
1746973|NCT00893789|6089834|P3|Overall Study|Taking Excluded Concomitant Medication|1
1746974|NCT00893789|6089835|P2|Overall Study|Taking Excluded Concomitant Medication|0
1746975|NCT00893789|6089836|P1|Overall Study|Taking Excluded Concomitant Medication|1
1746976|NCT00893789|6089833|P4|Overall Study|Noncompliance With Study Procedures|0
1746977|NCT00893789|6089834|P3|Overall Study|Noncompliance With Study Procedures|0
1746978|NCT00893789|6089835|P2|Overall Study|Noncompliance With Study Procedures|0
1746979|NCT00893789|6089836|P1|Overall Study|Noncompliance With Study Procedures|1
1746980|NCT00893789|6089833|P4|Overall Study|Noncompliance With Study Drug|2
1746981|NCT00893789|6089834|P3|Overall Study|Noncompliance With Study Drug|1
1746982|NCT00893789|6089835|P2|Overall Study|Noncompliance With Study Drug|0
1746983|NCT00893789|6089836|P1|Overall Study|Noncompliance With Study Drug|1
1746984|NCT00893789|6089833|P4|Overall Study|Withdrawal by Subject|1
1746985|NCT00893789|6089834|P3|Overall Study|Withdrawal by Subject|3
1746986|NCT00893789|6089835|P2|Overall Study|Withdrawal by Subject|1
1746987|NCT00893789|6089836|P1|Overall Study|Withdrawal by Subject|3
1746988|NCT00893763|6089920|P2|Overall Study|extubated|110
1746989|NCT00893763|6089921|P1|Overall Study|extubated|110
1746990|NCT00893737|6089929|P1|Overall Study|Lost to Follow-up|6
1746991|NCT00893737|6089929|P1|Overall Study|Withdrawal by Subject|2
1746992|NCT00893737|6089929|P1|Overall Study|Adverse Event|4
1746993|NCT00893464|6089943|P8|Overall Study|Did not complete therapy/experience PD|2
1746994|NCT00893464|6089944|P7|Overall Study|Did not complete therapy/experience PD|2
1746995|NCT00893464|6089945|P6|Overall Study|Did not complete therapy/experience PD|0
1746996|NCT00893464|6089946|P5|Overall Study|Did not complete therapy/experience PD|0
1746997|NCT00893464|6089947|P4|Overall Study|Did not complete therapy/experience PD|0
1746998|NCT00893464|6089948|P3|Overall Study|Did not complete therapy/experience PD|0
1746999|NCT00893464|6089949|P2|Overall Study|Did not complete therapy/experience PD|0
1747000|NCT00893464|6089950|P1|Overall Study|Did not complete therapy/experience PD|0
1747001|NCT00893113|6090077|P2|Overall Study|Withdrew Consent|7
1747002|NCT00893113|6090078|P1|Overall Study|Withdrew Consent|8
1747003|NCT00893113|6090077|P2|Overall Study|Early Termination|1
1747004|NCT00893113|6090078|P1|Overall Study|Early Termination|1
1747005|NCT00893113|6090077|P2|Overall Study|Lost to Follow-up|8
1747006|NCT00893113|6090078|P1|Overall Study|Lost to Follow-up|4
1747007|NCT00892957|6090108|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
1747008|NCT00892957|6090109|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
1747009|NCT00892957|6090108|P2|Between Postoperative Day 1 and Day 14|Death|2
1747010|NCT00892957|6090109|P1|Between Postoperative Day 1 and Day 14|Death|0
1747011|NCT00892775|6090197|P2|Overall Study|Lost to Follow-up|0
1747012|NCT00892775|6090198|P1|Overall Study|Lost to Follow-up|1
1747013|NCT00892775|6090197|P2|Overall Study|Withdrawal by Subject|1
1747014|NCT00892775|6090198|P1|Overall Study|Withdrawal by Subject|0
1747015|NCT00892775|6090197|P2|Overall Study|Migrated/ moved from study area|0
1747016|NCT00892775|6090198|P1|Overall Study|Migrated/ moved from study area|1
1747017|NCT00892775|6090197|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
1747018|NCT00892775|6090198|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
1747019|NCT00892775|6090197|P2|Overall Study|Subject difficulties with blood drawing|0
1747020|NCT00892775|6090198|P1|Overall Study|Subject difficulties with blood drawing|1
1747021|NCT00892775|6090197|P2|Overall Study|Protocol Violation|0
1747022|NCT00892775|6090198|P1|Overall Study|Protocol Violation|1
1747023|NCT00892723|6090225|P3|Overall Study|Withdrawal by Subject|1
1747024|NCT00892723|6090226|P2|Overall Study|Withdrawal by Subject|1
1747025|NCT00892723|6090227|P1|Overall Study|Withdrawal by Subject|1
1747026|NCT00892723|6090225|P3|Overall Study|Lost to Follow-up|1
1747027|NCT00892723|6090226|P2|Overall Study|Lost to Follow-up|3
1747028|NCT00892723|6090227|P1|Overall Study|Lost to Follow-up|1
1747029|NCT00892437|6090316|P2|Open-Label Extension Phase|Withdrew Consent|1
1747030|NCT00892437|6090317|P1|Open-Label Extension Phase|Withdrew Consent|3
1747031|NCT00892437|6090316|P2|Open-Label Extension Phase|Investigator's Discretion|0
1747032|NCT00892437|6090317|P1|Open-Label Extension Phase|Investigator's Discretion|1
1747033|NCT00892437|6090316|P2|Open-Label Extension Phase|Lost to Follow-up|1
1747034|NCT00892437|6090317|P1|Open-Label Extension Phase|Lost to Follow-up|3
1747035|NCT00892437|6090316|P2|Open-Label Extension Phase|Lack of Efficacy|0
1747036|NCT00892437|6090317|P1|Open-Label Extension Phase|Lack of Efficacy|1
1747037|NCT00892437|6090316|P2|Open-Label Extension Phase|Adverse Event|2
1747038|NCT00892437|6090317|P1|Open-Label Extension Phase|Adverse Event|4
1747039|NCT00892437|6090316|P2|Randomized Phase|Withdrew Consent|0
1747040|NCT00892437|6090317|P1|Randomized Phase|Withdrew Consent|1
1747041|NCT00892437|6090316|P2|Randomized Phase|Investigator’s Discretion|0
1747042|NCT00892437|6090317|P1|Randomized Phase|Investigator’s Discretion|1
1747043|NCT00892437|6090316|P2|Randomized Phase|Lost to Follow-up|3
1747044|NCT00892437|6090317|P1|Randomized Phase|Lost to Follow-up|1
1747045|NCT00892437|6090316|P2|Randomized Phase|Adverse Event|2
1747046|NCT00892437|6090317|P1|Randomized Phase|Adverse Event|2
1747047|NCT00892437|6090316|P2|Randomized Phase|Randomized but not treated|0
1747048|NCT00892437|6090317|P1|Randomized Phase|Randomized but not treated|6
1747049|NCT00892281|6090336|P2|Overall Study|Visit 4 date out of window|0
1747050|NCT00892281|6090337|P1|Overall Study|Visit 4 date out of window|1
1747051|NCT00892281|6090336|P2|Overall Study|Rash on hand|0
1747052|NCT00892281|6090337|P1|Overall Study|Rash on hand|1
1747053|NCT00892281|6090336|P2|Overall Study|Subject had history of drug abuse|0
1747054|NCT00892281|6090337|P1|Overall Study|Subject had history of drug abuse|1
1747055|NCT00892281|6090336|P2|Overall Study|Non-compliant with visits as scheduled|0
1747056|NCT00892281|6090337|P1|Overall Study|Non-compliant with visits as scheduled|1
1747057|NCT00892281|6090336|P2|Overall Study|Missed visits rescheduled out of window|0
1747058|NCT00892281|6090337|P1|Overall Study|Missed visits rescheduled out of window|1
1747059|NCT00892281|6090336|P2|Overall Study|Missed multiple visits|0
1747060|NCT00892281|6090337|P1|Overall Study|Missed multiple visits|1
1747061|NCT00892281|6090336|P2|Overall Study|No show Visit 2; prescription not filled|0
1747062|NCT00892281|6090337|P1|Overall Study|No show Visit 2; prescription not filled|1
1747063|NCT00892281|6090336|P2|Overall Study|Subject not seen by PI at final visit|0
1747064|NCT00892281|6090337|P1|Overall Study|Subject not seen by PI at final visit|1
1747065|NCT00892281|6090336|P2|Overall Study|Lack of efficacy of study product|0
1747066|NCT00892281|6090337|P1|Overall Study|Lack of efficacy of study product|2
1747067|NCT00892281|6090336|P2|Overall Study|Death in family|0
1747068|NCT00892281|6090337|P1|Overall Study|Death in family|1
1747069|NCT00892281|6090336|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
1747070|NCT00892281|6090337|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
1747071|NCT00892281|6090336|P2|Overall Study|Subject lost interest in program|1
1747072|NCT00892281|6090337|P1|Overall Study|Subject lost interest in program|0
1747073|NCT00892281|6090336|P2|Overall Study|PI complained of inadequate compensation|0
1747074|NCT00892281|6090337|P1|Overall Study|PI complained of inadequate compensation|3
1747075|NCT00892281|6090336|P2|Overall Study|Scheduled for knee replacement|1
1747076|NCT00892281|6090337|P1|Overall Study|Scheduled for knee replacement|0
1747077|NCT00892281|6090336|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
1747078|NCT00892281|6090337|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
1747079|NCT00892281|6090336|P2|Overall Study|Subject missed several visits/lost meds|0
1747080|NCT00892281|6090337|P1|Overall Study|Subject missed several visits/lost meds|1
1747081|NCT00892281|6090336|P2|Overall Study|Subject did not return for any visits|0
1747082|NCT00892281|6090337|P1|Overall Study|Subject did not return for any visits|1
1747083|NCT00892281|6090336|P2|Overall Study|Subject not good candidate for study|0
1747084|NCT00892281|6090337|P1|Overall Study|Subject not good candidate for study|1
1747085|NCT00892281|6090336|P2|Overall Study|Unable to redeem the drug voucher|0
1747086|NCT00892281|6090337|P1|Overall Study|Unable to redeem the drug voucher|1
1747087|NCT00892281|6090336|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
1747088|NCT00892281|6090337|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
1747089|NCT00892281|6090336|P2|Overall Study|Did not meet incl/excl criteria|0
1747090|NCT00892281|6090337|P1|Overall Study|Did not meet incl/excl criteria|1
1747091|NCT00892281|6090336|P2|Overall Study|Last visit not done - death in family|0
1747092|NCT00892281|6090337|P1|Overall Study|Last visit not done - death in family|1
1747093|NCT00892281|6090336|P2|Overall Study|Family emergency|0
1747094|NCT00892281|6090337|P1|Overall Study|Family emergency|1
1747095|NCT00892281|6090336|P2|Overall Study|Subject completed day after study closed|0
1747096|NCT00892281|6090337|P1|Overall Study|Subject completed day after study closed|1
1747097|NCT00892281|6090336|P2|Overall Study|Final visit completed 4 weeks late|1
1747098|NCT00892281|6090337|P1|Overall Study|Final visit completed 4 weeks late|0
1747099|NCT00892281|6090336|P2|Overall Study|Subject unable to keep follow-up visits|0
1747100|NCT00892281|6090337|P1|Overall Study|Subject unable to keep follow-up visits|1
1747101|NCT00892281|6090336|P2|Overall Study|Subject failed to return for final visit|0
1747102|NCT00892281|6090337|P1|Overall Study|Subject failed to return for final visit|2
1747103|NCT00892281|6090336|P2|Overall Study|Withdrawal by Subject|14
1747104|NCT00892281|6090337|P1|Overall Study|Withdrawal by Subject|86
1747105|NCT00892281|6090336|P2|Overall Study|Protocol Violation|2
1747106|NCT00892281|6090337|P1|Overall Study|Protocol Violation|7
1747107|NCT00892281|6090336|P2|Overall Study|Pregnancy|0
1747108|NCT00892281|6090337|P1|Overall Study|Pregnancy|1
1747109|NCT00892281|6090336|P2|Overall Study|Lost to Follow-up|8
1747110|NCT00892281|6090337|P1|Overall Study|Lost to Follow-up|81
1747111|NCT00892281|6090336|P2|Overall Study|Adverse Event|8
1747112|NCT00892281|6090337|P1|Overall Study|Adverse Event|65
1747113|NCT00892177|6090350|P6|Phase II|Withdrawal by Subject|1
1747114|NCT00892177|6090351|P5|Phase II|Withdrawal by Subject|4
1747115|NCT00892177|6090352|P4|Phase II|Withdrawal by Subject|0
1747116|NCT00892177|6090353|P3|Phase II|Withdrawal by Subject|0
1747117|NCT00892177|6090354|P2|Phase II|Withdrawal by Subject|0
1747118|NCT00892177|6090355|P1|Phase II|Withdrawal by Subject|0
1747119|NCT00892177|6090350|P6|Phase II|Ineligible|1
1747120|NCT00892177|6090351|P5|Phase II|Ineligible|1
1747121|NCT00892177|6090352|P4|Phase II|Ineligible|0
1747122|NCT00892177|6090353|P3|Phase II|Ineligible|0
1747123|NCT00892177|6090354|P2|Phase II|Ineligible|0
1747124|NCT00892177|6090355|P1|Phase II|Ineligible|0
1747125|NCT00892151|6090380|P1|Overall Study|Protocol Violation|1
1747126|NCT00892099|6090389|P3|Overall Study|Lost to Follow-up|1
1747127|NCT00892099|6090390|P2|Overall Study|Lost to Follow-up|0
1747128|NCT00892099|6090391|P1|Overall Study|Lost to Follow-up|0
1747129|NCT00892099|6090389|P3|Overall Study|investigator decision|1
1747130|NCT00892099|6090390|P2|Overall Study|investigator decision|0
1747131|NCT00892099|6090391|P1|Overall Study|investigator decision|0
1747132|NCT00892099|6090389|P3|Overall Study|kidney function recovered|0
1747133|NCT00892099|6090390|P2|Overall Study|kidney function recovered|1
1747134|NCT00892099|6090391|P1|Overall Study|kidney function recovered|0
1747135|NCT00892099|6090389|P3|Overall Study|no further details|1
1747136|NCT00892099|6090390|P2|Overall Study|no further details|0
1747137|NCT00892099|6090391|P1|Overall Study|no further details|1
1747138|NCT00892099|6090389|P3|Overall Study|Prolonged hospitalization|1
1747139|NCT00892099|6090390|P2|Overall Study|Prolonged hospitalization|0
1747140|NCT00892099|6090391|P1|Overall Study|Prolonged hospitalization|1
1747141|NCT00892099|6090389|P3|Overall Study|replocated|2
1747142|NCT00892099|6090390|P2|Overall Study|replocated|0
1747143|NCT00892099|6090391|P1|Overall Study|replocated|1
1747144|NCT00892099|6090389|P3|Overall Study|Adverse Event|0
1747145|NCT00892099|6090390|P2|Overall Study|Adverse Event|0
1747146|NCT00892099|6090391|P1|Overall Study|Adverse Event|1
1747147|NCT00892099|6090389|P3|Overall Study|Death|1
1747148|NCT00892099|6090390|P2|Overall Study|Death|0
1747149|NCT00892099|6090391|P1|Overall Study|Death|1
1747150|NCT00892047|6090416|P2|Overall Study|Lack of Efficacy|2
1747151|NCT00892047|6090417|P1|Overall Study|Lack of Efficacy|0
1747152|NCT00892047|6090416|P2|Overall Study|subject burden|3
1747153|NCT00892047|6090417|P1|Overall Study|subject burden|2
1747154|NCT00892047|6090416|P2|Overall Study|Adverse Event|2
1747155|NCT00892047|6090417|P1|Overall Study|Adverse Event|2
1747156|NCT00892008|6090433|P1|Overall Study|Adverse Event|37
1747157|NCT00892008|6090433|P1|Overall Study|Other|378
1747158|NCT00892008|6090433|P1|Overall Study|Lost to Follow-up|142
1747159|NCT00892008|6090433|P1|Overall Study|Lack of Efficacy|3
1747160|NCT00892008|6090433|P1|Overall Study|Death|5
1747161|NCT00891930|6090519|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
1747162|NCT00891930|6090519|P1|Part 2: Panitumumab + Ganitumab|Death|30
1747163|NCT00891930|6090519|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
1747164|NCT00891930|6090519|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
1747165|NCT00891930|6090519|P1|Part 1: Panitumumab +Irinotecan|Death|38
1747166|NCT00891904|6090540|P1|Overall Study|Adverse Event|1
1747167|NCT00891904|6090540|P1|Overall Study|Death|1
1747168|NCT00891839|6090566|P1|Overall Study|Disease progression|3
1747169|NCT00891839|6090566|P1|Overall Study|Withdrawal by Subject|2
1747170|NCT00891839|6090566|P1|Overall Study|Adverse Event|2
1747171|NCT00891813|6090575|P1|Overall Study|Protocol Violation|2
1747172|NCT00891813|6090575|P1|Overall Study|Patient Noncompliance|6
1747173|NCT00891813|6090575|P1|Overall Study|Withdrawal by Subject|1
1747174|NCT00891813|6090575|P1|Overall Study|Adverse Event|3
1747175|NCT00891774|6090581|P1|Overall Study|Protocol Violation|4
1747176|NCT00891774|6090581|P1|Overall Study|Withdrawal by Subject|2
1747177|NCT00891774|6090581|P1|Overall Study|Illness (Self/Mother)|3
1747178|NCT00891774|6090581|P1|Overall Study|Lost to Follow-up|5
1747179|NCT00891735|6090592|P4|Overall Study|Patient's decision to withdraw|8
1747180|NCT00891735|6090593|P3|Overall Study|Patient's decision to withdraw|4
1747181|NCT00891735|6090594|P2|Overall Study|Patient's decision to withdraw|9
1747182|NCT00891735|6090595|P1|Overall Study|Patient's decision to withdraw|4
1747183|NCT00891735|6090592|P4|Overall Study|Physician's decision to withdraw patient|0
1747184|NCT00891735|6090593|P3|Overall Study|Physician's decision to withdraw patient|0
1747185|NCT00891735|6090594|P2|Overall Study|Physician's decision to withdraw patient|0
1747186|NCT00891735|6090595|P1|Overall Study|Physician's decision to withdraw patient|1
1747187|NCT00891735|6090592|P4|Overall Study|Lost to Follow-up|2
1747188|NCT00891735|6090593|P3|Overall Study|Lost to Follow-up|2
1747189|NCT00891735|6090594|P2|Overall Study|Lost to Follow-up|2
1747190|NCT00891735|6090595|P1|Overall Study|Lost to Follow-up|2
1747191|NCT00891735|6090592|P4|Overall Study|Death|5
1747192|NCT00891735|6090593|P3|Overall Study|Death|4
1747193|NCT00891735|6090594|P2|Overall Study|Death|5
1747194|NCT00891735|6090595|P1|Overall Study|Death|8
1747195|NCT00891735|6090592|P4|Overall Study|Adverse Event|0
1747196|NCT00891735|6090593|P3|Overall Study|Adverse Event|2
1747197|NCT00891735|6090594|P2|Overall Study|Adverse Event|0
1747198|NCT00891735|6090595|P1|Overall Study|Adverse Event|2
1747199|NCT00891657|6090635|P2|Overall Study|Withdrawal by Subject|1
1747200|NCT00891657|6090636|P1|Overall Study|Withdrawal by Subject|1
1747201|NCT00891618|6090648|P1|Overall Study|Withdrawal by Subject|1
1747202|NCT00891527|6090652|P1|Overall Study|Withdrawal by Subject|2
1747203|NCT00891462|6090661|P3|Overall Study|Lost to Follow-up|0
1747204|NCT00891462|6090662|P2|Overall Study|Lost to Follow-up|2
1747205|NCT00891462|6090663|P1|Overall Study|Lost to Follow-up|0
1747206|NCT00891462|6090661|P3|Overall Study|Inclusion/exclusion criteria|2
1747207|NCT00891462|6090662|P2|Overall Study|Inclusion/exclusion criteria|2
1747208|NCT00891462|6090663|P1|Overall Study|Inclusion/exclusion criteria|0
1747209|NCT00891462|6090661|P3|Overall Study|Protocol Violation|3
1747210|NCT00891462|6090662|P2|Overall Study|Protocol Violation|1
1747211|NCT00891462|6090663|P1|Overall Study|Protocol Violation|2
1747212|NCT00891462|6090661|P3|Overall Study|Other Reason|3
1747213|NCT00891462|6090662|P2|Overall Study|Other Reason|5
1747214|NCT00891462|6090663|P1|Overall Study|Other Reason|2
1747215|NCT00891462|6090661|P3|Overall Study|COPD exacerbation|1
1747216|NCT00891462|6090662|P2|Overall Study|COPD exacerbation|4
1747217|NCT00891462|6090663|P1|Overall Study|COPD exacerbation|7
1747218|NCT00891462|6090661|P3|Overall Study|Lack of Efficacy|1
1747219|NCT00891462|6090662|P2|Overall Study|Lack of Efficacy|5
1747220|NCT00891462|6090663|P1|Overall Study|Lack of Efficacy|10
1747221|NCT00891462|6090661|P3|Overall Study|Adverse Event|7
1747222|NCT00891462|6090662|P2|Overall Study|Adverse Event|8
1747223|NCT00891462|6090663|P1|Overall Study|Adverse Event|7
1747224|NCT00891462|6090661|P3|Overall Study|Withdrawal by Subject|7
1747225|NCT00891462|6090662|P2|Overall Study|Withdrawal by Subject|6
1747226|NCT00891462|6090663|P1|Overall Study|Withdrawal by Subject|9
1747227|NCT00891371|6090685|P1|Treatment|Lost to Follow-up|1
1747228|NCT00891371|6090685|P1|Treatment|Death|1
1747229|NCT00891371|6090685|P1|Treatment|Adverse Event|2
1747230|NCT00891371|6090685|P1|Treatment|Lack of Efficacy|5
1747231|NCT00891371|6090685|P1|Pre-assignment|Consent withdrawal|1
1747232|NCT00891371|6090685|P1|Pre-assignment|Inclusion/exclusion|5
1747233|NCT00891293|6090707|P1|Overall Study|Sponsor termination|62
1747234|NCT00891293|6090707|P1|Overall Study|Subject withdrew consent|7
1747235|NCT00891293|6090707|P1|Overall Study|Lost to Follow-up|7
1747236|NCT00891293|6090707|P1|Overall Study|Laboratory abnormality|4
1747237|NCT00891293|6090707|P1|Overall Study|Protocol Violation|2
1747238|NCT00891293|6090707|P1|Overall Study|Adverse Event|2
1747239|NCT00891228|6090722|P3|Overall Study|Pregnancy|0
1747240|NCT00891228|6090723|P2|Overall Study|Pregnancy|1
1747241|NCT00891228|6090724|P1|Overall Study|Pregnancy|0
1747242|NCT00891228|6090722|P3|Overall Study|Lost to Follow-up|5
1747243|NCT00891228|6090723|P2|Overall Study|Lost to Follow-up|4
1747244|NCT00891228|6090724|P1|Overall Study|Lost to Follow-up|4
1747245|NCT00891228|6090722|P3|Overall Study|Physician Decision|0
1747246|NCT00891228|6090723|P2|Overall Study|Physician Decision|1
1747247|NCT00891228|6090724|P1|Overall Study|Physician Decision|2
1747248|NCT00891228|6090722|P3|Overall Study|Protocol Violation|2
1747249|NCT00891228|6090723|P2|Overall Study|Protocol Violation|1
1747250|NCT00891228|6090724|P1|Overall Study|Protocol Violation|3
1747251|NCT00891228|6090722|P3|Overall Study|Withdrawal by Subject|5
1747252|NCT00891228|6090723|P2|Overall Study|Withdrawal by Subject|4
1747253|NCT00891228|6090724|P1|Overall Study|Withdrawal by Subject|2
1747254|NCT00891228|6090722|P3|Overall Study|Adverse Event|3
1747255|NCT00891228|6090723|P2|Overall Study|Adverse Event|2
1747256|NCT00891228|6090724|P1|Overall Study|Adverse Event|0
1747257|NCT00891202|6090746|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
1747258|NCT00891202|6090747|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
1747259|NCT00891202|6090748|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
1747260|NCT00891202|6090749|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
1747261|NCT00891202|6090746|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1747262|NCT00891202|6090747|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
1747263|NCT00891202|6090748|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1747264|NCT00891202|6090749|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
1747265|NCT00891202|6090746|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1747266|NCT00891202|6090747|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
1747267|NCT00891202|6090748|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1747268|NCT00891202|6090749|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
1747269|NCT00891202|6090746|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
1747270|NCT00891202|6090747|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
1747271|NCT00891202|6090748|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
1747272|NCT00891202|6090749|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
1747273|NCT00891046|6090925|P5|Overall Study|Lost to Follow-up|1
1747274|NCT00891046|6090926|P4|Overall Study|Lost to Follow-up|0
1747275|NCT00891046|6090927|P3|Overall Study|Lost to Follow-up|0
1747276|NCT00891046|6090928|P2|Overall Study|Lost to Follow-up|0
1747277|NCT00891046|6090929|P1|Overall Study|Lost to Follow-up|0
1747278|NCT00891046|6090925|P5|Overall Study|Withdrawal by Subject|1
1747279|NCT00891046|6090926|P4|Overall Study|Withdrawal by Subject|1
1747280|NCT00891046|6090927|P3|Overall Study|Withdrawal by Subject|2
1747281|NCT00891046|6090928|P2|Overall Study|Withdrawal by Subject|1
1747282|NCT00891046|6090929|P1|Overall Study|Withdrawal by Subject|2
1747283|NCT00891046|6090925|P5|Overall Study|Adverse Event|14
1747284|NCT00891046|6090926|P4|Overall Study|Adverse Event|0
1747285|NCT00891046|6090927|P3|Overall Study|Adverse Event|2
1747286|NCT00891046|6090928|P2|Overall Study|Adverse Event|3
1747287|NCT00891046|6090929|P1|Overall Study|Adverse Event|4
1747288|NCT00891046|6090925|P5|Overall Study|Participant no longer required drug|1
1747289|NCT00891046|6090926|P4|Overall Study|Participant no longer required drug|0
1747290|NCT00891046|6090927|P3|Overall Study|Participant no longer required drug|0
1747291|NCT00891046|6090928|P2|Overall Study|Participant no longer required drug|2
1747292|NCT00891046|6090929|P1|Overall Study|Participant no longer required drug|0
1747293|NCT00891046|6090925|P5|Overall Study|Administrative problems|1
1747294|NCT00891046|6090926|P4|Overall Study|Administrative problems|0
1747295|NCT00891046|6090927|P3|Overall Study|Administrative problems|0
1747296|NCT00891046|6090928|P2|Overall Study|Administrative problems|0
1747297|NCT00891046|6090929|P1|Overall Study|Administrative problems|0
1747298|NCT00891046|6090925|P5|Overall Study|Unsatisfactory therapeutic effect|20
1747299|NCT00891046|6090926|P4|Overall Study|Unsatisfactory therapeutic effect|2
1747300|NCT00891046|6090927|P3|Overall Study|Unsatisfactory therapeutic effect|19
1747301|NCT00891046|6090928|P2|Overall Study|Unsatisfactory therapeutic effect|2
1747302|NCT00891046|6090929|P1|Overall Study|Unsatisfactory therapeutic effect|5
1747303|NCT00891046|6090925|P5|Overall Study|Protocol Violation|1
1747304|NCT00891046|6090926|P4|Overall Study|Protocol Violation|0
1747305|NCT00891046|6090927|P3|Overall Study|Protocol Violation|0
1747306|NCT00891046|6090928|P2|Overall Study|Protocol Violation|1
1747307|NCT00891046|6090929|P1|Overall Study|Protocol Violation|1
1747308|NCT00891020|6091005|P3|Long-term Extension Period|Administrative|2
1747309|NCT00891020|6091006|P2|Long-term Extension Period|Administrative|2
1747310|NCT00891020|6091007|P1|Long-term Extension Period|Administrative|1
1747311|NCT00891020|6091005|P3|Long-term Extension Period|Failure to return|3
1747312|NCT00891020|6091006|P2|Long-term Extension Period|Failure to return|2
1747313|NCT00891020|6091007|P1|Long-term Extension Period|Failure to return|0
1747314|NCT00891020|6091005|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
1747315|NCT00891020|6091006|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
1747316|NCT00891020|6091007|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
1747317|NCT00891020|6091005|P3|Long-term Extension Period|Protocol Violation|1
1747318|NCT00891020|6091006|P2|Long-term Extension Period|Protocol Violation|1
1747319|NCT00891020|6091007|P1|Long-term Extension Period|Protocol Violation|0
1747320|NCT00891020|6091005|P3|Long-term Extension Period|Insufficient therapeutic response|2
1747321|NCT00891020|6091006|P2|Long-term Extension Period|Insufficient therapeutic response|2
1747322|NCT00891020|6091007|P1|Long-term Extension Period|Insufficient therapeutic response|3
1747323|NCT00891020|6091005|P3|Long-term Extension Period|Death|1
1747324|NCT00891020|6091006|P2|Long-term Extension Period|Death|0
1747325|NCT00891020|6091007|P1|Long-term Extension Period|Death|0
1747326|NCT00891020|6091005|P3|Long-term Extension Period|Adverse Event|10
1747327|NCT00891020|6091006|P2|Long-term Extension Period|Adverse Event|11
1747328|NCT00891020|6091007|P1|Long-term Extension Period|Adverse Event|1
1747329|NCT00891020|6091005|P3|24 Week Treatment Period|Administrative/Other|1
1747330|NCT00891020|6091006|P2|24 Week Treatment Period|Administrative/Other|6
1747331|NCT00891020|6091007|P1|24 Week Treatment Period|Administrative/Other|5
1747332|NCT00891020|6091005|P3|24 Week Treatment Period|Withdrew consent|15
1747333|NCT00891020|6091006|P2|24 Week Treatment Period|Withdrew consent|3
1747334|NCT00891020|6091007|P1|24 Week Treatment Period|Withdrew consent|6
1747335|NCT00891020|6091005|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
1747336|NCT00891020|6091006|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
1747337|NCT00891020|6091007|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
1747338|NCT00891020|6091005|P3|24 Week Treatment Period|Other protocol violation|2
1747339|NCT00891020|6091006|P2|24 Week Treatment Period|Other protocol violation|1
1747340|NCT00891020|6091007|P1|24 Week Treatment Period|Other protocol violation|1
1747341|NCT00891020|6091005|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
1747342|NCT00891020|6091006|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
1747343|NCT00891020|6091007|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
1747344|NCT00891020|6091005|P3|24 Week Treatment Period|Failure to return|5
1747345|NCT00891020|6091006|P2|24 Week Treatment Period|Failure to return|5
1747346|NCT00891020|6091007|P1|24 Week Treatment Period|Failure to return|4
1747347|NCT00891020|6091005|P3|24 Week Treatment Period|Insufficient therapeutic response|15
1747348|NCT00891020|6091006|P2|24 Week Treatment Period|Insufficient therapeutic response|9
1747349|NCT00891020|6091007|P1|24 Week Treatment Period|Insufficient therapeutic response|6
1747350|NCT00891020|6091005|P3|24 Week Treatment Period|Death|0
1747351|NCT00891020|6091006|P2|24 Week Treatment Period|Death|2
1747352|NCT00891020|6091007|P1|24 Week Treatment Period|Death|0
1747353|NCT00891020|6091005|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
1747354|NCT00891020|6091006|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
1747355|NCT00891020|6091007|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
1747356|NCT00890929|6091071|P1|Overall Study|Physician Decision|1
1747357|NCT00890929|6091071|P1|Overall Study|Withdrawal by Subject|3
1747358|NCT00890929|6091071|P1|Overall Study|Death before treatment|2
1747359|NCT00890825|6091089|P2|Overall Study|Alive at data cut off (DCO)|14
1747360|NCT00890825|6091090|P1|Overall Study|Alive at data cut off (DCO)|13
1747361|NCT00890825|6091089|P2|Overall Study|Withdrawal by Subject|0
1747362|NCT00890825|6091090|P1|Overall Study|Withdrawal by Subject|1
1747363|NCT00890695|6091119|P2|Overall Study|Protocol Violation|0
1747364|NCT00890695|6091120|P1|Overall Study|Protocol Violation|1
1747365|NCT00890591|6091149|P1|Overall Study|Lack of Efficacy|20
1747366|NCT00890552|6091155|P1|On-treatment|Early prog disease/ death|10
1747367|NCT00890552|6091155|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
1747368|NCT00890409|6091164|P2|Overall Study|Lost to Follow-up|21
1747369|NCT00890409|6091165|P1|Overall Study|Lost to Follow-up|20
1747370|NCT00890201|6091175|P2|Overall Study|Protocol Violation|56
1747371|NCT00890201|6091176|P1|Overall Study|Protocol Violation|5
1747372|NCT00890097|6091194|P3|Overall Study|Protocol Deviation|1
1747373|NCT00890097|6091195|P2|Overall Study|Protocol Deviation|1
1747374|NCT00890097|6091196|P1|Overall Study|Protocol Deviation|1
1747375|NCT00890097|6091194|P3|Overall Study|Subject Moved|0
1747376|NCT00890097|6091195|P2|Overall Study|Subject Moved|4
1747377|NCT00890097|6091196|P1|Overall Study|Subject Moved|0
1747378|NCT00890097|6091194|P3|Overall Study|Transportation|0
1747379|NCT00890097|6091195|P2|Overall Study|Transportation|2
1747380|NCT00890097|6091196|P1|Overall Study|Transportation|0
1747381|NCT00890097|6091194|P3|Overall Study|Failed inclusion criteria|0
1747382|NCT00890097|6091195|P2|Overall Study|Failed inclusion criteria|4
1747383|NCT00890097|6091196|P1|Overall Study|Failed inclusion criteria|3
1747384|NCT00890097|6091194|P3|Overall Study|Randomization Error|0
1747385|NCT00890097|6091195|P2|Overall Study|Randomization Error|0
1747386|NCT00890097|6091196|P1|Overall Study|Randomization Error|2
1747387|NCT00890097|6091194|P3|Overall Study|Subject Decision|6
1747388|NCT00890097|6091195|P2|Overall Study|Subject Decision|2
1747389|NCT00890097|6091196|P1|Overall Study|Subject Decision|3
1747390|NCT00890097|6091194|P3|Overall Study|Did not attend final visit|0
1747391|NCT00890097|6091195|P2|Overall Study|Did not attend final visit|3
1747392|NCT00890097|6091196|P1|Overall Study|Did not attend final visit|2
1747393|NCT00890097|6091194|P3|Overall Study|Sponsor Decision|7
1747394|NCT00890097|6091195|P2|Overall Study|Sponsor Decision|11
1747395|NCT00890097|6091196|P1|Overall Study|Sponsor Decision|7
1747396|NCT00890097|6091194|P3|Overall Study|Noncompliance|4
1747397|NCT00890097|6091195|P2|Overall Study|Noncompliance|4
1747398|NCT00890097|6091196|P1|Overall Study|Noncompliance|0
1747399|NCT00890097|6091194|P3|Overall Study|Lost to Follow-up|5
1747400|NCT00890097|6091195|P2|Overall Study|Lost to Follow-up|5
1747401|NCT00890097|6091196|P1|Overall Study|Lost to Follow-up|5
1747402|NCT00890097|6091194|P3|Overall Study|Withdrew Consent|9
1747403|NCT00890097|6091195|P2|Overall Study|Withdrew Consent|6
1747404|NCT00890097|6091196|P1|Overall Study|Withdrew Consent|9
1747405|NCT00890097|6091194|P3|Overall Study|Decision Unrelated to an Adverse Event|17
1747406|NCT00890097|6091195|P2|Overall Study|Decision Unrelated to an Adverse Event|12
1747407|NCT00890097|6091196|P1|Overall Study|Decision Unrelated to an Adverse Event|15
1747408|NCT00890097|6091194|P3|Overall Study|Adverse Event|28
1747409|NCT00890097|6091195|P2|Overall Study|Adverse Event|32
1747410|NCT00890097|6091196|P1|Overall Study|Adverse Event|21
1747411|NCT00890084|6091204|P1|Overall Study|Lost to Follow-up|126
1747412|NCT00890084|6091204|P1|Overall Study|Adverse Event|16
1747413|NCT00889863|6091244|P2|Part II: Randomized Double Blind|Protocol deviation|1
1747414|NCT00889863|6091245|P1|Part II: Randomized Double Blind|Protocol deviation|0
1747415|NCT00889863|6091244|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
1747416|NCT00889863|6091245|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
1747417|NCT00889863|6091244|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
1747418|NCT00889863|6091245|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
1747419|NCT00889863|6091244|P2|Part II: Randomized Double Blind|Adverse Event|4
1747420|NCT00889863|6091245|P1|Part II: Randomized Double Blind|Adverse Event|0
1747421|NCT00889863|6091244|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
1747422|NCT00889863|6091245|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
1747423|NCT00889863|6091244|P2|Part I: Open Label|Adverse Event|0
1747424|NCT00889863|6091245|P1|Part I: Open Label|Adverse Event|4
1747425|NCT00889863|6091244|P2|Part I: Open Label|Death|0
1747426|NCT00889863|6091245|P1|Part I: Open Label|Death|1
1747427|NCT00889720|6091271|P1|Overall Study|Other|4
1747428|NCT00889720|6091271|P1|Overall Study|Withdrawal by Subject|4
1747429|NCT00889707|6091298|P2|Overall Study|Lack of Efficacy|5
1747430|NCT00889707|6091299|P1|Overall Study|Lack of Efficacy|2
1747431|NCT00889707|6091298|P2|Overall Study|Lost to Follow-up|2
1747432|NCT00889707|6091299|P1|Overall Study|Lost to Follow-up|0
1747433|NCT00889707|6091298|P2|Overall Study|Withdrawal by Subject|3
1747434|NCT00889707|6091299|P1|Overall Study|Withdrawal by Subject|4
1747435|NCT00889707|6091298|P2|Overall Study|Adverse Event|0
1747436|NCT00889707|6091299|P1|Overall Study|Adverse Event|1
1747437|NCT00889681|6091307|P1|Overall Study|Insurance disapproval|1
1747438|NCT00889681|6091307|P1|Overall Study|Not meeting qualification Criteria|2
1747439|NCT00889603|6091314|P1|Overall Study|Other|4
1747440|NCT00889603|6091314|P1|Overall Study|No longer willing to participant in stud|4
1747441|NCT00889603|6091314|P1|Overall Study|Lost to Follow-up|19
1747442|NCT00889603|6091314|P1|Overall Study|Death|3
1747443|NCT00889603|6091314|P1|Overall Study|Adverse Event|7
1747444|NCT00889421|6091336|P1|Overall Study|Lack of Efficacy|3
1747445|NCT00889265|6091377|P1|Overall Study|Protocol Violation|1
1747446|NCT00889265|6091377|P1|Overall Study|Lost to Follow-up|5
1747447|NCT00889265|6091377|P1|Overall Study|Adverse Event|1
1747448|NCT00889252|6091384|P2|Overall Study|Protocol Violation|0
1747449|NCT00889252|6091385|P1|Overall Study|Protocol Violation|2
1747450|NCT00889252|6091384|P2|Overall Study|Withdrawal by Subject|0
1747451|NCT00889252|6091385|P1|Overall Study|Withdrawal by Subject|3
1747452|NCT00889252|6091384|P2|Overall Study|Adverse Event|4
1747453|NCT00889252|6091385|P1|Overall Study|Adverse Event|2
1747454|NCT00889005|6091462|P2|Overall Study|Withdrawal by Subject|0
1747455|NCT00889005|6091463|P1|Overall Study|Withdrawal by Subject|4
1747456|NCT00889005|6091462|P2|Overall Study|Lost to Follow-up|2
1747457|NCT00889005|6091463|P1|Overall Study|Lost to Follow-up|4
1747458|NCT00888940|6091477|P2|Overall Study|Randomized Not Treated|13
1747459|NCT00888940|6091478|P1|Overall Study|Randomized Not Treated|11
1747460|NCT00888940|6091477|P2|Overall Study|Lost to Follow-up|5
1747461|NCT00888940|6091478|P1|Overall Study|Lost to Follow-up|5
1747462|NCT00888940|6091477|P2|Overall Study|Adverse Event|3
1747463|NCT00888940|6091478|P1|Overall Study|Adverse Event|12
1747464|NCT00888849|6091488|P2|Overall Study|Lost to Follow-up|2
1747465|NCT00888849|6091489|P1|Overall Study|Lost to Follow-up|1
1747466|NCT00888849|6091488|P2|Overall Study|Death|7
1747467|NCT00888849|6091489|P1|Overall Study|Death|4
1747468|NCT00888654|6091499|P1|Overall Study|Stopped meds due to headaches|1
1747469|NCT00888654|6091499|P1|Overall Study|Change in surg date|1
1747470|NCT00888654|6091499|P1|Overall Study|Inelig. due to contraindication of med|1
1747471|NCT00888654|6091499|P1|Overall Study|Withdrawal by Subject|1
1747472|NCT00888654|6091499|P1|Overall Study|Surgery aborted|2
1747473|NCT00888654|6091499|P1|Overall Study|Not enough oral meds before surgery|3
1747474|NCT00888654|6091499|P1|Overall Study|Problems swallowing oral meds.|1
1747475|NCT00888615|6091517|P1|Overall Study|No treatment|2
1747476|NCT00888433|6091537|P2|Overall Study|Missed Visit|1
1747477|NCT00888433|6091538|P1|Overall Study|Missed Visit|2
1747478|NCT00888433|6091537|P2|Overall Study|Withdrawal by Subject|2
1747479|NCT00888433|6091538|P1|Overall Study|Withdrawal by Subject|1
1747480|NCT00888381|6091546|P2|Overall Study|Lost to Follow-up|1
1747481|NCT00888381|6091547|P1|Overall Study|Lost to Follow-up|0
1747482|NCT00888355|6091567|P4|Overall Study|Withdrawal by Subject|3
1747483|NCT00888355|6091568|P3|Overall Study|Withdrawal by Subject|1
1747484|NCT00888355|6091569|P2|Overall Study|Withdrawal by Subject|3
1747485|NCT00888355|6091570|P1|Overall Study|Withdrawal by Subject|0
1747486|NCT00888355|6091567|P4|Overall Study|Protocol Violation|2
1747487|NCT00888355|6091568|P3|Overall Study|Protocol Violation|1
1747488|NCT00888355|6091569|P2|Overall Study|Protocol Violation|2
1747489|NCT00888355|6091570|P1|Overall Study|Protocol Violation|3
1747490|NCT00888355|6091567|P4|Overall Study|Lost to Follow-up|0
1747491|NCT00888355|6091568|P3|Overall Study|Lost to Follow-up|2
1747492|NCT00888355|6091569|P2|Overall Study|Lost to Follow-up|2
1747493|NCT00888355|6091570|P1|Overall Study|Lost to Follow-up|0
1747494|NCT00888355|6091567|P4|Overall Study|Lack of Efficacy|2
1747495|NCT00888355|6091568|P3|Overall Study|Lack of Efficacy|5
1747496|NCT00888355|6091569|P2|Overall Study|Lack of Efficacy|2
1747497|NCT00888355|6091570|P1|Overall Study|Lack of Efficacy|9
1747498|NCT00888355|6091567|P4|Overall Study|Adverse Event|3
1747499|NCT00888355|6091568|P3|Overall Study|Adverse Event|3
1747500|NCT00888355|6091569|P2|Overall Study|Adverse Event|0
1747501|NCT00888355|6091570|P1|Overall Study|Adverse Event|10
1747502|NCT00888329|6091626|P2|Overall Study|Physician Decision|9
1747503|NCT00888329|6091627|P1|Overall Study|Physician Decision|6
1747504|NCT00888238|6091633|P3|Washout Period After Period 2|Adverse Event|1
1747505|NCT00888238|6091634|P2|Washout Period After Period 2|Adverse Event|0
1747506|NCT00888238|6091635|P1|Washout Period After Period 2|Adverse Event|0
1747507|NCT00888173|6091643|P1|Overall Study|Ineligible: required test not done|1
1747508|NCT00888173|6091643|P1|Overall Study|Wrong Primary|1
1747509|NCT00888134|6091651|P1|Follow-up|being followed for long-term survival|1
1747510|NCT00888134|6091651|P1|Treatment With Study Drug|Withdrawal by Subject|1
1747511|NCT00887978|6091661|P2|Overall Study|Lost to Follow-up|1
1747512|NCT00887978|6091662|P1|Overall Study|Lost to Follow-up|0
1747513|NCT00887978|6091661|P2|Overall Study|Withdrawal by Subject|2
1747514|NCT00887978|6091662|P1|Overall Study|Withdrawal by Subject|1
1747515|NCT00887978|6091661|P2|Overall Study|Death|3
1747516|NCT00887978|6091662|P1|Overall Study|Death|2
1747517|NCT00887978|6091661|P2|Overall Study|Clinical Worsening|4
1747518|NCT00887978|6091662|P1|Overall Study|Clinical Worsening|4
1747519|NCT00887978|6091661|P2|Overall Study|Adverse Event|5
1747520|NCT00887978|6091662|P1|Overall Study|Adverse Event|18
1747521|NCT00887926|6091732|P4|Overall Study|Withdrawal by Subject|0
1747522|NCT00887926|6091733|P3|Overall Study|Withdrawal by Subject|0
1747523|NCT00887926|6091734|P2|Overall Study|Withdrawal by Subject|1
1747524|NCT00887926|6091735|P1|Overall Study|Withdrawal by Subject|0
1747525|NCT00887913|6091770|P1|Overall Study|Withdrawal by Subject|6
1747526|NCT00887822|6091778|P2|Overall Study|Randomized but not treated|1
1747527|NCT00887822|6091779|P1|Overall Study|Randomized but not treated|0
1747528|NCT00887822|6091778|P2|Overall Study|Protocol Violation|1
1747529|NCT00887822|6091779|P1|Overall Study|Protocol Violation|0
1747530|NCT00887822|6091778|P2|Overall Study|Death|3
1747531|NCT00887822|6091779|P1|Overall Study|Death|2
1747532|NCT00887822|6091778|P2|Overall Study|Administrative/Other than specified|4
1747533|NCT00887822|6091779|P1|Overall Study|Administrative/Other than specified|5
1747534|NCT00887822|6091778|P2|Overall Study|Refused treatment/Did not cooperate|10
1747535|NCT00887822|6091779|P1|Overall Study|Refused treatment/Did not cooperate|12
1747536|NCT00887822|6091778|P2|Overall Study|Failure to return|11
1747537|NCT00887822|6091779|P1|Overall Study|Failure to return|11
1747538|NCT00887822|6091778|P2|Overall Study|Adverse Event|17
1747539|NCT00887822|6091779|P1|Overall Study|Adverse Event|14
1747540|NCT00887822|6091778|P2|Overall Study|Insufficient therapeutic response|55
1747541|NCT00887822|6091779|P1|Overall Study|Insufficient therapeutic response|53
1747542|NCT00887809|6091811|P2|Overall Study|Death|0
1747543|NCT00887809|6091812|P1|Overall Study|Death|1
1747544|NCT00887809|6091811|P2|Overall Study|Patient Not Treated|0
1747545|NCT00887809|6091812|P1|Overall Study|Patient Not Treated|3
1747546|NCT00887744|6091818|P1|Overall Study|Various reasons|9
1747547|NCT00887744|6091818|P1|Overall Study|Withdrawal by Subject|18
1747548|NCT00887744|6091818|P1|Overall Study|Lost to Follow-up|3
1747549|NCT00887744|6091818|P1|Overall Study|Death|1
1747550|NCT00887744|6091818|P1|Overall Study|Adverse Event|3
1747551|NCT00887679|6091827|P1|Overall Study|Physician Decision|5
1747552|NCT00887679|6091827|P1|Overall Study|Lost to Follow-up|4
1747553|NCT00887679|6091827|P1|Overall Study|Withdrawal by Subject|1
1747554|NCT00887588|6091857|P2|Extension Period|Lost to Follow-up|0
1747555|NCT00887588|6091858|P1|Extension Period|Lost to Follow-up|1
1747556|NCT00887588|6091857|P2|Extension Period|Protocol deviation|0
1747557|NCT00887588|6091858|P1|Extension Period|Protocol deviation|1
1747558|NCT00887588|6091857|P2|Extension Period|Death|1
1747559|NCT00887588|6091858|P1|Extension Period|Death|0
1747560|NCT00887588|6091857|P2|Extension Period|Adverse Event|4
1747561|NCT00887588|6091858|P1|Extension Period|Adverse Event|4
1747562|NCT00887588|6091857|P2|Core Period|Adverse Event|11
1747563|NCT00887588|6091858|P1|Core Period|Adverse Event|9
1747564|NCT00887588|6091857|P2|Core Period|Withdrawal by Subject|8
1747565|NCT00887588|6091858|P1|Core Period|Withdrawal by Subject|6
1747566|NCT00887588|6091857|P2|Core Period|Lost to Follow-up|1
1747567|NCT00887588|6091858|P1|Core Period|Lost to Follow-up|3
1747568|NCT00887588|6091857|P2|Core Period|Death|1
1747569|NCT00887588|6091858|P1|Core Period|Death|1
1747570|NCT00887549|6091939|P1|Maintenance Therapy|Death due to adverse event|1
1747571|NCT00887549|6091939|P1|Maintenance Therapy|Progressive Disease|25
1747572|NCT00887549|6091939|P1|Maintenance Therapy|Physician Decision|1
1747573|NCT00887549|6091939|P1|Maintenance Therapy|Adverse Event|16
1747574|NCT00887549|6091939|P1|Induction Therapy|Death due to Study Drug Toxicity|1
1747575|NCT00887549|6091939|P1|Induction Therapy|Death due to Study Disease|4
1747576|NCT00887549|6091939|P1|Induction Therapy|Progressive Disease|13
1747577|NCT00887549|6091939|P1|Induction Therapy|Physician Decision|1
1747578|NCT00887549|6091939|P1|Induction Therapy|Adverse Event|8
1747579|NCT00887484|6091957|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
1747580|NCT00887484|6091957|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
1747581|NCT00887484|6091957|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
1747582|NCT00887354|6092045|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
1747583|NCT00887354|6092046|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
1747584|NCT00887354|6092045|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
1747585|NCT00887354|6092046|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
1747586|NCT00887354|6092045|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
1747587|NCT00887354|6092046|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
1747588|NCT00887354|6092045|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
1747589|NCT00887354|6092046|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
1747590|NCT00887354|6092045|P2|Open Label Phase (Week 26 to Week 78)|Death|2
1747591|NCT00887354|6092046|P1|Open Label Phase (Week 26 to Week 78)|Death|0
1747592|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
1747593|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
1747594|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
1747595|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
1747596|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
1747597|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
1747598|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
1747599|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
1747600|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
1747601|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
1747602|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
1747603|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
1747604|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
1747605|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
1747606|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
1747607|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
1747608|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
1747609|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
1747610|NCT00887354|6092045|P2|Treatment Phase (Week 0 to Week 26)|Death|1
1747611|NCT00887354|6092046|P1|Treatment Phase (Week 0 to Week 26)|Death|0
1747612|NCT00887341|6092066|P2|Overall Study|Lost to Follow-up|1
1747613|NCT00887341|6092067|P1|Overall Study|Lost to Follow-up|0
1747614|NCT00887341|6092066|P2|Overall Study|Adverse Event|1
1747615|NCT00887341|6092067|P1|Overall Study|Adverse Event|0
1747616|NCT00887341|6092066|P2|Overall Study|Withdrawal by Subject|1
1747617|NCT00887341|6092067|P1|Overall Study|Withdrawal by Subject|1
1747618|NCT00887341|6092066|P2|Overall Study|Refused treatment|0
1747619|NCT00887341|6092067|P1|Overall Study|Refused treatment|1
1747620|NCT00887315|6092103|P2|Overall Study|Study termination|4
1747621|NCT00887315|6092104|P1|Overall Study|Study termination|7
1747622|NCT00887289|6092112|P1|Overall Study|Other|20
1747623|NCT00887289|6092112|P1|Overall Study|Lost to Follow-up|8
1747624|NCT00887289|6092112|P1|Overall Study|Withdrawal by Subject|26
1747625|NCT00887289|6092112|P1|Overall Study|Adverse Event|27
1747626|NCT00887289|6092112|P1|Overall Study|Lack of Efficacy|14
1747627|NCT00887250|6092124|P3|Overall Study|Patient uncooperative|1
1747628|NCT00887250|6092125|P2|Overall Study|Patient uncooperative|0
1747629|NCT00887250|6092126|P1|Overall Study|Patient uncooperative|0
1747630|NCT00887250|6092124|P3|Overall Study|Withdrawal by Subject|2
1747631|NCT00887250|6092125|P2|Overall Study|Withdrawal by Subject|1
1747632|NCT00887250|6092126|P1|Overall Study|Withdrawal by Subject|2
1747633|NCT00887250|6092124|P3|Overall Study|Protocol Violation|1
1747634|NCT00887250|6092125|P2|Overall Study|Protocol Violation|2
1747635|NCT00887250|6092126|P1|Overall Study|Protocol Violation|2
1747636|NCT00887250|6092124|P3|Overall Study|Lost to Follow-up|1
1747637|NCT00887250|6092125|P2|Overall Study|Lost to Follow-up|3
1747638|NCT00887250|6092126|P1|Overall Study|Lost to Follow-up|2
1747639|NCT00887250|6092124|P3|Overall Study|Lack of Efficacy|1
1747640|NCT00887250|6092125|P2|Overall Study|Lack of Efficacy|6
1747641|NCT00887250|6092126|P1|Overall Study|Lack of Efficacy|9
1747642|NCT00887250|6092124|P3|Overall Study|Adverse Event|7
1747643|NCT00887250|6092125|P2|Overall Study|Adverse Event|0
1747644|NCT00887250|6092126|P1|Overall Study|Adverse Event|3
1747645|NCT00887224|6092149|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
1747646|NCT00887224|6092150|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
1747647|NCT00887224|6092151|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
1747648|NCT00887224|6092149|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
1747649|NCT00887224|6092150|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
1747650|NCT00887224|6092151|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
1747651|NCT00887224|6092149|P3|DB Taper Phase / Post Study Follow Up|Other|12
1747652|NCT00887224|6092150|P2|DB Taper Phase / Post Study Follow Up|Other|11
1747653|NCT00887224|6092151|P1|DB Taper Phase / Post Study Follow Up|Other|0
1747654|NCT00887224|6092149|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
1747655|NCT00887224|6092150|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
1747656|NCT00887224|6092151|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
1747657|NCT00887224|6092149|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
1747658|NCT00887224|6092150|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
1747659|NCT00887224|6092151|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
1747660|NCT00887224|6092149|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
1747661|NCT00887224|6092150|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
1747662|NCT00887224|6092151|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
1747663|NCT00887224|6092149|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
1747664|NCT00887224|6092150|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
1747665|NCT00887224|6092151|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
1747666|NCT00887224|6092149|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
1747667|NCT00887224|6092150|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
1747668|NCT00887224|6092151|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
1747669|NCT00887224|6092149|P3|Double-blind (DB) Phase|Protocol Violation|5
1747670|NCT00887224|6092150|P2|Double-blind (DB) Phase|Protocol Violation|8
1747671|NCT00887224|6092151|P1|Double-blind (DB) Phase|Protocol Violation|0
1747672|NCT00887224|6092149|P3|Double-blind (DB) Phase|Other|0
1747673|NCT00887224|6092150|P2|Double-blind (DB) Phase|Other|2
1747674|NCT00887224|6092151|P1|Double-blind (DB) Phase|Other|0
1747675|NCT00887224|6092149|P3|Double-blind (DB) Phase|Lost to Follow-up|8
1747676|NCT00887224|6092150|P2|Double-blind (DB) Phase|Lost to Follow-up|8
1747677|NCT00887224|6092151|P1|Double-blind (DB) Phase|Lost to Follow-up|0
1747678|NCT00887224|6092149|P3|Double-blind (DB) Phase|Lack of Efficacy|33
1747679|NCT00887224|6092150|P2|Double-blind (DB) Phase|Lack of Efficacy|67
1747680|NCT00887224|6092151|P1|Double-blind (DB) Phase|Lack of Efficacy|0
1747681|NCT00887224|6092149|P3|Double-blind (DB) Phase|Failed to return|2
1747682|NCT00887224|6092150|P2|Double-blind (DB) Phase|Failed to return|2
1747683|NCT00887224|6092151|P1|Double-blind (DB) Phase|Failed to return|0
1747684|NCT00887224|6092149|P3|Double-blind (DB) Phase|Adverse Event|2
1747685|NCT00887224|6092150|P2|Double-blind (DB) Phase|Adverse Event|7
1747686|NCT00887224|6092151|P1|Double-blind (DB) Phase|Adverse Event|0
1747687|NCT00887224|6092149|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
1747688|NCT00887224|6092150|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
1747853|NCT00886821|6092279|P11|Stage 2|Adverse Event|0
1747689|NCT00887224|6092151|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
1747690|NCT00887224|6092149|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
1747691|NCT00887224|6092150|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
1747692|NCT00887224|6092151|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
1747693|NCT00887224|6092149|P3|OL Taper Phase / OL Follow Up|Other|0
1747694|NCT00887224|6092150|P2|OL Taper Phase / OL Follow Up|Other|0
1747695|NCT00887224|6092151|P1|OL Taper Phase / OL Follow Up|Other|30
1747696|NCT00887224|6092149|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
1747697|NCT00887224|6092150|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
1747698|NCT00887224|6092151|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
1747699|NCT00887224|6092149|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
1747700|NCT00887224|6092150|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
1747701|NCT00887224|6092151|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
1747702|NCT00887224|6092149|P3|OL Taper Phase / OL Follow Up|Failed to return|0
1747703|NCT00887224|6092150|P2|OL Taper Phase / OL Follow Up|Failed to return|0
1747704|NCT00887224|6092151|P1|OL Taper Phase / OL Follow Up|Failed to return|17
1747705|NCT00887224|6092149|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
1747706|NCT00887224|6092150|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
1747707|NCT00887224|6092151|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
1747708|NCT00887224|6092149|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
1747709|NCT00887224|6092150|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
1747710|NCT00887224|6092151|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
1747711|NCT00887224|6092149|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
1747712|NCT00887224|6092150|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
1747713|NCT00887224|6092151|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
1747714|NCT00887224|6092149|P3|Open-label Stability (OLS) Phase|Other|0
1747715|NCT00887224|6092150|P2|Open-label Stability (OLS) Phase|Other|0
1747716|NCT00887224|6092151|P1|Open-label Stability (OLS) Phase|Other|1
1747717|NCT00887224|6092149|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
1747718|NCT00887224|6092150|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
1747719|NCT00887224|6092151|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
1747720|NCT00887224|6092149|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
1747721|NCT00887224|6092150|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
1747722|NCT00887224|6092151|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
1747723|NCT00887224|6092149|P3|Open-label Stability (OLS) Phase|Failed to return|0
1747724|NCT00887224|6092150|P2|Open-label Stability (OLS) Phase|Failed to return|0
1747725|NCT00887224|6092151|P1|Open-label Stability (OLS) Phase|Failed to return|3
1747726|NCT00887224|6092149|P3|Open-label Stability (OLS) Phase|Adverse Event|0
1747727|NCT00887224|6092150|P2|Open-label Stability (OLS) Phase|Adverse Event|0
1747728|NCT00887224|6092151|P1|Open-label Stability (OLS) Phase|Adverse Event|22
1747729|NCT00887224|6092149|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
1747730|NCT00887224|6092150|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
1747731|NCT00887224|6092151|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
1747732|NCT00887224|6092149|P3|Open-label Response (OLR) Phase|Protocol Violation|0
1747733|NCT00887224|6092150|P2|Open-label Response (OLR) Phase|Protocol Violation|0
1747734|NCT00887224|6092151|P1|Open-label Response (OLR) Phase|Protocol Violation|12
1747735|NCT00887224|6092149|P3|Open-label Response (OLR) Phase|Other|0
1747736|NCT00887224|6092150|P2|Open-label Response (OLR) Phase|Other|0
1747737|NCT00887224|6092151|P1|Open-label Response (OLR) Phase|Other|1
1747738|NCT00887224|6092149|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
1747739|NCT00887224|6092150|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
1747740|NCT00887224|6092151|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
1747741|NCT00887224|6092149|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
1747742|NCT00887224|6092150|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
1747743|NCT00887224|6092151|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
1747744|NCT00887224|6092149|P3|Open-label Response (OLR) Phase|Failed to return|0
1747745|NCT00887224|6092150|P2|Open-label Response (OLR) Phase|Failed to return|0
1747746|NCT00887224|6092151|P1|Open-label Response (OLR) Phase|Failed to return|6
1747747|NCT00887224|6092149|P3|Open-label Response (OLR) Phase|Adverse Event|0
1747748|NCT00887224|6092150|P2|Open-label Response (OLR) Phase|Adverse Event|0
1747749|NCT00887224|6092151|P1|Open-label Response (OLR) Phase|Adverse Event|46
1747750|NCT00887198|6092178|P3|Cross Over (Placebo to AA)|Other|19
1747751|NCT00887198|6092179|P2|Cross Over (Placebo to AA)|Other|0
1747752|NCT00887198|6092180|P1|Cross Over (Placebo to AA)|Other|0
1747753|NCT00887198|6092178|P3|Cross Over (Placebo to AA)|Progressive disease|20
1747754|NCT00887198|6092179|P2|Cross Over (Placebo to AA)|Progressive disease|0
1747755|NCT00887198|6092180|P1|Cross Over (Placebo to AA)|Progressive disease|0
1747756|NCT00887198|6092178|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
1747757|NCT00887198|6092179|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
1747758|NCT00887198|6092180|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
1747759|NCT00887198|6092178|P3|Cross Over (Placebo to AA)|Adverse Event|9
1747760|NCT00887198|6092179|P2|Cross Over (Placebo to AA)|Adverse Event|0
1747761|NCT00887198|6092180|P1|Cross Over (Placebo to AA)|Adverse Event|0
1747762|NCT00887198|6092178|P3|Cross Over (Placebo to AA)|Ongoing|35
1747763|NCT00887198|6092179|P2|Cross Over (Placebo to AA)|Ongoing|0
1747764|NCT00887198|6092180|P1|Cross Over (Placebo to AA)|Ongoing|0
1747765|NCT00887198|6092178|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
1747766|NCT00887198|6092179|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
1747767|NCT00887198|6092180|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
1747768|NCT00887198|6092178|P3|Randomized Period|Randomized, Not treated|0
1747769|NCT00887198|6092179|P2|Randomized Period|Randomized, Not treated|2
1747770|NCT00887198|6092180|P1|Randomized Period|Randomized, Not treated|4
1747771|NCT00887198|6092178|P3|Randomized Period|Other|0
1747772|NCT00887198|6092179|P2|Randomized Period|Other|30
1747773|NCT00887198|6092180|P1|Randomized Period|Other|42
1747774|NCT00887198|6092178|P3|Randomized Period|Progressive disease|0
1747775|NCT00887198|6092179|P2|Randomized Period|Progressive disease|370
1747776|NCT00887198|6092180|P1|Randomized Period|Progressive disease|366
1747777|NCT00887198|6092178|P3|Randomized Period|Withdrawal by Subject|0
1747778|NCT00887198|6092179|P2|Randomized Period|Withdrawal by Subject|56
1747779|NCT00887198|6092180|P1|Randomized Period|Withdrawal by Subject|41
1747780|NCT00887198|6092178|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
1747781|NCT00887198|6092179|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
1747782|NCT00887198|6092180|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
1747783|NCT00887198|6092178|P3|Randomized Period|Lost to Follow-up|0
1747784|NCT00887198|6092179|P2|Randomized Period|Lost to Follow-up|0
1747785|NCT00887198|6092180|P1|Randomized Period|Lost to Follow-up|1
1747786|NCT00887198|6092178|P3|Randomized Period|Adverse Event|0
1747787|NCT00887198|6092179|P2|Randomized Period|Adverse Event|33
1747788|NCT00887198|6092180|P1|Randomized Period|Adverse Event|50
1747789|NCT00887198|6092178|P3|Randomized Period|Ongoing|0
1747790|NCT00887198|6092179|P2|Randomized Period|Ongoing|0
1747791|NCT00887198|6092180|P1|Randomized Period|Ongoing|42
1747792|NCT00887159|6092211|P3|Overall Study|Never started assigned therapy|4
1747793|NCT00887159|6092212|P2|Overall Study|Never started assigned therapy|3
1747794|NCT00887159|6092213|P1|Overall Study|Never started assigned therapy|3
1747795|NCT00887159|6092211|P3|Overall Study|Ineligible|0
1747796|NCT00887159|6092212|P2|Overall Study|Ineligible|1
1747797|NCT00887159|6092213|P1|Overall Study|Ineligible|5
1747798|NCT00887159|6092211|P3|Overall Study|Received more tx instead of observation|0
1747799|NCT00887159|6092212|P2|Overall Study|Received more tx instead of observation|0
1747800|NCT00887159|6092213|P1|Overall Study|Received more tx instead of observation|1
1747801|NCT00887159|6092211|P3|Overall Study|Pt had PD but was SD when re-measured|0
1747802|NCT00887159|6092212|P2|Overall Study|Pt had PD but was SD when re-measured|1
1747803|NCT00887159|6092213|P1|Overall Study|Pt had PD but was SD when re-measured|0
1747804|NCT00887159|6092211|P3|Overall Study|Treatment delayed|0
1747805|NCT00887159|6092212|P2|Overall Study|Treatment delayed|1
1747806|NCT00887159|6092213|P1|Overall Study|Treatment delayed|1
1747807|NCT00887159|6092211|P3|Overall Study|Sympomatic deterioration|0
1747808|NCT00887159|6092212|P2|Overall Study|Sympomatic deterioration|0
1747809|NCT00887159|6092213|P1|Overall Study|Sympomatic deterioration|1
1747810|NCT00887159|6092211|P3|Overall Study|Physician Decision|0
1747811|NCT00887159|6092212|P2|Overall Study|Physician Decision|1
1747812|NCT00887159|6092213|P1|Overall Study|Physician Decision|1
1747813|NCT00887159|6092211|P3|Overall Study|Alternative therapy|0
1747814|NCT00887159|6092212|P2|Overall Study|Alternative therapy|0
1747815|NCT00887159|6092213|P1|Overall Study|Alternative therapy|2
1747816|NCT00887159|6092211|P3|Overall Study|Withdrawal by Subject|2
1747817|NCT00887159|6092212|P2|Overall Study|Withdrawal by Subject|4
1747818|NCT00887159|6092213|P1|Overall Study|Withdrawal by Subject|4
1747819|NCT00887159|6092211|P3|Overall Study|Death|0
1747820|NCT00887159|6092212|P2|Overall Study|Death|2
1747821|NCT00887159|6092213|P1|Overall Study|Death|2
1747822|NCT00887159|6092211|P3|Overall Study|Adverse Event|17
1747823|NCT00887159|6092212|P2|Overall Study|Adverse Event|4
1747824|NCT00887159|6092213|P1|Overall Study|Adverse Event|3
1747825|NCT00887159|6092211|P3|Overall Study|Disease progression|33
1747826|NCT00887159|6092212|P2|Overall Study|Disease progression|39
1747827|NCT00887159|6092213|P1|Overall Study|Disease progression|6
1747828|NCT00887068|6092231|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
1747829|NCT00887068|6092232|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
1747830|NCT00887068|6092231|P2|Overall Study|Withdrawal by Subject|0
1747831|NCT00887068|6092232|P1|Overall Study|Withdrawal by Subject|2
1747832|NCT00886938|6092240|P1|Overall Study|Withdrawal by Subject|1
1747833|NCT00886938|6092240|P1|Overall Study|Adverse Event|1
1747834|NCT00886834|6092253|P2|Overall Study|Protocol Violation|3
1747835|NCT00886834|6092254|P1|Overall Study|Protocol Violation|0
1747836|NCT00886821|6092276|P14|Stage 2|Lost to Follow-up|1
1747837|NCT00886821|6092277|P13|Stage 2|Lost to Follow-up|2
1747838|NCT00886821|6092278|P12|Stage 2|Lost to Follow-up|0
1747839|NCT00886821|6092279|P11|Stage 2|Lost to Follow-up|0
1747840|NCT00886821|6092280|P10|Stage 2|Lost to Follow-up|0
1747841|NCT00886821|6092281|P9|Stage 2|Lost to Follow-up|0
1747842|NCT00886821|6092282|P8|Stage 2|Lost to Follow-up|0
1747843|NCT00886821|6092283|P7|Stage 2|Lost to Follow-up|0
1747844|NCT00886821|6092284|P6|Stage 2|Lost to Follow-up|0
1747845|NCT00886821|6092285|P5|Stage 2|Lost to Follow-up|0
1747846|NCT00886821|6092286|P4|Stage 2|Lost to Follow-up|0
1747847|NCT00886821|6092287|P3|Stage 2|Lost to Follow-up|0
1747848|NCT00886821|6092288|P2|Stage 2|Lost to Follow-up|0
1747849|NCT00886821|6092289|P1|Stage 2|Lost to Follow-up|0
1747850|NCT00886821|6092276|P14|Stage 2|Adverse Event|0
1747851|NCT00886821|6092277|P13|Stage 2|Adverse Event|3
1747852|NCT00886821|6092278|P12|Stage 2|Adverse Event|1
1747854|NCT00886821|6092280|P10|Stage 2|Adverse Event|0
1747855|NCT00886821|6092281|P9|Stage 2|Adverse Event|0
1747856|NCT00886821|6092282|P8|Stage 2|Adverse Event|0
1747857|NCT00886821|6092283|P7|Stage 2|Adverse Event|0
1747858|NCT00886821|6092284|P6|Stage 2|Adverse Event|0
1747859|NCT00886821|6092285|P5|Stage 2|Adverse Event|0
1747860|NCT00886821|6092286|P4|Stage 2|Adverse Event|0
1747861|NCT00886821|6092287|P3|Stage 2|Adverse Event|0
1747862|NCT00886821|6092288|P2|Stage 2|Adverse Event|0
1747863|NCT00886821|6092289|P1|Stage 2|Adverse Event|0
1747864|NCT00886795|6092514|P1|Overall Study|Lack of Efficacy|1
1747865|NCT00886769|6092521|P2|Overall Study|Unsatisfactory therapeutic effect|37
1747866|NCT00886769|6092522|P1|Overall Study|Unsatisfactory therapeutic effect|6
1747867|NCT00886743|6092546|P1|Overall Study|Other|1
1747868|NCT00886743|6092546|P1|Overall Study|Adverse Event|3
1747869|NCT00886639|6092584|P1|Overall Study|non-compliance|2
1747870|NCT00886639|6092584|P1|Overall Study|acute exacerbation|14
1747871|NCT00886613|6092598|P3|Overall Study|Subject withdrew consent (Part A)|2
1747872|NCT00886613|6092599|P2|Overall Study|Subject withdrew consent (Part A)|0
1747873|NCT00886613|6092600|P1|Overall Study|Subject withdrew consent (Part A)|0
1747874|NCT00886613|6092598|P3|Overall Study|Lost to follow-up (Part B)|1
1747875|NCT00886613|6092599|P2|Overall Study|Lost to follow-up (Part B)|0
1747876|NCT00886613|6092600|P1|Overall Study|Lost to follow-up (Part B)|1
1747877|NCT00886613|6092598|P3|Overall Study|Protocol deviation (Part B)|0
1747878|NCT00886613|6092599|P2|Overall Study|Protocol deviation (Part B)|0
1747879|NCT00886613|6092600|P1|Overall Study|Protocol deviation (Part B)|1
1747880|NCT00886600|6092622|P4|Combination Therapy Period|Protocol Violation|0
1747881|NCT00886600|6092623|P3|Combination Therapy Period|Protocol Violation|1
1747882|NCT00886600|6092624|P2|Combination Therapy Period|Protocol Violation|0
1747883|NCT00886600|6092625|P1|Combination Therapy Period|Protocol Violation|0
1747884|NCT00886600|6092622|P4|Combination Therapy Period|Adverse Event|0
1747885|NCT00886600|6092623|P3|Combination Therapy Period|Adverse Event|1
1747886|NCT00886600|6092624|P2|Combination Therapy Period|Adverse Event|0
1747887|NCT00886600|6092625|P1|Combination Therapy Period|Adverse Event|0
1747888|NCT00886600|6092622|P4|Double-blind Monotherapy|Withdrawal by Subject|0
1747889|NCT00886600|6092623|P3|Double-blind Monotherapy|Withdrawal by Subject|0
1747890|NCT00886600|6092624|P2|Double-blind Monotherapy|Withdrawal by Subject|0
1747891|NCT00886600|6092625|P1|Double-blind Monotherapy|Withdrawal by Subject|1
1747892|NCT00886600|6092622|P4|Double-blind Monotherapy|Protocol Violation|1
1747893|NCT00886600|6092623|P3|Double-blind Monotherapy|Protocol Violation|0
1747894|NCT00886600|6092624|P2|Double-blind Monotherapy|Protocol Violation|0
1747895|NCT00886600|6092625|P1|Double-blind Monotherapy|Protocol Violation|0
1747896|NCT00886600|6092622|P4|Double-blind Monotherapy|Adverse Event|1
1747897|NCT00886600|6092623|P3|Double-blind Monotherapy|Adverse Event|1
1747898|NCT00886600|6092624|P2|Double-blind Monotherapy|Adverse Event|1
1747899|NCT00886600|6092625|P1|Double-blind Monotherapy|Adverse Event|1
1747900|NCT00886587|6092649|P2|Overall Study|Withdrawal by Subject|1
1747901|NCT00886587|6092650|P1|Overall Study|Withdrawal by Subject|0
1747902|NCT00886587|6092649|P2|Overall Study|Protocol Violation|0
1747903|NCT00886587|6092650|P1|Overall Study|Protocol Violation|2
1747904|NCT00886587|6092649|P2|Overall Study|Adverse Event|1
1747905|NCT00886587|6092650|P1|Overall Study|Adverse Event|2
1747906|NCT00886483|6092664|P2|Overall Study|Distance to center, poor grades|0
1747907|NCT00886483|6092665|P1|Overall Study|Distance to center, poor grades|1
1747908|NCT00886483|6092664|P2|Overall Study|Pursue medications|2
1747909|NCT00886483|6092665|P1|Overall Study|Pursue medications|1
1747910|NCT00886483|6092664|P2|Overall Study|Lost to Follow-up|1
1747911|NCT00886483|6092665|P1|Overall Study|Lost to Follow-up|0
1747912|NCT00886340|6092683|P2|Overall Study|Withdrawal by Subject|7
1747913|NCT00886340|6092684|P1|Overall Study|Withdrawal by Subject|0
1747914|NCT00886288|6092692|P2|Overall Study|Lost to Follow-up|0
1747915|NCT00886288|6092693|P1|Overall Study|Lost to Follow-up|86
1747916|NCT00886288|6092692|P2|Overall Study|no respect of the 12 weeks period|227
1747917|NCT00886288|6092693|P1|Overall Study|no respect of the 12 weeks period|657
1747918|NCT00886119|6092749|P2|Period 1|Did not meet inclusion criteria|0
1747919|NCT00886119|6092750|P1|Period 1|Did not meet inclusion criteria|1
1747920|NCT00886015|6092758|P2|Overall Study|Death|2
1747921|NCT00886015|6092759|P1|Overall Study|Death|0
1747922|NCT00885846|6092778|P3|Overall Study|Withdrawal by Subject|2
1747923|NCT00885846|6092779|P2|Overall Study|Withdrawal by Subject|5
1747924|NCT00885846|6092780|P1|Overall Study|Withdrawal by Subject|2
1747925|NCT00885755|6092795|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
1747926|NCT00885755|6092796|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
1747927|NCT00885755|6092797|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
1747928|NCT00885755|6092795|P3|Part I: Trastuzumab+Taxane|Death|1
1747929|NCT00885755|6092796|P2|Part I: Trastuzumab+Taxane|Death|0
1747930|NCT00885755|6092797|P1|Part I: Trastuzumab+Taxane|Death|0
1747931|NCT00885755|6092795|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
1747932|NCT00885755|6092796|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
1747933|NCT00885755|6092797|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
1747934|NCT00885755|6092795|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
1747935|NCT00885755|6092796|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
1747936|NCT00885755|6092797|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
1747937|NCT00885755|6092795|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
1747938|NCT00885755|6092796|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
1747939|NCT00885755|6092797|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
1747940|NCT00885703|6092840|P7|Overall Study|Ineligible (no CM)|1
1747941|NCT00885703|6092841|P6|Overall Study|Ineligible (no CM)|3
1747942|NCT00885703|6092842|P5|Overall Study|Ineligible (no CM)|2
1747943|NCT00885703|6092843|P4|Overall Study|Ineligible (no CM)|1
1747944|NCT00885703|6092844|P3|Overall Study|Ineligible (no CM)|2
1747945|NCT00885703|6092845|P2|Overall Study|Ineligible (no CM)|3
1747946|NCT00885703|6092846|P1|Overall Study|Ineligible (no CM)|1
1747947|NCT00885703|6092840|P7|Overall Study|Withdrawal by Subject|1
1747948|NCT00885703|6092841|P6|Overall Study|Withdrawal by Subject|1
1747949|NCT00885703|6092842|P5|Overall Study|Withdrawal by Subject|3
1747950|NCT00885703|6092843|P4|Overall Study|Withdrawal by Subject|1
1747951|NCT00885703|6092844|P3|Overall Study|Withdrawal by Subject|0
1747952|NCT00885703|6092845|P2|Overall Study|Withdrawal by Subject|0
1747953|NCT00885703|6092846|P1|Overall Study|Withdrawal by Subject|0
1747954|NCT00885703|6092840|P7|Overall Study|Lost to Follow-up|0
1747955|NCT00885703|6092841|P6|Overall Study|Lost to Follow-up|1
1747956|NCT00885703|6092842|P5|Overall Study|Lost to Follow-up|0
1747957|NCT00885703|6092843|P4|Overall Study|Lost to Follow-up|0
1747958|NCT00885703|6092844|P3|Overall Study|Lost to Follow-up|1
1747959|NCT00885703|6092845|P2|Overall Study|Lost to Follow-up|0
1747960|NCT00885703|6092846|P1|Overall Study|Lost to Follow-up|0
1747961|NCT00885703|6092840|P7|Overall Study|Death|4
1747962|NCT00885703|6092841|P6|Overall Study|Death|8
1747963|NCT00885703|6092842|P5|Overall Study|Death|7
1747964|NCT00885703|6092843|P4|Overall Study|Death|7
1747965|NCT00885703|6092844|P3|Overall Study|Death|8
1747966|NCT00885703|6092845|P2|Overall Study|Death|7
1747967|NCT00885703|6092846|P1|Overall Study|Death|9
1747968|NCT00885677|6092904|P2|Overall Study|Inclusion/exclusion not met|27
1747969|NCT00885677|6092905|P1|Overall Study|Inclusion/exclusion not met|25
1747970|NCT00885677|6092904|P2|Overall Study|Heart transplantation|0
1747971|NCT00885677|6092905|P1|Overall Study|Heart transplantation|1
1747972|NCT00885677|6092904|P2|Overall Study|device/lead revision or replacement|6
1747973|NCT00885677|6092905|P1|Overall Study|device/lead revision or replacement|7
1747974|NCT00885677|6092904|P2|Overall Study|premature study closure|44
1747975|NCT00885677|6092905|P1|Overall Study|premature study closure|41
1747976|NCT00885677|6092904|P2|Overall Study|Protocol Violation|54
1747977|NCT00885677|6092905|P1|Overall Study|Protocol Violation|54
1747978|NCT00885677|6092904|P2|Overall Study|Lost to Follow-up|13
1747979|NCT00885677|6092905|P1|Overall Study|Lost to Follow-up|15
1747980|NCT00885677|6092904|P2|Overall Study|Death|34
1747981|NCT00885677|6092905|P1|Overall Study|Death|40
1747982|NCT00885534|6092921|P1|Overall Study|Patient deemed ineligible|1
1747983|NCT00885482|6092925|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
1747984|NCT00885482|6092925|P1|Overall Study|Death|1
1747985|NCT00885482|6092925|P1|Overall Study|Lack of Efficacy|1
1747986|NCT00885482|6092925|P1|Overall Study|Pregnancy|1
1747987|NCT00885378|6092931|P2|Overall Study|Protocol Violation|0
1747988|NCT00885378|6092932|P1|Overall Study|Protocol Violation|2
1747989|NCT00885378|6092931|P2|Overall Study|Poor/Noncompliance|2
1747990|NCT00885378|6092932|P1|Overall Study|Poor/Noncompliance|2
1747991|NCT00885378|6092931|P2|Overall Study|Lost to Follow-up|2
1747992|NCT00885378|6092932|P1|Overall Study|Lost to Follow-up|1
1747993|NCT00885378|6092931|P2|Overall Study|Withdrawal by Subject|2
1747994|NCT00885378|6092932|P1|Overall Study|Withdrawal by Subject|1
1747995|NCT00885378|6092931|P2|Overall Study|Lack of Efficacy|2
1747996|NCT00885378|6092932|P1|Overall Study|Lack of Efficacy|2
1747997|NCT00885365|6092962|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
1747998|NCT00885365|6092963|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
1747999|NCT00885365|6092962|P2|4 Weeks ON Treatment|Protocol Violation|2
1748000|NCT00885365|6092963|P1|4 Weeks ON Treatment|Protocol Violation|1
1748001|NCT00885365|6092962|P2|4 Weeks ON Treatment|Adverse Event|4
1748002|NCT00885365|6092963|P1|4 Weeks ON Treatment|Adverse Event|2
1748003|NCT00885352|6092999|P2|Overall Study|Lab abnormalities|1
1748004|NCT00885352|6093000|P1|Overall Study|Lab abnormalities|1
1748005|NCT00885352|6092999|P2|Overall Study|Excluded medication|2
1748006|NCT00885352|6093000|P1|Overall Study|Excluded medication|2
1748007|NCT00885352|6092999|P2|Overall Study|Contradiction to study medication|2
1748008|NCT00885352|6093000|P1|Overall Study|Contradiction to study medication|0
1748009|NCT00885352|6092999|P2|Overall Study|Withdrawal by Subject|5
1748010|NCT00885352|6093000|P1|Overall Study|Withdrawal by Subject|1
1748011|NCT00885352|6092999|P2|Overall Study|Protocol Violation|2
1748012|NCT00885352|6093000|P1|Overall Study|Protocol Violation|0
1748013|NCT00885352|6092999|P2|Overall Study|Physician Decision|3
1748014|NCT00885352|6093000|P1|Overall Study|Physician Decision|0
1748015|NCT00885352|6092999|P2|Overall Study|Lost to Follow-up|2
1748016|NCT00885352|6093000|P1|Overall Study|Lost to Follow-up|2
1748017|NCT00885352|6092999|P2|Overall Study|Adverse Event|3
1748018|NCT00885352|6093000|P1|Overall Study|Adverse Event|2
1748019|NCT00885170|6093012|P2|Overall Study|Withdrawal by Subject|13
1748020|NCT00885170|6093013|P1|Overall Study|Withdrawal by Subject|13
1748021|NCT00885170|6093012|P2|Overall Study|Protocol Violation|1
1748022|NCT00885170|6093013|P1|Overall Study|Protocol Violation|3
1748023|NCT00885170|6093012|P2|Overall Study|Physician Decision|1
1748024|NCT00885170|6093013|P1|Overall Study|Physician Decision|2
1748025|NCT00885170|6093012|P2|Overall Study|Lost to Follow-up|1
1748026|NCT00885170|6093013|P1|Overall Study|Lost to Follow-up|2
1748027|NCT00885170|6093012|P2|Overall Study|Excessive bone loss|3
1748028|NCT00885170|6093013|P1|Overall Study|Excessive bone loss|6
1748029|NCT00885170|6093012|P2|Overall Study|Adverse Event|4
1748030|NCT00885170|6093013|P1|Overall Study|Adverse Event|12
1748031|NCT00885118|6093072|P5|Overall Study|Other reason not defined above|0
1748032|NCT00885118|6093073|P4|Overall Study|Other reason not defined above|0
1748033|NCT00885118|6093074|P3|Overall Study|Other reason not defined above|1
1748034|NCT00885118|6093075|P2|Overall Study|Other reason not defined above|0
1748035|NCT00885118|6093076|P1|Overall Study|Other reason not defined above|0
1748036|NCT00885118|6093072|P5|Overall Study|Withdrawal by Subject|1
1748037|NCT00885118|6093073|P4|Overall Study|Withdrawal by Subject|0
1748038|NCT00885118|6093074|P3|Overall Study|Withdrawal by Subject|0
1748039|NCT00885118|6093075|P2|Overall Study|Withdrawal by Subject|0
1748040|NCT00885118|6093076|P1|Overall Study|Withdrawal by Subject|0
1748041|NCT00885118|6093072|P5|Overall Study|Adverse Event|0
1748042|NCT00885118|6093073|P4|Overall Study|Adverse Event|0
1748043|NCT00885118|6093074|P3|Overall Study|Adverse Event|0
1748044|NCT00885118|6093075|P2|Overall Study|Adverse Event|0
1748045|NCT00885118|6093076|P1|Overall Study|Adverse Event|1
1748046|NCT00885105|6093215|P2|Overall Study|Protocol Violation|2
1748047|NCT00885105|6093216|P1|Overall Study|Protocol Violation|0
1748048|NCT00885105|6093215|P2|Overall Study|Adverse Event|0
1748049|NCT00885105|6093216|P1|Overall Study|Adverse Event|1
1748050|NCT00885105|6093215|P2|Overall Study|Withdrawal by Subject|8
1748051|NCT00885105|6093216|P1|Overall Study|Withdrawal by Subject|0
1748052|NCT00884949|6093256|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
1748053|NCT00884949|6093256|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
1748054|NCT00884832|6093291|P2|Overall Study|Withdrawal by Subject|1
1748055|NCT00884832|6093292|P1|Overall Study|Withdrawal by Subject|0
1748056|NCT00884793|6093327|P1|Overall Study|Withdrawal by Subject|1
1748057|NCT00884741|6093346|P4|Randomization|Protocol Violation|8
1748058|NCT00884741|6093347|P3|Randomization|Protocol Violation|8
1748059|NCT00884741|6093348|P2|Randomization|Protocol Violation|0
1748060|NCT00884741|6093349|P1|Randomization|Protocol Violation|0
1748061|NCT00884741|6093346|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
1748062|NCT00884741|6093347|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
1748063|NCT00884741|6093348|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
1748064|NCT00884741|6093349|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
1748065|NCT00884741|6093346|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
1748066|NCT00884741|6093347|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
1748067|NCT00884741|6093348|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
1748068|NCT00884741|6093349|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
1748069|NCT00884741|6093346|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
1748070|NCT00884741|6093347|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
1748071|NCT00884741|6093348|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
1748072|NCT00884741|6093349|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
1748073|NCT00884741|6093346|P4|Step 2 Registration: Tissue Analysis|Death|0
1748074|NCT00884741|6093347|P3|Step 2 Registration: Tissue Analysis|Death|0
1748075|NCT00884741|6093348|P2|Step 2 Registration: Tissue Analysis|Death|1
1748076|NCT00884741|6093349|P1|Step 2 Registration: Tissue Analysis|Death|0
1748077|NCT00884741|6093346|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1748078|NCT00884741|6093347|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1748079|NCT00884741|6093348|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
1748080|NCT00884741|6093349|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
1748081|NCT00884741|6093346|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
1748082|NCT00884741|6093347|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
1748083|NCT00884741|6093348|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
1748084|NCT00884741|6093349|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
1748085|NCT00884741|6093346|P4|Step 1 Registration: Tissue Screening|Disease progression|0
1748086|NCT00884741|6093347|P3|Step 1 Registration: Tissue Screening|Disease progression|0
1748087|NCT00884741|6093348|P2|Step 1 Registration: Tissue Screening|Disease progression|0
1748088|NCT00884741|6093349|P1|Step 1 Registration: Tissue Screening|Disease progression|12
1748089|NCT00884741|6093346|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1748090|NCT00884741|6093347|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1748091|NCT00884741|6093348|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
1748092|NCT00884741|6093349|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
1748093|NCT00884741|6093346|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
1748094|NCT00884741|6093347|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
1748095|NCT00884741|6093348|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
1748096|NCT00884741|6093349|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
1748097|NCT00884741|6093346|P4|Step 1 Registration: Tissue Screening|Death|0
1748098|NCT00884741|6093347|P3|Step 1 Registration: Tissue Screening|Death|0
1748099|NCT00884741|6093348|P2|Step 1 Registration: Tissue Screening|Death|0
1748100|NCT00884741|6093349|P1|Step 1 Registration: Tissue Screening|Death|3
1748101|NCT00884741|6093346|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
1748102|NCT00884741|6093347|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
1748103|NCT00884741|6093348|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
1748104|NCT00884741|6093349|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
1748105|NCT00884390|6093399|P2|Overall Study|Other|1
1748106|NCT00884390|6093400|P1|Overall Study|Other|11
1748107|NCT00884390|6093399|P2|Overall Study|Discontinuation of Study by Sponsor|2
1748108|NCT00884390|6093400|P1|Overall Study|Discontinuation of Study by Sponsor|2
1748109|NCT00884390|6093399|P2|Overall Study|Withdrawal by Subject|1
1748110|NCT00884390|6093400|P1|Overall Study|Withdrawal by Subject|4
1748111|NCT00884390|6093399|P2|Overall Study|Protocol Violation|1
1748112|NCT00884390|6093400|P1|Overall Study|Protocol Violation|4
1748113|NCT00884390|6093399|P2|Overall Study|Physician Decision|1
1748114|NCT00884390|6093400|P1|Overall Study|Physician Decision|2
1748115|NCT00884390|6093399|P2|Overall Study|Lost to Follow-up|1
1748116|NCT00884390|6093400|P1|Overall Study|Lost to Follow-up|0
1748117|NCT00884390|6093399|P2|Overall Study|Adverse Event|1
1748118|NCT00884390|6093400|P1|Overall Study|Adverse Event|0
1748119|NCT00884377|6093418|P2|Overall Study|Physician Decision|1
1748120|NCT00884377|6093419|P1|Overall Study|Physician Decision|0
1748121|NCT00884377|6093418|P2|Overall Study|Could not confirm diagnosis|0
1748122|NCT00884377|6093419|P1|Overall Study|Could not confirm diagnosis|1
1748123|NCT00884377|6093418|P2|Overall Study|Withdrawal by Subject|0
1748124|NCT00884377|6093419|P1|Overall Study|Withdrawal by Subject|1
1748125|NCT00884325|6093441|P2|Overall Study|Not provided|0
1748126|NCT00884325|6093442|P1|Overall Study|Not provided|1
1748127|NCT00884325|6093441|P2|Overall Study|Withdrawal by Subject|1
1748128|NCT00884325|6093442|P1|Overall Study|Withdrawal by Subject|1
1748129|NCT00884325|6093441|P2|Overall Study|Lack of Efficacy|1
1748130|NCT00884325|6093442|P1|Overall Study|Lack of Efficacy|0
1748131|NCT00884325|6093441|P2|Overall Study|Lost to Follow-up|2
1748132|NCT00884325|6093442|P1|Overall Study|Lost to Follow-up|1
1748133|NCT00884312|6093452|P2|Overall Study|Did Not Receive Study Drug|1
1748134|NCT00884312|6093453|P1|Overall Study|Did Not Receive Study Drug|0
1748135|NCT00884312|6093452|P2|Overall Study|Other|4
1748136|NCT00884312|6093453|P1|Overall Study|Other|0
1748137|NCT00884312|6093452|P2|Overall Study|Physician Decision|1
1748138|NCT00884312|6093453|P1|Overall Study|Physician Decision|0
1748139|NCT00884312|6093452|P2|Overall Study|Withdrawal by Subject|6
1748140|NCT00884312|6093453|P1|Overall Study|Withdrawal by Subject|0
1748141|NCT00884312|6093452|P2|Overall Study|Fatal Adverse Event|4
1748142|NCT00884312|6093453|P1|Overall Study|Fatal Adverse Event|1
1748143|NCT00884312|6093452|P2|Overall Study|Non-fatal Adverse Event|0
1748144|NCT00884312|6093453|P1|Overall Study|Non-fatal Adverse Event|1
1748145|NCT00884312|6093452|P2|Overall Study|Fatal Progressive Disease|1
1748146|NCT00884312|6093453|P1|Overall Study|Fatal Progressive Disease|0
1748147|NCT00884312|6093452|P2|Overall Study|Non-fatal Progressive Disease|8
1748148|NCT00884312|6093453|P1|Overall Study|Non-fatal Progressive Disease|0
1748149|NCT00884286|6093469|P2|Overall Study|Comprised lung carcinoma|1
1748150|NCT00884286|6093470|P1|Overall Study|Comprised lung carcinoma|0
1748151|NCT00884286|6093469|P2|Overall Study|Not treated|1
1748152|NCT00884286|6093470|P1|Overall Study|Not treated|2
1748153|NCT00884286|6093469|P2|Overall Study|Thrombus in right auricle|0
1748154|NCT00884286|6093470|P1|Overall Study|Thrombus in right auricle|1
1748155|NCT00884286|6093469|P2|Overall Study|Septic shock|0
1748156|NCT00884286|6093470|P1|Overall Study|Septic shock|1
1748157|NCT00884286|6093469|P2|Overall Study|Physician Decision|0
1748158|NCT00884286|6093470|P1|Overall Study|Physician Decision|1
1748159|NCT00884286|6093469|P2|Overall Study|Death|2
1748160|NCT00884286|6093470|P1|Overall Study|Death|2
1748161|NCT00884286|6093469|P2|Overall Study|Toxicity|1
1748162|NCT00884286|6093470|P1|Overall Study|Toxicity|4
1748163|NCT00884286|6093469|P2|Overall Study|Progressive disease|28
1748164|NCT00884286|6093470|P1|Overall Study|Progressive disease|21
1748165|NCT00884273|6093484|P2|Overall Study|Practical reasons|0
1748166|NCT00884273|6093485|P1|Overall Study|Practical reasons|1
1748167|NCT00884273|6093484|P2|Overall Study|Protocol Violation|3
1748168|NCT00884273|6093485|P1|Overall Study|Protocol Violation|1
1748169|NCT00884273|6093484|P2|Overall Study|Adverse Event|2
1748170|NCT00884273|6093485|P1|Overall Study|Adverse Event|0
1748171|NCT00884221|6093511|P2|Overall Study|Cancellation of Cycle and Other Reason|13
1748172|NCT00884221|6093512|P1|Overall Study|Cancellation of Cycle and Other Reason|12
1748173|NCT00884221|6093511|P2|Overall Study|Protocol Violation|13
1748174|NCT00884221|6093512|P1|Overall Study|Protocol Violation|16
1748175|NCT00884221|6093511|P2|Overall Study|Adverse Event|3
1748176|NCT00884221|6093512|P1|Overall Study|Adverse Event|6
1748177|NCT00884221|6093511|P2|Overall Study|Withdrawal by Subject|3
1748178|NCT00884221|6093512|P1|Overall Study|Withdrawal by Subject|0
1748179|NCT00884117|6093548|P1|Overall Study|Other|12
1748180|NCT00884117|6093548|P1|Overall Study|Lost to Follow-up|143
1748181|NCT00884117|6093548|P1|Overall Study|Death|3
1748182|NCT00884117|6093548|P1|Overall Study|Withdrawal by Subject|89
1748183|NCT00884117|6093548|P1|Overall Study|Adverse Event|2
1748184|NCT00884039|6093611|P2|Overall Study|Lack of Efficacy|0
1748185|NCT00884039|6093612|P1|Overall Study|Lack of Efficacy|2
1748186|NCT00884039|6093611|P2|Overall Study|Withdrawal by Subject|1
1748187|NCT00884039|6093612|P1|Overall Study|Withdrawal by Subject|0
1748188|NCT00883779|6093620|P2|Off-study Phase|Other|21
1748189|NCT00883779|6093621|P1|Off-study Phase|Other|18
1748190|NCT00883779|6093620|P2|Off-study Phase|Failure to return|6
1748191|NCT00883779|6093621|P1|Off-study Phase|Failure to return|5
1748192|NCT00883779|6093620|P2|Off-study Phase|Refused treatment|1
1748193|NCT00883779|6093621|P1|Off-study Phase|Refused treatment|1
1748194|NCT00883779|6093620|P2|Off-study Phase|Death|174
1748195|NCT00883779|6093621|P1|Off-study Phase|Death|185
1748196|NCT00883779|6093620|P2|Post-Study Treatment Phase|Ongoing in the study|6
1748197|NCT00883779|6093621|P1|Post-Study Treatment Phase|Ongoing in the study|0
1748198|NCT00883779|6093620|P2|Post-Study Treatment Phase|Other|0
1748199|NCT00883779|6093621|P1|Post-Study Treatment Phase|Other|3
1748200|NCT00883779|6093620|P2|Post-Study Treatment Phase|Disease progression|122
1748201|NCT00883779|6093621|P1|Post-Study Treatment Phase|Disease progression|103
1748202|NCT00883779|6093620|P2|Post-Study Treatment Phase|Refused Treatment|0
1748203|NCT00883779|6093621|P1|Post-Study Treatment Phase|Refused Treatment|3
1748204|NCT00883779|6093620|P2|Post-Study Treatment Phase|Protocol Violation|1
1748205|NCT00883779|6093621|P1|Post-Study Treatment Phase|Protocol Violation|0
1748206|NCT00883779|6093620|P2|Post-Study Treatment Phase|Death|3
1748207|NCT00883779|6093621|P1|Post-Study Treatment Phase|Death|1
1748208|NCT00883779|6093620|P2|Post-Study Treatment Phase|Adverse Event|3
1748209|NCT00883779|6093621|P1|Post-Study Treatment Phase|Adverse Event|2
1748210|NCT00883779|6093620|P2|Primary Study Treatment Phase|Other|0
1748211|NCT00883779|6093621|P1|Primary Study Treatment Phase|Other|3
1748212|NCT00883779|6093620|P2|Primary Study Treatment Phase|Refused Treatment|4
1748213|NCT00883779|6093621|P1|Primary Study Treatment Phase|Refused Treatment|5
1748214|NCT00883779|6093620|P2|Primary Study Treatment Phase|Death|3
1748215|NCT00883779|6093621|P1|Primary Study Treatment Phase|Death|2
1748216|NCT00883779|6093620|P2|Primary Study Treatment Phase|Adverse Event|16
1748217|NCT00883779|6093621|P1|Primary Study Treatment Phase|Adverse Event|16
1748218|NCT00883779|6093620|P2|Primary Study Treatment Phase|Disease progression|59
1748219|NCT00883779|6093621|P1|Primary Study Treatment Phase|Disease progression|75
1748220|NCT00883779|6093620|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
1748221|NCT00883779|6093621|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
1748222|NCT00883753|6093657|P1|Overall Study|Administrative/Other|8
1748223|NCT00883753|6093657|P1|Overall Study|Investigator's decision|17
1748224|NCT00883753|6093657|P1|Overall Study|Withdrew consent|10
1748225|NCT00883753|6093657|P1|Overall Study|Refused treatment|4
1748226|NCT00883753|6093657|P1|Overall Study|Protocol Violation|2
1748227|NCT00883753|6093657|P1|Overall Study|Violation of selection criteria at entry|7
1748228|NCT00883753|6093657|P1|Overall Study|Lost to Follow-up|4
1748229|NCT00883753|6093657|P1|Overall Study|Insufficient therapeutic response|16
1748230|NCT00883753|6093657|P1|Overall Study|Death|2
1748231|NCT00883753|6093657|P1|Overall Study|Adverse Event|37
1748232|NCT00883740|6093697|P2|Second Intervention|No longer willing to participate|1
1748233|NCT00883740|6093698|P1|Second Intervention|No longer willing to participate|0
1748234|NCT00883740|6093697|P2|Second Intervention|Protocol Violation|0
1748235|NCT00883740|6093698|P1|Second Intervention|Protocol Violation|1
1748236|NCT00883740|6093697|P2|First Intervention|Adverse Event|2
1748237|NCT00883740|6093698|P1|First Intervention|Adverse Event|1
1748238|NCT00883740|6093697|P2|First Intervention|Protocol Violation|6
1748239|NCT00883740|6093698|P1|First Intervention|Protocol Violation|3
1748240|NCT00883740|6093697|P2|First Intervention|No longer willing to participate|0
1748241|NCT00883740|6093698|P1|First Intervention|No longer willing to participate|2
1748242|NCT00883740|6093697|P2|First Intervention|Lost to Follow-up|0
1748243|NCT00883740|6093698|P1|First Intervention|Lost to Follow-up|1
1748244|NCT00883558|6093742|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
1748245|NCT00883558|6093743|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
1748246|NCT00883558|6093744|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
1748247|NCT00883558|6093742|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
1748248|NCT00883558|6093743|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
1748249|NCT00883558|6093744|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
1748250|NCT00883558|6093742|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
1748251|NCT00883558|6093743|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
1748252|NCT00883558|6093744|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
1748253|NCT00883558|6093742|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
1748254|NCT00883558|6093743|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
1748255|NCT00883558|6093744|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
1748256|NCT00883558|6093742|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
1748257|NCT00883558|6093743|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
1748258|NCT00883558|6093744|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
1748259|NCT00883493|6093756|P2|Overall Study|Other|3
1748260|NCT00883493|6093757|P1|Overall Study|Other|5
1748261|NCT00883493|6093756|P2|Overall Study|Study specific disc. criteria|0
1748262|NCT00883493|6093757|P1|Overall Study|Study specific disc. criteria|2
1748263|NCT00883493|6093756|P2|Overall Study|Eligibility Criteria not fullfilled|6
1748264|NCT00883493|6093757|P1|Overall Study|Eligibility Criteria not fullfilled|6
1748265|NCT00883493|6093756|P2|Overall Study|Withdrawal by Subject|20
1748266|NCT00883493|6093757|P1|Overall Study|Withdrawal by Subject|11
1748267|NCT00883493|6093756|P2|Overall Study|Lost to Follow-up|6
1748268|NCT00883493|6093757|P1|Overall Study|Lost to Follow-up|7
1748269|NCT00883493|6093756|P2|Overall Study|Lack of Efficacy|3
1748270|NCT00883493|6093757|P1|Overall Study|Lack of Efficacy|4
1748271|NCT00883493|6093756|P2|Overall Study|Adverse Event|12
1748272|NCT00883493|6093757|P1|Overall Study|Adverse Event|11
1748273|NCT00883337|6093788|P3|Extension Treatment Period|Other than above|5
1748274|NCT00883337|6093789|P2|Extension Treatment Period|Other than above|9
1748275|NCT00883337|6093790|P1|Extension Treatment Period|Other than above|10
1748276|NCT00883337|6093788|P3|Extension Treatment Period|Lost to Follow-up|0
1748277|NCT00883337|6093789|P2|Extension Treatment Period|Lost to Follow-up|0
1748278|NCT00883337|6093790|P1|Extension Treatment Period|Lost to Follow-up|1
1748279|NCT00883337|6093788|P3|Extension Treatment Period|Poor compliance to protocol|1
1748280|NCT00883337|6093789|P2|Extension Treatment Period|Poor compliance to protocol|1
1748281|NCT00883337|6093790|P1|Extension Treatment Period|Poor compliance to protocol|1
1748282|NCT00883337|6093788|P3|Extension Treatment Period|Lack of Efficacy|8
1748283|NCT00883337|6093789|P2|Extension Treatment Period|Lack of Efficacy|8
1748284|NCT00883337|6093790|P1|Extension Treatment Period|Lack of Efficacy|8
1748285|NCT00883337|6093788|P3|Extension Treatment Period|Adverse Event|5
1748286|NCT00883337|6093789|P2|Extension Treatment Period|Adverse Event|5
1748287|NCT00883337|6093790|P1|Extension Treatment Period|Adverse Event|8
1748288|NCT00883337|6093788|P3|Core Treatment Period|Other than above|1
1748289|NCT00883337|6093789|P2|Core Treatment Period|Other than above|1
1748290|NCT00883337|6093790|P1|Core Treatment Period|Other than above|0
1748291|NCT00883337|6093788|P3|Core Treatment Period|Poor compliance to protocol|1
1748292|NCT00883337|6093789|P2|Core Treatment Period|Poor compliance to protocol|0
1748293|NCT00883337|6093790|P1|Core Treatment Period|Poor compliance to protocol|0
1748294|NCT00883337|6093788|P3|Core Treatment Period|Wish to be pregnant|1
1748295|NCT00883337|6093789|P2|Core Treatment Period|Wish to be pregnant|2
1748296|NCT00883337|6093790|P1|Core Treatment Period|Wish to be pregnant|1
1748297|NCT00883337|6093788|P3|Core Treatment Period|Withdrawal by Subject|6
1748298|NCT00883337|6093789|P2|Core Treatment Period|Withdrawal by Subject|2
1748299|NCT00883337|6093790|P1|Core Treatment Period|Withdrawal by Subject|2
1748300|NCT00883337|6093788|P3|Core Treatment Period|Lost to Follow-up|0
1748301|NCT00883337|6093789|P2|Core Treatment Period|Lost to Follow-up|1
1748302|NCT00883337|6093790|P1|Core Treatment Period|Lost to Follow-up|1
1748303|NCT00883337|6093788|P3|Core Treatment Period|Lack of Efficacy|2
1748304|NCT00883337|6093789|P2|Core Treatment Period|Lack of Efficacy|4
1748305|NCT00883337|6093790|P1|Core Treatment Period|Lack of Efficacy|7
1748306|NCT00883337|6093788|P3|Core Treatment Period|Adverse Event|22
1748307|NCT00883337|6093789|P2|Core Treatment Period|Adverse Event|12
1748308|NCT00883337|6093790|P1|Core Treatment Period|Adverse Event|9
1748309|NCT00883181|6093857|P1|Overall Study|Noncompliance|3
1748310|NCT00883181|6093857|P1|Overall Study|Protocol Deviation|3
1748311|NCT00883181|6093857|P1|Overall Study|Other|38
1748312|NCT00883181|6093857|P1|Overall Study|Death|31
1748313|NCT00883181|6093857|P1|Overall Study|Withdrawal by Subject|4
1748314|NCT00883181|6093857|P1|Overall Study|Administrative Reason|24
1748315|NCT00883181|6093857|P1|Overall Study|Disease Progression|94
1748316|NCT00883181|6093857|P1|Overall Study|Non-hematological Adverse Event|55
1748317|NCT00883181|6093857|P1|Overall Study|Hematological Adverse Event|26
1748318|NCT00883129|6094093|P2|Overall Study|Defined Treatment Failure|2
1748319|NCT00883129|6094094|P1|Overall Study|Defined Treatment Failure|0
1748320|NCT00883129|6094093|P2|Overall Study|Death|2
1748321|NCT00883129|6094094|P1|Overall Study|Death|1
1748322|NCT00883129|6094093|P2|Overall Study|Lost to Follow-up|2
1748323|NCT00883129|6094094|P1|Overall Study|Lost to Follow-up|1
1748324|NCT00883129|6094093|P2|Overall Study|Non-compliance|6
1748325|NCT00883129|6094094|P1|Overall Study|Non-compliance|3
1748326|NCT00883129|6094093|P2|Overall Study|Withdrawal by Subject|9
1748327|NCT00883129|6094094|P1|Overall Study|Withdrawal by Subject|8
1748328|NCT00883129|6094093|P2|Overall Study|Adverse Event|15
1748329|NCT00883129|6094094|P1|Overall Study|Adverse Event|7
1748330|NCT00883116|6094118|P2|Overall Study|No longer meets study criteria|2
1748331|NCT00883116|6094119|P1|Overall Study|No longer meets study criteria|2
1748332|NCT00883116|6094118|P2|Overall Study|Withdrawal by Subject|8
1748333|NCT00883116|6094119|P1|Overall Study|Withdrawal by Subject|14
1748334|NCT00883116|6094118|P2|Overall Study|Study drug toxicity|16
1748335|NCT00883116|6094119|P1|Overall Study|Study drug toxicity|36
1748336|NCT00883116|6094118|P2|Overall Study|Not identified|6
1748337|NCT00883116|6094119|P1|Overall Study|Not identified|3
1748338|NCT00883116|6094118|P2|Overall Study|Maximum clinical benefit|46
1748339|NCT00883116|6094119|P1|Overall Study|Maximum clinical benefit|13
1748340|NCT00883116|6094118|P2|Overall Study|Lost to Follow-up|1
1748341|NCT00883116|6094119|P1|Overall Study|Lost to Follow-up|0
1748342|NCT00883116|6094118|P2|Overall Study|Disease progression|128
1748343|NCT00883116|6094119|P1|Overall Study|Disease progression|130
1748344|NCT00883116|6094118|P2|Overall Study|Death|2
1748345|NCT00883116|6094119|P1|Overall Study|Death|6
1748346|NCT00883116|6094118|P2|Overall Study|Adverse event unrelated to study drug|10
1748347|NCT00883116|6094119|P1|Overall Study|Adverse event unrelated to study drug|5
1748348|NCT00883090|6094141|P1|Overall Study|Withdrawal by Subject|1
1748349|NCT00883090|6094141|P1|Overall Study|Sponsor's decision|1
1748350|NCT00883051|6094161|P5|Overall Study|Did not use study medication|17
1748351|NCT00883051|6094162|P4|Overall Study|Did not use study medication|29
1748352|NCT00883051|6094163|P3|Overall Study|Did not use study medication|29
1748353|NCT00883051|6094164|P2|Overall Study|Did not use study medication|22
1748354|NCT00883051|6094165|P1|Overall Study|Did not use study medication|24
1748355|NCT00883051|6094161|P5|Overall Study|Lost to Follow-up|1
1748356|NCT00883051|6094162|P4|Overall Study|Lost to Follow-up|0
1748357|NCT00883051|6094163|P3|Overall Study|Lost to Follow-up|0
1748358|NCT00883051|6094164|P2|Overall Study|Lost to Follow-up|0
1748359|NCT00883051|6094165|P1|Overall Study|Lost to Follow-up|0
1748360|NCT00882999|6094269|P7|Overall Study|Physician Decision|1
1748361|NCT00882999|6094270|P6|Overall Study|Physician Decision|1
1748362|NCT00882999|6094271|P5|Overall Study|Physician Decision|0
1748363|NCT00882999|6094272|P4|Overall Study|Physician Decision|0
1748364|NCT00882999|6094273|P3|Overall Study|Physician Decision|0
1748365|NCT00882999|6094274|P2|Overall Study|Physician Decision|0
1748366|NCT00882999|6094275|P1|Overall Study|Physician Decision|1
1748367|NCT00882999|6094269|P7|Overall Study|Lost to Follow-up|2
1748368|NCT00882999|6094270|P6|Overall Study|Lost to Follow-up|1
1748369|NCT00882999|6094271|P5|Overall Study|Lost to Follow-up|1
1748370|NCT00882999|6094272|P4|Overall Study|Lost to Follow-up|2
1748371|NCT00882999|6094273|P3|Overall Study|Lost to Follow-up|1
1748372|NCT00882999|6094274|P2|Overall Study|Lost to Follow-up|1
1748373|NCT00882999|6094275|P1|Overall Study|Lost to Follow-up|0
1748374|NCT00882999|6094269|P7|Overall Study|Withdrawal by Subject|5
1748375|NCT00882999|6094270|P6|Overall Study|Withdrawal by Subject|5
1748376|NCT00882999|6094271|P5|Overall Study|Withdrawal by Subject|6
1748377|NCT00882999|6094272|P4|Overall Study|Withdrawal by Subject|3
1748378|NCT00882999|6094273|P3|Overall Study|Withdrawal by Subject|3
1748379|NCT00882999|6094274|P2|Overall Study|Withdrawal by Subject|6
1748380|NCT00882999|6094275|P1|Overall Study|Withdrawal by Subject|7
1748381|NCT00882999|6094269|P7|Overall Study|Death|0
1748382|NCT00882999|6094270|P6|Overall Study|Death|0
1748383|NCT00882999|6094271|P5|Overall Study|Death|0
1748384|NCT00882999|6094272|P4|Overall Study|Death|0
1748385|NCT00882999|6094273|P3|Overall Study|Death|0
1748386|NCT00882999|6094274|P2|Overall Study|Death|1
1748387|NCT00882999|6094275|P1|Overall Study|Death|0
1748388|NCT00882999|6094269|P7|Overall Study|Adverse Event|0
1748389|NCT00882999|6094270|P6|Overall Study|Adverse Event|0
1748390|NCT00882999|6094271|P5|Overall Study|Adverse Event|1
1748391|NCT00882999|6094272|P4|Overall Study|Adverse Event|0
1748392|NCT00882999|6094273|P3|Overall Study|Adverse Event|0
1748393|NCT00882999|6094274|P2|Overall Study|Adverse Event|0
1748394|NCT00882999|6094275|P1|Overall Study|Adverse Event|0
1748395|NCT00882921|6094402|P1|Overall Study|Withdrawal Of Consent|1
1748396|NCT00882921|6094402|P1|Overall Study|Termination By Investigator|3
1748397|NCT00882921|6094402|P1|Overall Study|Lost to Follow-up|2
1748398|NCT00882921|6094402|P1|Overall Study|Other|3
1748399|NCT00882921|6094402|P1|Overall Study|Death|2
1748400|NCT00882908|6094412|P5|Overall Study|Study terminated in error|0
1748401|NCT00882908|6094413|P4|Overall Study|Study terminated in error|1
1748402|NCT00882908|6094414|P3|Overall Study|Study terminated in error|0
1748403|NCT00882908|6094415|P2|Overall Study|Study terminated in error|0
1748404|NCT00882908|6094416|P1|Overall Study|Study terminated in error|0
1748405|NCT00882908|6094412|P5|Overall Study|Subject reached a virologic endpoint|1
1748406|NCT00882908|6094413|P4|Overall Study|Subject reached a virologic endpoint|0
1748407|NCT00882908|6094414|P3|Overall Study|Subject reached a virologic endpoint|0
1748408|NCT00882908|6094415|P2|Overall Study|Subject reached a virologic endpoint|0
1748409|NCT00882908|6094416|P1|Overall Study|Subject reached a virologic endpoint|0
1748410|NCT00882908|6094412|P5|Overall Study|Withdrawal by Subject|2
1748411|NCT00882908|6094413|P4|Overall Study|Withdrawal by Subject|5
1748412|NCT00882908|6094414|P3|Overall Study|Withdrawal by Subject|3
1748413|NCT00882908|6094415|P2|Overall Study|Withdrawal by Subject|0
1748414|NCT00882908|6094416|P1|Overall Study|Withdrawal by Subject|0
1748415|NCT00882908|6094412|P5|Overall Study|Protocol Violation|0
1748416|NCT00882908|6094413|P4|Overall Study|Protocol Violation|0
1748417|NCT00882908|6094414|P3|Overall Study|Protocol Violation|0
1748418|NCT00882908|6094415|P2|Overall Study|Protocol Violation|1
1748419|NCT00882908|6094416|P1|Overall Study|Protocol Violation|0
1748420|NCT00882908|6094412|P5|Overall Study|Lost to Follow-up|2
1748421|NCT00882908|6094413|P4|Overall Study|Lost to Follow-up|1
1748422|NCT00882908|6094414|P3|Overall Study|Lost to Follow-up|3
1748423|NCT00882908|6094415|P2|Overall Study|Lost to Follow-up|5
1748424|NCT00882908|6094416|P1|Overall Study|Lost to Follow-up|3
1748425|NCT00882908|6094412|P5|Overall Study|Adverse Event|1
1748426|NCT00882908|6094413|P4|Overall Study|Adverse Event|0
1748427|NCT00882908|6094414|P3|Overall Study|Adverse Event|1
1748428|NCT00882908|6094415|P2|Overall Study|Adverse Event|0
1748429|NCT00882908|6094416|P1|Overall Study|Adverse Event|0
1748430|NCT00882713|6094522|P1|Overall Study|Other - Reasons|2
1748431|NCT00882713|6094522|P1|Overall Study|Failure to return|2
1748432|NCT00882713|6094522|P1|Overall Study|Insufficient therapeutic response|3
1748433|NCT00882713|6094522|P1|Overall Study|Blood transfusion|2
1748434|NCT00882713|6094522|P1|Overall Study|refused treatment/withdrew consent|4
1748435|NCT00882713|6094522|P1|Overall Study|Administrative reasons|4
1748436|NCT00882713|6094522|P1|Overall Study|Death|3
1748437|NCT00882713|6094522|P1|Overall Study|Adverse Event|2
1748438|NCT00882583|6094615|P2|Overall Study|Adverse Event|1
1748439|NCT00882583|6094616|P1|Overall Study|Adverse Event|0
1748440|NCT00882583|6094615|P2|Overall Study|Physician Decision|0
1748441|NCT00882583|6094616|P1|Overall Study|Physician Decision|1
1748442|NCT00882557|6094624|P2|Overall Study|Randomized Not Treated|1
1748443|NCT00882557|6094625|P1|Overall Study|Randomized Not Treated|0
1748444|NCT00882557|6094624|P2|Overall Study|Trouble with Vein Access|0
1748445|NCT00882557|6094625|P1|Overall Study|Trouble with Vein Access|1
1748446|NCT00882557|6094624|P2|Overall Study|Withdrawal by Subject|0
1748447|NCT00882557|6094625|P1|Overall Study|Withdrawal by Subject|1
1748448|NCT00882518|6094645|P2|Overall Study|Allocating random number by mistake|1
1748449|NCT00882518|6094646|P1|Overall Study|Allocating random number by mistake|0
1748450|NCT00882518|6094645|P2|Overall Study|Central lab closure for National day|0
1748451|NCT00882518|6094646|P1|Overall Study|Central lab closure for National day|1
1748452|NCT00882518|6094645|P2|Overall Study|Incorrect enrolment|2
1748453|NCT00882518|6094646|P1|Overall Study|Incorrect enrolment|4
1748454|NCT00882518|6094645|P2|Overall Study|Severe non-compliance to protocol|1
1748455|NCT00882518|6094646|P1|Overall Study|Severe non-compliance to protocol|3
1748456|NCT00882518|6094645|P2|Overall Study|Lack of Efficacy|9
1748457|NCT00882518|6094646|P1|Overall Study|Lack of Efficacy|12
1748458|NCT00882518|6094645|P2|Overall Study|Withdrawal by Subject|13
1748459|NCT00882518|6094646|P1|Overall Study|Withdrawal by Subject|9
1748460|NCT00882518|6094645|P2|Overall Study|Adverse Event|18
1748461|NCT00882518|6094646|P1|Overall Study|Adverse Event|9
1748462|NCT00882440|6094675|P7|Overall Study|Patient Uncooperative|0
1748463|NCT00882440|6094676|P6|Overall Study|Patient Uncooperative|0
1748464|NCT00882440|6094677|P5|Overall Study|Patient Uncooperative|1
1748465|NCT00882440|6094678|P4|Overall Study|Patient Uncooperative|0
1748466|NCT00882440|6094679|P3|Overall Study|Patient Uncooperative|0
1748467|NCT00882440|6094680|P2|Overall Study|Patient Uncooperative|0
1748468|NCT00882440|6094681|P1|Overall Study|Patient Uncooperative|2
1748469|NCT00882440|6094675|P7|Overall Study|Withdrawal by Subject|1
1748470|NCT00882440|6094676|P6|Overall Study|Withdrawal by Subject|0
1748471|NCT00882440|6094677|P5|Overall Study|Withdrawal by Subject|6
1748472|NCT00882440|6094678|P4|Overall Study|Withdrawal by Subject|0
1748473|NCT00882440|6094679|P3|Overall Study|Withdrawal by Subject|1
1748474|NCT00882440|6094680|P2|Overall Study|Withdrawal by Subject|1
1748475|NCT00882440|6094681|P1|Overall Study|Withdrawal by Subject|2
1748476|NCT00882440|6094675|P7|Overall Study|Protocol Violation|0
1748477|NCT00882440|6094676|P6|Overall Study|Protocol Violation|0
1748478|NCT00882440|6094677|P5|Overall Study|Protocol Violation|1
1748479|NCT00882440|6094678|P4|Overall Study|Protocol Violation|1
1748480|NCT00882440|6094679|P3|Overall Study|Protocol Violation|1
1748481|NCT00882440|6094680|P2|Overall Study|Protocol Violation|0
1748482|NCT00882440|6094681|P1|Overall Study|Protocol Violation|0
1748483|NCT00882440|6094675|P7|Overall Study|Lost to Follow-up|1
1748484|NCT00882440|6094676|P6|Overall Study|Lost to Follow-up|0
1748485|NCT00882440|6094677|P5|Overall Study|Lost to Follow-up|1
1748486|NCT00882440|6094678|P4|Overall Study|Lost to Follow-up|1
1748487|NCT00882440|6094679|P3|Overall Study|Lost to Follow-up|1
1748488|NCT00882440|6094680|P2|Overall Study|Lost to Follow-up|0
1748489|NCT00882440|6094681|P1|Overall Study|Lost to Follow-up|2
1748490|NCT00882440|6094675|P7|Overall Study|Lack of Efficacy|0
1748491|NCT00882440|6094676|P6|Overall Study|Lack of Efficacy|3
1748492|NCT00882440|6094677|P5|Overall Study|Lack of Efficacy|0
1748493|NCT00882440|6094678|P4|Overall Study|Lack of Efficacy|0
1748494|NCT00882440|6094679|P3|Overall Study|Lack of Efficacy|2
1748495|NCT00882440|6094680|P2|Overall Study|Lack of Efficacy|5
1748496|NCT00882440|6094681|P1|Overall Study|Lack of Efficacy|3
1748497|NCT00882440|6094675|P7|Overall Study|Adverse Event|2
1748498|NCT00882440|6094676|P6|Overall Study|Adverse Event|4
1748499|NCT00882440|6094677|P5|Overall Study|Adverse Event|1
1748500|NCT00882440|6094678|P4|Overall Study|Adverse Event|1
1748501|NCT00882440|6094679|P3|Overall Study|Adverse Event|2
1748502|NCT00882440|6094680|P2|Overall Study|Adverse Event|2
1748503|NCT00882440|6094681|P1|Overall Study|Adverse Event|2
1748504|NCT00882362|6094706|P2|Overall Study|change of residence or other commitments|0
1748505|NCT00882362|6094707|P1|Overall Study|change of residence or other commitments|5
1748506|NCT00882362|6094706|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
1748507|NCT00882362|6094707|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
1748508|NCT00882362|6094706|P2|Overall Study|Physician Decision|1
1748509|NCT00882362|6094707|P1|Overall Study|Physician Decision|5
1748510|NCT00882362|6094706|P2|Overall Study|Pregnancy|0
1748511|NCT00882362|6094707|P1|Overall Study|Pregnancy|1
1748512|NCT00882362|6094706|P2|Overall Study|Protocol Violation|2
1748513|NCT00882362|6094707|P1|Overall Study|Protocol Violation|7
1748514|NCT00882362|6094706|P2|Overall Study|Lack of Efficacy|0
1748515|NCT00882362|6094707|P1|Overall Study|Lack of Efficacy|3
1748516|NCT00882362|6094706|P2|Overall Study|Withdrawal by Subject|10
1748517|NCT00882362|6094707|P1|Overall Study|Withdrawal by Subject|13
1748518|NCT00882362|6094706|P2|Overall Study|Adverse Event|10
1748519|NCT00882362|6094707|P1|Overall Study|Adverse Event|13
1748520|NCT00882310|6094713|P1|Overall Study|Adverse Event|1
1748521|NCT00882310|6094713|P1|Overall Study|Progression of disease|4
1748522|NCT00882310|6094713|P1|Overall Study|Death|6
1748523|NCT00882310|6094713|P1|Overall Study|Never received treatment|1
1748524|NCT00882310|6094713|P1|Overall Study|Screen Failure|10
1748525|NCT00882115|6094726|P1|Overall Study|did not respond to DEP challe|6
1748526|NCT00882115|6094726|P1|Overall Study|Withdrawal by Subject|3
1748527|NCT00881959|6094736|P2|Overall Study|Lost to Follow-up|4
1748528|NCT00881959|6094737|P1|Overall Study|Lost to Follow-up|2
1748529|NCT00881894|6094745|P2|Overall Study|Other reasons for premature termination|2
1748530|NCT00881894|6094746|P1|Overall Study|Other reasons for premature termination|1
1748531|NCT00881894|6094745|P2|Overall Study|Consent withdrawn|1
1748532|NCT00881894|6094746|P1|Overall Study|Consent withdrawn|0
1748533|NCT00881868|6094778|P2|Overall Study|Protocol Violation|0
1748534|NCT00881868|6094779|P1|Overall Study|Protocol Violation|2
1748535|NCT00881868|6094778|P2|Overall Study|Physician Decision|0
1748536|NCT00881868|6094779|P1|Overall Study|Physician Decision|4
1748537|NCT00881868|6094778|P2|Overall Study|Lost to Follow-up|1
1748538|NCT00881868|6094779|P1|Overall Study|Lost to Follow-up|2
1748539|NCT00881868|6094778|P2|Overall Study|Adverse Event|1
1748540|NCT00881868|6094779|P1|Overall Study|Adverse Event|0
1748541|NCT00881751|6094793|P2|Overall Study|Withdrawal by Subject|2
1748542|NCT00881751|6094794|P1|Overall Study|Withdrawal by Subject|0
1748543|NCT00881751|6094793|P2|Overall Study|Adverse Event|2
1748544|NCT00881751|6094794|P1|Overall Study|Adverse Event|0
1748545|NCT00881751|6094793|P2|Overall Study|Physician Decision|1
1748546|NCT00881751|6094794|P1|Overall Study|Physician Decision|0
1748547|NCT00881712|6094809|P3|Overall Study|Withdrawal by Subject|0
1748548|NCT00881712|6094810|P2|Overall Study|Withdrawal by Subject|0
1748549|NCT00881712|6094811|P1|Overall Study|Withdrawal by Subject|1
1748550|NCT00881712|6094809|P3|Overall Study|Death|0
1748551|NCT00881712|6094810|P2|Overall Study|Death|0
1748552|NCT00881712|6094811|P1|Overall Study|Death|1
1748553|NCT00881621|6094844|P1|Overall Study|Physician Decision|34
1748554|NCT00881608|6094856|P1|Overall Study|Study prematurely terminated|11
1748555|NCT00881530|6094879|P6|Overall Study|Other reason not defined above|2
1748556|NCT00881530|6094880|P5|Overall Study|Other reason not defined above|0
1748557|NCT00881530|6094881|P4|Overall Study|Other reason not defined above|0
1748558|NCT00881530|6094882|P3|Overall Study|Other reason not defined above|2
1748559|NCT00881530|6094883|P2|Overall Study|Other reason not defined above|1
1748560|NCT00881530|6094884|P1|Overall Study|Other reason not defined above|1
1748561|NCT00881530|6094879|P6|Overall Study|Refused to continue medication|0
1748562|NCT00881530|6094880|P5|Overall Study|Refused to continue medication|0
1748563|NCT00881530|6094881|P4|Overall Study|Refused to continue medication|2
1748564|NCT00881530|6094882|P3|Overall Study|Refused to continue medication|1
1748565|NCT00881530|6094883|P2|Overall Study|Refused to continue medication|2
1748566|NCT00881530|6094884|P1|Overall Study|Refused to continue medication|7
1748567|NCT00881530|6094879|P6|Overall Study|Lost to Follow-up|0
1748568|NCT00881530|6094880|P5|Overall Study|Lost to Follow-up|1
1748569|NCT00881530|6094881|P4|Overall Study|Lost to Follow-up|3
1748570|NCT00881530|6094882|P3|Overall Study|Lost to Follow-up|1
1748571|NCT00881530|6094883|P2|Overall Study|Lost to Follow-up|1
1748572|NCT00881530|6094884|P1|Overall Study|Lost to Follow-up|0
1748573|NCT00881530|6094879|P6|Overall Study|Not compliant with the protocol|0
1748574|NCT00881530|6094880|P5|Overall Study|Not compliant with the protocol|2
1748575|NCT00881530|6094881|P4|Overall Study|Not compliant with the protocol|0
1748576|NCT00881530|6094882|P3|Overall Study|Not compliant with the protocol|0
1748577|NCT00881530|6094883|P2|Overall Study|Not compliant with the protocol|0
1748578|NCT00881530|6094884|P1|Overall Study|Not compliant with the protocol|0
1748579|NCT00881530|6094879|P6|Overall Study|Lack of Efficacy|1
1748580|NCT00881530|6094880|P5|Overall Study|Lack of Efficacy|1
1748581|NCT00881530|6094881|P4|Overall Study|Lack of Efficacy|0
1748582|NCT00881530|6094882|P3|Overall Study|Lack of Efficacy|0
1748583|NCT00881530|6094883|P2|Overall Study|Lack of Efficacy|0
1748584|NCT00881530|6094884|P1|Overall Study|Lack of Efficacy|1
1748585|NCT00881530|6094879|P6|Overall Study|Adverse Event|2
1748586|NCT00881530|6094880|P5|Overall Study|Adverse Event|10
1748587|NCT00881530|6094881|P4|Overall Study|Adverse Event|4
1748588|NCT00881530|6094882|P3|Overall Study|Adverse Event|1
1748589|NCT00881530|6094883|P2|Overall Study|Adverse Event|1
1748590|NCT00881530|6094884|P1|Overall Study|Adverse Event|5
1748591|NCT00881504|6094940|P1|Overall Study|Withdrawal by Subject|1
1748592|NCT00881361|6094960|P3|Overall Study|Ineligible|2
1748593|NCT00881361|6094961|P2|Overall Study|Ineligible|2
1748594|NCT00881361|6094962|P1|Overall Study|Ineligible|17
1748595|NCT00881361|6094960|P3|Overall Study|Terminated prior to surgery|0
1748596|NCT00881361|6094961|P2|Overall Study|Terminated prior to surgery|7
1748597|NCT00881361|6094962|P1|Overall Study|Terminated prior to surgery|27
1748598|NCT00881335|6094977|P2|Overall Study|Lost to Follow-up|2
1748599|NCT00881335|6094978|P1|Overall Study|Lost to Follow-up|3
1748600|NCT00881205|6094998|P2|Overall Study|Condition no longer requires drug|0
1748601|NCT00881205|6094999|P1|Overall Study|Condition no longer requires drug|1
1748602|NCT00881205|6094998|P2|Overall Study|Administrative problems|1
1748603|NCT00881205|6094999|P1|Overall Study|Administrative problems|1
1748604|NCT00881205|6094998|P2|Overall Study|Lost to Follow-up|1
1748605|NCT00881205|6094999|P1|Overall Study|Lost to Follow-up|0
1748606|NCT00881205|6094998|P2|Overall Study|Withdrawal by Subject|2
1748607|NCT00881205|6094999|P1|Overall Study|Withdrawal by Subject|1
1748608|NCT00881205|6094998|P2|Overall Study|Adverse Event|3
1748609|NCT00881205|6094999|P1|Overall Study|Adverse Event|8
1748610|NCT00880906|6095067|P2|Overall Study|Did not meet criteria following patholog|6
1748611|NCT00880906|6095068|P1|Overall Study|Did not meet criteria following patholog|12
1748612|NCT00880906|6095067|P2|Overall Study|Lost to Follow-up|1
1748613|NCT00880906|6095068|P1|Overall Study|Lost to Follow-up|0
1748614|NCT00880893|6095078|P2|Overall Study|Serious adverse event|0
1748615|NCT00880893|6095079|P1|Overall Study|Serious adverse event|3
1748616|NCT00880893|6095078|P2|Overall Study|Lost to Follow-up|33
1748617|NCT00880893|6095079|P1|Overall Study|Lost to Follow-up|76
1748618|NCT00880893|6095078|P2|Overall Study|Withdrawal by Subject|11
1748619|NCT00880893|6095079|P1|Overall Study|Withdrawal by Subject|15
1748620|NCT00880893|6095078|P2|Overall Study|Protocol Violation|1
1748621|NCT00880893|6095079|P1|Overall Study|Protocol Violation|13
1748622|NCT00880763|6095131|P4|Extension Period (Part 2)|Lack of Efficacy|1
1748623|NCT00880763|6095132|P3|Extension Period (Part 2)|Lack of Efficacy|0
1748624|NCT00880763|6095133|P2|Extension Period (Part 2)|Lack of Efficacy|0
1748625|NCT00880763|6095134|P1|Extension Period (Part 2)|Lack of Efficacy|0
1748626|NCT00880763|6095131|P4|Extension Period (Part 2)|Physician Decision|0
1748627|NCT00880763|6095132|P3|Extension Period (Part 2)|Physician Decision|1
1748628|NCT00880763|6095133|P2|Extension Period (Part 2)|Physician Decision|1
1748629|NCT00880763|6095134|P1|Extension Period (Part 2)|Physician Decision|0
1748630|NCT00880763|6095131|P4|Extension Period (Part 2)|Withdrawal by Subject|1
1748631|NCT00880763|6095132|P3|Extension Period (Part 2)|Withdrawal by Subject|1
1748632|NCT00880763|6095133|P2|Extension Period (Part 2)|Withdrawal by Subject|2
1748633|NCT00880763|6095134|P1|Extension Period (Part 2)|Withdrawal by Subject|0
1748634|NCT00880763|6095131|P4|Extension Period (Part 2)|Adverse Event|1
1748635|NCT00880763|6095132|P3|Extension Period (Part 2)|Adverse Event|1
1748636|NCT00880763|6095133|P2|Extension Period (Part 2)|Adverse Event|0
1748637|NCT00880763|6095134|P1|Extension Period (Part 2)|Adverse Event|0
1748638|NCT00880750|6095166|P2|Second Intervention|Unable to collect urine|0
1748639|NCT00880750|6095167|P1|Second Intervention|Unable to collect urine|1
1748640|NCT00880750|6095166|P2|Second Intervention|Protocol Violation|0
1748641|NCT00880750|6095167|P1|Second Intervention|Protocol Violation|1
1748642|NCT00880750|6095166|P2|Second Intervention|Withdrawal by Subject|2
1748643|NCT00880750|6095167|P1|Second Intervention|Withdrawal by Subject|2
1748644|NCT00880750|6095166|P2|First Intervention|Lost to Follow-up|0
1748645|NCT00880750|6095167|P1|First Intervention|Lost to Follow-up|2
1748646|NCT00880750|6095166|P2|First Intervention|Withdrawal by Subject|0
1748647|NCT00880750|6095167|P1|First Intervention|Withdrawal by Subject|2
1748648|NCT00880750|6095166|P2|First Intervention|Non-compliance with meals|1
1748649|NCT00880750|6095167|P1|First Intervention|Non-compliance with meals|0
1748650|NCT00880750|6095166|P2|First Intervention|Unable to collect urine|0
1748651|NCT00880750|6095167|P1|First Intervention|Unable to collect urine|4
1748652|NCT00880750|6095166|P2|First Intervention|Adverse Event|0
1748653|NCT00880750|6095167|P1|First Intervention|Adverse Event|1
1748654|NCT00880698|6095185|P4|Overall Study|Lost to Follow-up|1
1748655|NCT00880698|6095186|P3|Overall Study|Lost to Follow-up|0
1748656|NCT00880698|6095187|P2|Overall Study|Lost to Follow-up|3
1748657|NCT00880698|6095188|P1|Overall Study|Lost to Follow-up|1
1748658|NCT00880698|6095185|P4|Overall Study|Death|2
1748659|NCT00880698|6095186|P3|Overall Study|Death|1
1748660|NCT00880698|6095187|P2|Overall Study|Death|0
1748661|NCT00880698|6095188|P1|Overall Study|Death|0
1748662|NCT00880685|6095214|P1|Memantine 20mg|Withdrawal by Subject|1
1748663|NCT00880685|6095214|P1|Memantine 10mg|Lost to Follow-up|2
1748664|NCT00880620|6095226|P4|Overall Study|Other|2
1748665|NCT00880620|6095227|P3|Overall Study|Other|2
1748666|NCT00880620|6095228|P2|Overall Study|Other|1
1748667|NCT00880620|6095229|P1|Overall Study|Other|1
1748668|NCT00880620|6095226|P4|Overall Study|Noncompliance|1
1748669|NCT00880620|6095227|P3|Overall Study|Noncompliance|1
1748670|NCT00880620|6095228|P2|Overall Study|Noncompliance|0
1748671|NCT00880620|6095229|P1|Overall Study|Noncompliance|0
1748672|NCT00880620|6095226|P4|Overall Study|Withdrawal by Subject|3
1748673|NCT00880620|6095227|P3|Overall Study|Withdrawal by Subject|1
1748674|NCT00880620|6095228|P2|Overall Study|Withdrawal by Subject|3
1748675|NCT00880620|6095229|P1|Overall Study|Withdrawal by Subject|4
1748676|NCT00880620|6095226|P4|Overall Study|Protocol Violation|2
1748677|NCT00880620|6095227|P3|Overall Study|Protocol Violation|0
1748678|NCT00880620|6095228|P2|Overall Study|Protocol Violation|1
1748679|NCT00880620|6095229|P1|Overall Study|Protocol Violation|0
1748680|NCT00880620|6095226|P4|Overall Study|Lost to Follow-up|0
1748681|NCT00880620|6095227|P3|Overall Study|Lost to Follow-up|1
1748682|NCT00880620|6095228|P2|Overall Study|Lost to Follow-up|1
1748683|NCT00880620|6095229|P1|Overall Study|Lost to Follow-up|0
1748684|NCT00880620|6095226|P4|Overall Study|Lack of Efficacy|1
1748685|NCT00880620|6095227|P3|Overall Study|Lack of Efficacy|0
1748686|NCT00880620|6095228|P2|Overall Study|Lack of Efficacy|4
1748687|NCT00880620|6095229|P1|Overall Study|Lack of Efficacy|12
1748688|NCT00880620|6095226|P4|Overall Study|Death|0
1748689|NCT00880620|6095227|P3|Overall Study|Death|1
1748690|NCT00880620|6095228|P2|Overall Study|Death|0
1748691|NCT00880620|6095229|P1|Overall Study|Death|0
1748692|NCT00880620|6095226|P4|Overall Study|Adverse Event|15
1748693|NCT00880620|6095227|P3|Overall Study|Adverse Event|15
1748694|NCT00880620|6095228|P2|Overall Study|Adverse Event|5
1748695|NCT00880620|6095229|P1|Overall Study|Adverse Event|4
1748696|NCT00880568|6095257|P9|Overall Study|Withdrawal by Subject|0
1748697|NCT00880568|6095258|P8|Overall Study|Withdrawal by Subject|1
1748698|NCT00880568|6095259|P7|Overall Study|Withdrawal by Subject|0
1748699|NCT00880568|6095260|P6|Overall Study|Withdrawal by Subject|0
1748700|NCT00880568|6095261|P5|Overall Study|Withdrawal by Subject|0
1748701|NCT00880568|6095262|P4|Overall Study|Withdrawal by Subject|0
1748702|NCT00880568|6095263|P3|Overall Study|Withdrawal by Subject|0
1748703|NCT00880568|6095264|P2|Overall Study|Withdrawal by Subject|0
1748704|NCT00880568|6095265|P1|Overall Study|Withdrawal by Subject|0
1748705|NCT00880568|6095257|P9|Overall Study|Adverse Event|0
1748706|NCT00880568|6095258|P8|Overall Study|Adverse Event|1
1748707|NCT00880568|6095259|P7|Overall Study|Adverse Event|1
1748708|NCT00880568|6095260|P6|Overall Study|Adverse Event|0
1748709|NCT00880568|6095261|P5|Overall Study|Adverse Event|0
1748710|NCT00880568|6095262|P4|Overall Study|Adverse Event|0
1748711|NCT00880568|6095263|P3|Overall Study|Adverse Event|0
1748712|NCT00880568|6095264|P2|Overall Study|Adverse Event|0
1748713|NCT00880568|6095265|P1|Overall Study|Adverse Event|0
1748714|NCT00880568|6095257|P9|Overall Study|Disease progression|3
1748715|NCT00880568|6095258|P8|Overall Study|Disease progression|0
1748716|NCT00880568|6095259|P7|Overall Study|Disease progression|5
1748717|NCT00880568|6095260|P6|Overall Study|Disease progression|3
1748718|NCT00880568|6095261|P5|Overall Study|Disease progression|3
1748719|NCT00880568|6095262|P4|Overall Study|Disease progression|1
1748720|NCT00880568|6095263|P3|Overall Study|Disease progression|3
1748721|NCT00880568|6095264|P2|Overall Study|Disease progression|3
1748722|NCT00880568|6095265|P1|Overall Study|Disease progression|3
1748723|NCT00880555|6095311|P6|Overall Study|Lost to Follow-up|0
1748724|NCT00880555|6095312|P5|Overall Study|Lost to Follow-up|0
1748725|NCT00880555|6095313|P4|Overall Study|Lost to Follow-up|0
1748726|NCT00880555|6095314|P3|Overall Study|Lost to Follow-up|0
1748727|NCT00880555|6095315|P2|Overall Study|Lost to Follow-up|1
1748728|NCT00880555|6095316|P1|Overall Study|Lost to Follow-up|0
1748729|NCT00880555|6095311|P6|Overall Study|Death|1
1748730|NCT00880555|6095312|P5|Overall Study|Death|0
1748731|NCT00880555|6095313|P4|Overall Study|Death|0
1748732|NCT00880555|6095314|P3|Overall Study|Death|0
1748733|NCT00880555|6095315|P2|Overall Study|Death|0
1748734|NCT00880555|6095316|P1|Overall Study|Death|0
1748735|NCT00880555|6095311|P6|Overall Study|Lack of resources (hired rater)|0
1748736|NCT00880555|6095312|P5|Overall Study|Lack of resources (hired rater)|0
1748737|NCT00880555|6095313|P4|Overall Study|Lack of resources (hired rater)|0
1748738|NCT00880555|6095314|P3|Overall Study|Lack of resources (hired rater)|5
1748739|NCT00880555|6095315|P2|Overall Study|Lack of resources (hired rater)|7
1748740|NCT00880555|6095316|P1|Overall Study|Lack of resources (hired rater)|9
1748741|NCT00880555|6095311|P6|Overall Study|Withdrawal by Subject|0
1748742|NCT00880555|6095312|P5|Overall Study|Withdrawal by Subject|0
1748743|NCT00880555|6095313|P4|Overall Study|Withdrawal by Subject|0
1748744|NCT00880555|6095314|P3|Overall Study|Withdrawal by Subject|0
1748745|NCT00880555|6095315|P2|Overall Study|Withdrawal by Subject|1
1748746|NCT00880555|6095316|P1|Overall Study|Withdrawal by Subject|1
1748747|NCT00880555|6095311|P6|Overall Study|Physician Decision|0
1748748|NCT00880555|6095312|P5|Overall Study|Physician Decision|1
1748749|NCT00880555|6095313|P4|Overall Study|Physician Decision|2
1748750|NCT00880555|6095314|P3|Overall Study|Physician Decision|0
1748751|NCT00880555|6095315|P2|Overall Study|Physician Decision|8
1748752|NCT00880555|6095316|P1|Overall Study|Physician Decision|0
1748753|NCT00880542|6095327|P1|REP: Surgical Resection|progressive disease|1
1748754|NCT00880542|6095327|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
1748755|NCT00880542|6095327|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
1748756|NCT00880399|6095344|P3|Overall Study|Withdrawal by Subject|3
1748757|NCT00880399|6095345|P2|Overall Study|Withdrawal by Subject|3
1748758|NCT00880399|6095346|P1|Overall Study|Withdrawal by Subject|6
1748759|NCT00880399|6095344|P3|Overall Study|Physician Decision|3
1748760|NCT00880399|6095345|P2|Overall Study|Physician Decision|0
1748761|NCT00880399|6095346|P1|Overall Study|Physician Decision|5
1748762|NCT00880399|6095344|P3|Overall Study|Lost to Follow-up|3
1748763|NCT00880399|6095345|P2|Overall Study|Lost to Follow-up|5
1748764|NCT00880399|6095346|P1|Overall Study|Lost to Follow-up|8
1748765|NCT00880399|6095344|P3|Overall Study|Study closed/terminated|4
1748766|NCT00880399|6095345|P2|Overall Study|Study closed/terminated|7
1748767|NCT00880399|6095346|P1|Overall Study|Study closed/terminated|3
1748768|NCT00880399|6095344|P3|Overall Study|Protocol Violation|6
1748769|NCT00880399|6095345|P2|Overall Study|Protocol Violation|4
1748770|NCT00880399|6095346|P1|Overall Study|Protocol Violation|4
1748771|NCT00880399|6095344|P3|Overall Study|Lack of Efficacy|2
1748772|NCT00880399|6095345|P2|Overall Study|Lack of Efficacy|4
1748773|NCT00880399|6095346|P1|Overall Study|Lack of Efficacy|1
1748774|NCT00880399|6095344|P3|Overall Study|Adverse Event|5
1748775|NCT00880399|6095345|P2|Overall Study|Adverse Event|6
1748776|NCT00880399|6095346|P1|Overall Study|Adverse Event|4
1748777|NCT00880334|6095409|P2|Randomized Phase|Crossover Participants|37
1748778|NCT00880334|6095410|P1|Randomized Phase|Crossover Participants|0
1748779|NCT00880334|6095409|P2|Randomized Phase|Brain Metastasis|1
1748780|NCT00880334|6095410|P1|Randomized Phase|Brain Metastasis|0
1748781|NCT00880334|6095409|P2|Randomized Phase|Inadequate Labs|1
1748782|NCT00880334|6095410|P1|Randomized Phase|Inadequate Labs|1
1748783|NCT00880334|6095409|P2|Randomized Phase|Withdrawal by Subject|1
1748784|NCT00880334|6095410|P1|Randomized Phase|Withdrawal by Subject|2
1748785|NCT00880334|6095409|P2|Randomized Phase|Physician Decision|0
1748786|NCT00880334|6095410|P1|Randomized Phase|Physician Decision|1
1748787|NCT00880269|6095427|P2|Overall Study|Adverse Event|9
1748788|NCT00880269|6095428|P1|Overall Study|Adverse Event|10
1748789|NCT00880269|6095427|P2|Overall Study|Withdrawal by Subject|4
1748790|NCT00880269|6095428|P1|Overall Study|Withdrawal by Subject|3
1748791|NCT00880269|6095427|P2|Overall Study|Lost to Follow-up|1
1748792|NCT00880269|6095428|P1|Overall Study|Lost to Follow-up|0
1748793|NCT00880269|6095427|P2|Overall Study|Death|2
1748794|NCT00880269|6095428|P1|Overall Study|Death|4
1748795|NCT00880269|6095427|P2|Overall Study|New Cancer Therapy|0
1748796|NCT00880269|6095428|P1|Overall Study|New Cancer Therapy|1
1748797|NCT00880269|6095427|P2|Overall Study|Disease Progression|11
1748798|NCT00880269|6095428|P1|Overall Study|Disease Progression|13
1748799|NCT00880269|6095427|P2|Overall Study|Protocol Violation|0
1748800|NCT00880269|6095428|P1|Overall Study|Protocol Violation|1
1748801|NCT00880256|6095444|P1|Overall Study|Lost to Follow-up|28
1748802|NCT00880191|6095471|P2|Overall Study|Hospitalization/efficacy|1
1748803|NCT00880191|6095472|P1|Overall Study|Hospitalization/efficacy|1
1748804|NCT00880191|6095471|P2|Overall Study|Adverse Event|6
1748805|NCT00880191|6095472|P1|Overall Study|Adverse Event|8
1748806|NCT00880191|6095471|P2|Overall Study|Refused further treatment|1
1748807|NCT00880191|6095472|P1|Overall Study|Refused further treatment|4
1748808|NCT00880165|6095492|P2|Overall Study|Lost to follow|15
1748809|NCT00880165|6095493|P1|Overall Study|Lost to follow|9
1748810|NCT00880165|6095492|P2|Overall Study|Required BIPAP or oxygen treatment|4
1748811|NCT00880165|6095493|P1|Overall Study|Required BIPAP or oxygen treatment|12
1748812|NCT00880165|6095492|P2|Overall Study|Not diagnosed with OSA|8
1748813|NCT00880165|6095493|P1|Overall Study|Not diagnosed with OSA|14
1748814|NCT00880165|6095492|P2|Overall Study|Withdrawal by Subject|23
1748815|NCT00880165|6095493|P1|Overall Study|Withdrawal by Subject|27
1748816|NCT00880100|6095503|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
1748817|NCT00880100|6095503|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
1748818|NCT00880100|6095503|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
1748819|NCT00880087|6095516|P2|Overall Study|Lost to Follow-up|2
1748820|NCT00880087|6095517|P1|Overall Study|Lost to Follow-up|0
1748821|NCT00880048|6095532|P3|Overall Study|Study closed/terminated|6
1748822|NCT00880048|6095533|P2|Overall Study|Study closed/terminated|7
1748823|NCT00880048|6095534|P1|Overall Study|Study closed/terminated|9
1748824|NCT00880048|6095532|P3|Overall Study|Withdrawal by Subject|5
1748825|NCT00880048|6095533|P2|Overall Study|Withdrawal by Subject|8
1748826|NCT00880048|6095534|P1|Overall Study|Withdrawal by Subject|5
1748827|NCT00880048|6095532|P3|Overall Study|Physician Decision|7
1748828|NCT00880048|6095533|P2|Overall Study|Physician Decision|1
1748829|NCT00880048|6095534|P1|Overall Study|Physician Decision|1
1748830|NCT00880048|6095532|P3|Overall Study|Lost to Follow-up|5
1748831|NCT00880048|6095533|P2|Overall Study|Lost to Follow-up|6
1748832|NCT00880048|6095534|P1|Overall Study|Lost to Follow-up|6
1748833|NCT00880048|6095532|P3|Overall Study|Protocol Violation|5
1748834|NCT00880048|6095533|P2|Overall Study|Protocol Violation|6
1748835|NCT00880048|6095534|P1|Overall Study|Protocol Violation|4
1748836|NCT00880048|6095532|P3|Overall Study|Lack of Efficacy|2
1748837|NCT00880048|6095533|P2|Overall Study|Lack of Efficacy|2
1748838|NCT00880048|6095534|P1|Overall Study|Lack of Efficacy|1
1748839|NCT00880048|6095532|P3|Overall Study|Adverse Event|5
1748840|NCT00880048|6095533|P2|Overall Study|Adverse Event|3
1748841|NCT00880048|6095534|P1|Overall Study|Adverse Event|2
1748842|NCT00880009|6095601|P1|Overall Study|Protocol Violation|1
1748843|NCT00880009|6095601|P1|Overall Study|Withdrawal by Subject|1
1748844|NCT00880009|6095601|P1|Overall Study|Study terminated by sponsor|14
1748845|NCT00879996|6095625|P2|Overall Study|put on parole|0
1748846|NCT00879996|6095626|P1|Overall Study|put on parole|1
1748847|NCT00879996|6095625|P2|Overall Study|psychiatric problem|1
1748848|NCT00879996|6095626|P1|Overall Study|psychiatric problem|0
1748849|NCT00879996|6095625|P2|Overall Study|Physician Decision|2
1748850|NCT00879996|6095626|P1|Overall Study|Physician Decision|1
1748851|NCT00879996|6095625|P2|Overall Study|non-compliance|4
1748852|NCT00879996|6095626|P1|Overall Study|non-compliance|6
1748853|NCT00879996|6095625|P2|Overall Study|Lost to Follow-up|6
1748854|NCT00879996|6095626|P1|Overall Study|Lost to Follow-up|7
1748855|NCT00879970|6095641|P5|Period 2 Vitamin D Randomization|Death|0
1748856|NCT00879970|6095642|P4|Period 2 Vitamin D Randomization|Death|2
1748857|NCT00879970|6095643|P3|Period 2 Vitamin D Randomization|Death|0
1748858|NCT00879970|6095644|P2|Period 2 Vitamin D Randomization|Death|0
1748859|NCT00879970|6095645|P1|Period 2 Vitamin D Randomization|Death|0
1748860|NCT00879970|6095641|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
1748861|NCT00879970|6095642|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1748862|NCT00879970|6095643|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1748863|NCT00879970|6095644|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1748864|NCT00879970|6095645|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
1748865|NCT00879970|6095641|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
1748866|NCT00879970|6095642|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
1748867|NCT00879970|6095643|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1748868|NCT00879970|6095644|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1748869|NCT00879970|6095645|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
1748870|NCT00879970|6095641|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1748871|NCT00879970|6095642|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1748872|NCT00879970|6095643|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
1748873|NCT00879970|6095644|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
1748874|NCT00879970|6095645|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
1748875|NCT00879970|6095641|P5|Period 1 TZD Randomization|Death|0
1748876|NCT00879970|6095642|P4|Period 1 TZD Randomization|Death|0
1748877|NCT00879970|6095643|P3|Period 1 TZD Randomization|Death|0
1748878|NCT00879970|6095644|P2|Period 1 TZD Randomization|Death|1
1748879|NCT00879970|6095645|P1|Period 1 TZD Randomization|Death|2
1748880|NCT00879970|6095641|P5|Period 1 TZD Randomization|Lost to Follow-up|0
1748881|NCT00879970|6095642|P4|Period 1 TZD Randomization|Lost to Follow-up|0
1748882|NCT00879970|6095643|P3|Period 1 TZD Randomization|Lost to Follow-up|1
1748883|NCT00879970|6095644|P2|Period 1 TZD Randomization|Lost to Follow-up|0
1748884|NCT00879970|6095645|P1|Period 1 TZD Randomization|Lost to Follow-up|1
1748885|NCT00879970|6095641|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
1748886|NCT00879970|6095642|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
1748887|NCT00879970|6095643|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
1748888|NCT00879970|6095644|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
1748889|NCT00879970|6095645|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
1748890|NCT00879879|6095727|P1|Overall Study|Physician Decision|1
1748891|NCT00879879|6095727|P1|Overall Study|Withdrawal by Subject|1
1748892|NCT00879879|6095727|P1|Overall Study|Death|1
1748893|NCT00879814|6095735|P4|Overall Study|Other|0
1748894|NCT00879814|6095736|P3|Overall Study|Other|1
1748895|NCT00879814|6095737|P2|Overall Study|Other|0
1748896|NCT00879814|6095738|P1|Overall Study|Other|0
1748897|NCT00879814|6095735|P4|Overall Study|Physician Decision|0
1748898|NCT00879814|6095736|P3|Overall Study|Physician Decision|1
1748899|NCT00879814|6095737|P2|Overall Study|Physician Decision|0
1748900|NCT00879814|6095738|P1|Overall Study|Physician Decision|0
1748901|NCT00879814|6095735|P4|Overall Study|Withdrawal by Subject|2
1748902|NCT00879814|6095736|P3|Overall Study|Withdrawal by Subject|1
1748903|NCT00879814|6095737|P2|Overall Study|Withdrawal by Subject|1
1748904|NCT00879814|6095738|P1|Overall Study|Withdrawal by Subject|3
1748905|NCT00879814|6095735|P4|Overall Study|Participant Failed to Return|1
1748906|NCT00879814|6095736|P3|Overall Study|Participant Failed to Return|0
1748907|NCT00879814|6095737|P2|Overall Study|Participant Failed to Return|0
1748908|NCT00879814|6095738|P1|Overall Study|Participant Failed to Return|0
1748909|NCT00879814|6095735|P4|Overall Study|Lost to Follow-up|2
1748910|NCT00879814|6095736|P3|Overall Study|Lost to Follow-up|0
1748911|NCT00879814|6095737|P2|Overall Study|Lost to Follow-up|0
1748912|NCT00879814|6095738|P1|Overall Study|Lost to Follow-up|1
1748913|NCT00879814|6095735|P4|Overall Study|Adverse Event|0
1748914|NCT00879814|6095736|P3|Overall Study|Adverse Event|0
1748915|NCT00879814|6095737|P2|Overall Study|Adverse Event|1
1748916|NCT00879814|6095738|P1|Overall Study|Adverse Event|0
1748917|NCT00879775|6095846|P2|Overall Study|Lost to Follow-up|1
1748918|NCT00879775|6095847|P1|Overall Study|Lost to Follow-up|2
1748919|NCT00879710|6095863|P4|Phase 1 - 6 Weeks|Adverse Event|0
1748920|NCT00879710|6095864|P3|Phase 1 - 6 Weeks|Adverse Event|1
1748921|NCT00879710|6095865|P2|Phase 1 - 6 Weeks|Adverse Event|0
1748922|NCT00879710|6095866|P1|Phase 1 - 6 Weeks|Adverse Event|0
1748923|NCT00879710|6095863|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
1748924|NCT00879710|6095864|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
1748925|NCT00879710|6095865|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
1748926|NCT00879710|6095866|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
1748927|NCT00879697|6095876|P2|Overall Study|Physician Decision|2
1748928|NCT00879697|6095877|P1|Overall Study|Physician Decision|2
1748929|NCT00879684|6095883|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
1748930|NCT00879684|6095884|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
1748931|NCT00879684|6095885|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
1748932|NCT00879684|6095886|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
1748933|NCT00879684|6095887|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
1748934|NCT00879684|6095888|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
1748935|NCT00879684|6095889|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
1748936|NCT00879684|6095883|P7|Stage 2: Expanded Cohort|Progressive Disease|11
1748937|NCT00879684|6095884|P6|Stage 2: Expanded Cohort|Progressive Disease|0
1748938|NCT00879684|6095885|P5|Stage 2: Expanded Cohort|Progressive Disease|0
1748939|NCT00879684|6095886|P4|Stage 2: Expanded Cohort|Progressive Disease|0
1748940|NCT00879684|6095887|P3|Stage 2: Expanded Cohort|Progressive Disease|0
1748941|NCT00879684|6095888|P2|Stage 2: Expanded Cohort|Progressive Disease|0
1748942|NCT00879684|6095889|P1|Stage 2: Expanded Cohort|Progressive Disease|0
1748943|NCT00879684|6095883|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
1748944|NCT00879684|6095884|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
1748945|NCT00879684|6095885|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
1748946|NCT00879684|6095886|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
1748947|NCT00879684|6095887|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
1748948|NCT00879684|6095888|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
1748949|NCT00879684|6095889|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
1748950|NCT00879684|6095883|P7|Stage 1: Dose Escalation|Death|0
1748951|NCT00879684|6095884|P6|Stage 1: Dose Escalation|Death|0
1748952|NCT00879684|6095885|P5|Stage 1: Dose Escalation|Death|0
1748953|NCT00879684|6095886|P4|Stage 1: Dose Escalation|Death|0
1748954|NCT00879684|6095887|P3|Stage 1: Dose Escalation|Death|1
1748955|NCT00879684|6095888|P2|Stage 1: Dose Escalation|Death|0
1748956|NCT00879684|6095889|P1|Stage 1: Dose Escalation|Death|0
1748957|NCT00879684|6095883|P7|Stage 1: Dose Escalation|Investigator declined participation|0
1748958|NCT00879684|6095884|P6|Stage 1: Dose Escalation|Investigator declined participation|0
1748959|NCT00879684|6095885|P5|Stage 1: Dose Escalation|Investigator declined participation|0
1748960|NCT00879684|6095886|P4|Stage 1: Dose Escalation|Investigator declined participation|2
1748961|NCT00879684|6095887|P3|Stage 1: Dose Escalation|Investigator declined participation|2
1748962|NCT00879684|6095888|P2|Stage 1: Dose Escalation|Investigator declined participation|0
1748963|NCT00879684|6095889|P1|Stage 1: Dose Escalation|Investigator declined participation|0
1748964|NCT00879684|6095883|P7|Stage 1: Dose Escalation|Progressive Disease|0
1748965|NCT00879684|6095884|P6|Stage 1: Dose Escalation|Progressive Disease|3
1748966|NCT00879684|6095885|P5|Stage 1: Dose Escalation|Progressive Disease|3
1748967|NCT00879684|6095886|P4|Stage 1: Dose Escalation|Progressive Disease|4
1748968|NCT00879684|6095887|P3|Stage 1: Dose Escalation|Progressive Disease|0
1748969|NCT00879684|6095888|P2|Stage 1: Dose Escalation|Progressive Disease|3
1748970|NCT00879684|6095889|P1|Stage 1: Dose Escalation|Progressive Disease|2
1748971|NCT00879684|6095883|P7|Stage 1: Dose Escalation|Adverse Event|0
1748972|NCT00879684|6095884|P6|Stage 1: Dose Escalation|Adverse Event|0
1748973|NCT00879684|6095885|P5|Stage 1: Dose Escalation|Adverse Event|0
1748974|NCT00879684|6095886|P4|Stage 1: Dose Escalation|Adverse Event|0
1748975|NCT00879684|6095887|P3|Stage 1: Dose Escalation|Adverse Event|0
1748976|NCT00879684|6095888|P2|Stage 1: Dose Escalation|Adverse Event|0
1748977|NCT00879684|6095889|P1|Stage 1: Dose Escalation|Adverse Event|1
1748978|NCT00879658|6095958|P7|Overall Study|misrandomized (never received study med)|0
1748979|NCT00879658|6095959|P6|Overall Study|misrandomized (never received study med)|0
1748980|NCT00879658|6095960|P5|Overall Study|misrandomized (never received study med)|0
1748981|NCT00879658|6095961|P4|Overall Study|misrandomized (never received study med)|1
1748982|NCT00879658|6095962|P3|Overall Study|misrandomized (never received study med)|0
1748983|NCT00879658|6095963|P2|Overall Study|misrandomized (never received study med)|0
1748984|NCT00879658|6095964|P1|Overall Study|misrandomized (never received study med)|0
1748985|NCT00879658|6095958|P7|Overall Study|Lack of Efficacy|0
1748986|NCT00879658|6095959|P6|Overall Study|Lack of Efficacy|0
1748987|NCT00879658|6095960|P5|Overall Study|Lack of Efficacy|0
1748988|NCT00879658|6095961|P4|Overall Study|Lack of Efficacy|0
1748989|NCT00879658|6095962|P3|Overall Study|Lack of Efficacy|2
1748990|NCT00879658|6095963|P2|Overall Study|Lack of Efficacy|0
1748991|NCT00879658|6095964|P1|Overall Study|Lack of Efficacy|0
1748992|NCT00879658|6095958|P7|Overall Study|Withdrawal by Subject|0
1748993|NCT00879658|6095959|P6|Overall Study|Withdrawal by Subject|1
1748994|NCT00879658|6095960|P5|Overall Study|Withdrawal by Subject|0
1748995|NCT00879658|6095961|P4|Overall Study|Withdrawal by Subject|0
1748996|NCT00879658|6095962|P3|Overall Study|Withdrawal by Subject|2
1748997|NCT00879658|6095963|P2|Overall Study|Withdrawal by Subject|0
1748998|NCT00879658|6095964|P1|Overall Study|Withdrawal by Subject|3
1748999|NCT00879658|6095958|P7|Overall Study|Protocol Violation|0
1749000|NCT00879658|6095959|P6|Overall Study|Protocol Violation|0
1749001|NCT00879658|6095960|P5|Overall Study|Protocol Violation|0
1749002|NCT00879658|6095961|P4|Overall Study|Protocol Violation|0
1749003|NCT00879658|6095962|P3|Overall Study|Protocol Violation|0
1749004|NCT00879658|6095963|P2|Overall Study|Protocol Violation|0
1749005|NCT00879658|6095964|P1|Overall Study|Protocol Violation|1
1749006|NCT00879658|6095958|P7|Overall Study|Adverse Event|0
1749007|NCT00879658|6095959|P6|Overall Study|Adverse Event|0
1749008|NCT00879658|6095960|P5|Overall Study|Adverse Event|2
1749009|NCT00879658|6095961|P4|Overall Study|Adverse Event|1
1749010|NCT00879658|6095962|P3|Overall Study|Adverse Event|3
1749011|NCT00879658|6095963|P2|Overall Study|Adverse Event|4
1749012|NCT00879658|6095964|P1|Overall Study|Adverse Event|6
1749013|NCT00879658|6095958|P7|Overall Study|Administrative problems|0
1749014|NCT00879658|6095959|P6|Overall Study|Administrative problems|0
1749015|NCT00879658|6095960|P5|Overall Study|Administrative problems|0
1749016|NCT00879658|6095961|P4|Overall Study|Administrative problems|1
1749017|NCT00879658|6095962|P3|Overall Study|Administrative problems|0
1749018|NCT00879658|6095963|P2|Overall Study|Administrative problems|1
1749019|NCT00879658|6095964|P1|Overall Study|Administrative problems|2
1749020|NCT00879658|6095958|P7|Overall Study|Abnormal laboratory value(s)|0
1749021|NCT00879658|6095959|P6|Overall Study|Abnormal laboratory value(s)|0
1749022|NCT00879658|6095960|P5|Overall Study|Abnormal laboratory value(s)|0
1749023|NCT00879658|6095961|P4|Overall Study|Abnormal laboratory value(s)|1
1749024|NCT00879658|6095962|P3|Overall Study|Abnormal laboratory value(s)|0
1749025|NCT00879658|6095963|P2|Overall Study|Abnormal laboratory value(s)|0
1749026|NCT00879658|6095964|P1|Overall Study|Abnormal laboratory value(s)|3
1749027|NCT00879645|6096050|P4|Overall Study|Adverse Event|0
1749028|NCT00879645|6096051|P3|Overall Study|Adverse Event|0
1749029|NCT00879645|6096052|P2|Overall Study|Adverse Event|0
1749030|NCT00879645|6096053|P1|Overall Study|Adverse Event|1
1749031|NCT00879411|6096080|P1|Overall Study|lost to follow-up (non-AE)|162
1749032|NCT00879398|6096086|P1|Overall Study|Other Reasons|171
1749033|NCT00879398|6096086|P1|Overall Study|Adverse Event|41
1749034|NCT00879398|6096086|P1|Overall Study|Lack of Efficacy|64
1749035|NCT00879398|6096086|P1|Overall Study|Visit Stop|399
1749036|NCT00879333|6096104|P2|Overall Study|Protocol Violation|1
1749037|NCT00879333|6096105|P1|Overall Study|Protocol Violation|1
1749038|NCT00879333|6096104|P2|Overall Study|Disease Progression|169
1749039|NCT00879333|6096105|P1|Overall Study|Disease Progression|292
1749040|NCT00879333|6096104|P2|Overall Study|Death|5
1749041|NCT00879333|6096105|P1|Overall Study|Death|16
1749042|NCT00879333|6096104|P2|Overall Study|Administrative Problems|0
1749043|NCT00879333|6096105|P1|Overall Study|Administrative Problems|2
1749044|NCT00879333|6096104|P2|Overall Study|Lost to Follow-up|1
1749045|NCT00879333|6096105|P1|Overall Study|Lost to Follow-up|2
1749046|NCT00879333|6096104|P2|Overall Study|Withdrawal by Subject|7
1749047|NCT00879333|6096105|P1|Overall Study|Withdrawal by Subject|20
1749048|NCT00879333|6096104|P2|Overall Study|Abnormal Laboratory Value|0
1749049|NCT00879333|6096105|P1|Overall Study|Abnormal Laboratory Value|1
1749050|NCT00879333|6096104|P2|Overall Study|Adverse Event|34
1749051|NCT00879333|6096105|P1|Overall Study|Adverse Event|94
1749052|NCT00879229|6096138|P2|Overall Study|Other|0
1749053|NCT00879229|6096139|P1|Overall Study|Other|1
1749054|NCT00879229|6096138|P2|Overall Study|Clinical status did not improve|0
1749055|NCT00879229|6096139|P1|Overall Study|Clinical status did not improve|1
1749056|NCT00879229|6096138|P2|Overall Study|Withdrawal by Subject|0
1749057|NCT00879229|6096139|P1|Overall Study|Withdrawal by Subject|1
1749058|NCT00879229|6096138|P2|Overall Study|Adverse Event|0
1749059|NCT00879229|6096139|P1|Overall Study|Adverse Event|2
1749060|NCT00879229|6096138|P2|Overall Study|Death|2
1749061|NCT00879229|6096139|P1|Overall Study|Death|4
1749062|NCT00879229|6096138|P2|Overall Study|Study terminated by Sponsor|12
1749063|NCT00879229|6096139|P1|Overall Study|Study terminated by Sponsor|13
1749064|NCT00878995|6096187|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
1749065|NCT00878995|6096188|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
1749066|NCT00878969|6096289|P3|Overall Study|Pregnancy|0
1749067|NCT00878969|6096290|P2|Overall Study|Pregnancy|1
1749068|NCT00878969|6096291|P1|Overall Study|Pregnancy|0
1749069|NCT00878969|6096289|P3|Overall Study|Death|2
1749070|NCT00878969|6096290|P2|Overall Study|Death|0
1749071|NCT00878969|6096291|P1|Overall Study|Death|0
1749072|NCT00878969|6096289|P3|Overall Study|Protocol Violation|0
1749073|NCT00878969|6096290|P2|Overall Study|Protocol Violation|0
1749074|NCT00878969|6096291|P1|Overall Study|Protocol Violation|2
1749075|NCT00878969|6096289|P3|Overall Study|Lost to Follow-up|0
1749076|NCT00878969|6096290|P2|Overall Study|Lost to Follow-up|1
1749077|NCT00878969|6096291|P1|Overall Study|Lost to Follow-up|2
1749078|NCT00878969|6096289|P3|Overall Study|Adverse Event|2
1749079|NCT00878969|6096290|P2|Overall Study|Adverse Event|1
1749080|NCT00878969|6096291|P1|Overall Study|Adverse Event|3
1749081|NCT00878969|6096289|P3|Overall Study|kidney transplant|2
1749082|NCT00878969|6096290|P2|Overall Study|kidney transplant|3
1749083|NCT00878969|6096291|P1|Overall Study|kidney transplant|2
1749084|NCT00878969|6096289|P3|Overall Study|Withdrawal by Subject|3
1749085|NCT00878969|6096290|P2|Overall Study|Withdrawal by Subject|6
1749086|NCT00878969|6096291|P1|Overall Study|Withdrawal by Subject|1
1749087|NCT00878969|6096289|P3|Overall Study|Physician Decision|2
1749088|NCT00878969|6096290|P2|Overall Study|Physician Decision|3
1749089|NCT00878969|6096291|P1|Overall Study|Physician Decision|5
1749090|NCT00878800|6096339|P5|Overall Study|Other|1
1749091|NCT00878800|6096340|P4|Overall Study|Other|0
1749092|NCT00878800|6096341|P3|Overall Study|Other|0
1749093|NCT00878800|6096342|P2|Overall Study|Other|1
1749094|NCT00878800|6096343|P1|Overall Study|Other|1
1749095|NCT00878800|6096339|P5|Overall Study|Death|0
1749096|NCT00878800|6096340|P4|Overall Study|Death|0
1749097|NCT00878800|6096341|P3|Overall Study|Death|1
1749098|NCT00878800|6096342|P2|Overall Study|Death|0
1749099|NCT00878800|6096343|P1|Overall Study|Death|0
1749100|NCT00878800|6096339|P5|Overall Study|Withdrew consent|1
1749101|NCT00878800|6096340|P4|Overall Study|Withdrew consent|1
1749102|NCT00878800|6096341|P3|Overall Study|Withdrew consent|0
1749103|NCT00878800|6096342|P2|Overall Study|Withdrew consent|1
1749104|NCT00878800|6096343|P1|Overall Study|Withdrew consent|1
1749105|NCT00878800|6096339|P5|Overall Study|Progressive disease|13
1749106|NCT00878800|6096340|P4|Overall Study|Progressive disease|5
1749107|NCT00878800|6096341|P3|Overall Study|Progressive disease|6
1749108|NCT00878800|6096342|P2|Overall Study|Progressive disease|5
1749109|NCT00878800|6096343|P1|Overall Study|Progressive disease|1
1749110|NCT00878800|6096339|P5|Overall Study|Adverse Event|1
1749111|NCT00878800|6096340|P4|Overall Study|Adverse Event|0
1749112|NCT00878800|6096341|P3|Overall Study|Adverse Event|2
1749113|NCT00878800|6096342|P2|Overall Study|Adverse Event|0
1749114|NCT00878800|6096343|P1|Overall Study|Adverse Event|0
1749115|NCT00878722|6096378|P8|Overall Study|Relapse|0
1749116|NCT00878722|6096379|P7|Overall Study|Relapse|0
1749117|NCT00878722|6096380|P6|Overall Study|Relapse|0
1749118|NCT00878722|6096381|P5|Overall Study|Relapse|0
1749119|NCT00878722|6096382|P4|Overall Study|Relapse|1
1749120|NCT00878722|6096383|P3|Overall Study|Relapse|0
1749121|NCT00878722|6096384|P2|Overall Study|Relapse|0
1749122|NCT00878722|6096385|P1|Overall Study|Relapse|0
1749123|NCT00878722|6096378|P8|Overall Study|Withdrawal by Subject|2
1749124|NCT00878722|6096379|P7|Overall Study|Withdrawal by Subject|0
1749125|NCT00878722|6096380|P6|Overall Study|Withdrawal by Subject|0
1749126|NCT00878722|6096381|P5|Overall Study|Withdrawal by Subject|0
1749127|NCT00878722|6096382|P4|Overall Study|Withdrawal by Subject|0
1749128|NCT00878722|6096383|P3|Overall Study|Withdrawal by Subject|0
1749129|NCT00878722|6096384|P2|Overall Study|Withdrawal by Subject|0
1749130|NCT00878722|6096385|P1|Overall Study|Withdrawal by Subject|0
1749131|NCT00878722|6096378|P8|Overall Study|Adverse Event|0
1749132|NCT00878722|6096379|P7|Overall Study|Adverse Event|2
1749133|NCT00878722|6096380|P6|Overall Study|Adverse Event|0
1749134|NCT00878722|6096381|P5|Overall Study|Adverse Event|0
1749135|NCT00878722|6096382|P4|Overall Study|Adverse Event|0
1749136|NCT00878722|6096383|P3|Overall Study|Adverse Event|0
1749137|NCT00878722|6096384|P2|Overall Study|Adverse Event|0
1749138|NCT00878722|6096385|P1|Overall Study|Adverse Event|0
1749139|NCT00878722|6096378|P8|Overall Study|Death|2
1749140|NCT00878722|6096379|P7|Overall Study|Death|0
1749141|NCT00878722|6096380|P6|Overall Study|Death|1
1749142|NCT00878722|6096381|P5|Overall Study|Death|0
1749143|NCT00878722|6096382|P4|Overall Study|Death|1
1749144|NCT00878722|6096383|P3|Overall Study|Death|0
1749145|NCT00878722|6096384|P2|Overall Study|Death|0
1749146|NCT00878722|6096385|P1|Overall Study|Death|0
1749147|NCT00878722|6096378|P8|Overall Study|Progressive disease|3
1749148|NCT00878722|6096379|P7|Overall Study|Progressive disease|4
1749149|NCT00878722|6096380|P6|Overall Study|Progressive disease|1
1749150|NCT00878722|6096381|P5|Overall Study|Progressive disease|7
1749151|NCT00878722|6096382|P4|Overall Study|Progressive disease|7
1749152|NCT00878722|6096383|P3|Overall Study|Progressive disease|3
1749153|NCT00878722|6096384|P2|Overall Study|Progressive disease|3
1749154|NCT00878722|6096385|P1|Overall Study|Progressive disease|3
1749155|NCT00878709|6096470|P2|Overall Study|Other Reasons|84
1749156|NCT00878709|6096471|P1|Overall Study|Other Reasons|93
1749157|NCT00878709|6096470|P2|Overall Study|Lost to Follow-up|33
1749158|NCT00878709|6096471|P1|Overall Study|Lost to Follow-up|35
1749159|NCT00878709|6096470|P2|Overall Study|Withdrawal by Subject|120
1749160|NCT00878709|6096471|P1|Overall Study|Withdrawal by Subject|197
1749161|NCT00878553|6096531|P5|PK Study|Withdrawal by Subject|0
1749162|NCT00878553|6096532|P4|PK Study|Withdrawal by Subject|1
1749163|NCT00878553|6096533|P3|PK Study|Withdrawal by Subject|0
1749164|NCT00878553|6096534|P2|PK Study|Withdrawal by Subject|0
1749165|NCT00878553|6096535|P1|PK Study|Withdrawal by Subject|0
1749166|NCT00878553|6096531|P5|Sleep Study|family emergency|0
1749167|NCT00878553|6096532|P4|Sleep Study|family emergency|0
1749168|NCT00878553|6096533|P3|Sleep Study|family emergency|0
1749169|NCT00878553|6096534|P2|Sleep Study|family emergency|0
1749170|NCT00878553|6096535|P1|Sleep Study|family emergency|1
1749171|NCT00878553|6096531|P5|Sleep Study|car accident|0
1749172|NCT00878553|6096532|P4|Sleep Study|car accident|0
1749173|NCT00878553|6096533|P3|Sleep Study|car accident|0
1749174|NCT00878553|6096534|P2|Sleep Study|car accident|0
1749175|NCT00878553|6096535|P1|Sleep Study|car accident|1
1749176|NCT00878553|6096531|P5|Sleep Study|Lost to Follow-up|0
1749177|NCT00878553|6096532|P4|Sleep Study|Lost to Follow-up|0
1749178|NCT00878553|6096533|P3|Sleep Study|Lost to Follow-up|0
1749179|NCT00878553|6096534|P2|Sleep Study|Lost to Follow-up|0
1749180|NCT00878553|6096535|P1|Sleep Study|Lost to Follow-up|1
1749181|NCT00878553|6096531|P5|Sleep Study|Withdrawal by Subject|0
1749182|NCT00878553|6096532|P4|Sleep Study|Withdrawal by Subject|0
1749183|NCT00878553|6096533|P3|Sleep Study|Withdrawal by Subject|0
1749184|NCT00878553|6096534|P2|Sleep Study|Withdrawal by Subject|0
1749185|NCT00878553|6096535|P1|Sleep Study|Withdrawal by Subject|2
1749186|NCT00878501|6096594|P3|Overall Study|Administrative|1
1749187|NCT00878501|6096595|P2|Overall Study|Administrative|0
1749188|NCT00878501|6096596|P1|Overall Study|Administrative|0
1749189|NCT00878501|6096594|P3|Overall Study|Mis-randomisation of patient|0
1749190|NCT00878501|6096595|P2|Overall Study|Mis-randomisation of patient|0
1749191|NCT00878501|6096596|P1|Overall Study|Mis-randomisation of patient|1
1749192|NCT00878501|6096594|P3|Overall Study|Intake of prohibited concom. medication|1
1749193|NCT00878501|6096595|P2|Overall Study|Intake of prohibited concom. medication|0
1749194|NCT00878501|6096596|P1|Overall Study|Intake of prohibited concom. medication|0
1749195|NCT00878501|6096594|P3|Overall Study|Incorrect enrolment|0
1749196|NCT00878501|6096595|P2|Overall Study|Incorrect enrolment|2
1749197|NCT00878501|6096596|P1|Overall Study|Incorrect enrolment|1
1749198|NCT00878501|6096594|P3|Overall Study|Protocol Violation|1
1749199|NCT00878501|6096595|P2|Overall Study|Protocol Violation|0
1749200|NCT00878501|6096596|P1|Overall Study|Protocol Violation|0
1749201|NCT00878501|6096594|P3|Overall Study|Withdrawal by Subject|2
1749202|NCT00878501|6096595|P2|Overall Study|Withdrawal by Subject|1
1749203|NCT00878501|6096596|P1|Overall Study|Withdrawal by Subject|2
1749204|NCT00878501|6096594|P3|Overall Study|Lack of Efficacy|0
1749205|NCT00878501|6096595|P2|Overall Study|Lack of Efficacy|1
1749206|NCT00878501|6096596|P1|Overall Study|Lack of Efficacy|2
1749207|NCT00878501|6096594|P3|Overall Study|Adverse Event|3
1749208|NCT00878501|6096595|P2|Overall Study|Adverse Event|3
1749209|NCT00878501|6096596|P1|Overall Study|Adverse Event|11
1749210|NCT00878215|6096645|P4|Overall Study|Determined to be ineligible|0
1749211|NCT00878215|6096646|P3|Overall Study|Determined to be ineligible|0
1749212|NCT00878215|6096647|P2|Overall Study|Determined to be ineligible|10
1749213|NCT00878215|6096648|P1|Overall Study|Determined to be ineligible|0
1749214|NCT00878189|6096660|P9|Overall Study|Objection Progression or Relapse|3
1749215|NCT00878189|6096661|P8|Overall Study|Objection Progression or Relapse|0
1749216|NCT00878189|6096662|P7|Overall Study|Objection Progression or Relapse|0
1749217|NCT00878189|6096663|P6|Overall Study|Objection Progression or Relapse|0
1749218|NCT00878189|6096664|P5|Overall Study|Objection Progression or Relapse|0
1749219|NCT00878189|6096665|P4|Overall Study|Objection Progression or Relapse|0
1749220|NCT00878189|6096666|P3|Overall Study|Objection Progression or Relapse|0
1749221|NCT00878189|6096667|P2|Overall Study|Objection Progression or Relapse|0
1749222|NCT00878189|6096668|P1|Overall Study|Objection Progression or Relapse|0
1749223|NCT00878189|6096660|P9|Overall Study|Lost to Follow-up|0
1749224|NCT00878189|6096661|P8|Overall Study|Lost to Follow-up|0
1749225|NCT00878189|6096662|P7|Overall Study|Lost to Follow-up|1
1749226|NCT00878189|6096663|P6|Overall Study|Lost to Follow-up|1
1749227|NCT00878189|6096664|P5|Overall Study|Lost to Follow-up|0
1749228|NCT00878189|6096665|P4|Overall Study|Lost to Follow-up|0
1749229|NCT00878189|6096666|P3|Overall Study|Lost to Follow-up|0
1749230|NCT00878189|6096667|P2|Overall Study|Lost to Follow-up|0
1749231|NCT00878189|6096668|P1|Overall Study|Lost to Follow-up|0
1749232|NCT00878189|6096660|P9|Overall Study|Other|4
1749233|NCT00878189|6096661|P8|Overall Study|Other|3
1749234|NCT00878189|6096662|P7|Overall Study|Other|15
1749235|NCT00878189|6096663|P6|Overall Study|Other|18
1749236|NCT00878189|6096664|P5|Overall Study|Other|4
1749237|NCT00878189|6096665|P4|Overall Study|Other|7
1749238|NCT00878189|6096666|P3|Overall Study|Other|4
1749239|NCT00878189|6096667|P2|Overall Study|Other|2
1749240|NCT00878189|6096668|P1|Overall Study|Other|3
1749241|NCT00878189|6096660|P9|Overall Study|Participant Refused to Follow-up|0
1749242|NCT00878189|6096661|P8|Overall Study|Participant Refused to Follow-up|0
1749243|NCT00878189|6096662|P7|Overall Study|Participant Refused to Follow-up|0
1749244|NCT00878189|6096663|P6|Overall Study|Participant Refused to Follow-up|4
1749245|NCT00878189|6096664|P5|Overall Study|Participant Refused to Follow-up|0
1749246|NCT00878189|6096665|P4|Overall Study|Participant Refused to Follow-up|0
1749247|NCT00878189|6096666|P3|Overall Study|Participant Refused to Follow-up|0
1749248|NCT00878189|6096667|P2|Overall Study|Participant Refused to Follow-up|0
1749249|NCT00878189|6096668|P1|Overall Study|Participant Refused to Follow-up|0
1749250|NCT00878189|6096660|P9|Overall Study|Death|1
1749251|NCT00878189|6096661|P8|Overall Study|Death|0
1749252|NCT00878189|6096662|P7|Overall Study|Death|0
1749253|NCT00878189|6096663|P6|Overall Study|Death|0
1749254|NCT00878189|6096664|P5|Overall Study|Death|0
1749255|NCT00878189|6096665|P4|Overall Study|Death|1
1749256|NCT00878189|6096666|P3|Overall Study|Death|0
1749257|NCT00878189|6096667|P2|Overall Study|Death|1
1749258|NCT00878189|6096668|P1|Overall Study|Death|0
1749259|NCT00877929|6096936|P2|Overall Study|Other reason (not specified)|6
1749260|NCT00877929|6096937|P1|Overall Study|Other reason (not specified)|2
1749261|NCT00877929|6096936|P2|Overall Study|Lack of Efficacy|1
1749262|NCT00877929|6096937|P1|Overall Study|Lack of Efficacy|0
1749263|NCT00877929|6096936|P2|Overall Study|Withdrawal by Subject|4
1749264|NCT00877929|6096937|P1|Overall Study|Withdrawal by Subject|4
1749265|NCT00877929|6096936|P2|Overall Study|Lost to Follow-up|1
1749266|NCT00877929|6096937|P1|Overall Study|Lost to Follow-up|0
1749267|NCT00877929|6096936|P2|Overall Study|Protocol Violation|3
1749268|NCT00877929|6096937|P1|Overall Study|Protocol Violation|3
1749269|NCT00877929|6096936|P2|Overall Study|Adverse Event|20
1749270|NCT00877929|6096937|P1|Overall Study|Adverse Event|11
1749271|NCT00877890|6097025|P2|Overall Study|Loss of Glucose Control|4
1749272|NCT00877890|6097026|P1|Overall Study|Loss of Glucose Control|3
1749273|NCT00877890|6097025|P2|Overall Study|Investigator Decision|2
1749274|NCT00877890|6097026|P1|Overall Study|Investigator Decision|0
1749275|NCT00877890|6097025|P2|Overall Study|Withdrawal of Consent|12
1749276|NCT00877890|6097026|P1|Overall Study|Withdrawal of Consent|6
1749277|NCT00877890|6097025|P2|Overall Study|Protocol Violation|1
1749278|NCT00877890|6097026|P1|Overall Study|Protocol Violation|0
1749279|NCT00877890|6097025|P2|Overall Study|Lost to Follow-up|5
1749280|NCT00877890|6097026|P1|Overall Study|Lost to Follow-up|5
1749281|NCT00877890|6097025|P2|Overall Study|Adverse Event|6
1749282|NCT00877890|6097026|P1|Overall Study|Adverse Event|6
1749283|NCT00877799|6097091|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
1749284|NCT00877799|6097092|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
1749285|NCT00877799|6097093|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1749286|NCT00877799|6097094|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1749287|NCT00877799|6097095|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
1749288|NCT00877799|6097091|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1749289|NCT00877799|6097092|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
1749290|NCT00877799|6097093|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1749291|NCT00877799|6097094|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1749292|NCT00877799|6097095|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
1749293|NCT00877799|6097091|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1749294|NCT00877799|6097092|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1749295|NCT00877799|6097093|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1749296|NCT00877799|6097094|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
1749297|NCT00877799|6097095|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
1749298|NCT00877799|6097091|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
1749299|NCT00877799|6097092|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
1749300|NCT00877799|6097093|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
1749301|NCT00877799|6097094|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
1749302|NCT00877799|6097095|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
1749303|NCT00877799|6097091|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
1749304|NCT00877799|6097092|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
1749305|NCT00877799|6097093|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
1749306|NCT00877799|6097094|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
1749307|NCT00877799|6097095|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
1749308|NCT00877773|6097110|P1|Overall Study|Disease Progression|44
1749309|NCT00877487|6097123|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
1749310|NCT00877487|6097124|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
1749311|NCT00877487|6097123|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
1749312|NCT00877487|6097124|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
1749313|NCT00877487|6097123|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
1749314|NCT00877487|6097124|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
1749315|NCT00877487|6097123|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
1749316|NCT00877487|6097124|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
1749317|NCT00877487|6097123|P2|Open-label Treatment Phase|Out of country for business|0
1749318|NCT00877487|6097124|P1|Open-label Treatment Phase|Out of country for business|1
1749319|NCT00877487|6097123|P2|Open-label Treatment Phase|Lost to Follow-up|0
1749320|NCT00877487|6097124|P1|Open-label Treatment Phase|Lost to Follow-up|1
1749321|NCT00877487|6097123|P2|Open-label Treatment Phase|Withdrawal by Subject|0
1749322|NCT00877487|6097124|P1|Open-label Treatment Phase|Withdrawal by Subject|1
1749323|NCT00877487|6097123|P2|Open-label Treatment Phase|Protocol Violation|0
1749324|NCT00877487|6097124|P1|Open-label Treatment Phase|Protocol Violation|3
1749325|NCT00877487|6097123|P2|Open-label Treatment Phase|Adverse Event|0
1749326|NCT00877487|6097124|P1|Open-label Treatment Phase|Adverse Event|1
1749327|NCT00877383|6097172|P2|Overall Study|Death|2
1749328|NCT00877383|6097173|P1|Overall Study|Death|1
1749329|NCT00877383|6097172|P2|Overall Study|Unsatisfactory therapeutic effect|0
1749330|NCT00877383|6097173|P1|Overall Study|Unsatisfactory therapeutic effect|1
1749331|NCT00877383|6097172|P2|Overall Study|Protocol deviation|6
1749332|NCT00877383|6097173|P1|Overall Study|Protocol deviation|2
1749333|NCT00877383|6097172|P2|Overall Study|Administrative problems|0
1749334|NCT00877383|6097173|P1|Overall Study|Administrative problems|2
1749335|NCT00877383|6097172|P2|Overall Study|Subject no longer requires study drug|0
1749336|NCT00877383|6097173|P1|Overall Study|Subject no longer requires study drug|2
1749337|NCT00877383|6097172|P2|Overall Study|Subject withdrew consent|12
1749338|NCT00877383|6097173|P1|Overall Study|Subject withdrew consent|3
1749339|NCT00877383|6097172|P2|Overall Study|Lost to Follow-up|3
1749340|NCT00877383|6097173|P1|Overall Study|Lost to Follow-up|5
1749341|NCT00877383|6097172|P2|Overall Study|Adverse Event|14
1749342|NCT00877383|6097173|P1|Overall Study|Adverse Event|13
1749343|NCT00877071|6097193|P1|Overall Study|disease progression|2
1749344|NCT00877032|6097226|P7|Overall Study|Did not meet entrance criteria|2
1749345|NCT00877032|6097227|P6|Overall Study|Did not meet entrance criteria|0
1749346|NCT00877032|6097228|P5|Overall Study|Did not meet entrance criteria|0
1749347|NCT00877032|6097229|P4|Overall Study|Did not meet entrance criteria|1
1749348|NCT00877032|6097230|P3|Overall Study|Did not meet entrance criteria|0
1749349|NCT00877032|6097231|P2|Overall Study|Did not meet entrance criteria|0
1749350|NCT00877032|6097232|P1|Overall Study|Did not meet entrance criteria|0
1749351|NCT00877006|6097333|P2|Long-Term Follow-up Period|Other|9
1749352|NCT00877006|6097334|P1|Long-Term Follow-up Period|Other|7
1749353|NCT00877006|6097333|P2|Long-Term Follow-up Period|Death|18
1749354|NCT00877006|6097334|P1|Long-Term Follow-up Period|Death|26
1749355|NCT00877006|6097333|P2|Long-Term Follow-up Period|Lost to Follow-up|9
1749356|NCT00877006|6097334|P1|Long-Term Follow-up Period|Lost to Follow-up|8
1749357|NCT00877006|6097333|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
1749358|NCT00877006|6097334|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
1749359|NCT00877006|6097333|P2|Treatment Period|Randomized but Not Treated|8
1749360|NCT00877006|6097334|P1|Treatment Period|Randomized but Not Treated|3
1749361|NCT00877006|6097333|P2|Treatment Period|Other|4
1749362|NCT00877006|6097334|P1|Treatment Period|Other|4
1749363|NCT00877006|6097333|P2|Treatment Period|Started New Treatment Regimen|5
1749364|NCT00877006|6097334|P1|Treatment Period|Started New Treatment Regimen|2
1749365|NCT00877006|6097333|P2|Treatment Period|Disease Progression|2
1749366|NCT00877006|6097334|P1|Treatment Period|Disease Progression|1
1749367|NCT00877006|6097333|P2|Treatment Period|Lost to Follow-up|1
1749368|NCT00877006|6097334|P1|Treatment Period|Lost to Follow-up|0
1749369|NCT00877006|6097333|P2|Treatment Period|Protocol Violation|0
1749370|NCT00877006|6097334|P1|Treatment Period|Protocol Violation|1
1749371|NCT00877006|6097333|P2|Treatment Period|Withdrawal by Subject|3
1749372|NCT00877006|6097334|P1|Treatment Period|Withdrawal by Subject|2
1749373|NCT00877006|6097333|P2|Treatment Period|Adverse Event|3
1749374|NCT00877006|6097334|P1|Treatment Period|Adverse Event|10
1749375|NCT00877006|6097333|P2|Treatment Period|Death|1
1749376|NCT00877006|6097334|P1|Treatment Period|Death|2
1749377|NCT00876928|6097410|P2|Overall Study|Hypokalemia-affects insulin secretion|0
1749378|NCT00876928|6097411|P1|Overall Study|Hypokalemia-affects insulin secretion|1
1749379|NCT00876928|6097410|P2|Overall Study|Lost to Follow-up|5
1749380|NCT00876928|6097411|P1|Overall Study|Lost to Follow-up|2
1749381|NCT00876733|6097448|P4|Overall Study|Data not available|1
1749382|NCT00876733|6097449|P3|Overall Study|Data not available|7
1749383|NCT00876733|6097450|P2|Overall Study|Data not available|3
1749384|NCT00876733|6097451|P1|Overall Study|Data not available|14
1749385|NCT00876733|6097448|P4|Overall Study|Lost to Follow-up|2
1749386|NCT00876733|6097449|P3|Overall Study|Lost to Follow-up|3
1749387|NCT00876733|6097450|P2|Overall Study|Lost to Follow-up|10
1749388|NCT00876733|6097451|P1|Overall Study|Lost to Follow-up|26
1749389|NCT00876733|6097448|P4|Overall Study|Lack of Efficacy|1
1749390|NCT00876733|6097449|P3|Overall Study|Lack of Efficacy|10
1749391|NCT00876733|6097450|P2|Overall Study|Lack of Efficacy|9
1749392|NCT00876733|6097451|P1|Overall Study|Lack of Efficacy|17
1749393|NCT00876733|6097448|P4|Overall Study|Adverse Event|3
1749394|NCT00876733|6097449|P3|Overall Study|Adverse Event|10
1749395|NCT00876733|6097450|P2|Overall Study|Adverse Event|20
1749396|NCT00876733|6097451|P1|Overall Study|Adverse Event|34
1749397|NCT00876694|6097559|P2|Overall Study|Death|0
1749398|NCT00876694|6097560|P1|Overall Study|Death|1
1749399|NCT00876694|6097559|P2|Overall Study|Administrative problems|1
1749400|NCT00876694|6097560|P1|Overall Study|Administrative problems|1
1749401|NCT00876694|6097559|P2|Overall Study|Abnormal test procedure result(s)|0
1749402|NCT00876694|6097560|P1|Overall Study|Abnormal test procedure result(s)|1
1749403|NCT00876694|6097559|P2|Overall Study|Unsatisfactory therapeutic effect|0
1749404|NCT00876694|6097560|P1|Overall Study|Unsatisfactory therapeutic effect|2
1749405|NCT00876694|6097559|P2|Overall Study|Subject withdrew consent|4
1749406|NCT00876694|6097560|P1|Overall Study|Subject withdrew consent|6
1749407|NCT00876694|6097559|P2|Overall Study|Adverse Event|7
1749408|NCT00876694|6097560|P1|Overall Study|Adverse Event|10
1749409|NCT00876460|6097586|P8|Mono Therapy Phase|Adverse Event|0
1749410|NCT00876460|6097587|P7|Mono Therapy Phase|Adverse Event|0
1749411|NCT00876460|6097588|P6|Mono Therapy Phase|Adverse Event|0
1749412|NCT00876460|6097589|P5|Mono Therapy Phase|Adverse Event|0
1749413|NCT00876460|6097590|P4|Mono Therapy Phase|Adverse Event|1
1749414|NCT00876460|6097591|P3|Mono Therapy Phase|Adverse Event|0
1749415|NCT00876460|6097592|P2|Mono Therapy Phase|Adverse Event|0
1749416|NCT00876460|6097593|P1|Mono Therapy Phase|Adverse Event|0
1749417|NCT00876460|6097586|P8|Mono Therapy Phase|Withdrawal by Subject|0
1749418|NCT00876460|6097587|P7|Mono Therapy Phase|Withdrawal by Subject|0
1749419|NCT00876460|6097588|P6|Mono Therapy Phase|Withdrawal by Subject|0
1749420|NCT00876460|6097589|P5|Mono Therapy Phase|Withdrawal by Subject|0
1749421|NCT00876460|6097590|P4|Mono Therapy Phase|Withdrawal by Subject|0
1749422|NCT00876460|6097591|P3|Mono Therapy Phase|Withdrawal by Subject|0
1749423|NCT00876460|6097592|P2|Mono Therapy Phase|Withdrawal by Subject|1
1749424|NCT00876460|6097593|P1|Mono Therapy Phase|Withdrawal by Subject|0
1749425|NCT00876460|6097586|P8|Mono Therapy Phase|Progressive disease|3
1749426|NCT00876460|6097587|P7|Mono Therapy Phase|Progressive disease|1
1749427|NCT00876460|6097588|P6|Mono Therapy Phase|Progressive disease|0
1749428|NCT00876460|6097589|P5|Mono Therapy Phase|Progressive disease|2
1749429|NCT00876460|6097590|P4|Mono Therapy Phase|Progressive disease|0
1749430|NCT00876460|6097591|P3|Mono Therapy Phase|Progressive disease|0
1749431|NCT00876460|6097592|P2|Mono Therapy Phase|Progressive disease|0
1749432|NCT00876460|6097593|P1|Mono Therapy Phase|Progressive disease|0
1749433|NCT00876460|6097586|P8|Combination Therapy Phase|Not treated|0
1749434|NCT00876460|6097587|P7|Combination Therapy Phase|Not treated|1
1749435|NCT00876460|6097588|P6|Combination Therapy Phase|Not treated|0
1749436|NCT00876460|6097589|P5|Combination Therapy Phase|Not treated|0
1749437|NCT00876460|6097590|P4|Combination Therapy Phase|Not treated|0
1749438|NCT00876460|6097591|P3|Combination Therapy Phase|Not treated|0
1749439|NCT00876460|6097592|P2|Combination Therapy Phase|Not treated|0
1749440|NCT00876460|6097593|P1|Combination Therapy Phase|Not treated|0
1749441|NCT00876460|6097586|P8|Combination Therapy Phase|Other reason not defined above|2
1749442|NCT00876460|6097587|P7|Combination Therapy Phase|Other reason not defined above|1
1749443|NCT00876460|6097588|P6|Combination Therapy Phase|Other reason not defined above|0
1749444|NCT00876460|6097589|P5|Combination Therapy Phase|Other reason not defined above|0
1749445|NCT00876460|6097590|P4|Combination Therapy Phase|Other reason not defined above|0
1749446|NCT00876460|6097591|P3|Combination Therapy Phase|Other reason not defined above|0
1749447|NCT00876460|6097592|P2|Combination Therapy Phase|Other reason not defined above|0
1749448|NCT00876460|6097593|P1|Combination Therapy Phase|Other reason not defined above|0
1749449|NCT00876460|6097586|P8|Combination Therapy Phase|Withdrawal by Subject|0
1749450|NCT00876460|6097587|P7|Combination Therapy Phase|Withdrawal by Subject|0
1749451|NCT00876460|6097588|P6|Combination Therapy Phase|Withdrawal by Subject|0
1749452|NCT00876460|6097589|P5|Combination Therapy Phase|Withdrawal by Subject|1
1749453|NCT00876460|6097590|P4|Combination Therapy Phase|Withdrawal by Subject|0
1749454|NCT00876460|6097591|P3|Combination Therapy Phase|Withdrawal by Subject|0
1749455|NCT00876460|6097592|P2|Combination Therapy Phase|Withdrawal by Subject|1
1749456|NCT00876460|6097593|P1|Combination Therapy Phase|Withdrawal by Subject|1
1749457|NCT00876460|6097586|P8|Combination Therapy Phase|Adverse Event|2
1749458|NCT00876460|6097587|P7|Combination Therapy Phase|Adverse Event|3
1749459|NCT00876460|6097588|P6|Combination Therapy Phase|Adverse Event|0
1749460|NCT00876460|6097589|P5|Combination Therapy Phase|Adverse Event|2
1749461|NCT00876460|6097590|P4|Combination Therapy Phase|Adverse Event|2
1749462|NCT00876460|6097591|P3|Combination Therapy Phase|Adverse Event|0
1749463|NCT00876460|6097592|P2|Combination Therapy Phase|Adverse Event|2
1749464|NCT00876460|6097593|P1|Combination Therapy Phase|Adverse Event|0
1749465|NCT00876460|6097586|P8|Combination Therapy Phase|Dose limiting toxicity|1
1749466|NCT00876460|6097587|P7|Combination Therapy Phase|Dose limiting toxicity|2
1749467|NCT00876460|6097588|P6|Combination Therapy Phase|Dose limiting toxicity|2
1749468|NCT00876460|6097589|P5|Combination Therapy Phase|Dose limiting toxicity|1
1749469|NCT00876460|6097590|P4|Combination Therapy Phase|Dose limiting toxicity|1
1749470|NCT00876460|6097591|P3|Combination Therapy Phase|Dose limiting toxicity|0
1749471|NCT00876460|6097592|P2|Combination Therapy Phase|Dose limiting toxicity|1
1749472|NCT00876460|6097593|P1|Combination Therapy Phase|Dose limiting toxicity|0
1749473|NCT00876460|6097586|P8|Combination Therapy Phase|Progressive disease|1
1749474|NCT00876460|6097587|P7|Combination Therapy Phase|Progressive disease|1
1749475|NCT00876460|6097588|P6|Combination Therapy Phase|Progressive disease|1
1749728|NCT00874770|6098418|P1|Overall Study|Adverse Event|1
1749476|NCT00876460|6097589|P5|Combination Therapy Phase|Progressive disease|3
1749477|NCT00876460|6097590|P4|Combination Therapy Phase|Progressive disease|3
1749478|NCT00876460|6097591|P3|Combination Therapy Phase|Progressive disease|3
1749479|NCT00876460|6097592|P2|Combination Therapy Phase|Progressive disease|3
1749480|NCT00876460|6097593|P1|Combination Therapy Phase|Progressive disease|2
1749481|NCT00876447|6097665|P2|Overall Study|Adverse Event|8
1749482|NCT00876447|6097666|P1|Overall Study|Adverse Event|4
1749483|NCT00876447|6097665|P2|Overall Study|Lack of Efficacy|3
1749484|NCT00876447|6097666|P1|Overall Study|Lack of Efficacy|5
1749485|NCT00876447|6097665|P2|Overall Study|Pregnancy|2
1749486|NCT00876447|6097666|P1|Overall Study|Pregnancy|4
1749487|NCT00876447|6097665|P2|Overall Study|Lost to Follow-up|15
1749488|NCT00876447|6097666|P1|Overall Study|Lost to Follow-up|6
1749489|NCT00876447|6097665|P2|Overall Study|Personal reasons|28
1749490|NCT00876447|6097666|P1|Overall Study|Personal reasons|30
1749491|NCT00876447|6097665|P2|Overall Study|Protocol Violation|3
1749492|NCT00876447|6097666|P1|Overall Study|Protocol Violation|9
1749493|NCT00876447|6097665|P2|Overall Study|Site closure|14
1749494|NCT00876447|6097666|P1|Overall Study|Site closure|19
1749495|NCT00876447|6097665|P2|Overall Study|Other miscellaneous reasons|8
1749496|NCT00876447|6097666|P1|Overall Study|Other miscellaneous reasons|3
1749497|NCT00876395|6097726|P2|Overall Study|Death|0
1749498|NCT00876395|6097727|P1|Overall Study|Death|12
1749499|NCT00876395|6097726|P2|Overall Study|Administrative problems|23
1749500|NCT00876395|6097727|P1|Overall Study|Administrative problems|39
1749501|NCT00876395|6097726|P2|Overall Study|Lost to Follow-up|0
1749502|NCT00876395|6097727|P1|Overall Study|Lost to Follow-up|2
1749503|NCT00876395|6097726|P2|Overall Study|Withdrawal by Subject|33
1749504|NCT00876395|6097727|P1|Overall Study|Withdrawal by Subject|66
1749505|NCT00876395|6097726|P2|Overall Study|Protocol Violation|2
1749506|NCT00876395|6097727|P1|Overall Study|Protocol Violation|5
1749507|NCT00876395|6097726|P2|Overall Study|New cancer therapy|7
1749508|NCT00876395|6097727|P1|Overall Study|New cancer therapy|25
1749509|NCT00876395|6097726|P2|Overall Study|Disease progression|162
1749510|NCT00876395|6097727|P1|Overall Study|Disease progression|259
1749511|NCT00876395|6097726|P2|Overall Study|Abnormal test procedure result(s)|0
1749512|NCT00876395|6097727|P1|Overall Study|Abnormal test procedure result(s)|1
1749513|NCT00876395|6097726|P2|Overall Study|Adverse Event|11
1749514|NCT00876395|6097727|P1|Overall Study|Adverse Event|63
1749515|NCT00876395|6097726|P2|Overall Study|Untreated|1
1749516|NCT00876395|6097727|P1|Overall Study|Untreated|8
1749517|NCT00876343|6097768|P3|Overall Study|Change of residence or other commitments|3
1749518|NCT00876343|6097769|P2|Overall Study|Change of residence or other commitments|2
1749519|NCT00876343|6097770|P1|Overall Study|Change of residence or other commitments|2
1749520|NCT00876343|6097768|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
1749521|NCT00876343|6097769|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
1749522|NCT00876343|6097770|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
1749523|NCT00876343|6097768|P3|Overall Study|Physician Decision|1
1749524|NCT00876343|6097769|P2|Overall Study|Physician Decision|1
1749525|NCT00876343|6097770|P1|Overall Study|Physician Decision|0
1749526|NCT00876343|6097768|P3|Overall Study|Protocol Violation|1
1749527|NCT00876343|6097769|P2|Overall Study|Protocol Violation|1
1749528|NCT00876343|6097770|P1|Overall Study|Protocol Violation|4
1749529|NCT00876343|6097768|P3|Overall Study|Lack of Efficacy|1
1749530|NCT00876343|6097769|P2|Overall Study|Lack of Efficacy|0
1749531|NCT00876343|6097770|P1|Overall Study|Lack of Efficacy|0
1749532|NCT00876343|6097768|P3|Overall Study|Withdrawal by Subject|3
1749533|NCT00876343|6097769|P2|Overall Study|Withdrawal by Subject|4
1749534|NCT00876343|6097770|P1|Overall Study|Withdrawal by Subject|4
1749535|NCT00876343|6097768|P3|Overall Study|Adverse Event|2
1749536|NCT00876343|6097769|P2|Overall Study|Adverse Event|8
1749537|NCT00876343|6097770|P1|Overall Study|Adverse Event|7
1749538|NCT00876265|6097784|P1|Overall Study|Withdrawal by Subject|2
1749539|NCT00876265|6097784|P1|Overall Study|Lost to Follow-up|6
1749540|NCT00876265|6097784|P1|Overall Study|Miscellaneous reasons|4
1749541|NCT00876018|6097802|P3|Overall Study|Withdrew Consent due to Adverse Event|2
1749542|NCT00876018|6097803|P2|Overall Study|Withdrew Consent due to Adverse Event|4
1749543|NCT00876018|6097804|P1|Overall Study|Withdrew Consent due to Adverse Event|5
1749544|NCT00876018|6097802|P3|Overall Study|Lost to Follow-up|1
1749545|NCT00876018|6097803|P2|Overall Study|Lost to Follow-up|1
1749546|NCT00876018|6097804|P1|Overall Study|Lost to Follow-up|0
1749547|NCT00875979|6097859|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
1749548|NCT00875979|6097860|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
1749549|NCT00875979|6097859|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
1749550|NCT00875979|6097860|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
1749551|NCT00875979|6097859|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
1749552|NCT00875979|6097860|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
1749553|NCT00875979|6097859|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
1749554|NCT00875979|6097860|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
1749555|NCT00875979|6097859|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
1749556|NCT00875979|6097860|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
1749557|NCT00875979|6097859|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
1749558|NCT00875979|6097860|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
1749559|NCT00875979|6097859|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
1749560|NCT00875979|6097860|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
1749561|NCT00875979|6097859|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
1749562|NCT00875979|6097860|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
1749563|NCT00875979|6097859|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
1749564|NCT00875979|6097860|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
1749565|NCT00875810|6097883|P1|Overall Study|Device explanted|1
1749566|NCT00875810|6097883|P1|Overall Study|Patient enroled but not implanted|2
1749567|NCT00875810|6097883|P1|Overall Study|Lost to Follow-up|39
1749568|NCT00875810|6097883|P1|Overall Study|Physician Decision|3
1749569|NCT00875810|6097883|P1|Overall Study|Withdrawal by Subject|1
1749570|NCT00875797|6097892|P2|Overall Study|Protocol Violation|3
1749571|NCT00875797|6097893|P1|Overall Study|Protocol Violation|6
1749572|NCT00875706|6097906|P3|Overall Study|Withdrawal by Subject|0
1749573|NCT00875706|6097907|P2|Overall Study|Withdrawal by Subject|0
1749574|NCT00875706|6097908|P1|Overall Study|Withdrawal by Subject|1
1749575|NCT00875667|6097927|P2|Overall Study|Randomized but no Study Drug Given|1
1749576|NCT00875667|6097928|P1|Overall Study|Randomized but no Study Drug Given|3
1749577|NCT00875667|6097927|P2|Overall Study|Miscellaneous|6
1749578|NCT00875667|6097928|P1|Overall Study|Miscellaneous|12
1749579|NCT00875667|6097927|P2|Overall Study|Disease Progression|49
1749580|NCT00875667|6097928|P1|Overall Study|Disease Progression|100
1749581|NCT00875667|6097927|P2|Overall Study|Protocol Violation|0
1749582|NCT00875667|6097928|P1|Overall Study|Protocol Violation|2
1749583|NCT00875667|6097927|P2|Overall Study|Death|2
1749584|NCT00875667|6097928|P1|Overall Study|Death|7
1749585|NCT00875667|6097927|P2|Overall Study|Withdrawal by Subject|5
1749586|NCT00875667|6097928|P1|Overall Study|Withdrawal by Subject|17
1749587|NCT00875667|6097927|P2|Overall Study|Adverse Event|10
1749588|NCT00875667|6097928|P1|Overall Study|Adverse Event|29
1749589|NCT00875615|6098063|P1|Overall Study|Withdrawal by Subject|1
1749590|NCT00875563|6098077|P1|Overall Study|Still be eligible for follow-up|7
1749591|NCT00875563|6098077|P1|Overall Study|No long-term (3-5 year) consent|6
1749592|NCT00875563|6098077|P1|Overall Study|Withdrawal by Subject|7
1749593|NCT00875563|6098077|P1|Overall Study|Death|4
1749594|NCT00875524|6098102|P2|Overall Study|Withdrawal by Subject|5
1749595|NCT00875524|6098103|P1|Overall Study|Withdrawal by Subject|3
1749596|NCT00875524|6098102|P2|Overall Study|Lost to Follow-up|0
1749597|NCT00875524|6098103|P1|Overall Study|Lost to Follow-up|1
1749598|NCT00875524|6098102|P2|Overall Study|Protocol Violation|0
1749599|NCT00875524|6098103|P1|Overall Study|Protocol Violation|4
1749600|NCT00875524|6098102|P2|Overall Study|Serious adverse event|1
1749601|NCT00875524|6098103|P1|Overall Study|Serious adverse event|0
1749602|NCT00875485|6098121|P2|Challenge Dose Epoch|Pregnancy|0
1749603|NCT00875485|6098122|P1|Challenge Dose Epoch|Pregnancy|1
1749604|NCT00875433|6098162|P1|Overall Study|Other|3
1749605|NCT00875433|6098162|P1|Overall Study|Withdrawal by Subject|2
1749606|NCT00875433|6098162|P1|Overall Study|Other Adverse Event|14
1749607|NCT00875433|6098162|P1|Overall Study|Progressive disease|41
1749608|NCT00875420|6098192|P5|Overall Study|Withdrawal by Subject|0
1749609|NCT00875420|6098193|P4|Overall Study|Withdrawal by Subject|0
1749610|NCT00875420|6098194|P3|Overall Study|Withdrawal by Subject|1
1749611|NCT00875420|6098195|P2|Overall Study|Withdrawal by Subject|0
1749612|NCT00875420|6098196|P1|Overall Study|Withdrawal by Subject|0
1749613|NCT00875420|6098192|P5|Overall Study|Sponsor decision|0
1749614|NCT00875420|6098193|P4|Overall Study|Sponsor decision|0
1749615|NCT00875420|6098194|P3|Overall Study|Sponsor decision|0
1749616|NCT00875420|6098195|P2|Overall Study|Sponsor decision|1
1749617|NCT00875420|6098196|P1|Overall Study|Sponsor decision|0
1749618|NCT00875420|6098192|P5|Overall Study|Prohibited medication|0
1749619|NCT00875420|6098193|P4|Overall Study|Prohibited medication|1
1749620|NCT00875420|6098194|P3|Overall Study|Prohibited medication|0
1749621|NCT00875420|6098195|P2|Overall Study|Prohibited medication|0
1749622|NCT00875420|6098196|P1|Overall Study|Prohibited medication|0
1749623|NCT00875420|6098192|P5|Overall Study|Personal reason|1
1749624|NCT00875420|6098193|P4|Overall Study|Personal reason|0
1749625|NCT00875420|6098194|P3|Overall Study|Personal reason|0
1749626|NCT00875420|6098195|P2|Overall Study|Personal reason|0
1749627|NCT00875420|6098196|P1|Overall Study|Personal reason|0
1749628|NCT00875420|6098192|P5|Overall Study|Lost to Follow-up|0
1749629|NCT00875420|6098193|P4|Overall Study|Lost to Follow-up|0
1749630|NCT00875420|6098194|P3|Overall Study|Lost to Follow-up|0
1749631|NCT00875420|6098195|P2|Overall Study|Lost to Follow-up|0
1749632|NCT00875420|6098196|P1|Overall Study|Lost to Follow-up|1
1749633|NCT00875420|6098192|P5|Overall Study|Inability to complete study procedures|1
1749634|NCT00875420|6098193|P4|Overall Study|Inability to complete study procedures|1
1749635|NCT00875420|6098194|P3|Overall Study|Inability to complete study procedures|1
1749636|NCT00875420|6098195|P2|Overall Study|Inability to complete study procedures|0
1749637|NCT00875420|6098196|P1|Overall Study|Inability to complete study procedures|1
1749638|NCT00875420|6098192|P5|Overall Study|Adverse Event|0
1749639|NCT00875420|6098193|P4|Overall Study|Adverse Event|0
1749640|NCT00875420|6098194|P3|Overall Study|Adverse Event|1
1749641|NCT00875420|6098195|P2|Overall Study|Adverse Event|1
1749642|NCT00875420|6098196|P1|Overall Study|Adverse Event|0
1749643|NCT00875017|6098338|P6|Fourth Intervention|Inability to comply with fasting|1
1749644|NCT00875017|6098339|P5|Fourth Intervention|Inability to comply with fasting|0
1749645|NCT00875017|6098340|P4|Fourth Intervention|Inability to comply with fasting|0
1749646|NCT00875017|6098341|P3|Fourth Intervention|Inability to comply with fasting|0
1749647|NCT00875017|6098342|P2|Fourth Intervention|Inability to comply with fasting|0
1749648|NCT00875017|6098343|P1|Fourth Intervention|Inability to comply with fasting|0
1749649|NCT00875017|6098338|P6|Washout|Withdrawal by Subject|0
1749650|NCT00875017|6098339|P5|Washout|Withdrawal by Subject|1
1749651|NCT00875017|6098340|P4|Washout|Withdrawal by Subject|0
1749652|NCT00875017|6098341|P3|Washout|Withdrawal by Subject|0
1749653|NCT00875017|6098342|P2|Washout|Withdrawal by Subject|0
1749654|NCT00875017|6098343|P1|Washout|Withdrawal by Subject|0
1749655|NCT00875017|6098338|P6|Third Intervention|Adverse Event|0
1749656|NCT00875017|6098339|P5|Third Intervention|Adverse Event|0
1749657|NCT00875017|6098340|P4|Third Intervention|Adverse Event|0
1749658|NCT00875017|6098341|P3|Third Intervention|Adverse Event|1
1749659|NCT00875017|6098342|P2|Third Intervention|Adverse Event|1
1749660|NCT00875017|6098343|P1|Third Intervention|Adverse Event|0
1749661|NCT00875017|6098338|P6|Washout|Problems collecting rectal effluent|0
1749662|NCT00875017|6098339|P5|Washout|Problems collecting rectal effluent|0
1749663|NCT00875017|6098340|P4|Washout|Problems collecting rectal effluent|0
1749664|NCT00875017|6098341|P3|Washout|Problems collecting rectal effluent|0
1749665|NCT00875017|6098342|P2|Washout|Problems collecting rectal effluent|1
1749666|NCT00875017|6098343|P1|Washout|Problems collecting rectal effluent|0
1749667|NCT00875017|6098338|P6|Second Intervention|Adverse Event|0
1749668|NCT00875017|6098339|P5|Second Intervention|Adverse Event|0
1749669|NCT00875017|6098340|P4|Second Intervention|Adverse Event|1
1749670|NCT00875017|6098341|P3|Second Intervention|Adverse Event|0
1749671|NCT00875017|6098342|P2|Second Intervention|Adverse Event|0
1749672|NCT00875017|6098343|P1|Second Intervention|Adverse Event|0
1749673|NCT00875017|6098338|P6|Washout|Problem collecting rectal effluent|0
1749674|NCT00875017|6098339|P5|Washout|Problem collecting rectal effluent|0
1749675|NCT00875017|6098340|P4|Washout|Problem collecting rectal effluent|0
1749676|NCT00875017|6098341|P3|Washout|Problem collecting rectal effluent|1
1749677|NCT00875017|6098342|P2|Washout|Problem collecting rectal effluent|0
1749678|NCT00875017|6098343|P1|Washout|Problem collecting rectal effluent|0
1749679|NCT00875017|6098338|P6|First Intervention|Intolerance to nasogastric tube|0
1749680|NCT00875017|6098339|P5|First Intervention|Intolerance to nasogastric tube|1
1749681|NCT00875017|6098340|P4|First Intervention|Intolerance to nasogastric tube|0
1749682|NCT00875017|6098341|P3|First Intervention|Intolerance to nasogastric tube|0
1749683|NCT00875017|6098342|P2|First Intervention|Intolerance to nasogastric tube|0
1749684|NCT00875017|6098343|P1|First Intervention|Intolerance to nasogastric tube|0
1749685|NCT00875017|6098338|P6|First Intervention|Problems collecting rectal effluent|0
1749686|NCT00875017|6098339|P5|First Intervention|Problems collecting rectal effluent|0
1749687|NCT00875017|6098340|P4|First Intervention|Problems collecting rectal effluent|0
1749688|NCT00875017|6098341|P3|First Intervention|Problems collecting rectal effluent|0
1749689|NCT00875017|6098342|P2|First Intervention|Problems collecting rectal effluent|0
1749690|NCT00875017|6098343|P1|First Intervention|Problems collecting rectal effluent|1
1749691|NCT00875017|6098338|P6|First Intervention|Adverse Event|0
1749692|NCT00875017|6098339|P5|First Intervention|Adverse Event|0
1749693|NCT00875017|6098340|P4|First Intervention|Adverse Event|1
1749694|NCT00875017|6098341|P3|First Intervention|Adverse Event|0
1749695|NCT00875017|6098342|P2|First Intervention|Adverse Event|0
1749696|NCT00875017|6098343|P1|First Intervention|Adverse Event|0
1749697|NCT00875017|6098338|P6|First Intervention|Withdrawal by Subject|0
1749698|NCT00875017|6098339|P5|First Intervention|Withdrawal by Subject|0
1749699|NCT00875017|6098340|P4|First Intervention|Withdrawal by Subject|0
1749700|NCT00875017|6098341|P3|First Intervention|Withdrawal by Subject|1
1749701|NCT00875017|6098342|P2|First Intervention|Withdrawal by Subject|0
1749702|NCT00875017|6098343|P1|First Intervention|Withdrawal by Subject|1
1749703|NCT00874939|6098357|P1|Overall Study|Study terminated|4
1749704|NCT00874848|6098390|P2|Overall Study|Physician Decision|2
1749705|NCT00874848|6098391|P1|Overall Study|Physician Decision|0
1749706|NCT00874848|6098390|P2|Overall Study|Failure to comply with protocol|1
1749707|NCT00874848|6098391|P1|Overall Study|Failure to comply with protocol|0
1749708|NCT00874848|6098390|P2|Overall Study|Noncompliance|1
1749709|NCT00874848|6098391|P1|Overall Study|Noncompliance|1
1749710|NCT00874848|6098390|P2|Overall Study|Withdrawal by Subject|4
1749711|NCT00874848|6098391|P1|Overall Study|Withdrawal by Subject|7
1749712|NCT00874848|6098390|P2|Overall Study|Progressive neoplastic disease|18
1749713|NCT00874848|6098391|P1|Overall Study|Progressive neoplastic disease|38
1749714|NCT00874848|6098390|P2|Overall Study|Adverse Event|2
1749715|NCT00874848|6098391|P1|Overall Study|Adverse Event|13
1749716|NCT00874822|6098407|P1|Overall Study|excluded by criteria|8
1749717|NCT00874770|6098415|P4|Overall Study|Subject no Longer Meets Study Criteria|0
1749718|NCT00874770|6098416|P3|Overall Study|Subject no Longer Meets Study Criteria|0
1749719|NCT00874770|6098417|P2|Overall Study|Subject no Longer Meets Study Criteria|0
1749720|NCT00874770|6098418|P1|Overall Study|Subject no Longer Meets Study Criteria|1
1749721|NCT00874770|6098415|P4|Overall Study|Lost to Follow-up|1
1749722|NCT00874770|6098416|P3|Overall Study|Lost to Follow-up|0
1749723|NCT00874770|6098417|P2|Overall Study|Lost to Follow-up|0
1749724|NCT00874770|6098418|P1|Overall Study|Lost to Follow-up|1
1749725|NCT00874770|6098415|P4|Overall Study|Adverse Event|2
1749726|NCT00874770|6098416|P3|Overall Study|Adverse Event|4
1749727|NCT00874770|6098417|P2|Overall Study|Adverse Event|1
1749729|NCT00874770|6098415|P4|Overall Study|Lack of Efficacy|2
1749730|NCT00874770|6098416|P3|Overall Study|Lack of Efficacy|0
1749731|NCT00874770|6098417|P2|Overall Study|Lack of Efficacy|0
1749732|NCT00874770|6098418|P1|Overall Study|Lack of Efficacy|2
1749733|NCT00874731|6098452|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
1749734|NCT00874731|6098453|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
1749735|NCT00874731|6098454|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
1749736|NCT00874731|6098452|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
1749737|NCT00874731|6098453|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
1749738|NCT00874731|6098454|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
1749739|NCT00874731|6098452|P3|Part 1, Day 1: Placebo|Disease Progression|0
1749740|NCT00874731|6098453|P2|Part 1, Day 1: Placebo|Disease Progression|0
1749741|NCT00874731|6098454|P1|Part 1, Day 1: Placebo|Disease Progression|1
1749742|NCT00874549|6098495|P4|Overall Study|Withdrawal by Subject|1
1749743|NCT00874549|6098496|P3|Overall Study|Withdrawal by Subject|0
1749744|NCT00874549|6098497|P2|Overall Study|Withdrawal by Subject|1
1749745|NCT00874549|6098498|P1|Overall Study|Withdrawal by Subject|0
1749746|NCT00874549|6098495|P4|Overall Study|Lost to Follow-up|0
1749747|NCT00874549|6098496|P3|Overall Study|Lost to Follow-up|1
1749748|NCT00874549|6098497|P2|Overall Study|Lost to Follow-up|0
1749749|NCT00874549|6098498|P1|Overall Study|Lost to Follow-up|0
1749750|NCT00874549|6098495|P4|Overall Study|Protocol Violation|1
1749751|NCT00874549|6098496|P3|Overall Study|Protocol Violation|2
1749752|NCT00874549|6098497|P2|Overall Study|Protocol Violation|0
1749753|NCT00874549|6098498|P1|Overall Study|Protocol Violation|1
1749754|NCT00874549|6098495|P4|Overall Study|Adverse Event|0
1749755|NCT00874549|6098496|P3|Overall Study|Adverse Event|1
1749756|NCT00874549|6098497|P2|Overall Study|Adverse Event|0
1749757|NCT00874549|6098498|P1|Overall Study|Adverse Event|0
1749758|NCT00874497|6098575|P2|Overall Study|Withdrawal by Subject|4
1749759|NCT00874497|6098576|P1|Overall Study|Withdrawal by Subject|5
1749760|NCT00874497|6098575|P2|Overall Study|Physician Decision|1
1749761|NCT00874497|6098576|P1|Overall Study|Physician Decision|1
1749762|NCT00874497|6098575|P2|Overall Study|Met Withdrawal Criteria|2
1749763|NCT00874497|6098576|P1|Overall Study|Met Withdrawal Criteria|4
1749764|NCT00874497|6098575|P2|Overall Study|Sponsor Discontinued Trial|3
1749765|NCT00874497|6098576|P1|Overall Study|Sponsor Discontinued Trial|7
1749766|NCT00874497|6098575|P2|Overall Study|Adverse Event|4
1749767|NCT00874497|6098576|P1|Overall Study|Adverse Event|9
1749768|NCT00874497|6098575|P2|Overall Study|Lost to Follow-up|4
1749769|NCT00874497|6098576|P1|Overall Study|Lost to Follow-up|2
1749770|NCT00874276|6098616|P2|Overall Study|Withdrawal by Subject|1
1749771|NCT00874276|6098617|P1|Overall Study|Withdrawal by Subject|1
1749772|NCT00874237|6098637|P6|Overall Study|Withdrawal by Subject|0
1749773|NCT00874237|6098638|P5|Overall Study|Withdrawal by Subject|0
1749774|NCT00874237|6098639|P4|Overall Study|Withdrawal by Subject|0
1749775|NCT00874237|6098640|P3|Overall Study|Withdrawal by Subject|1
1749776|NCT00874237|6098641|P2|Overall Study|Withdrawal by Subject|0
1749777|NCT00874237|6098642|P1|Overall Study|Withdrawal by Subject|0
1749778|NCT00874237|6098637|P6|Overall Study|Physician Decision|0
1749779|NCT00874237|6098638|P5|Overall Study|Physician Decision|0
1749780|NCT00874237|6098639|P4|Overall Study|Physician Decision|0
1749781|NCT00874237|6098640|P3|Overall Study|Physician Decision|0
1749782|NCT00874237|6098641|P2|Overall Study|Physician Decision|1
1749783|NCT00874237|6098642|P1|Overall Study|Physician Decision|0
1749784|NCT00874120|6098660|P2|Second Intervention|Protocol Violation|0
1749785|NCT00874120|6098661|P1|Second Intervention|Protocol Violation|1
1749786|NCT00874120|6098660|P2|Second Intervention|Withdrawal by Subject|0
1749787|NCT00874120|6098661|P1|Second Intervention|Withdrawal by Subject|1
1749788|NCT00874120|6098660|P2|First Intervention|positive drug test|0
1749789|NCT00874120|6098661|P1|First Intervention|positive drug test|1
1749790|NCT00874120|6098660|P2|First Intervention|Protocol Violation|0
1749791|NCT00874120|6098661|P1|First Intervention|Protocol Violation|3
1749792|NCT00874120|6098660|P2|First Intervention|Lost to Follow-up|1
1749793|NCT00874120|6098661|P1|First Intervention|Lost to Follow-up|0
1749794|NCT00874120|6098660|P2|First Intervention|Withdrawal by Subject|0
1749795|NCT00874120|6098661|P1|First Intervention|Withdrawal by Subject|2
1749796|NCT00874120|6098660|P2|First Intervention|Adverse Event|1
1749797|NCT00874120|6098661|P1|First Intervention|Adverse Event|0
1749798|NCT00874029|6098674|P1|Overall Study|Lost to Follow-up|5
1749799|NCT00874029|6098674|P1|Overall Study|Adverse Event|1
1749800|NCT00874029|6098674|P1|Overall Study|Physician Decision|1
1749801|NCT00874029|6098674|P1|Overall Study|Pregnancy|4
1749802|NCT00874029|6098674|P1|Overall Study|Withdrawal by Subject|10
1749803|NCT00873912|6098690|P2|Overall Study|Lost to Follow-up|0
1749804|NCT00873912|6098691|P1|Overall Study|Lost to Follow-up|2
1749805|NCT00873912|6098690|P2|Overall Study|Withdrawal by Subject|0
1749806|NCT00873912|6098691|P1|Overall Study|Withdrawal by Subject|1
1749807|NCT00873860|6098730|P4|Overall Study|Other|0
1749808|NCT00873860|6098731|P3|Overall Study|Other|1
1749809|NCT00873860|6098732|P2|Overall Study|Other|0
1749810|NCT00873860|6098733|P1|Overall Study|Other|1
1749811|NCT00873860|6098730|P4|Overall Study|Death|0
1749812|NCT00873860|6098731|P3|Overall Study|Death|0
1749813|NCT00873860|6098732|P2|Overall Study|Death|0
1749814|NCT00873860|6098733|P1|Overall Study|Death|1
1749815|NCT00873860|6098730|P4|Overall Study|Withdrawal by Subject|0
1749816|NCT00873860|6098731|P3|Overall Study|Withdrawal by Subject|2
1749817|NCT00873860|6098732|P2|Overall Study|Withdrawal by Subject|0
1749818|NCT00873860|6098733|P1|Overall Study|Withdrawal by Subject|1
1749819|NCT00873860|6098730|P4|Overall Study|Lost to Follow-up|1
1749820|NCT00873860|6098731|P3|Overall Study|Lost to Follow-up|0
1749821|NCT00873860|6098732|P2|Overall Study|Lost to Follow-up|0
1749822|NCT00873860|6098733|P1|Overall Study|Lost to Follow-up|1
1749823|NCT00873730|6098821|P2|Overall Study|Sponsor decision|0
1749824|NCT00873730|6098822|P1|Overall Study|Sponsor decision|1
1749825|NCT00873730|6098821|P2|Overall Study|Withdrawal by Subject|1
1749826|NCT00873730|6098822|P1|Overall Study|Withdrawal by Subject|0
1749827|NCT00873730|6098821|P2|Overall Study|Adverse Event|2
1749828|NCT00873730|6098822|P1|Overall Study|Adverse Event|0
1749829|NCT00873730|6098821|P2|Overall Study|Protocol Deviation|2
1749830|NCT00873730|6098822|P1|Overall Study|Protocol Deviation|5
1749831|NCT00873366|6098865|P1|Overall Study|Refused to continue DM-BT testing|3
1749832|NCT00873366|6098865|P1|Overall Study|Off tamoxifen due to side effects|2
1749833|NCT00873366|6098865|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
1749834|NCT00873119|6098890|P2|Overall Study|Not treated|0
1749835|NCT00873119|6098891|P1|Overall Study|Not treated|2
1749836|NCT00873119|6098890|P2|Overall Study|Other|5
1749837|NCT00873119|6098891|P1|Overall Study|Other|2
1749838|NCT00873119|6098890|P2|Overall Study|Death|1
1749839|NCT00873119|6098891|P1|Overall Study|Death|2
1749840|NCT00873119|6098890|P2|Overall Study|Progressive disease|18
1749841|NCT00873119|6098891|P1|Overall Study|Progressive disease|26
1749842|NCT00873119|6098890|P2|Overall Study|Adverse Event|0
1749843|NCT00873119|6098891|P1|Overall Study|Adverse Event|8
1749844|NCT00873119|6098890|P2|Overall Study|Patient request|2
1749845|NCT00873119|6098891|P1|Overall Study|Patient request|4
1749846|NCT00873093|6098912|P5|Overall Study|Ineligible|0
1749847|NCT00873093|6098913|P4|Overall Study|Ineligible|1
1749848|NCT00873093|6098914|P3|Overall Study|Ineligible|0
1749849|NCT00873093|6098915|P2|Overall Study|Ineligible|1
1749850|NCT00873093|6098916|P1|Overall Study|Ineligible|0
1749851|NCT00873093|6098912|P5|Overall Study|Withdrawal by Subject|0
1749852|NCT00873093|6098913|P4|Overall Study|Withdrawal by Subject|0
1749853|NCT00873093|6098914|P3|Overall Study|Withdrawal by Subject|4
1749854|NCT00873093|6098915|P2|Overall Study|Withdrawal by Subject|4
1749855|NCT00873093|6098916|P1|Overall Study|Withdrawal by Subject|1
1749856|NCT00873093|6098912|P5|Overall Study|Physician Decision|2
1749857|NCT00873093|6098913|P4|Overall Study|Physician Decision|10
1749858|NCT00873093|6098914|P3|Overall Study|Physician Decision|10
1749859|NCT00873093|6098915|P2|Overall Study|Physician Decision|17
1749860|NCT00873093|6098916|P1|Overall Study|Physician Decision|0
1749861|NCT00873093|6098912|P5|Overall Study|Death|0
1749862|NCT00873093|6098913|P4|Overall Study|Death|0
1749863|NCT00873093|6098914|P3|Overall Study|Death|2
1749864|NCT00873093|6098915|P2|Overall Study|Death|3
1749865|NCT00873093|6098916|P1|Overall Study|Death|0
1749866|NCT00873093|6098912|P5|Overall Study|Adverse Event|0
1749867|NCT00873093|6098913|P4|Overall Study|Adverse Event|0
1749868|NCT00873093|6098914|P3|Overall Study|Adverse Event|0
1749869|NCT00873093|6098915|P2|Overall Study|Adverse Event|2
1749870|NCT00873093|6098916|P1|Overall Study|Adverse Event|0
1749871|NCT00873041|6098973|P3|Extension Study|Administrative reasons|1
1749872|NCT00873041|6098974|P2|Extension Study|Administrative reasons|0
1749873|NCT00873041|6098975|P1|Extension Study|Administrative reasons|0
1749874|NCT00873041|6098973|P3|Extension Study|Adverse Event|1
1749875|NCT00873041|6098974|P2|Extension Study|Adverse Event|0
1749876|NCT00873041|6098975|P1|Extension Study|Adverse Event|1
1749877|NCT00873041|6098973|P3|Core Study|Protocol deviation|1
1749878|NCT00873041|6098974|P2|Core Study|Protocol deviation|0
1749879|NCT00873041|6098975|P1|Core Study|Protocol deviation|1
1749880|NCT00873041|6098973|P3|Core Study|Abnormal laboratory value|1
1749881|NCT00873041|6098974|P2|Core Study|Abnormal laboratory value|0
1749882|NCT00873041|6098975|P1|Core Study|Abnormal laboratory value|0
1749883|NCT00873041|6098973|P3|Core Study|Lost to Follow-up|0
1749884|NCT00873041|6098974|P2|Core Study|Lost to Follow-up|1
1749885|NCT00873041|6098975|P1|Core Study|Lost to Follow-up|3
1749886|NCT00873041|6098973|P3|Core Study|Withdrawal by Subject|2
1749887|NCT00873041|6098974|P2|Core Study|Withdrawal by Subject|2
1749888|NCT00873041|6098975|P1|Core Study|Withdrawal by Subject|1
1749889|NCT00873041|6098973|P3|Core Study|Adverse Event|1
1749890|NCT00873041|6098974|P2|Core Study|Adverse Event|3
1749891|NCT00873041|6098975|P1|Core Study|Adverse Event|2
1749892|NCT00873015|6099033|P4|Overall Study|Withdrawal by Subject|0
1749893|NCT00873015|6099034|P3|Overall Study|Withdrawal by Subject|0
1749894|NCT00873015|6099035|P2|Overall Study|Withdrawal by Subject|1
1749895|NCT00873015|6099036|P1|Overall Study|Withdrawal by Subject|0
1749896|NCT00872989|6099045|P2|Overall Study|Not protocol specified|8
1749897|NCT00872989|6099046|P1|Overall Study|Not protocol specified|3
1749898|NCT00872989|6099045|P2|Overall Study|Progression/relapse|35
1749899|NCT00872989|6099046|P1|Overall Study|Progression/relapse|47
1749900|NCT00872989|6099045|P2|Overall Study|Withdrawal by Subject|5
1749901|NCT00872989|6099046|P1|Overall Study|Withdrawal by Subject|8
1749902|NCT00872989|6099045|P2|Overall Study|Adverse Event|15
1749903|NCT00872989|6099046|P1|Overall Study|Adverse Event|7
1749904|NCT00872898|6099065|P2|Part Two - Double Blind|Other reasons|0
1749905|NCT00872898|6099066|P1|Part Two - Double Blind|Other reasons|2
1749906|NCT00872898|6099065|P2|Part Two - Double Blind|Lost to Follow-up|2
1749907|NCT00872898|6099066|P1|Part Two - Double Blind|Lost to Follow-up|0
1749908|NCT00872898|6099065|P2|Part Two - Double Blind|Withdrawal by Subject|1
1749909|NCT00872898|6099066|P1|Part Two - Double Blind|Withdrawal by Subject|3
1749910|NCT00872898|6099065|P2|Part Two - Double Blind|Protocol Violation|0
1749911|NCT00872898|6099066|P1|Part Two - Double Blind|Protocol Violation|1
1749912|NCT00872898|6099065|P2|Part Two - Double Blind|Lack of Efficacy|0
1749913|NCT00872898|6099066|P1|Part Two - Double Blind|Lack of Efficacy|1
1749914|NCT00872898|6099065|P2|Part Two - Double Blind|Adverse Event|3
1749915|NCT00872898|6099066|P1|Part Two - Double Blind|Adverse Event|4
1749916|NCT00872599|6099140|P2|Second Washout Period|Adverse Event|1
1749917|NCT00872599|6099141|P1|Second Washout Period|Adverse Event|1
1749918|NCT00872521|6099161|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
1749919|NCT00872521|6099162|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
1749920|NCT00872521|6099163|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
1749921|NCT00872521|6099161|P3|Completed 3-month Follow up|Physician Decision|0
1749922|NCT00872521|6099162|P2|Completed 3-month Follow up|Physician Decision|1
1749923|NCT00872521|6099163|P1|Completed 3-month Follow up|Physician Decision|0
1749924|NCT00872521|6099161|P3|Completed 3-month Follow up|Other|0
1749925|NCT00872521|6099162|P2|Completed 3-month Follow up|Other|2
1749926|NCT00872521|6099163|P1|Completed 3-month Follow up|Other|0
1749927|NCT00872521|6099161|P3|Primary Endpoint Analysis|Patient response missing|1
1749928|NCT00872521|6099162|P2|Primary Endpoint Analysis|Patient response missing|0
1749929|NCT00872521|6099163|P1|Primary Endpoint Analysis|Patient response missing|0
1749930|NCT00872521|6099161|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
1749931|NCT00872521|6099162|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
1749932|NCT00872521|6099163|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
1749933|NCT00872521|6099161|P3|Primary Endpoint Analysis|Patient choice|0
1749934|NCT00872521|6099162|P2|Primary Endpoint Analysis|Patient choice|1
1749935|NCT00872521|6099163|P1|Primary Endpoint Analysis|Patient choice|0
1749936|NCT00872521|6099161|P3|Primary Endpoint Analysis|Other|0
1749937|NCT00872521|6099162|P2|Primary Endpoint Analysis|Other|2
1749938|NCT00872521|6099163|P1|Primary Endpoint Analysis|Other|1
1749939|NCT00872521|6099161|P3|Completed PAD Induction|Death|0
1749940|NCT00872521|6099162|P2|Completed PAD Induction|Death|1
1749941|NCT00872521|6099163|P1|Completed PAD Induction|Death|1
1749942|NCT00872521|6099161|P3|Completed PAD Induction|Adverse Event|0
1749943|NCT00872521|6099162|P2|Completed PAD Induction|Adverse Event|0
1749944|NCT00872521|6099163|P1|Completed PAD Induction|Adverse Event|4
1749945|NCT00872521|6099161|P3|Completed PAD Induction|Disease progression|0
1749946|NCT00872521|6099162|P2|Completed PAD Induction|Disease progression|2
1749947|NCT00872521|6099163|P1|Completed PAD Induction|Disease progression|0
1749948|NCT00872521|6099161|P3|Completed PAD Induction|Patient choice|0
1749949|NCT00872521|6099162|P2|Completed PAD Induction|Patient choice|1
1749950|NCT00872521|6099163|P1|Completed PAD Induction|Patient choice|0
1749951|NCT00872170|6099234|P2|Overall Study|Adverse Event|0
1749952|NCT00872170|6099235|P1|Overall Study|Adverse Event|1
1749953|NCT00872001|6099265|P2|Overall Study|Administrative|15
1749954|NCT00872001|6099266|P1|Overall Study|Administrative|23
1749955|NCT00872001|6099265|P2|Overall Study|Did Not Meet Protocol Eligibility|36
1749956|NCT00872001|6099266|P1|Overall Study|Did Not Meet Protocol Eligibility|38
1749957|NCT00872001|6099265|P2|Overall Study|Protocol Violation|8
1749958|NCT00872001|6099266|P1|Overall Study|Protocol Violation|5
1749959|NCT00872001|6099265|P2|Overall Study|Withdrawal by Subject|30
1749960|NCT00872001|6099266|P1|Overall Study|Withdrawal by Subject|18
1749961|NCT00872001|6099265|P2|Overall Study|Lost to Follow-up|12
1749962|NCT00872001|6099266|P1|Overall Study|Lost to Follow-up|13
1749963|NCT00872001|6099265|P2|Overall Study|Protocol Defined Clinical Event|7
1749964|NCT00872001|6099266|P1|Overall Study|Protocol Defined Clinical Event|5
1749965|NCT00872001|6099265|P2|Overall Study|Adverse Event|23
1749966|NCT00872001|6099266|P1|Overall Study|Adverse Event|34
1749967|NCT00871975|6099274|P1|Overall Study|Motion artifact, tracing uninterpretable|5
1749968|NCT00871975|6099274|P1|Overall Study|Patient unable to void/insufficient vol|13
1749969|NCT00871975|6099274|P1|Overall Study|Catheters could not be inserted|1
1749970|NCT00871975|6099274|P1|Overall Study|Technical difficulty w155-1ith equipment|3
1749971|NCT00871871|6099280|P4|Part II|Protocol Violation|1
1749972|NCT00871871|6099281|P3|Part II|Protocol Violation|0
1749973|NCT00871871|6099282|P2|Part II|Protocol Violation|0
1749974|NCT00871871|6099283|P1|Part II|Protocol Violation|0
1749975|NCT00871871|6099280|P4|Part II|Adverse Event|2
1749976|NCT00871871|6099281|P3|Part II|Adverse Event|1
1749977|NCT00871871|6099282|P2|Part II|Adverse Event|0
1749978|NCT00871871|6099283|P1|Part II|Adverse Event|0
1749979|NCT00871871|6099280|P4|Part II|Withdrawal by Subject|1
1749980|NCT00871871|6099281|P3|Part II|Withdrawal by Subject|2
1749981|NCT00871871|6099282|P2|Part II|Withdrawal by Subject|0
1749982|NCT00871871|6099283|P1|Part II|Withdrawal by Subject|0
1749983|NCT00871871|6099280|P4|Part II|Lack of Efficacy|0
1749984|NCT00871871|6099281|P3|Part II|Lack of Efficacy|1
1749985|NCT00871871|6099282|P2|Part II|Lack of Efficacy|0
1749986|NCT00871871|6099283|P1|Part II|Lack of Efficacy|0
1749987|NCT00871871|6099280|P4|Part I|Laboratory abnormality|0
1749988|NCT00871871|6099281|P3|Part I|Laboratory abnormality|0
1749989|NCT00871871|6099282|P2|Part I|Laboratory abnormality|1
1749990|NCT00871871|6099283|P1|Part I|Laboratory abnormality|0
1749991|NCT00871871|6099280|P4|Part I|Withdrawal by Subject|0
1749992|NCT00871871|6099281|P3|Part I|Withdrawal by Subject|0
1749993|NCT00871871|6099282|P2|Part I|Withdrawal by Subject|0
1749994|NCT00871871|6099283|P1|Part I|Withdrawal by Subject|3
1749995|NCT00871871|6099280|P4|Part I|Adverse Event|0
1749996|NCT00871871|6099281|P3|Part I|Adverse Event|0
1749997|NCT00871871|6099282|P2|Part I|Adverse Event|2
1749998|NCT00871871|6099283|P1|Part I|Adverse Event|0
1749999|NCT00871780|6099320|P1|Overall Study|Physician Decision|1
1750000|NCT00871780|6099320|P1|Overall Study|Death|1
1750001|NCT00871780|6099320|P1|Overall Study|Voluntary Discontinuation|4
1750002|NCT00871780|6099320|P1|Overall Study|Adverse Event|6
1750003|NCT00871780|6099320|P1|Overall Study|Withdrawal by Subject|9
1750004|NCT00871780|6099320|P1|Overall Study|Enrolled But Not Treated|6
1750005|NCT00871741|6099340|P2|Overall Study|Premature study termination|7
1750006|NCT00871741|6099341|P1|Overall Study|Premature study termination|9
1750007|NCT00871728|6099355|P1|Overall Study|Withdrawal of Informed Consent|5
1750008|NCT00871728|6099355|P1|Overall Study|Participant Non-compliance|1
1750009|NCT00871728|6099355|P1|Overall Study|Failed to Visit Hospital|4
1750010|NCT00871728|6099355|P1|Overall Study|Lost to Follow-up|2
1750011|NCT00871728|6099355|P1|Overall Study|Protocol Violation|7
1750012|NCT00871728|6099355|P1|Overall Study|Adverse Event|1
1750013|NCT00871715|6099368|P3|Overall Study|Lost to Follow-up|9
1750014|NCT00871715|6099369|P2|Overall Study|Lost to Follow-up|6
1750015|NCT00871715|6099370|P1|Overall Study|Lost to Follow-up|3
1750016|NCT00871715|6099368|P3|Overall Study|Physician Decision|2
1750017|NCT00871715|6099369|P2|Overall Study|Physician Decision|0
1750018|NCT00871715|6099370|P1|Overall Study|Physician Decision|6
1750019|NCT00871715|6099368|P3|Overall Study|Withdrawal by Subject|15
1750020|NCT00871715|6099369|P2|Overall Study|Withdrawal by Subject|10
1750021|NCT00871715|6099370|P1|Overall Study|Withdrawal by Subject|6
1750022|NCT00871572|6099447|P4|Overall Study|Withdrawal by Subject|1
1750023|NCT00871572|6099448|P3|Overall Study|Withdrawal by Subject|3
1750024|NCT00871572|6099449|P2|Overall Study|Withdrawal by Subject|2
1750025|NCT00871572|6099450|P1|Overall Study|Withdrawal by Subject|1
1750026|NCT00871572|6099447|P4|Overall Study|Sponsor Decision|0
1750027|NCT00871572|6099448|P3|Overall Study|Sponsor Decision|0
1750028|NCT00871572|6099449|P2|Overall Study|Sponsor Decision|0
1750029|NCT00871572|6099450|P1|Overall Study|Sponsor Decision|1
1750030|NCT00871572|6099447|P4|Overall Study|Protocol Violation|1
1750031|NCT00871572|6099448|P3|Overall Study|Protocol Violation|1
1750032|NCT00871572|6099449|P2|Overall Study|Protocol Violation|0
1750033|NCT00871572|6099450|P1|Overall Study|Protocol Violation|0
1750034|NCT00871572|6099447|P4|Overall Study|Lost to Follow-up|1
1750035|NCT00871572|6099448|P3|Overall Study|Lost to Follow-up|0
1750036|NCT00871572|6099449|P2|Overall Study|Lost to Follow-up|1
1750037|NCT00871572|6099450|P1|Overall Study|Lost to Follow-up|0
1750038|NCT00871572|6099447|P4|Overall Study|Investigator Decision|1
1750039|NCT00871572|6099448|P3|Overall Study|Investigator Decision|0
1750040|NCT00871572|6099449|P2|Overall Study|Investigator Decision|1
1750041|NCT00871572|6099450|P1|Overall Study|Investigator Decision|0
1750042|NCT00871572|6099447|P4|Overall Study|Adverse Event|3
1750043|NCT00871572|6099448|P3|Overall Study|Adverse Event|0
1750044|NCT00871572|6099449|P2|Overall Study|Adverse Event|2
1750045|NCT00871572|6099450|P1|Overall Study|Adverse Event|0
1750046|NCT00871494|6099520|P1|Overall Study|Lost to Follow-up|1
1750047|NCT00871494|6099520|P1|Overall Study|Adverse Event|4
1750048|NCT00871494|6099520|P1|Overall Study|Lack of Efficacy|4
1750049|NCT00871494|6099520|P1|Overall Study|Protocol Violation|5
1750050|NCT00871429|6099527|P1|Overall Study|Questionnaire not completed|1
1750051|NCT00871429|6099527|P1|Overall Study|Withdrawal by Subject|17
1750052|NCT00871429|6099527|P1|Overall Study|Lost to Follow-up|6
1750053|NCT00871403|6099538|P3|Monotherapy Treatment Phase|Adverse Event|0
1750054|NCT00871403|6099539|P2|Monotherapy Treatment Phase|Adverse Event|4
1750055|NCT00871403|6099540|P1|Monotherapy Treatment Phase|Adverse Event|0
1750056|NCT00871403|6099538|P3|Monotherapy Treatment Phase|Disease Progression|1
1750057|NCT00871403|6099539|P2|Monotherapy Treatment Phase|Disease Progression|9
1750058|NCT00871403|6099540|P1|Monotherapy Treatment Phase|Disease Progression|0
1750059|NCT00871403|6099538|P3|Combination Treatment Phase|Physician Decision|3
1750060|NCT00871403|6099539|P2|Combination Treatment Phase|Physician Decision|1
1750061|NCT00871403|6099540|P1|Combination Treatment Phase|Physician Decision|0
1750062|NCT00871403|6099538|P3|Combination Treatment Phase|Withdrawal by Subject|1
1750063|NCT00871403|6099539|P2|Combination Treatment Phase|Withdrawal by Subject|3
1750064|NCT00871403|6099540|P1|Combination Treatment Phase|Withdrawal by Subject|0
1750065|NCT00871403|6099538|P3|Combination Treatment Phase|Disease Progression|5
1750066|NCT00871403|6099539|P2|Combination Treatment Phase|Disease Progression|8
1750067|NCT00871403|6099540|P1|Combination Treatment Phase|Disease Progression|0
1750068|NCT00871403|6099538|P3|Combination Treatment Phase|Adverse Event|2
1750069|NCT00871403|6099539|P2|Combination Treatment Phase|Adverse Event|17
1750070|NCT00871403|6099540|P1|Combination Treatment Phase|Adverse Event|0
1750071|NCT00871403|6099538|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
1750072|NCT00871403|6099539|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
1750073|NCT00871403|6099540|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
1750074|NCT00871403|6099538|P3|Combination Treatment Phase|Randomized but Not Treated|1
1750075|NCT00871403|6099539|P2|Combination Treatment Phase|Randomized but Not Treated|1
1750076|NCT00871403|6099540|P1|Combination Treatment Phase|Randomized but Not Treated|1
1750077|NCT00871377|6099553|P6|Third Intervention (10 Weeks)|Death|0
1750078|NCT00871377|6099554|P5|Third Intervention (10 Weeks)|Death|0
1750079|NCT00871377|6099555|P4|Third Intervention (10 Weeks)|Death|1
1750080|NCT00871377|6099556|P3|Third Intervention (10 Weeks)|Death|0
1750081|NCT00871377|6099557|P2|Third Intervention (10 Weeks)|Death|0
1750082|NCT00871377|6099558|P1|Third Intervention (10 Weeks)|Death|0
1750083|NCT00871377|6099553|P6|Washout (6 Weeks)|Withdrawal by Subject|1
1750084|NCT00871377|6099554|P5|Washout (6 Weeks)|Withdrawal by Subject|0
1750085|NCT00871377|6099555|P4|Washout (6 Weeks)|Withdrawal by Subject|0
1750086|NCT00871377|6099556|P3|Washout (6 Weeks)|Withdrawal by Subject|0
1750087|NCT00871377|6099557|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1750088|NCT00871377|6099558|P1|Washout (6 Weeks)|Withdrawal by Subject|0
1750089|NCT00871377|6099553|P6|Washout (6 Weeks)|Withdrawal by Subject|0
1750090|NCT00871377|6099554|P5|Washout (6 Weeks)|Withdrawal by Subject|0
1750091|NCT00871377|6099555|P4|Washout (6 Weeks)|Withdrawal by Subject|0
1750092|NCT00871377|6099556|P3|Washout (6 Weeks)|Withdrawal by Subject|0
1750093|NCT00871377|6099557|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1750094|NCT00871377|6099558|P1|Washout (6 Weeks)|Withdrawal by Subject|1
1750095|NCT00871377|6099553|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
1750096|NCT00871377|6099554|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
1750097|NCT00871377|6099555|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
1750098|NCT00871377|6099556|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
1750099|NCT00871377|6099557|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
1750100|NCT00871377|6099558|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
1750101|NCT00871377|6099553|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
1750102|NCT00871377|6099554|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
1750103|NCT00871377|6099555|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
1750104|NCT00871377|6099556|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
1750105|NCT00871377|6099557|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
1750106|NCT00871377|6099558|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
1750107|NCT00871351|6099569|P3|Overall Study|Adverse Event|0
1750108|NCT00871351|6099570|P2|Overall Study|Adverse Event|1
1750109|NCT00871351|6099571|P1|Overall Study|Adverse Event|3
1750110|NCT00871351|6099569|P3|Overall Study|Withdrawal by Subject|0
1750111|NCT00871351|6099570|P2|Overall Study|Withdrawal by Subject|0
1750112|NCT00871351|6099571|P1|Overall Study|Withdrawal by Subject|1
1750113|NCT00871338|6099593|P2|Prior to Booster|Lost to Follow-up|0
1750114|NCT00871338|6099594|P1|Prior to Booster|Lost to Follow-up|1
1750115|NCT00871338|6099593|P2|Prior to Booster|Withdrawal by Subject|3
1750116|NCT00871338|6099594|P1|Prior to Booster|Withdrawal by Subject|1
1750117|NCT00871234|6099683|P1|Overall Study|Lost to Follow-up|3
1750118|NCT00871234|6099683|P1|Overall Study|Adverse Event|2
1750119|NCT00871169|6099687|P1|Overall Study|Patient did not receive study treatment|2
1750120|NCT00871169|6099687|P1|Overall Study|Protocol Violation|1
1750121|NCT00871117|6099715|P2|Overall Study|Other|4
1750122|NCT00871117|6099716|P1|Overall Study|Other|0
1750123|NCT00871117|6099715|P2|Overall Study|Lost to Follow-up|6
1750124|NCT00871117|6099716|P1|Overall Study|Lost to Follow-up|5
1750125|NCT00871000|6099750|P2|Overall Study|Withdrawal by Subject|0
1750126|NCT00871000|6099751|P1|Overall Study|Withdrawal by Subject|1
1750127|NCT00870870|6099803|P4|Overall Study|Adverse Event|2
1750128|NCT00870870|6099804|P3|Overall Study|Adverse Event|2
1750129|NCT00870870|6099805|P2|Overall Study|Adverse Event|0
1750130|NCT00870870|6099806|P1|Overall Study|Adverse Event|0
1750131|NCT00870870|6099803|P4|Overall Study|Withdrawal by Subject|3
1750132|NCT00870870|6099804|P3|Overall Study|Withdrawal by Subject|1
1750133|NCT00870870|6099805|P2|Overall Study|Withdrawal by Subject|1
1750134|NCT00870870|6099806|P1|Overall Study|Withdrawal by Subject|0
1750135|NCT00870740|6099850|P6|Overall Study|Other|5
1750136|NCT00870740|6099851|P5|Overall Study|Other|3
1750137|NCT00870740|6099852|P4|Overall Study|Other|4
1750138|NCT00870740|6099853|P3|Overall Study|Other|2
1750139|NCT00870740|6099854|P2|Overall Study|Other|5
1750140|NCT00870740|6099855|P1|Overall Study|Other|2
1750141|NCT00870740|6099850|P6|Overall Study|Death|0
1750142|NCT00870740|6099851|P5|Overall Study|Death|1
1750143|NCT00870740|6099852|P4|Overall Study|Death|0
1750144|NCT00870740|6099853|P3|Overall Study|Death|0
1750145|NCT00870740|6099854|P2|Overall Study|Death|0
1750146|NCT00870740|6099855|P1|Overall Study|Death|0
1750147|NCT00870740|6099850|P6|Overall Study|Subject Non-compliance|1
1750148|NCT00870740|6099851|P5|Overall Study|Subject Non-compliance|0
1750149|NCT00870740|6099852|P4|Overall Study|Subject Non-compliance|0
1750150|NCT00870740|6099853|P3|Overall Study|Subject Non-compliance|0
1750151|NCT00870740|6099854|P2|Overall Study|Subject Non-compliance|0
1750152|NCT00870740|6099855|P1|Overall Study|Subject Non-compliance|0
1750153|NCT00870740|6099850|P6|Overall Study|Investigator Decision|0
1750154|NCT00870740|6099851|P5|Overall Study|Investigator Decision|0
1750155|NCT00870740|6099852|P4|Overall Study|Investigator Decision|0
1750156|NCT00870740|6099853|P3|Overall Study|Investigator Decision|1
1750157|NCT00870740|6099854|P2|Overall Study|Investigator Decision|0
1750158|NCT00870740|6099855|P1|Overall Study|Investigator Decision|2
1750159|NCT00870740|6099850|P6|Overall Study|Consent Withdrawn|5
1750160|NCT00870740|6099851|P5|Overall Study|Consent Withdrawn|6
1750161|NCT00870740|6099852|P4|Overall Study|Consent Withdrawn|6
1750162|NCT00870740|6099853|P3|Overall Study|Consent Withdrawn|4
1750163|NCT00870740|6099854|P2|Overall Study|Consent Withdrawn|3
1750164|NCT00870740|6099855|P1|Overall Study|Consent Withdrawn|6
1750165|NCT00870740|6099850|P6|Overall Study|Adverse Event|6
1750166|NCT00870740|6099851|P5|Overall Study|Adverse Event|1
1750167|NCT00870740|6099852|P4|Overall Study|Adverse Event|2
1750168|NCT00870740|6099853|P3|Overall Study|Adverse Event|3
1750169|NCT00870740|6099854|P2|Overall Study|Adverse Event|1
1750170|NCT00870740|6099855|P1|Overall Study|Adverse Event|2
1750171|NCT00870727|6099931|P2|Overall Study|Adverse Event|1
1750172|NCT00870727|6099932|P1|Overall Study|Adverse Event|0
1750173|NCT00870727|6099931|P2|Overall Study|Lack of Efficacy|3
1750174|NCT00870727|6099932|P1|Overall Study|Lack of Efficacy|1
1750175|NCT00870727|6099931|P2|Overall Study|Lost to Follow-up|1
1750176|NCT00870727|6099932|P1|Overall Study|Lost to Follow-up|0
1750177|NCT00870688|6099948|P1|Overall Study|Granules in the Stools|1
1750178|NCT00870688|6099948|P1|Overall Study|Death, Unrelated|1
1750179|NCT00870688|6099948|P1|Overall Study|Lost to Follow-up|2
1750180|NCT00870584|6099953|P2|Overall Study|Protocol Deviation|2
1750181|NCT00870584|6099954|P1|Overall Study|Protocol Deviation|2
1750182|NCT00870584|6099953|P2|Overall Study|Lost to Follow-up|1
1750183|NCT00870584|6099954|P1|Overall Study|Lost to Follow-up|5
1750184|NCT00870584|6099953|P2|Overall Study|Withdrawal by Subject|7
1750185|NCT00870584|6099954|P1|Overall Study|Withdrawal by Subject|6
1750186|NCT00870584|6099953|P2|Overall Study|Adverse Event|3
1750187|NCT00870584|6099954|P1|Overall Study|Adverse Event|3
1750188|NCT00870233|6100063|P1|Overall Study|Death|1
1750189|NCT00870233|6100063|P1|Overall Study|Incompatible internet browser|2
1750190|NCT00870233|6100063|P1|Overall Study|Did not undergo laparotomy|3
1750191|NCT00870233|6100063|P1|Overall Study|Withdrawal by Subject|18
1750192|NCT00870194|6100072|P2|Overall Study|Subject Decision|2
1750193|NCT00870194|6100073|P1|Overall Study|Subject Decision|7
1750194|NCT00870194|6100072|P2|Overall Study|Entry Criteria Not Met|2
1750195|NCT00870194|6100073|P1|Overall Study|Entry Criteria Not Met|1
1750196|NCT00870194|6100072|P2|Overall Study|Protocol Violation|3
1750197|NCT00870194|6100073|P1|Overall Study|Protocol Violation|3
1750198|NCT00870194|6100072|P2|Overall Study|Physician Decision|1
1750199|NCT00870194|6100073|P1|Overall Study|Physician Decision|3
1750200|NCT00870194|6100072|P2|Overall Study|Lost to Follow-up|0
1750201|NCT00870194|6100073|P1|Overall Study|Lost to Follow-up|2
1750202|NCT00870194|6100072|P2|Overall Study|Lack of Efficacy|1
1750203|NCT00870194|6100073|P1|Overall Study|Lack of Efficacy|0
1750204|NCT00870194|6100072|P2|Overall Study|Adverse Event|5
1750205|NCT00870194|6100073|P1|Overall Study|Adverse Event|10
1750206|NCT00870103|6100111|P1|Overall Study|Lost to Follow-up|2
1750207|NCT00870103|6100111|P1|Overall Study|Physician Decision|2
1750208|NCT00869999|6100116|P1|Overall Study|removed prior to starting therapy|1
1750209|NCT00869999|6100116|P1|Overall Study|Withdrawal by Subject|1
1750210|NCT00869960|6100122|P1|Overall Study|Lost to Follow-up|2
1750211|NCT00869778|6100171|P3|Overall Study|Unblinding|0
1750212|NCT00869778|6100172|P2|Overall Study|Unblinding|0
1750213|NCT00869778|6100173|P1|Overall Study|Unblinding|1
1750214|NCT00869778|6100171|P3|Overall Study|Protocol Violation|5
1750215|NCT00869778|6100172|P2|Overall Study|Protocol Violation|3
1750216|NCT00869778|6100173|P1|Overall Study|Protocol Violation|5
1750217|NCT00869778|6100171|P3|Overall Study|Pregnancy|0
1750218|NCT00869778|6100172|P2|Overall Study|Pregnancy|0
1750219|NCT00869778|6100173|P1|Overall Study|Pregnancy|1
1750220|NCT00869778|6100171|P3|Overall Study|Withdrawal by Subject|5
1750221|NCT00869778|6100172|P2|Overall Study|Withdrawal by Subject|4
1750222|NCT00869778|6100173|P1|Overall Study|Withdrawal by Subject|3
1750223|NCT00869778|6100171|P3|Overall Study|Adverse Event|0
1750224|NCT00869778|6100172|P2|Overall Study|Adverse Event|0
1750225|NCT00869778|6100173|P1|Overall Study|Adverse Event|2
1750226|NCT00869557|6100248|P2|Extension Phase|Withdrew Consent|0
1750227|NCT00869557|6100249|P1|Extension Phase|Withdrew Consent|2
1750228|NCT00869557|6100248|P2|Extension Phase|Investigator's Discretion|0
1750229|NCT00869557|6100249|P1|Extension Phase|Investigator's Discretion|2
1750230|NCT00869557|6100248|P2|Extension Phase|Lost to Follow-up|1
1750231|NCT00869557|6100249|P1|Extension Phase|Lost to Follow-up|3
1750232|NCT00869557|6100248|P2|Extension Phase|Lack of Efficacy|0
1750233|NCT00869557|6100249|P1|Extension Phase|Lack of Efficacy|1
1750234|NCT00869557|6100248|P2|Extension Phase|Adverse Event|2
1750235|NCT00869557|6100249|P1|Extension Phase|Adverse Event|2
1750236|NCT00869557|6100248|P2|Randomized Phase|Withdrew Consent|1
1750237|NCT00869557|6100249|P1|Randomized Phase|Withdrew Consent|0
1750238|NCT00869557|6100248|P2|Randomized Phase|Investigator's Discretion|0
1750239|NCT00869557|6100249|P1|Randomized Phase|Investigator's Discretion|1
1750240|NCT00869557|6100248|P2|Randomized Phase|Lost to Follow-up|1
1750241|NCT00869557|6100249|P1|Randomized Phase|Lost to Follow-up|2
1750242|NCT00869518|6100268|P2|Overall Study|Lost to Follow-up|1
1750243|NCT00869518|6100269|P1|Overall Study|Lost to Follow-up|1
1750244|NCT00869440|6100285|P4|Overall Study|Physician Decision|0
1750245|NCT00869440|6100286|P3|Overall Study|Physician Decision|0
1750246|NCT00869440|6100287|P2|Overall Study|Physician Decision|1
1750247|NCT00869440|6100288|P1|Overall Study|Physician Decision|1
1750248|NCT00869440|6100285|P4|Overall Study|Withdrawal by Subject|0
1750249|NCT00869440|6100286|P3|Overall Study|Withdrawal by Subject|0
1750250|NCT00869440|6100287|P2|Overall Study|Withdrawal by Subject|0
1750251|NCT00869440|6100288|P1|Overall Study|Withdrawal by Subject|1
1750252|NCT00869401|6100322|P5|Overall Study|Withdrawal by Subject|3
1750253|NCT00869401|6100323|P4|Overall Study|Withdrawal by Subject|5
1750254|NCT00869401|6100324|P3|Overall Study|Withdrawal by Subject|0
1750255|NCT00869401|6100325|P2|Overall Study|Withdrawal by Subject|0
1750256|NCT00869401|6100326|P1|Overall Study|Withdrawal by Subject|0
1750257|NCT00869362|6100355|P2|Overall Study|Lost to Follow-up|3
1750258|NCT00869362|6100356|P1|Overall Study|Lost to Follow-up|1
1750259|NCT00869362|6100355|P2|Overall Study|Death|2
1750260|NCT00869362|6100356|P1|Overall Study|Death|0
1750261|NCT00869323|6100377|P1|Maintenance Therapy|concurrent illness|1
1750262|NCT00869258|6100385|P1|Overall Study|Physician Decision|1
1750263|NCT00869128|6100450|P2|Overall Study|lack of Compliance|6
1750264|NCT00869128|6100451|P1|Overall Study|lack of Compliance|6
1750265|NCT00869089|6100455|P1|Overall Study|Screen Fail|1
1750266|NCT00869089|6100455|P1|Overall Study|Withdrawal by Subject|1
1750267|NCT00869089|6100455|P1|Overall Study|Lost to Follow-up|1
1750268|NCT00869050|6100459|P1|Overall Study|Screen Failure|3
1750269|NCT00868998|6100464|P1|Overall Study|Death|1
1750270|NCT00868998|6100464|P1|Overall Study|Progression of disease|2
1750271|NCT00868998|6100464|P1|Overall Study|Withdrawal by Subject|1
1750272|NCT00868998|6100464|P1|Overall Study|Screen Failure|1
1750273|NCT00868790|6100475|P14|Post-study|Excluded Medication|0
1750274|NCT00868790|6100476|P13|Post-study|Excluded Medication|0
1750275|NCT00868790|6100477|P12|Post-study|Excluded Medication|0
1750276|NCT00868790|6100478|P11|Post-study|Excluded Medication|0
1750277|NCT00868790|6100479|P10|Post-study|Excluded Medication|1
1750278|NCT00868790|6100480|P9|Post-study|Excluded Medication|0
1750279|NCT00868790|6100481|P8|Post-study|Excluded Medication|2
1750280|NCT00868790|6100482|P7|Post-study|Excluded Medication|0
1750281|NCT00868790|6100483|P6|Post-study|Excluded Medication|0
1750282|NCT00868790|6100484|P5|Post-study|Excluded Medication|0
1750283|NCT00868790|6100485|P4|Post-study|Excluded Medication|0
1750284|NCT00868790|6100486|P3|Post-study|Excluded Medication|0
1750285|NCT00868790|6100487|P2|Post-study|Excluded Medication|0
1750286|NCT00868790|6100488|P1|Post-study|Excluded Medication|0
1750287|NCT00868790|6100475|P14|Post-study|Withdrawal by Subject|0
1750288|NCT00868790|6100476|P13|Post-study|Withdrawal by Subject|0
1750289|NCT00868790|6100477|P12|Post-study|Withdrawal by Subject|0
1750290|NCT00868790|6100478|P11|Post-study|Withdrawal by Subject|0
1750291|NCT00868790|6100479|P10|Post-study|Withdrawal by Subject|0
1750292|NCT00868790|6100480|P9|Post-study|Withdrawal by Subject|0
1750293|NCT00868790|6100481|P8|Post-study|Withdrawal by Subject|0
1750294|NCT00868790|6100482|P7|Post-study|Withdrawal by Subject|0
1750295|NCT00868790|6100483|P6|Post-study|Withdrawal by Subject|0
1750296|NCT00868790|6100484|P5|Post-study|Withdrawal by Subject|1
1750297|NCT00868790|6100485|P4|Post-study|Withdrawal by Subject|0
1750298|NCT00868790|6100486|P3|Post-study|Withdrawal by Subject|0
1750299|NCT00868790|6100487|P2|Post-study|Withdrawal by Subject|0
1750300|NCT00868790|6100488|P1|Post-study|Withdrawal by Subject|0
1750301|NCT00868790|6100475|P14|Period 4|Abnormal ALT/AST|0
1750302|NCT00868790|6100476|P13|Period 4|Abnormal ALT/AST|0
1750303|NCT00868790|6100477|P12|Period 4|Abnormal ALT/AST|0
1750304|NCT00868790|6100478|P11|Period 4|Abnormal ALT/AST|0
1750305|NCT00868790|6100479|P10|Period 4|Abnormal ALT/AST|0
1750306|NCT00868790|6100480|P9|Period 4|Abnormal ALT/AST|0
1750307|NCT00868790|6100481|P8|Period 4|Abnormal ALT/AST|0
1750308|NCT00868790|6100482|P7|Period 4|Abnormal ALT/AST|0
1750309|NCT00868790|6100483|P6|Period 4|Abnormal ALT/AST|0
1750310|NCT00868790|6100484|P5|Period 4|Abnormal ALT/AST|0
1750311|NCT00868790|6100485|P4|Period 4|Abnormal ALT/AST|0
1750312|NCT00868790|6100486|P3|Period 4|Abnormal ALT/AST|1
1750313|NCT00868790|6100487|P2|Period 4|Abnormal ALT/AST|0
1750314|NCT00868790|6100488|P1|Period 4|Abnormal ALT/AST|0
1750315|NCT00868790|6100475|P14|Period 4|Study Terminated by Sponsor|1
1750316|NCT00868790|6100476|P13|Period 4|Study Terminated by Sponsor|0
1750317|NCT00868790|6100477|P12|Period 4|Study Terminated by Sponsor|1
1750318|NCT00868790|6100478|P11|Period 4|Study Terminated by Sponsor|2
1750319|NCT00868790|6100479|P10|Period 4|Study Terminated by Sponsor|0
1750320|NCT00868790|6100480|P9|Period 4|Study Terminated by Sponsor|2
1750321|NCT00868790|6100481|P8|Period 4|Study Terminated by Sponsor|1
1750322|NCT00868790|6100482|P7|Period 4|Study Terminated by Sponsor|0
1750323|NCT00868790|6100483|P6|Period 4|Study Terminated by Sponsor|0
1750324|NCT00868790|6100484|P5|Period 4|Study Terminated by Sponsor|0
1750325|NCT00868790|6100485|P4|Period 4|Study Terminated by Sponsor|0
1750326|NCT00868790|6100486|P3|Period 4|Study Terminated by Sponsor|0
1750327|NCT00868790|6100487|P2|Period 4|Study Terminated by Sponsor|0
1750328|NCT00868790|6100488|P1|Period 4|Study Terminated by Sponsor|2
1750329|NCT00868790|6100475|P14|Period 4|Lost to Follow-up|0
1750330|NCT00868790|6100476|P13|Period 4|Lost to Follow-up|0
1750331|NCT00868790|6100477|P12|Period 4|Lost to Follow-up|0
1750332|NCT00868790|6100478|P11|Period 4|Lost to Follow-up|0
1750333|NCT00868790|6100479|P10|Period 4|Lost to Follow-up|0
1750334|NCT00868790|6100480|P9|Period 4|Lost to Follow-up|0
1750335|NCT00868790|6100481|P8|Period 4|Lost to Follow-up|1
1750336|NCT00868790|6100482|P7|Period 4|Lost to Follow-up|0
1750337|NCT00868790|6100483|P6|Period 4|Lost to Follow-up|0
1750338|NCT00868790|6100484|P5|Period 4|Lost to Follow-up|0
1750339|NCT00868790|6100485|P4|Period 4|Lost to Follow-up|0
1750340|NCT00868790|6100486|P3|Period 4|Lost to Follow-up|0
1750341|NCT00868790|6100487|P2|Period 4|Lost to Follow-up|0
1750342|NCT00868790|6100488|P1|Period 4|Lost to Follow-up|0
1750343|NCT00868790|6100475|P14|Period 4|Adverse Event|0
1750344|NCT00868790|6100476|P13|Period 4|Adverse Event|1
1750345|NCT00868790|6100477|P12|Period 4|Adverse Event|0
1750346|NCT00868790|6100478|P11|Period 4|Adverse Event|1
1750347|NCT00868790|6100479|P10|Period 4|Adverse Event|0
1750348|NCT00868790|6100480|P9|Period 4|Adverse Event|0
1750349|NCT00868790|6100481|P8|Period 4|Adverse Event|1
1750350|NCT00868790|6100482|P7|Period 4|Adverse Event|0
1750351|NCT00868790|6100483|P6|Period 4|Adverse Event|0
1750352|NCT00868790|6100484|P5|Period 4|Adverse Event|0
1750353|NCT00868790|6100485|P4|Period 4|Adverse Event|0
1750354|NCT00868790|6100486|P3|Period 4|Adverse Event|0
1750355|NCT00868790|6100487|P2|Period 4|Adverse Event|0
1750356|NCT00868790|6100488|P1|Period 4|Adverse Event|0
1750357|NCT00868790|6100475|P14|Period 3|Study Terminated by Sponsor|0
1750358|NCT00868790|6100476|P13|Period 3|Study Terminated by Sponsor|0
1750359|NCT00868790|6100477|P12|Period 3|Study Terminated by Sponsor|0
1750360|NCT00868790|6100478|P11|Period 3|Study Terminated by Sponsor|0
1750361|NCT00868790|6100479|P10|Period 3|Study Terminated by Sponsor|0
1750362|NCT00868790|6100480|P9|Period 3|Study Terminated by Sponsor|0
1750363|NCT00868790|6100481|P8|Period 3|Study Terminated by Sponsor|0
1750364|NCT00868790|6100482|P7|Period 3|Study Terminated by Sponsor|0
1750365|NCT00868790|6100483|P6|Period 3|Study Terminated by Sponsor|0
1750366|NCT00868790|6100484|P5|Period 3|Study Terminated by Sponsor|0
1750367|NCT00868790|6100485|P4|Period 3|Study Terminated by Sponsor|1
1750368|NCT00868790|6100486|P3|Period 3|Study Terminated by Sponsor|0
1750369|NCT00868790|6100487|P2|Period 3|Study Terminated by Sponsor|0
1750370|NCT00868790|6100488|P1|Period 3|Study Terminated by Sponsor|0
1750371|NCT00868790|6100475|P14|Period 3|Protocol Violation|0
1750372|NCT00868790|6100476|P13|Period 3|Protocol Violation|0
1750373|NCT00868790|6100477|P12|Period 3|Protocol Violation|0
1750374|NCT00868790|6100478|P11|Period 3|Protocol Violation|1
1750375|NCT00868790|6100479|P10|Period 3|Protocol Violation|0
1750376|NCT00868790|6100480|P9|Period 3|Protocol Violation|0
1750377|NCT00868790|6100481|P8|Period 3|Protocol Violation|0
1750378|NCT00868790|6100482|P7|Period 3|Protocol Violation|0
1750379|NCT00868790|6100483|P6|Period 3|Protocol Violation|0
1750380|NCT00868790|6100484|P5|Period 3|Protocol Violation|0
1750381|NCT00868790|6100485|P4|Period 3|Protocol Violation|0
1750382|NCT00868790|6100486|P3|Period 3|Protocol Violation|0
1750383|NCT00868790|6100487|P2|Period 3|Protocol Violation|0
1750384|NCT00868790|6100488|P1|Period 3|Protocol Violation|0
1750385|NCT00868790|6100475|P14|Period 3|Adverse Event|0
1750386|NCT00868790|6100476|P13|Period 3|Adverse Event|0
1750387|NCT00868790|6100477|P12|Period 3|Adverse Event|0
1750388|NCT00868790|6100478|P11|Period 3|Adverse Event|0
1750389|NCT00868790|6100479|P10|Period 3|Adverse Event|1
1750390|NCT00868790|6100480|P9|Period 3|Adverse Event|0
1750391|NCT00868790|6100481|P8|Period 3|Adverse Event|0
1750392|NCT00868790|6100482|P7|Period 3|Adverse Event|0
1750393|NCT00868790|6100483|P6|Period 3|Adverse Event|0
1750394|NCT00868790|6100484|P5|Period 3|Adverse Event|0
1750395|NCT00868790|6100485|P4|Period 3|Adverse Event|0
1750396|NCT00868790|6100486|P3|Period 3|Adverse Event|0
1750397|NCT00868790|6100487|P2|Period 3|Adverse Event|0
1750398|NCT00868790|6100488|P1|Period 3|Adverse Event|0
1750399|NCT00868790|6100475|P14|Period 2|Withdrawal by Subject|1
1750400|NCT00868790|6100476|P13|Period 2|Withdrawal by Subject|0
1750401|NCT00868790|6100477|P12|Period 2|Withdrawal by Subject|0
1750402|NCT00868790|6100478|P11|Period 2|Withdrawal by Subject|0
1750403|NCT00868790|6100479|P10|Period 2|Withdrawal by Subject|0
1750404|NCT00868790|6100480|P9|Period 2|Withdrawal by Subject|1
1750405|NCT00868790|6100481|P8|Period 2|Withdrawal by Subject|0
1750406|NCT00868790|6100482|P7|Period 2|Withdrawal by Subject|0
1750407|NCT00868790|6100483|P6|Period 2|Withdrawal by Subject|0
1750408|NCT00868790|6100484|P5|Period 2|Withdrawal by Subject|0
1750409|NCT00868790|6100485|P4|Period 2|Withdrawal by Subject|0
1750410|NCT00868790|6100486|P3|Period 2|Withdrawal by Subject|0
1750411|NCT00868790|6100487|P2|Period 2|Withdrawal by Subject|0
1750412|NCT00868790|6100488|P1|Period 2|Withdrawal by Subject|0
1750413|NCT00868790|6100475|P14|Period 2|Lost to Follow-up|0
1750414|NCT00868790|6100476|P13|Period 2|Lost to Follow-up|0
1750415|NCT00868790|6100477|P12|Period 2|Lost to Follow-up|0
1750416|NCT00868790|6100478|P11|Period 2|Lost to Follow-up|0
1750417|NCT00868790|6100479|P10|Period 2|Lost to Follow-up|0
1750418|NCT00868790|6100480|P9|Period 2|Lost to Follow-up|0
1750419|NCT00868790|6100481|P8|Period 2|Lost to Follow-up|0
1750420|NCT00868790|6100482|P7|Period 2|Lost to Follow-up|0
1750421|NCT00868790|6100483|P6|Period 2|Lost to Follow-up|1
1750422|NCT00868790|6100484|P5|Period 2|Lost to Follow-up|0
1750423|NCT00868790|6100485|P4|Period 2|Lost to Follow-up|0
1750424|NCT00868790|6100486|P3|Period 2|Lost to Follow-up|0
1750425|NCT00868790|6100487|P2|Period 2|Lost to Follow-up|1
1750426|NCT00868790|6100488|P1|Period 2|Lost to Follow-up|0
1750427|NCT00868790|6100475|P14|Period 2|Adverse Event|0
1750428|NCT00868790|6100476|P13|Period 2|Adverse Event|0
1750429|NCT00868790|6100477|P12|Period 2|Adverse Event|0
1750430|NCT00868790|6100478|P11|Period 2|Adverse Event|0
1750431|NCT00868790|6100479|P10|Period 2|Adverse Event|0
1750432|NCT00868790|6100480|P9|Period 2|Adverse Event|1
1750433|NCT00868790|6100481|P8|Period 2|Adverse Event|0
1750434|NCT00868790|6100482|P7|Period 2|Adverse Event|0
1750435|NCT00868790|6100483|P6|Period 2|Adverse Event|0
1750436|NCT00868790|6100484|P5|Period 2|Adverse Event|0
1750437|NCT00868790|6100485|P4|Period 2|Adverse Event|0
1750438|NCT00868790|6100486|P3|Period 2|Adverse Event|0
1750439|NCT00868790|6100487|P2|Period 2|Adverse Event|0
1750440|NCT00868790|6100488|P1|Period 2|Adverse Event|0
1750441|NCT00868790|6100475|P14|Period 1|Lost to Follow-up|0
1750442|NCT00868790|6100476|P13|Period 1|Lost to Follow-up|0
1750443|NCT00868790|6100477|P12|Period 1|Lost to Follow-up|0
1750444|NCT00868790|6100478|P11|Period 1|Lost to Follow-up|0
1750445|NCT00868790|6100479|P10|Period 1|Lost to Follow-up|0
1750446|NCT00868790|6100480|P9|Period 1|Lost to Follow-up|0
1750447|NCT00868790|6100481|P8|Period 1|Lost to Follow-up|0
1750448|NCT00868790|6100482|P7|Period 1|Lost to Follow-up|0
1750449|NCT00868790|6100483|P6|Period 1|Lost to Follow-up|1
1750450|NCT00868790|6100484|P5|Period 1|Lost to Follow-up|0
1750451|NCT00868790|6100485|P4|Period 1|Lost to Follow-up|0
1750452|NCT00868790|6100486|P3|Period 1|Lost to Follow-up|0
1750453|NCT00868790|6100487|P2|Period 1|Lost to Follow-up|0
1750454|NCT00868790|6100488|P1|Period 1|Lost to Follow-up|0
1750455|NCT00868790|6100475|P14|Period 1|Abnormal Triglycerides|0
1750456|NCT00868790|6100476|P13|Period 1|Abnormal Triglycerides|0
1750457|NCT00868790|6100477|P12|Period 1|Abnormal Triglycerides|0
1750458|NCT00868790|6100478|P11|Period 1|Abnormal Triglycerides|0
1750459|NCT00868790|6100479|P10|Period 1|Abnormal Triglycerides|0
1750460|NCT00868790|6100480|P9|Period 1|Abnormal Triglycerides|0
1750461|NCT00868790|6100481|P8|Period 1|Abnormal Triglycerides|0
1750462|NCT00868790|6100482|P7|Period 1|Abnormal Triglycerides|0
1750463|NCT00868790|6100483|P6|Period 1|Abnormal Triglycerides|0
1750464|NCT00868790|6100484|P5|Period 1|Abnormal Triglycerides|1
1750465|NCT00868790|6100485|P4|Period 1|Abnormal Triglycerides|0
1750466|NCT00868790|6100486|P3|Period 1|Abnormal Triglycerides|0
1750467|NCT00868790|6100487|P2|Period 1|Abnormal Triglycerides|0
1750468|NCT00868790|6100488|P1|Period 1|Abnormal Triglycerides|0
1750469|NCT00868790|6100475|P14|Period 1|Withdrawal by Subject|1
1750470|NCT00868790|6100476|P13|Period 1|Withdrawal by Subject|0
1750471|NCT00868790|6100477|P12|Period 1|Withdrawal by Subject|0
1750472|NCT00868790|6100478|P11|Period 1|Withdrawal by Subject|0
1750473|NCT00868790|6100479|P10|Period 1|Withdrawal by Subject|0
1750474|NCT00868790|6100480|P9|Period 1|Withdrawal by Subject|0
1750475|NCT00868790|6100481|P8|Period 1|Withdrawal by Subject|0
1750476|NCT00868790|6100482|P7|Period 1|Withdrawal by Subject|0
1750477|NCT00868790|6100483|P6|Period 1|Withdrawal by Subject|0
1750478|NCT00868790|6100484|P5|Period 1|Withdrawal by Subject|0
1750479|NCT00868790|6100485|P4|Period 1|Withdrawal by Subject|0
1750480|NCT00868790|6100486|P3|Period 1|Withdrawal by Subject|0
1750481|NCT00868790|6100487|P2|Period 1|Withdrawal by Subject|1
1750482|NCT00868790|6100488|P1|Period 1|Withdrawal by Subject|0
1750483|NCT00868790|6100475|P14|Period 1|Protocol Violation|0
1750484|NCT00868790|6100476|P13|Period 1|Protocol Violation|0
1750485|NCT00868790|6100477|P12|Period 1|Protocol Violation|0
1750486|NCT00868790|6100478|P11|Period 1|Protocol Violation|0
1750487|NCT00868790|6100479|P10|Period 1|Protocol Violation|0
1750488|NCT00868790|6100480|P9|Period 1|Protocol Violation|0
1750489|NCT00868790|6100481|P8|Period 1|Protocol Violation|0
1750490|NCT00868790|6100482|P7|Period 1|Protocol Violation|0
1750491|NCT00868790|6100483|P6|Period 1|Protocol Violation|0
1750492|NCT00868790|6100484|P5|Period 1|Protocol Violation|0
1750493|NCT00868790|6100485|P4|Period 1|Protocol Violation|0
1750494|NCT00868790|6100486|P3|Period 1|Protocol Violation|0
1750495|NCT00868790|6100487|P2|Period 1|Protocol Violation|0
1750496|NCT00868790|6100488|P1|Period 1|Protocol Violation|1
1750497|NCT00868790|6100475|P14|Period 1|Adverse Event|1
1750498|NCT00868790|6100476|P13|Period 1|Adverse Event|0
1750499|NCT00868790|6100477|P12|Period 1|Adverse Event|0
1750500|NCT00868790|6100478|P11|Period 1|Adverse Event|0
1750501|NCT00868790|6100479|P10|Period 1|Adverse Event|0
1750502|NCT00868790|6100480|P9|Period 1|Adverse Event|1
1750503|NCT00868790|6100481|P8|Period 1|Adverse Event|3
1750504|NCT00868790|6100482|P7|Period 1|Adverse Event|0
1750505|NCT00868790|6100483|P6|Period 1|Adverse Event|0
1750506|NCT00868790|6100484|P5|Period 1|Adverse Event|0
1750507|NCT00868790|6100485|P4|Period 1|Adverse Event|0
1750508|NCT00868790|6100486|P3|Period 1|Adverse Event|0
1750509|NCT00868790|6100487|P2|Period 1|Adverse Event|0
1750510|NCT00868790|6100488|P1|Period 1|Adverse Event|1
1750511|NCT00868608|6100571|P3|Overall Study|Other - Unspecified|0
1750512|NCT00868608|6100572|P2|Overall Study|Other - Unspecified|0
1750513|NCT00868608|6100573|P1|Overall Study|Other - Unspecified|1
1750514|NCT00868608|6100571|P3|Overall Study|Death|4
1750515|NCT00868608|6100572|P2|Overall Study|Death|2
1750516|NCT00868608|6100573|P1|Overall Study|Death|16
1750517|NCT00868608|6100571|P3|Overall Study|Lost to Follow-up|1
1750518|NCT00868608|6100572|P2|Overall Study|Lost to Follow-up|0
1750519|NCT00868608|6100573|P1|Overall Study|Lost to Follow-up|3
1750520|NCT00868608|6100571|P3|Overall Study|Withdrawal by Subject|0
1750521|NCT00868608|6100572|P2|Overall Study|Withdrawal by Subject|1
1750522|NCT00868608|6100573|P1|Overall Study|Withdrawal by Subject|3
1750523|NCT00868530|6100597|P1|Overall Study|Lost to Follow-up|1
1750524|NCT00868530|6100597|P1|Overall Study|Adverse Event|3
1750525|NCT00868517|6100612|P3|Overall Study|Protocol Violation|0
1750526|NCT00868517|6100613|P2|Overall Study|Protocol Violation|1
1750527|NCT00868517|6100614|P1|Overall Study|Protocol Violation|1
1750528|NCT00868517|6100612|P3|Overall Study|Withdrawal by Subject|2
1750529|NCT00868517|6100613|P2|Overall Study|Withdrawal by Subject|3
1750530|NCT00868517|6100614|P1|Overall Study|Withdrawal by Subject|3
1750531|NCT00868439|6100652|P2|Overall Study|Withdrawal by Subject|1
1750532|NCT00868439|6100653|P1|Overall Study|Withdrawal by Subject|0
1750533|NCT00868439|6100652|P2|Overall Study|Physician Decision|0
1750534|NCT00868439|6100653|P1|Overall Study|Physician Decision|1
1750535|NCT00868439|6100652|P2|Overall Study|Protocol Violation|1
1750536|NCT00868439|6100653|P1|Overall Study|Protocol Violation|1
1750537|NCT00868439|6100652|P2|Overall Study|Death|1
1750538|NCT00868439|6100653|P1|Overall Study|Death|0
1750539|NCT00868439|6100652|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
1750540|NCT00868439|6100653|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
1750541|NCT00868439|6100652|P2|Overall Study|Adverse Event|3
1750542|NCT00868439|6100653|P1|Overall Study|Adverse Event|4
1750543|NCT00868296|6100710|P2|Overall Study|Withdrawal by Subject|1
1750544|NCT00868296|6100711|P1|Overall Study|Withdrawal by Subject|0
1750545|NCT00868296|6100710|P2|Overall Study|Adverse Event|2
1750546|NCT00868296|6100711|P1|Overall Study|Adverse Event|0
1750547|NCT00868231|6100719|P6|Treatment Period 3|Adverse Event|0
1750548|NCT00868231|6100720|P5|Treatment Period 3|Adverse Event|0
1750549|NCT00868231|6100721|P4|Treatment Period 3|Adverse Event|0
1750550|NCT00868231|6100722|P3|Treatment Period 3|Adverse Event|1
1750551|NCT00868231|6100723|P2|Treatment Period 3|Adverse Event|0
1750552|NCT00868231|6100724|P1|Treatment Period 3|Adverse Event|0
1750553|NCT00868231|6100719|P6|Treatment Period 2|Adverse Event|0
1750554|NCT00868231|6100720|P5|Treatment Period 2|Adverse Event|0
1750555|NCT00868231|6100721|P4|Treatment Period 2|Adverse Event|0
1750556|NCT00868231|6100722|P3|Treatment Period 2|Adverse Event|0
1750557|NCT00868231|6100723|P2|Treatment Period 2|Adverse Event|0
1750558|NCT00868231|6100724|P1|Treatment Period 2|Adverse Event|1
1750559|NCT00868231|6100719|P6|Treatment Period 1|Adverse Event|0
1750560|NCT00868231|6100720|P5|Treatment Period 1|Adverse Event|1
1750561|NCT00868231|6100721|P4|Treatment Period 1|Adverse Event|0
1750562|NCT00868231|6100722|P3|Treatment Period 1|Adverse Event|0
1750563|NCT00868231|6100723|P2|Treatment Period 1|Adverse Event|0
1750564|NCT00868231|6100724|P1|Treatment Period 1|Adverse Event|0
1750565|NCT00868192|6100790|P1|Overall Study|Ineligible|4
1750580|NCT00867815|6100870|P1|Overall Study|Lost to Follow-up|1
1750581|NCT00867568|6100881|P1|Overall Study|Withdrawal by Subject|1
1750582|NCT00867568|6100881|P1|Overall Study|Adverse Event|4
1750583|NCT00867568|6100881|P1|Overall Study|Lack of Efficacy|10
1750584|NCT00867503|6100898|P1|Overall Study|Withdrawal by Subject|1
1750585|NCT00867490|6100904|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
1750586|NCT00867490|6100904|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
1750587|NCT00867490|6100904|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
1750588|NCT00867490|6100904|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
1750589|NCT00867490|6100904|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
1750590|NCT00867360|6100946|P2|Overall Study|Physician Decision|1
1750591|NCT00867360|6100947|P1|Overall Study|Physician Decision|0
1750592|NCT00867360|6100946|P2|Overall Study|Withdrawal by Subject|0
1750593|NCT00867360|6100947|P1|Overall Study|Withdrawal by Subject|1
1750594|NCT00867334|6100959|P2|Overall Study|Physician Decision|0
1750595|NCT00867334|6100960|P1|Overall Study|Physician Decision|1
1750596|NCT00867334|6100959|P2|Overall Study|Withdrawal by Subject|0
1750597|NCT00867334|6100960|P1|Overall Study|Withdrawal by Subject|1
1750598|NCT00867334|6100959|P2|Overall Study|Withdrawal by Subject|1
1750599|NCT00867334|6100960|P1|Overall Study|Withdrawal by Subject|0
1750600|NCT00867308|6100996|P2|Overall Study|Withdrawal by Subject|2
1750601|NCT00867308|6100997|P1|Overall Study|Withdrawal by Subject|1
1750602|NCT00867308|6100996|P2|Overall Study|Lack of Efficacy|12
1750603|NCT00867308|6100997|P1|Overall Study|Lack of Efficacy|6
1750604|NCT00867308|6100996|P2|Overall Study|Adverse Event|4
1750605|NCT00867308|6100997|P1|Overall Study|Adverse Event|1
1750606|NCT00867308|6100996|P2|Overall Study|Death|0
1750607|NCT00867308|6100997|P1|Overall Study|Death|1
1750608|NCT00867165|6101016|P2|Overall Study|Withdrawal by Subject|0
1750609|NCT00867165|6101017|P1|Overall Study|Withdrawal by Subject|1
1750610|NCT00867165|6101016|P2|Overall Study|Adverse Event|0
1750611|NCT00867165|6101017|P1|Overall Study|Adverse Event|3
1750612|NCT00867113|6101165|P1|Post Treatment After Survival Follow-up|Administrative problems|4
1750613|NCT00867113|6101165|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
1750614|NCT00867113|6101165|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
1750615|NCT00867113|6101165|P1|Post Treatment After Survival Follow-up|Death|1
1750616|NCT00867113|6101165|P1|Treatment Period|Protocol Violation|4
1750617|NCT00867113|6101165|P1|Treatment Period|Disease progression/relapse|1
1750618|NCT00867113|6101165|P1|Treatment Period|Administrative problems|1
1750619|NCT00867113|6101165|P1|Treatment Period|Lost to Follow-up|3
1750620|NCT00867113|6101165|P1|Treatment Period|Withdrawal by Subject|19
1750621|NCT00867113|6101165|P1|Treatment Period|Death|2
1750622|NCT00867113|6101165|P1|Treatment Period|Adverse Event|15
1750623|NCT00867087|6101229|P1|Overall Study|Death|37
1750624|NCT00867087|6101229|P1|Overall Study|Withdrawal by Subject|4
1750625|NCT00867087|6101229|P1|Overall Study|Other|1
1750626|NCT00867035|6101245|P2|Baseline to 1 Week|Withdrawal by Subject|0
1750627|NCT00867035|6101246|P1|Baseline to 1 Week|Withdrawal by Subject|1
1750628|NCT00867035|6101245|P2|Baseline to 1 Hour|Withdrawal by Subject|1
1750629|NCT00867035|6101246|P1|Baseline to 1 Hour|Withdrawal by Subject|1
1750630|NCT00867009|6101272|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
1750631|NCT00867009|6101272|P1|Induction Period|Progressive Disease (PD)|25
1750632|NCT00867009|6101272|P1|Induction Period|Physician Decision|3
1750633|NCT00867009|6101272|P1|Induction Period|Withdrawal by Subject|8
1750634|NCT00867009|6101272|P1|Induction Period|Protocol Violation|1
1750635|NCT00867009|6101272|P1|Induction Period|Death due to Study Disease|4
1750636|NCT00867009|6101272|P1|Induction Period|Death due to serious adverse event|6
1750637|NCT00867009|6101272|P1|Induction Period|Serious Adverse Event|10
1750638|NCT00867009|6101272|P1|Induction Period|Nonserious Adverse Event|5
1750639|NCT00866918|6101281|P2|Overall Study|Secondary malignancy|0
1750640|NCT00866918|6101282|P1|Overall Study|Secondary malignancy|1
1750641|NCT00866918|6101281|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
1750642|NCT00866918|6101282|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
1750643|NCT00866918|6101281|P2|Overall Study|Ineligible|4
1750644|NCT00866918|6101282|P1|Overall Study|Ineligible|2
1750645|NCT00866918|6101281|P2|Overall Study|Physician Decision|2
1750646|NCT00866918|6101282|P1|Overall Study|Physician Decision|10
1750647|NCT00866918|6101281|P2|Overall Study|Lack of Efficacy|1
1750648|NCT00866918|6101282|P1|Overall Study|Lack of Efficacy|1
1750649|NCT00866918|6101281|P2|Overall Study|Death|5
1750650|NCT00866918|6101282|P1|Overall Study|Death|1
1750651|NCT00866814|6101316|P1|Overall Study|Moved to area without study site|1
1750652|NCT00866814|6101316|P1|Overall Study|Unable to meet follow-up requirements|2
1750653|NCT00866814|6101316|P1|Overall Study|No longer wished to participate|1
1750654|NCT00866814|6101316|P1|Overall Study|Death|1
1750655|NCT00866814|6101316|P1|Overall Study|Physician Decision|1
1750656|NCT00866814|6101316|P1|Overall Study|Adverse Event|2
1750657|NCT00866814|6101316|P1|Overall Study|Lost to Follow-up|12
1750658|NCT00866788|6101329|P4|Overall Study|Physician Decision|1
1750659|NCT00866788|6101330|P3|Overall Study|Physician Decision|1
1750660|NCT00866788|6101331|P2|Overall Study|Physician Decision|0
1750661|NCT00866788|6101332|P1|Overall Study|Physician Decision|0
1750662|NCT00866788|6101329|P4|Overall Study|Disease progression|0
1750663|NCT00866788|6101330|P3|Overall Study|Disease progression|1
1750664|NCT00866788|6101331|P2|Overall Study|Disease progression|1
1750665|NCT00866788|6101332|P1|Overall Study|Disease progression|3
1750666|NCT00866788|6101329|P4|Overall Study|Pregnancy|0
1750667|NCT00866788|6101330|P3|Overall Study|Pregnancy|0
1750668|NCT00866788|6101331|P2|Overall Study|Pregnancy|1
1750669|NCT00866788|6101332|P1|Overall Study|Pregnancy|0
1750670|NCT00866788|6101329|P4|Overall Study|Withdrawal by Subject|1
1750671|NCT00866788|6101330|P3|Overall Study|Withdrawal by Subject|0
1750672|NCT00866788|6101331|P2|Overall Study|Withdrawal by Subject|1
1750673|NCT00866788|6101332|P1|Overall Study|Withdrawal by Subject|2
1750674|NCT00866788|6101329|P4|Overall Study|Lost to Follow-up|2
1750675|NCT00866788|6101330|P3|Overall Study|Lost to Follow-up|0
1750676|NCT00866788|6101331|P2|Overall Study|Lost to Follow-up|1
1750677|NCT00866788|6101332|P1|Overall Study|Lost to Follow-up|1
1750678|NCT00866788|6101329|P4|Overall Study|Adverse Event|1
1750679|NCT00866788|6101330|P3|Overall Study|Adverse Event|0
1750680|NCT00866788|6101331|P2|Overall Study|Adverse Event|2
1750681|NCT00866788|6101332|P1|Overall Study|Adverse Event|0
1750682|NCT00866775|6101380|P2|Overall Study|discontinued due to communication error|1
1750683|NCT00866775|6101381|P1|Overall Study|discontinued due to communication error|0
1750684|NCT00866775|6101380|P2|Overall Study|met exit criteria|17
1750685|NCT00866775|6101381|P1|Overall Study|met exit criteria|23
1750686|NCT00866775|6101380|P2|Overall Study|Withdrawal by Subject|4
1750687|NCT00866775|6101381|P1|Overall Study|Withdrawal by Subject|4
1750688|NCT00866775|6101380|P2|Overall Study|Protocol Violation|4
1750689|NCT00866775|6101381|P1|Overall Study|Protocol Violation|3
1750690|NCT00866775|6101380|P2|Overall Study|Physician Decision|3
1750691|NCT00866775|6101381|P1|Overall Study|Physician Decision|0
1750692|NCT00866775|6101380|P2|Overall Study|Lost to Follow-up|4
1750693|NCT00866775|6101381|P1|Overall Study|Lost to Follow-up|0
1750694|NCT00866775|6101380|P2|Overall Study|Death|0
1750695|NCT00866775|6101381|P1|Overall Study|Death|1
1750696|NCT00866775|6101380|P2|Overall Study|Adverse Event|19
1750697|NCT00866775|6101381|P1|Overall Study|Adverse Event|5
1750698|NCT00866723|6101424|P1|Overall Study|Disease Progression|4
1750699|NCT00866723|6101424|P1|Overall Study|Withdrawal by Subject|1
1750700|NCT00866697|6101431|P2|Overall Study|Withdrawal by Subject|57
1750701|NCT00866697|6101432|P1|Overall Study|Withdrawal by Subject|33
1750702|NCT00866697|6101431|P2|Overall Study|Physician Decision|5
1750703|NCT00866697|6101432|P1|Overall Study|Physician Decision|3
1750704|NCT00866697|6101431|P2|Overall Study|Lost to Follow-up|28
1750705|NCT00866697|6101432|P1|Overall Study|Lost to Follow-up|22
1750706|NCT00866697|6101431|P2|Overall Study|Study closed/terminated|138
1750707|NCT00866697|6101432|P1|Overall Study|Study closed/terminated|156
1750708|NCT00866658|6101474|P2|Overall Study|Familial and Personal Reasons|5
1750709|NCT00866658|6101475|P1|Overall Study|Familial and Personal Reasons|4
1750710|NCT00866658|6101474|P2|Overall Study|Protocol Violation|1
1750711|NCT00866658|6101475|P1|Overall Study|Protocol Violation|1
1750712|NCT00866658|6101474|P2|Overall Study|Withdrawal by Subject|0
1750713|NCT00866658|6101475|P1|Overall Study|Withdrawal by Subject|1
1750714|NCT00866658|6101474|P2|Overall Study|Lack of Efficacy|1
1750715|NCT00866658|6101475|P1|Overall Study|Lack of Efficacy|2
1750716|NCT00866658|6101474|P2|Overall Study|Adverse Event|14
1750717|NCT00866658|6101475|P1|Overall Study|Adverse Event|5
1750718|NCT00866619|6101507|P4|Overall Study|Lost to Follow-up|425
1750719|NCT00866619|6101508|P3|Overall Study|Lost to Follow-up|568
1750720|NCT00866619|6101509|P2|Overall Study|Lost to Follow-up|830
1750721|NCT00866619|6101510|P1|Overall Study|Lost to Follow-up|1145
1750722|NCT00866619|6101507|P4|Overall Study|Withdrawal by Subject|144
1750723|NCT00866619|6101508|P3|Overall Study|Withdrawal by Subject|272
1750724|NCT00866619|6101509|P2|Overall Study|Withdrawal by Subject|295
1750725|NCT00866619|6101510|P1|Overall Study|Withdrawal by Subject|587
1750726|NCT00866619|6101507|P4|Overall Study|Protocol Violation|17
1750727|NCT00866619|6101508|P3|Overall Study|Protocol Violation|2
1750728|NCT00866619|6101509|P2|Overall Study|Protocol Violation|39
1750729|NCT00866619|6101510|P1|Overall Study|Protocol Violation|2
1750730|NCT00866619|6101507|P4|Overall Study|Adverse Event|44
1750731|NCT00866619|6101508|P3|Overall Study|Adverse Event|47
1750732|NCT00866619|6101509|P2|Overall Study|Adverse Event|106
1750733|NCT00866619|6101510|P1|Overall Study|Adverse Event|112
1750734|NCT00866606|6101830|P1|Overall Study|Adverse Event|1
1750735|NCT00866606|6101830|P1|Overall Study|Lost to Follow-up|3
1750736|NCT00866359|6101844|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
1750737|NCT00866359|6101845|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
1750738|NCT00866359|6101846|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
1750739|NCT00866359|6101847|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
1750740|NCT00866359|6101844|P4|Treatment Phase (Days 1 to 85)|Other|0
1750741|NCT00866359|6101845|P3|Treatment Phase (Days 1 to 85)|Other|0
1750742|NCT00866359|6101846|P2|Treatment Phase (Days 1 to 85)|Other|0
1750743|NCT00866359|6101847|P1|Treatment Phase (Days 1 to 85)|Other|1
1750744|NCT00866359|6101844|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
1750745|NCT00866359|6101845|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
1750746|NCT00866359|6101846|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
1750747|NCT00866359|6101847|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
1750748|NCT00866359|6101844|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1750749|NCT00866359|6101845|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1750750|NCT00866359|6101846|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
1750751|NCT00866359|6101847|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
1750752|NCT00866359|6101844|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1750753|NCT00866359|6101845|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1750754|NCT00866359|6101846|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
1750755|NCT00866359|6101847|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
1750756|NCT00866359|6101844|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
1750757|NCT00866359|6101845|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
1750758|NCT00866359|6101846|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
1750759|NCT00866359|6101847|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
1750760|NCT00866333|6101903|P3|Overall Study|Study Terminated by Sponsor|9
1750761|NCT00866333|6101904|P2|Overall Study|Study Terminated by Sponsor|5
1750762|NCT00866333|6101905|P1|Overall Study|Study Terminated by Sponsor|2
1750763|NCT00866333|6101903|P3|Overall Study|Reason not Specified|1
1750764|NCT00866333|6101904|P2|Overall Study|Reason not Specified|1
1750765|NCT00866333|6101905|P1|Overall Study|Reason not Specified|3
1750766|NCT00866333|6101903|P3|Overall Study|Withdrawal of consent|2
1750767|NCT00866333|6101904|P2|Overall Study|Withdrawal of consent|1
1750768|NCT00866333|6101905|P1|Overall Study|Withdrawal of consent|0
1750769|NCT00866320|6101922|P1|Overall Study|Death|2
1750770|NCT00866320|6101922|P1|Overall Study|Withdrawal by Subject|4
1750771|NCT00866307|6101929|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
1750772|NCT00866307|6101930|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
1750773|NCT00866307|6101931|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
1750774|NCT00866307|6101929|P3|Consolidation/Maintenance|Non-compliance|1
1750775|NCT00866307|6101930|P2|Consolidation/Maintenance|Non-compliance|0
1750776|NCT00866307|6101931|P1|Consolidation/Maintenance|Non-compliance|0
1750777|NCT00866307|6101929|P3|Consolidation/Maintenance|Therapy error|0
1750778|NCT00866307|6101930|P2|Consolidation/Maintenance|Therapy error|1
1750779|NCT00866307|6101931|P1|Consolidation/Maintenance|Therapy error|0
1750780|NCT00866307|6101929|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
1750781|NCT00866307|6101930|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
1750782|NCT00866307|6101931|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
1750783|NCT00866307|6101929|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
1750784|NCT00866307|6101930|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
1750785|NCT00866307|6101931|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
1750786|NCT00866307|6101929|P3|Consolidation/Maintenance|Withdrawal by Subject|1
1750787|NCT00866307|6101930|P2|Consolidation/Maintenance|Withdrawal by Subject|1
1750788|NCT00866307|6101931|P1|Consolidation/Maintenance|Withdrawal by Subject|0
1750789|NCT00866307|6101929|P3|Consolidation/Maintenance|Physician Decision|2
1750790|NCT00866307|6101930|P2|Consolidation/Maintenance|Physician Decision|3
1750791|NCT00866307|6101931|P1|Consolidation/Maintenance|Physician Decision|0
1750792|NCT00866307|6101929|P3|Consolidation/Maintenance|Death|1
1750793|NCT00866307|6101930|P2|Consolidation/Maintenance|Death|0
1750794|NCT00866307|6101931|P1|Consolidation/Maintenance|Death|0
1750795|NCT00866307|6101929|P3|Consolidation/Maintenance|Adverse Event|8
1750796|NCT00866307|6101930|P2|Consolidation/Maintenance|Adverse Event|0
1750797|NCT00866307|6101931|P1|Consolidation/Maintenance|Adverse Event|0
1750798|NCT00866307|6101929|P3|Induction|Study was closed at the time|0
1750799|NCT00866307|6101930|P2|Induction|Study was closed at the time|0
1750800|NCT00866307|6101931|P1|Induction|Study was closed at the time|1
1750801|NCT00866307|6101929|P3|Induction|Improper post-induction consent|0
1750802|NCT00866307|6101930|P2|Induction|Improper post-induction consent|0
1750803|NCT00866307|6101931|P1|Induction|Improper post-induction consent|2
1750804|NCT00866307|6101929|P3|Induction|Inadequate cytognetic samples th|0
1750805|NCT00866307|6101930|P2|Induction|Inadequate cytognetic samples th|0
1750806|NCT00866307|6101931|P1|Induction|Inadequate cytognetic samples th|1
1750807|NCT00866307|6101929|P3|Induction|Identification of Patients with Day 29 M|0
1750808|NCT00866307|6101930|P2|Induction|Identification of Patients with Day 29 M|0
1750809|NCT00866307|6101931|P1|Induction|Identification of Patients with Day 29 M|3
1750810|NCT00866307|6101929|P3|Induction|Progressive Disease|0
1750811|NCT00866307|6101930|P2|Induction|Progressive Disease|0
1750812|NCT00866307|6101931|P1|Induction|Progressive Disease|1
1750813|NCT00866307|6101929|P3|Induction|Physician Decision|0
1750814|NCT00866307|6101930|P2|Induction|Physician Decision|0
1750815|NCT00866307|6101931|P1|Induction|Physician Decision|5
1750816|NCT00866307|6101929|P3|Induction|Death|0
1750817|NCT00866307|6101930|P2|Induction|Death|0
1750818|NCT00866307|6101931|P1|Induction|Death|2
1750819|NCT00866307|6101929|P3|Induction|Adverse Event|0
1750820|NCT00866307|6101930|P2|Induction|Adverse Event|0
1750821|NCT00866307|6101931|P1|Induction|Adverse Event|5
1750822|NCT00866294|6101941|P3|Overall Study|Physician Decision|1
1750823|NCT00866294|6101942|P2|Overall Study|Physician Decision|2
1750824|NCT00866294|6101943|P1|Overall Study|Physician Decision|6
1750825|NCT00866294|6101941|P3|Overall Study|Lost to Follow-up|0
1750826|NCT00866294|6101942|P2|Overall Study|Lost to Follow-up|3
1750827|NCT00866294|6101943|P1|Overall Study|Lost to Follow-up|1
1750828|NCT00866294|6101941|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
1750829|NCT00866294|6101942|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1750830|NCT00866294|6101943|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
1750831|NCT00866294|6101941|P3|Overall Study|Protocol Violation|0
1750832|NCT00866294|6101942|P2|Overall Study|Protocol Violation|0
1750833|NCT00866294|6101943|P1|Overall Study|Protocol Violation|2
1750834|NCT00866294|6101941|P3|Overall Study|Lack of Efficacy|0
1750835|NCT00866294|6101942|P2|Overall Study|Lack of Efficacy|1
1750836|NCT00866294|6101943|P1|Overall Study|Lack of Efficacy|7
1750837|NCT00866294|6101941|P3|Overall Study|Adverse Event|9
1750838|NCT00866294|6101942|P2|Overall Study|Adverse Event|13
1750839|NCT00866294|6101943|P1|Overall Study|Adverse Event|12
1750840|NCT00866281|6101972|P2|Overall Study|New cancer therapy|4
1750841|NCT00866281|6101973|P1|Overall Study|New cancer therapy|0
1750842|NCT00866281|6101972|P2|Overall Study|Disease progression|11
1750843|NCT00866281|6101973|P1|Overall Study|Disease progression|3
1750844|NCT00866281|6101972|P2|Overall Study|Withdrawal by participants|0
1750845|NCT00866281|6101973|P1|Overall Study|Withdrawal by participants|3
1750846|NCT00866281|6101972|P2|Overall Study|Adverse Event|0
1750847|NCT00866281|6101973|P1|Overall Study|Adverse Event|1
1750848|NCT00866177|6101989|P1|Overall Study|Not Treated|151
1750849|NCT00866177|6101989|P1|Overall Study|Withdrawal by Subject|1
1750850|NCT00866047|6101993|P1|Follow-up Period|Lost to Follow-up|5
1750851|NCT00866047|6101993|P1|Treatment Period|Withdrawal by Subject|5
1750852|NCT00866047|6101993|P1|Treatment Period|Physician Decision|14
1750853|NCT00866047|6101993|P1|Treatment Period|Adverse Event|16
1750854|NCT00866047|6101993|P1|Treatment Period|Progressive disease|13
1750855|NCT00865904|6102025|P5|Overall Study|Randomized but not Treated|1
1750856|NCT00865904|6102026|P4|Overall Study|Randomized but not Treated|1
1750857|NCT00865904|6102027|P3|Overall Study|Randomized but not Treated|0
1750858|NCT00865904|6102028|P2|Overall Study|Randomized but not Treated|0
1750859|NCT00865904|6102029|P1|Overall Study|Randomized but not Treated|2
1750860|NCT00865709|6102086|P2|Treatment|Surgery|3
1750861|NCT00865709|6102087|P1|Treatment|Surgery|8
1750862|NCT00865709|6102086|P2|Treatment|Physician Decision|2
1750863|NCT00865709|6102087|P1|Treatment|Physician Decision|3
1750864|NCT00865709|6102086|P2|Treatment|Withdrawal by Subject|7
1750865|NCT00865709|6102087|P1|Treatment|Withdrawal by Subject|10
1750866|NCT00865709|6102086|P2|Treatment|Adverse Event|6
1750867|NCT00865709|6102087|P1|Treatment|Adverse Event|9
1750868|NCT00865566|6102105|P2|Overall Study|HIV infection|7
1750869|NCT00865566|6102106|P1|Overall Study|HIV infection|5
1750870|NCT00865566|6102105|P2|Overall Study|Other; N=245 due to early study closure|139
1750871|NCT00865566|6102106|P1|Overall Study|Other; N=245 due to early study closure|154
1750872|NCT00865566|6102105|P2|Overall Study|Participant unable to adhere|42
1750873|NCT00865566|6102106|P1|Overall Study|Participant unable to adhere|27
1750874|NCT00865566|6102105|P2|Overall Study|Participant relocated|107
1750875|NCT00865566|6102106|P1|Overall Study|Participant relocated|78
1750876|NCT00865566|6102105|P2|Overall Study|Physician Decision|1
1750877|NCT00865566|6102106|P1|Overall Study|Physician Decision|0
1750878|NCT00865566|6102105|P2|Overall Study|Withdrawal by Subject|65
1750879|NCT00865566|6102106|P1|Overall Study|Withdrawal by Subject|45
1750880|NCT00865566|6102105|P2|Overall Study|Lost to Follow-up|315
1750881|NCT00865566|6102106|P1|Overall Study|Lost to Follow-up|314
1750882|NCT00865566|6102105|P2|Overall Study|Death|11
1750883|NCT00865566|6102106|P1|Overall Study|Death|1
1750884|NCT00865514|6102126|P1|Overall Study|Infusion cost exceeded funding|2
1750885|NCT00865345|6102131|P1|Overall Study|Withdrawal by Subject|2
1750886|NCT00865306|6102138|P2|Controlled Trial|Withdrawal by Subject|1
1750887|NCT00865306|6102139|P1|Controlled Trial|Withdrawal by Subject|0
1750888|NCT00865306|6102138|P2|Controlled Trial|Sought treatment for conduct disorder|0
1750889|NCT00865306|6102139|P1|Controlled Trial|Sought treatment for conduct disorder|1
1750890|NCT00865306|6102138|P2|Controlled Trial|Improved btw baseline and first session|0
1750891|NCT00865306|6102139|P1|Controlled Trial|Improved btw baseline and first session|1
1750892|NCT00865306|6102138|P2|Controlled Trial|Difficulty commuting|0
1750893|NCT00865306|6102139|P1|Controlled Trial|Difficulty commuting|2
1750894|NCT00865306|6102138|P2|Controlled Trial|Lost to Follow-up|1
1750895|NCT00865306|6102139|P1|Controlled Trial|Lost to Follow-up|1
1750896|NCT00865189|6102168|P2|Overall Study|Withdrawal by Subject|0
1750897|NCT00865189|6102169|P1|Overall Study|Withdrawal by Subject|1
1750898|NCT00865189|6102168|P2|Overall Study|Lost to Follow-up|6
1750899|NCT00865189|6102169|P1|Overall Study|Lost to Follow-up|6
1750900|NCT00865189|6102168|P2|Overall Study|Death|11
1750901|NCT00865189|6102169|P1|Overall Study|Death|4
1750902|NCT00865189|6102168|P2|Overall Study|Other|2
1750903|NCT00865189|6102169|P1|Overall Study|Other|1
1750904|NCT00865124|6102197|P3|Overall Study|Withdrawn consent|0
1750905|NCT00865124|6102198|P2|Overall Study|Withdrawn consent|0
1750906|NCT00865124|6102199|P1|Overall Study|Withdrawn consent|2
1750907|NCT00865124|6102197|P3|Overall Study|Physician Decision|0
1750908|NCT00865124|6102198|P2|Overall Study|Physician Decision|1
1750909|NCT00865124|6102199|P1|Overall Study|Physician Decision|2
1750910|NCT00865098|6102216|P1|Overall Study|Progressive disease|1
1750911|NCT00865046|6102228|P3|Overall Study|Withdrawal by Subject|0
1750912|NCT00865046|6102229|P2|Overall Study|Withdrawal by Subject|0
1750913|NCT00865046|6102230|P1|Overall Study|Withdrawal by Subject|5
1750914|NCT00865046|6102228|P3|Overall Study|Death|1
1750915|NCT00865046|6102229|P2|Overall Study|Death|1
1750916|NCT00865046|6102230|P1|Overall Study|Death|0
1750917|NCT00865046|6102228|P3|Overall Study|Lost to Follow-up|0
1750918|NCT00865046|6102229|P2|Overall Study|Lost to Follow-up|4
1750919|NCT00865046|6102230|P1|Overall Study|Lost to Follow-up|1
1750920|NCT00865020|6102240|P2|Overall Study|Randomized but discontinued|4
1750921|NCT00865020|6102241|P1|Overall Study|Randomized but discontinued|2
1750922|NCT00865020|6102240|P2|Overall Study|Death|1
1750923|NCT00865020|6102241|P1|Overall Study|Death|0
1750924|NCT00865020|6102240|P2|Overall Study|Abnormal laboratory value(s)|1
1750925|NCT00865020|6102241|P1|Overall Study|Abnormal laboratory value(s)|0
1750926|NCT00865020|6102240|P2|Overall Study|Administrative problems|2
1750927|NCT00865020|6102241|P1|Overall Study|Administrative problems|0
1750928|NCT00865020|6102240|P2|Overall Study|Protocol deviation|1
1750929|NCT00865020|6102241|P1|Overall Study|Protocol deviation|4
1750930|NCT00865020|6102240|P2|Overall Study|Lost to Follow-up|4
1750931|NCT00865020|6102241|P1|Overall Study|Lost to Follow-up|6
1750932|NCT00865020|6102240|P2|Overall Study|Abnormal test procedure result(s)|8
1750933|NCT00865020|6102241|P1|Overall Study|Abnormal test procedure result(s)|6
1750934|NCT00865020|6102240|P2|Overall Study|Adverse Event|14
1750935|NCT00865020|6102241|P1|Overall Study|Adverse Event|9
1750936|NCT00865020|6102240|P2|Overall Study|Withdrawal by Subject|16
1750937|NCT00865020|6102241|P1|Overall Study|Withdrawal by Subject|22
1750938|NCT00864916|6102257|P2|Overall Study|Withdrawal by Subject|0
1750939|NCT00864916|6102258|P1|Overall Study|Withdrawal by Subject|1
1750940|NCT00864916|6102257|P2|Overall Study|Protocol Violation|0
1750941|NCT00864916|6102258|P1|Overall Study|Protocol Violation|1
1750942|NCT00864916|6102257|P2|Overall Study|Lost to Follow-up|4
1750943|NCT00864916|6102258|P1|Overall Study|Lost to Follow-up|4
1750944|NCT00864851|6102267|P3|Overall Study|Patient uncooperative|0
1750945|NCT00864851|6102268|P2|Overall Study|Patient uncooperative|0
1750946|NCT00864851|6102269|P1|Overall Study|Patient uncooperative|1
1750947|NCT00864851|6102267|P3|Overall Study|Death|0
1750948|NCT00864851|6102268|P2|Overall Study|Death|0
1750949|NCT00864851|6102269|P1|Overall Study|Death|1
1750950|NCT00864851|6102267|P3|Overall Study|Physician Decision|0
1750951|NCT00864851|6102268|P2|Overall Study|Physician Decision|0
1750952|NCT00864851|6102269|P1|Overall Study|Physician Decision|1
1750953|NCT00864851|6102267|P3|Overall Study|Withdrawal by Subject|0
1750954|NCT00864851|6102268|P2|Overall Study|Withdrawal by Subject|1
1750955|NCT00864851|6102269|P1|Overall Study|Withdrawal by Subject|0
1750956|NCT00864721|6102303|P1|Overall Study|Adverse Event|21
1750957|NCT00864721|6102303|P1|Overall Study|Drug hold/delay more than 4 weeks|1
1750958|NCT00864721|6102303|P1|Overall Study|Hospitalized|1
1750959|NCT00864721|6102303|P1|Overall Study|Patient request|11
1750960|NCT00864682|6102323|P3|Overall Study|Protocol Violation|2
1750961|NCT00864682|6102324|P2|Overall Study|Protocol Violation|1
1750962|NCT00864682|6102325|P1|Overall Study|Protocol Violation|2
1750963|NCT00864513|6102364|P1|Overall Study|Withdrawal by Subject|3
1750964|NCT00864253|6102448|P2|Overall Study|Untreated|7
1750965|NCT00864253|6102449|P1|Overall Study|Untreated|7
1750966|NCT00864253|6102448|P2|Overall Study|Ongoing|3
1750967|NCT00864253|6102449|P1|Overall Study|Ongoing|2
1750968|NCT00864253|6102448|P2|Overall Study|Death|0
1750969|NCT00864253|6102449|P1|Overall Study|Death|1
1750970|NCT00864253|6102448|P2|Overall Study|Withdrawal by Subject|18
1750971|NCT00864253|6102449|P1|Overall Study|Withdrawal by Subject|18
1750972|NCT00864253|6102448|P2|Overall Study|Lost to Follow-up|1
1750973|NCT00864253|6102449|P1|Overall Study|Lost to Follow-up|1
1750974|NCT00864253|6102448|P2|Overall Study|Protocol Violation|2
1750975|NCT00864253|6102449|P1|Overall Study|Protocol Violation|0
1750976|NCT00864253|6102448|P2|Overall Study|Physician Decision|15
1750977|NCT00864253|6102449|P1|Overall Study|Physician Decision|11
1750978|NCT00864253|6102448|P2|Overall Study|Unrelated Adverse Event|1
1750979|NCT00864253|6102449|P1|Overall Study|Unrelated Adverse Event|3
1750980|NCT00864253|6102448|P2|Overall Study|Adverse Event|11
1750981|NCT00864253|6102449|P1|Overall Study|Adverse Event|56
1750982|NCT00864227|6102479|P1|Overall Study|Disease Relapse/Progression|3
1750983|NCT00864227|6102479|P1|Overall Study|Withdrawal by Subject|1
1750984|NCT00863928|6102540|P2|Overall Study|medication allergy|0
1750985|NCT00863928|6102541|P1|Overall Study|medication allergy|3
1750986|NCT00863928|6102540|P2|Overall Study|surgery cancellation|0
1750987|NCT00863928|6102541|P1|Overall Study|surgery cancellation|4
1750988|NCT00863928|6102540|P2|Overall Study|Withdrawal by Subject|0
1750989|NCT00863928|6102541|P1|Overall Study|Withdrawal by Subject|3
1750990|NCT00863928|6102540|P2|Overall Study|Protocol Violation|0
1750991|NCT00863928|6102541|P1|Overall Study|Protocol Violation|26
1750992|NCT00863798|6102550|P3|Overall Study|Randomized not treated|3
1750993|NCT00863798|6102551|P2|Overall Study|Randomized not treated|2
1750994|NCT00863798|6102552|P1|Overall Study|Randomized not treated|4
1750995|NCT00863798|6102550|P3|Overall Study|Withdrawal by Subject|4
1750996|NCT00863798|6102551|P2|Overall Study|Withdrawal by Subject|7
1750997|NCT00863798|6102552|P1|Overall Study|Withdrawal by Subject|8
1750998|NCT00863798|6102550|P3|Overall Study|Protocol Violation|1
1750999|NCT00863798|6102551|P2|Overall Study|Protocol Violation|1
1751000|NCT00863798|6102552|P1|Overall Study|Protocol Violation|0
1751001|NCT00863798|6102550|P3|Overall Study|Other|1
1751002|NCT00863798|6102551|P2|Overall Study|Other|3
1751003|NCT00863798|6102552|P1|Overall Study|Other|2
1751004|NCT00863798|6102550|P3|Overall Study|Lost to Follow-up|5
1751005|NCT00863798|6102551|P2|Overall Study|Lost to Follow-up|9
1751006|NCT00863798|6102552|P1|Overall Study|Lost to Follow-up|6
1751007|NCT00863798|6102550|P3|Overall Study|Lack of Efficacy|6
1751008|NCT00863798|6102551|P2|Overall Study|Lack of Efficacy|3
1751009|NCT00863798|6102552|P1|Overall Study|Lack of Efficacy|4
1751010|NCT00863798|6102550|P3|Overall Study|Investigator request|1
1751011|NCT00863798|6102551|P2|Overall Study|Investigator request|2
1751012|NCT00863798|6102552|P1|Overall Study|Investigator request|1
1751013|NCT00863798|6102550|P3|Overall Study|Participant failed to return|0
1751014|NCT00863798|6102551|P2|Overall Study|Participant failed to return|1
1751015|NCT00863798|6102552|P1|Overall Study|Participant failed to return|2
1751016|NCT00863798|6102550|P3|Overall Study|Adverse Event|4
1751017|NCT00863798|6102551|P2|Overall Study|Adverse Event|2
1751018|NCT00863798|6102552|P1|Overall Study|Adverse Event|5
1751019|NCT00863746|6102604|P2|Survival Follow up|Consent Withdrawn|8
1751020|NCT00863746|6102605|P1|Survival Follow up|Consent Withdrawn|7
1751021|NCT00863746|6102604|P2|Survival Follow up|Lost to Follow-up|1
1751022|NCT00863746|6102605|P1|Survival Follow up|Lost to Follow-up|2
1751023|NCT00863746|6102604|P2|Survival Follow up|Death|271
1751024|NCT00863746|6102605|P1|Survival Follow up|Death|244
1751025|NCT00863746|6102604|P2|Treatment|Other|0
1751026|NCT00863746|6102605|P1|Treatment|Other|1
1751027|NCT00863746|6102604|P2|Treatment|Protocol Violation|3
1751028|NCT00863746|6102605|P1|Treatment|Protocol Violation|5
1751029|NCT00863746|6102604|P2|Treatment|Lost to Follow-up|0
1751030|NCT00863746|6102605|P1|Treatment|Lost to Follow-up|1
1751031|NCT00863746|6102604|P2|Treatment|Consent withdrawn|14
1751032|NCT00863746|6102605|P1|Treatment|Consent withdrawn|15
1751033|NCT00863746|6102604|P2|Treatment|non-compliant with study medication|0
1751034|NCT00863746|6102605|P1|Treatment|non-compliant with study medication|4
1751035|NCT00863746|6102604|P2|Treatment|Adverse Event|16
1751036|NCT00863746|6102605|P1|Treatment|Adverse Event|41
1751037|NCT00863746|6102604|P2|Treatment|Not treated|2
1751038|NCT00863746|6102605|P1|Treatment|Not treated|4
1751039|NCT00863707|6102631|P2|Overall Study|Randomized, but drug not received|3
1751040|NCT00863707|6102632|P1|Overall Study|Randomized, but drug not received|4
1751041|NCT00863655|6102640|P2|Overall Study|Treatment completed as per protocol|1
1751042|NCT00863655|6102641|P1|Overall Study|Treatment completed as per protocol|5
1751043|NCT00863655|6102640|P2|Overall Study|Disease progression|221
1751044|NCT00863655|6102641|P1|Overall Study|Disease progression|364
1751045|NCT00863655|6102640|P2|Overall Study|New cancer therapy|1
1751046|NCT00863655|6102641|P1|Overall Study|New cancer therapy|5
1751047|NCT00863655|6102640|P2|Overall Study|Death|1
1751048|NCT00863655|6102641|P1|Overall Study|Death|7
1751049|NCT00863655|6102640|P2|Overall Study|Administrative problems|0
1751050|NCT00863655|6102641|P1|Overall Study|Administrative problems|1
1751051|NCT00863655|6102640|P2|Overall Study|Withdrawal by Subject|7
1751052|NCT00863655|6102641|P1|Overall Study|Withdrawal by Subject|47
1751053|NCT00863655|6102640|P2|Overall Study|Adverse Event|8
1751054|NCT00863655|6102641|P1|Overall Study|Adverse Event|52
1751055|NCT00863655|6102640|P2|Overall Study|Protocol Violation|0
1751056|NCT00863655|6102641|P1|Overall Study|Protocol Violation|4
1751057|NCT00863512|6102678|P2|Overall Study|Physician Decision|0
1751058|NCT00863512|6102679|P1|Overall Study|Physician Decision|1
1751059|NCT00863512|6102678|P2|Overall Study|Withdrawal by Subject|0
1751060|NCT00863512|6102679|P1|Overall Study|Withdrawal by Subject|11
1751061|NCT00863512|6102678|P2|Overall Study|Adverse Event|0
1751062|NCT00863512|6102679|P1|Overall Study|Adverse Event|2
1751063|NCT00863330|6102710|P1|Overall Study|study terminated early due to administra|6
1751064|NCT00863317|6102716|P2|Overall Study|Lost to Follow-up|9
1751065|NCT00863317|6102717|P1|Overall Study|Lost to Follow-up|8
1751066|NCT00863057|6102773|P4|Period 2 (Weeks 6-10)|Physician Decision|1
1751067|NCT00863057|6102774|P3|Period 2 (Weeks 6-10)|Physician Decision|0
1751068|NCT00863057|6102775|P2|Period 2 (Weeks 6-10)|Physician Decision|0
1751069|NCT00863057|6102776|P1|Period 2 (Weeks 6-10)|Physician Decision|0
1751070|NCT00863057|6102773|P4|Period 2 (Weeks 6-10)|Adverse Event|0
1751071|NCT00863057|6102774|P3|Period 2 (Weeks 6-10)|Adverse Event|1
1751072|NCT00863057|6102775|P2|Period 2 (Weeks 6-10)|Adverse Event|1
1751073|NCT00863057|6102776|P1|Period 2 (Weeks 6-10)|Adverse Event|0
1751074|NCT00863057|6102773|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1751075|NCT00863057|6102774|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1751076|NCT00863057|6102775|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
1751077|NCT00863057|6102776|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
1751078|NCT00863057|6102773|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1751079|NCT00863057|6102774|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
1751080|NCT00863057|6102775|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1751081|NCT00863057|6102776|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
1751082|NCT00862979|6102834|P2|Overall Study|Death|1
1751083|NCT00862979|6102835|P1|Overall Study|Death|0
1751084|NCT00862979|6102834|P2|Overall Study|Administrative problems|1
1751085|NCT00862979|6102835|P1|Overall Study|Administrative problems|0
1751086|NCT00862979|6102834|P2|Overall Study|Patient withdrew consent|1
1751087|NCT00862979|6102835|P1|Overall Study|Patient withdrew consent|2
1751088|NCT00862979|6102834|P2|Overall Study|Protocol Violation|1
1751089|NCT00862979|6102835|P1|Overall Study|Protocol Violation|0
1751090|NCT00862979|6102834|P2|Overall Study|Adverse Event|3
1751091|NCT00862979|6102835|P1|Overall Study|Adverse Event|6
1751092|NCT00862940|6102853|P2|Overall Study|Administrative or other reason(s)|3
1751093|NCT00862940|6102854|P1|Overall Study|Administrative or other reason(s)|4
1751094|NCT00862940|6102853|P2|Overall Study|Lost to Follow-up|1
1751095|NCT00862940|6102854|P1|Overall Study|Lost to Follow-up|0
1751096|NCT00862940|6102853|P2|Overall Study|Non-compliance|0
1751097|NCT00862940|6102854|P1|Overall Study|Non-compliance|4
1751098|NCT00862940|6102853|P2|Overall Study|Withdrawal by Subject|6
1751099|NCT00862940|6102854|P1|Overall Study|Withdrawal by Subject|4
1751100|NCT00862940|6102853|P2|Overall Study|Protocol Violation|5
1751101|NCT00862940|6102854|P1|Overall Study|Protocol Violation|2
1751102|NCT00862940|6102853|P2|Overall Study|Lack of Efficacy|3
1751103|NCT00862940|6102854|P1|Overall Study|Lack of Efficacy|1
1751104|NCT00862940|6102853|P2|Overall Study|Adverse Event|12
1751105|NCT00862940|6102854|P1|Overall Study|Adverse Event|15
1751106|NCT00862849|6102866|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
1751107|NCT00862849|6102867|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
1751108|NCT00862849|6102868|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
1751109|NCT00862849|6102869|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
1751110|NCT00862849|6102870|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
1751111|NCT00862849|6102871|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
1751112|NCT00862849|6102866|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1751113|NCT00862849|6102867|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1751114|NCT00862849|6102868|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1751115|NCT00862849|6102869|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1751116|NCT00862849|6102870|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
1751117|NCT00862849|6102871|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
1751118|NCT00862836|6102894|P1|Overall Study|Withdrawal by Subject|1
1751119|NCT00862823|6102905|P2|First Intervention|Withdrawal by Subject|1
1751120|NCT00862823|6102906|P1|First Intervention|Withdrawal by Subject|1
1751121|NCT00862719|6102955|P4|Overall Study|Veno-Occlusive Disease|0
1751122|NCT00862719|6102956|P3|Overall Study|Veno-Occlusive Disease|1
1751123|NCT00862719|6102957|P2|Overall Study|Veno-Occlusive Disease|0
1751124|NCT00862719|6102958|P1|Overall Study|Veno-Occlusive Disease|0
1751125|NCT00862719|6102955|P4|Overall Study|Engraftment failure|0
1751126|NCT00862719|6102956|P3|Overall Study|Engraftment failure|1
1751127|NCT00862719|6102957|P2|Overall Study|Engraftment failure|0
1751128|NCT00862719|6102958|P1|Overall Study|Engraftment failure|0
1751129|NCT00862719|6102955|P4|Overall Study|Death|1
1751130|NCT00862719|6102956|P3|Overall Study|Death|1
1751131|NCT00862719|6102957|P2|Overall Study|Death|6
1751132|NCT00862719|6102958|P1|Overall Study|Death|5
1751133|NCT00862719|6102955|P4|Overall Study|Disease Progression|0
1751134|NCT00862719|6102956|P3|Overall Study|Disease Progression|1
1751135|NCT00862719|6102957|P2|Overall Study|Disease Progression|0
1751136|NCT00862719|6102958|P1|Overall Study|Disease Progression|5
1751137|NCT00862654|6102981|P4|Overall Study|Included after end of inclusions|0
1751138|NCT00862654|6102982|P3|Overall Study|Included after end of inclusions|1
1751139|NCT00862654|6102983|P2|Overall Study|Included after end of inclusions|0
1751140|NCT00862654|6102984|P1|Overall Study|Included after end of inclusions|0
1751141|NCT00862654|6102981|P4|Overall Study|Never used study drugs|0
1751142|NCT00862654|6102982|P3|Overall Study|Never used study drugs|0
1751143|NCT00862654|6102983|P2|Overall Study|Never used study drugs|0
1751144|NCT00862654|6102984|P1|Overall Study|Never used study drugs|1
1751145|NCT00862654|6102981|P4|Overall Study|Familly constraint|0
1751146|NCT00862654|6102982|P3|Overall Study|Familly constraint|0
1751147|NCT00862654|6102983|P2|Overall Study|Familly constraint|1
1751148|NCT00862654|6102984|P1|Overall Study|Familly constraint|0
1751149|NCT00862654|6102981|P4|Overall Study|Subject mistake|0
1751150|NCT00862654|6102982|P3|Overall Study|Subject mistake|0
1751151|NCT00862654|6102983|P2|Overall Study|Subject mistake|1
1751152|NCT00862654|6102984|P1|Overall Study|Subject mistake|0
1751153|NCT00862654|6102981|P4|Overall Study|Withdrawal by Subject|3
1751154|NCT00862654|6102982|P3|Overall Study|Withdrawal by Subject|2
1751155|NCT00862654|6102983|P2|Overall Study|Withdrawal by Subject|2
1751156|NCT00862654|6102984|P1|Overall Study|Withdrawal by Subject|2
1751157|NCT00862654|6102981|P4|Overall Study|Pregnancy|0
1751158|NCT00862654|6102982|P3|Overall Study|Pregnancy|0
1751159|NCT00862654|6102983|P2|Overall Study|Pregnancy|1
1751160|NCT00862654|6102984|P1|Overall Study|Pregnancy|1
1751161|NCT00862654|6102981|P4|Overall Study|Adverse Event|0
1751162|NCT00862654|6102982|P3|Overall Study|Adverse Event|1
1751163|NCT00862654|6102983|P2|Overall Study|Adverse Event|1
1751164|NCT00862654|6102984|P1|Overall Study|Adverse Event|0
1751165|NCT00862654|6102981|P4|Overall Study|Lost to Follow-up|3
1751166|NCT00862654|6102982|P3|Overall Study|Lost to Follow-up|1
1751167|NCT00862654|6102983|P2|Overall Study|Lost to Follow-up|2
1751168|NCT00862654|6102984|P1|Overall Study|Lost to Follow-up|1
1751169|NCT00862654|6102981|P4|Overall Study|Lack of Efficacy|0
1751170|NCT00862654|6102982|P3|Overall Study|Lack of Efficacy|1
1751171|NCT00862654|6102983|P2|Overall Study|Lack of Efficacy|0
1751172|NCT00862654|6102984|P1|Overall Study|Lack of Efficacy|1
1751173|NCT00862641|6102998|P4|Overall Study|Randomized, but drug not received|4
1751174|NCT00862641|6102999|P3|Overall Study|Randomized, but drug not received|1
1751175|NCT00862641|6103000|P2|Overall Study|Randomized, but drug not received|4
1751176|NCT00862641|6103001|P1|Overall Study|Randomized, but drug not received|1
1751177|NCT00862459|6103095|P3|Overall Study|Administrative problems|0
1751178|NCT00862459|6103096|P2|Overall Study|Administrative problems|1
1751179|NCT00862459|6103097|P1|Overall Study|Administrative problems|0
1751180|NCT00862459|6103095|P3|Overall Study|Inclusion/exclusion criteria not met|0
1751181|NCT00862459|6103096|P2|Overall Study|Inclusion/exclusion criteria not met|1
1751182|NCT00862459|6103097|P1|Overall Study|Inclusion/exclusion criteria not met|0
1751183|NCT00862459|6103095|P3|Overall Study|Unable to hold still for imaging|0
1751184|NCT00862459|6103096|P2|Overall Study|Unable to hold still for imaging|1
1751185|NCT00862459|6103097|P1|Overall Study|Unable to hold still for imaging|0
1751186|NCT00862459|6103095|P3|Overall Study|Intravenous (IV) site problems|1
1751187|NCT00862459|6103096|P2|Overall Study|Intravenous (IV) site problems|0
1751188|NCT00862459|6103097|P1|Overall Study|Intravenous (IV) site problems|1
1751189|NCT00862459|6103095|P3|Overall Study|Operation|0
1751190|NCT00862459|6103096|P2|Overall Study|Operation|1
1751191|NCT00862459|6103097|P1|Overall Study|Operation|1
1751192|NCT00862459|6103095|P3|Overall Study|Personal reasons|0
1751193|NCT00862459|6103096|P2|Overall Study|Personal reasons|0
1751194|NCT00862459|6103097|P1|Overall Study|Personal reasons|1
1751195|NCT00862459|6103095|P3|Overall Study|Adverse Event|0
1751196|NCT00862459|6103096|P2|Overall Study|Adverse Event|1
1751197|NCT00862459|6103097|P1|Overall Study|Adverse Event|0
1751198|NCT00862459|6103095|P3|Overall Study|Withdrawal by Subject|3
1751199|NCT00862459|6103096|P2|Overall Study|Withdrawal by Subject|1
1751200|NCT00862459|6103097|P1|Overall Study|Withdrawal by Subject|1
1751201|NCT00862459|6103095|P3|Overall Study|Protocol Violation|0
1751202|NCT00862459|6103096|P2|Overall Study|Protocol Violation|0
1751203|NCT00862459|6103097|P1|Overall Study|Protocol Violation|1
1751204|NCT00862459|6103095|P3|Overall Study|Lost to Follow-up|2
1751205|NCT00862459|6103096|P2|Overall Study|Lost to Follow-up|2
1751206|NCT00862459|6103097|P1|Overall Study|Lost to Follow-up|1
1751207|NCT00862277|6103244|P3|Overall Study|Protocol Violation|5
1751208|NCT00862277|6103245|P2|Overall Study|Protocol Violation|2
1751209|NCT00862277|6103246|P1|Overall Study|Protocol Violation|1
1751210|NCT00862251|6103260|P3|Overall Study|Withdrawal by Subject|6
1751211|NCT00862251|6103261|P2|Overall Study|Withdrawal by Subject|2
1751212|NCT00862251|6103262|P1|Overall Study|Withdrawal by Subject|9
1751213|NCT00862251|6103260|P3|Overall Study|Protocol Violation|1
1751214|NCT00862251|6103261|P2|Overall Study|Protocol Violation|0
1751215|NCT00862251|6103262|P1|Overall Study|Protocol Violation|2
1751216|NCT00862251|6103260|P3|Overall Study|Lost to Follow-up|1
1751217|NCT00862251|6103261|P2|Overall Study|Lost to Follow-up|0
1751218|NCT00862251|6103262|P1|Overall Study|Lost to Follow-up|0
1751219|NCT00862251|6103260|P3|Overall Study|Adverse Event|1
1751220|NCT00862251|6103261|P2|Overall Study|Adverse Event|3
1751221|NCT00862251|6103262|P1|Overall Study|Adverse Event|8
1751222|NCT00862134|6103322|P2|Overall Study|Withdrew prior to dosing|0
1751223|NCT00862134|6103323|P1|Overall Study|Withdrew prior to dosing|2
1751224|NCT00862134|6103322|P2|Overall Study|Adverse Event|2
1751225|NCT00862134|6103323|P1|Overall Study|Adverse Event|2
1751226|NCT00862134|6103322|P2|Overall Study|Sponsor terminated study|7
1751227|NCT00862134|6103323|P1|Overall Study|Sponsor terminated study|5
1751228|NCT00862134|6103322|P2|Overall Study|Withdrawal by Subject|2
1751229|NCT00862134|6103323|P1|Overall Study|Withdrawal by Subject|1
1751230|NCT00862134|6103322|P2|Overall Study|Physician Decision|1
1751231|NCT00862134|6103323|P1|Overall Study|Physician Decision|0
1751232|NCT00862134|6103322|P2|Overall Study|Death|0
1751233|NCT00862134|6103323|P1|Overall Study|Death|1
1751234|NCT00862121|6103335|P2|Overall Study|Incorrect randomisation|1
1751235|NCT00862121|6103336|P1|Overall Study|Incorrect randomisation|0
1751236|NCT00862121|6103335|P2|Overall Study|Exclusion criterion violation|1
1751237|NCT00862121|6103336|P1|Overall Study|Exclusion criterion violation|0
1751238|NCT00862121|6103335|P2|Overall Study|Protocol Violation|1
1751239|NCT00862121|6103336|P1|Overall Study|Protocol Violation|0
1751240|NCT00862121|6103335|P2|Overall Study|Lack of Efficacy|3
1751241|NCT00862121|6103336|P1|Overall Study|Lack of Efficacy|0
1751242|NCT00862121|6103335|P2|Overall Study|Adverse Event|2
1751243|NCT00862121|6103336|P1|Overall Study|Adverse Event|1
1751244|NCT00862082|6103354|P2|Overall Study|Withdrawal by Subject|1
1751245|NCT00862082|6103355|P1|Overall Study|Withdrawal by Subject|0
1751246|NCT00862082|6103354|P2|Overall Study|Sponsor decision to terminate the study|0
1751247|NCT00862082|6103355|P1|Overall Study|Sponsor decision to terminate the study|5
1751248|NCT00861757|6103410|P4|Overall Study|Withdrawal by Subject|2
1751249|NCT00861757|6103411|P3|Overall Study|Withdrawal by Subject|5
1751250|NCT00861757|6103412|P2|Overall Study|Withdrawal by Subject|5
1751251|NCT00861757|6103413|P1|Overall Study|Withdrawal by Subject|1
1751252|NCT00861757|6103410|P4|Overall Study|Protocol Violation|1
1751253|NCT00861757|6103411|P3|Overall Study|Protocol Violation|4
1751254|NCT00861757|6103412|P2|Overall Study|Protocol Violation|2
1751255|NCT00861757|6103413|P1|Overall Study|Protocol Violation|2
1751256|NCT00861757|6103410|P4|Overall Study|Physician Decision|1
1751257|NCT00861757|6103411|P3|Overall Study|Physician Decision|0
1751258|NCT00861757|6103412|P2|Overall Study|Physician Decision|0
1751259|NCT00861757|6103413|P1|Overall Study|Physician Decision|0
1751260|NCT00861757|6103410|P4|Overall Study|Lost to Follow-up|1
1751261|NCT00861757|6103411|P3|Overall Study|Lost to Follow-up|1
1751262|NCT00861757|6103412|P2|Overall Study|Lost to Follow-up|0
1751263|NCT00861757|6103413|P1|Overall Study|Lost to Follow-up|1
1751264|NCT00861757|6103410|P4|Overall Study|Lack of Efficacy|1
1751265|NCT00861757|6103411|P3|Overall Study|Lack of Efficacy|0
1751266|NCT00861757|6103412|P2|Overall Study|Lack of Efficacy|1
1751267|NCT00861757|6103413|P1|Overall Study|Lack of Efficacy|3
1751268|NCT00861757|6103410|P4|Overall Study|Entry Criteria Not Met|1
1751269|NCT00861757|6103411|P3|Overall Study|Entry Criteria Not Met|1
1751270|NCT00861757|6103412|P2|Overall Study|Entry Criteria Not Met|2
1751271|NCT00861757|6103413|P1|Overall Study|Entry Criteria Not Met|1
1751272|NCT00861757|6103410|P4|Overall Study|Adverse Event|2
1751273|NCT00861757|6103411|P3|Overall Study|Adverse Event|7
1751274|NCT00861757|6103412|P2|Overall Study|Adverse Event|5
1751275|NCT00861757|6103413|P1|Overall Study|Adverse Event|1
1751276|NCT00861744|6103471|P4|Overall Study|Blood draws|1
1751277|NCT00861744|6103472|P3|Overall Study|Blood draws|0
1751278|NCT00861744|6103473|P2|Overall Study|Blood draws|0
1751279|NCT00861744|6103474|P1|Overall Study|Blood draws|0
1751280|NCT00861744|6103471|P4|Overall Study|Migration from study area|0
1751281|NCT00861744|6103472|P3|Overall Study|Migration from study area|1
1751282|NCT00861744|6103473|P2|Overall Study|Migration from study area|3
1751283|NCT00861744|6103474|P1|Overall Study|Migration from study area|0
1751284|NCT00861744|6103471|P4|Overall Study|Protocol Violation|0
1751285|NCT00861744|6103472|P3|Overall Study|Protocol Violation|0
1751286|NCT00861744|6103473|P2|Overall Study|Protocol Violation|1
1751287|NCT00861744|6103474|P1|Overall Study|Protocol Violation|0
1751288|NCT00861744|6103471|P4|Overall Study|Withdrawal by Subject|19
1751289|NCT00861744|6103472|P3|Overall Study|Withdrawal by Subject|6
1751290|NCT00861744|6103473|P2|Overall Study|Withdrawal by Subject|6
1751291|NCT00861744|6103474|P1|Overall Study|Withdrawal by Subject|10
1751292|NCT00861744|6103471|P4|Overall Study|Lost to Follow-up|12
1751293|NCT00861744|6103472|P3|Overall Study|Lost to Follow-up|17
1751294|NCT00861744|6103473|P2|Overall Study|Lost to Follow-up|19
1751295|NCT00861744|6103474|P1|Overall Study|Lost to Follow-up|7
1751296|NCT00861744|6103471|P4|Overall Study|Adverse Event|1
1751297|NCT00861744|6103472|P3|Overall Study|Adverse Event|0
1751298|NCT00861744|6103473|P2|Overall Study|Adverse Event|0
1751299|NCT00861744|6103474|P1|Overall Study|Adverse Event|0
1751300|NCT00861705|6103656|P4|Overall Study|Never Began Treatment|1
1751301|NCT00861705|6103657|P3|Overall Study|Never Began Treatment|0
1751302|NCT00861705|6103658|P2|Overall Study|Never Began Treatment|3
1751303|NCT00861705|6103659|P1|Overall Study|Never Began Treatment|7
1751304|NCT00861692|6103675|P1|Overall Study|Death|6
1751305|NCT00861614|6103687|P2|Overall Study|Other|22
1751306|NCT00861614|6103688|P1|Overall Study|Other|17
1751307|NCT00861614|6103687|P2|Overall Study|Withdrawal by Subject|35
1751308|NCT00861614|6103688|P1|Overall Study|Withdrawal by Subject|34
1751309|NCT00861614|6103687|P2|Overall Study|Adverse Event|23
1751310|NCT00861614|6103688|P1|Overall Study|Adverse Event|27
1751311|NCT00861614|6103687|P2|Overall Study|Death|19
1751312|NCT00861614|6103688|P1|Overall Study|Death|32
1751313|NCT00861614|6103687|P2|Overall Study|Study Drug Toxicity|6
1751314|NCT00861614|6103688|P1|Overall Study|Study Drug Toxicity|79
1751315|NCT00861614|6103687|P2|Overall Study|Disease Progression|263
1751316|NCT00861614|6103688|P1|Overall Study|Disease Progression|182
1751317|NCT00861471|6103773|P1|Overall Study|Physician Decision|2
1751318|NCT00861471|6103773|P1|Overall Study|treatment for lumbar laminectomy|1
1751319|NCT00861471|6103773|P1|Overall Study|Lack of Efficacy|3
1751320|NCT00861471|6103773|P1|Overall Study|Adverse Event|2
1751321|NCT00861471|6103773|P1|Overall Study|Withdrawal by Subject|1
1751322|NCT00861341|6103781|P1|Overall Study|Withdrawal by Subject|2
1751323|NCT00861198|6103790|P1|Overall Study|SpyGlass Failed|5
1751324|NCT00860951|6103807|P1|Overall Study|Lost to Follow-up|5
1751325|NCT00860951|6103807|P1|Overall Study|Withdrawal by Subject|2
1751326|NCT00860743|6103864|P2|Overall Study|Withdrawal by Subject|0
1751327|NCT00860743|6103865|P1|Overall Study|Withdrawal by Subject|3
1751328|NCT00860470|6103878|P2|Overall Study|Lost to Follow-up|39
1751329|NCT00860470|6103879|P1|Overall Study|Lost to Follow-up|34
1751330|NCT00860470|6103878|P2|Overall Study|Moved away|10
1751331|NCT00860470|6103879|P1|Overall Study|Moved away|8
1751332|NCT00860470|6103878|P2|Overall Study|Death|10
1751333|NCT00860470|6103879|P1|Overall Study|Death|6
1751334|NCT00860405|6103909|P2|Overall Study|Main reason: Follow-up data not complete|4
1751335|NCT00860405|6103910|P1|Overall Study|Main reason: Follow-up data not complete|5
1751336|NCT00860262|6103950|P3|Overall Study|Other|1
1751337|NCT00860262|6103951|P2|Overall Study|Other|3
1751338|NCT00860262|6103952|P1|Overall Study|Other|5
1751339|NCT00860262|6103950|P3|Overall Study|Lack of Efficacy|3
1751340|NCT00860262|6103951|P2|Overall Study|Lack of Efficacy|4
1751341|NCT00860262|6103952|P1|Overall Study|Lack of Efficacy|0
1751342|NCT00860262|6103950|P3|Overall Study|Withdrawal by Subject|6
1751343|NCT00860262|6103951|P2|Overall Study|Withdrawal by Subject|8
1751344|NCT00860262|6103952|P1|Overall Study|Withdrawal by Subject|4
1751345|NCT00860262|6103950|P3|Overall Study|Lost to Follow-up|1
1751346|NCT00860262|6103951|P2|Overall Study|Lost to Follow-up|0
1751347|NCT00860262|6103952|P1|Overall Study|Lost to Follow-up|2
1751348|NCT00860262|6103950|P3|Overall Study|Protocol Violation|0
1751349|NCT00860262|6103951|P2|Overall Study|Protocol Violation|1
1751350|NCT00860262|6103952|P1|Overall Study|Protocol Violation|0
1751351|NCT00860262|6103950|P3|Overall Study|Adverse Event|7
1751352|NCT00860262|6103951|P2|Overall Study|Adverse Event|6
1751353|NCT00860262|6103952|P1|Overall Study|Adverse Event|9
1751354|NCT00860249|6104065|P3|Overall Study|trial was terminated prior to completion|21
1751355|NCT00860249|6104066|P2|Overall Study|trial was terminated prior to completion|18
1751356|NCT00860249|6104067|P1|Overall Study|trial was terminated prior to completion|21
1751357|NCT00860158|6104087|P1|Overall Study|Study Terminated|1
1751358|NCT00860067|6104099|P3|Overall Study|Pregnancy|0
1751359|NCT00860067|6104100|P2|Overall Study|Pregnancy|0
1751360|NCT00860067|6104101|P1|Overall Study|Pregnancy|1
1751361|NCT00860067|6104099|P3|Overall Study|Withdrawal by Subject|0
1751362|NCT00860067|6104100|P2|Overall Study|Withdrawal by Subject|0
1751363|NCT00860067|6104101|P1|Overall Study|Withdrawal by Subject|4
1751364|NCT00860067|6104099|P3|Overall Study|Lost to Follow-up|9
1751365|NCT00860067|6104100|P2|Overall Study|Lost to Follow-up|9
1751366|NCT00860067|6104101|P1|Overall Study|Lost to Follow-up|46
1751367|NCT00860028|6104161|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
1751368|NCT00860028|6104162|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
1751369|NCT00859937|6104200|P2|Overall Study|Protocol Violation|0
1751370|NCT00859937|6104201|P1|Overall Study|Protocol Violation|1
1751371|NCT00859898|6104216|P3|Overall Study|non-specified|1
1751372|NCT00859898|6104217|P2|Overall Study|non-specified|1
1751373|NCT00859898|6104218|P1|Overall Study|non-specified|1
1751374|NCT00859898|6104216|P3|Overall Study|No longer meets criteria|0
1751375|NCT00859898|6104217|P2|Overall Study|No longer meets criteria|1
1751376|NCT00859898|6104218|P1|Overall Study|No longer meets criteria|0
1751377|NCT00859898|6104216|P3|Overall Study|poor/non-compliance|0
1751378|NCT00859898|6104217|P2|Overall Study|poor/non-compliance|0
1751379|NCT00859898|6104218|P1|Overall Study|poor/non-compliance|2
1751380|NCT00859898|6104216|P3|Overall Study|Lost to Follow-up|5
1751381|NCT00859898|6104217|P2|Overall Study|Lost to Follow-up|11
1751382|NCT00859898|6104218|P1|Overall Study|Lost to Follow-up|10
1751383|NCT00859898|6104216|P3|Overall Study|Death|1
1751384|NCT00859898|6104217|P2|Overall Study|Death|0
1751385|NCT00859898|6104218|P1|Overall Study|Death|0
1751386|NCT00859898|6104216|P3|Overall Study|Withdrawal by Subject|11
1751387|NCT00859898|6104217|P2|Overall Study|Withdrawal by Subject|8
1751388|NCT00859898|6104218|P1|Overall Study|Withdrawal by Subject|11
1751389|NCT00859898|6104216|P3|Overall Study|Adverse Event|8
1751390|NCT00859898|6104217|P2|Overall Study|Adverse Event|9
1751391|NCT00859898|6104218|P1|Overall Study|Adverse Event|4
1751392|NCT00859898|6104216|P3|Overall Study|Lack of Efficacy|1
1751393|NCT00859898|6104217|P2|Overall Study|Lack of Efficacy|1
1751394|NCT00859898|6104218|P1|Overall Study|Lack of Efficacy|0
1751395|NCT00859638|6104277|P2|Overall Study|Ill health|1
1751396|NCT00859638|6104278|P1|Overall Study|Ill health|1
1751397|NCT00859638|6104277|P2|Overall Study|Withdrawal by Subject|2
1751398|NCT00859638|6104278|P1|Overall Study|Withdrawal by Subject|3
1751399|NCT00859638|6104277|P2|Overall Study|Lost to Follow-up|1
1751400|NCT00859638|6104278|P1|Overall Study|Lost to Follow-up|6
1751401|NCT00859586|6104284|P1|Overall Study|Donors|4
1751402|NCT00859573|6104290|P2|Overall Study|Physician Decision|1
1751403|NCT00859573|6104291|P1|Overall Study|Physician Decision|1
1751404|NCT00859573|6104290|P2|Overall Study|Withdrawal by Subject|1
1751405|NCT00859573|6104291|P1|Overall Study|Withdrawal by Subject|4
1751406|NCT00859547|6104297|P1|Overall Study|Parent withdrew consent|1
1751407|NCT00859547|6104297|P1|Overall Study|Lost to Follow-up|1
1751408|NCT00859521|6104310|P2|Washout|Withdrawal by Subject|1
1751409|NCT00859521|6104311|P1|Washout|Withdrawal by Subject|0
1751410|NCT00859469|6104328|P1|Overall Study|Death|16
1751411|NCT00859469|6104328|P1|Overall Study|Withdrawal by Subject|1
1751412|NCT00859469|6104328|P1|Overall Study|Lack of Efficacy|9
1751413|NCT00859469|6104328|P1|Overall Study|Adverse Event|2
1751414|NCT00859456|6104334|P1|Overall Study|Non-compliance|3
1751415|NCT00859456|6104334|P1|Overall Study|Progressive disease|2
1751416|NCT00859456|6104334|P1|Overall Study|Adverse Event|3
1751417|NCT00859430|6104340|P2|First Intervention|Withdrawal by Subject|1
1751418|NCT00859430|6104341|P1|First Intervention|Withdrawal by Subject|0
1751419|NCT00859313|6104357|P1|Overall Study|staff error|1
1751420|NCT00859313|6104357|P1|Overall Study|Adverse Event|1
1751421|NCT00859313|6104357|P1|Overall Study|Lack of Efficacy|2
1751422|NCT00859222|6104364|P5|Overall Study|DLT|0
1751423|NCT00859222|6104365|P4|Overall Study|DLT|0
1751424|NCT00859222|6104366|P3|Overall Study|DLT|0
1751425|NCT00859222|6104367|P2|Overall Study|DLT|0
1751426|NCT00859222|6104368|P1|Overall Study|DLT|1
1751427|NCT00859222|6104364|P5|Overall Study|Adverse Event|15
1751428|NCT00859222|6104365|P4|Overall Study|Adverse Event|24
1751429|NCT00859222|6104366|P3|Overall Study|Adverse Event|6
1751430|NCT00859222|6104367|P2|Overall Study|Adverse Event|3
1751431|NCT00859222|6104368|P1|Overall Study|Adverse Event|2
1751432|NCT00859014|6104490|P1|Overall Study|Lost to Follow-up|1
1751433|NCT00859014|6104490|P1|Overall Study|Death|4
1751434|NCT00858988|6104497|P2|Analysis|Lactulose unable to be detected in urine|1
1751435|NCT00858988|6104498|P1|Analysis|Lactulose unable to be detected in urine|2
1751436|NCT00858845|6104514|P2|Overall Study|Patient underwent heart transplant.|1
1751437|NCT00858845|6104515|P1|Overall Study|Patient underwent heart transplant.|0
1751438|NCT00858832|6104527|P2|Overall Study|Adverse Event|1
1751439|NCT00858832|6104528|P1|Overall Study|Adverse Event|0
1751440|NCT00858832|6104527|P2|Overall Study|became ineligible: delivered vaginally|0
1751441|NCT00858832|6104528|P1|Overall Study|became ineligible: delivered vaginally|1
1751442|NCT00858780|6104534|P5|OL Re-Treatment (Failure to Week 48)|Other|1
1751443|NCT00858780|6104535|P4|OL Re-Treatment (Failure to Week 48)|Other|0
1751444|NCT00858780|6104536|P3|OL Re-Treatment (Failure to Week 48)|Other|0
1751445|NCT00858780|6104537|P2|OL Re-Treatment (Failure to Week 48)|Other|0
1751446|NCT00858780|6104538|P1|OL Re-Treatment (Failure to Week 48)|Other|0
1751447|NCT00858780|6104534|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
1751448|NCT00858780|6104535|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1751449|NCT00858780|6104536|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1751450|NCT00858780|6104537|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1751451|NCT00858780|6104538|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
1751452|NCT00858780|6104534|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1751453|NCT00858780|6104535|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1751454|NCT00858780|6104536|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1751455|NCT00858780|6104537|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
1751456|NCT00858780|6104538|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
1751457|NCT00858780|6104534|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
1751458|NCT00858780|6104535|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1751459|NCT00858780|6104536|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1751460|NCT00858780|6104537|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
1751461|NCT00858780|6104538|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
1751462|NCT00858780|6104534|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1751463|NCT00858780|6104535|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1751464|NCT00858780|6104536|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
1751465|NCT00858780|6104537|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1751466|NCT00858780|6104538|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
1751467|NCT00858780|6104534|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1751468|NCT00858780|6104535|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1751469|NCT00858780|6104536|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1751470|NCT00858780|6104537|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
1751471|NCT00858780|6104538|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
1751472|NCT00858702|6104613|P2|Overall Study|Withdrawal by Subject|0
1751473|NCT00858702|6104614|P1|Overall Study|Withdrawal by Subject|1
1751474|NCT00858702|6104613|P2|Overall Study|Other|1
1751475|NCT00858702|6104614|P1|Overall Study|Other|2
1751476|NCT00858702|6104613|P2|Overall Study|Protocol Violation|1
1751477|NCT00858702|6104614|P1|Overall Study|Protocol Violation|1
1751478|NCT00858702|6104613|P2|Overall Study|Lack of Efficacy|0
1751479|NCT00858702|6104614|P1|Overall Study|Lack of Efficacy|1
1751480|NCT00858637|6104629|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
1751481|NCT00858637|6104630|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1751482|NCT00858637|6104631|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1751483|NCT00858637|6104632|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1751484|NCT00858637|6104633|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1751485|NCT00858637|6104634|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
1751486|NCT00858637|6104629|P6|Placebo-controlled Withdrawal Phase|Death|0
1751487|NCT00858637|6104630|P5|Placebo-controlled Withdrawal Phase|Death|1
1751488|NCT00858637|6104631|P4|Placebo-controlled Withdrawal Phase|Death|0
1751489|NCT00858637|6104632|P3|Placebo-controlled Withdrawal Phase|Death|1
1751490|NCT00858637|6104633|P2|Placebo-controlled Withdrawal Phase|Death|0
1751491|NCT00858637|6104634|P1|Placebo-controlled Withdrawal Phase|Death|0
1751492|NCT00858637|6104629|P6|Active Comparison Phase|Other Reasons|0
1751493|NCT00858637|6104630|P5|Active Comparison Phase|Other Reasons|0
1751494|NCT00858637|6104631|P4|Active Comparison Phase|Other Reasons|1
1751495|NCT00858637|6104632|P3|Active Comparison Phase|Other Reasons|0
1751496|NCT00858637|6104633|P2|Active Comparison Phase|Other Reasons|0
1751497|NCT00858637|6104634|P1|Active Comparison Phase|Other Reasons|1
1751498|NCT00858637|6104629|P6|Active Comparison Phase|Withdrawal by Subject|0
1751499|NCT00858637|6104630|P5|Active Comparison Phase|Withdrawal by Subject|0
1751500|NCT00858637|6104631|P4|Active Comparison Phase|Withdrawal by Subject|6
1751501|NCT00858637|6104632|P3|Active Comparison Phase|Withdrawal by Subject|0
1751502|NCT00858637|6104633|P2|Active Comparison Phase|Withdrawal by Subject|0
1751503|NCT00858637|6104634|P1|Active Comparison Phase|Withdrawal by Subject|7
1751504|NCT00858637|6104629|P6|Active Comparison Phase|Physician Decision|0
1751505|NCT00858637|6104630|P5|Active Comparison Phase|Physician Decision|0
1751506|NCT00858637|6104631|P4|Active Comparison Phase|Physician Decision|1
1751507|NCT00858637|6104632|P3|Active Comparison Phase|Physician Decision|0
1751508|NCT00858637|6104633|P2|Active Comparison Phase|Physician Decision|0
1751509|NCT00858637|6104634|P1|Active Comparison Phase|Physician Decision|1
1751510|NCT00858637|6104629|P6|Active Comparison Phase|Death|0
1751511|NCT00858637|6104630|P5|Active Comparison Phase|Death|0
1751512|NCT00858637|6104631|P4|Active Comparison Phase|Death|1
1751513|NCT00858637|6104632|P3|Active Comparison Phase|Death|0
1751514|NCT00858637|6104633|P2|Active Comparison Phase|Death|0
1751515|NCT00858637|6104634|P1|Active Comparison Phase|Death|1
1751516|NCT00858637|6104629|P6|Active Comparison Phase|Adverse Event|0
1751517|NCT00858637|6104630|P5|Active Comparison Phase|Adverse Event|0
1751518|NCT00858637|6104631|P4|Active Comparison Phase|Adverse Event|9
1751519|NCT00858637|6104632|P3|Active Comparison Phase|Adverse Event|0
1751520|NCT00858637|6104633|P2|Active Comparison Phase|Adverse Event|0
1751521|NCT00858637|6104634|P1|Active Comparison Phase|Adverse Event|14
1751522|NCT00858442|6104675|P2|Compression:Start to Finish|Lost to Follow-up|3
1751523|NCT00858442|6104676|P1|Compression:Start to Finish|Lost to Follow-up|1
1751524|NCT00858403|6104686|P1|Overall Study|Disease Progression|1
1751525|NCT00858403|6104686|P1|Overall Study|Death|3
1751526|NCT00858403|6104686|P1|Overall Study|Withdrawal by Subject|1
1751527|NCT00858364|6104707|P2|Overall Study|Still on-study|247
1751528|NCT00858364|6104708|P1|Overall Study|Still on-study|114
1751529|NCT00858364|6104707|P2|Overall Study|Missing|1
1751530|NCT00858364|6104708|P1|Overall Study|Missing|1
1751531|NCT00858364|6104707|P2|Overall Study|Other|17
1751532|NCT00858364|6104708|P1|Overall Study|Other|9
1751533|NCT00858364|6104707|P2|Overall Study|Protocol Deviation|2
1751534|NCT00858364|6104708|P1|Overall Study|Protocol Deviation|0
1751535|NCT00858364|6104707|P2|Overall Study|Noncompliance|4
1751536|NCT00858364|6104708|P1|Overall Study|Noncompliance|3
1751537|NCT00858364|6104707|P2|Overall Study|Lost to Follow-up|54
1751538|NCT00858364|6104708|P1|Overall Study|Lost to Follow-up|24
1751539|NCT00858364|6104707|P2|Overall Study|Ineligibility Determined|10
1751540|NCT00858364|6104708|P1|Overall Study|Ineligibility Determined|1
1751541|NCT00858364|6104707|P2|Overall Study|Withdrawal by Subject|118
1751542|NCT00858364|6104708|P1|Overall Study|Withdrawal by Subject|44
1751543|NCT00858364|6104707|P2|Overall Study|Adverse Event|2
1751544|NCT00858364|6104708|P1|Overall Study|Adverse Event|5
1751545|NCT00858364|6104707|P2|Overall Study|Administrative Decision|2
1751546|NCT00858364|6104708|P1|Overall Study|Administrative Decision|3
1751547|NCT00858247|6104730|P2|Week 12 Follow-up|Withdrawal by Subject|1
1751548|NCT00858247|6104731|P1|Week 12 Follow-up|Withdrawal by Subject|0
1751549|NCT00858247|6104730|P2|Baseline Assessment|Protocol Violation|1
1751550|NCT00858247|6104731|P1|Baseline Assessment|Protocol Violation|0
1751551|NCT00858247|6104730|P2|Baseline Assessment|Poor IV access|0
1751552|NCT00858247|6104731|P1|Baseline Assessment|Poor IV access|1
1751553|NCT00858247|6104730|P2|Baseline Assessment|Withdrawal by Subject|1
1751554|NCT00858247|6104731|P1|Baseline Assessment|Withdrawal by Subject|1
1751555|NCT00858208|6104747|P1|Overall Study|Other|10
1751556|NCT00858208|6104747|P1|Overall Study|Participant refused|40
1751557|NCT00858208|6104747|P1|Overall Study|Lost to Follow-up|26
1751558|NCT00858208|6104747|P1|Overall Study|Adverse Event|3
1751559|NCT00858143|6104764|P1|Overall Study|Other|23
1751560|NCT00858143|6104764|P1|Overall Study|Death|7
1751561|NCT00858143|6104764|P1|Overall Study|Lack of Efficacy|4
1751562|NCT00858143|6104764|P1|Overall Study|Adverse Event|16
1751563|NCT00857948|6104876|P4|Overall Study|Protocol Violation|0
1751564|NCT00857948|6104877|P3|Overall Study|Protocol Violation|1
1751565|NCT00857948|6104878|P2|Overall Study|Protocol Violation|0
1751566|NCT00857948|6104879|P1|Overall Study|Protocol Violation|1
1751567|NCT00857948|6104876|P4|Overall Study|Withdrawal by Subject|0
1751568|NCT00857948|6104877|P3|Overall Study|Withdrawal by Subject|0
1751569|NCT00857948|6104878|P2|Overall Study|Withdrawal by Subject|0
1751570|NCT00857948|6104879|P1|Overall Study|Withdrawal by Subject|2
1751571|NCT00857896|6104901|P1|Baseline to Week 4|Withdrawal by Subject|1
1751572|NCT00857818|6105057|P2|Overall Study|Investigator decision|0
1751573|NCT00857818|6105058|P1|Overall Study|Investigator decision|1
1751574|NCT00857818|6105057|P2|Overall Study|Sponsor terminated study|4
1751575|NCT00857818|6105058|P1|Overall Study|Sponsor terminated study|6
1751576|NCT00857818|6105057|P2|Overall Study|Withdrawal by Subject|4
1751577|NCT00857818|6105058|P1|Overall Study|Withdrawal by Subject|0
1751578|NCT00857818|6105057|P2|Overall Study|Adverse Event|0
1751579|NCT00857818|6105058|P1|Overall Study|Adverse Event|3
1751580|NCT00857818|6105057|P2|Overall Study|Lack of Efficacy|0
1751581|NCT00857818|6105058|P1|Overall Study|Lack of Efficacy|1
1751582|NCT00857792|6105086|P1|Overall Study|inadequate image quality for analysis|12
1751583|NCT00857766|6105092|P2|Overall Study|Participant Withdrew Consent|4
1751584|NCT00857766|6105093|P1|Overall Study|Participant Withdrew Consent|4
1751585|NCT00857766|6105092|P2|Overall Study|Investigator Discretion|3
1751586|NCT00857766|6105093|P1|Overall Study|Investigator Discretion|2
1751587|NCT00857766|6105092|P2|Overall Study|Lost to Follow-up|0
1751588|NCT00857766|6105093|P1|Overall Study|Lost to Follow-up|1
1751589|NCT00857766|6105092|P2|Overall Study|Protocol Violation|11
1751590|NCT00857766|6105093|P1|Overall Study|Protocol Violation|11
1751591|NCT00857766|6105092|P2|Overall Study|Adverse Event|12
1751592|NCT00857766|6105093|P1|Overall Study|Adverse Event|13
1751593|NCT00857649|6105135|P2|Overall Study|Other Reasons|3
1751594|NCT00857649|6105136|P1|Overall Study|Other Reasons|1
1751595|NCT00857649|6105135|P2|Overall Study|Nursing Home Placement|9
1751596|NCT00857649|6105136|P1|Overall Study|Nursing Home Placement|2
1751597|NCT00857649|6105135|P2|Overall Study|Withdrawal of Consent|7
1751598|NCT00857649|6105136|P1|Overall Study|Withdrawal of Consent|10
1751599|NCT00857649|6105135|P2|Overall Study|Protocol Violation|2
1751600|NCT00857649|6105136|P1|Overall Study|Protocol Violation|2
1751601|NCT00857649|6105135|P2|Overall Study|Non-compliance|1
1751602|NCT00857649|6105136|P1|Overall Study|Non-compliance|1
1751603|NCT00857649|6105135|P2|Overall Study|Adverse Event|10
1751604|NCT00857649|6105136|P1|Overall Study|Adverse Event|15
1751605|NCT00857623|6105152|P2|Overall Study|Positive for HEP C|1
1751606|NCT00857623|6105153|P1|Overall Study|Positive for HEP C|0
1751607|NCT00857623|6105152|P2|Overall Study|Intake of prohibited medication|1
1751608|NCT00857623|6105153|P1|Overall Study|Intake of prohibited medication|0
1751609|NCT00857623|6105152|P2|Overall Study|Severe non-compliance to protocol|1
1751610|NCT00857623|6105153|P1|Overall Study|Severe non-compliance to protocol|1
1751611|NCT00857623|6105152|P2|Overall Study|Lack of Efficacy|1
1751612|NCT00857623|6105153|P1|Overall Study|Lack of Efficacy|1
1751613|NCT00857623|6105152|P2|Overall Study|Withdrawal by Subject|1
1751614|NCT00857623|6105153|P1|Overall Study|Withdrawal by Subject|2
1751615|NCT00857623|6105152|P2|Overall Study|Study-specific discontinuation criteria|3
1751616|NCT00857623|6105153|P1|Overall Study|Study-specific discontinuation criteria|5
1751617|NCT00857623|6105152|P2|Overall Study|Adverse Event|2
1751618|NCT00857623|6105153|P1|Overall Study|Adverse Event|5
1751619|NCT00857584|6105177|P2|Overall Study|Physician Decision|1
1751620|NCT00857584|6105178|P1|Overall Study|Physician Decision|1
1751621|NCT00857584|6105177|P2|Overall Study|Adverse Event|2
1751622|NCT00857584|6105178|P1|Overall Study|Adverse Event|2
1751623|NCT00857584|6105177|P2|Overall Study|Lack of Efficacy|2
1751624|NCT00857584|6105178|P1|Overall Study|Lack of Efficacy|1
1751625|NCT00857454|6105305|P1|Overall Study|MTE09 enrollment criteria not met|6
1751626|NCT00857454|6105305|P1|Overall Study|Total Testosterone <300 ng/dL|8
1751627|NCT00857454|6105305|P1|Overall Study|Total Testosterone >1050 ng/dL|1
1751628|NCT00857454|6105305|P1|Overall Study|Adverse Event|2
1751629|NCT00857454|6105305|P1|Overall Study|Lost to Follow-up|1
1751630|NCT00857454|6105305|P1|Overall Study|Withdrawal by Subject|2
1751631|NCT00857415|6105318|P2|Overall Study|Deceased with no autopsy|0
1751632|NCT00857415|6105319|P1|Overall Study|Deceased with no autopsy|2
1751633|NCT00857415|6105318|P2|Overall Study|Subject still living at end of study|0
1751634|NCT00857415|6105319|P1|Overall Study|Subject still living at end of study|110
1751635|NCT00857415|6105318|P2|Overall Study|Invalid image or not imaged|0
1751636|NCT00857415|6105319|P1|Overall Study|Invalid image or not imaged|3
1751637|NCT00857415|6105318|P2|Overall Study|Image acquisition failure|0
1751638|NCT00857415|6105319|P1|Overall Study|Image acquisition failure|2
1751639|NCT00857311|6105330|P4|Overall Study|Lost to Follow-up|0
1751640|NCT00857311|6105331|P3|Overall Study|Lost to Follow-up|0
1751641|NCT00857311|6105332|P2|Overall Study|Lost to Follow-up|0
1751642|NCT00857311|6105333|P1|Overall Study|Lost to Follow-up|1
1751643|NCT00857285|6105345|P2|Overall Study|Randomization criteria not met|1
1751644|NCT00857285|6105346|P1|Overall Study|Randomization criteria not met|1
1751645|NCT00857285|6105345|P2|Overall Study|Withdrawal by Subject|0
1751646|NCT00857285|6105346|P1|Overall Study|Withdrawal by Subject|4
1751647|NCT00857285|6105345|P2|Overall Study|Protocol Violation|1
1751648|NCT00857285|6105346|P1|Overall Study|Protocol Violation|3
1751649|NCT00857285|6105345|P2|Overall Study|Lack of Efficacy|2
1751650|NCT00857285|6105346|P1|Overall Study|Lack of Efficacy|0
1751651|NCT00857285|6105345|P2|Overall Study|Adverse Event|2
1751652|NCT00857285|6105346|P1|Overall Study|Adverse Event|4
1751653|NCT00857259|6105362|P3|Overall Study|Protocol Violation|1
1751654|NCT00857259|6105363|P2|Overall Study|Protocol Violation|0
1751655|NCT00857259|6105364|P1|Overall Study|Protocol Violation|1
1751656|NCT00857246|6105374|P1|ChemoRT|Adverse Event|2
1751657|NCT00857246|6105374|P1|ChemoRT|Withdrawal by Subject|1
1751658|NCT00857246|6105374|P1|Surgery (Curative)|disease progression|6
1751659|NCT00857246|6105374|P1|Induction Regimen|Withdrawal by Subject|1
1751660|NCT00857246|6105374|P1|Induction Regimen|disease-related complications|1
1751661|NCT00857246|6105374|P1|Induction Regimen|Adverse Event|1
1751662|NCT00857233|6105384|P1|Overall Study|Other Reasons|2
1751663|NCT00857233|6105384|P1|Overall Study|Nursing Home Placement|14
1751664|NCT00857233|6105384|P1|Overall Study|Lost to Follow-up|4
1751665|NCT00857233|6105384|P1|Overall Study|Withdrawal of Consent|9
1751666|NCT00857233|6105384|P1|Overall Study|Non-compliance|1
1751667|NCT00857233|6105384|P1|Overall Study|Lack of Efficacy|1
1751668|NCT00857233|6105384|P1|Overall Study|Adverse Event|24
1751669|NCT00857220|6105393|P1|Overall Study|Miscellaneous|8
1751670|NCT00857220|6105393|P1|Overall Study|Site Closed|5
1751671|NCT00857220|6105393|P1|Overall Study|Clinical Hold|6
1751672|NCT00857220|6105393|P1|Overall Study|Withdrawal by Subject|67
1751673|NCT00857220|6105393|P1|Overall Study|Protocol Violation|16
1751674|NCT00857220|6105393|P1|Overall Study|Physician Decision|4
1751675|NCT00857220|6105393|P1|Overall Study|Lost to Follow-up|30
1751676|NCT00857220|6105393|P1|Overall Study|Lack of Efficacy|11
1751677|NCT00857220|6105393|P1|Overall Study|Death|1
1751678|NCT00857220|6105393|P1|Overall Study|Adverse Event|35
1751679|NCT00856999|6105410|P1|Overall Study|Withdrawal by Subject|5
1751680|NCT00856986|6105420|P5|Extension Period, Weeks 26-52|Unclassified|0
1751681|NCT00856986|6105421|P4|Extension Period, Weeks 26-52|Unclassified|0
1751682|NCT00856986|6105422|P3|Extension Period, Weeks 26-52|Unclassified|11
1751683|NCT00856986|6105423|P2|Extension Period, Weeks 26-52|Unclassified|2
1751684|NCT00856986|6105424|P1|Extension Period, Weeks 26-52|Unclassified|4
1751685|NCT00856986|6105420|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
1751686|NCT00856986|6105421|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
1751687|NCT00856986|6105422|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
1751688|NCT00856986|6105423|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
1751689|NCT00856986|6105424|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
1751690|NCT00856986|6105420|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
1751691|NCT00856986|6105421|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
1751692|NCT00856986|6105422|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
1751693|NCT00856986|6105423|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
1751694|NCT00856986|6105424|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
1751695|NCT00856986|6105420|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1751696|NCT00856986|6105421|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1751697|NCT00856986|6105422|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
1751698|NCT00856986|6105423|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
1751699|NCT00856986|6105424|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
1751700|NCT00856986|6105420|P5|Extension Period, Weeks 26-52|Protocol Violation|0
1751701|NCT00856986|6105421|P4|Extension Period, Weeks 26-52|Protocol Violation|0
1751702|NCT00856986|6105422|P3|Extension Period, Weeks 26-52|Protocol Violation|5
1751703|NCT00856986|6105423|P2|Extension Period, Weeks 26-52|Protocol Violation|2
1751704|NCT00856986|6105424|P1|Extension Period, Weeks 26-52|Protocol Violation|6
1751705|NCT00856986|6105420|P5|Extension Period, Weeks 26-52|Adverse Event|0
1751706|NCT00856986|6105421|P4|Extension Period, Weeks 26-52|Adverse Event|0
1751707|NCT00856986|6105422|P3|Extension Period, Weeks 26-52|Adverse Event|10
1751708|NCT00856986|6105423|P2|Extension Period, Weeks 26-52|Adverse Event|3
1751709|NCT00856986|6105424|P1|Extension Period, Weeks 26-52|Adverse Event|3
1751710|NCT00856986|6105420|P5|Main Period, Weeks 0-26|Unclassified|0
1751711|NCT00856986|6105421|P4|Main Period, Weeks 0-26|Unclassified|0
1751712|NCT00856986|6105422|P3|Main Period, Weeks 0-26|Unclassified|7
1751713|NCT00856986|6105423|P2|Main Period, Weeks 0-26|Unclassified|6
1751714|NCT00856986|6105424|P1|Main Period, Weeks 0-26|Unclassified|7
1751715|NCT00856986|6105420|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
1751716|NCT00856986|6105421|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
1751717|NCT00856986|6105422|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
1751718|NCT00856986|6105423|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
1751719|NCT00856986|6105424|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
1751720|NCT00856986|6105420|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
1751721|NCT00856986|6105421|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
1751722|NCT00856986|6105422|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
1751723|NCT00856986|6105423|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
1751724|NCT00856986|6105424|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
1751725|NCT00856986|6105420|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
1751726|NCT00856986|6105421|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
1751727|NCT00856986|6105422|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
1751728|NCT00856986|6105423|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
1751729|NCT00856986|6105424|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
1751730|NCT00856986|6105420|P5|Main Period, Weeks 0-26|Protocol Violation|0
1751731|NCT00856986|6105421|P4|Main Period, Weeks 0-26|Protocol Violation|0
1751732|NCT00856986|6105422|P3|Main Period, Weeks 0-26|Protocol Violation|7
1751733|NCT00856986|6105423|P2|Main Period, Weeks 0-26|Protocol Violation|5
1751734|NCT00856986|6105424|P1|Main Period, Weeks 0-26|Protocol Violation|4
1751735|NCT00856986|6105420|P5|Main Period, Weeks 0-26|Adverse Event|0
1751736|NCT00856986|6105421|P4|Main Period, Weeks 0-26|Adverse Event|0
1751737|NCT00856986|6105422|P3|Main Period, Weeks 0-26|Adverse Event|9
1751738|NCT00856986|6105423|P2|Main Period, Weeks 0-26|Adverse Event|4
1751739|NCT00856986|6105424|P1|Main Period, Weeks 0-26|Adverse Event|6
1751740|NCT00856986|6105420|P5|Run-in Period, Weeks -12-0|Unclassified|0
1751741|NCT00856986|6105421|P4|Run-in Period, Weeks -12-0|Unclassified|24
1751742|NCT00856986|6105422|P3|Run-in Period, Weeks -12-0|Unclassified|0
1751743|NCT00856986|6105423|P2|Run-in Period, Weeks -12-0|Unclassified|0
1751744|NCT00856986|6105424|P1|Run-in Period, Weeks -12-0|Unclassified|0
1751745|NCT00856986|6105420|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1751746|NCT00856986|6105421|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
1751747|NCT00856986|6105422|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1751748|NCT00856986|6105423|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1751749|NCT00856986|6105424|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
1751750|NCT00856986|6105420|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1751751|NCT00856986|6105421|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
1751752|NCT00856986|6105422|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1751753|NCT00856986|6105423|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1751754|NCT00856986|6105424|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
1751755|NCT00856986|6105420|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1751756|NCT00856986|6105421|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
1751757|NCT00856986|6105422|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1751758|NCT00856986|6105423|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1751759|NCT00856986|6105424|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
1751760|NCT00856986|6105420|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
1751761|NCT00856986|6105421|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
1751762|NCT00856986|6105422|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
1751763|NCT00856986|6105423|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
1751764|NCT00856986|6105424|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
1751765|NCT00856986|6105420|P5|Run-in Period, Weeks -12-0|Adverse Event|0
1751766|NCT00856986|6105421|P4|Run-in Period, Weeks -12-0|Adverse Event|92
1751767|NCT00856986|6105422|P3|Run-in Period, Weeks -12-0|Adverse Event|0
1751768|NCT00856986|6105423|P2|Run-in Period, Weeks -12-0|Adverse Event|0
1751769|NCT00856986|6105424|P1|Run-in Period, Weeks -12-0|Adverse Event|0
1751770|NCT00856973|6105594|P3|Overall Study|Other|13
1751771|NCT00856973|6105595|P2|Overall Study|Other|12
1751772|NCT00856973|6105596|P1|Overall Study|Other|11
1751773|NCT00856973|6105594|P3|Overall Study|Withdrawal by Subject|15
1751774|NCT00856973|6105595|P2|Overall Study|Withdrawal by Subject|16
1751775|NCT00856973|6105596|P1|Overall Study|Withdrawal by Subject|13
1751776|NCT00856973|6105594|P3|Overall Study|Protocol Violation|1
1751777|NCT00856973|6105595|P2|Overall Study|Protocol Violation|2
1751778|NCT00856973|6105596|P1|Overall Study|Protocol Violation|1
1751779|NCT00856973|6105594|P3|Overall Study|Physician Decision|1
1751780|NCT00856973|6105595|P2|Overall Study|Physician Decision|3
1751781|NCT00856973|6105596|P1|Overall Study|Physician Decision|0
1751782|NCT00856973|6105594|P3|Overall Study|Lost to Follow-up|5
1751783|NCT00856973|6105595|P2|Overall Study|Lost to Follow-up|3
1751784|NCT00856973|6105596|P1|Overall Study|Lost to Follow-up|6
1751785|NCT00856973|6105594|P3|Overall Study|Adverse Event|3
1751786|NCT00856973|6105595|P2|Overall Study|Adverse Event|5
1751787|NCT00856973|6105596|P1|Overall Study|Adverse Event|5
1751788|NCT00856908|6105676|P2|Overall Study|Lost to Follow-up|0
1751789|NCT00856908|6105677|P1|Overall Study|Lost to Follow-up|1
1751790|NCT00856856|6105702|P1|4-year Clinical Follow-up|Missed visit|1
1751791|NCT00856856|6105702|P1|2-year Clinical Follow-up|Lost to Follow-up|1
1751792|NCT00856843|6105901|P2|Overall Study|Lack of Efficacy|0
1751793|NCT00856843|6105902|P1|Overall Study|Lack of Efficacy|1
1751794|NCT00856843|6105901|P2|Overall Study|Withdrawal by Subject|5
1751795|NCT00856843|6105902|P1|Overall Study|Withdrawal by Subject|1
1751796|NCT00856830|6105938|P4|Irinotecan & Bendamustine|Physician Decision|1
1751797|NCT00856830|6105939|P3|Irinotecan & Bendamustine|Physician Decision|0
1751798|NCT00856830|6105940|P2|Irinotecan & Bendamustine|Physician Decision|0
1751799|NCT00856830|6105941|P1|Irinotecan & Bendamustine|Physician Decision|0
1751800|NCT00856830|6105938|P4|Irinotecan & Bendamustine|Death|2
1751801|NCT00856830|6105939|P3|Irinotecan & Bendamustine|Death|0
1751802|NCT00856830|6105940|P2|Irinotecan & Bendamustine|Death|0
1751803|NCT00856830|6105941|P1|Irinotecan & Bendamustine|Death|0
1751804|NCT00856778|6105952|P1|Overall Study|Lost to Follow-up|5
1751805|NCT00856778|6105952|P1|Overall Study|Study deviation|2
1751806|NCT00856778|6105952|P1|Overall Study|Withdrawal by Subject|10
1751807|NCT00856778|6105952|P1|Overall Study|Adverse Event|7
1751808|NCT00856661|6105995|P2|Overall Study|Physician Judgement|5
1751809|NCT00856661|6105996|P1|Overall Study|Physician Judgement|8
1751810|NCT00856661|6105995|P2|Overall Study|Lost to Follow-up|3
1751811|NCT00856661|6105996|P1|Overall Study|Lost to Follow-up|1
1751812|NCT00856661|6105995|P2|Overall Study|Withdrawal by Subject|2
1751813|NCT00856661|6105996|P1|Overall Study|Withdrawal by Subject|1
1751814|NCT00856661|6105995|P2|Overall Study|Protocol Violation|1
1751815|NCT00856661|6105996|P1|Overall Study|Protocol Violation|2
1751816|NCT00856661|6105995|P2|Overall Study|Death|18
1751817|NCT00856661|6105996|P1|Overall Study|Death|15
1751818|NCT00856635|6106010|P2|Overall Study|Discontinued at Randomization|2
1751819|NCT00856635|6106011|P1|Overall Study|Discontinued at Randomization|2
1751820|NCT00856635|6106010|P2|Overall Study|Other|0
1751821|NCT00856635|6106011|P1|Overall Study|Other|1
1751822|NCT00856635|6106010|P2|Overall Study|Serious Adverse Event|0
1751823|NCT00856635|6106011|P1|Overall Study|Serious Adverse Event|1
1751824|NCT00856635|6106010|P2|Overall Study|Withdrawal by Subject|1
1751825|NCT00856635|6106011|P1|Overall Study|Withdrawal by Subject|3
1751826|NCT00856635|6106010|P2|Overall Study|Pregnancy|0
1751827|NCT00856635|6106011|P1|Overall Study|Pregnancy|1
1751828|NCT00856635|6106010|P2|Overall Study|Lost to Follow-up|5
1751829|NCT00856635|6106011|P1|Overall Study|Lost to Follow-up|2
1751830|NCT00856609|6106021|P2|Overall Study|Adverse Event|0
1751831|NCT00856609|6106022|P1|Overall Study|Adverse Event|1
1751832|NCT00856583|6106034|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
1751833|NCT00856583|6106035|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
1751834|NCT00856583|6106034|P2|Overall Study|Other|104
1751835|NCT00856583|6106035|P1|Overall Study|Other|92
1751836|NCT00856583|6106034|P2|Overall Study|Pregnancy|5
1751837|NCT00856583|6106035|P1|Overall Study|Pregnancy|14
1751838|NCT00856583|6106034|P2|Overall Study|Physician Decision|82
1751839|NCT00856583|6106035|P1|Overall Study|Physician Decision|59
1751840|NCT00856583|6106034|P2|Overall Study|Withdrawal by Subject|919
1751841|NCT00856583|6106035|P1|Overall Study|Withdrawal by Subject|1092
1751842|NCT00856583|6106034|P2|Overall Study|Non-compliance|262
1751843|NCT00856583|6106035|P1|Overall Study|Non-compliance|305
1751844|NCT00856583|6106034|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
1751845|NCT00856583|6106035|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
1751846|NCT00856583|6106034|P2|Overall Study|Serious Adverse Event (SAE)|65
1751847|NCT00856583|6106035|P1|Overall Study|Serious Adverse Event (SAE)|99
1751848|NCT00856583|6106034|P2|Overall Study|Lack of Efficacy|377
1751849|NCT00856583|6106035|P1|Overall Study|Lack of Efficacy|389
1751850|NCT00856557|6106065|P2|Overall Study|No patients with contextual flags|16
1751851|NCT00856557|6106066|P1|Overall Study|No patients with contextual flags|12
1751852|NCT00856544|6106080|P4|Overall Study|Withdrawal by Subject|1
1751853|NCT00856544|6106081|P3|Overall Study|Withdrawal by Subject|0
1751854|NCT00856544|6106082|P2|Overall Study|Withdrawal by Subject|5
1751855|NCT00856544|6106083|P1|Overall Study|Withdrawal by Subject|8
1751856|NCT00856544|6106080|P4|Overall Study|Lost to Follow-up|0
1751857|NCT00856544|6106081|P3|Overall Study|Lost to Follow-up|2
1751858|NCT00856544|6106082|P2|Overall Study|Lost to Follow-up|2
1751859|NCT00856544|6106083|P1|Overall Study|Lost to Follow-up|1
1751860|NCT00856544|6106080|P4|Overall Study|Other|6
1751861|NCT00856544|6106081|P3|Overall Study|Other|1
1751862|NCT00856544|6106082|P2|Overall Study|Other|16
1751863|NCT00856544|6106083|P1|Overall Study|Other|9
1751864|NCT00856544|6106080|P4|Overall Study|Lack of Efficacy|3
1751865|NCT00856544|6106081|P3|Overall Study|Lack of Efficacy|3
1751866|NCT00856544|6106082|P2|Overall Study|Lack of Efficacy|12
1751867|NCT00856544|6106083|P1|Overall Study|Lack of Efficacy|16
1751868|NCT00856544|6106080|P4|Overall Study|Adverse Event|3
1751869|NCT00856544|6106081|P3|Overall Study|Adverse Event|2
1751870|NCT00856544|6106082|P2|Overall Study|Adverse Event|29
1751871|NCT00856544|6106083|P1|Overall Study|Adverse Event|20
1751872|NCT00856544|6106080|P4|Overall Study|Death|0
1751873|NCT00856544|6106081|P3|Overall Study|Death|0
1751874|NCT00856544|6106082|P2|Overall Study|Death|2
1751875|NCT00856544|6106083|P1|Overall Study|Death|0
1751876|NCT00856544|6106080|P4|Overall Study|Randomized but not treated|0
1751877|NCT00856544|6106081|P3|Overall Study|Randomized but not treated|0
1751878|NCT00856544|6106082|P2|Overall Study|Randomized but not treated|0
1751879|NCT00856544|6106083|P1|Overall Study|Randomized but not treated|3
1751880|NCT00856518|6106262|P2|Overall Study|Lost to Follow-up|2
1751881|NCT00856518|6106263|P1|Overall Study|Lost to Follow-up|4
1751882|NCT00856492|6106276|P3|Overall Study|Ineligible or withdrew consent|2
1751883|NCT00856492|6106277|P2|Overall Study|Ineligible or withdrew consent|1
1751884|NCT00856492|6106278|P1|Overall Study|Ineligible or withdrew consent|1
1751885|NCT00856388|6106300|P1|Overall Study|Other|1
1751886|NCT00856349|6106311|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
1751887|NCT00856349|6106311|P1|Overall Study|Site closure|78
1751888|NCT00856349|6106311|P1|Overall Study|Device explant|33
1751889|NCT00856349|6106311|P1|Overall Study|Subject relocation|104
1751890|NCT00856349|6106311|P1|Overall Study|Physician Decision|13
1751891|NCT00856349|6106311|P1|Overall Study|Protocol Violation|38
1751892|NCT00856349|6106311|P1|Overall Study|Lost to Follow-up|91
1751893|NCT00856349|6106311|P1|Overall Study|Withdrawal by Subject|116
1751894|NCT00856349|6106311|P1|Overall Study|Death|418
1751895|NCT00856323|6106320|P1|Overall Study|Withdrawal by Subject|2
1751896|NCT00856297|6106332|P5|Overall Study|Unable to classify|0
1751897|NCT00856297|6106333|P4|Overall Study|Unable to classify|0
1751898|NCT00856297|6106334|P3|Overall Study|Unable to classify|0
1751899|NCT00856297|6106335|P2|Overall Study|Unable to classify|0
1751900|NCT00856297|6106336|P1|Overall Study|Unable to classify|2
1751901|NCT00856284|6106369|P3|Overall Study|Randomized in error|1
1751902|NCT00856284|6106370|P2|Overall Study|Randomized in error|0
1751903|NCT00856284|6106371|P1|Overall Study|Randomized in error|0
1751904|NCT00856284|6106369|P3|Overall Study|Other|14
1751905|NCT00856284|6106370|P2|Overall Study|Other|17
1751906|NCT00856284|6106371|P1|Overall Study|Other|15
1751907|NCT00856284|6106369|P3|Overall Study|Investigator discretion|10
1751908|NCT00856284|6106370|P2|Overall Study|Investigator discretion|8
1751909|NCT00856284|6106371|P1|Overall Study|Investigator discretion|9
1751910|NCT00856284|6106369|P3|Overall Study|Pregnancy|0
1751911|NCT00856284|6106370|P2|Overall Study|Pregnancy|2
1751912|NCT00856284|6106371|P1|Overall Study|Pregnancy|1
1751913|NCT00856284|6106369|P3|Overall Study|Voluntary withdrawal|62
1751914|NCT00856284|6106370|P2|Overall Study|Voluntary withdrawal|52
1751915|NCT00856284|6106371|P1|Overall Study|Voluntary withdrawal|48
1751916|NCT00856284|6106369|P3|Overall Study|Lost to Follow-up|28
1751917|NCT00856284|6106370|P2|Overall Study|Lost to Follow-up|22
1751918|NCT00856284|6106371|P1|Overall Study|Lost to Follow-up|20
1751919|NCT00856284|6106369|P3|Overall Study|Major protocol deviation|15
1751920|NCT00856284|6106370|P2|Overall Study|Major protocol deviation|16
1751921|NCT00856284|6106371|P1|Overall Study|Major protocol deviation|24
1751922|NCT00856284|6106369|P3|Overall Study|Adverse Event|82
1751923|NCT00856284|6106370|P2|Overall Study|Adverse Event|74
1751924|NCT00856284|6106371|P1|Overall Study|Adverse Event|60
1751925|NCT00856284|6106369|P3|Overall Study|Hyperglycemic rescue|235
1751926|NCT00856284|6106370|P2|Overall Study|Hyperglycemic rescue|201
1751927|NCT00856284|6106371|P1|Overall Study|Hyperglycemic rescue|231
1751928|NCT00856245|6106397|P1|Overall Study|Was not transplanted|5
1751929|NCT00856206|6106420|P2|Overall Study|Other than specified above|10
1751930|NCT00856206|6106421|P1|Overall Study|Other than specified above|3
1751931|NCT00856206|6106420|P2|Overall Study|Decision by the Sponsor|8
1751932|NCT00856206|6106421|P1|Overall Study|Decision by the Sponsor|4
1751933|NCT00856206|6106420|P2|Overall Study|Death|2
1751934|NCT00856206|6106421|P1|Overall Study|Death|2
1751935|NCT00856206|6106420|P2|Overall Study|Lost to Follow-up|39
1751936|NCT00856206|6106421|P1|Overall Study|Lost to Follow-up|13
1751937|NCT00856206|6106420|P2|Overall Study|Withdrawal by Subject|36
1751938|NCT00856206|6106421|P1|Overall Study|Withdrawal by Subject|15
1751939|NCT00856206|6106420|P2|Overall Study|Lack of Efficacy|2
1751940|NCT00856206|6106421|P1|Overall Study|Lack of Efficacy|1
1751941|NCT00856206|6106420|P2|Overall Study|Adverse Event|46
1751942|NCT00856206|6106421|P1|Overall Study|Adverse Event|10
1751943|NCT00856206|6106420|P2|Overall Study|Protocol Violation|18
1751944|NCT00856206|6106421|P1|Overall Study|Protocol Violation|6
1751945|NCT00856193|6106435|P2|Period 2|Lost to Follow-up|1
1751946|NCT00856193|6106436|P1|Period 2|Lost to Follow-up|0
1751947|NCT00856193|6106435|P2|Period 2|Abnormal test procedure results|1
1751948|NCT00856193|6106436|P1|Period 2|Abnormal test procedure results|0
1751949|NCT00856180|6106448|P1|Overall Study|Progressive Disease|16
1751950|NCT00856180|6106448|P1|Overall Study|Adverse Event|4
1751951|NCT00855959|6106473|P1|Overall Study|Incorrect enrolment|1
1751952|NCT00855959|6106473|P1|Overall Study|Pregnancy|1
1751953|NCT00855959|6106473|P1|Overall Study|Withdrawal by Subject|3
1751954|NCT00855959|6106473|P1|Overall Study|Lost to Follow-up|2
1751955|NCT00855959|6106473|P1|Overall Study|Adverse Event|2
1751956|NCT00855933|6106490|P2|Overall Study|Withdrawal by Subject|1
1751957|NCT00855933|6106491|P1|Overall Study|Withdrawal by Subject|0
1751958|NCT00855920|6106500|P3|Overall Study|Other than specified above|1
1751959|NCT00855920|6106501|P2|Overall Study|Other than specified above|1
1751960|NCT00855920|6106502|P1|Overall Study|Other than specified above|1
1751961|NCT00855920|6106500|P3|Overall Study|Decision by the sponsor|1
1751962|NCT00855920|6106501|P2|Overall Study|Decision by the sponsor|1
1751963|NCT00855920|6106502|P1|Overall Study|Decision by the sponsor|0
1751964|NCT00855920|6106500|P3|Overall Study|Death|0
1751965|NCT00855920|6106501|P2|Overall Study|Death|1
1751966|NCT00855920|6106502|P1|Overall Study|Death|0
1751967|NCT00855920|6106500|P3|Overall Study|Lost to Follow-up|2
1751968|NCT00855920|6106501|P2|Overall Study|Lost to Follow-up|0
1751969|NCT00855920|6106502|P1|Overall Study|Lost to Follow-up|1
1751970|NCT00855920|6106500|P3|Overall Study|Withdrawal by Subject|2
1751971|NCT00855920|6106501|P2|Overall Study|Withdrawal by Subject|3
1751972|NCT00855920|6106502|P1|Overall Study|Withdrawal by Subject|2
1751973|NCT00855920|6106500|P3|Overall Study|Lack of Efficacy|2
1751974|NCT00855920|6106501|P2|Overall Study|Lack of Efficacy|2
1751975|NCT00855920|6106502|P1|Overall Study|Lack of Efficacy|2
1751976|NCT00855920|6106500|P3|Overall Study|Adverse Event|1
1751977|NCT00855920|6106501|P2|Overall Study|Adverse Event|1
1751978|NCT00855920|6106502|P1|Overall Study|Adverse Event|2
1751979|NCT00855920|6106500|P3|Overall Study|Protocol Violation|2
1751980|NCT00855920|6106501|P2|Overall Study|Protocol Violation|0
1751981|NCT00855920|6106502|P1|Overall Study|Protocol Violation|0
1751982|NCT00855894|6106519|P1|Overall Study|Disease progression|1
1751983|NCT00855894|6106519|P1|Overall Study|Patient's decision|1
1751984|NCT00855894|6106519|P1|Overall Study|Death|31
1751985|NCT00855816|6106542|P2|Overall Study|Became ineligible|1
1751986|NCT00855816|6106543|P1|Overall Study|Became ineligible|0
1751987|NCT00855816|6106542|P2|Overall Study|Death|0
1751988|NCT00855816|6106543|P1|Overall Study|Death|1
1751989|NCT00855816|6106542|P2|Overall Study|Lost to Follow-up|5
1751990|NCT00855816|6106543|P1|Overall Study|Lost to Follow-up|3
1751991|NCT00855816|6106542|P2|Overall Study|Withdrawal by Subject|15
1751992|NCT00855816|6106543|P1|Overall Study|Withdrawal by Subject|22
1751993|NCT00855738|6106549|P1|Overall Study|Death|1
1751994|NCT00855738|6106549|P1|Overall Study|Subject Defaulted|1
1751995|NCT00855738|6106549|P1|Overall Study|Adverse Event|1
1751996|NCT00855738|6106549|P1|Overall Study|Lost to Follow-up|2
1751997|NCT00855595|6106577|P2|Overall Study|patient left country|1
1751998|NCT00855595|6106578|P1|Overall Study|patient left country|0
1751999|NCT00855595|6106577|P2|Overall Study|patient moved out of state|0
1752000|NCT00855595|6106578|P1|Overall Study|patient moved out of state|1
1752001|NCT00855595|6106577|P2|Overall Study|Adverse Event|1
1752002|NCT00855595|6106578|P1|Overall Study|Adverse Event|1
1752003|NCT00855595|6106577|P2|Overall Study|Lost to Follow-up|3
1752004|NCT00855595|6106578|P1|Overall Study|Lost to Follow-up|3
1752005|NCT00855595|6106577|P2|Overall Study|Withdrawal by Subject|2
1752006|NCT00855595|6106578|P1|Overall Study|Withdrawal by Subject|1
1752007|NCT00855582|6106617|P3|Overall Study|Withdrawal by Subject|8
1752008|NCT00855582|6106618|P2|Overall Study|Withdrawal by Subject|4
1752009|NCT00855582|6106619|P1|Overall Study|Withdrawal by Subject|7
1752010|NCT00855582|6106617|P3|Overall Study|Entry Criteria Not Met|3
1752011|NCT00855582|6106618|P2|Overall Study|Entry Criteria Not Met|6
1752012|NCT00855582|6106619|P1|Overall Study|Entry Criteria Not Met|8
1752013|NCT00855582|6106617|P3|Overall Study|Protocol Violation|6
1752014|NCT00855582|6106618|P2|Overall Study|Protocol Violation|2
1752015|NCT00855582|6106619|P1|Overall Study|Protocol Violation|6
1752016|NCT00855582|6106617|P3|Overall Study|Physician Decision|1
1752017|NCT00855582|6106618|P2|Overall Study|Physician Decision|0
1752018|NCT00855582|6106619|P1|Overall Study|Physician Decision|0
1752019|NCT00855582|6106617|P3|Overall Study|Lost to Follow-up|1
1752020|NCT00855582|6106618|P2|Overall Study|Lost to Follow-up|3
1752021|NCT00855582|6106619|P1|Overall Study|Lost to Follow-up|1
1752022|NCT00855582|6106617|P3|Overall Study|Lack of Efficacy|8
1752023|NCT00855582|6106618|P2|Overall Study|Lack of Efficacy|3
1752024|NCT00855582|6106619|P1|Overall Study|Lack of Efficacy|1
1752025|NCT00855582|6106617|P3|Overall Study|Death|0
1752026|NCT00855582|6106618|P2|Overall Study|Death|0
1752027|NCT00855582|6106619|P1|Overall Study|Death|1
1752028|NCT00855582|6106617|P3|Overall Study|Adverse Event|3
1752029|NCT00855582|6106618|P2|Overall Study|Adverse Event|6
1752030|NCT00855582|6106619|P1|Overall Study|Adverse Event|2
1752031|NCT00855465|6106708|P2|Follow-up Period (FUP)|Missing|0
1752032|NCT00855465|6106709|P1|Follow-up Period (FUP)|Missing|1
1752033|NCT00855465|6106708|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
1752034|NCT00855465|6106709|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
1752035|NCT00855465|6106708|P2|Follow-up Period (FUP)|Lost to Follow-up|0
1752036|NCT00855465|6106709|P1|Follow-up Period (FUP)|Lost to Follow-up|3
1752037|NCT00855465|6106708|P2|Follow-up Period (FUP)|Death|1
1752038|NCT00855465|6106709|P1|Follow-up Period (FUP)|Death|0
1752039|NCT00855465|6106708|P2|Follow-up Period (FUP)|Adverse Event|1
1752040|NCT00855465|6106709|P1|Follow-up Period (FUP)|Adverse Event|0
1752041|NCT00855465|6106708|P2|Treatment Period|Not treated|0
1752042|NCT00855465|6106709|P1|Treatment Period|Not treated|1
1752043|NCT00855465|6106708|P2|Treatment Period|Withdrawal by Subject|0
1752044|NCT00855465|6106709|P1|Treatment Period|Withdrawal by Subject|2
1752045|NCT00855465|6106708|P2|Treatment Period|Protocol Violation|0
1752046|NCT00855465|6106709|P1|Treatment Period|Protocol Violation|2
1752047|NCT00855465|6106708|P2|Treatment Period|Non-compliance|0
1752048|NCT00855465|6106709|P1|Treatment Period|Non-compliance|1
1752049|NCT00855465|6106708|P2|Treatment Period|Lack of Efficacy|1
1752050|NCT00855465|6106709|P1|Treatment Period|Lack of Efficacy|2
1752051|NCT00855465|6106708|P2|Treatment Period|Death|2
1752052|NCT00855465|6106709|P1|Treatment Period|Death|2
1752053|NCT00855465|6106708|P2|Treatment Period|Adverse Event|2
1752054|NCT00855465|6106709|P1|Treatment Period|Adverse Event|4
1752055|NCT00855439|6106799|P2|Overall Study|Pregnancy|0
1752056|NCT00855439|6106800|P1|Overall Study|Pregnancy|1
1752057|NCT00855439|6106799|P2|Overall Study|Withdrawal by Subject|0
1752058|NCT00855439|6106800|P1|Overall Study|Withdrawal by Subject|2
1752059|NCT00855335|6106858|P5|Overall Study|Other|1
1752060|NCT00855335|6106859|P4|Overall Study|Other|5
1752061|NCT00855335|6106860|P3|Overall Study|Other|2
1752062|NCT00855335|6106861|P2|Overall Study|Other|1
1752063|NCT00855335|6106862|P1|Overall Study|Other|2
1752064|NCT00855335|6106858|P5|Overall Study|Physician Decision|0
1752065|NCT00855335|6106859|P4|Overall Study|Physician Decision|0
1752066|NCT00855335|6106860|P3|Overall Study|Physician Decision|0
1752067|NCT00855335|6106861|P2|Overall Study|Physician Decision|1
1752068|NCT00855335|6106862|P1|Overall Study|Physician Decision|1
1752069|NCT00855335|6106858|P5|Overall Study|Adverse Event|0
1752070|NCT00855335|6106859|P4|Overall Study|Adverse Event|0
1752071|NCT00855335|6106860|P3|Overall Study|Adverse Event|0
1752072|NCT00855335|6106861|P2|Overall Study|Adverse Event|0
1752073|NCT00855335|6106862|P1|Overall Study|Adverse Event|2
1752074|NCT00855335|6106858|P5|Overall Study|Withdrawal by Subject|0
1752075|NCT00855335|6106859|P4|Overall Study|Withdrawal by Subject|1
1752076|NCT00855335|6106860|P3|Overall Study|Withdrawal by Subject|0
1752077|NCT00855335|6106861|P2|Overall Study|Withdrawal by Subject|0
1752078|NCT00855335|6106862|P1|Overall Study|Withdrawal by Subject|0
1752079|NCT00855335|6106858|P5|Overall Study|Lost to Follow-up|0
1752080|NCT00855335|6106859|P4|Overall Study|Lost to Follow-up|1
1752081|NCT00855335|6106860|P3|Overall Study|Lost to Follow-up|3
1752082|NCT00855335|6106861|P2|Overall Study|Lost to Follow-up|0
1752083|NCT00855335|6106862|P1|Overall Study|Lost to Follow-up|0
1752084|NCT00855309|6106949|P2|Overall Study|patient never recieved drug|0
1752085|NCT00855309|6106950|P1|Overall Study|patient never recieved drug|1
1752086|NCT00855218|6106958|P2|Overall Study|Clinical endpoint reached|13
1752087|NCT00855218|6106959|P1|Overall Study|Clinical endpoint reached|10
1752088|NCT00855218|6106958|P2|Overall Study|Progression measurement proven|15
1752089|NCT00855218|6106959|P1|Overall Study|Progression measurement proven|7
1752090|NCT00855218|6106958|P2|Overall Study|Second malignancy|1
1752091|NCT00855218|6106959|P1|Overall Study|Second malignancy|0
1752092|NCT00855218|6106958|P2|Overall Study|Untreatable disease progression|67
1752093|NCT00855218|6106959|P1|Overall Study|Untreatable disease progression|54
1752094|NCT00855218|6106958|P2|Overall Study|Still treated with study medication|1
1752095|NCT00855218|6106959|P1|Overall Study|Still treated with study medication|0
1752096|NCT00855218|6106958|P2|Overall Study|technical problems|1
1752097|NCT00855218|6106959|P1|Overall Study|technical problems|2
1752098|NCT00855218|6106958|P2|Overall Study|patient convenience|0
1752099|NCT00855218|6106959|P1|Overall Study|patient convenience|2
1752100|NCT00855218|6106958|P2|Overall Study|non-compliant with study drug|1
1752101|NCT00855218|6106959|P1|Overall Study|non-compliant with study drug|3
1752102|NCT00855218|6106958|P2|Overall Study|Protocol Violation|9
1752103|NCT00855218|6106959|P1|Overall Study|Protocol Violation|5
1752104|NCT00855218|6106958|P2|Overall Study|Lost to Follow-up|1
1752105|NCT00855218|6106959|P1|Overall Study|Lost to Follow-up|0
1752106|NCT00855218|6106958|P2|Overall Study|Physician Decision|11
1752107|NCT00855218|6106959|P1|Overall Study|Physician Decision|18
1752108|NCT00855218|6106958|P2|Overall Study|Withdrawal by Subject|6
1752109|NCT00855218|6106959|P1|Overall Study|Withdrawal by Subject|10
1752110|NCT00855218|6106958|P2|Overall Study|Adverse Event|27
1752111|NCT00855218|6106959|P1|Overall Study|Adverse Event|43
1752112|NCT00855166|6106977|P2|Overall Study|Subject no longer meets study criteria|1
1752113|NCT00855166|6106978|P1|Overall Study|Subject no longer meets study criteria|1
1752114|NCT00855166|6106977|P2|Overall Study|Administrative reasons by sponsor|0
1752115|NCT00855166|6106978|P1|Overall Study|Administrative reasons by sponsor|1
1752116|NCT00855166|6106977|P2|Overall Study|Poor/non-compliance|0
1752117|NCT00855166|6106978|P1|Overall Study|Poor/non-compliance|2
1752118|NCT00855166|6106977|P2|Overall Study|Withdrawal by Subject|4
1752119|NCT00855166|6106978|P1|Overall Study|Withdrawal by Subject|1
1752120|NCT00855166|6106977|P2|Overall Study|Death|1
1752121|NCT00855166|6106978|P1|Overall Study|Death|0
1752122|NCT00855166|6106977|P2|Overall Study|Adverse Event|2
1752123|NCT00855166|6106978|P1|Overall Study|Adverse Event|0
1752124|NCT00855062|6106998|P2|Step2|Initiation of antiretroviral therapy/ART|1
1752125|NCT00855062|6106999|P1|Step2|Initiation of antiretroviral therapy/ART|0
1752126|NCT00855062|6106998|P2|Step2|Adverse Event|3
1752127|NCT00855062|6106999|P1|Step2|Adverse Event|0
1752128|NCT00855062|6106998|P2|Step2|Early Study Closure|2
1752129|NCT00855062|6106999|P1|Step2|Early Study Closure|6
1752130|NCT00855062|6106998|P2|Step1|Withdrawal by Subject|3
1752131|NCT00855062|6106999|P1|Step1|Withdrawal by Subject|2
1752132|NCT00855062|6106998|P2|Step1|Pregnancy|0
1752133|NCT00855062|6106999|P1|Step1|Pregnancy|1
1752134|NCT00855062|6106998|P2|Step1|Protocol Violation|0
1752135|NCT00855062|6106999|P1|Step1|Protocol Violation|1
1752136|NCT00855062|6106998|P2|Step1|Adverse Event|1
1752137|NCT00855062|6106999|P1|Step1|Adverse Event|1
1752138|NCT00855062|6106998|P2|Step1|Early Study Closure|7
1752139|NCT00855062|6106999|P1|Step1|Early Study Closure|5
1752140|NCT00854906|6107048|P1|Overall Study|One person had no ocular history|1
1752141|NCT00854724|6107057|P2|Second Intervention|Physician Decision|1
1752142|NCT00854724|6107058|P1|Second Intervention|Physician Decision|0
1752143|NCT00854724|6107057|P2|Second Intervention|Protocol Violation|0
1752144|NCT00854724|6107058|P1|Second Intervention|Protocol Violation|1
1752145|NCT00854724|6107057|P2|Washout|Withdrawal by Subject|1
1752146|NCT00854724|6107058|P1|Washout|Withdrawal by Subject|0
1752147|NCT00854724|6107057|P2|Washout|Protocol Violation|0
1752148|NCT00854724|6107058|P1|Washout|Protocol Violation|1
1752149|NCT00854724|6107057|P2|First Intervention|Withdrawal by Subject|1
1752150|NCT00854724|6107058|P1|First Intervention|Withdrawal by Subject|1
1752151|NCT00854620|6107064|P1|Overall Study|Adverse Event|1
1752152|NCT00854607|6107068|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
1752153|NCT00854581|6107116|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
1752154|NCT00854581|6107116|P1|Induction (Up to Day 21)|Physician Decision|1
1752155|NCT00854581|6107116|P1|Induction (Up to Day 21)|Death|1
1752156|NCT00854581|6107116|P1|Induction (Up to Day 21)|Lack of Efficacy|4
1752157|NCT00854373|6107131|P2|Overall Study|Forgot to take study drug|1
1752158|NCT00854373|6107132|P1|Overall Study|Forgot to take study drug|1
1752159|NCT00854373|6107131|P2|Overall Study|Withdrawal by Subject|3
1752160|NCT00854373|6107132|P1|Overall Study|Withdrawal by Subject|1
1752161|NCT00854360|6107146|P4|Overall Study|Other|3
1752162|NCT00854360|6107147|P3|Overall Study|Other|0
1752163|NCT00854360|6107148|P2|Overall Study|Other|0
1752164|NCT00854360|6107149|P1|Overall Study|Other|0
1752165|NCT00854360|6107146|P4|Overall Study|Lack of Efficacy|0
1752166|NCT00854360|6107147|P3|Overall Study|Lack of Efficacy|0
1752167|NCT00854360|6107148|P2|Overall Study|Lack of Efficacy|1
1752168|NCT00854360|6107149|P1|Overall Study|Lack of Efficacy|2
1752169|NCT00854360|6107146|P4|Overall Study|Pregnancy|0
1752170|NCT00854360|6107147|P3|Overall Study|Pregnancy|0
1752171|NCT00854360|6107148|P2|Overall Study|Pregnancy|1
1752172|NCT00854360|6107149|P1|Overall Study|Pregnancy|0
1752173|NCT00854360|6107146|P4|Overall Study|Withdrawal by Subject|1
1752174|NCT00854360|6107147|P3|Overall Study|Withdrawal by Subject|0
1752175|NCT00854360|6107148|P2|Overall Study|Withdrawal by Subject|0
1752176|NCT00854360|6107149|P1|Overall Study|Withdrawal by Subject|0
1752177|NCT00854360|6107146|P4|Overall Study|Adverse Event|6
1752178|NCT00854360|6107147|P3|Overall Study|Adverse Event|2
1752179|NCT00854360|6107148|P2|Overall Study|Adverse Event|1
1752180|NCT00854360|6107149|P1|Overall Study|Adverse Event|0
1752181|NCT00854308|6107181|P2|Overall Study|Sponsor's decision to terminate study|1
1752182|NCT00854308|6107182|P1|Overall Study|Sponsor's decision to terminate study|0
1752183|NCT00854308|6107181|P2|Overall Study|Withdrawal by Subject|2
1752184|NCT00854308|6107182|P1|Overall Study|Withdrawal by Subject|4
1752185|NCT00854308|6107181|P2|Overall Study|Physician Decision|6
1752186|NCT00854308|6107182|P1|Overall Study|Physician Decision|6
1752187|NCT00854308|6107181|P2|Overall Study|Death|5
1752188|NCT00854308|6107182|P1|Overall Study|Death|2
1752189|NCT00854308|6107181|P2|Overall Study|Adverse Event|3
1752190|NCT00854308|6107182|P1|Overall Study|Adverse Event|8
1752191|NCT00854308|6107181|P2|Overall Study|Disease progression|50
1752192|NCT00854308|6107182|P1|Overall Study|Disease progression|42
1752193|NCT00854113|6107207|P11|Overall Study|Withdrawal by Subject|0
1752194|NCT00854113|6107208|P10|Overall Study|Withdrawal by Subject|0
1752195|NCT00854113|6107209|P9|Overall Study|Withdrawal by Subject|1
1752196|NCT00854113|6107210|P8|Overall Study|Withdrawal by Subject|1
1752197|NCT00854113|6107211|P7|Overall Study|Withdrawal by Subject|0
1752198|NCT00854113|6107212|P6|Overall Study|Withdrawal by Subject|0
1752199|NCT00854113|6107213|P5|Overall Study|Withdrawal by Subject|0
1752200|NCT00854113|6107214|P4|Overall Study|Withdrawal by Subject|0
1752201|NCT00854113|6107215|P3|Overall Study|Withdrawal by Subject|0
1752202|NCT00854113|6107216|P2|Overall Study|Withdrawal by Subject|0
1752203|NCT00854113|6107217|P1|Overall Study|Withdrawal by Subject|0
1752204|NCT00854113|6107207|P11|Overall Study|Adverse Event|0
1752205|NCT00854113|6107208|P10|Overall Study|Adverse Event|0
1752206|NCT00854113|6107209|P9|Overall Study|Adverse Event|0
1752207|NCT00854113|6107210|P8|Overall Study|Adverse Event|2
1752208|NCT00854113|6107211|P7|Overall Study|Adverse Event|0
1752209|NCT00854113|6107212|P6|Overall Study|Adverse Event|0
1752210|NCT00854113|6107213|P5|Overall Study|Adverse Event|0
1752211|NCT00854113|6107214|P4|Overall Study|Adverse Event|0
1752212|NCT00854113|6107215|P3|Overall Study|Adverse Event|0
1752213|NCT00854113|6107216|P2|Overall Study|Adverse Event|0
1752214|NCT00854113|6107217|P1|Overall Study|Adverse Event|0
1752215|NCT00854100|6107321|P3|Overall Study|Adverse Event|2
1752216|NCT00854100|6107322|P2|Overall Study|Adverse Event|1
1752217|NCT00854100|6107323|P1|Overall Study|Adverse Event|2
1752218|NCT00854100|6107321|P3|Overall Study|Protocol Violation|3
1752219|NCT00854100|6107322|P2|Overall Study|Protocol Violation|4
1752220|NCT00854100|6107323|P1|Overall Study|Protocol Violation|2
1752221|NCT00854100|6107321|P3|Overall Study|Withdrawal by Subject|2
1752222|NCT00854100|6107322|P2|Overall Study|Withdrawal by Subject|1
1752223|NCT00854100|6107323|P1|Overall Study|Withdrawal by Subject|3
1752224|NCT00854100|6107321|P3|Overall Study|Lost to Follow-up|3
1752225|NCT00854100|6107322|P2|Overall Study|Lost to Follow-up|0
1752226|NCT00854100|6107323|P1|Overall Study|Lost to Follow-up|2
1752227|NCT00854100|6107321|P3|Overall Study|Inability to complete the study visits|1
1752228|NCT00854100|6107322|P2|Overall Study|Inability to complete the study visits|0
1752229|NCT00854100|6107323|P1|Overall Study|Inability to complete the study visits|0
1752230|NCT00853970|6107356|P2|Overall Study|Cancelled surgery|2
1752231|NCT00853970|6107357|P1|Overall Study|Cancelled surgery|4
1752232|NCT00853970|6107356|P2|Overall Study|Withdrawal by Subject|1
1752233|NCT00853970|6107357|P1|Overall Study|Withdrawal by Subject|2
1752234|NCT00853957|6107367|P2|Overall Study|Protocol deviation|3
1752235|NCT00853957|6107368|P1|Overall Study|Protocol deviation|0
1752236|NCT00853957|6107367|P2|Overall Study|Lost to Follow-up|6
1752237|NCT00853957|6107368|P1|Overall Study|Lost to Follow-up|1
1752238|NCT00853957|6107367|P2|Overall Study|Subject withdrew consent|5
1752239|NCT00853957|6107368|P1|Overall Study|Subject withdrew consent|4
1752240|NCT00853957|6107367|P2|Overall Study|Unsatisfactory therapeutic effect|2
1752241|NCT00853957|6107368|P1|Overall Study|Unsatisfactory therapeutic effect|0
1752242|NCT00853957|6107367|P2|Overall Study|Adverse Event|3
1752243|NCT00853957|6107368|P1|Overall Study|Adverse Event|9
1752244|NCT00853905|6107386|P2|Overall Study|never had surgery|0
1752245|NCT00853905|6107387|P1|Overall Study|never had surgery|1
1752246|NCT00853905|6107386|P2|Overall Study|Withdrawal by Subject|1
1752247|NCT00853905|6107387|P1|Overall Study|Withdrawal by Subject|0
1752248|NCT00853905|6107386|P2|Overall Study|Lost to Follow-up|3
1752249|NCT00853905|6107387|P1|Overall Study|Lost to Follow-up|1
1752250|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Death|6
1752251|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Death|1
1752252|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Administrative problems|56
1752253|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Administrative problems|45
1752254|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
1752255|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
1752256|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
1752257|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
1752258|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
1752259|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
1752260|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
1752261|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
1752262|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
1752263|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
1752264|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
1752265|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
1752266|NCT00853827|6107419|P2|Double Blind Period (103 Weeks)|Adverse Event|14
1752267|NCT00853827|6107420|P1|Double Blind Period (103 Weeks)|Adverse Event|25
1752268|NCT00853827|6107419|P2|Single Blind Period (1 Week)|Protocol Violation|0
1752269|NCT00853827|6107420|P1|Single Blind Period (1 Week)|Protocol Violation|12
1752270|NCT00853827|6107419|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
1752271|NCT00853827|6107420|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
1752272|NCT00853827|6107419|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
1752273|NCT00853827|6107420|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
1752274|NCT00853827|6107419|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
1752275|NCT00853827|6107420|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
1752276|NCT00853827|6107419|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
1752277|NCT00853827|6107420|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
1752278|NCT00853827|6107419|P2|Single Blind Period (1 Week)|Adverse Event|0
1752279|NCT00853827|6107420|P1|Single Blind Period (1 Week)|Adverse Event|9
1752280|NCT00853827|6107419|P2|Single Blind Period (1 Week)|Other|0
1752281|NCT00853827|6107420|P1|Single Blind Period (1 Week)|Other|4
1752282|NCT00853762|6107436|P4|Overall Study|Randomised but not Treated|0
1752283|NCT00853762|6107437|P3|Overall Study|Randomised but not Treated|2
1752284|NCT00853762|6107438|P2|Overall Study|Randomised but not Treated|2
1752285|NCT00853762|6107439|P1|Overall Study|Randomised but not Treated|0
1752286|NCT00853762|6107436|P4|Overall Study|Other|0
1752287|NCT00853762|6107437|P3|Overall Study|Other|0
1752288|NCT00853762|6107438|P2|Overall Study|Other|2
1752289|NCT00853762|6107439|P1|Overall Study|Other|0
1752290|NCT00853762|6107436|P4|Overall Study|Withdrawal by Subject|0
1752291|NCT00853762|6107437|P3|Overall Study|Withdrawal by Subject|1
1752292|NCT00853762|6107438|P2|Overall Study|Withdrawal by Subject|0
1752293|NCT00853762|6107439|P1|Overall Study|Withdrawal by Subject|0
1752294|NCT00853762|6107436|P4|Overall Study|Protocol Violation|1
1752295|NCT00853762|6107437|P3|Overall Study|Protocol Violation|0
1752296|NCT00853762|6107438|P2|Overall Study|Protocol Violation|0
1752297|NCT00853762|6107439|P1|Overall Study|Protocol Violation|0
1752298|NCT00853762|6107436|P4|Overall Study|Premature Termination|21
1752299|NCT00853762|6107437|P3|Overall Study|Premature Termination|14
1752300|NCT00853762|6107438|P2|Overall Study|Premature Termination|15
1752301|NCT00853762|6107439|P1|Overall Study|Premature Termination|16
1752302|NCT00853749|6107507|P2|Overall Study|Lost to Follow-up|1
1752303|NCT00853749|6107508|P1|Overall Study|Lost to Follow-up|0
1752304|NCT00853723|6107529|P3|Overall Study|Protocol Violation|1
1752305|NCT00853723|6107530|P2|Overall Study|Protocol Violation|2
1752306|NCT00853723|6107531|P1|Overall Study|Protocol Violation|1
1752307|NCT00853723|6107529|P3|Overall Study|Withdrawal by Subject|0
1752308|NCT00853723|6107530|P2|Overall Study|Withdrawal by Subject|1
1752309|NCT00853723|6107531|P1|Overall Study|Withdrawal by Subject|2
1752310|NCT00853723|6107529|P3|Overall Study|Adverse Event|1
1752311|NCT00853723|6107530|P2|Overall Study|Adverse Event|4
1752312|NCT00853723|6107531|P1|Overall Study|Adverse Event|3
1752313|NCT00853658|6107585|P3|Overall Study|Missing study completion information|6
1752314|NCT00853658|6107586|P2|Overall Study|Missing study completion information|4
1752315|NCT00853658|6107587|P1|Overall Study|Missing study completion information|5
1752316|NCT00853658|6107585|P3|Overall Study|Patient's request|11
1752317|NCT00853658|6107586|P2|Overall Study|Patient's request|17
1752318|NCT00853658|6107587|P1|Overall Study|Patient's request|21
1752319|NCT00853658|6107585|P3|Overall Study|Vital Status at study end N/A|10
1752320|NCT00853658|6107586|P2|Overall Study|Vital Status at study end N/A|10
1752321|NCT00853658|6107587|P1|Overall Study|Vital Status at study end N/A|8
1752322|NCT00853658|6107585|P3|Overall Study|Vital Status unknown at study end|0
1752323|NCT00853658|6107586|P2|Overall Study|Vital Status unknown at study end|1
1752324|NCT00853658|6107587|P1|Overall Study|Vital Status unknown at study end|1
1752325|NCT00853658|6107585|P3|Overall Study|Vital Status known (alive) at study end|3
1752326|NCT00853658|6107586|P2|Overall Study|Vital Status known (alive) at study end|3
1752327|NCT00853658|6107587|P1|Overall Study|Vital Status known (alive) at study end|2
1752328|NCT00853658|6107585|P3|Overall Study|IRB request|2
1752329|NCT00853658|6107586|P2|Overall Study|IRB request|0
1752330|NCT00853658|6107587|P1|Overall Study|IRB request|0
1752331|NCT00853658|6107585|P3|Overall Study|H.A. Request|19
1752332|NCT00853658|6107586|P2|Overall Study|H.A. Request|23
1752333|NCT00853658|6107587|P1|Overall Study|H.A. Request|26
1752334|NCT00853658|6107585|P3|Overall Study|Lost to Follow-up|11
1752335|NCT00853658|6107586|P2|Overall Study|Lost to Follow-up|6
1752336|NCT00853658|6107587|P1|Overall Study|Lost to Follow-up|11
1752337|NCT00853658|6107585|P3|Overall Study|Death|753
1752338|NCT00853658|6107586|P2|Overall Study|Death|768
1752339|NCT00853658|6107587|P1|Overall Study|Death|713
1752340|NCT00853593|6107607|P1|Overall Study|Implant not attempted|4
1752341|NCT00853593|6107607|P1|Overall Study|Model 4396 lead not attempted|29
1752342|NCT00853593|6107607|P1|Overall Study|Subjects did not receive a 4396 lead|12
1752343|NCT00853580|6107634|P2|Overall Study|Commenced contraindicated therapy|2
1752344|NCT00853580|6107635|P1|Overall Study|Commenced contraindicated therapy|0
1752345|NCT00853580|6107634|P2|Overall Study|Withdrawal by Subject|8
1752346|NCT00853580|6107635|P1|Overall Study|Withdrawal by Subject|2
1752347|NCT00853580|6107634|P2|Overall Study|Protocol Violation|1
1752348|NCT00853580|6107635|P1|Overall Study|Protocol Violation|2
1752349|NCT00853580|6107634|P2|Overall Study|Lost to Follow-up|5
1752350|NCT00853580|6107635|P1|Overall Study|Lost to Follow-up|3
1752351|NCT00853567|6107682|P1|Overall Study|Study prematurely terminated|71
1752352|NCT00853489|6107692|P2|Overall Study|Lost to Follow-up|2
1752353|NCT00853489|6107693|P1|Overall Study|Lost to Follow-up|5
1752354|NCT00853385|6107708|P5|Overall Study|Other|12
1752355|NCT00853385|6107709|P4|Overall Study|Other|4
1752356|NCT00853385|6107710|P3|Overall Study|Other|4
1752357|NCT00853385|6107711|P2|Overall Study|Other|9
1752358|NCT00853385|6107712|P1|Overall Study|Other|18
1752359|NCT00853385|6107708|P5|Overall Study|Withdrawal by Subject|1
1752360|NCT00853385|6107709|P4|Overall Study|Withdrawal by Subject|1
1752361|NCT00853385|6107710|P3|Overall Study|Withdrawal by Subject|0
1752362|NCT00853385|6107711|P2|Overall Study|Withdrawal by Subject|2
1752363|NCT00853385|6107712|P1|Overall Study|Withdrawal by Subject|4
1752364|NCT00853385|6107708|P5|Overall Study|Lost to Follow-up|0
1752365|NCT00853385|6107709|P4|Overall Study|Lost to Follow-up|0
1752366|NCT00853385|6107710|P3|Overall Study|Lost to Follow-up|0
1752367|NCT00853385|6107711|P2|Overall Study|Lost to Follow-up|1
1752368|NCT00853385|6107712|P1|Overall Study|Lost to Follow-up|2
1752369|NCT00853385|6107708|P5|Overall Study|Lack of Efficacy|6
1752370|NCT00853385|6107709|P4|Overall Study|Lack of Efficacy|3
1752371|NCT00853385|6107710|P3|Overall Study|Lack of Efficacy|3
1752372|NCT00853385|6107711|P2|Overall Study|Lack of Efficacy|7
1752373|NCT00853385|6107712|P1|Overall Study|Lack of Efficacy|6
1752374|NCT00853385|6107708|P5|Overall Study|Adverse Event|22
1752375|NCT00853385|6107709|P4|Overall Study|Adverse Event|5
1752376|NCT00853385|6107710|P3|Overall Study|Adverse Event|2
1752377|NCT00853385|6107711|P2|Overall Study|Adverse Event|24
1752378|NCT00853385|6107712|P1|Overall Study|Adverse Event|24
1752379|NCT00853385|6107708|P5|Overall Study|Death|1
1752380|NCT00853385|6107709|P4|Overall Study|Death|0
1752381|NCT00853385|6107710|P3|Overall Study|Death|0
1752382|NCT00853385|6107711|P2|Overall Study|Death|0
1752383|NCT00853385|6107712|P1|Overall Study|Death|0
1752384|NCT00853307|6107940|P2|Overall Study|Reason Not Specified|1
1752385|NCT00853307|6107941|P1|Overall Study|Reason Not Specified|0
1752386|NCT00853307|6107940|P2|Overall Study|Withdrawal by Subject|2
1752387|NCT00853307|6107941|P1|Overall Study|Withdrawal by Subject|1
1752388|NCT00853307|6107940|P2|Overall Study|Adverse Event|2
1752389|NCT00853307|6107941|P1|Overall Study|Adverse Event|1
1752390|NCT00853242|6107968|P7|Overall Study|Other|2
1752391|NCT00853242|6107969|P6|Overall Study|Other|1
1752392|NCT00853242|6107970|P5|Overall Study|Other|0
1752393|NCT00853242|6107971|P4|Overall Study|Other|0
1752394|NCT00853242|6107972|P3|Overall Study|Other|2
1752395|NCT00853242|6107973|P2|Overall Study|Other|0
1752396|NCT00853242|6107974|P1|Overall Study|Other|2
1752397|NCT00853242|6107968|P7|Overall Study|Withdrawal by Subject|2
1752398|NCT00853242|6107969|P6|Overall Study|Withdrawal by Subject|0
1752399|NCT00853242|6107970|P5|Overall Study|Withdrawal by Subject|0
1752400|NCT00853242|6107971|P4|Overall Study|Withdrawal by Subject|4
1752401|NCT00853242|6107972|P3|Overall Study|Withdrawal by Subject|0
1752402|NCT00853242|6107973|P2|Overall Study|Withdrawal by Subject|2
1752403|NCT00853242|6107974|P1|Overall Study|Withdrawal by Subject|1
1752404|NCT00853242|6107968|P7|Overall Study|Noncompliant|0
1752405|NCT00853242|6107969|P6|Overall Study|Noncompliant|0
1752406|NCT00853242|6107970|P5|Overall Study|Noncompliant|1
1752407|NCT00853242|6107971|P4|Overall Study|Noncompliant|0
1752408|NCT00853242|6107972|P3|Overall Study|Noncompliant|0
1752409|NCT00853242|6107973|P2|Overall Study|Noncompliant|0
1752410|NCT00853242|6107974|P1|Overall Study|Noncompliant|0
1752411|NCT00853242|6107968|P7|Overall Study|Adverse Event|1
1752412|NCT00853242|6107969|P6|Overall Study|Adverse Event|1
1752413|NCT00853242|6107970|P5|Overall Study|Adverse Event|3
1752414|NCT00853242|6107971|P4|Overall Study|Adverse Event|0
1752415|NCT00853242|6107972|P3|Overall Study|Adverse Event|1
1752416|NCT00853242|6107973|P2|Overall Study|Adverse Event|1
1752417|NCT00853242|6107974|P1|Overall Study|Adverse Event|0
1752418|NCT00853229|6108016|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1752419|NCT00853229|6108017|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
1752420|NCT00853151|6108027|P4|Overall Study|Sponsor Decision|0
1752421|NCT00853151|6108028|P3|Overall Study|Sponsor Decision|0
1752422|NCT00853151|6108029|P2|Overall Study|Sponsor Decision|3
1752423|NCT00853151|6108030|P1|Overall Study|Sponsor Decision|0
1752424|NCT00853151|6108027|P4|Overall Study|Physician Decision|0
1752425|NCT00853151|6108028|P3|Overall Study|Physician Decision|1
1752426|NCT00853151|6108029|P2|Overall Study|Physician Decision|2
1752427|NCT00853151|6108030|P1|Overall Study|Physician Decision|0
1752428|NCT00853151|6108027|P4|Overall Study|Withdrawal by Subject|1
1752429|NCT00853151|6108028|P3|Overall Study|Withdrawal by Subject|2
1752430|NCT00853151|6108029|P2|Overall Study|Withdrawal by Subject|4
1752431|NCT00853151|6108030|P1|Overall Study|Withdrawal by Subject|5
1752432|NCT00853151|6108027|P4|Overall Study|Protocol Violation|1
1752433|NCT00853151|6108028|P3|Overall Study|Protocol Violation|0
1752434|NCT00853151|6108029|P2|Overall Study|Protocol Violation|0
1752435|NCT00853151|6108030|P1|Overall Study|Protocol Violation|0
1752436|NCT00853151|6108027|P4|Overall Study|Death|1
1752437|NCT00853151|6108028|P3|Overall Study|Death|0
1752438|NCT00853151|6108029|P2|Overall Study|Death|0
1752439|NCT00853151|6108030|P1|Overall Study|Death|1
1752440|NCT00853151|6108027|P4|Overall Study|Lost to Follow-up|0
1752441|NCT00853151|6108028|P3|Overall Study|Lost to Follow-up|3
1752442|NCT00853151|6108029|P2|Overall Study|Lost to Follow-up|0
1752443|NCT00853151|6108030|P1|Overall Study|Lost to Follow-up|2
1752444|NCT00853151|6108027|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1752445|NCT00853151|6108028|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1752446|NCT00853151|6108029|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1752447|NCT00853151|6108030|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1752448|NCT00853151|6108027|P4|Overall Study|Adverse Event|0
1752449|NCT00853151|6108028|P3|Overall Study|Adverse Event|2
1752450|NCT00853151|6108029|P2|Overall Study|Adverse Event|4
1752451|NCT00853151|6108030|P1|Overall Study|Adverse Event|1
1752452|NCT00853125|6108172|P1|Overall Study|Study participant's donor was CMV +|1
1752453|NCT00853112|6108184|P7|Overall Study|Randomized but not treated|1
1752454|NCT00853112|6108185|P6|Overall Study|Randomized but not treated|0
1752455|NCT00853112|6108186|P5|Overall Study|Randomized but not treated|0
1752456|NCT00853112|6108187|P4|Overall Study|Randomized but not treated|2
1752457|NCT00853112|6108188|P3|Overall Study|Randomized but not treated|0
1752458|NCT00853112|6108189|P2|Overall Study|Randomized but not treated|1
1752459|NCT00853112|6108190|P1|Overall Study|Randomized but not treated|0
1752460|NCT00853099|6108300|P4|Double-blind + Open-label Periods|Other|6
1752461|NCT00853099|6108301|P3|Double-blind + Open-label Periods|Other|0
1752462|NCT00853099|6108302|P2|Double-blind + Open-label Periods|Other|0
1752463|NCT00853099|6108303|P1|Double-blind + Open-label Periods|Other|0
1752464|NCT00853099|6108300|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
1752465|NCT00853099|6108301|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
1752466|NCT00853099|6108302|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
1752467|NCT00853099|6108303|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
1752468|NCT00853099|6108300|P4|Double-blind + Open-label Periods|Adverse Event|47
1752469|NCT00853099|6108301|P3|Double-blind + Open-label Periods|Adverse Event|0
1752470|NCT00853099|6108302|P2|Double-blind + Open-label Periods|Adverse Event|0
1752471|NCT00853099|6108303|P1|Double-blind + Open-label Periods|Adverse Event|0
1752472|NCT00853099|6108300|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
1752473|NCT00853099|6108301|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
1752474|NCT00853099|6108302|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
1752475|NCT00853099|6108303|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
1752476|NCT00853099|6108300|P4|Double-blind Period|Mistreated with rescue study drug|0
1752477|NCT00853099|6108301|P3|Double-blind Period|Mistreated with rescue study drug|1
1752478|NCT00853099|6108302|P2|Double-blind Period|Mistreated with rescue study drug|0
1752479|NCT00853099|6108303|P1|Double-blind Period|Mistreated with rescue study drug|0
1752480|NCT00853099|6108300|P4|Double-blind Period|Other|0
1752481|NCT00853099|6108301|P3|Double-blind Period|Other|1
1752482|NCT00853099|6108302|P2|Double-blind Period|Other|0
1752483|NCT00853099|6108303|P1|Double-blind Period|Other|0
1752484|NCT00853099|6108300|P4|Double-blind Period|Lack of Efficacy|0
1752485|NCT00853099|6108301|P3|Double-blind Period|Lack of Efficacy|16
1752486|NCT00853099|6108302|P2|Double-blind Period|Lack of Efficacy|17
1752487|NCT00853099|6108303|P1|Double-blind Period|Lack of Efficacy|14
1752488|NCT00853099|6108300|P4|Double-blind Period|Withdrawal by Subject|0
1752489|NCT00853099|6108301|P3|Double-blind Period|Withdrawal by Subject|0
1752490|NCT00853099|6108302|P2|Double-blind Period|Withdrawal by Subject|3
1752491|NCT00853099|6108303|P1|Double-blind Period|Withdrawal by Subject|2
1752492|NCT00853099|6108300|P4|Double-blind Period|Adverse Event|0
1752493|NCT00853099|6108301|P3|Double-blind Period|Adverse Event|13
1752494|NCT00853099|6108302|P2|Double-blind Period|Adverse Event|9
1752495|NCT00853099|6108303|P1|Double-blind Period|Adverse Event|7
1752496|NCT00853073|6108345|P2|Overall Study|Withdrawal by Subject|2
1752497|NCT00853073|6108346|P1|Overall Study|Withdrawal by Subject|3
1752498|NCT00853047|6108359|P6|Open-Label Extension Phase|Reason Not Specified|6
1752499|NCT00853047|6108360|P5|Open-Label Extension Phase|Reason Not Specified|0
1752500|NCT00853047|6108361|P4|Open-Label Extension Phase|Reason Not Specified|0
1752501|NCT00853047|6108362|P3|Open-Label Extension Phase|Reason Not Specified|0
1752502|NCT00853047|6108363|P2|Open-Label Extension Phase|Reason Not Specified|0
1752503|NCT00853047|6108364|P1|Open-Label Extension Phase|Reason Not Specified|0
1752504|NCT00853047|6108359|P6|Open-Label Extension Phase|Investigator Decision|1
1752505|NCT00853047|6108360|P5|Open-Label Extension Phase|Investigator Decision|0
1752506|NCT00853047|6108361|P4|Open-Label Extension Phase|Investigator Decision|0
1752507|NCT00853047|6108362|P3|Open-Label Extension Phase|Investigator Decision|0
1752508|NCT00853047|6108363|P2|Open-Label Extension Phase|Investigator Decision|0
1752509|NCT00853047|6108364|P1|Open-Label Extension Phase|Investigator Decision|0
1752510|NCT00853047|6108359|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
1752511|NCT00853047|6108360|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
1752512|NCT00853047|6108361|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
1752513|NCT00853047|6108362|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
1752514|NCT00853047|6108363|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
1752515|NCT00853047|6108364|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
1752516|NCT00853047|6108359|P6|Open-Label Extension Phase|Lost to Follow-up|1
1752517|NCT00853047|6108360|P5|Open-Label Extension Phase|Lost to Follow-up|0
1752518|NCT00853047|6108361|P4|Open-Label Extension Phase|Lost to Follow-up|0
1752519|NCT00853047|6108362|P3|Open-Label Extension Phase|Lost to Follow-up|0
1752520|NCT00853047|6108363|P2|Open-Label Extension Phase|Lost to Follow-up|0
1752521|NCT00853047|6108364|P1|Open-Label Extension Phase|Lost to Follow-up|0
1752522|NCT00853047|6108359|P6|Open-Label Extension Phase|Participant Request|7
1752523|NCT00853047|6108360|P5|Open-Label Extension Phase|Participant Request|0
1752524|NCT00853047|6108361|P4|Open-Label Extension Phase|Participant Request|0
1752525|NCT00853047|6108362|P3|Open-Label Extension Phase|Participant Request|0
1752526|NCT00853047|6108363|P2|Open-Label Extension Phase|Participant Request|0
1752527|NCT00853047|6108364|P1|Open-Label Extension Phase|Participant Request|0
1752528|NCT00853047|6108359|P6|Core Phase|Participant Request|0
1752529|NCT00853047|6108360|P5|Core Phase|Participant Request|0
1752530|NCT00853047|6108361|P4|Core Phase|Participant Request|1
1752531|NCT00853047|6108362|P3|Core Phase|Participant Request|0
1752532|NCT00853047|6108363|P2|Core Phase|Participant Request|0
1752533|NCT00853047|6108364|P1|Core Phase|Participant Request|0
1752534|NCT00853021|6108430|P1|Overall Study|Death|1
1752535|NCT00853021|6108430|P1|Overall Study|Withdrawal by Subject|2
1752536|NCT00853021|6108430|P1|Overall Study|Adverse Event|2
1752537|NCT00852995|6108442|P5|Overall Study|Moved Out of Area|0
1752538|NCT00852995|6108443|P4|Overall Study|Moved Out of Area|0
1752539|NCT00852995|6108444|P3|Overall Study|Moved Out of Area|0
1752540|NCT00852995|6108445|P2|Overall Study|Moved Out of Area|0
1752541|NCT00852995|6108446|P1|Overall Study|Moved Out of Area|1
1752542|NCT00852995|6108442|P5|Overall Study|Protocol Violation|1
1752543|NCT00852995|6108443|P4|Overall Study|Protocol Violation|0
1752544|NCT00852995|6108444|P3|Overall Study|Protocol Violation|0
1752545|NCT00852995|6108445|P2|Overall Study|Protocol Violation|0
1752546|NCT00852995|6108446|P1|Overall Study|Protocol Violation|0
1752547|NCT00852995|6108442|P5|Overall Study|Physician Decision|0
1752548|NCT00852995|6108443|P4|Overall Study|Physician Decision|0
1752549|NCT00852995|6108444|P3|Overall Study|Physician Decision|0
1752550|NCT00852995|6108445|P2|Overall Study|Physician Decision|0
1752551|NCT00852995|6108446|P1|Overall Study|Physician Decision|1
1752552|NCT00852995|6108442|P5|Overall Study|Progressive Disease|1
1752553|NCT00852995|6108443|P4|Overall Study|Progressive Disease|2
1752554|NCT00852995|6108444|P3|Overall Study|Progressive Disease|0
1752555|NCT00852995|6108445|P2|Overall Study|Progressive Disease|0
1752556|NCT00852995|6108446|P1|Overall Study|Progressive Disease|1
1752557|NCT00852995|6108442|P5|Overall Study|Non-Compliance|0
1752558|NCT00852995|6108443|P4|Overall Study|Non-Compliance|2
1752559|NCT00852995|6108444|P3|Overall Study|Non-Compliance|0
1752560|NCT00852995|6108445|P2|Overall Study|Non-Compliance|0
1752561|NCT00852995|6108446|P1|Overall Study|Non-Compliance|0
1752562|NCT00852995|6108442|P5|Overall Study|Withdrawal by Subject|2
1752563|NCT00852995|6108443|P4|Overall Study|Withdrawal by Subject|1
1752564|NCT00852995|6108444|P3|Overall Study|Withdrawal by Subject|0
1752565|NCT00852995|6108445|P2|Overall Study|Withdrawal by Subject|0
1752566|NCT00852995|6108446|P1|Overall Study|Withdrawal by Subject|4
1752567|NCT00852995|6108442|P5|Overall Study|Lost to Follow-up|0
1752568|NCT00852995|6108443|P4|Overall Study|Lost to Follow-up|0
1752569|NCT00852995|6108444|P3|Overall Study|Lost to Follow-up|1
1752570|NCT00852995|6108445|P2|Overall Study|Lost to Follow-up|1
1752571|NCT00852995|6108446|P1|Overall Study|Lost to Follow-up|0
1752572|NCT00852995|6108442|P5|Overall Study|Adverse Event|0
1752573|NCT00852995|6108443|P4|Overall Study|Adverse Event|0
1752574|NCT00852995|6108444|P3|Overall Study|Adverse Event|4
1752575|NCT00852995|6108445|P2|Overall Study|Adverse Event|0
1752576|NCT00852995|6108446|P1|Overall Study|Adverse Event|1
1752577|NCT00852969|6108490|P2|Overall Study|Lost to Follow-up|1
1752578|NCT00852969|6108491|P1|Overall Study|Lost to Follow-up|0
1752579|NCT00852969|6108490|P2|Overall Study|Adverse Event|1
1752580|NCT00852969|6108491|P1|Overall Study|Adverse Event|0
1752581|NCT00852930|6108502|P3|Overall Study|Physician Decision|1
1752582|NCT00852930|6108503|P2|Overall Study|Physician Decision|0
1752583|NCT00852930|6108504|P1|Overall Study|Physician Decision|0
1752584|NCT00852930|6108502|P3|Overall Study|Withdrawal by Subject|1
1752585|NCT00852930|6108503|P2|Overall Study|Withdrawal by Subject|1
1752586|NCT00852930|6108504|P1|Overall Study|Withdrawal by Subject|1
1752587|NCT00852917|6108525|P4|Overall Study|Death|1
1752588|NCT00852917|6108526|P3|Overall Study|Death|0
1752589|NCT00852917|6108527|P2|Overall Study|Death|0
1752590|NCT00852917|6108528|P1|Overall Study|Death|0
1752591|NCT00852917|6108525|P4|Overall Study|Physician Decision|19
1752592|NCT00852917|6108526|P3|Overall Study|Physician Decision|2
1752593|NCT00852917|6108527|P2|Overall Study|Physician Decision|7
1752594|NCT00852917|6108528|P1|Overall Study|Physician Decision|6
1752595|NCT00852917|6108525|P4|Overall Study|Withdrawal by Subject|9
1752596|NCT00852917|6108526|P3|Overall Study|Withdrawal by Subject|10
1752597|NCT00852917|6108527|P2|Overall Study|Withdrawal by Subject|8
1752598|NCT00852917|6108528|P1|Overall Study|Withdrawal by Subject|4
1752599|NCT00852917|6108525|P4|Overall Study|Lack of Efficacy|47
1752600|NCT00852917|6108526|P3|Overall Study|Lack of Efficacy|11
1752601|NCT00852917|6108527|P2|Overall Study|Lack of Efficacy|11
1752602|NCT00852917|6108528|P1|Overall Study|Lack of Efficacy|21
1752603|NCT00852917|6108525|P4|Overall Study|Adverse Event|17
1752604|NCT00852917|6108526|P3|Overall Study|Adverse Event|35
1752605|NCT00852917|6108527|P2|Overall Study|Adverse Event|20
1752606|NCT00852917|6108528|P1|Overall Study|Adverse Event|13
1752607|NCT00852540|6108656|P2|Overall Study|Did Not Receive Study Drug|3
1752608|NCT00852540|6108657|P1|Overall Study|Did Not Receive Study Drug|3
1752609|NCT00852540|6108656|P2|Overall Study|Withdrawal by Subject|1
1752610|NCT00852540|6108657|P1|Overall Study|Withdrawal by Subject|3
1752611|NCT00852540|6108656|P2|Overall Study|Investigator Discretion|3
1752612|NCT00852540|6108657|P1|Overall Study|Investigator Discretion|2
1752613|NCT00852540|6108656|P2|Overall Study|Lost to Follow-up|3
1752614|NCT00852540|6108657|P1|Overall Study|Lost to Follow-up|2
1752615|NCT00852540|6108656|P2|Overall Study|Protocol Violation|2
1752616|NCT00852540|6108657|P1|Overall Study|Protocol Violation|1
1752617|NCT00852540|6108656|P2|Overall Study|Lack of Efficacy|3
1752618|NCT00852540|6108657|P1|Overall Study|Lack of Efficacy|15
1752619|NCT00852540|6108656|P2|Overall Study|Adverse Event|3
1752620|NCT00852540|6108657|P1|Overall Study|Adverse Event|10
1752621|NCT00852475|6108691|P2|Overall Study|Lost to Follow-up|4
1752622|NCT00852475|6108692|P1|Overall Study|Lost to Follow-up|3
1752623|NCT00852397|6108703|P3|Overall Study|Protocol Violation|1
1752624|NCT00852397|6108704|P2|Overall Study|Protocol Violation|0
1752625|NCT00852397|6108705|P1|Overall Study|Protocol Violation|0
1752626|NCT00852397|6108703|P3|Overall Study|Difficulty in study site visit|0
1752627|NCT00852397|6108704|P2|Overall Study|Difficulty in study site visit|0
1752628|NCT00852397|6108705|P1|Overall Study|Difficulty in study site visit|1
1752629|NCT00852397|6108703|P3|Overall Study|Study terminated by sponsor|6
1752630|NCT00852397|6108704|P2|Overall Study|Study terminated by sponsor|1
1752631|NCT00852397|6108705|P1|Overall Study|Study terminated by sponsor|2
1752632|NCT00852397|6108703|P3|Overall Study|Withdrawal by Subject|2
1752633|NCT00852397|6108704|P2|Overall Study|Withdrawal by Subject|1
1752634|NCT00852397|6108705|P1|Overall Study|Withdrawal by Subject|4
1752635|NCT00852397|6108703|P3|Overall Study|Death|1
1752636|NCT00852397|6108704|P2|Overall Study|Death|0
1752637|NCT00852397|6108705|P1|Overall Study|Death|0
1752638|NCT00852397|6108703|P3|Overall Study|Adverse Event|4
1752639|NCT00852397|6108704|P2|Overall Study|Adverse Event|6
1752640|NCT00852397|6108705|P1|Overall Study|Adverse Event|4
1752641|NCT00852241|6108734|P1|Overall Study|Physician Decision|18
1752642|NCT00852202|6108741|P3|Overall Study|pregnancy,moving away and surgery|2
1752643|NCT00852202|6108742|P2|Overall Study|pregnancy,moving away and surgery|0
1752644|NCT00852202|6108743|P1|Overall Study|pregnancy,moving away and surgery|1
1752645|NCT00852202|6108741|P3|Overall Study|Lost to Follow-up|6
1752646|NCT00852202|6108742|P2|Overall Study|Lost to Follow-up|5
1752647|NCT00852202|6108743|P1|Overall Study|Lost to Follow-up|5
1752648|NCT00852202|6108741|P3|Overall Study|Withdrawal by Subject|2
1752649|NCT00852202|6108742|P2|Overall Study|Withdrawal by Subject|1
1752650|NCT00852202|6108743|P1|Overall Study|Withdrawal by Subject|3
1752651|NCT00852202|6108741|P3|Overall Study|Protocol Violation|7
1752652|NCT00852202|6108742|P2|Overall Study|Protocol Violation|2
1752653|NCT00852202|6108743|P1|Overall Study|Protocol Violation|2
1752654|NCT00852202|6108741|P3|Overall Study|Lack of Efficacy|2
1752655|NCT00852202|6108742|P2|Overall Study|Lack of Efficacy|1
1752656|NCT00852202|6108743|P1|Overall Study|Lack of Efficacy|4
1752657|NCT00852202|6108741|P3|Overall Study|Adverse Event|7
1752658|NCT00852202|6108742|P2|Overall Study|Adverse Event|3
1752659|NCT00852202|6108743|P1|Overall Study|Adverse Event|2
1752660|NCT00851903|6108785|P1|Overall Study|Withdrawal by Subject|2
1752661|NCT00851890|6108799|P4|Overall Study|Lost to Follow-up|1
1752662|NCT00851890|6108800|P3|Overall Study|Lost to Follow-up|0
1752663|NCT00851890|6108801|P2|Overall Study|Lost to Follow-up|1
1752664|NCT00851890|6108802|P1|Overall Study|Lost to Follow-up|0
1752665|NCT00851877|6108859|P3|Phase II|Withdrawal by Subject|3
1752666|NCT00851877|6108860|P2|Phase II|Withdrawal by Subject|0
1752667|NCT00851877|6108861|P1|Phase II|Withdrawal by Subject|0
1752668|NCT00851877|6108859|P3|Phase I-1|Death|0
1752669|NCT00851877|6108860|P2|Phase I-1|Death|0
1752670|NCT00851877|6108861|P1|Phase I-1|Death|1
1752671|NCT00851799|6108871|P3|Overall Study|Completed protocol due to pregnancy|1
1752672|NCT00851799|6108872|P2|Overall Study|Completed protocol due to pregnancy|0
1752673|NCT00851799|6108873|P1|Overall Study|Completed protocol due to pregnancy|0
1752674|NCT00851799|6108871|P3|Overall Study|Severe Debilitation|0
1752675|NCT00851799|6108872|P2|Overall Study|Severe Debilitation|1
1752676|NCT00851799|6108873|P1|Overall Study|Severe Debilitation|0
1752677|NCT00851799|6108871|P3|Overall Study|Withdrew consent prior study completion|1
1752678|NCT00851799|6108872|P2|Overall Study|Withdrew consent prior study completion|2
1752679|NCT00851799|6108873|P1|Overall Study|Withdrew consent prior study completion|1
1752680|NCT00851799|6108871|P3|Overall Study|Not willing to adhere to requirements|2
1752681|NCT00851799|6108872|P2|Overall Study|Not willing to adhere to requirements|2
1752682|NCT00851799|6108873|P1|Overall Study|Not willing to adhere to requirements|1
1752683|NCT00851799|6108871|P3|Overall Study|Not able to get to clinic|9
1752684|NCT00851799|6108872|P2|Overall Study|Not able to get to clinic|5
1752685|NCT00851799|6108873|P1|Overall Study|Not able to get to clinic|8
1752686|NCT00851799|6108871|P3|Overall Study|Lost to Follow-up|10
1752687|NCT00851799|6108872|P2|Overall Study|Lost to Follow-up|3
1752688|NCT00851799|6108873|P1|Overall Study|Lost to Follow-up|5
1752689|NCT00851799|6108871|P3|Overall Study|Death|1
1752690|NCT00851799|6108872|P2|Overall Study|Death|0
1752691|NCT00851799|6108873|P1|Overall Study|Death|1
1752692|NCT00851786|6108961|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
1752693|NCT00851786|6108962|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
1752694|NCT00851786|6108961|P2|Overall Study|Site Closure|0
1752695|NCT00851786|6108962|P1|Overall Study|Site Closure|1
1752696|NCT00851786|6108961|P2|Overall Study|Incarceration|0
1752697|NCT00851786|6108962|P1|Overall Study|Incarceration|1
1752698|NCT00851786|6108961|P2|Overall Study|Lost to Follow-up|0
1752699|NCT00851786|6108962|P1|Overall Study|Lost to Follow-up|1
1752700|NCT00851786|6108961|P2|Overall Study|Protocol Violation|1
1752701|NCT00851786|6108962|P1|Overall Study|Protocol Violation|0
1752702|NCT00851786|6108961|P2|Overall Study|Withdrawal by Subject|1
1752703|NCT00851786|6108962|P1|Overall Study|Withdrawal by Subject|0
1752704|NCT00851747|6108975|P3|Overall Study|Physician Decision|6
1752705|NCT00851747|6108976|P2|Overall Study|Physician Decision|6
1752706|NCT00851747|6108977|P1|Overall Study|Physician Decision|6
1752707|NCT00851721|6108986|P2|Overall Study|Adverse Event|1
1752708|NCT00851721|6108987|P1|Overall Study|Adverse Event|0
1752709|NCT00851721|6108986|P2|Overall Study|Death|0
1752710|NCT00851721|6108987|P1|Overall Study|Death|1
1752711|NCT00851721|6108986|P2|Overall Study|planned surgery|0
1752712|NCT00851721|6108987|P1|Overall Study|planned surgery|1
1752713|NCT00851682|6109077|P2|Overall Study|screen failure|0
1752714|NCT00851682|6109078|P1|Overall Study|screen failure|5
1752715|NCT00851643|6109092|P6|Extension Study (Up to 36 Months)|Moved|1
1752716|NCT00851643|6109093|P5|Extension Study (Up to 36 Months)|Moved|0
1752717|NCT00851643|6109094|P4|Extension Study (Up to 36 Months)|Moved|1
1752718|NCT00851643|6109095|P3|Extension Study (Up to 36 Months)|Moved|1
1752719|NCT00851643|6109096|P2|Extension Study (Up to 36 Months)|Moved|2
1752720|NCT00851643|6109097|P1|Extension Study (Up to 36 Months)|Moved|0
1752721|NCT00851643|6109092|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
1752722|NCT00851643|6109093|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
1752723|NCT00851643|6109094|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
1752724|NCT00851643|6109095|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
1752725|NCT00851643|6109096|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
1752726|NCT00851643|6109097|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
1752727|NCT00851643|6109092|P6|Base Study (Up to 12 Months)|Other|1
1752728|NCT00851643|6109093|P5|Base Study (Up to 12 Months)|Other|0
1752729|NCT00851643|6109094|P4|Base Study (Up to 12 Months)|Other|0
1752730|NCT00851643|6109095|P3|Base Study (Up to 12 Months)|Other|0
1752731|NCT00851643|6109096|P2|Base Study (Up to 12 Months)|Other|0
1752732|NCT00851643|6109097|P1|Base Study (Up to 12 Months)|Other|0
1752733|NCT00851643|6109092|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1752734|NCT00851643|6109093|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1752735|NCT00851643|6109094|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1752736|NCT00851643|6109095|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1752737|NCT00851643|6109096|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
1752738|NCT00851643|6109097|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
1752739|NCT00851630|6109118|P2|Overall Study|Clinical failure|1
1752740|NCT00851630|6109119|P1|Overall Study|Clinical failure|0
1752741|NCT00851630|6109118|P2|Overall Study|Death|1
1752742|NCT00851630|6109119|P1|Overall Study|Death|2
1752743|NCT00851591|6109133|P2|Overall Study|Withdrawal by Subject|0
1752744|NCT00851591|6109134|P1|Overall Study|Withdrawal by Subject|2
1752745|NCT00851552|6109140|P1|Overall Study|Disease Progression|4
1752746|NCT00851552|6109140|P1|Overall Study|Adverse Event|1
1752747|NCT00851552|6109140|P1|Overall Study|Death|2
1752748|NCT00851318|6109170|P4|Overall Study|Physician Decision|1
1752749|NCT00851318|6109171|P3|Overall Study|Physician Decision|1
1752750|NCT00851318|6109172|P2|Overall Study|Physician Decision|0
1752751|NCT00851318|6109173|P1|Overall Study|Physician Decision|0
1752752|NCT00851318|6109170|P4|Overall Study|Non-compliance with Study Procedures|0
1752753|NCT00851318|6109171|P3|Overall Study|Non-compliance with Study Procedures|1
1752754|NCT00851318|6109172|P2|Overall Study|Non-compliance with Study Procedures|0
1752755|NCT00851318|6109173|P1|Overall Study|Non-compliance with Study Procedures|2
1752756|NCT00851318|6109170|P4|Overall Study|Lack of Efficacy|2
1752757|NCT00851318|6109171|P3|Overall Study|Lack of Efficacy|4
1752758|NCT00851318|6109172|P2|Overall Study|Lack of Efficacy|2
1752759|NCT00851318|6109173|P1|Overall Study|Lack of Efficacy|8
1752760|NCT00851318|6109170|P4|Overall Study|Pregnancy|1
1752761|NCT00851318|6109171|P3|Overall Study|Pregnancy|1
1752762|NCT00851318|6109172|P2|Overall Study|Pregnancy|0
1752763|NCT00851318|6109173|P1|Overall Study|Pregnancy|0
1752764|NCT00851318|6109170|P4|Overall Study|Adverse Event|12
1752765|NCT00851318|6109171|P3|Overall Study|Adverse Event|9
1752766|NCT00851318|6109172|P2|Overall Study|Adverse Event|2
1752767|NCT00851318|6109173|P1|Overall Study|Adverse Event|13
1752768|NCT00851318|6109170|P4|Overall Study|Withdrawal by Subject|3
1752769|NCT00851318|6109171|P3|Overall Study|Withdrawal by Subject|5
1752770|NCT00851318|6109172|P2|Overall Study|Withdrawal by Subject|1
1752771|NCT00851318|6109173|P1|Overall Study|Withdrawal by Subject|7
1752772|NCT00851253|6109209|P2|Overall Study|Disease Progression|0
1752773|NCT00851253|6109210|P1|Overall Study|Disease Progression|1
1752774|NCT00851084|6109220|P2|Overall Study|Other|1
1752775|NCT00851084|6109221|P1|Overall Study|Other|7
1752776|NCT00851084|6109220|P2|Overall Study|Metastatic surgery|6
1752777|NCT00851084|6109221|P1|Overall Study|Metastatic surgery|6
1752778|NCT00851084|6109220|P2|Overall Study|Withdrawal by Subject|12
1752779|NCT00851084|6109221|P1|Overall Study|Withdrawal by Subject|11
1752780|NCT00851084|6109220|P2|Overall Study|Consent withdrawn|2
1752781|NCT00851084|6109221|P1|Overall Study|Consent withdrawn|0
1752782|NCT00851084|6109220|P2|Overall Study|Physician Decision|14
1752783|NCT00851084|6109221|P1|Overall Study|Physician Decision|13
1752784|NCT00851084|6109220|P2|Overall Study|Poor compliance to protocol|1
1752785|NCT00851084|6109221|P1|Overall Study|Poor compliance to protocol|1
1752786|NCT00851084|6109220|P2|Overall Study|Disease progression|47
1752787|NCT00851084|6109221|P1|Overall Study|Disease progression|52
1752788|NCT00851084|6109220|P2|Overall Study|Adverse Event|36
1752789|NCT00851084|6109221|P1|Overall Study|Adverse Event|26
1752790|NCT00851084|6109220|P2|Overall Study|Randomized but not treated|0
1752791|NCT00851084|6109221|P1|Overall Study|Randomized but not treated|1
1752792|NCT00850993|6109249|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
1752793|NCT00850993|6109250|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
1752794|NCT00850993|6109251|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
1752795|NCT00850993|6109252|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
1752796|NCT00850759|6109281|P4|Overall Study|Lost to Follow-up|3
1752797|NCT00850759|6109282|P3|Overall Study|Lost to Follow-up|5
1752798|NCT00850759|6109283|P2|Overall Study|Lost to Follow-up|5
1752799|NCT00850759|6109284|P1|Overall Study|Lost to Follow-up|7
1752800|NCT00850564|6109365|P1|Overall Study|Withdrawal by Subject|2
1752801|NCT00850538|6109370|P1|Overall Study|Protocol Violation|2
1752802|NCT00850538|6109370|P1|Overall Study|radiology error|2
1752803|NCT00850538|6109370|P1|Overall Study|Withdrawal by Subject|3
1752804|NCT00850538|6109370|P1|Overall Study|specimen unusable|7
1752805|NCT00850538|6109370|P1|Overall Study|specimen missed due to scheduling error|14
1752806|NCT00850538|6109370|P1|Overall Study|unable/unwilling to complete MRI|13
1752807|NCT00850499|6109376|P2|Overall Study|Lack of Efficacy|1
1752808|NCT00850499|6109377|P1|Overall Study|Lack of Efficacy|0
1752809|NCT00850499|6109376|P2|Overall Study|Adverse Event|1
1752810|NCT00850499|6109377|P1|Overall Study|Adverse Event|3
1752811|NCT00850460|6109391|P2|Overall Study|Lost to Follow-up|4
1752812|NCT00850460|6109392|P1|Overall Study|Lost to Follow-up|4
1752813|NCT00850395|6109406|P1|Overall Study|Other|5
1752814|NCT00850395|6109406|P1|Overall Study|Insufficient clinical response|3
1752815|NCT00850395|6109406|P1|Overall Study|Adverse Event|1
1752816|NCT00850395|6109406|P1|Overall Study|Death|1
1752817|NCT00850343|6109426|P4|Overall Study|Physician Decision|1
1752818|NCT00850343|6109427|P3|Overall Study|Physician Decision|1
1752819|NCT00850343|6109428|P2|Overall Study|Physician Decision|1
1752820|NCT00850343|6109429|P1|Overall Study|Physician Decision|2
1752821|NCT00850343|6109426|P4|Overall Study|Non-compliance with Study Procedures|1
1752822|NCT00850343|6109427|P3|Overall Study|Non-compliance with Study Procedures|1
1752823|NCT00850343|6109428|P2|Overall Study|Non-compliance with Study Procedures|0
1752824|NCT00850343|6109429|P1|Overall Study|Non-compliance with Study Procedures|1
1752825|NCT00850343|6109426|P4|Overall Study|Lack of Efficacy|2
1752826|NCT00850343|6109427|P3|Overall Study|Lack of Efficacy|3
1752827|NCT00850343|6109428|P2|Overall Study|Lack of Efficacy|0
1752828|NCT00850343|6109429|P1|Overall Study|Lack of Efficacy|17
1752829|NCT00850343|6109426|P4|Overall Study|Pregnancy|1
1752830|NCT00850343|6109427|P3|Overall Study|Pregnancy|0
1752831|NCT00850343|6109428|P2|Overall Study|Pregnancy|0
1752832|NCT00850343|6109429|P1|Overall Study|Pregnancy|0
1752833|NCT00850343|6109426|P4|Overall Study|Adverse Event|6
1752834|NCT00850343|6109427|P3|Overall Study|Adverse Event|6
1752835|NCT00850343|6109428|P2|Overall Study|Adverse Event|2
1752836|NCT00850343|6109429|P1|Overall Study|Adverse Event|15
1752837|NCT00850343|6109426|P4|Overall Study|Withdrawal by Subject|2
1752838|NCT00850343|6109427|P3|Overall Study|Withdrawal by Subject|3
1752839|NCT00850343|6109428|P2|Overall Study|Withdrawal by Subject|0
1752840|NCT00850343|6109429|P1|Overall Study|Withdrawal by Subject|11
1752841|NCT00850200|6109459|P1|Overall Study|Withdrawal by Subject|1
1752842|NCT00850200|6109459|P1|Overall Study|Did not recieve treatment|2
1752843|NCT00850200|6109459|P1|Overall Study|Physician Decision|2
1752844|NCT00850174|6109469|P2|Second Intervention|Withdrawal by Subject|0
1752845|NCT00850174|6109470|P1|Second Intervention|Withdrawal by Subject|1
1752846|NCT00850174|6109469|P2|Washout: One Week|Withdrawal by Subject|2
1752847|NCT00850174|6109470|P1|Washout: One Week|Withdrawal by Subject|0
1752848|NCT00850135|6109484|P1|Overall Study|Physician Decision|1
1752849|NCT00850070|6109503|P2|Overall Study|Adverse Event|0
1752850|NCT00850070|6109504|P1|Overall Study|Adverse Event|2
1752851|NCT00850070|6109503|P2|Overall Study|Lack of Efficacy|1
1752852|NCT00850070|6109504|P1|Overall Study|Lack of Efficacy|1
1752853|NCT00849940|6109533|P1|Overall Study|Physician Decision|4
1752854|NCT00849901|6109544|P3|Extension Phase|Lack of Efficacy|1
1752855|NCT00849901|6109545|P2|Extension Phase|Lack of Efficacy|4
1752856|NCT00849901|6109546|P1|Extension Phase|Lack of Efficacy|2
1752857|NCT00849901|6109544|P3|Extension Phase|Physician Decision|0
1752858|NCT00849901|6109545|P2|Extension Phase|Physician Decision|2
1752859|NCT00849901|6109546|P1|Extension Phase|Physician Decision|1
1752860|NCT00849901|6109544|P3|Extension Phase|Parent or Caregiver Decision|4
1752861|NCT00849901|6109545|P2|Extension Phase|Parent or Caregiver Decision|4
1752862|NCT00849901|6109546|P1|Extension Phase|Parent or Caregiver Decision|10
1752863|NCT00849901|6109544|P3|Extension Phase|Withdrawal by Subject|3
1752864|NCT00849901|6109545|P2|Extension Phase|Withdrawal by Subject|6
1752865|NCT00849901|6109546|P1|Extension Phase|Withdrawal by Subject|7
1752866|NCT00849901|6109544|P3|Extension Phase|Protocol Violation|4
1752867|NCT00849901|6109545|P2|Extension Phase|Protocol Violation|2
1752868|NCT00849901|6109546|P1|Extension Phase|Protocol Violation|2
1752869|NCT00849901|6109544|P3|Extension Phase|Lost to Follow-up|1
1752870|NCT00849901|6109545|P2|Extension Phase|Lost to Follow-up|0
1752871|NCT00849901|6109546|P1|Extension Phase|Lost to Follow-up|3
1752872|NCT00849901|6109544|P3|Extension Phase|Adverse Event|4
1752873|NCT00849901|6109545|P2|Extension Phase|Adverse Event|8
1752874|NCT00849901|6109546|P1|Extension Phase|Adverse Event|2
1752875|NCT00849901|6109544|P3|Acute Treatment Phase|Lack of Efficacy|2
1752876|NCT00849901|6109545|P2|Acute Treatment Phase|Lack of Efficacy|3
1752877|NCT00849901|6109546|P1|Acute Treatment Phase|Lack of Efficacy|2
1752878|NCT00849901|6109544|P3|Acute Treatment Phase|Sponsor Decision|0
1752879|NCT00849901|6109545|P2|Acute Treatment Phase|Sponsor Decision|0
1752880|NCT00849901|6109546|P1|Acute Treatment Phase|Sponsor Decision|1
1752881|NCT00849901|6109544|P3|Acute Treatment Phase|Physician Decision|1
1752882|NCT00849901|6109545|P2|Acute Treatment Phase|Physician Decision|1
1752883|NCT00849901|6109546|P1|Acute Treatment Phase|Physician Decision|1
1752884|NCT00849901|6109544|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
1752885|NCT00849901|6109545|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
1752886|NCT00849901|6109546|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
1752887|NCT00849901|6109544|P3|Acute Treatment Phase|Withdrawal by Subject|4
1752888|NCT00849901|6109545|P2|Acute Treatment Phase|Withdrawal by Subject|10
1752889|NCT00849901|6109546|P1|Acute Treatment Phase|Withdrawal by Subject|4
1752890|NCT00849901|6109544|P3|Acute Treatment Phase|Protocol Violation|1
1752891|NCT00849901|6109545|P2|Acute Treatment Phase|Protocol Violation|2
1752892|NCT00849901|6109546|P1|Acute Treatment Phase|Protocol Violation|0
1752893|NCT00849901|6109544|P3|Acute Treatment Phase|Lost to Follow-up|1
1752894|NCT00849901|6109545|P2|Acute Treatment Phase|Lost to Follow-up|4
1752895|NCT00849901|6109546|P1|Acute Treatment Phase|Lost to Follow-up|2
1752896|NCT00849901|6109544|P3|Acute Treatment Phase|Adverse Event|3
1752897|NCT00849901|6109545|P2|Acute Treatment Phase|Adverse Event|1
1752898|NCT00849901|6109546|P1|Acute Treatment Phase|Adverse Event|9
1752899|NCT00849875|6109593|P1|Overall Study|Lost to Follow-up|2
1752900|NCT00849875|6109593|P1|Overall Study|Others|6
1752901|NCT00849875|6109593|P1|Overall Study|Ongoing (unknown completion status)|11
1752902|NCT00849875|6109593|P1|Overall Study|Death|28
1752903|NCT00849797|6109690|P2|Washout: One Week|Withdrawal by Subject|2
1752904|NCT00849797|6109691|P1|Washout: One Week|Withdrawal by Subject|0
1752905|NCT00849797|6109690|P2|First Intervention|Adverse Event|1
1752906|NCT00849797|6109691|P1|First Intervention|Adverse Event|0
1752907|NCT00849797|6109690|P2|First Intervention|bad veins|0
1752908|NCT00849797|6109691|P1|First Intervention|bad veins|1
1752909|NCT00849693|6109709|P4|Extension Phase|Lack of Efficacy|1
1752910|NCT00849693|6109710|P3|Extension Phase|Lack of Efficacy|2
1752911|NCT00849693|6109711|P2|Extension Phase|Lack of Efficacy|2
1752912|NCT00849693|6109712|P1|Extension Phase|Lack of Efficacy|2
1752913|NCT00849693|6109709|P4|Extension Phase|Sponsor decision|1
1752914|NCT00849693|6109710|P3|Extension Phase|Sponsor decision|0
1752915|NCT00849693|6109711|P2|Extension Phase|Sponsor decision|0
1752916|NCT00849693|6109712|P1|Extension Phase|Sponsor decision|1
1752917|NCT00849693|6109709|P4|Extension Phase|Physician Decision|0
1752918|NCT00849693|6109710|P3|Extension Phase|Physician Decision|2
1752919|NCT00849693|6109711|P2|Extension Phase|Physician Decision|1
1752920|NCT00849693|6109712|P1|Extension Phase|Physician Decision|1
1752921|NCT00849693|6109709|P4|Extension Phase|Parent or caregiver decision|5
1752922|NCT00849693|6109710|P3|Extension Phase|Parent or caregiver decision|10
1752923|NCT00849693|6109711|P2|Extension Phase|Parent or caregiver decision|4
1752924|NCT00849693|6109712|P1|Extension Phase|Parent or caregiver decision|9
1752925|NCT00849693|6109709|P4|Extension Phase|Withdrawal by Subject|15
1752926|NCT00849693|6109710|P3|Extension Phase|Withdrawal by Subject|10
1752927|NCT00849693|6109711|P2|Extension Phase|Withdrawal by Subject|9
1752928|NCT00849693|6109712|P1|Extension Phase|Withdrawal by Subject|6
1752929|NCT00849693|6109709|P4|Extension Phase|Protocol Violation|3
1752930|NCT00849693|6109710|P3|Extension Phase|Protocol Violation|2
1752931|NCT00849693|6109711|P2|Extension Phase|Protocol Violation|3
1752932|NCT00849693|6109712|P1|Extension Phase|Protocol Violation|0
1752933|NCT00849693|6109709|P4|Extension Phase|Lost to Follow-up|6
1752934|NCT00849693|6109710|P3|Extension Phase|Lost to Follow-up|6
1752935|NCT00849693|6109711|P2|Extension Phase|Lost to Follow-up|5
1752936|NCT00849693|6109712|P1|Extension Phase|Lost to Follow-up|7
1752937|NCT00849693|6109709|P4|Extension Phase|Adverse Event|7
1752938|NCT00849693|6109710|P3|Extension Phase|Adverse Event|3
1752939|NCT00849693|6109711|P2|Extension Phase|Adverse Event|6
1752940|NCT00849693|6109712|P1|Extension Phase|Adverse Event|4
1752941|NCT00849693|6109709|P4|Acute Treatment Phase|Lack of Efficacy|2
1752942|NCT00849693|6109710|P3|Acute Treatment Phase|Lack of Efficacy|1
1752943|NCT00849693|6109711|P2|Acute Treatment Phase|Lack of Efficacy|3
1752944|NCT00849693|6109712|P1|Acute Treatment Phase|Lack of Efficacy|1
1752945|NCT00849693|6109709|P4|Acute Treatment Phase|Sponsor decision|0
1752946|NCT00849693|6109710|P3|Acute Treatment Phase|Sponsor decision|1
1752947|NCT00849693|6109711|P2|Acute Treatment Phase|Sponsor decision|0
1752948|NCT00849693|6109712|P1|Acute Treatment Phase|Sponsor decision|0
1752949|NCT00849693|6109709|P4|Acute Treatment Phase|Physician Decision|1
1752950|NCT00849693|6109710|P3|Acute Treatment Phase|Physician Decision|2
1752951|NCT00849693|6109711|P2|Acute Treatment Phase|Physician Decision|1
1752952|NCT00849693|6109712|P1|Acute Treatment Phase|Physician Decision|2
1752953|NCT00849693|6109709|P4|Acute Treatment Phase|Parent or caregiver decision|7
1752954|NCT00849693|6109710|P3|Acute Treatment Phase|Parent or caregiver decision|7
1752955|NCT00849693|6109711|P2|Acute Treatment Phase|Parent or caregiver decision|6
1752956|NCT00849693|6109712|P1|Acute Treatment Phase|Parent or caregiver decision|7
1752957|NCT00849693|6109709|P4|Acute Treatment Phase|Withdrawal by Subject|8
1752958|NCT00849693|6109710|P3|Acute Treatment Phase|Withdrawal by Subject|3
1752959|NCT00849693|6109711|P2|Acute Treatment Phase|Withdrawal by Subject|5
1752960|NCT00849693|6109712|P1|Acute Treatment Phase|Withdrawal by Subject|5
1752961|NCT00849693|6109709|P4|Acute Treatment Phase|Protocol Violation|6
1752962|NCT00849693|6109710|P3|Acute Treatment Phase|Protocol Violation|2
1752963|NCT00849693|6109711|P2|Acute Treatment Phase|Protocol Violation|5
1752964|NCT00849693|6109712|P1|Acute Treatment Phase|Protocol Violation|1
1752965|NCT00849693|6109709|P4|Acute Treatment Phase|Lost to Follow-up|9
1752966|NCT00849693|6109710|P3|Acute Treatment Phase|Lost to Follow-up|11
1752967|NCT00849693|6109711|P2|Acute Treatment Phase|Lost to Follow-up|8
1752968|NCT00849693|6109712|P1|Acute Treatment Phase|Lost to Follow-up|5
1752969|NCT00849693|6109709|P4|Acute Treatment Phase|Adverse Event|4
1752970|NCT00849693|6109710|P3|Acute Treatment Phase|Adverse Event|6
1752971|NCT00849693|6109711|P2|Acute Treatment Phase|Adverse Event|7
1752972|NCT00849693|6109712|P1|Acute Treatment Phase|Adverse Event|12
1752973|NCT00849680|6109779|P8|Overall Study|Subject unable to comply with protocol|0
1752974|NCT00849680|6109780|P7|Overall Study|Subject unable to comply with protocol|0
1752975|NCT00849680|6109781|P6|Overall Study|Subject unable to comply with protocol|0
1752976|NCT00849680|6109782|P5|Overall Study|Subject unable to comply with protocol|0
1752977|NCT00849680|6109783|P4|Overall Study|Subject unable to comply with protocol|0
1752978|NCT00849680|6109784|P3|Overall Study|Subject unable to comply with protocol|0
1752979|NCT00849680|6109785|P2|Overall Study|Subject unable to comply with protocol|0
1752980|NCT00849680|6109786|P1|Overall Study|Subject unable to comply with protocol|1
1752981|NCT00849680|6109779|P8|Overall Study|Withdrawal by Subject|1
1752982|NCT00849680|6109780|P7|Overall Study|Withdrawal by Subject|1
1752983|NCT00849680|6109781|P6|Overall Study|Withdrawal by Subject|2
1752984|NCT00849680|6109782|P5|Overall Study|Withdrawal by Subject|2
1752985|NCT00849680|6109783|P4|Overall Study|Withdrawal by Subject|2
1752986|NCT00849680|6109784|P3|Overall Study|Withdrawal by Subject|0
1752987|NCT00849680|6109785|P2|Overall Study|Withdrawal by Subject|0
1752988|NCT00849680|6109786|P1|Overall Study|Withdrawal by Subject|2
1752989|NCT00849680|6109779|P8|Overall Study|Subject moved|2
1752990|NCT00849680|6109780|P7|Overall Study|Subject moved|2
1752991|NCT00849680|6109781|P6|Overall Study|Subject moved|2
1752992|NCT00849680|6109782|P5|Overall Study|Subject moved|0
1752993|NCT00849680|6109783|P4|Overall Study|Subject moved|1
1752994|NCT00849680|6109784|P3|Overall Study|Subject moved|3
1752995|NCT00849680|6109785|P2|Overall Study|Subject moved|0
1752996|NCT00849680|6109786|P1|Overall Study|Subject moved|1
1752997|NCT00849680|6109779|P8|Overall Study|Lost to Follow-up|5
1752998|NCT00849680|6109780|P7|Overall Study|Lost to Follow-up|12
1752999|NCT00849680|6109781|P6|Overall Study|Lost to Follow-up|11
1753000|NCT00849680|6109782|P5|Overall Study|Lost to Follow-up|8
1753001|NCT00849680|6109783|P4|Overall Study|Lost to Follow-up|11
1753002|NCT00849680|6109784|P3|Overall Study|Lost to Follow-up|12
1753003|NCT00849680|6109785|P2|Overall Study|Lost to Follow-up|3
1753004|NCT00849680|6109786|P1|Overall Study|Lost to Follow-up|7
1753005|NCT00849680|6109779|P8|Overall Study|Adverse Event|0
1753006|NCT00849680|6109780|P7|Overall Study|Adverse Event|2
1753007|NCT00849680|6109781|P6|Overall Study|Adverse Event|0
1753008|NCT00849680|6109782|P5|Overall Study|Adverse Event|0
1753009|NCT00849680|6109783|P4|Overall Study|Adverse Event|0
1753010|NCT00849680|6109784|P3|Overall Study|Adverse Event|0
1753011|NCT00849680|6109785|P2|Overall Study|Adverse Event|0
1753012|NCT00849680|6109786|P1|Overall Study|Adverse Event|0
1753013|NCT00849524|6109828|P1|Overall Study|Lack of Efficacy|3
1753014|NCT00849472|6109845|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
1753015|NCT00849472|6109845|P1|Pazopanib Postsurgery Treatment|Moved|1
1753016|NCT00849472|6109845|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
1753017|NCT00849472|6109845|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
1753018|NCT00849472|6109845|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
1753019|NCT00849472|6109845|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
1753020|NCT00849472|6109845|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
1753021|NCT00849472|6109845|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
1753022|NCT00849472|6109845|P1|Weekly Paclitaxel|Physician Decision|3
1753023|NCT00849472|6109845|P1|Weekly Paclitaxel|Withdrawal by Subject|1
1753024|NCT00849472|6109845|P1|Weekly Paclitaxel|Adverse Event|11
1753025|NCT00849472|6109845|P1|Weekly Paclitaxel|Disease Progression|1
1753026|NCT00849472|6109845|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
1753027|NCT00849472|6109845|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
1753028|NCT00849472|6109845|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
1753029|NCT00849472|6109845|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
1753030|NCT00849472|6109845|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
1753031|NCT00849381|6109859|P1|Overall Study|Other|4
1753032|NCT00849381|6109859|P1|Overall Study|Withdrawal by Subject|6
1753033|NCT00849381|6109859|P1|Overall Study|Protocol Violation|5
1753034|NCT00849381|6109859|P1|Overall Study|Lost to Follow-up|129
1753035|NCT00849381|6109859|P1|Overall Study|Adverse Event|1
1753036|NCT00849290|6109865|P1|Overall Study|Disease Progression|20
1753037|NCT00849290|6109865|P1|Overall Study|Protocol Violation|5
1753038|NCT00849290|6109865|P1|Overall Study|Lost to Follow-up|2
1753039|NCT00849290|6109865|P1|Overall Study|Withdrawal by Subject|11
1753040|NCT00849290|6109865|P1|Overall Study|Death|14
1753041|NCT00849290|6109865|P1|Overall Study|Adverse Event|3
1753042|NCT00849212|6109876|P1|Overall Study|Miscellaneous|1
1753043|NCT00849212|6109876|P1|Overall Study|Adverse Event|2
1753044|NCT00849212|6109876|P1|Overall Study|Withdrawal by Subject|3
1753045|NCT00849212|6109876|P1|Overall Study|Lack of Efficacy|1
1753046|NCT00849186|6109881|P1|Overall Study|Other|1
1753047|NCT00849186|6109881|P1|Overall Study|not treated|6
1753048|NCT00849186|6109881|P1|Overall Study|Withdrawal by Subject|1
1753049|NCT00849186|6109881|P1|Overall Study|Adverse Event|2
1753050|NCT00849147|6109887|P1|Overall Study|Disease Relapse/Progression|2
1753051|NCT00849147|6109887|P1|Overall Study|Protocol Violation|2
1753052|NCT00849147|6109887|P1|Overall Study|Withdrawal by Subject|1
1753053|NCT00849108|6109920|P2|Cohort 2 Efficacy|Other|9
1753054|NCT00849108|6109921|P1|Cohort 2 Efficacy|Other|0
1753055|NCT00849108|6109920|P2|Cohort 2 Efficacy|Adverse Event|1
1753056|NCT00849108|6109921|P1|Cohort 2 Efficacy|Adverse Event|0
1753057|NCT00849108|6109920|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
1753058|NCT00849108|6109921|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
1753059|NCT00849056|6109931|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
1753060|NCT00849056|6109932|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
1753061|NCT00849056|6109931|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
1753062|NCT00849056|6109932|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
1753063|NCT00849056|6109931|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1753064|NCT00849056|6109932|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1753065|NCT00849056|6109931|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
1753066|NCT00849056|6109932|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
1753067|NCT00849056|6109931|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
1753068|NCT00849056|6109932|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
1753069|NCT00849056|6109931|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
1753070|NCT00849056|6109932|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
1753071|NCT00849056|6109931|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
1753072|NCT00849056|6109932|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1753073|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
1753074|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1753075|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
1753076|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
1753077|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
1753078|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
1753079|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
1753080|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
1753081|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
1753082|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
1753083|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
1753084|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
1753085|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
1753086|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
1753087|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
1753088|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
1753089|NCT00849056|6109931|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
1753090|NCT00849056|6109932|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
1753091|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
1753092|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
1753093|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
1753094|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
1753095|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
1753096|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
1753097|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Physician Decision|1
1753098|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Physician Decision|1
1753099|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Physician Decision|0
1753100|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
1753101|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
1753102|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
1753103|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
1753104|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
1753105|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
1753106|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
1753107|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
1753108|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
1753109|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Noncompliance|0
1753110|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Noncompliance|1
1753111|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1753112|NCT00849017|6109957|P3|Follow-up Period (8 Weeks)|Adverse Event|0
1753113|NCT00849017|6109958|P2|Follow-up Period (8 Weeks)|Adverse Event|0
1753114|NCT00849017|6109959|P1|Follow-up Period (8 Weeks)|Adverse Event|1
1753115|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
1753116|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
1753117|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
1753118|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Pregnancy|1
1753119|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Pregnancy|0
1753120|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Pregnancy|1
1753121|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
1753122|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
1753123|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
1753124|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
1753125|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
1753126|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
1753127|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
1753128|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
1753129|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
1753130|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
1753131|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
1753132|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
1753133|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Physician Decision|1
1753134|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Physician Decision|2
1753135|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Physician Decision|0
1753136|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
1753137|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
1753138|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
1753139|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
1753140|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
1753141|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
1753142|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Noncompliance|4
1753143|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Noncompliance|3
1753144|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Noncompliance|3
1753145|NCT00849017|6109957|P3|Treatment Period (156 Weeks)|Adverse Event|15
1753146|NCT00849017|6109958|P2|Treatment Period (156 Weeks)|Adverse Event|6
1753147|NCT00849017|6109959|P1|Treatment Period (156 Weeks)|Adverse Event|5
1753148|NCT00848965|6110002|P1|Overall Study|Withdrawal by Subject|1
1753149|NCT00848965|6110002|P1|Overall Study|Adverse Event|1
1753150|NCT00848926|6110044|P1|Follow-up Period|Other|2
1753151|NCT00848926|6110044|P1|Follow-up Period|Withdrawal by Subject|3
1753152|NCT00848926|6110044|P1|Follow-up Period|Lost to Follow-up|7
1753153|NCT00848926|6110044|P1|Treatment Period|Withdrawal by Subject|7
1753154|NCT00848926|6110044|P1|Treatment Period|Physician Decision|12
1753155|NCT00848926|6110044|P1|Treatment Period|Adverse Event|20
1753156|NCT00848926|6110044|P1|Treatment Period|Progressive disease|45
1753157|NCT00848718|6110094|P13|Overall Study|Progressive disease during treatment|2
1753158|NCT00848718|6110095|P12|Overall Study|Progressive disease during treatment|0
1753159|NCT00848718|6110096|P11|Overall Study|Progressive disease during treatment|0
1753160|NCT00848718|6110097|P10|Overall Study|Progressive disease during treatment|0
1753161|NCT00848718|6110098|P9|Overall Study|Progressive disease during treatment|0
1753162|NCT00848718|6110099|P8|Overall Study|Progressive disease during treatment|2
1753163|NCT00848718|6110100|P7|Overall Study|Progressive disease during treatment|0
1753164|NCT00848718|6110101|P6|Overall Study|Progressive disease during treatment|0
1753165|NCT00848718|6110102|P5|Overall Study|Progressive disease during treatment|0
1753166|NCT00848718|6110103|P4|Overall Study|Progressive disease during treatment|0
1753167|NCT00848718|6110104|P3|Overall Study|Progressive disease during treatment|3
1753168|NCT00848718|6110105|P2|Overall Study|Progressive disease during treatment|0
1753169|NCT00848718|6110106|P1|Overall Study|Progressive disease during treatment|3
1753170|NCT00848718|6110094|P13|Overall Study|Withdrawal by Subject|0
1753171|NCT00848718|6110095|P12|Overall Study|Withdrawal by Subject|0
1753172|NCT00848718|6110096|P11|Overall Study|Withdrawal by Subject|1
1753173|NCT00848718|6110097|P10|Overall Study|Withdrawal by Subject|0
1753174|NCT00848718|6110098|P9|Overall Study|Withdrawal by Subject|0
1753175|NCT00848718|6110099|P8|Overall Study|Withdrawal by Subject|0
1753176|NCT00848718|6110100|P7|Overall Study|Withdrawal by Subject|0
1753177|NCT00848718|6110101|P6|Overall Study|Withdrawal by Subject|0
1753178|NCT00848718|6110102|P5|Overall Study|Withdrawal by Subject|0
1753179|NCT00848718|6110103|P4|Overall Study|Withdrawal by Subject|1
1753180|NCT00848718|6110104|P3|Overall Study|Withdrawal by Subject|0
1753181|NCT00848718|6110105|P2|Overall Study|Withdrawal by Subject|0
1753182|NCT00848718|6110106|P1|Overall Study|Withdrawal by Subject|1
1753183|NCT00848718|6110094|P13|Overall Study|Protocol Violation|1
1753184|NCT00848718|6110095|P12|Overall Study|Protocol Violation|0
1753185|NCT00848718|6110096|P11|Overall Study|Protocol Violation|0
1753186|NCT00848718|6110097|P10|Overall Study|Protocol Violation|0
1753187|NCT00848718|6110098|P9|Overall Study|Protocol Violation|0
1753188|NCT00848718|6110099|P8|Overall Study|Protocol Violation|1
1753189|NCT00848718|6110100|P7|Overall Study|Protocol Violation|0
1753190|NCT00848718|6110101|P6|Overall Study|Protocol Violation|0
1753191|NCT00848718|6110102|P5|Overall Study|Protocol Violation|0
1753192|NCT00848718|6110103|P4|Overall Study|Protocol Violation|0
1753193|NCT00848718|6110104|P3|Overall Study|Protocol Violation|0
1753194|NCT00848718|6110105|P2|Overall Study|Protocol Violation|1
1753195|NCT00848718|6110106|P1|Overall Study|Protocol Violation|0
1753196|NCT00848718|6110094|P13|Overall Study|Progressive disease before treatment|2
1753197|NCT00848718|6110095|P12|Overall Study|Progressive disease before treatment|6
1753198|NCT00848718|6110096|P11|Overall Study|Progressive disease before treatment|3
1753199|NCT00848718|6110097|P10|Overall Study|Progressive disease before treatment|7
1753200|NCT00848718|6110098|P9|Overall Study|Progressive disease before treatment|2
1753201|NCT00848718|6110099|P8|Overall Study|Progressive disease before treatment|1
1753202|NCT00848718|6110100|P7|Overall Study|Progressive disease before treatment|2
1753203|NCT00848718|6110101|P6|Overall Study|Progressive disease before treatment|4
1753204|NCT00848718|6110102|P5|Overall Study|Progressive disease before treatment|4
1753205|NCT00848718|6110103|P4|Overall Study|Progressive disease before treatment|3
1753206|NCT00848718|6110104|P3|Overall Study|Progressive disease before treatment|1
1753207|NCT00848718|6110105|P2|Overall Study|Progressive disease before treatment|5
1753208|NCT00848718|6110106|P1|Overall Study|Progressive disease before treatment|1
1753209|NCT00848718|6110094|P13|Overall Study|Physician Decision|1
1753210|NCT00848718|6110095|P12|Overall Study|Physician Decision|0
1753211|NCT00848718|6110096|P11|Overall Study|Physician Decision|0
1753212|NCT00848718|6110097|P10|Overall Study|Physician Decision|2
1753213|NCT00848718|6110098|P9|Overall Study|Physician Decision|1
1753214|NCT00848718|6110099|P8|Overall Study|Physician Decision|0
1753215|NCT00848718|6110100|P7|Overall Study|Physician Decision|0
1753216|NCT00848718|6110101|P6|Overall Study|Physician Decision|1
1753217|NCT00848718|6110102|P5|Overall Study|Physician Decision|1
1753218|NCT00848718|6110103|P4|Overall Study|Physician Decision|0
1753219|NCT00848718|6110104|P3|Overall Study|Physician Decision|0
1753220|NCT00848718|6110105|P2|Overall Study|Physician Decision|1
1753221|NCT00848718|6110106|P1|Overall Study|Physician Decision|0
1753222|NCT00848718|6110094|P13|Overall Study|Lack of Efficacy|0
1753223|NCT00848718|6110095|P12|Overall Study|Lack of Efficacy|0
1753224|NCT00848718|6110096|P11|Overall Study|Lack of Efficacy|0
1753225|NCT00848718|6110097|P10|Overall Study|Lack of Efficacy|0
1753226|NCT00848718|6110098|P9|Overall Study|Lack of Efficacy|0
1753227|NCT00848718|6110099|P8|Overall Study|Lack of Efficacy|0
1753228|NCT00848718|6110100|P7|Overall Study|Lack of Efficacy|1
1753229|NCT00848718|6110101|P6|Overall Study|Lack of Efficacy|0
1753230|NCT00848718|6110102|P5|Overall Study|Lack of Efficacy|0
1753231|NCT00848718|6110103|P4|Overall Study|Lack of Efficacy|0
1753232|NCT00848718|6110104|P3|Overall Study|Lack of Efficacy|1
1753233|NCT00848718|6110105|P2|Overall Study|Lack of Efficacy|0
1753234|NCT00848718|6110106|P1|Overall Study|Lack of Efficacy|0
1753235|NCT00848718|6110094|P13|Overall Study|Adverse Event|2
1753236|NCT00848718|6110095|P12|Overall Study|Adverse Event|0
1753237|NCT00848718|6110096|P11|Overall Study|Adverse Event|0
1753238|NCT00848718|6110097|P10|Overall Study|Adverse Event|0
1753239|NCT00848718|6110098|P9|Overall Study|Adverse Event|1
1753240|NCT00848718|6110099|P8|Overall Study|Adverse Event|1
1753241|NCT00848718|6110100|P7|Overall Study|Adverse Event|0
1753242|NCT00848718|6110101|P6|Overall Study|Adverse Event|0
1753243|NCT00848718|6110102|P5|Overall Study|Adverse Event|1
1753244|NCT00848718|6110103|P4|Overall Study|Adverse Event|1
1753245|NCT00848718|6110104|P3|Overall Study|Adverse Event|1
1753246|NCT00848718|6110105|P2|Overall Study|Adverse Event|2
1753247|NCT00848718|6110106|P1|Overall Study|Adverse Event|2
1753248|NCT00848549|6110207|P2|E2090-E044-314 (Extension Study)|Other|6
1753249|NCT00848549|6110208|P1|E2090-E044-314 (Extension Study)|Other|5
1753250|NCT00848549|6110207|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
1753251|NCT00848549|6110208|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
1753252|NCT00848549|6110207|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
1753253|NCT00848549|6110208|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
1753254|NCT00848549|6110207|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
1753255|NCT00848549|6110208|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
1753256|NCT00848549|6110207|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
1753257|NCT00848549|6110208|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
1753258|NCT00848549|6110207|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
1753259|NCT00848549|6110208|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
1753260|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
1753261|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
1753262|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Disposition|Other|3
1753263|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Disposition|Other|4
1753264|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
1753265|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
1753266|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
1753267|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
1753268|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
1753269|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
1753270|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
1753271|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
1753272|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
1753273|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
1753274|NCT00848549|6110207|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
1753275|NCT00848549|6110208|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
1753276|NCT00848536|6110226|P2|Overall Study|Patient Moved|2
1753277|NCT00848536|6110227|P1|Overall Study|Patient Moved|0
1753278|NCT00848536|6110226|P2|Overall Study|Inadequate Control of IOP|1
1753279|NCT00848536|6110227|P1|Overall Study|Inadequate Control of IOP|1
1753280|NCT00848536|6110226|P2|Overall Study|Noncompliance|0
1753281|NCT00848536|6110227|P1|Overall Study|Noncompliance|1
1753282|NCT00848536|6110226|P2|Overall Study|Protocol Violation|1
1753283|NCT00848536|6110227|P1|Overall Study|Protocol Violation|0
1753284|NCT00848536|6110226|P2|Overall Study|Withdrawal by Subject|1
1753285|NCT00848536|6110227|P1|Overall Study|Withdrawal by Subject|0
1753286|NCT00848536|6110226|P2|Overall Study|Adverse Event|2
1753287|NCT00848536|6110227|P1|Overall Study|Adverse Event|2
1753288|NCT00848497|6110292|P2|Overall Study|Withdrawal by Subject|1
1753289|NCT00848497|6110293|P1|Overall Study|Withdrawal by Subject|0
1753290|NCT00848497|6110292|P2|Overall Study|Screen failure|0
1753291|NCT00848497|6110293|P1|Overall Study|Screen failure|2
1753292|NCT00848484|6110307|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
1753293|NCT00848484|6110308|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
1753294|NCT00848484|6110307|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
1753295|NCT00848484|6110308|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
1753296|NCT00848484|6110307|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
1753297|NCT00848484|6110308|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
1753298|NCT00848484|6110307|P2|First Intervention (Treatment Period 1)|Physician Decision|1
1753299|NCT00848484|6110308|P1|First Intervention (Treatment Period 1)|Physician Decision|0
1753300|NCT00848484|6110307|P2|First Intervention (Treatment Period 1)|Adverse Event|1
1753301|NCT00848484|6110308|P1|First Intervention (Treatment Period 1)|Adverse Event|2
1753302|NCT00848393|6110327|P3|Overall Study|surgical complications unrelated to stud|2
1753303|NCT00848393|6110328|P2|Overall Study|surgical complications unrelated to stud|0
1753304|NCT00848393|6110329|P1|Overall Study|surgical complications unrelated to stud|0
1753305|NCT00848393|6110327|P3|Overall Study|Protocol Violation|1
1753306|NCT00848393|6110328|P2|Overall Study|Protocol Violation|0
1753307|NCT00848393|6110329|P1|Overall Study|Protocol Violation|0
1753308|NCT00848354|6110368|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
1753309|NCT00848354|6110369|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
1753310|NCT00848354|6110368|P2|Phase 2 Year 2|Subject Request|1
1753311|NCT00848354|6110369|P1|Phase 2 Year 2|Subject Request|1
1753312|NCT00848354|6110368|P2|Phase 2 Year 2|Protocol Violation|1
1753313|NCT00848354|6110369|P1|Phase 2 Year 2|Protocol Violation|1
1753314|NCT00848354|6110368|P2|Phase 2 Year 2|Unspecified Reason|0
1753315|NCT00848354|6110369|P1|Phase 2 Year 2|Unspecified Reason|1
1753316|NCT00848354|6110368|P2|Phase 2 Year 2|Lost to Follow-up|3
1753317|NCT00848354|6110369|P1|Phase 2 Year 2|Lost to Follow-up|1
1753318|NCT00848354|6110368|P2|Phase 2 Year 2|Failed to return|0
1753319|NCT00848354|6110369|P1|Phase 2 Year 2|Failed to return|3
1753320|NCT00848354|6110368|P2|Phase 2 Year 2|Death|0
1753321|NCT00848354|6110369|P1|Phase 2 Year 2|Death|2
1753322|NCT00848354|6110368|P2|Phase 2 Year 2|Adverse Event|2
1753323|NCT00848354|6110369|P1|Phase 2 Year 2|Adverse Event|12
1753324|NCT00848354|6110368|P2|Phase 2 Year 1|Subject Request|2
1753325|NCT00848354|6110369|P1|Phase 2 Year 1|Subject Request|1
1753326|NCT00848354|6110368|P2|Phase 2 Year 1|Protocol Violation|1
1753327|NCT00848354|6110369|P1|Phase 2 Year 1|Protocol Violation|4
1753328|NCT00848354|6110368|P2|Phase 2 Year 1|Unspecified Reason|0
1753329|NCT00848354|6110369|P1|Phase 2 Year 1|Unspecified Reason|3
1753330|NCT00848354|6110368|P2|Phase 2 Year 1|Lost to Follow-up|0
1753331|NCT00848354|6110369|P1|Phase 2 Year 1|Lost to Follow-up|1
1753332|NCT00848354|6110368|P2|Phase 2 Year 1|Failed to Return|1
1753333|NCT00848354|6110369|P1|Phase 2 Year 1|Failed to Return|1
1753334|NCT00848354|6110368|P2|Phase 2 Year 1|Death|0
1753335|NCT00848354|6110369|P1|Phase 2 Year 1|Death|1
1753336|NCT00848354|6110368|P2|Phase 2 Year 1|Adverse Event|2
1753337|NCT00848354|6110369|P1|Phase 2 Year 1|Adverse Event|7
1753338|NCT00848354|6110368|P2|Phase 1|Lack of Efficacy|1
1753339|NCT00848354|6110369|P1|Phase 1|Lack of Efficacy|0
1753340|NCT00848354|6110368|P2|Phase 1|Withdrawal by Subject|4
1753341|NCT00848354|6110369|P1|Phase 1|Withdrawal by Subject|2
1753342|NCT00848354|6110368|P2|Phase 1|Protocol Violation|1
1753343|NCT00848354|6110369|P1|Phase 1|Protocol Violation|1
1753344|NCT00848354|6110368|P2|Phase 1|Unspecified Reason|1
1753345|NCT00848354|6110369|P1|Phase 1|Unspecified Reason|1
1753346|NCT00848354|6110368|P2|Phase 1|Lost to Follow-up|1
1753347|NCT00848354|6110369|P1|Phase 1|Lost to Follow-up|1
1753348|NCT00848354|6110368|P2|Phase 1|Failed to return|1
1753349|NCT00848354|6110369|P1|Phase 1|Failed to return|0
1753350|NCT00848354|6110368|P2|Phase 1|Discontinuation of study by sponsor|1
1753351|NCT00848354|6110369|P1|Phase 1|Discontinuation of study by sponsor|2
1753352|NCT00848354|6110368|P2|Phase 1|Adverse Event|4
1753353|NCT00848354|6110369|P1|Phase 1|Adverse Event|5
1753354|NCT00848250|6110521|P2|Overall Study|surgery was completed without cardiopulm|1
1753355|NCT00848250|6110522|P1|Overall Study|surgery was completed without cardiopulm|0
1753356|NCT00848211|6110553|P4|Overall Study|Adverse Event|0
1753357|NCT00848211|6110554|P3|Overall Study|Adverse Event|0
1753358|NCT00848211|6110555|P2|Overall Study|Adverse Event|0
1753359|NCT00848211|6110556|P1|Overall Study|Adverse Event|0
1753360|NCT00848211|6110553|P4|Overall Study|Protocol Violation|0
1753361|NCT00848211|6110554|P3|Overall Study|Protocol Violation|1
1753362|NCT00848211|6110555|P2|Overall Study|Protocol Violation|1
1753363|NCT00848211|6110556|P1|Overall Study|Protocol Violation|0
1753364|NCT00848198|6110574|P1|Overall Study|Incomplete Case Report Forms|15
1753365|NCT00848120|6110639|P1|Overall Study|Adverse Event|1
1753366|NCT00848107|6110651|P1|Overall Study|Pregnancy|1
1753367|NCT00848107|6110651|P1|Overall Study|Death|1
1753368|NCT00848107|6110651|P1|Overall Study|Adverse Event|9
1753369|NCT00848107|6110651|P1|Overall Study|Withdrawal by Subject|8
1753370|NCT00848107|6110651|P1|Overall Study|Lost to Follow-up|2
1753371|NCT00848081|6110661|P2|Overall Study|Withdrawal by Subject|3
1753372|NCT00848081|6110662|P1|Overall Study|Withdrawal by Subject|5
1753373|NCT00848081|6110661|P2|Overall Study|Physician Decision|3
1753374|NCT00848081|6110662|P1|Overall Study|Physician Decision|0
1753375|NCT00848081|6110661|P2|Overall Study|Lost to Follow-up|0
1753376|NCT00848081|6110662|P1|Overall Study|Lost to Follow-up|1
1753377|NCT00848081|6110661|P2|Overall Study|Protocol Violation|5
1753378|NCT00848081|6110662|P1|Overall Study|Protocol Violation|8
1753379|NCT00848081|6110661|P2|Overall Study|Adverse Event|7
1753380|NCT00848081|6110662|P1|Overall Study|Adverse Event|6
1753381|NCT00848042|6110679|P3|Overall Study|Other Therapy|0
1753382|NCT00848042|6110680|P2|Overall Study|Other Therapy|0
1753383|NCT00848042|6110681|P1|Overall Study|Other Therapy|3
1753384|NCT00848042|6110679|P3|Overall Study|Death|0
1753385|NCT00848042|6110680|P2|Overall Study|Death|2
1753386|NCT00848042|6110681|P1|Overall Study|Death|1
1753387|NCT00847912|6110717|P2|Overall Study|Withdrawal by Subject|6
1753388|NCT00847912|6110718|P1|Overall Study|Withdrawal by Subject|3
1753389|NCT00847912|6110717|P2|Overall Study|Protocol Violation|7
1753390|NCT00847912|6110718|P1|Overall Study|Protocol Violation|6
1753391|NCT00847886|6110728|P2|Overall Study|Adverse Event|1
1753392|NCT00847886|6110729|P1|Overall Study|Adverse Event|0
1753393|NCT00847808|6110755|P1|Overall Study|Participant Took Excluded Medication|1
1753394|NCT00847808|6110755|P1|Overall Study|Participant Reported Lack of Efficacy|1
1753395|NCT00847808|6110755|P1|Overall Study|Withdrawal by Subject|4
1753396|NCT00847808|6110755|P1|Overall Study|Lost to Follow-up|1
1753397|NCT00847808|6110755|P1|Overall Study|Protocol Violation|1
1753398|NCT00847808|6110755|P1|Overall Study|Adverse Event|7
1753399|NCT00847730|6110772|P1|Overall Study|Multiple interruptions in therapy|8
1753400|NCT00847704|6110776|P1|Overall Study|Withdrawal by Subject|1
1753401|NCT00847665|6110787|P2|Overall Study|Withdrawal by Subject|0
1753402|NCT00847665|6110788|P1|Overall Study|Withdrawal by Subject|1
1753403|NCT00847626|6110811|P11|Overall Study|Other|3
1753404|NCT00847626|6110812|P10|Overall Study|Other|1
1753405|NCT00847626|6110813|P9|Overall Study|Other|1
1753406|NCT00847626|6110814|P8|Overall Study|Other|3
1753407|NCT00847626|6110815|P7|Overall Study|Other|2
1753408|NCT00847626|6110816|P6|Overall Study|Other|2
1753409|NCT00847626|6110817|P5|Overall Study|Other|2
1753410|NCT00847626|6110818|P4|Overall Study|Other|1
1753411|NCT00847626|6110819|P3|Overall Study|Other|4
1753412|NCT00847626|6110820|P2|Overall Study|Other|5
1753413|NCT00847626|6110821|P1|Overall Study|Other|1
1753414|NCT00847626|6110811|P11|Overall Study|Lack of Efficacy|7
1753415|NCT00847626|6110812|P10|Overall Study|Lack of Efficacy|1
1753416|NCT00847626|6110813|P9|Overall Study|Lack of Efficacy|5
1753417|NCT00847626|6110814|P8|Overall Study|Lack of Efficacy|2
1753418|NCT00847626|6110815|P7|Overall Study|Lack of Efficacy|6
1753419|NCT00847626|6110816|P6|Overall Study|Lack of Efficacy|0
1753420|NCT00847626|6110817|P5|Overall Study|Lack of Efficacy|2
1753421|NCT00847626|6110818|P4|Overall Study|Lack of Efficacy|1
1753422|NCT00847626|6110819|P3|Overall Study|Lack of Efficacy|0
1753423|NCT00847626|6110820|P2|Overall Study|Lack of Efficacy|1
1753424|NCT00847626|6110821|P1|Overall Study|Lack of Efficacy|3
1753425|NCT00847626|6110811|P11|Overall Study|Withdrawal by Subject|2
1753426|NCT00847626|6110812|P10|Overall Study|Withdrawal by Subject|5
1753427|NCT00847626|6110813|P9|Overall Study|Withdrawal by Subject|4
1753428|NCT00847626|6110814|P8|Overall Study|Withdrawal by Subject|4
1753429|NCT00847626|6110815|P7|Overall Study|Withdrawal by Subject|8
1753430|NCT00847626|6110816|P6|Overall Study|Withdrawal by Subject|9
1753431|NCT00847626|6110817|P5|Overall Study|Withdrawal by Subject|12
1753432|NCT00847626|6110818|P4|Overall Study|Withdrawal by Subject|8
1753433|NCT00847626|6110819|P3|Overall Study|Withdrawal by Subject|3
1753434|NCT00847626|6110820|P2|Overall Study|Withdrawal by Subject|5
1753435|NCT00847626|6110821|P1|Overall Study|Withdrawal by Subject|5
1753436|NCT00847626|6110811|P11|Overall Study|Lost to Follow-up|1
1753437|NCT00847626|6110812|P10|Overall Study|Lost to Follow-up|0
1753438|NCT00847626|6110813|P9|Overall Study|Lost to Follow-up|1
1753439|NCT00847626|6110814|P8|Overall Study|Lost to Follow-up|3
1753440|NCT00847626|6110815|P7|Overall Study|Lost to Follow-up|1
1753441|NCT00847626|6110816|P6|Overall Study|Lost to Follow-up|3
1753442|NCT00847626|6110817|P5|Overall Study|Lost to Follow-up|0
1753443|NCT00847626|6110818|P4|Overall Study|Lost to Follow-up|1
1753444|NCT00847626|6110819|P3|Overall Study|Lost to Follow-up|1
1753445|NCT00847626|6110820|P2|Overall Study|Lost to Follow-up|1
1753446|NCT00847626|6110821|P1|Overall Study|Lost to Follow-up|0
1753447|NCT00847626|6110811|P11|Overall Study|Protocol Violation|1
1753448|NCT00847626|6110812|P10|Overall Study|Protocol Violation|1
1753449|NCT00847626|6110813|P9|Overall Study|Protocol Violation|0
1753450|NCT00847626|6110814|P8|Overall Study|Protocol Violation|1
1753451|NCT00847626|6110815|P7|Overall Study|Protocol Violation|1
1753452|NCT00847626|6110816|P6|Overall Study|Protocol Violation|1
1753453|NCT00847626|6110817|P5|Overall Study|Protocol Violation|1
1753454|NCT00847626|6110818|P4|Overall Study|Protocol Violation|1
1753455|NCT00847626|6110819|P3|Overall Study|Protocol Violation|2
1753456|NCT00847626|6110820|P2|Overall Study|Protocol Violation|1
1753457|NCT00847626|6110821|P1|Overall Study|Protocol Violation|2
1753458|NCT00847626|6110811|P11|Overall Study|Adverse Event|6
1753459|NCT00847626|6110812|P10|Overall Study|Adverse Event|6
1753460|NCT00847626|6110813|P9|Overall Study|Adverse Event|3
1753461|NCT00847626|6110814|P8|Overall Study|Adverse Event|6
1753462|NCT00847626|6110815|P7|Overall Study|Adverse Event|4
1753463|NCT00847626|6110816|P6|Overall Study|Adverse Event|22
1753464|NCT00847626|6110817|P5|Overall Study|Adverse Event|11
1753465|NCT00847626|6110818|P4|Overall Study|Adverse Event|19
1753466|NCT00847626|6110819|P3|Overall Study|Adverse Event|6
1753467|NCT00847626|6110820|P2|Overall Study|Adverse Event|10
1753468|NCT00847626|6110821|P1|Overall Study|Adverse Event|10
1753469|NCT00847613|6111020|P4|Overall Study|Other|0
1753470|NCT00847613|6111021|P3|Overall Study|Other|2
1753471|NCT00847613|6111022|P2|Overall Study|Other|1
1753472|NCT00847613|6111023|P1|Overall Study|Other|1
1753473|NCT00847613|6111020|P4|Overall Study|Randomized, but not treated|0
1753474|NCT00847613|6111021|P3|Overall Study|Randomized, but not treated|0
1753475|NCT00847613|6111022|P2|Overall Study|Randomized, but not treated|3
1753476|NCT00847613|6111023|P1|Overall Study|Randomized, but not treated|0
1753477|NCT00847613|6111020|P4|Overall Study|Sponsor request|0
1753478|NCT00847613|6111021|P3|Overall Study|Sponsor request|0
1753479|NCT00847613|6111022|P2|Overall Study|Sponsor request|1
1753480|NCT00847613|6111023|P1|Overall Study|Sponsor request|0
1753481|NCT00847613|6111020|P4|Overall Study|Participant moved|0
1753482|NCT00847613|6111021|P3|Overall Study|Participant moved|0
1753483|NCT00847613|6111022|P2|Overall Study|Participant moved|1
1753484|NCT00847613|6111023|P1|Overall Study|Participant moved|4
1753485|NCT00847613|6111020|P4|Overall Study|Withdrawal by Subject|2
1753486|NCT00847613|6111021|P3|Overall Study|Withdrawal by Subject|2
1753487|NCT00847613|6111022|P2|Overall Study|Withdrawal by Subject|11
1753488|NCT00847613|6111023|P1|Overall Study|Withdrawal by Subject|8
1753489|NCT00847613|6111020|P4|Overall Study|Site closure|1
1753490|NCT00847613|6111021|P3|Overall Study|Site closure|0
1753491|NCT00847613|6111022|P2|Overall Study|Site closure|0
1753492|NCT00847613|6111023|P1|Overall Study|Site closure|1
1753493|NCT00847613|6111020|P4|Overall Study|Pregnancy|0
1753494|NCT00847613|6111021|P3|Overall Study|Pregnancy|0
1753495|NCT00847613|6111022|P2|Overall Study|Pregnancy|1
1753496|NCT00847613|6111023|P1|Overall Study|Pregnancy|1
1753497|NCT00847613|6111020|P4|Overall Study|Protocol Violation|1
1753498|NCT00847613|6111021|P3|Overall Study|Protocol Violation|3
1753499|NCT00847613|6111022|P2|Overall Study|Protocol Violation|6
1753500|NCT00847613|6111023|P1|Overall Study|Protocol Violation|6
1753501|NCT00847613|6111020|P4|Overall Study|Lost to Follow-up|3
1753502|NCT00847613|6111021|P3|Overall Study|Lost to Follow-up|0
1753503|NCT00847613|6111022|P2|Overall Study|Lost to Follow-up|0
1753504|NCT00847613|6111023|P1|Overall Study|Lost to Follow-up|5
1753505|NCT00847613|6111020|P4|Overall Study|Study terminated by Sponsor|1
1753506|NCT00847613|6111021|P3|Overall Study|Study terminated by Sponsor|2
1753507|NCT00847613|6111022|P2|Overall Study|Study terminated by Sponsor|0
1753508|NCT00847613|6111023|P1|Overall Study|Study terminated by Sponsor|1
1753509|NCT00847613|6111020|P4|Overall Study|Lack of Efficacy|1
1753510|NCT00847613|6111021|P3|Overall Study|Lack of Efficacy|3
1753511|NCT00847613|6111022|P2|Overall Study|Lack of Efficacy|3
1753512|NCT00847613|6111023|P1|Overall Study|Lack of Efficacy|7
1753513|NCT00847613|6111020|P4|Overall Study|Adverse Event|6
1753514|NCT00847613|6111021|P3|Overall Study|Adverse Event|5
1753515|NCT00847613|6111022|P2|Overall Study|Adverse Event|26
1753516|NCT00847613|6111023|P1|Overall Study|Adverse Event|36
1753517|NCT00847613|6111020|P4|Overall Study|Death|0
1753518|NCT00847613|6111021|P3|Overall Study|Death|0
1753519|NCT00847613|6111022|P2|Overall Study|Death|1
1753520|NCT00847613|6111023|P1|Overall Study|Death|1
1753521|NCT00847613|6111020|P4|Overall Study|Ongoing at cut-off date|64
1753522|NCT00847613|6111021|P3|Overall Study|Ongoing at cut-off date|64
1753523|NCT00847613|6111022|P2|Overall Study|Ongoing at cut-off date|265
1753524|NCT00847613|6111023|P1|Overall Study|Ongoing at cut-off date|250
1753525|NCT00847561|6111274|P2|Overall Study|Unable to schedule|1
1753526|NCT00847561|6111275|P1|Overall Study|Unable to schedule|9
1753527|NCT00847561|6111274|P2|Overall Study|Withdrawal by Subject|3
1753528|NCT00847561|6111275|P1|Overall Study|Withdrawal by Subject|4
1753529|NCT00847535|6111281|P3|Overall Study|Lost to Follow-up|0
1753530|NCT00847535|6111282|P2|Overall Study|Lost to Follow-up|1
1753531|NCT00847535|6111283|P1|Overall Study|Lost to Follow-up|0
1753532|NCT00847535|6111281|P3|Overall Study|Withdrawal by Subject|1
1753533|NCT00847535|6111282|P2|Overall Study|Withdrawal by Subject|1
1753534|NCT00847535|6111283|P1|Overall Study|Withdrawal by Subject|2
1753535|NCT00847405|6111302|P2|Washout of 7 Days|Withdrawal by Subject|0
1753536|NCT00847405|6111303|P1|Washout of 7 Days|Withdrawal by Subject|1
1753537|NCT00847405|6111302|P2|First Intervention|Adverse Event|1
1753538|NCT00847405|6111303|P1|First Intervention|Adverse Event|0
1753539|NCT00847301|6111311|P1|Overall Study|Other reason not defined above|1
1753540|NCT00847301|6111311|P1|Overall Study|No prescription after hospital discharge|1
1753541|NCT00847301|6111311|P1|Overall Study|Lost to Follow-up|1
1753542|NCT00847301|6111311|P1|Overall Study|Switch to other anticoagulants|16
1753543|NCT00847301|6111311|P1|Overall Study|Adverse Event|35
1753544|NCT00847197|6111359|P2|Overall Study|Withdrawal by Subject|1
1753545|NCT00847197|6111360|P1|Overall Study|Withdrawal by Subject|3
1753546|NCT00847197|6111359|P2|Overall Study|Protocol Violation|1
1753547|NCT00847197|6111360|P1|Overall Study|Protocol Violation|0
1753548|NCT00847197|6111359|P2|Overall Study|Adverse Event|3
1753549|NCT00847197|6111360|P1|Overall Study|Adverse Event|21
1753550|NCT00847145|6111384|P8|Overall Study|Protocol Violation|1
1753551|NCT00847145|6111385|P7|Overall Study|Protocol Violation|0
1753552|NCT00847145|6111386|P6|Overall Study|Protocol Violation|0
1753553|NCT00847145|6111387|P5|Overall Study|Protocol Violation|1
1753554|NCT00847145|6111388|P4|Overall Study|Protocol Violation|0
1753555|NCT00847145|6111389|P3|Overall Study|Protocol Violation|3
1753556|NCT00847145|6111390|P2|Overall Study|Protocol Violation|0
1753557|NCT00847145|6111391|P1|Overall Study|Protocol Violation|0
1753558|NCT00847145|6111384|P8|Overall Study|Inappropriate enrollment|0
1753559|NCT00847145|6111385|P7|Overall Study|Inappropriate enrollment|0
1753560|NCT00847145|6111386|P6|Overall Study|Inappropriate enrollment|0
1753561|NCT00847145|6111387|P5|Overall Study|Inappropriate enrollment|1
1753562|NCT00847145|6111388|P4|Overall Study|Inappropriate enrollment|0
1753563|NCT00847145|6111389|P3|Overall Study|Inappropriate enrollment|0
1753564|NCT00847145|6111390|P2|Overall Study|Inappropriate enrollment|0
1753565|NCT00847145|6111391|P1|Overall Study|Inappropriate enrollment|0
1753566|NCT00847145|6111384|P8|Overall Study|Lost to Follow-up|2
1753567|NCT00847145|6111385|P7|Overall Study|Lost to Follow-up|8
1753568|NCT00847145|6111386|P6|Overall Study|Lost to Follow-up|4
1753569|NCT00847145|6111387|P5|Overall Study|Lost to Follow-up|4
1753570|NCT00847145|6111388|P4|Overall Study|Lost to Follow-up|0
1753571|NCT00847145|6111389|P3|Overall Study|Lost to Follow-up|1
1753572|NCT00847145|6111390|P2|Overall Study|Lost to Follow-up|1
1753573|NCT00847145|6111391|P1|Overall Study|Lost to Follow-up|3
1753574|NCT00847145|6111384|P8|Overall Study|Withdrawal by Subject|1
1753575|NCT00847145|6111385|P7|Overall Study|Withdrawal by Subject|1
1753576|NCT00847145|6111386|P6|Overall Study|Withdrawal by Subject|0
1753577|NCT00847145|6111387|P5|Overall Study|Withdrawal by Subject|0
1753578|NCT00847145|6111388|P4|Overall Study|Withdrawal by Subject|1
1753579|NCT00847145|6111389|P3|Overall Study|Withdrawal by Subject|6
1753580|NCT00847145|6111390|P2|Overall Study|Withdrawal by Subject|4
1753581|NCT00847145|6111391|P1|Overall Study|Withdrawal by Subject|3
1753582|NCT00847145|6111384|P8|Overall Study|AE or Death|0
1753583|NCT00847145|6111385|P7|Overall Study|AE or Death|0
1753584|NCT00847145|6111386|P6|Overall Study|AE or Death|0
1753585|NCT00847145|6111387|P5|Overall Study|AE or Death|0
1753586|NCT00847145|6111388|P4|Overall Study|AE or Death|0
1753587|NCT00847145|6111389|P3|Overall Study|AE or Death|1
1753588|NCT00847145|6111390|P2|Overall Study|AE or Death|1
1753589|NCT00847145|6111391|P1|Overall Study|AE or Death|0
1753590|NCT00847132|6111441|P2|Overall Study|Death|1
1753591|NCT00847132|6111442|P1|Overall Study|Death|1
1753592|NCT00847015|6111450|P1|Overall Study|partial cystectomy vs radical cystectomy|1
1753593|NCT00847015|6111450|P1|Overall Study|declined any surgery|1
1753594|NCT00847015|6111450|P1|Overall Study|Withdrawal by Subject|1
1753595|NCT00846846|6111478|P1|Overall Study|Withdrawal by Subject|19
1753596|NCT00846846|6111478|P1|Overall Study|Death|56
1753597|NCT00846807|6111483|P1|Overall Study|Other|60
1753598|NCT00846807|6111483|P1|Overall Study|No prescription after hospital discharge|56
1753599|NCT00846807|6111483|P1|Overall Study|Switch to other anticoagulants|89
1753600|NCT00846807|6111483|P1|Overall Study|Non compliant with European label|7
1753601|NCT00846807|6111483|P1|Overall Study|Withdrawal by Subject|56
1753602|NCT00846807|6111483|P1|Overall Study|Lost to Follow-up|94
1753603|NCT00846807|6111483|P1|Overall Study|Adverse Event|270
1753604|NCT00846768|6111491|P4|Overall Study|Adverse Event|0
1753605|NCT00846768|6111492|P3|Overall Study|Adverse Event|0
1753606|NCT00846768|6111493|P2|Overall Study|Adverse Event|1
1753607|NCT00846768|6111494|P1|Overall Study|Adverse Event|0
1753609|NCT00846586|6111591|P2|Overall Study|Unsatisfactory therapeutic effect|1
1753610|NCT00846586|6111592|P1|Overall Study|Unsatisfactory therapeutic effect|0
1753611|NCT00846586|6111591|P2|Overall Study|Lost to Follow-up|4
1753612|NCT00846586|6111592|P1|Overall Study|Lost to Follow-up|1
1753613|NCT00846586|6111591|P2|Overall Study|Abnormal test procedure result(s)|0
1753614|NCT00846586|6111592|P1|Overall Study|Abnormal test procedure result(s)|1
1753615|NCT00846586|6111591|P2|Overall Study|Protocol deviation|6
1753616|NCT00846586|6111592|P1|Overall Study|Protocol deviation|2
1753617|NCT00846586|6111591|P2|Overall Study|Death|0
1753618|NCT00846586|6111592|P1|Overall Study|Death|2
1753619|NCT00846586|6111591|P2|Overall Study|Administrative problems|4
1753620|NCT00846586|6111592|P1|Overall Study|Administrative problems|5
1753621|NCT00846586|6111591|P2|Overall Study|Subject withdrew consent|10
1753622|NCT00846586|6111592|P1|Overall Study|Subject withdrew consent|8
1753623|NCT00846586|6111591|P2|Overall Study|Adverse Event|10
1753624|NCT00846586|6111592|P1|Overall Study|Adverse Event|20
1753625|NCT00846521|6111626|P1|Overall Study|Protocol Violation|1
1753626|NCT00846521|6111626|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
1753627|NCT00846521|6111626|P1|Overall Study|Withdrawal by Subject|5
1753628|NCT00846495|6111633|P2|Overall Study|Physician Decision|0
1753629|NCT00846495|6111634|P1|Overall Study|Physician Decision|1
1753630|NCT00846495|6111633|P2|Overall Study|Lack of Efficacy|2
1753631|NCT00846495|6111634|P1|Overall Study|Lack of Efficacy|1
1753632|NCT00846495|6111633|P2|Overall Study|Adverse Event|1
1753633|NCT00846495|6111634|P1|Overall Study|Adverse Event|5
1753634|NCT00846495|6111633|P2|Overall Study|Lost to Follow-up|0
1753635|NCT00846495|6111634|P1|Overall Study|Lost to Follow-up|1
1753636|NCT00846391|6111657|P3|Overall Study|Study Terminated by Sponsor|2
1753637|NCT00846391|6111658|P2|Overall Study|Study Terminated by Sponsor|2
1753638|NCT00846391|6111659|P1|Overall Study|Study Terminated by Sponsor|1
1753639|NCT00846391|6111657|P3|Overall Study|Physician Decision|1
1753640|NCT00846391|6111658|P2|Overall Study|Physician Decision|0
1753641|NCT00846391|6111659|P1|Overall Study|Physician Decision|0
1753642|NCT00846365|6111670|P3|Overall Study|Other|6
1753643|NCT00846365|6111671|P2|Overall Study|Other|1
1753644|NCT00846365|6111672|P1|Overall Study|Other|9
1753645|NCT00846365|6111670|P3|Overall Study|Lack of Efficacy|2
1753646|NCT00846365|6111671|P2|Overall Study|Lack of Efficacy|1
1753647|NCT00846365|6111672|P1|Overall Study|Lack of Efficacy|1
1753648|NCT00846365|6111670|P3|Overall Study|Pregnancy|0
1753649|NCT00846365|6111671|P2|Overall Study|Pregnancy|0
1753650|NCT00846365|6111672|P1|Overall Study|Pregnancy|1
1753651|NCT00846365|6111670|P3|Overall Study|Withdrawal by Subject|9
1753652|NCT00846365|6111671|P2|Overall Study|Withdrawal by Subject|11
1753653|NCT00846365|6111672|P1|Overall Study|Withdrawal by Subject|11
1753654|NCT00846365|6111670|P3|Overall Study|Lost to Follow-up|5
1753655|NCT00846365|6111671|P2|Overall Study|Lost to Follow-up|2
1753656|NCT00846365|6111672|P1|Overall Study|Lost to Follow-up|8
1753657|NCT00846365|6111670|P3|Overall Study|Protocol Violation|0
1753658|NCT00846365|6111671|P2|Overall Study|Protocol Violation|4
1753659|NCT00846365|6111672|P1|Overall Study|Protocol Violation|5
1753660|NCT00846365|6111670|P3|Overall Study|Adverse Event|11
1753661|NCT00846365|6111671|P2|Overall Study|Adverse Event|30
1753662|NCT00846365|6111672|P1|Overall Study|Adverse Event|20
1753663|NCT00846053|6111753|P2|Overall Study|Physician Decision|0
1753664|NCT00846053|6111754|P1|Overall Study|Physician Decision|3
1753665|NCT00846027|6111762|P1|Overall Study|Subject Not Treated|7
1753666|NCT00846027|6111762|P1|Overall Study|Protocol Violation|2
1753667|NCT00846027|6111762|P1|Overall Study|Investigator Discretion|29
1753668|NCT00846027|6111762|P1|Overall Study|Patient Decision|7
1753669|NCT00846027|6111762|P1|Overall Study|Toxicity|12
1753670|NCT00846027|6111762|P1|Overall Study|Disease Progression|30
1753671|NCT00846027|6111762|P1|Overall Study|Death|3
1753672|NCT00845897|6111785|P3|Overall Study|Too ill to participate|0
1753673|NCT00845897|6111786|P2|Overall Study|Too ill to participate|1
1753674|NCT00845897|6111787|P1|Overall Study|Too ill to participate|0
1753675|NCT00845897|6111785|P3|Overall Study|Ulcer did not heal|1
1753676|NCT00845897|6111786|P2|Overall Study|Ulcer did not heal|0
1753677|NCT00845897|6111787|P1|Overall Study|Ulcer did not heal|1
1753678|NCT00845897|6111785|P3|Overall Study|Withdrawal by Subject|2
1753679|NCT00845897|6111786|P2|Overall Study|Withdrawal by Subject|3
1753680|NCT00845897|6111787|P1|Overall Study|Withdrawal by Subject|0
1753681|NCT00845897|6111785|P3|Overall Study|Lost to Follow-up|0
1753682|NCT00845897|6111786|P2|Overall Study|Lost to Follow-up|1
1753683|NCT00845897|6111787|P1|Overall Study|Lost to Follow-up|1
1753684|NCT00845858|6111801|P3|Overall Study|not eligible|2
1753685|NCT00845858|6111802|P2|Overall Study|not eligible|3
1753686|NCT00845858|6111803|P1|Overall Study|not eligible|0
1753687|NCT00845858|6111801|P3|Overall Study|Protocol Violation|1
1753688|NCT00845858|6111802|P2|Overall Study|Protocol Violation|0
1753689|NCT00845858|6111803|P1|Overall Study|Protocol Violation|0
1753690|NCT00845858|6111801|P3|Overall Study|Adverse Event|4
1753691|NCT00845858|6111802|P2|Overall Study|Adverse Event|8
1753692|NCT00845858|6111803|P1|Overall Study|Adverse Event|3
1753693|NCT00845858|6111801|P3|Overall Study|Withdrawal by Subject|1
1753694|NCT00845858|6111802|P2|Overall Study|Withdrawal by Subject|1
1753695|NCT00845858|6111803|P1|Overall Study|Withdrawal by Subject|5
1753696|NCT00845845|6111816|P2|Overall Study|Lost to Follow-up|4
1753697|NCT00845845|6111817|P1|Overall Study|Lost to Follow-up|0
1753698|NCT00845832|6111828|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
1753699|NCT00845832|6111829|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
1753700|NCT00845832|6111830|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
1753701|NCT00845832|6111828|P3|Safety Follow-Up|Withdrawal by Subject|0
1753702|NCT00845832|6111829|P2|Safety Follow-Up|Withdrawal by Subject|0
1753703|NCT00845832|6111830|P1|Safety Follow-Up|Withdrawal by Subject|1
1753704|NCT00845832|6111828|P3|Treatment Period|Protocol Violation|0
1753705|NCT00845832|6111829|P2|Treatment Period|Protocol Violation|1
1753706|NCT00845832|6111830|P1|Treatment Period|Protocol Violation|1
1753707|NCT00845832|6111828|P3|Treatment Period|Adverse Event|0
1753708|NCT00845832|6111829|P2|Treatment Period|Adverse Event|2
1753709|NCT00845832|6111830|P1|Treatment Period|Adverse Event|0
1753710|NCT00845728|6111876|P2|Overall Study|Withdrawal by Subject|108
1753711|NCT00845728|6111877|P1|Overall Study|Withdrawal by Subject|105
1753712|NCT00845728|6111876|P2|Overall Study|Adverse Event|96
1753713|NCT00845728|6111877|P1|Overall Study|Adverse Event|101
1753714|NCT00845728|6111876|P2|Overall Study|Lack of Efficacy|39
1753715|NCT00845728|6111877|P1|Overall Study|Lack of Efficacy|51
1753716|NCT00845728|6111876|P2|Overall Study|Protocol Violation|24
1753717|NCT00845728|6111877|P1|Overall Study|Protocol Violation|36
1753718|NCT00845728|6111876|P2|Overall Study|Administrative Problems|26
1753719|NCT00845728|6111877|P1|Overall Study|Administrative Problems|34
1753720|NCT00845728|6111876|P2|Overall Study|Death|26
1753721|NCT00845728|6111877|P1|Overall Study|Death|24
1753722|NCT00845728|6111876|P2|Overall Study|Lost to Follow-up|13
1753723|NCT00845728|6111877|P1|Overall Study|Lost to Follow-up|22
1753724|NCT00845728|6111876|P2|Overall Study|Abnormal test procedure result (s)|2
1753725|NCT00845728|6111877|P1|Overall Study|Abnormal test procedure result (s)|7
1753726|NCT00845728|6111876|P2|Overall Study|Patient's inability to use the device|6
1753727|NCT00845728|6111877|P1|Overall Study|Patient's inability to use the device|4
1753728|NCT00845728|6111876|P2|Overall Study|Abnormal laboratory value (s)|2
1753729|NCT00845728|6111877|P1|Overall Study|Abnormal laboratory value (s)|2
1753730|NCT00845676|6111891|P1|Overall Study|Adverse Event|1
1753731|NCT00845676|6111891|P1|Overall Study|Virologic breakthrough at week 20|1
1753732|NCT00845650|6111952|P6|Overall Study|Unable to access IV line|0
1753733|NCT00845650|6111953|P5|Overall Study|Unable to access IV line|0
1753734|NCT00845650|6111954|P4|Overall Study|Unable to access IV line|0
1753735|NCT00845650|6111955|P3|Overall Study|Unable to access IV line|0
1753736|NCT00845650|6111956|P2|Overall Study|Unable to access IV line|0
1753737|NCT00845650|6111957|P1|Overall Study|Unable to access IV line|1
1753738|NCT00845650|6111952|P6|Overall Study|Sponsor hold on dosing|1
1753739|NCT00845650|6111953|P5|Overall Study|Sponsor hold on dosing|1
1753740|NCT00845650|6111954|P4|Overall Study|Sponsor hold on dosing|0
1753741|NCT00845650|6111955|P3|Overall Study|Sponsor hold on dosing|0
1753742|NCT00845650|6111956|P2|Overall Study|Sponsor hold on dosing|0
1753743|NCT00845650|6111957|P1|Overall Study|Sponsor hold on dosing|0
1753744|NCT00845650|6111952|P6|Overall Study|Lost to Follow-up|1
1753745|NCT00845650|6111953|P5|Overall Study|Lost to Follow-up|0
1753746|NCT00845650|6111954|P4|Overall Study|Lost to Follow-up|1
1753747|NCT00845650|6111955|P3|Overall Study|Lost to Follow-up|3
1753748|NCT00845650|6111956|P2|Overall Study|Lost to Follow-up|0
1753749|NCT00845650|6111957|P1|Overall Study|Lost to Follow-up|0
1753750|NCT00845650|6111952|P6|Overall Study|Withdrawal by Subject|0
1753751|NCT00845650|6111953|P5|Overall Study|Withdrawal by Subject|2
1753752|NCT00845650|6111954|P4|Overall Study|Withdrawal by Subject|0
1753753|NCT00845650|6111955|P3|Overall Study|Withdrawal by Subject|0
1753754|NCT00845650|6111956|P2|Overall Study|Withdrawal by Subject|0
1753755|NCT00845650|6111957|P1|Overall Study|Withdrawal by Subject|0
1753756|NCT00845520|6111995|P3|Overall Study|Adverse Event|1
1753757|NCT00845520|6111996|P2|Overall Study|Adverse Event|0
1753758|NCT00845520|6111997|P1|Overall Study|Adverse Event|0
1753759|NCT00845520|6111995|P3|Overall Study|Lost to Follow-up|0
1753760|NCT00845520|6111996|P2|Overall Study|Lost to Follow-up|0
1753761|NCT00845520|6111997|P1|Overall Study|Lost to Follow-up|1
1753762|NCT00845520|6111995|P3|Overall Study|Death|0
1753763|NCT00845520|6111996|P2|Overall Study|Death|2
1753764|NCT00845520|6111997|P1|Overall Study|Death|1
1753765|NCT00845429|6112034|P3|Overall Study|Serious adverse event|1
1753766|NCT00845429|6112035|P2|Overall Study|Serious adverse event|0
1753767|NCT00845429|6112036|P1|Overall Study|Serious adverse event|0
1753768|NCT00845429|6112034|P3|Overall Study|Withdrawal by Subject|2
1753769|NCT00845429|6112035|P2|Overall Study|Withdrawal by Subject|2
1753770|NCT00845429|6112036|P1|Overall Study|Withdrawal by Subject|2
1753771|NCT00845429|6112034|P3|Overall Study|Lost to Follow-up|10
1753772|NCT00845429|6112035|P2|Overall Study|Lost to Follow-up|9
1753773|NCT00845429|6112036|P1|Overall Study|Lost to Follow-up|7
1753774|NCT00845429|6112034|P3|Overall Study|Protocol Violation|7
1753775|NCT00845429|6112035|P2|Overall Study|Protocol Violation|4
1753776|NCT00845429|6112036|P1|Overall Study|Protocol Violation|5
1753777|NCT00845182|6112071|P3|Overall Study|Physician Decision|1
1753778|NCT00845182|6112072|P2|Overall Study|Physician Decision|0
1753779|NCT00845182|6112073|P1|Overall Study|Physician Decision|0
1753780|NCT00845182|6112071|P3|Overall Study|Adverse Event|1
1753781|NCT00845182|6112072|P2|Overall Study|Adverse Event|1
1753782|NCT00845182|6112073|P1|Overall Study|Adverse Event|0
1753783|NCT00845182|6112071|P3|Overall Study|Lost to Follow-up|4
1753784|NCT00845182|6112072|P2|Overall Study|Lost to Follow-up|3
1753785|NCT00845182|6112073|P1|Overall Study|Lost to Follow-up|3
1753786|NCT00845065|6112098|P2|Overall Study|Non-Medical Reasons|11
1753787|NCT00845065|6112099|P1|Overall Study|Non-Medical Reasons|1
1753788|NCT00845065|6112098|P2|Overall Study|Lack of Efficacy|21
1753789|NCT00845065|6112099|P1|Overall Study|Lack of Efficacy|43
1753790|NCT00845065|6112098|P2|Overall Study|Adverse Event|23
1753791|NCT00845065|6112099|P1|Overall Study|Adverse Event|3
1753792|NCT00844896|6112167|P2|Overall Study|Parents did not have time to complete|1
1753793|NCT00844896|6112168|P1|Overall Study|Parents did not have time to complete|0
1753794|NCT00844896|6112167|P2|Overall Study|Lost to Follow-up|16
1753795|NCT00844896|6112168|P1|Overall Study|Lost to Follow-up|12
1753796|NCT00844883|6112190|P1|Overall Study|Bridged to resection|1
1753797|NCT00844883|6112190|P1|Overall Study|Bridged to liver transplant|3
1753798|NCT00844857|6112202|P2|Overall Study|Good Clinical Practice Violations|11
1753799|NCT00844857|6112203|P1|Overall Study|Good Clinical Practice Violations|21
1753800|NCT00844857|6112202|P2|Overall Study|Did Not Take Study Drug|1
1753801|NCT00844857|6112203|P1|Overall Study|Did Not Take Study Drug|3
1753802|NCT00844857|6112202|P2|Overall Study|Lost to Follow-up|3
1753803|NCT00844857|6112203|P1|Overall Study|Lost to Follow-up|2
1753804|NCT00844857|6112202|P2|Overall Study|Entry Criteria Not Met|1
1753805|NCT00844857|6112203|P1|Overall Study|Entry Criteria Not Met|0
1753806|NCT00844857|6112202|P2|Overall Study|Clinical Relapse|1
1753807|NCT00844857|6112203|P1|Overall Study|Clinical Relapse|0
1753808|NCT00844857|6112202|P2|Overall Study|Lack of Efficacy|5
1753809|NCT00844857|6112203|P1|Overall Study|Lack of Efficacy|5
1753810|NCT00844857|6112202|P2|Overall Study|Protocol Violation|0
1753811|NCT00844857|6112203|P1|Overall Study|Protocol Violation|6
1753812|NCT00844857|6112202|P2|Overall Study|Withdrawal by Subject|7
1753813|NCT00844857|6112203|P1|Overall Study|Withdrawal by Subject|8
1753814|NCT00844857|6112202|P2|Overall Study|Parent/Caregiver Decision|2
1753815|NCT00844857|6112203|P1|Overall Study|Parent/Caregiver Decision|6
1753816|NCT00844857|6112202|P2|Overall Study|Physician Decision|0
1753817|NCT00844857|6112203|P1|Overall Study|Physician Decision|2
1753818|NCT00844857|6112202|P2|Overall Study|Sponsor Decision|1
1753819|NCT00844857|6112203|P1|Overall Study|Sponsor Decision|1
1753820|NCT00844857|6112202|P2|Overall Study|Adverse Event|5
1753821|NCT00844857|6112203|P1|Overall Study|Adverse Event|24
1753822|NCT00844844|6112247|P1|Post Treatment Period|Withdrawal by Subject|1
1753823|NCT00844844|6112247|P1|Extension Treatment Period|Adverse Event|2
1753824|NCT00844844|6112247|P1|Treatment Period (26 Weeks)|Protocol Violation|1
1753825|NCT00844844|6112247|P1|Treatment Period (26 Weeks)|Adverse Event|1
1753826|NCT00844831|6112261|P1|Overall Study|Physician Decision|1
1753827|NCT00844831|6112261|P1|Overall Study|Adverse Event|1
1753828|NCT00844831|6112261|P1|Overall Study|Withdrawal by Subject|4
1753829|NCT00844805|6112271|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
1753830|NCT00844805|6112272|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1753831|NCT00844805|6112273|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1753832|NCT00844805|6112274|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
1753833|NCT00844805|6112271|P4|Follow-Up Phase|Relapse/Recurrence|4
1753834|NCT00844805|6112272|P3|Follow-Up Phase|Relapse/Recurrence|2
1753835|NCT00844805|6112273|P2|Follow-Up Phase|Relapse/Recurrence|0
1753836|NCT00844805|6112274|P1|Follow-Up Phase|Relapse/Recurrence|0
1753837|NCT00844805|6112271|P4|Follow-Up Phase|Noncompliance With Protocol|1
1753838|NCT00844805|6112272|P3|Follow-Up Phase|Noncompliance With Protocol|0
1753839|NCT00844805|6112273|P2|Follow-Up Phase|Noncompliance With Protocol|0
1753840|NCT00844805|6112274|P1|Follow-Up Phase|Noncompliance With Protocol|0
1753841|NCT00844805|6112271|P4|Follow-Up Phase|Withdrawal by Subject|3
1753842|NCT00844805|6112272|P3|Follow-Up Phase|Withdrawal by Subject|6
1753843|NCT00844805|6112273|P2|Follow-Up Phase|Withdrawal by Subject|0
1753844|NCT00844805|6112274|P1|Follow-Up Phase|Withdrawal by Subject|0
1753845|NCT00844805|6112271|P4|Follow-Up Phase|Adverse Event|0
1753846|NCT00844805|6112272|P3|Follow-Up Phase|Adverse Event|1
1753847|NCT00844805|6112273|P2|Follow-Up Phase|Adverse Event|0
1753848|NCT00844805|6112274|P1|Follow-Up Phase|Adverse Event|0
1753849|NCT00844805|6112271|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
1753850|NCT00844805|6112272|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
1753851|NCT00844805|6112273|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
1753852|NCT00844805|6112274|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
1753853|NCT00844805|6112271|P4|Treatment Phase|Noncompliance With Protocol|0
1753854|NCT00844805|6112272|P3|Treatment Phase|Noncompliance With Protocol|0
1753855|NCT00844805|6112273|P2|Treatment Phase|Noncompliance With Protocol|0
1753856|NCT00844805|6112274|P1|Treatment Phase|Noncompliance With Protocol|1
1753857|NCT00844805|6112271|P4|Treatment Phase|Withdrawal by Subject|0
1753858|NCT00844805|6112272|P3|Treatment Phase|Withdrawal by Subject|0
1753859|NCT00844805|6112273|P2|Treatment Phase|Withdrawal by Subject|4
1753860|NCT00844805|6112274|P1|Treatment Phase|Withdrawal by Subject|3
1753861|NCT00844805|6112271|P4|Treatment Phase|Adverse Event|0
1753862|NCT00844805|6112272|P3|Treatment Phase|Adverse Event|0
1753863|NCT00844805|6112273|P2|Treatment Phase|Adverse Event|1
1753864|NCT00844805|6112274|P1|Treatment Phase|Adverse Event|5
1753865|NCT00844753|6112318|P4|Overall Study|Withdrawal by Subject|3
1753866|NCT00844753|6112319|P3|Overall Study|Withdrawal by Subject|0
1753867|NCT00844753|6112320|P2|Overall Study|Withdrawal by Subject|0
1753868|NCT00844753|6112321|P1|Overall Study|Withdrawal by Subject|1
1753869|NCT00844753|6112318|P4|Overall Study|could not swallow medication|0
1753870|NCT00844753|6112319|P3|Overall Study|could not swallow medication|0
1753871|NCT00844753|6112320|P2|Overall Study|could not swallow medication|0
1753872|NCT00844753|6112321|P1|Overall Study|could not swallow medication|2
1753873|NCT00844753|6112318|P4|Overall Study|Lost to Follow-up|1
1753874|NCT00844753|6112319|P3|Overall Study|Lost to Follow-up|0
1753875|NCT00844753|6112320|P2|Overall Study|Lost to Follow-up|1
1753876|NCT00844753|6112321|P1|Overall Study|Lost to Follow-up|1
1753877|NCT00844753|6112318|P4|Overall Study|Adverse Event|5
1753878|NCT00844753|6112319|P3|Overall Study|Adverse Event|5
1753879|NCT00844753|6112320|P2|Overall Study|Adverse Event|2
1753880|NCT00844753|6112321|P1|Overall Study|Adverse Event|3
1753881|NCT00844753|6112318|P4|Overall Study|Lack of Efficacy|2
1753882|NCT00844753|6112319|P3|Overall Study|Lack of Efficacy|2
1753883|NCT00844753|6112320|P2|Overall Study|Lack of Efficacy|0
1753884|NCT00844753|6112321|P1|Overall Study|Lack of Efficacy|1
1753885|NCT00844649|6112339|P2|Overall Study|Withdrew prior to starting treatment|27
1753886|NCT00844649|6112340|P1|Overall Study|Withdrew prior to starting treatment|11
1753887|NCT00844649|6112339|P2|Overall Study|Other|10
1753888|NCT00844649|6112340|P1|Overall Study|Other|7
1753889|NCT00844649|6112339|P2|Overall Study|Withdrawal by Subject|39
1753890|NCT00844649|6112340|P1|Overall Study|Withdrawal by Subject|28
1753891|NCT00844649|6112339|P2|Overall Study|Protocol Violation|6
1753892|NCT00844649|6112340|P1|Overall Study|Protocol Violation|10
1753893|NCT00844649|6112339|P2|Overall Study|Physician Decision|18
1753894|NCT00844649|6112340|P1|Overall Study|Physician Decision|25
1753895|NCT00844649|6112339|P2|Overall Study|Adverse Event|73
1753896|NCT00844649|6112340|P1|Overall Study|Adverse Event|128
1753897|NCT00844649|6112339|P2|Overall Study|Progressive Disease|245
1753898|NCT00844649|6112340|P1|Overall Study|Progressive Disease|196
1753899|NCT00844597|6112364|P6|Overall Study|Adverse Event|0
1753900|NCT00844597|6112365|P5|Overall Study|Adverse Event|0
1753901|NCT00844597|6112366|P4|Overall Study|Adverse Event|1
1753902|NCT00844597|6112367|P3|Overall Study|Adverse Event|0
1753903|NCT00844597|6112368|P2|Overall Study|Adverse Event|0
1753904|NCT00844597|6112369|P1|Overall Study|Adverse Event|0
1753905|NCT00844558|6112389|P2|Overall Study|Physician Decision|0
1753906|NCT00844558|6112390|P1|Overall Study|Physician Decision|1
1753907|NCT00844558|6112389|P2|Overall Study|Lost to Follow-up|1
1753908|NCT00844558|6112390|P1|Overall Study|Lost to Follow-up|0
1753909|NCT00844558|6112389|P2|Overall Study|Protocol Violation|1
1753910|NCT00844558|6112390|P1|Overall Study|Protocol Violation|1
1753911|NCT00844558|6112389|P2|Overall Study|Death|0
1753912|NCT00844558|6112390|P1|Overall Study|Death|1
1753913|NCT00844558|6112389|P2|Overall Study|Withdrawal by Subject|2
1753914|NCT00844558|6112390|P1|Overall Study|Withdrawal by Subject|9
1753915|NCT00844545|6112406|P1|Post Treatment Period|Withdrawal by Subject|1
1753916|NCT00844545|6112406|P1|Extension Treatment Period|Adverse Event|2
1753917|NCT00844545|6112406|P1|Treatment Period (26 Weeks)|Protocol Violation|1
1753918|NCT00844545|6112406|P1|Treatment Period (26 Weeks)|Adverse Event|1
1753919|NCT00844532|6112420|P1|Overall Study|Lost to Follow-up|7
1753920|NCT00844532|6112420|P1|Overall Study|Withdrawal by Subject|16
1753921|NCT00844532|6112420|P1|Overall Study|Death|16
1753922|NCT00844519|6112506|P2|Overall Study|Adverse Event|0
1753923|NCT00844519|6112507|P1|Overall Study|Adverse Event|1
1753924|NCT00844519|6112506|P2|Overall Study|Withdrawal by Subject|1
1753925|NCT00844519|6112507|P1|Overall Study|Withdrawal by Subject|1
1753926|NCT00844480|6112515|P2|Overall Study|Withdrawal by Subject|3
1753927|NCT00844480|6112516|P1|Overall Study|Withdrawal by Subject|2
1753928|NCT00844428|6112524|P1|Post Treatment Period (Patients Who Disc|Death|1
1753929|NCT00844428|6112524|P1|Extension Treatment Period|Death|1
1753930|NCT00844428|6112524|P1|Screening Period|Screen Failure|3
1753931|NCT00844415|6112540|P1|Overall Study|Withdrawal by Subject|1
1753932|NCT00844376|6112554|P2|Period 1: First Intervention|Withdrawal by Subject|0
1753933|NCT00844376|6112555|P1|Period 1: First Intervention|Withdrawal by Subject|1
1753934|NCT00844194|6112579|P2|Overall Study|Other reason (not specified)|0
1753935|NCT00844194|6112580|P1|Overall Study|Other reason (not specified)|1
1753936|NCT00844194|6112579|P2|Overall Study|Lack of Efficacy|0
1753937|NCT00844194|6112580|P1|Overall Study|Lack of Efficacy|3
1753938|NCT00844194|6112579|P2|Overall Study|Withdrawal by Subject|1
1753939|NCT00844194|6112580|P1|Overall Study|Withdrawal by Subject|2
1753940|NCT00844194|6112579|P2|Overall Study|Lost to Follow-up|1
1753941|NCT00844194|6112580|P1|Overall Study|Lost to Follow-up|1
1753942|NCT00844194|6112579|P2|Overall Study|Protocol Violation|1
1753943|NCT00844194|6112580|P1|Overall Study|Protocol Violation|1
1753944|NCT00844194|6112579|P2|Overall Study|Adverse Event|5
1753945|NCT00844194|6112580|P1|Overall Study|Adverse Event|17
1753946|NCT00843856|6112835|P2|Overall Study|Lost to Follow-up|2
1753947|NCT00843856|6112836|P1|Overall Study|Lost to Follow-up|1
1753948|NCT00843843|6112846|P2|Overall Study|Protocol Violation|1
1753949|NCT00843843|6112847|P1|Overall Study|Protocol Violation|1
1753950|NCT00843843|6112846|P2|Overall Study|Physician Decision|1
1753951|NCT00843843|6112847|P1|Overall Study|Physician Decision|1
1753952|NCT00843778|6112860|P1|Overall Study|Withdrawal by Subject|4
1753953|NCT00843778|6112860|P1|Overall Study|Loss of efficacy|2
1753954|NCT00843778|6112860|P1|Overall Study|Lack of Efficacy|14
1753955|NCT00843778|6112860|P1|Overall Study|Adverse Event|15
1753956|NCT00843635|6112905|P3|Overall Study|Adverse Event|0
1753957|NCT00843635|6112906|P2|Overall Study|Adverse Event|2
1753958|NCT00843635|6112907|P1|Overall Study|Adverse Event|2
1753959|NCT00843518|6112936|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
1753960|NCT00843518|6112937|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
1753961|NCT00843518|6112936|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
1753962|NCT00843518|6112937|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
1753963|NCT00843518|6112936|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
1753964|NCT00843518|6112937|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
1753965|NCT00843518|6112936|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
1753966|NCT00843518|6112937|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
1753967|NCT00843518|6112936|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
1753968|NCT00843518|6112937|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
1753969|NCT00843518|6112936|P2|Period 2 (Double-blind Treatment)|Death|1
1753970|NCT00843518|6112937|P1|Period 2 (Double-blind Treatment)|Death|0
1753971|NCT00843518|6112936|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
1753972|NCT00843518|6112937|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
1753973|NCT00843492|6112967|P2|Overall Study|Deep-vein Thrombosis|0
1753974|NCT00843492|6112968|P1|Overall Study|Deep-vein Thrombosis|1
1753975|NCT00843492|6112967|P2|Overall Study|Visit Not Performed|0
1753976|NCT00843492|6112968|P1|Overall Study|Visit Not Performed|1
1753977|NCT00843492|6112967|P2|Overall Study|Orthopedic Surgery|2
1753978|NCT00843492|6112968|P1|Overall Study|Orthopedic Surgery|0
1753979|NCT00843492|6112967|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
1753980|NCT00843492|6112968|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
1753981|NCT00843492|6112967|P2|Overall Study|Immobilization Stopped|0
1753982|NCT00843492|6112968|P1|Overall Study|Immobilization Stopped|1
1753983|NCT00843492|6112967|P2|Overall Study|Withdrawal by Subject|4
1753984|NCT00843492|6112968|P1|Overall Study|Withdrawal by Subject|0
1753985|NCT00843492|6112967|P2|Overall Study|Lost to Follow-up|4
1753986|NCT00843492|6112968|P1|Overall Study|Lost to Follow-up|4
1753987|NCT00843492|6112967|P2|Overall Study|Adverse Event|3
1753988|NCT00843492|6112968|P1|Overall Study|Adverse Event|0
1753989|NCT00843284|6113039|P1|Overall Study|Death|3
1753990|NCT00843284|6113039|P1|Overall Study|Withdrawal by Subject|4
1753991|NCT00843284|6113039|P1|Overall Study|Other|10
1753992|NCT00843284|6113039|P1|Overall Study|Lost to Follow-up|11
1753993|NCT00843284|6113039|P1|Overall Study|Lack of Efficacy|5
1753994|NCT00843284|6113039|P1|Overall Study|Adverse Event|39
1753995|NCT00843193|6113049|P2|Overall Study|Withdrawal by Subject|3
1753996|NCT00843193|6113050|P1|Overall Study|Withdrawal by Subject|3
1753997|NCT00843193|6113049|P2|Overall Study|Physician Decision|1
1753998|NCT00843193|6113050|P1|Overall Study|Physician Decision|0
1753999|NCT00843193|6113049|P2|Overall Study|Lost to Follow-up|0
1754000|NCT00843193|6113050|P1|Overall Study|Lost to Follow-up|1
1754001|NCT00843193|6113049|P2|Overall Study|Protocol Violation|2
1754002|NCT00843193|6113050|P1|Overall Study|Protocol Violation|1
1754003|NCT00843193|6113049|P2|Overall Study|Lack of Efficacy|1
1754004|NCT00843193|6113050|P1|Overall Study|Lack of Efficacy|1
1754005|NCT00843193|6113049|P2|Overall Study|Adverse Event|4
1754006|NCT00843193|6113050|P1|Overall Study|Adverse Event|2
1754007|NCT00843167|6113101|P2|Treatment Period|Withdrawal by Subject|3
1754008|NCT00843167|6113102|P1|Treatment Period|Withdrawal by Subject|2
1754009|NCT00843167|6113101|P2|Treatment Period|Adverse Event|5
1754010|NCT00843167|6113102|P1|Treatment Period|Adverse Event|1
1754011|NCT00843115|6113115|P1|Overall Study|Syndrome De Glissement|1
1754012|NCT00843115|6113115|P1|Overall Study|week 12 not done|1
1754013|NCT00843115|6113115|P1|Overall Study|hospitalized due to deterioration|1
1754014|NCT00843115|6113115|P1|Overall Study|patient never took the medication|1
1754015|NCT00843115|6113115|P1|Overall Study|patient took for 2 days then stopped|1
1754016|NCT00843115|6113115|P1|Overall Study|Family discontinued meds|1
1754017|NCT00843115|6113115|P1|Overall Study|Physician Decision|1
1754018|NCT00843115|6113115|P1|Overall Study|Does not meet entrance criteria|1
1754019|NCT00843115|6113115|P1|Overall Study|Patient forgot to take meds|1
1754020|NCT00843115|6113115|P1|Overall Study|Family does not want continuation|1
1754021|NCT00843115|6113115|P1|Overall Study|Family wanted meds stopped|1
1754022|NCT00843115|6113115|P1|Overall Study|Withdrawal by Subject|17
1754023|NCT00843115|6113115|P1|Overall Study|Lost to Follow-up|4
1754024|NCT00843115|6113115|P1|Overall Study|Adverse Event|30
1754025|NCT00843115|6113115|P1|Overall Study|Death|4
1754026|NCT00843024|6113171|P6|Double-blind Treatment Phase|Lack of Efficacy|0
1754027|NCT00843024|6113172|P5|Double-blind Treatment Phase|Lack of Efficacy|1
1754028|NCT00843024|6113173|P4|Double-blind Treatment Phase|Lack of Efficacy|0
1754029|NCT00843024|6113174|P3|Double-blind Treatment Phase|Lack of Efficacy|0
1754030|NCT00843024|6113175|P2|Double-blind Treatment Phase|Lack of Efficacy|0
1754031|NCT00843024|6113176|P1|Double-blind Treatment Phase|Lack of Efficacy|0
1754032|NCT00843024|6113171|P6|Double-blind Treatment Phase|Adverse Event|1
1754033|NCT00843024|6113172|P5|Double-blind Treatment Phase|Adverse Event|1
1754034|NCT00843024|6113173|P4|Double-blind Treatment Phase|Adverse Event|0
1754035|NCT00843024|6113174|P3|Double-blind Treatment Phase|Adverse Event|0
1754036|NCT00843024|6113175|P2|Double-blind Treatment Phase|Adverse Event|0
1754037|NCT00843024|6113176|P1|Double-blind Treatment Phase|Adverse Event|0
1754038|NCT00843024|6113171|P6|Double-blind Treatment Phase|Physician Decision|1
1754039|NCT00843024|6113172|P5|Double-blind Treatment Phase|Physician Decision|1
1754040|NCT00843024|6113173|P4|Double-blind Treatment Phase|Physician Decision|3
1754041|NCT00843024|6113174|P3|Double-blind Treatment Phase|Physician Decision|0
1754042|NCT00843024|6113175|P2|Double-blind Treatment Phase|Physician Decision|0
1754043|NCT00843024|6113176|P1|Double-blind Treatment Phase|Physician Decision|0
1754044|NCT00843024|6113171|P6|Double-blind Treatment Phase|Protocol Violation|3
1754045|NCT00843024|6113172|P5|Double-blind Treatment Phase|Protocol Violation|0
1754046|NCT00843024|6113173|P4|Double-blind Treatment Phase|Protocol Violation|0
1754047|NCT00843024|6113174|P3|Double-blind Treatment Phase|Protocol Violation|3
1754048|NCT00843024|6113175|P2|Double-blind Treatment Phase|Protocol Violation|0
1754049|NCT00843024|6113176|P1|Double-blind Treatment Phase|Protocol Violation|0
1754050|NCT00843024|6113171|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
1754051|NCT00843024|6113172|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
1754052|NCT00843024|6113173|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
1754053|NCT00843024|6113174|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
1754054|NCT00843024|6113175|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
1754055|NCT00843024|6113176|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
1754056|NCT00843024|6113171|P6|Double-blind Treatment Phase|Lost to Follow-up|4
1754057|NCT00843024|6113172|P5|Double-blind Treatment Phase|Lost to Follow-up|4
1754058|NCT00843024|6113173|P4|Double-blind Treatment Phase|Lost to Follow-up|4
1754059|NCT00843024|6113174|P3|Double-blind Treatment Phase|Lost to Follow-up|8
1754060|NCT00843024|6113175|P2|Double-blind Treatment Phase|Lost to Follow-up|0
1754061|NCT00843024|6113176|P1|Double-blind Treatment Phase|Lost to Follow-up|0
1754062|NCT00843024|6113171|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
1754063|NCT00843024|6113172|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
1754064|NCT00843024|6113173|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
1754065|NCT00843024|6113174|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
1754066|NCT00843024|6113175|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
1754067|NCT00843024|6113176|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
1754068|NCT00843024|6113171|P6|Single-blind Placebo Run-In Phase|Other|0
1754069|NCT00843024|6113172|P5|Single-blind Placebo Run-In Phase|Other|0
1754070|NCT00843024|6113173|P4|Single-blind Placebo Run-In Phase|Other|0
1754071|NCT00843024|6113174|P3|Single-blind Placebo Run-In Phase|Other|0
1754072|NCT00843024|6113175|P2|Single-blind Placebo Run-In Phase|Other|1
1754073|NCT00843024|6113176|P1|Single-blind Placebo Run-In Phase|Other|0
1754074|NCT00843024|6113171|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
1754075|NCT00843024|6113172|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
1754076|NCT00843024|6113173|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
1754077|NCT00843024|6113174|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
1754078|NCT00843024|6113175|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
1754079|NCT00843024|6113176|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
1754080|NCT00843024|6113171|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
1754081|NCT00843024|6113172|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
1754082|NCT00843024|6113173|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
1754083|NCT00843024|6113174|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
1754084|NCT00843024|6113175|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
1754085|NCT00843024|6113176|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
1754086|NCT00843024|6113171|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
1754087|NCT00843024|6113172|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
1754088|NCT00843024|6113173|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
1754089|NCT00843024|6113174|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
1754090|NCT00843024|6113175|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
1754091|NCT00843024|6113176|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
1754092|NCT00843024|6113171|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1754093|NCT00843024|6113172|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1754094|NCT00843024|6113173|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1754095|NCT00843024|6113174|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
1754096|NCT00843024|6113175|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
1754097|NCT00843024|6113176|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
1754098|NCT00843024|6113171|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1754099|NCT00843024|6113172|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1754100|NCT00843024|6113173|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1754101|NCT00843024|6113174|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
1754102|NCT00843024|6113175|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
1754103|NCT00843024|6113176|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
1754104|NCT00843024|6113171|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1754105|NCT00843024|6113172|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1754106|NCT00843024|6113173|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1754107|NCT00843024|6113174|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
1754108|NCT00843024|6113175|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
1754109|NCT00843024|6113176|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
1754110|NCT00842985|6113241|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
1754111|NCT00842985|6113241|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
1754112|NCT00842985|6113241|P1|First Intervention|Protocol Violation|3
1754113|NCT00842985|6113241|P1|First Intervention|Withdrawal by Subject|3
1754114|NCT00842985|6113241|P1|Screening|Did not meet entrance requirements|27
1754115|NCT00842829|6113259|P3|Continuation Period|Non-compliance to study drug|1
1754116|NCT00842829|6113260|P2|Continuation Period|Non-compliance to study drug|0
1754117|NCT00842829|6113261|P1|Continuation Period|Non-compliance to study drug|0
1754118|NCT00842829|6113259|P3|Continuation Period|Non-compliance to study procedures|2
1754119|NCT00842829|6113260|P2|Continuation Period|Non-compliance to study procedures|0
1754120|NCT00842829|6113261|P1|Continuation Period|Non-compliance to study procedures|0
1754121|NCT00842829|6113259|P3|Continuation Period|Other|7
1754122|NCT00842829|6113260|P2|Continuation Period|Other|0
1754123|NCT00842829|6113261|P1|Continuation Period|Other|0
1754124|NCT00842829|6113259|P3|Continuation Period|Withdrawal by Subject|10
1754125|NCT00842829|6113260|P2|Continuation Period|Withdrawal by Subject|0
1754126|NCT00842829|6113261|P1|Continuation Period|Withdrawal by Subject|0
1754127|NCT00842829|6113259|P3|Continuation Period|Unstable persistent cancer pain|3
1754128|NCT00842829|6113260|P2|Continuation Period|Unstable persistent cancer pain|0
1754129|NCT00842829|6113261|P1|Continuation Period|Unstable persistent cancer pain|0
1754130|NCT00842829|6113259|P3|Continuation Period|Lack of Efficacy|6
1754131|NCT00842829|6113260|P2|Continuation Period|Lack of Efficacy|0
1754132|NCT00842829|6113261|P1|Continuation Period|Lack of Efficacy|0
1754133|NCT00842829|6113259|P3|Continuation Period|Adverse Event|32
1754134|NCT00842829|6113260|P2|Continuation Period|Adverse Event|0
1754135|NCT00842829|6113261|P1|Continuation Period|Adverse Event|0
1754136|NCT00842829|6113259|P3|Treatment Period|Unclear completion status|1
1754137|NCT00842829|6113260|P2|Treatment Period|Unclear completion status|0
1754138|NCT00842829|6113261|P1|Treatment Period|Unclear completion status|0
1754139|NCT00842829|6113259|P3|Treatment Period|Non-compliance to study procedures|4
1754140|NCT00842829|6113260|P2|Treatment Period|Non-compliance to study procedures|0
1754141|NCT00842829|6113261|P1|Treatment Period|Non-compliance to study procedures|0
1754142|NCT00842829|6113259|P3|Treatment Period|Other|18
1754143|NCT00842829|6113260|P2|Treatment Period|Other|0
1754144|NCT00842829|6113261|P1|Treatment Period|Other|0
1754145|NCT00842829|6113259|P3|Treatment Period|Protocol Violation|2
1754146|NCT00842829|6113260|P2|Treatment Period|Protocol Violation|0
1754147|NCT00842829|6113261|P1|Treatment Period|Protocol Violation|0
1754148|NCT00842829|6113259|P3|Treatment Period|Consistently >4 BTP episodes daily|1
1754149|NCT00842829|6113260|P2|Treatment Period|Consistently >4 BTP episodes daily|0
1754150|NCT00842829|6113261|P1|Treatment Period|Consistently >4 BTP episodes daily|0
1754151|NCT00842829|6113259|P3|Treatment Period|Withdrawal by Subject|11
1754152|NCT00842829|6113260|P2|Treatment Period|Withdrawal by Subject|0
1754153|NCT00842829|6113261|P1|Treatment Period|Withdrawal by Subject|0
1754154|NCT00842829|6113259|P3|Treatment Period|Unstable persistent cancer pain|5
1754155|NCT00842829|6113260|P2|Treatment Period|Unstable persistent cancer pain|0
1754156|NCT00842829|6113261|P1|Treatment Period|Unstable persistent cancer pain|0
1754157|NCT00842829|6113259|P3|Treatment Period|Lack of Efficacy|6
1754158|NCT00842829|6113260|P2|Treatment Period|Lack of Efficacy|0
1754159|NCT00842829|6113261|P1|Treatment Period|Lack of Efficacy|0
1754160|NCT00842829|6113259|P3|Treatment Period|Adverse Event|15
1754161|NCT00842829|6113260|P2|Treatment Period|Adverse Event|0
1754162|NCT00842829|6113261|P1|Treatment Period|Adverse Event|0
1754163|NCT00842829|6113259|P3|Dose Titration Period|Non-compliance to study drug|0
1754164|NCT00842829|6113260|P2|Dose Titration Period|Non-compliance to study drug|1
1754165|NCT00842829|6113261|P1|Dose Titration Period|Non-compliance to study drug|2
1754166|NCT00842829|6113259|P3|Dose Titration Period|Non-compliance to study procedures|0
1754167|NCT00842829|6113260|P2|Dose Titration Period|Non-compliance to study procedures|1
1754168|NCT00842829|6113261|P1|Dose Titration Period|Non-compliance to study procedures|1
1754169|NCT00842829|6113259|P3|Dose Titration Period|Other|0
1754170|NCT00842829|6113260|P2|Dose Titration Period|Other|4
1754171|NCT00842829|6113261|P1|Dose Titration Period|Other|5
1754172|NCT00842829|6113259|P3|Dose Titration Period|Withdrawal by Subject|0
1754173|NCT00842829|6113260|P2|Dose Titration Period|Withdrawal by Subject|6
1754174|NCT00842829|6113261|P1|Dose Titration Period|Withdrawal by Subject|2
1754175|NCT00842829|6113259|P3|Dose Titration Period|Unstable persistent cancer pain|0
1754176|NCT00842829|6113260|P2|Dose Titration Period|Unstable persistent cancer pain|0
1754177|NCT00842829|6113261|P1|Dose Titration Period|Unstable persistent cancer pain|1
1754178|NCT00842829|6113259|P3|Dose Titration Period|Lack of Efficacy|0
1754179|NCT00842829|6113260|P2|Dose Titration Period|Lack of Efficacy|1
1754180|NCT00842829|6113261|P1|Dose Titration Period|Lack of Efficacy|4
1754181|NCT00842829|6113259|P3|Dose Titration Period|Adverse Event|0
1754182|NCT00842829|6113260|P2|Dose Titration Period|Adverse Event|10
1754183|NCT00842829|6113261|P1|Dose Titration Period|Adverse Event|11
1754184|NCT00842712|6113320|P7|Randomized Part|Ongoing at cut-off date|2
1754185|NCT00842712|6113321|P6|Randomized Part|Ongoing at cut-off date|0
1754186|NCT00842712|6113322|P5|Randomized Part|Ongoing at cut-off date|0
1754187|NCT00842712|6113323|P4|Randomized Part|Ongoing at cut-off date|0
1754188|NCT00842712|6113324|P3|Randomized Part|Ongoing at cut-off date|0
1754189|NCT00842712|6113325|P2|Randomized Part|Ongoing at cut-off date|0
1754190|NCT00842712|6113326|P1|Randomized Part|Ongoing at cut-off date|0
1754191|NCT00842712|6113320|P7|Randomized Part|Randomized but not treated|4
1754192|NCT00842712|6113321|P6|Randomized Part|Randomized but not treated|1
1754193|NCT00842712|6113322|P5|Randomized Part|Randomized but not treated|0
1754194|NCT00842712|6113323|P4|Randomized Part|Randomized but not treated|0
1754195|NCT00842712|6113324|P3|Randomized Part|Randomized but not treated|0
1754196|NCT00842712|6113325|P2|Randomized Part|Randomized but not treated|0
1754197|NCT00842712|6113326|P1|Randomized Part|Randomized but not treated|0
1754198|NCT00842712|6113320|P7|Safety Run-in Part|Progressive disease|0
1754199|NCT00842712|6113321|P6|Safety Run-in Part|Progressive disease|0
1754200|NCT00842712|6113322|P5|Safety Run-in Part|Progressive disease|0
1754201|NCT00842712|6113323|P4|Safety Run-in Part|Progressive disease|1
1754202|NCT00842712|6113324|P3|Safety Run-in Part|Progressive disease|0
1754203|NCT00842712|6113325|P2|Safety Run-in Part|Progressive disease|1
1754204|NCT00842712|6113326|P1|Safety Run-in Part|Progressive disease|3
1754205|NCT00842712|6113320|P7|Safety Run-in Part|Adverse Event|0
1754206|NCT00842712|6113321|P6|Safety Run-in Part|Adverse Event|0
1754207|NCT00842712|6113322|P5|Safety Run-in Part|Adverse Event|0
1754208|NCT00842712|6113323|P4|Safety Run-in Part|Adverse Event|0
1754209|NCT00842712|6113324|P3|Safety Run-in Part|Adverse Event|0
1754210|NCT00842712|6113325|P2|Safety Run-in Part|Adverse Event|1
1754211|NCT00842712|6113326|P1|Safety Run-in Part|Adverse Event|0
1754212|NCT00842543|6113383|P4|Overall Study|Withdrawal by Subject|4
1754213|NCT00842543|6113384|P3|Overall Study|Withdrawal by Subject|3
1754214|NCT00842543|6113385|P2|Overall Study|Withdrawal by Subject|0
1754215|NCT00842543|6113386|P1|Overall Study|Withdrawal by Subject|2
1754216|NCT00842530|6113400|P2|Overall Study|Withdrawal by Subject|28
1754217|NCT00842530|6113401|P1|Overall Study|Withdrawal by Subject|73
1754218|NCT00842530|6113400|P2|Overall Study|Lost to Follow-up|8
1754219|NCT00842530|6113401|P1|Overall Study|Lost to Follow-up|6
1754220|NCT00842530|6113400|P2|Overall Study|Protocol Violation|14
1754221|NCT00842530|6113401|P1|Overall Study|Protocol Violation|32
1754222|NCT00842530|6113400|P2|Overall Study|Other adverse event|1
1754223|NCT00842530|6113401|P1|Overall Study|Other adverse event|6
1754224|NCT00842530|6113400|P2|Overall Study|Serious adverse event|6
1754225|NCT00842530|6113401|P1|Overall Study|Serious adverse event|0
1754226|NCT00842361|6113431|P2|Overall Study|Unclassified|2
1754227|NCT00842361|6113432|P1|Overall Study|Unclassified|0
1754228|NCT00842361|6113431|P2|Overall Study|Protocol Violation|0
1754229|NCT00842361|6113432|P1|Overall Study|Protocol Violation|1
1754230|NCT00842348|6113452|P2|Study 729|Surgical resection|0
1754231|NCT00842348|6113453|P1|Study 729|Surgical resection|1
1754232|NCT00842348|6113452|P2|Study 729|Sponsor's decision|0
1754233|NCT00842348|6113453|P1|Study 729|Sponsor's decision|1
1754234|NCT00842348|6113452|P2|Study 729|Due to non-availability of IP|1
1754235|NCT00842348|6113453|P1|Study 729|Due to non-availability of IP|0
1754236|NCT00842348|6113452|P2|Study 729|Due to Sponsor stopping the study|1
1754237|NCT00842348|6113453|P1|Study 729|Due to Sponsor stopping the study|1
1754238|NCT00842348|6113452|P2|Study 729|Withdrawal by Subject|4
1754239|NCT00842348|6113453|P1|Study 729|Withdrawal by Subject|2
1754240|NCT00842348|6113452|P2|Study 729|Protocol Violation|1
1754241|NCT00842348|6113453|P1|Study 729|Protocol Violation|1
1754242|NCT00842348|6113452|P2|Study 729|Adverse Event|1
1754243|NCT00842348|6113453|P1|Study 729|Adverse Event|1
1754244|NCT00842348|6113452|P2|Study 729|Disease progression/death|30
1754245|NCT00842348|6113453|P1|Study 729|Disease progression/death|19
1754246|NCT00842348|6113452|P2|Patients Randomised in Study 726|Did not enter Study 729|56
1754247|NCT00842348|6113453|P1|Patients Randomised in Study 726|Did not enter Study 729|59
1754248|NCT00842309|6113472|P2|Overall Study|Withdrawal by Subject|1
1754249|NCT00842309|6113473|P1|Overall Study|Withdrawal by Subject|3
1754250|NCT00842257|6113507|P1|Overall Study|Adverse Event|1
1754251|NCT00842244|6113514|P1|Overall Study|Other|17
1754252|NCT00842244|6113514|P1|Overall Study|Withdrawal by Subject|1
1754253|NCT00842244|6113514|P1|Overall Study|Death|3
1754254|NCT00842153|6113541|P2|Overall Study|Lost to Follow-up|2
1754255|NCT00842153|6113542|P1|Overall Study|Lost to Follow-up|1
1754256|NCT00842153|6113541|P2|Overall Study|Adverse Event|1
1754257|NCT00842153|6113542|P1|Overall Study|Adverse Event|0
1754258|NCT00841906|6113617|P2|Overall Study|Withdrawal by Subject|0
1754259|NCT00841906|6113618|P1|Overall Study|Withdrawal by Subject|2
1754260|NCT00841815|6113643|P2|Washout|Withdrawal by Subject|1
1754261|NCT00841815|6113644|P1|Washout|Withdrawal by Subject|0
1754262|NCT00841776|6113654|P2|Overall Study|Withdrawal by Subject|1
1754263|NCT00841776|6113655|P1|Overall Study|Withdrawal by Subject|0
1754264|NCT00841776|6113654|P2|Overall Study|Lost to Follow-up|1
1754265|NCT00841776|6113655|P1|Overall Study|Lost to Follow-up|2
1754266|NCT00841776|6113654|P2|Overall Study|Lack of Efficacy|1
1754267|NCT00841776|6113655|P1|Overall Study|Lack of Efficacy|0
1754268|NCT00841763|6113673|P4|Overall Study|Unable to Classify|0
1754269|NCT00841763|6113674|P3|Overall Study|Unable to Classify|0
1754270|NCT00841763|6113675|P2|Overall Study|Unable to Classify|1
1754271|NCT00841763|6113676|P1|Overall Study|Unable to Classify|7
1754272|NCT00841763|6113673|P4|Overall Study|Administrative Reasons|0
1754273|NCT00841763|6113674|P3|Overall Study|Administrative Reasons|0
1754274|NCT00841763|6113675|P2|Overall Study|Administrative Reasons|1
1754275|NCT00841763|6113676|P1|Overall Study|Administrative Reasons|3
1754276|NCT00841763|6113673|P4|Overall Study|Protocol Violation|0
1754277|NCT00841763|6113674|P3|Overall Study|Protocol Violation|1
1754278|NCT00841763|6113675|P2|Overall Study|Protocol Violation|3
1754279|NCT00841763|6113676|P1|Overall Study|Protocol Violation|20
1754280|NCT00841763|6113673|P4|Overall Study|Lost to Follow-up|0
1754281|NCT00841763|6113674|P3|Overall Study|Lost to Follow-up|0
1754282|NCT00841763|6113675|P2|Overall Study|Lost to Follow-up|25
1754283|NCT00841763|6113676|P1|Overall Study|Lost to Follow-up|63
1754284|NCT00841763|6113673|P4|Overall Study|Adverse Event|2
1754285|NCT00841763|6113674|P3|Overall Study|Adverse Event|3
1754286|NCT00841763|6113675|P2|Overall Study|Adverse Event|10
1754287|NCT00841763|6113676|P1|Overall Study|Adverse Event|9
1754288|NCT00841763|6113673|P4|Overall Study|Withdrawal by Subject|1
1754289|NCT00841763|6113674|P3|Overall Study|Withdrawal by Subject|4
1754290|NCT00841763|6113675|P2|Overall Study|Withdrawal by Subject|17
1754291|NCT00841763|6113676|P1|Overall Study|Withdrawal by Subject|60
1754292|NCT00841698|6113738|P2|First Intervention|Withdrawal by Subject|0
1754293|NCT00841698|6113739|P1|First Intervention|Withdrawal by Subject|1
1754294|NCT00841672|6113749|P2|Overall Study|Protocol Deviation|1
1754295|NCT00841672|6113750|P1|Overall Study|Protocol Deviation|0
1754296|NCT00841672|6113749|P2|Overall Study|Misrandomized|0
1754297|NCT00841672|6113750|P1|Overall Study|Misrandomized|1
1754298|NCT00841672|6113749|P2|Overall Study|Administrative problems|9
1754299|NCT00841672|6113750|P1|Overall Study|Administrative problems|9
1754300|NCT00841672|6113749|P2|Overall Study|Lost to Follow-up|1
1754301|NCT00841672|6113750|P1|Overall Study|Lost to Follow-up|1
1754302|NCT00841672|6113749|P2|Overall Study|Subject withdrew consent|4
1754303|NCT00841672|6113750|P1|Overall Study|Subject withdrew consent|2
1754304|NCT00841672|6113749|P2|Overall Study|Abnormal test procedure result(s)|1
1754305|NCT00841672|6113750|P1|Overall Study|Abnormal test procedure result(s)|0
1754306|NCT00841672|6113749|P2|Overall Study|Adverse Event|16
1754307|NCT00841672|6113750|P1|Overall Study|Adverse Event|7
1754308|NCT00841659|6113766|P2|Washout: 2 Weeks|Protocol Violation|0
1754309|NCT00841659|6113767|P1|Washout: 2 Weeks|Protocol Violation|1
1754310|NCT00841568|6113775|P1|Overall Study|Creatinine over the withdrawal criteria|1
1754311|NCT00841568|6113775|P1|Overall Study|Withdrawal by Subject|2
1754312|NCT00841568|6113775|P1|Overall Study|Death|1
1754313|NCT00841568|6113775|P1|Overall Study|Adverse Event|1
1754314|NCT00841542|6113803|P2|Period 1|Adverse Event|0
1754315|NCT00841542|6113804|P1|Period 1|Adverse Event|1
1754316|NCT00841321|6113819|P2|Overall Study|Adverse Event|2
1754317|NCT00841321|6113820|P1|Overall Study|Adverse Event|0
1754318|NCT00841321|6113819|P2|Overall Study|Lost to Follow-up|1
1754319|NCT00841321|6113820|P1|Overall Study|Lost to Follow-up|1
1754320|NCT00841100|6113867|P1|Phase 1 (28 Days)|Participant non-compliance|2
1754321|NCT00841100|6113867|P1|Phase 1 (28 Days)|Adverse Event|1
1754322|NCT00841035|6113892|P1|Phase 1 Overall Study|Physician Decision|13
1754323|NCT00840996|6113899|P2|Overall Study|Withdrawal by Subject|0
1754324|NCT00840996|6113900|P1|Overall Study|Withdrawal by Subject|1
1754325|NCT00840879|6113920|P2|Second Intervention|Withdrawal by Subject|0
1754326|NCT00840879|6113921|P1|Second Intervention|Withdrawal by Subject|1
1754327|NCT00840827|6113957|P1|Overall Study|Physician Decision|1
1754328|NCT00840827|6113957|P1|Overall Study|Lack of Efficacy|4
1754329|NCT00840827|6113957|P1|Overall Study|Adverse Event|1
1754330|NCT00840658|6113974|P4|Overall Study|Lost to Follow-up|1
1754331|NCT00840658|6113975|P3|Overall Study|Lost to Follow-up|2
1754332|NCT00840658|6113976|P2|Overall Study|Lost to Follow-up|1
1754333|NCT00840658|6113977|P1|Overall Study|Lost to Follow-up|3
1754334|NCT00840658|6113974|P4|Overall Study|Death|3
1754335|NCT00840658|6113975|P3|Overall Study|Death|3
1754336|NCT00840658|6113976|P2|Overall Study|Death|2
1754337|NCT00840658|6113977|P1|Overall Study|Death|2
1754338|NCT00840632|6113989|P2|Washout|Withdrawal by Subject|1
1754339|NCT00840632|6113990|P1|Washout|Withdrawal by Subject|1
1754340|NCT00840632|6113989|P2|First Intervention|Withdrawal by Subject|1
1754341|NCT00840632|6113990|P1|First Intervention|Withdrawal by Subject|0
1754342|NCT00840463|6114017|P2|Overall Study|Adverse Event|0
1754343|NCT00840463|6114018|P1|Overall Study|Adverse Event|1
1754344|NCT00840450|6114032|P1|Overall Study|Lack of Efficacy|2
1754345|NCT00840450|6114032|P1|Overall Study|Adverse Event|1
1754346|NCT00840411|6114040|P2|Washout|Withdrawal by Subject|0
1754347|NCT00840411|6114041|P1|Washout|Withdrawal by Subject|1
1754348|NCT00840411|6114040|P2|First Intervention|Adverse Event|0
1754349|NCT00840411|6114041|P1|First Intervention|Adverse Event|1
1754350|NCT00840294|6114055|P2|Overall Study|Illness|1
1754351|NCT00840294|6114056|P1|Overall Study|Illness|0
1754352|NCT00840294|6114055|P2|Overall Study|Protocol Violation|3
1754353|NCT00840294|6114056|P1|Overall Study|Protocol Violation|1
1754354|NCT00840294|6114055|P2|Overall Study|Withdrawal by Subject|1
1754355|NCT00840294|6114056|P1|Overall Study|Withdrawal by Subject|2
1754356|NCT00840216|6114077|P2|Washout: 7 Days|Withdrawal by Subject|0
1754357|NCT00840216|6114078|P1|Washout: 7 Days|Withdrawal by Subject|1
1754358|NCT00840203|6114088|P2|Washout|Protocol Violation|0
1754359|NCT00840203|6114089|P1|Washout|Protocol Violation|1
1754360|NCT00840203|6114088|P2|First Intervention|Protocol Violation|1
1754361|NCT00840203|6114089|P1|First Intervention|Protocol Violation|1
1754362|NCT00840177|6114106|P3|Overall Study|Did not start treatment|1
1754363|NCT00840177|6114107|P2|Overall Study|Did not start treatment|0
1754364|NCT00840177|6114108|P1|Overall Study|Did not start treatment|0
1754365|NCT00840177|6114106|P3|Overall Study|Ineligible|3
1754366|NCT00840177|6114107|P2|Overall Study|Ineligible|0
1754367|NCT00840177|6114108|P1|Overall Study|Ineligible|0
1754368|NCT00840177|6114106|P3|Overall Study|not protocol specified|0
1754369|NCT00840177|6114107|P2|Overall Study|not protocol specified|3
1754370|NCT00840177|6114108|P1|Overall Study|not protocol specified|6
1754371|NCT00840177|6114106|P3|Overall Study|Death|5
1754372|NCT00840177|6114107|P2|Overall Study|Death|5
1754373|NCT00840177|6114108|P1|Overall Study|Death|4
1754374|NCT00840177|6114106|P3|Overall Study|Progression/relapse|0
1754375|NCT00840177|6114107|P2|Overall Study|Progression/relapse|0
1754376|NCT00840177|6114108|P1|Overall Study|Progression/relapse|2
1754377|NCT00840177|6114106|P3|Overall Study|Refusal unrelated to adverse events|1
1754378|NCT00840177|6114107|P2|Overall Study|Refusal unrelated to adverse events|0
1754379|NCT00840177|6114108|P1|Overall Study|Refusal unrelated to adverse events|1
1754380|NCT00840177|6114106|P3|Overall Study|Adverse Event|1
1754381|NCT00840177|6114107|P2|Overall Study|Adverse Event|1
1754382|NCT00840177|6114108|P1|Overall Study|Adverse Event|5
1754383|NCT00840086|6114142|P1|Overall Study|Lost to Follow-up|1
1754384|NCT00840086|6114142|P1|Overall Study|Protocol Violation|2
1754385|NCT00840086|6114142|P1|Overall Study|Adverse Event|1
1754386|NCT00840073|6114151|P2|Second Intervention|Missed 72 hour blood draw|1
1754387|NCT00840073|6114152|P1|Second Intervention|Missed 72 hour blood draw|1
1754388|NCT00840060|6114166|P2|Overall Study|Change in emotional/behavioral status|1
1754389|NCT00840060|6114167|P1|Overall Study|Change in emotional/behavioral status|0
1754390|NCT00840060|6114166|P2|Overall Study|Withdrawal by Subject|0
1754391|NCT00840060|6114167|P1|Overall Study|Withdrawal by Subject|1
1754392|NCT00840034|6114177|P2|Taper Phase|Withdrawal by Subject|1
1754393|NCT00840034|6114178|P1|Taper Phase|Withdrawal by Subject|1
1754394|NCT00840034|6114177|P2|Taper Phase|Lost to Follow-up|1
1754395|NCT00840034|6114178|P1|Taper Phase|Lost to Follow-up|1
1754396|NCT00840034|6114177|P2|Taper Phase|Adverse Event|0
1754397|NCT00840034|6114178|P1|Taper Phase|Adverse Event|1
1754398|NCT00840034|6114177|P2|Acute Treatment Phase|Withdrawal by Subject|11
1754399|NCT00840034|6114178|P1|Acute Treatment Phase|Withdrawal by Subject|6
1754400|NCT00840034|6114177|P2|Acute Treatment Phase|Protocol Violation|4
1754401|NCT00840034|6114178|P1|Acute Treatment Phase|Protocol Violation|2
1754402|NCT00840034|6114177|P2|Acute Treatment Phase|Physician Decision|1
1754403|NCT00840034|6114178|P1|Acute Treatment Phase|Physician Decision|0
1754404|NCT00840034|6114177|P2|Acute Treatment Phase|Lost to Follow-up|12
1754405|NCT00840034|6114178|P1|Acute Treatment Phase|Lost to Follow-up|5
1754406|NCT00840034|6114177|P2|Acute Treatment Phase|Lack of Efficacy|0
1754407|NCT00840034|6114178|P1|Acute Treatment Phase|Lack of Efficacy|2
1754408|NCT00840034|6114177|P2|Acute Treatment Phase|Adverse Event|8
1754409|NCT00840034|6114178|P1|Acute Treatment Phase|Adverse Event|6
1754410|NCT00839956|6114231|P1|Overall Study|Withdrawal by Subject|3
1754411|NCT00839956|6114231|P1|Overall Study|Physician Decision|1
1754412|NCT00839956|6114231|P1|Overall Study|Lack of Efficacy|6
1754413|NCT00839956|6114231|P1|Overall Study|Adverse Event|2
1754414|NCT00839917|6114251|P2|Overall Study|Did not receive vaccine|1
1754415|NCT00839917|6114252|P1|Overall Study|Did not receive vaccine|0
1754416|NCT00839917|6114251|P2|Overall Study|Lost to Follow-up|0
1754417|NCT00839917|6114252|P1|Overall Study|Lost to Follow-up|1
1754418|NCT00839852|6114288|P1|Overall Study|Pregnancy|1
1754419|NCT00839852|6114288|P1|Overall Study|Lack of Compliance While in Jail|1
1754420|NCT00839852|6114288|P1|Overall Study|Lost to Follow-up|7
1754421|NCT00839852|6114288|P1|Overall Study|Withdrawal of Consent|16
1754422|NCT00839852|6114288|P1|Overall Study|Protocol Violation|9
1754423|NCT00839852|6114288|P1|Overall Study|Insufficient Therapeutic Response|3
1754424|NCT00839852|6114288|P1|Overall Study|Adverse Event|10
1754425|NCT00839800|6114295|P2|Overall Study|Severe Non-Compliance to Protocol|7
1754426|NCT00839800|6114296|P1|Overall Study|Severe Non-Compliance to Protocol|7
1754427|NCT00839800|6114295|P2|Overall Study|Other|14
1754428|NCT00839800|6114296|P1|Overall Study|Other|8
1754429|NCT00839800|6114295|P2|Overall Study|Safety Reasons|1
1754430|NCT00839800|6114296|P1|Overall Study|Safety Reasons|2
1754431|NCT00839800|6114295|P2|Overall Study|Study-Specific Discontinuation Criteria|13
1754432|NCT00839800|6114296|P1|Overall Study|Study-Specific Discontinuation Criteria|6
1754433|NCT00839800|6114295|P2|Overall Study|Incorrect Enrolment|3
1754434|NCT00839800|6114296|P1|Overall Study|Incorrect Enrolment|3
1754435|NCT00839800|6114295|P2|Overall Study|Withdrawal by Subject|34
1754436|NCT00839800|6114296|P1|Overall Study|Withdrawal by Subject|28
1754437|NCT00839800|6114295|P2|Overall Study|Lost to Follow-up|26
1754438|NCT00839800|6114296|P1|Overall Study|Lost to Follow-up|31
1754439|NCT00839800|6114295|P2|Overall Study|Adverse Event|12
1754440|NCT00839800|6114296|P1|Overall Study|Adverse Event|8
1754441|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
1754442|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
1754443|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
1754444|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
1754445|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
1754446|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
1754447|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
1754448|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
1754449|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
1754450|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
1754451|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
1754452|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
1754453|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
1754454|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
1754455|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
1754456|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
1754457|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
1754458|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
1754459|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
1754460|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
1754461|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
1754462|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
1754463|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
1754464|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
1754465|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
1754466|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
1754467|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
1754468|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
1754469|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
1754470|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
1754471|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
1754472|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
1754473|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
1754474|NCT00839527|6114342|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1754475|NCT00839527|6114343|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
1754476|NCT00839527|6114344|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
1754477|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
1754478|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
1754479|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
1754480|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
1754481|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
1754482|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
1754483|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1754484|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
1754485|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
1754486|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
1754487|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
1754488|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
1754489|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Missing|0
1754490|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Missing|1
1754491|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Missing|0
1754492|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
1754493|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
1754494|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
1754495|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
1754496|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
1754497|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
1754498|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
1754499|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
1754500|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
1754501|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
1754502|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
1754503|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
1754504|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
1754505|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
1754506|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
1754507|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
1754508|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
1754509|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
1754510|NCT00839527|6114342|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
1754511|NCT00839527|6114343|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
1754512|NCT00839527|6114344|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
1754513|NCT00839436|6114379|P3|Overall Study|Study drug no longer available|1
1754514|NCT00839436|6114380|P2|Overall Study|Study drug no longer available|0
1754515|NCT00839436|6114381|P1|Overall Study|Study drug no longer available|0
1754516|NCT00839436|6114379|P3|Overall Study|Withdrawal by Subject|0
1754517|NCT00839436|6114380|P2|Overall Study|Withdrawal by Subject|1
1754518|NCT00839436|6114381|P1|Overall Study|Withdrawal by Subject|0
1754519|NCT00839436|6114379|P3|Overall Study|Developed exclusionary condition|0
1754520|NCT00839436|6114380|P2|Overall Study|Developed exclusionary condition|0
1754521|NCT00839436|6114381|P1|Overall Study|Developed exclusionary condition|1
1754522|NCT00839423|6114393|P4|Overall Study|Administrative or other reasons|0
1754523|NCT00839423|6114394|P3|Overall Study|Administrative or other reasons|1
1754524|NCT00839423|6114395|P2|Overall Study|Administrative or other reasons|0
1754525|NCT00839423|6114396|P1|Overall Study|Administrative or other reasons|3
1754526|NCT00839423|6114393|P4|Overall Study|Lost to Follow-up|0
1754527|NCT00839423|6114394|P3|Overall Study|Lost to Follow-up|1
1754528|NCT00839423|6114395|P2|Overall Study|Lost to Follow-up|0
1754529|NCT00839423|6114396|P1|Overall Study|Lost to Follow-up|1
1754530|NCT00839423|6114393|P4|Overall Study|Withdrawal of consent|1
1754531|NCT00839423|6114394|P3|Overall Study|Withdrawal of consent|4
1754532|NCT00839423|6114395|P2|Overall Study|Withdrawal of consent|0
1754533|NCT00839423|6114396|P1|Overall Study|Withdrawal of consent|4
1754534|NCT00839423|6114393|P4|Overall Study|Protocol Violation|0
1754535|NCT00839423|6114394|P3|Overall Study|Protocol Violation|2
1754536|NCT00839423|6114395|P2|Overall Study|Protocol Violation|1
1754537|NCT00839423|6114396|P1|Overall Study|Protocol Violation|0
1754538|NCT00839423|6114393|P4|Overall Study|Non-compliance|1
1754539|NCT00839423|6114394|P3|Overall Study|Non-compliance|0
1754540|NCT00839423|6114395|P2|Overall Study|Non-compliance|0
1754541|NCT00839423|6114396|P1|Overall Study|Non-compliance|0
1754542|NCT00839423|6114393|P4|Overall Study|Lack of Efficacy|2
1754543|NCT00839423|6114394|P3|Overall Study|Lack of Efficacy|3
1754544|NCT00839423|6114395|P2|Overall Study|Lack of Efficacy|6
1754545|NCT00839423|6114396|P1|Overall Study|Lack of Efficacy|6
1754546|NCT00839423|6114393|P4|Overall Study|Adverse Event|16
1754547|NCT00839423|6114394|P3|Overall Study|Adverse Event|7
1754548|NCT00839423|6114395|P2|Overall Study|Adverse Event|3
1754549|NCT00839423|6114396|P1|Overall Study|Adverse Event|4
1754550|NCT00839332|6114437|P3|Phase 2|Lost to Follow-up|1
1754551|NCT00839332|6114438|P2|Phase 2|Lost to Follow-up|0
1754552|NCT00839332|6114439|P1|Phase 2|Lost to Follow-up|0
1754553|NCT00839332|6114437|P3|Phase 2|Physician Decision|1
1754554|NCT00839332|6114438|P2|Phase 2|Physician Decision|4
1754555|NCT00839332|6114439|P1|Phase 2|Physician Decision|0
1754556|NCT00839332|6114437|P3|Phase 2|Withdrawal by Subject|8
1754557|NCT00839332|6114438|P2|Phase 2|Withdrawal by Subject|5
1754558|NCT00839332|6114439|P1|Phase 2|Withdrawal by Subject|0
1754559|NCT00839332|6114437|P3|Phase 2|Death|2
1754560|NCT00839332|6114438|P2|Phase 2|Death|4
1754561|NCT00839332|6114439|P1|Phase 2|Death|0
1754562|NCT00839332|6114437|P3|Phase 2|Adverse Event|6
1754563|NCT00839332|6114438|P2|Phase 2|Adverse Event|8
1754564|NCT00839332|6114439|P1|Phase 2|Adverse Event|0
1754565|NCT00839332|6114437|P3|Phase 2|Disease Progression|21
1754566|NCT00839332|6114438|P2|Phase 2|Disease Progression|46
1754567|NCT00839332|6114439|P1|Phase 2|Disease Progression|0
1754568|NCT00839332|6114437|P3|Phase 2|Protocol Violation|0
1754569|NCT00839332|6114438|P2|Phase 2|Protocol Violation|1
1754570|NCT00839332|6114439|P1|Phase 2|Protocol Violation|0
1754571|NCT00839332|6114437|P3|Phase 1|Physician Decision|0
1754572|NCT00839332|6114438|P2|Phase 1|Physician Decision|0
1754573|NCT00839332|6114439|P1|Phase 1|Physician Decision|2
1754574|NCT00839332|6114437|P3|Phase 1|Withdrawal by Subject|0
1754575|NCT00839332|6114438|P2|Phase 1|Withdrawal by Subject|0
1754576|NCT00839332|6114439|P1|Phase 1|Withdrawal by Subject|4
1754577|NCT00839332|6114437|P3|Phase 1|Adverse Event|0
1754578|NCT00839332|6114438|P2|Phase 1|Adverse Event|0
1754579|NCT00839332|6114439|P1|Phase 1|Adverse Event|6
1754580|NCT00839332|6114437|P3|Phase 1|Disease Progression|0
1754581|NCT00839332|6114438|P2|Phase 1|Disease Progression|0
1754582|NCT00839332|6114439|P1|Phase 1|Disease Progression|38
1754583|NCT00839306|6114500|P2|Overall Study|Other|18
1754584|NCT00839306|6114501|P1|Overall Study|Other|6
1754585|NCT00839306|6114500|P2|Overall Study|Lack of Efficacy|4
1754586|NCT00839306|6114501|P1|Overall Study|Lack of Efficacy|5
1754587|NCT00839306|6114500|P2|Overall Study|Withdrawal by Subject|7
1754588|NCT00839306|6114501|P1|Overall Study|Withdrawal by Subject|5
1754589|NCT00839306|6114500|P2|Overall Study|Lost to Follow-up|9
1754590|NCT00839306|6114501|P1|Overall Study|Lost to Follow-up|6
1754591|NCT00839306|6114500|P2|Overall Study|Adverse Event|5
1754592|NCT00839306|6114501|P1|Overall Study|Adverse Event|3
1754593|NCT00839098|6114599|P3|Overall Study|Withdrawal by Subject|7
1754594|NCT00839098|6114600|P2|Overall Study|Withdrawal by Subject|1
1754595|NCT00839098|6114601|P1|Overall Study|Withdrawal by Subject|2
1754596|NCT00839072|6114627|P2|Second Intervention Period|Withdrawal by Subject|0
1754597|NCT00839072|6114628|P1|Second Intervention Period|Withdrawal by Subject|1
1754598|NCT00839072|6114627|P2|First Intervention Period|Adverse Event|1
1754599|NCT00839072|6114628|P1|First Intervention Period|Adverse Event|1
1754600|NCT00839072|6114627|P2|First Intervention Period|Withdrawal by Subject|0
1754601|NCT00839072|6114628|P1|First Intervention Period|Withdrawal by Subject|1
1754602|NCT00838929|6114672|P3|Overall Study|Disease progression|1
1754603|NCT00838929|6114673|P2|Overall Study|Disease progression|2
1754604|NCT00838929|6114674|P1|Overall Study|Disease progression|0
1754605|NCT00838929|6114672|P3|Overall Study|Protocol Violation|0
1754606|NCT00838929|6114673|P2|Overall Study|Protocol Violation|1
1754607|NCT00838929|6114674|P1|Overall Study|Protocol Violation|0
1754608|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Missing|0
1754609|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Missing|3
1754610|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
1754611|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
1754612|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
1754613|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
1754614|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Physician Decision|0
1754615|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Physician Decision|2
1754616|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
1754617|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
1754618|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
1754619|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
1754620|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
1754621|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
1754622|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Noncompliance|5
1754623|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Noncompliance|6
1754624|NCT00838916|6114682|P2|Follow-up Period (8 Weeks)|Adverse Event|5
1754625|NCT00838916|6114683|P1|Follow-up Period (8 Weeks)|Adverse Event|10
1754626|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Pregnancy|0
1754627|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Pregnancy|2
1754628|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Missing|1
1754629|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Missing|3
1754630|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
1754631|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
1754632|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Physician Decision|1
1754633|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Physician Decision|6
1754634|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
1754635|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
1754636|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
1754637|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
1754638|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1754639|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
1754640|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Noncompliance|14
1754641|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Noncompliance|21
1754642|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Protocol Violation|3
1754643|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Protocol Violation|12
1754644|NCT00838916|6114682|P2|Treatment Period (156 Weeks)|Adverse Event|11
1754645|NCT00838916|6114683|P1|Treatment Period (156 Weeks)|Adverse Event|50
1754646|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Missing|1
1754647|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Missing|1
1754648|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Missing|2
1754649|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Missing|1
1754650|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
1754651|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1754652|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1754653|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
1754654|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1754655|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1754656|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
1754657|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
1754658|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1754659|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1754660|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
1754661|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
1754662|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1754663|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
1754664|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
1754665|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
1754666|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Physician Decision|1
1754667|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Physician Decision|1
1754668|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Physician Decision|1
1754669|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Physician Decision|1
1754670|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
1754671|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
1754672|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
1754673|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
1754674|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
1754675|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
1754676|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
1754677|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
1754678|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
1754679|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
1754680|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
1754681|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
1754682|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Noncompliance|5
1754683|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Noncompliance|5
1754684|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Noncompliance|8
1754685|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Noncompliance|2
1754686|NCT00838903|6114712|P4|Follow-up Period (8 Weeks)|Adverse Event|1
1754687|NCT00838903|6114713|P3|Follow-up Period (8 Weeks)|Adverse Event|3
1754688|NCT00838903|6114714|P2|Follow-up Period (8 Weeks)|Adverse Event|0
1754689|NCT00838903|6114715|P1|Follow-up Period (8 Weeks)|Adverse Event|0
1754690|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1754691|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1754692|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
1754693|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
1754694|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
1754695|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
1754696|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
1754697|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
1754698|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1754699|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1754700|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
1754701|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
1754702|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Site closed|0
1754703|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Site closed|1
1754704|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Site closed|0
1754705|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Site closed|0
1754706|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1754707|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
1754708|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1754709|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
1754710|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Pregnancy|0
1754711|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Pregnancy|1
1754712|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Pregnancy|0
1754713|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Pregnancy|0
1754714|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1754715|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1754716|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
1754717|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
1754718|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
1754719|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1754720|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1754721|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
1754722|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1754723|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1754724|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
1754725|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
1754726|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
1754727|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
1754728|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
1754729|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
1754730|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Physician Decision|2
1754731|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Physician Decision|1
1754732|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Physician Decision|2
1754733|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Physician Decision|1
1754734|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
1754735|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
1754736|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
1754737|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
1754738|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
1754739|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
1754740|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
1754741|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
1754742|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1754743|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
1754744|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1754745|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
1754746|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Noncompliance|6
1754747|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Noncompliance|12
1754748|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Noncompliance|13
1754749|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Noncompliance|9
1754750|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Protocol Violation|5
1754751|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Protocol Violation|6
1754752|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Protocol Violation|6
1754753|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Protocol Violation|1
1754754|NCT00838903|6114712|P4|Treatment Period (156 Weeks)|Adverse Event|25
1754755|NCT00838903|6114713|P3|Treatment Period (156 Weeks)|Adverse Event|17
1754756|NCT00838903|6114714|P2|Treatment Period (156 Weeks)|Adverse Event|13
1754757|NCT00838903|6114715|P1|Treatment Period (156 Weeks)|Adverse Event|5
1754758|NCT00838682|6114770|P2|Overall Study|Withdrawal by Subject|1
1754759|NCT00838682|6114771|P1|Overall Study|Withdrawal by Subject|0
1754760|NCT00838682|6114770|P2|Overall Study|Protocol Violation|1
1754761|NCT00838682|6114771|P1|Overall Study|Protocol Violation|0
1754762|NCT00838682|6114770|P2|Overall Study|detection of exclusion criteria|3
1754763|NCT00838682|6114771|P1|Overall Study|detection of exclusion criteria|4
1754764|NCT00838682|6114770|P2|Overall Study|Lost to Follow-up|14
1754765|NCT00838682|6114771|P1|Overall Study|Lost to Follow-up|21
1754766|NCT00838630|6114789|P2|Washout: 7 Days|Protocol Violation|0
1754767|NCT00838630|6114790|P1|Washout: 7 Days|Protocol Violation|1
1754768|NCT00838630|6114789|P2|First Intervention|Adverse Event|0
1754769|NCT00838630|6114790|P1|First Intervention|Adverse Event|1
1754770|NCT00838578|6114798|P1|Overall Study|Protocol Violation|2
1754771|NCT00838565|6114812|P6|Overall Study|Randomized but not Treated|0
1754772|NCT00838565|6114813|P5|Overall Study|Randomized but not Treated|0
1754773|NCT00838565|6114814|P4|Overall Study|Randomized but not Treated|0
1754774|NCT00838565|6114815|P3|Overall Study|Randomized but not Treated|0
1754775|NCT00838565|6114816|P2|Overall Study|Randomized but not Treated|1
1754776|NCT00838565|6114817|P1|Overall Study|Randomized but not Treated|0
1754777|NCT00838565|6114812|P6|Overall Study|Other|0
1754778|NCT00838565|6114813|P5|Overall Study|Other|0
1754779|NCT00838565|6114814|P4|Overall Study|Other|0
1754780|NCT00838565|6114815|P3|Overall Study|Other|0
1754781|NCT00838565|6114816|P2|Overall Study|Other|2
1754782|NCT00838565|6114817|P1|Overall Study|Other|0
1754783|NCT00838565|6114812|P6|Overall Study|Withdrawal by Subject|2
1754784|NCT00838565|6114813|P5|Overall Study|Withdrawal by Subject|0
1754785|NCT00838565|6114814|P4|Overall Study|Withdrawal by Subject|0
1754786|NCT00838565|6114815|P3|Overall Study|Withdrawal by Subject|1
1754787|NCT00838565|6114816|P2|Overall Study|Withdrawal by Subject|0
1754788|NCT00838565|6114817|P1|Overall Study|Withdrawal by Subject|0
1754789|NCT00838539|6114922|P12|Overall Study|Symptomatic Deterioration|0
1754790|NCT00838539|6114923|P11|Overall Study|Symptomatic Deterioration|0
1754791|NCT00838539|6114924|P10|Overall Study|Symptomatic Deterioration|1
1754792|NCT00838539|6114925|P9|Overall Study|Symptomatic Deterioration|0
1754793|NCT00838539|6114926|P8|Overall Study|Symptomatic Deterioration|0
1754794|NCT00838539|6114927|P7|Overall Study|Symptomatic Deterioration|0
1754795|NCT00838539|6114928|P6|Overall Study|Symptomatic Deterioration|1
1754796|NCT00838539|6114929|P5|Overall Study|Symptomatic Deterioration|0
1754797|NCT00838539|6114930|P4|Overall Study|Symptomatic Deterioration|1
1754798|NCT00838539|6114931|P3|Overall Study|Symptomatic Deterioration|1
1754799|NCT00838539|6114932|P2|Overall Study|Symptomatic Deterioration|0
1754800|NCT00838539|6114933|P1|Overall Study|Symptomatic Deterioration|0
1754801|NCT00838539|6114922|P12|Overall Study|Clinical Progression|0
1754802|NCT00838539|6114923|P11|Overall Study|Clinical Progression|0
1754803|NCT00838539|6114924|P10|Overall Study|Clinical Progression|0
1754804|NCT00838539|6114925|P9|Overall Study|Clinical Progression|0
1754805|NCT00838539|6114926|P8|Overall Study|Clinical Progression|0
1754806|NCT00838539|6114927|P7|Overall Study|Clinical Progression|1
1754807|NCT00838539|6114928|P6|Overall Study|Clinical Progression|0
1754808|NCT00838539|6114929|P5|Overall Study|Clinical Progression|0
1754809|NCT00838539|6114930|P4|Overall Study|Clinical Progression|0
1754810|NCT00838539|6114931|P3|Overall Study|Clinical Progression|0
1754811|NCT00838539|6114932|P2|Overall Study|Clinical Progression|0
1754812|NCT00838539|6114933|P1|Overall Study|Clinical Progression|0
1754813|NCT00838539|6114922|P12|Overall Study|Physician Decision|0
1754814|NCT00838539|6114923|P11|Overall Study|Physician Decision|0
1754815|NCT00838539|6114924|P10|Overall Study|Physician Decision|0
1754816|NCT00838539|6114925|P9|Overall Study|Physician Decision|1
1754817|NCT00838539|6114926|P8|Overall Study|Physician Decision|0
1754818|NCT00838539|6114927|P7|Overall Study|Physician Decision|0
1754819|NCT00838539|6114928|P6|Overall Study|Physician Decision|0
1754820|NCT00838539|6114929|P5|Overall Study|Physician Decision|0
1754821|NCT00838539|6114930|P4|Overall Study|Physician Decision|0
1754822|NCT00838539|6114931|P3|Overall Study|Physician Decision|0
1754823|NCT00838539|6114932|P2|Overall Study|Physician Decision|0
1754824|NCT00838539|6114933|P1|Overall Study|Physician Decision|0
1754825|NCT00838539|6114922|P12|Overall Study|Death|0
1754826|NCT00838539|6114923|P11|Overall Study|Death|0
1754827|NCT00838539|6114924|P10|Overall Study|Death|0
1754828|NCT00838539|6114925|P9|Overall Study|Death|0
1754829|NCT00838539|6114926|P8|Overall Study|Death|0
1754830|NCT00838539|6114927|P7|Overall Study|Death|1
1754831|NCT00838539|6114928|P6|Overall Study|Death|0
1754832|NCT00838539|6114929|P5|Overall Study|Death|0
1754833|NCT00838539|6114930|P4|Overall Study|Death|0
1754834|NCT00838539|6114931|P3|Overall Study|Death|0
1754835|NCT00838539|6114932|P2|Overall Study|Death|0
1754836|NCT00838539|6114933|P1|Overall Study|Death|0
1754837|NCT00838539|6114922|P12|Overall Study|Withdrawal by Subject|0
1754838|NCT00838539|6114923|P11|Overall Study|Withdrawal by Subject|2
1754839|NCT00838539|6114924|P10|Overall Study|Withdrawal by Subject|1
1754840|NCT00838539|6114925|P9|Overall Study|Withdrawal by Subject|0
1754841|NCT00838539|6114926|P8|Overall Study|Withdrawal by Subject|0
1754842|NCT00838539|6114927|P7|Overall Study|Withdrawal by Subject|0
1754843|NCT00838539|6114928|P6|Overall Study|Withdrawal by Subject|0
1754844|NCT00838539|6114929|P5|Overall Study|Withdrawal by Subject|0
1754845|NCT00838539|6114930|P4|Overall Study|Withdrawal by Subject|0
1754846|NCT00838539|6114931|P3|Overall Study|Withdrawal by Subject|0
1754847|NCT00838539|6114932|P2|Overall Study|Withdrawal by Subject|1
1754848|NCT00838539|6114933|P1|Overall Study|Withdrawal by Subject|0
1754849|NCT00838539|6114922|P12|Overall Study|Adverse Event|0
1754850|NCT00838539|6114923|P11|Overall Study|Adverse Event|2
1754851|NCT00838539|6114924|P10|Overall Study|Adverse Event|1
1754852|NCT00838539|6114925|P9|Overall Study|Adverse Event|0
1754853|NCT00838539|6114926|P8|Overall Study|Adverse Event|2
1754854|NCT00838539|6114927|P7|Overall Study|Adverse Event|0
1754855|NCT00838539|6114928|P6|Overall Study|Adverse Event|1
1754856|NCT00838539|6114929|P5|Overall Study|Adverse Event|2
1754857|NCT00838539|6114930|P4|Overall Study|Adverse Event|1
1754858|NCT00838539|6114931|P3|Overall Study|Adverse Event|1
1754859|NCT00838539|6114932|P2|Overall Study|Adverse Event|1
1754860|NCT00838539|6114933|P1|Overall Study|Adverse Event|1
1754861|NCT00838539|6114922|P12|Overall Study|Disease Progression|4
1754862|NCT00838539|6114923|P11|Overall Study|Disease Progression|1
1754863|NCT00838539|6114924|P10|Overall Study|Disease Progression|5
1754864|NCT00838539|6114925|P9|Overall Study|Disease Progression|4
1754865|NCT00838539|6114926|P8|Overall Study|Disease Progression|4
1754866|NCT00838539|6114927|P7|Overall Study|Disease Progression|3
1754867|NCT00838539|6114928|P6|Overall Study|Disease Progression|2
1754868|NCT00838539|6114929|P5|Overall Study|Disease Progression|4
1754869|NCT00838539|6114930|P4|Overall Study|Disease Progression|2
1754870|NCT00838539|6114931|P3|Overall Study|Disease Progression|3
1754871|NCT00838539|6114932|P2|Overall Study|Disease Progression|4
1754872|NCT00838539|6114933|P1|Overall Study|Disease Progression|2
1754873|NCT00838526|6114983|P2|Overall Study|Other|7
1754874|NCT00838526|6114984|P1|Overall Study|Other|11
1754875|NCT00838526|6114983|P2|Overall Study|Lack of Efficacy|3
1754876|NCT00838526|6114984|P1|Overall Study|Lack of Efficacy|2
1754877|NCT00838526|6114983|P2|Overall Study|Withdrawal by Subject|5
1754878|NCT00838526|6114984|P1|Overall Study|Withdrawal by Subject|4
1754879|NCT00838526|6114983|P2|Overall Study|Lost to Follow-up|12
1754880|NCT00838526|6114984|P1|Overall Study|Lost to Follow-up|4
1754881|NCT00838526|6114983|P2|Overall Study|Adverse Event|12
1754882|NCT00838526|6114984|P1|Overall Study|Adverse Event|3
1754883|NCT00838513|6114992|P1|Post Treatment Period (Patients Who Disc|Death|1
1754884|NCT00838513|6114992|P1|Extension Treatment Period|Death|1
1754885|NCT00838513|6114992|P1|Screening Period|Screen Failure|3
1754886|NCT00838331|6115008|P1|Aged Blood Transfusion|Withdrawal by Subject|9
1754887|NCT00838279|6115014|P2|Washout|Withdrawal by Subject|1
1754888|NCT00838279|6115015|P1|Washout|Withdrawal by Subject|0
1754889|NCT00838279|6115014|P2|Washout|Protocol Violation|0
1754890|NCT00838279|6115015|P1|Washout|Protocol Violation|1
1754891|NCT00838201|6115025|P2|Overall Study|Death|13
1754892|NCT00838201|6115026|P1|Overall Study|Death|11
1754893|NCT00838201|6115025|P2|Overall Study|Adverse Event|9
1754894|NCT00838201|6115026|P1|Overall Study|Adverse Event|5
1754895|NCT00838201|6115025|P2|Overall Study|Lost to Follow-up|3
1754896|NCT00838201|6115026|P1|Overall Study|Lost to Follow-up|4
1754897|NCT00838201|6115025|P2|Overall Study|Consent withdrawn|19
1754898|NCT00838201|6115026|P1|Overall Study|Consent withdrawn|16
1754899|NCT00838201|6115025|P2|Overall Study|Disease progression|3
1754900|NCT00838201|6115026|P1|Overall Study|Disease progression|3
1754901|NCT00838201|6115025|P2|Overall Study|Administrative decision|2
1754902|NCT00838201|6115026|P1|Overall Study|Administrative decision|1
1754903|NCT00838201|6115025|P2|Overall Study|Noncompliance|1
1754904|NCT00838201|6115026|P1|Overall Study|Noncompliance|0
1754905|NCT00838201|6115025|P2|Overall Study|Investigator decision, or other reasons|3
1754906|NCT00838201|6115026|P1|Overall Study|Investigator decision, or other reasons|2
1754907|NCT00838110|6115094|P4|Overall Study|Randomized but not treated|0
1754908|NCT00838110|6115095|P3|Overall Study|Randomized but not treated|0
1754909|NCT00838110|6115096|P2|Overall Study|Randomized but not treated|1
1754910|NCT00838110|6115097|P1|Overall Study|Randomized but not treated|0
1754911|NCT00838110|6115094|P4|Overall Study|Did not meet eligibility criteria|2
1754912|NCT00838110|6115095|P3|Overall Study|Did not meet eligibility criteria|1
1754913|NCT00838110|6115096|P2|Overall Study|Did not meet eligibility criteria|0
1754914|NCT00838110|6115097|P1|Overall Study|Did not meet eligibility criteria|0
1754915|NCT00838110|6115094|P4|Overall Study|Lost to Follow-up|0
1754916|NCT00838110|6115095|P3|Overall Study|Lost to Follow-up|0
1754917|NCT00838110|6115096|P2|Overall Study|Lost to Follow-up|0
1754918|NCT00838110|6115097|P1|Overall Study|Lost to Follow-up|3
1754919|NCT00838110|6115094|P4|Overall Study|Protocol Violation|1
1754920|NCT00838110|6115095|P3|Overall Study|Protocol Violation|1
1754921|NCT00838110|6115096|P2|Overall Study|Protocol Violation|2
1754922|NCT00838110|6115097|P1|Overall Study|Protocol Violation|0
1754923|NCT00838110|6115094|P4|Overall Study|Other|2
1754924|NCT00838110|6115095|P3|Overall Study|Other|3
1754925|NCT00838110|6115096|P2|Overall Study|Other|3
1754926|NCT00838110|6115097|P1|Overall Study|Other|3
1754927|NCT00838110|6115094|P4|Overall Study|Withdrawal by Subject|4
1754928|NCT00838110|6115095|P3|Overall Study|Withdrawal by Subject|3
1754929|NCT00838110|6115096|P2|Overall Study|Withdrawal by Subject|6
1754930|NCT00838110|6115097|P1|Overall Study|Withdrawal by Subject|5
1754931|NCT00838110|6115094|P4|Overall Study|Adverse Event|7
1754932|NCT00838110|6115095|P3|Overall Study|Adverse Event|8
1754933|NCT00838110|6115096|P2|Overall Study|Adverse Event|10
1754934|NCT00838110|6115097|P1|Overall Study|Adverse Event|11
1754935|NCT00838110|6115094|P4|Overall Study|Death|2
1754936|NCT00838110|6115095|P3|Overall Study|Death|1
1754937|NCT00838110|6115096|P2|Overall Study|Death|0
1754938|NCT00838110|6115097|P1|Overall Study|Death|0
1754939|NCT00838097|6115117|P1|Overall Study|Protocol-specified criteria|142
1754940|NCT00838097|6115117|P1|Overall Study|Death|6
1754941|NCT00838097|6115117|P1|Overall Study|Lost to Follow-up|11
1754942|NCT00838097|6115117|P1|Overall Study|Physician Decision|4
1754943|NCT00838097|6115117|P1|Overall Study|Requirement for alternative therapy|2
1754944|NCT00838097|6115117|P1|Overall Study|Withdrawal by Subject|3
1754945|NCT00838097|6115117|P1|Overall Study|Adverse Event|2
1754946|NCT00838097|6115117|P1|Overall Study|Ineligibility determined|6
1754947|NCT00837967|6115125|P2|Washout Period of 7 - 14 Days|Adverse Event|0
1754948|NCT00837967|6115126|P1|Washout Period of 7 - 14 Days|Adverse Event|2
1754949|NCT00837876|6115152|P1|Overall Study|disease progression|24
1754950|NCT00837876|6115152|P1|Overall Study|Withdrawal by Subject|3
1754951|NCT00837876|6115152|P1|Overall Study|Physician Decision|1
1754952|NCT00837876|6115152|P1|Overall Study|Adverse Event|7
1754953|NCT00837876|6115152|P1|Overall Study|Death|2
1754954|NCT00837811|6115174|P3|Overall Study|Sponsor Decision|0
1754955|NCT00837811|6115175|P2|Overall Study|Sponsor Decision|2
1754956|NCT00837811|6115176|P1|Overall Study|Sponsor Decision|0
1754957|NCT00837811|6115174|P3|Overall Study|Withdrawal by Subject|0
1754958|NCT00837811|6115175|P2|Overall Study|Withdrawal by Subject|9
1754959|NCT00837811|6115176|P1|Overall Study|Withdrawal by Subject|1
1754960|NCT00837811|6115174|P3|Overall Study|Physician Decision|1
1754961|NCT00837811|6115175|P2|Overall Study|Physician Decision|2
1754962|NCT00837811|6115176|P1|Overall Study|Physician Decision|0
1754963|NCT00837811|6115174|P3|Overall Study|Lost to Follow-up|0
1754964|NCT00837811|6115175|P2|Overall Study|Lost to Follow-up|3
1754965|NCT00837811|6115176|P1|Overall Study|Lost to Follow-up|1
1754966|NCT00837811|6115174|P3|Overall Study|Lack of Efficacy|0
1754967|NCT00837811|6115175|P2|Overall Study|Lack of Efficacy|11
1754968|NCT00837811|6115176|P1|Overall Study|Lack of Efficacy|0
1754969|NCT00837811|6115174|P3|Overall Study|Death|0
1754970|NCT00837811|6115175|P2|Overall Study|Death|1
1754971|NCT00837811|6115176|P1|Overall Study|Death|1
1754972|NCT00837811|6115174|P3|Overall Study|Adverse Event|0
1754973|NCT00837811|6115175|P2|Overall Study|Adverse Event|6
1754974|NCT00837811|6115176|P1|Overall Study|Adverse Event|4
1754975|NCT00837759|6115261|P1|Overall Study|Lost to Follow-up|1
1754976|NCT00837759|6115261|P1|Overall Study|Protocol Violation|3
1754977|NCT00837694|6115276|P6|Overall Study|Lost to Follow-up|1
1754978|NCT00837694|6115277|P5|Overall Study|Lost to Follow-up|1
1754979|NCT00837694|6115278|P4|Overall Study|Lost to Follow-up|1
1754980|NCT00837694|6115279|P3|Overall Study|Lost to Follow-up|2
1754981|NCT00837694|6115280|P2|Overall Study|Lost to Follow-up|0
1754982|NCT00837694|6115281|P1|Overall Study|Lost to Follow-up|2
1754983|NCT00837616|6115297|P2|Overall Study|Withdrawal by Subject|1
1754984|NCT00837616|6115298|P1|Overall Study|Withdrawal by Subject|0
1754985|NCT00837577|6115337|P2|Open-label Period|Other Reason|1
1754986|NCT00837577|6115338|P1|Open-label Period|Other Reason|1
1754987|NCT00837577|6115337|P2|Open-label Period|Withdrawal by Subject|2
1754988|NCT00837577|6115338|P1|Open-label Period|Withdrawal by Subject|1
1754989|NCT00837577|6115337|P2|Open-label Period|Lack of Efficacy|3
1754990|NCT00837577|6115338|P1|Open-label Period|Lack of Efficacy|4
1754991|NCT00837577|6115337|P2|Open-label Period|Laboratory Adverse Event|1
1754992|NCT00837577|6115338|P1|Open-label Period|Laboratory Adverse Event|0
1754993|NCT00837577|6115337|P2|Open-label Period|Clinical Adverse Event|2
1754994|NCT00837577|6115338|P1|Open-label Period|Clinical Adverse Event|2
1754995|NCT00837577|6115337|P2|Double-blind Period|Withdrawal by Subject|0
1754996|NCT00837577|6115338|P1|Double-blind Period|Withdrawal by Subject|1
1754997|NCT00837577|6115337|P2|Double-blind Period|Clinical Adverse Event|0
1754998|NCT00837577|6115338|P1|Double-blind Period|Clinical Adverse Event|1
1754999|NCT00837486|6115358|P2|Long-term Follow-up Phase - Open Label|Death|0
1755000|NCT00837486|6115359|P1|Long-term Follow-up Phase - Open Label|Death|1
1755001|NCT00837486|6115358|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
1755002|NCT00837486|6115359|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
1755003|NCT00837486|6115358|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
1755004|NCT00837486|6115359|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
1755005|NCT00837486|6115358|P2|Blinded-treatment Phase|Physician Decision|0
1755006|NCT00837486|6115359|P1|Blinded-treatment Phase|Physician Decision|1
1755007|NCT00837473|6115371|P1|Overall Study|Withdrawal by Subject|2
1755008|NCT00837473|6115371|P1|Overall Study|Lost to Follow-up|1
1755009|NCT00837434|6115391|P2|Overall Study|Unable to obtain study drug|0
1755010|NCT00837434|6115392|P1|Overall Study|Unable to obtain study drug|1
1755011|NCT00837434|6115391|P2|Overall Study|Baseline assessments not done in time|0
1755012|NCT00837434|6115392|P1|Overall Study|Baseline assessments not done in time|1
1755013|NCT00837434|6115391|P2|Overall Study|Noncompliant|0
1755014|NCT00837434|6115392|P1|Overall Study|Noncompliant|2
1755015|NCT00837434|6115391|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
1755016|NCT00837434|6115392|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
1755017|NCT00837434|6115391|P2|Overall Study|Lost to Follow-up|1
1755018|NCT00837434|6115392|P1|Overall Study|Lost to Follow-up|1
1755019|NCT00837434|6115391|P2|Overall Study|Physician Decision|0
1755020|NCT00837434|6115392|P1|Overall Study|Physician Decision|3
1755021|NCT00837330|6115412|P2|Overall Study|Lost to Follow-up|3
1755022|NCT00837330|6115413|P1|Overall Study|Lost to Follow-up|1
1755023|NCT00837213|6115436|P2|Overall Study|not stated|1
1755024|NCT00837213|6115437|P1|Overall Study|not stated|1
1755025|NCT00837213|6115436|P2|Overall Study|Withdrawal by Subject|2
1755026|NCT00837213|6115437|P1|Overall Study|Withdrawal by Subject|2
1755027|NCT00837213|6115436|P2|Overall Study|Lost to Follow-up|2
1755028|NCT00837213|6115437|P1|Overall Study|Lost to Follow-up|3
1755029|NCT00837161|6115463|P1|Overall Study|refused hysterectomy|2
1755030|NCT00837148|6115471|P1|Overall Study|Death|1
1755031|NCT00837148|6115471|P1|Overall Study|Adverse Event|1
1755032|NCT00837096|6115477|P2|Overall Study|Not reported|8
1755033|NCT00837096|6115478|P1|Overall Study|Not reported|9
1755034|NCT00837096|6115477|P2|Overall Study|Physician Decision|1
1755035|NCT00837096|6115478|P1|Overall Study|Physician Decision|1
1755036|NCT00836953|6115490|P1|Overall Study|Lost to Follow-up|1
1755037|NCT00836953|6115490|P1|Overall Study|Withdrawal by Subject|1
1755038|NCT00836927|6115501|P5|Overall Study|Withdrawal by Subject|0
1755039|NCT00836927|6115502|P4|Overall Study|Withdrawal by Subject|0
1755040|NCT00836927|6115503|P3|Overall Study|Withdrawal by Subject|0
1755041|NCT00836927|6115504|P2|Overall Study|Withdrawal by Subject|0
1755042|NCT00836927|6115505|P1|Overall Study|Withdrawal by Subject|1
1755043|NCT00836927|6115501|P5|Overall Study|Progressive disease|1
1755044|NCT00836927|6115502|P4|Overall Study|Progressive disease|1
1755045|NCT00836927|6115503|P3|Overall Study|Progressive disease|0
1755046|NCT00836927|6115504|P2|Overall Study|Progressive disease|0
1755047|NCT00836927|6115505|P1|Overall Study|Progressive disease|2
1755048|NCT00836901|6115541|P2|First Intervention|Withdrawal by Subject|0
1755049|NCT00836901|6115542|P1|First Intervention|Withdrawal by Subject|1
1755050|NCT00836875|6115558|P2|Overall Study|Withdrawal by Subject|1
1755051|NCT00836875|6115559|P1|Overall Study|Withdrawal by Subject|0
1755052|NCT00836875|6115558|P2|Overall Study|Death|2
1755053|NCT00836875|6115559|P1|Overall Study|Death|3
1755054|NCT00836810|6115575|P2|Overall Study|New diagnosis|0
1755055|NCT00836810|6115576|P1|Overall Study|New diagnosis|1
1755056|NCT00836745|6115598|P1|Overall Study|Other|2
1755057|NCT00836745|6115598|P1|Overall Study|Objective progression or relapse|4
1755058|NCT00836745|6115598|P1|Overall Study|Adverse Event|3
1755059|NCT00836745|6115598|P1|Overall Study|Lost to Follow-up|10
1755060|NCT00836745|6115598|P1|Overall Study|Death|2
1755061|NCT00836706|6115612|P2|Washout: 7 Days|Withdrawal by Subject|1
1755062|NCT00836706|6115613|P1|Washout: 7 Days|Withdrawal by Subject|0
1755063|NCT00836693|6115623|P2|Overall Study|Lost to Follow-up|0
1755064|NCT00836693|6115624|P1|Overall Study|Lost to Follow-up|1
1755065|NCT00836693|6115623|P2|Overall Study|Protocol Violation|0
1755066|NCT00836693|6115624|P1|Overall Study|Protocol Violation|1
1755067|NCT00836693|6115623|P2|Overall Study|Withdrawal by Subject|4
1755068|NCT00836693|6115624|P1|Overall Study|Withdrawal by Subject|9
1755069|NCT00836693|6115623|P2|Overall Study|Physician Decision|0
1755070|NCT00836693|6115624|P1|Overall Study|Physician Decision|2
1755071|NCT00836693|6115623|P2|Overall Study|Sponsor Decision|1
1755072|NCT00836693|6115624|P1|Overall Study|Sponsor Decision|0
1755073|NCT00836693|6115623|P2|Overall Study|Adverse Event|1
1755074|NCT00836693|6115624|P1|Overall Study|Adverse Event|4
1755075|NCT00836589|6115674|P1|Overall Study|Withdrawal by Subject or Physician|591
1755076|NCT00836589|6115674|P1|Overall Study|Death|429
1755077|NCT00836589|6115674|P1|Overall Study|Lost to Follow-up|246
1755078|NCT00836498|6115707|P2|Overall Study|Withdrawal by Subject|1
1755079|NCT00836498|6115708|P1|Overall Study|Withdrawal by Subject|2
1755080|NCT00836498|6115707|P2|Overall Study|Lost to Follow-up|0
1755081|NCT00836498|6115708|P1|Overall Study|Lost to Follow-up|1
1755082|NCT00836498|6115707|P2|Overall Study|Adverse Event|0
1755083|NCT00836498|6115708|P1|Overall Study|Adverse Event|1
1755084|NCT00836472|6115740|P2|Washout|Withdrawal by Subject|1
1755085|NCT00836472|6115741|P1|Washout|Withdrawal by Subject|1
1755086|NCT00836472|6115740|P2|Washout|Adverse Event|2
1755087|NCT00836472|6115741|P1|Washout|Adverse Event|1
1755088|NCT00836277|6115818|P1|Overall Study|Not evaluable for response|6
1755089|NCT00836095|6115828|P2|Overall Study|Physician Decision|3
1755090|NCT00836095|6115829|P1|Overall Study|Physician Decision|0
1755091|NCT00836056|6115839|P2|First Intervention|Adverse Event|0
1755092|NCT00836056|6115840|P1|First Intervention|Adverse Event|1
1755093|NCT00835991|6115869|P2|Washout|Withdrawal by Subject|1
1755094|NCT00835991|6115870|P1|Washout|Withdrawal by Subject|3
1755095|NCT00835991|6115869|P2|Washout|Protocol Violation|2
1755096|NCT00835991|6115870|P1|Washout|Protocol Violation|0
1755097|NCT00835991|6115869|P2|First Intervention|Adverse Event|1
1755098|NCT00835991|6115870|P1|First Intervention|Adverse Event|0
1755099|NCT00835978|6115888|P4|Overall Study|Study terminated by sponsor|0
1755100|NCT00835978|6115889|P3|Overall Study|Study terminated by sponsor|30
1755101|NCT00835978|6115890|P2|Overall Study|Study terminated by sponsor|8
1755102|NCT00835978|6115891|P1|Overall Study|Study terminated by sponsor|12
1755103|NCT00835978|6115888|P4|Overall Study|Withdrawal by Subject|5
1755104|NCT00835978|6115889|P3|Overall Study|Withdrawal by Subject|0
1755105|NCT00835978|6115890|P2|Overall Study|Withdrawal by Subject|3
1755106|NCT00835978|6115891|P1|Overall Study|Withdrawal by Subject|0
1755107|NCT00835978|6115888|P4|Overall Study|Adverse Event|0
1755108|NCT00835978|6115889|P3|Overall Study|Adverse Event|1
1755109|NCT00835978|6115890|P2|Overall Study|Adverse Event|0
1755110|NCT00835978|6115891|P1|Overall Study|Adverse Event|1
1755111|NCT00835978|6115888|P4|Overall Study|Objective progression or relapse|0
1755112|NCT00835978|6115889|P3|Overall Study|Objective progression or relapse|1
1755113|NCT00835978|6115890|P2|Overall Study|Objective progression or relapse|0
1755114|NCT00835978|6115891|P1|Overall Study|Objective progression or relapse|2
1755115|NCT00835978|6115888|P4|Overall Study|Other|0
1755116|NCT00835978|6115889|P3|Overall Study|Other|8
1755117|NCT00835978|6115890|P2|Overall Study|Other|1
1755118|NCT00835978|6115891|P1|Overall Study|Other|5
1755119|NCT00835978|6115888|P4|Overall Study|Lost to Follow-up|1
1755120|NCT00835978|6115889|P3|Overall Study|Lost to Follow-up|2
1755121|NCT00835978|6115890|P2|Overall Study|Lost to Follow-up|4
1755122|NCT00835978|6115891|P1|Overall Study|Lost to Follow-up|3
1755123|NCT00835978|6115888|P4|Overall Study|Death|4
1755124|NCT00835978|6115889|P3|Overall Study|Death|49
1755125|NCT00835978|6115890|P2|Overall Study|Death|40
1755126|NCT00835978|6115891|P1|Overall Study|Death|33
1755127|NCT00835796|6116002|P2|First Intervention|Withdrawal by Subject|1
1755128|NCT00835796|6116003|P1|First Intervention|Withdrawal by Subject|0
1755129|NCT00835731|6116013|P2|Overall Study|Physician Decision|1
1755130|NCT00835731|6116014|P1|Overall Study|Physician Decision|1
1755131|NCT00835731|6116013|P2|Overall Study|Withdrawal by Subject|0
1755132|NCT00835731|6116014|P1|Overall Study|Withdrawal by Subject|1
1755133|NCT00835705|6116034|P2|Second Intervention|Difficulty with vein|0
1755134|NCT00835705|6116035|P1|Second Intervention|Difficulty with vein|1
1755135|NCT00835705|6116034|P2|First Intervention|Difficulty with vein|0
1755136|NCT00835705|6116035|P1|First Intervention|Difficulty with vein|1
1755137|NCT00835692|6116051|P2|First Intervention|Withdrawal by Subject|0
1755138|NCT00835692|6116052|P1|First Intervention|Withdrawal by Subject|1
1755139|NCT00835679|6116064|P4|Overall Study|Withdrawal by Subject|0
1755140|NCT00835679|6116065|P3|Overall Study|Withdrawal by Subject|0
1755141|NCT00835679|6116066|P2|Overall Study|Withdrawal by Subject|0
1755142|NCT00835679|6116067|P1|Overall Study|Withdrawal by Subject|1
1755143|NCT00835666|6116091|P2|Washout|Withdrawal by Subject|0
1755144|NCT00835666|6116092|P1|Washout|Withdrawal by Subject|1
1755145|NCT00835666|6116091|P2|Washout|Protocol Violation|0
1755146|NCT00835666|6116092|P1|Washout|Protocol Violation|1
1755147|NCT00835640|6116102|P2|Second Intervention|Protocol Violation|0
1755148|NCT00835640|6116103|P1|Second Intervention|Protocol Violation|1
1755149|NCT00835575|6116135|P2|Washout of 14 Days|Withdrawal by Subject|0
1755150|NCT00835575|6116136|P1|Washout of 14 Days|Withdrawal by Subject|1
1755151|NCT00835549|6116146|P2|Washout of 7 Days|Withdrawal by Subject|0
1755152|NCT00835549|6116147|P1|Washout of 7 Days|Withdrawal by Subject|2
1755153|NCT00835536|6116157|P2|Washout of 5 Weeks|Withdrawal by Subject|0
1755154|NCT00835536|6116158|P1|Washout of 5 Weeks|Withdrawal by Subject|1
1755155|NCT00835406|6116219|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
1755156|NCT00835406|6116220|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
1755157|NCT00835406|6116219|P2|Period: First Intervention|Withdrawal by Subject|0
1755158|NCT00835406|6116220|P1|Period: First Intervention|Withdrawal by Subject|2
1755159|NCT00835406|6116219|P2|Period: First Intervention|Adverse Event|1
1755160|NCT00835406|6116220|P1|Period: First Intervention|Adverse Event|0
1755161|NCT00835380|6116226|P1|Overall Study|Withdrawal by Subject|2
1755162|NCT00835367|6116233|P2|Second Intervention|Adverse Event|1
1755163|NCT00835367|6116234|P1|Second Intervention|Adverse Event|1
1755164|NCT00835367|6116233|P2|Washout|Withdrawal by Subject|0
1755165|NCT00835367|6116234|P1|Washout|Withdrawal by Subject|1
1755166|NCT00835367|6116233|P2|Washout|Adverse Event|0
1755167|NCT00835367|6116234|P1|Washout|Adverse Event|2
1755168|NCT00835354|6116256|P2|First Intervention|Adverse Event|1
1755169|NCT00835354|6116257|P1|First Intervention|Adverse Event|0
1755170|NCT00835341|6116267|P2|Overall Study|Lost to Follow-up|12
1755171|NCT00835341|6116268|P1|Overall Study|Lost to Follow-up|3
1755172|NCT00835263|6116287|P2|Second Intervention|Adverse Event|0
1755173|NCT00835263|6116288|P1|Second Intervention|Adverse Event|1
1755174|NCT00835237|6116298|P2|Overall Study|Withdrawal by Subject|0
1755175|NCT00835237|6116299|P1|Overall Study|Withdrawal by Subject|2
1755176|NCT00835237|6116298|P2|Overall Study|Lost to Follow-up|0
1755177|NCT00835237|6116299|P1|Overall Study|Lost to Follow-up|4
1755178|NCT00835211|6116339|P2|Washout: 7 Days|Withdrawal by Subject|0
1755179|NCT00835211|6116340|P1|Washout: 7 Days|Withdrawal by Subject|1
1755180|NCT00835211|6116339|P2|Washout: 7 Days|Adverse Event|1
1755181|NCT00835211|6116340|P1|Washout: 7 Days|Adverse Event|2
1755182|NCT00835211|6116339|P2|First Intervention|Withdrawal by Subject|1
1755183|NCT00835211|6116340|P1|First Intervention|Withdrawal by Subject|0
1755184|NCT00835172|6116386|P2|Washout|Protocol Violation|1
1755185|NCT00835172|6116387|P1|Washout|Protocol Violation|0
1755186|NCT00835120|6116413|P1|Overall Study|Withdrawal by Subject|2
1755187|NCT00835120|6116413|P1|Overall Study|Adverse Event|2
1755188|NCT00835120|6116413|P1|Overall Study|Lost to Follow-up|3
1755189|NCT00835120|6116413|P1|Overall Study|Lack of Efficacy|1
1755190|NCT00835081|6116423|P2|Washout of 7 Days|Withdrawal by Subject|0
1755191|NCT00835081|6116424|P1|Washout of 7 Days|Withdrawal by Subject|1
1755192|NCT00835068|6116434|P2|Overall Study|Withdrawal by Subject|0
1755193|NCT00835068|6116435|P1|Overall Study|Withdrawal by Subject|1
1755194|NCT00835068|6116434|P2|Overall Study|Other|0
1755195|NCT00835068|6116435|P1|Overall Study|Other|8
1755196|NCT00835068|6116434|P2|Overall Study|Adverse Event|1
1755197|NCT00835068|6116435|P1|Overall Study|Adverse Event|0
1755198|NCT00835068|6116434|P2|Overall Study|Death|0
1755199|NCT00835068|6116435|P1|Overall Study|Death|1
1755200|NCT00835042|6116455|P2|Washout of 21 Days|Withdrawal by Subject|2
1755201|NCT00835042|6116456|P1|Washout of 21 Days|Withdrawal by Subject|0
1755202|NCT00835042|6116455|P2|First Intervention|Adverse Event|2
1755203|NCT00835042|6116456|P1|First Intervention|Adverse Event|1
1755204|NCT00835042|6116455|P2|First Intervention|Withdrawal by Subject|0
1755205|NCT00835042|6116456|P1|First Intervention|Withdrawal by Subject|3
1755206|NCT00834912|6116542|P6|Treatment Period 2|Withdrawal by Subject|0
1755207|NCT00834912|6116543|P5|Treatment Period 2|Withdrawal by Subject|1
1755208|NCT00834912|6116544|P4|Treatment Period 2|Withdrawal by Subject|0
1755209|NCT00834912|6116545|P3|Treatment Period 2|Withdrawal by Subject|1
1755210|NCT00834912|6116546|P2|Treatment Period 2|Withdrawal by Subject|0
1755211|NCT00834912|6116547|P1|Treatment Period 2|Withdrawal by Subject|0
1755212|NCT00834912|6116542|P6|Treatment Period 1|Adverse Event|0
1755213|NCT00834912|6116543|P5|Treatment Period 1|Adverse Event|0
1755214|NCT00834912|6116544|P4|Treatment Period 1|Adverse Event|1
1755215|NCT00834912|6116545|P3|Treatment Period 1|Adverse Event|0
1755216|NCT00834912|6116546|P2|Treatment Period 1|Adverse Event|1
1755217|NCT00834912|6116547|P1|Treatment Period 1|Adverse Event|0
1755218|NCT00834899|6116569|P2|Overall Study|Withdrawal by Subject|1
1755219|NCT00834899|6116570|P1|Overall Study|Withdrawal by Subject|1
1755220|NCT00834873|6116609|P2|First Intervention|Adverse Event|1
1755221|NCT00834873|6116610|P1|First Intervention|Adverse Event|0
1755222|NCT00834834|6116620|P2|Overall Study|Withdrawal by Subject|3
1755223|NCT00834834|6116621|P1|Overall Study|Withdrawal by Subject|4
1755224|NCT00834795|6116656|P2|Second Intervention|Adverse Event|0
1755225|NCT00834795|6116657|P1|Second Intervention|Adverse Event|1
1755226|NCT00834795|6116656|P2|Washout: 7 Days|Withdrawal by Subject|1
1755227|NCT00834795|6116657|P1|Washout: 7 Days|Withdrawal by Subject|0
1755228|NCT00834756|6116667|P2|Washout: 21 Days|Withdrawal by Subject|0
1755229|NCT00834756|6116668|P1|Washout: 21 Days|Withdrawal by Subject|1
1755230|NCT00834756|6116667|P2|First Intervention|Adverse Event|0
1755231|NCT00834756|6116668|P1|First Intervention|Adverse Event|1
1755232|NCT00834743|6116678|P2|Second Intervention|Withdrawal by Subject|0
1755233|NCT00834743|6116679|P1|Second Intervention|Withdrawal by Subject|1
1755234|NCT00834717|6116689|P2|First Intervention|Withdrawal by Subject|1
1755235|NCT00834717|6116690|P1|First Intervention|Withdrawal by Subject|0
1755236|NCT00834717|6116689|P2|First Intervention|Adverse Event|0
1755237|NCT00834717|6116690|P1|First Intervention|Adverse Event|1
1755238|NCT00834639|6116721|P2|Second Intervention|Physician Decision|2
1755239|NCT00834639|6116722|P1|Second Intervention|Physician Decision|0
1755240|NCT00834613|6116739|P2|First Intervention|Protocol Violation|0
1755241|NCT00834613|6116740|P1|First Intervention|Protocol Violation|1
1755242|NCT00834587|6116750|P2|Washout: 7 Days|Withdrawal by Subject|0
1755243|NCT00834587|6116751|P1|Washout: 7 Days|Withdrawal by Subject|1
1755244|NCT00834522|6116800|P2|Washout|Withdrawal by Subject|1
1755245|NCT00834522|6116801|P1|Washout|Withdrawal by Subject|2
1755246|NCT00834522|6116800|P2|Washout|Adverse Event|0
1755247|NCT00834522|6116801|P1|Washout|Adverse Event|1
1755248|NCT00834444|6116824|P2|Second Intervention|Adverse Event|0
1755249|NCT00834444|6116825|P1|Second Intervention|Adverse Event|1
1755250|NCT00834444|6116824|P2|Washout of 7 Days|Withdrawal by Subject|1
1755251|NCT00834444|6116825|P1|Washout of 7 Days|Withdrawal by Subject|0
1755252|NCT00834444|6116824|P2|First Intervention|Intolerance to Venopuncture|1
1755253|NCT00834444|6116825|P1|First Intervention|Intolerance to Venopuncture|0
1755254|NCT00834444|6116824|P2|First Intervention|Adverse Event|0
1755255|NCT00834444|6116825|P1|First Intervention|Adverse Event|1
1755256|NCT00834431|6116835|P2|Washout of 7 Days|Withdrawal by Subject|1
1755257|NCT00834431|6116836|P1|Washout of 7 Days|Withdrawal by Subject|0
1755258|NCT00834431|6116835|P2|First Intervention|Adverse Event|1
1755259|NCT00834431|6116836|P1|First Intervention|Adverse Event|0
1755260|NCT00834418|6116846|P2|Overall Study|Adverse Event|2
1755261|NCT00834418|6116847|P1|Overall Study|Adverse Event|0
1755262|NCT00834366|6116864|P2|Treatment Period 1|Adverse Event|1
1755263|NCT00834366|6116865|P1|Treatment Period 1|Adverse Event|1
1755264|NCT00834340|6116881|P2|Washout|Withdrawal by Subject|0
1755265|NCT00834340|6116882|P1|Washout|Withdrawal by Subject|1
1755266|NCT00834340|6116881|P2|Washout|Adverse Event|0
1755267|NCT00834340|6116882|P1|Washout|Adverse Event|1
1755268|NCT00834249|6116926|P2|Second Intervention|Adverse Event|0
1755269|NCT00834249|6116927|P1|Second Intervention|Adverse Event|1
1755270|NCT00834249|6116926|P2|Washout: 7 Days|Withdrawal by Subject|1
1755271|NCT00834249|6116927|P1|Washout: 7 Days|Withdrawal by Subject|1
1755272|NCT00834080|6117023|P1|Overall Study|Subject Relocated|1
1755273|NCT00834080|6117023|P1|Overall Study|Physician Decision|1
1755274|NCT00834080|6117023|P1|Overall Study|Other - False positive tests of the UDS|1
1755275|NCT00834080|6117023|P1|Overall Study|Other - Pregnancy|1
1755276|NCT00834080|6117023|P1|Overall Study|Withdrawal by Subject|5
1755277|NCT00834080|6117023|P1|Overall Study|Lost to Follow-up|7
1755278|NCT00834080|6117023|P1|Overall Study|Adverse Event|7
1755279|NCT00834067|6117029|P2|Washout of 21 Days|Protocol Violation|1
1755280|NCT00834067|6117030|P1|Washout of 21 Days|Protocol Violation|0
1755281|NCT00834041|6117052|P2|Overall Study|Lost to Follow-up|1
1755282|NCT00834041|6117053|P1|Overall Study|Lost to Follow-up|0
1755283|NCT00834041|6117052|P2|Overall Study|Withdrawal by Subject|0
1755284|NCT00834041|6117053|P1|Overall Study|Withdrawal by Subject|1
1755285|NCT00833989|6117071|P4|Overall Study|Withdrawal by Subject|1
1755286|NCT00833989|6117072|P3|Overall Study|Withdrawal by Subject|1
1755287|NCT00833989|6117073|P2|Overall Study|Withdrawal by Subject|0
1755288|NCT00833989|6117074|P1|Overall Study|Withdrawal by Subject|3
1755289|NCT00833989|6117071|P4|Overall Study|Physician Decision|1
1755290|NCT00833989|6117072|P3|Overall Study|Physician Decision|0
1755291|NCT00833989|6117073|P2|Overall Study|Physician Decision|0
1755292|NCT00833989|6117074|P1|Overall Study|Physician Decision|0
1755293|NCT00833976|6117178|P1|Overall Study|Physician Decision|1
1755294|NCT00833976|6117178|P1|Overall Study|Did not meet eligibility criteria|41
1755295|NCT00833976|6117178|P1|Overall Study|Lost to Follow-up|4
1755296|NCT00833976|6117178|P1|Overall Study|Withdrawal by Subject|5
1755297|NCT00833937|6117186|P2|Washout|Withdrawal by Subject|0
1755298|NCT00833937|6117187|P1|Washout|Withdrawal by Subject|1
1755299|NCT00833924|6117195|P1|Overall Study|In study follow-up|71
1755300|NCT00833924|6117195|P1|Overall Study|Withdrawal by Subject|13
1755301|NCT00833924|6117195|P1|Overall Study|Lost to Follow-up|2
1755302|NCT00833924|6117195|P1|Overall Study|Conversion|2
1755303|NCT00833924|6117195|P1|Overall Study|Death|21
1755304|NCT00833911|6117200|P1|Maintenance Phase II|Lack of Efficacy|1
1755305|NCT00833911|6117200|P1|Maintenance Phase II|Withdrawal by Subject|1
1755306|NCT00833911|6117200|P1|Maintenance Phase II|Physician Decision|2
1755307|NCT00833911|6117200|P1|Maintenance Phase II|Adverse Event|6
1755308|NCT00833911|6117200|P1|Maintenance Phase I|Lack of Efficacy|4
1755309|NCT00833911|6117200|P1|Maintenance Phase I|Physician Decision|10
1755310|NCT00833911|6117200|P1|Maintenance Phase I|Withdrawal by Subject|11
1755311|NCT00833911|6117200|P1|Maintenance Phase I|Adverse Event|73
1755312|NCT00833911|6117200|P1|Titration|Withdrawal by Subject|3
1755313|NCT00833911|6117200|P1|Titration|Adverse Event|18
1755314|NCT00833898|6117210|P2|Overall Study|Patient did not receive transplant|2
1755315|NCT00833898|6117211|P1|Overall Study|Patient did not receive transplant|0
1755316|NCT00833898|6117210|P2|Overall Study|Lost to Follow-up|7
1755317|NCT00833898|6117211|P1|Overall Study|Lost to Follow-up|7
1755318|NCT00833898|6117210|P2|Overall Study|Withdrawal by Subject|27
1755319|NCT00833898|6117211|P1|Overall Study|Withdrawal by Subject|33
1755320|NCT00833833|6117270|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
1755321|NCT00833833|6117271|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1755322|NCT00833833|6117272|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1755323|NCT00833833|6117273|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1755324|NCT00833833|6117274|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1755325|NCT00833833|6117275|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
1755326|NCT00833833|6117270|P6|Phase 2 (as of 01 April 2011)|Other|3
1755327|NCT00833833|6117271|P5|Phase 2 (as of 01 April 2011)|Other|4
1755328|NCT00833833|6117272|P4|Phase 2 (as of 01 April 2011)|Other|0
1755329|NCT00833833|6117273|P3|Phase 2 (as of 01 April 2011)|Other|0
1755330|NCT00833833|6117274|P2|Phase 2 (as of 01 April 2011)|Other|0
1755331|NCT00833833|6117275|P1|Phase 2 (as of 01 April 2011)|Other|0
1755332|NCT00833833|6117270|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
1755333|NCT00833833|6117271|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
1755334|NCT00833833|6117272|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1755335|NCT00833833|6117273|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1755336|NCT00833833|6117274|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1755337|NCT00833833|6117275|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
1755338|NCT00833833|6117270|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
1755339|NCT00833833|6117271|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
1755340|NCT00833833|6117272|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755341|NCT00833833|6117273|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755342|NCT00833833|6117274|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755343|NCT00833833|6117275|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755344|NCT00833833|6117270|P6|Phase 2 (as of 01 April 2011)|Death|9
1755345|NCT00833833|6117271|P5|Phase 2 (as of 01 April 2011)|Death|8
1755346|NCT00833833|6117272|P4|Phase 2 (as of 01 April 2011)|Death|0
1755347|NCT00833833|6117273|P3|Phase 2 (as of 01 April 2011)|Death|0
1755348|NCT00833833|6117274|P2|Phase 2 (as of 01 April 2011)|Death|0
1755349|NCT00833833|6117275|P1|Phase 2 (as of 01 April 2011)|Death|0
1755350|NCT00833833|6117270|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
1755351|NCT00833833|6117271|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
1755352|NCT00833833|6117272|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
1755353|NCT00833833|6117273|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
1755354|NCT00833833|6117274|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
1755355|NCT00833833|6117275|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
1755356|NCT00833833|6117270|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
1755357|NCT00833833|6117271|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
1755358|NCT00833833|6117272|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
1755359|NCT00833833|6117273|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
1755360|NCT00833833|6117274|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
1755361|NCT00833833|6117275|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
1755362|NCT00833833|6117270|P6|Phase 1 (as of 01 April 2011)|Other|0
1755363|NCT00833833|6117271|P5|Phase 1 (as of 01 April 2011)|Other|0
1755364|NCT00833833|6117272|P4|Phase 1 (as of 01 April 2011)|Other|1
1755365|NCT00833833|6117273|P3|Phase 1 (as of 01 April 2011)|Other|0
1755366|NCT00833833|6117274|P2|Phase 1 (as of 01 April 2011)|Other|3
1755367|NCT00833833|6117275|P1|Phase 1 (as of 01 April 2011)|Other|1
1755368|NCT00833833|6117270|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755369|NCT00833833|6117271|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755370|NCT00833833|6117272|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755371|NCT00833833|6117273|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
1755372|NCT00833833|6117274|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
1755373|NCT00833833|6117275|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
1755374|NCT00833833|6117270|P6|Phase 1 (as of 01 April 2011)|Death|0
1755375|NCT00833833|6117271|P5|Phase 1 (as of 01 April 2011)|Death|0
1755376|NCT00833833|6117272|P4|Phase 1 (as of 01 April 2011)|Death|0
1755377|NCT00833833|6117273|P3|Phase 1 (as of 01 April 2011)|Death|2
1755378|NCT00833833|6117274|P2|Phase 1 (as of 01 April 2011)|Death|1
1755379|NCT00833833|6117275|P1|Phase 1 (as of 01 April 2011)|Death|0
1755380|NCT00833833|6117270|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
1755381|NCT00833833|6117271|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
1755382|NCT00833833|6117272|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
1755383|NCT00833833|6117273|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
1755384|NCT00833833|6117274|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
1755385|NCT00833833|6117275|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
1755386|NCT00833833|6117270|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
1755387|NCT00833833|6117271|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
1755388|NCT00833833|6117272|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
1755389|NCT00833833|6117273|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
1755390|NCT00833833|6117274|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
1755391|NCT00833833|6117275|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
1755392|NCT00833833|6117270|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
1755393|NCT00833833|6117271|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
1755394|NCT00833833|6117272|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
1755395|NCT00833833|6117273|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
1755396|NCT00833833|6117274|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
1755397|NCT00833833|6117275|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
1755398|NCT00833794|6117315|P2|Double-blind Phase|Administrative reason|3
1755399|NCT00833794|6117316|P1|Double-blind Phase|Administrative reason|1
1755400|NCT00833794|6117315|P2|Double-blind Phase|Physician Decision|7
1755401|NCT00833794|6117316|P1|Double-blind Phase|Physician Decision|4
1755402|NCT00833794|6117315|P2|Double-blind Phase|Withdrawal by Subject|6
1755403|NCT00833794|6117316|P1|Double-blind Phase|Withdrawal by Subject|23
1755404|NCT00833794|6117315|P2|Double-blind Phase|Lack of Efficacy|22
1755405|NCT00833794|6117316|P1|Double-blind Phase|Lack of Efficacy|34
1755406|NCT00833794|6117315|P2|Double-blind Phase|Adverse Event|11
1755407|NCT00833794|6117316|P1|Double-blind Phase|Adverse Event|44
1755408|NCT00833794|6117315|P2|Open-label Phase|enrolled in error (immediately D/C)|0
1755409|NCT00833794|6117316|P1|Open-label Phase|enrolled in error (immediately D/C)|1
1755410|NCT00833794|6117315|P2|Open-label Phase|Did not complete wash-out period|0
1755411|NCT00833794|6117316|P1|Open-label Phase|Did not complete wash-out period|12
1755412|NCT00833794|6117315|P2|Open-label Phase|Protocol Violation|0
1755413|NCT00833794|6117316|P1|Open-label Phase|Protocol Violation|47
1755414|NCT00833794|6117315|P2|Open-label Phase|Administrative reason|0
1755415|NCT00833794|6117316|P1|Open-label Phase|Administrative reason|1
1755416|NCT00833794|6117315|P2|Open-label Phase|Physician Decision|0
1755417|NCT00833794|6117316|P1|Open-label Phase|Physician Decision|20
1755418|NCT00833794|6117315|P2|Open-label Phase|Withdrawal by Subject|0
1755419|NCT00833794|6117316|P1|Open-label Phase|Withdrawal by Subject|48
1755420|NCT00833794|6117315|P2|Open-label Phase|Lack of Efficacy|0
1755421|NCT00833794|6117316|P1|Open-label Phase|Lack of Efficacy|28
1755422|NCT00833794|6117315|P2|Open-label Phase|Adverse Event|0
1755423|NCT00833794|6117316|P1|Open-label Phase|Adverse Event|225
1755424|NCT00833755|6117360|P4|Overall Study|Subject had scheduling issues|0
1755425|NCT00833755|6117361|P3|Overall Study|Subject had scheduling issues|0
1755426|NCT00833755|6117362|P2|Overall Study|Subject had scheduling issues|1
1755427|NCT00833755|6117363|P1|Overall Study|Subject had scheduling issues|0
1755428|NCT00833755|6117360|P4|Overall Study|Physician Decision|6
1755429|NCT00833755|6117361|P3|Overall Study|Physician Decision|2
1755430|NCT00833755|6117362|P2|Overall Study|Physician Decision|4
1755431|NCT00833755|6117363|P1|Overall Study|Physician Decision|4
1755432|NCT00833703|6117383|P2|Overall Study|Parent(s)/guardian(s)'s request|1
1755433|NCT00833703|6117384|P1|Overall Study|Parent(s)/guardian(s)'s request|0
1755434|NCT00833690|6117397|P3|Overall Study|Discontinued study drug|0
1755435|NCT00833690|6117398|P2|Overall Study|Discontinued study drug|2
1755436|NCT00833690|6117399|P1|Overall Study|Discontinued study drug|3
1755437|NCT00833690|6117397|P3|Overall Study|Withdrawal by Subject|0
1755438|NCT00833690|6117398|P2|Overall Study|Withdrawal by Subject|0
1755439|NCT00833690|6117399|P1|Overall Study|Withdrawal by Subject|1
1755440|NCT00833638|6117535|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
1755441|NCT00833638|6117536|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
1755442|NCT00833638|6117537|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
1755443|NCT00833638|6117535|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
1755444|NCT00833638|6117536|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
1755445|NCT00833638|6117537|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
1755446|NCT00833638|6117535|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
1755447|NCT00833638|6117536|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
1755448|NCT00833638|6117537|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
1755449|NCT00833638|6117535|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
1755450|NCT00833638|6117536|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
1755451|NCT00833638|6117537|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
1755452|NCT00833638|6117535|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1755453|NCT00833638|6117536|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1755454|NCT00833638|6117537|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
1755455|NCT00833638|6117535|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
1755456|NCT00833638|6117536|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
1755457|NCT00833638|6117537|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
1755458|NCT00833638|6117535|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
1755459|NCT00833638|6117536|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
1755460|NCT00833638|6117537|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
1755461|NCT00833638|6117535|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
1755462|NCT00833638|6117536|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
1755463|NCT00833638|6117537|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
1755464|NCT00833638|6117535|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
1755465|NCT00833638|6117536|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
1755466|NCT00833638|6117537|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
1755467|NCT00833560|6117588|P1|Overall Study|Other|5
1755468|NCT00833560|6117588|P1|Overall Study|Pregression of other disease|1
1755469|NCT00833560|6117588|P1|Overall Study|Death|2
1755470|NCT00833560|6117588|P1|Overall Study|Lack of Efficacy|4
1755471|NCT00833560|6117588|P1|Overall Study|Protocol Violation|6
1755472|NCT00833560|6117588|P1|Overall Study|Adverse Event|11
1755473|NCT00833560|6117588|P1|Overall Study|Toxicity|13
1755474|NCT00833547|6117597|P2|Overall Study|Withdrawal by Subject|2
1755475|NCT00833547|6117598|P1|Overall Study|Withdrawal by Subject|2
1755476|NCT00833482|6117619|P6|Days 21-30|Withdrawal by Subject|0
1755477|NCT00833482|6117620|P5|Days 21-30|Withdrawal by Subject|1
1755478|NCT00833482|6117621|P4|Days 21-30|Withdrawal by Subject|0
1755479|NCT00833482|6117622|P3|Days 21-30|Withdrawal by Subject|0
1755480|NCT00833482|6117623|P2|Days 21-30|Withdrawal by Subject|0
1755481|NCT00833482|6117624|P1|Days 21-30|Withdrawal by Subject|0
1755482|NCT00833482|6117619|P6|Days 21-30|Adverse Event|0
1755483|NCT00833482|6117620|P5|Days 21-30|Adverse Event|0
1755484|NCT00833482|6117621|P4|Days 21-30|Adverse Event|0
1755485|NCT00833482|6117622|P3|Days 21-30|Adverse Event|1
1755486|NCT00833482|6117623|P2|Days 21-30|Adverse Event|0
1755487|NCT00833482|6117624|P1|Days 21-30|Adverse Event|0
1755488|NCT00833482|6117619|P6|Days 11-20|Withdrawal by Subject|0
1755489|NCT00833482|6117620|P5|Days 11-20|Withdrawal by Subject|0
1755490|NCT00833482|6117621|P4|Days 11-20|Withdrawal by Subject|0
1755491|NCT00833482|6117622|P3|Days 11-20|Withdrawal by Subject|0
1755492|NCT00833482|6117623|P2|Days 11-20|Withdrawal by Subject|1
1755493|NCT00833482|6117624|P1|Days 11-20|Withdrawal by Subject|0
1755494|NCT00833482|6117619|P6|Days 11-20|Adverse Event|0
1755495|NCT00833482|6117620|P5|Days 11-20|Adverse Event|0
1755496|NCT00833482|6117621|P4|Days 11-20|Adverse Event|0
1755497|NCT00833482|6117622|P3|Days 11-20|Adverse Event|0
1755498|NCT00833482|6117623|P2|Days 11-20|Adverse Event|2
1755499|NCT00833482|6117624|P1|Days 11-20|Adverse Event|0
1755500|NCT00833469|6117680|P1|Overall Study|Lost to Follow-up|1
1755501|NCT00833469|6117680|P1|Overall Study|Withdrawal by Subject|1
1755502|NCT00833417|6117703|P2|Overall Study|Reason Not Specified|1
1755503|NCT00833417|6117704|P1|Overall Study|Reason Not Specified|0
1755504|NCT00833417|6117703|P2|Overall Study|Disease Progression|17
1755505|NCT00833417|6117704|P1|Overall Study|Disease Progression|18
1755506|NCT00833417|6117703|P2|Overall Study|Sponsor Decision to Terminate Study|2
1755507|NCT00833417|6117704|P1|Overall Study|Sponsor Decision to Terminate Study|1
1755508|NCT00833417|6117703|P2|Overall Study|Patient Decision to Withdraw|23
1755509|NCT00833417|6117704|P1|Overall Study|Patient Decision to Withdraw|4
1755510|NCT00833417|6117703|P2|Overall Study|Physician Decision to Withdraw Patient|7
1755511|NCT00833417|6117704|P1|Overall Study|Physician Decision to Withdraw Patient|3
1755512|NCT00833417|6117703|P2|Overall Study|Lost to Follow-up|2
1755513|NCT00833417|6117704|P1|Overall Study|Lost to Follow-up|1
1755514|NCT00833417|6117703|P2|Overall Study|Death|3
1755515|NCT00833417|6117704|P1|Overall Study|Death|1
1755516|NCT00833417|6117703|P2|Overall Study|Adverse Event|16
1755517|NCT00833417|6117704|P1|Overall Study|Adverse Event|5
1755518|NCT00833261|6117728|P1|Overall Study|Withdrawal by Subject|4
1755519|NCT00833248|6117735|P2|Overall Study|Withdrawal by Subject|1
1755520|NCT00833248|6117736|P1|Overall Study|Withdrawal by Subject|0
1755521|NCT00833248|6117735|P2|Overall Study|Protocol Violation|2
1755522|NCT00833248|6117736|P1|Overall Study|Protocol Violation|1
1755523|NCT00833248|6117735|P2|Overall Study|Adverse Event|0
1755524|NCT00833248|6117736|P1|Overall Study|Adverse Event|3
1755525|NCT00833105|6117758|P1|Overall Study|Adverse Event|2
1755526|NCT00833105|6117758|P1|Overall Study|Withdrawal by Subject|1
1755527|NCT00833092|6117776|P2|Overall Study|constipation|1
1755528|NCT00833092|6117777|P1|Overall Study|constipation|0
1755529|NCT00833092|6117776|P2|Overall Study|Diarrhea|2
1755530|NCT00833092|6117777|P1|Overall Study|Diarrhea|0
1755531|NCT00833092|6117776|P2|Overall Study|Protocol Violation|1
1755532|NCT00833092|6117777|P1|Overall Study|Protocol Violation|2
1755533|NCT00833092|6117776|P2|Overall Study|Withdrawal by Subject|3
1755534|NCT00833092|6117777|P1|Overall Study|Withdrawal by Subject|2
1755535|NCT00833053|6117785|P2|Overall Study|Protocol Violation|1
1755536|NCT00833053|6117786|P1|Overall Study|Protocol Violation|2
1755537|NCT00833053|6117785|P2|Overall Study|Withdrawal by Subject|1
1755538|NCT00833053|6117786|P1|Overall Study|Withdrawal by Subject|0
1755539|NCT00833053|6117785|P2|Overall Study|Treatment Failure|1
1755540|NCT00833053|6117786|P1|Overall Study|Treatment Failure|3
1755541|NCT00833053|6117785|P2|Overall Study|Adverse Event|0
1755542|NCT00833053|6117786|P1|Overall Study|Adverse Event|4
1755543|NCT00833040|6117804|P6|Overall Study|Adverse Event|1
1755544|NCT00833040|6117805|P5|Overall Study|Adverse Event|0
1755545|NCT00833040|6117806|P4|Overall Study|Adverse Event|0
1755546|NCT00833040|6117807|P3|Overall Study|Adverse Event|0
1755547|NCT00833040|6117808|P2|Overall Study|Adverse Event|0
1755548|NCT00833040|6117809|P1|Overall Study|Adverse Event|0
1755549|NCT00833027|6117814|P1|Overall Study|Missing|10
1755550|NCT00833027|6117814|P1|Overall Study|Withdrawal by Subject|16
1755551|NCT00833027|6117814|P1|Overall Study|Protocol Violation|115
1755552|NCT00833027|6117814|P1|Overall Study|Lost to Follow-up|24
1755553|NCT00833027|6117814|P1|Overall Study|Lack of Efficacy|12
1755554|NCT00833027|6117814|P1|Overall Study|Death|1
1755555|NCT00833027|6117814|P1|Overall Study|Adverse Event|33
1755556|NCT00832975|6117819|P1|Overall Study|Other reasons|14
1755557|NCT00832975|6117819|P1|Overall Study|Withdrawal by Subject|3
1755558|NCT00832975|6117819|P1|Overall Study|Physician Decision|4
1755559|NCT00832975|6117819|P1|Overall Study|Death|5
1755560|NCT00832975|6117819|P1|Overall Study|Protocol Violation|6
1755561|NCT00832975|6117819|P1|Overall Study|Lost to Follow-up|7
1755562|NCT00832819|6117833|P3|Overall Study|Protocol Violation|1
1755563|NCT00832819|6117834|P2|Overall Study|Protocol Violation|0
1755564|NCT00832819|6117835|P1|Overall Study|Protocol Violation|0
1755565|NCT00832819|6117833|P3|Overall Study|Adverse Event|0
1755566|NCT00832819|6117834|P2|Overall Study|Adverse Event|1
1755567|NCT00832819|6117835|P1|Overall Study|Adverse Event|0
1755568|NCT00832780|6117841|P1|Overall Study|Physician Decision|1
1755569|NCT00832780|6117841|P1|Overall Study|other complicating condition|2
1755570|NCT00832780|6117841|P1|Overall Study|no reason given|2
1755571|NCT00832780|6117841|P1|Overall Study|Lost to Follow-up|4
1755572|NCT00832780|6117841|P1|Overall Study|Death|16
1755573|NCT00832650|6117883|P3|Overall Study|Randomized but not treated|1
1755574|NCT00832650|6117884|P2|Overall Study|Randomized but not treated|0
1755575|NCT00832650|6117885|P1|Overall Study|Randomized but not treated|0
1755576|NCT00832624|6117925|P1|Overall Study|Study Terminated|10
1755577|NCT00832585|6117935|P1|Overall Study|Lost to Follow-up|1
1755578|NCT00832585|6117935|P1|Overall Study|Withdrawal by Subject|1
1755579|NCT00832455|6117960|P1|Overall Study|Patient moved|1
1755580|NCT00832455|6117960|P1|Overall Study|No improvement|3
1755581|NCT00832455|6117960|P1|Overall Study|Parent dissatisfied|1
1755582|NCT00832455|6117960|P1|Overall Study|Parent misunderstood study|1
1755583|NCT00832455|6117960|P1|Overall Study|Stopped Medication|4
1755584|NCT00832455|6117960|P1|Overall Study|Screening Failure|2
1755585|NCT00832455|6117960|P1|Overall Study|Withdrawal by Subject|17
1755586|NCT00832455|6117960|P1|Overall Study|Protocol Violation|4
1755587|NCT00832455|6117960|P1|Overall Study|Lost to Follow-up|26
1755588|NCT00832455|6117960|P1|Overall Study|Adverse Event|13
1755589|NCT00832416|6117984|P4|Overall Study|Death|0
1755590|NCT00832416|6117985|P3|Overall Study|Death|0
1755591|NCT00832416|6117986|P2|Overall Study|Death|0
1755592|NCT00832416|6117987|P1|Overall Study|Death|1
1755593|NCT00832416|6117984|P4|Overall Study|Adverse Event|10
1755594|NCT00832416|6117985|P3|Overall Study|Adverse Event|41
1755595|NCT00832416|6117986|P2|Overall Study|Adverse Event|19
1755596|NCT00832416|6117987|P1|Overall Study|Adverse Event|21
1755597|NCT00832416|6117984|P4|Overall Study|Administrative|1
1755598|NCT00832416|6117985|P3|Overall Study|Administrative|0
1755599|NCT00832416|6117986|P2|Overall Study|Administrative|0
1755600|NCT00832416|6117987|P1|Overall Study|Administrative|0
1755601|NCT00832416|6117984|P4|Overall Study|Physician Decision|10
1755602|NCT00832416|6117985|P3|Overall Study|Physician Decision|5
1755603|NCT00832416|6117986|P2|Overall Study|Physician Decision|12
1755604|NCT00832416|6117987|P1|Overall Study|Physician Decision|2
1755605|NCT00832416|6117984|P4|Overall Study|Withdrawal by Subject|10
1755606|NCT00832416|6117985|P3|Overall Study|Withdrawal by Subject|2
1755607|NCT00832416|6117986|P2|Overall Study|Withdrawal by Subject|7
1755608|NCT00832416|6117987|P1|Overall Study|Withdrawal by Subject|5
1755609|NCT00832416|6117984|P4|Overall Study|Lack of Efficacy|52
1755610|NCT00832416|6117985|P3|Overall Study|Lack of Efficacy|13
1755611|NCT00832416|6117986|P2|Overall Study|Lack of Efficacy|15
1755612|NCT00832416|6117987|P1|Overall Study|Lack of Efficacy|17
1755613|NCT00832377|6118038|P1|Overall Study|Protocol Violation|1
1755614|NCT00832117|6118084|P1|Overall Study|Disease Progression|11
1755615|NCT00832117|6118084|P1|Overall Study|Death|1
1755616|NCT00832091|6118103|P2|Overall Study|Prohibited Medication|0
1755617|NCT00832091|6118104|P1|Overall Study|Prohibited Medication|1
1755618|NCT00832091|6118103|P2|Overall Study|Withdrawal by Subject|1
1755619|NCT00832091|6118104|P1|Overall Study|Withdrawal by Subject|2
1755620|NCT00832091|6118103|P2|Overall Study|Protocol Violation|0
1755621|NCT00832091|6118104|P1|Overall Study|Protocol Violation|1
1755622|NCT00832091|6118103|P2|Overall Study|Adverse Event|1
1755623|NCT00832091|6118104|P1|Overall Study|Adverse Event|1
1755624|NCT00832078|6118112|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
1755625|NCT00832078|6118113|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
1755626|NCT00832078|6118112|P2|Test Day 1-2 Period|Lack of Efficacy|2
1755627|NCT00832078|6118113|P1|Test Day 1-2 Period|Lack of Efficacy|0
1755628|NCT00832000|6118119|P2|Overall Study|No calls to IVR in period 2|0
1755629|NCT00832000|6118120|P1|Overall Study|No calls to IVR in period 2|2
1755630|NCT00832000|6118119|P2|Overall Study|No calls to IVR in either period|1
1755631|NCT00832000|6118120|P1|Overall Study|No calls to IVR in either period|1
1755632|NCT00832000|6118119|P2|Overall Study|Withdrawal by Subject|0
1755633|NCT00832000|6118120|P1|Overall Study|Withdrawal by Subject|1
1755634|NCT00832000|6118119|P2|Overall Study|Adverse Event|0
1755635|NCT00832000|6118120|P1|Overall Study|Adverse Event|2
1755636|NCT00831844|6118181|P10|Overall Study|Ineligible|0
1755637|NCT00831844|6118182|P9|Overall Study|Ineligible|0
1755638|NCT00831844|6118183|P8|Overall Study|Ineligible|0
1755639|NCT00831844|6118184|P7|Overall Study|Ineligible|0
1755640|NCT00831844|6118185|P6|Overall Study|Ineligible|0
1755641|NCT00831844|6118186|P5|Overall Study|Ineligible|1
1755642|NCT00831844|6118187|P4|Overall Study|Ineligible|0
1755643|NCT00831844|6118188|P3|Overall Study|Ineligible|1
1755644|NCT00831844|6118189|P2|Overall Study|Ineligible|1
1755645|NCT00831844|6118190|P1|Overall Study|Ineligible|0
1755646|NCT00831844|6118181|P10|Overall Study|Withdrawal by Subject|0
1755647|NCT00831844|6118182|P9|Overall Study|Withdrawal by Subject|1
1755648|NCT00831844|6118183|P8|Overall Study|Withdrawal by Subject|1
1755649|NCT00831844|6118184|P7|Overall Study|Withdrawal by Subject|0
1755650|NCT00831844|6118185|P6|Overall Study|Withdrawal by Subject|0
1755651|NCT00831844|6118186|P5|Overall Study|Withdrawal by Subject|0
1755652|NCT00831844|6118187|P4|Overall Study|Withdrawal by Subject|0
1755653|NCT00831844|6118188|P3|Overall Study|Withdrawal by Subject|1
1755654|NCT00831844|6118189|P2|Overall Study|Withdrawal by Subject|0
1755655|NCT00831844|6118190|P1|Overall Study|Withdrawal by Subject|0
1755656|NCT00831844|6118181|P10|Overall Study|Physician Decision|0
1755657|NCT00831844|6118182|P9|Overall Study|Physician Decision|1
1755658|NCT00831844|6118183|P8|Overall Study|Physician Decision|0
1755659|NCT00831844|6118184|P7|Overall Study|Physician Decision|0
1755660|NCT00831844|6118185|P6|Overall Study|Physician Decision|1
1755661|NCT00831844|6118186|P5|Overall Study|Physician Decision|1
1755662|NCT00831844|6118187|P4|Overall Study|Physician Decision|1
1755663|NCT00831844|6118188|P3|Overall Study|Physician Decision|3
1755664|NCT00831844|6118189|P2|Overall Study|Physician Decision|1
1755665|NCT00831844|6118190|P1|Overall Study|Physician Decision|0
1755666|NCT00831844|6118181|P10|Overall Study|Lack of Efficacy|0
1755667|NCT00831844|6118182|P9|Overall Study|Lack of Efficacy|7
1755668|NCT00831844|6118183|P8|Overall Study|Lack of Efficacy|9
1755669|NCT00831844|6118184|P7|Overall Study|Lack of Efficacy|8
1755670|NCT00831844|6118185|P6|Overall Study|Lack of Efficacy|17
1755671|NCT00831844|6118186|P5|Overall Study|Lack of Efficacy|11
1755672|NCT00831844|6118187|P4|Overall Study|Lack of Efficacy|8
1755673|NCT00831844|6118188|P3|Overall Study|Lack of Efficacy|15
1755674|NCT00831844|6118189|P2|Overall Study|Lack of Efficacy|10
1755675|NCT00831844|6118190|P1|Overall Study|Lack of Efficacy|8
1755676|NCT00831844|6118181|P10|Overall Study|Death|0
1755677|NCT00831844|6118182|P9|Overall Study|Death|0
1755678|NCT00831844|6118183|P8|Overall Study|Death|0
1755679|NCT00831844|6118184|P7|Overall Study|Death|0
1755680|NCT00831844|6118185|P6|Overall Study|Death|0
1755681|NCT00831844|6118186|P5|Overall Study|Death|0
1755682|NCT00831844|6118187|P4|Overall Study|Death|1
1755683|NCT00831844|6118188|P3|Overall Study|Death|0
1755684|NCT00831844|6118189|P2|Overall Study|Death|0
1755685|NCT00831844|6118190|P1|Overall Study|Death|0
1755686|NCT00831844|6118181|P10|Overall Study|Adverse Event|0
1755687|NCT00831844|6118182|P9|Overall Study|Adverse Event|0
1755688|NCT00831844|6118183|P8|Overall Study|Adverse Event|0
1755689|NCT00831844|6118184|P7|Overall Study|Adverse Event|2
1755690|NCT00831844|6118185|P6|Overall Study|Adverse Event|1
1755691|NCT00831844|6118186|P5|Overall Study|Adverse Event|1
1755692|NCT00831844|6118187|P4|Overall Study|Adverse Event|0
1755693|NCT00831844|6118188|P3|Overall Study|Adverse Event|0
1755694|NCT00831844|6118189|P2|Overall Study|Adverse Event|0
1755695|NCT00831844|6118190|P1|Overall Study|Adverse Event|2
1755696|NCT00831792|6118212|P1|Overall Study|Lack of Efficacy|1
1755697|NCT00831792|6118212|P1|Overall Study|Death|1
1755698|NCT00831792|6118212|P1|Overall Study|Adverse Event|1
1755699|NCT00831792|6118212|P1|Overall Study|Not Eligible|3
1755700|NCT00831779|6118218|P2|Overall Study|No longer met criteria|1
1755701|NCT00831779|6118219|P1|Overall Study|No longer met criteria|0
1755702|NCT00831779|6118218|P2|Overall Study|Lost to Follow-up|0
1755703|NCT00831779|6118219|P1|Overall Study|Lost to Follow-up|1
1755704|NCT00831701|6118256|P2|Overall Study|Lost to Follow-up|3
1755705|NCT00831701|6118257|P1|Overall Study|Lost to Follow-up|1
1755706|NCT00831701|6118256|P2|Overall Study|Stone expulsion before first medication|2
1755707|NCT00831701|6118257|P1|Overall Study|Stone expulsion before first medication|2
1755708|NCT00831701|6118256|P2|Overall Study|Withdrawal by Subject|0
1755709|NCT00831701|6118257|P1|Overall Study|Withdrawal by Subject|2
1755710|NCT00831493|6118286|P1|Overall Study|Intractable nausea and vomiting|1
1755711|NCT00831441|6118296|P2|Follow Up (30 Days)|missing end of study status|1
1755712|NCT00831441|6118297|P1|Follow Up (30 Days)|missing end of study status|0
1755713|NCT00831441|6118296|P2|Follow Up (30 Days)|non-specified|26
1755714|NCT00831441|6118297|P1|Follow Up (30 Days)|non-specified|16
1755715|NCT00831441|6118296|P2|Follow Up (30 Days)|Death|86
1755716|NCT00831441|6118297|P1|Follow Up (30 Days)|Death|63
1755717|NCT00831441|6118296|P2|Follow Up (30 Days)|Lost to Follow-up|27
1755718|NCT00831441|6118297|P1|Follow Up (30 Days)|Lost to Follow-up|13
1755719|NCT00831441|6118296|P2|Follow Up (30 Days)|Withdrawal by Subject|34
1755720|NCT00831441|6118297|P1|Follow Up (30 Days)|Withdrawal by Subject|41
1755721|NCT00831441|6118296|P2|Randomized|non-specified|266
1755722|NCT00831441|6118297|P1|Randomized|non-specified|276
1755723|NCT00831441|6118296|P2|Randomized|poor/non-compliance|38
1755724|NCT00831441|6118297|P1|Randomized|poor/non-compliance|30
1755725|NCT00831441|6118296|P2|Randomized|Administrative reason by sponsor|2671
1755726|NCT00831441|6118297|P1|Randomized|Administrative reason by sponsor|2780
1755727|NCT00831441|6118296|P2|Randomized|Lost to Follow-up|35
1755728|NCT00831441|6118297|P1|Randomized|Lost to Follow-up|26
1755729|NCT00831441|6118296|P2|Randomized|Withdrawal by Subject|212
1755730|NCT00831441|6118297|P1|Randomized|Withdrawal by Subject|178
1755731|NCT00831441|6118296|P2|Randomized|No longer met criteria|19
1755732|NCT00831441|6118297|P1|Randomized|No longer met criteria|13
1755733|NCT00831441|6118296|P2|Randomized|Physician Decision|35
1755734|NCT00831441|6118297|P1|Randomized|Physician Decision|26
1755735|NCT00831441|6118296|P2|Randomized|Elective procedure|25
1755736|NCT00831441|6118297|P1|Randomized|Elective procedure|26
1755737|NCT00831441|6118296|P2|Randomized|Emergency procedure|2
1755738|NCT00831441|6118297|P1|Randomized|Emergency procedure|2
1755739|NCT00831441|6118296|P2|Randomized|Adverse Event|321
1755740|NCT00831441|6118297|P1|Randomized|Adverse Event|248
1755741|NCT00831441|6118296|P2|Randomized|Death|81
1755742|NCT00831441|6118297|P1|Randomized|Death|82
1755743|NCT00831415|6118329|P1|Overall Study|Death|1
1755744|NCT00831415|6118329|P1|Overall Study|Unsatisfactory response - Efficacy|4
1755745|NCT00831415|6118329|P1|Overall Study|Withdrawal by Subject|35
1755746|NCT00831415|6118329|P1|Overall Study|Protocol Violation|3
1755747|NCT00831415|6118329|P1|Overall Study|Lost to Follow-up|9
1755748|NCT00831415|6118329|P1|Overall Study|Physician Decision|6
1755749|NCT00831415|6118329|P1|Overall Study|Failed to return|3
1755750|NCT00831415|6118329|P1|Overall Study|Adverse Event|14
1755751|NCT00831389|6118338|P2|Overall Study|Withdrawal by Subject|1
1755752|NCT00831389|6118339|P1|Overall Study|Withdrawal by Subject|0
1755753|NCT00831311|6118365|P2|Overall Study|Withdrawal by Subject|4
1755754|NCT00831311|6118366|P1|Overall Study|Withdrawal by Subject|6
1755755|NCT00831311|6118365|P2|Overall Study|Physician Decision|1
1755756|NCT00831311|6118366|P1|Overall Study|Physician Decision|0
1755757|NCT00831311|6118365|P2|Overall Study|Lost to Follow-up|0
1755758|NCT00831311|6118366|P1|Overall Study|Lost to Follow-up|3
1755759|NCT00831311|6118365|P2|Overall Study|Definitive Contraindication|3
1755760|NCT00831311|6118366|P1|Overall Study|Definitive Contraindication|3
1755761|NCT00831233|6118403|P2|Overall Study|Selection Criteria Not Met|0
1755762|NCT00831233|6118404|P1|Overall Study|Selection Criteria Not Met|2
1755763|NCT00831233|6118403|P2|Overall Study|Protocol Violation|0
1755764|NCT00831233|6118404|P1|Overall Study|Protocol Violation|1
1755765|NCT00831233|6118403|P2|Overall Study|Adverse Event|1
1755766|NCT00831233|6118404|P1|Overall Study|Adverse Event|0
1755767|NCT00831181|6118428|P1|Overall Study|Adverse Event|12
1755768|NCT00831129|6118441|P2|Overall Study|9 lost to follow-up reasons uknown|9
1755769|NCT00831129|6118442|P1|Overall Study|9 lost to follow-up reasons uknown|0
1755770|NCT00831129|6118441|P2|Overall Study|Adverse Event|1
1755771|NCT00831129|6118442|P1|Overall Study|Adverse Event|0
1755772|NCT00830960|6118484|P6|Overall Study|No study drug received|7
1755773|NCT00830960|6118485|P5|Overall Study|No study drug received|5
1755774|NCT00830960|6118486|P4|Overall Study|No study drug received|3
1755775|NCT00830960|6118487|P3|Overall Study|No study drug received|4
1755776|NCT00830960|6118488|P2|Overall Study|No study drug received|2
1755777|NCT00830960|6118489|P1|Overall Study|No study drug received|7
1755778|NCT00830960|6118484|P6|Overall Study|Sponsor Decision|7
1755779|NCT00830960|6118485|P5|Overall Study|Sponsor Decision|5
1755780|NCT00830960|6118486|P4|Overall Study|Sponsor Decision|4
1755781|NCT00830960|6118487|P3|Overall Study|Sponsor Decision|3
1755782|NCT00830960|6118488|P2|Overall Study|Sponsor Decision|2
1755783|NCT00830960|6118489|P1|Overall Study|Sponsor Decision|1
1755784|NCT00830960|6118484|P6|Overall Study|Withdrawal by Subject|21
1755785|NCT00830960|6118485|P5|Overall Study|Withdrawal by Subject|16
1755786|NCT00830960|6118486|P4|Overall Study|Withdrawal by Subject|23
1755787|NCT00830960|6118487|P3|Overall Study|Withdrawal by Subject|18
1755788|NCT00830960|6118488|P2|Overall Study|Withdrawal by Subject|19
1755789|NCT00830960|6118489|P1|Overall Study|Withdrawal by Subject|19
1755790|NCT00830960|6118484|P6|Overall Study|Lost to Follow-up|1
1755791|NCT00830960|6118485|P5|Overall Study|Lost to Follow-up|0
1755792|NCT00830960|6118486|P4|Overall Study|Lost to Follow-up|0
1755793|NCT00830960|6118487|P3|Overall Study|Lost to Follow-up|1
1755794|NCT00830960|6118488|P2|Overall Study|Lost to Follow-up|1
1755795|NCT00830960|6118489|P1|Overall Study|Lost to Follow-up|1
1755796|NCT00830960|6118484|P6|Overall Study|Death|1
1755797|NCT00830960|6118485|P5|Overall Study|Death|6
1755798|NCT00830960|6118486|P4|Overall Study|Death|2
1755799|NCT00830960|6118487|P3|Overall Study|Death|3
1755800|NCT00830960|6118488|P2|Overall Study|Death|4
1755801|NCT00830960|6118489|P1|Overall Study|Death|5
1755802|NCT00830947|6118605|P2|Overall Study|Lost to Follow-up|4
1755803|NCT00830947|6118606|P1|Overall Study|Lost to Follow-up|4
1755804|NCT00830869|6118624|P12|Period 2: Part 2|Other|0
1755805|NCT00830869|6118625|P11|Period 2: Part 2|Other|0
1755806|NCT00830869|6118626|P10|Period 2: Part 2|Other|1
1755807|NCT00830869|6118627|P9|Period 2: Part 2|Other|0
1755808|NCT00830869|6118628|P8|Period 2: Part 2|Other|0
1755809|NCT00830869|6118629|P7|Period 2: Part 2|Other|0
1755810|NCT00830869|6118630|P6|Period 2: Part 2|Other|0
1755811|NCT00830869|6118631|P5|Period 2: Part 2|Other|0
1755812|NCT00830869|6118632|P4|Period 2: Part 2|Other|0
1755813|NCT00830869|6118633|P3|Period 2: Part 2|Other|0
1755814|NCT00830869|6118634|P2|Period 2: Part 2|Other|0
1755815|NCT00830869|6118635|P1|Period 2: Part 2|Other|0
1755816|NCT00830869|6118624|P12|Period 2: Part 2|Progressive disease|15
1755817|NCT00830869|6118625|P11|Period 2: Part 2|Progressive disease|8
1755818|NCT00830869|6118626|P10|Period 2: Part 2|Progressive disease|12
1755819|NCT00830869|6118627|P9|Period 2: Part 2|Progressive disease|11
1755820|NCT00830869|6118628|P8|Period 2: Part 2|Progressive disease|14
1755821|NCT00830869|6118629|P7|Period 2: Part 2|Progressive disease|0
1755822|NCT00830869|6118630|P6|Period 2: Part 2|Progressive disease|0
1755823|NCT00830869|6118631|P5|Period 2: Part 2|Progressive disease|0
1755824|NCT00830869|6118632|P4|Period 2: Part 2|Progressive disease|0
1755825|NCT00830869|6118633|P3|Period 2: Part 2|Progressive disease|0
1755826|NCT00830869|6118634|P2|Period 2: Part 2|Progressive disease|0
1755827|NCT00830869|6118635|P1|Period 2: Part 2|Progressive disease|0
1755828|NCT00830869|6118624|P12|Period 2: Part 2|Symptomatic Deterioration|4
1755829|NCT00830869|6118625|P11|Period 2: Part 2|Symptomatic Deterioration|1
1755830|NCT00830869|6118626|P10|Period 2: Part 2|Symptomatic Deterioration|3
1755831|NCT00830869|6118627|P9|Period 2: Part 2|Symptomatic Deterioration|6
1755832|NCT00830869|6118628|P8|Period 2: Part 2|Symptomatic Deterioration|0
1755833|NCT00830869|6118629|P7|Period 2: Part 2|Symptomatic Deterioration|0
1755834|NCT00830869|6118630|P6|Period 2: Part 2|Symptomatic Deterioration|0
1755835|NCT00830869|6118631|P5|Period 2: Part 2|Symptomatic Deterioration|0
1755836|NCT00830869|6118632|P4|Period 2: Part 2|Symptomatic Deterioration|0
1755837|NCT00830869|6118633|P3|Period 2: Part 2|Symptomatic Deterioration|0
1755838|NCT00830869|6118634|P2|Period 2: Part 2|Symptomatic Deterioration|0
1755839|NCT00830869|6118635|P1|Period 2: Part 2|Symptomatic Deterioration|0
1755840|NCT00830869|6118624|P12|Period 2: Part 2|Adverse Event|0
1755841|NCT00830869|6118625|P11|Period 2: Part 2|Adverse Event|2
1755842|NCT00830869|6118626|P10|Period 2: Part 2|Adverse Event|2
1755843|NCT00830869|6118627|P9|Period 2: Part 2|Adverse Event|3
1755844|NCT00830869|6118628|P8|Period 2: Part 2|Adverse Event|4
1755845|NCT00830869|6118629|P7|Period 2: Part 2|Adverse Event|0
1755846|NCT00830869|6118630|P6|Period 2: Part 2|Adverse Event|0
1755847|NCT00830869|6118631|P5|Period 2: Part 2|Adverse Event|0
1755848|NCT00830869|6118632|P4|Period 2: Part 2|Adverse Event|0
1755849|NCT00830869|6118633|P3|Period 2: Part 2|Adverse Event|0
1755850|NCT00830869|6118634|P2|Period 2: Part 2|Adverse Event|0
1755851|NCT00830869|6118635|P1|Period 2: Part 2|Adverse Event|0
1755852|NCT00830869|6118624|P12|Period 2: Part 2|Withdrawal by Subject|1
1755853|NCT00830869|6118625|P11|Period 2: Part 2|Withdrawal by Subject|0
1755854|NCT00830869|6118626|P10|Period 2: Part 2|Withdrawal by Subject|1
1755855|NCT00830869|6118627|P9|Period 2: Part 2|Withdrawal by Subject|2
1755856|NCT00830869|6118628|P8|Period 2: Part 2|Withdrawal by Subject|1
1755857|NCT00830869|6118629|P7|Period 2: Part 2|Withdrawal by Subject|0
1755858|NCT00830869|6118630|P6|Period 2: Part 2|Withdrawal by Subject|0
1755859|NCT00830869|6118631|P5|Period 2: Part 2|Withdrawal by Subject|0
1755860|NCT00830869|6118632|P4|Period 2: Part 2|Withdrawal by Subject|0
1755861|NCT00830869|6118633|P3|Period 2: Part 2|Withdrawal by Subject|0
1755862|NCT00830869|6118634|P2|Period 2: Part 2|Withdrawal by Subject|0
1755863|NCT00830869|6118635|P1|Period 2: Part 2|Withdrawal by Subject|0
1755864|NCT00830869|6118624|P12|Period 2: Part 2|Protocol Violation|0
1755865|NCT00830869|6118625|P11|Period 2: Part 2|Protocol Violation|0
1755866|NCT00830869|6118626|P10|Period 2: Part 2|Protocol Violation|1
1755867|NCT00830869|6118627|P9|Period 2: Part 2|Protocol Violation|0
1755868|NCT00830869|6118628|P8|Period 2: Part 2|Protocol Violation|1
1755869|NCT00830869|6118629|P7|Period 2: Part 2|Protocol Violation|0
1755870|NCT00830869|6118630|P6|Period 2: Part 2|Protocol Violation|0
1755871|NCT00830869|6118631|P5|Period 2: Part 2|Protocol Violation|0
1755872|NCT00830869|6118632|P4|Period 2: Part 2|Protocol Violation|0
1755873|NCT00830869|6118633|P3|Period 2: Part 2|Protocol Violation|0
1755874|NCT00830869|6118634|P2|Period 2: Part 2|Protocol Violation|0
1755875|NCT00830869|6118635|P1|Period 2: Part 2|Protocol Violation|0
1755876|NCT00830869|6118624|P12|Period 1: Part 1|Progressive disease|0
1755877|NCT00830869|6118625|P11|Period 1: Part 1|Progressive disease|0
1755878|NCT00830869|6118626|P10|Period 1: Part 1|Progressive disease|0
1755879|NCT00830869|6118627|P9|Period 1: Part 1|Progressive disease|0
1755880|NCT00830869|6118628|P8|Period 1: Part 1|Progressive disease|0
1755881|NCT00830869|6118629|P7|Period 1: Part 1|Progressive disease|1
1755882|NCT00830869|6118630|P6|Period 1: Part 1|Progressive disease|4
1755883|NCT00830869|6118631|P5|Period 1: Part 1|Progressive disease|4
1755884|NCT00830869|6118632|P4|Period 1: Part 1|Progressive disease|6
1755885|NCT00830869|6118633|P3|Period 1: Part 1|Progressive disease|1
1755886|NCT00830869|6118634|P2|Period 1: Part 1|Progressive disease|0
1755887|NCT00830869|6118635|P1|Period 1: Part 1|Progressive disease|1
1755888|NCT00830869|6118624|P12|Period 1: Part 1|Adverse Event|0
1755889|NCT00830869|6118625|P11|Period 1: Part 1|Adverse Event|0
1755890|NCT00830869|6118626|P10|Period 1: Part 1|Adverse Event|0
1755891|NCT00830869|6118627|P9|Period 1: Part 1|Adverse Event|0
1755892|NCT00830869|6118628|P8|Period 1: Part 1|Adverse Event|0
1755893|NCT00830869|6118629|P7|Period 1: Part 1|Adverse Event|1
1755894|NCT00830869|6118630|P6|Period 1: Part 1|Adverse Event|1
1755895|NCT00830869|6118631|P5|Period 1: Part 1|Adverse Event|0
1755896|NCT00830869|6118632|P4|Period 1: Part 1|Adverse Event|0
1755897|NCT00830869|6118633|P3|Period 1: Part 1|Adverse Event|0
1755898|NCT00830869|6118634|P2|Period 1: Part 1|Adverse Event|0
1755899|NCT00830869|6118635|P1|Period 1: Part 1|Adverse Event|0
1755900|NCT00830869|6118624|P12|Period 1: Part 1|Withdrawal by Subject|0
1755901|NCT00830869|6118625|P11|Period 1: Part 1|Withdrawal by Subject|0
1755902|NCT00830869|6118626|P10|Period 1: Part 1|Withdrawal by Subject|0
1755903|NCT00830869|6118627|P9|Period 1: Part 1|Withdrawal by Subject|0
1755904|NCT00830869|6118628|P8|Period 1: Part 1|Withdrawal by Subject|0
1755905|NCT00830869|6118629|P7|Period 1: Part 1|Withdrawal by Subject|0
1755906|NCT00830869|6118630|P6|Period 1: Part 1|Withdrawal by Subject|0
1755907|NCT00830869|6118631|P5|Period 1: Part 1|Withdrawal by Subject|0
1755908|NCT00830869|6118632|P4|Period 1: Part 1|Withdrawal by Subject|0
1755909|NCT00830869|6118633|P3|Period 1: Part 1|Withdrawal by Subject|0
1755910|NCT00830869|6118634|P2|Period 1: Part 1|Withdrawal by Subject|1
1755911|NCT00830869|6118635|P1|Period 1: Part 1|Withdrawal by Subject|0
1755912|NCT00830869|6118624|P12|Period 1: Part 1|Symptomatic deterioration|0
1755913|NCT00830869|6118625|P11|Period 1: Part 1|Symptomatic deterioration|0
1755914|NCT00830869|6118626|P10|Period 1: Part 1|Symptomatic deterioration|0
1755915|NCT00830869|6118627|P9|Period 1: Part 1|Symptomatic deterioration|0
1755916|NCT00830869|6118628|P8|Period 1: Part 1|Symptomatic deterioration|0
1755917|NCT00830869|6118629|P7|Period 1: Part 1|Symptomatic deterioration|1
1755918|NCT00830869|6118630|P6|Period 1: Part 1|Symptomatic deterioration|1
1755919|NCT00830869|6118631|P5|Period 1: Part 1|Symptomatic deterioration|0
1755920|NCT00830869|6118632|P4|Period 1: Part 1|Symptomatic deterioration|1
1755921|NCT00830869|6118633|P3|Period 1: Part 1|Symptomatic deterioration|0
1755922|NCT00830869|6118634|P2|Period 1: Part 1|Symptomatic deterioration|0
1755923|NCT00830869|6118635|P1|Period 1: Part 1|Symptomatic deterioration|0
1755924|NCT00830804|6118771|P1|Overall Study|Unwilling to adhere to study requirement|1
1755925|NCT00830804|6118771|P1|Overall Study|Consent withdrawn|2
1755926|NCT00830804|6118771|P1|Overall Study|Unable to get to clinic|7
1755927|NCT00830804|6118771|P1|Overall Study|Death|1
1755928|NCT00830804|6118771|P1|Overall Study|Lost to Follow-up|4
1755929|NCT00830765|6118851|P2|Overall Study|Protocol Violation|2
1755930|NCT00830765|6118852|P1|Overall Study|Protocol Violation|3
1755931|NCT00830518|6118885|P2|Overall Study|Reason not Specified|1
1755932|NCT00830518|6118886|P1|Overall Study|Reason not Specified|8
1755933|NCT00830518|6118885|P2|Overall Study|Withdrawal by Patient|0
1755934|NCT00830518|6118886|P1|Overall Study|Withdrawal by Patient|2
1755935|NCT00830518|6118885|P2|Overall Study|Adverse Event|1
1755936|NCT00830518|6118886|P1|Overall Study|Adverse Event|14
1755937|NCT00830518|6118885|P2|Overall Study|Symptomatic Deterioration|1
1755938|NCT00830518|6118886|P1|Overall Study|Symptomatic Deterioration|4
1755939|NCT00830518|6118885|P2|Overall Study|Progressive Disease|8
1755940|NCT00830518|6118886|P1|Overall Study|Progressive Disease|18
1755941|NCT00830440|6118905|P2|Overall Study|Adverse Event|0
1755942|NCT00830440|6118906|P1|Overall Study|Adverse Event|2
1755943|NCT00830440|6118905|P2|Overall Study|unsuccessful procedure|0
1755944|NCT00830440|6118906|P1|Overall Study|unsuccessful procedure|4
1755945|NCT00830440|6118905|P2|Overall Study|Withdrawal by Subject|0
1755946|NCT00830440|6118906|P1|Overall Study|Withdrawal by Subject|1
1755947|NCT00830440|6118905|P2|Overall Study|Protocol Violation|0
1755948|NCT00830440|6118906|P1|Overall Study|Protocol Violation|1
1755949|NCT00830375|6118921|P1|Overall Study|Lost to Follow-up|1
1755950|NCT00830336|6118936|P2|Washout: 21 Days|Withdrawal by Subject|0
1755951|NCT00830336|6118937|P1|Washout: 21 Days|Withdrawal by Subject|1
1755952|NCT00830258|6118964|P2|Washout: 7 Days|Protocol Violation|0
1755953|NCT00830258|6118965|P1|Washout: 7 Days|Protocol Violation|1
1755954|NCT00830258|6118964|P2|First Intervention|Adverse Event|0
1755955|NCT00830258|6118965|P1|First Intervention|Adverse Event|1
1755956|NCT00830219|6118984|P2|Washout of 7 Days|Withdrawal by Subject|1
1755957|NCT00830219|6118985|P1|Washout of 7 Days|Withdrawal by Subject|1
1755958|NCT00830206|6118995|P2|Washout: 21 Days|Withdrawal by Subject|1
1755959|NCT00830206|6118996|P1|Washout: 21 Days|Withdrawal by Subject|1
1755960|NCT00830167|6119006|P2|Overall Study|Other|2
1755961|NCT00830167|6119007|P1|Overall Study|Other|2
1755962|NCT00830167|6119006|P2|Overall Study|Protocol Violation|1
1755963|NCT00830167|6119007|P1|Overall Study|Protocol Violation|0
1755964|NCT00830167|6119006|P2|Overall Study|Lost to Follow-up|1
1755965|NCT00830167|6119007|P1|Overall Study|Lost to Follow-up|0
1755966|NCT00830167|6119006|P2|Overall Study|Withdrawal by Subject|0
1755967|NCT00830167|6119007|P1|Overall Study|Withdrawal by Subject|2
1755968|NCT00830167|6119006|P2|Overall Study|Not meeting entrance criteria|5
1755969|NCT00830167|6119007|P1|Overall Study|Not meeting entrance criteria|2
1755970|NCT00830167|6119006|P2|Overall Study|Adverse Event|24
1755971|NCT00830167|6119007|P1|Overall Study|Adverse Event|8
1755972|NCT00830167|6119006|P2|Overall Study|Lack of Efficacy|10
1755973|NCT00830167|6119007|P1|Overall Study|Lack of Efficacy|26
1755974|NCT00830128|6119077|P1|Overall Study|Operating a vehicle|1
1755975|NCT00830128|6119077|P1|Overall Study|Work obligation|1
1755976|NCT00830128|6119077|P1|Overall Study|Relocation|1
1755977|NCT00830128|6119077|P1|Overall Study|Family obligation|1
1755978|NCT00830128|6119077|P1|Overall Study|Withdrawal by Subject|2
1755979|NCT00830128|6119077|P1|Overall Study|Protocol Violation|1
1755980|NCT00830128|6119077|P1|Overall Study|Lack of Efficacy|7
1755981|NCT00830128|6119077|P1|Overall Study|Adverse Event|5
1755982|NCT00830115|6119092|P1|Overall Study|Improvement/recovery|1
1755983|NCT00830115|6119092|P1|Overall Study|Adverse Event|2
1755984|NCT00830037|6119119|P2|Overall Study|Active when terminated by DSMB|14
1755985|NCT00830037|6119120|P1|Overall Study|Active when terminated by DSMB|15
1755986|NCT00830037|6119119|P2|Overall Study|Lost to Follow-up|2
1755987|NCT00830037|6119120|P1|Overall Study|Lost to Follow-up|1
1755988|NCT00830037|6119119|P2|Overall Study|Withdrawal by Subject|3
1755989|NCT00830037|6119120|P1|Overall Study|Withdrawal by Subject|2
1755990|NCT00830024|6119130|P2|Washout: 7 Days|Withdrawal by Subject|0
1755991|NCT00830024|6119131|P1|Washout: 7 Days|Withdrawal by Subject|1
1755992|NCT00829998|6119141|P2|Washout|Adverse Event|1
1755993|NCT00829998|6119142|P1|Washout|Adverse Event|0
1755994|NCT00829933|6119171|P4|Overall Study|withdrew before treatment started|9
1755995|NCT00829933|6119172|P3|Overall Study|withdrew before treatment started|2
1755996|NCT00829933|6119173|P2|Overall Study|withdrew before treatment started|1
1755997|NCT00829933|6119174|P1|Overall Study|withdrew before treatment started|5
1755998|NCT00829933|6119171|P4|Overall Study|Protocol Violation|0
1755999|NCT00829933|6119172|P3|Overall Study|Protocol Violation|0
1756000|NCT00829933|6119173|P2|Overall Study|Protocol Violation|1
1756001|NCT00829933|6119174|P1|Overall Study|Protocol Violation|2
1756002|NCT00829933|6119171|P4|Overall Study|Pregnancy|2
1756003|NCT00829933|6119172|P3|Overall Study|Pregnancy|0
1756004|NCT00829933|6119173|P2|Overall Study|Pregnancy|0
1756005|NCT00829933|6119174|P1|Overall Study|Pregnancy|0
1756006|NCT00829933|6119171|P4|Overall Study|Physician Decision|1
1756007|NCT00829933|6119172|P3|Overall Study|Physician Decision|8
1756008|NCT00829933|6119173|P2|Overall Study|Physician Decision|7
1756009|NCT00829933|6119174|P1|Overall Study|Physician Decision|5
1756010|NCT00829933|6119171|P4|Overall Study|Lack of Efficacy|0
1756011|NCT00829933|6119172|P3|Overall Study|Lack of Efficacy|0
1756012|NCT00829933|6119173|P2|Overall Study|Lack of Efficacy|1
1756013|NCT00829933|6119174|P1|Overall Study|Lack of Efficacy|0
1756014|NCT00829933|6119171|P4|Overall Study|Death|1
1756015|NCT00829933|6119172|P3|Overall Study|Death|1
1756016|NCT00829933|6119173|P2|Overall Study|Death|0
1756017|NCT00829933|6119174|P1|Overall Study|Death|0
1756018|NCT00829933|6119171|P4|Overall Study|Adverse Event|1
1756019|NCT00829933|6119172|P3|Overall Study|Adverse Event|2
1756020|NCT00829933|6119173|P2|Overall Study|Adverse Event|3
1756021|NCT00829933|6119174|P1|Overall Study|Adverse Event|2
1756022|NCT00829868|6119186|P2|Washout|Physician Decision|0
1756023|NCT00829868|6119187|P1|Washout|Physician Decision|1
1756024|NCT00829829|6119198|P3|Overall Study|Other than specified above|1
1756025|NCT00829829|6119199|P2|Overall Study|Other than specified above|2
1756026|NCT00829829|6119200|P1|Overall Study|Other than specified above|2
1756027|NCT00829829|6119198|P3|Overall Study|Lost to Follow-up|3
1756028|NCT00829829|6119199|P2|Overall Study|Lost to Follow-up|3
1756029|NCT00829829|6119200|P1|Overall Study|Lost to Follow-up|7
1756030|NCT00829829|6119198|P3|Overall Study|Decision by the Sponsor|2
1756031|NCT00829829|6119199|P2|Overall Study|Decision by the Sponsor|0
1756032|NCT00829829|6119200|P1|Overall Study|Decision by the Sponsor|1
1756033|NCT00829829|6119198|P3|Overall Study|Withdrawal by Subject|2
1756034|NCT00829829|6119199|P2|Overall Study|Withdrawal by Subject|4
1756035|NCT00829829|6119200|P1|Overall Study|Withdrawal by Subject|8
1756036|NCT00829829|6119198|P3|Overall Study|Adverse Event|3
1756037|NCT00829829|6119199|P2|Overall Study|Adverse Event|4
1756038|NCT00829829|6119200|P1|Overall Study|Adverse Event|4
1756039|NCT00829829|6119198|P3|Overall Study|Protocol Violation|0
1756040|NCT00829829|6119199|P2|Overall Study|Protocol Violation|3
1756041|NCT00829829|6119200|P1|Overall Study|Protocol Violation|0
1756042|NCT00829790|6119225|P2|Washout of 14 Days|Withdrawal by Subject|1
1756043|NCT00829790|6119226|P1|Washout of 14 Days|Withdrawal by Subject|0
1756044|NCT00829764|6119236|P2|First Intervention|Withdrawal by Subject|1
1756045|NCT00829764|6119237|P1|First Intervention|Withdrawal by Subject|1
1756046|NCT00829764|6119236|P2|First Intervention|Adverse Event|0
1756047|NCT00829764|6119237|P1|First Intervention|Adverse Event|1
1756048|NCT00829712|6119263|P2|Washout of 7 Days|Withdrawal by Subject|1
1756049|NCT00829712|6119264|P1|Washout of 7 Days|Withdrawal by Subject|0
1756050|NCT00829673|6119283|P2|Washout of 7 Days|Withdrawal by Subject|0
1756051|NCT00829673|6119284|P1|Washout of 7 Days|Withdrawal by Subject|1
1756052|NCT00829621|6119294|P2|Overall Study|Lost to Follow-up|4
1756053|NCT00829621|6119295|P1|Overall Study|Lost to Follow-up|3
1756054|NCT00829621|6119294|P2|Overall Study|Death|0
1756055|NCT00829621|6119295|P1|Overall Study|Death|1
1756056|NCT00829530|6119303|P2|Second Intervention|Intolerance to Venopuncture|0
1756057|NCT00829530|6119304|P1|Second Intervention|Intolerance to Venopuncture|1
1756058|NCT00829530|6119303|P2|First Intervention|Intolerance to Venopuncture|1
1756059|NCT00829530|6119304|P1|First Intervention|Intolerance to Venopuncture|0
1756060|NCT00829530|6119303|P2|First Intervention|Adverse Event|1
1756061|NCT00829530|6119304|P1|First Intervention|Adverse Event|0
1756062|NCT00829504|6119318|P2|Second Intervention|Physician Decision|0
1756063|NCT00829504|6119319|P1|Second Intervention|Physician Decision|1
1756064|NCT00829504|6119318|P2|Washout of 7 Days|Withdrawal by Subject|0
1756065|NCT00829504|6119319|P1|Washout of 7 Days|Withdrawal by Subject|1
1756066|NCT00829504|6119318|P2|First Intervention|Adverse Event|0
1756067|NCT00829504|6119319|P1|First Intervention|Adverse Event|1
1756068|NCT00829452|6119329|P2|Second Intervention|Physician Decision|1
1756069|NCT00829452|6119330|P1|Second Intervention|Physician Decision|0
1756070|NCT00829452|6119329|P2|Washout of 42 Days|Withdrawal by Subject|1
1756071|NCT00829452|6119330|P1|Washout of 42 Days|Withdrawal by Subject|0
1756072|NCT00829452|6119329|P2|First Intervention|Withdrawal by Subject|1
1756073|NCT00829452|6119330|P1|First Intervention|Withdrawal by Subject|0
1756074|NCT00829439|6119342|P4|Overall Study|Adverse Event|0
1756075|NCT00829439|6119343|P3|Overall Study|Adverse Event|1
1756076|NCT00829439|6119344|P2|Overall Study|Adverse Event|0
1756077|NCT00829439|6119345|P1|Overall Study|Adverse Event|0
1756078|NCT00829426|6119351|P2|Washout: 7 Days|Withdrawal by Subject|0
1756079|NCT00829426|6119352|P1|Washout: 7 Days|Withdrawal by Subject|1
1756080|NCT00829413|6119360|P1|Overall Study|Indeterminate diagnosis from truth stand|3
1756081|NCT00829413|6119360|P1|Overall Study|Technically inadequate truth standard|2
1756082|NCT00829413|6119360|P1|Overall Study|No truth standard procedure available|9
1756083|NCT00829413|6119360|P1|Overall Study|Training Patients|67
1756084|NCT00829413|6119360|P1|Overall Study|No study drug admimnistered|13
1756085|NCT00829387|6119409|P2|Overall Study|Disqualified by PI|0
1756086|NCT00829387|6119410|P1|Overall Study|Disqualified by PI|1
1756087|NCT00829387|6119409|P2|Overall Study|Withdrawal by Subject|3
1756088|NCT00829387|6119410|P1|Overall Study|Withdrawal by Subject|2
1756089|NCT00829309|6119428|P2|Washout: 7 Days|Protocol Violation|0
1756090|NCT00829309|6119429|P1|Washout: 7 Days|Protocol Violation|1
1756091|NCT00829296|6119439|P2|Overall Study|Adverse Event|4
1756092|NCT00829296|6119440|P1|Overall Study|Adverse Event|5
1756093|NCT00829283|6119454|P2|Overall Study|Lost to Follow-up|25
1756094|NCT00829283|6119455|P1|Overall Study|Lost to Follow-up|7
1756095|NCT00829244|6119465|P2|Overall Study|No embryo cleavage|2
1756096|NCT00829244|6119466|P1|Overall Study|No embryo cleavage|0
1756097|NCT00829244|6119465|P2|Overall Study|All embryos discarded|3
1756098|NCT00829244|6119466|P1|Overall Study|All embryos discarded|0
1756099|NCT00829244|6119465|P2|Overall Study|No fertilization|2
1756100|NCT00829244|6119466|P1|Overall Study|No fertilization|2
1756101|NCT00829244|6119465|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
1756102|NCT00829244|6119466|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
1756103|NCT00829244|6119465|P2|Overall Study|Lack of ovarian response to stimulation|5
1756104|NCT00829244|6119466|P1|Overall Study|Lack of ovarian response to stimulation|9
1756105|NCT00829244|6119465|P2|Overall Study|Protocol Violation|0
1756106|NCT00829244|6119466|P1|Overall Study|Protocol Violation|1
1756107|NCT00829244|6119465|P2|Overall Study|Adverse Event|3
1756108|NCT00829244|6119466|P1|Overall Study|Adverse Event|1
1756109|NCT00829179|6119496|P1|Overall Study|Withdrawal by Subject|1
1756110|NCT00829166|6119502|P2|Overall Study|Reason Not Specified|3
1756111|NCT00829166|6119503|P1|Overall Study|Reason Not Specified|3
1756112|NCT00829166|6119502|P2|Overall Study|Sponsor’s Decision|98
1756113|NCT00829166|6119503|P1|Overall Study|Sponsor’s Decision|137
1756114|NCT00829166|6119502|P2|Overall Study|Subject's Decision|55
1756115|NCT00829166|6119503|P1|Overall Study|Subject's Decision|41
1756116|NCT00829166|6119502|P2|Overall Study|Physician's Decision|3
1756117|NCT00829166|6119503|P1|Overall Study|Physician's Decision|4
1756118|NCT00829166|6119502|P2|Overall Study|Lost to Follow-up|4
1756119|NCT00829166|6119503|P1|Overall Study|Lost to Follow-up|5
1756120|NCT00829166|6119502|P2|Overall Study|Death|333
1756121|NCT00829166|6119503|P1|Overall Study|Death|305
1756122|NCT00829010|6119566|P5|Overall Study|Migrated/Moved from study area|0
1756123|NCT00829010|6119567|P4|Overall Study|Migrated/Moved from study area|5
1756124|NCT00829010|6119568|P3|Overall Study|Migrated/Moved from study area|0
1756125|NCT00829010|6119569|P2|Overall Study|Migrated/Moved from study area|4
1756126|NCT00829010|6119570|P1|Overall Study|Migrated/Moved from study area|3
1756127|NCT00829010|6119566|P5|Overall Study|Fatality|0
1756128|NCT00829010|6119567|P4|Overall Study|Fatality|3
1756129|NCT00829010|6119568|P3|Overall Study|Fatality|0
1756130|NCT00829010|6119569|P2|Overall Study|Fatality|4
1756131|NCT00829010|6119570|P1|Overall Study|Fatality|5
1756132|NCT00829010|6119566|P5|Overall Study|Lost to Follow-up|0
1756133|NCT00829010|6119567|P4|Overall Study|Lost to Follow-up|0
1756134|NCT00829010|6119568|P3|Overall Study|Lost to Follow-up|2
1756135|NCT00829010|6119569|P2|Overall Study|Lost to Follow-up|0
1756136|NCT00829010|6119570|P1|Overall Study|Lost to Follow-up|1
1756137|NCT00829010|6119566|P5|Overall Study|Withdrawal by Subject|2
1756138|NCT00829010|6119567|P4|Overall Study|Withdrawal by Subject|0
1756139|NCT00829010|6119568|P3|Overall Study|Withdrawal by Subject|1
1756140|NCT00829010|6119569|P2|Overall Study|Withdrawal by Subject|1
1756141|NCT00829010|6119570|P1|Overall Study|Withdrawal by Subject|0
1756142|NCT00829010|6119566|P5|Overall Study|Adverse Event|0
1756143|NCT00829010|6119567|P4|Overall Study|Adverse Event|0
1756144|NCT00829010|6119568|P3|Overall Study|Adverse Event|0
1756145|NCT00829010|6119569|P2|Overall Study|Adverse Event|0
1756146|NCT00829010|6119570|P1|Overall Study|Adverse Event|1
1756147|NCT00828984|6119735|P3|Overall Study|ConMed|1
1756148|NCT00828984|6119736|P2|Overall Study|ConMed|1
1756149|NCT00828984|6119737|P1|Overall Study|ConMed|1
1756150|NCT00828984|6119735|P3|Overall Study|Noncompliant|3
1756151|NCT00828984|6119736|P2|Overall Study|Noncompliant|2
1756152|NCT00828984|6119737|P1|Overall Study|Noncompliant|1
1756153|NCT00828984|6119735|P3|Overall Study|Medical Contraindication|0
1756154|NCT00828984|6119736|P2|Overall Study|Medical Contraindication|1
1756155|NCT00828984|6119737|P1|Overall Study|Medical Contraindication|0
1756156|NCT00828984|6119735|P3|Overall Study|Ineligable|0
1756157|NCT00828984|6119736|P2|Overall Study|Ineligable|2
1756158|NCT00828984|6119737|P1|Overall Study|Ineligable|1
1756159|NCT00828984|6119735|P3|Overall Study|Withdrawal by Subject|4
1756160|NCT00828984|6119736|P2|Overall Study|Withdrawal by Subject|4
1756161|NCT00828984|6119737|P1|Overall Study|Withdrawal by Subject|4
1756162|NCT00828984|6119735|P3|Overall Study|Lost to Follow-up|1
1756163|NCT00828984|6119736|P2|Overall Study|Lost to Follow-up|3
1756164|NCT00828984|6119737|P1|Overall Study|Lost to Follow-up|5
1756165|NCT00828984|6119735|P3|Overall Study|Adverse Event|0
1756166|NCT00828984|6119736|P2|Overall Study|Adverse Event|3
1756167|NCT00828984|6119737|P1|Overall Study|Adverse Event|2
1756168|NCT00828945|6119760|P1|Overall Study|Other|36
1756169|NCT00828945|6119760|P1|Overall Study|Participant was missing|1
1756170|NCT00828945|6119760|P1|Overall Study|Death|4
1756171|NCT00828750|6119792|P1|Overall Study|Normal PC Remained While No Treatment|1
1756172|NCT00828750|6119792|P1|Overall Study|Lack of Efficacy|3
1756173|NCT00828711|6119806|P3|Overall Study|Lost to Follow-up|0
1756174|NCT00828711|6119807|P2|Overall Study|Lost to Follow-up|0
1756175|NCT00828711|6119808|P1|Overall Study|Lost to Follow-up|1
1756176|NCT00828672|6119839|P2|Post-surgery (<30 Days)|No central review materials|1
1756177|NCT00828672|6119840|P1|Post-surgery (<30 Days)|No central review materials|0
1756178|NCT00828672|6119839|P2|Study Treatment|Complete response, no surgery|1
1756179|NCT00828672|6119840|P1|Study Treatment|Complete response, no surgery|1
1756180|NCT00828672|6119839|P2|Study Treatment|Adverse Event|1
1756181|NCT00828672|6119840|P1|Study Treatment|Adverse Event|0
1756182|NCT00828672|6119839|P2|Study Treatment|Lost to Follow-up|0
1756183|NCT00828672|6119840|P1|Study Treatment|Lost to Follow-up|1
1756184|NCT00828568|6119861|P3|Treated - Received at Least One Dose|Protocol Violation|3
1756185|NCT00828568|6119862|P2|Treated - Received at Least One Dose|Protocol Violation|5
1756186|NCT00828568|6119863|P1|Treated - Received at Least One Dose|Protocol Violation|9
1756187|NCT00828568|6119861|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
1756188|NCT00828568|6119862|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
1756189|NCT00828568|6119863|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
1756190|NCT00828568|6119861|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
1756191|NCT00828568|6119862|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
1756192|NCT00828568|6119863|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
1756193|NCT00828568|6119861|P3|Treated - Received at Least One Dose|Adverse Event|1
1756194|NCT00828568|6119862|P2|Treated - Received at Least One Dose|Adverse Event|8
1756195|NCT00828568|6119863|P1|Treated - Received at Least One Dose|Adverse Event|11
1756196|NCT00828568|6119861|P3|Randomized|Withdrawal by Subject|2
1756197|NCT00828568|6119862|P2|Randomized|Withdrawal by Subject|0
1756198|NCT00828568|6119863|P1|Randomized|Withdrawal by Subject|1
1756199|NCT00828516|6119885|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
1756200|NCT00828464|6119890|P1|Overall Study|Withdrawal by Subject|1
1756201|NCT00828451|6119907|P1|Overall Study|Deterioration in clinical status|1
1756202|NCT00828451|6119907|P1|Overall Study|Withdrawal by Subject|1
1756203|NCT00828451|6119907|P1|Overall Study|Lack of intravenous line|7
1756204|NCT00828451|6119907|P1|Overall Study|Death|2
1756205|NCT00828321|6119933|P2|Second Intervention|Protocol Violation|1
1756206|NCT00828321|6119934|P1|Second Intervention|Protocol Violation|0
1756207|NCT00828321|6119933|P2|Washout of 42 Days|Withdrawal by Subject|0
1756208|NCT00828321|6119934|P1|Washout of 42 Days|Withdrawal by Subject|2
1756209|NCT00828204|6119963|P2|Extension Study|Physician Decision|2
1756210|NCT00828204|6119964|P1|Extension Study|Physician Decision|0
1756211|NCT00828204|6119963|P2|Extension Study|Lost to Follow-up|1
1756212|NCT00828204|6119964|P1|Extension Study|Lost to Follow-up|0
1756213|NCT00828204|6119963|P2|Main Study: After Study Restart|Noncompliance|1
1756214|NCT00828204|6119964|P1|Main Study: After Study Restart|Noncompliance|0
1756215|NCT00828204|6119963|P2|Main Study: After Study Restart|Adverse Event|2
1756216|NCT00828204|6119964|P1|Main Study: After Study Restart|Adverse Event|0
1756217|NCT00828204|6119963|P2|Main Study: Prior to Study Suspension|Study Suspension|0
1756218|NCT00828204|6119964|P1|Main Study: Prior to Study Suspension|Study Suspension|11
1756219|NCT00828204|6119963|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
1756220|NCT00828204|6119964|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
1756221|NCT00828204|6119963|P2|Main Study: Prior to Study Suspension|Adverse Event|0
1756222|NCT00828204|6119964|P1|Main Study: Prior to Study Suspension|Adverse Event|1
1756223|NCT00828139|6120011|P4|Overall Study|Other|2
1756224|NCT00828139|6120012|P3|Overall Study|Other|5
1756225|NCT00828139|6120013|P2|Overall Study|Other|2
1756226|NCT00828139|6120014|P1|Overall Study|Other|4
1756227|NCT00828139|6120011|P4|Overall Study|Disease Progression|39
1756228|NCT00828139|6120012|P3|Overall Study|Disease Progression|35
1756229|NCT00828139|6120013|P2|Overall Study|Disease Progression|33
1756230|NCT00828139|6120014|P1|Overall Study|Disease Progression|24
1756231|NCT00828139|6120011|P4|Overall Study|Refusal unrelated to toxicity|3
1756232|NCT00828139|6120012|P3|Overall Study|Refusal unrelated to toxicity|5
1756233|NCT00828139|6120013|P2|Overall Study|Refusal unrelated to toxicity|4
1756234|NCT00828139|6120014|P1|Overall Study|Refusal unrelated to toxicity|3
1756235|NCT00828139|6120011|P4|Overall Study|Death|2
1756236|NCT00828139|6120012|P3|Overall Study|Death|0
1756237|NCT00828139|6120013|P2|Overall Study|Death|1
1756238|NCT00828139|6120014|P1|Overall Study|Death|2
1756239|NCT00828139|6120011|P4|Overall Study|Adverse Event|5
1756240|NCT00828139|6120012|P3|Overall Study|Adverse Event|10
1756241|NCT00828139|6120013|P2|Overall Study|Adverse Event|1
1756242|NCT00828139|6120014|P1|Overall Study|Adverse Event|8
1756243|NCT00828113|6120034|P2|Overall Study|Lost to Follow-up|5
1756244|NCT00828113|6120035|P1|Overall Study|Lost to Follow-up|3
1756245|NCT00828113|6120034|P2|Overall Study|Withdrawal by Subject|26
1756246|NCT00828113|6120035|P1|Overall Study|Withdrawal by Subject|27
1756247|NCT00828009|6120073|P1|Step 2 - Maintenance Therapy|Other|1
1756248|NCT00828009|6120073|P1|Step 2 - Maintenance Therapy|Complicating disease|2
1756249|NCT00828009|6120073|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
1756250|NCT00828009|6120073|P1|Step 2 - Maintenance Therapy|Death|1
1756251|NCT00828009|6120073|P1|Step 2 - Maintenance Therapy|Adverse Event|13
1756252|NCT00828009|6120073|P1|Step 2 - Maintenance Therapy|Progressive disease|12
1756253|NCT00828009|6120073|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
1756254|NCT00828009|6120073|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
1756255|NCT00828009|6120073|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
1756256|NCT00828009|6120073|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
1756257|NCT00828009|6120073|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
1756258|NCT00828009|6120073|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
1756259|NCT00828009|6120073|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
1756260|NCT00827931|6120116|P2|Overall Study|Other|0
1756261|NCT00827931|6120117|P1|Overall Study|Other|1
1756262|NCT00827931|6120116|P2|Overall Study|Withdrawal by Subject|1
1756263|NCT00827931|6120117|P1|Overall Study|Withdrawal by Subject|0
1756264|NCT00827931|6120116|P2|Overall Study|Lost to Follow-up|0
1756265|NCT00827931|6120117|P1|Overall Study|Lost to Follow-up|1
1756266|NCT00827931|6120116|P2|Overall Study|Adverse Event|0
1756267|NCT00827931|6120117|P1|Overall Study|Adverse Event|1
1756268|NCT00827931|6120116|P2|Overall Study|Death|5
1756269|NCT00827931|6120117|P1|Overall Study|Death|3
1756270|NCT00827918|6120138|P3|Overall Study|Withdrawal by Subject|6
1756271|NCT00827918|6120139|P2|Overall Study|Withdrawal by Subject|2
1756272|NCT00827918|6120140|P1|Overall Study|Withdrawal by Subject|6
1756273|NCT00827918|6120138|P3|Overall Study|Protocol Violation|0
1756274|NCT00827918|6120139|P2|Overall Study|Protocol Violation|1
1756275|NCT00827918|6120140|P1|Overall Study|Protocol Violation|0
1756276|NCT00827918|6120138|P3|Overall Study|Progressive Disease|0
1756277|NCT00827918|6120139|P2|Overall Study|Progressive Disease|1
1756278|NCT00827918|6120140|P1|Overall Study|Progressive Disease|1
1756279|NCT00827918|6120138|P3|Overall Study|Pregnancy|0
1756280|NCT00827918|6120139|P2|Overall Study|Pregnancy|1
1756281|NCT00827918|6120140|P1|Overall Study|Pregnancy|0
1756282|NCT00827918|6120138|P3|Overall Study|Physician Decision|0
1756283|NCT00827918|6120139|P2|Overall Study|Physician Decision|0
1756284|NCT00827918|6120140|P1|Overall Study|Physician Decision|1
1756285|NCT00827918|6120138|P3|Overall Study|Lack of Efficacy|15
1756286|NCT00827918|6120139|P2|Overall Study|Lack of Efficacy|4
1756287|NCT00827918|6120140|P1|Overall Study|Lack of Efficacy|16
1756288|NCT00827918|6120138|P3|Overall Study|Adverse Event|0
1756289|NCT00827918|6120139|P2|Overall Study|Adverse Event|0
1756290|NCT00827918|6120140|P1|Overall Study|Adverse Event|4
1756291|NCT00827827|6120168|P2|Overall Study|Burned with water at home|0
1756292|NCT00827827|6120169|P1|Overall Study|Burned with water at home|1
1756293|NCT00827827|6120168|P2|Overall Study|Transportation issues|0
1756294|NCT00827827|6120169|P1|Overall Study|Transportation issues|1
1756295|NCT00827827|6120168|P2|Overall Study|Gout|0
1756296|NCT00827827|6120169|P1|Overall Study|Gout|1
1756297|NCT00827827|6120168|P2|Overall Study|Another cerebrovascular accident (CVA)|0
1756298|NCT00827827|6120169|P1|Overall Study|Another cerebrovascular accident (CVA)|1
1756299|NCT00827827|6120168|P2|Overall Study|Fall at home- hospitalization|0
1756300|NCT00827827|6120169|P1|Overall Study|Fall at home- hospitalization|1
1756301|NCT00827827|6120168|P2|Overall Study|Lost to Follow-up|0
1756302|NCT00827827|6120169|P1|Overall Study|Lost to Follow-up|3
1756303|NCT00827632|6120213|P2|Overall Study|Early withdrawal|11
1756304|NCT00827632|6120214|P1|Overall Study|Early withdrawal|14
1756305|NCT00827632|6120213|P2|Overall Study|Lost to Follow-up|12
1756306|NCT00827632|6120214|P1|Overall Study|Lost to Follow-up|8
1756307|NCT00827606|6120226|P2|Overall Study|Adverse Event|2
1756308|NCT00827606|6120227|P1|Overall Study|Adverse Event|4
1756309|NCT00827606|6120226|P2|Overall Study|LDL below 2.59 mmol/L|12
1756310|NCT00827606|6120227|P1|Overall Study|LDL below 2.59 mmol/L|4
1756311|NCT00827606|6120226|P2|Overall Study|Other|13
1756312|NCT00827606|6120227|P1|Overall Study|Other|5
1756313|NCT00827606|6120226|P2|Overall Study|Pregnancy|1
1756314|NCT00827606|6120227|P1|Overall Study|Pregnancy|0
1756315|NCT00827606|6120226|P2|Overall Study|Withdrawal by Subject|6
1756316|NCT00827606|6120227|P1|Overall Study|Withdrawal by Subject|7
1756317|NCT00827606|6120226|P2|Overall Study|Lost to Follow-up|1
1756318|NCT00827606|6120227|P1|Overall Study|Lost to Follow-up|3
1756319|NCT00827606|6120226|P2|Overall Study|Protocol Violation|3
1756320|NCT00827606|6120227|P1|Overall Study|Protocol Violation|4
1756321|NCT00827567|6120288|P1|Overall Study|Progression of Disease/Screen Failure|4
1756322|NCT00827541|6120294|P2|Overall Study|Lack of effectiveness|0
1756323|NCT00827541|6120295|P1|Overall Study|Lack of effectiveness|1
1756324|NCT00827541|6120294|P2|Overall Study|Pathogen not susceptible|0
1756325|NCT00827541|6120295|P1|Overall Study|Pathogen not susceptible|1
1756326|NCT00827541|6120294|P2|Overall Study|Other|3
1756327|NCT00827541|6120295|P1|Overall Study|Other|1
1756328|NCT00827541|6120294|P2|Overall Study|Exitus|8
1756329|NCT00827541|6120295|P1|Overall Study|Exitus|1
1756330|NCT00827502|6120307|P1|Overall Study|Withdrawal by Subject|5
1756331|NCT00827502|6120307|P1|Overall Study|Lost to Follow-up|4
1756332|NCT00827502|6120307|P1|Overall Study|Adverse Event|1
1756333|NCT00827502|6120307|P1|Overall Study|randomized but not treated|11
1756334|NCT00827372|6120313|P1|Overall Study|Lack of Efficacy|3
1756335|NCT00827372|6120313|P1|Overall Study|Adverse Event|5
1756336|NCT00827242|6120328|P2|Overall Study|Lack of Efficacy|0
1756337|NCT00827242|6120329|P1|Overall Study|Lack of Efficacy|1
1756338|NCT00827242|6120328|P2|Overall Study|Death|0
1756339|NCT00827242|6120329|P1|Overall Study|Death|1
1756340|NCT00827242|6120328|P2|Overall Study|Physician Decision|0
1756341|NCT00827242|6120329|P1|Overall Study|Physician Decision|2
1756342|NCT00827242|6120328|P2|Overall Study|Entry Criteria Not Met|1
1756343|NCT00827242|6120329|P1|Overall Study|Entry Criteria Not Met|4
1756344|NCT00827242|6120328|P2|Overall Study|Adverse Event Excluding Death|1
1756345|NCT00827242|6120329|P1|Overall Study|Adverse Event Excluding Death|2
1756346|NCT00827242|6120328|P2|Overall Study|Lost to Follow-up|3
1756347|NCT00827242|6120329|P1|Overall Study|Lost to Follow-up|0
1756348|NCT00827242|6120328|P2|Overall Study|Protocol Violation|3
1756349|NCT00827242|6120329|P1|Overall Study|Protocol Violation|1
1756350|NCT00827242|6120328|P2|Overall Study|Withdrawal by Subject|4
1756351|NCT00827242|6120329|P1|Overall Study|Withdrawal by Subject|2
1756352|NCT00827112|6120367|P2|Overall Study|Other|3
1756353|NCT00827112|6120368|P1|Overall Study|Other|1
1756354|NCT00827112|6120367|P2|Overall Study|Randomized but not treated|3
1756355|NCT00827112|6120368|P1|Overall Study|Randomized but not treated|5
1756356|NCT00827112|6120367|P2|Overall Study|Withdrawal by Subject|1
1756357|NCT00827112|6120368|P1|Overall Study|Withdrawal by Subject|2
1756358|NCT00827112|6120367|P2|Overall Study|Protocol Violation|2
1756359|NCT00827112|6120368|P1|Overall Study|Protocol Violation|0
1756360|NCT00827112|6120367|P2|Overall Study|Pregnancy|1
1756361|NCT00827112|6120368|P1|Overall Study|Pregnancy|0
1756362|NCT00827112|6120367|P2|Overall Study|Lost to Follow-up|2
1756363|NCT00827112|6120368|P1|Overall Study|Lost to Follow-up|3
1756364|NCT00827112|6120367|P2|Overall Study|Lack of Efficacy|0
1756365|NCT00827112|6120368|P1|Overall Study|Lack of Efficacy|2
1756366|NCT00827112|6120367|P2|Overall Study|Adverse Event|0
1756367|NCT00827112|6120368|P1|Overall Study|Adverse Event|2
1756368|NCT00826943|6120421|P6|Overall Study|Withdrawal by Subject|0
1756369|NCT00826943|6120422|P5|Overall Study|Withdrawal by Subject|1
1756370|NCT00826943|6120423|P4|Overall Study|Withdrawal by Subject|0
1756371|NCT00826943|6120424|P3|Overall Study|Withdrawal by Subject|0
1756372|NCT00826943|6120425|P2|Overall Study|Withdrawal by Subject|0
1756373|NCT00826943|6120426|P1|Overall Study|Withdrawal by Subject|0
1756374|NCT00826748|6120447|P3|Overall Study|Samples Did Not pass QC|1
1756375|NCT00826748|6120448|P2|Overall Study|Samples Did Not pass QC|0
1756376|NCT00826748|6120449|P1|Overall Study|Samples Did Not pass QC|0
1756377|NCT00826748|6120447|P3|Overall Study|Physician Decision|1
1756378|NCT00826748|6120448|P2|Overall Study|Physician Decision|0
1756379|NCT00826748|6120449|P1|Overall Study|Physician Decision|0
1756380|NCT00826748|6120447|P3|Overall Study|Withdrawal by Subject|2
1756381|NCT00826748|6120448|P2|Overall Study|Withdrawal by Subject|0
1756382|NCT00826748|6120449|P1|Overall Study|Withdrawal by Subject|0
1756383|NCT00826618|6120457|P1|Overall Study|Withdrawal by Subject|1
1756384|NCT00826540|6120461|P1|Overall Study|Withdrawal by Subject|1
1756385|NCT00826540|6120461|P1|Overall Study|ineligible|3
1756386|NCT00826449|6120467|P1|Overall Study|Withdrawal by Subject|1
1756387|NCT00826449|6120467|P1|Overall Study|Disease Progression|4
1756388|NCT00826280|6120476|P3|Overall Study|One or more non-interpretable scan|1
1756389|NCT00826280|6120477|P2|Overall Study|One or more non-interpretable scan|1
1756390|NCT00826280|6120478|P1|Overall Study|One or more non-interpretable scan|0
1756391|NCT00826280|6120476|P3|Overall Study|Machine Failure|0
1756392|NCT00826280|6120477|P2|Overall Study|Machine Failure|1
1756393|NCT00826280|6120478|P1|Overall Study|Machine Failure|1
1756394|NCT00826280|6120476|P3|Overall Study|Interpretation Failure|0
1756395|NCT00826280|6120477|P2|Overall Study|Interpretation Failure|0
1756396|NCT00826280|6120478|P1|Overall Study|Interpretation Failure|1
1756397|NCT00826280|6120476|P3|Overall Study|Reversible ischemic defect not present|44
1756398|NCT00826280|6120477|P2|Overall Study|Reversible ischemic defect not present|40
1756399|NCT00826280|6120478|P1|Overall Study|Reversible ischemic defect not present|43
1756400|NCT00826280|6120476|P3|Overall Study|Sponsor discontinued subject or study|0
1756401|NCT00826280|6120477|P2|Overall Study|Sponsor discontinued subject or study|0
1756402|NCT00826280|6120478|P1|Overall Study|Sponsor discontinued subject or study|1
1756403|NCT00826280|6120476|P3|Overall Study|Lost to Follow-up|0
1756404|NCT00826280|6120477|P2|Overall Study|Lost to Follow-up|1
1756405|NCT00826280|6120478|P1|Overall Study|Lost to Follow-up|0
1756406|NCT00826280|6120476|P3|Overall Study|Adverse Event|0
1756407|NCT00826280|6120477|P2|Overall Study|Adverse Event|3
1756408|NCT00826280|6120478|P1|Overall Study|Adverse Event|1
1756409|NCT00826280|6120476|P3|Overall Study|Randomized but drug not received|1
1756410|NCT00826280|6120477|P2|Overall Study|Randomized but drug not received|0
1756411|NCT00826280|6120478|P1|Overall Study|Randomized but drug not received|1
1756412|NCT00826267|6120507|P3|Overall Study|Other Adverse Event|0
1756413|NCT00826267|6120508|P2|Overall Study|Other Adverse Event|0
1756414|NCT00826267|6120509|P1|Overall Study|Other Adverse Event|1
1756415|NCT00826241|6120527|P1|Overall Study|Pt opt not to proceed w/trmt|1
1756416|NCT00826241|6120527|P1|Overall Study|Pt unable to proceed to registration|1
1756417|NCT00826241|6120527|P1|Overall Study|Screen failure|2
1756418|NCT00826241|6120527|P1|Overall Study|Could not obtain records|1
1756419|NCT00826241|6120527|P1|Overall Study|Lost to Follow-up|9
1756420|NCT00826241|6120527|P1|Overall Study|Patient refused follow-up|3
1756421|NCT00826241|6120527|P1|Overall Study|Progression of disease|1
1756422|NCT00826241|6120527|P1|Overall Study|Non-compliance|1
1756423|NCT00826241|6120527|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
1756424|NCT00826241|6120527|P1|Overall Study|Death|4
1756425|NCT00826241|6120527|P1|Overall Study|Withdrew consent|2
1756426|NCT00826241|6120527|P1|Overall Study|Withdrawal from Follow-up|1
1756427|NCT00826228|6120533|P1|Overall Study|Withdrawal by Subject|1
1756428|NCT00826176|6120555|P2|Overall Study|Administrative|0
1756429|NCT00826176|6120556|P1|Overall Study|Administrative|9
1756430|NCT00826176|6120555|P2|Overall Study|Subject Withdrew Consent|0
1756431|NCT00826176|6120556|P1|Overall Study|Subject Withdrew Consent|3
1756432|NCT00826176|6120555|P2|Overall Study|Lost to Follow-up|0
1756433|NCT00826176|6120556|P1|Overall Study|Lost to Follow-up|1
1756434|NCT00826111|6120605|P2|Overall Study|Physician Decision|1
1756435|NCT00826111|6120606|P1|Overall Study|Physician Decision|1
1756436|NCT00826111|6120605|P2|Overall Study|Withdrawal by Subject|0
1756437|NCT00826111|6120606|P1|Overall Study|Withdrawal by Subject|5
1756438|NCT00826111|6120605|P2|Overall Study|Protocol Violation|0
1756439|NCT00826111|6120606|P1|Overall Study|Protocol Violation|1
1756440|NCT00826111|6120605|P2|Overall Study|Lost to Follow-up|1
1756441|NCT00826111|6120606|P1|Overall Study|Lost to Follow-up|0
1756442|NCT00825994|6120641|P1|Overall Study|Placebo Responder at V2|1
1756443|NCT00825994|6120641|P1|Overall Study|Protocol Violation|1
1756444|NCT00825994|6120641|P1|Overall Study|Lost to Follow-up|1
1756445|NCT00825994|6120641|P1|Overall Study|Withdrawal by Subject|2
1756446|NCT00825916|6120649|P3|Overall Study|Lost to Follow-up|1
1756447|NCT00825916|6120650|P2|Overall Study|Lost to Follow-up|2
1756448|NCT00825916|6120651|P1|Overall Study|Lost to Follow-up|4
1756449|NCT00825825|6120692|P6|Third Medication Period (14 Days)|poor data quality|0
1756450|NCT00825825|6120693|P5|Third Medication Period (14 Days)|poor data quality|0
1756451|NCT00825825|6120694|P4|Third Medication Period (14 Days)|poor data quality|0
1756452|NCT00825825|6120695|P3|Third Medication Period (14 Days)|poor data quality|0
1756453|NCT00825825|6120696|P2|Third Medication Period (14 Days)|poor data quality|1
1756454|NCT00825825|6120697|P1|Third Medication Period (14 Days)|poor data quality|0
1756455|NCT00825825|6120692|P6|Third Medication Period (14 Days)|Protocol Violation|2
1756456|NCT00825825|6120693|P5|Third Medication Period (14 Days)|Protocol Violation|0
1756457|NCT00825825|6120694|P4|Third Medication Period (14 Days)|Protocol Violation|0
1756458|NCT00825825|6120695|P3|Third Medication Period (14 Days)|Protocol Violation|0
1756459|NCT00825825|6120696|P2|Third Medication Period (14 Days)|Protocol Violation|0
1756460|NCT00825825|6120697|P1|Third Medication Period (14 Days)|Protocol Violation|0
1756461|NCT00825825|6120692|P6|Third Medication Period (14 Days)|Adverse Event|0
1756462|NCT00825825|6120693|P5|Third Medication Period (14 Days)|Adverse Event|0
1756463|NCT00825825|6120694|P4|Third Medication Period (14 Days)|Adverse Event|0
1756464|NCT00825825|6120695|P3|Third Medication Period (14 Days)|Adverse Event|0
1756465|NCT00825825|6120696|P2|Third Medication Period (14 Days)|Adverse Event|1
1756466|NCT00825825|6120697|P1|Third Medication Period (14 Days)|Adverse Event|0
1756467|NCT00825825|6120692|P6|Second Medication Period (14 Days)|Protocol Violation|0
1756468|NCT00825825|6120693|P5|Second Medication Period (14 Days)|Protocol Violation|1
1756469|NCT00825825|6120694|P4|Second Medication Period (14 Days)|Protocol Violation|0
1756470|NCT00825825|6120695|P3|Second Medication Period (14 Days)|Protocol Violation|0
1756471|NCT00825825|6120696|P2|Second Medication Period (14 Days)|Protocol Violation|0
1756472|NCT00825825|6120697|P1|Second Medication Period (14 Days)|Protocol Violation|1
1756473|NCT00825825|6120692|P6|Second Medication Period (14 Days)|Physician Decision|0
1756474|NCT00825825|6120693|P5|Second Medication Period (14 Days)|Physician Decision|0
1756475|NCT00825825|6120694|P4|Second Medication Period (14 Days)|Physician Decision|2
1756476|NCT00825825|6120695|P3|Second Medication Period (14 Days)|Physician Decision|0
1756477|NCT00825825|6120696|P2|Second Medication Period (14 Days)|Physician Decision|0
1756478|NCT00825825|6120697|P1|Second Medication Period (14 Days)|Physician Decision|1
1756479|NCT00825825|6120692|P6|First Medication Period (14 Days)|Physician Decision|1
1756480|NCT00825825|6120693|P5|First Medication Period (14 Days)|Physician Decision|0
1756481|NCT00825825|6120694|P4|First Medication Period (14 Days)|Physician Decision|0
1756482|NCT00825825|6120695|P3|First Medication Period (14 Days)|Physician Decision|1
1756483|NCT00825825|6120696|P2|First Medication Period (14 Days)|Physician Decision|0
1756484|NCT00825825|6120697|P1|First Medication Period (14 Days)|Physician Decision|2
1756485|NCT00825825|6120692|P6|First Medication Period (14 Days)|Adverse Event|1
1756486|NCT00825825|6120693|P5|First Medication Period (14 Days)|Adverse Event|0
1756487|NCT00825825|6120694|P4|First Medication Period (14 Days)|Adverse Event|0
1756488|NCT00825825|6120695|P3|First Medication Period (14 Days)|Adverse Event|0
1756489|NCT00825825|6120696|P2|First Medication Period (14 Days)|Adverse Event|0
1756490|NCT00825825|6120697|P1|First Medication Period (14 Days)|Adverse Event|1
1756491|NCT00825812|6120713|P4|Overall Study|Administrative|5
1756492|NCT00825812|6120714|P3|Overall Study|Administrative|3
1756493|NCT00825812|6120715|P2|Overall Study|Administrative|1
1756494|NCT00825812|6120716|P1|Overall Study|Administrative|0
1756495|NCT00825812|6120713|P4|Overall Study|Non-compliance with protocol|1
1756496|NCT00825812|6120714|P3|Overall Study|Non-compliance with protocol|0
1756497|NCT00825812|6120715|P2|Overall Study|Non-compliance with protocol|0
1756498|NCT00825812|6120716|P1|Overall Study|Non-compliance with protocol|0
1756499|NCT00825812|6120713|P4|Overall Study|Subject withdrew consent|2
1756500|NCT00825812|6120714|P3|Overall Study|Subject withdrew consent|3
1756501|NCT00825812|6120715|P2|Overall Study|Subject withdrew consent|0
1756502|NCT00825812|6120716|P1|Overall Study|Subject withdrew consent|0
1756503|NCT00825812|6120713|P4|Overall Study|Adverse Event|1
1756504|NCT00825812|6120714|P3|Overall Study|Adverse Event|0
1756505|NCT00825812|6120715|P2|Overall Study|Adverse Event|0
1756506|NCT00825812|6120716|P1|Overall Study|Adverse Event|0
1756507|NCT00825812|6120713|P4|Overall Study|Never entered follow up|1
1756508|NCT00825812|6120714|P3|Overall Study|Never entered follow up|0
1756509|NCT00825812|6120715|P2|Overall Study|Never entered follow up|0
1756510|NCT00825812|6120716|P1|Overall Study|Never entered follow up|0
1756511|NCT00825682|6120763|P2|Overall Study|personal reasons/ inconvenience|5
1756512|NCT00825682|6120764|P1|Overall Study|personal reasons/ inconvenience|13
1756513|NCT00825305|6120855|P2|Overall Study|Can not be classified|1
1756514|NCT00825305|6120856|P1|Overall Study|Can not be classified|0
1756515|NCT00825305|6120855|P2|Overall Study|Protocol Violation|9
1756516|NCT00825305|6120856|P1|Overall Study|Protocol Violation|9
1756517|NCT00825305|6120855|P2|Overall Study|Inappropriate inclusion|0
1756518|NCT00825305|6120856|P1|Overall Study|Inappropriate inclusion|1
1756519|NCT00825305|6120855|P2|Overall Study|Withdrawal by Subject|12
1756520|NCT00825305|6120856|P1|Overall Study|Withdrawal by Subject|6
1756521|NCT00825305|6120855|P2|Overall Study|Adverse Event|1
1756522|NCT00825305|6120856|P1|Overall Study|Adverse Event|1
1756523|NCT00825175|6120896|P2|Overall Study|Withdrawal by Subject|5
1756524|NCT00825175|6120897|P1|Overall Study|Withdrawal by Subject|0
1756525|NCT00825162|6120906|P3|Overall Study|Unable to attend the study visit|0
1756526|NCT00825162|6120907|P2|Overall Study|Unable to attend the study visit|2
1756527|NCT00825162|6120908|P1|Overall Study|Unable to attend the study visit|5
1756528|NCT00825162|6120906|P3|Overall Study|Move away from the study area|0
1756529|NCT00825162|6120907|P2|Overall Study|Move away from the study area|0
1756530|NCT00825162|6120908|P1|Overall Study|Move away from the study area|1
1756531|NCT00825162|6120906|P3|Overall Study|Physician Decision|0
1756532|NCT00825162|6120907|P2|Overall Study|Physician Decision|0
1756533|NCT00825162|6120908|P1|Overall Study|Physician Decision|2
1756534|NCT00825162|6120906|P3|Overall Study|Lost to Follow-up|3
1756535|NCT00825162|6120907|P2|Overall Study|Lost to Follow-up|6
1756536|NCT00825162|6120908|P1|Overall Study|Lost to Follow-up|9
1756537|NCT00825162|6120906|P3|Overall Study|Withdrawal by Subject|3
1756538|NCT00825162|6120907|P2|Overall Study|Withdrawal by Subject|13
1756539|NCT00825162|6120908|P1|Overall Study|Withdrawal by Subject|11
1756540|NCT00824993|6120934|P2|Overall Study|Death|3
1756541|NCT00824993|6120935|P1|Overall Study|Death|0
1756542|NCT00824993|6120934|P2|Overall Study|Insurance Issue|1
1756543|NCT00824993|6120935|P1|Overall Study|Insurance Issue|2
1756544|NCT00824993|6120934|P2|Overall Study|Non-Compliant|1
1756545|NCT00824993|6120935|P1|Overall Study|Non-Compliant|2
1756546|NCT00824993|6120934|P2|Overall Study|Rapid Bone Loss|1
1756547|NCT00824993|6120935|P1|Overall Study|Rapid Bone Loss|0
1756548|NCT00824993|6120934|P2|Overall Study|Malignancy Relapse|10
1756549|NCT00824993|6120935|P1|Overall Study|Malignancy Relapse|9
1756550|NCT00824993|6120934|P2|Overall Study|Withdrawal by Subject|1
1756551|NCT00824993|6120935|P1|Overall Study|Withdrawal by Subject|1
1756552|NCT00824850|6120943|P2|Overall Study|Withdrawal by Subject|1
1756553|NCT00824850|6120944|P1|Overall Study|Withdrawal by Subject|0
1756554|NCT00824772|6120997|P1|Overall Study|Withdrawal by Subject|8
1756555|NCT00824720|6121017|P3|Overall Study|Protocol Violation|1
1756556|NCT00824720|6121018|P2|Overall Study|Protocol Violation|0
1756557|NCT00824720|6121019|P1|Overall Study|Protocol Violation|0
1756558|NCT00824720|6121017|P3|Overall Study|failed plug insertion|0
1756559|NCT00824720|6121018|P2|Overall Study|failed plug insertion|1
1756560|NCT00824720|6121019|P1|Overall Study|failed plug insertion|3
1756561|NCT00824655|6121035|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
1756562|NCT00824655|6121036|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
1756563|NCT00824655|6121035|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
1756564|NCT00824655|6121036|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
1756565|NCT00824616|6121056|P2|Overall Study|Withdrawal by Subject|1
1756566|NCT00824616|6121057|P1|Overall Study|Withdrawal by Subject|1
1756567|NCT00824616|6121056|P2|Overall Study|Lost to Follow-up|1
1756568|NCT00824616|6121057|P1|Overall Study|Lost to Follow-up|0
1756569|NCT00824616|6121056|P2|Overall Study|Lack of Efficacy|1
1756570|NCT00824616|6121057|P1|Overall Study|Lack of Efficacy|2
1756571|NCT00824616|6121056|P2|Overall Study|Hyperglycemia|1
1756572|NCT00824616|6121057|P1|Overall Study|Hyperglycemia|1
1756573|NCT00824616|6121056|P2|Overall Study|Creatinine/Creatinine Clearance|2
1756574|NCT00824616|6121057|P1|Overall Study|Creatinine/Creatinine Clearance|0
1756575|NCT00824616|6121056|P2|Overall Study|Adverse Event|1
1756576|NCT00824616|6121057|P1|Overall Study|Adverse Event|2
1756577|NCT00824564|6121067|P2|Overall Study|Randomized, but not treated|0
1756578|NCT00824564|6121068|P1|Overall Study|Randomized, but not treated|1
1756579|NCT00824564|6121067|P2|Overall Study|Other|2
1756580|NCT00824564|6121068|P1|Overall Study|Other|1
1756581|NCT00824564|6121067|P2|Overall Study|Withdrawal by Subject|1
1756582|NCT00824564|6121068|P1|Overall Study|Withdrawal by Subject|1
1756583|NCT00824564|6121067|P2|Overall Study|Lost to Follow-up|7
1756584|NCT00824564|6121068|P1|Overall Study|Lost to Follow-up|5
1756585|NCT00824473|6121147|P2|Overall Study|Other|1
1756586|NCT00824473|6121148|P1|Overall Study|Other|1
1756587|NCT00824473|6121147|P2|Overall Study|Withdrawal by Subject|3
1756588|NCT00824473|6121148|P1|Overall Study|Withdrawal by Subject|2
1756589|NCT00824473|6121147|P2|Overall Study|Non-Compliance|2
1756590|NCT00824473|6121148|P1|Overall Study|Non-Compliance|4
1756591|NCT00824473|6121147|P2|Overall Study|Protocol Violation|0
1756592|NCT00824473|6121148|P1|Overall Study|Protocol Violation|2
1756593|NCT00824473|6121147|P2|Overall Study|Lack of Efficacy|2
1756594|NCT00824473|6121148|P1|Overall Study|Lack of Efficacy|2
1756595|NCT00824473|6121147|P2|Overall Study|Adverse Event|5
1756596|NCT00824473|6121148|P1|Overall Study|Adverse Event|4
1756597|NCT00824421|6121229|P3|Overall Study|Other|0
1756598|NCT00824421|6121230|P2|Overall Study|Other|1
1756599|NCT00824421|6121231|P1|Overall Study|Other|0
1756600|NCT00824421|6121229|P3|Overall Study|Randomized but not Treated|0
1756601|NCT00824421|6121230|P2|Overall Study|Randomized but not Treated|1
1756602|NCT00824421|6121231|P1|Overall Study|Randomized but not Treated|1
1756603|NCT00824421|6121229|P3|Overall Study|Withdrawal by Subject|3
1756604|NCT00824421|6121230|P2|Overall Study|Withdrawal by Subject|3
1756605|NCT00824421|6121231|P1|Overall Study|Withdrawal by Subject|2
1756606|NCT00824421|6121229|P3|Overall Study|Pregnancy|1
1756607|NCT00824421|6121230|P2|Overall Study|Pregnancy|0
1756608|NCT00824421|6121231|P1|Overall Study|Pregnancy|1
1756609|NCT00824421|6121229|P3|Overall Study|Lost to Follow-up|0
1756610|NCT00824421|6121230|P2|Overall Study|Lost to Follow-up|3
1756611|NCT00824421|6121231|P1|Overall Study|Lost to Follow-up|2
1756612|NCT00824421|6121229|P3|Overall Study|Lack of Efficacy|4
1756613|NCT00824421|6121230|P2|Overall Study|Lack of Efficacy|7
1756614|NCT00824421|6121231|P1|Overall Study|Lack of Efficacy|5
1756615|NCT00824421|6121229|P3|Overall Study|Death|0
1756616|NCT00824421|6121230|P2|Overall Study|Death|1
1756617|NCT00824421|6121231|P1|Overall Study|Death|0
1756618|NCT00824421|6121229|P3|Overall Study|Adverse Event|6
1756619|NCT00824421|6121230|P2|Overall Study|Adverse Event|6
1756620|NCT00824421|6121231|P1|Overall Study|Adverse Event|6
1756621|NCT00824408|6121282|P5|Randomized Phase|Other reason not defined above|4
1756622|NCT00824408|6121283|P4|Randomized Phase|Other reason not defined above|2
1756623|NCT00824408|6121284|P3|Randomized Phase|Other reason not defined above|4
1756624|NCT00824408|6121285|P2|Randomized Phase|Other reason not defined above|0
1756625|NCT00824408|6121286|P1|Randomized Phase|Other reason not defined above|0
1756626|NCT00824408|6121282|P5|Randomized Phase|Refused to continue medication|2
1756627|NCT00824408|6121283|P4|Randomized Phase|Refused to continue medication|2
1756628|NCT00824408|6121284|P3|Randomized Phase|Refused to continue medication|2
1756629|NCT00824408|6121285|P2|Randomized Phase|Refused to continue medication|0
1756630|NCT00824408|6121286|P1|Randomized Phase|Refused to continue medication|0
1756631|NCT00824408|6121282|P5|Randomized Phase|Adverse Event|5
1756632|NCT00824408|6121283|P4|Randomized Phase|Adverse Event|5
1756633|NCT00824408|6121284|P3|Randomized Phase|Adverse Event|4
1756634|NCT00824408|6121285|P2|Randomized Phase|Adverse Event|0
1756635|NCT00824408|6121286|P1|Randomized Phase|Adverse Event|0
1756636|NCT00824408|6121282|P5|Randomized Phase|Progressive disease|34
1756637|NCT00824408|6121283|P4|Randomized Phase|Progressive disease|36
1756638|NCT00824408|6121284|P3|Randomized Phase|Progressive disease|25
1756639|NCT00824408|6121285|P2|Randomized Phase|Progressive disease|0
1756640|NCT00824408|6121286|P1|Randomized Phase|Progressive disease|0
1756641|NCT00824408|6121282|P5|Randomized Phase|Not treated|1
1756642|NCT00824408|6121283|P4|Randomized Phase|Not treated|1
1756643|NCT00824408|6121284|P3|Randomized Phase|Not treated|1
1756644|NCT00824408|6121285|P2|Randomized Phase|Not treated|0
1756645|NCT00824408|6121286|P1|Randomized Phase|Not treated|0
1756646|NCT00824408|6121282|P5|Run-in Phase|Other reason not defined above|0
1756647|NCT00824408|6121283|P4|Run-in Phase|Other reason not defined above|0
1756648|NCT00824408|6121284|P3|Run-in Phase|Other reason not defined above|0
1756649|NCT00824408|6121285|P2|Run-in Phase|Other reason not defined above|1
1756650|NCT00824408|6121286|P1|Run-in Phase|Other reason not defined above|0
1756651|NCT00824408|6121282|P5|Run-in Phase|Refused to continue medication|0
1756652|NCT00824408|6121283|P4|Run-in Phase|Refused to continue medication|0
1756653|NCT00824408|6121284|P3|Run-in Phase|Refused to continue medication|0
1756654|NCT00824408|6121285|P2|Run-in Phase|Refused to continue medication|0
1756655|NCT00824408|6121286|P1|Run-in Phase|Refused to continue medication|1
1756656|NCT00824408|6121282|P5|Run-in Phase|Adverse Event|0
1756657|NCT00824408|6121283|P4|Run-in Phase|Adverse Event|0
1756658|NCT00824408|6121284|P3|Run-in Phase|Adverse Event|0
1756659|NCT00824408|6121285|P2|Run-in Phase|Adverse Event|1
1756660|NCT00824408|6121286|P1|Run-in Phase|Adverse Event|1
1756661|NCT00824408|6121282|P5|Run-in Phase|Progressive disease|0
1756662|NCT00824408|6121283|P4|Run-in Phase|Progressive disease|0
1756663|NCT00824408|6121284|P3|Run-in Phase|Progressive disease|0
1756664|NCT00824408|6121285|P2|Run-in Phase|Progressive disease|4
1756665|NCT00824408|6121286|P1|Run-in Phase|Progressive disease|4
1756666|NCT00824382|6121338|P4|Overall Study|Investigator's decision|0
1756667|NCT00824382|6121339|P3|Overall Study|Investigator's decision|2
1756668|NCT00824382|6121340|P2|Overall Study|Investigator's decision|1
1756669|NCT00824382|6121341|P1|Overall Study|Investigator's decision|0
1756670|NCT00824382|6121338|P4|Overall Study|Protocol Violation|1
1756671|NCT00824382|6121339|P3|Overall Study|Protocol Violation|0
1756672|NCT00824382|6121340|P2|Overall Study|Protocol Violation|0
1756673|NCT00824382|6121341|P1|Overall Study|Protocol Violation|1
1756674|NCT00824382|6121338|P4|Overall Study|Adverse Event|4
1756675|NCT00824382|6121339|P3|Overall Study|Adverse Event|1
1756676|NCT00824382|6121340|P2|Overall Study|Adverse Event|1
1756677|NCT00824382|6121341|P1|Overall Study|Adverse Event|4
1756678|NCT00824369|6121417|P6|Overall Study|Lost to Follow-up|0
1756679|NCT00824369|6121418|P5|Overall Study|Lost to Follow-up|1
1756680|NCT00824369|6121419|P4|Overall Study|Lost to Follow-up|0
1756681|NCT00824369|6121420|P3|Overall Study|Lost to Follow-up|0
1756682|NCT00824369|6121421|P2|Overall Study|Lost to Follow-up|0
1756683|NCT00824369|6121422|P1|Overall Study|Lost to Follow-up|0
1756684|NCT00824369|6121417|P6|Overall Study|Nolonger willing to participate in study|1
1756685|NCT00824369|6121418|P5|Overall Study|Nolonger willing to participate in study|0
1756686|NCT00824369|6121419|P4|Overall Study|Nolonger willing to participate in study|2
1756687|NCT00824369|6121420|P3|Overall Study|Nolonger willing to participate in study|1
1756688|NCT00824369|6121421|P2|Overall Study|Nolonger willing to participate in study|0
1756689|NCT00824369|6121422|P1|Overall Study|Nolonger willing to participate in study|1
1756690|NCT00824291|6121462|P2|Overall Study|Participant on prohibited medication|0
1756691|NCT00824291|6121463|P1|Overall Study|Participant on prohibited medication|1
1756692|NCT00824291|6121462|P2|Overall Study|Lack of Efficacy|8
1756693|NCT00824291|6121463|P1|Overall Study|Lack of Efficacy|7
1756694|NCT00824291|6121462|P2|Overall Study|Withdrawal by Subject|8
1756695|NCT00824291|6121463|P1|Overall Study|Withdrawal by Subject|14
1756696|NCT00824291|6121462|P2|Overall Study|Protocol Violation|1
1756697|NCT00824291|6121463|P1|Overall Study|Protocol Violation|4
1756698|NCT00824291|6121462|P2|Overall Study|Non-compliance|1
1756699|NCT00824291|6121463|P1|Overall Study|Non-compliance|1
1756700|NCT00824291|6121462|P2|Overall Study|Lost to Follow-up|9
1756701|NCT00824291|6121463|P1|Overall Study|Lost to Follow-up|11
1756702|NCT00824291|6121462|P2|Overall Study|Discontinuation of Study by Sponsor|2
1756703|NCT00824291|6121463|P1|Overall Study|Discontinuation of Study by Sponsor|1
1756704|NCT00824291|6121462|P2|Overall Study|Adverse Event|6
1756705|NCT00824291|6121463|P1|Overall Study|Adverse Event|15
1756706|NCT00824265|6121485|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
1756795|NCT00823212|6121939|P2|Overall Study|Incarcerated|1
1756707|NCT00824265|6121486|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
1756708|NCT00824265|6121485|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
1756709|NCT00824265|6121486|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
1756710|NCT00824265|6121485|P2|Treatment Phase|Withdrawal by Subject|15
1756711|NCT00824265|6121486|P1|Treatment Phase|Withdrawal by Subject|6
1756712|NCT00824265|6121485|P2|Treatment Phase|Physician Decision|12
1756713|NCT00824265|6121486|P1|Treatment Phase|Physician Decision|6
1756714|NCT00824265|6121485|P2|Treatment Phase|Lost to Follow-up|1
1756715|NCT00824265|6121486|P1|Treatment Phase|Lost to Follow-up|1
1756716|NCT00824265|6121485|P2|Treatment Phase|Protocol Violation|0
1756717|NCT00824265|6121486|P1|Treatment Phase|Protocol Violation|1
1756718|NCT00824265|6121485|P2|Treatment Phase|Adverse Event,non-fatal|52
1756719|NCT00824265|6121486|P1|Treatment Phase|Adverse Event,non-fatal|50
1756720|NCT00824161|6121547|P1|Overall Study|Screen Failure|1
1756721|NCT00824161|6121547|P1|Overall Study|Withdrawal by Subject|1
1756722|NCT00824005|6121613|P2|Overall Study|Lost to Follow-up|1
1756723|NCT00824005|6121614|P1|Overall Study|Lost to Follow-up|0
1756724|NCT00824005|6121613|P2|Overall Study|Death|1
1756725|NCT00824005|6121614|P1|Overall Study|Death|0
1756726|NCT00823979|6121649|P3|Overall Study|Study Terminated by Sponsor|7
1756727|NCT00823979|6121650|P2|Overall Study|Study Terminated by Sponsor|5
1756728|NCT00823979|6121651|P1|Overall Study|Study Terminated by Sponsor|5
1756729|NCT00823979|6121649|P3|Overall Study|Randomized but not Treated|1
1756730|NCT00823979|6121650|P2|Overall Study|Randomized but not Treated|3
1756731|NCT00823979|6121651|P1|Overall Study|Randomized but not Treated|4
1756732|NCT00823979|6121649|P3|Overall Study|Other|1
1756733|NCT00823979|6121650|P2|Overall Study|Other|0
1756734|NCT00823979|6121651|P1|Overall Study|Other|2
1756735|NCT00823979|6121649|P3|Overall Study|Adverse Event|4
1756736|NCT00823979|6121650|P2|Overall Study|Adverse Event|2
1756737|NCT00823979|6121651|P1|Overall Study|Adverse Event|0
1756738|NCT00823979|6121649|P3|Overall Study|Pregnancy|0
1756739|NCT00823979|6121650|P2|Overall Study|Pregnancy|1
1756740|NCT00823979|6121651|P1|Overall Study|Pregnancy|0
1756741|NCT00823979|6121649|P3|Overall Study|Protocol Violation|0
1756742|NCT00823979|6121650|P2|Overall Study|Protocol Violation|1
1756743|NCT00823979|6121651|P1|Overall Study|Protocol Violation|1
1756744|NCT00823979|6121649|P3|Overall Study|Withdrawal by Subject|2
1756745|NCT00823979|6121650|P2|Overall Study|Withdrawal by Subject|3
1756746|NCT00823979|6121651|P1|Overall Study|Withdrawal by Subject|2
1756747|NCT00823979|6121649|P3|Overall Study|Lost to Follow-up|0
1756748|NCT00823979|6121650|P2|Overall Study|Lost to Follow-up|1
1756749|NCT00823979|6121651|P1|Overall Study|Lost to Follow-up|2
1756750|NCT00823979|6121649|P3|Overall Study|Lack of Efficacy|9
1756751|NCT00823979|6121650|P2|Overall Study|Lack of Efficacy|16
1756752|NCT00823979|6121651|P1|Overall Study|Lack of Efficacy|13
1756753|NCT00823901|6121696|P2|Overall Study|Lost to Follow-up|1
1756754|NCT00823901|6121697|P1|Overall Study|Lost to Follow-up|2
1756755|NCT00823901|6121696|P2|Overall Study|Lack of Efficacy|0
1756756|NCT00823901|6121697|P1|Overall Study|Lack of Efficacy|1
1756757|NCT00823901|6121696|P2|Overall Study|Adverse Event|1
1756758|NCT00823901|6121697|P1|Overall Study|Adverse Event|1
1756759|NCT00823836|6121705|P2|Long-term Phase|Withdrawal by Subject|1
1756760|NCT00823836|6121706|P1|Long-term Phase|Withdrawal by Subject|1
1756761|NCT00823836|6121705|P2|Long-term Phase|Physician Decision|2
1756762|NCT00823836|6121706|P1|Long-term Phase|Physician Decision|1
1756763|NCT00823836|6121705|P2|Long-term Phase|Adverse Event|2
1756764|NCT00823836|6121706|P1|Long-term Phase|Adverse Event|3
1756765|NCT00823836|6121705|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
1756766|NCT00823836|6121706|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
1756767|NCT00823836|6121705|P2|NV and PR/XR Switching Phases|Physician Decision|2
1756768|NCT00823836|6121706|P1|NV and PR/XR Switching Phases|Physician Decision|5
1756769|NCT00823836|6121705|P2|NV and PR/XR Switching Phases|Protocol Violation|1
1756770|NCT00823836|6121706|P1|NV and PR/XR Switching Phases|Protocol Violation|1
1756771|NCT00823836|6121705|P2|NV and PR/XR Switching Phases|Adverse Event|21
1756772|NCT00823836|6121706|P1|NV and PR/XR Switching Phases|Adverse Event|22
1756773|NCT00823823|6121812|P2|Overall Study|Protocol Violation|5
1756774|NCT00823823|6121813|P1|Overall Study|Protocol Violation|5
1756775|NCT00823823|6121812|P2|Overall Study|Lost to Follow-up|1
1756776|NCT00823823|6121813|P1|Overall Study|Lost to Follow-up|3
1756777|NCT00823719|6121837|P2|Overall Study|Disease Progression|4
1756778|NCT00823719|6121838|P1|Overall Study|Disease Progression|4
1756779|NCT00823719|6121837|P2|Overall Study|Withdrawal by Subject|1
1756780|NCT00823719|6121838|P1|Overall Study|Withdrawal by Subject|0
1756781|NCT00823719|6121837|P2|Overall Study|Physician Decision|4
1756782|NCT00823719|6121838|P1|Overall Study|Physician Decision|1
1756783|NCT00823719|6121837|P2|Overall Study|Adverse Event|2
1756784|NCT00823719|6121838|P1|Overall Study|Adverse Event|1
1756785|NCT00823615|6121891|P2|Period 2|Time/Job Conflict|2
1756786|NCT00823615|6121892|P1|Period 2|Time/Job Conflict|1
1756787|NCT00823615|6121891|P2|Period 2|Lost to Follow-up|0
1756788|NCT00823615|6121892|P1|Period 2|Lost to Follow-up|2
1756789|NCT00823472|6121902|P2|Overall Study|Physician Decision|28
1756790|NCT00823472|6121903|P1|Overall Study|Physician Decision|24
1756791|NCT00823264|6121930|P2|Overall Study|Protocol Violation|0
1756792|NCT00823264|6121931|P1|Overall Study|Protocol Violation|2
1756793|NCT00823212|6121939|P2|Overall Study|Missed 12-month visit|21
1756794|NCT00823212|6121940|P1|Overall Study|Missed 12-month visit|21
1756796|NCT00823212|6121940|P1|Overall Study|Incarcerated|0
1756797|NCT00823212|6121939|P2|Overall Study|Withdrawal by Subject|1
1756798|NCT00823212|6121940|P1|Overall Study|Withdrawal by Subject|6
1756799|NCT00823212|6121939|P2|Overall Study|Death|10
1756800|NCT00823212|6121940|P1|Overall Study|Death|8
1756801|NCT00823199|6122022|P1|Overall Study|Withdrawal by Subject|2
1756802|NCT00822926|6122091|P2|Second Injection Visit|Withdrawal by Subject|1
1756803|NCT00822926|6122092|P1|Second Injection Visit|Withdrawal by Subject|0
1756804|NCT00822926|6122091|P2|Second Injection Visit|Lost to Follow-up|0
1756805|NCT00822926|6122092|P1|Second Injection Visit|Lost to Follow-up|1
1756806|NCT00822900|6122106|P2|Overall Study|Became a ward of the state|1
1756807|NCT00822900|6122107|P1|Overall Study|Became a ward of the state|2
1756808|NCT00822900|6122106|P2|Overall Study|Death|69
1756809|NCT00822900|6122107|P1|Overall Study|Death|83
1756810|NCT00822900|6122106|P2|Overall Study|Lost to Follow-up|9
1756811|NCT00822900|6122107|P1|Overall Study|Lost to Follow-up|9
1756812|NCT00822900|6122106|P2|Overall Study|Withdrawal by Subject|14
1756813|NCT00822900|6122107|P1|Overall Study|Withdrawal by Subject|14
1756814|NCT00822692|6122154|P2|Overall Study|Lost to Follow-up|25
1756815|NCT00822692|6122155|P1|Overall Study|Lost to Follow-up|17
1756816|NCT00822237|6122293|P2|Dose 2 Vaccination|Lost to Follow-up|9
1756817|NCT00822237|6122294|P1|Dose 2 Vaccination|Lost to Follow-up|2
1756818|NCT00822237|6122293|P2|Dose 2 Vaccination|Withdrawal by Subject|2
1756819|NCT00822237|6122294|P1|Dose 2 Vaccination|Withdrawal by Subject|2
1756820|NCT00822237|6122293|P2|Dose 1 Vaccination|Lost to Follow-up|12
1756821|NCT00822237|6122294|P1|Dose 1 Vaccination|Lost to Follow-up|9
1756822|NCT00822237|6122293|P2|Dose 1 Vaccination|Withdrawal by Subject|14
1756823|NCT00822237|6122294|P1|Dose 1 Vaccination|Withdrawal by Subject|13
1756824|NCT00822237|6122293|P2|Dose 1 Vaccination|Not vaccinated|0
1756825|NCT00822237|6122294|P1|Dose 1 Vaccination|Not vaccinated|3
1756826|NCT00822172|6122375|P2|Overall Study|Other|1
1756827|NCT00822172|6122376|P1|Overall Study|Other|0
1756828|NCT00822172|6122375|P2|Overall Study|site closed|1
1756829|NCT00822172|6122376|P1|Overall Study|site closed|0
1756830|NCT00822172|6122375|P2|Overall Study|Withdrawal by Subject|4
1756831|NCT00822172|6122376|P1|Overall Study|Withdrawal by Subject|1
1756832|NCT00822172|6122375|P2|Overall Study|Lost to Follow-up|1
1756833|NCT00822172|6122376|P1|Overall Study|Lost to Follow-up|3
1756834|NCT00822172|6122375|P2|Overall Study|Death|0
1756835|NCT00822172|6122376|P1|Overall Study|Death|1
1756836|NCT00822172|6122375|P2|Overall Study|Adverse Event|12
1756837|NCT00822172|6122376|P1|Overall Study|Adverse Event|10
1756838|NCT00822120|6122396|P6|PET-directed Therapy|Protocol Violation|0
1756839|NCT00822120|6122397|P5|PET-directed Therapy|Protocol Violation|0
1756840|NCT00822120|6122398|P4|PET-directed Therapy|Protocol Violation|6
1756841|NCT00822120|6122399|P3|PET-directed Therapy|Protocol Violation|0
1756842|NCT00822120|6122400|P2|PET-directed Therapy|Protocol Violation|0
1756843|NCT00822120|6122401|P1|PET-directed Therapy|Protocol Violation|0
1756844|NCT00822120|6122396|P6|PET-directed Therapy|Death|0
1756845|NCT00822120|6122397|P5|PET-directed Therapy|Death|0
1756846|NCT00822120|6122398|P4|PET-directed Therapy|Death|2
1756847|NCT00822120|6122399|P3|PET-directed Therapy|Death|0
1756848|NCT00822120|6122400|P2|PET-directed Therapy|Death|0
1756849|NCT00822120|6122401|P1|PET-directed Therapy|Death|0
1756850|NCT00822120|6122396|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1756851|NCT00822120|6122397|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1756852|NCT00822120|6122398|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
1756853|NCT00822120|6122399|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1756854|NCT00822120|6122400|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1756855|NCT00822120|6122401|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
1756856|NCT00822120|6122396|P6|PET-directed Therapy|Adverse Event|0
1756857|NCT00822120|6122397|P5|PET-directed Therapy|Adverse Event|0
1756858|NCT00822120|6122398|P4|PET-directed Therapy|Adverse Event|1
1756859|NCT00822120|6122399|P3|PET-directed Therapy|Adverse Event|0
1756860|NCT00822120|6122400|P2|PET-directed Therapy|Adverse Event|0
1756861|NCT00822120|6122401|P1|PET-directed Therapy|Adverse Event|0
1756862|NCT00822120|6122396|P6|Initial Registration|Ineligible|0
1756863|NCT00822120|6122397|P5|Initial Registration|Ineligible|0
1756864|NCT00822120|6122398|P4|Initial Registration|Ineligible|0
1756865|NCT00822120|6122399|P3|Initial Registration|Ineligible|0
1756866|NCT00822120|6122400|P2|Initial Registration|Ineligible|1
1756867|NCT00822120|6122401|P1|Initial Registration|Ineligible|22
1756868|NCT00822120|6122396|P6|Initial Registration|Reasons not Protocol Specified|0
1756869|NCT00822120|6122397|P5|Initial Registration|Reasons not Protocol Specified|0
1756870|NCT00822120|6122398|P4|Initial Registration|Reasons not Protocol Specified|0
1756871|NCT00822120|6122399|P3|Initial Registration|Reasons not Protocol Specified|0
1756872|NCT00822120|6122400|P2|Initial Registration|Reasons not Protocol Specified|0
1756873|NCT00822120|6122401|P1|Initial Registration|Reasons not Protocol Specified|2
1756874|NCT00822120|6122396|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
1756875|NCT00822120|6122397|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
1756876|NCT00822120|6122398|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
1756877|NCT00822120|6122399|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
1756878|NCT00822120|6122400|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
1756879|NCT00822120|6122401|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
1756880|NCT00822120|6122396|P6|Initial Registration|Adverse Event|0
1756881|NCT00822120|6122397|P5|Initial Registration|Adverse Event|0
1756882|NCT00822120|6122398|P4|Initial Registration|Adverse Event|0
1756883|NCT00822120|6122399|P3|Initial Registration|Adverse Event|0
1756884|NCT00822120|6122400|P2|Initial Registration|Adverse Event|0
1756885|NCT00822120|6122401|P1|Initial Registration|Adverse Event|1
1756886|NCT00821873|6122467|P1|Overall Study|Lost to Follow-up|4
1756887|NCT00821678|6122488|P2|Overall Study|Death|2
1756888|NCT00821678|6122489|P1|Overall Study|Death|0
1756889|NCT00821678|6122488|P2|Overall Study|Lost to Follow-up|12
1756890|NCT00821678|6122489|P1|Overall Study|Lost to Follow-up|13
1756891|NCT00821678|6122488|P2|Overall Study|Withdrawal by Subject|0
1756892|NCT00821678|6122489|P1|Overall Study|Withdrawal by Subject|8
1756893|NCT00821587|6122511|P2|Overall Study|Physician Decision|1
1756894|NCT00821587|6122512|P1|Overall Study|Physician Decision|0
1756895|NCT00821509|6122521|P3|Overall Study|Withdrawal by Subject|34
1756896|NCT00821509|6122522|P2|Overall Study|Withdrawal by Subject|11
1756897|NCT00821509|6122523|P1|Overall Study|Withdrawal by Subject|12
1756898|NCT00821431|6122536|P2|Overall Study|Physician Decision|1
1756899|NCT00821431|6122537|P1|Overall Study|Physician Decision|0
1756900|NCT00821431|6122536|P2|Overall Study|Protocol Violation|1
1756901|NCT00821431|6122537|P1|Overall Study|Protocol Violation|3
1756902|NCT00821431|6122536|P2|Overall Study|Lost to Follow-up|0
1756903|NCT00821431|6122537|P1|Overall Study|Lost to Follow-up|1
1756904|NCT00821431|6122536|P2|Overall Study|Withdrawal by Subject|0
1756905|NCT00821431|6122537|P1|Overall Study|Withdrawal by Subject|5
1756906|NCT00821431|6122536|P2|Overall Study|Adverse Event|3
1756907|NCT00821431|6122537|P1|Overall Study|Adverse Event|6
1756908|NCT00821327|6122545|P1|Overall Study|Other/Unknown|5
1756909|NCT00821327|6122545|P1|Overall Study|Disease Progression|13
1756910|NCT00821327|6122545|P1|Overall Study|Sponsor Request|1
1756911|NCT00821327|6122545|P1|Overall Study|Investigator Request|2
1756912|NCT00821327|6122545|P1|Overall Study|Patient Request|1
1756913|NCT00821327|6122545|P1|Overall Study|Adverse Event|13
1756914|NCT00821236|6122554|P1|Overall Study|Lost to Follow-up|3
1756915|NCT00821093|6122594|P2|Overall Study|Administrative problems|2
1756916|NCT00821093|6122595|P1|Overall Study|Administrative problems|1
1756917|NCT00821093|6122594|P2|Overall Study|Abnormal test procedure result(s)|1
1756918|NCT00821093|6122595|P1|Overall Study|Abnormal test procedure result(s)|1
1756919|NCT00821093|6122594|P2|Overall Study|Death|1
1756920|NCT00821093|6122595|P1|Overall Study|Death|2
1756921|NCT00821093|6122594|P2|Overall Study|Lack of Efficacy|2
1756922|NCT00821093|6122595|P1|Overall Study|Lack of Efficacy|2
1756923|NCT00821093|6122594|P2|Overall Study|Abnormal laboratory value(s)|0
1756924|NCT00821093|6122595|P1|Overall Study|Abnormal laboratory value(s)|2
1756925|NCT00821093|6122594|P2|Overall Study|Protocol deviation|6
1756926|NCT00821093|6122595|P1|Overall Study|Protocol deviation|3
1756927|NCT00821093|6122594|P2|Overall Study|Lost to Follow-up|3
1756928|NCT00821093|6122595|P1|Overall Study|Lost to Follow-up|9
1756929|NCT00821093|6122594|P2|Overall Study|Withdrawal by Subject|13
1756930|NCT00821093|6122595|P1|Overall Study|Withdrawal by Subject|9
1756931|NCT00821093|6122594|P2|Overall Study|Adverse Event|12
1756932|NCT00821093|6122595|P1|Overall Study|Adverse Event|20
1756933|NCT00821015|6122614|P1|Overall Study|Lost to Follow-up|12
1756934|NCT00820898|6122625|P1|Overall Study|Inelgible - wrong primary site|1
1756935|NCT00820755|6122639|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
1756936|NCT00820755|6122640|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
1756937|NCT00820755|6122641|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
1756938|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Other|0
1756939|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Other|0
1756940|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Other|11
1756941|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
1756942|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
1756943|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
1756944|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Progressive disease|0
1756945|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Progressive disease|0
1756946|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Progressive disease|114
1756947|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
1756948|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
1756949|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
1756950|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
1756951|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
1756952|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
1756953|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
1756954|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
1756955|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
1756956|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Death|0
1756957|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Death|0
1756958|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Death|28
1756959|NCT00820755|6122639|P3|Period 1: Combination Therapy Phase|Adverse Event|0
1756960|NCT00820755|6122640|P2|Period 1: Combination Therapy Phase|Adverse Event|0
1756961|NCT00820755|6122641|P1|Period 1: Combination Therapy Phase|Adverse Event|77
1756962|NCT00820248|6122734|P2|Overall Study|No treated|1
1756963|NCT00820248|6122735|P1|Overall Study|No treated|4
1756964|NCT00820222|6122745|P2|Overall Study|Unkown|7
1756965|NCT00820222|6122746|P1|Overall Study|Unkown|11
1756966|NCT00820222|6122745|P2|Overall Study|Sponsor Terminated Study|65
1756967|NCT00820222|6122746|P1|Overall Study|Sponsor Terminated Study|43
1756968|NCT00820222|6122745|P2|Overall Study|Physician Decision|88
1756969|NCT00820222|6122746|P1|Overall Study|Physician Decision|93
1756970|NCT00820222|6122745|P2|Overall Study|Withdrawal by Subject|21
1756971|NCT00820222|6122746|P1|Overall Study|Withdrawal by Subject|19
1756972|NCT00820222|6122745|P2|Overall Study|Lost to Follow-up|9
1756973|NCT00820222|6122746|P1|Overall Study|Lost to Follow-up|10
1756974|NCT00820170|6122777|P5|Overall Study|Progressive Disease|2
1756975|NCT00820170|6122778|P4|Overall Study|Progressive Disease|0
1756976|NCT00820170|6122779|P3|Overall Study|Progressive Disease|0
1756977|NCT00820170|6122780|P2|Overall Study|Progressive Disease|0
1756978|NCT00820170|6122781|P1|Overall Study|Progressive Disease|0
1756979|NCT00820170|6122777|P5|Overall Study|Adverse Event|2
1756980|NCT00820170|6122778|P4|Overall Study|Adverse Event|0
1756981|NCT00820170|6122779|P3|Overall Study|Adverse Event|0
1756982|NCT00820170|6122780|P2|Overall Study|Adverse Event|0
1756983|NCT00820170|6122781|P1|Overall Study|Adverse Event|0
1756984|NCT00819910|6122833|P4|Overall Study|Lost to Follow-up|0
1756985|NCT00819910|6122834|P3|Overall Study|Lost to Follow-up|0
1756986|NCT00819910|6122835|P2|Overall Study|Lost to Follow-up|0
1756987|NCT00819910|6122836|P1|Overall Study|Lost to Follow-up|1
1756988|NCT00819910|6122833|P4|Overall Study|Withdrawal by Subject|0
1756989|NCT00819910|6122834|P3|Overall Study|Withdrawal by Subject|1
1756990|NCT00819910|6122835|P2|Overall Study|Withdrawal by Subject|1
1756991|NCT00819910|6122836|P1|Overall Study|Withdrawal by Subject|1
1756992|NCT00819910|6122833|P4|Overall Study|Adverse Event|1
1756993|NCT00819910|6122834|P3|Overall Study|Adverse Event|2
1756994|NCT00819910|6122835|P2|Overall Study|Adverse Event|0
1756995|NCT00819910|6122836|P1|Overall Study|Adverse Event|0
1756996|NCT00819832|6122868|P6|Overall Study|Sponsor Termination of Study|0
1756997|NCT00819832|6122869|P5|Overall Study|Sponsor Termination of Study|0
1756998|NCT00819832|6122870|P4|Overall Study|Sponsor Termination of Study|0
1756999|NCT00819832|6122871|P3|Overall Study|Sponsor Termination of Study|0
1757000|NCT00819832|6122872|P2|Overall Study|Sponsor Termination of Study|0
1757001|NCT00819832|6122873|P1|Overall Study|Sponsor Termination of Study|3
1757002|NCT00819780|6122894|P2|Overall Study|Still in treatment|17
1757003|NCT00819780|6122895|P1|Overall Study|Still in treatment|25
1757004|NCT00819780|6122894|P2|Overall Study|Did not receive study drug|4
1757005|NCT00819780|6122895|P1|Overall Study|Did not receive study drug|3
1757006|NCT00819767|6122929|P2|Overall Study|Unsatisfactory therapeutic effect|2
1757007|NCT00819767|6122930|P1|Overall Study|Unsatisfactory therapeutic effect|1
1757008|NCT00819741|6122942|P2|Overall Study|Reasons unknown|3
1757009|NCT00819741|6122943|P1|Overall Study|Reasons unknown|3
1757010|NCT00819741|6122942|P2|Overall Study|Unclassified|0
1757011|NCT00819741|6122943|P1|Overall Study|Unclassified|6
1757012|NCT00819741|6122942|P2|Overall Study|Withdrawal by Subject|2
1757013|NCT00819741|6122943|P1|Overall Study|Withdrawal by Subject|2
1757014|NCT00819741|6122942|P2|Overall Study|Protocol Violation|4
1757015|NCT00819741|6122943|P1|Overall Study|Protocol Violation|3
1757016|NCT00819741|6122942|P2|Overall Study|Lost to Follow-up|1
1757017|NCT00819741|6122943|P1|Overall Study|Lost to Follow-up|3
1757018|NCT00819741|6122942|P2|Overall Study|Lack of Efficacy|2
1757019|NCT00819741|6122943|P1|Overall Study|Lack of Efficacy|0
1757020|NCT00819741|6122942|P2|Overall Study|Adverse Event|2
1757021|NCT00819741|6122943|P1|Overall Study|Adverse Event|5
1757022|NCT00819585|6122997|P11|Extension Study|Death|0
1757023|NCT00819585|6122998|P10|Extension Study|Death|0
1757024|NCT00819585|6122999|P9|Extension Study|Death|2
1757025|NCT00819585|6123000|P8|Extension Study|Death|0
1757026|NCT00819585|6123001|P7|Extension Study|Death|0
1757027|NCT00819585|6123002|P6|Extension Study|Death|0
1757028|NCT00819585|6123003|P5|Extension Study|Death|0
1757029|NCT00819585|6123004|P4|Extension Study|Death|0
1757030|NCT00819585|6123005|P3|Extension Study|Death|0
1757031|NCT00819585|6123006|P2|Extension Study|Death|0
1757032|NCT00819585|6123007|P1|Extension Study|Death|0
1757033|NCT00819585|6122997|P11|Extension Study|Lost to Follow-up|1
1757034|NCT00819585|6122998|P10|Extension Study|Lost to Follow-up|1
1757035|NCT00819585|6122999|P9|Extension Study|Lost to Follow-up|2
1757036|NCT00819585|6123000|P8|Extension Study|Lost to Follow-up|0
1757037|NCT00819585|6123001|P7|Extension Study|Lost to Follow-up|0
1757038|NCT00819585|6123002|P6|Extension Study|Lost to Follow-up|0
1757039|NCT00819585|6123003|P5|Extension Study|Lost to Follow-up|0
1757040|NCT00819585|6123004|P4|Extension Study|Lost to Follow-up|0
1757041|NCT00819585|6123005|P3|Extension Study|Lost to Follow-up|0
1757042|NCT00819585|6123006|P2|Extension Study|Lost to Follow-up|0
1757043|NCT00819585|6123007|P1|Extension Study|Lost to Follow-up|0
1757044|NCT00819585|6122997|P11|Extension Study|Subject Withdrew Consent|1
1757045|NCT00819585|6122998|P10|Extension Study|Subject Withdrew Consent|0
1757046|NCT00819585|6122999|P9|Extension Study|Subject Withdrew Consent|3
1757047|NCT00819585|6123000|P8|Extension Study|Subject Withdrew Consent|0
1757048|NCT00819585|6123001|P7|Extension Study|Subject Withdrew Consent|0
1757049|NCT00819585|6123002|P6|Extension Study|Subject Withdrew Consent|0
1757050|NCT00819585|6123003|P5|Extension Study|Subject Withdrew Consent|0
1757051|NCT00819585|6123004|P4|Extension Study|Subject Withdrew Consent|0
1757052|NCT00819585|6123005|P3|Extension Study|Subject Withdrew Consent|0
1757053|NCT00819585|6123006|P2|Extension Study|Subject Withdrew Consent|0
1757054|NCT00819585|6123007|P1|Extension Study|Subject Withdrew Consent|0
1757055|NCT00819585|6122997|P11|Extension Study|Abnormal Laboratory Value(s)|0
1757056|NCT00819585|6122998|P10|Extension Study|Abnormal Laboratory Value(s)|0
1757057|NCT00819585|6122999|P9|Extension Study|Abnormal Laboratory Value(s)|1
1757058|NCT00819585|6123000|P8|Extension Study|Abnormal Laboratory Value(s)|0
1757059|NCT00819585|6123001|P7|Extension Study|Abnormal Laboratory Value(s)|0
1757060|NCT00819585|6123002|P6|Extension Study|Abnormal Laboratory Value(s)|0
1757061|NCT00819585|6123003|P5|Extension Study|Abnormal Laboratory Value(s)|0
1757062|NCT00819585|6123004|P4|Extension Study|Abnormal Laboratory Value(s)|0
1757063|NCT00819585|6123005|P3|Extension Study|Abnormal Laboratory Value(s)|0
1757064|NCT00819585|6123006|P2|Extension Study|Abnormal Laboratory Value(s)|0
1757065|NCT00819585|6123007|P1|Extension Study|Abnormal Laboratory Value(s)|0
1757066|NCT00819585|6122997|P11|Core Study|Protocol Violation|0
1757067|NCT00819585|6122998|P10|Core Study|Protocol Violation|0
1757068|NCT00819585|6122999|P9|Core Study|Protocol Violation|0
1757069|NCT00819585|6123000|P8|Core Study|Protocol Violation|0
1757070|NCT00819585|6123001|P7|Core Study|Protocol Violation|3
1757071|NCT00819585|6123002|P6|Core Study|Protocol Violation|1
1757072|NCT00819585|6123003|P5|Core Study|Protocol Violation|0
1757073|NCT00819585|6123004|P4|Core Study|Protocol Violation|0
1757074|NCT00819585|6123005|P3|Core Study|Protocol Violation|1
1757075|NCT00819585|6123006|P2|Core Study|Protocol Violation|0
1757076|NCT00819585|6123007|P1|Core Study|Protocol Violation|0
1757077|NCT00819585|6122997|P11|Core Study|Death|0
1757078|NCT00819585|6122998|P10|Core Study|Death|0
1757079|NCT00819585|6122999|P9|Core Study|Death|0
1757080|NCT00819585|6123000|P8|Core Study|Death|0
1757081|NCT00819585|6123001|P7|Core Study|Death|1
1757082|NCT00819585|6123002|P6|Core Study|Death|0
1757083|NCT00819585|6123003|P5|Core Study|Death|0
1757084|NCT00819585|6123004|P4|Core Study|Death|0
1757085|NCT00819585|6123005|P3|Core Study|Death|0
1757086|NCT00819585|6123006|P2|Core Study|Death|0
1757087|NCT00819585|6123007|P1|Core Study|Death|0
1757088|NCT00819585|6122997|P11|Core Study|Administrative Problems|0
1757089|NCT00819585|6122998|P10|Core Study|Administrative Problems|0
1757090|NCT00819585|6122999|P9|Core Study|Administrative Problems|0
1757091|NCT00819585|6123000|P8|Core Study|Administrative Problems|0
1757092|NCT00819585|6123001|P7|Core Study|Administrative Problems|2
1757093|NCT00819585|6123002|P6|Core Study|Administrative Problems|0
1757094|NCT00819585|6123003|P5|Core Study|Administrative Problems|0
1757095|NCT00819585|6123004|P4|Core Study|Administrative Problems|0
1757096|NCT00819585|6123005|P3|Core Study|Administrative Problems|0
1757097|NCT00819585|6123006|P2|Core Study|Administrative Problems|0
1757098|NCT00819585|6123007|P1|Core Study|Administrative Problems|0
1757099|NCT00819585|6122997|P11|Core Study|Lost to Follow-up|0
1757100|NCT00819585|6122998|P10|Core Study|Lost to Follow-up|0
1757101|NCT00819585|6122999|P9|Core Study|Lost to Follow-up|0
1757102|NCT00819585|6123000|P8|Core Study|Lost to Follow-up|0
1757103|NCT00819585|6123001|P7|Core Study|Lost to Follow-up|1
1757104|NCT00819585|6123002|P6|Core Study|Lost to Follow-up|1
1757105|NCT00819585|6123003|P5|Core Study|Lost to Follow-up|1
1757106|NCT00819585|6123004|P4|Core Study|Lost to Follow-up|0
1757107|NCT00819585|6123005|P3|Core Study|Lost to Follow-up|2
1757108|NCT00819585|6123006|P2|Core Study|Lost to Follow-up|1
1757109|NCT00819585|6123007|P1|Core Study|Lost to Follow-up|2
1757110|NCT00819585|6122997|P11|Core Study|Subject Withdrew Consent|0
1757111|NCT00819585|6122998|P10|Core Study|Subject Withdrew Consent|0
1757112|NCT00819585|6122999|P9|Core Study|Subject Withdrew Consent|0
1757113|NCT00819585|6123000|P8|Core Study|Subject Withdrew Consent|0
1757114|NCT00819585|6123001|P7|Core Study|Subject Withdrew Consent|3
1757115|NCT00819585|6123002|P6|Core Study|Subject Withdrew Consent|0
1757116|NCT00819585|6123003|P5|Core Study|Subject Withdrew Consent|0
1757117|NCT00819585|6123004|P4|Core Study|Subject Withdrew Consent|1
1757118|NCT00819585|6123005|P3|Core Study|Subject Withdrew Consent|2
1757119|NCT00819585|6123006|P2|Core Study|Subject Withdrew Consent|3
1757120|NCT00819585|6123007|P1|Core Study|Subject Withdrew Consent|0
1757121|NCT00819585|6122997|P11|Core Study|Subject No Longer Requires Study Drug|0
1757122|NCT00819585|6122998|P10|Core Study|Subject No Longer Requires Study Drug|0
1757123|NCT00819585|6122999|P9|Core Study|Subject No Longer Requires Study Drug|0
1757124|NCT00819585|6123000|P8|Core Study|Subject No Longer Requires Study Drug|0
1757125|NCT00819585|6123001|P7|Core Study|Subject No Longer Requires Study Drug|0
1757126|NCT00819585|6123002|P6|Core Study|Subject No Longer Requires Study Drug|0
1757127|NCT00819585|6123003|P5|Core Study|Subject No Longer Requires Study Drug|1
1757128|NCT00819585|6123004|P4|Core Study|Subject No Longer Requires Study Drug|0
1757129|NCT00819585|6123005|P3|Core Study|Subject No Longer Requires Study Drug|0
1757130|NCT00819585|6123006|P2|Core Study|Subject No Longer Requires Study Drug|0
1757131|NCT00819585|6123007|P1|Core Study|Subject No Longer Requires Study Drug|0
1757132|NCT00819585|6122997|P11|Core Study|Unsatisfactory Therapeutic Effect|0
1757133|NCT00819585|6122998|P10|Core Study|Unsatisfactory Therapeutic Effect|0
1757134|NCT00819585|6122999|P9|Core Study|Unsatisfactory Therapeutic Effect|0
1757135|NCT00819585|6123000|P8|Core Study|Unsatisfactory Therapeutic Effect|0
1757136|NCT00819585|6123001|P7|Core Study|Unsatisfactory Therapeutic Effect|1
1757137|NCT00819585|6123002|P6|Core Study|Unsatisfactory Therapeutic Effect|0
1757138|NCT00819585|6123003|P5|Core Study|Unsatisfactory Therapeutic Effect|0
1757139|NCT00819585|6123004|P4|Core Study|Unsatisfactory Therapeutic Effect|0
1757140|NCT00819585|6123005|P3|Core Study|Unsatisfactory Therapeutic Effect|0
1757141|NCT00819585|6123006|P2|Core Study|Unsatisfactory Therapeutic Effect|1
1757142|NCT00819585|6123007|P1|Core Study|Unsatisfactory Therapeutic Effect|0
1757143|NCT00819585|6122997|P11|Core Study|Abnormal Laboratory Value(s)|0
1757144|NCT00819585|6122998|P10|Core Study|Abnormal Laboratory Value(s)|0
1757145|NCT00819585|6122999|P9|Core Study|Abnormal Laboratory Value(s)|0
1757146|NCT00819585|6123000|P8|Core Study|Abnormal Laboratory Value(s)|0
1757147|NCT00819585|6123001|P7|Core Study|Abnormal Laboratory Value(s)|0
1757148|NCT00819585|6123002|P6|Core Study|Abnormal Laboratory Value(s)|0
1757149|NCT00819585|6123003|P5|Core Study|Abnormal Laboratory Value(s)|0
1757150|NCT00819585|6123004|P4|Core Study|Abnormal Laboratory Value(s)|0
1757151|NCT00819585|6123005|P3|Core Study|Abnormal Laboratory Value(s)|0
1757152|NCT00819585|6123006|P2|Core Study|Abnormal Laboratory Value(s)|0
1757153|NCT00819585|6123007|P1|Core Study|Abnormal Laboratory Value(s)|2
1757154|NCT00819585|6122997|P11|Core Study|Adverse Event|0
1757155|NCT00819585|6122998|P10|Core Study|Adverse Event|0
1757156|NCT00819585|6122999|P9|Core Study|Adverse Event|0
1757157|NCT00819585|6123000|P8|Core Study|Adverse Event|0
1757158|NCT00819585|6123001|P7|Core Study|Adverse Event|2
1757159|NCT00819585|6123002|P6|Core Study|Adverse Event|0
1757160|NCT00819585|6123003|P5|Core Study|Adverse Event|1
1757161|NCT00819585|6123004|P4|Core Study|Adverse Event|4
1757162|NCT00819585|6123005|P3|Core Study|Adverse Event|1
1757163|NCT00819585|6123006|P2|Core Study|Adverse Event|1
1757164|NCT00819585|6123007|P1|Core Study|Adverse Event|2
1757165|NCT00819390|6123098|P4|Overall Study|Adverse Event|0
1757166|NCT00819390|6123099|P3|Overall Study|Adverse Event|1
1757167|NCT00819390|6123100|P2|Overall Study|Adverse Event|0
1757168|NCT00819390|6123101|P1|Overall Study|Adverse Event|0
1757169|NCT00819390|6123098|P4|Overall Study|Withdrawal by Subject|0
1757170|NCT00819390|6123099|P3|Overall Study|Withdrawal by Subject|0
1757171|NCT00819390|6123100|P2|Overall Study|Withdrawal by Subject|0
1757172|NCT00819390|6123101|P1|Overall Study|Withdrawal by Subject|2
1757173|NCT00819390|6123098|P4|Overall Study|Lost to Follow-up|0
1757174|NCT00819390|6123099|P3|Overall Study|Lost to Follow-up|0
1757175|NCT00819390|6123100|P2|Overall Study|Lost to Follow-up|1
1757176|NCT00819390|6123101|P1|Overall Study|Lost to Follow-up|1
1757177|NCT00819247|6123237|P3|Overall Study|Other|0
1757178|NCT00819247|6123238|P2|Overall Study|Other|0
1757179|NCT00819247|6123239|P1|Overall Study|Other|1
1757180|NCT00819247|6123237|P3|Overall Study|Bad prostate-specific antigen response|0
1757181|NCT00819247|6123238|P2|Overall Study|Bad prostate-specific antigen response|2
1757182|NCT00819247|6123239|P1|Overall Study|Bad prostate-specific antigen response|3
1757183|NCT00819247|6123237|P3|Overall Study|Mistakenly withdrawn|0
1757184|NCT00819247|6123238|P2|Overall Study|Mistakenly withdrawn|1
1757185|NCT00819247|6123239|P1|Overall Study|Mistakenly withdrawn|0
1757186|NCT00819247|6123237|P3|Overall Study|Protocol Violation|1
1757187|NCT00819247|6123238|P2|Overall Study|Protocol Violation|0
1757188|NCT00819247|6123239|P1|Overall Study|Protocol Violation|1
1757189|NCT00819247|6123237|P3|Overall Study|Withdrawal by Subject|0
1757190|NCT00819247|6123238|P2|Overall Study|Withdrawal by Subject|0
1757191|NCT00819247|6123239|P1|Overall Study|Withdrawal by Subject|1
1757192|NCT00819247|6123237|P3|Overall Study|Insufficient testosterone response|10
1757193|NCT00819247|6123238|P2|Overall Study|Insufficient testosterone response|8
1757194|NCT00819247|6123239|P1|Overall Study|Insufficient testosterone response|5
1757195|NCT00819247|6123237|P3|Overall Study|Adverse Event|3
1757196|NCT00819247|6123238|P2|Overall Study|Adverse Event|5
1757197|NCT00819247|6123239|P1|Overall Study|Adverse Event|0
1757198|NCT00819234|6123265|P10|Overall Study|Lost to Follow-up|2
1757199|NCT00819234|6123266|P9|Overall Study|Lost to Follow-up|1
1757200|NCT00819234|6123267|P8|Overall Study|Lost to Follow-up|1
1757201|NCT00819234|6123268|P7|Overall Study|Lost to Follow-up|1
1757202|NCT00819234|6123269|P6|Overall Study|Lost to Follow-up|1
1757203|NCT00819234|6123270|P5|Overall Study|Lost to Follow-up|1
1757204|NCT00819234|6123271|P4|Overall Study|Lost to Follow-up|2
1757205|NCT00819234|6123272|P3|Overall Study|Lost to Follow-up|0
1757206|NCT00819234|6123273|P2|Overall Study|Lost to Follow-up|2
1757207|NCT00819234|6123274|P1|Overall Study|Lost to Follow-up|2
1757208|NCT00819234|6123265|P10|Overall Study|Protocol Violation|0
1757209|NCT00819234|6123266|P9|Overall Study|Protocol Violation|0
1757210|NCT00819234|6123267|P8|Overall Study|Protocol Violation|0
1757211|NCT00819234|6123268|P7|Overall Study|Protocol Violation|0
1757212|NCT00819234|6123269|P6|Overall Study|Protocol Violation|0
1757213|NCT00819234|6123270|P5|Overall Study|Protocol Violation|0
1757214|NCT00819234|6123271|P4|Overall Study|Protocol Violation|0
1757215|NCT00819234|6123272|P3|Overall Study|Protocol Violation|1
1757216|NCT00819234|6123273|P2|Overall Study|Protocol Violation|0
1757217|NCT00819234|6123274|P1|Overall Study|Protocol Violation|0
1757218|NCT00819234|6123265|P10|Overall Study|Physician Decision|2
1757219|NCT00819234|6123266|P9|Overall Study|Physician Decision|0
1757220|NCT00819234|6123267|P8|Overall Study|Physician Decision|0
1757221|NCT00819234|6123268|P7|Overall Study|Physician Decision|0
1757222|NCT00819234|6123269|P6|Overall Study|Physician Decision|0
1757223|NCT00819234|6123270|P5|Overall Study|Physician Decision|0
1757224|NCT00819234|6123271|P4|Overall Study|Physician Decision|1
1757225|NCT00819234|6123272|P3|Overall Study|Physician Decision|0
1757226|NCT00819234|6123273|P2|Overall Study|Physician Decision|0
1757227|NCT00819234|6123274|P1|Overall Study|Physician Decision|0
1757228|NCT00819234|6123265|P10|Overall Study|Adverse Event|0
1757229|NCT00819234|6123266|P9|Overall Study|Adverse Event|0
1757230|NCT00819234|6123267|P8|Overall Study|Adverse Event|0
1757231|NCT00819234|6123268|P7|Overall Study|Adverse Event|0
1757232|NCT00819234|6123269|P6|Overall Study|Adverse Event|2
1757233|NCT00819234|6123270|P5|Overall Study|Adverse Event|0
1757234|NCT00819234|6123271|P4|Overall Study|Adverse Event|0
1757235|NCT00819234|6123272|P3|Overall Study|Adverse Event|1
1757236|NCT00819234|6123273|P2|Overall Study|Adverse Event|0
1757237|NCT00819234|6123274|P1|Overall Study|Adverse Event|0
1757238|NCT00819234|6123265|P10|Overall Study|Withdrawal by Subject|3
1757239|NCT00819234|6123266|P9|Overall Study|Withdrawal by Subject|5
1757240|NCT00819234|6123267|P8|Overall Study|Withdrawal by Subject|8
1757241|NCT00819234|6123268|P7|Overall Study|Withdrawal by Subject|4
1757242|NCT00819234|6123269|P6|Overall Study|Withdrawal by Subject|4
1757243|NCT00819234|6123270|P5|Overall Study|Withdrawal by Subject|0
1757244|NCT00819234|6123271|P4|Overall Study|Withdrawal by Subject|3
1757245|NCT00819234|6123272|P3|Overall Study|Withdrawal by Subject|6
1757246|NCT00819234|6123273|P2|Overall Study|Withdrawal by Subject|13
1757247|NCT00819234|6123274|P1|Overall Study|Withdrawal by Subject|8
1757248|NCT00819156|6123473|P6|Overall Study|Prostate-specific antigen progression|0
1757249|NCT00819156|6123474|P5|Overall Study|Prostate-specific antigen progression|1
1757250|NCT00819156|6123475|P4|Overall Study|Prostate-specific antigen progression|0
1757251|NCT00819156|6123476|P3|Overall Study|Prostate-specific antigen progression|0
1757252|NCT00819156|6123477|P2|Overall Study|Prostate-specific antigen progression|0
1757253|NCT00819156|6123478|P1|Overall Study|Prostate-specific antigen progression|0
1757254|NCT00819156|6123473|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1757255|NCT00819156|6123474|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
1757256|NCT00819156|6123475|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1757257|NCT00819156|6123476|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1757258|NCT00819156|6123477|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
1757259|NCT00819156|6123478|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
1757260|NCT00819156|6123473|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
1757261|NCT00819156|6123474|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
1757262|NCT00819156|6123475|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
1757263|NCT00819156|6123476|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
1757264|NCT00819156|6123477|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
1757265|NCT00819156|6123478|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
1757266|NCT00819156|6123473|P6|Overall Study|Lost to Follow-up|2
1757267|NCT00819156|6123474|P5|Overall Study|Lost to Follow-up|0
1757268|NCT00819156|6123475|P4|Overall Study|Lost to Follow-up|0
1757269|NCT00819156|6123476|P3|Overall Study|Lost to Follow-up|0
1757270|NCT00819156|6123477|P2|Overall Study|Lost to Follow-up|1
1757271|NCT00819156|6123478|P1|Overall Study|Lost to Follow-up|0
1757272|NCT00819156|6123473|P6|Overall Study|Protocol Violation|1
1757273|NCT00819156|6123474|P5|Overall Study|Protocol Violation|0
1757274|NCT00819156|6123475|P4|Overall Study|Protocol Violation|0
1757275|NCT00819156|6123476|P3|Overall Study|Protocol Violation|1
1757276|NCT00819156|6123477|P2|Overall Study|Protocol Violation|0
1757277|NCT00819156|6123478|P1|Overall Study|Protocol Violation|1
1757278|NCT00819156|6123473|P6|Overall Study|Withdrawal by Subject|0
1757279|NCT00819156|6123474|P5|Overall Study|Withdrawal by Subject|1
1757280|NCT00819156|6123475|P4|Overall Study|Withdrawal by Subject|0
1757281|NCT00819156|6123476|P3|Overall Study|Withdrawal by Subject|2
1757282|NCT00819156|6123477|P2|Overall Study|Withdrawal by Subject|3
1757283|NCT00819156|6123478|P1|Overall Study|Withdrawal by Subject|0
1757284|NCT00819156|6123473|P6|Overall Study|Adverse Event|3
1757285|NCT00819156|6123474|P5|Overall Study|Adverse Event|2
1757286|NCT00819156|6123475|P4|Overall Study|Adverse Event|1
1757287|NCT00819156|6123476|P3|Overall Study|Adverse Event|2
1757288|NCT00819156|6123477|P2|Overall Study|Adverse Event|4
1757289|NCT00819156|6123478|P1|Overall Study|Adverse Event|1
1757290|NCT00819091|6123568|P2|Overall Study|Other|2
1757291|NCT00819091|6123569|P1|Overall Study|Other|1
1757292|NCT00819091|6123568|P2|Overall Study|Withdrawal by Subject|2
1757293|NCT00819091|6123569|P1|Overall Study|Withdrawal by Subject|1
1757294|NCT00819091|6123568|P2|Overall Study|Lost to Follow-up|0
1757295|NCT00819091|6123569|P1|Overall Study|Lost to Follow-up|2
1757296|NCT00819091|6123568|P2|Overall Study|Protocol Violation|1
1757297|NCT00819091|6123569|P1|Overall Study|Protocol Violation|0
1757298|NCT00819091|6123568|P2|Overall Study|Adverse Event|5
1757299|NCT00819091|6123569|P1|Overall Study|Adverse Event|3
1757300|NCT00819052|6123595|P2|Overall Study|Death or events leading to death|0
1757301|NCT00819052|6123596|P1|Overall Study|Death or events leading to death|1
1757302|NCT00819052|6123595|P2|Overall Study|Pregnancy|2
1757303|NCT00819052|6123596|P1|Overall Study|Pregnancy|1
1757304|NCT00819052|6123595|P2|Overall Study|Lack of Efficacy|1
1757305|NCT00819052|6123596|P1|Overall Study|Lack of Efficacy|1
1757306|NCT00819052|6123595|P2|Overall Study|Withdrawal by Subject|2
1757307|NCT00819052|6123596|P1|Overall Study|Withdrawal by Subject|1
1757308|NCT00819052|6123595|P2|Overall Study|Lost to Follow-up|2
1757309|NCT00819052|6123596|P1|Overall Study|Lost to Follow-up|1
1757310|NCT00819052|6123595|P2|Overall Study|Protocol Violation|2
1757311|NCT00819052|6123596|P1|Overall Study|Protocol Violation|1
1757312|NCT00819052|6123595|P2|Overall Study|Adverse Event|5
1757313|NCT00819052|6123596|P1|Overall Study|Adverse Event|0
1757314|NCT00819039|6123711|P3|Overall Study|Protocol Violation|0
1757315|NCT00819039|6123712|P2|Overall Study|Protocol Violation|0
1757316|NCT00819039|6123713|P1|Overall Study|Protocol Violation|1
1757317|NCT00819039|6123711|P3|Overall Study|Physician Decision|1
1757318|NCT00819039|6123712|P2|Overall Study|Physician Decision|0
1757319|NCT00819039|6123713|P1|Overall Study|Physician Decision|1
1757320|NCT00819013|6123743|P4|Overall Study|Death|1
1757321|NCT00819013|6123744|P3|Overall Study|Death|0
1757322|NCT00819013|6123745|P2|Overall Study|Death|0
1757323|NCT00819013|6123746|P1|Overall Study|Death|0
1757324|NCT00819013|6123743|P4|Overall Study|Lost to Follow-up|2
1757325|NCT00819013|6123744|P3|Overall Study|Lost to Follow-up|1
1757326|NCT00819013|6123745|P2|Overall Study|Lost to Follow-up|0
1757327|NCT00819013|6123746|P1|Overall Study|Lost to Follow-up|0
1757328|NCT00819013|6123743|P4|Overall Study|Withdrawal by Subject|0
1757329|NCT00819013|6123744|P3|Overall Study|Withdrawal by Subject|1
1757330|NCT00819013|6123745|P2|Overall Study|Withdrawal by Subject|0
1757331|NCT00819013|6123746|P1|Overall Study|Withdrawal by Subject|1
1757332|NCT00819013|6123743|P4|Overall Study|Adverse Event|0
1757333|NCT00819013|6123744|P3|Overall Study|Adverse Event|1
1757334|NCT00819013|6123745|P2|Overall Study|Adverse Event|0
1757335|NCT00819013|6123746|P1|Overall Study|Adverse Event|0
1757336|NCT00819013|6123743|P4|Overall Study|Not meeting continuing study eligibility|1
1757337|NCT00819013|6123744|P3|Overall Study|Not meeting continuing study eligibility|2
1757338|NCT00819013|6123745|P2|Overall Study|Not meeting continuing study eligibility|1
1757339|NCT00819013|6123746|P1|Overall Study|Not meeting continuing study eligibility|2
1757340|NCT00818883|6123812|P2|Overall Study|Other|7
1757341|NCT00818883|6123813|P1|Overall Study|Other|2
1757342|NCT00818883|6123812|P2|Overall Study|Lack of Efficacy|2
1757343|NCT00818883|6123813|P1|Overall Study|Lack of Efficacy|0
1757344|NCT00818883|6123812|P2|Overall Study|Withdrawal by Subject|14
1757345|NCT00818883|6123813|P1|Overall Study|Withdrawal by Subject|16
1757346|NCT00818883|6123812|P2|Overall Study|Lost to Follow-up|2
1757347|NCT00818883|6123813|P1|Overall Study|Lost to Follow-up|3
1757348|NCT00818883|6123812|P2|Overall Study|Protocol Violation|2
1757349|NCT00818883|6123813|P1|Overall Study|Protocol Violation|2
1757350|NCT00818883|6123812|P2|Overall Study|Adverse Event|19
1757351|NCT00818883|6123813|P1|Overall Study|Adverse Event|28
1757352|NCT00818779|6123860|P2|Overall Study|Adverse Event|1
1757353|NCT00818779|6123861|P1|Overall Study|Adverse Event|4
1757354|NCT00818779|6123860|P2|Overall Study|Lost to Follow-up|0
1757355|NCT00818779|6123861|P1|Overall Study|Lost to Follow-up|1
1757356|NCT00818779|6123860|P2|Overall Study|Protocol Violation|0
1757357|NCT00818779|6123861|P1|Overall Study|Protocol Violation|1
1757358|NCT00818766|6123877|P2|Overall Study|Did not Receive Allocated Intervention|0
1757359|NCT00818766|6123878|P1|Overall Study|Did not Receive Allocated Intervention|3
1757360|NCT00818766|6123877|P2|Overall Study|Death|0
1757361|NCT00818766|6123878|P1|Overall Study|Death|1
1757362|NCT00818766|6123877|P2|Overall Study|Could not be Contacted on Day 28|10
1757363|NCT00818766|6123878|P1|Overall Study|Could not be Contacted on Day 28|11
1757364|NCT00818753|6123907|P3|Overall Study|Randomised and not treated|0
1757365|NCT00818753|6123908|P2|Overall Study|Randomised and not treated|0
1757366|NCT00818753|6123909|P1|Overall Study|Randomised and not treated|2
1757367|NCT00818753|6123907|P3|Overall Study|Other reason (not specified)|1
1757368|NCT00818753|6123908|P2|Overall Study|Other reason (not specified)|0
1757369|NCT00818753|6123909|P1|Overall Study|Other reason (not specified)|0
1757370|NCT00818753|6123907|P3|Overall Study|Protocol Violation|0
1757371|NCT00818753|6123908|P2|Overall Study|Protocol Violation|0
1757372|NCT00818753|6123909|P1|Overall Study|Protocol Violation|1
1757373|NCT00818662|6123933|P4|Overall Study|Admitted to long term nursing care|0
1757374|NCT00818662|6123934|P3|Overall Study|Admitted to long term nursing care|0
1757375|NCT00818662|6123935|P2|Overall Study|Admitted to long term nursing care|1
1757376|NCT00818662|6123936|P1|Overall Study|Admitted to long term nursing care|0
1757377|NCT00818662|6123933|P4|Overall Study|Study partner decision|1
1757378|NCT00818662|6123934|P3|Overall Study|Study partner decision|0
1757379|NCT00818662|6123935|P2|Overall Study|Study partner decision|0
1757380|NCT00818662|6123936|P1|Overall Study|Study partner decision|0
1757381|NCT00818662|6123933|P4|Overall Study|Change in living situation|1
1757382|NCT00818662|6123934|P3|Overall Study|Change in living situation|0
1757383|NCT00818662|6123935|P2|Overall Study|Change in living situation|0
1757384|NCT00818662|6123936|P1|Overall Study|Change in living situation|0
1757385|NCT00818662|6123933|P4|Overall Study|Declined move to another study site|0
1757386|NCT00818662|6123934|P3|Overall Study|Declined move to another study site|0
1757387|NCT00818662|6123935|P2|Overall Study|Declined move to another study site|0
1757388|NCT00818662|6123936|P1|Overall Study|Declined move to another study site|1
1757389|NCT00818662|6123933|P4|Overall Study|Moving out of state|1
1757390|NCT00818662|6123934|P3|Overall Study|Moving out of state|0
1757391|NCT00818662|6123935|P2|Overall Study|Moving out of state|0
1757392|NCT00818662|6123936|P1|Overall Study|Moving out of state|0
1757393|NCT00818662|6123933|P4|Overall Study|Caregiver to pursue other treatment|0
1757394|NCT00818662|6123934|P3|Overall Study|Caregiver to pursue other treatment|0
1757395|NCT00818662|6123935|P2|Overall Study|Caregiver to pursue other treatment|1
1757396|NCT00818662|6123936|P1|Overall Study|Caregiver to pursue other treatment|0
1757397|NCT00818662|6123933|P4|Overall Study|Participant's health declined|1
1757398|NCT00818662|6123934|P3|Overall Study|Participant's health declined|0
1757399|NCT00818662|6123935|P2|Overall Study|Participant's health declined|0
1757400|NCT00818662|6123936|P1|Overall Study|Participant's health declined|0
1757401|NCT00818662|6123933|P4|Overall Study|Study Partner Unwilling or Unable|1
1757402|NCT00818662|6123934|P3|Overall Study|Study Partner Unwilling or Unable|1
1757403|NCT00818662|6123935|P2|Overall Study|Study Partner Unwilling or Unable|2
1757404|NCT00818662|6123936|P1|Overall Study|Study Partner Unwilling or Unable|3
1757405|NCT00818662|6123933|P4|Overall Study|Safety Risk|1
1757406|NCT00818662|6123934|P3|Overall Study|Safety Risk|0
1757407|NCT00818662|6123935|P2|Overall Study|Safety Risk|1
1757408|NCT00818662|6123936|P1|Overall Study|Safety Risk|1
1757409|NCT00818662|6123933|P4|Overall Study|Requires a Prohibited Medication|0
1757410|NCT00818662|6123934|P3|Overall Study|Requires a Prohibited Medication|0
1757411|NCT00818662|6123935|P2|Overall Study|Requires a Prohibited Medication|0
1757412|NCT00818662|6123936|P1|Overall Study|Requires a Prohibited Medication|1
1757413|NCT00818662|6123933|P4|Overall Study|Protocol Violation|0
1757414|NCT00818662|6123934|P3|Overall Study|Protocol Violation|0
1757415|NCT00818662|6123935|P2|Overall Study|Protocol Violation|1
1757416|NCT00818662|6123936|P1|Overall Study|Protocol Violation|1
1757417|NCT00818662|6123933|P4|Overall Study|Unwilling or Unable to Participate|4
1757418|NCT00818662|6123934|P3|Overall Study|Unwilling or Unable to Participate|2
1757419|NCT00818662|6123935|P2|Overall Study|Unwilling or Unable to Participate|6
1757420|NCT00818662|6123936|P1|Overall Study|Unwilling or Unable to Participate|4
1757421|NCT00818662|6123933|P4|Overall Study|Lost to Follow-up|1
1757422|NCT00818662|6123934|P3|Overall Study|Lost to Follow-up|0
1757423|NCT00818662|6123935|P2|Overall Study|Lost to Follow-up|0
1757424|NCT00818662|6123936|P1|Overall Study|Lost to Follow-up|0
1757425|NCT00818662|6123933|P4|Overall Study|Physician Decision|0
1757426|NCT00818662|6123934|P3|Overall Study|Physician Decision|0
1757427|NCT00818662|6123935|P2|Overall Study|Physician Decision|0
1757428|NCT00818662|6123936|P1|Overall Study|Physician Decision|1
1757429|NCT00818662|6123933|P4|Overall Study|Death|0
1757430|NCT00818662|6123934|P3|Overall Study|Death|0
1757431|NCT00818662|6123935|P2|Overall Study|Death|3
1757432|NCT00818662|6123936|P1|Overall Study|Death|1
1757433|NCT00818662|6123933|P4|Overall Study|Withdrawal by Subject|2
1757434|NCT00818662|6123934|P3|Overall Study|Withdrawal by Subject|2
1757435|NCT00818662|6123935|P2|Overall Study|Withdrawal by Subject|4
1757436|NCT00818662|6123936|P1|Overall Study|Withdrawal by Subject|5
1757437|NCT00818662|6123933|P4|Overall Study|Adverse Event|3
1757438|NCT00818662|6123934|P3|Overall Study|Adverse Event|4
1757439|NCT00818662|6123935|P2|Overall Study|Adverse Event|14
1757440|NCT00818662|6123936|P1|Overall Study|Adverse Event|5
1757441|NCT00818649|6124022|P1|Overall Study|Adverse Event|1
1757442|NCT00818649|6124022|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
1757443|NCT00818649|6124022|P1|Overall Study|Declining performance status|2
1757444|NCT00818623|6124036|P8|Overall Study|Disease progression|0
1757445|NCT00818623|6124037|P7|Overall Study|Disease progression|1
1757446|NCT00818623|6124038|P6|Overall Study|Disease progression|0
1757447|NCT00818623|6124039|P5|Overall Study|Disease progression|0
1757448|NCT00818623|6124040|P4|Overall Study|Disease progression|0
1757449|NCT00818623|6124041|P3|Overall Study|Disease progression|0
1757450|NCT00818623|6124042|P2|Overall Study|Disease progression|0
1757451|NCT00818623|6124043|P1|Overall Study|Disease progression|0
1757452|NCT00818623|6124036|P8|Overall Study|Lack of trial drug at site|0
1757453|NCT00818623|6124037|P7|Overall Study|Lack of trial drug at site|1
1757454|NCT00818623|6124038|P6|Overall Study|Lack of trial drug at site|0
1757455|NCT00818623|6124039|P5|Overall Study|Lack of trial drug at site|2
1757456|NCT00818623|6124040|P4|Overall Study|Lack of trial drug at site|0
1757457|NCT00818623|6124041|P3|Overall Study|Lack of trial drug at site|0
1757458|NCT00818623|6124042|P2|Overall Study|Lack of trial drug at site|0
1757459|NCT00818623|6124043|P1|Overall Study|Lack of trial drug at site|0
1757460|NCT00818623|6124036|P8|Overall Study|Need of additional treatment|0
1757461|NCT00818623|6124037|P7|Overall Study|Need of additional treatment|0
1757462|NCT00818623|6124038|P6|Overall Study|Need of additional treatment|0
1757463|NCT00818623|6124039|P5|Overall Study|Need of additional treatment|1
1757464|NCT00818623|6124040|P4|Overall Study|Need of additional treatment|0
1757465|NCT00818623|6124041|P3|Overall Study|Need of additional treatment|0
1757466|NCT00818623|6124042|P2|Overall Study|Need of additional treatment|0
1757467|NCT00818623|6124043|P1|Overall Study|Need of additional treatment|0
1757468|NCT00818623|6124036|P8|Overall Study|Protocol Violation|0
1757469|NCT00818623|6124037|P7|Overall Study|Protocol Violation|1
1757470|NCT00818623|6124038|P6|Overall Study|Protocol Violation|0
1757471|NCT00818623|6124039|P5|Overall Study|Protocol Violation|1
1757472|NCT00818623|6124040|P4|Overall Study|Protocol Violation|0
1757473|NCT00818623|6124041|P3|Overall Study|Protocol Violation|0
1757474|NCT00818623|6124042|P2|Overall Study|Protocol Violation|0
1757475|NCT00818623|6124043|P1|Overall Study|Protocol Violation|1
1757476|NCT00818623|6124036|P8|Overall Study|Withdrawal by Subject|1
1757477|NCT00818623|6124037|P7|Overall Study|Withdrawal by Subject|1
1757478|NCT00818623|6124038|P6|Overall Study|Withdrawal by Subject|1
1757479|NCT00818623|6124039|P5|Overall Study|Withdrawal by Subject|0
1757480|NCT00818623|6124040|P4|Overall Study|Withdrawal by Subject|0
1757481|NCT00818623|6124041|P3|Overall Study|Withdrawal by Subject|1
1757482|NCT00818623|6124042|P2|Overall Study|Withdrawal by Subject|1
1757483|NCT00818623|6124043|P1|Overall Study|Withdrawal by Subject|0
1757484|NCT00818623|6124036|P8|Overall Study|Bad prostate specific antigen response|0
1757485|NCT00818623|6124037|P7|Overall Study|Bad prostate specific antigen response|0
1757486|NCT00818623|6124038|P6|Overall Study|Bad prostate specific antigen response|1
1757487|NCT00818623|6124039|P5|Overall Study|Bad prostate specific antigen response|0
1757488|NCT00818623|6124040|P4|Overall Study|Bad prostate specific antigen response|5
1757489|NCT00818623|6124041|P3|Overall Study|Bad prostate specific antigen response|2
1757490|NCT00818623|6124042|P2|Overall Study|Bad prostate specific antigen response|3
1757491|NCT00818623|6124043|P1|Overall Study|Bad prostate specific antigen response|0
1757492|NCT00818623|6124036|P8|Overall Study|Adverse Event|0
1757493|NCT00818623|6124037|P7|Overall Study|Adverse Event|0
1757494|NCT00818623|6124038|P6|Overall Study|Adverse Event|1
1757495|NCT00818623|6124039|P5|Overall Study|Adverse Event|0
1757496|NCT00818623|6124040|P4|Overall Study|Adverse Event|0
1757497|NCT00818623|6124041|P3|Overall Study|Adverse Event|1
1757498|NCT00818623|6124042|P2|Overall Study|Adverse Event|0
1757499|NCT00818623|6124043|P1|Overall Study|Adverse Event|1
1757500|NCT00818519|6124119|P2|Overall Study|participant will leave for long tme|0
1757501|NCT00818519|6124120|P1|Overall Study|participant will leave for long tme|1
1757502|NCT00818519|6124119|P2|Overall Study|participant recovered completely|0
1757503|NCT00818519|6124120|P1|Overall Study|participant recovered completely|1
1757504|NCT00818519|6124119|P2|Overall Study|Withdrawal by Subject|9
1757505|NCT00818519|6124120|P1|Overall Study|Withdrawal by Subject|4
1757506|NCT00818519|6124119|P2|Overall Study|Pregnancy|1
1757507|NCT00818519|6124120|P1|Overall Study|Pregnancy|0
1757508|NCT00818519|6124119|P2|Overall Study|Protocol Violation|1
1757509|NCT00818519|6124120|P1|Overall Study|Protocol Violation|2
1757510|NCT00818519|6124119|P2|Overall Study|Lost to Follow-up|6
1757511|NCT00818519|6124120|P1|Overall Study|Lost to Follow-up|4
1757512|NCT00818519|6124119|P2|Overall Study|Adverse Event|2
1757513|NCT00818519|6124120|P1|Overall Study|Adverse Event|2
1757514|NCT00818454|6124150|P4|Treatment Period 3|Adverse Event|1
1757515|NCT00818454|6124151|P3|Treatment Period 3|Adverse Event|0
1757516|NCT00818454|6124152|P2|Treatment Period 3|Adverse Event|0
1757517|NCT00818454|6124153|P1|Treatment Period 3|Adverse Event|0
1757518|NCT00818454|6124150|P4|Treatment Period 2|Other|0
1757519|NCT00818454|6124151|P3|Treatment Period 2|Other|0
1757520|NCT00818454|6124152|P2|Treatment Period 2|Other|1
1757521|NCT00818454|6124153|P1|Treatment Period 2|Other|2
1757522|NCT00818454|6124150|P4|Washout Period of 1 Week|Other|0
1757523|NCT00818454|6124151|P3|Washout Period of 1 Week|Other|0
1757524|NCT00818454|6124152|P2|Washout Period of 1 Week|Other|2
1757525|NCT00818454|6124153|P1|Washout Period of 1 Week|Other|1
1757526|NCT00818454|6124150|P4|Washout Period of 1 Week|Protocol Violation|0
1757527|NCT00818454|6124151|P3|Washout Period of 1 Week|Protocol Violation|0
1757528|NCT00818454|6124152|P2|Washout Period of 1 Week|Protocol Violation|0
1757529|NCT00818454|6124153|P1|Washout Period of 1 Week|Protocol Violation|2
1757530|NCT00818454|6124150|P4|Washout Period of 1 Week|Adverse Event|0
1757531|NCT00818454|6124151|P3|Washout Period of 1 Week|Adverse Event|0
1757532|NCT00818454|6124152|P2|Washout Period of 1 Week|Adverse Event|1
1757533|NCT00818454|6124153|P1|Washout Period of 1 Week|Adverse Event|1
1757534|NCT00818454|6124150|P4|Treatment Period 1|Other|0
1757535|NCT00818454|6124151|P3|Treatment Period 1|Other|0
1757536|NCT00818454|6124152|P2|Treatment Period 1|Other|0
1757537|NCT00818454|6124153|P1|Treatment Period 1|Other|3
1757538|NCT00818454|6124150|P4|Treatment Period 1|Adverse Event|0
1757539|NCT00818454|6124151|P3|Treatment Period 1|Adverse Event|0
1757540|NCT00818454|6124152|P2|Treatment Period 1|Adverse Event|1
1757541|NCT00818454|6124153|P1|Treatment Period 1|Adverse Event|0
1757542|NCT00818441|6124181|P2|Overall Study|Study terminated by sponsor|2
1757543|NCT00818441|6124182|P1|Overall Study|Study terminated by sponsor|11
1757544|NCT00818441|6124181|P2|Overall Study|Adverse Event|1
1757545|NCT00818441|6124182|P1|Overall Study|Adverse Event|0
1757546|NCT00818441|6124181|P2|Overall Study|Withdrawal by Subject|0
1757547|NCT00818441|6124182|P1|Overall Study|Withdrawal by Subject|2
1757548|NCT00818441|6124181|P2|Overall Study|Lost to Follow-up|1
1757549|NCT00818441|6124182|P1|Overall Study|Lost to Follow-up|2
1757550|NCT00818441|6124181|P2|Overall Study|Other|0
1757551|NCT00818441|6124182|P1|Overall Study|Other|5
1757552|NCT00818441|6124181|P2|Overall Study|Death|26
1757553|NCT00818441|6124182|P1|Overall Study|Death|69
1757554|NCT00818389|6124204|P2|Overall Study|Adverse Event|1
1757555|NCT00818389|6124205|P1|Overall Study|Adverse Event|0
1757556|NCT00818389|6124204|P2|Overall Study|Withdrawal by Subject|2
1757557|NCT00818389|6124205|P1|Overall Study|Withdrawal by Subject|2
1757558|NCT00818389|6124204|P2|Overall Study|ALS Disease Progression|0
1757559|NCT00818389|6124205|P1|Overall Study|ALS Disease Progression|1
1757560|NCT00818389|6124204|P2|Overall Study|Death|3
1757561|NCT00818389|6124205|P1|Overall Study|Death|1
1757562|NCT00818259|6124240|P9|Part V|Adverse Event|0
1757563|NCT00818259|6124241|P8|Part V|Adverse Event|1
1757564|NCT00818259|6124242|P7|Part V|Adverse Event|0
1757565|NCT00818259|6124243|P6|Part V|Adverse Event|0
1757566|NCT00818259|6124244|P5|Part V|Adverse Event|0
1757567|NCT00818259|6124245|P4|Part V|Adverse Event|0
1757568|NCT00818259|6124246|P3|Part V|Adverse Event|0
1757569|NCT00818259|6124247|P2|Part V|Adverse Event|0
1757570|NCT00818259|6124248|P1|Part V|Adverse Event|0
1757571|NCT00818259|6124240|P9|Part IV|Physician Decision|0
1757572|NCT00818259|6124241|P8|Part IV|Physician Decision|0
1757573|NCT00818259|6124242|P7|Part IV|Physician Decision|0
1757574|NCT00818259|6124243|P6|Part IV|Physician Decision|1
1757575|NCT00818259|6124244|P5|Part IV|Physician Decision|0
1757576|NCT00818259|6124245|P4|Part IV|Physician Decision|0
1757577|NCT00818259|6124246|P3|Part IV|Physician Decision|0
1757578|NCT00818259|6124247|P2|Part IV|Physician Decision|0
1757579|NCT00818259|6124248|P1|Part IV|Physician Decision|0
1757580|NCT00818259|6124240|P9|Part II|Not Treated|0
1757581|NCT00818259|6124241|P8|Part II|Not Treated|0
1757582|NCT00818259|6124242|P7|Part II|Not Treated|0
1757583|NCT00818259|6124243|P6|Part II|Not Treated|0
1757584|NCT00818259|6124244|P5|Part II|Not Treated|0
1757585|NCT00818259|6124245|P4|Part II|Not Treated|1
1757586|NCT00818259|6124246|P3|Part II|Not Treated|0
1757587|NCT00818259|6124247|P2|Part II|Not Treated|0
1757588|NCT00818259|6124248|P1|Part II|Not Treated|0
1757589|NCT00818259|6124240|P9|Part II|Lack of Efficacy|0
1757590|NCT00818259|6124241|P8|Part II|Lack of Efficacy|0
1757591|NCT00818259|6124242|P7|Part II|Lack of Efficacy|0
1757592|NCT00818259|6124243|P6|Part II|Lack of Efficacy|0
1757593|NCT00818259|6124244|P5|Part II|Lack of Efficacy|0
1757594|NCT00818259|6124245|P4|Part II|Lack of Efficacy|1
1757595|NCT00818259|6124246|P3|Part II|Lack of Efficacy|0
1757596|NCT00818259|6124247|P2|Part II|Lack of Efficacy|0
1757597|NCT00818259|6124248|P1|Part II|Lack of Efficacy|0
1757598|NCT00818259|6124240|P9|Part II|Physician Decision|0
1757599|NCT00818259|6124241|P8|Part II|Physician Decision|0
1757600|NCT00818259|6124242|P7|Part II|Physician Decision|0
1757601|NCT00818259|6124243|P6|Part II|Physician Decision|0
1757602|NCT00818259|6124244|P5|Part II|Physician Decision|0
1757603|NCT00818259|6124245|P4|Part II|Physician Decision|0
1757604|NCT00818259|6124246|P3|Part II|Physician Decision|1
1757605|NCT00818259|6124247|P2|Part II|Physician Decision|0
1757606|NCT00818259|6124248|P1|Part II|Physician Decision|0
1757607|NCT00818259|6124240|P9|Part I|Withdrawal by Subject|0
1757608|NCT00818259|6124241|P8|Part I|Withdrawal by Subject|0
1757609|NCT00818259|6124242|P7|Part I|Withdrawal by Subject|0
1757610|NCT00818259|6124243|P6|Part I|Withdrawal by Subject|0
1757611|NCT00818259|6124244|P5|Part I|Withdrawal by Subject|0
1757612|NCT00818259|6124245|P4|Part I|Withdrawal by Subject|0
1757613|NCT00818259|6124246|P3|Part I|Withdrawal by Subject|0
1757614|NCT00818259|6124247|P2|Part I|Withdrawal by Subject|0
1757615|NCT00818259|6124248|P1|Part I|Withdrawal by Subject|1
1757616|NCT00818246|6124320|P1|Overall Study|Impossible to match pictures|5
1757617|NCT00818207|6124329|P2|Overall Study|Death|5
1757618|NCT00818207|6124330|P1|Overall Study|Death|3
1757619|NCT00818207|6124329|P2|Overall Study|Withdrawal by Subject|104
1757620|NCT00818207|6124330|P1|Overall Study|Withdrawal by Subject|42
1757621|NCT00818207|6124329|P2|Overall Study|Multiple reasons|12
1757622|NCT00818207|6124330|P1|Overall Study|Multiple reasons|11
1757623|NCT00818207|6124329|P2|Overall Study|Lost to Follow-up|146
1757624|NCT00818207|6124330|P1|Overall Study|Lost to Follow-up|160
1757625|NCT00818207|6124329|P2|Overall Study|Adverse Event|0
1757626|NCT00818207|6124330|P1|Overall Study|Adverse Event|6
1757627|NCT00818168|6124344|P1|Overall Study|Participant Moved|2
1757628|NCT00818168|6124344|P1|Overall Study|Reason for Non-completion Not reported|6
1757629|NCT00818168|6124344|P1|Overall Study|Adverse Event|19
1757630|NCT00818168|6124344|P1|Overall Study|Lost to Follow-up|7
1757631|NCT00818168|6124344|P1|Overall Study|Withdrawal by Subject|16
1757632|NCT00818168|6124344|P1|Overall Study|Pregnancy|2
1757633|NCT00818168|6124344|P1|Overall Study|Lack of Efficacy|18
1757634|NCT00817778|6124384|P2|Overall Study|Poor venous access|0
1757635|NCT00817778|6124385|P1|Overall Study|Poor venous access|1
1757636|NCT00817778|6124384|P2|Overall Study|Study-specific discontinuation criteria|1
1757637|NCT00817778|6124385|P1|Overall Study|Study-specific discontinuation criteria|0
1757638|NCT00817778|6124384|P2|Overall Study|Protocol Violation|1
1757639|NCT00817778|6124385|P1|Overall Study|Protocol Violation|0
1757640|NCT00817778|6124384|P2|Overall Study|Withdrawal by Subject|1
1757641|NCT00817778|6124385|P1|Overall Study|Withdrawal by Subject|1
1757642|NCT00817778|6124384|P2|Overall Study|Adverse Event|0
1757643|NCT00817778|6124385|P1|Overall Study|Adverse Event|1
1757644|NCT00817531|6124414|P1|Overall Study|Lack of Efficacy|1
1757645|NCT00817531|6124414|P1|Overall Study|Adverse Event|1
1757646|NCT00817479|6124420|P2|Overall Study|Physician Decision|1
1757647|NCT00817479|6124421|P1|Overall Study|Physician Decision|1
1757648|NCT00817336|6124431|P2|Overall Study|Withdrawal by Subject|1
1757649|NCT00817336|6124432|P1|Overall Study|Withdrawal by Subject|1
1757650|NCT00817206|6124458|P2|Overall Study|Physician Decision|0
1757651|NCT00817206|6124459|P1|Overall Study|Physician Decision|2
1757652|NCT00817206|6124458|P2|Overall Study|Withdrawal by Subject|3
1757653|NCT00817206|6124459|P1|Overall Study|Withdrawal by Subject|7
1757654|NCT00817206|6124458|P2|Overall Study|Death|0
1757655|NCT00817206|6124459|P1|Overall Study|Death|2
1757656|NCT00817206|6124458|P2|Overall Study|Lost to Follow-up|1
1757657|NCT00817206|6124459|P1|Overall Study|Lost to Follow-up|0
1757658|NCT00817206|6124458|P2|Overall Study|Protocol Violation|2
1757659|NCT00817206|6124459|P1|Overall Study|Protocol Violation|0
1757660|NCT00817206|6124458|P2|Overall Study|Adverse Event|3
1757661|NCT00817206|6124459|P1|Overall Study|Adverse Event|10
1757662|NCT00817089|6124469|P4|Second Alcohol Challenge|Lost to Follow-up|0
1757663|NCT00817089|6124470|P3|Second Alcohol Challenge|Lost to Follow-up|0
1757664|NCT00817089|6124471|P2|Second Alcohol Challenge|Lost to Follow-up|1
1757665|NCT00817089|6124472|P1|Second Alcohol Challenge|Lost to Follow-up|0
1757666|NCT00817089|6124469|P4|First Alcohol Challenge|Lost to Follow-up|1
1757667|NCT00817089|6124470|P3|First Alcohol Challenge|Lost to Follow-up|0
1757668|NCT00817089|6124471|P2|First Alcohol Challenge|Lost to Follow-up|0
1757669|NCT00817089|6124472|P1|First Alcohol Challenge|Lost to Follow-up|0
1757670|NCT00817063|6124488|P2|Overall Study|Abnormality of Laboratory Test|1
1757671|NCT00817063|6124489|P1|Overall Study|Abnormality of Laboratory Test|2
1757672|NCT00817063|6124488|P2|Overall Study|Administrative|4
1757673|NCT00817063|6124489|P1|Overall Study|Administrative|10
1757674|NCT00817063|6124488|P2|Overall Study|Early Improvement|4
1757675|NCT00817063|6124489|P1|Overall Study|Early Improvement|19
1757676|NCT00817063|6124488|P2|Overall Study|Withdrawal by Subject|37
1757677|NCT00817063|6124489|P1|Overall Study|Withdrawal by Subject|17
1757678|NCT00817063|6124488|P2|Overall Study|Protocol Violation|8
1757679|NCT00817063|6124489|P1|Overall Study|Protocol Violation|3
1757680|NCT00817063|6124488|P2|Overall Study|Violation of Selection at Entry|4
1757681|NCT00817063|6124489|P1|Overall Study|Violation of Selection at Entry|7
1757682|NCT00817063|6124488|P2|Overall Study|Failure to Return|12
1757683|NCT00817063|6124489|P1|Overall Study|Failure to Return|13
1757684|NCT00817063|6124488|P2|Overall Study|Lack of Efficacy|86
1757685|NCT00817063|6124489|P1|Overall Study|Lack of Efficacy|33
1757686|NCT00817063|6124488|P2|Overall Study|Death|1
1757687|NCT00817063|6124489|P1|Overall Study|Death|1
1757688|NCT00817063|6124488|P2|Overall Study|Adverse Event|13
1757689|NCT00817063|6124489|P1|Overall Study|Adverse Event|32
1757690|NCT00816595|6124617|P2|Overall Study|Withdrawal by Subject|0
1757691|NCT00816595|6124618|P1|Overall Study|Withdrawal by Subject|2
1757692|NCT00816556|6124631|P3|Overall Study|Lost to Follow-up|1
1757693|NCT00816556|6124632|P2|Overall Study|Lost to Follow-up|0
1757694|NCT00816556|6124633|P1|Overall Study|Lost to Follow-up|0
1757695|NCT00816556|6124631|P3|Overall Study|Withdrawal by Subject|1
1757696|NCT00816556|6124632|P2|Overall Study|Withdrawal by Subject|1
1757697|NCT00816556|6124633|P1|Overall Study|Withdrawal by Subject|1
1757698|NCT00816556|6124631|P3|Overall Study|Adverse Event|1
1757699|NCT00816556|6124632|P2|Overall Study|Adverse Event|1
1757700|NCT00816556|6124633|P1|Overall Study|Adverse Event|1
1757701|NCT00816400|6124656|P9|Overall Study|In hospice care at the end of the study|0
1757702|NCT00816400|6124657|P8|Overall Study|In hospice care at the end of the study|0
1757703|NCT00816400|6124658|P7|Overall Study|In hospice care at the end of the study|0
1757704|NCT00816400|6124659|P6|Overall Study|In hospice care at the end of the study|0
1757705|NCT00816400|6124660|P5|Overall Study|In hospice care at the end of the study|0
1757706|NCT00816400|6124661|P4|Overall Study|In hospice care at the end of the study|0
1757707|NCT00816400|6124662|P3|Overall Study|In hospice care at the end of the study|2
1757708|NCT00816400|6124663|P2|Overall Study|In hospice care at the end of the study|0
1757709|NCT00816400|6124664|P1|Overall Study|In hospice care at the end of the study|0
1757710|NCT00816400|6124656|P9|Overall Study|Death|6
1757711|NCT00816400|6124657|P8|Overall Study|Death|5
1757712|NCT00816400|6124658|P7|Overall Study|Death|2
1757713|NCT00816400|6124659|P6|Overall Study|Death|3
1757714|NCT00816400|6124660|P5|Overall Study|Death|2
1757715|NCT00816400|6124661|P4|Overall Study|Death|3
1757716|NCT00816400|6124662|P3|Overall Study|Death|3
1757717|NCT00816400|6124663|P2|Overall Study|Death|3
1757718|NCT00816400|6124664|P1|Overall Study|Death|2
1757719|NCT00816361|6124855|P9|Overall Study|Other|1
1757720|NCT00816361|6124856|P8|Overall Study|Other|0
1757721|NCT00816361|6124857|P7|Overall Study|Other|0
1757722|NCT00816361|6124858|P6|Overall Study|Other|0
1757723|NCT00816361|6124859|P5|Overall Study|Other|0
1757724|NCT00816361|6124860|P4|Overall Study|Other|0
1757725|NCT00816361|6124861|P3|Overall Study|Other|0
1757726|NCT00816361|6124862|P2|Overall Study|Other|0
1757727|NCT00816361|6124863|P1|Overall Study|Other|0
1757728|NCT00816361|6124855|P9|Overall Study|Death|8
1757729|NCT00816361|6124856|P8|Overall Study|Death|7
1757730|NCT00816361|6124857|P7|Overall Study|Death|3
1757731|NCT00816361|6124858|P6|Overall Study|Death|1
1757732|NCT00816361|6124859|P5|Overall Study|Death|1
1757733|NCT00816361|6124860|P4|Overall Study|Death|3
1757734|NCT00816361|6124861|P3|Overall Study|Death|3
1757735|NCT00816361|6124862|P2|Overall Study|Death|3
1757736|NCT00816361|6124863|P1|Overall Study|Death|4
1757737|NCT00816361|6124855|P9|Overall Study|Withdrawal by Subject|1
1757738|NCT00816361|6124856|P8|Overall Study|Withdrawal by Subject|2
1757739|NCT00816361|6124857|P7|Overall Study|Withdrawal by Subject|0
1757740|NCT00816361|6124858|P6|Overall Study|Withdrawal by Subject|2
1757741|NCT00816361|6124859|P5|Overall Study|Withdrawal by Subject|1
1757742|NCT00816361|6124860|P4|Overall Study|Withdrawal by Subject|0
1757743|NCT00816361|6124861|P3|Overall Study|Withdrawal by Subject|0
1757744|NCT00816361|6124862|P2|Overall Study|Withdrawal by Subject|0
1757745|NCT00816361|6124863|P1|Overall Study|Withdrawal by Subject|0
1757746|NCT00816166|6125022|P2|Overall Study|Death|2
1757747|NCT00816166|6125023|P1|Overall Study|Death|4
1757748|NCT00816166|6125022|P2|Overall Study|Lost to Follow-up|10
1757749|NCT00816166|6125023|P1|Overall Study|Lost to Follow-up|6
1757750|NCT00816036|6125055|P2|Overall Study|Withdrawal by Subject|23
1757751|NCT00816036|6125056|P1|Overall Study|Withdrawal by Subject|54
1757752|NCT00816036|6125055|P2|Overall Study|Lost to Follow-up|57
1757753|NCT00816036|6125056|P1|Overall Study|Lost to Follow-up|75
1757754|NCT00816036|6125055|P2|Overall Study|Death|28
1757755|NCT00816036|6125056|P1|Overall Study|Death|47
1757756|NCT00816023|6125070|P4|Overall Study|Randomized Not Treated|11
1757757|NCT00816023|6125071|P3|Overall Study|Randomized Not Treated|6
1757758|NCT00816023|6125072|P2|Overall Study|Randomized Not Treated|4
1757759|NCT00816023|6125073|P1|Overall Study|Randomized Not Treated|6
1757760|NCT00816023|6125070|P4|Overall Study|assessments complete prior to window|1
1757761|NCT00816023|6125071|P3|Overall Study|assessments complete prior to window|2
1757762|NCT00816023|6125072|P2|Overall Study|assessments complete prior to window|1
1757763|NCT00816023|6125073|P1|Overall Study|assessments complete prior to window|1
1757764|NCT00816023|6125070|P4|Overall Study|Physician Decision|0
1757765|NCT00816023|6125071|P3|Overall Study|Physician Decision|1
1757766|NCT00816023|6125072|P2|Overall Study|Physician Decision|0
1757767|NCT00816023|6125073|P1|Overall Study|Physician Decision|0
1757768|NCT00816023|6125070|P4|Overall Study|Withdrawal by Subject|0
1757769|NCT00816023|6125071|P3|Overall Study|Withdrawal by Subject|0
1757770|NCT00816023|6125072|P2|Overall Study|Withdrawal by Subject|0
1757771|NCT00816023|6125073|P1|Overall Study|Withdrawal by Subject|1
1757772|NCT00816023|6125070|P4|Overall Study|Lost to Follow-up|0
1757773|NCT00816023|6125071|P3|Overall Study|Lost to Follow-up|0
1757774|NCT00816023|6125072|P2|Overall Study|Lost to Follow-up|1
1757775|NCT00816023|6125073|P1|Overall Study|Lost to Follow-up|1
1757776|NCT00815919|6125110|P1|Overall Study|Lack of Efficacy|2
1757777|NCT00815919|6125110|P1|Overall Study|AML Relapse|1
1757778|NCT00815919|6125110|P1|Overall Study|Unrelated Fungal Infection|1
1757779|NCT00815659|6125153|P1|Overall Study|Protocol Violation|1
1757780|NCT00815659|6125153|P1|Overall Study|Lost to Follow-up|4
1757781|NCT00815659|6125153|P1|Overall Study|Withdrawal by Subject|9
1757782|NCT00815659|6125153|P1|Overall Study|Adverse Event|9
1757783|NCT00815633|6125196|P1|Overall Study|study terminated|1
1757784|NCT00815516|6125203|P2|Overall Study|Physician Decision|0
1757785|NCT00815516|6125204|P1|Overall Study|Physician Decision|1
1757786|NCT00815516|6125203|P2|Overall Study|Death|1
1757787|NCT00815516|6125204|P1|Overall Study|Death|3
1757788|NCT00815308|6125269|P1|Overall Study|Protocol Violation|6
1757789|NCT00815308|6125269|P1|Overall Study|Withdrawal by Subject|0
1757790|NCT00815308|6125269|P1|Overall Study|Adverse Event|4
1757791|NCT00815295|6125278|P3|Overall Study|Cetuximab hypersensitivity reaction|3
1757792|NCT00815295|6125279|P2|Overall Study|Cetuximab hypersensitivity reaction|1
1757793|NCT00815295|6125280|P1|Overall Study|Cetuximab hypersensitivity reaction|0
1757794|NCT00815191|6125292|P2|Overall Study|Protocol Violation|1
1757795|NCT00815191|6125293|P1|Overall Study|Protocol Violation|1
1757796|NCT00814983|6125330|P2|Overall Study|Graft failure|0
1757797|NCT00814983|6125331|P1|Overall Study|Graft failure|1
1757798|NCT00814983|6125330|P2|Overall Study|Withdrawal by Subject|0
1757799|NCT00814983|6125331|P1|Overall Study|Withdrawal by Subject|1
1757800|NCT00814983|6125330|P2|Overall Study|Screen failure|0
1757801|NCT00814983|6125331|P1|Overall Study|Screen failure|1
1757802|NCT00814892|6125362|P1|Overall Study|Study Termination|1
1757803|NCT00814892|6125362|P1|Overall Study|Disease Progression|1
1757804|NCT00814879|6125374|P2|By Week 48|Death|1
1757805|NCT00814879|6125375|P1|By Week 48|Death|0
1757806|NCT00814879|6125374|P2|By Week 48|Lost to Follow-up|2
1757807|NCT00814879|6125375|P1|By Week 48|Lost to Follow-up|2
1757808|NCT00814879|6125374|P2|By Week 24|Incarceration|1
1757809|NCT00814879|6125375|P1|By Week 24|Incarceration|0
1757810|NCT00814879|6125374|P2|By Week 24|Cancer Diagnosis|0
1757811|NCT00814879|6125375|P1|By Week 24|Cancer Diagnosis|1
1757812|NCT00814801|6125394|P3|Overall Study|Other|4
1757813|NCT00814801|6125395|P2|Overall Study|Other|6
1757814|NCT00814801|6125396|P1|Overall Study|Other|2
1757815|NCT00814801|6125394|P3|Overall Study|Non-compliance|1
1757816|NCT00814801|6125395|P2|Overall Study|Non-compliance|1
1757817|NCT00814801|6125396|P1|Overall Study|Non-compliance|0
1757818|NCT00814801|6125394|P3|Overall Study|Missing or change of caregiver|4
1757819|NCT00814801|6125395|P2|Overall Study|Missing or change of caregiver|2
1757820|NCT00814801|6125396|P1|Overall Study|Missing or change of caregiver|6
1757821|NCT00814801|6125394|P3|Overall Study|Change of patients for CIBIC plus-J|0
1757822|NCT00814801|6125395|P2|Overall Study|Change of patients for CIBIC plus-J|1
1757823|NCT00814801|6125396|P1|Overall Study|Change of patients for CIBIC plus-J|1
1757824|NCT00814801|6125394|P3|Overall Study|Inappropriate as a subject|1
1757825|NCT00814801|6125395|P2|Overall Study|Inappropriate as a subject|1
1757826|NCT00814801|6125396|P1|Overall Study|Inappropriate as a subject|1
1757827|NCT00814801|6125394|P3|Overall Study|Withdrawal by Subject|14
1757828|NCT00814801|6125395|P2|Overall Study|Withdrawal by Subject|11
1757829|NCT00814801|6125396|P1|Overall Study|Withdrawal by Subject|9
1757830|NCT00814801|6125394|P3|Overall Study|Adverse Event|19
1757831|NCT00814801|6125395|P2|Overall Study|Adverse Event|16
1757832|NCT00814801|6125396|P1|Overall Study|Adverse Event|15
1757833|NCT00814710|6125435|P2|Overall Study|Lost to Follow-up|3
1757834|NCT00814710|6125436|P1|Overall Study|Lost to Follow-up|7
1757835|NCT00814710|6125435|P2|Overall Study|Adverse Event|0
1757836|NCT00814710|6125436|P1|Overall Study|Adverse Event|1
1757837|NCT00814658|6125504|P2|Overall Study|Adverse Event|3
1757838|NCT00814658|6125505|P1|Overall Study|Adverse Event|3
1757839|NCT00814658|6125504|P2|Overall Study|Physician Decision|0
1757840|NCT00814658|6125505|P1|Overall Study|Physician Decision|1
1757841|NCT00814658|6125504|P2|Overall Study|Lost to Follow-up|1
1757842|NCT00814658|6125505|P1|Overall Study|Lost to Follow-up|0
1757843|NCT00814632|6125571|P1|Overall Study|Lack of Efficacy|2
1757844|NCT00814580|6125577|P2|Overall Study|Did Not Take Drug|2
1757845|NCT00814580|6125578|P1|Overall Study|Did Not Take Drug|2
1757846|NCT00814580|6125577|P2|Overall Study|Other|3
1757847|NCT00814580|6125578|P1|Overall Study|Other|1
1757848|NCT00814580|6125577|P2|Overall Study|Withdrawal by Subject|2
1757849|NCT00814580|6125578|P1|Overall Study|Withdrawal by Subject|2
1757850|NCT00814580|6125577|P2|Overall Study|Protocol Violation|0
1757851|NCT00814580|6125578|P1|Overall Study|Protocol Violation|2
1757852|NCT00814580|6125577|P2|Overall Study|Lack of Efficacy|25
1757853|NCT00814580|6125578|P1|Overall Study|Lack of Efficacy|18
1757854|NCT00814580|6125577|P2|Overall Study|Adverse Event|15
1757855|NCT00814580|6125578|P1|Overall Study|Adverse Event|6
1757856|NCT00814502|6125708|P2|Overall Study|Withdrawal by Subject|2
1757857|NCT00814502|6125709|P1|Overall Study|Withdrawal by Subject|0
1757858|NCT00814502|6125708|P2|Overall Study|Adverse Event|0
1757859|NCT00814502|6125709|P1|Overall Study|Adverse Event|1
1757860|NCT00814489|6125722|P3|Overall Study|Other|1
1757861|NCT00814489|6125723|P2|Overall Study|Other|0
1757862|NCT00814489|6125724|P1|Overall Study|Other|2
1757863|NCT00814463|6125756|P1|Overall Study|Lost to Follow-up|1
1757864|NCT00814346|6125769|P2|Open Phase (17 Months)|Not otherwise specified|0
1757865|NCT00814346|6125770|P1|Open Phase (17 Months)|Not otherwise specified|1
1757866|NCT00814346|6125769|P2|Open Phase (17 Months)|Lost to Follow-up|0
1757867|NCT00814346|6125770|P1|Open Phase (17 Months)|Lost to Follow-up|2
1757868|NCT00814346|6125769|P2|Open Phase (17 Months)|Consent|0
1757869|NCT00814346|6125770|P1|Open Phase (17 Months)|Consent|2
1757870|NCT00814346|6125769|P2|Open Phase (17 Months)|Adverse Event|0
1757871|NCT00814346|6125770|P1|Open Phase (17 Months)|Adverse Event|5
1757872|NCT00814346|6125769|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
1757873|NCT00814346|6125770|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
1757874|NCT00814346|6125769|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
1757875|NCT00814346|6125770|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
1757876|NCT00814333|6125836|P2|Enrollment|Lost to Follow-up|0
1757877|NCT00814333|6125837|P1|Enrollment|Lost to Follow-up|1
1757878|NCT00814320|6125845|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
1757879|NCT00814320|6125846|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
1757880|NCT00814320|6125845|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
1757881|NCT00814320|6125846|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
1757882|NCT00814320|6125845|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
1757883|NCT00814320|6125846|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
1757884|NCT00814320|6125845|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
1757885|NCT00814320|6125846|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
1757886|NCT00814320|6125845|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
1757887|NCT00814320|6125846|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
1757888|NCT00814320|6125845|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
1757889|NCT00814320|6125846|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
1757890|NCT00814320|6125845|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
1757891|NCT00814320|6125846|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
1757892|NCT00814320|6125845|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
1757893|NCT00814320|6125846|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
1757894|NCT00814320|6125845|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
1757895|NCT00814320|6125846|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
1757896|NCT00814320|6125845|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
1757897|NCT00814320|6125846|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
1757898|NCT00814307|6125978|P4|Overall Study|Death|0
1757899|NCT00814307|6125979|P3|Overall Study|Death|0
1757900|NCT00814307|6125980|P2|Overall Study|Death|1
1757901|NCT00814307|6125981|P1|Overall Study|Death|0
1757902|NCT00814307|6125978|P4|Overall Study|Withdrawal by Subject|2
1757903|NCT00814307|6125979|P3|Overall Study|Withdrawal by Subject|0
1757904|NCT00814307|6125980|P2|Overall Study|Withdrawal by Subject|6
1757905|NCT00814307|6125981|P1|Overall Study|Withdrawal by Subject|4
1757906|NCT00814307|6125978|P4|Overall Study|Protocol Violation|1
1757907|NCT00814307|6125979|P3|Overall Study|Protocol Violation|1
1757908|NCT00814307|6125980|P2|Overall Study|Protocol Violation|8
1757909|NCT00814307|6125981|P1|Overall Study|Protocol Violation|2
1757910|NCT00814307|6125978|P4|Overall Study|Other|1
1757911|NCT00814307|6125979|P3|Overall Study|Other|0
1757912|NCT00814307|6125980|P2|Overall Study|Other|2
1757913|NCT00814307|6125981|P1|Overall Study|Other|1
1757914|NCT00814307|6125978|P4|Overall Study|Lack of Efficacy|4
1757915|NCT00814307|6125979|P3|Overall Study|Lack of Efficacy|3
1757916|NCT00814307|6125980|P2|Overall Study|Lack of Efficacy|1
1757917|NCT00814307|6125981|P1|Overall Study|Lack of Efficacy|1
1757918|NCT00814307|6125978|P4|Overall Study|Adverse Event|2
1757919|NCT00814307|6125979|P3|Overall Study|Adverse Event|3
1757920|NCT00814307|6125980|P2|Overall Study|Adverse Event|9
1757921|NCT00814307|6125981|P1|Overall Study|Adverse Event|3
1757922|NCT00814307|6125978|P4|Overall Study|Randomized but not treated|0
1757923|NCT00814307|6125979|P3|Overall Study|Randomized but not treated|0
1757924|NCT00814307|6125980|P2|Overall Study|Randomized but not treated|0
1757925|NCT00814307|6125981|P1|Overall Study|Randomized but not treated|1
1757926|NCT00814164|6126177|P1|Overall Study|Death|5
1757927|NCT00814164|6126177|P1|Overall Study|not stated|7
1757928|NCT00814164|6126177|P1|Overall Study|Progression|7
1757929|NCT00813995|6126211|P2|Overall Study|Withdrawal by Subject|5
1757930|NCT00813995|6126212|P1|Overall Study|Withdrawal by Subject|0
1757931|NCT00813995|6126211|P2|Overall Study|Subject moved|0
1757932|NCT00813995|6126212|P1|Overall Study|Subject moved|4
1757933|NCT00813995|6126211|P2|Overall Study|Protocol Violation|2
1757934|NCT00813995|6126212|P1|Overall Study|Protocol Violation|3
1757935|NCT00813995|6126211|P2|Overall Study|Other reason|2
1757936|NCT00813995|6126212|P1|Overall Study|Other reason|2
1757937|NCT00813995|6126211|P2|Overall Study|Lost to Follow-up|2
1757938|NCT00813995|6126212|P1|Overall Study|Lost to Follow-up|4
1757939|NCT00813995|6126211|P2|Overall Study|Lack of Efficacy|0
1757940|NCT00813995|6126212|P1|Overall Study|Lack of Efficacy|1
1757941|NCT00813995|6126211|P2|Overall Study|Laboratory adverse event|2
1757942|NCT00813995|6126212|P1|Overall Study|Laboratory adverse event|0
1757943|NCT00813995|6126211|P2|Overall Study|Clinical adverse event|3
1757944|NCT00813995|6126212|P1|Overall Study|Clinical adverse event|9
1757945|NCT00813943|6126235|P3|Overall Study|Ongoing at cut-off date|3
1757946|NCT00813943|6126236|P2|Overall Study|Ongoing at cut-off date|5
1757947|NCT00813943|6126237|P1|Overall Study|Ongoing at cut-off date|5
1757948|NCT00813917|6126267|P2|Overall Study|Lost to Follow-up|1
1757949|NCT00813917|6126268|P1|Overall Study|Lost to Follow-up|3
1757950|NCT00813917|6126267|P2|Overall Study|Withdrawal by Subject|4
1757951|NCT00813917|6126268|P1|Overall Study|Withdrawal by Subject|3
1757952|NCT00813917|6126267|P2|Overall Study|Adverse Event|1
1757953|NCT00813917|6126268|P1|Overall Study|Adverse Event|0
1757954|NCT00813904|6126274|P1|Overall Study|Death|1
1757955|NCT00813865|6126280|P1|Overall Study|Withdrawal by Subject|1
1757956|NCT00813865|6126280|P1|Overall Study|Lost to Follow-up|3
1757957|NCT00813865|6126280|P1|Overall Study|Failure to Respond|3
1757958|NCT00813813|6126288|P2|Overall Study|Other|1
1757959|NCT00813813|6126289|P1|Overall Study|Other|0
1757960|NCT00813813|6126288|P2|Overall Study|Lost to Follow-up|7
1757961|NCT00813813|6126289|P1|Overall Study|Lost to Follow-up|2
1757962|NCT00813813|6126288|P2|Overall Study|Withdrawal by Subject|1
1757963|NCT00813813|6126289|P1|Overall Study|Withdrawal by Subject|1
1757964|NCT00813800|6126305|P1|Overall Study|Physician Decision|1
1757965|NCT00813800|6126305|P1|Overall Study|Worsening of depression|2
1757966|NCT00813800|6126305|P1|Overall Study|Adverse Event|1
1757967|NCT00813800|6126305|P1|Overall Study|Screen Failure after Consent|2
1757968|NCT00813761|6126313|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
1757969|NCT00813761|6126314|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
1757970|NCT00813761|6126315|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
1757971|NCT00813761|6126316|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
1757972|NCT00813761|6126313|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
1757973|NCT00813761|6126314|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
1757974|NCT00813761|6126315|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
1757975|NCT00813761|6126316|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
1757976|NCT00813761|6126313|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
1757977|NCT00813761|6126314|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1757978|NCT00813761|6126315|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1757979|NCT00813761|6126316|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
1757980|NCT00813761|6126313|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
1757981|NCT00813761|6126314|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
1757982|NCT00813761|6126315|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
1757983|NCT00813761|6126316|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
1757984|NCT00813761|6126313|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
1757985|NCT00813761|6126314|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
1757986|NCT00813761|6126315|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
1757987|NCT00813761|6126316|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
1757988|NCT00813761|6126313|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
1757989|NCT00813761|6126314|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
1757990|NCT00813761|6126315|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
1757991|NCT00813761|6126316|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
1757992|NCT00813761|6126313|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1757993|NCT00813761|6126314|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1757994|NCT00813761|6126315|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
1757995|NCT00813761|6126316|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
1757996|NCT00813761|6126313|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1757997|NCT00813761|6126314|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
1757998|NCT00813761|6126315|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1757999|NCT00813761|6126316|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
1758000|NCT00813761|6126313|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1758001|NCT00813761|6126314|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
1758002|NCT00813761|6126315|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1758003|NCT00813761|6126316|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
1758004|NCT00813761|6126313|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
1758005|NCT00813761|6126314|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1758006|NCT00813761|6126315|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1758007|NCT00813761|6126316|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
1758008|NCT00813761|6126313|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
1758009|NCT00813761|6126314|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
1758010|NCT00813761|6126315|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
1758011|NCT00813761|6126316|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
1758012|NCT00813761|6126313|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1758013|NCT00813761|6126314|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1758014|NCT00813761|6126315|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
1758015|NCT00813761|6126316|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
1758016|NCT00813748|6126366|P2|Skin Test Substudy|Physician Decision|1
1758017|NCT00813748|6126367|P1|Skin Test Substudy|Physician Decision|0
1758018|NCT00813709|6126396|P6|Open Label Period|Other|6
1758019|NCT00813709|6126397|P5|Open Label Period|Other|5
1758020|NCT00813709|6126398|P4|Open Label Period|Other|11
1758021|NCT00813709|6126399|P3|Open Label Period|Other|0
1758022|NCT00813709|6126400|P2|Open Label Period|Other|0
1758023|NCT00813709|6126401|P1|Open Label Period|Other|0
1758024|NCT00813709|6126396|P6|Open Label Period|Randomized but not treated|1
1758025|NCT00813709|6126397|P5|Open Label Period|Randomized but not treated|0
1758026|NCT00813709|6126398|P4|Open Label Period|Randomized but not treated|1
1758027|NCT00813709|6126399|P3|Open Label Period|Randomized but not treated|0
1758028|NCT00813709|6126400|P2|Open Label Period|Randomized but not treated|0
1758029|NCT00813709|6126401|P1|Open Label Period|Randomized but not treated|0
1758030|NCT00813709|6126396|P6|Open Label Period|Lack of Efficacy|1
1758031|NCT00813709|6126397|P5|Open Label Period|Lack of Efficacy|1
1758032|NCT00813709|6126398|P4|Open Label Period|Lack of Efficacy|3
1758033|NCT00813709|6126399|P3|Open Label Period|Lack of Efficacy|0
1758034|NCT00813709|6126400|P2|Open Label Period|Lack of Efficacy|0
1758035|NCT00813709|6126401|P1|Open Label Period|Lack of Efficacy|0
1758036|NCT00813709|6126396|P6|Open Label Period|Adverse Event|3
1758037|NCT00813709|6126397|P5|Open Label Period|Adverse Event|4
1758038|NCT00813709|6126398|P4|Open Label Period|Adverse Event|5
1758039|NCT00813709|6126399|P3|Open Label Period|Adverse Event|0
1758040|NCT00813709|6126400|P2|Open Label Period|Adverse Event|0
1758041|NCT00813709|6126401|P1|Open Label Period|Adverse Event|0
1758042|NCT00813709|6126396|P6|Double Blind Period|Other|0
1758043|NCT00813709|6126397|P5|Double Blind Period|Other|0
1758044|NCT00813709|6126398|P4|Double Blind Period|Other|0
1758045|NCT00813709|6126399|P3|Double Blind Period|Other|6
1758046|NCT00813709|6126400|P2|Double Blind Period|Other|9
1758047|NCT00813709|6126401|P1|Double Blind Period|Other|14
1758048|NCT00813709|6126396|P6|Double Blind Period|Randomized but not treated|0
1758049|NCT00813709|6126397|P5|Double Blind Period|Randomized but not treated|0
1758050|NCT00813709|6126398|P4|Double Blind Period|Randomized but not treated|0
1758051|NCT00813709|6126399|P3|Double Blind Period|Randomized but not treated|1
1758052|NCT00813709|6126400|P2|Double Blind Period|Randomized but not treated|3
1758053|NCT00813709|6126401|P1|Double Blind Period|Randomized but not treated|1
1758054|NCT00813709|6126396|P6|Double Blind Period|Switched to open label phase|0
1758055|NCT00813709|6126397|P5|Double Blind Period|Switched to open label phase|0
1758056|NCT00813709|6126398|P4|Double Blind Period|Switched to open label phase|0
1758057|NCT00813709|6126399|P3|Double Blind Period|Switched to open label phase|18
1758058|NCT00813709|6126400|P2|Double Blind Period|Switched to open label phase|26
1758059|NCT00813709|6126401|P1|Double Blind Period|Switched to open label phase|9
1758060|NCT00813709|6126396|P6|Double Blind Period|Lost to Follow-up|0
1758061|NCT00813709|6126397|P5|Double Blind Period|Lost to Follow-up|0
1758062|NCT00813709|6126398|P4|Double Blind Period|Lost to Follow-up|0
1758063|NCT00813709|6126399|P3|Double Blind Period|Lost to Follow-up|2
1758064|NCT00813709|6126400|P2|Double Blind Period|Lost to Follow-up|2
1758065|NCT00813709|6126401|P1|Double Blind Period|Lost to Follow-up|3
1758066|NCT00813709|6126396|P6|Double Blind Period|Adverse Event|0
1758067|NCT00813709|6126397|P5|Double Blind Period|Adverse Event|0
1758068|NCT00813709|6126398|P4|Double Blind Period|Adverse Event|0
1758069|NCT00813709|6126399|P3|Double Blind Period|Adverse Event|4
1758070|NCT00813709|6126400|P2|Double Blind Period|Adverse Event|1
1758071|NCT00813709|6126401|P1|Double Blind Period|Adverse Event|4
1758072|NCT00813592|6126481|P1|Overall Study|Disease assessment was not completed per|2
1758073|NCT00813488|6126490|P2|Open-label Extension|Other|0
1758074|NCT00813488|6126491|P1|Open-label Extension|Other|1
1758075|NCT00813488|6126490|P2|Open-label Extension|Non-compliance study procedures|1
1758076|NCT00813488|6126491|P1|Open-label Extension|Non-compliance study procedures|2
1758077|NCT00813488|6126490|P2|Open-label Extension|Non-compliance study medication|0
1758078|NCT00813488|6126491|P1|Open-label Extension|Non-compliance study medication|4
1758079|NCT00813488|6126490|P2|Open-label Extension|Protocol Violation|2
1758080|NCT00813488|6126491|P1|Open-label Extension|Protocol Violation|1
1758081|NCT00813488|6126490|P2|Open-label Extension|Withdrawal by Subject|2
1758082|NCT00813488|6126491|P1|Open-label Extension|Withdrawal by Subject|0
1758083|NCT00813488|6126490|P2|Open-label Extension|Lack of Efficacy|0
1758084|NCT00813488|6126491|P1|Open-label Extension|Lack of Efficacy|3
1758085|NCT00813488|6126490|P2|Open-label Extension|Adverse Event|2
1758086|NCT00813488|6126491|P1|Open-label Extension|Adverse Event|1
1758087|NCT00813488|6126490|P2|Double-blind Treatment Period 2|Other|0
1758088|NCT00813488|6126491|P1|Double-blind Treatment Period 2|Other|1
1758089|NCT00813488|6126490|P2|Double-blind Treatment Period 2|Protocol Violation|0
1758090|NCT00813488|6126491|P1|Double-blind Treatment Period 2|Protocol Violation|2
1758091|NCT00813488|6126490|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
1758092|NCT00813488|6126491|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
1758093|NCT00813488|6126490|P2|Double-blind Treatment Period 2|Adverse Event|0
1758094|NCT00813488|6126491|P1|Double-blind Treatment Period 2|Adverse Event|1
1758095|NCT00813488|6126490|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
1758096|NCT00813488|6126491|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
1758097|NCT00813488|6126490|P2|Double-blind Treatment Period 1|Protocol Violation|2
1758098|NCT00813488|6126491|P1|Double-blind Treatment Period 1|Protocol Violation|0
1758183|NCT00812955|6126748|P3|Overall Study|randomized in error|1
1758099|NCT00813488|6126490|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
1758100|NCT00813488|6126491|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
1758101|NCT00813488|6126490|P2|Double-blind Treatment Period 1|Adverse Event|1
1758102|NCT00813488|6126491|P1|Double-blind Treatment Period 1|Adverse Event|1
1758103|NCT00813488|6126490|P2|Titration Period 2|Non-compliance with study procedures|1
1758104|NCT00813488|6126491|P1|Titration Period 2|Non-compliance with study procedures|2
1758105|NCT00813488|6126490|P2|Titration Period 2|Lost to Follow-up|0
1758106|NCT00813488|6126491|P1|Titration Period 2|Lost to Follow-up|1
1758107|NCT00813488|6126490|P2|Titration Period 2|Protocol Violation|2
1758108|NCT00813488|6126491|P1|Titration Period 2|Protocol Violation|3
1758109|NCT00813488|6126490|P2|Titration Period 2|Lack of Efficacy|4
1758110|NCT00813488|6126491|P1|Titration Period 2|Lack of Efficacy|8
1758111|NCT00813488|6126490|P2|Titration Period 2|Adverse Event|3
1758112|NCT00813488|6126491|P1|Titration Period 2|Adverse Event|2
1758113|NCT00813488|6126490|P2|Titration Period 1|Technical Difficulties|1
1758114|NCT00813488|6126491|P1|Titration Period 1|Technical Difficulties|0
1758115|NCT00813488|6126490|P2|Titration Period 1|Non-compliance to study procedures|2
1758116|NCT00813488|6126491|P1|Titration Period 1|Non-compliance to study procedures|2
1758117|NCT00813488|6126490|P2|Titration Period 1|Non-compliance to study medication|1
1758118|NCT00813488|6126491|P1|Titration Period 1|Non-compliance to study medication|4
1758119|NCT00813488|6126490|P2|Titration Period 1|Protocol Violation|3
1758120|NCT00813488|6126491|P1|Titration Period 1|Protocol Violation|4
1758121|NCT00813488|6126490|P2|Titration Period 1|Withdrawal by Subject|2
1758122|NCT00813488|6126491|P1|Titration Period 1|Withdrawal by Subject|2
1758123|NCT00813488|6126490|P2|Titration Period 1|Lack of Efficacy|7
1758124|NCT00813488|6126491|P1|Titration Period 1|Lack of Efficacy|9
1758125|NCT00813488|6126490|P2|Titration Period 1|Adverse Event|1
1758126|NCT00813488|6126491|P1|Titration Period 1|Adverse Event|6
1758127|NCT00813150|6126621|P2|Long Term Follow-up|Progression/Relapse|24
1758128|NCT00813150|6126622|P1|Long Term Follow-up|Progression/Relapse|22
1758129|NCT00813150|6126621|P2|Long Term Follow-up|Lost to Follow-up|0
1758130|NCT00813150|6126622|P1|Long Term Follow-up|Lost to Follow-up|2
1758131|NCT00813150|6126621|P2|Long Term Follow-up|Other|3
1758132|NCT00813150|6126622|P1|Long Term Follow-up|Other|0
1758133|NCT00813150|6126621|P2|Long Term Follow-up|Death|4
1758134|NCT00813150|6126622|P1|Long Term Follow-up|Death|0
1758135|NCT00813150|6126621|P2|Treatment Period|Data not available|2
1758136|NCT00813150|6126622|P1|Treatment Period|Data not available|1
1758137|NCT00813150|6126621|P2|Treatment Period|Reason not specified|4
1758138|NCT00813150|6126622|P1|Treatment Period|Reason not specified|3
1758139|NCT00813150|6126621|P2|Treatment Period|Non compliance|1
1758140|NCT00813150|6126622|P1|Treatment Period|Non compliance|0
1758141|NCT00813150|6126621|P2|Treatment Period|Withdrawal by Subject|3
1758142|NCT00813150|6126622|P1|Treatment Period|Withdrawal by Subject|5
1758143|NCT00813150|6126621|P2|Treatment Period|Protocol Violation|4
1758144|NCT00813150|6126622|P1|Treatment Period|Protocol Violation|3
1758145|NCT00813150|6126621|P2|Treatment Period|Stable disease|2
1758146|NCT00813150|6126622|P1|Treatment Period|Stable disease|1
1758147|NCT00813150|6126621|P2|Treatment Period|Complete response|1
1758148|NCT00813150|6126622|P1|Treatment Period|Complete response|0
1758149|NCT00813150|6126621|P2|Treatment Period|Progressive disease|0
1758150|NCT00813150|6126622|P1|Treatment Period|Progressive disease|1
1758151|NCT00813150|6126621|P2|Treatment Period|Death|0
1758152|NCT00813150|6126622|P1|Treatment Period|Death|2
1758153|NCT00813150|6126621|P2|Treatment Period|Adverse Event|15
1758154|NCT00813150|6126622|P1|Treatment Period|Adverse Event|16
1758155|NCT00813098|6126646|P3|Overall Study|Withdrew Consent|0
1758156|NCT00813098|6126647|P2|Overall Study|Withdrew Consent|1
1758157|NCT00813098|6126648|P1|Overall Study|Withdrew Consent|0
1758158|NCT00813098|6126646|P3|Overall Study|Principal Investigator decision|0
1758159|NCT00813098|6126647|P2|Overall Study|Principal Investigator decision|1
1758160|NCT00813098|6126648|P1|Overall Study|Principal Investigator decision|0
1758161|NCT00813098|6126646|P3|Overall Study|Protocol Violation|1
1758162|NCT00813098|6126647|P2|Overall Study|Protocol Violation|0
1758163|NCT00813098|6126648|P1|Overall Study|Protocol Violation|0
1758164|NCT00813098|6126646|P3|Overall Study|Lost to Follow-up|0
1758165|NCT00813098|6126647|P2|Overall Study|Lost to Follow-up|1
1758166|NCT00813098|6126648|P1|Overall Study|Lost to Follow-up|0
1758167|NCT00813098|6126646|P3|Overall Study|Inability to complete study procedures|0
1758168|NCT00813098|6126647|P2|Overall Study|Inability to complete study procedures|0
1758169|NCT00813098|6126648|P1|Overall Study|Inability to complete study procedures|1
1758170|NCT00813098|6126646|P3|Overall Study|Withdrawal by Subject|0
1758171|NCT00813098|6126647|P2|Overall Study|Withdrawal by Subject|1
1758172|NCT00813098|6126648|P1|Overall Study|Withdrawal by Subject|0
1758173|NCT00813098|6126646|P3|Overall Study|Adverse Event|1
1758174|NCT00813098|6126647|P2|Overall Study|Adverse Event|4
1758175|NCT00813098|6126648|P1|Overall Study|Adverse Event|2
1758176|NCT00812981|6126673|P2|Overall Study|Other|1
1758177|NCT00812981|6126674|P1|Overall Study|Other|0
1758178|NCT00812968|6126712|P1|Overall Study|Study closed due to marketing approval|3
1758179|NCT00812968|6126712|P1|Overall Study|No further treatment required|1
1758180|NCT00812968|6126712|P1|Overall Study|Disease progression|1
1758181|NCT00812968|6126712|P1|Overall Study|Relapse after erythroid response|6
1758182|NCT00812955|6126747|P4|Overall Study|randomized in error|0
1758184|NCT00812955|6126749|P2|Overall Study|randomized in error|0
1758185|NCT00812955|6126750|P1|Overall Study|randomized in error|0
1758186|NCT00812955|6126747|P4|Overall Study|Withdrawal by Subject|2
1758187|NCT00812955|6126748|P3|Overall Study|Withdrawal by Subject|1
1758188|NCT00812955|6126749|P2|Overall Study|Withdrawal by Subject|0
1758189|NCT00812955|6126750|P1|Overall Study|Withdrawal by Subject|1
1758190|NCT00812955|6126747|P4|Overall Study|Lost to Follow-up|2
1758191|NCT00812955|6126748|P3|Overall Study|Lost to Follow-up|1
1758192|NCT00812955|6126749|P2|Overall Study|Lost to Follow-up|1
1758193|NCT00812955|6126750|P1|Overall Study|Lost to Follow-up|2
1758194|NCT00812955|6126747|P4|Overall Study|Adverse Event|4
1758195|NCT00812955|6126748|P3|Overall Study|Adverse Event|3
1758196|NCT00812955|6126749|P2|Overall Study|Adverse Event|6
1758197|NCT00812955|6126750|P1|Overall Study|Adverse Event|7
1758198|NCT00812929|6126770|P10|Washout Period 3 (7 Days)|Adverse Event|0
1758199|NCT00812929|6126771|P9|Washout Period 3 (7 Days)|Adverse Event|0
1758200|NCT00812929|6126772|P8|Washout Period 3 (7 Days)|Adverse Event|0
1758201|NCT00812929|6126773|P7|Washout Period 3 (7 Days)|Adverse Event|0
1758202|NCT00812929|6126774|P6|Washout Period 3 (7 Days)|Adverse Event|1
1758203|NCT00812929|6126775|P5|Washout Period 3 (7 Days)|Adverse Event|0
1758204|NCT00812929|6126776|P4|Washout Period 3 (7 Days)|Adverse Event|0
1758205|NCT00812929|6126777|P3|Washout Period 3 (7 Days)|Adverse Event|0
1758206|NCT00812929|6126778|P2|Washout Period 3 (7 Days)|Adverse Event|0
1758207|NCT00812929|6126779|P1|Washout Period 3 (7 Days)|Adverse Event|0
1758208|NCT00812929|6126770|P10|Washout Period 2 (7 Days)|Physician Decision|1
1758209|NCT00812929|6126771|P9|Washout Period 2 (7 Days)|Physician Decision|0
1758210|NCT00812929|6126772|P8|Washout Period 2 (7 Days)|Physician Decision|0
1758211|NCT00812929|6126773|P7|Washout Period 2 (7 Days)|Physician Decision|0
1758212|NCT00812929|6126774|P6|Washout Period 2 (7 Days)|Physician Decision|0
1758213|NCT00812929|6126775|P5|Washout Period 2 (7 Days)|Physician Decision|0
1758214|NCT00812929|6126776|P4|Washout Period 2 (7 Days)|Physician Decision|0
1758215|NCT00812929|6126777|P3|Washout Period 2 (7 Days)|Physician Decision|0
1758216|NCT00812929|6126778|P2|Washout Period 2 (7 Days)|Physician Decision|0
1758217|NCT00812929|6126779|P1|Washout Period 2 (7 Days)|Physician Decision|0
1758218|NCT00812929|6126770|P10|Washout Period 1 (7 Days)|Physician Decision|0
1758219|NCT00812929|6126771|P9|Washout Period 1 (7 Days)|Physician Decision|0
1758220|NCT00812929|6126772|P8|Washout Period 1 (7 Days)|Physician Decision|0
1758221|NCT00812929|6126773|P7|Washout Period 1 (7 Days)|Physician Decision|0
1758222|NCT00812929|6126774|P6|Washout Period 1 (7 Days)|Physician Decision|0
1758223|NCT00812929|6126775|P5|Washout Period 1 (7 Days)|Physician Decision|0
1758224|NCT00812929|6126776|P4|Washout Period 1 (7 Days)|Physician Decision|0
1758225|NCT00812929|6126777|P3|Washout Period 1 (7 Days)|Physician Decision|1
1758226|NCT00812929|6126778|P2|Washout Period 1 (7 Days)|Physician Decision|0
1758227|NCT00812929|6126779|P1|Washout Period 1 (7 Days)|Physician Decision|0
1758228|NCT00812812|6126934|P2|Overall Study|Withdrawal by Subject|2
1758229|NCT00812812|6126935|P1|Overall Study|Withdrawal by Subject|0
1758230|NCT00812812|6126934|P2|Overall Study|Lost to Follow-up|1
1758231|NCT00812812|6126935|P1|Overall Study|Lost to Follow-up|0
1758232|NCT00812812|6126934|P2|Overall Study|Lack of Efficacy|0
1758233|NCT00812812|6126935|P1|Overall Study|Lack of Efficacy|1
1758234|NCT00812812|6126934|P2|Overall Study|Adverse Event|1
1758235|NCT00812812|6126935|P1|Overall Study|Adverse Event|2
1758236|NCT00812708|6126948|P1|Overall Study|Signed consent but later withdrew|3
1758237|NCT00812708|6126948|P1|Overall Study|Surgery cancelled due to uveitis|1
1758238|NCT00812708|6126948|P1|Overall Study|Switched to another study|1
1758239|NCT00812708|6126948|P1|Overall Study|Lack of medical insurance|1
1758240|NCT00812708|6126948|P1|Overall Study|Device could not be implanted|2
1758241|NCT00812565|6126976|P8|Overall Study|Reason Not Specified|0
1758242|NCT00812565|6126977|P7|Overall Study|Reason Not Specified|0
1758243|NCT00812565|6126978|P6|Overall Study|Reason Not Specified|1
1758244|NCT00812565|6126979|P5|Overall Study|Reason Not Specified|0
1758245|NCT00812565|6126980|P4|Overall Study|Reason Not Specified|0
1758246|NCT00812565|6126981|P3|Overall Study|Reason Not Specified|0
1758247|NCT00812565|6126982|P2|Overall Study|Reason Not Specified|0
1758248|NCT00812565|6126983|P1|Overall Study|Reason Not Specified|0
1758249|NCT00812565|6126976|P8|Overall Study|Withdrawal of Consent|0
1758250|NCT00812565|6126977|P7|Overall Study|Withdrawal of Consent|0
1758251|NCT00812565|6126978|P6|Overall Study|Withdrawal of Consent|0
1758252|NCT00812565|6126979|P5|Overall Study|Withdrawal of Consent|1
1758253|NCT00812565|6126980|P4|Overall Study|Withdrawal of Consent|0
1758254|NCT00812565|6126981|P3|Overall Study|Withdrawal of Consent|0
1758255|NCT00812565|6126982|P2|Overall Study|Withdrawal of Consent|0
1758256|NCT00812565|6126983|P1|Overall Study|Withdrawal of Consent|1
1758257|NCT00812565|6126976|P8|Overall Study|Did Not Come to Study Visit|0
1758258|NCT00812565|6126977|P7|Overall Study|Did Not Come to Study Visit|0
1758259|NCT00812565|6126978|P6|Overall Study|Did Not Come to Study Visit|0
1758260|NCT00812565|6126979|P5|Overall Study|Did Not Come to Study Visit|0
1758261|NCT00812565|6126980|P4|Overall Study|Did Not Come to Study Visit|0
1758262|NCT00812565|6126981|P3|Overall Study|Did Not Come to Study Visit|0
1758263|NCT00812565|6126982|P2|Overall Study|Did Not Come to Study Visit|0
1758264|NCT00812565|6126983|P1|Overall Study|Did Not Come to Study Visit|1
1758265|NCT00812565|6126976|P8|Overall Study|Adverse Event|1
1758266|NCT00812565|6126977|P7|Overall Study|Adverse Event|0
1758267|NCT00812565|6126978|P6|Overall Study|Adverse Event|0
1758268|NCT00812565|6126979|P5|Overall Study|Adverse Event|0
1758269|NCT00812565|6126980|P4|Overall Study|Adverse Event|2
1758270|NCT00812565|6126981|P3|Overall Study|Adverse Event|0
1758271|NCT00812565|6126982|P2|Overall Study|Adverse Event|0
1758272|NCT00812565|6126983|P1|Overall Study|Adverse Event|0
1758273|NCT00812565|6126976|P8|Overall Study|Did Not Receive Study Medication|0
1758274|NCT00812565|6126977|P7|Overall Study|Did Not Receive Study Medication|0
1758275|NCT00812565|6126978|P6|Overall Study|Did Not Receive Study Medication|0
1758276|NCT00812565|6126979|P5|Overall Study|Did Not Receive Study Medication|0
1758277|NCT00812565|6126980|P4|Overall Study|Did Not Receive Study Medication|0
1758278|NCT00812565|6126981|P3|Overall Study|Did Not Receive Study Medication|0
1758279|NCT00812565|6126982|P2|Overall Study|Did Not Receive Study Medication|1
1758280|NCT00812565|6126983|P1|Overall Study|Did Not Receive Study Medication|1
1758281|NCT00812487|6127107|P2|Overall Study|Protocol Violation|1
1758282|NCT00812487|6127108|P1|Overall Study|Protocol Violation|0
1758283|NCT00812487|6127107|P2|Overall Study|Transfer to ICU prior to intervention|0
1758284|NCT00812487|6127108|P1|Overall Study|Transfer to ICU prior to intervention|1
1758285|NCT00812487|6127107|P2|Overall Study|Withdrawal by Subject|2
1758286|NCT00812487|6127108|P1|Overall Study|Withdrawal by Subject|3
1758287|NCT00812487|6127107|P2|Overall Study|Lost to Follow-up|0
1758288|NCT00812487|6127108|P1|Overall Study|Lost to Follow-up|2
1758289|NCT00812461|6127134|P2|All Treated Patients|Other Reason|21
1758290|NCT00812461|6127135|P1|All Treated Patients|Other Reason|13
1758291|NCT00812461|6127134|P2|All Treated Patients|Lost to Follow-up|14
1758292|NCT00812461|6127135|P1|All Treated Patients|Lost to Follow-up|11
1758293|NCT00812461|6127134|P2|All Treated Patients|Withdrawal by Subject|54
1758294|NCT00812461|6127135|P1|All Treated Patients|Withdrawal by Subject|45
1758295|NCT00812461|6127134|P2|All Treated Patients|Protocol Violation|27
1758296|NCT00812461|6127135|P1|All Treated Patients|Protocol Violation|36
1758297|NCT00812461|6127134|P2|All Treated Patients|Non-compliance|9
1758298|NCT00812461|6127135|P1|All Treated Patients|Non-compliance|6
1758299|NCT00812461|6127134|P2|All Treated Patients|Lack of Efficacy|7
1758300|NCT00812461|6127135|P1|All Treated Patients|Lack of Efficacy|13
1758301|NCT00812461|6127134|P2|All Treated Patients|Adverse Event|15
1758302|NCT00812461|6127135|P1|All Treated Patients|Adverse Event|8
1758303|NCT00812461|6127134|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
1758304|NCT00812461|6127135|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
1758305|NCT00812331|6127158|P5|Overall Study|Adverse Event|0
1758306|NCT00812331|6127159|P4|Overall Study|Adverse Event|0
1758307|NCT00812331|6127160|P3|Overall Study|Adverse Event|0
1758308|NCT00812331|6127161|P2|Overall Study|Adverse Event|0
1758309|NCT00812331|6127162|P1|Overall Study|Adverse Event|1
1758310|NCT00812253|6127237|P2|Overall Study|Lost to Follow-up|0
1758311|NCT00812253|6127238|P1|Overall Study|Lost to Follow-up|2
1758312|NCT00812253|6127237|P2|Overall Study|Protocol Violation|1
1758313|NCT00812253|6127238|P1|Overall Study|Protocol Violation|1
1758314|NCT00812253|6127237|P2|Overall Study|Withdrawal by Subject|2
1758315|NCT00812253|6127238|P1|Overall Study|Withdrawal by Subject|3
1758316|NCT00812097|6127263|P4|Overall Study|Unknown reasons and patient/doctor moves|5
1758317|NCT00812097|6127264|P3|Overall Study|Unknown reasons and patient/doctor moves|15
1758318|NCT00812097|6127265|P2|Overall Study|Unknown reasons and patient/doctor moves|24
1758319|NCT00812097|6127266|P1|Overall Study|Unknown reasons and patient/doctor moves|111
1758320|NCT00812097|6127263|P4|Overall Study|Explantation of study device(s)|20
1758321|NCT00812097|6127264|P3|Overall Study|Explantation of study device(s)|14
1758322|NCT00812097|6127265|P2|Overall Study|Explantation of study device(s)|29
1758323|NCT00812097|6127266|P1|Overall Study|Explantation of study device(s)|27
1758324|NCT00812097|6127263|P4|Overall Study|Lost to Follow-up|5
1758325|NCT00812097|6127264|P3|Overall Study|Lost to Follow-up|17
1758326|NCT00812097|6127265|P2|Overall Study|Lost to Follow-up|14
1758327|NCT00812097|6127266|P1|Overall Study|Lost to Follow-up|90
1758328|NCT00812097|6127263|P4|Overall Study|Withdrawal by Subject|2
1758329|NCT00812097|6127264|P3|Overall Study|Withdrawal by Subject|8
1758330|NCT00812097|6127265|P2|Overall Study|Withdrawal by Subject|12
1758331|NCT00812097|6127266|P1|Overall Study|Withdrawal by Subject|14
1758332|NCT00812097|6127263|P4|Overall Study|Death|3
1758333|NCT00812097|6127264|P3|Overall Study|Death|3
1758334|NCT00812097|6127265|P2|Overall Study|Death|10
1758335|NCT00812097|6127266|P1|Overall Study|Death|3
1758336|NCT00812006|6127295|P3|Overall Study|Lack of Qualifying Event|2
1758337|NCT00812006|6127296|P2|Overall Study|Lack of Qualifying Event|2
1758338|NCT00812006|6127297|P1|Overall Study|Lack of Qualifying Event|4
1758339|NCT00812006|6127295|P3|Overall Study|Withdrawal by Subject|1
1758340|NCT00812006|6127296|P2|Overall Study|Withdrawal by Subject|1
1758341|NCT00812006|6127297|P1|Overall Study|Withdrawal by Subject|2
1758342|NCT00812006|6127295|P3|Overall Study|Physician Decision|1
1758343|NCT00812006|6127296|P2|Overall Study|Physician Decision|0
1758344|NCT00812006|6127297|P1|Overall Study|Physician Decision|0
1758345|NCT00812006|6127295|P3|Overall Study|Lost to Follow-up|2
1758346|NCT00812006|6127296|P2|Overall Study|Lost to Follow-up|0
1758347|NCT00812006|6127297|P1|Overall Study|Lost to Follow-up|0
1758348|NCT00811954|6127314|P3|Overall Study|Complete Protocol: No follow-up|1
1758349|NCT00811954|6127315|P2|Overall Study|Complete Protocol: No follow-up|0
1758350|NCT00811954|6127316|P1|Overall Study|Complete Protocol: No follow-up|0
1758351|NCT00811954|6127314|P3|Overall Study|Severe Debilitation|1
1758352|NCT00811954|6127315|P2|Overall Study|Severe Debilitation|0
1758353|NCT00811954|6127316|P1|Overall Study|Severe Debilitation|2
1758354|NCT00811954|6127314|P3|Overall Study|Site Closure|1
1758355|NCT00811954|6127315|P2|Overall Study|Site Closure|0
1758356|NCT00811954|6127316|P1|Overall Study|Site Closure|4
1758357|NCT00811954|6127314|P3|Overall Study|Withdraw consent prior study completion|5
1758358|NCT00811954|6127315|P2|Overall Study|Withdraw consent prior study completion|6
1758359|NCT00811954|6127316|P1|Overall Study|Withdraw consent prior study completion|4
1758360|NCT00811954|6127314|P3|Overall Study|Not willing to adhere to requirements|16
1758361|NCT00811954|6127315|P2|Overall Study|Not willing to adhere to requirements|2
1758362|NCT00811954|6127316|P1|Overall Study|Not willing to adhere to requirements|12
1758363|NCT00811954|6127314|P3|Overall Study|Not able to get to clinic|30
1758364|NCT00811954|6127315|P2|Overall Study|Not able to get to clinic|35
1758365|NCT00811954|6127316|P1|Overall Study|Not able to get to clinic|28
1758366|NCT00811954|6127314|P3|Overall Study|Lost to Follow-up|34
1758367|NCT00811954|6127315|P2|Overall Study|Lost to Follow-up|23
1758368|NCT00811954|6127316|P1|Overall Study|Lost to Follow-up|29
1758369|NCT00811954|6127314|P3|Overall Study|Death|13
1758370|NCT00811954|6127315|P2|Overall Study|Death|6
1758371|NCT00811954|6127316|P1|Overall Study|Death|10
1758372|NCT00811941|6127380|P2|All Treated Patients|Other Reason|14
1758373|NCT00811941|6127381|P1|All Treated Patients|Other Reason|4
1758374|NCT00811941|6127380|P2|All Treated Patients|Lost to Follow-up|12
1758375|NCT00811941|6127381|P1|All Treated Patients|Lost to Follow-up|3
1758376|NCT00811941|6127380|P2|All Treated Patients|Withdrawal by Subject|94
1758377|NCT00811941|6127381|P1|All Treated Patients|Withdrawal by Subject|35
1758378|NCT00811941|6127380|P2|All Treated Patients|Protocol Violation|17
1758379|NCT00811941|6127381|P1|All Treated Patients|Protocol Violation|5
1758380|NCT00811941|6127380|P2|All Treated Patients|Non-compliance|8
1758381|NCT00811941|6127381|P1|All Treated Patients|Non-compliance|1
1758382|NCT00811941|6127380|P2|All Treated Patients|Lack of Efficacy|3
1758383|NCT00811941|6127381|P1|All Treated Patients|Lack of Efficacy|2
1758384|NCT00811941|6127380|P2|All Treated Patients|Adverse Event|43
1758385|NCT00811941|6127381|P1|All Treated Patients|Adverse Event|2
1758386|NCT00811941|6127380|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
1758387|NCT00811941|6127381|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
1758388|NCT00811928|6127419|P2|Overall Study|Poor Compliance|5
1758389|NCT00811928|6127420|P1|Overall Study|Poor Compliance|2
1758390|NCT00811928|6127419|P2|Overall Study|Investigator Decision|1
1758391|NCT00811928|6127420|P1|Overall Study|Investigator Decision|2
1758392|NCT00811928|6127419|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
1758393|NCT00811928|6127420|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
1758394|NCT00811928|6127419|P2|Overall Study|Did Not Take Study Drug|0
1758395|NCT00811928|6127420|P1|Overall Study|Did Not Take Study Drug|3
1758396|NCT00811928|6127419|P2|Overall Study|Withdrawal by Subject|12
1758397|NCT00811928|6127420|P1|Overall Study|Withdrawal by Subject|18
1758398|NCT00811928|6127419|P2|Overall Study|AEs and SAEs Including Death|11
1758399|NCT00811928|6127420|P1|Overall Study|AEs and SAEs Including Death|7
1758400|NCT00811733|6127464|P2|Overall Study|Withdrawal by Subject|2
1758401|NCT00811733|6127465|P1|Overall Study|Withdrawal by Subject|1
1758402|NCT00811733|6127464|P2|Overall Study|Investigator Discretion|8
1758403|NCT00811733|6127465|P1|Overall Study|Investigator Discretion|10
1758404|NCT00811720|6127513|P2|All Treated Patients|Other Reason|4
1758405|NCT00811720|6127514|P1|All Treated Patients|Other Reason|7
1758406|NCT00811720|6127513|P2|All Treated Patients|Lost to Follow-up|16
1758407|NCT00811720|6127514|P1|All Treated Patients|Lost to Follow-up|10
1758408|NCT00811720|6127513|P2|All Treated Patients|Withdrawal by Subject|34
1758409|NCT00811720|6127514|P1|All Treated Patients|Withdrawal by Subject|28
1758410|NCT00811720|6127513|P2|All Treated Patients|Protocol Violation|16
1758411|NCT00811720|6127514|P1|All Treated Patients|Protocol Violation|9
1758412|NCT00811720|6127513|P2|All Treated Patients|Non-compliance|14
1758413|NCT00811720|6127514|P1|All Treated Patients|Non-compliance|0
1758414|NCT00811720|6127513|P2|All Treated Patients|Lack of Efficacy|18
1758415|NCT00811720|6127514|P1|All Treated Patients|Lack of Efficacy|22
1758416|NCT00811720|6127513|P2|All Treated Patients|Adverse Event|62
1758417|NCT00811720|6127514|P1|All Treated Patients|Adverse Event|20
1758418|NCT00811720|6127513|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
1758419|NCT00811720|6127514|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
1758420|NCT00811655|6127532|P1|Overall Study|Physician Decision|1
1758421|NCT00811642|6127544|P1|Overall Study|Cumulative use of antifungal agent|2
1758422|NCT00811642|6127544|P1|Overall Study|Withdrawal by Subject|7
1758423|NCT00811642|6127544|P1|Overall Study|Death|2
1758424|NCT00811642|6127544|P1|Overall Study|Protocol Violation|1
1758425|NCT00811642|6127544|P1|Overall Study|Adverse Event|3
1758426|NCT00811577|6127560|P2|Overall Study|Withdrawal by Subject|0
1758427|NCT00811577|6127561|P1|Overall Study|Withdrawal by Subject|3
1758428|NCT00811577|6127560|P2|Overall Study|Lost to Follow-up|1
1758429|NCT00811577|6127561|P1|Overall Study|Lost to Follow-up|7
1758430|NCT00811473|6127621|P2|Overall Study|Safety Reasons|0
1758431|NCT00811473|6127622|P1|Overall Study|Safety Reasons|1
1758432|NCT00811473|6127621|P2|Overall Study|Incorrect Enrollment|0
1758433|NCT00811473|6127622|P1|Overall Study|Incorrect Enrollment|1
1758434|NCT00811473|6127621|P2|Overall Study|Other 2|1
1758435|NCT00811473|6127622|P1|Overall Study|Other 2|4
1758436|NCT00811473|6127621|P2|Overall Study|Condition under investigation worsened|3
1758437|NCT00811473|6127622|P1|Overall Study|Condition under investigation worsened|1
1758438|NCT00811473|6127621|P2|Overall Study|Lack of therapeutic response|1
1758439|NCT00811473|6127622|P1|Overall Study|Lack of therapeutic response|4
1758440|NCT00811473|6127621|P2|Overall Study|Severe non-compliance to protocol|4
1758441|NCT00811473|6127622|P1|Overall Study|Severe non-compliance to protocol|2
1758442|NCT00811473|6127621|P2|Overall Study|Withdrawal by Subject|4
1758443|NCT00811473|6127622|P1|Overall Study|Withdrawal by Subject|2
1758444|NCT00811473|6127621|P2|Overall Study|Lost to Follow-up|1
1758445|NCT00811473|6127622|P1|Overall Study|Lost to Follow-up|5
1758446|NCT00811473|6127621|P2|Overall Study|Adverse Event|12
1758447|NCT00811473|6127622|P1|Overall Study|Adverse Event|3
1758448|NCT00811395|6127653|P6|Extension Treatment|Other than above|0
1758449|NCT00811395|6127654|P5|Extension Treatment|Other than above|0
1758450|NCT00811395|6127655|P4|Extension Treatment|Other than above|0
1758451|NCT00811395|6127656|P3|Extension Treatment|Other than above|1
1758452|NCT00811395|6127657|P2|Extension Treatment|Other than above|0
1758453|NCT00811395|6127658|P1|Extension Treatment|Other than above|0
1758454|NCT00811395|6127653|P6|Extension Treatment|Participant did not wish to continue|1
1758455|NCT00811395|6127654|P5|Extension Treatment|Participant did not wish to continue|0
1758456|NCT00811395|6127655|P4|Extension Treatment|Participant did not wish to continue|1
1758457|NCT00811395|6127656|P3|Extension Treatment|Participant did not wish to continue|0
1758458|NCT00811395|6127657|P2|Extension Treatment|Participant did not wish to continue|3
1758459|NCT00811395|6127658|P1|Extension Treatment|Participant did not wish to continue|0
1758460|NCT00811395|6127653|P6|Extension Treatment|Progressive disease|0
1758461|NCT00811395|6127654|P5|Extension Treatment|Progressive disease|0
1758462|NCT00811395|6127655|P4|Extension Treatment|Progressive disease|0
1758463|NCT00811395|6127656|P3|Extension Treatment|Progressive disease|0
1758464|NCT00811395|6127657|P2|Extension Treatment|Progressive disease|1
1758465|NCT00811395|6127658|P1|Extension Treatment|Progressive disease|1
1758466|NCT00811395|6127653|P6|Extension Treatment|Adverse Event|1
1758467|NCT00811395|6127654|P5|Extension Treatment|Adverse Event|0
1758468|NCT00811395|6127655|P4|Extension Treatment|Adverse Event|2
1758469|NCT00811395|6127656|P3|Extension Treatment|Adverse Event|2
1758470|NCT00811395|6127657|P2|Extension Treatment|Adverse Event|2
1758471|NCT00811395|6127658|P1|Extension Treatment|Adverse Event|1
1758472|NCT00811252|6127764|P3|Overall Study|Administrative or Other Reasons|2
1758473|NCT00811252|6127765|P2|Overall Study|Administrative or Other Reasons|3
1758474|NCT00811252|6127766|P1|Overall Study|Administrative or Other Reasons|0
1758475|NCT00811252|6127764|P3|Overall Study|Lost to Follow-up|2
1758476|NCT00811252|6127765|P2|Overall Study|Lost to Follow-up|0
1758477|NCT00811252|6127766|P1|Overall Study|Lost to Follow-up|0
1758478|NCT00811252|6127764|P3|Overall Study|Withdrawal of Consent|2
1758479|NCT00811252|6127765|P2|Overall Study|Withdrawal of Consent|2
1758480|NCT00811252|6127766|P1|Overall Study|Withdrawal of Consent|1
1758481|NCT00811252|6127764|P3|Overall Study|Protocol Violation|2
1758482|NCT00811252|6127765|P2|Overall Study|Protocol Violation|3
1758483|NCT00811252|6127766|P1|Overall Study|Protocol Violation|3
1758484|NCT00811252|6127764|P3|Overall Study|Lack of Efficacy|0
1758485|NCT00811252|6127765|P2|Overall Study|Lack of Efficacy|2
1758486|NCT00811252|6127766|P1|Overall Study|Lack of Efficacy|7
1758487|NCT00811252|6127764|P3|Overall Study|Adverse Event|15
1758488|NCT00811252|6127765|P2|Overall Study|Adverse Event|10
1758489|NCT00811252|6127766|P1|Overall Study|Adverse Event|6
1758490|NCT00811187|6127812|P2|Overall Study|Unable to place device / procedure abort|3
1758491|NCT00811187|6127813|P1|Overall Study|Unable to place device / procedure abort|3
1758492|NCT00811174|6127819|P1|Overall Study|Sponsors Decision|1
1758493|NCT00811174|6127819|P1|Overall Study|Protocol Violation|2
1758494|NCT00811135|6127830|P1|Overall Study|Ongoing|59
1758495|NCT00811135|6127830|P1|Overall Study|Administrative/Other Unspecified|11
1758496|NCT00811135|6127830|P1|Overall Study|Withdrawal by Subject|3
1758497|NCT00811135|6127830|P1|Overall Study|Refused Treatment|1
1758498|NCT00811135|6127830|P1|Overall Study|Violation of Selection Criteria|1
1758499|NCT00811135|6127830|P1|Overall Study|Protocol Violation|2
1758500|NCT00811135|6127830|P1|Overall Study|Death|3
1758501|NCT00811135|6127830|P1|Overall Study|Adverse Event/Intercurrent Illness|8
1758502|NCT00811070|6127848|P6|Overall Study|Physician Decision|1
1758503|NCT00811070|6127849|P5|Overall Study|Physician Decision|0
1758504|NCT00811070|6127850|P4|Overall Study|Physician Decision|0
1758505|NCT00811070|6127851|P3|Overall Study|Physician Decision|0
1758506|NCT00811070|6127852|P2|Overall Study|Physician Decision|0
1758507|NCT00811070|6127853|P1|Overall Study|Physician Decision|0
1758508|NCT00811070|6127848|P6|Overall Study|Withdrawal by Subject|0
1758509|NCT00811070|6127849|P5|Overall Study|Withdrawal by Subject|0
1758510|NCT00811070|6127850|P4|Overall Study|Withdrawal by Subject|0
1758511|NCT00811070|6127851|P3|Overall Study|Withdrawal by Subject|0
1758512|NCT00811070|6127852|P2|Overall Study|Withdrawal by Subject|1
1758513|NCT00811070|6127853|P1|Overall Study|Withdrawal by Subject|0
1758514|NCT00811070|6127848|P6|Overall Study|Other|0
1758515|NCT00811070|6127849|P5|Overall Study|Other|0
1758516|NCT00811070|6127850|P4|Overall Study|Other|0
1758517|NCT00811070|6127851|P3|Overall Study|Other|0
1758518|NCT00811070|6127852|P2|Overall Study|Other|0
1758519|NCT00811070|6127853|P1|Overall Study|Other|1
1758520|NCT00811070|6127848|P6|Overall Study|Death|0
1758521|NCT00811070|6127849|P5|Overall Study|Death|5
1758522|NCT00811070|6127850|P4|Overall Study|Death|2
1758523|NCT00811070|6127851|P3|Overall Study|Death|0
1758524|NCT00811070|6127852|P2|Overall Study|Death|0
1758525|NCT00811070|6127853|P1|Overall Study|Death|0
1758526|NCT00811057|6127913|P3|Overall Study|Protocol Violation|10
1758527|NCT00811057|6127914|P2|Overall Study|Protocol Violation|10
1758528|NCT00811057|6127915|P1|Overall Study|Protocol Violation|5
1758529|NCT00811018|6127926|P1|Overall Study|Other|26
1758530|NCT00811018|6127926|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
1758531|NCT00811018|6127926|P1|Overall Study|Withdrawal by Subject|70
1758532|NCT00811018|6127926|P1|Overall Study|Sponsor Decision|450
1758533|NCT00811018|6127926|P1|Overall Study|Pregnancy|6
1758534|NCT00811018|6127926|P1|Overall Study|Lost to Follow-up|19
1758535|NCT00811018|6127926|P1|Overall Study|Investigator Decision|57
1758536|NCT00811018|6127926|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
1758537|NCT00811018|6127926|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
1758538|NCT00811018|6127926|P1|Overall Study|Death|147
1758539|NCT00811018|6127926|P1|Overall Study|Adverse Event|79
1758540|NCT00811018|6127926|P1|Overall Study|Additional Chronic Treatment|31
1758541|NCT00810901|6127944|P2|Overall Study|Lost to Follow-up|58
1758542|NCT00810901|6127945|P1|Overall Study|Lost to Follow-up|88
1758543|NCT00810810|6127991|P4|Overall Study|Physician Decision|5
1758544|NCT00810810|6127992|P3|Overall Study|Physician Decision|1
1758545|NCT00810810|6127993|P2|Overall Study|Physician Decision|3
1758546|NCT00810810|6127994|P1|Overall Study|Physician Decision|0
1758547|NCT00810810|6127991|P4|Overall Study|Withdrawal by Subject|8
1758548|NCT00810810|6127992|P3|Overall Study|Withdrawal by Subject|10
1758549|NCT00810810|6127993|P2|Overall Study|Withdrawal by Subject|8
1758550|NCT00810810|6127994|P1|Overall Study|Withdrawal by Subject|0
1758551|NCT00810693|6128042|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
1758552|NCT00810693|6128043|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
1758553|NCT00810693|6128044|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
1758554|NCT00810693|6128042|P3|Follow-up Period (FUP)|Protocol Violation|0
1758555|NCT00810693|6128043|P2|Follow-up Period (FUP)|Protocol Violation|1
1758556|NCT00810693|6128044|P1|Follow-up Period (FUP)|Protocol Violation|0
1758557|NCT00810693|6128042|P3|Follow-up Period (FUP)|Lost to Follow-up|2
1758558|NCT00810693|6128043|P2|Follow-up Period (FUP)|Lost to Follow-up|0
1758559|NCT00810693|6128044|P1|Follow-up Period (FUP)|Lost to Follow-up|1
1758560|NCT00810693|6128042|P3|Follow-up Period (FUP)|Death|1
1758561|NCT00810693|6128043|P2|Follow-up Period (FUP)|Death|0
1758562|NCT00810693|6128044|P1|Follow-up Period (FUP)|Death|2
1758563|NCT00810693|6128042|P3|Follow-up Period (FUP)|Adverse Event|1
1758564|NCT00810693|6128043|P2|Follow-up Period (FUP)|Adverse Event|1
1758565|NCT00810693|6128044|P1|Follow-up Period (FUP)|Adverse Event|3
1758566|NCT00810693|6128042|P3|Treatment Period|Not treated|1
1758567|NCT00810693|6128043|P2|Treatment Period|Not treated|1
1758568|NCT00810693|6128044|P1|Treatment Period|Not treated|0
1758569|NCT00810693|6128042|P3|Treatment Period|Withdrawal by Subject|3
1758570|NCT00810693|6128043|P2|Treatment Period|Withdrawal by Subject|2
1758571|NCT00810693|6128044|P1|Treatment Period|Withdrawal by Subject|6
1758572|NCT00810693|6128042|P3|Treatment Period|Protocol Violation|2
1758573|NCT00810693|6128043|P2|Treatment Period|Protocol Violation|2
1758574|NCT00810693|6128044|P1|Treatment Period|Protocol Violation|1
1758575|NCT00810693|6128042|P3|Treatment Period|Non-compliance|0
1758576|NCT00810693|6128043|P2|Treatment Period|Non-compliance|0
1758577|NCT00810693|6128044|P1|Treatment Period|Non-compliance|1
1758578|NCT00810693|6128042|P3|Treatment Period|Lost to Follow-up|0
1758579|NCT00810693|6128043|P2|Treatment Period|Lost to Follow-up|0
1758580|NCT00810693|6128044|P1|Treatment Period|Lost to Follow-up|1
1758581|NCT00810693|6128042|P3|Treatment Period|Lack of Efficacy|1
1758582|NCT00810693|6128043|P2|Treatment Period|Lack of Efficacy|0
1758583|NCT00810693|6128044|P1|Treatment Period|Lack of Efficacy|0
1758584|NCT00810693|6128042|P3|Treatment Period|Death|2
1758585|NCT00810693|6128043|P2|Treatment Period|Death|1
1758586|NCT00810693|6128044|P1|Treatment Period|Death|0
1758587|NCT00810693|6128042|P3|Treatment Period|Adverse Event|7
1758588|NCT00810693|6128043|P2|Treatment Period|Adverse Event|1
1758589|NCT00810693|6128044|P1|Treatment Period|Adverse Event|8
1758590|NCT00810641|6128076|P3|Overall Study|Withdrawal by Subject|2
1758591|NCT00810641|6128077|P2|Overall Study|Withdrawal by Subject|1
1758592|NCT00810641|6128078|P1|Overall Study|Withdrawal by Subject|0
1758593|NCT00810615|6128088|P2|Overall Study|Withdrawal by Subject|1
1758594|NCT00810615|6128089|P1|Overall Study|Withdrawal by Subject|1
1758595|NCT00810602|6128139|P2|Overall Study|Withdrawal by Subject|3
1758596|NCT00810602|6128140|P1|Overall Study|Withdrawal by Subject|8
1758597|NCT00810511|6128153|P2|Overall Study|deposits on contact lens|1
1758598|NCT00810511|6128154|P1|Overall Study|deposits on contact lens|0
1758599|NCT00810511|6128153|P2|Overall Study|Lost to Follow-up|0
1758600|NCT00810511|6128154|P1|Overall Study|Lost to Follow-up|1
1758601|NCT00810511|6128153|P2|Overall Study|death in the family|1
1758602|NCT00810511|6128154|P1|Overall Study|death in the family|0
1758603|NCT00810511|6128153|P2|Overall Study|Lack of Efficacy|1
1758604|NCT00810511|6128154|P1|Overall Study|Lack of Efficacy|9
1758605|NCT00810511|6128153|P2|Overall Study|Protocol Violation|1
1758606|NCT00810511|6128154|P1|Overall Study|Protocol Violation|0
1758607|NCT00810407|6128172|P1|Overall Study|No Visit After First Day of Treatment|3
1758608|NCT00810407|6128172|P1|Overall Study|Protocol Violation|3
1758609|NCT00810394|6128184|P1|Overall Study|Withdrawal by Subject|3
1758610|NCT00810368|6128192|P2|Overall Study|Lack of Efficacy|0
1758611|NCT00810368|6128193|P1|Overall Study|Lack of Efficacy|2
1758612|NCT00810368|6128192|P2|Overall Study|Lost to Follow-up|2
1758613|NCT00810368|6128193|P1|Overall Study|Lost to Follow-up|4
1758614|NCT00810355|6128214|P3|Overall Study|Withdrawal by Subject|0
1758615|NCT00810355|6128215|P2|Overall Study|Withdrawal by Subject|0
1758616|NCT00810355|6128216|P1|Overall Study|Withdrawal by Subject|1
1758617|NCT00810355|6128214|P3|Overall Study|Lost to Follow-up|11
1758618|NCT00810355|6128215|P2|Overall Study|Lost to Follow-up|17
1758619|NCT00810355|6128216|P1|Overall Study|Lost to Follow-up|13
1758620|NCT00810342|6128232|P2|12-month Followup|Lost to Follow-up|1
1758621|NCT00810342|6128233|P1|12-month Followup|Lost to Follow-up|3
1758622|NCT00810342|6128232|P2|12-month Followup|Pregnancy|10
1758623|NCT00810342|6128233|P1|12-month Followup|Pregnancy|9
1758624|NCT00810342|6128232|P2|6-month Follow-up|Pregnancy|2
1758625|NCT00810342|6128233|P1|6-month Follow-up|Pregnancy|6
1758626|NCT00810342|6128232|P2|6-month Follow-up|Lost to Follow-up|6
1758627|NCT00810342|6128233|P1|6-month Follow-up|Lost to Follow-up|18
1758628|NCT00810342|6128232|P2|Month 1 Follow-up|Pregnancy|0
1758629|NCT00810342|6128233|P1|Month 1 Follow-up|Pregnancy|1
1758630|NCT00810342|6128232|P2|Month 1 Follow-up|Lost to Follow-up|2
1758631|NCT00810342|6128233|P1|Month 1 Follow-up|Lost to Follow-up|4
1758632|NCT00810277|6128266|P1|Overall Study|Adverse Event|1
1758633|NCT00810264|6128279|P1|Overall Study|Death|641
1758634|NCT00810264|6128279|P1|Overall Study|Withdrawal by subject or physician|721
1758635|NCT00810264|6128279|P1|Overall Study|Lost to Follow-up|191
1758636|NCT00810199|6128306|P2|Overall Study|Did not receive study drug|1
1758637|NCT00810199|6128307|P1|Overall Study|Did not receive study drug|2
1758638|NCT00810199|6128306|P2|Overall Study|Failure to return|4
1758639|NCT00810199|6128307|P1|Overall Study|Failure to return|1
1758640|NCT00810199|6128306|P2|Overall Study|Protocol Violation|6
1758641|NCT00810199|6128307|P1|Overall Study|Protocol Violation|2
1758642|NCT00810199|6128306|P2|Overall Study|Administrative/Other|6
1758643|NCT00810199|6128307|P1|Overall Study|Administrative/Other|5
1758644|NCT00810199|6128306|P2|Overall Study|Refused treatment/Did not cooperate|7
1758645|NCT00810199|6128307|P1|Overall Study|Refused treatment/Did not cooperate|7
1758646|NCT00810199|6128306|P2|Overall Study|Insufficient therapeutic response|14
1758647|NCT00810199|6128307|P1|Overall Study|Insufficient therapeutic response|5
1758648|NCT00810199|6128306|P2|Overall Study|Withdrew consent|12
1758649|NCT00810199|6128307|P1|Overall Study|Withdrew consent|9
1758650|NCT00810199|6128306|P2|Overall Study|Death|6
1758651|NCT00810199|6128307|P1|Overall Study|Death|4
1758652|NCT00810199|6128306|P2|Overall Study|Adverse Event|26
1758653|NCT00810199|6128307|P1|Overall Study|Adverse Event|24
1758654|NCT00810108|6128385|P2|Overall Study|Withdrawal by Subject|0
1758655|NCT00810108|6128386|P1|Overall Study|Withdrawal by Subject|1
1758656|NCT00810082|6128400|P2|Overall Study|Lost to Follow-up|4
1758657|NCT00810082|6128401|P1|Overall Study|Lost to Follow-up|0
1758658|NCT00810069|6128409|P3|Double-Blind Period II|Protocol Violation|6
1758659|NCT00810069|6128410|P2|Double-Blind Period II|Protocol Violation|7
1758660|NCT00810069|6128411|P1|Double-Blind Period II|Protocol Violation|0
1758661|NCT00810069|6128409|P3|Double-Blind Period II|Clinical relapse|0
1758662|NCT00810069|6128410|P2|Double-Blind Period II|Clinical relapse|3
1758663|NCT00810069|6128411|P1|Double-Blind Period II|Clinical relapse|0
1758664|NCT00810069|6128409|P3|Double-Blind Period II|Protocol entry criterion not met|1
1758665|NCT00810069|6128410|P2|Double-Blind Period II|Protocol entry criterion not met|0
1758666|NCT00810069|6128411|P1|Double-Blind Period II|Protocol entry criterion not met|0
1758667|NCT00810069|6128409|P3|Double-Blind Period II|Withdrawal by Subject|35
1758668|NCT00810069|6128410|P2|Double-Blind Period II|Withdrawal by Subject|21
1758669|NCT00810069|6128411|P1|Double-Blind Period II|Withdrawal by Subject|0
1758670|NCT00810069|6128409|P3|Double-Blind Period II|Physician Decision|1
1758671|NCT00810069|6128410|P2|Double-Blind Period II|Physician Decision|0
1758672|NCT00810069|6128411|P1|Double-Blind Period II|Physician Decision|0
1758673|NCT00810069|6128409|P3|Double-Blind Period II|Lost to Follow-up|9
1758674|NCT00810069|6128410|P2|Double-Blind Period II|Lost to Follow-up|9
1758675|NCT00810069|6128411|P1|Double-Blind Period II|Lost to Follow-up|0
1758676|NCT00810069|6128409|P3|Double-Blind Period II|Lack of Efficacy|12
1758677|NCT00810069|6128410|P2|Double-Blind Period II|Lack of Efficacy|7
1758678|NCT00810069|6128411|P1|Double-Blind Period II|Lack of Efficacy|0
1758679|NCT00810069|6128409|P3|Double-Blind Period II|Adverse Event|8
1758680|NCT00810069|6128410|P2|Double-Blind Period II|Adverse Event|9
1758681|NCT00810069|6128411|P1|Double-Blind Period II|Adverse Event|0
1758682|NCT00810069|6128409|P3|Lead-in Period I|Randomization criteria not met|0
1758683|NCT00810069|6128410|P2|Lead-in Period I|Randomization criteria not met|0
1758684|NCT00810069|6128411|P1|Lead-in Period I|Randomization criteria not met|158
1758685|NCT00810069|6128409|P3|Lead-in Period I|Protocol entry criterion not met|0
1758686|NCT00810069|6128410|P2|Lead-in Period I|Protocol entry criterion not met|0
1758687|NCT00810069|6128411|P1|Lead-in Period I|Protocol entry criterion not met|5
1758688|NCT00810069|6128409|P3|Lead-in Period I|Withdrawal by Subject|0
1758689|NCT00810069|6128410|P2|Lead-in Period I|Withdrawal by Subject|0
1758690|NCT00810069|6128411|P1|Lead-in Period I|Withdrawal by Subject|46
1758691|NCT00810069|6128409|P3|Lead-in Period I|Protocol Violation|0
1758692|NCT00810069|6128410|P2|Lead-in Period I|Protocol Violation|0
1758693|NCT00810069|6128411|P1|Lead-in Period I|Protocol Violation|1
1758694|NCT00810069|6128409|P3|Lead-in Period I|Physician Decision|0
1758695|NCT00810069|6128410|P2|Lead-in Period I|Physician Decision|0
1758696|NCT00810069|6128411|P1|Lead-in Period I|Physician Decision|1
1758697|NCT00810069|6128409|P3|Lead-in Period I|Lost to Follow-up|0
1758698|NCT00810069|6128410|P2|Lead-in Period I|Lost to Follow-up|0
1758699|NCT00810069|6128411|P1|Lead-in Period I|Lost to Follow-up|19
1758700|NCT00810069|6128409|P3|Lead-in Period I|Lack of Efficacy|0
1758701|NCT00810069|6128410|P2|Lead-in Period I|Lack of Efficacy|0
1758702|NCT00810069|6128411|P1|Lead-in Period I|Lack of Efficacy|1
1758703|NCT00810069|6128409|P3|Lead-in Period I|Adverse Event|0
1758704|NCT00810069|6128410|P2|Lead-in Period I|Adverse Event|0
1758705|NCT00810069|6128411|P1|Lead-in Period I|Adverse Event|43
1758706|NCT00810043|6128456|P3|Overall Study|No longer met enrollment criteria|3
1758707|NCT00810043|6128457|P2|Overall Study|No longer met enrollment criteria|0
1758708|NCT00810043|6128458|P1|Overall Study|No longer met enrollment criteria|0
1758709|NCT00810043|6128456|P3|Overall Study|Non-medical problem|1
1758710|NCT00810043|6128457|P2|Overall Study|Non-medical problem|0
1758711|NCT00810043|6128458|P1|Overall Study|Non-medical problem|0
1758712|NCT00810043|6128456|P3|Overall Study|Unrelated medical problem|0
1758713|NCT00810043|6128457|P2|Overall Study|Unrelated medical problem|1
1758714|NCT00810043|6128458|P1|Overall Study|Unrelated medical problem|0
1758715|NCT00810043|6128456|P3|Overall Study|Death|0
1758716|NCT00810043|6128457|P2|Overall Study|Death|0
1758717|NCT00810043|6128458|P1|Overall Study|Death|2
1758718|NCT00810043|6128456|P3|Overall Study|Physician Decision|2
1758719|NCT00810043|6128457|P2|Overall Study|Physician Decision|0
1758720|NCT00810043|6128458|P1|Overall Study|Physician Decision|0
1758721|NCT00810043|6128456|P3|Overall Study|Lost to Follow-up|0
1758722|NCT00810043|6128457|P2|Overall Study|Lost to Follow-up|0
1758723|NCT00810043|6128458|P1|Overall Study|Lost to Follow-up|1
1758724|NCT00810043|6128456|P3|Overall Study|Withdrawal by Subject|2
1758725|NCT00810043|6128457|P2|Overall Study|Withdrawal by Subject|0
1758726|NCT00810043|6128458|P1|Overall Study|Withdrawal by Subject|1
1758727|NCT00809965|6128480|P3|Overall Study|Other Reason|189
1758728|NCT00809965|6128481|P2|Overall Study|Other Reason|170
1758729|NCT00809965|6128482|P1|Overall Study|Other Reason|167
1758730|NCT00809965|6128480|P3|Overall Study|Withdrawal by Subject|441
1758731|NCT00809965|6128481|P2|Overall Study|Withdrawal by Subject|448
1758732|NCT00809965|6128482|P1|Overall Study|Withdrawal by Subject|405
1758733|NCT00809965|6128480|P3|Overall Study|Lost to Follow-up|18
1758734|NCT00809965|6128481|P2|Overall Study|Lost to Follow-up|10
1758735|NCT00809965|6128482|P1|Overall Study|Lost to Follow-up|17
1758736|NCT00809965|6128480|P3|Overall Study|Death|196
1758737|NCT00809965|6128481|P2|Overall Study|Death|147
1758738|NCT00809965|6128482|P1|Overall Study|Death|194
1758739|NCT00809926|6128504|P2|Overall Study|Protocol deviation|2
1758740|NCT00809926|6128505|P1|Overall Study|Protocol deviation|0
1758741|NCT00809926|6128504|P2|Overall Study|Administrative Problems|1
1758742|NCT00809926|6128505|P1|Overall Study|Administrative Problems|0
1758743|NCT00809926|6128504|P2|Overall Study|Lost to Follow-up|1
1758744|NCT00809926|6128505|P1|Overall Study|Lost to Follow-up|2
1758745|NCT00809926|6128504|P2|Overall Study|Patient withdrew consent|6
1758746|NCT00809926|6128505|P1|Overall Study|Patient withdrew consent|8
1758747|NCT00809926|6128504|P2|Overall Study|Unsatisfactory therapeutic effect|3
1758748|NCT00809926|6128505|P1|Overall Study|Unsatisfactory therapeutic effect|3
1758749|NCT00809926|6128504|P2|Overall Study|Adverse Event|10
1758750|NCT00809926|6128505|P1|Overall Study|Adverse Event|18
1758751|NCT00809835|6128559|P4|Overall Study|Withdrawal by Subject|0
1758752|NCT00809835|6128560|P3|Overall Study|Withdrawal by Subject|1
1758753|NCT00809835|6128561|P2|Overall Study|Withdrawal by Subject|1
1758754|NCT00809835|6128562|P1|Overall Study|Withdrawal by Subject|1
1758755|NCT00809835|6128559|P4|Overall Study|Lost to Follow-up|2
1758756|NCT00809835|6128560|P3|Overall Study|Lost to Follow-up|10
1758757|NCT00809835|6128561|P2|Overall Study|Lost to Follow-up|6
1758758|NCT00809835|6128562|P1|Overall Study|Lost to Follow-up|7
1758759|NCT00809757|6128592|P3|Overall Study|Noncompliance with Medication|1
1758760|NCT00809757|6128593|P2|Overall Study|Noncompliance with Medication|0
1758761|NCT00809757|6128594|P1|Overall Study|Noncompliance with Medication|0
1758762|NCT00809757|6128592|P3|Overall Study|Subject Uncooperative|2
1758763|NCT00809757|6128593|P2|Overall Study|Subject Uncooperative|0
1758764|NCT00809757|6128594|P1|Overall Study|Subject Uncooperative|1
1758765|NCT00809757|6128592|P3|Overall Study|Withdrawal by Subject|3
1758766|NCT00809757|6128593|P2|Overall Study|Withdrawal by Subject|1
1758767|NCT00809757|6128594|P1|Overall Study|Withdrawal by Subject|2
1758768|NCT00809757|6128592|P3|Overall Study|Protocol Violation|1
1758769|NCT00809757|6128593|P2|Overall Study|Protocol Violation|1
1758770|NCT00809757|6128594|P1|Overall Study|Protocol Violation|1
1758771|NCT00809757|6128592|P3|Overall Study|Lost to Follow-up|1
1758772|NCT00809757|6128593|P2|Overall Study|Lost to Follow-up|0
1758773|NCT00809757|6128594|P1|Overall Study|Lost to Follow-up|0
1758774|NCT00809757|6128592|P3|Overall Study|Adverse Event|3
1758775|NCT00809757|6128593|P2|Overall Study|Adverse Event|3
1758776|NCT00809757|6128594|P1|Overall Study|Adverse Event|2
1758777|NCT00809614|6128679|P2|Overall Study|Withdrawal by Subject|1
1758778|NCT00809614|6128680|P1|Overall Study|Withdrawal by Subject|1
1758779|NCT00809614|6128679|P2|Overall Study|Lack of Efficacy|3
1758780|NCT00809614|6128680|P1|Overall Study|Lack of Efficacy|2
1758781|NCT00809471|6128724|P3|Overall Study|Requirement for restricted medication|0
1758782|NCT00809471|6128725|P2|Overall Study|Requirement for restricted medication|1
1758783|NCT00809471|6128726|P1|Overall Study|Requirement for restricted medication|1
1758784|NCT00809471|6128724|P3|Overall Study|Adverse Event|2
1758785|NCT00809471|6128725|P2|Overall Study|Adverse Event|2
1758786|NCT00809471|6128726|P1|Overall Study|Adverse Event|0
1758787|NCT00809471|6128724|P3|Overall Study|Lost to Follow-up|9
1758788|NCT00809471|6128725|P2|Overall Study|Lost to Follow-up|2
1758789|NCT00809471|6128726|P1|Overall Study|Lost to Follow-up|4
1758790|NCT00809471|6128724|P3|Overall Study|Protocol non-compliance|6
1758791|NCT00809471|6128725|P2|Overall Study|Protocol non-compliance|15
1758792|NCT00809471|6128726|P1|Overall Study|Protocol non-compliance|15
1758793|NCT00809445|6128756|P3|6 Month Follow-up|Withdrew consent|1
1758794|NCT00809445|6128757|P2|6 Month Follow-up|Withdrew consent|0
1758795|NCT00809445|6128758|P1|6 Month Follow-up|Withdrew consent|0
1758796|NCT00809445|6128756|P3|6 Month Follow-up|Incarcerated|8
1758797|NCT00809445|6128757|P2|6 Month Follow-up|Incarcerated|8
1758798|NCT00809445|6128758|P1|6 Month Follow-up|Incarcerated|6
1758799|NCT00809445|6128756|P3|6 Month Follow-up|Death|1
1758800|NCT00809445|6128757|P2|6 Month Follow-up|Death|1
1758801|NCT00809445|6128758|P1|6 Month Follow-up|Death|2
1758802|NCT00809445|6128756|P3|6 Month Follow-up|Lost contact|14
1758803|NCT00809445|6128757|P2|6 Month Follow-up|Lost contact|14
1758804|NCT00809445|6128758|P1|6 Month Follow-up|Lost contact|16
1758805|NCT00809445|6128756|P3|1 Month Follow-up|Incarcerated|1
1758806|NCT00809445|6128757|P2|1 Month Follow-up|Incarcerated|0
1758807|NCT00809445|6128758|P1|1 Month Follow-up|Incarcerated|0
1758808|NCT00809445|6128756|P3|1 Month Follow-up|Death|1
1758809|NCT00809445|6128757|P2|1 Month Follow-up|Death|1
1758810|NCT00809445|6128758|P1|1 Month Follow-up|Death|0
1758811|NCT00809445|6128756|P3|1 Month Follow-up|Withdrew consent|1
1758812|NCT00809445|6128757|P2|1 Month Follow-up|Withdrew consent|1
1758813|NCT00809445|6128758|P1|1 Month Follow-up|Withdrew consent|1
1758814|NCT00809445|6128756|P3|1 Month Follow-up|Lost contact|1
1758815|NCT00809445|6128757|P2|1 Month Follow-up|Lost contact|2
1758816|NCT00809445|6128758|P1|1 Month Follow-up|Lost contact|1
1758817|NCT00809341|6128777|P2|Overall Study|Physician Decision|1
1758818|NCT00809341|6128778|P1|Overall Study|Physician Decision|0
1758819|NCT00809328|6128786|P1|Overall Study|Withdrawal by Subject|2
1758820|NCT00809328|6128786|P1|Overall Study|Protocol Violation|3
1758821|NCT00809328|6128786|P1|Overall Study|Adverse Event|6
1758822|NCT00809328|6128786|P1|Overall Study|Lack of Efficacy|18
1758823|NCT00809159|6128808|P6|Part 1 and 2|Withdrawal by Subject|1
1758824|NCT00809159|6128809|P5|Part 1 and 2|Withdrawal by Subject|0
1758825|NCT00809159|6128810|P4|Part 1 and 2|Withdrawal by Subject|0
1758826|NCT00809159|6128811|P3|Part 1 and 2|Withdrawal by Subject|4
1758827|NCT00809159|6128812|P2|Part 1 and 2|Withdrawal by Subject|0
1758828|NCT00809159|6128813|P1|Part 1 and 2|Withdrawal by Subject|0
1758829|NCT00809159|6128808|P6|Part 1 and 2|Lost to Follow-up|0
1758830|NCT00809159|6128809|P5|Part 1 and 2|Lost to Follow-up|0
1758831|NCT00809159|6128810|P4|Part 1 and 2|Lost to Follow-up|1
1758832|NCT00809159|6128811|P3|Part 1 and 2|Lost to Follow-up|1
1758833|NCT00809159|6128812|P2|Part 1 and 2|Lost to Follow-up|0
1758834|NCT00809159|6128813|P1|Part 1 and 2|Lost to Follow-up|0
1758835|NCT00809159|6128808|P6|Part 1 and 2|Adverse Event|1
1758836|NCT00809159|6128809|P5|Part 1 and 2|Adverse Event|1
1758837|NCT00809159|6128810|P4|Part 1 and 2|Adverse Event|0
1758838|NCT00809159|6128811|P3|Part 1 and 2|Adverse Event|1
1758839|NCT00809159|6128812|P2|Part 1 and 2|Adverse Event|0
1758840|NCT00809159|6128813|P1|Part 1 and 2|Adverse Event|0
1758841|NCT00809159|6128808|P6|Part 1 and 2|Administrative problems|0
1758842|NCT00809159|6128809|P5|Part 1 and 2|Administrative problems|0
1758843|NCT00809159|6128810|P4|Part 1 and 2|Administrative problems|1
1758844|NCT00809159|6128811|P3|Part 1 and 2|Administrative problems|0
1758845|NCT00809159|6128812|P2|Part 1 and 2|Administrative problems|0
1758846|NCT00809159|6128813|P1|Part 1 and 2|Administrative problems|0
1758847|NCT00809159|6128808|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
1758848|NCT00809159|6128809|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
1758849|NCT00809159|6128810|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
1758850|NCT00809159|6128811|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
1758851|NCT00809159|6128812|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
1758852|NCT00809159|6128813|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
1758853|NCT00809159|6128808|P6|Part 1|Unsatisfactory therapeutic effect|0
1758854|NCT00809159|6128809|P5|Part 1|Unsatisfactory therapeutic effect|0
1758855|NCT00809159|6128810|P4|Part 1|Unsatisfactory therapeutic effect|0
1758856|NCT00809159|6128811|P3|Part 1|Unsatisfactory therapeutic effect|0
1758857|NCT00809159|6128812|P2|Part 1|Unsatisfactory therapeutic effect|1
1758858|NCT00809159|6128813|P1|Part 1|Unsatisfactory therapeutic effect|3
1758859|NCT00809159|6128808|P6|Part 1|Withdrawal by Subject|0
1758860|NCT00809159|6128809|P5|Part 1|Withdrawal by Subject|0
1758861|NCT00809159|6128810|P4|Part 1|Withdrawal by Subject|0
1758862|NCT00809159|6128811|P3|Part 1|Withdrawal by Subject|0
1758863|NCT00809159|6128812|P2|Part 1|Withdrawal by Subject|1
1758864|NCT00809159|6128813|P1|Part 1|Withdrawal by Subject|3
1758865|NCT00809159|6128808|P6|Part 1|Lost to Follow-up|0
1758866|NCT00809159|6128809|P5|Part 1|Lost to Follow-up|0
1758867|NCT00809159|6128810|P4|Part 1|Lost to Follow-up|0
1758868|NCT00809159|6128811|P3|Part 1|Lost to Follow-up|0
1758869|NCT00809159|6128812|P2|Part 1|Lost to Follow-up|0
1758870|NCT00809159|6128813|P1|Part 1|Lost to Follow-up|1
1758871|NCT00809159|6128808|P6|Part 1|Adverse Event|0
1758872|NCT00809159|6128809|P5|Part 1|Adverse Event|0
1758873|NCT00809159|6128810|P4|Part 1|Adverse Event|0
1758874|NCT00809159|6128811|P3|Part 1|Adverse Event|0
1758875|NCT00809159|6128812|P2|Part 1|Adverse Event|1
1758876|NCT00809159|6128813|P1|Part 1|Adverse Event|1
1758877|NCT00809133|6128918|P14|Overall Study|Other not mentioned above|0
1758878|NCT00809133|6128919|P13|Overall Study|Other not mentioned above|0
1758879|NCT00809133|6128920|P12|Overall Study|Other not mentioned above|0
1758880|NCT00809133|6128921|P11|Overall Study|Other not mentioned above|0
1758881|NCT00809133|6128922|P10|Overall Study|Other not mentioned above|0
1758882|NCT00809133|6128923|P9|Overall Study|Other not mentioned above|0
1758883|NCT00809133|6128924|P8|Overall Study|Other not mentioned above|0
1758884|NCT00809133|6128925|P7|Overall Study|Other not mentioned above|0
1758885|NCT00809133|6128926|P6|Overall Study|Other not mentioned above|1
1758886|NCT00809133|6128927|P5|Overall Study|Other not mentioned above|0
1758887|NCT00809133|6128928|P4|Overall Study|Other not mentioned above|0
1758888|NCT00809133|6128929|P3|Overall Study|Other not mentioned above|0
1758889|NCT00809133|6128930|P2|Overall Study|Other not mentioned above|1
1758890|NCT00809133|6128931|P1|Overall Study|Other not mentioned above|0
1758891|NCT00809133|6128918|P14|Overall Study|Consent withdrawn|0
1758892|NCT00809133|6128919|P13|Overall Study|Consent withdrawn|0
1758893|NCT00809133|6128920|P12|Overall Study|Consent withdrawn|0
1758894|NCT00809133|6128921|P11|Overall Study|Consent withdrawn|0
1758895|NCT00809133|6128922|P10|Overall Study|Consent withdrawn|0
1758896|NCT00809133|6128923|P9|Overall Study|Consent withdrawn|0
1758897|NCT00809133|6128924|P8|Overall Study|Consent withdrawn|0
1758898|NCT00809133|6128925|P7|Overall Study|Consent withdrawn|0
1758899|NCT00809133|6128926|P6|Overall Study|Consent withdrawn|0
1758900|NCT00809133|6128927|P5|Overall Study|Consent withdrawn|1
1758901|NCT00809133|6128928|P4|Overall Study|Consent withdrawn|0
1758902|NCT00809133|6128929|P3|Overall Study|Consent withdrawn|0
1758903|NCT00809133|6128930|P2|Overall Study|Consent withdrawn|0
1758904|NCT00809133|6128931|P1|Overall Study|Consent withdrawn|0
1758905|NCT00809133|6128918|P14|Overall Study|Lost to Follow-up|0
1758906|NCT00809133|6128919|P13|Overall Study|Lost to Follow-up|0
1758907|NCT00809133|6128920|P12|Overall Study|Lost to Follow-up|0
1758908|NCT00809133|6128921|P11|Overall Study|Lost to Follow-up|0
1758909|NCT00809133|6128922|P10|Overall Study|Lost to Follow-up|0
1758910|NCT00809133|6128923|P9|Overall Study|Lost to Follow-up|0
1758911|NCT00809133|6128924|P8|Overall Study|Lost to Follow-up|0
1758912|NCT00809133|6128925|P7|Overall Study|Lost to Follow-up|0
1758913|NCT00809133|6128926|P6|Overall Study|Lost to Follow-up|1
1758914|NCT00809133|6128927|P5|Overall Study|Lost to Follow-up|0
1758915|NCT00809133|6128928|P4|Overall Study|Lost to Follow-up|0
1758916|NCT00809133|6128929|P3|Overall Study|Lost to Follow-up|0
1758917|NCT00809133|6128930|P2|Overall Study|Lost to Follow-up|0
1758918|NCT00809133|6128931|P1|Overall Study|Lost to Follow-up|0
1758919|NCT00809133|6128918|P14|Overall Study|Other adverse event|1
1758920|NCT00809133|6128919|P13|Overall Study|Other adverse event|0
1758921|NCT00809133|6128920|P12|Overall Study|Other adverse event|1
1758922|NCT00809133|6128921|P11|Overall Study|Other adverse event|1
1758923|NCT00809133|6128922|P10|Overall Study|Other adverse event|0
1758924|NCT00809133|6128923|P9|Overall Study|Other adverse event|0
1758925|NCT00809133|6128924|P8|Overall Study|Other adverse event|4
1758926|NCT00809133|6128925|P7|Overall Study|Other adverse event|2
1758927|NCT00809133|6128926|P6|Overall Study|Other adverse event|3
1758928|NCT00809133|6128927|P5|Overall Study|Other adverse event|0
1758929|NCT00809133|6128928|P4|Overall Study|Other adverse event|0
1758930|NCT00809133|6128929|P3|Overall Study|Other adverse event|1
1758931|NCT00809133|6128930|P2|Overall Study|Other adverse event|1
1758932|NCT00809133|6128931|P1|Overall Study|Other adverse event|1
1758933|NCT00809133|6128918|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
1758934|NCT00809133|6128919|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
1758935|NCT00809133|6128920|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
1758936|NCT00809133|6128921|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
1758937|NCT00809133|6128922|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
1758938|NCT00809133|6128923|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
1758939|NCT00809133|6128924|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
1758940|NCT00809133|6128925|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
1758941|NCT00809133|6128926|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
1758942|NCT00809133|6128927|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
1758943|NCT00809133|6128928|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1758944|NCT00809133|6128929|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
1758945|NCT00809133|6128930|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1758946|NCT00809133|6128931|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
1758947|NCT00809133|6128918|P14|Overall Study|Progressive disease|4
1758948|NCT00809133|6128919|P13|Overall Study|Progressive disease|5
1758949|NCT00809133|6128920|P12|Overall Study|Progressive disease|7
1758950|NCT00809133|6128921|P11|Overall Study|Progressive disease|5
1758951|NCT00809133|6128922|P10|Overall Study|Progressive disease|9
1758952|NCT00809133|6128923|P9|Overall Study|Progressive disease|3
1758953|NCT00809133|6128924|P8|Overall Study|Progressive disease|3
1758954|NCT00809133|6128925|P7|Overall Study|Progressive disease|3
1758955|NCT00809133|6128926|P6|Overall Study|Progressive disease|1
1758956|NCT00809133|6128927|P5|Overall Study|Progressive disease|4
1758957|NCT00809133|6128928|P4|Overall Study|Progressive disease|3
1758958|NCT00809133|6128929|P3|Overall Study|Progressive disease|5
1758959|NCT00809133|6128930|P2|Overall Study|Progressive disease|5
1758960|NCT00809133|6128931|P1|Overall Study|Progressive disease|2
1758961|NCT00809094|6129085|P2|Overall Study|Lost to Follow-up|1
1758962|NCT00809094|6129086|P1|Overall Study|Lost to Follow-up|0
1758963|NCT00808899|6129131|P1|Overall Study|Physician Decision|3
1758964|NCT00808899|6129131|P1|Overall Study|Death|1
1758965|NCT00808808|6129145|P3|Overall Study|Employee was not vaccinated.|2255
1758966|NCT00808808|6129146|P2|Overall Study|Employee was not vaccinated.|2268
1758967|NCT00808808|6129147|P1|Overall Study|Employee was not vaccinated.|2686
1758968|NCT00808808|6129145|P3|Overall Study|Vaccinated; survey not completed|302
1758969|NCT00808808|6129146|P2|Overall Study|Vaccinated; survey not completed|169
1758970|NCT00808808|6129147|P1|Overall Study|Vaccinated; survey not completed|131
1758971|NCT00808665|6129182|P2|Overall Study|Medication stopped by resident|1
1758972|NCT00808665|6129183|P1|Overall Study|Medication stopped by resident|0
1758973|NCT00808665|6129182|P2|Overall Study|Physician Decision|1
1758974|NCT00808665|6129183|P1|Overall Study|Physician Decision|3
1758975|NCT00808665|6129182|P2|Overall Study|required an additional procedure|1
1758976|NCT00808665|6129183|P1|Overall Study|required an additional procedure|0
1758977|NCT00808665|6129182|P2|Overall Study|surgery cancelled|0
1758978|NCT00808665|6129183|P1|Overall Study|surgery cancelled|1
1758979|NCT00808665|6129182|P2|Overall Study|only required minimally invasive surgery|0
1758980|NCT00808665|6129183|P1|Overall Study|only required minimally invasive surgery|1
1758981|NCT00808665|6129182|P2|Overall Study|Withdrawal by Subject|0
1758982|NCT00808665|6129183|P1|Overall Study|Withdrawal by Subject|1
1758983|NCT00808639|6129189|P1|Overall Study|Disease progression before surgery.|1
1758984|NCT00808509|6129197|P2|Randomized Phase|Patient refused rescue therapy|3
1758985|NCT00808509|6129198|P1|Randomized Phase|Patient refused rescue therapy|0
1758986|NCT00808509|6129197|P2|Randomized Phase|Reduced methotrexate dose|2
1758987|NCT00808509|6129198|P1|Randomized Phase|Reduced methotrexate dose|1
1758988|NCT00808509|6129197|P2|Randomized Phase|Did not meet eligibility criteria|0
1758989|NCT00808509|6129198|P1|Randomized Phase|Did not meet eligibility criteria|1
1758990|NCT00808483|6129296|P2|From 5 Months to 12 Months|Lack of Efficacy|0
1758991|NCT00808483|6129297|P1|From 5 Months to 12 Months|Lack of Efficacy|1
1758992|NCT00808483|6129296|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
1758993|NCT00808483|6129297|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
1758994|NCT00808483|6129296|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
1758995|NCT00808483|6129297|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
1758996|NCT00808444|6129334|P2|Overall Study|Lost to Follow-up|1
1758997|NCT00808444|6129335|P1|Overall Study|Lost to Follow-up|0
1758998|NCT00808444|6129334|P2|Overall Study|Withdrawal by Subject|0
1758999|NCT00808444|6129335|P1|Overall Study|Withdrawal by Subject|1
1759000|NCT00808249|6129410|P4|Overall Study|All other reasons|1
1759001|NCT00808249|6129411|P3|Overall Study|All other reasons|3
1759002|NCT00808249|6129412|P2|Overall Study|All other reasons|1
1759003|NCT00808249|6129413|P1|Overall Study|All other reasons|2
1759004|NCT00808249|6129410|P4|Overall Study|study specific discontinuation criteria|0
1759005|NCT00808249|6129411|P3|Overall Study|study specific discontinuation criteria|1
1759006|NCT00808249|6129412|P2|Overall Study|study specific discontinuation criteria|0
1759007|NCT00808249|6129413|P1|Overall Study|study specific discontinuation criteria|1
1759008|NCT00808249|6129410|P4|Overall Study|Lack of Efficacy|0
1759009|NCT00808249|6129411|P3|Overall Study|Lack of Efficacy|0
1759010|NCT00808249|6129412|P2|Overall Study|Lack of Efficacy|1
1759011|NCT00808249|6129413|P1|Overall Study|Lack of Efficacy|1
1759012|NCT00808249|6129410|P4|Overall Study|Protocol Violation|0
1759013|NCT00808249|6129411|P3|Overall Study|Protocol Violation|3
1759014|NCT00808249|6129412|P2|Overall Study|Protocol Violation|3
1759015|NCT00808249|6129413|P1|Overall Study|Protocol Violation|3
1759016|NCT00808249|6129410|P4|Overall Study|Withdrawal by Subject|4
1759017|NCT00808249|6129411|P3|Overall Study|Withdrawal by Subject|2
1759018|NCT00808249|6129412|P2|Overall Study|Withdrawal by Subject|0
1759019|NCT00808249|6129413|P1|Overall Study|Withdrawal by Subject|4
1759020|NCT00808249|6129410|P4|Overall Study|Lost to Follow-up|5
1759021|NCT00808249|6129411|P3|Overall Study|Lost to Follow-up|3
1759022|NCT00808249|6129412|P2|Overall Study|Lost to Follow-up|3
1759023|NCT00808249|6129413|P1|Overall Study|Lost to Follow-up|2
1759024|NCT00808249|6129410|P4|Overall Study|Adverse Event|6
1759025|NCT00808249|6129411|P3|Overall Study|Adverse Event|10
1759026|NCT00808249|6129412|P2|Overall Study|Adverse Event|7
1759027|NCT00808249|6129413|P1|Overall Study|Adverse Event|4
1759028|NCT00808236|6129441|P2|Overall Study|Death|30
1759029|NCT00808236|6129442|P1|Overall Study|Death|18
1759030|NCT00808236|6129441|P2|Overall Study|Physician Decision|1
1759031|NCT00808236|6129442|P1|Overall Study|Physician Decision|0
1759032|NCT00808236|6129441|P2|Overall Study|Lost to Follow-up|1
1759033|NCT00808236|6129442|P1|Overall Study|Lost to Follow-up|1
1759034|NCT00808236|6129441|P2|Overall Study|Pre-defined exclusion|3
1759035|NCT00808236|6129442|P1|Overall Study|Pre-defined exclusion|13
1759036|NCT00808236|6129441|P2|Overall Study|Was not resuscitated|56
1759037|NCT00808236|6129442|P1|Overall Study|Was not resuscitated|50
1759038|NCT00808132|6129475|P5|Overall Study|Unsatisfactory response|12
1759039|NCT00808132|6129476|P4|Overall Study|Unsatisfactory response|4
1759040|NCT00808132|6129477|P3|Overall Study|Unsatisfactory response|6
1759041|NCT00808132|6129478|P2|Overall Study|Unsatisfactory response|6
1759042|NCT00808132|6129479|P1|Overall Study|Unsatisfactory response|5
1759043|NCT00808132|6129475|P5|Overall Study|Randomized, but not treated|9
1759044|NCT00808132|6129476|P4|Overall Study|Randomized, but not treated|8
1759045|NCT00808132|6129477|P3|Overall Study|Randomized, but not treated|9
1759046|NCT00808132|6129478|P2|Overall Study|Randomized, but not treated|7
1759047|NCT00808132|6129479|P1|Overall Study|Randomized, but not treated|10
1759048|NCT00808132|6129475|P5|Overall Study|Other|15
1759049|NCT00808132|6129476|P4|Overall Study|Other|2
1759050|NCT00808132|6129477|P3|Overall Study|Other|6
1759051|NCT00808132|6129478|P2|Overall Study|Other|4
1759052|NCT00808132|6129479|P1|Overall Study|Other|6
1759053|NCT00808132|6129475|P5|Overall Study|Withdrawal by Subject|16
1759054|NCT00808132|6129476|P4|Overall Study|Withdrawal by Subject|7
1759055|NCT00808132|6129477|P3|Overall Study|Withdrawal by Subject|2
1759056|NCT00808132|6129478|P2|Overall Study|Withdrawal by Subject|18
1759057|NCT00808132|6129479|P1|Overall Study|Withdrawal by Subject|27
1759058|NCT00808132|6129475|P5|Overall Study|Protocol Violation|5
1759059|NCT00808132|6129476|P4|Overall Study|Protocol Violation|9
1759060|NCT00808132|6129477|P3|Overall Study|Protocol Violation|4
1759061|NCT00808132|6129478|P2|Overall Study|Protocol Violation|9
1759062|NCT00808132|6129479|P1|Overall Study|Protocol Violation|8
1759063|NCT00808132|6129475|P5|Overall Study|Lost to Follow-up|9
1759064|NCT00808132|6129476|P4|Overall Study|Lost to Follow-up|8
1759065|NCT00808132|6129477|P3|Overall Study|Lost to Follow-up|11
1759066|NCT00808132|6129478|P2|Overall Study|Lost to Follow-up|10
1759067|NCT00808132|6129479|P1|Overall Study|Lost to Follow-up|8
1759068|NCT00808132|6129475|P5|Overall Study|Physician Decision|0
1759069|NCT00808132|6129476|P4|Overall Study|Physician Decision|0
1759070|NCT00808132|6129477|P3|Overall Study|Physician Decision|0
1759071|NCT00808132|6129478|P2|Overall Study|Physician Decision|1
1759072|NCT00808132|6129479|P1|Overall Study|Physician Decision|0
1759073|NCT00808132|6129475|P5|Overall Study|Death|1
1759074|NCT00808132|6129476|P4|Overall Study|Death|0
1759075|NCT00808132|6129477|P3|Overall Study|Death|0
1759076|NCT00808132|6129478|P2|Overall Study|Death|0
1759077|NCT00808132|6129479|P1|Overall Study|Death|0
1759078|NCT00808132|6129475|P5|Overall Study|Adverse Event|33
1759079|NCT00808132|6129476|P4|Overall Study|Adverse Event|31
1759080|NCT00808132|6129477|P3|Overall Study|Adverse Event|16
1759081|NCT00808132|6129478|P2|Overall Study|Adverse Event|33
1759082|NCT00808132|6129479|P1|Overall Study|Adverse Event|34
1759083|NCT00808080|6129551|P1|Overall Study|Patients Became Ineligible for infusion|6
1759084|NCT00808067|6129558|P2|Overall Study|Excluded from analysis|19
1759085|NCT00808067|6129559|P1|Overall Study|Excluded from analysis|13
1759086|NCT00808067|6129558|P2|Overall Study|Other reason not defined above|5
1759087|NCT00808067|6129559|P1|Overall Study|Other reason not defined above|5
1759088|NCT00808067|6129558|P2|Overall Study|Site closed for cause|19
1759089|NCT00808067|6129559|P1|Overall Study|Site closed for cause|19
1759090|NCT00808067|6129558|P2|Overall Study|Patient elected|9
1759091|NCT00808067|6129559|P1|Overall Study|Patient elected|7
1759092|NCT00808067|6129558|P2|Overall Study|Protocol Violation|11
1759093|NCT00808067|6129559|P1|Overall Study|Protocol Violation|3
1759094|NCT00808067|6129558|P2|Overall Study|Physician Decision|38
1759095|NCT00808067|6129559|P1|Overall Study|Physician Decision|47
1759096|NCT00808067|6129558|P2|Overall Study|Site closed|3
1759097|NCT00808067|6129559|P1|Overall Study|Site closed|4
1759098|NCT00808067|6129558|P2|Overall Study|Withdrawal by Subject|25
1759099|NCT00808067|6129559|P1|Overall Study|Withdrawal by Subject|21
1759100|NCT00808067|6129558|P2|Overall Study|Procedure|7
1759101|NCT00808067|6129559|P1|Overall Study|Procedure|6
1759102|NCT00808067|6129558|P2|Overall Study|Death|1
1759103|NCT00808067|6129559|P1|Overall Study|Death|1
1759104|NCT00808067|6129558|P2|Overall Study|Missing|0
1759105|NCT00808067|6129559|P1|Overall Study|Missing|1
1759106|NCT00808067|6129558|P2|Overall Study|Patient refused to take study medication|76
1759107|NCT00808067|6129559|P1|Overall Study|Patient refused to take study medication|65
1759108|NCT00808067|6129558|P2|Overall Study|Elevated LFT results|3
1759109|NCT00808067|6129559|P1|Overall Study|Elevated LFT results|7
1759110|NCT00808067|6129558|P2|Overall Study|Reduced creatinine clearance|55
1759111|NCT00808067|6129559|P1|Overall Study|Reduced creatinine clearance|53
1759112|NCT00808067|6129558|P2|Overall Study|Hospitalization due to surgery|40
1759113|NCT00808067|6129559|P1|Overall Study|Hospitalization due to surgery|37
1759114|NCT00808067|6129558|P2|Overall Study|Hospitalization (not including surgery)|17
1759115|NCT00808067|6129559|P1|Overall Study|Hospitalization (not including surgery)|18
1759116|NCT00808067|6129558|P2|Overall Study|Adverse Event|121
1759117|NCT00808067|6129559|P1|Overall Study|Adverse Event|111
1759118|NCT00808067|6129558|P2|Overall Study|Outcome event - other|25
1759119|NCT00808067|6129559|P1|Overall Study|Outcome event - other|33
1759120|NCT00808067|6129558|P2|Overall Study|Major/minor bleed|44
1759121|NCT00808067|6129559|P1|Overall Study|Major/minor bleed|30
1759122|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1759123|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
1759124|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1759125|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
1759126|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Death|0
1759127|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Death|1
1759128|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Death|0
1759129|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Death|0
1759130|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1759131|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
1759132|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1759133|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
1759134|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Other|1
1759135|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Other|1
1759136|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Other|0
1759137|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Other|0
1759138|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
1759139|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
1759140|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
1759141|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
1759142|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
1759143|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
1759144|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
1759145|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
1759146|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
1759147|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
1759148|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
1759149|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
1759150|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1759151|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
1759152|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1759153|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
1759154|NCT00808028|6129595|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
1759155|NCT00808028|6129596|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
1759156|NCT00808028|6129597|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
1759157|NCT00808028|6129598|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
1759158|NCT00808028|6129595|P4|Stage 1 (6 Months)|Protocol Violation|1
1759159|NCT00808028|6129596|P3|Stage 1 (6 Months)|Protocol Violation|0
1759160|NCT00808028|6129597|P2|Stage 1 (6 Months)|Protocol Violation|0
1759161|NCT00808028|6129598|P1|Stage 1 (6 Months)|Protocol Violation|0
1759162|NCT00808028|6129595|P4|Stage 1 (6 Months)|Lost to Follow-up|0
1759163|NCT00808028|6129596|P3|Stage 1 (6 Months)|Lost to Follow-up|1
1759164|NCT00808028|6129597|P2|Stage 1 (6 Months)|Lost to Follow-up|0
1759165|NCT00808028|6129598|P1|Stage 1 (6 Months)|Lost to Follow-up|1
1759166|NCT00808028|6129595|P4|Stage 1 (6 Months)|Adverse Event|2
1759167|NCT00808028|6129596|P3|Stage 1 (6 Months)|Adverse Event|1
1759168|NCT00808028|6129597|P2|Stage 1 (6 Months)|Adverse Event|0
1759169|NCT00808028|6129598|P1|Stage 1 (6 Months)|Adverse Event|0
1759170|NCT00808028|6129595|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
1759171|NCT00808028|6129596|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
1759172|NCT00808028|6129597|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
1759173|NCT00808028|6129598|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
1759174|NCT00808028|6129595|P4|Stage 1 (6 Months)|Other|4
1759175|NCT00808028|6129596|P3|Stage 1 (6 Months)|Other|2
1759176|NCT00808028|6129597|P2|Stage 1 (6 Months)|Other|0
1759177|NCT00808028|6129598|P1|Stage 1 (6 Months)|Other|1
1759178|NCT00808028|6129595|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
1759179|NCT00808028|6129596|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
1759180|NCT00808028|6129597|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
1759181|NCT00808028|6129598|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
1759182|NCT00808015|6129634|P1|Overall Study|Enrolled but not treated|4
1759183|NCT00808015|6129634|P1|Overall Study|Other|25
1759184|NCT00808015|6129634|P1|Overall Study|Adverse Event|22
1759185|NCT00808015|6129634|P1|Overall Study|Participants not willing to participate|158
1759186|NCT00808015|6129634|P1|Overall Study|Lost to Follow-up|76
1759187|NCT00808015|6129634|P1|Overall Study|Lack of Efficacy|58
1759188|NCT00808015|6129634|P1|Overall Study|Death|1
1759189|NCT00807937|6129663|P4|Overall Study|All other reasons (not provided)|1
1759190|NCT00807937|6129664|P3|Overall Study|All other reasons (not provided)|0
1759191|NCT00807937|6129665|P2|Overall Study|All other reasons (not provided)|4
1759192|NCT00807937|6129666|P1|Overall Study|All other reasons (not provided)|2
1759193|NCT00807937|6129663|P4|Overall Study|Intake of prohibited medicine|0
1759194|NCT00807937|6129664|P3|Overall Study|Intake of prohibited medicine|2
1759195|NCT00807937|6129665|P2|Overall Study|Intake of prohibited medicine|0
1759196|NCT00807937|6129666|P1|Overall Study|Intake of prohibited medicine|0
1759197|NCT00807937|6129663|P4|Overall Study|Lack of Efficacy|2
1759198|NCT00807937|6129664|P3|Overall Study|Lack of Efficacy|1
1759199|NCT00807937|6129665|P2|Overall Study|Lack of Efficacy|0
1759200|NCT00807937|6129666|P1|Overall Study|Lack of Efficacy|0
1759201|NCT00807937|6129663|P4|Overall Study|Lost to Follow-up|1
1759202|NCT00807937|6129664|P3|Overall Study|Lost to Follow-up|2
1759203|NCT00807937|6129665|P2|Overall Study|Lost to Follow-up|0
1759204|NCT00807937|6129666|P1|Overall Study|Lost to Follow-up|4
1759205|NCT00807937|6129663|P4|Overall Study|Withdrawal by Subject|4
1759206|NCT00807937|6129664|P3|Overall Study|Withdrawal by Subject|1
1759207|NCT00807937|6129665|P2|Overall Study|Withdrawal by Subject|4
1759208|NCT00807937|6129666|P1|Overall Study|Withdrawal by Subject|5
1759209|NCT00807937|6129663|P4|Overall Study|Protocol Violation|3
1759210|NCT00807937|6129664|P3|Overall Study|Protocol Violation|3
1759211|NCT00807937|6129665|P2|Overall Study|Protocol Violation|5
1759212|NCT00807937|6129666|P1|Overall Study|Protocol Violation|4
1759213|NCT00807937|6129663|P4|Overall Study|Adverse Event|4
1759214|NCT00807937|6129664|P3|Overall Study|Adverse Event|5
1759215|NCT00807937|6129665|P2|Overall Study|Adverse Event|12
1759216|NCT00807937|6129666|P1|Overall Study|Adverse Event|12
1759217|NCT00807885|6129701|P9|Overall Study|Lost to Follow-up|0
1759218|NCT00807885|6129702|P8|Overall Study|Lost to Follow-up|0
1759219|NCT00807885|6129703|P7|Overall Study|Lost to Follow-up|0
1759220|NCT00807885|6129704|P6|Overall Study|Lost to Follow-up|1
1759221|NCT00807885|6129705|P5|Overall Study|Lost to Follow-up|0
1759222|NCT00807885|6129706|P4|Overall Study|Lost to Follow-up|0
1759223|NCT00807885|6129707|P3|Overall Study|Lost to Follow-up|0
1759224|NCT00807885|6129708|P2|Overall Study|Lost to Follow-up|0
1759225|NCT00807885|6129709|P1|Overall Study|Lost to Follow-up|0
1759226|NCT00807846|6129758|P2|Overall Study|Other|2
1759227|NCT00807846|6129759|P1|Overall Study|Other|1
1759228|NCT00807846|6129758|P2|Overall Study|Withdrawal by Subject|1
1759229|NCT00807846|6129759|P1|Overall Study|Withdrawal by Subject|2
1759230|NCT00807846|6129758|P2|Overall Study|Protocol Violation|1
1759231|NCT00807846|6129759|P1|Overall Study|Protocol Violation|2
1759232|NCT00807846|6129758|P2|Overall Study|Lack of Efficacy|0
1759233|NCT00807846|6129759|P1|Overall Study|Lack of Efficacy|2
1759234|NCT00807846|6129758|P2|Overall Study|Adverse Event|0
1759235|NCT00807846|6129759|P1|Overall Study|Adverse Event|5
1759236|NCT00807742|6129812|P2|Overall Study|Lost to Follow-up|51
1759237|NCT00807742|6129813|P1|Overall Study|Lost to Follow-up|35
1759238|NCT00807742|6129812|P2|Overall Study|Withdrawal by Subject|1
1759239|NCT00807742|6129813|P1|Overall Study|Withdrawal by Subject|2
1759240|NCT00807742|6129812|P2|Overall Study|Death|2
1759241|NCT00807742|6129813|P1|Overall Study|Death|9
1759242|NCT00807599|6129872|P3|Overall Study|Withdrawal by Subject|1
1759243|NCT00807599|6129873|P2|Overall Study|Withdrawal by Subject|0
1759244|NCT00807599|6129874|P1|Overall Study|Withdrawal by Subject|0
1759245|NCT00807599|6129872|P3|Overall Study|Inadequate response to induction|9
1759246|NCT00807599|6129873|P2|Overall Study|Inadequate response to induction|0
1759247|NCT00807599|6129874|P1|Overall Study|Inadequate response to induction|0
1759248|NCT00807599|6129872|P3|Overall Study|Adverse Event|5
1759249|NCT00807599|6129873|P2|Overall Study|Adverse Event|0
1759250|NCT00807599|6129874|P1|Overall Study|Adverse Event|0
1759251|NCT00807599|6129872|P3|Overall Study|Not treated on protocol study|2
1759252|NCT00807599|6129873|P2|Overall Study|Not treated on protocol study|0
1759253|NCT00807599|6129874|P1|Overall Study|Not treated on protocol study|0
1759254|NCT00807573|6129901|P1|Overall Study|Adverse Event|1
1759255|NCT00807573|6129901|P1|Overall Study|Withdrawal by Subject|1
1759256|NCT00807495|6129947|P5|Overall Study|Reason Not Specified|3
1759257|NCT00807495|6129948|P4|Overall Study|Reason Not Specified|0
1759258|NCT00807495|6129949|P3|Overall Study|Reason Not Specified|2
1759259|NCT00807495|6129950|P2|Overall Study|Reason Not Specified|3
1759260|NCT00807495|6129951|P1|Overall Study|Reason Not Specified|0
1759261|NCT00807495|6129947|P5|Overall Study|Withdrawal by Patient|0
1759262|NCT00807495|6129948|P4|Overall Study|Withdrawal by Patient|0
1759263|NCT00807495|6129949|P3|Overall Study|Withdrawal by Patient|1
1759264|NCT00807495|6129950|P2|Overall Study|Withdrawal by Patient|0
1759265|NCT00807495|6129951|P1|Overall Study|Withdrawal by Patient|2
1759266|NCT00807495|6129947|P5|Overall Study|Adverse Event|2
1759267|NCT00807495|6129948|P4|Overall Study|Adverse Event|1
1759268|NCT00807495|6129949|P3|Overall Study|Adverse Event|1
1759269|NCT00807495|6129950|P2|Overall Study|Adverse Event|3
1759270|NCT00807495|6129951|P1|Overall Study|Adverse Event|6
1759271|NCT00807365|6129997|P1|Overall Study|Study Terminated|5
1759272|NCT00807248|6130005|P4|Overall Study|Other Reason|0
1759273|NCT00807248|6130006|P3|Overall Study|Other Reason|2
1759274|NCT00807248|6130007|P2|Overall Study|Other Reason|0
1759275|NCT00807248|6130008|P1|Overall Study|Other Reason|0
1759276|NCT00807248|6130005|P4|Overall Study|Lost to Follow-up|0
1759277|NCT00807248|6130006|P3|Overall Study|Lost to Follow-up|0
1759278|NCT00807248|6130007|P2|Overall Study|Lost to Follow-up|0
1759279|NCT00807248|6130008|P1|Overall Study|Lost to Follow-up|1
1759280|NCT00807248|6130005|P4|Overall Study|Withdrawal of Consent|5
1759281|NCT00807248|6130006|P3|Overall Study|Withdrawal of Consent|5
1759282|NCT00807248|6130007|P2|Overall Study|Withdrawal of Consent|5
1759283|NCT00807248|6130008|P1|Overall Study|Withdrawal of Consent|5
1759284|NCT00807248|6130005|P4|Overall Study|Protocol Violation|0
1759285|NCT00807248|6130006|P3|Overall Study|Protocol Violation|1
1759286|NCT00807248|6130007|P2|Overall Study|Protocol Violation|1
1759287|NCT00807248|6130008|P1|Overall Study|Protocol Violation|0
1759288|NCT00807248|6130005|P4|Overall Study|Lack of Efficacy|3
1759289|NCT00807248|6130006|P3|Overall Study|Lack of Efficacy|8
1759290|NCT00807248|6130007|P2|Overall Study|Lack of Efficacy|4
1759291|NCT00807248|6130008|P1|Overall Study|Lack of Efficacy|14
1759292|NCT00807248|6130005|P4|Overall Study|Adverse Event|6
1759293|NCT00807248|6130006|P3|Overall Study|Adverse Event|2
1759294|NCT00807248|6130007|P2|Overall Study|Adverse Event|2
1759295|NCT00807248|6130008|P1|Overall Study|Adverse Event|1
1759296|NCT00807235|6130052|P2|Overall Study|Adverse Event|0
1759297|NCT00807235|6130053|P1|Overall Study|Adverse Event|1
1759298|NCT00807092|6130098|P2|Overall Study|CGMS data collection failed|1
1759299|NCT00807092|6130099|P1|Overall Study|CGMS data collection failed|0
1759300|NCT00807092|6130098|P2|Overall Study|Withdrawal by Subject|0
1759301|NCT00807092|6130099|P1|Overall Study|Withdrawal by Subject|1
1759302|NCT00807092|6130098|P2|Overall Study|Protocol Violation|2
1759303|NCT00807092|6130099|P1|Overall Study|Protocol Violation|0
1759304|NCT00807092|6130098|P2|Overall Study|Adverse Event|1
1759305|NCT00807092|6130099|P1|Overall Study|Adverse Event|0
1759306|NCT00807040|6130129|P2|Overall Study|Lost to Follow-up|6
1759307|NCT00807040|6130130|P1|Overall Study|Lost to Follow-up|4
1759308|NCT00807040|6130129|P2|Overall Study|Withdrawal by Subject|6
1759309|NCT00807040|6130130|P1|Overall Study|Withdrawal by Subject|8
1759310|NCT00807040|6130129|P2|Overall Study|Death|29
1759311|NCT00807040|6130130|P1|Overall Study|Death|24
1759312|NCT00807014|6130140|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
1759313|NCT00807014|6130141|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
1759314|NCT00807014|6130140|P2|Overall Study|Recovery|0
1759315|NCT00807014|6130141|P1|Overall Study|Recovery|1
1759316|NCT00807014|6130140|P2|Overall Study|Lost to Follow-up|7
1759317|NCT00807014|6130141|P1|Overall Study|Lost to Follow-up|9
1759318|NCT00807014|6130140|P2|Overall Study|Adverse Event|2
1759319|NCT00807014|6130141|P1|Overall Study|Adverse Event|0
1759320|NCT00807014|6130140|P2|Overall Study|Protocol Violation|8
1759321|NCT00807014|6130141|P1|Overall Study|Protocol Violation|2
1759322|NCT00807014|6130140|P2|Overall Study|Participant Considered Disease Not Cured|7
1759323|NCT00807014|6130141|P1|Overall Study|Participant Considered Disease Not Cured|2
1759324|NCT00807014|6130140|P2|Overall Study|Participant Considered Disease Cured|2
1759325|NCT00807014|6130141|P1|Overall Study|Participant Considered Disease Cured|13
1759326|NCT00807001|6130172|P5|Overall Study|Non-compliance|0
1759327|NCT00807001|6130173|P4|Overall Study|Non-compliance|0
1759328|NCT00807001|6130174|P3|Overall Study|Non-compliance|0
1759329|NCT00807001|6130175|P2|Overall Study|Non-compliance|1
1759330|NCT00807001|6130176|P1|Overall Study|Non-compliance|0
1759331|NCT00806988|6130195|P2|Overall Study|Lost to Follow-up|19
1759332|NCT00806988|6130196|P1|Overall Study|Lost to Follow-up|4
1759333|NCT00806988|6130195|P2|Overall Study|Withdrawal by Subject|8
1759334|NCT00806988|6130196|P1|Overall Study|Withdrawal by Subject|8
1759335|NCT00806988|6130195|P2|Overall Study|Death|16
1759336|NCT00806988|6130196|P1|Overall Study|Death|15
1759337|NCT00806819|6130206|P2|Overall Study|Reasons other than stated above|41
1759338|NCT00806819|6130207|P1|Overall Study|Reasons other than stated above|25
1759339|NCT00806819|6130206|P2|Overall Study|Not treated|3
1759340|NCT00806819|6130207|P1|Overall Study|Not treated|6
1759341|NCT00806819|6130206|P2|Overall Study|Withdrawal by Subject|29
1759342|NCT00806819|6130207|P1|Overall Study|Withdrawal by Subject|32
1759343|NCT00806819|6130206|P2|Overall Study|Lost to Follow-up|0
1759344|NCT00806819|6130207|P1|Overall Study|Lost to Follow-up|1
1759345|NCT00806819|6130206|P2|Overall Study|Protocol Violation|4
1759346|NCT00806819|6130207|P1|Overall Study|Protocol Violation|9
1759347|NCT00806819|6130206|P2|Overall Study|Other AE|40
1759348|NCT00806819|6130207|P1|Overall Study|Other AE|38
1759349|NCT00806819|6130206|P2|Overall Study|Worsening or AE of underlying disease|25
1759350|NCT00806819|6130207|P1|Overall Study|Worsening or AE of underlying disease|18
1759351|NCT00806819|6130206|P2|Overall Study|progressive disease (modified RECIST )|216
1759352|NCT00806819|6130207|P1|Overall Study|progressive disease (modified RECIST )|217
1759353|NCT00806624|6130276|P3|Overall Study|discontinued before start of treatment|1
1759354|NCT00806624|6130277|P2|Overall Study|discontinued before start of treatment|0
1759355|NCT00806624|6130278|P1|Overall Study|discontinued before start of treatment|0
1759356|NCT00806624|6130276|P3|Overall Study|Withdrawal by Subject|3
1759357|NCT00806624|6130277|P2|Overall Study|Withdrawal by Subject|3
1759358|NCT00806624|6130278|P1|Overall Study|Withdrawal by Subject|6
1759359|NCT00806624|6130276|P3|Overall Study|Lost to Follow-up|1
1759360|NCT00806624|6130277|P2|Overall Study|Lost to Follow-up|0
1759361|NCT00806624|6130278|P1|Overall Study|Lost to Follow-up|1
1759362|NCT00806624|6130276|P3|Overall Study|Death|1
1759363|NCT00806624|6130277|P2|Overall Study|Death|1
1759364|NCT00806624|6130278|P1|Overall Study|Death|0
1759365|NCT00806624|6130276|P3|Overall Study|Adverse Event|0
1759366|NCT00806624|6130277|P2|Overall Study|Adverse Event|8
1759367|NCT00806624|6130278|P1|Overall Study|Adverse Event|2
1759368|NCT00806585|6130295|P5|Overall Study|Completion status unknown|12
1759369|NCT00806585|6130296|P4|Overall Study|Completion status unknown|4
1759370|NCT00806585|6130297|P3|Overall Study|Completion status unknown|12
1759371|NCT00806585|6130298|P2|Overall Study|Completion status unknown|14
1759372|NCT00806585|6130299|P1|Overall Study|Completion status unknown|15
1759373|NCT00806585|6130295|P5|Overall Study|Withdrawal by Subject|11
1759374|NCT00806585|6130296|P4|Overall Study|Withdrawal by Subject|3
1759375|NCT00806585|6130297|P3|Overall Study|Withdrawal by Subject|9
1759376|NCT00806585|6130298|P2|Overall Study|Withdrawal by Subject|8
1759377|NCT00806585|6130299|P1|Overall Study|Withdrawal by Subject|10
1759378|NCT00806585|6130295|P5|Overall Study|Adverse Event|2
1759379|NCT00806585|6130296|P4|Overall Study|Adverse Event|4
1759380|NCT00806585|6130297|P3|Overall Study|Adverse Event|3
1759381|NCT00806585|6130298|P2|Overall Study|Adverse Event|5
1759382|NCT00806585|6130299|P1|Overall Study|Adverse Event|1
1759383|NCT00806585|6130295|P5|Overall Study|Lack of Efficacy|0
1759384|NCT00806585|6130296|P4|Overall Study|Lack of Efficacy|0
1759385|NCT00806585|6130297|P3|Overall Study|Lack of Efficacy|0
1759386|NCT00806585|6130298|P2|Overall Study|Lack of Efficacy|0
1759387|NCT00806585|6130299|P1|Overall Study|Lack of Efficacy|1
1759388|NCT00806585|6130295|P5|Overall Study|Lost to Follow-up|5
1759389|NCT00806585|6130296|P4|Overall Study|Lost to Follow-up|2
1759390|NCT00806585|6130297|P3|Overall Study|Lost to Follow-up|2
1759391|NCT00806585|6130298|P2|Overall Study|Lost to Follow-up|1
1759392|NCT00806585|6130299|P1|Overall Study|Lost to Follow-up|2
1759393|NCT00806585|6130295|P5|Overall Study|Physician Decision|1
1759394|NCT00806585|6130296|P4|Overall Study|Physician Decision|0
1759395|NCT00806585|6130297|P3|Overall Study|Physician Decision|3
1759396|NCT00806585|6130298|P2|Overall Study|Physician Decision|2
1759397|NCT00806585|6130299|P1|Overall Study|Physician Decision|0
1759398|NCT00806585|6130295|P5|Overall Study|Protocol Violation|0
1759399|NCT00806585|6130296|P4|Overall Study|Protocol Violation|0
1759400|NCT00806585|6130297|P3|Overall Study|Protocol Violation|2
1759401|NCT00806585|6130298|P2|Overall Study|Protocol Violation|1
1759402|NCT00806585|6130299|P1|Overall Study|Protocol Violation|3
1759403|NCT00806585|6130295|P5|Overall Study|Study terminated by Sponsor|0
1759404|NCT00806585|6130296|P4|Overall Study|Study terminated by Sponsor|2
1759405|NCT00806585|6130297|P3|Overall Study|Study terminated by Sponsor|1
1759406|NCT00806585|6130298|P2|Overall Study|Study terminated by Sponsor|0
1759407|NCT00806585|6130299|P1|Overall Study|Study terminated by Sponsor|0
1759408|NCT00806546|6130331|P1|Overall Study|Various|42
1759409|NCT00806546|6130331|P1|Overall Study|Protocol Violation|49
1759410|NCT00806546|6130331|P1|Overall Study|Withdrawal by Subject|75
1759411|NCT00806546|6130331|P1|Overall Study|Adverse Event|74
1759412|NCT00806546|6130331|P1|Overall Study|Lost to Follow-up|32
1759413|NCT00806546|6130331|P1|Overall Study|Enrolled, not treated|35
1759414|NCT00806494|6130335|P1|Overall Study|Withdrawal by Subject|5
1759415|NCT00806494|6130335|P1|Overall Study|Other|30
1759416|NCT00806494|6130335|P1|Overall Study|Lost to Follow-up|10
1759417|NCT00806494|6130335|P1|Overall Study|Lack of Efficacy|6
1759418|NCT00806494|6130335|P1|Overall Study|Adverse Event|29
1759419|NCT00806442|6130359|P2|Overall Study|Withdrawal by Subject|5
1759420|NCT00806442|6130360|P1|Overall Study|Withdrawal by Subject|1
1759421|NCT00806442|6130359|P2|Overall Study|Lost to Follow-up|2
1759422|NCT00806442|6130360|P1|Overall Study|Lost to Follow-up|3
1759423|NCT00806416|6130382|P4|Period 1 - Part II|Withdrawal by Subject|2
1759424|NCT00806416|6130383|P3|Period 1 - Part II|Withdrawal by Subject|0
1759425|NCT00806416|6130384|P2|Period 1 - Part II|Withdrawal by Subject|0
1759426|NCT00806416|6130385|P1|Period 1 - Part II|Withdrawal by Subject|0
1759427|NCT00806416|6130382|P4|Period 1 - Part I|Withdrawal by Subject|0
1759428|NCT00806416|6130383|P3|Period 1 - Part I|Withdrawal by Subject|0
1759429|NCT00806416|6130384|P2|Period 1 - Part I|Withdrawal by Subject|1
1759430|NCT00806416|6130385|P1|Period 1 - Part I|Withdrawal by Subject|3
1759431|NCT00806416|6130382|P4|Period 1 - Part I|Lost to Follow-up|0
1759432|NCT00806416|6130383|P3|Period 1 - Part I|Lost to Follow-up|0
1759433|NCT00806416|6130384|P2|Period 1 - Part I|Lost to Follow-up|2
1759434|NCT00806416|6130385|P1|Period 1 - Part I|Lost to Follow-up|0
1759435|NCT00806416|6130382|P4|Period 1 - Part I|Adverse Event|0
1759436|NCT00806416|6130383|P3|Period 1 - Part I|Adverse Event|0
1759437|NCT00806416|6130384|P2|Period 1 - Part I|Adverse Event|1
1759438|NCT00806416|6130385|P1|Period 1 - Part I|Adverse Event|0
1759439|NCT00806403|6130398|P2|Overall Study|Death|3
1759440|NCT00806403|6130399|P1|Overall Study|Death|4
1759441|NCT00806351|6130422|P2|Overall Study|Death|4
1759442|NCT00806351|6130423|P1|Overall Study|Death|5
1759443|NCT00806260|6130460|P6|Period 3|Pregnancy|0
1759444|NCT00806260|6130461|P5|Period 3|Pregnancy|0
1759445|NCT00806260|6130462|P4|Period 3|Pregnancy|0
1759446|NCT00806260|6130463|P3|Period 3|Pregnancy|0
1759447|NCT00806260|6130464|P2|Period 3|Pregnancy|0
1759448|NCT00806260|6130465|P1|Period 3|Pregnancy|1
1759449|NCT00806260|6130460|P6|Period 3|Protocol Violation|0
1759450|NCT00806260|6130461|P5|Period 3|Protocol Violation|0
1759451|NCT00806260|6130462|P4|Period 3|Protocol Violation|0
1759452|NCT00806260|6130463|P3|Period 3|Protocol Violation|1
1759453|NCT00806260|6130464|P2|Period 3|Protocol Violation|1
1759454|NCT00806260|6130465|P1|Period 3|Protocol Violation|0
1759455|NCT00806260|6130460|P6|Period 2|sponsor request|0
1759456|NCT00806260|6130461|P5|Period 2|sponsor request|0
1759457|NCT00806260|6130462|P4|Period 2|sponsor request|1
1759458|NCT00806260|6130463|P3|Period 2|sponsor request|1
1759459|NCT00806260|6130464|P2|Period 2|sponsor request|0
1759460|NCT00806260|6130465|P1|Period 2|sponsor request|0
1759461|NCT00806260|6130460|P6|Period 2|Need to take concomitant medication|0
1759462|NCT00806260|6130461|P5|Period 2|Need to take concomitant medication|0
1759463|NCT00806260|6130462|P4|Period 2|Need to take concomitant medication|0
1759464|NCT00806260|6130463|P3|Period 2|Need to take concomitant medication|0
1759465|NCT00806260|6130464|P2|Period 2|Need to take concomitant medication|0
1759466|NCT00806260|6130465|P1|Period 2|Need to take concomitant medication|1
1759467|NCT00806260|6130460|P6|Period 2|Protocol Violation|0
1759468|NCT00806260|6130461|P5|Period 2|Protocol Violation|0
1759469|NCT00806260|6130462|P4|Period 2|Protocol Violation|0
1759470|NCT00806260|6130463|P3|Period 2|Protocol Violation|1
1759471|NCT00806260|6130464|P2|Period 2|Protocol Violation|0
1759472|NCT00806260|6130465|P1|Period 2|Protocol Violation|1
1759473|NCT00806260|6130460|P6|Period 2|Adverse Event|0
1759474|NCT00806260|6130461|P5|Period 2|Adverse Event|0
1759475|NCT00806260|6130462|P4|Period 2|Adverse Event|1
1759476|NCT00806260|6130463|P3|Period 2|Adverse Event|0
1759477|NCT00806260|6130464|P2|Period 2|Adverse Event|0
1759478|NCT00806260|6130465|P1|Period 2|Adverse Event|0
1759479|NCT00806260|6130460|P6|Period 1 (1 Day)|Adverse Event|0
1759480|NCT00806260|6130461|P5|Period 1 (1 Day)|Adverse Event|3
1759481|NCT00806260|6130462|P4|Period 1 (1 Day)|Adverse Event|0
1759482|NCT00806260|6130463|P3|Period 1 (1 Day)|Adverse Event|0
1759483|NCT00806260|6130464|P2|Period 1 (1 Day)|Adverse Event|0
1759484|NCT00806260|6130465|P1|Period 1 (1 Day)|Adverse Event|0
1759485|NCT00806195|6130510|P4|Overall Study|Protocol Violation|9
1759486|NCT00806195|6130511|P3|Overall Study|Protocol Violation|26
1759487|NCT00806195|6130512|P2|Overall Study|Protocol Violation|24
1759488|NCT00806195|6130513|P1|Overall Study|Protocol Violation|34
1759489|NCT00806195|6130510|P4|Overall Study|Administrative Reason|26
1759490|NCT00806195|6130511|P3|Overall Study|Administrative Reason|66
1759491|NCT00806195|6130512|P2|Overall Study|Administrative Reason|35
1759492|NCT00806195|6130513|P1|Overall Study|Administrative Reason|113
1759493|NCT00806195|6130510|P4|Overall Study|Inappropriate Enrollment|0
1759494|NCT00806195|6130511|P3|Overall Study|Inappropriate Enrollment|0
1759495|NCT00806195|6130512|P2|Overall Study|Inappropriate Enrollment|1
1759496|NCT00806195|6130513|P1|Overall Study|Inappropriate Enrollment|0
1759497|NCT00806195|6130510|P4|Overall Study|Lost to Follow-up|34
1759498|NCT00806195|6130511|P3|Overall Study|Lost to Follow-up|90
1759499|NCT00806195|6130512|P2|Overall Study|Lost to Follow-up|66
1759500|NCT00806195|6130513|P1|Overall Study|Lost to Follow-up|217
1759501|NCT00806195|6130510|P4|Overall Study|Withdrawal by Subject|35
1759502|NCT00806195|6130511|P3|Overall Study|Withdrawal by Subject|76
1759503|NCT00806195|6130512|P2|Overall Study|Withdrawal by Subject|31
1759504|NCT00806195|6130513|P1|Overall Study|Withdrawal by Subject|119
1759505|NCT00806195|6130510|P4|Overall Study|Adverse Event|2
1759506|NCT00806195|6130511|P3|Overall Study|Adverse Event|11
1759507|NCT00806195|6130512|P2|Overall Study|Adverse Event|5
1759508|NCT00806195|6130513|P1|Overall Study|Adverse Event|25
1759509|NCT00806195|6130510|P4|Overall Study|Death|0
1759510|NCT00806195|6130511|P3|Overall Study|Death|1
1759511|NCT00806195|6130512|P2|Overall Study|Death|0
1759512|NCT00806195|6130513|P1|Overall Study|Death|6
1759513|NCT00806026|6130544|P6|Overall Study|Adverse Event|9
1759514|NCT00806026|6130545|P5|Overall Study|Adverse Event|9
1759515|NCT00806026|6130546|P4|Overall Study|Adverse Event|17
1759516|NCT00806026|6130547|P3|Overall Study|Adverse Event|44
1759517|NCT00806026|6130548|P2|Overall Study|Adverse Event|35
1759518|NCT00806026|6130549|P1|Overall Study|Adverse Event|52
1759519|NCT00806026|6130544|P6|Overall Study|Protocol Violation|3
1759520|NCT00806026|6130545|P5|Overall Study|Protocol Violation|2
1759521|NCT00806026|6130546|P4|Overall Study|Protocol Violation|0
1759522|NCT00806026|6130547|P3|Overall Study|Protocol Violation|9
1759523|NCT00806026|6130548|P2|Overall Study|Protocol Violation|9
1759524|NCT00806026|6130549|P1|Overall Study|Protocol Violation|6
1759525|NCT00806026|6130544|P6|Overall Study|Other|4
1759526|NCT00806026|6130545|P5|Overall Study|Other|0
1759527|NCT00806026|6130546|P4|Overall Study|Other|2
1759528|NCT00806026|6130547|P3|Overall Study|Other|8
1759529|NCT00806026|6130548|P2|Overall Study|Other|6
1759530|NCT00806026|6130549|P1|Overall Study|Other|3
1759531|NCT00806026|6130544|P6|Overall Study|Withdrawal by Subject|3
1759532|NCT00806026|6130545|P5|Overall Study|Withdrawal by Subject|5
1759533|NCT00806026|6130546|P4|Overall Study|Withdrawal by Subject|2
1759534|NCT00806026|6130547|P3|Overall Study|Withdrawal by Subject|9
1759535|NCT00806026|6130548|P2|Overall Study|Withdrawal by Subject|17
1759536|NCT00806026|6130549|P1|Overall Study|Withdrawal by Subject|14
1759537|NCT00806026|6130544|P6|Overall Study|Lost to Follow-up|6
1759538|NCT00806026|6130545|P5|Overall Study|Lost to Follow-up|6
1759539|NCT00806026|6130546|P4|Overall Study|Lost to Follow-up|2
1759540|NCT00806026|6130547|P3|Overall Study|Lost to Follow-up|8
1759541|NCT00806026|6130548|P2|Overall Study|Lost to Follow-up|15
1759542|NCT00806026|6130549|P1|Overall Study|Lost to Follow-up|8
1759543|NCT00806026|6130544|P6|Overall Study|Lack of Efficacy|7
1759544|NCT00806026|6130545|P5|Overall Study|Lack of Efficacy|8
1759545|NCT00806026|6130546|P4|Overall Study|Lack of Efficacy|4
1759546|NCT00806026|6130547|P3|Overall Study|Lack of Efficacy|13
1759547|NCT00806026|6130548|P2|Overall Study|Lack of Efficacy|18
1759548|NCT00806026|6130549|P1|Overall Study|Lack of Efficacy|5
1759549|NCT00806026|6130544|P6|Overall Study|Did not meet entrance criteria|0
1759550|NCT00806026|6130545|P5|Overall Study|Did not meet entrance criteria|0
1759551|NCT00806026|6130546|P4|Overall Study|Did not meet entrance criteria|1
1759552|NCT00806026|6130547|P3|Overall Study|Did not meet entrance criteria|2
1759553|NCT00806026|6130548|P2|Overall Study|Did not meet entrance criteria|1
1759554|NCT00806026|6130549|P1|Overall Study|Did not meet entrance criteria|4
1759555|NCT00806026|6130544|P6|Overall Study|Death|0
1759556|NCT00806026|6130545|P5|Overall Study|Death|0
1759557|NCT00806026|6130546|P4|Overall Study|Death|1
1759558|NCT00806026|6130547|P3|Overall Study|Death|0
1759559|NCT00806026|6130548|P2|Overall Study|Death|0
1759560|NCT00806026|6130549|P1|Overall Study|Death|0
1759561|NCT00805961|6130644|P1|Maintenance Treatment|Withdrawn Consent|1
1759562|NCT00805961|6130644|P1|Maintenance Treatment|Symptomatic Deterioration|2
1759563|NCT00805961|6130644|P1|Maintenance Treatment|Withdrawal by Subject|5
1759564|NCT00805961|6130644|P1|Maintenance Treatment|Adverse Event|6
1759565|NCT00805961|6130644|P1|Maintenance Treatment|Intercurrent Illness|7
1759566|NCT00805961|6130644|P1|Maintenance Treatment|Lack of Efficacy|13
1759567|NCT00805961|6130644|P1|Treatment-Free Interval|Lack of Efficacy|1
1759568|NCT00805961|6130644|P1|Treatment-Free Interval|Physician Decision|1
1759569|NCT00805961|6130644|P1|Treatment-Free Interval|Intercurrent Illness|2
1759570|NCT00805961|6130644|P1|Treatment-Free Interval|Adverse Event|3
1759571|NCT00805961|6130644|P1|Modality Therapy|Disease Progression|2
1759572|NCT00805961|6130644|P1|Modality Therapy|Adverse Event|1
1759573|NCT00805961|6130644|P1|Modality Therapy|Withdrawal by Subject|1
1759574|NCT00805935|6130668|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
1759575|NCT00805935|6130669|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
1759576|NCT00805935|6130670|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
1759577|NCT00805935|6130671|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
1759578|NCT00805935|6130668|P4|Overall Study|Ectopic pregnancy|0
1759579|NCT00805935|6130669|P3|Overall Study|Ectopic pregnancy|1
1759580|NCT00805935|6130670|P2|Overall Study|Ectopic pregnancy|0
1759581|NCT00805935|6130671|P1|Overall Study|Ectopic pregnancy|0
1759582|NCT00805935|6130668|P4|Overall Study|Chemical pregnancy|2
1759583|NCT00805935|6130669|P3|Overall Study|Chemical pregnancy|3
1759584|NCT00805935|6130670|P2|Overall Study|Chemical pregnancy|5
1759585|NCT00805935|6130671|P1|Overall Study|Chemical pregnancy|0
1759586|NCT00805935|6130668|P4|Overall Study|Biochemical pregnancy|0
1759587|NCT00805935|6130669|P3|Overall Study|Biochemical pregnancy|0
1759588|NCT00805935|6130670|P2|Overall Study|Biochemical pregnancy|1
1759589|NCT00805935|6130671|P1|Overall Study|Biochemical pregnancy|0
1759590|NCT00805935|6130668|P4|Overall Study|Pregnancy loss/miscarriage|0
1759591|NCT00805935|6130669|P3|Overall Study|Pregnancy loss/miscarriage|0
1759592|NCT00805935|6130670|P2|Overall Study|Pregnancy loss/miscarriage|0
1759593|NCT00805935|6130671|P1|Overall Study|Pregnancy loss/miscarriage|2
1759594|NCT00805935|6130668|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
1759595|NCT00805935|6130669|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
1759596|NCT00805935|6130670|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
1759597|NCT00805935|6130671|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
1759598|NCT00805935|6130668|P4|Overall Study|No positive serum pregnancy|5
1759599|NCT00805935|6130669|P3|Overall Study|No positive serum pregnancy|6
1759600|NCT00805935|6130670|P2|Overall Study|No positive serum pregnancy|7
1759601|NCT00805935|6130671|P1|Overall Study|No positive serum pregnancy|8
1759602|NCT00805935|6130668|P4|Overall Study|Lost to Follow-up|0
1759603|NCT00805935|6130669|P3|Overall Study|Lost to Follow-up|0
1759604|NCT00805935|6130670|P2|Overall Study|Lost to Follow-up|0
1759605|NCT00805935|6130671|P1|Overall Study|Lost to Follow-up|1
1759606|NCT00805935|6130668|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
1759607|NCT00805935|6130669|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1759608|NCT00805935|6130670|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1759609|NCT00805935|6130671|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
1759610|NCT00805935|6130668|P4|Overall Study|Cycle cancellation for risk of OHSS|0
1759611|NCT00805935|6130669|P3|Overall Study|Cycle cancellation for risk of OHSS|1
1759612|NCT00805935|6130670|P2|Overall Study|Cycle cancellation for risk of OHSS|0
1759613|NCT00805935|6130671|P1|Overall Study|Cycle cancellation for risk of OHSS|1
1759614|NCT00805935|6130668|P4|Overall Study|Cycle cancelled|0
1759615|NCT00805935|6130669|P3|Overall Study|Cycle cancelled|2
1759616|NCT00805935|6130670|P2|Overall Study|Cycle cancelled|0
1759617|NCT00805935|6130671|P1|Overall Study|Cycle cancelled|0
1759618|NCT00805935|6130668|P4|Overall Study|Stimulation Failure|2
1759619|NCT00805935|6130669|P3|Overall Study|Stimulation Failure|2
1759620|NCT00805935|6130670|P2|Overall Study|Stimulation Failure|5
1759621|NCT00805935|6130671|P1|Overall Study|Stimulation Failure|1
1759622|NCT00805792|6130738|P1|Overall Study|Lost to Follow-up|2
1759623|NCT00805792|6130738|P1|Overall Study|Death|3
1759624|NCT00805766|6130746|P1|Increased Dose Period|Withdrawal by Subject|1
1759625|NCT00805766|6130746|P1|Increased Dose Period|Pregnancy|1
1759626|NCT00805766|6130746|P1|Increased Dose Period|Lack of Efficacy|7
1759627|NCT00805766|6130746|P1|Increased Dose Period|Adverse Event|4
1759628|NCT00805766|6130746|P1|Screening Period|Responder|2
1759629|NCT00805766|6130746|P1|Screening Period|Pregnancy|1
1759630|NCT00805766|6130746|P1|Screening Period|Lack of Efficacy|2
1759631|NCT00805766|6130746|P1|Screening Period|Adverse Event|1
1759632|NCT00805740|6130760|P2|Overall Study|Randomized, but not treated|0
1759633|NCT00805740|6130761|P1|Overall Study|Randomized, but not treated|2
1759634|NCT00805740|6130760|P2|Overall Study|Lost to Follow-up|0
1759635|NCT00805740|6130761|P1|Overall Study|Lost to Follow-up|1
1759636|NCT00805740|6130760|P2|Overall Study|Withdrawal by Subject|0
1759637|NCT00805740|6130761|P1|Overall Study|Withdrawal by Subject|1
1759638|NCT00805740|6130760|P2|Overall Study|Death|4
1759639|NCT00805740|6130761|P1|Overall Study|Death|7
1759640|NCT00805675|6130786|P3|Overall Study|Adverse Event|1
1759641|NCT00805675|6130787|P2|Overall Study|Adverse Event|0
1759642|NCT00805675|6130788|P1|Overall Study|Adverse Event|0
1759643|NCT00805545|6130822|P2|Overall Study|Protocol Violation|1
1759644|NCT00805545|6130823|P1|Overall Study|Protocol Violation|3
1759645|NCT00805545|6130822|P2|Overall Study|Protocol Violation|2
1759646|NCT00805545|6130823|P1|Overall Study|Protocol Violation|3
1759647|NCT00805532|6130831|P2|Overall Study|invalid data|1
1759648|NCT00805532|6130832|P1|Overall Study|invalid data|0
1759649|NCT00805480|6130866|P4|Overall Study|Adverse Event|0
1759650|NCT00805480|6130867|P3|Overall Study|Adverse Event|1
1759651|NCT00805480|6130868|P2|Overall Study|Adverse Event|0
1759652|NCT00805480|6130869|P1|Overall Study|Adverse Event|0
1759653|NCT00805480|6130866|P4|Overall Study|Lost to Follow-up|0
1759654|NCT00805480|6130867|P3|Overall Study|Lost to Follow-up|0
1759655|NCT00805480|6130868|P2|Overall Study|Lost to Follow-up|2
1759656|NCT00805480|6130869|P1|Overall Study|Lost to Follow-up|1
1759657|NCT00805480|6130866|P4|Overall Study|Withdrawal by Subject|5
1759658|NCT00805480|6130867|P3|Overall Study|Withdrawal by Subject|11
1759659|NCT00805480|6130868|P2|Overall Study|Withdrawal by Subject|5
1759660|NCT00805480|6130869|P1|Overall Study|Withdrawal by Subject|13
1759661|NCT00805467|6130898|P4|Overall Study|Not reported|7
1759662|NCT00805467|6130899|P3|Overall Study|Not reported|3
1759663|NCT00805467|6130900|P2|Overall Study|Not reported|0
1759664|NCT00805467|6130901|P1|Overall Study|Not reported|0
1759665|NCT00805467|6130898|P4|Overall Study|Physician Decision|6
1759666|NCT00805467|6130899|P3|Overall Study|Physician Decision|2
1759667|NCT00805467|6130900|P2|Overall Study|Physician Decision|1
1759668|NCT00805467|6130901|P1|Overall Study|Physician Decision|0
1759669|NCT00805467|6130898|P4|Overall Study|Death|5
1759670|NCT00805467|6130899|P3|Overall Study|Death|7
1759671|NCT00805467|6130900|P2|Overall Study|Death|2
1759672|NCT00805467|6130901|P1|Overall Study|Death|0
1759673|NCT00805467|6130898|P4|Overall Study|Adverse Event|57
1759674|NCT00805467|6130899|P3|Overall Study|Adverse Event|26
1759675|NCT00805467|6130900|P2|Overall Study|Adverse Event|13
1759676|NCT00805467|6130901|P1|Overall Study|Adverse Event|0
1759677|NCT00805467|6130898|P4|Overall Study|Protocol Violation|5
1759678|NCT00805467|6130899|P3|Overall Study|Protocol Violation|0
1759679|NCT00805467|6130900|P2|Overall Study|Protocol Violation|3
1759680|NCT00805467|6130901|P1|Overall Study|Protocol Violation|0
1759681|NCT00805467|6130898|P4|Overall Study|Withdrawal by Subject|50
1759682|NCT00805467|6130899|P3|Overall Study|Withdrawal by Subject|45
1759683|NCT00805467|6130900|P2|Overall Study|Withdrawal by Subject|6
1759684|NCT00805467|6130901|P1|Overall Study|Withdrawal by Subject|0
1759685|NCT00805467|6130898|P4|Overall Study|Lost to Follow-up|21
1759686|NCT00805467|6130899|P3|Overall Study|Lost to Follow-up|7
1759687|NCT00805467|6130900|P2|Overall Study|Lost to Follow-up|1
1759688|NCT00805467|6130901|P1|Overall Study|Lost to Follow-up|0
1759689|NCT00805467|6130898|P4|Overall Study|Lack of Efficacy|86
1759690|NCT00805467|6130899|P3|Overall Study|Lack of Efficacy|13
1759691|NCT00805467|6130900|P2|Overall Study|Lack of Efficacy|8
1759692|NCT00805467|6130901|P1|Overall Study|Lack of Efficacy|0
1759693|NCT00805441|6130921|P2|Overall Study|Acute Alcohol Withdrawal|1
1759694|NCT00805441|6130922|P1|Overall Study|Acute Alcohol Withdrawal|0
1759695|NCT00805441|6130921|P2|Overall Study|Physician Decision|1
1759696|NCT00805441|6130922|P1|Overall Study|Physician Decision|0
1759697|NCT00805441|6130921|P2|Overall Study|Withdrawal by Subject|9
1759698|NCT00805441|6130922|P1|Overall Study|Withdrawal by Subject|15
1759699|NCT00805441|6130921|P2|Overall Study|Lost to Follow-up|13
1759700|NCT00805441|6130922|P1|Overall Study|Lost to Follow-up|10
1759701|NCT00805441|6130921|P2|Overall Study|Protocol Violation|8
1759702|NCT00805441|6130922|P1|Overall Study|Protocol Violation|4
1759703|NCT00805441|6130921|P2|Overall Study|Lack of Efficacy|2
1759704|NCT00805441|6130922|P1|Overall Study|Lack of Efficacy|0
1759705|NCT00805441|6130921|P2|Overall Study|Adverse Event|2
1759706|NCT00805441|6130922|P1|Overall Study|Adverse Event|5
1759707|NCT00805389|6130957|P5|Overall Study|Withdrawal by Subject|4
1759708|NCT00805389|6130958|P4|Overall Study|Withdrawal by Subject|5
1759709|NCT00805389|6130959|P3|Overall Study|Withdrawal by Subject|4
1759710|NCT00805389|6130960|P2|Overall Study|Withdrawal by Subject|2
1759711|NCT00805389|6130961|P1|Overall Study|Withdrawal by Subject|3
1759712|NCT00805389|6130957|P5|Overall Study|Protocol Violation|0
1759713|NCT00805389|6130958|P4|Overall Study|Protocol Violation|0
1759714|NCT00805389|6130959|P3|Overall Study|Protocol Violation|1
1759715|NCT00805389|6130960|P2|Overall Study|Protocol Violation|0
1759716|NCT00805389|6130961|P1|Overall Study|Protocol Violation|0
1759717|NCT00805389|6130957|P5|Overall Study|Lost to Follow-up|9
1759718|NCT00805389|6130958|P4|Overall Study|Lost to Follow-up|10
1759719|NCT00805389|6130959|P3|Overall Study|Lost to Follow-up|6
1759720|NCT00805389|6130960|P2|Overall Study|Lost to Follow-up|3
1759721|NCT00805389|6130961|P1|Overall Study|Lost to Follow-up|4
1759722|NCT00805389|6130957|P5|Overall Study|Adverse Event|0
1759723|NCT00805389|6130958|P4|Overall Study|Adverse Event|2
1759724|NCT00805389|6130959|P3|Overall Study|Adverse Event|1
1759725|NCT00805389|6130960|P2|Overall Study|Adverse Event|0
1759726|NCT00805389|6130961|P1|Overall Study|Adverse Event|0
1759727|NCT00805285|6131208|P1|Overall Study|Lack of Efficacy|1
1759728|NCT00805207|6131225|P9|Overall Study|Withdrawal by Subject|0
1759729|NCT00805207|6131226|P8|Overall Study|Withdrawal by Subject|0
1759730|NCT00805207|6131227|P7|Overall Study|Withdrawal by Subject|0
1759731|NCT00805207|6131228|P6|Overall Study|Withdrawal by Subject|2
1759732|NCT00805207|6131229|P5|Overall Study|Withdrawal by Subject|1
1759733|NCT00805207|6131230|P4|Overall Study|Withdrawal by Subject|0
1759734|NCT00805207|6131231|P3|Overall Study|Withdrawal by Subject|0
1759735|NCT00805207|6131232|P2|Overall Study|Withdrawal by Subject|1
1759736|NCT00805207|6131233|P1|Overall Study|Withdrawal by Subject|0
1759737|NCT00805207|6131225|P9|Overall Study|Physician Decision|0
1759738|NCT00805207|6131226|P8|Overall Study|Physician Decision|0
1759739|NCT00805207|6131227|P7|Overall Study|Physician Decision|0
1759740|NCT00805207|6131228|P6|Overall Study|Physician Decision|1
1759741|NCT00805207|6131229|P5|Overall Study|Physician Decision|0
1759742|NCT00805207|6131230|P4|Overall Study|Physician Decision|0
1759743|NCT00805207|6131231|P3|Overall Study|Physician Decision|0
1759744|NCT00805207|6131232|P2|Overall Study|Physician Decision|1
1759745|NCT00805207|6131233|P1|Overall Study|Physician Decision|0
1759746|NCT00805207|6131225|P9|Overall Study|Protocol Violation|0
1759747|NCT00805207|6131226|P8|Overall Study|Protocol Violation|0
1759748|NCT00805207|6131227|P7|Overall Study|Protocol Violation|0
1759749|NCT00805207|6131228|P6|Overall Study|Protocol Violation|0
1759750|NCT00805207|6131229|P5|Overall Study|Protocol Violation|0
1759751|NCT00805207|6131230|P4|Overall Study|Protocol Violation|0
1759752|NCT00805207|6131231|P3|Overall Study|Protocol Violation|1
1759753|NCT00805207|6131232|P2|Overall Study|Protocol Violation|0
1759754|NCT00805207|6131233|P1|Overall Study|Protocol Violation|0
1759755|NCT00805194|6131291|P2|Overall Study|Reasons other than stated above|16
1759756|NCT00805194|6131292|P1|Overall Study|Reasons other than stated above|20
1759757|NCT00805194|6131291|P2|Overall Study|Not treated|4
1759758|NCT00805194|6131292|P1|Overall Study|Not treated|3
1759759|NCT00805194|6131291|P2|Overall Study|Withdrawal by Subject|42
1759760|NCT00805194|6131292|P1|Overall Study|Withdrawal by Subject|60
1759761|NCT00805194|6131291|P2|Overall Study|Lost to Follow-up|5
1759762|NCT00805194|6131292|P1|Overall Study|Lost to Follow-up|5
1759763|NCT00805194|6131291|P2|Overall Study|Protocol Violation|9
1759764|NCT00805194|6131292|P1|Overall Study|Protocol Violation|9
1759765|NCT00805194|6131291|P2|Overall Study|Other AE|73
1759766|NCT00805194|6131292|P1|Overall Study|Other AE|84
1759767|NCT00805194|6131291|P2|Overall Study|Worsening or AE of underlying disease|70
1759768|NCT00805194|6131292|P1|Overall Study|Worsening or AE of underlying disease|64
1759769|NCT00805194|6131291|P2|Overall Study|Progressive disease (modified RECIST)|435
1759770|NCT00805194|6131292|P1|Overall Study|Progressive disease (modified RECIST)|404
1759771|NCT00805142|6131326|P2|Maintenance Period|Other|1
1759772|NCT00805142|6131327|P1|Maintenance Period|Other|0
1759773|NCT00805142|6131326|P2|Maintenance Period|Adverse Event|1
1759774|NCT00805142|6131327|P1|Maintenance Period|Adverse Event|0
1759775|NCT00805142|6131326|P2|Titration Period|Other|3
1759776|NCT00805142|6131327|P1|Titration Period|Other|0
1759777|NCT00805142|6131326|P2|Titration Period|Withdrawal of consent|1
1759778|NCT00805142|6131327|P1|Titration Period|Withdrawal of consent|0
1759779|NCT00805142|6131326|P2|Titration Period|Disease Progression|1
1759780|NCT00805142|6131327|P1|Titration Period|Disease Progression|2
1759781|NCT00805142|6131326|P2|Titration Period|Lost to Follow-up|1
1759782|NCT00805142|6131327|P1|Titration Period|Lost to Follow-up|0
1759783|NCT00805142|6131326|P2|Titration Period|Lack of Efficacy|1
1759784|NCT00805142|6131327|P1|Titration Period|Lack of Efficacy|1
1759785|NCT00805142|6131326|P2|Titration Period|Adverse Event|3
1759786|NCT00805142|6131327|P1|Titration Period|Adverse Event|3
1759787|NCT00805025|6131360|P1|Overall Study|Physician Decision|1
1759788|NCT00805025|6131360|P1|Overall Study|Withdrawal by Subject|2
1759789|NCT00805025|6131360|P1|Overall Study|Adverse Event|4
1759790|NCT00805025|6131360|P1|Overall Study|Screened but not enrolled/treated|42
1759791|NCT00804986|6131389|P6|Overall Study|Physician Decision|0
1759792|NCT00804986|6131390|P5|Overall Study|Physician Decision|0
1759793|NCT00804986|6131391|P4|Overall Study|Physician Decision|0
1759794|NCT00804986|6131392|P3|Overall Study|Physician Decision|0
1759795|NCT00804986|6131393|P2|Overall Study|Physician Decision|0
1759796|NCT00804986|6131394|P1|Overall Study|Physician Decision|1
1759797|NCT00804986|6131389|P6|Overall Study|Sponsor Decision|0
1759798|NCT00804986|6131390|P5|Overall Study|Sponsor Decision|0
1759799|NCT00804986|6131391|P4|Overall Study|Sponsor Decision|0
1759800|NCT00804986|6131392|P3|Overall Study|Sponsor Decision|0
1759801|NCT00804986|6131393|P2|Overall Study|Sponsor Decision|1
1759802|NCT00804986|6131394|P1|Overall Study|Sponsor Decision|0
1759803|NCT00804986|6131389|P6|Overall Study|Inclusion/Exclusion criteria not met|1
1759804|NCT00804986|6131390|P5|Overall Study|Inclusion/Exclusion criteria not met|0
1759805|NCT00804986|6131391|P4|Overall Study|Inclusion/Exclusion criteria not met|1
1759806|NCT00804986|6131392|P3|Overall Study|Inclusion/Exclusion criteria not met|0
1759807|NCT00804986|6131393|P2|Overall Study|Inclusion/Exclusion criteria not met|2
1759808|NCT00804986|6131394|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1759809|NCT00804986|6131389|P6|Overall Study|Withdrawal by Subject|3
1759810|NCT00804986|6131390|P5|Overall Study|Withdrawal by Subject|5
1759811|NCT00804986|6131391|P4|Overall Study|Withdrawal by Subject|3
1759812|NCT00804986|6131392|P3|Overall Study|Withdrawal by Subject|0
1759813|NCT00804986|6131393|P2|Overall Study|Withdrawal by Subject|3
1759814|NCT00804986|6131394|P1|Overall Study|Withdrawal by Subject|0
1759815|NCT00804986|6131389|P6|Overall Study|Protocol Violation|0
1759816|NCT00804986|6131390|P5|Overall Study|Protocol Violation|0
1759817|NCT00804986|6131391|P4|Overall Study|Protocol Violation|1
1759818|NCT00804986|6131392|P3|Overall Study|Protocol Violation|0
1759819|NCT00804986|6131393|P2|Overall Study|Protocol Violation|1
1759820|NCT00804986|6131394|P1|Overall Study|Protocol Violation|0
1759821|NCT00804986|6131389|P6|Overall Study|Lost to Follow-up|3
1759822|NCT00804986|6131390|P5|Overall Study|Lost to Follow-up|1
1759823|NCT00804986|6131391|P4|Overall Study|Lost to Follow-up|1
1759824|NCT00804986|6131392|P3|Overall Study|Lost to Follow-up|0
1759825|NCT00804986|6131393|P2|Overall Study|Lost to Follow-up|0
1759826|NCT00804986|6131394|P1|Overall Study|Lost to Follow-up|0
1759827|NCT00804986|6131389|P6|Overall Study|Lack of Efficacy|3
1759828|NCT00804986|6131390|P5|Overall Study|Lack of Efficacy|0
1759829|NCT00804986|6131391|P4|Overall Study|Lack of Efficacy|1
1759830|NCT00804986|6131392|P3|Overall Study|Lack of Efficacy|0
1759831|NCT00804986|6131393|P2|Overall Study|Lack of Efficacy|0
1759832|NCT00804986|6131394|P1|Overall Study|Lack of Efficacy|0
1759833|NCT00804986|6131389|P6|Overall Study|Adverse Event|0
1759834|NCT00804986|6131390|P5|Overall Study|Adverse Event|3
1759835|NCT00804986|6131391|P4|Overall Study|Adverse Event|1
1759836|NCT00804986|6131392|P3|Overall Study|Adverse Event|2
1759837|NCT00804986|6131393|P2|Overall Study|Adverse Event|1
1759838|NCT00804986|6131394|P1|Overall Study|Adverse Event|0
1759839|NCT00804908|6131489|P3|Overall Study|Other|114
1759840|NCT00804908|6131490|P2|Overall Study|Other|116
1759841|NCT00804908|6131491|P1|Overall Study|Other|115
1759842|NCT00804843|6131522|P2|Overall Study|Withdrawal by Subject|2
1759843|NCT00804843|6131523|P1|Overall Study|Withdrawal by Subject|1
1759844|NCT00804843|6131522|P2|Overall Study|Adverse Event|5
1759845|NCT00804843|6131523|P1|Overall Study|Adverse Event|8
1759846|NCT00804843|6131522|P2|Overall Study|Protocol Violation|0
1759847|NCT00804843|6131523|P1|Overall Study|Protocol Violation|1
1759848|NCT00804687|6131541|P6|Period 5: Treatment Period|Positive drug test|0
1759849|NCT00804687|6131542|P5|Period 5: Treatment Period|Positive drug test|0
1759850|NCT00804687|6131543|P4|Period 5: Treatment Period|Positive drug test|0
1759851|NCT00804687|6131544|P3|Period 5: Treatment Period|Positive drug test|0
1759852|NCT00804687|6131545|P2|Period 5: Treatment Period|Positive drug test|0
1759853|NCT00804687|6131546|P1|Period 5: Treatment Period|Positive drug test|1
1759854|NCT00804687|6131541|P6|Period 5: Treatment Period|Positive drugs of abuse|0
1759855|NCT00804687|6131542|P5|Period 5: Treatment Period|Positive drugs of abuse|0
1759856|NCT00804687|6131543|P4|Period 5: Treatment Period|Positive drugs of abuse|0
1759857|NCT00804687|6131544|P3|Period 5: Treatment Period|Positive drugs of abuse|1
1759858|NCT00804687|6131545|P2|Period 5: Treatment Period|Positive drugs of abuse|0
1759859|NCT00804687|6131546|P1|Period 5: Treatment Period|Positive drugs of abuse|0
1759860|NCT00804687|6131541|P6|Period 5: Treatment Period|Withdrawal by Subject|0
1759861|NCT00804687|6131542|P5|Period 5: Treatment Period|Withdrawal by Subject|1
1759862|NCT00804687|6131543|P4|Period 5: Treatment Period|Withdrawal by Subject|0
1759863|NCT00804687|6131544|P3|Period 5: Treatment Period|Withdrawal by Subject|0
1759864|NCT00804687|6131545|P2|Period 5: Treatment Period|Withdrawal by Subject|0
1759865|NCT00804687|6131546|P1|Period 5: Treatment Period|Withdrawal by Subject|0
1759866|NCT00804687|6131541|P6|Period 3: Treatment Period|Positive Drug screen|0
1759867|NCT00804687|6131542|P5|Period 3: Treatment Period|Positive Drug screen|0
1759868|NCT00804687|6131543|P4|Period 3: Treatment Period|Positive Drug screen|1
1759869|NCT00804687|6131544|P3|Period 3: Treatment Period|Positive Drug screen|0
1759870|NCT00804687|6131545|P2|Period 3: Treatment Period|Positive Drug screen|0
1759871|NCT00804687|6131546|P1|Period 3: Treatment Period|Positive Drug screen|0
1759872|NCT00804570|6131625|P2|Overall Study|Withdrawal by Subject|38
1759873|NCT00804570|6131626|P1|Overall Study|Withdrawal by Subject|21
1759874|NCT00804570|6131625|P2|Overall Study|Sponsor decision|4
1759875|NCT00804570|6131626|P1|Overall Study|Sponsor decision|1
1759876|NCT00804570|6131625|P2|Overall Study|Physician Decision|2
1759877|NCT00804570|6131626|P1|Overall Study|Physician Decision|1
1759878|NCT00804570|6131625|P2|Overall Study|Protocol Violation|16
1759879|NCT00804570|6131626|P1|Overall Study|Protocol Violation|12
1759880|NCT00804570|6131625|P2|Overall Study|Entry criteria not met|5
1759881|NCT00804570|6131626|P1|Overall Study|Entry criteria not met|5
1759882|NCT00804570|6131625|P2|Overall Study|Lost to Follow-up|21
1759883|NCT00804570|6131626|P1|Overall Study|Lost to Follow-up|18
1759884|NCT00804570|6131625|P2|Overall Study|Lack of Efficacy|1
1759885|NCT00804570|6131626|P1|Overall Study|Lack of Efficacy|0
1759886|NCT00804570|6131625|P2|Overall Study|Adverse Event|7
1759887|NCT00804570|6131626|P1|Overall Study|Adverse Event|14
1759888|NCT00804193|6131685|P3|Overall Study|Withdrawal by Subject|2
1759889|NCT00804193|6131686|P2|Overall Study|Withdrawal by Subject|1
1759890|NCT00804193|6131687|P1|Overall Study|Withdrawal by Subject|3
1759891|NCT00804193|6131685|P3|Overall Study|Lost to Follow-up|4
1759892|NCT00804193|6131686|P2|Overall Study|Lost to Follow-up|3
1759893|NCT00804193|6131687|P1|Overall Study|Lost to Follow-up|3
1759894|NCT00804193|6131685|P3|Overall Study|Protocol Violation|2
1759895|NCT00804193|6131686|P2|Overall Study|Protocol Violation|8
1759896|NCT00804193|6131687|P1|Overall Study|Protocol Violation|0
1759897|NCT00804193|6131685|P3|Overall Study|Lack of Efficacy|3
1759898|NCT00804193|6131686|P2|Overall Study|Lack of Efficacy|1
1759899|NCT00804193|6131687|P1|Overall Study|Lack of Efficacy|1
1759900|NCT00804193|6131685|P3|Overall Study|Adverse Event|2
1759901|NCT00804193|6131686|P2|Overall Study|Adverse Event|0
1759902|NCT00804193|6131687|P1|Overall Study|Adverse Event|0
1759903|NCT00804193|6131685|P3|Overall Study|Lack of baseline fungus|19
1759904|NCT00804193|6131686|P2|Overall Study|Lack of baseline fungus|31
1759905|NCT00804193|6131687|P1|Overall Study|Lack of baseline fungus|32
1759906|NCT00804141|6131701|P1|Overall Study|Enrolled but not treated|6
1759907|NCT00804141|6131701|P1|Overall Study|Other than specified|30
1759908|NCT00804141|6131701|P1|Overall Study|Lack of Efficacy|46
1759909|NCT00804141|6131701|P1|Overall Study|Withdrawal by Subject|131
1759910|NCT00804141|6131701|P1|Overall Study|Protocol Violation|85
1759911|NCT00804141|6131701|P1|Overall Study|Investigator request|8
1759912|NCT00804141|6131701|P1|Overall Study|Failed to return|96
1759913|NCT00804141|6131701|P1|Overall Study|Death|4
1759914|NCT00804141|6131701|P1|Overall Study|Adverse Event|157
1759915|NCT00803790|6131741|P4|Period 2|Positive Drug Screen or Personal Reasons|0
1759916|NCT00803790|6131742|P3|Period 2|Positive Drug Screen or Personal Reasons|0
1759917|NCT00803790|6131743|P2|Period 2|Positive Drug Screen or Personal Reasons|0
1759918|NCT00803790|6131744|P1|Period 2|Positive Drug Screen or Personal Reasons|1
1759919|NCT00803790|6131741|P4|Period 2|Withdrawal by Subject|0
1759920|NCT00803790|6131742|P3|Period 2|Withdrawal by Subject|0
1759921|NCT00803790|6131743|P2|Period 2|Withdrawal by Subject|0
1759922|NCT00803790|6131744|P1|Period 2|Withdrawal by Subject|1
1759923|NCT00803790|6131741|P4|Period 2|Adverse Event|1
1759924|NCT00803790|6131742|P3|Period 2|Adverse Event|1
1759925|NCT00803790|6131743|P2|Period 2|Adverse Event|0
1759926|NCT00803790|6131744|P1|Period 2|Adverse Event|0
1759927|NCT00803790|6131741|P4|Period 1|Protocol Violation|0
1759928|NCT00803790|6131742|P3|Period 1|Protocol Violation|1
1759929|NCT00803790|6131743|P2|Period 1|Protocol Violation|0
1759930|NCT00803790|6131744|P1|Period 1|Protocol Violation|0
1759931|NCT00803790|6131741|P4|Period 1|positive drug screen or personal reasons|4
1759932|NCT00803790|6131742|P3|Period 1|positive drug screen or personal reasons|0
1759933|NCT00803790|6131743|P2|Period 1|positive drug screen or personal reasons|3
1759934|NCT00803790|6131744|P1|Period 1|positive drug screen or personal reasons|0
1759935|NCT00803790|6131741|P4|Period 1|Withdrawal by Subject|0
1759936|NCT00803790|6131742|P3|Period 1|Withdrawal by Subject|0
1759937|NCT00803790|6131743|P2|Period 1|Withdrawal by Subject|6
1759938|NCT00803790|6131744|P1|Period 1|Withdrawal by Subject|8
1759939|NCT00803790|6131741|P4|Period 1|Lost to Follow-up|0
1759940|NCT00803790|6131742|P3|Period 1|Lost to Follow-up|0
1759941|NCT00803790|6131743|P2|Period 1|Lost to Follow-up|2
1759942|NCT00803790|6131744|P1|Period 1|Lost to Follow-up|1
1759943|NCT00803790|6131741|P4|Period 1|Adverse Event|0
1759944|NCT00803790|6131742|P3|Period 1|Adverse Event|0
1759945|NCT00803790|6131743|P2|Period 1|Adverse Event|1
1759946|NCT00803790|6131744|P1|Period 1|Adverse Event|0
1759947|NCT00803738|6131784|P2|Overall Study|Positive Results for STD or abnormal PAP|8
1759948|NCT00803738|6131785|P1|Overall Study|Positive Results for STD or abnormal PAP|2
1759949|NCT00803738|6131784|P2|Overall Study|Negative Baseline Culture of Candida|63
1759950|NCT00803738|6131785|P1|Overall Study|Negative Baseline Culture of Candida|56
1759951|NCT00803738|6131784|P2|Overall Study|Lack of Efficacy|16
1759952|NCT00803738|6131785|P1|Overall Study|Lack of Efficacy|10
1759953|NCT00803738|6131784|P2|Overall Study|Withdrawal by Subject|4
1759954|NCT00803738|6131785|P1|Overall Study|Withdrawal by Subject|1
1759955|NCT00803738|6131784|P2|Overall Study|Protocol Violation|10
1759956|NCT00803738|6131785|P1|Overall Study|Protocol Violation|18
1759957|NCT00803738|6131784|P2|Overall Study|Lost to Follow-up|4
1759958|NCT00803738|6131785|P1|Overall Study|Lost to Follow-up|4
1759959|NCT00803738|6131784|P2|Overall Study|Adverse Event|5
1759960|NCT00803738|6131785|P1|Overall Study|Adverse Event|3
1759961|NCT00803712|6131797|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
1759962|NCT00803712|6131798|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
1759963|NCT00803712|6131797|P2|Overall Study|Administrative decision|3
1759964|NCT00803712|6131798|P1|Overall Study|Administrative decision|2
1759965|NCT00803712|6131797|P2|Overall Study|Protocol criteria (renal transplant)|8
1759966|NCT00803712|6131798|P1|Overall Study|Protocol criteria (renal transplant)|12
1759967|NCT00803712|6131797|P2|Overall Study|Protocol criteria (other)|2
1759968|NCT00803712|6131798|P1|Overall Study|Protocol criteria (other)|0
1759969|NCT00803712|6131797|P2|Overall Study|"Other in electronic Case Report Form"|1
1759970|NCT00803712|6131798|P1|Overall Study|"Other in electronic Case Report Form"|0
1759971|NCT00803712|6131797|P2|Overall Study|Withdrawal by Subject|4
1759972|NCT00803712|6131798|P1|Overall Study|Withdrawal by Subject|2
1759973|NCT00803712|6131797|P2|Overall Study|Lost to Follow-up|1
1759974|NCT00803712|6131798|P1|Overall Study|Lost to Follow-up|3
1759975|NCT00803712|6131797|P2|Overall Study|Death|7
1759976|NCT00803712|6131798|P1|Overall Study|Death|8
1759977|NCT00803712|6131797|P2|Overall Study|Adverse Event|0
1759978|NCT00803712|6131798|P1|Overall Study|Adverse Event|5
1759979|NCT00803712|6131797|P2|Overall Study|Noncompliance|0
1759980|NCT00803712|6131798|P1|Overall Study|Noncompliance|3
1759981|NCT00803634|6131897|P2|Overall Study|Death|2
1759982|NCT00803634|6131898|P1|Overall Study|Death|3
1759983|NCT00803634|6131897|P2|Overall Study|Lost to Follow-up|3
1759984|NCT00803634|6131898|P1|Overall Study|Lost to Follow-up|2
1759985|NCT00803634|6131897|P2|Overall Study|Withdrew Consent|0
1759986|NCT00803634|6131898|P1|Overall Study|Withdrew Consent|1
1759987|NCT00803595|6131927|P3|Overall Study|Withdrawal by Subject|3
1759988|NCT00803595|6131928|P2|Overall Study|Withdrawal by Subject|2
1759989|NCT00803595|6131929|P1|Overall Study|Withdrawal by Subject|5
1759990|NCT00803595|6131927|P3|Overall Study|Protocol Violation|12
1759991|NCT00803595|6131928|P2|Overall Study|Protocol Violation|2
1759992|NCT00803595|6131929|P1|Overall Study|Protocol Violation|7
1759993|NCT00803595|6131927|P3|Overall Study|Adverse Event|1
1759994|NCT00803595|6131928|P2|Overall Study|Adverse Event|4
1759995|NCT00803595|6131929|P1|Overall Study|Adverse Event|3
1759996|NCT00803569|6131940|P1|Overall Study|Noncompliance|1
1759997|NCT00803569|6131940|P1|Overall Study|Progressive Disease|3
1759998|NCT00803452|6131974|P2|Overall Study|Lost to Follow-up|3
1759999|NCT00803452|6131975|P1|Overall Study|Lost to Follow-up|0
1760000|NCT00803452|6131974|P2|Overall Study|Adverse Event|2
1760001|NCT00803452|6131975|P1|Overall Study|Adverse Event|0
1760002|NCT00803361|6132013|P2|Overall Study|Withdrawal by Subject|6
1760003|NCT00803361|6132014|P1|Overall Study|Withdrawal by Subject|5
1760004|NCT00803361|6132013|P2|Overall Study|Protocol Violation|4
1760005|NCT00803361|6132014|P1|Overall Study|Protocol Violation|2
1760006|NCT00803361|6132013|P2|Overall Study|Physician Decision|0
1760007|NCT00803361|6132014|P1|Overall Study|Physician Decision|1
1760008|NCT00803361|6132013|P2|Overall Study|Lost to Follow-up|2
1760009|NCT00803361|6132014|P1|Overall Study|Lost to Follow-up|1
1760010|NCT00803361|6132013|P2|Overall Study|Lack of Efficacy|13
1760011|NCT00803361|6132014|P1|Overall Study|Lack of Efficacy|4
1760012|NCT00803361|6132013|P2|Overall Study|Adverse Event|3
1760013|NCT00803361|6132014|P1|Overall Study|Adverse Event|13
1760014|NCT00803270|6132061|P2|Overall Study|Lost to Follow-up|2
1760015|NCT00803270|6132062|P1|Overall Study|Lost to Follow-up|1
1760016|NCT00803244|6132072|P2|Overall Study|Any other reason not above-mentioned|10
1760017|NCT00803244|6132073|P1|Overall Study|Any other reason not above-mentioned|4
1760018|NCT00803244|6132072|P2|Overall Study|Withdrawal by Subject|3
1760019|NCT00803244|6132073|P1|Overall Study|Withdrawal by Subject|2
1760020|NCT00803244|6132072|P2|Overall Study|Adverse Event|2
1760021|NCT00803244|6132073|P1|Overall Study|Adverse Event|1
1760022|NCT00803179|6132081|P1|Overall Study|Lost to Follow-up|3
1760023|NCT00803101|6132100|P2|Overall Study|Patient did not have surgery|1
1760024|NCT00803101|6132101|P1|Overall Study|Patient did not have surgery|1
1760025|NCT00803101|6132100|P2|Overall Study|Patient did not attend scheduled visit|1
1760026|NCT00803101|6132101|P1|Overall Study|Patient did not attend scheduled visit|2
1760027|NCT00803101|6132100|P2|Overall Study|Patient died outside SAE report period|0
1760028|NCT00803101|6132101|P1|Overall Study|Patient died outside SAE report period|1
1760029|NCT00803101|6132100|P2|Overall Study|Surgery finished outside protocol window|1
1760030|NCT00803101|6132101|P1|Overall Study|Surgery finished outside protocol window|1
1760031|NCT00803101|6132100|P2|Overall Study|Protocol Violation|7
1760032|NCT00803101|6132101|P1|Overall Study|Protocol Violation|1
1760033|NCT00803101|6132100|P2|Overall Study|Lost to Follow-up|2
1760034|NCT00803101|6132101|P1|Overall Study|Lost to Follow-up|2
1760035|NCT00803101|6132100|P2|Overall Study|Withdrawal by Subject|4
1760036|NCT00803101|6132101|P1|Overall Study|Withdrawal by Subject|6
1760037|NCT00803101|6132100|P2|Overall Study|Death / Serious Adverse Event|6
1760038|NCT00803101|6132101|P1|Overall Study|Death / Serious Adverse Event|4
1760039|NCT00803049|6132152|P4|Overall Study|Other than Specified Above|5
1760040|NCT00803049|6132153|P3|Overall Study|Other than Specified Above|2
1760041|NCT00803049|6132154|P2|Overall Study|Other than Specified Above|9
1760042|NCT00803049|6132155|P1|Overall Study|Other than Specified Above|3
1760043|NCT00803049|6132152|P4|Overall Study|Randomized and Not Treated|2
1760044|NCT00803049|6132153|P3|Overall Study|Randomized and Not Treated|0
1760045|NCT00803049|6132154|P2|Overall Study|Randomized and Not Treated|0
1760046|NCT00803049|6132155|P1|Overall Study|Randomized and Not Treated|0
1760047|NCT00803049|6132152|P4|Overall Study|Protocol Violation|0
1760048|NCT00803049|6132153|P3|Overall Study|Protocol Violation|1
1760049|NCT00803049|6132154|P2|Overall Study|Protocol Violation|1
1760050|NCT00803049|6132155|P1|Overall Study|Protocol Violation|0
1760051|NCT00803049|6132152|P4|Overall Study|Withdrawal by Subject|44
1760052|NCT00803049|6132153|P3|Overall Study|Withdrawal by Subject|16
1760053|NCT00803049|6132154|P2|Overall Study|Withdrawal by Subject|43
1760054|NCT00803049|6132155|P1|Overall Study|Withdrawal by Subject|19
1760055|NCT00803049|6132152|P4|Overall Study|Progressive Disease|6
1760056|NCT00803049|6132153|P3|Overall Study|Progressive Disease|6
1760057|NCT00803049|6132154|P2|Overall Study|Progressive Disease|10
1760058|NCT00803049|6132155|P1|Overall Study|Progressive Disease|6
1760059|NCT00803049|6132152|P4|Overall Study|Death|2
1760060|NCT00803049|6132153|P3|Overall Study|Death|0
1760061|NCT00803049|6132154|P2|Overall Study|Death|1
1760062|NCT00803049|6132155|P1|Overall Study|Death|2
1760063|NCT00803049|6132152|P4|Overall Study|Lost to Follow-up|3
1760064|NCT00803049|6132153|P3|Overall Study|Lost to Follow-up|0
1760065|NCT00803049|6132154|P2|Overall Study|Lost to Follow-up|2
1760066|NCT00803049|6132155|P1|Overall Study|Lost to Follow-up|0
1760067|NCT00803049|6132152|P4|Overall Study|Lack of Efficacy|13
1760068|NCT00803049|6132153|P3|Overall Study|Lack of Efficacy|6
1760069|NCT00803049|6132154|P2|Overall Study|Lack of Efficacy|19
1760070|NCT00803049|6132155|P1|Overall Study|Lack of Efficacy|10
1760071|NCT00803049|6132152|P4|Overall Study|Adverse Event|27
1760072|NCT00803049|6132153|P3|Overall Study|Adverse Event|13
1760073|NCT00803049|6132154|P2|Overall Study|Adverse Event|33
1760074|NCT00803049|6132155|P1|Overall Study|Adverse Event|21
1760075|NCT00803023|6132189|P4|Overall Study|Lack of Efficacy|1
1760076|NCT00803023|6132190|P3|Overall Study|Lack of Efficacy|1
1760077|NCT00803023|6132191|P2|Overall Study|Lack of Efficacy|1
1760078|NCT00803023|6132192|P1|Overall Study|Lack of Efficacy|0
1760079|NCT00803023|6132189|P4|Overall Study|Lost to Follow-up|1
1760080|NCT00803023|6132190|P3|Overall Study|Lost to Follow-up|2
1760081|NCT00803023|6132191|P2|Overall Study|Lost to Follow-up|1
1760082|NCT00803023|6132192|P1|Overall Study|Lost to Follow-up|0
1760083|NCT00803023|6132189|P4|Overall Study|Withdrawal by Subject|0
1760084|NCT00803023|6132190|P3|Overall Study|Withdrawal by Subject|0
1760085|NCT00803023|6132191|P2|Overall Study|Withdrawal by Subject|2
1760086|NCT00803023|6132192|P1|Overall Study|Withdrawal by Subject|0
1760087|NCT00803023|6132189|P4|Overall Study|Adverse Event|6
1760088|NCT00803023|6132190|P3|Overall Study|Adverse Event|8
1760089|NCT00803023|6132191|P2|Overall Study|Adverse Event|4
1760090|NCT00803023|6132192|P1|Overall Study|Adverse Event|5
1760091|NCT00802945|6132230|P2|Overall Study|Terminated by sponsor|12
1760092|NCT00802945|6132231|P1|Overall Study|Terminated by sponsor|8
1760093|NCT00802945|6132230|P2|Overall Study|Death|23
1760094|NCT00802945|6132231|P1|Overall Study|Death|27
1760095|NCT00802893|6132262|P1|Overall Study|study terminated|3
1760096|NCT00802867|6132286|P1|Overall Study|Withdrawal by Subject|1
1760097|NCT00802867|6132286|P1|Overall Study|Protocol Violation|6
1760098|NCT00802867|6132286|P1|Overall Study|Lost to Follow-up|6
1760099|NCT00802841|6132309|P2|Overall Study|Treatment duration completed|76
1760100|NCT00802841|6132310|P1|Overall Study|Treatment duration completed|66
1760101|NCT00802841|6132309|P2|Overall Study|Protocol deviation|6
1760102|NCT00802841|6132310|P1|Overall Study|Protocol deviation|2
1760103|NCT00802841|6132309|P2|Overall Study|Withdrawal by Subject|5
1760104|NCT00802841|6132310|P1|Overall Study|Withdrawal by Subject|9
1760105|NCT00802841|6132309|P2|Overall Study|Disease progression|3
1760106|NCT00802841|6132310|P1|Overall Study|Disease progression|7
1760107|NCT00802841|6132309|P2|Overall Study|Adverse Event|2
1760108|NCT00802841|6132310|P1|Overall Study|Adverse Event|8
1760109|NCT00802841|6132309|P2|Overall Study|Death|2
1760110|NCT00802841|6132310|P1|Overall Study|Death|1
1760111|NCT00802841|6132309|P2|Overall Study|Lost to Follow-up|1
1760112|NCT00802841|6132310|P1|Overall Study|Lost to Follow-up|2
1760113|NCT00802841|6132309|P2|Overall Study|Administrative problems|0
1760114|NCT00802841|6132310|P1|Overall Study|Administrative problems|1
1760115|NCT00802737|6132335|P3|Overall Study|Participant too Unwell|0
1760116|NCT00802737|6132336|P2|Overall Study|Participant too Unwell|2
1760117|NCT00802737|6132337|P1|Overall Study|Participant too Unwell|0
1760118|NCT00802737|6132335|P3|Overall Study|Ongoing CLL-Treatment|0
1760119|NCT00802737|6132336|P2|Overall Study|Ongoing CLL-Treatment|1
1760120|NCT00802737|6132337|P1|Overall Study|Ongoing CLL-Treatment|0
1760121|NCT00802737|6132335|P3|Overall Study|Received Prohibited Therapy|0
1760122|NCT00802737|6132336|P2|Overall Study|Received Prohibited Therapy|0
1760123|NCT00802737|6132337|P1|Overall Study|Received Prohibited Therapy|1
1760124|NCT00802737|6132335|P3|Overall Study|Adverse Event|0
1760125|NCT00802737|6132336|P2|Overall Study|Adverse Event|0
1760126|NCT00802737|6132337|P1|Overall Study|Adverse Event|1
1760127|NCT00802737|6132335|P3|Overall Study|Death|1
1760128|NCT00802737|6132336|P2|Overall Study|Death|5
1760129|NCT00802737|6132337|P1|Overall Study|Death|6
1760130|NCT00802737|6132335|P3|Overall Study|Withdrawn due to Disease Progression|0
1760131|NCT00802737|6132336|P2|Overall Study|Withdrawn due to Disease Progression|3
1760132|NCT00802737|6132337|P1|Overall Study|Withdrawn due to Disease Progression|9
1760133|NCT00802672|6132397|P3|Overall Study|other|2
1760134|NCT00802672|6132398|P2|Overall Study|other|1
1760135|NCT00802672|6132399|P1|Overall Study|other|3
1760136|NCT00802672|6132397|P3|Overall Study|Withdrawal by Subject|2
1760137|NCT00802672|6132398|P2|Overall Study|Withdrawal by Subject|1
1760138|NCT00802672|6132399|P1|Overall Study|Withdrawal by Subject|1
1760139|NCT00802672|6132397|P3|Overall Study|Lost to Follow-up|3
1760140|NCT00802672|6132398|P2|Overall Study|Lost to Follow-up|5
1760141|NCT00802672|6132399|P1|Overall Study|Lost to Follow-up|5
1760142|NCT00802672|6132397|P3|Overall Study|Protocol Violation|1
1760143|NCT00802672|6132398|P2|Overall Study|Protocol Violation|1
1760144|NCT00802672|6132399|P1|Overall Study|Protocol Violation|2
1760145|NCT00802672|6132397|P3|Overall Study|Adverse Event|1
1760146|NCT00802672|6132398|P2|Overall Study|Adverse Event|1
1760147|NCT00802672|6132399|P1|Overall Study|Adverse Event|1
1760148|NCT00802672|6132397|P3|Overall Study|Lack of fungal pathogen at baseline|25
1760149|NCT00802672|6132398|P2|Overall Study|Lack of fungal pathogen at baseline|43
1760150|NCT00802672|6132399|P1|Overall Study|Lack of fungal pathogen at baseline|56
1760151|NCT00802659|6132417|P4|Overall Study|Physician Decision|0
1760152|NCT00802659|6132418|P3|Overall Study|Physician Decision|0
1760153|NCT00802659|6132419|P2|Overall Study|Physician Decision|1
1760154|NCT00802659|6132420|P1|Overall Study|Physician Decision|0
1760155|NCT00802529|6132459|P2|Overall Study|Lost to Follow-up|1
1760156|NCT00802529|6132460|P1|Overall Study|Lost to Follow-up|0
1760157|NCT00802464|6132499|P4|Month 8 - Month 14|Lost to Follow-up|0
1760158|NCT00802464|6132500|P3|Month 8 - Month 14|Lost to Follow-up|1
1760159|NCT00802464|6132501|P2|Month 8 - Month 14|Lost to Follow-up|0
1760160|NCT00802464|6132502|P1|Month 8 - Month 14|Lost to Follow-up|0
1760161|NCT00802464|6132499|P4|Month 8 - Month 14|Withdrawal by Subject|0
1760162|NCT00802464|6132500|P3|Month 8 - Month 14|Withdrawal by Subject|0
1760163|NCT00802464|6132501|P2|Month 8 - Month 14|Withdrawal by Subject|1
1760164|NCT00802464|6132502|P1|Month 8 - Month 14|Withdrawal by Subject|1
1760165|NCT00802464|6132499|P4|Month 8 - Month 14|Adverse Event|0
1760166|NCT00802464|6132500|P3|Month 8 - Month 14|Adverse Event|0
1760167|NCT00802464|6132501|P2|Month 8 - Month 14|Adverse Event|1
1760168|NCT00802464|6132502|P1|Month 8 - Month 14|Adverse Event|0
1760169|NCT00802464|6132499|P4|Month 0 - Month 8|Other|0
1760170|NCT00802464|6132500|P3|Month 0 - Month 8|Other|1
1760171|NCT00802464|6132501|P2|Month 0 - Month 8|Other|0
1760172|NCT00802464|6132502|P1|Month 0 - Month 8|Other|0
1760173|NCT00802464|6132499|P4|Month 0 - Month 8|Lost to Follow-up|2
1760174|NCT00802464|6132500|P3|Month 0 - Month 8|Lost to Follow-up|2
1760175|NCT00802464|6132501|P2|Month 0 - Month 8|Lost to Follow-up|1
1760176|NCT00802464|6132502|P1|Month 0 - Month 8|Lost to Follow-up|0
1760177|NCT00802464|6132499|P4|Month 0 - Month 8|Withdrawal by Subject|5
1760178|NCT00802464|6132500|P3|Month 0 - Month 8|Withdrawal by Subject|2
1760179|NCT00802464|6132501|P2|Month 0 - Month 8|Withdrawal by Subject|1
1760180|NCT00802464|6132502|P1|Month 0 - Month 8|Withdrawal by Subject|0
1760181|NCT00802464|6132499|P4|Month 0 - Month 8|Protocol Violation|0
1760182|NCT00802464|6132500|P3|Month 0 - Month 8|Protocol Violation|1
1760183|NCT00802464|6132501|P2|Month 0 - Month 8|Protocol Violation|0
1760184|NCT00802464|6132502|P1|Month 0 - Month 8|Protocol Violation|0
1760185|NCT00802464|6132499|P4|Month 0 - Month 8|Adverse Event|2
1760186|NCT00802464|6132500|P3|Month 0 - Month 8|Adverse Event|1
1760187|NCT00802464|6132501|P2|Month 0 - Month 8|Adverse Event|1
1760188|NCT00802464|6132502|P1|Month 0 - Month 8|Adverse Event|0
1760189|NCT00802438|6132588|P1|Overall Study|Physician Decision|1
1760190|NCT00802438|6132588|P1|Overall Study|Withdrawal by Subject|7
1760191|NCT00802438|6132588|P1|Overall Study|Screen Failure|20
1760192|NCT00802360|6132608|P4|Overall Study|Other|3
1760193|NCT00802360|6132609|P3|Overall Study|Other|6
1760194|NCT00802360|6132610|P2|Overall Study|Other|3
1760195|NCT00802360|6132611|P1|Overall Study|Other|2
1760196|NCT00802360|6132608|P4|Overall Study|Pregnancy loss/miscarriage|3
1760197|NCT00802360|6132609|P3|Overall Study|Pregnancy loss/miscarriage|0
1760198|NCT00802360|6132610|P2|Overall Study|Pregnancy loss/miscarriage|2
1760199|NCT00802360|6132611|P1|Overall Study|Pregnancy loss/miscarriage|0
1760200|NCT00802360|6132608|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
1760201|NCT00802360|6132609|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
1760202|NCT00802360|6132610|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
1760203|NCT00802360|6132611|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
1760204|NCT00802360|6132608|P4|Overall Study|No positive serum pregnancy|10
1760205|NCT00802360|6132609|P3|Overall Study|No positive serum pregnancy|14
1760206|NCT00802360|6132610|P2|Overall Study|No positive serum pregnancy|20
1760207|NCT00802360|6132611|P1|Overall Study|No positive serum pregnancy|17
1760208|NCT00802360|6132608|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
1760209|NCT00802360|6132609|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1760210|NCT00802360|6132610|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1760211|NCT00802360|6132611|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
1760212|NCT00802360|6132608|P4|Overall Study|Cycle cancelled|1
1760213|NCT00802360|6132609|P3|Overall Study|Cycle cancelled|1
1760214|NCT00802360|6132610|P2|Overall Study|Cycle cancelled|1
1760215|NCT00802360|6132611|P1|Overall Study|Cycle cancelled|0
1760216|NCT00802360|6132608|P4|Overall Study|Inadequate number of oocytes retrieved|1
1760217|NCT00802360|6132609|P3|Overall Study|Inadequate number of oocytes retrieved|0
1760218|NCT00802360|6132610|P2|Overall Study|Inadequate number of oocytes retrieved|0
1760219|NCT00802360|6132611|P1|Overall Study|Inadequate number of oocytes retrieved|0
1760220|NCT00802360|6132608|P4|Overall Study|Stimulation failure|3
1760221|NCT00802360|6132609|P3|Overall Study|Stimulation failure|3
1760222|NCT00802360|6132610|P2|Overall Study|Stimulation failure|0
1760223|NCT00802360|6132611|P1|Overall Study|Stimulation failure|4
1760224|NCT00802178|6132678|P1|Overall Study|Patients wish and other reason|1
1760225|NCT00802178|6132678|P1|Overall Study|IT and patient wish|8
1760226|NCT00802178|6132678|P1|Overall Study|Lack of efficacy and patient wish|1
1760227|NCT00802178|6132678|P1|Overall Study|Other|32
1760228|NCT00802178|6132678|P1|Overall Study|Withdrawal by Subject|18
1760229|NCT00802178|6132678|P1|Overall Study|Insufficient tolerability (IT)|17
1760230|NCT00802178|6132678|P1|Overall Study|Lack of Efficacy|36
1760231|NCT00802074|6132726|P6|Overall Study|Withdrawal by Subject|0
1760232|NCT00802074|6132727|P5|Overall Study|Withdrawal by Subject|0
1760233|NCT00802074|6132728|P4|Overall Study|Withdrawal by Subject|0
1760234|NCT00802074|6132729|P3|Overall Study|Withdrawal by Subject|0
1760235|NCT00802074|6132730|P2|Overall Study|Withdrawal by Subject|0
1760236|NCT00802074|6132731|P1|Overall Study|Withdrawal by Subject|1
1760237|NCT00802074|6132726|P6|Overall Study|Adverse Event|0
1760238|NCT00802074|6132727|P5|Overall Study|Adverse Event|0
1760239|NCT00802074|6132728|P4|Overall Study|Adverse Event|0
1760240|NCT00802074|6132729|P3|Overall Study|Adverse Event|1
1760241|NCT00802074|6132730|P2|Overall Study|Adverse Event|1
1760242|NCT00802074|6132731|P1|Overall Study|Adverse Event|1
1760243|NCT00801983|6132765|P2|Period 2|Withdrawal by Subject|1
1760244|NCT00801983|6132766|P1|Period 2|Withdrawal by Subject|2
1760245|NCT00801983|6132765|P2|Period 1|Withdrawal by Subject|8
1760246|NCT00801983|6132766|P1|Period 1|Withdrawal by Subject|2
1760247|NCT00801983|6132765|P2|Period 1|Lost to Follow-up|0
1760248|NCT00801983|6132766|P1|Period 1|Lost to Follow-up|2
1760249|NCT00801892|6132781|P2|Sham Crossover Period|Lost to Follow-up|2
1760250|NCT00801892|6132782|P1|Sham Crossover Period|Lost to Follow-up|0
1760251|NCT00801892|6132781|P2|Main Study Period|Withdrawal by Subject|1
1760252|NCT00801892|6132782|P1|Main Study Period|Withdrawal by Subject|0
1760253|NCT00801632|6132829|P1|Overall Study|Re-transplant|1
1760254|NCT00801242|6132907|P1|Overall Study|Miscellaneous reasons|20
1760255|NCT00801242|6132907|P1|Overall Study|Lost to Follow-up|1
1760256|NCT00801242|6132907|P1|Overall Study|Physician Decision|3
1760257|NCT00801242|6132907|P1|Overall Study|Protocol Violation|5
1760258|NCT00801242|6132907|P1|Overall Study|Withdrawal by Subject|13
1760259|NCT00801242|6132907|P1|Overall Study|Adverse Event|10
1760260|NCT00801229|6132920|P2|Received Study Drug/Placebo|Adverse Event|1
1760261|NCT00801229|6132921|P1|Received Study Drug/Placebo|Adverse Event|1
1760262|NCT00801229|6132920|P2|Received Study Drug/Placebo|Lost to Follow-up|1
1760263|NCT00801229|6132921|P1|Received Study Drug/Placebo|Lost to Follow-up|0
1760264|NCT00801229|6132920|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
1760265|NCT00801229|6132921|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
1760266|NCT00801229|6132920|P2|Received Study Drug/Placebo|Simulator sickness|1
1760267|NCT00801229|6132921|P1|Received Study Drug/Placebo|Simulator sickness|1
1760268|NCT00801229|6132920|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
1760269|NCT00801229|6132921|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
1760270|NCT00801229|6132920|P2|Received Study Drug/Placebo|Elevated SGOT level|0
1760271|NCT00801229|6132921|P1|Received Study Drug/Placebo|Elevated SGOT level|1
1760272|NCT00801229|6132920|P2|Signed Consent|Found Ineligible|1
1760273|NCT00801229|6132921|P1|Signed Consent|Found Ineligible|1
1760274|NCT00801229|6132920|P2|Signed Consent|Withdrawal by Subject|2
1760275|NCT00801229|6132921|P1|Signed Consent|Withdrawal by Subject|2
1760276|NCT00801099|6132956|P1|Overall Study|Lost to Follow-up|101
1760277|NCT00800982|6132962|P2|Overall Study|Patient moved out of state|0
1760278|NCT00800982|6132963|P1|Overall Study|Patient moved out of state|1
1760279|NCT00800982|6132962|P2|Overall Study|Withdrawal by Subject|1
1760280|NCT00800982|6132963|P1|Overall Study|Withdrawal by Subject|0
1760281|NCT00800982|6132962|P2|Overall Study|Lost to Follow-up|2
1760282|NCT00800982|6132963|P1|Overall Study|Lost to Follow-up|1
1760283|NCT00800735|6132989|P1|Overall Study|Withdrew Consent|3
1760284|NCT00800735|6132989|P1|Overall Study|Violation of Selection Criteria at Entry|7
1760285|NCT00800735|6132989|P1|Overall Study|Insufficient Therapeutic Response|2
1760286|NCT00800735|6132989|P1|Overall Study|Administrative/Other|2
1760287|NCT00800683|6132995|P2|Overall Study|Other|2
1760288|NCT00800683|6132996|P1|Overall Study|Other|1
1760289|NCT00800683|6132995|P2|Overall Study|Lack of Efficacy|1
1760290|NCT00800683|6132996|P1|Overall Study|Lack of Efficacy|1
1760291|NCT00800683|6132995|P2|Overall Study|Withdrawal by Subject|7
1760292|NCT00800683|6132996|P1|Overall Study|Withdrawal by Subject|1
1760293|NCT00800683|6132995|P2|Overall Study|Lost to Follow-up|1
1760294|NCT00800683|6132996|P1|Overall Study|Lost to Follow-up|3
1760295|NCT00800683|6132995|P2|Overall Study|Adverse Event|8
1760296|NCT00800683|6132996|P1|Overall Study|Adverse Event|11
1760297|NCT00800540|6133042|P2|Period 2: 6 Weeks|Adverse Event|1
1760298|NCT00800540|6133043|P1|Period 2: 6 Weeks|Adverse Event|0
1760299|NCT00800540|6133042|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
1760300|NCT00800540|6133043|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
1760301|NCT00800540|6133042|P2|Period One: 6 Weeks|Noncompliance|0
1760302|NCT00800540|6133043|P1|Period One: 6 Weeks|Noncompliance|1
1760303|NCT00800436|6133078|P7|Overall Study|Withdrawal by Subject|0
1760304|NCT00800436|6133079|P6|Overall Study|Withdrawal by Subject|0
1760305|NCT00800436|6133080|P5|Overall Study|Withdrawal by Subject|0
1760306|NCT00800436|6133081|P4|Overall Study|Withdrawal by Subject|1
1760307|NCT00800436|6133082|P3|Overall Study|Withdrawal by Subject|1
1760308|NCT00800436|6133083|P2|Overall Study|Withdrawal by Subject|0
1760309|NCT00800436|6133084|P1|Overall Study|Withdrawal by Subject|0
1760310|NCT00800384|6133130|P2|Overall Study|Lost to Follow-up|26
1760311|NCT00800384|6133131|P1|Overall Study|Lost to Follow-up|17
1760312|NCT00800384|6133130|P2|Overall Study|Withdrawal by Subject|17
1760313|NCT00800384|6133131|P1|Overall Study|Withdrawal by Subject|24
1760314|NCT00800202|6133169|P2|Overall Study|Disease Progression|18
1760315|NCT00800202|6133170|P1|Overall Study|Disease Progression|54
1760316|NCT00800202|6133169|P2|Overall Study|Other|0
1760317|NCT00800202|6133170|P1|Overall Study|Other|5
1760318|NCT00800202|6133169|P2|Overall Study|Death|0
1760319|NCT00800202|6133170|P1|Overall Study|Death|1
1760320|NCT00800202|6133169|P2|Overall Study|Adverse Event|6
1760321|NCT00800202|6133170|P1|Overall Study|Adverse Event|7
1760322|NCT00799903|6133190|P2|Overall Study|Lost to Follow-up|80
1760323|NCT00799903|6133191|P1|Overall Study|Lost to Follow-up|69
1760324|NCT00799903|6133190|P2|Overall Study|Withdrawal by Subject|175
1760325|NCT00799903|6133191|P1|Overall Study|Withdrawal by Subject|179
1760326|NCT00799903|6133190|P2|Overall Study|Investigator Site Closed|23
1760327|NCT00799903|6133191|P1|Overall Study|Investigator Site Closed|25
1760328|NCT00799825|6133211|P1|Overall Study|Pregnancy|3
1760329|NCT00799825|6133211|P1|Overall Study|Lost to Follow-up|38
1760330|NCT00799825|6133211|P1|Overall Study|Withdrawal by Subject|6
1760331|NCT00799825|6133211|P1|Overall Study|Adverse Event|1
1760332|NCT00799708|6133251|P3|Overall Study|non-compliance|0
1760333|NCT00799708|6133252|P2|Overall Study|non-compliance|0
1760334|NCT00799708|6133253|P1|Overall Study|non-compliance|1
1760335|NCT00799617|6133276|P2|Anemia Trial|Withdrawal by Subject|3
1760336|NCT00799617|6133277|P1|Anemia Trial|Withdrawal by Subject|3
1760337|NCT00799617|6133276|P2|Cognitive Function Trial|Lost to Follow-up|1
1760338|NCT00799617|6133277|P1|Cognitive Function Trial|Lost to Follow-up|0
1760339|NCT00799617|6133276|P2|Bone Trial|Month 12 scan not available|16
1760340|NCT00799617|6133277|P1|Bone Trial|Month 12 scan not available|6
1760341|NCT00799617|6133276|P2|Cardiovascular Trial|Baseline scan not analyzable|2
1760342|NCT00799617|6133277|P1|Cardiovascular Trial|Baseline scan not analyzable|0
1760343|NCT00799617|6133276|P2|Cardiovascular Trial|Month 12 scan not available|15
1760344|NCT00799617|6133277|P1|Cardiovascular Trial|Month 12 scan not available|15
1760345|NCT00799617|6133276|P2|Vitality Trial|Lost to Follow-up|22
1760346|NCT00799617|6133277|P1|Vitality Trial|Lost to Follow-up|7
1760347|NCT00799617|6133276|P2|Physical Function Trial|Lost to Follow-up|11
1760348|NCT00799617|6133277|P1|Physical Function Trial|Lost to Follow-up|6
1760349|NCT00799617|6133276|P2|Sexual Funtion Trial|No Baseline Data|7
1760350|NCT00799617|6133277|P1|Sexual Funtion Trial|No Baseline Data|4
1760351|NCT00799617|6133276|P2|Sexual Funtion Trial|Lost to Follow-up|14
1760352|NCT00799617|6133277|P1|Sexual Funtion Trial|Lost to Follow-up|12
1760353|NCT00799617|6133276|P2|Main Testosterone Trial|Lost to Follow-up|20
1760354|NCT00799617|6133277|P1|Main Testosterone Trial|Lost to Follow-up|18
1760355|NCT00799617|6133276|P2|Main Testosterone Trial|Randomized in error|1
1760356|NCT00799617|6133277|P1|Main Testosterone Trial|Randomized in error|1
1760357|NCT00799591|6133384|P1|Overall Study|Infectious origin not probable|1
1760358|NCT00799591|6133384|P1|Overall Study|Antibiotic changed, no apparent reason|1
1760359|NCT00799591|6133384|P1|Overall Study|Persistance of fever undetermined origin|1
1760360|NCT00799591|6133384|P1|Overall Study|Resistance germ and technical failure|2
1760361|NCT00799591|6133384|P1|Overall Study|New infection|4
1760362|NCT00799591|6133384|P1|Overall Study|Resistant germ|11
1760363|NCT00799591|6133384|P1|Overall Study|Technical failure|12
1760364|NCT00799591|6133384|P1|Overall Study|Death|14
1760365|NCT00799591|6133384|P1|Overall Study|De-escalation of doses|20
1760366|NCT00799487|6133402|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
1760367|NCT00799487|6133403|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
1760368|NCT00799487|6133404|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
1760369|NCT00799487|6133402|P3|Double-Blind Assessment Period|Subject was out of the state|1
1760370|NCT00799487|6133403|P2|Double-Blind Assessment Period|Subject was out of the state|0
1760371|NCT00799487|6133404|P1|Double-Blind Assessment Period|Subject was out of the state|0
1760372|NCT00799487|6133402|P3|Double-Blind Assessment Period|Lost to Follow-up|1
1760373|NCT00799487|6133403|P2|Double-Blind Assessment Period|Lost to Follow-up|0
1760374|NCT00799487|6133404|P1|Double-Blind Assessment Period|Lost to Follow-up|0
1760375|NCT00799487|6133402|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
1760376|NCT00799487|6133403|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
1760377|NCT00799487|6133404|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
1760378|NCT00799487|6133402|P3|Dose Adjustment Period|Missed laboratory day 1|0
1760379|NCT00799487|6133403|P2|Dose Adjustment Period|Missed laboratory day 1|0
1760380|NCT00799487|6133404|P1|Dose Adjustment Period|Missed laboratory day 1|1
1760381|NCT00799487|6133402|P3|Dose Adjustment Period|Child too young (exclusion)|0
1760382|NCT00799487|6133403|P2|Dose Adjustment Period|Child too young (exclusion)|0
1760383|NCT00799487|6133404|P1|Dose Adjustment Period|Child too young (exclusion)|1
1760384|NCT00799487|6133402|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
1760385|NCT00799487|6133403|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
1760386|NCT00799487|6133404|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
1760387|NCT00799487|6133402|P3|Dose Adjustment Period|Withdrawal by Subject|0
1760388|NCT00799487|6133403|P2|Dose Adjustment Period|Withdrawal by Subject|0
1760389|NCT00799487|6133404|P1|Dose Adjustment Period|Withdrawal by Subject|3
1760390|NCT00799487|6133402|P3|Dose Adjustment Period|Investigator Discretion|0
1760391|NCT00799487|6133403|P2|Dose Adjustment Period|Investigator Discretion|0
1760392|NCT00799487|6133404|P1|Dose Adjustment Period|Investigator Discretion|2
1760393|NCT00799487|6133402|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
1760394|NCT00799487|6133403|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
1760395|NCT00799487|6133404|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
1760396|NCT00799487|6133402|P3|Dose Adjustment Period|Adverse Event|0
1760397|NCT00799487|6133403|P2|Dose Adjustment Period|Adverse Event|0
1760398|NCT00799487|6133404|P1|Dose Adjustment Period|Adverse Event|2
1760399|NCT00799487|6133402|P3|Dose Adjustment Period|Lost to Follow-up|0
1760400|NCT00799487|6133403|P2|Dose Adjustment Period|Lost to Follow-up|0
1760401|NCT00799487|6133404|P1|Dose Adjustment Period|Lost to Follow-up|1
1760402|NCT00799422|6133499|P6|First Week of Wear|Adverse Event|0
1760403|NCT00799422|6133500|P5|First Week of Wear|Adverse Event|0
1760404|NCT00799422|6133501|P4|First Week of Wear|Adverse Event|1
1760405|NCT00799422|6133502|P3|First Week of Wear|Adverse Event|0
1760406|NCT00799422|6133503|P2|First Week of Wear|Adverse Event|0
1760407|NCT00799422|6133504|P1|First Week of Wear|Adverse Event|0
1760408|NCT00799422|6133499|P6|First Week of Wear|Lost to Follow-up|0
1760409|NCT00799422|6133500|P5|First Week of Wear|Lost to Follow-up|0
1760410|NCT00799422|6133501|P4|First Week of Wear|Lost to Follow-up|0
1760411|NCT00799422|6133502|P3|First Week of Wear|Lost to Follow-up|1
1760412|NCT00799422|6133503|P2|First Week of Wear|Lost to Follow-up|0
1760413|NCT00799422|6133504|P1|First Week of Wear|Lost to Follow-up|0
1760414|NCT00799409|6133521|P3|Overall Study|medication compliance|0
1760415|NCT00799409|6133522|P2|Overall Study|medication compliance|0
1760416|NCT00799409|6133523|P1|Overall Study|medication compliance|1
1760417|NCT00799409|6133521|P3|Overall Study|Did not attend lab school day 1|0
1760418|NCT00799409|6133522|P2|Overall Study|Did not attend lab school day 1|0
1760419|NCT00799409|6133523|P1|Overall Study|Did not attend lab school day 1|1
1760420|NCT00799409|6133521|P3|Overall Study|Failure to follow study protocol)|0
1760421|NCT00799409|6133522|P2|Overall Study|Failure to follow study protocol)|0
1760422|NCT00799409|6133523|P1|Overall Study|Failure to follow study protocol)|1
1760423|NCT00799409|6133521|P3|Overall Study|Optimal Dose Not Achieved|0
1760424|NCT00799409|6133522|P2|Overall Study|Optimal Dose Not Achieved|0
1760425|NCT00799409|6133523|P1|Overall Study|Optimal Dose Not Achieved|2
1760426|NCT00799409|6133521|P3|Overall Study|Lost to Follow-up|0
1760427|NCT00799409|6133522|P2|Overall Study|Lost to Follow-up|0
1760428|NCT00799409|6133523|P1|Overall Study|Lost to Follow-up|1
1760429|NCT00799409|6133521|P3|Overall Study|Withdrawal by Subject|0
1760430|NCT00799409|6133522|P2|Overall Study|Withdrawal by Subject|0
1760431|NCT00799409|6133523|P1|Overall Study|Withdrawal by Subject|1
1760432|NCT00799396|6133603|P1|Clopidogrel Plus Aspirin|Physician Decision|4
1760433|NCT00799396|6133603|P1|Clopidogrel Plus Aspirin|Adverse Event|2
1760434|NCT00799396|6133603|P1|Clopidogrel Treatment|Withdrawal by Subject|2
1760435|NCT00799396|6133603|P1|Clopidogrel Treatment|Physician Decision|5
1760436|NCT00799396|6133603|P1|Clopidogrel Treatment|Adverse Event|6
1760437|NCT00799383|6133610|P2|Overall Study|Withdrawal by Subject|1
1760438|NCT00799383|6133611|P1|Overall Study|Withdrawal by Subject|0
1760439|NCT00799383|6133610|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
1760440|NCT00799383|6133611|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
1760441|NCT00799383|6133610|P2|Overall Study|Lost to Follow-up|2
1760442|NCT00799383|6133611|P1|Overall Study|Lost to Follow-up|1
1760443|NCT00799383|6133610|P2|Overall Study|Adverse Event|1
1760444|NCT00799383|6133611|P1|Overall Study|Adverse Event|0
1760445|NCT00799383|6133610|P2|Overall Study|Protocol Violation|1
1760446|NCT00799383|6133611|P1|Overall Study|Protocol Violation|1
1760447|NCT00799266|6133640|P2|Overall Study|Subject withdrew consent|0
1760448|NCT00799266|6133641|P1|Overall Study|Subject withdrew consent|3
1760449|NCT00799266|6133640|P2|Overall Study|Adverse Event|1
1760450|NCT00799266|6133641|P1|Overall Study|Adverse Event|0
1760451|NCT00798967|6133681|P2|Overall Study|Randomized in error by site|0
1760452|NCT00798967|6133682|P1|Overall Study|Randomized in error by site|1
1760453|NCT00798967|6133681|P2|Overall Study|Physician Decision|0
1760454|NCT00798967|6133682|P1|Overall Study|Physician Decision|1
1760455|NCT00798967|6133681|P2|Overall Study|Withdrawal by Subject|1
1760456|NCT00798967|6133682|P1|Overall Study|Withdrawal by Subject|0
1760457|NCT00798967|6133681|P2|Overall Study|Adverse Event|3
1760458|NCT00798967|6133682|P1|Overall Study|Adverse Event|2
1760459|NCT00798889|6133690|P1|Overall Study|Enrolled, Not treated|3
1760460|NCT00798889|6133690|P1|Overall Study|Decision of Sponsor|11
1760461|NCT00798889|6133690|P1|Overall Study|Lack of Efficacy|213
1760462|NCT00798889|6133690|P1|Overall Study|Lost to Follow-up|1
1760463|NCT00798889|6133690|P1|Overall Study|Withdrawal by Subject|31
1760464|NCT00798889|6133690|P1|Overall Study|Protocol Violation|2
1760465|NCT00798889|6133690|P1|Overall Study|Adverse Event|53
1760466|NCT00798759|6133696|P2|Overall Study|Other|1
1760467|NCT00798759|6133697|P1|Overall Study|Other|0
1760468|NCT00798759|6133696|P2|Overall Study|Protocol Violation|8
1760469|NCT00798759|6133697|P1|Overall Study|Protocol Violation|4
1760470|NCT00798759|6133696|P2|Overall Study|Lost to Follow-up|1
1760471|NCT00798759|6133697|P1|Overall Study|Lost to Follow-up|1
1760472|NCT00798759|6133696|P2|Overall Study|Adverse Event|3
1760473|NCT00798759|6133697|P1|Overall Study|Adverse Event|3
1760474|NCT00798707|6133715|P3|Overall Study|Randomized not treated|1
1760475|NCT00798707|6133716|P2|Overall Study|Randomized not treated|5
1760476|NCT00798707|6133717|P1|Overall Study|Randomized not treated|4
1760477|NCT00798707|6133715|P3|Overall Study|Withdrawal by Subject|2
1760478|NCT00798707|6133716|P2|Overall Study|Withdrawal by Subject|8
1760479|NCT00798707|6133717|P1|Overall Study|Withdrawal by Subject|3
1760480|NCT00798707|6133715|P3|Overall Study|Protocol Violation|2
1760481|NCT00798707|6133716|P2|Overall Study|Protocol Violation|0
1760482|NCT00798707|6133717|P1|Overall Study|Protocol Violation|4
1760483|NCT00798707|6133715|P3|Overall Study|Other|0
1760484|NCT00798707|6133716|P2|Overall Study|Other|1
1760485|NCT00798707|6133717|P1|Overall Study|Other|0
1760486|NCT00798707|6133715|P3|Overall Study|Lost to Follow-up|6
1760487|NCT00798707|6133716|P2|Overall Study|Lost to Follow-up|6
1760488|NCT00798707|6133717|P1|Overall Study|Lost to Follow-up|5
1760489|NCT00798707|6133715|P3|Overall Study|Lack of Efficacy|1
1760490|NCT00798707|6133716|P2|Overall Study|Lack of Efficacy|2
1760491|NCT00798707|6133717|P1|Overall Study|Lack of Efficacy|2
1760492|NCT00798707|6133715|P3|Overall Study|Investigator|2
1760493|NCT00798707|6133716|P2|Overall Study|Investigator|1
1760494|NCT00798707|6133717|P1|Overall Study|Investigator|0
1760495|NCT00798707|6133715|P3|Overall Study|Failed to return|0
1760496|NCT00798707|6133716|P2|Overall Study|Failed to return|2
1760497|NCT00798707|6133717|P1|Overall Study|Failed to return|2
1760498|NCT00798707|6133715|P3|Overall Study|Adverse Event|8
1760499|NCT00798707|6133716|P2|Overall Study|Adverse Event|8
1760500|NCT00798707|6133717|P1|Overall Study|Adverse Event|6
1760501|NCT00798694|6133769|P2|Overall Study|Physician Decision|0
1760502|NCT00798694|6133770|P1|Overall Study|Physician Decision|1
1760503|NCT00798694|6133769|P2|Overall Study|Lost to Follow-up|1
1760504|NCT00798694|6133770|P1|Overall Study|Lost to Follow-up|1
1760505|NCT00798655|6133794|P1|Overall Study|Did not receive at least one dose of pan|2
1760506|NCT00798603|6133799|P1|Overall Study|Lack of insurance coverage|1
1760507|NCT00798603|6133799|P1|Overall Study|Physician Decision|1
1760508|NCT00798603|6133799|P1|Overall Study|Adverse Event|22
1760509|NCT00798603|6133799|P1|Overall Study|Withdrawal by Subject|10
1760510|NCT00798603|6133799|P1|Overall Study|Still on treatment as of 11/6/2012|1
1760511|NCT00798590|6133821|P2|Overall Study|P.I, Left institution. Study terminated|8
1760512|NCT00798590|6133822|P1|Overall Study|P.I, Left institution. Study terminated|11
1760513|NCT00798434|6133856|P2|Open-Label|Not Treated|1
1760514|NCT00798434|6133857|P1|Open-Label|Not Treated|0
1760515|NCT00798434|6133856|P2|Open-Label|Other|2
1760516|NCT00798434|6133857|P1|Open-Label|Other|1
1760517|NCT00798434|6133856|P2|Open-Label|Protocol Violation|0
1760518|NCT00798434|6133857|P1|Open-Label|Protocol Violation|1
1760519|NCT00798434|6133856|P2|Open-Label|Withdrawal by Subject|7
1760520|NCT00798434|6133857|P1|Open-Label|Withdrawal by Subject|2
1760521|NCT00798434|6133856|P2|Open-Label|Lack of Efficacy|11
1760522|NCT00798434|6133857|P1|Open-Label|Lack of Efficacy|5
1760523|NCT00798434|6133856|P2|Open-Label|Adverse Event|11
1760524|NCT00798434|6133857|P1|Open-Label|Adverse Event|33
1760525|NCT00798434|6133856|P2|Double-Blind|Not Treated|6
1760526|NCT00798434|6133857|P1|Double-Blind|Not Treated|3
1760527|NCT00798434|6133856|P2|Double-Blind|Other|0
1760528|NCT00798434|6133857|P1|Double-Blind|Other|1
1760529|NCT00798434|6133856|P2|Double-Blind|Did Not Meet Entrance Criteria|1
1760530|NCT00798434|6133857|P1|Double-Blind|Did Not Meet Entrance Criteria|2
1760531|NCT00798434|6133856|P2|Double-Blind|Protocol Violation|4
1760532|NCT00798434|6133857|P1|Double-Blind|Protocol Violation|1
1760533|NCT00798434|6133856|P2|Double-Blind|Withdrawal by Subject|14
1760534|NCT00798434|6133857|P1|Double-Blind|Withdrawal by Subject|17
1760535|NCT00798434|6133856|P2|Double-Blind|Lack of Efficacy|12
1760536|NCT00798434|6133857|P1|Double-Blind|Lack of Efficacy|8
1760537|NCT00798434|6133856|P2|Double-Blind|Lost to Follow-up|0
1760538|NCT00798434|6133857|P1|Double-Blind|Lost to Follow-up|1
1760539|NCT00798434|6133856|P2|Double-Blind|Death|1
1760540|NCT00798434|6133857|P1|Double-Blind|Death|0
1760541|NCT00798434|6133856|P2|Double-Blind|Adverse Event|46
1760542|NCT00798434|6133857|P1|Double-Blind|Adverse Event|22
1760543|NCT00798369|6133943|P6|Overall Study|Adminstrative problems|1
1760544|NCT00798369|6133944|P5|Overall Study|Adminstrative problems|0
1760545|NCT00798369|6133945|P4|Overall Study|Adminstrative problems|0
1760546|NCT00798369|6133946|P3|Overall Study|Adminstrative problems|0
1760547|NCT00798369|6133947|P2|Overall Study|Adminstrative problems|0
1760548|NCT00798369|6133948|P1|Overall Study|Adminstrative problems|0
1760549|NCT00798369|6133943|P6|Overall Study|Lost to Follow-up|0
1760550|NCT00798369|6133944|P5|Overall Study|Lost to Follow-up|1
1760551|NCT00798369|6133945|P4|Overall Study|Lost to Follow-up|0
1760552|NCT00798369|6133946|P3|Overall Study|Lost to Follow-up|1
1760553|NCT00798369|6133947|P2|Overall Study|Lost to Follow-up|1
1760554|NCT00798369|6133948|P1|Overall Study|Lost to Follow-up|1
1760555|NCT00798369|6133943|P6|Overall Study|Subject withdrew consent|2
1760556|NCT00798369|6133944|P5|Overall Study|Subject withdrew consent|0
1760557|NCT00798369|6133945|P4|Overall Study|Subject withdrew consent|1
1760558|NCT00798369|6133946|P3|Overall Study|Subject withdrew consent|1
1760559|NCT00798369|6133947|P2|Overall Study|Subject withdrew consent|0
1760560|NCT00798369|6133948|P1|Overall Study|Subject withdrew consent|0
1760561|NCT00798317|6133995|P2|Overall Study|Death|0
1760562|NCT00798317|6133996|P1|Overall Study|Death|1
1760563|NCT00798317|6133995|P2|Overall Study|Adverse Event|0
1760564|NCT00798317|6133996|P1|Overall Study|Adverse Event|2
1760565|NCT00798317|6133995|P2|Overall Study|Lost to Follow-up|2
1760566|NCT00798317|6133996|P1|Overall Study|Lost to Follow-up|2
1760567|NCT00798317|6133995|P2|Overall Study|Withdrawal by Subject|4
1760568|NCT00798317|6133996|P1|Overall Study|Withdrawal by Subject|5
1760569|NCT00798317|6133995|P2|Overall Study|Physician Decision|1
1760570|NCT00798317|6133996|P1|Overall Study|Physician Decision|0
1760571|NCT00798304|6134007|P3|Overall Study|Discontinuation by Sponsor|9
1760572|NCT00798304|6134008|P2|Overall Study|Discontinuation by Sponsor|21
1760573|NCT00798304|6134009|P1|Overall Study|Discontinuation by Sponsor|14
1760574|NCT00798304|6134007|P3|Overall Study|Adverse Event|1
1760575|NCT00798304|6134008|P2|Overall Study|Adverse Event|1
1760576|NCT00798304|6134009|P1|Overall Study|Adverse Event|0
1760577|NCT00798174|6134035|P2|Overall Study|Inability to sedate for DFT testing|0
1760578|NCT00798174|6134036|P1|Overall Study|Inability to sedate for DFT testing|1
1760579|NCT00798174|6134035|P2|Overall Study|inability to implant azygos coil|3
1760580|NCT00798174|6134036|P1|Overall Study|inability to implant azygos coil|3
1760581|NCT00798161|6134047|P7|Overall Study|Other reason (incl. lack of efficacy)|5
1760582|NCT00798161|6134048|P6|Overall Study|Other reason (incl. lack of efficacy)|4
1760583|NCT00798161|6134049|P5|Overall Study|Other reason (incl. lack of efficacy)|2
1760584|NCT00798161|6134050|P4|Overall Study|Other reason (incl. lack of efficacy)|5
1760585|NCT00798161|6134051|P3|Overall Study|Other reason (incl. lack of efficacy)|3
1760586|NCT00798161|6134052|P2|Overall Study|Other reason (incl. lack of efficacy)|5
1760587|NCT00798161|6134053|P1|Overall Study|Other reason (incl. lack of efficacy)|7
1760588|NCT00798161|6134047|P7|Overall Study|Withdrawal by Subject|1
1760589|NCT00798161|6134048|P6|Overall Study|Withdrawal by Subject|3
1760590|NCT00798161|6134049|P5|Overall Study|Withdrawal by Subject|2
1760591|NCT00798161|6134050|P4|Overall Study|Withdrawal by Subject|4
1760592|NCT00798161|6134051|P3|Overall Study|Withdrawal by Subject|5
1760593|NCT00798161|6134052|P2|Overall Study|Withdrawal by Subject|4
1760594|NCT00798161|6134053|P1|Overall Study|Withdrawal by Subject|5
1760595|NCT00798161|6134047|P7|Overall Study|Lost to Follow-up|0
1760596|NCT00798161|6134048|P6|Overall Study|Lost to Follow-up|0
1760597|NCT00798161|6134049|P5|Overall Study|Lost to Follow-up|4
1760598|NCT00798161|6134050|P4|Overall Study|Lost to Follow-up|3
1760599|NCT00798161|6134051|P3|Overall Study|Lost to Follow-up|4
1760600|NCT00798161|6134052|P2|Overall Study|Lost to Follow-up|3
1760601|NCT00798161|6134053|P1|Overall Study|Lost to Follow-up|1
1760602|NCT00798161|6134047|P7|Overall Study|Protocol Violation|0
1760603|NCT00798161|6134048|P6|Overall Study|Protocol Violation|2
1760604|NCT00798161|6134049|P5|Overall Study|Protocol Violation|3
1760605|NCT00798161|6134050|P4|Overall Study|Protocol Violation|3
1760606|NCT00798161|6134051|P3|Overall Study|Protocol Violation|3
1760607|NCT00798161|6134052|P2|Overall Study|Protocol Violation|1
1760608|NCT00798161|6134053|P1|Overall Study|Protocol Violation|2
1760609|NCT00798161|6134047|P7|Overall Study|Adverse Event|4
1760610|NCT00798161|6134048|P6|Overall Study|Adverse Event|2
1760611|NCT00798161|6134049|P5|Overall Study|Adverse Event|5
1760612|NCT00798161|6134050|P4|Overall Study|Adverse Event|6
1760613|NCT00798161|6134051|P3|Overall Study|Adverse Event|6
1760614|NCT00798161|6134052|P2|Overall Study|Adverse Event|4
1760615|NCT00798161|6134053|P1|Overall Study|Adverse Event|3
1760616|NCT00798135|6134160|P1|Overall Study|Physician Decision|1
1760617|NCT00798135|6134160|P1|Overall Study|Disease progression, refractory|1
1760618|NCT00798135|6134160|P1|Overall Study|Disease progression, relapse|11
1760619|NCT00798096|6134166|P1|Overall Study|Ongoing|2
1760620|NCT00797966|6134194|P6|Phase A+|Protocol deviation|4
1760621|NCT00797966|6134195|P5|Phase A+|Protocol deviation|0
1760622|NCT00797966|6134196|P4|Phase A+|Protocol deviation|0
1760623|NCT00797966|6134197|P3|Phase A+|Protocol deviation|0
1760624|NCT00797966|6134198|P2|Phase A+|Protocol deviation|0
1760625|NCT00797966|6134199|P1|Phase A+|Protocol deviation|0
1760626|NCT00797966|6134194|P6|Phase A+|Adverse Event|4
1760627|NCT00797966|6134195|P5|Phase A+|Adverse Event|0
1760628|NCT00797966|6134196|P4|Phase A+|Adverse Event|0
1760629|NCT00797966|6134197|P3|Phase A+|Adverse Event|0
1760630|NCT00797966|6134198|P2|Phase A+|Adverse Event|0
1760631|NCT00797966|6134199|P1|Phase A+|Adverse Event|0
1760632|NCT00797966|6134194|P6|Phase A+|Withdrawal by Subject|6
1760633|NCT00797966|6134195|P5|Phase A+|Withdrawal by Subject|0
1760634|NCT00797966|6134196|P4|Phase A+|Withdrawal by Subject|0
1760635|NCT00797966|6134197|P3|Phase A+|Withdrawal by Subject|0
1760636|NCT00797966|6134198|P2|Phase A+|Withdrawal by Subject|0
1760637|NCT00797966|6134199|P1|Phase A+|Withdrawal by Subject|0
1760638|NCT00797966|6134194|P6|Phase A+|Met withdrawal criteria|5
1760639|NCT00797966|6134195|P5|Phase A+|Met withdrawal criteria|0
1760640|NCT00797966|6134196|P4|Phase A+|Met withdrawal criteria|0
1760641|NCT00797966|6134197|P3|Phase A+|Met withdrawal criteria|0
1760642|NCT00797966|6134198|P2|Phase A+|Met withdrawal criteria|0
1760643|NCT00797966|6134199|P1|Phase A+|Met withdrawal criteria|0
1760644|NCT00797966|6134194|P6|Phase A+|Lost to Follow-up|9
1760645|NCT00797966|6134195|P5|Phase A+|Lost to Follow-up|0
1760646|NCT00797966|6134196|P4|Phase A+|Lost to Follow-up|0
1760647|NCT00797966|6134197|P3|Phase A+|Lost to Follow-up|0
1760648|NCT00797966|6134198|P2|Phase A+|Lost to Follow-up|0
1760649|NCT00797966|6134199|P1|Phase A+|Lost to Follow-up|0
1760650|NCT00797966|6134194|P6|Phase B|Lack of Efficacy|0
1760651|NCT00797966|6134195|P5|Phase B|Lack of Efficacy|0
1760652|NCT00797966|6134196|P4|Phase B|Lack of Efficacy|4
1760653|NCT00797966|6134197|P3|Phase B|Lack of Efficacy|1
1760654|NCT00797966|6134198|P2|Phase B|Lack of Efficacy|1
1760655|NCT00797966|6134199|P1|Phase B|Lack of Efficacy|0
1760656|NCT00797966|6134194|P6|Phase B|Protocol Deviation|0
1760657|NCT00797966|6134195|P5|Phase B|Protocol Deviation|0
1760658|NCT00797966|6134196|P4|Phase B|Protocol Deviation|6
1760659|NCT00797966|6134197|P3|Phase B|Protocol Deviation|2
1760660|NCT00797966|6134198|P2|Phase B|Protocol Deviation|8
1760661|NCT00797966|6134199|P1|Phase B|Protocol Deviation|4
1760662|NCT00797966|6134194|P6|Phase B|Withdrawal by Subject|0
1760663|NCT00797966|6134195|P5|Phase B|Withdrawal by Subject|0
1760664|NCT00797966|6134196|P4|Phase B|Withdrawal by Subject|3
1760665|NCT00797966|6134197|P3|Phase B|Withdrawal by Subject|3
1760666|NCT00797966|6134198|P2|Phase B|Withdrawal by Subject|4
1760667|NCT00797966|6134199|P1|Phase B|Withdrawal by Subject|1
1760668|NCT00797966|6134194|P6|Phase B|Physician Decision|0
1760669|NCT00797966|6134195|P5|Phase B|Physician Decision|0
1760670|NCT00797966|6134196|P4|Phase B|Physician Decision|1
1760671|NCT00797966|6134197|P3|Phase B|Physician Decision|3
1760672|NCT00797966|6134198|P2|Phase B|Physician Decision|0
1760673|NCT00797966|6134199|P1|Phase B|Physician Decision|1
1760674|NCT00797966|6134194|P6|Phase B|Met Withdrawal Criteria|0
1760675|NCT00797966|6134195|P5|Phase B|Met Withdrawal Criteria|0
1760676|NCT00797966|6134196|P4|Phase B|Met Withdrawal Criteria|1
1760677|NCT00797966|6134197|P3|Phase B|Met Withdrawal Criteria|6
1760678|NCT00797966|6134198|P2|Phase B|Met Withdrawal Criteria|3
1760679|NCT00797966|6134199|P1|Phase B|Met Withdrawal Criteria|3
1760680|NCT00797966|6134194|P6|Phase B|Adverse Event|0
1760681|NCT00797966|6134195|P5|Phase B|Adverse Event|0
1760682|NCT00797966|6134196|P4|Phase B|Adverse Event|1
1760683|NCT00797966|6134197|P3|Phase B|Adverse Event|3
1760684|NCT00797966|6134198|P2|Phase B|Adverse Event|1
1760685|NCT00797966|6134199|P1|Phase B|Adverse Event|2
1760686|NCT00797966|6134194|P6|Phase B|Lost to Follow-up|0
1760687|NCT00797966|6134195|P5|Phase B|Lost to Follow-up|0
1760688|NCT00797966|6134196|P4|Phase B|Lost to Follow-up|0
1760689|NCT00797966|6134197|P3|Phase B|Lost to Follow-up|3
1760690|NCT00797966|6134198|P2|Phase B|Lost to Follow-up|1
1760691|NCT00797966|6134199|P1|Phase B|Lost to Follow-up|0
1760692|NCT00797966|6134194|P6|Phase A|Protocol deviation|0
1760693|NCT00797966|6134195|P5|Phase A|Protocol deviation|56
1760694|NCT00797966|6134196|P4|Phase A|Protocol deviation|0
1760695|NCT00797966|6134197|P3|Phase A|Protocol deviation|0
1760696|NCT00797966|6134198|P2|Phase A|Protocol deviation|0
1760697|NCT00797966|6134199|P1|Phase A|Protocol deviation|0
1760698|NCT00797966|6134194|P6|Phase A|Withdrawal by Subject|0
1760699|NCT00797966|6134195|P5|Phase A|Withdrawal by Subject|33
1760700|NCT00797966|6134196|P4|Phase A|Withdrawal by Subject|0
1760701|NCT00797966|6134197|P3|Phase A|Withdrawal by Subject|0
1760702|NCT00797966|6134198|P2|Phase A|Withdrawal by Subject|0
1760703|NCT00797966|6134199|P1|Phase A|Withdrawal by Subject|0
1760704|NCT00797966|6134194|P6|Phase A|Physician Decision|0
1760705|NCT00797966|6134195|P5|Phase A|Physician Decision|13
1760706|NCT00797966|6134196|P4|Phase A|Physician Decision|0
1760707|NCT00797966|6134197|P3|Phase A|Physician Decision|0
1760708|NCT00797966|6134198|P2|Phase A|Physician Decision|0
1760709|NCT00797966|6134199|P1|Phase A|Physician Decision|0
1760710|NCT00797966|6134194|P6|Phase A|Met withdrawal criteria|0
1760711|NCT00797966|6134195|P5|Phase A|Met withdrawal criteria|4
1760712|NCT00797966|6134196|P4|Phase A|Met withdrawal criteria|0
1760713|NCT00797966|6134197|P3|Phase A|Met withdrawal criteria|0
1760714|NCT00797966|6134198|P2|Phase A|Met withdrawal criteria|0
1760715|NCT00797966|6134199|P1|Phase A|Met withdrawal criteria|0
1760716|NCT00797966|6134194|P6|Phase A|Adverse Event|0
1760717|NCT00797966|6134195|P5|Phase A|Adverse Event|46
1760718|NCT00797966|6134196|P4|Phase A|Adverse Event|0
1760719|NCT00797966|6134197|P3|Phase A|Adverse Event|0
1760720|NCT00797966|6134198|P2|Phase A|Adverse Event|0
1760721|NCT00797966|6134199|P1|Phase A|Adverse Event|0
1760722|NCT00797966|6134194|P6|Phase A|Lost to Follow-up|0
1760723|NCT00797966|6134195|P5|Phase A|Lost to Follow-up|33
1760724|NCT00797966|6134196|P4|Phase A|Lost to Follow-up|0
1760725|NCT00797966|6134197|P3|Phase A|Lost to Follow-up|0
1760726|NCT00797966|6134198|P2|Phase A|Lost to Follow-up|0
1760727|NCT00797966|6134199|P1|Phase A|Lost to Follow-up|0
1760728|NCT00797862|6134264|P3|Overall Study|Mis-randomized|1
1760729|NCT00797862|6134265|P2|Overall Study|Mis-randomized|3
1760730|NCT00797862|6134266|P1|Overall Study|Mis-randomized|3
1760731|NCT00797862|6134264|P3|Overall Study|Protocol Violation|8
1760732|NCT00797862|6134265|P2|Overall Study|Protocol Violation|6
1760733|NCT00797862|6134266|P1|Overall Study|Protocol Violation|4
1760734|NCT00797862|6134264|P3|Overall Study|Administrative Problem|0
1760735|NCT00797862|6134265|P2|Overall Study|Administrative Problem|0
1760736|NCT00797862|6134266|P1|Overall Study|Administrative Problem|4
1760737|NCT00797862|6134264|P3|Overall Study|Lost to Follow-up|5
1760738|NCT00797862|6134265|P2|Overall Study|Lost to Follow-up|0
1760739|NCT00797862|6134266|P1|Overall Study|Lost to Follow-up|11
1760740|NCT00797862|6134264|P3|Overall Study|Withdrawal by Subject|7
1760741|NCT00797862|6134265|P2|Overall Study|Withdrawal by Subject|7
1760742|NCT00797862|6134266|P1|Overall Study|Withdrawal by Subject|14
1760743|NCT00797862|6134264|P3|Overall Study|No longer required study medication|0
1760744|NCT00797862|6134265|P2|Overall Study|No longer required study medication|0
1760745|NCT00797862|6134266|P1|Overall Study|No longer required study medication|1
1760746|NCT00797862|6134264|P3|Overall Study|Lack of Efficacy|6
1760747|NCT00797862|6134265|P2|Overall Study|Lack of Efficacy|7
1760748|NCT00797862|6134266|P1|Overall Study|Lack of Efficacy|1
1760749|NCT00797862|6134264|P3|Overall Study|Abnormal Test Procedure Result|1
1760750|NCT00797862|6134265|P2|Overall Study|Abnormal Test Procedure Result|1
1760751|NCT00797862|6134266|P1|Overall Study|Abnormal Test Procedure Result|0
1760752|NCT00797862|6134264|P3|Overall Study|Adverse Event|58
1760753|NCT00797862|6134265|P2|Overall Study|Adverse Event|44
1760754|NCT00797862|6134266|P1|Overall Study|Adverse Event|86
1760755|NCT00797823|6134295|P3|First Period (Initial Randomization)|Physician Decision|0
1760756|NCT00797823|6134296|P2|First Period (Initial Randomization)|Physician Decision|0
1760757|NCT00797823|6134297|P1|First Period (Initial Randomization)|Physician Decision|1
1760758|NCT00797732|6134319|P3|Overall Study|Refused to Participate|123
1760759|NCT00797732|6134320|P2|Overall Study|Refused to Participate|0
1760760|NCT00797732|6134321|P1|Overall Study|Refused to Participate|0
1760761|NCT00797732|6134319|P3|Overall Study|Excluded due to time constraints|24
1760762|NCT00797732|6134320|P2|Overall Study|Excluded due to time constraints|0
1760763|NCT00797732|6134321|P1|Overall Study|Excluded due to time constraints|0
1760764|NCT00797732|6134319|P3|Overall Study|Not meet inclusion criteria|7
1760765|NCT00797732|6134320|P2|Overall Study|Not meet inclusion criteria|0
1760766|NCT00797732|6134321|P1|Overall Study|Not meet inclusion criteria|0
1760767|NCT00797732|6134319|P3|Overall Study|Death|0
1760768|NCT00797732|6134320|P2|Overall Study|Death|0
1760769|NCT00797732|6134321|P1|Overall Study|Death|1
1760770|NCT00797732|6134319|P3|Overall Study|Lost to Follow-up|0
1760771|NCT00797732|6134320|P2|Overall Study|Lost to Follow-up|0
1760772|NCT00797732|6134321|P1|Overall Study|Lost to Follow-up|1
1760773|NCT00797732|6134319|P3|Overall Study|Withdrawal by Subject|0
1760774|NCT00797732|6134320|P2|Overall Study|Withdrawal by Subject|3
1760775|NCT00797732|6134321|P1|Overall Study|Withdrawal by Subject|3
1760776|NCT00797667|6134336|P3|Overall Study|Adverse Event|8
1760777|NCT00797667|6134337|P2|Overall Study|Adverse Event|8
1760778|NCT00797667|6134338|P1|Overall Study|Adverse Event|19
1760779|NCT00797667|6134336|P3|Overall Study|Withdrawal by Subject|2
1760780|NCT00797667|6134337|P2|Overall Study|Withdrawal by Subject|14
1760781|NCT00797667|6134338|P1|Overall Study|Withdrawal by Subject|9
1760782|NCT00797667|6134336|P3|Overall Study|Study Terminated by Sponsor|115
1760783|NCT00797667|6134337|P2|Overall Study|Study Terminated by Sponsor|216
1760784|NCT00797667|6134338|P1|Overall Study|Study Terminated by Sponsor|217
1760785|NCT00797667|6134336|P3|Overall Study|Protocol Violation|0
1760786|NCT00797667|6134337|P2|Overall Study|Protocol Violation|7
1760787|NCT00797667|6134338|P1|Overall Study|Protocol Violation|2
1760788|NCT00797667|6134336|P3|Overall Study|Pregnancy|0
1760789|NCT00797667|6134337|P2|Overall Study|Pregnancy|0
1760790|NCT00797667|6134338|P1|Overall Study|Pregnancy|2
1760791|NCT00797667|6134336|P3|Overall Study|Physician Decision|0
1760792|NCT00797667|6134337|P2|Overall Study|Physician Decision|1
1760793|NCT00797667|6134338|P1|Overall Study|Physician Decision|3
1760794|NCT00797667|6134336|P3|Overall Study|Lost to Follow-up|2
1760795|NCT00797667|6134337|P2|Overall Study|Lost to Follow-up|12
1760796|NCT00797667|6134338|P1|Overall Study|Lost to Follow-up|8
1760797|NCT00797667|6134336|P3|Overall Study|Lack of Efficacy|0
1760798|NCT00797667|6134337|P2|Overall Study|Lack of Efficacy|1
1760799|NCT00797667|6134338|P1|Overall Study|Lack of Efficacy|0
1760800|NCT00797563|6134364|P1|Overall Study|Adverse Event|1
1760801|NCT00797511|6134370|P1|Overall Study|Withdrawal by Subject|1
1760802|NCT00797316|6134388|P2|Overall Study|Unsatisfactory therapeutic effect|13
1760803|NCT00797316|6134389|P1|Overall Study|Unsatisfactory therapeutic effect|0
1760804|NCT00797316|6134388|P2|Overall Study|Patient withdrew consent|6
1760805|NCT00797316|6134389|P1|Overall Study|Patient withdrew consent|12
1760806|NCT00797316|6134388|P2|Overall Study|Protocol Deviation|2
1760807|NCT00797316|6134389|P1|Overall Study|Protocol Deviation|1
1760808|NCT00797316|6134388|P2|Overall Study|Lost to Follow-up|8
1760809|NCT00797316|6134389|P1|Overall Study|Lost to Follow-up|4
1760810|NCT00797316|6134388|P2|Overall Study|Adverse Event|3
1760811|NCT00797316|6134389|P1|Overall Study|Adverse Event|5
1760812|NCT00797316|6134388|P2|Overall Study|Administrative problems|0
1760813|NCT00797316|6134389|P1|Overall Study|Administrative problems|1
1760814|NCT00797225|6134418|P8|Weeks 13 to 24|Sponsor Decision|0
1760815|NCT00797225|6134419|P7|Weeks 13 to 24|Sponsor Decision|1
1760816|NCT00797225|6134420|P6|Weeks 13 to 24|Sponsor Decision|0
1760817|NCT00797225|6134421|P5|Weeks 13 to 24|Sponsor Decision|0
1760818|NCT00797225|6134422|P4|Weeks 13 to 24|Sponsor Decision|0
1760819|NCT00797225|6134423|P3|Weeks 13 to 24|Sponsor Decision|0
1760820|NCT00797225|6134424|P2|Weeks 13 to 24|Sponsor Decision|0
1760821|NCT00797225|6134425|P1|Weeks 13 to 24|Sponsor Decision|0
1760822|NCT00797225|6134418|P8|Weeks 13 to 24|Adverse Event|0
1760823|NCT00797225|6134419|P7|Weeks 13 to 24|Adverse Event|1
1760824|NCT00797225|6134420|P6|Weeks 13 to 24|Adverse Event|0
1760825|NCT00797225|6134421|P5|Weeks 13 to 24|Adverse Event|0
1760826|NCT00797225|6134422|P4|Weeks 13 to 24|Adverse Event|0
1760827|NCT00797225|6134423|P3|Weeks 13 to 24|Adverse Event|0
1760828|NCT00797225|6134424|P2|Weeks 13 to 24|Adverse Event|1
1760829|NCT00797225|6134425|P1|Weeks 13 to 24|Adverse Event|0
1760830|NCT00797225|6134418|P8|Weeks 13 to 24|Lost to Follow-up|0
1760831|NCT00797225|6134419|P7|Weeks 13 to 24|Lost to Follow-up|0
1760832|NCT00797225|6134420|P6|Weeks 13 to 24|Lost to Follow-up|0
1760833|NCT00797225|6134421|P5|Weeks 13 to 24|Lost to Follow-up|1
1760834|NCT00797225|6134422|P4|Weeks 13 to 24|Lost to Follow-up|0
1760835|NCT00797225|6134423|P3|Weeks 13 to 24|Lost to Follow-up|1
1760836|NCT00797225|6134424|P2|Weeks 13 to 24|Lost to Follow-up|0
1760837|NCT00797225|6134425|P1|Weeks 13 to 24|Lost to Follow-up|0
1760838|NCT00797225|6134418|P8|Weeks 13 to 24|Withdrawal by Subject|0
1760839|NCT00797225|6134419|P7|Weeks 13 to 24|Withdrawal by Subject|0
1760840|NCT00797225|6134420|P6|Weeks 13 to 24|Withdrawal by Subject|0
1760841|NCT00797225|6134421|P5|Weeks 13 to 24|Withdrawal by Subject|0
1760842|NCT00797225|6134422|P4|Weeks 13 to 24|Withdrawal by Subject|0
1760843|NCT00797225|6134423|P3|Weeks 13 to 24|Withdrawal by Subject|1
1760844|NCT00797225|6134424|P2|Weeks 13 to 24|Withdrawal by Subject|1
1760845|NCT00797225|6134425|P1|Weeks 13 to 24|Withdrawal by Subject|0
1760846|NCT00797225|6134418|P8|Weeks 13 to 24|Non-compliance|0
1760847|NCT00797225|6134419|P7|Weeks 13 to 24|Non-compliance|0
1760848|NCT00797225|6134420|P6|Weeks 13 to 24|Non-compliance|0
1760849|NCT00797225|6134421|P5|Weeks 13 to 24|Non-compliance|0
1760850|NCT00797225|6134422|P4|Weeks 13 to 24|Non-compliance|0
1760851|NCT00797225|6134423|P3|Weeks 13 to 24|Non-compliance|0
1760852|NCT00797225|6134424|P2|Weeks 13 to 24|Non-compliance|2
1760853|NCT00797225|6134425|P1|Weeks 13 to 24|Non-compliance|0
1760854|NCT00797225|6134418|P8|Weeks 1 to 12|Sponsor Decision|0
1760855|NCT00797225|6134419|P7|Weeks 1 to 12|Sponsor Decision|0
1760856|NCT00797225|6134420|P6|Weeks 1 to 12|Sponsor Decision|0
1760857|NCT00797225|6134421|P5|Weeks 1 to 12|Sponsor Decision|0
1760858|NCT00797225|6134422|P4|Weeks 1 to 12|Sponsor Decision|0
1760859|NCT00797225|6134423|P3|Weeks 1 to 12|Sponsor Decision|0
1760860|NCT00797225|6134424|P2|Weeks 1 to 12|Sponsor Decision|0
1760861|NCT00797225|6134425|P1|Weeks 1 to 12|Sponsor Decision|1
1760862|NCT00797225|6134418|P8|Weeks 1 to 12|Lack of Efficacy|0
1760863|NCT00797225|6134419|P7|Weeks 1 to 12|Lack of Efficacy|0
1760864|NCT00797225|6134420|P6|Weeks 1 to 12|Lack of Efficacy|0
1760865|NCT00797225|6134421|P5|Weeks 1 to 12|Lack of Efficacy|0
1760866|NCT00797225|6134422|P4|Weeks 1 to 12|Lack of Efficacy|0
1760867|NCT00797225|6134423|P3|Weeks 1 to 12|Lack of Efficacy|0
1760868|NCT00797225|6134424|P2|Weeks 1 to 12|Lack of Efficacy|0
1760869|NCT00797225|6134425|P1|Weeks 1 to 12|Lack of Efficacy|1
1760870|NCT00797225|6134418|P8|Weeks 1 to 12|Non-compliance|0
1760871|NCT00797225|6134419|P7|Weeks 1 to 12|Non-compliance|0
1760872|NCT00797225|6134420|P6|Weeks 1 to 12|Non-compliance|0
1760873|NCT00797225|6134421|P5|Weeks 1 to 12|Non-compliance|0
1760874|NCT00797225|6134422|P4|Weeks 1 to 12|Non-compliance|0
1760875|NCT00797225|6134423|P3|Weeks 1 to 12|Non-compliance|0
1760876|NCT00797225|6134424|P2|Weeks 1 to 12|Non-compliance|1
1760877|NCT00797225|6134425|P1|Weeks 1 to 12|Non-compliance|0
1760878|NCT00797225|6134418|P8|Weeks 1 to 12|Adverse Event|0
1760879|NCT00797225|6134419|P7|Weeks 1 to 12|Adverse Event|0
1760880|NCT00797225|6134420|P6|Weeks 1 to 12|Adverse Event|0
1760881|NCT00797225|6134421|P5|Weeks 1 to 12|Adverse Event|0
1760882|NCT00797225|6134422|P4|Weeks 1 to 12|Adverse Event|0
1760883|NCT00797225|6134423|P3|Weeks 1 to 12|Adverse Event|1
1760884|NCT00797225|6134424|P2|Weeks 1 to 12|Adverse Event|0
1760885|NCT00797225|6134425|P1|Weeks 1 to 12|Adverse Event|0
1760886|NCT00797108|6134542|P3|Overall Study|Randomized but not Treated|0
1760887|NCT00797108|6134543|P2|Overall Study|Randomized but not Treated|0
1760888|NCT00797108|6134544|P1|Overall Study|Randomized but not Treated|2
1760889|NCT00797108|6134542|P3|Overall Study|Other|2
1760890|NCT00797108|6134543|P2|Overall Study|Other|0
1760891|NCT00797108|6134544|P1|Overall Study|Other|0
1760892|NCT00797108|6134542|P3|Overall Study|Lack of Efficacy|1
1760893|NCT00797108|6134543|P2|Overall Study|Lack of Efficacy|0
1760894|NCT00797108|6134544|P1|Overall Study|Lack of Efficacy|1
1760895|NCT00797108|6134542|P3|Overall Study|Global Deterioration of Health Status|0
1760896|NCT00797108|6134543|P2|Overall Study|Global Deterioration of Health Status|1
1760897|NCT00797108|6134544|P1|Overall Study|Global Deterioration of Health Status|0
1760898|NCT00797108|6134542|P3|Overall Study|Did Not Meet Entrance Criteria|0
1760899|NCT00797108|6134543|P2|Overall Study|Did Not Meet Entrance Criteria|1
1760900|NCT00797108|6134544|P1|Overall Study|Did Not Meet Entrance Criteria|0
1760901|NCT00797108|6134542|P3|Overall Study|Adverse Event|3
1760902|NCT00797108|6134543|P2|Overall Study|Adverse Event|0
1760903|NCT00797108|6134544|P1|Overall Study|Adverse Event|1
1760904|NCT00796991|6134579|P3|Overall Study|Withdrawal by Subject|1
1760905|NCT00796991|6134580|P2|Overall Study|Withdrawal by Subject|0
1760906|NCT00796991|6134581|P1|Overall Study|Withdrawal by Subject|0
1760907|NCT00796991|6134579|P3|Overall Study|Study Drug Toxicity|5
1760908|NCT00796991|6134580|P2|Overall Study|Study Drug Toxicity|3
1760909|NCT00796991|6134581|P1|Overall Study|Study Drug Toxicity|3
1760910|NCT00796991|6134579|P3|Overall Study|Disease Progression|7
1760911|NCT00796991|6134580|P2|Overall Study|Disease Progression|9
1760912|NCT00796991|6134581|P1|Overall Study|Disease Progression|10
1760913|NCT00796991|6134579|P3|Overall Study|Death|0
1760914|NCT00796991|6134580|P2|Overall Study|Death|0
1760915|NCT00796991|6134581|P1|Overall Study|Death|2
1760916|NCT00796991|6134579|P3|Overall Study|Adverse Event|1
1760917|NCT00796991|6134580|P2|Overall Study|Adverse Event|0
1760918|NCT00796991|6134581|P1|Overall Study|Adverse Event|0
1760919|NCT00796861|6134688|P1|Overall Study|Death|2
1760920|NCT00796861|6134688|P1|Overall Study|Withdrawal by Subject|2
1760921|NCT00796822|6134694|P2|Overall Study|Adverse Event|0
1760922|NCT00796822|6134695|P1|Overall Study|Adverse Event|1
1760923|NCT00796822|6134694|P2|Overall Study|Lost to Follow-up|0
1760924|NCT00796822|6134695|P1|Overall Study|Lost to Follow-up|2
1760925|NCT00796757|6134703|P1|Overall Study|Other|7
1760926|NCT00796757|6134703|P1|Overall Study|Investigator's decision|2
1760927|NCT00796757|6134703|P1|Overall Study|Participant noncompliance|1
1760928|NCT00796757|6134703|P1|Overall Study|Protocol Violation|1
1760929|NCT00796757|6134703|P1|Overall Study|Death|61
1760930|NCT00796757|6134703|P1|Overall Study|Withdrawal by Subject|14
1760931|NCT00796718|6134737|P1|Overall Study|Withdrawal by Informed Consent|1
1760932|NCT00796718|6134737|P1|Overall Study|Lost to Follow-up|5
1760933|NCT00796718|6134737|P1|Overall Study|Exclusion Criteria|1
1760934|NCT00796718|6134737|P1|Overall Study|Adverse Event|2
1760935|NCT00796666|6134789|P2|Overall Study|Randomized and not treated|0
1760936|NCT00796666|6134790|P1|Overall Study|Randomized and not treated|1
1760937|NCT00796666|6134789|P2|Overall Study|Terminated by sponsor|55
1760938|NCT00796666|6134790|P1|Overall Study|Terminated by sponsor|53
1760939|NCT00796666|6134789|P2|Overall Study|Other|0
1760940|NCT00796666|6134790|P1|Overall Study|Other|1
1760941|NCT00796666|6134789|P2|Overall Study|Protocol Violation|0
1760942|NCT00796666|6134790|P1|Overall Study|Protocol Violation|1
1760943|NCT00796666|6134789|P2|Overall Study|Adverse Event|5
1760944|NCT00796666|6134790|P1|Overall Study|Adverse Event|7
1760945|NCT00796666|6134789|P2|Overall Study|Withdrawal by Subject|0
1760946|NCT00796666|6134790|P1|Overall Study|Withdrawal by Subject|2
1760947|NCT00796666|6134789|P2|Overall Study|Death|4
1760948|NCT00796666|6134790|P1|Overall Study|Death|2
1760949|NCT00796653|6134824|P4|Overall Study|Other reason not described above|4
1760950|NCT00796653|6134825|P3|Overall Study|Other reason not described above|7
1760951|NCT00796653|6134826|P2|Overall Study|Other reason not described above|9
1760952|NCT00796653|6134827|P1|Overall Study|Other reason not described above|4
1760953|NCT00796653|6134824|P4|Overall Study|Non compliance with protocol|2
1760954|NCT00796653|6134825|P3|Overall Study|Non compliance with protocol|0
1760955|NCT00796653|6134826|P2|Overall Study|Non compliance with protocol|2
1760956|NCT00796653|6134827|P1|Overall Study|Non compliance with protocol|2
1760957|NCT00796653|6134824|P4|Overall Study|Lack of Efficacy|2
1760958|NCT00796653|6134825|P3|Overall Study|Lack of Efficacy|3
1760959|NCT00796653|6134826|P2|Overall Study|Lack of Efficacy|1
1760960|NCT00796653|6134827|P1|Overall Study|Lack of Efficacy|8
1760961|NCT00796653|6134824|P4|Overall Study|Withdrawal by Subject|13
1760962|NCT00796653|6134825|P3|Overall Study|Withdrawal by Subject|8
1760963|NCT00796653|6134826|P2|Overall Study|Withdrawal by Subject|8
1760964|NCT00796653|6134827|P1|Overall Study|Withdrawal by Subject|16
1760965|NCT00796653|6134824|P4|Overall Study|Lost to Follow-up|3
1760966|NCT00796653|6134825|P3|Overall Study|Lost to Follow-up|2
1760967|NCT00796653|6134826|P2|Overall Study|Lost to Follow-up|1
1760968|NCT00796653|6134827|P1|Overall Study|Lost to Follow-up|2
1760969|NCT00796653|6134824|P4|Overall Study|Adverse Event|16
1760970|NCT00796653|6134825|P3|Overall Study|Adverse Event|16
1760971|NCT00796653|6134826|P2|Overall Study|Adverse Event|16
1760972|NCT00796653|6134827|P1|Overall Study|Adverse Event|19
1760973|NCT00796614|6135112|P4|Overall Study|Other than stated|0
1760974|NCT00796614|6135113|P3|Overall Study|Other than stated|0
1760975|NCT00796614|6135114|P2|Overall Study|Other than stated|0
1760976|NCT00796614|6135115|P1|Overall Study|Other than stated|1
1760977|NCT00796614|6135112|P4|Overall Study|Withdrawal by Subject|1
1760978|NCT00796614|6135113|P3|Overall Study|Withdrawal by Subject|0
1760979|NCT00796614|6135114|P2|Overall Study|Withdrawal by Subject|0
1760980|NCT00796614|6135115|P1|Overall Study|Withdrawal by Subject|1
1760981|NCT00796614|6135112|P4|Overall Study|Lost to Follow-up|0
1760982|NCT00796614|6135113|P3|Overall Study|Lost to Follow-up|1
1760983|NCT00796614|6135114|P2|Overall Study|Lost to Follow-up|2
1760984|NCT00796614|6135115|P1|Overall Study|Lost to Follow-up|2
1760985|NCT00796614|6135112|P4|Overall Study|Protocol Violation|0
1760986|NCT00796614|6135113|P3|Overall Study|Protocol Violation|2
1760987|NCT00796614|6135114|P2|Overall Study|Protocol Violation|0
1760988|NCT00796614|6135115|P1|Overall Study|Protocol Violation|0
1760989|NCT00796614|6135112|P4|Overall Study|Adverse Event|0
1760990|NCT00796614|6135113|P3|Overall Study|Adverse Event|0
1760991|NCT00796614|6135114|P2|Overall Study|Adverse Event|2
1760992|NCT00796614|6135115|P1|Overall Study|Adverse Event|1
1760993|NCT00796562|6135157|P1|Overall Study|Death|49
1760994|NCT00796549|6135166|P1|Overall Study|Progressive disease|56
1760995|NCT00796549|6135166|P1|Overall Study|Other|2
1760996|NCT00796549|6135166|P1|Overall Study|not entered|149
1760997|NCT00796549|6135166|P1|Overall Study|Adverse Event|11
1760998|NCT00796523|6135183|P2|Overall Study|Lost to Follow-up|7
1760999|NCT00796523|6135184|P1|Overall Study|Lost to Follow-up|9
1761000|NCT00796510|6135194|P2|Overall Study|Study Terminated|0
1761001|NCT00796510|6135195|P1|Overall Study|Study Terminated|2
1761002|NCT00796510|6135194|P2|Overall Study|Death|0
1761003|NCT00796510|6135195|P1|Overall Study|Death|1
1761004|NCT00796445|6135207|P2|Overall Study|Withdrawal by Subject|9
1761005|NCT00796445|6135208|P1|Overall Study|Withdrawal by Subject|18
1761006|NCT00796445|6135207|P2|Overall Study|Other|7
1761007|NCT00796445|6135208|P1|Overall Study|Other|10
1761008|NCT00796445|6135207|P2|Overall Study|Disease progression/recurrence|268
1761009|NCT00796445|6135208|P1|Overall Study|Disease progression/recurrence|537
1761010|NCT00796445|6135207|P2|Overall Study|Adverse event, non-fatal|0
1761011|NCT00796445|6135208|P1|Overall Study|Adverse event, non-fatal|4
1761012|NCT00796445|6135207|P2|Overall Study|Adverse event, serious fatal|5
1761013|NCT00796445|6135208|P1|Overall Study|Adverse event, serious fatal|10
1761014|NCT00796445|6135207|P2|Overall Study|Protocol Violation|3
1761015|NCT00796445|6135208|P1|Overall Study|Protocol Violation|5
1761016|NCT00796419|6135260|P2|Overall Study|Death|1
1761017|NCT00796419|6135261|P1|Overall Study|Death|0
1761018|NCT00796367|6135274|P3|Overall Study|other|3
1761019|NCT00796367|6135275|P2|Overall Study|other|4
1761020|NCT00796367|6135276|P1|Overall Study|other|2
1761021|NCT00796367|6135274|P3|Overall Study|Requirement for restricted medication|2
1761022|NCT00796367|6135275|P2|Overall Study|Requirement for restricted medication|0
1761023|NCT00796367|6135276|P1|Overall Study|Requirement for restricted medication|2
1761024|NCT00796367|6135274|P3|Overall Study|Pregnancy|1
1761025|NCT00796367|6135275|P2|Overall Study|Pregnancy|0
1761026|NCT00796367|6135276|P1|Overall Study|Pregnancy|1
1761027|NCT00796367|6135274|P3|Overall Study|non compliance|1
1761028|NCT00796367|6135275|P2|Overall Study|non compliance|1
1761029|NCT00796367|6135276|P1|Overall Study|non compliance|3
1761030|NCT00796367|6135274|P3|Overall Study|Lack of Efficacy|0
1761031|NCT00796367|6135275|P2|Overall Study|Lack of Efficacy|1
1761032|NCT00796367|6135276|P1|Overall Study|Lack of Efficacy|2
1761033|NCT00796367|6135274|P3|Overall Study|Withdrawal by Subject|12
1761034|NCT00796367|6135275|P2|Overall Study|Withdrawal by Subject|11
1761035|NCT00796367|6135276|P1|Overall Study|Withdrawal by Subject|9
1761036|NCT00796367|6135274|P3|Overall Study|Lost to Follow-up|21
1761037|NCT00796367|6135275|P2|Overall Study|Lost to Follow-up|4
1761038|NCT00796367|6135276|P1|Overall Study|Lost to Follow-up|5
1761039|NCT00796367|6135274|P3|Overall Study|Adverse Event|7
1761040|NCT00796367|6135275|P2|Overall Study|Adverse Event|4
1761041|NCT00796367|6135276|P1|Overall Study|Adverse Event|6
1761042|NCT00796328|6135287|P1|Overall Study|experienced hypotension requiring tx|6
1761043|NCT00796315|6135291|P3|Overall Study|Protocol Violation|0
1761044|NCT00796315|6135292|P2|Overall Study|Protocol Violation|1
1761045|NCT00796315|6135293|P1|Overall Study|Protocol Violation|0
1761046|NCT00796224|6135321|P2|Overall Study|Protocol Violation|1
1761047|NCT00796224|6135322|P1|Overall Study|Protocol Violation|0
1761048|NCT00796224|6135321|P2|Overall Study|Adverse Event|0
1761049|NCT00796224|6135322|P1|Overall Study|Adverse Event|1
1761050|NCT00796120|6135342|P2|Overall Study|Randomized but not treated|3
1761051|NCT00796120|6135343|P1|Overall Study|Randomized but not treated|0
1761052|NCT00796120|6135342|P2|Overall Study|Physician Decision|17
1761053|NCT00796120|6135343|P1|Overall Study|Physician Decision|16
1761054|NCT00796120|6135342|P2|Overall Study|Other|17
1761055|NCT00796120|6135343|P1|Overall Study|Other|6
1761056|NCT00796120|6135342|P2|Overall Study|Participant refusal|4
1761057|NCT00796120|6135343|P1|Overall Study|Participant refusal|3
1761058|NCT00796120|6135342|P2|Overall Study|Progressive disease|13
1761059|NCT00796120|6135343|P1|Overall Study|Progressive disease|22
1761060|NCT00796120|6135342|P2|Overall Study|Adverse Event|6
1761061|NCT00796120|6135343|P1|Overall Study|Adverse Event|11
1761062|NCT00796120|6135342|P2|Overall Study|Death|0
1761063|NCT00796120|6135343|P1|Overall Study|Death|3
1761064|NCT00796003|6135359|P2|Overall Study|Participants Not treated|2
1761065|NCT00796003|6135360|P1|Overall Study|Participants Not treated|0
1761066|NCT00796003|6135359|P2|Overall Study|Other|1
1761067|NCT00796003|6135360|P1|Overall Study|Other|0
1761068|NCT00796003|6135359|P2|Overall Study|Withdrawal by Subject|1
1761069|NCT00796003|6135360|P1|Overall Study|Withdrawal by Subject|0
1761070|NCT00796003|6135359|P2|Overall Study|Physician Decision|4
1761071|NCT00796003|6135360|P1|Overall Study|Physician Decision|0
1761072|NCT00796003|6135359|P2|Overall Study|Specified organ function not met|1
1761073|NCT00796003|6135360|P1|Overall Study|Specified organ function not met|0
1761074|NCT00796003|6135359|P2|Overall Study|Adverse Event|7
1761075|NCT00796003|6135360|P1|Overall Study|Adverse Event|1
1761076|NCT00796003|6135359|P2|Overall Study|Disease Progression|13
1761077|NCT00796003|6135360|P1|Overall Study|Disease Progression|2
1761078|NCT00795951|6135381|P1|Overall Study|Withdrawal by Subject|1
1761079|NCT00795951|6135381|P1|Overall Study|Lost to Follow-up|1
1761080|NCT00795886|6135418|P1|Overall Study|Death|10
1761081|NCT00795821|6135426|P2|Taper Phase|Withdrawal by Subject|0
1761082|NCT00795821|6135427|P1|Taper Phase|Withdrawal by Subject|4
1761083|NCT00795821|6135426|P2|Taper Phase|Physician Decision|0
1761084|NCT00795821|6135427|P1|Taper Phase|Physician Decision|2
1761085|NCT00795821|6135426|P2|Taper Phase|Lost to Follow-up|0
1761086|NCT00795821|6135427|P1|Taper Phase|Lost to Follow-up|1
1761087|NCT00795821|6135426|P2|Taper Phase|Adverse Event|0
1761088|NCT00795821|6135427|P1|Taper Phase|Adverse Event|2
1761089|NCT00795821|6135426|P2|Long-term Extension Phase|Withdrawal by Subject|25
1761090|NCT00795821|6135427|P1|Long-term Extension Phase|Withdrawal by Subject|25
1761091|NCT00795821|6135426|P2|Long-term Extension Phase|Protocol Violation|5
1761092|NCT00795821|6135427|P1|Long-term Extension Phase|Protocol Violation|3
1761093|NCT00795821|6135426|P2|Long-term Extension Phase|Physician Decision|2
1761094|NCT00795821|6135427|P1|Long-term Extension Phase|Physician Decision|1
1761095|NCT00795821|6135426|P2|Long-term Extension Phase|Lost to Follow-up|16
1761096|NCT00795821|6135427|P1|Long-term Extension Phase|Lost to Follow-up|20
1761097|NCT00795821|6135426|P2|Long-term Extension Phase|Lack of Efficacy|12
1761098|NCT00795821|6135427|P1|Long-term Extension Phase|Lack of Efficacy|16
1761099|NCT00795821|6135426|P2|Long-term Extension Phase|Adverse Event|32
1761100|NCT00795821|6135427|P1|Long-term Extension Phase|Adverse Event|25
1761101|NCT00795821|6135426|P2|Acute Treatment Phase|Withdrawal by Subject|10
1761102|NCT00795821|6135427|P1|Acute Treatment Phase|Withdrawal by Subject|16
1761103|NCT00795821|6135426|P2|Acute Treatment Phase|Protocol Violation|2
1761104|NCT00795821|6135427|P1|Acute Treatment Phase|Protocol Violation|1
1761105|NCT00795821|6135426|P2|Acute Treatment Phase|Physician Decision|1
1761106|NCT00795821|6135427|P1|Acute Treatment Phase|Physician Decision|1
1761107|NCT00795821|6135426|P2|Acute Treatment Phase|Lost to Follow-up|12
1761108|NCT00795821|6135427|P1|Acute Treatment Phase|Lost to Follow-up|9
1761109|NCT00795821|6135426|P2|Acute Treatment Phase|Lack of Efficacy|2
1761110|NCT00795821|6135427|P1|Acute Treatment Phase|Lack of Efficacy|5
1761111|NCT00795821|6135426|P2|Acute Treatment Phase|Death|0
1761112|NCT00795821|6135427|P1|Acute Treatment Phase|Death|1
1761113|NCT00795821|6135426|P2|Acute Treatment Phase|Adverse Event|4
1761114|NCT00795821|6135427|P1|Acute Treatment Phase|Adverse Event|23
1761115|NCT00795717|6135502|P2|Phase II|too busy|1
1761116|NCT00795717|6135503|P1|Phase II|too busy|0
1761117|NCT00795717|6135502|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
1761118|NCT00795717|6135503|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
1761119|NCT00795717|6135502|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
1761120|NCT00795717|6135503|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
1761121|NCT00795717|6135502|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
1761122|NCT00795717|6135503|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
1761123|NCT00795704|6135515|P2|Overall Study|Adverse Event|1
1761124|NCT00795704|6135516|P1|Overall Study|Adverse Event|1
1761125|NCT00795704|6135515|P2|Overall Study|Withdrawal by Subject|2
1761126|NCT00795704|6135516|P1|Overall Study|Withdrawal by Subject|3
1761127|NCT00795639|6135528|P2|Overall Study|Randomized and not treated|1
1761128|NCT00795639|6135529|P1|Overall Study|Randomized and not treated|0
1761129|NCT00795639|6135528|P2|Overall Study|Terminated by sponsor|12
1761130|NCT00795639|6135529|P1|Overall Study|Terminated by sponsor|13
1761131|NCT00795639|6135528|P2|Overall Study|Other|2
1761132|NCT00795639|6135529|P1|Overall Study|Other|0
1761133|NCT00795639|6135528|P2|Overall Study|Adverse Event|2
1761134|NCT00795639|6135529|P1|Overall Study|Adverse Event|5
1761135|NCT00795639|6135528|P2|Overall Study|Pregnancy|0
1761136|NCT00795639|6135529|P1|Overall Study|Pregnancy|1
1761137|NCT00795639|6135528|P2|Overall Study|Withdrawal by Subject|3
1761138|NCT00795639|6135529|P1|Overall Study|Withdrawal by Subject|1
1761139|NCT00795639|6135528|P2|Overall Study|Death|6
1761140|NCT00795639|6135529|P1|Overall Study|Death|1
1761141|NCT00795600|6135541|P2|Overall Study|Unclassified|1
1761142|NCT00795600|6135542|P1|Overall Study|Unclassified|1
1761143|NCT00795600|6135541|P2|Overall Study|Withdrawal by Subject|0
1761144|NCT00795600|6135542|P1|Overall Study|Withdrawal by Subject|1
1761145|NCT00795600|6135541|P2|Overall Study|Protocol Violation|2
1761146|NCT00795600|6135542|P1|Overall Study|Protocol Violation|1
1761147|NCT00795600|6135541|P2|Overall Study|Adverse Event|1
1761148|NCT00795600|6135542|P1|Overall Study|Adverse Event|1
1761149|NCT00795535|6135662|P1|Overall Study|incomplete data and technical problems|20
1761150|NCT00795509|6135669|P1|Overall Study|Protocol Violation|31
1761151|NCT00795184|6135738|P2|Overall Study|Tissue sampling incomplete/conclusive|13
1761152|NCT00795184|6135739|P1|Overall Study|Tissue sampling incomplete/conclusive|8
1761153|NCT00795132|6135800|P1|Overall Study|Relapse|2
1761154|NCT00795132|6135800|P1|Overall Study|Death|1
1761155|NCT00794963|6135827|P2|Overall Study|Withdrawal by Subject|4
1761156|NCT00794963|6135828|P1|Overall Study|Withdrawal by Subject|1
1761157|NCT00794950|6135834|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
1761158|NCT00794950|6135834|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
1761159|NCT00794950|6135834|P1|Beginning Sunitinib Treatment|Physician Decision|5
1761160|NCT00794950|6135834|P1|Beginning Sunitinib Treatment|cystectomy|5
1761161|NCT00794950|6135834|P1|BCG Induction|Adverse Event|1
1761162|NCT00794950|6135834|P1|BCG Induction|noncompliant w. BCG|1
1761163|NCT00794950|6135834|P1|BCG Induction|ineligible|3
1761164|NCT00794950|6135834|P1|BCG Induction|Withdrawal by Subject|2
1761165|NCT00794924|6135843|P2|Overall Study|Adverse Event|2
1761166|NCT00794924|6135844|P1|Overall Study|Adverse Event|6
1761167|NCT00794924|6135843|P2|Overall Study|Withdrawal by Subject|60
1761168|NCT00794924|6135844|P1|Overall Study|Withdrawal by Subject|48
1761169|NCT00794924|6135843|P2|Overall Study|Lost to Follow-up|8
1761170|NCT00794924|6135844|P1|Overall Study|Lost to Follow-up|6
1761171|NCT00794820|6135848|P1|Overall Study|Ineligible/Screen Failure|1
1761172|NCT00794820|6135848|P1|Overall Study|Resistant Disease|2
1761173|NCT00794820|6135848|P1|Overall Study|Secondary Malignancies|2
1761174|NCT00794820|6135848|P1|Overall Study|Adverse Event|11
1761175|NCT00794677|6135856|P2|First Intervention|Withdrawal by Subject|0
1761176|NCT00794677|6135857|P1|First Intervention|Withdrawal by Subject|2
1761177|NCT00794664|6135879|P2|Follow-up Period|Protocol non-compliance|1
1761178|NCT00794664|6135880|P1|Follow-up Period|Protocol non-compliance|0
1761179|NCT00794664|6135879|P2|Follow-up Period|Withdrawal by Subject|2
1761180|NCT00794664|6135880|P1|Follow-up Period|Withdrawal by Subject|0
1761181|NCT00794664|6135879|P2|Follow-up Period|Other|2
1761182|NCT00794664|6135880|P1|Follow-up Period|Other|1
1761183|NCT00794664|6135879|P2|Treatment Period|Adverse Event|8
1761184|NCT00794664|6135880|P1|Treatment Period|Adverse Event|1
1761185|NCT00794664|6135879|P2|Treatment Period|Other|1
1761186|NCT00794664|6135880|P1|Treatment Period|Other|0
1761187|NCT00794664|6135879|P2|Treatment Period|Protocol non-compliance|1
1761188|NCT00794664|6135880|P1|Treatment Period|Protocol non-compliance|0
1761189|NCT00794664|6135879|P2|Treatment Period|Withdrawal by Subject|2
1761190|NCT00794664|6135880|P1|Treatment Period|Withdrawal by Subject|0
1761191|NCT00794573|6135926|P2|Overall Study|Lost to Follow-up|33
1761192|NCT00794573|6135927|P1|Overall Study|Lost to Follow-up|26
1761193|NCT00794573|6135926|P2|Overall Study|Withdrawal by Subject|12
1761194|NCT00794573|6135927|P1|Overall Study|Withdrawal by Subject|9
1761195|NCT00794573|6135926|P2|Overall Study|Death|0
1761196|NCT00794573|6135927|P1|Overall Study|Death|3
1761197|NCT00794365|6135996|P1|Overall Study|Lack of Efficacy|3
1761198|NCT00794365|6135996|P1|Overall Study|Adverse Event|10
1761199|NCT00794365|6135996|P1|Overall Study|Poor Compliance|11
1761200|NCT00794365|6135996|P1|Overall Study|Other|17
1761201|NCT00794365|6135996|P1|Overall Study|Lost to Follow-up|38
1761202|NCT00794196|6136017|P2|Overall Study|Lost to Follow-up|23
1761203|NCT00794196|6136018|P1|Overall Study|Lost to Follow-up|5
1761204|NCT00794157|6136038|P3|Overall Study|Protocol deviation|1
1761205|NCT00794157|6136039|P2|Overall Study|Protocol deviation|1
1761206|NCT00794157|6136040|P1|Overall Study|Protocol deviation|0
1761207|NCT00794157|6136038|P3|Overall Study|Abnormal test procedure result(s)|0
1761208|NCT00794157|6136039|P2|Overall Study|Abnormal test procedure result(s)|1
1761209|NCT00794157|6136040|P1|Overall Study|Abnormal test procedure result(s)|0
1761210|NCT00794157|6136038|P3|Overall Study|Administrative problems|4
1761211|NCT00794157|6136039|P2|Overall Study|Administrative problems|7
1761212|NCT00794157|6136040|P1|Overall Study|Administrative problems|1
1761213|NCT00794157|6136038|P3|Overall Study|Unsatisfactory therapeutic effect|2
1761214|NCT00794157|6136039|P2|Overall Study|Unsatisfactory therapeutic effect|0
1761215|NCT00794157|6136040|P1|Overall Study|Unsatisfactory therapeutic effect|1
1761216|NCT00794157|6136038|P3|Overall Study|Lost to Follow-up|1
1761217|NCT00794157|6136039|P2|Overall Study|Lost to Follow-up|0
1761218|NCT00794157|6136040|P1|Overall Study|Lost to Follow-up|2
1761219|NCT00794157|6136038|P3|Overall Study|Subject withdrew consent|3
1761220|NCT00794157|6136039|P2|Overall Study|Subject withdrew consent|0
1761221|NCT00794157|6136040|P1|Overall Study|Subject withdrew consent|2
1761222|NCT00794157|6136038|P3|Overall Study|Adverse Event|8
1761223|NCT00794157|6136039|P2|Overall Study|Adverse Event|1
1761224|NCT00794157|6136040|P1|Overall Study|Adverse Event|4
1761225|NCT00794118|6136069|P1|Overall Study|Changed hospital center|2
1761226|NCT00794118|6136069|P1|Overall Study|Withdrawal by Subject|9
1761227|NCT00794118|6136069|P1|Overall Study|Lost to Follow-up|16
1761228|NCT00794040|6136129|P2|Overall Study|Physician Decision|1
1761229|NCT00794040|6136130|P1|Overall Study|Physician Decision|0
1761230|NCT00794040|6136129|P2|Overall Study|Withdrawal by Subject|4
1761231|NCT00794040|6136130|P1|Overall Study|Withdrawal by Subject|3
1761232|NCT00793910|6136146|P2|Overall Study|Withdrawal by Subject|1
1761233|NCT00793910|6136147|P1|Overall Study|Withdrawal by Subject|0
1761234|NCT00793910|6136146|P2|Overall Study|decided to undergo LASIK instead of PRK|1
1761235|NCT00793910|6136147|P1|Overall Study|decided to undergo LASIK instead of PRK|2
1761236|NCT00793910|6136146|P2|Overall Study|ineligible based on entry criteria|3
1761237|NCT00793910|6136147|P1|Overall Study|ineligible based on entry criteria|2
1761238|NCT00793910|6136146|P2|Overall Study|did not pick up medications|1
1761239|NCT00793910|6136147|P1|Overall Study|did not pick up medications|1
1761240|NCT00793910|6136146|P2|Overall Study|discarded study pills|1
1761241|NCT00793910|6136147|P1|Overall Study|discarded study pills|0
1761242|NCT00793871|6136161|P1|Overall Study|Study terminated by the Sponsor|7
1761243|NCT00793871|6136161|P1|Overall Study|Lost to Follow-up|3
1761244|NCT00793871|6136161|P1|Overall Study|Death|50
1761245|NCT00793819|6136175|P2|Overall Study|Lost to Follow-up|1
1761246|NCT00793819|6136176|P1|Overall Study|Lost to Follow-up|1
1761247|NCT00793819|6136175|P2|Overall Study|Withdrawal by Subject|3
1761248|NCT00793819|6136176|P1|Overall Study|Withdrawal by Subject|4
1761249|NCT00793819|6136175|P2|Overall Study|Lack of Efficacy|1
1761250|NCT00793819|6136176|P1|Overall Study|Lack of Efficacy|1
1761251|NCT00793819|6136175|P2|Overall Study|Adverse Event|4
1761252|NCT00793819|6136176|P1|Overall Study|Adverse Event|8
1761253|NCT00793793|6136194|P12|Overall Study|reason not specified|4
1761254|NCT00793793|6136195|P11|Overall Study|reason not specified|2
1761255|NCT00793793|6136196|P10|Overall Study|reason not specified|6
1761256|NCT00793793|6136197|P9|Overall Study|reason not specified|7
1761257|NCT00793793|6136198|P8|Overall Study|reason not specified|0
1761258|NCT00793793|6136199|P7|Overall Study|reason not specified|2
1761259|NCT00793793|6136200|P6|Overall Study|reason not specified|1
1761260|NCT00793793|6136201|P5|Overall Study|reason not specified|1
1761261|NCT00793793|6136202|P4|Overall Study|reason not specified|1
1761262|NCT00793793|6136203|P3|Overall Study|reason not specified|0
1761263|NCT00793793|6136204|P2|Overall Study|reason not specified|1
1761264|NCT00793793|6136205|P1|Overall Study|reason not specified|0
1761265|NCT00793793|6136194|P12|Overall Study|Withdrawal by Subject|0
1761266|NCT00793793|6136195|P11|Overall Study|Withdrawal by Subject|0
1761267|NCT00793793|6136196|P10|Overall Study|Withdrawal by Subject|0
1761268|NCT00793793|6136197|P9|Overall Study|Withdrawal by Subject|1
1761269|NCT00793793|6136198|P8|Overall Study|Withdrawal by Subject|0
1761270|NCT00793793|6136199|P7|Overall Study|Withdrawal by Subject|0
1761271|NCT00793793|6136200|P6|Overall Study|Withdrawal by Subject|0
1761272|NCT00793793|6136201|P5|Overall Study|Withdrawal by Subject|1
1761273|NCT00793793|6136202|P4|Overall Study|Withdrawal by Subject|0
1761274|NCT00793793|6136203|P3|Overall Study|Withdrawal by Subject|0
1761275|NCT00793793|6136204|P2|Overall Study|Withdrawal by Subject|0
1761276|NCT00793793|6136205|P1|Overall Study|Withdrawal by Subject|0
1761277|NCT00793793|6136194|P12|Overall Study|Lost to Follow-up|0
1761278|NCT00793793|6136195|P11|Overall Study|Lost to Follow-up|1
1761279|NCT00793793|6136196|P10|Overall Study|Lost to Follow-up|3
1761280|NCT00793793|6136197|P9|Overall Study|Lost to Follow-up|1
1761281|NCT00793793|6136198|P8|Overall Study|Lost to Follow-up|0
1761282|NCT00793793|6136199|P7|Overall Study|Lost to Follow-up|0
1761283|NCT00793793|6136200|P6|Overall Study|Lost to Follow-up|0
1761284|NCT00793793|6136201|P5|Overall Study|Lost to Follow-up|0
1761285|NCT00793793|6136202|P4|Overall Study|Lost to Follow-up|0
1761286|NCT00793793|6136203|P3|Overall Study|Lost to Follow-up|1
1761287|NCT00793793|6136204|P2|Overall Study|Lost to Follow-up|0
1761288|NCT00793793|6136205|P1|Overall Study|Lost to Follow-up|0
1761289|NCT00793793|6136194|P12|Overall Study|Protocol Violation|0
1761290|NCT00793793|6136195|P11|Overall Study|Protocol Violation|0
1761291|NCT00793793|6136196|P10|Overall Study|Protocol Violation|0
1761292|NCT00793793|6136197|P9|Overall Study|Protocol Violation|0
1761293|NCT00793793|6136198|P8|Overall Study|Protocol Violation|0
1761294|NCT00793793|6136199|P7|Overall Study|Protocol Violation|0
1761295|NCT00793793|6136200|P6|Overall Study|Protocol Violation|0
1761296|NCT00793793|6136201|P5|Overall Study|Protocol Violation|0
1761297|NCT00793793|6136202|P4|Overall Study|Protocol Violation|1
1761298|NCT00793793|6136203|P3|Overall Study|Protocol Violation|0
1761299|NCT00793793|6136204|P2|Overall Study|Protocol Violation|0
1761300|NCT00793793|6136205|P1|Overall Study|Protocol Violation|0
1761301|NCT00793793|6136194|P12|Overall Study|Adverse Event|2
1761302|NCT00793793|6136195|P11|Overall Study|Adverse Event|0
1761303|NCT00793793|6136196|P10|Overall Study|Adverse Event|0
1761304|NCT00793793|6136197|P9|Overall Study|Adverse Event|0
1761305|NCT00793793|6136198|P8|Overall Study|Adverse Event|0
1761306|NCT00793793|6136199|P7|Overall Study|Adverse Event|2
1761307|NCT00793793|6136200|P6|Overall Study|Adverse Event|1
1761308|NCT00793793|6136201|P5|Overall Study|Adverse Event|0
1761309|NCT00793793|6136202|P4|Overall Study|Adverse Event|1
1761310|NCT00793793|6136203|P3|Overall Study|Adverse Event|1
1761311|NCT00793793|6136204|P2|Overall Study|Adverse Event|0
1761312|NCT00793793|6136205|P1|Overall Study|Adverse Event|0
1761313|NCT00793780|6136580|P2|Overall Study|Withdrawal by Subject|1
1761314|NCT00793780|6136581|P1|Overall Study|Withdrawal by Subject|2
1761315|NCT00793624|6136612|P4|Overall Study|Other reason not described above|3
1761316|NCT00793624|6136613|P3|Overall Study|Other reason not described above|6
1761317|NCT00793624|6136614|P2|Overall Study|Other reason not described above|4
1761318|NCT00793624|6136615|P1|Overall Study|Other reason not described above|6
1761319|NCT00793624|6136612|P4|Overall Study|Non compliance with protocol|3
1761320|NCT00793624|6136613|P3|Overall Study|Non compliance with protocol|2
1761321|NCT00793624|6136614|P2|Overall Study|Non compliance with protocol|3
1761322|NCT00793624|6136615|P1|Overall Study|Non compliance with protocol|2
1761323|NCT00793624|6136612|P4|Overall Study|Lack of Efficacy|3
1761324|NCT00793624|6136613|P3|Overall Study|Lack of Efficacy|1
1761325|NCT00793624|6136614|P2|Overall Study|Lack of Efficacy|2
1761326|NCT00793624|6136615|P1|Overall Study|Lack of Efficacy|9
1761327|NCT00793624|6136612|P4|Overall Study|Withdrawal by Subject|14
1761328|NCT00793624|6136613|P3|Overall Study|Withdrawal by Subject|11
1761329|NCT00793624|6136614|P2|Overall Study|Withdrawal by Subject|9
1761330|NCT00793624|6136615|P1|Overall Study|Withdrawal by Subject|20
1761331|NCT00793624|6136612|P4|Overall Study|Lost to Follow-up|0
1761332|NCT00793624|6136613|P3|Overall Study|Lost to Follow-up|4
1761333|NCT00793624|6136614|P2|Overall Study|Lost to Follow-up|2
1761334|NCT00793624|6136615|P1|Overall Study|Lost to Follow-up|2
1761335|NCT00793624|6136612|P4|Overall Study|Adverse Event|20
1761336|NCT00793624|6136613|P3|Overall Study|Adverse Event|15
1761337|NCT00793624|6136614|P2|Overall Study|Adverse Event|16
1761338|NCT00793624|6136615|P1|Overall Study|Adverse Event|18
1761339|NCT00793585|6136896|P2|Overall Study|Protocol Violation|2
1761340|NCT00793585|6136897|P1|Overall Study|Protocol Violation|1
1761341|NCT00793585|6136896|P2|Overall Study|Adverse Event|1
1761342|NCT00793585|6136897|P1|Overall Study|Adverse Event|1
1761343|NCT00793546|6136916|P2|Overall Study|Other|0
1761344|NCT00793546|6136917|P1|Overall Study|Other|1
1761345|NCT00793546|6136916|P2|Overall Study|Study Terminated by Sponsor|27
1761346|NCT00793546|6136917|P1|Overall Study|Study Terminated by Sponsor|8
1761347|NCT00793546|6136916|P2|Overall Study|Withdrawal by Subject|1
1761348|NCT00793546|6136917|P1|Overall Study|Withdrawal by Subject|1
1761349|NCT00793546|6136916|P2|Overall Study|Lost to Follow-up|0
1761350|NCT00793546|6136917|P1|Overall Study|Lost to Follow-up|1
1761351|NCT00793546|6136916|P2|Overall Study|Death|0
1761352|NCT00793546|6136917|P1|Overall Study|Death|3
1761353|NCT00793403|6136967|P1|Overall Study|Other|73
1761354|NCT00793325|6137014|P1|Overall Study|Lost to Follow-up|1
1761355|NCT00793325|6137014|P1|Overall Study|Protocol Violation|18
1761356|NCT00793182|6137040|P2|Overall Study|Adverse Event|1
1761357|NCT00793182|6137041|P1|Overall Study|Adverse Event|0
1761358|NCT00793104|6137051|P1|Overall Study|Lost to Follow-up|1
1761366|NCT00792935|6137070|P2|Overall Study|Withdrawal by Subject|1
1761367|NCT00792935|6137071|P1|Overall Study|Withdrawal by Subject|0
1761368|NCT00792935|6137070|P2|Overall Study|Protocol Violation|0
1761369|NCT00792935|6137071|P1|Overall Study|Protocol Violation|2
1761370|NCT00792935|6137070|P2|Overall Study|Lost to Follow-up|1
1761371|NCT00792935|6137071|P1|Overall Study|Lost to Follow-up|0
1761372|NCT00792935|6137070|P2|Overall Study|Adverse Event|1
1761373|NCT00792935|6137071|P1|Overall Study|Adverse Event|2
1761374|NCT00792909|6137103|P3|Overall Study|Withdrawal by Subject|0
1761375|NCT00792909|6137104|P2|Overall Study|Withdrawal by Subject|1
1761376|NCT00792909|6137105|P1|Overall Study|Withdrawal by Subject|0
1761377|NCT00792805|6137161|P3|Overall Study|Protocol deviation|1
1761378|NCT00792805|6137162|P2|Overall Study|Protocol deviation|1
1761379|NCT00792805|6137163|P1|Overall Study|Protocol deviation|0
1761380|NCT00792805|6137161|P3|Overall Study|Abnormal laboratory value(s)|1
1761381|NCT00792805|6137162|P2|Overall Study|Abnormal laboratory value(s)|0
1761382|NCT00792805|6137163|P1|Overall Study|Abnormal laboratory value(s)|0
1761383|NCT00792805|6137161|P3|Overall Study|Lost to Follow-up|6
1761384|NCT00792805|6137162|P2|Overall Study|Lost to Follow-up|1
1761385|NCT00792805|6137163|P1|Overall Study|Lost to Follow-up|1
1761386|NCT00792805|6137161|P3|Overall Study|Unsatisfactory therapeutic effect|6
1761387|NCT00792805|6137162|P2|Overall Study|Unsatisfactory therapeutic effect|6
1761388|NCT00792805|6137163|P1|Overall Study|Unsatisfactory therapeutic effect|1
1761389|NCT00792805|6137161|P3|Overall Study|Abnormal test procedure result(s)|0
1761390|NCT00792805|6137162|P2|Overall Study|Abnormal test procedure result(s)|2
1761391|NCT00792805|6137163|P1|Overall Study|Abnormal test procedure result(s)|1
1761392|NCT00792805|6137161|P3|Overall Study|Administrative problems|4
1761393|NCT00792805|6137162|P2|Overall Study|Administrative problems|0
1761394|NCT00792805|6137163|P1|Overall Study|Administrative problems|2
1761395|NCT00792805|6137161|P3|Overall Study|Subject withdrew consent|5
1761396|NCT00792805|6137162|P2|Overall Study|Subject withdrew consent|6
1761397|NCT00792805|6137163|P1|Overall Study|Subject withdrew consent|5
1761398|NCT00792805|6137161|P3|Overall Study|Adverse Event|10
1761399|NCT00792805|6137162|P2|Overall Study|Adverse Event|10
1761400|NCT00792805|6137163|P1|Overall Study|Adverse Event|12
1761401|NCT00792701|6137173|P2|Overall Study|Not protocol specified|0
1761402|NCT00792701|6137174|P1|Overall Study|Not protocol specified|17
1761403|NCT00792701|6137173|P2|Overall Study|Withdrawal by Subject|19
1761404|NCT00792701|6137174|P1|Overall Study|Withdrawal by Subject|1
1761405|NCT00792701|6137173|P2|Overall Study|Ineligible|3
1761406|NCT00792701|6137174|P1|Overall Study|Ineligible|1
1761407|NCT00792701|6137173|P2|Overall Study|Adverse Event|22
1761408|NCT00792701|6137174|P1|Overall Study|Adverse Event|0
1761409|NCT00792636|6137204|P3|Overall Study|Investigator Discretion|2
1761410|NCT00792636|6137205|P2|Overall Study|Investigator Discretion|0
1761411|NCT00792636|6137206|P1|Overall Study|Investigator Discretion|2
1761412|NCT00792636|6137204|P3|Overall Study|Adverse Event|3
1761413|NCT00792636|6137205|P2|Overall Study|Adverse Event|2
1761414|NCT00792636|6137206|P1|Overall Study|Adverse Event|4
1761415|NCT00792636|6137204|P3|Overall Study|Lack of Efficacy|13
1761416|NCT00792636|6137205|P2|Overall Study|Lack of Efficacy|4
1761417|NCT00792636|6137206|P1|Overall Study|Lack of Efficacy|3
1761418|NCT00792636|6137204|P3|Overall Study|Withdrew Consent|9
1761419|NCT00792636|6137205|P2|Overall Study|Withdrew Consent|13
1761420|NCT00792636|6137206|P1|Overall Study|Withdrew Consent|10
1761421|NCT00792636|6137204|P3|Overall Study|Lost to Follow-up|14
1761422|NCT00792636|6137205|P2|Overall Study|Lost to Follow-up|19
1761423|NCT00792636|6137206|P1|Overall Study|Lost to Follow-up|13
1761424|NCT00792636|6137204|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
1761425|NCT00792636|6137205|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
1761426|NCT00792636|6137206|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
1761427|NCT00792636|6137204|P3|Overall Study|Protocol Violation|20
1761428|NCT00792636|6137205|P2|Overall Study|Protocol Violation|23
1761429|NCT00792636|6137206|P1|Overall Study|Protocol Violation|17
1761430|NCT00792623|6137243|P1|Overall Study|Withdrawal by Subject|5
1761431|NCT00792623|6137243|P1|Overall Study|Adverse Event|2
1761432|NCT00792571|6137260|P1|Overall Study|Other|4
1761433|NCT00792571|6137260|P1|Overall Study|Withdrawal by Subject|1
1761434|NCT00792571|6137260|P1|Overall Study|Adverse Event|4
1761435|NCT00792571|6137260|P1|Overall Study|Death|1
1761436|NCT00792298|6137280|P8|Treatment Period 2|Withdrawal by Subject|2
1761437|NCT00792298|6137281|P7|Treatment Period 2|Withdrawal by Subject|0
1761438|NCT00792298|6137282|P6|Treatment Period 2|Withdrawal by Subject|0
1761439|NCT00792298|6137283|P5|Treatment Period 2|Withdrawal by Subject|1
1761440|NCT00792298|6137284|P4|Treatment Period 2|Withdrawal by Subject|2
1761441|NCT00792298|6137285|P3|Treatment Period 2|Withdrawal by Subject|0
1761442|NCT00792298|6137286|P2|Treatment Period 2|Withdrawal by Subject|1
1761443|NCT00792298|6137287|P1|Treatment Period 2|Withdrawal by Subject|1
1761444|NCT00792298|6137280|P8|Treatment Period 2|Pregnancy|0
1761445|NCT00792298|6137281|P7|Treatment Period 2|Pregnancy|0
1761446|NCT00792298|6137282|P6|Treatment Period 2|Pregnancy|0
1761447|NCT00792298|6137283|P5|Treatment Period 2|Pregnancy|0
1761448|NCT00792298|6137284|P4|Treatment Period 2|Pregnancy|0
1761449|NCT00792298|6137285|P3|Treatment Period 2|Pregnancy|1
1761450|NCT00792298|6137286|P2|Treatment Period 2|Pregnancy|0
1761451|NCT00792298|6137287|P1|Treatment Period 2|Pregnancy|0
1761452|NCT00792298|6137280|P8|Treatment Period 2|Physician Decision|0
1761453|NCT00792298|6137281|P7|Treatment Period 2|Physician Decision|1
1761454|NCT00792298|6137282|P6|Treatment Period 2|Physician Decision|0
1761455|NCT00792298|6137283|P5|Treatment Period 2|Physician Decision|0
1761456|NCT00792298|6137284|P4|Treatment Period 2|Physician Decision|0
1761457|NCT00792298|6137285|P3|Treatment Period 2|Physician Decision|0
1761458|NCT00792298|6137286|P2|Treatment Period 2|Physician Decision|0
1761459|NCT00792298|6137287|P1|Treatment Period 2|Physician Decision|0
1761460|NCT00792298|6137280|P8|Treatment Period 2|Lack of Efficacy|0
1761461|NCT00792298|6137281|P7|Treatment Period 2|Lack of Efficacy|0
1761462|NCT00792298|6137282|P6|Treatment Period 2|Lack of Efficacy|0
1761463|NCT00792298|6137283|P5|Treatment Period 2|Lack of Efficacy|1
1761464|NCT00792298|6137284|P4|Treatment Period 2|Lack of Efficacy|0
1761465|NCT00792298|6137285|P3|Treatment Period 2|Lack of Efficacy|0
1761466|NCT00792298|6137286|P2|Treatment Period 2|Lack of Efficacy|0
1761467|NCT00792298|6137287|P1|Treatment Period 2|Lack of Efficacy|0
1761468|NCT00792298|6137280|P8|Washout|Withdrawal by Subject|0
1761469|NCT00792298|6137281|P7|Washout|Withdrawal by Subject|0
1761470|NCT00792298|6137282|P6|Washout|Withdrawal by Subject|1
1761471|NCT00792298|6137283|P5|Washout|Withdrawal by Subject|0
1761472|NCT00792298|6137284|P4|Washout|Withdrawal by Subject|0
1761473|NCT00792298|6137285|P3|Washout|Withdrawal by Subject|1
1761474|NCT00792298|6137286|P2|Washout|Withdrawal by Subject|0
1761475|NCT00792298|6137287|P1|Washout|Withdrawal by Subject|0
1761476|NCT00792298|6137280|P8|Washout|Adverse Event|0
1761477|NCT00792298|6137281|P7|Washout|Adverse Event|0
1761478|NCT00792298|6137282|P6|Washout|Adverse Event|1
1761479|NCT00792298|6137283|P5|Washout|Adverse Event|0
1761480|NCT00792298|6137284|P4|Washout|Adverse Event|0
1761481|NCT00792298|6137285|P3|Washout|Adverse Event|0
1761482|NCT00792298|6137286|P2|Washout|Adverse Event|0
1761483|NCT00792298|6137287|P1|Washout|Adverse Event|0
1761484|NCT00792298|6137280|P8|Treatment Period 1|Protocol Violation|1
1761485|NCT00792298|6137281|P7|Treatment Period 1|Protocol Violation|0
1761486|NCT00792298|6137282|P6|Treatment Period 1|Protocol Violation|0
1761487|NCT00792298|6137283|P5|Treatment Period 1|Protocol Violation|0
1761488|NCT00792298|6137284|P4|Treatment Period 1|Protocol Violation|0
1761489|NCT00792298|6137285|P3|Treatment Period 1|Protocol Violation|0
1761490|NCT00792298|6137286|P2|Treatment Period 1|Protocol Violation|0
1761491|NCT00792298|6137287|P1|Treatment Period 1|Protocol Violation|0
1761492|NCT00792298|6137280|P8|Treatment Period 1|Physician Decision|0
1761493|NCT00792298|6137281|P7|Treatment Period 1|Physician Decision|1
1761494|NCT00792298|6137282|P6|Treatment Period 1|Physician Decision|0
1761495|NCT00792298|6137283|P5|Treatment Period 1|Physician Decision|0
1761496|NCT00792298|6137284|P4|Treatment Period 1|Physician Decision|1
1761497|NCT00792298|6137285|P3|Treatment Period 1|Physician Decision|0
1761498|NCT00792298|6137286|P2|Treatment Period 1|Physician Decision|0
1761499|NCT00792298|6137287|P1|Treatment Period 1|Physician Decision|0
1761500|NCT00792298|6137280|P8|Treatment Period 1|Lost to Follow-up|0
1761501|NCT00792298|6137281|P7|Treatment Period 1|Lost to Follow-up|1
1761502|NCT00792298|6137282|P6|Treatment Period 1|Lost to Follow-up|0
1761503|NCT00792298|6137283|P5|Treatment Period 1|Lost to Follow-up|0
1761504|NCT00792298|6137284|P4|Treatment Period 1|Lost to Follow-up|0
1761505|NCT00792298|6137285|P3|Treatment Period 1|Lost to Follow-up|0
1761506|NCT00792298|6137286|P2|Treatment Period 1|Lost to Follow-up|0
1761507|NCT00792298|6137287|P1|Treatment Period 1|Lost to Follow-up|0
1761508|NCT00792298|6137280|P8|Treatment Period 1|Withdrawal by Subject|0
1761509|NCT00792298|6137281|P7|Treatment Period 1|Withdrawal by Subject|1
1761510|NCT00792298|6137282|P6|Treatment Period 1|Withdrawal by Subject|2
1761511|NCT00792298|6137283|P5|Treatment Period 1|Withdrawal by Subject|0
1761512|NCT00792298|6137284|P4|Treatment Period 1|Withdrawal by Subject|2
1761513|NCT00792298|6137285|P3|Treatment Period 1|Withdrawal by Subject|1
1761514|NCT00792298|6137286|P2|Treatment Period 1|Withdrawal by Subject|0
1761515|NCT00792298|6137287|P1|Treatment Period 1|Withdrawal by Subject|1
1761516|NCT00792298|6137280|P8|Treatment Period 1|Lack of Efficacy|0
1761517|NCT00792298|6137281|P7|Treatment Period 1|Lack of Efficacy|0
1761518|NCT00792298|6137282|P6|Treatment Period 1|Lack of Efficacy|0
1761519|NCT00792298|6137283|P5|Treatment Period 1|Lack of Efficacy|0
1761520|NCT00792298|6137284|P4|Treatment Period 1|Lack of Efficacy|0
1761521|NCT00792298|6137285|P3|Treatment Period 1|Lack of Efficacy|1
1761522|NCT00792298|6137286|P2|Treatment Period 1|Lack of Efficacy|0
1761523|NCT00792298|6137287|P1|Treatment Period 1|Lack of Efficacy|0
1761524|NCT00792298|6137280|P8|Treatment Period 1|Adverse Event|0
1761525|NCT00792298|6137281|P7|Treatment Period 1|Adverse Event|1
1761526|NCT00792298|6137282|P6|Treatment Period 1|Adverse Event|1
1761527|NCT00792298|6137283|P5|Treatment Period 1|Adverse Event|0
1761528|NCT00792298|6137284|P4|Treatment Period 1|Adverse Event|1
1761529|NCT00792298|6137285|P3|Treatment Period 1|Adverse Event|0
1761530|NCT00792298|6137286|P2|Treatment Period 1|Adverse Event|1
1761531|NCT00792298|6137287|P1|Treatment Period 1|Adverse Event|0
1761532|NCT00792259|6137317|P3|Overall Study|Poor Quality Scans|0
1761533|NCT00792259|6137318|P2|Overall Study|Poor Quality Scans|0
1761534|NCT00792259|6137319|P1|Overall Study|Poor Quality Scans|1
1761535|NCT00792116|6137329|P2|Overall Study|Discontnued intervention|0
1761536|NCT00792116|6137330|P1|Overall Study|Discontnued intervention|1
1761537|NCT00792116|6137329|P2|Overall Study|Lost to Follow-up|1
1761538|NCT00792116|6137330|P1|Overall Study|Lost to Follow-up|0
1761539|NCT00792103|6137340|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
1761540|NCT00792103|6137340|P1|Overall Study|Protocol Violation|10
1761541|NCT00792103|6137340|P1|Overall Study|Withdrawal by Subject|52
1761542|NCT00792103|6137340|P1|Overall Study|Adverse Event|25
1761543|NCT00792103|6137340|P1|Overall Study|Lost to Follow-up|17
1761544|NCT00792103|6137340|P1|Overall Study|Enrolled, not treated|15
1761545|NCT00791999|6137352|P4|Overall Study|Reason other than those above|0
1761546|NCT00791999|6137353|P3|Overall Study|Reason other than those above|1
1761547|NCT00791999|6137354|P2|Overall Study|Reason other than those above|0
1761548|NCT00791999|6137355|P1|Overall Study|Reason other than those above|1
1761549|NCT00791999|6137352|P4|Overall Study|Lack of Efficacy|2
1761550|NCT00791999|6137353|P3|Overall Study|Lack of Efficacy|0
1761551|NCT00791999|6137354|P2|Overall Study|Lack of Efficacy|1
1761552|NCT00791999|6137355|P1|Overall Study|Lack of Efficacy|0
1761553|NCT00791999|6137352|P4|Overall Study|Adverse Event|3
1761554|NCT00791999|6137353|P3|Overall Study|Adverse Event|7
1761555|NCT00791999|6137354|P2|Overall Study|Adverse Event|3
1761556|NCT00791999|6137355|P1|Overall Study|Adverse Event|3
1761557|NCT00791999|6137352|P4|Overall Study|Protocol Violation|0
1761558|NCT00791999|6137353|P3|Overall Study|Protocol Violation|1
1761559|NCT00791999|6137354|P2|Overall Study|Protocol Violation|0
1761560|NCT00791999|6137355|P1|Overall Study|Protocol Violation|3
1761561|NCT00791999|6137352|P4|Overall Study|Withdrawal by Subject|2
1761562|NCT00791999|6137353|P3|Overall Study|Withdrawal by Subject|0
1761563|NCT00791999|6137354|P2|Overall Study|Withdrawal by Subject|1
1761564|NCT00791999|6137355|P1|Overall Study|Withdrawal by Subject|0
1761565|NCT00791999|6137352|P4|Overall Study|Protocol planed withdrawal|45
1761566|NCT00791999|6137353|P3|Overall Study|Protocol planed withdrawal|11
1761567|NCT00791999|6137354|P2|Overall Study|Protocol planed withdrawal|11
1761568|NCT00791999|6137355|P1|Overall Study|Protocol planed withdrawal|14
1761569|NCT00791934|6137380|P1|Overall Study|Did not consent for extended follow-up|13
1761570|NCT00791934|6137380|P1|Overall Study|Withdrawal by Subject|2
1761571|NCT00791921|6137390|P2|Overall Study|Reason other than those above|1
1761572|NCT00791921|6137391|P1|Overall Study|Reason other than those above|0
1761573|NCT00791921|6137390|P2|Overall Study|Lack of study drug administration|1
1761574|NCT00791921|6137391|P1|Overall Study|Lack of study drug administration|1
1761575|NCT00791921|6137390|P2|Overall Study|Lack of Efficacy|2
1761576|NCT00791921|6137391|P1|Overall Study|Lack of Efficacy|0
1761577|NCT00791921|6137390|P2|Overall Study|Adverse Event|2
1761578|NCT00791921|6137391|P1|Overall Study|Adverse Event|8
1761579|NCT00791921|6137390|P2|Overall Study|Withdrawal by Subject|2
1761580|NCT00791921|6137391|P1|Overall Study|Withdrawal by Subject|1
1761581|NCT00791921|6137390|P2|Overall Study|Protocol planed|88
1761582|NCT00791921|6137391|P1|Overall Study|Protocol planed|24
1761583|NCT00791778|6137422|P2|Follow-up|Lost to Follow-up|1
1761584|NCT00791778|6137423|P1|Follow-up|Lost to Follow-up|2
1761585|NCT00791778|6137422|P2|Follow-up|Withdrawal by Subject|0
1761586|NCT00791778|6137423|P1|Follow-up|Withdrawal by Subject|3
1761587|NCT00791778|6137422|P2|Double-blind Treatment|Non-compliant with study medication|0
1761588|NCT00791778|6137423|P1|Double-blind Treatment|Non-compliant with study medication|2
1761589|NCT00791778|6137422|P2|Double-blind Treatment|Withdrawal by Subject|9
1761590|NCT00791778|6137423|P1|Double-blind Treatment|Withdrawal by Subject|20
1761591|NCT00791778|6137422|P2|Double-blind Treatment|Protocol Violation|4
1761592|NCT00791778|6137423|P1|Double-blind Treatment|Protocol Violation|0
1761593|NCT00791778|6137422|P2|Double-blind Treatment|Physician Decision|26
1761594|NCT00791778|6137423|P1|Double-blind Treatment|Physician Decision|6
1761595|NCT00791778|6137422|P2|Double-blind Treatment|Adverse Event|9
1761596|NCT00791778|6137423|P1|Double-blind Treatment|Adverse Event|49
1761597|NCT00791765|6137477|P2|Weeks 13 to 24|Other|1
1761598|NCT00791765|6137478|P1|Weeks 13 to 24|Other|0
1761599|NCT00791765|6137477|P2|Weeks 13 to 24|Lost to Follow-up|2
1761600|NCT00791765|6137478|P1|Weeks 13 to 24|Lost to Follow-up|1
1761601|NCT00791765|6137477|P2|Weeks 13 to 24|Disease progression|1
1761602|NCT00791765|6137478|P1|Weeks 13 to 24|Disease progression|0
1761603|NCT00791765|6137477|P2|Weeks 13 to 24|Withdrawal by Subject|1
1761604|NCT00791765|6137478|P1|Weeks 13 to 24|Withdrawal by Subject|2
1761605|NCT00791765|6137477|P2|Weeks 13 to 24|Adverse Event|3
1761606|NCT00791765|6137478|P1|Weeks 13 to 24|Adverse Event|0
1761607|NCT00791765|6137477|P2|Weeks 13 to 24|Protocol deviation|0
1761608|NCT00791765|6137478|P1|Weeks 13 to 24|Protocol deviation|2
1761609|NCT00791765|6137477|P2|Weeks 1 to 12|Ineligibility determined|3
1761610|NCT00791765|6137478|P1|Weeks 1 to 12|Ineligibility determined|0
1761611|NCT00791765|6137477|P2|Weeks 1 to 12|Disease progression|0
1761612|NCT00791765|6137478|P1|Weeks 1 to 12|Disease progression|3
1761613|NCT00791765|6137477|P2|Weeks 1 to 12|Physician Decision|0
1761614|NCT00791765|6137478|P1|Weeks 1 to 12|Physician Decision|1
1761615|NCT00791765|6137477|P2|Weeks 1 to 12|Withdrawal by Subject|0
1761616|NCT00791765|6137478|P1|Weeks 1 to 12|Withdrawal by Subject|3
1761617|NCT00791765|6137477|P2|Weeks 1 to 12|Lost to Follow-up|0
1761618|NCT00791765|6137478|P1|Weeks 1 to 12|Lost to Follow-up|1
1761619|NCT00791765|6137477|P2|Weeks 1 to 12|Adverse Event|1
1761620|NCT00791765|6137478|P1|Weeks 1 to 12|Adverse Event|0
1761621|NCT00791700|6137493|P4|Overall Study|Blood sampling not done before Stage 1|1
1761622|NCT00791700|6137494|P3|Overall Study|Blood sampling not done before Stage 1|0
1761623|NCT00791700|6137495|P2|Overall Study|Blood sampling not done before Stage 1|0
1761624|NCT00791700|6137496|P1|Overall Study|Blood sampling not done before Stage 1|0
1761625|NCT00791700|6137493|P4|Overall Study|Non-compliance with study treatment|2
1761626|NCT00791700|6137494|P3|Overall Study|Non-compliance with study treatment|0
1761627|NCT00791700|6137495|P2|Overall Study|Non-compliance with study treatment|0
1761628|NCT00791700|6137496|P1|Overall Study|Non-compliance with study treatment|1
1761629|NCT00791700|6137493|P4|Overall Study|No longer willing to participate|1
1761630|NCT00791700|6137494|P3|Overall Study|No longer willing to participate|0
1761631|NCT00791700|6137495|P2|Overall Study|No longer willing to participate|1
1761632|NCT00791700|6137496|P1|Overall Study|No longer willing to participate|0
1761633|NCT00791700|6137493|P4|Overall Study|Adverse Event|1
1761634|NCT00791700|6137494|P3|Overall Study|Adverse Event|1
1761635|NCT00791700|6137495|P2|Overall Study|Adverse Event|0
1761636|NCT00791700|6137496|P1|Overall Study|Adverse Event|0
1761637|NCT00791700|6137493|P4|Overall Study|Insufficient clinical response|13
1761638|NCT00791700|6137494|P3|Overall Study|Insufficient clinical response|3
1761639|NCT00791700|6137495|P2|Overall Study|Insufficient clinical response|4
1761640|NCT00791700|6137496|P1|Overall Study|Insufficient clinical response|3
1761641|NCT00791661|6137584|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
1761642|NCT00791661|6137585|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
1761643|NCT00791661|6137586|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
1761644|NCT00791661|6137584|P3|7 Day Wash-out|Adverse Event|1
1761645|NCT00791661|6137585|P2|7 Day Wash-out|Adverse Event|0
1761646|NCT00791661|6137586|P1|7 Day Wash-out|Adverse Event|0
1761647|NCT00791648|6137679|P2|Overall Study|Withdrawal by Subject|1
1761648|NCT00791648|6137680|P1|Overall Study|Withdrawal by Subject|0
1761649|NCT00791648|6137679|P2|Overall Study|Physician Decision|1
1761650|NCT00791648|6137680|P1|Overall Study|Physician Decision|0
1761651|NCT00791557|6137716|P1|Overall Study|Adverse Event|1
1761652|NCT00791518|6137720|P1|Overall Study|Protocol Violation|93
1761653|NCT00791492|6137748|P2|Overall Study|Liver transplantation|1
1761654|NCT00791492|6137749|P1|Overall Study|Liver transplantation|5
1761655|NCT00791492|6137748|P2|Overall Study|Withdrawal by Subject|2
1761656|NCT00791492|6137749|P1|Overall Study|Withdrawal by Subject|1
1761657|NCT00791479|6137797|P6|Overall Study|Withdrawal by Subject|1
1761658|NCT00791479|6137798|P5|Overall Study|Withdrawal by Subject|0
1761659|NCT00791479|6137799|P4|Overall Study|Withdrawal by Subject|1
1761660|NCT00791479|6137800|P3|Overall Study|Withdrawal by Subject|0
1761661|NCT00791479|6137801|P2|Overall Study|Withdrawal by Subject|0
1761662|NCT00791479|6137802|P1|Overall Study|Withdrawal by Subject|0
1761663|NCT00791479|6137797|P6|Overall Study|Protocol Violation|0
1761664|NCT00791479|6137798|P5|Overall Study|Protocol Violation|0
1761665|NCT00791479|6137799|P4|Overall Study|Protocol Violation|1
1761666|NCT00791479|6137800|P3|Overall Study|Protocol Violation|0
1761667|NCT00791479|6137801|P2|Overall Study|Protocol Violation|1
1761668|NCT00791479|6137802|P1|Overall Study|Protocol Violation|2
1761669|NCT00791479|6137797|P6|Overall Study|Lost to Follow-up|1
1761670|NCT00791479|6137798|P5|Overall Study|Lost to Follow-up|0
1761671|NCT00791479|6137799|P4|Overall Study|Lost to Follow-up|0
1761672|NCT00791479|6137800|P3|Overall Study|Lost to Follow-up|0
1761673|NCT00791479|6137801|P2|Overall Study|Lost to Follow-up|1
1761674|NCT00791479|6137802|P1|Overall Study|Lost to Follow-up|0
1761675|NCT00791479|6137797|P6|Overall Study|Adverse Event|1
1761676|NCT00791479|6137798|P5|Overall Study|Adverse Event|0
1761677|NCT00791479|6137799|P4|Overall Study|Adverse Event|2
1761678|NCT00791479|6137800|P3|Overall Study|Adverse Event|0
1761679|NCT00791479|6137801|P2|Overall Study|Adverse Event|1
1761680|NCT00791479|6137802|P1|Overall Study|Adverse Event|0
1761681|NCT00791479|6137797|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
1761682|NCT00791479|6137798|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
1761683|NCT00791479|6137799|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
1761684|NCT00791479|6137800|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
1761685|NCT00791479|6137801|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
1761686|NCT00791479|6137802|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
1761687|NCT00791388|6137901|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
1761688|NCT00791388|6137902|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
1761689|NCT00791388|6137903|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
1761690|NCT00791388|6137904|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
1761691|NCT00791388|6137905|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
1761692|NCT00791388|6137901|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1761693|NCT00791388|6137902|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1761694|NCT00791388|6137903|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1761695|NCT00791388|6137904|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
1761696|NCT00791388|6137905|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
1761697|NCT00791388|6137901|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1761698|NCT00791388|6137902|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1761699|NCT00791388|6137903|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1761700|NCT00791388|6137904|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
1761701|NCT00791388|6137905|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
1761702|NCT00791258|6137947|P1|Overall Study|Lack of Efficacy|1
1761703|NCT00791258|6137947|P1|Overall Study|Subject required restricted medication|1
1761704|NCT00791258|6137947|P1|Overall Study|Subject incarcerated|1
1761705|NCT00791258|6137947|P1|Overall Study|non-compliance|3
1761706|NCT00791258|6137947|P1|Overall Study|subject left area|2
1761707|NCT00791258|6137947|P1|Overall Study|Did not take medication for >3 days|1
1761708|NCT00791258|6137947|P1|Overall Study|Withdrawal by Subject|40
1761709|NCT00791258|6137947|P1|Overall Study|Protocol Violation|109
1761710|NCT00791258|6137947|P1|Overall Study|Lost to Follow-up|18
1761711|NCT00791258|6137947|P1|Overall Study|Adverse Event|87
1761712|NCT00791128|6138009|P1|Overall Study|abdominal tumor, unrelated to device|1
1761713|NCT00791128|6138009|P1|Overall Study|non-compliance by subject|2
1761714|NCT00791128|6138009|P1|Overall Study|Device migration|2
1761715|NCT00791128|6138009|P1|Overall Study|Adverse Event|4
1761716|NCT00791076|6138040|P1|Overall Study|Study was terminated,PI left institution|8
1761717|NCT00790933|6138060|P5|Overall Study|Reason Not Specified|9
1761718|NCT00790933|6138061|P4|Overall Study|Reason Not Specified|1
1761719|NCT00790933|6138062|P3|Overall Study|Reason Not Specified|4
1761720|NCT00790933|6138063|P2|Overall Study|Reason Not Specified|16
1761721|NCT00790933|6138064|P1|Overall Study|Reason Not Specified|8
1761722|NCT00790933|6138060|P5|Overall Study|Lost to Follow-up|15
1761723|NCT00790933|6138061|P4|Overall Study|Lost to Follow-up|1
1761724|NCT00790933|6138062|P3|Overall Study|Lost to Follow-up|10
1761725|NCT00790933|6138063|P2|Overall Study|Lost to Follow-up|31
1761726|NCT00790933|6138064|P1|Overall Study|Lost to Follow-up|13
1761727|NCT00790933|6138060|P5|Overall Study|Withdrawal by Subject|50
1761728|NCT00790933|6138061|P4|Overall Study|Withdrawal by Subject|6
1761729|NCT00790933|6138062|P3|Overall Study|Withdrawal by Subject|52
1761730|NCT00790933|6138063|P2|Overall Study|Withdrawal by Subject|120
1761731|NCT00790933|6138064|P1|Overall Study|Withdrawal by Subject|123
1761732|NCT00790933|6138060|P5|Overall Study|Study Terminated by Sponsor|0
1761733|NCT00790933|6138061|P4|Overall Study|Study Terminated by Sponsor|0
1761734|NCT00790933|6138062|P3|Overall Study|Study Terminated by Sponsor|1
1761735|NCT00790933|6138063|P2|Overall Study|Study Terminated by Sponsor|0
1761736|NCT00790933|6138064|P1|Overall Study|Study Terminated by Sponsor|0
1761737|NCT00790933|6138060|P5|Overall Study|Lack of Efficacy|121
1761738|NCT00790933|6138061|P4|Overall Study|Lack of Efficacy|1
1761739|NCT00790933|6138062|P3|Overall Study|Lack of Efficacy|130
1761740|NCT00790933|6138063|P2|Overall Study|Lack of Efficacy|176
1761741|NCT00790933|6138064|P1|Overall Study|Lack of Efficacy|192
1761742|NCT00790933|6138060|P5|Overall Study|Protocol Violation(s)|12
1761743|NCT00790933|6138061|P4|Overall Study|Protocol Violation(s)|0
1761744|NCT00790933|6138062|P3|Overall Study|Protocol Violation(s)|7
1761745|NCT00790933|6138063|P2|Overall Study|Protocol Violation(s)|18
1761746|NCT00790933|6138064|P1|Overall Study|Protocol Violation(s)|8
1761747|NCT00790933|6138060|P5|Overall Study|Adverse Event|69
1761748|NCT00790933|6138061|P4|Overall Study|Adverse Event|5
1761749|NCT00790933|6138062|P3|Overall Study|Adverse Event|65
1761750|NCT00790933|6138063|P2|Overall Study|Adverse Event|119
1761751|NCT00790933|6138064|P1|Overall Study|Adverse Event|94
1761752|NCT00790907|6138595|P3|Overall Study|Did Not Receive Study Drug|0
1761753|NCT00790907|6138596|P2|Overall Study|Did Not Receive Study Drug|0
1761754|NCT00790907|6138597|P1|Overall Study|Did Not Receive Study Drug|10
1761755|NCT00790907|6138595|P3|Overall Study|Verbatim Reason on the Case Report Form|29
1761756|NCT00790907|6138596|P2|Overall Study|Verbatim Reason on the Case Report Form|20
1761757|NCT00790907|6138597|P1|Overall Study|Verbatim Reason on the Case Report Form|74
1761758|NCT00790907|6138595|P3|Overall Study|Qualifying Condition Not Present|16
1761759|NCT00790907|6138596|P2|Overall Study|Qualifying Condition Not Present|14
1761760|NCT00790907|6138597|P1|Overall Study|Qualifying Condition Not Present|29
1761761|NCT00790907|6138595|P3|Overall Study|Required Protocol-prohibited Therapy|7
1761762|NCT00790907|6138596|P2|Overall Study|Required Protocol-prohibited Therapy|5
1761763|NCT00790907|6138597|P1|Overall Study|Required Protocol-prohibited Therapy|17
1761764|NCT00790907|6138595|P3|Overall Study|Bleeding Event|21
1761765|NCT00790907|6138596|P2|Overall Study|Bleeding Event|16
1761766|NCT00790907|6138597|P1|Overall Study|Bleeding Event|11
1761767|NCT00790907|6138595|P3|Overall Study|Withdrawal by Subject|5
1761768|NCT00790907|6138596|P2|Overall Study|Withdrawal by Subject|7
1761769|NCT00790907|6138597|P1|Overall Study|Withdrawal by Subject|1
1761770|NCT00790907|6138595|P3|Overall Study|Physician Decision|255
1761771|NCT00790907|6138596|P2|Overall Study|Physician Decision|271
1761772|NCT00790907|6138597|P1|Overall Study|Physician Decision|304
1761773|NCT00790907|6138595|P3|Overall Study|Adverse Event|6
1761774|NCT00790907|6138596|P2|Overall Study|Adverse Event|7
1761775|NCT00790907|6138597|P1|Overall Study|Adverse Event|9
1761776|NCT00790868|6138620|P2|Overall Study|Lost to Follow-up|12
1761777|NCT00790868|6138621|P1|Overall Study|Lost to Follow-up|2
1761778|NCT00790868|6138620|P2|Overall Study|Withdrawal by Subject|5
1761779|NCT00790868|6138621|P1|Overall Study|Withdrawal by Subject|4
1761780|NCT00790842|6138643|P11|Expansion Cohort|Study Closure|0
1761781|NCT00790842|6138644|P10|Expansion Cohort|Study Closure|0
1761782|NCT00790842|6138645|P9|Expansion Cohort|Study Closure|0
1761783|NCT00790842|6138646|P8|Expansion Cohort|Study Closure|0
1761784|NCT00790842|6138647|P7|Expansion Cohort|Study Closure|0
1761785|NCT00790842|6138648|P6|Expansion Cohort|Study Closure|0
1761786|NCT00790842|6138649|P5|Expansion Cohort|Study Closure|0
1761787|NCT00790842|6138650|P4|Expansion Cohort|Study Closure|0
1761788|NCT00790842|6138651|P3|Expansion Cohort|Study Closure|1
1761789|NCT00790842|6138652|P2|Expansion Cohort|Study Closure|0
1761790|NCT00790842|6138653|P1|Expansion Cohort|Study Closure|0
1761791|NCT00790842|6138643|P11|Expansion Cohort|Withdrawal by Subject|0
1761792|NCT00790842|6138644|P10|Expansion Cohort|Withdrawal by Subject|0
1761793|NCT00790842|6138645|P9|Expansion Cohort|Withdrawal by Subject|0
1761794|NCT00790842|6138646|P8|Expansion Cohort|Withdrawal by Subject|0
1761795|NCT00790842|6138647|P7|Expansion Cohort|Withdrawal by Subject|0
1761796|NCT00790842|6138648|P6|Expansion Cohort|Withdrawal by Subject|0
1761797|NCT00790842|6138649|P5|Expansion Cohort|Withdrawal by Subject|0
1761798|NCT00790842|6138650|P4|Expansion Cohort|Withdrawal by Subject|0
1761799|NCT00790842|6138651|P3|Expansion Cohort|Withdrawal by Subject|3
1761800|NCT00790842|6138652|P2|Expansion Cohort|Withdrawal by Subject|0
1761801|NCT00790842|6138653|P1|Expansion Cohort|Withdrawal by Subject|0
1761802|NCT00790842|6138643|P11|Expansion Cohort|Physician Decision|0
1761803|NCT00790842|6138644|P10|Expansion Cohort|Physician Decision|0
1761804|NCT00790842|6138645|P9|Expansion Cohort|Physician Decision|0
1761805|NCT00790842|6138646|P8|Expansion Cohort|Physician Decision|0
1761806|NCT00790842|6138647|P7|Expansion Cohort|Physician Decision|0
1761807|NCT00790842|6138648|P6|Expansion Cohort|Physician Decision|0
1761808|NCT00790842|6138649|P5|Expansion Cohort|Physician Decision|0
1761809|NCT00790842|6138650|P4|Expansion Cohort|Physician Decision|0
1761810|NCT00790842|6138651|P3|Expansion Cohort|Physician Decision|1
1761811|NCT00790842|6138652|P2|Expansion Cohort|Physician Decision|0
1761812|NCT00790842|6138653|P1|Expansion Cohort|Physician Decision|0
1761813|NCT00790842|6138643|P11|Expansion Cohort|Death|0
1761814|NCT00790842|6138644|P10|Expansion Cohort|Death|0
1761815|NCT00790842|6138645|P9|Expansion Cohort|Death|0
1761816|NCT00790842|6138646|P8|Expansion Cohort|Death|0
1761817|NCT00790842|6138647|P7|Expansion Cohort|Death|0
1761818|NCT00790842|6138648|P6|Expansion Cohort|Death|0
1761819|NCT00790842|6138649|P5|Expansion Cohort|Death|0
1761820|NCT00790842|6138650|P4|Expansion Cohort|Death|0
1761821|NCT00790842|6138651|P3|Expansion Cohort|Death|2
1761822|NCT00790842|6138652|P2|Expansion Cohort|Death|0
1761823|NCT00790842|6138653|P1|Expansion Cohort|Death|0
1761824|NCT00790842|6138643|P11|Expansion Cohort|Adverse Event|0
1761825|NCT00790842|6138644|P10|Expansion Cohort|Adverse Event|0
1761826|NCT00790842|6138645|P9|Expansion Cohort|Adverse Event|0
1761827|NCT00790842|6138646|P8|Expansion Cohort|Adverse Event|0
1761828|NCT00790842|6138647|P7|Expansion Cohort|Adverse Event|1
1761829|NCT00790842|6138648|P6|Expansion Cohort|Adverse Event|0
1761830|NCT00790842|6138649|P5|Expansion Cohort|Adverse Event|0
1761831|NCT00790842|6138650|P4|Expansion Cohort|Adverse Event|0
1761832|NCT00790842|6138651|P3|Expansion Cohort|Adverse Event|0
1761833|NCT00790842|6138652|P2|Expansion Cohort|Adverse Event|0
1761834|NCT00790842|6138653|P1|Expansion Cohort|Adverse Event|0
1761835|NCT00790842|6138643|P11|Dose Level 4|Withdrawal by Subject|1
1761836|NCT00790842|6138644|P10|Dose Level 4|Withdrawal by Subject|0
1761837|NCT00790842|6138645|P9|Dose Level 4|Withdrawal by Subject|0
1761838|NCT00790842|6138646|P8|Dose Level 4|Withdrawal by Subject|0
1761839|NCT00790842|6138647|P7|Dose Level 4|Withdrawal by Subject|0
1761840|NCT00790842|6138648|P6|Dose Level 4|Withdrawal by Subject|0
1761841|NCT00790842|6138649|P5|Dose Level 4|Withdrawal by Subject|0
1761842|NCT00790842|6138650|P4|Dose Level 4|Withdrawal by Subject|0
1761843|NCT00790842|6138651|P3|Dose Level 4|Withdrawal by Subject|0
1761844|NCT00790842|6138652|P2|Dose Level 4|Withdrawal by Subject|0
1761845|NCT00790842|6138653|P1|Dose Level 4|Withdrawal by Subject|0
1761846|NCT00790842|6138643|P11|Dose Level 4|Physician Decision|1
1761847|NCT00790842|6138644|P10|Dose Level 4|Physician Decision|0
1761848|NCT00790842|6138645|P9|Dose Level 4|Physician Decision|0
1761849|NCT00790842|6138646|P8|Dose Level 4|Physician Decision|0
1761850|NCT00790842|6138647|P7|Dose Level 4|Physician Decision|1
1761851|NCT00790842|6138648|P6|Dose Level 4|Physician Decision|0
1761852|NCT00790842|6138649|P5|Dose Level 4|Physician Decision|0
1761853|NCT00790842|6138650|P4|Dose Level 4|Physician Decision|0
1761854|NCT00790842|6138651|P3|Dose Level 4|Physician Decision|0
1761855|NCT00790842|6138652|P2|Dose Level 4|Physician Decision|0
1761856|NCT00790842|6138653|P1|Dose Level 4|Physician Decision|0
1761857|NCT00790842|6138643|P11|Dose Level 4|Adverse Event|0
1761858|NCT00790842|6138644|P10|Dose Level 4|Adverse Event|0
1761859|NCT00790842|6138645|P9|Dose Level 4|Adverse Event|0
1761860|NCT00790842|6138646|P8|Dose Level 4|Adverse Event|0
1761861|NCT00790842|6138647|P7|Dose Level 4|Adverse Event|1
1761862|NCT00790842|6138648|P6|Dose Level 4|Adverse Event|0
1761863|NCT00790842|6138649|P5|Dose Level 4|Adverse Event|0
1761864|NCT00790842|6138650|P4|Dose Level 4|Adverse Event|0
1761865|NCT00790842|6138651|P3|Dose Level 4|Adverse Event|0
1761866|NCT00790842|6138652|P2|Dose Level 4|Adverse Event|0
1761867|NCT00790842|6138653|P1|Dose Level 4|Adverse Event|0
1761868|NCT00790842|6138643|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761869|NCT00790842|6138644|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761870|NCT00790842|6138645|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761871|NCT00790842|6138646|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761872|NCT00790842|6138647|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761873|NCT00790842|6138648|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761874|NCT00790842|6138649|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761875|NCT00790842|6138650|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761876|NCT00790842|6138651|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
1761877|NCT00790842|6138652|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761878|NCT00790842|6138653|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
1761879|NCT00790842|6138643|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761880|NCT00790842|6138644|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761881|NCT00790842|6138645|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761882|NCT00790842|6138646|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761883|NCT00790842|6138647|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761884|NCT00790842|6138648|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
1761885|NCT00790842|6138649|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761886|NCT00790842|6138650|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761887|NCT00790842|6138651|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761888|NCT00790842|6138652|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761889|NCT00790842|6138653|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
1761890|NCT00790842|6138643|P11|Dose Level 3|Withdrawal by Subject|0
1761891|NCT00790842|6138644|P10|Dose Level 3|Withdrawal by Subject|2
1761892|NCT00790842|6138645|P9|Dose Level 3|Withdrawal by Subject|0
1761893|NCT00790842|6138646|P8|Dose Level 3|Withdrawal by Subject|0
1761894|NCT00790842|6138647|P7|Dose Level 3|Withdrawal by Subject|0
1761895|NCT00790842|6138648|P6|Dose Level 3|Withdrawal by Subject|0
1761896|NCT00790842|6138649|P5|Dose Level 3|Withdrawal by Subject|0
1761897|NCT00790842|6138650|P4|Dose Level 3|Withdrawal by Subject|0
1761898|NCT00790842|6138651|P3|Dose Level 3|Withdrawal by Subject|3
1761899|NCT00790842|6138652|P2|Dose Level 3|Withdrawal by Subject|0
1761900|NCT00790842|6138653|P1|Dose Level 3|Withdrawal by Subject|0
1761901|NCT00790842|6138643|P11|Dose Level 3|Adverse Event|0
1761902|NCT00790842|6138644|P10|Dose Level 3|Adverse Event|0
1761903|NCT00790842|6138645|P9|Dose Level 3|Adverse Event|0
1761904|NCT00790842|6138646|P8|Dose Level 3|Adverse Event|0
1761905|NCT00790842|6138647|P7|Dose Level 3|Adverse Event|0
1761906|NCT00790842|6138648|P6|Dose Level 3|Adverse Event|0
1761907|NCT00790842|6138649|P5|Dose Level 3|Adverse Event|0
1761908|NCT00790842|6138650|P4|Dose Level 3|Adverse Event|0
1761909|NCT00790842|6138651|P3|Dose Level 3|Adverse Event|1
1761910|NCT00790842|6138652|P2|Dose Level 3|Adverse Event|0
1761911|NCT00790842|6138653|P1|Dose Level 3|Adverse Event|0
1761912|NCT00790842|6138643|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761913|NCT00790842|6138644|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761914|NCT00790842|6138645|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
1761915|NCT00790842|6138646|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761916|NCT00790842|6138647|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761917|NCT00790842|6138648|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761918|NCT00790842|6138649|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761919|NCT00790842|6138650|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761920|NCT00790842|6138651|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761921|NCT00790842|6138652|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761922|NCT00790842|6138653|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
1761923|NCT00790842|6138643|P11|Dose Level 2|Withdrawal by Subject|0
1761924|NCT00790842|6138644|P10|Dose Level 2|Withdrawal by Subject|0
1761925|NCT00790842|6138645|P9|Dose Level 2|Withdrawal by Subject|0
1761926|NCT00790842|6138646|P8|Dose Level 2|Withdrawal by Subject|0
1761927|NCT00790842|6138647|P7|Dose Level 2|Withdrawal by Subject|0
1761928|NCT00790842|6138648|P6|Dose Level 2|Withdrawal by Subject|0
1761929|NCT00790842|6138649|P5|Dose Level 2|Withdrawal by Subject|0
1761930|NCT00790842|6138650|P4|Dose Level 2|Withdrawal by Subject|0
1761931|NCT00790842|6138651|P3|Dose Level 2|Withdrawal by Subject|0
1761932|NCT00790842|6138652|P2|Dose Level 2|Withdrawal by Subject|1
1761933|NCT00790842|6138653|P1|Dose Level 2|Withdrawal by Subject|0
1761934|NCT00790842|6138643|P11|Dose Level 2|Physician Decision|0
1761935|NCT00790842|6138644|P10|Dose Level 2|Physician Decision|0
1761936|NCT00790842|6138645|P9|Dose Level 2|Physician Decision|0
1761937|NCT00790842|6138646|P8|Dose Level 2|Physician Decision|0
1761938|NCT00790842|6138647|P7|Dose Level 2|Physician Decision|0
1761939|NCT00790842|6138648|P6|Dose Level 2|Physician Decision|0
1761940|NCT00790842|6138649|P5|Dose Level 2|Physician Decision|0
1761941|NCT00790842|6138650|P4|Dose Level 2|Physician Decision|0
1761942|NCT00790842|6138651|P3|Dose Level 2|Physician Decision|0
1761943|NCT00790842|6138652|P2|Dose Level 2|Physician Decision|1
1761944|NCT00790842|6138653|P1|Dose Level 2|Physician Decision|0
1761945|NCT00790842|6138643|P11|Dose Level 2|Death|0
1761946|NCT00790842|6138644|P10|Dose Level 2|Death|0
1761947|NCT00790842|6138645|P9|Dose Level 2|Death|0
1761948|NCT00790842|6138646|P8|Dose Level 2|Death|0
1761949|NCT00790842|6138647|P7|Dose Level 2|Death|0
1761950|NCT00790842|6138648|P6|Dose Level 2|Death|0
1761951|NCT00790842|6138649|P5|Dose Level 2|Death|1
1761952|NCT00790842|6138650|P4|Dose Level 2|Death|0
1761953|NCT00790842|6138651|P3|Dose Level 2|Death|0
1761954|NCT00790842|6138652|P2|Dose Level 2|Death|1
1761955|NCT00790842|6138653|P1|Dose Level 2|Death|0
1761956|NCT00790842|6138643|P11|Dose Level 1|Withdrawal by Subject|0
1761957|NCT00790842|6138644|P10|Dose Level 1|Withdrawal by Subject|0
1761958|NCT00790842|6138645|P9|Dose Level 1|Withdrawal by Subject|0
1761959|NCT00790842|6138646|P8|Dose Level 1|Withdrawal by Subject|0
1761960|NCT00790842|6138647|P7|Dose Level 1|Withdrawal by Subject|0
1761961|NCT00790842|6138648|P6|Dose Level 1|Withdrawal by Subject|0
1761962|NCT00790842|6138649|P5|Dose Level 1|Withdrawal by Subject|0
1761963|NCT00790842|6138650|P4|Dose Level 1|Withdrawal by Subject|0
1761964|NCT00790842|6138651|P3|Dose Level 1|Withdrawal by Subject|0
1761965|NCT00790842|6138652|P2|Dose Level 1|Withdrawal by Subject|0
1761966|NCT00790842|6138653|P1|Dose Level 1|Withdrawal by Subject|1
1761967|NCT00790842|6138643|P11|Dose Level 1|Physician Decision|0
1761968|NCT00790842|6138644|P10|Dose Level 1|Physician Decision|0
1761969|NCT00790842|6138645|P9|Dose Level 1|Physician Decision|0
1761970|NCT00790842|6138646|P8|Dose Level 1|Physician Decision|1
1761971|NCT00790842|6138647|P7|Dose Level 1|Physician Decision|0
1761972|NCT00790842|6138648|P6|Dose Level 1|Physician Decision|0
1761973|NCT00790842|6138649|P5|Dose Level 1|Physician Decision|0
1761974|NCT00790842|6138650|P4|Dose Level 1|Physician Decision|0
1761975|NCT00790842|6138651|P3|Dose Level 1|Physician Decision|0
1761976|NCT00790842|6138652|P2|Dose Level 1|Physician Decision|0
1761977|NCT00790842|6138653|P1|Dose Level 1|Physician Decision|1
1761978|NCT00790842|6138643|P11|Dose Level 1|Adverse Event|0
1761979|NCT00790842|6138644|P10|Dose Level 1|Adverse Event|0
1761980|NCT00790842|6138645|P9|Dose Level 1|Adverse Event|0
1761981|NCT00790842|6138646|P8|Dose Level 1|Adverse Event|1
1761982|NCT00790842|6138647|P7|Dose Level 1|Adverse Event|0
1761983|NCT00790842|6138648|P6|Dose Level 1|Adverse Event|0
1761984|NCT00790842|6138649|P5|Dose Level 1|Adverse Event|0
1761985|NCT00790842|6138650|P4|Dose Level 1|Adverse Event|2
1761986|NCT00790842|6138651|P3|Dose Level 1|Adverse Event|0
1761987|NCT00790842|6138652|P2|Dose Level 1|Adverse Event|0
1761988|NCT00790842|6138653|P1|Dose Level 1|Adverse Event|1
1761989|NCT00790790|6138721|P3|Study Period 2: Therapy Phase|Physician Decision|0
1761990|NCT00790790|6138722|P2|Study Period 2: Therapy Phase|Physician Decision|1
1761991|NCT00790790|6138723|P1|Study Period 2: Therapy Phase|Physician Decision|0
1761992|NCT00790790|6138721|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
1761993|NCT00790790|6138722|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
1761994|NCT00790790|6138723|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
1761995|NCT00790790|6138721|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
1761996|NCT00790790|6138722|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
1761997|NCT00790790|6138723|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
1761998|NCT00790790|6138721|P3|Study Period 2: Therapy Phase|Protocol Violation|0
1761999|NCT00790790|6138722|P2|Study Period 2: Therapy Phase|Protocol Violation|1
1762000|NCT00790790|6138723|P1|Study Period 2: Therapy Phase|Protocol Violation|1
1762001|NCT00790790|6138721|P3|Study Period 2: Therapy Phase|Adverse Event|16
1762002|NCT00790790|6138722|P2|Study Period 2: Therapy Phase|Adverse Event|16
1762003|NCT00790790|6138723|P1|Study Period 2: Therapy Phase|Adverse Event|3
1762004|NCT00790751|6138800|P4|Overall Study|Physician Decision|1
1762005|NCT00790751|6138801|P3|Overall Study|Physician Decision|0
1762006|NCT00790751|6138802|P2|Overall Study|Physician Decision|0
1762007|NCT00790751|6138803|P1|Overall Study|Physician Decision|0
1762008|NCT00790751|6138800|P4|Overall Study|Death|0
1762009|NCT00790751|6138801|P3|Overall Study|Death|1
1762010|NCT00790751|6138802|P2|Overall Study|Death|0
1762011|NCT00790751|6138803|P1|Overall Study|Death|0
1762012|NCT00790751|6138800|P4|Overall Study|Requirement for restricted medication|0
1762013|NCT00790751|6138801|P3|Overall Study|Requirement for restricted medication|0
1762014|NCT00790751|6138802|P2|Overall Study|Requirement for restricted medication|2
1762015|NCT00790751|6138803|P1|Overall Study|Requirement for restricted medication|0
1762016|NCT00790751|6138800|P4|Overall Study|Adverse Event|4
1762017|NCT00790751|6138801|P3|Overall Study|Adverse Event|5
1762018|NCT00790751|6138802|P2|Overall Study|Adverse Event|3
1762019|NCT00790751|6138803|P1|Overall Study|Adverse Event|5
1762020|NCT00790751|6138800|P4|Overall Study|Lost to Follow-up|5
1762021|NCT00790751|6138801|P3|Overall Study|Lost to Follow-up|4
1762022|NCT00790751|6138802|P2|Overall Study|Lost to Follow-up|9
1762023|NCT00790751|6138803|P1|Overall Study|Lost to Follow-up|4
1762024|NCT00790751|6138800|P4|Overall Study|Protocol non-compliance|11
1762025|NCT00790751|6138801|P3|Overall Study|Protocol non-compliance|10
1762026|NCT00790751|6138802|P2|Overall Study|Protocol non-compliance|16
1762027|NCT00790751|6138803|P1|Overall Study|Protocol non-compliance|16
1762028|NCT00790647|6138851|P1|Overall Study|Adverse Event|1
1762029|NCT00790569|6138861|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
1762030|NCT00790569|6138862|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
1762031|NCT00790569|6138863|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
1762032|NCT00790569|6138861|P3|End of Treatment (6 Month Interview)|Incarcerated|3
1762033|NCT00790569|6138862|P2|End of Treatment (6 Month Interview)|Incarcerated|0
1762034|NCT00790569|6138863|P1|End of Treatment (6 Month Interview)|Incarcerated|0
1762035|NCT00790569|6138861|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
1762036|NCT00790569|6138862|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
1762037|NCT00790569|6138863|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
1762038|NCT00790569|6138861|P3|End of Treatment (6 Month Interview)|Hospitalized|0
1762039|NCT00790569|6138862|P2|End of Treatment (6 Month Interview)|Hospitalized|0
1762040|NCT00790569|6138863|P1|End of Treatment (6 Month Interview)|Hospitalized|2
1762041|NCT00790569|6138861|P3|End of Treatment (6 Month Interview)|Death|1
1762042|NCT00790569|6138862|P2|End of Treatment (6 Month Interview)|Death|2
1762043|NCT00790569|6138863|P1|End of Treatment (6 Month Interview)|Death|0
1762044|NCT00790569|6138861|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
1762045|NCT00790569|6138862|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
1762046|NCT00790569|6138863|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
1762047|NCT00790556|6138904|P2|Treatment Period 1|Withdrawal by Subject|0
1762048|NCT00790556|6138905|P1|Treatment Period 1|Withdrawal by Subject|1
1762049|NCT00790556|6138904|P2|Treatment Period 1|Physician Decision|0
1762050|NCT00790556|6138905|P1|Treatment Period 1|Physician Decision|1
1762051|NCT00790452|6138917|P2|Overall Study|Drug supply issue|0
1762052|NCT00790452|6138918|P1|Overall Study|Drug supply issue|1
1762053|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|New treatment|0
1762054|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|New treatment|2
1762055|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
1762056|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
1762057|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Disease progression|0
1762058|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Disease progression|5
1762059|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Death|0
1762060|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Death|1
1762061|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Administrative problems|0
1762062|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Administrative problems|2
1762063|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
1762064|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
1762065|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
1762066|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
1762067|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
1762068|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
1762069|NCT00790400|6138926|P2|Everolimus Period (Core or Extension)|Adverse Event|0
1762070|NCT00790400|6138927|P1|Everolimus Period (Core or Extension)|Adverse Event|9
1762071|NCT00790400|6138926|P2|Double-blind Period (Core Phase)|Death|0
1762072|NCT00790400|6138927|P1|Double-blind Period (Core Phase)|Death|1
1762073|NCT00790400|6138926|P2|Double-blind Period (Core Phase)|Administrative problems|0
1762074|NCT00790400|6138927|P1|Double-blind Period (Core Phase)|Administrative problems|1
1762075|NCT00790400|6138926|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
1762076|NCT00790400|6138927|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
1762077|NCT00790400|6138926|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
1762078|NCT00790400|6138927|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
1762079|NCT00790400|6138926|P2|Double-blind Period (Core Phase)|Adverse Event|4
1762080|NCT00790400|6138927|P1|Double-blind Period (Core Phase)|Adverse Event|2
1762081|NCT00790400|6138926|P2|Double-blind Period (Core Phase)|Progressive disease|9
1762082|NCT00790400|6138927|P1|Double-blind Period (Core Phase)|Progressive disease|0
1762083|NCT00790400|6138926|P2|Double-blind Period (Core Phase)|Protocol Violation|0
1762084|NCT00790400|6138927|P1|Double-blind Period (Core Phase)|Protocol Violation|1
1762085|NCT00790296|6139017|P2|Overall Study|Adverse Event|1
1762086|NCT00790296|6139018|P1|Overall Study|Adverse Event|0
1762087|NCT00790296|6139017|P2|Overall Study|Did not meet study eligibility criteria|1
1762088|NCT00790296|6139018|P1|Overall Study|Did not meet study eligibility criteria|1
1762089|NCT00790218|6139040|P3|Overall Study|Death|0
1762090|NCT00790218|6139041|P2|Overall Study|Death|0
1762091|NCT00790218|6139042|P1|Overall Study|Death|1
1762092|NCT00790205|6139052|P2|Overall Study|Withdrawal by Subject|363
1762093|NCT00790205|6139053|P1|Overall Study|Withdrawal by Subject|299
1762094|NCT00790205|6139052|P2|Overall Study|Lost to Follow-up|71
1762095|NCT00790205|6139053|P1|Overall Study|Lost to Follow-up|61
1762096|NCT00790088|6139114|P1|Overall Study|Physician Decision|4
1762097|NCT00790088|6139114|P1|Overall Study|Lost to Follow-up|7
1762098|NCT00790088|6139114|P1|Overall Study|Withdrawal by Subject|17
1762099|NCT00790088|6139114|P1|Overall Study|Protocol Violation|11
1762100|NCT00790036|6139160|P2|Overall Study|Subject/guardian decision|7
1762101|NCT00790036|6139161|P1|Overall Study|Subject/guardian decision|20
1762102|NCT00790036|6139160|P2|Overall Study|Withdrawal by Subject|7
1762103|NCT00790036|6139161|P1|Overall Study|Withdrawal by Subject|18
1762104|NCT00790036|6139160|P2|Overall Study|Protocol Violation|2
1762105|NCT00790036|6139161|P1|Overall Study|Protocol Violation|10
1762106|NCT00790036|6139160|P2|Overall Study|Lost to Follow-up|2
1762107|NCT00790036|6139161|P1|Overall Study|Lost to Follow-up|1
1762108|NCT00790036|6139160|P2|Overall Study|Disease progression|48
1762109|NCT00790036|6139161|P1|Overall Study|Disease progression|24
1762110|NCT00790036|6139160|P2|Overall Study|Death|0
1762111|NCT00790036|6139161|P1|Overall Study|Death|1
1762112|NCT00790036|6139160|P2|Overall Study|Adverse Event|44
1762113|NCT00790036|6139161|P1|Overall Study|Adverse Event|113
1762114|NCT00790036|6139160|P2|Overall Study|Administrative problems|9
1762115|NCT00790036|6139161|P1|Overall Study|Administrative problems|5
1762116|NCT00790036|6139160|P2|Overall Study|Abnormal lab values|2
1762117|NCT00790036|6139161|P1|Overall Study|Abnormal lab values|3
1762118|NCT00790023|6139175|P3|Overall Study|Other|8
1762119|NCT00790023|6139176|P2|Overall Study|Other|5
1762120|NCT00790023|6139177|P1|Overall Study|Other|5
1762121|NCT00790023|6139175|P3|Overall Study|Lost to Follow-up|1
1762122|NCT00790023|6139176|P2|Overall Study|Lost to Follow-up|0
1762123|NCT00790023|6139177|P1|Overall Study|Lost to Follow-up|0
1762124|NCT00790023|6139175|P3|Overall Study|Withdrawal by Subject|6
1762125|NCT00790023|6139176|P2|Overall Study|Withdrawal by Subject|0
1762126|NCT00790023|6139177|P1|Overall Study|Withdrawal by Subject|2
1762127|NCT00790023|6139175|P3|Overall Study|Protocol Violation|2
1762128|NCT00790023|6139176|P2|Overall Study|Protocol Violation|4
1762129|NCT00790023|6139177|P1|Overall Study|Protocol Violation|2
1762130|NCT00790023|6139175|P3|Overall Study|Adverse Event|4
1762131|NCT00790023|6139176|P2|Overall Study|Adverse Event|1
1762132|NCT00790023|6139177|P1|Overall Study|Adverse Event|2
1762133|NCT00789958|6139276|P1|Overall Study|Not eligible/not analyzable|26
1762134|NCT00789958|6139276|P1|Overall Study|not protocol specified|1
1762135|NCT00789958|6139276|P1|Overall Study|Progression|3
1762136|NCT00789958|6139276|P1|Overall Study|Withdrawal by Subject|4
1762137|NCT00789958|6139276|P1|Overall Study|Adverse Event|3
1762138|NCT00789880|6139295|P6|Overall Study|Withdrawal by Subject|0
1762139|NCT00789880|6139296|P5|Overall Study|Withdrawal by Subject|2
1762140|NCT00789880|6139297|P4|Overall Study|Withdrawal by Subject|0
1762141|NCT00789880|6139298|P3|Overall Study|Withdrawal by Subject|0
1762142|NCT00789880|6139299|P2|Overall Study|Withdrawal by Subject|0
1762143|NCT00789880|6139300|P1|Overall Study|Withdrawal by Subject|1
1762144|NCT00789880|6139295|P6|Overall Study|Protocol Violation|0
1762145|NCT00789880|6139296|P5|Overall Study|Protocol Violation|0
1762146|NCT00789880|6139297|P4|Overall Study|Protocol Violation|1
1762147|NCT00789880|6139298|P3|Overall Study|Protocol Violation|0
1762148|NCT00789880|6139299|P2|Overall Study|Protocol Violation|1
1762149|NCT00789880|6139300|P1|Overall Study|Protocol Violation|0
1762150|NCT00789880|6139295|P6|Overall Study|Adverse Event|0
1762151|NCT00789880|6139296|P5|Overall Study|Adverse Event|1
1762152|NCT00789880|6139297|P4|Overall Study|Adverse Event|0
1762153|NCT00789880|6139298|P3|Overall Study|Adverse Event|0
1762154|NCT00789880|6139299|P2|Overall Study|Adverse Event|0
1762155|NCT00789880|6139300|P1|Overall Study|Adverse Event|0
1762156|NCT00789854|6139357|P3|Overall Study|Other|5
1762157|NCT00789854|6139358|P2|Overall Study|Other|0
1762158|NCT00789854|6139359|P1|Overall Study|Other|6
1762159|NCT00789854|6139357|P3|Overall Study|Safety reasons|2
1762160|NCT00789854|6139358|P2|Overall Study|Safety reasons|0
1762161|NCT00789854|6139359|P1|Overall Study|Safety reasons|0
1762162|NCT00789854|6139357|P3|Overall Study|Severe non-compliance to the protocol|0
1762163|NCT00789854|6139358|P2|Overall Study|Severe non-compliance to the protocol|0
1762164|NCT00789854|6139359|P1|Overall Study|Severe non-compliance to the protocol|3
1762165|NCT00789854|6139357|P3|Overall Study|Eligibility criteria not fulfilled|1
1762166|NCT00789854|6139358|P2|Overall Study|Eligibility criteria not fulfilled|5
1762167|NCT00789854|6139359|P1|Overall Study|Eligibility criteria not fulfilled|2
1762168|NCT00789854|6139357|P3|Overall Study|Withdrawal by Subject|17
1762169|NCT00789854|6139358|P2|Overall Study|Withdrawal by Subject|6
1762170|NCT00789854|6139359|P1|Overall Study|Withdrawal by Subject|9
1762171|NCT00789854|6139357|P3|Overall Study|Lost to Follow-up|4
1762172|NCT00789854|6139358|P2|Overall Study|Lost to Follow-up|1
1762173|NCT00789854|6139359|P1|Overall Study|Lost to Follow-up|1
1762174|NCT00789854|6139357|P3|Overall Study|Adverse Event|18
1762175|NCT00789854|6139358|P2|Overall Study|Adverse Event|23
1762176|NCT00789854|6139359|P1|Overall Study|Adverse Event|28
1762177|NCT00789828|6139456|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
1762178|NCT00789828|6139457|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
1762179|NCT00789828|6139456|P2|Open-label Extension Period (4 Years)|Disease progression|0
1762180|NCT00789828|6139457|P1|Open-label Extension Period (4 Years)|Disease progression|1
1762181|NCT00789828|6139456|P2|Open-label Extension Period (4 Years)|Death|0
1762182|NCT00789828|6139457|P1|Open-label Extension Period (4 Years)|Death|1
1762183|NCT00789828|6139456|P2|Open-label Extension Period (4 Years)|Administrative problems|0
1762184|NCT00789828|6139457|P1|Open-label Extension Period (4 Years)|Administrative problems|7
1762185|NCT00789828|6139456|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
1762186|NCT00789828|6139457|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
1762187|NCT00789828|6139456|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
1762188|NCT00789828|6139457|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
1762189|NCT00789828|6139456|P2|Open-label Extension Period (4 Years)|Adverse Event|0
1762190|NCT00789828|6139457|P1|Open-label Extension Period (4 Years)|Adverse Event|10
1762191|NCT00789828|6139456|P2|Core Period (48 Weeks)|Lost to Follow-up|1
1762192|NCT00789828|6139457|P1|Core Period (48 Weeks)|Lost to Follow-up|0
1762193|NCT00789828|6139456|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
1762194|NCT00789828|6139457|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
1762195|NCT00789828|6139456|P2|Core Period (48 Weeks)|Administrative problems|1
1762196|NCT00789828|6139457|P1|Core Period (48 Weeks)|Administrative problems|0
1762197|NCT00789815|6139491|P2|Overall Study|Intubation due to massive bleeding|0
1762198|NCT00789815|6139492|P1|Overall Study|Intubation due to massive bleeding|1
1762199|NCT00789815|6139491|P2|Overall Study|Protocol Violation|1
1762200|NCT00789815|6139492|P1|Overall Study|Protocol Violation|6
1762201|NCT00789737|6139602|P2|Overall Study|Other|7
1762202|NCT00789737|6139603|P1|Overall Study|Other|11
1762203|NCT00789737|6139602|P2|Overall Study|hyperglycemia that met protocol-specifie|4
1762204|NCT00789737|6139603|P1|Overall Study|hyperglycemia that met protocol-specifie|0
1762205|NCT00789737|6139602|P2|Overall Study|Lack of Efficacy|0
1762206|NCT00789737|6139603|P1|Overall Study|Lack of Efficacy|3
1762207|NCT00789737|6139602|P2|Overall Study|Protocol Violation|0
1762208|NCT00789737|6139603|P1|Overall Study|Protocol Violation|3
1762209|NCT00789737|6139602|P2|Overall Study|Adverse Event|8
1762210|NCT00789737|6139603|P1|Overall Study|Adverse Event|8
1762211|NCT00789737|6139602|P2|Overall Study|Lost to Follow-up|14
1762212|NCT00789737|6139603|P1|Overall Study|Lost to Follow-up|10
1762213|NCT00789737|6139602|P2|Overall Study|Withdrawal by Subject|22
1762214|NCT00789737|6139603|P1|Overall Study|Withdrawal by Subject|13
1762215|NCT00789698|6139646|P4|Overall Study|Administrative|1
1762216|NCT00789698|6139647|P3|Overall Study|Administrative|3
1762217|NCT00789698|6139648|P2|Overall Study|Administrative|3
1762218|NCT00789698|6139649|P1|Overall Study|Administrative|0
1762219|NCT00789698|6139646|P4|Overall Study|Withdrawal by Subject|19
1762220|NCT00789698|6139647|P3|Overall Study|Withdrawal by Subject|12
1762221|NCT00789698|6139648|P2|Overall Study|Withdrawal by Subject|15
1762222|NCT00789698|6139649|P1|Overall Study|Withdrawal by Subject|14
1762223|NCT00789698|6139646|P4|Overall Study|Protocol Violation|1
1762224|NCT00789698|6139647|P3|Overall Study|Protocol Violation|2
1762225|NCT00789698|6139648|P2|Overall Study|Protocol Violation|1
1762226|NCT00789698|6139649|P1|Overall Study|Protocol Violation|6
1762227|NCT00789698|6139646|P4|Overall Study|Lost to Follow-up|9
1762228|NCT00789698|6139647|P3|Overall Study|Lost to Follow-up|2
1762229|NCT00789698|6139648|P2|Overall Study|Lost to Follow-up|5
1762230|NCT00789698|6139649|P1|Overall Study|Lost to Follow-up|5
1762231|NCT00789698|6139646|P4|Overall Study|Adverse Event|4
1762232|NCT00789698|6139647|P3|Overall Study|Adverse Event|3
1762233|NCT00789698|6139648|P2|Overall Study|Adverse Event|5
1762234|NCT00789698|6139649|P1|Overall Study|Adverse Event|5
1762235|NCT00789698|6139646|P4|Overall Study|Lack of Efficacy|18
1762236|NCT00789698|6139647|P3|Overall Study|Lack of Efficacy|5
1762237|NCT00789698|6139648|P2|Overall Study|Lack of Efficacy|4
1762238|NCT00789698|6139649|P1|Overall Study|Lack of Efficacy|10
1762239|NCT00789581|6139704|P2|Adjuvant Therapy|Other|1
1762240|NCT00789581|6139705|P1|Adjuvant Therapy|Other|0
1762241|NCT00789581|6139704|P2|Adjuvant Therapy|Protocol Violation|1
1762242|NCT00789581|6139705|P1|Adjuvant Therapy|Protocol Violation|1
1762243|NCT00789581|6139704|P2|Adjuvant Therapy|Intercurrent Illness|3
1762244|NCT00789581|6139705|P1|Adjuvant Therapy|Intercurrent Illness|1
1762245|NCT00789581|6139704|P2|Adjuvant Therapy|Disease recurrence|1
1762246|NCT00789581|6139705|P1|Adjuvant Therapy|Disease recurrence|2
1762247|NCT00789581|6139704|P2|Adjuvant Therapy|Withdrawal by Subject|5
1762248|NCT00789581|6139705|P1|Adjuvant Therapy|Withdrawal by Subject|14
1762249|NCT00789581|6139704|P2|Adjuvant Therapy|Adverse Event|44
1762250|NCT00789581|6139705|P1|Adjuvant Therapy|Adverse Event|20
1762251|NCT00789581|6139704|P2|Adjuvant Therapy|Never treated|2
1762252|NCT00789581|6139705|P1|Adjuvant Therapy|Never treated|2
1762253|NCT00789581|6139704|P2|AC Therapy|Other|2
1762254|NCT00789581|6139705|P1|AC Therapy|Other|0
1762255|NCT00789581|6139704|P2|AC Therapy|Never Treated|4
1762256|NCT00789581|6139705|P1|AC Therapy|Never Treated|1
1762257|NCT00789581|6139704|P2|AC Therapy|Intercurrent Illness|0
1762258|NCT00789581|6139705|P1|AC Therapy|Intercurrent Illness|1
1762259|NCT00789581|6139704|P2|AC Therapy|Disease recurrence|1
1762260|NCT00789581|6139705|P1|AC Therapy|Disease recurrence|3
1762261|NCT00789581|6139704|P2|AC Therapy|Withdrawal by Subject|7
1762262|NCT00789581|6139705|P1|AC Therapy|Withdrawal by Subject|4
1762263|NCT00789581|6139704|P2|AC Therapy|Adverse Event|3
1762264|NCT00789581|6139705|P1|AC Therapy|Adverse Event|2
1762265|NCT00789555|6139716|P3|Overall Study|Protocol Violation|13
1762266|NCT00789555|6139717|P2|Overall Study|Protocol Violation|9
1762267|NCT00789555|6139718|P1|Overall Study|Protocol Violation|6
1762268|NCT00789555|6139716|P3|Overall Study|Treatment failure|12
1762269|NCT00789555|6139717|P2|Overall Study|Treatment failure|8
1762270|NCT00789555|6139718|P1|Overall Study|Treatment failure|11
1762271|NCT00789555|6139716|P3|Overall Study|Patient decision unnrelated to adv event|26
1762272|NCT00789555|6139717|P2|Overall Study|Patient decision unnrelated to adv event|29
1762273|NCT00789555|6139718|P1|Overall Study|Patient decision unnrelated to adv event|38
1762274|NCT00789555|6139716|P3|Overall Study|Lost to Follow-up|18
1762275|NCT00789555|6139717|P2|Overall Study|Lost to Follow-up|10
1762276|NCT00789555|6139718|P1|Overall Study|Lost to Follow-up|9
1762277|NCT00789555|6139716|P3|Overall Study|Adverse Event|10
1762278|NCT00789555|6139717|P2|Overall Study|Adverse Event|7
1762279|NCT00789555|6139718|P1|Overall Study|Adverse Event|17
1762280|NCT00789555|6139716|P3|Overall Study|Protocol Amendment|80
1762281|NCT00789555|6139717|P2|Overall Study|Protocol Amendment|76
1762282|NCT00789555|6139718|P1|Overall Study|Protocol Amendment|78
1762283|NCT00789529|6139743|P2|Overall Study|Other Reason|0
1762284|NCT00789529|6139744|P1|Overall Study|Other Reason|1
1762285|NCT00789529|6139743|P2|Overall Study|Withdrawal by Subject|1
1762286|NCT00789529|6139744|P1|Overall Study|Withdrawal by Subject|0
1762287|NCT00789477|6139757|P5|Overall Study|Other|0
1762288|NCT00789477|6139758|P4|Overall Study|Other|3
1762289|NCT00789477|6139759|P3|Overall Study|Other|1
1762290|NCT00789477|6139760|P2|Overall Study|Other|0
1762291|NCT00789477|6139761|P1|Overall Study|Other|2
1762292|NCT00789477|6139757|P5|Overall Study|Lack of Efficacy|0
1762293|NCT00789477|6139758|P4|Overall Study|Lack of Efficacy|0
1762294|NCT00789477|6139759|P3|Overall Study|Lack of Efficacy|0
1762295|NCT00789477|6139760|P2|Overall Study|Lack of Efficacy|0
1762296|NCT00789477|6139761|P1|Overall Study|Lack of Efficacy|2
1762297|NCT00789477|6139757|P5|Overall Study|Lost to Follow-up|4
1762298|NCT00789477|6139758|P4|Overall Study|Lost to Follow-up|2
1762299|NCT00789477|6139759|P3|Overall Study|Lost to Follow-up|4
1762300|NCT00789477|6139760|P2|Overall Study|Lost to Follow-up|1
1762301|NCT00789477|6139761|P1|Overall Study|Lost to Follow-up|0
1762302|NCT00789477|6139757|P5|Overall Study|Death|0
1762303|NCT00789477|6139758|P4|Overall Study|Death|2
1762304|NCT00789477|6139759|P3|Overall Study|Death|2
1762305|NCT00789477|6139760|P2|Overall Study|Death|1
1762306|NCT00789477|6139761|P1|Overall Study|Death|1
1762307|NCT00789477|6139757|P5|Overall Study|Adverse Event|0
1762308|NCT00789477|6139758|P4|Overall Study|Adverse Event|0
1762309|NCT00789477|6139759|P3|Overall Study|Adverse Event|1
1762310|NCT00789477|6139760|P2|Overall Study|Adverse Event|3
1762311|NCT00789477|6139761|P1|Overall Study|Adverse Event|3
1762312|NCT00789477|6139757|P5|Overall Study|Protocol Violation|0
1762313|NCT00789477|6139758|P4|Overall Study|Protocol Violation|1
1762314|NCT00789477|6139759|P3|Overall Study|Protocol Violation|0
1762315|NCT00789477|6139760|P2|Overall Study|Protocol Violation|0
1762316|NCT00789477|6139761|P1|Overall Study|Protocol Violation|1
1762317|NCT00789477|6139757|P5|Overall Study|Withdrawal by Subject|3
1762318|NCT00789477|6139758|P4|Overall Study|Withdrawal by Subject|2
1762319|NCT00789477|6139759|P3|Overall Study|Withdrawal by Subject|3
1762320|NCT00789477|6139760|P2|Overall Study|Withdrawal by Subject|1
1762321|NCT00789477|6139761|P1|Overall Study|Withdrawal by Subject|2
1762322|NCT00789373|6139806|P3|Maintenance|Participants On-Going at Data Cut-Off|0
1762323|NCT00789373|6139807|P2|Maintenance|Participants On-Going at Data Cut-Off|4
1762324|NCT00789373|6139808|P1|Maintenance|Participants On-Going at Data Cut-Off|0
1762325|NCT00789373|6139806|P3|Maintenance|Sponsor Decision|2
1762326|NCT00789373|6139807|P2|Maintenance|Sponsor Decision|0
1762327|NCT00789373|6139808|P1|Maintenance|Sponsor Decision|0
1762328|NCT00789373|6139806|P3|Maintenance|Withdrawal by Subject|8
1762329|NCT00789373|6139807|P2|Maintenance|Withdrawal by Subject|21
1762330|NCT00789373|6139808|P1|Maintenance|Withdrawal by Subject|0
1762331|NCT00789373|6139806|P3|Maintenance|Progressive Disease|152
1762332|NCT00789373|6139807|P2|Maintenance|Progressive Disease|253
1762333|NCT00789373|6139808|P1|Maintenance|Progressive Disease|0
1762334|NCT00789373|6139806|P3|Maintenance|Lost to Follow-up|0
1762335|NCT00789373|6139807|P2|Maintenance|Lost to Follow-up|2
1762336|NCT00789373|6139808|P1|Maintenance|Lost to Follow-up|0
1762337|NCT00789373|6139806|P3|Maintenance|Protocol entry criteria not met|0
1762338|NCT00789373|6139807|P2|Maintenance|Protocol entry criteria not met|2
1762339|NCT00789373|6139808|P1|Maintenance|Protocol entry criteria not met|0
1762340|NCT00789373|6139806|P3|Maintenance|Investigator Decision|2
1762341|NCT00789373|6139807|P2|Maintenance|Investigator Decision|4
1762342|NCT00789373|6139808|P1|Maintenance|Investigator Decision|0
1762343|NCT00789373|6139806|P3|Maintenance|Death due to toxicity|2
1762344|NCT00789373|6139807|P2|Maintenance|Death due to toxicity|1
1762345|NCT00789373|6139808|P1|Maintenance|Death due to toxicity|0
1762346|NCT00789373|6139806|P3|Maintenance|Death due to adverse event|1
1762347|NCT00789373|6139807|P2|Maintenance|Death due to adverse event|4
1762348|NCT00789373|6139808|P1|Maintenance|Death due to adverse event|0
1762349|NCT00789373|6139806|P3|Maintenance|Death due to study disease|1
1762350|NCT00789373|6139807|P2|Maintenance|Death due to study disease|3
1762351|NCT00789373|6139808|P1|Maintenance|Death due to study disease|0
1762352|NCT00789373|6139806|P3|Maintenance|Adverse Event|12
1762353|NCT00789373|6139807|P2|Maintenance|Adverse Event|65
1762354|NCT00789373|6139808|P1|Maintenance|Adverse Event|0
1762355|NCT00789373|6139806|P3|Induction|Withdrawal by Subject|0
1762356|NCT00789373|6139807|P2|Induction|Withdrawal by Subject|0
1762357|NCT00789373|6139808|P1|Induction|Withdrawal by Subject|37
1762358|NCT00789373|6139806|P3|Induction|Progressive Disease|0
1762359|NCT00789373|6139807|P2|Induction|Progressive Disease|0
1762360|NCT00789373|6139808|P1|Induction|Progressive Disease|220
1762361|NCT00789373|6139806|P3|Induction|Protocol Violation|0
1762362|NCT00789373|6139807|P2|Induction|Protocol Violation|0
1762363|NCT00789373|6139808|P1|Induction|Protocol Violation|1
1762364|NCT00789373|6139806|P3|Induction|Lost to Follow-up|0
1762365|NCT00789373|6139807|P2|Induction|Lost to Follow-up|0
1762366|NCT00789373|6139808|P1|Induction|Lost to Follow-up|6
1762367|NCT00789373|6139806|P3|Induction|Protocol entry criteria not met|0
1762368|NCT00789373|6139807|P2|Induction|Protocol entry criteria not met|0
1762369|NCT00789373|6139808|P1|Induction|Protocol entry criteria not met|9
1762370|NCT00789373|6139806|P3|Induction|Investigator decision|0
1762371|NCT00789373|6139807|P2|Induction|Investigator decision|0
1762372|NCT00789373|6139808|P1|Induction|Investigator decision|7
1762373|NCT00789373|6139806|P3|Induction|Death due to procedure|0
1762374|NCT00789373|6139807|P2|Induction|Death due to procedure|0
1762375|NCT00789373|6139808|P1|Induction|Death due to procedure|1
1762376|NCT00789373|6139806|P3|Induction|Death due to toxicity|0
1762377|NCT00789373|6139807|P2|Induction|Death due to toxicity|0
1762378|NCT00789373|6139808|P1|Induction|Death due to toxicity|11
1762379|NCT00789373|6139806|P3|Induction|Death due to adverse event|0
1762380|NCT00789373|6139807|P2|Induction|Death due to adverse event|0
1762381|NCT00789373|6139808|P1|Induction|Death due to adverse event|19
1762382|NCT00789373|6139806|P3|Induction|Death Due to study disease|0
1762383|NCT00789373|6139807|P2|Induction|Death Due to study disease|0
1762384|NCT00789373|6139808|P1|Induction|Death Due to study disease|24
1762385|NCT00789373|6139806|P3|Induction|Adverse Event|0
1762386|NCT00789373|6139807|P2|Induction|Adverse Event|0
1762387|NCT00789373|6139808|P1|Induction|Adverse Event|64
1762388|NCT00789360|6139835|P2|Overall Study|Protocol Violation|1
1762389|NCT00789360|6139836|P1|Overall Study|Protocol Violation|3
1762390|NCT00789321|6139846|P2|Overall Study|Adverse Event|1
1762391|NCT00789321|6139847|P1|Overall Study|Adverse Event|0
1762392|NCT00789191|6139869|P2|Overall Study|Unclassified|3
1762393|NCT00789191|6139870|P1|Overall Study|Unclassified|5
1762394|NCT00789191|6139869|P2|Overall Study|Withdrawal Criteria|4
1762395|NCT00789191|6139870|P1|Overall Study|Withdrawal Criteria|2
1762396|NCT00789191|6139869|P2|Overall Study|Protocol Violation|3
1762397|NCT00789191|6139870|P1|Overall Study|Protocol Violation|5
1762398|NCT00789191|6139869|P2|Overall Study|Lack of Efficacy|5
1762399|NCT00789191|6139870|P1|Overall Study|Lack of Efficacy|0
1762400|NCT00789191|6139869|P2|Overall Study|Adverse Event|4
1762401|NCT00789191|6139870|P1|Overall Study|Adverse Event|2
1762402|NCT00789035|6139927|P5|Overall Study|Other reason not defined above|1
1762403|NCT00789035|6139928|P4|Overall Study|Other reason not defined above|0
1762404|NCT00789035|6139929|P3|Overall Study|Other reason not defined above|1
1762405|NCT00789035|6139930|P2|Overall Study|Other reason not defined above|3
1762406|NCT00789035|6139931|P1|Overall Study|Other reason not defined above|2
1762407|NCT00789035|6139927|P5|Overall Study|Withdrawal by Subject|0
1762408|NCT00789035|6139928|P4|Overall Study|Withdrawal by Subject|0
1762409|NCT00789035|6139929|P3|Overall Study|Withdrawal by Subject|0
1762410|NCT00789035|6139930|P2|Overall Study|Withdrawal by Subject|2
1762411|NCT00789035|6139931|P1|Overall Study|Withdrawal by Subject|0
1762412|NCT00789035|6139927|P5|Overall Study|Protocol Violation|0
1762413|NCT00789035|6139928|P4|Overall Study|Protocol Violation|0
1762414|NCT00789035|6139929|P3|Overall Study|Protocol Violation|0
1762415|NCT00789035|6139930|P2|Overall Study|Protocol Violation|0
1762416|NCT00789035|6139931|P1|Overall Study|Protocol Violation|1
1762417|NCT00789035|6139927|P5|Overall Study|Lack of Efficacy|2
1762418|NCT00789035|6139928|P4|Overall Study|Lack of Efficacy|0
1762419|NCT00789035|6139929|P3|Overall Study|Lack of Efficacy|0
1762420|NCT00789035|6139930|P2|Overall Study|Lack of Efficacy|0
1762421|NCT00789035|6139931|P1|Overall Study|Lack of Efficacy|3
1762422|NCT00789035|6139927|P5|Overall Study|Adverse Event|3
1762423|NCT00789035|6139928|P4|Overall Study|Adverse Event|1
1762424|NCT00789035|6139929|P3|Overall Study|Adverse Event|0
1762425|NCT00789035|6139930|P2|Overall Study|Adverse Event|2
1762426|NCT00789035|6139931|P1|Overall Study|Adverse Event|0
1762427|NCT00788957|6139990|P6|Part 3|On-study at time of data cut-off|0
1762428|NCT00788957|6139991|P5|Part 3|On-study at time of data cut-off|1
1762429|NCT00788957|6139992|P4|Part 3|On-study at time of data cut-off|0
1762430|NCT00788957|6139993|P3|Part 3|On-study at time of data cut-off|0
1762431|NCT00788957|6139994|P2|Part 3|On-study at time of data cut-off|0
1762432|NCT00788957|6139995|P1|Part 3|On-study at time of data cut-off|0
1762433|NCT00788957|6139990|P6|Part 3|Death|9
1762434|NCT00788957|6139991|P5|Part 3|Death|8
1762435|NCT00788957|6139992|P4|Part 3|Death|0
1762436|NCT00788957|6139993|P3|Part 3|Death|0
1762437|NCT00788957|6139994|P2|Part 3|Death|0
1762438|NCT00788957|6139995|P1|Part 3|Death|0
1762439|NCT00788957|6139990|P6|Part 3|Withdrawal by Subject|2
1762440|NCT00788957|6139991|P5|Part 3|Withdrawal by Subject|0
1762441|NCT00788957|6139992|P4|Part 3|Withdrawal by Subject|0
1762442|NCT00788957|6139993|P3|Part 3|Withdrawal by Subject|0
1762443|NCT00788957|6139994|P2|Part 3|Withdrawal by Subject|0
1762444|NCT00788957|6139995|P1|Part 3|Withdrawal by Subject|0
1762445|NCT00788957|6139990|P6|Part 2|On-study at time of data cut-off|0
1762446|NCT00788957|6139991|P5|Part 2|On-study at time of data cut-off|0
1762447|NCT00788957|6139992|P4|Part 2|On-study at time of data cut-off|1
1762448|NCT00788957|6139993|P3|Part 2|On-study at time of data cut-off|1
1762449|NCT00788957|6139994|P2|Part 2|On-study at time of data cut-off|1
1762450|NCT00788957|6139995|P1|Part 2|On-study at time of data cut-off|0
1762451|NCT00788957|6139990|P6|Part 2|Lost to Follow-up|0
1762452|NCT00788957|6139991|P5|Part 2|Lost to Follow-up|0
1762453|NCT00788957|6139992|P4|Part 2|Lost to Follow-up|0
1762454|NCT00788957|6139993|P3|Part 2|Lost to Follow-up|3
1762455|NCT00788957|6139994|P2|Part 2|Lost to Follow-up|0
1762456|NCT00788957|6139995|P1|Part 2|Lost to Follow-up|0
1762457|NCT00788957|6139990|P6|Part 2|Death|0
1762458|NCT00788957|6139991|P5|Part 2|Death|0
1762459|NCT00788957|6139992|P4|Part 2|Death|37
1762460|NCT00788957|6139993|P3|Part 2|Death|35
1762461|NCT00788957|6139994|P2|Part 2|Death|32
1762462|NCT00788957|6139995|P1|Part 2|Death|0
1762463|NCT00788957|6139990|P6|Part 2|Withdrawal by Subject|0
1762464|NCT00788957|6139991|P5|Part 2|Withdrawal by Subject|0
1762465|NCT00788957|6139992|P4|Part 2|Withdrawal by Subject|3
1762466|NCT00788957|6139993|P3|Part 2|Withdrawal by Subject|5
1762467|NCT00788957|6139994|P2|Part 2|Withdrawal by Subject|9
1762468|NCT00788957|6139995|P1|Part 2|Withdrawal by Subject|0
1762469|NCT00788957|6139990|P6|Part 1|Lost to Follow-up|0
1762470|NCT00788957|6139991|P5|Part 1|Lost to Follow-up|0
1762471|NCT00788957|6139992|P4|Part 1|Lost to Follow-up|0
1762472|NCT00788957|6139993|P3|Part 1|Lost to Follow-up|0
1762473|NCT00788957|6139994|P2|Part 1|Lost to Follow-up|0
1762474|NCT00788957|6139995|P1|Part 1|Lost to Follow-up|1
1762475|NCT00788957|6139990|P6|Part 1|Death|0
1762476|NCT00788957|6139991|P5|Part 1|Death|0
1762477|NCT00788957|6139992|P4|Part 1|Death|0
1762478|NCT00788957|6139993|P3|Part 1|Death|0
1762479|NCT00788957|6139994|P2|Part 1|Death|0
1762480|NCT00788957|6139995|P1|Part 1|Death|8
1762481|NCT00788827|6140068|P1|Overall Study|Lack of Efficacy|2
1762482|NCT00788775|6140082|P2|Overall Study|Patient's measurable disease resected.|0
1762483|NCT00788775|6140083|P1|Overall Study|Patient's measurable disease resected.|1
1762484|NCT00788775|6140082|P2|Overall Study|Patient Non-Compliance|0
1762485|NCT00788775|6140083|P1|Overall Study|Patient Non-Compliance|1
1762486|NCT00788775|6140082|P2|Overall Study|Withdrawal by Subject|2
1762487|NCT00788775|6140083|P1|Overall Study|Withdrawal by Subject|0
1762488|NCT00788775|6140082|P2|Overall Study|Progressive Disease|6
1762489|NCT00788775|6140083|P1|Overall Study|Progressive Disease|8
1762490|NCT00788710|6140098|P3|Overall Study|Withdrawal by Subject|0
1762491|NCT00788710|6140099|P2|Overall Study|Withdrawal by Subject|2
1762492|NCT00788710|6140100|P1|Overall Study|Withdrawal by Subject|2
1762493|NCT00788710|6140098|P3|Overall Study|Protocol Violation|1
1762494|NCT00788710|6140099|P2|Overall Study|Protocol Violation|1
1762495|NCT00788710|6140100|P1|Overall Study|Protocol Violation|0
1762496|NCT00788710|6140098|P3|Overall Study|Physician Decision|0
1762497|NCT00788710|6140099|P2|Overall Study|Physician Decision|1
1762498|NCT00788710|6140100|P1|Overall Study|Physician Decision|2
1762499|NCT00788710|6140098|P3|Overall Study|Lost to Follow-up|0
1762500|NCT00788710|6140099|P2|Overall Study|Lost to Follow-up|1
1762501|NCT00788710|6140100|P1|Overall Study|Lost to Follow-up|0
1762502|NCT00788710|6140098|P3|Overall Study|Lack of Efficacy|1
1762503|NCT00788710|6140099|P2|Overall Study|Lack of Efficacy|0
1762504|NCT00788710|6140100|P1|Overall Study|Lack of Efficacy|0
1762505|NCT00788710|6140098|P3|Overall Study|Adverse Event|4
1762506|NCT00788710|6140099|P2|Overall Study|Adverse Event|3
1762507|NCT00788710|6140100|P1|Overall Study|Adverse Event|1
1762508|NCT00788697|6140114|P1|Overall Study|Indeterminate diagnosis from truth stand|17
1762509|NCT00788697|6140114|P1|Overall Study|Technically inadequate truth standard|1
1762510|NCT00788697|6140114|P1|Overall Study|no truth standard procedure available|5
1762511|NCT00788697|6140114|P1|Overall Study|Training Patients|74
1762512|NCT00788697|6140114|P1|Overall Study|No study drug administered|12
1762513|NCT00788593|6140161|P3|Second Intervention Period|Other|1
1762514|NCT00788593|6140162|P2|Second Intervention Period|Other|0
1762515|NCT00788593|6140163|P1|Second Intervention Period|Other|0
1762516|NCT00788593|6140161|P3|Second Intervention Period|Lost to Follow-up|0
1762517|NCT00788593|6140162|P2|Second Intervention Period|Lost to Follow-up|1
1762518|NCT00788593|6140163|P1|Second Intervention Period|Lost to Follow-up|0
1762519|NCT00788593|6140161|P3|First Intervention Period|Adverse Event|0
1762520|NCT00788593|6140162|P2|First Intervention Period|Adverse Event|1
1762521|NCT00788593|6140163|P1|First Intervention Period|Adverse Event|0
1762522|NCT00788593|6140161|P3|Placebo Run-in Phase|Protocol Violation|0
1762523|NCT00788593|6140162|P2|Placebo Run-in Phase|Protocol Violation|0
1762524|NCT00788593|6140163|P1|Placebo Run-in Phase|Protocol Violation|2
1762525|NCT00788593|6140161|P3|Placebo Run-in Phase|Withdrawal by Subject|0
1762526|NCT00788593|6140162|P2|Placebo Run-in Phase|Withdrawal by Subject|0
1762527|NCT00788593|6140163|P1|Placebo Run-in Phase|Withdrawal by Subject|2
1762528|NCT00788593|6140161|P3|Placebo Run-in Phase|Adverse Event|0
1762529|NCT00788593|6140162|P2|Placebo Run-in Phase|Adverse Event|0
1762530|NCT00788593|6140163|P1|Placebo Run-in Phase|Adverse Event|2
1762531|NCT00788372|6140180|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
1762532|NCT00788372|6140180|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
1762533|NCT00788372|6140180|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
1762534|NCT00788372|6140180|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
1762535|NCT00788372|6140180|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
1762536|NCT00788372|6140180|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
1762537|NCT00788372|6140180|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
1762538|NCT00788151|6140209|P2|Overall Study|Enrolled but not treated|1
1762539|NCT00788151|6140210|P1|Overall Study|Enrolled but not treated|1
1762540|NCT00788151|6140209|P2|Overall Study|Withdrawal by Subject|6
1762541|NCT00788151|6140210|P1|Overall Study|Withdrawal by Subject|13
1762542|NCT00788151|6140209|P2|Overall Study|Protocol Violation|1
1762543|NCT00788151|6140210|P1|Overall Study|Protocol Violation|0
1762544|NCT00788151|6140209|P2|Overall Study|Other adverse event|2
1762545|NCT00788151|6140210|P1|Overall Study|Other adverse event|0
1762546|NCT00788073|6140254|P2|Placebo Then STX209|Protocol Violation|1
1762547|NCT00788073|6140255|P1|Placebo Then STX209|Protocol Violation|0
1762548|NCT00788073|6140254|P2|Placebo Then STX209|Adverse Event|0
1762549|NCT00788073|6140255|P1|Placebo Then STX209|Adverse Event|2
1762550|NCT00788073|6140254|P2|STX209 Then Placebo|unable to return due to travel|1
1762551|NCT00788073|6140255|P1|STX209 Then Placebo|unable to return due to travel|0
1762552|NCT00788073|6140254|P2|STX209 Then Placebo|Withdrawal by Subject|1
1762553|NCT00788073|6140255|P1|STX209 Then Placebo|Withdrawal by Subject|0
1762554|NCT00788073|6140254|P2|STX209 Then Placebo|Lost to Follow-up|1
1762555|NCT00788073|6140255|P1|STX209 Then Placebo|Lost to Follow-up|0
1762556|NCT00788073|6140254|P2|STX209 Then Placebo|Adverse Event|0
1762557|NCT00788073|6140255|P1|STX209 Then Placebo|Adverse Event|1
1762558|NCT00787930|6140280|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
1762559|NCT00787917|6140295|P2|Open Label|Administrative problems|0
1762560|NCT00787917|6140296|P1|Open Label|Administrative problems|3
1762561|NCT00787917|6140295|P2|Open Label|Unsatisfactory therapeutic effect|0
1762562|NCT00787917|6140296|P1|Open Label|Unsatisfactory therapeutic effect|1
1762563|NCT00787917|6140295|P2|Blinded Treatment|Administrative problems|2
1762564|NCT00787917|6140296|P1|Blinded Treatment|Administrative problems|3
1762565|NCT00787917|6140295|P2|Blinded Treatment|Lack of Efficacy|0
1762566|NCT00787917|6140296|P1|Blinded Treatment|Lack of Efficacy|1
1762567|NCT00787917|6140295|P2|Blinded Treatment|Adverse Event|0
1762568|NCT00787917|6140296|P1|Blinded Treatment|Adverse Event|1
1762569|NCT00787891|6140326|P2|Maintenance Double-blind Phase (Part 2)|Other|2
1762570|NCT00787891|6140327|P1|Maintenance Double-blind Phase (Part 2)|Other|5
1762571|NCT00787891|6140326|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
1762572|NCT00787891|6140327|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
1762573|NCT00787891|6140326|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
1762574|NCT00787891|6140327|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
1762575|NCT00787891|6140326|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
1762576|NCT00787891|6140327|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
1762577|NCT00787891|6140326|P2|Short-term Double-blind Phase (Part 1)|Other|2
1762578|NCT00787891|6140327|P1|Short-term Double-blind Phase (Part 1)|Other|0
1762579|NCT00787891|6140326|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
1762580|NCT00787891|6140327|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
1762581|NCT00787891|6140326|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
1762582|NCT00787891|6140327|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
1762583|NCT00787891|6140326|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
1762584|NCT00787891|6140327|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
1762585|NCT00787891|6140326|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
1762586|NCT00787891|6140327|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
1762587|NCT00787891|6140326|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
1762588|NCT00787891|6140327|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
1762589|NCT00787839|6140354|P1|Overall Study|Failure to have the OGTT was most common|404
1762590|NCT00787800|6140377|P2|Overall Study|Death|2
1762591|NCT00787800|6140378|P1|Overall Study|Death|0
1762592|NCT00787800|6140377|P2|Overall Study|Withdrawal by Subject|5
1762593|NCT00787800|6140378|P1|Overall Study|Withdrawal by Subject|3
1762594|NCT00787787|6140394|P1|Overall Study|Adverse Event|3
1762595|NCT00787787|6140394|P1|Overall Study|Lack of Efficacy|4
1762596|NCT00787644|6140413|P2|Overall Study|Withdrawal by Subject|1
1762597|NCT00787644|6140414|P1|Overall Study|Withdrawal by Subject|1
1762598|NCT00787644|6140413|P2|Overall Study|Lost to Follow-up|1
1762599|NCT00787644|6140414|P1|Overall Study|Lost to Follow-up|1
1762600|NCT00787605|6140435|P2|Overall Study|Lack of Efficacy|9
1762601|NCT00787605|6140436|P1|Overall Study|Lack of Efficacy|13
1762602|NCT00787605|6140435|P2|Overall Study|Withdrawal by Subject|13
1762603|NCT00787605|6140436|P1|Overall Study|Withdrawal by Subject|6
1762604|NCT00787605|6140435|P2|Overall Study|Protocol Violation|3
1762605|NCT00787605|6140436|P1|Overall Study|Protocol Violation|7
1762606|NCT00787605|6140435|P2|Overall Study|Lost to Follow-up|6
1762607|NCT00787605|6140436|P1|Overall Study|Lost to Follow-up|3
1762608|NCT00787605|6140435|P2|Overall Study|Adverse Event|25
1762609|NCT00787605|6140436|P1|Overall Study|Adverse Event|14
1762610|NCT00787605|6140435|P2|Overall Study|Administrative Problems|0
1762611|NCT00787605|6140436|P1|Overall Study|Administrative Problems|3
1762612|NCT00787566|6140455|P3|Overall Study|AE related to chemotherapy|0
1762613|NCT00787566|6140456|P2|Overall Study|AE related to chemotherapy|1
1762614|NCT00787566|6140457|P1|Overall Study|AE related to chemotherapy|0
1762615|NCT00787527|6140465|P1|Overall Study|Toxicity|3
1762616|NCT00787319|6140482|P1|Overall Study|Inactive disease|5
1762617|NCT00787319|6140482|P1|Overall Study|Stabilized disease findings|3
1762618|NCT00787319|6140482|P1|Overall Study|No health insurance reimbursement|2
1762619|NCT00787319|6140482|P1|Overall Study|Unresponsiveness to visit invitation|1
1762620|NCT00787319|6140482|P1|Overall Study|Budget exhausted/exceeded|1
1762621|NCT00787319|6140482|P1|Overall Study|Lack of Efficacy|1
1762622|NCT00787319|6140482|P1|Overall Study|Objective progression or relapse|30
1762623|NCT00787319|6140482|P1|Overall Study|Adverse Event|3
1762624|NCT00787319|6140482|P1|Overall Study|Withdrawal by Subject|15
1762625|NCT00787319|6140482|P1|Overall Study|Lost to Follow-up|2
1762626|NCT00787267|6140494|P1|Overall Study|Withdrawal by Subject|1
1762627|NCT00787267|6140494|P1|Overall Study|No Reason Provided|1
1762628|NCT00787267|6140494|P1|Overall Study|Screen failure/Ineligible|10
1762629|NCT00787254|6140504|P2|Overall Study|Physician Decision|8
1762630|NCT00787254|6140505|P1|Overall Study|Physician Decision|4
1762631|NCT00787254|6140504|P2|Overall Study|Institution closed|0
1762632|NCT00787254|6140505|P1|Overall Study|Institution closed|1
1762633|NCT00787254|6140504|P2|Overall Study|NSAIDs discontinuation|2
1762634|NCT00787254|6140505|P1|Overall Study|NSAIDs discontinuation|1
1762635|NCT00787254|6140504|P2|Overall Study|Lack of Efficacy|15
1762636|NCT00787254|6140505|P1|Overall Study|Lack of Efficacy|4
1762637|NCT00787254|6140504|P2|Overall Study|Withdrawal by Subject|11
1762638|NCT00787254|6140505|P1|Overall Study|Withdrawal by Subject|16
1762639|NCT00787254|6140504|P2|Overall Study|Protocol Violation|23
1762640|NCT00787254|6140505|P1|Overall Study|Protocol Violation|26
1762641|NCT00787254|6140504|P2|Overall Study|Adverse Event|23
1762642|NCT00787254|6140505|P1|Overall Study|Adverse Event|24
1762643|NCT00787202|6140629|P5|Overall Study|Randomized, not treated|0
1762644|NCT00787202|6140630|P4|Overall Study|Randomized, not treated|0
1762645|NCT00787202|6140631|P3|Overall Study|Randomized, not treated|0
1762646|NCT00787202|6140632|P2|Overall Study|Randomized, not treated|0
1762647|NCT00787202|6140633|P1|Overall Study|Randomized, not treated|1
1762648|NCT00787202|6140629|P5|Overall Study|Protocol Violation|1
1762649|NCT00787202|6140630|P4|Overall Study|Protocol Violation|0
1762650|NCT00787202|6140631|P3|Overall Study|Protocol Violation|0
1762651|NCT00787202|6140632|P2|Overall Study|Protocol Violation|1
1762652|NCT00787202|6140633|P1|Overall Study|Protocol Violation|2
1762653|NCT00787202|6140629|P5|Overall Study|Withdrawal by Subject|0
1762654|NCT00787202|6140630|P4|Overall Study|Withdrawal by Subject|0
1762655|NCT00787202|6140631|P3|Overall Study|Withdrawal by Subject|2
1762656|NCT00787202|6140632|P2|Overall Study|Withdrawal by Subject|2
1762657|NCT00787202|6140633|P1|Overall Study|Withdrawal by Subject|2
1762658|NCT00787202|6140629|P5|Overall Study|Lost to Follow-up|0
1762659|NCT00787202|6140630|P4|Overall Study|Lost to Follow-up|0
1762660|NCT00787202|6140631|P3|Overall Study|Lost to Follow-up|0
1762661|NCT00787202|6140632|P2|Overall Study|Lost to Follow-up|0
1762662|NCT00787202|6140633|P1|Overall Study|Lost to Follow-up|1
1762663|NCT00787202|6140629|P5|Overall Study|Lack of Efficacy|1
1762664|NCT00787202|6140630|P4|Overall Study|Lack of Efficacy|2
1762665|NCT00787202|6140631|P3|Overall Study|Lack of Efficacy|5
1762666|NCT00787202|6140632|P2|Overall Study|Lack of Efficacy|6
1762667|NCT00787202|6140633|P1|Overall Study|Lack of Efficacy|5
1762668|NCT00787202|6140629|P5|Overall Study|Adverse Event|2
1762669|NCT00787202|6140630|P4|Overall Study|Adverse Event|0
1762670|NCT00787202|6140631|P3|Overall Study|Adverse Event|0
1762671|NCT00787202|6140632|P2|Overall Study|Adverse Event|2
1762672|NCT00787202|6140633|P1|Overall Study|Adverse Event|3
1762673|NCT00787189|6140686|P2|Overall Study|Lost to Follow-up|2
1762674|NCT00787189|6140687|P1|Overall Study|Lost to Follow-up|2
1762675|NCT00787150|6140696|P3|Overall Study|Dosing incorrect study durg|0
1762676|NCT00787150|6140697|P2|Overall Study|Dosing incorrect study durg|0
1762677|NCT00787150|6140698|P1|Overall Study|Dosing incorrect study durg|2
1762678|NCT00787150|6140696|P3|Overall Study|Withdrawal by Subject|0
1762679|NCT00787150|6140697|P2|Overall Study|Withdrawal by Subject|1
1762680|NCT00787150|6140698|P1|Overall Study|Withdrawal by Subject|2
1762681|NCT00787150|6140696|P3|Overall Study|Physician Decision|1
1762682|NCT00787150|6140697|P2|Overall Study|Physician Decision|2
1762683|NCT00787150|6140698|P1|Overall Study|Physician Decision|1
1762684|NCT00787150|6140696|P3|Overall Study|Adverse Event|4
1762685|NCT00787150|6140697|P2|Overall Study|Adverse Event|4
1762686|NCT00787150|6140698|P1|Overall Study|Adverse Event|4
1762687|NCT00787137|6140743|P3|Overall Study|Study Termination|1
1762688|NCT00787137|6140744|P2|Overall Study|Study Termination|0
1762689|NCT00787137|6140745|P1|Overall Study|Study Termination|0
1762690|NCT00786864|6140820|P2|Overall Study|Sustained serious back injury|0
1762691|NCT00786864|6140821|P1|Overall Study|Sustained serious back injury|1
1762692|NCT00786864|6140820|P2|Overall Study|Lost to Follow-up|1
1762693|NCT00786864|6140821|P1|Overall Study|Lost to Follow-up|0
1762694|NCT00786838|6140833|P1|Overall Study|Withdrawal by Subject|4
1762695|NCT00786838|6140833|P1|Overall Study|Progressive disease|31
1762696|NCT00786838|6140833|P1|Overall Study|Adverse Event|6
1762697|NCT00786838|6140833|P1|Overall Study|Death|4
1762698|NCT00786838|6140833|P1|Overall Study|Physician Decision|4
1762699|NCT00786799|6140869|P2|Overall Study|Lost to Follow-up|1
1762700|NCT00786799|6140870|P1|Overall Study|Lost to Follow-up|1
1762701|NCT00786565|6140900|P1|Post Surgery|Adapt AO implanted posterior side up|1
1762702|NCT00786565|6140900|P1|Post Surgery|Abnormal macular pucker|1
1762703|NCT00786565|6140900|P1|Enrollment Prior to Surgery|Protocol Violation|3
1762704|NCT00786565|6140900|P1|Enrollment Prior to Surgery|Site Closed|3
1762705|NCT00786474|6140957|P2|Overall Study|Other|4
1762706|NCT00786474|6140958|P1|Overall Study|Other|4
1762707|NCT00786474|6140957|P2|Overall Study|Physician Decision|1
1762708|NCT00786474|6140958|P1|Overall Study|Physician Decision|2
1762709|NCT00786474|6140957|P2|Overall Study|Lost to Follow-up|3
1762710|NCT00786474|6140958|P1|Overall Study|Lost to Follow-up|3
1762711|NCT00786474|6140957|P2|Overall Study|Withdrawal by Subject|31
1762712|NCT00786474|6140958|P1|Overall Study|Withdrawal by Subject|23
1762713|NCT00786474|6140957|P2|Overall Study|Death|4
1762714|NCT00786474|6140958|P1|Overall Study|Death|5
1762715|NCT00786422|6140970|P1|Follow-up Period|End-of-study done up to 4 days early|2
1762716|NCT00786422|6140970|P1|Follow-up Period|Death|1
1762717|NCT00786422|6140970|P1|Rivaroxaban Treatment|Adverse Event|2
1762718|NCT00786422|6140970|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
1762719|NCT00786422|6140970|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
1762720|NCT00786422|6140970|P1|Rivaroxaban Treatment|Physician Decision|1
1762721|NCT00786422|6140970|P1|Rivaroxaban Treatment|Lack of Efficacy|1
1762722|NCT00786422|6140970|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
1762723|NCT00786422|6140970|P1|Rivaroxaban Treatment|Death|2
1762724|NCT00786409|6140986|P1|Overall Study|Lost to Follow-up|1
1762725|NCT00786409|6140986|P1|Overall Study|Pregnancy|2
1762726|NCT00786409|6140986|P1|Overall Study|Adverse Event|2
1762727|NCT00786409|6140986|P1|Overall Study|Withdrawal by Subject|2
1762728|NCT00786188|6141003|P2|Overall Study|Withdrawal by Subject|0
1762729|NCT00786188|6141004|P1|Overall Study|Withdrawal by Subject|2
1762730|NCT00786188|6141003|P2|Overall Study|Adverse Event|1
1762731|NCT00786188|6141004|P1|Overall Study|Adverse Event|3
1762732|NCT00786032|6141030|P1|Overall Study|Did not complete in the timeframe|6
1762733|NCT00786032|6141030|P1|Overall Study|Withdrawal by Subject|14
1762734|NCT00786032|6141030|P1|Overall Study|Death|4
1762735|NCT00785980|6141051|P1|7 Day Washout Period|Protocol Violation|3
1762736|NCT00785928|6141069|P7|Treatment Phase|Withdrawal by Subject|0
1762737|NCT00785928|6141070|P6|Treatment Phase|Withdrawal by Subject|0
1762738|NCT00785928|6141071|P5|Treatment Phase|Withdrawal by Subject|1
1762739|NCT00785928|6141072|P4|Treatment Phase|Withdrawal by Subject|0
1762740|NCT00785928|6141073|P3|Treatment Phase|Withdrawal by Subject|0
1762741|NCT00785928|6141074|P2|Treatment Phase|Withdrawal by Subject|2
1762742|NCT00785928|6141075|P1|Treatment Phase|Withdrawal by Subject|1
1762743|NCT00785928|6141069|P7|Treatment Phase|Sponsor Decision|1
1762744|NCT00785928|6141070|P6|Treatment Phase|Sponsor Decision|0
1762745|NCT00785928|6141071|P5|Treatment Phase|Sponsor Decision|0
1762746|NCT00785928|6141072|P4|Treatment Phase|Sponsor Decision|0
1762747|NCT00785928|6141073|P3|Treatment Phase|Sponsor Decision|0
1762748|NCT00785928|6141074|P2|Treatment Phase|Sponsor Decision|0
1762749|NCT00785928|6141075|P1|Treatment Phase|Sponsor Decision|1
1762750|NCT00785928|6141069|P7|Treatment Phase|Physician Decision|0
1762751|NCT00785928|6141070|P6|Treatment Phase|Physician Decision|0
1762752|NCT00785928|6141071|P5|Treatment Phase|Physician Decision|1
1762753|NCT00785928|6141072|P4|Treatment Phase|Physician Decision|0
1762754|NCT00785928|6141073|P3|Treatment Phase|Physician Decision|0
1762755|NCT00785928|6141074|P2|Treatment Phase|Physician Decision|0
1762756|NCT00785928|6141075|P1|Treatment Phase|Physician Decision|0
1762757|NCT00785928|6141069|P7|Treatment Phase|Lack of Efficacy|0
1762758|NCT00785928|6141070|P6|Treatment Phase|Lack of Efficacy|0
1762759|NCT00785928|6141071|P5|Treatment Phase|Lack of Efficacy|0
1762760|NCT00785928|6141072|P4|Treatment Phase|Lack of Efficacy|0
1762761|NCT00785928|6141073|P3|Treatment Phase|Lack of Efficacy|1
1762762|NCT00785928|6141074|P2|Treatment Phase|Lack of Efficacy|1
1762763|NCT00785928|6141075|P1|Treatment Phase|Lack of Efficacy|0
1762764|NCT00785928|6141069|P7|Treatment Phase|Inadequate Response|0
1762765|NCT00785928|6141070|P6|Treatment Phase|Inadequate Response|0
1762766|NCT00785928|6141071|P5|Treatment Phase|Inadequate Response|0
1762767|NCT00785928|6141072|P4|Treatment Phase|Inadequate Response|0
1762768|NCT00785928|6141073|P3|Treatment Phase|Inadequate Response|0
1762769|NCT00785928|6141074|P2|Treatment Phase|Inadequate Response|1
1762770|NCT00785928|6141075|P1|Treatment Phase|Inadequate Response|0
1762771|NCT00785928|6141069|P7|Treatment Phase|Adverse Event|2
1762772|NCT00785928|6141070|P6|Treatment Phase|Adverse Event|0
1762773|NCT00785928|6141071|P5|Treatment Phase|Adverse Event|0
1762774|NCT00785928|6141072|P4|Treatment Phase|Adverse Event|0
1762775|NCT00785928|6141073|P3|Treatment Phase|Adverse Event|2
1762776|NCT00785928|6141074|P2|Treatment Phase|Adverse Event|1
1762777|NCT00785928|6141075|P1|Treatment Phase|Adverse Event|1
1762778|NCT00785785|6141222|P2|Optional Extension Phase|Study terminated by sponsor|37
1762779|NCT00785785|6141223|P1|Optional Extension Phase|Study terminated by sponsor|3
1762780|NCT00785785|6141222|P2|Optional Extension Phase|Protocol deviation|2
1762781|NCT00785785|6141223|P1|Optional Extension Phase|Protocol deviation|0
1762782|NCT00785785|6141222|P2|Optional Extension Phase|Disease progression|70
1762783|NCT00785785|6141223|P1|Optional Extension Phase|Disease progression|22
1762784|NCT00785785|6141222|P2|Optional Extension Phase|Death|5
1762785|NCT00785785|6141223|P1|Optional Extension Phase|Death|1
1762786|NCT00785785|6141222|P2|Optional Extension Phase|Administrative problems|0
1762787|NCT00785785|6141223|P1|Optional Extension Phase|Administrative problems|2
1762788|NCT00785785|6141222|P2|Optional Extension Phase|Lost to Follow-up|0
1762789|NCT00785785|6141223|P1|Optional Extension Phase|Lost to Follow-up|1
1762790|NCT00785785|6141222|P2|Optional Extension Phase|Withdrawal by Subject|6
1762791|NCT00785785|6141223|P1|Optional Extension Phase|Withdrawal by Subject|6
1762792|NCT00785785|6141222|P2|Optional Extension Phase|Adverse Event|5
1762793|NCT00785785|6141223|P1|Optional Extension Phase|Adverse Event|4
1762960|NCT00784875|6141558|P2|Period D|Protocol Violation|0
1762794|NCT00785785|6141222|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
1762795|NCT00785785|6141223|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
1762796|NCT00785785|6141222|P2|Core Phase up to 36 Months|Protocol deviation|6
1762797|NCT00785785|6141223|P1|Core Phase up to 36 Months|Protocol deviation|5
1762798|NCT00785785|6141222|P2|Core Phase up to 36 Months|Disease progression|119
1762799|NCT00785785|6141223|P1|Core Phase up to 36 Months|Disease progression|139
1762800|NCT00785785|6141222|P2|Core Phase up to 36 Months|Death|8
1762801|NCT00785785|6141223|P1|Core Phase up to 36 Months|Death|5
1762802|NCT00785785|6141222|P2|Core Phase up to 36 Months|Administrative problems|3
1762803|NCT00785785|6141223|P1|Core Phase up to 36 Months|Administrative problems|3
1762804|NCT00785785|6141222|P2|Core Phase up to 36 Months|Lost to Follow-up|7
1762805|NCT00785785|6141223|P1|Core Phase up to 36 Months|Lost to Follow-up|3
1762806|NCT00785785|6141222|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
1762807|NCT00785785|6141223|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
1762808|NCT00785785|6141222|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
1762809|NCT00785785|6141223|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
1762810|NCT00785785|6141222|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
1762811|NCT00785785|6141223|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
1762812|NCT00785785|6141222|P2|Core Phase up to 36 Months|Adverse Event|21
1762813|NCT00785785|6141223|P1|Core Phase up to 36 Months|Adverse Event|31
1762814|NCT00785785|6141222|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
1762815|NCT00785785|6141223|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
1762816|NCT00785707|6141237|P1|Overall Study|Lost to Follow-up|7
1762817|NCT00785629|6141246|P4|Overall Study|Withdrawal by Subject|2
1762818|NCT00785629|6141247|P3|Overall Study|Withdrawal by Subject|2
1762819|NCT00785629|6141248|P2|Overall Study|Withdrawal by Subject|1
1762820|NCT00785629|6141249|P1|Overall Study|Withdrawal by Subject|0
1762821|NCT00785629|6141246|P4|Overall Study|administrative decision|4
1762822|NCT00785629|6141247|P3|Overall Study|administrative decision|3
1762823|NCT00785629|6141248|P2|Overall Study|administrative decision|1
1762824|NCT00785629|6141249|P1|Overall Study|administrative decision|5
1762825|NCT00785629|6141246|P4|Overall Study|Protocol Violation|5
1762826|NCT00785629|6141247|P3|Overall Study|Protocol Violation|4
1762827|NCT00785629|6141248|P2|Overall Study|Protocol Violation|2
1762828|NCT00785629|6141249|P1|Overall Study|Protocol Violation|1
1762829|NCT00785629|6141246|P4|Overall Study|Adverse Event|5
1762830|NCT00785629|6141247|P3|Overall Study|Adverse Event|1
1762831|NCT00785629|6141248|P2|Overall Study|Adverse Event|1
1762832|NCT00785629|6141249|P1|Overall Study|Adverse Event|2
1762833|NCT00785577|6141262|P5|Study Period 3: 1-Week Washout Phase|Death|1
1762834|NCT00785577|6141263|P4|Study Period 3: 1-Week Washout Phase|Death|0
1762835|NCT00785577|6141264|P3|Study Period 3: 1-Week Washout Phase|Death|0
1762836|NCT00785577|6141265|P2|Study Period 3: 1-Week Washout Phase|Death|0
1762837|NCT00785577|6141266|P1|Study Period 3: 1-Week Washout Phase|Death|0
1762838|NCT00785577|6141262|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1762839|NCT00785577|6141263|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
1762840|NCT00785577|6141264|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1762841|NCT00785577|6141265|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1762842|NCT00785577|6141266|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
1762843|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
1762844|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
1762845|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
1762846|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
1762847|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
1762848|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
1762849|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1762850|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1762851|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
1762852|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
1762853|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1762854|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
1762855|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1762856|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
1762857|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
1762858|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Protocol Violation|1
1762859|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Protocol Violation|0
1762860|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Protocol Violation|1
1762861|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Protocol Violation|1
1762862|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Protocol Violation|1
1762863|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Physician Decision|0
1762864|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Physician Decision|0
1762865|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Physician Decision|0
1762866|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Physician Decision|0
1762867|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Physician Decision|1
1762868|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
1762869|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
1762870|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
1762871|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
1762872|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
1762873|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
1762874|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
1762875|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
1762876|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
1762877|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
1762878|NCT00785577|6141262|P5|Study Period 2: Therapy Phase|Adverse Event|17
1762879|NCT00785577|6141263|P4|Study Period 2: Therapy Phase|Adverse Event|10
1762880|NCT00785577|6141264|P3|Study Period 2: Therapy Phase|Adverse Event|14
1762881|NCT00785577|6141265|P2|Study Period 2: Therapy Phase|Adverse Event|7
1762882|NCT00785577|6141266|P1|Study Period 2: Therapy Phase|Adverse Event|5
1762883|NCT00785538|6141406|P4|Treatment Period|Withdrawal by Subject|1
1762884|NCT00785538|6141407|P3|Treatment Period|Withdrawal by Subject|0
1762885|NCT00785538|6141408|P2|Treatment Period|Withdrawal by Subject|0
1762886|NCT00785538|6141409|P1|Treatment Period|Withdrawal by Subject|0
1762887|NCT00785538|6141406|P4|Treatment Period|Adverse Event|0
1762888|NCT00785538|6141407|P3|Treatment Period|Adverse Event|2
1762889|NCT00785538|6141408|P2|Treatment Period|Adverse Event|2
1762890|NCT00785538|6141409|P1|Treatment Period|Adverse Event|1
1762891|NCT00785512|6141457|P2|Overall Study|Lack of compliance|1
1762892|NCT00785512|6141458|P1|Overall Study|Lack of compliance|0
1762893|NCT00785512|6141457|P2|Overall Study|Physician Decision|0
1762894|NCT00785512|6141458|P1|Overall Study|Physician Decision|0
1762895|NCT00785512|6141457|P2|Overall Study|IVRS Programing Error|0
1762896|NCT00785512|6141458|P1|Overall Study|IVRS Programing Error|0
1762897|NCT00785512|6141457|P2|Overall Study|Precedure Refused|0
1762898|NCT00785512|6141458|P1|Overall Study|Precedure Refused|0
1762899|NCT00785512|6141457|P2|Overall Study|Lost to Follow-up|0
1762900|NCT00785512|6141458|P1|Overall Study|Lost to Follow-up|3
1762901|NCT00785512|6141457|P2|Overall Study|Withdrawal by Subject|1
1762902|NCT00785512|6141458|P1|Overall Study|Withdrawal by Subject|0
1762903|NCT00785512|6141457|P2|Overall Study|Lack of Efficacy|2
1762904|NCT00785512|6141458|P1|Overall Study|Lack of Efficacy|0
1762905|NCT00785512|6141457|P2|Overall Study|Adverse Event|0
1762906|NCT00785512|6141458|P1|Overall Study|Adverse Event|0
1762907|NCT00785512|6141457|P2|Overall Study|Inclusion/Exclusion not meet|0
1762908|NCT00785512|6141458|P1|Overall Study|Inclusion/Exclusion not meet|0
1762909|NCT00785486|6141467|P1|Midazolam Alone|Withdrawal by Subject|1
1762910|NCT00785356|6141491|P1|Overall Study|Study prematurely terminated|8
1762932|NCT00785213|6141524|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
1762933|NCT00785213|6141524|P1|Quinine Sulfate Alone|Adverse Event|4
1762934|NCT00785044|6141535|P1|Overall Study|Withdrawal by Subject|1
1762935|NCT00785044|6141535|P1|Overall Study|Lost to Follow-up|266
1762936|NCT00785044|6141535|P1|Overall Study|Death|77
1762937|NCT00785044|6141535|P1|Overall Study|Dosed at non-participating sites|152
1762938|NCT00784979|6141540|P1|Overall Study|incomplete data|6
1762939|NCT00784927|6141544|P1|Overall Study|Ineligible|1
1762940|NCT00784927|6141544|P1|Overall Study|Protocol Violation|1
1762941|NCT00784927|6141544|P1|Overall Study|Cancel Prior to Initiating Treatment|1
1762942|NCT00784875|6141556|P4|Period D|Lost to Follow-up|1
1762943|NCT00784875|6141557|P3|Period D|Lost to Follow-up|1
1762944|NCT00784875|6141558|P2|Period D|Lost to Follow-up|0
1762945|NCT00784875|6141559|P1|Period D|Lost to Follow-up|1
1762946|NCT00784875|6141556|P4|Period D|Sponsor Decision|0
1762947|NCT00784875|6141557|P3|Period D|Sponsor Decision|1
1762948|NCT00784875|6141558|P2|Period D|Sponsor Decision|1
1762949|NCT00784875|6141559|P1|Period D|Sponsor Decision|1
1762950|NCT00784875|6141556|P4|Period D|Physician Decision|0
1762951|NCT00784875|6141557|P3|Period D|Physician Decision|0
1762952|NCT00784875|6141558|P2|Period D|Physician Decision|1
1762953|NCT00784875|6141559|P1|Period D|Physician Decision|0
1762954|NCT00784875|6141556|P4|Period D|Withdrawal by Subject|0
1762955|NCT00784875|6141557|P3|Period D|Withdrawal by Subject|2
1762956|NCT00784875|6141558|P2|Period D|Withdrawal by Subject|0
1762957|NCT00784875|6141559|P1|Period D|Withdrawal by Subject|2
1762958|NCT00784875|6141556|P4|Period D|Protocol Violation|0
1762959|NCT00784875|6141557|P3|Period D|Protocol Violation|0
1762961|NCT00784875|6141559|P1|Period D|Protocol Violation|1
1762962|NCT00784875|6141556|P4|Period D|Adverse Event|0
1762963|NCT00784875|6141557|P3|Period D|Adverse Event|2
1762964|NCT00784875|6141558|P2|Period D|Adverse Event|2
1762965|NCT00784875|6141559|P1|Period D|Adverse Event|0
1762966|NCT00784875|6141556|P4|Period C|Sponsor Decision|2
1762967|NCT00784875|6141557|P3|Period C|Sponsor Decision|4
1762968|NCT00784875|6141558|P2|Period C|Sponsor Decision|5
1762969|NCT00784875|6141559|P1|Period C|Sponsor Decision|5
1762970|NCT00784875|6141556|P4|Period C|Physician Decision|1
1762971|NCT00784875|6141557|P3|Period C|Physician Decision|1
1762972|NCT00784875|6141558|P2|Period C|Physician Decision|0
1762973|NCT00784875|6141559|P1|Period C|Physician Decision|0
1762974|NCT00784875|6141556|P4|Period C|Withdrawal by Subject|0
1762975|NCT00784875|6141557|P3|Period C|Withdrawal by Subject|2
1762976|NCT00784875|6141558|P2|Period C|Withdrawal by Subject|1
1762977|NCT00784875|6141559|P1|Period C|Withdrawal by Subject|1
1762978|NCT00784875|6141556|P4|Period C|Lack of Efficacy|0
1762979|NCT00784875|6141557|P3|Period C|Lack of Efficacy|1
1762980|NCT00784875|6141558|P2|Period C|Lack of Efficacy|0
1762981|NCT00784875|6141559|P1|Period C|Lack of Efficacy|0
1762982|NCT00784875|6141556|P4|Period C|Protocol Violation|2
1762983|NCT00784875|6141557|P3|Period C|Protocol Violation|1
1762984|NCT00784875|6141558|P2|Period C|Protocol Violation|0
1762985|NCT00784875|6141559|P1|Period C|Protocol Violation|0
1762986|NCT00784875|6141556|P4|Period C|Adverse Event|2
1762987|NCT00784875|6141557|P3|Period C|Adverse Event|4
1762988|NCT00784875|6141558|P2|Period C|Adverse Event|0
1762989|NCT00784875|6141559|P1|Period C|Adverse Event|1
1762990|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
1762991|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
1762992|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
1762993|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
1762994|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
1762995|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
1762996|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
1762997|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
1762998|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Physician Decision|0
1762999|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Physician Decision|1
1763000|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Physician Decision|0
1763001|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Physician Decision|0
1763002|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
1763003|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
1763004|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
1763005|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
1763006|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
1763007|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
1763008|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
1763009|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
1763010|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Protocol Violation|3
1763011|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Protocol Violation|2
1763012|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Protocol Violation|1
1763013|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Protocol Violation|1
1763014|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Adverse Event|1
1763015|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Adverse Event|2
1763016|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Adverse Event|3
1763017|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Adverse Event|0
1763018|NCT00784875|6141556|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
1763019|NCT00784875|6141557|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
1763020|NCT00784875|6141558|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
1763021|NCT00784875|6141559|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
1763022|NCT00784875|6141556|P4|Period A - Baseline|Lost to Follow-up|2
1763023|NCT00784875|6141557|P3|Period A - Baseline|Lost to Follow-up|0
1763024|NCT00784875|6141558|P2|Period A - Baseline|Lost to Follow-up|0
1763025|NCT00784875|6141559|P1|Period A - Baseline|Lost to Follow-up|0
1763026|NCT00784875|6141556|P4|Period A - Baseline|Sponsor Decision|113
1763027|NCT00784875|6141557|P3|Period A - Baseline|Sponsor Decision|0
1763028|NCT00784875|6141558|P2|Period A - Baseline|Sponsor Decision|0
1763029|NCT00784875|6141559|P1|Period A - Baseline|Sponsor Decision|0
1763030|NCT00784875|6141556|P4|Period A - Baseline|Physician Decision|2
1763031|NCT00784875|6141557|P3|Period A - Baseline|Physician Decision|0
1763032|NCT00784875|6141558|P2|Period A - Baseline|Physician Decision|0
1763033|NCT00784875|6141559|P1|Period A - Baseline|Physician Decision|0
1763034|NCT00784875|6141556|P4|Period A - Baseline|Withdrawal by Subject|27
1763035|NCT00784875|6141557|P3|Period A - Baseline|Withdrawal by Subject|0
1763036|NCT00784875|6141558|P2|Period A - Baseline|Withdrawal by Subject|0
1763037|NCT00784875|6141559|P1|Period A - Baseline|Withdrawal by Subject|0
1763038|NCT00784875|6141556|P4|Period A - Baseline|Protocol Violation|25
1763039|NCT00784875|6141557|P3|Period A - Baseline|Protocol Violation|0
1763040|NCT00784875|6141558|P2|Period A - Baseline|Protocol Violation|0
1763041|NCT00784875|6141559|P1|Period A - Baseline|Protocol Violation|0
1763042|NCT00784875|6141556|P4|Period A - Baseline|Adverse Event|8
1763043|NCT00784875|6141557|P3|Period A - Baseline|Adverse Event|0
1763044|NCT00784875|6141558|P2|Period A - Baseline|Adverse Event|0
1763045|NCT00784875|6141559|P1|Period A - Baseline|Adverse Event|0
1763046|NCT00784875|6141556|P4|Period A - Baseline|Entry Criteria Not Met|5
1763047|NCT00784875|6141557|P3|Period A - Baseline|Entry Criteria Not Met|0
1763048|NCT00784875|6141558|P2|Period A - Baseline|Entry Criteria Not Met|0
1763049|NCT00784875|6141559|P1|Period A - Baseline|Entry Criteria Not Met|0
1763050|NCT00784836|6141679|P1|Overall Study|Early Study Termination|3
1763051|NCT00784810|6141686|P2|Overall Study|Lost to Follow-up|1
1763052|NCT00784810|6141687|P1|Overall Study|Lost to Follow-up|1
1763053|NCT00784810|6141686|P2|Overall Study|Administrative|8
1763054|NCT00784810|6141687|P1|Overall Study|Administrative|5
1763055|NCT00784810|6141686|P2|Overall Study|Withdrawal by Subject|9
1763056|NCT00784810|6141687|P1|Overall Study|Withdrawal by Subject|11
1763057|NCT00784810|6141686|P2|Overall Study|Lack of Efficacy|11
1763058|NCT00784810|6141687|P1|Overall Study|Lack of Efficacy|14
1763059|NCT00784810|6141686|P2|Overall Study|Adverse Event|20
1763060|NCT00784810|6141687|P1|Overall Study|Adverse Event|32
1763061|NCT00784784|6141697|P2|Overall Study|Withdrawal by Subject|2
1763062|NCT00784784|6141698|P1|Overall Study|Withdrawal by Subject|2
1763063|NCT00784758|6141708|P2|Overall Study|Adverse Event|0
1763064|NCT00784758|6141709|P1|Overall Study|Adverse Event|1
1763065|NCT00784758|6141708|P2|Overall Study|Withdrawal by Subject|0
1763066|NCT00784758|6141709|P1|Overall Study|Withdrawal by Subject|3
1763067|NCT00784719|6141758|P7|Overall Study|Withdrawal by Subject|1
1763068|NCT00784719|6141759|P6|Overall Study|Withdrawal by Subject|0
1763069|NCT00784719|6141760|P5|Overall Study|Withdrawal by Subject|2
1763070|NCT00784719|6141761|P4|Overall Study|Withdrawal by Subject|0
1763071|NCT00784719|6141762|P3|Overall Study|Withdrawal by Subject|0
1763072|NCT00784719|6141763|P2|Overall Study|Withdrawal by Subject|0
1763073|NCT00784719|6141764|P1|Overall Study|Withdrawal by Subject|1
1763074|NCT00784719|6141758|P7|Overall Study|Other|3
1763075|NCT00784719|6141759|P6|Overall Study|Other|1
1763076|NCT00784719|6141760|P5|Overall Study|Other|2
1763077|NCT00784719|6141761|P4|Overall Study|Other|0
1763078|NCT00784719|6141762|P3|Overall Study|Other|1
1763079|NCT00784719|6141763|P2|Overall Study|Other|1
1763080|NCT00784719|6141764|P1|Overall Study|Other|2
1763081|NCT00784719|6141758|P7|Overall Study|Lost to Follow-up|0
1763082|NCT00784719|6141759|P6|Overall Study|Lost to Follow-up|1
1763083|NCT00784719|6141760|P5|Overall Study|Lost to Follow-up|1
1763084|NCT00784719|6141761|P4|Overall Study|Lost to Follow-up|0
1763085|NCT00784719|6141762|P3|Overall Study|Lost to Follow-up|0
1763086|NCT00784719|6141763|P2|Overall Study|Lost to Follow-up|0
1763087|NCT00784719|6141764|P1|Overall Study|Lost to Follow-up|0
1763088|NCT00784719|6141758|P7|Overall Study|Adverse Event|1
1763089|NCT00784719|6141759|P6|Overall Study|Adverse Event|1
1763090|NCT00784719|6141760|P5|Overall Study|Adverse Event|1
1763091|NCT00784719|6141761|P4|Overall Study|Adverse Event|0
1763092|NCT00784719|6141762|P3|Overall Study|Adverse Event|0
1763093|NCT00784719|6141763|P2|Overall Study|Adverse Event|2
1763094|NCT00784719|6141764|P1|Overall Study|Adverse Event|0
1763095|NCT00784654|6141934|P3|Randomized Withdrawal Period|Family reasons|1
1763096|NCT00784654|6141935|P2|Randomized Withdrawal Period|Family reasons|0
1763097|NCT00784654|6141936|P1|Randomized Withdrawal Period|Family reasons|0
1763098|NCT00784654|6141934|P3|Randomized Withdrawal Period|Did not complete a visit|0
1763099|NCT00784654|6141935|P2|Randomized Withdrawal Period|Did not complete a visit|1
1763100|NCT00784654|6141936|P1|Randomized Withdrawal Period|Did not complete a visit|0
1763101|NCT00784654|6141934|P3|Randomized Withdrawal Period|Adverse Event|1
1763102|NCT00784654|6141935|P2|Randomized Withdrawal Period|Adverse Event|1
1763103|NCT00784654|6141936|P1|Randomized Withdrawal Period|Adverse Event|0
1763104|NCT00784654|6141934|P3|Randomized Withdrawal Period|Protocol Violation|1
1763105|NCT00784654|6141935|P2|Randomized Withdrawal Period|Protocol Violation|2
1763106|NCT00784654|6141936|P1|Randomized Withdrawal Period|Protocol Violation|0
1763107|NCT00784654|6141934|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
1763108|NCT00784654|6141935|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
1763109|NCT00784654|6141936|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
1763110|NCT00784654|6141934|P3|Randomized Withdrawal Period|Lack of Efficacy|18
1763111|NCT00784654|6141935|P2|Randomized Withdrawal Period|Lack of Efficacy|5
1763112|NCT00784654|6141936|P1|Randomized Withdrawal Period|Lack of Efficacy|0
1763113|NCT00784654|6141934|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
1763114|NCT00784654|6141935|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
1763115|NCT00784654|6141936|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
1763116|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
1763117|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
1763118|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
1763119|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
1763120|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
1763121|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
1763122|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
1763123|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
1763124|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
1763125|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
1763126|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
1763127|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
1763128|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
1763129|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
1763130|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
1763131|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
1763132|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
1763133|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
1763134|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
1763135|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
1763136|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
1763137|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
1763138|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
1763139|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
1763140|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
1763141|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
1763142|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
1763143|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
1763144|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
1763145|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
1763146|NCT00784654|6141934|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
1763147|NCT00784654|6141935|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
1763148|NCT00784654|6141936|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
1763149|NCT00784563|6141971|P3|Year 3|Adverse Event|1
1763150|NCT00784563|6141972|P2|Year 3|Adverse Event|0
1763151|NCT00784563|6141973|P1|Year 3|Adverse Event|0
1763152|NCT00784563|6141971|P3|Year 3|Withdrawal by Subject|2
1763153|NCT00784563|6141972|P2|Year 3|Withdrawal by Subject|0
1763154|NCT00784563|6141973|P1|Year 3|Withdrawal by Subject|0
1763155|NCT00784563|6141971|P3|Years 1 & 2|Adverse Event|0
1763156|NCT00784563|6141972|P2|Years 1 & 2|Adverse Event|3
1763157|NCT00784563|6141973|P1|Years 1 & 2|Adverse Event|0
1763158|NCT00784563|6141971|P3|Years 1 & 2|Withdrawal by Subject|0
1763159|NCT00784563|6141972|P2|Years 1 & 2|Withdrawal by Subject|2
1763160|NCT00784563|6141973|P1|Years 1 & 2|Withdrawal by Subject|3
1763161|NCT00784550|6141991|P2|Overall Study|Withdrawal by Subject|13
1763162|NCT00784550|6141992|P1|Overall Study|Withdrawal by Subject|4
1763163|NCT00784550|6141991|P2|Overall Study|Physician Decision|3
1763164|NCT00784550|6141992|P1|Overall Study|Physician Decision|2
1763165|NCT00784550|6141991|P2|Overall Study|Lost to Follow-up|5
1763166|NCT00784550|6141992|P1|Overall Study|Lost to Follow-up|8
1763167|NCT00784550|6141991|P2|Overall Study|Protocol Violation|10
1763168|NCT00784550|6141992|P1|Overall Study|Protocol Violation|10
1763169|NCT00784550|6141991|P2|Overall Study|Lack of Efficacy|1
1763170|NCT00784550|6141992|P1|Overall Study|Lack of Efficacy|0
1763171|NCT00784550|6141991|P2|Overall Study|Adverse Event|10
1763172|NCT00784550|6141992|P1|Overall Study|Adverse Event|12
1763173|NCT00784459|6142018|P2|Overall Study|Adverse Event|2
1763174|NCT00784459|6142019|P1|Overall Study|Adverse Event|0
1763175|NCT00784368|6142030|P3|Overall Study|Withdrawal of informed consent|0
1763176|NCT00784368|6142031|P2|Overall Study|Withdrawal of informed consent|1
1763177|NCT00784368|6142032|P1|Overall Study|Withdrawal of informed consent|0
1763178|NCT00784368|6142030|P3|Overall Study|Worsening of symptoms|0
1763179|NCT00784368|6142031|P2|Overall Study|Worsening of symptoms|1
1763180|NCT00784368|6142032|P1|Overall Study|Worsening of symptoms|0
1763181|NCT00784368|6142030|P3|Overall Study|Worsening of complications|1
1763182|NCT00784368|6142031|P2|Overall Study|Worsening of complications|0
1763183|NCT00784368|6142032|P1|Overall Study|Worsening of complications|0
1763184|NCT00784368|6142030|P3|Overall Study|Diagnosis of fever|1
1763185|NCT00784368|6142031|P2|Overall Study|Diagnosis of fever|0
1763186|NCT00784368|6142032|P1|Overall Study|Diagnosis of fever|0
1763187|NCT00784368|6142030|P3|Overall Study|Adverse Event|2
1763188|NCT00784368|6142031|P2|Overall Study|Adverse Event|9
1763189|NCT00784368|6142032|P1|Overall Study|Adverse Event|6
1763190|NCT00784368|6142030|P3|Overall Study|Lack of Efficacy|1
1763191|NCT00784368|6142031|P2|Overall Study|Lack of Efficacy|0
1763192|NCT00784368|6142032|P1|Overall Study|Lack of Efficacy|2
1763193|NCT00784368|6142030|P3|Overall Study|Physician Decision|6
1763194|NCT00784368|6142031|P2|Overall Study|Physician Decision|0
1763195|NCT00784368|6142032|P1|Overall Study|Physician Decision|0
1763196|NCT00784303|6142068|P2|Overall Study|Withdrawal by Subject|0
1763197|NCT00784303|6142069|P1|Overall Study|Withdrawal by Subject|1
1763198|NCT00784303|6142068|P2|Overall Study|Participant choice|2
1763199|NCT00784303|6142069|P1|Overall Study|Participant choice|2
1763200|NCT00784303|6142068|P2|Overall Study|Adverse Event|13
1763201|NCT00784303|6142069|P1|Overall Study|Adverse Event|14
1763202|NCT00784277|6142108|P7|ER Treatment|Other|2
1763203|NCT00784277|6142109|P6|ER Treatment|Other|3
1763204|NCT00784277|6142110|P5|ER Treatment|Other|1
1763205|NCT00784277|6142111|P4|ER Treatment|Other|0
1763206|NCT00784277|6142112|P3|ER Treatment|Other|0
1763207|NCT00784277|6142113|P2|ER Treatment|Other|0
1763208|NCT00784277|6142114|P1|ER Treatment|Other|0
1763209|NCT00784277|6142108|P7|ER Treatment|Study Medication Non-Compliant|3
1763210|NCT00784277|6142109|P6|ER Treatment|Study Medication Non-Compliant|3
1763211|NCT00784277|6142110|P5|ER Treatment|Study Medication Non-Compliant|2
1763212|NCT00784277|6142111|P4|ER Treatment|Study Medication Non-Compliant|0
1763213|NCT00784277|6142112|P3|ER Treatment|Study Medication Non-Compliant|0
1763214|NCT00784277|6142113|P2|ER Treatment|Study Medication Non-Compliant|0
1763215|NCT00784277|6142114|P1|ER Treatment|Study Medication Non-Compliant|0
1763216|NCT00784277|6142108|P7|ER Treatment|Withdrawal by Subject|3
1763217|NCT00784277|6142109|P6|ER Treatment|Withdrawal by Subject|5
1763218|NCT00784277|6142110|P5|ER Treatment|Withdrawal by Subject|2
1763219|NCT00784277|6142111|P4|ER Treatment|Withdrawal by Subject|0
1763220|NCT00784277|6142112|P3|ER Treatment|Withdrawal by Subject|0
1763221|NCT00784277|6142113|P2|ER Treatment|Withdrawal by Subject|0
1763222|NCT00784277|6142114|P1|ER Treatment|Withdrawal by Subject|0
1763223|NCT00784277|6142108|P7|ER Treatment|Lost to Follow-up|0
1763224|NCT00784277|6142109|P6|ER Treatment|Lost to Follow-up|2
1763225|NCT00784277|6142110|P5|ER Treatment|Lost to Follow-up|0
1763226|NCT00784277|6142111|P4|ER Treatment|Lost to Follow-up|0
1763227|NCT00784277|6142112|P3|ER Treatment|Lost to Follow-up|0
1763228|NCT00784277|6142113|P2|ER Treatment|Lost to Follow-up|0
1763229|NCT00784277|6142114|P1|ER Treatment|Lost to Follow-up|0
1763230|NCT00784277|6142108|P7|ER Treatment|Lack of Efficacy|0
1763231|NCT00784277|6142109|P6|ER Treatment|Lack of Efficacy|4
1763232|NCT00784277|6142110|P5|ER Treatment|Lack of Efficacy|3
1763233|NCT00784277|6142111|P4|ER Treatment|Lack of Efficacy|0
1763234|NCT00784277|6142112|P3|ER Treatment|Lack of Efficacy|0
1763235|NCT00784277|6142113|P2|ER Treatment|Lack of Efficacy|0
1763236|NCT00784277|6142114|P1|ER Treatment|Lack of Efficacy|0
1763237|NCT00784277|6142108|P7|ER Treatment|Adverse Event|7
1763238|NCT00784277|6142109|P6|ER Treatment|Adverse Event|7
1763239|NCT00784277|6142110|P5|ER Treatment|Adverse Event|1
1763240|NCT00784277|6142111|P4|ER Treatment|Adverse Event|0
1763241|NCT00784277|6142112|P3|ER Treatment|Adverse Event|0
1763242|NCT00784277|6142113|P2|ER Treatment|Adverse Event|0
1763243|NCT00784277|6142114|P1|ER Treatment|Adverse Event|0
1763244|NCT00784277|6142108|P7|IR Treatment|Other|0
1763245|NCT00784277|6142109|P6|IR Treatment|Other|0
1763246|NCT00784277|6142110|P5|IR Treatment|Other|0
1763247|NCT00784277|6142111|P4|IR Treatment|Other|2
1763248|NCT00784277|6142112|P3|IR Treatment|Other|3
1763249|NCT00784277|6142113|P2|IR Treatment|Other|3
1763250|NCT00784277|6142114|P1|IR Treatment|Other|2
1763251|NCT00784277|6142108|P7|IR Treatment|Resolution Of Pain|0
1763252|NCT00784277|6142109|P6|IR Treatment|Resolution Of Pain|0
1763253|NCT00784277|6142110|P5|IR Treatment|Resolution Of Pain|0
1763254|NCT00784277|6142111|P4|IR Treatment|Resolution Of Pain|0
1763255|NCT00784277|6142112|P3|IR Treatment|Resolution Of Pain|0
1763256|NCT00784277|6142113|P2|IR Treatment|Resolution Of Pain|1
1763257|NCT00784277|6142114|P1|IR Treatment|Resolution Of Pain|0
1763258|NCT00784277|6142108|P7|IR Treatment|Withdrawal by Subject|0
1763259|NCT00784277|6142109|P6|IR Treatment|Withdrawal by Subject|0
1763260|NCT00784277|6142110|P5|IR Treatment|Withdrawal by Subject|0
1763261|NCT00784277|6142111|P4|IR Treatment|Withdrawal by Subject|6
1763262|NCT00784277|6142112|P3|IR Treatment|Withdrawal by Subject|4
1763263|NCT00784277|6142113|P2|IR Treatment|Withdrawal by Subject|1
1763264|NCT00784277|6142114|P1|IR Treatment|Withdrawal by Subject|5
1763265|NCT00784277|6142108|P7|IR Treatment|Lost to Follow-up|0
1763266|NCT00784277|6142109|P6|IR Treatment|Lost to Follow-up|0
1763267|NCT00784277|6142110|P5|IR Treatment|Lost to Follow-up|0
1763268|NCT00784277|6142111|P4|IR Treatment|Lost to Follow-up|0
1763269|NCT00784277|6142112|P3|IR Treatment|Lost to Follow-up|1
1763270|NCT00784277|6142113|P2|IR Treatment|Lost to Follow-up|0
1763271|NCT00784277|6142114|P1|IR Treatment|Lost to Follow-up|1
1763272|NCT00784277|6142108|P7|IR Treatment|Lack of Efficacy|0
1763273|NCT00784277|6142109|P6|IR Treatment|Lack of Efficacy|0
1763274|NCT00784277|6142110|P5|IR Treatment|Lack of Efficacy|0
1763275|NCT00784277|6142111|P4|IR Treatment|Lack of Efficacy|0
1763276|NCT00784277|6142112|P3|IR Treatment|Lack of Efficacy|1
1763277|NCT00784277|6142113|P2|IR Treatment|Lack of Efficacy|4
1763278|NCT00784277|6142114|P1|IR Treatment|Lack of Efficacy|4
1763279|NCT00784277|6142108|P7|IR Treatment|Adverse Event|0
1763280|NCT00784277|6142109|P6|IR Treatment|Adverse Event|0
1763281|NCT00784277|6142110|P5|IR Treatment|Adverse Event|0
1763282|NCT00784277|6142111|P4|IR Treatment|Adverse Event|35
1763283|NCT00784277|6142112|P3|IR Treatment|Adverse Event|19
1763284|NCT00784277|6142113|P2|IR Treatment|Adverse Event|8
1763285|NCT00784277|6142114|P1|IR Treatment|Adverse Event|4
1763286|NCT00784238|6142131|P1|Overall Study|Other|14
1763287|NCT00784238|6142131|P1|Overall Study|Withdrawal by Subject|26
1763288|NCT00784238|6142131|P1|Overall Study|Pregnancy|1
1763289|NCT00784238|6142131|P1|Overall Study|Lost to Follow-up|29
1763290|NCT00784238|6142131|P1|Overall Study|Lack of Efficacy|33
1763291|NCT00784238|6142131|P1|Overall Study|Death|2
1763292|NCT00784238|6142131|P1|Overall Study|Adverse Event|14
1763293|NCT00784147|6142203|P2|Overall Study|Death|0
1763294|NCT00784147|6142204|P1|Overall Study|Death|2
1763295|NCT00784147|6142203|P2|Overall Study|Protocol Violation|1
1763296|NCT00784147|6142204|P1|Overall Study|Protocol Violation|1
1763297|NCT00784147|6142203|P2|Overall Study|Physician Decision|1
1763298|NCT00784147|6142204|P1|Overall Study|Physician Decision|2
1763299|NCT00784147|6142203|P2|Overall Study|Withdrawal by Subject|3
1763300|NCT00784147|6142204|P1|Overall Study|Withdrawal by Subject|1
1763301|NCT00784147|6142203|P2|Overall Study|Lost to Follow-up|4
1763302|NCT00784147|6142204|P1|Overall Study|Lost to Follow-up|2
1763303|NCT00784134|6142224|P2|Overall Study|Lost to Follow-up|6
1763304|NCT00784134|6142225|P1|Overall Study|Lost to Follow-up|3
1763305|NCT00784043|6142348|P2|Overall Study|Protocol Terminated|1
1763306|NCT00784043|6142349|P1|Overall Study|Protocol Terminated|23
1763307|NCT00784043|6142348|P2|Overall Study|Withdrawal by Subject|5
1763308|NCT00784043|6142349|P1|Overall Study|Withdrawal by Subject|8
1763309|NCT00783835|6142384|P1|Overall Study|Participant not Adherent|3
1763310|NCT00783835|6142384|P1|Overall Study|Lost to Follow-up|1
1763311|NCT00783835|6142384|P1|Overall Study|Withdrawal by Subject|2
1763312|NCT00783835|6142384|P1|Overall Study|Medical Criteria|1
1763313|NCT00783835|6142384|P1|Overall Study|Adverse Event|3
1763314|NCT00783796|6142396|P1|Overall Study|Received commercial XIENCE V stent|1
1763315|NCT00783796|6142396|P1|Overall Study|Received non-XIENCE V stent|1
1763316|NCT00783796|6142396|P1|Overall Study|Did not receive any stent|4
1763317|NCT00783718|6142501|P7|Maintenance Phase|Lost to Follow-up|2
1763318|NCT00783718|6142502|P6|Maintenance Phase|Lost to Follow-up|0
1763319|NCT00783718|6142503|P5|Maintenance Phase|Lost to Follow-up|2
1763320|NCT00783718|6142504|P4|Maintenance Phase|Lost to Follow-up|0
1763321|NCT00783718|6142505|P3|Maintenance Phase|Lost to Follow-up|0
1763322|NCT00783718|6142506|P2|Maintenance Phase|Lost to Follow-up|0
1763323|NCT00783718|6142507|P1|Maintenance Phase|Lost to Follow-up|3
1763324|NCT00783718|6142501|P7|Maintenance Phase|Withdrawal by Subject|20
1763325|NCT00783718|6142502|P6|Maintenance Phase|Withdrawal by Subject|2
1763326|NCT00783718|6142503|P5|Maintenance Phase|Withdrawal by Subject|5
1763327|NCT00783718|6142504|P4|Maintenance Phase|Withdrawal by Subject|2
1763328|NCT00783718|6142505|P3|Maintenance Phase|Withdrawal by Subject|0
1763329|NCT00783718|6142506|P2|Maintenance Phase|Withdrawal by Subject|0
1763330|NCT00783718|6142507|P1|Maintenance Phase|Withdrawal by Subject|6
1763331|NCT00783718|6142501|P7|Maintenance Phase|Lack of Efficacy|155
1763332|NCT00783718|6142502|P6|Maintenance Phase|Lack of Efficacy|33
1763333|NCT00783718|6142503|P5|Maintenance Phase|Lack of Efficacy|31
1763334|NCT00783718|6142504|P4|Maintenance Phase|Lack of Efficacy|61
1763335|NCT00783718|6142505|P3|Maintenance Phase|Lack of Efficacy|0
1763336|NCT00783718|6142506|P2|Maintenance Phase|Lack of Efficacy|0
1763337|NCT00783718|6142507|P1|Maintenance Phase|Lack of Efficacy|83
1763338|NCT00783718|6142501|P7|Maintenance Phase|Protocol Violation|2
1763339|NCT00783718|6142502|P6|Maintenance Phase|Protocol Violation|0
1763340|NCT00783718|6142503|P5|Maintenance Phase|Protocol Violation|0
1763341|NCT00783718|6142504|P4|Maintenance Phase|Protocol Violation|0
1763342|NCT00783718|6142505|P3|Maintenance Phase|Protocol Violation|0
1763343|NCT00783718|6142506|P2|Maintenance Phase|Protocol Violation|0
1763344|NCT00783718|6142507|P1|Maintenance Phase|Protocol Violation|1
1763345|NCT00783718|6142501|P7|Maintenance Phase|Adverse Event|16
1763346|NCT00783718|6142502|P6|Maintenance Phase|Adverse Event|6
1763347|NCT00783718|6142503|P5|Maintenance Phase|Adverse Event|7
1763348|NCT00783718|6142504|P4|Maintenance Phase|Adverse Event|15
1763349|NCT00783718|6142505|P3|Maintenance Phase|Adverse Event|0
1763350|NCT00783718|6142506|P2|Maintenance Phase|Adverse Event|0
1763351|NCT00783718|6142507|P1|Maintenance Phase|Adverse Event|12
1763352|NCT00783718|6142501|P7|Induction Phase|Lost to Follow-up|0
1763353|NCT00783718|6142502|P6|Induction Phase|Lost to Follow-up|0
1763354|NCT00783718|6142503|P5|Induction Phase|Lost to Follow-up|0
1763355|NCT00783718|6142504|P4|Induction Phase|Lost to Follow-up|0
1763356|NCT00783718|6142505|P3|Induction Phase|Lost to Follow-up|1
1763357|NCT00783718|6142506|P2|Induction Phase|Lost to Follow-up|0
1763358|NCT00783718|6142507|P1|Induction Phase|Lost to Follow-up|1
1763359|NCT00783718|6142501|P7|Induction Phase|Withdrawal by Subject|0
1763360|NCT00783718|6142502|P6|Induction Phase|Withdrawal by Subject|0
1763361|NCT00783718|6142503|P5|Induction Phase|Withdrawal by Subject|0
1763362|NCT00783718|6142504|P4|Induction Phase|Withdrawal by Subject|0
1763363|NCT00783718|6142505|P3|Induction Phase|Withdrawal by Subject|8
1763364|NCT00783718|6142506|P2|Induction Phase|Withdrawal by Subject|4
1763365|NCT00783718|6142507|P1|Induction Phase|Withdrawal by Subject|3
1763366|NCT00783718|6142501|P7|Induction Phase|Lack of Efficacy|0
1763367|NCT00783718|6142502|P6|Induction Phase|Lack of Efficacy|0
1763368|NCT00783718|6142503|P5|Induction Phase|Lack of Efficacy|0
1763369|NCT00783718|6142504|P4|Induction Phase|Lack of Efficacy|0
1763370|NCT00783718|6142505|P3|Induction Phase|Lack of Efficacy|14
1763371|NCT00783718|6142506|P2|Induction Phase|Lack of Efficacy|2
1763372|NCT00783718|6142507|P1|Induction Phase|Lack of Efficacy|5
1763373|NCT00783718|6142501|P7|Induction Phase|Protocol Violation|0
1763374|NCT00783718|6142502|P6|Induction Phase|Protocol Violation|0
1763375|NCT00783718|6142503|P5|Induction Phase|Protocol Violation|0
1763376|NCT00783718|6142504|P4|Induction Phase|Protocol Violation|0
1763377|NCT00783718|6142505|P3|Induction Phase|Protocol Violation|6
1763378|NCT00783718|6142506|P2|Induction Phase|Protocol Violation|1
1763379|NCT00783718|6142507|P1|Induction Phase|Protocol Violation|1
1763380|NCT00783718|6142501|P7|Induction Phase|Adverse Event|0
1763381|NCT00783718|6142502|P6|Induction Phase|Adverse Event|0
1763382|NCT00783718|6142503|P5|Induction Phase|Adverse Event|0
1763383|NCT00783718|6142504|P4|Induction Phase|Adverse Event|0
1763384|NCT00783718|6142505|P3|Induction Phase|Adverse Event|7
1763385|NCT00783718|6142506|P2|Induction Phase|Adverse Event|0
1763386|NCT00783718|6142507|P1|Induction Phase|Adverse Event|4
1763387|NCT00783705|6142535|P2|Overall Study|Lost to Follow-up|3
1763388|NCT00783705|6142536|P1|Overall Study|Lost to Follow-up|1
1763389|NCT00783705|6142535|P2|Overall Study|Withdrawal by Subject|2
1763390|NCT00783705|6142536|P1|Overall Study|Withdrawal by Subject|3
1763391|NCT00783705|6142535|P2|Overall Study|Adverse Event|0
1763392|NCT00783705|6142536|P1|Overall Study|Adverse Event|2
1763393|NCT00783692|6142583|P7|Maintenance Phase|Other|1
1763394|NCT00783692|6142584|P6|Maintenance Phase|Other|1
1763395|NCT00783692|6142585|P5|Maintenance Phase|Other|0
1763396|NCT00783692|6142586|P4|Maintenance Phase|Other|1
1763397|NCT00783692|6142587|P3|Maintenance Phase|Other|0
1763398|NCT00783692|6142588|P2|Maintenance Phase|Other|0
1763399|NCT00783692|6142589|P1|Maintenance Phase|Other|0
1763400|NCT00783692|6142583|P7|Maintenance Phase|Lost to Follow-up|5
1763401|NCT00783692|6142584|P6|Maintenance Phase|Lost to Follow-up|2
1763402|NCT00783692|6142585|P5|Maintenance Phase|Lost to Follow-up|3
1763403|NCT00783692|6142586|P4|Maintenance Phase|Lost to Follow-up|1
1763404|NCT00783692|6142587|P3|Maintenance Phase|Lost to Follow-up|0
1763405|NCT00783692|6142588|P2|Maintenance Phase|Lost to Follow-up|0
1763406|NCT00783692|6142589|P1|Maintenance Phase|Lost to Follow-up|2
1763407|NCT00783692|6142583|P7|Maintenance Phase|Withdrawal by Subject|24
1763408|NCT00783692|6142584|P6|Maintenance Phase|Withdrawal by Subject|9
1763409|NCT00783692|6142585|P5|Maintenance Phase|Withdrawal by Subject|6
1763410|NCT00783692|6142586|P4|Maintenance Phase|Withdrawal by Subject|7
1763411|NCT00783692|6142587|P3|Maintenance Phase|Withdrawal by Subject|0
1763412|NCT00783692|6142588|P2|Maintenance Phase|Withdrawal by Subject|0
1763413|NCT00783692|6142589|P1|Maintenance Phase|Withdrawal by Subject|7
1763414|NCT00783692|6142583|P7|Maintenance Phase|Lack of Efficacy|177
1763415|NCT00783692|6142584|P6|Maintenance Phase|Lack of Efficacy|48
1763416|NCT00783692|6142585|P5|Maintenance Phase|Lack of Efficacy|58
1763417|NCT00783692|6142586|P4|Maintenance Phase|Lack of Efficacy|64
1763418|NCT00783692|6142587|P3|Maintenance Phase|Lack of Efficacy|0
1763419|NCT00783692|6142588|P2|Maintenance Phase|Lack of Efficacy|0
1763420|NCT00783692|6142589|P1|Maintenance Phase|Lack of Efficacy|79
1763421|NCT00783692|6142583|P7|Maintenance Phase|Protocol Violation|4
1763422|NCT00783692|6142584|P6|Maintenance Phase|Protocol Violation|3
1763423|NCT00783692|6142585|P5|Maintenance Phase|Protocol Violation|2
1763424|NCT00783692|6142586|P4|Maintenance Phase|Protocol Violation|1
1763425|NCT00783692|6142587|P3|Maintenance Phase|Protocol Violation|0
1763426|NCT00783692|6142588|P2|Maintenance Phase|Protocol Violation|0
1763427|NCT00783692|6142589|P1|Maintenance Phase|Protocol Violation|0
1763428|NCT00783692|6142583|P7|Maintenance Phase|Adverse Event|38
1763429|NCT00783692|6142584|P6|Maintenance Phase|Adverse Event|9
1763430|NCT00783692|6142585|P5|Maintenance Phase|Adverse Event|12
1763431|NCT00783692|6142586|P4|Maintenance Phase|Adverse Event|15
1763432|NCT00783692|6142587|P3|Maintenance Phase|Adverse Event|0
1763433|NCT00783692|6142588|P2|Maintenance Phase|Adverse Event|0
1763434|NCT00783692|6142589|P1|Maintenance Phase|Adverse Event|7
1763435|NCT00783692|6142583|P7|Induction Phase|Other|0
1763436|NCT00783692|6142584|P6|Induction Phase|Other|0
1763437|NCT00783692|6142585|P5|Induction Phase|Other|0
1763438|NCT00783692|6142586|P4|Induction Phase|Other|0
1763439|NCT00783692|6142587|P3|Induction Phase|Other|2
1763440|NCT00783692|6142588|P2|Induction Phase|Other|0
1763441|NCT00783692|6142589|P1|Induction Phase|Other|0
1763442|NCT00783692|6142583|P7|Induction Phase|Lost to Follow-up|0
1763443|NCT00783692|6142584|P6|Induction Phase|Lost to Follow-up|0
1763444|NCT00783692|6142585|P5|Induction Phase|Lost to Follow-up|0
1763445|NCT00783692|6142586|P4|Induction Phase|Lost to Follow-up|0
1763446|NCT00783692|6142587|P3|Induction Phase|Lost to Follow-up|3
1763447|NCT00783692|6142588|P2|Induction Phase|Lost to Follow-up|0
1763448|NCT00783692|6142589|P1|Induction Phase|Lost to Follow-up|0
1763449|NCT00783692|6142583|P7|Induction Phase|Withdrawal by Subject|0
1763450|NCT00783692|6142584|P6|Induction Phase|Withdrawal by Subject|0
1763451|NCT00783692|6142585|P5|Induction Phase|Withdrawal by Subject|0
1763452|NCT00783692|6142586|P4|Induction Phase|Withdrawal by Subject|0
1763453|NCT00783692|6142587|P3|Induction Phase|Withdrawal by Subject|16
1763454|NCT00783692|6142588|P2|Induction Phase|Withdrawal by Subject|9
1763455|NCT00783692|6142589|P1|Induction Phase|Withdrawal by Subject|3
1763456|NCT00783692|6142583|P7|Induction Phase|Lack of Efficacy|0
1763457|NCT00783692|6142584|P6|Induction Phase|Lack of Efficacy|0
1763458|NCT00783692|6142585|P5|Induction Phase|Lack of Efficacy|0
1763459|NCT00783692|6142586|P4|Induction Phase|Lack of Efficacy|0
1763460|NCT00783692|6142587|P3|Induction Phase|Lack of Efficacy|28
1763461|NCT00783692|6142588|P2|Induction Phase|Lack of Efficacy|3
1763462|NCT00783692|6142589|P1|Induction Phase|Lack of Efficacy|1
1763463|NCT00783692|6142583|P7|Induction Phase|Protocol Violation|0
1763464|NCT00783692|6142584|P6|Induction Phase|Protocol Violation|0
1763465|NCT00783692|6142585|P5|Induction Phase|Protocol Violation|0
1763466|NCT00783692|6142586|P4|Induction Phase|Protocol Violation|0
1763467|NCT00783692|6142587|P3|Induction Phase|Protocol Violation|1
1763468|NCT00783692|6142588|P2|Induction Phase|Protocol Violation|0
1763469|NCT00783692|6142589|P1|Induction Phase|Protocol Violation|0
1763470|NCT00783692|6142583|P7|Induction Phase|Adverse Event|0
1763471|NCT00783692|6142584|P6|Induction Phase|Adverse Event|0
1763472|NCT00783692|6142585|P5|Induction Phase|Adverse Event|0
1763473|NCT00783692|6142586|P4|Induction Phase|Adverse Event|0
1763474|NCT00783692|6142587|P3|Induction Phase|Adverse Event|24
1763475|NCT00783692|6142588|P2|Induction Phase|Adverse Event|9
1763476|NCT00783692|6142589|P1|Induction Phase|Adverse Event|7
1763477|NCT00783432|6142635|P2|Overall Study|Protocol Violation|9
1763478|NCT00783432|6142636|P1|Overall Study|Protocol Violation|6
1763479|NCT00783432|6142635|P2|Overall Study|subject moved|5
1763480|NCT00783432|6142636|P1|Overall Study|subject moved|3
1763481|NCT00783432|6142635|P2|Overall Study|Withdrawal by Subject|20
1763482|NCT00783432|6142636|P1|Overall Study|Withdrawal by Subject|23
1763483|NCT00783432|6142635|P2|Overall Study|Lost to Follow-up|6
1763484|NCT00783432|6142636|P1|Overall Study|Lost to Follow-up|11
1763485|NCT00783432|6142635|P2|Overall Study|Lack of Efficacy|21
1763486|NCT00783432|6142636|P1|Overall Study|Lack of Efficacy|20
1763487|NCT00783432|6142635|P2|Overall Study|Adverse Event|17
1763488|NCT00783432|6142636|P1|Overall Study|Adverse Event|22
1763489|NCT00783302|6142646|P1|Overall Study|Withdrawal by Subject|3
1763490|NCT00783302|6142646|P1|Overall Study|Physician Decision|1
1763491|NCT00783302|6142646|P1|Overall Study|Protocol Violation|3
1763492|NCT00783302|6142646|P1|Overall Study|Technical Problems|11
1763493|NCT00783302|6142646|P1|Overall Study|Lost to Follow-up|17
1763494|NCT00783289|6142668|P4|Overall Study|Protocol Violation|0
1763495|NCT00783289|6142669|P3|Overall Study|Protocol Violation|0
1763496|NCT00783289|6142670|P2|Overall Study|Protocol Violation|1
1763497|NCT00783289|6142671|P1|Overall Study|Protocol Violation|0
1763498|NCT00783263|6142701|P4|Overall Study|Withdrawal by Subject|2
1763499|NCT00783263|6142702|P3|Overall Study|Withdrawal by Subject|1
1763500|NCT00783263|6142703|P2|Overall Study|Withdrawal by Subject|1
1763501|NCT00783263|6142704|P1|Overall Study|Withdrawal by Subject|0
1763502|NCT00783263|6142701|P4|Overall Study|Lost to Follow-up|0
1763503|NCT00783263|6142702|P3|Overall Study|Lost to Follow-up|0
1763504|NCT00783263|6142703|P2|Overall Study|Lost to Follow-up|1
1763505|NCT00783263|6142704|P1|Overall Study|Lost to Follow-up|1
1763506|NCT00783263|6142701|P4|Overall Study|Adverse Event|1
1763507|NCT00783263|6142702|P3|Overall Study|Adverse Event|2
1763508|NCT00783263|6142703|P2|Overall Study|Adverse Event|0
1763509|NCT00783263|6142704|P1|Overall Study|Adverse Event|3
1763510|NCT00783224|6142734|P4|Overall Study|Inappropriate as a study subject|1
1763511|NCT00783224|6142735|P3|Overall Study|Inappropriate as a study subject|0
1763512|NCT00783224|6142736|P2|Overall Study|Inappropriate as a study subject|0
1763513|NCT00783224|6142737|P1|Overall Study|Inappropriate as a study subject|0
1763514|NCT00783224|6142734|P4|Overall Study|Discarded the Investigational Drug Used|1
1763515|NCT00783224|6142735|P3|Overall Study|Discarded the Investigational Drug Used|0
1763516|NCT00783224|6142736|P2|Overall Study|Discarded the Investigational Drug Used|0
1763517|NCT00783224|6142737|P1|Overall Study|Discarded the Investigational Drug Used|0
1763518|NCT00783224|6142734|P4|Overall Study|Adverse Event|0
1763519|NCT00783224|6142735|P3|Overall Study|Adverse Event|1
1763520|NCT00783224|6142736|P2|Overall Study|Adverse Event|0
1763521|NCT00783224|6142737|P1|Overall Study|Adverse Event|0
1763522|NCT00783198|6142749|P3|Overall Study|Administrative|2
1763523|NCT00783198|6142750|P2|Overall Study|Administrative|1
1763524|NCT00783198|6142751|P1|Overall Study|Administrative|2
1763525|NCT00783198|6142749|P3|Overall Study|Did not meet protocol eligibility|0
1763526|NCT00783198|6142750|P2|Overall Study|Did not meet protocol eligibility|1
1763527|NCT00783198|6142751|P1|Overall Study|Did not meet protocol eligibility|0
1763528|NCT00783198|6142749|P3|Overall Study|Noncompliance with protocol|10
1763529|NCT00783198|6142750|P2|Overall Study|Noncompliance with protocol|7
1763530|NCT00783198|6142751|P1|Overall Study|Noncompliance with protocol|7
1763531|NCT00783198|6142749|P3|Overall Study|Withdrawal by Subject|20
1763532|NCT00783198|6142750|P2|Overall Study|Withdrawal by Subject|14
1763533|NCT00783198|6142751|P1|Overall Study|Withdrawal by Subject|22
1763534|NCT00783198|6142749|P3|Overall Study|Lost to Follow-up|7
1763535|NCT00783198|6142750|P2|Overall Study|Lost to Follow-up|1
1763536|NCT00783198|6142751|P1|Overall Study|Lost to Follow-up|11
1763537|NCT00783198|6142749|P3|Overall Study|Adverse Event|3
1763538|NCT00783198|6142750|P2|Overall Study|Adverse Event|19
1763539|NCT00783198|6142751|P1|Overall Study|Adverse Event|15
1763540|NCT00783094|6142774|P3|Open-Label Extension Period|Lack of Efficacy|0
1763541|NCT00783094|6142775|P2|Open-Label Extension Period|Lack of Efficacy|4
1763542|NCT00783094|6142776|P1|Open-Label Extension Period|Lack of Efficacy|1
1763543|NCT00783094|6142774|P3|Open-Label Extension Period|Physician Decision|3
1763544|NCT00783094|6142775|P2|Open-Label Extension Period|Physician Decision|2
1763545|NCT00783094|6142776|P1|Open-Label Extension Period|Physician Decision|4
1763546|NCT00783094|6142774|P3|Open-Label Extension Period|Withdrawal by Subject|3
1763547|NCT00783094|6142775|P2|Open-Label Extension Period|Withdrawal by Subject|1
1763548|NCT00783094|6142776|P1|Open-Label Extension Period|Withdrawal by Subject|1
1763549|NCT00783094|6142774|P3|Open-Label Extension Period|Protocol Violation|7
1763550|NCT00783094|6142775|P2|Open-Label Extension Period|Protocol Violation|5
1763551|NCT00783094|6142776|P1|Open-Label Extension Period|Protocol Violation|4
1763552|NCT00783094|6142774|P3|Open-Label Extension Period|Death|1
1763553|NCT00783094|6142775|P2|Open-Label Extension Period|Death|0
1763554|NCT00783094|6142776|P1|Open-Label Extension Period|Death|0
1763555|NCT00783094|6142774|P3|Open-Label Extension Period|Adverse Event|16
1763556|NCT00783094|6142775|P2|Open-Label Extension Period|Adverse Event|7
1763557|NCT00783094|6142776|P1|Open-Label Extension Period|Adverse Event|12
1763558|NCT00783094|6142774|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
1763559|NCT00783094|6142775|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
1763560|NCT00783094|6142776|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
1763561|NCT00783094|6142774|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
1763562|NCT00783094|6142775|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
1763563|NCT00783094|6142776|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
1763564|NCT00783094|6142774|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
1763565|NCT00783094|6142775|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
1763566|NCT00783094|6142776|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
1763567|NCT00783094|6142774|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
1763568|NCT00783094|6142775|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
1763569|NCT00783094|6142776|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
1763570|NCT00783094|6142774|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
1763571|NCT00783094|6142775|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
1763572|NCT00783094|6142776|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
1763573|NCT00782834|6142852|P1|Treatment Phase|fibrous tumor not GIST|1
1763574|NCT00782795|6142892|P2|Overall Study|Withdrawal by Subject|2
1763575|NCT00782795|6142893|P1|Overall Study|Withdrawal by Subject|1
1763576|NCT00782717|6142933|P2|Overall Study|Exited in error|2
1763577|NCT00782717|6142934|P1|Overall Study|Exited in error|0
1763578|NCT00782717|6142933|P2|Overall Study|Did not meet entrance criteria|3
1763579|NCT00782717|6142934|P1|Overall Study|Did not meet entrance criteria|1
1763580|NCT00782717|6142933|P2|Overall Study|Enrollment close prior to surgery|0
1763581|NCT00782717|6142934|P1|Overall Study|Enrollment close prior to surgery|1
1763582|NCT00782717|6142933|P2|Overall Study|Treatment failure|14
1763583|NCT00782717|6142934|P1|Overall Study|Treatment failure|3
1763584|NCT00782717|6142933|P2|Overall Study|Noncompliance|1
1763585|NCT00782717|6142934|P1|Overall Study|Noncompliance|2
1763586|NCT00782717|6142933|P2|Overall Study|Patient decision unrelated to AE|3
1763587|NCT00782717|6142934|P1|Overall Study|Patient decision unrelated to AE|6
1763588|NCT00782717|6142933|P2|Overall Study|Adverse Event|5
1763589|NCT00782717|6142934|P1|Overall Study|Adverse Event|2
1763590|NCT00782626|6142961|P1|Overall Study|Other Complicating Disease|1
1763591|NCT00782626|6142961|P1|Overall Study|Progressive Disease|5
1763592|NCT00782626|6142961|P1|Overall Study|Adverse Event|1
1763593|NCT00782509|6142968|P3|Overall Study|Lack of Efficacy|2
1763594|NCT00782509|6142969|P2|Overall Study|Lack of Efficacy|5
1763595|NCT00782509|6142970|P1|Overall Study|Lack of Efficacy|10
1763596|NCT00782509|6142968|P3|Overall Study|Other reasons not stated above|3
1763597|NCT00782509|6142969|P2|Overall Study|Other reasons not stated above|2
1763598|NCT00782509|6142970|P1|Overall Study|Other reasons not stated above|5
1763599|NCT00782509|6142968|P3|Overall Study|Non compliance with protocol|0
1763600|NCT00782509|6142969|P2|Overall Study|Non compliance with protocol|0
1763601|NCT00782509|6142970|P1|Overall Study|Non compliance with protocol|2
1763602|NCT00782509|6142968|P3|Overall Study|Withdrawal by Subject|8
1763603|NCT00782509|6142969|P2|Overall Study|Withdrawal by Subject|5
1763604|NCT00782509|6142970|P1|Overall Study|Withdrawal by Subject|3
1763605|NCT00782509|6142968|P3|Overall Study|Lost to Follow-up|3
1763606|NCT00782509|6142969|P2|Overall Study|Lost to Follow-up|2
1763607|NCT00782509|6142970|P1|Overall Study|Lost to Follow-up|1
1763608|NCT00782509|6142968|P3|Overall Study|Adverse Event|20
1763609|NCT00782509|6142969|P2|Overall Study|Adverse Event|10
1763610|NCT00782509|6142970|P1|Overall Study|Adverse Event|20
1763611|NCT00782496|6143163|P2|Overall Study|Lost to Follow-up|15
1763612|NCT00782496|6143164|P1|Overall Study|Lost to Follow-up|14
1763613|NCT00782483|6143171|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
1763614|NCT00782418|6143175|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1763615|NCT00782418|6143176|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1763616|NCT00782418|6143177|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1763617|NCT00782418|6143178|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1763618|NCT00782418|6143179|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1763619|NCT00782418|6143180|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
1763620|NCT00782418|6143181|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
1763621|NCT00782418|6143175|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
1763622|NCT00782418|6143176|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
1763623|NCT00782418|6143177|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
1763624|NCT00782418|6143178|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
1763625|NCT00782418|6143179|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
1763626|NCT00782418|6143180|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
1763627|NCT00782418|6143181|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
1763628|NCT00782340|6143218|P3|Open Label Titration|Randomized in error|0
1763629|NCT00782340|6143219|P2|Open Label Titration|Randomized in error|0
1763630|NCT00782340|6143220|P1|Open Label Titration|Randomized in error|6
1763631|NCT00782340|6143218|P3|Open Label Titration|Lost to Follow-up|0
1763632|NCT00782340|6143219|P2|Open Label Titration|Lost to Follow-up|0
1763633|NCT00782340|6143220|P1|Open Label Titration|Lost to Follow-up|5
1763634|NCT00782340|6143218|P3|Open Label Titration|Did not meet responder criteria|0
1763635|NCT00782340|6143219|P2|Open Label Titration|Did not meet responder criteria|0
1763636|NCT00782340|6143220|P1|Open Label Titration|Did not meet responder criteria|2
1763637|NCT00782340|6143218|P3|Open Label Titration|Enrollment capped|0
1763638|NCT00782340|6143219|P2|Open Label Titration|Enrollment capped|0
1763639|NCT00782340|6143220|P1|Open Label Titration|Enrollment capped|16
1763640|NCT00782340|6143218|P3|Open Label Titration|Withdrawal by Subject|0
1763641|NCT00782340|6143219|P2|Open Label Titration|Withdrawal by Subject|0
1763642|NCT00782340|6143220|P1|Open Label Titration|Withdrawal by Subject|5
1763643|NCT00782340|6143218|P3|Open Label Titration|Protocol Violation|0
1763644|NCT00782340|6143219|P2|Open Label Titration|Protocol Violation|0
1763645|NCT00782340|6143220|P1|Open Label Titration|Protocol Violation|5
1763646|NCT00782340|6143218|P3|Open Label Titration|Treatment failure|0
1763647|NCT00782340|6143219|P2|Open Label Titration|Treatment failure|0
1763648|NCT00782340|6143220|P1|Open Label Titration|Treatment failure|50
1763649|NCT00782340|6143218|P3|Open Label Titration|Adverse Event|0
1763650|NCT00782340|6143219|P2|Open Label Titration|Adverse Event|0
1763651|NCT00782340|6143220|P1|Open Label Titration|Adverse Event|12
1763652|NCT00782275|6143290|P1|Overall Study|Other|3
1763653|NCT00782275|6143290|P1|Overall Study|Not started treatment|1
1763654|NCT00782275|6143290|P1|Overall Study|Physician Decision|4
1763655|NCT00782275|6143290|P1|Overall Study|Progressive Disease|21
1763656|NCT00782275|6143290|P1|Overall Study|Withdrawal by Subject|1
1763657|NCT00782275|6143290|P1|Overall Study|Adverse Event|11
1763658|NCT00782210|6143299|P3|Overall Study|Other reason not described above|3
1763659|NCT00782210|6143300|P2|Overall Study|Other reason not described above|2
1763660|NCT00782210|6143301|P1|Overall Study|Other reason not described above|3
1763661|NCT00782210|6143299|P3|Overall Study|Lack of Efficacy|1
1763662|NCT00782210|6143300|P2|Overall Study|Lack of Efficacy|4
1763663|NCT00782210|6143301|P1|Overall Study|Lack of Efficacy|13
1763664|NCT00782210|6143299|P3|Overall Study|Non compliance with protocol|2
1763665|NCT00782210|6143300|P2|Overall Study|Non compliance with protocol|3
1763666|NCT00782210|6143301|P1|Overall Study|Non compliance with protocol|0
1763667|NCT00782210|6143299|P3|Overall Study|Withdrawal by Subject|11
1763668|NCT00782210|6143300|P2|Overall Study|Withdrawal by Subject|8
1763669|NCT00782210|6143301|P1|Overall Study|Withdrawal by Subject|11
1763670|NCT00782210|6143299|P3|Overall Study|Lost to Follow-up|2
1763671|NCT00782210|6143300|P2|Overall Study|Lost to Follow-up|1
1763672|NCT00782210|6143301|P1|Overall Study|Lost to Follow-up|2
1763673|NCT00782210|6143299|P3|Overall Study|Adverse Event|16
1763674|NCT00782210|6143300|P2|Overall Study|Adverse Event|17
1763675|NCT00782210|6143301|P1|Overall Study|Adverse Event|21
1763676|NCT00782184|6143494|P2|Overall Study|Withdrawal by Subject|2
1763677|NCT00782184|6143495|P1|Overall Study|Withdrawal by Subject|3
1763678|NCT00782184|6143494|P2|Overall Study|Protocol Violation|1
1763679|NCT00782184|6143495|P1|Overall Study|Protocol Violation|0
1763680|NCT00782184|6143494|P2|Overall Study|Adverse Event|2
1763681|NCT00782184|6143495|P1|Overall Study|Adverse Event|1
1763682|NCT00782171|6143532|P2|Overall Study|not eligible|6
1763683|NCT00782171|6143533|P1|Overall Study|not eligible|8
1763684|NCT00782171|6143532|P2|Overall Study|others|9
1763685|NCT00782171|6143533|P1|Overall Study|others|7
1763686|NCT00782171|6143532|P2|Overall Study|complications|1
1763687|NCT00782171|6143533|P1|Overall Study|complications|3
1763688|NCT00782171|6143532|P2|Overall Study|Withdrawal by Subject|1
1763689|NCT00782171|6143533|P1|Overall Study|Withdrawal by Subject|2
1763690|NCT00782171|6143532|P2|Overall Study|Lost to Follow-up|2
1763691|NCT00782171|6143533|P1|Overall Study|Lost to Follow-up|2
1763692|NCT00782067|6143565|P1|Overall Study|Protocol deviation|2
1763693|NCT00782067|6143565|P1|Overall Study|Disease progression|43
1763694|NCT00782067|6143565|P1|Overall Study|Death|9
1763695|NCT00782067|6143565|P1|Overall Study|Administrative problems|14
1763696|NCT00782067|6143565|P1|Overall Study|Lost to Follow-up|2
1763697|NCT00782067|6143565|P1|Overall Study|Subject withdrew consent|11
1763698|NCT00782067|6143565|P1|Overall Study|Adverse Event|35
1763699|NCT00781963|6143577|P2|Overall Study|Refused follow-up|0
1763700|NCT00781963|6143578|P1|Overall Study|Refused follow-up|9
1763701|NCT00781963|6143577|P2|Overall Study|Withdrawal by Subject|1
1763702|NCT00781963|6143578|P1|Overall Study|Withdrawal by Subject|3
1763703|NCT00781963|6143577|P2|Overall Study|Lost to Follow-up|1
1763704|NCT00781963|6143578|P1|Overall Study|Lost to Follow-up|2
1763705|NCT00781963|6143577|P2|Overall Study|Death|0
1763706|NCT00781963|6143578|P1|Overall Study|Death|3
1763707|NCT00781937|6143607|P2|Follow up Period (Week 56-68)|Unclassified|4
1763708|NCT00781937|6143608|P1|Follow up Period (Week 56-68)|Unclassified|5
1763709|NCT00781937|6143607|P2|Follow up Period (Week 56-68)|Protocol Violation|1
1763710|NCT00781937|6143608|P1|Follow up Period (Week 56-68)|Protocol Violation|1
1763711|NCT00781937|6143607|P2|Main Trial Period Through Week 56|Unclassified|15
1763712|NCT00781937|6143608|P1|Main Trial Period Through Week 56|Unclassified|10
1763713|NCT00781937|6143607|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
1763714|NCT00781937|6143608|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
1763715|NCT00781937|6143607|P2|Main Trial Period Through Week 56|Protocol Violation|5
1763716|NCT00781937|6143608|P1|Main Trial Period Through Week 56|Protocol Violation|8
1763717|NCT00781937|6143607|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
1763718|NCT00781937|6143608|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
1763719|NCT00781937|6143607|P2|Main Trial Period Through Week 56|Adverse Event|18
1763720|NCT00781937|6143608|P1|Main Trial Period Through Week 56|Adverse Event|18
1763721|NCT00781911|6143666|P2|Overall Study|Sponsor Decision|0
1763722|NCT00781911|6143667|P1|Overall Study|Sponsor Decision|1
1763723|NCT00781911|6143666|P2|Overall Study|Physician Decision|2
1763724|NCT00781911|6143667|P1|Overall Study|Physician Decision|0
1763725|NCT00781911|6143666|P2|Overall Study|Withdrawal by Subject|2
1763726|NCT00781911|6143667|P1|Overall Study|Withdrawal by Subject|1
1763727|NCT00781911|6143666|P2|Overall Study|Adverse Event|4
1763728|NCT00781911|6143667|P1|Overall Study|Adverse Event|4
1763729|NCT00781859|6143704|P2|Overall Study|Death|0
1763730|NCT00781859|6143705|P1|Overall Study|Death|3
1763731|NCT00781859|6143704|P2|Overall Study|Lost to Follow-up|3
1763732|NCT00781859|6143705|P1|Overall Study|Lost to Follow-up|6
1763733|NCT00781859|6143704|P2|Overall Study|Withdrawal by Subject|4
1763734|NCT00781859|6143705|P1|Overall Study|Withdrawal by Subject|8
1763735|NCT00781859|6143704|P2|Overall Study|Adverse Event|2
1763736|NCT00781859|6143705|P1|Overall Study|Adverse Event|2
1763737|NCT00781768|6143715|P2|Overall Study|Not transplanted.|2
1763738|NCT00781768|6143716|P1|Overall Study|Not transplanted.|0
1763739|NCT00781599|6143724|P2|Overall Study|Lost to Follow-up|4
1763740|NCT00781599|6143725|P1|Overall Study|Lost to Follow-up|7
1763741|NCT00781456|6143750|P2|Overall Study|Other Reason, Unknown|1
1763742|NCT00781456|6143751|P1|Overall Study|Other Reason, Unknown|0
1763743|NCT00781456|6143750|P2|Overall Study|Lost to Follow-up|5
1763744|NCT00781456|6143751|P1|Overall Study|Lost to Follow-up|10
1763745|NCT00781456|6143750|P2|Overall Study|Noncompliance With Protocol|1
1763746|NCT00781456|6143751|P1|Overall Study|Noncompliance With Protocol|1
1763747|NCT00781456|6143750|P2|Overall Study|Protocol Violation|1
1763748|NCT00781456|6143751|P1|Overall Study|Protocol Violation|4
1763749|NCT00781456|6143750|P2|Overall Study|Withdrawal by Subject|5
1763750|NCT00781456|6143751|P1|Overall Study|Withdrawal by Subject|3
1763751|NCT00781456|6143750|P2|Overall Study|Adverse Event|3
1763752|NCT00781456|6143751|P1|Overall Study|Adverse Event|3
1763753|NCT00781391|6143774|P3|Overall Study|Lost to Follow-up|1
1763754|NCT00781391|6143775|P2|Overall Study|Lost to Follow-up|0
1763755|NCT00781391|6143776|P1|Overall Study|Lost to Follow-up|0
1763756|NCT00781391|6143774|P3|Overall Study|Withdrawal by Subject|25
1763757|NCT00781391|6143775|P2|Overall Study|Withdrawal by Subject|37
1763758|NCT00781391|6143776|P1|Overall Study|Withdrawal by Subject|47
1763759|NCT00781391|6143774|P3|Overall Study|Death|706
1763760|NCT00781391|6143775|P2|Overall Study|Death|730
1763761|NCT00781391|6143776|P1|Overall Study|Death|789
1763762|NCT00781391|6143774|P3|Overall Study|Protocol Violation|20
1763763|NCT00781391|6143775|P2|Overall Study|Protocol Violation|17
1763764|NCT00781391|6143776|P1|Overall Study|Protocol Violation|19
1763765|NCT00781391|6143774|P3|Overall Study|never received study drug|32
1763766|NCT00781391|6143775|P2|Overall Study|never received study drug|23
1763767|NCT00781391|6143776|P1|Overall Study|never received study drug|24
1763768|NCT00781365|6143810|P2|Overall Study|Language barrier|0
1763769|NCT00781365|6143811|P1|Overall Study|Language barrier|1
1763770|NCT00781365|6143810|P2|Overall Study|Did Not Attend Visit|28
1763771|NCT00781365|6143811|P1|Overall Study|Did Not Attend Visit|20
1763772|NCT00781365|6143810|P2|Overall Study|Withdrawal by Subject|8
1763773|NCT00781365|6143811|P1|Overall Study|Withdrawal by Subject|13
1763774|NCT00781326|6143821|P1|Phase I|Physician Decision|2
1763775|NCT00781326|6143821|P1|Phase I|Withdrawal by Subject|1
1763776|NCT00781326|6143821|P1|Phase I|Adverse Event|1
1763777|NCT00781274|6143825|P1|Overall Study|Withdrawal by Subject|2
1763778|NCT00780910|6143857|P1|Overall Study|Adverse Event|2
1763779|NCT00780559|6143919|P2|Overall Study|Death|0
1763780|NCT00780559|6143920|P1|Overall Study|Death|1
1763781|NCT00780559|6143919|P2|Overall Study|Lost to Follow-up|7
1763782|NCT00780559|6143920|P1|Overall Study|Lost to Follow-up|2
1763783|NCT00780416|6143988|P2|Overall Study|Withdrawal by Subject|6
1763784|NCT00780416|6143989|P1|Overall Study|Withdrawal by Subject|8
1763785|NCT00780416|6143988|P2|Overall Study|Protocol Violation|0
1763786|NCT00780416|6143989|P1|Overall Study|Protocol Violation|1
1763787|NCT00780416|6143988|P2|Overall Study|Physician Decision|3
1763788|NCT00780416|6143989|P1|Overall Study|Physician Decision|3
1763789|NCT00780273|6144034|P1|Overall Study|Lost to Follow-up|1
1763790|NCT00780273|6144034|P1|Overall Study|Death|1
1763791|NCT00780143|6144057|P1|Overall Study|Adverse Event|1
1763792|NCT00780143|6144057|P1|Overall Study|Toxicity|1
1763793|NCT00780143|6144057|P1|Overall Study|Progressive disease|1
1763794|NCT00779909|6144088|P4|Overall Study|Withdrawal by Subject|0
1763795|NCT00779909|6144089|P3|Overall Study|Withdrawal by Subject|0
1763796|NCT00779909|6144090|P2|Overall Study|Withdrawal by Subject|1
1763797|NCT00779909|6144091|P1|Overall Study|Withdrawal by Subject|0
1763798|NCT00779909|6144088|P4|Overall Study|Lost to Follow-up|1
1763799|NCT00779909|6144089|P3|Overall Study|Lost to Follow-up|0
1763800|NCT00779909|6144090|P2|Overall Study|Lost to Follow-up|0
1763801|NCT00779909|6144091|P1|Overall Study|Lost to Follow-up|1
1763802|NCT00779857|6144155|P1|Overall Study|Missed Visit|2
1763803|NCT00779857|6144155|P1|Overall Study|Withdrawal by Subject|3
1763804|NCT00779857|6144155|P1|Overall Study|Death|1
1763805|NCT00779779|6144160|P1|Overall Study|Lost to Follow-up|5
1763806|NCT00779779|6144160|P1|Overall Study|Withdrawal by Subject|4
1763807|NCT00779779|6144160|P1|Overall Study|Protocol Violation|14
1763808|NCT00779779|6144160|P1|Overall Study|Adverse Event|1
1763809|NCT00779766|6144169|P2|Month 72|Other|1
1763810|NCT00779766|6144170|P1|Month 72|Other|0
1763811|NCT00779766|6144169|P2|Month 72|Lost to Follow-up|8
1763812|NCT00779766|6144170|P1|Month 72|Lost to Follow-up|6
1763813|NCT00779766|6144169|P2|Month 72|Migrated/moved from study area|109
1763814|NCT00779766|6144170|P1|Month 72|Migrated/moved from study area|124
1763815|NCT00779766|6144169|P2|Month 72|Withdrawal by Subject|71
1763816|NCT00779766|6144170|P1|Month 72|Withdrawal by Subject|55
1763817|NCT00779766|6144169|P2|Month 48|Other|0
1763818|NCT00779766|6144170|P1|Month 48|Other|1
1763819|NCT00779766|6144169|P2|Month 48|Lost to Follow-up|30
1763820|NCT00779766|6144170|P1|Month 48|Lost to Follow-up|29
1763821|NCT00779766|6144169|P2|Month 48|Migrated/moved from study area|75
1763822|NCT00779766|6144170|P1|Month 48|Migrated/moved from study area|76
1763823|NCT00779766|6144169|P2|Month 48|Withdrawal by Subject|63
1763824|NCT00779766|6144170|P1|Month 48|Withdrawal by Subject|68
1763825|NCT00779766|6144169|P2|Month 24|Other|27
1763826|NCT00779766|6144170|P1|Month 24|Other|18
1763827|NCT00779766|6144169|P2|Month 24|Lost to Follow-up|9
1763828|NCT00779766|6144170|P1|Month 24|Lost to Follow-up|9
1763829|NCT00779766|6144169|P2|Month 24|Migrated/moved from study area|162
1763830|NCT00779766|6144170|P1|Month 24|Migrated/moved from study area|138
1763831|NCT00779766|6144169|P2|Month 24|Withdrawal by Subject|127
1763832|NCT00779766|6144170|P1|Month 24|Withdrawal by Subject|159
1763833|NCT00779766|6144169|P2|Month 24|Protocol Violation|1
1763834|NCT00779766|6144170|P1|Month 24|Protocol Violation|3
1763835|NCT00779766|6144169|P2|Month 24|Adverse Event|3
1763836|NCT00779766|6144170|P1|Month 24|Adverse Event|3
1763837|NCT00779766|6144169|P2|Month 24|Serious Adverse Event|3
1763838|NCT00779766|6144170|P1|Month 24|Serious Adverse Event|2
1763839|NCT00779675|6144258|P1|Extended Treatment Period|Lost to Follow-up|6
1763840|NCT00779675|6144258|P1|Extended Treatment Period|Protocol defined clinical event|1
1763841|NCT00779675|6144258|P1|Extended Treatment Period|Treatment Failure|11
1763842|NCT00779675|6144258|P1|Extended Treatment Period|Adverse Event|6
1763843|NCT00779675|6144258|P1|Extended Treatment Period|Protocol Violation|13
1763844|NCT00779675|6144258|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
1763845|NCT00779675|6144258|P1|Treatment Period|Administrative|3
1763846|NCT00779675|6144258|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
1763847|NCT00779675|6144258|P1|Treatment Period|Protocol Violation|54
1763848|NCT00779675|6144258|P1|Treatment Period|Withdrawal by Subject|46
1763849|NCT00779675|6144258|P1|Treatment Period|Lost to Follow-up|23
1763850|NCT00779675|6144258|P1|Treatment Period|Transferred to Another Study|38
1763851|NCT00779675|6144258|P1|Treatment Period|Treatment Failure|80
1763852|NCT00779675|6144258|P1|Treatment Period|Adverse Event|87
1763853|NCT00779584|6144286|P9|Overall Study|Ongoing in Study|0
1763854|NCT00779584|6144287|P8|Overall Study|Ongoing in Study|0
1763855|NCT00779584|6144288|P7|Overall Study|Ongoing in Study|0
1763856|NCT00779584|6144289|P6|Overall Study|Ongoing in Study|1
1763857|NCT00779584|6144290|P5|Overall Study|Ongoing in Study|1
1763858|NCT00779584|6144291|P4|Overall Study|Ongoing in Study|0
1763859|NCT00779584|6144292|P3|Overall Study|Ongoing in Study|0
1763860|NCT00779584|6144293|P2|Overall Study|Ongoing in Study|0
1763861|NCT00779584|6144294|P1|Overall Study|Ongoing in Study|0
1763862|NCT00779584|6144286|P9|Overall Study|Symptomatic Deterioration|0
1763863|NCT00779584|6144287|P8|Overall Study|Symptomatic Deterioration|0
1763864|NCT00779584|6144288|P7|Overall Study|Symptomatic Deterioration|1
1763865|NCT00779584|6144289|P6|Overall Study|Symptomatic Deterioration|1
1763866|NCT00779584|6144290|P5|Overall Study|Symptomatic Deterioration|0
1763867|NCT00779584|6144291|P4|Overall Study|Symptomatic Deterioration|0
1763868|NCT00779584|6144292|P3|Overall Study|Symptomatic Deterioration|1
1763869|NCT00779584|6144293|P2|Overall Study|Symptomatic Deterioration|1
1763870|NCT00779584|6144294|P1|Overall Study|Symptomatic Deterioration|1
1763871|NCT00779584|6144286|P9|Overall Study|Adverse Event|1
1763872|NCT00779584|6144287|P8|Overall Study|Adverse Event|1
1763873|NCT00779584|6144288|P7|Overall Study|Adverse Event|2
1763874|NCT00779584|6144289|P6|Overall Study|Adverse Event|0
1763875|NCT00779584|6144290|P5|Overall Study|Adverse Event|0
1763876|NCT00779584|6144291|P4|Overall Study|Adverse Event|0
1763877|NCT00779584|6144292|P3|Overall Study|Adverse Event|2
1763878|NCT00779584|6144293|P2|Overall Study|Adverse Event|0
1763879|NCT00779584|6144294|P1|Overall Study|Adverse Event|1
1763880|NCT00779584|6144286|P9|Overall Study|Progression of Disease|1
1763881|NCT00779584|6144287|P8|Overall Study|Progression of Disease|2
1763882|NCT00779584|6144288|P7|Overall Study|Progression of Disease|4
1763883|NCT00779584|6144289|P6|Overall Study|Progression of Disease|1
1763884|NCT00779584|6144290|P5|Overall Study|Progression of Disease|5
1763885|NCT00779584|6144291|P4|Overall Study|Progression of Disease|6
1763886|NCT00779584|6144292|P3|Overall Study|Progression of Disease|2
1763887|NCT00779584|6144293|P2|Overall Study|Progression of Disease|1
1763888|NCT00779584|6144294|P1|Overall Study|Progression of Disease|0
1763889|NCT00779584|6144286|P9|Overall Study|Lost to Follow-up|0
1763890|NCT00779584|6144287|P8|Overall Study|Lost to Follow-up|0
1763891|NCT00779584|6144288|P7|Overall Study|Lost to Follow-up|0
1763892|NCT00779584|6144289|P6|Overall Study|Lost to Follow-up|0
1763893|NCT00779584|6144290|P5|Overall Study|Lost to Follow-up|1
1763894|NCT00779584|6144291|P4|Overall Study|Lost to Follow-up|0
1763895|NCT00779584|6144292|P3|Overall Study|Lost to Follow-up|0
1763896|NCT00779584|6144293|P2|Overall Study|Lost to Follow-up|0
1763897|NCT00779584|6144294|P1|Overall Study|Lost to Follow-up|0
1763898|NCT00779584|6144286|P9|Overall Study|Withdrawal by Subject|0
1763899|NCT00779584|6144287|P8|Overall Study|Withdrawal by Subject|0
1763900|NCT00779584|6144288|P7|Overall Study|Withdrawal by Subject|1
1763901|NCT00779584|6144289|P6|Overall Study|Withdrawal by Subject|2
1763902|NCT00779584|6144290|P5|Overall Study|Withdrawal by Subject|0
1763903|NCT00779584|6144291|P4|Overall Study|Withdrawal by Subject|0
1763904|NCT00779584|6144292|P3|Overall Study|Withdrawal by Subject|2
1763905|NCT00779584|6144293|P2|Overall Study|Withdrawal by Subject|1
1763906|NCT00779584|6144294|P1|Overall Study|Withdrawal by Subject|1
1763907|NCT00779584|6144286|P9|Overall Study|Protocol Violation|0
1763908|NCT00779584|6144287|P8|Overall Study|Protocol Violation|0
1763909|NCT00779584|6144288|P7|Overall Study|Protocol Violation|0
1763910|NCT00779584|6144289|P6|Overall Study|Protocol Violation|1
1763911|NCT00779584|6144290|P5|Overall Study|Protocol Violation|0
1763912|NCT00779584|6144291|P4|Overall Study|Protocol Violation|0
1763913|NCT00779584|6144292|P3|Overall Study|Protocol Violation|0
1763914|NCT00779584|6144293|P2|Overall Study|Protocol Violation|0
1763915|NCT00779584|6144294|P1|Overall Study|Protocol Violation|0
1763916|NCT00779506|6144385|P1|Overall Study|Lost to Follow-up|1
1763917|NCT00779506|6144385|P1|Overall Study|Withdrawal by Subject|6
1763918|NCT00779506|6144385|P1|Overall Study|Protocol Violation|5
1763919|NCT00779506|6144385|P1|Overall Study|Lack of Efficacy|11
1763920|NCT00779506|6144385|P1|Overall Study|Adverse Event|4
1763921|NCT00779506|6144385|P1|Overall Study|Screening Failed|2
1763922|NCT00779467|6144399|P4|Overall Study|unavailable research staff|1
1763923|NCT00779467|6144400|P3|Overall Study|unavailable research staff|0
1763924|NCT00779467|6144401|P2|Overall Study|unavailable research staff|0
1763925|NCT00779467|6144402|P1|Overall Study|unavailable research staff|0
1763926|NCT00779467|6144399|P4|Overall Study|technical issue|1
1763927|NCT00779467|6144400|P3|Overall Study|technical issue|2
1763928|NCT00779467|6144401|P2|Overall Study|technical issue|0
1763929|NCT00779467|6144402|P1|Overall Study|technical issue|0
1763930|NCT00779467|6144399|P4|Overall Study|missing data|4
1763931|NCT00779467|6144400|P3|Overall Study|missing data|1
1763932|NCT00779467|6144401|P2|Overall Study|missing data|0
1763933|NCT00779467|6144402|P1|Overall Study|missing data|1
1763934|NCT00779467|6144399|P4|Overall Study|failed inclusion criteria|2
1763935|NCT00779467|6144400|P3|Overall Study|failed inclusion criteria|1
1763936|NCT00779467|6144401|P2|Overall Study|failed inclusion criteria|3
1763937|NCT00779467|6144402|P1|Overall Study|failed inclusion criteria|3
1763938|NCT00779467|6144399|P4|Overall Study|Lack of Efficacy|11
1763939|NCT00779467|6144400|P3|Overall Study|Lack of Efficacy|6
1763940|NCT00779467|6144401|P2|Overall Study|Lack of Efficacy|2
1763941|NCT00779467|6144402|P1|Overall Study|Lack of Efficacy|11
1763942|NCT00779402|6144442|P2|Long-term Follow-up|Completed Protocol Visits|2
1763943|NCT00779402|6144443|P1|Long-term Follow-up|Completed Protocol Visits|6
1763944|NCT00779402|6144442|P2|Long-term Follow-up|Closure of Study|4
1763945|NCT00779402|6144443|P1|Long-term Follow-up|Closure of Study|8
1763946|NCT00779402|6144442|P2|Long-term Follow-up|Other|0
1763947|NCT00779402|6144443|P1|Long-term Follow-up|Other|5
1763948|NCT00779402|6144442|P2|Long-term Follow-up|Patient refused to continue|0
1763949|NCT00779402|6144443|P1|Long-term Follow-up|Patient refused to continue|2
1763950|NCT00779402|6144442|P2|Surveillance Phase|Completed Protocol Visits|2
1763951|NCT00779402|6144443|P1|Surveillance Phase|Completed Protocol Visits|3
1763952|NCT00779402|6144442|P2|Surveillance Phase|Closure of study|6
1763953|NCT00779402|6144443|P1|Surveillance Phase|Closure of study|5
1763954|NCT00779402|6144442|P2|Surveillance Phase|Withdrawal by Subject|1
1763955|NCT00779402|6144443|P1|Surveillance Phase|Withdrawal by Subject|4
1763956|NCT00779402|6144442|P2|Surveillance Phase|Other|5
1763957|NCT00779402|6144443|P1|Surveillance Phase|Other|5
1763958|NCT00779402|6144442|P2|Surveillance Phase|Intercurrent Illness|0
1763959|NCT00779402|6144443|P1|Surveillance Phase|Intercurrent Illness|2
1763960|NCT00779402|6144442|P2|Surveillance Phase|Death|1
1763961|NCT00779402|6144443|P1|Surveillance Phase|Death|0
1763962|NCT00779402|6144442|P2|Surveillance Phase|Lost to Follow-up|1
1763963|NCT00779402|6144443|P1|Surveillance Phase|Lost to Follow-up|2
1763964|NCT00779402|6144442|P2|Surveillance Phase|Patient refused to continue|14
1763965|NCT00779402|6144443|P1|Surveillance Phase|Patient refused to continue|22
1763966|NCT00779402|6144442|P2|Surveillance Phase|Protocol Violation|1
1763967|NCT00779402|6144443|P1|Surveillance Phase|Protocol Violation|0
1763968|NCT00779402|6144442|P2|Treatment Phase 1|Completed Protocol Visits|6
1763969|NCT00779402|6144443|P1|Treatment Phase 1|Completed Protocol Visits|3
1763970|NCT00779402|6144442|P2|Treatment Phase 1|Closure of Study|2
1763971|NCT00779402|6144443|P1|Treatment Phase 1|Closure of Study|3
1763972|NCT00779402|6144442|P2|Treatment Phase 1|Other|2
1763973|NCT00779402|6144443|P1|Treatment Phase 1|Other|4
1763974|NCT00779402|6144442|P2|Treatment Phase 1|Withdrawal by Subject|0
1763975|NCT00779402|6144443|P1|Treatment Phase 1|Withdrawal by Subject|1
1763976|NCT00779402|6144442|P2|Treatment Phase 1|Intercurrent Illness|1
1763977|NCT00779402|6144443|P1|Treatment Phase 1|Intercurrent Illness|1
1763978|NCT00779402|6144442|P2|Treatment Phase 1|Death|1
1763979|NCT00779402|6144443|P1|Treatment Phase 1|Death|0
1763980|NCT00779402|6144442|P2|Treatment Phase 1|Lost to Follow-up|1
1763981|NCT00779402|6144443|P1|Treatment Phase 1|Lost to Follow-up|0
1763982|NCT00779402|6144442|P2|Treatment Phase 1|Patient Refused to Continue|2
1763983|NCT00779402|6144443|P1|Treatment Phase 1|Patient Refused to Continue|17
1763984|NCT00779402|6144442|P2|Treatment Phase 1|Protocol Violation|0
1763985|NCT00779402|6144443|P1|Treatment Phase 1|Protocol Violation|1
1763986|NCT00779402|6144442|P2|Treatment Phase 1|Adverse Event|0
1763987|NCT00779402|6144443|P1|Treatment Phase 1|Adverse Event|2
1763988|NCT00779402|6144442|P2|Treatment Phase 1|Disease Progression|0
1763989|NCT00779402|6144443|P1|Treatment Phase 1|Disease Progression|1
1763990|NCT00779259|6144486|P1|Quinine Alone|Adverse Event|2
1763991|NCT00779246|6144507|P2|Overall Study|Missing sufficient data for analysis|53
1763992|NCT00779246|6144508|P1|Overall Study|Missing sufficient data for analysis|33
1763993|NCT00779142|6144527|P1|Overall Study|Screen Failures|3
1763994|NCT00779038|6144541|P1|Overall Study|Study Prematurely Terminated|13
1763995|NCT00779025|6144550|P1|Overall Study|Withdrawal by Subject|1
1763996|NCT00778999|6144561|P2|Overall Study|Did not receive recFSH|20
1763997|NCT00778999|6144562|P1|Overall Study|Did not receive recFSH|14
1763998|NCT00778999|6144561|P2|Overall Study|Discontinuation: no embryo transfer|14
1763999|NCT00778999|6144562|P1|Overall Study|Discontinuation: no embryo transfer|14
1764000|NCT00778921|6144571|P3|Overall Study|Not treated|2
1764001|NCT00778921|6144572|P2|Overall Study|Not treated|2
1764002|NCT00778921|6144573|P1|Overall Study|Not treated|0
1764003|NCT00778921|6144571|P3|Overall Study|Protocol Violation|2
1764004|NCT00778921|6144572|P2|Overall Study|Protocol Violation|0
1764005|NCT00778921|6144573|P1|Overall Study|Protocol Violation|3
1764006|NCT00778921|6144571|P3|Overall Study|Administrative Problems|0
1764007|NCT00778921|6144572|P2|Overall Study|Administrative Problems|2
1764008|NCT00778921|6144573|P1|Overall Study|Administrative Problems|1
1764009|NCT00778921|6144571|P3|Overall Study|Lost to Follow-up|1
1764010|NCT00778921|6144572|P2|Overall Study|Lost to Follow-up|2
1764011|NCT00778921|6144573|P1|Overall Study|Lost to Follow-up|0
1764012|NCT00778921|6144571|P3|Overall Study|Patient withdrew request|6
1764013|NCT00778921|6144572|P2|Overall Study|Patient withdrew request|1
1764014|NCT00778921|6144573|P1|Overall Study|Patient withdrew request|3
1764015|NCT00778921|6144571|P3|Overall Study|Patient No Longer Requires Study Drug|0
1764016|NCT00778921|6144572|P2|Overall Study|Patient No Longer Requires Study Drug|1
1764017|NCT00778921|6144573|P1|Overall Study|Patient No Longer Requires Study Drug|0
1764018|NCT00778921|6144571|P3|Overall Study|Unsatisfactory therapeutic response|1
1764019|NCT00778921|6144572|P2|Overall Study|Unsatisfactory therapeutic response|1
1764020|NCT00778921|6144573|P1|Overall Study|Unsatisfactory therapeutic response|1
1764021|NCT00778921|6144571|P3|Overall Study|Abnormal Test Procedure Result(s)|2
1764022|NCT00778921|6144572|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1764023|NCT00778921|6144573|P1|Overall Study|Abnormal Test Procedure Result(s)|0
1764024|NCT00778921|6144571|P3|Overall Study|Abnormal Laboratory Value(s)|0
1764025|NCT00778921|6144572|P2|Overall Study|Abnormal Laboratory Value(s)|0
1764026|NCT00778921|6144573|P1|Overall Study|Abnormal Laboratory Value(s)|1
1764027|NCT00778921|6144571|P3|Overall Study|Adverse Event|14
1764028|NCT00778921|6144572|P2|Overall Study|Adverse Event|10
1764029|NCT00778921|6144573|P1|Overall Study|Adverse Event|9
1764030|NCT00778895|6144590|P3|ESFU Phase|Other|0
1764031|NCT00778895|6144591|P2|ESFU Phase|Other|0
1764032|NCT00778895|6144592|P1|ESFU Phase|Other|2
1764033|NCT00778895|6144590|P3|ESFU Phase|Lost to Follow-up|2
1764034|NCT00778895|6144591|P2|ESFU Phase|Lost to Follow-up|7
1764035|NCT00778895|6144592|P1|ESFU Phase|Lost to Follow-up|6
1764036|NCT00778895|6144590|P3|ESFU Phase|Withdrawal by Subject|0
1764037|NCT00778895|6144591|P2|ESFU Phase|Withdrawal by Subject|4
1764038|NCT00778895|6144592|P1|ESFU Phase|Withdrawal by Subject|1
1764039|NCT00778895|6144590|P3|ESFU Phase|Adverse Event|0
1764040|NCT00778895|6144591|P2|ESFU Phase|Adverse Event|1
1764041|NCT00778895|6144592|P1|ESFU Phase|Adverse Event|2
1764042|NCT00778895|6144590|P3|Active Phase|Other|0
1764043|NCT00778895|6144591|P2|Active Phase|Other|0
1764044|NCT00778895|6144592|P1|Active Phase|Other|2
1764045|NCT00778895|6144590|P3|Active Phase|Lost to Follow-up|0
1764046|NCT00778895|6144591|P2|Active Phase|Lost to Follow-up|1
1764047|NCT00778895|6144592|P1|Active Phase|Lost to Follow-up|1
1764048|NCT00778895|6144590|P3|Active Phase|Withdrawal by Subject|0
1764049|NCT00778895|6144591|P2|Active Phase|Withdrawal by Subject|4
1764050|NCT00778895|6144592|P1|Active Phase|Withdrawal by Subject|1
1764051|NCT00778895|6144590|P3|Active Phase|Adverse Event|0
1764052|NCT00778895|6144591|P2|Active Phase|Adverse Event|1
1764053|NCT00778895|6144592|P1|Active Phase|Adverse Event|3
1764054|NCT00778830|6144636|P2|Overall Study|Ongoing at data cut-off|1
1764055|NCT00778830|6144637|P1|Overall Study|Ongoing at data cut-off|0
1764056|NCT00778817|6144649|P1|Overall Study|Withdrawal by Subject|2
1764057|NCT00778817|6144649|P1|Overall Study|Adverse Event|2
1764058|NCT00778622|6144676|P3|Overall Study|Other|1
1764059|NCT00778622|6144677|P2|Overall Study|Other|0
1764060|NCT00778622|6144678|P1|Overall Study|Other|1
1764061|NCT00778622|6144676|P3|Overall Study|immigration|0
1764062|NCT00778622|6144677|P2|Overall Study|immigration|0
1764063|NCT00778622|6144678|P1|Overall Study|immigration|1
1764064|NCT00778622|6144676|P3|Overall Study|Lack of Efficacy|0
1764065|NCT00778622|6144677|P2|Overall Study|Lack of Efficacy|0
1764066|NCT00778622|6144678|P1|Overall Study|Lack of Efficacy|2
1764067|NCT00778622|6144676|P3|Overall Study|Protocol Violation|0
1764068|NCT00778622|6144677|P2|Overall Study|Protocol Violation|3
1764069|NCT00778622|6144678|P1|Overall Study|Protocol Violation|0
1764070|NCT00778622|6144676|P3|Overall Study|Lost to Follow-up|2
1764071|NCT00778622|6144677|P2|Overall Study|Lost to Follow-up|3
1764072|NCT00778622|6144678|P1|Overall Study|Lost to Follow-up|3
1764073|NCT00778622|6144676|P3|Overall Study|Withdrawal by Subject|5
1764074|NCT00778622|6144677|P2|Overall Study|Withdrawal by Subject|5
1764075|NCT00778622|6144678|P1|Overall Study|Withdrawal by Subject|4
1764076|NCT00778622|6144676|P3|Overall Study|Adverse Event|7
1764077|NCT00778622|6144677|P2|Overall Study|Adverse Event|4
1764078|NCT00778622|6144678|P1|Overall Study|Adverse Event|5
1764079|NCT00778375|6144731|P1|Overall Study|Ineligible|3
1764080|NCT00778336|6144745|P4|3 Month Follow Up|Death|0
1764081|NCT00778336|6144746|P3|3 Month Follow Up|Death|2
1764082|NCT00778336|6144747|P2|3 Month Follow Up|Death|3
1764083|NCT00778336|6144748|P1|3 Month Follow Up|Death|8
1764084|NCT00778336|6144745|P4|3 Month Follow Up|Lost to Follow-up|0
1764085|NCT00778336|6144746|P3|3 Month Follow Up|Lost to Follow-up|3
1764086|NCT00778336|6144747|P2|3 Month Follow Up|Lost to Follow-up|20
1764087|NCT00778336|6144748|P1|3 Month Follow Up|Lost to Follow-up|15
1764088|NCT00778336|6144745|P4|Index Procedure-Discharge|Death|0
1764089|NCT00778336|6144746|P3|Index Procedure-Discharge|Death|2
1764090|NCT00778336|6144747|P2|Index Procedure-Discharge|Death|3
1764091|NCT00778336|6144748|P1|Index Procedure-Discharge|Death|6
1764092|NCT00778258|6144786|P9|Overall Study|Other|0
1764093|NCT00778258|6144787|P8|Overall Study|Other|0
1764094|NCT00778258|6144788|P7|Overall Study|Other|1
1764095|NCT00778258|6144789|P6|Overall Study|Other|0
1764096|NCT00778258|6144790|P5|Overall Study|Other|0
1764097|NCT00778258|6144791|P4|Overall Study|Other|0
1764098|NCT00778258|6144792|P3|Overall Study|Other|0
1764099|NCT00778258|6144793|P2|Overall Study|Other|0
1764100|NCT00778258|6144794|P1|Overall Study|Other|0
1764101|NCT00778258|6144786|P9|Overall Study|Non-compliance|0
1764102|NCT00778258|6144787|P8|Overall Study|Non-compliance|0
1764103|NCT00778258|6144788|P7|Overall Study|Non-compliance|0
1764104|NCT00778258|6144789|P6|Overall Study|Non-compliance|0
1764105|NCT00778258|6144790|P5|Overall Study|Non-compliance|0
1764106|NCT00778258|6144791|P4|Overall Study|Non-compliance|1
1764107|NCT00778258|6144792|P3|Overall Study|Non-compliance|0
1764108|NCT00778258|6144793|P2|Overall Study|Non-compliance|0
1764109|NCT00778258|6144794|P1|Overall Study|Non-compliance|0
1764110|NCT00778258|6144786|P9|Overall Study|New Contraindication|0
1764111|NCT00778258|6144787|P8|Overall Study|New Contraindication|1
1764112|NCT00778258|6144788|P7|Overall Study|New Contraindication|0
1764113|NCT00778258|6144789|P6|Overall Study|New Contraindication|0
1764114|NCT00778258|6144790|P5|Overall Study|New Contraindication|0
1764115|NCT00778258|6144791|P4|Overall Study|New Contraindication|0
1764116|NCT00778258|6144792|P3|Overall Study|New Contraindication|0
1764117|NCT00778258|6144793|P2|Overall Study|New Contraindication|0
1764118|NCT00778258|6144794|P1|Overall Study|New Contraindication|0
1764119|NCT00778258|6144786|P9|Overall Study|Withdrawal by Subject|4
1764120|NCT00778258|6144787|P8|Overall Study|Withdrawal by Subject|12
1764121|NCT00778258|6144788|P7|Overall Study|Withdrawal by Subject|12
1764122|NCT00778258|6144789|P6|Overall Study|Withdrawal by Subject|6
1764123|NCT00778258|6144790|P5|Overall Study|Withdrawal by Subject|0
1764124|NCT00778258|6144791|P4|Overall Study|Withdrawal by Subject|2
1764125|NCT00778258|6144792|P3|Overall Study|Withdrawal by Subject|8
1764126|NCT00778258|6144793|P2|Overall Study|Withdrawal by Subject|2
1764127|NCT00778258|6144794|P1|Overall Study|Withdrawal by Subject|6
1764128|NCT00778258|6144786|P9|Overall Study|Lost to Follow-up|0
1764129|NCT00778258|6144787|P8|Overall Study|Lost to Follow-up|2
1764130|NCT00778258|6144788|P7|Overall Study|Lost to Follow-up|2
1764131|NCT00778258|6144789|P6|Overall Study|Lost to Follow-up|3
1764132|NCT00778258|6144790|P5|Overall Study|Lost to Follow-up|0
1764133|NCT00778258|6144791|P4|Overall Study|Lost to Follow-up|0
1764134|NCT00778258|6144792|P3|Overall Study|Lost to Follow-up|2
1764135|NCT00778258|6144793|P2|Overall Study|Lost to Follow-up|0
1764136|NCT00778258|6144794|P1|Overall Study|Lost to Follow-up|0
1764137|NCT00778258|6144786|P9|Overall Study|Adverse Event|0
1764138|NCT00778258|6144787|P8|Overall Study|Adverse Event|0
1764139|NCT00778258|6144788|P7|Overall Study|Adverse Event|0
1764140|NCT00778258|6144789|P6|Overall Study|Adverse Event|1
1764141|NCT00778258|6144790|P5|Overall Study|Adverse Event|0
1764142|NCT00778258|6144791|P4|Overall Study|Adverse Event|0
1764143|NCT00778258|6144792|P3|Overall Study|Adverse Event|0
1764144|NCT00778258|6144793|P2|Overall Study|Adverse Event|0
1764145|NCT00778258|6144794|P1|Overall Study|Adverse Event|1
1764146|NCT00778102|6144861|P2|Overall Study|Administrative Reason|10
1764147|NCT00778102|6144862|P1|Overall Study|Administrative Reason|7
1764148|NCT00778102|6144861|P2|Overall Study|Withdrawal by Subject|1
1764149|NCT00778102|6144862|P1|Overall Study|Withdrawal by Subject|1
1764150|NCT00778102|6144861|P2|Overall Study|Refused Treatment|3
1764151|NCT00778102|6144862|P1|Overall Study|Refused Treatment|2
1764152|NCT00778102|6144861|P2|Overall Study|Protocol Violation|1
1764153|NCT00778102|6144862|P1|Overall Study|Protocol Violation|0
1764154|NCT00778102|6144861|P2|Overall Study|Violation of Selection Criteria|1
1764155|NCT00778102|6144862|P1|Overall Study|Violation of Selection Criteria|1
1764156|NCT00778102|6144861|P2|Overall Study|Lost to Follow-up|0
1764157|NCT00778102|6144862|P1|Overall Study|Lost to Follow-up|1
1764158|NCT00778102|6144861|P2|Overall Study|Death|1
1764159|NCT00778102|6144862|P1|Overall Study|Death|1
1764160|NCT00778102|6144861|P2|Overall Study|Adverse Event|5
1764161|NCT00778102|6144862|P1|Overall Study|Adverse Event|8
1764162|NCT00777946|6144897|P3|Overall Study|Randomized in error|0
1764163|NCT00777946|6144898|P2|Overall Study|Randomized in error|1
1764164|NCT00777946|6144899|P1|Overall Study|Randomized in error|1
1764165|NCT00777946|6144897|P3|Overall Study|Protocol deviation|1
1764166|NCT00777946|6144898|P2|Overall Study|Protocol deviation|1
1764167|NCT00777946|6144899|P1|Overall Study|Protocol deviation|2
1764168|NCT00777946|6144897|P3|Overall Study|Lost to Follow-up|0
1764169|NCT00777946|6144898|P2|Overall Study|Lost to Follow-up|1
1764170|NCT00777946|6144899|P1|Overall Study|Lost to Follow-up|3
1764171|NCT00777946|6144897|P3|Overall Study|Patient withdrew consent|3
1764172|NCT00777946|6144898|P2|Overall Study|Patient withdrew consent|2
1764173|NCT00777946|6144899|P1|Overall Study|Patient withdrew consent|3
1764174|NCT00777946|6144897|P3|Overall Study|Condition no longer required study drug|0
1764175|NCT00777946|6144898|P2|Overall Study|Condition no longer required study drug|0
1764176|NCT00777946|6144899|P1|Overall Study|Condition no longer required study drug|1
1764177|NCT00777946|6144897|P3|Overall Study|Lack of Efficacy|9
1764178|NCT00777946|6144898|P2|Overall Study|Lack of Efficacy|0
1764179|NCT00777946|6144899|P1|Overall Study|Lack of Efficacy|0
1764180|NCT00777946|6144897|P3|Overall Study|Adverse Event|3
1764181|NCT00777946|6144898|P2|Overall Study|Adverse Event|1
1764182|NCT00777946|6144899|P1|Overall Study|Adverse Event|11
1764183|NCT00777803|6144934|P2|Overall Study|Non-compliance|2
1764184|NCT00777803|6144935|P1|Overall Study|Non-compliance|2
1764185|NCT00777803|6144934|P2|Overall Study|Adverse Event|0
1764186|NCT00777803|6144935|P1|Overall Study|Adverse Event|1
1764187|NCT00777803|6144934|P2|Overall Study|Lost to Follow-up|5
1764188|NCT00777803|6144935|P1|Overall Study|Lost to Follow-up|12
1764189|NCT00777608|6145014|P2|Overall Study|Investigator Decision|2
1764190|NCT00777608|6145015|P1|Overall Study|Investigator Decision|1
1764191|NCT00777608|6145014|P2|Overall Study|Protocol Violation|0
1764192|NCT00777608|6145015|P1|Overall Study|Protocol Violation|1
1764193|NCT00777608|6145014|P2|Overall Study|Withdrawal by Subject|3
1764194|NCT00777608|6145015|P1|Overall Study|Withdrawal by Subject|1
1764195|NCT00777608|6145014|P2|Overall Study|Lost to Follow-up|1
1764196|NCT00777608|6145015|P1|Overall Study|Lost to Follow-up|1
1764197|NCT00777556|6145025|P1|Overall Study|Did not complete all 3 follow-up visits|20
1764198|NCT00777556|6145025|P1|Overall Study|Dispensed but did not use product|12
1764199|NCT00777556|6145025|P1|Overall Study|Inappropriate self-selection|34
1764200|NCT00777491|6145034|P2|Overall Study|Did not receive any protocol treatment|0
1764201|NCT00777491|6145035|P1|Overall Study|Did not receive any protocol treatment|2
1764202|NCT00777491|6145034|P2|Overall Study|Protocol Violation|2
1764203|NCT00777491|6145035|P1|Overall Study|Protocol Violation|0
1764204|NCT00777296|6145068|P4|Overall Study|CRF form not completed|0
1764205|NCT00777296|6145069|P3|Overall Study|CRF form not completed|2
1764206|NCT00777296|6145070|P2|Overall Study|CRF form not completed|0
1764207|NCT00777296|6145071|P1|Overall Study|CRF form not completed|0
1764208|NCT00777296|6145068|P4|Overall Study|Withdrawal by Subject|0
1764209|NCT00777296|6145069|P3|Overall Study|Withdrawal by Subject|0
1764210|NCT00777296|6145070|P2|Overall Study|Withdrawal by Subject|0
1764211|NCT00777296|6145071|P1|Overall Study|Withdrawal by Subject|1
1764212|NCT00777296|6145068|P4|Overall Study|Adverse Event|1
1764213|NCT00777296|6145069|P3|Overall Study|Adverse Event|0
1764214|NCT00777296|6145070|P2|Overall Study|Adverse Event|1
1764215|NCT00777296|6145071|P1|Overall Study|Adverse Event|0
1764216|NCT00777257|6145113|P3|Overall Study|Withdrawal by Subject|5
1764217|NCT00777257|6145114|P2|Overall Study|Withdrawal by Subject|6
1764218|NCT00777257|6145115|P1|Overall Study|Withdrawal by Subject|3
1764219|NCT00777257|6145113|P3|Overall Study|Protocol Violation|2
1764220|NCT00777257|6145114|P2|Overall Study|Protocol Violation|2
1764221|NCT00777257|6145115|P1|Overall Study|Protocol Violation|2
1764222|NCT00777257|6145113|P3|Overall Study|Lost to Follow-up|2
1764223|NCT00777257|6145114|P2|Overall Study|Lost to Follow-up|3
1764224|NCT00777257|6145115|P1|Overall Study|Lost to Follow-up|3
1764225|NCT00777257|6145113|P3|Overall Study|Adverse Event|0
1764226|NCT00777257|6145114|P2|Overall Study|Adverse Event|1
1764227|NCT00777257|6145115|P1|Overall Study|Adverse Event|3
1764228|NCT00777205|6145134|P2|Overall Study|Protocol Violation|56
1764229|NCT00777205|6145135|P1|Overall Study|Protocol Violation|0
1764230|NCT00777205|6145134|P2|Overall Study|Death|2
1764231|NCT00777205|6145135|P1|Overall Study|Death|0
1764232|NCT00777205|6145134|P2|Overall Study|Withdrawal by Subject|4
1764233|NCT00777205|6145135|P1|Overall Study|Withdrawal by Subject|6
1764234|NCT00777205|6145134|P2|Overall Study|Lost to Follow-up|9
1764235|NCT00777205|6145135|P1|Overall Study|Lost to Follow-up|25
1764236|NCT00777153|6145169|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
1764237|NCT00777153|6145170|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
1764238|NCT00777153|6145171|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
1764239|NCT00777153|6145169|P3|Overall Study|Withdrawal by Subject|3
1764240|NCT00777153|6145170|P2|Overall Study|Withdrawal by Subject|4
1764241|NCT00777153|6145171|P1|Overall Study|Withdrawal by Subject|3
1764242|NCT00777153|6145169|P3|Overall Study|Death|33
1764243|NCT00777153|6145170|P2|Overall Study|Death|73
1764244|NCT00777153|6145171|P1|Overall Study|Death|85
1764245|NCT00777153|6145169|P3|Overall Study|Lost to Follow-up|0
1764246|NCT00777153|6145170|P2|Overall Study|Lost to Follow-up|1
1764247|NCT00777153|6145171|P1|Overall Study|Lost to Follow-up|1
1764248|NCT00777101|6145196|P2|Overall Study|Failed to Return|1
1764249|NCT00777101|6145197|P1|Overall Study|Failed to Return|0
1764250|NCT00777101|6145196|P2|Overall Study|Discontinuation of Study by Sponsor|0
1764251|NCT00777101|6145197|P1|Overall Study|Discontinuation of Study by Sponsor|1
1764252|NCT00777101|6145196|P2|Overall Study|Lost to Follow-up|1
1764253|NCT00777101|6145197|P1|Overall Study|Lost to Follow-up|2
1764254|NCT00777101|6145196|P2|Overall Study|Withdrawal by Subject|6
1764255|NCT00777101|6145197|P1|Overall Study|Withdrawal by Subject|11
1764256|NCT00777101|6145196|P2|Overall Study|Death|43
1764257|NCT00777101|6145197|P1|Overall Study|Death|48
1764258|NCT00777088|6145215|P1|Overall Study|PED Treatment not attempted|1
1764259|NCT00777049|6145240|P2|Overall Study|No treatment (elevated liver enzymes)|1
1764350|NCT00776919|6145454|P1|Overall Study|Adverse Event|1
1764260|NCT00777049|6145241|P1|Overall Study|No treatment (elevated liver enzymes)|0
1764261|NCT00777049|6145240|P2|Overall Study|Withdrawal by Subject|0
1764262|NCT00777049|6145241|P1|Overall Study|Withdrawal by Subject|1
1764263|NCT00777036|6145250|P3|Follow-Up|Death|0
1764264|NCT00777036|6145251|P2|Follow-Up|Death|8
1764265|NCT00777036|6145252|P1|Follow-Up|Death|1
1764266|NCT00777036|6145250|P3|Follow-Up|Withdrawal by Subject|4
1764267|NCT00777036|6145251|P2|Follow-Up|Withdrawal by Subject|0
1764268|NCT00777036|6145252|P1|Follow-Up|Withdrawal by Subject|1
1764269|NCT00777036|6145250|P3|Follow-Up|Reason Not Specified|0
1764270|NCT00777036|6145251|P2|Follow-Up|Reason Not Specified|0
1764271|NCT00777036|6145252|P1|Follow-Up|Reason Not Specified|2
1764272|NCT00777036|6145250|P3|Follow-Up|Lost to Follow-up|0
1764273|NCT00777036|6145251|P2|Follow-Up|Lost to Follow-up|0
1764274|NCT00777036|6145252|P1|Follow-Up|Lost to Follow-up|1
1764275|NCT00777036|6145250|P3|On Treatment|Progressive Disease|6
1764276|NCT00777036|6145251|P2|On Treatment|Progressive Disease|4
1764277|NCT00777036|6145252|P1|On Treatment|Progressive Disease|5
1764278|NCT00777036|6145250|P3|On Treatment|Study Drug Toxicity|1
1764279|NCT00777036|6145251|P2|On Treatment|Study Drug Toxicity|0
1764280|NCT00777036|6145252|P1|On Treatment|Study Drug Toxicity|0
1764281|NCT00777036|6145250|P3|On Treatment|Death|0
1764282|NCT00777036|6145251|P2|On Treatment|Death|2
1764283|NCT00777036|6145252|P1|On Treatment|Death|0
1764284|NCT00777036|6145250|P3|On Treatment|Withdrawal by Subject|3
1764285|NCT00777036|6145251|P2|On Treatment|Withdrawal by Subject|2
1764286|NCT00777036|6145252|P1|On Treatment|Withdrawal by Subject|3
1764287|NCT00777036|6145250|P3|On Treatment|Maximum Clinical Benefit|1
1764288|NCT00777036|6145251|P2|On Treatment|Maximum Clinical Benefit|0
1764289|NCT00777036|6145252|P1|On Treatment|Maximum Clinical Benefit|2
1764290|NCT00777036|6145250|P3|On Treatment|Non-compliance with Study Drug|0
1764291|NCT00777036|6145251|P2|On Treatment|Non-compliance with Study Drug|0
1764292|NCT00777036|6145252|P1|On Treatment|Non-compliance with Study Drug|1
1764293|NCT00777036|6145250|P3|On Treatment|Failure to Meet Study Criteria|0
1764294|NCT00777036|6145251|P2|On Treatment|Failure to Meet Study Criteria|1
1764295|NCT00777036|6145252|P1|On Treatment|Failure to Meet Study Criteria|0
1764296|NCT00777036|6145250|P3|On Treatment|Reason Not Specified|12
1764297|NCT00777036|6145251|P2|On Treatment|Reason Not Specified|7
1764298|NCT00777036|6145252|P1|On Treatment|Reason Not Specified|4
1764299|NCT00777023|6145348|P3|Overall Study|Last dose date unknown|1
1764300|NCT00777023|6145349|P2|Overall Study|Last dose date unknown|3
1764301|NCT00777023|6145350|P1|Overall Study|Last dose date unknown|3
1764302|NCT00777023|6145348|P3|Overall Study|Reasons not specified|2
1764303|NCT00777023|6145349|P2|Overall Study|Reasons not specified|4
1764304|NCT00777023|6145350|P1|Overall Study|Reasons not specified|4
1764305|NCT00777023|6145348|P3|Overall Study|Missing data|0
1764306|NCT00777023|6145349|P2|Overall Study|Missing data|1
1764307|NCT00777023|6145350|P1|Overall Study|Missing data|1
1764308|NCT00777023|6145348|P3|Overall Study|Withdrawal by Subject|8
1764309|NCT00777023|6145349|P2|Overall Study|Withdrawal by Subject|7
1764310|NCT00777023|6145350|P1|Overall Study|Withdrawal by Subject|7
1764311|NCT00777023|6145348|P3|Overall Study|Death|0
1764312|NCT00777023|6145349|P2|Overall Study|Death|1
1764313|NCT00777023|6145350|P1|Overall Study|Death|0
1764314|NCT00777023|6145348|P3|Overall Study|Lost to Follow-up|3
1764315|NCT00777023|6145349|P2|Overall Study|Lost to Follow-up|3
1764316|NCT00777023|6145350|P1|Overall Study|Lost to Follow-up|2
1764317|NCT00777023|6145348|P3|Overall Study|Protocol Violation|1
1764318|NCT00777023|6145349|P2|Overall Study|Protocol Violation|1
1764319|NCT00777023|6145350|P1|Overall Study|Protocol Violation|2
1764320|NCT00777023|6145348|P3|Overall Study|Lack of Efficacy|14
1764321|NCT00777023|6145349|P2|Overall Study|Lack of Efficacy|0
1764322|NCT00777023|6145350|P1|Overall Study|Lack of Efficacy|1
1764323|NCT00777023|6145348|P3|Overall Study|Adverse Event|8
1764324|NCT00777023|6145349|P2|Overall Study|Adverse Event|21
1764325|NCT00777023|6145350|P1|Overall Study|Adverse Event|15
1764326|NCT00776997|6145367|P1|Overall Study|Adverse Event|2
1764327|NCT00776984|6145376|P2|Overall Study|Other|9
1764328|NCT00776984|6145377|P1|Overall Study|Other|5
1764329|NCT00776984|6145376|P2|Overall Study|Lack of Efficacy|1
1764330|NCT00776984|6145377|P1|Overall Study|Lack of Efficacy|0
1764331|NCT00776984|6145376|P2|Overall Study|Withdrawal by Subject|7
1764332|NCT00776984|6145377|P1|Overall Study|Withdrawal by Subject|12
1764333|NCT00776984|6145376|P2|Overall Study|Lost to Follow-up|0
1764334|NCT00776984|6145377|P1|Overall Study|Lost to Follow-up|2
1764335|NCT00776984|6145376|P2|Overall Study|Protocol Violation|2
1764336|NCT00776984|6145377|P1|Overall Study|Protocol Violation|4
1764337|NCT00776984|6145376|P2|Overall Study|Adverse Event|2
1764338|NCT00776984|6145377|P1|Overall Study|Adverse Event|8
1764339|NCT00776919|6145451|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
1764340|NCT00776919|6145452|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
1764341|NCT00776919|6145453|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
1764342|NCT00776919|6145454|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
1764343|NCT00776919|6145451|P4|Overall Study|Protocol Violation|1
1764344|NCT00776919|6145452|P3|Overall Study|Protocol Violation|0
1764345|NCT00776919|6145453|P2|Overall Study|Protocol Violation|2
1764346|NCT00776919|6145454|P1|Overall Study|Protocol Violation|1
1764347|NCT00776919|6145451|P4|Overall Study|Adverse Event|2
1764348|NCT00776919|6145452|P3|Overall Study|Adverse Event|2
1764349|NCT00776919|6145453|P2|Overall Study|Adverse Event|0
1764351|NCT00776919|6145451|P4|Overall Study|Lost to Follow-up|8
1764352|NCT00776919|6145452|P3|Overall Study|Lost to Follow-up|11
1764353|NCT00776919|6145453|P2|Overall Study|Lost to Follow-up|12
1764354|NCT00776919|6145454|P1|Overall Study|Lost to Follow-up|8
1764355|NCT00776919|6145451|P4|Overall Study|Withdrawal by Subject|26
1764356|NCT00776919|6145452|P3|Overall Study|Withdrawal by Subject|15
1764357|NCT00776919|6145453|P2|Overall Study|Withdrawal by Subject|14
1764358|NCT00776919|6145454|P1|Overall Study|Withdrawal by Subject|16
1764359|NCT00776789|6145518|P2|Overall Study|Poor quality video|1
1764360|NCT00776789|6145519|P1|Overall Study|Poor quality video|1
1764361|NCT00776789|6145518|P2|Overall Study|Consent refusal|2
1764362|NCT00776789|6145519|P1|Overall Study|Consent refusal|2
1764363|NCT00776659|6145531|P1|Overall Study|Study Terminated by Sponsor|1
1764364|NCT00776659|6145531|P1|Overall Study|Withdrawal by Subject|10
1764365|NCT00776659|6145531|P1|Overall Study|Lost to Follow-up|15
1764366|NCT00776555|6145558|P2|Overall Study|Study terminated|0
1764367|NCT00776555|6145559|P1|Overall Study|Study terminated|3
1764368|NCT00776230|6145577|P3|Overall Study|Subject missed Visit 4|0
1764369|NCT00776230|6145578|P2|Overall Study|Subject missed Visit 4|1
1764370|NCT00776230|6145579|P1|Overall Study|Subject missed Visit 4|0
1764371|NCT00776230|6145577|P3|Overall Study|Withdrawal by Subject|0
1764372|NCT00776230|6145578|P2|Overall Study|Withdrawal by Subject|1
1764373|NCT00776230|6145579|P1|Overall Study|Withdrawal by Subject|0
1764374|NCT00776230|6145577|P3|Overall Study|Not vaccinated at Day 0|0
1764375|NCT00776230|6145578|P2|Overall Study|Not vaccinated at Day 0|0
1764376|NCT00776230|6145579|P1|Overall Study|Not vaccinated at Day 0|1
1764377|NCT00776230|6145577|P3|Overall Study|Lost to Follow-up|5
1764378|NCT00776230|6145578|P2|Overall Study|Lost to Follow-up|1
1764379|NCT00776230|6145579|P1|Overall Study|Lost to Follow-up|2
1764380|NCT00776100|6145589|P2|Overall Study|Disease Progression|0
1764381|NCT00776100|6145590|P1|Overall Study|Disease Progression|1
1764382|NCT00776009|6145612|P6|Period 3: Third Intervention|Withdrawal by Subject|0
1764383|NCT00776009|6145613|P5|Period 3: Third Intervention|Withdrawal by Subject|0
1764384|NCT00776009|6145614|P4|Period 3: Third Intervention|Withdrawal by Subject|0
1764385|NCT00776009|6145615|P3|Period 3: Third Intervention|Withdrawal by Subject|0
1764386|NCT00776009|6145616|P2|Period 3: Third Intervention|Withdrawal by Subject|0
1764387|NCT00776009|6145617|P1|Period 3: Third Intervention|Withdrawal by Subject|1
1764388|NCT00776009|6145612|P6|Period 2: Second Intervention|Protocol Violation|0
1764389|NCT00776009|6145613|P5|Period 2: Second Intervention|Protocol Violation|0
1764390|NCT00776009|6145614|P4|Period 2: Second Intervention|Protocol Violation|0
1764391|NCT00776009|6145615|P3|Period 2: Second Intervention|Protocol Violation|1
1764392|NCT00776009|6145616|P2|Period 2: Second Intervention|Protocol Violation|0
1764393|NCT00776009|6145617|P1|Period 2: Second Intervention|Protocol Violation|1
1764394|NCT00776009|6145612|P6|Period 2: Second Intervention|Withdrawal by Subject|1
1764395|NCT00776009|6145613|P5|Period 2: Second Intervention|Withdrawal by Subject|0
1764396|NCT00776009|6145614|P4|Period 2: Second Intervention|Withdrawal by Subject|0
1764397|NCT00776009|6145615|P3|Period 2: Second Intervention|Withdrawal by Subject|0
1764398|NCT00776009|6145616|P2|Period 2: Second Intervention|Withdrawal by Subject|0
1764399|NCT00776009|6145617|P1|Period 2: Second Intervention|Withdrawal by Subject|0
1764400|NCT00776009|6145612|P6|Period 1: First Intervention|Protocol Violation|0
1764401|NCT00776009|6145613|P5|Period 1: First Intervention|Protocol Violation|1
1764402|NCT00776009|6145614|P4|Period 1: First Intervention|Protocol Violation|0
1764403|NCT00776009|6145615|P3|Period 1: First Intervention|Protocol Violation|0
1764404|NCT00776009|6145616|P2|Period 1: First Intervention|Protocol Violation|1
1764405|NCT00776009|6145617|P1|Period 1: First Intervention|Protocol Violation|0
1764406|NCT00776009|6145612|P6|Period 1: First Intervention|Withdrawal by Subject|0
1764407|NCT00776009|6145613|P5|Period 1: First Intervention|Withdrawal by Subject|1
1764408|NCT00776009|6145614|P4|Period 1: First Intervention|Withdrawal by Subject|0
1764409|NCT00776009|6145615|P3|Period 1: First Intervention|Withdrawal by Subject|1
1764410|NCT00776009|6145616|P2|Period 1: First Intervention|Withdrawal by Subject|0
1764411|NCT00776009|6145617|P1|Period 1: First Intervention|Withdrawal by Subject|0
1764412|NCT00775983|6145639|P2|Overall Study|Protocol Violation|2
1764413|NCT00775983|6145640|P1|Overall Study|Protocol Violation|1
1764414|NCT00775606|6145766|P2|Overall Study|Study sponsor terminated funding|0
1764415|NCT00775606|6145767|P1|Overall Study|Study sponsor terminated funding|3
1764416|NCT00775593|6145777|P1|Overall Study|Death|1
1764417|NCT00775593|6145777|P1|Overall Study|Unmet eligibility criteria|6
1764418|NCT00775528|6145784|P1|Overall Study|Protocol Violation|1
1764419|NCT00775463|6145793|P2|Overall Study|Lack of Efficacy|1
1764420|NCT00775463|6145794|P1|Overall Study|Lack of Efficacy|1
1764421|NCT00775463|6145793|P2|Overall Study|Lost to Follow-up|0
1764422|NCT00775463|6145794|P1|Overall Study|Lost to Follow-up|1
1764423|NCT00775463|6145793|P2|Overall Study|Protocol Violation|2
1764424|NCT00775463|6145794|P1|Overall Study|Protocol Violation|2
1764425|NCT00775463|6145793|P2|Overall Study|Adverse Event|9
1764426|NCT00775463|6145794|P1|Overall Study|Adverse Event|7
1764427|NCT00775463|6145793|P2|Overall Study|Withdrawal by Subject|1
1764428|NCT00775463|6145794|P1|Overall Study|Withdrawal by Subject|0
1764429|NCT00775450|6145831|P5|Overall Study|Withdrawal by Subject|1
1764430|NCT00775450|6145832|P4|Overall Study|Withdrawal by Subject|0
1764431|NCT00775450|6145833|P3|Overall Study|Withdrawal by Subject|0
1764432|NCT00775450|6145834|P2|Overall Study|Withdrawal by Subject|0
1764433|NCT00775450|6145835|P1|Overall Study|Withdrawal by Subject|1
1764434|NCT00775450|6145831|P5|Overall Study|Protocol Violation|1
1764435|NCT00775450|6145832|P4|Overall Study|Protocol Violation|0
1764436|NCT00775450|6145833|P3|Overall Study|Protocol Violation|0
1764437|NCT00775450|6145834|P2|Overall Study|Protocol Violation|0
1764438|NCT00775450|6145835|P1|Overall Study|Protocol Violation|0
1764439|NCT00775450|6145831|P5|Overall Study|Serious Adverse Event|0
1764440|NCT00775450|6145832|P4|Overall Study|Serious Adverse Event|0
1764441|NCT00775450|6145833|P3|Overall Study|Serious Adverse Event|0
1764442|NCT00775450|6145834|P2|Overall Study|Serious Adverse Event|0
1764443|NCT00775450|6145835|P1|Overall Study|Serious Adverse Event|2
1764444|NCT00775437|6145862|P1|Overall Study|Lost to Follow-up|1
1764445|NCT00775437|6145862|P1|Overall Study|Withdrawal by Subject|3
1764446|NCT00775437|6145862|P1|Overall Study|Loss of efficacy|2
1764447|NCT00775203|6145937|P2|Overall Study|Physician Decision|1
1764448|NCT00775203|6145938|P1|Overall Study|Physician Decision|0
1764449|NCT00775203|6145937|P2|Overall Study|Entered other study|0
1764450|NCT00775203|6145938|P1|Overall Study|Entered other study|1
1764451|NCT00775203|6145937|P2|Overall Study|Protocol Violation|1
1764452|NCT00775203|6145938|P1|Overall Study|Protocol Violation|0
1764453|NCT00775203|6145937|P2|Overall Study|Noncompliance|2
1764454|NCT00775203|6145938|P1|Overall Study|Noncompliance|4
1764455|NCT00775203|6145937|P2|Overall Study|Administrative reason|0
1764456|NCT00775203|6145938|P1|Overall Study|Administrative reason|2
1764457|NCT00775203|6145937|P2|Overall Study|Lost to Follow-up|15
1764458|NCT00775203|6145938|P1|Overall Study|Lost to Follow-up|11
1764459|NCT00775203|6145937|P2|Overall Study|Withdrawal by Subject|9
1764460|NCT00775203|6145938|P1|Overall Study|Withdrawal by Subject|11
1764461|NCT00775203|6145937|P2|Overall Study|Lack of Efficacy|9
1764462|NCT00775203|6145938|P1|Overall Study|Lack of Efficacy|8
1764463|NCT00775203|6145937|P2|Overall Study|Adverse Event|6
1764464|NCT00775203|6145938|P1|Overall Study|Adverse Event|25
1764465|NCT00775190|6145972|P2|Overall Study|Protocol Violation|0
1764466|NCT00775190|6145973|P1|Overall Study|Protocol Violation|1
1764467|NCT00775190|6145972|P2|Overall Study|Withdrawal by Subject|2
1764468|NCT00775190|6145973|P1|Overall Study|Withdrawal by Subject|1
1764469|NCT00775190|6145972|P2|Overall Study|Lost to Follow-up|3
1764470|NCT00775190|6145973|P1|Overall Study|Lost to Follow-up|2
1764471|NCT00775138|6145999|P4|Overall Study|Adverse Event|0
1764472|NCT00775138|6146000|P3|Overall Study|Adverse Event|1
1764473|NCT00775138|6146001|P2|Overall Study|Adverse Event|0
1764474|NCT00775138|6146002|P1|Overall Study|Adverse Event|0
1764475|NCT00775138|6145999|P4|Overall Study|Withdrawal by Subject|2
1764476|NCT00775138|6146000|P3|Overall Study|Withdrawal by Subject|2
1764477|NCT00775138|6146001|P2|Overall Study|Withdrawal by Subject|0
1764478|NCT00775138|6146002|P1|Overall Study|Withdrawal by Subject|0
1764479|NCT00775021|6146048|P2|Second Intervention|Adverse Event|1
1764480|NCT00775021|6146049|P1|Second Intervention|Adverse Event|0
1764481|NCT00775021|6146048|P2|First Intervention|Lost to Follow-up|0
1764482|NCT00775021|6146049|P1|First Intervention|Lost to Follow-up|1
1764483|NCT00774995|6146067|P4|Overall Study|Protocol Violation|0
1764484|NCT00774995|6146068|P3|Overall Study|Protocol Violation|1
1764485|NCT00774995|6146069|P2|Overall Study|Protocol Violation|0
1764486|NCT00774995|6146070|P1|Overall Study|Protocol Violation|0
1764487|NCT00774930|6146110|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
1764488|NCT00774930|6146111|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
1764489|NCT00774930|6146110|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
1764490|NCT00774930|6146111|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
1764491|NCT00774930|6146110|P2|LTOLE Phase|Disease Progression|5
1764492|NCT00774930|6146111|P1|LTOLE Phase|Disease Progression|2
1764493|NCT00774930|6146110|P2|LTOLE Phase|Sponsor decision|1
1764494|NCT00774930|6146111|P1|LTOLE Phase|Sponsor decision|2
1764495|NCT00774930|6146110|P2|LTOLE Phase|Physician Decision|1
1764496|NCT00774930|6146111|P1|LTOLE Phase|Physician Decision|4
1764497|NCT00774930|6146110|P2|LTOLE Phase|Subject decision|5
1764498|NCT00774930|6146111|P1|LTOLE Phase|Subject decision|0
1764499|NCT00774930|6146110|P2|LTOLE Phase|Adverse Event|3
1764500|NCT00774930|6146111|P1|LTOLE Phase|Adverse Event|7
1764501|NCT00774930|6146110|P2|IOL Phase|Brain radiation|1
1764502|NCT00774930|6146111|P1|IOL Phase|Brain radiation|0
1764503|NCT00774930|6146110|P2|IOL Phase|Other|0
1764504|NCT00774930|6146111|P1|IOL Phase|Other|1
1764505|NCT00774930|6146110|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
1764506|NCT00774930|6146111|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
1764507|NCT00774930|6146110|P2|IOL Phase|Subject Consumed Prohibited Medication|0
1764508|NCT00774930|6146111|P1|IOL Phase|Subject Consumed Prohibited Medication|1
1764509|NCT00774930|6146110|P2|IOL Phase|Disease Progression|1
1764510|NCT00774930|6146111|P1|IOL Phase|Disease Progression|2
1764511|NCT00774930|6146110|P2|IOL Phase|Sponsor Decision|0
1764512|NCT00774930|6146111|P1|IOL Phase|Sponsor Decision|1
1764513|NCT00774930|6146110|P2|IOL Phase|Physician Decision|2
1764514|NCT00774930|6146111|P1|IOL Phase|Physician Decision|3
1764515|NCT00774930|6146110|P2|IOL Phase|Subject Decision|3
1764516|NCT00774930|6146111|P1|IOL Phase|Subject Decision|4
1764517|NCT00774930|6146110|P2|IOL Phase|Adverse Event|1
1764518|NCT00774930|6146111|P1|IOL Phase|Adverse Event|1
1764519|NCT00774930|6146110|P2|DB Phase|Started Nonprotocol Radiation therapy|1
1764520|NCT00774930|6146111|P1|DB Phase|Started Nonprotocol Radiation therapy|0
1764521|NCT00774930|6146110|P2|DB Phase|Disease Progression|1
1764522|NCT00774930|6146111|P1|DB Phase|Disease Progression|1
1764523|NCT00774930|6146110|P2|DB Phase|Sponsor Decision|1
1764524|NCT00774930|6146111|P1|DB Phase|Sponsor Decision|0
1764525|NCT00774930|6146110|P2|DB Phase|Subject Decision|5
1764526|NCT00774930|6146111|P1|DB Phase|Subject Decision|1
1764527|NCT00774930|6146110|P2|DB Phase|Adverse Event|2
1764528|NCT00774930|6146111|P1|DB Phase|Adverse Event|1
1764529|NCT00774930|6146110|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
1764530|NCT00774930|6146111|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
1764531|NCT00774852|6146139|P2|Overall Study|Subject received prohibited medication|0
1764532|NCT00774852|6146140|P1|Overall Study|Subject received prohibited medication|1
1764533|NCT00774852|6146139|P2|Overall Study|Protocol Violation|0
1764534|NCT00774852|6146140|P1|Overall Study|Protocol Violation|1
1764535|NCT00774852|6146139|P2|Overall Study|Subject non-compliance|1
1764536|NCT00774852|6146140|P1|Overall Study|Subject non-compliance|0
1764537|NCT00774852|6146139|P2|Overall Study|Non-responder|11
1764538|NCT00774852|6146140|P1|Overall Study|Non-responder|15
1764539|NCT00774852|6146139|P2|Overall Study|Withdrawal by Subject|2
1764540|NCT00774852|6146140|P1|Overall Study|Withdrawal by Subject|2
1764541|NCT00774852|6146139|P2|Overall Study|Pregnancy|2
1764542|NCT00774852|6146140|P1|Overall Study|Pregnancy|1
1764543|NCT00774852|6146139|P2|Overall Study|Physician Decision|6
1764544|NCT00774852|6146140|P1|Overall Study|Physician Decision|2
1764545|NCT00774852|6146139|P2|Overall Study|Lost to Follow-up|5
1764546|NCT00774852|6146140|P1|Overall Study|Lost to Follow-up|9
1764547|NCT00774852|6146139|P2|Overall Study|Lack of Efficacy|7
1764548|NCT00774852|6146140|P1|Overall Study|Lack of Efficacy|3
1764549|NCT00774852|6146139|P2|Overall Study|Death|1
1764550|NCT00774852|6146140|P1|Overall Study|Death|2
1764551|NCT00774852|6146139|P2|Overall Study|Adverse Event|6
1764552|NCT00774852|6146140|P1|Overall Study|Adverse Event|9
1764553|NCT00774800|6146188|P1|Intervention 4|Withdrawal by Subject|1
1764554|NCT00774787|6146210|P1|Overall Study|Lost to Follow-up|1
1764555|NCT00774748|6146217|P1|Overall Study|Lost to Follow-up|3
1764556|NCT00774397|6146243|P7|Overall Study|Other than those stated above|1
1764557|NCT00774397|6146244|P6|Overall Study|Other than those stated above|0
1764558|NCT00774397|6146245|P5|Overall Study|Other than those stated above|2
1764559|NCT00774397|6146246|P4|Overall Study|Other than those stated above|2
1764560|NCT00774397|6146247|P3|Overall Study|Other than those stated above|3
1764561|NCT00774397|6146248|P2|Overall Study|Other than those stated above|1
1764562|NCT00774397|6146249|P1|Overall Study|Other than those stated above|1
1764563|NCT00774397|6146243|P7|Overall Study|Not treated|1
1764564|NCT00774397|6146244|P6|Overall Study|Not treated|0
1764565|NCT00774397|6146245|P5|Overall Study|Not treated|1
1764566|NCT00774397|6146246|P4|Overall Study|Not treated|0
1764567|NCT00774397|6146247|P3|Overall Study|Not treated|0
1764568|NCT00774397|6146248|P2|Overall Study|Not treated|0
1764569|NCT00774397|6146249|P1|Overall Study|Not treated|0
1764570|NCT00774397|6146243|P7|Overall Study|Refused to continue trial medication|3
1764571|NCT00774397|6146244|P6|Overall Study|Refused to continue trial medication|2
1764572|NCT00774397|6146245|P5|Overall Study|Refused to continue trial medication|6
1764573|NCT00774397|6146246|P4|Overall Study|Refused to continue trial medication|2
1764574|NCT00774397|6146247|P3|Overall Study|Refused to continue trial medication|2
1764575|NCT00774397|6146248|P2|Overall Study|Refused to continue trial medication|3
1764576|NCT00774397|6146249|P1|Overall Study|Refused to continue trial medication|1
1764577|NCT00774397|6146243|P7|Overall Study|Lost to Follow-up|0
1764578|NCT00774397|6146244|P6|Overall Study|Lost to Follow-up|1
1764579|NCT00774397|6146245|P5|Overall Study|Lost to Follow-up|0
1764580|NCT00774397|6146246|P4|Overall Study|Lost to Follow-up|1
1764581|NCT00774397|6146247|P3|Overall Study|Lost to Follow-up|1
1764582|NCT00774397|6146248|P2|Overall Study|Lost to Follow-up|1
1764583|NCT00774397|6146249|P1|Overall Study|Lost to Follow-up|0
1764584|NCT00774397|6146243|P7|Overall Study|Protocol Violation|0
1764585|NCT00774397|6146244|P6|Overall Study|Protocol Violation|1
1764586|NCT00774397|6146245|P5|Overall Study|Protocol Violation|2
1764587|NCT00774397|6146246|P4|Overall Study|Protocol Violation|1
1764588|NCT00774397|6146247|P3|Overall Study|Protocol Violation|3
1764589|NCT00774397|6146248|P2|Overall Study|Protocol Violation|1
1764590|NCT00774397|6146249|P1|Overall Study|Protocol Violation|0
1764591|NCT00774397|6146243|P7|Overall Study|Lack of Efficacy|9
1764592|NCT00774397|6146244|P6|Overall Study|Lack of Efficacy|15
1764593|NCT00774397|6146245|P5|Overall Study|Lack of Efficacy|27
1764594|NCT00774397|6146246|P4|Overall Study|Lack of Efficacy|3
1764595|NCT00774397|6146247|P3|Overall Study|Lack of Efficacy|5
1764596|NCT00774397|6146248|P2|Overall Study|Lack of Efficacy|4
1764597|NCT00774397|6146249|P1|Overall Study|Lack of Efficacy|11
1764598|NCT00774397|6146243|P7|Overall Study|Adverse Event|16
1764599|NCT00774397|6146244|P6|Overall Study|Adverse Event|3
1764600|NCT00774397|6146245|P5|Overall Study|Adverse Event|8
1764601|NCT00774397|6146246|P4|Overall Study|Adverse Event|8
1764602|NCT00774397|6146247|P3|Overall Study|Adverse Event|16
1764603|NCT00774397|6146248|P2|Overall Study|Adverse Event|3
1764604|NCT00774397|6146249|P1|Overall Study|Adverse Event|1
1764605|NCT00774306|6146485|P4|Overall Study|Death|0
1764606|NCT00774306|6146486|P3|Overall Study|Death|0
1764607|NCT00774306|6146487|P2|Overall Study|Death|1
1764608|NCT00774306|6146488|P1|Overall Study|Death|1
1764609|NCT00774306|6146485|P4|Overall Study|Lost to Follow-up|5
1764610|NCT00774306|6146486|P3|Overall Study|Lost to Follow-up|4
1764611|NCT00774306|6146487|P2|Overall Study|Lost to Follow-up|0
1764612|NCT00774306|6146488|P1|Overall Study|Lost to Follow-up|6
1764613|NCT00774306|6146485|P4|Overall Study|Withdrawal by Subject|0
1764614|NCT00774306|6146486|P3|Overall Study|Withdrawal by Subject|1
1764615|NCT00774306|6146487|P2|Overall Study|Withdrawal by Subject|1
1764616|NCT00774306|6146488|P1|Overall Study|Withdrawal by Subject|6
1764617|NCT00774306|6146485|P4|Overall Study|Protocol Violation|0
1764618|NCT00774306|6146486|P3|Overall Study|Protocol Violation|3
1764619|NCT00774306|6146487|P2|Overall Study|Protocol Violation|0
1764620|NCT00774306|6146488|P1|Overall Study|Protocol Violation|2
1764621|NCT00774306|6146485|P4|Overall Study|Adverse Event|0
1764622|NCT00774306|6146486|P3|Overall Study|Adverse Event|0
1764623|NCT00774306|6146487|P2|Overall Study|Adverse Event|0
1764624|NCT00774306|6146488|P1|Overall Study|Adverse Event|3
1764625|NCT00774046|6146569|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
1764626|NCT00774046|6146569|P1|Enrollment|Desired other therapy/refused|28
1764627|NCT00774046|6146569|P1|Screening|Not eligible|56
1764628|NCT00773968|6146579|P1|Overall Study|Other|8
1764629|NCT00773968|6146579|P1|Overall Study|Screen Failure|17
1764630|NCT00773968|6146579|P1|Overall Study|Withdrawal by Subject|11
1764631|NCT00773968|6146579|P1|Overall Study|Protocol Violation|1
1764632|NCT00773968|6146579|P1|Overall Study|Lack of Efficacy|3
1764633|NCT00773968|6146579|P1|Overall Study|Failure to Return|2
1764634|NCT00773968|6146579|P1|Overall Study|Death|1
1764635|NCT00773968|6146579|P1|Overall Study|Adverse Event|2
1764636|NCT00773734|6146610|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1764637|NCT00773734|6146611|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1764638|NCT00773734|6146612|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
1764639|NCT00773734|6146613|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
1764640|NCT00773734|6146614|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1764641|NCT00773734|6146615|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
1764642|NCT00773734|6146610|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1764643|NCT00773734|6146611|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1764644|NCT00773734|6146612|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
1764645|NCT00773734|6146613|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
1764646|NCT00773734|6146614|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1764647|NCT00773734|6146615|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
1764648|NCT00773734|6146610|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1764649|NCT00773734|6146611|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1764650|NCT00773734|6146612|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
1764651|NCT00773734|6146613|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
1764652|NCT00773734|6146614|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1764653|NCT00773734|6146615|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
1764654|NCT00773734|6146610|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
1764655|NCT00773734|6146611|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
1764656|NCT00773734|6146612|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
1764657|NCT00773734|6146613|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
1764658|NCT00773734|6146614|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
1764659|NCT00773734|6146615|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
1764660|NCT00773734|6146610|P6|Extension: Active Treatment Week 24-52|Other|1
1764661|NCT00773734|6146611|P5|Extension: Active Treatment Week 24-52|Other|0
1764662|NCT00773734|6146612|P4|Extension: Active Treatment Week 24-52|Other|2
1764663|NCT00773734|6146613|P3|Extension: Active Treatment Week 24-52|Other|1
1764664|NCT00773734|6146614|P2|Extension: Active Treatment Week 24-52|Other|0
1764665|NCT00773734|6146615|P1|Extension: Active Treatment Week 24-52|Other|0
1764666|NCT00773734|6146610|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
1764667|NCT00773734|6146611|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
1764668|NCT00773734|6146612|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
1764669|NCT00773734|6146613|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
1764670|NCT00773734|6146614|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
1764671|NCT00773734|6146615|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
1764672|NCT00773734|6146610|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
1764673|NCT00773734|6146611|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
1764674|NCT00773734|6146612|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
1764675|NCT00773734|6146613|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
1764676|NCT00773734|6146614|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
1764677|NCT00773734|6146615|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
1764678|NCT00773734|6146610|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
1764679|NCT00773734|6146611|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
1764680|NCT00773734|6146612|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
1764681|NCT00773734|6146613|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
1764682|NCT00773734|6146614|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
1764683|NCT00773734|6146615|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
1764684|NCT00773734|6146610|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
1764685|NCT00773734|6146611|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
1764686|NCT00773734|6146612|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
1764687|NCT00773734|6146613|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
1764688|NCT00773734|6146614|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
1764689|NCT00773734|6146615|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
1764690|NCT00773734|6146610|P6|Core: Active Treatment Phase Week 16-24|Other|0
1764691|NCT00773734|6146611|P5|Core: Active Treatment Phase Week 16-24|Other|0
1764692|NCT00773734|6146612|P4|Core: Active Treatment Phase Week 16-24|Other|0
1764693|NCT00773734|6146613|P3|Core: Active Treatment Phase Week 16-24|Other|0
1764694|NCT00773734|6146614|P2|Core: Active Treatment Phase Week 16-24|Other|1
1764695|NCT00773734|6146615|P1|Core: Active Treatment Phase Week 16-24|Other|0
1764696|NCT00773734|6146610|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1764697|NCT00773734|6146611|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
1764698|NCT00773734|6146612|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1764699|NCT00773734|6146613|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1764700|NCT00773734|6146614|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
1764701|NCT00773734|6146615|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
1764702|NCT00773734|6146610|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1764703|NCT00773734|6146611|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1764704|NCT00773734|6146612|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1764705|NCT00773734|6146613|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
1764706|NCT00773734|6146614|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
1764707|NCT00773734|6146615|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
1764708|NCT00773734|6146610|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
1764709|NCT00773734|6146611|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1764710|NCT00773734|6146612|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1764711|NCT00773734|6146613|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
1764712|NCT00773734|6146614|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
1764713|NCT00773734|6146615|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
1764714|NCT00773734|6146610|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1764715|NCT00773734|6146611|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1764716|NCT00773734|6146612|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
1764717|NCT00773734|6146613|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
1764718|NCT00773734|6146614|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
1764719|NCT00773734|6146615|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
1764720|NCT00773734|6146610|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
1764721|NCT00773734|6146611|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
1764722|NCT00773734|6146612|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1764723|NCT00773734|6146613|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1764724|NCT00773734|6146614|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
1764725|NCT00773734|6146615|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
1764726|NCT00773734|6146610|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
1764727|NCT00773734|6146611|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
1764728|NCT00773734|6146612|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
1764729|NCT00773734|6146613|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
1764730|NCT00773734|6146614|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
1764731|NCT00773734|6146615|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
1764732|NCT00773734|6146610|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1764733|NCT00773734|6146611|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1764734|NCT00773734|6146612|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
1764735|NCT00773734|6146613|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
1764736|NCT00773734|6146614|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
1764737|NCT00773734|6146615|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
1764738|NCT00773734|6146610|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1764739|NCT00773734|6146611|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1764740|NCT00773734|6146612|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
1764741|NCT00773734|6146613|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1764742|NCT00773734|6146614|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
1764743|NCT00773734|6146615|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
1764744|NCT00773734|6146610|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
1764745|NCT00773734|6146611|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
1764746|NCT00773734|6146612|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
1764747|NCT00773734|6146613|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
1764748|NCT00773734|6146614|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
1764749|NCT00773734|6146615|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
1764750|NCT00773734|6146610|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
1764751|NCT00773734|6146611|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
1764752|NCT00773734|6146612|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
1764753|NCT00773734|6146613|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
1764754|NCT00773734|6146614|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
1764755|NCT00773734|6146615|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
1764756|NCT00773734|6146610|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
1764757|NCT00773734|6146611|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
1764758|NCT00773734|6146612|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
1764759|NCT00773734|6146613|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
1764760|NCT00773734|6146614|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
1764761|NCT00773734|6146615|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
1764762|NCT00773734|6146610|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
1764763|NCT00773734|6146611|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
1764764|NCT00773734|6146612|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
1764765|NCT00773734|6146613|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
1764766|NCT00773734|6146614|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
1764767|NCT00773734|6146615|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
1764768|NCT00773513|6147183|P2|Overall Study|Death|545
1764769|NCT00773513|6147184|P1|Overall Study|Death|531
1764770|NCT00773513|6147183|P2|Overall Study|Reason Not Specified|126
1764771|NCT00773513|6147184|P1|Overall Study|Reason Not Specified|159
1764772|NCT00773513|6147183|P2|Overall Study|Insufficient Therapeutic Response|18
1764773|NCT00773513|6147184|P1|Overall Study|Insufficient Therapeutic Response|1
1764774|NCT00773513|6147183|P2|Overall Study|Failure to Return|8
1764775|NCT00773513|6147184|P1|Overall Study|Failure to Return|22
1764776|NCT00773513|6147183|P2|Overall Study|Refused Treatment / Did not Cooperate|32
1764777|NCT00773513|6147184|P1|Overall Study|Refused Treatment / Did not Cooperate|26
1764778|NCT00773513|6147183|P2|Overall Study|Withdrew Consent|69
1764779|NCT00773513|6147184|P1|Overall Study|Withdrew Consent|68
1764780|NCT00773513|6147183|P2|Overall Study|Adverse Event / Intercurrent Illness|48
1764781|NCT00773513|6147184|P1|Overall Study|Adverse Event / Intercurrent Illness|40
1764782|NCT00773513|6147183|P2|Overall Study|Renal Transplant|263
1764783|NCT00773513|6147184|P1|Overall Study|Renal Transplant|254
1764784|NCT00773461|6147213|P2|Overall Study|Withdrawal by Subject|1
1764785|NCT00773461|6147214|P1|Overall Study|Withdrawal by Subject|4
1764786|NCT00773461|6147213|P2|Overall Study|Adverse Event|3
1764787|NCT00773461|6147214|P1|Overall Study|Adverse Event|1
1764788|NCT00773383|6147268|P1|Overall Study|No study dose received|1
1764789|NCT00773383|6147268|P1|Overall Study|Other|2
1764790|NCT00773383|6147268|P1|Overall Study|Progression of Disease|23
1764791|NCT00773383|6147268|P1|Overall Study|Death|1
1764792|NCT00773383|6147268|P1|Overall Study|Adverse Event|4
1764793|NCT00773279|6147303|P2|Period 2|Unclassified|2
1764794|NCT00773279|6147304|P1|Period 2|Unclassified|2
1764795|NCT00773279|6147303|P2|Period 2|Protocol Violation|3
1764796|NCT00773279|6147304|P1|Period 2|Protocol Violation|0
1764797|NCT00773279|6147303|P2|Period 2|Lack of Efficacy|0
1764798|NCT00773279|6147304|P1|Period 2|Lack of Efficacy|1
1764799|NCT00773279|6147303|P2|Period 2|Adverse Event|1
1764800|NCT00773279|6147304|P1|Period 2|Adverse Event|0
1764801|NCT00773279|6147303|P2|Period 1|Unclassified|1
1764802|NCT00773279|6147304|P1|Period 1|Unclassified|5
1764803|NCT00773279|6147303|P2|Period 1|Lack of Efficacy|2
1764804|NCT00773279|6147304|P1|Period 1|Lack of Efficacy|0
1764805|NCT00773279|6147303|P2|Period 1|Adverse Event|1
1764806|NCT00773279|6147304|P1|Period 1|Adverse Event|2
1764807|NCT00773253|6147325|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
1764808|NCT00773253|6147326|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
1764809|NCT00773175|6147334|P2|Overall Study|Consent Withdrawn|2
1764810|NCT00773175|6147335|P1|Overall Study|Consent Withdrawn|0
1764811|NCT00773175|6147334|P2|Overall Study|Adverse Event|0
1764812|NCT00773175|6147335|P1|Overall Study|Adverse Event|2
1764813|NCT00773136|6147427|P1|Overall Study|Physician Decision|2
1764814|NCT00773097|6147432|P1|Overall Study|Physician Decision|6
1764815|NCT00773097|6147432|P1|Overall Study|Withdrawal by Subject|1
1764816|NCT00772967|6147438|P6|Crossover Treatment 3|Adverse Event|0
1764817|NCT00772967|6147439|P5|Crossover Treatment 3|Adverse Event|1
1764818|NCT00772967|6147440|P4|Crossover Treatment 3|Adverse Event|0
1764819|NCT00772967|6147441|P3|Crossover Treatment 3|Adverse Event|0
1764820|NCT00772967|6147442|P2|Crossover Treatment 3|Adverse Event|0
1764821|NCT00772967|6147443|P1|Crossover Treatment 3|Adverse Event|0
1764822|NCT00772967|6147438|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
1764823|NCT00772967|6147439|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
1764824|NCT00772967|6147440|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
1764825|NCT00772967|6147441|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
1764826|NCT00772967|6147442|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
1764827|NCT00772967|6147443|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
1764828|NCT00772967|6147438|P6|Crossover Treatment 1|Adverse Event (Pain)|0
1764829|NCT00772967|6147439|P5|Crossover Treatment 1|Adverse Event (Pain)|0
1764830|NCT00772967|6147440|P4|Crossover Treatment 1|Adverse Event (Pain)|1
1764831|NCT00772967|6147441|P3|Crossover Treatment 1|Adverse Event (Pain)|0
1764832|NCT00772967|6147442|P2|Crossover Treatment 1|Adverse Event (Pain)|0
1764833|NCT00772967|6147443|P1|Crossover Treatment 1|Adverse Event (Pain)|0
1764834|NCT00772954|6147463|P3|Overall Study|Adverse Event|1
1764835|NCT00772954|6147464|P2|Overall Study|Adverse Event|0
1764836|NCT00772954|6147465|P1|Overall Study|Adverse Event|0
1764837|NCT00772941|6147473|P1|Overall Study|GPSP Violation|90
1764838|NCT00772941|6147473|P1|Overall Study|Poor Compliance|7
1764839|NCT00772941|6147473|P1|Overall Study|Missed Visits|374
1764840|NCT00772941|6147473|P1|Overall Study|Study not completed|16
1764841|NCT00772941|6147473|P1|Overall Study|CRFs not available|195
1764842|NCT00772928|6147504|P2|Overall Study|Did not receive vaccine|1
1764843|NCT00772928|6147505|P1|Overall Study|Did not receive vaccine|0
1764844|NCT00772928|6147504|P2|Overall Study|Withdrawal by Subject|22
1764845|NCT00772928|6147505|P1|Overall Study|Withdrawal by Subject|25
1764846|NCT00772928|6147504|P2|Overall Study|Protocol Violation|12
1764847|NCT00772928|6147505|P1|Overall Study|Protocol Violation|10
1764848|NCT00772928|6147504|P2|Overall Study|Lost to Follow-up|6
1764849|NCT00772928|6147505|P1|Overall Study|Lost to Follow-up|9
1764850|NCT00772889|6147526|P3|Overall Study|Lost to Follow-up|7
1764851|NCT00772889|6147527|P2|Overall Study|Lost to Follow-up|6
1764852|NCT00772889|6147528|P1|Overall Study|Lost to Follow-up|6
1764853|NCT00772889|6147526|P3|Overall Study|Withdrawal by Subject|9
1764854|NCT00772889|6147527|P2|Overall Study|Withdrawal by Subject|8
1764855|NCT00772889|6147528|P1|Overall Study|Withdrawal by Subject|9
1764856|NCT00772889|6147526|P3|Overall Study|Adverse Event|0
1764857|NCT00772889|6147527|P2|Overall Study|Adverse Event|4
1764858|NCT00772889|6147528|P1|Overall Study|Adverse Event|7
1764859|NCT00772707|6147586|P1|Overall Study|Withdrawn|3
1764860|NCT00772668|6147591|P1|Overall Study|Physician Decision|3
1764861|NCT00772629|6147600|P2|Overall Study|Subject was not vaccinated|0
1764862|NCT00772629|6147601|P1|Overall Study|Subject was not vaccinated|1
1764863|NCT00772603|6147610|P3|Overall Study|Other|2
1764864|NCT00772603|6147611|P2|Overall Study|Other|0
1764865|NCT00772603|6147612|P1|Overall Study|Other|2
1764866|NCT00772603|6147610|P3|Overall Study|Physician Decision|1
1764867|NCT00772603|6147611|P2|Overall Study|Physician Decision|0
1764868|NCT00772603|6147612|P1|Overall Study|Physician Decision|0
1764869|NCT00772603|6147610|P3|Overall Study|Lost to Follow-up|2
1764870|NCT00772603|6147611|P2|Overall Study|Lost to Follow-up|5
1764871|NCT00772603|6147612|P1|Overall Study|Lost to Follow-up|1
1764872|NCT00772603|6147610|P3|Overall Study|Protocol Violation|1
1764873|NCT00772603|6147611|P2|Overall Study|Protocol Violation|1
1764874|NCT00772603|6147612|P1|Overall Study|Protocol Violation|0
1764875|NCT00772603|6147610|P3|Overall Study|Subject Non-compliance|4
1764876|NCT00772603|6147611|P2|Overall Study|Subject Non-compliance|6
1764877|NCT00772603|6147612|P1|Overall Study|Subject Non-compliance|1
1764878|NCT00772603|6147610|P3|Overall Study|Adverse Event|10
1764879|NCT00772603|6147611|P2|Overall Study|Adverse Event|18
1764880|NCT00772603|6147612|P1|Overall Study|Adverse Event|37
1764881|NCT00772603|6147610|P3|Overall Study|Withdrawal by Subject|6
1764882|NCT00772603|6147611|P2|Overall Study|Withdrawal by Subject|10
1764883|NCT00772603|6147612|P1|Overall Study|Withdrawal by Subject|11
1764884|NCT00772577|6147651|P2|Overall Study|Protocol Deviation|2
1764885|NCT00772577|6147652|P1|Overall Study|Protocol Deviation|3
1764886|NCT00772577|6147651|P2|Overall Study|Administrative problems|1
1764887|NCT00772577|6147652|P1|Overall Study|Administrative problems|2
1764888|NCT00772577|6147651|P2|Overall Study|Lost to Follow-up|3
1764889|NCT00772577|6147652|P1|Overall Study|Lost to Follow-up|4
1764890|NCT00772577|6147651|P2|Overall Study|Patient withdrew consent|5
1764891|NCT00772577|6147652|P1|Overall Study|Patient withdrew consent|8
1764892|NCT00772577|6147651|P2|Overall Study|Unsatisfactory therapeutic effect|8
1764893|NCT00772577|6147652|P1|Overall Study|Unsatisfactory therapeutic effect|0
1764894|NCT00772577|6147651|P2|Overall Study|Abnormal laboratory values|1
1764895|NCT00772577|6147652|P1|Overall Study|Abnormal laboratory values|0
1764896|NCT00772577|6147651|P2|Overall Study|Adverse Event|3
1764897|NCT00772577|6147652|P1|Overall Study|Adverse Event|6
1764898|NCT00772538|6147668|P2|Overall Study|Other|7
1764899|NCT00772538|6147669|P1|Overall Study|Other|7
1764900|NCT00772538|6147668|P2|Overall Study|Lack of Efficacy|1
1764901|NCT00772538|6147669|P1|Overall Study|Lack of Efficacy|0
1764902|NCT00772538|6147668|P2|Overall Study|Withdrawal by Subject|8
1764903|NCT00772538|6147669|P1|Overall Study|Withdrawal by Subject|3
1764904|NCT00772538|6147668|P2|Overall Study|Lost to Follow-up|1
1764905|NCT00772538|6147669|P1|Overall Study|Lost to Follow-up|1
1764906|NCT00772538|6147668|P2|Overall Study|Protocol Violation|3
1764907|NCT00772538|6147669|P1|Overall Study|Protocol Violation|3
1764908|NCT00772538|6147668|P2|Overall Study|Adverse Event|6
1764909|NCT00772538|6147669|P1|Overall Study|Adverse Event|6
1764910|NCT00772447|6147741|P2|Overall Study|all others|2
1764911|NCT00772447|6147742|P1|Overall Study|all others|2
1764912|NCT00772447|6147741|P2|Overall Study|Protocol Violation|1
1764913|NCT00772447|6147742|P1|Overall Study|Protocol Violation|0
1764914|NCT00772447|6147741|P2|Overall Study|incorrect enrolment|4
1764915|NCT00772447|6147742|P1|Overall Study|incorrect enrolment|3
1764916|NCT00772447|6147741|P2|Overall Study|Lost to Follow-up|4
1764917|NCT00772447|6147742|P1|Overall Study|Lost to Follow-up|2
1764918|NCT00772447|6147741|P2|Overall Study|Physician Decision|8
1764919|NCT00772447|6147742|P1|Overall Study|Physician Decision|4
1764920|NCT00772447|6147741|P2|Overall Study|Withdrawal by Subject|5
1764921|NCT00772447|6147742|P1|Overall Study|Withdrawal by Subject|9
1764922|NCT00772382|6147770|P1|Overall Study|Other Reasons|10
1764923|NCT00772382|6147770|P1|Overall Study|Withdrawal by Subject|10
1764924|NCT00772382|6147770|P1|Overall Study|Protocol Violation|1
1764925|NCT00772382|6147770|P1|Overall Study|Physician Decision|5
1764926|NCT00772382|6147770|P1|Overall Study|Lack of Efficacy|4
1764927|NCT00772382|6147770|P1|Overall Study|Death|6
1764928|NCT00772382|6147770|P1|Overall Study|Adverse Event|19
1764929|NCT00772369|6147775|P1|Overall Study|Did not return record release form|1
1764930|NCT00772148|6147786|P2|Maintenance Phase (Week 52)|Administrative/other|2
1764931|NCT00772148|6147787|P1|Maintenance Phase (Week 52)|Administrative/other|1
1764932|NCT00772148|6147786|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
1764933|NCT00772148|6147787|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
1764934|NCT00772148|6147786|P2|Maintenance Phase (Week 52)|Adverse Event|0
1764935|NCT00772148|6147787|P1|Maintenance Phase (Week 52)|Adverse Event|1
1764936|NCT00772148|6147786|P2|Maintenance Phase (Week 52)|Death|2
1764937|NCT00772148|6147787|P1|Maintenance Phase (Week 52)|Death|2
1764938|NCT00772148|6147786|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
1764939|NCT00772148|6147787|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
1764940|NCT00772148|6147786|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
1764941|NCT00772148|6147787|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
1764942|NCT00772148|6147786|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
1764943|NCT00772148|6147787|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
1764944|NCT00772109|6147807|P4|Overall Study|Withdrawal by Subject|16
1764945|NCT00772109|6147808|P3|Overall Study|Withdrawal by Subject|6
1764946|NCT00772109|6147809|P2|Overall Study|Withdrawal by Subject|8
1764947|NCT00772109|6147810|P1|Overall Study|Withdrawal by Subject|8
1764948|NCT00772109|6147807|P4|Overall Study|Lost to Follow-up|9
1764949|NCT00772109|6147808|P3|Overall Study|Lost to Follow-up|5
1764950|NCT00772109|6147809|P2|Overall Study|Lost to Follow-up|3
1764951|NCT00772109|6147810|P1|Overall Study|Lost to Follow-up|7
1764952|NCT00772109|6147807|P4|Overall Study|Protocol Violation|6
1764953|NCT00772109|6147808|P3|Overall Study|Protocol Violation|7
1764954|NCT00772109|6147809|P2|Overall Study|Protocol Violation|8
1764955|NCT00772109|6147810|P1|Overall Study|Protocol Violation|5
1764956|NCT00772109|6147807|P4|Overall Study|Serious adverse event|0
1764957|NCT00772109|6147808|P3|Overall Study|Serious adverse event|1
1764958|NCT00772109|6147809|P2|Overall Study|Serious adverse event|0
1764959|NCT00772109|6147810|P1|Overall Study|Serious adverse event|1
1764960|NCT00772070|6147834|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
1764961|NCT00772070|6147835|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
1764962|NCT00772070|6147834|P2|Overall Study|Withdrawal by Subject|2
1764963|NCT00772070|6147835|P1|Overall Study|Withdrawal by Subject|0
1764964|NCT00772070|6147834|P2|Overall Study|Lost to Follow-up|8
1764965|NCT00772070|6147835|P1|Overall Study|Lost to Follow-up|0
1764966|NCT00772031|6147847|P2|Overall Study|Lost to Follow-up|33
1764967|NCT00772031|6147848|P1|Overall Study|Lost to Follow-up|20
1764968|NCT00772031|6147847|P2|Overall Study|Early termination of trial|10
1764969|NCT00772031|6147848|P1|Overall Study|Early termination of trial|12
1764970|NCT00772005|6147874|P4|Overall Study|Non-compliance with drug administration|1
1764971|NCT00772005|6147875|P3|Overall Study|Non-compliance with drug administration|1
1764972|NCT00772005|6147876|P2|Overall Study|Non-compliance with drug administration|0
1764973|NCT00772005|6147877|P1|Overall Study|Non-compliance with drug administration|3
1764974|NCT00772005|6147874|P4|Overall Study|Non-compliance with study procedures|1
1764975|NCT00772005|6147875|P3|Overall Study|Non-compliance with study procedures|0
1764976|NCT00772005|6147876|P2|Overall Study|Non-compliance with study procedures|1
1764977|NCT00772005|6147877|P1|Overall Study|Non-compliance with study procedures|1
1764978|NCT00772005|6147874|P4|Overall Study|Lost to Follow-up|3
1764979|NCT00772005|6147875|P3|Overall Study|Lost to Follow-up|6
1764980|NCT00772005|6147876|P2|Overall Study|Lost to Follow-up|3
1764981|NCT00772005|6147877|P1|Overall Study|Lost to Follow-up|7
1764982|NCT00772005|6147874|P4|Overall Study|Protocol Violation|6
1764983|NCT00772005|6147875|P3|Overall Study|Protocol Violation|1
1764984|NCT00772005|6147876|P2|Overall Study|Protocol Violation|4
1764985|NCT00772005|6147877|P1|Overall Study|Protocol Violation|2
1764986|NCT00772005|6147874|P4|Overall Study|Withdrawal by Subject|2
1764987|NCT00772005|6147875|P3|Overall Study|Withdrawal by Subject|10
1764988|NCT00772005|6147876|P2|Overall Study|Withdrawal by Subject|7
1764989|NCT00772005|6147877|P1|Overall Study|Withdrawal by Subject|3
1764990|NCT00772005|6147874|P4|Overall Study|Lack of Efficacy|0
1764991|NCT00772005|6147875|P3|Overall Study|Lack of Efficacy|0
1764992|NCT00772005|6147876|P2|Overall Study|Lack of Efficacy|1
1764993|NCT00772005|6147877|P1|Overall Study|Lack of Efficacy|0
1764994|NCT00772005|6147874|P4|Overall Study|Adverse Event|13
1764995|NCT00772005|6147875|P3|Overall Study|Adverse Event|10
1764996|NCT00772005|6147876|P2|Overall Study|Adverse Event|14
1764997|NCT00772005|6147877|P1|Overall Study|Adverse Event|9
1764998|NCT00771953|6148565|P2|Overall Study|Withdrawal by Subject|3
1764999|NCT00771953|6148566|P1|Overall Study|Withdrawal by Subject|0
1765000|NCT00771953|6148565|P2|Overall Study|Other complicating disease|0
1765001|NCT00771953|6148566|P1|Overall Study|Other complicating disease|1
1765002|NCT00771953|6148565|P2|Overall Study|Sponsor decision|0
1765003|NCT00771953|6148566|P1|Overall Study|Sponsor decision|1
1765004|NCT00771953|6148565|P2|Overall Study|Progression before active Tx|2
1765005|NCT00771953|6148566|P1|Overall Study|Progression before active Tx|1
1765006|NCT00771953|6148565|P2|Overall Study|Death|2
1765007|NCT00771953|6148566|P1|Overall Study|Death|2
1765008|NCT00771953|6148565|P2|Overall Study|Adverse Event|3
1765009|NCT00771953|6148566|P1|Overall Study|Adverse Event|5
1765010|NCT00771927|6148576|P2|Overall Study|Other reason|27
1765011|NCT00771927|6148577|P1|Overall Study|Other reason|23
1765012|NCT00771927|6148576|P2|Overall Study|Withdrawal by Subject|17
1765013|NCT00771927|6148577|P1|Overall Study|Withdrawal by Subject|16
1765014|NCT00771927|6148576|P2|Overall Study|Lost to Follow-up|46
1765015|NCT00771927|6148577|P1|Overall Study|Lost to Follow-up|46
1765016|NCT00771927|6148576|P2|Overall Study|Lack of Efficacy|42
1765017|NCT00771927|6148577|P1|Overall Study|Lack of Efficacy|70
1765018|NCT00771927|6148576|P2|Overall Study|Adverse Event|105
1765019|NCT00771927|6148577|P1|Overall Study|Adverse Event|100
1765020|NCT00771914|6148589|P4|Overall Study|Lost to Follow-up|1
1765021|NCT00771914|6148590|P3|Overall Study|Lost to Follow-up|0
1765022|NCT00771914|6148591|P2|Overall Study|Lost to Follow-up|0
1765023|NCT00771914|6148592|P1|Overall Study|Lost to Follow-up|0
1765024|NCT00771914|6148589|P4|Overall Study|Physician Decision|1
1765025|NCT00771914|6148590|P3|Overall Study|Physician Decision|0
1765026|NCT00771914|6148591|P2|Overall Study|Physician Decision|0
1765027|NCT00771914|6148592|P1|Overall Study|Physician Decision|0
1765028|NCT00771901|6148605|P3|Overall Study|Dissat w/# of study medication (40/day)|4
1765029|NCT00771901|6148606|P2|Overall Study|Dissat w/# of study medication (40/day)|0
1765030|NCT00771901|6148607|P1|Overall Study|Dissat w/# of study medication (40/day)|0
1765031|NCT00771849|6148654|P2|Overall Study|Not vaccinated|1
1765032|NCT00771849|6148655|P1|Overall Study|Not vaccinated|0
1765033|NCT00771849|6148654|P2|Overall Study|Withdrawal by Subject|1
1765034|NCT00771849|6148655|P1|Overall Study|Withdrawal by Subject|1
1765035|NCT00771849|6148654|P2|Overall Study|Lost to Follow-up|2
1765036|NCT00771849|6148655|P1|Overall Study|Lost to Follow-up|1
1765037|NCT00771810|6148666|P3|Overall Study|Other|1
1765038|NCT00771810|6148667|P2|Overall Study|Other|0
1765039|NCT00771810|6148668|P1|Overall Study|Other|0
1765040|NCT00771810|6148666|P3|Overall Study|Withdrawal by Subject|0
1765041|NCT00771810|6148667|P2|Overall Study|Withdrawal by Subject|2
1765042|NCT00771810|6148668|P1|Overall Study|Withdrawal by Subject|1
1765043|NCT00771810|6148666|P3|Overall Study|Protocol Violation|1
1765044|NCT00771810|6148667|P2|Overall Study|Protocol Violation|1
1765045|NCT00771810|6148668|P1|Overall Study|Protocol Violation|0
1765046|NCT00771810|6148666|P3|Overall Study|Physician Decision|2
1765047|NCT00771810|6148667|P2|Overall Study|Physician Decision|2
1765048|NCT00771810|6148668|P1|Overall Study|Physician Decision|1
1765049|NCT00771810|6148666|P3|Overall Study|Lost to Follow-up|1
1765050|NCT00771810|6148667|P2|Overall Study|Lost to Follow-up|0
1765051|NCT00771810|6148668|P1|Overall Study|Lost to Follow-up|0
1765052|NCT00771810|6148666|P3|Overall Study|Adverse Event|2
1765053|NCT00771810|6148667|P2|Overall Study|Adverse Event|0
1765054|NCT00771810|6148668|P1|Overall Study|Adverse Event|3
1765055|NCT00771758|6148706|P3|Overall Study|Other|0
1765056|NCT00771758|6148707|P2|Overall Study|Other|2
1765057|NCT00771758|6148708|P1|Overall Study|Other|3
1765058|NCT00771758|6148706|P3|Overall Study|Withdrawal by Subject|0
1765059|NCT00771758|6148707|P2|Overall Study|Withdrawal by Subject|0
1765060|NCT00771758|6148708|P1|Overall Study|Withdrawal by Subject|1
1765061|NCT00771758|6148706|P3|Overall Study|Protocol Violation|0
1765062|NCT00771758|6148707|P2|Overall Study|Protocol Violation|0
1765063|NCT00771758|6148708|P1|Overall Study|Protocol Violation|1
1765064|NCT00771758|6148706|P3|Overall Study|Lost to Follow-up|0
1765065|NCT00771758|6148707|P2|Overall Study|Lost to Follow-up|0
1765066|NCT00771758|6148708|P1|Overall Study|Lost to Follow-up|1
1765067|NCT00771758|6148706|P3|Overall Study|Lack of Efficacy|1
1765068|NCT00771758|6148707|P2|Overall Study|Lack of Efficacy|2
1765069|NCT00771758|6148708|P1|Overall Study|Lack of Efficacy|0
1765070|NCT00771758|6148706|P3|Overall Study|Adverse Event|1
1765071|NCT00771758|6148707|P2|Overall Study|Adverse Event|8
1765072|NCT00771758|6148708|P1|Overall Study|Adverse Event|2
1765073|NCT00771667|6148869|P10|Maintenance Phase|Other|3
1765074|NCT00771667|6148870|P9|Maintenance Phase|Other|3
1765075|NCT00771667|6148871|P8|Maintenance Phase|Other|2
1765076|NCT00771667|6148872|P7|Maintenance Phase|Other|2
1765077|NCT00771667|6148873|P6|Maintenance Phase|Other|1
1765078|NCT00771667|6148874|P5|Maintenance Phase|Other|0
1765079|NCT00771667|6148875|P4|Maintenance Phase|Other|0
1765080|NCT00771667|6148876|P3|Maintenance Phase|Other|0
1765081|NCT00771667|6148877|P2|Maintenance Phase|Other|0
1765082|NCT00771667|6148878|P1|Maintenance Phase|Other|0
1765083|NCT00771667|6148869|P10|Maintenance Phase|Lack of Efficacy|7
1765084|NCT00771667|6148870|P9|Maintenance Phase|Lack of Efficacy|11
1765085|NCT00771667|6148871|P8|Maintenance Phase|Lack of Efficacy|2
1765086|NCT00771667|6148872|P7|Maintenance Phase|Lack of Efficacy|3
1765087|NCT00771667|6148873|P6|Maintenance Phase|Lack of Efficacy|3
1765088|NCT00771667|6148874|P5|Maintenance Phase|Lack of Efficacy|1
1765089|NCT00771667|6148875|P4|Maintenance Phase|Lack of Efficacy|0
1765090|NCT00771667|6148876|P3|Maintenance Phase|Lack of Efficacy|0
1765091|NCT00771667|6148877|P2|Maintenance Phase|Lack of Efficacy|0
1765092|NCT00771667|6148878|P1|Maintenance Phase|Lack of Efficacy|0
1765093|NCT00771667|6148869|P10|Maintenance Phase|Adverse Event|7
1765094|NCT00771667|6148870|P9|Maintenance Phase|Adverse Event|8
1765095|NCT00771667|6148871|P8|Maintenance Phase|Adverse Event|1
1765096|NCT00771667|6148872|P7|Maintenance Phase|Adverse Event|5
1765097|NCT00771667|6148873|P6|Maintenance Phase|Adverse Event|3
1765098|NCT00771667|6148874|P5|Maintenance Phase|Adverse Event|1
1765099|NCT00771667|6148875|P4|Maintenance Phase|Adverse Event|0
1765100|NCT00771667|6148876|P3|Maintenance Phase|Adverse Event|0
1765101|NCT00771667|6148877|P2|Maintenance Phase|Adverse Event|0
1765102|NCT00771667|6148878|P1|Maintenance Phase|Adverse Event|0
1765103|NCT00771667|6148869|P10|Induction Phase|Other|0
1765104|NCT00771667|6148870|P9|Induction Phase|Other|0
1765105|NCT00771667|6148871|P8|Induction Phase|Other|0
1765106|NCT00771667|6148872|P7|Induction Phase|Other|0
1765107|NCT00771667|6148873|P6|Induction Phase|Other|0
1765108|NCT00771667|6148874|P5|Induction Phase|Other|0
1765109|NCT00771667|6148875|P4|Induction Phase|Other|4
1765110|NCT00771667|6148876|P3|Induction Phase|Other|3
1765111|NCT00771667|6148877|P2|Induction Phase|Other|6
1765112|NCT00771667|6148878|P1|Induction Phase|Other|4
1765113|NCT00771667|6148869|P10|Induction Phase|Lost to Follow-up|0
1765114|NCT00771667|6148870|P9|Induction Phase|Lost to Follow-up|0
1765115|NCT00771667|6148871|P8|Induction Phase|Lost to Follow-up|0
1765116|NCT00771667|6148872|P7|Induction Phase|Lost to Follow-up|0
1765117|NCT00771667|6148873|P6|Induction Phase|Lost to Follow-up|0
1765118|NCT00771667|6148874|P5|Induction Phase|Lost to Follow-up|0
1765119|NCT00771667|6148875|P4|Induction Phase|Lost to Follow-up|0
1765120|NCT00771667|6148876|P3|Induction Phase|Lost to Follow-up|1
1765121|NCT00771667|6148877|P2|Induction Phase|Lost to Follow-up|0
1765122|NCT00771667|6148878|P1|Induction Phase|Lost to Follow-up|1
1765123|NCT00771667|6148869|P10|Induction Phase|Lack of Efficacy|0
1765124|NCT00771667|6148870|P9|Induction Phase|Lack of Efficacy|0
1765125|NCT00771667|6148871|P8|Induction Phase|Lack of Efficacy|0
1765126|NCT00771667|6148872|P7|Induction Phase|Lack of Efficacy|0
1765127|NCT00771667|6148873|P6|Induction Phase|Lack of Efficacy|0
1765128|NCT00771667|6148874|P5|Induction Phase|Lack of Efficacy|0
1765129|NCT00771667|6148875|P4|Induction Phase|Lack of Efficacy|3
1765130|NCT00771667|6148876|P3|Induction Phase|Lack of Efficacy|4
1765131|NCT00771667|6148877|P2|Induction Phase|Lack of Efficacy|2
1765132|NCT00771667|6148878|P1|Induction Phase|Lack of Efficacy|9
1765133|NCT00771667|6148869|P10|Induction Phase|Adverse Event|0
1765134|NCT00771667|6148870|P9|Induction Phase|Adverse Event|0
1765135|NCT00771667|6148871|P8|Induction Phase|Adverse Event|0
1765136|NCT00771667|6148872|P7|Induction Phase|Adverse Event|0
1765137|NCT00771667|6148873|P6|Induction Phase|Adverse Event|0
1765138|NCT00771667|6148874|P5|Induction Phase|Adverse Event|0
1765139|NCT00771667|6148875|P4|Induction Phase|Adverse Event|1
1765140|NCT00771667|6148876|P3|Induction Phase|Adverse Event|4
1765141|NCT00771667|6148877|P2|Induction Phase|Adverse Event|2
1765142|NCT00771667|6148878|P1|Induction Phase|Adverse Event|5
1765143|NCT00771615|6148923|P9|Overall Study|Lost to Follow-up|0
1765144|NCT00771615|6148924|P8|Overall Study|Lost to Follow-up|0
1765145|NCT00771615|6148925|P7|Overall Study|Lost to Follow-up|1
1765146|NCT00771615|6148926|P6|Overall Study|Lost to Follow-up|1
1765147|NCT00771615|6148927|P5|Overall Study|Lost to Follow-up|0
1765148|NCT00771615|6148928|P4|Overall Study|Lost to Follow-up|1
1765149|NCT00771615|6148929|P3|Overall Study|Lost to Follow-up|1
1765150|NCT00771615|6148930|P2|Overall Study|Lost to Follow-up|1
1765151|NCT00771615|6148931|P1|Overall Study|Lost to Follow-up|1
1765152|NCT00771615|6148923|P9|Overall Study|Withdrawal by Subject|0
1765153|NCT00771615|6148924|P8|Overall Study|Withdrawal by Subject|1
1765154|NCT00771615|6148925|P7|Overall Study|Withdrawal by Subject|0
1765155|NCT00771615|6148926|P6|Overall Study|Withdrawal by Subject|0
1765156|NCT00771615|6148927|P5|Overall Study|Withdrawal by Subject|0
1765157|NCT00771615|6148928|P4|Overall Study|Withdrawal by Subject|0
1765158|NCT00771615|6148929|P3|Overall Study|Withdrawal by Subject|0
1765159|NCT00771615|6148930|P2|Overall Study|Withdrawal by Subject|1
1765160|NCT00771615|6148931|P1|Overall Study|Withdrawal by Subject|0
1765161|NCT00771472|6149192|P2|Overall Study|Protocol Violation|0
1765162|NCT00771472|6149193|P1|Overall Study|Protocol Violation|1
1765163|NCT00771472|6149192|P2|Overall Study|Progressive Disease|1
1765164|NCT00771472|6149193|P1|Overall Study|Progressive Disease|3
1765165|NCT00771472|6149192|P2|Overall Study|Physician Decision|3
1765166|NCT00771472|6149193|P1|Overall Study|Physician Decision|2
1765167|NCT00771316|6149213|P2|Overall Study|Discontinued due to early termination|0
1765168|NCT00771316|6149214|P1|Overall Study|Discontinued due to early termination|1
1765169|NCT00771316|6149213|P2|Overall Study|Patient withdrew consent|0
1765170|NCT00771316|6149214|P1|Overall Study|Patient withdrew consent|1
1765171|NCT00771316|6149213|P2|Overall Study|Adverse Event|1
1765172|NCT00771316|6149214|P1|Overall Study|Adverse Event|0
1765173|NCT00770991|6149266|P2|Overall Study|Pregnancy|0
1765174|NCT00770991|6149267|P1|Overall Study|Pregnancy|1
1765175|NCT00770991|6149266|P2|Overall Study|Adverse Event|5
1765176|NCT00770991|6149267|P1|Overall Study|Adverse Event|1
1765177|NCT00770991|6149266|P2|Overall Study|Withdrawal by Subject|0
1765178|NCT00770991|6149267|P1|Overall Study|Withdrawal by Subject|1
1765179|NCT00770991|6149266|P2|Overall Study|Physician Decision|0
1765180|NCT00770991|6149267|P1|Overall Study|Physician Decision|2
1765181|NCT00770965|6149283|P4|Excluded Set|Withdrawal by Subject|3
1765182|NCT00770965|6149284|P3|Excluded Set|Withdrawal by Subject|2
1765183|NCT00770965|6149285|P2|Excluded Set|Withdrawal by Subject|1
1765184|NCT00770965|6149286|P1|Excluded Set|Withdrawal by Subject|1
1765185|NCT00770965|6149283|P4|Excluded Set|Administrative problems|10
1765186|NCT00770965|6149284|P3|Excluded Set|Administrative problems|12
1765187|NCT00770965|6149285|P2|Excluded Set|Administrative problems|12
1765188|NCT00770965|6149286|P1|Excluded Set|Administrative problems|14
1765189|NCT00770965|6149283|P4|Safety Set|Protocol deviation|0
1765190|NCT00770965|6149284|P3|Safety Set|Protocol deviation|1
1765191|NCT00770965|6149285|P2|Safety Set|Protocol deviation|0
1765192|NCT00770965|6149286|P1|Safety Set|Protocol deviation|0
1765193|NCT00770965|6149283|P4|Safety Set|Withdrawal by Subject|1
1765194|NCT00770965|6149284|P3|Safety Set|Withdrawal by Subject|0
1765195|NCT00770965|6149285|P2|Safety Set|Withdrawal by Subject|0
1765196|NCT00770965|6149286|P1|Safety Set|Withdrawal by Subject|0
1765197|NCT00770913|6149307|P3|Overall Study|Incorrect drug was allocated|0
1765198|NCT00770913|6149308|P2|Overall Study|Incorrect drug was allocated|0
1765199|NCT00770913|6149309|P1|Overall Study|Incorrect drug was allocated|1
1765200|NCT00770913|6149307|P3|Overall Study|Protocol Violation|1
1765201|NCT00770913|6149308|P2|Overall Study|Protocol Violation|0
1765202|NCT00770913|6149309|P1|Overall Study|Protocol Violation|3
1765203|NCT00770913|6149307|P3|Overall Study|Physician Decision|1
1765204|NCT00770913|6149308|P2|Overall Study|Physician Decision|1
1765205|NCT00770913|6149309|P1|Overall Study|Physician Decision|0
1765206|NCT00770913|6149307|P3|Overall Study|Refusal to continue participation|5
1765207|NCT00770913|6149308|P2|Overall Study|Refusal to continue participation|4
1765208|NCT00770913|6149309|P1|Overall Study|Refusal to continue participation|6
1765209|NCT00770913|6149307|P3|Overall Study|Adverse Event|6
1765210|NCT00770913|6149308|P2|Overall Study|Adverse Event|3
1765211|NCT00770913|6149309|P1|Overall Study|Adverse Event|1
1765212|NCT00770809|6149342|P3|Overall Study|Other Medical Reasons|3
1765213|NCT00770809|6149343|P2|Overall Study|Other Medical Reasons|4
1765214|NCT00770809|6149344|P1|Overall Study|Other Medical Reasons|2
1765215|NCT00770809|6149342|P3|Overall Study|Complicating illness|1
1765216|NCT00770809|6149343|P2|Overall Study|Complicating illness|0
1765217|NCT00770809|6149344|P1|Overall Study|Complicating illness|0
1765218|NCT00770809|6149342|P3|Overall Study|Progression|0
1765219|NCT00770809|6149343|P2|Overall Study|Progression|2
1765220|NCT00770809|6149344|P1|Overall Study|Progression|2
1765221|NCT00770809|6149342|P3|Overall Study|Withdrawal by Subject|7
1765222|NCT00770809|6149343|P2|Overall Study|Withdrawal by Subject|3
1765223|NCT00770809|6149344|P1|Overall Study|Withdrawal by Subject|3
1765224|NCT00770809|6149342|P3|Overall Study|Death|0
1765225|NCT00770809|6149343|P2|Overall Study|Death|0
1765226|NCT00770809|6149344|P1|Overall Study|Death|1
1765227|NCT00770809|6149342|P3|Overall Study|Adverse Event|12
1765228|NCT00770809|6149343|P2|Overall Study|Adverse Event|1
1765229|NCT00770809|6149344|P1|Overall Study|Adverse Event|9
1765230|NCT00770770|6149354|P2|Overall Study|Study Terminated|0
1765231|NCT00770770|6149355|P1|Overall Study|Study Terminated|8
1765232|NCT00770770|6149354|P2|Overall Study|Death|1
1765233|NCT00770770|6149355|P1|Overall Study|Death|0
1765234|NCT00770770|6149354|P2|Overall Study|Withdrawal by Subject|0
1765235|NCT00770770|6149355|P1|Overall Study|Withdrawal by Subject|1
1765236|NCT00770770|6149354|P2|Overall Study|Lost to Follow-up|0
1765237|NCT00770770|6149355|P1|Overall Study|Lost to Follow-up|1
1765238|NCT00770692|6149373|P4|Overall Study|Investigator judgment|1
1765239|NCT00770692|6149374|P3|Overall Study|Investigator judgment|1
1765240|NCT00770692|6149375|P2|Overall Study|Investigator judgment|0
1765241|NCT00770692|6149376|P1|Overall Study|Investigator judgment|2
1765242|NCT00770692|6149373|P4|Overall Study|Adverse Event|4
1765243|NCT00770692|6149374|P3|Overall Study|Adverse Event|4
1765244|NCT00770692|6149375|P2|Overall Study|Adverse Event|0
1765245|NCT00770692|6149376|P1|Overall Study|Adverse Event|3
1765246|NCT00770692|6149373|P4|Overall Study|Withdrawal by Subject|6
1765247|NCT00770692|6149374|P3|Overall Study|Withdrawal by Subject|9
1765248|NCT00770692|6149375|P2|Overall Study|Withdrawal by Subject|9
1765249|NCT00770692|6149376|P1|Overall Study|Withdrawal by Subject|7
1765250|NCT00770679|6149402|P1|Overall Study|Follow-up LDL measurement not collected|3
1765251|NCT00770679|6149402|P1|Overall Study|Lost to Follow-up|3
1765252|NCT00770653|6149410|P2|Overall Study|Physician Decision|0
1765253|NCT00770653|6149411|P1|Overall Study|Physician Decision|1
1765254|NCT00770653|6149410|P2|Overall Study|Lost to Follow-up|2
1765255|NCT00770653|6149411|P1|Overall Study|Lost to Follow-up|1
1765256|NCT00770653|6149410|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
1765257|NCT00770653|6149411|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
1765258|NCT00770653|6149410|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
1765259|NCT00770653|6149411|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
1765260|NCT00770653|6149410|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
1765261|NCT00770653|6149411|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
1765262|NCT00770653|6149410|P2|Overall Study|Lack of Compliance|4
1765263|NCT00770653|6149411|P1|Overall Study|Lack of Compliance|1
1765264|NCT00770653|6149410|P2|Overall Study|Withdrawal by Subject|7
1765265|NCT00770653|6149411|P1|Overall Study|Withdrawal by Subject|4
1765266|NCT00770653|6149410|P2|Overall Study|Protocol Violation|6
1765267|NCT00770653|6149411|P1|Overall Study|Protocol Violation|8
1765268|NCT00770653|6149410|P2|Overall Study|Adverse Event|5
1765269|NCT00770653|6149411|P1|Overall Study|Adverse Event|13
1765270|NCT00770588|6149481|P2|Overall Study|Withdrawal by Subject|1
1765271|NCT00770588|6149482|P1|Overall Study|Withdrawal by Subject|1
1765272|NCT00770588|6149481|P2|Overall Study|Lost to Follow-up|1
1765273|NCT00770588|6149482|P1|Overall Study|Lost to Follow-up|1
1765274|NCT00770588|6149481|P2|Overall Study|Death caused by progression of disease|91
1765275|NCT00770588|6149482|P1|Overall Study|Death caused by progression of disease|70
1765276|NCT00770588|6149481|P2|Overall Study|Adverse Event|2
1765277|NCT00770588|6149482|P1|Overall Study|Adverse Event|9
1765278|NCT00770562|6149498|P2|Overall Study|Did not take treatment|1
1765279|NCT00770562|6149499|P1|Overall Study|Did not take treatment|1
1765280|NCT00770510|6149510|P1|Overall Study|Withdrawal by Subject|2
1765281|NCT00770510|6149510|P1|Overall Study|Pregnancy|1
1765282|NCT00770510|6149510|P1|Overall Study|Lost to Follow-up|2
1765283|NCT00770484|6149549|P2|Overall Study|Withdrawal by Subject|0
1765284|NCT00770484|6149550|P1|Overall Study|Withdrawal by Subject|1
1765285|NCT00770432|6149558|P2|Overall Study|Non-compliance|1
1765286|NCT00770432|6149559|P1|Overall Study|Non-compliance|0
1765287|NCT00770432|6149558|P2|Overall Study|Other|6
1765288|NCT00770432|6149559|P1|Overall Study|Other|4
1765289|NCT00770367|6149567|P2|Second Intervention|Lost to Follow-up|0
1765290|NCT00770367|6149568|P1|Second Intervention|Lost to Follow-up|2
1765291|NCT00770367|6149567|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
1765292|NCT00770367|6149568|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
1765293|NCT00770367|6149567|P2|First Intervention|Withdrawal by Subject|2
1765294|NCT00770367|6149568|P1|First Intervention|Withdrawal by Subject|0
1765295|NCT00770341|6149579|P3|Overall Study|Not treated|0
1765296|NCT00770341|6149580|P2|Overall Study|Not treated|0
1765297|NCT00770341|6149581|P1|Overall Study|Not treated|1
1765298|NCT00770341|6149579|P3|Overall Study|Other|0
1765299|NCT00770341|6149580|P2|Overall Study|Other|0
1765300|NCT00770341|6149581|P1|Overall Study|Other|1
1765301|NCT00770341|6149579|P3|Overall Study|Lack of Efficacy|1
1765302|NCT00770341|6149580|P2|Overall Study|Lack of Efficacy|0
1765303|NCT00770341|6149581|P1|Overall Study|Lack of Efficacy|3
1765304|NCT00770341|6149579|P3|Overall Study|Laboratory adverse event|0
1765305|NCT00770341|6149580|P2|Overall Study|Laboratory adverse event|3
1765306|NCT00770341|6149581|P1|Overall Study|Laboratory adverse event|3
1765307|NCT00770341|6149579|P3|Overall Study|Clinical Adverse Event|2
1765308|NCT00770341|6149580|P2|Overall Study|Clinical Adverse Event|1
1765309|NCT00770341|6149581|P1|Overall Study|Clinical Adverse Event|3
1765310|NCT00770341|6149579|P3|Overall Study|Withdrawal by Subject|0
1765311|NCT00770341|6149580|P2|Overall Study|Withdrawal by Subject|1
1765312|NCT00770341|6149581|P1|Overall Study|Withdrawal by Subject|0
1765313|NCT00770341|6149579|P3|Overall Study|Did not meet eligibility criteria|0
1765314|NCT00770341|6149580|P2|Overall Study|Did not meet eligibility criteria|0
1765315|NCT00770341|6149581|P1|Overall Study|Did not meet eligibility criteria|1
1765316|NCT00770328|6149607|P2|Overall Study|Lost to Follow-up|2
1765317|NCT00770328|6149608|P1|Overall Study|Lost to Follow-up|2
1765318|NCT00770328|6149607|P2|Overall Study|Adverse Event|2
1765319|NCT00770328|6149608|P1|Overall Study|Adverse Event|11
1765320|NCT00770315|6149624|P4|Overall Study|Noncompliance with Protocol|9
1765321|NCT00770315|6149625|P3|Overall Study|Noncompliance with Protocol|7
1765322|NCT00770315|6149626|P2|Overall Study|Noncompliance with Protocol|4
1765323|NCT00770315|6149627|P1|Overall Study|Noncompliance with Protocol|7
1765324|NCT00770315|6149624|P4|Overall Study|Withdrawal by Subject|20
1765325|NCT00770315|6149625|P3|Overall Study|Withdrawal by Subject|24
1765326|NCT00770315|6149626|P2|Overall Study|Withdrawal by Subject|17
1765327|NCT00770315|6149627|P1|Overall Study|Withdrawal by Subject|13
1765328|NCT00770315|6149624|P4|Overall Study|Lost to Follow-up|3
1765329|NCT00770315|6149625|P3|Overall Study|Lost to Follow-up|10
1765330|NCT00770315|6149626|P2|Overall Study|Lost to Follow-up|5
1765331|NCT00770315|6149627|P1|Overall Study|Lost to Follow-up|9
1765332|NCT00770315|6149624|P4|Overall Study|Adverse Event|6
1765333|NCT00770315|6149625|P3|Overall Study|Adverse Event|16
1765334|NCT00770315|6149626|P2|Overall Study|Adverse Event|17
1765335|NCT00770315|6149627|P1|Overall Study|Adverse Event|11
1765336|NCT00770289|6149653|P1|Overall Study|Other|6
1765337|NCT00770224|6149662|P2|Step 2: Maintenance|Ineligible|2
1765338|NCT00770224|6149663|P1|Step 2: Maintenance|Ineligible|0
1765339|NCT00770224|6149662|P2|Step 2: Maintenance|Other reason not protocol specified|7
1765340|NCT00770224|6149663|P1|Step 2: Maintenance|Other reason not protocol specified|0
1765341|NCT00770224|6149662|P2|Step 2: Maintenance|Death|2
1765342|NCT00770224|6149663|P1|Step 2: Maintenance|Death|0
1765343|NCT00770224|6149662|P2|Step 2: Maintenance|Progression/relapse|1
1765344|NCT00770224|6149663|P1|Step 2: Maintenance|Progression/relapse|0
1765345|NCT00770224|6149662|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
1765346|NCT00770224|6149663|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
1765347|NCT00770224|6149662|P2|Step 2: Maintenance|Adverse Event|10
1765348|NCT00770224|6149663|P1|Step 2: Maintenance|Adverse Event|0
1765349|NCT00770224|6149662|P2|Step 1: Induction|No protocol treatment given|0
1765350|NCT00770224|6149663|P1|Step 1: Induction|No protocol treatment given|1
1765351|NCT00770224|6149662|P2|Step 1: Induction|Ineligible|0
1765352|NCT00770224|6149663|P1|Step 1: Induction|Ineligible|2
1765353|NCT00770224|6149662|P2|Step 1: Induction|Other reason not protocol specified|0
1765354|NCT00770224|6149663|P1|Step 1: Induction|Other reason not protocol specified|2
1765355|NCT00770224|6149662|P2|Step 1: Induction|Refusal unrelated to adverse event|0
1765356|NCT00770224|6149663|P1|Step 1: Induction|Refusal unrelated to adverse event|6
1765357|NCT00770224|6149662|P2|Step 1: Induction|Adverse Event|0
1765358|NCT00770224|6149663|P1|Step 1: Induction|Adverse Event|3
1765359|NCT00770211|6149675|P2|Overall Study|Withdrawal by Subject|2
1765360|NCT00770211|6149676|P1|Overall Study|Withdrawal by Subject|0
1765361|NCT00770211|6149675|P2|Overall Study|Lost to Follow-up|0
1765362|NCT00770211|6149676|P1|Overall Study|Lost to Follow-up|1
1765363|NCT00770146|6149692|P2|Follow-up Period|Other|5
1765364|NCT00770146|6149693|P1|Follow-up Period|Other|4
1765365|NCT00770146|6149692|P2|Follow-up Period|Adverse Event|2
1765366|NCT00770146|6149693|P1|Follow-up Period|Adverse Event|0
1765367|NCT00770146|6149692|P2|Follow-up Period|Withdrawal by Subject|13
1765368|NCT00770146|6149693|P1|Follow-up Period|Withdrawal by Subject|7
1765369|NCT00770146|6149692|P2|Treatment Period|Protocol non-compliance|1
1765370|NCT00770146|6149693|P1|Treatment Period|Protocol non-compliance|0
1765371|NCT00770146|6149692|P2|Treatment Period|Other|5
1765372|NCT00770146|6149693|P1|Treatment Period|Other|1
1765373|NCT00770146|6149692|P2|Treatment Period|Adverse Event|26
1765374|NCT00770146|6149693|P1|Treatment Period|Adverse Event|2
1765375|NCT00770146|6149692|P2|Treatment Period|Withdrawal by Subject|13
1765376|NCT00770146|6149693|P1|Treatment Period|Withdrawal by Subject|6
1765377|NCT00770120|6149737|P1|Overall Study|Reason under Review|1
1765378|NCT00770120|6149737|P1|Overall Study|Never Received Treatment/Not Analyzable|1
1765379|NCT00770120|6149737|P1|Overall Study|Ineligible|1
1765380|NCT00770120|6149737|P1|Overall Study|Withdrawal by Subject|2
1765381|NCT00770120|6149737|P1|Overall Study|Death|3
1765382|NCT00770120|6149737|P1|Overall Study|Not Protocol Specified|11
1765383|NCT00770120|6149737|P1|Overall Study|Adverse Event|11
1765384|NCT00770120|6149737|P1|Overall Study|Progression|31
1765385|NCT00770029|6149746|P2|Overall Study|Adverse Event|0
1765386|NCT00770029|6149747|P1|Overall Study|Adverse Event|1
1765387|NCT00770029|6149746|P2|Overall Study|Withdrawal by Subject|3
1765388|NCT00770029|6149747|P1|Overall Study|Withdrawal by Subject|3
1765389|NCT00770029|6149746|P2|Overall Study|Lost to Follow-up|0
1765390|NCT00770029|6149747|P1|Overall Study|Lost to Follow-up|2
1765391|NCT00769860|6149763|P2|Overall Study|Withdrawal by Subject|0
1765392|NCT00769860|6149764|P1|Overall Study|Withdrawal by Subject|2
1765393|NCT00769704|6149792|P2|Overall Study|Other|2
1765394|NCT00769704|6149793|P1|Overall Study|Other|1
1765395|NCT00769704|6149792|P2|Overall Study|Withdrawal by Subject|5
1765396|NCT00769704|6149793|P1|Overall Study|Withdrawal by Subject|12
1765397|NCT00769704|6149792|P2|Overall Study|Death|190
1765398|NCT00769704|6149793|P1|Overall Study|Death|95
1765399|NCT00769704|6149792|P2|Overall Study|Lost to Follow-up|2
1765400|NCT00769704|6149793|P1|Overall Study|Lost to Follow-up|3
1765401|NCT00769561|6149843|P2|Overall Study|Lost to Follow-up|3
1765402|NCT00769561|6149844|P1|Overall Study|Lost to Follow-up|1
1765403|NCT00769561|6149843|P2|Overall Study|Withdrawal by Subject|2
1765404|NCT00769561|6149844|P1|Overall Study|Withdrawal by Subject|2
1765405|NCT00769483|6149870|P6|Overall Study|Withdrawal by Subject|0
1765406|NCT00769483|6149871|P5|Overall Study|Withdrawal by Subject|1
1765407|NCT00769483|6149872|P4|Overall Study|Withdrawal by Subject|0
1765408|NCT00769483|6149873|P3|Overall Study|Withdrawal by Subject|0
1765409|NCT00769483|6149874|P2|Overall Study|Withdrawal by Subject|1
1765410|NCT00769483|6149875|P1|Overall Study|Withdrawal by Subject|0
1765411|NCT00769184|6149947|P2|No Treatment (6 Weeks)|Adverse Event|1
1765412|NCT00769184|6149948|P1|No Treatment (6 Weeks)|Adverse Event|1
1765413|NCT00769184|6149947|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
1765414|NCT00769184|6149948|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
1765415|NCT00769184|6149947|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
1765416|NCT00769184|6149948|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
1765417|NCT00769132|6149956|P4|Period 4|Withdrawal by Subject|0
1765418|NCT00769132|6149957|P3|Period 4|Withdrawal by Subject|0
1765419|NCT00769132|6149958|P2|Period 4|Withdrawal by Subject|1
1765420|NCT00769132|6149959|P1|Period 4|Withdrawal by Subject|0
1765421|NCT00769132|6149956|P4|Period 3|Withdrawal by Subject|0
1765422|NCT00769132|6149957|P3|Period 3|Withdrawal by Subject|0
1765423|NCT00769132|6149958|P2|Period 3|Withdrawal by Subject|0
1765424|NCT00769132|6149959|P1|Period 3|Withdrawal by Subject|1
1765425|NCT00769132|6149956|P4|Period 2|Withdrawal by Subject|1
1765426|NCT00769132|6149957|P3|Period 2|Withdrawal by Subject|0
1765427|NCT00769132|6149958|P2|Period 2|Withdrawal by Subject|0
1765428|NCT00769132|6149959|P1|Period 2|Withdrawal by Subject|0
1765429|NCT00769132|6149956|P4|Period 1|Adverse Event|1
1765430|NCT00769132|6149957|P3|Period 1|Adverse Event|0
1765431|NCT00769132|6149958|P2|Period 1|Adverse Event|0
1765432|NCT00769132|6149959|P1|Period 1|Adverse Event|1
1765433|NCT00769119|6149975|P2|Overall Study|Disallowed medication|0
1765434|NCT00769119|6149976|P1|Overall Study|Disallowed medication|1
1765435|NCT00769119|6149975|P2|Overall Study|Adverse Event|1
1765436|NCT00769119|6149976|P1|Overall Study|Adverse Event|1
1765437|NCT00769119|6149975|P2|Overall Study|Voluntary discontinuation|2
1765438|NCT00769119|6149976|P1|Overall Study|Voluntary discontinuation|0
1765439|NCT00769067|6150022|P2|Overall Study|Withdrawal by Subject|1
1765440|NCT00769067|6150023|P1|Overall Study|Withdrawal by Subject|0
1765441|NCT00769067|6150022|P2|Overall Study|Other|3
1765442|NCT00769067|6150023|P1|Overall Study|Other|1
1765443|NCT00769067|6150022|P2|Overall Study|Study terminated by sponsor|3
1765444|NCT00769067|6150023|P1|Overall Study|Study terminated by sponsor|1
1765445|NCT00769067|6150022|P2|Overall Study|Lost to Follow-up|1
1765446|NCT00769067|6150023|P1|Overall Study|Lost to Follow-up|3
1765447|NCT00769067|6150022|P2|Overall Study|Death|86
1765448|NCT00769067|6150023|P1|Overall Study|Death|89
1765449|NCT00768989|6150071|P2|On or After Week 36|Sponsor Termination|26
1765450|NCT00768989|6150072|P1|On or After Week 36|Sponsor Termination|45
1765451|NCT00768989|6150071|P2|On or After Week 36|Did not attend termination visit|0
1765452|NCT00768989|6150072|P1|On or After Week 36|Did not attend termination visit|2
1765453|NCT00768989|6150071|P2|On or After Week 36|Protocol Violation|0
1765454|NCT00768989|6150072|P1|On or After Week 36|Protocol Violation|1
1765455|NCT00768989|6150071|P2|On or After Week 36|Poor Compliance|0
1765456|NCT00768989|6150072|P1|On or After Week 36|Poor Compliance|1
1765457|NCT00768989|6150071|P2|On or After Week 36|Lost to Follow-up|0
1765458|NCT00768989|6150072|P1|On or After Week 36|Lost to Follow-up|1
1765459|NCT00768989|6150071|P2|On or After Week 36|Adverse Event|1
1765460|NCT00768989|6150072|P1|On or After Week 36|Adverse Event|0
1765461|NCT00768989|6150071|P2|On or After Week 36|Lack of Efficacy|0
1765462|NCT00768989|6150072|P1|On or After Week 36|Lack of Efficacy|1
1765463|NCT00768989|6150071|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
1765464|NCT00768989|6150072|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
1765465|NCT00768989|6150071|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
1765466|NCT00768989|6150072|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
1765467|NCT00768989|6150071|P2|Week 24 to Prior to Week 36|Adverse Event|0
1765468|NCT00768989|6150072|P1|Week 24 to Prior to Week 36|Adverse Event|1
1765469|NCT00768989|6150071|P2|Prior to Week 24|Protocol Violation|2
1765470|NCT00768989|6150072|P1|Prior to Week 24|Protocol Violation|0
1765471|NCT00768989|6150071|P2|Prior to Week 24|Lost to Follow-up|1
1765472|NCT00768989|6150072|P1|Prior to Week 24|Lost to Follow-up|0
1765473|NCT00768989|6150071|P2|Prior to Week 24|Adverse Event|0
1765474|NCT00768989|6150072|P1|Prior to Week 24|Adverse Event|3
1765475|NCT00768989|6150071|P2|Prior to Week 24|Withdrawal by Subject|0
1765476|NCT00768989|6150072|P1|Prior to Week 24|Withdrawal by Subject|1
1765477|NCT00768898|6150120|P1|Overall Study|Headache|1
1765478|NCT00768898|6150120|P1|Overall Study|Unrelated injury|1
1765479|NCT00768755|6150144|P4|Phase 2|Randomized but not treated|2
1765480|NCT00768755|6150145|P3|Phase 2|Randomized but not treated|0
1765481|NCT00768755|6150146|P2|Phase 2|Randomized but not treated|0
1765482|NCT00768755|6150147|P1|Phase 2|Randomized but not treated|0
1765483|NCT00768755|6150144|P4|Phase 2|Study Terminated by Sponsor|14
1765484|NCT00768755|6150145|P3|Phase 2|Study Terminated by Sponsor|7
1765485|NCT00768755|6150146|P2|Phase 2|Study Terminated by Sponsor|13
1765486|NCT00768755|6150147|P1|Phase 2|Study Terminated by Sponsor|0
1765487|NCT00768755|6150144|P4|Phase 2|Other|4
1765488|NCT00768755|6150145|P3|Phase 2|Other|2
1765489|NCT00768755|6150146|P2|Phase 2|Other|1
1765490|NCT00768755|6150147|P1|Phase 2|Other|0
1765491|NCT00768755|6150144|P4|Phase 2|Withdrawal by Subject|1
1765492|NCT00768755|6150145|P3|Phase 2|Withdrawal by Subject|0
1765493|NCT00768755|6150146|P2|Phase 2|Withdrawal by Subject|1
1765494|NCT00768755|6150147|P1|Phase 2|Withdrawal by Subject|0
1765495|NCT00768755|6150144|P4|Phase 2|Lost to Follow-up|4
1765496|NCT00768755|6150145|P3|Phase 2|Lost to Follow-up|1
1765497|NCT00768755|6150146|P2|Phase 2|Lost to Follow-up|1
1765498|NCT00768755|6150147|P1|Phase 2|Lost to Follow-up|0
1765499|NCT00768755|6150144|P4|Phase 2|Protocol Violation|1
1765500|NCT00768755|6150145|P3|Phase 2|Protocol Violation|0
1765501|NCT00768755|6150146|P2|Phase 2|Protocol Violation|2
1765502|NCT00768755|6150147|P1|Phase 2|Protocol Violation|0
1765503|NCT00768755|6150144|P4|Phase 2|Death|31
1765504|NCT00768755|6150145|P3|Phase 2|Death|48
1765505|NCT00768755|6150146|P2|Phase 2|Death|37
1765506|NCT00768755|6150147|P1|Phase 2|Death|0
1765507|NCT00768755|6150144|P4|Phase 1|Other|0
1765508|NCT00768755|6150145|P3|Phase 1|Other|0
1765509|NCT00768755|6150146|P2|Phase 1|Other|0
1765510|NCT00768755|6150147|P1|Phase 1|Other|4
1765511|NCT00768755|6150144|P4|Phase 1|Death|0
1765512|NCT00768755|6150145|P3|Phase 1|Death|0
1765513|NCT00768755|6150146|P2|Phase 1|Death|0
1765514|NCT00768755|6150147|P1|Phase 1|Death|6
1765515|NCT00768651|6150195|P1|Overall Study|Withdrawal by Subject|1
1765516|NCT00768560|6150234|P6|Intervention Set 1|Adverse Event|0
1765517|NCT00768560|6150235|P5|Intervention Set 1|Adverse Event|0
1765518|NCT00768560|6150236|P4|Intervention Set 1|Adverse Event|0
1765519|NCT00768560|6150237|P3|Intervention Set 1|Adverse Event|0
1765520|NCT00768560|6150238|P2|Intervention Set 1|Adverse Event|1
1765521|NCT00768560|6150239|P1|Intervention Set 1|Adverse Event|0
1765522|NCT00768469|6150276|P2|Overall Study|Withdrawal by Subject|1
1765523|NCT00768469|6150277|P1|Overall Study|Withdrawal by Subject|0
1765524|NCT00768469|6150276|P2|Overall Study|Disease Progression|4
1765525|NCT00768469|6150277|P1|Overall Study|Disease Progression|3
1765526|NCT00768469|6150276|P2|Overall Study|Adverse Event|2
1765527|NCT00768469|6150277|P1|Overall Study|Adverse Event|0
1765528|NCT00768430|6150292|P2|7 Day Endpoint|Withdrawal by Subject|3
1765529|NCT00768430|6150293|P1|7 Day Endpoint|Withdrawal by Subject|2
1765530|NCT00768300|6150301|P2|Overall Study|Missing data|0
1765531|NCT00768300|6150302|P1|Overall Study|Missing data|1
1765532|NCT00768300|6150301|P2|Overall Study|Treated but never dosed with Study drug|0
1765533|NCT00768300|6150302|P1|Overall Study|Treated but never dosed with Study drug|1
1765534|NCT00768300|6150301|P2|Overall Study|Began prohibited concomitant medication|1
1765535|NCT00768300|6150302|P1|Overall Study|Began prohibited concomitant medication|0
1765536|NCT00768300|6150301|P2|Overall Study|Lost to Follow-up|1
1765537|NCT00768300|6150302|P1|Overall Study|Lost to Follow-up|0
1765538|NCT00768300|6150301|P2|Overall Study|Received lung transplant|1
1765539|NCT00768300|6150302|P1|Overall Study|Received lung transplant|1
1765540|NCT00768300|6150301|P2|Overall Study|Screen failure following randomization|0
1765541|NCT00768300|6150302|P1|Overall Study|Screen failure following randomization|1
1765542|NCT00768300|6150301|P2|Overall Study|Subject moved to pursue lung transplant|1
1765543|NCT00768300|6150302|P1|Overall Study|Subject moved to pursue lung transplant|1
1765544|NCT00768300|6150301|P2|Overall Study|Death|5
1765545|NCT00768300|6150302|P1|Overall Study|Death|21
1765546|NCT00768300|6150301|P2|Overall Study|Study discontinued by Sponsor|140
1765547|NCT00768300|6150302|P1|Overall Study|Study discontinued by Sponsor|271
1765548|NCT00768300|6150301|P2|Overall Study|Physician Decision|3
1765549|NCT00768300|6150302|P1|Overall Study|Physician Decision|2
1765550|NCT00768300|6150301|P2|Overall Study|Withdrawal by Subject|7
1765551|NCT00768300|6150302|P1|Overall Study|Withdrawal by Subject|13
1765552|NCT00768300|6150301|P2|Overall Study|Protocol Violation|1
1765553|NCT00768300|6150302|P1|Overall Study|Protocol Violation|6
1765554|NCT00768300|6150301|P2|Overall Study|Adverse Event|2
1765555|NCT00768300|6150302|P1|Overall Study|Adverse Event|10
1765556|NCT00768300|6150301|P2|Overall Study|Randomized but not treated|1
1765557|NCT00768300|6150302|P1|Overall Study|Randomized but not treated|1
1765558|NCT00768248|6150386|P2|Overall Study|Research coordinator didn't collect data|1
1765559|NCT00768248|6150387|P1|Overall Study|Research coordinator didn't collect data|1
1765560|NCT00768222|6150403|P2|Overall Study|Protocol Violation|2
1765561|NCT00768222|6150404|P1|Overall Study|Protocol Violation|0
1765562|NCT00768222|6150403|P2|Overall Study|Withdrawal by Subject|1
1765563|NCT00768222|6150404|P1|Overall Study|Withdrawal by Subject|3
1765564|NCT00768222|6150403|P2|Overall Study|Lost to Follow-up|1
1765565|NCT00768222|6150404|P1|Overall Study|Lost to Follow-up|1
1765566|NCT00768144|6150426|P1|Overall Study|Pt Withdrew Consent|1
1765567|NCT00768144|6150426|P1|Overall Study|Patient or MD Decision to End Treatment|1
1765568|NCT00768144|6150426|P1|Overall Study|Progressive Disease|21
1765569|NCT00768144|6150426|P1|Overall Study|Adverse Event|13
1765570|NCT00768066|6150439|P3|Overall Study|Did not receive study product injection.|0
1765571|NCT00768066|6150440|P2|Overall Study|Did not receive study product injection.|3
1765572|NCT00768066|6150441|P1|Overall Study|Did not receive study product injection.|3
1765573|NCT00768053|6150473|P1|Overall Study|Lost to Follow-up|1
1765574|NCT00768053|6150473|P1|Overall Study|Adverse Event|10
1765575|NCT00768040|6150504|P2|Overall Study|Abnormal laboratory value|1
1765576|NCT00768040|6150505|P1|Overall Study|Abnormal laboratory value|1
1765577|NCT00768040|6150504|P2|Overall Study|Adverse Event|2
1765578|NCT00768040|6150505|P1|Overall Study|Adverse Event|3
1765579|NCT00767819|6150514|P3|Overall Study|Lost to Follow-up|0
1765580|NCT00767819|6150515|P2|Overall Study|Lost to Follow-up|0
1765581|NCT00767819|6150516|P1|Overall Study|Lost to Follow-up|1
1765582|NCT00767819|6150514|P3|Overall Study|Abnormal lab values|0
1765583|NCT00767819|6150515|P2|Overall Study|Abnormal lab values|0
1765584|NCT00767819|6150516|P1|Overall Study|Abnormal lab values|1
1765585|NCT00767819|6150514|P3|Overall Study|Adverse Event|0
1765586|NCT00767819|6150515|P2|Overall Study|Adverse Event|0
1765587|NCT00767819|6150516|P1|Overall Study|Adverse Event|2
1765588|NCT00767819|6150514|P3|Overall Study|Death|0
1765589|NCT00767819|6150515|P2|Overall Study|Death|3
1765590|NCT00767819|6150516|P1|Overall Study|Death|2
1765591|NCT00767819|6150514|P3|Overall Study|Administrative problems|0
1765592|NCT00767819|6150515|P2|Overall Study|Administrative problems|1
1765593|NCT00767819|6150516|P1|Overall Study|Administrative problems|0
1765594|NCT00767819|6150514|P3|Overall Study|Withdrawal by Subject|0
1765595|NCT00767819|6150515|P2|Overall Study|Withdrawal by Subject|1
1765596|NCT00767819|6150516|P1|Overall Study|Withdrawal by Subject|1
1765597|NCT00767819|6150514|P3|Overall Study|Unsatisfactory therapeutic effect|0
1765598|NCT00767819|6150515|P2|Overall Study|Unsatisfactory therapeutic effect|14
1765599|NCT00767819|6150516|P1|Overall Study|Unsatisfactory therapeutic effect|18
1765600|NCT00767806|6150541|P2|Overall Study|Sponsor Decision|1
1765601|NCT00767806|6150542|P1|Overall Study|Sponsor Decision|0
1765602|NCT00767806|6150541|P2|Overall Study|Entry Criteria Not Met|1
1765603|NCT00767806|6150542|P1|Overall Study|Entry Criteria Not Met|1
1765604|NCT00767806|6150541|P2|Overall Study|Lost to Follow-up|4
1765605|NCT00767806|6150542|P1|Overall Study|Lost to Follow-up|1
1765606|NCT00767806|6150541|P2|Overall Study|Physician Decision|3
1765607|NCT00767806|6150542|P1|Overall Study|Physician Decision|4
1765608|NCT00767806|6150541|P2|Overall Study|Lack of Efficacy|9
1765609|NCT00767806|6150542|P1|Overall Study|Lack of Efficacy|1
1765610|NCT00767806|6150541|P2|Overall Study|Protocol Violation|5
1765611|NCT00767806|6150542|P1|Overall Study|Protocol Violation|6
1765612|NCT00767806|6150541|P2|Overall Study|Withdrawal by Subject|13
1765613|NCT00767806|6150542|P1|Overall Study|Withdrawal by Subject|8
1765614|NCT00767806|6150541|P2|Overall Study|Adverse Event|11
1765615|NCT00767806|6150542|P1|Overall Study|Adverse Event|30
1765616|NCT00767676|6150619|P1|Overall Study|Investigator error|54
1765617|NCT00767520|6150642|P2|Overall Study|Randomized in error and Never treated|2
1765618|NCT00767520|6150643|P1|Overall Study|Randomized in error and Never treated|0
1765619|NCT00767520|6150642|P2|Overall Study|Participants still on treatment|15
1765620|NCT00767520|6150643|P1|Overall Study|Participants still on treatment|11
1765621|NCT00767455|6150696|P1|Overall Study|Investigator error|19
1765622|NCT00767325|6150730|P1|Overall Study|Missed visit due to family reasons|1
1765623|NCT00767325|6150730|P1|Overall Study|No longer met study criteria|2
1765624|NCT00767325|6150730|P1|Overall Study|Lost to Follow-up|3
1765625|NCT00767325|6150730|P1|Overall Study|Adverse Event|7
1765626|NCT00767325|6150730|P1|Overall Study|Lack of Efficacy|2
1765627|NCT00767104|6150741|P2|Overall Study|Lost to Follow-up|2
1765628|NCT00767104|6150742|P1|Overall Study|Lost to Follow-up|1
1765629|NCT00767039|6150752|P2|Overall Study|Death|2
1765630|NCT00767039|6150753|P1|Overall Study|Death|5
1765631|NCT00767000|6150784|P5|Optional 104-week Extension|Study terminated by sponsor|4
1765632|NCT00767000|6150785|P4|Optional 104-week Extension|Study terminated by sponsor|2
1765633|NCT00767000|6150786|P3|Optional 104-week Extension|Study terminated by sponsor|7
1765634|NCT00767000|6150787|P2|Optional 104-week Extension|Study terminated by sponsor|3
1765635|NCT00767000|6150788|P1|Optional 104-week Extension|Study terminated by sponsor|7
1765636|NCT00767000|6150784|P5|54-week Study|Reason not reported|0
1765637|NCT00767000|6150785|P4|54-week Study|Reason not reported|1
1765638|NCT00767000|6150786|P3|54-week Study|Reason not reported|0
1765639|NCT00767000|6150787|P2|54-week Study|Reason not reported|0
1765640|NCT00767000|6150788|P1|54-week Study|Reason not reported|0
1765641|NCT00767000|6150784|P5|54-week Study|Study terminated by sponsor|194
1765642|NCT00767000|6150785|P4|54-week Study|Study terminated by sponsor|196
1765643|NCT00767000|6150786|P3|54-week Study|Study terminated by sponsor|89
1765644|NCT00767000|6150787|P2|54-week Study|Study terminated by sponsor|102
1765645|NCT00767000|6150788|P1|54-week Study|Study terminated by sponsor|90
1765646|NCT00767000|6150784|P5|54-week Study|Withdrawal by Subject|13
1765647|NCT00767000|6150785|P4|54-week Study|Withdrawal by Subject|11
1765648|NCT00767000|6150786|P3|54-week Study|Withdrawal by Subject|5
1765649|NCT00767000|6150787|P2|54-week Study|Withdrawal by Subject|3
1765650|NCT00767000|6150788|P1|54-week Study|Withdrawal by Subject|2
1765651|NCT00767000|6150784|P5|54-week Study|Protocol Violation|0
1765652|NCT00767000|6150785|P4|54-week Study|Protocol Violation|2
1765653|NCT00767000|6150786|P3|54-week Study|Protocol Violation|1
1765654|NCT00767000|6150787|P2|54-week Study|Protocol Violation|0
1765655|NCT00767000|6150788|P1|54-week Study|Protocol Violation|0
1765656|NCT00767000|6150784|P5|54-week Study|Progressive disease|0
1765657|NCT00767000|6150785|P4|54-week Study|Progressive disease|0
1765658|NCT00767000|6150786|P3|54-week Study|Progressive disease|1
1765659|NCT00767000|6150787|P2|54-week Study|Progressive disease|0
1765660|NCT00767000|6150788|P1|54-week Study|Progressive disease|0
1765661|NCT00767000|6150784|P5|54-week Study|Physician Decision|1
1765662|NCT00767000|6150785|P4|54-week Study|Physician Decision|1
1765663|NCT00767000|6150786|P3|54-week Study|Physician Decision|1
1765664|NCT00767000|6150787|P2|54-week Study|Physician Decision|0
1765665|NCT00767000|6150788|P1|54-week Study|Physician Decision|4
1765666|NCT00767000|6150784|P5|54-week Study|Lost to Follow-up|2
1765667|NCT00767000|6150785|P4|54-week Study|Lost to Follow-up|4
1765668|NCT00767000|6150786|P3|54-week Study|Lost to Follow-up|1
1765669|NCT00767000|6150787|P2|54-week Study|Lost to Follow-up|0
1765670|NCT00767000|6150788|P1|54-week Study|Lost to Follow-up|4
1765671|NCT00767000|6150784|P5|54-week Study|Lack of Efficacy|5
1765672|NCT00767000|6150785|P4|54-week Study|Lack of Efficacy|0
1765673|NCT00767000|6150786|P3|54-week Study|Lack of Efficacy|1
1765674|NCT00767000|6150787|P2|54-week Study|Lack of Efficacy|0
1765675|NCT00767000|6150788|P1|54-week Study|Lack of Efficacy|2
1765676|NCT00767000|6150784|P5|54-week Study|Interruption of study medication|0
1765677|NCT00767000|6150785|P4|54-week Study|Interruption of study medication|0
1765678|NCT00767000|6150786|P3|54-week Study|Interruption of study medication|1
1765679|NCT00767000|6150787|P2|54-week Study|Interruption of study medication|0
1765680|NCT00767000|6150788|P1|54-week Study|Interruption of study medication|0
1765681|NCT00767000|6150784|P5|54-week Study|Hypoglycemia|0
1765682|NCT00767000|6150785|P4|54-week Study|Hypoglycemia|0
1765683|NCT00767000|6150786|P3|54-week Study|Hypoglycemia|0
1765684|NCT00767000|6150787|P2|54-week Study|Hypoglycemia|1
1765685|NCT00767000|6150788|P1|54-week Study|Hypoglycemia|0
1765686|NCT00767000|6150784|P5|54-week Study|Hyperglycemia|1
1765687|NCT00767000|6150785|P4|54-week Study|Hyperglycemia|0
1765688|NCT00767000|6150786|P3|54-week Study|Hyperglycemia|1
1765689|NCT00767000|6150787|P2|54-week Study|Hyperglycemia|0
1765690|NCT00767000|6150788|P1|54-week Study|Hyperglycemia|0
1765691|NCT00767000|6150784|P5|54-week Study|Creaninine/creatinine clearance|4
1765692|NCT00767000|6150785|P4|54-week Study|Creaninine/creatinine clearance|2
1765693|NCT00767000|6150786|P3|54-week Study|Creaninine/creatinine clearance|2
1765694|NCT00767000|6150787|P2|54-week Study|Creaninine/creatinine clearance|1
1765695|NCT00767000|6150788|P1|54-week Study|Creaninine/creatinine clearance|2
1765696|NCT00767000|6150784|P5|54-week Study|Adverse Event|4
1765697|NCT00767000|6150785|P4|54-week Study|Adverse Event|8
1765698|NCT00767000|6150786|P3|54-week Study|Adverse Event|6
1765699|NCT00767000|6150787|P2|54-week Study|Adverse Event|6
1765700|NCT00767000|6150788|P1|54-week Study|Adverse Event|4
1765701|NCT00766831|6150830|P1|Overall Study|Other|28
1765702|NCT00766831|6150830|P1|Overall Study|Non cooperation by participants|14
1765703|NCT00766831|6150830|P1|Overall Study|Withdrawal of consent|26
1765704|NCT00766831|6150830|P1|Overall Study|Physician Decision|5
1765705|NCT00766831|6150830|P1|Overall Study|Protocol Violation|15
1765706|NCT00766831|6150830|P1|Overall Study|Adverse Event|20
1765707|NCT00766831|6150830|P1|Overall Study|Lost to Follow-up|3
1765708|NCT00766831|6150830|P1|Overall Study|Withdrawal by Subject|4
1765709|NCT00766675|6150860|P1|Overall Study|Insufficient therapy|1
1765710|NCT00766675|6150860|P1|Overall Study|Receive other anti-neoplastic treatment|1
1765711|NCT00766675|6150860|P1|Overall Study|Participant took prohibited medication|1
1765712|NCT00766675|6150860|P1|Overall Study|Protocol Violation|8
1765713|NCT00766675|6150860|P1|Overall Study|Withdrawal by Subject|11
1765714|NCT00766675|6150860|P1|Overall Study|Lost to Follow-up|2
1765715|NCT00766675|6150860|P1|Overall Study|Adverse Event|16
1765716|NCT00766636|6150887|P2|Overall Study|Disease Progression|0
1765717|NCT00766636|6150888|P1|Overall Study|Disease Progression|1
1765718|NCT00766636|6150887|P2|Overall Study|Adverse Event|0
1765719|NCT00766636|6150888|P1|Overall Study|Adverse Event|1
1765720|NCT00766636|6150887|P2|Overall Study|Incomplete Treatment|1
1765721|NCT00766636|6150888|P1|Overall Study|Incomplete Treatment|0
1765722|NCT00766636|6150887|P2|Overall Study|Withdrawal by Subject|1
1765723|NCT00766636|6150888|P1|Overall Study|Withdrawal by Subject|1
1765724|NCT00766597|6150894|P1|Overall Study|Without CCR5-tropic virus|5
1765725|NCT00766597|6150894|P1|Overall Study|Unexpected closure of study|4
1765726|NCT00766532|6150906|P1|Overall Study|Protocol Violation|2
1765727|NCT00766506|6150912|P2|Overall Study|Other|2
1765728|NCT00766506|6150913|P1|Overall Study|Other|2
1765729|NCT00766506|6150912|P2|Overall Study|Use rescue medication after 3 hours|0
1765730|NCT00766506|6150913|P1|Overall Study|Use rescue medication after 3 hours|3
1765731|NCT00766493|6150937|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
1765732|NCT00766493|6150937|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
1765733|NCT00766493|6150937|P1|30 Days Post-Procedure|Discontinued|7
1765734|NCT00766467|6150947|P2|Overall Study|Physician Decision|0
1765735|NCT00766467|6150948|P1|Overall Study|Physician Decision|1
1765736|NCT00766467|6150947|P2|Overall Study|Tumor Progression on Study|1
1765737|NCT00766467|6150948|P1|Overall Study|Tumor Progression on Study|0
1765738|NCT00766467|6150947|P2|Overall Study|Protocol Violation|4
1765739|NCT00766467|6150948|P1|Overall Study|Protocol Violation|2
1765740|NCT00766467|6150947|P2|Overall Study|Adverse Event|1
1765741|NCT00766467|6150948|P1|Overall Study|Adverse Event|1
1765742|NCT00766467|6150947|P2|Overall Study|Withdrawal by Subject|2
1765743|NCT00766467|6150948|P1|Overall Study|Withdrawal by Subject|7
1765744|NCT00766415|6150960|P2|Overall Study|Withdrawal by Subject|1
1765745|NCT00766415|6150961|P1|Overall Study|Withdrawal by Subject|0
1765746|NCT00766376|6151009|P1|Overall Study|Withdrawal by Subject|27
1765747|NCT00766363|6151018|P4|Overall Study|Adverse Event Prior to Randomization|0
1765748|NCT00766363|6151019|P3|Overall Study|Adverse Event Prior to Randomization|0
1765749|NCT00766363|6151020|P2|Overall Study|Adverse Event Prior to Randomization|1
1765750|NCT00766363|6151021|P1|Overall Study|Adverse Event Prior to Randomization|0
1765751|NCT00766363|6151018|P4|Overall Study|Withdrawal by Subject|0
1765752|NCT00766363|6151019|P3|Overall Study|Withdrawal by Subject|0
1765753|NCT00766363|6151020|P2|Overall Study|Withdrawal by Subject|0
1765754|NCT00766363|6151021|P1|Overall Study|Withdrawal by Subject|1
1765755|NCT00766090|6151067|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765756|NCT00766090|6151068|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765757|NCT00766090|6151069|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765758|NCT00766090|6151070|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765759|NCT00766090|6151071|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765760|NCT00766090|6151072|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765761|NCT00766090|6151073|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765762|NCT00766090|6151074|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
1765763|NCT00766090|6151075|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765764|NCT00766090|6151076|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765765|NCT00766090|6151077|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765766|NCT00766090|6151078|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
1765767|NCT00766090|6151067|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1765768|NCT00766090|6151068|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765769|NCT00766090|6151069|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765770|NCT00766090|6151070|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765771|NCT00766090|6151071|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765772|NCT00766090|6151072|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765773|NCT00766090|6151073|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765774|NCT00766090|6151074|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765775|NCT00766090|6151075|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1765776|NCT00766090|6151076|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765777|NCT00766090|6151077|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
1765778|NCT00766090|6151078|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
1765779|NCT00766090|6151067|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
1765780|NCT00766090|6151068|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
1765781|NCT00766090|6151069|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
1765782|NCT00766090|6151070|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
1765783|NCT00766090|6151071|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
1765784|NCT00766090|6151072|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
1765785|NCT00766090|6151073|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
1765786|NCT00766090|6151074|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
1765787|NCT00766090|6151075|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
1765788|NCT00766090|6151076|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
1765789|NCT00766090|6151077|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
1765790|NCT00766090|6151078|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
1765791|NCT00766090|6151067|P12|Washout Period 2 (14 Days)|Physician Decision|0
1765792|NCT00766090|6151068|P11|Washout Period 2 (14 Days)|Physician Decision|0
1765793|NCT00766090|6151069|P10|Washout Period 2 (14 Days)|Physician Decision|0
1765794|NCT00766090|6151070|P9|Washout Period 2 (14 Days)|Physician Decision|0
1765795|NCT00766090|6151071|P8|Washout Period 2 (14 Days)|Physician Decision|0
1765796|NCT00766090|6151072|P7|Washout Period 2 (14 Days)|Physician Decision|0
1765797|NCT00766090|6151073|P6|Washout Period 2 (14 Days)|Physician Decision|0
1765798|NCT00766090|6151074|P5|Washout Period 2 (14 Days)|Physician Decision|0
1765799|NCT00766090|6151075|P4|Washout Period 2 (14 Days)|Physician Decision|0
1765800|NCT00766090|6151076|P3|Washout Period 2 (14 Days)|Physician Decision|1
1765801|NCT00766090|6151077|P2|Washout Period 2 (14 Days)|Physician Decision|0
1765802|NCT00766090|6151078|P1|Washout Period 2 (14 Days)|Physician Decision|0
1765803|NCT00766090|6151067|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765804|NCT00766090|6151068|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765805|NCT00766090|6151069|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765806|NCT00766090|6151070|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765807|NCT00766090|6151071|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765808|NCT00766090|6151072|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765809|NCT00766090|6151073|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765810|NCT00766090|6151074|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765811|NCT00766090|6151075|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765812|NCT00766090|6151076|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
1765813|NCT00766090|6151077|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765814|NCT00766090|6151078|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
1765815|NCT00766090|6151067|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765816|NCT00766090|6151068|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765817|NCT00766090|6151069|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765818|NCT00766090|6151070|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765819|NCT00766090|6151071|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765820|NCT00766090|6151072|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765821|NCT00766090|6151073|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765822|NCT00766090|6151074|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
1765823|NCT00766090|6151075|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765824|NCT00766090|6151076|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765825|NCT00766090|6151077|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765826|NCT00766090|6151078|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
1765827|NCT00766090|6151067|P12|Washout Period 1 (14 Days)|Protocol Violation|0
1765828|NCT00766090|6151068|P11|Washout Period 1 (14 Days)|Protocol Violation|0
1765829|NCT00766090|6151069|P10|Washout Period 1 (14 Days)|Protocol Violation|0
1765830|NCT00766090|6151070|P9|Washout Period 1 (14 Days)|Protocol Violation|0
1765831|NCT00766090|6151071|P8|Washout Period 1 (14 Days)|Protocol Violation|0
1765832|NCT00766090|6151072|P7|Washout Period 1 (14 Days)|Protocol Violation|0
1765833|NCT00766090|6151073|P6|Washout Period 1 (14 Days)|Protocol Violation|0
1765834|NCT00766090|6151074|P5|Washout Period 1 (14 Days)|Protocol Violation|0
1765835|NCT00766090|6151075|P4|Washout Period 1 (14 Days)|Protocol Violation|0
1765836|NCT00766090|6151076|P3|Washout Period 1 (14 Days)|Protocol Violation|1
1765837|NCT00766090|6151077|P2|Washout Period 1 (14 Days)|Protocol Violation|0
1765838|NCT00766090|6151078|P1|Washout Period 1 (14 Days)|Protocol Violation|0
1765839|NCT00766090|6151067|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765840|NCT00766090|6151068|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765841|NCT00766090|6151069|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765842|NCT00766090|6151070|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765843|NCT00766090|6151071|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765844|NCT00766090|6151072|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765845|NCT00766090|6151073|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765846|NCT00766090|6151074|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765847|NCT00766090|6151075|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1765848|NCT00766090|6151076|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765849|NCT00766090|6151077|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
1765850|NCT00766090|6151078|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
1765851|NCT00766090|6151067|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765852|NCT00766090|6151068|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765853|NCT00766090|6151069|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765854|NCT00766090|6151070|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765855|NCT00766090|6151071|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765856|NCT00766090|6151072|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765857|NCT00766090|6151073|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765858|NCT00766090|6151074|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765859|NCT00766090|6151075|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765860|NCT00766090|6151076|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765861|NCT00766090|6151077|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
1765862|NCT00766090|6151078|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
1765863|NCT00766090|6151067|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765864|NCT00766090|6151068|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765865|NCT00766090|6151069|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765866|NCT00766090|6151070|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
1765867|NCT00766090|6151071|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765868|NCT00766090|6151072|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765869|NCT00766090|6151073|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765870|NCT00766090|6151074|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765871|NCT00766090|6151075|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765872|NCT00766090|6151076|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765873|NCT00766090|6151077|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765874|NCT00766090|6151078|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
1765875|NCT00766051|6151119|P2|Overall Study|Withdrawal by Subject|0
1765876|NCT00766051|6151120|P1|Overall Study|Withdrawal by Subject|2
1765877|NCT00766038|6151132|P2|Overall Study|Lost to Follow-up|14
1765878|NCT00766038|6151133|P1|Overall Study|Lost to Follow-up|15
1765879|NCT00765999|6151149|P1|Overall Study|Other Miscellaneous Reasons|51
1765880|NCT00765999|6151149|P1|Overall Study|Study Terminated by Sponsor|2
1765881|NCT00765999|6151149|P1|Overall Study|Lost to Follow-up|131
1765882|NCT00765999|6151149|P1|Overall Study|Consent Withdrawn|202
1765883|NCT00765999|6151149|P1|Overall Study|Protocol Violation|95
1765884|NCT00765999|6151149|P1|Overall Study|Insufficient Therapeutic Response|100
1765885|NCT00765999|6151149|P1|Overall Study|Adverse Event|203
1765886|NCT00765882|6151176|P3|Overall Study|Other Reason|2
1765887|NCT00765882|6151177|P2|Overall Study|Other Reason|1
1765888|NCT00765882|6151178|P1|Overall Study|Other Reason|3
1765889|NCT00765882|6151176|P3|Overall Study|Lost to Follow-up|6
1765890|NCT00765882|6151177|P2|Overall Study|Lost to Follow-up|9
1765891|NCT00765882|6151178|P1|Overall Study|Lost to Follow-up|1
1765892|NCT00765882|6151176|P3|Overall Study|Withdrawal by Subject|6
1765893|NCT00765882|6151177|P2|Overall Study|Withdrawal by Subject|6
1765894|NCT00765882|6151178|P1|Overall Study|Withdrawal by Subject|2
1765895|NCT00765882|6151176|P3|Overall Study|Protocol Violation|1
1765896|NCT00765882|6151177|P2|Overall Study|Protocol Violation|3
1765897|NCT00765882|6151178|P1|Overall Study|Protocol Violation|4
1765898|NCT00765882|6151176|P3|Overall Study|Lack of Efficacy|1
1765899|NCT00765882|6151177|P2|Overall Study|Lack of Efficacy|0
1765900|NCT00765882|6151178|P1|Overall Study|Lack of Efficacy|4
1765901|NCT00765882|6151176|P3|Overall Study|Adverse Event|20
1765902|NCT00765882|6151177|P2|Overall Study|Adverse Event|21
1765903|NCT00765882|6151178|P1|Overall Study|Adverse Event|10
1765904|NCT00765843|6151210|P3|Overall Study|Adverse Event|1
1765905|NCT00765843|6151211|P2|Overall Study|Adverse Event|0
1765906|NCT00765843|6151212|P1|Overall Study|Adverse Event|0
1765907|NCT00765843|6151210|P3|Overall Study|did not return to receive intervention|0
1765908|NCT00765843|6151211|P2|Overall Study|did not return to receive intervention|1
1765909|NCT00765843|6151212|P1|Overall Study|did not return to receive intervention|0
1765910|NCT00765843|6151210|P3|Overall Study|Lost to Follow-up|2
1765911|NCT00765843|6151211|P2|Overall Study|Lost to Follow-up|3
1765912|NCT00765843|6151212|P1|Overall Study|Lost to Follow-up|1
1765913|NCT00765817|6151222|P2|Overall Study|Subject decision|11
1765914|NCT00765817|6151223|P1|Overall Study|Subject decision|7
1765915|NCT00765817|6151222|P2|Overall Study|Protocol Violation|1
1765916|NCT00765817|6151223|P1|Overall Study|Protocol Violation|1
1765917|NCT00765817|6151222|P2|Overall Study|Physician Decision|1
1765918|NCT00765817|6151223|P1|Overall Study|Physician Decision|2
1765919|NCT00765817|6151222|P2|Overall Study|Lost to Follow-up|3
1765920|NCT00765817|6151223|P1|Overall Study|Lost to Follow-up|1
1765921|NCT00765817|6151222|P2|Overall Study|Loss of glucose control|2
1765922|NCT00765817|6151223|P1|Overall Study|Loss of glucose control|0
1765923|NCT00765817|6151222|P2|Overall Study|Entry criteria not met|2
1765924|NCT00765817|6151223|P1|Overall Study|Entry criteria not met|2
1765925|NCT00765817|6151222|P2|Overall Study|Death|1
1765926|NCT00765817|6151223|P1|Overall Study|Death|0
1765927|NCT00765817|6151222|P2|Overall Study|Adverse Event|1
1765928|NCT00765817|6151223|P1|Overall Study|Adverse Event|13
1765929|NCT00765726|6151271|P1|Overall Study|Discontinuation of study by sponsor|8
1765930|NCT00765726|6151271|P1|Overall Study|Withdrawal by Subject|1
1765931|NCT00765674|6151279|P4|Overall Study|Randomized in Error - No Study Drug|1
1765932|NCT00765674|6151280|P3|Overall Study|Randomized in Error - No Study Drug|0
1765933|NCT00765674|6151281|P2|Overall Study|Randomized in Error - No Study Drug|1
1765934|NCT00765674|6151282|P1|Overall Study|Randomized in Error - No Study Drug|0
1765935|NCT00765674|6151279|P4|Overall Study|Lost to Follow-up|1
1765936|NCT00765674|6151280|P3|Overall Study|Lost to Follow-up|2
1765937|NCT00765674|6151281|P2|Overall Study|Lost to Follow-up|6
1765938|NCT00765674|6151282|P1|Overall Study|Lost to Follow-up|4
1765939|NCT00765674|6151279|P4|Overall Study|Withdrawal by Subject|8
1765940|NCT00765674|6151280|P3|Overall Study|Withdrawal by Subject|3
1765941|NCT00765674|6151281|P2|Overall Study|Withdrawal by Subject|7
1765942|NCT00765674|6151282|P1|Overall Study|Withdrawal by Subject|5
1765943|NCT00765674|6151279|P4|Overall Study|Protocol Violation|0
1765944|NCT00765674|6151280|P3|Overall Study|Protocol Violation|1
1765945|NCT00765674|6151281|P2|Overall Study|Protocol Violation|0
1765946|NCT00765674|6151282|P1|Overall Study|Protocol Violation|2
1765947|NCT00765674|6151279|P4|Overall Study|Lack of Efficacy|2
1765948|NCT00765674|6151280|P3|Overall Study|Lack of Efficacy|1
1765949|NCT00765674|6151281|P2|Overall Study|Lack of Efficacy|3
1765950|NCT00765674|6151282|P1|Overall Study|Lack of Efficacy|2
1765951|NCT00765674|6151279|P4|Overall Study|Abnormal Test Procedure Result(s)|2
1765952|NCT00765674|6151280|P3|Overall Study|Abnormal Test Procedure Result(s)|1
1765953|NCT00765674|6151281|P2|Overall Study|Abnormal Test Procedure Result(s)|3
1765954|NCT00765674|6151282|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1765955|NCT00765674|6151279|P4|Overall Study|Abnormal Laboratory Value(s)|0
1765956|NCT00765674|6151280|P3|Overall Study|Abnormal Laboratory Value(s)|1
1765957|NCT00765674|6151281|P2|Overall Study|Abnormal Laboratory Value(s)|0
1765958|NCT00765674|6151282|P1|Overall Study|Abnormal Laboratory Value(s)|0
1765959|NCT00765674|6151279|P4|Overall Study|Adverse Event|11
1765960|NCT00765674|6151280|P3|Overall Study|Adverse Event|8
1765961|NCT00765674|6151281|P2|Overall Study|Adverse Event|2
1765962|NCT00765674|6151282|P1|Overall Study|Adverse Event|7
1765963|NCT00765388|6151349|P2|Period 1|Hip operation|1
1765964|NCT00765388|6151350|P1|Period 1|Hip operation|0
1765965|NCT00765388|6151349|P2|Period 1|Herpes Zoster|1
1765966|NCT00765388|6151350|P1|Period 1|Herpes Zoster|0
1765967|NCT00765388|6151349|P2|Period 1|Lost to Follow-up|1
1765968|NCT00765388|6151350|P1|Period 1|Lost to Follow-up|0
1765969|NCT00765388|6151349|P2|Period 1|Lack of Efficacy|2
1765970|NCT00765388|6151350|P1|Period 1|Lack of Efficacy|1
1765971|NCT00765362|6151384|P1|Overall Study|Lost to Follow-up|95
1765972|NCT00765362|6151384|P1|Overall Study|Withdrawal by Subject|13
1765973|NCT00765362|6151384|P1|Overall Study|Protocol Violation|18
1765974|NCT00765362|6151384|P1|Overall Study|Adverse Event|2
1765975|NCT00765362|6151384|P1|Overall Study|Death|9
1765976|NCT00765336|6151392|P2|Overall Study|Adverse Event|1
1765977|NCT00765336|6151393|P1|Overall Study|Adverse Event|2
1765978|NCT00765336|6151392|P2|Overall Study|Lost to Follow-up|9
1765979|NCT00765336|6151393|P1|Overall Study|Lost to Follow-up|7
1765980|NCT00765336|6151392|P2|Overall Study|Withdrawal by Subject|4
1765981|NCT00765336|6151393|P1|Overall Study|Withdrawal by Subject|6
1765982|NCT00765336|6151392|P2|Overall Study|Protocol Violation|2
1765983|NCT00765336|6151393|P1|Overall Study|Protocol Violation|4
1765984|NCT00765245|6151401|P2|Overall Study|Death|0
1765985|NCT00765245|6151402|P1|Overall Study|Death|1
1765986|NCT00765245|6151401|P2|Overall Study|Physician Decision|0
1765987|NCT00765245|6151402|P1|Overall Study|Physician Decision|1
1765988|NCT00765245|6151401|P2|Overall Study|Adverse Event|0
1765989|NCT00765245|6151402|P1|Overall Study|Adverse Event|5
1765990|NCT00765245|6151401|P2|Overall Study|Withdrawal by Subject|0
1765991|NCT00765245|6151402|P1|Overall Study|Withdrawal by Subject|3
1765992|NCT00765245|6151401|P2|Overall Study|disease progression|2
1765993|NCT00765245|6151402|P1|Overall Study|disease progression|3
1765994|NCT00765102|6151448|P1|Overall Study|Protocol Violation|1
1765995|NCT00765102|6151448|P1|Overall Study|Withdrawal by Subject|2
1765996|NCT00765102|6151448|P1|Overall Study|Physician Decision|4
1765997|NCT00765102|6151448|P1|Overall Study|Adverse Event|6
1765998|NCT00765102|6151448|P1|Overall Study|Progressive disease|18
1765999|NCT00765076|6151473|P3|Overall Study|Withdrawal by Subject|1
1766000|NCT00765076|6151474|P2|Overall Study|Withdrawal by Subject|0
1766001|NCT00765076|6151475|P1|Overall Study|Withdrawal by Subject|0
1766002|NCT00765076|6151473|P3|Overall Study|Adverse Event|0
1766003|NCT00765076|6151474|P2|Overall Study|Adverse Event|0
1766004|NCT00765076|6151475|P1|Overall Study|Adverse Event|1
1766005|NCT00765063|6151528|P1|Overall Study|Adverse Event|4
1766006|NCT00765063|6151528|P1|Overall Study|Protocol Violation|6
1766007|NCT00765063|6151528|P1|Overall Study|Other|16
1766008|NCT00765063|6151528|P1|Overall Study|Withdrawal by Subject|1
1766009|NCT00765063|6151528|P1|Overall Study|Lack of Efficacy|5
1766010|NCT00765037|6151544|P1|Overall Study|Adverse Event|1
1766011|NCT00765037|6151544|P1|Overall Study|Lost to Follow-up|5
1766012|NCT00764946|6151551|P3|Overall Study|Never Treated|1
1766013|NCT00764946|6151552|P2|Overall Study|Never Treated|1
1766014|NCT00764946|6151553|P1|Overall Study|Never Treated|1
1766015|NCT00764946|6151551|P3|Overall Study|Withdrawal by Subject|2
1766016|NCT00764946|6151552|P2|Overall Study|Withdrawal by Subject|6
1766017|NCT00764946|6151553|P1|Overall Study|Withdrawal by Subject|3
1766018|NCT00764946|6151551|P3|Overall Study|Adverse Event|1
1766019|NCT00764946|6151552|P2|Overall Study|Adverse Event|2
1766020|NCT00764946|6151553|P1|Overall Study|Adverse Event|3
1766021|NCT00764946|6151551|P3|Overall Study|Physician Decision|0
1766022|NCT00764946|6151552|P2|Overall Study|Physician Decision|4
1766023|NCT00764946|6151553|P1|Overall Study|Physician Decision|2
1766024|NCT00764946|6151551|P3|Overall Study|Lost to Follow-up|0
1766025|NCT00764946|6151552|P2|Overall Study|Lost to Follow-up|4
1766026|NCT00764946|6151553|P1|Overall Study|Lost to Follow-up|3
1766027|NCT00764946|6151551|P3|Overall Study|Lack of Efficacy|0
1766028|NCT00764946|6151552|P2|Overall Study|Lack of Efficacy|0
1766029|NCT00764946|6151553|P1|Overall Study|Lack of Efficacy|1
1766030|NCT00764881|6151581|P2|Overall Study|no treatment or no observation|2
1766031|NCT00764881|6151582|P1|Overall Study|no treatment or no observation|2
1766032|NCT00764881|6151581|P2|Overall Study|Possibly noncompliant (study drug)|2
1766033|NCT00764881|6151582|P1|Overall Study|Possibly noncompliant (study drug)|0
1766034|NCT00764881|6151581|P2|Overall Study|Carcinoma detected|0
1766035|NCT00764881|6151582|P1|Overall Study|Carcinoma detected|1
1766036|NCT00764881|6151581|P2|Overall Study|Wished to become pregnant|0
1766037|NCT00764881|6151582|P1|Overall Study|Wished to become pregnant|1
1766038|NCT00764881|6151581|P2|Overall Study|Accidentally discontinued study drug|0
1766039|NCT00764881|6151582|P1|Overall Study|Accidentally discontinued study drug|1
1766040|NCT00764881|6151581|P2|Overall Study|Noncompliant|0
1766041|NCT00764881|6151582|P1|Overall Study|Noncompliant|1
1766042|NCT00764881|6151581|P2|Overall Study|Lost to Follow-up|0
1766043|NCT00764881|6151582|P1|Overall Study|Lost to Follow-up|2
1766044|NCT00764881|6151581|P2|Overall Study|Protocol Violation|2
1766045|NCT00764881|6151582|P1|Overall Study|Protocol Violation|2
1766046|NCT00764881|6151581|P2|Overall Study|Withdrawal by Subject|3
1766047|NCT00764881|6151582|P1|Overall Study|Withdrawal by Subject|1
1766048|NCT00764881|6151581|P2|Overall Study|Adverse Event|1
1766049|NCT00764881|6151582|P1|Overall Study|Adverse Event|5
1766050|NCT00764868|6151806|P1|Overall Study|Sponsor requested withdrawal|1
1766051|NCT00764868|6151806|P1|Overall Study|Positive drug screen|2
1766052|NCT00764868|6151806|P1|Overall Study|Met an exclusion criteria|1
1766053|NCT00764868|6151806|P1|Overall Study|Subject sent to boarding school|1
1766054|NCT00764868|6151806|P1|Overall Study|Misuse and compliance of study drug|1
1766055|NCT00764868|6151806|P1|Overall Study|Out of town|1
1766056|NCT00764868|6151806|P1|Overall Study|Prohibited medication|1
1766057|NCT00764868|6151806|P1|Overall Study|Pregnancy|3
1766058|NCT00764868|6151806|P1|Overall Study|Subject moved|7
1766059|NCT00764868|6151806|P1|Overall Study|Lack of Efficacy|5
1766060|NCT00764868|6151806|P1|Overall Study|Lost to Follow-up|25
1766061|NCT00764868|6151806|P1|Overall Study|Non-compliance|16
1766062|NCT00764868|6151806|P1|Overall Study|Withdrawal by Subject|31
1766063|NCT00764868|6151806|P1|Overall Study|Adverse Event|18
1766064|NCT00764790|6151815|P3|Overall Study|Lost to Follow-up|23
1766065|NCT00764790|6151816|P2|Overall Study|Lost to Follow-up|29
1766066|NCT00764790|6151817|P1|Overall Study|Lost to Follow-up|28
1766067|NCT00764790|6151815|P3|Overall Study|Withdrawal by Subject|6
1766068|NCT00764790|6151816|P2|Overall Study|Withdrawal by Subject|12
1766069|NCT00764790|6151817|P1|Overall Study|Withdrawal by Subject|10
1766070|NCT00764790|6151815|P3|Overall Study|Protocol Violation|1
1766071|NCT00764790|6151816|P2|Overall Study|Protocol Violation|0
1766072|NCT00764790|6151817|P1|Overall Study|Protocol Violation|0
1766073|NCT00764751|6151851|P2|Overall Study|Psoriasis flare up on the scalp|0
1766074|NCT00764751|6151852|P1|Overall Study|Psoriasis flare up on the scalp|1
1766075|NCT00764751|6151851|P2|Overall Study|Adverse Event|1
1766076|NCT00764751|6151852|P1|Overall Study|Adverse Event|1
1766077|NCT00764699|6151886|P1|Overall Study|PI left and study terminated|3
1766078|NCT00764673|6151890|P1|Overall Study|Revision of Device|2
1766079|NCT00764673|6151890|P1|Overall Study|Withdrawal by Subject|6
1766080|NCT00764673|6151890|P1|Overall Study|Lost to Follow-up|3
1766081|NCT00764673|6151890|P1|Overall Study|Death|1
1766082|NCT00764660|6151900|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1766083|NCT00764660|6151901|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1766084|NCT00764660|6151900|P2|Overall Study|Noncompliance With Protocol|1
1766085|NCT00764660|6151901|P1|Overall Study|Noncompliance With Protocol|5
1766086|NCT00764660|6151900|P2|Overall Study|Withdrawal by Subject|3
1766087|NCT00764660|6151901|P1|Overall Study|Withdrawal by Subject|7
1766088|NCT00764660|6151900|P2|Overall Study|Lost to Follow-up|4
1766089|NCT00764660|6151901|P1|Overall Study|Lost to Follow-up|3
1766090|NCT00764660|6151900|P2|Overall Study|Adverse Event|3
1766091|NCT00764660|6151901|P1|Overall Study|Adverse Event|6
1766092|NCT00764517|6151935|P2|Overall Study|Physician Decision|0
1766093|NCT00764517|6151936|P1|Overall Study|Physician Decision|3
1766094|NCT00764517|6151935|P2|Overall Study|Death|11
1766095|NCT00764517|6151936|P1|Overall Study|Death|3
1766096|NCT00764517|6151935|P2|Overall Study|Adverse Event|3
1766097|NCT00764517|6151936|P1|Overall Study|Adverse Event|9
1766098|NCT00764504|6151957|P3|Overall Study|Lost to Follow-up|72
1766099|NCT00764504|6151958|P2|Overall Study|Lost to Follow-up|34
1766100|NCT00764504|6151959|P1|Overall Study|Lost to Follow-up|40
1766101|NCT00764504|6151957|P3|Overall Study|Withdrawal by Subject|4
1766102|NCT00764504|6151958|P2|Overall Study|Withdrawal by Subject|7
1766103|NCT00764504|6151959|P1|Overall Study|Withdrawal by Subject|1
1766104|NCT00764504|6151957|P3|Overall Study|Physician Decision|0
1766105|NCT00764504|6151958|P2|Overall Study|Physician Decision|0
1766106|NCT00764504|6151959|P1|Overall Study|Physician Decision|1
1766107|NCT00764504|6151957|P3|Overall Study|Revision of Device|14
1766108|NCT00764504|6151958|P2|Overall Study|Revision of Device|23
1766109|NCT00764504|6151959|P1|Overall Study|Revision of Device|12
1766110|NCT00764504|6151957|P3|Overall Study|Death|13
1766111|NCT00764504|6151958|P2|Overall Study|Death|6
1766112|NCT00764504|6151959|P1|Overall Study|Death|12
1766113|NCT00764478|6151988|P3|Overall Study|Protocol Violation|1
1766114|NCT00764478|6151989|P2|Overall Study|Protocol Violation|1
1766115|NCT00764478|6151990|P1|Overall Study|Protocol Violation|0
1766116|NCT00764478|6151988|P3|Overall Study|Lost to Follow-up|5
1766117|NCT00764478|6151989|P2|Overall Study|Lost to Follow-up|8
1766118|NCT00764478|6151990|P1|Overall Study|Lost to Follow-up|7
1766119|NCT00764478|6151988|P3|Overall Study|Withdrawal by Subject|1
1766120|NCT00764478|6151989|P2|Overall Study|Withdrawal by Subject|12
1766121|NCT00764478|6151990|P1|Overall Study|Withdrawal by Subject|7
1766122|NCT00764478|6151988|P3|Overall Study|Adverse Event|1
1766123|NCT00764478|6151989|P2|Overall Study|Adverse Event|1
1766124|NCT00764478|6151990|P1|Overall Study|Adverse Event|1
1766125|NCT00764465|6152070|P6|Overall Study|Withdrawal by Subject|0
1766126|NCT00764465|6152071|P5|Overall Study|Withdrawal by Subject|0
1766127|NCT00764465|6152072|P4|Overall Study|Withdrawal by Subject|0
1766128|NCT00764465|6152073|P3|Overall Study|Withdrawal by Subject|1
1766129|NCT00764465|6152074|P2|Overall Study|Withdrawal by Subject|1
1766130|NCT00764465|6152075|P1|Overall Study|Withdrawal by Subject|0
1766131|NCT00764465|6152070|P6|Overall Study|Adverse Event|1
1766132|NCT00764465|6152071|P5|Overall Study|Adverse Event|1
1766133|NCT00764465|6152072|P4|Overall Study|Adverse Event|1
1766134|NCT00764465|6152073|P3|Overall Study|Adverse Event|0
1766135|NCT00764465|6152074|P2|Overall Study|Adverse Event|0
1766136|NCT00764465|6152075|P1|Overall Study|Adverse Event|2
1766137|NCT00764361|6152103|P2|Overall Study|Adverse Event|1
1766138|NCT00764361|6152104|P1|Overall Study|Adverse Event|0
1766139|NCT00764361|6152103|P2|Overall Study|Withdrawal by Subject|3
1766140|NCT00764361|6152104|P1|Overall Study|Withdrawal by Subject|2
1766141|NCT00764322|6152112|P1|Overall Study|No CYP2D6 genotyping|9
1766142|NCT00764322|6152112|P1|Overall Study|Withdrawal by Subject|11
1766143|NCT00763971|6152139|P3|Overall Study|Participation in 489-326 required|0
1766144|NCT00763971|6152140|P2|Overall Study|Participation in 489-326 required|0
1766145|NCT00763971|6152141|P1|Overall Study|Participation in 489-326 required|1
1766146|NCT00763971|6152139|P3|Overall Study|Performed final visit on phone|0
1766147|NCT00763971|6152140|P2|Overall Study|Performed final visit on phone|1
1766148|NCT00763971|6152141|P1|Overall Study|Performed final visit on phone|0
1766149|NCT00763971|6152139|P3|Overall Study|Lack of availability|0
1766150|NCT00763971|6152140|P2|Overall Study|Lack of availability|1
1766151|NCT00763971|6152141|P1|Overall Study|Lack of availability|0
1766152|NCT00763971|6152139|P3|Overall Study|Subject wanted dose reduction|0
1766153|NCT00763971|6152140|P2|Overall Study|Subject wanted dose reduction|1
1766154|NCT00763971|6152141|P1|Overall Study|Subject wanted dose reduction|0
1766155|NCT00763971|6152139|P3|Overall Study|Moved to another country|0
1766156|NCT00763971|6152140|P2|Overall Study|Moved to another country|1
1766157|NCT00763971|6152141|P1|Overall Study|Moved to another country|0
1766158|NCT00763971|6152139|P3|Overall Study|Medical monitor decision|1
1766159|NCT00763971|6152140|P2|Overall Study|Medical monitor decision|0
1766160|NCT00763971|6152141|P1|Overall Study|Medical monitor decision|0
1766161|NCT00763971|6152139|P3|Overall Study|Randomization error|1
1766162|NCT00763971|6152140|P2|Overall Study|Randomization error|0
1766163|NCT00763971|6152141|P1|Overall Study|Randomization error|0
1766164|NCT00763971|6152139|P3|Overall Study|Due to holiday season|1
1766165|NCT00763971|6152140|P2|Overall Study|Due to holiday season|0
1766166|NCT00763971|6152141|P1|Overall Study|Due to holiday season|2
1766167|NCT00763971|6152139|P3|Overall Study|Sponsor decision|0
1766168|NCT00763971|6152140|P2|Overall Study|Sponsor decision|0
1766169|NCT00763971|6152141|P1|Overall Study|Sponsor decision|1
1766170|NCT00763971|6152139|P3|Overall Study|Exclusion criteria met|0
1766171|NCT00763971|6152140|P2|Overall Study|Exclusion criteria met|0
1766172|NCT00763971|6152141|P1|Overall Study|Exclusion criteria met|1
1766173|NCT00763971|6152139|P3|Overall Study|Personal reason|0
1766174|NCT00763971|6152140|P2|Overall Study|Personal reason|0
1766175|NCT00763971|6152141|P1|Overall Study|Personal reason|3
1766176|NCT00763971|6152139|P3|Overall Study|Unable to swallow capsule|1
1766177|NCT00763971|6152140|P2|Overall Study|Unable to swallow capsule|1
1766178|NCT00763971|6152141|P1|Overall Study|Unable to swallow capsule|2
1766179|NCT00763971|6152139|P3|Overall Study|Lack of Efficacy|54
1766180|NCT00763971|6152140|P2|Overall Study|Lack of Efficacy|22
1766181|NCT00763971|6152141|P1|Overall Study|Lack of Efficacy|11
1766182|NCT00763971|6152139|P3|Overall Study|Lost to Follow-up|0
1766183|NCT00763971|6152140|P2|Overall Study|Lost to Follow-up|1
1766184|NCT00763971|6152141|P1|Overall Study|Lost to Follow-up|0
1766185|NCT00763971|6152139|P3|Overall Study|Withdrawal by Subject|5
1766186|NCT00763971|6152140|P2|Overall Study|Withdrawal by Subject|5
1766187|NCT00763971|6152141|P1|Overall Study|Withdrawal by Subject|4
1766188|NCT00763971|6152139|P3|Overall Study|Protocol Violation|2
1766189|NCT00763971|6152140|P2|Overall Study|Protocol Violation|3
1766190|NCT00763971|6152141|P1|Overall Study|Protocol Violation|3
1766191|NCT00763971|6152139|P3|Overall Study|Adverse Event|4
1766192|NCT00763971|6152140|P2|Overall Study|Adverse Event|2
1766193|NCT00763971|6152141|P1|Overall Study|Adverse Event|5
1766194|NCT00763958|6152172|P2|Overall Study|Believed they were receiving placebo|5
1766195|NCT00763958|6152173|P1|Overall Study|Believed they were receiving placebo|0
1766196|NCT00763958|6152172|P2|Overall Study|Lost to Follow-up|2
1766197|NCT00763958|6152173|P1|Overall Study|Lost to Follow-up|10
1766198|NCT00763958|6152172|P2|Overall Study|did not meet final criteria|4
1766199|NCT00763958|6152173|P1|Overall Study|did not meet final criteria|4
1766200|NCT00763815|6152308|P2|Overall Study|Sponsor's Decision|1
1766201|NCT00763815|6152309|P1|Overall Study|Sponsor's Decision|0
1766202|NCT00763815|6152308|P2|Overall Study|Protocol Violation|5
1766203|NCT00763815|6152309|P1|Overall Study|Protocol Violation|2
1766204|NCT00763815|6152308|P2|Overall Study|Withdrawal by Subject|12
1766205|NCT00763815|6152309|P1|Overall Study|Withdrawal by Subject|7
1766206|NCT00763815|6152308|P2|Overall Study|Physician Decision|0
1766207|NCT00763815|6152309|P1|Overall Study|Physician Decision|1
1766208|NCT00763815|6152308|P2|Overall Study|Familial and Personal Reasons|16
1766209|NCT00763815|6152309|P1|Overall Study|Familial and Personal Reasons|9
1766210|NCT00763815|6152308|P2|Overall Study|Early Termination|0
1766211|NCT00763815|6152309|P1|Overall Study|Early Termination|1
1766212|NCT00763815|6152308|P2|Overall Study|Lost to Follow-up|4
1766213|NCT00763815|6152309|P1|Overall Study|Lost to Follow-up|2
1766214|NCT00763815|6152308|P2|Overall Study|Poor Compliance to Protocol|6
1766215|NCT00763815|6152309|P1|Overall Study|Poor Compliance to Protocol|6
1766216|NCT00763815|6152308|P2|Overall Study|Lack of Efficacy|11
1766217|NCT00763815|6152309|P1|Overall Study|Lack of Efficacy|10
1766218|NCT00763815|6152308|P2|Overall Study|Adverse Event|29
1766219|NCT00763815|6152309|P1|Overall Study|Adverse Event|14
1766220|NCT00763698|6152337|P1|Overall Study|Withdrawal by Subject|1
1766221|NCT00763698|6152337|P1|Overall Study|Death|4
1766222|NCT00763698|6152337|P1|Overall Study|Unsuccessful Implant|5
1766223|NCT00763451|6152354|P4|Overall Study|Study Site Reason|1
1766224|NCT00763451|6152355|P3|Overall Study|Study Site Reason|1
1766225|NCT00763451|6152356|P2|Overall Study|Study Site Reason|1
1766226|NCT00763451|6152357|P1|Overall Study|Study Site Reason|0
1766227|NCT00763451|6152354|P4|Overall Study|Randomized but not Treated|0
1766228|NCT00763451|6152355|P3|Overall Study|Randomized but not Treated|0
1766229|NCT00763451|6152356|P2|Overall Study|Randomized but not Treated|1
1766230|NCT00763451|6152357|P1|Overall Study|Randomized but not Treated|1
1766231|NCT00763451|6152354|P4|Overall Study|Familial and Personal Reasons|4
1766232|NCT00763451|6152355|P3|Overall Study|Familial and Personal Reasons|5
1766233|NCT00763451|6152356|P2|Overall Study|Familial and Personal Reasons|3
1766234|NCT00763451|6152357|P1|Overall Study|Familial and Personal Reasons|5
1766235|NCT00763451|6152354|P4|Overall Study|Poor Compliance to Protocol|2
1766236|NCT00763451|6152355|P3|Overall Study|Poor Compliance to Protocol|2
1766237|NCT00763451|6152356|P2|Overall Study|Poor Compliance to Protocol|1
1766238|NCT00763451|6152357|P1|Overall Study|Poor Compliance to Protocol|1
1766239|NCT00763451|6152354|P4|Overall Study|Protocol Violation|0
1766240|NCT00763451|6152355|P3|Overall Study|Protocol Violation|1
1766241|NCT00763451|6152356|P2|Overall Study|Protocol Violation|0
1766242|NCT00763451|6152357|P1|Overall Study|Protocol Violation|0
1766243|NCT00763451|6152354|P4|Overall Study|Withdrawal by Subject|7
1766244|NCT00763451|6152355|P3|Overall Study|Withdrawal by Subject|9
1766245|NCT00763451|6152356|P2|Overall Study|Withdrawal by Subject|6
1766246|NCT00763451|6152357|P1|Overall Study|Withdrawal by Subject|1
1766247|NCT00763451|6152354|P4|Overall Study|Lack of Efficacy|2
1766248|NCT00763451|6152355|P3|Overall Study|Lack of Efficacy|3
1766249|NCT00763451|6152356|P2|Overall Study|Lack of Efficacy|4
1766250|NCT00763451|6152357|P1|Overall Study|Lack of Efficacy|1
1766251|NCT00763451|6152354|P4|Overall Study|Adverse Event|14
1766252|NCT00763451|6152355|P3|Overall Study|Adverse Event|19
1766253|NCT00763451|6152356|P2|Overall Study|Adverse Event|6
1766254|NCT00763451|6152357|P1|Overall Study|Adverse Event|4
1766255|NCT00763386|6152416|P2|Overall Study|Study Prosthesis Removed|0
1766256|NCT00763386|6152417|P1|Overall Study|Study Prosthesis Removed|1
1766257|NCT00763386|6152416|P2|Overall Study|CRF missing|1
1766258|NCT00763386|6152417|P1|Overall Study|CRF missing|0
1766259|NCT00763386|6152416|P2|Overall Study|Withdrawal by Subject|1
1766260|NCT00763386|6152417|P1|Overall Study|Withdrawal by Subject|0
1766261|NCT00763386|6152416|P2|Overall Study|Lost to Follow-up|3
1766262|NCT00763386|6152417|P1|Overall Study|Lost to Follow-up|3
1766263|NCT00763386|6152416|P2|Overall Study|Death|2
1766264|NCT00763386|6152417|P1|Overall Study|Death|1
1766265|NCT00763386|6152416|P2|Overall Study|Adverse Event|33
1766266|NCT00763386|6152417|P1|Overall Study|Adverse Event|43
1766267|NCT00763321|6152450|P3|Double-blind Period|Other|3
1766268|NCT00763321|6152451|P2|Double-blind Period|Other|2
1766269|NCT00763321|6152452|P1|Double-blind Period|Other|0
1766270|NCT00763321|6152450|P3|Double-blind Period|Withdrawal by Subject|3
1766271|NCT00763321|6152451|P2|Double-blind Period|Withdrawal by Subject|2
1766272|NCT00763321|6152452|P1|Double-blind Period|Withdrawal by Subject|0
1766273|NCT00763321|6152450|P3|Double-blind Period|Lost to Follow-up|2
1766274|NCT00763321|6152451|P2|Double-blind Period|Lost to Follow-up|4
1766275|NCT00763321|6152452|P1|Double-blind Period|Lost to Follow-up|0
1766276|NCT00763321|6152450|P3|Double-blind Period|Adverse Event|4
1766277|NCT00763321|6152451|P2|Double-blind Period|Adverse Event|4
1766278|NCT00763321|6152452|P1|Double-blind Period|Adverse Event|0
1766279|NCT00763321|6152450|P3|Double-blind Period|Lack of Efficacy|17
1766280|NCT00763321|6152451|P2|Double-blind Period|Lack of Efficacy|9
1766281|NCT00763321|6152452|P1|Double-blind Period|Lack of Efficacy|0
1766282|NCT00763321|6152450|P3|Open-label Period|Other|0
1766283|NCT00763321|6152451|P2|Open-label Period|Other|0
1766284|NCT00763321|6152452|P1|Open-label Period|Other|4
1766285|NCT00763321|6152450|P3|Open-label Period|Lack of Efficacy|0
1766286|NCT00763321|6152451|P2|Open-label Period|Lack of Efficacy|0
1766287|NCT00763321|6152452|P1|Open-label Period|Lack of Efficacy|2
1766288|NCT00763321|6152450|P3|Open-label Period|Did not meet DB randomization criteria|0
1766289|NCT00763321|6152451|P2|Open-label Period|Did not meet DB randomization criteria|0
1766290|NCT00763321|6152452|P1|Open-label Period|Did not meet DB randomization criteria|5
1766291|NCT00763321|6152450|P3|Open-label Period|Subject noncompliant|0
1766292|NCT00763321|6152451|P2|Open-label Period|Subject noncompliant|0
1766293|NCT00763321|6152452|P1|Open-label Period|Subject noncompliant|7
1766294|NCT00763321|6152450|P3|Open-label Period|Withdrawal by Subject|0
1766295|NCT00763321|6152451|P2|Open-label Period|Withdrawal by Subject|0
1766296|NCT00763321|6152452|P1|Open-label Period|Withdrawal by Subject|7
1766297|NCT00763321|6152450|P3|Open-label Period|Lost to Follow-up|0
1766298|NCT00763321|6152451|P2|Open-label Period|Lost to Follow-up|0
1766299|NCT00763321|6152452|P1|Open-label Period|Lost to Follow-up|14
1766300|NCT00763321|6152450|P3|Open-label Period|Adverse Event|0
1766301|NCT00763321|6152451|P2|Open-label Period|Adverse Event|0
1766302|NCT00763321|6152452|P1|Open-label Period|Adverse Event|24
1766303|NCT00763282|6152463|P2|Overall Study|Lost to Follow-up|26
1766304|NCT00763282|6152464|P1|Overall Study|Lost to Follow-up|22
1766305|NCT00763282|6152463|P2|Overall Study|Death|3
1766306|NCT00763282|6152464|P1|Overall Study|Death|4
1766307|NCT00763282|6152463|P2|Overall Study|Withdrawal by Subject|5
1766308|NCT00763282|6152464|P1|Overall Study|Withdrawal by Subject|6
1766309|NCT00763269|6152480|P2|Overall Study|Lost to Follow-up|13
1766310|NCT00763269|6152481|P1|Overall Study|Lost to Follow-up|12
1766311|NCT00763256|6152495|P2|Overall Study|Didn't return for appointments|10
1766312|NCT00763256|6152496|P1|Overall Study|Didn't return for appointments|7
1766313|NCT00763139|6152532|P2|Overall Study|med change not allowed by protocol|0
1766314|NCT00763139|6152533|P1|Overall Study|med change not allowed by protocol|1
1766315|NCT00763139|6152532|P2|Overall Study|Withdrawal by Subject|1
1766316|NCT00763139|6152533|P1|Overall Study|Withdrawal by Subject|0
1766317|NCT00763139|6152532|P2|Overall Study|Adverse Event|2
1766318|NCT00763139|6152533|P1|Overall Study|Adverse Event|4
1766319|NCT00763035|6152595|P2|Second Intervention|Physician Decision|0
1766320|NCT00763035|6152596|P1|Second Intervention|Physician Decision|2
1766321|NCT00763035|6152595|P2|Second Intervention|Adverse Event|0
1766322|NCT00763035|6152596|P1|Second Intervention|Adverse Event|1
1766323|NCT00763035|6152595|P2|First Intervention|Adverse Event|1
1766324|NCT00763035|6152596|P1|First Intervention|Adverse Event|0
1766325|NCT00763035|6152595|P2|First Intervention|Did not meeting inclusion/exclusion|0
1766326|NCT00763035|6152596|P1|First Intervention|Did not meeting inclusion/exclusion|1
1766327|NCT00763009|6152614|P1|Overall Study|Coronary Anatomy unsuitable|1
1766328|NCT00762996|6152619|P4|Period One|Withdrawal by Subject|0
1766329|NCT00762996|6152620|P3|Period One|Withdrawal by Subject|1
1766330|NCT00762996|6152621|P2|Period One|Withdrawal by Subject|0
1766331|NCT00762996|6152622|P1|Period One|Withdrawal by Subject|0
1766332|NCT00762996|6152619|P4|Period One|Adverse Event|0
1766333|NCT00762996|6152620|P3|Period One|Adverse Event|1
1766334|NCT00762996|6152621|P2|Period One|Adverse Event|0
1766335|NCT00762996|6152622|P1|Period One|Adverse Event|0
1766336|NCT00762996|6152619|P4|Period One|ineligible|1
1766337|NCT00762996|6152620|P3|Period One|ineligible|1
1766338|NCT00762996|6152621|P2|Period One|ineligible|0
1766339|NCT00762996|6152622|P1|Period One|ineligible|0
1766340|NCT00762996|6152619|P4|Period One|Protocol Violation|0
1766341|NCT00762996|6152620|P3|Period One|Protocol Violation|1
1766342|NCT00762996|6152621|P2|Period One|Protocol Violation|0
1766343|NCT00762996|6152622|P1|Period One|Protocol Violation|0
1766344|NCT00762970|6152635|P3|Overall Study|Difficulty of handling lens|0
1766345|NCT00762970|6152636|P2|Overall Study|Difficulty of handling lens|2
1766346|NCT00762970|6152637|P1|Overall Study|Difficulty of handling lens|1
1766347|NCT00762970|6152635|P3|Overall Study|Lost to Follow-up|0
1766348|NCT00762970|6152636|P2|Overall Study|Lost to Follow-up|2
1766349|NCT00762970|6152637|P1|Overall Study|Lost to Follow-up|1
1766350|NCT00762970|6152635|P3|Overall Study|Protocol Violation|1
1766351|NCT00762970|6152636|P2|Overall Study|Protocol Violation|1
1766352|NCT00762970|6152637|P1|Overall Study|Protocol Violation|3
1766353|NCT00762970|6152635|P3|Overall Study|Withdrawal by Subject|0
1766354|NCT00762970|6152636|P2|Overall Study|Withdrawal by Subject|4
1766355|NCT00762970|6152637|P1|Overall Study|Withdrawal by Subject|7
1766356|NCT00762892|6152655|P2|Overall Study|Incarceration|0
1766357|NCT00762892|6152656|P1|Overall Study|Incarceration|1
1766358|NCT00762892|6152655|P2|Overall Study|Pregnancy|0
1766359|NCT00762892|6152656|P1|Overall Study|Pregnancy|1
1766360|NCT00762892|6152655|P2|Overall Study|Death|0
1766361|NCT00762892|6152656|P1|Overall Study|Death|1
1766362|NCT00762892|6152655|P2|Overall Study|Withdrawal by Subject|1
1766363|NCT00762892|6152656|P1|Overall Study|Withdrawal by Subject|0
1766364|NCT00762892|6152655|P2|Overall Study|Lost to Follow-up|5
1766365|NCT00762892|6152656|P1|Overall Study|Lost to Follow-up|2
1766366|NCT00762788|6152685|P6|Overall Study|Lost to Follow-up|21
1766367|NCT00762788|6152686|P5|Overall Study|Lost to Follow-up|13
1766368|NCT00762788|6152687|P4|Overall Study|Lost to Follow-up|26
1766369|NCT00762788|6152688|P3|Overall Study|Lost to Follow-up|21
1766370|NCT00762788|6152689|P2|Overall Study|Lost to Follow-up|37
1766371|NCT00762788|6152690|P1|Overall Study|Lost to Follow-up|26
1766372|NCT00762762|6152712|P2|Overall Study|Did not report for appointments|10
1766373|NCT00762762|6152713|P1|Overall Study|Did not report for appointments|8
1766374|NCT00762723|6152730|P3|Overall Study|Study Terminated slow enrollement|3
1766375|NCT00762723|6152731|P2|Overall Study|Study Terminated slow enrollement|5
1766376|NCT00762723|6152732|P1|Overall Study|Study Terminated slow enrollement|5
1766377|NCT00762606|6152896|P2|Overall Study|Lost to Follow-up|13
1766378|NCT00762606|6152897|P1|Overall Study|Lost to Follow-up|18
1766379|NCT00762502|6152942|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
1766380|NCT00762502|6152943|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
1766381|NCT00762502|6152944|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
1766382|NCT00762502|6152942|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
1766383|NCT00762502|6152943|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
1766384|NCT00762502|6152944|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
1766385|NCT00762502|6152942|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
1766386|NCT00762502|6152943|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
1766387|NCT00762502|6152944|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
1766388|NCT00762476|6152958|P2|Overall Study|Seasonal allergies|0
1766389|NCT00762476|6152959|P1|Overall Study|Seasonal allergies|1
1766390|NCT00762476|6152958|P2|Overall Study|non-compliance with study visits|2
1766391|NCT00762476|6152959|P1|Overall Study|non-compliance with study visits|0
1766392|NCT00762476|6152958|P2|Overall Study|antibiotic use|1
1766393|NCT00762476|6152959|P1|Overall Study|antibiotic use|0
1766394|NCT00762476|6152958|P2|Overall Study|Withdrawal by Subject|12
1766395|NCT00762476|6152959|P1|Overall Study|Withdrawal by Subject|6
1766396|NCT00762476|6152958|P2|Overall Study|Physician Decision|14
1766397|NCT00762476|6152959|P1|Overall Study|Physician Decision|2
1766398|NCT00762476|6152958|P2|Overall Study|Protocol Violation|6
1766399|NCT00762476|6152959|P1|Overall Study|Protocol Violation|5
1766400|NCT00762476|6152958|P2|Overall Study|Lost to Follow-up|0
1766401|NCT00762476|6152959|P1|Overall Study|Lost to Follow-up|2
1766402|NCT00762476|6152958|P2|Overall Study|Adverse Event|1
1766403|NCT00762476|6152959|P1|Overall Study|Adverse Event|7
1766404|NCT00762463|6152971|P4|Extension Phase (Week 6 to Week 12)|Other|1
1766405|NCT00762463|6152972|P3|Extension Phase (Week 6 to Week 12)|Other|0
1766406|NCT00762463|6152973|P2|Extension Phase (Week 6 to Week 12)|Other|0
1766407|NCT00762463|6152974|P1|Extension Phase (Week 6 to Week 12)|Other|0
1766408|NCT00762463|6152971|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
1766409|NCT00762463|6152972|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
1766410|NCT00762463|6152973|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
1766411|NCT00762463|6152974|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
1766412|NCT00762463|6152971|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1766413|NCT00762463|6152972|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
1766414|NCT00762463|6152973|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1766415|NCT00762463|6152974|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
1766416|NCT00762463|6152971|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
1766417|NCT00762463|6152972|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
1766418|NCT00762463|6152973|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
1766419|NCT00762463|6152974|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
1766420|NCT00762463|6152971|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
1766421|NCT00762463|6152972|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
1766422|NCT00762463|6152973|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
1766423|NCT00762463|6152974|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
1766424|NCT00762463|6152971|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
1766425|NCT00762463|6152972|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
1766426|NCT00762463|6152973|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
1766427|NCT00762463|6152974|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
1766428|NCT00762463|6152971|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
1766429|NCT00762463|6152972|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
1766430|NCT00762463|6152973|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
1766431|NCT00762463|6152974|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
1766432|NCT00762463|6152971|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
1766433|NCT00762463|6152972|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
1766434|NCT00762463|6152973|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
1766435|NCT00762463|6152974|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
1766436|NCT00762411|6153080|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
1766437|NCT00762411|6153081|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
1766438|NCT00762411|6153080|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
1766439|NCT00762411|6153081|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
1766440|NCT00762411|6153080|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
1766441|NCT00762411|6153081|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
1766442|NCT00762411|6153080|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
1766443|NCT00762411|6153081|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
1766444|NCT00762411|6153080|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
1766445|NCT00762411|6153081|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
1766446|NCT00762411|6153080|P2|Safety Follow Up (SFU)-Optional|Death|8
1766447|NCT00762411|6153081|P1|Safety Follow Up (SFU)-Optional|Death|1
1766448|NCT00762411|6153080|P2|Delayed Start|Caregiver Decision|1
1766449|NCT00762411|6153081|P1|Delayed Start|Caregiver Decision|1
1766450|NCT00762411|6153080|P2|Delayed Start|Sponsor Decision|20
1766451|NCT00762411|6153081|P1|Delayed Start|Sponsor Decision|16
1766452|NCT00762411|6153080|P2|Delayed Start|Protocol Violation|1
1766453|NCT00762411|6153081|P1|Delayed Start|Protocol Violation|0
1766454|NCT00762411|6153080|P2|Delayed Start|Adverse Event|4
1766455|NCT00762411|6153081|P1|Delayed Start|Adverse Event|0
1766456|NCT00762411|6153080|P2|Initial Treatment|Entry Criteria Exclusion|1
1766457|NCT00762411|6153081|P1|Initial Treatment|Entry Criteria Exclusion|0
1766458|NCT00762411|6153080|P2|Initial Treatment|Abnormal Lab/ECG Result|4
1766459|NCT00762411|6153081|P1|Initial Treatment|Abnormal Lab/ECG Result|6
1766460|NCT00762411|6153080|P2|Initial Treatment|Caregiver Decision|16
1766461|NCT00762411|6153081|P1|Initial Treatment|Caregiver Decision|21
1766462|NCT00762411|6153080|P2|Initial Treatment|Lost to Follow-up|0
1766463|NCT00762411|6153081|P1|Initial Treatment|Lost to Follow-up|5
1766464|NCT00762411|6153080|P2|Initial Treatment|Sponsor Decision|401
1766465|NCT00762411|6153081|P1|Initial Treatment|Sponsor Decision|293
1766466|NCT00762411|6153080|P2|Initial Treatment|Physician Decision|0
1766467|NCT00762411|6153081|P1|Initial Treatment|Physician Decision|1
1766468|NCT00762411|6153080|P2|Initial Treatment|Withdrawal by Subject|52
1766469|NCT00762411|6153081|P1|Initial Treatment|Withdrawal by Subject|65
1766470|NCT00762411|6153080|P2|Initial Treatment|Protocol Violation|1
1766471|NCT00762411|6153081|P1|Initial Treatment|Protocol Violation|4
1766472|NCT00762411|6153080|P2|Initial Treatment|Adverse Event|40
1766473|NCT00762411|6153081|P1|Initial Treatment|Adverse Event|132
1766474|NCT00762411|6153080|P2|Initial Treatment|Death|6
1766475|NCT00762411|6153081|P1|Initial Treatment|Death|7
1766476|NCT00762385|6153145|P2|Second Intervention|Protocol Violation|3
1766477|NCT00762385|6153146|P1|Second Intervention|Protocol Violation|3
1766478|NCT00762385|6153145|P2|First Intervention|Protocol Violation|1
1766479|NCT00762385|6153146|P1|First Intervention|Protocol Violation|0
1766480|NCT00762385|6153145|P2|First Intervention|Ineligible|0
1766481|NCT00762385|6153146|P1|First Intervention|Ineligible|1
1766482|NCT00762385|6153145|P2|First Intervention|Lost to Follow-up|2
1766483|NCT00762385|6153146|P1|First Intervention|Lost to Follow-up|0
1766484|NCT00762385|6153145|P2|First Intervention|Lens Issue|1
1766485|NCT00762385|6153146|P1|First Intervention|Lens Issue|1
1766486|NCT00762372|6153159|P3|Overall Study|Adverse Event|0
1766487|NCT00762372|6153160|P2|Overall Study|Adverse Event|0
1766488|NCT00762372|6153161|P1|Overall Study|Adverse Event|1
1766489|NCT00762359|6153237|P2|Overall Study|Withdrew consent|0
1766490|NCT00762359|6153238|P1|Overall Study|Withdrew consent|1
1766491|NCT00762359|6153237|P2|Overall Study|Removal|1
1766492|NCT00762359|6153238|P1|Overall Study|Removal|0
1766493|NCT00762359|6153237|P2|Overall Study|Physician Decision|3
1766494|NCT00762359|6153238|P1|Overall Study|Physician Decision|2
1766495|NCT00762359|6153237|P2|Overall Study|Institution closed|3
1766496|NCT00762359|6153238|P1|Overall Study|Institution closed|2
1766497|NCT00762359|6153237|P2|Overall Study|Lack of Efficacy|4
1766498|NCT00762359|6153238|P1|Overall Study|Lack of Efficacy|0
1766499|NCT00762359|6153237|P2|Overall Study|Withdrawal by Subject|10
1766500|NCT00762359|6153238|P1|Overall Study|Withdrawal by Subject|13
1766501|NCT00762359|6153237|P2|Overall Study|Protocol Violation|13
1766502|NCT00762359|6153238|P1|Overall Study|Protocol Violation|21
1766503|NCT00762359|6153237|P2|Overall Study|Adverse Event|23
1766504|NCT00762359|6153238|P1|Overall Study|Adverse Event|20
1766505|NCT00762268|6153355|P2|Overall Study|Withdrawal by Subject|3
1766506|NCT00762268|6153356|P1|Overall Study|Withdrawal by Subject|3
1766507|NCT00762229|6153368|P2|Overall Study|did not recveive intervention|1
1766508|NCT00762229|6153369|P1|Overall Study|did not recveive intervention|0
1766509|NCT00762229|6153368|P2|Overall Study|Lost to Follow-up|1
1766510|NCT00762229|6153369|P1|Overall Study|Lost to Follow-up|1
1766511|NCT00762164|6153466|P2|Overall Study|Withdrawal by Subject|1
1766512|NCT00762164|6153467|P1|Overall Study|Withdrawal by Subject|0
1766513|NCT00762164|6153466|P2|Overall Study|Discontinued medication|0
1766514|NCT00762164|6153467|P1|Overall Study|Discontinued medication|2
1766515|NCT00762164|6153466|P2|Overall Study|Lost to Follow-up|1
1766516|NCT00762164|6153467|P1|Overall Study|Lost to Follow-up|1
1766517|NCT00762086|6153477|P2|Overall Study|Ineligible to participate in the study|0
1766518|NCT00762086|6153478|P1|Overall Study|Ineligible to participate in the study|1
1766519|NCT00762086|6153477|P2|Overall Study|Withdrawal by Subject|2
1766520|NCT00762086|6153478|P1|Overall Study|Withdrawal by Subject|2
1766521|NCT00762086|6153477|P2|Overall Study|Non compliance|0
1766522|NCT00762086|6153478|P1|Overall Study|Non compliance|1
1766523|NCT00762086|6153477|P2|Overall Study|Lost to Follow-up|2
1766524|NCT00762086|6153478|P1|Overall Study|Lost to Follow-up|0
1766525|NCT00762086|6153477|P2|Overall Study|Adverse Event|0
1766526|NCT00762086|6153478|P1|Overall Study|Adverse Event|2
1766527|NCT00762073|6153488|P4|Overall Study|Not on treatment for >/= 77 days|0
1766528|NCT00762073|6153489|P3|Overall Study|Not on treatment for >/= 77 days|0
1766529|NCT00762073|6153490|P2|Overall Study|Not on treatment for >/= 77 days|0
1766530|NCT00762073|6153491|P1|Overall Study|Not on treatment for >/= 77 days|1
1766531|NCT00762073|6153488|P4|Overall Study|Withdrawal by Subject|1
1766532|NCT00762073|6153489|P3|Overall Study|Withdrawal by Subject|1
1766533|NCT00762073|6153490|P2|Overall Study|Withdrawal by Subject|2
1766534|NCT00762073|6153491|P1|Overall Study|Withdrawal by Subject|1
1766535|NCT00762073|6153488|P4|Overall Study|Significant Subject Noncompliance|1
1766536|NCT00762073|6153489|P3|Overall Study|Significant Subject Noncompliance|0
1766537|NCT00762073|6153490|P2|Overall Study|Significant Subject Noncompliance|1
1766538|NCT00762073|6153491|P1|Overall Study|Significant Subject Noncompliance|0
1766539|NCT00762073|6153488|P4|Overall Study|Adverse Event|1
1766540|NCT00762073|6153489|P3|Overall Study|Adverse Event|1
1766541|NCT00762073|6153490|P2|Overall Study|Adverse Event|0
1766542|NCT00762073|6153491|P1|Overall Study|Adverse Event|1
1766543|NCT00762073|6153488|P4|Overall Study|Lack of Efficacy|0
1766544|NCT00762073|6153489|P3|Overall Study|Lack of Efficacy|0
1766545|NCT00762073|6153490|P2|Overall Study|Lack of Efficacy|1
1766546|NCT00762073|6153491|P1|Overall Study|Lack of Efficacy|1
1766547|NCT00762034|6153555|P2|Maintenance Period|Other|1
1766548|NCT00762034|6153556|P1|Maintenance Period|Other|1
1766549|NCT00762034|6153555|P2|Maintenance Period|Death due to study disease|3
1766550|NCT00762034|6153556|P1|Maintenance Period|Death due to study disease|3
1766551|NCT00762034|6153555|P2|Maintenance Period|Death not due to study disease|5
1766552|NCT00762034|6153556|P1|Maintenance Period|Death not due to study disease|2
1766553|NCT00762034|6153555|P2|Maintenance Period|Withdrawal by Subject|14
1766554|NCT00762034|6153556|P1|Maintenance Period|Withdrawal by Subject|34
1766555|NCT00762034|6153555|P2|Maintenance Period|Physician Decision|20
1766556|NCT00762034|6153556|P1|Maintenance Period|Physician Decision|25
1766557|NCT00762034|6153555|P2|Maintenance Period|Progressive Disease|224
1766558|NCT00762034|6153556|P1|Maintenance Period|Progressive Disease|186
1766559|NCT00762034|6153555|P2|Maintenance Period|Adverse Event|26
1766560|NCT00762034|6153556|P1|Maintenance Period|Adverse Event|42
1766561|NCT00762034|6153555|P2|Maintenance Period|Entry Criterion Not Met|2
1766562|NCT00762034|6153556|P1|Maintenance Period|Entry Criterion Not Met|0
1766563|NCT00762034|6153555|P2|Maintenance Period|Protocol Violation|3
1766564|NCT00762034|6153556|P1|Maintenance Period|Protocol Violation|1
1766565|NCT00762034|6153555|P2|Induction Period|Deaths Due to Study Disease|9
1766566|NCT00762034|6153556|P1|Induction Period|Deaths Due to Study Disease|9
1766567|NCT00762034|6153555|P2|Induction Period|Deaths Not Due to Study Disease|14
1766568|NCT00762034|6153556|P1|Induction Period|Deaths Not Due to Study Disease|19
1766569|NCT00762034|6153555|P2|Induction Period|Withdrawal by Subject|19
1766570|NCT00762034|6153556|P1|Induction Period|Withdrawal by Subject|15
1766571|NCT00762034|6153555|P2|Induction Period|Physician Decision|20
1766572|NCT00762034|6153556|P1|Induction Period|Physician Decision|21
1766573|NCT00762034|6153555|P2|Induction Period|Progressive Disease|55
1766574|NCT00762034|6153556|P1|Induction Period|Progressive Disease|73
1766575|NCT00762034|6153555|P2|Induction Period|Lost to Follow-up|1
1766576|NCT00762034|6153556|P1|Induction Period|Lost to Follow-up|1
1766577|NCT00762034|6153555|P2|Induction Period|Adverse Event|38
1766578|NCT00762034|6153556|P1|Induction Period|Adverse Event|27
1766579|NCT00762034|6153555|P2|Induction Period|Entry Criterion Not Met|11
1766580|NCT00762034|6153556|P1|Induction Period|Entry Criterion Not Met|12
1766581|NCT00762034|6153555|P2|Induction Period|Protocol Violation|2
1766582|NCT00762034|6153556|P1|Induction Period|Protocol Violation|1
1766583|NCT00761969|6153628|P2|Overall Study|Lost to Follow-up|93
1766584|NCT00761969|6153629|P1|Overall Study|Lost to Follow-up|88
1766585|NCT00761969|6153628|P2|Overall Study|Death|47
1766586|NCT00761969|6153629|P1|Overall Study|Death|112
1766587|NCT00761956|6153639|P2|Overall Study|Adverse Event|34
1766588|NCT00761956|6153640|P1|Overall Study|Adverse Event|26
1766589|NCT00761956|6153639|P2|Overall Study|Death|1
1766590|NCT00761956|6153640|P1|Overall Study|Death|0
1766591|NCT00761956|6153639|P2|Overall Study|Withdrawal by Subject|8
1766592|NCT00761956|6153640|P1|Overall Study|Withdrawal by Subject|3
1766593|NCT00761956|6153639|P2|Overall Study|Lost to Follow-up|11
1766594|NCT00761956|6153640|P1|Overall Study|Lost to Follow-up|6
1766595|NCT00761891|6153667|P1|Overall Study|Withdrawal by Subject|10
1766596|NCT00761865|6153674|P2|Overall Study|Lost to Follow-up|7
1766597|NCT00761865|6153675|P1|Overall Study|Lost to Follow-up|8
1766598|NCT00761774|6153696|P1|Overall Study|IP stopped by hospital physician|1
1766599|NCT00761774|6153696|P1|Overall Study|Subject IP non-compliance|1
1766600|NCT00761774|6153696|P1|Overall Study|Coordinator leaving site|1
1766601|NCT00761774|6153696|P1|Overall Study|Patient moved out of study area|1
1766602|NCT00761774|6153696|P1|Overall Study|Investigator clinical judgement|1
1766603|NCT00761774|6153696|P1|Overall Study|Sponsor decision|1
1766604|NCT00761774|6153696|P1|Overall Study|Medical decision to read SUSAR reports|1
1766605|NCT00761774|6153696|P1|Overall Study|Reclassification of seizures|1
1766606|NCT00761774|6153696|P1|Overall Study|End of study|2
1766607|NCT00761774|6153696|P1|Overall Study|Non-compliance|4
1766608|NCT00761774|6153696|P1|Overall Study|Withdrawal by Subject|9
1766609|NCT00761774|6153696|P1|Overall Study|Lost to Follow-up|2
1766610|NCT00761774|6153696|P1|Overall Study|Lack of Efficacy|37
1766611|NCT00761774|6153696|P1|Overall Study|Adverse Event|17
1766612|NCT00761761|6153707|P2|Overall Study|Withdrawal by Subject|0
1766613|NCT00761761|6153708|P1|Overall Study|Withdrawal by Subject|3
1766614|NCT00761761|6153707|P2|Overall Study|Lost to Follow-up|1
1766615|NCT00761761|6153708|P1|Overall Study|Lost to Follow-up|3
1766616|NCT00761748|6153720|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
1766617|NCT00761748|6153721|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
1766618|NCT00761748|6153720|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
1766619|NCT00761748|6153721|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
1766620|NCT00761735|6153727|P1|Overall Study|Administrative|1
1766621|NCT00761735|6153727|P1|Overall Study|Non-compliance with protocol|1
1766622|NCT00761735|6153727|P1|Overall Study|Withdrawal by Subject|6
1766623|NCT00761735|6153727|P1|Overall Study|Lost to Follow-up|6
1766624|NCT00761631|6153743|P6|Overall Study|Other|1
1766625|NCT00761631|6153744|P5|Overall Study|Other|1
1766626|NCT00761631|6153745|P4|Overall Study|Other|0
1766627|NCT00761631|6153746|P3|Overall Study|Other|0
1766628|NCT00761631|6153747|P2|Overall Study|Other|0
1766629|NCT00761631|6153748|P1|Overall Study|Other|0
1766630|NCT00761631|6153743|P6|Overall Study|Physician Decision|0
1766631|NCT00761631|6153744|P5|Overall Study|Physician Decision|0
1766632|NCT00761631|6153745|P4|Overall Study|Physician Decision|0
1766633|NCT00761631|6153746|P3|Overall Study|Physician Decision|0
1766634|NCT00761631|6153747|P2|Overall Study|Physician Decision|0
1766635|NCT00761631|6153748|P1|Overall Study|Physician Decision|1
1766636|NCT00761631|6153743|P6|Overall Study|Failed to return|2
1766637|NCT00761631|6153744|P5|Overall Study|Failed to return|5
1766638|NCT00761631|6153745|P4|Overall Study|Failed to return|1
1766639|NCT00761631|6153746|P3|Overall Study|Failed to return|1
1766640|NCT00761631|6153747|P2|Overall Study|Failed to return|0
1766641|NCT00761631|6153748|P1|Overall Study|Failed to return|1
1766642|NCT00761631|6153743|P6|Overall Study|Randomized, not treated|0
1766643|NCT00761631|6153744|P5|Overall Study|Randomized, not treated|0
1766644|NCT00761631|6153745|P4|Overall Study|Randomized, not treated|0
1766645|NCT00761631|6153746|P3|Overall Study|Randomized, not treated|0
1766646|NCT00761631|6153747|P2|Overall Study|Randomized, not treated|0
1766647|NCT00761631|6153748|P1|Overall Study|Randomized, not treated|1
1766648|NCT00761631|6153743|P6|Overall Study|Protocol Violation|1
1766649|NCT00761631|6153744|P5|Overall Study|Protocol Violation|5
1766650|NCT00761631|6153745|P4|Overall Study|Protocol Violation|1
1766651|NCT00761631|6153746|P3|Overall Study|Protocol Violation|0
1766652|NCT00761631|6153747|P2|Overall Study|Protocol Violation|0
1766653|NCT00761631|6153748|P1|Overall Study|Protocol Violation|2
1766654|NCT00761631|6153743|P6|Overall Study|Lost to Follow-up|1
1766655|NCT00761631|6153744|P5|Overall Study|Lost to Follow-up|6
1766656|NCT00761631|6153745|P4|Overall Study|Lost to Follow-up|1
1766657|NCT00761631|6153746|P3|Overall Study|Lost to Follow-up|7
1766658|NCT00761631|6153747|P2|Overall Study|Lost to Follow-up|4
1766659|NCT00761631|6153748|P1|Overall Study|Lost to Follow-up|2
1766660|NCT00761631|6153743|P6|Overall Study|Parent/legal guardian request|0
1766661|NCT00761631|6153744|P5|Overall Study|Parent/legal guardian request|5
1766662|NCT00761631|6153745|P4|Overall Study|Parent/legal guardian request|0
1766663|NCT00761631|6153746|P3|Overall Study|Parent/legal guardian request|8
1766664|NCT00761631|6153747|P2|Overall Study|Parent/legal guardian request|3
1766665|NCT00761631|6153748|P1|Overall Study|Parent/legal guardian request|8
1766666|NCT00761605|6153783|P1|Overall Study|Other|21
1766667|NCT00761605|6153783|P1|Overall Study|Withdrawal by Subject|37
1766668|NCT00761605|6153783|P1|Overall Study|Lost to Follow-up|29
1766669|NCT00761605|6153783|P1|Overall Study|Lack of Efficacy|26
1766670|NCT00761605|6153783|P1|Overall Study|Death|2
1766671|NCT00761605|6153783|P1|Overall Study|Adverse Event|26
1766672|NCT00761579|6153827|P1|Overall Study|Intake of prohibited concomitant drug|1
1766673|NCT00761579|6153827|P1|Overall Study|Lost survey form|1
1766674|NCT00761579|6153827|P1|Overall Study|Aggravation of symptoms by changing drug|1
1766675|NCT00761579|6153827|P1|Overall Study|Aggravation of depression|1
1766676|NCT00761579|6153827|P1|Overall Study|Drug overdose|1
1766677|NCT00761579|6153827|P1|Overall Study|Protocol deviation|1
1766678|NCT00761579|6153827|P1|Overall Study|Lack of compliance|2
1766679|NCT00761579|6153827|P1|Overall Study|Withdrawal by Subject|34
1766680|NCT00761579|6153827|P1|Overall Study|Pregnancy|1
1766681|NCT00761579|6153827|P1|Overall Study|Lost to Follow-up|16
1766682|NCT00761579|6153827|P1|Overall Study|Lack of Efficacy|21
1766683|NCT00761579|6153827|P1|Overall Study|Death|2
1766684|NCT00761579|6153827|P1|Overall Study|Adverse Event|10
1766685|NCT00761527|6153860|P1|Overall Study|Unknown reason|2
1766686|NCT00761527|6153860|P1|Overall Study|Lost to Follow-up|9
1766687|NCT00761527|6153860|P1|Overall Study|Poor Compliance|8
1766688|NCT00761527|6153860|P1|Overall Study|Adverse Event|3
1766689|NCT00761514|6153867|P1|Overall Study|Unable to pay for medications|1
1766690|NCT00761514|6153867|P1|Overall Study|Problem complying with study visit|1
1766691|NCT00761514|6153867|P1|Overall Study|Health insurance didn't cover study drug|1
1766692|NCT00761514|6153867|P1|Overall Study|Lost to Follow-up|1
1766693|NCT00761514|6153867|P1|Overall Study|Withdrawal by Subject|2
1766694|NCT00761514|6153867|P1|Overall Study|Adverse Event|1
1766695|NCT00761462|6153874|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
1766696|NCT00761462|6153875|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
1766697|NCT00761462|6153874|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
1766698|NCT00761462|6153875|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
1766699|NCT00761462|6153874|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
1766700|NCT00761462|6153875|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
1766701|NCT00761462|6153874|P2|Treatment|Subjects never received study medication|12
1766702|NCT00761462|6153875|P1|Treatment|Subjects never received study medication|23
1766703|NCT00761319|6153889|P2|Overall Study|Missing|0
1766704|NCT00761319|6153890|P1|Overall Study|Missing|1
1766705|NCT00761319|6153889|P2|Overall Study|Nonspecified|2
1766706|NCT00761319|6153890|P1|Overall Study|Nonspecified|2
1766707|NCT00761319|6153889|P2|Overall Study|Lost to Follow-up|1
1766708|NCT00761319|6153890|P1|Overall Study|Lost to Follow-up|1
1766709|NCT00761319|6153889|P2|Overall Study|Noncompliance|3
1766710|NCT00761319|6153890|P1|Overall Study|Noncompliance|4
1766711|NCT00761319|6153889|P2|Overall Study|Withdrawal by Subject|7
1766712|NCT00761319|6153890|P1|Overall Study|Withdrawal by Subject|8
1766713|NCT00761319|6153889|P2|Overall Study|Adverse Event|7
1766714|NCT00761319|6153890|P1|Overall Study|Adverse Event|11
1766715|NCT00761319|6153889|P2|Overall Study|Protocol Violation|14
1766716|NCT00761319|6153890|P1|Overall Study|Protocol Violation|21
1766717|NCT00761306|6153898|P1|Overall Study|Administrative or Other Reasons|5
1766718|NCT00761306|6153898|P1|Overall Study|Lost to Follow-up|1
1766719|NCT00761306|6153898|P1|Overall Study|Withdrawal of Consent|3
1766720|NCT00761306|6153898|P1|Overall Study|Protocol Violation|2
1766721|NCT00761306|6153898|P1|Overall Study|Lack of Efficacy|4
1766722|NCT00761306|6153898|P1|Overall Study|Adverse Event|5
1766723|NCT00761280|6153909|P2|First Dose to End of Study|Lost to Follow-up|1
1766724|NCT00761280|6153910|P1|First Dose to End of Study|Lost to Follow-up|0
1766725|NCT00761280|6153909|P2|First Dose to End of Study|Death|0
1766726|NCT00761280|6153910|P1|First Dose to End of Study|Death|1
1766727|NCT00761280|6153909|P2|First Dose to End of Study|Sponsor decision|2
1766728|NCT00761280|6153910|P1|First Dose to End of Study|Sponsor decision|1
1766729|NCT00761280|6153909|P2|First Dose to End of Study|Progressive disease|3
1766730|NCT00761280|6153910|P1|First Dose to End of Study|Progressive disease|5
1766731|NCT00761280|6153909|P2|First Dose to End of Study|End of trial|5
1766732|NCT00761280|6153910|P1|First Dose to End of Study|End of trial|5
1766733|NCT00761280|6153909|P2|Randomization to First Dose|Other|0
1766734|NCT00761280|6153910|P1|Randomization to First Dose|Other|1
1766735|NCT00761280|6153909|P2|Randomization to First Dose|Sponsor decision|0
1766736|NCT00761280|6153910|P1|Randomization to First Dose|Sponsor decision|1
1766737|NCT00761280|6153909|P2|Randomization to First Dose|Withdrawal by Subject|2
1766738|NCT00761280|6153910|P1|Randomization to First Dose|Withdrawal by Subject|0
1766739|NCT00761267|6153941|P3|Overall Study|Withdrawal by Subject|0
1766740|NCT00761267|6153942|P2|Overall Study|Withdrawal by Subject|1
1766741|NCT00761267|6153943|P1|Overall Study|Withdrawal by Subject|0
1766742|NCT00761267|6153941|P3|Overall Study|Randomized but not treated|0
1766743|NCT00761267|6153942|P2|Overall Study|Randomized but not treated|1
1766744|NCT00761267|6153943|P1|Overall Study|Randomized but not treated|1
1766745|NCT00761267|6153941|P3|Overall Study|Lost to Follow-up|1
1766746|NCT00761267|6153942|P2|Overall Study|Lost to Follow-up|0
1766747|NCT00761267|6153943|P1|Overall Study|Lost to Follow-up|0
1766748|NCT00761267|6153941|P3|Overall Study|Death|5
1766749|NCT00761267|6153942|P2|Overall Study|Death|2
1766750|NCT00761267|6153943|P1|Overall Study|Death|1
1766751|NCT00761215|6153994|P3|Overall Study|Bacteremia|0
1766752|NCT00761215|6153995|P2|Overall Study|Bacteremia|0
1766753|NCT00761215|6153996|P1|Overall Study|Bacteremia|1
1766754|NCT00761215|6153994|P3|Overall Study|Withdrawal by Subject|0
1766755|NCT00761215|6153995|P2|Overall Study|Withdrawal by Subject|0
1766756|NCT00761215|6153996|P1|Overall Study|Withdrawal by Subject|1
1766757|NCT00761215|6153994|P3|Overall Study|Lost to Follow-up|6
1766758|NCT00761215|6153995|P2|Overall Study|Lost to Follow-up|3
1766759|NCT00761215|6153996|P1|Overall Study|Lost to Follow-up|6
1766760|NCT00761215|6153994|P3|Overall Study|Randomized but didn't receive drug|2
1766761|NCT00761215|6153995|P2|Overall Study|Randomized but didn't receive drug|1
1766762|NCT00761215|6153996|P1|Overall Study|Randomized but didn't receive drug|1
1766763|NCT00761189|6154038|P1|Overall Study|Other|13
1766764|NCT00761189|6154038|P1|Overall Study|Withdrawal by Subject|49
1766765|NCT00761189|6154038|P1|Overall Study|Lost to Follow-up|36
1766766|NCT00761189|6154038|P1|Overall Study|Lack of Efficacy|45
1766767|NCT00761189|6154038|P1|Overall Study|Adverse Event|42
1766768|NCT00761176|6154055|P2|Overall Study|Withdrawal by Subject|1
1766769|NCT00761176|6154056|P1|Overall Study|Withdrawal by Subject|1
1766770|NCT00761176|6154055|P2|Overall Study|Death|0
1766771|NCT00761176|6154056|P1|Overall Study|Death|1
1766772|NCT00761150|6154065|P3|Double-blind Period|Other|3
1766773|NCT00761150|6154066|P2|Double-blind Period|Other|3
1766774|NCT00761150|6154067|P1|Double-blind Period|Other|0
1766775|NCT00761150|6154065|P3|Double-blind Period|Noncompliance|0
1766776|NCT00761150|6154066|P2|Double-blind Period|Noncompliance|1
1766777|NCT00761150|6154067|P1|Double-blind Period|Noncompliance|0
1766778|NCT00761150|6154065|P3|Double-blind Period|Did not meet DB randomization criteria|1
1766779|NCT00761150|6154066|P2|Double-blind Period|Did not meet DB randomization criteria|0
1766780|NCT00761150|6154067|P1|Double-blind Period|Did not meet DB randomization criteria|0
1766781|NCT00761150|6154065|P3|Double-blind Period|Lost to Follow-up|1
1766782|NCT00761150|6154066|P2|Double-blind Period|Lost to Follow-up|2
1766783|NCT00761150|6154067|P1|Double-blind Period|Lost to Follow-up|0
1766784|NCT00761150|6154065|P3|Double-blind Period|Withdrawal by Subject|2
1766785|NCT00761150|6154066|P2|Double-blind Period|Withdrawal by Subject|3
1766786|NCT00761150|6154067|P1|Double-blind Period|Withdrawal by Subject|0
1766787|NCT00761150|6154065|P3|Double-blind Period|Adverse Event|3
1766788|NCT00761150|6154066|P2|Double-blind Period|Adverse Event|3
1766789|NCT00761150|6154067|P1|Double-blind Period|Adverse Event|0
1766790|NCT00761150|6154065|P3|Double-blind Period|Lack of Efficacy|19
1766791|NCT00761150|6154066|P2|Double-blind Period|Lack of Efficacy|2
1766792|NCT00761150|6154067|P1|Double-blind Period|Lack of Efficacy|0
1766793|NCT00761150|6154065|P3|Open-label Period|Other|0
1766794|NCT00761150|6154066|P2|Open-label Period|Other|0
1766795|NCT00761150|6154067|P1|Open-label Period|Other|5
1766796|NCT00761150|6154065|P3|Open-label Period|Noncompliance|0
1766797|NCT00761150|6154066|P2|Open-label Period|Noncompliance|0
1766798|NCT00761150|6154067|P1|Open-label Period|Noncompliance|2
1766799|NCT00761150|6154065|P3|Open-label Period|Withdrawal by Subject|0
1766800|NCT00761150|6154066|P2|Open-label Period|Withdrawal by Subject|0
1766801|NCT00761150|6154067|P1|Open-label Period|Withdrawal by Subject|5
1766802|NCT00761150|6154065|P3|Open-label Period|Lack of Efficacy|0
1766803|NCT00761150|6154066|P2|Open-label Period|Lack of Efficacy|0
1766804|NCT00761150|6154067|P1|Open-label Period|Lack of Efficacy|4
1766805|NCT00761150|6154065|P3|Open-label Period|Lost to Follow-up|0
1766806|NCT00761150|6154066|P2|Open-label Period|Lost to Follow-up|0
1766807|NCT00761150|6154067|P1|Open-label Period|Lost to Follow-up|7
1766808|NCT00761150|6154065|P3|Open-label Period|Did not meet DB randomization criteria|0
1766809|NCT00761150|6154066|P2|Open-label Period|Did not meet DB randomization criteria|0
1766810|NCT00761150|6154067|P1|Open-label Period|Did not meet DB randomization criteria|11
1766811|NCT00761150|6154065|P3|Open-label Period|Adverse Event|0
1766812|NCT00761150|6154066|P2|Open-label Period|Adverse Event|0
1766813|NCT00761150|6154067|P1|Open-label Period|Adverse Event|36
1766814|NCT00760877|6154139|P2|Overall Study|Treatment failure|0
1766815|NCT00760877|6154140|P1|Overall Study|Treatment failure|1
1766816|NCT00760877|6154139|P2|Overall Study|Participants transferred to AMN107A2408|1
1766817|NCT00760877|6154140|P1|Overall Study|Participants transferred to AMN107A2408|11
1766818|NCT00760877|6154139|P2|Overall Study|Physician Decision|2
1766819|NCT00760877|6154140|P1|Overall Study|Physician Decision|1
1766820|NCT00760877|6154139|P2|Overall Study|Participant not eligible to cross-over|1
1766821|NCT00760877|6154140|P1|Overall Study|Participant not eligible to cross-over|0
1766822|NCT00760877|6154139|P2|Overall Study|Participant diagnosed with AML|1
1766823|NCT00760877|6154140|P1|Overall Study|Participant diagnosed with AML|0
1766824|NCT00760877|6154139|P2|Overall Study|Adverse Event|12
1766825|NCT00760877|6154140|P1|Overall Study|Adverse Event|19
1766826|NCT00760877|6154139|P2|Overall Study|Withdrawal by Subject|3
1766827|NCT00760877|6154140|P1|Overall Study|Withdrawal by Subject|7
1766828|NCT00760877|6154139|P2|Overall Study|Death|1
1766829|NCT00760877|6154140|P1|Overall Study|Death|2
1766830|NCT00760877|6154139|P2|Overall Study|Pregnancy|4
1766831|NCT00760877|6154140|P1|Overall Study|Pregnancy|1
1766832|NCT00760877|6154139|P2|Overall Study|Non-compliance with protocol treatment|1
1766833|NCT00760877|6154140|P1|Overall Study|Non-compliance with protocol treatment|2
1766834|NCT00760877|6154139|P2|Overall Study|Protocol Violation|0
1766835|NCT00760877|6154140|P1|Overall Study|Protocol Violation|1
1766836|NCT00760838|6154158|P2|Overall Study|Withdrawal by Subject|1
1766837|NCT00760838|6154159|P1|Overall Study|Withdrawal by Subject|1
1766838|NCT00760838|6154158|P2|Overall Study|Lost to Follow-up|0
1766839|NCT00760838|6154159|P1|Overall Study|Lost to Follow-up|2
1766840|NCT00760838|6154158|P2|Overall Study|Lack of Efficacy|0
1766841|NCT00760838|6154159|P1|Overall Study|Lack of Efficacy|1
1766842|NCT00760838|6154158|P2|Overall Study|Adverse Event|1
1766843|NCT00760838|6154159|P1|Overall Study|Adverse Event|1
1766844|NCT00760747|6154177|P2|Study Period III|Physician Decision|1
1766845|NCT00760747|6154178|P1|Study Period III|Physician Decision|0
1766846|NCT00760747|6154177|P2|Study Period III|Protocol Violation|1
1766847|NCT00760747|6154178|P1|Study Period III|Protocol Violation|1
1766848|NCT00760747|6154177|P2|Study Period III|Parent/Caregiver Decision|1
1766849|NCT00760747|6154178|P1|Study Period III|Parent/Caregiver Decision|0
1766850|NCT00760747|6154177|P2|Study Period III|Lack of Efficacy|0
1766851|NCT00760747|6154178|P1|Study Period III|Lack of Efficacy|1
1766852|NCT00760747|6154177|P2|Study Period III|Adverse Event|0
1766853|NCT00760747|6154178|P1|Study Period III|Adverse Event|1
1766854|NCT00760747|6154177|P2|Study Period II|No drug administered|1
1766855|NCT00760747|6154178|P1|Study Period II|No drug administered|0
1766856|NCT00760747|6154177|P2|Study Period II|Withdrawal by Subject|0
1766857|NCT00760747|6154178|P1|Study Period II|Withdrawal by Subject|1
1766858|NCT00760747|6154177|P2|Study Period II|Protocol Violation|3
1766859|NCT00760747|6154178|P1|Study Period II|Protocol Violation|6
1766860|NCT00760747|6154177|P2|Study Period II|Parent/Caregiver Decision|0
1766861|NCT00760747|6154178|P1|Study Period II|Parent/Caregiver Decision|3
1766862|NCT00760747|6154177|P2|Study Period II|Lack of Efficacy|6
1766863|NCT00760747|6154178|P1|Study Period II|Lack of Efficacy|0
1766864|NCT00760747|6154177|P2|Study Period II|Adverse Event|4
1766865|NCT00760747|6154178|P1|Study Period II|Adverse Event|3
1766866|NCT00760669|6154206|P1|Overall Study|Took drug before entering in contract|5
1766867|NCT00760669|6154206|P1|Overall Study|Participants with overlapping cases|1
1766868|NCT00760669|6154206|P1|Overall Study|Participants missing efficacy assessment|6
1766869|NCT00760669|6154206|P1|Overall Study|Not assessed for overall improvement|18
1766870|NCT00760617|6154223|P3|Overall Study|Lost to Follow-up|5
1766871|NCT00760617|6154224|P2|Overall Study|Lost to Follow-up|0
1766872|NCT00760617|6154225|P1|Overall Study|Lost to Follow-up|0
1766873|NCT00760617|6154223|P3|Overall Study|Adverse Event|0
1766874|NCT00760617|6154224|P2|Overall Study|Adverse Event|2
1766875|NCT00760617|6154225|P1|Overall Study|Adverse Event|5
1766876|NCT00760552|6154339|P2|Overall Study|Lost to Follow-up|10
1766877|NCT00760552|6154340|P1|Overall Study|Lost to Follow-up|11
1766878|NCT00760552|6154339|P2|Overall Study|Death|0
1766879|NCT00760552|6154340|P1|Overall Study|Death|2
1766880|NCT00760513|6154376|P2|Overall Study|Withdrawal by Subject|7
1766881|NCT00760513|6154377|P1|Overall Study|Withdrawal by Subject|5
1766882|NCT00760487|6154387|P1|Overall Study|Unilateral implantation|3
1766883|NCT00760474|6154393|P2|Period 2 (P2)|Adverse Event|1
1766884|NCT00760474|6154394|P1|Period 2 (P2)|Adverse Event|0
1766885|NCT00760474|6154393|P2|Period 2 (P2)|Lost to Follow-up|0
1766886|NCT00760474|6154394|P1|Period 2 (P2)|Lost to Follow-up|1
1766887|NCT00760474|6154393|P2|Placebo Washout Period|Other|1
1766888|NCT00760474|6154394|P1|Placebo Washout Period|Other|0
1766889|NCT00760474|6154393|P2|Period 1 (P1)|Discontinued then re-entered|1
1766890|NCT00760474|6154394|P1|Period 1 (P1)|Discontinued then re-entered|1
1766891|NCT00760383|6154451|P2|Overall Study|moved away; withdrew; medical reasons|7
1766892|NCT00760383|6154452|P1|Overall Study|moved away; withdrew; medical reasons|5
1766893|NCT00760266|6154464|P2|Overall Study|Administrative Problems|1
1766894|NCT00760266|6154465|P1|Overall Study|Administrative Problems|0
1766895|NCT00760266|6154464|P2|Overall Study|Lost to Follow-up|1
1766896|NCT00760266|6154465|P1|Overall Study|Lost to Follow-up|2
1766897|NCT00760266|6154464|P2|Overall Study|Patient withdrew consent|3
1766898|NCT00760266|6154465|P1|Overall Study|Patient withdrew consent|3
1766899|NCT00760266|6154464|P2|Overall Study|Protocol deviation|4
1766900|NCT00760266|6154465|P1|Overall Study|Protocol deviation|2
1766901|NCT00760266|6154464|P2|Overall Study|Lack of Efficacy|2
1766902|NCT00760266|6154465|P1|Overall Study|Lack of Efficacy|2
1766903|NCT00760266|6154464|P2|Overall Study|Abnormal test procedure result(s)|0
1766904|NCT00760266|6154465|P1|Overall Study|Abnormal test procedure result(s)|1
1766905|NCT00760266|6154464|P2|Overall Study|Abnormal laboratory value(s)|0
1766906|NCT00760266|6154465|P1|Overall Study|Abnormal laboratory value(s)|1
1766907|NCT00760266|6154464|P2|Overall Study|Adverse Event|7
1766908|NCT00760266|6154465|P1|Overall Study|Adverse Event|13
1766909|NCT00760214|6154482|P3|Overall Study|Other|6
1766910|NCT00760214|6154483|P2|Overall Study|Other|4
1766911|NCT00760214|6154484|P1|Overall Study|Other|3
1766912|NCT00760214|6154482|P3|Overall Study|Physician Decision|1
1766913|NCT00760214|6154483|P2|Overall Study|Physician Decision|1
1766914|NCT00760214|6154484|P1|Overall Study|Physician Decision|1
1766915|NCT00760214|6154482|P3|Overall Study|Pregnancy|1
1766916|NCT00760214|6154483|P2|Overall Study|Pregnancy|0
1766917|NCT00760214|6154484|P1|Overall Study|Pregnancy|0
1766918|NCT00760214|6154482|P3|Overall Study|Lack of Efficacy|4
1766919|NCT00760214|6154483|P2|Overall Study|Lack of Efficacy|2
1766920|NCT00760214|6154484|P1|Overall Study|Lack of Efficacy|3
1766921|NCT00760214|6154482|P3|Overall Study|Withdrawal by Subject|13
1766922|NCT00760214|6154483|P2|Overall Study|Withdrawal by Subject|14
1766923|NCT00760214|6154484|P1|Overall Study|Withdrawal by Subject|12
1766924|NCT00760214|6154482|P3|Overall Study|Lost to Follow-up|1
1766925|NCT00760214|6154483|P2|Overall Study|Lost to Follow-up|0
1766926|NCT00760214|6154484|P1|Overall Study|Lost to Follow-up|0
1766927|NCT00760214|6154482|P3|Overall Study|Protocol Violation|3
1766928|NCT00760214|6154483|P2|Overall Study|Protocol Violation|0
1766929|NCT00760214|6154484|P1|Overall Study|Protocol Violation|3
1766930|NCT00760214|6154482|P3|Overall Study|Adverse Event|12
1766931|NCT00760214|6154483|P2|Overall Study|Adverse Event|9
1766932|NCT00760214|6154484|P1|Overall Study|Adverse Event|8
1766933|NCT00760084|6154525|P1|Overall Study|Progressive Disease|3
1766934|NCT00760084|6154525|P1|Overall Study|Withdrawal by Subject|2
1766935|NCT00760084|6154525|P1|Overall Study|Physician Decision|5
1766936|NCT00759954|6154568|P2|Overall Study|Adverse Event|2
1766937|NCT00759954|6154569|P1|Overall Study|Adverse Event|1
1766938|NCT00759954|6154568|P2|Overall Study|Personal reason|0
1766939|NCT00759954|6154569|P1|Overall Study|Personal reason|1
1766940|NCT00759941|6154583|P2|Overall Study|Exited in error by site|1
1766941|NCT00759941|6154584|P1|Overall Study|Exited in error by site|1
1766942|NCT00759941|6154583|P2|Overall Study|Adverse Event|0
1766943|NCT00759941|6154584|P1|Overall Study|Adverse Event|1
1766944|NCT00759941|6154583|P2|Overall Study|Use of medication|0
1766945|NCT00759941|6154584|P1|Overall Study|Use of medication|1
1766946|NCT00759915|6154598|P2|Overall Study|Adverse Event|1
1766947|NCT00759915|6154599|P1|Overall Study|Adverse Event|0
1766948|NCT00759915|6154598|P2|Overall Study|Withdrawal by Subject|0
1766949|NCT00759915|6154599|P1|Overall Study|Withdrawal by Subject|1
1766950|NCT00759902|6154613|P2|Overall Study|Adverse Event|1
1766951|NCT00759902|6154614|P1|Overall Study|Adverse Event|0
1766952|NCT00759863|6154628|P2|Overall Study|Death, moved, or lost contact|18
1766953|NCT00759863|6154629|P1|Overall Study|Death, moved, or lost contact|20
1766954|NCT00759785|6154650|P2|Overall Study|Withdrawal by Subject|1
1766955|NCT00759785|6154651|P1|Overall Study|Withdrawal by Subject|0
1766956|NCT00759785|6154650|P2|Overall Study|Physician Decision|1
1766957|NCT00759785|6154651|P1|Overall Study|Physician Decision|0
1766958|NCT00759785|6154650|P2|Overall Study|Protocol Violation|0
1766959|NCT00759785|6154651|P1|Overall Study|Protocol Violation|1
1766960|NCT00759785|6154650|P2|Overall Study|Participant sample lost|1
1766961|NCT00759785|6154651|P1|Overall Study|Participant sample lost|0
1766962|NCT00759785|6154650|P2|Overall Study|Participant sample not evaluable|2
1766963|NCT00759785|6154651|P1|Overall Study|Participant sample not evaluable|11
1766964|NCT00759759|6154674|P2|Overall Study|Withdrawal by Subject|1
1766965|NCT00759759|6154675|P1|Overall Study|Withdrawal by Subject|2
1766966|NCT00759759|6154674|P2|Overall Study|Didn't receive drug in period 2|0
1766967|NCT00759759|6154675|P1|Overall Study|Didn't receive drug in period 2|1
1766968|NCT00759759|6154674|P2|Overall Study|didn't return for period 2|0
1766969|NCT00759759|6154675|P1|Overall Study|didn't return for period 2|1
1766970|NCT00759681|6154693|P2|Overall Study|Lost to Follow-up|5
1766971|NCT00759681|6154694|P1|Overall Study|Lost to Follow-up|8
1766972|NCT00759681|6154693|P2|Overall Study|Death|5
1766973|NCT00759681|6154694|P1|Overall Study|Death|2
1766974|NCT00759655|6154721|P1|Overall Study|Termination of the study by sponsor|1
1766975|NCT00759564|6154749|P5|Washout Period (at Least 14 Days)|Adverse Event|1
1766976|NCT00759564|6154750|P4|Washout Period (at Least 14 Days)|Adverse Event|0
1766977|NCT00759564|6154751|P3|Washout Period (at Least 14 Days)|Adverse Event|0
1766978|NCT00759564|6154752|P2|Washout Period (at Least 14 Days)|Adverse Event|0
1766979|NCT00759564|6154753|P1|Washout Period (at Least 14 Days)|Adverse Event|0
1766980|NCT00759395|6154930|P2|Overall Study|Lack of Efficacy|2
1766981|NCT00759395|6154931|P1|Overall Study|Lack of Efficacy|0
1766982|NCT00759395|6154930|P2|Overall Study|Withdrawal by Subject|0
1766983|NCT00759395|6154931|P1|Overall Study|Withdrawal by Subject|1
1766984|NCT00759395|6154930|P2|Overall Study|Adverse Event|0
1766985|NCT00759395|6154931|P1|Overall Study|Adverse Event|1
1766986|NCT00759356|6154947|P2|Overall Study|Subject was unable to return|0
1766987|NCT00759356|6154948|P1|Overall Study|Subject was unable to return|1
1766988|NCT00759356|6154947|P2|Overall Study|Withdrawal by Subject|2
1766989|NCT00759356|6154948|P1|Overall Study|Withdrawal by Subject|0
1766990|NCT00759356|6154947|P2|Overall Study|Adverse Event|1
1766991|NCT00759356|6154948|P1|Overall Study|Adverse Event|0
1766992|NCT00759174|6155028|P2|Overall Study|Other|2
1766993|NCT00759174|6155029|P1|Overall Study|Other|0
1766994|NCT00759148|6155053|P2|Overall Study|Reason not given|0
1766995|NCT00759148|6155054|P1|Overall Study|Reason not given|1
1766996|NCT00759148|6155053|P2|Overall Study|Treatment Failure|10
1766997|NCT00759148|6155054|P1|Overall Study|Treatment Failure|6
1766998|NCT00759148|6155053|P2|Overall Study|Lost to Follow-up|9
1766999|NCT00759148|6155054|P1|Overall Study|Lost to Follow-up|3
1767000|NCT00759148|6155053|P2|Overall Study|Withdrawal by Subject|7
1767001|NCT00759148|6155054|P1|Overall Study|Withdrawal by Subject|3
1767002|NCT00759148|6155053|P2|Overall Study|Adverse Event|6
1767003|NCT00759148|6155054|P1|Overall Study|Adverse Event|1
1767004|NCT00759109|6155064|P2|Overall Study|Lost during study|0
1767005|NCT00759109|6155065|P1|Overall Study|Lost during study|1
1767006|NCT00759109|6155064|P2|Overall Study|Participant had a liver transplant|1
1767007|NCT00759109|6155065|P1|Overall Study|Participant had a liver transplant|0
1767008|NCT00759109|6155064|P2|Overall Study|Participant moved to a different city|1
1767009|NCT00759109|6155065|P1|Overall Study|Participant moved to a different city|0
1767010|NCT00759109|6155064|P2|Overall Study|HCV RNA negative|0
1767011|NCT00759109|6155065|P1|Overall Study|HCV RNA negative|1
1767012|NCT00759109|6155064|P2|Overall Study|Started new therapy|6
1767013|NCT00759109|6155065|P1|Overall Study|Started new therapy|2
1767014|NCT00759109|6155064|P2|Overall Study|Lost to Follow-up|6
1767015|NCT00759109|6155065|P1|Overall Study|Lost to Follow-up|4
1767016|NCT00759109|6155064|P2|Overall Study|Death|3
1767017|NCT00759109|6155065|P1|Overall Study|Death|4
1767018|NCT00759109|6155064|P2|Overall Study|Withdrawal by Subject|5
1767019|NCT00759109|6155065|P1|Overall Study|Withdrawal by Subject|9
1767020|NCT00759109|6155064|P2|Overall Study|Inability to comply|1
1767021|NCT00759109|6155065|P1|Overall Study|Inability to comply|1
1767022|NCT00759109|6155064|P2|Overall Study|Adverse Event|12
1767023|NCT00759109|6155065|P1|Overall Study|Adverse Event|17
1767024|NCT00759031|6155087|P2|First Intervention (1 Day)|Screening failure|0
1767025|NCT00759031|6155088|P1|First Intervention (1 Day)|Screening failure|1
1767026|NCT00759031|6155087|P2|First Intervention (1 Day)|Withdrawal by Subject|1
1767027|NCT00759031|6155088|P1|First Intervention (1 Day)|Withdrawal by Subject|0
1767028|NCT00759031|6155087|P2|First Intervention (1 Day)|Physician Decision|0
1767029|NCT00759031|6155088|P1|First Intervention (1 Day)|Physician Decision|1
1767030|NCT00758771|6155141|P2|Overall Study|Did not meet eligibility criteria|4
1767031|NCT00758771|6155142|P1|Overall Study|Did not meet eligibility criteria|2
1767032|NCT00758771|6155141|P2|Overall Study|Withdrawal by Subject|1
1767033|NCT00758771|6155142|P1|Overall Study|Withdrawal by Subject|1
1767034|NCT00758706|6155200|P2|Overall Study|Adverse Event|4
1767035|NCT00758706|6155201|P1|Overall Study|Adverse Event|4
1767036|NCT00758680|6155237|P10|Overall Study|Withdrawal by Subject|0
1767037|NCT00758680|6155238|P9|Overall Study|Withdrawal by Subject|1
1767038|NCT00758680|6155239|P8|Overall Study|Withdrawal by Subject|0
1767039|NCT00758680|6155240|P7|Overall Study|Withdrawal by Subject|1
1767040|NCT00758680|6155241|P6|Overall Study|Withdrawal by Subject|0
1767041|NCT00758680|6155242|P5|Overall Study|Withdrawal by Subject|0
1767042|NCT00758680|6155243|P4|Overall Study|Withdrawal by Subject|0
1767043|NCT00758680|6155244|P3|Overall Study|Withdrawal by Subject|0
1767044|NCT00758680|6155245|P2|Overall Study|Withdrawal by Subject|0
1767045|NCT00758680|6155246|P1|Overall Study|Withdrawal by Subject|0
1767046|NCT00758680|6155237|P10|Overall Study|Laboratory Adverse Event|0
1767047|NCT00758680|6155238|P9|Overall Study|Laboratory Adverse Event|1
1767048|NCT00758680|6155239|P8|Overall Study|Laboratory Adverse Event|0
1767049|NCT00758680|6155240|P7|Overall Study|Laboratory Adverse Event|0
1767050|NCT00758680|6155241|P6|Overall Study|Laboratory Adverse Event|0
1767051|NCT00758680|6155242|P5|Overall Study|Laboratory Adverse Event|0
1767052|NCT00758680|6155243|P4|Overall Study|Laboratory Adverse Event|0
1767053|NCT00758680|6155244|P3|Overall Study|Laboratory Adverse Event|0
1767054|NCT00758680|6155245|P2|Overall Study|Laboratory Adverse Event|0
1767055|NCT00758680|6155246|P1|Overall Study|Laboratory Adverse Event|0
1767056|NCT00758680|6155237|P10|Overall Study|Adverse Event|1
1767057|NCT00758680|6155238|P9|Overall Study|Adverse Event|0
1767058|NCT00758680|6155239|P8|Overall Study|Adverse Event|1
1767059|NCT00758680|6155240|P7|Overall Study|Adverse Event|0
1767060|NCT00758680|6155241|P6|Overall Study|Adverse Event|0
1767061|NCT00758680|6155242|P5|Overall Study|Adverse Event|0
1767062|NCT00758680|6155243|P4|Overall Study|Adverse Event|0
1767063|NCT00758680|6155244|P3|Overall Study|Adverse Event|0
1767064|NCT00758680|6155245|P2|Overall Study|Adverse Event|0
1767065|NCT00758680|6155246|P1|Overall Study|Adverse Event|0
1767066|NCT00758602|6155299|P2|Overall Study|Reason not specified|3
1767067|NCT00758602|6155300|P1|Overall Study|Reason not specified|3
1767068|NCT00758602|6155299|P2|Overall Study|Death|1
1767069|NCT00758602|6155300|P1|Overall Study|Death|0
1767070|NCT00758602|6155299|P2|Overall Study|Protocol Violation|2
1767071|NCT00758602|6155300|P1|Overall Study|Protocol Violation|0
1767072|NCT00758602|6155299|P2|Overall Study|Withdrawal by Subject|3
1767073|NCT00758602|6155300|P1|Overall Study|Withdrawal by Subject|1
1767074|NCT00758602|6155299|P2|Overall Study|Lost to Follow-up|3
1767075|NCT00758602|6155300|P1|Overall Study|Lost to Follow-up|4
1767076|NCT00758602|6155299|P2|Overall Study|Adverse Event|10
1767077|NCT00758602|6155300|P1|Overall Study|Adverse Event|11
1767078|NCT00758589|6155326|P4|Overall Study|Palm stopped to work|1
1767079|NCT00758589|6155327|P3|Overall Study|Palm stopped to work|0
1767080|NCT00758589|6155328|P2|Overall Study|Palm stopped to work|0
1767081|NCT00758589|6155329|P1|Overall Study|Palm stopped to work|0
1767082|NCT00758589|6155326|P4|Overall Study|Withdrawal by Subject|1
1767083|NCT00758589|6155327|P3|Overall Study|Withdrawal by Subject|1
1767084|NCT00758589|6155328|P2|Overall Study|Withdrawal by Subject|1
1767085|NCT00758589|6155329|P1|Overall Study|Withdrawal by Subject|0
1767086|NCT00758589|6155326|P4|Overall Study|Adverse Event|4
1767087|NCT00758589|6155327|P3|Overall Study|Adverse Event|5
1767088|NCT00758589|6155328|P2|Overall Study|Adverse Event|2
1767089|NCT00758589|6155329|P1|Overall Study|Adverse Event|3
1767090|NCT00758498|6155422|P3|Overall Study|Noncompliance to study procedures|1
1767091|NCT00758498|6155423|P2|Overall Study|Noncompliance to study procedures|0
1767092|NCT00758498|6155424|P1|Overall Study|Noncompliance to study procedures|0
1767093|NCT00758498|6155422|P3|Overall Study|Withdrawal by Subject|1
1767094|NCT00758498|6155423|P2|Overall Study|Withdrawal by Subject|0
1767095|NCT00758498|6155424|P1|Overall Study|Withdrawal by Subject|0
1767096|NCT00758498|6155422|P3|Overall Study|Subject legally detained out of state|0
1767097|NCT00758498|6155423|P2|Overall Study|Subject legally detained out of state|0
1767098|NCT00758498|6155424|P1|Overall Study|Subject legally detained out of state|1
1767099|NCT00758498|6155422|P3|Overall Study|Adverse Event|3
1767100|NCT00758498|6155423|P2|Overall Study|Adverse Event|2
1767101|NCT00758498|6155424|P1|Overall Study|Adverse Event|2
1767102|NCT00758485|6155509|P2|Overall Study|Not Treated|2
1767103|NCT00758485|6155510|P1|Overall Study|Not Treated|1
1767104|NCT00758485|6155509|P2|Overall Study|Lost to Follow-up|1
1767105|NCT00758485|6155510|P1|Overall Study|Lost to Follow-up|0
1767106|NCT00758459|6155522|P2|Overall Study|Withdrawal by Subject|1
1767107|NCT00758459|6155523|P1|Overall Study|Withdrawal by Subject|0
1767108|NCT00758459|6155522|P2|Overall Study|Protocol Violation|1
1767109|NCT00758459|6155523|P1|Overall Study|Protocol Violation|0
1767110|NCT00758459|6155522|P2|Overall Study|Adverse Event|2
1767111|NCT00758459|6155523|P1|Overall Study|Adverse Event|3
1767112|NCT00758394|6155568|P4|3rd Intervention|Lost to Follow-up|1
1767113|NCT00758394|6155569|P3|3rd Intervention|Lost to Follow-up|0
1767114|NCT00758394|6155570|P2|3rd Intervention|Lost to Follow-up|0
1767115|NCT00758394|6155571|P1|3rd Intervention|Lost to Follow-up|1
1767116|NCT00758394|6155568|P4|2nd Intervention Order|Lost to Follow-up|0
1767117|NCT00758394|6155569|P3|2nd Intervention Order|Lost to Follow-up|0
1767118|NCT00758394|6155570|P2|2nd Intervention Order|Lost to Follow-up|1
1767119|NCT00758394|6155571|P1|2nd Intervention Order|Lost to Follow-up|0
1767120|NCT00758264|6155600|P3|Active Phase|Other|4
1767121|NCT00758264|6155601|P2|Active Phase|Other|0
1767122|NCT00758264|6155602|P1|Active Phase|Other|0
1767123|NCT00758264|6155600|P3|Active Phase|Lost to Follow-up|0
1767124|NCT00758264|6155601|P2|Active Phase|Lost to Follow-up|0
1767125|NCT00758264|6155602|P1|Active Phase|Lost to Follow-up|1
1767126|NCT00758264|6155600|P3|Active Phase|Withdrawal by Subject|1
1767127|NCT00758264|6155601|P2|Active Phase|Withdrawal by Subject|0
1767128|NCT00758264|6155602|P1|Active Phase|Withdrawal by Subject|0
1767129|NCT00758160|6155661|P1|Overall Study|Withdrawal by Subject|8
1767130|NCT00758160|6155661|P1|Overall Study|Protocol Violation|12
1767131|NCT00758160|6155661|P1|Overall Study|Lost to Follow-up|14
1767132|NCT00758160|6155661|P1|Overall Study|Lack of Efficacy|10
1767133|NCT00758160|6155661|P1|Overall Study|Adverse Event|15
1767134|NCT00758160|6155661|P1|Overall Study|Administration Problems|3
1767135|NCT00758160|6155661|P1|Overall Study|No Longer Requires Study Medication|4
1767136|NCT00758069|6155682|P3|Overall Study|Incorrect Study Drug|0
1767137|NCT00758069|6155683|P2|Overall Study|Incorrect Study Drug|0
1767138|NCT00758069|6155684|P1|Overall Study|Incorrect Study Drug|1
1767139|NCT00758069|6155682|P3|Overall Study|Lack of Efficacy|1
1767140|NCT00758069|6155683|P2|Overall Study|Lack of Efficacy|0
1767141|NCT00758069|6155684|P1|Overall Study|Lack of Efficacy|0
1767142|NCT00758043|6155699|P4|Overall Study|Other Reasons|5
1767143|NCT00758043|6155700|P3|Overall Study|Other Reasons|0
1767144|NCT00758043|6155701|P2|Overall Study|Other Reasons|1
1767145|NCT00758043|6155702|P1|Overall Study|Other Reasons|0
1767146|NCT00758043|6155699|P4|Overall Study|Non-Compliant With study Drug|1
1767147|NCT00758043|6155700|P3|Overall Study|Non-Compliant With study Drug|0
1767148|NCT00758043|6155701|P2|Overall Study|Non-Compliant With study Drug|0
1767149|NCT00758043|6155702|P1|Overall Study|Non-Compliant With study Drug|0
1767150|NCT00758043|6155699|P4|Overall Study|Required Prohibited Medication|3
1767151|NCT00758043|6155700|P3|Overall Study|Required Prohibited Medication|1
1767152|NCT00758043|6155701|P2|Overall Study|Required Prohibited Medication|0
1767153|NCT00758043|6155702|P1|Overall Study|Required Prohibited Medication|0
1767154|NCT00758043|6155699|P4|Overall Study|Withdrawal by Subject|4
1767155|NCT00758043|6155700|P3|Overall Study|Withdrawal by Subject|1
1767156|NCT00758043|6155701|P2|Overall Study|Withdrawal by Subject|1
1767157|NCT00758043|6155702|P1|Overall Study|Withdrawal by Subject|0
1767158|NCT00758043|6155699|P4|Overall Study|Lost to Follow-up|5
1767159|NCT00758043|6155700|P3|Overall Study|Lost to Follow-up|2
1767160|NCT00758043|6155701|P2|Overall Study|Lost to Follow-up|2
1767161|NCT00758043|6155702|P1|Overall Study|Lost to Follow-up|0
1767162|NCT00758043|6155699|P4|Overall Study|Refused Further Treatment|8
1767163|NCT00758043|6155700|P3|Overall Study|Refused Further Treatment|5
1767164|NCT00758043|6155701|P2|Overall Study|Refused Further Treatment|11
1767165|NCT00758043|6155702|P1|Overall Study|Refused Further Treatment|0
1767166|NCT00758043|6155699|P4|Overall Study|Lack of Efficacy|12
1767167|NCT00758043|6155700|P3|Overall Study|Lack of Efficacy|18
1767168|NCT00758043|6155701|P2|Overall Study|Lack of Efficacy|6
1767169|NCT00758043|6155702|P1|Overall Study|Lack of Efficacy|0
1767170|NCT00758043|6155699|P4|Overall Study|Adverse Event|62
1767171|NCT00758043|6155700|P3|Overall Study|Adverse Event|12
1767172|NCT00758043|6155701|P2|Overall Study|Adverse Event|20
1767173|NCT00758043|6155702|P1|Overall Study|Adverse Event|1
1767174|NCT00757848|6155730|P2|Overall Study|Incorrect enrolment|0
1767175|NCT00757848|6155731|P1|Overall Study|Incorrect enrolment|1
1767176|NCT00757848|6155730|P2|Overall Study|Adverse Event|2
1767177|NCT00757848|6155731|P1|Overall Study|Adverse Event|1
1767178|NCT00757848|6155730|P2|Overall Study|Voluntary discontinuation|0
1767179|NCT00757848|6155731|P1|Overall Study|Voluntary discontinuation|1
1767180|NCT00757783|6155800|P2|Overall Study|Other|2
1767181|NCT00757783|6155801|P1|Overall Study|Other|1
1767182|NCT00757783|6155800|P2|Overall Study|Withdrawal by Subject|1
1767183|NCT00757783|6155801|P1|Overall Study|Withdrawal by Subject|2
1767184|NCT00757783|6155800|P2|Overall Study|Protocol Violation|0
1767185|NCT00757783|6155801|P1|Overall Study|Protocol Violation|1
1767186|NCT00757783|6155800|P2|Overall Study|Lost to Follow-up|1
1767187|NCT00757783|6155801|P1|Overall Study|Lost to Follow-up|1
1767188|NCT00757783|6155800|P2|Overall Study|Adverse Event|2
1767189|NCT00757783|6155801|P1|Overall Study|Adverse Event|0
1767190|NCT00757705|6155837|P1|Overall Study|Other|18
1767191|NCT00757705|6155837|P1|Overall Study|Non-compliant|9
1767192|NCT00757705|6155837|P1|Overall Study|Ineligible to continue|8
1767193|NCT00757705|6155837|P1|Overall Study|Insufficient Response|26
1767194|NCT00757705|6155837|P1|Overall Study|Withdrawal by Subject|25
1767195|NCT00757705|6155837|P1|Overall Study|Lost to Follow-up|16
1767196|NCT00757705|6155837|P1|Overall Study|Adverse Event|19
1767197|NCT00757627|6155866|P1|Overall Study|Other|1
1767198|NCT00757627|6155866|P1|Overall Study|Withdrawal by Subject|27
1767199|NCT00757627|6155866|P1|Overall Study|Lost to Follow-up|28
1767200|NCT00757627|6155866|P1|Overall Study|Lack of Efficacy|10
1767201|NCT00757627|6155866|P1|Overall Study|Adverse Event|15
1767202|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|Other|0
1767203|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|Other|1
1767204|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
1767205|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
1767206|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
1767207|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
1767208|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
1767209|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
1767210|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
1767211|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
1767212|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
1767213|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
1767214|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
1767215|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
1767216|NCT00757588|6156001|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
1767217|NCT00757588|6156002|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
1767218|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|Other|1
1767219|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|Other|0
1767220|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
1767221|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
1767222|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
1767223|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
1767224|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
1767225|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
1767226|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|Death|0
1767227|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|Death|1
1767228|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
1767229|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
1767230|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
1767231|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
1767232|NCT00757588|6156001|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
1767233|NCT00757588|6156002|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
1767234|NCT00757237|6156043|P2|Overall Study|Other|2
1767235|NCT00757237|6156044|P1|Overall Study|Other|0
1767236|NCT00757237|6156043|P2|Overall Study|Safety or Tolerability|5
1767237|NCT00757237|6156044|P1|Overall Study|Safety or Tolerability|3
1767238|NCT00757237|6156043|P2|Overall Study|Withdrawal by Subject|12
1767239|NCT00757237|6156044|P1|Overall Study|Withdrawal by Subject|8
1767240|NCT00757237|6156043|P2|Overall Study|Physician Decision|3
1767241|NCT00757237|6156044|P1|Overall Study|Physician Decision|2
1767242|NCT00757237|6156043|P2|Overall Study|Protocol Violation|2
1767243|NCT00757237|6156044|P1|Overall Study|Protocol Violation|0
1767244|NCT00757237|6156043|P2|Overall Study|Lost to Follow-up|1
1767245|NCT00757237|6156044|P1|Overall Study|Lost to Follow-up|0
1767246|NCT00757172|6156072|P1|Overall Study|Progression|4
1767247|NCT00757172|6156072|P1|Overall Study|Physician Decision|3
1767248|NCT00757172|6156072|P1|Overall Study|Withdrawal by Subject|4
1767249|NCT00757003|6156080|P1|Overall Study|Not implanted|1
1767250|NCT00757003|6156080|P1|Overall Study|Surgically explanted|2
1767251|NCT00757003|6156080|P1|Overall Study|Withdrawal by Subject|4
1767252|NCT00757003|6156080|P1|Overall Study|Lost to Follow-up|9
1767253|NCT00757003|6156080|P1|Overall Study|Death|33
1767254|NCT00756938|6156127|P4|Optional Extension|Adverse Event|1
1767255|NCT00756938|6156128|P3|Optional Extension|Adverse Event|0
1767256|NCT00756938|6156129|P2|Optional Extension|Adverse Event|0
1767257|NCT00756938|6156130|P1|Optional Extension|Adverse Event|0
1767258|NCT00756938|6156127|P4|Optional Extension|Withdrawal by Subject|10
1767259|NCT00756938|6156128|P3|Optional Extension|Withdrawal by Subject|0
1767260|NCT00756938|6156129|P2|Optional Extension|Withdrawal by Subject|0
1767261|NCT00756938|6156130|P1|Optional Extension|Withdrawal by Subject|0
1767262|NCT00756938|6156127|P4|Optional Extension|Protocol Violation|1
1767263|NCT00756938|6156128|P3|Optional Extension|Protocol Violation|0
1767264|NCT00756938|6156129|P2|Optional Extension|Protocol Violation|0
1767265|NCT00756938|6156130|P1|Optional Extension|Protocol Violation|0
1767266|NCT00756938|6156127|P4|Optional Extension|Lost to Follow-up|1
1767267|NCT00756938|6156128|P3|Optional Extension|Lost to Follow-up|0
1767268|NCT00756938|6156129|P2|Optional Extension|Lost to Follow-up|0
1767269|NCT00756938|6156130|P1|Optional Extension|Lost to Follow-up|0
1767270|NCT00756938|6156127|P4|Optional Extension|Physician Decision|3
1767271|NCT00756938|6156128|P3|Optional Extension|Physician Decision|0
1767272|NCT00756938|6156129|P2|Optional Extension|Physician Decision|0
1767273|NCT00756938|6156130|P1|Optional Extension|Physician Decision|0
1767274|NCT00756938|6156127|P4|Optional Extension|Protocol-specific criteria met|9
1767275|NCT00756938|6156128|P3|Optional Extension|Protocol-specific criteria met|0
1767276|NCT00756938|6156129|P2|Optional Extension|Protocol-specific criteria met|0
1767277|NCT00756938|6156130|P1|Optional Extension|Protocol-specific criteria met|0
1767278|NCT00756938|6156127|P4|Optional Extension|End of Study|11
1767279|NCT00756938|6156128|P3|Optional Extension|End of Study|0
1767280|NCT00756938|6156129|P2|Optional Extension|End of Study|0
1767281|NCT00756938|6156130|P1|Optional Extension|End of Study|0
1767282|NCT00756938|6156127|P4|Optional Extension|Lack of Efficacy|1
1767283|NCT00756938|6156128|P3|Optional Extension|Lack of Efficacy|0
1767284|NCT00756938|6156129|P2|Optional Extension|Lack of Efficacy|0
1767285|NCT00756938|6156130|P1|Optional Extension|Lack of Efficacy|0
1767286|NCT00756938|6156127|P4|12-week Base Study|Lost to Follow-up|0
1767287|NCT00756938|6156128|P3|12-week Base Study|Lost to Follow-up|0
1767288|NCT00756938|6156129|P2|12-week Base Study|Lost to Follow-up|0
1767289|NCT00756938|6156130|P1|12-week Base Study|Lost to Follow-up|1
1767290|NCT00756938|6156127|P4|12-week Base Study|Protocol Violation|0
1767291|NCT00756938|6156128|P3|12-week Base Study|Protocol Violation|1
1767292|NCT00756938|6156129|P2|12-week Base Study|Protocol Violation|0
1767293|NCT00756938|6156130|P1|12-week Base Study|Protocol Violation|0
1767294|NCT00756938|6156127|P4|12-week Base Study|Protocol-specific Criteria Met|0
1767295|NCT00756938|6156128|P3|12-week Base Study|Protocol-specific Criteria Met|1
1767296|NCT00756938|6156129|P2|12-week Base Study|Protocol-specific Criteria Met|0
1767297|NCT00756938|6156130|P1|12-week Base Study|Protocol-specific Criteria Met|1
1767298|NCT00756886|6156158|P2|Overall Study|Ineligible|4
1767299|NCT00756886|6156159|P1|Overall Study|Ineligible|9
1767300|NCT00756886|6156158|P2|Overall Study|Lack of Efficacy|0
1767301|NCT00756886|6156159|P1|Overall Study|Lack of Efficacy|1
1767302|NCT00756886|6156158|P2|Overall Study|Adverse Event|3
1767303|NCT00756886|6156159|P1|Overall Study|Adverse Event|0
1767304|NCT00756886|6156158|P2|Overall Study|Lost to Follow-up|0
1767305|NCT00756886|6156159|P1|Overall Study|Lost to Follow-up|1
1767306|NCT00756730|6156167|P2|Overall Study|persistent low-level viremmia|1
1767307|NCT00756730|6156168|P1|Overall Study|persistent low-level viremmia|0
1767308|NCT00756730|6156167|P2|Overall Study|discontinued due to rash prior to week 4|1
1767309|NCT00756730|6156168|P1|Overall Study|discontinued due to rash prior to week 4|0
1767310|NCT00756717|6156188|P1|Overall Study|Withdrawal by Subject|2
1767311|NCT00756574|6156221|P2|Overall Study|Lost to Follow-up|4
1767312|NCT00756574|6156222|P1|Overall Study|Lost to Follow-up|4
1767313|NCT00756574|6156221|P2|Overall Study|Withdrawal by Subject|7
1767314|NCT00756574|6156222|P1|Overall Study|Withdrawal by Subject|9
1767315|NCT00756470|6156266|P1|Overall Study|Adverse Event|4
1767316|NCT00756470|6156266|P1|Overall Study|Withdrawal by Subject|1
1767317|NCT00756457|6156273|P2|Overall Study|Lost to Follow-up|2
1767318|NCT00756457|6156274|P1|Overall Study|Lost to Follow-up|1
1767319|NCT00756444|6156304|P2|Overall Study|Ineligibility Determined|0
1767320|NCT00756444|6156305|P1|Overall Study|Ineligibility Determined|1
1767321|NCT00756444|6156304|P2|Overall Study|Disease Progression|7
1767322|NCT00756444|6156305|P1|Overall Study|Disease Progression|2
1767323|NCT00756444|6156304|P2|Overall Study|Death|4
1767324|NCT00756444|6156305|P1|Overall Study|Death|5
1767325|NCT00756444|6156304|P2|Overall Study|Lost to Follow-up|1
1767326|NCT00756444|6156305|P1|Overall Study|Lost to Follow-up|0
1767327|NCT00756444|6156304|P2|Overall Study|Withdrawal by Subject|8
1767328|NCT00756444|6156305|P1|Overall Study|Withdrawal by Subject|6
1767329|NCT00756444|6156304|P2|Overall Study|Adverse Event|1
1767330|NCT00756444|6156305|P1|Overall Study|Adverse Event|1
1767331|NCT00756314|6156316|P2|Overall Study|Lost to Follow-up|59
1767332|NCT00756314|6156317|P1|Overall Study|Lost to Follow-up|2
1767333|NCT00756275|6156333|P2|Overall Study|Withdrawal by Subject|7
1767334|NCT00756275|6156334|P1|Overall Study|Withdrawal by Subject|4
1767335|NCT00756275|6156333|P2|Overall Study|Lost to Follow-up|21
1767336|NCT00756275|6156334|P1|Overall Study|Lost to Follow-up|25
1767337|NCT00756002|6156386|P2|Double-Blind Treatment Period|Other|2
1767338|NCT00756002|6156387|P1|Double-Blind Treatment Period|Other|2
1767339|NCT00756002|6156386|P2|Double-Blind Treatment Period|Protocol Violation|5
1767340|NCT00756002|6156387|P1|Double-Blind Treatment Period|Protocol Violation|6
1767341|NCT00756002|6156386|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
1767342|NCT00756002|6156387|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
1767343|NCT00756002|6156386|P2|Double-Blind Treatment Period|Lost to Follow-up|1
1767344|NCT00756002|6156387|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1767345|NCT00756002|6156386|P2|Double-Blind Treatment Period|Lack of Efficacy|1
1767346|NCT00756002|6156387|P1|Double-Blind Treatment Period|Lack of Efficacy|1
1767347|NCT00755937|6156481|P1|Observational Follow-up|Lost to Follow-up|148
1767348|NCT00755937|6156481|P1|Recruitment|Unknown if infliximab received|164
1767349|NCT00755846|6156508|P6|Overall Study|Participant Non-compliance|0
1767350|NCT00755846|6156509|P5|Overall Study|Participant Non-compliance|1
1767351|NCT00755846|6156510|P4|Overall Study|Participant Non-compliance|0
1767352|NCT00755846|6156511|P3|Overall Study|Participant Non-compliance|0
1767353|NCT00755846|6156512|P2|Overall Study|Participant Non-compliance|0
1767354|NCT00755846|6156513|P1|Overall Study|Participant Non-compliance|0
1767355|NCT00755846|6156508|P6|Overall Study|Administrative Error|0
1767356|NCT00755846|6156509|P5|Overall Study|Administrative Error|0
1767357|NCT00755846|6156510|P4|Overall Study|Administrative Error|0
1767358|NCT00755846|6156511|P3|Overall Study|Administrative Error|0
1767359|NCT00755846|6156512|P2|Overall Study|Administrative Error|1
1767360|NCT00755846|6156513|P1|Overall Study|Administrative Error|0
1767361|NCT00755846|6156508|P6|Overall Study|Physician Decision|1
1767362|NCT00755846|6156509|P5|Overall Study|Physician Decision|0
1767363|NCT00755846|6156510|P4|Overall Study|Physician Decision|1
1767364|NCT00755846|6156511|P3|Overall Study|Physician Decision|0
1767365|NCT00755846|6156512|P2|Overall Study|Physician Decision|3
1767366|NCT00755846|6156513|P1|Overall Study|Physician Decision|1
1767367|NCT00755846|6156508|P6|Overall Study|Hyperglycemic Rescue|7
1767368|NCT00755846|6156509|P5|Overall Study|Hyperglycemic Rescue|8
1767369|NCT00755846|6156510|P4|Overall Study|Hyperglycemic Rescue|8
1767370|NCT00755846|6156511|P3|Overall Study|Hyperglycemic Rescue|5
1767371|NCT00755846|6156512|P2|Overall Study|Hyperglycemic Rescue|7
1767372|NCT00755846|6156513|P1|Overall Study|Hyperglycemic Rescue|21
1767373|NCT00755846|6156508|P6|Overall Study|Withdrawal by Subject|1
1767374|NCT00755846|6156509|P5|Overall Study|Withdrawal by Subject|0
1767375|NCT00755846|6156510|P4|Overall Study|Withdrawal by Subject|2
1767376|NCT00755846|6156511|P3|Overall Study|Withdrawal by Subject|5
1767377|NCT00755846|6156512|P2|Overall Study|Withdrawal by Subject|3
1767378|NCT00755846|6156513|P1|Overall Study|Withdrawal by Subject|2
1767379|NCT00755846|6156508|P6|Overall Study|Lost to Follow-up|2
1767380|NCT00755846|6156509|P5|Overall Study|Lost to Follow-up|4
1767381|NCT00755846|6156510|P4|Overall Study|Lost to Follow-up|0
1767382|NCT00755846|6156511|P3|Overall Study|Lost to Follow-up|1
1767383|NCT00755846|6156512|P2|Overall Study|Lost to Follow-up|2
1767384|NCT00755846|6156513|P1|Overall Study|Lost to Follow-up|0
1767385|NCT00755846|6156508|P6|Overall Study|Protocol Violation|1
1767386|NCT00755846|6156509|P5|Overall Study|Protocol Violation|1
1767387|NCT00755846|6156510|P4|Overall Study|Protocol Violation|1
1767388|NCT00755846|6156511|P3|Overall Study|Protocol Violation|1
1767389|NCT00755846|6156512|P2|Overall Study|Protocol Violation|1
1767390|NCT00755846|6156513|P1|Overall Study|Protocol Violation|1
1767391|NCT00755846|6156508|P6|Overall Study|Adverse Event|2
1767392|NCT00755846|6156509|P5|Overall Study|Adverse Event|3
1767393|NCT00755846|6156510|P4|Overall Study|Adverse Event|1
1767394|NCT00755846|6156511|P3|Overall Study|Adverse Event|0
1767395|NCT00755846|6156512|P2|Overall Study|Adverse Event|0
1767396|NCT00755846|6156513|P1|Overall Study|Adverse Event|0
1767397|NCT00755807|6156613|P2|Open-label Extension Phase|Sponsor Decision|1
1767398|NCT00755807|6156614|P1|Open-label Extension Phase|Sponsor Decision|0
1767399|NCT00755807|6156613|P2|Open-label Extension Phase|Lost to Follow-up|0
1767400|NCT00755807|6156614|P1|Open-label Extension Phase|Lost to Follow-up|2
1767401|NCT00755807|6156613|P2|Open-label Extension Phase|Withdrawal by Subject|3
1767402|NCT00755807|6156614|P1|Open-label Extension Phase|Withdrawal by Subject|1
1767403|NCT00755807|6156613|P2|Open-label Extension Phase|Lack of Efficacy|3
1767404|NCT00755807|6156614|P1|Open-label Extension Phase|Lack of Efficacy|3
1767405|NCT00755807|6156613|P2|Open-label Extension Phase|Protocol Violation|2
1767406|NCT00755807|6156614|P1|Open-label Extension Phase|Protocol Violation|5
1767407|NCT00755807|6156613|P2|Open-label Extension Phase|Adverse Event|7
1767408|NCT00755807|6156614|P1|Open-label Extension Phase|Adverse Event|7
1767409|NCT00755807|6156613|P2|Acute Phase|Physician Decision|1
1767410|NCT00755807|6156614|P1|Acute Phase|Physician Decision|0
1767411|NCT00755807|6156613|P2|Acute Phase|Lack of Efficacy|1
1767412|NCT00755807|6156614|P1|Acute Phase|Lack of Efficacy|0
1767413|NCT00755807|6156613|P2|Acute Phase|Withdrawal by Subject|2
1767414|NCT00755807|6156614|P1|Acute Phase|Withdrawal by Subject|1
1767415|NCT00755807|6156613|P2|Acute Phase|Protocol Violation|3
1767416|NCT00755807|6156614|P1|Acute Phase|Protocol Violation|1
1767417|NCT00755807|6156613|P2|Acute Phase|Adverse Event|5
1767418|NCT00755807|6156614|P1|Acute Phase|Adverse Event|16
1767419|NCT00755716|6156694|P3|Overall Study|work schedule issues|1
1767420|NCT00755716|6156695|P2|Overall Study|work schedule issues|1
1767421|NCT00755716|6156696|P1|Overall Study|work schedule issues|0
1767422|NCT00755716|6156694|P3|Overall Study|Lost to Follow-up|1
1767423|NCT00755716|6156695|P2|Overall Study|Lost to Follow-up|3
1767424|NCT00755716|6156696|P1|Overall Study|Lost to Follow-up|5
1767425|NCT00755716|6156694|P3|Overall Study|Lack of Efficacy|0
1767426|NCT00755716|6156695|P2|Overall Study|Lack of Efficacy|0
1767427|NCT00755716|6156696|P1|Overall Study|Lack of Efficacy|2
1767428|NCT00755716|6156694|P3|Overall Study|Adverse Event|1
1767429|NCT00755716|6156695|P2|Overall Study|Adverse Event|4
1767430|NCT00755716|6156696|P1|Overall Study|Adverse Event|1
1767431|NCT00755417|6156710|P3|Overall Study|Not specified or missing data|12
1767432|NCT00755417|6156711|P2|Overall Study|Not specified or missing data|18
1767433|NCT00755417|6156712|P1|Overall Study|Not specified or missing data|9
1767434|NCT00755417|6156710|P3|Overall Study|Withdrawal by Subject|12
1767435|NCT00755417|6156711|P2|Overall Study|Withdrawal by Subject|12
1767436|NCT00755417|6156712|P1|Overall Study|Withdrawal by Subject|12
1767437|NCT00755417|6156710|P3|Overall Study|Lost to Follow-up|1
1767438|NCT00755417|6156711|P2|Overall Study|Lost to Follow-up|0
1767439|NCT00755417|6156712|P1|Overall Study|Lost to Follow-up|3
1767440|NCT00755417|6156710|P3|Overall Study|Protocol Violation|1
1767441|NCT00755417|6156711|P2|Overall Study|Protocol Violation|1
1767442|NCT00755417|6156712|P1|Overall Study|Protocol Violation|2
1767443|NCT00755417|6156710|P3|Overall Study|Lack of Efficacy|9
1767444|NCT00755417|6156711|P2|Overall Study|Lack of Efficacy|4
1767445|NCT00755417|6156712|P1|Overall Study|Lack of Efficacy|8
1767446|NCT00755417|6156710|P3|Overall Study|Adverse Event|7
1767447|NCT00755417|6156711|P2|Overall Study|Adverse Event|20
1767448|NCT00755417|6156712|P1|Overall Study|Adverse Event|28
1767449|NCT00755326|6156731|P2|Overall Study|Lost to Follow-up|3
1767450|NCT00755326|6156732|P1|Overall Study|Lost to Follow-up|2
1767451|NCT00755222|6156782|P2|Overall Study|Protocol Violation|0
1767452|NCT00755222|6156783|P1|Overall Study|Protocol Violation|2
1767453|NCT00755222|6156782|P2|Overall Study|Adverse Event|0
1767454|NCT00755222|6156783|P1|Overall Study|Adverse Event|2
1767455|NCT00755222|6156782|P2|Overall Study|Withdrawal by Subject|2
1767456|NCT00755222|6156783|P1|Overall Study|Withdrawal by Subject|4
1767457|NCT00755196|6156797|P1|Overall Study|Lack of Efficiency|1
1767458|NCT00755196|6156797|P1|Overall Study|Lost to Follow-up|1
1767459|NCT00755105|6156818|P3|Overall Study|Withdrawal by Subject|4
1767460|NCT00755105|6156819|P2|Overall Study|Withdrawal by Subject|11
1767461|NCT00755105|6156820|P1|Overall Study|Withdrawal by Subject|9
1767462|NCT00755079|6156830|P2|Overall Study|Withdrawal by Subject|2
1767463|NCT00755079|6156831|P1|Overall Study|Withdrawal by Subject|0
1767464|NCT00755079|6156830|P2|Overall Study|Adverse Event|1
1767465|NCT00755079|6156831|P1|Overall Study|Adverse Event|0
1767466|NCT00755079|6156830|P2|Overall Study|Lost to Follow-up|3
1767467|NCT00755079|6156831|P1|Overall Study|Lost to Follow-up|1
1767468|NCT00754936|6156850|P1|Overall Study|Inter-current medical events|3
1767469|NCT00754936|6156850|P1|Overall Study|Side Effects|3
1767470|NCT00754936|6156850|P1|Overall Study|Withdrawal by Subject|2
1767471|NCT00754936|6156850|P1|Overall Study|Physician Decision|1
1767472|NCT00754936|6156850|P1|Overall Study|Lost to Follow-up|3
1767473|NCT00754793|6156890|P2|Overall Study|voluntary withdrawn from study|1
1767474|NCT00754793|6156891|P1|Overall Study|voluntary withdrawn from study|0
1767475|NCT00754741|6156909|P3|Overall Study|Died or disenrolled|54
1767476|NCT00754741|6156910|P2|Overall Study|Died or disenrolled|69
1767477|NCT00754741|6156911|P1|Overall Study|Died or disenrolled|57
1767478|NCT00754650|6156958|P1|Overall Study|Disease Progression|2
1767479|NCT00754624|6156963|P1|Overall Study|Lost to Follow-up|3
1767480|NCT00754624|6156963|P1|Overall Study|Various|12
1767481|NCT00754624|6156963|P1|Overall Study|Withdrawal by Subject|28
1767482|NCT00754624|6156963|P1|Overall Study|Protocol Violation|1
1767483|NCT00754624|6156963|P1|Overall Study|Physician Decision|8
1767484|NCT00754624|6156963|P1|Overall Study|Death|1
1767485|NCT00754624|6156963|P1|Overall Study|Adverse Event|16
1767486|NCT00754572|6156973|P1|Overall Study|Lost to Follow-up|1
1767487|NCT00754572|6156973|P1|Overall Study|Administrative Reason|3
1767488|NCT00754572|6156973|P1|Overall Study|Death|1
1767489|NCT00754572|6156973|P1|Overall Study|Lack of Efficacy|2
1767490|NCT00754572|6156973|P1|Overall Study|Withdrawal by Subject|3
1767491|NCT00754572|6156973|P1|Overall Study|Protocol Violation|3
1767492|NCT00754572|6156973|P1|Overall Study|Other|39
1767493|NCT00754572|6156973|P1|Overall Study|Adverse Event|19
1767494|NCT00754559|6157000|P1|Overall Study|Withdrawal by Subject|3
1767495|NCT00754559|6157000|P1|Overall Study|Other|5
1767496|NCT00754559|6157000|P1|Overall Study|Administrative reason|1
1767497|NCT00754559|6157000|P1|Overall Study|Lost to Follow-up|2
1767498|NCT00754559|6157000|P1|Overall Study|Lack of Efficacy|10
1767499|NCT00754559|6157000|P1|Overall Study|Protocol Violation|11
1767500|NCT00754559|6157000|P1|Overall Study|Adverse Event|15
1767501|NCT00754442|6157100|P2|Overall Study|Withdrawal by Subject|3
1767502|NCT00754442|6157101|P1|Overall Study|Withdrawal by Subject|5
1767503|NCT00754390|6157108|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
1767504|NCT00754390|6157108|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
1767505|NCT00754390|6157108|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
1767506|NCT00754390|6157108|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
1767507|NCT00754338|6157130|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
1767508|NCT00754338|6157131|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
1767509|NCT00754338|6157132|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
1767510|NCT00754338|6157133|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
1767511|NCT00754338|6157130|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
1767512|NCT00754338|6157131|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
1767513|NCT00754338|6157132|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
1767514|NCT00754338|6157133|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
1767515|NCT00754325|6157165|P2|Initial Treatment|Disease Progression|35
1767516|NCT00754325|6157166|P1|Initial Treatment|Disease Progression|35
1767517|NCT00754325|6157165|P2|Initial Treatment|Sponsor Request|1
1767518|NCT00754325|6157166|P1|Initial Treatment|Sponsor Request|0
1767519|NCT00754325|6157165|P2|Initial Treatment|Physician Decision|0
1767520|NCT00754325|6157166|P1|Initial Treatment|Physician Decision|2
1767521|NCT00754325|6157165|P2|Initial Treatment|Withdrawal by Subject|2
1767522|NCT00754325|6157166|P1|Initial Treatment|Withdrawal by Subject|2
1767523|NCT00754325|6157165|P2|Initial Treatment|Adverse Event|6
1767524|NCT00754325|6157166|P1|Initial Treatment|Adverse Event|7
1767525|NCT00754325|6157165|P2|Initial Treatment|Continuing Active Treatment|5
1767526|NCT00754325|6157166|P1|Initial Treatment|Continuing Active Treatment|4
1767527|NCT00754234|6157219|P1|Overall Study|Withdrawal by Subject|3
1767528|NCT00754065|6157305|P2|Overall Study|Reason not specified or unknown, etc.|27
1767529|NCT00754065|6157306|P1|Overall Study|Reason not specified or unknown, etc.|21
1767530|NCT00754065|6157305|P2|Overall Study|Pregnancy|0
1767531|NCT00754065|6157306|P1|Overall Study|Pregnancy|6
1767532|NCT00754065|6157305|P2|Overall Study|Withdrawal by Subject|5
1767533|NCT00754065|6157306|P1|Overall Study|Withdrawal by Subject|4
1767534|NCT00754065|6157305|P2|Overall Study|Protocol Violation|10
1767535|NCT00754065|6157306|P1|Overall Study|Protocol Violation|12
1767536|NCT00754065|6157305|P2|Overall Study|Lost to Follow-up|11
1767537|NCT00754065|6157306|P1|Overall Study|Lost to Follow-up|7
1767538|NCT00754065|6157305|P2|Overall Study|Adverse Event|25
1767539|NCT00754065|6157306|P1|Overall Study|Adverse Event|19
1767540|NCT00754065|6157305|P2|Overall Study|Never received treatment|2
1767541|NCT00754065|6157306|P1|Overall Study|Never received treatment|12
1767542|NCT00754052|6157546|P2|Overall Study|Study terminated by Sponsor|3
1767543|NCT00754052|6157547|P1|Overall Study|Study terminated by Sponsor|5
1767544|NCT00754013|6157561|P2|Overall Study|didn't return after study termed|4
1767545|NCT00754013|6157562|P1|Overall Study|didn't return after study termed|3
1767546|NCT00754013|6157561|P2|Overall Study|Lost to Follow-up|1
1767547|NCT00754013|6157562|P1|Overall Study|Lost to Follow-up|1
1767548|NCT00753922|6157596|P4|Overall Study|Discontinuation Due to Explantation|4
1767549|NCT00753922|6157597|P3|Overall Study|Discontinuation Due to Explantation|14
1767550|NCT00753922|6157598|P2|Overall Study|Discontinuation Due to Explantation|14
1767551|NCT00753922|6157599|P1|Overall Study|Discontinuation Due to Explantation|14
1767552|NCT00753922|6157596|P4|Overall Study|Death|1
1767553|NCT00753922|6157597|P3|Overall Study|Death|2
1767554|NCT00753922|6157598|P2|Overall Study|Death|23
1767555|NCT00753922|6157599|P1|Overall Study|Death|2
1767556|NCT00753922|6157596|P4|Overall Study|Patients Not Completing Visit|0
1767557|NCT00753922|6157597|P3|Overall Study|Patients Not Completing Visit|1
1767558|NCT00753922|6157598|P2|Overall Study|Patients Not Completing Visit|0
1767559|NCT00753922|6157599|P1|Overall Study|Patients Not Completing Visit|11
1767560|NCT00753922|6157596|P4|Overall Study|Patient Non-compliance|11
1767561|NCT00753922|6157597|P3|Overall Study|Patient Non-compliance|14
1767562|NCT00753922|6157598|P2|Overall Study|Patient Non-compliance|22
1767563|NCT00753922|6157599|P1|Overall Study|Patient Non-compliance|55
1767564|NCT00753922|6157596|P4|Overall Study|Withdrawal by Subject|2
1767565|NCT00753922|6157597|P3|Overall Study|Withdrawal by Subject|4
1767566|NCT00753922|6157598|P2|Overall Study|Withdrawal by Subject|11
1767567|NCT00753922|6157599|P1|Overall Study|Withdrawal by Subject|9
1767568|NCT00753922|6157596|P4|Overall Study|Lost to Follow-up|5
1767569|NCT00753922|6157597|P3|Overall Study|Lost to Follow-up|28
1767570|NCT00753922|6157598|P2|Overall Study|Lost to Follow-up|24
1767571|NCT00753922|6157599|P1|Overall Study|Lost to Follow-up|155
1767572|NCT00753896|6157629|P1|Overall Study|Entry Criteria Not Met|4
1767573|NCT00753896|6157629|P1|Overall Study|Withdrawal by Subject|4
1767574|NCT00753896|6157629|P1|Overall Study|Protocol Violation|1
1767575|NCT00753896|6157629|P1|Overall Study|Lost to Follow-up|2
1767576|NCT00753896|6157629|P1|Overall Study|Death|1
1767577|NCT00753896|6157629|P1|Overall Study|Adverse Event|4
1767578|NCT00753766|6157645|P2|Overall Study|Physician Decision|0
1767579|NCT00753766|6157646|P1|Overall Study|Physician Decision|1
1767580|NCT00753714|6157668|P2|Overall Study|Other|5
1767581|NCT00753714|6157669|P1|Overall Study|Other|7
1767582|NCT00753714|6157668|P2|Overall Study|Death|3
1767583|NCT00753714|6157669|P1|Overall Study|Death|3
1767584|NCT00753714|6157668|P2|Overall Study|Withdrawal by Subject|1
1767585|NCT00753714|6157669|P1|Overall Study|Withdrawal by Subject|2
1767586|NCT00753714|6157668|P2|Overall Study|Lost to Follow-up|1
1767587|NCT00753714|6157669|P1|Overall Study|Lost to Follow-up|0
1767588|NCT00753714|6157668|P2|Overall Study|Protocol Violation|0
1767589|NCT00753714|6157669|P1|Overall Study|Protocol Violation|1
1767590|NCT00753714|6157668|P2|Overall Study|Adverse Event|18
1767591|NCT00753714|6157669|P1|Overall Study|Adverse Event|26
1767592|NCT00753714|6157668|P2|Overall Study|Lack of Efficacy|34
1767593|NCT00753714|6157669|P1|Overall Study|Lack of Efficacy|21
1767594|NCT00753688|6157685|P2|Overall Study|Adverse Event|1
1767595|NCT00753688|6157686|P1|Overall Study|Adverse Event|0
1767596|NCT00753688|6157685|P2|Overall Study|Ongoing - in Follow-up|31
1767597|NCT00753688|6157686|P1|Overall Study|Ongoing - in Follow-up|15
1767598|NCT00753688|6157685|P2|Overall Study|Participant Withdrew Consent|2
1767599|NCT00753688|6157686|P1|Overall Study|Participant Withdrew Consent|2
1767600|NCT00753688|6157685|P2|Overall Study|Missing|9
1767601|NCT00753688|6157686|P1|Overall Study|Missing|4
1767602|NCT00753688|6157685|P2|Overall Study|Death|203
1767603|NCT00753688|6157686|P1|Overall Study|Death|102
1767604|NCT00753675|6157715|P3|Overall Study|Lost to Follow-up|0
1767605|NCT00753675|6157716|P2|Overall Study|Lost to Follow-up|0
1767606|NCT00753675|6157717|P1|Overall Study|Lost to Follow-up|1
1767607|NCT00753675|6157715|P3|Overall Study|Withdrawal by Subject|0
1767608|NCT00753675|6157716|P2|Overall Study|Withdrawal by Subject|1
1767609|NCT00753675|6157717|P1|Overall Study|Withdrawal by Subject|0
1767610|NCT00753675|6157715|P3|Overall Study|Objective progression of disease|35
1767611|NCT00753675|6157716|P2|Overall Study|Objective progression of disease|35
1767612|NCT00753675|6157717|P1|Overall Study|Objective progression of disease|35
1767613|NCT00753675|6157715|P3|Overall Study|Adverse Event|4
1767614|NCT00753675|6157716|P2|Overall Study|Adverse Event|9
1767615|NCT00753675|6157717|P1|Overall Study|Adverse Event|11
1767616|NCT00753675|6157715|P3|Overall Study|Death|4
1767617|NCT00753675|6157716|P2|Overall Study|Death|2
1767618|NCT00753675|6157717|P1|Overall Study|Death|1
1767619|NCT00753675|6157715|P3|Overall Study|other reason|13
1767620|NCT00753675|6157716|P2|Overall Study|other reason|12
1767621|NCT00753675|6157717|P1|Overall Study|other reason|11
1767622|NCT00753649|6157739|P2|Overall Study|Protocol Violation|0
1767623|NCT00753649|6157740|P1|Overall Study|Protocol Violation|2
1767624|NCT00753649|6157739|P2|Overall Study|Lost to follow-up-complete vaccination|0
1767625|NCT00753649|6157740|P1|Overall Study|Lost to follow-up-complete vaccination|1
1767626|NCT00753649|6157739|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
1767627|NCT00753649|6157740|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
1767628|NCT00753649|6157739|P2|Overall Study|Migrated/moved from study area|0
1767629|NCT00753649|6157740|P1|Overall Study|Migrated/moved from study area|1
1767630|NCT00753623|6157772|P2|Phase II (14 Days)|Physician Decision|1
1767631|NCT00753623|6157773|P1|Phase II (14 Days)|Physician Decision|0
1767632|NCT00753623|6157772|P2|Washout (7 Days)|Physician Decision|0
1767633|NCT00753623|6157773|P1|Washout (7 Days)|Physician Decision|1
1767634|NCT00753623|6157772|P2|Phase I (14 Days)|Adverse Event|1
1767635|NCT00753623|6157773|P1|Phase I (14 Days)|Adverse Event|0
1767636|NCT00753623|6157772|P2|Phase I (14 Days)|Physician Decision|2
1767637|NCT00753623|6157773|P1|Phase I (14 Days)|Physician Decision|1
1767638|NCT00753623|6157772|P2|Phase I (14 Days)|Withdrawal by Subject|1
1767639|NCT00753623|6157773|P1|Phase I (14 Days)|Withdrawal by Subject|1
1767640|NCT00753545|6157781|P2|Overall Study|Voluntary Discontinuation of Patient|3
1767641|NCT00753545|6157782|P1|Overall Study|Voluntary Discontinuation of Patient|7
1767642|NCT00753545|6157781|P2|Overall Study|Protocol Violation|0
1767643|NCT00753545|6157782|P1|Overall Study|Protocol Violation|1
1767644|NCT00753545|6157781|P2|Overall Study|Lost to Follow-up|3
1767645|NCT00753545|6157782|P1|Overall Study|Lost to Follow-up|2
1767646|NCT00753545|6157781|P2|Overall Study|Death|112
1767647|NCT00753545|6157782|P1|Overall Study|Death|98
1767648|NCT00753519|6157820|P2|Overall Study|Withdrawal by Subject|2
1767649|NCT00753519|6157821|P1|Overall Study|Withdrawal by Subject|0
1767650|NCT00753506|6157843|P2|Overall Study|Other reason|1
1767651|NCT00753506|6157844|P1|Overall Study|Other reason|1
1767652|NCT00753506|6157843|P2|Overall Study|Lost to Follow-up|0
1767653|NCT00753506|6157844|P1|Overall Study|Lost to Follow-up|2
1767654|NCT00753506|6157843|P2|Overall Study|Withdrawal by Subject|1
1767655|NCT00753506|6157844|P1|Overall Study|Withdrawal by Subject|4
1767656|NCT00753454|6157850|P1|Overall Study|Investigator Decision|1
1767657|NCT00753454|6157850|P1|Overall Study|Withdrawal by Subject|5
1767658|NCT00753454|6157850|P1|Overall Study|Lost to Follow-up|3
1767659|NCT00753454|6157850|P1|Overall Study|Lack of Efficacy|1
1767660|NCT00753454|6157850|P1|Overall Study|Adverse Event|4
1767661|NCT00753415|6157884|P10|Part B|Disease progression|1
1767662|NCT00753415|6157885|P9|Part B|Disease progression|2
1767663|NCT00753415|6157886|P8|Part B|Disease progression|0
1767664|NCT00753415|6157887|P7|Part B|Disease progression|0
1767665|NCT00753415|6157888|P6|Part B|Disease progression|0
1767666|NCT00753415|6157889|P5|Part B|Disease progression|0
1767667|NCT00753415|6157890|P4|Part B|Disease progression|0
1767668|NCT00753415|6157891|P3|Part B|Disease progression|0
1767669|NCT00753415|6157892|P2|Part B|Disease progression|0
1767670|NCT00753415|6157893|P1|Part B|Disease progression|0
1767671|NCT00753415|6157884|P10|Part B|Lost to Follow-up|0
1767672|NCT00753415|6157885|P9|Part B|Lost to Follow-up|1
1767673|NCT00753415|6157886|P8|Part B|Lost to Follow-up|1
1767674|NCT00753415|6157887|P7|Part B|Lost to Follow-up|0
1767675|NCT00753415|6157888|P6|Part B|Lost to Follow-up|0
1767676|NCT00753415|6157889|P5|Part B|Lost to Follow-up|0
1767677|NCT00753415|6157890|P4|Part B|Lost to Follow-up|0
1767678|NCT00753415|6157891|P3|Part B|Lost to Follow-up|0
1767679|NCT00753415|6157892|P2|Part B|Lost to Follow-up|0
1767680|NCT00753415|6157893|P1|Part B|Lost to Follow-up|0
1767681|NCT00753415|6157884|P10|Part A|Withdrawal by Subject|0
1767682|NCT00753415|6157885|P9|Part A|Withdrawal by Subject|0
1767683|NCT00753415|6157886|P8|Part A|Withdrawal by Subject|0
1767684|NCT00753415|6157887|P7|Part A|Withdrawal by Subject|0
1767685|NCT00753415|6157888|P6|Part A|Withdrawal by Subject|0
1767686|NCT00753415|6157889|P5|Part A|Withdrawal by Subject|0
1767687|NCT00753415|6157890|P4|Part A|Withdrawal by Subject|0
1767688|NCT00753415|6157891|P3|Part A|Withdrawal by Subject|1
1767689|NCT00753415|6157892|P2|Part A|Withdrawal by Subject|0
1767690|NCT00753415|6157893|P1|Part A|Withdrawal by Subject|0
1767691|NCT00753415|6157884|P10|Part A|Disease progression|0
1767692|NCT00753415|6157885|P9|Part A|Disease progression|0
1767693|NCT00753415|6157886|P8|Part A|Disease progression|0
1767694|NCT00753415|6157887|P7|Part A|Disease progression|0
1767695|NCT00753415|6157888|P6|Part A|Disease progression|0
1767696|NCT00753415|6157889|P5|Part A|Disease progression|0
1767697|NCT00753415|6157890|P4|Part A|Disease progression|2
1767698|NCT00753415|6157891|P3|Part A|Disease progression|1
1767699|NCT00753415|6157892|P2|Part A|Disease progression|0
1767700|NCT00753415|6157893|P1|Part A|Disease progression|1
1767701|NCT00753272|6157983|P2|Overall Study|Other|1088
1767702|NCT00753272|6157984|P1|Overall Study|Other|1104
1767703|NCT00753272|6157983|P2|Overall Study|Lost to Follow-up|497
1767704|NCT00753272|6157984|P1|Overall Study|Lost to Follow-up|491
1767705|NCT00753272|6157983|P2|Overall Study|Withdrawal by Subject|2407
1767706|NCT00753272|6157984|P1|Overall Study|Withdrawal by Subject|2481
1767707|NCT00753272|6157983|P2|Overall Study|Protocol Violation|46
1767708|NCT00753272|6157984|P1|Overall Study|Protocol Violation|28
1767709|NCT00753272|6157983|P2|Overall Study|Adverse Event|869
1767710|NCT00753272|6157984|P1|Overall Study|Adverse Event|878
1767711|NCT00753012|6158068|P2|Overall Study|Confounded endpoint data|0
1767712|NCT00753012|6158069|P1|Overall Study|Confounded endpoint data|1
1767713|NCT00753012|6158068|P2|Overall Study|Lost to Follow-up|0
1767714|NCT00753012|6158069|P1|Overall Study|Lost to Follow-up|4
1767715|NCT00753012|6158068|P2|Overall Study|Withdrawal by Subject|1
1767716|NCT00753012|6158069|P1|Overall Study|Withdrawal by Subject|0
1767717|NCT00753012|6158068|P2|Overall Study|Adverse Event|0
1767718|NCT00753012|6158069|P1|Overall Study|Adverse Event|2
1767719|NCT00753012|6158068|P2|Overall Study|Ineligible, abnormal cardiac histo|0
1767720|NCT00753012|6158069|P1|Overall Study|Ineligible, abnormal cardiac histo|1
1767721|NCT00752986|6158082|P3|Overall Study|Protocol Violation|0
1767722|NCT00752986|6158083|P2|Overall Study|Protocol Violation|0
1767723|NCT00752986|6158084|P1|Overall Study|Protocol Violation|3
1767724|NCT00752986|6158082|P3|Overall Study|Withdrawal by Subject|2
1767725|NCT00752986|6158083|P2|Overall Study|Withdrawal by Subject|1
1767726|NCT00752986|6158084|P1|Overall Study|Withdrawal by Subject|2
1767727|NCT00752895|6158124|P2|Overall Study|Withdrawal by Subject|3
1767728|NCT00752895|6158125|P1|Overall Study|Withdrawal by Subject|8
1767729|NCT00752791|6158133|P1|Overall Study|Protocol deviation|1
1767730|NCT00752791|6158133|P1|Overall Study|Switched to hemodialysis|2
1767731|NCT00752791|6158133|P1|Overall Study|Renal transplant|3
1767732|NCT00752791|6158133|P1|Overall Study|Death|1
1767733|NCT00752791|6158133|P1|Overall Study|Physician Decision|1
1767734|NCT00752791|6158133|P1|Overall Study|Withdrawal by Subject|1
1767735|NCT00752791|6158133|P1|Overall Study|Adverse Event|7
1767736|NCT00752726|6158145|P2|Overall Study|Other Reason|2
1767737|NCT00752726|6158146|P1|Overall Study|Other Reason|1
1767738|NCT00752726|6158145|P2|Overall Study|Withdrawal by Subject|10
1767739|NCT00752726|6158146|P1|Overall Study|Withdrawal by Subject|5
1767740|NCT00752726|6158145|P2|Overall Study|Adverse Event|0
1767741|NCT00752726|6158146|P1|Overall Study|Adverse Event|3
1767742|NCT00752726|6158145|P2|Overall Study|Lost to Follow-up|1
1767743|NCT00752726|6158146|P1|Overall Study|Lost to Follow-up|2
1767744|NCT00752622|6158171|P1|Interventional Phase|Premature Study Termination|5
1767745|NCT00752622|6158171|P1|Interventional Phase|Physician Decision|1
1767746|NCT00752622|6158171|P1|Interventional Phase|Non-responder|2
1767747|NCT00752622|6158171|P1|Observational Phase|Other|2
1767748|NCT00752622|6158171|P1|Observational Phase|Adverse Event|1
1767749|NCT00752622|6158171|P1|Observational Phase|Withdrawal by Subject|2
1767750|NCT00752622|6158171|P1|Observational Phase|Non-responder|2
1767751|NCT00752622|6158171|P1|Observational Phase|Premature Study Termination|36
1767752|NCT00752622|6158171|P1|Induction Phase|Premature study termination|14
1767753|NCT00752622|6158171|P1|Induction Phase|Withdrawal by Subject|1
1767754|NCT00752622|6158171|P1|Induction Phase|Non-responder|14
1767755|NCT00752622|6158171|P1|Induction Phase|Other|3
1767756|NCT00752622|6158171|P1|Induction Phase|Adverse Event|3
1767757|NCT00752609|6158184|P2|Overall Study|Received Aranesp in error|0
1767758|NCT00752609|6158185|P1|Overall Study|Received Aranesp in error|1
1767759|NCT00752609|6158184|P2|Overall Study|Met exclusion criteria|0
1767760|NCT00752609|6158185|P1|Overall Study|Met exclusion criteria|1
1767761|NCT00752609|6158184|P2|Overall Study|Death|0
1767762|NCT00752609|6158185|P1|Overall Study|Death|1
1767763|NCT00752609|6158184|P2|Overall Study|Physician Decision|0
1767764|NCT00752609|6158185|P1|Overall Study|Physician Decision|1
1767765|NCT00752609|6158184|P2|Overall Study|Withdrawal by Subject|0
1767766|NCT00752609|6158185|P1|Overall Study|Withdrawal by Subject|3
1767767|NCT00752609|6158184|P2|Overall Study|Adverse Event|2
1767768|NCT00752609|6158185|P1|Overall Study|Adverse Event|2
1767769|NCT00752232|6158211|P7|Overall Study|Caregiver could not attend the subject|0
1767770|NCT00752232|6158212|P6|Overall Study|Caregiver could not attend the subject|0
1767771|NCT00752232|6158213|P5|Overall Study|Caregiver could not attend the subject|1
1767772|NCT00752232|6158214|P4|Overall Study|Caregiver could not attend the subject|0
1767773|NCT00752232|6158215|P3|Overall Study|Caregiver could not attend the subject|0
1767774|NCT00752232|6158216|P2|Overall Study|Caregiver could not attend the subject|0
1767775|NCT00752232|6158217|P1|Overall Study|Caregiver could not attend the subject|0
1767776|NCT00752232|6158211|P7|Overall Study|Group home admission|0
1767777|NCT00752232|6158212|P6|Overall Study|Group home admission|0
1767778|NCT00752232|6158213|P5|Overall Study|Group home admission|0
1767779|NCT00752232|6158214|P4|Overall Study|Group home admission|1
1767780|NCT00752232|6158215|P3|Overall Study|Group home admission|0
1767781|NCT00752232|6158216|P2|Overall Study|Group home admission|0
1767782|NCT00752232|6158217|P1|Overall Study|Group home admission|0
1767783|NCT00752232|6158211|P7|Overall Study|Subject request|0
1767784|NCT00752232|6158212|P6|Overall Study|Subject request|0
1767785|NCT00752232|6158213|P5|Overall Study|Subject request|0
1767786|NCT00752232|6158214|P4|Overall Study|Subject request|0
1767787|NCT00752232|6158215|P3|Overall Study|Subject request|1
1767788|NCT00752232|6158216|P2|Overall Study|Subject request|0
1767789|NCT00752232|6158217|P1|Overall Study|Subject request|0
1767790|NCT00752232|6158211|P7|Overall Study|Investigator request|0
1767791|NCT00752232|6158212|P6|Overall Study|Investigator request|0
1767792|NCT00752232|6158213|P5|Overall Study|Investigator request|1
1767793|NCT00752232|6158214|P4|Overall Study|Investigator request|0
1767794|NCT00752232|6158215|P3|Overall Study|Investigator request|0
1767795|NCT00752232|6158216|P2|Overall Study|Investigator request|0
1767796|NCT00752232|6158217|P1|Overall Study|Investigator request|0
1767797|NCT00752232|6158211|P7|Overall Study|Caregiver request|0
1767798|NCT00752232|6158212|P6|Overall Study|Caregiver request|0
1767799|NCT00752232|6158213|P5|Overall Study|Caregiver request|1
1767800|NCT00752232|6158214|P4|Overall Study|Caregiver request|0
1767801|NCT00752232|6158215|P3|Overall Study|Caregiver request|0
1767802|NCT00752232|6158216|P2|Overall Study|Caregiver request|0
1767803|NCT00752232|6158217|P1|Overall Study|Caregiver request|2
1767804|NCT00752232|6158211|P7|Overall Study|Protocol Violation|0
1767805|NCT00752232|6158212|P6|Overall Study|Protocol Violation|1
1767806|NCT00752232|6158213|P5|Overall Study|Protocol Violation|0
1767807|NCT00752232|6158214|P4|Overall Study|Protocol Violation|0
1767808|NCT00752232|6158215|P3|Overall Study|Protocol Violation|0
1767809|NCT00752232|6158216|P2|Overall Study|Protocol Violation|0
1767810|NCT00752232|6158217|P1|Overall Study|Protocol Violation|0
1767811|NCT00752219|6158291|P2|Overall Study|Other|0
1767812|NCT00752219|6158292|P1|Overall Study|Other|3
1767813|NCT00752219|6158291|P2|Overall Study|Randomized but not treated|0
1767814|NCT00752219|6158292|P1|Overall Study|Randomized but not treated|1
1767815|NCT00752219|6158291|P2|Overall Study|Lost to Follow-up|2
1767816|NCT00752219|6158292|P1|Overall Study|Lost to Follow-up|1
1767817|NCT00752219|6158291|P2|Overall Study|Protocol deviation|0
1767818|NCT00752219|6158292|P1|Overall Study|Protocol deviation|1
1767819|NCT00752219|6158291|P2|Overall Study|Adverse Event|3
1767820|NCT00752219|6158292|P1|Overall Study|Adverse Event|5
1767821|NCT00752219|6158291|P2|Overall Study|Clinical failure|1
1767822|NCT00752219|6158292|P1|Overall Study|Clinical failure|0
1767823|NCT00752206|6158318|P2|Overall Study|Pregnancy|0
1767824|NCT00752206|6158319|P1|Overall Study|Pregnancy|1
1767825|NCT00752206|6158318|P2|Overall Study|Disease progression|11
1767826|NCT00752206|6158319|P1|Overall Study|Disease progression|8
1767827|NCT00752128|6158337|P1|Overall Study|Withdrawal by Subject|4
1767828|NCT00752089|6158351|P1|Overall Study|Cannot continue the study|1
1767829|NCT00752089|6158351|P1|Overall Study|Not capable of wearing partial denture|1
1767830|NCT00752089|6158351|P1|Overall Study|Could not attend visit 9|1
1767831|NCT00752089|6158351|P1|Overall Study|Protocol Deviation|2
1767832|NCT00752089|6158351|P1|Overall Study|Adverse Event|1
1767833|NCT00751998|6158365|P1|Overall Study|Withdrawal by Subject|2
1767834|NCT00751998|6158365|P1|Overall Study|Death|11
1767835|NCT00751998|6158365|P1|Overall Study|Lost to Follow-up|7
1767836|NCT00751933|6158384|P4|Overall Study|Physician Decision|1
1767837|NCT00751933|6158385|P3|Overall Study|Physician Decision|1
1767838|NCT00751933|6158386|P2|Overall Study|Physician Decision|0
1767839|NCT00751933|6158387|P1|Overall Study|Physician Decision|0
1767840|NCT00751933|6158384|P4|Overall Study|Withdrawal by Subject|0
1767841|NCT00751933|6158385|P3|Overall Study|Withdrawal by Subject|0
1767842|NCT00751933|6158386|P2|Overall Study|Withdrawal by Subject|1
1767843|NCT00751933|6158387|P1|Overall Study|Withdrawal by Subject|0
1767844|NCT00751881|6158395|P3|Extension Study Period|Other than specified above|18
1767845|NCT00751881|6158396|P2|Extension Study Period|Other than specified above|30
1767846|NCT00751881|6158397|P1|Extension Study Period|Other than specified above|26
1767847|NCT00751881|6158395|P3|Extension Study Period|Poor Compliance to Protocol|1
1767848|NCT00751881|6158396|P2|Extension Study Period|Poor Compliance to Protocol|2
1767849|NCT00751881|6158397|P1|Extension Study Period|Poor Compliance to Protocol|3
1767850|NCT00751881|6158395|P3|Extension Study Period|Lost to Follow-up|6
1767851|NCT00751881|6158396|P2|Extension Study Period|Lost to Follow-up|9
1767852|NCT00751881|6158397|P1|Extension Study Period|Lost to Follow-up|4
1767853|NCT00751881|6158395|P3|Extension Study Period|Lack of Efficacy|20
1767854|NCT00751881|6158396|P2|Extension Study Period|Lack of Efficacy|10
1767855|NCT00751881|6158397|P1|Extension Study Period|Lack of Efficacy|14
1767856|NCT00751881|6158395|P3|Extension Study Period|Adverse Event|21
1767857|NCT00751881|6158396|P2|Extension Study Period|Adverse Event|20
1767858|NCT00751881|6158397|P1|Extension Study Period|Adverse Event|18
1767859|NCT00751881|6158395|P3|Core Treatment Period|Other:participant's decision/unspecified|16
1767860|NCT00751881|6158396|P2|Core Treatment Period|Other:participant's decision/unspecified|22
1767861|NCT00751881|6158397|P1|Core Treatment Period|Other:participant's decision/unspecified|19
1767862|NCT00751881|6158395|P3|Core Treatment Period|Other: tolerability complaints|0
1767863|NCT00751881|6158396|P2|Core Treatment Period|Other: tolerability complaints|0
1767864|NCT00751881|6158397|P1|Core Treatment Period|Other: tolerability complaints|2
1767865|NCT00751881|6158395|P3|Core Treatment Period|Other: MS treatment change|4
1767866|NCT00751881|6158396|P2|Core Treatment Period|Other: MS treatment change|4
1767867|NCT00751881|6158397|P1|Core Treatment Period|Other: MS treatment change|6
1767868|NCT00751881|6158395|P3|Core Treatment Period|Other: personal/family constraints|10
1767869|NCT00751881|6158396|P2|Core Treatment Period|Other: personal/family constraints|7
1767870|NCT00751881|6158397|P1|Core Treatment Period|Other: personal/family constraints|6
1767871|NCT00751881|6158395|P3|Core Treatment Period|Other: wish to parent|4
1767872|NCT00751881|6158396|P2|Core Treatment Period|Other: wish to parent|7
1767873|NCT00751881|6158397|P1|Core Treatment Period|Other: wish to parent|5
1767874|NCT00751881|6158395|P3|Core Treatment Period|Other: protocol deviation|7
1767875|NCT00751881|6158396|P2|Core Treatment Period|Other: protocol deviation|3
1767876|NCT00751881|6158397|P1|Core Treatment Period|Other: protocol deviation|3
1767877|NCT00751881|6158395|P3|Core Treatment Period|Lost to Follow-up|3
1767878|NCT00751881|6158396|P2|Core Treatment Period|Lost to Follow-up|4
1767879|NCT00751881|6158397|P1|Core Treatment Period|Lost to Follow-up|6
1767880|NCT00751881|6158395|P3|Core Treatment Period|Poor compliance to protocol|4
1767881|NCT00751881|6158396|P2|Core Treatment Period|Poor compliance to protocol|3
1767882|NCT00751881|6158397|P1|Core Treatment Period|Poor compliance to protocol|15
1767883|NCT00751881|6158395|P3|Core Treatment Period|Lack of Efficacy|20
1767884|NCT00751881|6158396|P2|Core Treatment Period|Lack of Efficacy|30
1767885|NCT00751881|6158397|P1|Core Treatment Period|Lack of Efficacy|37
1767886|NCT00751881|6158395|P3|Core Treatment Period|Adverse Event|58
1767887|NCT00751881|6158396|P2|Core Treatment Period|Adverse Event|54
1767888|NCT00751881|6158397|P1|Core Treatment Period|Adverse Event|26
1767889|NCT00751881|6158395|P3|Core Treatment Period|Not treated|2
1767890|NCT00751881|6158396|P2|Core Treatment Period|Not treated|1
1767891|NCT00751881|6158397|P1|Core Treatment Period|Not treated|1
1767892|NCT00751790|6158444|P1|Overall Study|Withdrawal by Subject|1
1767893|NCT00751790|6158444|P1|Overall Study|Death|3
1767894|NCT00751790|6158444|P1|Overall Study|Lost to Follow-up|1
1767895|NCT00751621|6158475|P1|Overall Study|Poor adherence to asthma treatment|1
1767896|NCT00751621|6158475|P1|Overall Study|Subject moved to another country|1
1767897|NCT00751621|6158475|P1|Overall Study|Withdrawal by Subject|1
1767898|NCT00751621|6158475|P1|Overall Study|Adverse Event|1
1767899|NCT00751400|6158509|P1|Overall Study|Lost to Follow-up|10
1767900|NCT00751348|6158524|P2|Overall Study|Migration from study area|0
1767901|NCT00751348|6158525|P1|Overall Study|Migration from study area|1
1767902|NCT00751348|6158524|P2|Overall Study|Withdrawal by Subject|2
1767903|NCT00751348|6158525|P1|Overall Study|Withdrawal by Subject|5
1767904|NCT00751296|6158547|P1|Overall Study|Adverse Event|2
1767905|NCT00751140|6158575|P1|Overall Study|benign angioma excluded from analysis|1
1767906|NCT00751114|6158585|P2|Overall Study|Move to another city|0
1767907|NCT00751114|6158586|P1|Overall Study|Move to another city|1
1767908|NCT00751114|6158585|P2|Overall Study|Out of country for 2 months|0
1767909|NCT00751114|6158586|P1|Overall Study|Out of country for 2 months|1
1767910|NCT00751114|6158585|P2|Overall Study|Not Treated|1
1767911|NCT00751114|6158586|P1|Overall Study|Not Treated|13
1767912|NCT00751114|6158585|P2|Overall Study|Lack of Efficacy|7
1767913|NCT00751114|6158586|P1|Overall Study|Lack of Efficacy|0
1767914|NCT00751114|6158585|P2|Overall Study|Lost to Follow-up|7
1767915|NCT00751114|6158586|P1|Overall Study|Lost to Follow-up|4
1767916|NCT00751114|6158585|P2|Overall Study|Withdrawal by Subject|4
1767917|NCT00751114|6158586|P1|Overall Study|Withdrawal by Subject|9
1767918|NCT00751114|6158585|P2|Overall Study|Protocol Violation|9
1767919|NCT00751114|6158586|P1|Overall Study|Protocol Violation|8
1767920|NCT00751114|6158585|P2|Overall Study|Adverse Event|4
1767921|NCT00751114|6158586|P1|Overall Study|Adverse Event|2
1767922|NCT00751036|6158611|P2|Overall Study|Missing end of Treatment Page|3
1767923|NCT00751036|6158612|P1|Overall Study|Missing end of Treatment Page|2
1767924|NCT00751036|6158611|P2|Overall Study|Protocol Violation|0
1767925|NCT00751036|6158612|P1|Overall Study|Protocol Violation|1
1767926|NCT00751036|6158611|P2|Overall Study|Lost to Follow-up|1
1767927|NCT00751036|6158612|P1|Overall Study|Lost to Follow-up|0
1767928|NCT00751036|6158611|P2|Overall Study|Death|3
1767929|NCT00751036|6158612|P1|Overall Study|Death|3
1767930|NCT00751036|6158611|P2|Overall Study|Withdrawal by Subject|2
1767931|NCT00751036|6158612|P1|Overall Study|Withdrawal by Subject|5
1767932|NCT00751036|6158611|P2|Overall Study|Administrative Problems|4
1767933|NCT00751036|6158612|P1|Overall Study|Administrative Problems|3
1767934|NCT00751036|6158611|P2|Overall Study|Adverse Event|4
1767935|NCT00751036|6158612|P1|Overall Study|Adverse Event|6
1767936|NCT00751036|6158611|P2|Overall Study|Disease Progression|29
1767937|NCT00751036|6158612|P1|Overall Study|Disease Progression|28
1767938|NCT00751023|6158626|P2|Overall Study|Lost to Follow-up|7
1767939|NCT00751023|6158627|P1|Overall Study|Lost to Follow-up|11
1767940|NCT00750919|6158647|P1|Overall Study|Other|36
1767941|NCT00750919|6158647|P1|Overall Study|Could not cooperate, unrelated to trial|4
1767942|NCT00750919|6158647|P1|Overall Study|Lack of Efficacy|8
1767943|NCT00750919|6158647|P1|Overall Study|Withdrawal by Subject|1
1767944|NCT00750919|6158647|P1|Overall Study|Adverse Event|9
1767945|NCT00750893|6158655|P1|Overall Study|Other|17
1767946|NCT00750893|6158655|P1|Overall Study|Lost to Follow-up|510
1767947|NCT00750893|6158655|P1|Overall Study|Withdrawal by Subject|10
1767948|NCT00750893|6158655|P1|Overall Study|Adverse Event|5
1767949|NCT00750880|6158667|P1|Overall Study|Administrative|11
1767950|NCT00750880|6158667|P1|Overall Study|Physician Decision|20
1767951|NCT00750880|6158667|P1|Overall Study|Withdrawal by Subject|33
1767952|NCT00750880|6158667|P1|Overall Study|Protocol Violation|15
1767953|NCT00750880|6158667|P1|Overall Study|Lost to Follow-up|10
1767954|NCT00750880|6158667|P1|Overall Study|Lack of Efficacy|46
1767955|NCT00750880|6158667|P1|Overall Study|Death|4
1767956|NCT00750880|6158667|P1|Overall Study|Adverse Event|76
1767957|NCT00750867|6158690|P1|Overall Study|Adverse Event|2
1767958|NCT00750737|6158711|P2|Overall Study|Withdrawal by Subject|3
1767959|NCT00750737|6158712|P1|Overall Study|Withdrawal by Subject|3
1767960|NCT00750438|6158727|P2|Overall Study|Withdrawal by Subject|1
1767961|NCT00750438|6158728|P1|Overall Study|Withdrawal by Subject|1
1767962|NCT00750438|6158727|P2|Overall Study|Physician Decision|2
1767963|NCT00750438|6158728|P1|Overall Study|Physician Decision|2
1767964|NCT00750438|6158727|P2|Overall Study|Protocol Violation|1
1767965|NCT00750438|6158728|P1|Overall Study|Protocol Violation|4
1767966|NCT00750308|6158794|P12|Third Treatment|Withdrawal by Subject|0
1767967|NCT00750308|6158795|P11|Third Treatment|Withdrawal by Subject|0
1767968|NCT00750308|6158796|P10|Third Treatment|Withdrawal by Subject|0
1767969|NCT00750308|6158797|P9|Third Treatment|Withdrawal by Subject|0
1767970|NCT00750308|6158798|P8|Third Treatment|Withdrawal by Subject|0
1767971|NCT00750308|6158799|P7|Third Treatment|Withdrawal by Subject|0
1767972|NCT00750308|6158800|P6|Third Treatment|Withdrawal by Subject|0
1767973|NCT00750308|6158801|P5|Third Treatment|Withdrawal by Subject|0
1767974|NCT00750308|6158802|P4|Third Treatment|Withdrawal by Subject|0
1767975|NCT00750308|6158803|P3|Third Treatment|Withdrawal by Subject|0
1767976|NCT00750308|6158804|P2|Third Treatment|Withdrawal by Subject|1
1767977|NCT00750308|6158805|P1|Third Treatment|Withdrawal by Subject|0
1767978|NCT00750308|6158794|P12|Second Treatment|Withdrawal by Subject|0
1767979|NCT00750308|6158795|P11|Second Treatment|Withdrawal by Subject|0
1767980|NCT00750308|6158796|P10|Second Treatment|Withdrawal by Subject|0
1767981|NCT00750308|6158797|P9|Second Treatment|Withdrawal by Subject|0
1767982|NCT00750308|6158798|P8|Second Treatment|Withdrawal by Subject|0
1767983|NCT00750308|6158799|P7|Second Treatment|Withdrawal by Subject|0
1767984|NCT00750308|6158800|P6|Second Treatment|Withdrawal by Subject|0
1767985|NCT00750308|6158801|P5|Second Treatment|Withdrawal by Subject|1
1767986|NCT00750308|6158802|P4|Second Treatment|Withdrawal by Subject|0
1767987|NCT00750308|6158803|P3|Second Treatment|Withdrawal by Subject|0
1767988|NCT00750308|6158804|P2|Second Treatment|Withdrawal by Subject|0
1767989|NCT00750308|6158805|P1|Second Treatment|Withdrawal by Subject|0
1767990|NCT00750308|6158794|P12|Second Treatment|Adverse Event|0
1767991|NCT00750308|6158795|P11|Second Treatment|Adverse Event|0
1767992|NCT00750308|6158796|P10|Second Treatment|Adverse Event|0
1767993|NCT00750308|6158797|P9|Second Treatment|Adverse Event|1
1767994|NCT00750308|6158798|P8|Second Treatment|Adverse Event|0
1767995|NCT00750308|6158799|P7|Second Treatment|Adverse Event|0
1767996|NCT00750308|6158800|P6|Second Treatment|Adverse Event|1
1767997|NCT00750308|6158801|P5|Second Treatment|Adverse Event|0
1767998|NCT00750308|6158802|P4|Second Treatment|Adverse Event|0
1767999|NCT00750308|6158803|P3|Second Treatment|Adverse Event|0
1768000|NCT00750308|6158804|P2|Second Treatment|Adverse Event|0
1768001|NCT00750308|6158805|P1|Second Treatment|Adverse Event|0
1768002|NCT00750308|6158794|P12|First Treatment|Withdrawal by Subject|0
1768003|NCT00750308|6158795|P11|First Treatment|Withdrawal by Subject|0
1768004|NCT00750308|6158796|P10|First Treatment|Withdrawal by Subject|0
1768005|NCT00750308|6158797|P9|First Treatment|Withdrawal by Subject|0
1768006|NCT00750308|6158798|P8|First Treatment|Withdrawal by Subject|1
1768007|NCT00750308|6158799|P7|First Treatment|Withdrawal by Subject|0
1768008|NCT00750308|6158800|P6|First Treatment|Withdrawal by Subject|0
1768009|NCT00750308|6158801|P5|First Treatment|Withdrawal by Subject|0
1768010|NCT00750308|6158802|P4|First Treatment|Withdrawal by Subject|1
1768011|NCT00750308|6158803|P3|First Treatment|Withdrawal by Subject|0
1768012|NCT00750308|6158804|P2|First Treatment|Withdrawal by Subject|0
1768013|NCT00750308|6158805|P1|First Treatment|Withdrawal by Subject|0
1768014|NCT00750308|6158794|P12|First Treatment|Adverse Event|1
1768015|NCT00750308|6158795|P11|First Treatment|Adverse Event|1
1768016|NCT00750308|6158796|P10|First Treatment|Adverse Event|0
1768017|NCT00750308|6158797|P9|First Treatment|Adverse Event|0
1768018|NCT00750308|6158798|P8|First Treatment|Adverse Event|0
1768019|NCT00750308|6158799|P7|First Treatment|Adverse Event|0
1768020|NCT00750308|6158800|P6|First Treatment|Adverse Event|0
1768021|NCT00750308|6158801|P5|First Treatment|Adverse Event|0
1768022|NCT00750308|6158802|P4|First Treatment|Adverse Event|0
1768023|NCT00750308|6158803|P3|First Treatment|Adverse Event|0
1768024|NCT00750308|6158804|P2|First Treatment|Adverse Event|1
1768025|NCT00750308|6158805|P1|First Treatment|Adverse Event|0
1768026|NCT00750269|6158855|P5|Overall Study|Fiducials could not be placed|1
1768027|NCT00750269|6158856|P4|Overall Study|Fiducials could not be placed|0
1768028|NCT00750269|6158857|P3|Overall Study|Fiducials could not be placed|0
1768029|NCT00750269|6158858|P2|Overall Study|Fiducials could not be placed|0
1768030|NCT00750269|6158859|P1|Overall Study|Fiducials could not be placed|0
1768031|NCT00750269|6158855|P5|Overall Study|SBRT plan could not be drawn|1
1768032|NCT00750269|6158856|P4|Overall Study|SBRT plan could not be drawn|0
1768033|NCT00750269|6158857|P3|Overall Study|SBRT plan could not be drawn|0
1768034|NCT00750269|6158858|P2|Overall Study|SBRT plan could not be drawn|0
1768035|NCT00750269|6158859|P1|Overall Study|SBRT plan could not be drawn|0
1768036|NCT00750269|6158855|P5|Overall Study|Site error|0
1768037|NCT00750269|6158856|P4|Overall Study|Site error|1
1768038|NCT00750269|6158857|P3|Overall Study|Site error|0
1768039|NCT00750269|6158858|P2|Overall Study|Site error|0
1768040|NCT00750269|6158859|P1|Overall Study|Site error|0
1768041|NCT00750269|6158855|P5|Overall Study|Patient too large for positioning|0
1768042|NCT00750269|6158856|P4|Overall Study|Patient too large for positioning|0
1768043|NCT00750269|6158857|P3|Overall Study|Patient too large for positioning|1
1768044|NCT00750269|6158858|P2|Overall Study|Patient too large for positioning|0
1768045|NCT00750269|6158859|P1|Overall Study|Patient too large for positioning|0
1768046|NCT00750269|6158855|P5|Overall Study|Physician Decision|2
1768047|NCT00750269|6158856|P4|Overall Study|Physician Decision|0
1768048|NCT00750269|6158857|P3|Overall Study|Physician Decision|0
1768049|NCT00750269|6158858|P2|Overall Study|Physician Decision|0
1768050|NCT00750269|6158859|P1|Overall Study|Physician Decision|0
1768051|NCT00750269|6158855|P5|Overall Study|Withdrawal by Subject|2
1768052|NCT00750269|6158856|P4|Overall Study|Withdrawal by Subject|2
1768053|NCT00750269|6158857|P3|Overall Study|Withdrawal by Subject|2
1768054|NCT00750269|6158858|P2|Overall Study|Withdrawal by Subject|0
1768055|NCT00750269|6158859|P1|Overall Study|Withdrawal by Subject|0
1768056|NCT00750269|6158855|P5|Overall Study|Protocol Violation|4
1768057|NCT00750269|6158856|P4|Overall Study|Protocol Violation|2
1768058|NCT00750269|6158857|P3|Overall Study|Protocol Violation|1
1768059|NCT00750269|6158858|P2|Overall Study|Protocol Violation|1
1768060|NCT00750269|6158859|P1|Overall Study|Protocol Violation|0
1768061|NCT00750204|6158906|P2|Overall Study|study halted prematurely|1
1768062|NCT00750204|6158907|P1|Overall Study|study halted prematurely|1
1768063|NCT00750152|6158937|P2|Overall Study|Other|8
1768064|NCT00750152|6158938|P1|Overall Study|Other|7
1768065|NCT00750152|6158937|P2|Overall Study|Termination by sponsor|0
1768066|NCT00750152|6158938|P1|Overall Study|Termination by sponsor|1
1768067|NCT00750152|6158937|P2|Overall Study|Non-compliance|1
1768068|NCT00750152|6158938|P1|Overall Study|Non-compliance|0
1768069|NCT00750152|6158937|P2|Overall Study|Physician Decision|1
1768070|NCT00750152|6158938|P1|Overall Study|Physician Decision|1
1768071|NCT00750152|6158937|P2|Overall Study|Withdrawal by Subject|3
1768072|NCT00750152|6158938|P1|Overall Study|Withdrawal by Subject|3
1768073|NCT00750152|6158937|P2|Overall Study|Lost to Follow-up|13
1768074|NCT00750152|6158938|P1|Overall Study|Lost to Follow-up|8
1768075|NCT00750152|6158937|P2|Overall Study|Adverse Event|1
1768076|NCT00750152|6158938|P1|Overall Study|Adverse Event|2
1768077|NCT00750139|6158950|P4|Overall Study|Non-specific|33
1768078|NCT00750139|6158951|P3|Overall Study|Non-specific|79
1768079|NCT00750139|6158952|P2|Overall Study|Non-specific|42
1768080|NCT00750139|6158953|P1|Overall Study|Non-specific|62
1768081|NCT00750139|6158950|P4|Overall Study|Termination by sponsor|1
1768082|NCT00750139|6158951|P3|Overall Study|Termination by sponsor|0
1768083|NCT00750139|6158952|P2|Overall Study|Termination by sponsor|0
1768084|NCT00750139|6158953|P1|Overall Study|Termination by sponsor|4
1768085|NCT00750139|6158950|P4|Overall Study|Non-compliance|3
1768086|NCT00750139|6158951|P3|Overall Study|Non-compliance|1
1768087|NCT00750139|6158952|P2|Overall Study|Non-compliance|0
1768088|NCT00750139|6158953|P1|Overall Study|Non-compliance|1
1768089|NCT00750139|6158950|P4|Overall Study|Physician Decision|0
1768090|NCT00750139|6158951|P3|Overall Study|Physician Decision|0
1768091|NCT00750139|6158952|P2|Overall Study|Physician Decision|1
1768092|NCT00750139|6158953|P1|Overall Study|Physician Decision|1
1768093|NCT00750139|6158950|P4|Overall Study|Withdrawal by Subject|2
1768094|NCT00750139|6158951|P3|Overall Study|Withdrawal by Subject|6
1768095|NCT00750139|6158952|P2|Overall Study|Withdrawal by Subject|2
1768096|NCT00750139|6158953|P1|Overall Study|Withdrawal by Subject|3
1768097|NCT00750139|6158950|P4|Overall Study|Lost to Follow-up|6
1768098|NCT00750139|6158951|P3|Overall Study|Lost to Follow-up|15
1768099|NCT00750139|6158952|P2|Overall Study|Lost to Follow-up|12
1768100|NCT00750139|6158953|P1|Overall Study|Lost to Follow-up|17
1768101|NCT00750139|6158950|P4|Overall Study|Adverse Event|1
1768102|NCT00750139|6158951|P3|Overall Study|Adverse Event|0
1768103|NCT00750139|6158952|P2|Overall Study|Adverse Event|2
1768104|NCT00750139|6158953|P1|Overall Study|Adverse Event|1
1768105|NCT00750061|6158969|P2|Overall Study|Physician Decision|1
1768106|NCT00750061|6158970|P1|Overall Study|Physician Decision|0
1768107|NCT00750061|6158969|P2|Overall Study|Withdrawal by Subject|1
1768108|NCT00750061|6158970|P1|Overall Study|Withdrawal by Subject|0
1768109|NCT00750061|6158969|P2|Overall Study|Adverse Event|0
1768110|NCT00750061|6158970|P1|Overall Study|Adverse Event|2
1768111|NCT00749996|6158980|P2|Overall Study|Death|0
1768112|NCT00749996|6158981|P1|Overall Study|Death|1
1768113|NCT00749996|6158980|P2|Overall Study|Adverse Event|0
1768114|NCT00749996|6158981|P1|Overall Study|Adverse Event|1
1768115|NCT00749996|6158980|P2|Overall Study|Pregnancy|2
1768116|NCT00749996|6158981|P1|Overall Study|Pregnancy|0
1768117|NCT00749996|6158980|P2|Overall Study|Physician Decision|0
1768118|NCT00749996|6158981|P1|Overall Study|Physician Decision|2
1768119|NCT00749996|6158980|P2|Overall Study|Protocol Violation|3
1768120|NCT00749996|6158981|P1|Overall Study|Protocol Violation|2
1768121|NCT00749996|6158980|P2|Overall Study|Withdrawal by Subject|4
1768122|NCT00749996|6158981|P1|Overall Study|Withdrawal by Subject|5
1768123|NCT00749996|6158980|P2|Overall Study|Lost to Follow-up|4
1768124|NCT00749996|6158981|P1|Overall Study|Lost to Follow-up|7
1768125|NCT00749944|6159004|P2|Overall Study|Withdrawal by Subject|0
1768126|NCT00749944|6159005|P1|Overall Study|Withdrawal by Subject|2
1768127|NCT00749944|6159004|P2|Overall Study|Other|0
1768128|NCT00749944|6159005|P1|Overall Study|Other|1
1768129|NCT00749944|6159004|P2|Overall Study|Lost to Follow-up|1
1768130|NCT00749944|6159005|P1|Overall Study|Lost to Follow-up|2
1768131|NCT00749775|6159116|P1|Overall Study|No drug administration|3
1768132|NCT00749775|6159116|P1|Overall Study|No visit after first day of treatment|44
1768133|NCT00749775|6159116|P1|Overall Study|Lost to Follow-up|36
1768134|NCT00749775|6159116|P1|Overall Study|Protocol Violation|24
1768135|NCT00749684|6159132|P1|Overall Study|Missing|9
1768136|NCT00749684|6159132|P1|Overall Study|AE+discontinuation on participants wish|1
1768137|NCT00749684|6159132|P1|Overall Study|Therapy according to protocol + AE|2
1768138|NCT00749684|6159132|P1|Overall Study|Progressive Desease|31
1768139|NCT00749684|6159132|P1|Overall Study|Not Documented|1
1768140|NCT00749684|6159132|P1|Overall Study|Participant's Wish|10
1768141|NCT00749684|6159132|P1|Overall Study|Adverse Event|27
1768142|NCT00749684|6159132|P1|Overall Study|Death|1
1768143|NCT00749580|6159171|P2|Overall Study|Adverse Event|1
1768144|NCT00749580|6159172|P1|Overall Study|Adverse Event|0
1768145|NCT00749580|6159171|P2|Overall Study|Lost to Follow-up|8
1768146|NCT00749580|6159172|P1|Overall Study|Lost to Follow-up|4
1768147|NCT00749463|6159206|P3|Overall Study|Withdrawal by Subject|0
1768148|NCT00749463|6159207|P2|Overall Study|Withdrawal by Subject|0
1768149|NCT00749463|6159208|P1|Overall Study|Withdrawal by Subject|1
1768150|NCT00749463|6159206|P3|Overall Study|Adverse Event|1
1768151|NCT00749463|6159207|P2|Overall Study|Adverse Event|4
1768152|NCT00749463|6159208|P1|Overall Study|Adverse Event|0
1768153|NCT00749398|6159234|P1|Overall Study|Unknown reason|1
1768154|NCT00749398|6159234|P1|Overall Study|Reason not specified|2
1768155|NCT00749398|6159234|P1|Overall Study|Lost to Follow-up|11
1768156|NCT00749398|6159234|P1|Overall Study|Withdrawal by Subject|17
1768157|NCT00749398|6159234|P1|Overall Study|Serious adverse event|11
1768158|NCT00749398|6159234|P1|Overall Study|Adverse Event|4
1768159|NCT00749398|6159234|P1|Overall Study|Lack of Efficacy|7
1768160|NCT00749203|6159277|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
1768161|NCT00749203|6159278|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
1768162|NCT00749203|6159277|P2|Second Infusion at 2 Weeks|Protocol Violation|1
1768163|NCT00749203|6159278|P1|Second Infusion at 2 Weeks|Protocol Violation|0
1768164|NCT00749203|6159277|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
1768165|NCT00749203|6159278|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
1768166|NCT00749203|6159277|P2|no Infusion at Week 1|delayed-onset sedation|1
1768167|NCT00749203|6159278|P1|no Infusion at Week 1|delayed-onset sedation|0
1768168|NCT00749203|6159277|P2|no Infusion at Week 1|Withdrawal by Subject|1
1768169|NCT00749203|6159278|P1|no Infusion at Week 1|Withdrawal by Subject|0
1768170|NCT00749203|6159277|P2|no Infusion at Week 1|Lost to Follow-up|1
1768171|NCT00749203|6159278|P1|no Infusion at Week 1|Lost to Follow-up|0
1768172|NCT00749190|6159299|P7|Overall Study|Other reason not defined above|0
1768173|NCT00749190|6159300|P6|Overall Study|Other reason not defined above|0
1768174|NCT00749190|6159301|P5|Overall Study|Other reason not defined above|0
1768175|NCT00749190|6159302|P4|Overall Study|Other reason not defined above|1
1768176|NCT00749190|6159303|P3|Overall Study|Other reason not defined above|0
1768177|NCT00749190|6159304|P2|Overall Study|Other reason not defined above|0
1768178|NCT00749190|6159305|P1|Overall Study|Other reason not defined above|0
1768179|NCT00749190|6159299|P7|Overall Study|Protocol Violation|1
1768180|NCT00749190|6159300|P6|Overall Study|Protocol Violation|0
1768181|NCT00749190|6159301|P5|Overall Study|Protocol Violation|0
1768182|NCT00749190|6159302|P4|Overall Study|Protocol Violation|0
1768183|NCT00749190|6159303|P3|Overall Study|Protocol Violation|0
1768184|NCT00749190|6159304|P2|Overall Study|Protocol Violation|1
1768185|NCT00749190|6159305|P1|Overall Study|Protocol Violation|0
1768186|NCT00749190|6159299|P7|Overall Study|Withdrawal by Subject|0
1768187|NCT00749190|6159300|P6|Overall Study|Withdrawal by Subject|1
1768188|NCT00749190|6159301|P5|Overall Study|Withdrawal by Subject|0
1768189|NCT00749190|6159302|P4|Overall Study|Withdrawal by Subject|0
1768190|NCT00749190|6159303|P3|Overall Study|Withdrawal by Subject|0
1768191|NCT00749190|6159304|P2|Overall Study|Withdrawal by Subject|1
1768192|NCT00749190|6159305|P1|Overall Study|Withdrawal by Subject|2
1768193|NCT00749190|6159299|P7|Overall Study|Lack of Efficacy|0
1768194|NCT00749190|6159300|P6|Overall Study|Lack of Efficacy|1
1768195|NCT00749190|6159301|P5|Overall Study|Lack of Efficacy|0
1768196|NCT00749190|6159302|P4|Overall Study|Lack of Efficacy|0
1768197|NCT00749190|6159303|P3|Overall Study|Lack of Efficacy|1
1768198|NCT00749190|6159304|P2|Overall Study|Lack of Efficacy|1
1768199|NCT00749190|6159305|P1|Overall Study|Lack of Efficacy|3
1768200|NCT00749190|6159299|P7|Overall Study|Adverse Event|0
1768201|NCT00749190|6159300|P6|Overall Study|Adverse Event|3
1768202|NCT00749190|6159301|P5|Overall Study|Adverse Event|0
1768203|NCT00749190|6159302|P4|Overall Study|Adverse Event|4
1768204|NCT00749190|6159303|P3|Overall Study|Adverse Event|0
1768205|NCT00749190|6159304|P2|Overall Study|Adverse Event|2
1768206|NCT00749190|6159305|P1|Overall Study|Adverse Event|0
1768207|NCT00748969|6159414|P2|Overall Study|Withdrawal by Subject|1
1768208|NCT00748969|6159415|P1|Overall Study|Withdrawal by Subject|0
1768209|NCT00748969|6159414|P2|Overall Study|Withdrawal by Subject|0
1768210|NCT00748969|6159415|P1|Overall Study|Withdrawal by Subject|1
1768211|NCT00748709|6159465|P1|Overall Study|Other Reasons|1
1768212|NCT00748709|6159465|P1|Overall Study|Withdrawal by Subject|1
1768213|NCT00748709|6159465|P1|Overall Study|Other Adverse Event|1
1768214|NCT00748709|6159465|P1|Overall Study|Drug reducing Toxity|2
1768215|NCT00748709|6159465|P1|Overall Study|Progressive disease|15
1768216|NCT00748566|6159508|P1|Overall Study|Other|9
1768217|NCT00748566|6159508|P1|Overall Study|Study terminated by sponsor|5
1768218|NCT00748566|6159508|P1|Overall Study|Withdrawal by Subject|22
1768219|NCT00748566|6159508|P1|Overall Study|Protocol Violation|13
1768220|NCT00748566|6159508|P1|Overall Study|Lost to Follow-up|1
1768221|NCT00748566|6159508|P1|Overall Study|Lack of Efficacy|12
1768222|NCT00748566|6159508|P1|Overall Study|Death|1
1768223|NCT00748566|6159508|P1|Overall Study|Adverse Event|49
1768224|NCT00748553|6159538|P2|Overall Study|noncompliance|0
1768225|NCT00748553|6159539|P1|Overall Study|noncompliance|1
1768226|NCT00748553|6159538|P2|Overall Study|disease progression|0
1768227|NCT00748553|6159539|P1|Overall Study|disease progression|2
1768228|NCT00748553|6159538|P2|Overall Study|Adverse Event|1
1768229|NCT00748553|6159539|P1|Overall Study|Adverse Event|0
1768230|NCT00748540|6159546|P1|Overall Study|Physician Decision|1
1768231|NCT00748241|6159572|P1|Overall Study|Death|2
1768232|NCT00748241|6159572|P1|Overall Study|Lost to Follow-up|5
1768233|NCT00748241|6159572|P1|Overall Study|Implant failure|1
1768234|NCT00748189|6159582|P2|Overall Study|Study terminated by Sponsor|79
1768235|NCT00748189|6159583|P1|Overall Study|Study terminated by Sponsor|70
1768236|NCT00748189|6159582|P2|Overall Study|Lost to Follow-up|15
1768237|NCT00748189|6159583|P1|Overall Study|Lost to Follow-up|8
1768238|NCT00748189|6159582|P2|Overall Study|Physician Decision|5
1768239|NCT00748189|6159583|P1|Overall Study|Physician Decision|16
1768240|NCT00748189|6159582|P2|Overall Study|Withdrawal by Subject|29
1768241|NCT00748189|6159583|P1|Overall Study|Withdrawal by Subject|23
1768242|NCT00748189|6159582|P2|Overall Study|Death|84
1768243|NCT00748189|6159583|P1|Overall Study|Death|99
1768244|NCT00748098|6159638|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
1768245|NCT00748098|6159639|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
1768246|NCT00748098|6159638|P2|Second Treatment Intervention Period|Lost to Follow-up|1
1768247|NCT00748098|6159639|P1|Second Treatment Intervention Period|Lost to Follow-up|1
1768248|NCT00748098|6159638|P2|Second Treatment Intervention Period|Adverse Event|1
1768249|NCT00748098|6159639|P1|Second Treatment Intervention Period|Adverse Event|4
1768250|NCT00748098|6159638|P2|1-Week Washout Period|Withdrawal by Subject|0
1768251|NCT00748098|6159639|P1|1-Week Washout Period|Withdrawal by Subject|2
1768252|NCT00748098|6159638|P2|1-Week Washout Period|Adverse Event|1
1768253|NCT00748098|6159639|P1|1-Week Washout Period|Adverse Event|0
1768254|NCT00748098|6159638|P2|First Taper Period|Protocol Stopping Criteria Met|1
1768255|NCT00748098|6159639|P1|First Taper Period|Protocol Stopping Criteria Met|0
1768256|NCT00748098|6159638|P2|First Taper Period|Withdrawal by Subject|0
1768257|NCT00748098|6159639|P1|First Taper Period|Withdrawal by Subject|2
1768258|NCT00748098|6159638|P2|First Taper Period|Protocol Violation|0
1768259|NCT00748098|6159639|P1|First Taper Period|Protocol Violation|1
1768260|NCT00748098|6159638|P2|First Treatment Intervention Period|Withdrawal by Subject|0
1768261|NCT00748098|6159639|P1|First Treatment Intervention Period|Withdrawal by Subject|2
1768262|NCT00748098|6159638|P2|First Treatment Intervention Period|Lost to Follow-up|0
1768263|NCT00748098|6159639|P1|First Treatment Intervention Period|Lost to Follow-up|1
1768264|NCT00748098|6159638|P2|First Treatment Intervention Period|Protocol Violation|0
1768265|NCT00748098|6159639|P1|First Treatment Intervention Period|Protocol Violation|1
1768266|NCT00748098|6159638|P2|First Treatment Intervention Period|Adverse Event|1
1768267|NCT00748098|6159639|P1|First Treatment Intervention Period|Adverse Event|1
1768268|NCT00747812|6159720|P2|Overall Study|Research Site Staff Relocation|3
1768269|NCT00747812|6159721|P1|Overall Study|Research Site Staff Relocation|5
1768270|NCT00747643|6159759|P2|Overall Study|Withdrawal by Subject|27
1768271|NCT00747643|6159760|P1|Overall Study|Withdrawal by Subject|36
1768272|NCT00747617|6159774|P2|Overall Study|Lost to Follow-up|1
1768273|NCT00747617|6159775|P1|Overall Study|Lost to Follow-up|3
1768274|NCT00747565|6159785|P2|Overall Study|Lost to Follow-up|1
1768275|NCT00747565|6159786|P1|Overall Study|Lost to Follow-up|4
1768276|NCT00747565|6159785|P2|Overall Study|Withdrawal by Subject|6
1768277|NCT00747565|6159786|P1|Overall Study|Withdrawal by Subject|10
1768278|NCT00747474|6159799|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768279|NCT00747474|6159800|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768280|NCT00747474|6159801|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768281|NCT00747474|6159802|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768282|NCT00747474|6159803|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
1768283|NCT00747474|6159804|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768284|NCT00747474|6159805|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768285|NCT00747474|6159806|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768286|NCT00747474|6159807|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768287|NCT00747474|6159808|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768288|NCT00747474|6159809|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768289|NCT00747474|6159810|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
1768290|NCT00747461|6159836|P1|Overall Study|study terminated by sponsor|5
1768291|NCT00747435|6159841|P1|Overall Study|Still undergoing follow up|1
1768292|NCT00747435|6159841|P1|Overall Study|Withdrawal by Subject|3
1768293|NCT00747435|6159841|P1|Overall Study|Lost to Follow-up|2
1768294|NCT00747344|6159851|P4|After Controlled Period|Adverse Event|1
1768295|NCT00747344|6159852|P3|After Controlled Period|Adverse Event|0
1768296|NCT00747344|6159853|P2|After Controlled Period|Adverse Event|0
1768297|NCT00747344|6159854|P1|After Controlled Period|Adverse Event|0
1768298|NCT00747344|6159851|P4|Controlled Period|Other|0
1768299|NCT00747344|6159852|P3|Controlled Period|Other|0
1768300|NCT00747344|6159853|P2|Controlled Period|Other|3
1768301|NCT00747344|6159854|P1|Controlled Period|Other|0
1768302|NCT00747344|6159851|P4|Controlled Period|Lack of Efficacy|0
1768303|NCT00747344|6159852|P3|Controlled Period|Lack of Efficacy|0
1768304|NCT00747344|6159853|P2|Controlled Period|Lack of Efficacy|1
1768305|NCT00747344|6159854|P1|Controlled Period|Lack of Efficacy|2
1768306|NCT00747344|6159851|P4|Controlled Period|Adverse Event|0
1768307|NCT00747344|6159852|P3|Controlled Period|Adverse Event|0
1768308|NCT00747344|6159853|P2|Controlled Period|Adverse Event|0
1768309|NCT00747344|6159854|P1|Controlled Period|Adverse Event|3
1768310|NCT00747227|6159868|P2|Overall Study|Illness|1
1768311|NCT00747227|6159869|P1|Overall Study|Illness|1
1768312|NCT00747227|6159868|P2|Overall Study|Lost to Follow-up|2
1768313|NCT00747227|6159869|P1|Overall Study|Lost to Follow-up|1
1768314|NCT00747227|6159868|P2|Overall Study|Withdrawal by Subject|0
1768315|NCT00747227|6159869|P1|Overall Study|Withdrawal by Subject|1
1768316|NCT00747227|6159868|P2|Overall Study|Death|1
1768317|NCT00747227|6159869|P1|Overall Study|Death|3
1768318|NCT00747149|6159898|P2|Overall Study|Not reported|4
1768319|NCT00747149|6159899|P1|Overall Study|Not reported|1
1768320|NCT00747149|6159898|P2|Overall Study|Severe non-compliance to protocol|1
1768321|NCT00747149|6159899|P1|Overall Study|Severe non-compliance to protocol|0
1768322|NCT00747149|6159898|P2|Overall Study|Incorrect enrollment|6
1768323|NCT00747149|6159899|P1|Overall Study|Incorrect enrollment|0
1768324|NCT00747149|6159898|P2|Overall Study|Did not receive treatment|1
1768325|NCT00747149|6159899|P1|Overall Study|Did not receive treatment|0
1768326|NCT00747149|6159898|P2|Overall Study|Withdrawal by Subject|6
1768327|NCT00747149|6159899|P1|Overall Study|Withdrawal by Subject|0
1768328|NCT00747149|6159898|P2|Overall Study|Lost to Follow-up|10
1768329|NCT00747149|6159899|P1|Overall Study|Lost to Follow-up|0
1768330|NCT00747149|6159898|P2|Overall Study|Adverse Event|15
1768331|NCT00747149|6159899|P1|Overall Study|Adverse Event|0
1768332|NCT00747006|6159914|P3|Overall Study|Physician Decision|1
1768333|NCT00747006|6159915|P2|Overall Study|Physician Decision|0
1768334|NCT00747006|6159916|P1|Overall Study|Physician Decision|2
1768335|NCT00747006|6159914|P3|Overall Study|Lost to Follow-up|0
1768336|NCT00747006|6159915|P2|Overall Study|Lost to Follow-up|1
1768337|NCT00747006|6159916|P1|Overall Study|Lost to Follow-up|0
1768338|NCT00747006|6159914|P3|Overall Study|Adverse Event|0
1768339|NCT00747006|6159915|P2|Overall Study|Adverse Event|0
1768340|NCT00747006|6159916|P1|Overall Study|Adverse Event|1
1768341|NCT00746941|6159994|P4|Overall Study|Adverse Event|1
1768342|NCT00746941|6159995|P3|Overall Study|Adverse Event|0
1768343|NCT00746941|6159996|P2|Overall Study|Adverse Event|0
1768344|NCT00746941|6159997|P1|Overall Study|Adverse Event|0
1768345|NCT00746941|6159994|P4|Overall Study|Other, reason not provided|4
1768346|NCT00746941|6159995|P3|Overall Study|Other, reason not provided|0
1768347|NCT00746941|6159996|P2|Overall Study|Other, reason not provided|4
1768348|NCT00746941|6159997|P1|Overall Study|Other, reason not provided|2
1768349|NCT00746941|6159994|P4|Overall Study|Withdrawal by Subject|2
1768350|NCT00746941|6159995|P3|Overall Study|Withdrawal by Subject|0
1768351|NCT00746941|6159996|P2|Overall Study|Withdrawal by Subject|0
1768352|NCT00746941|6159997|P1|Overall Study|Withdrawal by Subject|3
1768353|NCT00746941|6159994|P4|Overall Study|Physician Decision|0
1768354|NCT00746941|6159995|P3|Overall Study|Physician Decision|2
1768355|NCT00746941|6159996|P2|Overall Study|Physician Decision|0
1768356|NCT00746941|6159997|P1|Overall Study|Physician Decision|0
1768357|NCT00746941|6159994|P4|Overall Study|Death|6
1768358|NCT00746941|6159995|P3|Overall Study|Death|0
1768359|NCT00746941|6159996|P2|Overall Study|Death|0
1768360|NCT00746941|6159997|P1|Overall Study|Death|2
1768361|NCT00746798|6160055|P4|Overall Study|Participant unable to return for visit|0
1768362|NCT00746798|6160056|P3|Overall Study|Participant unable to return for visit|0
1768363|NCT00746798|6160057|P2|Overall Study|Participant unable to return for visit|0
1768364|NCT00746798|6160058|P1|Overall Study|Participant unable to return for visit|1
1768365|NCT00746798|6160055|P4|Overall Study|Death|0
1768366|NCT00746798|6160056|P3|Overall Study|Death|2
1768367|NCT00746798|6160057|P2|Overall Study|Death|0
1768368|NCT00746798|6160058|P1|Overall Study|Death|0
1768369|NCT00746798|6160055|P4|Overall Study|Withdrawal by Subject|0
1768370|NCT00746798|6160056|P3|Overall Study|Withdrawal by Subject|1
1768371|NCT00746798|6160057|P2|Overall Study|Withdrawal by Subject|1
1768372|NCT00746798|6160058|P1|Overall Study|Withdrawal by Subject|0
1768373|NCT00746798|6160055|P4|Overall Study|Protocol Violation|0
1768374|NCT00746798|6160056|P3|Overall Study|Protocol Violation|0
1768375|NCT00746798|6160057|P2|Overall Study|Protocol Violation|1
1768376|NCT00746798|6160058|P1|Overall Study|Protocol Violation|0
1768377|NCT00746785|6160083|P3|Overall Study|Lost to Follow-up|27
1768378|NCT00746785|6160084|P2|Overall Study|Lost to Follow-up|25
1768379|NCT00746785|6160085|P1|Overall Study|Lost to Follow-up|29
1768380|NCT00746733|6160093|P2|Third Intervention|Withdrawal by Subject|1
1768381|NCT00746733|6160094|P1|Third Intervention|Withdrawal by Subject|1
1768382|NCT00746733|6160093|P2|Second Intervention|Adverse Event|0
1768383|NCT00746733|6160094|P1|Second Intervention|Adverse Event|1
1768384|NCT00746590|6160178|P1|Overall Study|Death|1
1768385|NCT00746564|6160182|P1|Overall Study|Required Pacemaker/ICD Implant|2
1768386|NCT00746551|6160197|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
1768387|NCT00746551|6160198|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
1768388|NCT00746551|6160197|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
1768389|NCT00746551|6160198|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
1768390|NCT00746551|6160197|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
1768391|NCT00746551|6160198|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
1768392|NCT00746356|6160249|P2|Overall Study|Patient relocated|0
1768393|NCT00746356|6160250|P1|Overall Study|Patient relocated|1
1768394|NCT00746356|6160249|P2|Overall Study|Removal of Device|1
1768395|NCT00746356|6160250|P1|Overall Study|Removal of Device|0
1768396|NCT00746356|6160249|P2|Overall Study|Lost to Follow-up|0
1768397|NCT00746356|6160250|P1|Overall Study|Lost to Follow-up|1
1768398|NCT00746356|6160249|P2|Overall Study|Death|3
1768399|NCT00746356|6160250|P1|Overall Study|Death|7
1768400|NCT00746356|6160249|P2|Overall Study|Withdrawal by Subject|3
1768401|NCT00746356|6160250|P1|Overall Study|Withdrawal by Subject|2
1768402|NCT00746330|6160262|P4|Period 1|Abnormal test procedure result|0
1768403|NCT00746330|6160263|P3|Period 1|Abnormal test procedure result|1
1768404|NCT00746330|6160264|P2|Period 1|Abnormal test procedure result|0
1768405|NCT00746330|6160265|P1|Period 1|Abnormal test procedure result|0
1768406|NCT00746252|6160295|P2|Overall Study|weight gain >7.5 %|2
1768407|NCT00746252|6160296|P1|Overall Study|weight gain >7.5 %|1
1768408|NCT00746096|6160331|P2|Overall Study|No study drug treatment|1
1768409|NCT00746096|6160332|P1|Overall Study|No study drug treatment|1
1768410|NCT00746096|6160331|P2|Overall Study|Protocol Violation|0
1768411|NCT00746096|6160332|P1|Overall Study|Protocol Violation|1
1768412|NCT00746096|6160331|P2|Overall Study|Lost to Follow-up|1
1768413|NCT00746096|6160332|P1|Overall Study|Lost to Follow-up|2
1768414|NCT00746096|6160331|P2|Overall Study|Withdrawal by Subject|1
1768415|NCT00746096|6160332|P1|Overall Study|Withdrawal by Subject|5
1768416|NCT00746096|6160331|P2|Overall Study|Adverse Event|0
1768417|NCT00746096|6160332|P1|Overall Study|Adverse Event|1
1768418|NCT00745901|6160363|P2|Overall Study|Patient didn't take any study medication|3
1768419|NCT00745901|6160364|P1|Overall Study|Patient didn't take any study medication|7
1768420|NCT00745901|6160363|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
1768421|NCT00745901|6160364|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
1768422|NCT00745901|6160363|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
1768423|NCT00745901|6160364|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
1768424|NCT00745901|6160363|P2|Overall Study|Patient's next menses did not start with|0
1768425|NCT00745901|6160364|P1|Overall Study|Patient's next menses did not start with|1
1768426|NCT00745901|6160363|P2|Overall Study|Lack of compliance|2
1768427|NCT00745901|6160364|P1|Overall Study|Lack of compliance|2
1768428|NCT00745901|6160363|P2|Overall Study|Pregnancy|4
1768429|NCT00745901|6160364|P1|Overall Study|Pregnancy|2
1768430|NCT00745901|6160363|P2|Overall Study|Lost to Follow-up|4
1768431|NCT00745901|6160364|P1|Overall Study|Lost to Follow-up|7
1768432|NCT00745901|6160363|P2|Overall Study|Withdrawal by Subject|0
1768433|NCT00745901|6160364|P1|Overall Study|Withdrawal by Subject|1
1768434|NCT00745901|6160363|P2|Overall Study|Protocol Violation|1
1768435|NCT00745901|6160364|P1|Overall Study|Protocol Violation|0
1768436|NCT00745901|6160363|P2|Overall Study|Adverse Event|4
1768437|NCT00745901|6160364|P1|Overall Study|Adverse Event|3
1768438|NCT00745875|6160410|P2|Overall Study|Continuing study treatment|4
1768439|NCT00745875|6160411|P1|Overall Study|Continuing study treatment|4
1768440|NCT00745849|6160419|P2|Second Intervention|Lost to Follow-up|1
1768441|NCT00745849|6160420|P1|Second Intervention|Lost to Follow-up|2
1768442|NCT00745849|6160419|P2|First Intervention|Lost to Follow-up|1
1768443|NCT00745849|6160420|P1|First Intervention|Lost to Follow-up|1
1768444|NCT00745849|6160419|P2|First Intervention|Withdrawal by Subject|1
1768445|NCT00745849|6160420|P1|First Intervention|Withdrawal by Subject|0
1768446|NCT00745823|6160428|P2|Overall Study|Study Terminated by Sponsor|349
1768447|NCT00745823|6160429|P1|Overall Study|Study Terminated by Sponsor|326
1768448|NCT00745823|6160428|P2|Overall Study|Withdrawal by Subject|8
1768449|NCT00745823|6160429|P1|Overall Study|Withdrawal by Subject|14
1768450|NCT00745823|6160428|P2|Overall Study|Pregnancy|4
1768451|NCT00745823|6160429|P1|Overall Study|Pregnancy|0
1768452|NCT00745823|6160428|P2|Overall Study|Physician Decision|5
1768453|NCT00745823|6160429|P1|Overall Study|Physician Decision|10
1768454|NCT00745823|6160428|P2|Overall Study|Lost to Follow-up|11
1768455|NCT00745823|6160429|P1|Overall Study|Lost to Follow-up|10
1768456|NCT00745823|6160428|P2|Overall Study|Lack of Efficacy|6
1768457|NCT00745823|6160429|P1|Overall Study|Lack of Efficacy|20
1768458|NCT00745823|6160428|P2|Overall Study|Adverse Event|3
1768459|NCT00745823|6160429|P1|Overall Study|Adverse Event|5
1768460|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
1768461|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
1768462|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
1768463|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
1768464|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
1768465|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
1768466|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Death|1
1768467|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Death|0
1768468|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Death|0
1768469|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Death|0
1768470|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Death|0
1768471|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Death|0
1768472|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
1768473|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
1768474|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
1768475|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
1768476|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
1768477|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
1768478|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
1768479|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
1768480|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
1768481|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
1768482|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
1768483|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
1768484|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
1768485|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
1768486|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
1768487|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
1768488|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
1768489|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
1768490|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
1768491|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
1768492|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
1768493|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
1768494|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
1768495|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
1768496|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
1768497|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
1768498|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
1768499|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
1768500|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
1768501|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
1768502|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
1768503|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
1768504|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
1768505|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
1768506|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
1768507|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
1768508|NCT00745615|6160457|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
1768509|NCT00745615|6160458|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
1768510|NCT00745615|6160459|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
1768511|NCT00745615|6160460|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
1768512|NCT00745615|6160461|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
1768513|NCT00745615|6160462|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
1768514|NCT00745615|6160457|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
1768515|NCT00745615|6160458|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
1768516|NCT00745615|6160459|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
1768517|NCT00745615|6160460|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
1768518|NCT00745615|6160461|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
1768519|NCT00745615|6160462|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
1768520|NCT00745615|6160457|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
1768521|NCT00745615|6160458|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
1768522|NCT00745615|6160459|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
1768523|NCT00745615|6160460|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
1768524|NCT00745615|6160461|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
1768525|NCT00745615|6160462|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
1768526|NCT00745615|6160457|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
1768527|NCT00745615|6160458|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
1768528|NCT00745615|6160459|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
1768529|NCT00745615|6160460|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
1768530|NCT00745615|6160461|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
1768531|NCT00745615|6160462|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
1768532|NCT00745615|6160457|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
1768533|NCT00745615|6160458|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
1768534|NCT00745615|6160459|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
1768535|NCT00745615|6160460|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
1768536|NCT00745615|6160461|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
1768537|NCT00745615|6160462|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
1768538|NCT00745615|6160457|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
1768539|NCT00745615|6160458|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
1768540|NCT00745615|6160459|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
1768541|NCT00745615|6160460|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
1768542|NCT00745615|6160461|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
1768543|NCT00745615|6160462|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
1768544|NCT00745498|6160511|P3|Overall Study|Edophthalmitis after preoperative IVB|0
1768545|NCT00745498|6160512|P2|Overall Study|Edophthalmitis after preoperative IVB|0
1768546|NCT00745498|6160513|P1|Overall Study|Edophthalmitis after preoperative IVB|1
1768547|NCT00745498|6160511|P3|Overall Study|Non-PDR related VH|1
1768548|NCT00745498|6160512|P2|Overall Study|Non-PDR related VH|1
1768549|NCT00745498|6160513|P1|Overall Study|Non-PDR related VH|0
1768550|NCT00745498|6160511|P3|Overall Study|Injection of intravitreal silicone oil o|4
1768551|NCT00745498|6160512|P2|Overall Study|Injection of intravitreal silicone oil o|4
1768552|NCT00745498|6160513|P1|Overall Study|Injection of intravitreal silicone oil o|3
1768553|NCT00745498|6160511|P3|Overall Study|Lost to Follow-up|3
1768554|NCT00745498|6160512|P2|Overall Study|Lost to Follow-up|1
1768555|NCT00745498|6160513|P1|Overall Study|Lost to Follow-up|1
1768556|NCT00745420|6160527|P1|Overall Study|Ineligible|1
1768557|NCT00745368|6160544|P1|Overall Study|Unable to provide sample|3
1768558|NCT00745251|6160566|P2|Overall Study|Withdrawal by Subject|1
1768559|NCT00745251|6160567|P1|Overall Study|Withdrawal by Subject|1
1768560|NCT00745251|6160566|P2|Overall Study|Adverse Event|2
1768561|NCT00745251|6160567|P1|Overall Study|Adverse Event|1
1768562|NCT00745121|6160577|P2|Overall Study|Withdrawal by Subject|2
1768563|NCT00745121|6160578|P1|Overall Study|Withdrawal by Subject|4
1768564|NCT00745121|6160577|P2|Overall Study|Lost to Follow-up|0
1768565|NCT00745121|6160578|P1|Overall Study|Lost to Follow-up|1
1768566|NCT00745121|6160577|P2|Overall Study|Adverse Event|0
1768567|NCT00745121|6160578|P1|Overall Study|Adverse Event|1
1768568|NCT00745121|6160577|P2|Overall Study|Death|0
1768569|NCT00745121|6160578|P1|Overall Study|Death|3
1768570|NCT00745095|6160590|P6|Overall Study|Ineligible due to GFR criteria|28
1768571|NCT00745095|6160591|P5|Overall Study|Ineligible due to GFR criteria|30
1768572|NCT00745095|6160592|P4|Overall Study|Ineligible due to GFR criteria|3
1768573|NCT00745095|6160593|P3|Overall Study|Ineligible due to GFR criteria|3
1768574|NCT00745095|6160594|P2|Overall Study|Ineligible due to GFR criteria|2
1768575|NCT00745095|6160595|P1|Overall Study|Ineligible due to GFR criteria|0
1768576|NCT00745095|6160590|P6|Overall Study|Declined to participate|95
1768577|NCT00745095|6160591|P5|Overall Study|Declined to participate|92
1768578|NCT00745095|6160592|P4|Overall Study|Declined to participate|0
1768579|NCT00745095|6160593|P3|Overall Study|Declined to participate|0
1768580|NCT00745095|6160594|P2|Overall Study|Declined to participate|0
1768581|NCT00745095|6160595|P1|Overall Study|Declined to participate|1
1768582|NCT00744978|6160626|P2|Period 2|Adverse Event|1
1768583|NCT00744978|6160627|P1|Period 2|Adverse Event|0
1768584|NCT00744978|6160626|P2|Period 1|Randomized but not Treated|1
1768585|NCT00744978|6160627|P1|Period 1|Randomized but not Treated|1
1768586|NCT00744978|6160626|P2|Period 1|Adverse Event|0
1768587|NCT00744978|6160627|P1|Period 1|Adverse Event|4
1768588|NCT00744978|6160626|P2|Period 1|Other|2
1768589|NCT00744978|6160627|P1|Period 1|Other|0
1768590|NCT00744978|6160626|P2|Period 1|Withdrawal by Subject|2
1768591|NCT00744978|6160627|P1|Period 1|Withdrawal by Subject|0
1768592|NCT00744978|6160626|P2|Period 1|Lost to Follow-up|0
1768593|NCT00744978|6160627|P1|Period 1|Lost to Follow-up|1
1768594|NCT00744939|6160679|P1|Overall Study|incorrect race|1
1768595|NCT00744939|6160679|P1|Overall Study|coma|1
1768596|NCT00744939|6160679|P1|Overall Study|Failed inclusion/exclusion criteria|19
1768597|NCT00744939|6160679|P1|Overall Study|Did not receive Magnevist|7
1768598|NCT00744939|6160679|P1|Overall Study|Medical history exclusionary|1
1768599|NCT00744939|6160679|P1|Overall Study|Lost to Follow-up|12
1768600|NCT00744939|6160679|P1|Overall Study|distance|4
1768601|NCT00744939|6160679|P1|Overall Study|Death|24
1768602|NCT00744939|6160679|P1|Overall Study|Protocol Violation|13
1768603|NCT00744939|6160679|P1|Overall Study|Withdrawal by Subject|9
1768604|NCT00744874|6160715|P1|Overall Study|Unable to accomodate schedule|1
1768605|NCT00744874|6160715|P1|Overall Study|Study Device not available at procedure|1
1768606|NCT00744874|6160715|P1|Overall Study|Withdrawal by Subject|1
1768607|NCT00744874|6160715|P1|Overall Study|Lost to Follow-up|1
1768608|NCT00744757|6160740|P1|Overall Study|Adverse Event|2
1768609|NCT00744757|6160740|P1|Overall Study|Death|6
1768610|NCT00744757|6160740|P1|Overall Study|Withdrawal by Subject|1
1768611|NCT00744757|6160740|P1|Overall Study|Physician Decision|5
1768612|NCT00744757|6160740|P1|Overall Study|Objective disease progression|7
1768613|NCT00744653|6160765|P1|Overall Study|Physician Decision|3
1768614|NCT00744653|6160765|P1|Overall Study|Lost to Follow-up|1
1768615|NCT00744653|6160765|P1|Overall Study|Death|1
1768616|NCT00744653|6160765|P1|Overall Study|antineoplastic treatment|11
1768617|NCT00744627|6160773|P2|Overall Study|Other|0
1768618|NCT00744627|6160774|P1|Overall Study|Other|1
1768619|NCT00744627|6160773|P2|Overall Study|Lost to Follow-up|1
1768620|NCT00744627|6160774|P1|Overall Study|Lost to Follow-up|2
1768621|NCT00744627|6160773|P2|Overall Study|Voluntary Withdrawal|6
1768622|NCT00744627|6160774|P1|Overall Study|Voluntary Withdrawal|9
1768623|NCT00744627|6160773|P2|Overall Study|Protocol Deviations|2
1768624|NCT00744627|6160774|P1|Overall Study|Protocol Deviations|0
1768625|NCT00744627|6160773|P2|Overall Study|Noncompliance|1
1768626|NCT00744627|6160774|P1|Overall Study|Noncompliance|0
1768627|NCT00744627|6160773|P2|Overall Study|Lack of Efficacy|3
1768628|NCT00744627|6160774|P1|Overall Study|Lack of Efficacy|7
1768629|NCT00744627|6160773|P2|Overall Study|Adverse Event|9
1768630|NCT00744627|6160774|P1|Overall Study|Adverse Event|6
1768631|NCT00744523|6160830|P2|30 Days After the Procedure|Insufficient follow-up|5
1768632|NCT00744523|6160831|P1|30 Days After the Procedure|Insufficient follow-up|0
1768633|NCT00744497|6160851|P2|Overall Study|Not defined|13
1768634|NCT00744497|6160852|P1|Overall Study|Not defined|19
1768635|NCT00744497|6160851|P2|Overall Study|Maximum clinical benefit|142
1768636|NCT00744497|6160852|P1|Overall Study|Maximum clinical benefit|141
1768637|NCT00744497|6160851|P2|Overall Study|Patient requested to stop study drug|80
1768638|NCT00744497|6160852|P1|Overall Study|Patient requested to stop study drug|65
1768639|NCT00744497|6160851|P2|Overall Study|Adverse event unrelated to study drug|122
1768640|NCT00744497|6160852|P1|Overall Study|Adverse event unrelated to study drug|78
1768641|NCT00744497|6160851|P2|Overall Study|Study drug toxicity|141
1768642|NCT00744497|6160852|P1|Overall Study|Study drug toxicity|68
1768643|NCT00744497|6160851|P2|Overall Study|Disease progression|219
1768644|NCT00744497|6160852|P1|Overall Study|Disease progression|312
1768645|NCT00744497|6160851|P2|Overall Study|Administrative Reason By Sponsor|8
1768646|NCT00744497|6160852|P1|Overall Study|Administrative Reason By Sponsor|25
1768647|NCT00744497|6160851|P2|Overall Study|No longer meets study criteria|3
1768648|NCT00744497|6160852|P1|Overall Study|No longer meets study criteria|7
1768649|NCT00744497|6160851|P2|Overall Study|Poor compliance/noncompliance|5
1768650|NCT00744497|6160852|P1|Overall Study|Poor compliance/noncompliance|9
1768651|NCT00744497|6160851|P2|Overall Study|Lost to Follow-up|2
1768652|NCT00744497|6160852|P1|Overall Study|Lost to Follow-up|4
1768653|NCT00744497|6160851|P2|Overall Study|Death|9
1768654|NCT00744497|6160852|P1|Overall Study|Death|11
1768655|NCT00744497|6160851|P2|Overall Study|Withdrawal by Subject|18
1768656|NCT00744497|6160852|P1|Overall Study|Withdrawal by Subject|21
1768657|NCT00744328|6160912|P3|Overall Study|Found ineligible after randomization|1
1768658|NCT00744328|6160913|P2|Overall Study|Found ineligible after randomization|0
1768659|NCT00744328|6160914|P1|Overall Study|Found ineligible after randomization|0
1768660|NCT00744328|6160912|P3|Overall Study|Withdrawal by Subject|4
1768661|NCT00744328|6160913|P2|Overall Study|Withdrawal by Subject|3
1768662|NCT00744328|6160914|P1|Overall Study|Withdrawal by Subject|5
1768663|NCT00744328|6160912|P3|Overall Study|Lost to Follow-up|3
1768664|NCT00744328|6160913|P2|Overall Study|Lost to Follow-up|5
1768665|NCT00744328|6160914|P1|Overall Study|Lost to Follow-up|2
1768666|NCT00744263|6160927|P2|Overall Study|Other|2
1768667|NCT00744263|6160928|P1|Overall Study|Other|2
1768668|NCT00744263|6160927|P2|Overall Study|Adverse Event|0
1768669|NCT00744263|6160928|P1|Overall Study|Adverse Event|1
1768670|NCT00744263|6160927|P2|Overall Study|Protocol Violation|5
1768671|NCT00744263|6160928|P1|Overall Study|Protocol Violation|3
1768672|NCT00744263|6160927|P2|Overall Study|Physician Decision|23
1768673|NCT00744263|6160928|P1|Overall Study|Physician Decision|20
1768674|NCT00744263|6160927|P2|Overall Study|Withdrawal by Subject|150
1768675|NCT00744263|6160928|P1|Overall Study|Withdrawal by Subject|166
1768676|NCT00744263|6160927|P2|Overall Study|Lost to Follow-up|2135
1768677|NCT00744263|6160928|P1|Overall Study|Lost to Follow-up|2038
1768678|NCT00744263|6160927|P2|Overall Study|Death|3005
1768679|NCT00744263|6160928|P1|Overall Study|Death|3006
1768680|NCT00744237|6160951|P3|Overall Study|Adverse Event|5
1768681|NCT00744237|6160952|P2|Overall Study|Adverse Event|13
1768682|NCT00744237|6160953|P1|Overall Study|Adverse Event|9
1768683|NCT00744237|6160951|P3|Overall Study|Administrative. Site Closed|1
1768684|NCT00744237|6160952|P2|Overall Study|Administrative. Site Closed|1
1768685|NCT00744237|6160953|P1|Overall Study|Administrative. Site Closed|1
1768686|NCT00744237|6160951|P3|Overall Study|Poor Compliance|0
1768687|NCT00744237|6160952|P2|Overall Study|Poor Compliance|2
1768688|NCT00744237|6160953|P1|Overall Study|Poor Compliance|0
1768689|NCT00744237|6160951|P3|Overall Study|Prohibited Concomitant Medication|1
1768690|NCT00744237|6160952|P2|Overall Study|Prohibited Concomitant Medication|0
1768691|NCT00744237|6160953|P1|Overall Study|Prohibited Concomitant Medication|0
1768692|NCT00744237|6160951|P3|Overall Study|Study Drug Error|0
1768693|NCT00744237|6160952|P2|Overall Study|Study Drug Error|0
1768694|NCT00744237|6160953|P1|Overall Study|Study Drug Error|1
1768695|NCT00744237|6160951|P3|Overall Study|Dosing Error|1
1768696|NCT00744237|6160952|P2|Overall Study|Dosing Error|0
1768697|NCT00744237|6160953|P1|Overall Study|Dosing Error|1
1768698|NCT00744237|6160951|P3|Overall Study|Inclusion/Exclusion criteria not met|0
1768699|NCT00744237|6160952|P2|Overall Study|Inclusion/Exclusion criteria not met|0
1768700|NCT00744237|6160953|P1|Overall Study|Inclusion/Exclusion criteria not met|1
1768701|NCT00744237|6160951|P3|Overall Study|Protocol Violation|3
1768702|NCT00744237|6160952|P2|Overall Study|Protocol Violation|4
1768703|NCT00744237|6160953|P1|Overall Study|Protocol Violation|3
1768704|NCT00744237|6160951|P3|Overall Study|Lost to Follow-up|1
1768705|NCT00744237|6160952|P2|Overall Study|Lost to Follow-up|1
1768706|NCT00744237|6160953|P1|Overall Study|Lost to Follow-up|1
1768707|NCT00744237|6160951|P3|Overall Study|Withdrawal by Subject|3
1768708|NCT00744237|6160952|P2|Overall Study|Withdrawal by Subject|5
1768709|NCT00744237|6160953|P1|Overall Study|Withdrawal by Subject|9
1768710|NCT00744237|6160951|P3|Overall Study|Lack of Efficacy|0
1768711|NCT00744237|6160952|P2|Overall Study|Lack of Efficacy|1
1768712|NCT00744237|6160953|P1|Overall Study|Lack of Efficacy|1
1768713|NCT00744055|6160987|P2|Overall Study|Lost to Follow-up|1
1768714|NCT00744055|6160988|P1|Overall Study|Lost to Follow-up|0
1768715|NCT00744055|6160987|P2|Overall Study|Protocol Violation|1
1768716|NCT00744055|6160988|P1|Overall Study|Protocol Violation|1
1768717|NCT00744055|6160987|P2|Overall Study|Physician Decision|2
1768718|NCT00744055|6160988|P1|Overall Study|Physician Decision|0
1768719|NCT00744055|6160987|P2|Overall Study|Lack of Efficacy|1
1768720|NCT00744055|6160988|P1|Overall Study|Lack of Efficacy|0
1768721|NCT00744055|6160987|P2|Overall Study|Withdrawal by Subject|9
1768722|NCT00744055|6160988|P1|Overall Study|Withdrawal by Subject|6
1768723|NCT00744042|6160996|P1|Overall Study|Withdrawal by Subject|1
1768724|NCT00743652|6161042|P5|Overall Study|Lost to Follow-up|0
1768725|NCT00743652|6161043|P4|Overall Study|Lost to Follow-up|0
1768726|NCT00743652|6161044|P3|Overall Study|Lost to Follow-up|0
1768727|NCT00743652|6161045|P2|Overall Study|Lost to Follow-up|0
1768728|NCT00743652|6161046|P1|Overall Study|Lost to Follow-up|1
1768729|NCT00743652|6161042|P5|Overall Study|Other|0
1768730|NCT00743652|6161043|P4|Overall Study|Other|0
1768731|NCT00743652|6161044|P3|Overall Study|Other|0
1768732|NCT00743652|6161045|P2|Overall Study|Other|1
1768733|NCT00743652|6161046|P1|Overall Study|Other|1
1768734|NCT00743652|6161042|P5|Overall Study|Investigator Request|0
1768735|NCT00743652|6161043|P4|Overall Study|Investigator Request|2
1768736|NCT00743652|6161044|P3|Overall Study|Investigator Request|0
1768737|NCT00743652|6161045|P2|Overall Study|Investigator Request|0
1768738|NCT00743652|6161046|P1|Overall Study|Investigator Request|0
1768739|NCT00743652|6161042|P5|Overall Study|Death|0
1768740|NCT00743652|6161043|P4|Overall Study|Death|0
1768741|NCT00743652|6161044|P3|Overall Study|Death|0
1768742|NCT00743652|6161045|P2|Overall Study|Death|0
1768743|NCT00743652|6161046|P1|Overall Study|Death|2
1768744|NCT00743652|6161042|P5|Overall Study|Adverse Event|0
1768745|NCT00743652|6161043|P4|Overall Study|Adverse Event|0
1768746|NCT00743652|6161044|P3|Overall Study|Adverse Event|0
1768747|NCT00743652|6161045|P2|Overall Study|Adverse Event|0
1768748|NCT00743652|6161046|P1|Overall Study|Adverse Event|3
1768749|NCT00743652|6161042|P5|Overall Study|Parent/Legal Guardian Request|0
1768750|NCT00743652|6161043|P4|Overall Study|Parent/Legal Guardian Request|2
1768751|NCT00743652|6161044|P3|Overall Study|Parent/Legal Guardian Request|2
1768752|NCT00743652|6161045|P2|Overall Study|Parent/Legal Guardian Request|2
1768753|NCT00743652|6161046|P1|Overall Study|Parent/Legal Guardian Request|3
1768754|NCT00743509|6161130|P1|Overall Study|Withdrawal by Subject|2
1768755|NCT00743483|6161135|P1|Treatment Period|Adverse Event|1
1768756|NCT00743483|6161135|P1|Baseline Period|Physician Decision|1
1768757|NCT00743444|6161139|P2|Washout Period|Adverse Event|1
1768758|NCT00743444|6161140|P1|Washout Period|Adverse Event|0
1768759|NCT00743444|6161139|P2|First Intervention|Catheter placement problems|1
1768760|NCT00743444|6161140|P1|First Intervention|Catheter placement problems|0
1768761|NCT00743431|6161149|P1|Overall Study|No documentation available|13
1768762|NCT00743431|6161149|P1|Overall Study|Reason for discontinuation not specified|29
1768763|NCT00743431|6161149|P1|Overall Study|Death|9
1768764|NCT00743431|6161149|P1|Overall Study|Withdrawal by Subject|13
1768765|NCT00743431|6161149|P1|Overall Study|Tumor progression|56
1768766|NCT00743431|6161149|P1|Overall Study|Toxicity|6
1768767|NCT00743366|6161153|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
1768768|NCT00743366|6161154|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
1768769|NCT00743340|6161160|P1|Overall Study|Participant Relocated|1
1768770|NCT00743340|6161160|P1|Overall Study|Rolled over to other Gilead Study|23
1768771|NCT00743340|6161160|P1|Overall Study|Pregnancy|1
1768772|NCT00743340|6161160|P1|Overall Study|Virologic failure|8
1768773|NCT00743340|6161160|P1|Overall Study|Protocol Violation|1
1768774|NCT00743340|6161160|P1|Overall Study|Withdrawal from the Study|5
1768775|NCT00743340|6161160|P1|Overall Study|Lost to Follow-up|1
1768776|NCT00743340|6161160|P1|Overall Study|Study medication non-compliance|1
1768777|NCT00743288|6161164|P7|Overall Study|Worsening of condition (Not PD)|0
1768778|NCT00743288|6161165|P6|Overall Study|Worsening of condition (Not PD)|0
1768779|NCT00743288|6161166|P5|Overall Study|Worsening of condition (Not PD)|0
1768780|NCT00743288|6161167|P4|Overall Study|Worsening of condition (Not PD)|1
1768781|NCT00743288|6161168|P3|Overall Study|Worsening of condition (Not PD)|1
1768782|NCT00743288|6161169|P2|Overall Study|Worsening of condition (Not PD)|2
1768783|NCT00743288|6161170|P1|Overall Study|Worsening of condition (Not PD)|0
1768784|NCT00743288|6161164|P7|Overall Study|Progressive disease (PD)|6
1768785|NCT00743288|6161165|P6|Overall Study|Progressive disease (PD)|3
1768786|NCT00743288|6161166|P5|Overall Study|Progressive disease (PD)|5
1768787|NCT00743288|6161167|P4|Overall Study|Progressive disease (PD)|4
1768788|NCT00743288|6161168|P3|Overall Study|Progressive disease (PD)|1
1768789|NCT00743288|6161169|P2|Overall Study|Progressive disease (PD)|0
1768790|NCT00743288|6161170|P1|Overall Study|Progressive disease (PD)|2
1768791|NCT00743288|6161164|P7|Overall Study|Withdrawal by Subject|1
1768792|NCT00743288|6161165|P6|Overall Study|Withdrawal by Subject|1
1768793|NCT00743288|6161166|P5|Overall Study|Withdrawal by Subject|0
1768794|NCT00743288|6161167|P4|Overall Study|Withdrawal by Subject|0
1768795|NCT00743288|6161168|P3|Overall Study|Withdrawal by Subject|1
1768796|NCT00743288|6161169|P2|Overall Study|Withdrawal by Subject|0
1768797|NCT00743288|6161170|P1|Overall Study|Withdrawal by Subject|0
1768798|NCT00743288|6161164|P7|Overall Study|Adverse Event|2
1768799|NCT00743288|6161165|P6|Overall Study|Adverse Event|1
1768800|NCT00743288|6161166|P5|Overall Study|Adverse Event|1
1768801|NCT00743288|6161167|P4|Overall Study|Adverse Event|2
1768802|NCT00743288|6161168|P3|Overall Study|Adverse Event|2
1768803|NCT00743288|6161169|P2|Overall Study|Adverse Event|1
1768804|NCT00743288|6161170|P1|Overall Study|Adverse Event|1
1768805|NCT00743275|6161184|P2|Overall Study|Protocol Violation|1
1768806|NCT00743275|6161185|P1|Overall Study|Protocol Violation|0
1768807|NCT00743249|6161205|P2|Overall Study|Unsuccessful insertion of stent|1
1768808|NCT00743249|6161206|P1|Overall Study|Unsuccessful insertion of stent|2
1768809|NCT00743249|6161205|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
1768810|NCT00743249|6161206|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
1768811|NCT00743249|6161205|P2|Overall Study|Adverse Event|4
1768812|NCT00743249|6161206|P1|Overall Study|Adverse Event|0
1768813|NCT00743197|6161216|P2|Overall Study|Study terminated due to departure of PI.|2
1768814|NCT00743197|6161217|P1|Overall Study|Study terminated due to departure of PI.|1
1768815|NCT00743145|6161223|P1|Overall Study|Pregnancy|1
1768816|NCT00743145|6161223|P1|Overall Study|Adverse Event|2
1768817|NCT00743145|6161223|P1|Overall Study|Withdrawal by Subject|1
1768818|NCT00743119|6161237|P1|Overall Study|Withdrawal by Subject|1
1768819|NCT00743119|6161237|P1|Overall Study|unreliable|3
1768820|NCT00743106|6161251|P2|Overall Study|Met intraoperative exclusion criterion|5
1768821|NCT00743106|6161252|P1|Overall Study|Met intraoperative exclusion criterion|8
1768822|NCT00742924|6161279|P4|Overall Study|Withdrawal by Subject|0
1768823|NCT00742924|6161280|P3|Overall Study|Withdrawal by Subject|1
1768824|NCT00742924|6161281|P2|Overall Study|Withdrawal by Subject|1
1768825|NCT00742924|6161282|P1|Overall Study|Withdrawal by Subject|0
1768826|NCT00742924|6161279|P4|Overall Study|Physician Decision|1
1768827|NCT00742924|6161280|P3|Overall Study|Physician Decision|0
1768828|NCT00742924|6161281|P2|Overall Study|Physician Decision|0
1768829|NCT00742924|6161282|P1|Overall Study|Physician Decision|0
1768830|NCT00742924|6161279|P4|Overall Study|Lack of Efficacy|4
1768831|NCT00742924|6161280|P3|Overall Study|Lack of Efficacy|2
1768832|NCT00742924|6161281|P2|Overall Study|Lack of Efficacy|1
1768833|NCT00742924|6161282|P1|Overall Study|Lack of Efficacy|5
1768834|NCT00742924|6161279|P4|Overall Study|Adverse Event|1
1768835|NCT00742924|6161280|P3|Overall Study|Adverse Event|1
1768836|NCT00742924|6161281|P2|Overall Study|Adverse Event|0
1768837|NCT00742924|6161282|P1|Overall Study|Adverse Event|0
1768838|NCT00742885|6161294|P2|Overall Study|Lost to Follow-up|0
1768839|NCT00742885|6161295|P1|Overall Study|Lost to Follow-up|1
1768840|NCT00742859|6161354|P4|Overall Study|Site error|1
1768841|NCT00742859|6161355|P3|Overall Study|Site error|1
1768842|NCT00742859|6161356|P2|Overall Study|Site error|0
1768843|NCT00742859|6161357|P1|Overall Study|Site error|0
1768844|NCT00742859|6161354|P4|Overall Study|Sponsor request patient out of town|1
1768845|NCT00742859|6161355|P3|Overall Study|Sponsor request patient out of town|1
1768846|NCT00742859|6161356|P2|Overall Study|Sponsor request patient out of town|0
1768847|NCT00742859|6161357|P1|Overall Study|Sponsor request patient out of town|0
1768848|NCT00742859|6161354|P4|Overall Study|Sponsor req visit schedule noncompliance|1
1768849|NCT00742859|6161355|P3|Overall Study|Sponsor req visit schedule noncompliance|0
1768850|NCT00742859|6161356|P2|Overall Study|Sponsor req visit schedule noncompliance|0
1768851|NCT00742859|6161357|P1|Overall Study|Sponsor req visit schedule noncompliance|0
1768852|NCT00742859|6161354|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
1768853|NCT00742859|6161355|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
1768854|NCT00742859|6161356|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
1768855|NCT00742859|6161357|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
1768856|NCT00742859|6161354|P4|Overall Study|Endpoint|2
1768857|NCT00742859|6161355|P3|Overall Study|Endpoint|1
1768858|NCT00742859|6161356|P2|Overall Study|Endpoint|1
1768859|NCT00742859|6161357|P1|Overall Study|Endpoint|0
1768860|NCT00742859|6161354|P4|Overall Study|Withdrawal by Subject|1
1768861|NCT00742859|6161355|P3|Overall Study|Withdrawal by Subject|4
1768862|NCT00742859|6161356|P2|Overall Study|Withdrawal by Subject|2
1768863|NCT00742859|6161357|P1|Overall Study|Withdrawal by Subject|4
1768864|NCT00742859|6161354|P4|Overall Study|Physician Decision|0
1768865|NCT00742859|6161355|P3|Overall Study|Physician Decision|0
1768866|NCT00742859|6161356|P2|Overall Study|Physician Decision|2
1768867|NCT00742859|6161357|P1|Overall Study|Physician Decision|1
1768868|NCT00742859|6161354|P4|Overall Study|Death|1
1768869|NCT00742859|6161355|P3|Overall Study|Death|0
1768870|NCT00742859|6161356|P2|Overall Study|Death|0
1768871|NCT00742859|6161357|P1|Overall Study|Death|1
1768872|NCT00742859|6161354|P4|Overall Study|Adverse Event|1
1768873|NCT00742859|6161355|P3|Overall Study|Adverse Event|3
1768874|NCT00742859|6161356|P2|Overall Study|Adverse Event|6
1768875|NCT00742859|6161357|P1|Overall Study|Adverse Event|5
1768876|NCT00742781|6161371|P1|Overall Study|Withdrawal by Subject|3
1768877|NCT00742625|6161380|P1|Consolidation|Non protocol therapy|13
1768878|NCT00742625|6161380|P1|Consolidation|Refused|1
1768879|NCT00742625|6161380|P1|Consolidation|Death|1
1768880|NCT00742625|6161380|P1|Consolidation|Adverse Event|1
1768881|NCT00742625|6161380|P1|Consolidation|Progression|5
1768882|NCT00742625|6161380|P1|Remission Induction|Other, not specified|5
1768883|NCT00742625|6161380|P1|Remission Induction|Non protocol treatment|17
1768884|NCT00742625|6161380|P1|Remission Induction|Refusal|5
1768885|NCT00742625|6161380|P1|Remission Induction|Death|10
1768886|NCT00742625|6161380|P1|Remission Induction|Adverse Event|3
1768887|NCT00742625|6161380|P1|Remission Induction|Failed induction|8
1768888|NCT00742625|6161380|P1|Remission Induction|Progression|6
1768889|NCT00742560|6161394|P5|Overall Study|MIssing|1
1768890|NCT00742560|6161395|P4|Overall Study|MIssing|0
1768891|NCT00742560|6161396|P3|Overall Study|MIssing|0
1768892|NCT00742560|6161397|P2|Overall Study|MIssing|0
1768893|NCT00742560|6161398|P1|Overall Study|MIssing|0
1768894|NCT00742560|6161394|P5|Overall Study|Other|9
1768895|NCT00742560|6161395|P4|Overall Study|Other|9
1768896|NCT00742560|6161396|P3|Overall Study|Other|8
1768897|NCT00742560|6161397|P2|Overall Study|Other|1
1768898|NCT00742560|6161398|P1|Overall Study|Other|0
1768899|NCT00742560|6161394|P5|Overall Study|New Multiple Myeloma Therapy|4
1768900|NCT00742560|6161395|P4|Overall Study|New Multiple Myeloma Therapy|3
1768901|NCT00742560|6161396|P3|Overall Study|New Multiple Myeloma Therapy|2
1768902|NCT00742560|6161397|P2|Overall Study|New Multiple Myeloma Therapy|0
1768903|NCT00742560|6161398|P1|Overall Study|New Multiple Myeloma Therapy|1
1768904|NCT00742560|6161394|P5|Overall Study|Disease Progression|16
1768905|NCT00742560|6161395|P4|Overall Study|Disease Progression|17
1768906|NCT00742560|6161396|P3|Overall Study|Disease Progression|5
1768907|NCT00742560|6161397|P2|Overall Study|Disease Progression|0
1768908|NCT00742560|6161398|P1|Overall Study|Disease Progression|1
1768909|NCT00742560|6161394|P5|Overall Study|Investigator's Decision|0
1768910|NCT00742560|6161395|P4|Overall Study|Investigator's Decision|1
1768911|NCT00742560|6161396|P3|Overall Study|Investigator's Decision|4
1768912|NCT00742560|6161397|P2|Overall Study|Investigator's Decision|0
1768913|NCT00742560|6161398|P1|Overall Study|Investigator's Decision|0
1768914|NCT00742560|6161394|P5|Overall Study|Subject's Decision|3
1768915|NCT00742560|6161395|P4|Overall Study|Subject's Decision|3
1768916|NCT00742560|6161396|P3|Overall Study|Subject's Decision|2
1768917|NCT00742560|6161397|P2|Overall Study|Subject's Decision|0
1768918|NCT00742560|6161398|P1|Overall Study|Subject's Decision|1
1768919|NCT00742560|6161394|P5|Overall Study|Death|3
1768920|NCT00742560|6161395|P4|Overall Study|Death|2
1768921|NCT00742560|6161396|P3|Overall Study|Death|0
1768922|NCT00742560|6161397|P2|Overall Study|Death|2
1768923|NCT00742560|6161398|P1|Overall Study|Death|0
1768924|NCT00742560|6161394|P5|Overall Study|Adverse Event|1
1768925|NCT00742560|6161395|P4|Overall Study|Adverse Event|1
1768926|NCT00742560|6161396|P3|Overall Study|Adverse Event|1
1768927|NCT00742560|6161397|P2|Overall Study|Adverse Event|0
1768928|NCT00742560|6161398|P1|Overall Study|Adverse Event|0
1768929|NCT00742508|6161472|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
1768930|NCT00742508|6161473|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
1768931|NCT00742508|6161472|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
1768932|NCT00742508|6161473|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
1768933|NCT00742508|6161472|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
1768934|NCT00742508|6161473|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
1768935|NCT00742508|6161472|P2|8-Week Primary Evaluation Period|Protocol Violation|0
1768936|NCT00742508|6161473|P1|8-Week Primary Evaluation Period|Protocol Violation|1
1768937|NCT00742508|6161472|P2|8-Week Primary Evaluation Period|Adverse Event|4
1768938|NCT00742508|6161473|P1|8-Week Primary Evaluation Period|Adverse Event|2
1768939|NCT00742417|6161546|P2|Intensive Period|Adverse Event|0
1768940|NCT00742417|6161547|P1|Intensive Period|Adverse Event|2
1768941|NCT00742417|6161546|P2|Intensive Period|Withdrawal by Subject|1
1768942|NCT00742417|6161547|P1|Intensive Period|Withdrawal by Subject|1
1768943|NCT00742417|6161546|P2|Randomized|Physician Decision|0
1768944|NCT00742417|6161547|P1|Randomized|Physician Decision|1
1768945|NCT00742417|6161546|P2|Randomized|Withdrawal by Subject|0
1768946|NCT00742417|6161547|P1|Randomized|Withdrawal by Subject|1
1768947|NCT00742417|6161546|P2|Randomized|Withdrawal by legal representative|1
1768948|NCT00742417|6161547|P1|Randomized|Withdrawal by legal representative|0
1768949|NCT00742391|6161571|P2|Overall Study|Protocol Violation|0
1768950|NCT00742391|6161572|P1|Overall Study|Protocol Violation|1
1768951|NCT00742391|6161571|P2|Overall Study|Lost to Follow-up|0
1768952|NCT00742391|6161572|P1|Overall Study|Lost to Follow-up|1
1768953|NCT00742391|6161571|P2|Overall Study|Adverse Event|1
1768954|NCT00742391|6161572|P1|Overall Study|Adverse Event|2
1768955|NCT00742326|6161582|P2|Overall Study|Physician Decision|1
1768956|NCT00742326|6161583|P1|Overall Study|Physician Decision|0
1768957|NCT00742274|6161602|P2|Overall Study|Removed for medical reasons|1
1768958|NCT00742274|6161603|P1|Overall Study|Removed for medical reasons|1
1768959|NCT00742274|6161602|P2|Overall Study|Withdrawal by Subject|2
1768960|NCT00742274|6161603|P1|Overall Study|Withdrawal by Subject|1
1768961|NCT00742274|6161602|P2|Overall Study|Death|0
1768962|NCT00742274|6161603|P1|Overall Study|Death|1
1768963|NCT00742235|6161611|P2|Overall Study|Lost to Follow-up|31
1768964|NCT00742235|6161612|P1|Overall Study|Lost to Follow-up|0
1768965|NCT00742209|6161625|P5|Overall Study|Investigator Discretion|1
1768966|NCT00742209|6161626|P4|Overall Study|Investigator Discretion|1
1768967|NCT00742209|6161627|P3|Overall Study|Investigator Discretion|5
1768968|NCT00742209|6161628|P2|Overall Study|Investigator Discretion|0
1768969|NCT00742209|6161629|P1|Overall Study|Investigator Discretion|0
1768970|NCT00742209|6161625|P5|Overall Study|Lack of Efficacy|1
1768971|NCT00742209|6161626|P4|Overall Study|Lack of Efficacy|3
1768972|NCT00742209|6161627|P3|Overall Study|Lack of Efficacy|1
1768973|NCT00742209|6161628|P2|Overall Study|Lack of Efficacy|1
1768974|NCT00742209|6161629|P1|Overall Study|Lack of Efficacy|6
1768975|NCT00742209|6161625|P5|Overall Study|Lost to Follow-up|3
1768976|NCT00742209|6161626|P4|Overall Study|Lost to Follow-up|5
1768977|NCT00742209|6161627|P3|Overall Study|Lost to Follow-up|5
1768978|NCT00742209|6161628|P2|Overall Study|Lost to Follow-up|4
1768979|NCT00742209|6161629|P1|Overall Study|Lost to Follow-up|3
1768980|NCT00742209|6161625|P5|Overall Study|Protocol Violation|3
1768981|NCT00742209|6161626|P4|Overall Study|Protocol Violation|5
1768982|NCT00742209|6161627|P3|Overall Study|Protocol Violation|4
1768983|NCT00742209|6161628|P2|Overall Study|Protocol Violation|5
1768984|NCT00742209|6161629|P1|Overall Study|Protocol Violation|6
1768985|NCT00742209|6161625|P5|Overall Study|Participant Withdrew Consent|4
1768986|NCT00742209|6161626|P4|Overall Study|Participant Withdrew Consent|7
1768987|NCT00742209|6161627|P3|Overall Study|Participant Withdrew Consent|14
1768988|NCT00742209|6161628|P2|Overall Study|Participant Withdrew Consent|4
1768989|NCT00742209|6161629|P1|Overall Study|Participant Withdrew Consent|8
1768990|NCT00742209|6161625|P5|Overall Study|Adverse Event|13
1768991|NCT00742209|6161626|P4|Overall Study|Adverse Event|16
1768992|NCT00742209|6161627|P3|Overall Study|Adverse Event|17
1768993|NCT00742209|6161628|P2|Overall Study|Adverse Event|4
1768994|NCT00742209|6161629|P1|Overall Study|Adverse Event|11
1768995|NCT00742183|6161732|P2|Overall Study|Lack of Efficacy|3
1768996|NCT00742183|6161733|P1|Overall Study|Lack of Efficacy|0
1768997|NCT00742183|6161732|P2|Overall Study|Withdrawal by Subject|0
1768998|NCT00742183|6161733|P1|Overall Study|Withdrawal by Subject|1
1768999|NCT00742183|6161732|P2|Overall Study|Required skin-graft|1
1769000|NCT00742183|6161733|P1|Overall Study|Required skin-graft|1
1769001|NCT00742183|6161732|P2|Overall Study|Lost to Follow-up|4
1769002|NCT00742183|6161733|P1|Overall Study|Lost to Follow-up|4
1769003|NCT00742183|6161732|P2|Overall Study|Physician Decision|2
1769004|NCT00742183|6161733|P1|Overall Study|Physician Decision|0
1769005|NCT00742183|6161732|P2|Overall Study|Death|0
1769006|NCT00742183|6161733|P1|Overall Study|Death|1
1769007|NCT00742183|6161732|P2|Overall Study|Adverse Event|2
1769008|NCT00742183|6161733|P1|Overall Study|Adverse Event|2
1769009|NCT00742079|6161752|P2|Overall Study|Lost to Follow-up|1
1769010|NCT00742079|6161753|P1|Overall Study|Lost to Follow-up|0
1769011|NCT00742001|6161774|P3|Overall Study|Withdrawn; health exclusion (flu)|1
1769012|NCT00742001|6161775|P2|Overall Study|Withdrawn; health exclusion (flu)|0
1769013|NCT00742001|6161776|P1|Overall Study|Withdrawn; health exclusion (flu)|0
1769014|NCT00741988|6161792|P2|Overall Study|Lack of Efficacy|0
1769015|NCT00741988|6161793|P1|Overall Study|Lack of Efficacy|2
1769016|NCT00741988|6161792|P2|Overall Study|Adverse Event|4
1769017|NCT00741988|6161793|P1|Overall Study|Adverse Event|2
1769018|NCT00741936|6161805|P2|Overall Study|Low compliance|0
1769019|NCT00741936|6161806|P1|Overall Study|Low compliance|3
1769020|NCT00741936|6161805|P2|Overall Study|Lack of Efficacy|2
1769021|NCT00741936|6161806|P1|Overall Study|Lack of Efficacy|0
1769022|NCT00741936|6161805|P2|Overall Study|Protocol Violation|0
1769023|NCT00741936|6161806|P1|Overall Study|Protocol Violation|2
1769024|NCT00741936|6161805|P2|Overall Study|Pregnancy|1
1769025|NCT00741936|6161806|P1|Overall Study|Pregnancy|0
1769026|NCT00741936|6161805|P2|Overall Study|Adverse Event|4
1769027|NCT00741936|6161806|P1|Overall Study|Adverse Event|3
1769028|NCT00741936|6161805|P2|Overall Study|Lost to Follow-up|1
1769029|NCT00741936|6161806|P1|Overall Study|Lost to Follow-up|1
1769030|NCT00741819|6161841|P1|Overall Study|Disease progression|1
1769031|NCT00741819|6161841|P1|Overall Study|Death|1
1769032|NCT00741819|6161841|P1|Overall Study|Withdrawal by Subject|3
1769033|NCT00741819|6161841|P1|Overall Study|Adverse Event|3
1769034|NCT00741611|6161855|P3|Overall Study|Withdrawal by Subject|2
1769035|NCT00741611|6161856|P2|Overall Study|Withdrawal by Subject|2
1769036|NCT00741611|6161857|P1|Overall Study|Withdrawal by Subject|0
1769037|NCT00741611|6161855|P3|Overall Study|Death|1
1769038|NCT00741611|6161856|P2|Overall Study|Death|0
1769039|NCT00741611|6161857|P1|Overall Study|Death|0
1769040|NCT00741598|6161876|P2|Overall Study|Withdrawal by Subject|2
1769041|NCT00741598|6161877|P1|Overall Study|Withdrawal by Subject|3
1769042|NCT00741598|6161876|P2|Overall Study|Pregnancy|0
1769043|NCT00741598|6161877|P1|Overall Study|Pregnancy|1
1769044|NCT00741598|6161876|P2|Overall Study|Physician Decision|1
1769045|NCT00741598|6161877|P1|Overall Study|Physician Decision|1
1769046|NCT00741598|6161876|P2|Overall Study|Lack of Efficacy|2
1769047|NCT00741598|6161877|P1|Overall Study|Lack of Efficacy|1
1769048|NCT00741598|6161876|P2|Overall Study|Lost to Follow-up|4
1769049|NCT00741598|6161877|P1|Overall Study|Lost to Follow-up|3
1769050|NCT00741338|6161923|P2|Overall Study|Adverse Event|1
1769051|NCT00741338|6161924|P1|Overall Study|Adverse Event|0
1769052|NCT00741286|6161934|P2|Overall Study|Primary Outcome|1
1769053|NCT00741286|6161935|P1|Overall Study|Primary Outcome|1
1769054|NCT00741286|6161934|P2|Overall Study|Protocol Violation|2
1769055|NCT00741286|6161935|P1|Overall Study|Protocol Violation|3
1769056|NCT00741286|6161934|P2|Overall Study|Adverse Event|6
1769057|NCT00741286|6161935|P1|Overall Study|Adverse Event|1
1769058|NCT00741286|6161934|P2|Overall Study|Lost to Follow-up|10
1769059|NCT00741286|6161935|P1|Overall Study|Lost to Follow-up|15
1769060|NCT00741260|6161969|P7|Overall Study|Other|1
1769061|NCT00741260|6161970|P6|Overall Study|Other|3
1769062|NCT00741260|6161971|P5|Overall Study|Other|1
1769063|NCT00741260|6161972|P4|Overall Study|Other|2
1769064|NCT00741260|6161973|P3|Overall Study|Other|1
1769065|NCT00741260|6161974|P2|Overall Study|Other|1
1769066|NCT00741260|6161975|P1|Overall Study|Other|2
1769067|NCT00741260|6161969|P7|Overall Study|Physician Decision|0
1769068|NCT00741260|6161970|P6|Overall Study|Physician Decision|0
1769069|NCT00741260|6161971|P5|Overall Study|Physician Decision|0
1769070|NCT00741260|6161972|P4|Overall Study|Physician Decision|0
1769071|NCT00741260|6161973|P3|Overall Study|Physician Decision|0
1769072|NCT00741260|6161974|P2|Overall Study|Physician Decision|1
1769073|NCT00741260|6161975|P1|Overall Study|Physician Decision|1
1769074|NCT00741260|6161969|P7|Overall Study|Withdrawal by Subject|1
1769075|NCT00741260|6161970|P6|Overall Study|Withdrawal by Subject|3
1769076|NCT00741260|6161971|P5|Overall Study|Withdrawal by Subject|1
1769077|NCT00741260|6161972|P4|Overall Study|Withdrawal by Subject|0
1769078|NCT00741260|6161973|P3|Overall Study|Withdrawal by Subject|0
1769079|NCT00741260|6161974|P2|Overall Study|Withdrawal by Subject|0
1769080|NCT00741260|6161975|P1|Overall Study|Withdrawal by Subject|0
1769081|NCT00741260|6161969|P7|Overall Study|Death|1
1769082|NCT00741260|6161970|P6|Overall Study|Death|2
1769083|NCT00741260|6161971|P5|Overall Study|Death|2
1769084|NCT00741260|6161972|P4|Overall Study|Death|1
1769085|NCT00741260|6161973|P3|Overall Study|Death|0
1769086|NCT00741260|6161974|P2|Overall Study|Death|1
1769087|NCT00741260|6161975|P1|Overall Study|Death|0
1769088|NCT00741260|6161969|P7|Overall Study|Disease Progression|4
1769089|NCT00741260|6161970|P6|Overall Study|Disease Progression|37
1769090|NCT00741260|6161971|P5|Overall Study|Disease Progression|5
1769091|NCT00741260|6161972|P4|Overall Study|Disease Progression|3
1769092|NCT00741260|6161973|P3|Overall Study|Disease Progression|3
1769093|NCT00741260|6161974|P2|Overall Study|Disease Progression|5
1769094|NCT00741260|6161975|P1|Overall Study|Disease Progression|3
1769095|NCT00741091|6162024|P1|Overall Study|Missed Visit|22
1769096|NCT00741091|6162024|P1|Overall Study|Withdrawal by Subject|6
1769097|NCT00741091|6162024|P1|Overall Study|Lost to Follow-up|16
1769098|NCT00741091|6162024|P1|Overall Study|Death|13
1769099|NCT00741039|6162034|P2|Overall Study|Patient non-compliance|0
1769100|NCT00741039|6162035|P1|Overall Study|Patient non-compliance|2
1769101|NCT00741013|6162072|P3|Overall Study|Discovered failed screen after enrolled|0
1769102|NCT00741013|6162073|P2|Overall Study|Discovered failed screen after enrolled|2
1769103|NCT00741013|6162074|P1|Overall Study|Discovered failed screen after enrolled|0
1769104|NCT00741013|6162072|P3|Overall Study|Withdrawal by Subject|1
1769105|NCT00741013|6162073|P2|Overall Study|Withdrawal by Subject|0
1769106|NCT00741013|6162074|P1|Overall Study|Withdrawal by Subject|0
1769107|NCT00741013|6162072|P3|Overall Study|Adverse Event|0
1769108|NCT00741013|6162073|P2|Overall Study|Adverse Event|0
1769109|NCT00741013|6162074|P1|Overall Study|Adverse Event|1
1769110|NCT00740870|6162085|P1|Overall Study|Further testing contraindicated implant|17
1769111|NCT00740870|6162085|P1|Overall Study|Not Catheterized|4
1769112|NCT00740857|6162100|P3|Overall Study|Withdrawal by Subject|0
1769113|NCT00740857|6162101|P2|Overall Study|Withdrawal by Subject|0
1769114|NCT00740857|6162102|P1|Overall Study|Withdrawal by Subject|1
1769115|NCT00740792|6162157|P4|Overall Study|administrative|2
1769116|NCT00740792|6162158|P3|Overall Study|administrative|8
1769117|NCT00740792|6162159|P2|Overall Study|administrative|3
1769118|NCT00740792|6162160|P1|Overall Study|administrative|3
1769119|NCT00740792|6162157|P4|Overall Study|Withdrawal by Subject|0
1769120|NCT00740792|6162158|P3|Overall Study|Withdrawal by Subject|0
1769121|NCT00740792|6162159|P2|Overall Study|Withdrawal by Subject|1
1769122|NCT00740792|6162160|P1|Overall Study|Withdrawal by Subject|1
1769123|NCT00740792|6162157|P4|Overall Study|Protocol Violation|2
1769124|NCT00740792|6162158|P3|Overall Study|Protocol Violation|0
1769125|NCT00740792|6162159|P2|Overall Study|Protocol Violation|1
1769126|NCT00740792|6162160|P1|Overall Study|Protocol Violation|0
1769127|NCT00740792|6162157|P4|Overall Study|Lost to Follow-up|0
1769128|NCT00740792|6162158|P3|Overall Study|Lost to Follow-up|0
1769129|NCT00740792|6162159|P2|Overall Study|Lost to Follow-up|1
1769130|NCT00740792|6162160|P1|Overall Study|Lost to Follow-up|2
1769131|NCT00740792|6162157|P4|Overall Study|Lack of Efficacy|3
1769132|NCT00740792|6162158|P3|Overall Study|Lack of Efficacy|0
1769133|NCT00740792|6162159|P2|Overall Study|Lack of Efficacy|1
1769134|NCT00740792|6162160|P1|Overall Study|Lack of Efficacy|1
1769135|NCT00740792|6162157|P4|Overall Study|Adverse Event|3
1769136|NCT00740792|6162158|P3|Overall Study|Adverse Event|1
1769137|NCT00740792|6162159|P2|Overall Study|Adverse Event|1
1769138|NCT00740792|6162160|P1|Overall Study|Adverse Event|3
1769139|NCT00740779|6162181|P3|Overall Study|Lost to Follow-up|5
1769140|NCT00740779|6162182|P2|Overall Study|Lost to Follow-up|3
1769141|NCT00740779|6162183|P1|Overall Study|Lost to Follow-up|2
1769142|NCT00740779|6162181|P3|Overall Study|Withdrawal by Subject|2
1769143|NCT00740779|6162182|P2|Overall Study|Withdrawal by Subject|4
1769144|NCT00740779|6162183|P1|Overall Study|Withdrawal by Subject|2
1769145|NCT00740779|6162181|P3|Overall Study|Lack of Efficacy|2
1769146|NCT00740779|6162182|P2|Overall Study|Lack of Efficacy|0
1769147|NCT00740779|6162183|P1|Overall Study|Lack of Efficacy|0
1769148|NCT00740779|6162181|P3|Overall Study|Protocol Violation|1
1769149|NCT00740779|6162182|P2|Overall Study|Protocol Violation|1
1769150|NCT00740779|6162183|P1|Overall Study|Protocol Violation|1
1769151|NCT00740779|6162181|P3|Overall Study|Adverse Event|3
1769152|NCT00740779|6162182|P2|Overall Study|Adverse Event|6
1769153|NCT00740779|6162183|P1|Overall Study|Adverse Event|4
1769154|NCT00740714|6162200|P3|Overall Study|Withdrawal by Subject|29
1769155|NCT00740714|6162201|P2|Overall Study|Withdrawal by Subject|19
1769156|NCT00740714|6162202|P1|Overall Study|Withdrawal by Subject|17
1769157|NCT00740636|6162278|P2|Overall Study|Death|0
1769158|NCT00740636|6162279|P1|Overall Study|Death|1
1769159|NCT00740636|6162278|P2|Overall Study|Progressive Disease|0
1769160|NCT00740636|6162279|P1|Overall Study|Progressive Disease|1
1769161|NCT00740636|6162278|P2|Overall Study|Patient Not Treated|1
1769162|NCT00740636|6162279|P1|Overall Study|Patient Not Treated|0
1769163|NCT00740636|6162278|P2|Overall Study|Patient Ineligible|1
1769164|NCT00740636|6162279|P1|Overall Study|Patient Ineligible|0
1769165|NCT00740636|6162278|P2|Overall Study|Adverse Event|2
1769166|NCT00740636|6162279|P1|Overall Study|Adverse Event|0
1769167|NCT00740597|6162285|P1|Overall Study|insurance would not cover treatment|1
1769168|NCT00740584|6162289|P1|Overall Study|Withdrawal by Subject|1
1769169|NCT00740480|6162294|P1|Overall Study|Physician Decision|1
1769170|NCT00740480|6162294|P1|Overall Study|Adverse Event|1
1769171|NCT00740220|6162319|P1|Overall Study|screen failures (non-COPD patients)|9
1769172|NCT00740051|6162344|P2|Overall Study|Other reason (not specified)|1
1769173|NCT00740051|6162345|P1|Overall Study|Other reason (not specified)|4
1769174|NCT00740051|6162344|P2|Overall Study|Withdrawal by Subject|8
1769175|NCT00740051|6162345|P1|Overall Study|Withdrawal by Subject|6
1769176|NCT00740051|6162344|P2|Overall Study|Lost to Follow-up|8
1769177|NCT00740051|6162345|P1|Overall Study|Lost to Follow-up|3
1769178|NCT00740051|6162344|P2|Overall Study|Protocol Violation|6
1769179|NCT00740051|6162345|P1|Overall Study|Protocol Violation|2
1769180|NCT00740051|6162344|P2|Overall Study|Adverse Event|4
1769181|NCT00740051|6162345|P1|Overall Study|Adverse Event|1
1769182|NCT00740051|6162344|P2|Overall Study|Lack of Efficacy|5
1769183|NCT00740051|6162345|P1|Overall Study|Lack of Efficacy|2
1769184|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1769185|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1769186|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
1769187|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1769188|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1769189|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1769190|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1769191|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
1769192|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
1769193|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1769194|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1769195|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1769196|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
1769197|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1769198|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
1769199|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
1769200|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
1769201|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
1769202|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769203|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769204|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
1769205|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769206|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769207|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769208|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769209|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769210|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
1769211|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
1769212|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
1769213|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
1769214|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1769215|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1769216|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
1769217|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
1769218|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
1769219|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
1769220|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1769221|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
1769222|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
1769223|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1769224|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1769225|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
1769226|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1769227|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
1769228|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
1769229|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769230|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769231|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769232|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769378|NCT00739674|6162648|P1|Overall Study|Reason missing|2
1769233|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769234|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769235|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
1769236|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769237|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
1769238|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1769239|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
1769240|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
1769241|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1769242|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
1769243|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
1769244|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
1769245|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
1769246|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
1769247|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1769248|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1769249|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1769250|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1769251|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1769252|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1769253|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
1769254|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
1769255|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
1769256|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1769257|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
1769258|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1769259|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1769260|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
1769261|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1769262|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1769263|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1769264|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
1769265|NCT00739973|6162448|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
1769266|NCT00739973|6162449|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
1769267|NCT00739973|6162450|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
1769268|NCT00739973|6162451|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1769269|NCT00739973|6162452|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
1769270|NCT00739973|6162453|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
1769271|NCT00739973|6162454|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
1769272|NCT00739973|6162455|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1769273|NCT00739973|6162456|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
1769274|NCT00739973|6162448|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769275|NCT00739973|6162449|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769276|NCT00739973|6162450|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769277|NCT00739973|6162451|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769278|NCT00739973|6162452|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769279|NCT00739973|6162453|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769280|NCT00739973|6162454|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769281|NCT00739973|6162455|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
1769282|NCT00739973|6162456|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
1769283|NCT00739973|6162448|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769284|NCT00739973|6162449|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769285|NCT00739973|6162450|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769286|NCT00739973|6162451|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769287|NCT00739973|6162452|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769288|NCT00739973|6162453|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769289|NCT00739973|6162454|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769290|NCT00739973|6162455|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
1769291|NCT00739973|6162456|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
1769292|NCT00739973|6162448|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769293|NCT00739973|6162449|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769294|NCT00739973|6162450|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769295|NCT00739973|6162451|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769296|NCT00739973|6162452|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769297|NCT00739973|6162453|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769298|NCT00739973|6162454|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769299|NCT00739973|6162455|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
1769300|NCT00739973|6162456|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
1769301|NCT00739973|6162448|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769302|NCT00739973|6162449|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769303|NCT00739973|6162450|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769304|NCT00739973|6162451|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769305|NCT00739973|6162452|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769306|NCT00739973|6162453|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769307|NCT00739973|6162454|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769308|NCT00739973|6162455|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
1769309|NCT00739973|6162456|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
1769310|NCT00739973|6162448|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769311|NCT00739973|6162449|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769312|NCT00739973|6162450|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769313|NCT00739973|6162451|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769314|NCT00739973|6162452|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769315|NCT00739973|6162453|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769316|NCT00739973|6162454|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769317|NCT00739973|6162455|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
1769318|NCT00739973|6162456|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
1769319|NCT00739973|6162448|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769320|NCT00739973|6162449|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769321|NCT00739973|6162450|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769322|NCT00739973|6162451|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769323|NCT00739973|6162452|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769324|NCT00739973|6162453|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769325|NCT00739973|6162454|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769326|NCT00739973|6162455|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
1769327|NCT00739973|6162456|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
1769328|NCT00739973|6162448|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769329|NCT00739973|6162449|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769330|NCT00739973|6162450|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769331|NCT00739973|6162451|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769332|NCT00739973|6162452|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769333|NCT00739973|6162453|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769334|NCT00739973|6162454|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769335|NCT00739973|6162455|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
1769336|NCT00739973|6162456|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
1769337|NCT00739934|6162542|P1|Voriconazole Oral|Other|3
1769338|NCT00739934|6162542|P1|Voriconazole IV|Adverse Event|6
1769339|NCT00739908|6162564|P2|Overall Study|Relocation|1
1769340|NCT00739908|6162565|P1|Overall Study|Relocation|0
1769341|NCT00739908|6162564|P2|Overall Study|Lack of Efficacy|1
1769342|NCT00739908|6162565|P1|Overall Study|Lack of Efficacy|0
1769343|NCT00739908|6162564|P2|Overall Study|Non-Compliance With Study Medication|3
1769344|NCT00739908|6162565|P1|Overall Study|Non-Compliance With Study Medication|0
1769345|NCT00739908|6162564|P2|Overall Study|Non-Compliance With Study Procedures|3
1769346|NCT00739908|6162565|P1|Overall Study|Non-Compliance With Study Procedures|2
1769347|NCT00739908|6162564|P2|Overall Study|Lost to Follow-up|9
1769348|NCT00739908|6162565|P1|Overall Study|Lost to Follow-up|14
1769349|NCT00739908|6162564|P2|Overall Study|Withdrawal by Subject|2
1769350|NCT00739908|6162565|P1|Overall Study|Withdrawal by Subject|4
1769351|NCT00739908|6162564|P2|Overall Study|Adverse Event|6
1769352|NCT00739908|6162565|P1|Overall Study|Adverse Event|5
1769353|NCT00739882|6162585|P2|Open-label Period|Other|5
1769354|NCT00739882|6162586|P1|Open-label Period|Other|9
1769355|NCT00739882|6162585|P2|Open-label Period|Adverse Event|0
1769356|NCT00739882|6162586|P1|Open-label Period|Adverse Event|1
1769357|NCT00739882|6162585|P2|Double-blind Period|Other|8
1769358|NCT00739882|6162586|P1|Double-blind Period|Other|16
1769359|NCT00739882|6162585|P2|Double-blind Period|Lack of Efficacy|1
1769360|NCT00739882|6162586|P1|Double-blind Period|Lack of Efficacy|1
1769361|NCT00739882|6162585|P2|Double-blind Period|Protocol Violation|0
1769362|NCT00739882|6162586|P1|Double-blind Period|Protocol Violation|1
1769363|NCT00739882|6162585|P2|Double-blind Period|Adverse Event|2
1769364|NCT00739882|6162586|P1|Double-blind Period|Adverse Event|1
1769365|NCT00739674|6162647|P2|Overall Study|Erectile dysfunction|1
1769366|NCT00739674|6162648|P1|Overall Study|Erectile dysfunction|0
1769367|NCT00739674|6162647|P2|Overall Study|Home monitoring off meds|0
1769368|NCT00739674|6162648|P1|Overall Study|Home monitoring off meds|1
1769369|NCT00739674|6162647|P2|Overall Study|Unable to attend visit|1
1769370|NCT00739674|6162648|P1|Overall Study|Unable to attend visit|3
1769371|NCT00739674|6162647|P2|Overall Study|Non compliant|0
1769372|NCT00739674|6162648|P1|Overall Study|Non compliant|4
1769373|NCT00739674|6162647|P2|Overall Study|Patient moved|2
1769374|NCT00739674|6162648|P1|Overall Study|Patient moved|3
1769375|NCT00739674|6162647|P2|Overall Study|Clinic closed|4
1769376|NCT00739674|6162648|P1|Overall Study|Clinic closed|6
1769377|NCT00739674|6162647|P2|Overall Study|Reason missing|0
1769379|NCT00739674|6162647|P2|Overall Study|Withdrawal by Subject|9
1769380|NCT00739674|6162648|P1|Overall Study|Withdrawal by Subject|9
1769381|NCT00739674|6162647|P2|Overall Study|Protocol Violation|5
1769382|NCT00739674|6162648|P1|Overall Study|Protocol Violation|5
1769383|NCT00739674|6162647|P2|Overall Study|Lost to Follow-up|30
1769384|NCT00739674|6162648|P1|Overall Study|Lost to Follow-up|52
1769385|NCT00739674|6162647|P2|Overall Study|Lack of Efficacy|0
1769386|NCT00739674|6162648|P1|Overall Study|Lack of Efficacy|1
1769387|NCT00739674|6162647|P2|Overall Study|Death|0
1769388|NCT00739674|6162648|P1|Overall Study|Death|1
1769389|NCT00739674|6162647|P2|Overall Study|Adverse Event|13
1769390|NCT00739674|6162648|P1|Overall Study|Adverse Event|22
1769391|NCT00739674|6162647|P2|Overall Study|Dietician consultation >30 days|9
1769392|NCT00739674|6162648|P1|Overall Study|Dietician consultation >30 days|1
1769393|NCT00739674|6162647|P2|Overall Study|No follow-up data|18
1769394|NCT00739674|6162648|P1|Overall Study|No follow-up data|33
1769395|NCT00739674|6162647|P2|Overall Study|Site 212 removal|13
1769396|NCT00739674|6162648|P1|Overall Study|Site 212 removal|19
1769397|NCT00739674|6162647|P2|Overall Study|Screening failures|17
1769398|NCT00739674|6162648|P1|Overall Study|Screening failures|19
1769399|NCT00739661|6162676|P2|Overall Study|Reason for discontinuation not available|1
1769400|NCT00739661|6162677|P1|Overall Study|Reason for discontinuation not available|1
1769401|NCT00739661|6162676|P2|Overall Study|Disease progression, radiographic|37
1769402|NCT00739661|6162677|P1|Overall Study|Disease progression, radiographic|33
1769403|NCT00739661|6162676|P2|Overall Study|Patient decision to withdraw|4
1769404|NCT00739661|6162677|P1|Overall Study|Patient decision to withdraw|9
1769405|NCT00739661|6162676|P2|Overall Study|Physician decision to withdraw patient|0
1769406|NCT00739661|6162677|P1|Overall Study|Physician decision to withdraw patient|1
1769407|NCT00739661|6162676|P2|Overall Study|Adverse Event|0
1769408|NCT00739661|6162677|P1|Overall Study|Adverse Event|2
1769409|NCT00739648|6162689|P2|Overall Study|Do not know|6
1769410|NCT00739648|6162690|P1|Overall Study|Do not know|4
1769411|NCT00739648|6162689|P2|Overall Study|Death|0
1769412|NCT00739648|6162690|P1|Overall Study|Death|2
1769413|NCT00739648|6162689|P2|Overall Study|Lost to Follow-up|7
1769414|NCT00739648|6162690|P1|Overall Study|Lost to Follow-up|4
1769415|NCT00739648|6162689|P2|Overall Study|Withdrawal by Subject|25
1769416|NCT00739648|6162690|P1|Overall Study|Withdrawal by Subject|13
1769417|NCT00739648|6162689|P2|Overall Study|Adverse Event|15
1769418|NCT00739648|6162690|P1|Overall Study|Adverse Event|3
1769419|NCT00739596|6162704|P2|Overall Study|Protocol Deviation|1
1769420|NCT00739596|6162705|P1|Overall Study|Protocol Deviation|1
1769421|NCT00739596|6162704|P2|Overall Study|Lost to Follow-up|2
1769422|NCT00739596|6162705|P1|Overall Study|Lost to Follow-up|0
1769423|NCT00739596|6162704|P2|Overall Study|Patient Withdrew Consent|8
1769424|NCT00739596|6162705|P1|Overall Study|Patient Withdrew Consent|8
1769425|NCT00739596|6162704|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1769426|NCT00739596|6162705|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
1769427|NCT00739596|6162704|P2|Overall Study|Adverse Event|6
1769428|NCT00739596|6162705|P1|Overall Study|Adverse Event|12
1769429|NCT00739310|6162747|P1|Overall Study|Lost to Follow-up|2
1769430|NCT00739310|6162747|P1|Overall Study|Withdrawal by Subject|1
1769431|NCT00739310|6162747|P1|Overall Study|Poor adherance to prescribed therapy|4
1769432|NCT00739297|6162752|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
1769433|NCT00739297|6162753|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
1769434|NCT00739297|6162754|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1769435|NCT00739297|6162755|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1769436|NCT00739297|6162756|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1769437|NCT00739297|6162757|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1769438|NCT00739297|6162758|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
1769439|NCT00739297|6162752|P7|First Washout Period of 4-7 Days|Adverse Event|2
1769440|NCT00739297|6162753|P6|First Washout Period of 4-7 Days|Adverse Event|0
1769441|NCT00739297|6162754|P5|First Washout Period of 4-7 Days|Adverse Event|0
1769442|NCT00739297|6162755|P4|First Washout Period of 4-7 Days|Adverse Event|2
1769443|NCT00739297|6162756|P3|First Washout Period of 4-7 Days|Adverse Event|0
1769444|NCT00739297|6162757|P2|First Washout Period of 4-7 Days|Adverse Event|0
1769445|NCT00739297|6162758|P1|First Washout Period of 4-7 Days|Adverse Event|0
1769446|NCT00739102|6162786|P1|Overall Study|Withdrawal by Subject|10
1769447|NCT00739102|6162786|P1|Overall Study|Death|5
1769448|NCT00739063|6162802|P1|Overall Study|Screen failures|8
1769449|NCT00738894|6162847|P2|Overall Study|Death|0
1769450|NCT00738894|6162848|P1|Overall Study|Death|2
1769451|NCT00738894|6162847|P2|Overall Study|Physician Decision|5
1769452|NCT00738894|6162848|P1|Overall Study|Physician Decision|4
1769453|NCT00738894|6162847|P2|Overall Study|Withdrawal by Subject|15
1769454|NCT00738894|6162848|P1|Overall Study|Withdrawal by Subject|10
1769455|NCT00738894|6162847|P2|Overall Study|Lost to Follow-up|13
1769456|NCT00738894|6162848|P1|Overall Study|Lost to Follow-up|23
1769457|NCT00738881|6162861|P2|Overall Study|Withdrawal by Subject|2
1769458|NCT00738881|6162862|P1|Overall Study|Withdrawal by Subject|0
1769459|NCT00738699|6162876|P2|Overall Study|Other|0
1769460|NCT00738699|6162877|P1|Overall Study|Other|2
1769461|NCT00738699|6162876|P2|Overall Study|Discontinuation of study by Sponsor|72
1769462|NCT00738699|6162877|P1|Overall Study|Discontinuation of study by Sponsor|123
1769463|NCT00738699|6162876|P2|Overall Study|Death|68
1769464|NCT00738699|6162877|P1|Overall Study|Death|144
1769465|NCT00738699|6162876|P2|Overall Study|Lost to Follow-up|0
1769466|NCT00738699|6162877|P1|Overall Study|Lost to Follow-up|1
1769467|NCT00738699|6162876|P2|Overall Study|Withdrawal by Subject|0
1769468|NCT00738699|6162877|P1|Overall Study|Withdrawal by Subject|5
1769469|NCT00738673|6162895|P2|Overall Study|Withdrawal by Subject|1
1769470|NCT00738673|6162896|P1|Overall Study|Withdrawal by Subject|3
1769471|NCT00738673|6162895|P2|Overall Study|Protocol Violation|2
1769472|NCT00738673|6162896|P1|Overall Study|Protocol Violation|1
1769473|NCT00738673|6162895|P2|Overall Study|Lack of Efficacy|8
1769474|NCT00738673|6162896|P1|Overall Study|Lack of Efficacy|19
1769475|NCT00738673|6162895|P2|Overall Study|Adverse Event|0
1769476|NCT00738673|6162896|P1|Overall Study|Adverse Event|1
1769477|NCT00738530|6162934|P2|Overall Study|Withdrawal by Subject|8
1769478|NCT00738530|6162935|P1|Overall Study|Withdrawal by Subject|6
1769479|NCT00738530|6162934|P2|Overall Study|Lost to Follow-up|6
1769480|NCT00738530|6162935|P1|Overall Study|Lost to Follow-up|8
1769481|NCT00738530|6162934|P2|Overall Study|Death|224
1769482|NCT00738530|6162935|P1|Overall Study|Death|220
1769483|NCT00738400|6162970|P2|Overall Study|Non-compliant with study medication|1
1769484|NCT00738400|6162971|P1|Overall Study|Non-compliant with study medication|0
1769485|NCT00738400|6162970|P2|Overall Study|Protocol Violation|0
1769486|NCT00738400|6162971|P1|Overall Study|Protocol Violation|1
1769487|NCT00738400|6162970|P2|Overall Study|Lost to Follow-up|3
1769488|NCT00738400|6162971|P1|Overall Study|Lost to Follow-up|0
1769489|NCT00738400|6162970|P2|Overall Study|Lack of Efficacy|1
1769490|NCT00738400|6162971|P1|Overall Study|Lack of Efficacy|0
1769491|NCT00738400|6162970|P2|Overall Study|Withdrawal by Subject|1
1769492|NCT00738400|6162971|P1|Overall Study|Withdrawal by Subject|0
1769493|NCT00738400|6162970|P2|Overall Study|Adverse Event|1
1769494|NCT00738400|6162971|P1|Overall Study|Adverse Event|3
1769495|NCT00738374|6162992|P4|Maintenance Treatment/Observation Phase|Other|0
1769496|NCT00738374|6162993|P3|Maintenance Treatment/Observation Phase|Other|0
1769497|NCT00738374|6162994|P2|Maintenance Treatment/Observation Phase|Other|1
1769498|NCT00738374|6162995|P1|Maintenance Treatment/Observation Phase|Other|0
1769499|NCT00738374|6162992|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
1769500|NCT00738374|6162993|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
1769501|NCT00738374|6162994|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
1769502|NCT00738374|6162995|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
1769503|NCT00738374|6162992|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
1769504|NCT00738374|6162993|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1769505|NCT00738374|6162994|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1769506|NCT00738374|6162995|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
1769507|NCT00738374|6162992|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
1769508|NCT00738374|6162993|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
1769509|NCT00738374|6162994|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
1769510|NCT00738374|6162995|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
1769511|NCT00738374|6162992|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
1769512|NCT00738374|6162993|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
1769513|NCT00738374|6162994|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
1769514|NCT00738374|6162995|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
1769515|NCT00738374|6162992|P4|Induction Treatment Phase|Withdrawal by Subject|0
1769516|NCT00738374|6162993|P3|Induction Treatment Phase|Withdrawal by Subject|0
1769517|NCT00738374|6162994|P2|Induction Treatment Phase|Withdrawal by Subject|0
1769518|NCT00738374|6162995|P1|Induction Treatment Phase|Withdrawal by Subject|1
1769519|NCT00738374|6162992|P4|Induction Treatment Phase|Non-compliance|0
1769520|NCT00738374|6162993|P3|Induction Treatment Phase|Non-compliance|0
1769521|NCT00738374|6162994|P2|Induction Treatment Phase|Non-compliance|0
1769522|NCT00738374|6162995|P1|Induction Treatment Phase|Non-compliance|1
1769523|NCT00738374|6162992|P4|Induction Treatment Phase|Protocol Violation|0
1769524|NCT00738374|6162993|P3|Induction Treatment Phase|Protocol Violation|0
1769525|NCT00738374|6162994|P2|Induction Treatment Phase|Protocol Violation|0
1769526|NCT00738374|6162995|P1|Induction Treatment Phase|Protocol Violation|2
1769527|NCT00738374|6162992|P4|Induction Treatment Phase|Physician Decision|0
1769528|NCT00738374|6162993|P3|Induction Treatment Phase|Physician Decision|0
1769529|NCT00738374|6162994|P2|Induction Treatment Phase|Physician Decision|0
1769530|NCT00738374|6162995|P1|Induction Treatment Phase|Physician Decision|2
1769531|NCT00738374|6162992|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
1769532|NCT00738374|6162993|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
1769533|NCT00738374|6162994|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
1769534|NCT00738374|6162995|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
1769535|NCT00738374|6162992|P4|Induction Treatment Phase|Adverse Event|0
1769536|NCT00738374|6162993|P3|Induction Treatment Phase|Adverse Event|0
1769537|NCT00738374|6162994|P2|Induction Treatment Phase|Adverse Event|0
1769538|NCT00738374|6162995|P1|Induction Treatment Phase|Adverse Event|14
1769539|NCT00738283|6163033|P1|Overall Study|Discharge home prior to end of study|1
1769540|NCT00738283|6163033|P1|Overall Study|Transfer to another facility|2
1769541|NCT00738283|6163033|P1|Overall Study|Death|1
1769542|NCT00738062|6163040|P3|Open-Label Extension|Study Terminated|0
1769543|NCT00738062|6163041|P2|Open-Label Extension|Study Terminated|0
1769544|NCT00738062|6163042|P1|Open-Label Extension|Study Terminated|2
1769545|NCT00738062|6163040|P3|Open-Label Extension|Protocol Violation|0
1769546|NCT00738062|6163041|P2|Open-Label Extension|Protocol Violation|0
1769547|NCT00738062|6163042|P1|Open-Label Extension|Protocol Violation|1
1769548|NCT00738062|6163040|P3|Open-Label Extension|Withdrawal by Subject|0
1769549|NCT00738062|6163041|P2|Open-Label Extension|Withdrawal by Subject|0
1769550|NCT00738062|6163042|P1|Open-Label Extension|Withdrawal by Subject|6
1769551|NCT00738062|6163040|P3|Open-Label Extension|Lack of Efficacy|0
1769552|NCT00738062|6163041|P2|Open-Label Extension|Lack of Efficacy|0
1769553|NCT00738062|6163042|P1|Open-Label Extension|Lack of Efficacy|2
1769554|NCT00738062|6163040|P3|Open-Label Extension|Physician Decision|0
1769555|NCT00738062|6163041|P2|Open-Label Extension|Physician Decision|0
1769556|NCT00738062|6163042|P1|Open-Label Extension|Physician Decision|1
1769557|NCT00738062|6163040|P3|Open-Label Extension|Adverse Event|0
1769558|NCT00738062|6163041|P2|Open-Label Extension|Adverse Event|0
1769559|NCT00738062|6163042|P1|Open-Label Extension|Adverse Event|5
1769560|NCT00738062|6163040|P3|Open Label Treatment|Investigator Decision|0
1769561|NCT00738062|6163041|P2|Open Label Treatment|Investigator Decision|0
1769562|NCT00738062|6163042|P1|Open Label Treatment|Investigator Decision|1
1769563|NCT00738062|6163040|P3|Open Label Treatment|Withdrawal by Subject|0
1769564|NCT00738062|6163041|P2|Open Label Treatment|Withdrawal by Subject|0
1769565|NCT00738062|6163042|P1|Open Label Treatment|Withdrawal by Subject|9
1769566|NCT00738062|6163040|P3|Open Label Treatment|Protocol Violation|0
1769567|NCT00738062|6163041|P2|Open Label Treatment|Protocol Violation|0
1769568|NCT00738062|6163042|P1|Open Label Treatment|Protocol Violation|2
1769569|NCT00738062|6163040|P3|Open Label Treatment|Adverse Event|0
1769570|NCT00738062|6163041|P2|Open Label Treatment|Adverse Event|0
1769571|NCT00738062|6163042|P1|Open Label Treatment|Adverse Event|11
1769572|NCT00738062|6163040|P3|Open Label Treatment|Lack of Efficacy|0
1769573|NCT00738062|6163041|P2|Open Label Treatment|Lack of Efficacy|0
1769574|NCT00738062|6163042|P1|Open Label Treatment|Lack of Efficacy|5
1769575|NCT00737711|6163104|P1|Overall Study|Other|5
1769576|NCT00737711|6163104|P1|Overall Study|Blood transfusion|6
1769577|NCT00737711|6163104|P1|Overall Study|Withdrawal by Subject|5
1769578|NCT00737711|6163104|P1|Overall Study|Protocol Violation|1
1769579|NCT00737711|6163104|P1|Overall Study|Failure to return|4
1769580|NCT00737711|6163104|P1|Overall Study|Death|8
1769581|NCT00737711|6163104|P1|Overall Study|Adverse Event|2
1769582|NCT00737698|6163138|P3|Overall Study|Death|1
1769583|NCT00737698|6163139|P2|Overall Study|Death|0
1769584|NCT00737698|6163140|P1|Overall Study|Death|0
1769585|NCT00737698|6163138|P3|Overall Study|Withdrawal by Subject|3
1769586|NCT00737698|6163139|P2|Overall Study|Withdrawal by Subject|5
1769587|NCT00737698|6163140|P1|Overall Study|Withdrawal by Subject|6
1769588|NCT00737672|6163150|P2|Overall Study|Physician Decision|2
1769589|NCT00737672|6163151|P1|Overall Study|Physician Decision|0
1769590|NCT00737672|6163150|P2|Overall Study|Miscellaneous|1
1769591|NCT00737672|6163151|P1|Overall Study|Miscellaneous|7
1769592|NCT00737672|6163150|P2|Overall Study|Lost to Follow-up|0
1769593|NCT00737672|6163151|P1|Overall Study|Lost to Follow-up|1
1769594|NCT00737672|6163150|P2|Overall Study|Withdrawal by Subject|2
1769595|NCT00737672|6163151|P1|Overall Study|Withdrawal by Subject|1
1769596|NCT00737672|6163150|P2|Overall Study|Death|22
1769597|NCT00737672|6163151|P1|Overall Study|Death|23
1769598|NCT00737672|6163150|P2|Overall Study|Graft Abandonment|56
1769599|NCT00737672|6163151|P1|Overall Study|Graft Abandonment|48
1769600|NCT00737633|6163189|P2|Overall Study|protocol non-compliance|1
1769601|NCT00737633|6163190|P1|Overall Study|protocol non-compliance|0
1769602|NCT00737633|6163189|P2|Overall Study|Lost to Follow-up|1
1769603|NCT00737633|6163190|P1|Overall Study|Lost to Follow-up|0
1769604|NCT00737633|6163189|P2|Overall Study|Study terminated by sponsor|55
1769605|NCT00737633|6163190|P1|Overall Study|Study terminated by sponsor|44
1769606|NCT00737568|6163213|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
1769607|NCT00737568|6163214|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
1769608|NCT00737568|6163213|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
1769609|NCT00737568|6163214|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
1769610|NCT00737568|6163213|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
1769611|NCT00737568|6163214|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
1769612|NCT00737568|6163213|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
1769613|NCT00737568|6163214|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
1769614|NCT00737568|6163213|P2|Treatment Period Through Week 240|Protocol Violation|3
1769615|NCT00737568|6163214|P1|Treatment Period Through Week 240|Protocol Violation|2
1769616|NCT00737568|6163213|P2|Treatment Period Through Week 240|Lost to Follow-up|3
1769617|NCT00737568|6163214|P1|Treatment Period Through Week 240|Lost to Follow-up|3
1769618|NCT00737568|6163213|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
1769619|NCT00737568|6163214|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
1769620|NCT00737568|6163213|P2|Treatment Period Through Week 240|Withdrew Consent|6
1769621|NCT00737568|6163214|P1|Treatment Period Through Week 240|Withdrew Consent|5
1769622|NCT00737568|6163213|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
1769623|NCT00737568|6163214|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
1769624|NCT00737529|6163244|P1|Overall Study|Other|4
1769625|NCT00737529|6163244|P1|Overall Study|Protocol Violation|1
1769626|NCT00737529|6163244|P1|Overall Study|Death|4
1769627|NCT00737529|6163244|P1|Overall Study|Withdrawal by Subject|5
1769628|NCT00737529|6163244|P1|Overall Study|Adverse Event|24
1769629|NCT00737529|6163244|P1|Overall Study|Disease Progression|95
1769630|NCT00737477|6163258|P1|Overall Study|Other|4
1769631|NCT00737477|6163258|P1|Overall Study|Renal Transplantation|10
1769632|NCT00737477|6163258|P1|Overall Study|Withdrawal by Subject|1
1769633|NCT00737477|6163258|P1|Overall Study|Treatment Refusal|1
1769634|NCT00737477|6163258|P1|Overall Study|Death|9
1769635|NCT00737477|6163258|P1|Overall Study|Adverse Event|9
1769636|NCT00737464|6163274|P1|Overall Study|Other reasons|4
1769637|NCT00737464|6163274|P1|Overall Study|Refused Treatment / Withdrew Consent|6
1769638|NCT00737464|6163274|P1|Overall Study|Other - Failure to Return|1
1769639|NCT00737464|6163274|P1|Overall Study|Death|6
1769640|NCT00737464|6163274|P1|Overall Study|Adverse Event|1
1769641|NCT00737438|6163295|P1|Overall Study|Patient ineligible|1
1769642|NCT00737438|6163295|P1|Overall Study|Withdrawal by Subject|2
1769643|NCT00737282|6163308|P1|Overall Study|Study prematurely terminated|175
1769644|NCT00737100|6163351|P3|Overall Study|Reason discontinued not explained above|1
1769645|NCT00737100|6163352|P2|Overall Study|Reason discontinued not explained above|1
1769646|NCT00737100|6163353|P1|Overall Study|Reason discontinued not explained above|1
1769647|NCT00737100|6163351|P3|Overall Study|Withdrawal by Subject|3
1769648|NCT00737100|6163352|P2|Overall Study|Withdrawal by Subject|0
1769649|NCT00737100|6163353|P1|Overall Study|Withdrawal by Subject|0
1769650|NCT00737100|6163351|P3|Overall Study|Lost to Follow-up|0
1769651|NCT00737100|6163352|P2|Overall Study|Lost to Follow-up|1
1769652|NCT00737100|6163353|P1|Overall Study|Lost to Follow-up|0
1769653|NCT00737100|6163351|P3|Overall Study|Adverse Event|3
1769654|NCT00737100|6163352|P2|Overall Study|Adverse Event|5
1769655|NCT00737100|6163353|P1|Overall Study|Adverse Event|6
1769656|NCT00737061|6163397|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
1769657|NCT00737061|6163397|P1|1 Year Wearing Period|Discontinued reilance|3
1769658|NCT00737061|6163397|P1|1 Year Wearing Period|Withdrawal by Subject|2
1769659|NCT00737061|6163397|P1|1 Year Wearing Period|Lost to Follow-up|11
1769660|NCT00737061|6163397|P1|Waiting Period|Elected surgical tubal ligation|5
1769661|NCT00737061|6163397|P1|Waiting Period|Alternative contraception failure|3
1769662|NCT00737061|6163397|P1|Waiting Period|Deemed patent following HSG|26
1769663|NCT00737061|6163397|P1|Waiting Period|Bilateral placement failure|34
1769664|NCT00737061|6163397|P1|Waiting Period|Withdrawal by Subject|1
1769665|NCT00737061|6163397|P1|Waiting Period|Lost to Follow-up|6
1769666|NCT00737048|6163414|P3|Overall Study|Worsening of the symptoms|3
1769667|NCT00737048|6163415|P2|Overall Study|Worsening of the symptoms|5
1769668|NCT00737048|6163416|P1|Overall Study|Worsening of the symptoms|3
1769669|NCT00737048|6163414|P3|Overall Study|Adverse Event|0
1769670|NCT00737048|6163415|P2|Overall Study|Adverse Event|1
1769671|NCT00737048|6163416|P1|Overall Study|Adverse Event|0
1769672|NCT00737048|6163414|P3|Overall Study|Physician Decision|1
1769673|NCT00737048|6163415|P2|Overall Study|Physician Decision|0
1769674|NCT00737048|6163416|P1|Overall Study|Physician Decision|0
1769675|NCT00736996|6163460|P3|Overall Study|Lost to Follow-up|2
1769676|NCT00736996|6163461|P2|Overall Study|Lost to Follow-up|9
1769677|NCT00736996|6163462|P1|Overall Study|Lost to Follow-up|1
1769678|NCT00736957|6163476|P1|Overall Study|Physician Decision|5
1769679|NCT00736957|6163476|P1|Overall Study|not eligible for Treatment Period I|22
1769680|NCT00736957|6163476|P1|Overall Study|did not attend hospital appointments|1
1769681|NCT00736957|6163476|P1|Overall Study|violation of eligibility criteria|2
1769682|NCT00736957|6163476|P1|Overall Study|Withdrawal by Subject|49
1769683|NCT00736957|6163476|P1|Overall Study|Adverse Event|43
1769686|NCT00736879|6163517|P4|Follow up Period - No Drug Treatment|non-specified|0
1769687|NCT00736879|6163518|P3|Follow up Period - No Drug Treatment|non-specified|0
1769688|NCT00736879|6163519|P2|Follow up Period - No Drug Treatment|non-specified|2
1769689|NCT00736879|6163520|P1|Follow up Period - No Drug Treatment|non-specified|1
1769690|NCT00736879|6163517|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1769691|NCT00736879|6163518|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1769692|NCT00736879|6163519|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
1769693|NCT00736879|6163520|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
1769694|NCT00736879|6163517|P4|Double Blind Treatment Period|non-specified|0
1769695|NCT00736879|6163518|P3|Double Blind Treatment Period|non-specified|0
1769696|NCT00736879|6163519|P2|Double Blind Treatment Period|non-specified|1
1769697|NCT00736879|6163520|P1|Double Blind Treatment Period|non-specified|0
1769698|NCT00736879|6163517|P4|Double Blind Treatment Period|No longer met criteria|0
1769699|NCT00736879|6163518|P3|Double Blind Treatment Period|No longer met criteria|0
1769700|NCT00736879|6163519|P2|Double Blind Treatment Period|No longer met criteria|1
1769701|NCT00736879|6163520|P1|Double Blind Treatment Period|No longer met criteria|0
1769702|NCT00736879|6163517|P4|Double Blind Treatment Period|Poor non-compliance|1
1769703|NCT00736879|6163518|P3|Double Blind Treatment Period|Poor non-compliance|1
1769704|NCT00736879|6163519|P2|Double Blind Treatment Period|Poor non-compliance|0
1769705|NCT00736879|6163520|P1|Double Blind Treatment Period|Poor non-compliance|0
1769706|NCT00736879|6163517|P4|Double Blind Treatment Period|Lost to Follow-up|1
1769707|NCT00736879|6163518|P3|Double Blind Treatment Period|Lost to Follow-up|2
1769708|NCT00736879|6163519|P2|Double Blind Treatment Period|Lost to Follow-up|0
1769709|NCT00736879|6163520|P1|Double Blind Treatment Period|Lost to Follow-up|0
1769710|NCT00736879|6163517|P4|Double Blind Treatment Period|Withdrawal by Subject|3
1769711|NCT00736879|6163518|P3|Double Blind Treatment Period|Withdrawal by Subject|3
1769712|NCT00736879|6163519|P2|Double Blind Treatment Period|Withdrawal by Subject|1
1769713|NCT00736879|6163520|P1|Double Blind Treatment Period|Withdrawal by Subject|2
1769714|NCT00736879|6163517|P4|Double Blind Treatment Period|Adverse Event|0
1769715|NCT00736879|6163518|P3|Double Blind Treatment Period|Adverse Event|1
1769716|NCT00736879|6163519|P2|Double Blind Treatment Period|Adverse Event|1
1769717|NCT00736879|6163520|P1|Double Blind Treatment Period|Adverse Event|0
1769718|NCT00736879|6163517|P4|Double Blind Treatment Period|Lack of Efficacy|0
1769719|NCT00736879|6163518|P3|Double Blind Treatment Period|Lack of Efficacy|0
1769720|NCT00736879|6163519|P2|Double Blind Treatment Period|Lack of Efficacy|0
1769721|NCT00736879|6163520|P1|Double Blind Treatment Period|Lack of Efficacy|1
1769722|NCT00736853|6163574|P3|Double-Blind Period|Ineligible to participate the study|0
1769723|NCT00736853|6163575|P2|Double-Blind Period|Ineligible to participate the study|1
1769724|NCT00736853|6163576|P1|Double-Blind Period|Ineligible to participate the study|0
1769725|NCT00736853|6163574|P3|Double-Blind Period|Withdrawal by Subject|4
1769726|NCT00736853|6163575|P2|Double-Blind Period|Withdrawal by Subject|1
1769727|NCT00736853|6163576|P1|Double-Blind Period|Withdrawal by Subject|0
1769728|NCT00736853|6163574|P3|Double-Blind Period|Adverse Event|2
1769729|NCT00736853|6163575|P2|Double-Blind Period|Adverse Event|3
1769730|NCT00736853|6163576|P1|Double-Blind Period|Adverse Event|0
1769731|NCT00736853|6163574|P3|Double-Blind Period|Lack of Efficacy|42
1769732|NCT00736853|6163575|P2|Double-Blind Period|Lack of Efficacy|19
1769733|NCT00736853|6163576|P1|Double-Blind Period|Lack of Efficacy|0
1769734|NCT00736853|6163574|P3|Open-Label Period|Unable to attend hospital appointments|0
1769735|NCT00736853|6163575|P2|Open-Label Period|Unable to attend hospital appointments|0
1769736|NCT00736853|6163576|P1|Open-Label Period|Unable to attend hospital appointments|1
1769737|NCT00736853|6163574|P3|Open-Label Period|Failed to meet the transfer criteria|0
1769738|NCT00736853|6163575|P2|Open-Label Period|Failed to meet the transfer criteria|0
1769739|NCT00736853|6163576|P1|Open-Label Period|Failed to meet the transfer criteria|40
1769740|NCT00736853|6163574|P3|Open-Label Period|Started but not treated|0
1769741|NCT00736853|6163575|P2|Open-Label Period|Started but not treated|0
1769742|NCT00736853|6163576|P1|Open-Label Period|Started but not treated|42
1769743|NCT00736853|6163574|P3|Open-Label Period|Withdrawal by Subject|0
1769744|NCT00736853|6163575|P2|Open-Label Period|Withdrawal by Subject|0
1769745|NCT00736853|6163576|P1|Open-Label Period|Withdrawal by Subject|16
1769746|NCT00736853|6163574|P3|Open-Label Period|Adverse Event|0
1769747|NCT00736853|6163575|P2|Open-Label Period|Adverse Event|0
1769748|NCT00736853|6163576|P1|Open-Label Period|Adverse Event|31
1769749|NCT00736853|6163574|P3|Open-Label Period|Physician Decision|0
1769750|NCT00736853|6163575|P2|Open-Label Period|Physician Decision|0
1769751|NCT00736853|6163576|P1|Open-Label Period|Physician Decision|2
1769752|NCT00736840|6163616|P1|Overall Study|Lost to Follow-up|13
1769753|NCT00736723|6163623|P2|Overall Study|Withdrawal by Subject|3
1769754|NCT00736723|6163624|P1|Overall Study|Withdrawal by Subject|4
1769755|NCT00736645|6163634|P4|Overall Study|Adverse Event|0
1769756|NCT00736645|6163635|P3|Overall Study|Adverse Event|0
1769757|NCT00736645|6163636|P2|Overall Study|Adverse Event|2
1769758|NCT00736645|6163637|P1|Overall Study|Adverse Event|0
1769759|NCT00736502|6163687|P1|Overall Study|Lost to Follow-up|27
1769760|NCT00736502|6163687|P1|Overall Study|Lack of Efficacy|16
1769761|NCT00736502|6163687|P1|Overall Study|Adverse Event|22
1769762|NCT00736489|6163693|P6|Period 1|Withdrawal by Subject|1
1769763|NCT00736489|6163694|P5|Period 1|Withdrawal by Subject|0
1769764|NCT00736489|6163695|P4|Period 1|Withdrawal by Subject|0
1769765|NCT00736489|6163696|P3|Period 1|Withdrawal by Subject|0
1769766|NCT00736489|6163697|P2|Period 1|Withdrawal by Subject|0
1769767|NCT00736489|6163698|P1|Period 1|Withdrawal by Subject|0
1769768|NCT00736489|6163693|P6|Period 1|Lost to Follow-up|0
1769769|NCT00736489|6163694|P5|Period 1|Lost to Follow-up|0
1769770|NCT00736489|6163695|P4|Period 1|Lost to Follow-up|0
1769771|NCT00736489|6163696|P3|Period 1|Lost to Follow-up|0
1769772|NCT00736489|6163697|P2|Period 1|Lost to Follow-up|0
1769773|NCT00736489|6163698|P1|Period 1|Lost to Follow-up|1
1769774|NCT00736476|6163852|P2|Overall Study|Adverse Event|0
1769775|NCT00736476|6163853|P1|Overall Study|Adverse Event|1
1769776|NCT00736450|6163873|P1|Overall Study|Physician Decision|1
1769777|NCT00736450|6163873|P1|Overall Study|Withdrawal by Subject|5
1769778|NCT00736450|6163873|P1|Overall Study|Not ABC gene eligible|19
1769779|NCT00736385|6163881|P2|Overall Study|Adverse Event|1
1769780|NCT00736385|6163882|P1|Overall Study|Adverse Event|0
1769781|NCT00736385|6163881|P2|Overall Study|Withdrawal by Subject|2
1769782|NCT00736385|6163882|P1|Overall Study|Withdrawal by Subject|2
1769783|NCT00736333|6163894|P1|Overall Study|Other|4
1769784|NCT00736333|6163894|P1|Overall Study|Death|7
1769785|NCT00736333|6163894|P1|Overall Study|Withdrawal by Subject|10
1769786|NCT00736333|6163894|P1|Overall Study|Toxicity|6
1769787|NCT00736333|6163894|P1|Overall Study|Tumor Progression|75
1769788|NCT00736333|6163894|P1|Overall Study|Data Missing|2
1769789|NCT00736333|6163894|P1|Overall Study|Did Not Receive Drug or Not Documented|7
1769790|NCT00736255|6163905|P2|Overall Study|Non-compliance|1
1769791|NCT00736255|6163906|P1|Overall Study|Non-compliance|1
1769792|NCT00736255|6163905|P2|Overall Study|Physician Decision|0
1769793|NCT00736255|6163906|P1|Overall Study|Physician Decision|1
1769794|NCT00736255|6163905|P2|Overall Study|Adverse Event|0
1769795|NCT00736255|6163906|P1|Overall Study|Adverse Event|1
1769796|NCT00736190|6163953|P1|Overall Study|Adverse Event|1
1769797|NCT00736190|6163953|P1|Overall Study|Withdrawal by Subject|1
1769798|NCT00736190|6163953|P1|Overall Study|Pregnancy|1
1769799|NCT00736099|6163983|P2|Overall Study|Other reason|10
1769800|NCT00736099|6163984|P1|Overall Study|Other reason|43
1769801|NCT00736099|6163983|P2|Overall Study|Lack of Efficacy|8
1769802|NCT00736099|6163984|P1|Overall Study|Lack of Efficacy|15
1769803|NCT00736099|6163983|P2|Overall Study|Withdrawal by Subject|13
1769804|NCT00736099|6163984|P1|Overall Study|Withdrawal by Subject|42
1769805|NCT00736099|6163983|P2|Overall Study|Lost to Follow-up|5
1769806|NCT00736099|6163984|P1|Overall Study|Lost to Follow-up|12
1769807|NCT00736099|6163983|P2|Overall Study|Protocol Violation|4
1769808|NCT00736099|6163984|P1|Overall Study|Protocol Violation|10
1769809|NCT00736099|6163983|P2|Overall Study|Adverse Event|18
1769810|NCT00736099|6163984|P1|Overall Study|Adverse Event|61
1769811|NCT00736034|6164093|P1|Overall Study|Adverse Event|2
1769812|NCT00735943|6164101|P1|Overall Study|Adverse Event|1
1769813|NCT00735943|6164101|P1|Overall Study|Lost to Follow-up|1
1769814|NCT00735904|6164126|P1|Overall Study|Other|8
1769815|NCT00735904|6164126|P1|Overall Study|Study Terminated by Sponsor|5
1769816|NCT00735904|6164126|P1|Overall Study|Withdrawal by Subject|1
1769817|NCT00735904|6164126|P1|Overall Study|Protocol Violation|1
1769818|NCT00735904|6164126|P1|Overall Study|Death|20
1769819|NCT00735904|6164126|P1|Overall Study|Adverse Event|3
1769820|NCT00735878|6164136|P3|Phase I- Dose Determination|Withdrawal by Subject|1
1769821|NCT00735878|6164137|P2|Phase I- Dose Determination|Withdrawal by Subject|0
1769822|NCT00735878|6164138|P1|Phase I- Dose Determination|Withdrawal by Subject|0
1769823|NCT00735709|6164217|P4|Overall Study|Excluded medication|1
1769824|NCT00735709|6164218|P3|Overall Study|Excluded medication|0
1769825|NCT00735709|6164219|P2|Overall Study|Excluded medication|0
1769826|NCT00735709|6164220|P1|Overall Study|Excluded medication|1
1769827|NCT00735709|6164217|P4|Overall Study|Lost to Follow-up|1
1769828|NCT00735709|6164218|P3|Overall Study|Lost to Follow-up|1
1769829|NCT00735709|6164219|P2|Overall Study|Lost to Follow-up|1
1769830|NCT00735709|6164220|P1|Overall Study|Lost to Follow-up|0
1769831|NCT00735709|6164217|P4|Overall Study|Voluntary Withdrawal|7
1769832|NCT00735709|6164218|P3|Overall Study|Voluntary Withdrawal|5
1769833|NCT00735709|6164219|P2|Overall Study|Voluntary Withdrawal|3
1769834|NCT00735709|6164220|P1|Overall Study|Voluntary Withdrawal|1
1769835|NCT00735709|6164217|P4|Overall Study|Protocol deviations|1
1769836|NCT00735709|6164218|P3|Overall Study|Protocol deviations|1
1769837|NCT00735709|6164219|P2|Overall Study|Protocol deviations|2
1769838|NCT00735709|6164220|P1|Overall Study|Protocol deviations|1
1769839|NCT00735709|6164217|P4|Overall Study|Noncompliance|0
1769840|NCT00735709|6164218|P3|Overall Study|Noncompliance|1
1769841|NCT00735709|6164219|P2|Overall Study|Noncompliance|0
1769842|NCT00735709|6164220|P1|Overall Study|Noncompliance|0
1769843|NCT00735709|6164217|P4|Overall Study|Lack of Efficacy|3
1769844|NCT00735709|6164218|P3|Overall Study|Lack of Efficacy|2
1769845|NCT00735709|6164219|P2|Overall Study|Lack of Efficacy|4
1769846|NCT00735709|6164220|P1|Overall Study|Lack of Efficacy|8
1769847|NCT00735709|6164217|P4|Overall Study|Adverse Event|5
1769848|NCT00735709|6164218|P3|Overall Study|Adverse Event|1
1769849|NCT00735709|6164219|P2|Overall Study|Adverse Event|3
1769850|NCT00735709|6164220|P1|Overall Study|Adverse Event|2
1769851|NCT00735696|6164330|P1|Overall Study|Enrolled but never Treated|1
1769852|NCT00735696|6164330|P1|Overall Study|Withdrawal by Subject|1
1769853|NCT00735644|6164358|P5|Overall Study|Withdrawal by Subject|0
1769854|NCT00735644|6164359|P4|Overall Study|Withdrawal by Subject|1
1769855|NCT00735644|6164360|P3|Overall Study|Withdrawal by Subject|1
1769856|NCT00735644|6164361|P2|Overall Study|Withdrawal by Subject|1
1769857|NCT00735644|6164362|P1|Overall Study|Withdrawal by Subject|0
1769858|NCT00735644|6164358|P5|Overall Study|Did not receive study vaccine|0
1769859|NCT00735644|6164359|P4|Overall Study|Did not receive study vaccine|0
1769860|NCT00735644|6164360|P3|Overall Study|Did not receive study vaccine|0
1769861|NCT00735644|6164361|P2|Overall Study|Did not receive study vaccine|1
1769862|NCT00735644|6164362|P1|Overall Study|Did not receive study vaccine|0
1769863|NCT00735553|6164406|P1|Overall Study|Study prematurely terminated|77
1769864|NCT00735475|6164416|P2|Overall Study|Withdrawal by Subject|5
1769865|NCT00735475|6164417|P1|Overall Study|Withdrawal by Subject|4
1769866|NCT00735475|6164416|P2|Overall Study|Physician Decision|1
1769867|NCT00735475|6164417|P1|Overall Study|Physician Decision|0
1769868|NCT00735475|6164416|P2|Overall Study|Lost to Follow-up|3
1769869|NCT00735475|6164417|P1|Overall Study|Lost to Follow-up|3
1769870|NCT00735475|6164416|P2|Overall Study|Death|1
1769871|NCT00735475|6164417|P1|Overall Study|Death|1
1769872|NCT00735475|6164416|P2|Overall Study|Adverse Event|1
1769873|NCT00735475|6164417|P1|Overall Study|Adverse Event|0
1769874|NCT00735397|6164477|P1|Overall Study|Administrative/Other|502
1769875|NCT00735397|6164477|P1|Overall Study|Inadequate therapeutic effect|202
1769876|NCT00735397|6164477|P1|Overall Study|Participant choice|252
1769877|NCT00735397|6164477|P1|Overall Study|Lost to Follow-up|33
1769878|NCT00735397|6164477|P1|Overall Study|Adverse Event|194
1769879|NCT00735371|6164491|P4|Overall Study|Exclusion criteria|0
1769880|NCT00735371|6164492|P3|Overall Study|Exclusion criteria|0
1769881|NCT00735371|6164493|P2|Overall Study|Exclusion criteria|0
1769882|NCT00735371|6164494|P1|Overall Study|Exclusion criteria|1
1769883|NCT00735371|6164491|P4|Overall Study|Prior Vyvanse Exposure|0
1769884|NCT00735371|6164492|P3|Overall Study|Prior Vyvanse Exposure|0
1769885|NCT00735371|6164493|P2|Overall Study|Prior Vyvanse Exposure|1
1769886|NCT00735371|6164494|P1|Overall Study|Prior Vyvanse Exposure|1
1769887|NCT00735371|6164491|P4|Overall Study|Protocol Violation|0
1769888|NCT00735371|6164492|P3|Overall Study|Protocol Violation|2
1769889|NCT00735371|6164493|P2|Overall Study|Protocol Violation|1
1769890|NCT00735371|6164494|P1|Overall Study|Protocol Violation|0
1769891|NCT00735371|6164491|P4|Overall Study|Sponsor Decision|1
1769892|NCT00735371|6164492|P3|Overall Study|Sponsor Decision|0
1769893|NCT00735371|6164493|P2|Overall Study|Sponsor Decision|1
1769894|NCT00735371|6164494|P1|Overall Study|Sponsor Decision|3
1769895|NCT00735371|6164491|P4|Overall Study|Lack of Efficacy|4
1769896|NCT00735371|6164492|P3|Overall Study|Lack of Efficacy|0
1769897|NCT00735371|6164493|P2|Overall Study|Lack of Efficacy|2
1769898|NCT00735371|6164494|P1|Overall Study|Lack of Efficacy|4
1769899|NCT00735371|6164491|P4|Overall Study|Lost to Follow-up|1
1769900|NCT00735371|6164492|P3|Overall Study|Lost to Follow-up|3
1769901|NCT00735371|6164493|P2|Overall Study|Lost to Follow-up|1
1769902|NCT00735371|6164494|P1|Overall Study|Lost to Follow-up|1
1769903|NCT00735371|6164491|P4|Overall Study|Withdrawal by Subject|0
1769904|NCT00735371|6164492|P3|Overall Study|Withdrawal by Subject|2
1769905|NCT00735371|6164493|P2|Overall Study|Withdrawal by Subject|2
1769906|NCT00735371|6164494|P1|Overall Study|Withdrawal by Subject|0
1769907|NCT00735371|6164491|P4|Overall Study|Protocol Violation|3
1769908|NCT00735371|6164492|P3|Overall Study|Protocol Violation|0
1769909|NCT00735371|6164493|P2|Overall Study|Protocol Violation|2
1769910|NCT00735371|6164494|P1|Overall Study|Protocol Violation|2
1769911|NCT00735371|6164491|P4|Overall Study|Adverse Event|1
1769912|NCT00735371|6164492|P3|Overall Study|Adverse Event|4
1769913|NCT00735371|6164493|P2|Overall Study|Adverse Event|3
1769914|NCT00735371|6164494|P1|Overall Study|Adverse Event|3
1769915|NCT00735254|6164522|P4|Overall Study|Protocol Violation|0
1769916|NCT00735254|6164523|P3|Overall Study|Protocol Violation|1
1769917|NCT00735254|6164524|P2|Overall Study|Protocol Violation|1
1769918|NCT00735254|6164525|P1|Overall Study|Protocol Violation|1
1769919|NCT00735072|6164537|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
1769920|NCT00735072|6164538|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
1769921|NCT00735072|6164537|P2|Overall Study|interrupted study med during ARV change|0
1769922|NCT00735072|6164538|P1|Overall Study|interrupted study med during ARV change|1
1769923|NCT00735007|6164544|P1|Overall Study|Protocol Violation|1
1769924|NCT00735007|6164544|P1|Overall Study|Adverse Event|4
1769925|NCT00734994|6164569|P1|Overall Study|Withdrawal by Subject|1
1769926|NCT00734929|6164589|P2|Overall Study|No intervention/ screen fail|3
1769927|NCT00734929|6164590|P1|Overall Study|No intervention/ screen fail|5
1769928|NCT00734929|6164589|P2|Overall Study|Lost to Follow-up|2
1769929|NCT00734929|6164590|P1|Overall Study|Lost to Follow-up|1
1769930|NCT00734851|6164647|P1|Overall Study|Physician Decision|18
1769931|NCT00734851|6164647|P1|Overall Study|Lost to Follow-up|1
1769932|NCT00734851|6164647|P1|Overall Study|Withdrawal by Subject|2
1769933|NCT00734747|6164668|P1|6 Month Follow-up|Did not meet inclusion criteria|3
1769934|NCT00734747|6164668|P1|SRS Procedure|No staples placed|3
1769935|NCT00734656|6164682|P4|Lab Session 4|Withdrawal by Subject|1
1769936|NCT00734656|6164683|P3|Lab Session 4|Withdrawal by Subject|0
1769937|NCT00734656|6164684|P2|Lab Session 4|Withdrawal by Subject|0
1769938|NCT00734656|6164685|P1|Lab Session 4|Withdrawal by Subject|0
1769939|NCT00734656|6164682|P4|Washout 3|Withdrawal by Subject|1
1769940|NCT00734656|6164683|P3|Washout 3|Withdrawal by Subject|0
1769941|NCT00734656|6164684|P2|Washout 3|Withdrawal by Subject|0
1769942|NCT00734656|6164685|P1|Washout 3|Withdrawal by Subject|1
1769943|NCT00734656|6164682|P4|Washout 2|Withdrawal by Subject|0
1769944|NCT00734656|6164683|P3|Washout 2|Withdrawal by Subject|1
1769945|NCT00734656|6164684|P2|Washout 2|Withdrawal by Subject|1
1769946|NCT00734656|6164685|P1|Washout 2|Withdrawal by Subject|1
1769947|NCT00734656|6164682|P4|Lab Session 2|Withdrawal by Subject|1
1769948|NCT00734656|6164683|P3|Lab Session 2|Withdrawal by Subject|0
1769949|NCT00734656|6164684|P2|Lab Session 2|Withdrawal by Subject|0
1769950|NCT00734656|6164685|P1|Lab Session 2|Withdrawal by Subject|1
1769951|NCT00734656|6164682|P4|Washout 1|Withdrawal by Subject|3
1769952|NCT00734656|6164683|P3|Washout 1|Withdrawal by Subject|2
1769953|NCT00734656|6164684|P2|Washout 1|Withdrawal by Subject|5
1769954|NCT00734656|6164685|P1|Washout 1|Withdrawal by Subject|1
1769955|NCT00734656|6164682|P4|Lab Session 1|Withdrawal by Subject|0
1769956|NCT00734656|6164683|P3|Lab Session 1|Withdrawal by Subject|0
1769957|NCT00734656|6164684|P2|Lab Session 1|Withdrawal by Subject|0
1769958|NCT00734656|6164685|P1|Lab Session 1|Withdrawal by Subject|2
1769959|NCT00734630|6164709|P2|Overall Study|Poor Compliance|1
1769960|NCT00734630|6164710|P1|Overall Study|Poor Compliance|1
1769961|NCT00734630|6164709|P2|Overall Study|Tested Positive for Illegal Drug Use|1
1769962|NCT00734630|6164710|P1|Overall Study|Tested Positive for Illegal Drug Use|1
1769963|NCT00734630|6164709|P2|Overall Study|Randomized in Error|1
1769964|NCT00734630|6164710|P1|Overall Study|Randomized in Error|0
1769965|NCT00734630|6164709|P2|Overall Study|Adverse Event|6
1769966|NCT00734630|6164710|P1|Overall Study|Adverse Event|3
1769967|NCT00734630|6164709|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1769968|NCT00734630|6164710|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1769969|NCT00734630|6164709|P2|Overall Study|Protocol Violation|3
1769970|NCT00734630|6164710|P1|Overall Study|Protocol Violation|0
1769971|NCT00734630|6164709|P2|Overall Study|Lost to Follow-up|7
1769972|NCT00734630|6164710|P1|Overall Study|Lost to Follow-up|13
1769973|NCT00734630|6164709|P2|Overall Study|Withdrawal by Subject|9
1769974|NCT00734630|6164710|P1|Overall Study|Withdrawal by Subject|7
1769975|NCT00734630|6164709|P2|Overall Study|Lack of Efficacy|4
1769976|NCT00734630|6164710|P1|Overall Study|Lack of Efficacy|4
1769977|NCT00734617|6164720|P2|Overall Study|Withdrawal by Subject|95
1769978|NCT00734617|6164721|P1|Overall Study|Withdrawal by Subject|103
1769979|NCT00734617|6164720|P2|Overall Study|Adverse Event|7
1769980|NCT00734617|6164721|P1|Overall Study|Adverse Event|4
1769981|NCT00734604|6164733|P6|Overall Study|Lack of Efficacy|0
1769982|NCT00734604|6164734|P5|Overall Study|Lack of Efficacy|0
1769983|NCT00734604|6164735|P4|Overall Study|Lack of Efficacy|0
1769984|NCT00734604|6164736|P3|Overall Study|Lack of Efficacy|1
1769985|NCT00734604|6164737|P2|Overall Study|Lack of Efficacy|1
1769986|NCT00734604|6164738|P1|Overall Study|Lack of Efficacy|0
1769987|NCT00734604|6164733|P6|Overall Study|Withdrawal by Subject|1
1769988|NCT00734604|6164734|P5|Overall Study|Withdrawal by Subject|2
1769989|NCT00734604|6164735|P4|Overall Study|Withdrawal by Subject|1
1769990|NCT00734604|6164736|P3|Overall Study|Withdrawal by Subject|0
1769991|NCT00734604|6164737|P2|Overall Study|Withdrawal by Subject|2
1769992|NCT00734604|6164738|P1|Overall Study|Withdrawal by Subject|0
1769993|NCT00734604|6164733|P6|Overall Study|Sponsor Decision|0
1769994|NCT00734604|6164734|P5|Overall Study|Sponsor Decision|2
1769995|NCT00734604|6164735|P4|Overall Study|Sponsor Decision|0
1769996|NCT00734604|6164736|P3|Overall Study|Sponsor Decision|1
1769997|NCT00734604|6164737|P2|Overall Study|Sponsor Decision|2
1769998|NCT00734604|6164738|P1|Overall Study|Sponsor Decision|1
1769999|NCT00734604|6164733|P6|Overall Study|Protocol Violation|0
1770000|NCT00734604|6164734|P5|Overall Study|Protocol Violation|1
1770001|NCT00734604|6164735|P4|Overall Study|Protocol Violation|0
1770002|NCT00734604|6164736|P3|Overall Study|Protocol Violation|0
1770003|NCT00734604|6164737|P2|Overall Study|Protocol Violation|2
1770004|NCT00734604|6164738|P1|Overall Study|Protocol Violation|0
1770005|NCT00734604|6164733|P6|Overall Study|Physician Decision|0
1770006|NCT00734604|6164734|P5|Overall Study|Physician Decision|0
1770007|NCT00734604|6164735|P4|Overall Study|Physician Decision|0
1770008|NCT00734604|6164736|P3|Overall Study|Physician Decision|1
1770009|NCT00734604|6164737|P2|Overall Study|Physician Decision|1
1770010|NCT00734604|6164738|P1|Overall Study|Physician Decision|0
1770011|NCT00734604|6164733|P6|Overall Study|Lost to Follow-up|3
1770012|NCT00734604|6164734|P5|Overall Study|Lost to Follow-up|2
1770013|NCT00734604|6164735|P4|Overall Study|Lost to Follow-up|4
1770014|NCT00734604|6164736|P3|Overall Study|Lost to Follow-up|2
1770015|NCT00734604|6164737|P2|Overall Study|Lost to Follow-up|2
1770016|NCT00734604|6164738|P1|Overall Study|Lost to Follow-up|1
1770017|NCT00734604|6164733|P6|Overall Study|Serious Adverse Event|1
1770018|NCT00734604|6164734|P5|Overall Study|Serious Adverse Event|0
1770019|NCT00734604|6164735|P4|Overall Study|Serious Adverse Event|2
1770020|NCT00734604|6164736|P3|Overall Study|Serious Adverse Event|1
1770021|NCT00734604|6164737|P2|Overall Study|Serious Adverse Event|0
1770022|NCT00734604|6164738|P1|Overall Study|Serious Adverse Event|1
1770023|NCT00734604|6164733|P6|Overall Study|Adverse Event|1
1770024|NCT00734604|6164734|P5|Overall Study|Adverse Event|1
1770025|NCT00734604|6164735|P4|Overall Study|Adverse Event|2
1770026|NCT00734604|6164736|P3|Overall Study|Adverse Event|0
1770027|NCT00734604|6164737|P2|Overall Study|Adverse Event|2
1770028|NCT00734604|6164738|P1|Overall Study|Adverse Event|0
1770029|NCT00734591|6164788|P2|Prospective Period|Other|2
1770030|NCT00734591|6164789|P1|Prospective Period|Other|2
1770031|NCT00734591|6164788|P2|Prospective Period|Study Terminated|0
1770032|NCT00734591|6164789|P1|Prospective Period|Study Terminated|1
1770033|NCT00734591|6164788|P2|Prospective Period|Lost to Follow-up|33
1770034|NCT00734591|6164789|P1|Prospective Period|Lost to Follow-up|37
1770035|NCT00734591|6164788|P2|Prospective Period|Withdrawal by Subject|9
1770036|NCT00734591|6164789|P1|Prospective Period|Withdrawal by Subject|11
1770037|NCT00734591|6164788|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
1770038|NCT00734591|6164789|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
1770039|NCT00734591|6164788|P2|Screening for Prospective Period|Site did not participate|1488
1770040|NCT00734591|6164789|P1|Screening for Prospective Period|Site did not participate|1604
1770041|NCT00734578|6164804|P3|Overall Study|Exclusion criteria|0
1770042|NCT00734578|6164805|P2|Overall Study|Exclusion criteria|0
1770043|NCT00734578|6164806|P1|Overall Study|Exclusion criteria|1
1770044|NCT00734578|6164804|P3|Overall Study|Randomized in error|0
1770045|NCT00734578|6164805|P2|Overall Study|Randomized in error|0
1770046|NCT00734578|6164806|P1|Overall Study|Randomized in error|1
1770047|NCT00734578|6164804|P3|Overall Study|Lack of Efficacy|5
1770048|NCT00734578|6164805|P2|Overall Study|Lack of Efficacy|2
1770049|NCT00734578|6164806|P1|Overall Study|Lack of Efficacy|3
1770050|NCT00734578|6164804|P3|Overall Study|Lost to Follow-up|5
1770051|NCT00734578|6164805|P2|Overall Study|Lost to Follow-up|3
1770052|NCT00734578|6164806|P1|Overall Study|Lost to Follow-up|9
1770053|NCT00734578|6164804|P3|Overall Study|Withdrawal by Subject|11
1770054|NCT00734578|6164805|P2|Overall Study|Withdrawal by Subject|8
1770055|NCT00734578|6164806|P1|Overall Study|Withdrawal by Subject|7
1770056|NCT00734578|6164804|P3|Overall Study|Protocol Violation|3
1770057|NCT00734578|6164805|P2|Overall Study|Protocol Violation|6
1770058|NCT00734578|6164806|P1|Overall Study|Protocol Violation|8
1770059|NCT00734578|6164804|P3|Overall Study|Adverse Event|1
1770060|NCT00734578|6164805|P2|Overall Study|Adverse Event|6
1770061|NCT00734578|6164806|P1|Overall Study|Adverse Event|4
1770062|NCT00734539|6164840|P2|Main Study|Enrolled in error; ineligible|0
1770063|NCT00734539|6164841|P1|Main Study|Enrolled in error; ineligible|1
1770064|NCT00734539|6164840|P2|Main Study|Withdrawal by Subject|3
1770065|NCT00734539|6164841|P1|Main Study|Withdrawal by Subject|1
1770066|NCT00734539|6164840|P2|Main Study|Physician Decision|0
1770067|NCT00734539|6164841|P1|Main Study|Physician Decision|2
1770068|NCT00734539|6164840|P2|Main Study|Death|32
1770069|NCT00734539|6164841|P1|Main Study|Death|33
1770070|NCT00734474|6164883|P9|Overall Study|Lack of Efficacy|6
1770071|NCT00734474|6164884|P8|Overall Study|Lack of Efficacy|4
1770072|NCT00734474|6164885|P7|Overall Study|Lack of Efficacy|0
1770073|NCT00734474|6164886|P6|Overall Study|Lack of Efficacy|0
1770074|NCT00734474|6164887|P5|Overall Study|Lack of Efficacy|0
1770075|NCT00734474|6164888|P4|Overall Study|Lack of Efficacy|0
1770076|NCT00734474|6164889|P3|Overall Study|Lack of Efficacy|4
1770077|NCT00734474|6164890|P2|Overall Study|Lack of Efficacy|0
1770078|NCT00734474|6164891|P1|Overall Study|Lack of Efficacy|0
1770079|NCT00734474|6164883|P9|Overall Study|Death|1
1770080|NCT00734474|6164884|P8|Overall Study|Death|2
1770081|NCT00734474|6164885|P7|Overall Study|Death|0
1770082|NCT00734474|6164886|P6|Overall Study|Death|0
1770083|NCT00734474|6164887|P5|Overall Study|Death|0
1770084|NCT00734474|6164888|P4|Overall Study|Death|0
1770085|NCT00734474|6164889|P3|Overall Study|Death|1
1770086|NCT00734474|6164890|P2|Overall Study|Death|0
1770087|NCT00734474|6164891|P1|Overall Study|Death|0
1770088|NCT00734474|6164883|P9|Overall Study|Sponsor Decision|0
1770089|NCT00734474|6164884|P8|Overall Study|Sponsor Decision|0
1770090|NCT00734474|6164885|P7|Overall Study|Sponsor Decision|0
1770091|NCT00734474|6164886|P6|Overall Study|Sponsor Decision|0
1770092|NCT00734474|6164887|P5|Overall Study|Sponsor Decision|2
1770093|NCT00734474|6164888|P4|Overall Study|Sponsor Decision|0
1770094|NCT00734474|6164889|P3|Overall Study|Sponsor Decision|0
1770095|NCT00734474|6164890|P2|Overall Study|Sponsor Decision|0
1770096|NCT00734474|6164891|P1|Overall Study|Sponsor Decision|0
1770097|NCT00734474|6164883|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
1770098|NCT00734474|6164884|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
1770099|NCT00734474|6164885|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
1770100|NCT00734474|6164886|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
1770101|NCT00734474|6164887|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
1770102|NCT00734474|6164888|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
1770103|NCT00734474|6164889|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
1770104|NCT00734474|6164890|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
1770105|NCT00734474|6164891|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
1770106|NCT00734474|6164883|P9|Overall Study|Protocol Violation|1
1770107|NCT00734474|6164884|P8|Overall Study|Protocol Violation|3
1770108|NCT00734474|6164885|P7|Overall Study|Protocol Violation|0
1770109|NCT00734474|6164886|P6|Overall Study|Protocol Violation|0
1770110|NCT00734474|6164887|P5|Overall Study|Protocol Violation|3
1770111|NCT00734474|6164888|P4|Overall Study|Protocol Violation|0
1770112|NCT00734474|6164889|P3|Overall Study|Protocol Violation|4
1770113|NCT00734474|6164890|P2|Overall Study|Protocol Violation|0
1770114|NCT00734474|6164891|P1|Overall Study|Protocol Violation|0
1770115|NCT00734474|6164883|P9|Overall Study|Adverse Event|39
1770116|NCT00734474|6164884|P8|Overall Study|Adverse Event|65
1770117|NCT00734474|6164885|P7|Overall Study|Adverse Event|1
1770118|NCT00734474|6164886|P6|Overall Study|Adverse Event|0
1770119|NCT00734474|6164887|P5|Overall Study|Adverse Event|64
1770120|NCT00734474|6164888|P4|Overall Study|Adverse Event|1
1770121|NCT00734474|6164889|P3|Overall Study|Adverse Event|63
1770122|NCT00734474|6164890|P2|Overall Study|Adverse Event|4
1770123|NCT00734474|6164891|P1|Overall Study|Adverse Event|4
1770124|NCT00734474|6164883|P9|Overall Study|Physician Decision|9
1770125|NCT00734474|6164884|P8|Overall Study|Physician Decision|9
1770126|NCT00734474|6164885|P7|Overall Study|Physician Decision|0
1770127|NCT00734474|6164886|P6|Overall Study|Physician Decision|0
1770128|NCT00734474|6164887|P5|Overall Study|Physician Decision|11
1770129|NCT00734474|6164888|P4|Overall Study|Physician Decision|1
1770130|NCT00734474|6164889|P3|Overall Study|Physician Decision|4
1770131|NCT00734474|6164890|P2|Overall Study|Physician Decision|0
1770132|NCT00734474|6164891|P1|Overall Study|Physician Decision|0
1770133|NCT00734474|6164883|P9|Overall Study|Withdrawal by Subject|21
1770134|NCT00734474|6164884|P8|Overall Study|Withdrawal by Subject|36
1770135|NCT00734474|6164885|P7|Overall Study|Withdrawal by Subject|0
1770136|NCT00734474|6164886|P6|Overall Study|Withdrawal by Subject|2
1770137|NCT00734474|6164887|P5|Overall Study|Withdrawal by Subject|24
1770138|NCT00734474|6164888|P4|Overall Study|Withdrawal by Subject|0
1770139|NCT00734474|6164889|P3|Overall Study|Withdrawal by Subject|18
1770140|NCT00734474|6164890|P2|Overall Study|Withdrawal by Subject|1
1770141|NCT00734474|6164891|P1|Overall Study|Withdrawal by Subject|2
1770142|NCT00734474|6164883|P9|Overall Study|Lost to Follow-up|4
1770143|NCT00734474|6164884|P8|Overall Study|Lost to Follow-up|9
1770144|NCT00734474|6164885|P7|Overall Study|Lost to Follow-up|0
1770145|NCT00734474|6164886|P6|Overall Study|Lost to Follow-up|1
1770146|NCT00734474|6164887|P5|Overall Study|Lost to Follow-up|11
1770147|NCT00734474|6164888|P4|Overall Study|Lost to Follow-up|0
1770148|NCT00734474|6164889|P3|Overall Study|Lost to Follow-up|13
1770149|NCT00734474|6164890|P2|Overall Study|Lost to Follow-up|0
1770150|NCT00734474|6164891|P1|Overall Study|Lost to Follow-up|1
1770151|NCT00734474|6164883|P9|Overall Study|Entry Criteria Not Met|1
1770152|NCT00734474|6164884|P8|Overall Study|Entry Criteria Not Met|1
1770153|NCT00734474|6164885|P7|Overall Study|Entry Criteria Not Met|0
1770154|NCT00734474|6164886|P6|Overall Study|Entry Criteria Not Met|1
1770155|NCT00734474|6164887|P5|Overall Study|Entry Criteria Not Met|3
1770156|NCT00734474|6164888|P4|Overall Study|Entry Criteria Not Met|0
1770157|NCT00734474|6164889|P3|Overall Study|Entry Criteria Not Met|5
1770158|NCT00734474|6164890|P2|Overall Study|Entry Criteria Not Met|0
1770159|NCT00734474|6164891|P1|Overall Study|Entry Criteria Not Met|0
1770160|NCT00734214|6165181|P2|Overall Study|MD withdrawal|0
1770161|NCT00734214|6165182|P1|Overall Study|MD withdrawal|1
1770162|NCT00734214|6165181|P2|Overall Study|Withdrawal by Subject|4
1770163|NCT00734214|6165182|P1|Overall Study|Withdrawal by Subject|3
1770164|NCT00734162|6165192|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
1770165|NCT00734162|6165193|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
1770166|NCT00734162|6165194|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
1770167|NCT00734162|6165195|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
1770168|NCT00734162|6165192|P4|Open-Label Phase|Lost to Follow-up|1
1770169|NCT00734162|6165193|P3|Open-Label Phase|Lost to Follow-up|0
1770170|NCT00734162|6165194|P2|Open-Label Phase|Lost to Follow-up|2
1770171|NCT00734162|6165195|P1|Open-Label Phase|Lost to Follow-up|1
1770172|NCT00734162|6165192|P4|Open-Label Phase|Withdrew Consent|1
1770173|NCT00734162|6165193|P3|Open-Label Phase|Withdrew Consent|1
1770174|NCT00734162|6165194|P2|Open-Label Phase|Withdrew Consent|0
1770175|NCT00734162|6165195|P1|Open-Label Phase|Withdrew Consent|1
1770176|NCT00734162|6165192|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1770177|NCT00734162|6165193|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1770178|NCT00734162|6165194|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
1770179|NCT00734162|6165195|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
1770180|NCT00734162|6165192|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
1770181|NCT00734162|6165193|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1770182|NCT00734162|6165194|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1770183|NCT00734162|6165195|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
1770184|NCT00734162|6165192|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
1770185|NCT00734162|6165193|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
1770186|NCT00734162|6165194|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
1770187|NCT00734162|6165195|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
1770188|NCT00734149|6165419|P1|Overall Study|Withdrawal by Subject|1
1770189|NCT00734097|6165426|P1|Open Label|Protocol Violation|4
1770190|NCT00734097|6165426|P1|Open Label|Withdrawal by Subject|5
1770191|NCT00734097|6165426|P1|Open Label|Lost to Follow-up|7
1770192|NCT00734097|6165426|P1|Screening|Unconfirmed pregnancy|1
1770193|NCT00734097|6165426|P1|Screening|Lost to Follow-up|2
1770194|NCT00734097|6165426|P1|Screening|Withdrawal by Subject|5
1770195|NCT00734097|6165426|P1|Screening|Protocol Violation|12
1770196|NCT00734071|6165443|P2|Overall Study|Other|2
1770197|NCT00734071|6165444|P1|Overall Study|Other|1
1770198|NCT00734071|6165443|P2|Overall Study|Lost to Follow-up|8
1770199|NCT00734071|6165444|P1|Overall Study|Lost to Follow-up|16
1770200|NCT00734071|6165443|P2|Overall Study|Voluntary Withdrawal|7
1770201|NCT00734071|6165444|P1|Overall Study|Voluntary Withdrawal|9
1770202|NCT00734071|6165443|P2|Overall Study|Protocol Deviations|4
1770203|NCT00734071|6165444|P1|Overall Study|Protocol Deviations|3
1770204|NCT00734071|6165443|P2|Overall Study|Noncompliance|2
1770205|NCT00734071|6165444|P1|Overall Study|Noncompliance|2
1770206|NCT00734071|6165443|P2|Overall Study|Lack of Efficacy|1
1770207|NCT00734071|6165444|P1|Overall Study|Lack of Efficacy|3
1770208|NCT00734071|6165443|P2|Overall Study|Adverse Event|3
1770209|NCT00734071|6165444|P1|Overall Study|Adverse Event|4
1770210|NCT00734032|6165502|P4|Overall Study|Adverse Event|0
1770211|NCT00734032|6165503|P3|Overall Study|Adverse Event|0
1770212|NCT00734032|6165504|P2|Overall Study|Adverse Event|1
1770213|NCT00734032|6165505|P1|Overall Study|Adverse Event|0
1770214|NCT00733980|6165561|P2|Overall Study|Withdrawal by Subject|2
1770215|NCT00733980|6165562|P1|Overall Study|Withdrawal by Subject|6
1770216|NCT00733980|6165561|P2|Overall Study|Physician Decision|3
1770217|NCT00733980|6165562|P1|Overall Study|Physician Decision|2
1770218|NCT00733980|6165561|P2|Overall Study|Lost to Follow-up|11
1770219|NCT00733980|6165562|P1|Overall Study|Lost to Follow-up|6
1770220|NCT00733980|6165561|P2|Overall Study|Protocol defined stopping criteria reach|1
1770221|NCT00733980|6165562|P1|Overall Study|Protocol defined stopping criteria reach|1
1770222|NCT00733980|6165561|P2|Overall Study|Protocol Violation|1
1770223|NCT00733980|6165562|P1|Overall Study|Protocol Violation|2
1770224|NCT00733980|6165561|P2|Overall Study|Lack of Efficacy|1
1770225|NCT00733980|6165562|P1|Overall Study|Lack of Efficacy|0
1770226|NCT00733980|6165561|P2|Overall Study|Adverse Event|2
1770227|NCT00733980|6165562|P1|Overall Study|Adverse Event|5
1770228|NCT00733954|6165606|P2|Overall Study|Withdrawal by Subject|0
1770229|NCT00733954|6165607|P1|Overall Study|Withdrawal by Subject|2
1770230|NCT00733954|6165606|P2|Overall Study|Protocol Violation|0
1770231|NCT00733954|6165607|P1|Overall Study|Protocol Violation|1
1770232|NCT00733954|6165606|P2|Overall Study|Lost to Follow-up|2
1770233|NCT00733954|6165607|P1|Overall Study|Lost to Follow-up|5
1770234|NCT00733824|6165654|P5|Phase I|Withdrawal by Subject|0
1770235|NCT00733824|6165655|P4|Phase I|Withdrawal by Subject|0
1770236|NCT00733824|6165656|P3|Phase I|Withdrawal by Subject|0
1770237|NCT00733824|6165657|P2|Phase I|Withdrawal by Subject|0
1770238|NCT00733824|6165658|P1|Phase I|Withdrawal by Subject|1
1770239|NCT00733746|6165677|P1|Overall Study|Ineligible|5
1770240|NCT00733499|6165692|P2|10 Year Followup|missing, unable to locate|2
1770241|NCT00733499|6165693|P1|10 Year Followup|missing, unable to locate|0
1770242|NCT00733499|6165692|P2|10 Year Followup|Withdrawal by Subject|5
1770243|NCT00733499|6165693|P1|10 Year Followup|Withdrawal by Subject|5
1770244|NCT00733499|6165692|P2|10 Year Followup|Lost to Follow-up|2
1770245|NCT00733499|6165693|P1|10 Year Followup|Lost to Follow-up|3
1770246|NCT00733499|6165692|P2|10 Year Followup|Adverse Event|3
1770247|NCT00733499|6165693|P1|10 Year Followup|Adverse Event|3
1770248|NCT00733499|6165692|P2|10 Year Followup|Death|7
1770249|NCT00733499|6165693|P1|10 Year Followup|Death|9
1770250|NCT00733499|6165692|P2|5 Year Followup|Withdrawal by Subject|1
1770251|NCT00733499|6165693|P1|5 Year Followup|Withdrawal by Subject|4
1770252|NCT00733499|6165692|P2|5 Year Followup|missing, unable to locate|1
1770253|NCT00733499|6165693|P1|5 Year Followup|missing, unable to locate|0
1770254|NCT00733499|6165692|P2|5 Year Followup|Death|19
1770255|NCT00733499|6165693|P1|5 Year Followup|Death|13
1770256|NCT00733499|6165692|P2|5 Year Followup|Lost to Follow-up|0
1770257|NCT00733499|6165693|P1|5 Year Followup|Lost to Follow-up|2
1770258|NCT00733499|6165692|P2|5 Year Followup|Revision of Study Implant|1
1770259|NCT00733499|6165693|P1|5 Year Followup|Revision of Study Implant|0
1770260|NCT00733499|6165692|P2|5 Year Followup|Non device related AE|1
1770261|NCT00733499|6165693|P1|5 Year Followup|Non device related AE|0
1770262|NCT00733499|6165692|P2|5 Year Followup|Adverse Event|2
1770263|NCT00733499|6165693|P1|5 Year Followup|Adverse Event|2
1770264|NCT00733499|6165692|P2|24 Months Follow-up|Death|1
1770265|NCT00733499|6165693|P1|24 Months Follow-up|Death|0
1770266|NCT00733499|6165692|P2|12 Months Follow-up|Death|1
1770267|NCT00733499|6165693|P1|12 Months Follow-up|Death|2
1770268|NCT00733499|6165692|P2|6 Months Follow-up|Adverse Event|1
1770269|NCT00733499|6165693|P1|6 Months Follow-up|Adverse Event|0
1770270|NCT00733499|6165692|P2|6 Months Follow-up|Death|2
1770271|NCT00733499|6165693|P1|6 Months Follow-up|Death|0
1770272|NCT00733499|6165692|P2|3 Months Follow-up|Death|2
1770273|NCT00733499|6165693|P1|3 Months Follow-up|Death|1
1770274|NCT00733499|6165692|P2|Pre-operative|Protocol Violation|1
1770275|NCT00733499|6165693|P1|Pre-operative|Protocol Violation|0
1770276|NCT00733421|6165753|P2|Overall Study|Withdrawal by Subject|1
1770277|NCT00733421|6165754|P1|Overall Study|Withdrawal by Subject|1
1770278|NCT00733408|6165776|P1|Overall Study|Adverse Event|4
1770279|NCT00733369|6165788|P2|Overall Study|Protocol Violation|4
1770280|NCT00733369|6165789|P1|Overall Study|Protocol Violation|4
1770281|NCT00733369|6165788|P2|Overall Study|Adverse Event|4
1770282|NCT00733369|6165789|P1|Overall Study|Adverse Event|4
1770283|NCT00733369|6165788|P2|Overall Study|Lost to Follow-up|1
1770284|NCT00733369|6165789|P1|Overall Study|Lost to Follow-up|2
1770285|NCT00733304|6165997|P3|Overall Study|Withdrawal by Subject|0
1770286|NCT00733304|6165998|P2|Overall Study|Withdrawal by Subject|1
1770287|NCT00733304|6165999|P1|Overall Study|Withdrawal by Subject|1
1770288|NCT00733304|6165997|P3|Overall Study|Physician Decision|3
1770289|NCT00733304|6165998|P2|Overall Study|Physician Decision|1
1770290|NCT00733304|6165999|P1|Overall Study|Physician Decision|3
1770291|NCT00733304|6165997|P3|Overall Study|Lost to Follow-up|0
1770292|NCT00733304|6165998|P2|Overall Study|Lost to Follow-up|1
1770293|NCT00733304|6165999|P1|Overall Study|Lost to Follow-up|0
1770294|NCT00733304|6165997|P3|Overall Study|Lack of Efficacy|2
1770295|NCT00733304|6165998|P2|Overall Study|Lack of Efficacy|0
1770296|NCT00733304|6165999|P1|Overall Study|Lack of Efficacy|0
1770297|NCT00733304|6165997|P3|Overall Study|Adverse Event|0
1770298|NCT00733304|6165998|P2|Overall Study|Adverse Event|0
1770299|NCT00733304|6165999|P1|Overall Study|Adverse Event|3
1770300|NCT00733291|6166081|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1770301|NCT00733291|6166082|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1770302|NCT00733291|6166083|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
1770303|NCT00733291|6166084|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
1770304|NCT00733226|6166113|P2|Overall Study|moved to another place|0
1770305|NCT00733226|6166114|P1|Overall Study|moved to another place|2
1770306|NCT00733226|6166113|P2|Overall Study|Lost to Follow-up|0
1770307|NCT00733226|6166114|P1|Overall Study|Lost to Follow-up|2
1770308|NCT00733226|6166113|P2|Overall Study|Withdrawal by Subject|0
1770309|NCT00733226|6166114|P1|Overall Study|Withdrawal by Subject|1
1770310|NCT00733005|6166163|P2|Overall Study|Protocol Violation|0
1770311|NCT00733005|6166164|P1|Overall Study|Protocol Violation|2
1770312|NCT00733005|6166163|P2|Overall Study|Withdrawal by Subject|1
1770313|NCT00733005|6166164|P1|Overall Study|Withdrawal by Subject|0
1770314|NCT00733005|6166163|P2|Overall Study|Treatment Failure|1
1770315|NCT00733005|6166164|P1|Overall Study|Treatment Failure|0
1770316|NCT00733005|6166163|P2|Overall Study|Adverse Event|1
1770317|NCT00733005|6166164|P1|Overall Study|Adverse Event|0
1770318|NCT00732992|6166174|P2|Overall Study|Withdrawal by Subject|0
1770319|NCT00732992|6166175|P1|Overall Study|Withdrawal by Subject|1
1770320|NCT00732992|6166174|P2|Overall Study|Global Deterioration of Health Status|0
1770321|NCT00732992|6166175|P1|Overall Study|Global Deterioration of Health Status|1
1770322|NCT00732992|6166174|P2|Overall Study|Objective Progression or Relapse|5
1770323|NCT00732992|6166175|P1|Overall Study|Objective Progression or Relapse|3
1770324|NCT00732992|6166174|P2|Overall Study|Adverse Event|1
1770325|NCT00732992|6166175|P1|Overall Study|Adverse Event|1
1770326|NCT00732940|6166194|P2|Overall Study|Lost to Follow-up|0
1770327|NCT00732940|6166195|P1|Overall Study|Lost to Follow-up|1
1770328|NCT00732940|6166194|P2|Overall Study|Adverse Event|1
1770329|NCT00732940|6166195|P1|Overall Study|Adverse Event|0
1770330|NCT00732940|6166194|P2|Overall Study|Withdrawal by Subject|2
1770331|NCT00732940|6166195|P1|Overall Study|Withdrawal by Subject|1
1770332|NCT00732875|6166276|P1|Overall Study|Lack of Efficacy|13
1770333|NCT00732875|6166276|P1|Overall Study|Withdrawal by Subject|6
1770334|NCT00732875|6166276|P1|Overall Study|Adverse Event|16
1770335|NCT00732758|6166284|P2|Overall Study|Lost to Follow-up|16
1770336|NCT00732758|6166285|P1|Overall Study|Lost to Follow-up|8
1770337|NCT00732641|6166325|P2|Overall Study|Other|5
1770338|NCT00732641|6166326|P1|Overall Study|Other|18
1770339|NCT00732641|6166325|P2|Overall Study|Unable to Complete|1
1770340|NCT00732641|6166326|P1|Overall Study|Unable to Complete|1
1770341|NCT00732641|6166325|P2|Overall Study|Withdrawal by Subject|2
1770342|NCT00732641|6166326|P1|Overall Study|Withdrawal by Subject|4
1770343|NCT00732641|6166325|P2|Overall Study|Physician Decision|0
1770344|NCT00732641|6166326|P1|Overall Study|Physician Decision|6
1770345|NCT00732641|6166325|P2|Overall Study|Serious Adverse Events|3
1770346|NCT00732641|6166326|P1|Overall Study|Serious Adverse Events|12
1770347|NCT00732641|6166325|P2|Overall Study|Relapse or Progressive Disease|101
1770348|NCT00732641|6166326|P1|Overall Study|Relapse or Progressive Disease|65
1770349|NCT00732615|6166346|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
1770350|NCT00732615|6166347|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
1770351|NCT00732615|6166346|P2|Overall Study|Physician Decision|0
1770352|NCT00732615|6166347|P1|Overall Study|Physician Decision|3
1770353|NCT00732615|6166346|P2|Overall Study|Adverse Event|2
1770354|NCT00732615|6166347|P1|Overall Study|Adverse Event|0
1770355|NCT00732615|6166346|P2|Overall Study|Lost to Follow-up|1
1770356|NCT00732615|6166347|P1|Overall Study|Lost to Follow-up|0
1770357|NCT00732615|6166346|P2|Overall Study|Withdrawal by Subject|1
1770358|NCT00732615|6166347|P1|Overall Study|Withdrawal by Subject|3
1770359|NCT00732498|6166359|P1|Overall Study|Physician Decision|3
1770360|NCT00732498|6166359|P1|Overall Study|Adverse Event|2
1770361|NCT00732498|6166359|P1|Overall Study|Ineligible|1
1770362|NCT00732472|6166370|P4|Overall Study|Withdrawal by Subject|1
1770363|NCT00732472|6166371|P3|Overall Study|Withdrawal by Subject|0
1770364|NCT00732472|6166372|P2|Overall Study|Withdrawal by Subject|2
1770365|NCT00732472|6166373|P1|Overall Study|Withdrawal by Subject|0
1770366|NCT00732472|6166370|P4|Overall Study|Protocol Violation|1
1770367|NCT00732472|6166371|P3|Overall Study|Protocol Violation|0
1770368|NCT00732472|6166372|P2|Overall Study|Protocol Violation|0
1770369|NCT00732472|6166373|P1|Overall Study|Protocol Violation|0
1770370|NCT00732472|6166370|P4|Overall Study|Adverse Event|1
1770371|NCT00732472|6166371|P3|Overall Study|Adverse Event|1
1770372|NCT00732472|6166372|P2|Overall Study|Adverse Event|1
1770373|NCT00732472|6166373|P1|Overall Study|Adverse Event|0
1770374|NCT00732381|6166473|P2|Overall Study|Treatment Failure|1
1770375|NCT00732381|6166474|P1|Overall Study|Treatment Failure|1
1770376|NCT00732381|6166473|P2|Overall Study|Adverse Event|0
1770377|NCT00732381|6166474|P1|Overall Study|Adverse Event|1
1770378|NCT00732303|6166482|P1|Overall Study|Study Terminated|2
1770379|NCT00732251|6166488|P1|Overall Study|Early Term due to Site Closure|1
1770380|NCT00732251|6166488|P1|Overall Study|Withdrawal by Subject|3
1770381|NCT00732251|6166488|P1|Overall Study|Lost to Follow-up|3
1770382|NCT00732238|6166496|P2|Overall Study|Asymptomatic bacteriuria|0
1770383|NCT00732238|6166497|P1|Overall Study|Asymptomatic bacteriuria|1
1770384|NCT00732238|6166496|P2|Overall Study|Bacteremia|1
1770385|NCT00732238|6166497|P1|Overall Study|Bacteremia|4
1770386|NCT00732199|6166598|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
1770387|NCT00732199|6166599|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
1770388|NCT00732199|6166598|P2|Overall Study|Withdrawal by Subject|18
1770389|NCT00732199|6166599|P1|Overall Study|Withdrawal by Subject|25
1770390|NCT00732160|6166614|P4|Overall Study|scheduling|1
1770391|NCT00732160|6166615|P3|Overall Study|scheduling|2
1770392|NCT00732160|6166616|P2|Overall Study|scheduling|4
1770393|NCT00732160|6166617|P1|Overall Study|scheduling|4
1770394|NCT00732160|6166614|P4|Overall Study|Adverse Event|1
1770395|NCT00732160|6166615|P3|Overall Study|Adverse Event|1
1770396|NCT00732160|6166616|P2|Overall Study|Adverse Event|0
1770397|NCT00732160|6166617|P1|Overall Study|Adverse Event|1
1770398|NCT00732069|6166631|P6|Washout After First Study Drug|Adverse Event|0
1770399|NCT00732069|6166632|P5|Washout After First Study Drug|Adverse Event|0
1770400|NCT00732069|6166633|P4|Washout After First Study Drug|Adverse Event|0
1770401|NCT00732069|6166634|P3|Washout After First Study Drug|Adverse Event|0
1770402|NCT00732069|6166635|P2|Washout After First Study Drug|Adverse Event|0
1770403|NCT00732069|6166636|P1|Washout After First Study Drug|Adverse Event|1
1770404|NCT00731939|6166654|P1|Overall Study|Did not meet enrollment criteria|2
1770405|NCT00731939|6166654|P1|Overall Study|Withdrawal by Subject|2
1770406|NCT00731939|6166654|P1|Overall Study|Not implanted with study device|9
1770407|NCT00731939|6166654|P1|Overall Study|Lost to Follow-up|15
1770408|NCT00731939|6166654|P1|Overall Study|Adverse Event|6
1770409|NCT00731822|6166731|P2|Overall Study|Lost to Follow-up|0
1770410|NCT00731822|6166732|P1|Overall Study|Lost to Follow-up|1
1770411|NCT00731822|6166731|P2|Overall Study|Protocol Violation|0
1770412|NCT00731822|6166732|P1|Overall Study|Protocol Violation|1
1770413|NCT00731822|6166731|P2|Overall Study|Adverse Event|1
1770414|NCT00731822|6166732|P1|Overall Study|Adverse Event|2
1770415|NCT00731783|6166746|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
1770416|NCT00731783|6166747|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
1770417|NCT00731783|6166746|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
1770418|NCT00731783|6166747|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
1770419|NCT00731783|6166746|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
1770420|NCT00731783|6166747|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
1770421|NCT00731783|6166746|P2|One Month Follow-Up Visit|Lost to Follow-up|22
1770422|NCT00731783|6166747|P1|One Month Follow-Up Visit|Lost to Follow-up|14
1770423|NCT00731731|6166781|P3|Overall Study|Cancel prior to treatment|2
1770424|NCT00731731|6166782|P2|Overall Study|Cancel prior to treatment|0
1770425|NCT00731731|6166783|P1|Overall Study|Cancel prior to treatment|0
1770426|NCT00731731|6166781|P3|Overall Study|Protocol Violation|1
1770427|NCT00731731|6166782|P2|Overall Study|Protocol Violation|0
1770428|NCT00731731|6166783|P1|Overall Study|Protocol Violation|0
1770429|NCT00731692|6166801|P3|Extension Phase|Adverse Event|15
1770430|NCT00731692|6166802|P2|Extension Phase|Adverse Event|1
1770431|NCT00731692|6166803|P1|Extension Phase|Adverse Event|1
1770432|NCT00731692|6166801|P3|Extension Phase|Withdrawal by Subject|3
1770433|NCT00731692|6166802|P2|Extension Phase|Withdrawal by Subject|5
1770434|NCT00731692|6166803|P1|Extension Phase|Withdrawal by Subject|4
1770435|NCT00731692|6166801|P3|Extension Phase|Lost to Follow-up|4
1770436|NCT00731692|6166802|P2|Extension Phase|Lost to Follow-up|1
1770437|NCT00731692|6166803|P1|Extension Phase|Lost to Follow-up|0
1770438|NCT00731692|6166801|P3|Extension Phase|Abnormal lab values|1
1770439|NCT00731692|6166802|P2|Extension Phase|Abnormal lab values|0
1770440|NCT00731692|6166803|P1|Extension Phase|Abnormal lab values|0
1770441|NCT00731692|6166801|P3|Extension Phase|Abnormal test procedure|1
1770442|NCT00731692|6166802|P2|Extension Phase|Abnormal test procedure|0
1770443|NCT00731692|6166803|P1|Extension Phase|Abnormal test procedure|0
1770444|NCT00731692|6166801|P3|Extension Phase|Admin Problems: Terminated # patients|277
1770445|NCT00731692|6166802|P2|Extension Phase|Admin Problems: Terminated # patients|189
1770446|NCT00731692|6166803|P1|Extension Phase|Admin Problems: Terminated # patients|69
1770447|NCT00731692|6166801|P3|Core Study (36 Months)|Withdrawal by Subject|46
1770448|NCT00731692|6166802|P2|Core Study (36 Months)|Withdrawal by Subject|32
1770449|NCT00731692|6166803|P1|Core Study (36 Months)|Withdrawal by Subject|12
1770450|NCT00731692|6166801|P3|Core Study (36 Months)|Adverse Event|29
1770451|NCT00731692|6166802|P2|Core Study (36 Months)|Adverse Event|28
1770452|NCT00731692|6166803|P1|Core Study (36 Months)|Adverse Event|25
1770453|NCT00731692|6166801|P3|Core Study (36 Months)|Abnormal Lab values|5
1770454|NCT00731692|6166802|P2|Core Study (36 Months)|Abnormal Lab values|19
1770455|NCT00731692|6166803|P1|Core Study (36 Months)|Abnormal Lab values|6
1770456|NCT00731692|6166801|P3|Core Study (36 Months)|Protocol Violation|8
1770457|NCT00731692|6166802|P2|Core Study (36 Months)|Protocol Violation|5
1770458|NCT00731692|6166803|P1|Core Study (36 Months)|Protocol Violation|4
1770459|NCT00731692|6166801|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
1770460|NCT00731692|6166802|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
1770461|NCT00731692|6166803|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
1770462|NCT00731692|6166801|P3|Core Study (36 Months)|Administrative|6
1770463|NCT00731692|6166802|P2|Core Study (36 Months)|Administrative|2
1770464|NCT00731692|6166803|P1|Core Study (36 Months)|Administrative|2
1770465|NCT00731692|6166801|P3|Core Study (36 Months)|Lost to Follow-up|3
1770466|NCT00731692|6166802|P2|Core Study (36 Months)|Lost to Follow-up|3
1770467|NCT00731692|6166803|P1|Core Study (36 Months)|Lost to Follow-up|1
1770468|NCT00731692|6166801|P3|Core Study (36 Months)|Death|2
1770469|NCT00731692|6166802|P2|Core Study (36 Months)|Death|1
1770470|NCT00731692|6166803|P1|Core Study (36 Months)|Death|2
1770471|NCT00731692|6166801|P3|Core Study (36 Months)|Physician Decision|2
1770472|NCT00731692|6166802|P2|Core Study (36 Months)|Physician Decision|0
1770473|NCT00731692|6166803|P1|Core Study (36 Months)|Physician Decision|1
1770474|NCT00731692|6166801|P3|Core Study (36 Months)|Lack of Efficacy|64
1770475|NCT00731692|6166802|P2|Core Study (36 Months)|Lack of Efficacy|23
1770476|NCT00731692|6166803|P1|Core Study (36 Months)|Lack of Efficacy|11
1770477|NCT00731679|6166849|P2|Overall Study|Pregnancy|1
1770478|NCT00731679|6166850|P1|Overall Study|Pregnancy|0
1770479|NCT00731679|6166849|P2|Overall Study|Noncompliance|1
1770480|NCT00731679|6166850|P1|Overall Study|Noncompliance|0
1770481|NCT00731679|6166849|P2|Overall Study|Lost to Follow-up|8
1770482|NCT00731679|6166850|P1|Overall Study|Lost to Follow-up|7
1770483|NCT00731679|6166849|P2|Overall Study|Withdrawal by Subject|8
1770484|NCT00731679|6166850|P1|Overall Study|Withdrawal by Subject|8
1770485|NCT00731679|6166849|P2|Overall Study|Adverse Event|8
1770486|NCT00731679|6166850|P1|Overall Study|Adverse Event|7
1770487|NCT00731666|6166858|P1|Overall Study|Withdrawal by Subject|2
1770488|NCT00731666|6166858|P1|Overall Study|Lost to Follow-up|8
1770489|NCT00731666|6166858|P1|Overall Study|Adverse Event|2
1770490|NCT00731549|6166894|P1|Overall Study|Lack of efficacy without AE|6
1770491|NCT00731549|6166894|P1|Overall Study|Lack of efficacy with AE|37
1770492|NCT00731549|6166894|P1|Overall Study|Adverse Event|31
1770493|NCT00731549|6166894|P1|Overall Study|Protocol deviation|1
1770494|NCT00731549|6166894|P1|Overall Study|Withdrawal by Subject|89
1770495|NCT00731549|6166894|P1|Overall Study|Physician Decision|16
1770496|NCT00731549|6166894|P1|Overall Study|Met withdrawal criteria|24
1770497|NCT00731549|6166894|P1|Overall Study|Lost to Follow-up|19
1770498|NCT00731133|6166934|P1|Overall Study|Withdrawal by Subject|10
1770499|NCT00731120|6166942|P3|Overall Study|Other|1
1770500|NCT00731120|6166943|P2|Overall Study|Other|0
1770501|NCT00731120|6166944|P1|Overall Study|Other|4
1770502|NCT00731120|6166942|P3|Overall Study|Lost to Follow-up|17
1770503|NCT00731120|6166943|P2|Overall Study|Lost to Follow-up|15
1770504|NCT00731120|6166944|P1|Overall Study|Lost to Follow-up|10
1770505|NCT00731120|6166942|P3|Overall Study|Withdrawal of Consent|4
1770506|NCT00731120|6166943|P2|Overall Study|Withdrawal of Consent|8
1770507|NCT00731120|6166944|P1|Overall Study|Withdrawal of Consent|13
1770508|NCT00731120|6166942|P3|Overall Study|Protocol Deviations|1
1770509|NCT00731120|6166943|P2|Overall Study|Protocol Deviations|6
1770510|NCT00731120|6166944|P1|Overall Study|Protocol Deviations|1
1770511|NCT00731120|6166942|P3|Overall Study|Noncompliance with Study Drug|1
1770512|NCT00731120|6166943|P2|Overall Study|Noncompliance with Study Drug|3
1770513|NCT00731120|6166944|P1|Overall Study|Noncompliance with Study Drug|3
1770514|NCT00731120|6166942|P3|Overall Study|Lack of Efficacy|4
1770515|NCT00731120|6166943|P2|Overall Study|Lack of Efficacy|5
1770516|NCT00731120|6166944|P1|Overall Study|Lack of Efficacy|4
1770517|NCT00731120|6166942|P3|Overall Study|Adverse Event|8
1770518|NCT00731120|6166943|P2|Overall Study|Adverse Event|6
1770519|NCT00731120|6166944|P1|Overall Study|Adverse Event|7
1770520|NCT00731042|6167061|P2|Second Intervention|Did not meet inclusion criteria|2
1770521|NCT00731042|6167062|P1|Second Intervention|Did not meet inclusion criteria|0
1770522|NCT00730925|6167073|P1|Overall Study|Other|1
1770523|NCT00730925|6167073|P1|Overall Study|Switch to combination therapy|8
1770524|NCT00730925|6167073|P1|Overall Study|Withdrawal by Subject|1
1770525|NCT00730925|6167073|P1|Overall Study|Protocol Violation|1
1770526|NCT00730925|6167073|P1|Overall Study|Other Averse Event|7
1770527|NCT00730925|6167073|P1|Overall Study|Dose reducing Event|2
1770528|NCT00730925|6167073|P1|Overall Study|Progressive Disease|21
1770529|NCT00730912|6167083|P3|Overall Study|Discontinued|1
1770530|NCT00730912|6167084|P2|Overall Study|Discontinued|0
1770531|NCT00730912|6167085|P1|Overall Study|Discontinued|0
1770532|NCT00730886|6167098|P2|Overall Study|Physician Decision|0
1770533|NCT00730886|6167099|P1|Overall Study|Physician Decision|1
1770534|NCT00730886|6167098|P2|Overall Study|Lost to Follow-up|0
1770535|NCT00730886|6167099|P1|Overall Study|Lost to Follow-up|1
1770536|NCT00730847|6167123|P1|Overall Study|Other|24
1770537|NCT00730847|6167123|P1|Overall Study|Unknown completion status|21
1770538|NCT00730847|6167123|P1|Overall Study|Lost to Follow-up|67
1770539|NCT00730847|6167123|P1|Overall Study|Withdrawal by Subject|16
1770540|NCT00730847|6167123|P1|Overall Study|Protocol Violation|2
1770541|NCT00730847|6167123|P1|Overall Study|Adverse Event|1
1770542|NCT00730756|6167132|P2|Overall Study|Withdrew Consent|1
1770543|NCT00730756|6167133|P1|Overall Study|Withdrew Consent|0
1770544|NCT00730756|6167132|P2|Overall Study|Lost to Follow-up|1
1770545|NCT00730756|6167133|P1|Overall Study|Lost to Follow-up|0
1770546|NCT00730756|6167132|P2|Overall Study|Protocol Deviation|2
1770547|NCT00730756|6167133|P1|Overall Study|Protocol Deviation|1
1770548|NCT00730756|6167132|P2|Overall Study|Lack of Efficacy|1
1770549|NCT00730756|6167133|P1|Overall Study|Lack of Efficacy|1
1770550|NCT00730756|6167132|P2|Overall Study|Adverse Event|0
1770551|NCT00730756|6167133|P1|Overall Study|Adverse Event|2
1770552|NCT00730691|6167167|P5|Overall Study|Other|2
1770553|NCT00730691|6167168|P4|Overall Study|Other|2
1770554|NCT00730691|6167169|P3|Overall Study|Other|1
1770555|NCT00730691|6167170|P2|Overall Study|Other|1
1770556|NCT00730691|6167171|P1|Overall Study|Other|1
1770557|NCT00730691|6167167|P5|Overall Study|Lost to Follow-up|13
1770558|NCT00730691|6167168|P4|Overall Study|Lost to Follow-up|15
1770559|NCT00730691|6167169|P3|Overall Study|Lost to Follow-up|13
1770560|NCT00730691|6167170|P2|Overall Study|Lost to Follow-up|8
1770561|NCT00730691|6167171|P1|Overall Study|Lost to Follow-up|11
1770562|NCT00730691|6167167|P5|Overall Study|Withdrawal of Consent|3
1770563|NCT00730691|6167168|P4|Overall Study|Withdrawal of Consent|6
1770564|NCT00730691|6167169|P3|Overall Study|Withdrawal of Consent|3
1770565|NCT00730691|6167170|P2|Overall Study|Withdrawal of Consent|9
1770566|NCT00730691|6167171|P1|Overall Study|Withdrawal of Consent|7
1770567|NCT00730691|6167167|P5|Overall Study|Protocol Deviations|5
1770568|NCT00730691|6167168|P4|Overall Study|Protocol Deviations|7
1770569|NCT00730691|6167169|P3|Overall Study|Protocol Deviations|3
1770570|NCT00730691|6167170|P2|Overall Study|Protocol Deviations|5
1770571|NCT00730691|6167171|P1|Overall Study|Protocol Deviations|3
1770572|NCT00730691|6167167|P5|Overall Study|Non-compliance with Study Drug|3
1770573|NCT00730691|6167168|P4|Overall Study|Non-compliance with Study Drug|3
1770574|NCT00730691|6167169|P3|Overall Study|Non-compliance with Study Drug|6
1770575|NCT00730691|6167170|P2|Overall Study|Non-compliance with Study Drug|1
1770576|NCT00730691|6167171|P1|Overall Study|Non-compliance with Study Drug|6
1770577|NCT00730691|6167167|P5|Overall Study|Lack of Efficacy|1
1770578|NCT00730691|6167168|P4|Overall Study|Lack of Efficacy|1
1770579|NCT00730691|6167169|P3|Overall Study|Lack of Efficacy|2
1770580|NCT00730691|6167170|P2|Overall Study|Lack of Efficacy|4
1770581|NCT00730691|6167171|P1|Overall Study|Lack of Efficacy|4
1770582|NCT00730691|6167167|P5|Overall Study|Adverse Event|23
1770583|NCT00730691|6167168|P4|Overall Study|Adverse Event|11
1770584|NCT00730691|6167169|P3|Overall Study|Adverse Event|11
1770585|NCT00730691|6167170|P2|Overall Study|Adverse Event|8
1770586|NCT00730691|6167171|P1|Overall Study|Adverse Event|4
1770587|NCT00730639|6167263|P5|Overall Study|Treatment on-going|4
1770588|NCT00730639|6167264|P4|Overall Study|Treatment on-going|4
1770589|NCT00730639|6167265|P3|Overall Study|Treatment on-going|5
1770590|NCT00730639|6167266|P2|Overall Study|Treatment on-going|5
1770591|NCT00730639|6167267|P1|Overall Study|Treatment on-going|2
1770592|NCT00730639|6167263|P5|Overall Study|Withdrawal by Subject|4
1770593|NCT00730639|6167264|P4|Overall Study|Withdrawal by Subject|3
1770594|NCT00730639|6167265|P3|Overall Study|Withdrawal by Subject|6
1770595|NCT00730639|6167266|P2|Overall Study|Withdrawal by Subject|0
1770596|NCT00730639|6167267|P1|Overall Study|Withdrawal by Subject|0
1770597|NCT00730639|6167263|P5|Overall Study|Protocol Violation|0
1770598|NCT00730639|6167264|P4|Overall Study|Protocol Violation|0
1770599|NCT00730639|6167265|P3|Overall Study|Protocol Violation|1
1770600|NCT00730639|6167266|P2|Overall Study|Protocol Violation|0
1770601|NCT00730639|6167267|P1|Overall Study|Protocol Violation|0
1770602|NCT00730639|6167263|P5|Overall Study|non-specified|3
1770603|NCT00730639|6167264|P4|Overall Study|non-specified|2
1770604|NCT00730639|6167265|P3|Overall Study|non-specified|4
1770605|NCT00730639|6167266|P2|Overall Study|non-specified|0
1770606|NCT00730639|6167267|P1|Overall Study|non-specified|0
1770607|NCT00730639|6167263|P5|Overall Study|Disease Progression|88
1770608|NCT00730639|6167264|P4|Overall Study|Disease Progression|32
1770609|NCT00730639|6167265|P3|Overall Study|Disease Progression|48
1770610|NCT00730639|6167266|P2|Overall Study|Disease Progression|13
1770611|NCT00730639|6167267|P1|Overall Study|Disease Progression|12
1770612|NCT00730639|6167263|P5|Overall Study|Death|2
1770613|NCT00730639|6167264|P4|Overall Study|Death|0
1770614|NCT00730639|6167265|P3|Overall Study|Death|0
1770615|NCT00730639|6167266|P2|Overall Study|Death|0
1770616|NCT00730639|6167267|P1|Overall Study|Death|0
1770617|NCT00730639|6167263|P5|Overall Study|Completed Maximum Cycles|6
1770618|NCT00730639|6167264|P4|Overall Study|Completed Maximum Cycles|3
1770619|NCT00730639|6167265|P3|Overall Study|Completed Maximum Cycles|11
1770620|NCT00730639|6167266|P2|Overall Study|Completed Maximum Cycles|0
1770621|NCT00730639|6167267|P1|Overall Study|Completed Maximum Cycles|0
1770622|NCT00730639|6167263|P5|Overall Study|Complete Response|1
1770623|NCT00730639|6167264|P4|Overall Study|Complete Response|2
1770624|NCT00730639|6167265|P3|Overall Study|Complete Response|2
1770625|NCT00730639|6167266|P2|Overall Study|Complete Response|0
1770626|NCT00730639|6167267|P1|Overall Study|Complete Response|0
1770627|NCT00730639|6167263|P5|Overall Study|Adverse Event|23
1770628|NCT00730639|6167264|P4|Overall Study|Adverse Event|8
1770629|NCT00730639|6167265|P3|Overall Study|Adverse Event|9
1770630|NCT00730639|6167266|P2|Overall Study|Adverse Event|0
1770631|NCT00730639|6167267|P1|Overall Study|Adverse Event|3
1770632|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
1770633|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
1770634|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
1770635|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
1770636|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
1770637|NCT00730405|6167344|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1770638|NCT00730405|6167345|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
1770639|NCT00730405|6167346|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1770640|NCT00730405|6167347|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1770641|NCT00730405|6167348|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
1770642|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Other Protocol violation|0
1770643|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Other Protocol violation|0
1770644|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Other Protocol violation|1
1770645|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Other Protocol violation|0
1770646|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Other Protocol violation|0
1770647|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Mis-randomized|0
1770648|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Mis-randomized|0
1770649|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Mis-randomized|0
1770650|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Mis-randomized|1
1770651|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Mis-randomized|0
1770652|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1770653|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1770654|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
1770655|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1770656|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
1770657|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
1770658|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
1770659|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
1770660|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
1770661|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
1770662|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Missing|0
1770663|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Missing|0
1770664|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Missing|2
1770665|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Missing|0
1770666|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Missing|0
1770667|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Non-compliance|0
1770668|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Non-compliance|0
1770669|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Non-compliance|2
1770670|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Non-compliance|0
1770671|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Non-compliance|1
1770672|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Use of restricted medication|0
1770673|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Use of restricted medication|0
1770674|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Use of restricted medication|0
1770675|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Use of restricted medication|1
1770676|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Use of restricted medication|0
1770677|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1770678|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1770679|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
1770680|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
1770681|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
1770682|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1770683|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1770684|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
1770685|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
1770686|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
1770687|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1770688|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
1770689|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1770690|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1770691|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
1770692|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1770693|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1770694|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1770695|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
1770696|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
1770697|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
1770698|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1770699|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1770700|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1770701|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
1770702|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1770703|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1770704|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
1770705|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1770706|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
1770707|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1770708|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1770709|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
1770710|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1770711|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
1770712|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Did not met eligibility|0
1770713|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Did not met eligibility|0
1770714|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Did not met eligibility|1
1770715|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Did not met eligibility|0
1770716|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Did not met eligibility|0
1770717|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Change of location|0
1770718|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Change of location|1
1770719|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Change of location|0
1770720|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Change of location|1
1770721|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Change of location|1
1770722|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Death|0
1770723|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Death|1
1770724|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Death|0
1770725|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Death|1
1770726|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Death|0
1770727|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
1770728|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
1770729|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
1770730|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
1770731|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
1770732|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
1770733|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
1770734|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
1770735|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
1770736|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
1770737|NCT00730405|6167344|P5|Overall Study-follow-up Phase|Adverse Event|4
1770738|NCT00730405|6167345|P4|Overall Study-follow-up Phase|Adverse Event|3
1770739|NCT00730405|6167346|P3|Overall Study-follow-up Phase|Adverse Event|2
1770740|NCT00730405|6167347|P2|Overall Study-follow-up Phase|Adverse Event|6
1770741|NCT00730405|6167348|P1|Overall Study-follow-up Phase|Adverse Event|2
1770742|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
1770743|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
1770744|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
1770745|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
1770746|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
1770747|NCT00730405|6167344|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
1770748|NCT00730405|6167345|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1770749|NCT00730405|6167346|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1770750|NCT00730405|6167347|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1770751|NCT00730405|6167348|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
1770752|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Pregnancy|0
1770753|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Pregnancy|0
1770754|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Pregnancy|0
1770755|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Pregnancy|1
1770756|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Pregnancy|0
1770757|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Change of location|0
1770758|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Change of location|1
1770759|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Change of location|0
1770760|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Change of location|0
1770761|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Change of location|0
1770762|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1770763|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1770764|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
1770765|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1770766|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
1770767|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1770768|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
1770769|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1770770|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1770771|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
1770772|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Study drug interrupted|0
1770773|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Study drug interrupted|0
1770774|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Study drug interrupted|0
1770775|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Study drug interrupted|1
1770776|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Study drug interrupted|0
1770777|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Misrandomized|0
1770778|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Misrandomized|0
1770779|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Misrandomized|0
1770780|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Misrandomized|1
1770781|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Misrandomized|0
1770782|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1770783|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1770784|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
1770785|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1770786|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
1770787|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
1770788|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
1770789|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
1770790|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
1770791|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
1770792|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
1770793|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
1770794|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
1770795|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
1770796|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
1770797|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1770798|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1770799|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1770800|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
1770801|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
1770802|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
1770803|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
1770804|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
1770805|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
1770806|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
1770807|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Did not met eligibility|0
1770808|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Did not met eligibility|0
1770809|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Did not met eligibility|1
1770810|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Did not met eligibility|0
1770811|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Did not met eligibility|0
1770812|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
1770813|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
1770814|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
1770815|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
1770816|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
1770817|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
1770818|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
1770819|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
1770820|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
1770821|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
1770822|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
1770823|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
1770824|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
1770825|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
1770826|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
1770827|NCT00730405|6167344|P5|Overall Study-Treatment Phase|Adverse Event|4
1770828|NCT00730405|6167345|P4|Overall Study-Treatment Phase|Adverse Event|8
1770829|NCT00730405|6167346|P3|Overall Study-Treatment Phase|Adverse Event|4
1770830|NCT00730405|6167347|P2|Overall Study-Treatment Phase|Adverse Event|10
1770831|NCT00730405|6167348|P1|Overall Study-Treatment Phase|Adverse Event|5
1770832|NCT00730327|6167395|P2|Overall Study|Subject withdrew (reason not specified)|7
1770833|NCT00730327|6167396|P1|Overall Study|Subject withdrew (reason not specified)|2
1770834|NCT00730327|6167395|P2|Overall Study|Withdrawal by Subject|13
1770835|NCT00730327|6167396|P1|Overall Study|Withdrawal by Subject|3
1770836|NCT00730327|6167395|P2|Overall Study|Adverse Event|1
1770837|NCT00730327|6167396|P1|Overall Study|Adverse Event|8
1770838|NCT00730327|6167395|P2|Overall Study|Lost to Follow-up|16
1770839|NCT00730327|6167396|P1|Overall Study|Lost to Follow-up|14
1770840|NCT00730275|6167421|P4|Overall Study|Withdrawal by Subject|1
1770841|NCT00730275|6167422|P3|Overall Study|Withdrawal by Subject|0
1770842|NCT00730275|6167423|P2|Overall Study|Withdrawal by Subject|0
1770843|NCT00730275|6167424|P1|Overall Study|Withdrawal by Subject|0
1770844|NCT00730236|6167450|P1|Overall Study|Non-compliance|1
1770845|NCT00730236|6167450|P1|Overall Study|Withdrawal by Subject|1
1770846|NCT00730236|6167450|P1|Overall Study|Adverse Event|4
1770847|NCT00730171|6167465|P1|Overall Study|Other|61
1770848|NCT00730171|6167465|P1|Overall Study|Insufficient Therapeutic Response|141
1770849|NCT00730171|6167465|P1|Overall Study|Lost to Follow-up|121
1770850|NCT00730171|6167465|P1|Overall Study|Withdrawal by Subject|202
1770851|NCT00730171|6167465|P1|Overall Study|Protocol Violation|48
1770852|NCT00730171|6167465|P1|Overall Study|Adverse Event|193
1770853|NCT00730171|6167465|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
1770854|NCT00730158|6167475|P2|Overall Study|Withdrawal by Subject|1
1770855|NCT00730158|6167476|P1|Overall Study|Withdrawal by Subject|1
1770856|NCT00730132|6167514|P1|Overall Study|Death|1
1770857|NCT00730132|6167514|P1|Overall Study|Protocol Violation|154
1770858|NCT00730041|6167532|P2|Overall Study|Lost to Follow-up|2
1770859|NCT00730041|6167533|P1|Overall Study|Lost to Follow-up|0
1770860|NCT00730028|6167556|P5|Overall Study|Randomization Error|2
1770861|NCT00730028|6167557|P4|Overall Study|Randomization Error|0
1770862|NCT00730028|6167558|P3|Overall Study|Randomization Error|0
1770863|NCT00730028|6167559|P2|Overall Study|Randomization Error|0
1770864|NCT00730028|6167560|P1|Overall Study|Randomization Error|1
1770865|NCT00730028|6167556|P5|Overall Study|Treatment Failure|1
1770866|NCT00730028|6167557|P4|Overall Study|Treatment Failure|0
1770867|NCT00730028|6167558|P3|Overall Study|Treatment Failure|0
1770868|NCT00730028|6167559|P2|Overall Study|Treatment Failure|5
1770869|NCT00730028|6167560|P1|Overall Study|Treatment Failure|5
1770870|NCT00730028|6167556|P5|Overall Study|Physician Decision|2
1770871|NCT00730028|6167557|P4|Overall Study|Physician Decision|3
1770872|NCT00730028|6167558|P3|Overall Study|Physician Decision|2
1770873|NCT00730028|6167559|P2|Overall Study|Physician Decision|3
1770874|NCT00730028|6167560|P1|Overall Study|Physician Decision|3
1770875|NCT00730028|6167556|P5|Overall Study|Withdrawal by Subject|9
1770876|NCT00730028|6167557|P4|Overall Study|Withdrawal by Subject|5
1770877|NCT00730028|6167558|P3|Overall Study|Withdrawal by Subject|4
1770878|NCT00730028|6167559|P2|Overall Study|Withdrawal by Subject|5
1770879|NCT00730028|6167560|P1|Overall Study|Withdrawal by Subject|9
1770880|NCT00730028|6167556|P5|Overall Study|Protocol Violation|0
1770881|NCT00730028|6167557|P4|Overall Study|Protocol Violation|2
1770882|NCT00730028|6167558|P3|Overall Study|Protocol Violation|1
1770883|NCT00730028|6167559|P2|Overall Study|Protocol Violation|1
1770884|NCT00730028|6167560|P1|Overall Study|Protocol Violation|6
1770885|NCT00730028|6167556|P5|Overall Study|Lost to Follow-up|25
1770886|NCT00730028|6167557|P4|Overall Study|Lost to Follow-up|26
1770887|NCT00730028|6167558|P3|Overall Study|Lost to Follow-up|22
1770888|NCT00730028|6167559|P2|Overall Study|Lost to Follow-up|26
1770889|NCT00730028|6167560|P1|Overall Study|Lost to Follow-up|13
1770890|NCT00730028|6167556|P5|Overall Study|Adverse Event|43
1770891|NCT00730028|6167557|P4|Overall Study|Adverse Event|20
1770892|NCT00730028|6167558|P3|Overall Study|Adverse Event|16
1770893|NCT00730028|6167559|P2|Overall Study|Adverse Event|26
1770894|NCT00730028|6167560|P1|Overall Study|Adverse Event|23
1770895|NCT00730015|6167610|P3|Overall Study|Other Reason|1
1770896|NCT00730015|6167611|P2|Overall Study|Other Reason|0
1770897|NCT00730015|6167612|P1|Overall Study|Other Reason|1
1770898|NCT00730015|6167610|P3|Overall Study|Lack of Efficacy|8
1770899|NCT00730015|6167611|P2|Overall Study|Lack of Efficacy|2
1770900|NCT00730015|6167612|P1|Overall Study|Lack of Efficacy|1
1770901|NCT00730015|6167610|P3|Overall Study|Lost to Follow-up|3
1770902|NCT00730015|6167611|P2|Overall Study|Lost to Follow-up|10
1770903|NCT00730015|6167612|P1|Overall Study|Lost to Follow-up|4
1770904|NCT00730015|6167610|P3|Overall Study|Withdrawal by Subject|8
1770905|NCT00730015|6167611|P2|Overall Study|Withdrawal by Subject|12
1770906|NCT00730015|6167612|P1|Overall Study|Withdrawal by Subject|12
1770907|NCT00730015|6167610|P3|Overall Study|Protocol Violation|4
1770908|NCT00730015|6167611|P2|Overall Study|Protocol Violation|6
1770909|NCT00730015|6167612|P1|Overall Study|Protocol Violation|2
1770910|NCT00730015|6167610|P3|Overall Study|Adverse Event|8
1770911|NCT00730015|6167611|P2|Overall Study|Adverse Event|10
1770912|NCT00730015|6167612|P1|Overall Study|Adverse Event|11
1770913|NCT00729937|6167652|P6|Overall Study|Incarcerated|0
1770914|NCT00729937|6167653|P5|Overall Study|Incarcerated|0
1770915|NCT00729937|6167654|P4|Overall Study|Incarcerated|1
1770916|NCT00729937|6167655|P3|Overall Study|Incarcerated|1
1770917|NCT00729937|6167656|P2|Overall Study|Incarcerated|2
1770918|NCT00729937|6167657|P1|Overall Study|Incarcerated|0
1770919|NCT00729937|6167652|P6|Overall Study|Did not meet eligibility criteria|0
1770920|NCT00729937|6167653|P5|Overall Study|Did not meet eligibility criteria|0
1770921|NCT00729937|6167654|P4|Overall Study|Did not meet eligibility criteria|0
1770922|NCT00729937|6167655|P3|Overall Study|Did not meet eligibility criteria|0
1770923|NCT00729937|6167656|P2|Overall Study|Did not meet eligibility criteria|1
1770924|NCT00729937|6167657|P1|Overall Study|Did not meet eligibility criteria|2
1770925|NCT00729937|6167652|P6|Overall Study|Randomized but not treated|3
1770926|NCT00729937|6167653|P5|Overall Study|Randomized but not treated|1
1770927|NCT00729937|6167654|P4|Overall Study|Randomized but not treated|0
1770928|NCT00729937|6167655|P3|Overall Study|Randomized but not treated|1
1770929|NCT00729937|6167656|P2|Overall Study|Randomized but not treated|6
1770930|NCT00729937|6167657|P1|Overall Study|Randomized but not treated|12
1770931|NCT00729937|6167652|P6|Overall Study|Withdrawal by Subject|2
1770932|NCT00729937|6167653|P5|Overall Study|Withdrawal by Subject|4
1770933|NCT00729937|6167654|P4|Overall Study|Withdrawal by Subject|0
1770934|NCT00729937|6167655|P3|Overall Study|Withdrawal by Subject|6
1770935|NCT00729937|6167656|P2|Overall Study|Withdrawal by Subject|5
1770936|NCT00729937|6167657|P1|Overall Study|Withdrawal by Subject|3
1770937|NCT00729937|6167652|P6|Overall Study|Death|1
1770938|NCT00729937|6167653|P5|Overall Study|Death|0
1770939|NCT00729937|6167654|P4|Overall Study|Death|0
1770940|NCT00729937|6167655|P3|Overall Study|Death|1
1770941|NCT00729937|6167656|P2|Overall Study|Death|0
1770942|NCT00729937|6167657|P1|Overall Study|Death|1
1770943|NCT00729937|6167652|P6|Overall Study|Physician Decision|8
1770944|NCT00729937|6167653|P5|Overall Study|Physician Decision|5
1770945|NCT00729937|6167654|P4|Overall Study|Physician Decision|0
1770946|NCT00729937|6167655|P3|Overall Study|Physician Decision|2
1770947|NCT00729937|6167656|P2|Overall Study|Physician Decision|16
1770948|NCT00729937|6167657|P1|Overall Study|Physician Decision|7
1770949|NCT00729937|6167652|P6|Overall Study|Lost to Follow-up|23
1770950|NCT00729937|6167653|P5|Overall Study|Lost to Follow-up|18
1770951|NCT00729937|6167654|P4|Overall Study|Lost to Follow-up|33
1770952|NCT00729937|6167655|P3|Overall Study|Lost to Follow-up|18
1770953|NCT00729937|6167656|P2|Overall Study|Lost to Follow-up|58
1770954|NCT00729937|6167657|P1|Overall Study|Lost to Follow-up|49
1770955|NCT00729859|6167861|P3|Overall Study|Withdrawal by Subject|0
1770956|NCT00729859|6167862|P2|Overall Study|Withdrawal by Subject|1
1770957|NCT00729859|6167863|P1|Overall Study|Withdrawal by Subject|0
1770958|NCT00729859|6167861|P3|Overall Study|Adverse Event|0
1770959|NCT00729859|6167862|P2|Overall Study|Adverse Event|1
1770960|NCT00729859|6167863|P1|Overall Study|Adverse Event|0
1770961|NCT00729833|6167907|P4|Overall Study|Unspecified Reasons|1
1770962|NCT00729833|6167908|P3|Overall Study|Unspecified Reasons|5
1770963|NCT00729833|6167909|P2|Overall Study|Unspecified Reasons|5
1770964|NCT00729833|6167910|P1|Overall Study|Unspecified Reasons|11
1770965|NCT00729833|6167907|P4|Overall Study|Withdrawal by Subject|0
1770966|NCT00729833|6167908|P3|Overall Study|Withdrawal by Subject|3
1770967|NCT00729833|6167909|P2|Overall Study|Withdrawal by Subject|1
1770968|NCT00729833|6167910|P1|Overall Study|Withdrawal by Subject|3
1770969|NCT00729833|6167907|P4|Overall Study|Lost to Follow-up|0
1770970|NCT00729833|6167908|P3|Overall Study|Lost to Follow-up|0
1770971|NCT00729833|6167909|P2|Overall Study|Lost to Follow-up|0
1770972|NCT00729833|6167910|P1|Overall Study|Lost to Follow-up|1
1770973|NCT00729833|6167907|P4|Overall Study|Study Terminated by Sponsor|0
1770974|NCT00729833|6167908|P3|Overall Study|Study Terminated by Sponsor|1
1770975|NCT00729833|6167909|P2|Overall Study|Study Terminated by Sponsor|0
1770976|NCT00729833|6167910|P1|Overall Study|Study Terminated by Sponsor|0
1770977|NCT00729833|6167907|P4|Overall Study|Death|5
1770978|NCT00729833|6167908|P3|Overall Study|Death|3
1770979|NCT00729833|6167909|P2|Overall Study|Death|1
1770980|NCT00729833|6167910|P1|Overall Study|Death|5
1770981|NCT00729690|6167968|P3|Overall Study|IT Catheter Malfunction|2
1770982|NCT00729690|6167969|P2|Overall Study|IT Catheter Malfunction|2
1770983|NCT00729690|6167970|P1|Overall Study|IT Catheter Malfunction|0
1770984|NCT00729651|6168000|P2|Overall Study|Subject’s private reason|0
1770985|NCT00729651|6168001|P1|Overall Study|Subject’s private reason|2
1770986|NCT00729651|6168000|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
1770987|NCT00729651|6168001|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
1770988|NCT00729651|6168000|P2|Overall Study|Adverse Event|3
1770989|NCT00729651|6168001|P1|Overall Study|Adverse Event|7
1770990|NCT00729651|6168000|P2|Overall Study|Protocol Violation|1
1770991|NCT00729651|6168001|P1|Overall Study|Protocol Violation|0
1770992|NCT00729651|6168000|P2|Overall Study|Lost to Follow-up|4
1770993|NCT00729651|6168001|P1|Overall Study|Lost to Follow-up|5
1770994|NCT00729651|6168000|P2|Overall Study|Withdrawal by Subject|6
1770995|NCT00729651|6168001|P1|Overall Study|Withdrawal by Subject|5
1770996|NCT00729612|6168013|P1|Overall Study|Non evaluable for response|10
1770997|NCT00729586|6168022|P2|Overall Study|never treated|0
1770998|NCT00729586|6168023|P1|Overall Study|never treated|1
1770999|NCT00729586|6168022|P2|Overall Study|Ineligible|1
1771000|NCT00729586|6168023|P1|Overall Study|Ineligible|0
1771001|NCT00729560|6168036|P1|Overall Study|Withdrawal by Subject|3
1771002|NCT00729469|6168062|P2|Overall Study|Other-Not mentioned|4
1771003|NCT00729469|6168063|P1|Overall Study|Other-Not mentioned|9
1771004|NCT00729469|6168062|P2|Overall Study|Withdrawal by Subject|8
1771005|NCT00729469|6168063|P1|Overall Study|Withdrawal by Subject|19
1771006|NCT00729469|6168062|P2|Overall Study|Protocol Violation|1
1771007|NCT00729469|6168063|P1|Overall Study|Protocol Violation|2
1771008|NCT00729469|6168062|P2|Overall Study|Lost to Follow-up|9
1771009|NCT00729469|6168063|P1|Overall Study|Lost to Follow-up|9
1771010|NCT00729469|6168062|P2|Overall Study|Adverse Event|25
1771011|NCT00729469|6168063|P1|Overall Study|Adverse Event|14
1771012|NCT00729378|6168116|P2|36-months|Lost to Follow-up|6
1771013|NCT00729378|6168117|P1|36-months|Lost to Follow-up|15
1771014|NCT00729378|6168116|P2|24-months|Lost to Follow-up|51
1771015|NCT00729378|6168117|P1|24-months|Lost to Follow-up|72
1771016|NCT00729378|6168116|P2|12-months|Lost to Follow-up|65
1771017|NCT00729378|6168117|P1|12-months|Lost to Follow-up|100
1771018|NCT00729378|6168116|P2|Baseline|Withdrawal by Subject|59
1771019|NCT00729378|6168117|P1|Baseline|Withdrawal by Subject|66
1771020|NCT00729378|6168116|P2|Baseline|Did not complete study measurements|33
1771021|NCT00729378|6168117|P1|Baseline|Did not complete study measurements|72
1771022|NCT00729365|6168316|P3|Overall Study|Physician Decision|7
1771023|NCT00729365|6168317|P2|Overall Study|Physician Decision|6
1771024|NCT00729365|6168318|P1|Overall Study|Physician Decision|33
1771025|NCT00729326|6168331|P2|Overall Study|Sponsor Decision|2
1771026|NCT00729326|6168332|P1|Overall Study|Sponsor Decision|1
1771027|NCT00729326|6168331|P2|Overall Study|Subject Decision|4
1771028|NCT00729326|6168332|P1|Overall Study|Subject Decision|4
1771029|NCT00729326|6168331|P2|Overall Study|Protocol Violation|2
1771030|NCT00729326|6168332|P1|Overall Study|Protocol Violation|3
1771031|NCT00729326|6168331|P2|Overall Study|Physician Decision|1
1771032|NCT00729326|6168332|P1|Overall Study|Physician Decision|0
1771033|NCT00729326|6168331|P2|Overall Study|Lost to Follow-up|0
1771034|NCT00729326|6168332|P1|Overall Study|Lost to Follow-up|2
1771035|NCT00729248|6168374|P1|Overall Study|Physician Decision|2
1771036|NCT00729183|6168381|P2|Overall Study|Withdrawal by Subject|7
1771037|NCT00729183|6168382|P1|Overall Study|Withdrawal by Subject|9
1771038|NCT00729183|6168381|P2|Overall Study|Protocol Violation|0
1771039|NCT00729183|6168382|P1|Overall Study|Protocol Violation|1
1771040|NCT00729183|6168381|P2|Overall Study|Physician Decision|1
1771041|NCT00729183|6168382|P1|Overall Study|Physician Decision|1
1771042|NCT00729183|6168381|P2|Overall Study|Lost to Follow-up|1
1771043|NCT00729183|6168382|P1|Overall Study|Lost to Follow-up|3
1771044|NCT00729183|6168381|P2|Overall Study|Lack of Efficacy|1
1771045|NCT00729183|6168382|P1|Overall Study|Lack of Efficacy|0
1771046|NCT00729183|6168381|P2|Overall Study|Adverse Event|5
1771047|NCT00729183|6168382|P1|Overall Study|Adverse Event|11
1771048|NCT00729157|6168414|P1|Overall Study|Withdrawal by Subject|1
1771049|NCT00728988|6168457|P2|Overall Study|Withdrawal by Subject|6
1771050|NCT00728988|6168458|P1|Overall Study|Withdrawal by Subject|2
1771051|NCT00728988|6168457|P2|Overall Study|Other|77
1771052|NCT00728988|6168458|P1|Overall Study|Other|85
1771053|NCT00728988|6168457|P2|Overall Study|Adverse Event|2
1771054|NCT00728988|6168458|P1|Overall Study|Adverse Event|3
1771055|NCT00728988|6168457|P2|Overall Study|Death|1
1771056|NCT00728988|6168458|P1|Overall Study|Death|1
1771057|NCT00728988|6168457|P2|Overall Study|Not Treated|2
1771058|NCT00728988|6168458|P1|Overall Study|Not Treated|2
1771059|NCT00728962|6168476|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
1771060|NCT00728962|6168476|P1|Permanent Prosthesis Placement|Adverse Event|3
1771061|NCT00728962|6168476|P1|Implant Placement Surgery|Protocol Violation|1
1771062|NCT00728962|6168476|P1|Implant Placement Surgery|Lost to Follow-up|1
1771063|NCT00728962|6168476|P1|Implant Placement Surgery|Adverse Event|8
1771064|NCT00728949|6168482|P2|Overall Study|On treatment at cutoff date|0
1771065|NCT00728949|6168483|P1|Overall Study|On treatment at cutoff date|1
1771066|NCT00728949|6168482|P2|Overall Study|Abnormal Lab Results|2
1771067|NCT00728949|6168483|P1|Overall Study|Abnormal Lab Results|0
1771068|NCT00728949|6168482|P2|Overall Study|Withdrawal by Subject|2
1771069|NCT00728949|6168483|P1|Overall Study|Withdrawal by Subject|2
1771070|NCT00728949|6168482|P2|Overall Study|Adverse Event|0
1771071|NCT00728949|6168483|P1|Overall Study|Adverse Event|8
1771072|NCT00728936|6168508|P7|Overall Study|Withdrawal by Subject|0
1771073|NCT00728936|6168509|P6|Overall Study|Withdrawal by Subject|1
1771074|NCT00728936|6168510|P5|Overall Study|Withdrawal by Subject|0
1771075|NCT00728936|6168511|P4|Overall Study|Withdrawal by Subject|0
1771076|NCT00728936|6168512|P3|Overall Study|Withdrawal by Subject|0
1771077|NCT00728936|6168513|P2|Overall Study|Withdrawal by Subject|0
1771078|NCT00728936|6168514|P1|Overall Study|Withdrawal by Subject|0
1771079|NCT00728884|6168547|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
1771080|NCT00728884|6168547|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
1771081|NCT00728754|6168583|P2|One Year Post Placement Follow-up|Adverse Event|0
1771082|NCT00728754|6168584|P1|One Year Post Placement Follow-up|Adverse Event|1
1771083|NCT00728754|6168583|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
1771084|NCT00728754|6168584|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
1771085|NCT00728754|6168583|P2|Permanent Prosthesis Placement|Adverse Event|1
1771086|NCT00728754|6168584|P1|Permanent Prosthesis Placement|Adverse Event|1
1771087|NCT00728689|6168613|P2|Washout Period (Days 4 - 10)|Death in family|0
1771088|NCT00728689|6168614|P1|Washout Period (Days 4 - 10)|Death in family|1
1771089|NCT00728494|6168643|P2|Overall Study|No data available|1
1771090|NCT00728494|6168644|P1|Overall Study|No data available|0
1771091|NCT00728494|6168643|P2|Overall Study|Lack of Efficacy|4
1771092|NCT00728494|6168644|P1|Overall Study|Lack of Efficacy|2
1771093|NCT00728494|6168643|P2|Overall Study|Withdrawal by Subject|2
1771094|NCT00728494|6168644|P1|Overall Study|Withdrawal by Subject|0
1771095|NCT00728494|6168643|P2|Overall Study|Adverse Event|0
1771096|NCT00728494|6168644|P1|Overall Study|Adverse Event|7
1771097|NCT00728481|6168662|P2|Overall Study|Incorrectly assigned to opposite arm|0
1771098|NCT00728481|6168663|P1|Overall Study|Incorrectly assigned to opposite arm|1
1771099|NCT00728481|6168662|P2|Overall Study|Study medication non-compliance|2
1771100|NCT00728481|6168663|P1|Overall Study|Study medication non-compliance|0
1771101|NCT00728481|6168662|P2|Overall Study|Adverse Event|1
1771102|NCT00728481|6168663|P1|Overall Study|Adverse Event|0
1771103|NCT00728481|6168662|P2|Overall Study|Withdrawal by Subject|1
1771104|NCT00728481|6168663|P1|Overall Study|Withdrawal by Subject|0
1771105|NCT00728468|6168679|P1|Overall Study|Study terminated by sponsor|1
1771106|NCT00728468|6168679|P1|Overall Study|Objective progression or relapse|9
1771107|NCT00728468|6168679|P1|Overall Study|Protocol Violation|4
1771108|NCT00728468|6168679|P1|Overall Study|Death|1
1771109|NCT00728468|6168679|P1|Overall Study|Enrolled but not treated|1
1771110|NCT00728416|6168703|P2|Overall Study|Withdrawal by Subject|0
1771111|NCT00728416|6168704|P1|Overall Study|Withdrawal by Subject|1
1771112|NCT00728416|6168703|P2|Overall Study|Treatment Failure|1
1771113|NCT00728416|6168704|P1|Overall Study|Treatment Failure|0
1771114|NCT00728416|6168703|P2|Overall Study|Adverse Event|1
1771115|NCT00728416|6168704|P1|Overall Study|Adverse Event|1
1771116|NCT00728182|6168720|P2|Overall Study|Protocol Noncompliance|1
1771117|NCT00728182|6168721|P1|Overall Study|Protocol Noncompliance|0
1771118|NCT00728182|6168720|P2|Overall Study|Death|2
1771119|NCT00728182|6168721|P1|Overall Study|Death|0
1771120|NCT00728182|6168720|P2|Overall Study|Lost to Follow-up|0
1771121|NCT00728182|6168721|P1|Overall Study|Lost to Follow-up|2
1771122|NCT00728182|6168720|P2|Overall Study|Adverse Event|0
1771123|NCT00728182|6168721|P1|Overall Study|Adverse Event|1
1771124|NCT00728130|6168749|P1|Overall Study|Physician Decision|1
1771125|NCT00728130|6168749|P1|Overall Study|Paperwork not completed in time|1
1771126|NCT00728130|6168749|P1|Overall Study|Withdrawal by Subject|1
1771127|NCT00727961|6168754|P1|Overall Study|Progression|30
1771128|NCT00727961|6168754|P1|Overall Study|Patient's refusal|2
1771129|NCT00727961|6168754|P1|Overall Study|Adverse Event|4
1771130|NCT00727961|6168754|P1|Overall Study|Lost to Follow-up|1
1771131|NCT00727909|6168764|P4|Overall Study|Death|0
1771132|NCT00727909|6168765|P3|Overall Study|Death|1
1771133|NCT00727909|6168766|P2|Overall Study|Death|0
1771134|NCT00727909|6168767|P1|Overall Study|Death|0
1771135|NCT00727909|6168764|P4|Overall Study|Withdrawal by Subject|5
1771136|NCT00727909|6168765|P3|Overall Study|Withdrawal by Subject|8
1771137|NCT00727909|6168766|P2|Overall Study|Withdrawal by Subject|11
1771138|NCT00727909|6168767|P1|Overall Study|Withdrawal by Subject|5
1771139|NCT00727844|6168864|P4|Initial Randomization|Physician Decision|0
1771140|NCT00727844|6168865|P3|Initial Randomization|Physician Decision|0
1771141|NCT00727844|6168866|P2|Initial Randomization|Physician Decision|0
1771142|NCT00727844|6168867|P1|Initial Randomization|Physician Decision|2
1771143|NCT00727714|6168881|P1|Overall Study|Lost to Follow-up|2
1771144|NCT00727649|6168891|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
1771145|NCT00727649|6168892|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
1771146|NCT00727649|6168891|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
1771147|NCT00727649|6168892|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
1771148|NCT00727649|6168891|P2|Second Intervention (4-weeks)|Death|0
1771149|NCT00727649|6168892|P1|Second Intervention (4-weeks)|Death|1
1771150|NCT00727649|6168891|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
1771151|NCT00727649|6168892|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
1771152|NCT00727649|6168891|P2|Wash-out (2-weeks)|Lost to Follow-up|1
1771153|NCT00727649|6168892|P1|Wash-out (2-weeks)|Lost to Follow-up|3
1771154|NCT00727649|6168891|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
1771155|NCT00727649|6168892|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
1771156|NCT00727649|6168891|P2|First Intervention (4-weeks)|Lost to Follow-up|2
1771157|NCT00727649|6168892|P1|First Intervention (4-weeks)|Lost to Follow-up|1
1771158|NCT00727571|6168934|P4|Overall Study|Other|0
1771159|NCT00727571|6168935|P3|Overall Study|Other|6
1771160|NCT00727571|6168936|P2|Overall Study|Other|4
1771161|NCT00727571|6168937|P1|Overall Study|Other|0
1771162|NCT00727571|6168934|P4|Overall Study|AE not leading to hospitalization|0
1771163|NCT00727571|6168935|P3|Overall Study|AE not leading to hospitalization|2
1771164|NCT00727571|6168936|P2|Overall Study|AE not leading to hospitalization|0
1771165|NCT00727571|6168937|P1|Overall Study|AE not leading to hospitalization|0
1771166|NCT00727571|6168934|P4|Overall Study|Hospitalization|1
1771167|NCT00727571|6168935|P3|Overall Study|Hospitalization|0
1771168|NCT00727571|6168936|P2|Overall Study|Hospitalization|1
1771169|NCT00727571|6168937|P1|Overall Study|Hospitalization|0
1771170|NCT00727571|6168934|P4|Overall Study|Dismissed from nursing home|0
1771171|NCT00727571|6168935|P3|Overall Study|Dismissed from nursing home|5
1771172|NCT00727571|6168936|P2|Overall Study|Dismissed from nursing home|9
1771173|NCT00727571|6168937|P1|Overall Study|Dismissed from nursing home|0
1771174|NCT00727571|6168934|P4|Overall Study|Subject Non Compliance|4
1771175|NCT00727571|6168935|P3|Overall Study|Subject Non Compliance|0
1771176|NCT00727571|6168936|P2|Overall Study|Subject Non Compliance|6
1771177|NCT00727571|6168937|P1|Overall Study|Subject Non Compliance|0
1771178|NCT00727571|6168934|P4|Overall Study|Withdrawal by Subject|0
1771179|NCT00727571|6168935|P3|Overall Study|Withdrawal by Subject|11
1771180|NCT00727571|6168936|P2|Overall Study|Withdrawal by Subject|10
1771181|NCT00727571|6168937|P1|Overall Study|Withdrawal by Subject|0
1771182|NCT00727571|6168934|P4|Overall Study|Physician Decision|0
1771183|NCT00727571|6168935|P3|Overall Study|Physician Decision|0
1771184|NCT00727571|6168936|P2|Overall Study|Physician Decision|5
1771185|NCT00727571|6168937|P1|Overall Study|Physician Decision|0
1771186|NCT00727571|6168934|P4|Overall Study|Death|1
1771187|NCT00727571|6168935|P3|Overall Study|Death|5
1771188|NCT00727571|6168936|P2|Overall Study|Death|19
1771189|NCT00727571|6168937|P1|Overall Study|Death|0
1771190|NCT00727571|6168934|P4|Overall Study|Ineligibility determined|0
1771191|NCT00727571|6168935|P3|Overall Study|Ineligibility determined|1
1771192|NCT00727571|6168936|P2|Overall Study|Ineligibility determined|1
1771193|NCT00727571|6168937|P1|Overall Study|Ineligibility determined|1
1771194|NCT00727558|6168964|P2|Overall Study|Lost to Follow-up|0
1771195|NCT00727558|6168965|P1|Overall Study|Lost to Follow-up|1
1771196|NCT00727558|6168964|P2|Overall Study|Subject unable to return for follow-up|1
1771197|NCT00727558|6168965|P1|Overall Study|Subject unable to return for follow-up|1
1771198|NCT00727558|6168964|P2|Overall Study|Adverse Event|1
1771199|NCT00727558|6168965|P1|Overall Study|Adverse Event|0
1771200|NCT00727558|6168964|P2|Overall Study|Lens issue|1
1771201|NCT00727558|6168965|P1|Overall Study|Lens issue|0
1771202|NCT00727532|6168983|P1|Overall Study|Withdrawal by Subject|1
1771203|NCT00727532|6168983|P1|Overall Study|Adverse Event|1
1771204|NCT00727506|6168995|P6|Overall Study|Other reason not described above|1
1771205|NCT00727506|6168996|P5|Overall Study|Other reason not described above|1
1771206|NCT00727506|6168997|P4|Overall Study|Other reason not described above|4
1771207|NCT00727506|6168998|P3|Overall Study|Other reason not described above|1
1771208|NCT00727506|6168999|P2|Overall Study|Other reason not described above|0
1771209|NCT00727506|6169000|P1|Overall Study|Other reason not described above|0
1771210|NCT00727506|6168995|P6|Overall Study|Refused to continue medication|2
1771211|NCT00727506|6168996|P5|Overall Study|Refused to continue medication|1
1771212|NCT00727506|6168997|P4|Overall Study|Refused to continue medication|3
1771213|NCT00727506|6168998|P3|Overall Study|Refused to continue medication|2
1771214|NCT00727506|6168999|P2|Overall Study|Refused to continue medication|1
1771215|NCT00727506|6169000|P1|Overall Study|Refused to continue medication|0
1771216|NCT00727506|6168995|P6|Overall Study|Progressive disease|28
1771217|NCT00727506|6168996|P5|Overall Study|Progressive disease|38
1771218|NCT00727506|6168997|P4|Overall Study|Progressive disease|28
1771219|NCT00727506|6168998|P3|Overall Study|Progressive disease|9
1771220|NCT00727506|6168999|P2|Overall Study|Progressive disease|7
1771221|NCT00727506|6169000|P1|Overall Study|Progressive disease|4
1771222|NCT00727506|6168995|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
1771223|NCT00727506|6168996|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
1771224|NCT00727506|6168997|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
1771225|NCT00727506|6168998|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
1771226|NCT00727506|6168999|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
1771227|NCT00727506|6169000|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
1771228|NCT00727506|6168995|P6|Overall Study|Adverse Event|8
1771229|NCT00727506|6168996|P5|Overall Study|Adverse Event|1
1771230|NCT00727506|6168997|P4|Overall Study|Adverse Event|4
1771231|NCT00727506|6168998|P3|Overall Study|Adverse Event|4
1771232|NCT00727506|6168999|P2|Overall Study|Adverse Event|0
1771233|NCT00727506|6169000|P1|Overall Study|Adverse Event|0
1771249|NCT00727415|6169118|P1|Phase I|Dose Limiting Toxicity|2
1771250|NCT00727402|6169127|P1|Overall Study|Physician Decision|116
1771251|NCT00727311|6169156|P1|Overall Study|Multiple reasons|39
1771252|NCT00727311|6169156|P1|Overall Study|Other|97
1771253|NCT00727311|6169156|P1|Overall Study|Withdrawal by Subject|77
1771254|NCT00727311|6169156|P1|Overall Study|Lost to Follow-up|73
1771255|NCT00727311|6169156|P1|Overall Study|Lack of Efficacy|242
1771256|NCT00727311|6169156|P1|Overall Study|Adverse Event|58
1771257|NCT00727311|6169156|P1|Overall Study|Missing end of therapy data|205
1771258|NCT00727311|6169156|P1|Overall Study|Did not receive drug|316
1771259|NCT00727272|6169169|P3|Washout Period B|Withdrawal by Subject|1
1771260|NCT00727272|6169170|P2|Washout Period B|Withdrawal by Subject|0
1771261|NCT00727272|6169171|P1|Washout Period B|Withdrawal by Subject|0
1771262|NCT00727272|6169169|P3|Washout Period A|Adverse Event|1
1771263|NCT00727272|6169170|P2|Washout Period A|Adverse Event|0
1771264|NCT00727272|6169171|P1|Washout Period A|Adverse Event|0
1771265|NCT00727259|6169188|P1|Overall Study|Not all questionnaires completed|1055
1771266|NCT00727246|6169197|P4|Overall Study|withdrawn|0
1771267|NCT00727246|6169198|P3|Overall Study|withdrawn|1
1771268|NCT00727246|6169199|P2|Overall Study|withdrawn|0
1771269|NCT00727246|6169200|P1|Overall Study|withdrawn|0
1771270|NCT00727246|6169197|P4|Overall Study|incidental finding|1
1771271|NCT00727246|6169198|P3|Overall Study|incidental finding|0
1771272|NCT00727246|6169199|P2|Overall Study|incidental finding|0
1771273|NCT00727246|6169200|P1|Overall Study|incidental finding|0
1771274|NCT00727246|6169197|P4|Overall Study|could not complete MRI|1
1771275|NCT00727246|6169198|P3|Overall Study|could not complete MRI|0
1771276|NCT00727246|6169199|P2|Overall Study|could not complete MRI|1
1771277|NCT00727246|6169200|P1|Overall Study|could not complete MRI|0
1771278|NCT00727194|6169223|P3|Treatment Period 2|Lack of Efficacy|0
1771279|NCT00727194|6169224|P2|Treatment Period 2|Lack of Efficacy|1
1771280|NCT00727194|6169225|P1|Treatment Period 2|Lack of Efficacy|0
1771281|NCT00727194|6169223|P3|Screening Period|History of thymoma|1
1771282|NCT00727194|6169224|P2|Screening Period|History of thymoma|0
1771283|NCT00727194|6169225|P1|Screening Period|History of thymoma|0
1771284|NCT00727194|6169223|P3|Screening Period|Severe infections|2
1771285|NCT00727194|6169224|P2|Screening Period|Severe infections|0
1771286|NCT00727194|6169225|P1|Screening Period|Severe infections|0
1771287|NCT00727194|6169223|P3|Screening Period|Not stable on concomitant MG therapy|2
1771288|NCT00727194|6169224|P2|Screening Period|Not stable on concomitant MG therapy|0
1771289|NCT00727194|6169225|P1|Screening Period|Not stable on concomitant MG therapy|0
1771290|NCT00727194|6169223|P3|Screening Period|Lacked AChR antibodies|5
1771291|NCT00727194|6169224|P2|Screening Period|Lacked AChR antibodies|0
1771292|NCT00727194|6169225|P1|Screening Period|Lacked AChR antibodies|0
1771293|NCT00727194|6169223|P3|Screening Period|Low QMG scores|6
1771294|NCT00727194|6169224|P2|Screening Period|Low QMG scores|0
1771295|NCT00727194|6169225|P1|Screening Period|Low QMG scores|0
1771296|NCT00727025|6169297|P1|Overall Study|Physician Decision|23
1771297|NCT00726999|6169309|P2|Overall Study|Protocol Violation|0
1771298|NCT00726999|6169310|P1|Overall Study|Protocol Violation|1
1771299|NCT00726999|6169309|P2|Overall Study|Withdrawal by Subject|0
1771300|NCT00726999|6169310|P1|Overall Study|Withdrawal by Subject|2
1771301|NCT00726999|6169309|P2|Overall Study|Physician Decision|1
1771302|NCT00726999|6169310|P1|Overall Study|Physician Decision|0
1771303|NCT00726986|6169322|P1|Maintenance Phase|Lack of Efficacy|2
1771304|NCT00726986|6169322|P1|Maintenance Phase|Adverse Event|1
1771305|NCT00726986|6169322|P1|Induction Phase|Secondary Disease|2
1771306|NCT00726986|6169322|P1|Induction Phase|Lack of Efficacy|5
1771307|NCT00726986|6169322|P1|Induction Phase|Death|2
1771308|NCT00726986|6169322|P1|Induction Phase|Withdrawal by Subject|2
1771309|NCT00726986|6169322|P1|Induction Phase|Adverse Event|4
1771310|NCT00726895|6169329|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1771311|NCT00726895|6169330|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1771312|NCT00726882|6169343|P1|Overall Study|Other|10
1771313|NCT00726882|6169343|P1|Overall Study|Lost to Follow-up|7
1771314|NCT00726882|6169343|P1|Overall Study|Withdrawal by Subject|5
1771315|NCT00726752|6169358|P1|Overall Study|Lack of Efficacy|6
1771316|NCT00726661|6169420|P2|Overall Study|Other|35
1771317|NCT00726661|6169421|P1|Overall Study|Other|47
1771318|NCT00726661|6169420|P2|Overall Study|Physician Decision|13
1771319|NCT00726661|6169421|P1|Overall Study|Physician Decision|25
1771320|NCT00726661|6169420|P2|Overall Study|Death|159
1771321|NCT00726661|6169421|P1|Overall Study|Death|475
1771322|NCT00726661|6169420|P2|Overall Study|Trial terminated by sponsor|187
1771323|NCT00726661|6169421|P1|Overall Study|Trial terminated by sponsor|214
1771324|NCT00726661|6169420|P2|Overall Study|Withdrawal by Subject|13
1771325|NCT00726661|6169421|P1|Overall Study|Withdrawal by Subject|17
1771326|NCT00726661|6169420|P2|Overall Study|Lost to Follow-up|11
1771327|NCT00726661|6169421|P1|Overall Study|Lost to Follow-up|36
1771328|NCT00726622|6169438|P2|Overall Study|Metastasis|0
1771329|NCT00726622|6169439|P1|Overall Study|Metastasis|2
1771330|NCT00726622|6169438|P2|Overall Study|Physician Decision|1
1771331|NCT00726622|6169439|P1|Overall Study|Physician Decision|0
1771332|NCT00726622|6169438|P2|Overall Study|Withdrawal by Subject|2
1771333|NCT00726622|6169439|P1|Overall Study|Withdrawal by Subject|16
1771334|NCT00726609|6169457|P1|Overall Study|Other|3
1771335|NCT00726609|6169457|P1|Overall Study|Missing|42
1771336|NCT00726609|6169457|P1|Overall Study|Other|16
1771337|NCT00726609|6169457|P1|Overall Study|Lack of Efficacy|25
1771338|NCT00726609|6169457|P1|Overall Study|Withdrawal by Subject|2
1771339|NCT00726609|6169457|P1|Overall Study|Adverse Event|10
1771340|NCT00726557|6169461|P1|Overall Study|Inclusion criteria not met|15
1771341|NCT00726557|6169461|P1|Overall Study|Treatment less than 3 months|17
1771342|NCT00726557|6169461|P1|Overall Study|No follow-up documentation available|55
1771343|NCT00726557|6169461|P1|Overall Study|No end of treatment documentation|37
1771344|NCT00726557|6169461|P1|Overall Study|Screening failure|4
1771345|NCT00726453|6169468|P2|38 mm Length Group|Death|3
1771346|NCT00726453|6169469|P1|38 mm Length Group|Death|0
1771347|NCT00726453|6169468|P2|Primary Enrollment Group|Withdrawal by Subject|0
1771348|NCT00726453|6169469|P1|Primary Enrollment Group|Withdrawal by Subject|13
1771349|NCT00726453|6169468|P2|Primary Enrollment Group|Death|0
1771350|NCT00726453|6169469|P1|Primary Enrollment Group|Death|18
1771351|NCT00726323|6169497|P2|Overall Study|Metastatic lesions inferred cyst|1
1771352|NCT00726323|6169498|P1|Overall Study|Metastatic lesions inferred cyst|0
1771353|NCT00726323|6169497|P2|Overall Study|Participant wished to discontinue|1
1771354|NCT00726323|6169498|P1|Overall Study|Participant wished to discontinue|0
1771355|NCT00726323|6169497|P2|Overall Study|Death|0
1771356|NCT00726323|6169498|P1|Overall Study|Death|1
1771357|NCT00726323|6169497|P2|Overall Study|Adverse Event|9
1771358|NCT00726323|6169498|P1|Overall Study|Adverse Event|9
1771359|NCT00726323|6169497|P2|Overall Study|Clinical progression|3
1771360|NCT00726323|6169498|P1|Overall Study|Clinical progression|0
1771361|NCT00726323|6169497|P2|Overall Study|Progressive disease|16
1771362|NCT00726323|6169498|P1|Overall Study|Progressive disease|23
1771363|NCT00726323|6169497|P2|Overall Study|Physician Decision|0
1771364|NCT00726323|6169498|P1|Overall Study|Physician Decision|1
1771365|NCT00726323|6169497|P2|Overall Study|Withdrawal by Subject|1
1771366|NCT00726323|6169498|P1|Overall Study|Withdrawal by Subject|3
1771367|NCT00726232|6169528|P8|Expansion Phase|Unspecified reason|0
1771368|NCT00726232|6169529|P7|Expansion Phase|Unspecified reason|1
1771369|NCT00726232|6169530|P6|Expansion Phase|Unspecified reason|0
1771370|NCT00726232|6169531|P5|Expansion Phase|Unspecified reason|0
1771371|NCT00726232|6169532|P4|Expansion Phase|Unspecified reason|0
1771372|NCT00726232|6169533|P3|Expansion Phase|Unspecified reason|0
1771373|NCT00726232|6169534|P2|Expansion Phase|Unspecified reason|0
1771374|NCT00726232|6169535|P1|Expansion Phase|Unspecified reason|0
1771375|NCT00726232|6169528|P8|Expansion Phase|Per Investigator: lack of response|7
1771376|NCT00726232|6169529|P7|Expansion Phase|Per Investigator: lack of response|1
1771377|NCT00726232|6169530|P6|Expansion Phase|Per Investigator: lack of response|0
1771378|NCT00726232|6169531|P5|Expansion Phase|Per Investigator: lack of response|0
1771379|NCT00726232|6169532|P4|Expansion Phase|Per Investigator: lack of response|0
1771380|NCT00726232|6169533|P3|Expansion Phase|Per Investigator: lack of response|0
1771381|NCT00726232|6169534|P2|Expansion Phase|Per Investigator: lack of response|0
1771382|NCT00726232|6169535|P1|Expansion Phase|Per Investigator: lack of response|0
1771383|NCT00726232|6169528|P8|Expansion Phase|Termination of the trial by sponsor|16
1771384|NCT00726232|6169529|P7|Expansion Phase|Termination of the trial by sponsor|10
1771385|NCT00726232|6169530|P6|Expansion Phase|Termination of the trial by sponsor|0
1771386|NCT00726232|6169531|P5|Expansion Phase|Termination of the trial by sponsor|0
1771387|NCT00726232|6169532|P4|Expansion Phase|Termination of the trial by sponsor|0
1771388|NCT00726232|6169533|P3|Expansion Phase|Termination of the trial by sponsor|0
1771389|NCT00726232|6169534|P2|Expansion Phase|Termination of the trial by sponsor|0
1771390|NCT00726232|6169535|P1|Expansion Phase|Termination of the trial by sponsor|0
1771391|NCT00726232|6169528|P8|Expansion Phase|Disease progression|0
1771392|NCT00726232|6169529|P7|Expansion Phase|Disease progression|4
1771393|NCT00726232|6169530|P6|Expansion Phase|Disease progression|0
1771394|NCT00726232|6169531|P5|Expansion Phase|Disease progression|0
1771395|NCT00726232|6169532|P4|Expansion Phase|Disease progression|0
1771396|NCT00726232|6169533|P3|Expansion Phase|Disease progression|0
1771397|NCT00726232|6169534|P2|Expansion Phase|Disease progression|0
1771398|NCT00726232|6169535|P1|Expansion Phase|Disease progression|0
1771399|NCT00726232|6169528|P8|Expansion Phase|Withdrawal by Subject|3
1771400|NCT00726232|6169529|P7|Expansion Phase|Withdrawal by Subject|2
1771401|NCT00726232|6169530|P6|Expansion Phase|Withdrawal by Subject|0
1771402|NCT00726232|6169531|P5|Expansion Phase|Withdrawal by Subject|0
1771403|NCT00726232|6169532|P4|Expansion Phase|Withdrawal by Subject|0
1771404|NCT00726232|6169533|P3|Expansion Phase|Withdrawal by Subject|0
1771405|NCT00726232|6169534|P2|Expansion Phase|Withdrawal by Subject|0
1771406|NCT00726232|6169535|P1|Expansion Phase|Withdrawal by Subject|0
1771407|NCT00726232|6169528|P8|Expansion Phase|Adverse Event|11
1771408|NCT00726232|6169529|P7|Expansion Phase|Adverse Event|6
1771409|NCT00726232|6169530|P6|Expansion Phase|Adverse Event|0
1771410|NCT00726232|6169531|P5|Expansion Phase|Adverse Event|0
1771411|NCT00726232|6169532|P4|Expansion Phase|Adverse Event|0
1771412|NCT00726232|6169533|P3|Expansion Phase|Adverse Event|0
1771413|NCT00726232|6169534|P2|Expansion Phase|Adverse Event|0
1771414|NCT00726232|6169535|P1|Expansion Phase|Adverse Event|0
1771415|NCT00726232|6169528|P8|Expansion Phase|Death|1
1771416|NCT00726232|6169529|P7|Expansion Phase|Death|0
1771417|NCT00726232|6169530|P6|Expansion Phase|Death|0
1771418|NCT00726232|6169531|P5|Expansion Phase|Death|0
1771419|NCT00726232|6169532|P4|Expansion Phase|Death|0
1771420|NCT00726232|6169533|P3|Expansion Phase|Death|0
1771421|NCT00726232|6169534|P2|Expansion Phase|Death|0
1771422|NCT00726232|6169535|P1|Expansion Phase|Death|0
1771423|NCT00726232|6169528|P8|Initial Phase (Dose-finding)|Unspecified reason|0
1771424|NCT00726232|6169529|P7|Initial Phase (Dose-finding)|Unspecified reason|0
1771425|NCT00726232|6169530|P6|Initial Phase (Dose-finding)|Unspecified reason|0
1771426|NCT00726232|6169531|P5|Initial Phase (Dose-finding)|Unspecified reason|0
1771427|NCT00726232|6169532|P4|Initial Phase (Dose-finding)|Unspecified reason|0
1771428|NCT00726232|6169533|P3|Initial Phase (Dose-finding)|Unspecified reason|0
1771429|NCT00726232|6169534|P2|Initial Phase (Dose-finding)|Unspecified reason|0
1771430|NCT00726232|6169535|P1|Initial Phase (Dose-finding)|Unspecified reason|1
1771431|NCT00726232|6169528|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
1771432|NCT00726232|6169529|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
1771433|NCT00726232|6169530|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
1771434|NCT00726232|6169531|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
1771435|NCT00726232|6169532|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
1771436|NCT00726232|6169533|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
1771437|NCT00726232|6169534|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
1771438|NCT00726232|6169535|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
1771439|NCT00726232|6169528|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
1771440|NCT00726232|6169529|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
1771441|NCT00726232|6169530|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
1771442|NCT00726232|6169531|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
1771443|NCT00726232|6169532|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
1771444|NCT00726232|6169533|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
1771445|NCT00726232|6169534|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
1771446|NCT00726232|6169535|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
1771447|NCT00726232|6169528|P8|Initial Phase (Dose-finding)|Disease progression|0
1771448|NCT00726232|6169529|P7|Initial Phase (Dose-finding)|Disease progression|0
1771449|NCT00726232|6169530|P6|Initial Phase (Dose-finding)|Disease progression|0
1771450|NCT00726232|6169531|P5|Initial Phase (Dose-finding)|Disease progression|0
1771451|NCT00726232|6169532|P4|Initial Phase (Dose-finding)|Disease progression|0
1771452|NCT00726232|6169533|P3|Initial Phase (Dose-finding)|Disease progression|0
1771453|NCT00726232|6169534|P2|Initial Phase (Dose-finding)|Disease progression|1
1771454|NCT00726232|6169535|P1|Initial Phase (Dose-finding)|Disease progression|3
1771455|NCT00726232|6169528|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
1771456|NCT00726232|6169529|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
1771457|NCT00726232|6169530|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
1771458|NCT00726232|6169531|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
1771459|NCT00726232|6169532|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
1771460|NCT00726232|6169533|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
1771461|NCT00726232|6169534|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
1771462|NCT00726232|6169535|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
1771463|NCT00726232|6169528|P8|Initial Phase (Dose-finding)|Adverse Event|0
1771464|NCT00726232|6169529|P7|Initial Phase (Dose-finding)|Adverse Event|0
1771465|NCT00726232|6169530|P6|Initial Phase (Dose-finding)|Adverse Event|3
1771466|NCT00726232|6169531|P5|Initial Phase (Dose-finding)|Adverse Event|7
1771467|NCT00726232|6169532|P4|Initial Phase (Dose-finding)|Adverse Event|1
1771468|NCT00726232|6169533|P3|Initial Phase (Dose-finding)|Adverse Event|2
1771469|NCT00726232|6169534|P2|Initial Phase (Dose-finding)|Adverse Event|2
1771470|NCT00726232|6169535|P1|Initial Phase (Dose-finding)|Adverse Event|2
1771471|NCT00726232|6169528|P8|Initial Phase (Dose-finding)|Death|0
1771472|NCT00726232|6169529|P7|Initial Phase (Dose-finding)|Death|0
1771473|NCT00726232|6169530|P6|Initial Phase (Dose-finding)|Death|0
1771474|NCT00726232|6169531|P5|Initial Phase (Dose-finding)|Death|1
1771475|NCT00726232|6169532|P4|Initial Phase (Dose-finding)|Death|0
1771476|NCT00726232|6169533|P3|Initial Phase (Dose-finding)|Death|0
1771477|NCT00726232|6169534|P2|Initial Phase (Dose-finding)|Death|0
1771478|NCT00726232|6169535|P1|Initial Phase (Dose-finding)|Death|0
1771479|NCT00726063|6169587|P2|Overall Study|Adverse Event|7
1771480|NCT00726063|6169588|P1|Overall Study|Adverse Event|9
1771481|NCT00725985|6169602|P12|LTFU (No Cladribine Treatment)|Other|14
1771482|NCT00725985|6169603|P11|LTFU (No Cladribine Treatment)|Other|36
1771483|NCT00725985|6169604|P10|LTFU (No Cladribine Treatment)|Other|34
1771484|NCT00725985|6169605|P9|LTFU (No Cladribine Treatment)|Other|0
1771485|NCT00725985|6169606|P8|LTFU (No Cladribine Treatment)|Other|0
1771486|NCT00725985|6169607|P7|LTFU (No Cladribine Treatment)|Other|0
1771487|NCT00725985|6169608|P6|LTFU (No Cladribine Treatment)|Other|0
1771488|NCT00725985|6169609|P5|LTFU (No Cladribine Treatment)|Other|0
1771489|NCT00725985|6169610|P4|LTFU (No Cladribine Treatment)|Other|0
1771490|NCT00725985|6169611|P3|LTFU (No Cladribine Treatment)|Other|0
1771491|NCT00725985|6169612|P2|LTFU (No Cladribine Treatment)|Other|0
1771492|NCT00725985|6169613|P1|LTFU (No Cladribine Treatment)|Other|0
1771493|NCT00725985|6169602|P12|LTFU (With Cladribine Treatment)|Other|0
1771494|NCT00725985|6169603|P11|LTFU (With Cladribine Treatment)|Other|0
1771495|NCT00725985|6169604|P10|LTFU (With Cladribine Treatment)|Other|0
1771496|NCT00725985|6169605|P9|LTFU (With Cladribine Treatment)|Other|16
1771497|NCT00725985|6169606|P8|LTFU (With Cladribine Treatment)|Other|8
1771498|NCT00725985|6169607|P7|LTFU (With Cladribine Treatment)|Other|9
1771499|NCT00725985|6169608|P6|LTFU (With Cladribine Treatment)|Other|0
1771500|NCT00725985|6169609|P5|LTFU (With Cladribine Treatment)|Other|0
1771501|NCT00725985|6169610|P4|LTFU (With Cladribine Treatment)|Other|0
1771502|NCT00725985|6169611|P3|LTFU (With Cladribine Treatment)|Other|0
1771503|NCT00725985|6169612|P2|LTFU (With Cladribine Treatment)|Other|0
1771504|NCT00725985|6169613|P1|LTFU (With Cladribine Treatment)|Other|0
1771505|NCT00725985|6169602|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771506|NCT00725985|6169603|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771507|NCT00725985|6169604|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771508|NCT00725985|6169605|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
1771509|NCT00725985|6169606|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771510|NCT00725985|6169607|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771511|NCT00725985|6169608|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771512|NCT00725985|6169609|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771513|NCT00725985|6169610|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771514|NCT00725985|6169611|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771515|NCT00725985|6169612|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771516|NCT00725985|6169613|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
1771517|NCT00725985|6169602|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
1771518|NCT00725985|6169603|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
1771519|NCT00725985|6169604|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
1771520|NCT00725985|6169605|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
1771521|NCT00725985|6169606|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
1771522|NCT00725985|6169607|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
1771523|NCT00725985|6169608|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
1771524|NCT00725985|6169609|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
1771525|NCT00725985|6169610|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
1771526|NCT00725985|6169611|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
1771527|NCT00725985|6169612|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
1771528|NCT00725985|6169613|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
1771529|NCT00725985|6169602|P12|OLMP|Other|0
1771530|NCT00725985|6169603|P11|OLMP|Other|0
1771531|NCT00725985|6169604|P10|OLMP|Other|0
1771532|NCT00725985|6169605|P9|OLMP|Other|0
1771533|NCT00725985|6169606|P8|OLMP|Other|0
1771534|NCT00725985|6169607|P7|OLMP|Other|0
1771535|NCT00725985|6169608|P6|OLMP|Other|44
1771536|NCT00725985|6169609|P5|OLMP|Other|20
1771537|NCT00725985|6169610|P4|OLMP|Other|15
1771538|NCT00725985|6169611|P3|OLMP|Other|0
1771539|NCT00725985|6169612|P2|OLMP|Other|0
1771540|NCT00725985|6169613|P1|OLMP|Other|0
1771541|NCT00725985|6169602|P12|OLMP|Disease progression|0
1771542|NCT00725985|6169603|P11|OLMP|Disease progression|0
1771543|NCT00725985|6169604|P10|OLMP|Disease progression|0
1771544|NCT00725985|6169605|P9|OLMP|Disease progression|0
1771545|NCT00725985|6169606|P8|OLMP|Disease progression|0
1771546|NCT00725985|6169607|P7|OLMP|Disease progression|0
1771547|NCT00725985|6169608|P6|OLMP|Disease progression|4
1771548|NCT00725985|6169609|P5|OLMP|Disease progression|0
1771549|NCT00725985|6169610|P4|OLMP|Disease progression|0
1771550|NCT00725985|6169611|P3|OLMP|Disease progression|0
1771551|NCT00725985|6169612|P2|OLMP|Disease progression|0
1771552|NCT00725985|6169613|P1|OLMP|Disease progression|0
1771553|NCT00725985|6169602|P12|OLMP|Lost to Follow-up|0
1771554|NCT00725985|6169603|P11|OLMP|Lost to Follow-up|0
1771555|NCT00725985|6169604|P10|OLMP|Lost to Follow-up|0
1771556|NCT00725985|6169605|P9|OLMP|Lost to Follow-up|0
1771557|NCT00725985|6169606|P8|OLMP|Lost to Follow-up|0
1771558|NCT00725985|6169607|P7|OLMP|Lost to Follow-up|0
1771559|NCT00725985|6169608|P6|OLMP|Lost to Follow-up|0
1771560|NCT00725985|6169609|P5|OLMP|Lost to Follow-up|0
1771561|NCT00725985|6169610|P4|OLMP|Lost to Follow-up|1
1771562|NCT00725985|6169611|P3|OLMP|Lost to Follow-up|0
1771563|NCT00725985|6169612|P2|OLMP|Lost to Follow-up|0
1771564|NCT00725985|6169613|P1|OLMP|Lost to Follow-up|0
1771565|NCT00725985|6169602|P12|OLMP|Death|0
1771566|NCT00725985|6169603|P11|OLMP|Death|0
1771567|NCT00725985|6169604|P10|OLMP|Death|0
1771568|NCT00725985|6169605|P9|OLMP|Death|0
1771569|NCT00725985|6169606|P8|OLMP|Death|0
1771570|NCT00725985|6169607|P7|OLMP|Death|0
1771571|NCT00725985|6169608|P6|OLMP|Death|0
1771572|NCT00725985|6169609|P5|OLMP|Death|1
1771573|NCT00725985|6169610|P4|OLMP|Death|0
1771574|NCT00725985|6169611|P3|OLMP|Death|0
1771575|NCT00725985|6169612|P2|OLMP|Death|0
1771576|NCT00725985|6169613|P1|OLMP|Death|0
1771577|NCT00725985|6169602|P12|OLMP|Adverse Event|0
1771578|NCT00725985|6169603|P11|OLMP|Adverse Event|0
1771579|NCT00725985|6169604|P10|OLMP|Adverse Event|0
1771580|NCT00725985|6169605|P9|OLMP|Adverse Event|0
1771581|NCT00725985|6169606|P8|OLMP|Adverse Event|0
1771582|NCT00725985|6169607|P7|OLMP|Adverse Event|0
1771583|NCT00725985|6169608|P6|OLMP|Adverse Event|5
1771584|NCT00725985|6169609|P5|OLMP|Adverse Event|2
1771585|NCT00725985|6169610|P4|OLMP|Adverse Event|2
1771586|NCT00725985|6169611|P3|OLMP|Adverse Event|0
1771587|NCT00725985|6169612|P2|OLMP|Adverse Event|0
1771588|NCT00725985|6169613|P1|OLMP|Adverse Event|0
1771589|NCT00725985|6169602|P12|ITP (Up to 96 Weeks)|Other|0
1771590|NCT00725985|6169603|P11|ITP (Up to 96 Weeks)|Other|0
1771591|NCT00725985|6169604|P10|ITP (Up to 96 Weeks)|Other|0
1771592|NCT00725985|6169605|P9|ITP (Up to 96 Weeks)|Other|0
1771593|NCT00725985|6169606|P8|ITP (Up to 96 Weeks)|Other|0
1771594|NCT00725985|6169607|P7|ITP (Up to 96 Weeks)|Other|0
1771595|NCT00725985|6169608|P6|ITP (Up to 96 Weeks)|Other|0
1771596|NCT00725985|6169609|P5|ITP (Up to 96 Weeks)|Other|0
1771597|NCT00725985|6169610|P4|ITP (Up to 96 Weeks)|Other|0
1771598|NCT00725985|6169611|P3|ITP (Up to 96 Weeks)|Other|24
1771599|NCT00725985|6169612|P2|ITP (Up to 96 Weeks)|Other|38
1771600|NCT00725985|6169613|P1|ITP (Up to 96 Weeks)|Other|50
1771601|NCT00725985|6169602|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771602|NCT00725985|6169603|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771603|NCT00725985|6169604|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771604|NCT00725985|6169605|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771605|NCT00725985|6169606|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771606|NCT00725985|6169607|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771607|NCT00725985|6169608|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771608|NCT00725985|6169609|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771609|NCT00725985|6169610|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
1771610|NCT00725985|6169611|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
1771611|NCT00725985|6169612|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
1771612|NCT00725985|6169613|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
1771613|NCT00725985|6169602|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771614|NCT00725985|6169603|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771615|NCT00725985|6169604|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771616|NCT00725985|6169605|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771617|NCT00725985|6169606|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771618|NCT00725985|6169607|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771619|NCT00725985|6169608|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771620|NCT00725985|6169609|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771621|NCT00725985|6169610|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771622|NCT00725985|6169611|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771623|NCT00725985|6169612|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
1771624|NCT00725985|6169613|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
1771625|NCT00725985|6169602|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771626|NCT00725985|6169603|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771627|NCT00725985|6169604|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771628|NCT00725985|6169605|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771629|NCT00725985|6169606|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771630|NCT00725985|6169607|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771631|NCT00725985|6169608|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771632|NCT00725985|6169609|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771633|NCT00725985|6169610|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771634|NCT00725985|6169611|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
1771635|NCT00725985|6169612|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771636|NCT00725985|6169613|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
1771637|NCT00725985|6169602|P12|ITP (Up to 96 Weeks)|Adverse Event|0
1771638|NCT00725985|6169603|P11|ITP (Up to 96 Weeks)|Adverse Event|0
1771639|NCT00725985|6169604|P10|ITP (Up to 96 Weeks)|Adverse Event|0
1771640|NCT00725985|6169605|P9|ITP (Up to 96 Weeks)|Adverse Event|0
1771641|NCT00725985|6169606|P8|ITP (Up to 96 Weeks)|Adverse Event|0
1771642|NCT00725985|6169607|P7|ITP (Up to 96 Weeks)|Adverse Event|0
1771643|NCT00725985|6169608|P6|ITP (Up to 96 Weeks)|Adverse Event|0
1771644|NCT00725985|6169609|P5|ITP (Up to 96 Weeks)|Adverse Event|0
1771645|NCT00725985|6169610|P4|ITP (Up to 96 Weeks)|Adverse Event|0
1771646|NCT00725985|6169611|P3|ITP (Up to 96 Weeks)|Adverse Event|5
1771647|NCT00725985|6169612|P2|ITP (Up to 96 Weeks)|Adverse Event|10
1771648|NCT00725985|6169613|P1|ITP (Up to 96 Weeks)|Adverse Event|20
1771649|NCT00725920|6169650|P2|Overall Study|Lack of Efficacy|6
1771650|NCT00725920|6169651|P1|Overall Study|Lack of Efficacy|3
1771651|NCT00725842|6169657|P1|Overall Study|No Visit 1 data|1
1771652|NCT00725842|6169657|P1|Overall Study|Inclusion criterion not met|1
1771653|NCT00725842|6169657|P1|Overall Study|Consent date prior to study start date|5
1771654|NCT00725842|6169657|P1|Overall Study|Positive HCV-RNA at Visit 2|13
1771655|NCT00725842|6169657|P1|Overall Study|Death|1
1771656|NCT00725842|6169657|P1|Overall Study|Lost to Follow-up|19
1771657|NCT00725764|6169664|P1|Overall Study|Decline in performance status|1
1771658|NCT00725764|6169664|P1|Overall Study|Participant non compliant with protocol|1
1771659|NCT00725764|6169664|P1|Overall Study|Death|1
1771660|NCT00725764|6169664|P1|Overall Study|Lost to Follow-up|1
1771661|NCT00725764|6169664|P1|Overall Study|Progressive Disease|7
1771662|NCT00725764|6169664|P1|Overall Study|Physician Decision|1
1771663|NCT00725764|6169664|P1|Overall Study|Withdrawal by Subject|2
1771664|NCT00725725|6169697|P3|Overall Study|Protocol Violation|0
1771665|NCT00725725|6169698|P2|Overall Study|Protocol Violation|1
1771666|NCT00725725|6169699|P1|Overall Study|Protocol Violation|0
1771667|NCT00725725|6169697|P3|Overall Study|Withdrawal by Subject|1
1771668|NCT00725725|6169698|P2|Overall Study|Withdrawal by Subject|0
1771669|NCT00725725|6169699|P1|Overall Study|Withdrawal by Subject|1
1771670|NCT00725725|6169697|P3|Overall Study|Lost to Follow-up|2
1771671|NCT00725725|6169698|P2|Overall Study|Lost to Follow-up|0
1771672|NCT00725725|6169699|P1|Overall Study|Lost to Follow-up|2
1771673|NCT00725725|6169697|P3|Overall Study|Adverse Event|2
1771674|NCT00725725|6169698|P2|Overall Study|Adverse Event|3
1771675|NCT00725725|6169699|P1|Overall Study|Adverse Event|1
1771676|NCT00725712|6169742|P2|Overall Study|Hospitalized, unable to continue|1
1771677|NCT00725712|6169743|P1|Overall Study|Hospitalized, unable to continue|0
1771678|NCT00725712|6169742|P2|Overall Study|Other: Death|0
1771679|NCT00725712|6169743|P1|Overall Study|Other: Death|1
1771680|NCT00725712|6169742|P2|Overall Study|Death|0
1771681|NCT00725712|6169743|P1|Overall Study|Death|2
1771682|NCT00725712|6169742|P2|Overall Study|Adverse Event|5
1771683|NCT00725712|6169743|P1|Overall Study|Adverse Event|5
1771684|NCT00725712|6169742|P2|Overall Study|Clinical progression not based on RECIST|3
1771685|NCT00725712|6169743|P1|Overall Study|Clinical progression not based on RECIST|0
1771686|NCT00725712|6169742|P2|Overall Study|Progressive disease|16
1771687|NCT00725712|6169743|P1|Overall Study|Progressive disease|37
1771688|NCT00725712|6169742|P2|Overall Study|Protocol Violation|0
1771689|NCT00725712|6169743|P1|Overall Study|Protocol Violation|1
1771690|NCT00725712|6169742|P2|Overall Study|Withdrawal by Subject|1
1771691|NCT00725712|6169743|P1|Overall Study|Withdrawal by Subject|2
1771692|NCT00725621|6169779|P1|Overall Study|Reason not specified|55
1771693|NCT00725621|6169779|P1|Overall Study|Prepared for elective surgery|1
1771694|NCT00725621|6169779|P1|Overall Study|Switched to other drug|1
1771695|NCT00725621|6169779|P1|Overall Study|Switched to other study|1
1771696|NCT00725621|6169779|P1|Overall Study|Continued treatment by other physician|6
1771697|NCT00725621|6169779|P1|Overall Study|Non-compliance|8
1771698|NCT00725621|6169779|P1|Overall Study|Lost to Follow-up|52
1771699|NCT00725621|6169779|P1|Overall Study|Physician Decision|19
1771700|NCT00725621|6169779|P1|Overall Study|Withdrawal by Subject|57
1771701|NCT00725621|6169779|P1|Overall Study|Lack of Efficacy|46
1771702|NCT00725621|6169779|P1|Overall Study|Adverse Event|25
1771703|NCT00725608|6169802|P1|Overall Study|Other|7
1771704|NCT00725608|6169802|P1|Overall Study|Individual reasons|86
1771705|NCT00725608|6169802|P1|Overall Study|Adverse Event|14
1771706|NCT00725608|6169802|P1|Overall Study|Lost to Follow-up|60
1771707|NCT00725543|6169808|P1|Overall Study|Other|119
1771708|NCT00725543|6169808|P1|Overall Study|Non-compliance|2
1771709|NCT00725543|6169808|P1|Overall Study|Lost to Follow-up|4
1771710|NCT00725543|6169808|P1|Overall Study|Physician Decision|5
1771711|NCT00725543|6169808|P1|Overall Study|Withdrawal by Subject|10
1771712|NCT00725543|6169808|P1|Overall Study|Lack of Efficacy|3
1771713|NCT00725543|6169808|P1|Overall Study|Adverse Event|10
1771714|NCT00725491|6169833|P2|Overall Study|No/too few embryos/ bad quality embryos|2
1771715|NCT00725491|6169834|P1|Overall Study|No/too few embryos/ bad quality embryos|3
1771716|NCT00725491|6169833|P2|Overall Study|Fertilization failure|1
1771717|NCT00725491|6169834|P1|Overall Study|Fertilization failure|0
1771718|NCT00725491|6169833|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
1771719|NCT00725491|6169834|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
1771720|NCT00725491|6169833|P2|Overall Study|Risk for hyperstimulation|9
1771721|NCT00725491|6169834|P1|Overall Study|Risk for hyperstimulation|2
1771722|NCT00725491|6169833|P2|Overall Study|Pregnancy|3
1771723|NCT00725491|6169834|P1|Overall Study|Pregnancy|0
1771724|NCT00725491|6169833|P2|Overall Study|Adverse Event|2
1771725|NCT00725491|6169834|P1|Overall Study|Adverse Event|3
1771726|NCT00725452|6169840|P1|Overall Study|Lost to Follow-up|1
1771727|NCT00725452|6169840|P1|Overall Study|Withdrawal by Subject|3
1771728|NCT00725452|6169840|P1|Overall Study|Physician Decision|1
1771729|NCT00725452|6169840|P1|Overall Study|Reason not specified|1
1771730|NCT00725452|6169840|P1|Overall Study|Lack of Efficacy|2
1771731|NCT00725452|6169840|P1|Overall Study|Adverse Event|3
1771732|NCT00725322|6169859|P2|Washout (28 Days)|Protocol Violation|1
1771733|NCT00725322|6169860|P1|Washout (28 Days)|Protocol Violation|0
1771734|NCT00725322|6169859|P2|Washout (28 Days)|Withdrawal by Subject|0
1771735|NCT00725322|6169860|P1|Washout (28 Days)|Withdrawal by Subject|2
1771736|NCT00725296|6169868|P1|Overall Study|Other|38
1771737|NCT00725296|6169868|P1|Overall Study|Lost to Follow-up|1
1771738|NCT00725296|6169868|P1|Overall Study|Non-Compliance|2
1771739|NCT00725296|6169868|P1|Overall Study|Withdrawal by Subject|3
1771740|NCT00725296|6169868|P1|Overall Study|Lack of Efficacy|7
1771741|NCT00725296|6169868|P1|Overall Study|Adverse Event|11
1771742|NCT00725283|6169877|P1|Overall Study|Withdrawal by Subject|10
1771743|NCT00725283|6169877|P1|Overall Study|Other|6
1771744|NCT00725283|6169877|P1|Overall Study|Death|5
1771745|NCT00725283|6169877|P1|Overall Study|Missing Code|3
1771746|NCT00725205|6169898|P1|Overall Study|Treatment Failure|41
1771747|NCT00725205|6169898|P1|Overall Study|Protocol Defined Clinical Event|1
1771748|NCT00725205|6169898|P1|Overall Study|Other|8
1771749|NCT00725205|6169898|P1|Overall Study|Non-compliance With Protocol|14
1771750|NCT00725205|6169898|P1|Overall Study|Investigator Discontinued|1
1771751|NCT00725205|6169898|P1|Overall Study|Adverse Event|22
1771752|NCT00725101|6169911|P1|Overall Study|not specified/no reason given|11
1771753|NCT00725101|6169911|P1|Overall Study|Withdrawal by Subject|127
1771754|NCT00725101|6169911|P1|Overall Study|Protocol Violation|1
1771755|NCT00725101|6169911|P1|Overall Study|Lost to Follow-up|353
1771756|NCT00725101|6169911|P1|Overall Study|Death|3
1771757|NCT00725075|6169934|P3|Overall Study|Other|0
1771758|NCT00725075|6169935|P2|Overall Study|Other|0
1771759|NCT00725075|6169936|P1|Overall Study|Other|1
1771760|NCT00725075|6169934|P3|Overall Study|Inclusion/Exclusion Criteria|1
1771761|NCT00725075|6169935|P2|Overall Study|Inclusion/Exclusion Criteria|0
1771762|NCT00725075|6169936|P1|Overall Study|Inclusion/Exclusion Criteria|1
1771763|NCT00725075|6169934|P3|Overall Study|Worsening of Disease|2
1771764|NCT00725075|6169935|P2|Overall Study|Worsening of Disease|1
1771765|NCT00725075|6169936|P1|Overall Study|Worsening of Disease|2
1771766|NCT00725075|6169934|P3|Overall Study|Adverse Event|1
1771767|NCT00725075|6169935|P2|Overall Study|Adverse Event|1
1771768|NCT00725075|6169936|P1|Overall Study|Adverse Event|2
1771769|NCT00725075|6169934|P3|Overall Study|Withdrawal by Subject|4
1771770|NCT00725075|6169935|P2|Overall Study|Withdrawal by Subject|5
1771771|NCT00725075|6169936|P1|Overall Study|Withdrawal by Subject|4
1771772|NCT00725075|6169934|P3|Overall Study|Lost to Follow-up|0
1771773|NCT00725075|6169935|P2|Overall Study|Lost to Follow-up|0
1771774|NCT00725075|6169936|P1|Overall Study|Lost to Follow-up|1
1771775|NCT00725075|6169934|P3|Overall Study|Protocol Violation|1
1771776|NCT00725075|6169935|P2|Overall Study|Protocol Violation|0
1771777|NCT00725075|6169936|P1|Overall Study|Protocol Violation|0
1771778|NCT00725075|6169934|P3|Overall Study|Use of Excluded Medication|0
1771779|NCT00725075|6169935|P2|Overall Study|Use of Excluded Medication|1
1771780|NCT00725075|6169936|P1|Overall Study|Use of Excluded Medication|0
1771781|NCT00725010|6169989|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
1771782|NCT00725010|6169989|P1|Overall Study|No further documentation|1
1771783|NCT00725010|6169989|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
1771784|NCT00725010|6169989|P1|Overall Study|Hepatopathy probably not Temodal-related|1
1771785|NCT00725010|6169989|P1|Overall Study|Lost to Follow-up|1
1771786|NCT00725010|6169989|P1|Overall Study|Death|1
1771787|NCT00725010|6169989|P1|Overall Study|Withdrawal by Subject|2
1771788|NCT00725010|6169989|P1|Overall Study|Tumor Progression|7
1771789|NCT00725010|6169989|P1|Overall Study|Toxicity|9
1771790|NCT00724971|6170022|P1|Overall Study|Withdrawal by Subject|1
1771791|NCT00724971|6170022|P1|Overall Study|Adverse Event|5
1771792|NCT00724958|6170037|P1|Overall Study|No documentation for end of therapy|13
1771793|NCT00724958|6170037|P1|Overall Study|Other Reason|76
1771794|NCT00724958|6170037|P1|Overall Study|Remission|7
1771795|NCT00724958|6170037|P1|Overall Study|No Response|18
1771796|NCT00724958|6170037|P1|Overall Study|Loss of Response|40
1771797|NCT00724958|6170037|P1|Overall Study|Adverse Event|28
1771798|NCT00724945|6170046|P2|Period 2|lens physiology issue|0
1771799|NCT00724945|6170047|P1|Period 2|lens physiology issue|1
1771800|NCT00724945|6170046|P2|Period 2|lens comfort issue|0
1771801|NCT00724945|6170047|P1|Period 2|lens comfort issue|3
1771802|NCT00724945|6170046|P2|Period 1|Lost to Follow-up|0
1771803|NCT00724945|6170047|P1|Period 1|Lost to Follow-up|1
1771804|NCT00724945|6170046|P2|Period 1|Adverse Event|1
1771805|NCT00724945|6170047|P1|Period 1|Adverse Event|1
1771806|NCT00724945|6170046|P2|Period 1|non-compliance|0
1771807|NCT00724945|6170047|P1|Period 1|non-compliance|1
1771808|NCT00724932|6170059|P2|Overall Study|Not treated|3
1771809|NCT00724932|6170060|P1|Overall Study|Not treated|4
1771810|NCT00724932|6170059|P2|Overall Study|Lost to Follow-up|0
1771811|NCT00724932|6170060|P1|Overall Study|Lost to Follow-up|1
1771812|NCT00724893|6170131|P2|Overall Study|Unknown, missing data|1
1771813|NCT00724893|6170132|P1|Overall Study|Unknown, missing data|1
1771814|NCT00724893|6170131|P2|Overall Study|Lost to Follow-up|52
1771815|NCT00724893|6170132|P1|Overall Study|Lost to Follow-up|0
1771816|NCT00724893|6170131|P2|Overall Study|Assigned shorter treatment|2
1771817|NCT00724893|6170132|P1|Overall Study|Assigned shorter treatment|0
1771818|NCT00724893|6170131|P2|Overall Study|Financial reasons|2
1771819|NCT00724893|6170132|P1|Overall Study|Financial reasons|0
1771820|NCT00724893|6170131|P2|Overall Study|Substance abuse|3
1771821|NCT00724893|6170132|P1|Overall Study|Substance abuse|0
1771822|NCT00724893|6170131|P2|Overall Study|Incarceration|9
1771823|NCT00724893|6170132|P1|Overall Study|Incarceration|0
1771824|NCT00724893|6170131|P2|Overall Study|Geographic reasons|11
1771825|NCT00724893|6170132|P1|Overall Study|Geographic reasons|0
1771826|NCT00724893|6170131|P2|Overall Study|Patient choice|26
1771827|NCT00724893|6170132|P1|Overall Study|Patient choice|0
1771828|NCT00724893|6170131|P2|Overall Study|Reason not specified|7
1771829|NCT00724893|6170132|P1|Overall Study|Reason not specified|193
1771830|NCT00724893|6170131|P2|Overall Study|Lack of virologic response|202
1771831|NCT00724893|6170132|P1|Overall Study|Lack of virologic response|94
1771832|NCT00724893|6170131|P2|Overall Study|Withdrawal by Subject|1
1771833|NCT00724893|6170132|P1|Overall Study|Withdrawal by Subject|0
1771834|NCT00724893|6170131|P2|Overall Study|Adverse Event|142
1771835|NCT00724893|6170132|P1|Overall Study|Adverse Event|76
1771836|NCT00724867|6170200|P1|Overall Study|Elected to exit due to site closure|2
1771837|NCT00724867|6170200|P1|Overall Study|Subject moved out of state|1
1771838|NCT00724867|6170200|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
1771839|NCT00724867|6170200|P1|Overall Study|Subject incarcerated|1
1771840|NCT00724867|6170200|P1|Overall Study|Sponsor decision to end study|14
1771841|NCT00724867|6170200|P1|Overall Study|Withdrawal by Subject|31
1771842|NCT00724867|6170200|P1|Overall Study|Protocol Violation|1
1771843|NCT00724867|6170200|P1|Overall Study|Physician Decision|17
1771844|NCT00724867|6170200|P1|Overall Study|Non-compliance with study drug|6
1771845|NCT00724867|6170200|P1|Overall Study|Lost to Follow-up|12
1771846|NCT00724867|6170200|P1|Overall Study|Lack of Efficacy|14
1771847|NCT00724867|6170200|P1|Overall Study|Adverse Event|25
1771848|NCT00724854|6170240|P2|Overall Study|Adverse event + lack of efficacy|1
1771849|NCT00724854|6170241|P1|Overall Study|Adverse event + lack of efficacy|2
1771850|NCT00724854|6170240|P2|Overall Study|Withdrawal by Subject|0
1771851|NCT00724854|6170241|P1|Overall Study|Withdrawal by Subject|5
1771852|NCT00724854|6170240|P2|Overall Study|Change of treatment|0
1771853|NCT00724854|6170241|P1|Overall Study|Change of treatment|7
1771854|NCT00724854|6170240|P2|Overall Study|Death|0
1771855|NCT00724854|6170241|P1|Overall Study|Death|11
1771856|NCT00724854|6170240|P2|Overall Study|Other|3
1771857|NCT00724854|6170241|P1|Overall Study|Other|42
1771858|NCT00724854|6170240|P2|Overall Study|Adverse Event|4
1771859|NCT00724854|6170241|P1|Overall Study|Adverse Event|62
1771860|NCT00724854|6170240|P2|Overall Study|Lost to Follow-up|10
1771861|NCT00724854|6170241|P1|Overall Study|Lost to Follow-up|87
1771862|NCT00724854|6170240|P2|Overall Study|Lack of Efficacy|13
1771863|NCT00724854|6170241|P1|Overall Study|Lack of Efficacy|187
1771864|NCT00724815|6170258|P2|Overall Study|Other Various|5
1771865|NCT00724815|6170259|P1|Overall Study|Other Various|3
1771866|NCT00724815|6170258|P2|Overall Study|Lost to Follow-up|1
1771867|NCT00724815|6170259|P1|Overall Study|Lost to Follow-up|4
1771868|NCT00724815|6170258|P2|Overall Study|Adverse Event|3
1771869|NCT00724815|6170259|P1|Overall Study|Adverse Event|5
1771870|NCT00724815|6170258|P2|Overall Study|Randomized, not treated|30
1771871|NCT00724815|6170259|P1|Overall Study|Randomized, not treated|31
1771872|NCT00724711|6170292|P2|Overall Study|Protocol Violation|0
1771873|NCT00724711|6170293|P1|Overall Study|Protocol Violation|1
1771874|NCT00724711|6170292|P2|Overall Study|Lost to Follow-up|5
1771875|NCT00724711|6170293|P1|Overall Study|Lost to Follow-up|4
1771876|NCT00724711|6170292|P2|Overall Study|Withdrawal by Subject|4
1771877|NCT00724711|6170293|P1|Overall Study|Withdrawal by Subject|5
1771878|NCT00724711|6170292|P2|Overall Study|Physician Decision|3
1771879|NCT00724711|6170293|P1|Overall Study|Physician Decision|0
1771880|NCT00724711|6170292|P2|Overall Study|Lack of Efficacy|1
1771881|NCT00724711|6170293|P1|Overall Study|Lack of Efficacy|0
1771882|NCT00724711|6170292|P2|Overall Study|Pregnancy|1
1771883|NCT00724711|6170293|P1|Overall Study|Pregnancy|0
1771884|NCT00724711|6170292|P2|Overall Study|Adverse Event|3
1771885|NCT00724711|6170293|P1|Overall Study|Adverse Event|7
1771886|NCT00724698|6170325|P1|Overall Study|No Info|25
1771887|NCT00724698|6170325|P1|Overall Study|Lost to Follow-up|36
1771888|NCT00724698|6170325|P1|Overall Study|Poor Compliance|16
1771889|NCT00724698|6170325|P1|Overall Study|Failure of Therapy|4
1771890|NCT00724698|6170325|P1|Overall Study|Adverse Event|9
1771891|NCT00724503|6170378|P2|Overall Study|Not otherwise specified|7
1771892|NCT00724503|6170379|P1|Overall Study|Not otherwise specified|4
1771893|NCT00724503|6170378|P2|Overall Study|Adverse Event|0
1771894|NCT00724503|6170379|P1|Overall Study|Adverse Event|1
1771895|NCT00724503|6170378|P2|Overall Study|Death|182
1771896|NCT00724503|6170379|P1|Overall Study|Death|190
1771897|NCT00724503|6170378|P2|Overall Study|Withdrawal by Subject|23
1771898|NCT00724503|6170379|P1|Overall Study|Withdrawal by Subject|11
1771899|NCT00724503|6170378|P2|Overall Study|Lost to Follow-up|8
1771900|NCT00724503|6170379|P1|Overall Study|Lost to Follow-up|4
1771901|NCT00724451|6170403|P1|Overall Study|Investigator + Participant Decision|13
1771902|NCT00724451|6170403|P1|Overall Study|Withdrawal by Subject|45
1771903|NCT00724451|6170403|P1|Overall Study|Physician Decision|116
1771904|NCT00724451|6170403|P1|Overall Study|Unknown; No Data Sources Available|9
1771905|NCT00724451|6170403|P1|Overall Study|Never Started Treatment|89
1771906|NCT00724451|6170403|P1|Overall Study|Participant Refused Treatment|89
1771907|NCT00724451|6170403|P1|Overall Study|Not Eligible for Treatment|431
1771908|NCT00724451|6170403|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
1771909|NCT00724451|6170403|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
1771910|NCT00724373|6170409|P1|Overall Study|Tolerability|23
1771911|NCT00724373|6170409|P1|Overall Study|Drug Relapse|1
1771912|NCT00724373|6170409|P1|Overall Study|Acute HCV infection|1
1771913|NCT00724373|6170409|P1|Overall Study|Viral Relapse|1
1771914|NCT00724373|6170409|P1|Overall Study|Only to have 24 week regimen|1
1771915|NCT00724373|6170409|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
1771916|NCT00724373|6170409|P1|Overall Study|Participant moved away|1
1771917|NCT00724373|6170409|P1|Overall Study|HCV RNA negative after 4 weeks|9
1771918|NCT00724373|6170409|P1|Overall Study|Non-compliance|2
1771919|NCT00724373|6170409|P1|Overall Study|Lost to Follow-up|7
1771920|NCT00724373|6170409|P1|Overall Study|Lack of Efficacy|82
1771921|NCT00724373|6170409|P1|Overall Study|Adverse Event|41
1771922|NCT00724282|6170426|P1|Overall Study|Physician Decision|1
1771923|NCT00724282|6170426|P1|Overall Study|Withdrawal by Subject|3
1771924|NCT00724243|6170430|P1|Overall Study|Adverse Event|5
1771925|NCT00724243|6170430|P1|Overall Study|Lack of Efficacy|10
1771926|NCT00724152|6170440|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
1771927|NCT00724152|6170441|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
1771928|NCT00724152|6170442|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
1771929|NCT00724152|6170440|P3|Two-arm Study Period|Withdrawal by Subject|0
1771930|NCT00724152|6170441|P2|Two-arm Study Period|Withdrawal by Subject|2
1771931|NCT00724152|6170442|P1|Two-arm Study Period|Withdrawal by Subject|3
1771932|NCT00724126|6170459|P2|Overall Study|Subject had to leave vicinity of site|1
1771933|NCT00724126|6170460|P1|Overall Study|Subject had to leave vicinity of site|0
1771934|NCT00724126|6170459|P2|Overall Study|Subject randomized although ineligible|1
1771935|NCT00724126|6170460|P1|Overall Study|Subject randomized although ineligible|1
1771936|NCT00724126|6170459|P2|Overall Study|Noncompliance|1
1771937|NCT00724126|6170460|P1|Overall Study|Noncompliance|2
1771938|NCT00724126|6170459|P2|Overall Study|Lost to Follow-up|6
1771939|NCT00724126|6170460|P1|Overall Study|Lost to Follow-up|6
1771940|NCT00724126|6170459|P2|Overall Study|Withdrawal by Subject|6
1771941|NCT00724126|6170460|P1|Overall Study|Withdrawal by Subject|8
1771942|NCT00724126|6170459|P2|Overall Study|Adverse Event|0
1771943|NCT00724126|6170460|P1|Overall Study|Adverse Event|2
1771944|NCT00724061|6170468|P1|Dose Escalation Phase|Disease Progression|3
1771945|NCT00724061|6170468|P1|Dose Escalation Phase|Adverse Event|2
1771946|NCT00723957|6170488|P2|Overall Study|Never received treatment|3
1771947|NCT00723957|6170489|P1|Overall Study|Never received treatment|3
1771948|NCT00723957|6170488|P2|Overall Study|Reason not analyzed|0
1771949|NCT00723957|6170489|P1|Overall Study|Reason not analyzed|1
1771950|NCT00723957|6170488|P2|Overall Study|Withdrawal by Subject|5
1771951|NCT00723957|6170489|P1|Overall Study|Withdrawal by Subject|7
1771952|NCT00723957|6170488|P2|Overall Study|Study drug toxicity|6
1771953|NCT00723957|6170489|P1|Overall Study|Study drug toxicity|4
1771954|NCT00723957|6170488|P2|Overall Study|Investigator decision|1
1771955|NCT00723957|6170489|P1|Overall Study|Investigator decision|1
1771956|NCT00723957|6170488|P2|Overall Study|Maximum clinical benefit|5
1771957|NCT00723957|6170489|P1|Overall Study|Maximum clinical benefit|4
1771958|NCT00723957|6170488|P2|Overall Study|Disease progression|25
1771959|NCT00723957|6170489|P1|Overall Study|Disease progression|27
1771960|NCT00723957|6170488|P2|Overall Study|Death|4
1771961|NCT00723957|6170489|P1|Overall Study|Death|3
1771962|NCT00723957|6170488|P2|Overall Study|Adverse event unrelated to study drug|4
1771963|NCT00723957|6170489|P1|Overall Study|Adverse event unrelated to study drug|1
1771964|NCT00723944|6170513|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
1771965|NCT00723944|6170514|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
1771966|NCT00723944|6170513|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
1771967|NCT00723944|6170514|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
1771968|NCT00723944|6170513|P2|Permanent Prosthesis Placement|Adverse Event|7
1771969|NCT00723944|6170514|P1|Permanent Prosthesis Placement|Adverse Event|1
1771970|NCT00723892|6170527|P2|Overall Study|Drug addiction|0
1771971|NCT00723892|6170528|P1|Overall Study|Drug addiction|1
1771972|NCT00723892|6170527|P2|Overall Study|Intercurrent infection|0
1771973|NCT00723892|6170528|P1|Overall Study|Intercurrent infection|2
1771974|NCT00723892|6170527|P2|Overall Study|Alcohol abuse|1
1771975|NCT00723892|6170528|P1|Overall Study|Alcohol abuse|0
1771976|NCT00723892|6170527|P2|Overall Study|Weight loss|3
1771977|NCT00723892|6170528|P1|Overall Study|Weight loss|1
1771978|NCT00723892|6170527|P2|Overall Study|Study end|3
1771979|NCT00723892|6170528|P1|Overall Study|Study end|1
1771980|NCT00723892|6170527|P2|Overall Study|Other|3
1771981|NCT00723892|6170528|P1|Overall Study|Other|6
1771982|NCT00723892|6170527|P2|Overall Study|Multiple reasons|12
1771983|NCT00723892|6170528|P1|Overall Study|Multiple reasons|17
1771984|NCT00723892|6170527|P2|Overall Study|Bad tolerance|5
1771985|NCT00723892|6170528|P1|Overall Study|Bad tolerance|5
1771986|NCT00723892|6170527|P2|Overall Study|End planned|7
1771987|NCT00723892|6170528|P1|Overall Study|End planned|11
1771988|NCT00723892|6170527|P2|Overall Study|Withdrawal by Subject|9
1771989|NCT00723892|6170528|P1|Overall Study|Withdrawal by Subject|6
1771990|NCT00723892|6170527|P2|Overall Study|Virological criterion|9
1771991|NCT00723892|6170528|P1|Overall Study|Virological criterion|24
1771992|NCT00723892|6170527|P2|Overall Study|Participant not tracked|35
1771993|NCT00723892|6170528|P1|Overall Study|Participant not tracked|33
1771994|NCT00723840|6170535|P1|Overall Study|Unspecified reason|2
1771995|NCT00723840|6170535|P1|Overall Study|Other Medical Event|2
1771996|NCT00723840|6170535|P1|Overall Study|Serious Adverse Events|3
1771997|NCT00723840|6170535|P1|Overall Study|Withdrawal by Subject|55
1771998|NCT00723840|6170535|P1|Overall Study|Failure to return|18
1771999|NCT00723840|6170535|P1|Overall Study|Lost to Follow-up|2
1772000|NCT00723801|6170556|P2|Overall Study|Protocol Violation|1
1772001|NCT00723801|6170557|P1|Overall Study|Protocol Violation|2
1772002|NCT00723801|6170556|P2|Overall Study|Lost to Follow-up|2
1772003|NCT00723801|6170557|P1|Overall Study|Lost to Follow-up|1
1772004|NCT00723710|6170582|P1|Overall Study|Physician Decision|2
1772005|NCT00723710|6170582|P1|Overall Study|Withdrawal by Subject|36
1772006|NCT00723710|6170582|P1|Overall Study|Adverse Event|88
1772007|NCT00723710|6170582|P1|Overall Study|Disease progression|48
1772008|NCT00723697|6170586|P1|Overall Study|Other exclusion criteria applied|6
1772009|NCT00723697|6170586|P1|Overall Study|Missing Informed Consent Form|10
1772010|NCT00723697|6170586|P1|Overall Study|Physician questionnaires not received|2
1772011|NCT00723606|6170607|P2|Overall Study|Withdrawal by Subject|2
1772012|NCT00723606|6170608|P1|Overall Study|Withdrawal by Subject|0
1772013|NCT00723606|6170607|P2|Overall Study|Other|0
1772014|NCT00723606|6170608|P1|Overall Study|Other|2
1772015|NCT00723606|6170607|P2|Overall Study|Adverse Event|5
1772016|NCT00723606|6170608|P1|Overall Study|Adverse Event|2
1772017|NCT00723554|6170628|P1|Overall Study|Non-compliance|1
1772018|NCT00723554|6170628|P1|Overall Study|Lost to Follow-up|1
1772019|NCT00723554|6170628|P1|Overall Study|Other|3
1772020|NCT00723554|6170628|P1|Overall Study|Withdrawal of consent|3
1772021|NCT00723554|6170628|P1|Overall Study|Inhaled medication other than iloprost|4
1772022|NCT00723554|6170628|P1|Overall Study|Investigator's judgement|5
1772023|NCT00723554|6170628|P1|Overall Study|Adverse Event|12
1772024|NCT00723528|6170678|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
1772025|NCT00723528|6170679|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1772026|NCT00723528|6170680|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1772027|NCT00723528|6170681|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1772028|NCT00723528|6170682|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1772029|NCT00723528|6170683|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1772030|NCT00723528|6170684|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
1772031|NCT00723528|6170678|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
1772032|NCT00723528|6170679|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1772033|NCT00723528|6170680|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1772034|NCT00723528|6170681|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1772035|NCT00723528|6170682|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1772036|NCT00723528|6170683|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1772037|NCT00723528|6170684|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
1772038|NCT00723528|6170678|P7|Period 2: After Controlled Period|Adverse Event|1
1772039|NCT00723528|6170679|P6|Period 2: After Controlled Period|Adverse Event|0
1772040|NCT00723528|6170680|P5|Period 2: After Controlled Period|Adverse Event|1
1772041|NCT00723528|6170681|P4|Period 2: After Controlled Period|Adverse Event|0
1772042|NCT00723528|6170682|P3|Period 2: After Controlled Period|Adverse Event|0
1772043|NCT00723528|6170683|P2|Period 2: After Controlled Period|Adverse Event|0
1772044|NCT00723528|6170684|P1|Period 2: After Controlled Period|Adverse Event|0
1772045|NCT00723528|6170678|P7|Period 2: After Controlled Period|Other|0
1772046|NCT00723528|6170679|P6|Period 2: After Controlled Period|Other|4
1772047|NCT00723528|6170680|P5|Period 2: After Controlled Period|Other|1
1772048|NCT00723528|6170681|P4|Period 2: After Controlled Period|Other|0
1772049|NCT00723528|6170682|P3|Period 2: After Controlled Period|Other|0
1772050|NCT00723528|6170683|P2|Period 2: After Controlled Period|Other|0
1772051|NCT00723528|6170684|P1|Period 2: After Controlled Period|Other|0
1772052|NCT00723528|6170678|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1772053|NCT00723528|6170679|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
1772054|NCT00723528|6170680|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1772055|NCT00723528|6170681|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1772056|NCT00723528|6170682|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1772057|NCT00723528|6170683|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1772058|NCT00723528|6170684|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
1772059|NCT00723528|6170678|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
1772060|NCT00723528|6170679|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
1772061|NCT00723528|6170680|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
1772062|NCT00723528|6170681|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
1772063|NCT00723528|6170682|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
1772064|NCT00723528|6170683|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
1772065|NCT00723528|6170684|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
1772066|NCT00723528|6170678|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1772067|NCT00723528|6170679|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1772068|NCT00723528|6170680|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1772069|NCT00723528|6170681|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1772070|NCT00723528|6170682|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
1772071|NCT00723528|6170683|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
1772072|NCT00723528|6170684|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
1772073|NCT00723528|6170678|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1772074|NCT00723528|6170679|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1772075|NCT00723528|6170680|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1772076|NCT00723528|6170681|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1772077|NCT00723528|6170682|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
1772078|NCT00723528|6170683|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1772079|NCT00723528|6170684|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
1772080|NCT00723528|6170678|P7|Period 1: Controlled Period (CP)|Physician Decision|0
1772081|NCT00723528|6170679|P6|Period 1: Controlled Period (CP)|Physician Decision|0
1772082|NCT00723528|6170680|P5|Period 1: Controlled Period (CP)|Physician Decision|0
1772083|NCT00723528|6170681|P4|Period 1: Controlled Period (CP)|Physician Decision|0
1772084|NCT00723528|6170682|P3|Period 1: Controlled Period (CP)|Physician Decision|1
1772085|NCT00723528|6170683|P2|Period 1: Controlled Period (CP)|Physician Decision|0
1772086|NCT00723528|6170684|P1|Period 1: Controlled Period (CP)|Physician Decision|0
1772087|NCT00723528|6170678|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1772088|NCT00723528|6170679|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1772089|NCT00723528|6170680|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1772090|NCT00723528|6170681|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1772091|NCT00723528|6170682|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1772178|NCT00723398|6170827|P3|Overall Study|Protocol Violation|5
1772092|NCT00723528|6170683|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
1772093|NCT00723528|6170684|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
1772094|NCT00723528|6170678|P7|Period 1: Controlled Period (CP)|Adverse Event|0
1772095|NCT00723528|6170679|P6|Period 1: Controlled Period (CP)|Adverse Event|0
1772096|NCT00723528|6170680|P5|Period 1: Controlled Period (CP)|Adverse Event|0
1772097|NCT00723528|6170681|P4|Period 1: Controlled Period (CP)|Adverse Event|0
1772098|NCT00723528|6170682|P3|Period 1: Controlled Period (CP)|Adverse Event|1
1772099|NCT00723528|6170683|P2|Period 1: Controlled Period (CP)|Adverse Event|0
1772100|NCT00723528|6170684|P1|Period 1: Controlled Period (CP)|Adverse Event|0
1772101|NCT00723489|6170746|P4|Overall Study|Samples Collected Out of Window|0
1772102|NCT00723489|6170747|P3|Overall Study|Samples Collected Out of Window|0
1772103|NCT00723489|6170748|P2|Overall Study|Samples Collected Out of Window|3
1772104|NCT00723489|6170749|P1|Overall Study|Samples Collected Out of Window|0
1772105|NCT00723489|6170746|P4|Overall Study|Prohibited Medication|1
1772106|NCT00723489|6170747|P3|Overall Study|Prohibited Medication|0
1772107|NCT00723489|6170748|P2|Overall Study|Prohibited Medication|0
1772108|NCT00723489|6170749|P1|Overall Study|Prohibited Medication|0
1772109|NCT00723489|6170746|P4|Overall Study|Seropositive at baseline|0
1772110|NCT00723489|6170747|P3|Overall Study|Seropositive at baseline|0
1772111|NCT00723489|6170748|P2|Overall Study|Seropositive at baseline|0
1772112|NCT00723489|6170749|P1|Overall Study|Seropositive at baseline|1
1772113|NCT00723489|6170746|P4|Overall Study|Withdrawal by Subject|1
1772114|NCT00723489|6170747|P3|Overall Study|Withdrawal by Subject|0
1772115|NCT00723489|6170748|P2|Overall Study|Withdrawal by Subject|0
1772116|NCT00723489|6170749|P1|Overall Study|Withdrawal by Subject|0
1772117|NCT00723489|6170746|P4|Overall Study|Pregnancy|1
1772118|NCT00723489|6170747|P3|Overall Study|Pregnancy|0
1772119|NCT00723489|6170748|P2|Overall Study|Pregnancy|0
1772120|NCT00723489|6170749|P1|Overall Study|Pregnancy|0
1772121|NCT00723489|6170746|P4|Overall Study|Physician Decision|0
1772122|NCT00723489|6170747|P3|Overall Study|Physician Decision|0
1772123|NCT00723489|6170748|P2|Overall Study|Physician Decision|1
1772124|NCT00723489|6170749|P1|Overall Study|Physician Decision|0
1772125|NCT00723450|6170777|P3|Randomized Phase|Withdrawal by Subject|22
1772126|NCT00723450|6170778|P2|Randomized Phase|Withdrawal by Subject|14
1772127|NCT00723450|6170779|P1|Randomized Phase|Withdrawal by Subject|0
1772128|NCT00723450|6170777|P3|Randomized Phase|Physician Decision|1
1772129|NCT00723450|6170778|P2|Randomized Phase|Physician Decision|3
1772130|NCT00723450|6170779|P1|Randomized Phase|Physician Decision|0
1772131|NCT00723450|6170777|P3|Randomized Phase|Lost to Follow-up|3
1772132|NCT00723450|6170778|P2|Randomized Phase|Lost to Follow-up|2
1772133|NCT00723450|6170779|P1|Randomized Phase|Lost to Follow-up|0
1772134|NCT00723450|6170777|P3|Randomized Phase|Protocol Violation|13
1772135|NCT00723450|6170778|P2|Randomized Phase|Protocol Violation|9
1772136|NCT00723450|6170779|P1|Randomized Phase|Protocol Violation|0
1772137|NCT00723450|6170777|P3|Randomized Phase|Lack of Efficacy|11
1772138|NCT00723450|6170778|P2|Randomized Phase|Lack of Efficacy|11
1772139|NCT00723450|6170779|P1|Randomized Phase|Lack of Efficacy|0
1772140|NCT00723450|6170777|P3|Randomized Phase|Adverse Event|17
1772141|NCT00723450|6170778|P2|Randomized Phase|Adverse Event|26
1772142|NCT00723450|6170779|P1|Randomized Phase|Adverse Event|0
1772143|NCT00723450|6170777|P3|Open-Label Phase|Withdrawal by Subject|0
1772144|NCT00723450|6170778|P2|Open-Label Phase|Withdrawal by Subject|0
1772145|NCT00723450|6170779|P1|Open-Label Phase|Withdrawal by Subject|37
1772146|NCT00723450|6170777|P3|Open-Label Phase|Physician Decision|0
1772147|NCT00723450|6170778|P2|Open-Label Phase|Physician Decision|0
1772148|NCT00723450|6170779|P1|Open-Label Phase|Physician Decision|2
1772149|NCT00723450|6170777|P3|Open-Label Phase|Lost to Follow-up|0
1772150|NCT00723450|6170778|P2|Open-Label Phase|Lost to Follow-up|0
1772151|NCT00723450|6170779|P1|Open-Label Phase|Lost to Follow-up|7
1772152|NCT00723450|6170777|P3|Open-Label Phase|Protocol Violation|0
1772153|NCT00723450|6170778|P2|Open-Label Phase|Protocol Violation|0
1772154|NCT00723450|6170779|P1|Open-Label Phase|Protocol Violation|35
1772155|NCT00723450|6170777|P3|Open-Label Phase|Lack of Efficacy|0
1772156|NCT00723450|6170778|P2|Open-Label Phase|Lack of Efficacy|0
1772157|NCT00723450|6170779|P1|Open-Label Phase|Lack of Efficacy|18
1772158|NCT00723450|6170777|P3|Open-Label Phase|Adverse Event|0
1772159|NCT00723450|6170778|P2|Open-Label Phase|Adverse Event|0
1772160|NCT00723450|6170779|P1|Open-Label Phase|Adverse Event|26
1772161|NCT00723398|6170825|P5|Overall Study|Lost to Follow-up|0
1772162|NCT00723398|6170826|P4|Overall Study|Lost to Follow-up|0
1772163|NCT00723398|6170827|P3|Overall Study|Lost to Follow-up|0
1772164|NCT00723398|6170828|P2|Overall Study|Lost to Follow-up|1
1772165|NCT00723398|6170829|P1|Overall Study|Lost to Follow-up|0
1772166|NCT00723398|6170825|P5|Overall Study|Adverse Event|4
1772167|NCT00723398|6170826|P4|Overall Study|Adverse Event|1
1772168|NCT00723398|6170827|P3|Overall Study|Adverse Event|3
1772169|NCT00723398|6170828|P2|Overall Study|Adverse Event|5
1772170|NCT00723398|6170829|P1|Overall Study|Adverse Event|0
1772171|NCT00723398|6170825|P5|Overall Study|Physician Decision|1
1772172|NCT00723398|6170826|P4|Overall Study|Physician Decision|0
1772173|NCT00723398|6170827|P3|Overall Study|Physician Decision|5
1772174|NCT00723398|6170828|P2|Overall Study|Physician Decision|2
1772175|NCT00723398|6170829|P1|Overall Study|Physician Decision|2
1772176|NCT00723398|6170825|P5|Overall Study|Protocol Violation|0
1772177|NCT00723398|6170826|P4|Overall Study|Protocol Violation|0
1772179|NCT00723398|6170828|P2|Overall Study|Protocol Violation|1
1772180|NCT00723398|6170829|P1|Overall Study|Protocol Violation|2
1772181|NCT00723398|6170825|P5|Overall Study|Withdrawal by Subject|4
1772182|NCT00723398|6170826|P4|Overall Study|Withdrawal by Subject|4
1772183|NCT00723398|6170827|P3|Overall Study|Withdrawal by Subject|4
1772184|NCT00723398|6170828|P2|Overall Study|Withdrawal by Subject|6
1772185|NCT00723398|6170829|P1|Overall Study|Withdrawal by Subject|2
1772186|NCT00723294|6170891|P1|Overall Study|No treatment due to probe failure|1
1772187|NCT00723294|6170891|P1|Overall Study|Withdrawal by Subject|1
1772188|NCT00723294|6170891|P1|Overall Study|Benign lesion|1
1772189|NCT00723294|6170891|P1|Overall Study|Treated by non-credentialed surgeon|1
1772190|NCT00723294|6170891|P1|Overall Study|Treated prior to registration|1
1772191|NCT00723294|6170891|P1|Overall Study|Did not undergo surgery|1
1772192|NCT00723294|6170891|P1|Overall Study|No cryoabalation|2
1772193|NCT00723294|6170891|P1|Overall Study|1.0-Tesla MRI|1
1772194|NCT00723294|6170891|P1|Overall Study|No MRI tumor enhancement|1
1772195|NCT00723294|6170891|P1|Overall Study|>25% intraductal component|1
1772196|NCT00723294|6170891|P1|Overall Study|Lobular histology|2
1772197|NCT00723255|6170896|P1|Overall Study|Ineligible: Wrong Primary|2
1772198|NCT00723255|6170896|P1|Overall Study|Ineligible: Second primary|1
1772199|NCT00723255|6170896|P1|Overall Study|Ineligible: Inadequate pathology|1
1772200|NCT00723229|6170923|P2|First Intervention|Lost to Follow-up|3
1772201|NCT00723229|6170924|P1|First Intervention|Lost to Follow-up|7
1772202|NCT00723203|6170936|P1|Overall Study|Withdrawal by Subject|3
1772203|NCT00723190|6170940|P1|Overall Study|Other-Not included in safety population|2
1772204|NCT00723190|6170940|P1|Overall Study|Other-Premature Discontinuation|9
1772205|NCT00723190|6170940|P1|Overall Study|Protocol Violation|15
1772206|NCT00723190|6170940|P1|Overall Study|Lack of Efficacy|16
1772207|NCT00723190|6170940|P1|Overall Study|Adverse Event|18
1772208|NCT00723190|6170940|P1|Overall Study|Lost to Follow-up|37
1772209|NCT00723190|6170940|P1|Overall Study|Withdrawal by Subject|45
1772210|NCT00723125|6170973|P2|Overall Study|Adverse Event|0
1772211|NCT00723125|6170974|P1|Overall Study|Adverse Event|2
1772212|NCT00723125|6170973|P2|Overall Study|Withdrawal by Subject|6
1772213|NCT00723125|6170974|P1|Overall Study|Withdrawal by Subject|15
1772214|NCT00723125|6170973|P2|Overall Study|Met Dx|0
1772215|NCT00723125|6170974|P1|Overall Study|Met Dx|1
1772216|NCT00723021|6171023|P5|Intervention Period 4|Adverse Event|1
1772217|NCT00723021|6171024|P4|Intervention Period 4|Adverse Event|0
1772218|NCT00723021|6171025|P3|Intervention Period 4|Adverse Event|0
1772219|NCT00723021|6171026|P2|Intervention Period 4|Adverse Event|0
1772220|NCT00723021|6171027|P1|Intervention Period 4|Adverse Event|0
1772221|NCT00723008|6171081|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
1772222|NCT00723008|6171082|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
1772223|NCT00723008|6171081|P2|4-Week Unblinded Treatment|Adverse Event|0
1772224|NCT00723008|6171082|P1|4-Week Unblinded Treatment|Adverse Event|1
1772225|NCT00723008|6171081|P2|4-Week Double Blinded|Lost to Follow-up|3
1772226|NCT00723008|6171082|P1|4-Week Double Blinded|Lost to Follow-up|4
1772227|NCT00723008|6171081|P2|4-Week Double Blinded|Withdrawal by Subject|1
1772228|NCT00723008|6171082|P1|4-Week Double Blinded|Withdrawal by Subject|1
1772229|NCT00723008|6171081|P2|4-Week Double Blinded|Lack of Efficacy|1
1772230|NCT00723008|6171082|P1|4-Week Double Blinded|Lack of Efficacy|0
1772231|NCT00723008|6171081|P2|Enrollment|Lost to Follow-up|0
1772232|NCT00723008|6171082|P1|Enrollment|Lost to Follow-up|1
1772233|NCT00722800|6171114|P2|Overall Study|Physician Decision|0
1772234|NCT00722800|6171115|P1|Overall Study|Physician Decision|1
1772235|NCT00722800|6171114|P2|Overall Study|Withdrawal by Subject|0
1772236|NCT00722800|6171115|P1|Overall Study|Withdrawal by Subject|1
1772237|NCT00722761|6171127|P2|Overall Study|Withdrawal by Subject|2
1772238|NCT00722761|6171128|P1|Overall Study|Withdrawal by Subject|5
1772239|NCT00722761|6171127|P2|Overall Study|Lost to Follow-up|4
1772240|NCT00722761|6171128|P1|Overall Study|Lost to Follow-up|1
1772241|NCT00722423|6171185|P2|Overall Study|Protocol Violation|1
1772242|NCT00722423|6171186|P1|Overall Study|Protocol Violation|0
1772243|NCT00722371|6171201|P7|Overall Study|Withdrawal by Subject|26
1772244|NCT00722371|6171202|P6|Overall Study|Withdrawal by Subject|18
1772245|NCT00722371|6171203|P5|Overall Study|Withdrawal by Subject|19
1772246|NCT00722371|6171204|P4|Overall Study|Withdrawal by Subject|23
1772247|NCT00722371|6171205|P3|Overall Study|Withdrawal by Subject|19
1772248|NCT00722371|6171206|P2|Overall Study|Withdrawal by Subject|27
1772249|NCT00722371|6171207|P1|Overall Study|Withdrawal by Subject|18
1772250|NCT00722371|6171201|P7|Overall Study|Protocol Violation|1
1772251|NCT00722371|6171202|P6|Overall Study|Protocol Violation|2
1772252|NCT00722371|6171203|P5|Overall Study|Protocol Violation|4
1772253|NCT00722371|6171204|P4|Overall Study|Protocol Violation|1
1772254|NCT00722371|6171205|P3|Overall Study|Protocol Violation|0
1772255|NCT00722371|6171206|P2|Overall Study|Protocol Violation|1
1772256|NCT00722371|6171207|P1|Overall Study|Protocol Violation|6
1772257|NCT00722371|6171201|P7|Overall Study|Pregnancy|0
1772258|NCT00722371|6171202|P6|Overall Study|Pregnancy|1
1772259|NCT00722371|6171203|P5|Overall Study|Pregnancy|0
1772260|NCT00722371|6171204|P4|Overall Study|Pregnancy|0
1772261|NCT00722371|6171205|P3|Overall Study|Pregnancy|0
1772262|NCT00722371|6171206|P2|Overall Study|Pregnancy|1
1772263|NCT00722371|6171207|P1|Overall Study|Pregnancy|1
1772264|NCT00722371|6171201|P7|Overall Study|Physician Decision|4
1772265|NCT00722371|6171202|P6|Overall Study|Physician Decision|3
1772266|NCT00722371|6171203|P5|Overall Study|Physician Decision|2
1772267|NCT00722371|6171204|P4|Overall Study|Physician Decision|5
1772268|NCT00722371|6171205|P3|Overall Study|Physician Decision|2
1772269|NCT00722371|6171206|P2|Overall Study|Physician Decision|2
1772270|NCT00722371|6171207|P1|Overall Study|Physician Decision|5
1772271|NCT00722371|6171201|P7|Overall Study|Lost to Follow-up|13
1772272|NCT00722371|6171202|P6|Overall Study|Lost to Follow-up|16
1772273|NCT00722371|6171203|P5|Overall Study|Lost to Follow-up|8
1772274|NCT00722371|6171204|P4|Overall Study|Lost to Follow-up|13
1772275|NCT00722371|6171205|P3|Overall Study|Lost to Follow-up|21
1772276|NCT00722371|6171206|P2|Overall Study|Lost to Follow-up|14
1772277|NCT00722371|6171207|P1|Overall Study|Lost to Follow-up|11
1772278|NCT00722371|6171201|P7|Overall Study|Lack of Efficacy|0
1772279|NCT00722371|6171202|P6|Overall Study|Lack of Efficacy|3
1772280|NCT00722371|6171203|P5|Overall Study|Lack of Efficacy|2
1772281|NCT00722371|6171204|P4|Overall Study|Lack of Efficacy|6
1772282|NCT00722371|6171205|P3|Overall Study|Lack of Efficacy|6
1772283|NCT00722371|6171206|P2|Overall Study|Lack of Efficacy|6
1772284|NCT00722371|6171207|P1|Overall Study|Lack of Efficacy|4
1772285|NCT00722371|6171201|P7|Overall Study|Hypoglycemia|0
1772286|NCT00722371|6171202|P6|Overall Study|Hypoglycemia|0
1772287|NCT00722371|6171203|P5|Overall Study|Hypoglycemia|0
1772288|NCT00722371|6171204|P4|Overall Study|Hypoglycemia|0
1772289|NCT00722371|6171205|P3|Overall Study|Hypoglycemia|0
1772290|NCT00722371|6171206|P2|Overall Study|Hypoglycemia|0
1772291|NCT00722371|6171207|P1|Overall Study|Hypoglycemia|1
1772292|NCT00722371|6171201|P7|Overall Study|Hyperglycemia|1
1772293|NCT00722371|6171202|P6|Overall Study|Hyperglycemia|1
1772294|NCT00722371|6171203|P5|Overall Study|Hyperglycemia|5
1772295|NCT00722371|6171204|P4|Overall Study|Hyperglycemia|2
1772296|NCT00722371|6171205|P3|Overall Study|Hyperglycemia|4
1772297|NCT00722371|6171206|P2|Overall Study|Hyperglycemia|6
1772298|NCT00722371|6171207|P1|Overall Study|Hyperglycemia|2
1772299|NCT00722371|6171201|P7|Overall Study|Excluded medication|1
1772300|NCT00722371|6171202|P6|Overall Study|Excluded medication|0
1772301|NCT00722371|6171203|P5|Overall Study|Excluded medication|0
1772302|NCT00722371|6171204|P4|Overall Study|Excluded medication|0
1772303|NCT00722371|6171205|P3|Overall Study|Excluded medication|1
1772304|NCT00722371|6171206|P2|Overall Study|Excluded medication|1
1772305|NCT00722371|6171207|P1|Overall Study|Excluded medication|0
1772306|NCT00722371|6171201|P7|Overall Study|Creatinine / Creatinine clearance|1
1772307|NCT00722371|6171202|P6|Overall Study|Creatinine / Creatinine clearance|1
1772308|NCT00722371|6171203|P5|Overall Study|Creatinine / Creatinine clearance|2
1772309|NCT00722371|6171204|P4|Overall Study|Creatinine / Creatinine clearance|3
1772310|NCT00722371|6171205|P3|Overall Study|Creatinine / Creatinine clearance|2
1772311|NCT00722371|6171206|P2|Overall Study|Creatinine / Creatinine clearance|1
1772312|NCT00722371|6171207|P1|Overall Study|Creatinine / Creatinine clearance|2
1772313|NCT00722371|6171201|P7|Overall Study|Contraindication|0
1772314|NCT00722371|6171202|P6|Overall Study|Contraindication|0
1772315|NCT00722371|6171203|P5|Overall Study|Contraindication|0
1772316|NCT00722371|6171204|P4|Overall Study|Contraindication|0
1772317|NCT00722371|6171205|P3|Overall Study|Contraindication|1
1772318|NCT00722371|6171206|P2|Overall Study|Contraindication|0
1772319|NCT00722371|6171207|P1|Overall Study|Contraindication|0
1772320|NCT00722371|6171201|P7|Overall Study|Adverse Event|4
1772321|NCT00722371|6171202|P6|Overall Study|Adverse Event|8
1772322|NCT00722371|6171203|P5|Overall Study|Adverse Event|6
1772323|NCT00722371|6171204|P4|Overall Study|Adverse Event|10
1772324|NCT00722371|6171205|P3|Overall Study|Adverse Event|9
1772325|NCT00722371|6171206|P2|Overall Study|Adverse Event|13
1772326|NCT00722371|6171207|P1|Overall Study|Adverse Event|6
1772327|NCT00722137|6171260|P2|Overall Study|Randomized But Not Treated|3
1772328|NCT00722137|6171261|P1|Overall Study|Randomized But Not Treated|2
1772329|NCT00722137|6171260|P2|Overall Study|Other Reason Unknown|4
1772330|NCT00722137|6171261|P1|Overall Study|Other Reason Unknown|3
1772331|NCT00722137|6171260|P2|Overall Study|Withdrawal by Subject|9
1772332|NCT00722137|6171261|P1|Overall Study|Withdrawal by Subject|6
1772333|NCT00722137|6171260|P2|Overall Study|Death|7
1772334|NCT00722137|6171261|P1|Overall Study|Death|12
1772335|NCT00722137|6171260|P2|Overall Study|Adverse Event|21
1772336|NCT00722137|6171261|P1|Overall Study|Adverse Event|17
1772337|NCT00722137|6171260|P2|Overall Study|Overt Disease Progression|4
1772338|NCT00722137|6171261|P1|Overall Study|Overt Disease Progression|5
1772339|NCT00721968|6171339|P2|Overall Study|Lost to Follow-up|0
1772340|NCT00721968|6171340|P1|Overall Study|Lost to Follow-up|2
1772341|NCT00721955|6171351|P3|Overall Study|Adverse Event|2
1772342|NCT00721955|6171352|P2|Overall Study|Adverse Event|0
1772343|NCT00721955|6171353|P1|Overall Study|Adverse Event|0
1772344|NCT00721799|6171367|P1|Overall Study|withdraw by subject after scan 1|1
1772345|NCT00721799|6171367|P1|Overall Study|Withdrawal by Subject|7
1772346|NCT00721734|6171407|P5|Overall Study|Other|0
1772347|NCT00721734|6171408|P4|Overall Study|Other|1
1772348|NCT00721734|6171409|P3|Overall Study|Other|0
1772349|NCT00721734|6171410|P2|Overall Study|Other|0
1772350|NCT00721734|6171411|P1|Overall Study|Other|0
1772351|NCT00721734|6171407|P5|Overall Study|Withdrawal by Subject|1
1772352|NCT00721734|6171408|P4|Overall Study|Withdrawal by Subject|0
1772353|NCT00721734|6171409|P3|Overall Study|Withdrawal by Subject|0
1772354|NCT00721734|6171410|P2|Overall Study|Withdrawal by Subject|1
1772355|NCT00721734|6171411|P1|Overall Study|Withdrawal by Subject|2
1772356|NCT00721734|6171407|P5|Overall Study|Adverse Event|3
1772357|NCT00721734|6171408|P4|Overall Study|Adverse Event|0
1772358|NCT00721734|6171409|P3|Overall Study|Adverse Event|4
1772359|NCT00721734|6171410|P2|Overall Study|Adverse Event|1
1772360|NCT00721734|6171411|P1|Overall Study|Adverse Event|3
1772361|NCT00721734|6171407|P5|Overall Study|Progressive Disease|2
1772362|NCT00721734|6171408|P4|Overall Study|Progressive Disease|5
1772363|NCT00721734|6171409|P3|Overall Study|Progressive Disease|4
1772364|NCT00721734|6171410|P2|Overall Study|Progressive Disease|10
1772365|NCT00721734|6171411|P1|Overall Study|Progressive Disease|3
1772366|NCT00721630|6171523|P1|Overall Study|Participant found to be ineligible|1
1772367|NCT00721578|6171552|P2|Overall Study|Withdrawal by Subject|1
1772368|NCT00721578|6171553|P1|Overall Study|Withdrawal by Subject|1
1772369|NCT00721578|6171552|P2|Overall Study|Death|1
1772370|NCT00721578|6171553|P1|Overall Study|Death|1
1772371|NCT00721409|6171608|P3|Overall Study|Objective progression or relapse|62
1772372|NCT00721409|6171609|P2|Overall Study|Objective progression or relapse|55
1772373|NCT00721409|6171610|P1|Overall Study|Objective progression or relapse|8
1772374|NCT00721409|6171608|P3|Overall Study|Withdrawal by Subject|5
1772375|NCT00721409|6171609|P2|Overall Study|Withdrawal by Subject|6
1772376|NCT00721409|6171610|P1|Overall Study|Withdrawal by Subject|1
1772377|NCT00721409|6171608|P3|Overall Study|Lost to Follow-up|1
1772378|NCT00721409|6171609|P2|Overall Study|Lost to Follow-up|0
1772379|NCT00721409|6171610|P1|Overall Study|Lost to Follow-up|0
1772380|NCT00721409|6171608|P3|Overall Study|Adverse Event|2
1772381|NCT00721409|6171609|P2|Overall Study|Adverse Event|13
1772382|NCT00721409|6171610|P1|Overall Study|Adverse Event|0
1772383|NCT00721409|6171608|P3|Overall Study|Reason not specified|2
1772384|NCT00721409|6171609|P2|Overall Study|Reason not specified|0
1772385|NCT00721409|6171610|P1|Overall Study|Reason not specified|1
1772386|NCT00721409|6171608|P3|Overall Study|Randomized not Treated|4
1772387|NCT00721409|6171609|P2|Overall Study|Randomized not Treated|1
1772388|NCT00721409|6171610|P1|Overall Study|Randomized not Treated|0
1772389|NCT00721409|6171608|P3|Overall Study|Death|0
1772390|NCT00721409|6171609|P2|Overall Study|Death|1
1772391|NCT00721409|6171610|P1|Overall Study|Death|0
1772392|NCT00721409|6171608|P3|Overall Study|Global deterioration of health status|3
1772393|NCT00721409|6171609|P2|Overall Study|Global deterioration of health status|6
1772394|NCT00721409|6171610|P1|Overall Study|Global deterioration of health status|2
1772395|NCT00721396|6171737|P4|Overall Study|Administrative reason|0
1772396|NCT00721396|6171738|P3|Overall Study|Administrative reason|1
1772397|NCT00721396|6171739|P2|Overall Study|Administrative reason|0
1772398|NCT00721396|6171740|P1|Overall Study|Administrative reason|3
1772399|NCT00721396|6171737|P4|Overall Study|Inappropriate enrollment|0
1772400|NCT00721396|6171738|P3|Overall Study|Inappropriate enrollment|0
1772401|NCT00721396|6171739|P2|Overall Study|Inappropriate enrollment|2
1772402|NCT00721396|6171740|P1|Overall Study|Inappropriate enrollment|0
1772403|NCT00721396|6171737|P4|Overall Study|Protocol Violation|0
1772404|NCT00721396|6171738|P3|Overall Study|Protocol Violation|1
1772405|NCT00721396|6171739|P2|Overall Study|Protocol Violation|3
1772406|NCT00721396|6171740|P1|Overall Study|Protocol Violation|4
1772407|NCT00721396|6171737|P4|Overall Study|Lost to Follow-up|3
1772408|NCT00721396|6171738|P3|Overall Study|Lost to Follow-up|3
1772409|NCT00721396|6171739|P2|Overall Study|Lost to Follow-up|9
1772410|NCT00721396|6171740|P1|Overall Study|Lost to Follow-up|7
1772411|NCT00721396|6171737|P4|Overall Study|Withdrawal by Subject|7
1772412|NCT00721396|6171738|P3|Overall Study|Withdrawal by Subject|3
1772413|NCT00721396|6171739|P2|Overall Study|Withdrawal by Subject|15
1772414|NCT00721396|6171740|P1|Overall Study|Withdrawal by Subject|12
1772415|NCT00721396|6171737|P4|Overall Study|Adverse Event|0
1772416|NCT00721396|6171738|P3|Overall Study|Adverse Event|2
1772417|NCT00721396|6171739|P2|Overall Study|Adverse Event|7
1772418|NCT00721396|6171740|P1|Overall Study|Adverse Event|4
1772419|NCT00721279|6171791|P2|Overall Study|Other|16
1772420|NCT00721279|6171792|P1|Overall Study|Other|12
1772421|NCT00721279|6171791|P2|Overall Study|Withdrawal by Subject|3
1772422|NCT00721279|6171792|P1|Overall Study|Withdrawal by Subject|13
1772423|NCT00721279|6171791|P2|Overall Study|Tolerability insufficient|2
1772424|NCT00721279|6171792|P1|Overall Study|Tolerability insufficient|5
1772425|NCT00721279|6171791|P2|Overall Study|Lack of Efficacy|3
1772426|NCT00721279|6171792|P1|Overall Study|Lack of Efficacy|6
1772427|NCT00721227|6171820|P2|Overall Study|Noncompliance with scheduled visits.|0
1772428|NCT00721227|6171821|P1|Overall Study|Noncompliance with scheduled visits.|1
1772429|NCT00721227|6171820|P2|Overall Study|Lost to Follow-up|0
1772430|NCT00721227|6171821|P1|Overall Study|Lost to Follow-up|3
1772431|NCT00721214|6171831|P1|Overall Study|Death|3
1772432|NCT00721214|6171831|P1|Overall Study|Chose another center for transplant|1
1772433|NCT00721149|6171881|P1|Overall Study|Physician Decision|1
1772434|NCT00721123|6171915|P1|Overall Study|Withdrawal by Subject|5
1772435|NCT00721123|6171915|P1|Overall Study|Failure to Return|9
1772436|NCT00721123|6171915|P1|Overall Study|Refused Treatment|41
1772437|NCT00721123|6171915|P1|Overall Study|Protocol Violation|1
1772438|NCT00721123|6171915|P1|Overall Study|Insufficient Therapeutic Response|21
1772439|NCT00721123|6171915|P1|Overall Study|Death|10
1772440|NCT00721123|6171915|P1|Overall Study|Adverse Event|96
1772441|NCT00721110|6171993|P4|Overall Study|vertical incision|0
1772442|NCT00721110|6171994|P3|Overall Study|vertical incision|1
1772443|NCT00721110|6171995|P2|Overall Study|vertical incision|0
1772444|NCT00721110|6171996|P1|Overall Study|vertical incision|0
1772445|NCT00721110|6171993|P4|Overall Study|Ultram use|0
1772446|NCT00721110|6171994|P3|Overall Study|Ultram use|0
1772447|NCT00721110|6171995|P2|Overall Study|Ultram use|0
1772448|NCT00721110|6171996|P1|Overall Study|Ultram use|1
1772461|NCT00720876|6172065|P1|Overall Study|found to be ineligible after starting tx|2
1772462|NCT00720798|6172071|P1|Overall Study|Reason not Specified|83
1772463|NCT00720798|6172071|P1|Overall Study|Failure to Return|46
1772464|NCT00720798|6172071|P1|Overall Study|Refused Treatment|151
1772465|NCT00720798|6172071|P1|Overall Study|Protocol Violation|4
1772466|NCT00720798|6172071|P1|Overall Study|Insufficient Therapeutic Response|129
1772467|NCT00720798|6172071|P1|Overall Study|Death|39
1772468|NCT00720798|6172071|P1|Overall Study|Adverse Event|304
1772469|NCT00720759|6172094|P4|Overall Study|Lost to Follow-up|0
1772470|NCT00720759|6172095|P3|Overall Study|Lost to Follow-up|1
1772471|NCT00720759|6172096|P2|Overall Study|Lost to Follow-up|1
1772472|NCT00720759|6172097|P1|Overall Study|Lost to Follow-up|0
1772473|NCT00720499|6172117|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
1772474|NCT00720499|6172118|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
1772475|NCT00720499|6172117|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
1772476|NCT00720499|6172118|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
1772477|NCT00720499|6172117|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
1772478|NCT00720499|6172118|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
1772479|NCT00720434|6172211|P4|Open-Label Period (Week 5-72)|Other|2
1772480|NCT00720434|6172212|P3|Open-Label Period (Week 5-72)|Other|3
1772481|NCT00720434|6172213|P2|Open-Label Period (Week 5-72)|Other|3
1772482|NCT00720434|6172214|P1|Open-Label Period (Week 5-72)|Other|4
1772483|NCT00720434|6172211|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
1772484|NCT00720434|6172212|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
1772485|NCT00720434|6172213|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
1772486|NCT00720434|6172214|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
1772487|NCT00720434|6172211|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1772488|NCT00720434|6172212|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1772489|NCT00720434|6172213|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
1772490|NCT00720434|6172214|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
1772491|NCT00720434|6172211|P4|Open-Label Period (Week 5-72)|Adverse Event|2
1772492|NCT00720434|6172212|P3|Open-Label Period (Week 5-72)|Adverse Event|0
1772493|NCT00720434|6172213|P2|Open-Label Period (Week 5-72)|Adverse Event|0
1772494|NCT00720434|6172214|P1|Open-Label Period (Week 5-72)|Adverse Event|0
1772495|NCT00720434|6172211|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1772496|NCT00720434|6172212|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1772497|NCT00720434|6172213|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
1772498|NCT00720434|6172214|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
1772499|NCT00720382|6172238|P2|Overall Study|administrative|5
1772500|NCT00720382|6172239|P1|Overall Study|administrative|14
1772501|NCT00720382|6172238|P2|Overall Study|Lost to Follow-up|14
1772502|NCT00720382|6172239|P1|Overall Study|Lost to Follow-up|28
1772503|NCT00720382|6172238|P2|Overall Study|Withdrawal by Subject|11
1772504|NCT00720382|6172239|P1|Overall Study|Withdrawal by Subject|47
1772505|NCT00720382|6172238|P2|Overall Study|Non-Compliance|5
1772506|NCT00720382|6172239|P1|Overall Study|Non-Compliance|15
1772507|NCT00720382|6172238|P2|Overall Study|Lack of Efficacy|7
1772508|NCT00720382|6172239|P1|Overall Study|Lack of Efficacy|18
1772509|NCT00720382|6172238|P2|Overall Study|Adverse Event|17
1772510|NCT00720382|6172239|P1|Overall Study|Adverse Event|54
1772511|NCT00720356|6172258|P1|Follow up Until Death|Alive at last data collection|4
1772512|NCT00720356|6172258|P1|Follow up Until Death|Withdrawal by Subject|1
1772513|NCT00720356|6172258|P1|Went on to be Treated Cycle 3|Physician Decision|1
1772514|NCT00720356|6172258|P1|Went on to be Treated Cycle 3|Adverse Event|1
1772515|NCT00720356|6172258|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
1772516|NCT00720356|6172258|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
1772517|NCT00720356|6172258|P1|Registration to Study|Determined to have methylated MGMT|67
1772518|NCT00720343|6172272|P1|Overall Study|No data|3
1772519|NCT00720343|6172272|P1|Overall Study|Physician Decision|3
1772520|NCT00720278|6172306|P3|Overall Study|eligibility criteria violation|1
1772521|NCT00720278|6172307|P2|Overall Study|eligibility criteria violation|0
1772522|NCT00720278|6172308|P1|Overall Study|eligibility criteria violation|1
1772523|NCT00720278|6172306|P3|Overall Study|Non-compliance|0
1772524|NCT00720278|6172307|P2|Overall Study|Non-compliance|0
1772525|NCT00720278|6172308|P1|Overall Study|Non-compliance|1
1772526|NCT00720278|6172306|P3|Overall Study|Lost to Follow-up|1
1772527|NCT00720278|6172307|P2|Overall Study|Lost to Follow-up|0
1772528|NCT00720278|6172308|P1|Overall Study|Lost to Follow-up|0
1772529|NCT00720278|6172306|P3|Overall Study|Withdrawal by Subject|0
1772530|NCT00720278|6172307|P2|Overall Study|Withdrawal by Subject|1
1772531|NCT00720278|6172308|P1|Overall Study|Withdrawal by Subject|0
1772532|NCT00720278|6172306|P3|Overall Study|Adverse Event|4
1772533|NCT00720278|6172307|P2|Overall Study|Adverse Event|3
1772534|NCT00720278|6172308|P1|Overall Study|Adverse Event|5
1772535|NCT00720226|6172330|P2|Overall Study|Withdrawal by Subject|4
1772536|NCT00720226|6172331|P1|Overall Study|Withdrawal by Subject|7
1772537|NCT00720213|6172339|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
1772538|NCT00720213|6172340|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
1772539|NCT00720213|6172341|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
1772540|NCT00720122|6172379|P1|Overall Study|Withdrawal by Subject|7
1772541|NCT00720122|6172379|P1|Overall Study|Physician Decision|1
1772542|NCT00720122|6172379|P1|Overall Study|Lost to Follow-up|1
1772543|NCT00720109|6172383|P3|Risk Stratification Period|Development of second malignant neoplasm|0
1772544|NCT00720109|6172384|P2|Risk Stratification Period|Development of second malignant neoplasm|1
1772545|NCT00720109|6172385|P1|Risk Stratification Period|Development of second malignant neoplasm|0
1772546|NCT00720109|6172383|P3|Risk Stratification Period|Disease progression or relapse|0
1772547|NCT00720109|6172384|P2|Risk Stratification Period|Disease progression or relapse|2
1772548|NCT00720109|6172385|P1|Risk Stratification Period|Disease progression or relapse|0
1772549|NCT00720109|6172383|P3|Risk Stratification Period|Bone marrow transplant|7
1772550|NCT00720109|6172384|P2|Risk Stratification Period|Bone marrow transplant|9
1772551|NCT00720109|6172385|P1|Risk Stratification Period|Bone marrow transplant|0
1772552|NCT00720109|6172383|P3|Risk Stratification Period|Physician Decision|1
1772553|NCT00720109|6172384|P2|Risk Stratification Period|Physician Decision|2
1772554|NCT00720109|6172385|P1|Risk Stratification Period|Physician Decision|0
1772555|NCT00720109|6172383|P3|Risk Stratification Period|Adverse Event|0
1772556|NCT00720109|6172384|P2|Risk Stratification Period|Adverse Event|1
1772557|NCT00720109|6172385|P1|Risk Stratification Period|Adverse Event|0
1772558|NCT00720109|6172383|P3|Induction Period|Physician Decision|0
1772559|NCT00720109|6172384|P2|Induction Period|Physician Decision|0
1772560|NCT00720109|6172385|P1|Induction Period|Physician Decision|1
1772561|NCT00720109|6172383|P3|Induction Period|Bone Marrow Transplant|0
1772562|NCT00720109|6172384|P2|Induction Period|Bone Marrow Transplant|0
1772563|NCT00720109|6172385|P1|Induction Period|Bone Marrow Transplant|2
1772564|NCT00720109|6172383|P3|Induction Period|Did not meet eligibility criteria|0
1772565|NCT00720109|6172384|P2|Induction Period|Did not meet eligibility criteria|0
1772566|NCT00720109|6172385|P1|Induction Period|Did not meet eligibility criteria|3
1772567|NCT00720096|6172405|P2|Overall Study|Withdrawal by Subject|2
1772568|NCT00720096|6172406|P1|Overall Study|Withdrawal by Subject|0
1772569|NCT00720083|6172418|P2|Overall Study|Ineligible|2
1772570|NCT00720083|6172419|P1|Overall Study|Ineligible|1
1772571|NCT00720057|6172427|P2|Overall Study|Withdrawal by Subject|1
1772572|NCT00720057|6172428|P1|Overall Study|Withdrawal by Subject|0
1772573|NCT00720057|6172427|P2|Overall Study|Protocol Violation|0
1772574|NCT00720057|6172428|P1|Overall Study|Protocol Violation|1
1772575|NCT00720057|6172427|P2|Overall Study|Lost to Follow-up|2
1772576|NCT00720057|6172428|P1|Overall Study|Lost to Follow-up|0
1772577|NCT00719953|6172444|P1|Overall Study|Adverse Event|4
1772578|NCT00719901|6172457|P1|Overall Study|Availability of Study Drug|1
1772579|NCT00719901|6172457|P1|Overall Study|Disease Progression|3
1772580|NCT00719901|6172457|P1|Overall Study|Alternate Treatment|1
1772581|NCT00719901|6172457|P1|Overall Study|Withdrawal by Subject|1
1772582|NCT00719901|6172457|P1|Overall Study|Adverse Event|5
1772583|NCT00719862|6172469|P2|Overall Study|Other|3
1772584|NCT00719862|6172470|P1|Overall Study|Other|2
1772585|NCT00719862|6172469|P2|Overall Study|Lost to Follow-up|1
1772586|NCT00719862|6172470|P1|Overall Study|Lost to Follow-up|0
1772587|NCT00719862|6172469|P2|Overall Study|Withdrawal by Subject|0
1772588|NCT00719862|6172470|P1|Overall Study|Withdrawal by Subject|1
1772589|NCT00719862|6172469|P2|Overall Study|Non-Compliance|0
1772590|NCT00719862|6172470|P1|Overall Study|Non-Compliance|1
1772591|NCT00719862|6172469|P2|Overall Study|Lack of Efficacy|0
1772592|NCT00719862|6172470|P1|Overall Study|Lack of Efficacy|3
1772593|NCT00719862|6172469|P2|Overall Study|Adverse Event|2
1772594|NCT00719862|6172470|P1|Overall Study|Adverse Event|1
1772595|NCT00719849|6172488|P2|Overall Study|Death|1
1772596|NCT00719849|6172489|P1|Overall Study|Death|0
1772597|NCT00719810|6172528|P3|Overall Study|Withdrawal by Subject|2
1772598|NCT00719810|6172529|P2|Overall Study|Withdrawal by Subject|1
1772599|NCT00719810|6172530|P1|Overall Study|Withdrawal by Subject|1
1772600|NCT00719810|6172528|P3|Overall Study|Physician Decision|0
1772601|NCT00719810|6172529|P2|Overall Study|Physician Decision|1
1772602|NCT00719810|6172530|P1|Overall Study|Physician Decision|0
1772603|NCT00719810|6172528|P3|Overall Study|Lost to Follow-up|3
1772604|NCT00719810|6172529|P2|Overall Study|Lost to Follow-up|0
1772605|NCT00719810|6172530|P1|Overall Study|Lost to Follow-up|2
1772606|NCT00719810|6172528|P3|Overall Study|Adverse Event|3
1772607|NCT00719810|6172529|P2|Overall Study|Adverse Event|2
1772608|NCT00719810|6172530|P1|Overall Study|Adverse Event|0
1772609|NCT00719732|6172541|P1|Overall Study|Illness not associated with device|1
1772610|NCT00719732|6172541|P1|Overall Study|Unilateral (not bilateral) implantation|1
1772611|NCT00719732|6172541|P1|Overall Study|Lost to Follow-up|20
1772612|NCT00719706|6172547|P2|Overall Study|Protocol Violation|0
1772613|NCT00719706|6172548|P1|Overall Study|Protocol Violation|3
1772614|NCT00719706|6172547|P2|Overall Study|Withdrawal by Subject|2
1772615|NCT00719706|6172548|P1|Overall Study|Withdrawal by Subject|1
1772616|NCT00719706|6172547|P2|Overall Study|Adverse Event|4
1772617|NCT00719706|6172548|P1|Overall Study|Adverse Event|5
1772618|NCT00719680|6172562|P1|Overall Study|Withdrawal by Subject|3
1772619|NCT00719680|6172562|P1|Overall Study|Lost to Follow-up|1
1772620|NCT00719680|6172562|P1|Overall Study|Adverse Event|1
1772621|NCT00719563|6172618|P2|Overall Study|Lost to Follow-up|3
1772622|NCT00719563|6172619|P1|Overall Study|Lost to Follow-up|5
1772623|NCT00719563|6172618|P2|Overall Study|Noncompliant|1
1772624|NCT00719563|6172619|P1|Overall Study|Noncompliant|1
1772625|NCT00719563|6172618|P2|Overall Study|Unknown reasons|6
1772626|NCT00719563|6172619|P1|Overall Study|Unknown reasons|4
1772627|NCT00719563|6172618|P2|Overall Study|Personal reasons|7
1772628|NCT00719563|6172619|P1|Overall Study|Personal reasons|6
1772629|NCT00719563|6172618|P2|Overall Study|Lack of Efficacy|7
1772630|NCT00719563|6172619|P1|Overall Study|Lack of Efficacy|3
1772631|NCT00719563|6172618|P2|Overall Study|Medical condition changed|5
1772632|NCT00719563|6172619|P1|Overall Study|Medical condition changed|3
1772633|NCT00719563|6172618|P2|Overall Study|Adverse Event|13
1772634|NCT00719563|6172619|P1|Overall Study|Adverse Event|16
1772635|NCT00719537|6172651|P2|Overall Study|Lost to Follow-up|1
1772636|NCT00719537|6172652|P1|Overall Study|Lost to Follow-up|0
1772637|NCT00719537|6172651|P2|Overall Study|Withdrawal by Subject|0
1772638|NCT00719537|6172652|P1|Overall Study|Withdrawal by Subject|1
1772639|NCT00719472|6172658|P1|Received Cycle 2 Treatment|Various Reasons|25
1772640|NCT00719472|6172658|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
1772641|NCT00719472|6172658|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
1772642|NCT00719472|6172658|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
1772643|NCT00719472|6172658|P1|Received Cycle 2 Treatment|Disease progression|3
1772644|NCT00719472|6172658|P1|Received Cycle 2 Treatment|Death|6
1772645|NCT00719472|6172658|P1|Received Cycle 2 Treatment|Adverse Event|12
1772646|NCT00719472|6172658|P1|Received Cycle 1 Treatment|Various Reasons|13
1772647|NCT00719472|6172658|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
1772648|NCT00719472|6172658|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
1772649|NCT00719472|6172658|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
1772650|NCT00719472|6172658|P1|Received Cycle 1 Treatment|Death|5
1772651|NCT00719472|6172658|P1|Received Cycle 1 Treatment|Adverse Event|8
1772652|NCT00719472|6172658|P1|Enrolled in Study|Various Reasons|17
1772653|NCT00719472|6172658|P1|Enrolled in Study|Subject decision to withdraw|8
1772654|NCT00719472|6172658|P1|Enrolled in Study|Physician decision to withdraw patient|1
1772655|NCT00719355|6172669|P2|Overall Study|Moved|1
1772656|NCT00719355|6172670|P1|Overall Study|Moved|0
1772657|NCT00719355|6172669|P2|Overall Study|Compliance|6
1772658|NCT00719355|6172670|P1|Overall Study|Compliance|4
1772659|NCT00719355|6172669|P2|Overall Study|Medical|5
1772660|NCT00719355|6172670|P1|Overall Study|Medical|14
1772661|NCT00719355|6172669|P2|Overall Study|Death|1
1772662|NCT00719355|6172670|P1|Overall Study|Death|0
1772663|NCT00719264|6172699|P2|Overall Study|Disease Progression|107
1772664|NCT00719264|6172700|P1|Overall Study|Disease Progression|104
1772665|NCT00719264|6172699|P2|Overall Study|New Cancer Therapy|2
1772666|NCT00719264|6172700|P1|Overall Study|New Cancer Therapy|4
1772667|NCT00719264|6172699|P2|Overall Study|Protocol Deviation|3
1772668|NCT00719264|6172700|P1|Overall Study|Protocol Deviation|1
1772669|NCT00719264|6172699|P2|Overall Study|Withdrawal by Subject|7
1772670|NCT00719264|6172700|P1|Overall Study|Withdrawal by Subject|12
1772671|NCT00719264|6172699|P2|Overall Study|Lost to Follow-up|1
1772672|NCT00719264|6172700|P1|Overall Study|Lost to Follow-up|1
1772673|NCT00719264|6172699|P2|Overall Study|Administrative Problems|4
1772674|NCT00719264|6172700|P1|Overall Study|Administrative Problems|6
1772675|NCT00719264|6172699|P2|Overall Study|Death|10
1772676|NCT00719264|6172700|P1|Overall Study|Death|13
1772677|NCT00719264|6172699|P2|Overall Study|Adverse Event|49
1772678|NCT00719264|6172700|P1|Overall Study|Adverse Event|41
1772679|NCT00719212|6172719|P1|Overall Study|Withdrawal by Subject|1
1772680|NCT00719212|6172719|P1|Overall Study|Lost to Follow-up|2
1772681|NCT00719212|6172719|P1|Overall Study|Death|41
1772682|NCT00719043|6172767|P7|Overall Study|Withdrawal by Subject|14
1772683|NCT00719043|6172768|P6|Overall Study|Withdrawal by Subject|18
1772684|NCT00719043|6172769|P5|Overall Study|Withdrawal by Subject|16
1772685|NCT00719043|6172770|P4|Overall Study|Withdrawal by Subject|10
1772686|NCT00719043|6172771|P3|Overall Study|Withdrawal by Subject|9
1772687|NCT00719043|6172772|P2|Overall Study|Withdrawal by Subject|14
1772688|NCT00719043|6172773|P1|Overall Study|Withdrawal by Subject|12
1772689|NCT00719043|6172767|P7|Overall Study|Other|1
1772690|NCT00719043|6172768|P6|Overall Study|Other|2
1772691|NCT00719043|6172769|P5|Overall Study|Other|0
1772692|NCT00719043|6172770|P4|Overall Study|Other|2
1772693|NCT00719043|6172771|P3|Overall Study|Other|1
1772694|NCT00719043|6172772|P2|Overall Study|Other|0
1772695|NCT00719043|6172773|P1|Overall Study|Other|1
1772696|NCT00719043|6172767|P7|Overall Study|Protocol Violation|0
1772697|NCT00719043|6172768|P6|Overall Study|Protocol Violation|1
1772698|NCT00719043|6172769|P5|Overall Study|Protocol Violation|0
1772699|NCT00719043|6172770|P4|Overall Study|Protocol Violation|0
1772700|NCT00719043|6172771|P3|Overall Study|Protocol Violation|0
1772701|NCT00719043|6172772|P2|Overall Study|Protocol Violation|0
1772702|NCT00719043|6172773|P1|Overall Study|Protocol Violation|0
1772703|NCT00719043|6172767|P7|Overall Study|Lost to Follow-up|9
1772704|NCT00719043|6172768|P6|Overall Study|Lost to Follow-up|9
1772705|NCT00719043|6172769|P5|Overall Study|Lost to Follow-up|10
1772706|NCT00719043|6172770|P4|Overall Study|Lost to Follow-up|9
1772707|NCT00719043|6172771|P3|Overall Study|Lost to Follow-up|8
1772708|NCT00719043|6172772|P2|Overall Study|Lost to Follow-up|10
1772709|NCT00719043|6172773|P1|Overall Study|Lost to Follow-up|14
1772710|NCT00719043|6172767|P7|Overall Study|Adverse Event|4
1772711|NCT00719043|6172768|P6|Overall Study|Adverse Event|4
1772712|NCT00719043|6172769|P5|Overall Study|Adverse Event|1
1772713|NCT00719043|6172770|P4|Overall Study|Adverse Event|2
1772714|NCT00719043|6172771|P3|Overall Study|Adverse Event|2
1772715|NCT00719043|6172772|P2|Overall Study|Adverse Event|1
1772716|NCT00719043|6172773|P1|Overall Study|Adverse Event|5
1772717|NCT00718887|6172897|P2|Overall Study|Not identified|7
1772718|NCT00718887|6172898|P1|Overall Study|Not identified|2
1772719|NCT00718887|6172897|P2|Overall Study|Withdrawal by Subject|2
1772720|NCT00718887|6172898|P1|Overall Study|Withdrawal by Subject|3
1772721|NCT00718861|6172922|P2|Overall Study|Death|5
1772722|NCT00718861|6172923|P1|Overall Study|Death|1
1772723|NCT00718861|6172922|P2|Overall Study|Administrative Problems|1
1772724|NCT00718861|6172923|P1|Overall Study|Administrative Problems|1
1772725|NCT00718861|6172922|P2|Overall Study|Lost to Follow-up|1
1772726|NCT00718861|6172923|P1|Overall Study|Lost to Follow-up|2
1772727|NCT00718861|6172922|P2|Overall Study|Adverse Event|1
1772728|NCT00718861|6172923|P1|Overall Study|Adverse Event|2
1772729|NCT00718861|6172922|P2|Overall Study|Withdrawal by Subject|10
1772730|NCT00718861|6172923|P1|Overall Study|Withdrawal by Subject|15
1772731|NCT00718809|6172951|P2|Overall Study|Noncompliance|0
1772732|NCT00718809|6172952|P1|Overall Study|Noncompliance|1
1772733|NCT00718809|6172951|P2|Overall Study|Lost to Follow-up|0
1772734|NCT00718809|6172952|P1|Overall Study|Lost to Follow-up|1
1772735|NCT00718809|6172951|P2|Overall Study|Withdrawal by Subject|1
1772736|NCT00718809|6172952|P1|Overall Study|Withdrawal by Subject|0
1772737|NCT00718809|6172951|P2|Overall Study|Adverse Event|1
1772738|NCT00718809|6172952|P1|Overall Study|Adverse Event|1
1772739|NCT00718809|6172951|P2|Overall Study|Disease progression|7
1772740|NCT00718809|6172952|P1|Overall Study|Disease progression|9
1772741|NCT00718770|6172966|P1|Overall Study|Adverse Event|1
1772742|NCT00718770|6172966|P1|Overall Study|Lack of Efficacy|1
1772743|NCT00718770|6172966|P1|Overall Study|Adverse Event|1
1772744|NCT00718770|6172966|P1|Overall Study|Lack of Efficacy|1
1772745|NCT00718770|6172966|P1|Overall Study|Adverse Event|1
1772746|NCT00718770|6172966|P1|Overall Study|Lack of Efficacy|1
1772747|NCT00718770|6172966|P1|Overall Study|Lack of Efficacy|1
1772748|NCT00718770|6172966|P1|Overall Study|Adverse Event|1
1772749|NCT00718718|6172977|P10|Week 12 to End of Study|Other|0
1772750|NCT00718718|6172978|P9|Week 12 to End of Study|Other|0
1772751|NCT00718718|6172979|P8|Week 12 to End of Study|Other|0
1772752|NCT00718718|6172980|P7|Week 12 to End of Study|Other|1
1772753|NCT00718718|6172981|P6|Week 12 to End of Study|Other|0
1772754|NCT00718718|6172982|P5|Week 12 to End of Study|Other|0
1772755|NCT00718718|6172983|P4|Week 12 to End of Study|Other|1
1772756|NCT00718718|6172984|P3|Week 12 to End of Study|Other|0
1772757|NCT00718718|6172985|P2|Week 12 to End of Study|Other|1
1772758|NCT00718718|6172986|P1|Week 12 to End of Study|Other|0
1772759|NCT00718718|6172977|P10|Week 12 to End of Study|Lost to Follow-up|0
1772760|NCT00718718|6172978|P9|Week 12 to End of Study|Lost to Follow-up|1
1772761|NCT00718718|6172979|P8|Week 12 to End of Study|Lost to Follow-up|0
1772762|NCT00718718|6172980|P7|Week 12 to End of Study|Lost to Follow-up|0
1772763|NCT00718718|6172981|P6|Week 12 to End of Study|Lost to Follow-up|0
1772764|NCT00718718|6172982|P5|Week 12 to End of Study|Lost to Follow-up|0
1772765|NCT00718718|6172983|P4|Week 12 to End of Study|Lost to Follow-up|0
1772766|NCT00718718|6172984|P3|Week 12 to End of Study|Lost to Follow-up|0
1772767|NCT00718718|6172985|P2|Week 12 to End of Study|Lost to Follow-up|0
1772768|NCT00718718|6172986|P1|Week 12 to End of Study|Lost to Follow-up|0
1772769|NCT00718718|6172977|P10|Week 12 to End of Study|Withdrawal by Subject|0
1772770|NCT00718718|6172978|P9|Week 12 to End of Study|Withdrawal by Subject|0
1772771|NCT00718718|6172979|P8|Week 12 to End of Study|Withdrawal by Subject|0
1772772|NCT00718718|6172980|P7|Week 12 to End of Study|Withdrawal by Subject|1
1772773|NCT00718718|6172981|P6|Week 12 to End of Study|Withdrawal by Subject|2
1772774|NCT00718718|6172982|P5|Week 12 to End of Study|Withdrawal by Subject|0
1772775|NCT00718718|6172983|P4|Week 12 to End of Study|Withdrawal by Subject|0
1772776|NCT00718718|6172984|P3|Week 12 to End of Study|Withdrawal by Subject|0
1772777|NCT00718718|6172985|P2|Week 12 to End of Study|Withdrawal by Subject|0
1772778|NCT00718718|6172986|P1|Week 12 to End of Study|Withdrawal by Subject|0
1772779|NCT00718718|6172977|P10|Week 12 to End of Study|Death|0
1772780|NCT00718718|6172978|P9|Week 12 to End of Study|Death|0
1772781|NCT00718718|6172979|P8|Week 12 to End of Study|Death|0
1772782|NCT00718718|6172980|P7|Week 12 to End of Study|Death|0
1772783|NCT00718718|6172981|P6|Week 12 to End of Study|Death|1
1772784|NCT00718718|6172982|P5|Week 12 to End of Study|Death|0
1772785|NCT00718718|6172983|P4|Week 12 to End of Study|Death|0
1772786|NCT00718718|6172984|P3|Week 12 to End of Study|Death|0
1772787|NCT00718718|6172985|P2|Week 12 to End of Study|Death|0
1772788|NCT00718718|6172986|P1|Week 12 to End of Study|Death|0
1772789|NCT00718718|6172977|P10|Week 12 to End of Study|Adverse Event|0
1772790|NCT00718718|6172978|P9|Week 12 to End of Study|Adverse Event|0
1772791|NCT00718718|6172979|P8|Week 12 to End of Study|Adverse Event|1
1772792|NCT00718718|6172980|P7|Week 12 to End of Study|Adverse Event|0
1772793|NCT00718718|6172981|P6|Week 12 to End of Study|Adverse Event|0
1772794|NCT00718718|6172982|P5|Week 12 to End of Study|Adverse Event|0
1772795|NCT00718718|6172983|P4|Week 12 to End of Study|Adverse Event|0
1772796|NCT00718718|6172984|P3|Week 12 to End of Study|Adverse Event|0
1772797|NCT00718718|6172985|P2|Week 12 to End of Study|Adverse Event|0
1772798|NCT00718718|6172986|P1|Week 12 to End of Study|Adverse Event|0
1772799|NCT00718718|6172977|P10|Prior to Week 12|Other|0
1772800|NCT00718718|6172978|P9|Prior to Week 12|Other|0
1772801|NCT00718718|6172979|P8|Prior to Week 12|Other|0
1772802|NCT00718718|6172980|P7|Prior to Week 12|Other|0
1772803|NCT00718718|6172981|P6|Prior to Week 12|Other|0
1772804|NCT00718718|6172982|P5|Prior to Week 12|Other|0
1772805|NCT00718718|6172983|P4|Prior to Week 12|Other|0
1772806|NCT00718718|6172984|P3|Prior to Week 12|Other|1
1772807|NCT00718718|6172985|P2|Prior to Week 12|Other|0
1772808|NCT00718718|6172986|P1|Prior to Week 12|Other|1
1772809|NCT00718718|6172977|P10|Prior to Week 12|Withdrawal by Subject|0
1772810|NCT00718718|6172978|P9|Prior to Week 12|Withdrawal by Subject|1
1772811|NCT00718718|6172979|P8|Prior to Week 12|Withdrawal by Subject|1
1772812|NCT00718718|6172980|P7|Prior to Week 12|Withdrawal by Subject|1
1772813|NCT00718718|6172981|P6|Prior to Week 12|Withdrawal by Subject|0
1772814|NCT00718718|6172982|P5|Prior to Week 12|Withdrawal by Subject|3
1772815|NCT00718718|6172983|P4|Prior to Week 12|Withdrawal by Subject|0
1772816|NCT00718718|6172984|P3|Prior to Week 12|Withdrawal by Subject|0
1772817|NCT00718718|6172985|P2|Prior to Week 12|Withdrawal by Subject|0
1772818|NCT00718718|6172986|P1|Prior to Week 12|Withdrawal by Subject|0
1772819|NCT00718718|6172977|P10|Prior to Week 12|Adverse Event|0
1772820|NCT00718718|6172978|P9|Prior to Week 12|Adverse Event|1
1772821|NCT00718718|6172979|P8|Prior to Week 12|Adverse Event|1
1772822|NCT00718718|6172980|P7|Prior to Week 12|Adverse Event|0
1772823|NCT00718718|6172981|P6|Prior to Week 12|Adverse Event|0
1772824|NCT00718718|6172982|P5|Prior to Week 12|Adverse Event|0
1772825|NCT00718718|6172983|P4|Prior to Week 12|Adverse Event|0
1772826|NCT00718718|6172984|P3|Prior to Week 12|Adverse Event|0
1772827|NCT00718718|6172985|P2|Prior to Week 12|Adverse Event|0
1772828|NCT00718718|6172986|P1|Prior to Week 12|Adverse Event|0
1772829|NCT00718666|6173029|P3|Booster Phase Year 5|Lost to Follow-up|4
1772830|NCT00718666|6173030|P2|Booster Phase Year 5|Lost to Follow-up|0
1772831|NCT00718666|6173031|P1|Booster Phase Year 5|Lost to Follow-up|1
1772832|NCT00718666|6173029|P3|Booster Phase Year 5|Withdrawal by Subject|1
1772833|NCT00718666|6173030|P2|Booster Phase Year 5|Withdrawal by Subject|0
1772834|NCT00718666|6173031|P1|Booster Phase Year 5|Withdrawal by Subject|0
1772835|NCT00718666|6173029|P3|Booster Phase Year 5|Declined v-4 serology|0
1772836|NCT00718666|6173030|P2|Booster Phase Year 5|Declined v-4 serology|0
1772837|NCT00718666|6173031|P1|Booster Phase Year 5|Declined v-4 serology|1
1772838|NCT00718666|6173029|P3|Booster Phase Year 5|No active participation request|1
1772839|NCT00718666|6173030|P2|Booster Phase Year 5|No active participation request|0
1772840|NCT00718666|6173031|P1|Booster Phase Year 5|No active participation request|0
1772841|NCT00718640|6173115|P1|Overall Study|Unresolved toxicity after 2 weeks|2
1772842|NCT00718640|6173115|P1|Overall Study|Death|1
1772843|NCT00718640|6173115|P1|Overall Study|Adverse Event|4
1772844|NCT00718549|6173127|P3|Maintenance/ Observation Phase|Relapse|2
1772845|NCT00718549|6173128|P2|Maintenance/ Observation Phase|Relapse|3
1772846|NCT00718549|6173129|P1|Maintenance/ Observation Phase|Relapse|0
1772847|NCT00718549|6173127|P3|Maintenance/ Observation Phase|Progression|14
1772848|NCT00718549|6173128|P2|Maintenance/ Observation Phase|Progression|5
1772849|NCT00718549|6173129|P1|Maintenance/ Observation Phase|Progression|0
1772850|NCT00718549|6173127|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
1772851|NCT00718549|6173128|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
1772852|NCT00718549|6173129|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
1772853|NCT00718549|6173127|P3|Maintenance/ Observation Phase|Death|2
1772854|NCT00718549|6173128|P2|Maintenance/ Observation Phase|Death|1
1772855|NCT00718549|6173129|P1|Maintenance/ Observation Phase|Death|0
1772856|NCT00718549|6173127|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
1772857|NCT00718549|6173128|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
1772858|NCT00718549|6173129|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
1772859|NCT00718549|6173127|P3|Induction Phase|Early Termination - No Additional Info|0
1772860|NCT00718549|6173128|P2|Induction Phase|Early Termination - No Additional Info|0
1772861|NCT00718549|6173129|P1|Induction Phase|Early Termination - No Additional Info|59
1772862|NCT00718549|6173127|P3|Induction Phase|Eligibility Criteria Violation|0
1772863|NCT00718549|6173128|P2|Induction Phase|Eligibility Criteria Violation|0
1772864|NCT00718549|6173129|P1|Induction Phase|Eligibility Criteria Violation|2
1772865|NCT00718549|6173127|P3|Induction Phase|Disease Progression|0
1772866|NCT00718549|6173128|P2|Induction Phase|Disease Progression|0
1772867|NCT00718549|6173129|P1|Induction Phase|Disease Progression|1
1772868|NCT00718523|6173154|P2|Overall Study|Death|17
1772869|NCT00718523|6173155|P1|Overall Study|Death|13
1772870|NCT00718523|6173154|P2|Overall Study|Withdrawal by Subject|7
1772871|NCT00718523|6173155|P1|Overall Study|Withdrawal by Subject|5
1772872|NCT00718510|6173167|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
1772873|NCT00718510|6173168|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
1772874|NCT00718510|6173167|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
1772875|NCT00718510|6173168|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
1772876|NCT00718328|6173180|P2|Overall Study|Lost to Follow-up|0
1772877|NCT00718328|6173181|P1|Overall Study|Lost to Follow-up|1
1772878|NCT00718315|6173190|P3|Overall Study|Use of ATB and Corticoids|2
1772879|NCT00718315|6173191|P2|Overall Study|Use of ATB and Corticoids|1
1772880|NCT00718315|6173192|P1|Overall Study|Use of ATB and Corticoids|0
1772881|NCT00718315|6173190|P3|Overall Study|Other|1
1772882|NCT00718315|6173191|P2|Overall Study|Other|0
1772883|NCT00718315|6173192|P1|Overall Study|Other|0
1772884|NCT00718315|6173190|P3|Overall Study|Disease progression|1
1772885|NCT00718315|6173191|P2|Overall Study|Disease progression|1
1772886|NCT00718315|6173192|P1|Overall Study|Disease progression|0
1772887|NCT00718315|6173190|P3|Overall Study|Use of Minocyclin|1
1772888|NCT00718315|6173191|P2|Overall Study|Use of Minocyclin|1
1772889|NCT00718315|6173192|P1|Overall Study|Use of Minocyclin|1
1772890|NCT00718315|6173190|P3|Overall Study|Erlotinib dose decreased|1
1772891|NCT00718315|6173191|P2|Overall Study|Erlotinib dose decreased|3
1772892|NCT00718315|6173192|P1|Overall Study|Erlotinib dose decreased|4
1772893|NCT00718315|6173190|P3|Overall Study|Protocol Violation|3
1772894|NCT00718315|6173191|P2|Overall Study|Protocol Violation|5
1772895|NCT00718315|6173192|P1|Overall Study|Protocol Violation|5
1772896|NCT00718315|6173190|P3|Overall Study|Lost to Follow-up|4
1772897|NCT00718315|6173191|P2|Overall Study|Lost to Follow-up|3
1772898|NCT00718315|6173192|P1|Overall Study|Lost to Follow-up|2
1772899|NCT00718315|6173190|P3|Overall Study|Death|5
1772900|NCT00718315|6173191|P2|Overall Study|Death|6
1772901|NCT00718315|6173192|P1|Overall Study|Death|6
1772902|NCT00718315|6173190|P3|Overall Study|Adverse Event|3
1772903|NCT00718315|6173191|P2|Overall Study|Adverse Event|2
1772904|NCT00718315|6173192|P1|Overall Study|Adverse Event|1
1772905|NCT00718237|6173243|P2|Overall Study|Withdrawal by Subject|10
1772906|NCT00718237|6173244|P1|Overall Study|Withdrawal by Subject|9
1772907|NCT00718237|6173243|P2|Overall Study|Physician Decision|0
1772908|NCT00718237|6173244|P1|Overall Study|Physician Decision|1
1772909|NCT00718237|6173243|P2|Overall Study|Lost to Follow-up|2
1772910|NCT00718237|6173244|P1|Overall Study|Lost to Follow-up|2
1772911|NCT00718237|6173243|P2|Overall Study|Adverse Event|3
1772912|NCT00718237|6173244|P1|Overall Study|Adverse Event|1
1772913|NCT00718159|6173261|P7|Overall Study|Investigator Decision|1
1772914|NCT00718159|6173262|P6|Overall Study|Investigator Decision|1
1772915|NCT00718159|6173263|P5|Overall Study|Investigator Decision|0
1772916|NCT00718159|6173264|P4|Overall Study|Investigator Decision|0
1772917|NCT00718159|6173265|P3|Overall Study|Investigator Decision|0
1772918|NCT00718159|6173266|P2|Overall Study|Investigator Decision|0
1772919|NCT00718159|6173267|P1|Overall Study|Investigator Decision|0
1772920|NCT00718159|6173261|P7|Overall Study|Death due to Study Drug Toxicity|0
1772921|NCT00718159|6173262|P6|Overall Study|Death due to Study Drug Toxicity|0
1772922|NCT00718159|6173263|P5|Overall Study|Death due to Study Drug Toxicity|0
1772923|NCT00718159|6173264|P4|Overall Study|Death due to Study Drug Toxicity|2
1772924|NCT00718159|6173265|P3|Overall Study|Death due to Study Drug Toxicity|1
1772925|NCT00718159|6173266|P2|Overall Study|Death due to Study Drug Toxicity|0
1772926|NCT00718159|6173267|P1|Overall Study|Death due to Study Drug Toxicity|0
1772927|NCT00718159|6173261|P7|Overall Study|Death due to Adverse Event|0
1772928|NCT00718159|6173262|P6|Overall Study|Death due to Adverse Event|0
1772929|NCT00718159|6173263|P5|Overall Study|Death due to Adverse Event|2
1772930|NCT00718159|6173264|P4|Overall Study|Death due to Adverse Event|2
1772931|NCT00718159|6173265|P3|Overall Study|Death due to Adverse Event|0
1772932|NCT00718159|6173266|P2|Overall Study|Death due to Adverse Event|0
1772933|NCT00718159|6173267|P1|Overall Study|Death due to Adverse Event|0
1772934|NCT00718159|6173261|P7|Overall Study|Progressive Disease|0
1772935|NCT00718159|6173262|P6|Overall Study|Progressive Disease|0
1772936|NCT00718159|6173263|P5|Overall Study|Progressive Disease|6
1772937|NCT00718159|6173264|P4|Overall Study|Progressive Disease|0
1772938|NCT00718159|6173265|P3|Overall Study|Progressive Disease|2
1772939|NCT00718159|6173266|P2|Overall Study|Progressive Disease|3
1772940|NCT00718159|6173267|P1|Overall Study|Progressive Disease|3
1772941|NCT00718081|6173324|P3|Overall Study|Lack of Efficacy|21
1772942|NCT00718081|6173325|P2|Overall Study|Lack of Efficacy|3
1772943|NCT00718081|6173326|P1|Overall Study|Lack of Efficacy|7
1772944|NCT00718081|6173324|P3|Overall Study|Adverse Event|0
1772945|NCT00718081|6173325|P2|Overall Study|Adverse Event|1
1772946|NCT00718081|6173326|P1|Overall Study|Adverse Event|0
1772947|NCT00718042|6173343|P6|Donor Follow-up|Lost to Follow-up|0
1772948|NCT00718042|6173344|P5|Donor Follow-up|Lost to Follow-up|19
1772949|NCT00718042|6173345|P4|Donor Follow-up|Lost to Follow-up|0
1772950|NCT00718042|6173346|P3|Donor Follow-up|Lost to Follow-up|0
1772951|NCT00718042|6173347|P2|Donor Follow-up|Lost to Follow-up|0
1772952|NCT00718042|6173348|P1|Donor Follow-up|Lost to Follow-up|13
1772953|NCT00718042|6173343|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1772954|NCT00718042|6173344|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1772955|NCT00718042|6173345|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1772956|NCT00718042|6173346|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1772957|NCT00718042|6173347|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
1772958|NCT00718042|6173348|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
1772959|NCT00718042|6173343|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1772960|NCT00718042|6173344|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1772961|NCT00718042|6173345|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1772962|NCT00718042|6173346|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
1772963|NCT00718042|6173347|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
1772964|NCT00718042|6173348|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
1772965|NCT00718042|6173343|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1772966|NCT00718042|6173344|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
1772967|NCT00718042|6173345|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1772968|NCT00718042|6173346|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1772969|NCT00718042|6173347|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
1772970|NCT00718042|6173348|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
1772971|NCT00718042|6173343|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1772972|NCT00718042|6173344|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
1772973|NCT00718042|6173345|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1772974|NCT00718042|6173346|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1772975|NCT00718042|6173347|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1772976|NCT00718042|6173348|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
1772977|NCT00717886|6173404|P1|Overall Study|Treatment Failure|1
1772978|NCT00717886|6173404|P1|Overall Study|Withdrawal by Subject|3
1772979|NCT00717860|6173419|P2|Overall Study|Withdrew consent|3
1772980|NCT00717860|6173420|P1|Overall Study|Withdrew consent|7
1772981|NCT00717860|6173419|P2|Overall Study|Discontinued for other reason|1
1772982|NCT00717860|6173420|P1|Overall Study|Discontinued for other reason|6
1772983|NCT00717860|6173419|P2|Overall Study|Lack of Efficacy|13
1772984|NCT00717860|6173420|P1|Overall Study|Lack of Efficacy|7
1772985|NCT00717860|6173419|P2|Overall Study|Laboratory adverse experience|2
1772986|NCT00717860|6173420|P1|Overall Study|Laboratory adverse experience|2
1772987|NCT00717860|6173419|P2|Overall Study|Clinical adverse experience|9
1772988|NCT00717860|6173420|P1|Overall Study|Clinical adverse experience|5
1772990|NCT00717522|6173443|P1|Overall Study|Death|1
1772991|NCT00717522|6173443|P1|Overall Study|Adverse Event|1
1772992|NCT00717522|6173443|P1|Overall Study|Disease Progression|5
1772993|NCT00717366|6173479|P2|Extension Period (52 Weeks)|Withdrew consent|1
1772994|NCT00717366|6173480|P1|Extension Period (52 Weeks)|Withdrew consent|1
1772995|NCT00717366|6173479|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
1772996|NCT00717366|6173480|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
1772997|NCT00717366|6173479|P2|Extension Period (52 Weeks)|Renal transplant|13
1772998|NCT00717366|6173480|P1|Extension Period (52 Weeks)|Renal transplant|3
1772999|NCT00717366|6173479|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
1773000|NCT00717366|6173480|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
1773001|NCT00717366|6173479|P2|Core Study Period (20 Weeks)|Death|1
1773002|NCT00717366|6173480|P1|Core Study Period (20 Weeks)|Death|0
1773003|NCT00717366|6173479|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
1773004|NCT00717366|6173480|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
1773005|NCT00717366|6173479|P2|Core Study Period (20 Weeks)|Renal transplant|9
1773006|NCT00717366|6173480|P1|Core Study Period (20 Weeks)|Renal transplant|4
1773007|NCT00717314|6173504|P2|Overall Study|Withdrawal by Subject|3
1773008|NCT00717314|6173505|P1|Overall Study|Withdrawal by Subject|1
1773009|NCT00717314|6173504|P2|Overall Study|Lost to Follow-up|5
1773010|NCT00717314|6173505|P1|Overall Study|Lost to Follow-up|1
1773011|NCT00717314|6173504|P2|Overall Study|Protocol Violation|0
1773012|NCT00717314|6173505|P1|Overall Study|Protocol Violation|1
1773013|NCT00717314|6173504|P2|Overall Study|Adverse Event|2
1773014|NCT00717314|6173505|P1|Overall Study|Adverse Event|3
1773015|NCT00717275|6173542|P1|Overall Study|Premature study termination.|3
1773016|NCT00717249|6173548|P2|Overall Study|Headaches|0
1773017|NCT00717249|6173549|P1|Overall Study|Headaches|1
1773018|NCT00717249|6173548|P2|Overall Study|Subject relocated|0
1773019|NCT00717249|6173549|P1|Overall Study|Subject relocated|1
1773020|NCT00717249|6173548|P2|Overall Study|Diagnosed with Multiple Scletosis|0
1773021|NCT00717249|6173549|P1|Overall Study|Diagnosed with Multiple Scletosis|1
1773022|NCT00717249|6173548|P2|Overall Study|Diagnosed with Diabetes|0
1773023|NCT00717249|6173549|P1|Overall Study|Diagnosed with Diabetes|1
1773024|NCT00717249|6173548|P2|Overall Study|Gastric Surgery|1
1773025|NCT00717249|6173549|P1|Overall Study|Gastric Surgery|0
1773026|NCT00717249|6173548|P2|Overall Study|Unsatisfactory Physiological Response|1
1773027|NCT00717249|6173549|P1|Overall Study|Unsatisfactory Physiological Response|0
1773028|NCT00717249|6173548|P2|Overall Study|Subject became Ineligible|1
1773029|NCT00717249|6173549|P1|Overall Study|Subject became Ineligible|1
1773030|NCT00717249|6173548|P2|Overall Study|Protocol Violation|2
1773031|NCT00717249|6173549|P1|Overall Study|Protocol Violation|0
1773032|NCT00717249|6173548|P2|Overall Study|Pregnancy|3
1773033|NCT00717249|6173549|P1|Overall Study|Pregnancy|6
1773034|NCT00717249|6173548|P2|Overall Study|Withdrawal by Subject|2
1773035|NCT00717249|6173549|P1|Overall Study|Withdrawal by Subject|1
1773036|NCT00717249|6173548|P2|Overall Study|Lost to Follow-up|0
1773037|NCT00717249|6173549|P1|Overall Study|Lost to Follow-up|2
1773038|NCT00717249|6173548|P2|Overall Study|Adverse Event|2
1773039|NCT00717249|6173549|P1|Overall Study|Adverse Event|4
1773040|NCT00717249|6173548|P2|Overall Study|Unsatisfactory visual Response|2
1773041|NCT00717249|6173549|P1|Overall Study|Unsatisfactory visual Response|0
1773042|NCT00717249|6173548|P2|Overall Study|Lens Discomfort|1
1773043|NCT00717249|6173549|P1|Overall Study|Lens Discomfort|4
1773044|NCT00717236|6173563|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
1773045|NCT00717236|6173564|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
1773046|NCT00717236|6173563|P2|Open-Label Period|Other: Completion Accidently Performed|0
1773047|NCT00717236|6173564|P1|Open-Label Period|Other: Completion Accidently Performed|1
1773048|NCT00717236|6173563|P2|Open-Label Period|Other: Administration of Golimumab|0
1773049|NCT00717236|6173564|P1|Open-Label Period|Other: Administration of Golimumab|1
1773050|NCT00717236|6173563|P2|Open-Label Period|Other: Cataract Surgery|0
1773051|NCT00717236|6173564|P1|Open-Label Period|Other: Cataract Surgery|1
1773052|NCT00717236|6173563|P2|Open-Label Period|Other: Sponsor Request|0
1773053|NCT00717236|6173564|P1|Open-Label Period|Other: Sponsor Request|3
1773054|NCT00717236|6173563|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
1773055|NCT00717236|6173564|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
1773056|NCT00717236|6173563|P2|Open-Label Period|Other: Investigator Decision|0
1773057|NCT00717236|6173564|P1|Open-Label Period|Other: Investigator Decision|1
1773058|NCT00717236|6173563|P2|Open-Label Period|Other: Moved|0
1773059|NCT00717236|6173564|P1|Open-Label Period|Other: Moved|1
1773060|NCT00717236|6173563|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
1773061|NCT00717236|6173564|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
1773062|NCT00717236|6173563|P2|Open-Label Period|Other: Lack of Compliance|1
1773063|NCT00717236|6173564|P1|Open-Label Period|Other: Lack of Compliance|1
1773064|NCT00717236|6173563|P2|Open-Label Period|Other: Peripheral Neuropathy|1
1773065|NCT00717236|6173564|P1|Open-Label Period|Other: Peripheral Neuropathy|0
1773066|NCT00717236|6173563|P2|Open-Label Period|Loss of Efficacy|1
1773067|NCT00717236|6173564|P1|Open-Label Period|Loss of Efficacy|6
1773068|NCT00717236|6173563|P2|Open-Label Period|Withdrawal by Subject|2
1773069|NCT00717236|6173564|P1|Open-Label Period|Withdrawal by Subject|20
1773070|NCT00717236|6173563|P2|Open-Label Period|Lost to Follow-up|4
1773071|NCT00717236|6173564|P1|Open-Label Period|Lost to Follow-up|28
1773072|NCT00717236|6173563|P2|Open-Label Period|Lack of Efficacy|8
1773073|NCT00717236|6173564|P1|Open-Label Period|Lack of Efficacy|30
1773074|NCT00717236|6173563|P2|Open-Label Period|Adverse Event|4
1773075|NCT00717236|6173564|P1|Open-Label Period|Adverse Event|29
1773076|NCT00717236|6173563|P2|Double-Blind Period|Other: Investigator Decision|1
1773077|NCT00717236|6173564|P1|Double-Blind Period|Other: Investigator Decision|0
1773078|NCT00717236|6173563|P2|Double-Blind Period|Other: Transportation problems|1
1773079|NCT00717236|6173564|P1|Double-Blind Period|Other: Transportation problems|0
1773080|NCT00717236|6173563|P2|Double-Blind Period|Other: Prohibited medication taken|2
1773081|NCT00717236|6173564|P1|Double-Blind Period|Other: Prohibited medication taken|2
1773082|NCT00717236|6173563|P2|Double-Blind Period|Other: Stopped taking DMARD|0
1773083|NCT00717236|6173564|P1|Double-Blind Period|Other: Stopped taking DMARD|1
1773084|NCT00717236|6173563|P2|Double-Blind Period|Other: Subject moved|1
1773085|NCT00717236|6173564|P1|Double-Blind Period|Other: Subject moved|1
1773086|NCT00717236|6173563|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
1773087|NCT00717236|6173564|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
1773088|NCT00717236|6173563|P2|Double-Blind Period|Other: Inappropriate randomization|0
1773089|NCT00717236|6173564|P1|Double-Blind Period|Other: Inappropriate randomization|1
1773090|NCT00717236|6173563|P2|Double-Blind Period|Other: Sponsor request|0
1773091|NCT00717236|6173564|P1|Double-Blind Period|Other: Sponsor request|1
1773092|NCT00717236|6173563|P2|Double-Blind Period|Other: History of cancer|0
1773093|NCT00717236|6173564|P1|Double-Blind Period|Other: History of cancer|1
1773094|NCT00717236|6173563|P2|Double-Blind Period|Other: History of adenoid grown|0
1773095|NCT00717236|6173564|P1|Double-Blind Period|Other: History of adenoid grown|1
1773096|NCT00717236|6173563|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
1773097|NCT00717236|6173564|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
1773098|NCT00717236|6173563|P2|Double-Blind Period|Other: subject withdrew consent|1
1773099|NCT00717236|6173564|P1|Double-Blind Period|Other: subject withdrew consent|1
1773100|NCT00717236|6173563|P2|Double-Blind Period|Other: Screening failure|0
1773101|NCT00717236|6173564|P1|Double-Blind Period|Other: Screening failure|1
1773102|NCT00717236|6173563|P2|Double-Blind Period|Other: Site withdrew|0
1773103|NCT00717236|6173564|P1|Double-Blind Period|Other: Site withdrew|2
1773104|NCT00717236|6173563|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
1773105|NCT00717236|6173564|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
1773106|NCT00717236|6173563|P2|Double-Blind Period|Other: Protocol Violation|0
1773107|NCT00717236|6173564|P1|Double-Blind Period|Other: Protocol Violation|2
1773108|NCT00717236|6173563|P2|Double-Blind Period|Other: Pregnancy|0
1773109|NCT00717236|6173564|P1|Double-Blind Period|Other: Pregnancy|1
1773110|NCT00717236|6173563|P2|Double-Blind Period|Other: Death|0
1773111|NCT00717236|6173564|P1|Double-Blind Period|Other: Death|1
1773112|NCT00717236|6173563|P2|Double-Blind Period|Loss of efficacy|0
1773113|NCT00717236|6173564|P1|Double-Blind Period|Loss of efficacy|3
1773114|NCT00717236|6173563|P2|Double-Blind Period|Withdrawal by Subject|2
1773115|NCT00717236|6173564|P1|Double-Blind Period|Withdrawal by Subject|10
1773116|NCT00717236|6173563|P2|Double-Blind Period|Lost to Follow-up|5
1773117|NCT00717236|6173564|P1|Double-Blind Period|Lost to Follow-up|3
1773118|NCT00717236|6173563|P2|Double-Blind Period|Lack of Efficacy|6
1773119|NCT00717236|6173564|P1|Double-Blind Period|Lack of Efficacy|6
1773120|NCT00717236|6173563|P2|Double-Blind Period|Adverse Event|6
1773121|NCT00717236|6173564|P1|Double-Blind Period|Adverse Event|33
1773122|NCT00717197|6173633|P1|Overall Study|Physician Decision|1
1773123|NCT00717197|6173633|P1|Overall Study|Tumor Progression|1
1773124|NCT00717197|6173633|P1|Overall Study|Unable to purchase study drug|5
1773125|NCT00717093|6173639|P2|Overall Study|Randomized but not treated|0
1773126|NCT00717093|6173640|P1|Overall Study|Randomized but not treated|1
1773127|NCT00717093|6173639|P2|Overall Study|Other|1
1773128|NCT00717093|6173640|P1|Overall Study|Other|0
1773129|NCT00717093|6173639|P2|Overall Study|Withdrawal by Subject|19
1773130|NCT00717093|6173640|P1|Overall Study|Withdrawal by Subject|12
1773131|NCT00717093|6173639|P2|Overall Study|Lost to Follow-up|6
1773132|NCT00717093|6173640|P1|Overall Study|Lost to Follow-up|9
1773133|NCT00717093|6173639|P2|Overall Study|Lack of Efficacy|13
1773134|NCT00717093|6173640|P1|Overall Study|Lack of Efficacy|3
1773135|NCT00717093|6173639|P2|Overall Study|Adverse Event|9
1773136|NCT00717093|6173640|P1|Overall Study|Adverse Event|19
1773137|NCT00717067|6173657|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1773138|NCT00717067|6173658|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1773139|NCT00717067|6173659|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
1773140|NCT00717067|6173660|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1773141|NCT00717067|6173661|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
1773142|NCT00716976|6173768|P2|Overall Study|Ineligibles|2
1773143|NCT00716976|6173769|P1|Overall Study|Ineligibles|4
1773144|NCT00716976|6173768|P2|Overall Study|Radiation during protocol|0
1773145|NCT00716976|6173769|P1|Overall Study|Radiation during protocol|1
1773146|NCT00716976|6173768|P2|Overall Study|Premature discontinuation cisplatin|4
1773147|NCT00716976|6173769|P1|Overall Study|Premature discontinuation cisplatin|5
1773148|NCT00716976|6173768|P2|Overall Study|Withdrawal by Subject|1
1773149|NCT00716976|6173769|P1|Overall Study|Withdrawal by Subject|5
1773150|NCT00716976|6173768|P2|Overall Study|Physician Decision|2
1773151|NCT00716976|6173769|P1|Overall Study|Physician Decision|2
1773152|NCT00716976|6173768|P2|Overall Study|Death|0
1773153|NCT00716976|6173769|P1|Overall Study|Death|1
1773154|NCT00716976|6173768|P2|Overall Study|Adverse Event|0
1773155|NCT00716976|6173769|P1|Overall Study|Adverse Event|2
1773156|NCT00716859|6173809|P2|Overall Study|Not treated|1
1773157|NCT00716859|6173810|P1|Overall Study|Not treated|1
1773158|NCT00716859|6173809|P2|Overall Study|Withdrawal by Subject|3
1773159|NCT00716859|6173810|P1|Overall Study|Withdrawal by Subject|1
1773160|NCT00716859|6173809|P2|Overall Study|Lack of Efficacy|0
1773161|NCT00716859|6173810|P1|Overall Study|Lack of Efficacy|3
1773162|NCT00716859|6173809|P2|Overall Study|Adverse Event|1
1773163|NCT00716859|6173810|P1|Overall Study|Adverse Event|4
1773164|NCT00716625|6173895|P1|Overall Study|Safety was not Assessable|1
1773165|NCT00716482|6173920|P1|Overall Study|inclusion/exclusion criteria not met|25
1773166|NCT00716482|6173920|P1|Overall Study|technical/machine error|28
1773167|NCT00716482|6173920|P1|Overall Study|no pathology obtained|10
1773168|NCT00716482|6173920|P1|Overall Study|Inadequate acquisition or analysis|50
1773169|NCT00716482|6173920|P1|Overall Study|Lost to Follow-up|6
1773170|NCT00716456|6173933|P3|Overall Study|Adverse Event|0
1773171|NCT00716456|6173934|P2|Overall Study|Adverse Event|2
1773172|NCT00716456|6173935|P1|Overall Study|Adverse Event|0
1773173|NCT00716417|6173986|P10|Overall Study|On patient request due to toxicities|0
1773174|NCT00716417|6173987|P9|Overall Study|On patient request due to toxicities|0
1773175|NCT00716417|6173988|P8|Overall Study|On patient request due to toxicities|1
1773176|NCT00716417|6173989|P7|Overall Study|On patient request due to toxicities|0
1773177|NCT00716417|6173990|P6|Overall Study|On patient request due to toxicities|0
1773178|NCT00716417|6173991|P5|Overall Study|On patient request due to toxicities|0
1773179|NCT00716417|6173992|P4|Overall Study|On patient request due to toxicities|0
1773180|NCT00716417|6173993|P3|Overall Study|On patient request due to toxicities|0
1773181|NCT00716417|6173994|P2|Overall Study|On patient request due to toxicities|0
1773182|NCT00716417|6173995|P1|Overall Study|On patient request due to toxicities|0
1773183|NCT00716417|6173986|P10|Overall Study|Dose limiting toxicity (DLT)|0
1773184|NCT00716417|6173987|P9|Overall Study|Dose limiting toxicity (DLT)|0
1773185|NCT00716417|6173988|P8|Overall Study|Dose limiting toxicity (DLT)|0
1773186|NCT00716417|6173989|P7|Overall Study|Dose limiting toxicity (DLT)|0
1773187|NCT00716417|6173990|P6|Overall Study|Dose limiting toxicity (DLT)|0
1773188|NCT00716417|6173991|P5|Overall Study|Dose limiting toxicity (DLT)|1
1773189|NCT00716417|6173992|P4|Overall Study|Dose limiting toxicity (DLT)|0
1773190|NCT00716417|6173993|P3|Overall Study|Dose limiting toxicity (DLT)|0
1773191|NCT00716417|6173994|P2|Overall Study|Dose limiting toxicity (DLT)|0
1773192|NCT00716417|6173995|P1|Overall Study|Dose limiting toxicity (DLT)|0
1773193|NCT00716417|6173986|P10|Overall Study|Progressive disease|0
1773194|NCT00716417|6173987|P9|Overall Study|Progressive disease|5
1773195|NCT00716417|6173988|P8|Overall Study|Progressive disease|1
1773196|NCT00716417|6173989|P7|Overall Study|Progressive disease|3
1773197|NCT00716417|6173990|P6|Overall Study|Progressive disease|3
1773198|NCT00716417|6173991|P5|Overall Study|Progressive disease|0
1773199|NCT00716417|6173992|P4|Overall Study|Progressive disease|8
1773200|NCT00716417|6173993|P3|Overall Study|Progressive disease|3
1773201|NCT00716417|6173994|P2|Overall Study|Progressive disease|5
1773202|NCT00716417|6173995|P1|Overall Study|Progressive disease|3
1773203|NCT00716417|6173986|P10|Overall Study|Withdrawal by Subject|0
1773204|NCT00716417|6173987|P9|Overall Study|Withdrawal by Subject|0
1773205|NCT00716417|6173988|P8|Overall Study|Withdrawal by Subject|0
1773206|NCT00716417|6173989|P7|Overall Study|Withdrawal by Subject|1
1773207|NCT00716417|6173990|P6|Overall Study|Withdrawal by Subject|0
1773208|NCT00716417|6173991|P5|Overall Study|Withdrawal by Subject|0
1773209|NCT00716417|6173992|P4|Overall Study|Withdrawal by Subject|2
1773210|NCT00716417|6173993|P3|Overall Study|Withdrawal by Subject|0
1773211|NCT00716417|6173994|P2|Overall Study|Withdrawal by Subject|1
1773212|NCT00716417|6173995|P1|Overall Study|Withdrawal by Subject|0
1773213|NCT00716417|6173986|P10|Overall Study|Adverse Event|3
1773214|NCT00716417|6173987|P9|Overall Study|Adverse Event|0
1773215|NCT00716417|6173988|P8|Overall Study|Adverse Event|1
1773216|NCT00716417|6173989|P7|Overall Study|Adverse Event|3
1773217|NCT00716417|6173990|P6|Overall Study|Adverse Event|0
1773218|NCT00716417|6173991|P5|Overall Study|Adverse Event|0
1773219|NCT00716417|6173992|P4|Overall Study|Adverse Event|1
1773220|NCT00716417|6173993|P3|Overall Study|Adverse Event|2
1773221|NCT00716417|6173994|P2|Overall Study|Adverse Event|0
1773222|NCT00716417|6173995|P1|Overall Study|Adverse Event|0
1773223|NCT00716274|6174042|P6|Study Period III (16-Weeks)|Adverse Event|0
1773224|NCT00716274|6174043|P5|Study Period III (16-Weeks)|Adverse Event|1
1773225|NCT00716274|6174044|P4|Study Period III (16-Weeks)|Adverse Event|0
1773226|NCT00716274|6174045|P3|Study Period III (16-Weeks)|Adverse Event|0
1773227|NCT00716274|6174046|P2|Study Period III (16-Weeks)|Adverse Event|0
1773228|NCT00716274|6174047|P1|Study Period III (16-Weeks)|Adverse Event|0
1773229|NCT00716274|6174042|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1773230|NCT00716274|6174043|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
1773231|NCT00716274|6174044|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
1773232|NCT00716274|6174045|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1773233|NCT00716274|6174046|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1773234|NCT00716274|6174047|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
1773235|NCT00716274|6174042|P6|Study Period III (16-Weeks)|Physician Decision|0
1773236|NCT00716274|6174043|P5|Study Period III (16-Weeks)|Physician Decision|1
1773237|NCT00716274|6174044|P4|Study Period III (16-Weeks)|Physician Decision|0
1773238|NCT00716274|6174045|P3|Study Period III (16-Weeks)|Physician Decision|0
1773239|NCT00716274|6174046|P2|Study Period III (16-Weeks)|Physician Decision|0
1773240|NCT00716274|6174047|P1|Study Period III (16-Weeks)|Physician Decision|0
1773241|NCT00716274|6174042|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
1773242|NCT00716274|6174043|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
1773243|NCT00716274|6174044|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
1773244|NCT00716274|6174045|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
1773245|NCT00716274|6174046|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
1773246|NCT00716274|6174047|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
1773247|NCT00716274|6174042|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
1773248|NCT00716274|6174043|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
1773249|NCT00716274|6174044|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
1773250|NCT00716274|6174045|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
1773251|NCT00716274|6174046|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
1773252|NCT00716274|6174047|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
1773253|NCT00716274|6174042|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1773254|NCT00716274|6174043|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1773255|NCT00716274|6174044|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1773256|NCT00716274|6174045|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
1773257|NCT00716274|6174046|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
1773258|NCT00716274|6174047|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
1773259|NCT00716274|6174042|P6|Study Period II (16-Weeks)|Physician Decision|1
1773260|NCT00716274|6174043|P5|Study Period II (16-Weeks)|Physician Decision|0
1773261|NCT00716274|6174044|P4|Study Period II (16-Weeks)|Physician Decision|0
1773262|NCT00716274|6174045|P3|Study Period II (16-Weeks)|Physician Decision|0
1773263|NCT00716274|6174046|P2|Study Period II (16-Weeks)|Physician Decision|1
1773264|NCT00716274|6174047|P1|Study Period II (16-Weeks)|Physician Decision|3
1773265|NCT00716274|6174042|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
1773266|NCT00716274|6174043|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
1773267|NCT00716274|6174044|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
1773268|NCT00716274|6174045|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
1773269|NCT00716274|6174046|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
1773270|NCT00716274|6174047|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
1773271|NCT00716274|6174042|P6|Study Period II (16-Weeks)|Protocol Violation|1
1773272|NCT00716274|6174043|P5|Study Period II (16-Weeks)|Protocol Violation|0
1773273|NCT00716274|6174044|P4|Study Period II (16-Weeks)|Protocol Violation|0
1773274|NCT00716274|6174045|P3|Study Period II (16-Weeks)|Protocol Violation|0
1773275|NCT00716274|6174046|P2|Study Period II (16-Weeks)|Protocol Violation|3
1773276|NCT00716274|6174047|P1|Study Period II (16-Weeks)|Protocol Violation|0
1773277|NCT00716274|6174042|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1773278|NCT00716274|6174043|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1773279|NCT00716274|6174044|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1773280|NCT00716274|6174045|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1773281|NCT00716274|6174046|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
1773282|NCT00716274|6174047|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
1773283|NCT00716144|6174181|P4|Overall Study|Clinical Depression|0
1773284|NCT00716144|6174182|P3|Overall Study|Clinical Depression|0
1773285|NCT00716144|6174183|P2|Overall Study|Clinical Depression|1
1773286|NCT00716144|6174184|P1|Overall Study|Clinical Depression|0
1773287|NCT00716144|6174181|P4|Overall Study|Adverse event: left foot pain|0
1773288|NCT00716144|6174182|P3|Overall Study|Adverse event: left foot pain|0
1773289|NCT00716144|6174183|P2|Overall Study|Adverse event: left foot pain|1
1773290|NCT00716144|6174184|P1|Overall Study|Adverse event: left foot pain|0
1773291|NCT00716144|6174181|P4|Overall Study|Withdrew consent, allowed use of data|0
1773292|NCT00716144|6174182|P3|Overall Study|Withdrew consent, allowed use of data|1
1773293|NCT00716144|6174183|P2|Overall Study|Withdrew consent, allowed use of data|0
1773294|NCT00716144|6174184|P1|Overall Study|Withdrew consent, allowed use of data|0
1773295|NCT00716144|6174181|P4|Overall Study|Intercurrent illness|0
1773296|NCT00716144|6174182|P3|Overall Study|Intercurrent illness|1
1773297|NCT00716144|6174183|P2|Overall Study|Intercurrent illness|0
1773298|NCT00716144|6174184|P1|Overall Study|Intercurrent illness|0
1773299|NCT00716144|6174181|P4|Overall Study|Physician Decision|2
1773300|NCT00716144|6174182|P3|Overall Study|Physician Decision|2
1773301|NCT00716144|6174183|P2|Overall Study|Physician Decision|1
1773302|NCT00716144|6174184|P1|Overall Study|Physician Decision|0
1773303|NCT00716144|6174181|P4|Overall Study|Protocol Violation|0
1773304|NCT00716144|6174182|P3|Overall Study|Protocol Violation|1
1773305|NCT00716144|6174183|P2|Overall Study|Protocol Violation|0
1773306|NCT00716144|6174184|P1|Overall Study|Protocol Violation|2
1773307|NCT00716144|6174181|P4|Overall Study|Non-compliance|0
1773308|NCT00716144|6174182|P3|Overall Study|Non-compliance|0
1773309|NCT00716144|6174183|P2|Overall Study|Non-compliance|0
1773310|NCT00716144|6174184|P1|Overall Study|Non-compliance|1
1773311|NCT00716144|6174181|P4|Overall Study|Adverse Event|2
1773312|NCT00716144|6174182|P3|Overall Study|Adverse Event|0
1773313|NCT00716144|6174183|P2|Overall Study|Adverse Event|0
1773314|NCT00716144|6174184|P1|Overall Study|Adverse Event|0
1773315|NCT00716144|6174181|P4|Overall Study|Lost to Follow-up|2
1773316|NCT00716144|6174182|P3|Overall Study|Lost to Follow-up|1
1773317|NCT00716144|6174183|P2|Overall Study|Lost to Follow-up|2
1773318|NCT00716144|6174184|P1|Overall Study|Lost to Follow-up|2
1773319|NCT00716144|6174181|P4|Overall Study|Withdrawal by Subject|6
1773320|NCT00716144|6174182|P3|Overall Study|Withdrawal by Subject|6
1773321|NCT00716144|6174183|P2|Overall Study|Withdrawal by Subject|2
1773322|NCT00716144|6174184|P1|Overall Study|Withdrawal by Subject|4
1773323|NCT00716092|6174209|P3|Overall Study|Other incl. Lack of Efficacy|0
1773324|NCT00716092|6174210|P2|Overall Study|Other incl. Lack of Efficacy|1
1773325|NCT00716092|6174211|P1|Overall Study|Other incl. Lack of Efficacy|2
1773326|NCT00715949|6174264|P1|Overall Study|could not finish first test|4
1773327|NCT00715910|6174272|P6|Booster and ESFU Phase|Other|0
1773328|NCT00715910|6174273|P5|Booster and ESFU Phase|Other|1
1773329|NCT00715910|6174274|P4|Booster and ESFU Phase|Other|5
1773330|NCT00715910|6174275|P3|Booster and ESFU Phase|Other|0
1773331|NCT00715910|6174276|P2|Booster and ESFU Phase|Other|0
1773332|NCT00715910|6174277|P1|Booster and ESFU Phase|Other|0
1773333|NCT00715910|6174272|P6|Booster and ESFU Phase|Lost to Follow-up|13
1773334|NCT00715910|6174273|P5|Booster and ESFU Phase|Lost to Follow-up|1
1773335|NCT00715910|6174274|P4|Booster and ESFU Phase|Lost to Follow-up|6
1773336|NCT00715910|6174275|P3|Booster and ESFU Phase|Lost to Follow-up|0
1773337|NCT00715910|6174276|P2|Booster and ESFU Phase|Lost to Follow-up|0
1773338|NCT00715910|6174277|P1|Booster and ESFU Phase|Lost to Follow-up|0
1773339|NCT00715793|6174396|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
1773340|NCT00715793|6174397|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
1773341|NCT00715793|6174396|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
1773342|NCT00715793|6174397|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
1773343|NCT00715676|6174458|P3|Overall Study|Elevated Blood Glucose|0
1773344|NCT00715676|6174459|P2|Overall Study|Elevated Blood Glucose|1
1773345|NCT00715676|6174460|P1|Overall Study|Elevated Blood Glucose|0
1773346|NCT00715676|6174458|P3|Overall Study|Use of Exclusionary Medication|1
1773347|NCT00715676|6174459|P2|Overall Study|Use of Exclusionary Medication|0
1773348|NCT00715676|6174460|P1|Overall Study|Use of Exclusionary Medication|0
1773349|NCT00715676|6174458|P3|Overall Study|Did Not Meet Entry Criteria|1
1773350|NCT00715676|6174459|P2|Overall Study|Did Not Meet Entry Criteria|0
1773351|NCT00715676|6174460|P1|Overall Study|Did Not Meet Entry Criteria|0
1773352|NCT00715676|6174458|P3|Overall Study|Terminated by Sponsor|0
1773353|NCT00715676|6174459|P2|Overall Study|Terminated by Sponsor|0
1773354|NCT00715676|6174460|P1|Overall Study|Terminated by Sponsor|1
1773355|NCT00715676|6174458|P3|Overall Study|Lost to Follow-up|1
1773356|NCT00715676|6174459|P2|Overall Study|Lost to Follow-up|2
1773357|NCT00715676|6174460|P1|Overall Study|Lost to Follow-up|1
1773358|NCT00715676|6174458|P3|Overall Study|Withdrawal by Subject|8
1773359|NCT00715676|6174459|P2|Overall Study|Withdrawal by Subject|3
1773360|NCT00715676|6174460|P1|Overall Study|Withdrawal by Subject|1
1773361|NCT00715676|6174458|P3|Overall Study|Adverse Event|21
1773362|NCT00715676|6174459|P2|Overall Study|Adverse Event|5
1773363|NCT00715676|6174460|P1|Overall Study|Adverse Event|3
1773364|NCT00715624|6174503|P2|Overall Study|Other|1
1773365|NCT00715624|6174504|P1|Overall Study|Other|0
1773366|NCT00715624|6174503|P2|Overall Study|Incorrect randomization (not treated)|1
1773367|NCT00715624|6174504|P1|Overall Study|Incorrect randomization (not treated)|0
1773368|NCT00715624|6174503|P2|Overall Study|Sponsor decision|4
1773369|NCT00715624|6174504|P1|Overall Study|Sponsor decision|0
1773370|NCT00715624|6174503|P2|Overall Study|Poor compliance|13
1773371|NCT00715624|6174504|P1|Overall Study|Poor compliance|6
1773372|NCT00715624|6174503|P2|Overall Study|Familial and personal reasons|22
1773373|NCT00715624|6174504|P1|Overall Study|Familial and personal reasons|10
1773374|NCT00715624|6174503|P2|Overall Study|Withdrawal by Subject|25
1773375|NCT00715624|6174504|P1|Overall Study|Withdrawal by Subject|11
1773376|NCT00715624|6174503|P2|Overall Study|Protocol Violation|0
1773377|NCT00715624|6174504|P1|Overall Study|Protocol Violation|1
1773378|NCT00715624|6174503|P2|Overall Study|Lost to Follow-up|2
1773379|NCT00715624|6174504|P1|Overall Study|Lost to Follow-up|1
1773380|NCT00715624|6174503|P2|Overall Study|Lack of Efficacy|11
1773381|NCT00715624|6174504|P1|Overall Study|Lack of Efficacy|11
1773382|NCT00715624|6174503|P2|Overall Study|Adverse Event|37
1773383|NCT00715624|6174504|P1|Overall Study|Adverse Event|12
1773384|NCT00715559|6174532|P1|Overall Study|medication not tolerated - nausea|1
1773385|NCT00715520|6174542|P3|Overall Study|Withdrawal by Subject|1
1773386|NCT00715520|6174543|P2|Overall Study|Withdrawal by Subject|0
1773387|NCT00715520|6174544|P1|Overall Study|Withdrawal by Subject|2
1773388|NCT00715520|6174542|P3|Overall Study|Screen failure|1
1773389|NCT00715520|6174543|P2|Overall Study|Screen failure|1
1773390|NCT00715520|6174544|P1|Overall Study|Screen failure|8
1773391|NCT00715429|6174559|P2|Overall Study|Did not complete the study diary|1
1773392|NCT00715429|6174560|P1|Overall Study|Did not complete the study diary|0
1773393|NCT00715403|6174575|P7|Overall Study|Other reason not defined above|0
1773394|NCT00715403|6174576|P6|Overall Study|Other reason not defined above|1
1773395|NCT00715403|6174577|P5|Overall Study|Other reason not defined above|1
1773396|NCT00715403|6174578|P4|Overall Study|Other reason not defined above|0
1773397|NCT00715403|6174579|P3|Overall Study|Other reason not defined above|1
1773398|NCT00715403|6174580|P2|Overall Study|Other reason not defined above|0
1773399|NCT00715403|6174581|P1|Overall Study|Other reason not defined above|0
1773400|NCT00715403|6174575|P7|Overall Study|Protocol Violation|0
1773401|NCT00715403|6174576|P6|Overall Study|Protocol Violation|1
1773402|NCT00715403|6174577|P5|Overall Study|Protocol Violation|0
1773403|NCT00715403|6174578|P4|Overall Study|Protocol Violation|0
1773404|NCT00715403|6174579|P3|Overall Study|Protocol Violation|0
1773405|NCT00715403|6174580|P2|Overall Study|Protocol Violation|0
1773406|NCT00715403|6174581|P1|Overall Study|Protocol Violation|0
1773407|NCT00715403|6174575|P7|Overall Study|Other Adverse Event than DLT|0
1773408|NCT00715403|6174576|P6|Overall Study|Other Adverse Event than DLT|2
1773409|NCT00715403|6174577|P5|Overall Study|Other Adverse Event than DLT|0
1773410|NCT00715403|6174578|P4|Overall Study|Other Adverse Event than DLT|0
1773411|NCT00715403|6174579|P3|Overall Study|Other Adverse Event than DLT|0
1773412|NCT00715403|6174580|P2|Overall Study|Other Adverse Event than DLT|0
1773413|NCT00715403|6174581|P1|Overall Study|Other Adverse Event than DLT|1
1773414|NCT00715403|6174575|P7|Overall Study|Dose limiting Toxicity (DLT)|0
1773415|NCT00715403|6174576|P6|Overall Study|Dose limiting Toxicity (DLT)|1
1773416|NCT00715403|6174577|P5|Overall Study|Dose limiting Toxicity (DLT)|0
1773417|NCT00715403|6174578|P4|Overall Study|Dose limiting Toxicity (DLT)|0
1773418|NCT00715403|6174579|P3|Overall Study|Dose limiting Toxicity (DLT)|0
1773419|NCT00715403|6174580|P2|Overall Study|Dose limiting Toxicity (DLT)|0
1773420|NCT00715403|6174581|P1|Overall Study|Dose limiting Toxicity (DLT)|0
1773421|NCT00715403|6174575|P7|Overall Study|Progressive disease|1
1773422|NCT00715403|6174576|P6|Overall Study|Progressive disease|14
1773423|NCT00715403|6174577|P5|Overall Study|Progressive disease|5
1773424|NCT00715403|6174578|P4|Overall Study|Progressive disease|9
1773425|NCT00715403|6174579|P3|Overall Study|Progressive disease|3
1773426|NCT00715403|6174580|P2|Overall Study|Progressive disease|1
1773427|NCT00715403|6174581|P1|Overall Study|Progressive disease|0
1773428|NCT00715299|6174720|P1|Overall Study|failed the pre-screen exercise test|2
1773429|NCT00715299|6174720|P1|Overall Study|Adverse Event|3
1773430|NCT00715299|6174720|P1|Overall Study|Withdrawal by Subject|1
1773431|NCT00715208|6174726|P2|Overall Study|Lack of Efficacy|2
1773432|NCT00715208|6174727|P1|Overall Study|Lack of Efficacy|0
1773433|NCT00715208|6174726|P2|Overall Study|Adverse Event|6
1773434|NCT00715208|6174727|P1|Overall Study|Adverse Event|0
1773435|NCT00715208|6174726|P2|Overall Study|Withdrawal by Subject|1
1773436|NCT00715208|6174727|P1|Overall Study|Withdrawal by Subject|1
1773437|NCT00715117|6174743|P2|Overall Study|Crohn's flare and rescue with steroids|1
1773438|NCT00715117|6174744|P1|Overall Study|Crohn's flare and rescue with steroids|0
1773439|NCT00715078|6174812|P3|Overall Study|Unable to start due to disease prog.|1
1773440|NCT00715078|6174813|P2|Overall Study|Unable to start due to disease prog.|0
1773441|NCT00715078|6174814|P1|Overall Study|Unable to start due to disease prog.|0
1773442|NCT00715078|6174812|P3|Overall Study|Withdrawal by Subject|1
1773443|NCT00715078|6174813|P2|Overall Study|Withdrawal by Subject|0
1773444|NCT00715078|6174814|P1|Overall Study|Withdrawal by Subject|1
1773445|NCT00715078|6174812|P3|Overall Study|Death|36
1773446|NCT00715078|6174813|P2|Overall Study|Death|36
1773447|NCT00715078|6174814|P1|Overall Study|Death|29
1773448|NCT00715026|6174822|P1|Overall Study|Surgery done on non-study consented hip|1
1773449|NCT00715026|6174822|P1|Overall Study|Protocol Violation|1
1773450|NCT00715026|6174822|P1|Overall Study|Lost to Follow-up|3
1773451|NCT00715026|6174822|P1|Overall Study|Withdrawal by Subject|5
1773452|NCT00714948|6174827|P1|Overall Study|Adverse Event|2
1773453|NCT00714870|6174833|P2|Overall Study|did not attend minimum of 4 sessions|0
1773454|NCT00714870|6174834|P1|Overall Study|did not attend minimum of 4 sessions|4
1773455|NCT00714870|6174833|P2|Overall Study|patient unable to come b/c back pain|0
1773456|NCT00714870|6174834|P1|Overall Study|patient unable to come b/c back pain|1
1773457|NCT00714870|6174833|P2|Overall Study|Lost to Follow-up|5
1773458|NCT00714870|6174834|P1|Overall Study|Lost to Follow-up|22
1773459|NCT00714714|6174858|P1|Overall Study|Adverse Event|1
1773460|NCT00714688|6174867|P3|Overall Study|Other|5
1773461|NCT00714688|6174868|P2|Overall Study|Other|6
1773462|NCT00714688|6174869|P1|Overall Study|Other|1
1773463|NCT00714688|6174867|P3|Overall Study|Sponsor's Decision|0
1773464|NCT00714688|6174868|P2|Overall Study|Sponsor's Decision|2
1773465|NCT00714688|6174869|P1|Overall Study|Sponsor's Decision|0
1773466|NCT00714688|6174867|P3|Overall Study|Ineligible to Continue the Study|1
1773467|NCT00714688|6174868|P2|Overall Study|Ineligible to Continue the Study|1
1773468|NCT00714688|6174869|P1|Overall Study|Ineligible to Continue the Study|0
1773469|NCT00714688|6174867|P3|Overall Study|Subject Non-compliant|5
1773470|NCT00714688|6174868|P2|Overall Study|Subject Non-compliant|5
1773471|NCT00714688|6174869|P1|Overall Study|Subject Non-compliant|3
1773472|NCT00714688|6174867|P3|Overall Study|Adverse Event|19
1773473|NCT00714688|6174868|P2|Overall Study|Adverse Event|15
1773474|NCT00714688|6174869|P1|Overall Study|Adverse Event|2
1773475|NCT00714688|6174867|P3|Overall Study|Lost to Follow-up|0
1773476|NCT00714688|6174868|P2|Overall Study|Lost to Follow-up|2
1773477|NCT00714688|6174869|P1|Overall Study|Lost to Follow-up|5
1773478|NCT00714688|6174867|P3|Overall Study|Withdrawal by Subject|3
1773479|NCT00714688|6174868|P2|Overall Study|Withdrawal by Subject|3
1773480|NCT00714688|6174869|P1|Overall Study|Withdrawal by Subject|4
1773481|NCT00714688|6174867|P3|Overall Study|Lack of Efficacy|4
1773482|NCT00714688|6174868|P2|Overall Study|Lack of Efficacy|1
1773483|NCT00714688|6174869|P1|Overall Study|Lack of Efficacy|14
1773484|NCT00714493|6174911|P1|Overall Study|OTHER|2
1773485|NCT00714493|6174911|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
1773486|NCT00714493|6174911|P1|Overall Study|Protocol Violation|12
1773487|NCT00714493|6174911|P1|Overall Study|Lost to Follow-up|3
1773488|NCT00714493|6174911|P1|Overall Study|Lack of Efficacy|10
1773489|NCT00714493|6174911|P1|Overall Study|Death|3
1773490|NCT00714493|6174911|P1|Overall Study|Adverse Event|11
1773491|NCT00714415|6174923|P2|Overall Study|Death|0
1773492|NCT00714415|6174924|P1|Overall Study|Death|1
1773493|NCT00714415|6174923|P2|Overall Study|Lack of Efficacy|0
1773494|NCT00714415|6174924|P1|Overall Study|Lack of Efficacy|1
1773495|NCT00714285|6174974|P4|Overall Study|Migrated/moved from study area|0
1773496|NCT00714285|6174975|P3|Overall Study|Migrated/moved from study area|0
1773497|NCT00714285|6174976|P2|Overall Study|Migrated/moved from study area|1
1773498|NCT00714285|6174977|P1|Overall Study|Migrated/moved from study area|0
1773499|NCT00714285|6174974|P4|Overall Study|Lost to Follow-up|1
1773500|NCT00714285|6174975|P3|Overall Study|Lost to Follow-up|0
1773501|NCT00714285|6174976|P2|Overall Study|Lost to Follow-up|2
1773502|NCT00714285|6174977|P1|Overall Study|Lost to Follow-up|0
1773503|NCT00714259|6175027|P1|Overall Study|Death|2
1773504|NCT00714168|6175073|P2|Overall Study|Non-study medical condition|2
1773505|NCT00714168|6175074|P1|Overall Study|Non-study medical condition|3
1773506|NCT00714168|6175073|P2|Overall Study|Relocation|3
1773507|NCT00714168|6175074|P1|Overall Study|Relocation|4
1773508|NCT00714168|6175073|P2|Overall Study|Lost to Follow-up|50
1773509|NCT00714168|6175074|P1|Overall Study|Lost to Follow-up|32
1773510|NCT00714168|6175073|P2|Overall Study|Pregnancy|4
1773511|NCT00714168|6175074|P1|Overall Study|Pregnancy|5
1773512|NCT00714051|6175090|P2|Overall Study|Death|1
1773513|NCT00714051|6175091|P1|Overall Study|Death|0
1773514|NCT00714051|6175090|P2|Overall Study|Withdrawal by Subject|0
1773515|NCT00714051|6175091|P1|Overall Study|Withdrawal by Subject|1
1773516|NCT00713830|6175099|P2|Overall Study|Sponsor Decision|10
1773517|NCT00713830|6175100|P1|Overall Study|Sponsor Decision|4
1773518|NCT00713830|6175099|P2|Overall Study|Familial and Personal Reasons|34
1773519|NCT00713830|6175100|P1|Overall Study|Familial and Personal Reasons|9
1773520|NCT00713830|6175099|P2|Overall Study|Poor Compliance to Protocol|14
1773521|NCT00713830|6175100|P1|Overall Study|Poor Compliance to Protocol|7
1773522|NCT00713830|6175099|P2|Overall Study|Withdrawal by Subject|23
1773523|NCT00713830|6175100|P1|Overall Study|Withdrawal by Subject|13
1773524|NCT00713830|6175099|P2|Overall Study|Lost to Follow-up|9
1773525|NCT00713830|6175100|P1|Overall Study|Lost to Follow-up|2
1773526|NCT00713830|6175099|P2|Overall Study|Lack of Efficacy|16
1773527|NCT00713830|6175100|P1|Overall Study|Lack of Efficacy|24
1773528|NCT00713830|6175099|P2|Overall Study|Adverse Event|71
1773529|NCT00713830|6175100|P1|Overall Study|Adverse Event|23
1773530|NCT00713700|6175157|P1|Overall Study|Withdrawal by Subject|1
1773531|NCT00713700|6175157|P1|Overall Study|Lost to Follow-up|3
1773532|NCT00713648|6175183|P1|Overall Study|Development of antibodies|3
1773533|NCT00713648|6175183|P1|Overall Study|According to Protocol|2
1773534|NCT00713648|6175183|P1|Overall Study|Unclassified|2
1773535|NCT00713648|6175183|P1|Overall Study|Adverse Event|1
1773536|NCT00713609|6175196|P6|Overall Study|Protocol Violation|0
1773537|NCT00713609|6175197|P5|Overall Study|Protocol Violation|2
1773538|NCT00713609|6175198|P4|Overall Study|Protocol Violation|1
1773539|NCT00713609|6175199|P3|Overall Study|Protocol Violation|1
1773540|NCT00713609|6175200|P2|Overall Study|Protocol Violation|3
1773541|NCT00713609|6175201|P1|Overall Study|Protocol Violation|6
1773542|NCT00713609|6175196|P6|Overall Study|Withdrawal by Subject|7
1773543|NCT00713609|6175197|P5|Overall Study|Withdrawal by Subject|5
1773544|NCT00713609|6175198|P4|Overall Study|Withdrawal by Subject|1
1773545|NCT00713609|6175199|P3|Overall Study|Withdrawal by Subject|5
1773546|NCT00713609|6175200|P2|Overall Study|Withdrawal by Subject|1
1773547|NCT00713609|6175201|P1|Overall Study|Withdrawal by Subject|6
1773548|NCT00713609|6175196|P6|Overall Study|Non-Compliance with Study Treatment|0
1773549|NCT00713609|6175197|P5|Overall Study|Non-Compliance with Study Treatment|1
1773550|NCT00713609|6175198|P4|Overall Study|Non-Compliance with Study Treatment|0
1773551|NCT00713609|6175199|P3|Overall Study|Non-Compliance with Study Treatment|2
1773552|NCT00713609|6175200|P2|Overall Study|Non-Compliance with Study Treatment|1
1773553|NCT00713609|6175201|P1|Overall Study|Non-Compliance with Study Treatment|1
1773554|NCT00713609|6175196|P6|Overall Study|Lack of Efficacy|0
1773555|NCT00713609|6175197|P5|Overall Study|Lack of Efficacy|1
1773556|NCT00713609|6175198|P4|Overall Study|Lack of Efficacy|0
1773557|NCT00713609|6175199|P3|Overall Study|Lack of Efficacy|0
1773558|NCT00713609|6175200|P2|Overall Study|Lack of Efficacy|3
1773559|NCT00713609|6175201|P1|Overall Study|Lack of Efficacy|1
1773560|NCT00713609|6175196|P6|Overall Study|Lost to Follow-up|0
1773561|NCT00713609|6175197|P5|Overall Study|Lost to Follow-up|7
1773562|NCT00713609|6175198|P4|Overall Study|Lost to Follow-up|5
1773563|NCT00713609|6175199|P3|Overall Study|Lost to Follow-up|5
1773564|NCT00713609|6175200|P2|Overall Study|Lost to Follow-up|7
1773565|NCT00713609|6175201|P1|Overall Study|Lost to Follow-up|5
1773566|NCT00713609|6175196|P6|Overall Study|Adverse Event|1
1773567|NCT00713609|6175197|P5|Overall Study|Adverse Event|3
1773568|NCT00713609|6175198|P4|Overall Study|Adverse Event|2
1773569|NCT00713609|6175199|P3|Overall Study|Adverse Event|2
1773570|NCT00713609|6175200|P2|Overall Study|Adverse Event|0
1773571|NCT00713609|6175201|P1|Overall Study|Adverse Event|2
1773572|NCT00713596|6175236|P3|Overall Study|Study was terminated|2
1773573|NCT00713596|6175237|P2|Overall Study|Study was terminated|3
1773574|NCT00713596|6175238|P1|Overall Study|Study was terminated|2
1773575|NCT00713544|6175264|P6|Overall Study|Hepatotoxicity - not an AE|0
1773576|NCT00713544|6175265|P5|Overall Study|Hepatotoxicity - not an AE|1
1773577|NCT00713544|6175266|P4|Overall Study|Hepatotoxicity - not an AE|0
1773578|NCT00713544|6175267|P3|Overall Study|Hepatotoxicity - not an AE|0
1773579|NCT00713544|6175268|P2|Overall Study|Hepatotoxicity - not an AE|0
1773580|NCT00713544|6175269|P1|Overall Study|Hepatotoxicity - not an AE|0
1773581|NCT00713544|6175264|P6|Overall Study|Incorrect enrollment|0
1773582|NCT00713544|6175265|P5|Overall Study|Incorrect enrollment|0
1773583|NCT00713544|6175266|P4|Overall Study|Incorrect enrollment|0
1773584|NCT00713544|6175267|P3|Overall Study|Incorrect enrollment|0
1773585|NCT00713544|6175268|P2|Overall Study|Incorrect enrollment|1
1773586|NCT00713544|6175269|P1|Overall Study|Incorrect enrollment|0
1773587|NCT00713544|6175264|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
1773588|NCT00713544|6175265|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
1773589|NCT00713544|6175266|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
1773590|NCT00713544|6175267|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
1773591|NCT00713544|6175268|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
1773592|NCT00713544|6175269|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
1773593|NCT00713544|6175264|P6|Overall Study|Lost to Follow-up|0
1773594|NCT00713544|6175265|P5|Overall Study|Lost to Follow-up|0
1773595|NCT00713544|6175266|P4|Overall Study|Lost to Follow-up|0
1773596|NCT00713544|6175267|P3|Overall Study|Lost to Follow-up|1
1773597|NCT00713544|6175268|P2|Overall Study|Lost to Follow-up|0
1773598|NCT00713544|6175269|P1|Overall Study|Lost to Follow-up|0
1773599|NCT00713544|6175264|P6|Overall Study|Lack of Efficacy|0
1773600|NCT00713544|6175265|P5|Overall Study|Lack of Efficacy|1
1773601|NCT00713544|6175266|P4|Overall Study|Lack of Efficacy|1
1773602|NCT00713544|6175267|P3|Overall Study|Lack of Efficacy|0
1773603|NCT00713544|6175268|P2|Overall Study|Lack of Efficacy|1
1773604|NCT00713544|6175269|P1|Overall Study|Lack of Efficacy|0
1773605|NCT00713544|6175264|P6|Overall Study|Physician Decision|2
1773606|NCT00713544|6175265|P5|Overall Study|Physician Decision|0
1773607|NCT00713544|6175266|P4|Overall Study|Physician Decision|0
1773608|NCT00713544|6175267|P3|Overall Study|Physician Decision|0
1773609|NCT00713544|6175268|P2|Overall Study|Physician Decision|0
1773610|NCT00713544|6175269|P1|Overall Study|Physician Decision|0
1773611|NCT00713544|6175264|P6|Overall Study|Protocol Violation|1
1773612|NCT00713544|6175265|P5|Overall Study|Protocol Violation|0
1773613|NCT00713544|6175266|P4|Overall Study|Protocol Violation|0
1773614|NCT00713544|6175267|P3|Overall Study|Protocol Violation|0
1773615|NCT00713544|6175268|P2|Overall Study|Protocol Violation|0
1773616|NCT00713544|6175269|P1|Overall Study|Protocol Violation|0
1773617|NCT00713544|6175264|P6|Overall Study|Withdrawal by Subject|1
1773618|NCT00713544|6175265|P5|Overall Study|Withdrawal by Subject|3
1773619|NCT00713544|6175266|P4|Overall Study|Withdrawal by Subject|2
1773620|NCT00713544|6175267|P3|Overall Study|Withdrawal by Subject|3
1773621|NCT00713544|6175268|P2|Overall Study|Withdrawal by Subject|0
1773622|NCT00713544|6175269|P1|Overall Study|Withdrawal by Subject|2
1773623|NCT00713544|6175264|P6|Overall Study|Adverse Event|5
1773624|NCT00713544|6175265|P5|Overall Study|Adverse Event|3
1773625|NCT00713544|6175266|P4|Overall Study|Adverse Event|7
1773626|NCT00713544|6175267|P3|Overall Study|Adverse Event|7
1773627|NCT00713544|6175268|P2|Overall Study|Adverse Event|3
1773628|NCT00713544|6175269|P1|Overall Study|Adverse Event|5
1773629|NCT00713349|6175320|P1|Overall Study|Protocol Violation|1
1773630|NCT00713323|6175326|P1|Overall Study|Treatment that may interact with Sativex|1
1773631|NCT00713323|6175326|P1|Overall Study|Subject travelling to Dominica Republic|1
1773632|NCT00713323|6175326|P1|Overall Study|Subject travelling to USA|1
1773633|NCT00713323|6175326|P1|Overall Study|Pain resolved|1
1773634|NCT00713323|6175326|P1|Overall Study|Non-compliance|1
1773635|NCT00713323|6175326|P1|Overall Study|Pain free|1
1773636|NCT00713323|6175326|P1|Overall Study|Surgery cured allodynic pain|1
1773637|NCT00713323|6175326|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
1773638|NCT00713323|6175326|P1|Overall Study|Low creatine clearance at screening|1
1773639|NCT00713323|6175326|P1|Overall Study|Lack of Efficacy|36
1773640|NCT00713323|6175326|P1|Overall Study|Lost to Follow-up|11
1773641|NCT00713323|6175326|P1|Overall Study|Withdrawal by Subject|15
1773642|NCT00713323|6175326|P1|Overall Study|Adverse Event|75
1773643|NCT00713310|6175339|P2|Overall Study|Withdrawal by Subject|2
1773644|NCT00713310|6175340|P1|Overall Study|Withdrawal by Subject|0
1773645|NCT00713310|6175339|P2|Overall Study|Lack of Efficacy|2
1773646|NCT00713310|6175340|P1|Overall Study|Lack of Efficacy|0
1773647|NCT00713310|6175339|P2|Overall Study|Adverse Event|2
1773648|NCT00713310|6175340|P1|Overall Study|Adverse Event|5
1773649|NCT00713258|6175350|P2|Overall Study|Other|1
1773650|NCT00713258|6175351|P1|Overall Study|Other|1
1773651|NCT00713258|6175350|P2|Overall Study|Non-Compliance|1
1773652|NCT00713258|6175351|P1|Overall Study|Non-Compliance|2
1773653|NCT00713258|6175350|P2|Overall Study|Adverse Event|4
1773654|NCT00713258|6175351|P1|Overall Study|Adverse Event|2
1773655|NCT00713219|6175359|P1|Overall Study|Protocol Violation|1
1773656|NCT00713219|6175359|P1|Overall Study|Death|1
1773657|NCT00713206|6175365|P2|Overall Study|Adverse Event|1
1773658|NCT00713206|6175366|P1|Overall Study|Adverse Event|2
1773659|NCT00713206|6175365|P2|Overall Study|Lost to Follow-up|2
1773660|NCT00713206|6175366|P1|Overall Study|Lost to Follow-up|5
1773661|NCT00712985|6175372|P1|Overall Study|Lack of Efficacy|3
1773662|NCT00712985|6175372|P1|Overall Study|1 patient moved out of state|1
1773663|NCT00712985|6175372|P1|Overall Study|1 withdrew prior to start of drug|1
1773664|NCT00712959|6175378|P2|Overall Study|Withdrawal by Subject|0
1773665|NCT00712959|6175379|P1|Overall Study|Withdrawal by Subject|3
1773666|NCT00712959|6175378|P2|Overall Study|Lost to Follow-up|2
1773667|NCT00712959|6175379|P1|Overall Study|Lost to Follow-up|13
1773668|NCT00712959|6175378|P2|Overall Study|Protocol Violation|1
1773669|NCT00712959|6175379|P1|Overall Study|Protocol Violation|3
1773670|NCT00712933|6175397|P1|Overall Study|Withdrawal by Subject|151
1773671|NCT00712933|6175397|P1|Overall Study|Protocol Violation|4
1773672|NCT00712933|6175397|P1|Overall Study|Physician Decision|36
1773673|NCT00712933|6175397|P1|Overall Study|Participant received medication|1
1773674|NCT00712933|6175397|P1|Overall Study|Not committed to contraception|1
1773675|NCT00712933|6175397|P1|Overall Study|Other Physician decision|1
1773676|NCT00712933|6175397|P1|Overall Study|Death of patient|1
1773677|NCT00712933|6175397|P1|Overall Study|Participant travelled overseas|2
1773678|NCT00712933|6175397|P1|Overall Study|Participant hospitalized|1
1773679|NCT00712933|6175397|P1|Overall Study|Involved in Clinical research|3
1773680|NCT00712933|6175397|P1|Overall Study|Hip replacement surgery|1
1773681|NCT00712933|6175397|P1|Overall Study|Withdrew consent|4
1773682|NCT00712933|6175397|P1|Overall Study|Sponsor decision|14
1773683|NCT00712933|6175397|P1|Overall Study|Other Pregnancy|37
1773684|NCT00712933|6175397|P1|Overall Study|Non-compliance with study drug|13
1773685|NCT00712933|6175397|P1|Overall Study|Lost to Follow-up|22
1773686|NCT00712933|6175397|P1|Overall Study|Lack of Efficacy|6
1773687|NCT00712933|6175397|P1|Overall Study|Adverse Event|69
1773688|NCT00712920|6175427|P3|Overall Study|Non-compliance|0
1773689|NCT00712920|6175428|P2|Overall Study|Non-compliance|0
1773690|NCT00712920|6175429|P1|Overall Study|Non-compliance|3
1773691|NCT00712920|6175427|P3|Overall Study|Other|3
1773692|NCT00712920|6175428|P2|Overall Study|Other|7
1773693|NCT00712920|6175429|P1|Overall Study|Other|5
1773694|NCT00712920|6175427|P3|Overall Study|Lack of Efficacy|1
1773695|NCT00712920|6175428|P2|Overall Study|Lack of Efficacy|0
1773696|NCT00712920|6175429|P1|Overall Study|Lack of Efficacy|1
1773697|NCT00712920|6175427|P3|Overall Study|Lost to Follow-up|0
1773698|NCT00712920|6175428|P2|Overall Study|Lost to Follow-up|4
1773699|NCT00712920|6175429|P1|Overall Study|Lost to Follow-up|1
1773700|NCT00712920|6175427|P3|Overall Study|Withdrawal by Subject|1
1773701|NCT00712920|6175428|P2|Overall Study|Withdrawal by Subject|2
1773702|NCT00712920|6175429|P1|Overall Study|Withdrawal by Subject|4
1773703|NCT00712920|6175427|P3|Overall Study|Adverse Event|7
1773704|NCT00712920|6175428|P2|Overall Study|Adverse Event|4
1773705|NCT00712920|6175429|P1|Overall Study|Adverse Event|3
1773706|NCT00712725|6175457|P8|Overall Study|Protocol Specified Criteria|1
1773707|NCT00712725|6175458|P7|Overall Study|Protocol Specified Criteria|2
1773708|NCT00712725|6175459|P6|Overall Study|Protocol Specified Criteria|0
1773709|NCT00712725|6175460|P5|Overall Study|Protocol Specified Criteria|1
1773710|NCT00712725|6175461|P4|Overall Study|Protocol Specified Criteria|2
1773711|NCT00712725|6175462|P3|Overall Study|Protocol Specified Criteria|1
1773712|NCT00712725|6175463|P2|Overall Study|Protocol Specified Criteria|0
1773713|NCT00712725|6175464|P1|Overall Study|Protocol Specified Criteria|3
1773714|NCT00712725|6175457|P8|Overall Study|Lack of Qualifying Event|6
1773715|NCT00712725|6175458|P7|Overall Study|Lack of Qualifying Event|11
1773716|NCT00712725|6175459|P6|Overall Study|Lack of Qualifying Event|13
1773717|NCT00712725|6175460|P5|Overall Study|Lack of Qualifying Event|11
1773718|NCT00712725|6175461|P4|Overall Study|Lack of Qualifying Event|8
1773719|NCT00712725|6175462|P3|Overall Study|Lack of Qualifying Event|6
1773720|NCT00712725|6175463|P2|Overall Study|Lack of Qualifying Event|2
1773721|NCT00712725|6175464|P1|Overall Study|Lack of Qualifying Event|16
1773722|NCT00712725|6175457|P8|Overall Study|Withdrawal by Subject|2
1773723|NCT00712725|6175458|P7|Overall Study|Withdrawal by Subject|1
1773724|NCT00712725|6175459|P6|Overall Study|Withdrawal by Subject|1
1773725|NCT00712725|6175460|P5|Overall Study|Withdrawal by Subject|1
1773726|NCT00712725|6175461|P4|Overall Study|Withdrawal by Subject|2
1773727|NCT00712725|6175462|P3|Overall Study|Withdrawal by Subject|1
1773728|NCT00712725|6175463|P2|Overall Study|Withdrawal by Subject|1
1773729|NCT00712725|6175464|P1|Overall Study|Withdrawal by Subject|2
1773730|NCT00712725|6175457|P8|Overall Study|Protocol Violation|1
1773731|NCT00712725|6175458|P7|Overall Study|Protocol Violation|1
1773732|NCT00712725|6175459|P6|Overall Study|Protocol Violation|0
1773733|NCT00712725|6175460|P5|Overall Study|Protocol Violation|2
1773734|NCT00712725|6175461|P4|Overall Study|Protocol Violation|3
1773735|NCT00712725|6175462|P3|Overall Study|Protocol Violation|1
1773736|NCT00712725|6175463|P2|Overall Study|Protocol Violation|0
1773737|NCT00712725|6175464|P1|Overall Study|Protocol Violation|2
1773738|NCT00712725|6175457|P8|Overall Study|Pregnancy|0
1773739|NCT00712725|6175458|P7|Overall Study|Pregnancy|2
1773740|NCT00712725|6175459|P6|Overall Study|Pregnancy|0
1773741|NCT00712725|6175460|P5|Overall Study|Pregnancy|1
1773742|NCT00712725|6175461|P4|Overall Study|Pregnancy|0
1773743|NCT00712725|6175462|P3|Overall Study|Pregnancy|0
1773744|NCT00712725|6175463|P2|Overall Study|Pregnancy|1
1773745|NCT00712725|6175464|P1|Overall Study|Pregnancy|0
1773746|NCT00712725|6175457|P8|Overall Study|Physician Decision|0
1773747|NCT00712725|6175458|P7|Overall Study|Physician Decision|2
1773748|NCT00712725|6175459|P6|Overall Study|Physician Decision|0
1773749|NCT00712725|6175460|P5|Overall Study|Physician Decision|1
1773750|NCT00712725|6175461|P4|Overall Study|Physician Decision|0
1773751|NCT00712725|6175462|P3|Overall Study|Physician Decision|0
1773752|NCT00712725|6175463|P2|Overall Study|Physician Decision|0
1773753|NCT00712725|6175464|P1|Overall Study|Physician Decision|2
1773754|NCT00712725|6175457|P8|Overall Study|Lost to Follow-up|1
1773755|NCT00712725|6175458|P7|Overall Study|Lost to Follow-up|3
1773756|NCT00712725|6175459|P6|Overall Study|Lost to Follow-up|2
1773757|NCT00712725|6175460|P5|Overall Study|Lost to Follow-up|2
1773758|NCT00712725|6175461|P4|Overall Study|Lost to Follow-up|1
1773759|NCT00712725|6175462|P3|Overall Study|Lost to Follow-up|1
1773760|NCT00712725|6175463|P2|Overall Study|Lost to Follow-up|2
1773761|NCT00712725|6175464|P1|Overall Study|Lost to Follow-up|3
1773762|NCT00712725|6175457|P8|Overall Study|Adverse Event|0
1773763|NCT00712725|6175458|P7|Overall Study|Adverse Event|0
1773764|NCT00712725|6175459|P6|Overall Study|Adverse Event|0
1773765|NCT00712725|6175460|P5|Overall Study|Adverse Event|0
1773766|NCT00712725|6175461|P4|Overall Study|Adverse Event|1
1773767|NCT00712725|6175462|P3|Overall Study|Adverse Event|0
1773768|NCT00712725|6175463|P2|Overall Study|Adverse Event|0
1773769|NCT00712725|6175464|P1|Overall Study|Adverse Event|1
1773770|NCT00712673|6175525|P4|Overall Study|Protocol Violation|0
1773771|NCT00712673|6175526|P3|Overall Study|Protocol Violation|2
1773772|NCT00712673|6175527|P2|Overall Study|Protocol Violation|0
1773773|NCT00712673|6175528|P1|Overall Study|Protocol Violation|0
1773774|NCT00712673|6175525|P4|Overall Study|Investigator's Decision|0
1773775|NCT00712673|6175526|P3|Overall Study|Investigator's Decision|0
1773776|NCT00712673|6175527|P2|Overall Study|Investigator's Decision|0
1773777|NCT00712673|6175528|P1|Overall Study|Investigator's Decision|1
1773778|NCT00712673|6175525|P4|Overall Study|Familial and Personal Reasons|2
1773779|NCT00712673|6175526|P3|Overall Study|Familial and Personal Reasons|5
1773780|NCT00712673|6175527|P2|Overall Study|Familial and Personal Reasons|0
1773781|NCT00712673|6175528|P1|Overall Study|Familial and Personal Reasons|5
1773782|NCT00712673|6175525|P4|Overall Study|Withdrawal by Subject|20
1773783|NCT00712673|6175526|P3|Overall Study|Withdrawal by Subject|15
1773784|NCT00712673|6175527|P2|Overall Study|Withdrawal by Subject|7
1773785|NCT00712673|6175528|P1|Overall Study|Withdrawal by Subject|6
1773786|NCT00712673|6175525|P4|Overall Study|Lost to Follow-up|0
1773787|NCT00712673|6175526|P3|Overall Study|Lost to Follow-up|2
1773788|NCT00712673|6175527|P2|Overall Study|Lost to Follow-up|0
1773789|NCT00712673|6175528|P1|Overall Study|Lost to Follow-up|1
1773790|NCT00712673|6175525|P4|Overall Study|Poor Compliance to Protocol|16
1773791|NCT00712673|6175526|P3|Overall Study|Poor Compliance to Protocol|4
1773792|NCT00712673|6175527|P2|Overall Study|Poor Compliance to Protocol|3
1773793|NCT00712673|6175528|P1|Overall Study|Poor Compliance to Protocol|3
1773794|NCT00712673|6175525|P4|Overall Study|Lack of Efficacy|6
1773795|NCT00712673|6175526|P3|Overall Study|Lack of Efficacy|8
1773796|NCT00712673|6175527|P2|Overall Study|Lack of Efficacy|8
1773797|NCT00712673|6175528|P1|Overall Study|Lack of Efficacy|2
1773798|NCT00712673|6175525|P4|Overall Study|Adverse Event|26
1773799|NCT00712673|6175526|P3|Overall Study|Adverse Event|21
1773800|NCT00712673|6175527|P2|Overall Study|Adverse Event|3
1773801|NCT00712673|6175528|P1|Overall Study|Adverse Event|3
1773802|NCT00712543|6175592|P2|Day 8-14|Lost to Follow-up|2
1773803|NCT00712543|6175593|P1|Day 8-14|Lost to Follow-up|0
1773804|NCT00712348|6175627|P1|Overall Study|Withdrawal by Subject|1
1773805|NCT00712335|6175639|P5|Overall Study|Other Reason|0
1773806|NCT00712335|6175640|P4|Overall Study|Other Reason|0
1773807|NCT00712335|6175641|P3|Overall Study|Other Reason|1
1773808|NCT00712335|6175642|P2|Overall Study|Other Reason|3
1773809|NCT00712335|6175643|P1|Overall Study|Other Reason|0
1773810|NCT00712335|6175639|P5|Overall Study|Lack of Efficacy|0
1773811|NCT00712335|6175640|P4|Overall Study|Lack of Efficacy|1
1773812|NCT00712335|6175641|P3|Overall Study|Lack of Efficacy|1
1773813|NCT00712335|6175642|P2|Overall Study|Lack of Efficacy|0
1773814|NCT00712335|6175643|P1|Overall Study|Lack of Efficacy|0
1773815|NCT00712335|6175639|P5|Overall Study|Protocol Violation|0
1773816|NCT00712335|6175640|P4|Overall Study|Protocol Violation|0
1773817|NCT00712335|6175641|P3|Overall Study|Protocol Violation|1
1773818|NCT00712335|6175642|P2|Overall Study|Protocol Violation|2
1773819|NCT00712335|6175643|P1|Overall Study|Protocol Violation|1
1773820|NCT00712335|6175639|P5|Overall Study|Lost to Follow-up|0
1773821|NCT00712335|6175640|P4|Overall Study|Lost to Follow-up|1
1773822|NCT00712335|6175641|P3|Overall Study|Lost to Follow-up|0
1773823|NCT00712335|6175642|P2|Overall Study|Lost to Follow-up|5
1773824|NCT00712335|6175643|P1|Overall Study|Lost to Follow-up|2
1773825|NCT00712335|6175639|P5|Overall Study|Withdrawal by Subject|0
1773826|NCT00712335|6175640|P4|Overall Study|Withdrawal by Subject|3
1773827|NCT00712335|6175641|P3|Overall Study|Withdrawal by Subject|2
1773828|NCT00712335|6175642|P2|Overall Study|Withdrawal by Subject|7
1773829|NCT00712335|6175643|P1|Overall Study|Withdrawal by Subject|0
1773830|NCT00712270|6175688|P1|Overall Study|Screen Failure|3
1773831|NCT00712270|6175688|P1|Overall Study|Withdrawal by Subject|11
1773832|NCT00712166|6175752|P2|Overall Study|Noncompliance|1
1773833|NCT00712166|6175753|P1|Overall Study|Noncompliance|0
1773834|NCT00712010|6175796|P1|Washout (7 Days)|Withdrawal by Subject|1
1773835|NCT00711971|6175835|P3|Overall Study|Lost to Follow-up|1
1773836|NCT00711971|6175836|P2|Overall Study|Lost to Follow-up|4
1773837|NCT00711971|6175837|P1|Overall Study|Lost to Follow-up|3
1773838|NCT00711958|6175871|P2|Overall Study|Progression of disease|0
1773839|NCT00711958|6175872|P1|Overall Study|Progression of disease|1
1773840|NCT00711958|6175871|P2|Overall Study|Death|5
1773841|NCT00711958|6175872|P1|Overall Study|Death|10
1773842|NCT00711958|6175871|P2|Overall Study|Lost to Follow-up|2
1773843|NCT00711958|6175872|P1|Overall Study|Lost to Follow-up|2
1773844|NCT00711958|6175871|P2|Overall Study|Protocol Violation|0
1773845|NCT00711958|6175872|P1|Overall Study|Protocol Violation|1
1773846|NCT00711958|6175871|P2|Overall Study|Adverse Event|7
1773847|NCT00711958|6175872|P1|Overall Study|Adverse Event|9
1773848|NCT00711958|6175871|P2|Overall Study|Clinical deterioration|0
1773849|NCT00711958|6175872|P1|Overall Study|Clinical deterioration|1
1773850|NCT00711958|6175871|P2|Overall Study|Lack of Efficacy|1
1773851|NCT00711958|6175872|P1|Overall Study|Lack of Efficacy|3
1773852|NCT00711958|6175871|P2|Overall Study|Withdrawal by Subject|8
1773853|NCT00711958|6175872|P1|Overall Study|Withdrawal by Subject|6
1773854|NCT00711880|6175880|P2|Overall Study|Lack of Efficacy|5
1773855|NCT00711880|6175881|P1|Overall Study|Lack of Efficacy|1
1773856|NCT00711880|6175880|P2|Overall Study|Patient non-compliance|0
1773857|NCT00711880|6175881|P1|Overall Study|Patient non-compliance|1
1773858|NCT00711880|6175880|P2|Overall Study|Adverse Event|2
1773859|NCT00711880|6175881|P1|Overall Study|Adverse Event|11
1773860|NCT00711802|6175943|P8|Overall Study|Reason not reported|0
1773861|NCT00711802|6175944|P7|Overall Study|Reason not reported|1
1773862|NCT00711802|6175945|P6|Overall Study|Reason not reported|0
1773863|NCT00711802|6175946|P5|Overall Study|Reason not reported|1
1773864|NCT00711802|6175947|P4|Overall Study|Reason not reported|0
1773865|NCT00711802|6175948|P3|Overall Study|Reason not reported|1
1773866|NCT00711802|6175949|P2|Overall Study|Reason not reported|1
1773867|NCT00711802|6175950|P1|Overall Study|Reason not reported|0
1773868|NCT00711802|6175943|P8|Overall Study|Lost to Follow-up|2
1773869|NCT00711802|6175944|P7|Overall Study|Lost to Follow-up|4
1773870|NCT00711802|6175945|P6|Overall Study|Lost to Follow-up|6
1773871|NCT00711802|6175946|P5|Overall Study|Lost to Follow-up|10
1773872|NCT00711802|6175947|P4|Overall Study|Lost to Follow-up|1
1773873|NCT00711802|6175948|P3|Overall Study|Lost to Follow-up|3
1773874|NCT00711802|6175949|P2|Overall Study|Lost to Follow-up|0
1773875|NCT00711802|6175950|P1|Overall Study|Lost to Follow-up|0
1773876|NCT00711802|6175943|P8|Overall Study|Withdrawal by Subject|0
1773877|NCT00711802|6175944|P7|Overall Study|Withdrawal by Subject|0
1773878|NCT00711802|6175945|P6|Overall Study|Withdrawal by Subject|0
1773879|NCT00711802|6175946|P5|Overall Study|Withdrawal by Subject|0
1773880|NCT00711802|6175947|P4|Overall Study|Withdrawal by Subject|1
1773881|NCT00711802|6175948|P3|Overall Study|Withdrawal by Subject|0
1773882|NCT00711802|6175949|P2|Overall Study|Withdrawal by Subject|1
1773883|NCT00711802|6175950|P1|Overall Study|Withdrawal by Subject|0
1773884|NCT00711802|6175943|P8|Overall Study|Physician Decision|0
1773885|NCT00711802|6175944|P7|Overall Study|Physician Decision|0
1773886|NCT00711802|6175945|P6|Overall Study|Physician Decision|0
1773887|NCT00711802|6175946|P5|Overall Study|Physician Decision|0
1773888|NCT00711802|6175947|P4|Overall Study|Physician Decision|0
1773889|NCT00711802|6175948|P3|Overall Study|Physician Decision|0
1773890|NCT00711802|6175949|P2|Overall Study|Physician Decision|2
1773891|NCT00711802|6175950|P1|Overall Study|Physician Decision|0
1773892|NCT00711802|6175943|P8|Overall Study|Protocol Violation|0
1773893|NCT00711802|6175944|P7|Overall Study|Protocol Violation|0
1773894|NCT00711802|6175945|P6|Overall Study|Protocol Violation|0
1773895|NCT00711802|6175946|P5|Overall Study|Protocol Violation|0
1773896|NCT00711802|6175947|P4|Overall Study|Protocol Violation|1
1773897|NCT00711802|6175948|P3|Overall Study|Protocol Violation|0
1773898|NCT00711802|6175949|P2|Overall Study|Protocol Violation|0
1773899|NCT00711802|6175950|P1|Overall Study|Protocol Violation|0
1773900|NCT00711802|6175943|P8|Overall Study|Microbiological failure|0
1773901|NCT00711802|6175944|P7|Overall Study|Microbiological failure|0
1773902|NCT00711802|6175945|P6|Overall Study|Microbiological failure|1
1773903|NCT00711802|6175946|P5|Overall Study|Microbiological failure|0
1773904|NCT00711802|6175947|P4|Overall Study|Microbiological failure|0
1773905|NCT00711802|6175948|P3|Overall Study|Microbiological failure|0
1773906|NCT00711802|6175949|P2|Overall Study|Microbiological failure|1
1773907|NCT00711802|6175950|P1|Overall Study|Microbiological failure|0
1773908|NCT00711802|6175943|P8|Overall Study|Adverse Event|0
1773909|NCT00711802|6175944|P7|Overall Study|Adverse Event|0
1773910|NCT00711802|6175945|P6|Overall Study|Adverse Event|1
1773911|NCT00711802|6175946|P5|Overall Study|Adverse Event|1
1773912|NCT00711802|6175947|P4|Overall Study|Adverse Event|0
1773913|NCT00711802|6175948|P3|Overall Study|Adverse Event|0
1773914|NCT00711802|6175949|P2|Overall Study|Adverse Event|0
1773915|NCT00711802|6175950|P1|Overall Study|Adverse Event|0
1773916|NCT00711802|6175943|P8|Overall Study|Not treated (no further detail)|0
1773917|NCT00711802|6175944|P7|Overall Study|Not treated (no further detail)|0
1773918|NCT00711802|6175945|P6|Overall Study|Not treated (no further detail)|0
1773919|NCT00711802|6175946|P5|Overall Study|Not treated (no further detail)|2
1773920|NCT00711802|6175947|P4|Overall Study|Not treated (no further detail)|0
1773921|NCT00711802|6175948|P3|Overall Study|Not treated (no further detail)|2
1773922|NCT00711802|6175949|P2|Overall Study|Not treated (no further detail)|1
1773923|NCT00711802|6175950|P1|Overall Study|Not treated (no further detail)|2
1773924|NCT00711646|6175993|P2|Overall Study|patient non-compliance|0
1773925|NCT00711646|6175994|P1|Overall Study|patient non-compliance|1
1773926|NCT00711646|6175993|P2|Overall Study|administrative decision|1
1773927|NCT00711646|6175994|P1|Overall Study|administrative decision|0
1773928|NCT00711646|6175993|P2|Overall Study|Lost to Follow-up|0
1773929|NCT00711646|6175994|P1|Overall Study|Lost to Follow-up|1
1773930|NCT00711646|6175993|P2|Overall Study|Protocol Violation|1
1773931|NCT00711646|6175994|P1|Overall Study|Protocol Violation|0
1773932|NCT00711646|6175993|P2|Overall Study|Withdrawal by Subject|0
1773933|NCT00711646|6175994|P1|Overall Study|Withdrawal by Subject|4
1773934|NCT00711646|6175993|P2|Overall Study|Adverse Event|1
1773935|NCT00711646|6175994|P1|Overall Study|Adverse Event|6
1773936|NCT00711594|6176016|P4|Overall Study|Withdrawal by Subject|2
1773937|NCT00711594|6176017|P3|Overall Study|Withdrawal by Subject|0
1773938|NCT00711594|6176018|P2|Overall Study|Withdrawal by Subject|1
1773939|NCT00711594|6176019|P1|Overall Study|Withdrawal by Subject|0
1773940|NCT00711594|6176016|P4|Overall Study|Other Adverse Event|16
1773941|NCT00711594|6176017|P3|Overall Study|Other Adverse Event|0
1773942|NCT00711594|6176018|P2|Overall Study|Other Adverse Event|0
1773943|NCT00711594|6176019|P1|Overall Study|Other Adverse Event|1
1773944|NCT00711594|6176016|P4|Overall Study|Progressive disease|44
1773945|NCT00711594|6176017|P3|Overall Study|Progressive disease|6
1773946|NCT00711594|6176018|P2|Overall Study|Progressive disease|2
1773947|NCT00711594|6176019|P1|Overall Study|Progressive disease|2
1773948|NCT00711555|6176056|P1|Overall Study|Adverse Event|3
1773949|NCT00711529|6176065|P2|Overall Study|Withdrawal by Subject|6
1773950|NCT00711529|6176066|P1|Overall Study|Withdrawal by Subject|2
1773951|NCT00711529|6176065|P2|Overall Study|Protocol Violation|0
1773952|NCT00711529|6176066|P1|Overall Study|Protocol Violation|2
1773953|NCT00711516|6176090|P2|Overall Study|Protocol Violation|1
1773954|NCT00711516|6176091|P1|Overall Study|Protocol Violation|0
1773955|NCT00711516|6176090|P2|Overall Study|Withdrawal by Subject|1
1773956|NCT00711516|6176091|P1|Overall Study|Withdrawal by Subject|0
1773957|NCT00711516|6176090|P2|Overall Study|Adverse Event|1
1773958|NCT00711516|6176091|P1|Overall Study|Adverse Event|1
1773959|NCT00711477|6176198|P2|Overall Study|Noncompliance|1
1773960|NCT00711477|6176199|P1|Overall Study|Noncompliance|0
1773961|NCT00711477|6176198|P2|Overall Study|Lost to Follow-up|1
1773962|NCT00711477|6176199|P1|Overall Study|Lost to Follow-up|0
1773963|NCT00711477|6176198|P2|Overall Study|Adverse Event|1
1773964|NCT00711477|6176199|P1|Overall Study|Adverse Event|3
1773965|NCT00711425|6176245|P1|Overall Study|Lost to Follow-up|1
1773966|NCT00711425|6176245|P1|Overall Study|Death|2
1773967|NCT00711425|6176245|P1|Overall Study|Protocol Violation|1
1773968|NCT00711412|6176251|P1|Survival Follow up Until Death|Other|12
1773969|NCT00711412|6176251|P1|Evaluation for Response and Surgery|Death|1
1773970|NCT00711412|6176251|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
1773971|NCT00711412|6176251|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
1773972|NCT00711412|6176251|P1|Evaluation for Response and Surgery|Progressive Disease|2
1773973|NCT00711412|6176251|P1|Combination Treatment|Progressive Disease|1
1773974|NCT00711412|6176251|P1|Evaluated for Combination Treatment|Progressive disease|2
1773975|NCT00711412|6176251|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
1773976|NCT00711412|6176251|P1|Evaluated for Combination Treatment|Death|1
1773977|NCT00711412|6176251|P1|Evaluated for Combination Treatment|Adverse Event|2
1773978|NCT00711412|6176251|P1|Induction Treatment|Other|1
1773979|NCT00711412|6176251|P1|Induction Treatment|Adverse Event|1
1773980|NCT00711412|6176251|P1|Induction Treatment|Death|2
1773981|NCT00711243|6176329|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
1773982|NCT00711243|6176330|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1773983|NCT00711243|6176331|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1773984|NCT00711243|6176332|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1773985|NCT00711243|6176333|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1773986|NCT00711243|6176334|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
1773987|NCT00711243|6176329|P6|Treated Cycle 5 After First Response|Decline in performance status|1
1773988|NCT00711243|6176330|P5|Treated Cycle 5 After First Response|Decline in performance status|0
1773989|NCT00711243|6176331|P4|Treated Cycle 5 After First Response|Decline in performance status|0
1773990|NCT00711243|6176332|P3|Treated Cycle 5 After First Response|Decline in performance status|0
1773991|NCT00711243|6176333|P2|Treated Cycle 5 After First Response|Decline in performance status|0
1773992|NCT00711243|6176334|P1|Treated Cycle 5 After First Response|Decline in performance status|0
1773993|NCT00711243|6176329|P6|Treated Cycle 5 After First Response|Death|2
1773994|NCT00711243|6176330|P5|Treated Cycle 5 After First Response|Death|0
1773995|NCT00711243|6176331|P4|Treated Cycle 5 After First Response|Death|0
1773996|NCT00711243|6176332|P3|Treated Cycle 5 After First Response|Death|0
1773997|NCT00711243|6176333|P2|Treated Cycle 5 After First Response|Death|0
1773998|NCT00711243|6176334|P1|Treated Cycle 5 After First Response|Death|0
1773999|NCT00711243|6176329|P6|Treated Cycle 5 After First Response|Progressive disease|1
1774000|NCT00711243|6176330|P5|Treated Cycle 5 After First Response|Progressive disease|1
1774001|NCT00711243|6176331|P4|Treated Cycle 5 After First Response|Progressive disease|0
1774002|NCT00711243|6176332|P3|Treated Cycle 5 After First Response|Progressive disease|0
1774003|NCT00711243|6176333|P2|Treated Cycle 5 After First Response|Progressive disease|2
1774004|NCT00711243|6176334|P1|Treated Cycle 5 After First Response|Progressive disease|1
1774005|NCT00711243|6176329|P6|Reached First Response/4 Cycles|Progressive disease|0
1774006|NCT00711243|6176330|P5|Reached First Response/4 Cycles|Progressive disease|0
1774007|NCT00711243|6176331|P4|Reached First Response/4 Cycles|Progressive disease|1
1774008|NCT00711243|6176332|P3|Reached First Response/4 Cycles|Progressive disease|0
1774009|NCT00711243|6176333|P2|Reached First Response/4 Cycles|Progressive disease|0
1774010|NCT00711243|6176334|P1|Reached First Response/4 Cycles|Progressive disease|0
1774011|NCT00711243|6176329|P6|Reached First Response/4 Cycles|Death|2
1774012|NCT00711243|6176330|P5|Reached First Response/4 Cycles|Death|0
1774013|NCT00711243|6176331|P4|Reached First Response/4 Cycles|Death|0
1774014|NCT00711243|6176332|P3|Reached First Response/4 Cycles|Death|0
1774015|NCT00711243|6176333|P2|Reached First Response/4 Cycles|Death|0
1774016|NCT00711243|6176334|P1|Reached First Response/4 Cycles|Death|0
1774017|NCT00711243|6176329|P6|Registed and Started Treatment|Withdrawal by Subject|1
1774018|NCT00711243|6176330|P5|Registed and Started Treatment|Withdrawal by Subject|0
1774019|NCT00711243|6176331|P4|Registed and Started Treatment|Withdrawal by Subject|0
1774020|NCT00711243|6176332|P3|Registed and Started Treatment|Withdrawal by Subject|0
1774021|NCT00711243|6176333|P2|Registed and Started Treatment|Withdrawal by Subject|0
1774022|NCT00711243|6176334|P1|Registed and Started Treatment|Withdrawal by Subject|0
1774023|NCT00711191|6176357|P3|Overall Study|Withdrawal by Subject|3
1774024|NCT00711191|6176358|P2|Overall Study|Withdrawal by Subject|1
1774025|NCT00711191|6176359|P1|Overall Study|Withdrawal by Subject|0
1774026|NCT00711191|6176357|P3|Overall Study|Objective progression or relapse|7
1774027|NCT00711191|6176358|P2|Overall Study|Objective progression or relapse|3
1774028|NCT00711191|6176359|P1|Overall Study|Objective progression or relapse|2
1774029|NCT00711191|6176357|P3|Overall Study|Adverse Event|2
1774030|NCT00711191|6176358|P2|Overall Study|Adverse Event|1
1774031|NCT00711191|6176359|P1|Overall Study|Adverse Event|1
1774032|NCT00711113|6176396|P1|Overall Study|Implant lost|2
1774033|NCT00711113|6176396|P1|Overall Study|Lost to Follow-up|9
1774034|NCT00711100|6176402|P1|Overall Study|Withdrawal by Subject|8
1774035|NCT00711100|6176402|P1|Overall Study|Lack of Efficacy|5
1774036|NCT00711087|6176420|P2|Overall Study|Lost to Follow-up|0
1774037|NCT00711087|6176421|P1|Overall Study|Lost to Follow-up|1
1774038|NCT00711009|6176433|P2|Overall Study|Dose adjustment|0
1774039|NCT00711009|6176434|P1|Overall Study|Dose adjustment|1
1774040|NCT00711009|6176433|P2|Overall Study|Site closing|1
1774041|NCT00711009|6176434|P1|Overall Study|Site closing|0
1774042|NCT00711009|6176433|P2|Overall Study|Pregnancy|0
1774043|NCT00711009|6176434|P1|Overall Study|Pregnancy|1
1774044|NCT00711009|6176433|P2|Overall Study|Virologic Failure|1
1774045|NCT00711009|6176434|P1|Overall Study|Virologic Failure|2
1774046|NCT00711009|6176433|P2|Overall Study|Participant Noncompliant|1
1774047|NCT00711009|6176434|P1|Overall Study|Participant Noncompliant|0
1774048|NCT00711009|6176433|P2|Overall Study|Lost to Follow-up|9
1774049|NCT00711009|6176434|P1|Overall Study|Lost to Follow-up|3
1774050|NCT00711009|6176433|P2|Overall Study|Withdrawal by Subject|2
1774051|NCT00711009|6176434|P1|Overall Study|Withdrawal by Subject|4
1774052|NCT00711009|6176433|P2|Overall Study|Adverse Event/HIV-Related Event|5
1774053|NCT00711009|6176434|P1|Overall Study|Adverse Event/HIV-Related Event|4
1774054|NCT00710970|6176615|P1|Overall Study|Never took drug|2
1774055|NCT00710970|6176615|P1|Overall Study|Lost to Follow-up|8
1774056|NCT00710879|6176642|P2|Overall Study|Protocol Violation|3
1774057|NCT00710879|6176643|P1|Overall Study|Protocol Violation|0
1774058|NCT00710879|6176642|P2|Overall Study|Lost to Follow-up|1
1774059|NCT00710879|6176643|P1|Overall Study|Lost to Follow-up|2
1774060|NCT00710866|6176655|P2|Overall Study|Failed to meet eligibility|1
1774061|NCT00710866|6176656|P1|Overall Study|Failed to meet eligibility|1
1774062|NCT00710866|6176655|P2|Overall Study|Lost to Follow-up|0
1774063|NCT00710866|6176656|P1|Overall Study|Lost to Follow-up|1
1774064|NCT00710866|6176655|P2|Overall Study|Withdrawal by Subject|1
1774065|NCT00710866|6176656|P1|Overall Study|Withdrawal by Subject|2
1774066|NCT00710866|6176655|P2|Overall Study|Protocol Violation|4
1774067|NCT00710866|6176656|P1|Overall Study|Protocol Violation|5
1774068|NCT00710762|6176702|P2|Overall Study|Reason other than listed above|2
1774069|NCT00710762|6176703|P1|Overall Study|Reason other than listed above|2
1774070|NCT00710762|6176702|P2|Overall Study|Lost to Follow-up|0
1774071|NCT00710762|6176703|P1|Overall Study|Lost to Follow-up|1
1774072|NCT00710762|6176702|P2|Overall Study|Other Adverse Event|7
1774073|NCT00710762|6176703|P1|Overall Study|Other Adverse Event|7
1774074|NCT00710762|6176702|P2|Overall Study|Adverse Event other disease worsening|1
1774075|NCT00710762|6176703|P1|Overall Study|Adverse Event other disease worsening|2
1774076|NCT00710762|6176702|P2|Overall Study|Progressive disease|30
1774077|NCT00710762|6176703|P1|Overall Study|Progressive disease|27
1774078|NCT00710749|6176719|P2|First Intervention|Withdrawal by Subject|0
1774079|NCT00710749|6176720|P1|First Intervention|Withdrawal by Subject|1
1774080|NCT00710684|6176731|P3|Overall Study|Did not continue after week 24|16
1774081|NCT00710684|6176732|P2|Overall Study|Did not continue after week 24|21
1774082|NCT00710684|6176733|P1|Overall Study|Did not continue after week 24|25
1774083|NCT00710684|6176731|P3|Overall Study|Missing|0
1774084|NCT00710684|6176732|P2|Overall Study|Missing|0
1774085|NCT00710684|6176733|P1|Overall Study|Missing|1
1774086|NCT00710684|6176731|P3|Overall Study|Withdrawal by Subject|11
1774087|NCT00710684|6176732|P2|Overall Study|Withdrawal by Subject|18
1774088|NCT00710684|6176733|P1|Overall Study|Withdrawal by Subject|24
1774089|NCT00710684|6176731|P3|Overall Study|Physician Decision|4
1774090|NCT00710684|6176732|P2|Overall Study|Physician Decision|2
1774091|NCT00710684|6176733|P1|Overall Study|Physician Decision|0
1774092|NCT00710684|6176731|P3|Overall Study|Lost to Follow-up|7
1774093|NCT00710684|6176732|P2|Overall Study|Lost to Follow-up|6
1774094|NCT00710684|6176733|P1|Overall Study|Lost to Follow-up|4
1774095|NCT00710684|6176731|P3|Overall Study|Protocol Violation|5
1774096|NCT00710684|6176732|P2|Overall Study|Protocol Violation|5
1774097|NCT00710684|6176733|P1|Overall Study|Protocol Violation|5
1774098|NCT00710684|6176731|P3|Overall Study|Lack of Efficacy|5
1774099|NCT00710684|6176732|P2|Overall Study|Lack of Efficacy|3
1774100|NCT00710684|6176733|P1|Overall Study|Lack of Efficacy|4
1774101|NCT00710684|6176731|P3|Overall Study|Adverse Event|16
1774102|NCT00710684|6176732|P2|Overall Study|Adverse Event|19
1774103|NCT00710684|6176733|P1|Overall Study|Adverse Event|11
1774104|NCT00710606|6176790|P2|Overall Study|Adverse Event|2
1774105|NCT00710606|6176791|P1|Overall Study|Adverse Event|0
1774106|NCT00710593|6176803|P2|Overall Study|Prem disc vaccine, completed all visits|2
1774107|NCT00710593|6176804|P1|Overall Study|Prem disc vaccine, completed all visits|6
1774108|NCT00710593|6176803|P2|Overall Study|Protocol Violation|1
1774109|NCT00710593|6176804|P1|Overall Study|Protocol Violation|1
1774110|NCT00710593|6176803|P2|Overall Study|Failure to adhere or complete study eval|1
1774111|NCT00710593|6176804|P1|Overall Study|Failure to adhere or complete study eval|1
1774112|NCT00710593|6176803|P2|Overall Study|Moved out of area|0
1774113|NCT00710593|6176804|P1|Overall Study|Moved out of area|1
1774114|NCT00710593|6176803|P2|Overall Study|Lost to Follow-up|1
1774115|NCT00710593|6176804|P1|Overall Study|Lost to Follow-up|3
1774116|NCT00710593|6176803|P2|Overall Study|Unable to complete Wk 48 within window|0
1774117|NCT00710593|6176804|P1|Overall Study|Unable to complete Wk 48 within window|2
1774118|NCT00710593|6176803|P2|Overall Study|Incarceration|0
1774119|NCT00710593|6176804|P1|Overall Study|Incarceration|1
1774120|NCT00710554|6176847|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
1774121|NCT00710554|6176848|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
1774122|NCT00710554|6176847|P2|Overall Study|Lack of Efficacy|12
1774123|NCT00710554|6176848|P1|Overall Study|Lack of Efficacy|11
1774124|NCT00710554|6176847|P2|Overall Study|Lost to Follow-up|1
1774125|NCT00710554|6176848|P1|Overall Study|Lost to Follow-up|7
1774126|NCT00710554|6176847|P2|Overall Study|Withdrawal by Subject|3
1774127|NCT00710554|6176848|P1|Overall Study|Withdrawal by Subject|7
1774128|NCT00710554|6176847|P2|Overall Study|Adverse Event|7
1774129|NCT00710554|6176848|P1|Overall Study|Adverse Event|24
1774130|NCT00710424|6176876|P2|Overall Study|Felt good so stopped treatment|1
1774131|NCT00710424|6176877|P1|Overall Study|Felt good so stopped treatment|0
1774132|NCT00710424|6176876|P2|Overall Study|Subject preferred paracetamol|1
1774133|NCT00710424|6176877|P1|Overall Study|Subject preferred paracetamol|0
1774134|NCT00710424|6176876|P2|Overall Study|Ceased treatment due to travel|0
1774135|NCT00710424|6176877|P1|Overall Study|Ceased treatment due to travel|1
1774136|NCT00710424|6176876|P2|Overall Study|Subject thought medication changed|0
1774137|NCT00710424|6176877|P1|Overall Study|Subject thought medication changed|1
1774138|NCT00710424|6176876|P2|Overall Study|Did not meet entry criteria at visit 1|0
1774139|NCT00710424|6176877|P1|Overall Study|Did not meet entry criteria at visit 1|1
1774140|NCT00710424|6176876|P2|Overall Study|Non-compliance with stable analgesia|0
1774141|NCT00710424|6176877|P1|Overall Study|Non-compliance with stable analgesia|1
1774142|NCT00710424|6176876|P2|Overall Study|Refused medication, no side effects|0
1774143|NCT00710424|6176877|P1|Overall Study|Refused medication, no side effects|1
1774144|NCT00710424|6176876|P2|Overall Study|Lost to Follow-up|1
1774145|NCT00710424|6176877|P1|Overall Study|Lost to Follow-up|0
1774146|NCT00710424|6176876|P2|Overall Study|Withdrawal by Subject|3
1774147|NCT00710424|6176877|P1|Overall Study|Withdrawal by Subject|5
1774148|NCT00710424|6176876|P2|Overall Study|Lack of Efficacy|5
1774149|NCT00710424|6176877|P1|Overall Study|Lack of Efficacy|4
1774150|NCT00710424|6176876|P2|Overall Study|Adverse Event|12
1774151|NCT00710424|6176877|P1|Overall Study|Adverse Event|30
1774152|NCT00710385|6176901|P1|Overall Study|Undisclosed excessive methadone use|1
1774153|NCT00710385|6176901|P1|Overall Study|Physician Decision|1
1774154|NCT00710385|6176901|P1|Overall Study|Undisclosed back pain|1
1774155|NCT00710385|6176901|P1|Overall Study|Withdrawal by Subject|1
1774156|NCT00710385|6176901|P1|Overall Study|Did not qualify|1
1774157|NCT00710034|6176946|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
1774158|NCT00710034|6176947|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
1774159|NCT00710034|6176946|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
1774160|NCT00710034|6176947|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
1774161|NCT00710034|6176946|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
1774162|NCT00710034|6176947|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
1774163|NCT00710034|6176946|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
1774164|NCT00710034|6176947|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
1774165|NCT00710034|6176946|P2|Completed 12 Weeks of Treatment|Adverse Event|1
1774166|NCT00710034|6176947|P1|Completed 12 Weeks of Treatment|Adverse Event|0
1774167|NCT00710034|6176946|P2|Completed 6 Weeks of Treatment|Physician Decision|0
1774168|NCT00710034|6176947|P1|Completed 6 Weeks of Treatment|Physician Decision|1
1774169|NCT00710034|6176946|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
1774170|NCT00710034|6176947|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
1774171|NCT00710034|6176946|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
1774172|NCT00710034|6176947|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
1774173|NCT00710034|6176946|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
1774174|NCT00710034|6176947|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
1774175|NCT00710034|6176946|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
1774176|NCT00710034|6176947|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
1774177|NCT00710034|6176946|P2|Completed 6 Weeks of Treatment|Adverse Event|12
1774178|NCT00710034|6176947|P1|Completed 6 Weeks of Treatment|Adverse Event|5
1774179|NCT00710021|6176964|P3|Overall Study|Physician Decision|0
1774180|NCT00710021|6176965|P2|Overall Study|Physician Decision|1
1774181|NCT00710021|6176966|P1|Overall Study|Physician Decision|0
1774182|NCT00710021|6176964|P3|Overall Study|Subject misrandomized|1
1774183|NCT00710021|6176965|P2|Overall Study|Subject misrandomized|1
1774184|NCT00710021|6176966|P1|Overall Study|Subject misrandomized|0
1774185|NCT00710021|6176964|P3|Overall Study|Subject's Decision|0
1774186|NCT00710021|6176965|P2|Overall Study|Subject's Decision|1
1774187|NCT00710021|6176966|P1|Overall Study|Subject's Decision|0
1774188|NCT00710021|6176964|P3|Overall Study|Lost to Follow-up|0
1774189|NCT00710021|6176965|P2|Overall Study|Lost to Follow-up|0
1774190|NCT00710021|6176966|P1|Overall Study|Lost to Follow-up|1
1774191|NCT00709995|6177081|P2|Overall Study|Withdrawal by Subject|3
1774192|NCT00709995|6177082|P1|Overall Study|Withdrawal by Subject|1
1774193|NCT00709995|6177081|P2|Overall Study|Adverse Event|2
1774194|NCT00709995|6177082|P1|Overall Study|Adverse Event|4
1774195|NCT00709956|6177100|P2|Overall Study|Inclusion/exclusion criteria violation|3
1774196|NCT00709956|6177101|P1|Overall Study|Inclusion/exclusion criteria violation|2
1774197|NCT00709956|6177100|P2|Overall Study|Withdrawal by Subject|1
1774198|NCT00709956|6177101|P1|Overall Study|Withdrawal by Subject|1
1774199|NCT00709852|6177131|P2|Period 2|No 72-hour follow-up|0
1774200|NCT00709852|6177132|P1|Period 2|No 72-hour follow-up|3
1774201|NCT00709852|6177131|P2|Period 2|Lost to Follow-up|0
1774202|NCT00709852|6177132|P1|Period 2|Lost to Follow-up|1
1774203|NCT00709852|6177131|P2|Period 2|Adverse Event|1
1774204|NCT00709852|6177132|P1|Period 2|Adverse Event|1
1774205|NCT00709852|6177131|P2|Period 2|Protocol Violation|1
1774206|NCT00709852|6177132|P1|Period 2|Protocol Violation|4
1774207|NCT00709852|6177131|P2|Period 1|Lost to Follow-up|0
1774208|NCT00709852|6177132|P1|Period 1|Lost to Follow-up|1
1774209|NCT00709852|6177131|P2|Period 1|Defective scanner|1
1774210|NCT00709852|6177132|P1|Period 1|Defective scanner|0
1774211|NCT00709852|6177131|P2|Period 1|Protocol Violation|0
1774212|NCT00709852|6177132|P1|Period 1|Protocol Violation|1
1774213|NCT00709852|6177131|P2|Period 1|Withdrawal by Subject|2
1774214|NCT00709852|6177132|P1|Period 1|Withdrawal by Subject|4
1774215|NCT00709852|6177131|P2|Period 1|Adverse Event|0
1774216|NCT00709852|6177132|P1|Period 1|Adverse Event|2
1774217|NCT00709761|6177296|P1|Overall Study|Lost to Follow-up|2
1774218|NCT00709761|6177296|P1|Overall Study|study closed/terminated|17
1774219|NCT00709761|6177296|P1|Overall Study|Withdrawal by Subject|8
1774220|NCT00709735|6177307|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
1774221|NCT00709735|6177308|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
1774222|NCT00709735|6177307|P2|Overall Study|Relapse into Opioid Abuse|1
1774223|NCT00709735|6177308|P1|Overall Study|Relapse into Opioid Abuse|0
1774224|NCT00709735|6177307|P2|Overall Study|Lost to Follow-up|1
1774225|NCT00709735|6177308|P1|Overall Study|Lost to Follow-up|1
1774226|NCT00709722|6177316|P1|Overall Study|Adverse Event|1
1774227|NCT00709618|6177331|P1|Overall Study|Study Closed/Terminated|25
1774228|NCT00709618|6177331|P1|Overall Study|Lost to Follow-up|1
1774229|NCT00709618|6177331|P1|Overall Study|Withdrawal by Subject|4
1774230|NCT00709592|6177343|P2|Overall Study|Unable to proceed to transplant|1
1774231|NCT00709592|6177344|P1|Overall Study|Unable to proceed to transplant|0
1774232|NCT00709319|6177366|P1|Overall Study|Withdrawal by Subject|2
1774233|NCT00709319|6177366|P1|Overall Study|Death|4
1774234|NCT00709228|6177395|P1|Overall Study|Non-compliance|5
1774235|NCT00709228|6177395|P1|Overall Study|Lost to Follow-up|6
1774236|NCT00709228|6177395|P1|Overall Study|Disease progression|1
1774237|NCT00709228|6177395|P1|Overall Study|Discontinued follow-up|5
1774238|NCT00709228|6177395|P1|Overall Study|Did not enter follow-up|4
1774239|NCT00709228|6177395|P1|Overall Study|Discontinued treatment|14
1774240|NCT00709228|6177395|P1|Overall Study|Adverse events|2
1774241|NCT00709228|6177395|P1|Overall Study|Eligibility criteria not met|281
1774242|NCT00709228|6177395|P1|Overall Study|Not treated|14
1774243|NCT00709202|6177401|P2|Overall Study|Withdrawal by Subject|6
1774244|NCT00709202|6177402|P1|Overall Study|Withdrawal by Subject|6
1774245|NCT00709124|6177430|P2|Overall Study|encephalopathy; can't do assessment|0
1774246|NCT00709124|6177431|P1|Overall Study|encephalopathy; can't do assessment|1
1774247|NCT00709124|6177430|P2|Overall Study|Death|1
1774248|NCT00709124|6177431|P1|Overall Study|Death|3
1774249|NCT00709111|6177465|P1|Overall Study|Unable to attend clinic visits|1
1774250|NCT00709111|6177465|P1|Overall Study|Withdrawal by Subject|1
1774251|NCT00709098|6177506|P3|Open-label Period|Lost to Follow-up|1
1774252|NCT00709098|6177507|P2|Open-label Period|Lost to Follow-up|0
1774253|NCT00709098|6177508|P1|Open-label Period|Lost to Follow-up|0
1774254|NCT00709098|6177506|P3|Open-label Period|Death|1
1774255|NCT00709098|6177507|P2|Open-label Period|Death|0
1774256|NCT00709098|6177508|P1|Open-label Period|Death|0
1774257|NCT00709098|6177506|P3|Open-label Period|Administrative reason|5
1774258|NCT00709098|6177507|P2|Open-label Period|Administrative reason|0
1774259|NCT00709098|6177508|P1|Open-label Period|Administrative reason|0
1774260|NCT00709098|6177506|P3|Open-label Period|Withdrawal of consent|7
1774261|NCT00709098|6177507|P2|Open-label Period|Withdrawal of consent|0
1774262|NCT00709098|6177508|P1|Open-label Period|Withdrawal of consent|0
1774263|NCT00709098|6177506|P3|Double-blind Period|Lost to Follow-up|0
1774264|NCT00709098|6177507|P2|Double-blind Period|Lost to Follow-up|1
1774265|NCT00709098|6177508|P1|Double-blind Period|Lost to Follow-up|1
1774266|NCT00709098|6177506|P3|Double-blind Period|Death|0
1774267|NCT00709098|6177507|P2|Double-blind Period|Death|1
1774268|NCT00709098|6177508|P1|Double-blind Period|Death|1
1774269|NCT00709098|6177506|P3|Double-blind Period|Administrative reason|0
1774270|NCT00709098|6177507|P2|Double-blind Period|Administrative reason|3
1774271|NCT00709098|6177508|P1|Double-blind Period|Administrative reason|1
1774272|NCT00709098|6177506|P3|Double-blind Period|Withdrawal of consent|0
1774273|NCT00709098|6177507|P2|Double-blind Period|Withdrawal of consent|3
1774274|NCT00709098|6177508|P1|Double-blind Period|Withdrawal of consent|3
1774275|NCT00709059|6177527|P1|Overall Study|Serious side effects|11
1774276|NCT00709059|6177527|P1|Overall Study|Side effects|20
1774277|NCT00709059|6177527|P1|Overall Study|Disease complication|3
1774278|NCT00709059|6177527|P1|Overall Study|Physician Decision|7
1774279|NCT00709059|6177527|P1|Overall Study|Withdrawal by Subject|19
1774280|NCT00709059|6177527|P1|Overall Study|Lost to Follow-up|34
1774281|NCT00708734|6177574|P1|Overall Study|leg fracture|1
1774282|NCT00708734|6177574|P1|Overall Study|vertigo|1
1774283|NCT00708734|6177574|P1|Overall Study|knee replacement|1
1774284|NCT00708734|6177574|P1|Overall Study|leg injury|1
1774285|NCT00708734|6177574|P1|Overall Study|moved|1
1774286|NCT00708734|6177574|P1|Overall Study|scheduling conflict|2
1774287|NCT00708708|6177594|P1|Overall Study|Missing values|392
1774288|NCT00708708|6177594|P1|Overall Study|Adverse Event|3
1774289|NCT00708708|6177594|P1|Overall Study|Pregnancy|3
1774290|NCT00708708|6177594|P1|Overall Study|Lack of compliance|3
1774291|NCT00708708|6177594|P1|Overall Study|Lack of effectiveness|4
1774292|NCT00708708|6177594|P1|Overall Study|Administrative reasons|7
1774293|NCT00708708|6177594|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
1774294|NCT00708708|6177594|P1|Overall Study|Good effectiveness|9
1774295|NCT00708708|6177594|P1|Overall Study|Other unspecified|11
1774296|NCT00708708|6177594|P1|Overall Study|Another therapy along with Enbrel|15
1774297|NCT00708708|6177594|P1|Overall Study|Intolerance|42
1774298|NCT00708708|6177594|P1|Overall Study|Withdrawal by Subject|51
1774299|NCT00708708|6177594|P1|Overall Study|Lost to Follow-up|52
1774300|NCT00708708|6177594|P1|Overall Study|Another therapy instead of Enbrel|141
1774301|NCT00708682|6177642|P1|Toddler Dose|Failed to Return|4
1774302|NCT00708682|6177642|P1|Toddler Dose|Lost to Follow-up|3
1774303|NCT00708682|6177642|P1|Toddler Dose|Parent/Legal Guardian Request|1
1774304|NCT00708682|6177642|P1|After Infant Series|Parent/Legal Guardian Request|1
1774305|NCT00708682|6177642|P1|Infant Series|Other|19
1774306|NCT00708682|6177642|P1|Infant Series|Failed to return|2
1774307|NCT00708682|6177642|P1|Infant Series|Parent/legal guardian request|6
1774308|NCT00708682|6177642|P1|Infant Series|Protocol Violation|1
1774309|NCT00708682|6177642|P1|Infant Series|Lost to Follow-up|4
1774310|NCT00708682|6177642|P1|Infant Series|Adverse Event|1
1774311|NCT00708643|6177663|P2|Overall Study|Adverse Event|1
1774312|NCT00708643|6177664|P1|Overall Study|Adverse Event|0
1774313|NCT00708552|6177684|P4|Overall Study|Withdrawal by Subject|10
1774314|NCT00708552|6177685|P3|Overall Study|Withdrawal by Subject|8
1774315|NCT00708552|6177686|P2|Overall Study|Withdrawal by Subject|7
1774316|NCT00708552|6177687|P1|Overall Study|Withdrawal by Subject|12
1774317|NCT00708552|6177684|P4|Overall Study|Physician Decision|0
1774318|NCT00708552|6177685|P3|Overall Study|Physician Decision|0
1774319|NCT00708552|6177686|P2|Overall Study|Physician Decision|2
1774320|NCT00708552|6177687|P1|Overall Study|Physician Decision|1
1774321|NCT00708552|6177684|P4|Overall Study|Lost to Follow-up|1
1774322|NCT00708552|6177685|P3|Overall Study|Lost to Follow-up|0
1774323|NCT00708552|6177686|P2|Overall Study|Lost to Follow-up|2
1774324|NCT00708552|6177687|P1|Overall Study|Lost to Follow-up|4
1774325|NCT00708552|6177684|P4|Overall Study|Protocol Violation|4
1774326|NCT00708552|6177685|P3|Overall Study|Protocol Violation|2
1774327|NCT00708552|6177686|P2|Overall Study|Protocol Violation|0
1774328|NCT00708552|6177687|P1|Overall Study|Protocol Violation|0
1774329|NCT00708552|6177684|P4|Overall Study|Lack of Efficacy|0
1774330|NCT00708552|6177685|P3|Overall Study|Lack of Efficacy|1
1774331|NCT00708552|6177686|P2|Overall Study|Lack of Efficacy|4
1774332|NCT00708552|6177687|P1|Overall Study|Lack of Efficacy|0
1774333|NCT00708552|6177684|P4|Overall Study|Adverse Event|6
1774334|NCT00708552|6177685|P3|Overall Study|Adverse Event|4
1774335|NCT00708552|6177686|P2|Overall Study|Adverse Event|3
1774336|NCT00708552|6177687|P1|Overall Study|Adverse Event|10
1774337|NCT00708500|6177849|P3|FOLLOWUP|Non-compliance with protocol|1
1774338|NCT00708500|6177850|P2|FOLLOWUP|Non-compliance with protocol|0
1774339|NCT00708500|6177851|P1|FOLLOWUP|Non-compliance with protocol|5
1774340|NCT00708500|6177849|P3|FOLLOWUP|Subject withdrew consent|5
1774341|NCT00708500|6177850|P2|FOLLOWUP|Subject withdrew consent|4
1774342|NCT00708500|6177851|P1|FOLLOWUP|Subject withdrew consent|31
1774343|NCT00708500|6177849|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
1774344|NCT00708500|6177850|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
1774345|NCT00708500|6177851|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
1774346|NCT00708500|6177849|P3|FOLLOWUP|Lost to Follow-up|4
1774347|NCT00708500|6177850|P2|FOLLOWUP|Lost to Follow-up|6
1774348|NCT00708500|6177851|P1|FOLLOWUP|Lost to Follow-up|1
1774349|NCT00708500|6177849|P3|FOLLOWUP|Adverse Event|0
1774350|NCT00708500|6177850|P2|FOLLOWUP|Adverse Event|1
1774351|NCT00708500|6177851|P1|FOLLOWUP|Adverse Event|0
1774352|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
1774353|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
1774354|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
1774355|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
1774356|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
1774357|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
1774358|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
1774359|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
1774360|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
1774361|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
1774362|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
1774363|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
1774364|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
1774365|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
1774366|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
1774367|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
1774368|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
1774369|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
1774370|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
1774371|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
1774372|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
1774373|NCT00708500|6177849|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
1774374|NCT00708500|6177850|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
1774375|NCT00708500|6177851|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
1774376|NCT00708500|6177849|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
1774377|NCT00708500|6177850|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
1774378|NCT00708500|6177851|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
1774379|NCT00708500|6177849|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
1774380|NCT00708500|6177850|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
1774381|NCT00708500|6177851|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
1774382|NCT00708500|6177849|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
1774383|NCT00708500|6177850|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
1774384|NCT00708500|6177851|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
1774385|NCT00708500|6177849|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
1774386|NCT00708500|6177850|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
1774387|NCT00708500|6177851|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
1774388|NCT00708500|6177849|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
1774389|NCT00708500|6177850|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
1774390|NCT00708500|6177851|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
1774391|NCT00708461|6177870|P2|Overall Study|left workforce|180
1774392|NCT00708461|6177871|P1|Overall Study|left workforce|115
1774393|NCT00708461|6177870|P2|Overall Study|Withdrawal by Subject|9
1774394|NCT00708461|6177871|P1|Overall Study|Withdrawal by Subject|8
1774395|NCT00708461|6177870|P2|Overall Study|Lost to Follow-up|11
1774396|NCT00708461|6177871|P1|Overall Study|Lost to Follow-up|18
1774397|NCT00708435|6177879|P2|Overall Study|Refused hospitalization|0
1774398|NCT00708435|6177880|P1|Overall Study|Refused hospitalization|1
1774399|NCT00708435|6177879|P2|Overall Study|Intervention by primary care physician|0
1774400|NCT00708435|6177880|P1|Overall Study|Intervention by primary care physician|1
1774401|NCT00708435|6177879|P2|Overall Study|Protocol Violation|1
1774402|NCT00708435|6177880|P1|Overall Study|Protocol Violation|0
1774403|NCT00708435|6177879|P2|Overall Study|Adverse Event|0
1774404|NCT00708435|6177880|P1|Overall Study|Adverse Event|1
1774405|NCT00708435|6177879|P2|Overall Study|Withdrawal by Subject|7
1774406|NCT00708435|6177880|P1|Overall Study|Withdrawal by Subject|3
1774407|NCT00708435|6177879|P2|Overall Study|Lost to Follow-up|4
1774408|NCT00708435|6177880|P1|Overall Study|Lost to Follow-up|9
1774409|NCT00708435|6177879|P2|Overall Study|Death / Serious Adverse Event|5
1774410|NCT00708435|6177880|P1|Overall Study|Death / Serious Adverse Event|10
1774411|NCT00708422|6177907|P2|Overall Study|Withdrawal by Subject|0
1774412|NCT00708422|6177908|P1|Overall Study|Withdrawal by Subject|1
1774413|NCT00708422|6177907|P2|Overall Study|Adverse Event|1
1774414|NCT00708422|6177908|P1|Overall Study|Adverse Event|3
1774415|NCT00708305|6177916|P4|Period 3|Other Reason|0
1774416|NCT00708305|6177917|P3|Period 3|Other Reason|0
1774417|NCT00708305|6177918|P2|Period 3|Other Reason|0
1774418|NCT00708305|6177919|P1|Period 3|Other Reason|1
1774419|NCT00708305|6177916|P4|Period 3|Protocol Violation|0
1774420|NCT00708305|6177917|P3|Period 3|Protocol Violation|0
1774421|NCT00708305|6177918|P2|Period 3|Protocol Violation|2
1774422|NCT00708305|6177919|P1|Period 3|Protocol Violation|0
1774423|NCT00708305|6177916|P4|Period 2|Other Reason|1
1774424|NCT00708305|6177917|P3|Period 2|Other Reason|0
1774425|NCT00708305|6177918|P2|Period 2|Other Reason|0
1774426|NCT00708305|6177919|P1|Period 2|Other Reason|1
1774427|NCT00708305|6177916|P4|Period 2|Protocol Violation|0
1774428|NCT00708305|6177917|P3|Period 2|Protocol Violation|0
1774429|NCT00708305|6177918|P2|Period 2|Protocol Violation|1
1774430|NCT00708305|6177919|P1|Period 2|Protocol Violation|0
1774431|NCT00708305|6177916|P4|Period 2|Lost to Follow-up|0
1774432|NCT00708305|6177917|P3|Period 2|Lost to Follow-up|0
1774433|NCT00708305|6177918|P2|Period 2|Lost to Follow-up|1
1774434|NCT00708305|6177919|P1|Period 2|Lost to Follow-up|0
1774435|NCT00708305|6177916|P4|Period 1|Other Reason|2
1774436|NCT00708305|6177917|P3|Period 1|Other Reason|0
1774437|NCT00708305|6177918|P2|Period 1|Other Reason|0
1774438|NCT00708305|6177919|P1|Period 1|Other Reason|0
1774439|NCT00708305|6177916|P4|Period 1|Protocol Violation|0
1774440|NCT00708305|6177917|P3|Period 1|Protocol Violation|1
1774441|NCT00708305|6177918|P2|Period 1|Protocol Violation|0
1774442|NCT00708305|6177919|P1|Period 1|Protocol Violation|1
1774443|NCT00708227|6177955|P4|Overall Study|Withdrawal by Subject|1
1774444|NCT00708227|6177956|P3|Overall Study|Withdrawal by Subject|0
1774445|NCT00708227|6177957|P2|Overall Study|Withdrawal by Subject|2
1774446|NCT00708227|6177958|P1|Overall Study|Withdrawal by Subject|1
1774447|NCT00708227|6177955|P4|Overall Study|Physician Decision|2
1774448|NCT00708227|6177956|P3|Overall Study|Physician Decision|1
1774449|NCT00708227|6177957|P2|Overall Study|Physician Decision|3
1774450|NCT00708227|6177958|P1|Overall Study|Physician Decision|0
1774451|NCT00708214|6177991|P3|Overall Study|Progressive Disease|5
1774452|NCT00708214|6177992|P2|Overall Study|Progressive Disease|6
1774453|NCT00708214|6177993|P1|Overall Study|Progressive Disease|4
1774454|NCT00708214|6177991|P3|Overall Study|Other|1
1774455|NCT00708214|6177992|P2|Overall Study|Other|1
1774456|NCT00708214|6177993|P1|Overall Study|Other|0
1774457|NCT00708214|6177991|P3|Overall Study|Other Adverse Event|2
1774458|NCT00708214|6177992|P2|Overall Study|Other Adverse Event|6
1774459|NCT00708214|6177993|P1|Overall Study|Other Adverse Event|3
1774460|NCT00708201|6178036|P2|Overall Study|Protocol Violation|1
1774461|NCT00708201|6178037|P1|Overall Study|Protocol Violation|0
1774462|NCT00708201|6178036|P2|Overall Study|Lost to Follow-up|0
1774463|NCT00708201|6178037|P1|Overall Study|Lost to Follow-up|2
1774464|NCT00708201|6178036|P2|Overall Study|Withdrawal by Subject|1
1774465|NCT00708201|6178037|P1|Overall Study|Withdrawal by Subject|1
1774466|NCT00708201|6178036|P2|Overall Study|Adverse Event|4
1774467|NCT00708201|6178037|P1|Overall Study|Adverse Event|4
1774468|NCT00708175|6178061|P2|Overall Study|BMD loss >7%|3
1774469|NCT00708175|6178062|P1|Overall Study|BMD loss >7%|2
1774470|NCT00708175|6178061|P2|Overall Study|Withdrawal by Subject|7
1774471|NCT00708175|6178062|P1|Overall Study|Withdrawal by Subject|5
1774472|NCT00708175|6178061|P2|Overall Study|Lost to Follow-up|3
1774473|NCT00708175|6178062|P1|Overall Study|Lost to Follow-up|5
1774474|NCT00708175|6178061|P2|Overall Study|Protocol Violation|3
1774475|NCT00708175|6178062|P1|Overall Study|Protocol Violation|2
1774476|NCT00708175|6178061|P2|Overall Study|Adverse Event|5
1774477|NCT00708175|6178062|P1|Overall Study|Adverse Event|4
1774478|NCT00708162|6178078|P2|Open-Label Phase|Other|0
1774479|NCT00708162|6178079|P1|Open-Label Phase|Other|1
1774480|NCT00708162|6178078|P2|Open-Label Phase|Adverse Event|2
1774481|NCT00708162|6178079|P1|Open-Label Phase|Adverse Event|1
1774482|NCT00708162|6178078|P2|Open-Label Phase|Death|1
1774483|NCT00708162|6178079|P1|Open-Label Phase|Death|3
1774484|NCT00708162|6178078|P2|Open-Label Phase|Investigator's Discretion|2
1774485|NCT00708162|6178079|P1|Open-Label Phase|Investigator's Discretion|3
1774486|NCT00708162|6178078|P2|Open-Label Phase|Lack of Efficacy|4
1774487|NCT00708162|6178079|P1|Open-Label Phase|Lack of Efficacy|7
1774488|NCT00708162|6178078|P2|Open-Label Phase|Participant Noncompliance|7
1774489|NCT00708162|6178079|P1|Open-Label Phase|Participant Noncompliance|7
1774490|NCT00708162|6178078|P2|Open-Label Phase|Withdrew Consent|6
1774491|NCT00708162|6178079|P1|Open-Label Phase|Withdrew Consent|12
1774492|NCT00708162|6178078|P2|Open-Label Phase|Lost to Follow-up|8
1774493|NCT00708162|6178079|P1|Open-Label Phase|Lost to Follow-up|10
1774494|NCT00708162|6178078|P2|Randomized Phase|Pregnancy|0
1774495|NCT00708162|6178079|P1|Randomized Phase|Pregnancy|3
1774496|NCT00708162|6178078|P2|Randomized Phase|Death|9
1774497|NCT00708162|6178079|P1|Randomized Phase|Death|2
1774498|NCT00708162|6178078|P2|Randomized Phase|Investigator’s Discretion|10
1774499|NCT00708162|6178079|P1|Randomized Phase|Investigator’s Discretion|7
1774500|NCT00708162|6178078|P2|Randomized Phase|Adverse Event|12
1774501|NCT00708162|6178079|P1|Randomized Phase|Adverse Event|8
1774502|NCT00708162|6178078|P2|Randomized Phase|Protocol Violation|11
1774503|NCT00708162|6178079|P1|Randomized Phase|Protocol Violation|10
1774504|NCT00708162|6178078|P2|Randomized Phase|Lack of Efficacy|19
1774505|NCT00708162|6178079|P1|Randomized Phase|Lack of Efficacy|14
1774506|NCT00708162|6178078|P2|Randomized Phase|Withdrew Consent|22
1774507|NCT00708162|6178079|P1|Randomized Phase|Withdrew Consent|31
1774508|NCT00708162|6178078|P2|Randomized Phase|Lost to Follow-up|34
1774509|NCT00708162|6178079|P1|Randomized Phase|Lost to Follow-up|34
1774510|NCT00708162|6178078|P2|Randomized Phase|Participant Noncompliance|32
1774511|NCT00708162|6178079|P1|Randomized Phase|Participant Noncompliance|40
1774512|NCT00708162|6178078|P2|Randomized Phase|Randomized but Not Treated|5
1774513|NCT00708162|6178079|P1|Randomized Phase|Randomized but Not Treated|7
1774514|NCT00708123|6178120|P5|Period 4|Protocol Violation|0
1774515|NCT00708123|6178121|P4|Period 4|Protocol Violation|0
1774516|NCT00708123|6178122|P3|Period 4|Protocol Violation|0
1774517|NCT00708123|6178123|P2|Period 4|Protocol Violation|1
1774518|NCT00708123|6178124|P1|Period 4|Protocol Violation|0
1774519|NCT00708123|6178120|P5|Period 3|Lost to Follow-up|0
1774520|NCT00708123|6178121|P4|Period 3|Lost to Follow-up|1
1774521|NCT00708123|6178122|P3|Period 3|Lost to Follow-up|1
1774522|NCT00708123|6178123|P2|Period 3|Lost to Follow-up|0
1774523|NCT00708123|6178124|P1|Period 3|Lost to Follow-up|0
1774524|NCT00708123|6178120|P5|Period 2|Other Reason|0
1774525|NCT00708123|6178121|P4|Period 2|Other Reason|0
1774526|NCT00708123|6178122|P3|Period 2|Other Reason|0
1774527|NCT00708123|6178123|P2|Period 2|Other Reason|0
1774528|NCT00708123|6178124|P1|Period 2|Other Reason|1
1774529|NCT00708123|6178120|P5|Period 2|Protocol Violation|0
1774530|NCT00708123|6178121|P4|Period 2|Protocol Violation|1
1774531|NCT00708123|6178122|P3|Period 2|Protocol Violation|0
1774532|NCT00708123|6178123|P2|Period 2|Protocol Violation|0
1774533|NCT00708123|6178124|P1|Period 2|Protocol Violation|0
1774534|NCT00708123|6178120|P5|Period 1|Adverse Event|0
1774535|NCT00708123|6178121|P4|Period 1|Adverse Event|0
1774536|NCT00708123|6178122|P3|Period 1|Adverse Event|1
1774537|NCT00708123|6178123|P2|Period 1|Adverse Event|0
1774538|NCT00708123|6178124|P1|Period 1|Adverse Event|0
1774539|NCT00708123|6178120|P5|Period 1|Protocol Violation|0
1774540|NCT00708123|6178121|P4|Period 1|Protocol Violation|1
1774541|NCT00708123|6178122|P3|Period 1|Protocol Violation|0
1774542|NCT00708123|6178123|P2|Period 1|Protocol Violation|1
1774543|NCT00708123|6178124|P1|Period 1|Protocol Violation|0
1774544|NCT00708097|6178257|P5|Period 2|Protocol Violation|0
1774545|NCT00708097|6178258|P4|Period 2|Protocol Violation|1
1774546|NCT00708097|6178259|P3|Period 2|Protocol Violation|1
1774547|NCT00708097|6178260|P2|Period 2|Protocol Violation|1
1774548|NCT00708097|6178261|P1|Period 2|Protocol Violation|0
1774549|NCT00708097|6178257|P5|Period 1|Other Reason|1
1774550|NCT00708097|6178258|P4|Period 1|Other Reason|0
1774551|NCT00708097|6178259|P3|Period 1|Other Reason|0
1774552|NCT00708097|6178260|P2|Period 1|Other Reason|0
1774553|NCT00708097|6178261|P1|Period 1|Other Reason|0
1774554|NCT00708097|6178257|P5|Period 1|Protocol Violation|0
1774555|NCT00708097|6178258|P4|Period 1|Protocol Violation|2
1774556|NCT00708097|6178259|P3|Period 1|Protocol Violation|0
1774557|NCT00708097|6178260|P2|Period 1|Protocol Violation|1
1774558|NCT00708097|6178261|P1|Period 1|Protocol Violation|0
1774559|NCT00708032|6178371|P2|Overall Study|Withdrawal by Subject|1
1774560|NCT00708032|6178372|P1|Overall Study|Withdrawal by Subject|0
1774561|NCT00708032|6178371|P2|Overall Study|Protocol Violation|1
1774562|NCT00708032|6178372|P1|Overall Study|Protocol Violation|4
1774563|NCT00708032|6178371|P2|Overall Study|Did not meet protocol criteria|2
1774564|NCT00708032|6178372|P1|Overall Study|Did not meet protocol criteria|1
1774565|NCT00708032|6178371|P2|Overall Study|Visit out of range at month 12|1
1774566|NCT00708032|6178372|P1|Overall Study|Visit out of range at month 12|4
1774567|NCT00708032|6178371|P2|Overall Study|Poor vision|6
1774568|NCT00708032|6178372|P1|Overall Study|Poor vision|0
1774569|NCT00708032|6178371|P2|Overall Study|Pregnancy|1
1774570|NCT00708032|6178372|P1|Overall Study|Pregnancy|0
1774571|NCT00708032|6178371|P2|Overall Study|Lost to Follow-up|2
1774572|NCT00708032|6178372|P1|Overall Study|Lost to Follow-up|1
1774573|NCT00708032|6178371|P2|Overall Study|Adverse Event|2
1774574|NCT00708032|6178372|P1|Overall Study|Adverse Event|0
1774575|NCT00707993|6178399|P2|Overall Study|Other|0
1774576|NCT00707993|6178400|P1|Overall Study|Other|2
1774577|NCT00707993|6178399|P2|Overall Study|Hyperglycemic Rescue|47
1774578|NCT00707993|6178400|P1|Overall Study|Hyperglycemic Rescue|55
1774579|NCT00707993|6178399|P2|Overall Study|Withdrawal by Subject|16
1774580|NCT00707993|6178400|P1|Overall Study|Withdrawal by Subject|12
1774581|NCT00707993|6178399|P2|Overall Study|Lost to Follow-up|4
1774582|NCT00707993|6178400|P1|Overall Study|Lost to Follow-up|0
1774583|NCT00707993|6178399|P2|Overall Study|Protocol Violation|7
1774584|NCT00707993|6178400|P1|Overall Study|Protocol Violation|4
1774585|NCT00707993|6178399|P2|Overall Study|Adverse Event|20
1774586|NCT00707993|6178400|P1|Overall Study|Adverse Event|16
1774587|NCT00707980|6178442|P1|Overall Study|Other|39
1774588|NCT00707980|6178442|P1|Overall Study|Lost to Follow-up|59
1774589|NCT00707980|6178442|P1|Overall Study|Withdrawal of Consent|81
1774590|NCT00707980|6178442|P1|Overall Study|Protocol Deviations|19
1774591|NCT00707980|6178442|P1|Overall Study|Non-Compliance with Study Drug|28
1774592|NCT00707980|6178442|P1|Overall Study|Lack of Efficacy|35
1774593|NCT00707980|6178442|P1|Overall Study|Adverse Event|49
1774594|NCT00707954|6178526|P5|Overall Study|Physician Decision|1
1774595|NCT00707954|6178527|P4|Overall Study|Physician Decision|0
1774596|NCT00707954|6178528|P3|Overall Study|Physician Decision|0
1774597|NCT00707954|6178529|P2|Overall Study|Physician Decision|0
1774598|NCT00707954|6178530|P1|Overall Study|Physician Decision|0
1774599|NCT00707746|6178571|P2|Treatment Period|Ineligibility|1
1774600|NCT00707746|6178572|P1|Treatment Period|Ineligibility|0
1774601|NCT00707746|6178571|P2|Treatment Period|Adverse Event|4
1774602|NCT00707746|6178572|P1|Treatment Period|Adverse Event|2
1774603|NCT00707577|6178633|P2|Overall Study|Pregnancy|1
1774604|NCT00707577|6178634|P1|Overall Study|Pregnancy|4
1774605|NCT00707577|6178633|P2|Overall Study|Left employment|10
1774606|NCT00707577|6178634|P1|Overall Study|Left employment|13
1774607|NCT00707577|6178633|P2|Overall Study|Lost to Follow-up|25
1774608|NCT00707577|6178634|P1|Overall Study|Lost to Follow-up|34
1774609|NCT00707577|6178633|P2|Overall Study|Withdrawal by Subject|2
1774610|NCT00707577|6178634|P1|Overall Study|Withdrawal by Subject|3
1774611|NCT00707486|6178640|P1|Overall Study|Withdrawal by Subject|1
1774612|NCT00707239|6178683|P3|Overall Study|Other|5
1774613|NCT00707239|6178684|P2|Overall Study|Other|3
1774614|NCT00707239|6178685|P1|Overall Study|Other|8
1774615|NCT00707239|6178683|P3|Overall Study|Randomized, but not treated|1
1774616|NCT00707239|6178684|P2|Overall Study|Randomized, but not treated|1
1774617|NCT00707239|6178685|P1|Overall Study|Randomized, but not treated|1
1774618|NCT00707239|6178683|P3|Overall Study|Lack of Efficacy|0
1774619|NCT00707239|6178684|P2|Overall Study|Lack of Efficacy|2
1774620|NCT00707239|6178685|P1|Overall Study|Lack of Efficacy|1
1774621|NCT00707239|6178683|P3|Overall Study|Protocol Violation|1
1774622|NCT00707239|6178684|P2|Overall Study|Protocol Violation|0
1774623|NCT00707239|6178685|P1|Overall Study|Protocol Violation|0
1774624|NCT00707239|6178683|P3|Overall Study|Physician Decision|2
1774625|NCT00707239|6178684|P2|Overall Study|Physician Decision|1
1774626|NCT00707239|6178685|P1|Overall Study|Physician Decision|1
1774627|NCT00707239|6178683|P3|Overall Study|Death|3
1774628|NCT00707239|6178684|P2|Overall Study|Death|1
1774629|NCT00707239|6178685|P1|Overall Study|Death|3
1774630|NCT00707239|6178683|P3|Overall Study|Adverse Event|2
1774631|NCT00707239|6178684|P2|Overall Study|Adverse Event|3
1774632|NCT00707239|6178685|P1|Overall Study|Adverse Event|5
1774633|NCT00707174|6178733|P2|Overall Study|Withdrawal by Subject|1
1774634|NCT00707174|6178734|P1|Overall Study|Withdrawal by Subject|4
1774635|NCT00707174|6178733|P2|Overall Study|Adverse Event|6
1774636|NCT00707174|6178734|P1|Overall Study|Adverse Event|1
1774637|NCT00707161|6178740|P1|Overall Study|Physician Decision|6
1774638|NCT00707057|6178746|P2|Overall Study|Dosed incorrectly|1
1774639|NCT00707057|6178747|P1|Overall Study|Dosed incorrectly|0
1774640|NCT00707057|6178746|P2|Overall Study|Withdrawal by Subject|3
1774641|NCT00707057|6178747|P1|Overall Study|Withdrawal by Subject|8
1774642|NCT00707031|6178781|P2|Overall Study|Sponsor Decision|8
1774643|NCT00707031|6178782|P1|Overall Study|Sponsor Decision|9
1774644|NCT00707031|6178781|P2|Overall Study|Serious Noncompliance|3
1774645|NCT00707031|6178782|P1|Overall Study|Serious Noncompliance|2
1774646|NCT00707031|6178781|P2|Overall Study|Familial or Personal Reasons|15
1774647|NCT00707031|6178782|P1|Overall Study|Familial or Personal Reasons|12
1774648|NCT00707031|6178781|P2|Overall Study|Poor Compliance to Protocol|13
1774649|NCT00707031|6178782|P1|Overall Study|Poor Compliance to Protocol|7
1774650|NCT00707031|6178781|P2|Overall Study|Withdrawal by Subject|8
1774651|NCT00707031|6178782|P1|Overall Study|Withdrawal by Subject|7
1774652|NCT00707031|6178781|P2|Overall Study|Protocol Violation|0
1774653|NCT00707031|6178782|P1|Overall Study|Protocol Violation|1
1774654|NCT00707031|6178781|P2|Overall Study|Lost to Follow-up|1
1774655|NCT00707031|6178782|P1|Overall Study|Lost to Follow-up|2
1774656|NCT00707031|6178781|P2|Overall Study|Lack of Efficacy|6
1774657|NCT00707031|6178782|P1|Overall Study|Lack of Efficacy|19
1774658|NCT00707031|6178781|P2|Overall Study|Adverse Event|45
1774659|NCT00707031|6178782|P1|Overall Study|Adverse Event|45
1774660|NCT00706992|6178811|P7|Overall Study|Disease progression before treatment|0
1774661|NCT00706992|6178812|P6|Overall Study|Disease progression before treatment|0
1774662|NCT00706992|6178813|P5|Overall Study|Disease progression before treatment|1
1774663|NCT00706992|6178814|P4|Overall Study|Disease progression before treatment|0
1774664|NCT00706992|6178815|P3|Overall Study|Disease progression before treatment|0
1774665|NCT00706992|6178816|P2|Overall Study|Disease progression before treatment|0
1774666|NCT00706992|6178817|P1|Overall Study|Disease progression before treatment|0
1774667|NCT00706992|6178811|P7|Overall Study|Study termination|3
1774668|NCT00706992|6178812|P6|Overall Study|Study termination|2
1774669|NCT00706992|6178813|P5|Overall Study|Study termination|3
1774670|NCT00706992|6178814|P4|Overall Study|Study termination|2
1774671|NCT00706992|6178815|P3|Overall Study|Study termination|6
1774672|NCT00706992|6178816|P2|Overall Study|Study termination|5
1774673|NCT00706992|6178817|P1|Overall Study|Study termination|5
1774674|NCT00706966|6178849|P1|Overall Study|Adverse Event|1
1774675|NCT00706914|6178885|P3|Overall Study|Protocol Violation|1
1774676|NCT00706914|6178886|P2|Overall Study|Protocol Violation|1
1774677|NCT00706914|6178887|P1|Overall Study|Protocol Violation|3
1774678|NCT00706914|6178885|P3|Overall Study|Adverse Event|0
1774679|NCT00706914|6178886|P2|Overall Study|Adverse Event|2
1774680|NCT00706914|6178887|P1|Overall Study|Adverse Event|2
1774681|NCT00706914|6178885|P3|Overall Study|Lost to Follow-up|0
1774682|NCT00706914|6178886|P2|Overall Study|Lost to Follow-up|0
1774683|NCT00706914|6178887|P1|Overall Study|Lost to Follow-up|1
1774684|NCT00706914|6178885|P3|Overall Study|Lack of Efficacy|0
1774685|NCT00706914|6178886|P2|Overall Study|Lack of Efficacy|1
1774686|NCT00706914|6178887|P1|Overall Study|Lack of Efficacy|0
1774687|NCT00706901|6178910|P3|Overall Study|Death|0
1774688|NCT00706901|6178911|P2|Overall Study|Death|0
1774689|NCT00706901|6178912|P1|Overall Study|Death|1
1774690|NCT00706901|6178910|P3|Overall Study|In Jail|1
1774691|NCT00706901|6178911|P2|Overall Study|In Jail|0
1774692|NCT00706901|6178912|P1|Overall Study|In Jail|1
1774693|NCT00706901|6178910|P3|Overall Study|Withdrawal by Subject|5
1774694|NCT00706901|6178911|P2|Overall Study|Withdrawal by Subject|2
1774695|NCT00706901|6178912|P1|Overall Study|Withdrawal by Subject|4
1774696|NCT00706901|6178910|P3|Overall Study|Lost to Follow-up|2
1774697|NCT00706901|6178911|P2|Overall Study|Lost to Follow-up|3
1774698|NCT00706901|6178912|P1|Overall Study|Lost to Follow-up|2
1774699|NCT00706849|6178937|P2|Follow-up Period|Protocol non-compliance|1
1774700|NCT00706849|6178938|P1|Follow-up Period|Protocol non-compliance|0
1774701|NCT00706849|6178937|P2|Follow-up Period|Withdrawal by Subject|2
1774702|NCT00706849|6178938|P1|Follow-up Period|Withdrawal by Subject|0
1774703|NCT00706849|6178937|P2|Treatment Period|Other|1
1774704|NCT00706849|6178938|P1|Treatment Period|Other|0
1774705|NCT00706849|6178937|P2|Treatment Period|Adverse Event|9
1774706|NCT00706849|6178938|P1|Treatment Period|Adverse Event|0
1774707|NCT00706797|6179016|P2|Overall Study|Other|0
1774708|NCT00706797|6179017|P1|Overall Study|Other|1
1774709|NCT00706797|6179016|P2|Overall Study|Lost to Follow-up|2
1774710|NCT00706797|6179017|P1|Overall Study|Lost to Follow-up|1
1774711|NCT00706797|6179016|P2|Overall Study|Protocol Violation|2
1774712|NCT00706797|6179017|P1|Overall Study|Protocol Violation|3
1774713|NCT00706797|6179016|P2|Overall Study|Discontinuation of study by sponsor|63
1774714|NCT00706797|6179017|P1|Overall Study|Discontinuation of study by sponsor|52
1774715|NCT00706797|6179016|P2|Overall Study|Death|0
1774716|NCT00706797|6179017|P1|Overall Study|Death|1
1774717|NCT00706797|6179016|P2|Overall Study|Withdrawal by Subject|1
1774718|NCT00706797|6179017|P1|Overall Study|Withdrawal by Subject|8
1774719|NCT00706797|6179016|P2|Overall Study|Adverse Event|3
1774720|NCT00706797|6179017|P1|Overall Study|Adverse Event|0
1774721|NCT00706797|6179016|P2|Overall Study|Lack of Efficacy|0
1774722|NCT00706797|6179017|P1|Overall Study|Lack of Efficacy|3
1774723|NCT00706706|6179086|P1|Overall Study|Study endpoint had reached|45
1774724|NCT00706706|6179086|P1|Overall Study|Lost to Follow-up|7
1774725|NCT00706706|6179086|P1|Overall Study|Death|53
1774726|NCT00706654|6179096|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
1774727|NCT00706654|6179097|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
1774728|NCT00706654|6179098|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
1774729|NCT00706654|6179099|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
1774730|NCT00706654|6179096|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
1774731|NCT00706654|6179097|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
1774732|NCT00706654|6179098|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
1774733|NCT00706654|6179099|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
1774734|NCT00706654|6179096|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
1774735|NCT00706654|6179097|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
1774736|NCT00706654|6179098|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
1774737|NCT00706654|6179099|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
1774738|NCT00706654|6179096|P4|Depot Maintenance Phase|Protocol Deviation|1
1774739|NCT00706654|6179097|P3|Depot Maintenance Phase|Protocol Deviation|3
1774740|NCT00706654|6179098|P2|Depot Maintenance Phase|Protocol Deviation|2
1774741|NCT00706654|6179099|P1|Depot Maintenance Phase|Protocol Deviation|0
1774742|NCT00706654|6179096|P4|Depot Maintenance Phase|Withdrew Consent|14
1774743|NCT00706654|6179097|P3|Depot Maintenance Phase|Withdrew Consent|29
1774744|NCT00706654|6179098|P2|Depot Maintenance Phase|Withdrew Consent|21
1774745|NCT00706654|6179099|P1|Depot Maintenance Phase|Withdrew Consent|0
1774746|NCT00706654|6179096|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
1774747|NCT00706654|6179097|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
1774748|NCT00706654|6179098|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
1774749|NCT00706654|6179099|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
1774750|NCT00706654|6179096|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
1774751|NCT00706654|6179097|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
1774752|NCT00706654|6179098|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
1774753|NCT00706654|6179099|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
1774754|NCT00706654|6179096|P4|Depot Maintenance Phase|Lost to Follow-up|6
1774755|NCT00706654|6179097|P3|Depot Maintenance Phase|Lost to Follow-up|10
1774756|NCT00706654|6179098|P2|Depot Maintenance Phase|Lost to Follow-up|4
1774757|NCT00706654|6179099|P1|Depot Maintenance Phase|Lost to Follow-up|0
1774758|NCT00706654|6179096|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1774759|NCT00706654|6179097|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1774760|NCT00706654|6179098|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1774761|NCT00706654|6179099|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
1774762|NCT00706654|6179096|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1774763|NCT00706654|6179097|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1774764|NCT00706654|6179098|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1774765|NCT00706654|6179099|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
1774766|NCT00706654|6179096|P4|Oral Stabilization Phase|Adverse Event|0
1774767|NCT00706654|6179097|P3|Oral Stabilization Phase|Adverse Event|0
1774768|NCT00706654|6179098|P2|Oral Stabilization Phase|Adverse Event|0
1774769|NCT00706654|6179099|P1|Oral Stabilization Phase|Adverse Event|21
1774770|NCT00706654|6179096|P4|Oral Stabilization Phase|Protocol Deviation|0
1774771|NCT00706654|6179097|P3|Oral Stabilization Phase|Protocol Deviation|0
1774772|NCT00706654|6179098|P2|Oral Stabilization Phase|Protocol Deviation|0
1774773|NCT00706654|6179099|P1|Oral Stabilization Phase|Protocol Deviation|2
1774774|NCT00706654|6179096|P4|Oral Stabilization Phase|Withdrew consent|0
1774775|NCT00706654|6179097|P3|Oral Stabilization Phase|Withdrew consent|0
1774776|NCT00706654|6179098|P2|Oral Stabilization Phase|Withdrew consent|0
1774777|NCT00706654|6179099|P1|Oral Stabilization Phase|Withdrew consent|55
1774778|NCT00706654|6179096|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
1774779|NCT00706654|6179097|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
1774780|NCT00706654|6179098|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
1774781|NCT00706654|6179099|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
1774782|NCT00706654|6179096|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
1774783|NCT00706654|6179097|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
1774784|NCT00706654|6179098|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
1774785|NCT00706654|6179099|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
1774786|NCT00706654|6179096|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1774787|NCT00706654|6179097|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1774788|NCT00706654|6179098|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
1774789|NCT00706654|6179099|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
1774790|NCT00706654|6179096|P4|Oral Stabilization Phase|Lost to Follow-up|0
1774791|NCT00706654|6179097|P3|Oral Stabilization Phase|Lost to Follow-up|0
1774792|NCT00706654|6179098|P2|Oral Stabilization Phase|Lost to Follow-up|0
1774793|NCT00706654|6179099|P1|Oral Stabilization Phase|Lost to Follow-up|17
1774794|NCT00706654|6179096|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
1774795|NCT00706654|6179097|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
1774796|NCT00706654|6179098|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
1774797|NCT00706654|6179099|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
1774798|NCT00706654|6179096|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
1774799|NCT00706654|6179097|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
1774800|NCT00706654|6179098|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
1774801|NCT00706654|6179099|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
1774802|NCT00706654|6179096|P4|Conversion Phase|Adverse Event|0
1774803|NCT00706654|6179097|P3|Conversion Phase|Adverse Event|0
1774804|NCT00706654|6179098|P2|Conversion Phase|Adverse Event|0
1774805|NCT00706654|6179099|P1|Conversion Phase|Adverse Event|18
1774806|NCT00706654|6179096|P4|Conversion Phase|Withdrew Consent|0
1774807|NCT00706654|6179097|P3|Conversion Phase|Withdrew Consent|0
1774808|NCT00706654|6179098|P2|Conversion Phase|Withdrew Consent|0
1774809|NCT00706654|6179099|P1|Conversion Phase|Withdrew Consent|38
1774810|NCT00706654|6179096|P4|Conversion Phase|Withdrawn by Investigator|0
1774811|NCT00706654|6179097|P3|Conversion Phase|Withdrawn by Investigator|0
1774812|NCT00706654|6179098|P2|Conversion Phase|Withdrawn by Investigator|0
1774813|NCT00706654|6179099|P1|Conversion Phase|Withdrawn by Investigator|14
1774814|NCT00706654|6179096|P4|Conversion Phase|Met Withdrawal Criteria|0
1774815|NCT00706654|6179097|P3|Conversion Phase|Met Withdrawal Criteria|0
1774816|NCT00706654|6179098|P2|Conversion Phase|Met Withdrawal Criteria|0
1774817|NCT00706654|6179099|P1|Conversion Phase|Met Withdrawal Criteria|2
1774818|NCT00706654|6179096|P4|Conversion Phase|Sponsor Discontinued Trial|0
1774819|NCT00706654|6179097|P3|Conversion Phase|Sponsor Discontinued Trial|0
1774820|NCT00706654|6179098|P2|Conversion Phase|Sponsor Discontinued Trial|0
1774821|NCT00706654|6179099|P1|Conversion Phase|Sponsor Discontinued Trial|8
1774822|NCT00706654|6179096|P4|Conversion Phase|Lost to Follow-up|0
1774823|NCT00706654|6179097|P3|Conversion Phase|Lost to Follow-up|0
1774824|NCT00706654|6179098|P2|Conversion Phase|Lost to Follow-up|0
1774825|NCT00706654|6179099|P1|Conversion Phase|Lost to Follow-up|4
1774826|NCT00706641|6179118|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
1774827|NCT00706641|6179118|P1|Dasatinib Administration|Ineligible after start of therapy|1
1774828|NCT00706641|6179118|P1|Dasatinib Administration|Withdrawal by Subject|1
1774829|NCT00706628|6179132|P4|Overall Study|Not treated|0
1774830|NCT00706628|6179133|P3|Overall Study|Not treated|0
1774831|NCT00706628|6179134|P2|Overall Study|Not treated|1
1774832|NCT00706628|6179135|P1|Overall Study|Not treated|1
1774833|NCT00706628|6179132|P4|Overall Study|Other than those stated above|0
1774834|NCT00706628|6179133|P3|Overall Study|Other than those stated above|0
1774835|NCT00706628|6179134|P2|Overall Study|Other than those stated above|0
1774836|NCT00706628|6179135|P1|Overall Study|Other than those stated above|4
1774837|NCT00706628|6179132|P4|Overall Study|Progressive disease|1
1774838|NCT00706628|6179133|P3|Overall Study|Progressive disease|8
1774839|NCT00706628|6179134|P2|Overall Study|Progressive disease|13
1774840|NCT00706628|6179135|P1|Overall Study|Progressive disease|20
1774841|NCT00706628|6179132|P4|Overall Study|Consent withdrawn|0
1774842|NCT00706628|6179133|P3|Overall Study|Consent withdrawn|3
1774843|NCT00706628|6179134|P2|Overall Study|Consent withdrawn|1
1774844|NCT00706628|6179135|P1|Overall Study|Consent withdrawn|6
1774845|NCT00706628|6179132|P4|Overall Study|Non compliant with protocol|0
1774846|NCT00706628|6179133|P3|Overall Study|Non compliant with protocol|0
1774847|NCT00706628|6179134|P2|Overall Study|Non compliant with protocol|1
1774848|NCT00706628|6179135|P1|Overall Study|Non compliant with protocol|0
1774849|NCT00706628|6179132|P4|Overall Study|Other Adverse Event|2
1774850|NCT00706628|6179133|P3|Overall Study|Other Adverse Event|5
1774851|NCT00706628|6179134|P2|Overall Study|Other Adverse Event|5
1774852|NCT00706628|6179135|P1|Overall Study|Other Adverse Event|16
1774853|NCT00706433|6179295|P4|Overall Study|new job|1
1774854|NCT00706433|6179296|P3|Overall Study|new job|0
1774855|NCT00706433|6179297|P2|Overall Study|new job|0
1774856|NCT00706433|6179298|P1|Overall Study|new job|0
1774857|NCT00706433|6179295|P4|Overall Study|Protocol Violation|0
1774858|NCT00706433|6179296|P3|Overall Study|Protocol Violation|0
1774859|NCT00706433|6179297|P2|Overall Study|Protocol Violation|0
1774860|NCT00706433|6179298|P1|Overall Study|Protocol Violation|1
1774861|NCT00706433|6179295|P4|Overall Study|Adverse Event|0
1774862|NCT00706433|6179296|P3|Overall Study|Adverse Event|1
1774863|NCT00706433|6179297|P2|Overall Study|Adverse Event|0
1774864|NCT00706433|6179298|P1|Overall Study|Adverse Event|0
1774865|NCT00706433|6179295|P4|Overall Study|Withdrawal by Subject|1
1774866|NCT00706433|6179296|P3|Overall Study|Withdrawal by Subject|3
1774867|NCT00706433|6179297|P2|Overall Study|Withdrawal by Subject|2
1774868|NCT00706433|6179298|P1|Overall Study|Withdrawal by Subject|1
1774869|NCT00706433|6179295|P4|Overall Study|Lost to Follow-up|0
1774870|NCT00706433|6179296|P3|Overall Study|Lost to Follow-up|6
1774871|NCT00706433|6179297|P2|Overall Study|Lost to Follow-up|1
1774872|NCT00706433|6179298|P1|Overall Study|Lost to Follow-up|3
1774873|NCT00706355|6179625|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
1774874|NCT00706355|6179626|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1774875|NCT00706355|6179627|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1774876|NCT00706355|6179628|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
1774877|NCT00706355|6179625|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
1774878|NCT00706355|6179626|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
1774879|NCT00706355|6179627|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
1774880|NCT00706355|6179628|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
1774881|NCT00706355|6179625|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1774882|NCT00706355|6179626|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
1774883|NCT00706355|6179627|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1774884|NCT00706355|6179628|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
1774885|NCT00706355|6179625|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
1774886|NCT00706355|6179626|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
1774887|NCT00706355|6179627|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
1774888|NCT00706355|6179628|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
1774889|NCT00706355|6179625|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1774890|NCT00706355|6179626|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1774891|NCT00706355|6179627|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
1774892|NCT00706355|6179628|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
1774893|NCT00706355|6179625|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1774894|NCT00706355|6179626|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1774895|NCT00706355|6179627|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
1774896|NCT00706355|6179628|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
1774897|NCT00706355|6179625|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1774898|NCT00706355|6179626|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1774899|NCT00706355|6179627|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
1774900|NCT00706355|6179628|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
1774901|NCT00706355|6179625|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1774902|NCT00706355|6179626|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1774903|NCT00706355|6179627|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
1774904|NCT00706355|6179628|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
1774905|NCT00706355|6179625|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1774906|NCT00706355|6179626|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1774907|NCT00706355|6179627|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
1774908|NCT00706355|6179628|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
1774909|NCT00706342|6179680|P1|Overall Study|WIthdrawal of consent|1
1774910|NCT00706342|6179680|P1|Overall Study|Ongoing|6
1774911|NCT00706342|6179680|P1|Overall Study|Non-responder Week 12|1
1774912|NCT00706342|6179680|P1|Overall Study|Investigator discretion|2
1774913|NCT00706342|6179680|P1|Overall Study|Withdrew from the study on his own.|1
1774914|NCT00706342|6179680|P1|Overall Study|Death|1
1774915|NCT00706342|6179680|P1|Overall Study|Withdrawn due to failure to respond|1
1774916|NCT00706342|6179680|P1|Overall Study|Not responding to treatment|2
1774917|NCT00706342|6179680|P1|Overall Study|Adverse Event|3
1774918|NCT00706238|6179693|P1|Overall Study|Other|1
1774919|NCT00706238|6179693|P1|Overall Study|Disease progression|4
1774920|NCT00706134|6179710|P4|Overall Study|Did not meet study criteria|0
1774921|NCT00706134|6179711|P3|Overall Study|Did not meet study criteria|0
1774922|NCT00706134|6179712|P2|Overall Study|Did not meet study criteria|0
1774923|NCT00706134|6179713|P1|Overall Study|Did not meet study criteria|2
1774924|NCT00706134|6179710|P4|Overall Study|Unsatisfactory therapeutic effect|5
1774925|NCT00706134|6179711|P3|Overall Study|Unsatisfactory therapeutic effect|3
1774926|NCT00706134|6179712|P2|Overall Study|Unsatisfactory therapeutic effect|3
1774927|NCT00706134|6179713|P1|Overall Study|Unsatisfactory therapeutic effect|9
1774928|NCT00706134|6179710|P4|Overall Study|Withdrawal by Subject|0
1774929|NCT00706134|6179711|P3|Overall Study|Withdrawal by Subject|1
1774930|NCT00706134|6179712|P2|Overall Study|Withdrawal by Subject|2
1774931|NCT00706134|6179713|P1|Overall Study|Withdrawal by Subject|1
1774932|NCT00706134|6179710|P4|Overall Study|Protocol Violation|3
1774933|NCT00706134|6179711|P3|Overall Study|Protocol Violation|0
1774934|NCT00706134|6179712|P2|Overall Study|Protocol Violation|6
1774935|NCT00706134|6179713|P1|Overall Study|Protocol Violation|0
1774936|NCT00706134|6179710|P4|Overall Study|Lost to Follow-up|0
1774937|NCT00706134|6179711|P3|Overall Study|Lost to Follow-up|0
1774938|NCT00706134|6179712|P2|Overall Study|Lost to Follow-up|1
1774939|NCT00706134|6179713|P1|Overall Study|Lost to Follow-up|0
1774940|NCT00706134|6179710|P4|Overall Study|Adverse Event|3
1774941|NCT00706134|6179711|P3|Overall Study|Adverse Event|2
1774942|NCT00706134|6179712|P2|Overall Study|Adverse Event|7
1774943|NCT00706134|6179713|P1|Overall Study|Adverse Event|8
1774944|NCT00706095|6179779|P3|Overall Study|Withdrawal by Subject|0
1774945|NCT00706095|6179780|P2|Overall Study|Withdrawal by Subject|0
1774946|NCT00706095|6179781|P1|Overall Study|Withdrawal by Subject|1
1774947|NCT00706095|6179779|P3|Overall Study|Clinical Progression|2
1774948|NCT00706095|6179780|P2|Overall Study|Clinical Progression|2
1774949|NCT00706095|6179781|P1|Overall Study|Clinical Progression|1
1774950|NCT00706095|6179779|P3|Overall Study|Progressive Disease|3
1774951|NCT00706095|6179780|P2|Overall Study|Progressive Disease|5
1774952|NCT00706095|6179781|P1|Overall Study|Progressive Disease|4
1774953|NCT00706030|6179799|P4|Overall Study|Death|0
1774954|NCT00706030|6179800|P3|Overall Study|Death|1
1774955|NCT00706030|6179801|P2|Overall Study|Death|0
1774956|NCT00706030|6179802|P1|Overall Study|Death|0
1774957|NCT00706030|6179799|P4|Overall Study|No treatment received|1
1774958|NCT00706030|6179800|P3|Overall Study|No treatment received|0
1774959|NCT00706030|6179801|P2|Overall Study|No treatment received|0
1774960|NCT00706030|6179802|P1|Overall Study|No treatment received|0
1774961|NCT00706030|6179799|P4|Overall Study|Symptomatic Deterioration|0
1774962|NCT00706030|6179800|P3|Overall Study|Symptomatic Deterioration|1
1774963|NCT00706030|6179801|P2|Overall Study|Symptomatic Deterioration|0
1774964|NCT00706030|6179802|P1|Overall Study|Symptomatic Deterioration|0
1774965|NCT00706030|6179799|P4|Overall Study|Failed to return|0
1774966|NCT00706030|6179800|P3|Overall Study|Failed to return|1
1774967|NCT00706030|6179801|P2|Overall Study|Failed to return|0
1774968|NCT00706030|6179802|P1|Overall Study|Failed to return|0
1774969|NCT00706030|6179799|P4|Overall Study|Protocol Violation|1
1774970|NCT00706030|6179800|P3|Overall Study|Protocol Violation|1
1774971|NCT00706030|6179801|P2|Overall Study|Protocol Violation|0
1774972|NCT00706030|6179802|P1|Overall Study|Protocol Violation|0
1774973|NCT00706030|6179799|P4|Overall Study|Not recorded|0
1774974|NCT00706030|6179800|P3|Overall Study|Not recorded|2
1774975|NCT00706030|6179801|P2|Overall Study|Not recorded|0
1774976|NCT00706030|6179802|P1|Overall Study|Not recorded|0
1774977|NCT00706030|6179799|P4|Overall Study|Physician Decision|0
1774978|NCT00706030|6179800|P3|Overall Study|Physician Decision|2
1774979|NCT00706030|6179801|P2|Overall Study|Physician Decision|0
1774980|NCT00706030|6179802|P1|Overall Study|Physician Decision|0
1774981|NCT00706030|6179799|P4|Overall Study|Withdrawal by Subject|0
1774982|NCT00706030|6179800|P3|Overall Study|Withdrawal by Subject|2
1774983|NCT00706030|6179801|P2|Overall Study|Withdrawal by Subject|0
1774984|NCT00706030|6179802|P1|Overall Study|Withdrawal by Subject|1
1774985|NCT00706030|6179799|P4|Overall Study|Adverse Event|2
1774986|NCT00706030|6179800|P3|Overall Study|Adverse Event|4
1774987|NCT00706030|6179801|P2|Overall Study|Adverse Event|0
1774988|NCT00706030|6179802|P1|Overall Study|Adverse Event|1
1774989|NCT00706030|6179799|P4|Overall Study|Disease Progression|12
1774990|NCT00706030|6179800|P3|Overall Study|Disease Progression|46
1774991|NCT00706030|6179801|P2|Overall Study|Disease Progression|6
1774992|NCT00706030|6179802|P1|Overall Study|Disease Progression|4
1774993|NCT00706004|6179817|P1|Overall Study|Did not meet eligibility criteria|2
1774994|NCT00705939|6179845|P3|Overall Study|Physician Decision|0
1774995|NCT00705939|6179846|P2|Overall Study|Physician Decision|1
1774996|NCT00705939|6179847|P1|Overall Study|Physician Decision|0
1774997|NCT00705939|6179845|P3|Overall Study|Withdrawal by Subject|3
1774998|NCT00705939|6179846|P2|Overall Study|Withdrawal by Subject|1
1774999|NCT00705939|6179847|P1|Overall Study|Withdrawal by Subject|0
1775000|NCT00705939|6179845|P3|Overall Study|Protocol Violation|1
1775001|NCT00705939|6179846|P2|Overall Study|Protocol Violation|0
1775002|NCT00705939|6179847|P1|Overall Study|Protocol Violation|0
1775003|NCT00705783|6179901|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
1775004|NCT00705783|6179902|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
1775005|NCT00705783|6179903|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
1775006|NCT00705783|6179901|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
1775007|NCT00705783|6179902|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
1775008|NCT00705783|6179903|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
1775009|NCT00705783|6179901|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
1775010|NCT00705783|6179902|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
1775011|NCT00705783|6179903|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
1775012|NCT00705783|6179901|P3|Depot Maintenance Phase|Protocol Deviation|0
1775013|NCT00705783|6179902|P2|Depot Maintenance Phase|Protocol Deviation|2
1775014|NCT00705783|6179903|P1|Depot Maintenance Phase|Protocol Deviation|0
1775015|NCT00705783|6179901|P3|Depot Maintenance Phase|Withdrew Consent|4
1775016|NCT00705783|6179902|P2|Depot Maintenance Phase|Withdrew Consent|14
1775017|NCT00705783|6179903|P1|Depot Maintenance Phase|Withdrew Consent|0
1775018|NCT00705783|6179901|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
1775019|NCT00705783|6179902|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
1775020|NCT00705783|6179903|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
1775021|NCT00705783|6179901|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
1775022|NCT00705783|6179902|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
1775023|NCT00705783|6179903|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
1775024|NCT00705783|6179901|P3|Depot Maintenance Phase|Lost to Follow-up|3
1775025|NCT00705783|6179902|P2|Depot Maintenance Phase|Lost to Follow-up|5
1775026|NCT00705783|6179903|P1|Depot Maintenance Phase|Lost to Follow-up|0
1775027|NCT00705783|6179901|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
1775028|NCT00705783|6179902|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
1775029|NCT00705783|6179903|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
1775030|NCT00705783|6179901|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
1775031|NCT00705783|6179902|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
1775032|NCT00705783|6179903|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
1775033|NCT00705783|6179901|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
1775034|NCT00705783|6179902|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
1775035|NCT00705783|6179903|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
1775036|NCT00705783|6179901|P3|Depot Stabilization Phase|Adverse Event|0
1775037|NCT00705783|6179902|P2|Depot Stabilization Phase|Adverse Event|0
1775038|NCT00705783|6179903|P1|Depot Stabilization Phase|Adverse Event|17
1775039|NCT00705783|6179901|P3|Depot Stabilization Phase|Withdrew Consent|0
1775040|NCT00705783|6179902|P2|Depot Stabilization Phase|Withdrew Consent|0
1775041|NCT00705783|6179903|P1|Depot Stabilization Phase|Withdrew Consent|29
1775042|NCT00705783|6179901|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
1775043|NCT00705783|6179902|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
1775044|NCT00705783|6179903|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
1775045|NCT00705783|6179901|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
1775046|NCT00705783|6179902|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
1775047|NCT00705783|6179903|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
1775048|NCT00705783|6179901|P3|Depot Stabilization Phase|Lost to Follow-up|0
1775049|NCT00705783|6179902|P2|Depot Stabilization Phase|Lost to Follow-up|0
1775050|NCT00705783|6179903|P1|Depot Stabilization Phase|Lost to Follow-up|11
1775051|NCT00705783|6179901|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
1775052|NCT00705783|6179902|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
1775053|NCT00705783|6179903|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
1775054|NCT00705783|6179901|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1775055|NCT00705783|6179902|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
1775056|NCT00705783|6179903|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
1775057|NCT00705783|6179901|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1775058|NCT00705783|6179902|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
1775059|NCT00705783|6179903|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
1775060|NCT00705783|6179901|P3|Oral Stabilization Phase|Adverse Event|0
1775061|NCT00705783|6179902|P2|Oral Stabilization Phase|Adverse Event|0
1775062|NCT00705783|6179903|P1|Oral Stabilization Phase|Adverse Event|14
1775063|NCT00705783|6179901|P3|Oral Stabilization Phase|Withdrew Consent|0
1775064|NCT00705783|6179902|P2|Oral Stabilization Phase|Withdrew Consent|0
1775065|NCT00705783|6179903|P1|Oral Stabilization Phase|Withdrew Consent|29
1775066|NCT00705783|6179901|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
1775067|NCT00705783|6179902|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
1775068|NCT00705783|6179903|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
1775069|NCT00705783|6179901|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
1775070|NCT00705783|6179902|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
1775071|NCT00705783|6179903|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
1775072|NCT00705783|6179901|P3|Oral Stabilization Phase|Lost to Follow-up|0
1775073|NCT00705783|6179902|P2|Oral Stabilization Phase|Lost to Follow-up|0
1775074|NCT00705783|6179903|P1|Oral Stabilization Phase|Lost to Follow-up|7
1775075|NCT00705783|6179901|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
1775076|NCT00705783|6179902|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
1775165|NCT00705614|6180017|P2|Initial Intervention|Administrative Reason|38
1775077|NCT00705783|6179903|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
1775078|NCT00705783|6179901|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
1775079|NCT00705783|6179902|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
1775080|NCT00705783|6179903|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
1775081|NCT00705783|6179901|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
1775082|NCT00705783|6179902|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
1775083|NCT00705783|6179903|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
1775084|NCT00705783|6179901|P3|Conversion Phase|Adverse Event|0
1775085|NCT00705783|6179902|P2|Conversion Phase|Adverse Event|0
1775086|NCT00705783|6179903|P1|Conversion Phase|Adverse Event|11
1775087|NCT00705783|6179901|P3|Conversion Phase|Protocol Deviation|0
1775088|NCT00705783|6179902|P2|Conversion Phase|Protocol Deviation|0
1775089|NCT00705783|6179903|P1|Conversion Phase|Protocol Deviation|2
1775090|NCT00705783|6179901|P3|Conversion Phase|Withdrew Consent|0
1775091|NCT00705783|6179902|P2|Conversion Phase|Withdrew Consent|0
1775092|NCT00705783|6179903|P1|Conversion Phase|Withdrew Consent|24
1775093|NCT00705783|6179901|P3|Conversion Phase|Withdrawn by Investigator|0
1775094|NCT00705783|6179902|P2|Conversion Phase|Withdrawn by Investigator|0
1775095|NCT00705783|6179903|P1|Conversion Phase|Withdrawn by Investigator|4
1775096|NCT00705783|6179901|P3|Conversion Phase|Met Withdrawal Criteria|0
1775097|NCT00705783|6179902|P2|Conversion Phase|Met Withdrawal Criteria|0
1775098|NCT00705783|6179903|P1|Conversion Phase|Met Withdrawal Criteria|4
1775099|NCT00705783|6179901|P3|Conversion Phase|Lost to Follow-up|0
1775100|NCT00705783|6179902|P2|Conversion Phase|Lost to Follow-up|0
1775101|NCT00705783|6179903|P1|Conversion Phase|Lost to Follow-up|13
1775102|NCT00705783|6179901|P3|Conversion Phase|Sponsor Discontinued Study|0
1775103|NCT00705783|6179902|P2|Conversion Phase|Sponsor Discontinued Study|0
1775104|NCT00705783|6179903|P1|Conversion Phase|Sponsor Discontinued Study|54
1775105|NCT00705757|6179933|P3|Overall Study|Withdrawal by Subject|2
1775106|NCT00705757|6179934|P2|Overall Study|Withdrawal by Subject|1
1775107|NCT00705757|6179935|P1|Overall Study|Withdrawal by Subject|1
1775108|NCT00705757|6179933|P3|Overall Study|Lost to Follow-up|6
1775109|NCT00705757|6179934|P2|Overall Study|Lost to Follow-up|6
1775110|NCT00705757|6179935|P1|Overall Study|Lost to Follow-up|7
1775111|NCT00705757|6179933|P3|Overall Study|Lack of Efficacy|3
1775112|NCT00705757|6179934|P2|Overall Study|Lack of Efficacy|1
1775113|NCT00705757|6179935|P1|Overall Study|Lack of Efficacy|5
1775114|NCT00705718|6179945|P2|Overall Study|Follow up not done|4
1775115|NCT00705718|6179946|P1|Overall Study|Follow up not done|1
1775116|NCT00705718|6179945|P2|Overall Study|Not due for Visit|12
1775117|NCT00705718|6179946|P1|Overall Study|Not due for Visit|0
1775118|NCT00705718|6179945|P2|Overall Study|Death|6
1775119|NCT00705718|6179946|P1|Overall Study|Death|6
1775120|NCT00705679|6179967|P5|Overall Study|Withdrawal by Subject|33
1775121|NCT00705679|6179968|P4|Overall Study|Withdrawal by Subject|47
1775122|NCT00705679|6179969|P3|Overall Study|Withdrawal by Subject|68
1775123|NCT00705679|6179970|P2|Overall Study|Withdrawal by Subject|77
1775124|NCT00705679|6179971|P1|Overall Study|Withdrawal by Subject|32
1775125|NCT00705679|6179967|P5|Overall Study|Physician Decision|0
1775126|NCT00705679|6179968|P4|Overall Study|Physician Decision|1
1775127|NCT00705679|6179969|P3|Overall Study|Physician Decision|0
1775128|NCT00705679|6179970|P2|Overall Study|Physician Decision|1
1775129|NCT00705679|6179971|P1|Overall Study|Physician Decision|0
1775130|NCT00705679|6179967|P5|Overall Study|Lost to Follow-up|35
1775131|NCT00705679|6179968|P4|Overall Study|Lost to Follow-up|30
1775132|NCT00705679|6179969|P3|Overall Study|Lost to Follow-up|44
1775133|NCT00705679|6179970|P2|Overall Study|Lost to Follow-up|60
1775134|NCT00705679|6179971|P1|Overall Study|Lost to Follow-up|32
1775135|NCT00705679|6179967|P5|Overall Study|Death|1
1775136|NCT00705679|6179968|P4|Overall Study|Death|2
1775137|NCT00705679|6179969|P3|Overall Study|Death|3
1775138|NCT00705679|6179970|P2|Overall Study|Death|0
1775139|NCT00705679|6179971|P1|Overall Study|Death|0
1775140|NCT00705679|6179967|P5|Overall Study|Adverse Event|0
1775141|NCT00705679|6179968|P4|Overall Study|Adverse Event|0
1775142|NCT00705679|6179969|P3|Overall Study|Adverse Event|0
1775143|NCT00705679|6179970|P2|Overall Study|Adverse Event|1
1775144|NCT00705679|6179971|P1|Overall Study|Adverse Event|1
1775145|NCT00705666|6180006|P1|Overall Study|Untreated|5
1775146|NCT00705666|6180006|P1|Overall Study|Lack of data|3
1775147|NCT00705666|6180006|P1|Overall Study|Other|2
1775148|NCT00705666|6180006|P1|Overall Study|Other|12
1775149|NCT00705666|6180006|P1|Overall Study|Adverse Event|4
1775150|NCT00705666|6180006|P1|Overall Study|Death|1
1775151|NCT00705666|6180006|P1|Overall Study|Lost to Follow-up|5
1775152|NCT00705666|6180006|P1|Overall Study|Physician Decision|7
1775153|NCT00705666|6180006|P1|Overall Study|Withdrawal by Subject|21
1775154|NCT00705666|6180006|P1|Overall Study|No post-treatment questionnaire|279
1775155|NCT00705614|6180017|P2|Switch to Remicade|Administrative Reason|9
1775156|NCT00705614|6180018|P1|Switch to Remicade|Administrative Reason|0
1775157|NCT00705614|6180017|P2|Switch to Remicade|Withdrawal by Subject|12
1775158|NCT00705614|6180018|P1|Switch to Remicade|Withdrawal by Subject|0
1775159|NCT00705614|6180017|P2|Switch to Remicade|Lost to Follow-up|23
1775160|NCT00705614|6180018|P1|Switch to Remicade|Lost to Follow-up|0
1775161|NCT00705614|6180017|P2|Switch to Remicade|Adverse Event|5
1775162|NCT00705614|6180018|P1|Switch to Remicade|Adverse Event|0
1775163|NCT00705614|6180017|P2|Initial Intervention|Status completion unknown|0
1775164|NCT00705614|6180018|P1|Initial Intervention|Status completion unknown|3
1775166|NCT00705614|6180018|P1|Initial Intervention|Administrative Reason|51
1775167|NCT00705614|6180017|P2|Initial Intervention|Withdrawal by Subject|71
1775168|NCT00705614|6180018|P1|Initial Intervention|Withdrawal by Subject|114
1775169|NCT00705614|6180017|P2|Initial Intervention|Lost to Follow-up|191
1775170|NCT00705614|6180018|P1|Initial Intervention|Lost to Follow-up|310
1775171|NCT00705614|6180017|P2|Initial Intervention|Adverse Event|21
1775172|NCT00705614|6180018|P1|Initial Intervention|Adverse Event|40
1775173|NCT00705575|6180067|P2|Overall Study|Withdrawal by Subject|10
1775174|NCT00705575|6180068|P1|Overall Study|Withdrawal by Subject|5
1775175|NCT00705575|6180067|P2|Overall Study|Protocol Violation|2
1775176|NCT00705575|6180068|P1|Overall Study|Protocol Violation|2
1775177|NCT00705575|6180067|P2|Overall Study|Lost to Follow-up|4
1775178|NCT00705575|6180068|P1|Overall Study|Lost to Follow-up|3
1775179|NCT00705575|6180067|P2|Overall Study|Adverse Event|15
1775180|NCT00705575|6180068|P1|Overall Study|Adverse Event|11
1775181|NCT00705575|6180067|P2|Overall Study|Abnormal test procedure result(s)|12
1775182|NCT00705575|6180068|P1|Overall Study|Abnormal test procedure result(s)|2
1775183|NCT00705575|6180067|P2|Overall Study|Abnormal laboratory value(s)|3
1775184|NCT00705575|6180068|P1|Overall Study|Abnormal laboratory value(s)|0
1775185|NCT00705536|6180082|P4|Start Period 1|Withdrawal by Subject|1
1775186|NCT00705536|6180083|P3|Start Period 1|Withdrawal by Subject|0
1775187|NCT00705536|6180084|P2|Start Period 1|Withdrawal by Subject|0
1775188|NCT00705536|6180085|P1|Start Period 1|Withdrawal by Subject|0
1775189|NCT00705523|6180146|P2|Overall Study|Lost to Follow-up|3
1775190|NCT00705523|6180147|P1|Overall Study|Lost to Follow-up|2
1775191|NCT00705484|6180157|P2|Overall Study|Administrative|59
1775192|NCT00705484|6180158|P1|Overall Study|Administrative|89
1775193|NCT00705484|6180157|P2|Overall Study|Withdrawal by Subject|72
1775194|NCT00705484|6180158|P1|Overall Study|Withdrawal by Subject|96
1775195|NCT00705484|6180157|P2|Overall Study|Lost to Follow-up|250
1775196|NCT00705484|6180158|P1|Overall Study|Lost to Follow-up|169
1775197|NCT00705484|6180157|P2|Overall Study|Adverse Event|27
1775198|NCT00705484|6180158|P1|Overall Study|Adverse Event|28
1775199|NCT00705432|6180172|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
1775200|NCT00705432|6180173|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
1775201|NCT00705432|6180174|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
1775202|NCT00705432|6180175|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
1775203|NCT00705432|6180176|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
1775204|NCT00705432|6180177|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
1775205|NCT00705432|6180172|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
1775206|NCT00705432|6180173|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
1775207|NCT00705432|6180174|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
1775208|NCT00705432|6180175|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
1775209|NCT00705432|6180176|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
1775210|NCT00705432|6180177|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
1775211|NCT00705432|6180172|P6|Treatment Period|Non medical reason|7
1775212|NCT00705432|6180173|P5|Treatment Period|Non medical reason|7
1775213|NCT00705432|6180174|P4|Treatment Period|Non medical reason|4
1775214|NCT00705432|6180175|P3|Treatment Period|Non medical reason|37
1775215|NCT00705432|6180176|P2|Treatment Period|Non medical reason|32
1775216|NCT00705432|6180177|P1|Treatment Period|Non medical reason|26
1775217|NCT00705432|6180172|P6|Treatment Period|Treatment failure|14
1775218|NCT00705432|6180173|P5|Treatment Period|Treatment failure|13
1775219|NCT00705432|6180174|P4|Treatment Period|Treatment failure|25
1775220|NCT00705432|6180175|P3|Treatment Period|Treatment failure|33
1775221|NCT00705432|6180176|P2|Treatment Period|Treatment failure|42
1775222|NCT00705432|6180177|P1|Treatment Period|Treatment failure|92
1775223|NCT00705432|6180172|P6|Treatment Period|Adverse Event|9
1775224|NCT00705432|6180173|P5|Treatment Period|Adverse Event|8
1775225|NCT00705432|6180174|P4|Treatment Period|Adverse Event|12
1775226|NCT00705432|6180175|P3|Treatment Period|Adverse Event|51
1775227|NCT00705432|6180176|P2|Treatment Period|Adverse Event|37
1775228|NCT00705432|6180177|P1|Treatment Period|Adverse Event|45
1775229|NCT00705406|6180214|P2|Overall Study|Did not receive study drug|2
1775230|NCT00705406|6180215|P1|Overall Study|Did not receive study drug|1
1775231|NCT00705406|6180214|P2|Overall Study|Lost to Follow-up|3
1775232|NCT00705406|6180215|P1|Overall Study|Lost to Follow-up|3
1775233|NCT00705367|6180239|P2|Long-term Extension Period|Administrative reason by sponsor|0
1775234|NCT00705367|6180240|P1|Long-term Extension Period|Administrative reason by sponsor|3
1775235|NCT00705367|6180239|P2|Long-term Extension Period|No longer met study criteria|0
1775236|NCT00705367|6180240|P1|Long-term Extension Period|No longer met study criteria|1
1775237|NCT00705367|6180239|P2|Long-term Extension Period|Lack of Efficacy|0
1775238|NCT00705367|6180240|P1|Long-term Extension Period|Lack of Efficacy|1
1775239|NCT00705367|6180239|P2|Long-term Extension Period|Withdrawal by Subject|0
1775240|NCT00705367|6180240|P1|Long-term Extension Period|Withdrawal by Subject|2
1775241|NCT00705367|6180239|P2|Long-term Extension Period|Adverse Event|0
1775242|NCT00705367|6180240|P1|Long-term Extension Period|Adverse Event|2
1775243|NCT00705341|6180267|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
1775244|NCT00705341|6180268|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
1775245|NCT00705341|6180269|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
1775246|NCT00705341|6180270|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
1775247|NCT00705341|6180267|P4|Phase 2: Trial|Withdrawal by Subject|4
1775248|NCT00705341|6180268|P3|Phase 2: Trial|Withdrawal by Subject|6
1775249|NCT00705341|6180269|P2|Phase 2: Trial|Withdrawal by Subject|0
1775250|NCT00705341|6180270|P1|Phase 2: Trial|Withdrawal by Subject|0
1775251|NCT00705289|6180278|P1|Overall Study|Subject or treating physician's choice|131
1775252|NCT00705263|6180302|P1|Overall Study|Withdrawal by Subject|2
1775253|NCT00705250|6180306|P1|Overall Study|Patient died in car accident|1
1775254|NCT00705250|6180306|P1|Overall Study|Withdrawal by Subject|1
1775255|NCT00705224|6180310|P1|Overall Study|Lost to Follow-up|5
1775256|NCT00705224|6180310|P1|Overall Study|Withdrawal by Subject|3
1775257|NCT00705224|6180310|P1|Overall Study|Lack of Efficacy|2
1775258|NCT00705224|6180310|P1|Overall Study|Adverse Event|1
1775259|NCT00705159|6180326|P4|Overall Study|Screen Failure|1
1775260|NCT00705159|6180327|P3|Overall Study|Screen Failure|0
1775261|NCT00705159|6180328|P2|Overall Study|Screen Failure|0
1775262|NCT00705159|6180329|P1|Overall Study|Screen Failure|0
1775263|NCT00705159|6180326|P4|Overall Study|Lost to Follow-up|2
1775264|NCT00705159|6180327|P3|Overall Study|Lost to Follow-up|3
1775265|NCT00705159|6180328|P2|Overall Study|Lost to Follow-up|0
1775266|NCT00705159|6180329|P1|Overall Study|Lost to Follow-up|0
1775267|NCT00705159|6180326|P4|Overall Study|Adverse Event|0
1775268|NCT00705159|6180327|P3|Overall Study|Adverse Event|1
1775269|NCT00705159|6180328|P2|Overall Study|Adverse Event|0
1775270|NCT00705159|6180329|P1|Overall Study|Adverse Event|0
1775271|NCT00705159|6180326|P4|Overall Study|Protocol Violation|0
1775272|NCT00705159|6180327|P3|Overall Study|Protocol Violation|0
1775273|NCT00705159|6180328|P2|Overall Study|Protocol Violation|1
1775274|NCT00705159|6180329|P1|Overall Study|Protocol Violation|0
1775275|NCT00705159|6180326|P4|Overall Study|Withdrawal by Subject|1
1775276|NCT00705159|6180327|P3|Overall Study|Withdrawal by Subject|1
1775277|NCT00705159|6180328|P2|Overall Study|Withdrawal by Subject|1
1775278|NCT00705159|6180329|P1|Overall Study|Withdrawal by Subject|0
1775279|NCT00705146|6180349|P2|Overall Study|Lost to Follow-up|1
1775280|NCT00705146|6180350|P1|Overall Study|Lost to Follow-up|1
1775281|NCT00705016|6180379|P3|Overall Study|Other|6
1775282|NCT00705016|6180380|P2|Overall Study|Other|6
1775283|NCT00705016|6180381|P1|Overall Study|Other|9
1775284|NCT00705016|6180379|P3|Overall Study|Symptomatic Deterioration|1
1775285|NCT00705016|6180380|P2|Overall Study|Symptomatic Deterioration|1
1775286|NCT00705016|6180381|P1|Overall Study|Symptomatic Deterioration|3
1775287|NCT00705016|6180379|P3|Overall Study|Progressive Disease|33
1775288|NCT00705016|6180380|P2|Overall Study|Progressive Disease|29
1775289|NCT00705016|6180381|P1|Overall Study|Progressive Disease|33
1775290|NCT00705016|6180379|P3|Overall Study|Withdrawal by Subject|2
1775291|NCT00705016|6180380|P2|Overall Study|Withdrawal by Subject|3
1775292|NCT00705016|6180381|P1|Overall Study|Withdrawal by Subject|4
1775293|NCT00705016|6180379|P3|Overall Study|Protocol Violation|1
1775294|NCT00705016|6180380|P2|Overall Study|Protocol Violation|1
1775295|NCT00705016|6180381|P1|Overall Study|Protocol Violation|0
1775296|NCT00705016|6180379|P3|Overall Study|Death|5
1775297|NCT00705016|6180380|P2|Overall Study|Death|7
1775298|NCT00705016|6180381|P1|Overall Study|Death|5
1775299|NCT00705016|6180379|P3|Overall Study|Adverse Event|10
1775300|NCT00705016|6180380|P2|Overall Study|Adverse Event|11
1775301|NCT00705016|6180381|P1|Overall Study|Adverse Event|6
1775302|NCT00704964|6180432|P1|Overall Study|Not completed on time|328
1775303|NCT00704808|6180493|P1|Overall Study|Treatment change|1
1775304|NCT00704808|6180493|P1|Overall Study|Lost to Follow-up|1
1775305|NCT00704808|6180493|P1|Overall Study|Adverse Event|1
1775306|NCT00704808|6180493|P1|Overall Study|Early therapy discontinuation|16
1775307|NCT00704808|6180493|P1|Overall Study|Patient's decision|11
1775308|NCT00704808|6180493|P1|Overall Study|Tumor progression|80
1775309|NCT00704808|6180493|P1|Overall Study|Death|7
1775310|NCT00704808|6180493|P1|Overall Study|Discontinued prior to starting treatment|14
1775311|NCT00704730|6180504|P2|Overall Study|Withdrawal by Subject|13
1775312|NCT00704730|6180505|P1|Overall Study|Withdrawal by Subject|9
1775313|NCT00704730|6180504|P2|Overall Study|data unavailable|0
1775314|NCT00704730|6180505|P1|Overall Study|data unavailable|1
1775315|NCT00704730|6180504|P2|Overall Study|Disease progression per PI|67
1775316|NCT00704730|6180505|P1|Overall Study|Disease progression per PI|58
1775317|NCT00704730|6180504|P2|Overall Study|Did not receive drug|2
1775318|NCT00704730|6180505|P1|Overall Study|Did not receive drug|5
1775319|NCT00704730|6180504|P2|Overall Study|Physician Decision|0
1775320|NCT00704730|6180505|P1|Overall Study|Physician Decision|2
1775321|NCT00704730|6180504|P2|Overall Study|Death|5
1775322|NCT00704730|6180505|P1|Overall Study|Death|11
1775323|NCT00704730|6180504|P2|Overall Study|Adverse Event|9
1775324|NCT00704730|6180505|P1|Overall Study|Adverse Event|35
1775325|NCT00704535|6180525|P1|Overall Study|Completed status not on Case Report Form|124
1775326|NCT00704535|6180525|P1|Overall Study|Protocol Violation|10
1775327|NCT00704535|6180525|P1|Overall Study|Lost to Follow-up|8
1775328|NCT00704535|6180525|P1|Overall Study|Death|2
1775329|NCT00704535|6180525|P1|Overall Study|Adverse Event|2
1775330|NCT00704522|6180538|P2|Overall Study|No information on therapy end|2
1775331|NCT00704522|6180539|P1|Overall Study|No information on therapy end|27
1775332|NCT00704522|6180538|P2|Overall Study|Undefined causes|7
1775333|NCT00704522|6180539|P1|Overall Study|Undefined causes|9
1775334|NCT00704522|6180538|P2|Overall Study|Adverse Event|1
1775335|NCT00704522|6180539|P1|Overall Study|Adverse Event|9
1775336|NCT00704522|6180538|P2|Overall Study|Withdrawal by Subject|8
1775337|NCT00704522|6180539|P1|Overall Study|Withdrawal by Subject|17
1775338|NCT00704522|6180538|P2|Overall Study|Failure to appear again at hospital|10
1775339|NCT00704522|6180539|P1|Overall Study|Failure to appear again at hospital|56
1775340|NCT00704522|6180538|P2|Overall Study|Lack of Efficacy|17
1775341|NCT00704522|6180539|P1|Overall Study|Lack of Efficacy|65
1775342|NCT00704418|6180559|P2|Overall Study|Over-enrolled/surgery postponed|6
1775343|NCT00704418|6180560|P1|Overall Study|Over-enrolled/surgery postponed|3
1775344|NCT00704418|6180559|P2|Overall Study|Withdrawal by Subject|0
1775345|NCT00704418|6180560|P1|Overall Study|Withdrawal by Subject|2
1775346|NCT00704405|6180573|P5|Overall Study (C Population)|Lost to Follow-up|0
1775347|NCT00704405|6180574|P4|Overall Study (C Population)|Lost to Follow-up|0
1775348|NCT00704405|6180575|P3|Overall Study (C Population)|Lost to Follow-up|0
1775349|NCT00704405|6180576|P2|Overall Study (C Population)|Lost to Follow-up|2
1775350|NCT00704405|6180577|P1|Overall Study (C Population)|Lost to Follow-up|0
1775351|NCT00704405|6180573|P5|Overall Study (C Population)|Withdrawal by Subject|0
1775352|NCT00704405|6180574|P4|Overall Study (C Population)|Withdrawal by Subject|1
1775353|NCT00704405|6180575|P3|Overall Study (C Population)|Withdrawal by Subject|1
1775354|NCT00704405|6180576|P2|Overall Study (C Population)|Withdrawal by Subject|1
1775355|NCT00704405|6180577|P1|Overall Study (C Population)|Withdrawal by Subject|1
1775356|NCT00704405|6180573|P5|Overall Study (NC Population)|Other|1
1775357|NCT00704405|6180574|P4|Overall Study (NC Population)|Other|0
1775358|NCT00704405|6180575|P3|Overall Study (NC Population)|Other|0
1775359|NCT00704405|6180576|P2|Overall Study (NC Population)|Other|0
1775360|NCT00704405|6180577|P1|Overall Study (NC Population)|Other|0
1775361|NCT00704405|6180573|P5|Overall Study (NC Population)|Withdrawal by Subject|2
1775362|NCT00704405|6180574|P4|Overall Study (NC Population)|Withdrawal by Subject|2
1775363|NCT00704405|6180575|P3|Overall Study (NC Population)|Withdrawal by Subject|2
1775364|NCT00704405|6180576|P2|Overall Study (NC Population)|Withdrawal by Subject|3
1775365|NCT00704405|6180577|P1|Overall Study (NC Population)|Withdrawal by Subject|2
1775366|NCT00704405|6180573|P5|Overall Study (NC Population)|Lost to Follow-up|2
1775367|NCT00704405|6180574|P4|Overall Study (NC Population)|Lost to Follow-up|2
1775368|NCT00704405|6180575|P3|Overall Study (NC Population)|Lost to Follow-up|1
1775369|NCT00704405|6180576|P2|Overall Study (NC Population)|Lost to Follow-up|1
1775370|NCT00704405|6180577|P1|Overall Study (NC Population)|Lost to Follow-up|2
1775371|NCT00704405|6180573|P5|Overall Study (NC Population)|Adverse Event|0
1775372|NCT00704405|6180574|P4|Overall Study (NC Population)|Adverse Event|0
1775373|NCT00704405|6180575|P3|Overall Study (NC Population)|Adverse Event|0
1775374|NCT00704405|6180576|P2|Overall Study (NC Population)|Adverse Event|0
1775375|NCT00704405|6180577|P1|Overall Study (NC Population)|Adverse Event|1
1775376|NCT00704340|6180635|P2|Overall Study|Death|1
1775377|NCT00704340|6180636|P1|Overall Study|Death|0
1775378|NCT00704340|6180635|P2|Overall Study|Lost to Follow-up|1
1775379|NCT00704340|6180636|P1|Overall Study|Lost to Follow-up|2
1775380|NCT00704184|6180651|P5|Open-Label Treatment|Withdrawal by Subject|0
1775381|NCT00704184|6180652|P4|Open-Label Treatment|Withdrawal by Subject|3
1775382|NCT00704184|6180653|P3|Open-Label Treatment|Withdrawal by Subject|0
1775383|NCT00704184|6180654|P2|Open-Label Treatment|Withdrawal by Subject|0
1775384|NCT00704184|6180655|P1|Open-Label Treatment|Withdrawal by Subject|1
1775385|NCT00704184|6180651|P5|Open-Label Treatment|Physician Decision|1
1775386|NCT00704184|6180652|P4|Open-Label Treatment|Physician Decision|0
1775387|NCT00704184|6180653|P3|Open-Label Treatment|Physician Decision|0
1775388|NCT00704184|6180654|P2|Open-Label Treatment|Physician Decision|0
1775389|NCT00704184|6180655|P1|Open-Label Treatment|Physician Decision|0
1775390|NCT00704184|6180651|P5|Open-Label Treatment|Lack of Efficacy|1
1775391|NCT00704184|6180652|P4|Open-Label Treatment|Lack of Efficacy|2
1775392|NCT00704184|6180653|P3|Open-Label Treatment|Lack of Efficacy|2
1775393|NCT00704184|6180654|P2|Open-Label Treatment|Lack of Efficacy|2
1775394|NCT00704184|6180655|P1|Open-Label Treatment|Lack of Efficacy|0
1775395|NCT00704184|6180651|P5|Open-Label Treatment|Adverse Event|1
1775396|NCT00704184|6180652|P4|Open-Label Treatment|Adverse Event|0
1775397|NCT00704184|6180653|P3|Open-Label Treatment|Adverse Event|2
1775398|NCT00704184|6180654|P2|Open-Label Treatment|Adverse Event|0
1775399|NCT00704184|6180655|P1|Open-Label Treatment|Adverse Event|0
1775400|NCT00704184|6180651|P5|Double-Blind Treatment|Withdrawal by Subject|0
1775401|NCT00704184|6180652|P4|Double-Blind Treatment|Withdrawal by Subject|0
1775402|NCT00704184|6180653|P3|Double-Blind Treatment|Withdrawal by Subject|0
1775403|NCT00704184|6180654|P2|Double-Blind Treatment|Withdrawal by Subject|0
1775404|NCT00704184|6180655|P1|Double-Blind Treatment|Withdrawal by Subject|1
1775405|NCT00704171|6180694|P2|Overall Study|Withdrawal by Subject|0
1775406|NCT00704171|6180695|P1|Overall Study|Withdrawal by Subject|1
1775407|NCT00704132|6180713|P2|Overall Study|Withdrawal by Subject|1
1775408|NCT00704132|6180714|P1|Overall Study|Withdrawal by Subject|0
1775409|NCT00704132|6180713|P2|Overall Study|Lack of Efficacy|1
1775410|NCT00704132|6180714|P1|Overall Study|Lack of Efficacy|0
1775411|NCT00704132|6180713|P2|Overall Study|Clinical Adverse Experience|0
1775412|NCT00704132|6180714|P1|Overall Study|Clinical Adverse Experience|1
1775413|NCT00703963|6180742|P2|Overall Study|Physician Decision|1
1775414|NCT00703963|6180743|P1|Overall Study|Physician Decision|0
1775415|NCT00703963|6180742|P2|Overall Study|Withdrawal by Subject|13
1775416|NCT00703963|6180743|P1|Overall Study|Withdrawal by Subject|7
1775417|NCT00703924|6180764|P2|Overall Study|Withdrawal by Subject|1
1775418|NCT00703924|6180765|P1|Overall Study|Withdrawal by Subject|1
1775419|NCT00703911|6180781|P1|Overall Study|Withdrawal by Subject|2
1775420|NCT00703911|6180781|P1|Overall Study|Lost to Follow-up|1
1775421|NCT00703911|6180781|P1|Overall Study|Physician Decision|6
1775422|NCT00703911|6180781|P1|Overall Study|Death|1
1775423|NCT00703846|6180814|P1|Overall Study|Did Not Receive Study Drug|2
1775424|NCT00703846|6180814|P1|Overall Study|Other|14
1775425|NCT00703846|6180814|P1|Overall Study|Death|1
1775426|NCT00703846|6180814|P1|Overall Study|Withdrawal by Subject|40
1775427|NCT00703846|6180814|P1|Overall Study|Noncompliance with Study Treatment|2
1775428|NCT00703846|6180814|P1|Overall Study|Lack of Efficacy|15
1775429|NCT00703846|6180814|P1|Overall Study|Lost to Follow-up|55
1775430|NCT00703846|6180814|P1|Overall Study|Adverse Event|8
1775431|NCT00703820|6180830|P2|Overall Study|Withdrawal by Subject|1
1775432|NCT00703820|6180831|P1|Overall Study|Withdrawal by Subject|2
1775433|NCT00703820|6180830|P2|Overall Study|Physician Decision|5
1775434|NCT00703820|6180831|P1|Overall Study|Physician Decision|4
1775435|NCT00703820|6180830|P2|Overall Study|Received non-protocol therapy|0
1775436|NCT00703820|6180831|P1|Overall Study|Received non-protocol therapy|1
1775437|NCT00703820|6180830|P2|Overall Study|Lack of Efficacy|11
1775438|NCT00703820|6180831|P1|Overall Study|Lack of Efficacy|11
1775439|NCT00703820|6180830|P2|Overall Study|Death|0
1775440|NCT00703820|6180831|P1|Overall Study|Death|5
1775441|NCT00703820|6180830|P2|Overall Study|Adverse Event|17
1775442|NCT00703820|6180831|P1|Overall Study|Adverse Event|12
1775443|NCT00703781|6180840|P2|Overall Study|Cancelled surgery|0
1775444|NCT00703781|6180841|P1|Overall Study|Cancelled surgery|1
1775445|NCT00703781|6180840|P2|Overall Study|Withdrawal by Subject|2
1775446|NCT00703781|6180841|P1|Overall Study|Withdrawal by Subject|1
1775447|NCT00703677|6180886|P1|Overall Study|Dropout-withdrawal not related to drug|3
1775448|NCT00703534|6180926|P2|Overall Study|Severe Non Compliance|5
1775449|NCT00703534|6180927|P1|Overall Study|Severe Non Compliance|1
1775450|NCT00703534|6180926|P2|Overall Study|Lost to Follow-up|4
1775451|NCT00703534|6180927|P1|Overall Study|Lost to Follow-up|1
1775452|NCT00703534|6180926|P2|Overall Study|Incorrect Enrollment|6
1775453|NCT00703534|6180927|P1|Overall Study|Incorrect Enrollment|6
1775454|NCT00703534|6180926|P2|Overall Study|Withdrawal by Subject|7
1775455|NCT00703534|6180927|P1|Overall Study|Withdrawal by Subject|8
1775456|NCT00703534|6180926|P2|Overall Study|Adverse Event|3
1775457|NCT00703534|6180927|P1|Overall Study|Adverse Event|14
1775458|NCT00703326|6180999|P2|Overall Study|Withdrawal by Subject|20
1775459|NCT00703326|6181000|P1|Overall Study|Withdrawal by Subject|42
1775460|NCT00703326|6180999|P2|Overall Study|Lost to Follow-up|8
1775461|NCT00703326|6181000|P1|Overall Study|Lost to Follow-up|25
1775462|NCT00703326|6180999|P2|Overall Study|Still on study|197
1775463|NCT00703326|6181000|P1|Overall Study|Still on study|380
1775464|NCT00703157|6181032|P2|Overall Study|source data permanently lost/ other|1
1775465|NCT00703157|6181033|P1|Overall Study|source data permanently lost/ other|4
1775466|NCT00703157|6181032|P2|Overall Study|Lost to Follow-up|1
1775467|NCT00703157|6181033|P1|Overall Study|Lost to Follow-up|0
1775468|NCT00703118|6181067|P3|Overall Study|Other|1
1775469|NCT00703118|6181068|P2|Overall Study|Other|0
1775470|NCT00703118|6181069|P1|Overall Study|Other|0
1775471|NCT00703118|6181067|P3|Overall Study|Withdrawal by Subject|13
1775472|NCT00703118|6181068|P2|Overall Study|Withdrawal by Subject|7
1775473|NCT00703118|6181069|P1|Overall Study|Withdrawal by Subject|8
1775474|NCT00703118|6181067|P3|Overall Study|Lost to Follow-up|4
1775475|NCT00703118|6181068|P2|Overall Study|Lost to Follow-up|4
1775476|NCT00703118|6181069|P1|Overall Study|Lost to Follow-up|6
1775477|NCT00703118|6181067|P3|Overall Study|Subject Ineligible To Continue The Trial|2
1775478|NCT00703118|6181068|P2|Overall Study|Subject Ineligible To Continue The Trial|3
1775479|NCT00703118|6181069|P1|Overall Study|Subject Ineligible To Continue The Trial|6
1775480|NCT00703118|6181067|P3|Overall Study|Adverse Event|2
1775481|NCT00703118|6181068|P2|Overall Study|Adverse Event|2
1775482|NCT00703118|6181069|P1|Overall Study|Adverse Event|1
1775483|NCT00703092|6181100|P1|Overall Study|Withdrawal by Subject|2
1775484|NCT00703014|6181308|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
1775485|NCT00703014|6181309|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
1775486|NCT00703014|6181310|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1775487|NCT00703014|6181311|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
1775488|NCT00703014|6181308|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1775489|NCT00703014|6181309|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
1775490|NCT00703014|6181310|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
1775491|NCT00703014|6181311|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
1775492|NCT00702962|6181331|P2|Overall Study|Hospitalized for other health disorder|0
1775493|NCT00702962|6181332|P1|Overall Study|Hospitalized for other health disorder|1
1775494|NCT00702962|6181331|P2|Overall Study|Progressive disease|1
1775495|NCT00702962|6181332|P1|Overall Study|Progressive disease|0
1775496|NCT00702949|6181343|P3|Overall Study|Other Medical Reason/unknown|3
1775497|NCT00702949|6181344|P2|Overall Study|Other Medical Reason/unknown|1
1775498|NCT00702949|6181345|P1|Overall Study|Other Medical Reason/unknown|1
1775499|NCT00702949|6181343|P3|Overall Study|Adverse Event|3
1775500|NCT00702949|6181344|P2|Overall Study|Adverse Event|6
1775501|NCT00702949|6181345|P1|Overall Study|Adverse Event|1
1775502|NCT00702949|6181343|P3|Overall Study|Refusal|2
1775503|NCT00702949|6181344|P2|Overall Study|Refusal|2
1775504|NCT00702949|6181345|P1|Overall Study|Refusal|3
1775505|NCT00702923|6181370|P1|Overall Study|Adverse Event|1
1775506|NCT00702845|6181393|P2|Overall Study|Not randomized|1
1775507|NCT00702845|6181394|P1|Overall Study|Not randomized|0
1775508|NCT00702845|6181393|P2|Overall Study|Patient's decision|1
1775509|NCT00702845|6181394|P1|Overall Study|Patient's decision|2
1775510|NCT00702845|6181393|P2|Overall Study|No or abnormal fertilization|2
1775511|NCT00702845|6181394|P1|Overall Study|No or abnormal fertilization|4
1775512|NCT00702845|6181393|P2|Overall Study|No/too few/bad quality embryos retrieved|1
1775513|NCT00702845|6181394|P1|Overall Study|No/too few/bad quality embryos retrieved|7
1775514|NCT00702845|6181393|P2|Overall Study|Insufficient ovarian response|0
1775515|NCT00702845|6181394|P1|Overall Study|Insufficient ovarian response|1
1775516|NCT00702845|6181393|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
1775517|NCT00702845|6181394|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
1775518|NCT00702845|6181393|P2|Overall Study|Too high ovarian response|1
1775519|NCT00702845|6181394|P1|Overall Study|Too high ovarian response|5
1775520|NCT00702845|6181393|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
1775521|NCT00702845|6181394|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
1775522|NCT00702715|6181456|P2|Overall Study|Lost to Follow-up|0
1775523|NCT00702715|6181457|P1|Overall Study|Lost to Follow-up|1
1775524|NCT00702702|6181470|P1|Overall Study|Study prematurely terminated|56
1775525|NCT00702689|6181478|P1|Overall Study|Adverse Event|1
1775526|NCT00702689|6181478|P1|Overall Study|Recurrent malignancy|1
1775527|NCT00702689|6181478|P1|Overall Study|Withdrawal by Subject|4
1775528|NCT00702650|6181489|P1|Overall Study|Adverse Event|3
1775529|NCT00702650|6181489|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
1775530|NCT00702650|6181489|P1|Overall Study|Sponsor Request|1
1775531|NCT00702650|6181489|P1|Overall Study|Non-Compliance with Site Directives|1
1775532|NCT00702650|6181489|P1|Overall Study|Lost to Follow-up|2
1775533|NCT00702650|6181489|P1|Overall Study|Non-Compliance of Study Drug|3
1775534|NCT00702650|6181489|P1|Overall Study|Withdrawal by Subject|9
1775535|NCT00702520|6181551|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1775536|NCT00702520|6181552|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
1775537|NCT00702520|6181553|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
1775538|NCT00702520|6181554|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
1775539|NCT00702520|6181551|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1775540|NCT00702520|6181552|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
1775541|NCT00702520|6181553|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
1775542|NCT00702520|6181554|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
1775543|NCT00702520|6181551|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1775544|NCT00702520|6181552|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1775545|NCT00702520|6181553|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
1775546|NCT00702520|6181554|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
1775547|NCT00702507|6181570|P1|Follow-up Phase|Late Enrollment|1
1775548|NCT00702507|6181570|P1|Follow-up Phase|Lost to Follow-up|23
1775549|NCT00702507|6181570|P1|Follow-up Phase|Protocol Violation|2
1775550|NCT00702507|6181570|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
1775551|NCT00702507|6181570|P1|Initial Treatment Phase|Negative Candida Culture|34
1775552|NCT00702507|6181570|P1|Initial Treatment Phase|Lost to Follow-up|2
1775553|NCT00702507|6181570|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
1775554|NCT00702507|6181570|P1|Initial Treatment Phase|Adverse Event|2
1775555|NCT00702403|6181607|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
1775556|NCT00702403|6181607|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
1775557|NCT00702403|6181607|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
1775558|NCT00702403|6181607|P1|From Engraftment to Study Completion|Suicide|1
1775559|NCT00702403|6181607|P1|From Engraftment to Study Completion|Liver GVHD|1
1775560|NCT00702403|6181607|P1|From Engraftment to Study Completion|Adenocarcinoma|1
1775561|NCT00702403|6181607|P1|From Engraftment to Study Completion|Non-compliance|2
1775562|NCT00702403|6181607|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
1775563|NCT00702403|6181607|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
1775564|NCT00702403|6181607|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
1775565|NCT00702403|6181607|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
1775566|NCT00702403|6181607|P1|From Consent to Engraftment|Myocardial infarction|1
1775567|NCT00702403|6181607|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
1775568|NCT00702403|6181607|P1|From Consent to Engraftment|Critically ill|2
1775569|NCT00702403|6181607|P1|From Consent to Engraftment|Progressive leukemia|6
1775570|NCT00702325|6181661|P2|Overall Study|Incorrectly Discontinued|1
1775571|NCT00702325|6181662|P1|Overall Study|Incorrectly Discontinued|0
1775572|NCT00702325|6181661|P2|Overall Study|Withdrew consent|1
1775573|NCT00702325|6181662|P1|Overall Study|Withdrew consent|0
1775574|NCT00702325|6181661|P2|Overall Study|Didn't follow study medication dosage|2
1775575|NCT00702325|6181662|P1|Overall Study|Didn't follow study medication dosage|0
1775576|NCT00702325|6181661|P2|Overall Study|Termination due to lab results|0
1775577|NCT00702325|6181662|P1|Overall Study|Termination due to lab results|1
1775578|NCT00702325|6181661|P2|Overall Study|Severe noncompliance to protocol|3
1775579|NCT00702325|6181662|P1|Overall Study|Severe noncompliance to protocol|3
1775580|NCT00702325|6181661|P2|Overall Study|Developed study discontinuation criteria|28
1775581|NCT00702325|6181662|P1|Overall Study|Developed study discontinuation criteria|18
1775582|NCT00702325|6181661|P2|Overall Study|Incorrect enrollment|7
1775583|NCT00702325|6181662|P1|Overall Study|Incorrect enrollment|5
1775584|NCT00702325|6181661|P2|Overall Study|Lost to Follow-up|4
1775585|NCT00702325|6181662|P1|Overall Study|Lost to Follow-up|3
1775586|NCT00702325|6181661|P2|Overall Study|Withdrawal by Subject|7
1775587|NCT00702325|6181662|P1|Overall Study|Withdrawal by Subject|7
1775588|NCT00702325|6181661|P2|Overall Study|Adverse Event|0
1775589|NCT00702325|6181662|P1|Overall Study|Adverse Event|1
1775590|NCT00702221|6181758|P2|Overall Study|Adverse Event|3
1775591|NCT00702221|6181759|P1|Overall Study|Adverse Event|4
1775592|NCT00702208|6181765|P1|Overall Study|Unsatisfactory colposcopy|2
1775593|NCT00702208|6181765|P1|Overall Study|Did not self-lavage|1
1775594|NCT00702208|6181765|P1|Overall Study|Lost to Follow-up|28
1775595|NCT00702143|6181774|P3|Overall Study|Lost to Follow-up|1
1775596|NCT00702143|6181775|P2|Overall Study|Lost to Follow-up|0
1775597|NCT00702143|6181776|P1|Overall Study|Lost to Follow-up|0
1775598|NCT00701805|6181825|P4|Overall Study|Resumption criteria were not met|0
1775599|NCT00701805|6181826|P3|Overall Study|Resumption criteria were not met|0
1775600|NCT00701805|6181827|P2|Overall Study|Resumption criteria were not met|1
1775601|NCT00701805|6181828|P1|Overall Study|Resumption criteria were not met|0
1775602|NCT00701805|6181825|P4|Overall Study|Difficult to travel to dialysis site|0
1775603|NCT00701805|6181826|P3|Overall Study|Difficult to travel to dialysis site|1
1775604|NCT00701805|6181827|P2|Overall Study|Difficult to travel to dialysis site|0
1775605|NCT00701805|6181828|P1|Overall Study|Difficult to travel to dialysis site|0
1775606|NCT00701805|6181825|P4|Overall Study|Physician decision, change of therapy|1
1775607|NCT00701805|6181826|P3|Overall Study|Physician decision, change of therapy|0
1775608|NCT00701805|6181827|P2|Overall Study|Physician decision, change of therapy|0
1775609|NCT00701805|6181828|P1|Overall Study|Physician decision, change of therapy|0
1775610|NCT00701805|6181825|P4|Overall Study|Admitted to hospital for 2 weeks|0
1775611|NCT00701805|6181826|P3|Overall Study|Admitted to hospital for 2 weeks|1
1775612|NCT00701805|6181827|P2|Overall Study|Admitted to hospital for 2 weeks|0
1775613|NCT00701805|6181828|P1|Overall Study|Admitted to hospital for 2 weeks|0
1775614|NCT00701805|6181825|P4|Overall Study|Missed 7 consecutive doses|0
1775615|NCT00701805|6181826|P3|Overall Study|Missed 7 consecutive doses|0
1775616|NCT00701805|6181827|P2|Overall Study|Missed 7 consecutive doses|1
1775617|NCT00701805|6181828|P1|Overall Study|Missed 7 consecutive doses|0
1775618|NCT00701805|6181825|P4|Overall Study|Adverse Event|0
1775619|NCT00701805|6181826|P3|Overall Study|Adverse Event|1
1775620|NCT00701805|6181827|P2|Overall Study|Adverse Event|1
1775621|NCT00701805|6181828|P1|Overall Study|Adverse Event|0
1775622|NCT00701805|6181825|P4|Overall Study|Withdrawal by Subject|3
1775623|NCT00701805|6181826|P3|Overall Study|Withdrawal by Subject|4
1775624|NCT00701805|6181827|P2|Overall Study|Withdrawal by Subject|1
1775625|NCT00701805|6181828|P1|Overall Study|Withdrawal by Subject|3
1775626|NCT00701779|6181878|P1|Overall Study|Withdrawal by Subject|2
1775627|NCT00701779|6181878|P1|Overall Study|Lost to Follow-up|1
1775628|NCT00701779|6181878|P1|Overall Study|Adverse Event|6
1775629|NCT00701727|6181890|P2|Second Treatment Period|Withdrawal by Subject|0
1775630|NCT00701727|6181891|P1|Second Treatment Period|Withdrawal by Subject|2
1775631|NCT00701727|6181890|P2|First Treatment Period|Lost to Follow-up|1
1775632|NCT00701727|6181891|P1|First Treatment Period|Lost to Follow-up|0
1775633|NCT00701727|6181890|P2|First Treatment Period|sponsor decision|1
1775634|NCT00701727|6181891|P1|First Treatment Period|sponsor decision|0
1775635|NCT00701727|6181890|P2|First Treatment Period|Withdrawal by Subject|0
1775636|NCT00701727|6181891|P1|First Treatment Period|Withdrawal by Subject|1
1775637|NCT00701727|6181890|P2|First Treatment Period|Adverse Event|0
1775638|NCT00701727|6181891|P1|First Treatment Period|Adverse Event|0
1775639|NCT00701662|6181937|P1|Overall Study|Lack of Efficacy|1
1775640|NCT00701558|6181962|P1|Overall Study|Lost to Follow-up|8
1775641|NCT00701558|6181962|P1|Overall Study|Death|7
1775642|NCT00701441|6181970|P2|Overall Study|failure in cpap compliance|4
1775643|NCT00701441|6181971|P1|Overall Study|failure in cpap compliance|0
1775644|NCT00701415|6181983|P2|Overall Study|Social/family issues and needle phobia|0
1775645|NCT00701415|6181984|P1|Overall Study|Social/family issues and needle phobia|1
1775646|NCT00701415|6181983|P2|Overall Study|Adverse Event|1
1775647|NCT00701415|6181984|P1|Overall Study|Adverse Event|0
1775648|NCT00701363|6182019|P4|Treatment Phase 2|Withdrawal by Subject|0
1775649|NCT00701363|6182020|P3|Treatment Phase 2|Withdrawal by Subject|1
1775650|NCT00701363|6182021|P2|Treatment Phase 2|Withdrawal by Subject|0
1775651|NCT00701363|6182022|P1|Treatment Phase 2|Withdrawal by Subject|0
1775652|NCT00701363|6182019|P4|Treatment Phase 2|Adverse Event|0
1775653|NCT00701363|6182020|P3|Treatment Phase 2|Adverse Event|1
1775654|NCT00701363|6182021|P2|Treatment Phase 2|Adverse Event|0
1775655|NCT00701363|6182022|P1|Treatment Phase 2|Adverse Event|0
1775656|NCT00701363|6182019|P4|Treatment Phase 1|Lack of Efficacy|0
1775657|NCT00701363|6182020|P3|Treatment Phase 1|Lack of Efficacy|0
1775658|NCT00701363|6182021|P2|Treatment Phase 1|Lack of Efficacy|0
1775659|NCT00701363|6182022|P1|Treatment Phase 1|Lack of Efficacy|1
1775660|NCT00701363|6182019|P4|Treatment Phase 1|Withdrawal by Subject|0
1775661|NCT00701363|6182020|P3|Treatment Phase 1|Withdrawal by Subject|0
1775662|NCT00701363|6182021|P2|Treatment Phase 1|Withdrawal by Subject|0
1775663|NCT00701363|6182022|P1|Treatment Phase 1|Withdrawal by Subject|5
1775664|NCT00701363|6182019|P4|Treatment Phase 1|Protocol Violation|0
1775665|NCT00701363|6182020|P3|Treatment Phase 1|Protocol Violation|0
1775666|NCT00701363|6182021|P2|Treatment Phase 1|Protocol Violation|0
1775667|NCT00701363|6182022|P1|Treatment Phase 1|Protocol Violation|1
1775668|NCT00701363|6182019|P4|Treatment Phase 1|Adverse Event|0
1775669|NCT00701363|6182020|P3|Treatment Phase 1|Adverse Event|0
1775670|NCT00701363|6182021|P2|Treatment Phase 1|Adverse Event|0
1775671|NCT00701363|6182022|P1|Treatment Phase 1|Adverse Event|7
1775672|NCT00701363|6182019|P4|Treatment Phase 1|Does not meet entry Criteria|0
1775673|NCT00701363|6182020|P3|Treatment Phase 1|Does not meet entry Criteria|0
1775674|NCT00701363|6182021|P2|Treatment Phase 1|Does not meet entry Criteria|0
1775675|NCT00701363|6182022|P1|Treatment Phase 1|Does not meet entry Criteria|1
1775676|NCT00701363|6182019|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1775677|NCT00701363|6182020|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1775678|NCT00701363|6182021|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
1775679|NCT00701363|6182022|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
1775680|NCT00701311|6182062|P1|Overall Study|Withdrawal by Subject|2
1775681|NCT00701311|6182062|P1|Overall Study|Adverse Event|3
1775682|NCT00701311|6182062|P1|Overall Study|Lack of Efficacy|3
1775683|NCT00701129|6182066|P1|Overall Study|Death|2
1775684|NCT00701103|6182088|P11|Overall Study|Other|0
1775685|NCT00701103|6182089|P10|Overall Study|Other|1
1775686|NCT00701103|6182090|P9|Overall Study|Other|1
1775687|NCT00701103|6182091|P8|Overall Study|Other|0
1775688|NCT00701103|6182092|P7|Overall Study|Other|0
1775689|NCT00701103|6182093|P6|Overall Study|Other|0
1775690|NCT00701103|6182094|P5|Overall Study|Other|0
1775691|NCT00701103|6182095|P4|Overall Study|Other|0
1775692|NCT00701103|6182096|P3|Overall Study|Other|0
1775693|NCT00701103|6182097|P2|Overall Study|Other|0
1775694|NCT00701103|6182098|P1|Overall Study|Other|0
1775695|NCT00701103|6182088|P11|Overall Study|Withdrawal by Subject|0
1775696|NCT00701103|6182089|P10|Overall Study|Withdrawal by Subject|0
1775697|NCT00701103|6182090|P9|Overall Study|Withdrawal by Subject|0
1775698|NCT00701103|6182091|P8|Overall Study|Withdrawal by Subject|0
1775699|NCT00701103|6182092|P7|Overall Study|Withdrawal by Subject|0
1775700|NCT00701103|6182093|P6|Overall Study|Withdrawal by Subject|0
1775701|NCT00701103|6182094|P5|Overall Study|Withdrawal by Subject|0
1775702|NCT00701103|6182095|P4|Overall Study|Withdrawal by Subject|0
1775703|NCT00701103|6182096|P3|Overall Study|Withdrawal by Subject|1
1775704|NCT00701103|6182097|P2|Overall Study|Withdrawal by Subject|1
1775705|NCT00701103|6182098|P1|Overall Study|Withdrawal by Subject|0
1775706|NCT00701103|6182088|P11|Overall Study|Progressive Disease|11
1775707|NCT00701103|6182089|P10|Overall Study|Progressive Disease|8
1775708|NCT00701103|6182090|P9|Overall Study|Progressive Disease|8
1775709|NCT00701103|6182091|P8|Overall Study|Progressive Disease|7
1775710|NCT00701103|6182092|P7|Overall Study|Progressive Disease|7
1775711|NCT00701103|6182093|P6|Overall Study|Progressive Disease|5
1775712|NCT00701103|6182094|P5|Overall Study|Progressive Disease|6
1775713|NCT00701103|6182095|P4|Overall Study|Progressive Disease|5
1775714|NCT00701103|6182096|P3|Overall Study|Progressive Disease|6
1775715|NCT00701103|6182097|P2|Overall Study|Progressive Disease|2
1775716|NCT00701103|6182098|P1|Overall Study|Progressive Disease|5
1775717|NCT00701103|6182088|P11|Overall Study|Adverse Event|0
1775718|NCT00701103|6182089|P10|Overall Study|Adverse Event|2
1775719|NCT00701103|6182090|P9|Overall Study|Adverse Event|0
1775720|NCT00701103|6182091|P8|Overall Study|Adverse Event|0
1775721|NCT00701103|6182092|P7|Overall Study|Adverse Event|1
1775722|NCT00701103|6182093|P6|Overall Study|Adverse Event|1
1775723|NCT00701103|6182094|P5|Overall Study|Adverse Event|0
1775724|NCT00701103|6182095|P4|Overall Study|Adverse Event|1
1775725|NCT00701103|6182096|P3|Overall Study|Adverse Event|1
1775726|NCT00701103|6182097|P2|Overall Study|Adverse Event|0
1775727|NCT00701103|6182098|P1|Overall Study|Adverse Event|0
1775728|NCT00701090|6182204|P2|Overall Study|Other|12
1775729|NCT00701090|6182205|P1|Overall Study|Other|7
1775730|NCT00701090|6182204|P2|Overall Study|Withdrawal by Subject|16
1775731|NCT00701090|6182205|P1|Overall Study|Withdrawal by Subject|11
1775732|NCT00701090|6182204|P2|Overall Study|Protocol Violation|3
1775733|NCT00701090|6182205|P1|Overall Study|Protocol Violation|2
1775734|NCT00701090|6182204|P2|Overall Study|Physician Decision|4
1775735|NCT00701090|6182205|P1|Overall Study|Physician Decision|3
1775736|NCT00701090|6182204|P2|Overall Study|Lost to Follow-up|9
1775737|NCT00701090|6182205|P1|Overall Study|Lost to Follow-up|9
1775738|NCT00701090|6182204|P2|Overall Study|Lack of Efficacy|4
1775739|NCT00701090|6182205|P1|Overall Study|Lack of Efficacy|5
1775740|NCT00701090|6182204|P2|Overall Study|Death|1
1775741|NCT00701090|6182205|P1|Overall Study|Death|0
1775742|NCT00701090|6182204|P2|Overall Study|Adverse Event|2
1775743|NCT00701090|6182205|P1|Overall Study|Adverse Event|11
1775744|NCT00701064|6182223|P2|Overall Study|initiated other PTSD treatment|2
1775745|NCT00701064|6182224|P1|Overall Study|initiated other PTSD treatment|2
1775746|NCT00701064|6182223|P2|Overall Study|Withdrawal by Subject|1
1775747|NCT00701064|6182224|P1|Overall Study|Withdrawal by Subject|1
1775748|NCT00701064|6182223|P2|Overall Study|Protocol Violation|1
1775749|NCT00701064|6182224|P1|Overall Study|Protocol Violation|1
1775750|NCT00701051|6182236|P3|Exercise Intervention|time conflict; non-study related illness|3
1775751|NCT00701051|6182237|P2|Exercise Intervention|time conflict; non-study related illness|5
1775752|NCT00701051|6182238|P1|Exercise Intervention|time conflict; non-study related illness|0
1775753|NCT00701051|6182236|P3|Screening|Time conflicts|0
1775754|NCT00701051|6182237|P2|Screening|Time conflicts|0
1775755|NCT00701051|6182238|P1|Screening|Time conflicts|19
1775756|NCT00701051|6182236|P3|Screening|Failed Screening|0
1775757|NCT00701051|6182237|P2|Screening|Failed Screening|0
1775758|NCT00701051|6182238|P1|Screening|Failed Screening|40
1775759|NCT00701038|6182256|P2|Overall Study|study amended pilot group of patients|4
1775760|NCT00701038|6182257|P1|Overall Study|study amended pilot group of patients|4
1775761|NCT00700999|6182265|P2|Overall Study|Withdrawal by Subject|1
1775762|NCT00700999|6182266|P1|Overall Study|Withdrawal by Subject|8
1775763|NCT00700999|6182265|P2|Overall Study|Excluded - did not meet study criteria|1
1775764|NCT00700999|6182266|P1|Overall Study|Excluded - did not meet study criteria|0
1775765|NCT00700999|6182265|P2|Overall Study|Lost to Follow-up|7
1775766|NCT00700999|6182266|P1|Overall Study|Lost to Follow-up|7
1775770|NCT00700817|6182290|P5|Week 52-78 (Extension Period 2)|Unclassified|1
1775771|NCT00700817|6182291|P4|Week 52-78 (Extension Period 2)|Unclassified|0
1775772|NCT00700817|6182292|P3|Week 52-78 (Extension Period 2)|Unclassified|0
1775773|NCT00700817|6182293|P2|Week 52-78 (Extension Period 2)|Unclassified|4
1775774|NCT00700817|6182294|P1|Week 52-78 (Extension Period 2)|Unclassified|2
1775775|NCT00700817|6182290|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
1775776|NCT00700817|6182291|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
1775777|NCT00700817|6182292|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
1775778|NCT00700817|6182293|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
1775779|NCT00700817|6182294|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
1775780|NCT00700817|6182290|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1775781|NCT00700817|6182291|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1775782|NCT00700817|6182292|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
1775783|NCT00700817|6182293|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
1775784|NCT00700817|6182294|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
1775785|NCT00700817|6182290|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
1775786|NCT00700817|6182291|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
1775787|NCT00700817|6182292|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
1775788|NCT00700817|6182293|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
1775789|NCT00700817|6182294|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
1775790|NCT00700817|6182290|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
1775791|NCT00700817|6182291|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
1775792|NCT00700817|6182292|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
1775793|NCT00700817|6182293|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
1775794|NCT00700817|6182294|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
1775795|NCT00700817|6182290|P5|Week 26-52 (Extension Period 1)|Unclassified|0
1775796|NCT00700817|6182291|P4|Week 26-52 (Extension Period 1)|Unclassified|0
1775797|NCT00700817|6182292|P3|Week 26-52 (Extension Period 1)|Unclassified|1
1775798|NCT00700817|6182293|P2|Week 26-52 (Extension Period 1)|Unclassified|3
1775799|NCT00700817|6182294|P1|Week 26-52 (Extension Period 1)|Unclassified|4
1775800|NCT00700817|6182290|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
1775801|NCT00700817|6182291|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
1775802|NCT00700817|6182292|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
1775803|NCT00700817|6182293|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
1775804|NCT00700817|6182294|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
1775805|NCT00700817|6182290|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
1775806|NCT00700817|6182291|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
1775807|NCT00700817|6182292|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
1775808|NCT00700817|6182293|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
1775809|NCT00700817|6182294|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
1775810|NCT00700817|6182290|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
1775811|NCT00700817|6182291|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
1775812|NCT00700817|6182292|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
1775813|NCT00700817|6182293|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
1775814|NCT00700817|6182294|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
1775815|NCT00700817|6182290|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
1775816|NCT00700817|6182291|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
1775817|NCT00700817|6182292|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
1775818|NCT00700817|6182293|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
1775819|NCT00700817|6182294|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
1775820|NCT00700817|6182290|P5|Week 0-26 (Main Period)|Unclassified|0
1775821|NCT00700817|6182291|P4|Week 0-26 (Main Period)|Unclassified|0
1775822|NCT00700817|6182292|P3|Week 0-26 (Main Period)|Unclassified|8
1775823|NCT00700817|6182293|P2|Week 0-26 (Main Period)|Unclassified|4
1775824|NCT00700817|6182294|P1|Week 0-26 (Main Period)|Unclassified|14
1775825|NCT00700817|6182290|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
1775826|NCT00700817|6182291|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
1775827|NCT00700817|6182292|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
1775828|NCT00700817|6182293|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
1775829|NCT00700817|6182294|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
1775830|NCT00700817|6182290|P5|Week 0-26 (Main Period)|Protocol Violation|0
1775831|NCT00700817|6182291|P4|Week 0-26 (Main Period)|Protocol Violation|0
1775832|NCT00700817|6182292|P3|Week 0-26 (Main Period)|Protocol Violation|4
1775833|NCT00700817|6182293|P2|Week 0-26 (Main Period)|Protocol Violation|4
1775834|NCT00700817|6182294|P1|Week 0-26 (Main Period)|Protocol Violation|14
1775835|NCT00700817|6182290|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
1775836|NCT00700817|6182291|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
1775837|NCT00700817|6182292|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
1775838|NCT00700817|6182293|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
1775839|NCT00700817|6182294|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
1775840|NCT00700817|6182290|P5|Week 0-26 (Main Period)|Adverse Event|0
1775841|NCT00700817|6182291|P4|Week 0-26 (Main Period)|Adverse Event|0
1775842|NCT00700817|6182292|P3|Week 0-26 (Main Period)|Adverse Event|4
1775843|NCT00700817|6182293|P2|Week 0-26 (Main Period)|Adverse Event|15
1775844|NCT00700817|6182294|P1|Week 0-26 (Main Period)|Adverse Event|14
1775845|NCT00700804|6182676|P2|Overall Study|Loose Stools|1
1775846|NCT00700804|6182677|P1|Overall Study|Loose Stools|1
1775847|NCT00700804|6182676|P2|Overall Study|Protocol Violation|1
1775848|NCT00700804|6182677|P1|Overall Study|Protocol Violation|1
1775849|NCT00700804|6182676|P2|Overall Study|Withdrawal by Subject|2
1775850|NCT00700804|6182677|P1|Overall Study|Withdrawal by Subject|1
1775851|NCT00700752|6182685|P2|First Intervention|Withdrawal by Subject|2
1775852|NCT00700752|6182686|P1|First Intervention|Withdrawal by Subject|0
1775853|NCT00700739|6182694|P2|Overall Study|Lost to Follow-up|4
1775854|NCT00700739|6182695|P1|Overall Study|Lost to Follow-up|4
1775855|NCT00700713|6182734|P3|Overall Study|Withdrawal by Subject|1
1775856|NCT00700713|6182735|P2|Overall Study|Withdrawal by Subject|0
1775857|NCT00700713|6182736|P1|Overall Study|Withdrawal by Subject|0
1775858|NCT00700713|6182734|P3|Overall Study|Protocol Violation|1
1775859|NCT00700713|6182735|P2|Overall Study|Protocol Violation|0
1775860|NCT00700713|6182736|P1|Overall Study|Protocol Violation|1
1775861|NCT00700635|6182753|P3|Overall Study|Withdrawal by Subject|1
1775862|NCT00700635|6182754|P2|Overall Study|Withdrawal by Subject|3
1775863|NCT00700635|6182755|P1|Overall Study|Withdrawal by Subject|7
1775864|NCT00700635|6182753|P3|Overall Study|Protocol Violation|0
1775865|NCT00700635|6182754|P2|Overall Study|Protocol Violation|2
1775866|NCT00700635|6182755|P1|Overall Study|Protocol Violation|2
1775867|NCT00700635|6182753|P3|Overall Study|Lost to Follow-up|0
1775868|NCT00700635|6182754|P2|Overall Study|Lost to Follow-up|3
1775869|NCT00700635|6182755|P1|Overall Study|Lost to Follow-up|1
1775870|NCT00700635|6182753|P3|Overall Study|Adverse Event|0
1775871|NCT00700635|6182754|P2|Overall Study|Adverse Event|0
1775872|NCT00700635|6182755|P1|Overall Study|Adverse Event|1
1775873|NCT00700622|6182777|P2|Overall Study|Other|1
1775874|NCT00700622|6182778|P1|Overall Study|Other|3
1775875|NCT00700622|6182777|P2|Overall Study|Withdrawal by Subject|1
1775876|NCT00700622|6182778|P1|Overall Study|Withdrawal by Subject|4
1775877|NCT00700622|6182777|P2|Overall Study|Protocol Violation|1
1775878|NCT00700622|6182778|P1|Overall Study|Protocol Violation|0
1775879|NCT00700622|6182777|P2|Overall Study|Physician Decision|1
1775880|NCT00700622|6182778|P1|Overall Study|Physician Decision|2
1775881|NCT00700622|6182777|P2|Overall Study|Lost to Follow-up|1
1775882|NCT00700622|6182778|P1|Overall Study|Lost to Follow-up|0
1775883|NCT00700622|6182777|P2|Overall Study|Adverse Event|0
1775884|NCT00700622|6182778|P1|Overall Study|Adverse Event|4
1775885|NCT00700570|6182786|P2|Overall Study|Withdrawal by Subject|6
1775886|NCT00700570|6182787|P1|Overall Study|Withdrawal by Subject|1
1775887|NCT00700570|6182786|P2|Overall Study|Disease Progression|11
1775888|NCT00700570|6182787|P1|Overall Study|Disease Progression|8
1775889|NCT00700570|6182786|P2|Overall Study|Discretion of Investigator or Sponsor|3
1775890|NCT00700570|6182787|P1|Overall Study|Discretion of Investigator or Sponsor|0
1775891|NCT00700570|6182786|P2|Overall Study|Adverse Event|6
1775892|NCT00700570|6182787|P1|Overall Study|Adverse Event|2
1775893|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
1775894|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1775895|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1775896|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1775897|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
1775898|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
1775899|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1775900|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1775901|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1775902|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
1775903|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
1775904|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1775905|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1775906|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1775907|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
1775908|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
1775909|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1775910|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1775911|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1775912|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
1775913|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
1775914|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
1775915|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
1775916|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
1775917|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
1775918|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
1775919|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1775920|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1775921|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1775922|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
1775923|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
1775924|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1775925|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1775926|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1775927|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
1775928|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Death|1
1775929|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Death|0
1775930|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Death|0
1775931|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Death|0
1775932|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Death|0
1775933|NCT00700427|6182803|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
1775934|NCT00700427|6182804|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
1775935|NCT00700427|6182805|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
1775936|NCT00700427|6182806|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
1775937|NCT00700427|6182807|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
1775938|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Death|0
1775939|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Death|0
1775940|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Death|1
1775941|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Death|0
1775942|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Death|0
1775943|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1775944|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1775945|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
1775946|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1775947|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
1775948|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
1775949|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
1775950|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
1775951|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
1775952|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
1775953|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1775954|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
1775955|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1775956|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1775957|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
1775958|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1775959|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
1775960|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1775961|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1775962|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
1775963|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1775964|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
1775965|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
1775966|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1775967|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
1775968|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1775969|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
1775970|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
1775971|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1775972|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
1775973|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1775974|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
1775975|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
1775976|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1775977|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
1775978|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1775979|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
1775980|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
1775981|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1775982|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
1775983|NCT00700427|6182803|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1775984|NCT00700427|6182804|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
1775985|NCT00700427|6182805|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
1775986|NCT00700427|6182806|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1775987|NCT00700427|6182807|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
1775988|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1775989|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1775990|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1775991|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
1775992|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
1775993|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1775994|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1775995|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1775996|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
1775997|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
1775998|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1775999|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1776000|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1776001|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
1776002|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
1776003|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1776004|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1776005|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1776006|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
1776007|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
1776008|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1776009|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1776010|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1776011|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
1776012|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
1776013|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1776014|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1776015|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1776016|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
1776017|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
1776018|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1776019|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1776020|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1776021|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
1776022|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
1776023|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1776024|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1776025|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1776026|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
1776027|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
1776028|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1776029|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1776030|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1776031|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
1776032|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
1776033|NCT00700427|6182803|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1776034|NCT00700427|6182804|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1776035|NCT00700427|6182805|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1776036|NCT00700427|6182806|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
1776037|NCT00700427|6182807|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
1776038|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1776039|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1776040|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1776041|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
1776042|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
1776043|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1776044|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1776045|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1776046|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
1776047|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
1776048|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1776049|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1776050|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1776051|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
1776052|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
1776053|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1776054|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1776055|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1776056|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
1776057|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
1776058|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1776059|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1776060|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1776061|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
1776062|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
1776063|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1776064|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1776065|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1776066|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
1776067|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
1776068|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1776069|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1776070|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1776071|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
1776072|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
1776073|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1776074|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1776075|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1776076|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
1776077|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
1776078|NCT00700427|6182803|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1776079|NCT00700427|6182804|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1776080|NCT00700427|6182805|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1776081|NCT00700427|6182806|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
1776082|NCT00700427|6182807|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
1776083|NCT00700401|6182829|P1|Overall Study|Withdrawal by Subject|2
1776084|NCT00700401|6182829|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
1776085|NCT00700401|6182829|P1|Overall Study|Treatment never started|1
1776086|NCT00700401|6182829|P1|Overall Study|Lost to Follow-up|1
1776087|NCT00700401|6182829|P1|Overall Study|Refused Treatment|2
1776088|NCT00700401|6182829|P1|Overall Study|Adverse Event|5
1776089|NCT00700401|6182829|P1|Overall Study|Detectable HCV RNA after Week 4|82
1776090|NCT00700310|6182853|P4|Overall Study|Randomized, Not Treated|2
1776091|NCT00700310|6182854|P3|Overall Study|Randomized, Not Treated|2
1776092|NCT00700310|6182855|P2|Overall Study|Randomized, Not Treated|0
1776093|NCT00700310|6182856|P1|Overall Study|Randomized, Not Treated|2
1776094|NCT00700310|6182853|P4|Overall Study|Administrative/Other|3
1776095|NCT00700310|6182854|P3|Overall Study|Administrative/Other|1
1776096|NCT00700310|6182855|P2|Overall Study|Administrative/Other|3
1776097|NCT00700310|6182856|P1|Overall Study|Administrative/Other|1
1776098|NCT00700310|6182853|P4|Overall Study|Lack of Efficacy|1
1776099|NCT00700310|6182854|P3|Overall Study|Lack of Efficacy|0
1776100|NCT00700310|6182855|P2|Overall Study|Lack of Efficacy|3
1776101|NCT00700310|6182856|P1|Overall Study|Lack of Efficacy|0
1776102|NCT00700310|6182853|P4|Overall Study|Withdrawal by Subject|8
1776103|NCT00700310|6182854|P3|Overall Study|Withdrawal by Subject|8
1776104|NCT00700310|6182855|P2|Overall Study|Withdrawal by Subject|9
1776105|NCT00700310|6182856|P1|Overall Study|Withdrawal by Subject|8
1776106|NCT00700310|6182853|P4|Overall Study|Lost to Follow-up|1
1776107|NCT00700310|6182854|P3|Overall Study|Lost to Follow-up|0
1776108|NCT00700310|6182855|P2|Overall Study|Lost to Follow-up|1
1776109|NCT00700310|6182856|P1|Overall Study|Lost to Follow-up|4
1776110|NCT00700310|6182853|P4|Overall Study|Adverse Event|11
1776111|NCT00700310|6182854|P3|Overall Study|Adverse Event|5
1776112|NCT00700310|6182855|P2|Overall Study|Adverse Event|10
1776113|NCT00700310|6182856|P1|Overall Study|Adverse Event|6
1776114|NCT00700271|6182876|P2|Overall Study|Lost to Follow-up|2
1776115|NCT00700271|6182877|P1|Overall Study|Lost to Follow-up|2
1776116|NCT00700271|6182876|P2|Overall Study|Withdrawal by Subject|4
1776117|NCT00700271|6182877|P1|Overall Study|Withdrawal by Subject|6
1776118|NCT00700271|6182876|P2|Overall Study|Administrative Reasons|0
1776119|NCT00700271|6182877|P1|Overall Study|Administrative Reasons|1
1776120|NCT00700271|6182876|P2|Overall Study|Protocol Violation|0
1776121|NCT00700271|6182877|P1|Overall Study|Protocol Violation|1
1776122|NCT00700271|6182876|P2|Overall Study|Adverse Event|6
1776123|NCT00700271|6182877|P1|Overall Study|Adverse Event|4
1776124|NCT00700180|6182905|P2|Overall Study|Lost to Follow-up|5
1776125|NCT00700180|6182906|P1|Overall Study|Lost to Follow-up|4
1776126|NCT00700180|6182905|P2|Overall Study|Alive in follow-up|27
1776127|NCT00700180|6182906|P1|Overall Study|Alive in follow-up|46
1776128|NCT00700180|6182905|P2|Overall Study|Alive on treatment|3
1776129|NCT00700180|6182906|P1|Overall Study|Alive on treatment|5
1776130|NCT00700180|6182905|P2|Overall Study|Death|114
1776131|NCT00700180|6182906|P1|Overall Study|Death|99
1776132|NCT00700115|6182935|P2|Overall Study|Lost to Follow-up|1
1776133|NCT00700115|6182936|P1|Overall Study|Lost to Follow-up|0
1776134|NCT00700115|6182935|P2|Overall Study|Withdrawal by Subject|0
1776135|NCT00700115|6182936|P1|Overall Study|Withdrawal by Subject|1
1776136|NCT00700102|6182946|P2|Overall Study|Lost to Follow-up|10
1776137|NCT00700102|6182947|P1|Overall Study|Lost to Follow-up|8
1776138|NCT00700102|6182946|P2|Overall Study|Died|385
1776139|NCT00700102|6182947|P1|Overall Study|Died|394
1776140|NCT00700011|6183086|P2|Overall Study|Death|1
1776141|NCT00700011|6183087|P1|Overall Study|Death|0
1776142|NCT00699998|6183103|P4|Overall Study|Lost to Follow-up|1
1776143|NCT00699998|6183104|P3|Overall Study|Lost to Follow-up|3
1776144|NCT00699998|6183105|P2|Overall Study|Lost to Follow-up|1
1776145|NCT00699998|6183106|P1|Overall Study|Lost to Follow-up|2
1776146|NCT00699998|6183103|P4|Overall Study|Physician Decision|1
1776147|NCT00699998|6183104|P3|Overall Study|Physician Decision|1
1776148|NCT00699998|6183105|P2|Overall Study|Physician Decision|2
1776149|NCT00699998|6183106|P1|Overall Study|Physician Decision|3
1776150|NCT00699998|6183103|P4|Overall Study|Withdrawal by Subject|80
1776151|NCT00699998|6183104|P3|Overall Study|Withdrawal by Subject|202
1776152|NCT00699998|6183105|P2|Overall Study|Withdrawal by Subject|83
1776153|NCT00699998|6183106|P1|Overall Study|Withdrawal by Subject|194
1776154|NCT00699972|6183151|P3|Overall Study|Randomized, Not Treated|1
1776155|NCT00699972|6183152|P2|Overall Study|Randomized, Not Treated|0
1776156|NCT00699972|6183153|P1|Overall Study|Randomized, Not Treated|1
1776157|NCT00699972|6183151|P3|Overall Study|Administrative/Other|4
1776158|NCT00699972|6183152|P2|Overall Study|Administrative/Other|1
1776159|NCT00699972|6183153|P1|Overall Study|Administrative/Other|3
1776160|NCT00699972|6183151|P3|Overall Study|Lack of Efficacy|2
1776161|NCT00699972|6183152|P2|Overall Study|Lack of Efficacy|0
1776162|NCT00699972|6183153|P1|Overall Study|Lack of Efficacy|2
1776163|NCT00699972|6183151|P3|Overall Study|Withdrawal by Subject|4
1776164|NCT00699972|6183152|P2|Overall Study|Withdrawal by Subject|7
1776165|NCT00699972|6183153|P1|Overall Study|Withdrawal by Subject|3
1776166|NCT00699972|6183151|P3|Overall Study|Lost to Follow-up|0
1776167|NCT00699972|6183152|P2|Overall Study|Lost to Follow-up|2
1776168|NCT00699972|6183153|P1|Overall Study|Lost to Follow-up|0
1776169|NCT00699972|6183151|P3|Overall Study|Adverse Event|24
1776170|NCT00699972|6183152|P2|Overall Study|Adverse Event|9
1776171|NCT00699972|6183153|P1|Overall Study|Adverse Event|7
1776172|NCT00699907|6183170|P3|Overall Study|No usable sample|8
1776173|NCT00699907|6183171|P2|Overall Study|No usable sample|9
1776174|NCT00699907|6183172|P1|Overall Study|No usable sample|0
1776175|NCT00699907|6183170|P3|Overall Study|Withdrawal by Subject|0
1776176|NCT00699907|6183171|P2|Overall Study|Withdrawal by Subject|1
1776177|NCT00699907|6183172|P1|Overall Study|Withdrawal by Subject|2
1776178|NCT00699842|6183207|P3|Overall Study|Death|0
1776179|NCT00699842|6183208|P2|Overall Study|Death|1
1776180|NCT00699842|6183209|P1|Overall Study|Death|0
1776181|NCT00699816|6183222|P2|Overall Study|Protocol Violation|3
1776182|NCT00699816|6183223|P1|Overall Study|Protocol Violation|1
1776183|NCT00699751|6183241|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
1776184|NCT00699751|6183242|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
1776185|NCT00699751|6183241|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
1776186|NCT00699751|6183242|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
1776187|NCT00699751|6183241|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
1776188|NCT00699751|6183242|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
1776189|NCT00699751|6183241|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
1776190|NCT00699751|6183242|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
1776191|NCT00699751|6183241|P2|Period 1: Without/Before Drug Switch|Other|20
1776192|NCT00699751|6183242|P1|Period 1: Without/Before Drug Switch|Other|30
1776193|NCT00699751|6183241|P2|Period 1: Without/Before Drug Switch|Subject Request|23
1776194|NCT00699751|6183242|P1|Period 1: Without/Before Drug Switch|Subject Request|43
1776195|NCT00699751|6183241|P2|Period 1: Without/Before Drug Switch|Death|29
1776196|NCT00699751|6183242|P1|Period 1: Without/Before Drug Switch|Death|28
1776197|NCT00699751|6183241|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
1776198|NCT00699751|6183242|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
1776199|NCT00699699|6183327|P1|Overall Study|Individual different reasons|21
1776200|NCT00699699|6183327|P1|Overall Study|Adverse Event|36
1776201|NCT00699660|6183336|P2|Overall Study|missing reports and recording failures|6
1776202|NCT00699660|6183337|P1|Overall Study|missing reports and recording failures|10
1776203|NCT00699660|6183336|P2|Overall Study|Lost to Follow-up|2
1776204|NCT00699660|6183337|P1|Overall Study|Lost to Follow-up|4
1776205|NCT00699608|6183349|P6|Second Intervention|Withdrawal by Subject|0
1776206|NCT00699608|6183350|P5|Second Intervention|Withdrawal by Subject|0
1776207|NCT00699608|6183351|P4|Second Intervention|Withdrawal by Subject|1
1776208|NCT00699608|6183352|P3|Second Intervention|Withdrawal by Subject|0
1776209|NCT00699608|6183353|P2|Second Intervention|Withdrawal by Subject|0
1776210|NCT00699608|6183354|P1|Second Intervention|Withdrawal by Subject|0
1776211|NCT00699608|6183349|P6|Second Intervention|Adverse Event|0
1776212|NCT00699608|6183350|P5|Second Intervention|Adverse Event|0
1776213|NCT00699608|6183351|P4|Second Intervention|Adverse Event|0
1776214|NCT00699608|6183352|P3|Second Intervention|Adverse Event|1
1776215|NCT00699608|6183353|P2|Second Intervention|Adverse Event|0
1776216|NCT00699608|6183354|P1|Second Intervention|Adverse Event|0
1776217|NCT00699608|6183349|P6|First Intervention|Protocol Violation|0
1776218|NCT00699608|6183350|P5|First Intervention|Protocol Violation|1
1776219|NCT00699608|6183351|P4|First Intervention|Protocol Violation|0
1776220|NCT00699608|6183352|P3|First Intervention|Protocol Violation|0
1776221|NCT00699608|6183353|P2|First Intervention|Protocol Violation|0
1776222|NCT00699608|6183354|P1|First Intervention|Protocol Violation|0
1776223|NCT00699608|6183349|P6|First Intervention|Withdrawal by Subject|0
1776224|NCT00699608|6183350|P5|First Intervention|Withdrawal by Subject|0
1776225|NCT00699608|6183351|P4|First Intervention|Withdrawal by Subject|0
1776226|NCT00699608|6183352|P3|First Intervention|Withdrawal by Subject|1
1776227|NCT00699608|6183353|P2|First Intervention|Withdrawal by Subject|0
1776228|NCT00699608|6183354|P1|First Intervention|Withdrawal by Subject|0
1776229|NCT00699582|6183407|P3|Overall Study|Randomized, Not Treated|0
1776230|NCT00699582|6183408|P2|Overall Study|Randomized, Not Treated|1
1776231|NCT00699582|6183409|P1|Overall Study|Randomized, Not Treated|2
1776232|NCT00699582|6183407|P3|Overall Study|Administrative/Other|0
1776233|NCT00699582|6183408|P2|Overall Study|Administrative/Other|3
1776234|NCT00699582|6183409|P1|Overall Study|Administrative/Other|4
1776235|NCT00699582|6183407|P3|Overall Study|Progressive Disease|0
1776236|NCT00699582|6183408|P2|Overall Study|Progressive Disease|0
1776237|NCT00699582|6183409|P1|Overall Study|Progressive Disease|1
1776238|NCT00699582|6183407|P3|Overall Study|Lack of Efficacy|1
1776239|NCT00699582|6183408|P2|Overall Study|Lack of Efficacy|0
1776240|NCT00699582|6183409|P1|Overall Study|Lack of Efficacy|1
1776241|NCT00699582|6183407|P3|Overall Study|Withdrawal by Subject|4
1776242|NCT00699582|6183408|P2|Overall Study|Withdrawal by Subject|7
1776243|NCT00699582|6183409|P1|Overall Study|Withdrawal by Subject|6
1776244|NCT00699582|6183407|P3|Overall Study|Adverse Event|23
1776245|NCT00699582|6183408|P2|Overall Study|Adverse Event|11
1776246|NCT00699582|6183409|P1|Overall Study|Adverse Event|4
1776247|NCT00699413|6183464|P2|Overall Study|Study terminated by sponsor|2
1776248|NCT00699413|6183465|P1|Overall Study|Study terminated by sponsor|4
1776249|NCT00699413|6183464|P2|Overall Study|Withdrawal by Subject|2
1776250|NCT00699413|6183465|P1|Overall Study|Withdrawal by Subject|0
1776251|NCT00699374|6183519|P2|Overall Study|Died 28 days after last dose|9
1776252|NCT00699374|6183520|P1|Overall Study|Died 28 days after last dose|5
1776253|NCT00699374|6183519|P2|Overall Study|Randomized but not treated|2
1776254|NCT00699374|6183520|P1|Overall Study|Randomized but not treated|4
1776255|NCT00699374|6183519|P2|Overall Study|Study terminated by sponsor|28
1776256|NCT00699374|6183520|P1|Overall Study|Study terminated by sponsor|13
1776257|NCT00699374|6183519|P2|Overall Study|Protocol Violation|6
1776258|NCT00699374|6183520|P1|Overall Study|Protocol Violation|2
1776259|NCT00699374|6183519|P2|Overall Study|Other|15
1776260|NCT00699374|6183520|P1|Overall Study|Other|18
1776261|NCT00699374|6183519|P2|Overall Study|Objective progression or relapse|277
1776262|NCT00699374|6183520|P1|Overall Study|Objective progression or relapse|281
1776263|NCT00699374|6183519|P2|Overall Study|Withdrawal by Subject|44
1776264|NCT00699374|6183520|P1|Overall Study|Withdrawal by Subject|34
1776265|NCT00699374|6183519|P2|Overall Study|Lost to Follow-up|5
1776266|NCT00699374|6183520|P1|Overall Study|Lost to Follow-up|3
1776267|NCT00699374|6183519|P2|Overall Study|Global deterioration of health status|8
1776268|NCT00699374|6183520|P1|Overall Study|Global deterioration of health status|7
1776269|NCT00699374|6183519|P2|Overall Study|Adverse Event|67
1776270|NCT00699374|6183520|P1|Overall Study|Adverse Event|70
1776271|NCT00699374|6183519|P2|Overall Study|Death|83
1776272|NCT00699374|6183520|P1|Overall Study|Death|93
1776273|NCT00699348|6183532|P1|Overall Study|Other|5
1776274|NCT00699348|6183532|P1|Overall Study|Renal transplantation|10
1776275|NCT00699348|6183532|P1|Overall Study|Blood transfusion|24
1776276|NCT00699348|6183532|P1|Overall Study|Failure to return|1
1776277|NCT00699348|6183532|P1|Overall Study|Lack of Efficacy|8
1776278|NCT00699348|6183532|P1|Overall Study|Protocol Violation|10
1776279|NCT00699348|6183532|P1|Overall Study|Withdrawal by Subject|11
1776280|NCT00699348|6183532|P1|Overall Study|Adverse Event|15
1776281|NCT00699348|6183532|P1|Overall Study|Death|6
1776282|NCT00699335|6183541|P1|Overall Study|Missing data|52
1776283|NCT00699335|6183541|P1|Overall Study|Combination of multiple reasons|176
1776284|NCT00699283|6183574|P2|Overall Study|AE of unknown type|0
1776285|NCT00699283|6183575|P1|Overall Study|AE of unknown type|1
1776286|NCT00699283|6183574|P2|Overall Study|AE, non-serious non-fatal|1
1776287|NCT00699283|6183575|P1|Overall Study|AE, non-serious non-fatal|8
1776288|NCT00699283|6183574|P2|Overall Study|SAE, non-fatal|1
1776289|NCT00699283|6183575|P1|Overall Study|SAE, non-fatal|1
1776290|NCT00699283|6183574|P2|Overall Study|Other Reason|1
1776291|NCT00699283|6183575|P1|Overall Study|Other Reason|5
1776292|NCT00699283|6183574|P2|Overall Study|Withdrawal by Subject|0
1776293|NCT00699283|6183575|P1|Overall Study|Withdrawal by Subject|1
1776294|NCT00699283|6183574|P2|Overall Study|Lost to Follow-up|0
1776295|NCT00699283|6183575|P1|Overall Study|Lost to Follow-up|2
1776296|NCT00699283|6183574|P2|Overall Study|Lack of Efficacy|5
1776297|NCT00699283|6183575|P1|Overall Study|Lack of Efficacy|15
1776298|NCT00699192|6183588|P3|Overall Study|Protocol Violation|0
1776299|NCT00699192|6183589|P2|Overall Study|Protocol Violation|2
1776300|NCT00699192|6183590|P1|Overall Study|Protocol Violation|2
1776301|NCT00699192|6183588|P3|Overall Study|Administrative problems|1
1776302|NCT00699192|6183589|P2|Overall Study|Administrative problems|3
1776303|NCT00699192|6183590|P1|Overall Study|Administrative problems|1
1776304|NCT00699192|6183588|P3|Overall Study|Withdrawal by Subject|4
1776305|NCT00699192|6183589|P2|Overall Study|Withdrawal by Subject|2
1776306|NCT00699192|6183590|P1|Overall Study|Withdrawal by Subject|3
1776307|NCT00699192|6183588|P3|Overall Study|Lack of Efficacy|1
1776308|NCT00699192|6183589|P2|Overall Study|Lack of Efficacy|0
1776309|NCT00699192|6183590|P1|Overall Study|Lack of Efficacy|0
1776310|NCT00699192|6183588|P3|Overall Study|Abnormal test procedure result(s)|1
1776311|NCT00699192|6183589|P2|Overall Study|Abnormal test procedure result(s)|0
1776312|NCT00699192|6183590|P1|Overall Study|Abnormal test procedure result(s)|0
1776313|NCT00699192|6183588|P3|Overall Study|Adverse Event|3
1776314|NCT00699192|6183589|P2|Overall Study|Adverse Event|4
1776315|NCT00699192|6183590|P1|Overall Study|Adverse Event|9
1776316|NCT00699192|6183588|P3|Overall Study|Missing|1
1776317|NCT00699192|6183589|P2|Overall Study|Missing|1
1776318|NCT00699192|6183590|P1|Overall Study|Missing|1
1776319|NCT00699153|6183612|P2|Overall Study|Travel Problem|0
1776320|NCT00699153|6183613|P1|Overall Study|Travel Problem|1
1776321|NCT00699153|6183612|P2|Overall Study|Protocol Violation|0
1776322|NCT00699153|6183613|P1|Overall Study|Protocol Violation|1
1776323|NCT00699153|6183612|P2|Overall Study|Adverse Event|2
1776324|NCT00699153|6183613|P1|Overall Study|Adverse Event|0
1776325|NCT00699153|6183612|P2|Overall Study|Lost to Follow-up|0
1776326|NCT00699153|6183613|P1|Overall Study|Lost to Follow-up|1
1776331|NCT00698932|6183663|P2|Overall Study|Death|0
1776332|NCT00698932|6183664|P1|Overall Study|Death|1
1776333|NCT00698932|6183663|P2|Overall Study|Safety reasons|2
1776334|NCT00698932|6183664|P1|Overall Study|Safety reasons|0
1776335|NCT00698932|6183663|P2|Overall Study|Severe non-compliance to protocol|2
1776336|NCT00698932|6183664|P1|Overall Study|Severe non-compliance to protocol|1
1776337|NCT00698932|6183663|P2|Overall Study|Lost to Follow-up|1
1776338|NCT00698932|6183664|P1|Overall Study|Lost to Follow-up|6
1776339|NCT00698932|6183663|P2|Overall Study|Withdrawal by Subject|23
1776340|NCT00698932|6183664|P1|Overall Study|Withdrawal by Subject|11
1776341|NCT00698932|6183663|P2|Overall Study|Study specific discontinuation criteria|4
1776342|NCT00698932|6183664|P1|Overall Study|Study specific discontinuation criteria|3
1776343|NCT00698932|6183663|P2|Overall Study|Incorrect enrollment|2
1776344|NCT00698932|6183664|P1|Overall Study|Incorrect enrollment|0
1776345|NCT00698932|6183663|P2|Overall Study|Adverse Event|2
1776346|NCT00698932|6183664|P1|Overall Study|Adverse Event|0
1776347|NCT00698841|6183690|P1|Overall Study|Other|2
1776348|NCT00698841|6183690|P1|Overall Study|Study drug toxicity|2
1776349|NCT00698841|6183690|P1|Overall Study|Failure to meet eligibility criteria|2
1776350|NCT00698841|6183690|P1|Overall Study|Disease progression|7
1776351|NCT00698841|6183690|P1|Overall Study|Adverse Event|3
1776352|NCT00698841|6183690|P1|Overall Study|Withdrawal by Subject|2
1776353|NCT00698815|6183704|P3|Overall Study|Did not receive protocol treatment|2
1776354|NCT00698815|6183705|P2|Overall Study|Did not receive protocol treatment|2
1776355|NCT00698815|6183706|P1|Overall Study|Did not receive protocol treatment|1
1776356|NCT00698815|6183704|P3|Overall Study|MD discretion|2
1776357|NCT00698815|6183705|P2|Overall Study|MD discretion|7
1776358|NCT00698815|6183706|P1|Overall Study|MD discretion|2
1776359|NCT00698815|6183704|P3|Overall Study|Withdrawal by Subject|2
1776360|NCT00698815|6183705|P2|Overall Study|Withdrawal by Subject|3
1776361|NCT00698815|6183706|P1|Overall Study|Withdrawal by Subject|6
1776362|NCT00698815|6183704|P3|Overall Study|Death|4
1776363|NCT00698815|6183705|P2|Overall Study|Death|2
1776364|NCT00698815|6183706|P1|Overall Study|Death|1
1776365|NCT00698685|6183723|P1|Overall Study|Off study pre transplant by clinic MD|1
1776366|NCT00698685|6183723|P1|Overall Study|Sister withdrew as donor|1
1776367|NCT00698646|6183731|P3|Overall Study|Administrative problems|1
1776368|NCT00698646|6183732|P2|Overall Study|Administrative problems|0
1776369|NCT00698646|6183733|P1|Overall Study|Administrative problems|1
1776370|NCT00698646|6183731|P3|Overall Study|Lost to Follow-up|2
1776371|NCT00698646|6183732|P2|Overall Study|Lost to Follow-up|0
1776372|NCT00698646|6183733|P1|Overall Study|Lost to Follow-up|0
1776373|NCT00698646|6183731|P3|Overall Study|Withdrawal by Subject|8
1776374|NCT00698646|6183732|P2|Overall Study|Withdrawal by Subject|11
1776375|NCT00698646|6183733|P1|Overall Study|Withdrawal by Subject|10
1776376|NCT00698646|6183731|P3|Overall Study|Protocol Deviation|3
1776377|NCT00698646|6183732|P2|Overall Study|Protocol Deviation|2
1776378|NCT00698646|6183733|P1|Overall Study|Protocol Deviation|6
1776379|NCT00698646|6183731|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
1776380|NCT00698646|6183732|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
1776381|NCT00698646|6183733|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
1776382|NCT00698646|6183731|P3|Overall Study|Adverse Event|8
1776383|NCT00698646|6183732|P2|Overall Study|Adverse Event|7
1776384|NCT00698646|6183733|P1|Overall Study|Adverse Event|8
1776385|NCT00698581|6183758|P2|Overall Study|AE of unknown type|0
1776386|NCT00698581|6183759|P1|Overall Study|AE of unknown type|1
1776387|NCT00698581|6183758|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
1776388|NCT00698581|6183759|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
1776389|NCT00698581|6183758|P2|Overall Study|AE, non-serious non-fatal|0
1776390|NCT00698581|6183759|P1|Overall Study|AE, non-serious non-fatal|4
1776391|NCT00698581|6183758|P2|Overall Study|SAE, non-fatal|0
1776392|NCT00698581|6183759|P1|Overall Study|SAE, non-fatal|1
1776393|NCT00698581|6183758|P2|Overall Study|Other reason|1
1776394|NCT00698581|6183759|P1|Overall Study|Other reason|9
1776395|NCT00698581|6183758|P2|Overall Study|Withdrawal by Subject|0
1776396|NCT00698581|6183759|P1|Overall Study|Withdrawal by Subject|6
1776397|NCT00698581|6183758|P2|Overall Study|Lack of Efficacy|11
1776398|NCT00698581|6183759|P1|Overall Study|Lack of Efficacy|23
1776399|NCT00698516|6183770|P1|Overall Study|Withdrawal by Subject|3
1776400|NCT00698516|6183770|P1|Overall Study|Study Termination|2
1776401|NCT00698451|6183788|P1|Overall Study|Disease progression|3
1776402|NCT00698451|6183788|P1|Overall Study|Withdrawal by Subject|6
1776403|NCT00698451|6183788|P1|Overall Study|Protocol Violation|6
1776404|NCT00698451|6183788|P1|Overall Study|Physician Decision|2
1776405|NCT00698451|6183788|P1|Overall Study|Adverse Event|22
1776406|NCT00698204|6183795|P2|Overall Study|Withdrawal by Subject|0
1776407|NCT00698204|6183796|P1|Overall Study|Withdrawal by Subject|1
1776408|NCT00698009|6183856|P1|Overall Study|Withdrawal by Subject|1
1776409|NCT00697827|6183862|P2|Overall Study|enrolled but not treated|1
1776410|NCT00697827|6183863|P1|Overall Study|enrolled but not treated|2
1776411|NCT00697788|6183890|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1776412|NCT00697788|6183891|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1776413|NCT00697788|6183892|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1776414|NCT00697788|6183893|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
1776415|NCT00697788|6183894|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1776416|NCT00697788|6183895|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1776417|NCT00697788|6183896|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1776418|NCT00697788|6183897|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
1776419|NCT00697788|6183890|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1776420|NCT00697788|6183891|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1776421|NCT00697788|6183892|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1776422|NCT00697788|6183893|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1776423|NCT00697788|6183894|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1776424|NCT00697788|6183895|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1776425|NCT00697788|6183896|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
1776426|NCT00697788|6183897|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
1776427|NCT00697619|6183952|P2|Overall Study|Adverse Event|6
1776428|NCT00697619|6183953|P1|Overall Study|Adverse Event|4
1776429|NCT00697619|6183952|P2|Overall Study|Lack of Efficacy|2
1776430|NCT00697619|6183953|P1|Overall Study|Lack of Efficacy|2
1776431|NCT00697593|6183959|P1|Overall Study|Suspension of the study by sponsor|12
1776432|NCT00697593|6183959|P1|Overall Study|Lack of Efficacy|3
1776433|NCT00697593|6183959|P1|Overall Study|Protocol Violation|1
1776434|NCT00697593|6183959|P1|Overall Study|Adverse Event|3
1776435|NCT00697515|6184003|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
1776436|NCT00697515|6184004|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
1776437|NCT00697515|6184003|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
1776438|NCT00697515|6184004|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
1776439|NCT00697515|6184003|P2|First Intervention (Crossover Period)|Adverse Event|2
1776440|NCT00697515|6184004|P1|First Intervention (Crossover Period)|Adverse Event|0
1776441|NCT00697515|6184003|P2|First Intervention (Crossover Period)|Natural disaster|9
1776442|NCT00697515|6184004|P1|First Intervention (Crossover Period)|Natural disaster|8
1776443|NCT00697515|6184003|P2|Dose Optimization Period|elevated QTc|0
1776444|NCT00697515|6184004|P1|Dose Optimization Period|elevated QTc|1
1776445|NCT00697515|6184003|P2|Dose Optimization Period|called to active duty|0
1776446|NCT00697515|6184004|P1|Dose Optimization Period|called to active duty|1
1776447|NCT00697515|6184003|P2|Dose Optimization Period|sponsor request|0
1776448|NCT00697515|6184004|P1|Dose Optimization Period|sponsor request|2
1776449|NCT00697515|6184003|P2|Dose Optimization Period|Lost to Follow-up|0
1776450|NCT00697515|6184004|P1|Dose Optimization Period|Lost to Follow-up|2
1776451|NCT00697515|6184003|P2|Dose Optimization Period|Withdrawal by Subject|0
1776452|NCT00697515|6184004|P1|Dose Optimization Period|Withdrawal by Subject|5
1776453|NCT00697515|6184003|P2|Dose Optimization Period|Adverse Event|0
1776454|NCT00697515|6184004|P1|Dose Optimization Period|Adverse Event|4
1776455|NCT00697463|6184032|P1|Overall Study|Withdrawal by Subject|1
1776456|NCT00697346|6184039|P3|Overall Study|Reason not Specified|1
1776457|NCT00697346|6184040|P2|Overall Study|Reason not Specified|0
1776458|NCT00697346|6184041|P1|Overall Study|Reason not Specified|3
1776459|NCT00697346|6184039|P3|Overall Study|Withdrawal by Subject|0
1776460|NCT00697346|6184040|P2|Overall Study|Withdrawal by Subject|2
1776461|NCT00697346|6184041|P1|Overall Study|Withdrawal by Subject|2
1776462|NCT00697346|6184039|P3|Overall Study|Symptomatic Deterioration|0
1776463|NCT00697346|6184040|P2|Overall Study|Symptomatic Deterioration|1
1776464|NCT00697346|6184041|P1|Overall Study|Symptomatic Deterioration|0
1776465|NCT00697346|6184039|P3|Overall Study|Progressive Disease|0
1776466|NCT00697346|6184040|P2|Overall Study|Progressive Disease|18
1776467|NCT00697346|6184041|P1|Overall Study|Progressive Disease|19
1776468|NCT00697346|6184039|P3|Overall Study|Adverse Event|0
1776469|NCT00697346|6184040|P2|Overall Study|Adverse Event|5
1776470|NCT00697346|6184041|P1|Overall Study|Adverse Event|4
1776471|NCT00697255|6184149|P2|Stage 1b|Insufficient ovarian response|1
1776472|NCT00697255|6184150|P1|Stage 1b|Insufficient ovarian response|0
1776473|NCT00697255|6184149|P2|Stage 1b|Not growing of dominant follicle|1
1776474|NCT00697255|6184150|P1|Stage 1b|Not growing of dominant follicle|0
1776475|NCT00697255|6184149|P2|Stage 1a|Not growing of dominant follicle|0
1776476|NCT00697255|6184150|P1|Stage 1a|Not growing of dominant follicle|1
1776477|NCT00697255|6184149|P2|Stage 1a|Multifollicular growth|0
1776478|NCT00697255|6184150|P1|Stage 1a|Multifollicular growth|1
1776479|NCT00697255|6184149|P2|Stage 1a|Insufficient ovarian response|0
1776480|NCT00697255|6184150|P1|Stage 1a|Insufficient ovarian response|1
1776481|NCT00697112|6184238|P1|Overall Study|Did not meet inclusion criteria|1
1776482|NCT00697112|6184238|P1|Overall Study|Lost to Follow-up|1
1776483|NCT00697112|6184238|P1|Overall Study|Adverse Event|8
1776484|NCT00697073|6184262|P1|Overall Study|non compliance and other|6
1776485|NCT00697073|6184262|P1|Overall Study|Pregnancy|1
1776486|NCT00697073|6184262|P1|Overall Study|Withdrawal by Subject|2
1776487|NCT00696878|6184266|P1|Overall Study|Other reason (not specified)|55
1776488|NCT00696878|6184266|P1|Overall Study|Trial stopped|32
1776489|NCT00696878|6184266|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
1776490|NCT00696878|6184266|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
1776491|NCT00696878|6184266|P1|Overall Study|Withdrawal by Subject|87
1776492|NCT00696878|6184266|P1|Overall Study|Adverse Event|8
1776493|NCT00696800|6184340|P2|Overall Study|Not treated|2
1776494|NCT00696800|6184341|P1|Overall Study|Not treated|1
1776495|NCT00696800|6184340|P2|Overall Study|Other Reasons|3
1776496|NCT00696800|6184341|P1|Overall Study|Other Reasons|5
1776497|NCT00696800|6184340|P2|Overall Study|No/too few/bad quality embryos|18
1776498|NCT00696800|6184341|P1|Overall Study|No/too few/bad quality embryos|24
1776499|NCT00696800|6184340|P2|Overall Study|No/abnormal fertilization|13
1776500|NCT00696800|6184341|P1|Overall Study|No/abnormal fertilization|11
1776501|NCT00696800|6184340|P2|Overall Study|No/too few/bad quality oocytes|3
1776502|NCT00696800|6184341|P1|Overall Study|No/too few/bad quality oocytes|4
1776503|NCT00696800|6184340|P2|Overall Study|Too high ovarian response|1
1776504|NCT00696800|6184341|P1|Overall Study|Too high ovarian response|6
1776505|NCT00696800|6184340|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
1776506|NCT00696800|6184341|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
1776507|NCT00696800|6184340|P2|Overall Study|Insufficient ovarian response|1
1776508|NCT00696800|6184341|P1|Overall Study|Insufficient ovarian response|4
1776509|NCT00696800|6184340|P2|Overall Study|Insufficient ovarian response on Day 8|1
1776510|NCT00696800|6184341|P1|Overall Study|Insufficient ovarian response on Day 8|4
1776511|NCT00696800|6184340|P2|Overall Study|Insufficient compliance with medication|1
1776512|NCT00696800|6184341|P1|Overall Study|Insufficient compliance with medication|2
1776513|NCT00696800|6184340|P2|Overall Study|Adverse Event|3
1776514|NCT00696800|6184341|P1|Overall Study|Adverse Event|16
1776515|NCT00696787|6184394|P3|Overall Study|Failed to return|1
1776516|NCT00696787|6184395|P2|Overall Study|Failed to return|3
1776517|NCT00696787|6184396|P1|Overall Study|Failed to return|1
1776518|NCT00696787|6184394|P3|Overall Study|Withdrawal by Subject|2
1776519|NCT00696787|6184395|P2|Overall Study|Withdrawal by Subject|3
1776520|NCT00696787|6184396|P1|Overall Study|Withdrawal by Subject|0
1776521|NCT00696787|6184394|P3|Overall Study|Lost to Follow-up|3
1776522|NCT00696787|6184395|P2|Overall Study|Lost to Follow-up|0
1776523|NCT00696787|6184396|P1|Overall Study|Lost to Follow-up|4
1776524|NCT00696787|6184394|P3|Overall Study|Lack of Efficacy|0
1776525|NCT00696787|6184395|P2|Overall Study|Lack of Efficacy|1
1776526|NCT00696787|6184396|P1|Overall Study|Lack of Efficacy|0
1776527|NCT00696787|6184394|P3|Overall Study|Discontinuation by Sponsor|14
1776528|NCT00696787|6184395|P2|Overall Study|Discontinuation by Sponsor|13
1776529|NCT00696787|6184396|P1|Overall Study|Discontinuation by Sponsor|9
1776530|NCT00696787|6184394|P3|Overall Study|Adverse Event|6
1776531|NCT00696787|6184395|P2|Overall Study|Adverse Event|0
1776532|NCT00696787|6184396|P1|Overall Study|Adverse Event|1
1776533|NCT00696774|6184410|P3|Period III|Lack of Efficacy|0
1776534|NCT00696774|6184411|P2|Period III|Lack of Efficacy|2
1776535|NCT00696774|6184412|P1|Period III|Lack of Efficacy|0
1776536|NCT00696774|6184410|P3|Period III|Sponsor Decision|0
1776537|NCT00696774|6184411|P2|Period III|Sponsor Decision|0
1776538|NCT00696774|6184412|P1|Period III|Sponsor Decision|2
1776539|NCT00696774|6184410|P3|Period III|Withdrawal by Subject|0
1776540|NCT00696774|6184411|P2|Period III|Withdrawal by Subject|2
1776541|NCT00696774|6184412|P1|Period III|Withdrawal by Subject|1
1776542|NCT00696774|6184410|P3|Period III|Protocol Violation|0
1776543|NCT00696774|6184411|P2|Period III|Protocol Violation|1
1776544|NCT00696774|6184412|P1|Period III|Protocol Violation|1
1776545|NCT00696774|6184410|P3|Period III|Lost to Follow-up|0
1776546|NCT00696774|6184411|P2|Period III|Lost to Follow-up|1
1776547|NCT00696774|6184412|P1|Period III|Lost to Follow-up|2
1776548|NCT00696774|6184410|P3|Period III|Adverse Event|0
1776549|NCT00696774|6184411|P2|Period III|Adverse Event|1
1776550|NCT00696774|6184412|P1|Period III|Adverse Event|1
1776551|NCT00696774|6184410|P3|Period II|Lack of Efficacy|2
1776552|NCT00696774|6184411|P2|Period II|Lack of Efficacy|0
1776553|NCT00696774|6184412|P1|Period II|Lack of Efficacy|0
1776554|NCT00696774|6184410|P3|Period II|Sponsor Decision|0
1776555|NCT00696774|6184411|P2|Period II|Sponsor Decision|0
1776556|NCT00696774|6184412|P1|Period II|Sponsor Decision|0
1776557|NCT00696774|6184410|P3|Period II|Withdrawal by Subject|4
1776558|NCT00696774|6184411|P2|Period II|Withdrawal by Subject|0
1776559|NCT00696774|6184412|P1|Period II|Withdrawal by Subject|0
1776560|NCT00696774|6184410|P3|Period II|Protocol Violation|11
1776561|NCT00696774|6184411|P2|Period II|Protocol Violation|0
1776562|NCT00696774|6184412|P1|Period II|Protocol Violation|0
1776563|NCT00696774|6184410|P3|Period II|Lost to Follow-up|4
1776564|NCT00696774|6184411|P2|Period II|Lost to Follow-up|0
1776565|NCT00696774|6184412|P1|Period II|Lost to Follow-up|0
1776566|NCT00696774|6184410|P3|Period II|Adverse Event|15
1776567|NCT00696774|6184411|P2|Period II|Adverse Event|0
1776568|NCT00696774|6184412|P1|Period II|Adverse Event|0
1776569|NCT00696709|6184472|P5|Overall Study|Adverse Event|0
1776570|NCT00696709|6184473|P4|Overall Study|Adverse Event|1
1776571|NCT00696709|6184474|P3|Overall Study|Adverse Event|0
1776572|NCT00696709|6184475|P2|Overall Study|Adverse Event|0
1776573|NCT00696709|6184476|P1|Overall Study|Adverse Event|0
1776574|NCT00696709|6184472|P5|Overall Study|Lost to Follow-up|0
1776575|NCT00696709|6184473|P4|Overall Study|Lost to Follow-up|0
1776576|NCT00696709|6184474|P3|Overall Study|Lost to Follow-up|0
1776577|NCT00696709|6184475|P2|Overall Study|Lost to Follow-up|1
1776578|NCT00696709|6184476|P1|Overall Study|Lost to Follow-up|1
1776579|NCT00696709|6184472|P5|Overall Study|Protocol Violation|0
1776580|NCT00696709|6184473|P4|Overall Study|Protocol Violation|0
1776581|NCT00696709|6184474|P3|Overall Study|Protocol Violation|0
1776582|NCT00696709|6184475|P2|Overall Study|Protocol Violation|0
1776583|NCT00696709|6184476|P1|Overall Study|Protocol Violation|1
1776584|NCT00696709|6184472|P5|Overall Study|Withdrawal by Subject|3
1776585|NCT00696709|6184473|P4|Overall Study|Withdrawal by Subject|4
1776586|NCT00696709|6184474|P3|Overall Study|Withdrawal by Subject|1
1776587|NCT00696709|6184475|P2|Overall Study|Withdrawal by Subject|2
1776588|NCT00696709|6184476|P1|Overall Study|Withdrawal by Subject|1
1776589|NCT00696696|6184512|P1|Overall Study|Death|3
1776590|NCT00696696|6184512|P1|Overall Study|Physician Decision|2
1776591|NCT00696696|6184512|P1|Overall Study|Withdrawal by Subject|8
1776592|NCT00696696|6184512|P1|Overall Study|Adverse Event|5
1776593|NCT00696657|6184527|P9|Overall Study|Adverse Event|5
1776594|NCT00696657|6184528|P8|Overall Study|Adverse Event|2
1776595|NCT00696657|6184529|P7|Overall Study|Adverse Event|14
1776596|NCT00696657|6184530|P6|Overall Study|Adverse Event|9
1776597|NCT00696657|6184531|P5|Overall Study|Adverse Event|6
1776598|NCT00696657|6184532|P4|Overall Study|Adverse Event|7
1776599|NCT00696657|6184533|P3|Overall Study|Adverse Event|3
1776600|NCT00696657|6184534|P2|Overall Study|Adverse Event|0
1776601|NCT00696657|6184535|P1|Overall Study|Adverse Event|0
1776602|NCT00696657|6184527|P9|Overall Study|Unclassified|1
1776603|NCT00696657|6184528|P8|Overall Study|Unclassified|0
1776604|NCT00696657|6184529|P7|Overall Study|Unclassified|0
1776605|NCT00696657|6184530|P6|Overall Study|Unclassified|2
1776606|NCT00696657|6184531|P5|Overall Study|Unclassified|4
1776607|NCT00696657|6184532|P4|Overall Study|Unclassified|2
1776608|NCT00696657|6184533|P3|Overall Study|Unclassified|3
1776609|NCT00696657|6184534|P2|Overall Study|Unclassified|1
1776610|NCT00696657|6184535|P1|Overall Study|Unclassified|0
1776611|NCT00696657|6184527|P9|Overall Study|Withdrawal criteria|2
1776612|NCT00696657|6184528|P8|Overall Study|Withdrawal criteria|1
1776613|NCT00696657|6184529|P7|Overall Study|Withdrawal criteria|1
1776614|NCT00696657|6184530|P6|Overall Study|Withdrawal criteria|0
1776615|NCT00696657|6184531|P5|Overall Study|Withdrawal criteria|0
1776616|NCT00696657|6184532|P4|Overall Study|Withdrawal criteria|2
1776617|NCT00696657|6184533|P3|Overall Study|Withdrawal criteria|2
1776618|NCT00696657|6184534|P2|Overall Study|Withdrawal criteria|3
1776619|NCT00696657|6184535|P1|Overall Study|Withdrawal criteria|1
1776620|NCT00696657|6184527|P9|Overall Study|Lack of Efficacy|0
1776621|NCT00696657|6184528|P8|Overall Study|Lack of Efficacy|0
1776622|NCT00696657|6184529|P7|Overall Study|Lack of Efficacy|0
1776623|NCT00696657|6184530|P6|Overall Study|Lack of Efficacy|0
1776624|NCT00696657|6184531|P5|Overall Study|Lack of Efficacy|0
1776625|NCT00696657|6184532|P4|Overall Study|Lack of Efficacy|0
1776626|NCT00696657|6184533|P3|Overall Study|Lack of Efficacy|0
1776627|NCT00696657|6184534|P2|Overall Study|Lack of Efficacy|1
1776628|NCT00696657|6184535|P1|Overall Study|Lack of Efficacy|0
1776629|NCT00696657|6184527|P9|Overall Study|Protocol Violation|1
1776630|NCT00696657|6184528|P8|Overall Study|Protocol Violation|0
1776631|NCT00696657|6184529|P7|Overall Study|Protocol Violation|0
1776632|NCT00696657|6184530|P6|Overall Study|Protocol Violation|1
1776633|NCT00696657|6184531|P5|Overall Study|Protocol Violation|0
1776634|NCT00696657|6184532|P4|Overall Study|Protocol Violation|0
1776635|NCT00696657|6184533|P3|Overall Study|Protocol Violation|0
1776636|NCT00696657|6184534|P2|Overall Study|Protocol Violation|0
1776637|NCT00696657|6184535|P1|Overall Study|Protocol Violation|0
1776638|NCT00696436|6184904|P5|Overall Study|Missing|0
1776639|NCT00696436|6184905|P4|Overall Study|Missing|0
1776640|NCT00696436|6184906|P3|Overall Study|Missing|1
1776641|NCT00696436|6184907|P2|Overall Study|Missing|1
1776642|NCT00696436|6184908|P1|Overall Study|Missing|0
1776643|NCT00696436|6184904|P5|Overall Study|Administrative Decision|0
1776644|NCT00696436|6184905|P4|Overall Study|Administrative Decision|0
1776645|NCT00696436|6184906|P3|Overall Study|Administrative Decision|0
1776646|NCT00696436|6184907|P2|Overall Study|Administrative Decision|0
1776647|NCT00696436|6184908|P1|Overall Study|Administrative Decision|1
1776648|NCT00696436|6184904|P5|Overall Study|Participant Non-compliance|0
1776649|NCT00696436|6184905|P4|Overall Study|Participant Non-compliance|2
1776650|NCT00696436|6184906|P3|Overall Study|Participant Non-compliance|1
1776651|NCT00696436|6184907|P2|Overall Study|Participant Non-compliance|0
1776652|NCT00696436|6184908|P1|Overall Study|Participant Non-compliance|0
1776653|NCT00696436|6184904|P5|Overall Study|Administrative Error|0
1776654|NCT00696436|6184905|P4|Overall Study|Administrative Error|0
1776655|NCT00696436|6184906|P3|Overall Study|Administrative Error|2
1776656|NCT00696436|6184907|P2|Overall Study|Administrative Error|0
1776657|NCT00696436|6184908|P1|Overall Study|Administrative Error|2
1776658|NCT00696436|6184904|P5|Overall Study|Participant Unavailability|0
1776659|NCT00696436|6184905|P4|Overall Study|Participant Unavailability|1
1776660|NCT00696436|6184906|P3|Overall Study|Participant Unavailability|2
1776661|NCT00696436|6184907|P2|Overall Study|Participant Unavailability|0
1776662|NCT00696436|6184908|P1|Overall Study|Participant Unavailability|2
1776663|NCT00696436|6184904|P5|Overall Study|Lack of Efficacy|4
1776664|NCT00696436|6184905|P4|Overall Study|Lack of Efficacy|2
1776665|NCT00696436|6184906|P3|Overall Study|Lack of Efficacy|5
1776666|NCT00696436|6184907|P2|Overall Study|Lack of Efficacy|1
1776667|NCT00696436|6184908|P1|Overall Study|Lack of Efficacy|3
1776668|NCT00696436|6184904|P5|Overall Study|Withdrawal by Subject|1
1776669|NCT00696436|6184905|P4|Overall Study|Withdrawal by Subject|7
1776670|NCT00696436|6184906|P3|Overall Study|Withdrawal by Subject|5
1776671|NCT00696436|6184907|P2|Overall Study|Withdrawal by Subject|11
1776672|NCT00696436|6184908|P1|Overall Study|Withdrawal by Subject|4
1776673|NCT00696436|6184904|P5|Overall Study|Lost to Follow-up|3
1776674|NCT00696436|6184905|P4|Overall Study|Lost to Follow-up|4
1776675|NCT00696436|6184906|P3|Overall Study|Lost to Follow-up|2
1776676|NCT00696436|6184907|P2|Overall Study|Lost to Follow-up|6
1776677|NCT00696436|6184908|P1|Overall Study|Lost to Follow-up|1
1776678|NCT00696436|6184904|P5|Overall Study|Protocol Violation|1
1776679|NCT00696436|6184905|P4|Overall Study|Protocol Violation|0
1776680|NCT00696436|6184906|P3|Overall Study|Protocol Violation|2
1776681|NCT00696436|6184907|P2|Overall Study|Protocol Violation|2
1776682|NCT00696436|6184908|P1|Overall Study|Protocol Violation|3
1776683|NCT00696436|6184904|P5|Overall Study|Adverse Event|4
1776684|NCT00696436|6184905|P4|Overall Study|Adverse Event|6
1776685|NCT00696436|6184906|P3|Overall Study|Adverse Event|8
1776686|NCT00696436|6184907|P2|Overall Study|Adverse Event|9
1776687|NCT00696436|6184908|P1|Overall Study|Adverse Event|7
1776688|NCT00696423|6184992|P2|Overall Study|Lost to Follow-up|5
1776689|NCT00696423|6184993|P1|Overall Study|Lost to Follow-up|0
1776690|NCT00696410|6185025|P2|Overall Study|Physician Decision|0
1776691|NCT00696410|6185026|P1|Overall Study|Physician Decision|3
1776692|NCT00696410|6185025|P2|Overall Study|Withdrawal by Subject|0
1776693|NCT00696410|6185026|P1|Overall Study|Withdrawal by Subject|8
1776694|NCT00696410|6185025|P2|Overall Study|Lost to Follow-up|0
1776695|NCT00696410|6185026|P1|Overall Study|Lost to Follow-up|2
1776696|NCT00696384|6185040|P3|Double Blind Phase|Physician Decision|0
1776697|NCT00696384|6185041|P2|Double Blind Phase|Physician Decision|2
1776698|NCT00696384|6185042|P1|Double Blind Phase|Physician Decision|0
1776699|NCT00696384|6185040|P3|Double Blind Phase|Lack of Efficacy|0
1776700|NCT00696384|6185041|P2|Double Blind Phase|Lack of Efficacy|1
1776701|NCT00696384|6185042|P1|Double Blind Phase|Lack of Efficacy|0
1776702|NCT00696384|6185040|P3|Double Blind Phase|Withdrawal by Subject|3
1776703|NCT00696384|6185041|P2|Double Blind Phase|Withdrawal by Subject|4
1776704|NCT00696384|6185042|P1|Double Blind Phase|Withdrawal by Subject|0
1776705|NCT00696384|6185040|P3|Double Blind Phase|Lost to Follow-up|1
1776706|NCT00696384|6185041|P2|Double Blind Phase|Lost to Follow-up|2
1776707|NCT00696384|6185042|P1|Double Blind Phase|Lost to Follow-up|0
1776708|NCT00696384|6185040|P3|Double Blind Phase|Adverse Event|2
1776709|NCT00696384|6185041|P2|Double Blind Phase|Adverse Event|2
1776710|NCT00696384|6185042|P1|Double Blind Phase|Adverse Event|0
1776711|NCT00696384|6185040|P3|Open Label Phase|Physician Decision|0
1776712|NCT00696384|6185041|P2|Open Label Phase|Physician Decision|0
1776713|NCT00696384|6185042|P1|Open Label Phase|Physician Decision|4
1776714|NCT00696384|6185040|P3|Open Label Phase|Lack of Efficacy|0
1776715|NCT00696384|6185041|P2|Open Label Phase|Lack of Efficacy|0
1776716|NCT00696384|6185042|P1|Open Label Phase|Lack of Efficacy|3
1776717|NCT00696384|6185040|P3|Open Label Phase|Other|0
1776718|NCT00696384|6185041|P2|Open Label Phase|Other|0
1776719|NCT00696384|6185042|P1|Open Label Phase|Other|6
1776720|NCT00696384|6185040|P3|Open Label Phase|Withdrawal by Subject|0
1776721|NCT00696384|6185041|P2|Open Label Phase|Withdrawal by Subject|0
1776722|NCT00696384|6185042|P1|Open Label Phase|Withdrawal by Subject|37
1776723|NCT00696384|6185040|P3|Open Label Phase|Lost to Follow-up|0
1776724|NCT00696384|6185041|P2|Open Label Phase|Lost to Follow-up|0
1776725|NCT00696384|6185042|P1|Open Label Phase|Lost to Follow-up|24
1776726|NCT00696384|6185040|P3|Open Label Phase|Protocol Violation|0
1776727|NCT00696384|6185041|P2|Open Label Phase|Protocol Violation|0
1776728|NCT00696384|6185042|P1|Open Label Phase|Protocol Violation|18
1776729|NCT00696384|6185040|P3|Open Label Phase|Adverse Event|0
1776730|NCT00696384|6185041|P2|Open Label Phase|Adverse Event|0
1776731|NCT00696384|6185042|P1|Open Label Phase|Adverse Event|27
1776732|NCT00696241|6185066|P5|Overall Study|Other|1
1776733|NCT00696241|6185067|P4|Overall Study|Other|2
1776734|NCT00696241|6185068|P3|Overall Study|Other|5
1776735|NCT00696241|6185069|P2|Overall Study|Other|1
1776736|NCT00696241|6185070|P1|Overall Study|Other|6
1776737|NCT00696241|6185066|P5|Overall Study|Lack of Efficacy|3
1776738|NCT00696241|6185067|P4|Overall Study|Lack of Efficacy|5
1776739|NCT00696241|6185068|P3|Overall Study|Lack of Efficacy|4
1776740|NCT00696241|6185069|P2|Overall Study|Lack of Efficacy|5
1776741|NCT00696241|6185070|P1|Overall Study|Lack of Efficacy|1
1776742|NCT00696241|6185066|P5|Overall Study|Withdrawal by Subject|0
1776743|NCT00696241|6185067|P4|Overall Study|Withdrawal by Subject|1
1776744|NCT00696241|6185068|P3|Overall Study|Withdrawal by Subject|6
1776745|NCT00696241|6185069|P2|Overall Study|Withdrawal by Subject|8
1776746|NCT00696241|6185070|P1|Overall Study|Withdrawal by Subject|4
1776747|NCT00696241|6185066|P5|Overall Study|Lost to Follow-up|0
1776748|NCT00696241|6185067|P4|Overall Study|Lost to Follow-up|2
1776749|NCT00696241|6185068|P3|Overall Study|Lost to Follow-up|1
1776750|NCT00696241|6185069|P2|Overall Study|Lost to Follow-up|4
1776751|NCT00696241|6185070|P1|Overall Study|Lost to Follow-up|1
1776752|NCT00696241|6185066|P5|Overall Study|Protocol Violation|3
1776753|NCT00696241|6185067|P4|Overall Study|Protocol Violation|0
1776754|NCT00696241|6185068|P3|Overall Study|Protocol Violation|2
1776755|NCT00696241|6185069|P2|Overall Study|Protocol Violation|1
1776756|NCT00696241|6185070|P1|Overall Study|Protocol Violation|1
1776757|NCT00696241|6185066|P5|Overall Study|Adverse Event|5
1776758|NCT00696241|6185067|P4|Overall Study|Adverse Event|4
1776759|NCT00696241|6185068|P3|Overall Study|Adverse Event|6
1776760|NCT00696241|6185069|P2|Overall Study|Adverse Event|3
1776761|NCT00696241|6185070|P1|Overall Study|Adverse Event|11
1776762|NCT00696137|6185152|P1|Overall Study|Withdrawal by Subject|2
1776763|NCT00696072|6185158|P2|Overall Study|Non-specified|2
1776764|NCT00696072|6185159|P1|Overall Study|Non-specified|1
1776765|NCT00696072|6185158|P2|Overall Study|Disease Progression|30
1776766|NCT00696072|6185159|P1|Overall Study|Disease Progression|32
1776767|NCT00696072|6185158|P2|Overall Study|Sponsor Request|1
1776768|NCT00696072|6185159|P1|Overall Study|Sponsor Request|0
1776769|NCT00696072|6185158|P2|Overall Study|Investigator Request|4
1776770|NCT00696072|6185159|P1|Overall Study|Investigator Request|1
1776771|NCT00696072|6185158|P2|Overall Study|Patient Request|7
1776772|NCT00696072|6185159|P1|Overall Study|Patient Request|3
1776773|NCT00696072|6185158|P2|Overall Study|Adverse Event|6
1776774|NCT00696072|6185159|P1|Overall Study|Adverse Event|10
1776775|NCT00696072|6185158|P2|Overall Study|continuing active treatment|13
1776776|NCT00696072|6185159|P1|Overall Study|continuing active treatment|10
1776777|NCT00696020|6185180|P4|Overall Study|Other not stated above|1
1776778|NCT00696020|6185181|P3|Overall Study|Other not stated above|1
1776779|NCT00696020|6185182|P2|Overall Study|Other not stated above|0
1776780|NCT00696020|6185183|P1|Overall Study|Other not stated above|0
1776781|NCT00696020|6185180|P4|Overall Study|Withdrawal by Subject|1
1776782|NCT00696020|6185181|P3|Overall Study|Withdrawal by Subject|0
1776783|NCT00696020|6185182|P2|Overall Study|Withdrawal by Subject|1
1776784|NCT00696020|6185183|P1|Overall Study|Withdrawal by Subject|0
1776785|NCT00696020|6185180|P4|Overall Study|Protocol Violation|1
1776786|NCT00696020|6185181|P3|Overall Study|Protocol Violation|0
1776787|NCT00696020|6185182|P2|Overall Study|Protocol Violation|0
1776788|NCT00696020|6185183|P1|Overall Study|Protocol Violation|0
1776789|NCT00696020|6185180|P4|Overall Study|Lack of Efficacy|0
1776790|NCT00696020|6185181|P3|Overall Study|Lack of Efficacy|0
1776791|NCT00696020|6185182|P2|Overall Study|Lack of Efficacy|0
1776792|NCT00696020|6185183|P1|Overall Study|Lack of Efficacy|1
1776793|NCT00696020|6185180|P4|Overall Study|Adverse Event|1
1776794|NCT00696020|6185181|P3|Overall Study|Adverse Event|2
1776795|NCT00696020|6185182|P2|Overall Study|Adverse Event|1
1776796|NCT00696020|6185183|P1|Overall Study|Adverse Event|3
1776797|NCT00695955|6185291|P1|Cohort 2|Other|5
1776798|NCT00695955|6185291|P1|Cohort 2|Lack of Efficacy|4
1776799|NCT00695955|6185291|P1|Cohort 2|Withdrawal by Subject|28
1776800|NCT00695955|6185291|P1|Cohort 2|Lost to Follow-up|38
1776801|NCT00695955|6185291|P1|Cohort 2|Protocol Violation|5
1776802|NCT00695955|6185291|P1|Cohort 2|Adverse Event|24
1776803|NCT00695955|6185291|P1|Cohort 1|Other|16
1776804|NCT00695955|6185291|P1|Cohort 1|Lack of Efficacy|3
1776805|NCT00695955|6185291|P1|Cohort 1|Withdrawal by Subject|25
1776806|NCT00695955|6185291|P1|Cohort 1|Lost to Follow-up|30
1776807|NCT00695955|6185291|P1|Cohort 1|Protocol Violation|2
1776808|NCT00695955|6185291|P1|Cohort 1|Adverse Event|26
1776809|NCT00695903|6185303|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
1776810|NCT00695903|6185304|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
1776811|NCT00695903|6185303|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
1776812|NCT00695903|6185304|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
1776813|NCT00695903|6185303|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
1776814|NCT00695903|6185304|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
1776815|NCT00695903|6185303|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
1776816|NCT00695903|6185304|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
1776817|NCT00695903|6185303|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
1776818|NCT00695903|6185304|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
1776819|NCT00695903|6185303|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
1776820|NCT00695903|6185304|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
1776821|NCT00695903|6185303|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
1776822|NCT00695903|6185304|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
1776823|NCT00695903|6185303|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
1776824|NCT00695903|6185304|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
1776825|NCT00695903|6185303|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
1776826|NCT00695903|6185304|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
1776827|NCT00695864|6185316|P1|Placebo|Physician Decision|4
1776828|NCT00695864|6185316|P1|Placebo|Withdrawal by Subject|1
1776829|NCT00695669|6185326|P4|Overall Study|Lost to Follow-up|4
1776830|NCT00695669|6185327|P3|Overall Study|Lost to Follow-up|1
1776831|NCT00695669|6185328|P2|Overall Study|Lost to Follow-up|4
1776832|NCT00695669|6185329|P1|Overall Study|Lost to Follow-up|4
1776833|NCT00695669|6185326|P4|Overall Study|Adverse Event|0
1776834|NCT00695669|6185327|P3|Overall Study|Adverse Event|2
1776835|NCT00695669|6185328|P2|Overall Study|Adverse Event|0
1776836|NCT00695669|6185329|P1|Overall Study|Adverse Event|0
1776837|NCT00695565|6185414|P2|Overall Study|Subject did not follow instructions|1
1776838|NCT00695565|6185415|P1|Overall Study|Subject did not follow instructions|1
1776839|NCT00695565|6185414|P2|Overall Study|Lack of Efficacy|1
1776840|NCT00695565|6185415|P1|Overall Study|Lack of Efficacy|1
1776841|NCT00695565|6185414|P2|Overall Study|Withdrawal by Subject|1
1776842|NCT00695565|6185415|P1|Overall Study|Withdrawal by Subject|1
1776843|NCT00695565|6185414|P2|Overall Study|Protocol Violation|1
1776844|NCT00695565|6185415|P1|Overall Study|Protocol Violation|3
1776845|NCT00695565|6185414|P2|Overall Study|Adverse Event|1
1776846|NCT00695565|6185415|P1|Overall Study|Adverse Event|3
1776847|NCT00695565|6185414|P2|Overall Study|Lost to Follow-up|4
1776848|NCT00695565|6185415|P1|Overall Study|Lost to Follow-up|4
1776849|NCT00695396|6185488|P3|Overall Study|Withdrawal by Subject|0
1776850|NCT00695396|6185489|P2|Overall Study|Withdrawal by Subject|2
1776851|NCT00695396|6185490|P1|Overall Study|Withdrawal by Subject|2
1776852|NCT00695396|6185488|P3|Overall Study|Study Closed Prematurely|8
1776853|NCT00695396|6185489|P2|Overall Study|Study Closed Prematurely|6
1776854|NCT00695396|6185490|P1|Overall Study|Study Closed Prematurely|5
1776855|NCT00695318|6185506|P2|Overall Study|Study Terminated|0
1776856|NCT00695318|6185507|P1|Overall Study|Study Terminated|1
1776857|NCT00695318|6185506|P2|Overall Study|Death|1
1776858|NCT00695318|6185507|P1|Overall Study|Death|1
1776859|NCT00695318|6185506|P2|Overall Study|Withdrawal by Subject|0
1776860|NCT00695318|6185507|P1|Overall Study|Withdrawal by Subject|2
1776861|NCT00695318|6185506|P2|Overall Study|Lost to Follow-up|0
1776862|NCT00695318|6185507|P1|Overall Study|Lost to Follow-up|1
1776863|NCT00695136|6185532|P1|Overall Study|unrelated adverse event|1
1776864|NCT00695136|6185532|P1|Overall Study|Withdrawal by Subject|1
1776865|NCT00695019|6185548|P3|Overall Study|Various|4
1776866|NCT00695019|6185549|P2|Overall Study|Various|5
1776867|NCT00695019|6185550|P1|Overall Study|Various|4
1776868|NCT00695019|6185548|P3|Overall Study|Lack of Efficacy|1
1776869|NCT00695019|6185549|P2|Overall Study|Lack of Efficacy|0
1776870|NCT00695019|6185550|P1|Overall Study|Lack of Efficacy|0
1776871|NCT00695019|6185548|P3|Overall Study|Protocol Violation|1
1776872|NCT00695019|6185549|P2|Overall Study|Protocol Violation|3
1776873|NCT00695019|6185550|P1|Overall Study|Protocol Violation|1
1776874|NCT00695019|6185548|P3|Overall Study|Withdrawal by Subject|4
1776875|NCT00695019|6185549|P2|Overall Study|Withdrawal by Subject|6
1776876|NCT00695019|6185550|P1|Overall Study|Withdrawal by Subject|8
1776877|NCT00694707|6185584|P5|Overall Study|Notification of Past Head Injury|0
1776878|NCT00694707|6185585|P4|Overall Study|Notification of Past Head Injury|1
1776879|NCT00694707|6185586|P3|Overall Study|Notification of Past Head Injury|0
1776880|NCT00694707|6185587|P2|Overall Study|Notification of Past Head Injury|0
1776881|NCT00694707|6185588|P1|Overall Study|Notification of Past Head Injury|0
1776882|NCT00694707|6185584|P5|Overall Study|Administrative Reasons|0
1776883|NCT00694707|6185585|P4|Overall Study|Administrative Reasons|2
1776884|NCT00694707|6185586|P3|Overall Study|Administrative Reasons|0
1776885|NCT00694707|6185587|P2|Overall Study|Administrative Reasons|1
1776886|NCT00694707|6185588|P1|Overall Study|Administrative Reasons|0
1776887|NCT00694707|6185584|P5|Overall Study|Arrest by Police|0
1776888|NCT00694707|6185585|P4|Overall Study|Arrest by Police|0
1776889|NCT00694707|6185586|P3|Overall Study|Arrest by Police|0
1776890|NCT00694707|6185587|P2|Overall Study|Arrest by Police|1
1776891|NCT00694707|6185588|P1|Overall Study|Arrest by Police|0
1776892|NCT00694707|6185584|P5|Overall Study|Death in the Family|0
1776893|NCT00694707|6185585|P4|Overall Study|Death in the Family|0
1776894|NCT00694707|6185586|P3|Overall Study|Death in the Family|0
1776895|NCT00694707|6185587|P2|Overall Study|Death in the Family|0
1776896|NCT00694707|6185588|P1|Overall Study|Death in the Family|1
1776897|NCT00694707|6185584|P5|Overall Study|Jeopardizing Parole Status|0
1776898|NCT00694707|6185585|P4|Overall Study|Jeopardizing Parole Status|0
1776899|NCT00694707|6185586|P3|Overall Study|Jeopardizing Parole Status|0
1776900|NCT00694707|6185587|P2|Overall Study|Jeopardizing Parole Status|0
1776901|NCT00694707|6185588|P1|Overall Study|Jeopardizing Parole Status|1
1776902|NCT00694707|6185584|P5|Overall Study|Lost to Follow-up|0
1776903|NCT00694707|6185585|P4|Overall Study|Lost to Follow-up|0
1776904|NCT00694707|6185586|P3|Overall Study|Lost to Follow-up|2
1776905|NCT00694707|6185587|P2|Overall Study|Lost to Follow-up|1
1776906|NCT00694707|6185588|P1|Overall Study|Lost to Follow-up|0
1776907|NCT00694707|6185584|P5|Overall Study|Withdrawal of Consent|15
1776908|NCT00694707|6185585|P4|Overall Study|Withdrawal of Consent|16
1776909|NCT00694707|6185586|P3|Overall Study|Withdrawal of Consent|22
1776910|NCT00694707|6185587|P2|Overall Study|Withdrawal of Consent|18
1776911|NCT00694707|6185588|P1|Overall Study|Withdrawal of Consent|14
1776912|NCT00694707|6185584|P5|Overall Study|Protocol Violation|1
1776913|NCT00694707|6185585|P4|Overall Study|Protocol Violation|3
1776914|NCT00694707|6185586|P3|Overall Study|Protocol Violation|1
1776915|NCT00694707|6185587|P2|Overall Study|Protocol Violation|2
1776916|NCT00694707|6185588|P1|Overall Study|Protocol Violation|1
1776917|NCT00694707|6185584|P5|Overall Study|Insufficient Therapeutic Response|10
1776918|NCT00694707|6185585|P4|Overall Study|Insufficient Therapeutic Response|15
1776919|NCT00694707|6185586|P3|Overall Study|Insufficient Therapeutic Response|17
1776920|NCT00694707|6185587|P2|Overall Study|Insufficient Therapeutic Response|18
1776921|NCT00694707|6185588|P1|Overall Study|Insufficient Therapeutic Response|33
1776922|NCT00694707|6185584|P5|Overall Study|Adverse Event|13
1776923|NCT00694707|6185585|P4|Overall Study|Adverse Event|12
1776924|NCT00694707|6185586|P3|Overall Study|Adverse Event|8
1776925|NCT00694707|6185587|P2|Overall Study|Adverse Event|14
1776926|NCT00694707|6185588|P1|Overall Study|Adverse Event|22
1776927|NCT00694707|6185584|P5|Overall Study|Did Not Receive Treatment|1
1776928|NCT00694707|6185585|P4|Overall Study|Did Not Receive Treatment|1
1776929|NCT00694707|6185586|P3|Overall Study|Did Not Receive Treatment|1
1776930|NCT00694707|6185587|P2|Overall Study|Did Not Receive Treatment|0
1776931|NCT00694707|6185588|P1|Overall Study|Did Not Receive Treatment|0
1776932|NCT00694551|6185617|P3|Overall Study|Disease Progression|1
1776933|NCT00694551|6185618|P2|Overall Study|Disease Progression|0
1776934|NCT00694551|6185619|P1|Overall Study|Disease Progression|1
1776935|NCT00694369|6185648|P5|Overall Study|Withdrawal by Subject|2
1776936|NCT00694369|6185649|P4|Overall Study|Withdrawal by Subject|1
1776937|NCT00694369|6185650|P3|Overall Study|Withdrawal by Subject|1
1776938|NCT00694369|6185651|P2|Overall Study|Withdrawal by Subject|1
1776939|NCT00694369|6185652|P1|Overall Study|Withdrawal by Subject|1
1776940|NCT00694369|6185648|P5|Overall Study|Protocol Violation|0
1776941|NCT00694369|6185649|P4|Overall Study|Protocol Violation|0
1776942|NCT00694369|6185650|P3|Overall Study|Protocol Violation|0
1776943|NCT00694369|6185651|P2|Overall Study|Protocol Violation|1
1776944|NCT00694369|6185652|P1|Overall Study|Protocol Violation|0
1776945|NCT00694369|6185648|P5|Overall Study|Physician Decision|1
1776946|NCT00694369|6185649|P4|Overall Study|Physician Decision|0
1776947|NCT00694369|6185650|P3|Overall Study|Physician Decision|0
1776948|NCT00694369|6185651|P2|Overall Study|Physician Decision|0
1776949|NCT00694369|6185652|P1|Overall Study|Physician Decision|0
1776950|NCT00694369|6185648|P5|Overall Study|Lost to Follow-up|0
1776951|NCT00694369|6185649|P4|Overall Study|Lost to Follow-up|1
1776952|NCT00694369|6185650|P3|Overall Study|Lost to Follow-up|1
1776953|NCT00694369|6185651|P2|Overall Study|Lost to Follow-up|0
1776954|NCT00694369|6185652|P1|Overall Study|Lost to Follow-up|0
1776955|NCT00694369|6185648|P5|Overall Study|Adverse Event|3
1776956|NCT00694369|6185649|P4|Overall Study|Adverse Event|1
1776957|NCT00694369|6185650|P3|Overall Study|Adverse Event|0
1776958|NCT00694369|6185651|P2|Overall Study|Adverse Event|1
1776959|NCT00694369|6185652|P1|Overall Study|Adverse Event|0
1776960|NCT00694356|6185672|P3|Overall Study|Progressive Disease|6
1776961|NCT00694356|6185673|P2|Overall Study|Progressive Disease|6
1776962|NCT00694356|6185674|P1|Overall Study|Progressive Disease|2
1776963|NCT00694356|6185672|P3|Overall Study|Adverse Event|0
1776964|NCT00694356|6185673|P2|Overall Study|Adverse Event|0
1776965|NCT00694356|6185674|P1|Overall Study|Adverse Event|1
1776966|NCT00694304|6185709|P1|Overall Study|Administrative or Other Reasons|32
1776967|NCT00694304|6185709|P1|Overall Study|Lost to Follow-up|15
1776968|NCT00694304|6185709|P1|Overall Study|Withdrawal of Consent|61
1776969|NCT00694304|6185709|P1|Overall Study|Protocol Violation|6
1776970|NCT00694304|6185709|P1|Overall Study|Non-compliance With Study Product|16
1776971|NCT00694304|6185709|P1|Overall Study|Lack of Efficacy|35
1776972|NCT00694304|6185709|P1|Overall Study|Adverse Event|42
1776973|NCT00694161|6185722|P1|Part 2 (After Week 6 up to Month 12)|Death|1
1776974|NCT00694161|6185722|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
1776975|NCT00694161|6185722|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
1776976|NCT00694122|6185761|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
1776977|NCT00694122|6185762|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
1776978|NCT00694122|6185761|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
1776979|NCT00694122|6185762|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
1776980|NCT00694122|6185761|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
1776981|NCT00694122|6185762|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
1776982|NCT00694109|6185778|P1|Overall Study|Consented but no additional treatment|3
1776983|NCT00694109|6185778|P1|Overall Study|Other|2
1776984|NCT00694109|6185778|P1|Overall Study|Enrolled but not treated|1
1776985|NCT00694109|6185778|P1|Overall Study|Pregnancy|1
1776986|NCT00694109|6185778|P1|Overall Study|Withdrawal by Subject|13
1776987|NCT00694109|6185778|P1|Overall Study|Lack of Efficacy|2
1776988|NCT00694109|6185778|P1|Overall Study|Not consent of more 2 years of treatment|18
1776989|NCT00694109|6185778|P1|Overall Study|Adverse Event|74
1776990|NCT00694109|6185778|P1|Overall Study|Physician Decision|3
1776991|NCT00694096|6185802|P1|Overall Study|Withdrawal by Subject|5
1776992|NCT00693784|6185842|P1|Overall Study|Withdrawal by Subject|2
1776993|NCT00693784|6185842|P1|Overall Study|Lost to Follow-up|2
1776994|NCT00693706|6185855|P2|Overall Study|Protocol Violation|1
1776995|NCT00693706|6185856|P1|Overall Study|Protocol Violation|0
1776996|NCT00693693|6185883|P3|Overall Study|Lost to Follow-up|2
1776997|NCT00693693|6185884|P2|Overall Study|Lost to Follow-up|1
1776998|NCT00693693|6185885|P1|Overall Study|Lost to Follow-up|1
1776999|NCT00693472|6185944|P4|Part 2|Withdrew - reason unrelated to treatment|2
1777000|NCT00693472|6185945|P3|Part 2|Withdrew - reason unrelated to treatment|1
1777001|NCT00693472|6185946|P2|Part 2|Withdrew - reason unrelated to treatment|0
1777002|NCT00693472|6185947|P1|Part 2|Withdrew - reason unrelated to treatment|0
1777003|NCT00693472|6185944|P4|Part 2|Adverse Event|0
1777004|NCT00693472|6185945|P3|Part 2|Adverse Event|1
1777005|NCT00693472|6185946|P2|Part 2|Adverse Event|0
1777006|NCT00693472|6185947|P1|Part 2|Adverse Event|0
1777007|NCT00693472|6185944|P4|Part 1|Withdrew - reason unrelated to treatment|0
1777008|NCT00693472|6185945|P3|Part 1|Withdrew - reason unrelated to treatment|0
1777009|NCT00693472|6185946|P2|Part 1|Withdrew - reason unrelated to treatment|2
1777010|NCT00693472|6185947|P1|Part 1|Withdrew - reason unrelated to treatment|5
1777011|NCT00693472|6185944|P4|Part 1|Lost to Follow-up|0
1777012|NCT00693472|6185945|P3|Part 1|Lost to Follow-up|0
1777013|NCT00693472|6185946|P2|Part 1|Lost to Follow-up|1
1777014|NCT00693472|6185947|P1|Part 1|Lost to Follow-up|0
1777015|NCT00693472|6185944|P4|Part 1|Adverse Event|0
1777016|NCT00693472|6185945|P3|Part 1|Adverse Event|0
1777017|NCT00693472|6185946|P2|Part 1|Adverse Event|1
1777018|NCT00693472|6185947|P1|Part 1|Adverse Event|1
1777019|NCT00693420|6185967|P2|Overall Study|Personal Reasons|4
1777020|NCT00693420|6185968|P1|Overall Study|Personal Reasons|1
1777021|NCT00693420|6185967|P2|Overall Study|Sponsor Request - Conflict of Interest|2
1777022|NCT00693420|6185968|P1|Overall Study|Sponsor Request - Conflict of Interest|0
1777023|NCT00693420|6185967|P2|Overall Study|Protocol Violation|2
1777024|NCT00693420|6185968|P1|Overall Study|Protocol Violation|0
1777025|NCT00693420|6185967|P2|Overall Study|Withdrawal by Subject|0
1777026|NCT00693420|6185968|P1|Overall Study|Withdrawal by Subject|1
1777027|NCT00693420|6185967|P2|Overall Study|Lost to Follow-up|3
1777028|NCT00693420|6185968|P1|Overall Study|Lost to Follow-up|0
1777029|NCT00693420|6185967|P2|Overall Study|Adverse Event|4
1777030|NCT00693420|6185968|P1|Overall Study|Adverse Event|4
1777031|NCT00693225|6186007|P2|Overall Study|Adverse Event|3
1777032|NCT00693225|6186008|P1|Overall Study|Adverse Event|1
1777033|NCT00693225|6186007|P2|Overall Study|Lost to Follow-up|2
1777034|NCT00693225|6186008|P1|Overall Study|Lost to Follow-up|1
1777035|NCT00693017|6186031|P2|Overall Study|Death|1
1777036|NCT00693017|6186032|P1|Overall Study|Death|0
1777037|NCT00693017|6186031|P2|Overall Study|Sponsor Decision|1
1777038|NCT00693017|6186032|P1|Overall Study|Sponsor Decision|2
1777039|NCT00692913|6186042|P2|Overall Study|Withdrawal by Subject|20
1777040|NCT00692913|6186043|P1|Overall Study|Withdrawal by Subject|15
1777041|NCT00692913|6186042|P2|Overall Study|Protocol Violation|1
1777042|NCT00692913|6186043|P1|Overall Study|Protocol Violation|1
1777043|NCT00692913|6186042|P2|Overall Study|Physician Decision|0
1777044|NCT00692913|6186043|P1|Overall Study|Physician Decision|2
1777045|NCT00692913|6186042|P2|Overall Study|Lost to Follow-up|5
1777046|NCT00692913|6186043|P1|Overall Study|Lost to Follow-up|3
1777047|NCT00692913|6186042|P2|Overall Study|Adverse Event|4
1777048|NCT00692913|6186043|P1|Overall Study|Adverse Event|8
1777049|NCT00692770|6186065|P2|Overall Study|Randomized but not treated|4
1777050|NCT00692770|6186066|P1|Overall Study|Randomized but not treated|3
1777051|NCT00692770|6186065|P2|Overall Study|Study terminated by sponsor|2
1777052|NCT00692770|6186066|P1|Overall Study|Study terminated by sponsor|2
1777053|NCT00692770|6186065|P2|Overall Study|Clinical endpoint reached|43
1777054|NCT00692770|6186066|P1|Overall Study|Clinical endpoint reached|16
1777055|NCT00692770|6186065|P2|Overall Study|Radiological and clinical progression|8
1777056|NCT00692770|6186066|P1|Overall Study|Radiological and clinical progression|8
1777057|NCT00692770|6186065|P2|Overall Study|Completed all planned assessments|101
1777058|NCT00692770|6186066|P1|Overall Study|Completed all planned assessments|79
1777059|NCT00692770|6186065|P2|Overall Study|Protocol driven decision point|7
1777060|NCT00692770|6186066|P1|Overall Study|Protocol driven decision point|3
1777061|NCT00692770|6186065|P2|Overall Study|Disease progression, recurrence/relapse|279
1777062|NCT00692770|6186066|P1|Overall Study|Disease progression, recurrence/relapse|170
1777063|NCT00692770|6186065|P2|Overall Study|Physician decision not protocol driven|14
1777064|NCT00692770|6186066|P1|Overall Study|Physician decision not protocol driven|10
1777065|NCT00692770|6186065|P2|Overall Study|Progression by clinical judgment|3
1777066|NCT00692770|6186066|P1|Overall Study|Progression by clinical judgment|2
1777067|NCT00692770|6186065|P2|Overall Study|Non-compliant with study medication|5
1777068|NCT00692770|6186066|P1|Overall Study|Non-compliant with study medication|11
1777069|NCT00692770|6186065|P2|Overall Study|Lost to Follow-up|3
1777070|NCT00692770|6186066|P1|Overall Study|Lost to Follow-up|7
1777071|NCT00692770|6186065|P2|Overall Study|Death|5
1777072|NCT00692770|6186066|P1|Overall Study|Death|10
1777073|NCT00692770|6186065|P2|Overall Study|Adverse Event|41
1777074|NCT00692770|6186066|P1|Overall Study|Adverse Event|136
1777075|NCT00692770|6186065|P2|Overall Study|Withdrawal by Subject|36
1777076|NCT00692770|6186066|P1|Overall Study|Withdrawal by Subject|97
1777077|NCT00692770|6186065|P2|Overall Study|Protocol Violation|7
1777078|NCT00692770|6186066|P1|Overall Study|Protocol Violation|2
1777079|NCT00692406|6186112|P1|Overall Study|PI dropped, bad data|57
1777080|NCT00692237|6186174|P2|Overall Study|Adverse Event|1
1777081|NCT00692237|6186175|P1|Overall Study|Adverse Event|0
1777082|NCT00692237|6186174|P2|Overall Study|Withdrawal by Subject|3
1777083|NCT00692237|6186175|P1|Overall Study|Withdrawal by Subject|1
1777084|NCT00692003|6186262|P2|Overall Study|Sponsor Decision|1
1777085|NCT00692003|6186263|P1|Overall Study|Sponsor Decision|5
1777086|NCT00691938|6186278|P7|Overall Study|QTc prolongation|0
1777087|NCT00691938|6186279|P6|Overall Study|QTc prolongation|0
1777088|NCT00691938|6186280|P5|Overall Study|QTc prolongation|0
1777089|NCT00691938|6186281|P4|Overall Study|QTc prolongation|0
1777090|NCT00691938|6186282|P3|Overall Study|QTc prolongation|0
1777091|NCT00691938|6186283|P2|Overall Study|QTc prolongation|0
1777092|NCT00691938|6186284|P1|Overall Study|QTc prolongation|1
1777093|NCT00691704|6186351|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
1777094|NCT00691704|6186351|P1|Two Years of Maintenance Therapy|Physician Decision|4
1777095|NCT00691704|6186351|P1|Two Years of Maintenance Therapy|Disease Progression|8
1777096|NCT00691704|6186351|P1|Induction Therapy|Active Hepatitis|1
1777097|NCT00691704|6186351|P1|Induction Therapy|Disease Progression|1
1777098|NCT00691483|6186399|P2|Overall Study|Randomized by not treated|1
1777099|NCT00691483|6186400|P1|Overall Study|Randomized by not treated|7
1777100|NCT00691483|6186399|P2|Overall Study|Other known cause|1
1777101|NCT00691483|6186400|P1|Overall Study|Other known cause|6
1777102|NCT00691483|6186399|P2|Overall Study|Withdrawal by Subject|7
1777103|NCT00691483|6186400|P1|Overall Study|Withdrawal by Subject|24
1777104|NCT00691483|6186399|P2|Overall Study|Lost to Follow-up|10
1777105|NCT00691483|6186400|P1|Overall Study|Lost to Follow-up|17
1777106|NCT00691483|6186399|P2|Overall Study|Adverse Event|6
1777107|NCT00691483|6186400|P1|Overall Study|Adverse Event|14
1777108|NCT00691301|6186443|P1|Overall Study|Did not initiate study treatment|1
1777109|NCT00691301|6186443|P1|Overall Study|other reason|3
1777110|NCT00691301|6186443|P1|Overall Study|Concurrent illness|2
1777111|NCT00691301|6186443|P1|Overall Study|Withdrawal by Subject|4
1777112|NCT00691301|6186443|P1|Overall Study|Lack of Efficacy|32
1777113|NCT00691301|6186443|P1|Overall Study|Death|2
1777114|NCT00691301|6186443|P1|Overall Study|Adverse Event|10
1777115|NCT00691210|6186463|P8|Overall Study|Lack of Efficacy|0
1777116|NCT00691210|6186464|P7|Overall Study|Lack of Efficacy|0
1777117|NCT00691210|6186465|P6|Overall Study|Lack of Efficacy|1
1777118|NCT00691210|6186466|P5|Overall Study|Lack of Efficacy|0
1777119|NCT00691210|6186467|P4|Overall Study|Lack of Efficacy|1
1777120|NCT00691210|6186468|P3|Overall Study|Lack of Efficacy|0
1777121|NCT00691210|6186469|P2|Overall Study|Lack of Efficacy|0
1777122|NCT00691210|6186470|P1|Overall Study|Lack of Efficacy|0
1777123|NCT00691210|6186463|P8|Overall Study|Progression of Disease|0
1777124|NCT00691210|6186464|P7|Overall Study|Progression of Disease|0
1777125|NCT00691210|6186465|P6|Overall Study|Progression of Disease|0
1777126|NCT00691210|6186466|P5|Overall Study|Progression of Disease|0
1777127|NCT00691210|6186467|P4|Overall Study|Progression of Disease|2
1777128|NCT00691210|6186468|P3|Overall Study|Progression of Disease|0
1777129|NCT00691210|6186469|P2|Overall Study|Progression of Disease|0
1777130|NCT00691210|6186470|P1|Overall Study|Progression of Disease|0
1777131|NCT00691132|6186505|P2|Overall Study|Withdrawal by Subject|10
1777132|NCT00691132|6186506|P1|Overall Study|Withdrawal by Subject|10
1777133|NCT00691132|6186505|P2|Overall Study|Adverse Event|3
1777134|NCT00691132|6186506|P1|Overall Study|Adverse Event|2
1777135|NCT00691093|6186525|P1|Overall Study|Ongoing at Date of Cut-Off|4
1777136|NCT00691093|6186525|P1|Overall Study|Lack of Efficacy|1
1777137|NCT00691093|6186525|P1|Overall Study|Lost to Follow-up|1
1777138|NCT00691093|6186525|P1|Overall Study|Adverse Event|1
1777139|NCT00691054|6186559|P1|Overall Study|Withdrawal by Subject|1
1777140|NCT00691028|6186571|P4|Double-blind Period|not come to a hospital.|0
1777141|NCT00691028|6186572|P3|Double-blind Period|not come to a hospital.|0
1777142|NCT00691028|6186573|P2|Double-blind Period|not come to a hospital.|1
1777143|NCT00691028|6186574|P1|Double-blind Period|not come to a hospital.|0
1777144|NCT00691028|6186571|P4|Double-blind Period|Withdrawal by Subject|0
1777145|NCT00691028|6186572|P3|Double-blind Period|Withdrawal by Subject|1
1777146|NCT00691028|6186573|P2|Double-blind Period|Withdrawal by Subject|0
1777147|NCT00691028|6186574|P1|Double-blind Period|Withdrawal by Subject|1
1777148|NCT00691028|6186571|P4|Double-blind Period|Lack of Efficacy|0
1777149|NCT00691028|6186572|P3|Double-blind Period|Lack of Efficacy|2
1777150|NCT00691028|6186573|P2|Double-blind Period|Lack of Efficacy|3
1777151|NCT00691028|6186574|P1|Double-blind Period|Lack of Efficacy|4
1777152|NCT00691028|6186571|P4|Double-blind Period|Adverse Event|0
1777153|NCT00691028|6186572|P3|Double-blind Period|Adverse Event|6
1777154|NCT00691028|6186573|P2|Double-blind Period|Adverse Event|9
1777155|NCT00691028|6186574|P1|Double-blind Period|Adverse Event|8
1777156|NCT00691028|6186571|P4|Open-label Period|not come to a hospital|1
1777157|NCT00691028|6186572|P3|Open-label Period|not come to a hospital|0
1777158|NCT00691028|6186573|P2|Open-label Period|not come to a hospital|0
1777159|NCT00691028|6186574|P1|Open-label Period|not come to a hospital|0
1777160|NCT00691028|6186571|P4|Open-label Period|Withdrawal by Subject|3
1777161|NCT00691028|6186572|P3|Open-label Period|Withdrawal by Subject|0
1777162|NCT00691028|6186573|P2|Open-label Period|Withdrawal by Subject|0
1777163|NCT00691028|6186574|P1|Open-label Period|Withdrawal by Subject|0
1777164|NCT00691028|6186571|P4|Open-label Period|Adverse Event|16
1777165|NCT00691028|6186572|P3|Open-label Period|Adverse Event|0
1777166|NCT00691028|6186573|P2|Open-label Period|Adverse Event|0
1777167|NCT00691028|6186574|P1|Open-label Period|Adverse Event|0
1777168|NCT00691015|6186607|P1|Overall Study|Refused further treatment|1
1777169|NCT00690898|6186622|P1|TREATMENT|Other (not otherwise specified)|1
1777170|NCT00690898|6186622|P1|TREATMENT|Withdrawal by Subject|4
1777171|NCT00690898|6186622|P1|TREATMENT|Lack of Efficacy|18
1777172|NCT00690898|6186622|P1|TREATMENT|Adverse Event|3
1777173|NCT00690898|6186622|P1|SCREENING|Screen failure|18
1777174|NCT00690820|6186642|P2|Period 1|Withdrawal by Subject|1
1777175|NCT00690820|6186643|P1|Period 1|Withdrawal by Subject|0
1777176|NCT00690794|6186665|P2|Overall Study|Other not specified|3
1777177|NCT00690794|6186666|P1|Overall Study|Other not specified|1
1777178|NCT00690794|6186665|P2|Overall Study|Noncompliance|2
1777179|NCT00690794|6186666|P1|Overall Study|Noncompliance|1
1777180|NCT00690794|6186665|P2|Overall Study|Protocol Violation|7
1777181|NCT00690794|6186666|P1|Overall Study|Protocol Violation|6
1777182|NCT00690794|6186665|P2|Overall Study|Withdrawal by Subject|9
1777183|NCT00690794|6186666|P1|Overall Study|Withdrawal by Subject|0
1777184|NCT00690794|6186665|P2|Overall Study|Lost to Follow-up|4
1777185|NCT00690794|6186666|P1|Overall Study|Lost to Follow-up|1
1777186|NCT00690794|6186665|P2|Overall Study|Adverse Event|10
1777187|NCT00690794|6186666|P1|Overall Study|Adverse Event|12
1777188|NCT00690755|6186681|P7|Overall Study|Physician Decision|0
1777189|NCT00690755|6186682|P6|Overall Study|Physician Decision|4
1777190|NCT00690755|6186683|P5|Overall Study|Physician Decision|0
1777191|NCT00690755|6186684|P4|Overall Study|Physician Decision|5
1777192|NCT00690755|6186685|P3|Overall Study|Physician Decision|46
1777193|NCT00690755|6186686|P2|Overall Study|Physician Decision|0
1777194|NCT00690755|6186687|P1|Overall Study|Physician Decision|2
1777195|NCT00690612|6186703|P1|Overall Study|Withdrawal by Subject|2
1777196|NCT00690612|6186703|P1|Overall Study|Adverse Event|1
1777197|NCT00690573|6186708|P1|Overall Study|Withdrawal by Subject|1
1777198|NCT00690573|6186708|P1|Overall Study|Lack of Efficacy|8
1777199|NCT00690482|6186727|P2|Overall Study|withdrew consent at rand.day|1
1777200|NCT00690482|6186728|P1|Overall Study|withdrew consent at rand.day|0
1777201|NCT00690482|6186727|P2|Overall Study|Intake of prohibited medicine|0
1777202|NCT00690482|6186728|P1|Overall Study|Intake of prohibited medicine|1
1777203|NCT00690482|6186727|P2|Overall Study|Study-specific discontinuation criteria|0
1777204|NCT00690482|6186728|P1|Overall Study|Study-specific discontinuation criteria|1
1777205|NCT00690482|6186727|P2|Overall Study|Incorrect enrolment|1
1777206|NCT00690482|6186728|P1|Overall Study|Incorrect enrolment|0
1777207|NCT00690482|6186727|P2|Overall Study|Adverse Event|1
1777208|NCT00690482|6186728|P1|Overall Study|Adverse Event|2
1777209|NCT00690443|6186762|P2|Overall Study|Adverse Event|2
1777210|NCT00690443|6186763|P1|Overall Study|Adverse Event|1
1777211|NCT00690430|6186773|P3|Extension Phase|Early Termination|3
1777212|NCT00690430|6186774|P2|Extension Phase|Early Termination|1
1777213|NCT00690430|6186775|P1|Extension Phase|Early Termination|10
1777214|NCT00690430|6186773|P3|Extension Phase|Withdrawal by Subject|2
1777215|NCT00690430|6186774|P2|Extension Phase|Withdrawal by Subject|0
1777216|NCT00690430|6186775|P1|Extension Phase|Withdrawal by Subject|0
1777217|NCT00690430|6186773|P3|Extension Phase|Death|1
1777218|NCT00690430|6186774|P2|Extension Phase|Death|1
1777219|NCT00690430|6186775|P1|Extension Phase|Death|1
1777220|NCT00690430|6186773|P3|Extension Phase|Adverse Event|2
1777221|NCT00690430|6186774|P2|Extension Phase|Adverse Event|1
1777222|NCT00690430|6186775|P1|Extension Phase|Adverse Event|2
1777223|NCT00690430|6186773|P3|Extension Phase|Administrative Problems|1
1777224|NCT00690430|6186774|P2|Extension Phase|Administrative Problems|1
1777225|NCT00690430|6186775|P1|Extension Phase|Administrative Problems|0
1777226|NCT00690430|6186773|P3|Extension Phase|Abnormal test procedure results|0
1777227|NCT00690430|6186774|P2|Extension Phase|Abnormal test procedure results|0
1777228|NCT00690430|6186775|P1|Extension Phase|Abnormal test procedure results|1
1777229|NCT00690430|6186773|P3|Extension Phase|Abnormal Lab Values|0
1777230|NCT00690430|6186774|P2|Extension Phase|Abnormal Lab Values|0
1777231|NCT00690430|6186775|P1|Extension Phase|Abnormal Lab Values|1
1777232|NCT00690430|6186773|P3|Extension Phase|Lack of Efficacy|4
1777233|NCT00690430|6186774|P2|Extension Phase|Lack of Efficacy|1
1777234|NCT00690430|6186775|P1|Extension Phase|Lack of Efficacy|3
1777235|NCT00690430|6186773|P3|Core Phase|Early Termination|0
1777236|NCT00690430|6186774|P2|Core Phase|Early Termination|5
1777237|NCT00690430|6186775|P1|Core Phase|Early Termination|0
1777238|NCT00690430|6186773|P3|Core Phase|Administrative Problems|0
1777239|NCT00690430|6186774|P2|Core Phase|Administrative Problems|1
1777240|NCT00690430|6186775|P1|Core Phase|Administrative Problems|0
1777241|NCT00690430|6186773|P3|Core Phase|Lack of Efficacy|0
1777242|NCT00690430|6186774|P2|Core Phase|Lack of Efficacy|10
1777243|NCT00690430|6186775|P1|Core Phase|Lack of Efficacy|8
1777244|NCT00690430|6186773|P3|Core Phase|Subject no longer requires study drug|0
1777245|NCT00690430|6186774|P2|Core Phase|Subject no longer requires study drug|0
1777246|NCT00690430|6186775|P1|Core Phase|Subject no longer requires study drug|1
1777247|NCT00690430|6186773|P3|Core Phase|Withdrawal by Subject|0
1777248|NCT00690430|6186774|P2|Core Phase|Withdrawal by Subject|3
1777249|NCT00690430|6186775|P1|Core Phase|Withdrawal by Subject|3
1777250|NCT00690430|6186773|P3|Core Phase|Protocol Violation|0
1777251|NCT00690430|6186774|P2|Core Phase|Protocol Violation|0
1777252|NCT00690430|6186775|P1|Core Phase|Protocol Violation|1
1777253|NCT00690430|6186773|P3|Core Phase|Death|0
1777254|NCT00690430|6186774|P2|Core Phase|Death|2
1777255|NCT00690430|6186775|P1|Core Phase|Death|0
1777256|NCT00690430|6186773|P3|Core Phase|Adverse Event|0
1777257|NCT00690430|6186774|P2|Core Phase|Adverse Event|1
1777258|NCT00690430|6186775|P1|Core Phase|Adverse Event|5
1777259|NCT00690430|6186773|P3|Core Phase|Abnormal Laboratory value|0
1777260|NCT00690430|6186774|P2|Core Phase|Abnormal Laboratory value|1
1777261|NCT00690430|6186775|P1|Core Phase|Abnormal Laboratory value|0
1777262|NCT00690378|6186804|P2|Overall Study|Social problem|0
1777263|NCT00690378|6186805|P1|Overall Study|Social problem|1
1777264|NCT00690378|6186804|P2|Overall Study|Did not meet inc/exc criteria|11
1777265|NCT00690378|6186805|P1|Overall Study|Did not meet inc/exc criteria|13
1777266|NCT00690378|6186804|P2|Overall Study|Lost to Follow-up|3
1777267|NCT00690378|6186805|P1|Overall Study|Lost to Follow-up|2
1777268|NCT00690378|6186804|P2|Overall Study|Protocol Violation|0
1777269|NCT00690378|6186805|P1|Overall Study|Protocol Violation|1
1777270|NCT00690378|6186804|P2|Overall Study|Withdrawal by Subject|0
1777271|NCT00690378|6186805|P1|Overall Study|Withdrawal by Subject|2
1777272|NCT00690378|6186804|P2|Overall Study|Adverse Event|0
1777273|NCT00690378|6186805|P1|Overall Study|Adverse Event|1
1777274|NCT00689936|6186902|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
1777275|NCT00689936|6186903|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
1777276|NCT00689936|6186904|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
1777277|NCT00689936|6186902|P3|Active Treatment Phase|Miscellaneous|47
1777278|NCT00689936|6186903|P2|Active Treatment Phase|Miscellaneous|34
1777279|NCT00689936|6186904|P1|Active Treatment Phase|Miscellaneous|52
1777280|NCT00689936|6186902|P3|Active Treatment Phase|Study Close Out|21
1777281|NCT00689936|6186903|P2|Active Treatment Phase|Study Close Out|26
1777282|NCT00689936|6186904|P1|Active Treatment Phase|Study Close Out|64
1777283|NCT00689936|6186902|P3|Active Treatment Phase|Protocol Violation|4
1777284|NCT00689936|6186903|P2|Active Treatment Phase|Protocol Violation|2
1777285|NCT00689936|6186904|P1|Active Treatment Phase|Protocol Violation|2
1777286|NCT00689936|6186902|P3|Active Treatment Phase|Lost to Follow-up|2
1777287|NCT00689936|6186903|P2|Active Treatment Phase|Lost to Follow-up|2
1777288|NCT00689936|6186904|P1|Active Treatment Phase|Lost to Follow-up|0
1777289|NCT00689936|6186902|P3|Active Treatment Phase|Death|37
1777290|NCT00689936|6186903|P2|Active Treatment Phase|Death|28
1777291|NCT00689936|6186904|P1|Active Treatment Phase|Death|60
1777292|NCT00689936|6186902|P3|Active Treatment Phase|Withdrawal by Subject|21
1777293|NCT00689936|6186903|P2|Active Treatment Phase|Withdrawal by Subject|16
1777294|NCT00689936|6186904|P1|Active Treatment Phase|Withdrawal by Subject|16
1777295|NCT00689936|6186902|P3|Active Treatment Phase|Disease Progression|339
1777296|NCT00689936|6186903|P2|Active Treatment Phase|Disease Progression|362
1777297|NCT00689936|6186904|P1|Active Treatment Phase|Disease Progression|273
1777298|NCT00689936|6186902|P3|Active Treatment Phase|Adverse Event|76
1777299|NCT00689936|6186903|P2|Active Treatment Phase|Adverse Event|71
1777300|NCT00689936|6186904|P1|Active Treatment Phase|Adverse Event|68
1777301|NCT00689871|6187053|P4|Overall Study|Physician Decision|0
1777302|NCT00689871|6187054|P3|Overall Study|Physician Decision|1
1777303|NCT00689871|6187055|P2|Overall Study|Physician Decision|1
1777304|NCT00689871|6187056|P1|Overall Study|Physician Decision|2
1777305|NCT00689871|6187053|P4|Overall Study|Death|2
1777306|NCT00689871|6187054|P3|Overall Study|Death|2
1777307|NCT00689871|6187055|P2|Overall Study|Death|10
1777308|NCT00689871|6187056|P1|Overall Study|Death|1
1777309|NCT00689871|6187053|P4|Overall Study|Withdrawal by Subject|1
1777310|NCT00689871|6187054|P3|Overall Study|Withdrawal by Subject|4
1777311|NCT00689871|6187055|P2|Overall Study|Withdrawal by Subject|3
1777312|NCT00689871|6187056|P1|Overall Study|Withdrawal by Subject|13
1777313|NCT00689871|6187053|P4|Overall Study|Explanted of All Study Devices|3
1777314|NCT00689871|6187054|P3|Overall Study|Explanted of All Study Devices|29
1777315|NCT00689871|6187055|P2|Overall Study|Explanted of All Study Devices|25
1777316|NCT00689871|6187056|P1|Overall Study|Explanted of All Study Devices|36
1777317|NCT00689871|6187053|P4|Overall Study|Lost to Follow-up|1
1777318|NCT00689871|6187054|P3|Overall Study|Lost to Follow-up|37
1777319|NCT00689871|6187055|P2|Overall Study|Lost to Follow-up|13
1777320|NCT00689871|6187056|P1|Overall Study|Lost to Follow-up|123
1777321|NCT00689793|6187083|P2|Overall Study|Lost to Follow-up|5
1777322|NCT00689793|6187084|P1|Overall Study|Lost to Follow-up|4
1777323|NCT00689728|6187103|P3|Optional Follow-Up|Withdrawal by Subject|3
1777324|NCT00689728|6187104|P2|Optional Follow-Up|Withdrawal by Subject|4
1777325|NCT00689728|6187105|P1|Optional Follow-Up|Withdrawal by Subject|2
1777326|NCT00689728|6187103|P3|Optional Follow-Up|Protocol Violation|1
1777327|NCT00689728|6187104|P2|Optional Follow-Up|Protocol Violation|0
1777328|NCT00689728|6187105|P1|Optional Follow-Up|Protocol Violation|0
1777329|NCT00689728|6187103|P3|Optional Follow-Up|Lost to Follow-up|1
1777330|NCT00689728|6187104|P2|Optional Follow-Up|Lost to Follow-up|1
1777331|NCT00689728|6187105|P1|Optional Follow-Up|Lost to Follow-up|0
1777332|NCT00689728|6187103|P3|Optional Follow-Up|Lack of Efficacy|1
1777333|NCT00689728|6187104|P2|Optional Follow-Up|Lack of Efficacy|1
1777334|NCT00689728|6187105|P1|Optional Follow-Up|Lack of Efficacy|0
1777335|NCT00689728|6187103|P3|Optional Follow-Up|Adverse Event|0
1777336|NCT00689728|6187104|P2|Optional Follow-Up|Adverse Event|0
1777337|NCT00689728|6187105|P1|Optional Follow-Up|Adverse Event|1
1777338|NCT00689728|6187103|P3|Rescue|Withdrawal by Subject|1
1777339|NCT00689728|6187104|P2|Rescue|Withdrawal by Subject|1
1777340|NCT00689728|6187105|P1|Rescue|Withdrawal by Subject|1
1777341|NCT00689728|6187103|P3|Rescue|Adverse Event|0
1777342|NCT00689728|6187104|P2|Rescue|Adverse Event|1
1777343|NCT00689728|6187105|P1|Rescue|Adverse Event|0
1777344|NCT00689728|6187103|P3|Double-Blind Treatment|Lack of Efficacy|2
1777345|NCT00689728|6187104|P2|Double-Blind Treatment|Lack of Efficacy|1
1777346|NCT00689728|6187105|P1|Double-Blind Treatment|Lack of Efficacy|0
1777347|NCT00689728|6187103|P3|Double-Blind Treatment|Withdrawal by Subject|2
1777348|NCT00689728|6187104|P2|Double-Blind Treatment|Withdrawal by Subject|3
1777349|NCT00689728|6187105|P1|Double-Blind Treatment|Withdrawal by Subject|3
1777350|NCT00689728|6187103|P3|Double-Blind Treatment|Protocol Violation|1
1777351|NCT00689728|6187104|P2|Double-Blind Treatment|Protocol Violation|0
1777352|NCT00689728|6187105|P1|Double-Blind Treatment|Protocol Violation|0
1777353|NCT00689728|6187103|P3|Double-Blind Treatment|Adverse Event|0
1777354|NCT00689728|6187104|P2|Double-Blind Treatment|Adverse Event|0
1777355|NCT00689728|6187105|P1|Double-Blind Treatment|Adverse Event|1
1777356|NCT00689611|6187188|P2|Overall Study|Lost to Follow-up|28
1777357|NCT00689611|6187189|P1|Overall Study|Lost to Follow-up|27
1777358|NCT00689611|6187188|P2|Overall Study|Withdrawal by Subject|9
1777359|NCT00689611|6187189|P1|Overall Study|Withdrawal by Subject|8
1777360|NCT00689611|6187188|P2|Overall Study|Death|9
1777361|NCT00689611|6187189|P1|Overall Study|Death|6
1777362|NCT00689481|6187199|P2|Overall Study|Subject early term, left on vacation|1
1777363|NCT00689481|6187200|P1|Overall Study|Subject early term, left on vacation|0
1777364|NCT00689481|6187199|P2|Overall Study|Excluded medication started during study|1
1777365|NCT00689481|6187200|P1|Overall Study|Excluded medication started during study|0
1777366|NCT00689481|6187199|P2|Overall Study|Withdrawal by Subject|4
1777367|NCT00689481|6187200|P1|Overall Study|Withdrawal by Subject|8
1777368|NCT00689481|6187199|P2|Overall Study|Non-compliance with study treatment|1
1777369|NCT00689481|6187200|P1|Overall Study|Non-compliance with study treatment|1
1777370|NCT00689481|6187199|P2|Overall Study|Lack of Efficacy|3
1777371|NCT00689481|6187200|P1|Overall Study|Lack of Efficacy|4
1777372|NCT00689481|6187199|P2|Overall Study|Lost to Follow-up|3
1777373|NCT00689481|6187200|P1|Overall Study|Lost to Follow-up|4
1777374|NCT00689481|6187199|P2|Overall Study|Adverse Event|1
1777375|NCT00689481|6187200|P1|Overall Study|Adverse Event|7
1777376|NCT00689390|6187218|P2|Overall Study|Administrative|0
1777377|NCT00689390|6187219|P1|Overall Study|Administrative|37
1777378|NCT00689390|6187218|P2|Overall Study|Did Not Meet Protocol Eligibility|0
1777379|NCT00689390|6187219|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1777380|NCT00689390|6187218|P2|Overall Study|Non-Compliance With Protocol|0
1777381|NCT00689390|6187219|P1|Overall Study|Non-Compliance With Protocol|21
1777382|NCT00689390|6187218|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
1777383|NCT00689390|6187219|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
1777384|NCT00689390|6187218|P2|Overall Study|Withdrawal by Subject|3
1777385|NCT00689390|6187219|P1|Overall Study|Withdrawal by Subject|117
1777386|NCT00689390|6187218|P2|Overall Study|Lost to Follow-up|7
1777387|NCT00689390|6187219|P1|Overall Study|Lost to Follow-up|179
1777388|NCT00689390|6187218|P2|Overall Study|Adverse Event|0
1777389|NCT00689390|6187219|P1|Overall Study|Adverse Event|19
1777390|NCT00689351|6187237|P2|After Infant Series|Parent/legal guardian request|0
1777391|NCT00689351|6187238|P1|After Infant Series|Parent/legal guardian request|1
1777392|NCT00689351|6187237|P2|Infant Series of Dosing|Lost to Follow-up|1
1777393|NCT00689351|6187238|P1|Infant Series of Dosing|Lost to Follow-up|0
1777394|NCT00689351|6187237|P2|Infant Series of Dosing|Adverse Event|0
1777395|NCT00689351|6187238|P1|Infant Series of Dosing|Adverse Event|1
1777396|NCT00689351|6187237|P2|Infant Series of Dosing|Parent/legal guardian request|0
1777397|NCT00689351|6187238|P1|Infant Series of Dosing|Parent/legal guardian request|5
1777398|NCT00689338|6187270|P1|Overall Study|Protocol Violation|15
1777399|NCT00689338|6187270|P1|Overall Study|Withdrawal by Subject|3
1777400|NCT00689338|6187270|P1|Overall Study|Lost to Follow-up|5
1777401|NCT00689338|6187270|P1|Overall Study|Did not Meet Entrance Criteria|27
1777402|NCT00689338|6187270|P1|Overall Study|Other|8
1777403|NCT00689338|6187270|P1|Overall Study|Lack of Efficacy|6
1777404|NCT00689338|6187270|P1|Overall Study|Insufficient Clinical Response|1
1777405|NCT00689338|6187270|P1|Overall Study|Adverse Event|13
1777406|NCT00689338|6187270|P1|Overall Study|Death|65
1777407|NCT00689299|6187283|P3|Overall Study|Protocol Violation|0
1777408|NCT00689299|6187284|P2|Overall Study|Protocol Violation|0
1777409|NCT00689299|6187285|P1|Overall Study|Protocol Violation|1
1777410|NCT00689299|6187283|P3|Overall Study|Withdrawal by Subject|3
1777411|NCT00689299|6187284|P2|Overall Study|Withdrawal by Subject|1
1777412|NCT00689299|6187285|P1|Overall Study|Withdrawal by Subject|4
1777413|NCT00689299|6187283|P3|Overall Study|Lost to Follow-up|1
1777414|NCT00689299|6187284|P2|Overall Study|Lost to Follow-up|1
1777415|NCT00689299|6187285|P1|Overall Study|Lost to Follow-up|0
1777416|NCT00689299|6187283|P3|Overall Study|Adverse Event|1
1777417|NCT00689299|6187284|P2|Overall Study|Adverse Event|1
1777418|NCT00689299|6187285|P1|Overall Study|Adverse Event|2
1777419|NCT00689221|6187314|P2|Overall Study|Ongoing at cut-off date|36
1777420|NCT00689221|6187315|P1|Overall Study|Ongoing at cut-off date|39
1777421|NCT00689117|6187344|P4|Overall Study|Dispensing Error|0
1777422|NCT00689117|6187345|P3|Overall Study|Dispensing Error|0
1777423|NCT00689117|6187346|P2|Overall Study|Dispensing Error|1
1777424|NCT00689117|6187347|P1|Overall Study|Dispensing Error|0
1777425|NCT00689117|6187344|P4|Overall Study|Personal Reason|0
1777426|NCT00689117|6187345|P3|Overall Study|Personal Reason|0
1777427|NCT00689117|6187346|P2|Overall Study|Personal Reason|1
1777428|NCT00689117|6187347|P1|Overall Study|Personal Reason|0
1777429|NCT00689117|6187344|P4|Overall Study|Patient Withdrew from Study|1
1777430|NCT00689117|6187345|P3|Overall Study|Patient Withdrew from Study|0
1777431|NCT00689117|6187346|P2|Overall Study|Patient Withdrew from Study|0
1777432|NCT00689117|6187347|P1|Overall Study|Patient Withdrew from Study|0
1777433|NCT00689117|6187344|P4|Overall Study|Transportation|0
1777434|NCT00689117|6187345|P3|Overall Study|Transportation|0
1777435|NCT00689117|6187346|P2|Overall Study|Transportation|0
1777436|NCT00689117|6187347|P1|Overall Study|Transportation|1
1777437|NCT00689117|6187344|P4|Overall Study|Fear of Birth Defects|0
1777438|NCT00689117|6187345|P3|Overall Study|Fear of Birth Defects|1
1777439|NCT00689117|6187346|P2|Overall Study|Fear of Birth Defects|0
1777440|NCT00689117|6187347|P1|Overall Study|Fear of Birth Defects|0
1777441|NCT00689117|6187344|P4|Overall Study|Incarceration|0
1777442|NCT00689117|6187345|P3|Overall Study|Incarceration|0
1777443|NCT00689117|6187346|P2|Overall Study|Incarceration|0
1777444|NCT00689117|6187347|P1|Overall Study|Incarceration|2
1777445|NCT00689117|6187344|P4|Overall Study|Pregnancy|2
1777446|NCT00689117|6187345|P3|Overall Study|Pregnancy|0
1777447|NCT00689117|6187346|P2|Overall Study|Pregnancy|2
1777448|NCT00689117|6187347|P1|Overall Study|Pregnancy|0
1777449|NCT00689117|6187344|P4|Overall Study|Use of Prohibitive Medication|0
1777450|NCT00689117|6187345|P3|Overall Study|Use of Prohibitive Medication|3
1777451|NCT00689117|6187346|P2|Overall Study|Use of Prohibitive Medication|1
1777452|NCT00689117|6187347|P1|Overall Study|Use of Prohibitive Medication|2
1777453|NCT00689117|6187344|P4|Overall Study|Change/Discontinuation of Birth Control|0
1777454|NCT00689117|6187345|P3|Overall Study|Change/Discontinuation of Birth Control|1
1777455|NCT00689117|6187346|P2|Overall Study|Change/Discontinuation of Birth Control|1
1777456|NCT00689117|6187347|P1|Overall Study|Change/Discontinuation of Birth Control|1
1777457|NCT00689117|6187344|P4|Overall Study|Non-compliance with Treatment Regimen|0
1777458|NCT00689117|6187345|P3|Overall Study|Non-compliance with Treatment Regimen|0
1777459|NCT00689117|6187346|P2|Overall Study|Non-compliance with Treatment Regimen|1
1777460|NCT00689117|6187347|P1|Overall Study|Non-compliance with Treatment Regimen|0
1777461|NCT00689117|6187344|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1777462|NCT00689117|6187345|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1777463|NCT00689117|6187346|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1777464|NCT00689117|6187347|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
1777465|NCT00689117|6187344|P4|Overall Study|Unable to Comply with Visit Schedule|1
1777466|NCT00689117|6187345|P3|Overall Study|Unable to Comply with Visit Schedule|1
1777467|NCT00689117|6187346|P2|Overall Study|Unable to Comply with Visit Schedule|0
1777468|NCT00689117|6187347|P1|Overall Study|Unable to Comply with Visit Schedule|0
1777469|NCT00689117|6187344|P4|Overall Study|Withdrawal by Subject|13
1777470|NCT00689117|6187345|P3|Overall Study|Withdrawal by Subject|26
1777471|NCT00689117|6187346|P2|Overall Study|Withdrawal by Subject|18
1777472|NCT00689117|6187347|P1|Overall Study|Withdrawal by Subject|19
1777473|NCT00689117|6187344|P4|Overall Study|Non-Compliance with Study Treatment|1
1777474|NCT00689117|6187345|P3|Overall Study|Non-Compliance with Study Treatment|3
1777475|NCT00689117|6187346|P2|Overall Study|Non-Compliance with Study Treatment|3
1777476|NCT00689117|6187347|P1|Overall Study|Non-Compliance with Study Treatment|3
1777477|NCT00689117|6187344|P4|Overall Study|Lack of Efficacy|2
1777478|NCT00689117|6187345|P3|Overall Study|Lack of Efficacy|2
1777479|NCT00689117|6187346|P2|Overall Study|Lack of Efficacy|2
1777480|NCT00689117|6187347|P1|Overall Study|Lack of Efficacy|1
1777481|NCT00689117|6187344|P4|Overall Study|Lost to Follow-up|11
1777482|NCT00689117|6187345|P3|Overall Study|Lost to Follow-up|17
1777483|NCT00689117|6187346|P2|Overall Study|Lost to Follow-up|19
1777484|NCT00689117|6187347|P1|Overall Study|Lost to Follow-up|26
1777485|NCT00689117|6187344|P4|Overall Study|Adverse Event|0
1777486|NCT00689117|6187345|P3|Overall Study|Adverse Event|5
1777487|NCT00689117|6187346|P2|Overall Study|Adverse Event|0
1777488|NCT00689117|6187347|P1|Overall Study|Adverse Event|6
1777489|NCT00689104|6187377|P4|Overall Study|Non-compliance with study procedures|0
1777490|NCT00689104|6187378|P3|Overall Study|Non-compliance with study procedures|1
1777491|NCT00689104|6187379|P2|Overall Study|Non-compliance with study procedures|0
1777492|NCT00689104|6187380|P1|Overall Study|Non-compliance with study procedures|0
1777493|NCT00689104|6187377|P4|Overall Study|Physician Decision|0
1777494|NCT00689104|6187378|P3|Overall Study|Physician Decision|0
1777495|NCT00689104|6187379|P2|Overall Study|Physician Decision|0
1777496|NCT00689104|6187380|P1|Overall Study|Physician Decision|1
1777497|NCT00689104|6187377|P4|Overall Study|Randomized but never received study drug|0
1777498|NCT00689104|6187378|P3|Overall Study|Randomized but never received study drug|1
1777499|NCT00689104|6187379|P2|Overall Study|Randomized but never received study drug|1
1777500|NCT00689104|6187380|P1|Overall Study|Randomized but never received study drug|2
1777501|NCT00689104|6187377|P4|Overall Study|Protocol Violation|3
1777502|NCT00689104|6187378|P3|Overall Study|Protocol Violation|5
1777503|NCT00689104|6187379|P2|Overall Study|Protocol Violation|3
1777504|NCT00689104|6187380|P1|Overall Study|Protocol Violation|2
1777505|NCT00689104|6187377|P4|Overall Study|Lost to Follow-up|5
1777506|NCT00689104|6187378|P3|Overall Study|Lost to Follow-up|2
1777507|NCT00689104|6187379|P2|Overall Study|Lost to Follow-up|3
1777508|NCT00689104|6187380|P1|Overall Study|Lost to Follow-up|4
1777509|NCT00689104|6187377|P4|Overall Study|Withdrawal by Subject|11
1777510|NCT00689104|6187378|P3|Overall Study|Withdrawal by Subject|18
1777511|NCT00689104|6187379|P2|Overall Study|Withdrawal by Subject|11
1777512|NCT00689104|6187380|P1|Overall Study|Withdrawal by Subject|12
1777513|NCT00689104|6187377|P4|Overall Study|Lack of Efficacy|3
1777514|NCT00689104|6187378|P3|Overall Study|Lack of Efficacy|2
1777515|NCT00689104|6187379|P2|Overall Study|Lack of Efficacy|6
1777516|NCT00689104|6187380|P1|Overall Study|Lack of Efficacy|5
1777517|NCT00689104|6187377|P4|Overall Study|Adverse Event|24
1777518|NCT00689104|6187378|P3|Overall Study|Adverse Event|16
1777519|NCT00689104|6187379|P2|Overall Study|Adverse Event|25
1777520|NCT00689104|6187380|P1|Overall Study|Adverse Event|13
1777521|NCT00689104|6187377|P4|Overall Study|Eligibility criterion not met|4
1777522|NCT00689104|6187378|P3|Overall Study|Eligibility criterion not met|0
1777523|NCT00689104|6187379|P2|Overall Study|Eligibility criterion not met|8
1777524|NCT00689104|6187380|P1|Overall Study|Eligibility criterion not met|5
1777525|NCT00689052|6187586|P2|Overall Study|Early termination of the trial|24
1777526|NCT00689052|6187587|P1|Overall Study|Early termination of the trial|22
1777527|NCT00689052|6187586|P2|Overall Study|Withdrawal by Subject|0
1777528|NCT00689052|6187587|P1|Overall Study|Withdrawal by Subject|2
1777529|NCT00689052|6187586|P2|Overall Study|Lost to Follow-up|0
1777530|NCT00689052|6187587|P1|Overall Study|Lost to Follow-up|2
1777531|NCT00689052|6187586|P2|Overall Study|Protocol Violation|0
1777532|NCT00689052|6187587|P1|Overall Study|Protocol Violation|1
1777533|NCT00689052|6187586|P2|Overall Study|Adverse Event|6
1777534|NCT00689052|6187587|P1|Overall Study|Adverse Event|4
1777535|NCT00689026|6187619|P2|Overall Study|Withdrawal by Subject|6
1777536|NCT00689026|6187620|P1|Overall Study|Withdrawal by Subject|13
1777537|NCT00688870|6187633|P2|Infant Series|Parent or legal guardian request|0
1777538|NCT00688870|6187634|P1|Infant Series|Parent or legal guardian request|4
1777539|NCT00688844|6187666|P1|Overall Study|Lost to Follow-up|10
1777540|NCT00688753|6187676|P1|Overall Study|Lost to Follow-up|3
1777541|NCT00688753|6187676|P1|Overall Study|Protocol Violation|1
1777542|NCT00688753|6187676|P1|Overall Study|Adverse Event|20
1777543|NCT00688753|6187676|P1|Overall Study|Withdrawal by Subject|3
1777544|NCT00688753|6187676|P1|Overall Study|Death|9
1777545|NCT00688753|6187676|P1|Overall Study|Missing|1
1777546|NCT00688753|6187676|P1|Overall Study|Disease progression|55
1777547|NCT00688740|6187687|P2|Overall Study|Violation of Inclusion Criteria|3
1777548|NCT00688740|6187688|P1|Overall Study|Violation of Inclusion Criteria|1
1777549|NCT00688740|6187687|P2|Overall Study|Breast Cancer Relapse|4
1777550|NCT00688740|6187688|P1|Overall Study|Breast Cancer Relapse|1
1777551|NCT00688740|6187687|P2|Overall Study|Consent Withdrawn|17
1777552|NCT00688740|6187688|P1|Overall Study|Consent Withdrawn|17
1777553|NCT00688740|6187687|P2|Overall Study|Lost to Follow-up|1
1777554|NCT00688740|6187688|P1|Overall Study|Lost to Follow-up|0
1777555|NCT00688740|6187687|P2|Overall Study|Death|2
1777556|NCT00688740|6187688|P1|Overall Study|Death|2
1777557|NCT00688740|6187687|P2|Overall Study|Adverse Event|8
1777558|NCT00688740|6187688|P1|Overall Study|Adverse Event|45
1777559|NCT00688701|6187701|P4|Overall Study|Poor compliance to protocol|0
1777560|NCT00688701|6187702|P3|Overall Study|Poor compliance to protocol|1
1777561|NCT00688701|6187703|P2|Overall Study|Poor compliance to protocol|1
1777562|NCT00688701|6187704|P1|Overall Study|Poor compliance to protocol|0
1777563|NCT00688701|6187701|P4|Overall Study|Withdrawal by Subject|8
1777564|NCT00688701|6187702|P3|Overall Study|Withdrawal by Subject|4
1777565|NCT00688701|6187703|P2|Overall Study|Withdrawal by Subject|3
1777566|NCT00688701|6187704|P1|Overall Study|Withdrawal by Subject|3
1777567|NCT00688701|6187701|P4|Overall Study|Lack of Efficacy|0
1777568|NCT00688701|6187702|P3|Overall Study|Lack of Efficacy|0
1777569|NCT00688701|6187703|P2|Overall Study|Lack of Efficacy|1
1777570|NCT00688701|6187704|P1|Overall Study|Lack of Efficacy|0
1777571|NCT00688701|6187701|P4|Overall Study|Adverse Event|3
1777572|NCT00688701|6187702|P3|Overall Study|Adverse Event|5
1777573|NCT00688701|6187703|P2|Overall Study|Adverse Event|0
1777574|NCT00688701|6187704|P1|Overall Study|Adverse Event|1
1777575|NCT00688688|6187745|P3|Overall Study|Violation of exclusion criterion|0
1777576|NCT00688688|6187746|P2|Overall Study|Violation of exclusion criterion|1
1777577|NCT00688688|6187747|P1|Overall Study|Violation of exclusion criterion|0
1777578|NCT00688688|6187745|P3|Overall Study|Site closure|0
1777579|NCT00688688|6187746|P2|Overall Study|Site closure|1
1777580|NCT00688688|6187747|P1|Overall Study|Site closure|0
1777581|NCT00688688|6187745|P3|Overall Study|Taking exclusionary medications|0
1777582|NCT00688688|6187746|P2|Overall Study|Taking exclusionary medications|0
1777583|NCT00688688|6187747|P1|Overall Study|Taking exclusionary medications|1
1777584|NCT00688688|6187745|P3|Overall Study|Non-compliance with study procedures|4
1777585|NCT00688688|6187746|P2|Overall Study|Non-compliance with study procedures|3
1777586|NCT00688688|6187747|P1|Overall Study|Non-compliance with study procedures|5
1777587|NCT00688688|6187745|P3|Overall Study|Randomized but never received study drug|0
1777588|NCT00688688|6187746|P2|Overall Study|Randomized but never received study drug|0
1777589|NCT00688688|6187747|P1|Overall Study|Randomized but never received study drug|1
1777590|NCT00688688|6187745|P3|Overall Study|Protocol Violation|11
1777591|NCT00688688|6187746|P2|Overall Study|Protocol Violation|9
1777592|NCT00688688|6187747|P1|Overall Study|Protocol Violation|6
1777593|NCT00688688|6187745|P3|Overall Study|Lost to Follow-up|7
1777594|NCT00688688|6187746|P2|Overall Study|Lost to Follow-up|7
1777595|NCT00688688|6187747|P1|Overall Study|Lost to Follow-up|14
1777596|NCT00688688|6187745|P3|Overall Study|Withdrawal by Subject|65
1777597|NCT00688688|6187746|P2|Overall Study|Withdrawal by Subject|75
1777598|NCT00688688|6187747|P1|Overall Study|Withdrawal by Subject|66
1777599|NCT00688688|6187745|P3|Overall Study|Lack of Efficacy|45
1777600|NCT00688688|6187746|P2|Overall Study|Lack of Efficacy|25
1777601|NCT00688688|6187747|P1|Overall Study|Lack of Efficacy|34
1777602|NCT00688688|6187745|P3|Overall Study|Adverse Event|50
1777603|NCT00688688|6187746|P2|Overall Study|Adverse Event|51
1777604|NCT00688688|6187747|P1|Overall Study|Adverse Event|52
1777605|NCT00688688|6187745|P3|Overall Study|Eligibility criterion not met|10
1777606|NCT00688688|6187746|P2|Overall Study|Eligibility criterion not met|7
1777607|NCT00688688|6187747|P1|Overall Study|Eligibility criterion not met|7
1777608|NCT00688636|6187849|P2|Overall Study|Adverse Event|1
1777609|NCT00688636|6187850|P1|Overall Study|Adverse Event|2
1777610|NCT00688623|6187864|P1|Overall Study|Protocol Violation|2
1777611|NCT00688623|6187864|P1|Overall Study|disease progression|23
1777612|NCT00688623|6187864|P1|Overall Study|Death|3
1777613|NCT00688623|6187864|P1|Overall Study|Withdrawal by Subject|4
1777614|NCT00688623|6187864|P1|Overall Study|abnormal lab value|1
1777615|NCT00688623|6187864|P1|Overall Study|Adverse Event|22
1777616|NCT00688597|6187878|P3|Overall Study|Physician Decision|0
1777617|NCT00688597|6187879|P2|Overall Study|Physician Decision|0
1777618|NCT00688597|6187880|P1|Overall Study|Physician Decision|1
1777619|NCT00688597|6187878|P3|Overall Study|Adverse Event|0
1777620|NCT00688597|6187879|P2|Overall Study|Adverse Event|0
1777621|NCT00688597|6187880|P1|Overall Study|Adverse Event|2
1777622|NCT00688545|6187893|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
1777623|NCT00688545|6187894|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
1777624|NCT00688545|6187893|P2|Overall Study|Withdrawal by Subject|3
1777625|NCT00688545|6187894|P1|Overall Study|Withdrawal by Subject|2
1777626|NCT00688545|6187893|P2|Overall Study|Insurance/cost of drug|1
1777627|NCT00688545|6187894|P1|Overall Study|Insurance/cost of drug|0
1777628|NCT00688545|6187893|P2|Overall Study|Lost to Follow-up|4
1777629|NCT00688545|6187894|P1|Overall Study|Lost to Follow-up|1
1777630|NCT00688519|6187904|P2|Overall Study|Pregnancy|1
1777631|NCT00688519|6187905|P1|Overall Study|Pregnancy|0
1777632|NCT00688519|6187904|P2|Overall Study|Subject moved out of area|0
1777633|NCT00688519|6187905|P1|Overall Study|Subject moved out of area|1
1777634|NCT00688519|6187904|P2|Overall Study|Investigator decision|0
1777635|NCT00688519|6187905|P1|Overall Study|Investigator decision|1
1777636|NCT00688519|6187904|P2|Overall Study|Subject moved out of state|0
1777637|NCT00688519|6187905|P1|Overall Study|Subject moved out of state|1
1777638|NCT00688519|6187904|P2|Overall Study|Non-compliance|1
1777639|NCT00688519|6187905|P1|Overall Study|Non-compliance|0
1777640|NCT00688519|6187904|P2|Overall Study|Prohibited medication|0
1777641|NCT00688519|6187905|P1|Overall Study|Prohibited medication|1
1777642|NCT00688519|6187904|P2|Overall Study|Withdrawal by Subject|6
1777643|NCT00688519|6187905|P1|Overall Study|Withdrawal by Subject|7
1777644|NCT00688519|6187904|P2|Overall Study|Lack of Efficacy|1
1777645|NCT00688519|6187905|P1|Overall Study|Lack of Efficacy|3
1777646|NCT00688519|6187904|P2|Overall Study|Lost to Follow-up|3
1777647|NCT00688519|6187905|P1|Overall Study|Lost to Follow-up|3
1777648|NCT00688519|6187904|P2|Overall Study|Adverse Event|3
1777649|NCT00688519|6187905|P1|Overall Study|Adverse Event|2
1777650|NCT00688467|6187923|P2|Treatment Period 2|Adverse Event|1
1777651|NCT00688467|6187924|P1|Treatment Period 2|Adverse Event|0
1777652|NCT00688467|6187923|P2|Treatment Period 2|Protocol Violation|1
1777653|NCT00688467|6187924|P1|Treatment Period 2|Protocol Violation|0
1777654|NCT00688467|6187923|P2|Treatment Period 1|Did not meet protocol eligibility|1
1777655|NCT00688467|6187924|P1|Treatment Period 1|Did not meet protocol eligibility|0
1777656|NCT00688467|6187923|P2|Treatment Period 1|Adverse Event|1
1777657|NCT00688467|6187924|P1|Treatment Period 1|Adverse Event|2
1777658|NCT00688324|6187954|P1|Overall Study|Lost to Follow-up|1
1777659|NCT00688324|6187954|P1|Overall Study|Physician Decision|5
1777660|NCT00688324|6187954|P1|Overall Study|Withdrawal by Subject|2
1777661|NCT00688259|6187999|P2|Overall Study|Hospitalized at Follow-up|1
1777662|NCT00688259|6188000|P1|Overall Study|Hospitalized at Follow-up|0
1777663|NCT00688259|6187999|P2|Overall Study|Declined Interview|3
1777664|NCT00688259|6188000|P1|Overall Study|Declined Interview|2
1777665|NCT00688259|6187999|P2|Overall Study|Withdrawal by Subject|0
1777666|NCT00688259|6188000|P1|Overall Study|Withdrawal by Subject|2
1777667|NCT00688259|6187999|P2|Overall Study|Physician Decision|0
1777668|NCT00688259|6188000|P1|Overall Study|Physician Decision|1
1777669|NCT00688259|6187999|P2|Overall Study|Lost to Follow-up|4
1777670|NCT00688259|6188000|P1|Overall Study|Lost to Follow-up|2
1777671|NCT00688155|6188020|P4|Overall Study|Withdrawal by Subject|1
1777672|NCT00688155|6188021|P3|Overall Study|Withdrawal by Subject|1
1777673|NCT00688155|6188022|P2|Overall Study|Withdrawal by Subject|2
1777674|NCT00688155|6188023|P1|Overall Study|Withdrawal by Subject|2
1777675|NCT00688103|6188043|P2|Overall Study|complex reasons|9
1777676|NCT00688103|6188044|P1|Overall Study|complex reasons|11
1777677|NCT00688103|6188043|P2|Overall Study|Withdrawal by Subject|2
1777678|NCT00688103|6188044|P1|Overall Study|Withdrawal by Subject|4
1777679|NCT00688103|6188043|P2|Overall Study|Lack of Efficacy|1
1777680|NCT00688103|6188044|P1|Overall Study|Lack of Efficacy|11
1777681|NCT00688103|6188043|P2|Overall Study|Adverse Event|1
1777682|NCT00688103|6188044|P1|Overall Study|Adverse Event|4
1777683|NCT00688064|6188056|P2|Overall Study|Any other reasons|3
1777684|NCT00688064|6188057|P1|Overall Study|Any other reasons|1
1777685|NCT00688064|6188056|P2|Overall Study|Pregnancy|0
1777686|NCT00688064|6188057|P1|Overall Study|Pregnancy|1
1777687|NCT00688064|6188056|P2|Overall Study|Lack of Efficacy|1
1777688|NCT00688064|6188057|P1|Overall Study|Lack of Efficacy|0
1777689|NCT00688064|6188056|P2|Overall Study|Lost to Follow-up|10
1777690|NCT00688064|6188057|P1|Overall Study|Lost to Follow-up|10
1777691|NCT00688064|6188056|P2|Overall Study|Withdrawal by Subject|7
1777692|NCT00688064|6188057|P1|Overall Study|Withdrawal by Subject|7
1777693|NCT00688064|6188056|P2|Overall Study|Adverse Event|4
1777694|NCT00688064|6188057|P1|Overall Study|Adverse Event|2
1777695|NCT00688064|6188056|P2|Overall Study|Protocol Violation|1
1777696|NCT00688064|6188057|P1|Overall Study|Protocol Violation|0
1777697|NCT00687973|6188073|P2|Overall Study|Withdrawal by Subject|3
1777698|NCT00687973|6188074|P1|Overall Study|Withdrawal by Subject|3
1777699|NCT00687973|6188073|P2|Overall Study|Administrative Reasons|2
1777700|NCT00687973|6188074|P1|Overall Study|Administrative Reasons|0
1777701|NCT00687973|6188073|P2|Overall Study|Protocol Violation|2
1777702|NCT00687973|6188074|P1|Overall Study|Protocol Violation|1
1777703|NCT00687973|6188073|P2|Overall Study|Lack of Efficacy|3
1777704|NCT00687973|6188074|P1|Overall Study|Lack of Efficacy|2
1777705|NCT00687973|6188073|P2|Overall Study|Adverse Event|28
1777706|NCT00687973|6188074|P1|Overall Study|Adverse Event|18
1777707|NCT00687804|6188136|P3|Open-Label Extension Study|Death|3
1777708|NCT00687804|6188137|P2|Open-Label Extension Study|Death|3
1777709|NCT00687804|6188138|P1|Open-Label Extension Study|Death|2
1777710|NCT00687804|6188136|P3|Open-Label Extension Study|Administrative problems|0
1777711|NCT00687804|6188137|P2|Open-Label Extension Study|Administrative problems|1
1777712|NCT00687804|6188138|P1|Open-Label Extension Study|Administrative problems|1
1777713|NCT00687804|6188136|P3|Open-Label Extension Study|Lost to Follow-up|2
1777714|NCT00687804|6188137|P2|Open-Label Extension Study|Lost to Follow-up|1
1777715|NCT00687804|6188138|P1|Open-Label Extension Study|Lost to Follow-up|2
1777716|NCT00687804|6188136|P3|Open-Label Extension Study|Subject withdrew consent|4
1777717|NCT00687804|6188137|P2|Open-Label Extension Study|Subject withdrew consent|4
1777718|NCT00687804|6188138|P1|Open-Label Extension Study|Subject withdrew consent|3
1777719|NCT00687804|6188136|P3|Open-Label Extension Study|Adverse Event|2
1777720|NCT00687804|6188137|P2|Open-Label Extension Study|Adverse Event|2
1777721|NCT00687804|6188138|P1|Open-Label Extension Study|Adverse Event|2
1777722|NCT00687804|6188136|P3|Core Study|Protocol Violation|0
1777723|NCT00687804|6188137|P2|Core Study|Protocol Violation|1
1777724|NCT00687804|6188138|P1|Core Study|Protocol Violation|1
1777725|NCT00687804|6188136|P3|Core Study|Death|2
1777726|NCT00687804|6188137|P2|Core Study|Death|2
1777727|NCT00687804|6188138|P1|Core Study|Death|2
1777728|NCT00687804|6188136|P3|Core Study|Lost to Follow-up|0
1777729|NCT00687804|6188137|P2|Core Study|Lost to Follow-up|1
1777730|NCT00687804|6188138|P1|Core Study|Lost to Follow-up|0
1777731|NCT00687804|6188136|P3|Core Study|Withdrawal by Subject|7
1777732|NCT00687804|6188137|P2|Core Study|Withdrawal by Subject|7
1777733|NCT00687804|6188138|P1|Core Study|Withdrawal by Subject|4
1777734|NCT00687804|6188136|P3|Core Study|Lack of Efficacy|1
1777735|NCT00687804|6188137|P2|Core Study|Lack of Efficacy|1
1777736|NCT00687804|6188138|P1|Core Study|Lack of Efficacy|1
1777737|NCT00687804|6188136|P3|Core Study|Abnormal laboratory value(s)|0
1777738|NCT00687804|6188137|P2|Core Study|Abnormal laboratory value(s)|0
1777739|NCT00687804|6188138|P1|Core Study|Abnormal laboratory value(s)|1
1777740|NCT00687804|6188136|P3|Core Study|Adverse Event|3
1777741|NCT00687804|6188137|P2|Core Study|Adverse Event|3
1777742|NCT00687804|6188138|P1|Core Study|Adverse Event|5
1777743|NCT00687739|6188185|P4|Overall Study|Adverse Event|0
1777744|NCT00687739|6188186|P3|Overall Study|Adverse Event|1
1777745|NCT00687739|6188187|P2|Overall Study|Adverse Event|1
1777746|NCT00687739|6188188|P1|Overall Study|Adverse Event|0
1777747|NCT00687739|6188185|P4|Overall Study|Lost to Follow-up|2
1777748|NCT00687739|6188186|P3|Overall Study|Lost to Follow-up|1
1777749|NCT00687739|6188187|P2|Overall Study|Lost to Follow-up|2
1777750|NCT00687739|6188188|P1|Overall Study|Lost to Follow-up|2
1777751|NCT00687609|6188230|P1|Overall Study|Withdrawal by Subject|2
1777752|NCT00687609|6188230|P1|Overall Study|Physician Decision|1
1777753|NCT00687531|6188253|P1|Overall Study|Lost to Follow-up|26
1777754|NCT00687531|6188253|P1|Overall Study|Adverse Event|5
1777755|NCT00687531|6188253|P1|Overall Study|Did not meet protocol eligibility|104
1777756|NCT00687440|6188276|P1|Overall Study|Missing|1
1777757|NCT00687440|6188276|P1|Overall Study|Other|1
1777758|NCT00687440|6188276|P1|Overall Study|Death|2
1777759|NCT00687440|6188276|P1|Overall Study|Lack of Efficacy|2
1777760|NCT00687440|6188276|P1|Overall Study|Lost to Follow-up|3
1777761|NCT00687440|6188276|P1|Overall Study|Adverse Event|3
1777762|NCT00687401|6188280|P1|Overall Study|For reasons different from those above|4
1777763|NCT00687401|6188280|P1|Overall Study|Did not return for visit|3
1777764|NCT00687401|6188280|P1|Overall Study|Withdrawal by Subject|4
1777765|NCT00687401|6188280|P1|Overall Study|Lack of Efficacy|6
1777766|NCT00687401|6188280|P1|Overall Study|Adverse Event|6
1777767|NCT00687401|6188280|P1|Overall Study|Protocol Violation|7
1777768|NCT00687362|6188285|P1|Overall Study|Withdrawal by Subject|1
1777769|NCT00687362|6188285|P1|Overall Study|Protocol Violation|2
1777770|NCT00687323|6188289|P1|Overall Study|Screen failure|148
1777771|NCT00687323|6188289|P1|Overall Study|Excluded from efficacy evaluations|6
1777772|NCT00687323|6188289|P1|Overall Study|Withdrawal by Subject|1
1777773|NCT00687323|6188289|P1|Overall Study|Death|25
1777774|NCT00687297|6188305|P2|Induction|Other|1
1777775|NCT00687297|6188306|P1|Induction|Other|0
1777776|NCT00687297|6188305|P2|Induction|Physician Decision|2
1777777|NCT00687297|6188306|P1|Induction|Physician Decision|0
1777778|NCT00687297|6188305|P2|Induction|Patient Noncompliance|0
1777779|NCT00687297|6188306|P1|Induction|Patient Noncompliance|1
1777780|NCT00687297|6188305|P2|Induction|Ineligible|1
1777781|NCT00687297|6188306|P1|Induction|Ineligible|0
1777782|NCT00687297|6188305|P2|Induction|Lack of Efficacy|21
1777783|NCT00687297|6188306|P1|Induction|Lack of Efficacy|17
1777784|NCT00687297|6188305|P2|Induction|Death|11
1777785|NCT00687297|6188306|P1|Induction|Death|7
1777786|NCT00687297|6188305|P2|Induction|Adverse Event|15
1777787|NCT00687297|6188306|P1|Induction|Adverse Event|16
1777788|NCT00687297|6188305|P2|Induction|Withdrawal by Subject|4
1777789|NCT00687297|6188306|P1|Induction|Withdrawal by Subject|4
1777790|NCT00687297|6188305|P2|Randomization|Withdrew before treatment, ineligible|1
1777791|NCT00687297|6188306|P1|Randomization|Withdrew before treatment, ineligible|1
1777792|NCT00687297|6188305|P2|Randomization|Withdrawal by Subject|0
1777793|NCT00687297|6188306|P1|Randomization|Withdrawal by Subject|2
1777794|NCT00687271|6188320|P4|Overall Study|Withdrawal by Subject|0
1777795|NCT00687271|6188321|P3|Overall Study|Withdrawal by Subject|3
1777796|NCT00687271|6188322|P2|Overall Study|Withdrawal by Subject|1
1777797|NCT00687271|6188323|P1|Overall Study|Withdrawal by Subject|0
1777798|NCT00687271|6188320|P4|Overall Study|Protocol Violation|0
1777799|NCT00687271|6188321|P3|Overall Study|Protocol Violation|1
1777800|NCT00687271|6188322|P2|Overall Study|Protocol Violation|1
1777801|NCT00687271|6188323|P1|Overall Study|Protocol Violation|2
1777802|NCT00687271|6188320|P4|Overall Study|Lost to Follow-up|0
1777803|NCT00687271|6188321|P3|Overall Study|Lost to Follow-up|0
1777804|NCT00687271|6188322|P2|Overall Study|Lost to Follow-up|1
1777805|NCT00687271|6188323|P1|Overall Study|Lost to Follow-up|0
1777806|NCT00687271|6188320|P4|Overall Study|Adverse Event|0
1777807|NCT00687271|6188321|P3|Overall Study|Adverse Event|1
1777808|NCT00687271|6188322|P2|Overall Study|Adverse Event|3
1777809|NCT00687271|6188323|P1|Overall Study|Adverse Event|1
1777810|NCT00687219|6188361|P1|Overall Study|Lack of Efficacy|1
1777811|NCT00687219|6188361|P1|Overall Study|Withdrawal by Subject|1
1777812|NCT00687219|6188361|P1|Overall Study|HCV-RNA positive conversion|34
1777813|NCT00687219|6188361|P1|Overall Study|Discontinuance criteria met|7
1777814|NCT00687219|6188361|P1|Overall Study|Adverse Event|8
1777815|NCT00687193|6188373|P6|Overall Study|Protocol Violation|0
1777816|NCT00687193|6188374|P5|Overall Study|Protocol Violation|2
1777817|NCT00687193|6188375|P4|Overall Study|Protocol Violation|1
1777818|NCT00687193|6188376|P3|Overall Study|Protocol Violation|0
1777819|NCT00687193|6188377|P2|Overall Study|Protocol Violation|2
1777820|NCT00687193|6188378|P1|Overall Study|Protocol Violation|1
1777821|NCT00687193|6188373|P6|Overall Study|Lack of Efficacy|2
1777822|NCT00687193|6188374|P5|Overall Study|Lack of Efficacy|0
1777823|NCT00687193|6188375|P4|Overall Study|Lack of Efficacy|0
1777824|NCT00687193|6188376|P3|Overall Study|Lack of Efficacy|0
1777825|NCT00687193|6188377|P2|Overall Study|Lack of Efficacy|1
1777826|NCT00687193|6188378|P1|Overall Study|Lack of Efficacy|1
1777827|NCT00687193|6188373|P6|Overall Study|Adverse Event|2
1777828|NCT00687193|6188374|P5|Overall Study|Adverse Event|0
1777829|NCT00687193|6188375|P4|Overall Study|Adverse Event|3
1777830|NCT00687193|6188376|P3|Overall Study|Adverse Event|2
1777831|NCT00687193|6188377|P2|Overall Study|Adverse Event|1
1777832|NCT00687193|6188378|P1|Overall Study|Adverse Event|0
1777833|NCT00686998|6188588|P3|Overall Study|Safety Reasons|0
1777834|NCT00686998|6188589|P2|Overall Study|Safety Reasons|0
1777835|NCT00686998|6188590|P1|Overall Study|Safety Reasons|1
1777836|NCT00686998|6188588|P3|Overall Study|Other|1
1777837|NCT00686998|6188589|P2|Overall Study|Other|0
1777838|NCT00686998|6188590|P1|Overall Study|Other|0
1777839|NCT00686998|6188588|P3|Overall Study|Lack of Efficacy|0
1777840|NCT00686998|6188589|P2|Overall Study|Lack of Efficacy|5
1777841|NCT00686998|6188590|P1|Overall Study|Lack of Efficacy|7
1777842|NCT00686998|6188588|P3|Overall Study|Withdrawal by Subject|2
1777843|NCT00686998|6188589|P2|Overall Study|Withdrawal by Subject|1
1777844|NCT00686998|6188590|P1|Overall Study|Withdrawal by Subject|2
1777845|NCT00686998|6188588|P3|Overall Study|Adverse Event|1
1777846|NCT00686998|6188589|P2|Overall Study|Adverse Event|2
1777847|NCT00686998|6188590|P1|Overall Study|Adverse Event|3
1777848|NCT00686972|6188598|P1|Overall Study|P.I, Left institution. Study terminated|51
1777849|NCT00686959|6188604|P2|Overall Study|Participants censored (no death events)|117
1777850|NCT00686959|6188605|P1|Overall Study|Participants censored (no death events)|124
1777851|NCT00686920|6188625|P2|Overall Study|Principal Investigator Decision|0
1777852|NCT00686920|6188626|P1|Overall Study|Principal Investigator Decision|2
1777853|NCT00686920|6188625|P2|Overall Study|Noncompliance|0
1777854|NCT00686920|6188626|P1|Overall Study|Noncompliance|9
1777855|NCT00686920|6188625|P2|Overall Study|Transferred to Nursing Home|0
1777856|NCT00686920|6188626|P1|Overall Study|Transferred to Nursing Home|1
1777857|NCT00686920|6188625|P2|Overall Study|Moved to Another State|0
1777858|NCT00686920|6188626|P1|Overall Study|Moved to Another State|1
1777859|NCT00686920|6188625|P2|Overall Study|Lost to Follow-up|3
1777860|NCT00686920|6188626|P1|Overall Study|Lost to Follow-up|15
1777861|NCT00686920|6188625|P2|Overall Study|Personal Reason|1
1777862|NCT00686920|6188626|P1|Overall Study|Personal Reason|0
1777863|NCT00686920|6188625|P2|Overall Study|Adverse Event|2
1777864|NCT00686920|6188626|P1|Overall Study|Adverse Event|10
1777865|NCT00686920|6188625|P2|Overall Study|Protocol Violation|1
1777866|NCT00686920|6188626|P1|Overall Study|Protocol Violation|2
1777867|NCT00686920|6188625|P2|Overall Study|Withdrawal by Subject|5
1777868|NCT00686920|6188626|P1|Overall Study|Withdrawal by Subject|23
1777869|NCT00686920|6188625|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
1777870|NCT00686920|6188626|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
1777871|NCT00686920|6188625|P2|Overall Study|Liver Transplant|8
1777872|NCT00686920|6188626|P1|Overall Study|Liver Transplant|23
1777873|NCT00686920|6188625|P2|Overall Study|Death|14
1777874|NCT00686920|6188626|P1|Overall Study|Death|45
1777875|NCT00686894|6188638|P1|Overall Study|Protocol Violation|4
1777876|NCT00686894|6188638|P1|Overall Study|Relapse|2
1777877|NCT00686881|6188644|P2|Overall Study|Never received study drug|6
1777878|NCT00686881|6188645|P1|Overall Study|Never received study drug|2
1777879|NCT00686881|6188644|P2|Overall Study|Study discontinuation|32
1777880|NCT00686881|6188645|P1|Overall Study|Study discontinuation|35
1777881|NCT00686881|6188644|P2|Overall Study|Irregular visits|0
1777882|NCT00686881|6188645|P1|Overall Study|Irregular visits|1
1777883|NCT00686881|6188644|P2|Overall Study|Did not meet protocol eligibility|0
1777884|NCT00686881|6188645|P1|Overall Study|Did not meet protocol eligibility|1
1777885|NCT00686881|6188644|P2|Overall Study|Circumstances of site|1
1777886|NCT00686881|6188645|P1|Overall Study|Circumstances of site|1
1777887|NCT00686881|6188644|P2|Overall Study|Physician Decision|0
1777888|NCT00686881|6188645|P1|Overall Study|Physician Decision|1
1777889|NCT00686881|6188644|P2|Overall Study|Lack of Efficacy|3
1777890|NCT00686881|6188645|P1|Overall Study|Lack of Efficacy|4
1777891|NCT00686881|6188644|P2|Overall Study|Onset of malignant tumor|11
1777892|NCT00686881|6188645|P1|Overall Study|Onset of malignant tumor|11
1777893|NCT00686881|6188644|P2|Overall Study|Met discontinuation criteria|0
1777894|NCT00686881|6188645|P1|Overall Study|Met discontinuation criteria|5
1777895|NCT00686881|6188644|P2|Overall Study|Treatment-related adverse event|9
1777896|NCT00686881|6188645|P1|Overall Study|Treatment-related adverse event|10
1777897|NCT00686881|6188644|P2|Overall Study|Lost to Follow-up|1
1777898|NCT00686881|6188645|P1|Overall Study|Lost to Follow-up|0
1777899|NCT00686881|6188644|P2|Overall Study|Withdrawal by Subject|18
1777900|NCT00686881|6188645|P1|Overall Study|Withdrawal by Subject|11
1777901|NCT00686855|6188657|P2|Overall Study|Progressive GVHD|1
1777902|NCT00686855|6188658|P1|Overall Study|Progressive GVHD|0
1777903|NCT00686855|6188657|P2|Overall Study|Lost to Follow-up|0
1777904|NCT00686855|6188658|P1|Overall Study|Lost to Follow-up|1
1777905|NCT00686790|6188684|P1|Overall Study|Lost to Follow-up|12
1777906|NCT00686790|6188684|P1|Overall Study|Death|1
1777907|NCT00686790|6188684|P1|Overall Study|Withdrawal by Subject|1
1777908|NCT00686790|6188684|P1|Overall Study|Adverse Event|2
1777909|NCT00686777|6188692|P1|Overall Study|No Visit|1
1777910|NCT00686777|6188692|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
1777911|NCT00686777|6188692|P1|Overall Study|Withdrawal by Subject|2
1777912|NCT00686777|6188692|P1|Overall Study|Pregnancy|1
1777913|NCT00686777|6188692|P1|Overall Study|Adverse Event|2
1777914|NCT00686725|6188700|P2|Overall Study|Other|3
1777915|NCT00686725|6188701|P1|Overall Study|Other|1
1777916|NCT00686725|6188700|P2|Overall Study|Protocol Violation|3
1777917|NCT00686725|6188701|P1|Overall Study|Protocol Violation|1
1777918|NCT00686725|6188700|P2|Overall Study|Withdrawal by Subject|4
1777919|NCT00686725|6188701|P1|Overall Study|Withdrawal by Subject|13
1777920|NCT00686725|6188700|P2|Overall Study|Death|3
1777921|NCT00686725|6188701|P1|Overall Study|Death|6
1777922|NCT00686725|6188700|P2|Overall Study|Lost to Follow-up|5
1777923|NCT00686725|6188701|P1|Overall Study|Lost to Follow-up|7
1777924|NCT00686725|6188700|P2|Overall Study|Progressive Disease|23
1777925|NCT00686725|6188701|P1|Overall Study|Progressive Disease|17
1777926|NCT00686725|6188700|P2|Overall Study|Adverse Event|1
1777927|NCT00686725|6188701|P1|Overall Study|Adverse Event|1
1777928|NCT00686712|6188726|P3|Overall Study|Adverse Event|0
1777929|NCT00686712|6188727|P2|Overall Study|Adverse Event|1
1777930|NCT00686712|6188728|P1|Overall Study|Adverse Event|1
1777931|NCT00686712|6188726|P3|Overall Study|Lost to Follow-up|3
1777932|NCT00686712|6188727|P2|Overall Study|Lost to Follow-up|2
1777933|NCT00686712|6188728|P1|Overall Study|Lost to Follow-up|1
1777934|NCT00686712|6188726|P3|Overall Study|Protocol Violation|10
1777935|NCT00686712|6188727|P2|Overall Study|Protocol Violation|8
1777936|NCT00686712|6188728|P1|Overall Study|Protocol Violation|8
1777937|NCT00686699|6188756|P2|Treatment Period 1|Adverse Event|2
1777938|NCT00686699|6188757|P1|Treatment Period 1|Adverse Event|0
1777939|NCT00686686|6188781|P1|Overall Study|Lost to Follow-up|3
1777940|NCT00686686|6188781|P1|Overall Study|Adverse Event|2
1777941|NCT00686686|6188781|P1|Overall Study|Non-compliance|1
1777942|NCT00686647|6188789|P1|Overall Study|Death|1
1777943|NCT00686647|6188789|P1|Overall Study|Lost to Follow-up|1
1777944|NCT00686634|6188795|P1|Overall Study|Protocol Violation|6
1777945|NCT00686595|6188802|P1|Overall Study|Poor Compliance|1
1777946|NCT00686595|6188802|P1|Overall Study|Lack of Efficacy|1
1777947|NCT00686595|6188802|P1|Overall Study|Lost to Follow-up|1
1777948|NCT00686595|6188802|P1|Overall Study|Protocol Violation|1
1777949|NCT00686595|6188802|P1|Overall Study|Adverse Event|3
1777950|NCT00686543|6188862|P4|Overall Study|Protocol Violation|1
1777951|NCT00686543|6188863|P3|Overall Study|Protocol Violation|2
1777952|NCT00686543|6188864|P2|Overall Study|Protocol Violation|0
1777953|NCT00686543|6188865|P1|Overall Study|Protocol Violation|3
1777954|NCT00686543|6188862|P4|Overall Study|Withdrawal by Subject|0
1777955|NCT00686543|6188863|P3|Overall Study|Withdrawal by Subject|0
1777956|NCT00686543|6188864|P2|Overall Study|Withdrawal by Subject|0
1777957|NCT00686543|6188865|P1|Overall Study|Withdrawal by Subject|2
1777958|NCT00686543|6188862|P4|Overall Study|Adverse Event|2
1777959|NCT00686543|6188863|P3|Overall Study|Adverse Event|3
1777960|NCT00686543|6188864|P2|Overall Study|Adverse Event|1
1777961|NCT00686543|6188865|P1|Overall Study|Adverse Event|9
1777962|NCT00686517|6188886|P3|Treatment|Protocol Violation|0
1777963|NCT00686517|6188887|P2|Treatment|Protocol Violation|1
1777964|NCT00686517|6188888|P1|Treatment|Protocol Violation|2
1777965|NCT00686517|6188886|P3|Treatment|Poor Protocol Compliance|0
1777966|NCT00686517|6188887|P2|Treatment|Poor Protocol Compliance|0
1777967|NCT00686517|6188888|P1|Treatment|Poor Protocol Compliance|1
1777968|NCT00686517|6188886|P3|Treatment|Adverse Event|0
1777969|NCT00686517|6188887|P2|Treatment|Adverse Event|0
1777970|NCT00686517|6188888|P1|Treatment|Adverse Event|2
1777971|NCT00686517|6188886|P3|Treatment|Serious Adverse Event|1
1777972|NCT00686517|6188887|P2|Treatment|Serious Adverse Event|2
1777973|NCT00686517|6188888|P1|Treatment|Serious Adverse Event|1
1777974|NCT00686374|6188911|P1|Overall Study|Other, not specified|4
1777975|NCT00686374|6188911|P1|Overall Study|Missing reason|33
1777976|NCT00686374|6188911|P1|Overall Study|Lost to Follow-up|1
1777977|NCT00686374|6188911|P1|Overall Study|Withdrew consent|5
1777978|NCT00686374|6188911|P1|Overall Study|Adverse Event|8
1777979|NCT00686374|6188911|P1|Overall Study|Lack of Efficacy|10
1777980|NCT00686335|6188922|P1|Run-in Period|violation of inclusion/exclusion criteri|3
1777981|NCT00686335|6188922|P1|Run-in Period|asthma exacerbation|1
1777982|NCT00686335|6188922|P1|Run-in Period|Adverse Event|1
1777983|NCT00686205|6188966|P2|Overall Study|Specimens not confirmed HIV positive|981
1777984|NCT00686205|6188967|P1|Overall Study|Specimens not confirmed HIV positive|0
1777985|NCT00686205|6188966|P2|Overall Study|Specimen handling procedure altered|0
1777986|NCT00686205|6188967|P1|Overall Study|Specimen handling procedure altered|5878
1777987|NCT00686205|6188966|P2|Overall Study|Withdrawal by Subject|0
1777988|NCT00686205|6188967|P1|Overall Study|Withdrawal by Subject|2
1777989|NCT00686205|6188966|P2|Overall Study|Protocol Violation|0
1777990|NCT00686205|6188967|P1|Overall Study|Protocol Violation|127
1777991|NCT00686166|6188973|P1|Overall Study|Did not begin protocol therapy|4
1777992|NCT00686166|6188973|P1|Overall Study|Ineligible|5
1777993|NCT00686166|6188973|P1|Overall Study|Not Protocol Specified|1
1777994|NCT00686166|6188973|P1|Overall Study|Death|1
1777995|NCT00686166|6188973|P1|Overall Study|Progression/Relapse|1
1777996|NCT00686166|6188973|P1|Overall Study|Withdrawal by Subject|1
1777997|NCT00686166|6188973|P1|Overall Study|Adverse Event|7
1777998|NCT00686127|6188985|P2|Overall Study|Withdrawal by Subject|6
1777999|NCT00686127|6188986|P1|Overall Study|Withdrawal by Subject|14
1778000|NCT00686075|6189002|P10|Overall Study|Other|1
1778001|NCT00686075|6189003|P9|Overall Study|Other|0
1778002|NCT00686075|6189004|P8|Overall Study|Other|0
1778003|NCT00686075|6189005|P7|Overall Study|Other|0
1778004|NCT00686075|6189006|P6|Overall Study|Other|0
1778005|NCT00686075|6189007|P5|Overall Study|Other|0
1778006|NCT00686075|6189008|P4|Overall Study|Other|0
1778007|NCT00686075|6189009|P3|Overall Study|Other|0
1778008|NCT00686075|6189010|P2|Overall Study|Other|1
1778009|NCT00686075|6189011|P1|Overall Study|Other|1
1778010|NCT00686075|6189002|P10|Overall Study|Lost to Follow-up|3
1778011|NCT00686075|6189003|P9|Overall Study|Lost to Follow-up|2
1778012|NCT00686075|6189004|P8|Overall Study|Lost to Follow-up|0
1778013|NCT00686075|6189005|P7|Overall Study|Lost to Follow-up|0
1778014|NCT00686075|6189006|P6|Overall Study|Lost to Follow-up|3
1778015|NCT00686075|6189007|P5|Overall Study|Lost to Follow-up|3
1778016|NCT00686075|6189008|P4|Overall Study|Lost to Follow-up|2
1778017|NCT00686075|6189009|P3|Overall Study|Lost to Follow-up|3
1778018|NCT00686075|6189010|P2|Overall Study|Lost to Follow-up|6
1778019|NCT00686075|6189011|P1|Overall Study|Lost to Follow-up|3
1778020|NCT00686075|6189002|P10|Overall Study|Withdrawal by Subject|6
1778021|NCT00686075|6189003|P9|Overall Study|Withdrawal by Subject|4
1778022|NCT00686075|6189004|P8|Overall Study|Withdrawal by Subject|2
1778023|NCT00686075|6189005|P7|Overall Study|Withdrawal by Subject|0
1778024|NCT00686075|6189006|P6|Overall Study|Withdrawal by Subject|0
1778025|NCT00686075|6189007|P5|Overall Study|Withdrawal by Subject|1
1778026|NCT00686075|6189008|P4|Overall Study|Withdrawal by Subject|7
1778027|NCT00686075|6189009|P3|Overall Study|Withdrawal by Subject|3
1778028|NCT00686075|6189010|P2|Overall Study|Withdrawal by Subject|3
1778029|NCT00686075|6189011|P1|Overall Study|Withdrawal by Subject|4
1778030|NCT00686036|6189205|P2|Overall Study|Other reasons not identified|4
1778031|NCT00686036|6189206|P1|Overall Study|Other reasons not identified|0
1778032|NCT00686036|6189205|P2|Overall Study|PSA ≥ 10ng/mL|0
1778033|NCT00686036|6189206|P1|Overall Study|PSA ≥ 10ng/mL|1
1778034|NCT00686036|6189205|P2|Overall Study|Study terminated by AstraZeneca|1
1778035|NCT00686036|6189206|P1|Overall Study|Study terminated by AstraZeneca|2
1778036|NCT00686036|6189205|P2|Overall Study|Withdrawal by Subject|1
1778037|NCT00686036|6189206|P1|Overall Study|Withdrawal by Subject|3
1778038|NCT00686036|6189205|P2|Overall Study|Adverse Event|0
1778039|NCT00686036|6189206|P1|Overall Study|Adverse Event|3
1778040|NCT00685945|6189218|P1|L-NMMA + Bradykinin|Physician Decision|1
1778041|NCT00685802|6189253|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1778042|NCT00685802|6189254|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1778043|NCT00685802|6189253|P2|Washout Period of 7 Days|Protocol Violation|0
1778044|NCT00685802|6189254|P1|Washout Period of 7 Days|Protocol Violation|2
1778045|NCT00685763|6189264|P1|Overall Study|Protocol Violation|1
1778046|NCT00685763|6189264|P1|Overall Study|Intercurrent death-incomplete treatment|1
1778047|NCT00685750|6189275|P7|Overall Study|Eligibility criteria not fulfilled|0
1778048|NCT00685750|6189276|P6|Overall Study|Eligibility criteria not fulfilled|0
1778049|NCT00685750|6189277|P5|Overall Study|Eligibility criteria not fulfilled|0
1778050|NCT00685750|6189278|P4|Overall Study|Eligibility criteria not fulfilled|0
1778051|NCT00685750|6189279|P3|Overall Study|Eligibility criteria not fulfilled|1
1778052|NCT00685750|6189280|P2|Overall Study|Eligibility criteria not fulfilled|0
1778053|NCT00685750|6189281|P1|Overall Study|Eligibility criteria not fulfilled|0
1778054|NCT00685750|6189275|P7|Overall Study|Patient didn't receive the treatment|1
1778055|NCT00685750|6189276|P6|Overall Study|Patient didn't receive the treatment|0
1778056|NCT00685750|6189277|P5|Overall Study|Patient didn't receive the treatment|0
1778057|NCT00685750|6189278|P4|Overall Study|Patient didn't receive the treatment|0
1778058|NCT00685750|6189279|P3|Overall Study|Patient didn't receive the treatment|0
1778059|NCT00685750|6189280|P2|Overall Study|Patient didn't receive the treatment|0
1778060|NCT00685750|6189281|P1|Overall Study|Patient didn't receive the treatment|0
1778061|NCT00685750|6189275|P7|Overall Study|Tumor sampling failure|0
1778062|NCT00685750|6189276|P6|Overall Study|Tumor sampling failure|0
1778063|NCT00685750|6189277|P5|Overall Study|Tumor sampling failure|0
1778064|NCT00685750|6189278|P4|Overall Study|Tumor sampling failure|0
1778065|NCT00685750|6189279|P3|Overall Study|Tumor sampling failure|1
1778066|NCT00685750|6189280|P2|Overall Study|Tumor sampling failure|0
1778067|NCT00685750|6189281|P1|Overall Study|Tumor sampling failure|0
1778068|NCT00685698|6189309|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
1778069|NCT00685698|6189309|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
1778070|NCT00685698|6189309|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
1778071|NCT00685698|6189309|P1|Overall Study|Adverse Event|3
1778072|NCT00685698|6189309|P1|Overall Study|Protocol Violation|6
1778073|NCT00685698|6189309|P1|Overall Study|Withdrawal by Subject|1
1778074|NCT00685685|6189344|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1778075|NCT00685685|6189345|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1778076|NCT00685685|6189344|P2|Washout Period of 7 Days|Adverse Event|0
1778077|NCT00685685|6189345|P1|Washout Period of 7 Days|Adverse Event|2
1778078|NCT00685399|6189498|P8|Extension|Adverse Event|0
1778079|NCT00685399|6189499|P7|Extension|Adverse Event|0
1778080|NCT00685399|6189500|P6|Extension|Adverse Event|0
1778081|NCT00685399|6189501|P5|Extension|Adverse Event|0
1778082|NCT00685399|6189502|P4|Extension|Adverse Event|2
1778083|NCT00685399|6189503|P3|Extension|Adverse Event|0
1778084|NCT00685399|6189504|P2|Extension|Adverse Event|0
1778085|NCT00685399|6189505|P1|Extension|Adverse Event|0
1778086|NCT00685399|6189498|P8|Extension|Lack of Efficacy|0
1778087|NCT00685399|6189499|P7|Extension|Lack of Efficacy|0
1778088|NCT00685399|6189500|P6|Extension|Lack of Efficacy|0
1778089|NCT00685399|6189501|P5|Extension|Lack of Efficacy|0
1778090|NCT00685399|6189502|P4|Extension|Lack of Efficacy|2
1778091|NCT00685399|6189503|P3|Extension|Lack of Efficacy|0
1778092|NCT00685399|6189504|P2|Extension|Lack of Efficacy|0
1778093|NCT00685399|6189505|P1|Extension|Lack of Efficacy|0
1778094|NCT00685399|6189498|P8|Extension|Protocol Violation|0
1778095|NCT00685399|6189499|P7|Extension|Protocol Violation|0
1778096|NCT00685399|6189500|P6|Extension|Protocol Violation|0
1778097|NCT00685399|6189501|P5|Extension|Protocol Violation|0
1778098|NCT00685399|6189502|P4|Extension|Protocol Violation|1
1778099|NCT00685399|6189503|P3|Extension|Protocol Violation|0
1778100|NCT00685399|6189504|P2|Extension|Protocol Violation|0
1778101|NCT00685399|6189505|P1|Extension|Protocol Violation|0
1778102|NCT00685399|6189498|P8|Extension|Withdrawal by Subject|0
1778103|NCT00685399|6189499|P7|Extension|Withdrawal by Subject|0
1778104|NCT00685399|6189500|P6|Extension|Withdrawal by Subject|0
1778105|NCT00685399|6189501|P5|Extension|Withdrawal by Subject|0
1778106|NCT00685399|6189502|P4|Extension|Withdrawal by Subject|1
1778107|NCT00685399|6189503|P3|Extension|Withdrawal by Subject|0
1778108|NCT00685399|6189504|P2|Extension|Withdrawal by Subject|0
1778109|NCT00685399|6189505|P1|Extension|Withdrawal by Subject|0
1778110|NCT00685399|6189498|P8|Extension|Administrative Issues|0
1778111|NCT00685399|6189499|P7|Extension|Administrative Issues|0
1778112|NCT00685399|6189500|P6|Extension|Administrative Issues|0
1778113|NCT00685399|6189501|P5|Extension|Administrative Issues|0
1778114|NCT00685399|6189502|P4|Extension|Administrative Issues|1
1778115|NCT00685399|6189503|P3|Extension|Administrative Issues|0
1778116|NCT00685399|6189504|P2|Extension|Administrative Issues|0
1778117|NCT00685399|6189505|P1|Extension|Administrative Issues|0
1778118|NCT00685399|6189498|P8|Treatment Period 2|Lack of Efficacy|0
1778119|NCT00685399|6189499|P7|Treatment Period 2|Lack of Efficacy|0
1778120|NCT00685399|6189500|P6|Treatment Period 2|Lack of Efficacy|1
1778121|NCT00685399|6189501|P5|Treatment Period 2|Lack of Efficacy|0
1778122|NCT00685399|6189502|P4|Treatment Period 2|Lack of Efficacy|0
1778123|NCT00685399|6189503|P3|Treatment Period 2|Lack of Efficacy|2
1778124|NCT00685399|6189504|P2|Treatment Period 2|Lack of Efficacy|10
1778125|NCT00685399|6189505|P1|Treatment Period 2|Lack of Efficacy|0
1778126|NCT00685399|6189498|P8|Treatment Period 2|Adverse Event|0
1778127|NCT00685399|6189499|P7|Treatment Period 2|Adverse Event|0
1778128|NCT00685399|6189500|P6|Treatment Period 2|Adverse Event|1
1778129|NCT00685399|6189501|P5|Treatment Period 2|Adverse Event|0
1778130|NCT00685399|6189502|P4|Treatment Period 2|Adverse Event|0
1778131|NCT00685399|6189503|P3|Treatment Period 2|Adverse Event|0
1778132|NCT00685399|6189504|P2|Treatment Period 2|Adverse Event|0
1778133|NCT00685399|6189505|P1|Treatment Period 2|Adverse Event|0
1778134|NCT00685399|6189498|P8|Treatment Period 2|Withdrawal by Subject|2
1778135|NCT00685399|6189499|P7|Treatment Period 2|Withdrawal by Subject|0
1778136|NCT00685399|6189500|P6|Treatment Period 2|Withdrawal by Subject|0
1778137|NCT00685399|6189501|P5|Treatment Period 2|Withdrawal by Subject|0
1778138|NCT00685399|6189502|P4|Treatment Period 2|Withdrawal by Subject|0
1778139|NCT00685399|6189503|P3|Treatment Period 2|Withdrawal by Subject|0
1778140|NCT00685399|6189504|P2|Treatment Period 2|Withdrawal by Subject|0
1778141|NCT00685399|6189505|P1|Treatment Period 2|Withdrawal by Subject|0
1778142|NCT00685399|6189498|P8|Treatment Period 2|Administrative Problems|0
1778143|NCT00685399|6189499|P7|Treatment Period 2|Administrative Problems|0
1778144|NCT00685399|6189500|P6|Treatment Period 2|Administrative Problems|0
1778145|NCT00685399|6189501|P5|Treatment Period 2|Administrative Problems|0
1778146|NCT00685399|6189502|P4|Treatment Period 2|Administrative Problems|0
1778147|NCT00685399|6189503|P3|Treatment Period 2|Administrative Problems|1
1778148|NCT00685399|6189504|P2|Treatment Period 2|Administrative Problems|2
1778149|NCT00685399|6189505|P1|Treatment Period 2|Administrative Problems|0
1778150|NCT00685399|6189498|P8|Treatment Period 1|Lack of Efficacy|0
1778151|NCT00685399|6189499|P7|Treatment Period 1|Lack of Efficacy|0
1778152|NCT00685399|6189500|P6|Treatment Period 1|Lack of Efficacy|0
1778153|NCT00685399|6189501|P5|Treatment Period 1|Lack of Efficacy|0
1778154|NCT00685399|6189502|P4|Treatment Period 1|Lack of Efficacy|0
1778155|NCT00685399|6189503|P3|Treatment Period 1|Lack of Efficacy|0
1778156|NCT00685399|6189504|P2|Treatment Period 1|Lack of Efficacy|0
1778157|NCT00685399|6189505|P1|Treatment Period 1|Lack of Efficacy|1
1778158|NCT00685399|6189498|P8|Treatment Period 1|Administrative|0
1778159|NCT00685399|6189499|P7|Treatment Period 1|Administrative|0
1778160|NCT00685399|6189500|P6|Treatment Period 1|Administrative|0
1778161|NCT00685399|6189501|P5|Treatment Period 1|Administrative|0
1778162|NCT00685399|6189502|P4|Treatment Period 1|Administrative|0
1778163|NCT00685399|6189503|P3|Treatment Period 1|Administrative|0
1778164|NCT00685399|6189504|P2|Treatment Period 1|Administrative|0
1778165|NCT00685399|6189505|P1|Treatment Period 1|Administrative|2
1778166|NCT00685399|6189498|P8|Treatment Period 1|Protocol Violation|0
1778167|NCT00685399|6189499|P7|Treatment Period 1|Protocol Violation|0
1778168|NCT00685399|6189500|P6|Treatment Period 1|Protocol Violation|0
1778169|NCT00685399|6189501|P5|Treatment Period 1|Protocol Violation|0
1778170|NCT00685399|6189502|P4|Treatment Period 1|Protocol Violation|0
1778171|NCT00685399|6189503|P3|Treatment Period 1|Protocol Violation|0
1778172|NCT00685399|6189504|P2|Treatment Period 1|Protocol Violation|0
1778173|NCT00685399|6189505|P1|Treatment Period 1|Protocol Violation|1
1778174|NCT00685399|6189498|P8|Treatment Period 1|Withdrawal by Subject|0
1778175|NCT00685399|6189499|P7|Treatment Period 1|Withdrawal by Subject|0
1778176|NCT00685399|6189500|P6|Treatment Period 1|Withdrawal by Subject|0
1778177|NCT00685399|6189501|P5|Treatment Period 1|Withdrawal by Subject|0
1778178|NCT00685399|6189502|P4|Treatment Period 1|Withdrawal by Subject|0
1778179|NCT00685399|6189503|P3|Treatment Period 1|Withdrawal by Subject|0
1778180|NCT00685399|6189504|P2|Treatment Period 1|Withdrawal by Subject|0
1778181|NCT00685399|6189505|P1|Treatment Period 1|Withdrawal by Subject|2
1778182|NCT00685373|6189538|P1|Overall Study|Protocol Violation|1
1778183|NCT00685373|6189538|P1|Overall Study|Lost to Follow-up|2
1778184|NCT00685373|6189538|P1|Overall Study|Condition no longer requires study drug|1
1778185|NCT00685373|6189538|P1|Overall Study|Lack of Efficacy|3
1778186|NCT00685373|6189538|P1|Overall Study|Withdrawal by Subject|5
1778187|NCT00685373|6189538|P1|Overall Study|Adverse Event|3
1778188|NCT00685334|6189547|P2|Overall Study|Chose to enter hospital|1
1778189|NCT00685334|6189548|P1|Overall Study|Chose to enter hospital|1
1778190|NCT00685334|6189547|P2|Overall Study|Lost to Follow-up|0
1778191|NCT00685334|6189548|P1|Overall Study|Lost to Follow-up|4
1778192|NCT00685334|6189547|P2|Overall Study|Withdrawal by Subject|6
1778193|NCT00685334|6189548|P1|Overall Study|Withdrawal by Subject|5
1778194|NCT00685178|6189573|P4|Overall Study|Pregnancy|1
1778195|NCT00685178|6189574|P3|Overall Study|Pregnancy|0
1778196|NCT00685178|6189575|P2|Overall Study|Pregnancy|0
1778197|NCT00685178|6189576|P1|Overall Study|Pregnancy|0
1778198|NCT00685178|6189573|P4|Overall Study|administrative (disciplinary) discharge|2
1778199|NCT00685178|6189574|P3|Overall Study|administrative (disciplinary) discharge|0
1778200|NCT00685178|6189575|P2|Overall Study|administrative (disciplinary) discharge|1
1778201|NCT00685178|6189576|P1|Overall Study|administrative (disciplinary) discharge|0
1778202|NCT00685178|6189573|P4|Overall Study|incarcerated|0
1778203|NCT00685178|6189574|P3|Overall Study|incarcerated|7
1778204|NCT00685178|6189575|P2|Overall Study|incarcerated|3
1778205|NCT00685178|6189576|P1|Overall Study|incarcerated|1
1778206|NCT00685178|6189573|P4|Overall Study|voluntary study discharge|1
1778207|NCT00685178|6189574|P3|Overall Study|voluntary study discharge|1
1778208|NCT00685178|6189575|P2|Overall Study|voluntary study discharge|5
1778209|NCT00685178|6189576|P1|Overall Study|voluntary study discharge|4
1778210|NCT00685178|6189573|P4|Overall Study|missed 3 consecutive methadone clin days|6
1778211|NCT00685178|6189574|P3|Overall Study|missed 3 consecutive methadone clin days|2
1778212|NCT00685178|6189575|P2|Overall Study|missed 3 consecutive methadone clin days|5
1778213|NCT00685178|6189576|P1|Overall Study|missed 3 consecutive methadone clin days|7
1778214|NCT00685178|6189573|P4|Overall Study|Adverse Event|4
1778215|NCT00685178|6189574|P3|Overall Study|Adverse Event|2
1778216|NCT00685178|6189575|P2|Overall Study|Adverse Event|5
1778217|NCT00685178|6189576|P1|Overall Study|Adverse Event|1
1778218|NCT00685165|6189590|P2|Washout Period of 14 Days|Adverse Event|0
1778219|NCT00685165|6189591|P1|Washout Period of 14 Days|Adverse Event|1
1778220|NCT00685035|6189610|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
1778221|NCT00685035|6189611|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
1778222|NCT00684996|6189635|P1|Overall Study|Other reasons not protocol specified|1
1778223|NCT00684996|6189635|P1|Overall Study|Progression/relapse|2
1778224|NCT00684996|6189635|P1|Overall Study|Refusal unrelated to adverse event|1
1778225|NCT00684996|6189635|P1|Overall Study|Adverse Event|1
1778226|NCT00684814|6189667|P2|Second Intervention|Adverse Event|0
1778227|NCT00684814|6189668|P1|Second Intervention|Adverse Event|1
1778228|NCT00684814|6189667|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1778229|NCT00684814|6189668|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1778230|NCT00684814|6189667|P2|Washout Period of 7 Days|Adverse Event|2
1778231|NCT00684814|6189668|P1|Washout Period of 7 Days|Adverse Event|1
1778232|NCT00684762|6189720|P2|Washout Period of 7 Days|Withdrawal by Subject|2
1778233|NCT00684762|6189721|P1|Washout Period of 7 Days|Withdrawal by Subject|2
1778234|NCT00684671|6189749|P3|Overall Study|Alcoholic dependance|0
1778235|NCT00684671|6189750|P2|Overall Study|Alcoholic dependance|0
1778236|NCT00684671|6189751|P1|Overall Study|Alcoholic dependance|1
1778237|NCT00684671|6189749|P3|Overall Study|Lost to Follow-up|0
1778238|NCT00684671|6189750|P2|Overall Study|Lost to Follow-up|0
1778239|NCT00684671|6189751|P1|Overall Study|Lost to Follow-up|1
1778240|NCT00684671|6189749|P3|Overall Study|Adverse Event|0
1778241|NCT00684671|6189750|P2|Overall Study|Adverse Event|0
1778242|NCT00684671|6189751|P1|Overall Study|Adverse Event|1
1778243|NCT00684645|6189780|P1|Overall Study|Other|15
1778244|NCT00684645|6189780|P1|Overall Study|Lost to Follow-up|3
1778245|NCT00684645|6189780|P1|Overall Study|Adverse Event|27
1778246|NCT00684645|6189780|P1|Overall Study|Progressive disease|67
1778247|NCT00684645|6189780|P1|Overall Study|Death|2
1778248|NCT00684593|6189800|P2|Overall Study|Adverse Event|2
1778249|NCT00684593|6189801|P1|Overall Study|Adverse Event|0
1778250|NCT00684567|6189813|P1|Monotherapy Period|Progression of primary disease|11
1778251|NCT00684567|6189813|P1|Monotherapy Period|Death|1
1778252|NCT00684567|6189813|P1|Monotherapy Period|Adverse Event|2
1778253|NCT00684567|6189813|P1|Concomitant Radiotherapy Period|Adverse Event|2
1778254|NCT00684515|6189846|P3|Overall Study|Protocol-Defined Clinical Event|0
1778255|NCT00684515|6189847|P2|Overall Study|Protocol-Defined Clinical Event|0
1778256|NCT00684515|6189848|P1|Overall Study|Protocol-Defined Clinical Event|1
1778257|NCT00684515|6189846|P3|Overall Study|Adverse Event|1
1778258|NCT00684515|6189847|P2|Overall Study|Adverse Event|3
1778259|NCT00684515|6189848|P1|Overall Study|Adverse Event|3
1778260|NCT00684424|6189871|P1|Overall Study|Other|2
1778261|NCT00684424|6189871|P1|Overall Study|Lost to Follow-up|2
1778262|NCT00684424|6189871|P1|Overall Study|Adverse Event|1
1778263|NCT00684411|6189886|P1|Overall Study|Adverse Event|1
1778264|NCT00684411|6189886|P1|Overall Study|Disease Progression|10
1778265|NCT00684411|6189886|P1|Overall Study|New Primary Cancer|1
1778266|NCT00684307|6189908|P5|Overall Study|Criteria from the CSR|3
1778267|NCT00684307|6189909|P4|Overall Study|Criteria from the CSR|3
1778268|NCT00684307|6189910|P3|Overall Study|Criteria from the CSR|1
1778269|NCT00684307|6189911|P2|Overall Study|Criteria from the CSR|0
1778270|NCT00684307|6189912|P1|Overall Study|Criteria from the CSR|0
1778271|NCT00684307|6189908|P5|Overall Study|Participant not willing to continue|8
1778272|NCT00684307|6189909|P4|Overall Study|Participant not willing to continue|5
1778273|NCT00684307|6189910|P3|Overall Study|Participant not willing to continue|11
1778274|NCT00684307|6189911|P2|Overall Study|Participant not willing to continue|10
1778275|NCT00684307|6189912|P1|Overall Study|Participant not willing to continue|7
1778276|NCT00684307|6189908|P5|Overall Study|Severe non compliance to protocol|2
1778277|NCT00684307|6189909|P4|Overall Study|Severe non compliance to protocol|1
1778278|NCT00684307|6189910|P3|Overall Study|Severe non compliance to protocol|0
1778279|NCT00684307|6189911|P2|Overall Study|Severe non compliance to protocol|0
1778280|NCT00684307|6189912|P1|Overall Study|Severe non compliance to protocol|1
1778281|NCT00684307|6189908|P5|Overall Study|Interupted IP for more than 7 days|3
1778282|NCT00684307|6189909|P4|Overall Study|Interupted IP for more than 7 days|3
1778283|NCT00684307|6189910|P3|Overall Study|Interupted IP for more than 7 days|1
1778284|NCT00684307|6189911|P2|Overall Study|Interupted IP for more than 7 days|4
1778285|NCT00684307|6189912|P1|Overall Study|Interupted IP for more than 7 days|0
1778286|NCT00684307|6189908|P5|Overall Study|Incorrect enrolment or randomization|0
1778287|NCT00684307|6189909|P4|Overall Study|Incorrect enrolment or randomization|0
1778288|NCT00684307|6189910|P3|Overall Study|Incorrect enrolment or randomization|0
1778289|NCT00684307|6189911|P2|Overall Study|Incorrect enrolment or randomization|0
1778290|NCT00684307|6189912|P1|Overall Study|Incorrect enrolment or randomization|4
1778291|NCT00684307|6189908|P5|Overall Study|Fullfillment of exclusion criteria|1
1778292|NCT00684307|6189909|P4|Overall Study|Fullfillment of exclusion criteria|3
1778293|NCT00684307|6189910|P3|Overall Study|Fullfillment of exclusion criteria|0
1778294|NCT00684307|6189911|P2|Overall Study|Fullfillment of exclusion criteria|0
1778295|NCT00684307|6189912|P1|Overall Study|Fullfillment of exclusion criteria|1
1778296|NCT00684307|6189908|P5|Overall Study|Development of increasing Liver Function|0
1778297|NCT00684307|6189909|P4|Overall Study|Development of increasing Liver Function|1
1778298|NCT00684307|6189910|P3|Overall Study|Development of increasing Liver Function|0
1778299|NCT00684307|6189911|P2|Overall Study|Development of increasing Liver Function|2
1778300|NCT00684307|6189912|P1|Overall Study|Development of increasing Liver Function|0
1778301|NCT00684307|6189908|P5|Overall Study|Adverse Event|8
1778302|NCT00684307|6189909|P4|Overall Study|Adverse Event|16
1778303|NCT00684307|6189910|P3|Overall Study|Adverse Event|15
1778304|NCT00684307|6189911|P2|Overall Study|Adverse Event|6
1778305|NCT00684307|6189912|P1|Overall Study|Adverse Event|11
1778306|NCT00684203|6189994|P6|Overall Study|Did not meet protocol eligibility|0
1778307|NCT00684203|6189995|P5|Overall Study|Did not meet protocol eligibility|0
1778308|NCT00684203|6189996|P4|Overall Study|Did not meet protocol eligibility|0
1778309|NCT00684203|6189997|P3|Overall Study|Did not meet protocol eligibility|0
1778310|NCT00684203|6189998|P2|Overall Study|Did not meet protocol eligibility|1
1778311|NCT00684203|6189999|P1|Overall Study|Did not meet protocol eligibility|0
1778312|NCT00684203|6189994|P6|Overall Study|Withdrawal by Subject|0
1778313|NCT00684203|6189995|P5|Overall Study|Withdrawal by Subject|0
1778314|NCT00684203|6189996|P4|Overall Study|Withdrawal by Subject|0
1778315|NCT00684203|6189997|P3|Overall Study|Withdrawal by Subject|1
1778316|NCT00684203|6189998|P2|Overall Study|Withdrawal by Subject|2
1778317|NCT00684203|6189999|P1|Overall Study|Withdrawal by Subject|0
1778318|NCT00684203|6189994|P6|Overall Study|Protocol-defined clinical event|0
1778319|NCT00684203|6189995|P5|Overall Study|Protocol-defined clinical event|0
1778320|NCT00684203|6189996|P4|Overall Study|Protocol-defined clinical event|0
1778321|NCT00684203|6189997|P3|Overall Study|Protocol-defined clinical event|0
1778322|NCT00684203|6189998|P2|Overall Study|Protocol-defined clinical event|1
1778323|NCT00684203|6189999|P1|Overall Study|Protocol-defined clinical event|3
1778324|NCT00684203|6189994|P6|Overall Study|Adverse Event|0
1778325|NCT00684203|6189995|P5|Overall Study|Adverse Event|0
1778326|NCT00684203|6189996|P4|Overall Study|Adverse Event|0
1778327|NCT00684203|6189997|P3|Overall Study|Adverse Event|8
1778328|NCT00684203|6189998|P2|Overall Study|Adverse Event|4
1778329|NCT00684203|6189999|P1|Overall Study|Adverse Event|6
1778330|NCT00684177|6190060|P2|Overall Study|Other|2
1778331|NCT00684177|6190061|P1|Overall Study|Other|1
1778332|NCT00684177|6190060|P2|Overall Study|Withdrawal by Subject|2
1778333|NCT00684177|6190061|P1|Overall Study|Withdrawal by Subject|1
1778334|NCT00684177|6190060|P2|Overall Study|Physician Decision|0
1778335|NCT00684177|6190061|P1|Overall Study|Physician Decision|2
1778336|NCT00684177|6190060|P2|Overall Study|Lost to Follow-up|1
1778337|NCT00684177|6190061|P1|Overall Study|Lost to Follow-up|2
1778338|NCT00684177|6190060|P2|Overall Study|Protocol Violation|0
1778339|NCT00684177|6190061|P1|Overall Study|Protocol Violation|1
1778340|NCT00684177|6190060|P2|Overall Study|Lack of Efficacy|15
1778341|NCT00684177|6190061|P1|Overall Study|Lack of Efficacy|10
1778342|NCT00684177|6190060|P2|Overall Study|Adverse Event|3
1778343|NCT00684177|6190061|P1|Overall Study|Adverse Event|4
1778344|NCT00684073|6190096|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
1778345|NCT00684073|6190096|P1|Selection|request of the sponsor|1
1778346|NCT00684073|6190096|P1|Selection|Lost to Follow-up|1
1778347|NCT00684073|6190096|P1|Selection|noncompliance|1
1778348|NCT00684073|6190096|P1|Selection|Death|1
1778349|NCT00684073|6190096|P1|Selection|Selection/non-selection criteria|3
1778350|NCT00684060|6190106|P2|Overall Study|Death|1
1778351|NCT00684060|6190107|P1|Overall Study|Death|0
1778352|NCT00684060|6190106|P2|Overall Study|Unable to collect MRI|2
1778353|NCT00684060|6190107|P1|Overall Study|Unable to collect MRI|1
1778354|NCT00684060|6190106|P2|Overall Study|New stenosis identified|0
1778355|NCT00684060|6190107|P1|Overall Study|New stenosis identified|1
1778356|NCT00684060|6190106|P2|Overall Study|Lost to Follow-up|0
1778357|NCT00684060|6190107|P1|Overall Study|Lost to Follow-up|1
1778358|NCT00684021|6190146|P4|Overall Study|Death|0
1778359|NCT00684021|6190147|P3|Overall Study|Death|0
1778360|NCT00684021|6190148|P2|Overall Study|Death|0
1778361|NCT00684021|6190149|P1|Overall Study|Death|1
1778362|NCT00684021|6190146|P4|Overall Study|MRI not performed|2
1778363|NCT00684021|6190147|P3|Overall Study|MRI not performed|1
1778364|NCT00684021|6190148|P2|Overall Study|MRI not performed|1
1778365|NCT00684021|6190149|P1|Overall Study|MRI not performed|0
1778366|NCT00684021|6190146|P4|Overall Study|MRI Contraindicated|0
1778367|NCT00684021|6190147|P3|Overall Study|MRI Contraindicated|1
1778368|NCT00684021|6190148|P2|Overall Study|MRI Contraindicated|1
1778369|NCT00684021|6190149|P1|Overall Study|MRI Contraindicated|1
1778370|NCT00683917|6190210|P1|Overall Study|Study prematurely terminated|10
1778371|NCT00683904|6190220|P2|Dose Level 2|Adverse Event|2
1778372|NCT00683904|6190221|P1|Dose Level 2|Adverse Event|0
1778373|NCT00683904|6190220|P2|Dose Level 1|Adverse Event|0
1778374|NCT00683904|6190221|P1|Dose Level 1|Adverse Event|1
1778375|NCT00683904|6190220|P2|Dose Level 1|Disease progression|0
1778376|NCT00683904|6190221|P1|Dose Level 1|Disease progression|2
1778377|NCT00683878|6190257|P3|Overall Study|Non-compliance, not met criteria etc.|0
1778378|NCT00683878|6190258|P2|Overall Study|Non-compliance, not met criteria etc.|2
1778379|NCT00683878|6190259|P1|Overall Study|Non-compliance, not met criteria etc.|3
1778380|NCT00683878|6190257|P3|Overall Study|Lost to Follow-up|4
1778381|NCT00683878|6190258|P2|Overall Study|Lost to Follow-up|2
1778382|NCT00683878|6190259|P1|Overall Study|Lost to Follow-up|4
1778383|NCT00683878|6190257|P3|Overall Study|Death|0
1778384|NCT00683878|6190258|P2|Overall Study|Death|1
1778385|NCT00683878|6190259|P1|Overall Study|Death|0
1778386|NCT00683878|6190257|P3|Overall Study|Withdrawal by Subject|6
1778387|NCT00683878|6190258|P2|Overall Study|Withdrawal by Subject|8
1778388|NCT00683878|6190259|P1|Overall Study|Withdrawal by Subject|9
1778389|NCT00683878|6190257|P3|Overall Study|Adverse Event|3
1778390|NCT00683878|6190258|P2|Overall Study|Adverse Event|3
1778391|NCT00683878|6190259|P1|Overall Study|Adverse Event|4
1778392|NCT00683878|6190257|P3|Overall Study|Lack of Efficacy|1
1778393|NCT00683878|6190258|P2|Overall Study|Lack of Efficacy|0
1778394|NCT00683878|6190259|P1|Overall Study|Lack of Efficacy|3
1778395|NCT00683800|6190333|P2|Overall Study|Randomized, not treated|33
1778396|NCT00683800|6190334|P1|Overall Study|Randomized, not treated|35
1778397|NCT00683800|6190333|P2|Overall Study|Lack of Efficacy|104
1778398|NCT00683800|6190334|P1|Overall Study|Lack of Efficacy|61
1778399|NCT00683800|6190333|P2|Overall Study|Withdrawal by Subject|64
1778400|NCT00683800|6190334|P1|Overall Study|Withdrawal by Subject|66
1778401|NCT00683800|6190333|P2|Overall Study|Protocol Violation|16
1778402|NCT00683800|6190334|P1|Overall Study|Protocol Violation|13
1778403|NCT00683800|6190333|P2|Overall Study|Other|2
1778404|NCT00683800|6190334|P1|Overall Study|Other|5
1778405|NCT00683800|6190333|P2|Overall Study|Lost to Follow-up|44
1778406|NCT00683800|6190334|P1|Overall Study|Lost to Follow-up|57
1778407|NCT00683800|6190333|P2|Overall Study|Death|1
1778408|NCT00683800|6190334|P1|Overall Study|Death|0
1778409|NCT00683800|6190333|P2|Overall Study|Adverse Event|102
1778410|NCT00683800|6190334|P1|Overall Study|Adverse Event|195
1778411|NCT00683787|6190401|P3|Overall Study|Adverse Event|2
1778412|NCT00683787|6190402|P2|Overall Study|Adverse Event|0
1778413|NCT00683787|6190403|P1|Overall Study|Adverse Event|0
1778414|NCT00683787|6190401|P3|Overall Study|Progression|0
1778415|NCT00683787|6190402|P2|Overall Study|Progression|3
1778416|NCT00683787|6190403|P1|Overall Study|Progression|3
1778417|NCT00683774|6190422|P2|Overall Study|Physician Decision|0
1778418|NCT00683774|6190423|P1|Overall Study|Physician Decision|3
1778419|NCT00683774|6190422|P2|Overall Study|Withdrawal by Subject|1
1778420|NCT00683774|6190423|P1|Overall Study|Withdrawal by Subject|0
1778421|NCT00683696|6190433|P2|Overall Study|Death|30
1778422|NCT00683696|6190434|P1|Overall Study|Death|46
1778423|NCT00683696|6190433|P2|Overall Study|Vital status follow-up only|3
1778424|NCT00683696|6190434|P1|Overall Study|Vital status follow-up only|3
1778425|NCT00683696|6190433|P2|Overall Study|Lost to Follow-up|6
1778426|NCT00683696|6190434|P1|Overall Study|Lost to Follow-up|5
1778427|NCT00683696|6190433|P2|Overall Study|Withdrawn prior to study closure|28
1778428|NCT00683696|6190434|P1|Overall Study|Withdrawn prior to study closure|13
1778429|NCT00683696|6190433|P2|Overall Study|Withdrawn due to study closure|338
1778430|NCT00683696|6190434|P1|Overall Study|Withdrawn due to study closure|337
1778431|NCT00683657|6190453|P2|Overall Study|Subject Withdrew Consent|0
1778432|NCT00683657|6190454|P1|Overall Study|Subject Withdrew Consent|1
1778433|NCT00683657|6190453|P2|Overall Study|Adverse Event|1
1778434|NCT00683657|6190454|P1|Overall Study|Adverse Event|0
1778435|NCT00683644|6190470|P2|Overall Study|Low copper, other health problems,|6
1778436|NCT00683644|6190471|P1|Overall Study|Low copper, other health problems,|7
1778437|NCT00683644|6190470|P2|Overall Study|Adverse Event|2
1778438|NCT00683644|6190471|P1|Overall Study|Adverse Event|1
1778439|NCT00683644|6190470|P2|Overall Study|Lost to Follow-up|4
1778440|NCT00683644|6190471|P1|Overall Study|Lost to Follow-up|1
1778441|NCT00683644|6190470|P2|Overall Study|Withdrawal by Subject|2
1778442|NCT00683644|6190471|P1|Overall Study|Withdrawal by Subject|4
1778443|NCT00683618|6190484|P3|Extension Treatment Period|Protocol Violation|0
1778444|NCT00683618|6190485|P2|Extension Treatment Period|Protocol Violation|0
1778445|NCT00683618|6190486|P1|Extension Treatment Period|Protocol Violation|1
1778446|NCT00683618|6190484|P3|Extension Treatment Period|Adverse Event|0
1778447|NCT00683618|6190485|P2|Extension Treatment Period|Adverse Event|0
1778448|NCT00683618|6190486|P1|Extension Treatment Period|Adverse Event|1
1778449|NCT00683618|6190484|P3|Extension Treatment Period|Withdrawal by Subject|0
1778450|NCT00683618|6190485|P2|Extension Treatment Period|Withdrawal by Subject|0
1778451|NCT00683618|6190486|P1|Extension Treatment Period|Withdrawal by Subject|1
1778452|NCT00683618|6190484|P3|Randomised Treatment Period|Reason not provided|2
1778453|NCT00683618|6190485|P2|Randomised Treatment Period|Reason not provided|0
1778454|NCT00683618|6190486|P1|Randomised Treatment Period|Reason not provided|0
1778455|NCT00683618|6190484|P3|Randomised Treatment Period|Adverse Event|2
1778456|NCT00683618|6190485|P2|Randomised Treatment Period|Adverse Event|0
1778457|NCT00683618|6190486|P1|Randomised Treatment Period|Adverse Event|2
1778458|NCT00683618|6190484|P3|Randomised Treatment Period|Protocol Violation|0
1778459|NCT00683618|6190485|P2|Randomised Treatment Period|Protocol Violation|1
1778460|NCT00683618|6190486|P1|Randomised Treatment Period|Protocol Violation|0
1778461|NCT00683618|6190484|P3|Randomised Treatment Period|Withdrawal by Subject|2
1778462|NCT00683618|6190485|P2|Randomised Treatment Period|Withdrawal by Subject|1
1778463|NCT00683618|6190486|P1|Randomised Treatment Period|Withdrawal by Subject|4
1778464|NCT00683592|6190536|P2|Overall Study|Other|1
1778465|NCT00683592|6190537|P1|Overall Study|Other|1
1778466|NCT00683592|6190536|P2|Overall Study|Non-compliance|5
1778467|NCT00683592|6190537|P1|Overall Study|Non-compliance|3
1778468|NCT00683592|6190536|P2|Overall Study|Physician Decision|1
1778469|NCT00683592|6190537|P1|Overall Study|Physician Decision|0
1778470|NCT00683592|6190536|P2|Overall Study|Lack of Efficacy|7
1778471|NCT00683592|6190537|P1|Overall Study|Lack of Efficacy|3
1778472|NCT00683592|6190536|P2|Overall Study|Lost to Follow-up|17
1778473|NCT00683592|6190537|P1|Overall Study|Lost to Follow-up|17
1778474|NCT00683592|6190536|P2|Overall Study|Withdrawal by Subject|11
1778475|NCT00683592|6190537|P1|Overall Study|Withdrawal by Subject|11
1778476|NCT00683592|6190536|P2|Overall Study|Adverse Event|4
1778477|NCT00683592|6190537|P1|Overall Study|Adverse Event|12
1778478|NCT00683475|6190555|P2|Overall Study|Never Treated: Progressive Disease|0
1778479|NCT00683475|6190556|P1|Overall Study|Never Treated: Progressive Disease|1
1778480|NCT00683475|6190555|P2|Overall Study|Never Treated: Adverse Event|3
1778481|NCT00683475|6190556|P1|Overall Study|Never Treated: Adverse Event|2
1778482|NCT00683475|6190555|P2|Overall Study|Withdrawal by Subject|0
1778483|NCT00683475|6190556|P1|Overall Study|Withdrawal by Subject|1
1778484|NCT00683449|6190591|P5|Overall Study|Lost to Follow-up|0
1778485|NCT00683449|6190592|P4|Overall Study|Lost to Follow-up|0
1778486|NCT00683449|6190593|P3|Overall Study|Lost to Follow-up|0
1778487|NCT00683449|6190594|P2|Overall Study|Lost to Follow-up|1
1778488|NCT00683449|6190595|P1|Overall Study|Lost to Follow-up|0
1778489|NCT00683384|6190621|P1|Overall Study|Adverse Event|1
1778490|NCT00683384|6190621|P1|Overall Study|Death|1
1778491|NCT00683293|6190631|P2|Overall Study|Withdrawal by Subject|3
1778492|NCT00683293|6190632|P1|Overall Study|Withdrawal by Subject|2
1778493|NCT00682929|6190695|P3|Overall Study|lag in DEA renewal|0
1778494|NCT00682929|6190696|P2|Overall Study|lag in DEA renewal|0
1778495|NCT00682929|6190697|P1|Overall Study|lag in DEA renewal|1
1778496|NCT00682929|6190695|P3|Overall Study|dosing compliance < 80%|0
1778497|NCT00682929|6190696|P2|Overall Study|dosing compliance < 80%|2
1778498|NCT00682929|6190697|P1|Overall Study|dosing compliance < 80%|0
1778499|NCT00682929|6190695|P3|Overall Study|Withdrawal by Subject|1
1778500|NCT00682929|6190696|P2|Overall Study|Withdrawal by Subject|2
1778501|NCT00682929|6190697|P1|Overall Study|Withdrawal by Subject|1
1778502|NCT00682929|6190695|P3|Overall Study|Adverse Event|1
1778503|NCT00682929|6190696|P2|Overall Study|Adverse Event|1
1778504|NCT00682929|6190697|P1|Overall Study|Adverse Event|4
1778505|NCT00682890|6190866|P2|Overall Study|heavy menstrual bleeding|0
1778506|NCT00682890|6190867|P1|Overall Study|heavy menstrual bleeding|1
1778507|NCT00682890|6190866|P2|Overall Study|subject moved away|1
1778508|NCT00682890|6190867|P1|Overall Study|subject moved away|0
1778509|NCT00682890|6190866|P2|Overall Study|Lost to Follow-up|1
1778510|NCT00682890|6190867|P1|Overall Study|Lost to Follow-up|1
1778511|NCT00682786|6190909|P2|Overall Study|Did not receive irinotecan|1
1778512|NCT00682786|6190910|P1|Overall Study|Did not receive irinotecan|0
1778513|NCT00682786|6190909|P2|Overall Study|Withdrawal by Subject|2
1778514|NCT00682786|6190910|P1|Overall Study|Withdrawal by Subject|2
1778515|NCT00682643|6190959|P2|Overall Study|Did Not Receive Study Drug|1
1778516|NCT00682643|6190960|P1|Overall Study|Did Not Receive Study Drug|1
1778517|NCT00682643|6190959|P2|Overall Study|Withdrawal by Subject|53
1778518|NCT00682643|6190960|P1|Overall Study|Withdrawal by Subject|19
1778519|NCT00682643|6190959|P2|Overall Study|Physician Decision|6
1778520|NCT00682643|6190960|P1|Overall Study|Physician Decision|2
1778521|NCT00682643|6190959|P2|Overall Study|Lost to Follow-up|6
1778522|NCT00682643|6190960|P1|Overall Study|Lost to Follow-up|1
1778523|NCT00682643|6190959|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
1778524|NCT00682643|6190960|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
1778525|NCT00682643|6190959|P2|Overall Study|Protocol Violation|76
1778526|NCT00682643|6190960|P1|Overall Study|Protocol Violation|38
1778527|NCT00682643|6190959|P2|Overall Study|Lack of Efficacy|0
1778528|NCT00682643|6190960|P1|Overall Study|Lack of Efficacy|2
1778529|NCT00682643|6190959|P2|Overall Study|Adverse Event|23
1778530|NCT00682643|6190960|P1|Overall Study|Adverse Event|12
1778531|NCT00682539|6191021|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
1778532|NCT00682539|6191022|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
1778533|NCT00682539|6191023|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
1778534|NCT00682539|6191021|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
1778535|NCT00682539|6191022|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
1778536|NCT00682539|6191023|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
1778537|NCT00682461|6191036|P2|Overall Study|Withdrawal by Subject|19
1778538|NCT00682461|6191037|P1|Overall Study|Withdrawal by Subject|12
1778539|NCT00682461|6191036|P2|Overall Study|Lost to Follow-up|5
1778540|NCT00682461|6191037|P1|Overall Study|Lost to Follow-up|8
1778541|NCT00682461|6191036|P2|Overall Study|Adverse Event|7
1778542|NCT00682461|6191037|P1|Overall Study|Adverse Event|5
1778543|NCT00682435|6191051|P1|Overall Study|Erroneously enrolled twice|2
1778544|NCT00682435|6191051|P1|Overall Study|Insufficient data|5
1778545|NCT00681863|6191084|P1|Overall Study|Other|18
1778546|NCT00681863|6191084|P1|Overall Study|Lack of Efficacy|2
1778547|NCT00681863|6191084|P1|Overall Study|Lost to Follow-up|2
1778548|NCT00681863|6191084|P1|Overall Study|Adverse Event|1
1778549|NCT00681824|6191132|P3|Overall Study|Death|0
1778550|NCT00681824|6191133|P2|Overall Study|Death|1
1778551|NCT00681824|6191134|P1|Overall Study|Death|0
1778552|NCT00681824|6191132|P3|Overall Study|scheduling conflict|0
1778553|NCT00681824|6191133|P2|Overall Study|scheduling conflict|0
1778554|NCT00681824|6191134|P1|Overall Study|scheduling conflict|1
1778555|NCT00681824|6191132|P3|Overall Study|withdrawn by investigator|1
1778556|NCT00681824|6191133|P2|Overall Study|withdrawn by investigator|0
1778557|NCT00681824|6191134|P1|Overall Study|withdrawn by investigator|0
1778558|NCT00681811|6191152|P2|Overall Study|Non-compliance|1
1778559|NCT00681811|6191153|P1|Overall Study|Non-compliance|0
1778560|NCT00681811|6191152|P2|Overall Study|Withdrawal by Subject|2
1778561|NCT00681811|6191153|P1|Overall Study|Withdrawal by Subject|2
1778562|NCT00681811|6191152|P2|Overall Study|Adverse Event|1
1778563|NCT00681811|6191153|P1|Overall Study|Adverse Event|1
1778564|NCT00681668|6191181|P1|Overall Study|Withdrawal by Subject|1
1778565|NCT00681668|6191181|P1|Overall Study|Protocol Violation|1
1778566|NCT00681629|6191190|P2|Overall Study|Adverse Event|0
1778567|NCT00681629|6191191|P1|Overall Study|Adverse Event|1
1778568|NCT00681629|6191190|P2|Overall Study|Study termination|2
1778569|NCT00681629|6191191|P1|Overall Study|Study termination|4
1778570|NCT00681590|6191237|P2|Overall Study|Withdrawal by Subject|12
1778571|NCT00681590|6191238|P1|Overall Study|Withdrawal by Subject|2
1778572|NCT00681564|6191248|P2|Overall Study|Death|1
1778573|NCT00681564|6191249|P1|Overall Study|Death|0
1778574|NCT00681564|6191248|P2|Overall Study|Withdrawal by Subject|1
1778575|NCT00681564|6191249|P1|Overall Study|Withdrawal by Subject|0
1778576|NCT00681564|6191248|P2|Overall Study|Lost to Follow-up|6
1778577|NCT00681564|6191249|P1|Overall Study|Lost to Follow-up|6
1778578|NCT00681187|6191341|P2|Overall Study|Adverse Event|1
1778579|NCT00681187|6191342|P1|Overall Study|Adverse Event|0
1778580|NCT00681187|6191341|P2|Overall Study|Death|1
1778581|NCT00681187|6191342|P1|Overall Study|Death|0
1778582|NCT00681187|6191341|P2|Overall Study|Withdrawal by Subject|0
1778583|NCT00681187|6191342|P1|Overall Study|Withdrawal by Subject|1
1778584|NCT00681109|6191377|P3|Overall Study|Lost to Follow-up|0
1778585|NCT00681109|6191378|P2|Overall Study|Lost to Follow-up|6
1778586|NCT00681109|6191379|P1|Overall Study|Lost to Follow-up|2
1778587|NCT00680992|6191420|P3|Overall Study|Ineligibility Determined|0
1778588|NCT00680992|6191421|P2|Overall Study|Ineligibility Determined|1
1778589|NCT00680992|6191422|P1|Overall Study|Ineligibility Determined|0
1778590|NCT00680992|6191420|P3|Overall Study|Death|0
1778591|NCT00680992|6191421|P2|Overall Study|Death|1
1778592|NCT00680992|6191422|P1|Overall Study|Death|5
1778593|NCT00680992|6191420|P3|Overall Study|Pregnancy|1
1778594|NCT00680992|6191421|P2|Overall Study|Pregnancy|0
1778595|NCT00680992|6191422|P1|Overall Study|Pregnancy|5
1778596|NCT00680992|6191420|P3|Overall Study|Requirement for Alternative Therapy|0
1778597|NCT00680992|6191421|P2|Overall Study|Requirement for Alternative Therapy|2
1778598|NCT00680992|6191422|P1|Overall Study|Requirement for Alternative Therapy|8
1778599|NCT00680992|6191420|P3|Overall Study|Noncompliance|0
1778600|NCT00680992|6191421|P2|Overall Study|Noncompliance|6
1778601|NCT00680992|6191422|P1|Overall Study|Noncompliance|4
1778602|NCT00680992|6191420|P3|Overall Study|Lost to Follow-up|0
1778603|NCT00680992|6191421|P2|Overall Study|Lost to Follow-up|14
1778604|NCT00680992|6191422|P1|Overall Study|Lost to Follow-up|12
1778605|NCT00680992|6191420|P3|Overall Study|Disease Progression|0
1778606|NCT00680992|6191421|P2|Overall Study|Disease Progression|9
1778607|NCT00680992|6191422|P1|Overall Study|Disease Progression|21
1778608|NCT00680992|6191420|P3|Overall Study|Other|1
1778609|NCT00680992|6191421|P2|Overall Study|Other|14
1778610|NCT00680992|6191422|P1|Overall Study|Other|19
1778611|NCT00680992|6191420|P3|Overall Study|Adverse Event|1
1778612|NCT00680992|6191421|P2|Overall Study|Adverse Event|19
1778613|NCT00680992|6191422|P1|Overall Study|Adverse Event|21
1778614|NCT00680992|6191420|P3|Overall Study|Withdrawal by Subject|1
1778615|NCT00680992|6191421|P2|Overall Study|Withdrawal by Subject|11
1778616|NCT00680992|6191422|P1|Overall Study|Withdrawal by Subject|33
1778617|NCT00680992|6191420|P3|Overall Study|End of Trial|3
1778618|NCT00680992|6191421|P2|Overall Study|End of Trial|12
1778619|NCT00680992|6191422|P1|Overall Study|End of Trial|32
1778620|NCT00680992|6191420|P3|Overall Study|Administrative Decision|5
1778621|NCT00680992|6191421|P2|Overall Study|Administrative Decision|42
1778622|NCT00680992|6191422|P1|Overall Study|Administrative Decision|83
1778623|NCT00680992|6191420|P3|Overall Study|Complete Resection (as per protocol)|0
1778624|NCT00680992|6191421|P2|Overall Study|Complete Resection (as per protocol)|121
1778625|NCT00680992|6191422|P1|Overall Study|Complete Resection (as per protocol)|25
1778626|NCT00680914|6191456|P2|Overall Study|serious adverse event (SAE)|1
1778627|NCT00680914|6191457|P1|Overall Study|serious adverse event (SAE)|0
1778628|NCT00680914|6191456|P2|Overall Study|Lost to Follow-up|0
1778629|NCT00680914|6191457|P1|Overall Study|Lost to Follow-up|4
1778630|NCT00680914|6191456|P2|Overall Study|Consent withdrawal|3
1778631|NCT00680914|6191457|P1|Overall Study|Consent withdrawal|6
1778632|NCT00680901|6191491|P2|Overall Study|Ongoing: In Follow Up|41
1778633|NCT00680901|6191492|P1|Overall Study|Ongoing: In Follow Up|45
1778634|NCT00680901|6191491|P2|Overall Study|Ongoing: On Study Treatment|13
1778635|NCT00680901|6191492|P1|Overall Study|Ongoing: On Study Treatment|16
1778636|NCT00680901|6191491|P2|Overall Study|Physician Decision|1
1778637|NCT00680901|6191492|P1|Overall Study|Physician Decision|0
1778638|NCT00680901|6191491|P2|Overall Study|Withdrawal by Subject|13
1778639|NCT00680901|6191492|P1|Overall Study|Withdrawal by Subject|4
1778640|NCT00680901|6191491|P2|Overall Study|Lost to Follow-up|8
1778641|NCT00680901|6191492|P1|Overall Study|Lost to Follow-up|8
1778642|NCT00680836|6191530|P2|Overall Study|Physician Decision|1
1778643|NCT00680836|6191531|P1|Overall Study|Physician Decision|2
1778644|NCT00680836|6191530|P2|Overall Study|Lost to Follow-up|1
1778645|NCT00680836|6191531|P1|Overall Study|Lost to Follow-up|3
1778646|NCT00680836|6191530|P2|Overall Study|Withdrawal by Subject|0
1778647|NCT00680836|6191531|P1|Overall Study|Withdrawal by Subject|3
1778648|NCT00680771|6191585|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
1778649|NCT00680771|6191586|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
1778650|NCT00680771|6191585|P2|Overall Study|Sleep Apnea suspected after PSG|0
1778651|NCT00680771|6191586|P1|Overall Study|Sleep Apnea suspected after PSG|1
1778652|NCT00680771|6191585|P2|Overall Study|Withdrawal by Subject|0
1778653|NCT00680771|6191586|P1|Overall Study|Withdrawal by Subject|1
1778654|NCT00680745|6191596|P4|Overall Study|False Treatment|0
1778655|NCT00680745|6191597|P3|Overall Study|False Treatment|3
1778656|NCT00680745|6191598|P2|Overall Study|False Treatment|1
1778657|NCT00680745|6191599|P1|Overall Study|False Treatment|0
1778658|NCT00680745|6191596|P4|Overall Study|Subject No Longer Meets Study Criteria|2
1778659|NCT00680745|6191597|P3|Overall Study|Subject No Longer Meets Study Criteria|0
1778660|NCT00680745|6191598|P2|Overall Study|Subject No Longer Meets Study Criteria|2
1778661|NCT00680745|6191599|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1778662|NCT00680745|6191596|P4|Overall Study|Poor/Non-compliance|0
1778663|NCT00680745|6191597|P3|Overall Study|Poor/Non-compliance|0
1778664|NCT00680745|6191598|P2|Overall Study|Poor/Non-compliance|3
1778665|NCT00680745|6191599|P1|Overall Study|Poor/Non-compliance|0
1778666|NCT00680745|6191596|P4|Overall Study|Adverse Event|3
1778667|NCT00680745|6191597|P3|Overall Study|Adverse Event|3
1778668|NCT00680745|6191598|P2|Overall Study|Adverse Event|3
1778669|NCT00680745|6191599|P1|Overall Study|Adverse Event|5
1778670|NCT00680745|6191596|P4|Overall Study|Death|0
1778671|NCT00680745|6191597|P3|Overall Study|Death|1
1778672|NCT00680745|6191598|P2|Overall Study|Death|0
1778673|NCT00680745|6191599|P1|Overall Study|Death|1
1778674|NCT00680745|6191596|P4|Overall Study|Lost to Follow-up|0
1778675|NCT00680745|6191597|P3|Overall Study|Lost to Follow-up|1
1778676|NCT00680745|6191598|P2|Overall Study|Lost to Follow-up|1
1778677|NCT00680745|6191599|P1|Overall Study|Lost to Follow-up|0
1778678|NCT00680745|6191596|P4|Overall Study|Withdrawal by Subject|8
1778679|NCT00680745|6191597|P3|Overall Study|Withdrawal by Subject|2
1778680|NCT00680745|6191598|P2|Overall Study|Withdrawal by Subject|3
1778681|NCT00680745|6191599|P1|Overall Study|Withdrawal by Subject|8
1778682|NCT00680407|6191673|P3|Overall Study|Withdrawal by Subject|2
1778683|NCT00680407|6191674|P2|Overall Study|Withdrawal by Subject|2
1778684|NCT00680407|6191675|P1|Overall Study|Withdrawal by Subject|5
1778685|NCT00680407|6191673|P3|Overall Study|Lost to Follow-up|1
1778686|NCT00680407|6191674|P2|Overall Study|Lost to Follow-up|3
1778687|NCT00680407|6191675|P1|Overall Study|Lost to Follow-up|3
1778688|NCT00680368|6191689|P1|Overall Study|not supervised, not eligible|15
1778689|NCT00680186|6191717|P2|Overall Study|Other|1
1778690|NCT00680186|6191718|P1|Overall Study|Other|4
1778691|NCT00680186|6191717|P2|Overall Study|Withdrawal by Subject|39
1778692|NCT00680186|6191718|P1|Overall Study|Withdrawal by Subject|32
1778693|NCT00680186|6191717|P2|Overall Study|Lost to Follow-up|6
1778694|NCT00680186|6191718|P1|Overall Study|Lost to Follow-up|11
1778695|NCT00680186|6191717|P2|Overall Study|Protocol Violation|26
1778696|NCT00680186|6191718|P1|Overall Study|Protocol Violation|31
1778697|NCT00680186|6191717|P2|Overall Study|Adverse Event|44
1778698|NCT00680186|6191718|P1|Overall Study|Adverse Event|47
1778699|NCT00680121|6191744|P2|Overall Study|Lost to Follow-up|23
1778700|NCT00680121|6191745|P1|Overall Study|Lost to Follow-up|27
1778701|NCT00680056|6191759|P2|Second Intervention|Protocol Violation|1
1778702|NCT00680056|6191760|P1|Second Intervention|Protocol Violation|3
1778703|NCT00680056|6191759|P2|First Intervention|Mainly Exacerbation of COPD|2
1778704|NCT00680056|6191760|P1|First Intervention|Mainly Exacerbation of COPD|1
1778705|NCT00680043|6191771|P3|Overall Study|Renal Transplant|4
1778706|NCT00680043|6191772|P2|Overall Study|Renal Transplant|0
1778707|NCT00680043|6191773|P1|Overall Study|Renal Transplant|1
1778708|NCT00680043|6191771|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
1778709|NCT00680043|6191772|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
1778710|NCT00680043|6191773|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
1778711|NCT00680043|6191771|P3|Overall Study|Withdrawal by Subject|0
1778712|NCT00680043|6191772|P2|Overall Study|Withdrawal by Subject|0
1778713|NCT00680043|6191773|P1|Overall Study|Withdrawal by Subject|1
1778714|NCT00680017|6191789|P2|Overall Study|Lost to Follow-up|0
1778715|NCT00680017|6191790|P1|Overall Study|Lost to Follow-up|2
1778716|NCT00680017|6191789|P2|Overall Study|Withdrawal by Subject|5
1778717|NCT00680017|6191790|P1|Overall Study|Withdrawal by Subject|2
1778718|NCT00680017|6191789|P2|Overall Study|Adverse Event|7
1778719|NCT00680017|6191790|P1|Overall Study|Adverse Event|13
1778720|NCT00679939|6191809|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
1778721|NCT00679939|6191810|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
1778722|NCT00679939|6191809|P2|24-Week Open-Label (OL) Period|Physician Decision|0
1778723|NCT00679939|6191810|P1|24-Week Open-Label (OL) Period|Physician Decision|1
1778724|NCT00679939|6191809|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
1778725|NCT00679939|6191810|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
1778726|NCT00679939|6191809|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
1778727|NCT00679939|6191810|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
1778728|NCT00679939|6191809|P2|24-Week Open-Label (OL) Period|Adverse Event|1
1778729|NCT00679939|6191810|P1|24-Week Open-Label (OL) Period|Adverse Event|0
1778730|NCT00679939|6191809|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
1778731|NCT00679939|6191810|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1778732|NCT00679939|6191809|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
1778733|NCT00679939|6191810|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
1778734|NCT00679939|6191809|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
1778735|NCT00679939|6191810|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
1778736|NCT00679939|6191809|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
1778737|NCT00679939|6191810|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
1778738|NCT00679939|6191809|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
1778739|NCT00679939|6191810|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
1778740|NCT00679913|6191961|P2|Overall Study|Protocol Violation|13
1778741|NCT00679913|6191962|P1|Overall Study|Protocol Violation|18
1778742|NCT00679783|6191977|P7|Overall Study|Ongoing at data cut-off|0
1778743|NCT00679783|6191978|P6|Overall Study|Ongoing at data cut-off|0
1778744|NCT00679783|6191979|P5|Overall Study|Ongoing at data cut-off|1
1778745|NCT00679783|6191980|P4|Overall Study|Ongoing at data cut-off|9
1778746|NCT00679783|6191981|P3|Overall Study|Ongoing at data cut-off|0
1778747|NCT00679783|6191982|P2|Overall Study|Ongoing at data cut-off|2
1778748|NCT00679783|6191983|P1|Overall Study|Ongoing at data cut-off|2
1778749|NCT00679783|6191977|P7|Overall Study|Not Captured|0
1778750|NCT00679783|6191978|P6|Overall Study|Not Captured|0
1778751|NCT00679783|6191979|P5|Overall Study|Not Captured|0
1778752|NCT00679783|6191980|P4|Overall Study|Not Captured|5
1778753|NCT00679783|6191981|P3|Overall Study|Not Captured|0
1778754|NCT00679783|6191982|P2|Overall Study|Not Captured|0
1778755|NCT00679783|6191983|P1|Overall Study|Not Captured|0
1778756|NCT00679783|6191977|P7|Overall Study|Withdrawal by Subject|0
1778757|NCT00679783|6191978|P6|Overall Study|Withdrawal by Subject|0
1778758|NCT00679783|6191979|P5|Overall Study|Withdrawal by Subject|0
1778759|NCT00679783|6191980|P4|Overall Study|Withdrawal by Subject|1
1778760|NCT00679783|6191981|P3|Overall Study|Withdrawal by Subject|1
1778761|NCT00679783|6191982|P2|Overall Study|Withdrawal by Subject|0
1778762|NCT00679783|6191983|P1|Overall Study|Withdrawal by Subject|0
1778763|NCT00679783|6191977|P7|Overall Study|Lack of Efficacy|0
1778764|NCT00679783|6191978|P6|Overall Study|Lack of Efficacy|0
1778765|NCT00679783|6191979|P5|Overall Study|Lack of Efficacy|0
1778766|NCT00679783|6191980|P4|Overall Study|Lack of Efficacy|2
1778767|NCT00679783|6191981|P3|Overall Study|Lack of Efficacy|0
1778768|NCT00679783|6191982|P2|Overall Study|Lack of Efficacy|1
1778769|NCT00679783|6191983|P1|Overall Study|Lack of Efficacy|0
1778770|NCT00679783|6191977|P7|Overall Study|Adverse Event|1
1778771|NCT00679783|6191978|P6|Overall Study|Adverse Event|0
1778772|NCT00679783|6191979|P5|Overall Study|Adverse Event|0
1778773|NCT00679783|6191980|P4|Overall Study|Adverse Event|3
1778774|NCT00679783|6191981|P3|Overall Study|Adverse Event|0
1778775|NCT00679783|6191982|P2|Overall Study|Adverse Event|0
1778776|NCT00679783|6191983|P1|Overall Study|Adverse Event|0
1778777|NCT00679627|6192036|P2|Overall Study|Early Study Closure|405
1778778|NCT00679627|6192037|P1|Overall Study|Early Study Closure|425
1778779|NCT00679627|6192036|P2|Overall Study|Lost to Follow-up|26
1778780|NCT00679627|6192037|P1|Overall Study|Lost to Follow-up|22
1778781|NCT00679627|6192036|P2|Overall Study|Withdrawal by Subject|172
1778782|NCT00679627|6192037|P1|Overall Study|Withdrawal by Subject|168
1778783|NCT00679627|6192036|P2|Overall Study|Adverse Event|53
1778784|NCT00679627|6192037|P1|Overall Study|Adverse Event|43
1778785|NCT00679627|6192036|P2|Overall Study|Death|29
1778786|NCT00679627|6192037|P1|Overall Study|Death|41
1778787|NCT00679549|6192061|P2|Overall Study|missing outcome echocardiograms|5
1778788|NCT00679549|6192062|P1|Overall Study|missing outcome echocardiograms|4
1778789|NCT00679549|6192061|P2|Overall Study|dropout|4
1778790|NCT00679549|6192062|P1|Overall Study|dropout|2
1778791|NCT00679432|6192072|P4|Overall Study|Randomization error, return to prior Rx|0
1778792|NCT00679432|6192073|P3|Overall Study|Randomization error, return to prior Rx|3
1778793|NCT00679432|6192074|P2|Overall Study|Randomization error, return to prior Rx|0
1778794|NCT00679432|6192075|P1|Overall Study|Randomization error, return to prior Rx|0
1778795|NCT00679432|6192072|P4|Overall Study|Infectious colitis, normal histology|3
1778796|NCT00679432|6192073|P3|Overall Study|Infectious colitis, normal histology|8
1778797|NCT00679432|6192074|P2|Overall Study|Infectious colitis, normal histology|4
1778798|NCT00679432|6192075|P1|Overall Study|Infectious colitis, normal histology|5
1778799|NCT00679432|6192072|P4|Overall Study|Lack of Efficacy|8
1778800|NCT00679432|6192073|P3|Overall Study|Lack of Efficacy|14
1778801|NCT00679432|6192074|P2|Overall Study|Lack of Efficacy|9
1778802|NCT00679432|6192075|P1|Overall Study|Lack of Efficacy|13
1778803|NCT00679432|6192072|P4|Overall Study|Sponsor decision|0
1778804|NCT00679432|6192073|P3|Overall Study|Sponsor decision|0
1778805|NCT00679432|6192074|P2|Overall Study|Sponsor decision|0
1778806|NCT00679432|6192075|P1|Overall Study|Sponsor decision|1
1778807|NCT00679432|6192072|P4|Overall Study|Physician Decision|2
1778808|NCT00679432|6192073|P3|Overall Study|Physician Decision|2
1778809|NCT00679432|6192074|P2|Overall Study|Physician Decision|2
1778810|NCT00679432|6192075|P1|Overall Study|Physician Decision|3
1778811|NCT00679432|6192072|P4|Overall Study|Lost to Follow-up|2
1778812|NCT00679432|6192073|P3|Overall Study|Lost to Follow-up|4
1778813|NCT00679432|6192074|P2|Overall Study|Lost to Follow-up|5
1778814|NCT00679432|6192075|P1|Overall Study|Lost to Follow-up|1
1778815|NCT00679432|6192072|P4|Overall Study|Withdrawal by Subject|9
1778816|NCT00679432|6192073|P3|Overall Study|Withdrawal by Subject|10
1778817|NCT00679432|6192074|P2|Overall Study|Withdrawal by Subject|11
1778818|NCT00679432|6192075|P1|Overall Study|Withdrawal by Subject|8
1778819|NCT00679432|6192072|P4|Overall Study|Protocol Violation|1
1778820|NCT00679432|6192073|P3|Overall Study|Protocol Violation|2
1778821|NCT00679432|6192074|P2|Overall Study|Protocol Violation|1
1778822|NCT00679432|6192075|P1|Overall Study|Protocol Violation|1
1778823|NCT00679432|6192072|P4|Overall Study|Adverse Event|7
1778824|NCT00679432|6192073|P3|Overall Study|Adverse Event|10
1778825|NCT00679432|6192074|P2|Overall Study|Adverse Event|6
1778826|NCT00679432|6192075|P1|Overall Study|Adverse Event|5
1778827|NCT00679367|6192118|P1|Overall Study|Withdrawal by Subject|1
1778828|NCT00679367|6192118|P1|Overall Study|Lack of Efficacy|3
1778829|NCT00679367|6192118|P1|Overall Study|inability to swallow oral drugs|1
1778830|NCT00679367|6192118|P1|Overall Study|Adverse Event|7
1778831|NCT00679354|6192124|P1|Overall Study|Ineligible|1
1778832|NCT00679354|6192124|P1|Overall Study|Physician Decision|4
1778833|NCT00679354|6192124|P1|Overall Study|Lack of Efficacy|22
1778834|NCT00679354|6192124|P1|Overall Study|Death|3
1778835|NCT00679341|6192142|P2|Overall Study|Physician/patient decision to withdraw|6
1778836|NCT00679341|6192143|P1|Overall Study|Physician/patient decision to withdraw|0
1778837|NCT00679341|6192142|P2|Overall Study|Not treated|2
1778838|NCT00679341|6192143|P1|Overall Study|Not treated|0
1778839|NCT00679341|6192142|P2|Overall Study|Physician Decision|0
1778840|NCT00679341|6192143|P1|Overall Study|Physician Decision|1
1778841|NCT00679341|6192142|P2|Overall Study|Other|0
1778842|NCT00679341|6192143|P1|Overall Study|Other|1
1778843|NCT00679341|6192142|P2|Overall Study|Death|1
1778844|NCT00679341|6192143|P1|Overall Study|Death|1
1778845|NCT00679341|6192142|P2|Overall Study|Subject/guardian decision to discontinue|0
1778846|NCT00679341|6192143|P1|Overall Study|Subject/guardian decision to discontinue|3
1778847|NCT00679341|6192142|P2|Overall Study|Adverse Event|6
1778848|NCT00679341|6192143|P1|Overall Study|Adverse Event|5
1778849|NCT00679341|6192142|P2|Overall Study|Disease progression|36
1778850|NCT00679341|6192143|P1|Overall Study|Disease progression|42
1778851|NCT00679302|6192163|P2|Overall Study|Lost to Follow-up|4
1778852|NCT00679302|6192164|P1|Overall Study|Lost to Follow-up|8
1778853|NCT00679289|6192175|P3|Overall Study|Physician Decision|1
1778854|NCT00679289|6192176|P2|Overall Study|Physician Decision|0
1778855|NCT00679289|6192177|P1|Overall Study|Physician Decision|1
1778856|NCT00679289|6192175|P3|Overall Study|Adverse Event|3
1778857|NCT00679289|6192176|P2|Overall Study|Adverse Event|0
1778858|NCT00679289|6192177|P1|Overall Study|Adverse Event|0
1778859|NCT00679289|6192175|P3|Overall Study|Withdrawal by Subject|1
1778860|NCT00679289|6192176|P2|Overall Study|Withdrawal by Subject|1
1778861|NCT00679289|6192177|P1|Overall Study|Withdrawal by Subject|0
1778862|NCT00679289|6192175|P3|Overall Study|Progressive disease|18
1778863|NCT00679289|6192176|P2|Overall Study|Progressive disease|5
1778864|NCT00679289|6192177|P1|Overall Study|Progressive disease|4
1778865|NCT00679263|6192199|P3|Visit 2/Dose 1|subject not compliance|0
1778866|NCT00679263|6192200|P2|Visit 2/Dose 1|subject not compliance|1
1778867|NCT00679263|6192201|P1|Visit 2/Dose 1|subject not compliance|1
1778868|NCT00679263|6192199|P3|Visit 2/Dose 1|Adverse Event|0
1778869|NCT00679263|6192200|P2|Visit 2/Dose 1|Adverse Event|0
1778870|NCT00679263|6192201|P1|Visit 2/Dose 1|Adverse Event|1
1778871|NCT00679211|6192212|P1|Overall Study|Other|1
1778872|NCT00679211|6192212|P1|Overall Study|Transferred to extension study TDM4529g|12
1778873|NCT00679211|6192212|P1|Overall Study|Refused to undergo protocol procedures|1
1778874|NCT00679211|6192212|P1|Overall Study|Physician Decision|5
1778875|NCT00679211|6192212|P1|Overall Study|Withdrawal by Subject|2
1778876|NCT00679211|6192212|P1|Overall Study|Adverse Event|7
1778877|NCT00679211|6192212|P1|Overall Study|Progressive disease|82
1778878|NCT00679172|6192229|P5|Overall Study|Other not specified|0
1778879|NCT00679172|6192230|P4|Overall Study|Other not specified|0
1778880|NCT00679172|6192231|P3|Overall Study|Other not specified|1
1778881|NCT00679172|6192232|P2|Overall Study|Other not specified|0
1778882|NCT00679172|6192233|P1|Overall Study|Other not specified|0
1778883|NCT00679172|6192229|P5|Overall Study|Non-compliance|0
1778884|NCT00679172|6192230|P4|Overall Study|Non-compliance|1
1778885|NCT00679172|6192231|P3|Overall Study|Non-compliance|0
1778886|NCT00679172|6192232|P2|Overall Study|Non-compliance|1
1778887|NCT00679172|6192233|P1|Overall Study|Non-compliance|1
1778888|NCT00679081|6192296|P1|Overall Study|Lost to Follow-up|1
1778889|NCT00679055|6192306|P2|Overall Study|Study Terminated|1
1778890|NCT00679055|6192307|P1|Overall Study|Study Terminated|2
1778891|NCT00679055|6192306|P2|Overall Study|Other|3
1778892|NCT00679055|6192307|P1|Overall Study|Other|0
1778893|NCT00679055|6192306|P2|Overall Study|Adverse Event|1
1778894|NCT00679055|6192307|P1|Overall Study|Adverse Event|0
1778895|NCT00679029|6192317|P1|Overall Study|Lost to Follow-up|1
1778896|NCT00679029|6192317|P1|Overall Study|Withdrawal by Subject|1
1778897|NCT00679029|6192317|P1|Overall Study|Adverse Event|3
1778898|NCT00678899|6192324|P1|Overall Study|Adverse Event|1
1778899|NCT00678886|6192333|P4|Overall Study|Other|0
1778900|NCT00678886|6192334|P3|Overall Study|Other|1
1778901|NCT00678886|6192335|P2|Overall Study|Other|0
1778902|NCT00678886|6192336|P1|Overall Study|Other|0
1778903|NCT00678886|6192333|P4|Overall Study|Lost to Follow-up|2
1778904|NCT00678886|6192334|P3|Overall Study|Lost to Follow-up|3
1778905|NCT00678886|6192335|P2|Overall Study|Lost to Follow-up|0
1778906|NCT00678886|6192336|P1|Overall Study|Lost to Follow-up|0
1778907|NCT00678886|6192333|P4|Overall Study|Physician Decision|1
1778908|NCT00678886|6192334|P3|Overall Study|Physician Decision|1
1778909|NCT00678886|6192335|P2|Overall Study|Physician Decision|0
1778910|NCT00678886|6192336|P1|Overall Study|Physician Decision|0
1778911|NCT00678886|6192333|P4|Overall Study|Withdrawal by Subject|6
1778912|NCT00678886|6192334|P3|Overall Study|Withdrawal by Subject|4
1778913|NCT00678886|6192335|P2|Overall Study|Withdrawal by Subject|0
1778914|NCT00678886|6192336|P1|Overall Study|Withdrawal by Subject|0
1778915|NCT00678795|6192405|P2|Overall Study|Lack of Efficacy|1
1778916|NCT00678795|6192406|P1|Overall Study|Lack of Efficacy|1
1778917|NCT00678795|6192405|P2|Overall Study|Lost to Follow-up|1
1778918|NCT00678795|6192406|P1|Overall Study|Lost to Follow-up|0
1778919|NCT00678795|6192405|P2|Overall Study|Protocol Violation|1
1778920|NCT00678795|6192406|P1|Overall Study|Protocol Violation|0
1778921|NCT00678795|6192405|P2|Overall Study|Withdrawal by Subject|0
1778922|NCT00678795|6192406|P1|Overall Study|Withdrawal by Subject|3
1778923|NCT00678795|6192405|P2|Overall Study|Adverse Event|3
1778924|NCT00678795|6192406|P1|Overall Study|Adverse Event|7
1778925|NCT00678691|6192428|P2|Overall Study|Adverse Event|4
1778926|NCT00678691|6192429|P1|Overall Study|Adverse Event|6
1778927|NCT00678652|6192439|P4|Overall Study|Relocation|0
1778928|NCT00678652|6192440|P3|Overall Study|Relocation|0
1778929|NCT00678652|6192441|P2|Overall Study|Relocation|0
1778930|NCT00678652|6192442|P1|Overall Study|Relocation|1
1778931|NCT00678652|6192439|P4|Overall Study|Pregnancy|0
1778932|NCT00678652|6192440|P3|Overall Study|Pregnancy|1
1778933|NCT00678652|6192441|P2|Overall Study|Pregnancy|0
1778934|NCT00678652|6192442|P1|Overall Study|Pregnancy|0
1778935|NCT00678652|6192439|P4|Overall Study|Protocol Violation|0
1778936|NCT00678652|6192440|P3|Overall Study|Protocol Violation|0
1778937|NCT00678652|6192441|P2|Overall Study|Protocol Violation|0
1778938|NCT00678652|6192442|P1|Overall Study|Protocol Violation|2
1778939|NCT00678639|6192466|P2|Overall Study|Lost to Follow-up at 30 days|0
1778940|NCT00678639|6192467|P1|Overall Study|Lost to Follow-up at 30 days|2
1778941|NCT00678587|6192482|P2|Overall Study|Withdrew Consent|3
1778942|NCT00678587|6192483|P1|Overall Study|Withdrew Consent|8
1778943|NCT00678587|6192482|P2|Overall Study|Investigator Discretion|6
1778944|NCT00678587|6192483|P1|Overall Study|Investigator Discretion|2
1778945|NCT00678587|6192482|P2|Overall Study|Lost to Follow-up|5
1778946|NCT00678587|6192483|P1|Overall Study|Lost to Follow-up|3
1778947|NCT00678587|6192482|P2|Overall Study|Study Closed/Terminated|0
1778948|NCT00678587|6192483|P1|Overall Study|Study Closed/Terminated|1
1778949|NCT00678587|6192482|P2|Overall Study|Protocol Violation|1
1778950|NCT00678587|6192483|P1|Overall Study|Protocol Violation|2
1778951|NCT00678587|6192482|P2|Overall Study|Lack of Efficacy|0
1778952|NCT00678587|6192483|P1|Overall Study|Lack of Efficacy|1
1778953|NCT00678587|6192482|P2|Overall Study|Adverse Event|3
1778954|NCT00678587|6192483|P1|Overall Study|Adverse Event|3
1778955|NCT00678392|6192577|P2|Overall Study|Other|53
1778956|NCT00678392|6192578|P1|Overall Study|Other|56
1778957|NCT00678392|6192577|P2|Overall Study|Randomized But Not Treated|7
1778958|NCT00678392|6192578|P1|Overall Study|Randomized But Not Treated|2
1778959|NCT00678392|6192577|P2|Overall Study|Withdrawal by Subject|4
1778960|NCT00678392|6192578|P1|Overall Study|Withdrawal by Subject|4
1778961|NCT00678392|6192577|P2|Overall Study|Sponsor's Decision|2
1778962|NCT00678392|6192578|P1|Overall Study|Sponsor's Decision|1
1778963|NCT00678392|6192577|P2|Overall Study|Objective Progression or Relapse|8
1778964|NCT00678392|6192578|P1|Overall Study|Objective Progression or Relapse|3
1778965|NCT00678392|6192577|P2|Overall Study|Lost to Follow-up|13
1778966|NCT00678392|6192578|P1|Overall Study|Lost to Follow-up|15
1778967|NCT00678392|6192577|P2|Overall Study|Death|269
1778968|NCT00678392|6192578|P1|Overall Study|Death|280
1778969|NCT00678392|6192577|P2|Overall Study|Adverse Event|6
1778970|NCT00678392|6192578|P1|Overall Study|Adverse Event|0
1778971|NCT00678379|6192613|P3|Overall Study|Incomplete Data|3
1778972|NCT00678379|6192614|P2|Overall Study|Incomplete Data|3
1778973|NCT00678379|6192615|P1|Overall Study|Incomplete Data|4
1778974|NCT00678379|6192613|P3|Overall Study|Injection performed after tonsillectomy|1
1778975|NCT00678379|6192614|P2|Overall Study|Injection performed after tonsillectomy|0
1778976|NCT00678379|6192615|P1|Overall Study|Injection performed after tonsillectomy|2
1778977|NCT00678301|6192643|P2|Overall Study|Lost to Follow-up|1
1778978|NCT00678301|6192644|P1|Overall Study|Lost to Follow-up|3
1778979|NCT00678301|6192643|P2|Overall Study|Withdrawal by Subject|0
1778980|NCT00678301|6192644|P1|Overall Study|Withdrawal by Subject|4
1778981|NCT00678301|6192643|P2|Overall Study|Adverse Event|0
1778982|NCT00678301|6192644|P1|Overall Study|Adverse Event|1
1778983|NCT00678301|6192643|P2|Overall Study|Non-compliance with study procedures|1
1778984|NCT00678301|6192644|P1|Overall Study|Non-compliance with study procedures|0
1778985|NCT00678288|6192702|P2|Overall Study|Disease progression/recurrence/relapse|1
1778986|NCT00678288|6192703|P1|Overall Study|Disease progression/recurrence/relapse|6
1778987|NCT00678288|6192702|P2|Overall Study|Reason not reported|0
1778988|NCT00678288|6192703|P1|Overall Study|Reason not reported|1
1778989|NCT00678288|6192702|P2|Overall Study|Switch to commercial drug|1
1778990|NCT00678288|6192703|P1|Overall Study|Switch to commercial drug|0
1778991|NCT00678288|6192702|P2|Overall Study|Not compliant with study medication|1
1778992|NCT00678288|6192703|P1|Overall Study|Not compliant with study medication|0
1778993|NCT00678288|6192702|P2|Overall Study|Study terminated by the sponsor|0
1778994|NCT00678288|6192703|P1|Overall Study|Study terminated by the sponsor|2
1778995|NCT00678288|6192702|P2|Overall Study|Withdrawal by Subject|1
1778996|NCT00678288|6192703|P1|Overall Study|Withdrawal by Subject|1
1778997|NCT00678288|6192702|P2|Overall Study|Adverse Event|2
1778998|NCT00678288|6192703|P1|Overall Study|Adverse Event|0
1778999|NCT00678210|6192758|P4|Overall Study|Other|0
1779000|NCT00678210|6192759|P3|Overall Study|Other|1
1779001|NCT00678210|6192760|P2|Overall Study|Other|0
1779002|NCT00678210|6192761|P1|Overall Study|Other|1
1779003|NCT00678210|6192758|P4|Overall Study|Withdrawal by Subject|7
1779004|NCT00678210|6192759|P3|Overall Study|Withdrawal by Subject|1
1779005|NCT00678210|6192760|P2|Overall Study|Withdrawal by Subject|4
1779006|NCT00678210|6192761|P1|Overall Study|Withdrawal by Subject|3
1779007|NCT00678210|6192758|P4|Overall Study|Lost to Follow-up|1
1779008|NCT00678210|6192759|P3|Overall Study|Lost to Follow-up|0
1779009|NCT00678210|6192760|P2|Overall Study|Lost to Follow-up|2
1779010|NCT00678210|6192761|P1|Overall Study|Lost to Follow-up|4
1779011|NCT00678210|6192758|P4|Overall Study|Lack of Efficacy|9
1779012|NCT00678210|6192759|P3|Overall Study|Lack of Efficacy|1
1779013|NCT00678210|6192760|P2|Overall Study|Lack of Efficacy|3
1779014|NCT00678210|6192761|P1|Overall Study|Lack of Efficacy|2
1779015|NCT00678210|6192758|P4|Overall Study|Adverse Event|3
1779016|NCT00678210|6192759|P3|Overall Study|Adverse Event|3
1779017|NCT00678210|6192760|P2|Overall Study|Adverse Event|2
1779018|NCT00678210|6192761|P1|Overall Study|Adverse Event|1
1779019|NCT00678080|6192797|P2|Overall Study|Withdrawal by Subject|1
1779020|NCT00678080|6192798|P1|Overall Study|Withdrawal by Subject|0
1779021|NCT00678080|6192797|P2|Overall Study|Lost to Follow-up|0
1779022|NCT00678080|6192798|P1|Overall Study|Lost to Follow-up|1
1779023|NCT00678080|6192797|P2|Overall Study|Physician Decision|0
1779024|NCT00678080|6192798|P1|Overall Study|Physician Decision|2
1779025|NCT00678041|6192824|P2|Overall Study|Physician Decision|5
1779026|NCT00678041|6192825|P1|Overall Study|Physician Decision|5
1779027|NCT00677833|6192878|P4|Overall Study|Lost to Follow-up|0
1779028|NCT00677833|6192879|P3|Overall Study|Lost to Follow-up|1
1779029|NCT00677833|6192880|P2|Overall Study|Lost to Follow-up|0
1779030|NCT00677833|6192881|P1|Overall Study|Lost to Follow-up|0
1779031|NCT00677833|6192878|P4|Overall Study|Withdrawal by Subject|3
1779032|NCT00677833|6192879|P3|Overall Study|Withdrawal by Subject|1
1779033|NCT00677833|6192880|P2|Overall Study|Withdrawal by Subject|0
1779034|NCT00677833|6192881|P1|Overall Study|Withdrawal by Subject|4
1779035|NCT00677820|6192931|P2|Overall Study|Lost to Follow-up|0
1779036|NCT00677820|6192932|P1|Overall Study|Lost to Follow-up|1
1779037|NCT00677807|6192953|P3|Overall Study|Protocol Deviation|0
1779038|NCT00677807|6192954|P2|Overall Study|Protocol Deviation|3
1779039|NCT00677807|6192955|P1|Overall Study|Protocol Deviation|1
1779040|NCT00677807|6192953|P3|Overall Study|Death|1
1779041|NCT00677807|6192954|P2|Overall Study|Death|1
1779042|NCT00677807|6192955|P1|Overall Study|Death|0
1779043|NCT00677807|6192953|P3|Overall Study|Administrative problems|2
1779044|NCT00677807|6192954|P2|Overall Study|Administrative problems|1
1779045|NCT00677807|6192955|P1|Overall Study|Administrative problems|1
1779046|NCT00677807|6192953|P3|Overall Study|Lost to Follow-up|2
1779047|NCT00677807|6192954|P2|Overall Study|Lost to Follow-up|2
1779048|NCT00677807|6192955|P1|Overall Study|Lost to Follow-up|2
1779049|NCT00677807|6192953|P3|Overall Study|Withdrawal by Subject|6
1779050|NCT00677807|6192954|P2|Overall Study|Withdrawal by Subject|3
1779051|NCT00677807|6192955|P1|Overall Study|Withdrawal by Subject|10
1779052|NCT00677807|6192953|P3|Overall Study|Participant no longer needs study drug|1
1779053|NCT00677807|6192954|P2|Overall Study|Participant no longer needs study drug|0
1779054|NCT00677807|6192955|P1|Overall Study|Participant no longer needs study drug|0
1779055|NCT00677807|6192953|P3|Overall Study|Lack of Efficacy|2
1779056|NCT00677807|6192954|P2|Overall Study|Lack of Efficacy|0
1779057|NCT00677807|6192955|P1|Overall Study|Lack of Efficacy|0
1779058|NCT00677807|6192953|P3|Overall Study|Adverse Event|6
1779059|NCT00677807|6192954|P2|Overall Study|Adverse Event|1
1779060|NCT00677807|6192955|P1|Overall Study|Adverse Event|4
1779061|NCT00677534|6193001|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
1779062|NCT00677534|6193001|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
1779063|NCT00677534|6193001|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
1779064|NCT00677365|6193009|P4|Overall Study|Other reason|1
1779065|NCT00677365|6193010|P3|Overall Study|Other reason|0
1779066|NCT00677365|6193011|P2|Overall Study|Other reason|0
1779067|NCT00677365|6193012|P1|Overall Study|Other reason|0
1779068|NCT00677365|6193009|P4|Overall Study|Withdrawal by Subject|0
1779069|NCT00677365|6193010|P3|Overall Study|Withdrawal by Subject|1
1779070|NCT00677365|6193011|P2|Overall Study|Withdrawal by Subject|0
1779071|NCT00677365|6193012|P1|Overall Study|Withdrawal by Subject|0
1779072|NCT00677365|6193009|P4|Overall Study|Adverse Event|2
1779073|NCT00677365|6193010|P3|Overall Study|Adverse Event|1
1779074|NCT00677365|6193011|P2|Overall Study|Adverse Event|1
1779075|NCT00677365|6193012|P1|Overall Study|Adverse Event|2
1779076|NCT00677352|6193044|P2|Tapering Phase|Job transfer|1
1779077|NCT00677352|6193045|P1|Tapering Phase|Job transfer|0
1779078|NCT00677352|6193044|P2|Tapering Phase|Pregnancy|1
1779079|NCT00677352|6193045|P1|Tapering Phase|Pregnancy|0
1779080|NCT00677352|6193044|P2|Tapering Phase|Withdrawal by Subject|3
1779081|NCT00677352|6193045|P1|Tapering Phase|Withdrawal by Subject|5
1779082|NCT00677352|6193044|P2|Tapering Phase|Adverse Event|5
1779083|NCT00677352|6193045|P1|Tapering Phase|Adverse Event|1
1779084|NCT00677352|6193044|P2|Treatment Phase|Not treated|2
1779085|NCT00677352|6193045|P1|Treatment Phase|Not treated|0
1779086|NCT00677352|6193044|P2|Treatment Phase|Transference or work related matter|5
1779087|NCT00677352|6193045|P1|Treatment Phase|Transference or work related matter|0
1779088|NCT00677352|6193044|P2|Treatment Phase|Protocol Violation|1
1779089|NCT00677352|6193045|P1|Treatment Phase|Protocol Violation|1
1779090|NCT00677352|6193044|P2|Treatment Phase|Pregnancy|1
1779091|NCT00677352|6193045|P1|Treatment Phase|Pregnancy|0
1779092|NCT00677352|6193044|P2|Treatment Phase|Physician Decision|0
1779093|NCT00677352|6193045|P1|Treatment Phase|Physician Decision|1
1779094|NCT00677352|6193044|P2|Treatment Phase|Withdrawal by Subject|7
1779095|NCT00677352|6193045|P1|Treatment Phase|Withdrawal by Subject|7
1779096|NCT00677352|6193044|P2|Treatment Phase|Lost to Follow-up|1
1779097|NCT00677352|6193045|P1|Treatment Phase|Lost to Follow-up|0
1779098|NCT00677352|6193044|P2|Treatment Phase|Lack of Efficacy|3
1779099|NCT00677352|6193045|P1|Treatment Phase|Lack of Efficacy|2
1779100|NCT00677352|6193044|P2|Treatment Phase|Adverse Event|22
1779101|NCT00677352|6193045|P1|Treatment Phase|Adverse Event|14
1779102|NCT00677235|6193065|P2|Overall Study|Adverse Experience|0
1779103|NCT00677235|6193066|P1|Overall Study|Adverse Experience|1
1779104|NCT00677235|6193065|P2|Overall Study|Death|36
1779105|NCT00677235|6193066|P1|Overall Study|Death|37
1779106|NCT00677235|6193065|P2|Overall Study|Lost to Follow-up|1
1779107|NCT00677235|6193066|P1|Overall Study|Lost to Follow-up|2
1779108|NCT00677235|6193065|P2|Overall Study|Withdrawal by Subject|1
1779109|NCT00677235|6193066|P1|Overall Study|Withdrawal by Subject|1
1779110|NCT00677092|6193106|P1|Overall Study|Death Prior to Receiving Treatment|1
1779111|NCT00677092|6193106|P1|Overall Study|Withdrawal by Subject|3
1779112|NCT00677092|6193106|P1|Overall Study|Lost to Follow-up|1
1779113|NCT00677092|6193106|P1|Overall Study|Adverse Event|1
1779114|NCT00677014|6193123|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
1779115|NCT00677014|6193124|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
1779116|NCT00677014|6193125|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
1779117|NCT00677014|6193123|P3|Overall Study|Death|7
1779118|NCT00677014|6193124|P2|Overall Study|Death|15
1779119|NCT00677014|6193125|P1|Overall Study|Death|6
1779120|NCT00677014|6193123|P3|Overall Study|Lost to Follow-up|24
1779121|NCT00677014|6193124|P2|Overall Study|Lost to Follow-up|12
1779122|NCT00677014|6193125|P1|Overall Study|Lost to Follow-up|20
1779123|NCT00676715|6193178|P4|Overall Study|Participants Ongoing|24
1779124|NCT00676715|6193179|P3|Overall Study|Participants Ongoing|17
1779125|NCT00676715|6193180|P2|Overall Study|Participants Ongoing|29
1779126|NCT00676715|6193181|P1|Overall Study|Participants Ongoing|29
1779127|NCT00676715|6193178|P4|Overall Study|Adverse Event|0
1779128|NCT00676715|6193179|P3|Overall Study|Adverse Event|2
1779129|NCT00676715|6193180|P2|Overall Study|Adverse Event|1
1779130|NCT00676715|6193181|P1|Overall Study|Adverse Event|0
1779131|NCT00676715|6193178|P4|Overall Study|Death|0
1779132|NCT00676715|6193179|P3|Overall Study|Death|1
1779133|NCT00676715|6193180|P2|Overall Study|Death|1
1779134|NCT00676715|6193181|P1|Overall Study|Death|1
1779135|NCT00676715|6193178|P4|Overall Study|Lost to Follow-up|3
1779136|NCT00676715|6193179|P3|Overall Study|Lost to Follow-up|7
1779137|NCT00676715|6193180|P2|Overall Study|Lost to Follow-up|1
1779138|NCT00676715|6193181|P1|Overall Study|Lost to Follow-up|1
1779139|NCT00676715|6193178|P4|Overall Study|Other|3
1779140|NCT00676715|6193179|P3|Overall Study|Other|4
1779141|NCT00676715|6193180|P2|Overall Study|Other|6
1779142|NCT00676715|6193181|P1|Overall Study|Other|2
1779143|NCT00676715|6193178|P4|Overall Study|Withdrawal by Subject|10
1779144|NCT00676715|6193179|P3|Overall Study|Withdrawal by Subject|10
1779145|NCT00676715|6193180|P2|Overall Study|Withdrawal by Subject|9
1779146|NCT00676715|6193181|P1|Overall Study|Withdrawal by Subject|7
1779153|NCT00676663|6193223|P2|Overall Study|Lost to Follow-up|3
1779154|NCT00676663|6193224|P1|Overall Study|Lost to Follow-up|1
1779155|NCT00676663|6193223|P2|Overall Study|Withdrew Consent|8
1779156|NCT00676663|6193224|P1|Overall Study|Withdrew Consent|1
1779157|NCT00676663|6193223|P2|Overall Study|Death|27
1779158|NCT00676663|6193224|P1|Overall Study|Death|43
1779159|NCT00676650|6193240|P2|Overall Study|Randomized but not treated|4
1779160|NCT00676650|6193241|P1|Overall Study|Randomized but not treated|3
1779161|NCT00676650|6193240|P2|Overall Study|Withdrawal by Subject|24
1779162|NCT00676650|6193241|P1|Overall Study|Withdrawal by Subject|48
1779163|NCT00676650|6193240|P2|Overall Study|Study terminated by sponsor|43
1779164|NCT00676650|6193241|P1|Overall Study|Study terminated by sponsor|57
1779165|NCT00676650|6193240|P2|Overall Study|Protocol Violation|1
1779166|NCT00676650|6193241|P1|Overall Study|Protocol Violation|3
1779167|NCT00676650|6193240|P2|Overall Study|Other|10
1779168|NCT00676650|6193241|P1|Overall Study|Other|14
1779169|NCT00676650|6193240|P2|Overall Study|Objective progression or relapse|140
1779170|NCT00676650|6193241|P1|Overall Study|Objective progression or relapse|189
1779171|NCT00676650|6193240|P2|Overall Study|Lost to Follow-up|1
1779172|NCT00676650|6193241|P1|Overall Study|Lost to Follow-up|0
1779173|NCT00676650|6193240|P2|Overall Study|Global deterioration of health status|31
1779174|NCT00676650|6193241|P1|Overall Study|Global deterioration of health status|66
1779175|NCT00676650|6193240|P2|Overall Study|Adverse Event|21
1779176|NCT00676650|6193241|P1|Overall Study|Adverse Event|159
1779177|NCT00676650|6193240|P2|Overall Study|Death|14
1779178|NCT00676650|6193241|P1|Overall Study|Death|45
1779179|NCT00676520|6193283|P1|Overall Study|Other Reason|18
1779180|NCT00676520|6193283|P1|Overall Study|Ineligible for Randomization to DAPT|209
1779181|NCT00676520|6193283|P1|Overall Study|Physician Decision|20
1779182|NCT00676520|6193283|P1|Overall Study|Death|159
1779183|NCT00676520|6193283|P1|Overall Study|Lost to Follow-up|162
1779184|NCT00676520|6193283|P1|Overall Study|Withdrawal by Subject|163
1779185|NCT00676494|6193340|P1|Overall Study|Withdrawal by Subject|6
1779186|NCT00676494|6193340|P1|Overall Study|Missed Visit|8
1779187|NCT00676403|6193357|P6|Overall Study|Withdrawal by Subject|1
1779188|NCT00676403|6193358|P5|Overall Study|Withdrawal by Subject|0
1779189|NCT00676403|6193359|P4|Overall Study|Withdrawal by Subject|0
1779190|NCT00676403|6193360|P3|Overall Study|Withdrawal by Subject|0
1779191|NCT00676403|6193361|P2|Overall Study|Withdrawal by Subject|0
1779192|NCT00676403|6193362|P1|Overall Study|Withdrawal by Subject|0
1779193|NCT00676403|6193357|P6|Overall Study|Reason Unspecified|1
1779194|NCT00676403|6193358|P5|Overall Study|Reason Unspecified|0
1779195|NCT00676403|6193359|P4|Overall Study|Reason Unspecified|0
1779196|NCT00676403|6193360|P3|Overall Study|Reason Unspecified|1
1779197|NCT00676403|6193361|P2|Overall Study|Reason Unspecified|0
1779198|NCT00676403|6193362|P1|Overall Study|Reason Unspecified|1
1779199|NCT00676403|6193357|P6|Overall Study|Lost to Follow-up|1
1779200|NCT00676403|6193358|P5|Overall Study|Lost to Follow-up|0
1779201|NCT00676403|6193359|P4|Overall Study|Lost to Follow-up|0
1779202|NCT00676403|6193360|P3|Overall Study|Lost to Follow-up|0
1779203|NCT00676403|6193361|P2|Overall Study|Lost to Follow-up|0
1779204|NCT00676403|6193362|P1|Overall Study|Lost to Follow-up|0
1779205|NCT00676403|6193357|P6|Overall Study|Adverse Event|2
1779206|NCT00676403|6193358|P5|Overall Study|Adverse Event|1
1779207|NCT00676403|6193359|P4|Overall Study|Adverse Event|5
1779208|NCT00676403|6193360|P3|Overall Study|Adverse Event|0
1779209|NCT00676403|6193361|P2|Overall Study|Adverse Event|2
1779210|NCT00676403|6193362|P1|Overall Study|Adverse Event|1
1779211|NCT00676338|6193505|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1779212|NCT00676338|6193506|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
1779213|NCT00676338|6193507|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1779214|NCT00676338|6193508|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
1779215|NCT00676338|6193505|P4|Overall Study|Entry Criteria Not Met|1
1779216|NCT00676338|6193506|P3|Overall Study|Entry Criteria Not Met|1
1779217|NCT00676338|6193507|P2|Overall Study|Entry Criteria Not Met|2
1779218|NCT00676338|6193508|P1|Overall Study|Entry Criteria Not Met|0
1779219|NCT00676338|6193505|P4|Overall Study|Withdrawal by Subject|6
1779220|NCT00676338|6193506|P3|Overall Study|Withdrawal by Subject|12
1779221|NCT00676338|6193507|P2|Overall Study|Withdrawal by Subject|9
1779222|NCT00676338|6193508|P1|Overall Study|Withdrawal by Subject|17
1779223|NCT00676338|6193505|P4|Overall Study|Protocol Violation|5
1779224|NCT00676338|6193506|P3|Overall Study|Protocol Violation|2
1779225|NCT00676338|6193507|P2|Overall Study|Protocol Violation|9
1779226|NCT00676338|6193508|P1|Overall Study|Protocol Violation|5
1779227|NCT00676338|6193505|P4|Overall Study|Physician Decision|3
1779228|NCT00676338|6193506|P3|Overall Study|Physician Decision|2
1779229|NCT00676338|6193507|P2|Overall Study|Physician Decision|3
1779230|NCT00676338|6193508|P1|Overall Study|Physician Decision|3
1779231|NCT00676338|6193505|P4|Overall Study|Lost to Follow-up|4
1779232|NCT00676338|6193506|P3|Overall Study|Lost to Follow-up|3
1779233|NCT00676338|6193507|P2|Overall Study|Lost to Follow-up|1
1779234|NCT00676338|6193508|P1|Overall Study|Lost to Follow-up|4
1779235|NCT00676338|6193505|P4|Overall Study|Adverse Event|1
1779236|NCT00676338|6193506|P3|Overall Study|Adverse Event|5
1779237|NCT00676338|6193507|P2|Overall Study|Adverse Event|6
1779238|NCT00676338|6193508|P1|Overall Study|Adverse Event|6
1779239|NCT00676208|6193560|P2|Overall Study|Incomplete data|4
1779240|NCT00676208|6193561|P1|Overall Study|Incomplete data|2
1779241|NCT00676208|6193560|P2|Overall Study|Lost to Follow-up|2
1779242|NCT00676208|6193561|P1|Overall Study|Lost to Follow-up|0
1779243|NCT00676195|6193569|P1|Overall Study|Physician Decision|1
1779244|NCT00676195|6193569|P1|Overall Study|Adverse Event|1
1779245|NCT00676195|6193569|P1|Overall Study|Lost to Follow-up|1
1779246|NCT00676143|6193594|P2|Overall Study|Vasogenic edema recurrence|3
1779247|NCT00676143|6193595|P1|Overall Study|Vasogenic edema recurrence|1
1779248|NCT00676143|6193594|P2|Overall Study|Participant participation unknown|4
1779249|NCT00676143|6193595|P1|Overall Study|Participant participation unknown|1
1779250|NCT00676143|6193594|P2|Overall Study|Other|20
1779251|NCT00676143|6193595|P1|Overall Study|Other|11
1779252|NCT00676143|6193594|P2|Overall Study|Loss of caregiver|3
1779253|NCT00676143|6193595|P1|Overall Study|Loss of caregiver|5
1779254|NCT00676143|6193594|P2|Overall Study|Failed to return|1
1779255|NCT00676143|6193595|P1|Overall Study|Failed to return|2
1779256|NCT00676143|6193594|P2|Overall Study|Discontinuation of study by sponsor|88
1779257|NCT00676143|6193595|P1|Overall Study|Discontinuation of study by sponsor|65
1779258|NCT00676143|6193594|P2|Overall Study|Withdrawal by Subject|42
1779259|NCT00676143|6193595|P1|Overall Study|Withdrawal by Subject|24
1779260|NCT00676143|6193594|P2|Overall Study|Protocol Violation|8
1779261|NCT00676143|6193595|P1|Overall Study|Protocol Violation|4
1779262|NCT00676143|6193594|P2|Overall Study|Physician Decision|8
1779263|NCT00676143|6193595|P1|Overall Study|Physician Decision|5
1779264|NCT00676143|6193594|P2|Overall Study|Lost to Follow-up|13
1779265|NCT00676143|6193595|P1|Overall Study|Lost to Follow-up|0
1779266|NCT00676143|6193594|P2|Overall Study|Lack of Efficacy|6
1779267|NCT00676143|6193595|P1|Overall Study|Lack of Efficacy|0
1779268|NCT00676143|6193594|P2|Overall Study|Death|4
1779269|NCT00676143|6193595|P1|Overall Study|Death|4
1779270|NCT00676143|6193594|P2|Overall Study|Adverse Event|60
1779271|NCT00676143|6193595|P1|Overall Study|Adverse Event|34
1779272|NCT00676130|6193635|P2|Overall Study|Withdrawal by Subject|1
1779273|NCT00676130|6193636|P1|Overall Study|Withdrawal by Subject|0
1779274|NCT00676130|6193635|P2|Overall Study|Found ineligible|2
1779275|NCT00676130|6193636|P1|Overall Study|Found ineligible|3
1779276|NCT00676130|6193635|P2|Overall Study|Lost to Follow-up|1
1779277|NCT00676130|6193636|P1|Overall Study|Lost to Follow-up|0
1779278|NCT00676091|6193646|P2|Toddler Dose|Parent or legal guardian request|0
1779279|NCT00676091|6193647|P1|Toddler Dose|Parent or legal guardian request|1
1779280|NCT00676091|6193646|P2|Toddler Dose|Failed to return|0
1779281|NCT00676091|6193647|P1|Toddler Dose|Failed to return|2
1779282|NCT00676091|6193646|P2|After Infant Series|Failed to return|1
1779283|NCT00676091|6193647|P1|After Infant Series|Failed to return|1
1779284|NCT00676091|6193646|P2|After Infant Series|Protocol Violation|1
1779285|NCT00676091|6193647|P1|After Infant Series|Protocol Violation|0
1779286|NCT00676091|6193646|P2|After Infant Series|Adverse Event|1
1779287|NCT00676091|6193647|P1|After Infant Series|Adverse Event|0
1779288|NCT00676091|6193646|P2|Infant Series|Died prior to receiving 7vPnC|1
1779289|NCT00676091|6193647|P1|Infant Series|Died prior to receiving 7vPnC|0
1779290|NCT00676091|6193646|P2|Infant Series|Lost to Follow-up|0
1779291|NCT00676091|6193647|P1|Infant Series|Lost to Follow-up|1
1779292|NCT00676091|6193646|P2|Infant Series|Failed to return|3
1779293|NCT00676091|6193647|P1|Infant Series|Failed to return|1
1779294|NCT00676091|6193646|P2|Infant Series|Adverse Event|3
1779295|NCT00676091|6193647|P1|Infant Series|Adverse Event|2
1779296|NCT00676091|6193646|P2|Infant Series|Protocol Violation|3
1779297|NCT00676091|6193647|P1|Infant Series|Protocol Violation|6
1779298|NCT00676091|6193646|P2|Infant Series|Parent or legal guardian request|8
1779299|NCT00676091|6193647|P1|Infant Series|Parent or legal guardian request|10
1779300|NCT00676052|6193704|P6|Overall Study|Withdrawal by Subject|0
1779301|NCT00676052|6193705|P5|Overall Study|Withdrawal by Subject|0
1779302|NCT00676052|6193706|P4|Overall Study|Withdrawal by Subject|0
1779303|NCT00676052|6193707|P3|Overall Study|Withdrawal by Subject|1
1779304|NCT00676052|6193708|P2|Overall Study|Withdrawal by Subject|0
1779305|NCT00676052|6193709|P1|Overall Study|Withdrawal by Subject|1
1779306|NCT00676052|6193704|P6|Overall Study|Physician Decision|1
1779307|NCT00676052|6193705|P5|Overall Study|Physician Decision|0
1779308|NCT00676052|6193706|P4|Overall Study|Physician Decision|0
1779309|NCT00676052|6193707|P3|Overall Study|Physician Decision|1
1779310|NCT00676052|6193708|P2|Overall Study|Physician Decision|1
1779311|NCT00676052|6193709|P1|Overall Study|Physician Decision|1
1779312|NCT00676052|6193704|P6|Overall Study|Lost to Follow-up|0
1779313|NCT00676052|6193705|P5|Overall Study|Lost to Follow-up|1
1779314|NCT00676052|6193706|P4|Overall Study|Lost to Follow-up|0
1779315|NCT00676052|6193707|P3|Overall Study|Lost to Follow-up|0
1779316|NCT00676052|6193708|P2|Overall Study|Lost to Follow-up|0
1779317|NCT00676052|6193709|P1|Overall Study|Lost to Follow-up|0
1779318|NCT00676052|6193704|P6|Overall Study|Protocol Violation|2
1779319|NCT00676052|6193705|P5|Overall Study|Protocol Violation|1
1779320|NCT00676052|6193706|P4|Overall Study|Protocol Violation|2
1779321|NCT00676052|6193707|P3|Overall Study|Protocol Violation|2
1779322|NCT00676052|6193708|P2|Overall Study|Protocol Violation|3
1779323|NCT00676052|6193709|P1|Overall Study|Protocol Violation|5
1779324|NCT00676052|6193704|P6|Overall Study|Lack of Efficacy|1
1779325|NCT00676052|6193705|P5|Overall Study|Lack of Efficacy|2
1779326|NCT00676052|6193706|P4|Overall Study|Lack of Efficacy|1
1779327|NCT00676052|6193707|P3|Overall Study|Lack of Efficacy|1
1779328|NCT00676052|6193708|P2|Overall Study|Lack of Efficacy|2
1779329|NCT00676052|6193709|P1|Overall Study|Lack of Efficacy|2
1779330|NCT00676052|6193704|P6|Overall Study|Adverse Event|2
1779331|NCT00676052|6193705|P5|Overall Study|Adverse Event|2
1779332|NCT00676052|6193706|P4|Overall Study|Adverse Event|2
1779333|NCT00676052|6193707|P3|Overall Study|Adverse Event|1
1779334|NCT00676052|6193708|P2|Overall Study|Adverse Event|1
1779335|NCT00676052|6193709|P1|Overall Study|Adverse Event|0
1779336|NCT00675948|6193779|P2|Overall Study|Patient feels unable to take medication|1
1779337|NCT00675948|6193780|P1|Overall Study|Patient feels unable to take medication|0
1779338|NCT00675948|6193779|P2|Overall Study|Patient unable to comply with diaries|0
1779339|NCT00675948|6193780|P1|Overall Study|Patient unable to comply with diaries|1
1779340|NCT00675948|6193779|P2|Overall Study|Patient died|0
1779341|NCT00675948|6193780|P1|Overall Study|Patient died|1
1779342|NCT00675948|6193779|P2|Overall Study|Sponsor decision|1
1779343|NCT00675948|6193780|P1|Overall Study|Sponsor decision|0
1779344|NCT00675948|6193779|P2|Overall Study|Pain under control|0
1779345|NCT00675948|6193780|P1|Overall Study|Pain under control|1
1779346|NCT00675948|6193779|P2|Overall Study|Protocol Violation|0
1779347|NCT00675948|6193780|P1|Overall Study|Protocol Violation|1
1779348|NCT00675948|6193779|P2|Overall Study|Lost to Follow-up|0
1779349|NCT00675948|6193780|P1|Overall Study|Lost to Follow-up|2
1779350|NCT00675948|6193779|P2|Overall Study|Withdrawal by Subject|0
1779351|NCT00675948|6193780|P1|Overall Study|Withdrawal by Subject|7
1779352|NCT00675948|6193779|P2|Overall Study|Lack of Efficacy|0
1779353|NCT00675948|6193780|P1|Overall Study|Lack of Efficacy|3
1779354|NCT00675948|6193779|P2|Overall Study|Adverse Event|1
1779355|NCT00675948|6193780|P1|Overall Study|Adverse Event|23
1779356|NCT00675766|6193843|P4|Overall Study|Lost to Follow-up|26
1779357|NCT00675766|6193844|P3|Overall Study|Lost to Follow-up|21
1779358|NCT00675766|6193845|P2|Overall Study|Lost to Follow-up|5
1779359|NCT00675766|6193846|P1|Overall Study|Lost to Follow-up|6
1779360|NCT00675597|6193856|P1|Overall Study|Withdrawal by Subject|3
1779361|NCT00675506|6193910|P2|Overall Study|Schedule conflict|1
1779362|NCT00675506|6193911|P1|Overall Study|Schedule conflict|0
1779363|NCT00675506|6193910|P2|Overall Study|Declined participation|0
1779364|NCT00675506|6193911|P1|Overall Study|Declined participation|1
1779365|NCT00675506|6193910|P2|Overall Study|Disclosed history of cancer|0
1779366|NCT00675506|6193911|P1|Overall Study|Disclosed history of cancer|1
1779367|NCT00675506|6193910|P2|Overall Study|Hypersensitivity Reaction|0
1779368|NCT00675506|6193911|P1|Overall Study|Hypersensitivity Reaction|1
1779369|NCT00675506|6193910|P2|Overall Study|Elevated IGF-1|0
1779370|NCT00675506|6193911|P1|Overall Study|Elevated IGF-1|2
1779371|NCT00675506|6193910|P2|Overall Study|Elevated IGF-1 prior to treatment|0
1779372|NCT00675506|6193911|P1|Overall Study|Elevated IGF-1 prior to treatment|1
1779373|NCT00675506|6193910|P2|Overall Study|Elevated fasting glucose|1
1779374|NCT00675506|6193911|P1|Overall Study|Elevated fasting glucose|2
1779375|NCT00675506|6193910|P2|Overall Study|Lost interest|5
1779376|NCT00675506|6193911|P1|Overall Study|Lost interest|3
1779377|NCT00675506|6193910|P2|Overall Study|Lost to Follow-up|5
1779378|NCT00675506|6193911|P1|Overall Study|Lost to Follow-up|1
1779379|NCT00675441|6193927|P1|Overall Study|Death|1
1779380|NCT00675441|6193927|P1|Overall Study|Withdrawal by Subject|2
1779381|NCT00675428|6193933|P2|Overall Study|Physician Decision|0
1779382|NCT00675428|6193934|P1|Overall Study|Physician Decision|1
1779383|NCT00675428|6193933|P2|Overall Study|No Disease Response After Cycle 6|1
1779384|NCT00675428|6193934|P1|Overall Study|No Disease Response After Cycle 6|0
1779385|NCT00675428|6193933|P2|Overall Study|Disease Progression|2
1779386|NCT00675428|6193934|P1|Overall Study|Disease Progression|2
1779387|NCT00675103|6193976|P1|Overall Study|Adverse Event|1
1779388|NCT00675103|6193976|P1|Overall Study|Lack of Efficacy|2
1779389|NCT00674986|6193983|P2|Overall Study|Other reasons|8
1779390|NCT00674986|6193984|P1|Overall Study|Other reasons|4
1779391|NCT00674986|6193983|P2|Overall Study|Lost to Follow-up|53
1779392|NCT00674986|6193984|P1|Overall Study|Lost to Follow-up|25
1779393|NCT00674986|6193983|P2|Overall Study|Subject withdrew consent|19
1779394|NCT00674986|6193984|P1|Overall Study|Subject withdrew consent|12
1779395|NCT00674986|6193983|P2|Overall Study|Adverse Event|1
1779396|NCT00674986|6193984|P1|Overall Study|Adverse Event|2
1779397|NCT00674973|6194005|P2|Overall Study|Protocol Violation|1
1779398|NCT00674973|6194006|P1|Overall Study|Protocol Violation|0
1779399|NCT00674973|6194005|P2|Overall Study|Death|15
1779400|NCT00674973|6194006|P1|Overall Study|Death|19
1779401|NCT00674973|6194005|P2|Overall Study|Adverse Event|9
1779402|NCT00674973|6194006|P1|Overall Study|Adverse Event|2
1779403|NCT00674973|6194005|P2|Overall Study|Failure to Return|0
1779404|NCT00674973|6194006|P1|Overall Study|Failure to Return|1
1779405|NCT00674973|6194005|P2|Overall Study|Refused Treatment|5
1779406|NCT00674973|6194006|P1|Overall Study|Refused Treatment|1
1779407|NCT00674973|6194005|P2|Overall Study|Insufficient Therapeutic Response|72
1779408|NCT00674973|6194006|P1|Overall Study|Insufficient Therapeutic Response|77
1779409|NCT00674817|6194020|P1|Period 4|Adverse Event|1
1779410|NCT00674817|6194020|P1|Period 3|Protocol Violation|1
1779411|NCT00674817|6194020|P1|Period 3|Adverse Event|1
1779412|NCT00674817|6194020|P1|Period 1|Protocol Violation|1
1779413|NCT00674817|6194020|P1|Period 1|Withdrawal by Subject|2
1779414|NCT00674700|6194197|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
1779415|NCT00674700|6194198|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
1779416|NCT00674700|6194199|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
1779417|NCT00674700|6194197|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
1779418|NCT00674700|6194198|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
1779419|NCT00674700|6194199|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
1779420|NCT00674700|6194197|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
1779421|NCT00674700|6194198|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
1779422|NCT00674700|6194199|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
1779423|NCT00674700|6194197|P3|Year 1|Any other reason not above-mentioned|6
1779424|NCT00674700|6194198|P2|Year 1|Any other reason not above-mentioned|7
1779425|NCT00674700|6194199|P1|Year 1|Any other reason not above-mentioned|7
1779426|NCT00674700|6194197|P3|Year 1|Withdrawal by Subject|6
1779427|NCT00674700|6194198|P2|Year 1|Withdrawal by Subject|7
1779428|NCT00674700|6194199|P1|Year 1|Withdrawal by Subject|7
1779429|NCT00674700|6194197|P3|Year 1|Adverse Event|5
1779430|NCT00674700|6194198|P2|Year 1|Adverse Event|20
1779431|NCT00674700|6194199|P1|Year 1|Adverse Event|17
1779432|NCT00674661|6194212|P2|Overall Study|Withdrawal by Subject|5
1779433|NCT00674661|6194213|P1|Overall Study|Withdrawal by Subject|0
1779434|NCT00674661|6194212|P2|Overall Study|Lost to Follow-up|3
1779435|NCT00674661|6194213|P1|Overall Study|Lost to Follow-up|6
1779436|NCT00674661|6194212|P2|Overall Study|Other|7
1779437|NCT00674661|6194213|P1|Overall Study|Other|5
1779438|NCT00674570|6194311|P3|Overall Study|Withdrawal by Subject|0
1779439|NCT00674570|6194312|P2|Overall Study|Withdrawal by Subject|2
1779440|NCT00674570|6194313|P1|Overall Study|Withdrawal by Subject|0
1779441|NCT00674362|6194352|P2|Open Label|Other: Subject moved to extension study|0
1779442|NCT00674362|6194353|P1|Open Label|Other: Subject moved to extension study|1
1779443|NCT00674362|6194352|P2|Open Label|Adverse Event|0
1779444|NCT00674362|6194353|P1|Open Label|Adverse Event|1
1779445|NCT00674362|6194352|P2|Double Blind|Other: Surgery|1
1779446|NCT00674362|6194353|P1|Double Blind|Other: Surgery|0
1779447|NCT00674362|6194352|P2|Double Blind|Other: Loss of Patient Compliance|1
1779448|NCT00674362|6194353|P1|Double Blind|Other: Loss of Patient Compliance|0
1779449|NCT00674362|6194352|P2|Double Blind|Withdrawal by Subject|3
1779450|NCT00674362|6194353|P1|Double Blind|Withdrawal by Subject|4
1779451|NCT00674362|6194352|P2|Double Blind|Loss of efficacy|1
1779452|NCT00674362|6194353|P1|Double Blind|Loss of efficacy|0
1779453|NCT00674362|6194352|P2|Double Blind|Lack of Efficacy|6
1779454|NCT00674362|6194353|P1|Double Blind|Lack of Efficacy|2
1779455|NCT00674362|6194352|P2|Double Blind|Adverse Event|6
1779456|NCT00674362|6194353|P1|Double Blind|Adverse Event|6
1779457|NCT00674323|6194421|P3|Overall Study|Protocol Violation|0
1779458|NCT00674323|6194422|P2|Overall Study|Protocol Violation|0
1779459|NCT00674323|6194423|P1|Overall Study|Protocol Violation|1
1779460|NCT00674323|6194421|P3|Overall Study|Adverse Event|0
1779461|NCT00674323|6194422|P2|Overall Study|Adverse Event|1
1779462|NCT00674323|6194423|P1|Overall Study|Adverse Event|0
1779463|NCT00674154|6194474|P2|Overall Study|Did not want parathyroidectomy|2
1779464|NCT00674154|6194475|P1|Overall Study|Did not want parathyroidectomy|0
1779465|NCT00674154|6194474|P2|Overall Study|Withdrawal by Subject|1
1779466|NCT00674154|6194475|P1|Overall Study|Withdrawal by Subject|3
1779467|NCT00674128|6194483|P2|Overall Study|Withdrawal by Subject|23
1779468|NCT00674128|6194484|P1|Overall Study|Withdrawal by Subject|25
1779469|NCT00673933|6194509|P1|Overall Study|Lost to Follow-up|1
1779470|NCT00673933|6194509|P1|Overall Study|Withdrawal by Subject|2
1779471|NCT00673894|6194527|P2|First Intervention 4 Weeks|Adverse Event|0
1779472|NCT00673894|6194528|P1|First Intervention 4 Weeks|Adverse Event|1
1779473|NCT00673894|6194527|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
1779474|NCT00673894|6194528|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
1779475|NCT00673881|6194536|P1|Overall Study|Withdrawal by Subject|1
1779476|NCT00673816|6194550|P1|Overall Study|Withdrawal by Subject|1
1779477|NCT00673816|6194550|P1|Overall Study|Adverse Event|1
1779478|NCT00673673|6194585|P1|Overall Study|Investigators' discretion|2
1779479|NCT00673673|6194585|P1|Overall Study|Withdrawal by Subject|3
1779480|NCT00673673|6194585|P1|Overall Study|Adverse Event|4
1779481|NCT00673673|6194585|P1|Overall Study|Progressive disease|27
1779482|NCT00673660|6194591|P1|Overall Study|Lost to Follow-up|107
1779483|NCT00673465|6194613|P12|Part 1/Period 2 (United States)|Protocol Violation|0
1779484|NCT00673465|6194614|P11|Part 1/Period 2 (United States)|Protocol Violation|0
1779485|NCT00673465|6194615|P10|Part 1/Period 2 (United States)|Protocol Violation|0
1779486|NCT00673465|6194616|P9|Part 1/Period 2 (United States)|Protocol Violation|0
1779487|NCT00673465|6194617|P8|Part 1/Period 2 (United States)|Protocol Violation|0
1779488|NCT00673465|6194618|P7|Part 1/Period 2 (United States)|Protocol Violation|0
1779489|NCT00673465|6194619|P6|Part 1/Period 2 (United States)|Protocol Violation|0
1779490|NCT00673465|6194620|P5|Part 1/Period 2 (United States)|Protocol Violation|1
1779491|NCT00673465|6194621|P4|Part 1/Period 2 (United States)|Protocol Violation|0
1779492|NCT00673465|6194622|P3|Part 1/Period 2 (United States)|Protocol Violation|0
1779493|NCT00673465|6194623|P2|Part 1/Period 2 (United States)|Protocol Violation|0
1779494|NCT00673465|6194624|P1|Part 1/Period 2 (United States)|Protocol Violation|0
1779495|NCT00673465|6194613|P12|Part 1/Period 1 (United States)|Protocol Violation|0
1779496|NCT00673465|6194614|P11|Part 1/Period 1 (United States)|Protocol Violation|0
1779497|NCT00673465|6194615|P10|Part 1/Period 1 (United States)|Protocol Violation|0
1779498|NCT00673465|6194616|P9|Part 1/Period 1 (United States)|Protocol Violation|0
1779499|NCT00673465|6194617|P8|Part 1/Period 1 (United States)|Protocol Violation|0
1779500|NCT00673465|6194618|P7|Part 1/Period 1 (United States)|Protocol Violation|0
1779501|NCT00673465|6194619|P6|Part 1/Period 1 (United States)|Protocol Violation|1
1779502|NCT00673465|6194620|P5|Part 1/Period 1 (United States)|Protocol Violation|1
1779503|NCT00673465|6194621|P4|Part 1/Period 1 (United States)|Protocol Violation|0
1779504|NCT00673465|6194622|P3|Part 1/Period 1 (United States)|Protocol Violation|0
1779505|NCT00673465|6194623|P2|Part 1/Period 1 (United States)|Protocol Violation|0
1779506|NCT00673465|6194624|P1|Part 1/Period 1 (United States)|Protocol Violation|0
1779507|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
1779508|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
1779509|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Physician Decision|0
1779510|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Physician Decision|2
1779511|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Sponsor Decision|3
1779512|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Sponsor Decision|0
1779513|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Protocol Violation|3
1779514|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Protocol Violation|2
1779515|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
1779516|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
1779517|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
1779518|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
1779519|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
1779520|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
1779521|NCT00673452|6194673|P2|Continuation Double-Blind Phase|Adverse Event|13
1779522|NCT00673452|6194674|P1|Continuation Double-Blind Phase|Adverse Event|5
1779523|NCT00673452|6194673|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
1779524|NCT00673452|6194674|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
1779525|NCT00673452|6194673|P2|Acute Double-Blind Phase|Sponsor Decision|1
1779526|NCT00673452|6194674|P1|Acute Double-Blind Phase|Sponsor Decision|0
1779527|NCT00673452|6194673|P2|Acute Double-Blind Phase|Protocol Violation|3
1779528|NCT00673452|6194674|P1|Acute Double-Blind Phase|Protocol Violation|5
1779529|NCT00673452|6194673|P2|Acute Double-Blind Phase|Physician Decision|6
1779530|NCT00673452|6194674|P1|Acute Double-Blind Phase|Physician Decision|0
1779531|NCT00673452|6194673|P2|Acute Double-Blind Phase|Lost to Follow-up|19
1779532|NCT00673452|6194674|P1|Acute Double-Blind Phase|Lost to Follow-up|16
1779533|NCT00673452|6194673|P2|Acute Double-Blind Phase|Lack of Efficacy|14
1779534|NCT00673452|6194674|P1|Acute Double-Blind Phase|Lack of Efficacy|9
1779535|NCT00673452|6194673|P2|Acute Double-Blind Phase|Adverse Event|24
1779536|NCT00673452|6194674|P1|Acute Double-Blind Phase|Adverse Event|41
1779537|NCT00673387|6194738|P8|Overall Study|Lost to Follow-up|5
1779538|NCT00673387|6194739|P7|Overall Study|Lost to Follow-up|8
1779539|NCT00673387|6194740|P6|Overall Study|Lost to Follow-up|5
1779540|NCT00673387|6194741|P5|Overall Study|Lost to Follow-up|6
1779541|NCT00673387|6194742|P4|Overall Study|Lost to Follow-up|6
1779542|NCT00673387|6194743|P3|Overall Study|Lost to Follow-up|5
1779543|NCT00673387|6194744|P2|Overall Study|Lost to Follow-up|6
1779544|NCT00673387|6194745|P1|Overall Study|Lost to Follow-up|8
1779545|NCT00673387|6194738|P8|Overall Study|Protocol Violation|3
1779546|NCT00673387|6194739|P7|Overall Study|Protocol Violation|1
1779547|NCT00673387|6194740|P6|Overall Study|Protocol Violation|1
1779548|NCT00673387|6194741|P5|Overall Study|Protocol Violation|0
1779549|NCT00673387|6194742|P4|Overall Study|Protocol Violation|2
1779550|NCT00673387|6194743|P3|Overall Study|Protocol Violation|1
1779551|NCT00673387|6194744|P2|Overall Study|Protocol Violation|0
1779552|NCT00673387|6194745|P1|Overall Study|Protocol Violation|3
1779553|NCT00673387|6194738|P8|Overall Study|Physician Decision|1
1779554|NCT00673387|6194739|P7|Overall Study|Physician Decision|1
1779555|NCT00673387|6194740|P6|Overall Study|Physician Decision|5
1779556|NCT00673387|6194741|P5|Overall Study|Physician Decision|0
1779557|NCT00673387|6194742|P4|Overall Study|Physician Decision|0
1779558|NCT00673387|6194743|P3|Overall Study|Physician Decision|0
1779559|NCT00673387|6194744|P2|Overall Study|Physician Decision|0
1779560|NCT00673387|6194745|P1|Overall Study|Physician Decision|0
1779561|NCT00673387|6194738|P8|Overall Study|Adverse Event|5
1779562|NCT00673387|6194739|P7|Overall Study|Adverse Event|5
1779563|NCT00673387|6194740|P6|Overall Study|Adverse Event|2
1779564|NCT00673387|6194741|P5|Overall Study|Adverse Event|6
1779565|NCT00673387|6194742|P4|Overall Study|Adverse Event|2
1779566|NCT00673387|6194743|P3|Overall Study|Adverse Event|5
1779567|NCT00673387|6194744|P2|Overall Study|Adverse Event|1
1779568|NCT00673387|6194745|P1|Overall Study|Adverse Event|3
1779569|NCT00673387|6194738|P8|Overall Study|Withdrawal by Subject|21
1779570|NCT00673387|6194739|P7|Overall Study|Withdrawal by Subject|15
1779571|NCT00673387|6194740|P6|Overall Study|Withdrawal by Subject|21
1779572|NCT00673387|6194741|P5|Overall Study|Withdrawal by Subject|18
1779573|NCT00673387|6194742|P4|Overall Study|Withdrawal by Subject|16
1779574|NCT00673387|6194743|P3|Overall Study|Withdrawal by Subject|20
1779575|NCT00673387|6194744|P2|Overall Study|Withdrawal by Subject|16
1779576|NCT00673387|6194745|P1|Overall Study|Withdrawal by Subject|15
1779577|NCT00673361|6194961|P1|Overall Study|Screen Failure|2
1779578|NCT00673257|6194997|P1|Overall Study|Unable to obtain specimen|1
1779579|NCT00673257|6194997|P1|Overall Study|Withdrawal by Subject|4
1779580|NCT00673231|6195006|P4|Overall Study|Study criteria,compliance,safety, other|4
1779581|NCT00673231|6195007|P3|Overall Study|Study criteria,compliance,safety, other|7
1779582|NCT00673231|6195008|P2|Overall Study|Study criteria,compliance,safety, other|5
1779583|NCT00673231|6195009|P1|Overall Study|Study criteria,compliance,safety, other|8
1779584|NCT00673231|6195006|P4|Overall Study|Death|0
1779585|NCT00673231|6195007|P3|Overall Study|Death|1
1779586|NCT00673231|6195008|P2|Overall Study|Death|0
1779587|NCT00673231|6195009|P1|Overall Study|Death|0
1779588|NCT00673231|6195006|P4|Overall Study|Lost to Follow-up|2
1779589|NCT00673231|6195007|P3|Overall Study|Lost to Follow-up|1
1779590|NCT00673231|6195008|P2|Overall Study|Lost to Follow-up|2
1779591|NCT00673231|6195009|P1|Overall Study|Lost to Follow-up|1
1779592|NCT00673231|6195006|P4|Overall Study|Adverse Event|6
1779593|NCT00673231|6195007|P3|Overall Study|Adverse Event|9
1779594|NCT00673231|6195008|P2|Overall Study|Adverse Event|5
1779595|NCT00673231|6195009|P1|Overall Study|Adverse Event|6
1779596|NCT00673231|6195006|P4|Overall Study|Withdrawal by Subject|6
1779597|NCT00673231|6195007|P3|Overall Study|Withdrawal by Subject|8
1779598|NCT00673231|6195008|P2|Overall Study|Withdrawal by Subject|10
1779599|NCT00673231|6195009|P1|Overall Study|Withdrawal by Subject|14
1779600|NCT00673179|6195041|P2|Overall Study|Toxicity/Complications|0
1779601|NCT00673179|6195042|P1|Overall Study|Toxicity/Complications|3
1779602|NCT00673049|6195091|P4|After Progression on Erlotinib|study terminated by sponsor|4
1779603|NCT00673049|6195092|P3|After Progression on Erlotinib|study terminated by sponsor|0
1779604|NCT00673049|6195093|P2|After Progression on Erlotinib|study terminated by sponsor|0
1779605|NCT00673049|6195094|P1|After Progression on Erlotinib|study terminated by sponsor|0
1779606|NCT00673049|6195091|P4|After Progression on Erlotinib|Withdrawal by Subject|5
1779607|NCT00673049|6195092|P3|After Progression on Erlotinib|Withdrawal by Subject|0
1779608|NCT00673049|6195093|P2|After Progression on Erlotinib|Withdrawal by Subject|0
1779609|NCT00673049|6195094|P1|After Progression on Erlotinib|Withdrawal by Subject|0
1779610|NCT00673049|6195091|P4|After Progression on Erlotinib|Lost to Follow-up|3
1779611|NCT00673049|6195092|P3|After Progression on Erlotinib|Lost to Follow-up|0
1779612|NCT00673049|6195093|P2|After Progression on Erlotinib|Lost to Follow-up|0
1779613|NCT00673049|6195094|P1|After Progression on Erlotinib|Lost to Follow-up|0
1779614|NCT00673049|6195091|P4|After Progression on Erlotinib|Death|71
1779615|NCT00673049|6195092|P3|After Progression on Erlotinib|Death|0
1779616|NCT00673049|6195093|P2|After Progression on Erlotinib|Death|0
1779617|NCT00673049|6195094|P1|After Progression on Erlotinib|Death|0
1779618|NCT00673049|6195091|P4|Before Progression on Erlotinib|Switched to figitumumab|0
1779619|NCT00673049|6195092|P3|Before Progression on Erlotinib|Switched to figitumumab|0
1779620|NCT00673049|6195093|P2|Before Progression on Erlotinib|Switched to figitumumab|83
1779621|NCT00673049|6195094|P1|Before Progression on Erlotinib|Switched to figitumumab|0
1779622|NCT00673049|6195091|P4|Before Progression on Erlotinib|study terminated by sponsor|0
1779623|NCT00673049|6195092|P3|Before Progression on Erlotinib|study terminated by sponsor|0
1779624|NCT00673049|6195093|P2|Before Progression on Erlotinib|study terminated by sponsor|14
1779625|NCT00673049|6195094|P1|Before Progression on Erlotinib|study terminated by sponsor|18
1779626|NCT00673049|6195091|P4|Before Progression on Erlotinib|Other|0
1779627|NCT00673049|6195092|P3|Before Progression on Erlotinib|Other|0
1779628|NCT00673049|6195093|P2|Before Progression on Erlotinib|Other|2
1779629|NCT00673049|6195094|P1|Before Progression on Erlotinib|Other|1
1779630|NCT00673049|6195091|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
1779631|NCT00673049|6195092|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
1779632|NCT00673049|6195093|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
1779633|NCT00673049|6195094|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
1779634|NCT00673049|6195091|P4|Before Progression on Erlotinib|Lost to Follow-up|0
1779635|NCT00673049|6195092|P3|Before Progression on Erlotinib|Lost to Follow-up|0
1779636|NCT00673049|6195093|P2|Before Progression on Erlotinib|Lost to Follow-up|5
1779637|NCT00673049|6195094|P1|Before Progression on Erlotinib|Lost to Follow-up|9
1779638|NCT00673049|6195091|P4|Before Progression on Erlotinib|Death|0
1779639|NCT00673049|6195092|P3|Before Progression on Erlotinib|Death|1
1779640|NCT00673049|6195093|P2|Before Progression on Erlotinib|Death|167
1779641|NCT00673049|6195094|P1|Before Progression on Erlotinib|Death|235
1779642|NCT00673049|6195091|P4|Before Progression on Erlotinib|Randomized but not treated|0
1779643|NCT00673049|6195092|P3|Before Progression on Erlotinib|Randomized but not treated|0
1779644|NCT00673049|6195093|P2|Before Progression on Erlotinib|Randomized but not treated|1
1779645|NCT00673049|6195094|P1|Before Progression on Erlotinib|Randomized but not treated|3
1779646|NCT00672984|6195118|P3|Third Intervention|Adverse Event|1
1779647|NCT00672984|6195119|P2|Third Intervention|Adverse Event|0
1779648|NCT00672984|6195120|P1|Third Intervention|Adverse Event|1
1779649|NCT00672984|6195118|P3|Second Intervention|Protocol Violation|1
1779650|NCT00672984|6195119|P2|Second Intervention|Protocol Violation|1
1779651|NCT00672984|6195120|P1|Second Intervention|Protocol Violation|0
1779652|NCT00672984|6195118|P3|Second Intervention|Withdrawal by Subject|0
1779653|NCT00672984|6195119|P2|Second Intervention|Withdrawal by Subject|3
1779654|NCT00672984|6195120|P1|Second Intervention|Withdrawal by Subject|0
1779655|NCT00672984|6195118|P3|Second Intervention|Non-compliance with facility policies|0
1779656|NCT00672984|6195119|P2|Second Intervention|Non-compliance with facility policies|2
1779657|NCT00672984|6195120|P1|Second Intervention|Non-compliance with facility policies|0
1779658|NCT00672984|6195118|P3|First Intervention|Sponsor decision|0
1779659|NCT00672984|6195119|P2|First Intervention|Sponsor decision|0
1779660|NCT00672984|6195120|P1|First Intervention|Sponsor decision|3
1779661|NCT00672984|6195118|P3|First Intervention|Withdrawal by Subject|2
1779662|NCT00672984|6195119|P2|First Intervention|Withdrawal by Subject|2
1779663|NCT00672984|6195120|P1|First Intervention|Withdrawal by Subject|1
1779664|NCT00672984|6195118|P3|First Intervention|Adverse Event|0
1779665|NCT00672984|6195119|P2|First Intervention|Adverse Event|0
1779666|NCT00672984|6195120|P1|First Intervention|Adverse Event|5
1779667|NCT00672958|6195171|P2|Overall Study|Reason not specified|3
1779668|NCT00672958|6195172|P1|Overall Study|Reason not specified|0
1779669|NCT00672958|6195171|P2|Overall Study|Lost to Follow-up|17
1779670|NCT00672958|6195172|P1|Overall Study|Lost to Follow-up|22
1779671|NCT00672958|6195171|P2|Overall Study|Voluntary withdrawal|8
1779672|NCT00672958|6195172|P1|Overall Study|Voluntary withdrawal|12
1779673|NCT00672958|6195171|P2|Overall Study|Protocol deviations|5
1779674|NCT00672958|6195172|P1|Overall Study|Protocol deviations|11
1779675|NCT00672958|6195171|P2|Overall Study|Non-compliance with study drug|3
1779676|NCT00672958|6195172|P1|Overall Study|Non-compliance with study drug|2
1779677|NCT00672958|6195171|P2|Overall Study|Lack of Efficacy|11
1779678|NCT00672958|6195172|P1|Overall Study|Lack of Efficacy|6
1779679|NCT00672958|6195171|P2|Overall Study|Adverse Event|9
1779680|NCT00672958|6195172|P1|Overall Study|Adverse Event|11
1779681|NCT00672841|6195238|P2|Overall Study|Pregnancy|1
1779682|NCT00672841|6195239|P1|Overall Study|Pregnancy|0
1779683|NCT00672841|6195238|P2|Overall Study|Adverse Event|3
1779684|NCT00672841|6195239|P1|Overall Study|Adverse Event|0
1779685|NCT00672841|6195238|P2|Overall Study|Antifungal therapy, negative glucan|4
1779686|NCT00672841|6195239|P1|Overall Study|Antifungal therapy, negative glucan|0
1779687|NCT00672841|6195238|P2|Overall Study|icteric specimens|3
1779688|NCT00672841|6195239|P1|Overall Study|icteric specimens|0
1779689|NCT00672841|6195238|P2|Overall Study|Comfort care|4
1779690|NCT00672841|6195239|P1|Overall Study|Comfort care|1
1779691|NCT00672646|6195261|P3|Overall Study|Withdrawal by Subject|1
1779692|NCT00672646|6195262|P2|Overall Study|Withdrawal by Subject|0
1779693|NCT00672646|6195263|P1|Overall Study|Withdrawal by Subject|0
1779694|NCT00672646|6195261|P3|Overall Study|Lost to Follow-up|2
1779695|NCT00672646|6195262|P2|Overall Study|Lost to Follow-up|1
1779696|NCT00672646|6195263|P1|Overall Study|Lost to Follow-up|0
1779697|NCT00672633|6195288|P2|Overall Study|Withdrawal by Subject|1
1779698|NCT00672633|6195289|P1|Overall Study|Withdrawal by Subject|0
1779699|NCT00672620|6195303|P4|Overall Study|Reason not Specified|1
1779700|NCT00672620|6195304|P3|Overall Study|Reason not Specified|2
1779701|NCT00672620|6195305|P2|Overall Study|Reason not Specified|3
1779702|NCT00672620|6195306|P1|Overall Study|Reason not Specified|3
1779703|NCT00672620|6195303|P4|Overall Study|Lost to Follow-up|11
1779704|NCT00672620|6195304|P3|Overall Study|Lost to Follow-up|8
1779705|NCT00672620|6195305|P2|Overall Study|Lost to Follow-up|19
1779706|NCT00672620|6195306|P1|Overall Study|Lost to Follow-up|8
1779707|NCT00672620|6195303|P4|Overall Study|Withdrawal of Consent|6
1779708|NCT00672620|6195304|P3|Overall Study|Withdrawal of Consent|5
1779709|NCT00672620|6195305|P2|Overall Study|Withdrawal of Consent|12
1779710|NCT00672620|6195306|P1|Overall Study|Withdrawal of Consent|6
1779711|NCT00672620|6195303|P4|Overall Study|Protocol Deviations|5
1779712|NCT00672620|6195304|P3|Overall Study|Protocol Deviations|2
1779713|NCT00672620|6195305|P2|Overall Study|Protocol Deviations|7
1779714|NCT00672620|6195306|P1|Overall Study|Protocol Deviations|5
1779715|NCT00672620|6195303|P4|Overall Study|Noncompliance with Study Drug|2
1779716|NCT00672620|6195304|P3|Overall Study|Noncompliance with Study Drug|0
1779717|NCT00672620|6195305|P2|Overall Study|Noncompliance with Study Drug|4
1779718|NCT00672620|6195306|P1|Overall Study|Noncompliance with Study Drug|3
1779719|NCT00672620|6195303|P4|Overall Study|Lack of Efficacy|0
1779720|NCT00672620|6195304|P3|Overall Study|Lack of Efficacy|2
1779721|NCT00672620|6195305|P2|Overall Study|Lack of Efficacy|2
1779722|NCT00672620|6195306|P1|Overall Study|Lack of Efficacy|1
1779723|NCT00672620|6195303|P4|Overall Study|Adverse Event|17
1779724|NCT00672620|6195304|P3|Overall Study|Adverse Event|12
1779725|NCT00672620|6195305|P2|Overall Study|Adverse Event|7
1779726|NCT00672620|6195306|P1|Overall Study|Adverse Event|7
1779727|NCT00672555|6195371|P1|Overall Study|Did not want to answer questionnaire|2
1779728|NCT00672555|6195371|P1|Overall Study|Lost to Follow-up|4
1779729|NCT00672490|6195382|P2|Overall Study|No reason was provided|2
1779730|NCT00672490|6195383|P1|Overall Study|No reason was provided|6
1779731|NCT00672490|6195382|P2|Overall Study|Lost to Follow-up|5
1779732|NCT00672490|6195383|P1|Overall Study|Lost to Follow-up|1
1779733|NCT00672490|6195382|P2|Overall Study|Intolerance|2
1779734|NCT00672490|6195383|P1|Overall Study|Intolerance|0
1779735|NCT00672490|6195382|P2|Overall Study|Violation of Concomitant Medicine|0
1779736|NCT00672490|6195383|P1|Overall Study|Violation of Concomitant Medicine|1
1779737|NCT00672490|6195382|P2|Overall Study|Adverse Event|8
1779738|NCT00672490|6195383|P1|Overall Study|Adverse Event|5
1779739|NCT00672490|6195382|P2|Overall Study|Mismatch Include/Exclude Criteria|0
1779740|NCT00672490|6195383|P1|Overall Study|Mismatch Include/Exclude Criteria|1
1779741|NCT00672490|6195382|P2|Overall Study|Lack of Compliance|7
1779742|NCT00672490|6195383|P1|Overall Study|Lack of Compliance|2
1779743|NCT00672490|6195382|P2|Overall Study|Withdrawal by Subject|8
1779744|NCT00672490|6195383|P1|Overall Study|Withdrawal by Subject|8
1779745|NCT00672477|6195407|P2|Overall Study|no study drug for low GFR, health cond.|3
1779746|NCT00672477|6195408|P1|Overall Study|no study drug for low GFR, health cond.|1
1779747|NCT00672477|6195407|P2|Overall Study|Lack of Efficacy|1
1779748|NCT00672477|6195408|P1|Overall Study|Lack of Efficacy|1
1779749|NCT00672477|6195407|P2|Overall Study|Withdrawal by Subject|3
1779750|NCT00672477|6195408|P1|Overall Study|Withdrawal by Subject|5
1779751|NCT00672477|6195407|P2|Overall Study|Protocol Violation|1
1779752|NCT00672477|6195408|P1|Overall Study|Protocol Violation|1
1779753|NCT00672477|6195407|P2|Overall Study|Physician Decision|0
1779754|NCT00672477|6195408|P1|Overall Study|Physician Decision|2
1779755|NCT00672477|6195407|P2|Overall Study|Death|11
1779756|NCT00672477|6195408|P1|Overall Study|Death|7
1779757|NCT00672477|6195407|P2|Overall Study|Adverse Event|7
1779758|NCT00672477|6195408|P1|Overall Study|Adverse Event|10
1779759|NCT00672256|6195461|P1|Overall Study|PI dropped, bad data|44
1779760|NCT00672139|6195486|P2|Overall Study|hospice discharge, caregiver requests|2
1779761|NCT00672139|6195487|P1|Overall Study|hospice discharge, caregiver requests|3
1779762|NCT00672139|6195486|P2|Overall Study|Protocol Violation|1
1779763|NCT00672139|6195487|P1|Overall Study|Protocol Violation|1
1779764|NCT00672139|6195486|P2|Overall Study|Lack of Efficacy|1
1779765|NCT00672139|6195487|P1|Overall Study|Lack of Efficacy|4
1779766|NCT00672139|6195486|P2|Overall Study|Physician Decision|0
1779767|NCT00672139|6195487|P1|Overall Study|Physician Decision|2
1779768|NCT00672139|6195486|P2|Overall Study|Adverse Event|7
1779769|NCT00672139|6195487|P1|Overall Study|Adverse Event|4
1779770|NCT00672139|6195486|P2|Overall Study|Withdrawal by Subject|11
1779771|NCT00672139|6195487|P1|Overall Study|Withdrawal by Subject|2
1779772|NCT00672139|6195486|P2|Overall Study|Death|23
1779773|NCT00672139|6195487|P1|Overall Study|Death|14
1779774|NCT00671931|6195544|P5|Overall Study|Physician Decision|1
1779775|NCT00671931|6195545|P4|Overall Study|Physician Decision|2
1779776|NCT00671931|6195546|P3|Overall Study|Physician Decision|0
1779777|NCT00671931|6195547|P2|Overall Study|Physician Decision|0
1779778|NCT00671931|6195548|P1|Overall Study|Physician Decision|1
1779779|NCT00671879|6195568|P3|Overall Study|Withdrawal by Subject|6
1779780|NCT00671879|6195569|P2|Overall Study|Withdrawal by Subject|4
1779781|NCT00671879|6195570|P1|Overall Study|Withdrawal by Subject|0
1779782|NCT00671853|6195583|P2|Overall Study|Non-adherence with study procedures|4
1779783|NCT00671853|6195584|P1|Overall Study|Non-adherence with study procedures|1
1779784|NCT00671853|6195583|P2|Overall Study|Physician Decision|2
1779785|NCT00671853|6195584|P1|Overall Study|Physician Decision|0
1779786|NCT00671853|6195583|P2|Overall Study|Lost to Follow-up|8
1779787|NCT00671853|6195584|P1|Overall Study|Lost to Follow-up|8
1779788|NCT00671853|6195583|P2|Overall Study|Withdrawal by Subject|5
1779789|NCT00671853|6195584|P1|Overall Study|Withdrawal by Subject|1
1779790|NCT00671853|6195583|P2|Overall Study|Adverse Event|1
1779791|NCT00671853|6195584|P1|Overall Study|Adverse Event|7
1779792|NCT00671853|6195583|P2|Overall Study|Lack of Efficacy|7
1779793|NCT00671853|6195584|P1|Overall Study|Lack of Efficacy|3
1779794|NCT00671788|6195600|P1|Overall Study|Other|1
1779795|NCT00671788|6195600|P1|Overall Study|MD Decision|1
1779796|NCT00671788|6195600|P1|Overall Study|Ineligible|1
1779797|NCT00671788|6195600|P1|Overall Study|Refused further treatment|3
1779798|NCT00671788|6195600|P1|Overall Study|Adverse Event|8
1779799|NCT00671749|6195607|P1|Overall Study|Lost to Follow-up|1
1779800|NCT00671749|6195607|P1|Overall Study|Protocol Violation|1
1779801|NCT00671749|6195607|P1|Overall Study|Withdrawal by Subject|4
1779802|NCT00671749|6195607|P1|Overall Study|Adverse Event|2
1779803|NCT00671554|6195666|P1|Overall Study|Disease progression|3
1779804|NCT00671437|6195705|P1|Overall Study|Ineligible post-hoc|1
1779805|NCT00671437|6195705|P1|Overall Study|Adverse Event|3
1779806|NCT00671437|6195705|P1|Overall Study|Cutaneous SCC of head and neck|3
1779807|NCT00671437|6195705|P1|Overall Study|Progressive disease before C1 week 8|8
1779808|NCT00671060|6195739|P2|Overall Study|Physician Decision|1
1779809|NCT00671060|6195740|P1|Overall Study|Physician Decision|0
1779810|NCT00671060|6195739|P2|Overall Study|Protocol Violation|0
1779811|NCT00671060|6195740|P1|Overall Study|Protocol Violation|1
1779812|NCT00671034|6195749|P3|Overall Study|includes Alternative therapy, etc.|7
1779813|NCT00671034|6195750|P2|Overall Study|includes Alternative therapy, etc.|1
1779814|NCT00671034|6195751|P1|Overall Study|includes Alternative therapy, etc.|6
1779815|NCT00671034|6195749|P3|Overall Study|Refusal|5
1779816|NCT00671034|6195750|P2|Overall Study|Refusal|3
1779817|NCT00671034|6195751|P1|Overall Study|Refusal|5
1779818|NCT00671034|6195749|P3|Overall Study|VHR ALL feature|5
1779819|NCT00671034|6195750|P2|Overall Study|VHR ALL feature|3
1779820|NCT00671034|6195751|P1|Overall Study|VHR ALL feature|8
1779821|NCT00671034|6195749|P3|Overall Study|Physician Decision|5
1779822|NCT00671034|6195750|P2|Overall Study|Physician Decision|4
1779823|NCT00671034|6195751|P1|Overall Study|Physician Decision|12
1779824|NCT00671034|6195749|P3|Overall Study|Death|1
1779825|NCT00671034|6195750|P2|Overall Study|Death|2
1779826|NCT00671034|6195751|P1|Overall Study|Death|3
1779827|NCT00671034|6195749|P3|Overall Study|Adverse Event|1
1779828|NCT00671034|6195750|P2|Overall Study|Adverse Event|7
1779829|NCT00671034|6195751|P1|Overall Study|Adverse Event|5
1779830|NCT00670930|6195806|P2|Overall Study|Lost to Follow-up|0
1779831|NCT00670930|6195807|P1|Overall Study|Lost to Follow-up|1
1779832|NCT00670930|6195806|P2|Overall Study|Adminstrative Problem|1
1779833|NCT00670930|6195807|P1|Overall Study|Adminstrative Problem|0
1779834|NCT00670800|6195823|P2|Overall Study|2 controls were insulin resistant|2
1779835|NCT00670800|6195824|P1|Overall Study|2 controls were insulin resistant|0
1779836|NCT00670748|6195855|P4|Overall Study|Not off study|1
1779837|NCT00670748|6195856|P3|Overall Study|Not off study|1
1779838|NCT00670748|6195857|P2|Overall Study|Not off study|1
1779839|NCT00670748|6195858|P1|Overall Study|Not off study|2
1779840|NCT00670748|6195855|P4|Overall Study|Death during treatment|0
1779841|NCT00670748|6195856|P3|Overall Study|Death during treatment|1
1779842|NCT00670748|6195857|P2|Overall Study|Death during treatment|1
1779843|NCT00670748|6195858|P1|Overall Study|Death during treatment|1
1779844|NCT00670540|6195893|P1|Overall Study|missing information inclusion criteria|1
1779845|NCT00670540|6195893|P1|Overall Study|controls randomised for no follow up|2770
1779846|NCT00670540|6195893|P1|Overall Study|refused to participate|189
1779847|NCT00670540|6195893|P1|Overall Study|not living in France|348
1779848|NCT00670540|6195893|P1|Overall Study|ineligible|17
1779849|NCT00670488|6195913|P10|Overall Study|Withdrawal by Subject|0
1779850|NCT00670488|6195914|P9|Overall Study|Withdrawal by Subject|1
1779851|NCT00670488|6195915|P8|Overall Study|Withdrawal by Subject|0
1779852|NCT00670488|6195916|P7|Overall Study|Withdrawal by Subject|1
1779853|NCT00670488|6195917|P6|Overall Study|Withdrawal by Subject|0
1779854|NCT00670488|6195918|P5|Overall Study|Withdrawal by Subject|0
1779855|NCT00670488|6195919|P4|Overall Study|Withdrawal by Subject|1
1779856|NCT00670488|6195920|P3|Overall Study|Withdrawal by Subject|0
1779857|NCT00670488|6195921|P2|Overall Study|Withdrawal by Subject|1
1779858|NCT00670488|6195922|P1|Overall Study|Withdrawal by Subject|0
1779859|NCT00670488|6195913|P10|Overall Study|Progressive Disease|1
1779860|NCT00670488|6195914|P9|Overall Study|Progressive Disease|2
1779861|NCT00670488|6195915|P8|Overall Study|Progressive Disease|2
1779862|NCT00670488|6195916|P7|Overall Study|Progressive Disease|11
1779863|NCT00670488|6195917|P6|Overall Study|Progressive Disease|4
1779864|NCT00670488|6195918|P5|Overall Study|Progressive Disease|2
1779865|NCT00670488|6195919|P4|Overall Study|Progressive Disease|2
1779866|NCT00670488|6195920|P3|Overall Study|Progressive Disease|3
1779867|NCT00670488|6195921|P2|Overall Study|Progressive Disease|41
1779868|NCT00670488|6195922|P1|Overall Study|Progressive Disease|2
1779869|NCT00670488|6195913|P10|Overall Study|Physician Decision|0
1779870|NCT00670488|6195914|P9|Overall Study|Physician Decision|0
1779871|NCT00670488|6195915|P8|Overall Study|Physician Decision|0
1779872|NCT00670488|6195916|P7|Overall Study|Physician Decision|0
1779873|NCT00670488|6195917|P6|Overall Study|Physician Decision|0
1779874|NCT00670488|6195918|P5|Overall Study|Physician Decision|0
1779875|NCT00670488|6195919|P4|Overall Study|Physician Decision|1
1779876|NCT00670488|6195920|P3|Overall Study|Physician Decision|0
1779877|NCT00670488|6195921|P2|Overall Study|Physician Decision|9
1779878|NCT00670488|6195922|P1|Overall Study|Physician Decision|1
1779879|NCT00670488|6195913|P10|Overall Study|Adverse Event|1
1779880|NCT00670488|6195914|P9|Overall Study|Adverse Event|0
1779881|NCT00670488|6195915|P8|Overall Study|Adverse Event|1
1779882|NCT00670488|6195916|P7|Overall Study|Adverse Event|5
1779883|NCT00670488|6195917|P6|Overall Study|Adverse Event|1
1779884|NCT00670488|6195918|P5|Overall Study|Adverse Event|1
1779885|NCT00670488|6195919|P4|Overall Study|Adverse Event|3
1779886|NCT00670488|6195920|P3|Overall Study|Adverse Event|0
1779887|NCT00670488|6195921|P2|Overall Study|Adverse Event|7
1779888|NCT00670488|6195922|P1|Overall Study|Adverse Event|0
1779889|NCT00670449|6196109|P4|Overall Study|Abnormal Laboratory Value(s)|0
1779890|NCT00670449|6196110|P3|Overall Study|Abnormal Laboratory Value(s)|0
1779891|NCT00670449|6196111|P2|Overall Study|Abnormal Laboratory Value(s)|2
1779892|NCT00670449|6196112|P1|Overall Study|Abnormal Laboratory Value(s)|0
1779893|NCT00670449|6196109|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
1779894|NCT00670449|6196110|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
1779895|NCT00670449|6196111|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1779896|NCT00670449|6196112|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
1779897|NCT00670449|6196109|P4|Overall Study|Subject Withdrew Consent|1
1779898|NCT00670449|6196110|P3|Overall Study|Subject Withdrew Consent|0
1779899|NCT00670449|6196111|P2|Overall Study|Subject Withdrew Consent|2
1779900|NCT00670449|6196112|P1|Overall Study|Subject Withdrew Consent|0
1779901|NCT00670449|6196109|P4|Overall Study|Administrative Problems|1
1779902|NCT00670449|6196110|P3|Overall Study|Administrative Problems|0
1779903|NCT00670449|6196111|P2|Overall Study|Administrative Problems|2
1779904|NCT00670449|6196112|P1|Overall Study|Administrative Problems|0
1779905|NCT00670449|6196109|P4|Overall Study|Protocol Deviation|1
1779906|NCT00670449|6196110|P3|Overall Study|Protocol Deviation|0
1779907|NCT00670449|6196111|P2|Overall Study|Protocol Deviation|2
1779908|NCT00670449|6196112|P1|Overall Study|Protocol Deviation|1
1779909|NCT00670449|6196109|P4|Overall Study|Adverse Event|5
1779910|NCT00670449|6196110|P3|Overall Study|Adverse Event|8
1779911|NCT00670449|6196111|P2|Overall Study|Adverse Event|2
1779912|NCT00670449|6196112|P1|Overall Study|Adverse Event|6
1779913|NCT00670306|6196136|P1|Overall Study|incl/excl criterias did not meet|19
1779914|NCT00670306|6196136|P1|Overall Study|Lost to Follow-up|8
1779915|NCT00670306|6196136|P1|Overall Study|Physician Decision|1
1779916|NCT00670306|6196136|P1|Overall Study|Withdrawal by Subject|9
1779917|NCT00670306|6196136|P1|Overall Study|Lack of Efficacy|10
1779918|NCT00670306|6196136|P1|Overall Study|Adverse Event|8
1779919|NCT00670228|6196175|P2|Overall Study|Not meeting the selection criteria|0
1779920|NCT00670228|6196176|P1|Overall Study|Not meeting the selection criteria|2
1779921|NCT00670228|6196175|P2|Overall Study|Not treated|2
1779922|NCT00670228|6196176|P1|Overall Study|Not treated|2
1779923|NCT00670228|6196175|P2|Overall Study|Death or MACE|1
1779924|NCT00670228|6196176|P1|Overall Study|Death or MACE|0
1779925|NCT00670228|6196175|P2|Overall Study|Adverse Event|0
1779926|NCT00670228|6196176|P1|Overall Study|Adverse Event|1
1779927|NCT00670111|6196200|P3|Enrollment to One Month|Physician Decision|0
1779928|NCT00670111|6196201|P2|Enrollment to One Month|Physician Decision|0
1779929|NCT00670111|6196202|P1|Enrollment to One Month|Physician Decision|1
1779930|NCT00670111|6196200|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
1779931|NCT00670111|6196201|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
1779932|NCT00670111|6196202|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
1779933|NCT00670111|6196200|P3|Enrollment to One Month|Testing Failure|13
1779934|NCT00670111|6196201|P2|Enrollment to One Month|Testing Failure|0
1779935|NCT00670111|6196202|P1|Enrollment to One Month|Testing Failure|0
1779936|NCT00670046|6196212|P2|Overall Study|Withdrawal by Subject|1
1779937|NCT00670046|6196213|P1|Overall Study|Withdrawal by Subject|0
1779938|NCT00670046|6196212|P2|Overall Study|Lost to Follow-up|1
1779939|NCT00670046|6196213|P1|Overall Study|Lost to Follow-up|1
1779940|NCT00670007|6196227|P1|Overall Study|Withdrawal by Subject|4
1779941|NCT00670007|6196227|P1|Overall Study|Adverse Event|1
1779942|NCT00670007|6196227|P1|Overall Study|Adverse event, serious fatal|1
1779943|NCT00670007|6196227|P1|Overall Study|Travel/Vacation|1
1779944|NCT00670007|6196227|P1|Overall Study|Lung transplant|1
1779945|NCT00670007|6196227|P1|Overall Study|Drug abuse|1
1779946|NCT00669955|6196254|P2|Overall Study|not compliant with study drug/visit|3
1779947|NCT00669955|6196255|P1|Overall Study|not compliant with study drug/visit|2
1779948|NCT00669955|6196254|P2|Overall Study|Investigator Sponsor Judgement|1
1779949|NCT00669955|6196255|P1|Overall Study|Investigator Sponsor Judgement|0
1779950|NCT00669955|6196254|P2|Overall Study|Protocol Violation|7
1779951|NCT00669955|6196255|P1|Overall Study|Protocol Violation|2
1779952|NCT00669955|6196254|P2|Overall Study|Lost to Follow-up|7
1779953|NCT00669955|6196255|P1|Overall Study|Lost to Follow-up|5
1779954|NCT00669955|6196254|P2|Overall Study|Withdrawal by Subject|3
1779955|NCT00669955|6196255|P1|Overall Study|Withdrawal by Subject|2
1779956|NCT00669955|6196254|P2|Overall Study|Death|1
1779957|NCT00669955|6196255|P1|Overall Study|Death|0
1779958|NCT00669955|6196254|P2|Overall Study|Adverse Event|5
1779959|NCT00669955|6196255|P1|Overall Study|Adverse Event|3
1779960|NCT00669942|6196285|P12|Parts 2 and 3|Protocol Violation|0
1779961|NCT00669942|6196286|P11|Parts 2 and 3|Protocol Violation|0
1779962|NCT00669942|6196287|P10|Parts 2 and 3|Protocol Violation|0
1779963|NCT00669942|6196288|P9|Parts 2 and 3|Protocol Violation|0
1779964|NCT00669942|6196289|P8|Parts 2 and 3|Protocol Violation|0
1779965|NCT00669942|6196290|P7|Parts 2 and 3|Protocol Violation|0
1779966|NCT00669942|6196291|P6|Parts 2 and 3|Protocol Violation|1
1779967|NCT00669942|6196292|P5|Parts 2 and 3|Protocol Violation|0
1779968|NCT00669942|6196293|P4|Parts 2 and 3|Protocol Violation|0
1779969|NCT00669942|6196294|P3|Parts 2 and 3|Protocol Violation|0
1779970|NCT00669942|6196295|P2|Parts 2 and 3|Protocol Violation|0
1779971|NCT00669942|6196296|P1|Parts 2 and 3|Protocol Violation|0
1779972|NCT00669942|6196285|P12|Parts 2 and 3|Withdrawal by Subject|0
1779973|NCT00669942|6196286|P11|Parts 2 and 3|Withdrawal by Subject|0
1779974|NCT00669942|6196287|P10|Parts 2 and 3|Withdrawal by Subject|0
1779975|NCT00669942|6196288|P9|Parts 2 and 3|Withdrawal by Subject|2
1779976|NCT00669942|6196289|P8|Parts 2 and 3|Withdrawal by Subject|0
1779977|NCT00669942|6196290|P7|Parts 2 and 3|Withdrawal by Subject|0
1779978|NCT00669942|6196291|P6|Parts 2 and 3|Withdrawal by Subject|1
1779979|NCT00669942|6196292|P5|Parts 2 and 3|Withdrawal by Subject|0
1779980|NCT00669942|6196293|P4|Parts 2 and 3|Withdrawal by Subject|0
1779981|NCT00669942|6196294|P3|Parts 2 and 3|Withdrawal by Subject|0
1779982|NCT00669942|6196295|P2|Parts 2 and 3|Withdrawal by Subject|0
1779983|NCT00669942|6196296|P1|Parts 2 and 3|Withdrawal by Subject|0
1779984|NCT00669942|6196285|P12|Parts 2 and 3|Adverse Event|0
1779985|NCT00669942|6196286|P11|Parts 2 and 3|Adverse Event|0
1779986|NCT00669942|6196287|P10|Parts 2 and 3|Adverse Event|0
1779987|NCT00669942|6196288|P9|Parts 2 and 3|Adverse Event|1
1779988|NCT00669942|6196289|P8|Parts 2 and 3|Adverse Event|2
1779989|NCT00669942|6196290|P7|Parts 2 and 3|Adverse Event|0
1779990|NCT00669942|6196291|P6|Parts 2 and 3|Adverse Event|0
1779991|NCT00669942|6196292|P5|Parts 2 and 3|Adverse Event|0
1779992|NCT00669942|6196293|P4|Parts 2 and 3|Adverse Event|0
1779993|NCT00669942|6196294|P3|Parts 2 and 3|Adverse Event|0
1779994|NCT00669942|6196295|P2|Parts 2 and 3|Adverse Event|0
1779995|NCT00669942|6196296|P1|Parts 2 and 3|Adverse Event|0
1779996|NCT00669903|6196379|P4|Overall Study|Protocol Violation|0
1779997|NCT00669903|6196380|P3|Overall Study|Protocol Violation|0
1779998|NCT00669903|6196381|P2|Overall Study|Protocol Violation|1
1779999|NCT00669903|6196382|P1|Overall Study|Protocol Violation|0
1780000|NCT00669903|6196379|P4|Overall Study|Lost to Follow-up|1
1780001|NCT00669903|6196380|P3|Overall Study|Lost to Follow-up|0
1780002|NCT00669903|6196381|P2|Overall Study|Lost to Follow-up|1
1780003|NCT00669903|6196382|P1|Overall Study|Lost to Follow-up|1
1780004|NCT00669903|6196379|P4|Overall Study|Withdrawal by Subject|2
1780005|NCT00669903|6196380|P3|Overall Study|Withdrawal by Subject|2
1780006|NCT00669903|6196381|P2|Overall Study|Withdrawal by Subject|2
1780007|NCT00669903|6196382|P1|Overall Study|Withdrawal by Subject|0
1780008|NCT00669903|6196379|P4|Overall Study|Adverse Event|1
1780009|NCT00669903|6196380|P3|Overall Study|Adverse Event|3
1780010|NCT00669903|6196381|P2|Overall Study|Adverse Event|1
1780011|NCT00669903|6196382|P1|Overall Study|Adverse Event|0
1780012|NCT00669877|6196412|P1|Overall Study|Disease Progression/Death|4
1780013|NCT00669864|6196417|P1|Overall Study|Other|2
1780014|NCT00669864|6196417|P1|Overall Study|Withdrawal by Subject|3
1780015|NCT00669864|6196417|P1|Overall Study|Protocol Violation|2
1780016|NCT00669864|6196417|P1|Overall Study|Lost to Follow-up|2
1780017|NCT00669669|6196431|P1|Overall Study|To late to start treatment|1
1780018|NCT00669617|6196436|P5|Period 3|Lost to Follow-up|0
1780019|NCT00669617|6196437|P4|Period 3|Lost to Follow-up|0
1780020|NCT00669617|6196438|P3|Period 3|Lost to Follow-up|0
1780021|NCT00669617|6196439|P2|Period 3|Lost to Follow-up|0
1780022|NCT00669617|6196440|P1|Period 3|Lost to Follow-up|1
1780023|NCT00669617|6196436|P5|Period 1|Protocol Deviation|1
1780024|NCT00669617|6196437|P4|Period 1|Protocol Deviation|0
1780025|NCT00669617|6196438|P3|Period 1|Protocol Deviation|0
1780026|NCT00669617|6196439|P2|Period 1|Protocol Deviation|0
1780027|NCT00669617|6196440|P1|Period 1|Protocol Deviation|0
1780028|NCT00669617|6196436|P5|Period 1|Withdrawal by Subject|0
1780029|NCT00669617|6196437|P4|Period 1|Withdrawal by Subject|0
1780030|NCT00669617|6196438|P3|Period 1|Withdrawal by Subject|1
1780031|NCT00669617|6196439|P2|Period 1|Withdrawal by Subject|0
1780032|NCT00669617|6196440|P1|Period 1|Withdrawal by Subject|0
1780033|NCT00669396|6196488|P2|Overall Study|Lost to Follow-up|12
1780034|NCT00669396|6196489|P1|Overall Study|Lost to Follow-up|10
1780035|NCT00669331|6196516|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
1780036|NCT00669331|6196517|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
1780037|NCT00669331|6196516|P2|Blinded Treatment Period|Physician Decision|3
1780038|NCT00669331|6196517|P1|Blinded Treatment Period|Physician Decision|3
1780039|NCT00669331|6196516|P2|Blinded Treatment Period|Death|2
1780040|NCT00669331|6196517|P1|Blinded Treatment Period|Death|0
1780041|NCT00669331|6196516|P2|Blinded Treatment Period|Lost to Follow-up|2
1780042|NCT00669331|6196517|P1|Blinded Treatment Period|Lost to Follow-up|3
1780043|NCT00669331|6196516|P2|Blinded Treatment Period|Withdrawal by Subject|19
1780044|NCT00669331|6196517|P1|Blinded Treatment Period|Withdrawal by Subject|17
1780045|NCT00669331|6196516|P2|Blinded Treatment Period|Protocol Violation|1
1780046|NCT00669331|6196517|P1|Blinded Treatment Period|Protocol Violation|1
1780047|NCT00669331|6196516|P2|Blinded Treatment Period|Adverse Event|10
1780048|NCT00669331|6196517|P1|Blinded Treatment Period|Adverse Event|16
1780049|NCT00669331|6196516|P2|Randomisation to First Dose|Randomised in error|10
1780050|NCT00669331|6196517|P1|Randomisation to First Dose|Randomised in error|3
1780051|NCT00669331|6196516|P2|Randomisation to First Dose|Sponsor decision|1
1780052|NCT00669331|6196517|P1|Randomisation to First Dose|Sponsor decision|0
1780053|NCT00669331|6196516|P2|Randomisation to First Dose|Death|0
1780054|NCT00669331|6196517|P1|Randomisation to First Dose|Death|1
1780055|NCT00669331|6196516|P2|Randomisation to First Dose|Lost to Follow-up|0
1780056|NCT00669331|6196517|P1|Randomisation to First Dose|Lost to Follow-up|2
1780057|NCT00669331|6196516|P2|Randomisation to First Dose|Withdrawal by Subject|2
1780058|NCT00669331|6196517|P1|Randomisation to First Dose|Withdrawal by Subject|3
1780059|NCT00669331|6196516|P2|Randomisation to First Dose|Protocol Violation|0
1780060|NCT00669331|6196517|P1|Randomisation to First Dose|Protocol Violation|1
1780061|NCT00669331|6196516|P2|Randomisation to First Dose|Adverse Event|0
1780062|NCT00669331|6196517|P1|Randomisation to First Dose|Adverse Event|1
1780063|NCT00669318|6196559|P1|Overall Study|Withdrawal by Subject|2
1780064|NCT00669240|6196576|P1|Overall Study|Enrolled but no dosing record|1
1780065|NCT00669240|6196576|P1|Overall Study|Enrolled but not treated|15
1780066|NCT00669240|6196576|P1|Overall Study|Other|19
1780067|NCT00669240|6196576|P1|Overall Study|Adverse Event|21
1780068|NCT00669240|6196576|P1|Overall Study|Lost to Follow-up|34
1780069|NCT00669240|6196576|P1|Overall Study|Withdrawal by Subject|42
1780070|NCT00669240|6196576|P1|Overall Study|Lack of Efficacy|33
1780071|NCT00669162|6196625|P1|Overall Study|Withdrawal by Subject|1
1780072|NCT00669110|6196631|P2|Overall Study|Withdrawal by Subject|2
1780073|NCT00669110|6196632|P1|Overall Study|Withdrawal by Subject|0
1780074|NCT00669110|6196631|P2|Overall Study|Protocol Violation|5
1780075|NCT00669110|6196632|P1|Overall Study|Protocol Violation|0
1780076|NCT00669110|6196631|P2|Overall Study|Lost to Follow-up|0
1780077|NCT00669110|6196632|P1|Overall Study|Lost to Follow-up|1
1780078|NCT00669110|6196631|P2|Overall Study|Physician Decision|1
1780079|NCT00669110|6196632|P1|Overall Study|Physician Decision|0
1780080|NCT00669110|6196631|P2|Overall Study|Caregiver request|2
1780081|NCT00669110|6196632|P1|Overall Study|Caregiver request|3
1780082|NCT00669110|6196631|P2|Overall Study|Adverse Event|3
1780083|NCT00669110|6196632|P1|Overall Study|Adverse Event|4
1780084|NCT00669071|6196668|P1|Overall Study|Final visit 40 days out of window|1
1780085|NCT00669071|6196668|P1|Overall Study|Lost to Follow-up|3
1780086|NCT00669032|6196689|P2|Overall Study|No fulfilment of the selection criteria|5
1780087|NCT00669032|6196690|P1|Overall Study|No fulfilment of the selection criteria|5
1780088|NCT00669032|6196689|P2|Overall Study|Physician Decision|1
1780089|NCT00669032|6196690|P1|Overall Study|Physician Decision|1
1780090|NCT00669032|6196689|P2|Overall Study|Adverse Event|16
1780091|NCT00669032|6196690|P1|Overall Study|Adverse Event|12
1780092|NCT00669032|6196689|P2|Overall Study|Withdrawal by Subject|13
1780093|NCT00669032|6196690|P1|Overall Study|Withdrawal by Subject|12
1780094|NCT00669032|6196689|P2|Overall Study|Lack of Efficacy|19
1780095|NCT00669032|6196690|P1|Overall Study|Lack of Efficacy|8
1780096|NCT00669032|6196689|P2|Overall Study|Lost to Follow-up|5
1780097|NCT00669032|6196690|P1|Overall Study|Lost to Follow-up|6
1780098|NCT00668863|6196736|P1|Overall Study|Physician Decision|1
1780099|NCT00668863|6196736|P1|Overall Study|Subject’s work scheduling problem|1
1780100|NCT00668863|6196736|P1|Overall Study|Surgery|1
1780101|NCT00668863|6196736|P1|Overall Study|Withdrawal by Subject|1
1780102|NCT00668863|6196736|P1|Overall Study|Global Deterioration of Health Status|4
1780103|NCT00668863|6196736|P1|Overall Study|Study Terminated by Sponsor|8
1780104|NCT00668863|6196736|P1|Overall Study|Adverse Event|13
1780105|NCT00668863|6196736|P1|Overall Study|Objective Progression or Relapse|42
1780106|NCT00668746|6196768|P2|Overall Study|Lost to Follow-up|1
1780107|NCT00668746|6196769|P1|Overall Study|Lost to Follow-up|2
1780108|NCT00668733|6196789|P2|Overall Study|Withdrawal by Subject|4
1780109|NCT00668733|6196790|P1|Overall Study|Withdrawal by Subject|0
1780110|NCT00668733|6196789|P2|Overall Study|Lost to Follow-up|3
1780111|NCT00668733|6196790|P1|Overall Study|Lost to Follow-up|2
1780112|NCT00668395|6196835|P3|Overall Study|Physician Decision|0
1780113|NCT00668395|6196836|P2|Overall Study|Physician Decision|1
1780114|NCT00668395|6196837|P1|Overall Study|Physician Decision|1
1780115|NCT00668395|6196835|P3|Overall Study|Adverse Event|0
1780116|NCT00668395|6196836|P2|Overall Study|Adverse Event|1
1780117|NCT00668395|6196837|P1|Overall Study|Adverse Event|1
1780118|NCT00668395|6196835|P3|Overall Study|Withdrawal by Subject|1
1780119|NCT00668395|6196836|P2|Overall Study|Withdrawal by Subject|4
1780120|NCT00668395|6196837|P1|Overall Study|Withdrawal by Subject|4
1780121|NCT00668317|6196849|P1|Overall Study|Adverse Event|2
1780122|NCT00668200|6196864|P1|Overall Study|Lost to Follow-up|1
1780123|NCT00668200|6196864|P1|Overall Study|Withdrawal by Subject|2
1780124|NCT00668148|6196870|P1|Overall Study|Withdrawal of Consent|2
1780125|NCT00668148|6196870|P1|Overall Study|Progressive Disease Before Treatment|2
1780126|NCT00668148|6196870|P1|Overall Study|Subject Non-compliance|1
1780127|NCT00668148|6196870|P1|Overall Study|Adverse Event|5
1780128|NCT00667992|6196909|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
1780129|NCT00667992|6196910|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
1780130|NCT00667992|6196909|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
1780131|NCT00667992|6196910|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
1780132|NCT00667992|6196909|P2|Wash-out|Withdrawal by Subject|0
1780133|NCT00667992|6196910|P1|Wash-out|Withdrawal by Subject|1
1780134|NCT00667992|6196909|P2|Wash-out|Failure to wash-out|2
1780135|NCT00667992|6196910|P1|Wash-out|Failure to wash-out|2
1780136|NCT00667992|6196909|P2|Wash-out|Not within one doubling dilution|3
1780137|NCT00667992|6196910|P1|Wash-out|Not within one doubling dilution|4
1780138|NCT00667992|6196909|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
1780139|NCT00667992|6196910|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
1780140|NCT00667992|6196909|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
1780141|NCT00667992|6196910|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
1780142|NCT00667992|6196909|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
1780143|NCT00667992|6196910|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
1780144|NCT00667992|6196909|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
1780145|NCT00667992|6196910|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
1780146|NCT00667992|6196909|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
1780147|NCT00667992|6196910|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
1780148|NCT00667992|6196909|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
1780149|NCT00667992|6196910|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
1780150|NCT00667992|6196909|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
1780151|NCT00667992|6196910|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
1780152|NCT00667992|6196909|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
1780153|NCT00667992|6196910|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
1780154|NCT00667875|6196967|P3|Overall Study|Withdrawal by Subject|7
1780155|NCT00667875|6196968|P2|Overall Study|Withdrawal by Subject|9
1780156|NCT00667875|6196969|P1|Overall Study|Withdrawal by Subject|10
1780157|NCT00667875|6196967|P3|Overall Study|Adverse Event|6
1780158|NCT00667875|6196968|P2|Overall Study|Adverse Event|2
1780159|NCT00667875|6196969|P1|Overall Study|Adverse Event|0
1780160|NCT00667810|6197003|P4|Overall Study|Other|0
1780161|NCT00667810|6197004|P3|Overall Study|Other|5
1780162|NCT00667810|6197005|P2|Overall Study|Other|6
1780163|NCT00667810|6197006|P1|Overall Study|Other|6
1780164|NCT00667810|6197003|P4|Overall Study|Vasogenic Edema Recurrence|0
1780165|NCT00667810|6197004|P3|Overall Study|Vasogenic Edema Recurrence|0
1780166|NCT00667810|6197005|P2|Overall Study|Vasogenic Edema Recurrence|3
1780167|NCT00667810|6197006|P1|Overall Study|Vasogenic Edema Recurrence|0
1780168|NCT00667810|6197003|P4|Overall Study|Loss of Caregiver|0
1780169|NCT00667810|6197004|P3|Overall Study|Loss of Caregiver|3
1780170|NCT00667810|6197005|P2|Overall Study|Loss of Caregiver|1
1780171|NCT00667810|6197006|P1|Overall Study|Loss of Caregiver|0
1780172|NCT00667810|6197003|P4|Overall Study|Failed to Return|0
1780173|NCT00667810|6197004|P3|Overall Study|Failed to Return|2
1780174|NCT00667810|6197005|P2|Overall Study|Failed to Return|0
1780175|NCT00667810|6197006|P1|Overall Study|Failed to Return|0
1780176|NCT00667810|6197003|P4|Overall Study|Discontinuation of Study by Sponsor|0
1780177|NCT00667810|6197004|P3|Overall Study|Discontinuation of Study by Sponsor|155
1780178|NCT00667810|6197005|P2|Overall Study|Discontinuation of Study by Sponsor|118
1780179|NCT00667810|6197006|P1|Overall Study|Discontinuation of Study by Sponsor|130
1780180|NCT00667810|6197003|P4|Overall Study|Withdrawal by Subject|1
1780181|NCT00667810|6197004|P3|Overall Study|Withdrawal by Subject|29
1780182|NCT00667810|6197005|P2|Overall Study|Withdrawal by Subject|20
1780183|NCT00667810|6197006|P1|Overall Study|Withdrawal by Subject|14
1780184|NCT00667810|6197003|P4|Overall Study|Protocol Violation|0
1780185|NCT00667810|6197004|P3|Overall Study|Protocol Violation|0
1780186|NCT00667810|6197005|P2|Overall Study|Protocol Violation|2
1780187|NCT00667810|6197006|P1|Overall Study|Protocol Violation|0
1780188|NCT00667810|6197003|P4|Overall Study|Physician Decision|0
1780189|NCT00667810|6197004|P3|Overall Study|Physician Decision|2
1780190|NCT00667810|6197005|P2|Overall Study|Physician Decision|1
1780191|NCT00667810|6197006|P1|Overall Study|Physician Decision|1
1780192|NCT00667810|6197003|P4|Overall Study|Lost to Follow-up|0
1780193|NCT00667810|6197004|P3|Overall Study|Lost to Follow-up|2
1780194|NCT00667810|6197005|P2|Overall Study|Lost to Follow-up|4
1780195|NCT00667810|6197006|P1|Overall Study|Lost to Follow-up|1
1780196|NCT00667810|6197003|P4|Overall Study|Lack of Efficacy|0
1780197|NCT00667810|6197004|P3|Overall Study|Lack of Efficacy|2
1780198|NCT00667810|6197005|P2|Overall Study|Lack of Efficacy|0
1780199|NCT00667810|6197006|P1|Overall Study|Lack of Efficacy|1
1780200|NCT00667810|6197003|P4|Overall Study|Death|0
1780201|NCT00667810|6197004|P3|Overall Study|Death|3
1780202|NCT00667810|6197005|P2|Overall Study|Death|1
1780203|NCT00667810|6197006|P1|Overall Study|Death|1
1780204|NCT00667810|6197003|P4|Overall Study|Adverse Event|1
1780205|NCT00667810|6197004|P3|Overall Study|Adverse Event|19
1780206|NCT00667810|6197005|P2|Overall Study|Adverse Event|14
1780207|NCT00667810|6197006|P1|Overall Study|Adverse Event|13
1780208|NCT00667732|6197082|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
1780209|NCT00667732|6197083|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
1780210|NCT00667732|6197084|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
1780211|NCT00667732|6197082|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
1780212|NCT00667732|6197083|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
1780213|NCT00667732|6197084|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
1780214|NCT00667732|6197082|P3|Run -In (8 Weeks)|Adverse Event|0
1780215|NCT00667732|6197083|P2|Run -In (8 Weeks)|Adverse Event|0
1780216|NCT00667732|6197084|P1|Run -In (8 Weeks)|Adverse Event|4
1780217|NCT00667602|6197120|P3|Overall Study|Protocol Violation|0
1780218|NCT00667602|6197121|P2|Overall Study|Protocol Violation|1
1780219|NCT00667602|6197122|P1|Overall Study|Protocol Violation|0
1780220|NCT00667602|6197120|P3|Overall Study|Administrative reason|2
1780221|NCT00667602|6197121|P2|Overall Study|Administrative reason|0
1780222|NCT00667602|6197122|P1|Overall Study|Administrative reason|0
1780223|NCT00667602|6197120|P3|Overall Study|Lost to Follow-up|6
1780224|NCT00667602|6197121|P2|Overall Study|Lost to Follow-up|5
1780225|NCT00667602|6197122|P1|Overall Study|Lost to Follow-up|4
1780226|NCT00667602|6197120|P3|Overall Study|Withdrawal by Subject|10
1780227|NCT00667602|6197121|P2|Overall Study|Withdrawal by Subject|9
1780228|NCT00667602|6197122|P1|Overall Study|Withdrawal by Subject|4
1780229|NCT00667576|6197190|P5|Overall Study|Missed Visit|0
1780230|NCT00667576|6197191|P4|Overall Study|Missed Visit|1
1780231|NCT00667576|6197192|P3|Overall Study|Missed Visit|0
1780232|NCT00667576|6197193|P2|Overall Study|Missed Visit|0
1780233|NCT00667576|6197194|P1|Overall Study|Missed Visit|0
1780234|NCT00667576|6197190|P5|Overall Study|Physician Decision|0
1780235|NCT00667576|6197191|P4|Overall Study|Physician Decision|1
1780236|NCT00667576|6197192|P3|Overall Study|Physician Decision|0
1780237|NCT00667576|6197193|P2|Overall Study|Physician Decision|0
1780238|NCT00667576|6197194|P1|Overall Study|Physician Decision|0
1780239|NCT00667576|6197190|P5|Overall Study|Protocol Violation|0
1780240|NCT00667576|6197191|P4|Overall Study|Protocol Violation|1
1780241|NCT00667576|6197192|P3|Overall Study|Protocol Violation|0
1780242|NCT00667576|6197193|P2|Overall Study|Protocol Violation|0
1780243|NCT00667576|6197194|P1|Overall Study|Protocol Violation|0
1780244|NCT00667576|6197190|P5|Overall Study|Lost to Follow-up|0
1780245|NCT00667576|6197191|P4|Overall Study|Lost to Follow-up|0
1780246|NCT00667576|6197192|P3|Overall Study|Lost to Follow-up|1
1780247|NCT00667576|6197193|P2|Overall Study|Lost to Follow-up|0
1780248|NCT00667576|6197194|P1|Overall Study|Lost to Follow-up|0
1780249|NCT00667576|6197190|P5|Overall Study|Adverse Event|0
1780250|NCT00667576|6197191|P4|Overall Study|Adverse Event|0
1780251|NCT00667576|6197192|P3|Overall Study|Adverse Event|0
1780252|NCT00667576|6197193|P2|Overall Study|Adverse Event|1
1780253|NCT00667576|6197194|P1|Overall Study|Adverse Event|1
1780254|NCT00667576|6197190|P5|Overall Study|Withdrawal by Subject|1
1780255|NCT00667576|6197191|P4|Overall Study|Withdrawal by Subject|1
1780256|NCT00667576|6197192|P3|Overall Study|Withdrawal by Subject|1
1780257|NCT00667576|6197193|P2|Overall Study|Withdrawal by Subject|0
1780258|NCT00667576|6197194|P1|Overall Study|Withdrawal by Subject|1
1780259|NCT00667563|6197241|P1|Overall Study|Protocol Violation|24
1780260|NCT00667459|6197261|P2|Overall Study|Lost to Follow-up|43
1780261|NCT00667459|6197262|P1|Overall Study|Lost to Follow-up|8
1780262|NCT00667459|6197261|P2|Overall Study|Death|2
1780263|NCT00667459|6197262|P1|Overall Study|Death|0
1780264|NCT00667446|6197304|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
1780265|NCT00667446|6197305|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
1780266|NCT00667446|6197304|P2|Treatment Period (36 Months)|Therapeutic Failure|1
1780267|NCT00667446|6197305|P1|Treatment Period (36 Months)|Therapeutic Failure|1
1780268|NCT00667446|6197304|P2|Treatment Period (36 Months)|Protocol Violation|1
1780269|NCT00667446|6197305|P1|Treatment Period (36 Months)|Protocol Violation|1
1780270|NCT00667446|6197304|P2|Treatment Period (36 Months)|Lost to Follow-up|0
1780271|NCT00667446|6197305|P1|Treatment Period (36 Months)|Lost to Follow-up|1
1780272|NCT00667446|6197304|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
1780273|NCT00667446|6197305|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
1780274|NCT00667446|6197304|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
1780275|NCT00667446|6197305|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
1780276|NCT00667446|6197304|P2|Treatment Period (36 Months)|Personal reasons|2
1780277|NCT00667446|6197305|P1|Treatment Period (36 Months)|Personal reasons|2
1780278|NCT00667446|6197304|P2|Treatment Period (36 Months)|Other|2
1780279|NCT00667446|6197305|P1|Treatment Period (36 Months)|Other|2
1780280|NCT00667446|6197304|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
1780281|NCT00667446|6197305|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
1780282|NCT00667420|6197327|P1|Overall Study|Withdrawal by Subject|2
1780283|NCT00667420|6197327|P1|Overall Study|Physician Decision|1
1780284|NCT00667420|6197327|P1|Overall Study|Lack of Efficacy|5
1780285|NCT00667420|6197327|P1|Overall Study|Adverse Event|2
1780286|NCT00667394|6197337|P2|Overall Study|Progressive disease|0
1780287|NCT00667394|6197338|P1|Overall Study|Progressive disease|1
1780288|NCT00667394|6197337|P2|Overall Study|Adverse Event|0
1780289|NCT00667394|6197338|P1|Overall Study|Adverse Event|3
1780294|NCT00667355|6197374|P1|Overall Study|Other reason was not specified|5
1780295|NCT00667355|6197374|P1|Overall Study|Lost to Follow-up|1
1780296|NCT00667355|6197374|P1|Overall Study|Adverse Event|5
1780297|NCT00667342|6197399|P3|Overall Study|Ineligible|1
1780298|NCT00667342|6197400|P2|Overall Study|Ineligible|0
1780299|NCT00667342|6197401|P1|Overall Study|Ineligible|0
1780300|NCT00667342|6197399|P3|Overall Study|Adverse Event|1
1780301|NCT00667342|6197400|P2|Overall Study|Adverse Event|0
1780302|NCT00667342|6197401|P1|Overall Study|Adverse Event|0
1780303|NCT00667342|6197399|P3|Overall Study|Relapse or tumor progression|7
1780304|NCT00667342|6197400|P2|Overall Study|Relapse or tumor progression|0
1780305|NCT00667342|6197401|P1|Overall Study|Relapse or tumor progression|9
1780306|NCT00667342|6197399|P3|Overall Study|Physician Decision|0
1780307|NCT00667342|6197400|P2|Overall Study|Physician Decision|0
1780308|NCT00667342|6197401|P1|Overall Study|Physician Decision|3
1780309|NCT00667342|6197399|P3|Overall Study|Withdrawal by Subject|0
1780310|NCT00667342|6197400|P2|Overall Study|Withdrawal by Subject|0
1780311|NCT00667342|6197401|P1|Overall Study|Withdrawal by Subject|1
1780312|NCT00667342|6197399|P3|Overall Study|Protocol Violation|0
1780313|NCT00667342|6197400|P2|Overall Study|Protocol Violation|0
1780314|NCT00667342|6197401|P1|Overall Study|Protocol Violation|1
1780315|NCT00667277|6197439|P1|Overall Study|Withdrawal by Subject|2
1780326|NCT00667225|6197473|P2|Overall Study|Lost to Follow-up|1
1780327|NCT00667225|6197474|P1|Overall Study|Lost to Follow-up|0
1780328|NCT00667225|6197473|P2|Overall Study|Subject had no more lesions to treat.|0
1780329|NCT00667225|6197474|P1|Overall Study|Subject had no more lesions to treat.|1
1780330|NCT00667095|6197495|P2|Overall Study|Withdrawal by Subject|1
1780331|NCT00667095|6197496|P1|Overall Study|Withdrawal by Subject|0
1780332|NCT00667017|6197512|P1|Overall Study|Withdrawal by Subject|1
1780333|NCT00666965|6197532|P4|Overall Study|Withdrawal by Subject|2
1780334|NCT00666965|6197533|P3|Overall Study|Withdrawal by Subject|0
1780335|NCT00666965|6197534|P2|Overall Study|Withdrawal by Subject|0
1780336|NCT00666965|6197535|P1|Overall Study|Withdrawal by Subject|0
1780337|NCT00666965|6197532|P4|Overall Study|Discontinuation criteria|2
1780338|NCT00666965|6197533|P3|Overall Study|Discontinuation criteria|1
1780339|NCT00666965|6197534|P2|Overall Study|Discontinuation criteria|1
1780340|NCT00666965|6197535|P1|Overall Study|Discontinuation criteria|2
1780341|NCT00666965|6197532|P4|Overall Study|Protocol Violation|2
1780342|NCT00666965|6197533|P3|Overall Study|Protocol Violation|0
1780343|NCT00666965|6197534|P2|Overall Study|Protocol Violation|0
1780344|NCT00666965|6197535|P1|Overall Study|Protocol Violation|0
1780345|NCT00666965|6197532|P4|Overall Study|Lack of Efficacy|0
1780346|NCT00666965|6197533|P3|Overall Study|Lack of Efficacy|0
1780347|NCT00666965|6197534|P2|Overall Study|Lack of Efficacy|1
1780348|NCT00666965|6197535|P1|Overall Study|Lack of Efficacy|1
1780349|NCT00666965|6197532|P4|Overall Study|Adverse Event|9
1780350|NCT00666965|6197533|P3|Overall Study|Adverse Event|1
1780351|NCT00666965|6197534|P2|Overall Study|Adverse Event|2
1780352|NCT00666965|6197535|P1|Overall Study|Adverse Event|0
1780353|NCT00666926|6197565|P16|Overall Study|Death|0
1780354|NCT00666926|6197566|P15|Overall Study|Death|0
1780355|NCT00666926|6197567|P14|Overall Study|Death|0
1780356|NCT00666926|6197568|P13|Overall Study|Death|0
1780357|NCT00666926|6197569|P12|Overall Study|Death|1
1780358|NCT00666926|6197570|P11|Overall Study|Death|0
1780359|NCT00666926|6197571|P10|Overall Study|Death|0
1780360|NCT00666926|6197572|P9|Overall Study|Death|0
1780361|NCT00666926|6197573|P8|Overall Study|Death|0
1780362|NCT00666926|6197574|P7|Overall Study|Death|0
1780363|NCT00666926|6197575|P6|Overall Study|Death|0
1780364|NCT00666926|6197576|P5|Overall Study|Death|0
1780365|NCT00666926|6197577|P4|Overall Study|Death|0
1780366|NCT00666926|6197578|P3|Overall Study|Death|0
1780367|NCT00666926|6197579|P2|Overall Study|Death|0
1780368|NCT00666926|6197580|P1|Overall Study|Death|0
1780369|NCT00666926|6197565|P16|Overall Study|Withdrawal by Subject|3
1780370|NCT00666926|6197566|P15|Overall Study|Withdrawal by Subject|3
1780371|NCT00666926|6197567|P14|Overall Study|Withdrawal by Subject|1
1780372|NCT00666926|6197568|P13|Overall Study|Withdrawal by Subject|0
1780373|NCT00666926|6197569|P12|Overall Study|Withdrawal by Subject|3
1780374|NCT00666926|6197570|P11|Overall Study|Withdrawal by Subject|0
1780375|NCT00666926|6197571|P10|Overall Study|Withdrawal by Subject|3
1780376|NCT00666926|6197572|P9|Overall Study|Withdrawal by Subject|0
1780377|NCT00666926|6197573|P8|Overall Study|Withdrawal by Subject|1
1780378|NCT00666926|6197574|P7|Overall Study|Withdrawal by Subject|0
1780379|NCT00666926|6197575|P6|Overall Study|Withdrawal by Subject|0
1780380|NCT00666926|6197576|P5|Overall Study|Withdrawal by Subject|0
1780381|NCT00666926|6197577|P4|Overall Study|Withdrawal by Subject|0
1780382|NCT00666926|6197578|P3|Overall Study|Withdrawal by Subject|0
1780383|NCT00666926|6197579|P2|Overall Study|Withdrawal by Subject|0
1780384|NCT00666926|6197580|P1|Overall Study|Withdrawal by Subject|0
1780385|NCT00666926|6197565|P16|Overall Study|Other|4
1780386|NCT00666926|6197566|P15|Overall Study|Other|4
1780387|NCT00666926|6197567|P14|Overall Study|Other|2
1780388|NCT00666926|6197568|P13|Overall Study|Other|3
1780389|NCT00666926|6197569|P12|Overall Study|Other|26
1780390|NCT00666926|6197570|P11|Overall Study|Other|3
1780391|NCT00666926|6197571|P10|Overall Study|Other|5
1780392|NCT00666926|6197572|P9|Overall Study|Other|3
1780393|NCT00666926|6197573|P8|Overall Study|Other|0
1780394|NCT00666926|6197574|P7|Overall Study|Other|4
1780395|NCT00666926|6197575|P6|Overall Study|Other|3
1780396|NCT00666926|6197576|P5|Overall Study|Other|3
1780397|NCT00666926|6197577|P4|Overall Study|Other|3
1780398|NCT00666926|6197578|P3|Overall Study|Other|3
1780399|NCT00666926|6197579|P2|Overall Study|Other|4
1780400|NCT00666926|6197580|P1|Overall Study|Other|2
1780401|NCT00666926|6197565|P16|Overall Study|Lost to Follow-up|0
1780402|NCT00666926|6197566|P15|Overall Study|Lost to Follow-up|0
1780403|NCT00666926|6197567|P14|Overall Study|Lost to Follow-up|0
1780404|NCT00666926|6197568|P13|Overall Study|Lost to Follow-up|0
1780405|NCT00666926|6197569|P12|Overall Study|Lost to Follow-up|0
1780406|NCT00666926|6197570|P11|Overall Study|Lost to Follow-up|0
1780407|NCT00666926|6197571|P10|Overall Study|Lost to Follow-up|0
1780408|NCT00666926|6197572|P9|Overall Study|Lost to Follow-up|0
1780409|NCT00666926|6197573|P8|Overall Study|Lost to Follow-up|0
1780410|NCT00666926|6197574|P7|Overall Study|Lost to Follow-up|0
1780411|NCT00666926|6197575|P6|Overall Study|Lost to Follow-up|0
1780412|NCT00666926|6197576|P5|Overall Study|Lost to Follow-up|0
1780413|NCT00666926|6197577|P4|Overall Study|Lost to Follow-up|1
1780414|NCT00666926|6197578|P3|Overall Study|Lost to Follow-up|0
1780415|NCT00666926|6197579|P2|Overall Study|Lost to Follow-up|0
1780416|NCT00666926|6197580|P1|Overall Study|Lost to Follow-up|0
1780417|NCT00666926|6197565|P16|Overall Study|Lack of Efficacy|0
1780418|NCT00666926|6197566|P15|Overall Study|Lack of Efficacy|0
1780419|NCT00666926|6197567|P14|Overall Study|Lack of Efficacy|0
1780420|NCT00666926|6197568|P13|Overall Study|Lack of Efficacy|0
1780421|NCT00666926|6197569|P12|Overall Study|Lack of Efficacy|1
1780422|NCT00666926|6197570|P11|Overall Study|Lack of Efficacy|0
1780423|NCT00666926|6197571|P10|Overall Study|Lack of Efficacy|0
1780424|NCT00666926|6197572|P9|Overall Study|Lack of Efficacy|0
1780425|NCT00666926|6197573|P8|Overall Study|Lack of Efficacy|0
1780426|NCT00666926|6197574|P7|Overall Study|Lack of Efficacy|0
1780427|NCT00666926|6197575|P6|Overall Study|Lack of Efficacy|1
1780428|NCT00666926|6197576|P5|Overall Study|Lack of Efficacy|0
1780429|NCT00666926|6197577|P4|Overall Study|Lack of Efficacy|0
1780430|NCT00666926|6197578|P3|Overall Study|Lack of Efficacy|0
1780431|NCT00666926|6197579|P2|Overall Study|Lack of Efficacy|0
1780432|NCT00666926|6197580|P1|Overall Study|Lack of Efficacy|0
1780433|NCT00666926|6197565|P16|Overall Study|Laboratory abnormality|1
1780434|NCT00666926|6197566|P15|Overall Study|Laboratory abnormality|0
1780435|NCT00666926|6197567|P14|Overall Study|Laboratory abnormality|0
1780436|NCT00666926|6197568|P13|Overall Study|Laboratory abnormality|0
1780437|NCT00666926|6197569|P12|Overall Study|Laboratory abnormality|0
1780438|NCT00666926|6197570|P11|Overall Study|Laboratory abnormality|1
1780439|NCT00666926|6197571|P10|Overall Study|Laboratory abnormality|0
1780440|NCT00666926|6197572|P9|Overall Study|Laboratory abnormality|0
1780441|NCT00666926|6197573|P8|Overall Study|Laboratory abnormality|0
1780442|NCT00666926|6197574|P7|Overall Study|Laboratory abnormality|0
1780443|NCT00666926|6197575|P6|Overall Study|Laboratory abnormality|0
1780444|NCT00666926|6197576|P5|Overall Study|Laboratory abnormality|0
1780445|NCT00666926|6197577|P4|Overall Study|Laboratory abnormality|0
1780446|NCT00666926|6197578|P3|Overall Study|Laboratory abnormality|0
1780447|NCT00666926|6197579|P2|Overall Study|Laboratory abnormality|0
1780448|NCT00666926|6197580|P1|Overall Study|Laboratory abnormality|0
1780449|NCT00666926|6197565|P16|Overall Study|Adverse Event|0
1780450|NCT00666926|6197566|P15|Overall Study|Adverse Event|0
1780451|NCT00666926|6197567|P14|Overall Study|Adverse Event|1
1780452|NCT00666926|6197568|P13|Overall Study|Adverse Event|0
1780453|NCT00666926|6197569|P12|Overall Study|Adverse Event|2
1780454|NCT00666926|6197570|P11|Overall Study|Adverse Event|2
1780455|NCT00666926|6197571|P10|Overall Study|Adverse Event|2
1780456|NCT00666926|6197572|P9|Overall Study|Adverse Event|0
1780457|NCT00666926|6197573|P8|Overall Study|Adverse Event|0
1780458|NCT00666926|6197574|P7|Overall Study|Adverse Event|0
1780459|NCT00666926|6197575|P6|Overall Study|Adverse Event|0
1780460|NCT00666926|6197576|P5|Overall Study|Adverse Event|0
1780461|NCT00666926|6197577|P4|Overall Study|Adverse Event|0
1780462|NCT00666926|6197578|P3|Overall Study|Adverse Event|0
1780463|NCT00666926|6197579|P2|Overall Study|Adverse Event|0
1780464|NCT00666926|6197580|P1|Overall Study|Adverse Event|0
1780465|NCT00666835|6197889|P2|Overall Study|Physician Decision|2
1780466|NCT00666835|6197890|P1|Overall Study|Physician Decision|1
1780467|NCT00666835|6197889|P2|Overall Study|Planned operation|0
1780468|NCT00666835|6197890|P1|Overall Study|Planned operation|2
1780469|NCT00666835|6197889|P2|Overall Study|Hemoglobulin concentration|3
1780470|NCT00666835|6197890|P1|Overall Study|Hemoglobulin concentration|4
1780471|NCT00666835|6197889|P2|Overall Study|Kidney Transplantation (NTX)|2
1780472|NCT00666835|6197890|P1|Overall Study|Kidney Transplantation (NTX)|10
1780473|NCT00666835|6197889|P2|Overall Study|Death|4
1780474|NCT00666835|6197890|P1|Overall Study|Death|15
1780475|NCT00666835|6197889|P2|Overall Study|Protocol Violation|0
1780476|NCT00666835|6197890|P1|Overall Study|Protocol Violation|2
1780477|NCT00666835|6197889|P2|Overall Study|Adverse Event|6
1780478|NCT00666835|6197890|P1|Overall Study|Adverse Event|7
1780479|NCT00666835|6197889|P2|Overall Study|Incl./excl. not fulfilled|2
1780480|NCT00666835|6197890|P1|Overall Study|Incl./excl. not fulfilled|7
1780481|NCT00666835|6197889|P2|Overall Study|Lack of Efficacy|1
1780482|NCT00666835|6197890|P1|Overall Study|Lack of Efficacy|0
1780483|NCT00666835|6197889|P2|Overall Study|Withdrawal by Subject|2
1780484|NCT00666835|6197890|P1|Overall Study|Withdrawal by Subject|5
1780485|NCT00666757|6197900|P2|Overall Study|Sponsor decision|1
1780486|NCT00666757|6197901|P1|Overall Study|Sponsor decision|0
1780487|NCT00666757|6197900|P2|Overall Study|Physician Decision|2
1780488|NCT00666757|6197901|P1|Overall Study|Physician Decision|0
1780489|NCT00666757|6197900|P2|Overall Study|Lack of Efficacy|6
1780490|NCT00666757|6197901|P1|Overall Study|Lack of Efficacy|3
1780491|NCT00666757|6197900|P2|Overall Study|Withdrawal by Subject|17
1780492|NCT00666757|6197901|P1|Overall Study|Withdrawal by Subject|13
1780493|NCT00666757|6197900|P2|Overall Study|Adverse Event|12
1780494|NCT00666757|6197901|P1|Overall Study|Adverse Event|22
1780495|NCT00666757|6197900|P2|Overall Study|Protocol Violation|24
1780496|NCT00666757|6197901|P1|Overall Study|Protocol Violation|23
1780497|NCT00666757|6197900|P2|Overall Study|Lost to Follow-up|35
1780498|NCT00666757|6197901|P1|Overall Study|Lost to Follow-up|39
1780499|NCT00666718|6197960|P2|Overall Study|Physician Decision|2
1780500|NCT00666718|6197961|P1|Overall Study|Physician Decision|0
1780501|NCT00666718|6197960|P2|Overall Study|Withdrawal by Subject|12
1780502|NCT00666718|6197961|P1|Overall Study|Withdrawal by Subject|7
1780503|NCT00666718|6197960|P2|Overall Study|Protocol Violation|3
1780504|NCT00666718|6197961|P1|Overall Study|Protocol Violation|1
1780505|NCT00666718|6197960|P2|Overall Study|Entry Criteria Not Met|0
1780506|NCT00666718|6197961|P1|Overall Study|Entry Criteria Not Met|2
1780507|NCT00666718|6197960|P2|Overall Study|Lost to Follow-up|0
1780508|NCT00666718|6197961|P1|Overall Study|Lost to Follow-up|1
1780509|NCT00666718|6197960|P2|Overall Study|Death|0
1780510|NCT00666718|6197961|P1|Overall Study|Death|1
1780511|NCT00666718|6197960|P2|Overall Study|Adverse Event|1
1780512|NCT00666718|6197961|P1|Overall Study|Adverse Event|0
1780513|NCT00666705|6197987|P1|Overall Study|Withdrawal by Subject|1
1780514|NCT00666679|6198006|P2|Second Intervention|Death|1
1780515|NCT00666679|6198007|P1|Second Intervention|Death|0
1780516|NCT00666679|6198006|P2|Second Intervention|Adverse Event|0
1780517|NCT00666679|6198007|P1|Second Intervention|Adverse Event|1
1780518|NCT00666679|6198006|P2|Washout Period of 1 Week|Protocol Violation|1
1780519|NCT00666679|6198007|P1|Washout Period of 1 Week|Protocol Violation|0
1780520|NCT00666679|6198006|P2|Washout Period of 1 Week|Lost to Follow-up|1
1780521|NCT00666679|6198007|P1|Washout Period of 1 Week|Lost to Follow-up|0
1780522|NCT00666679|6198006|P2|First Intervention|Randomized did not start treatment|1
1780523|NCT00666679|6198007|P1|First Intervention|Randomized did not start treatment|1
1780524|NCT00666679|6198006|P2|First Intervention|Withdrawal by Subject|0
1780525|NCT00666679|6198007|P1|First Intervention|Withdrawal by Subject|1
1780526|NCT00666679|6198006|P2|First Intervention|Protocol Violation|0
1780527|NCT00666679|6198007|P1|First Intervention|Protocol Violation|1
1780528|NCT00666679|6198006|P2|First Intervention|Lost to Follow-up|0
1780529|NCT00666679|6198007|P1|First Intervention|Lost to Follow-up|1
1780530|NCT00666588|6198037|P4|Overall Study|inevaluable|0
1780531|NCT00666588|6198038|P3|Overall Study|inevaluable|0
1780532|NCT00666588|6198039|P2|Overall Study|inevaluable|0
1780533|NCT00666588|6198040|P1|Overall Study|inevaluable|2
1780534|NCT00666588|6198037|P4|Overall Study|ineligible|2
1780535|NCT00666588|6198038|P3|Overall Study|ineligible|0
1780536|NCT00666588|6198039|P2|Overall Study|ineligible|0
1780537|NCT00666588|6198040|P1|Overall Study|ineligible|2
1780538|NCT00666562|6198073|P3|Overall Study|Concomitant Medication|0
1780539|NCT00666562|6198074|P2|Overall Study|Concomitant Medication|1
1780540|NCT00666562|6198075|P1|Overall Study|Concomitant Medication|0
1780541|NCT00666562|6198073|P3|Overall Study|Withdrawal by Subject|0
1780542|NCT00666562|6198074|P2|Overall Study|Withdrawal by Subject|1
1780543|NCT00666562|6198075|P1|Overall Study|Withdrawal by Subject|0
1780544|NCT00666536|6198122|P2|Overall Study|Lost to Follow-up|3
1780545|NCT00666536|6198123|P1|Overall Study|Lost to Follow-up|4
1780546|NCT00666536|6198122|P2|Overall Study|Withdrawal by Subject|9
1780547|NCT00666536|6198123|P1|Overall Study|Withdrawal by Subject|10
1780548|NCT00666536|6198122|P2|Overall Study|Protocol deviation(s)|6
1780549|NCT00666536|6198123|P1|Overall Study|Protocol deviation(s)|8
1780550|NCT00666536|6198122|P2|Overall Study|Unsatisfactory therapeutic effect|0
1780551|NCT00666536|6198123|P1|Overall Study|Unsatisfactory therapeutic effect|2
1780552|NCT00666536|6198122|P2|Overall Study|Adverse Event|19
1780553|NCT00666536|6198123|P1|Overall Study|Adverse Event|9
1780554|NCT00666458|6198141|P2|Overall Study|Medical history of anemia|0
1780555|NCT00666458|6198142|P1|Overall Study|Medical history of anemia|1
1780556|NCT00666458|6198141|P2|Overall Study|Safety reasons|0
1780557|NCT00666458|6198142|P1|Overall Study|Safety reasons|1
1780558|NCT00666458|6198141|P2|Overall Study|Severe non-compliance to the protocol|1
1780559|NCT00666458|6198142|P1|Overall Study|Severe non-compliance to the protocol|1
1780560|NCT00666458|6198141|P2|Overall Study|Study specific discontinuation criteria|7
1780561|NCT00666458|6198142|P1|Overall Study|Study specific discontinuation criteria|14
1780562|NCT00666458|6198141|P2|Overall Study|Incorrect enrollment|1
1780563|NCT00666458|6198142|P1|Overall Study|Incorrect enrollment|7
1780564|NCT00666458|6198141|P2|Overall Study|Administrative reason by sponsor|1
1780565|NCT00666458|6198142|P1|Overall Study|Administrative reason by sponsor|1
1780566|NCT00666458|6198141|P2|Overall Study|Lost to Follow-up|3
1780567|NCT00666458|6198142|P1|Overall Study|Lost to Follow-up|0
1780568|NCT00666458|6198141|P2|Overall Study|Withdrawal by Subject|4
1780569|NCT00666458|6198142|P1|Overall Study|Withdrawal by Subject|5
1780570|NCT00666458|6198141|P2|Overall Study|Adverse Event|7
1780571|NCT00666458|6198142|P1|Overall Study|Adverse Event|8
1780572|NCT00666328|6198230|P1|Overall Study|No longer met eligibility criteria|1
1780573|NCT00666328|6198230|P1|Overall Study|Lost to Follow-up|2
1780574|NCT00666328|6198230|P1|Overall Study|Death|2
1780575|NCT00666276|6198243|P1|Overall Study|Protocol Violation|34
1780576|NCT00666263|6198267|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
1780577|NCT00666263|6198268|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
1780578|NCT00666263|6198267|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
1780579|NCT00666263|6198268|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
1780580|NCT00666263|6198267|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
1780581|NCT00666263|6198268|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
1780582|NCT00666224|6198412|P2|Open-Label|Undefined/Unknown|1
1780583|NCT00666224|6198413|P1|Open-Label|Undefined/Unknown|1
1780584|NCT00666224|6198412|P2|Open-Label|Noncompliance|1
1780585|NCT00666224|6198413|P1|Open-Label|Noncompliance|2
1780586|NCT00666224|6198412|P2|Open-Label|Pregnancy|5
1780587|NCT00666224|6198413|P1|Open-Label|Pregnancy|1
1780588|NCT00666224|6198412|P2|Open-Label|Physician Decision|5
1780589|NCT00666224|6198413|P1|Open-Label|Physician Decision|7
1780590|NCT00666224|6198412|P2|Open-Label|Withdrawal by Subject|25
1780591|NCT00666224|6198413|P1|Open-Label|Withdrawal by Subject|12
1780592|NCT00666224|6198412|P2|Open-Label|Lost to Follow-up|5
1780593|NCT00666224|6198413|P1|Open-Label|Lost to Follow-up|4
1780594|NCT00666224|6198412|P2|Open-Label|Adverse Event|43
1780595|NCT00666224|6198413|P1|Open-Label|Adverse Event|8
1780596|NCT00666224|6198412|P2|Double-Blind|Undefined/Unknown|1
1780597|NCT00666224|6198413|P1|Double-Blind|Undefined/Unknown|4
1780598|NCT00666224|6198412|P2|Double-Blind|Death|0
1780599|NCT00666224|6198413|P1|Double-Blind|Death|1
1780600|NCT00666224|6198412|P2|Double-Blind|Noncompliance|0
1780601|NCT00666224|6198413|P1|Double-Blind|Noncompliance|1
1780602|NCT00666224|6198412|P2|Double-Blind|Pregnancy|2
1780603|NCT00666224|6198413|P1|Double-Blind|Pregnancy|3
1780604|NCT00666224|6198412|P2|Double-Blind|Sponsor decision|0
1780605|NCT00666224|6198413|P1|Double-Blind|Sponsor decision|1
1780606|NCT00666224|6198412|P2|Double-Blind|Physician Decision|3
1780607|NCT00666224|6198413|P1|Double-Blind|Physician Decision|0
1780608|NCT00666224|6198412|P2|Double-Blind|Withdrawal by Subject|14
1780609|NCT00666224|6198413|P1|Double-Blind|Withdrawal by Subject|18
1780610|NCT00666224|6198412|P2|Double-Blind|Lost to Follow-up|2
1780611|NCT00666224|6198413|P1|Double-Blind|Lost to Follow-up|2
1780612|NCT00666224|6198412|P2|Double-Blind|Adverse Event|5
1780613|NCT00666224|6198413|P1|Double-Blind|Adverse Event|15
1780614|NCT00666211|6198432|P2|Overall Study|Physician Decision|1
1780615|NCT00666211|6198433|P1|Overall Study|Physician Decision|0
1780616|NCT00666211|6198432|P2|Overall Study|off tx for other complicating disease|1
1780617|NCT00666211|6198433|P1|Overall Study|off tx for other complicating disease|0
1780618|NCT00666211|6198432|P2|Overall Study|Death|2
1780619|NCT00666211|6198433|P1|Overall Study|Death|0
1780620|NCT00666211|6198432|P2|Overall Study|hospital admission|5
1780621|NCT00666211|6198433|P1|Overall Study|hospital admission|0
1780622|NCT00666211|6198432|P2|Overall Study|toxicity|2
1780623|NCT00666211|6198433|P1|Overall Study|toxicity|0
1780624|NCT00666211|6198432|P2|Overall Study|Lost to Follow-up|0
1780625|NCT00666211|6198433|P1|Overall Study|Lost to Follow-up|2
1780626|NCT00666211|6198432|P2|Overall Study|disease progression|8
1780627|NCT00666211|6198433|P1|Overall Study|disease progression|1
1780628|NCT00666211|6198432|P2|Overall Study|patient non-compliant|6
1780629|NCT00666211|6198433|P1|Overall Study|patient non-compliant|6
1780630|NCT00666211|6198432|P2|Overall Study|went off medication, no more pain|0
1780631|NCT00666211|6198433|P1|Overall Study|went off medication, no more pain|1
1780632|NCT00666211|6198432|P2|Overall Study|Withdrawal by Subject|13
1780633|NCT00666211|6198433|P1|Overall Study|Withdrawal by Subject|10
1780634|NCT00666198|6198451|P1|Overall Study|No Drug Administration|4
1780635|NCT00666198|6198451|P1|Overall Study|Safety Not Assessable|6
1780636|NCT00666198|6198451|P1|Overall Study|No Visit After First Day of Treatment|13
1780637|NCT00666198|6198451|P1|Overall Study|Protocol Violation|10
1780638|NCT00665925|6198479|P4|Overall Study|Due to exclusion criteria|0
1780639|NCT00665925|6198480|P3|Overall Study|Due to exclusion criteria|0
1780640|NCT00665925|6198481|P2|Overall Study|Due to exclusion criteria|0
1780641|NCT00665925|6198482|P1|Overall Study|Due to exclusion criteria|1
1780642|NCT00665925|6198479|P4|Overall Study|Enrolled by mistake|1
1780643|NCT00665925|6198480|P3|Overall Study|Enrolled by mistake|0
1780644|NCT00665925|6198481|P2|Overall Study|Enrolled by mistake|0
1780645|NCT00665925|6198482|P1|Overall Study|Enrolled by mistake|0
1780646|NCT00665925|6198479|P4|Overall Study|Adverse Event|5
1780647|NCT00665925|6198480|P3|Overall Study|Adverse Event|10
1780648|NCT00665925|6198481|P2|Overall Study|Adverse Event|5
1780649|NCT00665925|6198482|P1|Overall Study|Adverse Event|1
1780650|NCT00665925|6198479|P4|Overall Study|Severe Non-Compliance to Protocol|1
1780651|NCT00665925|6198480|P3|Overall Study|Severe Non-Compliance to Protocol|1
1780652|NCT00665925|6198481|P2|Overall Study|Severe Non-Compliance to Protocol|0
1780653|NCT00665925|6198482|P1|Overall Study|Severe Non-Compliance to Protocol|0
1780654|NCT00665925|6198479|P4|Overall Study|Physician Decision|2
1780655|NCT00665925|6198480|P3|Overall Study|Physician Decision|1
1780656|NCT00665925|6198481|P2|Overall Study|Physician Decision|0
1780657|NCT00665925|6198482|P1|Overall Study|Physician Decision|0
1780658|NCT00665925|6198479|P4|Overall Study|Withdrawal by Subject|2
1780659|NCT00665925|6198480|P3|Overall Study|Withdrawal by Subject|3
1780660|NCT00665925|6198481|P2|Overall Study|Withdrawal by Subject|2
1780661|NCT00665925|6198482|P1|Overall Study|Withdrawal by Subject|2
1780662|NCT00665925|6198479|P4|Overall Study|Lost to Follow-up|2
1780663|NCT00665925|6198480|P3|Overall Study|Lost to Follow-up|2
1780664|NCT00665925|6198481|P2|Overall Study|Lost to Follow-up|2
1780665|NCT00665925|6198482|P1|Overall Study|Lost to Follow-up|1
1780666|NCT00665925|6198479|P4|Overall Study|Lack of Efficacy|8
1780667|NCT00665925|6198480|P3|Overall Study|Lack of Efficacy|9
1780668|NCT00665925|6198481|P2|Overall Study|Lack of Efficacy|8
1780669|NCT00665925|6198482|P1|Overall Study|Lack of Efficacy|10
1780670|NCT00665847|6198893|P1|Overall Study|Switch to Commercial Medication|1
1780671|NCT00665847|6198893|P1|Overall Study|Subject ineligible to continue the trial|1
1780672|NCT00665847|6198893|P1|Overall Study|Resistance to TMC125|1
1780673|NCT00665847|6198893|P1|Overall Study|Subject reached a virologic endpoint|4
1780674|NCT00665847|6198893|P1|Overall Study|Subject non-compliant|8
1780675|NCT00665847|6198893|P1|Overall Study|Withdrawal by Subject|2
1780676|NCT00665847|6198893|P1|Overall Study|Adverse Event|8
1780677|NCT00665652|6198910|P1|Overall Study|No longer met inclusion criteria.|1
1780678|NCT00665652|6198910|P1|Overall Study|Death|1
1780679|NCT00665652|6198910|P1|Overall Study|Adverse Event|4
1780680|NCT00665626|6198916|P2|Overall Study|Death|0
1780681|NCT00665626|6198917|P1|Overall Study|Death|1
1780682|NCT00665626|6198916|P2|Overall Study|Unably to comply with dosing regimen|1
1780683|NCT00665626|6198917|P1|Overall Study|Unably to comply with dosing regimen|0
1780684|NCT00665626|6198916|P2|Overall Study|Did not fulfil inclusion criteria|1
1780685|NCT00665626|6198917|P1|Overall Study|Did not fulfil inclusion criteria|0
1780686|NCT00665626|6198916|P2|Overall Study|Due to exclusion criteria|1
1780687|NCT00665626|6198917|P1|Overall Study|Due to exclusion criteria|0
1780688|NCT00665626|6198916|P2|Overall Study|Adverse Event|9
1780689|NCT00665626|6198917|P1|Overall Study|Adverse Event|1
1780690|NCT00665626|6198916|P2|Overall Study|Protocol Violation|2
1780691|NCT00665626|6198917|P1|Overall Study|Protocol Violation|0
1780692|NCT00665626|6198916|P2|Overall Study|Withdrawal by Subject|1
1780693|NCT00665626|6198917|P1|Overall Study|Withdrawal by Subject|0
1780694|NCT00665626|6198916|P2|Overall Study|Lost to Follow-up|2
1780695|NCT00665626|6198917|P1|Overall Study|Lost to Follow-up|0
1780696|NCT00665626|6198916|P2|Overall Study|Lack of Efficacy|5
1780697|NCT00665626|6198917|P1|Overall Study|Lack of Efficacy|8
1780698|NCT00665444|6198999|P1|Overall Study|Study Terminated by Study Sponsor|1
1780699|NCT00665444|6198999|P1|Overall Study|Physician Decision|1
1780700|NCT00665431|6199011|P3|Overall Study|Other|2
1780701|NCT00665431|6199012|P2|Overall Study|Other|7
1780702|NCT00665431|6199013|P1|Overall Study|Other|4
1780703|NCT00665431|6199011|P3|Overall Study|Lost to Follow-up|1
1780704|NCT00665431|6199012|P2|Overall Study|Lost to Follow-up|3
1780705|NCT00665431|6199013|P1|Overall Study|Lost to Follow-up|3
1780706|NCT00665431|6199011|P3|Overall Study|Withdrawal by Subject|15
1780707|NCT00665431|6199012|P2|Overall Study|Withdrawal by Subject|25
1780708|NCT00665431|6199013|P1|Overall Study|Withdrawal by Subject|17
1780709|NCT00665431|6199011|P3|Overall Study|Adverse Event|6
1780710|NCT00665431|6199012|P2|Overall Study|Adverse Event|22
1780711|NCT00665431|6199013|P1|Overall Study|Adverse Event|16
1780712|NCT00665366|6199056|P2|Overall Study|Other reasons|1
1780713|NCT00665366|6199057|P1|Overall Study|Other reasons|4
1780714|NCT00665366|6199056|P2|Overall Study|No longer meets study criteria|1
1780715|NCT00665366|6199057|P1|Overall Study|No longer meets study criteria|0
1780716|NCT00665366|6199056|P2|Overall Study|Pregnancy|0
1780717|NCT00665366|6199057|P1|Overall Study|Pregnancy|1
1780718|NCT00665366|6199056|P2|Overall Study|Poor compliance/noncompliance|5
1780719|NCT00665366|6199057|P1|Overall Study|Poor compliance/noncompliance|3
1780720|NCT00665366|6199056|P2|Overall Study|Lost to Follow-up|5
1780721|NCT00665366|6199057|P1|Overall Study|Lost to Follow-up|3
1780722|NCT00665366|6199056|P2|Overall Study|Withdrawal by Subject|14
1780723|NCT00665366|6199057|P1|Overall Study|Withdrawal by Subject|11
1780724|NCT00665366|6199056|P2|Overall Study|Adverse Event|23
1780725|NCT00665366|6199057|P1|Overall Study|Adverse Event|25
1780726|NCT00665366|6199056|P2|Overall Study|Lack of Efficacy|10
1780727|NCT00665366|6199057|P1|Overall Study|Lack of Efficacy|11
1780728|NCT00665353|6199085|P1|Study Step 2|Lack of Efficacy|12
1780729|NCT00665353|6199085|P1|Study Step 2|Lost to Follow-up|2
1780730|NCT00665353|6199085|P1|Study Step 1|Withdrawal by Subject|2
1780731|NCT00665353|6199085|P1|Study Step 1|Adverse Event|1
1780732|NCT00665002|6199102|P1|Overall Study|Cytogenetic resistance|1
1780733|NCT00665002|6199102|P1|Overall Study|Progression/relapse during treatment|11
1780734|NCT00664742|6199116|P1|Overall Study|Lost to Follow-up|92
1780735|NCT00664742|6199116|P1|Overall Study|Withdrawal by Subject|31
1780736|NCT00664742|6199116|P1|Overall Study|Withdrawn due to adverse events|3
1780737|NCT00664560|6199124|P3|Overall Study|Other|5
1780738|NCT00664560|6199125|P2|Overall Study|Other|4
1780739|NCT00664560|6199126|P1|Overall Study|Other|11
1780740|NCT00664560|6199124|P3|Overall Study|Lost to Follow-up|0
1780741|NCT00664560|6199125|P2|Overall Study|Lost to Follow-up|2
1780742|NCT00664560|6199126|P1|Overall Study|Lost to Follow-up|0
1780743|NCT00664560|6199124|P3|Overall Study|Withdrawal by Subject|7
1780744|NCT00664560|6199125|P2|Overall Study|Withdrawal by Subject|13
1780745|NCT00664560|6199126|P1|Overall Study|Withdrawal by Subject|9
1780746|NCT00664560|6199124|P3|Overall Study|Adverse Event|7
1780747|NCT00664560|6199125|P2|Overall Study|Adverse Event|16
1780748|NCT00664560|6199126|P1|Overall Study|Adverse Event|19
1780749|NCT00664534|6199169|P2|Overall Study|Sponsor decision|6
1780750|NCT00664534|6199170|P1|Overall Study|Sponsor decision|8
1780751|NCT00664534|6199169|P2|Overall Study|Physician Decision|0
1780752|NCT00664534|6199170|P1|Overall Study|Physician Decision|8
1780753|NCT00664534|6199169|P2|Overall Study|Withdrawal by Subject|6
1780754|NCT00664534|6199170|P1|Overall Study|Withdrawal by Subject|7
1780755|NCT00664534|6199169|P2|Overall Study|Protocol Violation|8
1780756|NCT00664534|6199170|P1|Overall Study|Protocol Violation|10
1780757|NCT00664534|6199169|P2|Overall Study|Lost to Follow-up|10
1780758|NCT00664534|6199170|P1|Overall Study|Lost to Follow-up|6
1780759|NCT00664534|6199169|P2|Overall Study|Adverse Event|3
1780760|NCT00664534|6199170|P1|Overall Study|Adverse Event|2
1780761|NCT00664521|6199198|P2|Overall Study|Other|0
1780762|NCT00664521|6199199|P1|Overall Study|Other|1
1780763|NCT00664521|6199198|P2|Overall Study|Lost to Follow-up|0
1780764|NCT00664521|6199199|P1|Overall Study|Lost to Follow-up|1
1780765|NCT00664521|6199198|P2|Overall Study|Adverse Event|1
1780766|NCT00664521|6199199|P1|Overall Study|Adverse Event|4
1780767|NCT00664326|6199225|P1|Overall Study|ongoing with treatment|6
1780768|NCT00664326|6199225|P1|Overall Study|Physician Decision|1
1780769|NCT00664326|6199225|P1|Overall Study|Withdrawal by Subject|1
1780770|NCT00664326|6199225|P1|Overall Study|Noncompliance with study medication|3
1780771|NCT00664326|6199225|P1|Overall Study|Adverse Event|13
1780772|NCT00664209|6199244|P1|Study Treatment Period|Withdrawal by Subject|2
1780773|NCT00664209|6199244|P1|Study Treatment Period|Physician Decision|4
1780774|NCT00664209|6199244|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
1780775|NCT00664105|6199252|P1|Overall Study|Disease progression|7
1780776|NCT00664105|6199252|P1|Overall Study|Adverse Event|9
1780777|NCT00664105|6199252|P1|Overall Study|Withdrawal by Subject|5
1780778|NCT00664105|6199252|P1|Overall Study|Death|3
1780779|NCT00664066|6199259|P1|Overall Study|Study terminated|3
1780780|NCT00663962|6199265|P2|Overall Study|somnolence|0
1780781|NCT00663962|6199266|P1|Overall Study|somnolence|1
1780782|NCT00663923|6199272|P1|Overall Study|Lost to Follow-up|2
1780783|NCT00663858|6199289|P3|Overall Study|Other|4
1780784|NCT00663858|6199290|P2|Overall Study|Other|2
1780785|NCT00663858|6199291|P1|Overall Study|Other|8
1780786|NCT00663858|6199289|P3|Overall Study|Protocol Violation|4
1780787|NCT00663858|6199290|P2|Overall Study|Protocol Violation|3
1780788|NCT00663858|6199291|P1|Overall Study|Protocol Violation|5
1780789|NCT00663858|6199289|P3|Overall Study|Withdrawal by Subject|3
1780790|NCT00663858|6199290|P2|Overall Study|Withdrawal by Subject|3
1780791|NCT00663858|6199291|P1|Overall Study|Withdrawal by Subject|7
1780792|NCT00663858|6199289|P3|Overall Study|Lack of Efficacy|3
1780793|NCT00663858|6199290|P2|Overall Study|Lack of Efficacy|1
1780794|NCT00663858|6199291|P1|Overall Study|Lack of Efficacy|5
1780795|NCT00663858|6199289|P3|Overall Study|Adverse Event|6
1780796|NCT00663858|6199290|P2|Overall Study|Adverse Event|1
1780797|NCT00663858|6199291|P1|Overall Study|Adverse Event|9
1780798|NCT00663702|6199329|P2|Overall Study|Lack of Efficacy|3
1780799|NCT00663702|6199330|P1|Overall Study|Lack of Efficacy|3
1780800|NCT00663702|6199329|P2|Overall Study|Death|1
1780801|NCT00663702|6199330|P1|Overall Study|Death|1
1780802|NCT00663702|6199329|P2|Overall Study|Lost to Follow-up|0
1780803|NCT00663702|6199330|P1|Overall Study|Lost to Follow-up|3
1780804|NCT00663702|6199329|P2|Overall Study|Pregnancy|1
1780805|NCT00663702|6199330|P1|Overall Study|Pregnancy|0
1780806|NCT00663702|6199329|P2|Overall Study|Withdrawal by Subject|1
1780807|NCT00663702|6199330|P1|Overall Study|Withdrawal by Subject|3
1780808|NCT00663702|6199329|P2|Overall Study|Adverse Event|4
1780809|NCT00663702|6199330|P1|Overall Study|Adverse Event|8
1780810|NCT00663260|6199366|P3|Overall Study|non-compliance, not met criteria, etc.|3
1780811|NCT00663260|6199367|P2|Overall Study|non-compliance, not met criteria, etc.|2
1780812|NCT00663260|6199368|P1|Overall Study|non-compliance, not met criteria, etc.|3
1780813|NCT00663260|6199366|P3|Overall Study|Lost to Follow-up|0
1780814|NCT00663260|6199367|P2|Overall Study|Lost to Follow-up|1
1780815|NCT00663260|6199368|P1|Overall Study|Lost to Follow-up|0
1780816|NCT00663260|6199366|P3|Overall Study|Death|1
1780817|NCT00663260|6199367|P2|Overall Study|Death|0
1780818|NCT00663260|6199368|P1|Overall Study|Death|1
1780819|NCT00663260|6199366|P3|Overall Study|Withdrawal by Subject|6
1780820|NCT00663260|6199367|P2|Overall Study|Withdrawal by Subject|1
1780821|NCT00663260|6199368|P1|Overall Study|Withdrawal by Subject|3
1780822|NCT00663260|6199366|P3|Overall Study|Adverse Event|6
1780823|NCT00663260|6199367|P2|Overall Study|Adverse Event|7
1780824|NCT00663260|6199368|P1|Overall Study|Adverse Event|12
1780825|NCT00663260|6199366|P3|Overall Study|Lack of Efficacy|0
1780826|NCT00663260|6199367|P2|Overall Study|Lack of Efficacy|0
1780827|NCT00663260|6199368|P1|Overall Study|Lack of Efficacy|2
1780828|NCT00663234|6199382|P1|Overall Study|Not willing to adhere to requirements|1
1780829|NCT00663208|6199415|P7|Follow-up Period|Other reason|1
1780830|NCT00663208|6199416|P6|Follow-up Period|Other reason|0
1780831|NCT00663208|6199417|P5|Follow-up Period|Other reason|0
1780832|NCT00663208|6199418|P4|Follow-up Period|Other reason|0
1780833|NCT00663208|6199419|P3|Follow-up Period|Other reason|0
1780834|NCT00663208|6199420|P2|Follow-up Period|Other reason|0
1780835|NCT00663208|6199421|P1|Follow-up Period|Other reason|1
1780836|NCT00663208|6199415|P7|Follow-up Period|Lost to Follow-up|0
1780837|NCT00663208|6199416|P6|Follow-up Period|Lost to Follow-up|0
1780838|NCT00663208|6199417|P5|Follow-up Period|Lost to Follow-up|0
1780839|NCT00663208|6199418|P4|Follow-up Period|Lost to Follow-up|2
1780840|NCT00663208|6199419|P3|Follow-up Period|Lost to Follow-up|3
1780841|NCT00663208|6199420|P2|Follow-up Period|Lost to Follow-up|0
1780842|NCT00663208|6199421|P1|Follow-up Period|Lost to Follow-up|2
1780843|NCT00663208|6199415|P7|Treatment Period|Lost to Follow-up|0
1780844|NCT00663208|6199416|P6|Treatment Period|Lost to Follow-up|0
1780845|NCT00663208|6199417|P5|Treatment Period|Lost to Follow-up|0
1780846|NCT00663208|6199418|P4|Treatment Period|Lost to Follow-up|0
1780847|NCT00663208|6199419|P3|Treatment Period|Lost to Follow-up|0
1780848|NCT00663208|6199420|P2|Treatment Period|Lost to Follow-up|1
1780849|NCT00663208|6199421|P1|Treatment Period|Lost to Follow-up|0
1780850|NCT00663117|6199599|P2|Overall Study|Lack of Efficacy|0
1780851|NCT00663117|6199600|P1|Overall Study|Lack of Efficacy|1
1780852|NCT00663052|6199614|P2|Overall Study|Other|1
1780853|NCT00663052|6199615|P1|Overall Study|Other|0
1780854|NCT00663052|6199614|P2|Overall Study|Unsatisfactory Response - Efficacy|1
1780855|NCT00663052|6199615|P1|Overall Study|Unsatisfactory Response - Efficacy|1
1780856|NCT00663052|6199614|P2|Overall Study|Withdrawal by Subject|5
1780857|NCT00663052|6199615|P1|Overall Study|Withdrawal by Subject|2
1780858|NCT00663052|6199614|P2|Overall Study|Protocol Violation|0
1780859|NCT00663052|6199615|P1|Overall Study|Protocol Violation|1
1780860|NCT00663052|6199614|P2|Overall Study|Discontinuation of Study by Sponsor|0
1780861|NCT00663052|6199615|P1|Overall Study|Discontinuation of Study by Sponsor|2
1780862|NCT00663052|6199614|P2|Overall Study|Adverse Event|3
1780863|NCT00663052|6199615|P1|Overall Study|Adverse Event|6
1780864|NCT00663026|6199721|P3|Overall Study|Withdrawal by Subject|1
1780865|NCT00663026|6199722|P2|Overall Study|Withdrawal by Subject|0
1780866|NCT00663026|6199723|P1|Overall Study|Withdrawal by Subject|0
1780867|NCT00663026|6199721|P3|Overall Study|Caregiver Request|0
1780868|NCT00663026|6199722|P2|Overall Study|Caregiver Request|2
1780869|NCT00663026|6199723|P1|Overall Study|Caregiver Request|0
1780870|NCT00663026|6199721|P3|Overall Study|Adverse Event|3
1780871|NCT00663026|6199722|P2|Overall Study|Adverse Event|2
1780872|NCT00663026|6199723|P1|Overall Study|Adverse Event|0
1780873|NCT00663026|6199721|P3|Overall Study|Other|0
1780874|NCT00663026|6199722|P2|Overall Study|Other|2
1780875|NCT00663026|6199723|P1|Overall Study|Other|1
1780876|NCT00663026|6199721|P3|Overall Study|Lost to Follow-up|0
1780877|NCT00663026|6199722|P2|Overall Study|Lost to Follow-up|0
1780878|NCT00663026|6199723|P1|Overall Study|Lost to Follow-up|1
1780879|NCT00662909|6199746|P3|Overall Study|Eligibility criterion not met|1
1780880|NCT00662909|6199747|P2|Overall Study|Eligibility criterion not met|1
1780881|NCT00662909|6199748|P1|Overall Study|Eligibility criterion not met|0
1780882|NCT00662909|6199746|P3|Overall Study|Physician Decision|2
1780883|NCT00662909|6199747|P2|Overall Study|Physician Decision|1
1780884|NCT00662909|6199748|P1|Overall Study|Physician Decision|1
1780885|NCT00662909|6199746|P3|Overall Study|Non-compliance with study procedures|2
1780886|NCT00662909|6199747|P2|Overall Study|Non-compliance with study procedures|3
1780887|NCT00662909|6199748|P1|Overall Study|Non-compliance with study procedures|3
1780888|NCT00662909|6199746|P3|Overall Study|Randomized- never received study drug|0
1780889|NCT00662909|6199747|P2|Overall Study|Randomized- never received study drug|0
1780890|NCT00662909|6199748|P1|Overall Study|Randomized- never received study drug|1
1780891|NCT00662909|6199746|P3|Overall Study|Protocol Violation|5
1780892|NCT00662909|6199747|P2|Overall Study|Protocol Violation|4
1780893|NCT00662909|6199748|P1|Overall Study|Protocol Violation|7
1780894|NCT00662909|6199746|P3|Overall Study|Lost to Follow-up|3
1780895|NCT00662909|6199747|P2|Overall Study|Lost to Follow-up|9
1780896|NCT00662909|6199748|P1|Overall Study|Lost to Follow-up|2
1780897|NCT00662909|6199746|P3|Overall Study|Withdrawal by Subject|16
1780898|NCT00662909|6199747|P2|Overall Study|Withdrawal by Subject|22
1780899|NCT00662909|6199748|P1|Overall Study|Withdrawal by Subject|29
1780900|NCT00662909|6199746|P3|Overall Study|Lack of Efficacy|5
1780901|NCT00662909|6199747|P2|Overall Study|Lack of Efficacy|1
1780902|NCT00662909|6199748|P1|Overall Study|Lack of Efficacy|9
1780903|NCT00662909|6199746|P3|Overall Study|Adverse Event|19
1780904|NCT00662909|6199747|P2|Overall Study|Adverse Event|18
1780905|NCT00662909|6199748|P1|Overall Study|Adverse Event|17
1780906|NCT00662857|6199846|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
1780907|NCT00662857|6199847|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
1780908|NCT00662857|6199846|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
1780909|NCT00662857|6199847|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
1780910|NCT00662857|6199846|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
1780911|NCT00662857|6199847|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
1780912|NCT00662831|6199862|P2|Overall Study|Adverse Event|16
1780913|NCT00662831|6199863|P1|Overall Study|Adverse Event|23
1780914|NCT00662831|6199862|P2|Overall Study|Protocol Violation|4
1780915|NCT00662831|6199863|P1|Overall Study|Protocol Violation|8
1780916|NCT00662831|6199862|P2|Overall Study|Other|31
1780917|NCT00662831|6199863|P1|Overall Study|Other|62
1780918|NCT00662831|6199862|P2|Overall Study|Withdrawal by Subject|1
1780919|NCT00662831|6199863|P1|Overall Study|Withdrawal by Subject|2
1780920|NCT00662831|6199862|P2|Overall Study|Lost to Follow-up|0
1780921|NCT00662831|6199863|P1|Overall Study|Lost to Follow-up|1
1780922|NCT00662831|6199862|P2|Overall Study|Lack of Efficacy|6
1780923|NCT00662831|6199863|P1|Overall Study|Lack of Efficacy|6
1780924|NCT00662831|6199862|P2|Overall Study|Death|1
1780925|NCT00662831|6199863|P1|Overall Study|Death|4
1780926|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
1780927|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
1780928|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
1780929|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
1780930|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
1780931|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1780932|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1780933|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1780934|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
1780935|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
1780936|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
1780937|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
1780938|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
1780939|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
1780940|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
1780941|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
1780942|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
1780943|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
1780944|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
1780945|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
1780946|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
1780947|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
1780948|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
1780949|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
1780950|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
1780951|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Adverse Event|10
1780952|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Adverse Event|6
1780953|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Adverse Event|0
1780954|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Adverse Event|9
1780955|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Adverse Event|6
1780956|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Administrative problems|0
1780957|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Administrative problems|1
1780958|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Administrative problems|0
1780959|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Administrative problems|0
1780960|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Administrative problems|0
1780961|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
1780962|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
1780963|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
1780964|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
1780965|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
1780966|NCT00662649|6199943|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
1780967|NCT00662649|6199944|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
1780968|NCT00662649|6199945|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
1780969|NCT00662649|6199946|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
1780970|NCT00662649|6199947|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
1780971|NCT00662649|6199943|P5|Core Study (24 Months)|Death|0
1780972|NCT00662649|6199944|P4|Core Study (24 Months)|Death|0
1780973|NCT00662649|6199945|P3|Core Study (24 Months)|Death|2
1780974|NCT00662649|6199946|P2|Core Study (24 Months)|Death|0
1780975|NCT00662649|6199947|P1|Core Study (24 Months)|Death|1
1780976|NCT00662649|6199943|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
1780977|NCT00662649|6199944|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
1780978|NCT00662649|6199945|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
1780979|NCT00662649|6199946|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
1780980|NCT00662649|6199947|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
1780981|NCT00662649|6199943|P5|Core Study (24 Months)|Protocol Violation|0
1780982|NCT00662649|6199944|P4|Core Study (24 Months)|Protocol Violation|0
1780983|NCT00662649|6199945|P3|Core Study (24 Months)|Protocol Violation|4
1780984|NCT00662649|6199946|P2|Core Study (24 Months)|Protocol Violation|5
1780985|NCT00662649|6199947|P1|Core Study (24 Months)|Protocol Violation|5
1780986|NCT00662649|6199943|P5|Core Study (24 Months)|Lost to Follow-up|0
1780987|NCT00662649|6199944|P4|Core Study (24 Months)|Lost to Follow-up|0
1780988|NCT00662649|6199945|P3|Core Study (24 Months)|Lost to Follow-up|7
1780989|NCT00662649|6199946|P2|Core Study (24 Months)|Lost to Follow-up|5
1780990|NCT00662649|6199947|P1|Core Study (24 Months)|Lost to Follow-up|3
1780991|NCT00662649|6199943|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
1780992|NCT00662649|6199944|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
1780993|NCT00662649|6199945|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
1780994|NCT00662649|6199946|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
1780995|NCT00662649|6199947|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
1780996|NCT00662649|6199943|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
1780997|NCT00662649|6199944|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
1780998|NCT00662649|6199945|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
1780999|NCT00662649|6199946|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
1781000|NCT00662649|6199947|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
1781001|NCT00662649|6199943|P5|Core Study (24 Months)|Adverse Event|0
1781002|NCT00662649|6199944|P4|Core Study (24 Months)|Adverse Event|0
1781003|NCT00662649|6199945|P3|Core Study (24 Months)|Adverse Event|18
1781004|NCT00662649|6199946|P2|Core Study (24 Months)|Adverse Event|13
1781005|NCT00662649|6199947|P1|Core Study (24 Months)|Adverse Event|22
1781006|NCT00662649|6199943|P5|Core Study (24 Months)|Withdrawal by Subject|0
1781007|NCT00662649|6199944|P4|Core Study (24 Months)|Withdrawal by Subject|0
1781008|NCT00662649|6199945|P3|Core Study (24 Months)|Withdrawal by Subject|28
1781009|NCT00662649|6199946|P2|Core Study (24 Months)|Withdrawal by Subject|17
1781010|NCT00662649|6199947|P1|Core Study (24 Months)|Withdrawal by Subject|31
1781011|NCT00662558|6199987|P2|Overall Study|Randomized But Did Not Receive Treatment|8
1781012|NCT00662558|6199988|P1|Overall Study|Randomized But Did Not Receive Treatment|2
1781013|NCT00662558|6199987|P2|Overall Study|Withdrawal by Subject|12
1781014|NCT00662558|6199988|P1|Overall Study|Withdrawal by Subject|7
1781015|NCT00662558|6199987|P2|Overall Study|Other|14
1781016|NCT00662558|6199988|P1|Overall Study|Other|9
1781017|NCT00662558|6199987|P2|Overall Study|Lost to Follow-up|10
1781018|NCT00662558|6199988|P1|Overall Study|Lost to Follow-up|13
1781019|NCT00662558|6199987|P2|Overall Study|Lack of Efficacy|7
1781020|NCT00662558|6199988|P1|Overall Study|Lack of Efficacy|4
1781021|NCT00662558|6199987|P2|Overall Study|Adverse Event|59
1781022|NCT00662558|6199988|P1|Overall Study|Adverse Event|21
1781023|NCT00662532|6200039|P2|Overall Study|Lost to Follow-up|1
1781024|NCT00662532|6200040|P1|Overall Study|Lost to Follow-up|0
1781025|NCT00662532|6200039|P2|Overall Study|Adverse Event|1
1781026|NCT00662532|6200040|P1|Overall Study|Adverse Event|0
1781027|NCT00662363|6200055|P2|Overall Study|Protocol Violation|1
1781028|NCT00662363|6200056|P1|Overall Study|Protocol Violation|1
1781029|NCT00662363|6200055|P2|Overall Study|Discharged early from rehab|1
1781030|NCT00662363|6200056|P1|Overall Study|Discharged early from rehab|4
1781031|NCT00662363|6200055|P2|Overall Study|Adverse Event|3
1781032|NCT00662363|6200056|P1|Overall Study|Adverse Event|0
1781033|NCT00662363|6200055|P2|Overall Study|Withdrawal by Subject|5
1781034|NCT00662363|6200056|P1|Overall Study|Withdrawal by Subject|6
1781035|NCT00662311|6200067|P3|Overall Study|Respiratory Infection|0
1781036|NCT00662311|6200068|P2|Overall Study|Respiratory Infection|0
1781037|NCT00662311|6200069|P1|Overall Study|Respiratory Infection|1
1781038|NCT00662259|6200104|P2|Overall Study|Adverse Event|0
1781039|NCT00662259|6200105|P1|Overall Study|Adverse Event|2
1781040|NCT00662129|6200147|P1|Overall Study|Ineligible|1
1781041|NCT00662129|6200147|P1|Overall Study|Cancel prior to beginning treatment|1
1781042|NCT00662129|6200147|P1|Overall Study|Protocol Violation|1
1781043|NCT00662038|6200157|P1|Overall Study|Continued treatment|5
1781044|NCT00662038|6200157|P1|Overall Study|Adverse Event|358
1781045|NCT00662038|6200157|P1|Overall Study|Death|95
1781046|NCT00662038|6200157|P1|Overall Study|Lost to Follow-up|1
1781047|NCT00662038|6200157|P1|Overall Study|Lung transplantation|44
1781048|NCT00662038|6200157|P1|Overall Study|Physician Decision|19
1781049|NCT00662038|6200157|P1|Overall Study|Sponsor decision|1
1781050|NCT00662038|6200157|P1|Overall Study|Withdrawal by Subject|83
1781051|NCT00662038|6200157|P1|Overall Study|Withdrawn consent|22
1781052|NCT00662038|6200157|P1|Overall Study|Reason not specified|3
1781053|NCT00662025|6200161|P1|Overall Study|Domestic circumstances|1
1781054|NCT00662025|6200161|P1|Overall Study|Target lesion cannot be evaluated|1
1781055|NCT00662025|6200161|P1|Overall Study|Results of other clinical study|2
1781056|NCT00662025|6200161|P1|Overall Study|Withdrawal by Subject|1
1781057|NCT00662025|6200161|P1|Overall Study|Adverse Event|7
1781058|NCT00662025|6200161|P1|Overall Study|Objective progression or relapse|51
1781059|NCT00662012|6200181|P1|Overall Study|Withdrawal by Subject|1
1781060|NCT00662012|6200181|P1|Overall Study|Death|1
1781061|NCT00662012|6200181|P1|Overall Study|Lost to Follow-up|85
1781062|NCT00661999|6200189|P3|Overall Study|Other Medical Problems|9
1781063|NCT00661999|6200190|P2|Overall Study|Other Medical Problems|4
1781064|NCT00661999|6200191|P1|Overall Study|Other Medical Problems|4
1781065|NCT00661999|6200189|P3|Overall Study|Alternative Treatment|0
1781066|NCT00661999|6200190|P2|Overall Study|Alternative Treatment|0
1781067|NCT00661999|6200191|P1|Overall Study|Alternative Treatment|1
1781068|NCT00661999|6200189|P3|Overall Study|Withdrawal by Subject|14
1781069|NCT00661999|6200190|P2|Overall Study|Withdrawal by Subject|23
1781070|NCT00661999|6200191|P1|Overall Study|Withdrawal by Subject|30
1781071|NCT00661999|6200189|P3|Overall Study|Other Reasons|23
1781072|NCT00661999|6200190|P2|Overall Study|Other Reasons|12
1781073|NCT00661999|6200191|P1|Overall Study|Other Reasons|5
1781074|NCT00661999|6200189|P3|Overall Study|Death|3
1781075|NCT00661999|6200190|P2|Overall Study|Death|6
1781076|NCT00661999|6200191|P1|Overall Study|Death|8
1781077|NCT00661999|6200189|P3|Overall Study|Adverse Event|8
1781078|NCT00661999|6200190|P2|Overall Study|Adverse Event|5
1781079|NCT00661999|6200191|P1|Overall Study|Adverse Event|11
1781080|NCT00661830|6200268|P2|Overall Study|Other reason|5
1781081|NCT00661830|6200269|P1|Overall Study|Other reason|1
1781082|NCT00661830|6200268|P2|Overall Study|Withdrawal by Subject|1
1781083|NCT00661830|6200269|P1|Overall Study|Withdrawal by Subject|1
1781084|NCT00661830|6200268|P2|Overall Study|Lost to Follow-up|3
1781085|NCT00661830|6200269|P1|Overall Study|Lost to Follow-up|1
1781086|NCT00661830|6200268|P2|Overall Study|Death|33
1781087|NCT00661830|6200269|P1|Overall Study|Death|37
1781088|NCT00661778|6200281|P1|Overall Study|Withdrawal of Consent|1
1781089|NCT00661778|6200281|P1|Overall Study|Protocol Violation|2
1781090|NCT00661778|6200281|P1|Overall Study|Reason not Specified|6
1781091|NCT00661778|6200281|P1|Overall Study|Adverse Event|18
1781092|NCT00661778|6200281|P1|Overall Study|Disease Progression|23
1781093|NCT00661726|6200288|P1|Overall Study|Adverse Event|1
1781094|NCT00661713|6200311|P8|Overall Study|Inappropriate Enrollment|0
1781095|NCT00661713|6200312|P7|Overall Study|Inappropriate Enrollment|1
1781096|NCT00661713|6200313|P6|Overall Study|Inappropriate Enrollment|0
1781097|NCT00661713|6200314|P5|Overall Study|Inappropriate Enrollment|0
1781098|NCT00661713|6200315|P4|Overall Study|Inappropriate Enrollment|0
1781099|NCT00661713|6200316|P3|Overall Study|Inappropriate Enrollment|0
1781100|NCT00661713|6200317|P2|Overall Study|Inappropriate Enrollment|0
1781101|NCT00661713|6200318|P1|Overall Study|Inappropriate Enrollment|0
1781102|NCT00661713|6200311|P8|Overall Study|Adverse Event|0
1781103|NCT00661713|6200312|P7|Overall Study|Adverse Event|1
1781104|NCT00661713|6200313|P6|Overall Study|Adverse Event|0
1781105|NCT00661713|6200314|P5|Overall Study|Adverse Event|0
1781106|NCT00661713|6200315|P4|Overall Study|Adverse Event|0
1781107|NCT00661713|6200316|P3|Overall Study|Adverse Event|0
1781108|NCT00661713|6200317|P2|Overall Study|Adverse Event|0
1781109|NCT00661713|6200318|P1|Overall Study|Adverse Event|0
1781110|NCT00661713|6200311|P8|Overall Study|Administrative Reason|0
1781111|NCT00661713|6200312|P7|Overall Study|Administrative Reason|1
1781112|NCT00661713|6200313|P6|Overall Study|Administrative Reason|2
1781113|NCT00661713|6200314|P5|Overall Study|Administrative Reason|2
1781114|NCT00661713|6200315|P4|Overall Study|Administrative Reason|2
1781115|NCT00661713|6200316|P3|Overall Study|Administrative Reason|0
1781116|NCT00661713|6200317|P2|Overall Study|Administrative Reason|1
1781117|NCT00661713|6200318|P1|Overall Study|Administrative Reason|0
1781118|NCT00661713|6200311|P8|Overall Study|Lost to Follow-up|1
1781119|NCT00661713|6200312|P7|Overall Study|Lost to Follow-up|14
1781120|NCT00661713|6200313|P6|Overall Study|Lost to Follow-up|7
1781121|NCT00661713|6200314|P5|Overall Study|Lost to Follow-up|5
1781122|NCT00661713|6200315|P4|Overall Study|Lost to Follow-up|2
1781123|NCT00661713|6200316|P3|Overall Study|Lost to Follow-up|2
1781124|NCT00661713|6200317|P2|Overall Study|Lost to Follow-up|7
1781125|NCT00661713|6200318|P1|Overall Study|Lost to Follow-up|2
1781126|NCT00661713|6200311|P8|Overall Study|Withdrawal by Subject|9
1781127|NCT00661713|6200312|P7|Overall Study|Withdrawal by Subject|45
1781128|NCT00661713|6200313|P6|Overall Study|Withdrawal by Subject|26
1781129|NCT00661713|6200314|P5|Overall Study|Withdrawal by Subject|12
1781130|NCT00661713|6200315|P4|Overall Study|Withdrawal by Subject|21
1781131|NCT00661713|6200316|P3|Overall Study|Withdrawal by Subject|12
1781132|NCT00661713|6200317|P2|Overall Study|Withdrawal by Subject|25
1781133|NCT00661713|6200318|P1|Overall Study|Withdrawal by Subject|11
1781134|NCT00661713|6200311|P8|Overall Study|Protocol Violation|1
1781135|NCT00661713|6200312|P7|Overall Study|Protocol Violation|2
1781136|NCT00661713|6200313|P6|Overall Study|Protocol Violation|2
1781137|NCT00661713|6200314|P5|Overall Study|Protocol Violation|0
1781138|NCT00661713|6200315|P4|Overall Study|Protocol Violation|3
1781139|NCT00661713|6200316|P3|Overall Study|Protocol Violation|3
1781140|NCT00661713|6200317|P2|Overall Study|Protocol Violation|6
1781141|NCT00661713|6200318|P1|Overall Study|Protocol Violation|1
1781142|NCT00661713|6200311|P8|Overall Study|Unable to Classify|0
1781143|NCT00661713|6200312|P7|Overall Study|Unable to Classify|0
1781144|NCT00661713|6200313|P6|Overall Study|Unable to Classify|0
1781145|NCT00661713|6200314|P5|Overall Study|Unable to Classify|0
1781146|NCT00661713|6200315|P4|Overall Study|Unable to Classify|0
1781147|NCT00661713|6200316|P3|Overall Study|Unable to Classify|0
1781148|NCT00661713|6200317|P2|Overall Study|Unable to Classify|0
1781149|NCT00661713|6200318|P1|Overall Study|Unable to Classify|1
1781150|NCT00661713|6200311|P8|Overall Study|Death|0
1781151|NCT00661713|6200312|P7|Overall Study|Death|0
1781152|NCT00661713|6200313|P6|Overall Study|Death|0
1781153|NCT00661713|6200314|P5|Overall Study|Death|1
1781154|NCT00661713|6200315|P4|Overall Study|Death|0
1781155|NCT00661713|6200316|P3|Overall Study|Death|0
1781156|NCT00661713|6200317|P2|Overall Study|Death|0
1781157|NCT00661713|6200318|P1|Overall Study|Death|1
1781158|NCT00661687|6200410|P1|Overall Study|Adverse Event|2
1781159|NCT00661687|6200410|P1|Overall Study|Physician Decision|1
1781160|NCT00661687|6200410|P1|Overall Study|Inability to maintain wearing schedule|3
1781161|NCT00661687|6200410|P1|Overall Study|Positive slit lamp findings|4
1781162|NCT00661687|6200410|P1|Overall Study|Study related symptoms and complaints|5
1781163|NCT00661661|6200438|P2|Overall Study|Not assigned treatment|0
1781164|NCT00661661|6200439|P1|Overall Study|Not assigned treatment|1
1781165|NCT00661661|6200438|P2|Overall Study|Other|7
1781166|NCT00661661|6200439|P1|Overall Study|Other|22
1781167|NCT00661661|6200438|P2|Overall Study|Withdrawal by Subject|5
1781168|NCT00661661|6200439|P1|Overall Study|Withdrawal by Subject|15
1781169|NCT00661661|6200438|P2|Overall Study|Lost to Follow-up|1
1781170|NCT00661661|6200439|P1|Overall Study|Lost to Follow-up|0
1781171|NCT00661661|6200438|P2|Overall Study|Lack of Efficacy|2
1781172|NCT00661661|6200439|P1|Overall Study|Lack of Efficacy|3
1781173|NCT00661661|6200438|P2|Overall Study|Adverse Event|24
1781174|NCT00661661|6200439|P1|Overall Study|Adverse Event|99
1781175|NCT00661622|6200515|P2|Overall Study|Protocol Violation|0
1781176|NCT00661622|6200516|P1|Overall Study|Protocol Violation|1
1781177|NCT00661609|6200530|P1|Overall Study|Disease progression|3
1781178|NCT00661609|6200530|P1|Overall Study|Survival follow up stage discontinued|11
1781179|NCT00661609|6200530|P1|Overall Study|PI Decision|1
1781180|NCT00661609|6200530|P1|Overall Study|Withdrawal by Subject|2
1781181|NCT00661609|6200530|P1|Overall Study|Death|20
1781182|NCT00661609|6200530|P1|Overall Study|Adverse Event|4
1781183|NCT00661531|6200597|P1|Overall Study|Withdrawal by Subject|3
1781184|NCT00661505|6200602|P1|Overall Study|Other|2
1781185|NCT00661505|6200602|P1|Overall Study|Lost to Follow-up|3
1781186|NCT00661505|6200602|P1|Overall Study|Withdrawal by Subject|8
1781187|NCT00661505|6200602|P1|Overall Study|Protocol Violation|14
1781188|NCT00661505|6200602|P1|Overall Study|Adverse Event|3
1781189|NCT00661492|6200630|P2|Overall Study|Other|0
1781190|NCT00661492|6200631|P1|Overall Study|Other|1
1781191|NCT00661492|6200630|P2|Overall Study|Lost to Follow-up|1
1781192|NCT00661492|6200631|P1|Overall Study|Lost to Follow-up|0
1781193|NCT00661492|6200630|P2|Overall Study|Investigator Request|0
1781194|NCT00661492|6200631|P1|Overall Study|Investigator Request|1
1781195|NCT00661492|6200630|P2|Overall Study|Patient Request|1
1781196|NCT00661492|6200631|P1|Overall Study|Patient Request|6
1781197|NCT00661492|6200630|P2|Overall Study|Disease Progression|14
1781198|NCT00661492|6200631|P1|Overall Study|Disease Progression|44
1781199|NCT00661492|6200630|P2|Overall Study|Adverse Event|13
1781200|NCT00661492|6200631|P1|Overall Study|Adverse Event|16
1781201|NCT00661427|6200677|P2|Overall Study|Patient not treated|2
1781202|NCT00661427|6200678|P1|Overall Study|Patient not treated|0
1781203|NCT00661427|6200677|P2|Overall Study|Adverse Event|5
1781204|NCT00661427|6200678|P1|Overall Study|Adverse Event|5
1781205|NCT00661388|6200686|P1|Overall Study|Administrative reasons|1
1781206|NCT00661388|6200686|P1|Overall Study|Dialysis initiation|1
1781207|NCT00661388|6200686|P1|Overall Study|Renal transplantation|1
1781208|NCT00661388|6200686|P1|Overall Study|Protocol Violation|7
1781209|NCT00661388|6200686|P1|Overall Study|Adverse Event|14
1781210|NCT00661362|6200709|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
1781211|NCT00661362|6200710|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
1781212|NCT00661362|6200709|P2|Overall Study|Safety reasons|0
1781213|NCT00661362|6200710|P1|Overall Study|Safety reasons|1
1781214|NCT00661362|6200709|P2|Overall Study|Severe non-compliance to protocol|1
1781215|NCT00661362|6200710|P1|Overall Study|Severe non-compliance to protocol|0
1781216|NCT00661362|6200709|P2|Overall Study|Lost to Follow-up|1
1781217|NCT00661362|6200710|P1|Overall Study|Lost to Follow-up|3
1781218|NCT00661362|6200709|P2|Overall Study|Withdrawal by Subject|23
1781219|NCT00661362|6200710|P1|Overall Study|Withdrawal by Subject|13
1781220|NCT00661362|6200709|P2|Overall Study|Study specific discontinuation criteria|11
1781221|NCT00661362|6200710|P1|Overall Study|Study specific discontinuation criteria|4
1781222|NCT00661362|6200709|P2|Overall Study|Incorrect enrollment|0
1781223|NCT00661362|6200710|P1|Overall Study|Incorrect enrollment|2
1781224|NCT00661362|6200709|P2|Overall Study|Adverse Event|4
1781225|NCT00661362|6200710|P1|Overall Study|Adverse Event|5
1781226|NCT00661271|6200728|P2|Overall Study|Lost to Follow-up|25
1781227|NCT00661271|6200729|P1|Overall Study|Lost to Follow-up|28
1781228|NCT00661258|6200739|P2|Overall Study|caught by police and in detox center|1
1781229|NCT00661258|6200740|P1|Overall Study|caught by police and in detox center|2
1781230|NCT00661258|6200739|P2|Overall Study|Death|0
1781231|NCT00661258|6200740|P1|Overall Study|Death|1
1781240|NCT00661089|6200976|P2|Overall Study|death at 8 weeks due to new stroke|1
1781241|NCT00661089|6200977|P1|Overall Study|death at 8 weeks due to new stroke|0
1781242|NCT00661089|6200976|P2|Overall Study|1 subject withdrawal|1
1781243|NCT00661089|6200977|P1|Overall Study|1 subject withdrawal|0
1781244|NCT00660907|6201025|P2|Overall Study|Various|8
1781245|NCT00660907|6201026|P1|Overall Study|Various|11
1781246|NCT00660907|6201025|P2|Overall Study|Death|3
1781247|NCT00660907|6201026|P1|Overall Study|Death|1
1781248|NCT00660907|6201025|P2|Overall Study|Safety|0
1781249|NCT00660907|6201026|P1|Overall Study|Safety|1
1781250|NCT00660907|6201025|P2|Overall Study|Poor/Non-Compliance|1
1781251|NCT00660907|6201026|P1|Overall Study|Poor/Non-Compliance|5
1781252|NCT00660907|6201025|P2|Overall Study|Lost to Follow-up|3
1781253|NCT00660907|6201026|P1|Overall Study|Lost to Follow-up|3
1781254|NCT00660907|6201025|P2|Overall Study|Withdrawal by Subject|32
1781255|NCT00660907|6201026|P1|Overall Study|Withdrawal by Subject|23
1781256|NCT00660907|6201025|P2|Overall Study|Subject No Longer Meets Study Criteria|27
1781257|NCT00660907|6201026|P1|Overall Study|Subject No Longer Meets Study Criteria|6
1781258|NCT00660907|6201025|P2|Overall Study|Adverse Event|19
1781259|NCT00660907|6201026|P1|Overall Study|Adverse Event|33
1781260|NCT00660907|6201025|P2|Overall Study|Incorrect Enrollment|1
1781261|NCT00660907|6201026|P1|Overall Study|Incorrect Enrollment|1
1781262|NCT00660829|6201040|P2|Overall Study|Other|4
1781263|NCT00660829|6201041|P1|Overall Study|Other|9
1781264|NCT00660829|6201040|P2|Overall Study|Lost to Follow-up|2
1781265|NCT00660829|6201041|P1|Overall Study|Lost to Follow-up|3
1781266|NCT00660829|6201040|P2|Overall Study|Withdrawal by Subject|2
1781267|NCT00660829|6201041|P1|Overall Study|Withdrawal by Subject|1
1781268|NCT00660829|6201040|P2|Overall Study|Non-Compliance|4
1781269|NCT00660829|6201041|P1|Overall Study|Non-Compliance|0
1781270|NCT00660829|6201040|P2|Overall Study|Lack of Efficacy|3
1781271|NCT00660829|6201041|P1|Overall Study|Lack of Efficacy|2
1781272|NCT00660829|6201040|P2|Overall Study|Adverse Event|4
1781273|NCT00660829|6201041|P1|Overall Study|Adverse Event|3
1781274|NCT00660816|6201059|P2|Overall Study|Complicating Disease|1
1781275|NCT00660816|6201060|P1|Overall Study|Complicating Disease|0
1781276|NCT00660816|6201059|P2|Overall Study|Disease Progression|12
1781277|NCT00660816|6201060|P1|Overall Study|Disease Progression|16
1781278|NCT00660816|6201059|P2|Overall Study|Protocol Violation|0
1781279|NCT00660816|6201060|P1|Overall Study|Protocol Violation|1
1781280|NCT00660816|6201059|P2|Overall Study|Physician Decision|2
1781281|NCT00660816|6201060|P1|Overall Study|Physician Decision|0
1781282|NCT00660816|6201059|P2|Overall Study|Lack of Efficacy|0
1781283|NCT00660816|6201060|P1|Overall Study|Lack of Efficacy|1
1781284|NCT00660816|6201059|P2|Overall Study|Death|2
1781285|NCT00660816|6201060|P1|Overall Study|Death|0
1781286|NCT00660816|6201059|P2|Overall Study|Withdrawal by Subject|0
1781287|NCT00660816|6201060|P1|Overall Study|Withdrawal by Subject|1
1781288|NCT00660816|6201059|P2|Overall Study|Adverse Event|2
1781289|NCT00660816|6201060|P1|Overall Study|Adverse Event|1
1781290|NCT00660699|6201072|P1|Overall Study|Withdrawal by Subject|2
1781291|NCT00660660|6201088|P2|Overall Study|New medication after randomization|0
1781292|NCT00660660|6201089|P1|Overall Study|New medication after randomization|1
1781293|NCT00660660|6201088|P2|Overall Study|Incorrect enrollment and other|1
1781294|NCT00660660|6201089|P1|Overall Study|Incorrect enrollment and other|0
1781295|NCT00660660|6201088|P2|Overall Study|Withdrawal by Subject|0
1781296|NCT00660660|6201089|P1|Overall Study|Withdrawal by Subject|3
1781297|NCT00660660|6201088|P2|Overall Study|Lack of Efficacy|2
1781298|NCT00660660|6201089|P1|Overall Study|Lack of Efficacy|0
1781299|NCT00660660|6201088|P2|Overall Study|Lost to Follow-up|6
1781300|NCT00660660|6201089|P1|Overall Study|Lost to Follow-up|0
1781301|NCT00660660|6201088|P2|Overall Study|Adverse Event|0
1781302|NCT00660660|6201089|P1|Overall Study|Adverse Event|1
1781303|NCT00660595|6201189|P2|Overall Study|Non Specified reasons|0
1781304|NCT00660595|6201190|P1|Overall Study|Non Specified reasons|5
1781305|NCT00660595|6201189|P2|Overall Study|Participant left hospital|0
1781306|NCT00660595|6201190|P1|Overall Study|Participant left hospital|1
1781307|NCT00660595|6201189|P2|Overall Study|Did not consent to participate in study|8
1781308|NCT00660595|6201190|P1|Overall Study|Did not consent to participate in study|12
1781309|NCT00660595|6201189|P2|Overall Study|Lost to Follow-up|1
1781310|NCT00660595|6201190|P1|Overall Study|Lost to Follow-up|0
1781311|NCT00660400|6201251|P1|Overall Study|Withdrawal by Subject|1
1781312|NCT00660400|6201251|P1|Overall Study|Intracranial hemorrhage|1
1781313|NCT00660400|6201251|P1|Overall Study|Suboptimal organ function|1
1781314|NCT00660400|6201251|P1|Overall Study|Lack of insurance approval|1
1781315|NCT00660387|6201260|P2|Overall Study|Protocol Violation|0
1781316|NCT00660387|6201261|P1|Overall Study|Protocol Violation|1
1781317|NCT00660387|6201260|P2|Overall Study|Lack of Efficacy|1
1781318|NCT00660387|6201261|P1|Overall Study|Lack of Efficacy|0
1781319|NCT00660387|6201260|P2|Overall Study|Adverse Event|2
1781320|NCT00660387|6201261|P1|Overall Study|Adverse Event|1
1781321|NCT00660348|6201315|P2|Overall Study|Withdrawal by Subject|0
1781322|NCT00660348|6201316|P1|Overall Study|Withdrawal by Subject|1
1781323|NCT00660309|6201324|P2|Overall Study|Withdrawal by Subject|3
1781324|NCT00660309|6201325|P1|Overall Study|Withdrawal by Subject|0
1781325|NCT00660309|6201324|P2|Overall Study|Adverse Event|0
1781326|NCT00660309|6201325|P1|Overall Study|Adverse Event|2
1781327|NCT00660192|6201366|P2|Overall Study|Lost to Follow-up|3
1781328|NCT00660192|6201367|P1|Overall Study|Lost to Follow-up|2
1781329|NCT00660179|6201378|P3|Overall Study|Incorrect randomization|0
1781330|NCT00660179|6201379|P2|Overall Study|Incorrect randomization|0
1781331|NCT00660179|6201380|P1|Overall Study|Incorrect randomization|1
1781332|NCT00660179|6201378|P3|Overall Study|Administrative reason|1
1781333|NCT00660179|6201379|P2|Overall Study|Administrative reason|0
1781334|NCT00660179|6201380|P1|Overall Study|Administrative reason|0
1781335|NCT00660179|6201378|P3|Overall Study|Lost to Follow-up|2
1781336|NCT00660179|6201379|P2|Overall Study|Lost to Follow-up|5
1781337|NCT00660179|6201380|P1|Overall Study|Lost to Follow-up|7
1781338|NCT00660179|6201378|P3|Overall Study|Withdrawal of consent|4
1781339|NCT00660179|6201379|P2|Overall Study|Withdrawal of consent|6
1781340|NCT00660179|6201380|P1|Overall Study|Withdrawal of consent|4
1781341|NCT00660179|6201378|P3|Overall Study|Death|34
1781342|NCT00660179|6201379|P2|Overall Study|Death|47
1781343|NCT00660179|6201380|P1|Overall Study|Death|44
1781344|NCT00660023|6201425|P1|Overall Study|Other Screening Failure|9
1781345|NCT00660023|6201425|P1|Overall Study|Missed Pregnancy Test|1
1781346|NCT00660023|6201425|P1|Overall Study|Withdrawal by Subject|1
1781347|NCT00660023|6201425|P1|Overall Study|Renal Transplantation|3
1781348|NCT00660023|6201425|P1|Overall Study|Blood Transfusion|5
1781349|NCT00660023|6201425|P1|Overall Study|Death|8
1781350|NCT00660023|6201425|P1|Overall Study|Adverse Event|2
1781351|NCT00660010|6201436|P1|Overall Study|Noncompliance with visit schedule|3
1781352|NCT00660010|6201436|P1|Overall Study|Adverse Event|1
1781353|NCT00660010|6201436|P1|Overall Study|Lost to Follow-up|3
1781354|NCT00660010|6201436|P1|Overall Study|Withdrawal by Subject|2
1781355|NCT00659984|6201450|P1|Overall Study|Adverse Event|1
1781356|NCT00659880|6201470|P1|Overall Study|Lost to Follow-up|5
1781357|NCT00659815|6201483|P2|Overall Study|Withdrawal by Subject|1
1781358|NCT00659815|6201484|P1|Overall Study|Withdrawal by Subject|1
1781359|NCT00659815|6201483|P2|Overall Study|Inability to maintain wearing schedule|2
1781360|NCT00659815|6201484|P1|Overall Study|Inability to maintain wearing schedule|1
1781361|NCT00659815|6201483|P2|Overall Study|Study related symptoms and complaints|1
1781362|NCT00659815|6201484|P1|Overall Study|Study related symptoms and complaints|2
1781363|NCT00659607|6201544|P1|Overall Study|Inconsistent BP measuring date|2
1781364|NCT00659607|6201544|P1|Overall Study|No recorded efficacy data|15
1781365|NCT00659607|6201544|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
1781366|NCT00659607|6201544|P1|Overall Study|Unknown measuring date of blood pressure|85
1781367|NCT00659607|6201544|P1|Overall Study|No blood pressure recorded|147
1781368|NCT00659581|6201562|P1|Overall Study|Other|6393
1781369|NCT00659581|6201562|P1|Overall Study|Lack of Efficacy|1183
1781370|NCT00659581|6201562|P1|Overall Study|Adverse Event|1006
1781371|NCT00659529|6201574|P1|Overall Study|Screen failure|9
1781372|NCT00659529|6201574|P1|Overall Study|Protocol Violation|3
1781373|NCT00659529|6201574|P1|Overall Study|Withdrawal by Subject|4
1781374|NCT00659490|6201581|P3|Overall Study|Lost to Follow-up|1
1781375|NCT00659490|6201582|P2|Overall Study|Lost to Follow-up|0
1781376|NCT00659490|6201583|P1|Overall Study|Lost to Follow-up|2
1781377|NCT00659438|6201656|P2|Overall Study|Lost to Follow-up|0
1781378|NCT00659438|6201657|P1|Overall Study|Lost to Follow-up|1
1781379|NCT00659438|6201656|P2|Overall Study|Death|6
1781380|NCT00659438|6201657|P1|Overall Study|Death|11
1781381|NCT00659438|6201656|P2|Overall Study|Withdrawal by Subject|2
1781382|NCT00659438|6201657|P1|Overall Study|Withdrawal by Subject|2
1781383|NCT00659425|6201689|P10|Overall Study|Other|6
1781384|NCT00659425|6201690|P9|Overall Study|Other|0
1781385|NCT00659425|6201691|P8|Overall Study|Other|2
1781386|NCT00659425|6201692|P7|Overall Study|Other|3
1781387|NCT00659425|6201693|P6|Overall Study|Other|0
1781388|NCT00659425|6201694|P5|Overall Study|Other|4
1781389|NCT00659425|6201695|P4|Overall Study|Other|2
1781390|NCT00659425|6201696|P3|Overall Study|Other|1
1781391|NCT00659425|6201697|P2|Overall Study|Other|1
1781392|NCT00659425|6201698|P1|Overall Study|Other|0
1781393|NCT00659425|6201689|P10|Overall Study|Investigator Discretion|0
1781394|NCT00659425|6201690|P9|Overall Study|Investigator Discretion|0
1781395|NCT00659425|6201691|P8|Overall Study|Investigator Discretion|3
1781396|NCT00659425|6201692|P7|Overall Study|Investigator Discretion|0
1781397|NCT00659425|6201693|P6|Overall Study|Investigator Discretion|1
1781398|NCT00659425|6201694|P5|Overall Study|Investigator Discretion|0
1781399|NCT00659425|6201695|P4|Overall Study|Investigator Discretion|0
1781400|NCT00659425|6201696|P3|Overall Study|Investigator Discretion|0
1781401|NCT00659425|6201697|P2|Overall Study|Investigator Discretion|0
1781402|NCT00659425|6201698|P1|Overall Study|Investigator Discretion|0
1781403|NCT00659425|6201689|P10|Overall Study|Adverse Event|4
1781404|NCT00659425|6201690|P9|Overall Study|Adverse Event|1
1781405|NCT00659425|6201691|P8|Overall Study|Adverse Event|3
1781406|NCT00659425|6201692|P7|Overall Study|Adverse Event|0
1781407|NCT00659425|6201693|P6|Overall Study|Adverse Event|1
1781408|NCT00659425|6201694|P5|Overall Study|Adverse Event|0
1781409|NCT00659425|6201695|P4|Overall Study|Adverse Event|0
1781410|NCT00659425|6201696|P3|Overall Study|Adverse Event|0
1781411|NCT00659425|6201697|P2|Overall Study|Adverse Event|0
1781412|NCT00659425|6201698|P1|Overall Study|Adverse Event|0
1781413|NCT00659425|6201689|P10|Overall Study|Death|0
1781414|NCT00659425|6201690|P9|Overall Study|Death|0
1781415|NCT00659425|6201691|P8|Overall Study|Death|0
1781416|NCT00659425|6201692|P7|Overall Study|Death|1
1781417|NCT00659425|6201693|P6|Overall Study|Death|0
1781418|NCT00659425|6201694|P5|Overall Study|Death|0
1781419|NCT00659425|6201695|P4|Overall Study|Death|1
1781420|NCT00659425|6201696|P3|Overall Study|Death|0
1781421|NCT00659425|6201697|P2|Overall Study|Death|0
1781422|NCT00659425|6201698|P1|Overall Study|Death|0
1781423|NCT00659425|6201689|P10|Overall Study|Disease progression|3
1781424|NCT00659425|6201690|P9|Overall Study|Disease progression|5
1781425|NCT00659425|6201691|P8|Overall Study|Disease progression|3
1781426|NCT00659425|6201692|P7|Overall Study|Disease progression|4
1781427|NCT00659425|6201693|P6|Overall Study|Disease progression|2
1781428|NCT00659425|6201694|P5|Overall Study|Disease progression|0
1781429|NCT00659425|6201695|P4|Overall Study|Disease progression|1
1781430|NCT00659425|6201696|P3|Overall Study|Disease progression|0
1781431|NCT00659425|6201697|P2|Overall Study|Disease progression|0
1781432|NCT00659425|6201698|P1|Overall Study|Disease progression|1
1781433|NCT00659373|6201929|P2|Overall Study|Assessment Missed|2
1781434|NCT00659373|6201930|P1|Overall Study|Assessment Missed|2
1781435|NCT00659373|6201929|P2|Overall Study|Withdrawal by Subject|5
1781436|NCT00659373|6201930|P1|Overall Study|Withdrawal by Subject|3
1781437|NCT00659334|6201952|P7|Overall Study|Screen Failure|1
1781438|NCT00659334|6201953|P6|Overall Study|Screen Failure|0
1781439|NCT00659334|6201954|P5|Overall Study|Screen Failure|0
1781440|NCT00659334|6201955|P4|Overall Study|Screen Failure|0
1781441|NCT00659334|6201956|P3|Overall Study|Screen Failure|0
1781442|NCT00659334|6201957|P2|Overall Study|Screen Failure|5
1781443|NCT00659334|6201958|P1|Overall Study|Screen Failure|8
1781444|NCT00659269|6201985|P2|Overall Study|Physician Decision|1
1781445|NCT00659269|6201986|P1|Overall Study|Physician Decision|1
1781446|NCT00659230|6202016|P2|Overall Study|Did not return post-randomization|3
1781447|NCT00659230|6202017|P1|Overall Study|Did not return post-randomization|2
1781448|NCT00659230|6202016|P2|Overall Study|Lost source documentation|4
1781449|NCT00659230|6202017|P1|Overall Study|Lost source documentation|5
1781450|NCT00659230|6202016|P2|Overall Study|Lost to Follow-up|5
1781451|NCT00659230|6202017|P1|Overall Study|Lost to Follow-up|2
1781452|NCT00659061|6202040|P2|Overall Study|Migration due to political unrest|15
1781453|NCT00659061|6202041|P1|Overall Study|Migration due to political unrest|21
1781454|NCT00658996|6202059|P2|Second Intervention|Positive slit lamp finding|1
1781455|NCT00658996|6202060|P1|Second Intervention|Positive slit lamp finding|0
1781456|NCT00658996|6202059|P2|Second Intervention|Developed a stye on upper lid|0
1781457|NCT00658996|6202060|P1|Second Intervention|Developed a stye on upper lid|1
1781458|NCT00658996|6202059|P2|Crossover Period|Ineligible|1
1781459|NCT00658996|6202060|P1|Crossover Period|Ineligible|1
1781460|NCT00658996|6202059|P2|Crossover Period|Physician Decision|0
1781461|NCT00658996|6202060|P1|Crossover Period|Physician Decision|1
1781462|NCT00658996|6202059|P2|First Intervention|Lack of lenses|1
1781463|NCT00658996|6202060|P1|First Intervention|Lack of lenses|0
1781464|NCT00658996|6202059|P2|First Intervention|Positive slit lamp finding|0
1781465|NCT00658996|6202060|P1|First Intervention|Positive slit lamp finding|1
1781466|NCT00658879|6202070|P1|Overall Study|Protocol Violation|1
1781489|NCT00658788|6202102|P1|Overall Study|Treatment Discontinuation|32
1781490|NCT00658788|6202102|P1|Overall Study|Lost to Follow-up|18
1781491|NCT00658788|6202102|P1|Overall Study|Withdrawal by Subject|13
1781492|NCT00658788|6202102|P1|Overall Study|Adverse Event|11
1781493|NCT00658775|6202157|P2|Overall Study|Other|8
1781494|NCT00658775|6202158|P1|Overall Study|Other|7
1781495|NCT00658775|6202157|P2|Overall Study|Withdrawal of consent|7
1781496|NCT00658775|6202158|P1|Overall Study|Withdrawal of consent|8
1781497|NCT00658775|6202157|P2|Overall Study|Withdrawal by Subject|4
1781498|NCT00658775|6202158|P1|Overall Study|Withdrawal by Subject|6
1781499|NCT00658775|6202157|P2|Overall Study|Lost to Follow-up|18
1781500|NCT00658775|6202158|P1|Overall Study|Lost to Follow-up|17
1781501|NCT00658775|6202157|P2|Overall Study|Adverse Event|6
1781502|NCT00658775|6202158|P1|Overall Study|Adverse Event|4
1781503|NCT00658723|6202181|P3|Overall Study|Withdrawal by Subject|1
1781504|NCT00658723|6202182|P2|Overall Study|Withdrawal by Subject|0
1781505|NCT00658723|6202183|P1|Overall Study|Withdrawal by Subject|1
1781506|NCT00658723|6202181|P3|Overall Study|Scheduling Issue|0
1781507|NCT00658723|6202182|P2|Overall Study|Scheduling Issue|1
1781508|NCT00658723|6202183|P1|Overall Study|Scheduling Issue|1
1781509|NCT00658723|6202181|P3|Overall Study|Death|4
1781510|NCT00658723|6202182|P2|Overall Study|Death|1
1781511|NCT00658723|6202183|P1|Overall Study|Death|2
1781512|NCT00658723|6202181|P3|Overall Study|Lost to Follow-up|2
1781513|NCT00658723|6202182|P2|Overall Study|Lost to Follow-up|2
1781514|NCT00658723|6202183|P1|Overall Study|Lost to Follow-up|0
1781515|NCT00658684|6202221|P4|Overall Study|Pregnancy|0
1781516|NCT00658684|6202222|P3|Overall Study|Pregnancy|0
1781517|NCT00658684|6202223|P2|Overall Study|Pregnancy|1
1781518|NCT00658684|6202224|P1|Overall Study|Pregnancy|1
1781519|NCT00658684|6202221|P4|Overall Study|Protocol Violation|0
1781520|NCT00658684|6202222|P3|Overall Study|Protocol Violation|0
1781521|NCT00658684|6202223|P2|Overall Study|Protocol Violation|1
1781522|NCT00658684|6202224|P1|Overall Study|Protocol Violation|1
1781523|NCT00658684|6202221|P4|Overall Study|Lack of Efficacy|0
1781524|NCT00658684|6202222|P3|Overall Study|Lack of Efficacy|0
1781525|NCT00658684|6202223|P2|Overall Study|Lack of Efficacy|1
1781526|NCT00658684|6202224|P1|Overall Study|Lack of Efficacy|1
1781527|NCT00658684|6202221|P4|Overall Study|Withdrawal by Subject|1
1781528|NCT00658684|6202222|P3|Overall Study|Withdrawal by Subject|1
1781529|NCT00658684|6202223|P2|Overall Study|Withdrawal by Subject|4
1781530|NCT00658684|6202224|P1|Overall Study|Withdrawal by Subject|6
1781531|NCT00658684|6202221|P4|Overall Study|Adverse Event|0
1781532|NCT00658684|6202222|P3|Overall Study|Adverse Event|2
1781533|NCT00658684|6202223|P2|Overall Study|Adverse Event|8
1781534|NCT00658684|6202224|P1|Overall Study|Adverse Event|10
1781535|NCT00658658|6202279|P5|Overall Study|Other|1
1781536|NCT00658658|6202280|P4|Overall Study|Other|0
1781537|NCT00658658|6202281|P3|Overall Study|Other|0
1781538|NCT00658658|6202282|P2|Overall Study|Other|0
1781539|NCT00658658|6202283|P1|Overall Study|Other|0
1781540|NCT00658658|6202279|P5|Overall Study|Protocol-specified Criteria|0
1781541|NCT00658658|6202280|P4|Overall Study|Protocol-specified Criteria|0
1781542|NCT00658658|6202281|P3|Overall Study|Protocol-specified Criteria|0
1781543|NCT00658658|6202282|P2|Overall Study|Protocol-specified Criteria|0
1781544|NCT00658658|6202283|P1|Overall Study|Protocol-specified Criteria|1
1781545|NCT00658658|6202279|P5|Overall Study|Disease Progression|3
1781546|NCT00658658|6202280|P4|Overall Study|Disease Progression|1
1781547|NCT00658658|6202281|P3|Overall Study|Disease Progression|0
1781548|NCT00658658|6202282|P2|Overall Study|Disease Progression|1
1781549|NCT00658658|6202283|P1|Overall Study|Disease Progression|0
1781550|NCT00658658|6202279|P5|Overall Study|Death|1
1781551|NCT00658658|6202280|P4|Overall Study|Death|1
1781552|NCT00658658|6202281|P3|Overall Study|Death|0
1781553|NCT00658658|6202282|P2|Overall Study|Death|0
1781554|NCT00658658|6202283|P1|Overall Study|Death|4
1781555|NCT00658658|6202279|P5|Overall Study|Withdrawal by Subject|0
1781556|NCT00658658|6202280|P4|Overall Study|Withdrawal by Subject|0
1781557|NCT00658658|6202281|P3|Overall Study|Withdrawal by Subject|0
1781558|NCT00658658|6202282|P2|Overall Study|Withdrawal by Subject|1
1781559|NCT00658658|6202283|P1|Overall Study|Withdrawal by Subject|0
1781560|NCT00658632|6202342|P2|Overall Study|Other|8
1781561|NCT00658632|6202343|P1|Overall Study|Other|7
1781562|NCT00658632|6202342|P2|Overall Study|Pregnancy|1
1781563|NCT00658632|6202343|P1|Overall Study|Pregnancy|1
1781564|NCT00658632|6202342|P2|Overall Study|Withdrawal of consent|14
1781565|NCT00658632|6202343|P1|Overall Study|Withdrawal of consent|8
1781566|NCT00658632|6202342|P2|Overall Study|Lack of Efficacy|1
1781567|NCT00658632|6202343|P1|Overall Study|Lack of Efficacy|0
1781568|NCT00658632|6202342|P2|Overall Study|Withdrawal by Subject|7
1781569|NCT00658632|6202343|P1|Overall Study|Withdrawal by Subject|10
1781570|NCT00658632|6202342|P2|Overall Study|Lost to Follow-up|23
1781571|NCT00658632|6202343|P1|Overall Study|Lost to Follow-up|25
1781572|NCT00658632|6202342|P2|Overall Study|Adverse Event|11
1781573|NCT00658632|6202343|P1|Overall Study|Adverse Event|13
1781574|NCT00658606|6202384|P2|Overall Study|Lack of Compliance|3
1781575|NCT00658606|6202385|P1|Overall Study|Lack of Compliance|0
1781576|NCT00658606|6202384|P2|Overall Study|Withdrawal by Subject|16
1781577|NCT00658606|6202385|P1|Overall Study|Withdrawal by Subject|7
1781578|NCT00658606|6202384|P2|Overall Study|Lost to Follow-up|0
1781579|NCT00658606|6202385|P1|Overall Study|Lost to Follow-up|1
1781580|NCT00658606|6202384|P2|Overall Study|Lack of Efficacy|3
1781581|NCT00658606|6202385|P1|Overall Study|Lack of Efficacy|6
1781582|NCT00658606|6202384|P2|Overall Study|Adverse Event|1
1781583|NCT00658606|6202385|P1|Overall Study|Adverse Event|2
1781584|NCT00658567|6202414|P3|Overall Study|At Discretion of Sponsor|1
1781585|NCT00658567|6202415|P2|Overall Study|At Discretion of Sponsor|1
1781586|NCT00658567|6202416|P1|Overall Study|At Discretion of Sponsor|1
1781587|NCT00658567|6202414|P3|Overall Study|Physician Decision|0
1781588|NCT00658567|6202415|P2|Overall Study|Physician Decision|1
1781589|NCT00658567|6202416|P1|Overall Study|Physician Decision|0
1781590|NCT00658567|6202414|P3|Overall Study|Voluntary Withdrawal of Consent|2
1781591|NCT00658567|6202415|P2|Overall Study|Voluntary Withdrawal of Consent|0
1781592|NCT00658567|6202416|P1|Overall Study|Voluntary Withdrawal of Consent|2
1781593|NCT00658567|6202414|P3|Overall Study|Adverse Event|3
1781594|NCT00658567|6202415|P2|Overall Study|Adverse Event|2
1781595|NCT00658567|6202416|P1|Overall Study|Adverse Event|5
1781596|NCT00658541|6202427|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1781597|NCT00658541|6202428|P1|Washout Period of 7 Days|Withdrawal by Subject|0
1781598|NCT00658541|6202427|P2|Washout Period of 7 Days|Withdrawal by Subject|1
1781599|NCT00658541|6202428|P1|Washout Period of 7 Days|Withdrawal by Subject|1
1781600|NCT00658528|6202440|P2|Overall Study|Other|4
1781601|NCT00658528|6202441|P1|Overall Study|Other|8
1781602|NCT00658528|6202440|P2|Overall Study|Withdrawal of consent|6
1781603|NCT00658528|6202441|P1|Overall Study|Withdrawal of consent|5
1781604|NCT00658528|6202440|P2|Overall Study|Withdrawal by Subject|6
1781605|NCT00658528|6202441|P1|Overall Study|Withdrawal by Subject|8
1781606|NCT00658528|6202440|P2|Overall Study|Lost to Follow-up|22
1781607|NCT00658528|6202441|P1|Overall Study|Lost to Follow-up|14
1781608|NCT00658528|6202440|P2|Overall Study|Adverse Event|7
1781609|NCT00658528|6202441|P1|Overall Study|Adverse Event|5
1781610|NCT00658359|6202481|P3|Overall Study|Lack of Efficacy|0
1781611|NCT00658359|6202482|P2|Overall Study|Lack of Efficacy|1
1781612|NCT00658359|6202483|P1|Overall Study|Lack of Efficacy|0
1781613|NCT00658359|6202481|P3|Overall Study|Lost to Follow-up|4
1781614|NCT00658359|6202482|P2|Overall Study|Lost to Follow-up|2
1781615|NCT00658359|6202483|P1|Overall Study|Lost to Follow-up|2
1781616|NCT00658359|6202481|P3|Overall Study|Withdrawal by Subject|2
1781617|NCT00658359|6202482|P2|Overall Study|Withdrawal by Subject|4
1781618|NCT00658359|6202483|P1|Overall Study|Withdrawal by Subject|7
1781619|NCT00658359|6202481|P3|Overall Study|Includes protocol Amendments 3 and 4|29
1781620|NCT00658359|6202482|P2|Overall Study|Includes protocol Amendments 3 and 4|31
1781621|NCT00658359|6202483|P1|Overall Study|Includes protocol Amendments 3 and 4|2
1781622|NCT00658359|6202481|P3|Overall Study|Protocol Violation|0
1781623|NCT00658359|6202482|P2|Overall Study|Protocol Violation|0
1781624|NCT00658359|6202483|P1|Overall Study|Protocol Violation|1
1781625|NCT00658359|6202481|P3|Overall Study|Adverse Event|9
1781626|NCT00658359|6202482|P2|Overall Study|Adverse Event|6
1781627|NCT00658359|6202483|P1|Overall Study|Adverse Event|13
1781628|NCT00658359|6202481|P3|Overall Study|Death|2
1781629|NCT00658359|6202482|P2|Overall Study|Death|1
1781630|NCT00658359|6202483|P1|Overall Study|Death|3
1781631|NCT00658333|6202571|P2|Overall Study|Adverse Event|1
1781632|NCT00658333|6202572|P1|Overall Study|Adverse Event|2
1781633|NCT00658320|6202582|P2|Extension Study: After Month 24|Subject withdrew consent|0
1781634|NCT00658320|6202583|P1|Extension Study: After Month 24|Subject withdrew consent|2
1781635|NCT00658320|6202582|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
1781636|NCT00658320|6202583|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
1781637|NCT00658320|6202582|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
1781638|NCT00658320|6202583|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
1781639|NCT00658320|6202582|P2|Core Study: 12 Months|Subject withdrew consent|3
1781640|NCT00658320|6202583|P1|Core Study: 12 Months|Subject withdrew consent|5
1781641|NCT00657709|6202626|P5|Overall Study|Protocol Violation|2
1781642|NCT00657709|6202627|P4|Overall Study|Protocol Violation|1
1781643|NCT00657709|6202628|P3|Overall Study|Protocol Violation|0
1781644|NCT00657709|6202629|P2|Overall Study|Protocol Violation|2
1781645|NCT00657709|6202630|P1|Overall Study|Protocol Violation|0
1781646|NCT00657709|6202626|P5|Overall Study|Lost to Follow-up|21
1781647|NCT00657709|6202627|P4|Overall Study|Lost to Follow-up|1
1781648|NCT00657709|6202628|P3|Overall Study|Lost to Follow-up|7
1781649|NCT00657709|6202629|P2|Overall Study|Lost to Follow-up|9
1781650|NCT00657709|6202630|P1|Overall Study|Lost to Follow-up|9
1781651|NCT00657709|6202626|P5|Overall Study|Withdrawal by Subject|9
1781652|NCT00657709|6202627|P4|Overall Study|Withdrawal by Subject|5
1781653|NCT00657709|6202628|P3|Overall Study|Withdrawal by Subject|15
1781654|NCT00657709|6202629|P2|Overall Study|Withdrawal by Subject|15
1781655|NCT00657709|6202630|P1|Overall Study|Withdrawal by Subject|7
1781656|NCT00657709|6202626|P5|Overall Study|AE or Death|1
1781657|NCT00657709|6202627|P4|Overall Study|AE or Death|7
1781658|NCT00657709|6202628|P3|Overall Study|AE or Death|6
1781659|NCT00657709|6202629|P2|Overall Study|AE or Death|7
1781660|NCT00657709|6202630|P1|Overall Study|AE or Death|7
1781661|NCT00657618|6202679|P1|Overall Study|didn't start due to schedule conflicts|1
1781662|NCT00657618|6202679|P1|Overall Study|negative for leishmaniasis|2
1781663|NCT00657618|6202679|P1|Overall Study|Withdrawal by Subject|8
1781664|NCT00657618|6202679|P1|Overall Study|Adverse Event|32
1781665|NCT00657553|6202691|P2|Overall Study|low accrual, no analysis run|5
1781666|NCT00657553|6202692|P1|Overall Study|low accrual, no analysis run|5
1781667|NCT00657540|6202700|P2|Overall Study|Lost to Follow-up|4
1781668|NCT00657540|6202701|P1|Overall Study|Lost to Follow-up|1
1781669|NCT00657371|6202715|P1|Overall Study|Pre-existing medical condition|4
1781670|NCT00657371|6202715|P1|Overall Study|Device- related reasons|13
1781671|NCT00657371|6202715|P1|Overall Study|Protocol Violation|2
1781672|NCT00657371|6202715|P1|Overall Study|Unable to intubate the cecum|5
1781673|NCT00657371|6202715|P1|Overall Study|Poor bowel preparation|15
1781674|NCT00657358|6202720|P1|Overall Study|Lack of Efficacy|6
1781675|NCT00657267|6202732|P1|Overall Study|Adverse Event|9
1781676|NCT00657267|6202732|P1|Overall Study|Progressive disease|45
1781677|NCT00657150|6202742|P2|Treatment|Other|15
1781678|NCT00657150|6202743|P1|Treatment|Other|13
1781679|NCT00657150|6202742|P2|Treatment|Withdrawal by Subject|20
1781680|NCT00657150|6202743|P1|Treatment|Withdrawal by Subject|23
1781681|NCT00657150|6202742|P2|Treatment|Lost to Follow-up|0
1781682|NCT00657150|6202743|P1|Treatment|Lost to Follow-up|1
1781683|NCT00657150|6202742|P2|Treatment|Non-compliant with protocol|9
1781684|NCT00657150|6202743|P1|Treatment|Non-compliant with protocol|10
1781685|NCT00657150|6202742|P2|Treatment|Adverse Event|53
1781686|NCT00657150|6202743|P1|Treatment|Adverse Event|60
1781687|NCT00657150|6202742|P2|Overall Study|Other|38
1781688|NCT00657150|6202743|P1|Overall Study|Other|38
1781689|NCT00657150|6202742|P2|Overall Study|Withdrawal by Subject|36
1781690|NCT00657150|6202743|P1|Overall Study|Withdrawal by Subject|51
1781691|NCT00657150|6202742|P2|Overall Study|Lost to Follow-up|0
1781692|NCT00657150|6202743|P1|Overall Study|Lost to Follow-up|2
1781693|NCT00657150|6202742|P2|Overall Study|Non-compliant with protocol|9
1781694|NCT00657150|6202743|P1|Overall Study|Non-compliant with protocol|5
1781695|NCT00657150|6202742|P2|Overall Study|Adverse Event|10
1781696|NCT00657150|6202743|P1|Overall Study|Adverse Event|19
1781697|NCT00657046|6202774|P3|Overall Study|Surgery|1
1781698|NCT00657046|6202775|P2|Overall Study|Surgery|0
1781699|NCT00657046|6202776|P1|Overall Study|Surgery|0
1781700|NCT00657046|6202774|P3|Overall Study|Death|1
1781701|NCT00657046|6202775|P2|Overall Study|Death|0
1781702|NCT00657046|6202776|P1|Overall Study|Death|0
1781703|NCT00657046|6202774|P3|Overall Study|Withdrawal by Subject|0
1781704|NCT00657046|6202775|P2|Overall Study|Withdrawal by Subject|0
1781705|NCT00657046|6202776|P1|Overall Study|Withdrawal by Subject|1
1781706|NCT00657046|6202774|P3|Overall Study|Protocol Violation|0
1781707|NCT00657046|6202775|P2|Overall Study|Protocol Violation|2
1781708|NCT00657046|6202776|P1|Overall Study|Protocol Violation|2
1781709|NCT00657046|6202774|P3|Overall Study|Adverse Event|0
1781710|NCT00657046|6202775|P2|Overall Study|Adverse Event|1
1781711|NCT00657046|6202776|P1|Overall Study|Adverse Event|1
1781712|NCT00657020|6202808|P2|PERIOD 1|Adverse Event|1
1781713|NCT00657020|6202809|P1|PERIOD 1|Adverse Event|0
1781714|NCT00656851|6202859|P2|Overall Study|Withdrawal by Subject|4
1781715|NCT00656851|6202860|P1|Overall Study|Withdrawal by Subject|0
1781716|NCT00656799|6202882|P1|Overall Study|Death|2
1781717|NCT00656669|6202904|P1|AC (Cycles 6-9)|Did not start segment 3|1
1781718|NCT00656669|6202904|P1|AC (Cycles 6-9)|Adverse Event|1
1781719|NCT00656669|6202904|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
1781720|NCT00656669|6202904|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
1781721|NCT00656617|6202943|P1|Overall Study|Move to different clinical trial|2
1781722|NCT00656617|6202943|P1|Overall Study|Insurance Issues|2
1781723|NCT00656617|6202943|P1|Overall Study|Death|2
1781724|NCT00656617|6202943|P1|Overall Study|Adverse Event|1
1781725|NCT00656513|6202952|P3|Overall Study|Missing baseline form|5
1781726|NCT00656513|6202953|P2|Overall Study|Missing baseline form|5
1781727|NCT00656513|6202954|P1|Overall Study|Missing baseline form|0
1781728|NCT00656513|6202952|P3|Overall Study|Treatment completed outside of timeframe|1
1781729|NCT00656513|6202953|P2|Overall Study|Treatment completed outside of timeframe|3
1781730|NCT00656513|6202954|P1|Overall Study|Treatment completed outside of timeframe|0
1781731|NCT00656513|6202952|P3|Overall Study|Incomplete treatment|0
1781732|NCT00656513|6202953|P2|Overall Study|Incomplete treatment|0
1781733|NCT00656513|6202954|P1|Overall Study|Incomplete treatment|3
1781734|NCT00656513|6202952|P3|Overall Study|Missing data|9
1781735|NCT00656513|6202953|P2|Overall Study|Missing data|11
1781736|NCT00656513|6202954|P1|Overall Study|Missing data|0
1781737|NCT00656513|6202952|P3|Overall Study|Death|1
1781738|NCT00656513|6202953|P2|Overall Study|Death|0
1781739|NCT00656513|6202954|P1|Overall Study|Death|0
1781740|NCT00656513|6202952|P3|Overall Study|Withdrawal by Subject|4
1781741|NCT00656513|6202953|P2|Overall Study|Withdrawal by Subject|11
1781742|NCT00656513|6202954|P1|Overall Study|Withdrawal by Subject|0
1781743|NCT00656513|6202952|P3|Overall Study|Protocol Violation|2
1781744|NCT00656513|6202953|P2|Overall Study|Protocol Violation|0
1781745|NCT00656513|6202954|P1|Overall Study|Protocol Violation|1
1781746|NCT00656474|6203001|P1|Overall Study|Other Reason|1
1781747|NCT00656370|6203019|P1|Overall Study|Alternates|3
1781748|NCT00656370|6203019|P1|Overall Study|Screen Failures|7
1781749|NCT00656292|6203048|P2|Overall Study|Screen failure|2
1781750|NCT00656292|6203049|P1|Overall Study|Screen failure|1
1781751|NCT00656292|6203048|P2|Overall Study|Withdrawal by Subject|3
1781752|NCT00656292|6203049|P1|Overall Study|Withdrawal by Subject|2
1781753|NCT00656175|6203076|P2|Overall Study|Transportation issues|1
1781754|NCT00656175|6203077|P1|Overall Study|Transportation issues|0
1781755|NCT00656175|6203076|P2|Overall Study|Adverse Event|0
1781756|NCT00656175|6203077|P1|Overall Study|Adverse Event|1
1781757|NCT00656136|6203085|P2|Overall Study|Unknown and others|4
1781758|NCT00656136|6203086|P1|Overall Study|Unknown and others|4
1781759|NCT00656136|6203085|P2|Overall Study|Patient refused to take study medication|10
1781760|NCT00656136|6203086|P1|Overall Study|Patient refused to take study medication|7
1781761|NCT00656136|6203085|P2|Overall Study|Protocol Violation|3
1781762|NCT00656136|6203086|P1|Overall Study|Protocol Violation|2
1781763|NCT00656136|6203085|P2|Overall Study|Other Adverse Event|51
1781764|NCT00656136|6203086|P1|Overall Study|Other Adverse Event|5
1781765|NCT00656136|6203085|P2|Overall Study|Progressive disease|322
1781766|NCT00656136|6203086|P1|Overall Study|Progressive disease|177
1781767|NCT00656084|6203096|P1|Overall Study|Investigator Request|1
1781768|NCT00656084|6203096|P1|Overall Study|Patient Request|1
1781769|NCT00656084|6203096|P1|Overall Study|Withdrawal by Subject|1
1781770|NCT00656084|6203096|P1|Overall Study|Adverse Event|4
1781771|NCT00656058|6203103|P1|Overall Study|Withdrawal by Subject|4
1781772|NCT00656058|6203103|P1|Overall Study|Withdrawal by Subject|2
1781773|NCT00656019|6203116|P4|Overall Study|Lost to Follow-up|0
1781774|NCT00656019|6203117|P3|Overall Study|Lost to Follow-up|0
1781775|NCT00656019|6203118|P2|Overall Study|Lost to Follow-up|1
1781776|NCT00656019|6203119|P1|Overall Study|Lost to Follow-up|2
1781777|NCT00656019|6203116|P4|Overall Study|Withdrawal by Subject|0
1781778|NCT00656019|6203117|P3|Overall Study|Withdrawal by Subject|0
1781779|NCT00656019|6203118|P2|Overall Study|Withdrawal by Subject|0
1781780|NCT00656019|6203119|P1|Overall Study|Withdrawal by Subject|2
1781781|NCT00656019|6203116|P4|Overall Study|Not Eligible|0
1781782|NCT00656019|6203117|P3|Overall Study|Not Eligible|0
1781783|NCT00656019|6203118|P2|Overall Study|Not Eligible|0
1781784|NCT00656019|6203119|P1|Overall Study|Not Eligible|10
1781785|NCT00655928|6203131|P2|Overall Study|Physician Decision|1
1781786|NCT00655928|6203132|P1|Overall Study|Physician Decision|1
1781787|NCT00655928|6203131|P2|Overall Study|Withdrawal by Subject|1
1781788|NCT00655928|6203132|P1|Overall Study|Withdrawal by Subject|2
1781789|NCT00655889|6203138|P1|Overall Study|Protocol Violation|1
1781790|NCT00655889|6203138|P1|Overall Study|Inadequate cell growth|1
1781791|NCT00655876|6203145|P2|Overall Study|Protocol Violation|7
1781792|NCT00655876|6203146|P1|Overall Study|Protocol Violation|9
1781793|NCT00655863|6203165|P3|Overall Study|Lost to Follow-up|1
1781794|NCT00655863|6203166|P2|Overall Study|Lost to Follow-up|0
1781795|NCT00655863|6203167|P1|Overall Study|Lost to Follow-up|0
1781796|NCT00655850|6203226|P1|Overall Study|Withdrawal by Subject|1
1781797|NCT00655850|6203226|P1|Overall Study|Death|2
1781798|NCT00655824|6203233|P1|Overall Study|Deterioration of Trial Disease|2
1781799|NCT00655824|6203233|P1|Overall Study|Withdrawal by Subject|4
1781800|NCT00655824|6203233|P1|Overall Study|Protocol Violation|1
1781801|NCT00655824|6203233|P1|Overall Study|Early Termination of Study by Sponsor|74
1781802|NCT00655824|6203233|P1|Overall Study|Adverse Event|3
1781803|NCT00655746|6203281|P1|Overall Study|Withdrawal by Subject|1
1781804|NCT00655733|6203300|P2|Overall Study|Physician Decision|1
1781805|NCT00655733|6203301|P1|Overall Study|Physician Decision|0
1781806|NCT00655733|6203300|P2|Overall Study|Withdrawal by Subject|3
1781807|NCT00655733|6203301|P1|Overall Study|Withdrawal by Subject|3
1781808|NCT00655733|6203300|P2|Overall Study|Adverse Event|2
1781809|NCT00655733|6203301|P1|Overall Study|Adverse Event|2
1781810|NCT00655733|6203300|P2|Overall Study|Lost to Follow-up|2
1781811|NCT00655733|6203301|P1|Overall Study|Lost to Follow-up|2
1781812|NCT00655668|6203334|P1|Overall Study|Withdrawal by Subject|2
1781813|NCT00655668|6203334|P1|Overall Study|New Lymphoma Treatment Started|4
1781814|NCT00655668|6203334|P1|Overall Study|Other|1
1781815|NCT00655668|6203334|P1|Overall Study|Study Terminated|9
1781816|NCT00655668|6203334|P1|Overall Study|Disease Progression|27
1781817|NCT00655668|6203334|P1|Overall Study|Death|5
1781818|NCT00655668|6203334|P1|Overall Study|Adverse Event|6
1781819|NCT00655629|6203361|P2|Overall Study|consent withdrawn|4
1781820|NCT00655629|6203362|P1|Overall Study|consent withdrawn|6
1781821|NCT00655629|6203361|P2|Overall Study|Protocol Violation|3
1781822|NCT00655629|6203362|P1|Overall Study|Protocol Violation|5
1781823|NCT00655629|6203361|P2|Overall Study|Lost to Follow-up|3
1781824|NCT00655629|6203362|P1|Overall Study|Lost to Follow-up|4
1781825|NCT00655629|6203361|P2|Overall Study|Lack of Efficacy|12
1781826|NCT00655629|6203362|P1|Overall Study|Lack of Efficacy|2
1781827|NCT00655629|6203361|P2|Overall Study|Adverse Event|1
1781828|NCT00655629|6203362|P1|Overall Study|Adverse Event|4
1781829|NCT00655564|6203398|P1|Overall Study|Desired Alternate Therapy|1
1781830|NCT00655564|6203398|P1|Overall Study|Lost to Follow-up|1
1781831|NCT00655564|6203398|P1|Overall Study|Adverse Event|1
1781832|NCT00655551|6203406|P3|Period 4 (up to 7 Days)|Adverse Event|0
1781833|NCT00655551|6203407|P2|Period 4 (up to 7 Days)|Adverse Event|2
1781834|NCT00655551|6203408|P1|Period 4 (up to 7 Days)|Adverse Event|0
1781835|NCT00655551|6203406|P3|Period 3 (up to 7 Days)|Adverse Event|4
1781836|NCT00655551|6203407|P2|Period 3 (up to 7 Days)|Adverse Event|0
1781837|NCT00655551|6203408|P1|Period 3 (up to 7 Days)|Adverse Event|0
1781838|NCT00655551|6203406|P3|Period 2 (up to 7 Days)|Adverse Event|0
1781839|NCT00655551|6203407|P2|Period 2 (up to 7 Days)|Adverse Event|1
1781840|NCT00655551|6203408|P1|Period 2 (up to 7 Days)|Adverse Event|0
1781841|NCT00655551|6203406|P3|All Periods Combined|Adverse Event|4
1781842|NCT00655551|6203407|P2|All Periods Combined|Adverse Event|3
1781843|NCT00655551|6203408|P1|All Periods Combined|Adverse Event|0
1781844|NCT00655486|6203445|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
1781845|NCT00655486|6203445|P1|Overall Study|Other: Could not tolerate BID dosing|1
1781846|NCT00655486|6203445|P1|Overall Study|Other: Pregnancy|1
1781847|NCT00655486|6203445|P1|Overall Study|Unsatisfactory compliance|2
1781848|NCT00655486|6203445|P1|Overall Study|Protocol Violation|1
1781849|NCT00655486|6203445|P1|Overall Study|Withdrawal by Subject|4
1781850|NCT00655486|6203445|P1|Overall Study|Lack of Efficacy|8
1781851|NCT00655486|6203445|P1|Overall Study|Adverse Event|10
1781852|NCT00655356|6203473|P2|Overall Study|Other Reason|0
1781853|NCT00655356|6203474|P1|Overall Study|Other Reason|1
1781854|NCT00655356|6203473|P2|Overall Study|Protocol Violation|1
1781855|NCT00655356|6203474|P1|Overall Study|Protocol Violation|2
1781856|NCT00655356|6203473|P2|Overall Study|Adverse Event|1
1781857|NCT00655356|6203474|P1|Overall Study|Adverse Event|1
1781858|NCT00655356|6203473|P2|Overall Study|Sponsor Request|4
1781859|NCT00655356|6203474|P1|Overall Study|Sponsor Request|10
1781860|NCT00655356|6203473|P2|Overall Study|Withdrawal by Subject|4
1781861|NCT00655356|6203474|P1|Overall Study|Withdrawal by Subject|3
1781862|NCT00654940|6203525|P2|Period 1|Intolerable Pain Level|0
1781863|NCT00654940|6203526|P1|Period 1|Intolerable Pain Level|1
1781864|NCT00654940|6203525|P2|Period 1|Adverse Event|1
1781865|NCT00654940|6203526|P1|Period 1|Adverse Event|0
1781866|NCT00654901|6203550|P4|Overall Study|Withdrawal by Subject|0
1781867|NCT00654901|6203551|P3|Overall Study|Withdrawal by Subject|1
1781868|NCT00654901|6203552|P2|Overall Study|Withdrawal by Subject|0
1781869|NCT00654901|6203553|P1|Overall Study|Withdrawal by Subject|3
1781870|NCT00654901|6203550|P4|Overall Study|Lost to Follow-up|0
1781871|NCT00654901|6203551|P3|Overall Study|Lost to Follow-up|1
1781872|NCT00654901|6203552|P2|Overall Study|Lost to Follow-up|0
1781873|NCT00654901|6203553|P1|Overall Study|Lost to Follow-up|1
1781874|NCT00654875|6203573|P2|Overall Study|Administrative Problems|0
1781875|NCT00654875|6203574|P1|Overall Study|Administrative Problems|1
1781876|NCT00654875|6203573|P2|Overall Study|Abnormal Test Procedure Result(s)|0
1781877|NCT00654875|6203574|P1|Overall Study|Abnormal Test Procedure Result(s)|1
1781878|NCT00654875|6203573|P2|Overall Study|Lost to Follow-up|3
1781879|NCT00654875|6203574|P1|Overall Study|Lost to Follow-up|1
1781880|NCT00654875|6203573|P2|Overall Study|Lack of Efficacy|2
1781881|NCT00654875|6203574|P1|Overall Study|Lack of Efficacy|2
1781882|NCT00654875|6203573|P2|Overall Study|Protocol Violation|3
1781883|NCT00654875|6203574|P1|Overall Study|Protocol Violation|3
1781884|NCT00654875|6203573|P2|Overall Study|Withdrawal by Subject|4
1781885|NCT00654875|6203574|P1|Overall Study|Withdrawal by Subject|4
1781886|NCT00654875|6203573|P2|Overall Study|Adverse Event|5
1781887|NCT00654875|6203574|P1|Overall Study|Adverse Event|5
1781888|NCT00654745|6203607|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
1781889|NCT00654745|6203607|P1|Overall Study|Withdrawal by Subject|10
1781890|NCT00654745|6203607|P1|Overall Study|Protocol Violation|11
1781891|NCT00654745|6203607|P1|Overall Study|Lost to Follow-up|7
1781892|NCT00654745|6203607|P1|Overall Study|Adverse Event|12
1781893|NCT00654641|6203652|P2|Overall Study|Lost to Follow-up|3
1781894|NCT00654641|6203653|P1|Overall Study|Lost to Follow-up|2
1781895|NCT00654628|6203659|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
1781896|NCT00654628|6203659|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
1781897|NCT00654628|6203659|P1|6-week Active Treatment Period|Out of window period|1
1781898|NCT00654628|6203659|P1|6-week Active Treatment Period|Transferred to branch hospital|1
1781899|NCT00654628|6203659|P1|6-week Active Treatment Period|Lost to Follow-up|10
1781900|NCT00654628|6203659|P1|6-week Active Treatment Period|Adverse Event|9
1781901|NCT00654498|6203708|P2|Overall Study|Other reason not defined above|5
1781902|NCT00654498|6203709|P1|Overall Study|Other reason not defined above|4
1781903|NCT00654498|6203708|P2|Overall Study|Withdrawal by Subject|0
1781904|NCT00654498|6203709|P1|Overall Study|Withdrawal by Subject|1
1781905|NCT00654498|6203708|P2|Overall Study|Lost to Follow-up|5
1781906|NCT00654498|6203709|P1|Overall Study|Lost to Follow-up|1
1781907|NCT00654498|6203708|P2|Overall Study|Protocol Violation|1
1781908|NCT00654498|6203709|P1|Overall Study|Protocol Violation|1
1781909|NCT00654498|6203708|P2|Overall Study|Adverse Event|1
1781910|NCT00654498|6203709|P1|Overall Study|Adverse Event|6
1781911|NCT00654498|6203708|P2|Overall Study|Not Treated|0
1781912|NCT00654498|6203709|P1|Overall Study|Not Treated|1
1781913|NCT00654420|6203741|P4|Phase II|Missing Disposition Record|0
1781914|NCT00654420|6203742|P3|Phase II|Missing Disposition Record|1
1781915|NCT00654420|6203743|P2|Phase II|Missing Disposition Record|0
1781916|NCT00654420|6203744|P1|Phase II|Missing Disposition Record|0
1781917|NCT00654420|6203741|P4|Phase II|Withdrawal by Subject|1
1781918|NCT00654420|6203742|P3|Phase II|Withdrawal by Subject|4
1781919|NCT00654420|6203743|P2|Phase II|Withdrawal by Subject|0
1781920|NCT00654420|6203744|P1|Phase II|Withdrawal by Subject|0
1781921|NCT00654420|6203741|P4|Phase II|Progressive Disease|29
1781922|NCT00654420|6203742|P3|Phase II|Progressive Disease|29
1781923|NCT00654420|6203743|P2|Phase II|Progressive Disease|0
1781924|NCT00654420|6203744|P1|Phase II|Progressive Disease|0
1781925|NCT00654420|6203741|P4|Phase II|Physician Decision|4
1781926|NCT00654420|6203742|P3|Phase II|Physician Decision|0
1781927|NCT00654420|6203743|P2|Phase II|Physician Decision|0
1781928|NCT00654420|6203744|P1|Phase II|Physician Decision|0
1781929|NCT00654420|6203741|P4|Phase II|Lost to Follow-up|1
1781930|NCT00654420|6203742|P3|Phase II|Lost to Follow-up|0
1781931|NCT00654420|6203743|P2|Phase II|Lost to Follow-up|0
1781932|NCT00654420|6203744|P1|Phase II|Lost to Follow-up|0
1781933|NCT00654420|6203741|P4|Phase II|Adverse Event|3
1781934|NCT00654420|6203742|P3|Phase II|Adverse Event|3
1781935|NCT00654420|6203743|P2|Phase II|Adverse Event|0
1781936|NCT00654420|6203744|P1|Phase II|Adverse Event|0
1781937|NCT00654420|6203741|P4|Phase I (Dose Escalation)|Progressive Disease|0
1781938|NCT00654420|6203742|P3|Phase I (Dose Escalation)|Progressive Disease|0
1781939|NCT00654420|6203743|P2|Phase I (Dose Escalation)|Progressive Disease|15
1781940|NCT00654420|6203744|P1|Phase I (Dose Escalation)|Progressive Disease|4
1781941|NCT00654420|6203741|P4|Phase I (Dose Escalation)|Adverse Event|0
1781942|NCT00654420|6203742|P3|Phase I (Dose Escalation)|Adverse Event|0
1781943|NCT00654420|6203743|P2|Phase I (Dose Escalation)|Adverse Event|1
1781944|NCT00654420|6203744|P1|Phase I (Dose Escalation)|Adverse Event|0
1781945|NCT00654381|6203770|P6|Extension Stage|Closure of the trial site|1
1781946|NCT00654381|6203771|P5|Extension Stage|Closure of the trial site|1
1781947|NCT00654381|6203772|P4|Extension Stage|Closure of the trial site|0
1781948|NCT00654381|6203773|P3|Extension Stage|Closure of the trial site|0
1781949|NCT00654381|6203774|P2|Extension Stage|Closure of the trial site|0
1781950|NCT00654381|6203775|P1|Extension Stage|Closure of the trial site|0
1781951|NCT00654381|6203770|P6|Extension Stage|Withdrawal by Subject|1
1781952|NCT00654381|6203771|P5|Extension Stage|Withdrawal by Subject|1
1781953|NCT00654381|6203772|P4|Extension Stage|Withdrawal by Subject|1
1781954|NCT00654381|6203773|P3|Extension Stage|Withdrawal by Subject|1
1781955|NCT00654381|6203774|P2|Extension Stage|Withdrawal by Subject|0
1781956|NCT00654381|6203775|P1|Extension Stage|Withdrawal by Subject|0
1781957|NCT00654381|6203770|P6|Extension Stage|Lack of Efficacy|0
1781958|NCT00654381|6203771|P5|Extension Stage|Lack of Efficacy|0
1781959|NCT00654381|6203772|P4|Extension Stage|Lack of Efficacy|0
1781960|NCT00654381|6203773|P3|Extension Stage|Lack of Efficacy|1
1781961|NCT00654381|6203774|P2|Extension Stage|Lack of Efficacy|0
1781962|NCT00654381|6203775|P1|Extension Stage|Lack of Efficacy|0
1781963|NCT00654381|6203770|P6|Extension Stage|Protocol Violation|0
1781964|NCT00654381|6203771|P5|Extension Stage|Protocol Violation|0
1781965|NCT00654381|6203772|P4|Extension Stage|Protocol Violation|1
1781966|NCT00654381|6203773|P3|Extension Stage|Protocol Violation|0
1781967|NCT00654381|6203774|P2|Extension Stage|Protocol Violation|0
1781968|NCT00654381|6203775|P1|Extension Stage|Protocol Violation|0
1781969|NCT00654381|6203770|P6|Extension Stage|Adverse Event|1
1781970|NCT00654381|6203771|P5|Extension Stage|Adverse Event|1
1781971|NCT00654381|6203772|P4|Extension Stage|Adverse Event|7
1781972|NCT00654381|6203773|P3|Extension Stage|Adverse Event|9
1781973|NCT00654381|6203774|P2|Extension Stage|Adverse Event|2
1781974|NCT00654381|6203775|P1|Extension Stage|Adverse Event|1
1781975|NCT00654381|6203770|P6|2nd Stage|Investigator's decision|0
1781976|NCT00654381|6203771|P5|2nd Stage|Investigator's decision|0
1781977|NCT00654381|6203772|P4|2nd Stage|Investigator's decision|1
1781978|NCT00654381|6203773|P3|2nd Stage|Investigator's decision|1
1781979|NCT00654381|6203774|P2|2nd Stage|Investigator's decision|0
1781980|NCT00654381|6203775|P1|2nd Stage|Investigator's decision|0
1781981|NCT00654381|6203770|P6|2nd Stage|Withdrawal by Subject|1
1781982|NCT00654381|6203771|P5|2nd Stage|Withdrawal by Subject|1
1781983|NCT00654381|6203772|P4|2nd Stage|Withdrawal by Subject|0
1781984|NCT00654381|6203773|P3|2nd Stage|Withdrawal by Subject|0
1781985|NCT00654381|6203774|P2|2nd Stage|Withdrawal by Subject|0
1781986|NCT00654381|6203775|P1|2nd Stage|Withdrawal by Subject|0
1781987|NCT00654381|6203770|P6|2nd Stage|Adverse Event|2
1781988|NCT00654381|6203771|P5|2nd Stage|Adverse Event|7
1781989|NCT00654381|6203772|P4|2nd Stage|Adverse Event|3
1781990|NCT00654381|6203773|P3|2nd Stage|Adverse Event|2
1781991|NCT00654381|6203774|P2|2nd Stage|Adverse Event|0
1781992|NCT00654381|6203775|P1|2nd Stage|Adverse Event|2
1781993|NCT00654381|6203770|P6|1st Stage|Investigator's decision|0
1781994|NCT00654381|6203771|P5|1st Stage|Investigator's decision|0
1781995|NCT00654381|6203772|P4|1st Stage|Investigator's decision|1
1781996|NCT00654381|6203773|P3|1st Stage|Investigator's decision|0
1781997|NCT00654381|6203774|P2|1st Stage|Investigator's decision|0
1781998|NCT00654381|6203775|P1|1st Stage|Investigator's decision|0
1781999|NCT00654381|6203770|P6|1st Stage|Withdrawal by Subject|1
1782000|NCT00654381|6203771|P5|1st Stage|Withdrawal by Subject|0
1782001|NCT00654381|6203772|P4|1st Stage|Withdrawal by Subject|1
1782002|NCT00654381|6203773|P3|1st Stage|Withdrawal by Subject|0
1782003|NCT00654381|6203774|P2|1st Stage|Withdrawal by Subject|0
1782004|NCT00654381|6203775|P1|1st Stage|Withdrawal by Subject|0
1782005|NCT00654381|6203770|P6|1st Stage|Adverse Event|1
1782006|NCT00654381|6203771|P5|1st Stage|Adverse Event|2
1782007|NCT00654381|6203772|P4|1st Stage|Adverse Event|3
1782008|NCT00654381|6203773|P3|1st Stage|Adverse Event|3
1782009|NCT00654381|6203774|P2|1st Stage|Adverse Event|3
1782010|NCT00654381|6203775|P1|1st Stage|Adverse Event|3
1782011|NCT00654368|6203812|P3|Overall Study|Adverse Event|6
1782012|NCT00654368|6203813|P2|Overall Study|Adverse Event|9
1782013|NCT00654368|6203814|P1|Overall Study|Adverse Event|14
1782014|NCT00654368|6203812|P3|Overall Study|Other|3
1782015|NCT00654368|6203813|P2|Overall Study|Other|2
1782016|NCT00654368|6203814|P1|Overall Study|Other|0
1782017|NCT00654368|6203812|P3|Overall Study|Pregnancy|2
1782018|NCT00654368|6203813|P2|Overall Study|Pregnancy|0
1782019|NCT00654368|6203814|P1|Overall Study|Pregnancy|0
1782020|NCT00654368|6203812|P3|Overall Study|Death|0
1782021|NCT00654368|6203813|P2|Overall Study|Death|0
1782022|NCT00654368|6203814|P1|Overall Study|Death|1
1782023|NCT00654368|6203812|P3|Overall Study|Physician Decision|2
1782024|NCT00654368|6203813|P2|Overall Study|Physician Decision|0
1782025|NCT00654368|6203814|P1|Overall Study|Physician Decision|0
1782026|NCT00654368|6203812|P3|Overall Study|Requirement for alternative therapy|1
1782027|NCT00654368|6203813|P2|Overall Study|Requirement for alternative therapy|1
1782028|NCT00654368|6203814|P1|Overall Study|Requirement for alternative therapy|1
1782029|NCT00654368|6203812|P3|Overall Study|Disease progression|13
1782030|NCT00654368|6203813|P2|Overall Study|Disease progression|31
1782031|NCT00654368|6203814|P1|Overall Study|Disease progression|21
1782032|NCT00654368|6203812|P3|Overall Study|Withdrawal by Subject|2
1782033|NCT00654368|6203813|P2|Overall Study|Withdrawal by Subject|2
1782034|NCT00654368|6203814|P1|Overall Study|Withdrawal by Subject|5
1782035|NCT00654368|6203812|P3|Overall Study|Non-compliance|2
1782036|NCT00654368|6203813|P2|Overall Study|Non-compliance|1
1782037|NCT00654368|6203814|P1|Overall Study|Non-compliance|2
1782038|NCT00654368|6203812|P3|Overall Study|Protocol deviation|1
1782039|NCT00654368|6203813|P2|Overall Study|Protocol deviation|2
1782040|NCT00654368|6203814|P1|Overall Study|Protocol deviation|3
1782041|NCT00654368|6203812|P3|Overall Study|Ineligibility determined|0
1782042|NCT00654368|6203813|P2|Overall Study|Ineligibility determined|0
1782043|NCT00654368|6203814|P1|Overall Study|Ineligibility determined|6
1782044|NCT00654355|6203847|P2|Overall Study|Lost to Follow-up|2
1782045|NCT00654355|6203848|P1|Overall Study|Lost to Follow-up|2
1782046|NCT00654238|6203879|P1|Overall Study|Screen Failures|4
1782047|NCT00654186|6203884|P1|Overall Study|Withdrawal by Subject|5
1782048|NCT00654095|6203909|P1|Overall Study|Did not meet inclusion criteria|1
1782049|NCT00654095|6203909|P1|Overall Study|Adverse reaction did not improve (5)|4
1782050|NCT00654095|6203909|P1|Overall Study|Elevated alanine aminotransferase (4)|7
1782051|NCT00654095|6203909|P1|Overall Study|Withdrawal by Subject|5
1782052|NCT00654095|6203909|P1|Overall Study|Adverse Event|11
1782053|NCT00654095|6203909|P1|Overall Study|Elevated alanine aminotransferase (3)|1
1782054|NCT00654095|6203909|P1|Overall Study|Elevated triglyceride level (2)|1
1782055|NCT00654095|6203909|P1|Overall Study|Drop in low density lipoprotein (1)|2
1782056|NCT00654004|6203932|P2|Overall Study|Lost to Follow-up|0
1782057|NCT00654004|6203933|P1|Overall Study|Lost to Follow-up|1
1782058|NCT00653991|6203949|P2|6 Month Follow-up|Participant would not respond|141
1782059|NCT00653991|6203950|P1|6 Month Follow-up|Participant would not respond|133
1782060|NCT00653991|6203949|P2|3 Month Follow-up|Participant would not respond|157
1782061|NCT00653991|6203950|P1|3 Month Follow-up|Participant would not respond|150
1782062|NCT00653939|6203962|P2|Overall Study|Other|6
1782063|NCT00653939|6203963|P1|Overall Study|Other|2
1782064|NCT00653939|6203962|P2|Overall Study|Disease Progression|3
1782065|NCT00653939|6203963|P1|Overall Study|Disease Progression|2
1782066|NCT00653939|6203962|P2|Overall Study|Physician Decision|0
1782067|NCT00653939|6203963|P1|Overall Study|Physician Decision|4
1782068|NCT00653939|6203962|P2|Overall Study|Withdrawal by Subject|3
1782069|NCT00653939|6203963|P1|Overall Study|Withdrawal by Subject|3
1782070|NCT00653939|6203962|P2|Overall Study|Adverse Event|3
1782071|NCT00653939|6203963|P1|Overall Study|Adverse Event|1
1782072|NCT00653523|6203988|P1|Overall Study|Adverse reaction did not improve (4)|1
1782073|NCT00653523|6203988|P1|Overall Study|Elevated alanine aminotransferase (3)|2
1782074|NCT00653523|6203988|P1|Overall Study|Withdrawal by Subject|6
1782075|NCT00653523|6203988|P1|Overall Study|Adverse Event|7
1782076|NCT00653523|6203988|P1|Overall Study|Elevated creatine phosphokinase (2)|1
1782077|NCT00653523|6203988|P1|Overall Study|Drop in low density lipoprotein (1)|2
1782078|NCT00653328|6203992|P1|Overall Study|Drug manufacturer no longing making drug|2
1782079|NCT00653328|6203992|P1|Overall Study|Disease progression|10
1782080|NCT00653328|6203992|P1|Overall Study|Adverse Event|2
1782081|NCT00653328|6203992|P1|Overall Study|Withdrawal by Subject|1
1782082|NCT00653263|6203999|P1|Overall Study|Physician Decision|1
1782083|NCT00653263|6203999|P1|Overall Study|Withdrawal by Subject|1
1782084|NCT00653224|6204007|P2|Overall Study|Other|4
1782085|NCT00653224|6204008|P1|Overall Study|Other|2
1782086|NCT00653224|6204007|P2|Overall Study|Lost to Follow-up|0
1782087|NCT00653224|6204008|P1|Overall Study|Lost to Follow-up|1
1782088|NCT00653224|6204007|P2|Overall Study|Loss of efficacy|0
1782089|NCT00653224|6204008|P1|Overall Study|Loss of efficacy|1
1782090|NCT00653224|6204007|P2|Overall Study|Lack of Efficacy|2
1782091|NCT00653224|6204008|P1|Overall Study|Lack of Efficacy|1
1782092|NCT00653224|6204007|P2|Overall Study|Adverse Event|1
1782093|NCT00653224|6204008|P1|Overall Study|Adverse Event|2
1782094|NCT00653159|6204194|P2|Overall Study|Lost to Follow-up|2
1782095|NCT00653159|6204195|P1|Overall Study|Lost to Follow-up|1
1782096|NCT00653159|6204194|P2|Overall Study|Adverse Event|1
1782097|NCT00653159|6204195|P1|Overall Study|Adverse Event|4
1782098|NCT00653068|6204222|P1|Overall Study|Ineligible|2
1782099|NCT00653068|6204222|P1|Overall Study|Withdrawal by Subject|1
1782100|NCT00653068|6204222|P1|Overall Study|Physician Decision|4
1782101|NCT00653068|6204222|P1|Overall Study|Lack of Efficacy|34
1782102|NCT00653068|6204222|P1|Overall Study|Death|9
1782103|NCT00652951|6204236|P3|Booster Phase|Other|0
1782104|NCT00652951|6204237|P2|Booster Phase|Other|0
1782105|NCT00652951|6204238|P1|Booster Phase|Other|1
1782106|NCT00652951|6204236|P3|Booster Phase|Adverse event, non-fatal|0
1782107|NCT00652951|6204237|P2|Booster Phase|Adverse event, non-fatal|1
1782108|NCT00652951|6204238|P1|Booster Phase|Adverse event, non-fatal|0
1782109|NCT00652938|6204375|P3|Overall Study|fear of blood sampling|0
1782110|NCT00652938|6204376|P2|Overall Study|fear of blood sampling|1
1782111|NCT00652938|6204377|P1|Overall Study|fear of blood sampling|0
1782112|NCT00652938|6204375|P3|Overall Study|Lost to Follow-up|2
1782113|NCT00652938|6204376|P2|Overall Study|Lost to Follow-up|0
1782114|NCT00652938|6204377|P1|Overall Study|Lost to Follow-up|0
1782115|NCT00652938|6204375|P3|Overall Study|Withdrawal by Subject|1
1782116|NCT00652938|6204376|P2|Overall Study|Withdrawal by Subject|6
1782117|NCT00652938|6204377|P1|Overall Study|Withdrawal by Subject|0
1782118|NCT00652938|6204375|P3|Overall Study|Adverse Event|2
1782119|NCT00652938|6204376|P2|Overall Study|Adverse Event|0
1782120|NCT00652938|6204377|P1|Overall Study|Adverse Event|1
1782121|NCT00652899|6204442|P1|Overall Study|Treating physician decision|1
1782122|NCT00652899|6204442|P1|Overall Study|Death|1
1782123|NCT00652834|6204452|P1|Overall Study|Lost to Follow-up|2
1782124|NCT00652834|6204452|P1|Overall Study|Withdrawal by Subject|3
1782125|NCT00652743|6204459|P3|Months 36-42|Other|8
1782126|NCT00652743|6204460|P2|Months 36-42|Other|2
1782127|NCT00652743|6204461|P1|Months 36-42|Other|4
1782128|NCT00652743|6204459|P3|Months 36-42|Migrated/moved from study area|0
1782129|NCT00652743|6204460|P2|Months 36-42|Migrated/moved from study area|0
1782130|NCT00652743|6204461|P1|Months 36-42|Migrated/moved from study area|1
1782131|NCT00652743|6204459|P3|Months 36-42|Lost to Follow-up|0
1782132|NCT00652743|6204460|P2|Months 36-42|Lost to Follow-up|1
1782133|NCT00652743|6204461|P1|Months 36-42|Lost to Follow-up|0
1782134|NCT00652743|6204459|P3|Months 36-42|Withdrawal by Subject|0
1782135|NCT00652743|6204460|P2|Months 36-42|Withdrawal by Subject|1
1782136|NCT00652743|6204461|P1|Months 36-42|Withdrawal by Subject|1
1782137|NCT00652743|6204459|P3|Months 36-42|Serious Adverse Events|1
1782138|NCT00652743|6204460|P2|Months 36-42|Serious Adverse Events|1
1782139|NCT00652743|6204461|P1|Months 36-42|Serious Adverse Events|0
1782140|NCT00652743|6204459|P3|Months 24-30|Other|11
1782141|NCT00652743|6204460|P2|Months 24-30|Other|1
1782142|NCT00652743|6204461|P1|Months 24-30|Other|5
1782143|NCT00652743|6204459|P3|Months 12-18|Lost to Follow-up|7
1782144|NCT00652743|6204460|P2|Months 12-18|Lost to Follow-up|2
1782145|NCT00652743|6204461|P1|Months 12-18|Lost to Follow-up|1
1782146|NCT00652626|6204543|P7|Extension Phase|Death|1
1782147|NCT00652626|6204544|P6|Extension Phase|Death|1
1782148|NCT00652626|6204545|P5|Extension Phase|Death|0
1782149|NCT00652626|6204546|P4|Extension Phase|Death|0
1782150|NCT00652626|6204547|P3|Extension Phase|Death|0
1782151|NCT00652626|6204548|P2|Extension Phase|Death|0
1782152|NCT00652626|6204549|P1|Extension Phase|Death|0
1782153|NCT00652626|6204543|P7|Extension Phase|Physician Decision|1
1782154|NCT00652626|6204544|P6|Extension Phase|Physician Decision|1
1782155|NCT00652626|6204545|P5|Extension Phase|Physician Decision|0
1782156|NCT00652626|6204546|P4|Extension Phase|Physician Decision|0
1782157|NCT00652626|6204547|P3|Extension Phase|Physician Decision|0
1782158|NCT00652626|6204548|P2|Extension Phase|Physician Decision|0
1782159|NCT00652626|6204549|P1|Extension Phase|Physician Decision|0
1782160|NCT00652626|6204543|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
1782161|NCT00652626|6204544|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
1782162|NCT00652626|6204545|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
1782163|NCT00652626|6204546|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
1782164|NCT00652626|6204547|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
1782165|NCT00652626|6204548|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
1782166|NCT00652626|6204549|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
1782167|NCT00652626|6204543|P7|Extension Phase|Adverse Event|1
1782168|NCT00652626|6204544|P6|Extension Phase|Adverse Event|2
1782169|NCT00652626|6204545|P5|Extension Phase|Adverse Event|0
1782170|NCT00652626|6204546|P4|Extension Phase|Adverse Event|0
1782171|NCT00652626|6204547|P3|Extension Phase|Adverse Event|0
1782172|NCT00652626|6204548|P2|Extension Phase|Adverse Event|0
1782173|NCT00652626|6204549|P1|Extension Phase|Adverse Event|0
1782174|NCT00652626|6204543|P7|Extension Phase|Withdrawal by Subject|0
1782175|NCT00652626|6204544|P6|Extension Phase|Withdrawal by Subject|2
1782176|NCT00652626|6204545|P5|Extension Phase|Withdrawal by Subject|0
1782177|NCT00652626|6204546|P4|Extension Phase|Withdrawal by Subject|0
1782178|NCT00652626|6204547|P3|Extension Phase|Withdrawal by Subject|0
1782179|NCT00652626|6204548|P2|Extension Phase|Withdrawal by Subject|0
1782180|NCT00652626|6204549|P1|Extension Phase|Withdrawal by Subject|0
1782181|NCT00652626|6204543|P7|Initial Treatment Phase|Lost to Follow-up|0
1782182|NCT00652626|6204544|P6|Initial Treatment Phase|Lost to Follow-up|0
1782183|NCT00652626|6204545|P5|Initial Treatment Phase|Lost to Follow-up|1
1782184|NCT00652626|6204546|P4|Initial Treatment Phase|Lost to Follow-up|0
1782185|NCT00652626|6204547|P3|Initial Treatment Phase|Lost to Follow-up|0
1782186|NCT00652626|6204548|P2|Initial Treatment Phase|Lost to Follow-up|0
1782187|NCT00652626|6204549|P1|Initial Treatment Phase|Lost to Follow-up|0
1782188|NCT00652626|6204543|P7|Initial Treatment Phase|Sponsor Request|0
1782189|NCT00652626|6204544|P6|Initial Treatment Phase|Sponsor Request|0
1782190|NCT00652626|6204545|P5|Initial Treatment Phase|Sponsor Request|0
1782191|NCT00652626|6204546|P4|Initial Treatment Phase|Sponsor Request|0
1782192|NCT00652626|6204547|P3|Initial Treatment Phase|Sponsor Request|1
1782193|NCT00652626|6204548|P2|Initial Treatment Phase|Sponsor Request|0
1782194|NCT00652626|6204549|P1|Initial Treatment Phase|Sponsor Request|0
1782195|NCT00652626|6204543|P7|Initial Treatment Phase|Physician Decision|0
1782196|NCT00652626|6204544|P6|Initial Treatment Phase|Physician Decision|0
1782197|NCT00652626|6204545|P5|Initial Treatment Phase|Physician Decision|1
1782198|NCT00652626|6204546|P4|Initial Treatment Phase|Physician Decision|0
1782199|NCT00652626|6204547|P3|Initial Treatment Phase|Physician Decision|0
1782200|NCT00652626|6204548|P2|Initial Treatment Phase|Physician Decision|0
1782201|NCT00652626|6204549|P1|Initial Treatment Phase|Physician Decision|0
1782202|NCT00652626|6204543|P7|Initial Treatment Phase|Protocol Violation|0
1782203|NCT00652626|6204544|P6|Initial Treatment Phase|Protocol Violation|0
1782204|NCT00652626|6204545|P5|Initial Treatment Phase|Protocol Violation|0
1782205|NCT00652626|6204546|P4|Initial Treatment Phase|Protocol Violation|1
1782206|NCT00652626|6204547|P3|Initial Treatment Phase|Protocol Violation|0
1782207|NCT00652626|6204548|P2|Initial Treatment Phase|Protocol Violation|0
1782208|NCT00652626|6204549|P1|Initial Treatment Phase|Protocol Violation|0
1782209|NCT00652626|6204543|P7|Initial Treatment Phase|Adverse Event|0
1782210|NCT00652626|6204544|P6|Initial Treatment Phase|Adverse Event|0
1782211|NCT00652626|6204545|P5|Initial Treatment Phase|Adverse Event|1
1782212|NCT00652626|6204546|P4|Initial Treatment Phase|Adverse Event|0
1782213|NCT00652626|6204547|P3|Initial Treatment Phase|Adverse Event|0
1782214|NCT00652626|6204548|P2|Initial Treatment Phase|Adverse Event|0
1782215|NCT00652626|6204549|P1|Initial Treatment Phase|Adverse Event|0
1782216|NCT00652366|6204618|P5|Overall Study|Other|0
1782217|NCT00652366|6204619|P4|Overall Study|Other|4
1782218|NCT00652366|6204620|P3|Overall Study|Other|3
1782219|NCT00652366|6204621|P2|Overall Study|Other|2
1782220|NCT00652366|6204622|P1|Overall Study|Other|5
1782221|NCT00652366|6204618|P5|Overall Study|Refused treatment|5
1782222|NCT00652366|6204619|P4|Overall Study|Refused treatment|17
1782223|NCT00652366|6204620|P3|Overall Study|Refused treatment|6
1782224|NCT00652366|6204621|P2|Overall Study|Refused treatment|7
1782225|NCT00652366|6204622|P1|Overall Study|Refused treatment|3
1782226|NCT00652366|6204618|P5|Overall Study|Protocol Violation|0
1782227|NCT00652366|6204619|P4|Overall Study|Protocol Violation|0
1782228|NCT00652366|6204620|P3|Overall Study|Protocol Violation|0
1782229|NCT00652366|6204621|P2|Overall Study|Protocol Violation|0
1782230|NCT00652366|6204622|P1|Overall Study|Protocol Violation|1
1782231|NCT00652366|6204618|P5|Overall Study|Violation of Selection Criteria|0
1782232|NCT00652366|6204619|P4|Overall Study|Violation of Selection Criteria|0
1782233|NCT00652366|6204620|P3|Overall Study|Violation of Selection Criteria|1
1782234|NCT00652366|6204621|P2|Overall Study|Violation of Selection Criteria|0
1782235|NCT00652366|6204622|P1|Overall Study|Violation of Selection Criteria|0
1782236|NCT00652366|6204618|P5|Overall Study|Lack of Efficacy|13
1782237|NCT00652366|6204619|P4|Overall Study|Lack of Efficacy|133
1782238|NCT00652366|6204620|P3|Overall Study|Lack of Efficacy|53
1782239|NCT00652366|6204621|P2|Overall Study|Lack of Efficacy|58
1782240|NCT00652366|6204622|P1|Overall Study|Lack of Efficacy|84
1782241|NCT00652366|6204618|P5|Overall Study|Death|5
1782242|NCT00652366|6204619|P4|Overall Study|Death|8
1782243|NCT00652366|6204620|P3|Overall Study|Death|1
1782244|NCT00652366|6204621|P2|Overall Study|Death|4
1782245|NCT00652366|6204622|P1|Overall Study|Death|5
1782246|NCT00652366|6204618|P5|Overall Study|Adverse Event|13
1782247|NCT00652366|6204619|P4|Overall Study|Adverse Event|17
1782248|NCT00652366|6204620|P3|Overall Study|Adverse Event|7
1782249|NCT00652366|6204621|P2|Overall Study|Adverse Event|4
1782250|NCT00652366|6204622|P1|Overall Study|Adverse Event|8
1782251|NCT00652340|6204657|P2|Overall Study|Had not progressed.|3
1782252|NCT00652340|6204658|P1|Overall Study|Had not progressed.|4
1782253|NCT00652327|6204668|P2|Overall Study|Lost to Follow-up|3
1782254|NCT00652327|6204669|P1|Overall Study|Lost to Follow-up|0
1782255|NCT00652327|6204668|P2|Overall Study|Adverse Event|2
1782256|NCT00652327|6204669|P1|Overall Study|Adverse Event|0
1782257|NCT00652093|6204711|P6|Overall Study|Physician Decision|0
1782258|NCT00652093|6204712|P5|Overall Study|Physician Decision|1
1782259|NCT00652093|6204713|P4|Overall Study|Physician Decision|0
1782260|NCT00652093|6204714|P3|Overall Study|Physician Decision|0
1782261|NCT00652093|6204715|P2|Overall Study|Physician Decision|0
1782262|NCT00652093|6204716|P1|Overall Study|Physician Decision|0
1782263|NCT00652093|6204711|P6|Overall Study|Withdrawal by Subject|0
1782264|NCT00652093|6204712|P5|Overall Study|Withdrawal by Subject|1
1782265|NCT00652093|6204713|P4|Overall Study|Withdrawal by Subject|0
1782266|NCT00652093|6204714|P3|Overall Study|Withdrawal by Subject|1
1782267|NCT00652093|6204715|P2|Overall Study|Withdrawal by Subject|0
1782268|NCT00652093|6204716|P1|Overall Study|Withdrawal by Subject|0
1782269|NCT00652028|6204806|P4|Overall Study|Physician Decision|0
1782270|NCT00652028|6204807|P3|Overall Study|Physician Decision|1
1782271|NCT00652028|6204808|P2|Overall Study|Physician Decision|0
1782272|NCT00652028|6204809|P1|Overall Study|Physician Decision|0
1782273|NCT00652028|6204806|P4|Overall Study|No Longer Meets Entry Criteria|0
1782274|NCT00652028|6204807|P3|Overall Study|No Longer Meets Entry Criteria|0
1782275|NCT00652028|6204808|P2|Overall Study|No Longer Meets Entry Criteria|1
1782276|NCT00652028|6204809|P1|Overall Study|No Longer Meets Entry Criteria|0
1782277|NCT00652028|6204806|P4|Overall Study|Adverse Event|0
1782278|NCT00652028|6204807|P3|Overall Study|Adverse Event|0
1782279|NCT00652028|6204808|P2|Overall Study|Adverse Event|0
1782280|NCT00652028|6204809|P1|Overall Study|Adverse Event|1
1782281|NCT00651937|6204853|P2|Overall Study|Withdrawal by Subject|1
1782282|NCT00651937|6204854|P1|Overall Study|Withdrawal by Subject|4
1782283|NCT00651924|6204864|P2|Overall Study|Withdrawal by Subject|5
1782284|NCT00651924|6204865|P1|Overall Study|Withdrawal by Subject|0
1782285|NCT00651924|6204864|P2|Overall Study|Withdrawal by PI|2
1782286|NCT00651924|6204865|P1|Overall Study|Withdrawal by PI|0
1782287|NCT00651820|6204871|P1|Overall Study|Lost to Follow-up|2
1782288|NCT00651755|6204903|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
1782289|NCT00651755|6204904|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
1782290|NCT00651755|6204903|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
1782291|NCT00651755|6204904|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
1782292|NCT00651664|6204930|P10|Overall Study|Reason not Specified|0
1782293|NCT00651664|6204931|P9|Overall Study|Reason not Specified|0
1782294|NCT00651664|6204932|P8|Overall Study|Reason not Specified|0
1782295|NCT00651664|6204933|P7|Overall Study|Reason not Specified|1
1782296|NCT00651664|6204934|P6|Overall Study|Reason not Specified|0
1782297|NCT00651664|6204935|P5|Overall Study|Reason not Specified|0
1782298|NCT00651664|6204936|P4|Overall Study|Reason not Specified|0
1782299|NCT00651664|6204937|P3|Overall Study|Reason not Specified|0
1782300|NCT00651664|6204938|P2|Overall Study|Reason not Specified|0
1782301|NCT00651664|6204939|P1|Overall Study|Reason not Specified|0
1782302|NCT00651664|6204930|P10|Overall Study|Symptomatic Deterioration|0
1782303|NCT00651664|6204931|P9|Overall Study|Symptomatic Deterioration|1
1782304|NCT00651664|6204932|P8|Overall Study|Symptomatic Deterioration|0
1782305|NCT00651664|6204933|P7|Overall Study|Symptomatic Deterioration|1
1782306|NCT00651664|6204934|P6|Overall Study|Symptomatic Deterioration|0
1782307|NCT00651664|6204935|P5|Overall Study|Symptomatic Deterioration|0
1782308|NCT00651664|6204936|P4|Overall Study|Symptomatic Deterioration|1
1782309|NCT00651664|6204937|P3|Overall Study|Symptomatic Deterioration|0
1782310|NCT00651664|6204938|P2|Overall Study|Symptomatic Deterioration|0
1782311|NCT00651664|6204939|P1|Overall Study|Symptomatic Deterioration|0
1782312|NCT00651664|6204930|P10|Overall Study|Patient Declined Further Treatment|1
1782313|NCT00651664|6204931|P9|Overall Study|Patient Declined Further Treatment|0
1782314|NCT00651664|6204932|P8|Overall Study|Patient Declined Further Treatment|0
1782315|NCT00651664|6204933|P7|Overall Study|Patient Declined Further Treatment|0
1782316|NCT00651664|6204934|P6|Overall Study|Patient Declined Further Treatment|1
1782317|NCT00651664|6204935|P5|Overall Study|Patient Declined Further Treatment|1
1782318|NCT00651664|6204936|P4|Overall Study|Patient Declined Further Treatment|1
1782319|NCT00651664|6204937|P3|Overall Study|Patient Declined Further Treatment|0
1782320|NCT00651664|6204938|P2|Overall Study|Patient Declined Further Treatment|0
1782321|NCT00651664|6204939|P1|Overall Study|Patient Declined Further Treatment|0
1782322|NCT00651664|6204930|P10|Overall Study|Progressive Disease|5
1782323|NCT00651664|6204931|P9|Overall Study|Progressive Disease|5
1782324|NCT00651664|6204932|P8|Overall Study|Progressive Disease|6
1782325|NCT00651664|6204933|P7|Overall Study|Progressive Disease|3
1782326|NCT00651664|6204934|P6|Overall Study|Progressive Disease|1
1782327|NCT00651664|6204935|P5|Overall Study|Progressive Disease|4
1782328|NCT00651664|6204936|P4|Overall Study|Progressive Disease|12
1782329|NCT00651664|6204937|P3|Overall Study|Progressive Disease|3
1782330|NCT00651664|6204938|P2|Overall Study|Progressive Disease|3
1782331|NCT00651664|6204939|P1|Overall Study|Progressive Disease|3
1782332|NCT00651664|6204930|P10|Overall Study|Unsatisfactory Therapeutic Response|1
1782333|NCT00651664|6204931|P9|Overall Study|Unsatisfactory Therapeutic Response|0
1782334|NCT00651664|6204932|P8|Overall Study|Unsatisfactory Therapeutic Response|1
1782335|NCT00651664|6204933|P7|Overall Study|Unsatisfactory Therapeutic Response|0
1782336|NCT00651664|6204934|P6|Overall Study|Unsatisfactory Therapeutic Response|1
1782337|NCT00651664|6204935|P5|Overall Study|Unsatisfactory Therapeutic Response|1
1782338|NCT00651664|6204936|P4|Overall Study|Unsatisfactory Therapeutic Response|0
1782339|NCT00651664|6204937|P3|Overall Study|Unsatisfactory Therapeutic Response|0
1782340|NCT00651664|6204938|P2|Overall Study|Unsatisfactory Therapeutic Response|0
1782341|NCT00651664|6204939|P1|Overall Study|Unsatisfactory Therapeutic Response|0
1782342|NCT00651664|6204930|P10|Overall Study|Occurrence of Adverse Event(s)|0
1782343|NCT00651664|6204931|P9|Overall Study|Occurrence of Adverse Event(s)|1
1782344|NCT00651664|6204932|P8|Overall Study|Occurrence of Adverse Event(s)|0
1782345|NCT00651664|6204933|P7|Overall Study|Occurrence of Adverse Event(s)|1
1782346|NCT00651664|6204934|P6|Overall Study|Occurrence of Adverse Event(s)|0
1782347|NCT00651664|6204935|P5|Overall Study|Occurrence of Adverse Event(s)|0
1782348|NCT00651664|6204936|P4|Overall Study|Occurrence of Adverse Event(s)|0
1782349|NCT00651664|6204937|P3|Overall Study|Occurrence of Adverse Event(s)|0
1782350|NCT00651664|6204938|P2|Overall Study|Occurrence of Adverse Event(s)|0
1782351|NCT00651664|6204939|P1|Overall Study|Occurrence of Adverse Event(s)|0
1782352|NCT00651313|6205111|P2|Overall Study|Adminstrative Discontinuation|3
1782353|NCT00651313|6205112|P1|Overall Study|Adminstrative Discontinuation|2
1782354|NCT00651313|6205111|P2|Overall Study|Lost to Follow-up|1
1782355|NCT00651313|6205112|P1|Overall Study|Lost to Follow-up|1
1782356|NCT00651313|6205111|P2|Overall Study|Withdrawal by Subject|1
1782357|NCT00651313|6205112|P1|Overall Study|Withdrawal by Subject|3
1782358|NCT00651313|6205111|P2|Overall Study|Adverse Event|1
1782359|NCT00651313|6205112|P1|Overall Study|Adverse Event|0
1782360|NCT00651261|6205120|P2|Overall Study|Never treated|3
1782361|NCT00651261|6205121|P1|Overall Study|Never treated|5
1782362|NCT00651261|6205120|P2|Overall Study|Other disease or participant decisions|23
1782363|NCT00651261|6205121|P1|Overall Study|Other disease or participant decisions|23
1782364|NCT00651261|6205120|P2|Overall Study|Alternative therapy|107
1782365|NCT00651261|6205121|P1|Overall Study|Alternative therapy|109
1782366|NCT00651261|6205120|P2|Overall Study|Disease progression|58
1782367|NCT00651261|6205121|P1|Overall Study|Disease progression|58
1782368|NCT00651261|6205120|P2|Overall Study|Induction failure|35
1782369|NCT00651261|6205121|P1|Overall Study|Induction failure|24
1782370|NCT00651261|6205120|P2|Overall Study|Withdrawal by Subject|40
1782371|NCT00651261|6205121|P1|Overall Study|Withdrawal by Subject|22
1782372|NCT00651261|6205120|P2|Overall Study|Death|18
1782373|NCT00651261|6205121|P1|Overall Study|Death|18
1782374|NCT00651261|6205120|P2|Overall Study|Adverse Event|22
1782375|NCT00651261|6205121|P1|Overall Study|Adverse Event|32
1782376|NCT00651183|6205137|P2|Overall Study|missing|0
1782377|NCT00651183|6205138|P1|Overall Study|missing|1
1782378|NCT00651183|6205137|P2|Overall Study|Other reasons|2
1782379|NCT00651183|6205138|P1|Overall Study|Other reasons|4
1782380|NCT00651183|6205137|P2|Overall Study|Lost to Follow-up|1
1782381|NCT00651183|6205138|P1|Overall Study|Lost to Follow-up|3
1782382|NCT00651183|6205137|P2|Overall Study|Withdrawal by Subject|3
1782383|NCT00651183|6205138|P1|Overall Study|Withdrawal by Subject|6
1782384|NCT00651183|6205137|P2|Overall Study|Tolerability insufficient +Patients wish|1
1782385|NCT00651183|6205138|P1|Overall Study|Tolerability insufficient +Patients wish|0
1782386|NCT00651183|6205137|P2|Overall Study|Tolerability insufficient|2
1782387|NCT00651183|6205138|P1|Overall Study|Tolerability insufficient|5
1782388|NCT00651183|6205137|P2|Overall Study|Efficacy insufficient + patients wish|1
1782389|NCT00651183|6205138|P1|Overall Study|Efficacy insufficient + patients wish|0
1782390|NCT00651183|6205137|P2|Overall Study|Lack of Efficacy|0
1782391|NCT00651183|6205138|P1|Overall Study|Lack of Efficacy|1
1782392|NCT00651157|6205150|P1|Overall Study|Protocol Violation|1
1782393|NCT00651157|6205150|P1|Overall Study|Death|1
1782394|NCT00651118|6205160|P4|Overall Study|Withdrawal by Subject|1
1782395|NCT00651118|6205161|P3|Overall Study|Withdrawal by Subject|1
1782396|NCT00651118|6205162|P2|Overall Study|Withdrawal by Subject|1
1782397|NCT00651118|6205163|P1|Overall Study|Withdrawal by Subject|0
1782398|NCT00651118|6205160|P4|Overall Study|administrative|1
1782399|NCT00651118|6205161|P3|Overall Study|administrative|2
1782400|NCT00651118|6205162|P2|Overall Study|administrative|4
1782401|NCT00651118|6205163|P1|Overall Study|administrative|1
1782402|NCT00651118|6205160|P4|Overall Study|Lost to Follow-up|2
1782403|NCT00651118|6205161|P3|Overall Study|Lost to Follow-up|1
1782404|NCT00651118|6205162|P2|Overall Study|Lost to Follow-up|0
1782405|NCT00651118|6205163|P1|Overall Study|Lost to Follow-up|2
1782406|NCT00651118|6205160|P4|Overall Study|Protocol Violation|2
1782407|NCT00651118|6205161|P3|Overall Study|Protocol Violation|6
1782408|NCT00651118|6205162|P2|Overall Study|Protocol Violation|2
1782409|NCT00651118|6205163|P1|Overall Study|Protocol Violation|2
1782410|NCT00651118|6205160|P4|Overall Study|Adverse Event|1
1782411|NCT00651118|6205161|P3|Overall Study|Adverse Event|1
1782412|NCT00651118|6205162|P2|Overall Study|Adverse Event|0
1782413|NCT00651118|6205163|P1|Overall Study|Adverse Event|4
1782414|NCT00650845|6205232|P2|Overall Study|Protocol Violation|13
1782415|NCT00650845|6205233|P1|Overall Study|Protocol Violation|0
1782416|NCT00650845|6205232|P2|Overall Study|Withdrawal by Subject|0
1782417|NCT00650845|6205233|P1|Overall Study|Withdrawal by Subject|5
1782418|NCT00650806|6205253|P4|Overall Study|Other|0
1782419|NCT00650806|6205254|P3|Overall Study|Other|2
1782420|NCT00650806|6205255|P2|Overall Study|Other|1
1782421|NCT00650806|6205256|P1|Overall Study|Other|1
1782422|NCT00650806|6205253|P4|Overall Study|Study terminated by sponsor|4
1782423|NCT00650806|6205254|P3|Overall Study|Study terminated by sponsor|5
1782424|NCT00650806|6205255|P2|Overall Study|Study terminated by sponsor|3
1782425|NCT00650806|6205256|P1|Overall Study|Study terminated by sponsor|2
1782426|NCT00650806|6205253|P4|Overall Study|Noncompliance with study drug regimen|0
1782427|NCT00650806|6205254|P3|Overall Study|Noncompliance with study drug regimen|0
1782428|NCT00650806|6205255|P2|Overall Study|Noncompliance with study drug regimen|1
1782429|NCT00650806|6205256|P1|Overall Study|Noncompliance with study drug regimen|1
1782430|NCT00650806|6205253|P4|Overall Study|Withdrawal by Subject|6
1782431|NCT00650806|6205254|P3|Overall Study|Withdrawal by Subject|8
1782432|NCT00650806|6205255|P2|Overall Study|Withdrawal by Subject|5
1782433|NCT00650806|6205256|P1|Overall Study|Withdrawal by Subject|7
1782434|NCT00650806|6205253|P4|Overall Study|Pregnancy|1
1782435|NCT00650806|6205254|P3|Overall Study|Pregnancy|0
1782436|NCT00650806|6205255|P2|Overall Study|Pregnancy|0
1782437|NCT00650806|6205256|P1|Overall Study|Pregnancy|0
1782438|NCT00650806|6205253|P4|Overall Study|Protocol Violation|1
1782439|NCT00650806|6205254|P3|Overall Study|Protocol Violation|0
1782440|NCT00650806|6205255|P2|Overall Study|Protocol Violation|0
1782441|NCT00650806|6205256|P1|Overall Study|Protocol Violation|0
1782442|NCT00650806|6205253|P4|Overall Study|Lost to Follow-up|10
1782443|NCT00650806|6205254|P3|Overall Study|Lost to Follow-up|11
1782444|NCT00650806|6205255|P2|Overall Study|Lost to Follow-up|6
1782445|NCT00650806|6205256|P1|Overall Study|Lost to Follow-up|7
1782446|NCT00650806|6205253|P4|Overall Study|Adverse Event|4
1782447|NCT00650806|6205254|P3|Overall Study|Adverse Event|3
1782448|NCT00650806|6205255|P2|Overall Study|Adverse Event|5
1782449|NCT00650806|6205256|P1|Overall Study|Adverse Event|0
1782450|NCT00650767|6205298|P4|Overall Study|Other|0
1782451|NCT00650767|6205299|P3|Overall Study|Other|0
1782452|NCT00650767|6205300|P2|Overall Study|Other|1
1782453|NCT00650767|6205301|P1|Overall Study|Other|1
1782454|NCT00650767|6205298|P4|Overall Study|Lost to Follow-up|0
1782455|NCT00650767|6205299|P3|Overall Study|Lost to Follow-up|1
1782456|NCT00650767|6205300|P2|Overall Study|Lost to Follow-up|1
1782457|NCT00650767|6205301|P1|Overall Study|Lost to Follow-up|1
1782458|NCT00650767|6205298|P4|Overall Study|Withdrawal by Subject|3
1782459|NCT00650767|6205299|P3|Overall Study|Withdrawal by Subject|3
1782460|NCT00650767|6205300|P2|Overall Study|Withdrawal by Subject|4
1782461|NCT00650767|6205301|P1|Overall Study|Withdrawal by Subject|2
1782462|NCT00650767|6205298|P4|Overall Study|Death|0
1782463|NCT00650767|6205299|P3|Overall Study|Death|0
1782464|NCT00650767|6205300|P2|Overall Study|Death|0
1782465|NCT00650767|6205301|P1|Overall Study|Death|1
1782466|NCT00650767|6205298|P4|Overall Study|Adverse Event|8
1782467|NCT00650767|6205299|P3|Overall Study|Adverse Event|10
1782468|NCT00650767|6205300|P2|Overall Study|Adverse Event|3
1782469|NCT00650767|6205301|P1|Overall Study|Adverse Event|0
1782470|NCT00650585|6205805|P2|Overall Study|Excluded/ruled ineligible|129
1782471|NCT00650585|6205806|P1|Overall Study|Excluded/ruled ineligible|357
1782472|NCT00650585|6205805|P2|Overall Study|No parental consent|866
1782473|NCT00650585|6205806|P1|Overall Study|No parental consent|935
1782474|NCT00650585|6205805|P2|Overall Study|Lost to Follow-up|482
1782475|NCT00650585|6205806|P1|Overall Study|Lost to Follow-up|505
1782476|NCT00650104|6205850|P1|Overall Study|Sponsor Terminated Dosing|1
1782477|NCT00650104|6205850|P1|Overall Study|Non-compliance|2
1782478|NCT00650104|6205850|P1|Overall Study|Lost to Follow-up|1
1782479|NCT00650104|6205850|P1|Overall Study|Physician Decision|7
1782480|NCT00650104|6205850|P1|Overall Study|Withdrawal by Subject|11
1782481|NCT00650104|6205850|P1|Overall Study|Death|2
1782482|NCT00650104|6205850|P1|Overall Study|Adverse Event|17
1782483|NCT00650091|6205865|P3|Amended Study Design|Other|0
1782484|NCT00650091|6205866|P2|Amended Study Design|Other|3
1782485|NCT00650091|6205867|P1|Amended Study Design|Other|1
1782486|NCT00650091|6205865|P3|Amended Study Design|Lung transplantation|0
1782487|NCT00650091|6205866|P2|Amended Study Design|Lung transplantation|2
1782488|NCT00650091|6205867|P1|Amended Study Design|Lung transplantation|4
1782489|NCT00650091|6205865|P3|Amended Study Design|Adverse Event|0
1782490|NCT00650091|6205866|P2|Amended Study Design|Adverse Event|4
1782491|NCT00650091|6205867|P1|Amended Study Design|Adverse Event|1
1782492|NCT00650091|6205865|P3|Amended Study Design|Physician Decision|0
1782493|NCT00650091|6205866|P2|Amended Study Design|Physician Decision|0
1782494|NCT00650091|6205867|P1|Amended Study Design|Physician Decision|5
1782495|NCT00650091|6205865|P3|Amended Study Design|Withdrawal by Subject|0
1782496|NCT00650091|6205866|P2|Amended Study Design|Withdrawal by Subject|11
1782497|NCT00650091|6205867|P1|Amended Study Design|Withdrawal by Subject|12
1782498|NCT00649428|6205910|P2|Overall Study|Physician Decision|1
1782499|NCT00649428|6205911|P1|Overall Study|Physician Decision|0
1782500|NCT00649428|6205910|P2|Overall Study|Protocol Violation|2
1782501|NCT00649428|6205911|P1|Overall Study|Protocol Violation|6
1782502|NCT00649428|6205910|P2|Overall Study|Insufficient manufacturing yield|1
1782503|NCT00649428|6205911|P1|Overall Study|Insufficient manufacturing yield|5
1782504|NCT00649428|6205910|P2|Overall Study|Lost to Follow-up|3
1782505|NCT00649428|6205911|P1|Overall Study|Lost to Follow-up|1
1782506|NCT00649428|6205910|P2|Overall Study|Withdrawal by Subject|6
1782507|NCT00649428|6205911|P1|Overall Study|Withdrawal by Subject|6
1782508|NCT00649428|6205910|P2|Overall Study|Adverse Event|2
1782509|NCT00649428|6205911|P1|Overall Study|Adverse Event|2
1782510|NCT00649389|6205927|P4|Overall Study|Other|6
1782511|NCT00649389|6205928|P3|Overall Study|Other|1
1782512|NCT00649389|6205929|P2|Overall Study|Other|9
1782513|NCT00649389|6205930|P1|Overall Study|Other|3
1782514|NCT00649389|6205927|P4|Overall Study|Withdrawal by Subject|23
1782515|NCT00649389|6205928|P3|Overall Study|Withdrawal by Subject|19
1782516|NCT00649389|6205929|P2|Overall Study|Withdrawal by Subject|21
1782517|NCT00649389|6205930|P1|Overall Study|Withdrawal by Subject|20
1782518|NCT00649389|6205927|P4|Overall Study|Protocol Violation|8
1782519|NCT00649389|6205928|P3|Overall Study|Protocol Violation|9
1782520|NCT00649389|6205929|P2|Overall Study|Protocol Violation|13
1782521|NCT00649389|6205930|P1|Overall Study|Protocol Violation|11
1782522|NCT00649389|6205927|P4|Overall Study|Lost to Follow-up|26
1782523|NCT00649389|6205928|P3|Overall Study|Lost to Follow-up|21
1782524|NCT00649389|6205929|P2|Overall Study|Lost to Follow-up|17
1782525|NCT00649389|6205930|P1|Overall Study|Lost to Follow-up|15
1782526|NCT00649389|6205927|P4|Overall Study|Adverse Event|48
1782527|NCT00649389|6205928|P3|Overall Study|Adverse Event|38
1782528|NCT00649389|6205929|P2|Overall Study|Adverse Event|46
1782529|NCT00649389|6205930|P1|Overall Study|Adverse Event|22
1782530|NCT00649220|6205952|P1|Overall Study|Withdrawal by Subject|1
1782531|NCT00649220|6205952|P1|Overall Study|Adverse Event|2
1782532|NCT00648895|6205973|P2|Overall Study|Lack of Efficacy|1
1782533|NCT00648895|6205974|P1|Overall Study|Lack of Efficacy|0
1782534|NCT00648739|6205980|P7|Overall Study|Follow-up Visits Not Completed|0
1782535|NCT00648739|6205981|P6|Overall Study|Follow-up Visits Not Completed|0
1782536|NCT00648739|6205982|P5|Overall Study|Follow-up Visits Not Completed|0
1782537|NCT00648739|6205983|P4|Overall Study|Follow-up Visits Not Completed|0
1782538|NCT00648739|6205984|P3|Overall Study|Follow-up Visits Not Completed|0
1782539|NCT00648739|6205985|P2|Overall Study|Follow-up Visits Not Completed|1
1782540|NCT00648739|6205986|P1|Overall Study|Follow-up Visits Not Completed|0
1782541|NCT00648739|6205980|P7|Overall Study|Positive Human Anti-human Antibody|0
1782542|NCT00648739|6205981|P6|Overall Study|Positive Human Anti-human Antibody|0
1782543|NCT00648739|6205982|P5|Overall Study|Positive Human Anti-human Antibody|0
1782544|NCT00648739|6205983|P4|Overall Study|Positive Human Anti-human Antibody|0
1782545|NCT00648739|6205984|P3|Overall Study|Positive Human Anti-human Antibody|1
1782546|NCT00648739|6205985|P2|Overall Study|Positive Human Anti-human Antibody|0
1782547|NCT00648739|6205986|P1|Overall Study|Positive Human Anti-human Antibody|0
1782548|NCT00648739|6205980|P7|Overall Study|Death|0
1782549|NCT00648739|6205981|P6|Overall Study|Death|0
1782550|NCT00648739|6205982|P5|Overall Study|Death|0
1782551|NCT00648739|6205983|P4|Overall Study|Death|0
1782552|NCT00648739|6205984|P3|Overall Study|Death|0
1782553|NCT00648739|6205985|P2|Overall Study|Death|1
1782554|NCT00648739|6205986|P1|Overall Study|Death|0
1782555|NCT00648739|6205980|P7|Overall Study|Investigator Considered it Advisable|1
1782556|NCT00648739|6205981|P6|Overall Study|Investigator Considered it Advisable|1
1782557|NCT00648739|6205982|P5|Overall Study|Investigator Considered it Advisable|0
1782558|NCT00648739|6205983|P4|Overall Study|Investigator Considered it Advisable|0
1782559|NCT00648739|6205984|P3|Overall Study|Investigator Considered it Advisable|0
1782560|NCT00648739|6205985|P2|Overall Study|Investigator Considered it Advisable|0
1782561|NCT00648739|6205986|P1|Overall Study|Investigator Considered it Advisable|0
1782562|NCT00648739|6205980|P7|Overall Study|Lack of Efficacy|0
1782563|NCT00648739|6205981|P6|Overall Study|Lack of Efficacy|2
1782564|NCT00648739|6205982|P5|Overall Study|Lack of Efficacy|1
1782565|NCT00648739|6205983|P4|Overall Study|Lack of Efficacy|0
1782566|NCT00648739|6205984|P3|Overall Study|Lack of Efficacy|0
1782567|NCT00648739|6205985|P2|Overall Study|Lack of Efficacy|0
1782568|NCT00648739|6205986|P1|Overall Study|Lack of Efficacy|0
1782569|NCT00648739|6205980|P7|Overall Study|Withdrawal by Subject|0
1782570|NCT00648739|6205981|P6|Overall Study|Withdrawal by Subject|2
1782571|NCT00648739|6205982|P5|Overall Study|Withdrawal by Subject|0
1782572|NCT00648739|6205983|P4|Overall Study|Withdrawal by Subject|0
1782573|NCT00648739|6205984|P3|Overall Study|Withdrawal by Subject|1
1782574|NCT00648739|6205985|P2|Overall Study|Withdrawal by Subject|0
1782575|NCT00648739|6205986|P1|Overall Study|Withdrawal by Subject|1
1782576|NCT00648739|6205980|P7|Overall Study|Adverse Event|0
1782577|NCT00648739|6205981|P6|Overall Study|Adverse Event|0
1782578|NCT00648739|6205982|P5|Overall Study|Adverse Event|1
1782579|NCT00648739|6205983|P4|Overall Study|Adverse Event|2
1782580|NCT00648739|6205984|P3|Overall Study|Adverse Event|1
1782581|NCT00648739|6205985|P2|Overall Study|Adverse Event|0
1782582|NCT00648739|6205986|P1|Overall Study|Adverse Event|1
1782583|NCT00648167|6206320|P1|Overall Study|unable to swallow tablets|1
1782584|NCT00648167|6206320|P1|Overall Study|Adverse Event|6
1782585|NCT00648037|6206340|P1|Overall Study|Other|1
1782586|NCT00648037|6206340|P1|Overall Study|Relapse|2
1782587|NCT00648037|6206340|P1|Overall Study|Adverse Event|11
1782588|NCT00648037|6206340|P1|Overall Study|Withdrawal by Subject|1
1782589|NCT00648037|6206340|P1|Overall Study|Not Treated|1
1782590|NCT00647699|6206359|P2|Overall Study|Withdrawal by Subject|8
1782591|NCT00647699|6206360|P1|Overall Study|Withdrawal by Subject|3
1782592|NCT00647699|6206359|P2|Overall Study|Lost to Follow-up|4
1782593|NCT00647699|6206360|P1|Overall Study|Lost to Follow-up|5
1782594|NCT00647556|6206368|P2|Overall Study|Surgery for pre-existing neck pain|0
1782595|NCT00647556|6206369|P1|Overall Study|Surgery for pre-existing neck pain|1
1782596|NCT00647556|6206368|P2|Overall Study|Withdrawal by Subject|0
1782597|NCT00647556|6206369|P1|Overall Study|Withdrawal by Subject|1
1782598|NCT00647556|6206368|P2|Overall Study|Protocol Violation|1
1782599|NCT00647556|6206369|P1|Overall Study|Protocol Violation|0
1782600|NCT00647556|6206368|P2|Overall Study|Lost to Follow-up|0
1782601|NCT00647556|6206369|P1|Overall Study|Lost to Follow-up|1
1782602|NCT00647556|6206368|P2|Overall Study|Adverse Event|1
1782603|NCT00647556|6206369|P1|Overall Study|Adverse Event|0
1782604|NCT00647426|6206383|P1|Overall Study|Withdrawal by Subject|2
1782605|NCT00647348|6206405|P2|Overall Study|Lost to Follow-up|6
1782606|NCT00647348|6206406|P1|Overall Study|Lost to Follow-up|3
1782607|NCT00647270|6206431|P3|Period 2, Placebo Switched to Adalimumab|Other|0
1782608|NCT00647270|6206432|P2|Period 2, Placebo Switched to Adalimumab|Other|6
1782609|NCT00647270|6206433|P1|Period 2, Placebo Switched to Adalimumab|Other|2
1782610|NCT00647270|6206431|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
1782611|NCT00647270|6206432|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
1782612|NCT00647270|6206433|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
1782613|NCT00647270|6206431|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
1782614|NCT00647270|6206432|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
1782615|NCT00647270|6206433|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
1782616|NCT00647270|6206431|P3|Period 1, Placebo-control (12 Weeks)|Other|8
1782617|NCT00647270|6206432|P2|Period 1, Placebo-control (12 Weeks)|Other|4
1782618|NCT00647270|6206433|P1|Period 1, Placebo-control (12 Weeks)|Other|4
1782619|NCT00647270|6206431|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
1782620|NCT00647270|6206432|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
1782621|NCT00647270|6206433|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
1782622|NCT00647270|6206431|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
1782623|NCT00647270|6206432|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
1782624|NCT00647270|6206433|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
1782625|NCT00647270|6206431|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
1782626|NCT00647270|6206432|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
1782627|NCT00647270|6206433|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
1782628|NCT00646958|6206459|P3|Overall Study|Did not receive study drug|2
1782629|NCT00646958|6206460|P2|Overall Study|Did not receive study drug|0
1782630|NCT00646958|6206461|P1|Overall Study|Did not receive study drug|2
1782631|NCT00646958|6206459|P3|Overall Study|Withdrawal by Subject|0
1782632|NCT00646958|6206460|P2|Overall Study|Withdrawal by Subject|2
1782633|NCT00646958|6206461|P1|Overall Study|Withdrawal by Subject|1
1782634|NCT00646958|6206459|P3|Overall Study|Abnormal screening lab tests|0
1782635|NCT00646958|6206460|P2|Overall Study|Abnormal screening lab tests|1
1782636|NCT00646958|6206461|P1|Overall Study|Abnormal screening lab tests|1
1782637|NCT00646958|6206459|P3|Overall Study|Protocol Violation|0
1782638|NCT00646958|6206460|P2|Overall Study|Protocol Violation|1
1782639|NCT00646958|6206461|P1|Overall Study|Protocol Violation|1
1782640|NCT00646958|6206459|P3|Overall Study|Lost to Follow-up|7
1782641|NCT00646958|6206460|P2|Overall Study|Lost to Follow-up|5
1782642|NCT00646958|6206461|P1|Overall Study|Lost to Follow-up|1
1782643|NCT00646958|6206459|P3|Overall Study|Adverse Event|0
1782644|NCT00646958|6206460|P2|Overall Study|Adverse Event|0
1782645|NCT00646958|6206461|P1|Overall Study|Adverse Event|4
1782646|NCT00646958|6206459|P3|Overall Study|Lack of Efficacy|0
1782647|NCT00646958|6206460|P2|Overall Study|Lack of Efficacy|0
1782648|NCT00646958|6206461|P1|Overall Study|Lack of Efficacy|1
1782649|NCT00646906|6206476|P7|Crossover Period 2|Physician Decision|1
1782650|NCT00646906|6206477|P6|Crossover Period 2|Physician Decision|0
1782651|NCT00646906|6206478|P5|Crossover Period 2|Physician Decision|0
1782652|NCT00646906|6206479|P4|Crossover Period 2|Physician Decision|0
1782653|NCT00646906|6206480|P3|Crossover Period 2|Physician Decision|0
1782654|NCT00646906|6206481|P2|Crossover Period 2|Physician Decision|0
1782655|NCT00646906|6206482|P1|Crossover Period 2|Physician Decision|0
1782656|NCT00646906|6206476|P7|Crossover Period 2|Withdrawal by Subject|0
1782657|NCT00646906|6206477|P6|Crossover Period 2|Withdrawal by Subject|0
1782658|NCT00646906|6206478|P5|Crossover Period 2|Withdrawal by Subject|0
1782659|NCT00646906|6206479|P4|Crossover Period 2|Withdrawal by Subject|1
1782660|NCT00646906|6206480|P3|Crossover Period 2|Withdrawal by Subject|2
1782661|NCT00646906|6206481|P2|Crossover Period 2|Withdrawal by Subject|1
1782662|NCT00646906|6206482|P1|Crossover Period 2|Withdrawal by Subject|0
1782663|NCT00646906|6206476|P7|Crossover Period 1|Withdrawal by Subject|0
1782664|NCT00646906|6206477|P6|Crossover Period 1|Withdrawal by Subject|1
1782665|NCT00646906|6206478|P5|Crossover Period 1|Withdrawal by Subject|0
1782666|NCT00646906|6206479|P4|Crossover Period 1|Withdrawal by Subject|0
1782667|NCT00646906|6206480|P3|Crossover Period 1|Withdrawal by Subject|0
1782668|NCT00646906|6206481|P2|Crossover Period 1|Withdrawal by Subject|0
1782669|NCT00646906|6206482|P1|Crossover Period 1|Withdrawal by Subject|1
1782670|NCT00646776|6206501|P2|Overall Study|Investigator discretion|4
1782671|NCT00646776|6206502|P1|Overall Study|Investigator discretion|0
1782672|NCT00646776|6206501|P2|Overall Study|Adverse Event|9
1782673|NCT00646776|6206502|P1|Overall Study|Adverse Event|1
1782674|NCT00646399|6206600|P2|Overall Study|Other Reason|11
1782675|NCT00646399|6206601|P1|Overall Study|Other Reason|11
1782676|NCT00646399|6206600|P2|Overall Study|Withdrawal by Subject|10
1782677|NCT00646399|6206601|P1|Overall Study|Withdrawal by Subject|9
1782678|NCT00646399|6206600|P2|Overall Study|Death|53
1782679|NCT00646399|6206601|P1|Overall Study|Death|63
1782680|NCT00646282|6206609|P2|Overall Study|Protocol terminated|4
1782681|NCT00646282|6206610|P1|Overall Study|Protocol terminated|4
1782682|NCT00646113|6206616|P1|Overall Study|Adverse Event|3
1782683|NCT00646113|6206616|P1|Overall Study|Lost to Follow-up|5
1782684|NCT00645944|6206637|P2|Received Medication|Protocol Violation|1
1782685|NCT00645944|6206638|P1|Received Medication|Protocol Violation|2
1782686|NCT00645944|6206637|P2|Received Medication|Lost to Follow-up|0
1782687|NCT00645944|6206638|P1|Received Medication|Lost to Follow-up|1
1782688|NCT00645944|6206637|P2|Received Medication|Withdrawal by Subject|1
1782689|NCT00645944|6206638|P1|Received Medication|Withdrawal by Subject|1
1782690|NCT00645944|6206637|P2|Received Medication|Adverse Event|1
1782691|NCT00645944|6206638|P1|Received Medication|Adverse Event|2
1782692|NCT00645944|6206637|P2|Randomized|Withdrawal by Subject|2
1782693|NCT00645944|6206638|P1|Randomized|Withdrawal by Subject|1
1782694|NCT00645853|6206646|P2|Overall Study|recall of ICF, planned operation, death|4
1782695|NCT00645853|6206647|P1|Overall Study|recall of ICF, planned operation, death|7
1782696|NCT00645853|6206646|P2|Overall Study|Discontinuation criteria|2
1782697|NCT00645853|6206647|P1|Overall Study|Discontinuation criteria|2
1782698|NCT00645853|6206646|P2|Overall Study|Protocol Violation|2
1782699|NCT00645853|6206647|P1|Overall Study|Protocol Violation|0
1782700|NCT00645853|6206646|P2|Overall Study|Withdrawal by Subject|2
1782701|NCT00645853|6206647|P1|Overall Study|Withdrawal by Subject|5
1782702|NCT00645853|6206646|P2|Overall Study|AZ study closure in Hungary|40
1782703|NCT00645853|6206647|P1|Overall Study|AZ study closure in Hungary|60
1782704|NCT00645853|6206646|P2|Overall Study|Adverse Event|7
1782705|NCT00645853|6206647|P1|Overall Study|Adverse Event|18
1782706|NCT00645840|6206665|P1|Overall Study|Protocol Violation|3
1782707|NCT00645788|6206683|P4|Overall Study|Pulmonary exacerbation|9
1782708|NCT00645788|6206684|P3|Overall Study|Pulmonary exacerbation|11
1782709|NCT00645788|6206685|P2|Overall Study|Pulmonary exacerbation|16
1782710|NCT00645788|6206686|P1|Overall Study|Pulmonary exacerbation|13
1782711|NCT00645788|6206683|P4|Overall Study|Withdrawal by Subject|2
1782712|NCT00645788|6206684|P3|Overall Study|Withdrawal by Subject|0
1782713|NCT00645788|6206685|P2|Overall Study|Withdrawal by Subject|1
1782714|NCT00645788|6206686|P1|Overall Study|Withdrawal by Subject|0
1782715|NCT00645788|6206683|P4|Overall Study|Protocol Violation|0
1782716|NCT00645788|6206684|P3|Overall Study|Protocol Violation|2
1782717|NCT00645788|6206685|P2|Overall Study|Protocol Violation|0
1782718|NCT00645788|6206686|P1|Overall Study|Protocol Violation|1
1782719|NCT00645788|6206683|P4|Overall Study|Lost to Follow-up|0
1782720|NCT00645788|6206684|P3|Overall Study|Lost to Follow-up|0
1782721|NCT00645788|6206685|P2|Overall Study|Lost to Follow-up|0
1782722|NCT00645788|6206686|P1|Overall Study|Lost to Follow-up|1
1782723|NCT00645788|6206683|P4|Overall Study|Adverse Event|3
1782724|NCT00645788|6206684|P3|Overall Study|Adverse Event|5
1782725|NCT00645788|6206685|P2|Overall Study|Adverse Event|9
1782726|NCT00645788|6206686|P1|Overall Study|Adverse Event|4
1782727|NCT00645788|6206683|P4|Overall Study|Did not receive study drug|0
1782728|NCT00645788|6206684|P3|Overall Study|Did not receive study drug|0
1782729|NCT00645788|6206685|P2|Overall Study|Did not receive study drug|1
1782730|NCT00645788|6206686|P1|Overall Study|Did not receive study drug|1
1782731|NCT00645671|6206764|P2|Overall Study|Physician Decision|1
1782732|NCT00645671|6206765|P1|Overall Study|Physician Decision|0
1782733|NCT00645671|6206764|P2|Overall Study|Adverse Event|1
1782734|NCT00645671|6206765|P1|Overall Study|Adverse Event|0
1782735|NCT00645671|6206764|P2|Overall Study|Withdrawal by Subject|4
1782736|NCT00645671|6206765|P1|Overall Study|Withdrawal by Subject|0
1782737|NCT00645671|6206764|P2|Overall Study|Protocol Violation|0
1782738|NCT00645671|6206765|P1|Overall Study|Protocol Violation|1
1782739|NCT00645593|6206779|P2|Overall Study|Later found to be ineligible|0
1782740|NCT00645593|6206780|P1|Overall Study|Later found to be ineligible|1
1782741|NCT00645567|6206792|P1|Overall Study|Adverse Event|1
1782742|NCT00645528|6206800|P1|Overall Study|Did not show up for Visit 2|7
1782743|NCT00645411|6206822|P4|Overall Study|Unable to classify|4
1782744|NCT00645411|6206823|P3|Overall Study|Unable to classify|3
1782745|NCT00645411|6206824|P2|Overall Study|Unable to classify|0
1782746|NCT00645411|6206825|P1|Overall Study|Unable to classify|0
1782747|NCT00645411|6206822|P4|Overall Study|Inappropriate enrollment|1
1782748|NCT00645411|6206823|P3|Overall Study|Inappropriate enrollment|4
1782749|NCT00645411|6206824|P2|Overall Study|Inappropriate enrollment|0
1782750|NCT00645411|6206825|P1|Overall Study|Inappropriate enrollment|0
1782751|NCT00645411|6206822|P4|Overall Study|Protocol Violation|0
1782752|NCT00645411|6206823|P3|Overall Study|Protocol Violation|1
1782753|NCT00645411|6206824|P2|Overall Study|Protocol Violation|0
1782754|NCT00645411|6206825|P1|Overall Study|Protocol Violation|1
1782755|NCT00645411|6206822|P4|Overall Study|Lost to Follow-up|75
1782756|NCT00645411|6206823|P3|Overall Study|Lost to Follow-up|124
1782757|NCT00645411|6206824|P2|Overall Study|Lost to Follow-up|5
1782758|NCT00645411|6206825|P1|Overall Study|Lost to Follow-up|10
1782759|NCT00645411|6206822|P4|Overall Study|Withdrawal by Subject|21
1782760|NCT00645411|6206823|P3|Overall Study|Withdrawal by Subject|19
1782761|NCT00645411|6206824|P2|Overall Study|Withdrawal by Subject|1
1782762|NCT00645411|6206825|P1|Overall Study|Withdrawal by Subject|2
1782763|NCT00645411|6206822|P4|Overall Study|Adverse Event|2
1782764|NCT00645411|6206823|P3|Overall Study|Adverse Event|0
1782765|NCT00645411|6206824|P2|Overall Study|Adverse Event|0
1782766|NCT00645411|6206825|P1|Overall Study|Adverse Event|0
1782767|NCT00645164|6206867|P1|Overall Study|Protocol Violation|1
1782768|NCT00645164|6206867|P1|Overall Study|Withdrawal by Subject|4
1782769|NCT00645164|6206867|P1|Overall Study|Lost to Follow-up|2
1782770|NCT00645099|6206873|P2|Overall Study|Other|5
1782771|NCT00645099|6206874|P1|Overall Study|Other|9
1782772|NCT00645099|6206873|P2|Overall Study|Adverse Event|5
1782773|NCT00645099|6206874|P1|Overall Study|Adverse Event|11
1782774|NCT00645099|6206873|P2|Overall Study|Lost to Follow-up|4
1782775|NCT00645099|6206874|P1|Overall Study|Lost to Follow-up|6
1782776|NCT00645099|6206873|P2|Overall Study|Withdrawal by Subject|22
1782777|NCT00645099|6206874|P1|Overall Study|Withdrawal by Subject|30
1782778|NCT00645099|6206873|P2|Overall Study|Lack of Efficacy|6
1782779|NCT00645099|6206874|P1|Overall Study|Lack of Efficacy|15
1782780|NCT00644995|6206943|P2|Overall Study|Refused|0
1782781|NCT00644995|6206944|P1|Overall Study|Refused|1
1782782|NCT00644995|6206943|P2|Overall Study|Lost to Follow-up|4
1782783|NCT00644995|6206944|P1|Overall Study|Lost to Follow-up|1
1782784|NCT00644969|6206964|P2|Post Treatment Phase|Other|0
1782785|NCT00644969|6206965|P1|Post Treatment Phase|Other|1
1782786|NCT00644969|6206964|P2|Post Treatment Phase|Lost to Follow-up|1
1782787|NCT00644969|6206965|P1|Post Treatment Phase|Lost to Follow-up|4
1782788|NCT00644969|6206964|P2|Post Treatment Phase|Withdrawal by Subject|2
1782789|NCT00644969|6206965|P1|Post Treatment Phase|Withdrawal by Subject|4
1782790|NCT00644969|6206964|P2|Post Treatment Phase|Death|0
1782791|NCT00644969|6206965|P1|Post Treatment Phase|Death|1
1782792|NCT00644969|6206964|P2|Treatment Phase|Other|1
1782793|NCT00644969|6206965|P1|Treatment Phase|Other|4
1782794|NCT00644969|6206964|P2|Treatment Phase|Lost to Follow-up|2
1782795|NCT00644969|6206965|P1|Treatment Phase|Lost to Follow-up|2
1782796|NCT00644969|6206964|P2|Treatment Phase|Withdrawal by Subject|0
1782797|NCT00644969|6206965|P1|Treatment Phase|Withdrawal by Subject|4
1782798|NCT00644969|6206964|P2|Treatment Phase|Adverse Event|0
1782799|NCT00644969|6206965|P1|Treatment Phase|Adverse Event|3
1782800|NCT00644969|6206964|P2|Treatment Phase|Randomized, not treated|0
1782801|NCT00644969|6206965|P1|Treatment Phase|Randomized, not treated|1
1782802|NCT00644917|6207011|P1|Overall Study|Withdrawal by Subject|2
1782803|NCT00644787|6207019|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
1782804|NCT00644787|6207020|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
1782805|NCT00644787|6207021|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
1782806|NCT00644787|6207019|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
1782807|NCT00644787|6207020|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
1782808|NCT00644787|6207021|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
1782809|NCT00644787|6207019|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
1782810|NCT00644787|6207020|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
1782811|NCT00644787|6207021|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
1782812|NCT00644787|6207019|P3|Period 2: Double Blind Phase|Adverse Event|4
1782813|NCT00644787|6207020|P2|Period 2: Double Blind Phase|Adverse Event|2
1782814|NCT00644787|6207021|P1|Period 2: Double Blind Phase|Adverse Event|0
1782815|NCT00644787|6207019|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
1782816|NCT00644787|6207020|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
1782817|NCT00644787|6207021|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
1782818|NCT00644787|6207019|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
1782819|NCT00644787|6207020|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
1782820|NCT00644787|6207021|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
1782821|NCT00644787|6207019|P3|Period 1: Titration Phase|Worsening of symptoms|0
1782822|NCT00644787|6207020|P2|Period 1: Titration Phase|Worsening of symptoms|0
1782823|NCT00644787|6207021|P1|Period 1: Titration Phase|Worsening of symptoms|1
1782824|NCT00644787|6207019|P3|Period 1: Titration Phase|Worsening of complications|0
1782825|NCT00644787|6207020|P2|Period 1: Titration Phase|Worsening of complications|0
1782826|NCT00644787|6207021|P1|Period 1: Titration Phase|Worsening of complications|1
1782827|NCT00644787|6207019|P3|Period 1: Titration Phase|Worsening of underlying disease|0
1782828|NCT00644787|6207020|P2|Period 1: Titration Phase|Worsening of underlying disease|0
1782829|NCT00644787|6207021|P1|Period 1: Titration Phase|Worsening of underlying disease|5
1782830|NCT00644787|6207019|P3|Period 1: Titration Phase|Physician Decision|0
1782831|NCT00644787|6207020|P2|Period 1: Titration Phase|Physician Decision|0
1782832|NCT00644787|6207021|P1|Period 1: Titration Phase|Physician Decision|1
1782833|NCT00644787|6207019|P3|Period 1: Titration Phase|Withdrawal by Subject|0
1782834|NCT00644787|6207020|P2|Period 1: Titration Phase|Withdrawal by Subject|0
1782835|NCT00644787|6207021|P1|Period 1: Titration Phase|Withdrawal by Subject|2
1782836|NCT00644787|6207019|P3|Period 1: Titration Phase|Adverse Event|0
1782837|NCT00644787|6207020|P2|Period 1: Titration Phase|Adverse Event|0
1782838|NCT00644787|6207021|P1|Period 1: Titration Phase|Adverse Event|11
1782839|NCT00644423|6207065|P2|Overall Study|Lost to Follow-up|1
1782840|NCT00644423|6207066|P1|Overall Study|Lost to Follow-up|1
1782841|NCT00644358|6207084|P1|Overall Study|Other Unspecified|11
1782842|NCT00644358|6207084|P1|Overall Study|Noncompliance|14
1782843|NCT00644358|6207084|P1|Overall Study|Protocol Violation|5
1782844|NCT00644358|6207084|P1|Overall Study|Lack of Effectiveness|39
1782845|NCT00644358|6207084|P1|Overall Study|Consent Withdrawal|64
1782846|NCT00644358|6207084|P1|Overall Study|Lost to Follow-up|105
1782847|NCT00644358|6207084|P1|Overall Study|Adverse Event|124
1782848|NCT00644332|6207091|P1|Overall Study|Could Not Attend Scheduled Visits|1
1782849|NCT00644332|6207091|P1|Overall Study|Did Not Meet Eligibility Requirements|1
1782850|NCT00644332|6207091|P1|Overall Study|Completion Status Unknown|2
1782851|NCT00644332|6207091|P1|Overall Study|Withdrawal by Subject|6
1782852|NCT00644332|6207091|P1|Overall Study|Adverse Event|11
1782853|NCT00644228|6207117|P2|Maintenance|On Treatment|40
1782854|NCT00644228|6207118|P1|Maintenance|On Treatment|26
1782855|NCT00644228|6207117|P2|Maintenance|Not Protocol-Specified|15
1782856|NCT00644228|6207118|P1|Maintenance|Not Protocol-Specified|14
1782857|NCT00644228|6207117|P2|Maintenance|Death|3
1782858|NCT00644228|6207118|P1|Maintenance|Death|3
1782859|NCT00644228|6207117|P2|Maintenance|Progression/Relapse|42
1782860|NCT00644228|6207118|P1|Maintenance|Progression/Relapse|67
1782861|NCT00644228|6207117|P2|Maintenance|Withdrawal by Subject|4
1782862|NCT00644228|6207118|P1|Maintenance|Withdrawal by Subject|6
1782863|NCT00644228|6207117|P2|Maintenance|Adverse Event|31
1782864|NCT00644228|6207118|P1|Maintenance|Adverse Event|27
1782865|NCT00644228|6207117|P2|Induction Therapy|Not Protocol-Specified|28
1782866|NCT00644228|6207118|P1|Induction Therapy|Not Protocol-Specified|24
1782867|NCT00644228|6207117|P2|Induction Therapy|Death|7
1782868|NCT00644228|6207118|P1|Induction Therapy|Death|3
1782869|NCT00644228|6207117|P2|Induction Therapy|Progression/Relapse|12
1782870|NCT00644228|6207118|P1|Induction Therapy|Progression/Relapse|24
1782871|NCT00644228|6207117|P2|Induction Therapy|Withdrawal by Subject|3
1782872|NCT00644228|6207118|P1|Induction Therapy|Withdrawal by Subject|10
1782873|NCT00644228|6207117|P2|Induction Therapy|Adverse Event|55
1782874|NCT00644228|6207118|P1|Induction Therapy|Adverse Event|22
1782875|NCT00644228|6207117|P2|Randomization & Eligibility|Invalid Consent|1
1782876|NCT00644228|6207118|P1|Randomization & Eligibility|Invalid Consent|0
1782877|NCT00644228|6207117|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
1782878|NCT00644228|6207118|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
1782879|NCT00644228|6207117|P2|Randomization & Eligibility|Ineligible|21
1782880|NCT00644228|6207118|P1|Randomization & Eligibility|Ineligible|31
1782881|NCT00644059|6207147|P3|Overall Study|Unable to classify|3
1782882|NCT00644059|6207148|P2|Overall Study|Unable to classify|2
1782883|NCT00644059|6207149|P1|Overall Study|Unable to classify|6
1782884|NCT00644059|6207147|P3|Overall Study|Protocol Deviation/violation|15
1782885|NCT00644059|6207148|P2|Overall Study|Protocol Deviation/violation|19
1782886|NCT00644059|6207149|P1|Overall Study|Protocol Deviation/violation|20
1782887|NCT00644059|6207147|P3|Overall Study|Inappropriate Enrollment|0
1782888|NCT00644059|6207148|P2|Overall Study|Inappropriate Enrollment|3
1782889|NCT00644059|6207149|P1|Overall Study|Inappropriate Enrollment|1
1782890|NCT00644059|6207147|P3|Overall Study|Adverse Event|1
1782891|NCT00644059|6207148|P2|Overall Study|Adverse Event|5
1782892|NCT00644059|6207149|P1|Overall Study|Adverse Event|8
1782893|NCT00644059|6207147|P3|Overall Study|Withdrawal by Subject|30
1782894|NCT00644059|6207148|P2|Overall Study|Withdrawal by Subject|60
1782895|NCT00644059|6207149|P1|Overall Study|Withdrawal by Subject|52
1782896|NCT00644059|6207147|P3|Overall Study|Lost to Follow-up|16
1782897|NCT00644059|6207148|P2|Overall Study|Lost to Follow-up|34
1782898|NCT00644059|6207149|P1|Overall Study|Lost to Follow-up|37
1782899|NCT00643916|6207239|P6|Overall Study|Not Vaccinated|0
1782900|NCT00643916|6207240|P5|Overall Study|Not Vaccinated|2
1782901|NCT00643916|6207241|P4|Overall Study|Not Vaccinated|0
1782902|NCT00643916|6207242|P3|Overall Study|Not Vaccinated|3
1782903|NCT00643916|6207243|P2|Overall Study|Not Vaccinated|2
1782904|NCT00643916|6207244|P1|Overall Study|Not Vaccinated|2
1782905|NCT00643916|6207239|P6|Overall Study|Withdrawal by Subject|1
1782906|NCT00643916|6207240|P5|Overall Study|Withdrawal by Subject|0
1782907|NCT00643916|6207241|P4|Overall Study|Withdrawal by Subject|1
1782908|NCT00643916|6207242|P3|Overall Study|Withdrawal by Subject|2
1782909|NCT00643916|6207243|P2|Overall Study|Withdrawal by Subject|2
1782910|NCT00643916|6207244|P1|Overall Study|Withdrawal by Subject|2
1782911|NCT00643916|6207239|P6|Overall Study|Lost to Follow-up|0
1782912|NCT00643916|6207240|P5|Overall Study|Lost to Follow-up|0
1782913|NCT00643916|6207241|P4|Overall Study|Lost to Follow-up|0
1782914|NCT00643916|6207242|P3|Overall Study|Lost to Follow-up|0
1782915|NCT00643916|6207243|P2|Overall Study|Lost to Follow-up|1
1782916|NCT00643916|6207244|P1|Overall Study|Lost to Follow-up|0
1782917|NCT00643916|6207239|P6|Overall Study|Protocol Violation|0
1782918|NCT00643916|6207240|P5|Overall Study|Protocol Violation|0
1782919|NCT00643916|6207241|P4|Overall Study|Protocol Violation|1
1782920|NCT00643916|6207242|P3|Overall Study|Protocol Violation|1
1782921|NCT00643916|6207243|P2|Overall Study|Protocol Violation|1
1782922|NCT00643916|6207244|P1|Overall Study|Protocol Violation|0
1782923|NCT00643851|6207273|P3|Overall Study|Non-compl., not met criteria, etc.|6
1782924|NCT00643851|6207274|P2|Overall Study|Non-compl., not met criteria, etc.|4
1782925|NCT00643851|6207275|P1|Overall Study|Non-compl., not met criteria, etc.|3
1782926|NCT00643851|6207273|P3|Overall Study|Withdrawal by Subject|9
1782927|NCT00643851|6207274|P2|Overall Study|Withdrawal by Subject|15
1782928|NCT00643851|6207275|P1|Overall Study|Withdrawal by Subject|8
1782929|NCT00643851|6207273|P3|Overall Study|Lost to Follow-up|9
1782930|NCT00643851|6207274|P2|Overall Study|Lost to Follow-up|6
1782931|NCT00643851|6207275|P1|Overall Study|Lost to Follow-up|4
1782932|NCT00643851|6207273|P3|Overall Study|Adverse Event|6
1782933|NCT00643851|6207274|P2|Overall Study|Adverse Event|6
1782934|NCT00643851|6207275|P1|Overall Study|Adverse Event|2
1782935|NCT00643851|6207273|P3|Overall Study|Lack of Efficacy|0
1782936|NCT00643851|6207274|P2|Overall Study|Lack of Efficacy|1
1782937|NCT00643851|6207275|P1|Overall Study|Lack of Efficacy|0
1782938|NCT00643851|6207273|P3|Overall Study|Death|0
1782939|NCT00643851|6207274|P2|Overall Study|Death|1
1782940|NCT00643851|6207275|P1|Overall Study|Death|0
1782941|NCT00643760|6207303|P5|Overall Study|Withdrawal by Subject|1
1782942|NCT00643760|6207304|P4|Overall Study|Withdrawal by Subject|4
1782943|NCT00643760|6207305|P3|Overall Study|Withdrawal by Subject|2
1782944|NCT00643760|6207306|P2|Overall Study|Withdrawal by Subject|1
1782945|NCT00643760|6207307|P1|Overall Study|Withdrawal by Subject|3
1782946|NCT00643760|6207303|P5|Overall Study|Investigator Discretion|0
1782947|NCT00643760|6207304|P4|Overall Study|Investigator Discretion|2
1782948|NCT00643760|6207305|P3|Overall Study|Investigator Discretion|0
1782949|NCT00643760|6207306|P2|Overall Study|Investigator Discretion|0
1782950|NCT00643760|6207307|P1|Overall Study|Investigator Discretion|0
1782951|NCT00643760|6207303|P5|Overall Study|Lost to Follow-up|3
1782952|NCT00643760|6207304|P4|Overall Study|Lost to Follow-up|3
1782953|NCT00643760|6207305|P3|Overall Study|Lost to Follow-up|1
1782954|NCT00643760|6207306|P2|Overall Study|Lost to Follow-up|2
1782955|NCT00643760|6207307|P1|Overall Study|Lost to Follow-up|6
1782956|NCT00643760|6207303|P5|Overall Study|Protocol Violation|6
1782957|NCT00643760|6207304|P4|Overall Study|Protocol Violation|4
1782958|NCT00643760|6207305|P3|Overall Study|Protocol Violation|4
1782959|NCT00643760|6207306|P2|Overall Study|Protocol Violation|6
1782960|NCT00643760|6207307|P1|Overall Study|Protocol Violation|7
1782961|NCT00643760|6207303|P5|Overall Study|Lack of Efficacy|3
1782962|NCT00643760|6207304|P4|Overall Study|Lack of Efficacy|4
1782963|NCT00643760|6207305|P3|Overall Study|Lack of Efficacy|0
1782964|NCT00643760|6207306|P2|Overall Study|Lack of Efficacy|1
1782965|NCT00643760|6207307|P1|Overall Study|Lack of Efficacy|3
1782966|NCT00643760|6207303|P5|Overall Study|Adverse Event|6
1782967|NCT00643760|6207304|P4|Overall Study|Adverse Event|21
1782968|NCT00643760|6207305|P3|Overall Study|Adverse Event|12
1782969|NCT00643760|6207306|P2|Overall Study|Adverse Event|5
1782970|NCT00643760|6207307|P1|Overall Study|Adverse Event|11
1782971|NCT00643682|6207411|P2|Overall Study|did not keep appointment|509
1782972|NCT00643682|6207412|P1|Overall Study|did not keep appointment|522
1782973|NCT00643604|6207424|P1|Overall Study|Death|1
1782974|NCT00643565|6207452|P2|Overall Study|Adverse Event|8
1782975|NCT00643565|6207453|P1|Overall Study|Adverse Event|5
1782976|NCT00643565|6207452|P2|Overall Study|Administrative|16
1782977|NCT00643565|6207453|P1|Overall Study|Administrative|22
1782978|NCT00643565|6207452|P2|Overall Study|Did Not Cooperate|1
1782979|NCT00643565|6207453|P1|Overall Study|Did Not Cooperate|0
1782980|NCT00643565|6207452|P2|Overall Study|Protocol Violation|0
1782981|NCT00643565|6207453|P1|Overall Study|Protocol Violation|3
1782982|NCT00643565|6207452|P2|Overall Study|Progression of Disease|14
1782983|NCT00643565|6207453|P1|Overall Study|Progression of Disease|18
1782984|NCT00643565|6207452|P2|Overall Study|Recurrence of Disease|1
1782985|NCT00643565|6207453|P1|Overall Study|Recurrence of Disease|2
1782986|NCT00643565|6207452|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
1782987|NCT00643565|6207453|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
1782988|NCT00643565|6207452|P2|Overall Study|Other|8
1782989|NCT00643565|6207453|P1|Overall Study|Other|7
1782990|NCT00643565|6207452|P2|Overall Study|Lost to Follow-up|6
1782991|NCT00643565|6207453|P1|Overall Study|Lost to Follow-up|0
1782992|NCT00643565|6207452|P2|Overall Study|Withdrawal by Subject|1
1782993|NCT00643565|6207453|P1|Overall Study|Withdrawal by Subject|4
1782994|NCT00643565|6207452|P2|Overall Study|Death|11
1782995|NCT00643565|6207453|P1|Overall Study|Death|12
1782996|NCT00643487|6207475|P1|Overall Study|Technical difficulty|3
1782997|NCT00643448|6207482|P3|Overall Study|QTcF>550 ms|0
1782998|NCT00643448|6207483|P2|Overall Study|QTcF>550 ms|3
1782999|NCT00643448|6207484|P1|Overall Study|QTcF>550 ms|0
1783000|NCT00643448|6207482|P3|Overall Study|Adverse Event|2
1783001|NCT00643448|6207483|P2|Overall Study|Adverse Event|2
1783002|NCT00643448|6207484|P1|Overall Study|Adverse Event|2
1783003|NCT00643448|6207482|P3|Overall Study|Lack of Efficacy|4
1783004|NCT00643448|6207483|P2|Overall Study|Lack of Efficacy|0
1783005|NCT00643448|6207484|P1|Overall Study|Lack of Efficacy|2
1783006|NCT00643279|6207501|P2|Overall Study|Physician Decision|1
1783007|NCT00643279|6207502|P1|Overall Study|Physician Decision|0
1783008|NCT00643279|6207501|P2|Overall Study|Lost to Follow-up|1
1783009|NCT00643279|6207502|P1|Overall Study|Lost to Follow-up|0
1783010|NCT00643279|6207501|P2|Overall Study|Withdrawal by Subject|0
1783011|NCT00643279|6207502|P1|Overall Study|Withdrawal by Subject|3
1783012|NCT00643279|6207501|P2|Overall Study|Death|11
1783013|NCT00643279|6207502|P1|Overall Study|Death|13
1783014|NCT00643201|6207524|P2|Completed Study Follow Up|non-specified|0
1783015|NCT00643201|6207525|P1|Completed Study Follow Up|non-specified|1
1783016|NCT00643201|6207524|P2|Completed Study Follow Up|Lost to Follow-up|16
1783017|NCT00643201|6207525|P1|Completed Study Follow Up|Lost to Follow-up|18
1783018|NCT00643201|6207524|P2|Completed Study Follow Up|Withdrawal by Subject|29
1783019|NCT00643201|6207525|P1|Completed Study Follow Up|Withdrawal by Subject|23
1783020|NCT00643201|6207524|P2|Completed Study Follow Up|Death|34
1783021|NCT00643201|6207525|P1|Completed Study Follow Up|Death|28
1783022|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Other|107
1783023|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Other|107
1783024|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
1783025|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
1783026|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
1783027|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
1783028|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
1783029|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
1783030|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
1783031|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
1783032|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
1783033|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
1783034|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
1783035|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
1783036|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
1783037|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
1783038|NCT00643201|6207524|P2|Randomized, Completed 6 Months of Study|Death|26
1783039|NCT00643201|6207525|P1|Randomized, Completed 6 Months of Study|Death|20
1783040|NCT00643162|6207573|P2|Overall Study|Withdrawal by Subject|1
1783041|NCT00643162|6207574|P1|Overall Study|Withdrawal by Subject|1
1783042|NCT00643123|6207586|P2|Overall Study|Withdrawal by Subject|1
1783043|NCT00643123|6207587|P1|Overall Study|Withdrawal by Subject|1
1783044|NCT00643123|6207586|P2|Overall Study|Lost to Follow-up|0
1783045|NCT00643123|6207587|P1|Overall Study|Lost to Follow-up|4
1783046|NCT00643006|6207619|P2|Overall Study|Lost to Follow-up|4
1783047|NCT00643006|6207620|P1|Overall Study|Lost to Follow-up|5
1783048|NCT00642993|6207630|P2|Overall Study|Administrative|0
1783049|NCT00642993|6207631|P1|Overall Study|Administrative|1
1783050|NCT00642993|6207630|P2|Overall Study|Did not meet protocol eligibility|1
1783051|NCT00642993|6207631|P1|Overall Study|Did not meet protocol eligibility|0
1783052|NCT00642993|6207630|P2|Overall Study|Protocol Violation|4
1783053|NCT00642993|6207631|P1|Overall Study|Protocol Violation|1
1783054|NCT00642993|6207630|P2|Overall Study|Withdrew - reason unrelated to treatment|3
1783055|NCT00642993|6207631|P1|Overall Study|Withdrew - reason unrelated to treatment|11
1783056|NCT00642993|6207630|P2|Overall Study|Lost to Follow-up|4
1783057|NCT00642993|6207631|P1|Overall Study|Lost to Follow-up|8
1783058|NCT00642993|6207630|P2|Overall Study|Adverse Event|4
1783059|NCT00642993|6207631|P1|Overall Study|Adverse Event|85
1783060|NCT00642902|6207649|P4|Overall Study|Other|4
1783061|NCT00642902|6207650|P3|Overall Study|Other|1
1783062|NCT00642902|6207651|P2|Overall Study|Other|5
1783063|NCT00642902|6207652|P1|Overall Study|Other|1
1783064|NCT00642902|6207649|P4|Overall Study|Randomized, but not treated|0
1783065|NCT00642902|6207650|P3|Overall Study|Randomized, but not treated|1
1783066|NCT00642902|6207651|P2|Overall Study|Randomized, but not treated|0
1783067|NCT00642902|6207652|P1|Overall Study|Randomized, but not treated|0
1783068|NCT00642902|6207649|P4|Overall Study|Premature termination of clinical trial|35
1783069|NCT00642902|6207650|P3|Overall Study|Premature termination of clinical trial|35
1783070|NCT00642902|6207651|P2|Overall Study|Premature termination of clinical trial|32
1783071|NCT00642902|6207652|P1|Overall Study|Premature termination of clinical trial|37
1783072|NCT00642902|6207649|P4|Overall Study|Death|0
1783073|NCT00642902|6207650|P3|Overall Study|Death|0
1783074|NCT00642902|6207651|P2|Overall Study|Death|0
1783075|NCT00642902|6207652|P1|Overall Study|Death|1
1783076|NCT00642902|6207649|P4|Overall Study|Lack of Efficacy|0
1783077|NCT00642902|6207650|P3|Overall Study|Lack of Efficacy|3
1783078|NCT00642902|6207651|P2|Overall Study|Lack of Efficacy|3
1783079|NCT00642902|6207652|P1|Overall Study|Lack of Efficacy|0
1783080|NCT00642902|6207649|P4|Overall Study|Lost to Follow-up|0
1783081|NCT00642902|6207650|P3|Overall Study|Lost to Follow-up|0
1783082|NCT00642902|6207651|P2|Overall Study|Lost to Follow-up|1
1783083|NCT00642902|6207652|P1|Overall Study|Lost to Follow-up|1
1783084|NCT00642902|6207649|P4|Overall Study|Adverse Event|1
1783085|NCT00642902|6207650|P3|Overall Study|Adverse Event|3
1783086|NCT00642902|6207651|P2|Overall Study|Adverse Event|1
1783087|NCT00642902|6207652|P1|Overall Study|Adverse Event|0
1783088|NCT00642850|6207674|P1|Overall Study|Other reasons|7
1783089|NCT00642850|6207674|P1|Overall Study|Blood transfusion|6
1783090|NCT00642850|6207674|P1|Overall Study|Kidney transplantation|8
1783091|NCT00642850|6207674|P1|Overall Study|Protocol Violation|2
1783092|NCT00642850|6207674|P1|Overall Study|Lack of Efficacy|1
1783093|NCT00642850|6207674|P1|Overall Study|Adverse Event|2
1783094|NCT00642850|6207674|P1|Overall Study|Death|7
1783095|NCT00642811|6207690|P6|Overall Study|Other|0
1783096|NCT00642811|6207691|P5|Overall Study|Other|0
1783097|NCT00642811|6207692|P4|Overall Study|Other|1
1783098|NCT00642811|6207693|P3|Overall Study|Other|0
1783099|NCT00642811|6207694|P2|Overall Study|Other|1
1783100|NCT00642811|6207695|P1|Overall Study|Other|0
1783101|NCT00642811|6207690|P6|Overall Study|Severe Non-compliance to protocol|0
1783102|NCT00642811|6207691|P5|Overall Study|Severe Non-compliance to protocol|0
1783103|NCT00642811|6207692|P4|Overall Study|Severe Non-compliance to protocol|0
1783104|NCT00642811|6207693|P3|Overall Study|Severe Non-compliance to protocol|0
1783105|NCT00642811|6207694|P2|Overall Study|Severe Non-compliance to protocol|0
1783106|NCT00642811|6207695|P1|Overall Study|Severe Non-compliance to protocol|1
1783107|NCT00642811|6207690|P6|Overall Study|Developement of discontinuation criteria|0
1783108|NCT00642811|6207691|P5|Overall Study|Developement of discontinuation criteria|1
1783109|NCT00642811|6207692|P4|Overall Study|Developement of discontinuation criteria|0
1783110|NCT00642811|6207693|P3|Overall Study|Developement of discontinuation criteria|0
1783111|NCT00642811|6207694|P2|Overall Study|Developement of discontinuation criteria|0
1783112|NCT00642811|6207695|P1|Overall Study|Developement of discontinuation criteria|0
1783113|NCT00642811|6207690|P6|Overall Study|Adverse Event|1
1783114|NCT00642811|6207691|P5|Overall Study|Adverse Event|0
1783115|NCT00642811|6207692|P4|Overall Study|Adverse Event|0
1783116|NCT00642811|6207693|P3|Overall Study|Adverse Event|0
1783117|NCT00642811|6207694|P2|Overall Study|Adverse Event|3
1783118|NCT00642811|6207695|P1|Overall Study|Adverse Event|2
1783119|NCT00642772|6207717|P1|Overall Study|Withdrawal by Subject|7
1783120|NCT00642772|6207717|P1|Overall Study|Lost to Follow-up|3
1783121|NCT00642759|6207721|P1|Overall Study|Protocol Violation|1
1783122|NCT00642746|6207730|P2|Overall Study|Patient unevaluable|0
1783123|NCT00642746|6207731|P1|Overall Study|Patient unevaluable|1
1783124|NCT00642707|6207745|P4|Overall Study|Withdrawal by Subject|0
1783125|NCT00642707|6207746|P3|Overall Study|Withdrawal by Subject|0
1783126|NCT00642707|6207747|P2|Overall Study|Withdrawal by Subject|0
1783127|NCT00642707|6207748|P1|Overall Study|Withdrawal by Subject|1
1783128|NCT00642707|6207745|P4|Overall Study|Adverse Event|2
1783129|NCT00642707|6207746|P3|Overall Study|Adverse Event|0
1783130|NCT00642707|6207747|P2|Overall Study|Adverse Event|0
1783131|NCT00642707|6207748|P1|Overall Study|Adverse Event|0
1783132|NCT00642668|6207783|P1|Overall Study|Blood Transfusion|2
1783133|NCT00642668|6207783|P1|Overall Study|Dialysis Initiation|5
1783134|NCT00642668|6207783|P1|Overall Study|Failure to Return|1
1783135|NCT00642668|6207783|P1|Overall Study|Insufficient Therapeutic Response|1
1783136|NCT00642668|6207783|P1|Overall Study|Death|2
1783137|NCT00642668|6207783|P1|Overall Study|Adverse Event|2
1783138|NCT00642668|6207783|P1|Overall Study|Lost to Follow-up|1
1783139|NCT00642642|6207791|P1|Treatment & Follow Up|Lost to Follow-up|10
1783140|NCT00642642|6207791|P1|Treatment & Follow Up|Withdrawal by Subject|5
1783141|NCT00642642|6207791|P1|Treatment & Follow Up|Adverse Event|2
1783142|NCT00642616|6207808|P4|Overall Study|Physician Decision|1
1783143|NCT00642616|6207809|P3|Overall Study|Physician Decision|1
1783144|NCT00642616|6207810|P2|Overall Study|Physician Decision|0
1783145|NCT00642616|6207811|P1|Overall Study|Physician Decision|0
1783146|NCT00642616|6207808|P4|Overall Study|Protocol Violation|0
1783147|NCT00642616|6207809|P3|Overall Study|Protocol Violation|2
1783148|NCT00642616|6207810|P2|Overall Study|Protocol Violation|0
1783149|NCT00642616|6207811|P1|Overall Study|Protocol Violation|0
1783150|NCT00642616|6207808|P4|Overall Study|Withdrawal by Subject|1
1783151|NCT00642616|6207809|P3|Overall Study|Withdrawal by Subject|1
1783152|NCT00642616|6207810|P2|Overall Study|Withdrawal by Subject|1
1783153|NCT00642616|6207811|P1|Overall Study|Withdrawal by Subject|0
1783154|NCT00642616|6207808|P4|Overall Study|Study Terminated by Sponsor|5
1783155|NCT00642616|6207809|P3|Overall Study|Study Terminated by Sponsor|4
1783156|NCT00642616|6207810|P2|Overall Study|Study Terminated by Sponsor|6
1783157|NCT00642616|6207811|P1|Overall Study|Study Terminated by Sponsor|7
1783158|NCT00642616|6207808|P4|Overall Study|Adverse Event|0
1783159|NCT00642616|6207809|P3|Overall Study|Adverse Event|1
1783160|NCT00642616|6207810|P2|Overall Study|Adverse Event|0
1783161|NCT00642616|6207811|P1|Overall Study|Adverse Event|2
1783162|NCT00642473|6207844|P2|Overall Study|Other|2
1783163|NCT00642473|6207845|P1|Overall Study|Other|2
1783164|NCT00642473|6207844|P2|Overall Study|Progression or death|4
1783165|NCT00642473|6207845|P1|Overall Study|Progression or death|2
1783166|NCT00642473|6207844|P2|Overall Study|Withdrawal by Subject|5
1783167|NCT00642473|6207845|P1|Overall Study|Withdrawal by Subject|0
1783168|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
1783169|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
1783170|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
1783171|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
1783172|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
1783173|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
1783174|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
1783175|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
1783176|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
1783177|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
1783178|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
1783179|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
1783180|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Death|3
1783181|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Death|0
1783182|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Death|0
1783183|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Death|0
1783184|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Death|0
1783185|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Death|0
1783186|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Other|2
1783187|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Other|2
1783188|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Other|0
1783189|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Other|0
1783190|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Other|0
1783191|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Other|0
1783192|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
1783193|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
1783194|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1783195|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1783196|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1783197|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
1783198|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
1783199|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
1783200|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1783201|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1783202|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1783203|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
1783204|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
1783205|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
1783206|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1783207|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1783208|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1783209|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
1783210|NCT00642460|6207859|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
1783211|NCT00642460|6207860|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
1783212|NCT00642460|6207861|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
1783213|NCT00642460|6207862|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
1783214|NCT00642460|6207863|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
1783215|NCT00642460|6207864|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
1783216|NCT00642460|6207859|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
1783217|NCT00642460|6207860|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
1783218|NCT00642460|6207861|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
1783219|NCT00642460|6207862|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
1783220|NCT00642460|6207863|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
1783221|NCT00642460|6207864|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
1783222|NCT00642460|6207859|P6|Part II: Open-Label Up to Week 92|Failure to return|0
1783223|NCT00642460|6207860|P5|Part II: Open-Label Up to Week 92|Failure to return|0
1783224|NCT00642460|6207861|P4|Part II: Open-Label Up to Week 92|Failure to return|0
1783225|NCT00642460|6207862|P3|Part II: Open-Label Up to Week 92|Failure to return|0
1783226|NCT00642460|6207863|P2|Part II: Open-Label Up to Week 92|Failure to return|1
1783227|NCT00642460|6207864|P1|Part II: Open-Label Up to Week 92|Failure to return|0
1783228|NCT00642460|6207859|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
1783229|NCT00642460|6207860|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
1783230|NCT00642460|6207861|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
1783231|NCT00642460|6207862|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
1783232|NCT00642460|6207863|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
1783233|NCT00642460|6207864|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
1783234|NCT00642460|6207859|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1783235|NCT00642460|6207860|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1783236|NCT00642460|6207861|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1783237|NCT00642460|6207862|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
1783238|NCT00642460|6207863|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
1783239|NCT00642460|6207864|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
1783240|NCT00642460|6207859|P6|Part II: Open-Label Up to Week 92|Death|0
1783241|NCT00642460|6207860|P5|Part II: Open-Label Up to Week 92|Death|0
1783242|NCT00642460|6207861|P4|Part II: Open-Label Up to Week 92|Death|2
1783243|NCT00642460|6207862|P3|Part II: Open-Label Up to Week 92|Death|0
1783244|NCT00642460|6207863|P2|Part II: Open-Label Up to Week 92|Death|1
1783245|NCT00642460|6207864|P1|Part II: Open-Label Up to Week 92|Death|0
1783246|NCT00642460|6207859|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
1783247|NCT00642460|6207860|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
1783248|NCT00642460|6207861|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
1783249|NCT00642460|6207862|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
1783250|NCT00642460|6207863|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
1783251|NCT00642460|6207864|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
1783252|NCT00642460|6207859|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
1783253|NCT00642460|6207860|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
1783254|NCT00642460|6207861|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
1783255|NCT00642460|6207862|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
1783256|NCT00642460|6207863|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
1783257|NCT00642460|6207864|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
1783258|NCT00642460|6207859|P6|Part I: 12 Week Double-Blind|Adverse Event|0
1783259|NCT00642460|6207860|P5|Part I: 12 Week Double-Blind|Adverse Event|0
1783260|NCT00642460|6207861|P4|Part I: 12 Week Double-Blind|Adverse Event|0
1783261|NCT00642460|6207862|P3|Part I: 12 Week Double-Blind|Adverse Event|1
1783262|NCT00642460|6207863|P2|Part I: 12 Week Double-Blind|Adverse Event|1
1783263|NCT00642460|6207864|P1|Part I: 12 Week Double-Blind|Adverse Event|0
1783264|NCT00642369|6207939|P2|Overall Study|Lack of Efficacy|2
1783265|NCT00642369|6207940|P1|Overall Study|Lack of Efficacy|2
1783266|NCT00642369|6207939|P2|Overall Study|misdiagnosis|1
1783267|NCT00642369|6207940|P1|Overall Study|misdiagnosis|0
1783268|NCT00642369|6207939|P2|Overall Study|Withdrawal by Subject|0
1783269|NCT00642369|6207940|P1|Overall Study|Withdrawal by Subject|1
1783270|NCT00642369|6207939|P2|Overall Study|Adverse Event|3
1783271|NCT00642369|6207940|P1|Overall Study|Adverse Event|2
1783272|NCT00642356|6207950|P2|Overall Study|Lack of Efficacy|0
1783273|NCT00642356|6207951|P1|Overall Study|Lack of Efficacy|1
1783274|NCT00642356|6207950|P2|Overall Study|Protocol Violation|3
1783275|NCT00642356|6207951|P1|Overall Study|Protocol Violation|0
1783276|NCT00642356|6207950|P2|Overall Study|Adverse Event|0
1783277|NCT00642356|6207951|P1|Overall Study|Adverse Event|1
1783278|NCT00642304|6207959|P1|Overall Study|Transplantation|1
1783279|NCT00642304|6207959|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
1783280|NCT00642304|6207959|P1|Overall Study|Blood transfusion|2
1783281|NCT00642304|6207959|P1|Overall Study|Death|1
1783282|NCT00642304|6207959|P1|Overall Study|Adverse Event|1
1783283|NCT00642278|6207975|P7|Overall Study|Other|0
1783284|NCT00642278|6207976|P6|Overall Study|Other|1
1783285|NCT00642278|6207977|P5|Overall Study|Other|0
1783286|NCT00642278|6207978|P4|Overall Study|Other|1
1783287|NCT00642278|6207979|P3|Overall Study|Other|0
1783288|NCT00642278|6207980|P2|Overall Study|Other|1
1783289|NCT00642278|6207981|P1|Overall Study|Other|2
1783290|NCT00642278|6207975|P7|Overall Study|Noncompliance with study drug regimen|0
1783291|NCT00642278|6207976|P6|Overall Study|Noncompliance with study drug regimen|0
1783292|NCT00642278|6207977|P5|Overall Study|Noncompliance with study drug regimen|0
1783293|NCT00642278|6207978|P4|Overall Study|Noncompliance with study drug regimen|1
1783294|NCT00642278|6207979|P3|Overall Study|Noncompliance with study drug regimen|0
1783295|NCT00642278|6207980|P2|Overall Study|Noncompliance with study drug regimen|0
1783296|NCT00642278|6207981|P1|Overall Study|Noncompliance with study drug regimen|0
1783297|NCT00642278|6207975|P7|Overall Study|Withdrawal by Subject|2
1783298|NCT00642278|6207976|P6|Overall Study|Withdrawal by Subject|2
1783299|NCT00642278|6207977|P5|Overall Study|Withdrawal by Subject|6
1783300|NCT00642278|6207978|P4|Overall Study|Withdrawal by Subject|3
1783301|NCT00642278|6207979|P3|Overall Study|Withdrawal by Subject|1
1783302|NCT00642278|6207980|P2|Overall Study|Withdrawal by Subject|1
1783303|NCT00642278|6207981|P1|Overall Study|Withdrawal by Subject|1
1783304|NCT00642278|6207975|P7|Overall Study|Protocol Violation|2
1783305|NCT00642278|6207976|P6|Overall Study|Protocol Violation|1
1783306|NCT00642278|6207977|P5|Overall Study|Protocol Violation|0
1783307|NCT00642278|6207978|P4|Overall Study|Protocol Violation|1
1783308|NCT00642278|6207979|P3|Overall Study|Protocol Violation|1
1783309|NCT00642278|6207980|P2|Overall Study|Protocol Violation|0
1783310|NCT00642278|6207981|P1|Overall Study|Protocol Violation|0
1783311|NCT00642278|6207975|P7|Overall Study|Physician Decision|0
1783312|NCT00642278|6207976|P6|Overall Study|Physician Decision|0
1783313|NCT00642278|6207977|P5|Overall Study|Physician Decision|0
1783314|NCT00642278|6207978|P4|Overall Study|Physician Decision|1
1783315|NCT00642278|6207979|P3|Overall Study|Physician Decision|0
1783316|NCT00642278|6207980|P2|Overall Study|Physician Decision|0
1783317|NCT00642278|6207981|P1|Overall Study|Physician Decision|0
1783318|NCT00642278|6207975|P7|Overall Study|Lost to Follow-up|1
1783319|NCT00642278|6207976|P6|Overall Study|Lost to Follow-up|1
1783320|NCT00642278|6207977|P5|Overall Study|Lost to Follow-up|0
1783321|NCT00642278|6207978|P4|Overall Study|Lost to Follow-up|1
1783322|NCT00642278|6207979|P3|Overall Study|Lost to Follow-up|0
1783323|NCT00642278|6207980|P2|Overall Study|Lost to Follow-up|1
1783324|NCT00642278|6207981|P1|Overall Study|Lost to Follow-up|5
1783325|NCT00642278|6207975|P7|Overall Study|Lack of Efficacy|0
1783326|NCT00642278|6207976|P6|Overall Study|Lack of Efficacy|0
1783327|NCT00642278|6207977|P5|Overall Study|Lack of Efficacy|0
1783328|NCT00642278|6207978|P4|Overall Study|Lack of Efficacy|0
1783329|NCT00642278|6207979|P3|Overall Study|Lack of Efficacy|0
1783330|NCT00642278|6207980|P2|Overall Study|Lack of Efficacy|1
1783331|NCT00642278|6207981|P1|Overall Study|Lack of Efficacy|0
1783332|NCT00642278|6207975|P7|Overall Study|Adverse Event|0
1783333|NCT00642278|6207976|P6|Overall Study|Adverse Event|2
1783334|NCT00642278|6207977|P5|Overall Study|Adverse Event|2
1783335|NCT00642278|6207978|P4|Overall Study|Adverse Event|1
1783336|NCT00642278|6207979|P3|Overall Study|Adverse Event|3
1783337|NCT00642278|6207980|P2|Overall Study|Adverse Event|1
1783338|NCT00642278|6207981|P1|Overall Study|Adverse Event|2
1783339|NCT00642174|6208034|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
1783340|NCT00642174|6208035|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
1783341|NCT00642018|6208051|P2|Overall Study|Entry Criteria Not Met|1
1783342|NCT00642018|6208052|P1|Overall Study|Entry Criteria Not Met|0
1783343|NCT00642018|6208051|P2|Overall Study|Death|3
1783344|NCT00642018|6208052|P1|Overall Study|Death|0
1783345|NCT00642018|6208051|P2|Overall Study|Protocol Violation|1
1783346|NCT00642018|6208052|P1|Overall Study|Protocol Violation|0
1783347|NCT00642018|6208051|P2|Overall Study|Physician Decision|10
1783348|NCT00642018|6208052|P1|Overall Study|Physician Decision|0
1783349|NCT00642018|6208051|P2|Overall Study|Progressive Disease|18
1783350|NCT00642018|6208052|P1|Overall Study|Progressive Disease|13
1783351|NCT00642018|6208051|P2|Overall Study|Withdrawal by Subject|10
1783352|NCT00642018|6208052|P1|Overall Study|Withdrawal by Subject|4
1783353|NCT00642018|6208051|P2|Overall Study|Adverse Event|36
1783354|NCT00642018|6208052|P1|Overall Study|Adverse Event|11
1783355|NCT00641719|6208119|P2|Overall Study|Reason Not Specified|2
1783356|NCT00641719|6208120|P1|Overall Study|Reason Not Specified|1
1783357|NCT00641719|6208119|P2|Overall Study|Withdrawal by Subject|4
1783358|NCT00641719|6208120|P1|Overall Study|Withdrawal by Subject|4
1783359|NCT00641719|6208119|P2|Overall Study|Adverse Event|29
1783360|NCT00641719|6208120|P1|Overall Study|Adverse Event|24
1783361|NCT00641719|6208119|P2|Overall Study|Lack of Efficacy|2
1783362|NCT00641719|6208120|P1|Overall Study|Lack of Efficacy|1
1783363|NCT00641706|6208144|P2|Overall Study|Lead Investigator Decision|1
1783364|NCT00641706|6208145|P1|Overall Study|Lead Investigator Decision|0
1783365|NCT00641706|6208144|P2|Overall Study|Clinical Decline|0
1783366|NCT00641706|6208145|P1|Overall Study|Clinical Decline|1
1783367|NCT00641706|6208144|P2|Overall Study|Withdrawal by Subject|1
1783368|NCT00641706|6208145|P1|Overall Study|Withdrawal by Subject|6
1783369|NCT00641706|6208144|P2|Overall Study|Adverse Event|1
1783370|NCT00641706|6208145|P1|Overall Study|Adverse Event|2
1783371|NCT00641667|6208157|P1|Overall Study|Worsening of underlying disease|3
1783372|NCT00641667|6208157|P1|Overall Study|Physician Decision|1
1783373|NCT00641667|6208157|P1|Overall Study|Adverse Event|1
1783374|NCT00641667|6208157|P1|Overall Study|Withdrawal by Subject|1
1783375|NCT00641537|6208185|P8|24-Week Supplemental Follow-up Period|Other|1
1783376|NCT00641537|6208186|P7|24-Week Supplemental Follow-up Period|Other|1
1783377|NCT00641537|6208187|P6|24-Week Supplemental Follow-up Period|Other|0
1783378|NCT00641537|6208188|P5|24-Week Supplemental Follow-up Period|Other|3
1783379|NCT00641537|6208189|P4|24-Week Supplemental Follow-up Period|Other|1
1783380|NCT00641537|6208190|P3|24-Week Supplemental Follow-up Period|Other|2
1783381|NCT00641537|6208191|P2|24-Week Supplemental Follow-up Period|Other|2
1783382|NCT00641537|6208192|P1|24-Week Supplemental Follow-up Period|Other|0
1783383|NCT00641537|6208185|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1783384|NCT00641537|6208186|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1783385|NCT00641537|6208187|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1783386|NCT00641537|6208188|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
1783387|NCT00641537|6208189|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
1783388|NCT00641537|6208190|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1783389|NCT00641537|6208191|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
1783390|NCT00641537|6208192|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
1783391|NCT00641537|6208185|P8|96-week Period|Other|6
1783392|NCT00641537|6208186|P7|96-week Period|Other|4
1783393|NCT00641537|6208187|P6|96-week Period|Other|6
1783394|NCT00641537|6208188|P5|96-week Period|Other|12
1783395|NCT00641537|6208189|P4|96-week Period|Other|9
1783396|NCT00641537|6208190|P3|96-week Period|Other|14
1783397|NCT00641537|6208191|P2|96-week Period|Other|7
1783398|NCT00641537|6208192|P1|96-week Period|Other|4
1783399|NCT00641537|6208185|P8|96-week Period|Death|0
1783400|NCT00641537|6208186|P7|96-week Period|Death|0
1783401|NCT00641537|6208187|P6|96-week Period|Death|0
1783402|NCT00641537|6208188|P5|96-week Period|Death|0
1783403|NCT00641537|6208189|P4|96-week Period|Death|0
1783404|NCT00641537|6208190|P3|96-week Period|Death|1
1783405|NCT00641537|6208191|P2|96-week Period|Death|0
1783406|NCT00641537|6208192|P1|96-week Period|Death|2
1783407|NCT00641537|6208185|P8|96-week Period|Protocol Violation|0
1783408|NCT00641537|6208186|P7|96-week Period|Protocol Violation|0
1783409|NCT00641537|6208187|P6|96-week Period|Protocol Violation|1
1783410|NCT00641537|6208188|P5|96-week Period|Protocol Violation|0
1783411|NCT00641537|6208189|P4|96-week Period|Protocol Violation|1
1783412|NCT00641537|6208190|P3|96-week Period|Protocol Violation|0
1783413|NCT00641537|6208191|P2|96-week Period|Protocol Violation|1
1783414|NCT00641537|6208192|P1|96-week Period|Protocol Violation|0
1783415|NCT00641537|6208185|P8|96-week Period|Lost to Follow-up|0
1783416|NCT00641537|6208186|P7|96-week Period|Lost to Follow-up|1
1783417|NCT00641537|6208187|P6|96-week Period|Lost to Follow-up|0
1783418|NCT00641537|6208188|P5|96-week Period|Lost to Follow-up|4
1783419|NCT00641537|6208189|P4|96-week Period|Lost to Follow-up|2
1783420|NCT00641537|6208190|P3|96-week Period|Lost to Follow-up|2
1783421|NCT00641537|6208191|P2|96-week Period|Lost to Follow-up|1
1783422|NCT00641537|6208192|P1|96-week Period|Lost to Follow-up|3
1783423|NCT00641537|6208185|P8|96-week Period|Adverse Event|0
1783424|NCT00641537|6208186|P7|96-week Period|Adverse Event|0
1783425|NCT00641537|6208187|P6|96-week Period|Adverse Event|0
1783426|NCT00641537|6208188|P5|96-week Period|Adverse Event|2
1783427|NCT00641537|6208189|P4|96-week Period|Adverse Event|0
1783428|NCT00641537|6208190|P3|96-week Period|Adverse Event|3
1783429|NCT00641537|6208191|P2|96-week Period|Adverse Event|1
1783430|NCT00641537|6208192|P1|96-week Period|Adverse Event|0
1783431|NCT00641147|6208247|P2|Completed 16 Months.|Lost to Follow-up|0
1783432|NCT00641147|6208248|P1|Completed 16 Months.|Lost to Follow-up|1
1783433|NCT00641147|6208247|P2|Completed 16 Months.|Physician Decision|0
1783434|NCT00641147|6208248|P1|Completed 16 Months.|Physician Decision|1
1783435|NCT00641147|6208247|P2|Completed 12 Months.|Withdrawal by Subject|1
1783436|NCT00641147|6208248|P1|Completed 12 Months.|Withdrawal by Subject|0
1783437|NCT00641147|6208247|P2|Completed 12 Months.|Physician Decision|1
1783438|NCT00641147|6208248|P1|Completed 12 Months.|Physician Decision|1
1783439|NCT00641147|6208247|P2|Completed 8 Months.|Withdrawal by Subject|1
1783440|NCT00641147|6208248|P1|Completed 8 Months.|Withdrawal by Subject|0
1783441|NCT00641147|6208247|P2|Completed 8 Months.|non compliance|0
1783442|NCT00641147|6208248|P1|Completed 8 Months.|non compliance|1
1783443|NCT00641147|6208247|P2|Completed 8 Months.|Physician Decision|1
1783444|NCT00641147|6208248|P1|Completed 8 Months.|Physician Decision|2
1783445|NCT00641147|6208247|P2|Completed 4 Months.|Adverse Event|0
1783446|NCT00641147|6208248|P1|Completed 4 Months.|Adverse Event|1
1783447|NCT00641147|6208247|P2|Completed 4 Months.|Physician Decision|0
1783448|NCT00641147|6208248|P1|Completed 4 Months.|Physician Decision|1
1783449|NCT00641056|6208292|P2|Overall Study|Sponsor Decision|2
1783450|NCT00641056|6208293|P1|Overall Study|Sponsor Decision|1
1783451|NCT00641056|6208292|P2|Overall Study|Subject Decision|19
1783452|NCT00641056|6208293|P1|Overall Study|Subject Decision|6
1783453|NCT00641056|6208292|P2|Overall Study|Entry Criteria Not Met|0
1783454|NCT00641056|6208293|P1|Overall Study|Entry Criteria Not Met|3
1783455|NCT00641056|6208292|P2|Overall Study|Protocol Violation|0
1783456|NCT00641056|6208293|P1|Overall Study|Protocol Violation|2
1783457|NCT00641056|6208292|P2|Overall Study|Physician Decision|1
1783458|NCT00641056|6208293|P1|Overall Study|Physician Decision|3
1783459|NCT00641056|6208292|P2|Overall Study|Lost to Follow-up|1
1783460|NCT00641056|6208293|P1|Overall Study|Lost to Follow-up|2
1783461|NCT00641056|6208292|P2|Overall Study|Adverse Event|2
1783462|NCT00641056|6208293|P1|Overall Study|Adverse Event|12
1783463|NCT00641043|6208321|P2|Overall Study|Other incl. lack of efficacy|2
1783464|NCT00641043|6208322|P1|Overall Study|Other incl. lack of efficacy|4
1783465|NCT00641043|6208321|P2|Overall Study|Withdrawal by Subject|4
1783466|NCT00641043|6208322|P1|Overall Study|Withdrawal by Subject|4
1783467|NCT00641043|6208321|P2|Overall Study|Lost to Follow-up|2
1783468|NCT00641043|6208322|P1|Overall Study|Lost to Follow-up|3
1783469|NCT00641043|6208321|P2|Overall Study|Protocol Violation|3
1783470|NCT00641043|6208322|P1|Overall Study|Protocol Violation|2
1783471|NCT00641043|6208321|P2|Overall Study|Adverse Event|4
1783472|NCT00641043|6208322|P1|Overall Study|Adverse Event|6
1783473|NCT00640926|6208359|P3|Overall Study|Withdrawal by Subject|1
1783474|NCT00640926|6208360|P2|Overall Study|Withdrawal by Subject|0
1783475|NCT00640926|6208361|P1|Overall Study|Withdrawal by Subject|1
1783476|NCT00640926|6208359|P3|Overall Study|Lost to Follow-up|2
1783477|NCT00640926|6208360|P2|Overall Study|Lost to Follow-up|1
1783478|NCT00640926|6208361|P1|Overall Study|Lost to Follow-up|3
1783479|NCT00640926|6208359|P3|Overall Study|Protocol Violation|2
1783480|NCT00640926|6208360|P2|Overall Study|Protocol Violation|0
1783481|NCT00640926|6208361|P1|Overall Study|Protocol Violation|2
1783482|NCT00640926|6208359|P3|Overall Study|Lack of Efficacy|1
1783483|NCT00640926|6208360|P2|Overall Study|Lack of Efficacy|2
1783484|NCT00640926|6208361|P1|Overall Study|Lack of Efficacy|0
1783485|NCT00640926|6208359|P3|Overall Study|Adverse Event|2
1783486|NCT00640926|6208360|P2|Overall Study|Adverse Event|3
1783487|NCT00640926|6208361|P1|Overall Study|Adverse Event|2
1783488|NCT00640835|6208374|P2|Overall Study|Other Reason|4
1783489|NCT00640835|6208375|P1|Overall Study|Other Reason|19
1783490|NCT00640835|6208374|P2|Overall Study|Lost to Follow-up|13
1783491|NCT00640835|6208375|P1|Overall Study|Lost to Follow-up|17
1783492|NCT00640835|6208374|P2|Overall Study|Protocol Violation|2
1783493|NCT00640835|6208375|P1|Overall Study|Protocol Violation|2
1783494|NCT00640835|6208374|P2|Overall Study|Sponsor's Decision|7
1783495|NCT00640835|6208375|P1|Overall Study|Sponsor's Decision|11
1783496|NCT00640835|6208374|P2|Overall Study|Physician Decision|14
1783497|NCT00640835|6208375|P1|Overall Study|Physician Decision|10
1783498|NCT00640835|6208374|P2|Overall Study|Withdrawal by Subject|14
1783499|NCT00640835|6208375|P1|Overall Study|Withdrawal by Subject|12
1783500|NCT00640835|6208374|P2|Overall Study|Adverse Event|3
1783501|NCT00640835|6208375|P1|Overall Study|Adverse Event|5
1783502|NCT00640614|6208439|P2|Overall Study|Lost to Follow-up|0
1783503|NCT00640614|6208440|P1|Overall Study|Lost to Follow-up|1
1783504|NCT00640601|6208482|P1|Overall Study|treatment naive, combination therapy|10
1783505|NCT00640601|6208482|P1|Overall Study|Physician Decision|8
1783506|NCT00640601|6208482|P1|Overall Study|Lost to Follow-up|9
1783507|NCT00640601|6208482|P1|Overall Study|Lack of Efficacy|16
1783508|NCT00640601|6208482|P1|Overall Study|Protocol Violation|6
1783509|NCT00640601|6208482|P1|Overall Study|Withdrawal by Subject|20
1783510|NCT00640601|6208482|P1|Overall Study|Adverse Event|43
1783511|NCT00640562|6208498|P2|Overall Study|Glycosylated Hemoglobin >8|0
1783512|NCT00640562|6208499|P1|Overall Study|Glycosylated Hemoglobin >8|1
1783513|NCT00640562|6208498|P2|Overall Study|Low study drug dose|1
1783514|NCT00640562|6208499|P1|Overall Study|Low study drug dose|0
1783515|NCT00640562|6208498|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
1783516|NCT00640562|6208499|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
1783517|NCT00640562|6208498|P2|Overall Study|Known risperidone intolerance|1
1783518|NCT00640562|6208499|P1|Overall Study|Known risperidone intolerance|0
1783519|NCT00640562|6208498|P2|Overall Study|Withdrawal by Subject|10
1783520|NCT00640562|6208499|P1|Overall Study|Withdrawal by Subject|6
1783521|NCT00640562|6208498|P2|Overall Study|Protocol Violation|4
1783522|NCT00640562|6208499|P1|Overall Study|Protocol Violation|2
1783523|NCT00640562|6208498|P2|Overall Study|Lack of Efficacy|4
1783524|NCT00640562|6208499|P1|Overall Study|Lack of Efficacy|1
1783525|NCT00640562|6208498|P2|Overall Study|Adverse Event|5
1783526|NCT00640562|6208499|P1|Overall Study|Adverse Event|8
1783527|NCT00640510|6208527|P2|Overall Study|Physician Decision|1
1783528|NCT00640510|6208528|P1|Overall Study|Physician Decision|0
1783529|NCT00640510|6208527|P2|Overall Study|Protocol Violation|0
1783530|NCT00640510|6208528|P1|Overall Study|Protocol Violation|1
1783531|NCT00640510|6208527|P2|Overall Study|Lack of Efficacy|1
1783532|NCT00640510|6208528|P1|Overall Study|Lack of Efficacy|0
1783533|NCT00640393|6208540|P3|Part 2|Adverse Event|0
1783534|NCT00640393|6208541|P2|Part 2|Adverse Event|1
1783535|NCT00640393|6208542|P1|Part 2|Adverse Event|0
1783536|NCT00640393|6208540|P3|Part 2|Non-adherence|0
1783537|NCT00640393|6208541|P2|Part 2|Non-adherence|1
1783538|NCT00640393|6208542|P1|Part 2|Non-adherence|0
1783539|NCT00640393|6208540|P3|Part 2|Withdrawal by Subject|1
1783540|NCT00640393|6208541|P2|Part 2|Withdrawal by Subject|6
1783541|NCT00640393|6208542|P1|Part 2|Withdrawal by Subject|0
1783542|NCT00640393|6208540|P3|Part 2|Lost to Follow-up|2
1783543|NCT00640393|6208541|P2|Part 2|Lost to Follow-up|2
1783544|NCT00640393|6208542|P1|Part 2|Lost to Follow-up|0
1783545|NCT00640393|6208540|P3|Randomization|Never randomized by site|0
1783546|NCT00640393|6208541|P2|Randomization|Never randomized by site|0
1783547|NCT00640393|6208542|P1|Randomization|Never randomized by site|2
1783548|NCT00640393|6208540|P3|Randomization|Withdrawn per protocol|0
1783549|NCT00640393|6208541|P2|Randomization|Withdrawn per protocol|0
1783550|NCT00640393|6208542|P1|Randomization|Withdrawn per protocol|17
1783551|NCT00640393|6208540|P3|Part 1|Withdrawal by Subject|0
1783552|NCT00640393|6208541|P2|Part 1|Withdrawal by Subject|0
1783553|NCT00640393|6208542|P1|Part 1|Withdrawal by Subject|3
1783554|NCT00640393|6208540|P3|Part 1|Lost to Follow-up|0
1783555|NCT00640393|6208541|P2|Part 1|Lost to Follow-up|0
1783556|NCT00640393|6208542|P1|Part 1|Lost to Follow-up|2
1783557|NCT00640341|6208607|P3|Overall Study|Adverse event and positive slit lamp|0
1783558|NCT00640341|6208608|P2|Overall Study|Adverse event and positive slit lamp|0
1783559|NCT00640341|6208609|P1|Overall Study|Adverse event and positive slit lamp|1
1783560|NCT00640341|6208607|P3|Overall Study|Ineligable at Baseline|2
1783561|NCT00640341|6208608|P2|Overall Study|Ineligable at Baseline|3
1783562|NCT00640341|6208609|P1|Overall Study|Ineligable at Baseline|5
1783563|NCT00640341|6208607|P3|Overall Study|Poor fit/Uncomfortable|0
1783564|NCT00640341|6208608|P2|Overall Study|Poor fit/Uncomfortable|0
1783565|NCT00640341|6208609|P1|Overall Study|Poor fit/Uncomfortable|4
1783566|NCT00640341|6208607|P3|Overall Study|Unacceptable Lens Movement|0
1783567|NCT00640341|6208608|P2|Overall Study|Unacceptable Lens Movement|0
1783568|NCT00640341|6208609|P1|Overall Study|Unacceptable Lens Movement|1
1783569|NCT00640341|6208607|P3|Overall Study|Withdrawal by Subject|1
1783570|NCT00640341|6208608|P2|Overall Study|Withdrawal by Subject|0
1783571|NCT00640341|6208609|P1|Overall Study|Withdrawal by Subject|4
1783572|NCT00640341|6208607|P3|Overall Study|Lost to Follow-up|0
1783573|NCT00640341|6208608|P2|Overall Study|Lost to Follow-up|0
1783574|NCT00640341|6208609|P1|Overall Study|Lost to Follow-up|2
1783575|NCT00640341|6208607|P3|Overall Study|Failure to Follow Subject Instructions|0
1783576|NCT00640341|6208608|P2|Overall Study|Failure to Follow Subject Instructions|0
1783577|NCT00640341|6208609|P1|Overall Study|Failure to Follow Subject Instructions|1
1783578|NCT00640341|6208607|P3|Overall Study|Inability to Maintain Wearing Schedule|0
1783579|NCT00640341|6208608|P2|Overall Study|Inability to Maintain Wearing Schedule|1
1783580|NCT00640341|6208609|P1|Overall Study|Inability to Maintain Wearing Schedule|1
1783581|NCT00640341|6208607|P3|Overall Study|Study Related Symptoms/Complaints|2
1783582|NCT00640341|6208608|P2|Overall Study|Study Related Symptoms/Complaints|1
1783583|NCT00640341|6208609|P1|Overall Study|Study Related Symptoms/Complaints|2
1783584|NCT00640341|6208607|P3|Overall Study|Positive Slit Lamp Findings|1
1783585|NCT00640341|6208608|P2|Overall Study|Positive Slit Lamp Findings|0
1783586|NCT00640341|6208609|P1|Overall Study|Positive Slit Lamp Findings|0
1783587|NCT00640341|6208607|P3|Overall Study|Adverse Event|1
1783588|NCT00640341|6208608|P2|Overall Study|Adverse Event|0
1783589|NCT00640341|6208609|P1|Overall Study|Adverse Event|0
1783590|NCT00640328|6208629|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1783591|NCT00640328|6208630|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1783592|NCT00640328|6208631|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
1783593|NCT00640328|6208632|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1783594|NCT00640328|6208633|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
1783595|NCT00640328|6208634|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
1783596|NCT00640328|6208629|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1783597|NCT00640328|6208630|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1783598|NCT00640328|6208631|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1783599|NCT00640328|6208632|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
1783600|NCT00640328|6208633|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1783601|NCT00640328|6208634|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
1783602|NCT00640328|6208629|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1783603|NCT00640328|6208630|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
1783604|NCT00640328|6208631|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1783605|NCT00640328|6208632|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1783606|NCT00640328|6208633|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1783607|NCT00640328|6208634|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
1783608|NCT00640328|6208629|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
1783609|NCT00640328|6208630|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
1783610|NCT00640328|6208631|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
1783611|NCT00640328|6208632|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
1783612|NCT00640328|6208633|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
1783613|NCT00640328|6208634|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
1783614|NCT00640315|6208800|P2|Overall Study|Withdrawal by Subject|1
1783615|NCT00640315|6208801|P1|Overall Study|Withdrawal by Subject|0
1783616|NCT00640289|6208927|P1|Overall Study|Missing status|5
1783617|NCT00640289|6208927|P1|Overall Study|Transferred to another center|1
1783618|NCT00640289|6208927|P1|Overall Study|Data collected under different amendment|2
1783619|NCT00640289|6208927|P1|Overall Study|Lost to Follow-up|1
1783620|NCT00640289|6208927|P1|Overall Study|Withdrawal by Subject|1
1783621|NCT00640289|6208927|P1|Overall Study|Death|3
1783622|NCT00640224|6209039|P4|Overall Study|Headaches|0
1783623|NCT00640224|6209040|P3|Overall Study|Headaches|0
1783624|NCT00640224|6209041|P2|Overall Study|Headaches|1
1783625|NCT00640224|6209042|P1|Overall Study|Headaches|0
1783626|NCT00640224|6209039|P4|Overall Study|Withdrawal by Subject|0
1783627|NCT00640224|6209040|P3|Overall Study|Withdrawal by Subject|0
1783628|NCT00640224|6209041|P2|Overall Study|Withdrawal by Subject|0
1783629|NCT00640224|6209042|P1|Overall Study|Withdrawal by Subject|1
1783630|NCT00640224|6209039|P4|Overall Study|Lost to Follow-up|0
1783631|NCT00640224|6209040|P3|Overall Study|Lost to Follow-up|0
1783632|NCT00640224|6209041|P2|Overall Study|Lost to Follow-up|2
1783633|NCT00640224|6209042|P1|Overall Study|Lost to Follow-up|5
1783634|NCT00640146|6209142|P2|Overall Study|Randomized but not treated|3
1783635|NCT00640146|6209143|P1|Overall Study|Randomized but not treated|1
1783636|NCT00640146|6209142|P2|Overall Study|Withdrawal by Subject|1
1783637|NCT00640146|6209143|P1|Overall Study|Withdrawal by Subject|1
1783638|NCT00640146|6209142|P2|Overall Study|Lack of Efficacy|1
1783639|NCT00640146|6209143|P1|Overall Study|Lack of Efficacy|0
1783640|NCT00640146|6209142|P2|Overall Study|Lost to Follow-up|1
1783641|NCT00640146|6209143|P1|Overall Study|Lost to Follow-up|0
1783642|NCT00640146|6209142|P2|Overall Study|Adverse Event|0
1783643|NCT00640146|6209143|P1|Overall Study|Adverse Event|2
1783644|NCT00640133|6209155|P2|Open Label Phase (Month 4-12)|Adverse Event|0
1783645|NCT00640133|6209156|P1|Open Label Phase (Month 4-12)|Adverse Event|1
1783646|NCT00640133|6209155|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
1783647|NCT00640133|6209156|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
1783648|NCT00640133|6209155|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
1783649|NCT00640133|6209156|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
1783650|NCT00640042|6209176|P1|Enrollment|Did not receive study drug|83
1783651|NCT00640016|6209192|P4|Overall Study|Adverse Event|1
1783652|NCT00640016|6209193|P3|Overall Study|Adverse Event|0
1783653|NCT00640016|6209194|P2|Overall Study|Adverse Event|0
1783654|NCT00640016|6209195|P1|Overall Study|Adverse Event|0
1783655|NCT00640016|6209192|P4|Overall Study|Study termination|2
1783656|NCT00640016|6209193|P3|Overall Study|Study termination|3
1783657|NCT00640016|6209194|P2|Overall Study|Study termination|1
1783658|NCT00640016|6209195|P1|Overall Study|Study termination|2
1783659|NCT00640016|6209192|P4|Overall Study|Withdrawal by Subject|0
1783660|NCT00640016|6209193|P3|Overall Study|Withdrawal by Subject|0
1783661|NCT00640016|6209194|P2|Overall Study|Withdrawal by Subject|1
1783662|NCT00640016|6209195|P1|Overall Study|Withdrawal by Subject|0
1783663|NCT00639769|6209247|P1|Overall Study|Withdrawal by Subject|4
1783664|NCT00639769|6209247|P1|Overall Study|Disease progression|26
1783665|NCT00639769|6209247|P1|Overall Study|Lack of Efficacy|1
1783666|NCT00639769|6209247|P1|Overall Study|Adverse Event|7
1783667|NCT00639769|6209247|P1|Overall Study|Death|2
1783668|NCT00639678|6209264|P4|Overall Study|Lack of Compliance|0
1783669|NCT00639678|6209265|P3|Overall Study|Lack of Compliance|1
1783670|NCT00639678|6209266|P2|Overall Study|Lack of Compliance|0
1783671|NCT00639678|6209267|P1|Overall Study|Lack of Compliance|0
1783672|NCT00639678|6209264|P4|Overall Study|Adverse Event|0
1783673|NCT00639678|6209265|P3|Overall Study|Adverse Event|0
1783674|NCT00639678|6209266|P2|Overall Study|Adverse Event|1
1783675|NCT00639678|6209267|P1|Overall Study|Adverse Event|0
1783676|NCT00639678|6209264|P4|Overall Study|Lost to Follow-up|0
1783677|NCT00639678|6209265|P3|Overall Study|Lost to Follow-up|6
1783678|NCT00639678|6209266|P2|Overall Study|Lost to Follow-up|0
1783679|NCT00639678|6209267|P1|Overall Study|Lost to Follow-up|1
1783680|NCT00639678|6209264|P4|Overall Study|Withdrawal by Subject|0
1783681|NCT00639678|6209265|P3|Overall Study|Withdrawal by Subject|4
1783682|NCT00639678|6209266|P2|Overall Study|Withdrawal by Subject|0
1783683|NCT00639678|6209267|P1|Overall Study|Withdrawal by Subject|3
1783684|NCT00639509|6209332|P1|Overall Study|Death|1
1783685|NCT00639457|6209340|P2|Overall Study|Withdrawal by Subject|3
1783686|NCT00639457|6209341|P1|Overall Study|Withdrawal by Subject|2
1783687|NCT00639379|6209400|P2|Period 1 - 2 Weeks|lens issue|0
1783688|NCT00639379|6209401|P1|Period 1 - 2 Weeks|lens issue|3
1783689|NCT00639379|6209400|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
1783690|NCT00639379|6209401|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
1783691|NCT00639223|6209417|P2|Overall Study|Lost to Follow-up|2
1783692|NCT00639223|6209418|P1|Overall Study|Lost to Follow-up|0
1783693|NCT00639002|6209458|P1|Overall Study|Lack of Efficacy|1
1783694|NCT00639002|6209458|P1|Overall Study|Physician Decision|6
1783695|NCT00639002|6209458|P1|Overall Study|Disease progression|3
1783696|NCT00639002|6209458|P1|Overall Study|Protocol Violation|1
1783697|NCT00639002|6209458|P1|Overall Study|Adverse Event|1
1783698|NCT00639002|6209458|P1|Overall Study|Death|1
1783699|NCT00638989|6209467|P3|Overall Study|Lost to Follow-up|1
1783700|NCT00638989|6209468|P2|Overall Study|Lost to Follow-up|0
1783701|NCT00638989|6209469|P1|Overall Study|Lost to Follow-up|0
1783702|NCT00638963|6209509|P2|Overall Study|Withdrawal by Subject|0
1783703|NCT00638963|6209510|P1|Overall Study|Withdrawal by Subject|1
1783704|NCT00638846|6209551|P2|Overall Study|lens issue|3
1783705|NCT00638846|6209552|P1|Overall Study|lens issue|1
1783706|NCT00638846|6209551|P2|Overall Study|Lost to Follow-up|2
1783707|NCT00638846|6209552|P1|Overall Study|Lost to Follow-up|3
1783708|NCT00638846|6209551|P2|Overall Study|Adverse Event|1
1783709|NCT00638846|6209552|P1|Overall Study|Adverse Event|0
1783710|NCT00638690|6209596|P2|Overall Study|Lost to Follow-up|2
1783711|NCT00638690|6209597|P1|Overall Study|Lost to Follow-up|4
1783712|NCT00638690|6209596|P2|Overall Study|Withdrawal by Subject|5
1783713|NCT00638690|6209597|P1|Overall Study|Withdrawal by Subject|22
1783714|NCT00638690|6209596|P2|Overall Study|Death|335
1783715|NCT00638690|6209597|P1|Overall Study|Death|655
1783716|NCT00638508|6209617|P2|Overall Study|Physician Decision|2
1783717|NCT00638508|6209618|P1|Overall Study|Physician Decision|5
1783718|NCT00638456|6209664|P2|Overall Study|Withdrawal by Subject|2
1783719|NCT00638456|6209665|P1|Overall Study|Withdrawal by Subject|6
1783720|NCT00638443|6209675|P2|First Intervention|Adverse Event|1
1783721|NCT00638443|6209676|P1|First Intervention|Adverse Event|2
1783722|NCT00638404|6209706|P2|Overall Study|Physician Decision|0
1783723|NCT00638404|6209707|P1|Overall Study|Physician Decision|8
1783724|NCT00638378|6209719|P1|Overall Study|Physician Decision|4
1783725|NCT00638378|6209719|P1|Overall Study|Disease progression|15
1783726|NCT00638378|6209719|P1|Overall Study|Adverse Event|1
1783727|NCT00638378|6209719|P1|Overall Study|Death|2
1783728|NCT00638235|6209759|P9|Overall Study|Lost to Follow-up|18
1783729|NCT00638235|6209760|P8|Overall Study|Lost to Follow-up|1
1783730|NCT00638235|6209761|P7|Overall Study|Lost to Follow-up|0
1783731|NCT00638235|6209762|P6|Overall Study|Lost to Follow-up|26
1783732|NCT00638235|6209763|P5|Overall Study|Lost to Follow-up|13
1783733|NCT00638235|6209764|P4|Overall Study|Lost to Follow-up|10
1783734|NCT00638235|6209765|P3|Overall Study|Lost to Follow-up|18
1783735|NCT00638235|6209766|P2|Overall Study|Lost to Follow-up|3
1783736|NCT00638235|6209767|P1|Overall Study|Lost to Follow-up|31
1783737|NCT00638183|6210177|P1|Overall Study|Other reason not defined above|27
1783738|NCT00638183|6210177|P1|Overall Study|Lost to Follow-up|46
1783739|NCT00638183|6210177|P1|Overall Study|Physician Decision|9
1783740|NCT00638183|6210177|P1|Overall Study|Lack of Efficacy|14
1783741|NCT00638183|6210177|P1|Overall Study|Adverse Event|23
1783742|NCT00638157|6210186|P2|Overall Study|Randomized, not treated|0
1783743|NCT00638157|6210187|P1|Overall Study|Randomized, not treated|2
1783744|NCT00638157|6210186|P2|Overall Study|Other|2
1783745|NCT00638157|6210187|P1|Overall Study|Other|1
1783746|NCT00638157|6210186|P2|Overall Study|Physician Decision|0
1783747|NCT00638157|6210187|P1|Overall Study|Physician Decision|1
1783748|NCT00638157|6210186|P2|Overall Study|Lost to Follow-up|0
1783749|NCT00638157|6210187|P1|Overall Study|Lost to Follow-up|1
1783750|NCT00638157|6210186|P2|Overall Study|Microbiological failure|0
1783751|NCT00638157|6210187|P1|Overall Study|Microbiological failure|1
1783752|NCT00638157|6210186|P2|Overall Study|Clinical (symptomatic) failure|1
1783753|NCT00638157|6210187|P1|Overall Study|Clinical (symptomatic) failure|1
1783754|NCT00638157|6210186|P2|Overall Study|Adverse Event|1
1783755|NCT00638157|6210187|P1|Overall Study|Adverse Event|0
1783756|NCT00638027|6210197|P2|Overall Study|Adverse Event|2
1783757|NCT00638027|6210198|P1|Overall Study|Adverse Event|0
1783758|NCT00637806|6210245|P4|Extension Phase|Study Discontinued|1
1783759|NCT00637806|6210246|P3|Extension Phase|Study Discontinued|0
1783760|NCT00637806|6210247|P2|Extension Phase|Study Discontinued|0
1783761|NCT00637806|6210248|P1|Extension Phase|Study Discontinued|0
1783762|NCT00637806|6210245|P4|Double-blind Phase|Study Discontinued|0
1783763|NCT00637806|6210246|P3|Double-blind Phase|Study Discontinued|1
1783764|NCT00637806|6210247|P2|Double-blind Phase|Study Discontinued|0
1783765|NCT00637806|6210248|P1|Double-blind Phase|Study Discontinued|2
1783766|NCT00637728|6210283|P3|Double-blind Phase|Study Discontinued|0
1783767|NCT00637728|6210284|P2|Double-blind Phase|Study Discontinued|1
1783768|NCT00637728|6210285|P1|Double-blind Phase|Study Discontinued|1
1783769|NCT00637728|6210283|P3|Double-blind Phase|Non-compliance|0
1783770|NCT00637728|6210284|P2|Double-blind Phase|Non-compliance|0
1783771|NCT00637728|6210285|P1|Double-blind Phase|Non-compliance|2
1783772|NCT00637728|6210283|P3|Double-blind Phase|Adverse Event|0
1783773|NCT00637728|6210284|P2|Double-blind Phase|Adverse Event|0
1783774|NCT00637728|6210285|P1|Double-blind Phase|Adverse Event|1
1783775|NCT00637572|6210300|P2|Overall Study|Illicit Drug Use|0
1783776|NCT00637572|6210301|P1|Overall Study|Illicit Drug Use|1
1783777|NCT00637572|6210300|P2|Overall Study|Withdrawal by Subject|2
1783778|NCT00637572|6210301|P1|Overall Study|Withdrawal by Subject|0
1783779|NCT00637572|6210300|P2|Overall Study|Physician Decision|1
1783780|NCT00637572|6210301|P1|Overall Study|Physician Decision|1
1783781|NCT00637572|6210300|P2|Overall Study|Lost to Follow-up|1
1783782|NCT00637572|6210301|P1|Overall Study|Lost to Follow-up|0
1783783|NCT00637572|6210300|P2|Overall Study|Death|1
1783784|NCT00637572|6210301|P1|Overall Study|Death|0
1783785|NCT00637572|6210300|P2|Overall Study|Adverse Event|2
1783786|NCT00637572|6210301|P1|Overall Study|Adverse Event|1
1783787|NCT00637416|6210340|P2|Overall Study|Unable to take study drug|1
1783788|NCT00637416|6210341|P1|Overall Study|Unable to take study drug|0
1783789|NCT00637416|6210340|P2|Overall Study|Lost to Follow-up|1
1783790|NCT00637416|6210341|P1|Overall Study|Lost to Follow-up|1
1783791|NCT00637377|6210351|P4|Overall Study|Other (no further information available)|5
1783792|NCT00637377|6210352|P3|Overall Study|Other (no further information available)|10
1783793|NCT00637377|6210353|P2|Overall Study|Other (no further information available)|6
1783794|NCT00637377|6210354|P1|Overall Study|Other (no further information available)|7
1783795|NCT00637377|6210351|P4|Overall Study|Withdrawal by Subject|11
1783796|NCT00637377|6210352|P3|Overall Study|Withdrawal by Subject|13
1783797|NCT00637377|6210353|P2|Overall Study|Withdrawal by Subject|15
1783798|NCT00637377|6210354|P1|Overall Study|Withdrawal by Subject|11
1783799|NCT00637377|6210351|P4|Overall Study|Protocol Violation|0
1783800|NCT00637377|6210352|P3|Overall Study|Protocol Violation|1
1783801|NCT00637377|6210353|P2|Overall Study|Protocol Violation|1
1783802|NCT00637377|6210354|P1|Overall Study|Protocol Violation|2
1783803|NCT00637377|6210351|P4|Overall Study|Lost to Follow-up|2
1783804|NCT00637377|6210352|P3|Overall Study|Lost to Follow-up|2
1783805|NCT00637377|6210353|P2|Overall Study|Lost to Follow-up|1
1783806|NCT00637377|6210354|P1|Overall Study|Lost to Follow-up|4
1783807|NCT00637377|6210351|P4|Overall Study|Lack of Efficacy|1
1783808|NCT00637377|6210352|P3|Overall Study|Lack of Efficacy|1
1783809|NCT00637377|6210353|P2|Overall Study|Lack of Efficacy|0
1783810|NCT00637377|6210354|P1|Overall Study|Lack of Efficacy|0
1783811|NCT00637377|6210351|P4|Overall Study|Death|1
1783812|NCT00637377|6210352|P3|Overall Study|Death|2
1783813|NCT00637377|6210353|P2|Overall Study|Death|3
1783814|NCT00637377|6210354|P1|Overall Study|Death|1
1783815|NCT00637377|6210351|P4|Overall Study|Adverse Event|9
1783816|NCT00637377|6210352|P3|Overall Study|Adverse Event|8
1783817|NCT00637377|6210353|P2|Overall Study|Adverse Event|6
1783818|NCT00637377|6210354|P1|Overall Study|Adverse Event|2
1783819|NCT00637273|6210403|P3|Overall Study|Loss of Glucose Control|1
1783820|NCT00637273|6210404|P2|Overall Study|Loss of Glucose Control|1
1783821|NCT00637273|6210405|P1|Overall Study|Loss of Glucose Control|1
1783822|NCT00637273|6210403|P3|Overall Study|Administrative|0
1783823|NCT00637273|6210404|P2|Overall Study|Administrative|0
1783824|NCT00637273|6210405|P1|Overall Study|Administrative|2
1783825|NCT00637273|6210403|P3|Overall Study|Investigator Decision|1
1783826|NCT00637273|6210404|P2|Overall Study|Investigator Decision|3
1783827|NCT00637273|6210405|P1|Overall Study|Investigator Decision|1
1783828|NCT00637273|6210403|P3|Overall Study|Withdrawal of Consent|18
1783829|NCT00637273|6210404|P2|Overall Study|Withdrawal of Consent|6
1783830|NCT00637273|6210405|P1|Overall Study|Withdrawal of Consent|18
1783831|NCT00637273|6210403|P3|Overall Study|Protocol Violation|1
1783832|NCT00637273|6210404|P2|Overall Study|Protocol Violation|4
1783833|NCT00637273|6210405|P1|Overall Study|Protocol Violation|2
1783834|NCT00637273|6210403|P3|Overall Study|Lost to Follow-up|13
1783835|NCT00637273|6210404|P2|Overall Study|Lost to Follow-up|9
1783836|NCT00637273|6210405|P1|Overall Study|Lost to Follow-up|8
1783837|NCT00637273|6210403|P3|Overall Study|Adverse Event|7
1783838|NCT00637273|6210404|P2|Overall Study|Adverse Event|5
1783839|NCT00637273|6210405|P1|Overall Study|Adverse Event|11
1783840|NCT00637195|6210463|P2|Overall Study|Withdrawal by Subject|1
1783841|NCT00637195|6210464|P1|Overall Study|Withdrawal by Subject|0
1783842|NCT00637195|6210463|P2|Overall Study|Other|0
1783843|NCT00637195|6210464|P1|Overall Study|Other|2
1783844|NCT00637195|6210463|P2|Overall Study|Lost to Follow-up|0
1783845|NCT00637195|6210464|P1|Overall Study|Lost to Follow-up|1
1783846|NCT00637156|6210500|P2|Overall Study|Lost to Follow-up|16
1783847|NCT00637156|6210501|P1|Overall Study|Lost to Follow-up|10
1783848|NCT00637156|6210500|P2|Overall Study|Death|1
1783849|NCT00637156|6210501|P1|Overall Study|Death|0
1783850|NCT00637156|6210500|P2|Overall Study|Withdrawal by Subject|7
1783851|NCT00637156|6210501|P1|Overall Study|Withdrawal by Subject|0
1783852|NCT00637000|6210543|P2|Overall Study|Withdrawal by Subject|3
1783853|NCT00637000|6210544|P1|Overall Study|Withdrawal by Subject|4
1783854|NCT00636987|6210584|P1|Overall Study|5 year visit window not complete|69
1783855|NCT00636987|6210584|P1|Overall Study|Lost to Follow-up|63
1783856|NCT00636987|6210584|P1|Overall Study|Explanted|13
1783857|NCT00636987|6210584|P1|Overall Study|Death|44
1783858|NCT00636961|6210594|P2|Period 2|Adverse Event|0
1783859|NCT00636961|6210595|P1|Period 2|Adverse Event|1
1783860|NCT00636961|6210594|P2|Period 1|Administrative problems|1
1783861|NCT00636961|6210595|P1|Period 1|Administrative problems|1
1783862|NCT00636818|6210609|P1|Overall Study|Withdrawal by Subject|4
1783863|NCT00636818|6210609|P1|Overall Study|Protocol Violation|1
1783864|NCT00636818|6210609|P1|Overall Study|Entry Criteria Exclusion|3
1783865|NCT00636818|6210609|P1|Overall Study|Lost to Follow-up|2
1783866|NCT00636818|6210609|P1|Overall Study|Adverse Event|1
1783867|NCT00636792|6210634|P1|Overall Study|Other|3
1783868|NCT00636792|6210634|P1|Overall Study|Withdrawal by Subject|3
1783869|NCT00636792|6210634|P1|Overall Study|Progressive Disease|4
1783870|NCT00636792|6210634|P1|Overall Study|Physician Decision|7
1783871|NCT00636792|6210634|P1|Overall Study|Adverse Event|16
1783872|NCT00636675|6210650|P2|Overall Study|Withdrawal by Subject|10
1783873|NCT00636675|6210651|P1|Overall Study|Withdrawal by Subject|19
1783874|NCT00636675|6210650|P2|Overall Study|Lost to Follow-up|31
1783875|NCT00636675|6210651|P1|Overall Study|Lost to Follow-up|121
1783876|NCT00636636|6210694|P2|Overall Study|Withdrawal by Subject|9
1783877|NCT00636636|6210695|P1|Overall Study|Withdrawal by Subject|4
1783878|NCT00636636|6210694|P2|Overall Study|Death|1
1783879|NCT00636636|6210695|P1|Overall Study|Death|0
1783880|NCT00636636|6210694|P2|Overall Study|Lost to Follow-up|1
1783881|NCT00636636|6210695|P1|Overall Study|Lost to Follow-up|0
1783882|NCT00636636|6210694|P2|Overall Study|Protocol Violation|2
1783883|NCT00636636|6210695|P1|Overall Study|Protocol Violation|2
1783884|NCT00636636|6210694|P2|Overall Study|Lack of Efficacy|12
1783885|NCT00636636|6210695|P1|Overall Study|Lack of Efficacy|7
1783886|NCT00636636|6210694|P2|Overall Study|Adverse Event|8
1783887|NCT00636636|6210695|P1|Overall Study|Adverse Event|19
1783888|NCT00636636|6210694|P2|Overall Study|Other reason|6
1783889|NCT00636636|6210695|P1|Overall Study|Other reason|4
1783890|NCT00636610|6210711|P2|Overall Study|Reason for discontinuation not available|2
1783891|NCT00636610|6210712|P1|Overall Study|Reason for discontinuation not available|3
1783892|NCT00636610|6210711|P2|Overall Study|Disease progression - clinical|3
1783893|NCT00636610|6210712|P1|Overall Study|Disease progression - clinical|8
1783894|NCT00636610|6210711|P2|Overall Study|Disease progression - radiographic|51
1783895|NCT00636610|6210712|P1|Overall Study|Disease progression - radiographic|41
1783896|NCT00636610|6210711|P2|Overall Study|Subject decision to withdraw|11
1783897|NCT00636610|6210712|P1|Overall Study|Subject decision to withdraw|15
1783898|NCT00636610|6210711|P2|Overall Study|Physician decision to withdraw patient|9
1783899|NCT00636610|6210712|P1|Overall Study|Physician decision to withdraw patient|15
1783900|NCT00636610|6210711|P2|Overall Study|Death|3
1783901|NCT00636610|6210712|P1|Overall Study|Death|6
1783902|NCT00636610|6210711|P2|Overall Study|Adverse Event|4
1783903|NCT00636610|6210712|P1|Overall Study|Adverse Event|4
1783904|NCT00636506|6210722|P1|Overall Study|Procedure aborted|1
1783905|NCT00636506|6210722|P1|Overall Study|Withdrawal by Subject|6
1783906|NCT00636506|6210722|P1|Overall Study|Explanted|1
1783907|NCT00636506|6210722|P1|Overall Study|Lost to Follow-up|8
1783908|NCT00636441|6210769|P7|Overall Study|Screen Failure|17
1783909|NCT00636441|6210770|P6|Overall Study|Screen Failure|0
1783910|NCT00636441|6210771|P5|Overall Study|Screen Failure|0
1783911|NCT00636441|6210772|P4|Overall Study|Screen Failure|0
1783912|NCT00636441|6210773|P3|Overall Study|Screen Failure|0
1783913|NCT00636441|6210774|P2|Overall Study|Screen Failure|0
1783914|NCT00636441|6210775|P1|Overall Study|Screen Failure|0
1783915|NCT00636441|6210769|P7|Overall Study|Late, ineligible|1
1783916|NCT00636441|6210770|P6|Overall Study|Late, ineligible|0
1783917|NCT00636441|6210771|P5|Overall Study|Late, ineligible|0
1783918|NCT00636441|6210772|P4|Overall Study|Late, ineligible|0
1783919|NCT00636441|6210773|P3|Overall Study|Late, ineligible|0
1783920|NCT00636441|6210774|P2|Overall Study|Late, ineligible|0
1783921|NCT00636441|6210775|P1|Overall Study|Late, ineligible|0
1783922|NCT00636441|6210769|P7|Overall Study|Adverse Event|0
1783923|NCT00636441|6210770|P6|Overall Study|Adverse Event|1
1783924|NCT00636441|6210771|P5|Overall Study|Adverse Event|0
1783925|NCT00636441|6210772|P4|Overall Study|Adverse Event|0
1783926|NCT00636441|6210773|P3|Overall Study|Adverse Event|1
1783927|NCT00636441|6210774|P2|Overall Study|Adverse Event|1
1783928|NCT00636441|6210775|P1|Overall Study|Adverse Event|0
1783929|NCT00636363|6210818|P3|Overall Study|Withdrawal by Subject|2
1783930|NCT00636363|6210819|P2|Overall Study|Withdrawal by Subject|3
1783931|NCT00636363|6210820|P1|Overall Study|Withdrawal by Subject|1
1783932|NCT00636363|6210818|P3|Overall Study|Lost to Follow-up|2
1783933|NCT00636363|6210819|P2|Overall Study|Lost to Follow-up|4
1783934|NCT00636363|6210820|P1|Overall Study|Lost to Follow-up|3
1783935|NCT00636363|6210818|P3|Overall Study|Protocol Violation|0
1783936|NCT00636363|6210819|P2|Overall Study|Protocol Violation|3
1783937|NCT00636363|6210820|P1|Overall Study|Protocol Violation|0
1783938|NCT00636363|6210818|P3|Overall Study|Lack of motivation|1
1783939|NCT00636363|6210819|P2|Overall Study|Lack of motivation|0
1783940|NCT00636363|6210820|P1|Overall Study|Lack of motivation|1
1783941|NCT00636363|6210818|P3|Overall Study|Missed > 1 visit|3
1783942|NCT00636363|6210819|P2|Overall Study|Missed > 1 visit|1
1783943|NCT00636363|6210820|P1|Overall Study|Missed > 1 visit|0
1783944|NCT00636363|6210818|P3|Overall Study|Met ineligibility criteria|3
1783945|NCT00636363|6210819|P2|Overall Study|Met ineligibility criteria|0
1783946|NCT00636363|6210820|P1|Overall Study|Met ineligibility criteria|0
1783947|NCT00636363|6210818|P3|Overall Study|Study related symptoms/complaints|4
1783948|NCT00636363|6210819|P2|Overall Study|Study related symptoms/complaints|7
1783949|NCT00636363|6210820|P1|Overall Study|Study related symptoms/complaints|8
1783950|NCT00636363|6210818|P3|Overall Study|Positive slit lamp finding|1
1783951|NCT00636363|6210819|P2|Overall Study|Positive slit lamp finding|2
1783952|NCT00636363|6210820|P1|Overall Study|Positive slit lamp finding|0
1783953|NCT00636363|6210818|P3|Overall Study|Adverse Event|1
1783954|NCT00636363|6210819|P2|Overall Study|Adverse Event|0
1783955|NCT00636363|6210820|P1|Overall Study|Adverse Event|0
1783956|NCT00636363|6210818|P3|Overall Study|Conjunctivitis|1
1783957|NCT00636363|6210819|P2|Overall Study|Conjunctivitis|0
1783958|NCT00636363|6210820|P1|Overall Study|Conjunctivitis|0
1783959|NCT00636207|6210841|P7|Overall Study|Withdrawal by Subject|0
1783960|NCT00636207|6210842|P6|Overall Study|Withdrawal by Subject|0
1783961|NCT00636207|6210843|P5|Overall Study|Withdrawal by Subject|1
1783962|NCT00636207|6210844|P4|Overall Study|Withdrawal by Subject|0
1783963|NCT00636207|6210845|P3|Overall Study|Withdrawal by Subject|0
1783964|NCT00636207|6210846|P2|Overall Study|Withdrawal by Subject|1
1783965|NCT00636207|6210847|P1|Overall Study|Withdrawal by Subject|0
1783966|NCT00636207|6210841|P7|Overall Study|Adverse Event|0
1783967|NCT00636207|6210842|P6|Overall Study|Adverse Event|0
1783968|NCT00636207|6210843|P5|Overall Study|Adverse Event|0
1783969|NCT00636207|6210844|P4|Overall Study|Adverse Event|0
1783970|NCT00636207|6210845|P3|Overall Study|Adverse Event|0
1783971|NCT00636207|6210846|P2|Overall Study|Adverse Event|0
1783972|NCT00636207|6210847|P1|Overall Study|Adverse Event|1
1783973|NCT00636194|6210911|P2|Overall Study|Protocol Violation|0
1783974|NCT00636194|6210912|P1|Overall Study|Protocol Violation|2
1783975|NCT00636194|6210911|P2|Overall Study|Study related symptoms and complaints|0
1783976|NCT00636194|6210912|P1|Overall Study|Study related symptoms and complaints|1
1783977|NCT00636181|6210925|P3|Overall Study|Withdrawal by Subject|10
1783978|NCT00636181|6210926|P2|Overall Study|Withdrawal by Subject|6
1783979|NCT00636181|6210927|P1|Overall Study|Withdrawal by Subject|8
1783980|NCT00636168|6210955|P2|Long Term Follow-Up|Death|9
1783981|NCT00636168|6210956|P1|Long Term Follow-Up|Death|8
1783982|NCT00636168|6210955|P2|Long Term Follow-Up|Participant withdrew consent|2
1783983|NCT00636168|6210956|P1|Long Term Follow-Up|Participant withdrew consent|0
1783984|NCT00636168|6210955|P2|Long Term Follow-Up|Lost to Follow-up|3
1783985|NCT00636168|6210956|P1|Long Term Follow-Up|Lost to Follow-up|3
1783986|NCT00636168|6210955|P2|Treated With Study Drug|Other reason|3
1783987|NCT00636168|6210956|P1|Treated With Study Drug|Other reason|1
1783988|NCT00636168|6210955|P2|Treated With Study Drug|No longer meets study criteria|0
1783989|NCT00636168|6210956|P1|Treated With Study Drug|No longer meets study criteria|1
1783990|NCT00636168|6210955|P2|Treated With Study Drug|Pregnancy|0
1783991|NCT00636168|6210956|P1|Treated With Study Drug|Pregnancy|1
1783992|NCT00636168|6210955|P2|Treated With Study Drug|Death|0
1783993|NCT00636168|6210956|P1|Treated With Study Drug|Death|3
1783994|NCT00636168|6210955|P2|Treated With Study Drug|Poor/non-compliance|3
1783995|NCT00636168|6210956|P1|Treated With Study Drug|Poor/non-compliance|1
1783996|NCT00636168|6210955|P2|Treated With Study Drug|Participant withdrew consent|21
1783997|NCT00636168|6210956|P1|Treated With Study Drug|Participant withdrew consent|16
1783998|NCT00636168|6210955|P2|Treated With Study Drug|Adverse Event|22
1783999|NCT00636168|6210956|P1|Treated With Study Drug|Adverse Event|250
1784000|NCT00636168|6210955|P2|Treated With Study Drug|Recurrence of disease|282
1784001|NCT00636168|6210956|P1|Treated With Study Drug|Recurrence of disease|135
1784002|NCT00636168|6210955|P2|Randomized to Study Drug|No longer meets study criteria|0
1784003|NCT00636168|6210956|P1|Randomized to Study Drug|No longer meets study criteria|1
1784004|NCT00636168|6210955|P2|Randomized to Study Drug|Adverse Event|0
1784005|NCT00636168|6210956|P1|Randomized to Study Drug|Adverse Event|1
1784006|NCT00636168|6210955|P2|Randomized to Study Drug|Withdrawal by Subject|2
1784007|NCT00636168|6210956|P1|Randomized to Study Drug|Withdrawal by Subject|2
1784008|NCT00636155|6210984|P1|Overall Study|Physician Decision|5
1784009|NCT00636155|6210984|P1|Overall Study|Stem cell transplant|1
1784010|NCT00636155|6210984|P1|Overall Study|Withdrawal by Subject|3
1784011|NCT00636155|6210984|P1|Overall Study|Lack of Efficacy|1
1784012|NCT00636155|6210984|P1|Overall Study|Adverse Event|8
1784013|NCT00635999|6211026|P3|Overall Study|Withdrawal by Subject|1
1784014|NCT00635999|6211027|P2|Overall Study|Withdrawal by Subject|2
1784015|NCT00635999|6211028|P1|Overall Study|Withdrawal by Subject|4
1784016|NCT00635882|6211045|P6|Overall Study|Protocol Violation|0
1784017|NCT00635882|6211046|P5|Overall Study|Protocol Violation|0
1784018|NCT00635882|6211047|P4|Overall Study|Protocol Violation|0
1784019|NCT00635882|6211048|P3|Overall Study|Protocol Violation|0
1784020|NCT00635882|6211049|P2|Overall Study|Protocol Violation|0
1784021|NCT00635882|6211050|P1|Overall Study|Protocol Violation|1
1784022|NCT00635804|6211180|P8|Overall Study|Withdrawal by Subject|0
1784023|NCT00635804|6211181|P7|Overall Study|Withdrawal by Subject|0
1784024|NCT00635804|6211182|P6|Overall Study|Withdrawal by Subject|0
1784025|NCT00635804|6211183|P5|Overall Study|Withdrawal by Subject|0
1784026|NCT00635804|6211184|P4|Overall Study|Withdrawal by Subject|0
1784027|NCT00635804|6211185|P3|Overall Study|Withdrawal by Subject|0
1784028|NCT00635804|6211186|P2|Overall Study|Withdrawal by Subject|0
1784029|NCT00635804|6211187|P1|Overall Study|Withdrawal by Subject|1
1784030|NCT00635804|6211180|P8|Overall Study|Adverse Event|0
1784031|NCT00635804|6211181|P7|Overall Study|Adverse Event|0
1784032|NCT00635804|6211182|P6|Overall Study|Adverse Event|1
1784033|NCT00635804|6211183|P5|Overall Study|Adverse Event|0
1784034|NCT00635804|6211184|P4|Overall Study|Adverse Event|0
1784035|NCT00635804|6211185|P3|Overall Study|Adverse Event|0
1784036|NCT00635804|6211186|P2|Overall Study|Adverse Event|0
1784037|NCT00635804|6211187|P1|Overall Study|Adverse Event|0
1784038|NCT00635778|6211291|P7|Overall Study|Progressive disease|4
1784039|NCT00635778|6211292|P6|Overall Study|Progressive disease|14
1784040|NCT00635778|6211293|P5|Overall Study|Progressive disease|5
1784041|NCT00635778|6211294|P4|Overall Study|Progressive disease|4
1784042|NCT00635778|6211295|P3|Overall Study|Progressive disease|3
1784043|NCT00635778|6211296|P2|Overall Study|Progressive disease|3
1784044|NCT00635778|6211297|P1|Overall Study|Progressive disease|0
1784045|NCT00635778|6211291|P7|Overall Study|Withdrawal by Subject|1
1784046|NCT00635778|6211292|P6|Overall Study|Withdrawal by Subject|1
1784047|NCT00635778|6211293|P5|Overall Study|Withdrawal by Subject|0
1784048|NCT00635778|6211294|P4|Overall Study|Withdrawal by Subject|1
1784049|NCT00635778|6211295|P3|Overall Study|Withdrawal by Subject|0
1784050|NCT00635778|6211296|P2|Overall Study|Withdrawal by Subject|0
1784051|NCT00635778|6211297|P1|Overall Study|Withdrawal by Subject|0
1784052|NCT00635778|6211291|P7|Overall Study|Adverse Event|1
1784053|NCT00635778|6211292|P6|Overall Study|Adverse Event|6
1784054|NCT00635778|6211293|P5|Overall Study|Adverse Event|3
1784055|NCT00635778|6211294|P4|Overall Study|Adverse Event|3
1784056|NCT00635778|6211295|P3|Overall Study|Adverse Event|0
1784057|NCT00635778|6211296|P2|Overall Study|Adverse Event|0
1784058|NCT00635778|6211297|P1|Overall Study|Adverse Event|1
1784059|NCT00635661|6211368|P1|Overall Study|Withdrawal by Subject|4
1784060|NCT00635648|6211372|P1|Overall Study|Other reason|2
1784061|NCT00635648|6211372|P1|Overall Study|Noncompliance with protocol|1
1784062|NCT00635648|6211372|P1|Overall Study|No improvement after 7-10 days treatment|4
1784063|NCT00635648|6211372|P1|Overall Study|Use of other antifungal agent needed|1
1784064|NCT00635648|6211372|P1|Overall Study|Rapid progression of baseline disease|4
1784065|NCT00635648|6211372|P1|Overall Study|Physician Decision|4
1784066|NCT00635648|6211372|P1|Overall Study|Withdrawal by Subject|9
1784067|NCT00635648|6211372|P1|Overall Study|Adverse Event|12
1784068|NCT00635570|6211394|P2|Overall Study|Early termination(No sexual activity)|1
1784069|NCT00635570|6211395|P1|Overall Study|Early termination(No sexual activity)|1
1784070|NCT00635570|6211394|P2|Overall Study|Did not complete survey|1
1784071|NCT00635570|6211395|P1|Overall Study|Did not complete survey|2
1784072|NCT00635570|6211394|P2|Overall Study|Physician Decision|0
1784073|NCT00635570|6211395|P1|Overall Study|Physician Decision|1
1784074|NCT00635570|6211394|P2|Overall Study|Adverse Event|0
1784075|NCT00635570|6211395|P1|Overall Study|Adverse Event|2
1784076|NCT00635570|6211394|P2|Overall Study|Withdrawal by Subject|1
1784077|NCT00635570|6211395|P1|Overall Study|Withdrawal by Subject|1
1784078|NCT00635570|6211394|P2|Overall Study|Lost to Follow-up|8
1784079|NCT00635570|6211395|P1|Overall Study|Lost to Follow-up|8
1784080|NCT00635492|6211409|P2|Overall Study|Withdrawal by Subject|45
1784081|NCT00635492|6211410|P1|Overall Study|Withdrawal by Subject|82
1784082|NCT00635492|6211409|P2|Overall Study|Sponsor decision|3
1784083|NCT00635492|6211410|P1|Overall Study|Sponsor decision|2
1784084|NCT00635492|6211409|P2|Overall Study|Physician Decision|22
1784085|NCT00635492|6211410|P1|Overall Study|Physician Decision|32
1784086|NCT00635492|6211409|P2|Overall Study|Lost to Follow-up|172
1784087|NCT00635492|6211410|P1|Overall Study|Lost to Follow-up|151
1784088|NCT00635492|6211409|P2|Overall Study|Death|40
1784089|NCT00635492|6211410|P1|Overall Study|Death|12
1784090|NCT00635427|6211483|P5|Overall Study|Withdrawal Of Consent|2
1784091|NCT00635427|6211484|P4|Overall Study|Withdrawal Of Consent|2
1784092|NCT00635427|6211485|P3|Overall Study|Withdrawal Of Consent|0
1784093|NCT00635427|6211486|P2|Overall Study|Withdrawal Of Consent|0
1784094|NCT00635427|6211487|P1|Overall Study|Withdrawal Of Consent|0
1784095|NCT00635427|6211483|P5|Overall Study|Termination Of Study By Sponsor|6
1784096|NCT00635427|6211484|P4|Overall Study|Termination Of Study By Sponsor|6
1784097|NCT00635427|6211485|P3|Overall Study|Termination Of Study By Sponsor|10
1784098|NCT00635427|6211486|P2|Overall Study|Termination Of Study By Sponsor|6
1784099|NCT00635427|6211487|P1|Overall Study|Termination Of Study By Sponsor|12
1784100|NCT00635427|6211483|P5|Overall Study|Death|0
1784101|NCT00635427|6211484|P4|Overall Study|Death|1
1784102|NCT00635427|6211485|P3|Overall Study|Death|0
1784103|NCT00635427|6211486|P2|Overall Study|Death|0
1784104|NCT00635427|6211487|P1|Overall Study|Death|0
1784105|NCT00635427|6211483|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1784106|NCT00635427|6211484|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1784107|NCT00635427|6211485|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
1784108|NCT00635427|6211486|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1784109|NCT00635427|6211487|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
1784110|NCT00635349|6211526|P2|Overall Study|Adverse Event|9
1784111|NCT00635349|6211527|P1|Overall Study|Adverse Event|11
1784112|NCT00635349|6211526|P2|Overall Study|Lost to Follow-up|3
1784113|NCT00635349|6211527|P1|Overall Study|Lost to Follow-up|4
1784114|NCT00635349|6211526|P2|Overall Study|Withdrawal by Subject|8
1784115|NCT00635349|6211527|P1|Overall Study|Withdrawal by Subject|3
1784116|NCT00635349|6211526|P2|Overall Study|Protocol Violation|22
1784117|NCT00635349|6211527|P1|Overall Study|Protocol Violation|18
1784118|NCT00635349|6211526|P2|Overall Study|Other|6
1784119|NCT00635349|6211527|P1|Overall Study|Other|8
1784120|NCT00635219|6211581|P5|Overall Study|Administrative or Other Reasons|1
1784121|NCT00635219|6211582|P4|Overall Study|Administrative or Other Reasons|0
1784122|NCT00635219|6211583|P3|Overall Study|Administrative or Other Reasons|1
1784123|NCT00635219|6211584|P2|Overall Study|Administrative or Other Reasons|1
1784124|NCT00635219|6211585|P1|Overall Study|Administrative or Other Reasons|0
1784125|NCT00635219|6211581|P5|Overall Study|Lost to Follow-up|3
1784126|NCT00635219|6211582|P4|Overall Study|Lost to Follow-up|0
1784127|NCT00635219|6211583|P3|Overall Study|Lost to Follow-up|2
1784128|NCT00635219|6211584|P2|Overall Study|Lost to Follow-up|0
1784129|NCT00635219|6211585|P1|Overall Study|Lost to Follow-up|0
1784130|NCT00635219|6211581|P5|Overall Study|Withdrawal of Consent|8
1784131|NCT00635219|6211582|P4|Overall Study|Withdrawal of Consent|11
1784132|NCT00635219|6211583|P3|Overall Study|Withdrawal of Consent|8
1784133|NCT00635219|6211584|P2|Overall Study|Withdrawal of Consent|6
1784134|NCT00635219|6211585|P1|Overall Study|Withdrawal of Consent|8
1784135|NCT00635219|6211581|P5|Overall Study|Protocol Violation|4
1784136|NCT00635219|6211582|P4|Overall Study|Protocol Violation|2
1784137|NCT00635219|6211583|P3|Overall Study|Protocol Violation|3
1784138|NCT00635219|6211584|P2|Overall Study|Protocol Violation|2
1784139|NCT00635219|6211585|P1|Overall Study|Protocol Violation|0
1784140|NCT00635219|6211581|P5|Overall Study|Non-compliance With Study Product|1
1784141|NCT00635219|6211582|P4|Overall Study|Non-compliance With Study Product|2
1784142|NCT00635219|6211583|P3|Overall Study|Non-compliance With Study Product|0
1784143|NCT00635219|6211584|P2|Overall Study|Non-compliance With Study Product|0
1784144|NCT00635219|6211585|P1|Overall Study|Non-compliance With Study Product|0
1784145|NCT00635219|6211581|P5|Overall Study|Lack of Efficacy|6
1784146|NCT00635219|6211582|P4|Overall Study|Lack of Efficacy|4
1784147|NCT00635219|6211583|P3|Overall Study|Lack of Efficacy|3
1784148|NCT00635219|6211584|P2|Overall Study|Lack of Efficacy|6
1784149|NCT00635219|6211585|P1|Overall Study|Lack of Efficacy|5
1784150|NCT00635219|6211581|P5|Overall Study|Adverse Event|19
1784151|NCT00635219|6211582|P4|Overall Study|Adverse Event|15
1784152|NCT00635219|6211583|P3|Overall Study|Adverse Event|18
1784153|NCT00635219|6211584|P2|Overall Study|Adverse Event|10
1784154|NCT00635219|6211585|P1|Overall Study|Adverse Event|12
1784155|NCT00635154|6211648|P1|Overall Study|Still on treatment|21
1784156|NCT00635154|6211648|P1|Overall Study|Other|4
1784157|NCT00635154|6211648|P1|Overall Study|Alternative Treatment|8
1784158|NCT00635102|6211691|P2|Overall Study|Withdrawal by Subject|8
1784159|NCT00635102|6211692|P1|Overall Study|Withdrawal by Subject|7
1784160|NCT00635089|6211786|P1|Overall Study|Other|31
1784161|NCT00635089|6211786|P1|Overall Study|Lost to Follow-up|8
1784162|NCT00635089|6211786|P1|Overall Study|Protocol Deviation|4
1784163|NCT00635089|6211786|P1|Overall Study|Lack of Efficacy|28
1784164|NCT00635089|6211786|P1|Overall Study|Adverse Event|7
1784165|NCT00635050|6211813|P1|Overall Study|Withdrawal by Subject|1
1784166|NCT00635024|6211820|P1|Overall Study|Adverse Event|1
1784167|NCT00634933|6211831|P5|Part B: Week 24 to Week 52|Other|1
1784168|NCT00634933|6211832|P4|Part B: Week 24 to Week 52|Other|0
1784169|NCT00634933|6211833|P3|Part B: Week 24 to Week 52|Other|5
1784170|NCT00634933|6211834|P2|Part B: Week 24 to Week 52|Other|0
1784171|NCT00634933|6211835|P1|Part B: Week 24 to Week 52|Other|0
1784172|NCT00634933|6211831|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
1784173|NCT00634933|6211832|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
1784174|NCT00634933|6211833|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
1784175|NCT00634933|6211834|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
1784176|NCT00634933|6211835|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
1784177|NCT00634933|6211831|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
1784178|NCT00634933|6211832|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
1784179|NCT00634933|6211833|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1784180|NCT00634933|6211834|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1784181|NCT00634933|6211835|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
1784182|NCT00634933|6211831|P5|Part B: Week 24 to Week 52|Protocol Violation|1
1784183|NCT00634933|6211832|P4|Part B: Week 24 to Week 52|Protocol Violation|0
1784184|NCT00634933|6211833|P3|Part B: Week 24 to Week 52|Protocol Violation|0
1784185|NCT00634933|6211834|P2|Part B: Week 24 to Week 52|Protocol Violation|0
1784186|NCT00634933|6211835|P1|Part B: Week 24 to Week 52|Protocol Violation|0
1784187|NCT00634933|6211831|P5|Part B: Week 24 to Week 52|Physician Decision|0
1784188|NCT00634933|6211832|P4|Part B: Week 24 to Week 52|Physician Decision|0
1784189|NCT00634933|6211833|P3|Part B: Week 24 to Week 52|Physician Decision|1
1784190|NCT00634933|6211834|P2|Part B: Week 24 to Week 52|Physician Decision|1
1784191|NCT00634933|6211835|P1|Part B: Week 24 to Week 52|Physician Decision|0
1784192|NCT00634933|6211831|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
1784193|NCT00634933|6211832|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
1784194|NCT00634933|6211833|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
1784195|NCT00634933|6211834|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
1784196|NCT00634933|6211835|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
1784197|NCT00634933|6211831|P5|Part B: Week 24 to Week 52|Adverse Event|0
1784198|NCT00634933|6211832|P4|Part B: Week 24 to Week 52|Adverse Event|1
1784199|NCT00634933|6211833|P3|Part B: Week 24 to Week 52|Adverse Event|1
1784200|NCT00634933|6211834|P2|Part B: Week 24 to Week 52|Adverse Event|1
1784201|NCT00634933|6211835|P1|Part B: Week 24 to Week 52|Adverse Event|0
1784202|NCT00634933|6211831|P5|Between Part A and Part B|Physician Decision|0
1784203|NCT00634933|6211832|P4|Between Part A and Part B|Physician Decision|0
1784204|NCT00634933|6211833|P3|Between Part A and Part B|Physician Decision|0
1784205|NCT00634933|6211834|P2|Between Part A and Part B|Physician Decision|1
1784206|NCT00634933|6211835|P1|Between Part A and Part B|Physician Decision|0
1784207|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Other|0
1784208|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Other|0
1784209|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Other|5
1784210|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Other|8
1784211|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Other|1
1784212|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
1784213|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
1784214|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
1784215|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
1784216|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
1784217|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
1784218|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
1784219|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
1784220|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
1784221|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
1784222|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
1784223|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
1784224|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
1784225|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
1784226|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
1784227|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Investigator Request|0
1784228|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Investigator Request|0
1784229|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Investigator Request|1
1784230|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Investigator Request|1
1784231|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Investigator Request|1
1784232|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Failed to Return|0
1784233|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Failed to Return|0
1784234|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Failed to Return|0
1784235|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Failed to Return|0
1784236|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Failed to Return|1
1784237|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Death|0
1784238|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Death|0
1784239|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Death|0
1784240|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Death|0
1784241|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Death|1
1784242|NCT00634933|6211831|P5|Part A: Baseline to Week 24|Adverse Event|0
1784243|NCT00634933|6211832|P4|Part A: Baseline to Week 24|Adverse Event|0
1784244|NCT00634933|6211833|P3|Part A: Baseline to Week 24|Adverse Event|8
1784245|NCT00634933|6211834|P2|Part A: Baseline to Week 24|Adverse Event|4
1784246|NCT00634933|6211835|P1|Part A: Baseline to Week 24|Adverse Event|4
1784247|NCT00634920|6211904|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
1784248|NCT00634920|6211905|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
1784249|NCT00634920|6211906|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
1784250|NCT00634920|6211904|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
1784251|NCT00634920|6211905|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
1784252|NCT00634920|6211906|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
1784253|NCT00634920|6211904|P3|Period 2 - Post-Randomization|Death|0
1784254|NCT00634920|6211905|P2|Period 2 - Post-Randomization|Death|5
1784255|NCT00634920|6211906|P1|Period 2 - Post-Randomization|Death|2
1784256|NCT00634920|6211904|P3|Period 2 - Post-Randomization|Rejection|0
1784257|NCT00634920|6211905|P2|Period 2 - Post-Randomization|Rejection|5
1784258|NCT00634920|6211906|P1|Period 2 - Post-Randomization|Rejection|11
1784259|NCT00634920|6211904|P3|Period 2 - Post-Randomization|Adverse Event|0
1784260|NCT00634920|6211905|P2|Period 2 - Post-Randomization|Adverse Event|9
1784261|NCT00634920|6211906|P1|Period 2 - Post-Randomization|Adverse Event|37
1784262|NCT00634920|6211904|P3|Period 1 - Pre-Randomization|Other issues|6
1784263|NCT00634920|6211905|P2|Period 1 - Pre-Randomization|Other issues|0
1784264|NCT00634920|6211906|P1|Period 1 - Pre-Randomization|Other issues|0
1784265|NCT00634920|6211904|P3|Period 1 - Pre-Randomization|Non-Compliance|3
1784266|NCT00634920|6211905|P2|Period 1 - Pre-Randomization|Non-Compliance|0
1784267|NCT00634920|6211906|P1|Period 1 - Pre-Randomization|Non-Compliance|0
1784268|NCT00634920|6211904|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
1784269|NCT00634920|6211905|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
1784270|NCT00634920|6211906|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
1784271|NCT00634920|6211904|P3|Period 1 - Pre-Randomization|Rejections|55
1784272|NCT00634920|6211905|P2|Period 1 - Pre-Randomization|Rejections|0
1784273|NCT00634920|6211906|P1|Period 1 - Pre-Randomization|Rejections|0
1784274|NCT00634920|6211904|P3|Period 1 - Pre-Randomization|Wound healing problems|16
1784275|NCT00634920|6211905|P2|Period 1 - Pre-Randomization|Wound healing problems|0
1784276|NCT00634920|6211906|P1|Period 1 - Pre-Randomization|Wound healing problems|0
1784277|NCT00634920|6211904|P3|Period 1 - Pre-Randomization|Adverse Event|36
1784278|NCT00634920|6211905|P2|Period 1 - Pre-Randomization|Adverse Event|0
1784279|NCT00634920|6211906|P1|Period 1 - Pre-Randomization|Adverse Event|0
1784280|NCT00634907|6211950|P2|Overall Study|Withdrawal by Subject|8
1784281|NCT00634907|6211951|P1|Overall Study|Withdrawal by Subject|11
1784282|NCT00634907|6211950|P2|Overall Study|Physician Decision|9
1784283|NCT00634907|6211951|P1|Overall Study|Physician Decision|3
1784284|NCT00634907|6211950|P2|Overall Study|Withdrawal by Subject|0
1784285|NCT00634907|6211951|P1|Overall Study|Withdrawal by Subject|3
1784286|NCT00634842|6211975|P2|Overall Study|Subject off study drug for too long|1
1784287|NCT00634842|6211976|P1|Overall Study|Subject off study drug for too long|0
1784288|NCT00634842|6211975|P2|Overall Study|No wish to keep taking Avandia|1
1784289|NCT00634842|6211976|P1|Overall Study|No wish to keep taking Avandia|0
1784290|NCT00634842|6211975|P2|Overall Study|No need of study drug to treat diabetes|1
1784291|NCT00634842|6211976|P1|Overall Study|No need of study drug to treat diabetes|0
1784292|NCT00634842|6211975|P2|Overall Study|Discontinued due to injection|2
1784293|NCT00634842|6211976|P1|Overall Study|Discontinued due to injection|0
1784294|NCT00634842|6211975|P2|Overall Study|Lack of time and intolerance to drug|1
1784295|NCT00634842|6211976|P1|Overall Study|Lack of time and intolerance to drug|0
1784296|NCT00634842|6211975|P2|Overall Study|Withdrawal by Subject|3
1784297|NCT00634842|6211976|P1|Overall Study|Withdrawal by Subject|1
1784298|NCT00634842|6211975|P2|Overall Study|Physician Decision|0
1784299|NCT00634842|6211976|P1|Overall Study|Physician Decision|1
1784300|NCT00634842|6211975|P2|Overall Study|Lost to Follow-up|2
1784301|NCT00634842|6211976|P1|Overall Study|Lost to Follow-up|1
1784302|NCT00634842|6211975|P2|Overall Study|Inclusion criteria were not met|0
1784303|NCT00634842|6211976|P1|Overall Study|Inclusion criteria were not met|1
1784304|NCT00634842|6211975|P2|Overall Study|Move to another state|0
1784305|NCT00634842|6211976|P1|Overall Study|Move to another state|1
1784306|NCT00634842|6211975|P2|Overall Study|Protocol Violation|4
1784307|NCT00634842|6211976|P1|Overall Study|Protocol Violation|8
1784308|NCT00634842|6211975|P2|Overall Study|Adverse Event|3
1784309|NCT00634842|6211976|P1|Overall Study|Adverse Event|2
1784310|NCT00634751|6211992|P4|Pancreatic and Bilial Tract Cancer|Death|1
1784311|NCT00634751|6211993|P3|Pancreatic and Bilial Tract Cancer|Death|1
1784312|NCT00634751|6211994|P2|Pancreatic and Bilial Tract Cancer|Death|0
1784313|NCT00634751|6211995|P1|Pancreatic and Bilial Tract Cancer|Death|0
1784314|NCT00634751|6211992|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1784315|NCT00634751|6211993|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1784316|NCT00634751|6211994|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
1784317|NCT00634751|6211995|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
1784318|NCT00634751|6211992|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
1784319|NCT00634751|6211993|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
1784320|NCT00634751|6211994|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
1784321|NCT00634751|6211995|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
1784322|NCT00634647|6212013|P1|Overall Study|declined to participate before treatment|1
1784323|NCT00634647|6212013|P1|Overall Study|refused further treatment|3
1784324|NCT00634647|6212013|P1|Overall Study|death on study|3
1784325|NCT00634569|6212033|P2|Overall Study|Physician Decision|1
1784326|NCT00634569|6212034|P1|Overall Study|Physician Decision|0
1784327|NCT00634569|6212033|P2|Overall Study|Withdrawal by Subject|4
1784328|NCT00634569|6212034|P1|Overall Study|Withdrawal by Subject|0
1784329|NCT00634543|6212048|P2|Overall Study|Lost to Follow-up|1
1784330|NCT00634543|6212049|P1|Overall Study|Lost to Follow-up|0
1784331|NCT00634543|6212048|P2|Overall Study|Withdrawal by Subject|4
1784332|NCT00634543|6212049|P1|Overall Study|Withdrawal by Subject|4
1784333|NCT00634543|6212048|P2|Overall Study|Adverse Event|11
1784334|NCT00634543|6212049|P1|Overall Study|Adverse Event|11
1784335|NCT00634543|6212048|P2|Overall Study|Protocol Violation|3
1784336|NCT00634543|6212049|P1|Overall Study|Protocol Violation|3
1784337|NCT00634543|6212048|P2|Overall Study|Other|2
1784338|NCT00634543|6212049|P1|Overall Study|Other|1
1784339|NCT00634504|6212067|P2|Overall Study|Protocol Violation|0
1784340|NCT00634504|6212068|P1|Overall Study|Protocol Violation|1
1784341|NCT00634244|6212127|P3|Overall Study|Other complicating disease|0
1784342|NCT00634244|6212128|P2|Overall Study|Other complicating disease|1
1784343|NCT00634244|6212129|P1|Overall Study|Other complicating disease|0
1784344|NCT00634244|6212127|P3|Overall Study|Disease progression/relapse|0
1784345|NCT00634244|6212128|P2|Overall Study|Disease progression/relapse|1
1784346|NCT00634244|6212129|P1|Overall Study|Disease progression/relapse|0
1784347|NCT00634244|6212127|P3|Overall Study|Physician Decision|0
1784348|NCT00634244|6212128|P2|Overall Study|Physician Decision|1
1784349|NCT00634244|6212129|P1|Overall Study|Physician Decision|0
1784350|NCT00634244|6212127|P3|Overall Study|Withdrawal by Subject|0
1784351|NCT00634244|6212128|P2|Overall Study|Withdrawal by Subject|1
1784352|NCT00634244|6212129|P1|Overall Study|Withdrawal by Subject|0
1784353|NCT00634244|6212127|P3|Overall Study|Adverse Event|0
1784354|NCT00634244|6212128|P2|Overall Study|Adverse Event|2
1784355|NCT00634244|6212129|P1|Overall Study|Adverse Event|0
1784356|NCT00634244|6212127|P3|Overall Study|Death|0
1784357|NCT00634244|6212128|P2|Overall Study|Death|6
1784358|NCT00634244|6212129|P1|Overall Study|Death|1
1784359|NCT00634244|6212127|P3|Overall Study|Never started treatment|0
1784360|NCT00634244|6212128|P2|Overall Study|Never started treatment|1
1784361|NCT00634244|6212129|P1|Overall Study|Never started treatment|0
1784362|NCT00634179|6212140|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
1784363|NCT00634114|6212159|P3|Overall Study|Other reason|1
1784364|NCT00634114|6212160|P2|Overall Study|Other reason|1
1784365|NCT00634114|6212161|P1|Overall Study|Other reason|1
1784366|NCT00634114|6212159|P3|Overall Study|Difficult to continue|1
1784367|NCT00634114|6212160|P2|Overall Study|Difficult to continue|1
1784368|NCT00634114|6212161|P1|Overall Study|Difficult to continue|3
1784369|NCT00634114|6212159|P3|Overall Study|Recurrence of reflux esophagitis|21
1784370|NCT00634114|6212160|P2|Overall Study|Recurrence of reflux esophagitis|15
1784371|NCT00634114|6212161|P1|Overall Study|Recurrence of reflux esophagitis|5
1784372|NCT00634114|6212159|P3|Overall Study|Incorrect enrolment|0
1784373|NCT00634114|6212160|P2|Overall Study|Incorrect enrolment|1
1784374|NCT00634114|6212161|P1|Overall Study|Incorrect enrolment|0
1784375|NCT00634114|6212159|P3|Overall Study|Pregnancy|0
1784376|NCT00634114|6212160|P2|Overall Study|Pregnancy|0
1784377|NCT00634114|6212161|P1|Overall Study|Pregnancy|1
1784378|NCT00634114|6212159|P3|Overall Study|Protocol Violation|1
1784379|NCT00634114|6212160|P2|Overall Study|Protocol Violation|3
1784380|NCT00634114|6212161|P1|Overall Study|Protocol Violation|3
1784381|NCT00634114|6212159|P3|Overall Study|Lost to Follow-up|1
1784382|NCT00634114|6212160|P2|Overall Study|Lost to Follow-up|0
1784383|NCT00634114|6212161|P1|Overall Study|Lost to Follow-up|0
1784384|NCT00634114|6212159|P3|Overall Study|Withdrawal by Subject|11
1784385|NCT00634114|6212160|P2|Overall Study|Withdrawal by Subject|6
1784386|NCT00634114|6212161|P1|Overall Study|Withdrawal by Subject|9
1784387|NCT00634114|6212159|P3|Overall Study|Adverse Event|3
1784388|NCT00634114|6212160|P2|Overall Study|Adverse Event|8
1784389|NCT00634114|6212161|P1|Overall Study|Adverse Event|6
1784390|NCT00634088|6212179|P4|Time Period 3: Dose Level 3|Progressive disease|0
1784391|NCT00634088|6212180|P3|Time Period 3: Dose Level 3|Progressive disease|1
1784392|NCT00634088|6212181|P2|Time Period 3: Dose Level 3|Progressive disease|0
1784393|NCT00634088|6212182|P1|Time Period 3: Dose Level 3|Progressive disease|0
1784394|NCT00634088|6212179|P4|Time Period 2: Dose Level 2|Progressive disease|0
1784395|NCT00634088|6212180|P3|Time Period 2: Dose Level 2|Progressive disease|0
1784396|NCT00634088|6212181|P2|Time Period 2: Dose Level 2|Progressive disease|1
1784397|NCT00634088|6212182|P1|Time Period 2: Dose Level 2|Progressive disease|0
1784398|NCT00634088|6212179|P4|Time Period 2: Dose Level 2|Adverse Event|0
1784399|NCT00634088|6212180|P3|Time Period 2: Dose Level 2|Adverse Event|0
1784400|NCT00634088|6212181|P2|Time Period 2: Dose Level 2|Adverse Event|2
1784401|NCT00634088|6212182|P1|Time Period 2: Dose Level 2|Adverse Event|0
1784402|NCT00634088|6212179|P4|Time Period 1: Dose Level 1|Adverse Event|0
1784403|NCT00634088|6212180|P3|Time Period 1: Dose Level 1|Adverse Event|0
1784404|NCT00634088|6212181|P2|Time Period 1: Dose Level 1|Adverse Event|0
1784405|NCT00634088|6212182|P1|Time Period 1: Dose Level 1|Adverse Event|3
1784406|NCT00634088|6212179|P4|Time Period 1: Dose Level 1|Physician Decision|0
1784407|NCT00634088|6212180|P3|Time Period 1: Dose Level 1|Physician Decision|0
1784408|NCT00634088|6212181|P2|Time Period 1: Dose Level 1|Physician Decision|0
1784409|NCT00634088|6212182|P1|Time Period 1: Dose Level 1|Physician Decision|1
1784410|NCT00634088|6212179|P4|Time Period 1: Dose Level 1|Disease progression|0
1784411|NCT00634088|6212180|P3|Time Period 1: Dose Level 1|Disease progression|0
1784412|NCT00634088|6212181|P2|Time Period 1: Dose Level 1|Disease progression|0
1784413|NCT00634088|6212182|P1|Time Period 1: Dose Level 1|Disease progression|2
1784414|NCT00634049|6212233|P1|Overall Study|Screening failure|1
1784415|NCT00634049|6212233|P1|Overall Study|Died prior to receiving study drug|1
1784416|NCT00634049|6212233|P1|Overall Study|Never received study drug|1
1784417|NCT00634036|6212312|P2|Overall Study|Withdrawal by Subject|1
1784418|NCT00634036|6212313|P1|Overall Study|Withdrawal by Subject|1
1784419|NCT00634036|6212312|P2|Overall Study|Lost to Follow-up|1
1784420|NCT00634036|6212313|P1|Overall Study|Lost to Follow-up|1
1784421|NCT00634010|6212327|P2|Overall Study|Non-Compliant|1
1784422|NCT00634010|6212328|P1|Overall Study|Non-Compliant|1
1784423|NCT00634010|6212327|P2|Overall Study|Disease Progression|1
1784424|NCT00634010|6212328|P1|Overall Study|Disease Progression|1
1784425|NCT00634010|6212327|P2|Overall Study|Physician Decision|1
1784426|NCT00634010|6212328|P1|Overall Study|Physician Decision|1
1784427|NCT00634010|6212327|P2|Overall Study|Withdrawal by Subject|6
1784428|NCT00634010|6212328|P1|Overall Study|Withdrawal by Subject|5
1784429|NCT00634010|6212327|P2|Overall Study|Adverse Event|5
1784430|NCT00634010|6212328|P1|Overall Study|Adverse Event|2
1784431|NCT00633984|6212336|P2|Overall Study|Hospitalized|0
1784432|NCT00633984|6212337|P1|Overall Study|Hospitalized|1
1784433|NCT00633984|6212336|P2|Overall Study|Withdrawal by Subject|7
1784434|NCT00633984|6212337|P1|Overall Study|Withdrawal by Subject|8
1784435|NCT00633984|6212336|P2|Overall Study|Lost to Follow-up|6
1784436|NCT00633984|6212337|P1|Overall Study|Lost to Follow-up|0
1784437|NCT00633945|6212345|P1|Overall Study|Physician Decision|2
1784438|NCT00633932|6212361|P3|Overall Study|Moved Away|0
1784439|NCT00633932|6212362|P2|Overall Study|Moved Away|0
1784440|NCT00633932|6212363|P1|Overall Study|Moved Away|1
1784441|NCT00633932|6212361|P3|Overall Study|Doctor's judgement|0
1784442|NCT00633932|6212362|P2|Overall Study|Doctor's judgement|0
1784443|NCT00633932|6212363|P1|Overall Study|Doctor's judgement|1
1784444|NCT00633932|6212361|P3|Overall Study|Physician Decision|1
1784445|NCT00633932|6212362|P2|Overall Study|Physician Decision|0
1784446|NCT00633932|6212363|P1|Overall Study|Physician Decision|0
1784447|NCT00633932|6212361|P3|Overall Study|Protocol Violation|3
1784448|NCT00633932|6212362|P2|Overall Study|Protocol Violation|2
1784449|NCT00633932|6212363|P1|Overall Study|Protocol Violation|5
1784450|NCT00633932|6212361|P3|Overall Study|Lost to Follow-up|2
1784451|NCT00633932|6212362|P2|Overall Study|Lost to Follow-up|0
1784452|NCT00633932|6212363|P1|Overall Study|Lost to Follow-up|1
1784453|NCT00633932|6212361|P3|Overall Study|Withdrawal by Subject|1
1784454|NCT00633932|6212362|P2|Overall Study|Withdrawal by Subject|9
1784455|NCT00633932|6212363|P1|Overall Study|Withdrawal by Subject|3
1784456|NCT00633932|6212361|P3|Overall Study|Adverse Event|4
1784457|NCT00633932|6212362|P2|Overall Study|Adverse Event|3
1784458|NCT00633932|6212363|P1|Overall Study|Adverse Event|1
1784459|NCT00633893|6212394|P3|Overall Study|Other|31
1784460|NCT00633893|6212395|P2|Overall Study|Other|33
1784461|NCT00633893|6212396|P1|Overall Study|Other|28
1784462|NCT00633893|6212394|P3|Overall Study|Not meet/no longer meets criteria|4
1784463|NCT00633893|6212395|P2|Overall Study|Not meet/no longer meets criteria|6
1784464|NCT00633893|6212396|P1|Overall Study|Not meet/no longer meets criteria|4
1784465|NCT00633893|6212394|P3|Overall Study|Pregnancy|1
1784466|NCT00633893|6212395|P2|Overall Study|Pregnancy|1
1784467|NCT00633893|6212396|P1|Overall Study|Pregnancy|2
1784468|NCT00633893|6212394|P3|Overall Study|Poor/non-compliance|3
1784469|NCT00633893|6212395|P2|Overall Study|Poor/non-compliance|12
1784470|NCT00633893|6212396|P1|Overall Study|Poor/non-compliance|5
1784471|NCT00633893|6212394|P3|Overall Study|Lost to Follow-up|8
1784472|NCT00633893|6212395|P2|Overall Study|Lost to Follow-up|4
1784473|NCT00633893|6212396|P1|Overall Study|Lost to Follow-up|2
1784474|NCT00633893|6212394|P3|Overall Study|Withdrawal by Subject|6
1784475|NCT00633893|6212395|P2|Overall Study|Withdrawal by Subject|12
1784476|NCT00633893|6212396|P1|Overall Study|Withdrawal by Subject|7
1784477|NCT00633893|6212394|P3|Overall Study|Adverse Event|126
1784478|NCT00633893|6212395|P2|Overall Study|Adverse Event|58
1784479|NCT00633893|6212396|P1|Overall Study|Adverse Event|65
1784480|NCT00633893|6212394|P3|Overall Study|Death|9
1784481|NCT00633893|6212395|P2|Overall Study|Death|3
1784482|NCT00633893|6212396|P1|Overall Study|Death|1
1784483|NCT00633880|6212470|P3|Open Label Titration|Withdrawal by Subject|0
1784484|NCT00633880|6212471|P2|Open Label Titration|Withdrawal by Subject|0
1784485|NCT00633880|6212472|P1|Open Label Titration|Withdrawal by Subject|4
1784486|NCT00633880|6212470|P3|Open Label Titration|Physician Decision|0
1784487|NCT00633880|6212471|P2|Open Label Titration|Physician Decision|0
1784488|NCT00633880|6212472|P1|Open Label Titration|Physician Decision|1
1784489|NCT00633880|6212470|P3|Open Label Titration|Protocol Violation|0
1784490|NCT00633880|6212471|P2|Open Label Titration|Protocol Violation|0
1784491|NCT00633880|6212472|P1|Open Label Titration|Protocol Violation|6
1784492|NCT00633880|6212470|P3|Open Label Titration|Treatment Failure|0
1784493|NCT00633880|6212471|P2|Open Label Titration|Treatment Failure|0
1784494|NCT00633880|6212472|P1|Open Label Titration|Treatment Failure|55
1784495|NCT00633880|6212470|P3|Open Label Titration|Adverse Event|0
1784496|NCT00633880|6212471|P2|Open Label Titration|Adverse Event|0
1784497|NCT00633880|6212472|P1|Open Label Titration|Adverse Event|13
1784498|NCT00633880|6212470|P3|Open Label Titration|Lack of Efficacy|0
1784499|NCT00633880|6212471|P2|Open Label Titration|Lack of Efficacy|0
1784500|NCT00633880|6212472|P1|Open Label Titration|Lack of Efficacy|1
1784501|NCT00633750|6212508|P1|Overall Study|Withdrawal by Subject|3
1784502|NCT00633750|6212508|P1|Overall Study|Adverse Event|2
1784503|NCT00633594|6212517|P3|Overall Study|Disease Progression|1
1784504|NCT00633594|6212518|P2|Overall Study|Disease Progression|0
1784505|NCT00633594|6212519|P1|Overall Study|Disease Progression|0
1784506|NCT00633594|6212517|P3|Overall Study|Death|2
1784507|NCT00633594|6212518|P2|Overall Study|Death|1
1784508|NCT00633594|6212519|P1|Overall Study|Death|0
1784509|NCT00633594|6212517|P3|Overall Study|Adverse Event|7
1784510|NCT00633594|6212518|P2|Overall Study|Adverse Event|4
1784511|NCT00633594|6212519|P1|Overall Study|Adverse Event|0
1784512|NCT00633477|6212548|P2|Overall Study|Randomized but not treated|0
1784513|NCT00633477|6212549|P1|Overall Study|Randomized but not treated|1
1784514|NCT00633477|6212548|P2|Overall Study|Death|0
1784515|NCT00633477|6212549|P1|Overall Study|Death|1
1784516|NCT00633464|6212565|P2|Overall Study|Never Treated (Randomized in error)|1
1784517|NCT00633464|6212566|P1|Overall Study|Never Treated (Randomized in error)|0
1784518|NCT00633464|6212565|P2|Overall Study|Never Treated (Not met study criteria)|1
1784519|NCT00633464|6212566|P1|Overall Study|Never Treated (Not met study criteria)|0
1784520|NCT00633360|6212601|P2|Overall Study|Protocol Violation|1
1784521|NCT00633360|6212602|P1|Overall Study|Protocol Violation|0
1784522|NCT00633360|6212601|P2|Overall Study|Adverse Event|1
1784523|NCT00633360|6212602|P1|Overall Study|Adverse Event|3
1784524|NCT00633360|6212601|P2|Overall Study|Lost to Follow-up|1
1784525|NCT00633360|6212602|P1|Overall Study|Lost to Follow-up|1
1784526|NCT00633243|6212625|P2|Overall Study|Couldn't tolerate side-effects|1
1784527|NCT00633243|6212626|P1|Overall Study|Couldn't tolerate side-effects|1
1784528|NCT00633243|6212625|P2|Overall Study|Mental Health--Depression|1
1784529|NCT00633243|6212626|P1|Overall Study|Mental Health--Depression|0
1784530|NCT00633243|6212625|P2|Overall Study|Not comfortable with self-injecting|1
1784531|NCT00633243|6212626|P1|Overall Study|Not comfortable with self-injecting|0
1784532|NCT00633243|6212625|P2|Overall Study|Homeless--no refrigeration for meds|1
1784533|NCT00633243|6212626|P1|Overall Study|Homeless--no refrigeration for meds|0
1784534|NCT00633243|6212625|P2|Overall Study|incarceration|2
1784535|NCT00633243|6212626|P1|Overall Study|incarceration|0
1784536|NCT00633243|6212625|P2|Overall Study|Withdrawal by Subject|1
1784537|NCT00633243|6212626|P1|Overall Study|Withdrawal by Subject|0
1784538|NCT00633217|6212634|P2|Overall Study|Withdrew Consent|3
1784539|NCT00633217|6212635|P1|Overall Study|Withdrew Consent|3
1784540|NCT00633217|6212634|P2|Overall Study|Investigator Discretion|0
1784541|NCT00633217|6212635|P1|Overall Study|Investigator Discretion|2
1784542|NCT00633217|6212634|P2|Overall Study|Lost to Follow-up|2
1784543|NCT00633217|6212635|P1|Overall Study|Lost to Follow-up|2
1784544|NCT00633217|6212634|P2|Overall Study|Protocol Violation|7
1784545|NCT00633217|6212635|P1|Overall Study|Protocol Violation|3
1784546|NCT00633217|6212634|P2|Overall Study|Lack of Efficacy|2
1784547|NCT00633217|6212635|P1|Overall Study|Lack of Efficacy|0
1784548|NCT00633217|6212634|P2|Overall Study|Adverse Event|9
1784549|NCT00633217|6212635|P1|Overall Study|Adverse Event|5
1784550|NCT00633152|6212647|P2|Overall Study|Miscellaneous Other|2
1784551|NCT00633152|6212648|P1|Overall Study|Miscellaneous Other|3
1784552|NCT00633152|6212647|P2|Overall Study|Lost to Follow-up|1
1784553|NCT00633152|6212648|P1|Overall Study|Lost to Follow-up|4
1784554|NCT00633152|6212647|P2|Overall Study|Withdrawal by Subject|1
1784555|NCT00633152|6212648|P1|Overall Study|Withdrawal by Subject|1
1784556|NCT00633152|6212647|P2|Overall Study|Randomized, did not receive study drug|2
1784557|NCT00633152|6212648|P1|Overall Study|Randomized, did not receive study drug|5
1784558|NCT00633152|6212647|P2|Overall Study|Adverse Event|0
1784559|NCT00633152|6212648|P1|Overall Study|Adverse Event|1
1784560|NCT00633139|6212659|P3|Overall Study|Withdrawal by Subject|0
1784561|NCT00633139|6212660|P2|Overall Study|Withdrawal by Subject|1
1784562|NCT00633139|6212661|P1|Overall Study|Withdrawal by Subject|0
1784563|NCT00633139|6212659|P3|Overall Study|Non compliance|1
1784564|NCT00633139|6212660|P2|Overall Study|Non compliance|0
1784565|NCT00633139|6212661|P1|Overall Study|Non compliance|0
1784566|NCT00633126|6212675|P1|Overall Study|Did not receive full dose|1
1784567|NCT00633074|6212689|P2|Overall Study|Adverse Event|0
1784568|NCT00633074|6212690|P1|Overall Study|Adverse Event|1
1784569|NCT00633061|6212720|P2|Overall Study|Study closed|0
1784570|NCT00633061|6212721|P1|Overall Study|Study closed|86
1784571|NCT00633022|6212732|P3|Overall Study|Physician Decision|0
1784572|NCT00633022|6212733|P2|Overall Study|Physician Decision|1
1784573|NCT00633022|6212734|P1|Overall Study|Physician Decision|0
1784574|NCT00633022|6212732|P3|Overall Study|Adverse Event|5
1784575|NCT00633022|6212733|P2|Overall Study|Adverse Event|0
1784576|NCT00633022|6212734|P1|Overall Study|Adverse Event|1
1784577|NCT00632931|6212796|P3|Part 2|Withdrawal by Subject|3
1784578|NCT00632931|6212797|P2|Part 2|Withdrawal by Subject|0
1784579|NCT00632931|6212798|P1|Part 2|Withdrawal by Subject|0
1784580|NCT00632931|6212796|P3|Part 2|Lack of Efficacy|17
1784581|NCT00632931|6212797|P2|Part 2|Lack of Efficacy|0
1784582|NCT00632931|6212798|P1|Part 2|Lack of Efficacy|0
1784583|NCT00632931|6212796|P3|Part 2|Death|1
1784584|NCT00632931|6212797|P2|Part 2|Death|0
1784585|NCT00632931|6212798|P1|Part 2|Death|0
1784586|NCT00632931|6212796|P3|Part 2|Adverse Event|3
1784587|NCT00632931|6212797|P2|Part 2|Adverse Event|0
1784588|NCT00632931|6212798|P1|Part 2|Adverse Event|0
1784589|NCT00632931|6212796|P3|Part 1, Period 1|Withdrawal by Subject|0
1784590|NCT00632931|6212797|P2|Part 1, Period 1|Withdrawal by Subject|0
1784591|NCT00632931|6212798|P1|Part 1, Period 1|Withdrawal by Subject|1
1784592|NCT00632931|6212796|P3|Part 1, Period 1|Protocol Violation|0
1784593|NCT00632931|6212797|P2|Part 1, Period 1|Protocol Violation|0
1784594|NCT00632931|6212798|P1|Part 1, Period 1|Protocol Violation|1
1784595|NCT00632749|6212868|P14|Overall Study|Reason other than those specified above|2
1784596|NCT00632749|6212869|P13|Overall Study|Reason other than those specified above|0
1784597|NCT00632749|6212870|P12|Overall Study|Reason other than those specified above|1
1784598|NCT00632749|6212871|P11|Overall Study|Reason other than those specified above|2
1784599|NCT00632749|6212872|P10|Overall Study|Reason other than those specified above|0
1784600|NCT00632749|6212873|P9|Overall Study|Reason other than those specified above|0
1784601|NCT00632749|6212874|P8|Overall Study|Reason other than those specified above|0
1784602|NCT00632749|6212875|P7|Overall Study|Reason other than those specified above|1
1784603|NCT00632749|6212876|P6|Overall Study|Reason other than those specified above|0
1784604|NCT00632749|6212877|P5|Overall Study|Reason other than those specified above|1
1784605|NCT00632749|6212878|P4|Overall Study|Reason other than those specified above|0
1784606|NCT00632749|6212879|P3|Overall Study|Reason other than those specified above|0
1784607|NCT00632749|6212880|P2|Overall Study|Reason other than those specified above|2
1784608|NCT00632749|6212881|P1|Overall Study|Reason other than those specified above|0
1784609|NCT00632749|6212868|P14|Overall Study|Refuse to continue medication|0
1784610|NCT00632749|6212869|P13|Overall Study|Refuse to continue medication|0
1784611|NCT00632749|6212870|P12|Overall Study|Refuse to continue medication|0
1784612|NCT00632749|6212871|P11|Overall Study|Refuse to continue medication|0
1784613|NCT00632749|6212872|P10|Overall Study|Refuse to continue medication|1
1784614|NCT00632749|6212873|P9|Overall Study|Refuse to continue medication|0
1784615|NCT00632749|6212874|P8|Overall Study|Refuse to continue medication|0
1784616|NCT00632749|6212875|P7|Overall Study|Refuse to continue medication|0
1784617|NCT00632749|6212876|P6|Overall Study|Refuse to continue medication|0
1784618|NCT00632749|6212877|P5|Overall Study|Refuse to continue medication|0
1784619|NCT00632749|6212878|P4|Overall Study|Refuse to continue medication|1
1784620|NCT00632749|6212879|P3|Overall Study|Refuse to continue medication|0
1784621|NCT00632749|6212880|P2|Overall Study|Refuse to continue medication|0
1784622|NCT00632749|6212881|P1|Overall Study|Refuse to continue medication|0
1784623|NCT00632749|6212868|P14|Overall Study|Other Adverse event|0
1784624|NCT00632749|6212869|P13|Overall Study|Other Adverse event|1
1784625|NCT00632749|6212870|P12|Overall Study|Other Adverse event|0
1784626|NCT00632749|6212871|P11|Overall Study|Other Adverse event|1
1784627|NCT00632749|6212872|P10|Overall Study|Other Adverse event|0
1784628|NCT00632749|6212873|P9|Overall Study|Other Adverse event|2
1784629|NCT00632749|6212874|P8|Overall Study|Other Adverse event|2
1784630|NCT00632749|6212875|P7|Overall Study|Other Adverse event|1
1784631|NCT00632749|6212876|P6|Overall Study|Other Adverse event|4
1784632|NCT00632749|6212877|P5|Overall Study|Other Adverse event|2
1784633|NCT00632749|6212878|P4|Overall Study|Other Adverse event|1
1784634|NCT00632749|6212879|P3|Overall Study|Other Adverse event|1
1784635|NCT00632749|6212880|P2|Overall Study|Other Adverse event|1
1784636|NCT00632749|6212881|P1|Overall Study|Other Adverse event|1
1784637|NCT00632749|6212868|P14|Overall Study|Progressive disease|4
1784638|NCT00632749|6212869|P13|Overall Study|Progressive disease|2
1784639|NCT00632749|6212870|P12|Overall Study|Progressive disease|3
1784640|NCT00632749|6212871|P11|Overall Study|Progressive disease|4
1784641|NCT00632749|6212872|P10|Overall Study|Progressive disease|2
1784642|NCT00632749|6212873|P9|Overall Study|Progressive disease|3
1784643|NCT00632749|6212874|P8|Overall Study|Progressive disease|2
1784644|NCT00632749|6212875|P7|Overall Study|Progressive disease|3
1784645|NCT00632749|6212876|P6|Overall Study|Progressive disease|4
1784646|NCT00632749|6212877|P5|Overall Study|Progressive disease|4
1784647|NCT00632749|6212878|P4|Overall Study|Progressive disease|2
1784648|NCT00632749|6212879|P3|Overall Study|Progressive disease|2
1784649|NCT00632749|6212880|P2|Overall Study|Progressive disease|2
1784650|NCT00632749|6212881|P1|Overall Study|Progressive disease|3
1784651|NCT00632736|6213175|P1|Overall Study|Other|16
1784652|NCT00632736|6213175|P1|Overall Study|Non-compliance|10
1784653|NCT00632736|6213175|P1|Overall Study|Sponsor terminated study|5
1784654|NCT00632736|6213175|P1|Overall Study|Lack of Efficacy|5
1784655|NCT00632736|6213175|P1|Overall Study|Withdrawal by Subject|99
1784656|NCT00632736|6213175|P1|Overall Study|Protocol Violation|14
1784657|NCT00632736|6213175|P1|Overall Study|Lost to Follow-up|15
1784658|NCT00632736|6213175|P1|Overall Study|Adverse Event|104
1784659|NCT00632541|6213210|P1|Overall Study|Adverse Event|7
1784660|NCT00632502|6213219|P2|Overall Study|Randomized not treated|0
1784661|NCT00632502|6213220|P1|Overall Study|Randomized not treated|3
1784662|NCT00632502|6213219|P2|Overall Study|Adverse Event|1
1784663|NCT00632502|6213220|P1|Overall Study|Adverse Event|0
1784664|NCT00632463|6213264|P3|Overall Study|Adverse Event|0
1784665|NCT00632463|6213265|P2|Overall Study|Adverse Event|1
1784666|NCT00632463|6213266|P1|Overall Study|Adverse Event|0
1784667|NCT00632424|6213283|P1|Overall Study|Study Drug Toxicity|1
1784668|NCT00632424|6213283|P1|Overall Study|Disease Progression|17
1784669|NCT00632359|6213314|P1|Overall Study|Withdrawal by Subject|2
1784670|NCT00632229|6213327|P2|Overall Study|Undisclosed reasons within the first wee|1
1784671|NCT00632229|6213328|P1|Overall Study|Undisclosed reasons within the first wee|0
1784672|NCT00632229|6213327|P2|Overall Study|Lack of Efficacy|2
1784673|NCT00632229|6213328|P1|Overall Study|Lack of Efficacy|0
1784674|NCT00632229|6213327|P2|Overall Study|Lost to Follow-up|3
1784675|NCT00632229|6213328|P1|Overall Study|Lost to Follow-up|0
1784676|NCT00632229|6213327|P2|Overall Study|Adverse Event|0
1784677|NCT00632229|6213328|P1|Overall Study|Adverse Event|6
1784678|NCT00632203|6213338|P2|Overall Study|Did not start study treatment|0
1784679|NCT00632203|6213339|P1|Overall Study|Did not start study treatment|1
1784680|NCT00632125|6213357|P1|Overall Study|Moved to other dialysis unit, etc.|102
1784681|NCT00632125|6213357|P1|Overall Study|Development of uncontrolled hypertension|5
1784682|NCT00632125|6213357|P1|Overall Study|Non-compliance|8
1784683|NCT00632125|6213357|P1|Overall Study|Need for systemic immunosuppressive medi|8
1784684|NCT00632125|6213357|P1|Overall Study|Renal transplantation|17
1784685|NCT00632125|6213357|P1|Overall Study|Adverse Event|36
1784686|NCT00632125|6213357|P1|Overall Study|Withdrawal by Subject|44
1784687|NCT00632125|6213357|P1|Overall Study|Death|82
1784688|NCT00632099|6213363|P2|Overall Study|Lost to Follow-up|3
1784689|NCT00632099|6213364|P1|Overall Study|Lost to Follow-up|3
1784690|NCT00632021|6213372|P2|Overall Study|Withdrawal/death|7
1784691|NCT00632021|6213373|P1|Overall Study|Withdrawal/death|4
1784692|NCT00631969|6213383|P2|Overall Study|No Drug Exposure|2
1784693|NCT00631969|6213384|P1|Overall Study|No Drug Exposure|2
1784694|NCT00631969|6213383|P2|Overall Study|Noncompliant With Study Medication|1
1784695|NCT00631969|6213384|P1|Overall Study|Noncompliant With Study Medication|0
1784696|NCT00631969|6213383|P2|Overall Study|Consent Withdrawn|7
1784697|NCT00631969|6213384|P1|Overall Study|Consent Withdrawn|5
1784698|NCT00631969|6213383|P2|Overall Study|Protocol Violation|1
1784699|NCT00631969|6213384|P1|Overall Study|Protocol Violation|1
1784700|NCT00631969|6213383|P2|Overall Study|Lost to Follow-up|1
1784701|NCT00631969|6213384|P1|Overall Study|Lost to Follow-up|2
1784702|NCT00631969|6213383|P2|Overall Study|Lack of Efficacy|8
1784703|NCT00631969|6213384|P1|Overall Study|Lack of Efficacy|2
1784704|NCT00631969|6213383|P2|Overall Study|Adverse Event|1
1784705|NCT00631969|6213384|P1|Overall Study|Adverse Event|3
1784706|NCT00631917|6213430|P2|Overall Study|Death|0
1784707|NCT00631917|6213431|P1|Overall Study|Death|1
1784708|NCT00631917|6213430|P2|Overall Study|Administrative problems|0
1784709|NCT00631917|6213431|P1|Overall Study|Administrative problems|2
1784710|NCT00631917|6213430|P2|Overall Study|Lost to Follow-up|7
1784711|NCT00631917|6213431|P1|Overall Study|Lost to Follow-up|7
1784712|NCT00631917|6213430|P2|Overall Study|Subject withdrew consent|33
1784713|NCT00631917|6213431|P1|Overall Study|Subject withdrew consent|25
1784714|NCT00631917|6213430|P2|Overall Study|Protocol deviation|5
1784715|NCT00631917|6213431|P1|Overall Study|Protocol deviation|6
1784716|NCT00631917|6213430|P2|Overall Study|No longer required study drug|1
1784717|NCT00631917|6213431|P1|Overall Study|No longer required study drug|0
1784718|NCT00631917|6213430|P2|Overall Study|Unsatisfactory therapeutic effect|14
1784719|NCT00631917|6213431|P1|Overall Study|Unsatisfactory therapeutic effect|8
1784720|NCT00631917|6213430|P2|Overall Study|Abnormal test procedure result(s)|2
1784721|NCT00631917|6213431|P1|Overall Study|Abnormal test procedure result(s)|3
1784722|NCT00631917|6213430|P2|Overall Study|Abnormal laboratory value(s)|1
1784723|NCT00631917|6213431|P1|Overall Study|Abnormal laboratory value(s)|2
1784724|NCT00631917|6213430|P2|Overall Study|Adverse Event|45
1784725|NCT00631917|6213431|P1|Overall Study|Adverse Event|34
1784726|NCT00631696|6213458|P2|Overall Study|Adverse Event|0
1784727|NCT00631696|6213459|P1|Overall Study|Adverse Event|5
1784728|NCT00631696|6213458|P2|Overall Study|Study terminated by sponsor|3
1784729|NCT00631696|6213459|P1|Overall Study|Study terminated by sponsor|3
1784730|NCT00631696|6213458|P2|Overall Study|Protocol Violation|9
1784731|NCT00631696|6213459|P1|Overall Study|Protocol Violation|9
1784732|NCT00631696|6213458|P2|Overall Study|Other|8
1784733|NCT00631696|6213459|P1|Overall Study|Other|8
1784734|NCT00631696|6213458|P2|Overall Study|Withdrawal by Subject|9
1784735|NCT00631696|6213459|P1|Overall Study|Withdrawal by Subject|2
1784736|NCT00631696|6213458|P2|Overall Study|Lost to Follow-up|10
1784737|NCT00631696|6213459|P1|Overall Study|Lost to Follow-up|7
1784738|NCT00631696|6213458|P2|Overall Study|Follow up after database release date|0
1784739|NCT00631696|6213459|P1|Overall Study|Follow up after database release date|1
1784740|NCT00631696|6213458|P2|Overall Study|Discontinued after database release date|0
1784741|NCT00631696|6213459|P1|Overall Study|Discontinued after database release date|1
1784742|NCT00631696|6213458|P2|Overall Study|Entered, not randomized to treatment|1
1784743|NCT00631696|6213459|P1|Overall Study|Entered, not randomized to treatment|1
1784744|NCT00631657|6213502|P3|7-Day Discontinuation Period|Other|0
1784745|NCT00631657|6213503|P2|7-Day Discontinuation Period|Other|0
1784746|NCT00631657|6213504|P1|7-Day Discontinuation Period|Other|1
1784747|NCT00631657|6213502|P3|7-Day Discontinuation Period|Not Treated|1
1784748|NCT00631657|6213503|P2|7-Day Discontinuation Period|Not Treated|1
1784749|NCT00631657|6213504|P1|7-Day Discontinuation Period|Not Treated|1
1784750|NCT00631657|6213502|P3|6-Month Treatment Period|Not Treated|1
1784751|NCT00631657|6213503|P2|6-Month Treatment Period|Not Treated|0
1784752|NCT00631657|6213504|P1|6-Month Treatment Period|Not Treated|2
1784753|NCT00631657|6213502|P3|6-Month Treatment Period|Other|4
1784754|NCT00631657|6213503|P2|6-Month Treatment Period|Other|0
1784755|NCT00631657|6213504|P1|6-Month Treatment Period|Other|16
1784756|NCT00631657|6213502|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
1784757|NCT00631657|6213503|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
1784758|NCT00631657|6213504|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
1784759|NCT00631657|6213502|P3|6-Month Treatment Period|Lost to Follow-up|2
1784760|NCT00631657|6213503|P2|6-Month Treatment Period|Lost to Follow-up|0
1784761|NCT00631657|6213504|P1|6-Month Treatment Period|Lost to Follow-up|7
1784762|NCT00631657|6213502|P3|6-Month Treatment Period|Lack of Efficacy|25
1784763|NCT00631657|6213503|P2|6-Month Treatment Period|Lack of Efficacy|0
1784764|NCT00631657|6213504|P1|6-Month Treatment Period|Lack of Efficacy|34
1784765|NCT00631657|6213502|P3|6-Month Treatment Period|Withdrawal by Subject|5
1784766|NCT00631657|6213503|P2|6-Month Treatment Period|Withdrawal by Subject|0
1784767|NCT00631657|6213504|P1|6-Month Treatment Period|Withdrawal by Subject|14
1784768|NCT00631657|6213502|P3|6-Month Treatment Period|Adverse Event|7
1784769|NCT00631657|6213503|P2|6-Month Treatment Period|Adverse Event|0
1784770|NCT00631657|6213504|P1|6-Month Treatment Period|Adverse Event|47
1784771|NCT00631540|6213553|P1|Overall Study|Core Lab Data Unavailable|3
1784772|NCT00631540|6213553|P1|Overall Study|Lost to Follow-up|2
1784773|NCT00631540|6213553|P1|Overall Study|Death|4
1784774|NCT00631540|6213553|P1|Overall Study|Withdrawal by Subject|5
1784775|NCT00631488|6213565|P3|Overall Study|Protocol Violation|1
1784776|NCT00631488|6213566|P2|Overall Study|Protocol Violation|0
1784777|NCT00631488|6213567|P1|Overall Study|Protocol Violation|0
1784778|NCT00631488|6213565|P3|Overall Study|Physician Decision|1
1784779|NCT00631488|6213566|P2|Overall Study|Physician Decision|0
1784780|NCT00631488|6213567|P1|Overall Study|Physician Decision|1
1784781|NCT00631488|6213565|P3|Overall Study|Lost to Follow-up|0
1784782|NCT00631488|6213566|P2|Overall Study|Lost to Follow-up|2
1784783|NCT00631488|6213567|P1|Overall Study|Lost to Follow-up|2
1784784|NCT00631488|6213565|P3|Overall Study|Adverse Event|0
1784785|NCT00631488|6213566|P2|Overall Study|Adverse Event|0
1784786|NCT00631488|6213567|P1|Overall Study|Adverse Event|1
1784787|NCT00631475|6213587|P1|Overall Study|Preparation for lung transplant|8
1784788|NCT00631475|6213587|P1|Overall Study|Withdrew consent|5
1784789|NCT00631475|6213587|P1|Overall Study|Adverse Event|14
1784790|NCT00631475|6213587|P1|Overall Study|Death|18
1784791|NCT00631410|6213606|P2|Overall Study|Surgery|0
1784792|NCT00631410|6213607|P1|Overall Study|Surgery|1
1784793|NCT00631410|6213606|P2|Overall Study|Objective Progression or Relapse|3
1784794|NCT00631410|6213607|P1|Overall Study|Objective Progression or Relapse|4
1784795|NCT00631410|6213606|P2|Overall Study|Adverse Event|3
1784796|NCT00631410|6213607|P1|Overall Study|Adverse Event|1
1784797|NCT00631371|6213626|P2|Overall Study|Death|239
1784798|NCT00631371|6213627|P1|Overall Study|Death|263
1784799|NCT00631371|6213626|P2|Overall Study|Discontinuation of study by Sponsor|76
1784800|NCT00631371|6213627|P1|Overall Study|Discontinuation of study by Sponsor|70
1784801|NCT00631371|6213626|P2|Overall Study|subject request|45
1784802|NCT00631371|6213627|P1|Overall Study|subject request|38
1784803|NCT00631371|6213626|P2|Overall Study|Other reason|12
1784804|NCT00631371|6213627|P1|Overall Study|Other reason|5
1784805|NCT00631371|6213626|P2|Overall Study|Lost to Follow-up|19
1784806|NCT00631371|6213627|P1|Overall Study|Lost to Follow-up|24
1784807|NCT00631189|6213660|P4|Treatment Phase|patient did not take pravastatin|0
1784808|NCT00631189|6213661|P3|Treatment Phase|patient did not take pravastatin|1
1784809|NCT00631189|6213662|P2|Treatment Phase|patient did not take pravastatin|0
1784810|NCT00631189|6213663|P1|Treatment Phase|patient did not take pravastatin|0
1784811|NCT00631189|6213660|P4|Treatment Phase|Pregnancy|0
1784812|NCT00631189|6213661|P3|Treatment Phase|Pregnancy|1
1784813|NCT00631189|6213662|P2|Treatment Phase|Pregnancy|0
1784814|NCT00631189|6213663|P1|Treatment Phase|Pregnancy|0
1784815|NCT00631189|6213660|P4|Treatment Phase|Lost to Follow-up|0
1784816|NCT00631189|6213661|P3|Treatment Phase|Lost to Follow-up|0
1784817|NCT00631189|6213662|P2|Treatment Phase|Lost to Follow-up|1
1784818|NCT00631189|6213663|P1|Treatment Phase|Lost to Follow-up|0
1784819|NCT00631189|6213660|P4|Treatment Phase|Adverse Event|4
1784820|NCT00631189|6213661|P3|Treatment Phase|Adverse Event|2
1784821|NCT00631189|6213662|P2|Treatment Phase|Adverse Event|3
1784822|NCT00631189|6213663|P1|Treatment Phase|Adverse Event|0
1784823|NCT00631189|6213660|P4|Treatment Phase|Protocol Violation|2
1784824|NCT00631189|6213661|P3|Treatment Phase|Protocol Violation|6
1784825|NCT00631189|6213662|P2|Treatment Phase|Protocol Violation|1
1784826|NCT00631189|6213663|P1|Treatment Phase|Protocol Violation|0
1784827|NCT00631189|6213660|P4|Treatment Phase|Withdrawal by Subject|1
1784828|NCT00631189|6213661|P3|Treatment Phase|Withdrawal by Subject|1
1784829|NCT00631189|6213662|P2|Treatment Phase|Withdrawal by Subject|2
1784830|NCT00631189|6213663|P1|Treatment Phase|Withdrawal by Subject|0
1784831|NCT00631189|6213660|P4|Initial Phase|Withdrawal by Subject|0
1784832|NCT00631189|6213661|P3|Initial Phase|Withdrawal by Subject|0
1784833|NCT00631189|6213662|P2|Initial Phase|Withdrawal by Subject|0
1784834|NCT00631189|6213663|P1|Initial Phase|Withdrawal by Subject|4
1784835|NCT00631189|6213660|P4|Initial Phase|Protocol Violation|0
1784836|NCT00631189|6213661|P3|Initial Phase|Protocol Violation|0
1784837|NCT00631189|6213662|P2|Initial Phase|Protocol Violation|0
1784838|NCT00631189|6213663|P1|Initial Phase|Protocol Violation|347
1784839|NCT00631137|6213707|P2|Overall Study|Withdrawal by Subject|0
1784840|NCT00631137|6213708|P1|Overall Study|Withdrawal by Subject|1
1784841|NCT00631020|6213726|P1|Overall Study|Incarcerated|1
1784842|NCT00631020|6213726|P1|Overall Study|Lost to Follow-up|7
1784843|NCT00631007|6213741|P6|Overall Study|Other|0
1784844|NCT00631007|6213742|P5|Overall Study|Other|1
1784845|NCT00631007|6213743|P4|Overall Study|Other|0
1784846|NCT00631007|6213744|P3|Overall Study|Other|0
1784847|NCT00631007|6213745|P2|Overall Study|Other|1
1784848|NCT00631007|6213746|P1|Overall Study|Other|2
1784849|NCT00631007|6213741|P6|Overall Study|Withdrawal by Subject|3
1784850|NCT00631007|6213742|P5|Overall Study|Withdrawal by Subject|1
1784851|NCT00631007|6213743|P4|Overall Study|Withdrawal by Subject|2
1784852|NCT00631007|6213744|P3|Overall Study|Withdrawal by Subject|2
1784853|NCT00631007|6213745|P2|Overall Study|Withdrawal by Subject|5
1784854|NCT00631007|6213746|P1|Overall Study|Withdrawal by Subject|4
1784855|NCT00631007|6213741|P6|Overall Study|Persistent Hyperglycemia|5
1784856|NCT00631007|6213742|P5|Overall Study|Persistent Hyperglycemia|2
1784857|NCT00631007|6213743|P4|Overall Study|Persistent Hyperglycemia|1
1784858|NCT00631007|6213744|P3|Overall Study|Persistent Hyperglycemia|5
1784859|NCT00631007|6213745|P2|Overall Study|Persistent Hyperglycemia|2
1784860|NCT00631007|6213746|P1|Overall Study|Persistent Hyperglycemia|2
1784861|NCT00631007|6213741|P6|Overall Study|Physician Decision|2
1784862|NCT00631007|6213742|P5|Overall Study|Physician Decision|0
1784863|NCT00631007|6213743|P4|Overall Study|Physician Decision|0
1784864|NCT00631007|6213744|P3|Overall Study|Physician Decision|1
1784865|NCT00631007|6213745|P2|Overall Study|Physician Decision|0
1784866|NCT00631007|6213746|P1|Overall Study|Physician Decision|1
1784867|NCT00631007|6213741|P6|Overall Study|Lost to Follow-up|3
1784868|NCT00631007|6213742|P5|Overall Study|Lost to Follow-up|5
1784869|NCT00631007|6213743|P4|Overall Study|Lost to Follow-up|4
1784870|NCT00631007|6213744|P3|Overall Study|Lost to Follow-up|2
1784871|NCT00631007|6213745|P2|Overall Study|Lost to Follow-up|1
1784872|NCT00631007|6213746|P1|Overall Study|Lost to Follow-up|2
1784873|NCT00631007|6213741|P6|Overall Study|Adverse Event|2
1784874|NCT00631007|6213742|P5|Overall Study|Adverse Event|3
1784875|NCT00631007|6213743|P4|Overall Study|Adverse Event|2
1784876|NCT00631007|6213744|P3|Overall Study|Adverse Event|0
1784877|NCT00631007|6213745|P2|Overall Study|Adverse Event|2
1784878|NCT00631007|6213746|P1|Overall Study|Adverse Event|0
1784879|NCT00630994|6213766|P1|Overall Study|Other|1
1784880|NCT00630994|6213766|P1|Overall Study|Lack of Efficacy|1
1784881|NCT00630994|6213766|P1|Overall Study|Disease Progression|1
1784882|NCT00630994|6213766|P1|Overall Study|Adverse Event|1
1784883|NCT00630916|6213796|P1|Overall Study|Lack of Efficacy|3
1784884|NCT00630916|6213796|P1|Overall Study|Physician Decision|47
1784885|NCT00630916|6213796|P1|Overall Study|Protocol Violation|7
1784886|NCT00630916|6213796|P1|Overall Study|Withdrawal by Subject|30
1784887|NCT00630916|6213796|P1|Overall Study|Lost to Follow-up|5
1784888|NCT00630916|6213796|P1|Overall Study|Explant|8
1784889|NCT00630916|6213796|P1|Overall Study|Death|110
1784890|NCT00630877|6213806|P3|Overall Study|Personal reasons|1
1784891|NCT00630877|6213807|P2|Overall Study|Personal reasons|0
1784892|NCT00630877|6213808|P1|Overall Study|Personal reasons|0
1784893|NCT00630877|6213806|P3|Overall Study|Protocol violation|1
1784894|NCT00630877|6213807|P2|Overall Study|Protocol violation|0
1784895|NCT00630877|6213808|P1|Overall Study|Protocol violation|1
1784896|NCT00630877|6213806|P3|Overall Study|Noncompliance|1
1784897|NCT00630877|6213807|P2|Overall Study|Noncompliance|3
1784898|NCT00630877|6213808|P1|Overall Study|Noncompliance|2
1784899|NCT00630877|6213806|P3|Overall Study|Lost to Follow-up|0
1784900|NCT00630877|6213807|P2|Overall Study|Lost to Follow-up|0
1784901|NCT00630877|6213808|P1|Overall Study|Lost to Follow-up|2
1784902|NCT00630877|6213806|P3|Overall Study|Withdrawal by Subject|0
1784903|NCT00630877|6213807|P2|Overall Study|Withdrawal by Subject|4
1784904|NCT00630877|6213808|P1|Overall Study|Withdrawal by Subject|3
1784905|NCT00630877|6213806|P3|Overall Study|Adverse Event|7
1784906|NCT00630877|6213807|P2|Overall Study|Adverse Event|8
1784907|NCT00630877|6213808|P1|Overall Study|Adverse Event|11
1784908|NCT00630864|6213826|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
1784909|NCT00630864|6213826|P1|Part 1 (up to Week 6)|Adverse Event|1
1784910|NCT00630838|6213865|P2|Overall Study|Lost to Follow-up|1
1784911|NCT00630838|6213866|P1|Overall Study|Lost to Follow-up|0
1784912|NCT00630838|6213865|P2|Overall Study|Death|1
1784913|NCT00630838|6213866|P1|Overall Study|Death|0
1784914|NCT00630825|6213878|P4|Overall Study|Withdrawal by Subject|3
1784915|NCT00630825|6213879|P3|Overall Study|Withdrawal by Subject|2
1784916|NCT00630825|6213880|P2|Overall Study|Withdrawal by Subject|2
1784917|NCT00630825|6213881|P1|Overall Study|Withdrawal by Subject|2
1784918|NCT00630825|6213878|P4|Overall Study|Physician Decision|0
1784919|NCT00630825|6213879|P3|Overall Study|Physician Decision|0
1784920|NCT00630825|6213880|P2|Overall Study|Physician Decision|0
1784921|NCT00630825|6213881|P1|Overall Study|Physician Decision|1
1784922|NCT00630825|6213878|P4|Overall Study|Lost to Follow-up|1
1784923|NCT00630825|6213879|P3|Overall Study|Lost to Follow-up|1
1784924|NCT00630825|6213880|P2|Overall Study|Lost to Follow-up|1
1784925|NCT00630825|6213881|P1|Overall Study|Lost to Follow-up|1
1784926|NCT00630825|6213878|P4|Overall Study|Entry Criteria Not Met|1
1784927|NCT00630825|6213879|P3|Overall Study|Entry Criteria Not Met|2
1784928|NCT00630825|6213880|P2|Overall Study|Entry Criteria Not Met|0
1784929|NCT00630825|6213881|P1|Overall Study|Entry Criteria Not Met|1
1784930|NCT00630825|6213878|P4|Overall Study|Adverse Event|1
1784931|NCT00630825|6213879|P3|Overall Study|Adverse Event|3
1784932|NCT00630825|6213880|P2|Overall Study|Adverse Event|4
1784933|NCT00630825|6213881|P1|Overall Study|Adverse Event|4
1784934|NCT00630786|6213953|P3|Overall Study|Other|0
1784935|NCT00630786|6213954|P2|Overall Study|Other|0
1784936|NCT00630786|6213955|P1|Overall Study|Other|1
1784937|NCT00630786|6213953|P3|Overall Study|Lost to Follow-up|0
1784938|NCT00630786|6213954|P2|Overall Study|Lost to Follow-up|1
1784939|NCT00630786|6213955|P1|Overall Study|Lost to Follow-up|0
1784940|NCT00630786|6213953|P3|Overall Study|Withdrawal by Subject|1
1784941|NCT00630786|6213954|P2|Overall Study|Withdrawal by Subject|1
1784942|NCT00630786|6213955|P1|Overall Study|Withdrawal by Subject|0
1784943|NCT00630786|6213953|P3|Overall Study|Physician Decision|1
1784944|NCT00630786|6213954|P2|Overall Study|Physician Decision|0
1784945|NCT00630786|6213955|P1|Overall Study|Physician Decision|0
1784946|NCT00630747|6213974|P1|Overall Study|Returned to country of origin|1
1784947|NCT00630747|6213974|P1|Overall Study|Transferred to Study TKT031NPU|7
1784948|NCT00630747|6213974|P1|Overall Study|Death|1
1784949|NCT00630539|6214027|P4|Overall Study|Withdrawal by Subject|1
1784950|NCT00630539|6214028|P3|Overall Study|Withdrawal by Subject|0
1784951|NCT00630539|6214029|P2|Overall Study|Withdrawal by Subject|1
1784952|NCT00630539|6214030|P1|Overall Study|Withdrawal by Subject|0
1784953|NCT00630539|6214027|P4|Overall Study|Adverse Event|2
1784954|NCT00630539|6214028|P3|Overall Study|Adverse Event|1
1784955|NCT00630539|6214029|P2|Overall Study|Adverse Event|3
1784956|NCT00630539|6214030|P1|Overall Study|Adverse Event|1
1784957|NCT00630396|6214126|P1|Overall Study|Lost to Follow-up|3
1784958|NCT00630396|6214126|P1|Overall Study|Death|4
1784959|NCT00630344|6214132|P1|Overall Study|Other|1
1784960|NCT00630344|6214132|P1|Overall Study|Intercurrent Illness|1
1784961|NCT00630344|6214132|P1|Overall Study|Withdrawal by Subject|1
1784962|NCT00630344|6214132|P1|Overall Study|Physician Decision|9
1784963|NCT00630344|6214132|P1|Overall Study|Progressive Disease|19
1784964|NCT00630344|6214132|P1|Overall Study|Adverse Event|5
1784965|NCT00630331|6214144|P3|Overall Study|Protocol Violation|6
1784966|NCT00630331|6214145|P2|Overall Study|Protocol Violation|5
1784967|NCT00630331|6214146|P1|Overall Study|Protocol Violation|4
1784968|NCT00630331|6214144|P3|Overall Study|Unable to classify|3
1784969|NCT00630331|6214145|P2|Overall Study|Unable to classify|4
1784970|NCT00630331|6214146|P1|Overall Study|Unable to classify|9
1784971|NCT00630331|6214144|P3|Overall Study|Inappropriate enrollment|3
1784972|NCT00630331|6214145|P2|Overall Study|Inappropriate enrollment|6
1784973|NCT00630331|6214146|P1|Overall Study|Inappropriate enrollment|3
1784974|NCT00630331|6214144|P3|Overall Study|Lost to Follow-up|170
1784975|NCT00630331|6214145|P2|Overall Study|Lost to Follow-up|143
1784976|NCT00630331|6214146|P1|Overall Study|Lost to Follow-up|175
1784977|NCT00630331|6214144|P3|Overall Study|Withdrawal by Subject|5
1784978|NCT00630331|6214145|P2|Overall Study|Withdrawal by Subject|7
1784979|NCT00630331|6214146|P1|Overall Study|Withdrawal by Subject|12
1784980|NCT00630331|6214144|P3|Overall Study|Adverse Event|0
1784981|NCT00630331|6214145|P2|Overall Study|Adverse Event|0
1784982|NCT00630331|6214146|P1|Overall Study|Adverse Event|1
1784983|NCT00630331|6214144|P3|Overall Study|Death|1
1784984|NCT00630331|6214145|P2|Overall Study|Death|1
1784985|NCT00630331|6214146|P1|Overall Study|Death|2
1784986|NCT00630305|6214187|P1|Overall Study|Inability to insert contact lens|1
1784987|NCT00630305|6214187|P1|Overall Study|Withdrawal by Subject|1
1784988|NCT00630292|6214209|P1|Overall Study|Withdrawal by Subject|1
1784989|NCT00630058|6214215|P2|Overall Study|stopping criteria|2
1784990|NCT00630058|6214216|P1|Overall Study|stopping criteria|3
1784991|NCT00630058|6214215|P2|Overall Study|Withdrawal by Subject|1
1784992|NCT00630058|6214216|P1|Overall Study|Withdrawal by Subject|0
1784993|NCT00630058|6214215|P2|Overall Study|Adverse Event|1
1784994|NCT00630058|6214216|P1|Overall Study|Adverse Event|1
1784995|NCT00629772|6214247|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
1784996|NCT00629772|6214248|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
1784997|NCT00629772|6214247|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
1784998|NCT00629772|6214248|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
1784999|NCT00629707|6214268|P2|Overall Study|Physician Decision|1
1785000|NCT00629707|6214269|P1|Overall Study|Physician Decision|0
1785001|NCT00629707|6214268|P2|Overall Study|Withdrawal by Subject|1
1785002|NCT00629707|6214269|P1|Overall Study|Withdrawal by Subject|0
1785003|NCT00629265|6214289|P2|Overall Study|Unknown Reason|2
1785004|NCT00629265|6214290|P1|Overall Study|Unknown Reason|2
1785005|NCT00629265|6214289|P2|Overall Study|Unrelated Medical Complications|1
1785006|NCT00629265|6214290|P1|Overall Study|Unrelated Medical Complications|3
1785007|NCT00629265|6214289|P2|Overall Study|Needed Esophageal Dilation|1
1785008|NCT00629265|6214290|P1|Overall Study|Needed Esophageal Dilation|4
1785009|NCT00629265|6214289|P2|Overall Study|Other CA Requiring Treatment|3
1785010|NCT00629265|6214290|P1|Overall Study|Other CA Requiring Treatment|1
1785011|NCT00629265|6214289|P2|Overall Study|HNC Recurrence|0
1785012|NCT00629265|6214290|P1|Overall Study|HNC Recurrence|4
1785013|NCT00629265|6214289|P2|Overall Study|Adverse Event|0
1785014|NCT00629265|6214290|P1|Overall Study|Adverse Event|2
1785015|NCT00629265|6214289|P2|Overall Study|Death|0
1785016|NCT00629265|6214290|P1|Overall Study|Death|1
1785017|NCT00629265|6214289|P2|Overall Study|Withdrawal by Subject|8
1785018|NCT00629265|6214290|P1|Overall Study|Withdrawal by Subject|11
1785019|NCT00629265|6214289|P2|Overall Study|Lost to Follow-up|5
1785020|NCT00629265|6214290|P1|Overall Study|Lost to Follow-up|4
1785021|NCT00629239|6214300|P2|Overall Study|Physician Decision|0
1785022|NCT00629239|6214301|P1|Overall Study|Physician Decision|1
1785023|NCT00629239|6214300|P2|Overall Study|Adverse Event|4
1785024|NCT00629239|6214301|P1|Overall Study|Adverse Event|7
1785025|NCT00629083|6214354|P2|Overall Study|Refused to return for 12 month visit|0
1785026|NCT00629083|6214355|P1|Overall Study|Refused to return for 12 month visit|1
1785027|NCT00629083|6214354|P2|Overall Study|Moved out of country/state|1
1785028|NCT00629083|6214355|P1|Overall Study|Moved out of country/state|2
1785029|NCT00629083|6214354|P2|Overall Study|Lost to Follow-up|8
1785030|NCT00629083|6214355|P1|Overall Study|Lost to Follow-up|12
1785031|NCT00629083|6214354|P2|Overall Study|Withdrawal by Subject|2
1785032|NCT00629083|6214355|P1|Overall Study|Withdrawal by Subject|10
1785033|NCT00629083|6214354|P2|Overall Study|Lack of Efficacy|1
1785034|NCT00629083|6214355|P1|Overall Study|Lack of Efficacy|3
1785035|NCT00629083|6214354|P2|Overall Study|Adverse Event|2
1785036|NCT00629083|6214355|P1|Overall Study|Adverse Event|0
1785037|NCT00628927|6214386|P2|Overall Study|Equipment failure|0
1785038|NCT00628927|6214387|P1|Overall Study|Equipment failure|1
1785039|NCT00628927|6214386|P2|Overall Study|Lost to Follow-up|0
1785040|NCT00628927|6214387|P1|Overall Study|Lost to Follow-up|1
1785041|NCT00628927|6214386|P2|Overall Study|Problems performing blood draw|0
1785042|NCT00628927|6214387|P1|Overall Study|Problems performing blood draw|6
1785043|NCT00628862|6214432|P3|Overall Study|COPD Exacerbation|0
1785044|NCT00628862|6214433|P2|Overall Study|COPD Exacerbation|1
1785045|NCT00628862|6214434|P1|Overall Study|COPD Exacerbation|0
1785046|NCT00628862|6214432|P3|Overall Study|Protocol Violation|0
1785047|NCT00628862|6214433|P2|Overall Study|Protocol Violation|0
1785048|NCT00628862|6214434|P1|Overall Study|Protocol Violation|1
1785049|NCT00628862|6214432|P3|Overall Study|Lost to Follow-up|1
1785050|NCT00628862|6214433|P2|Overall Study|Lost to Follow-up|2
1785051|NCT00628862|6214434|P1|Overall Study|Lost to Follow-up|0
1785052|NCT00628862|6214432|P3|Overall Study|Withdrawal by Subject|11
1785053|NCT00628862|6214433|P2|Overall Study|Withdrawal by Subject|6
1785054|NCT00628862|6214434|P1|Overall Study|Withdrawal by Subject|4
1785055|NCT00628862|6214432|P3|Overall Study|Adverse Event|10
1785056|NCT00628862|6214433|P2|Overall Study|Adverse Event|8
1785057|NCT00628862|6214434|P1|Overall Study|Adverse Event|6
1785058|NCT00628758|6214480|P2|Overall Study|Treatment Failure|2
1785059|NCT00628758|6214481|P1|Overall Study|Treatment Failure|0
1785060|NCT00628758|6214480|P2|Overall Study|Investigator Moved|0
1785061|NCT00628758|6214481|P1|Overall Study|Investigator Moved|3
1785062|NCT00628758|6214480|P2|Overall Study|Pregnancy|2
1785063|NCT00628758|6214481|P1|Overall Study|Pregnancy|2
1785064|NCT00628758|6214480|P2|Overall Study|Lost to Follow-up|31
1785065|NCT00628758|6214481|P1|Overall Study|Lost to Follow-up|25
1785066|NCT00628758|6214480|P2|Overall Study|Protocol Violation|1
1785067|NCT00628758|6214481|P1|Overall Study|Protocol Violation|5
1785068|NCT00628758|6214480|P2|Overall Study|Death|0
1785069|NCT00628758|6214481|P1|Overall Study|Death|1
1785070|NCT00628758|6214480|P2|Overall Study|Withdrawal by Subject|3
1785071|NCT00628758|6214481|P1|Overall Study|Withdrawal by Subject|6
1785072|NCT00628758|6214480|P2|Overall Study|Adverse Event|3
1785073|NCT00628758|6214481|P1|Overall Study|Adverse Event|2
1785074|NCT00628446|6214525|P1|Overall Study|Protocol Violation|3
1785075|NCT00628446|6214525|P1|Overall Study|Withdrawal by Subject|1
1785076|NCT00628446|6214525|P1|Overall Study|Lost to Follow-up|3
1785077|NCT00628355|6214536|P2|Overall Study|Withdrawal by Subject|1
1785078|NCT00628355|6214537|P1|Overall Study|Withdrawal by Subject|1
1785079|NCT00628251|6214548|P3|Ongoing Initial Study Treatment at DCO|Other|2
1785080|NCT00628251|6214549|P2|Ongoing Initial Study Treatment at DCO|Other|0
1785081|NCT00628251|6214550|P1|Ongoing Initial Study Treatment at DCO|Other|1
1785082|NCT00628251|6214548|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
1785083|NCT00628251|6214549|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
1785084|NCT00628251|6214550|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
1785085|NCT00628251|6214548|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
1785086|NCT00628251|6214549|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
1785087|NCT00628251|6214550|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
1785088|NCT00628251|6214548|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
1785089|NCT00628251|6214549|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
1785090|NCT00628251|6214550|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
1785091|NCT00628251|6214548|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
1785092|NCT00628251|6214549|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
1785093|NCT00628251|6214550|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
1785094|NCT00628251|6214548|P3|Randomised Part|Withdrawal by Subject|1
1785095|NCT00628251|6214549|P2|Randomised Part|Withdrawal by Subject|0
1785096|NCT00628251|6214550|P1|Randomised Part|Withdrawal by Subject|0
1785097|NCT00628212|6214596|P4|Overall Study|Physician Decision|3
1785098|NCT00628212|6214597|P3|Overall Study|Physician Decision|2
1785099|NCT00628212|6214598|P2|Overall Study|Physician Decision|1
1785100|NCT00628212|6214599|P1|Overall Study|Physician Decision|1
1785101|NCT00628212|6214596|P4|Overall Study|Adverse Event|2
1785102|NCT00628212|6214597|P3|Overall Study|Adverse Event|1
1785103|NCT00628212|6214598|P2|Overall Study|Adverse Event|0
1785104|NCT00628212|6214599|P1|Overall Study|Adverse Event|2
1785105|NCT00628108|6214647|P2|Overall Study|Withdrawal by Subject|0
1785106|NCT00628108|6214648|P1|Overall Study|Withdrawal by Subject|1
1785107|NCT00628108|6214647|P2|Overall Study|Adverse Event|3
1785108|NCT00628108|6214648|P1|Overall Study|Adverse Event|0
1785109|NCT00628030|6214680|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
1785110|NCT00628030|6214681|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
1785111|NCT00628030|6214680|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
1785112|NCT00628030|6214681|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
1785113|NCT00628030|6214680|P2|Baseline to Post-Assessment|Lost to Follow-up|29
1785114|NCT00628030|6214681|P1|Baseline to Post-Assessment|Lost to Follow-up|28
1785115|NCT00627926|6214707|P3|Overall Study|Noncompliance/unspecified|17
1785116|NCT00627926|6214708|P2|Overall Study|Noncompliance/unspecified|23
1785117|NCT00627926|6214709|P1|Overall Study|Noncompliance/unspecified|8
1785118|NCT00627926|6214707|P3|Overall Study|Lack of Efficacy|38
1785119|NCT00627926|6214708|P2|Overall Study|Lack of Efficacy|40
1785120|NCT00627926|6214709|P1|Overall Study|Lack of Efficacy|118
1785121|NCT00627926|6214707|P3|Overall Study|Withdrawal by Subject|0
1785122|NCT00627926|6214708|P2|Overall Study|Withdrawal by Subject|1
1785123|NCT00627926|6214709|P1|Overall Study|Withdrawal by Subject|2
1785124|NCT00627926|6214707|P3|Overall Study|Lost to Follow-up|4
1785125|NCT00627926|6214708|P2|Overall Study|Lost to Follow-up|3
1785126|NCT00627926|6214709|P1|Overall Study|Lost to Follow-up|4
1785127|NCT00627926|6214707|P3|Overall Study|Death|0
1785128|NCT00627926|6214708|P2|Overall Study|Death|0
1785129|NCT00627926|6214709|P1|Overall Study|Death|1
1785130|NCT00627926|6214707|P3|Overall Study|Adverse Event|36
1785131|NCT00627926|6214708|P2|Overall Study|Adverse Event|37
1785132|NCT00627926|6214709|P1|Overall Study|Adverse Event|26
1785133|NCT00627705|6214761|P2|Overall Study|Lost to Follow-up|1
1785134|NCT00627705|6214762|P1|Overall Study|Lost to Follow-up|0
1785135|NCT00627705|6214761|P2|Overall Study|Withdrawal by Subject|2
1785136|NCT00627705|6214762|P1|Overall Study|Withdrawal by Subject|0
1785137|NCT00627705|6214761|P2|Overall Study|Adverse Event|0
1785138|NCT00627705|6214762|P1|Overall Study|Adverse Event|1
1785139|NCT00627705|6214761|P2|Overall Study|Unwilling to take the compound (taste)|3
1785140|NCT00627705|6214762|P1|Overall Study|Unwilling to take the compound (taste)|1
1785141|NCT00627523|6214813|P2|Overall Study|Other|0
1785142|NCT00627523|6214814|P1|Overall Study|Other|1
1785143|NCT00627523|6214813|P2|Overall Study|Withdrawal by Subject|2
1785144|NCT00627523|6214814|P1|Overall Study|Withdrawal by Subject|0
1785145|NCT00627523|6214813|P2|Overall Study|Lack of Efficacy|0
1785146|NCT00627523|6214814|P1|Overall Study|Lack of Efficacy|1
1785147|NCT00627497|6214842|P4|Overall Study|Lost to Follow-up|0
1785148|NCT00627497|6214843|P3|Overall Study|Lost to Follow-up|0
1785149|NCT00627497|6214844|P2|Overall Study|Lost to Follow-up|1
1785150|NCT00627497|6214845|P1|Overall Study|Lost to Follow-up|1
1785151|NCT00627458|6214906|P3|Overall Study|Lost to Follow-up|0
1785152|NCT00627458|6214907|P2|Overall Study|Lost to Follow-up|1
1785153|NCT00627458|6214908|P1|Overall Study|Lost to Follow-up|1
1785154|NCT00627458|6214906|P3|Overall Study|Withdrawal by Subject|5
1785155|NCT00627458|6214907|P2|Overall Study|Withdrawal by Subject|6
1785156|NCT00627458|6214908|P1|Overall Study|Withdrawal by Subject|2
1785157|NCT00627458|6214906|P3|Overall Study|Migrated from study area|1
1785158|NCT00627458|6214907|P2|Overall Study|Migrated from study area|0
1785159|NCT00627458|6214908|P1|Overall Study|Migrated from study area|1
1785160|NCT00627445|6214983|P2|Overall Study|Other|8
1785161|NCT00627445|6214984|P1|Overall Study|Other|6
1785162|NCT00627445|6214983|P2|Overall Study|Lack of Efficacy|1
1785163|NCT00627445|6214984|P1|Overall Study|Lack of Efficacy|0
1785164|NCT00627445|6214983|P2|Overall Study|Adverse Event|3
1785165|NCT00627445|6214984|P1|Overall Study|Adverse Event|3
1785166|NCT00627393|6215027|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
1785167|NCT00627393|6215028|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
1785168|NCT00627393|6215027|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
1785169|NCT00627393|6215028|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
1785170|NCT00627393|6215027|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
1785171|NCT00627393|6215028|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
1785172|NCT00627393|6215027|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
1785173|NCT00627393|6215028|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
1785174|NCT00627094|6215064|P2|Overall Study|Other reason|0
1785175|NCT00627094|6215065|P1|Overall Study|Other reason|1
1785176|NCT00627094|6215064|P2|Overall Study|ulcer healed|7
1785177|NCT00627094|6215065|P1|Overall Study|ulcer healed|1
1785178|NCT00627094|6215064|P2|Overall Study|Withdrawal by Subject|1
1785179|NCT00627094|6215065|P1|Overall Study|Withdrawal by Subject|1
1785180|NCT00627094|6215064|P2|Overall Study|Lost to Follow-up|0
1785181|NCT00627094|6215065|P1|Overall Study|Lost to Follow-up|1
1785182|NCT00627094|6215064|P2|Overall Study|Adverse Event|7
1785183|NCT00627094|6215065|P1|Overall Study|Adverse Event|8
1785184|NCT00627042|6215077|P1|Overall Study|Withdrawal by Subject|2
1785185|NCT00627016|6215089|P2|Overall Study|Pregnancy|0
1785186|NCT00627016|6215090|P1|Overall Study|Pregnancy|1
1785187|NCT00627016|6215089|P2|Overall Study|Placed on Excluded Drugs|0
1785188|NCT00627016|6215090|P1|Overall Study|Placed on Excluded Drugs|1
1785189|NCT00627016|6215089|P2|Overall Study|Lack of Efficacy|0
1785190|NCT00627016|6215090|P1|Overall Study|Lack of Efficacy|1
1785191|NCT00627016|6215089|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
1785192|NCT00627016|6215090|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
1785193|NCT00627016|6215089|P2|Overall Study|Withdrawal by Subject|1
1785194|NCT00627016|6215090|P1|Overall Study|Withdrawal by Subject|2
1785195|NCT00627016|6215089|P2|Overall Study|Lost to Follow-up|1
1785196|NCT00627016|6215090|P1|Overall Study|Lost to Follow-up|0
1785197|NCT00627016|6215089|P2|Overall Study|Protocol Violation|2
1785198|NCT00627016|6215090|P1|Overall Study|Protocol Violation|0
1785199|NCT00627016|6215089|P2|Overall Study|Adverse Event|1
1785200|NCT00627016|6215090|P1|Overall Study|Adverse Event|1
1785201|NCT00626925|6215102|P2|Overall Study|Time constraints|1
1785202|NCT00626925|6215103|P1|Overall Study|Time constraints|3
1785203|NCT00626925|6215102|P2|Overall Study|Lack of Efficacy|4
1785204|NCT00626925|6215103|P1|Overall Study|Lack of Efficacy|1
1785205|NCT00626925|6215102|P2|Overall Study|Adverse effect|2
1785206|NCT00626925|6215103|P1|Overall Study|Adverse effect|6
1785207|NCT00626925|6215102|P2|Overall Study|relapse|0
1785208|NCT00626925|6215103|P1|Overall Study|relapse|1
1785209|NCT00626925|6215102|P2|Overall Study|Lost to Follow-up|2
1785210|NCT00626925|6215103|P1|Overall Study|Lost to Follow-up|1
1785211|NCT00626821|6215150|P1|Overall Study|other/unknown reason|104
1785212|NCT00626821|6215150|P1|Overall Study|Product dysfunction|21
1785213|NCT00626821|6215150|P1|Overall Study|Physician Decision|9
1785214|NCT00626821|6215150|P1|Overall Study|Withdrawal by Subject|10
1785215|NCT00626821|6215150|P1|Overall Study|Protocol Violation|33
1785216|NCT00626821|6215150|P1|Overall Study|Adverse Event|44
1785217|NCT00626795|6215230|P3|Blinded Treatment|Missing reason for withdrawal|5
1785218|NCT00626795|6215231|P2|Blinded Treatment|Missing reason for withdrawal|3
1785219|NCT00626795|6215232|P1|Blinded Treatment|Missing reason for withdrawal|5
1785220|NCT00626795|6215230|P3|Blinded Treatment|Other reasons|2
1785221|NCT00626795|6215231|P2|Blinded Treatment|Other reasons|0
1785222|NCT00626795|6215232|P1|Blinded Treatment|Other reasons|2
1785223|NCT00626795|6215230|P3|Blinded Treatment|Withdrawal by Subject|0
1785224|NCT00626795|6215231|P2|Blinded Treatment|Withdrawal by Subject|1
1785225|NCT00626795|6215232|P1|Blinded Treatment|Withdrawal by Subject|1
1785226|NCT00626795|6215230|P3|Blinded Treatment|Protocol Violation|1
1785227|NCT00626795|6215231|P2|Blinded Treatment|Protocol Violation|1
1785228|NCT00626795|6215232|P1|Blinded Treatment|Protocol Violation|0
1785229|NCT00626795|6215230|P3|Blinded Treatment|Unacceptable adverse event|1
1785230|NCT00626795|6215231|P2|Blinded Treatment|Unacceptable adverse event|0
1785231|NCT00626795|6215232|P1|Blinded Treatment|Unacceptable adverse event|0
1785232|NCT00626795|6215230|P3|Blinded Treatment|Lack of Efficacy|0
1785233|NCT00626795|6215231|P2|Blinded Treatment|Lack of Efficacy|0
1785234|NCT00626795|6215232|P1|Blinded Treatment|Lack of Efficacy|2
1785235|NCT00626795|6215230|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
1785236|NCT00626795|6215231|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
1785237|NCT00626795|6215232|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
1785238|NCT00626639|6215283|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
1785239|NCT00626639|6215284|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
1785240|NCT00626561|6215330|P1|Overall Study|Disease Progression|2
1785241|NCT00626561|6215330|P1|Overall Study|Withdrawal by Subject|2
1785242|NCT00626548|6215336|P2|Overall Study|Other termination reason|613
1785243|NCT00626548|6215337|P1|Overall Study|Other termination reason|493
1785244|NCT00626548|6215336|P2|Overall Study|Lost to Follow-up|2
1785245|NCT00626548|6215337|P1|Overall Study|Lost to Follow-up|2
1785246|NCT00626548|6215336|P2|Overall Study|Protocol Violation|11
1785247|NCT00626548|6215337|P1|Overall Study|Protocol Violation|4
1785248|NCT00626548|6215336|P2|Overall Study|Withdrawal by Subject|46
1785249|NCT00626548|6215337|P1|Overall Study|Withdrawal by Subject|42
1785250|NCT00626548|6215336|P2|Overall Study|Adverse Event|44
1785251|NCT00626548|6215337|P1|Overall Study|Adverse Event|164
1785252|NCT00626522|6215351|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
1785253|NCT00626522|6215352|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
1785254|NCT00626522|6215353|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
1785255|NCT00626522|6215354|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
1785256|NCT00626522|6215355|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
1785257|NCT00626522|6215356|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
1785258|NCT00626522|6215351|P6|Overall Study|Inconsistent reason reported|0
1785259|NCT00626522|6215352|P5|Overall Study|Inconsistent reason reported|0
1785260|NCT00626522|6215353|P4|Overall Study|Inconsistent reason reported|0
1785261|NCT00626522|6215354|P3|Overall Study|Inconsistent reason reported|0
1785262|NCT00626522|6215355|P2|Overall Study|Inconsistent reason reported|0
1785263|NCT00626522|6215356|P1|Overall Study|Inconsistent reason reported|1
1785264|NCT00626522|6215351|P6|Overall Study|Lost to Follow-up|0
1785265|NCT00626522|6215352|P5|Overall Study|Lost to Follow-up|0
1785266|NCT00626522|6215353|P4|Overall Study|Lost to Follow-up|0
1785267|NCT00626522|6215354|P3|Overall Study|Lost to Follow-up|0
1785268|NCT00626522|6215355|P2|Overall Study|Lost to Follow-up|1
1785269|NCT00626522|6215356|P1|Overall Study|Lost to Follow-up|0
1785270|NCT00626522|6215351|P6|Overall Study|COPD exacerbation|0
1785271|NCT00626522|6215352|P5|Overall Study|COPD exacerbation|1
1785272|NCT00626522|6215353|P4|Overall Study|COPD exacerbation|1
1785273|NCT00626522|6215354|P3|Overall Study|COPD exacerbation|0
1785274|NCT00626522|6215355|P2|Overall Study|COPD exacerbation|0
1785275|NCT00626522|6215356|P1|Overall Study|COPD exacerbation|0
1785276|NCT00626522|6215351|P6|Overall Study|Withdrawal by Subject|1
1785277|NCT00626522|6215352|P5|Overall Study|Withdrawal by Subject|4
1785278|NCT00626522|6215353|P4|Overall Study|Withdrawal by Subject|0
1785279|NCT00626522|6215354|P3|Overall Study|Withdrawal by Subject|5
1785280|NCT00626522|6215355|P2|Overall Study|Withdrawal by Subject|5
1785281|NCT00626522|6215356|P1|Overall Study|Withdrawal by Subject|2
1785282|NCT00626522|6215351|P6|Overall Study|Adverse Event|1
1785283|NCT00626522|6215352|P5|Overall Study|Adverse Event|1
1785284|NCT00626522|6215353|P4|Overall Study|Adverse Event|0
1785285|NCT00626522|6215354|P3|Overall Study|Adverse Event|2
1785286|NCT00626522|6215355|P2|Overall Study|Adverse Event|1
1785287|NCT00626522|6215356|P1|Overall Study|Adverse Event|2
1785288|NCT00626522|6215351|P6|Overall Study|Protocol Violation|0
1785289|NCT00626522|6215352|P5|Overall Study|Protocol Violation|1
1785290|NCT00626522|6215353|P4|Overall Study|Protocol Violation|0
1785291|NCT00626522|6215354|P3|Overall Study|Protocol Violation|0
1785292|NCT00626522|6215355|P2|Overall Study|Protocol Violation|0
1785293|NCT00626522|6215356|P1|Overall Study|Protocol Violation|0
1785294|NCT00626405|6215419|P2|Overall Study|Withdrawal by Subject|1
1785295|NCT00626405|6215420|P1|Overall Study|Withdrawal by Subject|0
1785296|NCT00626405|6215419|P2|Overall Study|Deemed Ineligible|0
1785297|NCT00626405|6215420|P1|Overall Study|Deemed Ineligible|1
1785298|NCT00626392|6215436|P6|Coadministration Period|Other|1
1785299|NCT00626392|6215437|P5|Coadministration Period|Other|1
1785300|NCT00626392|6215438|P4|Coadministration Period|Other|1
1785301|NCT00626392|6215439|P3|Coadministration Period|Other|3
1785302|NCT00626392|6215440|P2|Coadministration Period|Other|2
1785303|NCT00626392|6215441|P1|Coadministration Period|Other|0
1785304|NCT00626392|6215436|P6|Coadministration Period|Protocol Violation|0
1785305|NCT00626392|6215437|P5|Coadministration Period|Protocol Violation|1
1785306|NCT00626392|6215438|P4|Coadministration Period|Protocol Violation|1
1785307|NCT00626392|6215439|P3|Coadministration Period|Protocol Violation|0
1785308|NCT00626392|6215440|P2|Coadministration Period|Protocol Violation|1
1785309|NCT00626392|6215441|P1|Coadministration Period|Protocol Violation|0
1785310|NCT00626392|6215436|P6|Coadministration Period|Withdrawal by Subject|1
1785311|NCT00626392|6215437|P5|Coadministration Period|Withdrawal by Subject|0
1785312|NCT00626392|6215438|P4|Coadministration Period|Withdrawal by Subject|1
1785313|NCT00626392|6215439|P3|Coadministration Period|Withdrawal by Subject|0
1785314|NCT00626392|6215440|P2|Coadministration Period|Withdrawal by Subject|1
1785315|NCT00626392|6215441|P1|Coadministration Period|Withdrawal by Subject|1
1785316|NCT00626392|6215436|P6|Coadministration Period|Adverse Event|4
1785317|NCT00626392|6215437|P5|Coadministration Period|Adverse Event|3
1785318|NCT00626392|6215438|P4|Coadministration Period|Adverse Event|4
1785319|NCT00626392|6215439|P3|Coadministration Period|Adverse Event|7
1785320|NCT00626392|6215440|P2|Coadministration Period|Adverse Event|1
1785321|NCT00626392|6215441|P1|Coadministration Period|Adverse Event|3
1785322|NCT00626392|6215436|P6|Run-in Period|Noncompliance|0
1785323|NCT00626392|6215437|P5|Run-in Period|Noncompliance|0
1785324|NCT00626392|6215438|P4|Run-in Period|Noncompliance|0
1785325|NCT00626392|6215439|P3|Run-in Period|Noncompliance|1
1785326|NCT00626392|6215440|P2|Run-in Period|Noncompliance|0
1785327|NCT00626392|6215441|P1|Run-in Period|Noncompliance|1
1785328|NCT00626392|6215436|P6|Run-in Period|Withdrawal by Subject|1
1785329|NCT00626392|6215437|P5|Run-in Period|Withdrawal by Subject|3
1785330|NCT00626392|6215438|P4|Run-in Period|Withdrawal by Subject|1
1785331|NCT00626392|6215439|P3|Run-in Period|Withdrawal by Subject|1
1785332|NCT00626392|6215440|P2|Run-in Period|Withdrawal by Subject|1
1785333|NCT00626392|6215441|P1|Run-in Period|Withdrawal by Subject|0
1785334|NCT00626392|6215436|P6|Run-in Period|Adverse Event|0
1785335|NCT00626392|6215437|P5|Run-in Period|Adverse Event|1
1785336|NCT00626392|6215438|P4|Run-in Period|Adverse Event|0
1785337|NCT00626392|6215439|P3|Run-in Period|Adverse Event|1
1785338|NCT00626392|6215440|P2|Run-in Period|Adverse Event|0
1785339|NCT00626392|6215441|P1|Run-in Period|Adverse Event|0
1785340|NCT00626327|6215469|P3|Overall Study|Protocol Violation|26
1785341|NCT00626327|6215470|P2|Overall Study|Protocol Violation|4
1785342|NCT00626327|6215471|P1|Overall Study|Protocol Violation|26
1785343|NCT00626327|6215469|P3|Overall Study|Administrative Reason|6
1785344|NCT00626327|6215470|P2|Overall Study|Administrative Reason|0
1785345|NCT00626327|6215471|P1|Overall Study|Administrative Reason|2
1785346|NCT00626327|6215469|P3|Overall Study|Inappropriate enrollment|3
1785347|NCT00626327|6215470|P2|Overall Study|Inappropriate enrollment|5
1785348|NCT00626327|6215471|P1|Overall Study|Inappropriate enrollment|4
1785349|NCT00626327|6215469|P3|Overall Study|Lost to Follow-up|23
1785350|NCT00626327|6215470|P2|Overall Study|Lost to Follow-up|21
1785351|NCT00626327|6215471|P1|Overall Study|Lost to Follow-up|24
1785352|NCT00626327|6215469|P3|Overall Study|Adverse Event|0
1785353|NCT00626327|6215470|P2|Overall Study|Adverse Event|0
1785354|NCT00626327|6215471|P1|Overall Study|Adverse Event|1
1785355|NCT00626327|6215469|P3|Overall Study|Withdrawal by Subject|30
1785356|NCT00626327|6215470|P2|Overall Study|Withdrawal by Subject|29
1785357|NCT00626327|6215471|P1|Overall Study|Withdrawal by Subject|21
1785358|NCT00626275|6215497|P8|Part B|Withdrawal by Subject|1
1785359|NCT00626275|6215498|P7|Part B|Withdrawal by Subject|0
1785360|NCT00626275|6215499|P6|Part B|Withdrawal by Subject|0
1785361|NCT00626275|6215500|P5|Part B|Withdrawal by Subject|0
1785362|NCT00626275|6215501|P4|Part B|Withdrawal by Subject|0
1785363|NCT00626275|6215502|P3|Part B|Withdrawal by Subject|0
1785364|NCT00626275|6215503|P2|Part B|Withdrawal by Subject|0
1785365|NCT00626275|6215504|P1|Part B|Withdrawal by Subject|0
1785366|NCT00626275|6215497|P8|Part B|Lost to Follow-up|0
1785367|NCT00626275|6215498|P7|Part B|Lost to Follow-up|1
1785368|NCT00626275|6215499|P6|Part B|Lost to Follow-up|0
1785369|NCT00626275|6215500|P5|Part B|Lost to Follow-up|0
1785370|NCT00626275|6215501|P4|Part B|Lost to Follow-up|0
1785371|NCT00626275|6215502|P3|Part B|Lost to Follow-up|0
1785372|NCT00626275|6215503|P2|Part B|Lost to Follow-up|0
1785373|NCT00626275|6215504|P1|Part B|Lost to Follow-up|0
1785374|NCT00626275|6215497|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
1785375|NCT00626275|6215498|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
1785376|NCT00626275|6215499|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
1785377|NCT00626275|6215500|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
1785378|NCT00626275|6215501|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
1785379|NCT00626275|6215502|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
1785380|NCT00626275|6215503|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
1785381|NCT00626275|6215504|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
1785382|NCT00626275|6215497|P8|Part A - Treatment Period 1|Adverse Event|0
1785383|NCT00626275|6215498|P7|Part A - Treatment Period 1|Adverse Event|0
1785384|NCT00626275|6215499|P6|Part A - Treatment Period 1|Adverse Event|0
1785385|NCT00626275|6215500|P5|Part A - Treatment Period 1|Adverse Event|0
1785386|NCT00626275|6215501|P4|Part A - Treatment Period 1|Adverse Event|0
1785387|NCT00626275|6215502|P3|Part A - Treatment Period 1|Adverse Event|0
1785388|NCT00626275|6215503|P2|Part A - Treatment Period 1|Adverse Event|0
1785389|NCT00626275|6215504|P1|Part A - Treatment Period 1|Adverse Event|1
1785390|NCT00626093|6215548|P1|Overall Study|One of the required devices not implante|6
1785391|NCT00626093|6215548|P1|Overall Study|Protocol Violation|1
1785392|NCT00626093|6215548|P1|Overall Study|Withdrawal by Subject|6
1785393|NCT00626093|6215548|P1|Overall Study|Physician Decision|4
1785394|NCT00626093|6215548|P1|Overall Study|Death|1
1785395|NCT00626093|6215548|P1|Overall Study|Lost to Follow-up|5
1785396|NCT00626028|6215555|P2|Overall Study|Inclusion/Exclusion Criteria|6
1785397|NCT00626028|6215556|P1|Overall Study|Inclusion/Exclusion Criteria|3
1785398|NCT00626028|6215555|P2|Overall Study|Physician Decision|1
1785399|NCT00626028|6215556|P1|Overall Study|Physician Decision|2
1785400|NCT00626028|6215555|P2|Overall Study|Device Failure|1
1785401|NCT00626028|6215556|P1|Overall Study|Device Failure|0
1785402|NCT00626028|6215555|P2|Overall Study|Adverse Event|1
1785403|NCT00626028|6215556|P1|Overall Study|Adverse Event|1
1785404|NCT00625872|6215580|P2|Overall Study|Randomized but not treated|1
1785405|NCT00625872|6215581|P1|Overall Study|Randomized but not treated|0
1785406|NCT00625872|6215580|P2|Overall Study|Terminated by sponsor|5
1785407|NCT00625872|6215581|P1|Overall Study|Terminated by sponsor|2
1785408|NCT00625872|6215580|P2|Overall Study|Does not meet inclusion criteria|0
1785409|NCT00625872|6215581|P1|Overall Study|Does not meet inclusion criteria|1
1785410|NCT00625872|6215580|P2|Overall Study|Withdrawal by Subject|0
1785411|NCT00625872|6215581|P1|Overall Study|Withdrawal by Subject|1
1785412|NCT00625820|6215691|P1|Overall Study|Withdrawal by Subject|1
1785413|NCT00625807|6215699|P2|Overall Study|schedule conflict|8
1785414|NCT00625807|6215700|P1|Overall Study|schedule conflict|2
1785415|NCT00625742|6215716|P1|Overall Study|Ineligible|1
1785416|NCT00625742|6215716|P1|Overall Study|Lost to Follow-up|4
1785417|NCT00625742|6215716|P1|Overall Study|Adverse Event|4
1785418|NCT00625742|6215716|P1|Overall Study|Withdrawal by Subject|1
1785419|NCT00625742|6215716|P1|Overall Study|Disease Progression|2
1785420|NCT00625586|6215730|P1|Overall Study|Adverse Event|1
1785421|NCT00625443|6215743|P3|Overall Study|Other|1
1785422|NCT00625443|6215744|P2|Overall Study|Other|1
1785423|NCT00625443|6215745|P1|Overall Study|Other|0
1785424|NCT00625443|6215743|P3|Overall Study|Physician Decision|2
1785425|NCT00625443|6215744|P2|Overall Study|Physician Decision|4
1785426|NCT00625443|6215745|P1|Overall Study|Physician Decision|0
1785427|NCT00625443|6215743|P3|Overall Study|Withdrawal by Subject|2
1785428|NCT00625443|6215744|P2|Overall Study|Withdrawal by Subject|1
1785429|NCT00625443|6215745|P1|Overall Study|Withdrawal by Subject|0
1785430|NCT00625443|6215743|P3|Overall Study|Platelet count increase >=500,000/mm3|0
1785431|NCT00625443|6215744|P2|Overall Study|Platelet count increase >=500,000/mm3|0
1785592|NCT00624377|6216231|P1|Overall Study|Lost to Follow-up|355
1785432|NCT00625443|6215745|P1|Overall Study|Platelet count increase >=500,000/mm3|1
1785433|NCT00625443|6215743|P3|Overall Study|Non-compliance with protocol|0
1785434|NCT00625443|6215744|P2|Overall Study|Non-compliance with protocol|1
1785435|NCT00625443|6215745|P1|Overall Study|Non-compliance with protocol|0
1785436|NCT00625443|6215743|P3|Overall Study|Adverse Event|0
1785437|NCT00625443|6215744|P2|Overall Study|Adverse Event|4
1785438|NCT00625443|6215745|P1|Overall Study|Adverse Event|1
1785439|NCT00625365|6215825|P1|Overall Study|VSD|1
1785440|NCT00625365|6215825|P1|Overall Study|No IV access|5
1785441|NCT00625365|6215825|P1|Overall Study|Withdrawal by Subject|1
1785442|NCT00625183|6215831|P1|Overall Study|Disease Progression|1
1785443|NCT00625131|6215842|P3|Overall Study|Withdrawal by Subject|5
1785444|NCT00625131|6215843|P2|Overall Study|Withdrawal by Subject|0
1785445|NCT00625131|6215844|P1|Overall Study|Withdrawal by Subject|1
1785446|NCT00625131|6215842|P3|Overall Study|Lost to Follow-up|0
1785447|NCT00625131|6215843|P2|Overall Study|Lost to Follow-up|2
1785448|NCT00625131|6215844|P1|Overall Study|Lost to Follow-up|3
1785449|NCT00624832|6215873|P4|Overall Study|Abnormal Laboratory Value|0
1785450|NCT00624832|6215874|P3|Overall Study|Abnormal Laboratory Value|0
1785451|NCT00624832|6215875|P2|Overall Study|Abnormal Laboratory Value|0
1785452|NCT00624832|6215876|P1|Overall Study|Abnormal Laboratory Value|2
1785453|NCT00624832|6215873|P4|Overall Study|Adverse Event|1
1785454|NCT00624832|6215874|P3|Overall Study|Adverse Event|0
1785455|NCT00624832|6215875|P2|Overall Study|Adverse Event|1
1785456|NCT00624832|6215876|P1|Overall Study|Adverse Event|0
1785457|NCT00624780|6215907|P6|Follow-up (Week 26)|Other|0
1785458|NCT00624780|6215908|P5|Follow-up (Week 26)|Other|0
1785459|NCT00624780|6215909|P4|Follow-up (Week 26)|Other|0
1785460|NCT00624780|6215910|P3|Follow-up (Week 26)|Other|0
1785461|NCT00624780|6215911|P2|Follow-up (Week 26)|Other|1
1785462|NCT00624780|6215912|P1|Follow-up (Week 26)|Other|1
1785463|NCT00624780|6215907|P6|Follow-up (Week 26)|Withdrawal by Subject|0
1785464|NCT00624780|6215908|P5|Follow-up (Week 26)|Withdrawal by Subject|0
1785465|NCT00624780|6215909|P4|Follow-up (Week 26)|Withdrawal by Subject|0
1785466|NCT00624780|6215910|P3|Follow-up (Week 26)|Withdrawal by Subject|0
1785467|NCT00624780|6215911|P2|Follow-up (Week 26)|Withdrawal by Subject|0
1785468|NCT00624780|6215912|P1|Follow-up (Week 26)|Withdrawal by Subject|1
1785469|NCT00624780|6215907|P6|Follow-up (Week 26)|Lost to Follow-up|0
1785470|NCT00624780|6215908|P5|Follow-up (Week 26)|Lost to Follow-up|1
1785471|NCT00624780|6215909|P4|Follow-up (Week 26)|Lost to Follow-up|0
1785472|NCT00624780|6215910|P3|Follow-up (Week 26)|Lost to Follow-up|1
1785473|NCT00624780|6215911|P2|Follow-up (Week 26)|Lost to Follow-up|0
1785474|NCT00624780|6215912|P1|Follow-up (Week 26)|Lost to Follow-up|0
1785475|NCT00624780|6215907|P6|Follow-up (Week 26)|Adverse Event|0
1785476|NCT00624780|6215908|P5|Follow-up (Week 26)|Adverse Event|1
1785477|NCT00624780|6215909|P4|Follow-up (Week 26)|Adverse Event|0
1785478|NCT00624780|6215910|P3|Follow-up (Week 26)|Adverse Event|0
1785479|NCT00624780|6215911|P2|Follow-up (Week 26)|Adverse Event|0
1785480|NCT00624780|6215912|P1|Follow-up (Week 26)|Adverse Event|0
1785481|NCT00624780|6215907|P6|Follow-up (Week 26)|Death|0
1785482|NCT00624780|6215908|P5|Follow-up (Week 26)|Death|0
1785483|NCT00624780|6215909|P4|Follow-up (Week 26)|Death|0
1785484|NCT00624780|6215910|P3|Follow-up (Week 26)|Death|1
1785485|NCT00624780|6215911|P2|Follow-up (Week 26)|Death|0
1785486|NCT00624780|6215912|P1|Follow-up (Week 26)|Death|0
1785487|NCT00624780|6215907|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1785488|NCT00624780|6215908|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1785489|NCT00624780|6215909|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1785490|NCT00624780|6215910|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
1785491|NCT00624780|6215911|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1785492|NCT00624780|6215912|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
1785493|NCT00624780|6215907|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1785494|NCT00624780|6215908|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1785495|NCT00624780|6215909|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1785496|NCT00624780|6215910|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1785497|NCT00624780|6215911|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
1785498|NCT00624780|6215912|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
1785499|NCT00624780|6215907|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
1785500|NCT00624780|6215908|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
1785501|NCT00624780|6215909|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
1785502|NCT00624780|6215910|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
1785503|NCT00624780|6215911|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
1785504|NCT00624780|6215912|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
1785505|NCT00624780|6215907|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
1785506|NCT00624780|6215908|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
1785507|NCT00624780|6215909|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
1785508|NCT00624780|6215910|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
1785509|NCT00624780|6215911|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
1785510|NCT00624780|6215912|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
1785511|NCT00624780|6215907|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
1785512|NCT00624780|6215908|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
1785513|NCT00624780|6215909|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
1785514|NCT00624780|6215910|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
1785515|NCT00624780|6215911|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
1785516|NCT00624780|6215912|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
1785517|NCT00624780|6215907|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1785518|NCT00624780|6215908|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1785519|NCT00624780|6215909|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
1785520|NCT00624780|6215910|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1785521|NCT00624780|6215911|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
1785522|NCT00624780|6215912|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
1785523|NCT00624780|6215907|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1785524|NCT00624780|6215908|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
1785525|NCT00624780|6215909|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
1785526|NCT00624780|6215910|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1785527|NCT00624780|6215911|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
1785528|NCT00624780|6215912|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
1785529|NCT00624780|6215907|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
1785530|NCT00624780|6215908|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
1785531|NCT00624780|6215909|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
1785532|NCT00624780|6215910|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
1785533|NCT00624780|6215911|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
1785534|NCT00624780|6215912|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
1785535|NCT00624780|6215907|P6|Treatment Optimization (Up to Week 12)|Other|0
1785536|NCT00624780|6215908|P5|Treatment Optimization (Up to Week 12)|Other|9
1785537|NCT00624780|6215909|P4|Treatment Optimization (Up to Week 12)|Other|2
1785538|NCT00624780|6215910|P3|Treatment Optimization (Up to Week 12)|Other|8
1785539|NCT00624780|6215911|P2|Treatment Optimization (Up to Week 12)|Other|4
1785540|NCT00624780|6215912|P1|Treatment Optimization (Up to Week 12)|Other|10
1785541|NCT00624780|6215907|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
1785542|NCT00624780|6215908|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
1785543|NCT00624780|6215909|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
1785544|NCT00624780|6215910|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
1785545|NCT00624780|6215911|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
1785546|NCT00624780|6215912|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
1785547|NCT00624780|6215907|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
1785548|NCT00624780|6215908|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
1785549|NCT00624780|6215909|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
1785550|NCT00624780|6215910|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
1785551|NCT00624780|6215911|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
1785552|NCT00624780|6215912|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
1785553|NCT00624780|6215907|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
1785554|NCT00624780|6215908|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
1785555|NCT00624780|6215909|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
1785556|NCT00624780|6215910|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
1785557|NCT00624780|6215911|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
1785558|NCT00624780|6215912|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
1785559|NCT00624780|6215907|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
1785560|NCT00624780|6215908|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
1785561|NCT00624780|6215909|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
1785562|NCT00624780|6215910|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
1785563|NCT00624780|6215911|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
1785564|NCT00624780|6215912|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
1785565|NCT00624585|6216103|P1|Overall Study|Adverse Event|3
1785566|NCT00624585|6216103|P1|Overall Study|Disease Progression|6
1785567|NCT00624585|6216103|P1|Overall Study|Death|3
1785568|NCT00624520|6216133|P2|Overall Study|Death|1
1785569|NCT00624520|6216134|P1|Overall Study|Death|0
1785570|NCT00624520|6216133|P2|Overall Study|Withdrawal by Subject|7
1785571|NCT00624520|6216134|P1|Overall Study|Withdrawal by Subject|12
1785572|NCT00624468|6216161|P4|Safety Follow-up (SFU) Period|Other|1
1785573|NCT00624468|6216162|P3|Safety Follow-up (SFU) Period|Other|1
1785574|NCT00624468|6216163|P2|Safety Follow-up (SFU) Period|Other|0
1785575|NCT00624468|6216164|P1|Safety Follow-up (SFU) Period|Other|0
1785576|NCT00624468|6216161|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
1785577|NCT00624468|6216162|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
1785578|NCT00624468|6216163|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
1785579|NCT00624468|6216164|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
1785580|NCT00624468|6216161|P4|Double-blind Period|Withdrew Prematurely|0
1785581|NCT00624468|6216162|P3|Double-blind Period|Withdrew Prematurely|0
1785582|NCT00624468|6216163|P2|Double-blind Period|Withdrew Prematurely|1
1785583|NCT00624468|6216164|P1|Double-blind Period|Withdrew Prematurely|1
1785584|NCT00624468|6216161|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
1785585|NCT00624468|6216162|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
1785586|NCT00624468|6216163|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
1785587|NCT00624468|6216164|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
1785588|NCT00624377|6216231|P1|Overall Study|Non-evaluable population|84
1785589|NCT00624377|6216231|P1|Overall Study|Other|91
1785590|NCT00624377|6216231|P1|Overall Study|Adverse Event|14
1785591|NCT00624377|6216231|P1|Overall Study|Withdrawal by Subject|100
1785593|NCT00624338|6216245|P3|Overall Study|Randomized but not treated|3
1785594|NCT00624338|6216246|P2|Overall Study|Randomized but not treated|1
1785595|NCT00624338|6216247|P1|Overall Study|Randomized but not treated|2
1785596|NCT00624338|6216245|P3|Overall Study|Other|9
1785597|NCT00624338|6216246|P2|Overall Study|Other|5
1785598|NCT00624338|6216247|P1|Overall Study|Other|15
1785599|NCT00624338|6216245|P3|Overall Study|Termination of 150 mg group by Sponsor|0
1785600|NCT00624338|6216246|P2|Overall Study|Termination of 150 mg group by Sponsor|55
1785601|NCT00624338|6216247|P1|Overall Study|Termination of 150 mg group by Sponsor|0
1785602|NCT00624338|6216245|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
1785603|NCT00624338|6216246|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
1785604|NCT00624338|6216247|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
1785605|NCT00624338|6216245|P3|Overall Study|Death|0
1785606|NCT00624338|6216246|P2|Overall Study|Death|2
1785607|NCT00624338|6216247|P1|Overall Study|Death|0
1785608|NCT00624338|6216245|P3|Overall Study|Protocol Violation|2
1785609|NCT00624338|6216246|P2|Overall Study|Protocol Violation|3
1785610|NCT00624338|6216247|P1|Overall Study|Protocol Violation|3
1785611|NCT00624338|6216245|P3|Overall Study|Lack of Efficacy|14
1785612|NCT00624338|6216246|P2|Overall Study|Lack of Efficacy|3
1785613|NCT00624338|6216247|P1|Overall Study|Lack of Efficacy|11
1785614|NCT00624338|6216245|P3|Overall Study|Lost to Follow-up|0
1785615|NCT00624338|6216246|P2|Overall Study|Lost to Follow-up|0
1785616|NCT00624338|6216247|P1|Overall Study|Lost to Follow-up|1
1785617|NCT00624338|6216245|P3|Overall Study|Adverse Event|18
1785618|NCT00624338|6216246|P2|Overall Study|Adverse Event|14
1785619|NCT00624338|6216247|P1|Overall Study|Adverse Event|14
1785620|NCT00624286|6216269|P2|Overall Study|Death|1
1785621|NCT00624286|6216270|P1|Overall Study|Death|0
1785622|NCT00624286|6216269|P2|Overall Study|Abnormal test procedure result(s)|1
1785623|NCT00624286|6216270|P1|Overall Study|Abnormal test procedure result(s)|0
1785624|NCT00624286|6216269|P2|Overall Study|Not stated|1
1785625|NCT00624286|6216270|P1|Overall Study|Not stated|0
1785626|NCT00624286|6216269|P2|Overall Study|Lack of Efficacy|6
1785627|NCT00624286|6216270|P1|Overall Study|Lack of Efficacy|1
1785628|NCT00624286|6216269|P2|Overall Study|Administrative problems|0
1785629|NCT00624286|6216270|P1|Overall Study|Administrative problems|3
1785630|NCT00624286|6216269|P2|Overall Study|Lost to Follow-up|2
1785631|NCT00624286|6216270|P1|Overall Study|Lost to Follow-up|3
1785632|NCT00624286|6216269|P2|Overall Study|Withdrawal by Subject|4
1785633|NCT00624286|6216270|P1|Overall Study|Withdrawal by Subject|5
1785634|NCT00624286|6216269|P2|Overall Study|Adverse Event|3
1785635|NCT00624286|6216270|P1|Overall Study|Adverse Event|6
1785636|NCT00624286|6216269|P2|Overall Study|Protocol Deviation|9
1785637|NCT00624286|6216270|P1|Overall Study|Protocol Deviation|7
1785638|NCT00624065|6216323|P2|Overall Study|Met protocol-defined stopping criteria|9
1785639|NCT00624065|6216324|P1|Overall Study|Met protocol-defined stopping criteria|4
1785640|NCT00624065|6216323|P2|Overall Study|Lack of Efficacy|3
1785641|NCT00624065|6216324|P1|Overall Study|Lack of Efficacy|0
1785642|NCT00624065|6216323|P2|Overall Study|Consent withdrawn|5
1785643|NCT00624065|6216324|P1|Overall Study|Consent withdrawn|6
1785644|NCT00624065|6216323|P2|Overall Study|Lost to Follow-up|1
1785645|NCT00624065|6216324|P1|Overall Study|Lost to Follow-up|4
1785646|NCT00624065|6216323|P2|Overall Study|Adverse Event|6
1785647|NCT00624065|6216324|P1|Overall Study|Adverse Event|5
1785648|NCT00624052|6216336|P4|Overall Study|Changed job/ran out if meds|0
1785649|NCT00624052|6216337|P3|Overall Study|Changed job/ran out if meds|0
1785650|NCT00624052|6216338|P2|Overall Study|Changed job/ran out if meds|2
1785651|NCT00624052|6216339|P1|Overall Study|Changed job/ran out if meds|0
1785652|NCT00624052|6216336|P4|Overall Study|Consent withdrawn|0
1785653|NCT00624052|6216337|P3|Overall Study|Consent withdrawn|1
1785654|NCT00624052|6216338|P2|Overall Study|Consent withdrawn|1
1785655|NCT00624052|6216339|P1|Overall Study|Consent withdrawn|3
1785656|NCT00624052|6216336|P4|Overall Study|Non compliant with the protocol|1
1785657|NCT00624052|6216337|P3|Overall Study|Non compliant with the protocol|1
1785658|NCT00624052|6216338|P2|Overall Study|Non compliant with the protocol|1
1785659|NCT00624052|6216339|P1|Overall Study|Non compliant with the protocol|2
1785660|NCT00624052|6216336|P4|Overall Study|Lost to Follow-up|0
1785661|NCT00624052|6216337|P3|Overall Study|Lost to Follow-up|1
1785662|NCT00624052|6216338|P2|Overall Study|Lost to Follow-up|3
1785663|NCT00624052|6216339|P1|Overall Study|Lost to Follow-up|2
1785664|NCT00624052|6216336|P4|Overall Study|Lack of Efficacy|0
1785665|NCT00624052|6216337|P3|Overall Study|Lack of Efficacy|0
1785666|NCT00624052|6216338|P2|Overall Study|Lack of Efficacy|1
1785667|NCT00624052|6216339|P1|Overall Study|Lack of Efficacy|1
1785668|NCT00624052|6216336|P4|Overall Study|Adverse Event|3
1785669|NCT00624052|6216337|P3|Overall Study|Adverse Event|0
1785670|NCT00624052|6216338|P2|Overall Study|Adverse Event|6
1785671|NCT00624052|6216339|P1|Overall Study|Adverse Event|7
1785672|NCT00623935|6216416|P1|Overall Study|Patient Declined Transplant|1
1785673|NCT00623935|6216416|P1|Overall Study|Death|1
1785674|NCT00623831|6216423|P2|Overall Study|Progressive Disease|1
1785675|NCT00623831|6216424|P1|Overall Study|Progressive Disease|0
1785676|NCT00623831|6216423|P2|Overall Study|Withdrawal by Subject|0
1785677|NCT00623831|6216424|P1|Overall Study|Withdrawal by Subject|1
1785678|NCT00623805|6216436|P2|Overall Study|Reason not Specified|6
1785679|NCT00623805|6216437|P1|Overall Study|Reason not Specified|3
1785680|NCT00623805|6216436|P2|Overall Study|Protocol Violation|1
1785681|NCT00623805|6216437|P1|Overall Study|Protocol Violation|1
1785682|NCT00623805|6216436|P2|Overall Study|Lost to Follow-up|2
1785683|NCT00623805|6216437|P1|Overall Study|Lost to Follow-up|2
1785684|NCT00623805|6216436|P2|Overall Study|Lack of Efficacy|7
1785685|NCT00623805|6216437|P1|Overall Study|Lack of Efficacy|3
1785686|NCT00623805|6216436|P2|Overall Study|Death|0
1785687|NCT00623805|6216437|P1|Overall Study|Death|2
1785688|NCT00623805|6216436|P2|Overall Study|Adverse Event|6
1785689|NCT00623805|6216437|P1|Overall Study|Adverse Event|9
1785690|NCT00623779|6216454|P3|Overall Study|Criteria from CSR|1
1785691|NCT00623779|6216455|P2|Overall Study|Criteria from CSR|0
1785692|NCT00623779|6216456|P1|Overall Study|Criteria from CSR|2
1785693|NCT00623779|6216454|P3|Overall Study|Adverse Event|0
1785694|NCT00623779|6216455|P2|Overall Study|Adverse Event|3
1785695|NCT00623779|6216456|P1|Overall Study|Adverse Event|1
1785696|NCT00623766|6216505|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
1785697|NCT00623766|6216506|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
1785698|NCT00623766|6216505|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
1785699|NCT00623766|6216506|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
1785700|NCT00623766|6216505|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
1785701|NCT00623766|6216506|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
1785702|NCT00623766|6216505|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
1785703|NCT00623766|6216506|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
1785704|NCT00623766|6216505|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
1785705|NCT00623766|6216506|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
1785706|NCT00623727|6216530|P2|Open Label Follow-up|Participant convenience|1
1785707|NCT00623727|6216531|P1|Open Label Follow-up|Participant convenience|0
1785708|NCT00623727|6216530|P2|Open Label Follow-up|Study termination|6
1785709|NCT00623727|6216531|P1|Open Label Follow-up|Study termination|0
1785710|NCT00623727|6216530|P2|Open Label Follow-up|Withdrawal by Subject|1
1785711|NCT00623727|6216531|P1|Open Label Follow-up|Withdrawal by Subject|0
1785712|NCT00623727|6216530|P2|Double Blind (DB)|Protocol Violation|2
1785713|NCT00623727|6216531|P1|Double Blind (DB)|Protocol Violation|2
1785714|NCT00623727|6216530|P2|Double Blind (DB)|Lost to Follow-up|1
1785715|NCT00623727|6216531|P1|Double Blind (DB)|Lost to Follow-up|1
1785716|NCT00623727|6216530|P2|Double Blind (DB)|Termination of the double-blind period|21
1785717|NCT00623727|6216531|P1|Double Blind (DB)|Termination of the double-blind period|22
1785718|NCT00623727|6216530|P2|Double Blind (DB)|Lack of Efficacy|2
1785719|NCT00623727|6216531|P1|Double Blind (DB)|Lack of Efficacy|2
1785720|NCT00623727|6216530|P2|Double Blind (DB)|Withdrawal by Subject|2
1785721|NCT00623727|6216531|P1|Double Blind (DB)|Withdrawal by Subject|8
1785722|NCT00623727|6216530|P2|Double Blind (DB)|Physician Decision|1
1785723|NCT00623727|6216531|P1|Double Blind (DB)|Physician Decision|0
1785724|NCT00623727|6216530|P2|Double Blind (DB)|Adverse Event|3
1785725|NCT00623727|6216531|P1|Double Blind (DB)|Adverse Event|1
1785726|NCT00623623|6216586|P2|Overall Study|Previous enrolment into this study|1
1785727|NCT00623623|6216587|P1|Overall Study|Previous enrolment into this study|1
1785728|NCT00623597|6216643|P2|Overall Study|Failed to return|0
1785729|NCT00623597|6216644|P1|Overall Study|Failed to return|1
1785730|NCT00623545|6216707|P1|Overall Study|Withdrawal by Subject|4
1785731|NCT00623545|6216707|P1|Overall Study|Adverse Event|6
1785732|NCT00623480|6216727|P2|Overall Study|Site closed by sponsor|1
1785733|NCT00623480|6216728|P1|Overall Study|Site closed by sponsor|0
1785734|NCT00623480|6216727|P2|Overall Study|Protocol Violation|1
1785735|NCT00623480|6216728|P1|Overall Study|Protocol Violation|0
1785736|NCT00623480|6216727|P2|Overall Study|Non-compliant with study medication|0
1785737|NCT00623480|6216728|P1|Overall Study|Non-compliant with study medication|4
1785738|NCT00623480|6216727|P2|Overall Study|Lack of Efficacy|0
1785739|NCT00623480|6216728|P1|Overall Study|Lack of Efficacy|1
1785740|NCT00623480|6216727|P2|Overall Study|Withdrawal by Subject|4
1785741|NCT00623480|6216728|P1|Overall Study|Withdrawal by Subject|2
1785742|NCT00623480|6216727|P2|Overall Study|Lost to Follow-up|1
1785743|NCT00623480|6216728|P1|Overall Study|Lost to Follow-up|0
1785744|NCT00623467|6216740|P1|Overall Study|Withdrawal by Subject|2
1785745|NCT00623467|6216740|P1|Overall Study|Protocol Violation|4
1785746|NCT00623467|6216740|P1|Overall Study|Lost to Follow-up|1
1785747|NCT00623428|6216810|P2|Follow-up Period|Death|1
1785748|NCT00623428|6216811|P1|Follow-up Period|Death|0
1785749|NCT00623428|6216810|P2|Follow-up Period|Reason not specified|1
1785750|NCT00623428|6216811|P1|Follow-up Period|Reason not specified|1
1785751|NCT00623428|6216810|P2|Follow-up Period|Did not cooperate|3
1785752|NCT00623428|6216811|P1|Follow-up Period|Did not cooperate|0
1785753|NCT00623428|6216810|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
1785754|NCT00623428|6216811|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
1785755|NCT00623428|6216810|P2|Follow-up Period|Patient withdrew consent|4
1785756|NCT00623428|6216811|P1|Follow-up Period|Patient withdrew consent|5
1785757|NCT00623428|6216810|P2|Follow-up Period|Failure to return|2
1785758|NCT00623428|6216811|P1|Follow-up Period|Failure to return|10
1785759|NCT00623428|6216810|P2|Follow-up Period|Relapse post-treatment|3
1785760|NCT00623428|6216811|P1|Follow-up Period|Relapse post-treatment|11
1785761|NCT00623428|6216810|P2|Treatment Period|Withdrawal by Subject|1
1785762|NCT00623428|6216811|P1|Treatment Period|Withdrawal by Subject|0
1785763|NCT00623428|6216810|P2|Treatment Period|Other|1
1785764|NCT00623428|6216811|P1|Treatment Period|Other|0
1785765|NCT00623428|6216810|P2|Treatment Period|Insufficient therapeutic response|2
1785766|NCT00623428|6216811|P1|Treatment Period|Insufficient therapeutic response|0
1785767|NCT00623428|6216810|P2|Treatment Period|Did not cooperate / refused treatment|13
1785768|NCT00623428|6216811|P1|Treatment Period|Did not cooperate / refused treatment|0
1785769|NCT00623428|6216810|P2|Treatment Period|Death|1
1785770|NCT00623428|6216811|P1|Treatment Period|Death|0
1785771|NCT00623428|6216810|P2|Treatment Period|Adverse event/intercurrent illness|9
1785772|NCT00623428|6216811|P1|Treatment Period|Adverse event/intercurrent illness|0
1785773|NCT00623233|6216829|P1|Overall Study|Withdrawal by Subject|3
1785774|NCT00623233|6216829|P1|Overall Study|Lost to Follow-up|1
1785775|NCT00623233|6216829|P1|Overall Study|Physician Decision|10
1785776|NCT00623233|6216829|P1|Overall Study|Adverse Event|10
1785777|NCT00623194|6216836|P1|Overall Study|Unclassified|1
1785778|NCT00623194|6216836|P1|Overall Study|Protocol Violation|3
1785779|NCT00623194|6216836|P1|Overall Study|Lack of Efficacy|1
1785780|NCT00623103|6216873|P2|Overall Study|Protocol deviation|1
1785781|NCT00623103|6216874|P1|Overall Study|Protocol deviation|2
1785782|NCT00623103|6216873|P2|Overall Study|Death|11
1785783|NCT00623103|6216874|P1|Overall Study|Death|11
1785784|NCT00623103|6216873|P2|Overall Study|Administrative problems|4
1785785|NCT00623103|6216874|P1|Overall Study|Administrative problems|2
1785786|NCT00623103|6216873|P2|Overall Study|Lost to Follow-up|1
1785787|NCT00623103|6216874|P1|Overall Study|Lost to Follow-up|4
1785788|NCT00623103|6216873|P2|Overall Study|Withdrawal by Subject|24
1785789|NCT00623103|6216874|P1|Overall Study|Withdrawal by Subject|18
1785790|NCT00623103|6216873|P2|Overall Study|Unsatisfactory therapeutic effect|12
1785791|NCT00623103|6216874|P1|Overall Study|Unsatisfactory therapeutic effect|4
1785792|NCT00623103|6216873|P2|Overall Study|Adverse Event|60
1785793|NCT00623103|6216874|P1|Overall Study|Adverse Event|70
1785794|NCT00622908|6216902|P2|Overall Study|Termination by study sponser|1
1785795|NCT00622908|6216903|P1|Overall Study|Termination by study sponser|0
1785796|NCT00622908|6216902|P2|Overall Study|Refusal|1
1785797|NCT00622908|6216903|P1|Overall Study|Refusal|0
1785798|NCT00622908|6216902|P2|Overall Study|Lost to Follow-up|0
1785799|NCT00622908|6216903|P1|Overall Study|Lost to Follow-up|1
1785800|NCT00622908|6216902|P2|Overall Study|Lack of Efficacy|7
1785801|NCT00622908|6216903|P1|Overall Study|Lack of Efficacy|1
1785802|NCT00622908|6216902|P2|Overall Study|Adverse Event|1
1785803|NCT00622908|6216903|P1|Overall Study|Adverse Event|0
1785804|NCT00622908|6216902|P2|Overall Study|Protocol Violation|0
1785805|NCT00622908|6216903|P1|Overall Study|Protocol Violation|1
1785806|NCT00622869|6216933|P3|Overall Study|Missing|1
1785807|NCT00622869|6216934|P2|Overall Study|Missing|1
1785808|NCT00622869|6216935|P1|Overall Study|Missing|0
1785809|NCT00622869|6216933|P3|Overall Study|Graft Loss|2
1785810|NCT00622869|6216934|P2|Overall Study|Graft Loss|3
1785811|NCT00622869|6216935|P1|Overall Study|Graft Loss|5
1785812|NCT00622869|6216933|P3|Overall Study|Lost to Follow-up|2
1785813|NCT00622869|6216934|P2|Overall Study|Lost to Follow-up|4
1785814|NCT00622869|6216935|P1|Overall Study|Lost to Follow-up|2
1785815|NCT00622869|6216933|P3|Overall Study|Death|10
1785816|NCT00622869|6216934|P2|Overall Study|Death|15
1785817|NCT00622869|6216935|P1|Overall Study|Death|12
1785818|NCT00622869|6216933|P3|Overall Study|Administrative Problems|13
1785819|NCT00622869|6216934|P2|Overall Study|Administrative Problems|17
1785820|NCT00622869|6216935|P1|Overall Study|Administrative Problems|11
1785821|NCT00622869|6216933|P3|Overall Study|Subject Withdrew Consent|11
1785822|NCT00622869|6216934|P2|Overall Study|Subject Withdrew Consent|17
1785823|NCT00622869|6216935|P1|Overall Study|Subject Withdrew Consent|13
1785824|NCT00622739|6216954|P2|Overall Study|Lost to Follow-up|1
1785825|NCT00622739|6216955|P1|Overall Study|Lost to Follow-up|0
1785826|NCT00622739|6216954|P2|Overall Study|Withdrawal by Subject|1
1785827|NCT00622739|6216955|P1|Overall Study|Withdrawal by Subject|0
1785828|NCT00622739|6216954|P2|Overall Study|Lack of Efficacy|2
1785829|NCT00622739|6216955|P1|Overall Study|Lack of Efficacy|0
1785830|NCT00622739|6216954|P2|Overall Study|Adverse Event|2
1785831|NCT00622739|6216955|P1|Overall Study|Adverse Event|1
1785832|NCT00622739|6216954|P2|Overall Study|Physician Decision|0
1785833|NCT00622739|6216955|P1|Overall Study|Physician Decision|1
1785834|NCT00622726|6216973|P2|August, 2010 to April, 2013|Death|5
1785835|NCT00622726|6216974|P1|August, 2010 to April, 2013|Death|1
1785836|NCT00622726|6216973|P2|March, 2008 to August, 2010|Death|2
1785837|NCT00622726|6216974|P1|March, 2008 to August, 2010|Death|5
1785838|NCT00622713|6216984|P1|Overall Study|Did not meet eligibility criteria|1
1785839|NCT00622713|6216984|P1|Overall Study|Subject no longer required study drug|1
1785840|NCT00622713|6216984|P1|Overall Study|Death|2
1785841|NCT00622713|6216984|P1|Overall Study|Lost to Follow-up|5
1785842|NCT00622713|6216984|P1|Overall Study|Withdrawal by Subject|11
1785843|NCT00622713|6216984|P1|Overall Study|Administrative problems|4
1785844|NCT00622713|6216984|P1|Overall Study|Adverse Event|35
1785845|NCT00622700|6216995|P7|Extension Treatment Period|Other than specified above|1
1785846|NCT00622700|6216996|P6|Extension Treatment Period|Other than specified above|1
1785847|NCT00622700|6216997|P5|Extension Treatment Period|Other than specified above|0
1785848|NCT00622700|6216998|P4|Extension Treatment Period|Other than specified above|0
1785849|NCT00622700|6216999|P3|Extension Treatment Period|Other than specified above|0
1785850|NCT00622700|6217000|P2|Extension Treatment Period|Other than specified above|0
1785851|NCT00622700|6217001|P1|Extension Treatment Period|Other than specified above|0
1785852|NCT00622700|6216995|P7|Extension Treatment Period|Missing|0
1785853|NCT00622700|6216996|P6|Extension Treatment Period|Missing|1
1785854|NCT00622700|6216997|P5|Extension Treatment Period|Missing|3
1785855|NCT00622700|6216998|P4|Extension Treatment Period|Missing|2
1785856|NCT00622700|6216999|P3|Extension Treatment Period|Missing|0
1785857|NCT00622700|6217000|P2|Extension Treatment Period|Missing|0
1785858|NCT00622700|6217001|P1|Extension Treatment Period|Missing|0
1785859|NCT00622700|6216995|P7|Extension Treatment Period|Withdrawal by Subject|10
1785860|NCT00622700|6216996|P6|Extension Treatment Period|Withdrawal by Subject|6
1785861|NCT00622700|6216997|P5|Extension Treatment Period|Withdrawal by Subject|16
1785862|NCT00622700|6216998|P4|Extension Treatment Period|Withdrawal by Subject|11
1785863|NCT00622700|6216999|P3|Extension Treatment Period|Withdrawal by Subject|0
1785864|NCT00622700|6217000|P2|Extension Treatment Period|Withdrawal by Subject|0
1785865|NCT00622700|6217001|P1|Extension Treatment Period|Withdrawal by Subject|0
1785866|NCT00622700|6216995|P7|Extension Treatment Period|Progressive Disease|2
1785867|NCT00622700|6216996|P6|Extension Treatment Period|Progressive Disease|0
1785868|NCT00622700|6216997|P5|Extension Treatment Period|Progressive Disease|2
1785869|NCT00622700|6216998|P4|Extension Treatment Period|Progressive Disease|1
1785870|NCT00622700|6216999|P3|Extension Treatment Period|Progressive Disease|0
1785871|NCT00622700|6217000|P2|Extension Treatment Period|Progressive Disease|0
1785872|NCT00622700|6217001|P1|Extension Treatment Period|Progressive Disease|0
1785873|NCT00622700|6216995|P7|Extension Treatment Period|Lost to Follow-up|0
1785874|NCT00622700|6216996|P6|Extension Treatment Period|Lost to Follow-up|0
1785875|NCT00622700|6216997|P5|Extension Treatment Period|Lost to Follow-up|1
1785876|NCT00622700|6216998|P4|Extension Treatment Period|Lost to Follow-up|0
1785877|NCT00622700|6216999|P3|Extension Treatment Period|Lost to Follow-up|0
1785878|NCT00622700|6217000|P2|Extension Treatment Period|Lost to Follow-up|0
1785879|NCT00622700|6217001|P1|Extension Treatment Period|Lost to Follow-up|0
1785880|NCT00622700|6216995|P7|Extension Treatment Period|Protocol Violation|0
1785881|NCT00622700|6216996|P6|Extension Treatment Period|Protocol Violation|2
1785882|NCT00622700|6216997|P5|Extension Treatment Period|Protocol Violation|0
1785883|NCT00622700|6216998|P4|Extension Treatment Period|Protocol Violation|0
1785884|NCT00622700|6216999|P3|Extension Treatment Period|Protocol Violation|0
1785885|NCT00622700|6217000|P2|Extension Treatment Period|Protocol Violation|0
1785886|NCT00622700|6217001|P1|Extension Treatment Period|Protocol Violation|0
1785887|NCT00622700|6216995|P7|Extension Treatment Period|Lack of Efficacy|9
1785888|NCT00622700|6216996|P6|Extension Treatment Period|Lack of Efficacy|1
1785889|NCT00622700|6216997|P5|Extension Treatment Period|Lack of Efficacy|8
1785890|NCT00622700|6216998|P4|Extension Treatment Period|Lack of Efficacy|2
1785891|NCT00622700|6216999|P3|Extension Treatment Period|Lack of Efficacy|0
1785892|NCT00622700|6217000|P2|Extension Treatment Period|Lack of Efficacy|0
1785893|NCT00622700|6217001|P1|Extension Treatment Period|Lack of Efficacy|0
1785894|NCT00622700|6216995|P7|Extension Treatment Period|Adverse Event|8
1785895|NCT00622700|6216996|P6|Extension Treatment Period|Adverse Event|6
1785896|NCT00622700|6216997|P5|Extension Treatment Period|Adverse Event|9
1785897|NCT00622700|6216998|P4|Extension Treatment Period|Adverse Event|5
1785898|NCT00622700|6216999|P3|Extension Treatment Period|Adverse Event|0
1785899|NCT00622700|6217000|P2|Extension Treatment Period|Adverse Event|0
1785900|NCT00622700|6217001|P1|Extension Treatment Period|Adverse Event|0
1785901|NCT00622700|6216995|P7|Core Treatment Period|Other than specified above|0
1785902|NCT00622700|6216996|P6|Core Treatment Period|Other than specified above|0
1785903|NCT00622700|6216997|P5|Core Treatment Period|Other than specified above|0
1785904|NCT00622700|6216998|P4|Core Treatment Period|Other than specified above|0
1785905|NCT00622700|6216999|P3|Core Treatment Period|Other than specified above|5
1785906|NCT00622700|6217000|P2|Core Treatment Period|Other than specified above|2
1785907|NCT00622700|6217001|P1|Core Treatment Period|Other than specified above|2
1785908|NCT00622700|6216995|P7|Core Treatment Period|Withdrawal by Subject|0
1785909|NCT00622700|6216996|P6|Core Treatment Period|Withdrawal by Subject|0
1785910|NCT00622700|6216997|P5|Core Treatment Period|Withdrawal by Subject|0
1785911|NCT00622700|6216998|P4|Core Treatment Period|Withdrawal by Subject|0
1785912|NCT00622700|6216999|P3|Core Treatment Period|Withdrawal by Subject|15
1785913|NCT00622700|6217000|P2|Core Treatment Period|Withdrawal by Subject|18
1785914|NCT00622700|6217001|P1|Core Treatment Period|Withdrawal by Subject|12
1785915|NCT00622700|6216995|P7|Core Treatment Period|Progressive Disease|0
1785916|NCT00622700|6216996|P6|Core Treatment Period|Progressive Disease|0
1785917|NCT00622700|6216997|P5|Core Treatment Period|Progressive Disease|0
1785918|NCT00622700|6216998|P4|Core Treatment Period|Progressive Disease|0
1785919|NCT00622700|6216999|P3|Core Treatment Period|Progressive Disease|0
1785920|NCT00622700|6217000|P2|Core Treatment Period|Progressive Disease|1
1785921|NCT00622700|6217001|P1|Core Treatment Period|Progressive Disease|3
1785922|NCT00622700|6216995|P7|Core Treatment Period|Death|0
1785923|NCT00622700|6216996|P6|Core Treatment Period|Death|0
1785924|NCT00622700|6216997|P5|Core Treatment Period|Death|0
1785925|NCT00622700|6216998|P4|Core Treatment Period|Death|0
1785926|NCT00622700|6216999|P3|Core Treatment Period|Death|0
1785927|NCT00622700|6217000|P2|Core Treatment Period|Death|0
1785928|NCT00622700|6217001|P1|Core Treatment Period|Death|1
1785929|NCT00622700|6216995|P7|Core Treatment Period|Lost to Follow-up|0
1785930|NCT00622700|6216996|P6|Core Treatment Period|Lost to Follow-up|0
1785931|NCT00622700|6216997|P5|Core Treatment Period|Lost to Follow-up|0
1785932|NCT00622700|6216998|P4|Core Treatment Period|Lost to Follow-up|0
1785933|NCT00622700|6216999|P3|Core Treatment Period|Lost to Follow-up|1
1785934|NCT00622700|6217000|P2|Core Treatment Period|Lost to Follow-up|1
1785935|NCT00622700|6217001|P1|Core Treatment Period|Lost to Follow-up|1
1785936|NCT00622700|6216995|P7|Core Treatment Period|Lack of Efficacy|0
1785937|NCT00622700|6216996|P6|Core Treatment Period|Lack of Efficacy|0
1785938|NCT00622700|6216997|P5|Core Treatment Period|Lack of Efficacy|0
1785939|NCT00622700|6216998|P4|Core Treatment Period|Lack of Efficacy|0
1785940|NCT00622700|6216999|P3|Core Treatment Period|Lack of Efficacy|12
1785941|NCT00622700|6217000|P2|Core Treatment Period|Lack of Efficacy|6
1785942|NCT00622700|6217001|P1|Core Treatment Period|Lack of Efficacy|19
1785943|NCT00622700|6216995|P7|Core Treatment Period|Adverse Event|0
1785944|NCT00622700|6216996|P6|Core Treatment Period|Adverse Event|0
1785945|NCT00622700|6216997|P5|Core Treatment Period|Adverse Event|0
1785946|NCT00622700|6216998|P4|Core Treatment Period|Adverse Event|0
1785947|NCT00622700|6216999|P3|Core Treatment Period|Adverse Event|18
1785948|NCT00622700|6217000|P2|Core Treatment Period|Adverse Event|25
1785949|NCT00622700|6217001|P1|Core Treatment Period|Adverse Event|18
1785950|NCT00622700|6216995|P7|Core Treatment Period|Randomized but Not Treated|0
1785951|NCT00622700|6216996|P6|Core Treatment Period|Randomized but Not Treated|0
1785952|NCT00622700|6216997|P5|Core Treatment Period|Randomized but Not Treated|0
1785953|NCT00622700|6216998|P4|Core Treatment Period|Randomized but Not Treated|0
1785954|NCT00622700|6216999|P3|Core Treatment Period|Randomized but Not Treated|2
1785955|NCT00622700|6217000|P2|Core Treatment Period|Randomized but Not Treated|2
1785956|NCT00622700|6217001|P1|Core Treatment Period|Randomized but Not Treated|0
1785957|NCT00622635|6217060|P6|Treatment Period 3|Withdrawal by Subject|0
1785958|NCT00622635|6217061|P5|Treatment Period 3|Withdrawal by Subject|0
1785959|NCT00622635|6217062|P4|Treatment Period 3|Withdrawal by Subject|1
1785960|NCT00622635|6217063|P3|Treatment Period 3|Withdrawal by Subject|0
1785961|NCT00622635|6217064|P2|Treatment Period 3|Withdrawal by Subject|0
1785962|NCT00622635|6217065|P1|Treatment Period 3|Withdrawal by Subject|0
1785963|NCT00622635|6217060|P6|Treatment Period 3|Adverse Event|0
1785964|NCT00622635|6217061|P5|Treatment Period 3|Adverse Event|0
1785965|NCT00622635|6217062|P4|Treatment Period 3|Adverse Event|2
1785966|NCT00622635|6217063|P3|Treatment Period 3|Adverse Event|0
1785967|NCT00622635|6217064|P2|Treatment Period 3|Adverse Event|0
1785968|NCT00622635|6217065|P1|Treatment Period 3|Adverse Event|0
1785969|NCT00622635|6217060|P6|Treatment Period 2|Adverse Event|0
1785970|NCT00622635|6217061|P5|Treatment Period 2|Adverse Event|0
1785971|NCT00622635|6217062|P4|Treatment Period 2|Adverse Event|0
1785972|NCT00622635|6217063|P3|Treatment Period 2|Adverse Event|0
1785973|NCT00622635|6217064|P2|Treatment Period 2|Adverse Event|0
1785974|NCT00622635|6217065|P1|Treatment Period 2|Adverse Event|1
1785975|NCT00622635|6217060|P6|Treatment Period 1|Abnormal test procedure result(s)|0
1785976|NCT00622635|6217061|P5|Treatment Period 1|Abnormal test procedure result(s)|1
1785977|NCT00622635|6217062|P4|Treatment Period 1|Abnormal test procedure result(s)|0
1785978|NCT00622635|6217063|P3|Treatment Period 1|Abnormal test procedure result(s)|0
1785979|NCT00622635|6217064|P2|Treatment Period 1|Abnormal test procedure result(s)|0
1785980|NCT00622635|6217065|P1|Treatment Period 1|Abnormal test procedure result(s)|0
1785981|NCT00622635|6217060|P6|Treatment Period 1|Withdrawal by Subject|0
1785982|NCT00622635|6217061|P5|Treatment Period 1|Withdrawal by Subject|0
1785983|NCT00622635|6217062|P4|Treatment Period 1|Withdrawal by Subject|0
1785984|NCT00622635|6217063|P3|Treatment Period 1|Withdrawal by Subject|0
1785985|NCT00622635|6217064|P2|Treatment Period 1|Withdrawal by Subject|1
1785986|NCT00622635|6217065|P1|Treatment Period 1|Withdrawal by Subject|0
1785987|NCT00622635|6217060|P6|Treatment Period 1|Adverse Event|0
1785988|NCT00622635|6217061|P5|Treatment Period 1|Adverse Event|0
1785989|NCT00622635|6217062|P4|Treatment Period 1|Adverse Event|0
1785990|NCT00622635|6217063|P3|Treatment Period 1|Adverse Event|1
1785991|NCT00622635|6217064|P2|Treatment Period 1|Adverse Event|0
1785992|NCT00622635|6217065|P1|Treatment Period 1|Adverse Event|0
1785993|NCT00622440|6217148|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
1785994|NCT00622440|6217149|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
1785995|NCT00622440|6217148|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
1785996|NCT00622440|6217149|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
1785997|NCT00622440|6217148|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
1785998|NCT00622440|6217149|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
1785999|NCT00622440|6217148|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
1786000|NCT00622440|6217149|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
1786001|NCT00622401|6217175|P3|Overall Study|Disease progression prior to treatment|0
1786002|NCT00622401|6217176|P2|Overall Study|Disease progression prior to treatment|2
1786003|NCT00622401|6217177|P1|Overall Study|Disease progression prior to treatment|3
1786004|NCT00622388|6217184|P1|Overall Study|Insurance Expired|1
1786005|NCT00622388|6217184|P1|Overall Study|Withdrew Consent|1
1786006|NCT00622388|6217184|P1|Overall Study|Took Prohibited Medication|2
1786007|NCT00622388|6217184|P1|Overall Study|Received Alternate Anticancer Therapy|8
1786008|NCT00622388|6217184|P1|Overall Study|Death|3
1786009|NCT00622388|6217184|P1|Overall Study|Participant Refusal|1
1786010|NCT00622388|6217184|P1|Overall Study|Protocol Violation|3
1786011|NCT00622388|6217184|P1|Overall Study|Adverse Event|6
1786012|NCT00622388|6217184|P1|Overall Study|Disease Progression|47
1786013|NCT00622336|6217202|P1|Extension Phase|Other|9
1786014|NCT00622336|6217202|P1|Extension Phase|Lost to Follow-up|1
1786015|NCT00622336|6217202|P1|Extension Phase|Withdrawal by Subject|1
1786016|NCT00622336|6217202|P1|Extension Phase|Lack of therapeutic effect|2
1786017|NCT00622336|6217202|P1|Extension Phase|Progressive Disease|6
1786018|NCT00622336|6217202|P1|Extension Phase|Adverse Event|2
1786019|NCT00622336|6217202|P1|Treatment Phase|Lost to Follow-up|2
1786020|NCT00622336|6217202|P1|Treatment Phase|Withdrawal by Subject|13
1786021|NCT00622336|6217202|P1|Treatment Phase|Lack of therapeutic effect|13
1786022|NCT00622336|6217202|P1|Treatment Phase|Death|14
1786023|NCT00622336|6217202|P1|Treatment Phase|Other|40
1786024|NCT00622336|6217202|P1|Treatment Phase|Adverse Event|46
1786025|NCT00622336|6217202|P1|Treatment Phase|Progression of Disease|181
1786026|NCT00622284|6217213|P2|Overall Study|Other reason (not specified)|24
1786027|NCT00622284|6217214|P1|Overall Study|Other reason (not specified)|33
1786028|NCT00622284|6217213|P2|Overall Study|Withdrawal by Subject|24
1786029|NCT00622284|6217214|P1|Overall Study|Withdrawal by Subject|27
1786030|NCT00622284|6217213|P2|Overall Study|Lost to Follow-up|13
1786031|NCT00622284|6217214|P1|Overall Study|Lost to Follow-up|11
1786032|NCT00622284|6217213|P2|Overall Study|Protocol Violation|5
1786033|NCT00622284|6217214|P1|Overall Study|Protocol Violation|12
1786034|NCT00622284|6217213|P2|Overall Study|Adverse Event|90
1786035|NCT00622284|6217214|P1|Overall Study|Adverse Event|61
1786036|NCT00622284|6217213|P2|Overall Study|Lack of Efficacy|15
1786037|NCT00622284|6217214|P1|Overall Study|Lack of Efficacy|45
1786038|NCT00622180|6217276|P2|Overall Study|Lost to Follow-up|2
1786039|NCT00622180|6217277|P1|Overall Study|Lost to Follow-up|1
1786040|NCT00622167|6217283|P1|Overall Study|Did not meet angiographic criteria|20
1786041|NCT00621985|6217287|P1|Dexamethasone Admission|Adverse Event|1
1786042|NCT00621959|6217295|P2|Overall Study|Other|3
1786043|NCT00621959|6217296|P1|Overall Study|Other|1
1786044|NCT00621959|6217295|P2|Overall Study|Withdrawal by Subject|1
1786045|NCT00621959|6217296|P1|Overall Study|Withdrawal by Subject|1
1786046|NCT00621959|6217295|P2|Overall Study|Lost to Follow-up|2
1786047|NCT00621959|6217296|P1|Overall Study|Lost to Follow-up|0
1786048|NCT00621959|6217295|P2|Overall Study|Lack of Efficacy|1
1786049|NCT00621959|6217296|P1|Overall Study|Lack of Efficacy|1
1786050|NCT00621959|6217295|P2|Overall Study|Adverse Event|2
1786051|NCT00621959|6217296|P1|Overall Study|Adverse Event|4
1786052|NCT00621855|6217335|P5|Overall Study|Patients did not receive study drug|2
1786053|NCT00621855|6217336|P4|Overall Study|Patients did not receive study drug|4
1786054|NCT00621855|6217337|P3|Overall Study|Patients did not receive study drug|5
1786055|NCT00621855|6217338|P2|Overall Study|Patients did not receive study drug|3
1786056|NCT00621855|6217339|P1|Overall Study|Patients did not receive study drug|3
1786057|NCT00621855|6217335|P5|Overall Study|Other|4
1786058|NCT00621855|6217336|P4|Overall Study|Other|5
1786059|NCT00621855|6217337|P3|Overall Study|Other|6
1786060|NCT00621855|6217338|P2|Overall Study|Other|7
1786061|NCT00621855|6217339|P1|Overall Study|Other|9
1786062|NCT00621855|6217335|P5|Overall Study|Withdrawal by Subject|9
1786063|NCT00621855|6217336|P4|Overall Study|Withdrawal by Subject|13
1786064|NCT00621855|6217337|P3|Overall Study|Withdrawal by Subject|13
1786065|NCT00621855|6217338|P2|Overall Study|Withdrawal by Subject|11
1786066|NCT00621855|6217339|P1|Overall Study|Withdrawal by Subject|16
1786067|NCT00621855|6217335|P5|Overall Study|Protocol Violation|8
1786068|NCT00621855|6217336|P4|Overall Study|Protocol Violation|7
1786069|NCT00621855|6217337|P3|Overall Study|Protocol Violation|6
1786070|NCT00621855|6217338|P2|Overall Study|Protocol Violation|8
1786071|NCT00621855|6217339|P1|Overall Study|Protocol Violation|16
1786072|NCT00621855|6217335|P5|Overall Study|Lost to Follow-up|1
1786073|NCT00621855|6217336|P4|Overall Study|Lost to Follow-up|4
1786074|NCT00621855|6217337|P3|Overall Study|Lost to Follow-up|3
1786075|NCT00621855|6217338|P2|Overall Study|Lost to Follow-up|1
1786076|NCT00621855|6217339|P1|Overall Study|Lost to Follow-up|0
1786077|NCT00621855|6217335|P5|Overall Study|Adverse Event|31
1786078|NCT00621855|6217336|P4|Overall Study|Adverse Event|34
1786079|NCT00621855|6217337|P3|Overall Study|Adverse Event|48
1786080|NCT00621855|6217338|P2|Overall Study|Adverse Event|31
1786081|NCT00621855|6217339|P1|Overall Study|Adverse Event|32
1786082|NCT00621842|6217381|P1|Overall Study|Lack of Efficacy|2
1786083|NCT00621842|6217381|P1|Overall Study|Protocol Violation|4
1786084|NCT00621842|6217381|P1|Overall Study|Withdrawal by Subject|7
1786085|NCT00621842|6217381|P1|Overall Study|Adverse Event|6
1786086|NCT00621777|6217398|P2|Randomized Phase|Death|1
1786087|NCT00621777|6217399|P1|Randomized Phase|Death|0
1786088|NCT00621777|6217398|P2|Randomized Phase|administrative|3
1786089|NCT00621777|6217399|P1|Randomized Phase|administrative|0
1786090|NCT00621777|6217398|P2|Randomized Phase|Withdrawal by Subject|9
1786091|NCT00621777|6217399|P1|Randomized Phase|Withdrawal by Subject|1
1786092|NCT00621777|6217398|P2|Randomized Phase|Lost to Follow-up|3
1786093|NCT00621777|6217399|P1|Randomized Phase|Lost to Follow-up|3
1786094|NCT00621777|6217398|P2|Randomized Phase|Adverse Event|3
1786095|NCT00621777|6217399|P1|Randomized Phase|Adverse Event|3
1786096|NCT00621777|6217398|P2|Open Phase|Lost to Follow-up|0
1786097|NCT00621777|6217399|P1|Open Phase|Lost to Follow-up|10
1786098|NCT00621777|6217398|P2|Open Phase|administrative|0
1786099|NCT00621777|6217399|P1|Open Phase|administrative|13
1786100|NCT00621777|6217398|P2|Open Phase|Withdrawal by Subject|0
1786101|NCT00621777|6217399|P1|Open Phase|Withdrawal by Subject|17
1786102|NCT00621777|6217398|P2|Open Phase|Did not abstain during open phase|0
1786103|NCT00621777|6217399|P1|Open Phase|Did not abstain during open phase|56
1786104|NCT00621777|6217398|P2|Open Phase|Adverse Event|0
1786105|NCT00621777|6217399|P1|Open Phase|Adverse Event|20
1786106|NCT00621764|6217414|P4|Overall Study|Protocol Violation|1
1786107|NCT00621764|6217415|P3|Overall Study|Protocol Violation|0
1786108|NCT00621764|6217416|P2|Overall Study|Protocol Violation|0
1786109|NCT00621764|6217417|P1|Overall Study|Protocol Violation|0
1786110|NCT00621621|6217463|P2|Overall Study|Subjects were exited at EP study|0
1786111|NCT00621621|6217464|P1|Overall Study|Subjects were exited at EP study|30
1786112|NCT00621582|6217472|P1|Overall Study|issues not identified by investigators|18
1786113|NCT00621582|6217472|P1|Overall Study|Lost to Follow-up|24
1786114|NCT00621582|6217472|P1|Overall Study|Protocol Violation|57
1786115|NCT00621582|6217472|P1|Overall Study|Adverse Event|7
1786116|NCT00621543|6217479|P1|Overall Study|Lost to Follow-up|23
1786117|NCT00621517|6217503|P2|Overall Study|Adverse Event|0
1786118|NCT00621517|6217504|P1|Overall Study|Adverse Event|1
1786119|NCT00621517|6217503|P2|Overall Study|Withdrawal by Subject|4
1786120|NCT00621517|6217504|P1|Overall Study|Withdrawal by Subject|3
1786121|NCT00621517|6217503|P2|Overall Study|Lost to Follow-up|3
1786122|NCT00621517|6217504|P1|Overall Study|Lost to Follow-up|3
1786123|NCT00621504|6217516|P2|Overall Study|Death|6
1786124|NCT00621504|6217517|P1|Overall Study|Death|6
1786125|NCT00621504|6217516|P2|Overall Study|Other|0
1786126|NCT00621504|6217517|P1|Overall Study|Other|1
1786127|NCT00621504|6217516|P2|Overall Study|Lost to Follow-up|10
1786128|NCT00621504|6217517|P1|Overall Study|Lost to Follow-up|8
1786129|NCT00621504|6217516|P2|Overall Study|Withdrew consent|6
1786130|NCT00621504|6217517|P1|Overall Study|Withdrew consent|9
1786131|NCT00621504|6217516|P2|Overall Study|At the request of sponsor/investigator|0
1786132|NCT00621504|6217517|P1|Overall Study|At the request of sponsor/investigator|1
1786133|NCT00621504|6217516|P2|Overall Study|Adverse Event|3
1786134|NCT00621504|6217517|P1|Overall Study|Adverse Event|1
1786135|NCT00621322|6217551|P6|Overall Study|Migrated/moved from study area|2
1786136|NCT00621322|6217552|P5|Overall Study|Migrated/moved from study area|0
1786137|NCT00621322|6217553|P4|Overall Study|Migrated/moved from study area|1
1786138|NCT00621322|6217554|P3|Overall Study|Migrated/moved from study area|1
1786139|NCT00621322|6217555|P2|Overall Study|Migrated/moved from study area|0
1786140|NCT00621322|6217556|P1|Overall Study|Migrated/moved from study area|1
1786141|NCT00621322|6217551|P6|Overall Study|Withdrawal by Subject|2
1786142|NCT00621322|6217552|P5|Overall Study|Withdrawal by Subject|0
1786143|NCT00621322|6217553|P4|Overall Study|Withdrawal by Subject|1
1786144|NCT00621322|6217554|P3|Overall Study|Withdrawal by Subject|0
1786145|NCT00621322|6217555|P2|Overall Study|Withdrawal by Subject|0
1786146|NCT00621322|6217556|P1|Overall Study|Withdrawal by Subject|0
1786147|NCT00621322|6217551|P6|Overall Study|Physician Decision|0
1786148|NCT00621322|6217552|P5|Overall Study|Physician Decision|0
1786149|NCT00621322|6217553|P4|Overall Study|Physician Decision|1
1786150|NCT00621322|6217554|P3|Overall Study|Physician Decision|1
1786151|NCT00621322|6217555|P2|Overall Study|Physician Decision|0
1786152|NCT00621322|6217556|P1|Overall Study|Physician Decision|0
1786153|NCT00621322|6217551|P6|Overall Study|Lost to Follow-up|0
1786154|NCT00621322|6217552|P5|Overall Study|Lost to Follow-up|1
1786155|NCT00621322|6217553|P4|Overall Study|Lost to Follow-up|0
1786156|NCT00621322|6217554|P3|Overall Study|Lost to Follow-up|0
1786157|NCT00621322|6217555|P2|Overall Study|Lost to Follow-up|0
1786158|NCT00621322|6217556|P1|Overall Study|Lost to Follow-up|0
1786159|NCT00621309|6217636|P6|Overall Study|Withdrawal by Subject|1
1786160|NCT00621309|6217637|P5|Overall Study|Withdrawal by Subject|1
1786161|NCT00621309|6217638|P4|Overall Study|Withdrawal by Subject|1
1786162|NCT00621309|6217639|P3|Overall Study|Withdrawal by Subject|1
1786163|NCT00621309|6217640|P2|Overall Study|Withdrawal by Subject|0
1786164|NCT00621309|6217641|P1|Overall Study|Withdrawal by Subject|2
1786165|NCT00621296|6217647|P1|Overall Study|Stopping Criteria|3
1786166|NCT00621296|6217647|P1|Overall Study|Unmatch Criteria|1
1786167|NCT00621296|6217647|P1|Overall Study|Physician Decision|7
1786168|NCT00621296|6217647|P1|Overall Study|Lack of Efficacy|1
1786169|NCT00621296|6217647|P1|Overall Study|Adverse Event|2
1786170|NCT00621257|6217656|P5|Overall Study|Withdrawal by Subject|1
1786171|NCT00621257|6217657|P4|Overall Study|Withdrawal by Subject|1
1786172|NCT00621257|6217658|P3|Overall Study|Withdrawal by Subject|0
1786173|NCT00621257|6217659|P2|Overall Study|Withdrawal by Subject|0
1786174|NCT00621257|6217660|P1|Overall Study|Withdrawal by Subject|0
1786175|NCT00621257|6217656|P5|Overall Study|Physician Decision|1
1786176|NCT00621257|6217657|P4|Overall Study|Physician Decision|1
1786177|NCT00621257|6217658|P3|Overall Study|Physician Decision|0
1786178|NCT00621257|6217659|P2|Overall Study|Physician Decision|2
1786179|NCT00621257|6217660|P1|Overall Study|Physician Decision|0
1786180|NCT00621257|6217656|P5|Overall Study|Adverse Event|0
1786181|NCT00621257|6217657|P4|Overall Study|Adverse Event|0
1786182|NCT00621257|6217658|P3|Overall Study|Adverse Event|1
1786183|NCT00621257|6217659|P2|Overall Study|Adverse Event|1
1786184|NCT00621257|6217660|P1|Overall Study|Adverse Event|0
1786185|NCT00621257|6217656|P5|Overall Study|Lost to Follow-up|7
1786186|NCT00621257|6217657|P4|Overall Study|Lost to Follow-up|4
1786187|NCT00621257|6217658|P3|Overall Study|Lost to Follow-up|2
1786188|NCT00621257|6217659|P2|Overall Study|Lost to Follow-up|0
1786189|NCT00621257|6217660|P1|Overall Study|Lost to Follow-up|4
1786190|NCT00621244|6217676|P4|Overall Study|Administrative problems|2
1786191|NCT00621244|6217677|P3|Overall Study|Administrative problems|0
1786192|NCT00621244|6217678|P2|Overall Study|Administrative problems|1
1786193|NCT00621244|6217679|P1|Overall Study|Administrative problems|5
1786194|NCT00621244|6217676|P4|Overall Study|Adverse Event|2
1786195|NCT00621244|6217677|P3|Overall Study|Adverse Event|9
1786196|NCT00621244|6217678|P2|Overall Study|Adverse Event|7
1786197|NCT00621244|6217679|P1|Overall Study|Adverse Event|27
1786198|NCT00621244|6217676|P4|Overall Study|Death|1
1786199|NCT00621244|6217677|P3|Overall Study|Death|1
1786200|NCT00621244|6217678|P2|Overall Study|Death|3
1786201|NCT00621244|6217679|P1|Overall Study|Death|3
1786202|NCT00621244|6217676|P4|Overall Study|Disease progression|15
1786203|NCT00621244|6217677|P3|Overall Study|Disease progression|20
1786204|NCT00621244|6217678|P2|Overall Study|Disease progression|20
1786205|NCT00621244|6217679|P1|Overall Study|Disease progression|44
1786206|NCT00621244|6217676|P4|Overall Study|Withdrawal by Subject|3
1786207|NCT00621244|6217677|P3|Overall Study|Withdrawal by Subject|3
1786208|NCT00621244|6217678|P2|Overall Study|Withdrawal by Subject|3
1786209|NCT00621244|6217679|P1|Overall Study|Withdrawal by Subject|7
1786210|NCT00621192|6217783|P4|Overall Study|Final Assessments not Completed|1
1786211|NCT00621192|6217784|P3|Overall Study|Final Assessments not Completed|3
1786212|NCT00621192|6217785|P2|Overall Study|Final Assessments not Completed|0
1786213|NCT00621192|6217786|P1|Overall Study|Final Assessments not Completed|0
1786214|NCT00621192|6217783|P4|Overall Study|Death|0
1786215|NCT00621192|6217784|P3|Overall Study|Death|0
1786216|NCT00621192|6217785|P2|Overall Study|Death|5
1786217|NCT00621192|6217786|P1|Overall Study|Death|2
1786218|NCT00621192|6217783|P4|Overall Study|Adverse Event|1
1786219|NCT00621192|6217784|P3|Overall Study|Adverse Event|0
1786220|NCT00621192|6217785|P2|Overall Study|Adverse Event|1
1786221|NCT00621192|6217786|P1|Overall Study|Adverse Event|0
1786222|NCT00621192|6217783|P4|Overall Study|Protocol Violation|1
1786223|NCT00621192|6217784|P3|Overall Study|Protocol Violation|0
1786224|NCT00621192|6217785|P2|Overall Study|Protocol Violation|0
1786225|NCT00621192|6217786|P1|Overall Study|Protocol Violation|1
1786226|NCT00621192|6217783|P4|Overall Study|Physician Decision|0
1786227|NCT00621192|6217784|P3|Overall Study|Physician Decision|0
1786228|NCT00621192|6217785|P2|Overall Study|Physician Decision|3
1786229|NCT00621192|6217786|P1|Overall Study|Physician Decision|1
1786230|NCT00621192|6217783|P4|Overall Study|Withdrawal by Subject|0
1786231|NCT00621192|6217784|P3|Overall Study|Withdrawal by Subject|2
1786232|NCT00621192|6217785|P2|Overall Study|Withdrawal by Subject|0
1786233|NCT00621192|6217786|P1|Overall Study|Withdrawal by Subject|0
1786234|NCT00621153|6217810|P2|Overall Study|Withdrawal by Subject|5
1786235|NCT00621153|6217811|P1|Overall Study|Withdrawal by Subject|4
1786236|NCT00621153|6217810|P2|Overall Study|Lost to Follow-up|1
1786237|NCT00621153|6217811|P1|Overall Study|Lost to Follow-up|5
1786238|NCT00621153|6217810|P2|Overall Study|Adverse Event|2
1786239|NCT00621153|6217811|P1|Overall Study|Adverse Event|3
1786240|NCT00621153|6217810|P2|Overall Study|Safety Reason|7
1786241|NCT00621153|6217811|P1|Overall Study|Safety Reason|8
1786242|NCT00621140|6217819|P2|Overall Study|Other incl. lack of efficacy|5
1786243|NCT00621140|6217820|P1|Overall Study|Other incl. lack of efficacy|6
1786244|NCT00621140|6217819|P2|Overall Study|Withdrawal by Subject|6
1786245|NCT00621140|6217820|P1|Overall Study|Withdrawal by Subject|4
1786246|NCT00621140|6217819|P2|Overall Study|Lost to Follow-up|2
1786247|NCT00621140|6217820|P1|Overall Study|Lost to Follow-up|1
1786248|NCT00621140|6217819|P2|Overall Study|Adverse Event|5
1786249|NCT00621140|6217820|P1|Overall Study|Adverse Event|4
1786250|NCT00621023|6217867|P1|Overall Study|Follow up discontinued|1
1786251|NCT00621023|6217867|P1|Overall Study|Death|5
1786252|NCT00620854|6217884|P6|Washout 1|Withdrawal by Subject|0
1786253|NCT00620854|6217885|P5|Washout 1|Withdrawal by Subject|0
1786254|NCT00620854|6217886|P4|Washout 1|Withdrawal by Subject|1
1786255|NCT00620854|6217887|P3|Washout 1|Withdrawal by Subject|1
1786256|NCT00620854|6217888|P2|Washout 1|Withdrawal by Subject|0
1786257|NCT00620854|6217889|P1|Washout 1|Withdrawal by Subject|0
1786258|NCT00620815|6217920|P3|Overall Study|Protocol Violation|1
1786259|NCT00620815|6217921|P2|Overall Study|Protocol Violation|2
1786260|NCT00620815|6217922|P1|Overall Study|Protocol Violation|1
1786261|NCT00620815|6217920|P3|Overall Study|Inappropriate enrolment|1
1786262|NCT00620815|6217921|P2|Overall Study|Inappropriate enrolment|0
1786263|NCT00620815|6217922|P1|Overall Study|Inappropriate enrolment|0
1786264|NCT00620815|6217920|P3|Overall Study|Lost to Follow-up|3
1786265|NCT00620815|6217921|P2|Overall Study|Lost to Follow-up|6
1786266|NCT00620815|6217922|P1|Overall Study|Lost to Follow-up|1
1786267|NCT00620815|6217920|P3|Overall Study|Withdrawal by Subject|0
1786268|NCT00620815|6217921|P2|Overall Study|Withdrawal by Subject|2
1786269|NCT00620815|6217922|P1|Overall Study|Withdrawal by Subject|1
1786270|NCT00620815|6217920|P3|Overall Study|Adverse Event|2
1786271|NCT00620815|6217921|P2|Overall Study|Adverse Event|1
1786272|NCT00620815|6217922|P1|Overall Study|Adverse Event|1
1786273|NCT00620776|6217962|P2|Overall Study|Withdrawal by Subject|2
1786274|NCT00620776|6217963|P1|Overall Study|Withdrawal by Subject|3
1786275|NCT00620776|6217962|P2|Overall Study|Lost to Follow-up|5
1786276|NCT00620776|6217963|P1|Overall Study|Lost to Follow-up|2
1786277|NCT00620776|6217962|P2|Overall Study|Lack of Efficacy|1
1786278|NCT00620776|6217963|P1|Overall Study|Lack of Efficacy|2
1786279|NCT00620776|6217962|P2|Overall Study|Adverse Event|3
1786280|NCT00620776|6217963|P1|Overall Study|Adverse Event|2
1786281|NCT00620776|6217962|P2|Overall Study|Did not receive treatment|5
1786282|NCT00620776|6217963|P1|Overall Study|Did not receive treatment|3
1786283|NCT00620763|6217991|P2|Period: Second Intervention|Withdrawal by Subject|0
1786284|NCT00620763|6217992|P1|Period: Second Intervention|Withdrawal by Subject|1
1786285|NCT00620763|6217991|P2|Period: First Intervention|Protocol Violation|3
1786286|NCT00620763|6217992|P1|Period: First Intervention|Protocol Violation|0
1786287|NCT00620763|6217991|P2|Period: First Intervention|Withdrawal by Subject|2
1786288|NCT00620763|6217992|P1|Period: First Intervention|Withdrawal by Subject|0
1786289|NCT00620750|6217998|P1|Overall Study|Lost to Follow-up|25
1786290|NCT00620659|6218013|P6|Treatment Period 3|Withdrawal by Subject|0
1786291|NCT00620659|6218014|P5|Treatment Period 3|Withdrawal by Subject|0
1786292|NCT00620659|6218015|P4|Treatment Period 3|Withdrawal by Subject|1
1786293|NCT00620659|6218016|P3|Treatment Period 3|Withdrawal by Subject|0
1786294|NCT00620659|6218017|P2|Treatment Period 3|Withdrawal by Subject|0
1786295|NCT00620659|6218018|P1|Treatment Period 3|Withdrawal by Subject|0
1786296|NCT00620659|6218013|P6|Treatment Period 3|Adverse Event|0
1786297|NCT00620659|6218014|P5|Treatment Period 3|Adverse Event|0
1786298|NCT00620659|6218015|P4|Treatment Period 3|Adverse Event|0
1786299|NCT00620659|6218016|P3|Treatment Period 3|Adverse Event|0
1786300|NCT00620659|6218017|P2|Treatment Period 3|Adverse Event|2
1786301|NCT00620659|6218018|P1|Treatment Period 3|Adverse Event|0
1786302|NCT00620659|6218013|P6|Placebo Washout Period 2|Adverse Event|0
1786303|NCT00620659|6218014|P5|Placebo Washout Period 2|Adverse Event|0
1786304|NCT00620659|6218015|P4|Placebo Washout Period 2|Adverse Event|0
1786305|NCT00620659|6218016|P3|Placebo Washout Period 2|Adverse Event|0
1786306|NCT00620659|6218017|P2|Placebo Washout Period 2|Adverse Event|0
1786307|NCT00620659|6218018|P1|Placebo Washout Period 2|Adverse Event|2
1786308|NCT00620659|6218013|P6|Treatment Period 2|Withdrawal by Subject|0
1786309|NCT00620659|6218014|P5|Treatment Period 2|Withdrawal by Subject|3
1786310|NCT00620659|6218015|P4|Treatment Period 2|Withdrawal by Subject|0
1786311|NCT00620659|6218016|P3|Treatment Period 2|Withdrawal by Subject|1
1786312|NCT00620659|6218017|P2|Treatment Period 2|Withdrawal by Subject|0
1786313|NCT00620659|6218018|P1|Treatment Period 2|Withdrawal by Subject|0
1786314|NCT00620659|6218013|P6|Treatment Period 2|Adverse Event|0
1786315|NCT00620659|6218014|P5|Treatment Period 2|Adverse Event|2
1786316|NCT00620659|6218015|P4|Treatment Period 2|Adverse Event|0
1786317|NCT00620659|6218016|P3|Treatment Period 2|Adverse Event|0
1786318|NCT00620659|6218017|P2|Treatment Period 2|Adverse Event|3
1786319|NCT00620659|6218018|P1|Treatment Period 2|Adverse Event|0
1786320|NCT00620659|6218013|P6|Placebo Washout Period 1|Withdrawal by Subject|0
1786321|NCT00620659|6218014|P5|Placebo Washout Period 1|Withdrawal by Subject|0
1786322|NCT00620659|6218015|P4|Placebo Washout Period 1|Withdrawal by Subject|1
1786323|NCT00620659|6218016|P3|Placebo Washout Period 1|Withdrawal by Subject|0
1786324|NCT00620659|6218017|P2|Placebo Washout Period 1|Withdrawal by Subject|0
1786325|NCT00620659|6218018|P1|Placebo Washout Period 1|Withdrawal by Subject|0
1786326|NCT00620659|6218013|P6|Treatment Period 1|Withdrawal by Subject|0
1786327|NCT00620659|6218014|P5|Treatment Period 1|Withdrawal by Subject|1
1786328|NCT00620659|6218015|P4|Treatment Period 1|Withdrawal by Subject|0
1786329|NCT00620659|6218016|P3|Treatment Period 1|Withdrawal by Subject|1
1786330|NCT00620659|6218017|P2|Treatment Period 1|Withdrawal by Subject|0
1786331|NCT00620659|6218018|P1|Treatment Period 1|Withdrawal by Subject|1
1786332|NCT00620659|6218013|P6|Treatment Period 1|Protocol Violation|0
1786333|NCT00620659|6218014|P5|Treatment Period 1|Protocol Violation|0
1786334|NCT00620659|6218015|P4|Treatment Period 1|Protocol Violation|0
1786335|NCT00620659|6218016|P3|Treatment Period 1|Protocol Violation|0
1786336|NCT00620659|6218017|P2|Treatment Period 1|Protocol Violation|0
1786337|NCT00620659|6218018|P1|Treatment Period 1|Protocol Violation|1
1786338|NCT00620659|6218013|P6|Treatment Period 1|Adverse Event|0
1786339|NCT00620659|6218014|P5|Treatment Period 1|Adverse Event|0
1786340|NCT00620659|6218015|P4|Treatment Period 1|Adverse Event|3
1786341|NCT00620659|6218016|P3|Treatment Period 1|Adverse Event|0
1786342|NCT00620659|6218017|P2|Treatment Period 1|Adverse Event|0
1786343|NCT00620659|6218018|P1|Treatment Period 1|Adverse Event|1
1786344|NCT00620555|6218036|P1|Overall Study|Visit failure against planned|1
1786345|NCT00620555|6218036|P1|Overall Study|Choice of other treatment|1
1786346|NCT00620555|6218036|P1|Overall Study|Withdrawal by Subject|1
1786347|NCT00620555|6218036|P1|Overall Study|Lack of Efficacy|12
1786348|NCT00620555|6218036|P1|Overall Study|Protocol Violation|2
1786349|NCT00620555|6218036|P1|Overall Study|Adverse Event|4
1786350|NCT00620542|6218045|P4|Part B (2 Year Core Study)|IVUS not available|2
1786351|NCT00620542|6218046|P3|Part B (2 Year Core Study)|IVUS not available|3
1786352|NCT00620542|6218047|P2|Part B (2 Year Core Study)|IVUS not available|0
1786353|NCT00620542|6218048|P1|Part B (2 Year Core Study)|IVUS not available|0
1786354|NCT00620542|6218045|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
1786355|NCT00620542|6218046|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
1786356|NCT00620542|6218047|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
1786357|NCT00620542|6218048|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
1786358|NCT00620542|6218045|P4|Part B (2 Year Core Study)|Safety reasons|3
1786359|NCT00620542|6218046|P3|Part B (2 Year Core Study)|Safety reasons|2
1786360|NCT00620542|6218047|P2|Part B (2 Year Core Study)|Safety reasons|0
1786361|NCT00620542|6218048|P1|Part B (2 Year Core Study)|Safety reasons|0
1786362|NCT00620542|6218045|P4|Part B (2 Year Core Study)|Protocol Violation|16
1786363|NCT00620542|6218046|P3|Part B (2 Year Core Study)|Protocol Violation|13
1786364|NCT00620542|6218047|P2|Part B (2 Year Core Study)|Protocol Violation|0
1786365|NCT00620542|6218048|P1|Part B (2 Year Core Study)|Protocol Violation|0
1786366|NCT00620542|6218045|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
1786367|NCT00620542|6218046|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
1786368|NCT00620542|6218047|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
1786369|NCT00620542|6218048|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
1786370|NCT00620542|6218045|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
1786371|NCT00620542|6218046|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
1786372|NCT00620542|6218047|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
1786373|NCT00620542|6218048|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
1786374|NCT00620542|6218045|P4|Part B (2 Year Core Study)|Protocol Violation|5
1786375|NCT00620542|6218046|P3|Part B (2 Year Core Study)|Protocol Violation|3
1786376|NCT00620542|6218047|P2|Part B (2 Year Core Study)|Protocol Violation|0
1786377|NCT00620542|6218048|P1|Part B (2 Year Core Study)|Protocol Violation|0
1786378|NCT00620542|6218045|P4|Part B (2 Year Core Study)|Adverse Event|49
1786379|NCT00620542|6218046|P3|Part B (2 Year Core Study)|Adverse Event|46
1786380|NCT00620542|6218047|P2|Part B (2 Year Core Study)|Adverse Event|0
1786381|NCT00620542|6218048|P1|Part B (2 Year Core Study)|Adverse Event|0
1786382|NCT00620542|6218045|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
1786383|NCT00620542|6218046|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
1786384|NCT00620542|6218047|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
1786385|NCT00620542|6218048|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
1786386|NCT00620542|6218045|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
1786387|NCT00620542|6218046|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
1786388|NCT00620542|6218047|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
1786389|NCT00620542|6218048|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
1786390|NCT00620542|6218045|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1786391|NCT00620542|6218046|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1786392|NCT00620542|6218047|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
1786393|NCT00620542|6218048|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1786394|NCT00620542|6218045|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
1786395|NCT00620542|6218046|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
1786396|NCT00620542|6218047|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
1786397|NCT00620542|6218048|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
1786398|NCT00620542|6218045|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
1786399|NCT00620542|6218046|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
1786400|NCT00620542|6218047|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
1786401|NCT00620542|6218048|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
1786402|NCT00620542|6218045|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1786403|NCT00620542|6218046|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
1786404|NCT00620542|6218047|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
1786405|NCT00620542|6218048|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
1786406|NCT00620542|6218045|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
1786407|NCT00620542|6218046|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
1786408|NCT00620542|6218047|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
1786409|NCT00620542|6218048|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
1786410|NCT00620464|6218113|P2|Overall Study|Used prohibited medication|0
1786411|NCT00620464|6218114|P1|Overall Study|Used prohibited medication|1
1786412|NCT00620464|6218113|P2|Overall Study|Personal|2
1786413|NCT00620464|6218114|P1|Overall Study|Personal|2
1786414|NCT00620464|6218113|P2|Overall Study|Planning Pregnancy|4
1786415|NCT00620464|6218114|P1|Overall Study|Planning Pregnancy|1
1786416|NCT00620464|6218113|P2|Overall Study|Lost to Follow-up|1
1786417|NCT00620464|6218114|P1|Overall Study|Lost to Follow-up|1
1786418|NCT00620464|6218113|P2|Overall Study|Adverse Event|17
1786419|NCT00620464|6218114|P1|Overall Study|Adverse Event|15
1786420|NCT00620373|6218133|P1|Overall Study|Unverified cancer status|33
1786421|NCT00620321|6218151|P2|Overall Study|Withdrawal by Subject|1
1786422|NCT00620321|6218152|P1|Overall Study|Withdrawal by Subject|1
1786423|NCT00620321|6218151|P2|Overall Study|Sponsor Decision|1
1786424|NCT00620321|6218152|P1|Overall Study|Sponsor Decision|0
1786425|NCT00620321|6218151|P2|Overall Study|Progressive Disease|5
1786426|NCT00620321|6218152|P1|Overall Study|Progressive Disease|5
1786427|NCT00620321|6218151|P2|Overall Study|Physician Decision|7
1786428|NCT00620321|6218152|P1|Overall Study|Physician Decision|0
1786429|NCT00620321|6218151|P2|Overall Study|Death|1
1786430|NCT00620321|6218152|P1|Overall Study|Death|1
1786431|NCT00620321|6218151|P2|Overall Study|Adverse Event|1
1786432|NCT00620321|6218152|P1|Overall Study|Adverse Event|1
1786433|NCT00620282|6218171|P3|Overall Study|Withdrawal by Subject|0
1786434|NCT00620282|6218172|P2|Overall Study|Withdrawal by Subject|1
1786435|NCT00620282|6218173|P1|Overall Study|Withdrawal by Subject|0
1786436|NCT00620282|6218171|P3|Overall Study|Arterial line unable to be placed|1
1786437|NCT00620282|6218172|P2|Overall Study|Arterial line unable to be placed|0
1786438|NCT00620282|6218173|P1|Overall Study|Arterial line unable to be placed|0
1786439|NCT00620282|6218171|P3|Overall Study|Adverse Event|0
1786440|NCT00620282|6218172|P2|Overall Study|Adverse Event|1
1786441|NCT00620282|6218173|P1|Overall Study|Adverse Event|0
1786442|NCT00620113|6218237|P4|Overall Study|Withdrawal by Subject|5
1786443|NCT00620113|6218238|P3|Overall Study|Withdrawal by Subject|3
1786444|NCT00620113|6218239|P2|Overall Study|Withdrawal by Subject|1
1786445|NCT00620113|6218240|P1|Overall Study|Withdrawal by Subject|5
1786446|NCT00620113|6218237|P4|Overall Study|Protocol Violation|0
1786447|NCT00620113|6218238|P3|Overall Study|Protocol Violation|0
1786448|NCT00620113|6218239|P2|Overall Study|Protocol Violation|1
1786449|NCT00620113|6218240|P1|Overall Study|Protocol Violation|2
1786450|NCT00620113|6218237|P4|Overall Study|Physician Decision|2
1786451|NCT00620113|6218238|P3|Overall Study|Physician Decision|0
1786452|NCT00620113|6218239|P2|Overall Study|Physician Decision|0
1786453|NCT00620113|6218240|P1|Overall Study|Physician Decision|1
1786454|NCT00620113|6218237|P4|Overall Study|Lack of Efficacy|2
1786455|NCT00620113|6218238|P3|Overall Study|Lack of Efficacy|0
1786456|NCT00620113|6218239|P2|Overall Study|Lack of Efficacy|3
1786457|NCT00620113|6218240|P1|Overall Study|Lack of Efficacy|2
1786458|NCT00620113|6218237|P4|Overall Study|Adverse Event|1
1786459|NCT00620113|6218238|P3|Overall Study|Adverse Event|2
1786460|NCT00620113|6218239|P2|Overall Study|Adverse Event|2
1786461|NCT00620113|6218240|P1|Overall Study|Adverse Event|3
1786462|NCT00620074|6218290|P1|Overall Study|Adverse Event|1
1786463|NCT00620035|6218313|P1|Overall Study|Other Reason|38
1786464|NCT00620035|6218313|P1|Overall Study|Withdrawal of Informed Consent|1
1786465|NCT00620035|6218313|P1|Overall Study|Adverse Event|106
1786466|NCT00620022|6218323|P2|Treatment Period 2|Adverse Event|2
1786467|NCT00620022|6218324|P1|Treatment Period 2|Adverse Event|2
1786468|NCT00620022|6218323|P2|Treatment Period 1|Subject withdrew consent|0
1786469|NCT00620022|6218324|P1|Treatment Period 1|Subject withdrew consent|1
1786470|NCT00620022|6218323|P2|Treatment Period 1|Adverse Event|6
1786471|NCT00620022|6218324|P1|Treatment Period 1|Adverse Event|4
1786472|NCT00619983|6218336|P4|Test Drug Alone|Failure of daily diary device|2
1786473|NCT00619983|6218337|P3|Test Drug Alone|Failure of daily diary device|2
1786474|NCT00619983|6218338|P2|Test Drug Alone|Failure of daily diary device|1
1786475|NCT00619983|6218339|P1|Test Drug Alone|Failure of daily diary device|1
1786476|NCT00619983|6218336|P4|Test Drug Alone|Withdrawal by Subject|1
1786477|NCT00619983|6218337|P3|Test Drug Alone|Withdrawal by Subject|0
1786478|NCT00619983|6218338|P2|Test Drug Alone|Withdrawal by Subject|0
1786479|NCT00619983|6218339|P1|Test Drug Alone|Withdrawal by Subject|1
1786480|NCT00619957|6218366|P2|Month 48 Open-Label|Withdrawal by Subject|9
1786481|NCT00619957|6218367|P1|Month 48 Open-Label|Withdrawal by Subject|6
1786482|NCT00619957|6218366|P2|Month 48 Open-Label|Lost to Follow-up|4
1786483|NCT00619957|6218367|P1|Month 48 Open-Label|Lost to Follow-up|2
1786484|NCT00619957|6218366|P2|Month 48 Open-Label|Adverse Event|4
1786485|NCT00619957|6218367|P1|Month 48 Open-Label|Adverse Event|4
1786486|NCT00619957|6218366|P2|Month 24 Double-Blind|Did not take any study medication|1
1786487|NCT00619957|6218367|P1|Month 24 Double-Blind|Did not take any study medication|0
1786488|NCT00619957|6218366|P2|Month 24 Double-Blind|Lost to Follow-up|0
1786489|NCT00619957|6218367|P1|Month 24 Double-Blind|Lost to Follow-up|1
1786490|NCT00619957|6218366|P2|Month 24 Double-Blind|Withdrawal by Subject|9
1786491|NCT00619957|6218367|P1|Month 24 Double-Blind|Withdrawal by Subject|7
1786492|NCT00619957|6218366|P2|Month 24 Double-Blind|Protocol Violation|0
1786493|NCT00619957|6218367|P1|Month 24 Double-Blind|Protocol Violation|1
1786494|NCT00619957|6218366|P2|Month 24 Double-Blind|Adverse Event|7
1786495|NCT00619957|6218367|P1|Month 24 Double-Blind|Adverse Event|9
1786496|NCT00619918|6218449|P2|Overall Study|Left before receiving first dose|8
1786497|NCT00619918|6218450|P1|Overall Study|Left before receiving first dose|5
1786498|NCT00619918|6218449|P2|Overall Study|Transfer to outside facility|3
1786499|NCT00619918|6218450|P1|Overall Study|Transfer to outside facility|3
1786500|NCT00619918|6218449|P2|Overall Study|Physician Decision|8
1786501|NCT00619918|6218450|P1|Overall Study|Physician Decision|8
1786502|NCT00619918|6218449|P2|Overall Study|Withdrawal by Subject|3
1786503|NCT00619918|6218450|P1|Overall Study|Withdrawal by Subject|4
1786504|NCT00619892|6218460|P2|Overall Study|Intercurrent illness|1
1786505|NCT00619892|6218461|P1|Overall Study|Intercurrent illness|0
1786506|NCT00619892|6218460|P2|Overall Study|Lost to Follow-up|1
1786507|NCT00619892|6218461|P1|Overall Study|Lost to Follow-up|0
1786508|NCT00619892|6218460|P2|Overall Study|Adverse Event|0
1786509|NCT00619892|6218461|P1|Overall Study|Adverse Event|3
1786510|NCT00619866|6218472|P5|Weeks 13 - 24|Lost to Follow-up|0
1786511|NCT00619866|6218473|P4|Weeks 13 - 24|Lost to Follow-up|0
1786512|NCT00619866|6218474|P3|Weeks 13 - 24|Lost to Follow-up|0
1786513|NCT00619866|6218475|P2|Weeks 13 - 24|Lost to Follow-up|3
1786514|NCT00619866|6218476|P1|Weeks 13 - 24|Lost to Follow-up|0
1786515|NCT00619866|6218472|P5|Weeks 13 - 24|Non-compliance|0
1786516|NCT00619866|6218473|P4|Weeks 13 - 24|Non-compliance|0
1786517|NCT00619866|6218474|P3|Weeks 13 - 24|Non-compliance|1
1786518|NCT00619866|6218475|P2|Weeks 13 - 24|Non-compliance|1
1786519|NCT00619866|6218476|P1|Weeks 13 - 24|Non-compliance|0
1786520|NCT00619866|6218472|P5|Weeks 13 - 24|Withdrawal by Subject|2
1786521|NCT00619866|6218473|P4|Weeks 13 - 24|Withdrawal by Subject|2
1786522|NCT00619866|6218474|P3|Weeks 13 - 24|Withdrawal by Subject|2
1786523|NCT00619866|6218475|P2|Weeks 13 - 24|Withdrawal by Subject|3
1786524|NCT00619866|6218476|P1|Weeks 13 - 24|Withdrawal by Subject|0
1786525|NCT00619866|6218472|P5|Weeks 13 - 24|Protocol Deviation|0
1786526|NCT00619866|6218473|P4|Weeks 13 - 24|Protocol Deviation|1
1786527|NCT00619866|6218474|P3|Weeks 13 - 24|Protocol Deviation|0
1786528|NCT00619866|6218475|P2|Weeks 13 - 24|Protocol Deviation|0
1786529|NCT00619866|6218476|P1|Weeks 13 - 24|Protocol Deviation|0
1786530|NCT00619866|6218472|P5|Weeks 13 - 24|Adverse Event|0
1786531|NCT00619866|6218473|P4|Weeks 13 - 24|Adverse Event|1
1786532|NCT00619866|6218474|P3|Weeks 13 - 24|Adverse Event|2
1786533|NCT00619866|6218475|P2|Weeks 13 - 24|Adverse Event|0
1786534|NCT00619866|6218476|P1|Weeks 13 - 24|Adverse Event|0
1786535|NCT00619866|6218472|P5|Weeks 1 - 12|Sponsor Decision|0
1786536|NCT00619866|6218473|P4|Weeks 1 - 12|Sponsor Decision|0
1786537|NCT00619866|6218474|P3|Weeks 1 - 12|Sponsor Decision|0
1786538|NCT00619866|6218475|P2|Weeks 1 - 12|Sponsor Decision|1
1786539|NCT00619866|6218476|P1|Weeks 1 - 12|Sponsor Decision|0
1786540|NCT00619866|6218472|P5|Weeks 1 - 12|Lost to Follow-up|0
1786541|NCT00619866|6218473|P4|Weeks 1 - 12|Lost to Follow-up|0
1786542|NCT00619866|6218474|P3|Weeks 1 - 12|Lost to Follow-up|2
1786543|NCT00619866|6218475|P2|Weeks 1 - 12|Lost to Follow-up|0
1786544|NCT00619866|6218476|P1|Weeks 1 - 12|Lost to Follow-up|4
1786545|NCT00619866|6218472|P5|Weeks 1 - 12|Lack of Efficacy|0
1786546|NCT00619866|6218473|P4|Weeks 1 - 12|Lack of Efficacy|0
1786547|NCT00619866|6218474|P3|Weeks 1 - 12|Lack of Efficacy|1
1786548|NCT00619866|6218475|P2|Weeks 1 - 12|Lack of Efficacy|2
1786549|NCT00619866|6218476|P1|Weeks 1 - 12|Lack of Efficacy|3
1786550|NCT00619866|6218472|P5|Weeks 1 - 12|Withdrawal by Subject|0
1786551|NCT00619866|6218473|P4|Weeks 1 - 12|Withdrawal by Subject|0
1786552|NCT00619866|6218474|P3|Weeks 1 - 12|Withdrawal by Subject|4
1786553|NCT00619866|6218475|P2|Weeks 1 - 12|Withdrawal by Subject|2
1786554|NCT00619866|6218476|P1|Weeks 1 - 12|Withdrawal by Subject|7
1786555|NCT00619866|6218472|P5|Weeks 1 - 12|Non-compliance|0
1786556|NCT00619866|6218473|P4|Weeks 1 - 12|Non-compliance|0
1786557|NCT00619866|6218474|P3|Weeks 1 - 12|Non-compliance|1
1786558|NCT00619866|6218475|P2|Weeks 1 - 12|Non-compliance|0
1786559|NCT00619866|6218476|P1|Weeks 1 - 12|Non-compliance|0
1786560|NCT00619866|6218472|P5|Weeks 1 - 12|Adverse Event|0
1786561|NCT00619866|6218473|P4|Weeks 1 - 12|Adverse Event|0
1786562|NCT00619866|6218474|P3|Weeks 1 - 12|Adverse Event|2
1786563|NCT00619866|6218475|P2|Weeks 1 - 12|Adverse Event|1
1786564|NCT00619866|6218476|P1|Weeks 1 - 12|Adverse Event|0
1786565|NCT00619827|6218563|P2|Overall Study|Withdrawal by Subject|2
1786566|NCT00619827|6218564|P1|Overall Study|Withdrawal by Subject|2
1786567|NCT00619827|6218563|P2|Overall Study|Adverse Event|2
1786568|NCT00619827|6218564|P1|Overall Study|Adverse Event|1
1786569|NCT00619801|6218572|P2|Overall Study|Loss of efficacy|1
1786570|NCT00619801|6218573|P1|Overall Study|Loss of efficacy|0
1786571|NCT00619801|6218572|P2|Overall Study|Withdrawal by Subject|1
1786572|NCT00619801|6218573|P1|Overall Study|Withdrawal by Subject|1
1786573|NCT00619801|6218572|P2|Overall Study|Lack of Efficacy|1
1786574|NCT00619801|6218573|P1|Overall Study|Lack of Efficacy|0
1786575|NCT00619645|6218630|P1|Overall Study|Adverse Event|1
1786576|NCT00619619|6218644|P8|Overall Study|Adverse Event|2
1786577|NCT00619619|6218645|P7|Overall Study|Adverse Event|0
1786578|NCT00619619|6218646|P6|Overall Study|Adverse Event|0
1786579|NCT00619619|6218647|P5|Overall Study|Adverse Event|2
1786580|NCT00619619|6218648|P4|Overall Study|Adverse Event|0
1786581|NCT00619619|6218649|P3|Overall Study|Adverse Event|0
1786582|NCT00619619|6218650|P2|Overall Study|Adverse Event|0
1786583|NCT00619619|6218651|P1|Overall Study|Adverse Event|0
1786584|NCT00619619|6218644|P8|Overall Study|Protocol Violation|1
1786585|NCT00619619|6218645|P7|Overall Study|Protocol Violation|1
1786586|NCT00619619|6218646|P6|Overall Study|Protocol Violation|0
1786587|NCT00619619|6218647|P5|Overall Study|Protocol Violation|0
1786588|NCT00619619|6218648|P4|Overall Study|Protocol Violation|1
1786589|NCT00619619|6218649|P3|Overall Study|Protocol Violation|0
1786590|NCT00619619|6218650|P2|Overall Study|Protocol Violation|0
1786591|NCT00619619|6218651|P1|Overall Study|Protocol Violation|0
1786592|NCT00619619|6218644|P8|Overall Study|Physician Decision|0
1786593|NCT00619619|6218645|P7|Overall Study|Physician Decision|0
1786594|NCT00619619|6218646|P6|Overall Study|Physician Decision|0
1786595|NCT00619619|6218647|P5|Overall Study|Physician Decision|0
1786596|NCT00619619|6218648|P4|Overall Study|Physician Decision|0
1786597|NCT00619619|6218649|P3|Overall Study|Physician Decision|1
1786598|NCT00619619|6218650|P2|Overall Study|Physician Decision|0
1786599|NCT00619619|6218651|P1|Overall Study|Physician Decision|0
1786600|NCT00619515|6218736|P1|Overall Study|Study Termination by IRB|73
1786601|NCT00619502|6218750|P2|Overall Study|Lost to Follow-up|10
1786602|NCT00619502|6218751|P1|Overall Study|Lost to Follow-up|8
1786603|NCT00619489|6218763|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
1786604|NCT00619489|6218764|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
1786605|NCT00619489|6218763|P2|Overall Study|Lack of Efficacy|11
1786606|NCT00619489|6218764|P1|Overall Study|Lack of Efficacy|0
1786607|NCT00619489|6218763|P2|Overall Study|Withdrawal by Subject|1
1786608|NCT00619489|6218764|P1|Overall Study|Withdrawal by Subject|1
1786609|NCT00619489|6218763|P2|Overall Study|Adverse Event|7
1786610|NCT00619489|6218764|P1|Overall Study|Adverse Event|0
1786611|NCT00619476|6218786|P4|Overall Study|Withdrawal by Subject|4
1786612|NCT00619476|6218787|P3|Overall Study|Withdrawal by Subject|5
1786613|NCT00619476|6218788|P2|Overall Study|Withdrawal by Subject|7
1786614|NCT00619476|6218789|P1|Overall Study|Withdrawal by Subject|5
1786615|NCT00619476|6218786|P4|Overall Study|Investigator Discretion|0
1786616|NCT00619476|6218787|P3|Overall Study|Investigator Discretion|2
1786617|NCT00619476|6218788|P2|Overall Study|Investigator Discretion|2
1786618|NCT00619476|6218789|P1|Overall Study|Investigator Discretion|2
1786619|NCT00619476|6218786|P4|Overall Study|Lost to Follow-up|1
1786620|NCT00619476|6218787|P3|Overall Study|Lost to Follow-up|0
1786621|NCT00619476|6218788|P2|Overall Study|Lost to Follow-up|2
1786622|NCT00619476|6218789|P1|Overall Study|Lost to Follow-up|1
1786623|NCT00619476|6218786|P4|Overall Study|Protocol Violation|9
1786624|NCT00619476|6218787|P3|Overall Study|Protocol Violation|4
1786625|NCT00619476|6218788|P2|Overall Study|Protocol Violation|4
1786626|NCT00619476|6218789|P1|Overall Study|Protocol Violation|5
1786627|NCT00619476|6218786|P4|Overall Study|Lack of Efficacy|4
1786628|NCT00619476|6218787|P3|Overall Study|Lack of Efficacy|1
1786629|NCT00619476|6218788|P2|Overall Study|Lack of Efficacy|1
1786630|NCT00619476|6218789|P1|Overall Study|Lack of Efficacy|6
1786631|NCT00619476|6218786|P4|Overall Study|Adverse Event|16
1786632|NCT00619476|6218787|P3|Overall Study|Adverse Event|12
1786633|NCT00619476|6218788|P2|Overall Study|Adverse Event|6
1786634|NCT00619476|6218789|P1|Overall Study|Adverse Event|12
1786635|NCT00619385|6218874|P3|Overall Study|Other|1
1786636|NCT00619385|6218875|P2|Overall Study|Other|2
1786637|NCT00619385|6218876|P1|Overall Study|Other|1
1786638|NCT00619385|6218874|P3|Overall Study|Adverse Event|3
1786639|NCT00619385|6218875|P2|Overall Study|Adverse Event|0
1786640|NCT00619385|6218876|P1|Overall Study|Adverse Event|0
1786641|NCT00619359|6218891|P2|Overall Study|Progressive Disease|1
1786642|NCT00619359|6218892|P1|Overall Study|Progressive Disease|3
1786643|NCT00619359|6218891|P2|Overall Study|Withdrawal by Subject|20
1786644|NCT00619359|6218892|P1|Overall Study|Withdrawal by Subject|19
1786645|NCT00619359|6218891|P2|Overall Study|Protocol Violation|1
1786646|NCT00619359|6218892|P1|Overall Study|Protocol Violation|1
1786647|NCT00619359|6218891|P2|Overall Study|Physician Decision|7
1786648|NCT00619359|6218892|P1|Overall Study|Physician Decision|0
1786649|NCT00619359|6218891|P2|Overall Study|Lost to Follow-up|16
1786650|NCT00619359|6218892|P1|Overall Study|Lost to Follow-up|12
1786651|NCT00619359|6218891|P2|Overall Study|Adverse Event|36
1786652|NCT00619359|6218892|P1|Overall Study|Adverse Event|32
1786653|NCT00619307|6218904|P2|Overall Study|MS attack plus steroids|1
1786654|NCT00619307|6218905|P1|Overall Study|MS attack plus steroids|0
1786655|NCT00619307|6218904|P2|Overall Study|Severe migraine|1
1786656|NCT00619307|6218905|P1|Overall Study|Severe migraine|0
1786657|NCT00619307|6218904|P2|Overall Study|Withdrew consent|0
1786658|NCT00619307|6218905|P1|Overall Study|Withdrew consent|1
1786659|NCT00619307|6218904|P2|Overall Study|Protocol Violation|0
1786660|NCT00619307|6218905|P1|Overall Study|Protocol Violation|3
1786661|NCT00619307|6218904|P2|Overall Study|Lost to Follow-up|1
1786662|NCT00619307|6218905|P1|Overall Study|Lost to Follow-up|0
1786663|NCT00619307|6218904|P2|Overall Study|Adverse Event|1
1786664|NCT00619307|6218905|P1|Overall Study|Adverse Event|0
1786665|NCT00619229|6218942|P2|Overall Study|Investigator planned Cataract Operation|0
1786666|NCT00619229|6218943|P1|Overall Study|Investigator planned Cataract Operation|1
1786667|NCT00619229|6218942|P2|Overall Study|Termination of the Study by the Sponsor|1
1786668|NCT00619229|6218943|P1|Overall Study|Termination of the Study by the Sponsor|1
1786669|NCT00619229|6218942|P2|Overall Study|Lost to Follow-up|0
1786670|NCT00619229|6218943|P1|Overall Study|Lost to Follow-up|1
1786671|NCT00619229|6218942|P2|Overall Study|Withdrawal by Subject|1
1786672|NCT00619229|6218943|P1|Overall Study|Withdrawal by Subject|1
1786673|NCT00619177|6218982|P1|Overall Study|Not specified reasons|6
1786674|NCT00619177|6218982|P1|Overall Study|Missing termination information|481
1786675|NCT00619177|6218982|P1|Overall Study|Lack of Efficacy|1
1786676|NCT00619177|6218982|P1|Overall Study|Lost to Follow-up|2
1786677|NCT00619177|6218982|P1|Overall Study|Adverse Event|18
1786678|NCT00619151|6218992|P2|Overall Study|Study terminated prior to followup|0
1786679|NCT00619151|6218993|P1|Overall Study|Study terminated prior to followup|1
1786680|NCT00619112|6219003|P2|Overall Study|Adverse Event|2
1786681|NCT00619112|6219004|P1|Overall Study|Adverse Event|1
1786682|NCT00619099|6219025|P2|Overall Study|Physician Decision|6
1786683|NCT00619099|6219026|P1|Overall Study|Physician Decision|9
1786684|NCT00619099|6219025|P2|Overall Study|Withdrawal by Subject|2
1786685|NCT00619099|6219026|P1|Overall Study|Withdrawal by Subject|10
1786686|NCT00619099|6219025|P2|Overall Study|Emergence of Clinically Significant Lab|2
1786687|NCT00619099|6219026|P1|Overall Study|Emergence of Clinically Significant Lab|1
1786688|NCT00619099|6219025|P2|Overall Study|Adverse Event|3
1786689|NCT00619099|6219026|P1|Overall Study|Adverse Event|4
1786690|NCT00619099|6219025|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
1786691|NCT00619099|6219026|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
1786692|NCT00619099|6219025|P2|Overall Study|Progressive Disease|5
1786693|NCT00619099|6219026|P1|Overall Study|Progressive Disease|7
1786694|NCT00618995|6219048|P4|Period 4|Adverse Event|0
1786695|NCT00618995|6219049|P3|Period 4|Adverse Event|0
1786696|NCT00618995|6219050|P2|Period 4|Adverse Event|0
1786697|NCT00618995|6219051|P1|Period 4|Adverse Event|1
1786698|NCT00618995|6219048|P4|Period 2|Protocol Violation|0
1786699|NCT00618995|6219049|P3|Period 2|Protocol Violation|1
1786700|NCT00618995|6219050|P2|Period 2|Protocol Violation|0
1786701|NCT00618995|6219051|P1|Period 2|Protocol Violation|0
1786702|NCT00618995|6219048|P4|Period 1|Protocol Violation|0
1786703|NCT00618995|6219049|P3|Period 1|Protocol Violation|1
1786704|NCT00618995|6219050|P2|Period 1|Protocol Violation|1
1786705|NCT00618995|6219051|P1|Period 1|Protocol Violation|0
1786706|NCT00618995|6219048|P4|Period 1|Adverse Event|0
1786707|NCT00618995|6219049|P3|Period 1|Adverse Event|1
1786708|NCT00618995|6219050|P2|Period 1|Adverse Event|0
1786709|NCT00618995|6219051|P1|Period 1|Adverse Event|0
1786710|NCT00618982|6219065|P1|Overall Study|ongoing, still treated with study med.|25
1786711|NCT00618982|6219065|P1|Overall Study|Protocol Violation|1
1786712|NCT00618982|6219065|P1|Overall Study|Withdrawal by Subject|1
1786713|NCT00618982|6219065|P1|Overall Study|Adverse Event|23
1786714|NCT00618956|6219088|P2|Overall Study|did not meet criteria, non-compliance|1
1786715|NCT00618956|6219089|P1|Overall Study|did not meet criteria, non-compliance|2
1786716|NCT00618956|6219088|P2|Overall Study|Protocol Violation|2
1786717|NCT00618956|6219089|P1|Overall Study|Protocol Violation|2
1786718|NCT00618956|6219088|P2|Overall Study|Lost to Follow-up|5
1786719|NCT00618956|6219089|P1|Overall Study|Lost to Follow-up|4
1786720|NCT00618956|6219088|P2|Overall Study|Withdrawal by Subject|7
1786721|NCT00618956|6219089|P1|Overall Study|Withdrawal by Subject|5
1786722|NCT00618956|6219088|P2|Overall Study|Lack of Efficacy|1
1786723|NCT00618956|6219089|P1|Overall Study|Lack of Efficacy|2
1786724|NCT00618956|6219088|P2|Overall Study|Adverse Event|34
1786725|NCT00618956|6219089|P1|Overall Study|Adverse Event|10
1786726|NCT00618826|6219114|P1|Overall Study|Adverse Event|1
1786727|NCT00618813|6219119|P1|Overall Study|Withdrawal by Subject|1
1786728|NCT00618813|6219119|P1|Overall Study|Physician Decision|2
1786729|NCT00618813|6219119|P1|Overall Study|Lack of Efficacy|1
1786730|NCT00618787|6219129|P2|Overall Study|Lost to Follow-up|0
1786731|NCT00618787|6219130|P1|Overall Study|Lost to Follow-up|1
1786732|NCT00618787|6219129|P2|Overall Study|Withdrawal by Subject|1
1786733|NCT00618787|6219130|P1|Overall Study|Withdrawal by Subject|2
1786734|NCT00618787|6219129|P2|Overall Study|Adverse Event|1
1786735|NCT00618787|6219130|P1|Overall Study|Adverse Event|0
1786736|NCT00618774|6219138|P2|Overall Study|Withdrawal by Subject|0
1786737|NCT00618774|6219139|P1|Overall Study|Withdrawal by Subject|1
1786738|NCT00618774|6219138|P2|Overall Study|Adverse Event|3
1786739|NCT00618774|6219139|P1|Overall Study|Adverse Event|5
1786740|NCT00618748|6219172|P3|Overall Study|Withdrawal by Subject|5
1786741|NCT00618748|6219173|P2|Overall Study|Withdrawal by Subject|1
1786742|NCT00618748|6219174|P1|Overall Study|Withdrawal by Subject|4
1786743|NCT00618748|6219172|P3|Overall Study|Physician Decision|1
1786744|NCT00618748|6219173|P2|Overall Study|Physician Decision|1
1786745|NCT00618748|6219174|P1|Overall Study|Physician Decision|3
1786746|NCT00618748|6219172|P3|Overall Study|Adverse Event|8
1786747|NCT00618748|6219173|P2|Overall Study|Adverse Event|3
1786748|NCT00618748|6219174|P1|Overall Study|Adverse Event|4
1786749|NCT00618722|6219219|P4|Overall Study|Miscellaneous Reasons|1
1786750|NCT00618722|6219220|P3|Overall Study|Miscellaneous Reasons|1
1786751|NCT00618722|6219221|P2|Overall Study|Miscellaneous Reasons|0
1786752|NCT00618722|6219222|P1|Overall Study|Miscellaneous Reasons|0
1786753|NCT00618722|6219219|P4|Overall Study|Lost to Follow-up|2
1786754|NCT00618722|6219220|P3|Overall Study|Lost to Follow-up|0
1786755|NCT00618722|6219221|P2|Overall Study|Lost to Follow-up|0
1786756|NCT00618722|6219222|P1|Overall Study|Lost to Follow-up|2
1786757|NCT00618722|6219219|P4|Overall Study|Inability to Complete Study Procedure|0
1786758|NCT00618722|6219220|P3|Overall Study|Inability to Complete Study Procedure|0
1786759|NCT00618722|6219221|P2|Overall Study|Inability to Complete Study Procedure|1
1786760|NCT00618722|6219222|P1|Overall Study|Inability to Complete Study Procedure|0
1786761|NCT00618722|6219219|P4|Overall Study|Patient Request|1
1786762|NCT00618722|6219220|P3|Overall Study|Patient Request|1
1786763|NCT00618722|6219221|P2|Overall Study|Patient Request|1
1786764|NCT00618722|6219222|P1|Overall Study|Patient Request|1
1786765|NCT00618722|6219219|P4|Overall Study|Refusal of Treatment|0
1786766|NCT00618722|6219220|P3|Overall Study|Refusal of Treatment|1
1786767|NCT00618722|6219221|P2|Overall Study|Refusal of Treatment|0
1786768|NCT00618722|6219222|P1|Overall Study|Refusal of Treatment|0
1786769|NCT00618618|6219260|P4|Overall Study|Death|0
1786770|NCT00618618|6219261|P3|Overall Study|Death|0
1786771|NCT00618618|6219262|P2|Overall Study|Death|1
1786772|NCT00618618|6219263|P1|Overall Study|Death|0
1786773|NCT00618618|6219260|P4|Overall Study|Did Not Meet Entry Criteria|0
1786774|NCT00618618|6219261|P3|Overall Study|Did Not Meet Entry Criteria|1
1786775|NCT00618618|6219262|P2|Overall Study|Did Not Meet Entry Criteria|0
1786776|NCT00618618|6219263|P1|Overall Study|Did Not Meet Entry Criteria|0
1786777|NCT00618618|6219260|P4|Overall Study|Non-compliance|0
1786778|NCT00618618|6219261|P3|Overall Study|Non-compliance|0
1786779|NCT00618618|6219262|P2|Overall Study|Non-compliance|1
1786780|NCT00618618|6219263|P1|Overall Study|Non-compliance|1
1786781|NCT00618618|6219260|P4|Overall Study|Lost to Follow-up|1
1786782|NCT00618618|6219261|P3|Overall Study|Lost to Follow-up|0
1786783|NCT00618618|6219262|P2|Overall Study|Lost to Follow-up|0
1786784|NCT00618618|6219263|P1|Overall Study|Lost to Follow-up|3
1786785|NCT00618618|6219260|P4|Overall Study|Inability to Complete Study Procedures|0
1786786|NCT00618618|6219261|P3|Overall Study|Inability to Complete Study Procedures|0
1786787|NCT00618618|6219262|P2|Overall Study|Inability to Complete Study Procedures|1
1786788|NCT00618618|6219263|P1|Overall Study|Inability to Complete Study Procedures|0
1786789|NCT00618618|6219260|P4|Overall Study|Patient Request|0
1786790|NCT00618618|6219261|P3|Overall Study|Patient Request|2
1786791|NCT00618618|6219262|P2|Overall Study|Patient Request|0
1786792|NCT00618618|6219263|P1|Overall Study|Patient Request|0
1786793|NCT00618514|6219322|P3|Overall Study|Lost to Follow-up|4
1786794|NCT00618514|6219323|P2|Overall Study|Lost to Follow-up|12
1786795|NCT00618514|6219324|P1|Overall Study|Lost to Follow-up|11
1786796|NCT00618449|6219344|P2|Overall Study|Lost to Follow-up|110
1786797|NCT00618449|6219345|P1|Overall Study|Lost to Follow-up|98
1786798|NCT00618410|6219364|P2|Washout Period (2 Weeks)|Physician Decision|1
1786799|NCT00618410|6219365|P1|Washout Period (2 Weeks)|Physician Decision|0
1786800|NCT00618371|6219381|P1|Overall Study|Withdrawal by Subject|2
1786801|NCT00618072|6219414|P3|Overall Study|Physician Decision|1
1786802|NCT00618072|6219415|P2|Overall Study|Physician Decision|1
1786803|NCT00618072|6219416|P1|Overall Study|Physician Decision|0
1786804|NCT00618072|6219414|P3|Overall Study|Lost to Follow-up|3
1786805|NCT00618072|6219415|P2|Overall Study|Lost to Follow-up|0
1786806|NCT00618072|6219416|P1|Overall Study|Lost to Follow-up|2
1786807|NCT00617929|6219472|P1|Overall Study|Physician Decision|1
1786808|NCT00617903|6219484|P2|Overall Study|noncompliance|1
1786809|NCT00617903|6219485|P1|Overall Study|noncompliance|0
1786810|NCT00617903|6219484|P2|Overall Study|Adverse Event|1
1786811|NCT00617903|6219485|P1|Overall Study|Adverse Event|0
1786812|NCT00617903|6219484|P2|Overall Study|Lack of Efficacy|1
1786813|NCT00617903|6219485|P1|Overall Study|Lack of Efficacy|0
1786814|NCT00617903|6219484|P2|Overall Study|Lost to Follow-up|1
1786815|NCT00617903|6219485|P1|Overall Study|Lost to Follow-up|1
1786816|NCT00617903|6219484|P2|Overall Study|Withdrawal by Subject|3
1786817|NCT00617903|6219485|P1|Overall Study|Withdrawal by Subject|2
1786818|NCT00617890|6219531|P4|Overall Study|Not treated|1
1786819|NCT00617890|6219532|P3|Overall Study|Not treated|1
1786820|NCT00617890|6219533|P2|Overall Study|Not treated|0
1786821|NCT00617890|6219534|P1|Overall Study|Not treated|1
1786822|NCT00617890|6219531|P4|Overall Study|Adverse Event|8
1786823|NCT00617890|6219532|P3|Overall Study|Adverse Event|3
1786824|NCT00617890|6219533|P2|Overall Study|Adverse Event|0
1786825|NCT00617890|6219534|P1|Overall Study|Adverse Event|1
1786826|NCT00617890|6219531|P4|Overall Study|Protocol Violation|0
1786827|NCT00617890|6219532|P3|Overall Study|Protocol Violation|0
1786828|NCT00617890|6219533|P2|Overall Study|Protocol Violation|1
1786829|NCT00617890|6219534|P1|Overall Study|Protocol Violation|2
1786830|NCT00617890|6219531|P4|Overall Study|Withdrawal by Subject|2
1786831|NCT00617890|6219532|P3|Overall Study|Withdrawal by Subject|0
1786832|NCT00617890|6219533|P2|Overall Study|Withdrawal by Subject|1
1786833|NCT00617890|6219534|P1|Overall Study|Withdrawal by Subject|4
1786834|NCT00617890|6219531|P4|Overall Study|Lost to Follow-up|2
1786835|NCT00617890|6219532|P3|Overall Study|Lost to Follow-up|1
1786836|NCT00617890|6219533|P2|Overall Study|Lost to Follow-up|0
1786837|NCT00617890|6219534|P1|Overall Study|Lost to Follow-up|0
1786838|NCT00617890|6219531|P4|Overall Study|Lack of Efficacy|97
1786839|NCT00617890|6219532|P3|Overall Study|Lack of Efficacy|30
1786840|NCT00617890|6219533|P2|Overall Study|Lack of Efficacy|26
1786841|NCT00617890|6219534|P1|Overall Study|Lack of Efficacy|23
1786842|NCT00617890|6219531|P4|Overall Study|Treatment ongoing at data cut-off|5
1786843|NCT00617890|6219532|P3|Overall Study|Treatment ongoing at data cut-off|0
1786844|NCT00617890|6219533|P2|Overall Study|Treatment ongoing at data cut-off|0
1786845|NCT00617890|6219534|P1|Overall Study|Treatment ongoing at data cut-off|0
1786846|NCT00617851|6219570|P4|Overall Study|Unable to classify|0
1786847|NCT00617851|6219571|P3|Overall Study|Unable to classify|1
1786848|NCT00617851|6219572|P2|Overall Study|Unable to classify|0
1786849|NCT00617851|6219573|P1|Overall Study|Unable to classify|1
1786850|NCT00617851|6219570|P4|Overall Study|Inappropriate Enrollment|1
1786851|NCT00617851|6219571|P3|Overall Study|Inappropriate Enrollment|1
1786852|NCT00617851|6219572|P2|Overall Study|Inappropriate Enrollment|4
1786853|NCT00617851|6219573|P1|Overall Study|Inappropriate Enrollment|5
1786854|NCT00617851|6219570|P4|Overall Study|Lost to Follow-up|19
1786855|NCT00617851|6219571|P3|Overall Study|Lost to Follow-up|31
1786856|NCT00617851|6219572|P2|Overall Study|Lost to Follow-up|29
1786857|NCT00617851|6219573|P1|Overall Study|Lost to Follow-up|27
1786858|NCT00617851|6219570|P4|Overall Study|Withdrawal by Subject|4
1786859|NCT00617851|6219571|P3|Overall Study|Withdrawal by Subject|12
1786860|NCT00617851|6219572|P2|Overall Study|Withdrawal by Subject|7
1786861|NCT00617851|6219573|P1|Overall Study|Withdrawal by Subject|14
1786862|NCT00617851|6219570|P4|Overall Study|Death|1
1786863|NCT00617851|6219571|P3|Overall Study|Death|0
1786864|NCT00617851|6219572|P2|Overall Study|Death|0
1786865|NCT00617851|6219573|P1|Overall Study|Death|0
1786866|NCT00617773|6219611|P1|Overall Study|Protocol Violation|1
1786867|NCT00617773|6219611|P1|Overall Study|Progressive disease|19
1786868|NCT00617773|6219611|P1|Overall Study|Death|1
1786869|NCT00617773|6219611|P1|Overall Study|Withdrawal by Subject|1
1786870|NCT00617773|6219611|P1|Overall Study|Lack of compliance with the protocol|1
1786871|NCT00617773|6219611|P1|Overall Study|Physician Decision|1
1786872|NCT00617734|6219628|P2|Overall Study|Lost to Follow-up|1
1786873|NCT00617734|6219629|P1|Overall Study|Lost to Follow-up|0
1786874|NCT00617734|6219628|P2|Overall Study|Found Ineligible After Randomization|4
1786875|NCT00617734|6219629|P1|Overall Study|Found Ineligible After Randomization|1
1786876|NCT00617734|6219628|P2|Overall Study|Protocol Violation|0
1786877|NCT00617734|6219629|P1|Overall Study|Protocol Violation|1
1786878|NCT00617734|6219628|P2|Overall Study|Adverse Event|1
1786879|NCT00617734|6219629|P1|Overall Study|Adverse Event|4
1786880|NCT00617734|6219628|P2|Overall Study|Withdrew Consent|0
1786881|NCT00617734|6219629|P1|Overall Study|Withdrew Consent|2
1786882|NCT00617708|6219650|P3|Overall Study|Not eligible|5
1786883|NCT00617708|6219651|P2|Overall Study|Not eligible|3
1786884|NCT00617708|6219652|P1|Overall Study|Not eligible|1
1786885|NCT00617708|6219650|P3|Overall Study|Not protocol specified|2
1786886|NCT00617708|6219651|P2|Overall Study|Not protocol specified|4
1786887|NCT00617708|6219652|P1|Overall Study|Not protocol specified|1
1786888|NCT00617708|6219650|P3|Overall Study|Progression/Relapse|36
1786889|NCT00617708|6219651|P2|Overall Study|Progression/Relapse|40
1786890|NCT00617708|6219652|P1|Overall Study|Progression/Relapse|7
1786891|NCT00617708|6219650|P3|Overall Study|Death|5
1786892|NCT00617708|6219651|P2|Overall Study|Death|6
1786893|NCT00617708|6219652|P1|Overall Study|Death|0
1786894|NCT00617708|6219650|P3|Overall Study|Withdrawal by Subject|7
1786895|NCT00617708|6219651|P2|Overall Study|Withdrawal by Subject|1
1786896|NCT00617708|6219652|P1|Overall Study|Withdrawal by Subject|1
1786897|NCT00617708|6219650|P3|Overall Study|Adverse Event|9
1786898|NCT00617708|6219651|P2|Overall Study|Adverse Event|6
1786899|NCT00617708|6219652|P1|Overall Study|Adverse Event|0
1786900|NCT00617669|6219669|P2|Overall Study|Patients randomized but not treated|3
1786901|NCT00617669|6219670|P1|Overall Study|Patients randomized but not treated|2
1786902|NCT00617669|6219669|P2|Overall Study|Reason not otherwise captured, eg; death|290
1786903|NCT00617669|6219670|P1|Overall Study|Reason not otherwise captured, eg; death|265
1786904|NCT00617669|6219669|P2|Overall Study|Protocol Violation|3
1786905|NCT00617669|6219670|P1|Overall Study|Protocol Violation|2
1786906|NCT00617669|6219669|P2|Overall Study|Adverse Event|76
1786907|NCT00617669|6219670|P1|Overall Study|Adverse Event|87
1786908|NCT00617669|6219669|P2|Overall Study|Lost to Follow-up|2
1786909|NCT00617669|6219670|P1|Overall Study|Lost to Follow-up|3
1786910|NCT00617669|6219669|P2|Overall Study|Withdrawal by Subject|77
1786911|NCT00617669|6219670|P1|Overall Study|Withdrawal by Subject|71
1786912|NCT00617604|6219692|P2|Overall Study|Randomized but Never Received Study Drug|3
1786913|NCT00617604|6219693|P1|Overall Study|Randomized but Never Received Study Drug|3
1786914|NCT00617604|6219692|P2|Overall Study|Withdrawal by Subject|6
1786915|NCT00617604|6219693|P1|Overall Study|Withdrawal by Subject|4
1786916|NCT00617604|6219692|P2|Overall Study|Miscellaneous Reasons|10
1786917|NCT00617604|6219693|P1|Overall Study|Miscellaneous Reasons|8
1786918|NCT00617604|6219692|P2|Overall Study|Lost to Follow-up|0
1786919|NCT00617604|6219693|P1|Overall Study|Lost to Follow-up|1
1786920|NCT00617604|6219692|P2|Overall Study|Death|1
1786921|NCT00617604|6219693|P1|Overall Study|Death|2
1786922|NCT00617591|6219737|P1|Overall Study|Withdrew consent during Maintenance|6
1786923|NCT00617591|6219737|P1|Overall Study|Withdrew consent during Induction|4
1786924|NCT00617461|6219753|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
1786925|NCT00617461|6219754|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
1786926|NCT00617461|6219753|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
1786927|NCT00617461|6219754|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
1786928|NCT00617461|6219753|P2|Second Treatment Intervention Period|Lack of Efficacy|3
1786929|NCT00617461|6219754|P1|Second Treatment Intervention Period|Lack of Efficacy|0
1786930|NCT00617461|6219753|P2|Second Treatment Intervention Period|Adverse Event|1
1786931|NCT00617461|6219754|P1|Second Treatment Intervention Period|Adverse Event|0
1786932|NCT00617461|6219753|P2|4-Day Crossover Period|Withdrawal by Subject|0
1786933|NCT00617461|6219754|P1|4-Day Crossover Period|Withdrawal by Subject|1
1786934|NCT00617461|6219753|P2|First Treatment Intervention Period|Withdrawal by Subject|0
1786935|NCT00617461|6219754|P1|First Treatment Intervention Period|Withdrawal by Subject|4
1786936|NCT00617461|6219753|P2|First Treatment Intervention Period|Investigator Discretion|1
1786937|NCT00617461|6219754|P1|First Treatment Intervention Period|Investigator Discretion|1
1786938|NCT00617461|6219753|P2|First Treatment Intervention Period|Lost to Follow-up|1
1786939|NCT00617461|6219754|P1|First Treatment Intervention Period|Lost to Follow-up|0
1786940|NCT00617461|6219753|P2|First Treatment Intervention Period|Protocol Violation|1
1786941|NCT00617461|6219754|P1|First Treatment Intervention Period|Protocol Violation|2
1786942|NCT00617461|6219753|P2|First Treatment Intervention Period|Lack of Efficacy|0
1786943|NCT00617461|6219754|P1|First Treatment Intervention Period|Lack of Efficacy|1
1786944|NCT00617461|6219753|P2|First Treatment Intervention Period|Adverse Event|0
1786945|NCT00617461|6219754|P1|First Treatment Intervention Period|Adverse Event|2
1786946|NCT00617409|6219810|P3|Overall Study|Alternative Therapy|0
1786947|NCT00617409|6219811|P2|Overall Study|Alternative Therapy|2
1786948|NCT00617409|6219812|P1|Overall Study|Alternative Therapy|1
1786949|NCT00617409|6219810|P3|Overall Study|Death|4
1786950|NCT00617409|6219811|P2|Overall Study|Death|5
1786951|NCT00617409|6219812|P1|Overall Study|Death|3
1786952|NCT00617409|6219810|P3|Overall Study|Disease Progression|18
1786953|NCT00617409|6219811|P2|Overall Study|Disease Progression|8
1786954|NCT00617409|6219812|P1|Overall Study|Disease Progression|8
1786955|NCT00617409|6219810|P3|Overall Study|Adverse Event|3
1786956|NCT00617409|6219811|P2|Overall Study|Adverse Event|2
1786957|NCT00617409|6219812|P1|Overall Study|Adverse Event|0
1786958|NCT00617409|6219810|P3|Overall Study|Withdrawal by Subject|2
1786959|NCT00617409|6219811|P2|Overall Study|Withdrawal by Subject|1
1786960|NCT00617409|6219812|P1|Overall Study|Withdrawal by Subject|4
1786961|NCT00617357|6219827|P1|Overall Study|Physician Decision|1
1786962|NCT00617357|6219827|P1|Overall Study|Withdrawal by Subject|1
1786963|NCT00617357|6219827|P1|Overall Study|insurance concerns|2
1786964|NCT00617357|6219827|P1|Overall Study|Death|5
1786965|NCT00617357|6219827|P1|Overall Study|Lost to Follow-up|7
1786966|NCT00617344|6219840|P3|Overall Study|Withdrawal by Subject|2
1786967|NCT00617344|6219841|P2|Overall Study|Withdrawal by Subject|9
1786968|NCT00617344|6219842|P1|Overall Study|Withdrawal by Subject|8
1786969|NCT00617344|6219840|P3|Overall Study|Lost to Follow-up|1
1786970|NCT00617344|6219841|P2|Overall Study|Lost to Follow-up|4
1786971|NCT00617344|6219842|P1|Overall Study|Lost to Follow-up|5
1786972|NCT00617344|6219840|P3|Overall Study|Protocol Violation|5
1786973|NCT00617344|6219841|P2|Overall Study|Protocol Violation|8
1786974|NCT00617344|6219842|P1|Overall Study|Protocol Violation|10
1786975|NCT00617344|6219840|P3|Overall Study|Other Adverse Event|0
1786976|NCT00617344|6219841|P2|Overall Study|Other Adverse Event|1
1786977|NCT00617344|6219842|P1|Overall Study|Other Adverse Event|1
1786978|NCT00617344|6219840|P3|Overall Study|Serious adverse event|0
1786979|NCT00617344|6219841|P2|Overall Study|Serious adverse event|0
1786980|NCT00617344|6219842|P1|Overall Study|Serious adverse event|1
1786981|NCT00617305|6219870|P3|Overall Study|Withdrawal by Subject|0
1786982|NCT00617305|6219871|P2|Overall Study|Withdrawal by Subject|0
1786983|NCT00617305|6219872|P1|Overall Study|Withdrawal by Subject|1
1786984|NCT00617305|6219870|P3|Overall Study|Protocol Violation|1
1786985|NCT00617305|6219871|P2|Overall Study|Protocol Violation|0
1786986|NCT00617305|6219872|P1|Overall Study|Protocol Violation|1
1786987|NCT00617305|6219870|P3|Overall Study|Physician Decision|0
1786988|NCT00617305|6219871|P2|Overall Study|Physician Decision|0
1786989|NCT00617305|6219872|P1|Overall Study|Physician Decision|1
1786990|NCT00617305|6219870|P3|Overall Study|Death|0
1786991|NCT00617305|6219871|P2|Overall Study|Death|0
1786992|NCT00617305|6219872|P1|Overall Study|Death|1
1786993|NCT00617305|6219870|P3|Overall Study|Adverse Event|0
1786994|NCT00617305|6219871|P2|Overall Study|Adverse Event|0
1786995|NCT00617305|6219872|P1|Overall Study|Adverse Event|4
1786996|NCT00617279|6219928|P2|Overall Study|Death|2
1786997|NCT00617279|6219929|P1|Overall Study|Death|1
1786998|NCT00617279|6219928|P2|Overall Study|Lost to Follow-up|0
1786999|NCT00617279|6219929|P1|Overall Study|Lost to Follow-up|1
1787000|NCT00617279|6219928|P2|Overall Study|Graft abandonment|0
1787001|NCT00617279|6219929|P1|Overall Study|Graft abandonment|2
1787002|NCT00617279|6219928|P2|Overall Study|Study terminated by Sponsor|15
1787003|NCT00617279|6219929|P1|Overall Study|Study terminated by Sponsor|10
1787004|NCT00617240|6219985|P2|Overall Study|Lack of Efficacy|0
1787005|NCT00617240|6219986|P1|Overall Study|Lack of Efficacy|1
1787006|NCT00617201|6220006|P2|Overall Study|Lost to Follow-up|13
1787007|NCT00617201|6220007|P1|Overall Study|Lost to Follow-up|9
1787008|NCT00617123|6220035|P2|Study Treatment Period|Noncompliance with Protocol|1
1787009|NCT00617123|6220036|P1|Study Treatment Period|Noncompliance with Protocol|0
1787010|NCT00617123|6220035|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
1787011|NCT00617123|6220036|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
1787012|NCT00617123|6220035|P2|Study Treatment Period|Adverse Event|3
1787013|NCT00617123|6220036|P1|Study Treatment Period|Adverse Event|7
1787014|NCT00617123|6220035|P2|Study Treatment Period|Withdrawal by Subject|12
1787015|NCT00617123|6220036|P1|Study Treatment Period|Withdrawal by Subject|8
1787016|NCT00617123|6220035|P2|Referral Screening Period|Adverse Event|1
1787017|NCT00617123|6220036|P1|Referral Screening Period|Adverse Event|0
1787018|NCT00617123|6220035|P2|Referral Screening Period|Did Not Wish To Continue|1
1787019|NCT00617123|6220036|P1|Referral Screening Period|Did Not Wish To Continue|3
1787020|NCT00617123|6220035|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
1787021|NCT00617123|6220036|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
1787022|NCT00617084|6220067|P2|Overall Study|Missed 12 Months visit|19
1787023|NCT00617084|6220068|P1|Overall Study|Missed 12 Months visit|16
1787024|NCT00617084|6220067|P2|Overall Study|Withdrawal by Subject|7
1787025|NCT00617084|6220068|P1|Overall Study|Withdrawal by Subject|5
1787029|NCT00616941|6220148|P3|Overall Study|Vaccination Suspended|3
1787030|NCT00616941|6220149|P2|Overall Study|Vaccination Suspended|0
1787031|NCT00616941|6220150|P1|Overall Study|Vaccination Suspended|0
1787032|NCT00616941|6220148|P3|Overall Study|Unrelated Medical Illness/Complication|0
1787033|NCT00616941|6220149|P2|Overall Study|Unrelated Medical Illness/Complication|2
1787034|NCT00616941|6220150|P1|Overall Study|Unrelated Medical Illness/Complication|0
1787035|NCT00616941|6220148|P3|Overall Study|Subject Non-compliance|1
1787036|NCT00616941|6220149|P2|Overall Study|Subject Non-compliance|0
1787037|NCT00616941|6220150|P1|Overall Study|Subject Non-compliance|0
1787038|NCT00616941|6220148|P3|Overall Study|Adverse Event|1
1787039|NCT00616941|6220149|P2|Overall Study|Adverse Event|1
1787040|NCT00616941|6220150|P1|Overall Study|Adverse Event|0
1787041|NCT00616941|6220148|P3|Overall Study|Progressive Disease|1
1787042|NCT00616941|6220149|P2|Overall Study|Progressive Disease|2
1787043|NCT00616941|6220150|P1|Overall Study|Progressive Disease|1
1787044|NCT00616928|6220177|P4|Overall Study|Lost to Follow-up|0
1787045|NCT00616928|6220178|P3|Overall Study|Lost to Follow-up|0
1787046|NCT00616928|6220179|P2|Overall Study|Lost to Follow-up|7
1787047|NCT00616928|6220180|P1|Overall Study|Lost to Follow-up|5
1787048|NCT00616928|6220177|P4|Overall Study|Other|5
1787049|NCT00616928|6220178|P3|Overall Study|Other|15
1787050|NCT00616928|6220179|P2|Overall Study|Other|8
1787051|NCT00616928|6220180|P1|Overall Study|Other|51
1787052|NCT00616928|6220177|P4|Overall Study|Adverse Event|2
1787053|NCT00616928|6220178|P3|Overall Study|Adverse Event|2
1787054|NCT00616928|6220179|P2|Overall Study|Adverse Event|3
1787055|NCT00616928|6220180|P1|Overall Study|Adverse Event|6
1787056|NCT00616902|6220244|P2|Overall Study|Termination of study|6
1787057|NCT00616902|6220245|P1|Overall Study|Termination of study|6
1787058|NCT00616759|6220288|P2|Overall Study|Withdrawal by Subject|2
1787059|NCT00616759|6220289|P1|Overall Study|Withdrawal by Subject|1
1787060|NCT00616759|6220288|P2|Overall Study|Physician Decision|0
1787061|NCT00616759|6220289|P1|Overall Study|Physician Decision|2
1787062|NCT00616655|6220298|P3|Overall Study|Other|5
1787063|NCT00616655|6220299|P2|Overall Study|Other|6
1787064|NCT00616655|6220300|P1|Overall Study|Other|6
1787065|NCT00616655|6220298|P3|Overall Study|Does not meet in/ex criteria|2
1787066|NCT00616655|6220299|P2|Overall Study|Does not meet in/ex criteria|0
1787067|NCT00616655|6220300|P1|Overall Study|Does not meet in/ex criteria|0
1787068|NCT00616655|6220298|P3|Overall Study|Withdrawal by Subject|11
1787069|NCT00616655|6220299|P2|Overall Study|Withdrawal by Subject|7
1787070|NCT00616655|6220300|P1|Overall Study|Withdrawal by Subject|9
1787071|NCT00616655|6220298|P3|Overall Study|Protocol Violation|3
1787072|NCT00616655|6220299|P2|Overall Study|Protocol Violation|4
1787073|NCT00616655|6220300|P1|Overall Study|Protocol Violation|2
1787074|NCT00616655|6220298|P3|Overall Study|Lost to Follow-up|10
1787075|NCT00616655|6220299|P2|Overall Study|Lost to Follow-up|12
1787076|NCT00616655|6220300|P1|Overall Study|Lost to Follow-up|3
1787077|NCT00616655|6220298|P3|Overall Study|Lack of Efficacy|5
1787078|NCT00616655|6220299|P2|Overall Study|Lack of Efficacy|5
1787079|NCT00616655|6220300|P1|Overall Study|Lack of Efficacy|5
1787080|NCT00616655|6220298|P3|Overall Study|Adverse Event|12
1787081|NCT00616655|6220299|P2|Overall Study|Adverse Event|7
1787082|NCT00616655|6220300|P1|Overall Study|Adverse Event|10
1787083|NCT00616642|6220340|P2|Overall Study|Withdrawal by Subject|1
1787084|NCT00616642|6220341|P1|Overall Study|Withdrawal by Subject|0
1787085|NCT00616629|6220352|P5|Overall Study|AV-block|0
1787086|NCT00616629|6220353|P4|Overall Study|AV-block|0
1787087|NCT00616629|6220354|P3|Overall Study|AV-block|0
1787088|NCT00616629|6220355|P2|Overall Study|AV-block|0
1787089|NCT00616629|6220356|P1|Overall Study|AV-block|1
1787090|NCT00616629|6220352|P5|Overall Study|Protocol Violation|0
1787091|NCT00616629|6220353|P4|Overall Study|Protocol Violation|0
1787092|NCT00616629|6220354|P3|Overall Study|Protocol Violation|1
1787093|NCT00616629|6220355|P2|Overall Study|Protocol Violation|2
1787094|NCT00616629|6220356|P1|Overall Study|Protocol Violation|1
1787095|NCT00616603|6220401|P3|Overall Study|Physician Decision|2
1787096|NCT00616603|6220402|P2|Overall Study|Physician Decision|0
1787097|NCT00616603|6220403|P1|Overall Study|Physician Decision|2
1787098|NCT00616434|6220426|P2|Overall Study|Protocol deviation|1
1787099|NCT00616434|6220427|P1|Overall Study|Protocol deviation|0
1787100|NCT00616434|6220426|P2|Overall Study|Withdrawal by Subject|1
1787101|NCT00616434|6220427|P1|Overall Study|Withdrawal by Subject|1
1787102|NCT00616434|6220426|P2|Overall Study|Physician Decision|4
1787103|NCT00616434|6220427|P1|Overall Study|Physician Decision|0
1787104|NCT00616434|6220426|P2|Overall Study|Adverse Event|2
1787105|NCT00616434|6220427|P1|Overall Study|Adverse Event|5
1787106|NCT00616421|6220440|P3|Overall Study|Unable to classify|0
1787107|NCT00616421|6220441|P2|Overall Study|Unable to classify|0
1787108|NCT00616421|6220442|P1|Overall Study|Unable to classify|1
1787109|NCT00616421|6220440|P3|Overall Study|Protocol Violation|2
1787110|NCT00616421|6220441|P2|Overall Study|Protocol Violation|1
1787111|NCT00616421|6220442|P1|Overall Study|Protocol Violation|0
1787112|NCT00616421|6220440|P3|Overall Study|Administrative reason|0
1787113|NCT00616421|6220441|P2|Overall Study|Administrative reason|0
1787114|NCT00616421|6220442|P1|Overall Study|Administrative reason|1
1787115|NCT00616421|6220440|P3|Overall Study|Inappropriate enrollment|1
1787116|NCT00616421|6220441|P2|Overall Study|Inappropriate enrollment|0
1787117|NCT00616421|6220442|P1|Overall Study|Inappropriate enrollment|3
1787118|NCT00616421|6220440|P3|Overall Study|Lost to Follow-up|30
1787119|NCT00616421|6220441|P2|Overall Study|Lost to Follow-up|26
1787120|NCT00616421|6220442|P1|Overall Study|Lost to Follow-up|12
1787121|NCT00616421|6220440|P3|Overall Study|Withdrawal by Subject|8
1787122|NCT00616421|6220441|P2|Overall Study|Withdrawal by Subject|11
1787123|NCT00616421|6220442|P1|Overall Study|Withdrawal by Subject|9
1787124|NCT00616239|6220483|P1|Overall Study|Withdrawal by Subject|2
1787125|NCT00616018|6220513|P1|Overall Study|Protocol Violation|3
1787126|NCT00615992|6220518|P1|Overall Study|Protocol Violation|67
1787127|NCT00615914|6220544|P1|Overall Study|Irregularly enrolled patients|10
1787128|NCT00615914|6220544|P1|Overall Study|No treatment|2
1787129|NCT00615914|6220544|P1|Overall Study|No data was collected.|65
1787130|NCT00615914|6220544|P1|Overall Study|Physician Decision|4
1787131|NCT00615914|6220544|P1|Overall Study|Withdrawal by Subject|16
1787132|NCT00615914|6220544|P1|Overall Study|Lost to Follow-up|187
1787133|NCT00615914|6220544|P1|Overall Study|Lack of Efficacy|59
1787134|NCT00615914|6220544|P1|Overall Study|Death|20
1787135|NCT00615914|6220544|P1|Overall Study|Adverse Event|274
1787136|NCT00615901|6220551|P1|Overall Study|Adverse Event|7
1787137|NCT00615901|6220551|P1|Overall Study|Withdrawal by Subject|2
1787138|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1787139|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1787140|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1787141|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
1787142|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
1787143|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Not reported|0
1787144|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Not reported|4
1787145|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Not reported|1
1787146|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Not reported|4
1787147|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Not reported|6
1787148|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Other|0
1787149|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Other|8
1787150|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Other|8
1787151|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Other|7
1787152|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Other|10
1787153|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
1787154|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
1787155|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
1787156|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
1787157|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
1787158|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
1787159|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
1787160|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
1787161|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
1787162|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
1787163|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
1787164|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
1787165|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
1787166|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
1787167|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
1787168|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
1787169|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
1787170|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
1787171|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
1787172|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
1787173|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
1787174|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
1787175|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
1787176|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
1787177|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
1787178|NCT00615836|6220559|P5|Extension Study (FE992026 CS31)|Adverse Event|0
1787179|NCT00615836|6220560|P4|Extension Study (FE992026 CS31)|Adverse Event|13
1787180|NCT00615836|6220561|P3|Extension Study (FE992026 CS31)|Adverse Event|15
1787181|NCT00615836|6220562|P2|Extension Study (FE992026 CS31)|Adverse Event|12
1787182|NCT00615836|6220563|P1|Extension Study (FE992026 CS31)|Adverse Event|7
1787183|NCT00615719|6220623|P1|Overall Study|Physician Decision|5
1787184|NCT00615550|6220637|P2|Overall Study|Lost to Follow-up|1
1787185|NCT00615550|6220638|P1|Overall Study|Lost to Follow-up|6
1787186|NCT00615459|6220661|P4|Period III|Unsatisfactory therapeutic effect|0
1787187|NCT00615459|6220662|P3|Period III|Unsatisfactory therapeutic effect|0
1787188|NCT00615459|6220663|P2|Period III|Unsatisfactory therapeutic effect|1
1787189|NCT00615459|6220664|P1|Period III|Unsatisfactory therapeutic effect|0
1787190|NCT00615459|6220661|P4|Period III|Administrative problems|0
1787191|NCT00615459|6220662|P3|Period III|Administrative problems|1
1787192|NCT00615459|6220663|P2|Period III|Administrative problems|1
1787193|NCT00615459|6220664|P1|Period III|Administrative problems|0
1787194|NCT00615459|6220661|P4|Period III|Adverse Event|0
1787195|NCT00615459|6220662|P3|Period III|Adverse Event|0
1787196|NCT00615459|6220663|P2|Period III|Adverse Event|1
1787197|NCT00615459|6220664|P1|Period III|Adverse Event|0
1787198|NCT00615459|6220661|P4|Period II|Lost to Follow-up|1
1787199|NCT00615459|6220662|P3|Period II|Lost to Follow-up|0
1787200|NCT00615459|6220663|P2|Period II|Lost to Follow-up|0
1787201|NCT00615459|6220664|P1|Period II|Lost to Follow-up|0
1787202|NCT00615459|6220661|P4|Period II|Adverse Event|0
1787203|NCT00615459|6220662|P3|Period II|Adverse Event|0
1787204|NCT00615459|6220663|P2|Period II|Adverse Event|0
1787205|NCT00615459|6220664|P1|Period II|Adverse Event|1
1787206|NCT00615459|6220661|P4|Period I|Abnormal test procedure results|0
1787207|NCT00615459|6220662|P3|Period I|Abnormal test procedure results|1
1787208|NCT00615459|6220663|P2|Period I|Abnormal test procedure results|1
1787209|NCT00615459|6220664|P1|Period I|Abnormal test procedure results|1
1787210|NCT00615459|6220661|P4|Period I|Subject withdrew consent|1
1787211|NCT00615459|6220662|P3|Period I|Subject withdrew consent|0
1787212|NCT00615459|6220663|P2|Period I|Subject withdrew consent|0
1787213|NCT00615459|6220664|P1|Period I|Subject withdrew consent|1
1787214|NCT00615459|6220661|P4|Period I|Adverse Event|0
1787215|NCT00615459|6220662|P3|Period I|Adverse Event|1
1787216|NCT00615459|6220663|P2|Period I|Adverse Event|0
1787217|NCT00615459|6220664|P1|Period I|Adverse Event|2
1787218|NCT00615290|6220710|P1|Overall Study|Other|2
1787219|NCT00615290|6220710|P1|Overall Study|Withdrawal by Subject|1
1787220|NCT00615290|6220710|P1|Overall Study|Lost to Follow-up|3
1787221|NCT00615290|6220710|P1|Overall Study|Adverse Event|2
1787222|NCT00615264|6220724|P2|Overall Study|Dermal Hypersensitivity|3
1787223|NCT00615264|6220725|P1|Overall Study|Dermal Hypersensitivity|0
1787224|NCT00615264|6220724|P2|Overall Study|Not defined|4
1787225|NCT00615264|6220725|P1|Overall Study|Not defined|7
1787226|NCT00615264|6220724|P2|Overall Study|Protocol Violation|7
1787227|NCT00615264|6220725|P1|Overall Study|Protocol Violation|11
1787228|NCT00615264|6220724|P2|Overall Study|Death|1
1787229|NCT00615264|6220725|P1|Overall Study|Death|1
1787230|NCT00615264|6220724|P2|Overall Study|Adverse Event|5
1787231|NCT00615264|6220725|P1|Overall Study|Adverse Event|8
1787232|NCT00615264|6220724|P2|Overall Study|Lost to Follow-up|13
1787233|NCT00615264|6220725|P1|Overall Study|Lost to Follow-up|6
1787234|NCT00615264|6220724|P2|Overall Study|Withdrawal by Subject|19
1787235|NCT00615264|6220725|P1|Overall Study|Withdrawal by Subject|17
1787236|NCT00615199|6220737|P4|Overall Study|Withdrawal by Subject|0
1787237|NCT00615199|6220738|P3|Overall Study|Withdrawal by Subject|0
1787238|NCT00615199|6220739|P2|Overall Study|Withdrawal by Subject|1
1787239|NCT00615199|6220740|P1|Overall Study|Withdrawal by Subject|2
1787240|NCT00615199|6220737|P4|Overall Study|Other|1
1787241|NCT00615199|6220738|P3|Overall Study|Other|0
1787242|NCT00615199|6220739|P2|Overall Study|Other|0
1787243|NCT00615199|6220740|P1|Overall Study|Other|0
1787244|NCT00615199|6220737|P4|Overall Study|Lost to Follow-up|0
1787245|NCT00615199|6220738|P3|Overall Study|Lost to Follow-up|0
1787246|NCT00615199|6220739|P2|Overall Study|Lost to Follow-up|0
1787247|NCT00615199|6220740|P1|Overall Study|Lost to Follow-up|1
1787248|NCT00615199|6220737|P4|Overall Study|Lack of Efficacy|1
1787249|NCT00615199|6220738|P3|Overall Study|Lack of Efficacy|0
1787250|NCT00615199|6220739|P2|Overall Study|Lack of Efficacy|0
1787251|NCT00615199|6220740|P1|Overall Study|Lack of Efficacy|2
1787252|NCT00615199|6220737|P4|Overall Study|Adverse Event|0
1787253|NCT00615199|6220738|P3|Overall Study|Adverse Event|1
1787254|NCT00615199|6220739|P2|Overall Study|Adverse Event|1
1787255|NCT00615199|6220740|P1|Overall Study|Adverse Event|3
1787256|NCT00615108|6220774|P1|Overall Study|Lost to Follow-up|15
1787257|NCT00615108|6220774|P1|Overall Study|Other|370
1787258|NCT00615108|6220774|P1|Overall Study|Adverse Event|122
1787259|NCT00615069|6220789|P1|Overall Study|Withdrawal by Subject|4
1787260|NCT00615069|6220789|P1|Overall Study|Physician Decision|2
1787261|NCT00615069|6220789|P1|Overall Study|Death|10
1787262|NCT00615056|6220798|P4|Overall Study|Randomized but not treated|0
1787263|NCT00615056|6220799|P3|Overall Study|Randomized but not treated|0
1787264|NCT00615056|6220800|P2|Overall Study|Randomized but not treated|0
1787265|NCT00615056|6220801|P1|Overall Study|Randomized but not treated|3
1787266|NCT00615056|6220798|P4|Overall Study|Discontinued by Sponsor|0
1787267|NCT00615056|6220799|P3|Overall Study|Discontinued by Sponsor|0
1787268|NCT00615056|6220800|P2|Overall Study|Discontinued by Sponsor|0
1787269|NCT00615056|6220801|P1|Overall Study|Discontinued by Sponsor|1
1787270|NCT00615056|6220798|P4|Overall Study|Withdrawal by Subject|0
1787271|NCT00615056|6220799|P3|Overall Study|Withdrawal by Subject|1
1787272|NCT00615056|6220800|P2|Overall Study|Withdrawal by Subject|1
1787273|NCT00615056|6220801|P1|Overall Study|Withdrawal by Subject|0
1787274|NCT00615056|6220798|P4|Overall Study|Objective progression or relapse|0
1787275|NCT00615056|6220799|P3|Overall Study|Objective progression or relapse|0
1787276|NCT00615056|6220800|P2|Overall Study|Objective progression or relapse|2
1787277|NCT00615056|6220801|P1|Overall Study|Objective progression or relapse|0
1787278|NCT00615056|6220798|P4|Overall Study|Other|7
1787279|NCT00615056|6220799|P3|Overall Study|Other|10
1787280|NCT00615056|6220800|P2|Overall Study|Other|15
1787281|NCT00615056|6220801|P1|Overall Study|Other|13
1787282|NCT00615056|6220798|P4|Overall Study|Lost to Follow-up|5
1787283|NCT00615056|6220799|P3|Overall Study|Lost to Follow-up|4
1787284|NCT00615056|6220800|P2|Overall Study|Lost to Follow-up|2
1787285|NCT00615056|6220801|P1|Overall Study|Lost to Follow-up|1
1787286|NCT00615056|6220798|P4|Overall Study|Death|23
1787287|NCT00615056|6220799|P3|Overall Study|Death|21
1787288|NCT00615056|6220800|P2|Overall Study|Death|31
1787289|NCT00615056|6220801|P1|Overall Study|Death|31
1787290|NCT00615030|6220831|P12|Period III|Administrative problems|0
1787291|NCT00615030|6220832|P11|Period III|Administrative problems|0
1787292|NCT00615030|6220833|P10|Period III|Administrative problems|0
1787293|NCT00615030|6220834|P9|Period III|Administrative problems|0
1787294|NCT00615030|6220835|P8|Period III|Administrative problems|0
1787295|NCT00615030|6220836|P7|Period III|Administrative problems|0
1787296|NCT00615030|6220837|P6|Period III|Administrative problems|0
1787297|NCT00615030|6220838|P5|Period III|Administrative problems|0
1787298|NCT00615030|6220839|P4|Period III|Administrative problems|1
1787299|NCT00615030|6220840|P3|Period III|Administrative problems|0
1787300|NCT00615030|6220841|P2|Period III|Administrative problems|0
1787301|NCT00615030|6220842|P1|Period III|Administrative problems|1
1787302|NCT00615030|6220831|P12|Period II|Subject withdrew consent|0
1787303|NCT00615030|6220832|P11|Period II|Subject withdrew consent|0
1787304|NCT00615030|6220833|P10|Period II|Subject withdrew consent|0
1787305|NCT00615030|6220834|P9|Period II|Subject withdrew consent|0
1787306|NCT00615030|6220835|P8|Period II|Subject withdrew consent|0
1787307|NCT00615030|6220836|P7|Period II|Subject withdrew consent|1
1787308|NCT00615030|6220837|P6|Period II|Subject withdrew consent|0
1787309|NCT00615030|6220838|P5|Period II|Subject withdrew consent|0
1787310|NCT00615030|6220839|P4|Period II|Subject withdrew consent|1
1787311|NCT00615030|6220840|P3|Period II|Subject withdrew consent|0
1787312|NCT00615030|6220841|P2|Period II|Subject withdrew consent|0
1787313|NCT00615030|6220842|P1|Period II|Subject withdrew consent|0
1787314|NCT00615030|6220831|P12|Period II|Adverse Event|0
1787315|NCT00615030|6220832|P11|Period II|Adverse Event|0
1787316|NCT00615030|6220833|P10|Period II|Adverse Event|0
1787317|NCT00615030|6220834|P9|Period II|Adverse Event|1
1787318|NCT00615030|6220835|P8|Period II|Adverse Event|0
1787319|NCT00615030|6220836|P7|Period II|Adverse Event|0
1787320|NCT00615030|6220837|P6|Period II|Adverse Event|0
1787321|NCT00615030|6220838|P5|Period II|Adverse Event|0
1787322|NCT00615030|6220839|P4|Period II|Adverse Event|0
1787323|NCT00615030|6220840|P3|Period II|Adverse Event|1
1787324|NCT00615030|6220841|P2|Period II|Adverse Event|0
1787325|NCT00615030|6220842|P1|Period II|Adverse Event|0
1787326|NCT00615030|6220831|P12|Period I|Abnormal laboratory value(s)|0
1787327|NCT00615030|6220832|P11|Period I|Abnormal laboratory value(s)|0
1787328|NCT00615030|6220833|P10|Period I|Abnormal laboratory value(s)|0
1787329|NCT00615030|6220834|P9|Period I|Abnormal laboratory value(s)|0
1787330|NCT00615030|6220835|P8|Period I|Abnormal laboratory value(s)|0
1787331|NCT00615030|6220836|P7|Period I|Abnormal laboratory value(s)|0
1787332|NCT00615030|6220837|P6|Period I|Abnormal laboratory value(s)|1
1787333|NCT00615030|6220838|P5|Period I|Abnormal laboratory value(s)|0
1787334|NCT00615030|6220839|P4|Period I|Abnormal laboratory value(s)|0
1787335|NCT00615030|6220840|P3|Period I|Abnormal laboratory value(s)|0
1787336|NCT00615030|6220841|P2|Period I|Abnormal laboratory value(s)|0
1787337|NCT00615030|6220842|P1|Period I|Abnormal laboratory value(s)|0
1787338|NCT00615030|6220831|P12|Period I|Subject withdrew consent|1
1787339|NCT00615030|6220832|P11|Period I|Subject withdrew consent|1
1787340|NCT00615030|6220833|P10|Period I|Subject withdrew consent|0
1787341|NCT00615030|6220834|P9|Period I|Subject withdrew consent|1
1787342|NCT00615030|6220835|P8|Period I|Subject withdrew consent|0
1787343|NCT00615030|6220836|P7|Period I|Subject withdrew consent|0
1787344|NCT00615030|6220837|P6|Period I|Subject withdrew consent|0
1787345|NCT00615030|6220838|P5|Period I|Subject withdrew consent|0
1787346|NCT00615030|6220839|P4|Period I|Subject withdrew consent|0
1787347|NCT00615030|6220840|P3|Period I|Subject withdrew consent|0
1787348|NCT00615030|6220841|P2|Period I|Subject withdrew consent|0
1787349|NCT00615030|6220842|P1|Period I|Subject withdrew consent|0
1787350|NCT00615030|6220831|P12|Period I|Protocol deviation|0
1787351|NCT00615030|6220832|P11|Period I|Protocol deviation|0
1787352|NCT00615030|6220833|P10|Period I|Protocol deviation|0
1787353|NCT00615030|6220834|P9|Period I|Protocol deviation|0
1787354|NCT00615030|6220835|P8|Period I|Protocol deviation|0
1787355|NCT00615030|6220836|P7|Period I|Protocol deviation|0
1787356|NCT00615030|6220837|P6|Period I|Protocol deviation|0
1787357|NCT00615030|6220838|P5|Period I|Protocol deviation|0
1787358|NCT00615030|6220839|P4|Period I|Protocol deviation|0
1787359|NCT00615030|6220840|P3|Period I|Protocol deviation|0
1787360|NCT00615030|6220841|P2|Period I|Protocol deviation|0
1787361|NCT00615030|6220842|P1|Period I|Protocol deviation|1
1787362|NCT00615030|6220831|P12|Period I|Administrative problem|0
1787363|NCT00615030|6220832|P11|Period I|Administrative problem|0
1787364|NCT00615030|6220833|P10|Period I|Administrative problem|0
1787365|NCT00615030|6220834|P9|Period I|Administrative problem|0
1787366|NCT00615030|6220835|P8|Period I|Administrative problem|0
1787367|NCT00615030|6220836|P7|Period I|Administrative problem|0
1787368|NCT00615030|6220837|P6|Period I|Administrative problem|0
1787369|NCT00615030|6220838|P5|Period I|Administrative problem|1
1787370|NCT00615030|6220839|P4|Period I|Administrative problem|0
1787371|NCT00615030|6220840|P3|Period I|Administrative problem|0
1787372|NCT00615030|6220841|P2|Period I|Administrative problem|0
1787373|NCT00615030|6220842|P1|Period I|Administrative problem|0
1787374|NCT00615017|6220862|P6|Overall Study|Physician discontinued drug|1
1787375|NCT00615017|6220863|P5|Overall Study|Physician discontinued drug|0
1787376|NCT00615017|6220864|P4|Overall Study|Physician discontinued drug|0
1787377|NCT00615017|6220865|P3|Overall Study|Physician discontinued drug|0
1787378|NCT00615017|6220866|P2|Overall Study|Physician discontinued drug|0
1787379|NCT00615017|6220867|P1|Overall Study|Physician discontinued drug|0
1787380|NCT00615017|6220862|P6|Overall Study|Transferred out of Intensive Care Unit|0
1787381|NCT00615017|6220863|P5|Overall Study|Transferred out of Intensive Care Unit|0
1787382|NCT00615017|6220864|P4|Overall Study|Transferred out of Intensive Care Unit|1
1787383|NCT00615017|6220865|P3|Overall Study|Transferred out of Intensive Care Unit|0
1787384|NCT00615017|6220866|P2|Overall Study|Transferred out of Intensive Care Unit|0
1787385|NCT00615017|6220867|P1|Overall Study|Transferred out of Intensive Care Unit|0
1787386|NCT00615017|6220862|P6|Overall Study|Sepsis resolved|0
1787387|NCT00615017|6220863|P5|Overall Study|Sepsis resolved|0
1787388|NCT00615017|6220864|P4|Overall Study|Sepsis resolved|0
1787389|NCT00615017|6220865|P3|Overall Study|Sepsis resolved|1
1787390|NCT00615017|6220866|P2|Overall Study|Sepsis resolved|0
1787391|NCT00615017|6220867|P1|Overall Study|Sepsis resolved|0
1787392|NCT00615017|6220862|P6|Overall Study|Death|1
1787393|NCT00615017|6220863|P5|Overall Study|Death|1
1787394|NCT00615017|6220864|P4|Overall Study|Death|0
1787395|NCT00615017|6220865|P3|Overall Study|Death|2
1787396|NCT00615017|6220866|P2|Overall Study|Death|0
1787397|NCT00615017|6220867|P1|Overall Study|Death|0
1787398|NCT00615017|6220862|P6|Overall Study|Adverse Event|1
1787399|NCT00615017|6220863|P5|Overall Study|Adverse Event|0
1787400|NCT00615017|6220864|P4|Overall Study|Adverse Event|0
1787401|NCT00615017|6220865|P3|Overall Study|Adverse Event|2
1787402|NCT00615017|6220866|P2|Overall Study|Adverse Event|1
1787403|NCT00615017|6220867|P1|Overall Study|Adverse Event|0
1787404|NCT00614991|6221025|P6|Overall Study|Adverse Event|0
1787405|NCT00614991|6221026|P5|Overall Study|Adverse Event|1
1787406|NCT00614991|6221027|P4|Overall Study|Adverse Event|0
1787407|NCT00614991|6221028|P3|Overall Study|Adverse Event|0
1787408|NCT00614991|6221029|P2|Overall Study|Adverse Event|3
1787409|NCT00614991|6221030|P1|Overall Study|Adverse Event|3
1787410|NCT00614939|6221064|P2|Overall Study|Hospitalized due to kidney transplant|0
1787411|NCT00614939|6221065|P1|Overall Study|Hospitalized due to kidney transplant|1
1787412|NCT00614939|6221064|P2|Overall Study|Poor/non-compliance|0
1787413|NCT00614939|6221065|P1|Overall Study|Poor/non-compliance|4
1787414|NCT00614939|6221064|P2|Overall Study|Death|3
1787415|NCT00614939|6221065|P1|Overall Study|Death|4
1787416|NCT00614939|6221064|P2|Overall Study|Incorrect enrollment|2
1787417|NCT00614939|6221065|P1|Overall Study|Incorrect enrollment|1
1787418|NCT00614939|6221064|P2|Overall Study|Adverse Event|5
1787419|NCT00614939|6221065|P1|Overall Study|Adverse Event|2
1787420|NCT00614939|6221064|P2|Overall Study|Study specific discontinuation criteris|16
1787421|NCT00614939|6221065|P1|Overall Study|Study specific discontinuation criteris|13
1787422|NCT00614939|6221064|P2|Overall Study|Withdrawal by Subject|17
1787423|NCT00614939|6221065|P1|Overall Study|Withdrawal by Subject|10
1787424|NCT00614926|6221099|P2|Overall Study|Adverse Event|0
1787425|NCT00614926|6221100|P1|Overall Study|Adverse Event|3
1787426|NCT00614926|6221099|P2|Overall Study|Burden of travel|0
1787427|NCT00614926|6221100|P1|Overall Study|Burden of travel|1
1787428|NCT00614874|6221113|P1|Overall Study|Withdrawal by Subject|1
1787429|NCT00614874|6221113|P1|Overall Study|Protocol Violation|1
1787430|NCT00614822|6221120|P1|Overall Study|Adverse Event|3
1787431|NCT00614744|6221129|P2|Overall Study|Incomplete for Behavior Issues|2
1787432|NCT00614744|6221130|P1|Overall Study|Incomplete for Behavior Issues|0
1787433|NCT00614744|6221129|P2|Overall Study|Lost to Follow-up|4
1787434|NCT00614744|6221130|P1|Overall Study|Lost to Follow-up|5
1787435|NCT00614614|6221156|P5|Booster Vaccination Phase|Other|1
1787436|NCT00614614|6221157|P4|Booster Vaccination Phase|Other|2
1787437|NCT00614614|6221158|P3|Booster Vaccination Phase|Other|3
1787438|NCT00614614|6221159|P2|Booster Vaccination Phase|Other|1
1787439|NCT00614614|6221160|P1|Booster Vaccination Phase|Other|0
1787440|NCT00614614|6221156|P5|Booster Vaccination Phase|Protocol Violation|0
1787441|NCT00614614|6221157|P4|Booster Vaccination Phase|Protocol Violation|3
1787442|NCT00614614|6221158|P3|Booster Vaccination Phase|Protocol Violation|2
1787443|NCT00614614|6221159|P2|Booster Vaccination Phase|Protocol Violation|0
1787444|NCT00614614|6221160|P1|Booster Vaccination Phase|Protocol Violation|0
1787445|NCT00614614|6221156|P5|Booster Vaccination Phase|Lost to Follow-up|8
1787446|NCT00614614|6221157|P4|Booster Vaccination Phase|Lost to Follow-up|10
1787447|NCT00614614|6221158|P3|Booster Vaccination Phase|Lost to Follow-up|17
1787448|NCT00614614|6221159|P2|Booster Vaccination Phase|Lost to Follow-up|5
1787449|NCT00614614|6221160|P1|Booster Vaccination Phase|Lost to Follow-up|0
1787450|NCT00614614|6221156|P5|Booster Vaccination Phase|Withdrawal by Subject|4
1787451|NCT00614614|6221157|P4|Booster Vaccination Phase|Withdrawal by Subject|3
1787452|NCT00614614|6221158|P3|Booster Vaccination Phase|Withdrawal by Subject|4
1787453|NCT00614614|6221159|P2|Booster Vaccination Phase|Withdrawal by Subject|0
1787454|NCT00614614|6221160|P1|Booster Vaccination Phase|Withdrawal by Subject|0
1787455|NCT00614614|6221156|P5|Booster Vaccination Phase|Adverse Event|0
1787456|NCT00614614|6221157|P4|Booster Vaccination Phase|Adverse Event|1
1787457|NCT00614614|6221158|P3|Booster Vaccination Phase|Adverse Event|1
1787458|NCT00614614|6221159|P2|Booster Vaccination Phase|Adverse Event|0
1787459|NCT00614614|6221160|P1|Booster Vaccination Phase|Adverse Event|0
1787460|NCT00614614|6221156|P5|Primary Vaccination Phase|Other|0
1787461|NCT00614614|6221157|P4|Primary Vaccination Phase|Other|0
1787462|NCT00614614|6221158|P3|Primary Vaccination Phase|Other|0
1787463|NCT00614614|6221159|P2|Primary Vaccination Phase|Other|0
1787464|NCT00614614|6221160|P1|Primary Vaccination Phase|Other|4
1787465|NCT00614614|6221156|P5|Primary Vaccination Phase|Protocol Violation|0
1787466|NCT00614614|6221157|P4|Primary Vaccination Phase|Protocol Violation|0
1787467|NCT00614614|6221158|P3|Primary Vaccination Phase|Protocol Violation|0
1787468|NCT00614614|6221159|P2|Primary Vaccination Phase|Protocol Violation|3
1787469|NCT00614614|6221160|P1|Primary Vaccination Phase|Protocol Violation|9
1787470|NCT00614614|6221156|P5|Primary Vaccination Phase|Lost to Follow-up|0
1787471|NCT00614614|6221157|P4|Primary Vaccination Phase|Lost to Follow-up|0
1787472|NCT00614614|6221158|P3|Primary Vaccination Phase|Lost to Follow-up|0
1787473|NCT00614614|6221159|P2|Primary Vaccination Phase|Lost to Follow-up|8
1787474|NCT00614614|6221160|P1|Primary Vaccination Phase|Lost to Follow-up|26
1787475|NCT00614614|6221156|P5|Primary Vaccination Phase|Withdrawal by Subject|0
1787476|NCT00614614|6221157|P4|Primary Vaccination Phase|Withdrawal by Subject|0
1787477|NCT00614614|6221158|P3|Primary Vaccination Phase|Withdrawal by Subject|0
1787478|NCT00614614|6221159|P2|Primary Vaccination Phase|Withdrawal by Subject|6
1787479|NCT00614614|6221160|P1|Primary Vaccination Phase|Withdrawal by Subject|45
1787480|NCT00614614|6221156|P5|Primary Vaccination Phase|Adverse Event|0
1787481|NCT00614614|6221157|P4|Primary Vaccination Phase|Adverse Event|0
1787482|NCT00614614|6221158|P3|Primary Vaccination Phase|Adverse Event|0
1787483|NCT00614614|6221159|P2|Primary Vaccination Phase|Adverse Event|0
1787484|NCT00614614|6221160|P1|Primary Vaccination Phase|Adverse Event|6
1787485|NCT00614575|6221283|P1|Overall Study|No treatment|1
1787486|NCT00614575|6221283|P1|Overall Study|Irregularly enrolled patients|23
1787487|NCT00614575|6221283|P1|Overall Study|No data were collected.|18
1787488|NCT00614575|6221283|P1|Overall Study|Physician Decision|2
1787489|NCT00614575|6221283|P1|Overall Study|Death|3
1787490|NCT00614575|6221283|P1|Overall Study|Withdrawal by Subject|6
1787491|NCT00614575|6221283|P1|Overall Study|Lack of Efficacy|14
1787492|NCT00614575|6221283|P1|Overall Study|Lost to Follow-up|55
1787493|NCT00614575|6221283|P1|Overall Study|Adverse Event|106
1787494|NCT00614523|6221294|P2|Overall Study|Administrative Decision|46
1787495|NCT00614523|6221295|P1|Overall Study|Administrative Decision|23
1787496|NCT00614523|6221294|P2|Overall Study|Disease Progression|8
1787497|NCT00614523|6221295|P1|Overall Study|Disease Progression|0
1787498|NCT00614523|6221294|P2|Overall Study|Ineligibility Determined|2
1787499|NCT00614523|6221295|P1|Overall Study|Ineligibility Determined|1
1787500|NCT00614523|6221294|P2|Overall Study|Other|11
1787501|NCT00614523|6221295|P1|Overall Study|Other|6
1787502|NCT00614523|6221294|P2|Overall Study|Withdrawal by Subject|22
1787503|NCT00614523|6221295|P1|Overall Study|Withdrawal by Subject|12
1787504|NCT00614523|6221294|P2|Overall Study|Protocol Violation|2
1787505|NCT00614523|6221295|P1|Overall Study|Protocol Violation|3
1787506|NCT00614523|6221294|P2|Overall Study|Lost to Follow-up|1
1787507|NCT00614523|6221295|P1|Overall Study|Lost to Follow-up|0
1787508|NCT00614523|6221294|P2|Overall Study|Lack of Efficacy|11
1787509|NCT00614523|6221295|P1|Overall Study|Lack of Efficacy|9
1787510|NCT00614523|6221294|P2|Overall Study|Death|8
1787511|NCT00614523|6221295|P1|Overall Study|Death|5
1787512|NCT00614523|6221294|P2|Overall Study|Adverse Event|20
1787513|NCT00614523|6221295|P1|Overall Study|Adverse Event|4
1787514|NCT00614393|6221360|P5|Overall Study|Not Treated|2
1787515|NCT00614393|6221361|P4|Overall Study|Not Treated|0
1787516|NCT00614393|6221362|P3|Overall Study|Not Treated|0
1787517|NCT00614393|6221363|P2|Overall Study|Not Treated|0
1787518|NCT00614393|6221364|P1|Overall Study|Not Treated|0
1787519|NCT00614393|6221360|P5|Overall Study|Other|2
1787520|NCT00614393|6221361|P4|Overall Study|Other|4
1787521|NCT00614393|6221362|P3|Overall Study|Other|0
1787522|NCT00614393|6221363|P2|Overall Study|Other|0
1787523|NCT00614393|6221364|P1|Overall Study|Other|4
1787524|NCT00614393|6221360|P5|Overall Study|Withdrawal by Subject|13
1787525|NCT00614393|6221361|P4|Overall Study|Withdrawal by Subject|16
1787526|NCT00614393|6221362|P3|Overall Study|Withdrawal by Subject|1
1787527|NCT00614393|6221363|P2|Overall Study|Withdrawal by Subject|1
1787528|NCT00614393|6221364|P1|Overall Study|Withdrawal by Subject|20
1787529|NCT00614393|6221360|P5|Overall Study|Terminated by Sponsor|1
1787530|NCT00614393|6221361|P4|Overall Study|Terminated by Sponsor|0
1787531|NCT00614393|6221362|P3|Overall Study|Terminated by Sponsor|0
1787532|NCT00614393|6221363|P2|Overall Study|Terminated by Sponsor|0
1787533|NCT00614393|6221364|P1|Overall Study|Terminated by Sponsor|0
1787534|NCT00614393|6221360|P5|Overall Study|Protocol Violation|0
1787535|NCT00614393|6221361|P4|Overall Study|Protocol Violation|0
1787536|NCT00614393|6221362|P3|Overall Study|Protocol Violation|0
1787537|NCT00614393|6221363|P2|Overall Study|Protocol Violation|0
1787538|NCT00614393|6221364|P1|Overall Study|Protocol Violation|1
1787539|NCT00614393|6221360|P5|Overall Study|Progressive Disease|130
1787540|NCT00614393|6221361|P4|Overall Study|Progressive Disease|138
1787541|NCT00614393|6221362|P3|Overall Study|Progressive Disease|5
1787542|NCT00614393|6221363|P2|Overall Study|Progressive Disease|5
1787543|NCT00614393|6221364|P1|Overall Study|Progressive Disease|118
1787544|NCT00614393|6221360|P5|Overall Study|Physician Decision|9
1787545|NCT00614393|6221361|P4|Overall Study|Physician Decision|8
1787546|NCT00614393|6221362|P3|Overall Study|Physician Decision|1
1787547|NCT00614393|6221363|P2|Overall Study|Physician Decision|0
1787548|NCT00614393|6221364|P1|Overall Study|Physician Decision|17
1787549|NCT00614393|6221360|P5|Overall Study|Lost to Follow-up|2
1787550|NCT00614393|6221361|P4|Overall Study|Lost to Follow-up|1
1787551|NCT00614393|6221362|P3|Overall Study|Lost to Follow-up|0
1787552|NCT00614393|6221363|P2|Overall Study|Lost to Follow-up|0
1787553|NCT00614393|6221364|P1|Overall Study|Lost to Follow-up|0
1787554|NCT00614393|6221360|P5|Overall Study|Adverse Event|21
1787555|NCT00614393|6221361|P4|Overall Study|Adverse Event|13
1787556|NCT00614393|6221362|P3|Overall Study|Adverse Event|3
1787557|NCT00614393|6221363|P2|Overall Study|Adverse Event|2
1787558|NCT00614393|6221364|P1|Overall Study|Adverse Event|20
1787559|NCT00614380|6221410|P4|Overall Study|Consent withdrawn|0
1787560|NCT00614380|6221411|P3|Overall Study|Consent withdrawn|0
1787561|NCT00614380|6221412|P2|Overall Study|Consent withdrawn|1
1787562|NCT00614380|6221413|P1|Overall Study|Consent withdrawn|3
1787563|NCT00614380|6221410|P4|Overall Study|Non compliant with the protocol|2
1787564|NCT00614380|6221411|P3|Overall Study|Non compliant with the protocol|1
1787565|NCT00614380|6221412|P2|Overall Study|Non compliant with the protocol|2
1787566|NCT00614380|6221413|P1|Overall Study|Non compliant with the protocol|12
1787567|NCT00614380|6221410|P4|Overall Study|Lost to Follow-up|0
1787568|NCT00614380|6221411|P3|Overall Study|Lost to Follow-up|0
1787569|NCT00614380|6221412|P2|Overall Study|Lost to Follow-up|1
1787570|NCT00614380|6221413|P1|Overall Study|Lost to Follow-up|6
1787571|NCT00614380|6221410|P4|Overall Study|Adverse Event|0
1787572|NCT00614380|6221411|P3|Overall Study|Adverse Event|0
1787573|NCT00614380|6221412|P2|Overall Study|Adverse Event|4
1787574|NCT00614380|6221413|P1|Overall Study|Adverse Event|14
1787575|NCT00614120|6221480|P4|Overall Study|Lost to Follow-up|4
1787576|NCT00614120|6221481|P3|Overall Study|Lost to Follow-up|3
1787577|NCT00614120|6221482|P2|Overall Study|Lost to Follow-up|2
1787578|NCT00614120|6221483|P1|Overall Study|Lost to Follow-up|1
1787579|NCT00614120|6221480|P4|Overall Study|Taken inhibition medication eg Prandin|1
1787580|NCT00614120|6221481|P3|Overall Study|Taken inhibition medication eg Prandin|1
1787581|NCT00614120|6221482|P2|Overall Study|Taken inhibition medication eg Prandin|0
1787582|NCT00614120|6221483|P1|Overall Study|Taken inhibition medication eg Prandin|0
1787583|NCT00614120|6221480|P4|Overall Study|Late syphilis, latent|0
1787584|NCT00614120|6221481|P3|Overall Study|Late syphilis, latent|0
1787585|NCT00614120|6221482|P2|Overall Study|Late syphilis, latent|0
1787586|NCT00614120|6221483|P1|Overall Study|Late syphilis, latent|1
1787587|NCT00614120|6221480|P4|Overall Study|Lack of trial product|0
1787588|NCT00614120|6221481|P3|Overall Study|Lack of trial product|2
1787589|NCT00614120|6221482|P2|Overall Study|Lack of trial product|3
1787590|NCT00614120|6221483|P1|Overall Study|Lack of trial product|3
1787591|NCT00614120|6221480|P4|Overall Study|Hypoglycaemia|1
1787592|NCT00614120|6221481|P3|Overall Study|Hypoglycaemia|0
1787593|NCT00614120|6221482|P2|Overall Study|Hypoglycaemia|0
1787594|NCT00614120|6221483|P1|Overall Study|Hypoglycaemia|0
1787595|NCT00614120|6221480|P4|Overall Study|hCG positive (not pregnant)|0
1787596|NCT00614120|6221481|P3|Overall Study|hCG positive (not pregnant)|1
1787597|NCT00614120|6221482|P2|Overall Study|hCG positive (not pregnant)|0
1787598|NCT00614120|6221483|P1|Overall Study|hCG positive (not pregnant)|0
1787599|NCT00614120|6221480|P4|Overall Study|Did not meet trial criteria|1
1787600|NCT00614120|6221481|P3|Overall Study|Did not meet trial criteria|1
1787601|NCT00614120|6221482|P2|Overall Study|Did not meet trial criteria|1
1787602|NCT00614120|6221483|P1|Overall Study|Did not meet trial criteria|0
1787603|NCT00614120|6221480|P4|Overall Study|Withdrawal by Subject|3
1787604|NCT00614120|6221481|P3|Overall Study|Withdrawal by Subject|16
1787605|NCT00614120|6221482|P2|Overall Study|Withdrawal by Subject|10
1787606|NCT00614120|6221483|P1|Overall Study|Withdrawal by Subject|9
1787607|NCT00614120|6221480|P4|Overall Study|Withdrawal criteria|0
1787608|NCT00614120|6221481|P3|Overall Study|Withdrawal criteria|0
1787609|NCT00614120|6221482|P2|Overall Study|Withdrawal criteria|0
1787610|NCT00614120|6221483|P1|Overall Study|Withdrawal criteria|1
1787611|NCT00614120|6221480|P4|Overall Study|Protocol Violation|1
1787612|NCT00614120|6221481|P3|Overall Study|Protocol Violation|3
1787613|NCT00614120|6221482|P2|Overall Study|Protocol Violation|5
1787614|NCT00614120|6221483|P1|Overall Study|Protocol Violation|2
1787615|NCT00614120|6221480|P4|Overall Study|Lack of Efficacy|2
1787616|NCT00614120|6221481|P3|Overall Study|Lack of Efficacy|2
1787617|NCT00614120|6221482|P2|Overall Study|Lack of Efficacy|3
1787618|NCT00614120|6221483|P1|Overall Study|Lack of Efficacy|3
1787619|NCT00614120|6221480|P4|Overall Study|Adverse Event|3
1787620|NCT00614120|6221481|P3|Overall Study|Adverse Event|30
1787621|NCT00614120|6221482|P2|Overall Study|Adverse Event|22
1787622|NCT00614120|6221483|P1|Overall Study|Adverse Event|9
1787623|NCT00614055|6221524|P3|Overall Study|Unclassified|2
1787624|NCT00614055|6221525|P2|Overall Study|Unclassified|4
1787625|NCT00614055|6221526|P1|Overall Study|Unclassified|1
1787626|NCT00614055|6221524|P3|Overall Study|Lack of Efficacy|2
1787627|NCT00614055|6221525|P2|Overall Study|Lack of Efficacy|0
1787628|NCT00614055|6221526|P1|Overall Study|Lack of Efficacy|0
1787629|NCT00614055|6221524|P3|Overall Study|Protocol Violation|1
1787630|NCT00614055|6221525|P2|Overall Study|Protocol Violation|2
1787631|NCT00614055|6221526|P1|Overall Study|Protocol Violation|2
1787632|NCT00614055|6221524|P3|Overall Study|Adverse Event|0
1787633|NCT00614055|6221525|P2|Overall Study|Adverse Event|0
1787634|NCT00614055|6221526|P1|Overall Study|Adverse Event|1
1787635|NCT00613951|6221573|P3|Overall Study|Unclassified|2
1787636|NCT00613951|6221574|P2|Overall Study|Unclassified|3
1787637|NCT00613951|6221575|P1|Overall Study|Unclassified|5
1787638|NCT00613951|6221573|P3|Overall Study|Protocol Violation|1
1787639|NCT00613951|6221574|P2|Overall Study|Protocol Violation|1
1787640|NCT00613951|6221575|P1|Overall Study|Protocol Violation|1
1787641|NCT00613951|6221573|P3|Overall Study|Lack of Efficacy|1
1787642|NCT00613951|6221574|P2|Overall Study|Lack of Efficacy|1
1787643|NCT00613951|6221575|P1|Overall Study|Lack of Efficacy|0
1787644|NCT00613951|6221573|P3|Overall Study|Adverse Event|1
1787645|NCT00613951|6221574|P2|Overall Study|Adverse Event|0
1787646|NCT00613951|6221575|P1|Overall Study|Adverse Event|1
1787647|NCT00613938|6221620|P4|Overall Study|Other|3
1787648|NCT00613938|6221621|P3|Overall Study|Other|1
1787649|NCT00613938|6221622|P2|Overall Study|Other|2
1787650|NCT00613938|6221623|P1|Overall Study|Other|1
1787651|NCT00613938|6221620|P4|Overall Study|Lack of Efficacy|9
1787652|NCT00613938|6221621|P3|Overall Study|Lack of Efficacy|5
1787653|NCT00613938|6221622|P2|Overall Study|Lack of Efficacy|18
1787654|NCT00613938|6221623|P1|Overall Study|Lack of Efficacy|16
1787655|NCT00613938|6221620|P4|Overall Study|Adverse Event|5
1787656|NCT00613938|6221621|P3|Overall Study|Adverse Event|8
1787657|NCT00613938|6221622|P2|Overall Study|Adverse Event|4
1787658|NCT00613938|6221623|P1|Overall Study|Adverse Event|1
1787659|NCT00613938|6221620|P4|Overall Study|Withdrawal by Subject|9
1787660|NCT00613938|6221621|P3|Overall Study|Withdrawal by Subject|9
1787661|NCT00613938|6221622|P2|Overall Study|Withdrawal by Subject|4
1787662|NCT00613938|6221623|P1|Overall Study|Withdrawal by Subject|2
1787663|NCT00613925|6221655|P2|Overall Study|1 did not tolerate outpatient biopsy|1
1787664|NCT00613925|6221656|P1|Overall Study|1 did not tolerate outpatient biopsy|0
1787665|NCT00613834|6221666|P2|Overall Study|Withdrawal by Subject|3
1787666|NCT00613834|6221667|P1|Overall Study|Withdrawal by Subject|0
1787667|NCT00613821|6221679|P2|Overall Study|Physician Decision|1
1787668|NCT00613821|6221680|P1|Overall Study|Physician Decision|1
1787669|NCT00613821|6221679|P2|Overall Study|Withdrawal by Subject|0
1787670|NCT00613821|6221680|P1|Overall Study|Withdrawal by Subject|1
1787671|NCT00613730|6221686|P1|Overall Study|Administrative decision|1
1787672|NCT00613730|6221686|P1|Overall Study|Disease progression|2
1787673|NCT00613626|6221695|P3|Overall Study|Ineligible|0
1787674|NCT00613626|6221696|P2|Overall Study|Ineligible|1
1787675|NCT00613626|6221697|P1|Overall Study|Ineligible|0
1787676|NCT00613574|6221713|P1|Overall Study|Other|1
1787677|NCT00613574|6221713|P1|Overall Study|Lost to Follow-up|2
1787678|NCT00613574|6221713|P1|Overall Study|Adverse Event|3
1787679|NCT00613509|6221725|P2|Cycle 1|Other administrative reason|1
1787680|NCT00613509|6221726|P1|Cycle 1|Other administrative reason|0
1787681|NCT00613509|6221725|P2|Cycle 1|Unacceptable Toxicity|0
1787682|NCT00613509|6221726|P1|Cycle 1|Unacceptable Toxicity|1
1787683|NCT00613509|6221725|P2|Cycle 1|Disease Progression|6
1787684|NCT00613509|6221726|P1|Cycle 1|Disease Progression|2
1787685|NCT00613509|6221725|P2|Cycle 1|Adverse Event|1
1787686|NCT00613509|6221726|P1|Cycle 1|Adverse Event|2
1787687|NCT00613366|6221772|P2|Overall Study|Withdrawal by Subject|2
1787688|NCT00613366|6221773|P1|Overall Study|Withdrawal by Subject|3
1787689|NCT00613327|6221781|P1|Overall Study|Other|47
1787690|NCT00613327|6221781|P1|Overall Study|Protocol Violation|2
1787691|NCT00613327|6221781|P1|Overall Study|Withdrawal by Subject|6
1787692|NCT00613327|6221781|P1|Overall Study|Lost to Follow-up|8
1787693|NCT00613327|6221781|P1|Overall Study|Adverse Event|38
1787694|NCT00613314|6221800|P1|Overall Study|Other reason not defined above|90
1787695|NCT00613314|6221800|P1|Overall Study|Lost to Follow-up|46
1787696|NCT00613314|6221800|P1|Overall Study|Protocol Violation|14
1787697|NCT00613314|6221800|P1|Overall Study|Adverse Event|5
1787698|NCT00613301|6221808|P1|Overall Study|Irregularly enrolled patients|12
1787699|NCT00613301|6221808|P1|Overall Study|No data was collected|53
1787700|NCT00613301|6221808|P1|Overall Study|Physician Decision|2
1787701|NCT00613301|6221808|P1|Overall Study|Lack of Efficacy|13
1787702|NCT00613301|6221808|P1|Overall Study|Death|6
1787703|NCT00613301|6221808|P1|Overall Study|Withdrawal by Subject|5
1787704|NCT00613301|6221808|P1|Overall Study|Lost to Follow-up|88
1787705|NCT00613301|6221808|P1|Overall Study|Adverse Event|49
1787706|NCT00613106|6221817|P2|Overall Study|misc|3
1787707|NCT00613106|6221818|P1|Overall Study|misc|4
1787708|NCT00613106|6221817|P2|Overall Study|Lost to Follow-up|2
1787709|NCT00613106|6221818|P1|Overall Study|Lost to Follow-up|7
1787710|NCT00613106|6221817|P2|Overall Study|Withdrawal by Subject|3
1787711|NCT00613106|6221818|P1|Overall Study|Withdrawal by Subject|6
1787712|NCT00613106|6221817|P2|Overall Study|Adverse Event|1
1787713|NCT00613106|6221818|P1|Overall Study|Adverse Event|3
1787714|NCT00613080|6221824|P1|Overall Study|Ineligible / no protocol treatment|11
1787715|NCT00613015|6221859|P6|Overall Study|Lost to Follow-up|3
1787716|NCT00613015|6221860|P5|Overall Study|Lost to Follow-up|2
1787717|NCT00613015|6221861|P4|Overall Study|Lost to Follow-up|3
1787718|NCT00613015|6221862|P3|Overall Study|Lost to Follow-up|3
1787719|NCT00613015|6221863|P2|Overall Study|Lost to Follow-up|1
1787720|NCT00613015|6221864|P1|Overall Study|Lost to Follow-up|0
1787721|NCT00612807|6221900|P2|Overall Study|Withdrawal by Subject|0
1787722|NCT00612807|6221901|P1|Overall Study|Withdrawal by Subject|2
1787723|NCT00612690|6221936|P2|Overall Study|Withdrawal by Site|0
1787724|NCT00612690|6221937|P1|Overall Study|Withdrawal by Site|11
1787725|NCT00612690|6221936|P2|Overall Study|Withdrawal by Subject|20
1787726|NCT00612690|6221937|P1|Overall Study|Withdrawal by Subject|32
1787727|NCT00612690|6221936|P2|Overall Study|Lost to Follow-up|98
1787728|NCT00612690|6221937|P1|Overall Study|Lost to Follow-up|72
1787729|NCT00612677|6221945|P1|Overall Study|study closed before treatment started|1
1787730|NCT00612534|6222013|P4|Overall Study|Other Reason|0
1787731|NCT00612534|6222014|P3|Overall Study|Other Reason|0
1787732|NCT00612534|6222015|P2|Overall Study|Other Reason|1
1787733|NCT00612534|6222016|P1|Overall Study|Other Reason|0
1787734|NCT00612534|6222013|P4|Overall Study|Lack of Efficacy|16
1787735|NCT00612534|6222014|P3|Overall Study|Lack of Efficacy|5
1787736|NCT00612534|6222015|P2|Overall Study|Lack of Efficacy|12
1787737|NCT00612534|6222016|P1|Overall Study|Lack of Efficacy|13
1787738|NCT00612534|6222013|P4|Overall Study|Adverse Event|1
1787739|NCT00612534|6222014|P3|Overall Study|Adverse Event|2
1787740|NCT00612534|6222015|P2|Overall Study|Adverse Event|4
1787741|NCT00612534|6222016|P1|Overall Study|Adverse Event|0
1787742|NCT00612508|6222028|P2|Overall Study|Withdrawal by Subject|4
1787743|NCT00612508|6222029|P1|Overall Study|Withdrawal by Subject|3
1787744|NCT00612456|6222040|P3|Overall Study|Withdrawal by Subject|0
1787745|NCT00612456|6222041|P2|Overall Study|Withdrawal by Subject|1
1787746|NCT00612456|6222042|P1|Overall Study|Withdrawal by Subject|0
1787747|NCT00612456|6222040|P3|Overall Study|Lack of Efficacy|0
1787748|NCT00612456|6222041|P2|Overall Study|Lack of Efficacy|1
1787749|NCT00612456|6222042|P1|Overall Study|Lack of Efficacy|1
1787750|NCT00612456|6222040|P3|Overall Study|Adverse Event|0
1787751|NCT00612456|6222041|P2|Overall Study|Adverse Event|0
1787752|NCT00612456|6222042|P1|Overall Study|Adverse Event|1
1787753|NCT00612352|6222105|P2|Overall Study|didn't return calls/show up on test date|1
1787754|NCT00612352|6222106|P1|Overall Study|didn't return calls/show up on test date|4
1787755|NCT00612352|6222105|P2|Overall Study|moved out of state|0
1787756|NCT00612352|6222106|P1|Overall Study|moved out of state|1
1787757|NCT00612352|6222105|P2|Overall Study|Withdrawal by Subject|5
1787758|NCT00612352|6222106|P1|Overall Study|Withdrawal by Subject|3
1787759|NCT00612352|6222105|P2|Overall Study|Adverse Event|0
1787760|NCT00612352|6222106|P1|Overall Study|Adverse Event|1
1787761|NCT00612313|6222226|P2|Overall Study|Lost to Follow-up|4
1787762|NCT00612313|6222227|P1|Overall Study|Lost to Follow-up|11
1787763|NCT00612313|6222226|P2|Overall Study|Withdrawal by Subject|9
1787764|NCT00612313|6222227|P1|Overall Study|Withdrawal by Subject|6
1787765|NCT00612105|6222269|P2|Period Title 3: 3-Week Taper Phase|Other|0
1787766|NCT00612105|6222270|P1|Period Title 3: 3-Week Taper Phase|Other|1
1787767|NCT00612105|6222269|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
1787768|NCT00612105|6222270|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
1787769|NCT00612105|6222269|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
1787770|NCT00612105|6222270|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
1787771|NCT00612105|6222269|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
1787772|NCT00612105|6222270|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
1787773|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Other|1
1787774|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Other|0
1787775|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
1787776|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
1787777|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
1787778|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
1787779|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
1787780|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
1787781|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
1787782|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
1787783|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
1787784|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
1787785|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
1787786|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
1787787|NCT00612105|6222269|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
1787788|NCT00612105|6222270|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
1787789|NCT00612066|6222320|P1|Overall Study|Adverse Event|1
1787790|NCT00612040|6222327|P3|Overall Study|Unclassified|5
1787791|NCT00612040|6222328|P2|Overall Study|Unclassified|2
1787792|NCT00612040|6222329|P1|Overall Study|Unclassified|2
1787793|NCT00612040|6222327|P3|Overall Study|Lack of Efficacy|0
1787794|NCT00612040|6222328|P2|Overall Study|Lack of Efficacy|1
1787795|NCT00612040|6222329|P1|Overall Study|Lack of Efficacy|2
1787796|NCT00612040|6222327|P3|Overall Study|Protocol Violation|1
1787797|NCT00612040|6222328|P2|Overall Study|Protocol Violation|2
1787798|NCT00612040|6222329|P1|Overall Study|Protocol Violation|1
1787799|NCT00612040|6222327|P3|Overall Study|Adverse Event|1
1787800|NCT00612040|6222328|P2|Overall Study|Adverse Event|2
1787801|NCT00612040|6222329|P1|Overall Study|Adverse Event|0
1787802|NCT00611923|6222375|P2|Overall Study|Withdrawal by Subject|2
1787803|NCT00611923|6222376|P1|Overall Study|Withdrawal by Subject|2
1787804|NCT00611884|6222421|P4|Overall Study|Unclassified|3
1787805|NCT00611884|6222422|P3|Overall Study|Unclassified|2
1787806|NCT00611884|6222423|P2|Overall Study|Unclassified|4
1787807|NCT00611884|6222424|P1|Overall Study|Unclassified|7
1787808|NCT00611884|6222421|P4|Overall Study|Lack of Efficacy|0
1787809|NCT00611884|6222422|P3|Overall Study|Lack of Efficacy|0
1787810|NCT00611884|6222423|P2|Overall Study|Lack of Efficacy|1
1787811|NCT00611884|6222424|P1|Overall Study|Lack of Efficacy|0
1787812|NCT00611884|6222421|P4|Overall Study|Non-Compliance|2
1787813|NCT00611884|6222422|P3|Overall Study|Non-Compliance|2
1787814|NCT00611884|6222423|P2|Overall Study|Non-Compliance|4
1787815|NCT00611884|6222424|P1|Overall Study|Non-Compliance|1
1787816|NCT00611884|6222421|P4|Overall Study|Adverse Event|1
1787817|NCT00611884|6222422|P3|Overall Study|Adverse Event|0
1787818|NCT00611884|6222423|P2|Overall Study|Adverse Event|0
1787819|NCT00611884|6222424|P1|Overall Study|Adverse Event|1
1787820|NCT00611858|6222478|P1|Overall Study|Withdrawal by Subject|2
1787821|NCT00611858|6222478|P1|Overall Study|Adverse Event|2
1787822|NCT00611806|6222490|P2|Overall Study|Lost to Follow-up|0
1787823|NCT00611806|6222491|P1|Overall Study|Lost to Follow-up|6
1787824|NCT00611806|6222490|P2|Overall Study|Adverse Event|1
1787825|NCT00611806|6222491|P1|Overall Study|Adverse Event|2
1787826|NCT00611806|6222490|P2|Overall Study|Withdrawal by Subject|2
1787827|NCT00611806|6222491|P1|Overall Study|Withdrawal by Subject|8
1787828|NCT00611767|6222505|P2|Overall Study|Physician Decision|0
1787829|NCT00611767|6222506|P1|Overall Study|Physician Decision|1
1787830|NCT00611767|6222505|P2|Overall Study|didn't like the medication|1
1787831|NCT00611767|6222506|P1|Overall Study|didn't like the medication|1
1787832|NCT00611767|6222505|P2|Overall Study|Thiopental not available|0
1787833|NCT00611767|6222506|P1|Overall Study|Thiopental not available|3
1787834|NCT00611767|6222505|P2|Overall Study|Withdrawal by Subject|1
1787835|NCT00611767|6222506|P1|Overall Study|Withdrawal by Subject|4
1787836|NCT00611715|6222668|P2|Overall Study|two patients are still on treatment|0
1787837|NCT00611715|6222669|P1|Overall Study|two patients are still on treatment|2
1787838|NCT00611715|6222668|P2|Overall Study|Death|0
1787839|NCT00611715|6222669|P1|Overall Study|Death|1
1787840|NCT00611715|6222668|P2|Overall Study|Adverse Event|1
1787841|NCT00611715|6222669|P1|Overall Study|Adverse Event|9
1787842|NCT00611715|6222668|P2|Overall Study|Withdrawal by Subject|1
1787843|NCT00611715|6222669|P1|Overall Study|Withdrawal by Subject|5
1787844|NCT00611715|6222668|P2|Overall Study|Disease Progression|4
1787845|NCT00611715|6222669|P1|Overall Study|Disease Progression|24
1787846|NCT00611559|6222689|P3|Overall Study|Protocol Violation|1
1787847|NCT00611559|6222690|P2|Overall Study|Protocol Violation|0
1787848|NCT00611559|6222691|P1|Overall Study|Protocol Violation|1
1787849|NCT00611559|6222689|P3|Overall Study|Lost to Follow-up|0
1787850|NCT00611559|6222690|P2|Overall Study|Lost to Follow-up|1
1787851|NCT00611559|6222691|P1|Overall Study|Lost to Follow-up|0
1787852|NCT00611533|6222750|P2|Second Intervention (6 Weeks)|Adverse Event|2
1787853|NCT00611533|6222751|P1|Second Intervention (6 Weeks)|Adverse Event|0
1787854|NCT00611533|6222750|P2|First Intervention (6 Weeks)|Adverse Event|1
1787855|NCT00611533|6222751|P1|First Intervention (6 Weeks)|Adverse Event|0
1787856|NCT00611533|6222750|P2|First Intervention (6 Weeks)|Never started study|1
1787857|NCT00611533|6222751|P1|First Intervention (6 Weeks)|Never started study|0
1787858|NCT00611455|6222785|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
1787859|NCT00611455|6222786|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
1787860|NCT00611455|6222787|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
1787861|NCT00611455|6222785|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
1787862|NCT00611455|6222786|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
1787863|NCT00611455|6222787|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
1787864|NCT00611455|6222785|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
1787865|NCT00611455|6222786|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
1787866|NCT00611455|6222787|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
1787867|NCT00611455|6222785|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
1787868|NCT00611455|6222786|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
1787869|NCT00611455|6222787|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
1787870|NCT00611455|6222785|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
1787871|NCT00611455|6222786|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
1787872|NCT00611455|6222787|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
1787873|NCT00611455|6222785|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
1787874|NCT00611455|6222786|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
1787875|NCT00611455|6222787|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
1787876|NCT00611455|6222785|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
1787877|NCT00611455|6222786|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
1787878|NCT00611455|6222787|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
1787879|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1787880|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
1787881|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1787882|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
1787883|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
1787884|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
1787885|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
1787886|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
1787887|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
1787888|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1787889|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
1787890|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1787891|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1787892|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
1787893|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1787894|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
1787895|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
1787896|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
1787897|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1787898|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
1787899|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1787900|NCT00611455|6222785|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
1787901|NCT00611455|6222786|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
1787902|NCT00611455|6222787|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
1787903|NCT00611455|6222785|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
1787904|NCT00611455|6222786|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
1787905|NCT00611455|6222787|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
1787906|NCT00611455|6222785|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
1787907|NCT00611455|6222786|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
1787908|NCT00611455|6222787|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
1787909|NCT00611455|6222785|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
1787910|NCT00611455|6222786|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
1787911|NCT00611455|6222787|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
1787912|NCT00611455|6222785|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
1787913|NCT00611455|6222786|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
1787914|NCT00611455|6222787|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
1787915|NCT00611455|6222785|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1787916|NCT00611455|6222786|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1787917|NCT00611455|6222787|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
1787918|NCT00611455|6222785|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
1787919|NCT00611455|6222786|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
1787920|NCT00611455|6222787|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
1787921|NCT00611247|6222967|P2|Overall Study|Lack of Efficacy|16
1787922|NCT00611247|6222968|P1|Overall Study|Lack of Efficacy|1
1787923|NCT00611247|6222967|P2|Overall Study|Death|5
1787924|NCT00611247|6222968|P1|Overall Study|Death|1
1787925|NCT00611130|6222980|P2|Overall Study|Death|0
1787926|NCT00611130|6222981|P1|Overall Study|Death|1
1787927|NCT00611130|6222980|P2|Overall Study|Adverse Event|0
1787928|NCT00611130|6222981|P1|Overall Study|Adverse Event|1
1787929|NCT00611130|6222980|P2|Overall Study|Administrative|1
1787930|NCT00611130|6222981|P1|Overall Study|Administrative|1
1787931|NCT00611130|6222980|P2|Overall Study|Incarceration|2
1787932|NCT00611130|6222981|P1|Overall Study|Incarceration|3
1787933|NCT00611130|6222980|P2|Overall Study|Other|4
1787934|NCT00611130|6222981|P1|Overall Study|Other|5
1787935|NCT00611130|6222980|P2|Overall Study|Withdrawal by Subject|5
1787936|NCT00611130|6222981|P1|Overall Study|Withdrawal by Subject|6
1787937|NCT00611130|6222980|P2|Overall Study|Protocol noncompliance|6
1787938|NCT00611130|6222981|P1|Overall Study|Protocol noncompliance|7
1787939|NCT00611130|6222980|P2|Overall Study|Lost to Follow-up|29
1787940|NCT00611130|6222981|P1|Overall Study|Lost to Follow-up|25
1787941|NCT00611026|6222991|P3|Double-blind Treatment Period|Other|18
1787942|NCT00611026|6222992|P2|Double-blind Treatment Period|Other|20
1787943|NCT00611026|6222993|P1|Double-blind Treatment Period|Other|13
1787944|NCT00611026|6222991|P3|Double-blind Treatment Period|Withdrawal by Subject|16
1787945|NCT00611026|6222992|P2|Double-blind Treatment Period|Withdrawal by Subject|19
1787946|NCT00611026|6222993|P1|Double-blind Treatment Period|Withdrawal by Subject|7
1787947|NCT00611026|6222991|P3|Double-blind Treatment Period|Lost to Follow-up|14
1787948|NCT00611026|6222992|P2|Double-blind Treatment Period|Lost to Follow-up|11
1787949|NCT00611026|6222993|P1|Double-blind Treatment Period|Lost to Follow-up|6
1787950|NCT00611026|6222991|P3|Double-blind Treatment Period|Lack of Efficacy|4
1787951|NCT00611026|6222992|P2|Double-blind Treatment Period|Lack of Efficacy|10
1787952|NCT00611026|6222993|P1|Double-blind Treatment Period|Lack of Efficacy|11
1787953|NCT00611026|6222991|P3|Double-blind Treatment Period|Adverse Event|46
1787954|NCT00611026|6222992|P2|Double-blind Treatment Period|Adverse Event|28
1787955|NCT00611026|6222993|P1|Double-blind Treatment Period|Adverse Event|9
1787956|NCT00611026|6222991|P3|Double-blind Treatment Period|Death|0
1787957|NCT00611026|6222992|P2|Double-blind Treatment Period|Death|0
1787958|NCT00611026|6222993|P1|Double-blind Treatment Period|Death|1
1787959|NCT00611026|6222991|P3|Randomized to Double-blind Treatment|Not treated|3
1787960|NCT00611026|6222992|P2|Randomized to Double-blind Treatment|Not treated|1
1787961|NCT00611026|6222993|P1|Randomized to Double-blind Treatment|Not treated|2
1787962|NCT00610857|6223070|P1|Overall Study|Not evaluable for response|2
1787963|NCT00610714|6223114|P2|Overall Study|Study completion at 120 PFS events|2
1787964|NCT00610714|6223115|P1|Overall Study|Study completion at 120 PFS events|2
1787965|NCT00610714|6223114|P2|Overall Study|Withdrawal by Subject|3
1787966|NCT00610714|6223115|P1|Overall Study|Withdrawal by Subject|9
1787967|NCT00610714|6223114|P2|Overall Study|Death|18
1787968|NCT00610714|6223115|P1|Overall Study|Death|12
1787969|NCT00610714|6223114|P2|Overall Study|Adverse Event|1
1787970|NCT00610714|6223115|P1|Overall Study|Adverse Event|3
1787971|NCT00610675|6223153|P1|Overall Study|Other reason (not specified)|25
1787972|NCT00610675|6223153|P1|Overall Study|Lost to Follow-up|31
1787973|NCT00610675|6223153|P1|Overall Study|Lack of Compliance|7
1787974|NCT00610675|6223153|P1|Overall Study|Reasons unrelated to trial|27
1787975|NCT00610675|6223153|P1|Overall Study|Withdrawal by Subject|28
1787976|NCT00610675|6223153|P1|Overall Study|Insufficient Effect|31
1787977|NCT00610675|6223153|P1|Overall Study|Adverse Event|67
1787978|NCT00610675|6223153|P1|Overall Study|Untreated|4
1787979|NCT00610649|6223175|P11|Overall Study|Withdrawal by Subject|0
1787980|NCT00610649|6223176|P10|Overall Study|Withdrawal by Subject|1
1787981|NCT00610649|6223177|P9|Overall Study|Withdrawal by Subject|0
1787982|NCT00610649|6223178|P8|Overall Study|Withdrawal by Subject|0
1787983|NCT00610649|6223179|P7|Overall Study|Withdrawal by Subject|0
1787984|NCT00610649|6223180|P6|Overall Study|Withdrawal by Subject|0
1787985|NCT00610649|6223181|P5|Overall Study|Withdrawal by Subject|0
1787986|NCT00610649|6223182|P4|Overall Study|Withdrawal by Subject|0
1787987|NCT00610649|6223183|P3|Overall Study|Withdrawal by Subject|0
1787988|NCT00610649|6223184|P2|Overall Study|Withdrawal by Subject|0
1787989|NCT00610649|6223185|P1|Overall Study|Withdrawal by Subject|0
1787990|NCT00610649|6223175|P11|Overall Study|Family Emergency|0
1787991|NCT00610649|6223176|P10|Overall Study|Family Emergency|0
1787992|NCT00610649|6223177|P9|Overall Study|Family Emergency|0
1787993|NCT00610649|6223178|P8|Overall Study|Family Emergency|0
1787994|NCT00610649|6223179|P7|Overall Study|Family Emergency|0
1787995|NCT00610649|6223180|P6|Overall Study|Family Emergency|0
1787996|NCT00610649|6223181|P5|Overall Study|Family Emergency|0
1787997|NCT00610649|6223182|P4|Overall Study|Family Emergency|0
1787998|NCT00610649|6223183|P3|Overall Study|Family Emergency|0
1787999|NCT00610649|6223184|P2|Overall Study|Family Emergency|1
1788000|NCT00610649|6223185|P1|Overall Study|Family Emergency|0
1788001|NCT00610649|6223175|P11|Overall Study|Adverse Event|1
1788002|NCT00610649|6223176|P10|Overall Study|Adverse Event|0
1788003|NCT00610649|6223177|P9|Overall Study|Adverse Event|0
1788004|NCT00610649|6223178|P8|Overall Study|Adverse Event|0
1788005|NCT00610649|6223179|P7|Overall Study|Adverse Event|0
1788006|NCT00610649|6223180|P6|Overall Study|Adverse Event|0
1788007|NCT00610649|6223181|P5|Overall Study|Adverse Event|0
1788008|NCT00610649|6223182|P4|Overall Study|Adverse Event|0
1788009|NCT00610649|6223183|P3|Overall Study|Adverse Event|0
1788010|NCT00610649|6223184|P2|Overall Study|Adverse Event|0
1788011|NCT00610649|6223185|P1|Overall Study|Adverse Event|1
1788012|NCT00610441|6223262|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1788013|NCT00610441|6223263|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1788014|NCT00610441|6223264|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
1788015|NCT00610441|6223265|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
1788016|NCT00610441|6223262|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
1788017|NCT00610441|6223263|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
1788018|NCT00610441|6223264|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
1788019|NCT00610441|6223265|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
1788020|NCT00610441|6223262|P4|Treatment Period 2 - 3 Weeks|Other|1
1788021|NCT00610441|6223263|P3|Treatment Period 2 - 3 Weeks|Other|0
1788022|NCT00610441|6223264|P2|Treatment Period 2 - 3 Weeks|Other|1
1788023|NCT00610441|6223265|P1|Treatment Period 2 - 3 Weeks|Other|1
1788024|NCT00610441|6223262|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1788025|NCT00610441|6223263|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1788026|NCT00610441|6223264|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
1788027|NCT00610441|6223265|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
1788028|NCT00610441|6223262|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
1788029|NCT00610441|6223263|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
1788030|NCT00610441|6223264|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
1788031|NCT00610441|6223265|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
1788032|NCT00610441|6223262|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1788033|NCT00610441|6223263|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1788034|NCT00610441|6223264|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
1788035|NCT00610441|6223265|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
1788036|NCT00610441|6223262|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
1788037|NCT00610441|6223263|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1788038|NCT00610441|6223264|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1788039|NCT00610441|6223265|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
1788040|NCT00610441|6223262|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1788041|NCT00610441|6223263|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
1788042|NCT00610441|6223264|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1788043|NCT00610441|6223265|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
1788044|NCT00610441|6223262|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
1788045|NCT00610441|6223263|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
1788046|NCT00610441|6223264|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
1788047|NCT00610441|6223265|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
1788048|NCT00610363|6223374|P2|Overall Study|Other than specified above|1
1788049|NCT00610363|6223375|P1|Overall Study|Other than specified above|1
1788050|NCT00610363|6223374|P2|Overall Study|Withdrawal by Subject|0
1788051|NCT00610363|6223375|P1|Overall Study|Withdrawal by Subject|1
1788052|NCT00610363|6223374|P2|Overall Study|Lost to Follow-up|0
1788053|NCT00610363|6223375|P1|Overall Study|Lost to Follow-up|4
1788054|NCT00610363|6223374|P2|Overall Study|Lack of Efficacy|0
1788055|NCT00610363|6223375|P1|Overall Study|Lack of Efficacy|2
1788056|NCT00610363|6223374|P2|Overall Study|Adverse Event|1
1788057|NCT00610363|6223375|P1|Overall Study|Adverse Event|3
1788058|NCT00610363|6223374|P2|Overall Study|Non-compliance with protocol|1
1788059|NCT00610363|6223375|P1|Overall Study|Non-compliance with protocol|0
1788060|NCT00610207|6223400|P1|Overall Study|Lost to Follow-up|3
1788061|NCT00610168|6223407|P2|Overall Study|Withdrawal by Subject|0
1788062|NCT00610168|6223408|P1|Overall Study|Withdrawal by Subject|2
1788063|NCT00610155|6223427|P6|Period 3|Adverse Event|0
1788064|NCT00610155|6223428|P5|Period 3|Adverse Event|0
1788065|NCT00610155|6223429|P4|Period 3|Adverse Event|0
1788066|NCT00610155|6223430|P3|Period 3|Adverse Event|0
1788067|NCT00610155|6223431|P2|Period 3|Adverse Event|0
1788068|NCT00610155|6223432|P1|Period 3|Adverse Event|1
1788069|NCT00610155|6223427|P6|Period 1|Withdrawal by Subject|0
1788070|NCT00610155|6223428|P5|Period 1|Withdrawal by Subject|0
1788071|NCT00610155|6223429|P4|Period 1|Withdrawal by Subject|0
1788072|NCT00610155|6223430|P3|Period 1|Withdrawal by Subject|1
1788073|NCT00610155|6223431|P2|Period 1|Withdrawal by Subject|0
1788074|NCT00610155|6223432|P1|Period 1|Withdrawal by Subject|0
1788075|NCT00610129|6223479|P1|Overall Study|Not treated since patients ineligible|3
1788076|NCT00609986|6223485|P2|Overall Study|Did not receive transplant or treatment|3
1788077|NCT00609986|6223486|P1|Overall Study|Did not receive transplant or treatment|8
1788078|NCT00609973|6223500|P2|Overall Study|Withdrawal by Subject|1
1788079|NCT00609973|6223501|P1|Overall Study|Withdrawal by Subject|0
1788080|NCT00609973|6223500|P2|Overall Study|Lost to Follow-up|1
1788081|NCT00609973|6223501|P1|Overall Study|Lost to Follow-up|2
1788082|NCT00609973|6223500|P2|Overall Study|Protocol Violation|3
1788083|NCT00609973|6223501|P1|Overall Study|Protocol Violation|4
1788084|NCT00609973|6223500|P2|Overall Study|Adverse Event|1
1788085|NCT00609973|6223501|P1|Overall Study|Adverse Event|2
1788086|NCT00609947|6223509|P1|Overall Study|Death|1
1788087|NCT00609869|6223514|P1|Overall Study|Mantle cell: not evaluable|4
1788177|NCT00608985|6223857|P2|Overall Study|Administrative/Other|4
1788088|NCT00609869|6223514|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
1788089|NCT00609869|6223514|P1|Overall Study|Hepatitis B infection|1
1788090|NCT00609869|6223514|P1|Overall Study|Severe tumor flare reaction|1
1788091|NCT00609869|6223514|P1|Overall Study|Seizures|1
1788092|NCT00609869|6223514|P1|Overall Study|Withdrawal by Subject|1
1788093|NCT00609869|6223514|P1|Overall Study|Severe hematologic toxicity|1
1788094|NCT00609869|6223514|P1|Overall Study|Withdrawn, ischemic stroke|1
1788095|NCT00609765|6223533|P1|Overall Study|Study ended prior to 12 months|1
1788096|NCT00609674|6223547|P2|Overall Study|Withdrew consent|1
1788097|NCT00609674|6223548|P1|Overall Study|Withdrew consent|2
1788098|NCT00609674|6223547|P2|Overall Study|Lost to Follow-up|0
1788099|NCT00609674|6223548|P1|Overall Study|Lost to Follow-up|1
1788100|NCT00609674|6223547|P2|Overall Study|Protocol Violation|5
1788101|NCT00609674|6223548|P1|Overall Study|Protocol Violation|3
1788102|NCT00609674|6223547|P2|Overall Study|Adverse Event|1
1788103|NCT00609674|6223548|P1|Overall Study|Adverse Event|1
1788104|NCT00609622|6223584|P2|Overall Study|Global deterioration of health status|2
1788105|NCT00609622|6223585|P1|Overall Study|Global deterioration of health status|6
1788106|NCT00609622|6223584|P2|Overall Study|Other|14
1788107|NCT00609622|6223585|P1|Overall Study|Other|7
1788108|NCT00609622|6223584|P2|Overall Study|Study terminated by sponsor|3
1788109|NCT00609622|6223585|P1|Overall Study|Study terminated by sponsor|16
1788110|NCT00609622|6223584|P2|Overall Study|Objective progression or relapse|41
1788111|NCT00609622|6223585|P1|Overall Study|Objective progression or relapse|47
1788112|NCT00609622|6223584|P2|Overall Study|Protocol Violation|1
1788113|NCT00609622|6223585|P1|Overall Study|Protocol Violation|1
1788114|NCT00609622|6223584|P2|Overall Study|Death|4
1788115|NCT00609622|6223585|P1|Overall Study|Death|1
1788116|NCT00609622|6223584|P2|Overall Study|Withdrawal by Subject|20
1788117|NCT00609622|6223585|P1|Overall Study|Withdrawal by Subject|4
1788118|NCT00609622|6223584|P2|Overall Study|Adverse Event|10
1788119|NCT00609622|6223585|P1|Overall Study|Adverse Event|14
1788120|NCT00609609|6223607|P2|Overall Study|Progression|2
1788121|NCT00609609|6223608|P1|Overall Study|Progression|4
1788122|NCT00609609|6223607|P2|Overall Study|Withdrawal by Subject|0
1788123|NCT00609609|6223608|P1|Overall Study|Withdrawal by Subject|2
1788124|NCT00609518|6223620|P2|Overall Study|Death from Adverse Event|2
1788125|NCT00609518|6223621|P1|Overall Study|Death from Adverse Event|2
1788126|NCT00609518|6223620|P2|Overall Study|Physician Decision|3
1788127|NCT00609518|6223621|P1|Overall Study|Physician Decision|1
1788128|NCT00609518|6223620|P2|Overall Study|Lost to Follow-up|0
1788129|NCT00609518|6223621|P1|Overall Study|Lost to Follow-up|3
1788130|NCT00609518|6223620|P2|Overall Study|Withdrawal by Subject|3
1788131|NCT00609518|6223621|P1|Overall Study|Withdrawal by Subject|5
1788132|NCT00609518|6223620|P2|Overall Study|Death from Study Disease|32
1788133|NCT00609518|6223621|P1|Overall Study|Death from Study Disease|32
1788134|NCT00609492|6223636|P3|Overall Study|Lost to Follow-up|4
1788135|NCT00609492|6223637|P2|Overall Study|Lost to Follow-up|1
1788136|NCT00609492|6223638|P1|Overall Study|Lost to Follow-up|1
1788137|NCT00609492|6223636|P3|Overall Study|Withdrawal by Subject|3
1788138|NCT00609492|6223637|P2|Overall Study|Withdrawal by Subject|2
1788139|NCT00609492|6223638|P1|Overall Study|Withdrawal by Subject|0
1788140|NCT00609466|6223723|P3|Overall Study|Lack of Efficacy|2
1788141|NCT00609466|6223724|P2|Overall Study|Lack of Efficacy|2
1788142|NCT00609466|6223725|P1|Overall Study|Lack of Efficacy|0
1788143|NCT00609466|6223723|P3|Overall Study|Adverse Event|1
1788144|NCT00609466|6223724|P2|Overall Study|Adverse Event|3
1788145|NCT00609466|6223725|P1|Overall Study|Adverse Event|2
1788146|NCT00609466|6223723|P3|Overall Study|Withdrawal by Subject|1
1788147|NCT00609466|6223724|P2|Overall Study|Withdrawal by Subject|1
1788148|NCT00609466|6223725|P1|Overall Study|Withdrawal by Subject|0
1788149|NCT00609362|6223753|P2|Overall Study|Adverse Event|0
1788150|NCT00609362|6223754|P1|Overall Study|Adverse Event|1
1788151|NCT00609362|6223753|P2|Overall Study|Withdrawal by Subject|1
1788152|NCT00609362|6223754|P1|Overall Study|Withdrawal by Subject|2
1788153|NCT00609336|6223764|P1|Overall Study|LA or Met at Surgery|9
1788154|NCT00609336|6223764|P1|Overall Study|Death|1
1788155|NCT00609336|6223764|P1|Overall Study|Protocol Violation|3
1788156|NCT00609245|6223815|P1|Overall Study|Adverse Event|1
1788157|NCT00609167|6223823|P2|Overall Study|Stem Cell Transplant|6
1788158|NCT00609167|6223824|P1|Overall Study|Stem Cell Transplant|0
1788159|NCT00609167|6223823|P2|Overall Study|Disease Progression|0
1788160|NCT00609167|6223824|P1|Overall Study|Disease Progression|1
1788161|NCT00609167|6223823|P2|Overall Study|Adverse Event|1
1788162|NCT00609167|6223824|P1|Overall Study|Adverse Event|5
1788163|NCT00609167|6223823|P2|Overall Study|Lack of Efficacy|0
1788164|NCT00609167|6223824|P1|Overall Study|Lack of Efficacy|1
1788165|NCT00609167|6223823|P2|Overall Study|Withdrawal by Subject|0
1788166|NCT00609167|6223824|P1|Overall Study|Withdrawal by Subject|1
1788167|NCT00608985|6223855|P4|Overall Study|Lost to Follow-up|0
1788168|NCT00608985|6223856|P3|Overall Study|Lost to Follow-up|0
1788169|NCT00608985|6223857|P2|Overall Study|Lost to Follow-up|1
1788170|NCT00608985|6223858|P1|Overall Study|Lost to Follow-up|2
1788171|NCT00608985|6223855|P4|Overall Study|Withdrawal of Consent|1
1788172|NCT00608985|6223856|P3|Overall Study|Withdrawal of Consent|1
1788173|NCT00608985|6223857|P2|Overall Study|Withdrawal of Consent|1
1788174|NCT00608985|6223858|P1|Overall Study|Withdrawal of Consent|5
1788175|NCT00608985|6223855|P4|Overall Study|Administrative/Other|2
1788176|NCT00608985|6223856|P3|Overall Study|Administrative/Other|1
1788178|NCT00608985|6223858|P1|Overall Study|Administrative/Other|7
1788179|NCT00608985|6223855|P4|Overall Study|Adverse Event|6
1788180|NCT00608985|6223856|P3|Overall Study|Adverse Event|4
1788181|NCT00608985|6223857|P2|Overall Study|Adverse Event|7
1788182|NCT00608985|6223858|P1|Overall Study|Adverse Event|2
1788183|NCT00608959|6223890|P1|Part 1|Did not meet eligibility criteria|1
1788184|NCT00608907|6223903|P3|Overall Study|Progressive Disease|0
1788185|NCT00608907|6223904|P2|Overall Study|Progressive Disease|0
1788186|NCT00608907|6223905|P1|Overall Study|Progressive Disease|1
1788187|NCT00608907|6223903|P3|Overall Study|Withdrawal by Subject|0
1788188|NCT00608907|6223904|P2|Overall Study|Withdrawal by Subject|0
1788189|NCT00608907|6223905|P1|Overall Study|Withdrawal by Subject|4
1788190|NCT00608907|6223903|P3|Overall Study|Death|0
1788191|NCT00608907|6223904|P2|Overall Study|Death|0
1788192|NCT00608907|6223905|P1|Overall Study|Death|1
1788193|NCT00608907|6223903|P3|Overall Study|Adverse Event|1
1788194|NCT00608907|6223904|P2|Overall Study|Adverse Event|0
1788195|NCT00608907|6223905|P1|Overall Study|Adverse Event|6
1788196|NCT00608881|6223915|P2|Overall Study|Institutionalized|2
1788197|NCT00608881|6223916|P1|Overall Study|Institutionalized|1
1788198|NCT00608881|6223915|P2|Overall Study|Physician Decision|5
1788199|NCT00608881|6223916|P1|Overall Study|Physician Decision|5
1788200|NCT00608881|6223915|P2|Overall Study|Withdrawal by Subject|29
1788201|NCT00608881|6223916|P1|Overall Study|Withdrawal by Subject|18
1788202|NCT00608881|6223915|P2|Overall Study|Lost to Follow-up|14
1788203|NCT00608881|6223916|P1|Overall Study|Lost to Follow-up|28
1788204|NCT00608881|6223915|P2|Overall Study|Adverse Event|3
1788205|NCT00608881|6223916|P1|Overall Study|Adverse Event|5
1788206|NCT00608881|6223915|P2|Overall Study|Death|13
1788207|NCT00608881|6223916|P1|Overall Study|Death|22
1788208|NCT00608868|6223950|P1|Overall Study|Physician Decision|2
1788209|NCT00608868|6223950|P1|Overall Study|Adverse Event|1
1788210|NCT00608868|6223950|P1|Overall Study|Lost to Follow-up|2
1788211|NCT00608868|6223950|P1|Overall Study|Protocol Violation|3
1788212|NCT00608868|6223950|P1|Overall Study|Withdrawal by Subject|7
1788213|NCT00608842|6223961|P4|Overall Study|Lost to Follow-up|0
1788214|NCT00608842|6223962|P3|Overall Study|Lost to Follow-up|0
1788215|NCT00608842|6223963|P2|Overall Study|Lost to Follow-up|0
1788216|NCT00608842|6223964|P1|Overall Study|Lost to Follow-up|1
1788217|NCT00608842|6223961|P4|Overall Study|Participant's Request|1
1788218|NCT00608842|6223962|P3|Overall Study|Participant's Request|2
1788219|NCT00608842|6223963|P2|Overall Study|Participant's Request|1
1788220|NCT00608842|6223964|P1|Overall Study|Participant's Request|0
1788221|NCT00608829|6223998|P1|Overall Study|Subject refuses to follow up or return.|5
1788222|NCT00608829|6223998|P1|Overall Study|Withdrawal by Subject|4
1788223|NCT00608829|6223998|P1|Overall Study|Death|6
1788224|NCT00608582|6224024|P2|Overall Study|Early stage Design Change|3
1788225|NCT00608582|6224025|P1|Overall Study|Early stage Design Change|0
1788226|NCT00608582|6224024|P2|Overall Study|Illicit Drug Use|0
1788227|NCT00608582|6224025|P1|Overall Study|Illicit Drug Use|1
1788228|NCT00608582|6224024|P2|Overall Study|No Best Response in Phase 1 located|1
1788229|NCT00608582|6224025|P1|Overall Study|No Best Response in Phase 1 located|1
1788230|NCT00608582|6224024|P2|Overall Study|Lost to Follow-up|0
1788231|NCT00608582|6224025|P1|Overall Study|Lost to Follow-up|2
1788232|NCT00608569|6224035|P2|Overall Study|Unable to adhere with study requirements|1
1788233|NCT00608569|6224036|P1|Overall Study|Unable to adhere with study requirements|0
1788234|NCT00608569|6224035|P2|Overall Study|Adverse Event|0
1788235|NCT00608569|6224036|P1|Overall Study|Adverse Event|1
1788236|NCT00608569|6224035|P2|Overall Study|Withdrawal by Subject|0
1788237|NCT00608569|6224036|P1|Overall Study|Withdrawal by Subject|1
1788238|NCT00608569|6224035|P2|Overall Study|Lost to Follow-up|5
1788239|NCT00608569|6224036|P1|Overall Study|Lost to Follow-up|4
1788240|NCT00608569|6224035|P2|Overall Study|Death|3
1788241|NCT00608569|6224036|P1|Overall Study|Death|4
1788242|NCT00608543|6224056|P1|Overall Study|Adverse Event|4
1788243|NCT00608530|6224069|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1788244|NCT00608530|6224070|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
1788245|NCT00608530|6224071|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1788246|NCT00608530|6224072|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
1788247|NCT00608530|6224069|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
1788248|NCT00608530|6224070|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
1788249|NCT00608530|6224071|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
1788250|NCT00608530|6224072|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
1788251|NCT00608530|6224069|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1788252|NCT00608530|6224070|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
1788253|NCT00608530|6224071|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1788254|NCT00608530|6224072|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
1788255|NCT00608530|6224069|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
1788256|NCT00608530|6224070|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
1788257|NCT00608530|6224071|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
1788258|NCT00608530|6224072|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
1788259|NCT00608530|6224069|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
1788260|NCT00608530|6224070|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
1788261|NCT00608530|6224071|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
1788262|NCT00608530|6224072|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
1788263|NCT00608530|6224069|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
1788264|NCT00608530|6224070|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
1788265|NCT00608530|6224071|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
1788266|NCT00608530|6224072|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
1788267|NCT00608517|6224093|P3|Overall Study|Death|0
1788268|NCT00608517|6224094|P2|Overall Study|Death|0
1788269|NCT00608517|6224095|P1|Overall Study|Death|1
1788270|NCT00608426|6224275|P2|Overall Study|refused, health issues, wrong address|348
1788271|NCT00608426|6224276|P1|Overall Study|refused, health issues, wrong address|319
1788272|NCT00608426|6224275|P2|Overall Study|Lost to Follow-up|521
1788273|NCT00608426|6224276|P1|Overall Study|Lost to Follow-up|485
1788274|NCT00608426|6224275|P2|Overall Study|Death|36
1788275|NCT00608426|6224276|P1|Overall Study|Death|32
1788276|NCT00608322|6224288|P2|Overall Study|Death|1
1788277|NCT00608322|6224289|P1|Overall Study|Death|2
1788278|NCT00608244|6224295|P1|Overall Study|Low trough levels|1
1788279|NCT00608244|6224295|P1|Overall Study|Adverse Event|1
1788280|NCT00608205|6224306|P2|Overall Study|Patient non-compliant|1
1788281|NCT00608205|6224307|P1|Overall Study|Patient non-compliant|0
1788282|NCT00608205|6224306|P2|Overall Study|Adverse Event|2
1788283|NCT00608205|6224307|P1|Overall Study|Adverse Event|3
1788284|NCT00608023|6224424|P3|Overall Study|Unknown reason|0
1788285|NCT00608023|6224425|P2|Overall Study|Unknown reason|3
1788286|NCT00608023|6224426|P1|Overall Study|Unknown reason|0
1788287|NCT00608023|6224424|P3|Overall Study|Protocol Violation|1
1788288|NCT00608023|6224425|P2|Overall Study|Protocol Violation|3
1788289|NCT00608023|6224426|P1|Overall Study|Protocol Violation|1
1788290|NCT00608023|6224424|P3|Overall Study|Lost to Follow-up|1
1788291|NCT00608023|6224425|P2|Overall Study|Lost to Follow-up|2
1788292|NCT00608023|6224426|P1|Overall Study|Lost to Follow-up|2
1788293|NCT00608023|6224424|P3|Overall Study|Adverse Event|5
1788294|NCT00608023|6224425|P2|Overall Study|Adverse Event|4
1788295|NCT00608023|6224426|P1|Overall Study|Adverse Event|1
1788296|NCT00608023|6224424|P3|Overall Study|Withdrawal by Subject|7
1788297|NCT00608023|6224425|P2|Overall Study|Withdrawal by Subject|10
1788298|NCT00608023|6224426|P1|Overall Study|Withdrawal by Subject|8
1788299|NCT00607997|6224450|P4|Overall Study|Other without explanation|1
1788300|NCT00607997|6224451|P3|Overall Study|Other without explanation|4
1788301|NCT00607997|6224452|P2|Overall Study|Other without explanation|0
1788302|NCT00607997|6224453|P1|Overall Study|Other without explanation|2
1788303|NCT00607997|6224450|P4|Overall Study|Relapse, recurrent illness|0
1788304|NCT00607997|6224451|P3|Overall Study|Relapse, recurrent illness|2
1788305|NCT00607997|6224452|P2|Overall Study|Relapse, recurrent illness|0
1788306|NCT00607997|6224453|P1|Overall Study|Relapse, recurrent illness|4
1788307|NCT00607997|6224450|P4|Overall Study|Physician Decision|0
1788308|NCT00607997|6224451|P3|Overall Study|Physician Decision|0
1788309|NCT00607997|6224452|P2|Overall Study|Physician Decision|1
1788310|NCT00607997|6224453|P1|Overall Study|Physician Decision|4
1788311|NCT00607997|6224450|P4|Overall Study|Adverse Event|0
1788312|NCT00607997|6224451|P3|Overall Study|Adverse Event|2
1788313|NCT00607997|6224452|P2|Overall Study|Adverse Event|1
1788314|NCT00607997|6224453|P1|Overall Study|Adverse Event|3
1788315|NCT00607997|6224450|P4|Overall Study|Death|5
1788316|NCT00607997|6224451|P3|Overall Study|Death|2
1788317|NCT00607997|6224452|P2|Overall Study|Death|5
1788318|NCT00607997|6224453|P1|Overall Study|Death|8
1788319|NCT00607997|6224450|P4|Overall Study|Lack of Efficacy|10
1788320|NCT00607997|6224451|P3|Overall Study|Lack of Efficacy|14
1788321|NCT00607997|6224452|P2|Overall Study|Lack of Efficacy|20
1788322|NCT00607997|6224453|P1|Overall Study|Lack of Efficacy|6
1788323|NCT00607919|6224511|P2|Open-Label Phase|Parent/Caregiver Decision|2
1788324|NCT00607919|6224512|P1|Open-Label Phase|Parent/Caregiver Decision|1
1788325|NCT00607919|6224511|P2|Open-Label Phase|Withdrawal by Subject|2
1788326|NCT00607919|6224512|P1|Open-Label Phase|Withdrawal by Subject|2
1788327|NCT00607919|6224511|P2|Open-Label Phase|Protocol Violation|2
1788328|NCT00607919|6224512|P1|Open-Label Phase|Protocol Violation|2
1788329|NCT00607919|6224511|P2|Open-Label Phase|Lost to Follow-up|1
1788330|NCT00607919|6224512|P1|Open-Label Phase|Lost to Follow-up|4
1788331|NCT00607919|6224511|P2|Open-Label Phase|Adverse Event|5
1788332|NCT00607919|6224512|P1|Open-Label Phase|Adverse Event|1
1788333|NCT00607919|6224511|P2|Acute Phase|Withdrawal by Subject|3
1788334|NCT00607919|6224512|P1|Acute Phase|Withdrawal by Subject|3
1788335|NCT00607919|6224511|P2|Acute Phase|Protocol Violation|1
1788336|NCT00607919|6224512|P1|Acute Phase|Protocol Violation|5
1788337|NCT00607919|6224511|P2|Acute Phase|Parent/Caregiver Decision|4
1788338|NCT00607919|6224512|P1|Acute Phase|Parent/Caregiver Decision|6
1788339|NCT00607919|6224511|P2|Acute Phase|Lost to Follow-up|3
1788340|NCT00607919|6224512|P1|Acute Phase|Lost to Follow-up|9
1788341|NCT00607919|6224511|P2|Acute Phase|Lack of Efficacy|2
1788342|NCT00607919|6224512|P1|Acute Phase|Lack of Efficacy|1
1788343|NCT00607919|6224511|P2|Acute Phase|Entry Criteria Not Met|1
1788344|NCT00607919|6224512|P1|Acute Phase|Entry Criteria Not Met|1
1788345|NCT00607919|6224511|P2|Acute Phase|Adverse Event|2
1788346|NCT00607919|6224512|P1|Acute Phase|Adverse Event|9
1788347|NCT00607893|6224570|P2|Overall Study|Withdrew due to hypertensive urgency|1
1788348|NCT00607893|6224571|P1|Overall Study|Withdrew due to hypertensive urgency|1
1788349|NCT00607893|6224570|P2|Overall Study|Declined to be treated|0
1788350|NCT00607893|6224571|P1|Overall Study|Declined to be treated|1
1788351|NCT00607893|6224570|P2|Overall Study|withdrew could not tolerate CPAP|1
1788352|NCT00607893|6224571|P1|Overall Study|withdrew could not tolerate CPAP|0
1788353|NCT00607893|6224570|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
1788354|NCT00607893|6224571|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
1788355|NCT00607893|6224570|P2|Overall Study|withdrew due to loss of interest|1
1788356|NCT00607893|6224571|P1|Overall Study|withdrew due to loss of interest|0
1788357|NCT00607893|6224570|P2|Overall Study|Lost to Follow-up|0
1788358|NCT00607893|6224571|P1|Overall Study|Lost to Follow-up|4
1788359|NCT00607880|6224599|P2|Overall Study|Unable to place port due to occlusion|0
1788360|NCT00607880|6224600|P1|Overall Study|Unable to place port due to occlusion|1
1788361|NCT00607789|6224650|P2|Overall Study|Withdrawal by Subject|0
1788362|NCT00607789|6224651|P1|Overall Study|Withdrawal by Subject|1
1788363|NCT00607789|6224650|P2|Overall Study|Lost to Follow-up|5
1788364|NCT00607789|6224651|P1|Overall Study|Lost to Follow-up|0
1788365|NCT00607789|6224650|P2|Overall Study|Inadequate adherence|0
1788366|NCT00607789|6224651|P1|Overall Study|Inadequate adherence|3
1788367|NCT00607789|6224650|P2|Overall Study|Lack of Efficacy|1
1788368|NCT00607789|6224651|P1|Overall Study|Lack of Efficacy|0
1788369|NCT00607789|6224650|P2|Overall Study|Adverse Event|0
1788370|NCT00607789|6224651|P1|Overall Study|Adverse Event|3
1788371|NCT00607724|6224666|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1788372|NCT00607724|6224667|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1788373|NCT00607724|6224668|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1788374|NCT00607724|6224669|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
1788375|NCT00607724|6224670|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1788376|NCT00607724|6224671|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1788377|NCT00607724|6224672|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
1788378|NCT00607724|6224666|P7|Stage 2: Expanded Cohort|Physician Decision|0
1788379|NCT00607724|6224667|P6|Stage 2: Expanded Cohort|Physician Decision|1
1788380|NCT00607724|6224668|P5|Stage 2: Expanded Cohort|Physician Decision|1
1788381|NCT00607724|6224669|P4|Stage 2: Expanded Cohort|Physician Decision|0
1788382|NCT00607724|6224670|P3|Stage 2: Expanded Cohort|Physician Decision|0
1788383|NCT00607724|6224671|P2|Stage 2: Expanded Cohort|Physician Decision|0
1788384|NCT00607724|6224672|P1|Stage 2: Expanded Cohort|Physician Decision|0
1788385|NCT00607724|6224666|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
1788386|NCT00607724|6224667|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
1788387|NCT00607724|6224668|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
1788388|NCT00607724|6224669|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
1788389|NCT00607724|6224670|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1788390|NCT00607724|6224671|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1788391|NCT00607724|6224672|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
1788392|NCT00607724|6224666|P7|Stage 2: Expanded Cohort|Adverse Event|1
1788393|NCT00607724|6224667|P6|Stage 2: Expanded Cohort|Adverse Event|0
1788394|NCT00607724|6224668|P5|Stage 2: Expanded Cohort|Adverse Event|0
1788395|NCT00607724|6224669|P4|Stage 2: Expanded Cohort|Adverse Event|0
1788396|NCT00607724|6224670|P3|Stage 2: Expanded Cohort|Adverse Event|0
1788397|NCT00607724|6224671|P2|Stage 2: Expanded Cohort|Adverse Event|0
1788398|NCT00607724|6224672|P1|Stage 2: Expanded Cohort|Adverse Event|0
1788399|NCT00607724|6224666|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1788400|NCT00607724|6224667|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1788401|NCT00607724|6224668|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1788402|NCT00607724|6224669|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
1788403|NCT00607724|6224670|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
1788404|NCT00607724|6224671|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
1788405|NCT00607724|6224672|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
1788406|NCT00607386|6224835|P1|Overall Study|Physician Decision|1
1788407|NCT00607373|6224850|P2|Follow-up Period|Withdrawal by Subject|3
1788408|NCT00607373|6224851|P1|Follow-up Period|Withdrawal by Subject|1
1788409|NCT00607373|6224850|P2|Follow-up Period|Protocol Violation|1
1788410|NCT00607373|6224851|P1|Follow-up Period|Protocol Violation|0
1788411|NCT00607373|6224850|P2|Follow-up Period|Other|1
1788412|NCT00607373|6224851|P1|Follow-up Period|Other|0
1788413|NCT00607373|6224850|P2|Treatment Period|Withdrawal by Subject|1
1788414|NCT00607373|6224851|P1|Treatment Period|Withdrawal by Subject|0
1788415|NCT00607373|6224850|P2|Treatment Period|Physician Decision|1
1788416|NCT00607373|6224851|P1|Treatment Period|Physician Decision|0
1788417|NCT00607373|6224850|P2|Treatment Period|Adverse Event|4
1788418|NCT00607373|6224851|P1|Treatment Period|Adverse Event|0
1788419|NCT00607087|6224953|P3|Period 3|Adverse Event|0
1788420|NCT00607087|6224954|P2|Period 3|Adverse Event|1
1788421|NCT00607087|6224955|P1|Period 3|Adverse Event|0
1788422|NCT00607087|6224953|P3|Period 3|Withdrawal by Subject|0
1788423|NCT00607087|6224954|P2|Period 3|Withdrawal by Subject|1
1788424|NCT00607087|6224955|P1|Period 3|Withdrawal by Subject|2
1788425|NCT00607087|6224953|P3|Period 2|Poor compliance to protocol|1
1788426|NCT00607087|6224954|P2|Period 2|Poor compliance to protocol|0
1788427|NCT00607087|6224955|P1|Period 2|Poor compliance to protocol|0
1788428|NCT00607087|6224953|P3|Period 2|Adverse Event|3
1788429|NCT00607087|6224954|P2|Period 2|Adverse Event|1
1788430|NCT00607087|6224955|P1|Period 2|Adverse Event|0
1788431|NCT00607087|6224953|P3|Period 2|Other reason|0
1788432|NCT00607087|6224954|P2|Period 2|Other reason|1
1788433|NCT00607087|6224955|P1|Period 2|Other reason|1
1788434|NCT00607087|6224953|P3|Period 2|Withdrawal by Subject|1
1788435|NCT00607087|6224954|P2|Period 2|Withdrawal by Subject|1
1788436|NCT00607087|6224955|P1|Period 2|Withdrawal by Subject|0
1788437|NCT00607087|6224953|P3|Period 1|Other reason|2
1788438|NCT00607087|6224954|P2|Period 1|Other reason|4
1788439|NCT00607087|6224955|P1|Period 1|Other reason|0
1788440|NCT00607087|6224953|P3|Period 1|Lost to Follow-up|0
1788441|NCT00607087|6224954|P2|Period 1|Lost to Follow-up|0
1788442|NCT00607087|6224955|P1|Period 1|Lost to Follow-up|1
1788443|NCT00607087|6224953|P3|Period 1|Poor compliance to protocol|0
1788444|NCT00607087|6224954|P2|Period 1|Poor compliance to protocol|0
1788445|NCT00607087|6224955|P1|Period 1|Poor compliance to protocol|1
1788446|NCT00607087|6224953|P3|Period 1|Adverse Event|0
1788447|NCT00607087|6224954|P2|Period 1|Adverse Event|0
1788448|NCT00607087|6224955|P1|Period 1|Adverse Event|3
1788449|NCT00607087|6224953|P3|Period 1|Withdrawal by Subject|3
1788450|NCT00607087|6224954|P2|Period 1|Withdrawal by Subject|2
1788451|NCT00607087|6224955|P1|Period 1|Withdrawal by Subject|7
1788452|NCT00607087|6224953|P3|Overall Study|Lost to Follow-up|0
1788453|NCT00607087|6224954|P2|Overall Study|Lost to Follow-up|0
1788454|NCT00607087|6224955|P1|Overall Study|Lost to Follow-up|1
1788455|NCT00607087|6224953|P3|Overall Study|Poor compliance to protocol|1
1788456|NCT00607087|6224954|P2|Overall Study|Poor compliance to protocol|0
1788457|NCT00607087|6224955|P1|Overall Study|Poor compliance to protocol|1
1788458|NCT00607087|6224953|P3|Overall Study|Other reason|2
1788459|NCT00607087|6224954|P2|Overall Study|Other reason|5
1788460|NCT00607087|6224955|P1|Overall Study|Other reason|1
1788461|NCT00607087|6224953|P3|Overall Study|Adverse Event|3
1788462|NCT00607087|6224954|P2|Overall Study|Adverse Event|2
1788463|NCT00607087|6224955|P1|Overall Study|Adverse Event|3
1788464|NCT00607087|6224953|P3|Overall Study|Withdrawal by Subject|4
1788465|NCT00607087|6224954|P2|Overall Study|Withdrawal by Subject|4
1788466|NCT00607087|6224955|P1|Overall Study|Withdrawal by Subject|9
1788467|NCT00607048|6225013|P6|Overall Study|Other|1
1788468|NCT00607048|6225014|P5|Overall Study|Other|0
1788469|NCT00607048|6225015|P4|Overall Study|Other|0
1788470|NCT00607048|6225016|P3|Overall Study|Other|0
1788471|NCT00607048|6225017|P2|Overall Study|Other|1
1788472|NCT00607048|6225018|P1|Overall Study|Other|1
1788473|NCT00607048|6225013|P6|Overall Study|Withdrawal by Subject|2
1788474|NCT00607048|6225014|P5|Overall Study|Withdrawal by Subject|0
1788475|NCT00607048|6225015|P4|Overall Study|Withdrawal by Subject|1
1788476|NCT00607048|6225016|P3|Overall Study|Withdrawal by Subject|0
1788477|NCT00607048|6225017|P2|Overall Study|Withdrawal by Subject|0
1788478|NCT00607048|6225018|P1|Overall Study|Withdrawal by Subject|0
1788479|NCT00607048|6225013|P6|Overall Study|Objective disease progression - relapse|2
1788480|NCT00607048|6225014|P5|Overall Study|Objective disease progression - relapse|2
1788481|NCT00607048|6225015|P4|Overall Study|Objective disease progression - relapse|2
1788482|NCT00607048|6225016|P3|Overall Study|Objective disease progression - relapse|4
1788483|NCT00607048|6225017|P2|Overall Study|Objective disease progression - relapse|2
1788484|NCT00607048|6225018|P1|Overall Study|Objective disease progression - relapse|1
1788485|NCT00607048|6225013|P6|Overall Study|Global deterioration of health|0
1788486|NCT00607048|6225014|P5|Overall Study|Global deterioration of health|0
1788487|NCT00607048|6225015|P4|Overall Study|Global deterioration of health|0
1788488|NCT00607048|6225016|P3|Overall Study|Global deterioration of health|0
1788489|NCT00607048|6225017|P2|Overall Study|Global deterioration of health|0
1788490|NCT00607048|6225018|P1|Overall Study|Global deterioration of health|1
1788491|NCT00607048|6225013|P6|Overall Study|Adverse Event|0
1788492|NCT00607048|6225014|P5|Overall Study|Adverse Event|4
1788493|NCT00607048|6225015|P4|Overall Study|Adverse Event|0
1788494|NCT00607048|6225016|P3|Overall Study|Adverse Event|0
1788495|NCT00607048|6225017|P2|Overall Study|Adverse Event|1
1788496|NCT00607048|6225018|P1|Overall Study|Adverse Event|0
1788497|NCT00607022|6225103|P3|Overall Study|Withdrawal by Subject|0
1788498|NCT00607022|6225104|P2|Overall Study|Withdrawal by Subject|0
1788499|NCT00607022|6225105|P1|Overall Study|Withdrawal by Subject|1
1788500|NCT00606931|6225122|P1|Overall Study|Withdrawal by Subject|3
1788501|NCT00606905|6225130|P2|Overall Study|Withdrew|5
1788502|NCT00606905|6225131|P1|Overall Study|Withdrew|5
1788503|NCT00606905|6225130|P2|Overall Study|Non-Index Pregnancy|4
1788504|NCT00606905|6225131|P1|Overall Study|Non-Index Pregnancy|1
1788505|NCT00606905|6225130|P2|Overall Study|No Pregnancy|6
1788506|NCT00606905|6225131|P1|Overall Study|No Pregnancy|9
1788507|NCT00606892|6225137|P2|First Intervention|Protocol Violation|4
1788508|NCT00606892|6225138|P1|First Intervention|Protocol Violation|1
1788509|NCT00606801|6225172|P2|Intervention|Protocol Violation|3
1788510|NCT00606801|6225173|P1|Intervention|Protocol Violation|3
1788511|NCT00606684|6225201|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
1788512|NCT00606684|6225202|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
1788513|NCT00606684|6225203|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
1788514|NCT00606684|6225204|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
1788515|NCT00606684|6225205|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
1788516|NCT00606684|6225206|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
1788517|NCT00606684|6225207|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
1788518|NCT00606684|6225201|P7|Double-Blind Treatment Period|Physician Decision|2
1788519|NCT00606684|6225202|P6|Double-Blind Treatment Period|Physician Decision|1
1788520|NCT00606684|6225203|P5|Double-Blind Treatment Period|Physician Decision|3
1788521|NCT00606684|6225204|P4|Double-Blind Treatment Period|Physician Decision|0
1788522|NCT00606684|6225205|P3|Double-Blind Treatment Period|Physician Decision|1
1788523|NCT00606684|6225206|P2|Double-Blind Treatment Period|Physician Decision|5
1788524|NCT00606684|6225207|P1|Double-Blind Treatment Period|Physician Decision|0
1788525|NCT00606684|6225201|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1788526|NCT00606684|6225202|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
1788527|NCT00606684|6225203|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
1788528|NCT00606684|6225204|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1788529|NCT00606684|6225205|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
1788530|NCT00606684|6225206|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
1788531|NCT00606684|6225207|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
1788532|NCT00606684|6225201|P7|Double-Blind Treatment Period|Protocol Violation|4
1788533|NCT00606684|6225202|P6|Double-Blind Treatment Period|Protocol Violation|3
1788534|NCT00606684|6225203|P5|Double-Blind Treatment Period|Protocol Violation|0
1788535|NCT00606684|6225204|P4|Double-Blind Treatment Period|Protocol Violation|3
1788536|NCT00606684|6225205|P3|Double-Blind Treatment Period|Protocol Violation|5
1788537|NCT00606684|6225206|P2|Double-Blind Treatment Period|Protocol Violation|5
1788538|NCT00606684|6225207|P1|Double-Blind Treatment Period|Protocol Violation|0
1788539|NCT00606684|6225201|P7|Double-Blind Treatment Period|Lack of Efficacy|0
1788540|NCT00606684|6225202|P6|Double-Blind Treatment Period|Lack of Efficacy|0
1788541|NCT00606684|6225203|P5|Double-Blind Treatment Period|Lack of Efficacy|1
1788542|NCT00606684|6225204|P4|Double-Blind Treatment Period|Lack of Efficacy|0
1788543|NCT00606684|6225205|P3|Double-Blind Treatment Period|Lack of Efficacy|0
1788544|NCT00606684|6225206|P2|Double-Blind Treatment Period|Lack of Efficacy|1
1788545|NCT00606684|6225207|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1788546|NCT00606684|6225201|P7|Double-Blind Treatment Period|Adverse Event|1
1788547|NCT00606684|6225202|P6|Double-Blind Treatment Period|Adverse Event|0
1788548|NCT00606684|6225203|P5|Double-Blind Treatment Period|Adverse Event|2
1788549|NCT00606684|6225204|P4|Double-Blind Treatment Period|Adverse Event|4
1788550|NCT00606684|6225205|P3|Double-Blind Treatment Period|Adverse Event|2
1788551|NCT00606684|6225206|P2|Double-Blind Treatment Period|Adverse Event|3
1788552|NCT00606684|6225207|P1|Double-Blind Treatment Period|Adverse Event|0
1788553|NCT00606684|6225201|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1788554|NCT00606684|6225202|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1788555|NCT00606684|6225203|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1788556|NCT00606684|6225204|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1788557|NCT00606684|6225205|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1788558|NCT00606684|6225206|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
1788559|NCT00606684|6225207|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
1788560|NCT00606684|6225201|P7|2-week Single-Blind Run-in Period|Adverse Event|0
1788561|NCT00606684|6225202|P6|2-week Single-Blind Run-in Period|Adverse Event|0
1788562|NCT00606684|6225203|P5|2-week Single-Blind Run-in Period|Adverse Event|0
1788563|NCT00606684|6225204|P4|2-week Single-Blind Run-in Period|Adverse Event|0
1788564|NCT00606684|6225205|P3|2-week Single-Blind Run-in Period|Adverse Event|0
1788565|NCT00606684|6225206|P2|2-week Single-Blind Run-in Period|Adverse Event|0
1788566|NCT00606684|6225207|P1|2-week Single-Blind Run-in Period|Adverse Event|2
1788567|NCT00606684|6225201|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1788568|NCT00606684|6225202|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1788569|NCT00606684|6225203|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1788570|NCT00606684|6225204|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1788571|NCT00606684|6225205|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1788572|NCT00606684|6225206|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
1788573|NCT00606684|6225207|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
1788574|NCT00606684|6225201|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1788575|NCT00606684|6225202|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1788576|NCT00606684|6225203|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1788577|NCT00606684|6225204|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1788578|NCT00606684|6225205|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1788579|NCT00606684|6225206|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
1788580|NCT00606684|6225207|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
1788581|NCT00606684|6225201|P7|2-week Single-Blind Run-in Period|Physician Decision|0
1788582|NCT00606684|6225202|P6|2-week Single-Blind Run-in Period|Physician Decision|0
1788583|NCT00606684|6225203|P5|2-week Single-Blind Run-in Period|Physician Decision|0
1788584|NCT00606684|6225204|P4|2-week Single-Blind Run-in Period|Physician Decision|0
1788585|NCT00606684|6225205|P3|2-week Single-Blind Run-in Period|Physician Decision|0
1788586|NCT00606684|6225206|P2|2-week Single-Blind Run-in Period|Physician Decision|0
1788587|NCT00606684|6225207|P1|2-week Single-Blind Run-in Period|Physician Decision|18
1788588|NCT00606684|6225201|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1788589|NCT00606684|6225202|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1788590|NCT00606684|6225203|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1788591|NCT00606684|6225204|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1788592|NCT00606684|6225205|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1788593|NCT00606684|6225206|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
1788594|NCT00606684|6225207|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
1788595|NCT00606684|6225201|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1788596|NCT00606684|6225202|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1788597|NCT00606684|6225203|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1788598|NCT00606684|6225204|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1788599|NCT00606684|6225205|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1788600|NCT00606684|6225206|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
1788601|NCT00606684|6225207|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
1788602|NCT00606632|6225239|P1|Overall Study|Miscellaneous reasons|9
1788603|NCT00606632|6225239|P1|Overall Study|Withdrawal by Subject|13
1788604|NCT00606593|6225252|P10|Overall Study|Administrative/Other|0
1788605|NCT00606593|6225253|P9|Overall Study|Administrative/Other|0
1788606|NCT00606593|6225254|P8|Overall Study|Administrative/Other|0
1788607|NCT00606593|6225255|P7|Overall Study|Administrative/Other|0
1788608|NCT00606593|6225256|P6|Overall Study|Administrative/Other|0
1788609|NCT00606593|6225257|P5|Overall Study|Administrative/Other|0
1788610|NCT00606593|6225258|P4|Overall Study|Administrative/Other|0
1788611|NCT00606593|6225259|P3|Overall Study|Administrative/Other|1
1788612|NCT00606593|6225260|P2|Overall Study|Administrative/Other|0
1788613|NCT00606593|6225261|P1|Overall Study|Administrative/Other|0
1788614|NCT00606593|6225252|P10|Overall Study|Withdrawal of consent|0
1788615|NCT00606593|6225253|P9|Overall Study|Withdrawal of consent|0
1788616|NCT00606593|6225254|P8|Overall Study|Withdrawal of consent|0
1788617|NCT00606593|6225255|P7|Overall Study|Withdrawal of consent|0
1788618|NCT00606593|6225256|P6|Overall Study|Withdrawal of consent|0
1788619|NCT00606593|6225257|P5|Overall Study|Withdrawal of consent|0
1788620|NCT00606593|6225258|P4|Overall Study|Withdrawal of consent|0
1788621|NCT00606593|6225259|P3|Overall Study|Withdrawal of consent|1
1788622|NCT00606593|6225260|P2|Overall Study|Withdrawal of consent|0
1788623|NCT00606593|6225261|P1|Overall Study|Withdrawal of consent|1
1788624|NCT00606593|6225252|P10|Overall Study|Adverse Event|0
1788625|NCT00606593|6225253|P9|Overall Study|Adverse Event|1
1788626|NCT00606593|6225254|P8|Overall Study|Adverse Event|2
1788627|NCT00606593|6225255|P7|Overall Study|Adverse Event|1
1788628|NCT00606593|6225256|P6|Overall Study|Adverse Event|0
1788629|NCT00606593|6225257|P5|Overall Study|Adverse Event|1
1788630|NCT00606593|6225258|P4|Overall Study|Adverse Event|1
1788631|NCT00606593|6225259|P3|Overall Study|Adverse Event|0
1788632|NCT00606593|6225260|P2|Overall Study|Adverse Event|0
1788633|NCT00606593|6225261|P1|Overall Study|Adverse Event|0
1788634|NCT00606580|6225282|P3|Overall Study|Withdrawal by Subject|0
1788635|NCT00606580|6225283|P2|Overall Study|Withdrawal by Subject|1
1788636|NCT00606580|6225284|P1|Overall Study|Withdrawal by Subject|0
1788637|NCT00606580|6225282|P3|Overall Study|Withdrawal by investigator|6
1788638|NCT00606580|6225283|P2|Overall Study|Withdrawal by investigator|1
1788639|NCT00606580|6225284|P1|Overall Study|Withdrawal by investigator|0
1788640|NCT00606580|6225282|P3|Overall Study|Clinical failures|12
1788641|NCT00606580|6225283|P2|Overall Study|Clinical failures|0
1788642|NCT00606580|6225284|P1|Overall Study|Clinical failures|1
1788643|NCT00606580|6225282|P3|Overall Study|Lost to Follow-up|4
1788644|NCT00606580|6225283|P2|Overall Study|Lost to Follow-up|1
1788645|NCT00606580|6225284|P1|Overall Study|Lost to Follow-up|1
1788646|NCT00606502|6225350|P2|Treatment|Treatment ongoing at time of data cutoff|3
1788647|NCT00606502|6225351|P1|Treatment|Treatment ongoing at time of data cutoff|0
1788648|NCT00606502|6225350|P2|Randomization|Randomized but not treated|0
1788649|NCT00606502|6225351|P1|Randomization|Randomized but not treated|3
1788650|NCT00606320|6225372|P1|Overall Study|Progression to depressive phase|4
1788651|NCT00606320|6225372|P1|Overall Study|Withdrawal by Subject|10
1788652|NCT00606320|6225372|P1|Overall Study|Protocol Violation|8
1788653|NCT00606320|6225372|P1|Overall Study|Physician Decision|7
1788654|NCT00606320|6225372|P1|Overall Study|Lack of Efficacy|5
1788655|NCT00606320|6225372|P1|Overall Study|Adverse Event|3
1788656|NCT00606307|6225377|P1|Overall Study|QTc prolongation|1
1788657|NCT00606307|6225377|P1|Overall Study|Disease progression|6
1788658|NCT00606307|6225377|P1|Overall Study|Withdrawal by Subject|2
1788659|NCT00606307|6225377|P1|Overall Study|Adverse Event|2
1788660|NCT00606281|6225385|P2|Overall Study|Change of residence or other commitments|1
1788661|NCT00606281|6225386|P1|Overall Study|Change of residence or other commitments|1
1788662|NCT00606281|6225385|P2|Overall Study|Progression to depressive phase|1
1788663|NCT00606281|6225386|P1|Overall Study|Progression to depressive phase|1
1788664|NCT00606281|6225385|P2|Overall Study|Withdrawal by Subject|13
1788665|NCT00606281|6225386|P1|Overall Study|Withdrawal by Subject|11
1788666|NCT00606281|6225385|P2|Overall Study|Protocol Violation|3
1788667|NCT00606281|6225386|P1|Overall Study|Protocol Violation|3
1788668|NCT00606281|6225385|P2|Overall Study|Physician Decision|1
1788669|NCT00606281|6225386|P1|Overall Study|Physician Decision|0
1788670|NCT00606281|6225385|P2|Overall Study|Lack of Efficacy|35
1788671|NCT00606281|6225386|P1|Overall Study|Lack of Efficacy|28
1788672|NCT00606281|6225385|P2|Overall Study|Death|0
1788673|NCT00606281|6225386|P1|Overall Study|Death|1
1788674|NCT00606281|6225385|P2|Overall Study|Adverse Event|12
1788675|NCT00606281|6225386|P1|Overall Study|Adverse Event|11
1788676|NCT00606229|6225394|P1|Overall Study|change of residence or other commitments|2
1788677|NCT00606229|6225394|P1|Overall Study|does not meet inclusion criterion 1-3|4
1788678|NCT00606229|6225394|P1|Overall Study|Withdrawal by Subject|4
1788679|NCT00606229|6225394|P1|Overall Study|Lack of Efficacy|1
1788680|NCT00606229|6225394|P1|Overall Study|Adverse Event|11
1788681|NCT00606177|6225401|P2|Overall Study|Change of residence or other commitments|1
1788682|NCT00606177|6225402|P1|Overall Study|Change of residence or other commitments|1
1788683|NCT00606177|6225401|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
1788684|NCT00606177|6225402|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
1788685|NCT00606177|6225401|P2|Overall Study|Progression to depressive phase|1
1788686|NCT00606177|6225402|P1|Overall Study|Progression to depressive phase|6
1788687|NCT00606177|6225401|P2|Overall Study|Withdrawal by Subject|6
1788688|NCT00606177|6225402|P1|Overall Study|Withdrawal by Subject|5
1788689|NCT00606177|6225401|P2|Overall Study|Protocol Violation|4
1788690|NCT00606177|6225402|P1|Overall Study|Protocol Violation|1
1788691|NCT00606177|6225401|P2|Overall Study|Physician Decision|0
1788692|NCT00606177|6225402|P1|Overall Study|Physician Decision|1
1788693|NCT00606177|6225401|P2|Overall Study|Lack of Efficacy|7
1788694|NCT00606177|6225402|P1|Overall Study|Lack of Efficacy|3
1788695|NCT00606177|6225401|P2|Overall Study|Adverse Event|5
1788696|NCT00606177|6225402|P1|Overall Study|Adverse Event|9
1788697|NCT00606086|6225429|P2|Overall Study|Randomized, not treated|2
1788698|NCT00606086|6225430|P1|Overall Study|Randomized, not treated|1
1788699|NCT00606086|6225429|P2|Overall Study|Non-compliance|1
1788700|NCT00606086|6225430|P1|Overall Study|Non-compliance|0
1788701|NCT00606086|6225429|P2|Overall Study|Withdrawal by Subject|3
1788702|NCT00606086|6225430|P1|Overall Study|Withdrawal by Subject|5
1788703|NCT00606086|6225429|P2|Overall Study|Protocol Violation|0
1788704|NCT00606086|6225430|P1|Overall Study|Protocol Violation|1
1788705|NCT00606086|6225429|P2|Overall Study|Lost to Follow-up|8
1788706|NCT00606086|6225430|P1|Overall Study|Lost to Follow-up|4
1788707|NCT00606086|6225429|P2|Overall Study|Adverse Event|1
1788708|NCT00606086|6225430|P1|Overall Study|Adverse Event|1
1788709|NCT00606034|6225436|P1|Overall Study|incarceration|1
1788710|NCT00606021|6225444|P3|Maintenance Phase|Lost to Follow-up|2
1788711|NCT00606021|6225445|P2|Maintenance Phase|Lost to Follow-up|5
1788712|NCT00606021|6225446|P1|Maintenance Phase|Lost to Follow-up|0
1788713|NCT00606021|6225444|P3|Maintenance Phase|Physician Decision|0
1788714|NCT00606021|6225445|P2|Maintenance Phase|Physician Decision|1
1788715|NCT00606021|6225446|P1|Maintenance Phase|Physician Decision|0
1788716|NCT00606021|6225444|P3|Maintenance Phase|Death|15
1788717|NCT00606021|6225445|P2|Maintenance Phase|Death|17
1788718|NCT00606021|6225446|P1|Maintenance Phase|Death|0
1788719|NCT00606021|6225444|P3|Induction Phase|Lost to Follow-up|0
1788720|NCT00606021|6225445|P2|Induction Phase|Lost to Follow-up|0
1788721|NCT00606021|6225446|P1|Induction Phase|Lost to Follow-up|10
1788722|NCT00606021|6225444|P3|Induction Phase|Withdrawal by Subject|0
1788723|NCT00606021|6225445|P2|Induction Phase|Withdrawal by Subject|0
1788724|NCT00606021|6225446|P1|Induction Phase|Withdrawal by Subject|2
1788725|NCT00606021|6225444|P3|Induction Phase|Physician Decision|0
1788726|NCT00606021|6225445|P2|Induction Phase|Physician Decision|0
1788727|NCT00606021|6225446|P1|Induction Phase|Physician Decision|2
1788728|NCT00606021|6225444|P3|Induction Phase|Death|0
1788729|NCT00606021|6225445|P2|Induction Phase|Death|0
1788730|NCT00606021|6225446|P1|Induction Phase|Death|73
1788731|NCT00606008|6225464|P1|Overall Study|Withdrawal by Subject|4
1788732|NCT00606008|6225464|P1|Overall Study|Adverse Event|1
1788733|NCT00605917|6225478|P1|Overall Study|Protocol Violation|79
1788734|NCT00605865|6225530|P1|Overall Study|Protocol Violation|115
1788735|NCT00605839|6225572|P3|Overall Study|Protocol Violation|0
1788736|NCT00605839|6225573|P2|Overall Study|Protocol Violation|0
1788737|NCT00605839|6225574|P1|Overall Study|Protocol Violation|1
1788738|NCT00605813|6225582|P1|Overall Study|Protocol Violation|25
1788739|NCT00605722|6225595|P1|Overall Study|Failure to return|1
1788740|NCT00605722|6225595|P1|Overall Study|Insufficient therapeutic response|44
1788741|NCT00605722|6225595|P1|Overall Study|Adverse Event|6
1788742|NCT00605657|6225616|P1|Overall Study|Protocol Violation|1
1788743|NCT00605657|6225616|P1|Overall Study|Adverse Event|1
1788744|NCT00605566|6225621|P1|Overall Study|Poor compliance in run-in period|1
1788745|NCT00605566|6225621|P1|Overall Study|Clinical deterioration|1
1788746|NCT00605566|6225621|P1|Overall Study|Adverse Event|1
1788747|NCT00605540|6225629|P1|Overall Study|Lost to Follow-up|23
1788748|NCT00605540|6225629|P1|Overall Study|Death|15
1788749|NCT00605475|6225647|P10|Overall Study|Withdrawal by Subject|1
1788750|NCT00605475|6225648|P9|Overall Study|Withdrawal by Subject|0
1788751|NCT00605475|6225649|P8|Overall Study|Withdrawal by Subject|0
1788752|NCT00605475|6225650|P7|Overall Study|Withdrawal by Subject|0
1788753|NCT00605475|6225651|P6|Overall Study|Withdrawal by Subject|2
1788754|NCT00605475|6225652|P5|Overall Study|Withdrawal by Subject|0
1788755|NCT00605475|6225653|P4|Overall Study|Withdrawal by Subject|0
1788756|NCT00605475|6225654|P3|Overall Study|Withdrawal by Subject|0
1788757|NCT00605475|6225655|P2|Overall Study|Withdrawal by Subject|0
1788758|NCT00605475|6225656|P1|Overall Study|Withdrawal by Subject|0
1788759|NCT00605475|6225647|P10|Overall Study|Protocol Violation|0
1788760|NCT00605475|6225648|P9|Overall Study|Protocol Violation|0
1788761|NCT00605475|6225649|P8|Overall Study|Protocol Violation|0
1788762|NCT00605475|6225650|P7|Overall Study|Protocol Violation|0
1788763|NCT00605475|6225651|P6|Overall Study|Protocol Violation|0
1788764|NCT00605475|6225652|P5|Overall Study|Protocol Violation|1
1788765|NCT00605475|6225653|P4|Overall Study|Protocol Violation|0
1788766|NCT00605475|6225654|P3|Overall Study|Protocol Violation|0
1788767|NCT00605475|6225655|P2|Overall Study|Protocol Violation|0
1788768|NCT00605475|6225656|P1|Overall Study|Protocol Violation|0
1788769|NCT00605475|6225647|P10|Overall Study|Lost to Follow-up|1
1788770|NCT00605475|6225648|P9|Overall Study|Lost to Follow-up|1
1788771|NCT00605475|6225649|P8|Overall Study|Lost to Follow-up|0
1788772|NCT00605475|6225650|P7|Overall Study|Lost to Follow-up|0
1788773|NCT00605475|6225651|P6|Overall Study|Lost to Follow-up|0
1788774|NCT00605475|6225652|P5|Overall Study|Lost to Follow-up|0
1788775|NCT00605475|6225653|P4|Overall Study|Lost to Follow-up|0
1788776|NCT00605475|6225654|P3|Overall Study|Lost to Follow-up|0
1788777|NCT00605475|6225655|P2|Overall Study|Lost to Follow-up|0
1788778|NCT00605475|6225656|P1|Overall Study|Lost to Follow-up|0
1788779|NCT00605475|6225647|P10|Overall Study|Administrative problems|0
1788780|NCT00605475|6225648|P9|Overall Study|Administrative problems|0
1788781|NCT00605475|6225649|P8|Overall Study|Administrative problems|0
1788782|NCT00605475|6225650|P7|Overall Study|Administrative problems|1
1788783|NCT00605475|6225651|P6|Overall Study|Administrative problems|0
1788784|NCT00605475|6225652|P5|Overall Study|Administrative problems|0
1788785|NCT00605475|6225653|P4|Overall Study|Administrative problems|0
1788786|NCT00605475|6225654|P3|Overall Study|Administrative problems|0
1788787|NCT00605475|6225655|P2|Overall Study|Administrative problems|0
1788788|NCT00605475|6225656|P1|Overall Study|Administrative problems|0
1788789|NCT00605475|6225647|P10|Overall Study|Abnormal Laboratory Values|0
1788790|NCT00605475|6225648|P9|Overall Study|Abnormal Laboratory Values|1
1788791|NCT00605475|6225649|P8|Overall Study|Abnormal Laboratory Values|0
1788792|NCT00605475|6225650|P7|Overall Study|Abnormal Laboratory Values|0
1788793|NCT00605475|6225651|P6|Overall Study|Abnormal Laboratory Values|0
1788794|NCT00605475|6225652|P5|Overall Study|Abnormal Laboratory Values|0
1788795|NCT00605475|6225653|P4|Overall Study|Abnormal Laboratory Values|0
1788796|NCT00605475|6225654|P3|Overall Study|Abnormal Laboratory Values|0
1788797|NCT00605475|6225655|P2|Overall Study|Abnormal Laboratory Values|0
1788798|NCT00605475|6225656|P1|Overall Study|Abnormal Laboratory Values|0
1788799|NCT00605345|6225833|P2|Overall Study|Protocol Violation|2
1788800|NCT00605345|6225834|P1|Overall Study|Protocol Violation|0
1788801|NCT00605345|6225833|P2|Overall Study|Adverse Event|1
1788802|NCT00605345|6225834|P1|Overall Study|Adverse Event|0
1788803|NCT00605345|6225833|P2|Overall Study|Withdrawal by Subject|0
1788804|NCT00605345|6225834|P1|Overall Study|Withdrawal by Subject|1
1788805|NCT00605319|6225850|P1|Overall Study|Adverse Event|6
1788806|NCT00605306|6225862|P2|Overall Study|Adverse Event|1
1788807|NCT00605306|6225863|P1|Overall Study|Adverse Event|0
1788808|NCT00605293|6225877|P2|Overall Study|Principal Investigator Decision|1
1788809|NCT00605293|6225878|P1|Overall Study|Principal Investigator Decision|0
1788810|NCT00605293|6225877|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
1788811|NCT00605293|6225878|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
1788812|NCT00605293|6225877|P2|Overall Study|Incorrect Epoetin Beta Administration|0
1788813|NCT00605293|6225878|P1|Overall Study|Incorrect Epoetin Beta Administration|1
1788814|NCT00605293|6225877|P2|Overall Study|Renal Transplantation|1
1788815|NCT00605293|6225878|P1|Overall Study|Renal Transplantation|3
1788816|NCT00605293|6225877|P2|Overall Study|Blood Transfusion|1
1788817|NCT00605293|6225878|P1|Overall Study|Blood Transfusion|7
1788818|NCT00605293|6225877|P2|Overall Study|Holidays Dialysis Out|0
1788819|NCT00605293|6225878|P1|Overall Study|Holidays Dialysis Out|1
1788820|NCT00605293|6225877|P2|Overall Study|Adverse Event|0
1788821|NCT00605293|6225878|P1|Overall Study|Adverse Event|1
1788822|NCT00605293|6225877|P2|Overall Study|Insufficient Therapeutic Response|0
1788823|NCT00605293|6225878|P1|Overall Study|Insufficient Therapeutic Response|2
1788824|NCT00605293|6225877|P2|Overall Study|Death|1
1788825|NCT00605293|6225878|P1|Overall Study|Death|2
1788826|NCT00605280|6225898|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1788827|NCT00605280|6225899|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1788828|NCT00605280|6225900|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
1788829|NCT00605280|6225901|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
1788830|NCT00605280|6225898|P4|Year 3 Extension|Other|0
1788831|NCT00605280|6225899|P3|Year 3 Extension|Other|0
1788832|NCT00605280|6225900|P2|Year 3 Extension|Other|0
1788833|NCT00605280|6225901|P1|Year 3 Extension|Other|2
1788834|NCT00605280|6225898|P4|Year 3 Extension|Withdrawal by Subject|5
1788835|NCT00605280|6225899|P3|Year 3 Extension|Withdrawal by Subject|0
1788836|NCT00605280|6225900|P2|Year 3 Extension|Withdrawal by Subject|0
1788837|NCT00605280|6225901|P1|Year 3 Extension|Withdrawal by Subject|2
1788838|NCT00605280|6225898|P4|Year 3 Extension|Physician Decision|2
1788839|NCT00605280|6225899|P3|Year 3 Extension|Physician Decision|0
1788840|NCT00605280|6225900|P2|Year 3 Extension|Physician Decision|0
1788841|NCT00605280|6225901|P1|Year 3 Extension|Physician Decision|0
1788842|NCT00605280|6225898|P4|Year 3 Extension|Adverse Event|2
1788843|NCT00605280|6225899|P3|Year 3 Extension|Adverse Event|0
1788844|NCT00605280|6225900|P2|Year 3 Extension|Adverse Event|0
1788845|NCT00605280|6225901|P1|Year 3 Extension|Adverse Event|2
1788846|NCT00605280|6225898|P4|Year 2|Lost to Follow-up or Patient non-comply|2
1788847|NCT00605280|6225899|P3|Year 2|Lost to Follow-up or Patient non-comply|0
1788848|NCT00605280|6225900|P2|Year 2|Lost to Follow-up or Patient non-comply|0
1788849|NCT00605280|6225901|P1|Year 2|Lost to Follow-up or Patient non-comply|4
1788850|NCT00605280|6225898|P4|Year 2|Other|1
1788851|NCT00605280|6225899|P3|Year 2|Other|0
1788852|NCT00605280|6225900|P2|Year 2|Other|0
1788853|NCT00605280|6225901|P1|Year 2|Other|1
1788854|NCT00605280|6225898|P4|Year 2|Withdrawal by Subject|4
1788855|NCT00605280|6225899|P3|Year 2|Withdrawal by Subject|0
1788856|NCT00605280|6225900|P2|Year 2|Withdrawal by Subject|0
1788857|NCT00605280|6225901|P1|Year 2|Withdrawal by Subject|4
1788858|NCT00605280|6225898|P4|Year 2|Physician Decision|11
1788859|NCT00605280|6225899|P3|Year 2|Physician Decision|4
1788860|NCT00605280|6225900|P2|Year 2|Physician Decision|6
1788861|NCT00605280|6225901|P1|Year 2|Physician Decision|11
1788862|NCT00605280|6225898|P4|Year 2|Adverse Event|4
1788863|NCT00605280|6225899|P3|Year 2|Adverse Event|2
1788864|NCT00605280|6225900|P2|Year 2|Adverse Event|0
1788865|NCT00605280|6225901|P1|Year 2|Adverse Event|4
1788866|NCT00605280|6225898|P4|Year 1|Lost to Follow-up or Patient non-comply|2
1788867|NCT00605280|6225899|P3|Year 1|Lost to Follow-up or Patient non-comply|0
1788868|NCT00605280|6225900|P2|Year 1|Lost to Follow-up or Patient non-comply|1
1788869|NCT00605280|6225901|P1|Year 1|Lost to Follow-up or Patient non-comply|5
1788870|NCT00605280|6225898|P4|Year 1|Other|1
1788871|NCT00605280|6225899|P3|Year 1|Other|0
1788872|NCT00605280|6225900|P2|Year 1|Other|1
1788873|NCT00605280|6225901|P1|Year 1|Other|2
1788874|NCT00605280|6225898|P4|Year 1|Withdrawal by Subject|4
1788875|NCT00605280|6225899|P3|Year 1|Withdrawal by Subject|0
1788876|NCT00605280|6225900|P2|Year 1|Withdrawal by Subject|4
1788877|NCT00605280|6225901|P1|Year 1|Withdrawal by Subject|2
1788878|NCT00605280|6225898|P4|Year 1|Physician Decision|6
1788879|NCT00605280|6225899|P3|Year 1|Physician Decision|0
1788880|NCT00605280|6225900|P2|Year 1|Physician Decision|4
1788881|NCT00605280|6225901|P1|Year 1|Physician Decision|7
1788882|NCT00605280|6225898|P4|Year 1|Adverse Event|5
1788883|NCT00605280|6225899|P3|Year 1|Adverse Event|1
1788884|NCT00605280|6225900|P2|Year 1|Adverse Event|1
1788885|NCT00605280|6225901|P1|Year 1|Adverse Event|3
1788886|NCT00605280|6225898|P4|Year 1|Protocol Violation|1
1788887|NCT00605280|6225899|P3|Year 1|Protocol Violation|0
1788888|NCT00605280|6225900|P2|Year 1|Protocol Violation|0
1788889|NCT00605280|6225901|P1|Year 1|Protocol Violation|0
1788890|NCT00605267|6225935|P2|Overall Study|Withdrawal by Subject|3
1788891|NCT00605267|6225936|P1|Overall Study|Withdrawal by Subject|2
1788892|NCT00605267|6225935|P2|Overall Study|Lack of Efficacy|5
1788893|NCT00605267|6225936|P1|Overall Study|Lack of Efficacy|1
1788894|NCT00605267|6225935|P2|Overall Study|Adverse Event|1
1788895|NCT00605267|6225936|P1|Overall Study|Adverse Event|0
1788896|NCT00605189|6225984|P3|Overall Study|Other|0
1788897|NCT00605189|6225985|P2|Overall Study|Other|2
1788898|NCT00605189|6225986|P1|Overall Study|Other|2
1788899|NCT00605189|6225984|P3|Overall Study|Adverse Event|0
1788900|NCT00605189|6225985|P2|Overall Study|Adverse Event|0
1788901|NCT00605189|6225986|P1|Overall Study|Adverse Event|1
1788902|NCT00605176|6225997|P3|Overall Study|Other (not due to AE)|0
1788903|NCT00605176|6225998|P2|Overall Study|Other (not due to AE)|1
1788904|NCT00605176|6225999|P1|Overall Study|Other (not due to AE)|1
1788905|NCT00605176|6225997|P3|Overall Study|Use of concomitant therapy|1
1788906|NCT00605176|6225998|P2|Overall Study|Use of concomitant therapy|0
1788907|NCT00605176|6225999|P1|Overall Study|Use of concomitant therapy|1
1788908|NCT00605176|6225997|P3|Overall Study|Non-complicance with study procedures|0
1788909|NCT00605176|6225998|P2|Overall Study|Non-complicance with study procedures|0
1788910|NCT00605176|6225999|P1|Overall Study|Non-complicance with study procedures|1
1788911|NCT00605176|6225997|P3|Overall Study|Lost to Follow-up|1
1788912|NCT00605176|6225998|P2|Overall Study|Lost to Follow-up|2
1788913|NCT00605176|6225999|P1|Overall Study|Lost to Follow-up|2
1788914|NCT00605176|6225997|P3|Overall Study|Withdrawal by Subject|4
1788915|NCT00605176|6225998|P2|Overall Study|Withdrawal by Subject|2
1788916|NCT00605176|6225999|P1|Overall Study|Withdrawal by Subject|4
1788917|NCT00605176|6225997|P3|Overall Study|Adverse Event|3
1788918|NCT00605176|6225998|P2|Overall Study|Adverse Event|1
1788919|NCT00605176|6225999|P1|Overall Study|Adverse Event|2
1788920|NCT00605085|6226023|P2|Overall Study|administrative reasons|8
1788921|NCT00605085|6226024|P1|Overall Study|administrative reasons|18
1788922|NCT00605085|6226023|P2|Overall Study|Lost to Follow-up|5
1788923|NCT00605085|6226024|P1|Overall Study|Lost to Follow-up|10
1788924|NCT00605085|6226023|P2|Overall Study|Protocol Violation|2
1788925|NCT00605085|6226024|P1|Overall Study|Protocol Violation|3
1788926|NCT00605085|6226023|P2|Overall Study|Pregnancy|0
1788927|NCT00605085|6226024|P1|Overall Study|Pregnancy|2
1788928|NCT00605085|6226023|P2|Overall Study|Adverse Event|5
1788929|NCT00605085|6226024|P1|Overall Study|Adverse Event|9
1788930|NCT00605085|6226023|P2|Overall Study|Withdrawal by Subject|5
1788931|NCT00605085|6226024|P1|Overall Study|Withdrawal by Subject|8
1788932|NCT00605033|6226057|P2|Overall Study|Protocol Violation|1
1788933|NCT00605033|6226058|P1|Overall Study|Protocol Violation|1
1788934|NCT00605033|6226057|P2|Overall Study|Withdrawal by Subject|4
1788935|NCT00605033|6226058|P1|Overall Study|Withdrawal by Subject|3
1788936|NCT00605033|6226057|P2|Overall Study|Lost to Follow-up|1
1788937|NCT00605033|6226058|P1|Overall Study|Lost to Follow-up|1
1788938|NCT00605033|6226057|P2|Overall Study|Adverse Event|2
1788939|NCT00605033|6226058|P1|Overall Study|Adverse Event|2
1788940|NCT00604825|6226102|P4|Overall Study|Exclusion criterion met|1
1788941|NCT00604825|6226103|P3|Overall Study|Exclusion criterion met|0
1788942|NCT00604825|6226104|P2|Overall Study|Exclusion criterion met|0
1788943|NCT00604825|6226105|P1|Overall Study|Exclusion criterion met|0
1788944|NCT00604825|6226102|P4|Overall Study|Physician Decision|1
1788945|NCT00604825|6226103|P3|Overall Study|Physician Decision|0
1788946|NCT00604825|6226104|P2|Overall Study|Physician Decision|0
1788947|NCT00604825|6226105|P1|Overall Study|Physician Decision|0
1788948|NCT00604825|6226102|P4|Overall Study|Did not meet eligibility criteria|0
1788949|NCT00604825|6226103|P3|Overall Study|Did not meet eligibility criteria|2
1788950|NCT00604825|6226104|P2|Overall Study|Did not meet eligibility criteria|0
1788951|NCT00604825|6226105|P1|Overall Study|Did not meet eligibility criteria|0
1788952|NCT00604825|6226102|P4|Overall Study|Lack of Efficacy|0
1788953|NCT00604825|6226103|P3|Overall Study|Lack of Efficacy|1
1788954|NCT00604825|6226104|P2|Overall Study|Lack of Efficacy|2
1788955|NCT00604825|6226105|P1|Overall Study|Lack of Efficacy|3
1788956|NCT00604825|6226102|P4|Overall Study|Withdrawal by Subject|5
1788957|NCT00604825|6226103|P3|Overall Study|Withdrawal by Subject|5
1788958|NCT00604825|6226104|P2|Overall Study|Withdrawal by Subject|3
1788959|NCT00604825|6226105|P1|Overall Study|Withdrawal by Subject|4
1788960|NCT00604825|6226102|P4|Overall Study|Protocol Violation|0
1788961|NCT00604825|6226103|P3|Overall Study|Protocol Violation|0
1788962|NCT00604825|6226104|P2|Overall Study|Protocol Violation|1
1788963|NCT00604825|6226105|P1|Overall Study|Protocol Violation|0
1788964|NCT00604825|6226102|P4|Overall Study|Lost to Follow-up|0
1788965|NCT00604825|6226103|P3|Overall Study|Lost to Follow-up|1
1788966|NCT00604825|6226104|P2|Overall Study|Lost to Follow-up|3
1788967|NCT00604825|6226105|P1|Overall Study|Lost to Follow-up|0
1788968|NCT00604825|6226102|P4|Overall Study|Adverse Event|4
1788969|NCT00604825|6226103|P3|Overall Study|Adverse Event|7
1788970|NCT00604825|6226104|P2|Overall Study|Adverse Event|6
1788971|NCT00604825|6226105|P1|Overall Study|Adverse Event|2
1788972|NCT00604786|6226333|P2|Overall Study|Lost to Follow-up|0
1788973|NCT00604786|6226334|P1|Overall Study|Lost to Follow-up|2
1788974|NCT00604721|6226340|P1|Overall Study|Withdrawal by Subject|1
1788975|NCT00604721|6226340|P1|Overall Study|Physician Decision|1
1788976|NCT00604708|6226348|P2|Overall Study|Adverse Event|6
1788977|NCT00604708|6226349|P1|Overall Study|Adverse Event|6
1788978|NCT00604708|6226348|P2|Overall Study|administrative reasons|11
1788979|NCT00604708|6226349|P1|Overall Study|administrative reasons|9
1788980|NCT00604708|6226348|P2|Overall Study|Lost to Follow-up|5
1788981|NCT00604708|6226349|P1|Overall Study|Lost to Follow-up|5
1788982|NCT00604708|6226348|P2|Overall Study|Protocol Violation|8
1788983|NCT00604708|6226349|P1|Overall Study|Protocol Violation|2
1788984|NCT00604708|6226348|P2|Overall Study|Withdrawal by Subject|10
1788985|NCT00604708|6226349|P1|Overall Study|Withdrawal by Subject|9
1788986|NCT00604695|6226359|P2|Overall Study|Did not receive first bolus.|4
1788987|NCT00604695|6226360|P1|Overall Study|Did not receive first bolus.|0
1788988|NCT00604669|6226382|P1|Overall Study|lack of information in chart|7
1788989|NCT00604565|6226388|P2|Overall Study|Study terminated|3
1788990|NCT00604565|6226389|P1|Overall Study|Study terminated|0
1788991|NCT00604500|6226408|P1|Overall Study|Did not meet protocol eligibility|1
1788992|NCT00604500|6226408|P1|Overall Study|Administrative|1
1788993|NCT00604500|6226408|P1|Overall Study|Withdrawal by Subject|4
1788994|NCT00604500|6226408|P1|Overall Study|Treatment Failure|1
1788995|NCT00604500|6226408|P1|Overall Study|Protocol Violation|2
1788996|NCT00604500|6226408|P1|Overall Study|Adverse Event|2
1788997|NCT00604383|6226422|P2|Overall Study|Physician Decision|3
1788998|NCT00604383|6226423|P1|Overall Study|Physician Decision|0
1788999|NCT00604383|6226422|P2|Overall Study|Adverse Event|9
1789000|NCT00604383|6226423|P1|Overall Study|Adverse Event|16
1789001|NCT00604383|6226422|P2|Overall Study|Death|22
1789002|NCT00604383|6226423|P1|Overall Study|Death|14
1789003|NCT00604383|6226422|P2|Overall Study|Lost to Follow-up|19
1789004|NCT00604383|6226423|P1|Overall Study|Lost to Follow-up|24
1789005|NCT00604383|6226422|P2|Overall Study|Withdrawal by Subject|31
1789006|NCT00604383|6226423|P1|Overall Study|Withdrawal by Subject|33
1789007|NCT00604279|6226439|P2|Overall Study|Other|4
1789008|NCT00604279|6226440|P1|Overall Study|Other|8
1789009|NCT00604279|6226439|P2|Overall Study|Adverse Event|5
1789010|NCT00604279|6226440|P1|Overall Study|Adverse Event|4
1789011|NCT00604279|6226439|P2|Overall Study|Withdrawal by Subject|5
1789012|NCT00604279|6226440|P1|Overall Study|Withdrawal by Subject|16
1789013|NCT00604279|6226439|P2|Overall Study|Protocol Violation|1
1789014|NCT00604279|6226440|P1|Overall Study|Protocol Violation|3
1789015|NCT00604279|6226439|P2|Overall Study|Pregnancy|0
1789016|NCT00604279|6226440|P1|Overall Study|Pregnancy|2
1789017|NCT00604279|6226439|P2|Overall Study|Lost to Follow-up|14
1789018|NCT00604279|6226440|P1|Overall Study|Lost to Follow-up|9
1789019|NCT00604279|6226439|P2|Overall Study|Lack of Efficacy|9
1789020|NCT00604279|6226440|P1|Overall Study|Lack of Efficacy|22
1789021|NCT00604214|6226456|P2|Day 91 to Day 180|Withdrawal by Subject|1
1789022|NCT00604214|6226457|P1|Day 91 to Day 180|Withdrawal by Subject|1
1789023|NCT00604214|6226456|P2|Day 91 to Day 180|Lost to Follow-up|8
1789024|NCT00604214|6226457|P1|Day 91 to Day 180|Lost to Follow-up|6
1789025|NCT00604214|6226456|P2|Day 91 to Day 180|Death|23
1789026|NCT00604214|6226457|P1|Day 91 to Day 180|Death|19
1789027|NCT00604214|6226456|P2|Day 29 to Day 90|Withdrawal by Subject|6
1789028|NCT00604214|6226457|P1|Day 29 to Day 90|Withdrawal by Subject|0
1789029|NCT00604214|6226456|P2|Day 29 to Day 90|Lost to Follow-up|6
1789030|NCT00604214|6226457|P1|Day 29 to Day 90|Lost to Follow-up|4
1789031|NCT00604214|6226456|P2|Day 29 to Day 90|Death|67
1789032|NCT00604214|6226457|P1|Day 29 to Day 90|Death|64
1789033|NCT00604214|6226456|P2|Baseline to Day 28|Withdrawal by Subject|7
1789034|NCT00604214|6226457|P1|Baseline to Day 28|Withdrawal by Subject|3
1789035|NCT00604214|6226456|P2|Baseline to Day 28|Lost to Follow-up|4
1789036|NCT00604214|6226457|P1|Baseline to Day 28|Lost to Follow-up|2
1789037|NCT00604214|6226456|P2|Baseline to Day 28|Death|202
1789038|NCT00604214|6226457|P1|Baseline to Day 28|Death|223
1789039|NCT00604188|6226489|P2|Overall Study|Did not receive study drug|1
1789040|NCT00604188|6226490|P1|Overall Study|Did not receive study drug|0
1789041|NCT00604188|6226489|P2|Overall Study|Non-compliance with protocol|4
1789042|NCT00604188|6226490|P1|Overall Study|Non-compliance with protocol|4
1789043|NCT00604188|6226489|P2|Overall Study|Withdrawal by Subject|1
1789044|NCT00604188|6226490|P1|Overall Study|Withdrawal by Subject|5
1789045|NCT00604188|6226489|P2|Overall Study|Lost to Follow-up|15
1789046|NCT00604188|6226490|P1|Overall Study|Lost to Follow-up|17
1789047|NCT00604188|6226489|P2|Overall Study|Adverse Event|4
1789048|NCT00604188|6226490|P1|Overall Study|Adverse Event|1
1789049|NCT00604175|6226513|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
1789050|NCT00604175|6226514|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
1789051|NCT00604175|6226515|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
1789052|NCT00604175|6226513|P3|Week 29 Through Week 72|Site closure|0
1789053|NCT00604175|6226514|P2|Week 29 Through Week 72|Site closure|1
1789054|NCT00604175|6226515|P1|Week 29 Through Week 72|Site closure|0
1789055|NCT00604175|6226513|P3|Week 29 Through Week 72|Lost to Follow-up|2
1789056|NCT00604175|6226514|P2|Week 29 Through Week 72|Lost to Follow-up|6
1789057|NCT00604175|6226515|P1|Week 29 Through Week 72|Lost to Follow-up|12
1789058|NCT00604175|6226513|P3|Week 29 Through Week 72|Death|1
1789059|NCT00604175|6226514|P2|Week 29 Through Week 72|Death|0
1789060|NCT00604175|6226515|P1|Week 29 Through Week 72|Death|0
1789061|NCT00604175|6226513|P3|Entry Through Week 28|Did not start intervention|1
1789062|NCT00604175|6226514|P2|Entry Through Week 28|Did not start intervention|0
1789063|NCT00604175|6226515|P1|Entry Through Week 28|Did not start intervention|2
1789064|NCT00604175|6226513|P3|Entry Through Week 28|Ineligible|0
1789065|NCT00604175|6226514|P2|Entry Through Week 28|Ineligible|0
1789066|NCT00604175|6226515|P1|Entry Through Week 28|Ineligible|1
1789067|NCT00604175|6226513|P3|Entry Through Week 28|Lost to Follow-up|0
1789068|NCT00604175|6226514|P2|Entry Through Week 28|Lost to Follow-up|3
1789069|NCT00604175|6226515|P1|Entry Through Week 28|Lost to Follow-up|4
1789070|NCT00604175|6226513|P3|Entry Through Week 28|Withdrawal by Subject|0
1789071|NCT00604175|6226514|P2|Entry Through Week 28|Withdrawal by Subject|0
1789072|NCT00604175|6226515|P1|Entry Through Week 28|Withdrawal by Subject|1
1789073|NCT00604175|6226513|P3|Entry Through Week 28|Death|0
1789074|NCT00604175|6226514|P2|Entry Through Week 28|Death|0
1789075|NCT00604175|6226515|P1|Entry Through Week 28|Death|2
1789076|NCT00604162|6226568|P1|Overall Study|Withdrawal by Subject|1
1789077|NCT00604162|6226568|P1|Overall Study|Physician Decision|3
1789078|NCT00603980|6226610|P1|Main Study|14th subject completed trial|1
1789079|NCT00603980|6226610|P1|Study Qualification|Inconsistent data reporting|13
1789080|NCT00603980|6226610|P1|Study Qualification|Protocol Violation|3
1789081|NCT00603915|6226726|P1|Overall Study|Physician Decision|1
1789082|NCT00603837|6226756|P2|Overall Study|Physician Decision|0
1789083|NCT00603837|6226757|P1|Overall Study|Physician Decision|3
1789084|NCT00603798|6226766|P3|Overall Study|Not due to AE|4
1789085|NCT00603798|6226767|P2|Overall Study|Not due to AE|1
1789086|NCT00603798|6226768|P1|Overall Study|Not due to AE|1
1789087|NCT00603798|6226766|P3|Overall Study|Non-compliance with study procedures|0
1789088|NCT00603798|6226767|P2|Overall Study|Non-compliance with study procedures|1
1789089|NCT00603798|6226768|P1|Overall Study|Non-compliance with study procedures|0
1789090|NCT00603798|6226766|P3|Overall Study|Lost to Follow-up|1
1789091|NCT00603798|6226767|P2|Overall Study|Lost to Follow-up|0
1789092|NCT00603798|6226768|P1|Overall Study|Lost to Follow-up|1
1789093|NCT00603798|6226766|P3|Overall Study|Withdrawal by Subject|4
1789094|NCT00603798|6226767|P2|Overall Study|Withdrawal by Subject|3
1789095|NCT00603798|6226768|P1|Overall Study|Withdrawal by Subject|4
1789096|NCT00603798|6226766|P3|Overall Study|Adverse Event|1
1789097|NCT00603798|6226767|P2|Overall Study|Adverse Event|2
1789098|NCT00603798|6226768|P1|Overall Study|Adverse Event|4
1789099|NCT00603746|6226791|P6|Overall Study|Withdrawal by Subject|1
1789100|NCT00603746|6226792|P5|Overall Study|Withdrawal by Subject|3
1789101|NCT00603746|6226793|P4|Overall Study|Withdrawal by Subject|1
1789102|NCT00603746|6226794|P3|Overall Study|Withdrawal by Subject|0
1789103|NCT00603746|6226795|P2|Overall Study|Withdrawal by Subject|0
1789104|NCT00603746|6226796|P1|Overall Study|Withdrawal by Subject|1
1789105|NCT00603746|6226791|P6|Overall Study|Physician Decision|0
1789106|NCT00603746|6226792|P5|Overall Study|Physician Decision|1
1789107|NCT00603746|6226793|P4|Overall Study|Physician Decision|0
1789108|NCT00603746|6226794|P3|Overall Study|Physician Decision|0
1789109|NCT00603746|6226795|P2|Overall Study|Physician Decision|0
1789110|NCT00603746|6226796|P1|Overall Study|Physician Decision|1
1789111|NCT00603746|6226791|P6|Overall Study|Lost to Follow-up|0
1789112|NCT00603746|6226792|P5|Overall Study|Lost to Follow-up|0
1789113|NCT00603746|6226793|P4|Overall Study|Lost to Follow-up|0
1789114|NCT00603746|6226794|P3|Overall Study|Lost to Follow-up|1
1789115|NCT00603746|6226795|P2|Overall Study|Lost to Follow-up|1
1789116|NCT00603746|6226796|P1|Overall Study|Lost to Follow-up|0
1789117|NCT00603746|6226791|P6|Overall Study|Protocol Violation|0
1789118|NCT00603746|6226792|P5|Overall Study|Protocol Violation|1
1789119|NCT00603746|6226793|P4|Overall Study|Protocol Violation|0
1789120|NCT00603746|6226794|P3|Overall Study|Protocol Violation|1
1789121|NCT00603746|6226795|P2|Overall Study|Protocol Violation|3
1789122|NCT00603746|6226796|P1|Overall Study|Protocol Violation|0
1789123|NCT00603746|6226791|P6|Overall Study|Lack of Efficacy|8
1789124|NCT00603746|6226792|P5|Overall Study|Lack of Efficacy|12
1789125|NCT00603746|6226793|P4|Overall Study|Lack of Efficacy|11
1789126|NCT00603746|6226794|P3|Overall Study|Lack of Efficacy|6
1789127|NCT00603746|6226795|P2|Overall Study|Lack of Efficacy|11
1789128|NCT00603746|6226796|P1|Overall Study|Lack of Efficacy|34
1789129|NCT00603746|6226791|P6|Overall Study|Adverse Event|4
1789130|NCT00603746|6226792|P5|Overall Study|Adverse Event|0
1789131|NCT00603746|6226793|P4|Overall Study|Adverse Event|1
1789132|NCT00603746|6226794|P3|Overall Study|Adverse Event|0
1789133|NCT00603746|6226795|P2|Overall Study|Adverse Event|3
1789134|NCT00603746|6226796|P1|Overall Study|Adverse Event|2
1789135|NCT00603733|6226944|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
1789136|NCT00603733|6226945|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
1789137|NCT00603733|6226944|P2|Maintenance Phase ITT|Physician Decision|1
1789138|NCT00603733|6226945|P1|Maintenance Phase ITT|Physician Decision|0
1789139|NCT00603733|6226944|P2|Maintenance Phase ITT|Lack of Efficacy|2
1789140|NCT00603733|6226945|P1|Maintenance Phase ITT|Lack of Efficacy|2
1789141|NCT00603733|6226944|P2|Maintenance Phase ITT|Lost to Follow-up|1
1789142|NCT00603733|6226945|P1|Maintenance Phase ITT|Lost to Follow-up|0
1789143|NCT00603733|6226944|P2|Maintenance Phase ITT|Protocol Violation|1
1789144|NCT00603733|6226945|P1|Maintenance Phase ITT|Protocol Violation|1
1789145|NCT00603733|6226944|P2|Maintenance Phase ITT|Withdrawal by Subject|0
1789146|NCT00603733|6226945|P1|Maintenance Phase ITT|Withdrawal by Subject|1
1789147|NCT00603733|6226944|P2|Maintenance Phase ITT|Adverse Event|6
1789148|NCT00603733|6226945|P1|Maintenance Phase ITT|Adverse Event|3
1789149|NCT00603733|6226944|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
1789150|NCT00603733|6226945|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
1789151|NCT00603733|6226944|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
1789152|NCT00603733|6226945|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
1789153|NCT00603733|6226944|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
1789154|NCT00603733|6226945|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
1789155|NCT00603733|6226944|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
1789156|NCT00603733|6226945|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
1789157|NCT00603733|6226944|P2|Run-In Phase - 4 Weeks|Adverse Event|1
1789158|NCT00603733|6226945|P1|Run-In Phase - 4 Weeks|Adverse Event|2
1789159|NCT00603733|6226944|P2|Active Phase ITT|Subject moved, site closed|1
1789160|NCT00603733|6226945|P1|Active Phase ITT|Subject moved, site closed|1
1789161|NCT00603733|6226944|P2|Active Phase ITT|Lack of Efficacy|2
1789162|NCT00603733|6226945|P1|Active Phase ITT|Lack of Efficacy|1
1789163|NCT00603733|6226944|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
1789164|NCT00603733|6226945|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
1789165|NCT00603733|6226944|P2|Active Phase ITT|Lost to Follow-up|1
1789166|NCT00603733|6226945|P1|Active Phase ITT|Lost to Follow-up|0
1789167|NCT00603733|6226944|P2|Active Phase ITT|Withdrawal by Subject|3
1789168|NCT00603733|6226945|P1|Active Phase ITT|Withdrawal by Subject|0
1789169|NCT00603733|6226944|P2|Active Phase ITT|Adverse Event|7
1789170|NCT00603733|6226945|P1|Active Phase ITT|Adverse Event|8
1789171|NCT00603590|6226995|P2|Overall Study|Cardiovascular event|1
1789172|NCT00603590|6226996|P1|Overall Study|Cardiovascular event|0
1789173|NCT00603590|6226995|P2|Overall Study|Lost to Follow-up|4
1789174|NCT00603590|6226996|P1|Overall Study|Lost to Follow-up|8
1789175|NCT00603590|6226995|P2|Overall Study|Adverse Event|0
1789176|NCT00603590|6226996|P1|Overall Study|Adverse Event|2
1789177|NCT00603590|6226995|P2|Overall Study|Patient discontinued study drug|15
1789178|NCT00603590|6226996|P1|Overall Study|Patient discontinued study drug|22
1789179|NCT00603590|6226995|P2|Overall Study|Refused blood test|1
1789180|NCT00603590|6226996|P1|Overall Study|Refused blood test|5
1789181|NCT00603590|6226995|P2|Overall Study|Did not attend study clinic|30
1789182|NCT00603590|6226996|P1|Overall Study|Did not attend study clinic|39
1789183|NCT00603538|6227020|P3|Overall Study|Objective progression or relapse|0
1789184|NCT00603538|6227021|P2|Overall Study|Objective progression or relapse|0
1789185|NCT00603538|6227022|P1|Overall Study|Objective progression or relapse|3
1789186|NCT00603538|6227020|P3|Overall Study|Adverse Event|2
1789187|NCT00603538|6227021|P2|Overall Study|Adverse Event|4
1789188|NCT00603538|6227022|P1|Overall Study|Adverse Event|0
1789189|NCT00603525|6227062|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
1789190|NCT00603525|6227063|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
1789191|NCT00603525|6227064|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
1789192|NCT00603525|6227062|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1789193|NCT00603525|6227063|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
1789194|NCT00603525|6227064|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
1789195|NCT00603525|6227062|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
1789196|NCT00603525|6227063|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
1789197|NCT00603525|6227064|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
1789198|NCT00603525|6227062|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1789199|NCT00603525|6227063|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
1789200|NCT00603525|6227064|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
1789201|NCT00603525|6227062|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1789202|NCT00603525|6227063|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
1789203|NCT00603525|6227064|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
1789204|NCT00603525|6227062|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
1789205|NCT00603525|6227063|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
1789206|NCT00603525|6227064|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
1789207|NCT00603525|6227062|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1789208|NCT00603525|6227063|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
1789209|NCT00603525|6227064|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
1789210|NCT00603525|6227062|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
1789211|NCT00603525|6227063|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
1789212|NCT00603525|6227064|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
1789213|NCT00603525|6227062|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
1789214|NCT00603525|6227063|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
1789215|NCT00603525|6227064|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
1789216|NCT00603525|6227062|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
1789217|NCT00603525|6227063|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
1789218|NCT00603525|6227064|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
1789219|NCT00603525|6227062|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
1789220|NCT00603525|6227063|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
1789221|NCT00603525|6227064|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
1789222|NCT00603525|6227062|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
1789223|NCT00603525|6227063|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
1789224|NCT00603525|6227064|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
1789225|NCT00603525|6227062|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
1789226|NCT00603525|6227063|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
1789227|NCT00603525|6227064|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
1789228|NCT00603525|6227062|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1789229|NCT00603525|6227063|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
1789230|NCT00603525|6227064|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
1789231|NCT00603525|6227062|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
1789232|NCT00603525|6227063|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
1789233|NCT00603525|6227064|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
1789234|NCT00603512|6227196|P5|Overall Study|Randomized but not treated|0
1789235|NCT00603512|6227197|P4|Overall Study|Randomized but not treated|2
1789236|NCT00603512|6227198|P3|Overall Study|Randomized but not treated|1
1789237|NCT00603512|6227199|P2|Overall Study|Randomized but not treated|1
1789238|NCT00603512|6227200|P1|Overall Study|Randomized but not treated|0
1789239|NCT00603512|6227196|P5|Overall Study|Withdrawal by Subject|1
1789240|NCT00603512|6227197|P4|Overall Study|Withdrawal by Subject|0
1789241|NCT00603512|6227198|P3|Overall Study|Withdrawal by Subject|0
1789242|NCT00603512|6227199|P2|Overall Study|Withdrawal by Subject|0
1789243|NCT00603512|6227200|P1|Overall Study|Withdrawal by Subject|0
1789244|NCT00603512|6227196|P5|Overall Study|Other|1
1789245|NCT00603512|6227197|P4|Overall Study|Other|1
1789246|NCT00603512|6227198|P3|Overall Study|Other|0
1789247|NCT00603512|6227199|P2|Overall Study|Other|1
1789248|NCT00603512|6227200|P1|Overall Study|Other|2
1789249|NCT00603512|6227196|P5|Overall Study|Lack of Efficacy|1
1789250|NCT00603512|6227197|P4|Overall Study|Lack of Efficacy|0
1789251|NCT00603512|6227198|P3|Overall Study|Lack of Efficacy|0
1789252|NCT00603512|6227199|P2|Overall Study|Lack of Efficacy|1
1789253|NCT00603512|6227200|P1|Overall Study|Lack of Efficacy|0
1789254|NCT00603512|6227196|P5|Overall Study|Adverse Event|2
1789255|NCT00603512|6227197|P4|Overall Study|Adverse Event|4
1789256|NCT00603512|6227198|P3|Overall Study|Adverse Event|4
1789257|NCT00603512|6227199|P2|Overall Study|Adverse Event|2
1789258|NCT00603512|6227200|P1|Overall Study|Adverse Event|0
1789259|NCT00603473|6227342|P1|Overall Study|Protocol Violation|1
1789260|NCT00603473|6227342|P1|Overall Study|Lack of Efficacy|4
1789261|NCT00603473|6227342|P1|Overall Study|Adverse Event|4
1789262|NCT00603447|6227355|P7|Overall Study|Withdrew Consent|1
1789263|NCT00603447|6227356|P6|Overall Study|Withdrew Consent|0
1789264|NCT00603447|6227357|P5|Overall Study|Withdrew Consent|1
1789265|NCT00603447|6227358|P4|Overall Study|Withdrew Consent|0
1789266|NCT00603447|6227359|P3|Overall Study|Withdrew Consent|0
1789267|NCT00603447|6227360|P2|Overall Study|Withdrew Consent|2
1789268|NCT00603447|6227361|P1|Overall Study|Withdrew Consent|0
1789269|NCT00603447|6227355|P7|Overall Study|Other|13
1789270|NCT00603447|6227356|P6|Overall Study|Other|0
1789271|NCT00603447|6227357|P5|Overall Study|Other|3
1789272|NCT00603447|6227358|P4|Overall Study|Other|0
1789273|NCT00603447|6227359|P3|Overall Study|Other|1
1789274|NCT00603447|6227360|P2|Overall Study|Other|0
1789275|NCT00603447|6227361|P1|Overall Study|Other|0
1789276|NCT00603447|6227355|P7|Overall Study|Adverse Event|10
1789277|NCT00603447|6227356|P6|Overall Study|Adverse Event|2
1789278|NCT00603447|6227357|P5|Overall Study|Adverse Event|1
1789279|NCT00603447|6227358|P4|Overall Study|Adverse Event|2
1789280|NCT00603447|6227359|P3|Overall Study|Adverse Event|1
1789281|NCT00603447|6227360|P2|Overall Study|Adverse Event|1
1789282|NCT00603447|6227361|P1|Overall Study|Adverse Event|0
1789283|NCT00603382|6227400|P6|Overall Study|Withdrawal by Subject|1
1789284|NCT00603382|6227401|P5|Overall Study|Withdrawal by Subject|0
1789285|NCT00603382|6227402|P4|Overall Study|Withdrawal by Subject|1
1789286|NCT00603382|6227403|P3|Overall Study|Withdrawal by Subject|1
1789287|NCT00603382|6227404|P2|Overall Study|Withdrawal by Subject|3
1789288|NCT00603382|6227405|P1|Overall Study|Withdrawal by Subject|3
1789289|NCT00603382|6227400|P6|Overall Study|Physician Decision|3
1789290|NCT00603382|6227401|P5|Overall Study|Physician Decision|1
1789291|NCT00603382|6227402|P4|Overall Study|Physician Decision|0
1789292|NCT00603382|6227403|P3|Overall Study|Physician Decision|2
1789293|NCT00603382|6227404|P2|Overall Study|Physician Decision|0
1789294|NCT00603382|6227405|P1|Overall Study|Physician Decision|0
1789295|NCT00603382|6227400|P6|Overall Study|Lost to Follow-up|1
1789296|NCT00603382|6227401|P5|Overall Study|Lost to Follow-up|0
1789297|NCT00603382|6227402|P4|Overall Study|Lost to Follow-up|1
1789298|NCT00603382|6227403|P3|Overall Study|Lost to Follow-up|1
1789299|NCT00603382|6227404|P2|Overall Study|Lost to Follow-up|1
1789300|NCT00603382|6227405|P1|Overall Study|Lost to Follow-up|0
1789301|NCT00603382|6227400|P6|Overall Study|Protocol Violation|0
1789302|NCT00603382|6227401|P5|Overall Study|Protocol Violation|1
1789303|NCT00603382|6227402|P4|Overall Study|Protocol Violation|2
1789304|NCT00603382|6227403|P3|Overall Study|Protocol Violation|1
1789305|NCT00603382|6227404|P2|Overall Study|Protocol Violation|0
1789306|NCT00603382|6227405|P1|Overall Study|Protocol Violation|1
1789307|NCT00603382|6227400|P6|Overall Study|Lack of Efficacy|11
1789308|NCT00603382|6227401|P5|Overall Study|Lack of Efficacy|6
1789309|NCT00603382|6227402|P4|Overall Study|Lack of Efficacy|6
1789310|NCT00603382|6227403|P3|Overall Study|Lack of Efficacy|3
1789311|NCT00603382|6227404|P2|Overall Study|Lack of Efficacy|9
1789312|NCT00603382|6227405|P1|Overall Study|Lack of Efficacy|14
1789313|NCT00603382|6227400|P6|Overall Study|Adverse Event|2
1789314|NCT00603382|6227401|P5|Overall Study|Adverse Event|1
1789315|NCT00603382|6227402|P4|Overall Study|Adverse Event|2
1789316|NCT00603382|6227403|P3|Overall Study|Adverse Event|1
1789317|NCT00603382|6227404|P2|Overall Study|Adverse Event|1
1789318|NCT00603382|6227405|P1|Overall Study|Adverse Event|0
1789319|NCT00603304|6227553|P2|Overall Study|Patient Decision|0
1789320|NCT00603304|6227554|P1|Overall Study|Patient Decision|2
1789321|NCT00603304|6227553|P2|Overall Study|Other|0
1789322|NCT00603304|6227554|P1|Overall Study|Other|2
1789323|NCT00603304|6227553|P2|Overall Study|Moved Away|2
1789324|NCT00603304|6227554|P1|Overall Study|Moved Away|0
1789325|NCT00603304|6227553|P2|Overall Study|Non-Compliant|1
1789326|NCT00603304|6227554|P1|Overall Study|Non-Compliant|0
1789327|NCT00603304|6227553|P2|Overall Study|Exclusionary Medication|3
1789328|NCT00603304|6227554|P1|Overall Study|Exclusionary Medication|2
1789329|NCT00603304|6227553|P2|Overall Study|Crossed Over to Open Label Therapy|3
1789330|NCT00603304|6227554|P1|Overall Study|Crossed Over to Open Label Therapy|3
1789331|NCT00603304|6227553|P2|Overall Study|Unacceptable Treatment Toxicity|8
1789332|NCT00603304|6227554|P1|Overall Study|Unacceptable Treatment Toxicity|5
1789333|NCT00603304|6227553|P2|Overall Study|Adverse Event|2
1789334|NCT00603304|6227554|P1|Overall Study|Adverse Event|4
1789335|NCT00603304|6227553|P2|Overall Study|Protocol Violation|0
1789336|NCT00603304|6227554|P1|Overall Study|Protocol Violation|1
1789337|NCT00603304|6227553|P2|Overall Study|Withdrawal by Subject|5
1789338|NCT00603304|6227554|P1|Overall Study|Withdrawal by Subject|8
1789339|NCT00603304|6227553|P2|Overall Study|Lost to Follow-up|7
1789340|NCT00603304|6227554|P1|Overall Study|Lost to Follow-up|5
1789341|NCT00603278|6227610|P6|Overall Study|Lost to Follow-up|0
1789342|NCT00603278|6227611|P5|Overall Study|Lost to Follow-up|1
1789343|NCT00603278|6227612|P4|Overall Study|Lost to Follow-up|0
1789344|NCT00603278|6227613|P3|Overall Study|Lost to Follow-up|0
1789345|NCT00603278|6227614|P2|Overall Study|Lost to Follow-up|0
1789346|NCT00603278|6227615|P1|Overall Study|Lost to Follow-up|1
1789347|NCT00603278|6227610|P6|Overall Study|Physician Decision|1
1789348|NCT00603278|6227611|P5|Overall Study|Physician Decision|2
1789349|NCT00603278|6227612|P4|Overall Study|Physician Decision|0
1789350|NCT00603278|6227613|P3|Overall Study|Physician Decision|0
1789351|NCT00603278|6227614|P2|Overall Study|Physician Decision|1
1789352|NCT00603278|6227615|P1|Overall Study|Physician Decision|0
1789353|NCT00603278|6227610|P6|Overall Study|Protocol Violation|1
1789354|NCT00603278|6227611|P5|Overall Study|Protocol Violation|0
1789355|NCT00603278|6227612|P4|Overall Study|Protocol Violation|1
1789356|NCT00603278|6227613|P3|Overall Study|Protocol Violation|1
1789357|NCT00603278|6227614|P2|Overall Study|Protocol Violation|0
1789358|NCT00603278|6227615|P1|Overall Study|Protocol Violation|3
1789359|NCT00603278|6227610|P6|Overall Study|Withdrawal by Subject|2
1789360|NCT00603278|6227611|P5|Overall Study|Withdrawal by Subject|1
1789361|NCT00603278|6227612|P4|Overall Study|Withdrawal by Subject|2
1789362|NCT00603278|6227613|P3|Overall Study|Withdrawal by Subject|1
1789363|NCT00603278|6227614|P2|Overall Study|Withdrawal by Subject|3
1789364|NCT00603278|6227615|P1|Overall Study|Withdrawal by Subject|2
1789365|NCT00603278|6227610|P6|Overall Study|Adverse Event|1
1789366|NCT00603278|6227611|P5|Overall Study|Adverse Event|2
1789367|NCT00603278|6227612|P4|Overall Study|Adverse Event|0
1789368|NCT00603278|6227613|P3|Overall Study|Adverse Event|1
1789369|NCT00603278|6227614|P2|Overall Study|Adverse Event|3
1789370|NCT00603278|6227615|P1|Overall Study|Adverse Event|0
1789371|NCT00603278|6227610|P6|Overall Study|Lack of Efficacy|14
1789372|NCT00603278|6227611|P5|Overall Study|Lack of Efficacy|7
1789373|NCT00603278|6227612|P4|Overall Study|Lack of Efficacy|8
1789374|NCT00603278|6227613|P3|Overall Study|Lack of Efficacy|11
1789375|NCT00603278|6227614|P2|Overall Study|Lack of Efficacy|10
1789376|NCT00603278|6227615|P1|Overall Study|Lack of Efficacy|35
1789377|NCT00603265|6227764|P3|Overall Study|Protocol Violation|0
1789378|NCT00603265|6227765|P2|Overall Study|Protocol Violation|0
1789379|NCT00603265|6227766|P1|Overall Study|Protocol Violation|1
1789380|NCT00603265|6227764|P3|Overall Study|Participant Left Country, No Responses|0
1789381|NCT00603265|6227765|P2|Overall Study|Participant Left Country, No Responses|1
1789382|NCT00603265|6227766|P1|Overall Study|Participant Left Country, No Responses|0
1789383|NCT00603265|6227764|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
1789384|NCT00603265|6227765|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
1789385|NCT00603265|6227766|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
1789386|NCT00603265|6227764|P3|Overall Study|Lost to Follow-up|0
1789387|NCT00603265|6227765|P2|Overall Study|Lost to Follow-up|1
1789388|NCT00603265|6227766|P1|Overall Study|Lost to Follow-up|0
1789389|NCT00603265|6227764|P3|Overall Study|Lack of Efficacy|3
1789390|NCT00603265|6227765|P2|Overall Study|Lack of Efficacy|0
1789391|NCT00603265|6227766|P1|Overall Study|Lack of Efficacy|3
1789392|NCT00603265|6227764|P3|Overall Study|Withdrawal by Subject|1
1789393|NCT00603265|6227765|P2|Overall Study|Withdrawal by Subject|2
1789394|NCT00603265|6227766|P1|Overall Study|Withdrawal by Subject|1
1789395|NCT00603265|6227764|P3|Overall Study|Adverse Event|1
1789396|NCT00603265|6227765|P2|Overall Study|Adverse Event|11
1789397|NCT00603265|6227766|P1|Overall Study|Adverse Event|2
1789398|NCT00603239|6227794|P2|Overall Study|Subject decision|1
1789399|NCT00603239|6227795|P1|Overall Study|Subject decision|2
1789400|NCT00603239|6227794|P2|Overall Study|Protocol Violation|0
1789401|NCT00603239|6227795|P1|Overall Study|Protocol Violation|2
1789402|NCT00603239|6227794|P2|Overall Study|Physician Decision|0
1789403|NCT00603239|6227795|P1|Overall Study|Physician Decision|2
1789404|NCT00603239|6227794|P2|Overall Study|Lost to Follow-up|1
1789405|NCT00603239|6227795|P1|Overall Study|Lost to Follow-up|2
1789406|NCT00603239|6227794|P2|Overall Study|Loss of glucose control|0
1789407|NCT00603239|6227795|P1|Overall Study|Loss of glucose control|3
1789408|NCT00603239|6227794|P2|Overall Study|Entry criteria not met|1
1789409|NCT00603239|6227795|P1|Overall Study|Entry criteria not met|0
1789410|NCT00603239|6227794|P2|Overall Study|Adverse Event|1
1789411|NCT00603239|6227795|P1|Overall Study|Adverse Event|4
1789412|NCT00602979|6227856|P5|Overall Study|Failed Intubation|0
1789413|NCT00602979|6227857|P4|Overall Study|Failed Intubation|1
1789414|NCT00602979|6227858|P3|Overall Study|Failed Intubation|0
1789415|NCT00602979|6227859|P2|Overall Study|Failed Intubation|1
1789416|NCT00602979|6227860|P1|Overall Study|Failed Intubation|0
1789417|NCT00602979|6227856|P5|Overall Study|Lost to Follow-up|3
1789418|NCT00602979|6227857|P4|Overall Study|Lost to Follow-up|2
1789419|NCT00602979|6227858|P3|Overall Study|Lost to Follow-up|3
1789420|NCT00602979|6227859|P2|Overall Study|Lost to Follow-up|2
1789421|NCT00602979|6227860|P1|Overall Study|Lost to Follow-up|3
1789422|NCT00602927|6227910|P2|Period 3: 13 Days|MRI data quality|2
1789423|NCT00602927|6227911|P1|Period 3: 13 Days|MRI data quality|2
1789424|NCT00602927|6227910|P2|Period 3: 13 Days|Protocol Violation|1
1789425|NCT00602927|6227911|P1|Period 3: 13 Days|Protocol Violation|0
1789426|NCT00602927|6227910|P2|Period 2: 14 Days|Protocol Violation|2
1789427|NCT00602927|6227911|P1|Period 2: 14 Days|Protocol Violation|0
1789428|NCT00602927|6227910|P2|Period 1: 13 Days|Claustrophobia|1
1789429|NCT00602927|6227911|P1|Period 1: 13 Days|Claustrophobia|0
1789430|NCT00602927|6227910|P2|Period 1: 13 Days|Time|0
1789431|NCT00602927|6227911|P1|Period 1: 13 Days|Time|1
1789432|NCT00602927|6227910|P2|Period 1: 13 Days|MRI scanner technical issue|0
1789433|NCT00602927|6227911|P1|Period 1: 13 Days|MRI scanner technical issue|1
1789434|NCT00602927|6227910|P2|Period 1: 13 Days|Protocol Violation|4
1789435|NCT00602927|6227911|P1|Period 1: 13 Days|Protocol Violation|2
1789436|NCT00602797|6227928|P1|Overall Study|Adverse Event|1
1789437|NCT00602667|6227946|P3|Overall Study|Progressive disease prior to therapy|1
1789438|NCT00602667|6227947|P2|Overall Study|Progressive disease prior to therapy|0
1789439|NCT00602667|6227948|P1|Overall Study|Progressive disease prior to therapy|0
1789440|NCT00602667|6227946|P3|Overall Study|Progressive disease|45
1789441|NCT00602667|6227947|P2|Overall Study|Progressive disease|48
1789442|NCT00602667|6227948|P1|Overall Study|Progressive disease|13
1789443|NCT00602667|6227946|P3|Overall Study|Physician Decision|8
1789444|NCT00602667|6227947|P2|Overall Study|Physician Decision|3
1789445|NCT00602667|6227948|P1|Overall Study|Physician Decision|2
1789446|NCT00602667|6227946|P3|Overall Study|Second malignancy|0
1789447|NCT00602667|6227947|P2|Overall Study|Second malignancy|1
1789448|NCT00602667|6227948|P1|Overall Study|Second malignancy|0
1789449|NCT00602667|6227946|P3|Overall Study|Excessive toxicity|0
1789450|NCT00602667|6227947|P2|Overall Study|Excessive toxicity|1
1789451|NCT00602667|6227948|P1|Overall Study|Excessive toxicity|1
1789452|NCT00602667|6227946|P3|Overall Study|Family request|6
1789453|NCT00602667|6227947|P2|Overall Study|Family request|25
1789454|NCT00602667|6227948|P1|Overall Study|Family request|3
1789455|NCT00602667|6227946|P3|Overall Study|Death|1
1789456|NCT00602667|6227947|P2|Overall Study|Death|1
1789457|NCT00602667|6227948|P1|Overall Study|Death|0
1789458|NCT00602667|6227946|P3|Overall Study|Still on Therapy|2
1789459|NCT00602667|6227947|P2|Overall Study|Still on Therapy|2
1789460|NCT00602667|6227948|P1|Overall Study|Still on Therapy|0
1789461|NCT00602641|6228127|P2|Overall Study|Other|1
1789462|NCT00602641|6228128|P1|Overall Study|Other|3
1789463|NCT00602641|6228127|P2|Overall Study|Administrative Closure|1
1789464|NCT00602641|6228128|P1|Overall Study|Administrative Closure|1
1789465|NCT00602641|6228127|P2|Overall Study|Physician Decision|4
1789466|NCT00602641|6228128|P1|Overall Study|Physician Decision|5
1789467|NCT00602641|6228127|P2|Overall Study|Other Complicating Disease|2
1789468|NCT00602641|6228128|P1|Overall Study|Other Complicating Disease|5
1789469|NCT00602641|6228127|P2|Overall Study|Alternative therapy|2
1789470|NCT00602641|6228128|P1|Overall Study|Alternative therapy|5
1789471|NCT00602641|6228127|P2|Overall Study|Withdrawal by Subject|12
1789472|NCT00602641|6228128|P1|Overall Study|Withdrawal by Subject|15
1789473|NCT00602641|6228127|P2|Overall Study|Death|5
1789474|NCT00602641|6228128|P1|Overall Study|Death|6
1789475|NCT00602641|6228127|P2|Overall Study|Disease progression|55
1789476|NCT00602641|6228128|P1|Overall Study|Disease progression|38
1789477|NCT00602641|6228127|P2|Overall Study|Adverse Event|53
1789478|NCT00602641|6228128|P1|Overall Study|Adverse Event|62
1789479|NCT00602641|6228127|P2|Overall Study|Still on treatment at time of analysis|15
1789480|NCT00602641|6228128|P1|Overall Study|Still on treatment at time of analysis|8
1789481|NCT00602641|6228127|P2|Overall Study|Never started protocol therapy|2
1789482|NCT00602641|6228128|P1|Overall Study|Never started protocol therapy|6
1789483|NCT00602537|6228142|P2|Follow Up Study Comparison|Withdrawal by Subject|2
1789484|NCT00602537|6228143|P1|Follow Up Study Comparison|Withdrawal by Subject|2
1789485|NCT00602537|6228142|P2|Follow Up Study Comparison|Lost to Follow-up|1
1789486|NCT00602537|6228143|P1|Follow Up Study Comparison|Lost to Follow-up|8
1789487|NCT00602537|6228142|P2|Follow Up Study Comparison|Adverse Event|0
1789488|NCT00602537|6228143|P1|Follow Up Study Comparison|Adverse Event|1
1789489|NCT00602537|6228142|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
1789490|NCT00602537|6228143|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
1789491|NCT00602537|6228142|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
1789492|NCT00602537|6228143|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
1789493|NCT00602537|6228142|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
1789494|NCT00602537|6228143|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
1789495|NCT00602537|6228142|P2|12 Week Double Blind Comparison|Adverse Event|5
1789496|NCT00602537|6228143|P1|12 Week Double Blind Comparison|Adverse Event|2
1789497|NCT00602472|6228153|P2|Overall Study|Other incl. lack of efficacy|2
1789498|NCT00602472|6228154|P1|Overall Study|Other incl. lack of efficacy|4
1789499|NCT00602472|6228153|P2|Overall Study|Withdrawal by Subject|14
1789500|NCT00602472|6228154|P1|Overall Study|Withdrawal by Subject|8
1789501|NCT00602472|6228153|P2|Overall Study|Protocol Violation|19
1789502|NCT00602472|6228154|P1|Overall Study|Protocol Violation|4
1789503|NCT00602472|6228153|P2|Overall Study|Adverse Event|23
1789504|NCT00602472|6228154|P1|Overall Study|Adverse Event|5
1789505|NCT00602420|6228219|P2|Overall Study|Adverse Event|0
1789506|NCT00602420|6228220|P1|Overall Study|Adverse Event|1
1789507|NCT00602420|6228219|P2|Overall Study|Withdrawal by Subject|17
1789508|NCT00602420|6228220|P1|Overall Study|Withdrawal by Subject|18
1789509|NCT00602420|6228219|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
1789510|NCT00602420|6228220|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
1789511|NCT00602420|6228219|P2|Overall Study|Death|4
1789512|NCT00602420|6228220|P1|Overall Study|Death|1
1789515|NCT00601835|6228345|P2|Overall Study|Relocate|2
1789516|NCT00601835|6228346|P1|Overall Study|Relocate|12
1789517|NCT00601835|6228345|P2|Overall Study|Adverse Event|1
1789518|NCT00601835|6228346|P1|Overall Study|Adverse Event|1
1789519|NCT00601835|6228345|P2|Overall Study|Lost to Follow-up|5
1789520|NCT00601835|6228346|P1|Overall Study|Lost to Follow-up|37
1789521|NCT00601835|6228345|P2|Overall Study|Physician Decision|0
1789522|NCT00601835|6228346|P1|Overall Study|Physician Decision|1
1789523|NCT00601835|6228345|P2|Overall Study|Withdrawal by Subject|6
1789524|NCT00601835|6228346|P1|Overall Study|Withdrawal by Subject|9
1789525|NCT00601705|6228435|P1|Overall Study|Withdrawal by Subject|1
1789526|NCT00601640|6228447|P3|Overall Study|change in eligibility status|1
1789527|NCT00601640|6228448|P2|Overall Study|change in eligibility status|1
1789528|NCT00601640|6228449|P1|Overall Study|change in eligibility status|0
1789529|NCT00601640|6228447|P3|Overall Study|intercurrent illness|0
1789530|NCT00601640|6228448|P2|Overall Study|intercurrent illness|0
1789531|NCT00601640|6228449|P1|Overall Study|intercurrent illness|1
1789532|NCT00601640|6228447|P3|Overall Study|Adverse Event|2
1789533|NCT00601640|6228448|P2|Overall Study|Adverse Event|4
1789534|NCT00601640|6228449|P1|Overall Study|Adverse Event|0
1789535|NCT00601640|6228447|P3|Overall Study|Death|0
1789536|NCT00601640|6228448|P2|Overall Study|Death|0
1789537|NCT00601640|6228449|P1|Overall Study|Death|1
1789538|NCT00601640|6228447|P3|Overall Study|Withdrawal by Subject|7
1789539|NCT00601640|6228448|P2|Overall Study|Withdrawal by Subject|0
1789540|NCT00601640|6228449|P1|Overall Study|Withdrawal by Subject|3
1789541|NCT00601523|6228474|P2|Overall Study|Other|1
1789542|NCT00601523|6228475|P1|Overall Study|Other|9
1789543|NCT00601523|6228474|P2|Overall Study|Withdrawal by Subject|9
1789544|NCT00601523|6228475|P1|Overall Study|Withdrawal by Subject|18
1789545|NCT00601523|6228474|P2|Overall Study|Lost to Follow-up|1
1789546|NCT00601523|6228475|P1|Overall Study|Lost to Follow-up|0
1789547|NCT00601523|6228474|P2|Overall Study|Protocol Violation|1
1789548|NCT00601523|6228475|P1|Overall Study|Protocol Violation|5
1789549|NCT00601523|6228474|P2|Overall Study|Lack of Efficacy|0
1789550|NCT00601523|6228475|P1|Overall Study|Lack of Efficacy|3
1789551|NCT00601523|6228474|P2|Overall Study|Adverse Event|14
1789552|NCT00601523|6228475|P1|Overall Study|Adverse Event|42
1789553|NCT00601458|6228510|P3|Overall Study|Early Termination|1
1789554|NCT00601458|6228511|P2|Overall Study|Early Termination|1
1789555|NCT00601458|6228512|P1|Overall Study|Early Termination|0
1789556|NCT00601458|6228510|P3|Overall Study|Protocol Violation|1
1789557|NCT00601458|6228511|P2|Overall Study|Protocol Violation|2
1789558|NCT00601458|6228512|P1|Overall Study|Protocol Violation|3
1789559|NCT00601458|6228510|P3|Overall Study|Incomplete Data|0
1789560|NCT00601458|6228511|P2|Overall Study|Incomplete Data|2
1789561|NCT00601458|6228512|P1|Overall Study|Incomplete Data|0
1789562|NCT00601458|6228510|P3|Overall Study|Dosing Error|0
1789563|NCT00601458|6228511|P2|Overall Study|Dosing Error|0
1789564|NCT00601458|6228512|P1|Overall Study|Dosing Error|1
1789565|NCT00601419|6228523|P1|Overall Study|Missed Visits|1
1789566|NCT00601419|6228523|P1|Overall Study|Lost to Follow-up|3
1789567|NCT00601354|6228553|P2|Overall Study|Lost to Follow-up|5
1789568|NCT00601354|6228554|P1|Overall Study|Lost to Follow-up|4
1789569|NCT00601250|6228566|P2|Overall Study|Other incl. lack of efficacy|9
1789570|NCT00601250|6228567|P1|Overall Study|Other incl. lack of efficacy|2
1789571|NCT00601250|6228566|P2|Overall Study|Withdrawal by Subject|13
1789572|NCT00601250|6228567|P1|Overall Study|Withdrawal by Subject|4
1789573|NCT00601250|6228566|P2|Overall Study|Lost to Follow-up|6
1789574|NCT00601250|6228567|P1|Overall Study|Lost to Follow-up|2
1789575|NCT00601250|6228566|P2|Overall Study|Protocol Violation|2
1789576|NCT00601250|6228567|P1|Overall Study|Protocol Violation|3
1789577|NCT00601250|6228566|P2|Overall Study|Adverse Event|9
1789578|NCT00601250|6228567|P1|Overall Study|Adverse Event|3
1789579|NCT00601172|6228603|P2|Overall Study|Did not meet continuation criteria|20
1789580|NCT00601172|6228604|P1|Overall Study|Did not meet continuation criteria|19
1789581|NCT00601172|6228603|P2|Overall Study|Withdrawal by Subject|27
1789582|NCT00601172|6228604|P1|Overall Study|Withdrawal by Subject|35
1789583|NCT00601172|6228603|P2|Overall Study|Physician Decision|28
1789584|NCT00601172|6228604|P1|Overall Study|Physician Decision|27
1789585|NCT00601172|6228603|P2|Overall Study|Lost to Follow-up|3
1789586|NCT00601172|6228604|P1|Overall Study|Lost to Follow-up|4
1789587|NCT00601172|6228603|P2|Overall Study|Protocol Violation|5
1789588|NCT00601172|6228604|P1|Overall Study|Protocol Violation|2
1789589|NCT00601172|6228603|P2|Overall Study|Lack of Efficacy|12
1789590|NCT00601172|6228604|P1|Overall Study|Lack of Efficacy|11
1789591|NCT00601172|6228603|P2|Overall Study|Adverse Event|32
1789592|NCT00601172|6228604|P1|Overall Study|Adverse Event|43
1789593|NCT00601107|6228661|P4|Overall Study|Undefined|0
1789594|NCT00601107|6228662|P3|Overall Study|Undefined|1
1789595|NCT00601107|6228663|P2|Overall Study|Undefined|0
1789596|NCT00601107|6228664|P1|Overall Study|Undefined|1
1789597|NCT00601107|6228661|P4|Overall Study|Worsening of Psoriasis|4
1789598|NCT00601107|6228662|P3|Overall Study|Worsening of Psoriasis|1
1789599|NCT00601107|6228663|P2|Overall Study|Worsening of Psoriasis|1
1789600|NCT00601107|6228664|P1|Overall Study|Worsening of Psoriasis|4
1789601|NCT00601107|6228661|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
1789602|NCT00601107|6228662|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1789603|NCT00601107|6228663|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1789604|NCT00601107|6228664|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
1789605|NCT00601107|6228661|P4|Overall Study|Lost to Follow-up|3
1789606|NCT00601107|6228662|P3|Overall Study|Lost to Follow-up|0
1789607|NCT00601107|6228663|P2|Overall Study|Lost to Follow-up|3
1789608|NCT00601107|6228664|P1|Overall Study|Lost to Follow-up|3
1789609|NCT00601107|6228661|P4|Overall Study|Withdrawal by Subject|4
1789610|NCT00601107|6228662|P3|Overall Study|Withdrawal by Subject|7
1789611|NCT00601107|6228663|P2|Overall Study|Withdrawal by Subject|4
1789612|NCT00601107|6228664|P1|Overall Study|Withdrawal by Subject|5
1789613|NCT00601107|6228661|P4|Overall Study|Adverse Event|0
1789614|NCT00601107|6228662|P3|Overall Study|Adverse Event|3
1789615|NCT00601107|6228663|P2|Overall Study|Adverse Event|1
1789616|NCT00601107|6228664|P1|Overall Study|Adverse Event|0
1789617|NCT00600938|6228684|P4|Extension Study|Death|0
1789618|NCT00600938|6228685|P3|Extension Study|Death|0
1789619|NCT00600938|6228686|P2|Extension Study|Death|0
1789620|NCT00600938|6228687|P1|Extension Study|Death|1
1789621|NCT00600938|6228684|P4|Extension Study|Lost to Follow-up|0
1789622|NCT00600938|6228685|P3|Extension Study|Lost to Follow-up|2
1789623|NCT00600938|6228686|P2|Extension Study|Lost to Follow-up|1
1789624|NCT00600938|6228687|P1|Extension Study|Lost to Follow-up|1
1789625|NCT00600938|6228684|P4|Extension Study|Withdrawal by Subject|0
1789626|NCT00600938|6228685|P3|Extension Study|Withdrawal by Subject|3
1789627|NCT00600938|6228686|P2|Extension Study|Withdrawal by Subject|2
1789628|NCT00600938|6228687|P1|Extension Study|Withdrawal by Subject|2
1789629|NCT00600938|6228684|P4|Extension Study|Unsatisfactory therapeutic effect|0
1789630|NCT00600938|6228685|P3|Extension Study|Unsatisfactory therapeutic effect|1
1789631|NCT00600938|6228686|P2|Extension Study|Unsatisfactory therapeutic effect|1
1789632|NCT00600938|6228687|P1|Extension Study|Unsatisfactory therapeutic effect|4
1789633|NCT00600938|6228684|P4|Extension Study|Abnormal test procedure results|1
1789634|NCT00600938|6228685|P3|Extension Study|Abnormal test procedure results|1
1789635|NCT00600938|6228686|P2|Extension Study|Abnormal test procedure results|1
1789636|NCT00600938|6228687|P1|Extension Study|Abnormal test procedure results|0
1789637|NCT00600938|6228684|P4|Extension Study|Adverse Event|0
1789638|NCT00600938|6228685|P3|Extension Study|Adverse Event|2
1789639|NCT00600938|6228686|P2|Extension Study|Adverse Event|0
1789640|NCT00600938|6228687|P1|Extension Study|Adverse Event|1
1789641|NCT00600938|6228684|P4|Core Study|Protocol Violation|0
1789642|NCT00600938|6228685|P3|Core Study|Protocol Violation|0
1789643|NCT00600938|6228686|P2|Core Study|Protocol Violation|2
1789644|NCT00600938|6228687|P1|Core Study|Protocol Violation|1
1789645|NCT00600938|6228684|P4|Core Study|Death|0
1789646|NCT00600938|6228685|P3|Core Study|Death|0
1789647|NCT00600938|6228686|P2|Core Study|Death|1
1789648|NCT00600938|6228687|P1|Core Study|Death|1
1789649|NCT00600938|6228684|P4|Core Study|Lost to Follow-up|0
1789650|NCT00600938|6228685|P3|Core Study|Lost to Follow-up|0
1789651|NCT00600938|6228686|P2|Core Study|Lost to Follow-up|2
1789652|NCT00600938|6228687|P1|Core Study|Lost to Follow-up|3
1789653|NCT00600938|6228684|P4|Core Study|Patient withdrew consent|0
1789654|NCT00600938|6228685|P3|Core Study|Patient withdrew consent|0
1789655|NCT00600938|6228686|P2|Core Study|Patient withdrew consent|12
1789656|NCT00600938|6228687|P1|Core Study|Patient withdrew consent|7
1789657|NCT00600938|6228684|P4|Core Study|Unsatisfactory therapeutic effect|0
1789658|NCT00600938|6228685|P3|Core Study|Unsatisfactory therapeutic effect|0
1789659|NCT00600938|6228686|P2|Core Study|Unsatisfactory therapeutic effect|2
1789660|NCT00600938|6228687|P1|Core Study|Unsatisfactory therapeutic effect|1
1789661|NCT00600938|6228684|P4|Core Study|Abnormal test procedure result(s)|0
1789662|NCT00600938|6228685|P3|Core Study|Abnormal test procedure result(s)|0
1789663|NCT00600938|6228686|P2|Core Study|Abnormal test procedure result(s)|2
1789664|NCT00600938|6228687|P1|Core Study|Abnormal test procedure result(s)|3
1789665|NCT00600886|6228751|P2|Extension - After Crossover (CAS)|Death|0
1789666|NCT00600886|6228752|P1|Extension - After Crossover (CAS)|Death|1
1789667|NCT00600886|6228751|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
1789668|NCT00600886|6228752|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
1789669|NCT00600886|6228751|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
1789670|NCT00600886|6228752|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
1789671|NCT00600886|6228751|P2|Extension - After Crossover (CAS)|Administrative Problems|4
1789672|NCT00600886|6228752|P1|Extension - After Crossover (CAS)|Administrative Problems|4
1789673|NCT00600886|6228751|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
1789674|NCT00600886|6228752|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
1789675|NCT00600886|6228751|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
1789676|NCT00600886|6228752|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
1789677|NCT00600886|6228751|P2|Extension - After Crossover (CAS)|Adverse Event|1
1789678|NCT00600886|6228752|P1|Extension - After Crossover (CAS)|Adverse Event|19
1789679|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
1789680|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
1789681|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Death|1
1789682|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Death|1
1789683|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
1789684|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
1789685|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Adverse Event|1
1789686|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Adverse Event|4
1789687|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
1789688|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
1789689|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
1789690|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
1789691|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
1789692|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
1789693|NCT00600886|6228751|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
1789694|NCT00600886|6228752|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
1789695|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Death|1
1789696|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Death|0
1789697|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
1789698|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
1789699|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
1789700|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
1789701|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
1789702|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
1789703|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
1789704|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
1789705|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
1789706|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
1789707|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
1789708|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
1789709|NCT00600886|6228751|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
1789710|NCT00600886|6228752|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
1789711|NCT00600821|6228816|P2|Overall Study|Other|3
1789712|NCT00600821|6228817|P1|Overall Study|Other|2
1789713|NCT00600821|6228816|P2|Overall Study|Randomized but not treated|1
1789714|NCT00600821|6228817|P1|Overall Study|Randomized but not treated|0
1789715|NCT00600821|6228816|P2|Overall Study|Objective progression or relapse|1
1789716|NCT00600821|6228817|P1|Overall Study|Objective progression or relapse|0
1789717|NCT00600821|6228816|P2|Overall Study|Terminated by sponsor|6
1789718|NCT00600821|6228817|P1|Overall Study|Terminated by sponsor|8
1789719|NCT00600821|6228816|P2|Overall Study|Withdrawal by Subject|1
1789720|NCT00600821|6228817|P1|Overall Study|Withdrawal by Subject|1
1789721|NCT00600821|6228816|P2|Overall Study|Lost to Follow-up|2
1789722|NCT00600821|6228817|P1|Overall Study|Lost to Follow-up|2
1789723|NCT00600821|6228816|P2|Overall Study|Death|46
1789724|NCT00600821|6228817|P1|Overall Study|Death|45
1789725|NCT00600756|6228845|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
1789726|NCT00600756|6228846|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
1789727|NCT00600756|6228845|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
1789728|NCT00600756|6228846|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
1789729|NCT00600756|6228845|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
1789730|NCT00600756|6228846|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
1789731|NCT00600756|6228845|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
1789732|NCT00600756|6228846|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
1789733|NCT00600756|6228845|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
1789734|NCT00600756|6228846|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
1789735|NCT00600756|6228845|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
1789736|NCT00600756|6228846|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
1789737|NCT00600756|6228845|P2|Overall Study Analysis After 12 Months|Adverse Event|44
1789738|NCT00600756|6228846|P1|Overall Study Analysis After 12 Months|Adverse Event|53
1789739|NCT00600756|6228845|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
1789740|NCT00600756|6228846|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
1789741|NCT00600756|6228845|P2|Analysis After 6 Months|Lost to Follow-up|8
1789742|NCT00600756|6228846|P1|Analysis After 6 Months|Lost to Follow-up|10
1789743|NCT00600756|6228845|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
1789744|NCT00600756|6228846|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
1789745|NCT00600756|6228845|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
1789746|NCT00600756|6228846|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
1789747|NCT00600756|6228845|P2|Analysis After 6 Months|Incorrect Enrollment|21
1789748|NCT00600756|6228846|P1|Analysis After 6 Months|Incorrect Enrollment|12
1789749|NCT00600756|6228845|P2|Analysis After 6 Months|Withdrawal by Subject|30
1789750|NCT00600756|6228846|P1|Analysis After 6 Months|Withdrawal by Subject|38
1789751|NCT00600756|6228845|P2|Analysis After 6 Months|Adverse Event|33
1789752|NCT00600756|6228846|P1|Analysis After 6 Months|Adverse Event|43
1789753|NCT00600613|6228955|P1|Overall Study|Protocol Deviation|1
1789754|NCT00600353|6228961|P2|Overall Study|History of prepartive regimen|1
1789755|NCT00600353|6228962|P1|Overall Study|History of prepartive regimen|0
1789756|NCT00600353|6228961|P2|Overall Study|history of malignancy within 5 years|0
1789757|NCT00600353|6228962|P1|Overall Study|history of malignancy within 5 years|1
1789758|NCT00600171|6229025|P6|Overall Study|Lost to Follow-up|0
1789759|NCT00600171|6229026|P5|Overall Study|Lost to Follow-up|0
1789760|NCT00600171|6229027|P4|Overall Study|Lost to Follow-up|1
1789761|NCT00600171|6229028|P3|Overall Study|Lost to Follow-up|0
1789762|NCT00600171|6229029|P2|Overall Study|Lost to Follow-up|0
1789763|NCT00600171|6229030|P1|Overall Study|Lost to Follow-up|0
1789764|NCT00600171|6229025|P6|Overall Study|Physician Decision|2
1789765|NCT00600171|6229026|P5|Overall Study|Physician Decision|0
1789766|NCT00600171|6229027|P4|Overall Study|Physician Decision|1
1789767|NCT00600171|6229028|P3|Overall Study|Physician Decision|0
1789768|NCT00600171|6229029|P2|Overall Study|Physician Decision|1
1789769|NCT00600171|6229030|P1|Overall Study|Physician Decision|0
1789770|NCT00600171|6229025|P6|Overall Study|Withdrawal by Subject|1
1789771|NCT00600171|6229026|P5|Overall Study|Withdrawal by Subject|1
1789772|NCT00600171|6229027|P4|Overall Study|Withdrawal by Subject|1
1789773|NCT00600171|6229028|P3|Overall Study|Withdrawal by Subject|0
1789774|NCT00600171|6229029|P2|Overall Study|Withdrawal by Subject|0
1789775|NCT00600171|6229030|P1|Overall Study|Withdrawal by Subject|3
1789776|NCT00600171|6229025|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
1789777|NCT00600171|6229026|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
1789778|NCT00600171|6229027|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
1789779|NCT00600171|6229028|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
1789780|NCT00600171|6229029|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
1789781|NCT00600171|6229030|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
1789782|NCT00600171|6229025|P6|Overall Study|Protocol Violation|0
1789783|NCT00600171|6229026|P5|Overall Study|Protocol Violation|0
1789784|NCT00600171|6229027|P4|Overall Study|Protocol Violation|1
1789785|NCT00600171|6229028|P3|Overall Study|Protocol Violation|0
1789786|NCT00600171|6229029|P2|Overall Study|Protocol Violation|2
1789787|NCT00600171|6229030|P1|Overall Study|Protocol Violation|1
1789788|NCT00600171|6229025|P6|Overall Study|Lack of Efficacy|0
1789789|NCT00600171|6229026|P5|Overall Study|Lack of Efficacy|4
1789790|NCT00600171|6229027|P4|Overall Study|Lack of Efficacy|5
1789791|NCT00600171|6229028|P3|Overall Study|Lack of Efficacy|3
1789792|NCT00600171|6229029|P2|Overall Study|Lack of Efficacy|12
1789793|NCT00600171|6229030|P1|Overall Study|Lack of Efficacy|9
1789794|NCT00600171|6229025|P6|Overall Study|Adverse Event|0
1789795|NCT00600171|6229026|P5|Overall Study|Adverse Event|1
1789796|NCT00600171|6229027|P4|Overall Study|Adverse Event|0
1789797|NCT00600171|6229028|P3|Overall Study|Adverse Event|0
1789798|NCT00600171|6229029|P2|Overall Study|Adverse Event|1
1789799|NCT00600171|6229030|P1|Overall Study|Adverse Event|0
1789800|NCT00600119|6229104|P6|Follow-up Period|Other|0
1789801|NCT00600119|6229105|P5|Follow-up Period|Other|0
1789802|NCT00600119|6229106|P4|Follow-up Period|Other|0
1789803|NCT00600119|6229107|P3|Follow-up Period|Other|0
1789804|NCT00600119|6229108|P2|Follow-up Period|Other|0
1789805|NCT00600119|6229109|P1|Follow-up Period|Other|1
1789806|NCT00600119|6229104|P6|Follow-up Period|Adverse Event|1
1789807|NCT00600119|6229105|P5|Follow-up Period|Adverse Event|0
1789808|NCT00600119|6229106|P4|Follow-up Period|Adverse Event|0
1789809|NCT00600119|6229107|P3|Follow-up Period|Adverse Event|0
1789810|NCT00600119|6229108|P2|Follow-up Period|Adverse Event|0
1789811|NCT00600119|6229109|P1|Follow-up Period|Adverse Event|0
1789812|NCT00600119|6229104|P6|Double-blind Treatment Period|Adverse Event|10
1789813|NCT00600119|6229105|P5|Double-blind Treatment Period|Adverse Event|2
1789814|NCT00600119|6229106|P4|Double-blind Treatment Period|Adverse Event|1
1789815|NCT00600119|6229107|P3|Double-blind Treatment Period|Adverse Event|0
1789816|NCT00600119|6229108|P2|Double-blind Treatment Period|Adverse Event|1
1789817|NCT00600119|6229109|P1|Double-blind Treatment Period|Adverse Event|1
1789818|NCT00600119|6229104|P6|Double-blind Treatment Period|Lost to Follow-up|0
1789819|NCT00600119|6229105|P5|Double-blind Treatment Period|Lost to Follow-up|0
1789820|NCT00600119|6229106|P4|Double-blind Treatment Period|Lost to Follow-up|0
1789821|NCT00600119|6229107|P3|Double-blind Treatment Period|Lost to Follow-up|0
1789822|NCT00600119|6229108|P2|Double-blind Treatment Period|Lost to Follow-up|1
1789823|NCT00600119|6229109|P1|Double-blind Treatment Period|Lost to Follow-up|0
1789824|NCT00600119|6229104|P6|Double-blind Treatment Period|Physician Decision|0
1789825|NCT00600119|6229105|P5|Double-blind Treatment Period|Physician Decision|0
1789826|NCT00600119|6229106|P4|Double-blind Treatment Period|Physician Decision|0
1789827|NCT00600119|6229107|P3|Double-blind Treatment Period|Physician Decision|0
1789828|NCT00600119|6229108|P2|Double-blind Treatment Period|Physician Decision|0
1789829|NCT00600119|6229109|P1|Double-blind Treatment Period|Physician Decision|2
1789830|NCT00600119|6229104|P6|Double-blind Treatment Period|Sponsor Decision|0
1789831|NCT00600119|6229105|P5|Double-blind Treatment Period|Sponsor Decision|1
1789832|NCT00600119|6229106|P4|Double-blind Treatment Period|Sponsor Decision|0
1789833|NCT00600119|6229107|P3|Double-blind Treatment Period|Sponsor Decision|0
1789834|NCT00600119|6229108|P2|Double-blind Treatment Period|Sponsor Decision|1
1789835|NCT00600119|6229109|P1|Double-blind Treatment Period|Sponsor Decision|0
1789836|NCT00600119|6229104|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1789837|NCT00600119|6229105|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1789838|NCT00600119|6229106|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1789839|NCT00600119|6229107|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1789840|NCT00600119|6229108|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
1789841|NCT00600119|6229109|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
1789842|NCT00600119|6229104|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1789843|NCT00600119|6229105|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
1789844|NCT00600119|6229106|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1789845|NCT00600119|6229107|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1789846|NCT00600119|6229108|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
1789847|NCT00600119|6229109|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
1789848|NCT00600119|6229104|P6|Double-blind Treatment Period|Other|1
1789849|NCT00600119|6229105|P5|Double-blind Treatment Period|Other|2
1789850|NCT00600119|6229106|P4|Double-blind Treatment Period|Other|0
1789851|NCT00600119|6229107|P3|Double-blind Treatment Period|Other|0
1789852|NCT00600119|6229108|P2|Double-blind Treatment Period|Other|0
1789853|NCT00600119|6229109|P1|Double-blind Treatment Period|Other|0
1789854|NCT00600119|6229104|P6|Double-blind Treatment Period|Withdrawal by Subject|3
1789855|NCT00600119|6229105|P5|Double-blind Treatment Period|Withdrawal by Subject|0
1789856|NCT00600119|6229106|P4|Double-blind Treatment Period|Withdrawal by Subject|1
1789857|NCT00600119|6229107|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1789858|NCT00600119|6229108|P2|Double-blind Treatment Period|Withdrawal by Subject|0
1789859|NCT00600119|6229109|P1|Double-blind Treatment Period|Withdrawal by Subject|2
1789860|NCT00600119|6229104|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1789861|NCT00600119|6229105|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1789862|NCT00600119|6229106|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1789863|NCT00600119|6229107|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
1789864|NCT00600119|6229108|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
1789865|NCT00600119|6229109|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
1789866|NCT00600119|6229104|P6|Single-blind Placebo run-in Period|Adverse Event|1
1789867|NCT00600119|6229105|P5|Single-blind Placebo run-in Period|Adverse Event|0
1789868|NCT00600119|6229106|P4|Single-blind Placebo run-in Period|Adverse Event|1
1789869|NCT00600119|6229107|P3|Single-blind Placebo run-in Period|Adverse Event|0
1789870|NCT00600119|6229108|P2|Single-blind Placebo run-in Period|Adverse Event|0
1789871|NCT00600119|6229109|P1|Single-blind Placebo run-in Period|Adverse Event|0
1789872|NCT00600119|6229104|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
1789873|NCT00600119|6229105|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
1789874|NCT00600119|6229106|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
1789875|NCT00600119|6229107|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
1789876|NCT00600119|6229108|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
1789877|NCT00600119|6229109|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
1789878|NCT00600119|6229104|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
1789879|NCT00600119|6229105|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
1789880|NCT00600119|6229106|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
1789881|NCT00600119|6229107|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
1789882|NCT00600119|6229108|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
1789883|NCT00600119|6229109|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
1789884|NCT00600119|6229104|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1789885|NCT00600119|6229105|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1789886|NCT00600119|6229106|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1789887|NCT00600119|6229107|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
1789888|NCT00600119|6229108|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
1789889|NCT00600119|6229109|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
1789890|NCT00600119|6229104|P6|Single-blind Placebo run-in Period|Other - Not specified|1
1789891|NCT00600119|6229105|P5|Single-blind Placebo run-in Period|Other - Not specified|1
1789892|NCT00600119|6229106|P4|Single-blind Placebo run-in Period|Other - Not specified|0
1789893|NCT00600119|6229107|P3|Single-blind Placebo run-in Period|Other - Not specified|0
1789894|NCT00600119|6229108|P2|Single-blind Placebo run-in Period|Other - Not specified|0
1789895|NCT00600119|6229109|P1|Single-blind Placebo run-in Period|Other - Not specified|1
1789896|NCT00600106|6229143|P2|Overall Study|Withdrawal by Subject|1
1789897|NCT00600106|6229144|P1|Overall Study|Withdrawal by Subject|1
1789898|NCT00600067|6229191|P2|Overall Study|Lack of Efficacy|0
1789899|NCT00600067|6229192|P1|Overall Study|Lack of Efficacy|1
1789900|NCT00600067|6229191|P2|Overall Study|protocol non-compliance|3
1789901|NCT00600067|6229192|P1|Overall Study|protocol non-compliance|0
1789902|NCT00600067|6229191|P2|Overall Study|Lost to Follow-up|3
1789903|NCT00600067|6229192|P1|Overall Study|Lost to Follow-up|2
1789904|NCT00600067|6229191|P2|Overall Study|Adverse Event|1
1789905|NCT00600067|6229192|P1|Overall Study|Adverse Event|0
1789906|NCT00600028|6229202|P2|Second Intervention (12 Weeks)|Adverse Event|2
1789907|NCT00600028|6229203|P1|Second Intervention (12 Weeks)|Adverse Event|0
1789908|NCT00600028|6229202|P2|First Intervention (12 Weeks)|Adverse Event|1
1789909|NCT00600028|6229203|P1|First Intervention (12 Weeks)|Adverse Event|0
1789910|NCT00600028|6229202|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
1789911|NCT00600028|6229203|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
1789912|NCT00599924|6229233|P7|Overall Study|Other|2
1789913|NCT00599924|6229234|P6|Overall Study|Other|0
1789914|NCT00599924|6229235|P5|Overall Study|Other|2
1789915|NCT00599924|6229236|P4|Overall Study|Other|1
1789916|NCT00599924|6229237|P3|Overall Study|Other|0
1789917|NCT00599924|6229238|P2|Overall Study|Other|0
1789918|NCT00599924|6229239|P1|Overall Study|Other|0
1789919|NCT00599924|6229233|P7|Overall Study|Withdrawal by Subject|0
1789920|NCT00599924|6229234|P6|Overall Study|Withdrawal by Subject|0
1789921|NCT00599924|6229235|P5|Overall Study|Withdrawal by Subject|1
1789922|NCT00599924|6229236|P4|Overall Study|Withdrawal by Subject|0
1789923|NCT00599924|6229237|P3|Overall Study|Withdrawal by Subject|1
1789924|NCT00599924|6229238|P2|Overall Study|Withdrawal by Subject|0
1789925|NCT00599924|6229239|P1|Overall Study|Withdrawal by Subject|0
1789926|NCT00599924|6229233|P7|Overall Study|Protocol Violation|0
1789927|NCT00599924|6229234|P6|Overall Study|Protocol Violation|0
1789928|NCT00599924|6229235|P5|Overall Study|Protocol Violation|0
1789929|NCT00599924|6229236|P4|Overall Study|Protocol Violation|1
1789930|NCT00599924|6229237|P3|Overall Study|Protocol Violation|0
1789931|NCT00599924|6229238|P2|Overall Study|Protocol Violation|0
1789932|NCT00599924|6229239|P1|Overall Study|Protocol Violation|0
1789933|NCT00599924|6229233|P7|Overall Study|Death|1
1789934|NCT00599924|6229234|P6|Overall Study|Death|2
1789935|NCT00599924|6229235|P5|Overall Study|Death|0
1789936|NCT00599924|6229236|P4|Overall Study|Death|2
1789937|NCT00599924|6229237|P3|Overall Study|Death|0
1789938|NCT00599924|6229238|P2|Overall Study|Death|0
1789939|NCT00599924|6229239|P1|Overall Study|Death|0
1789940|NCT00599924|6229233|P7|Overall Study|Adverse Event|2
1789941|NCT00599924|6229234|P6|Overall Study|Adverse Event|0
1789942|NCT00599924|6229235|P5|Overall Study|Adverse Event|0
1789943|NCT00599924|6229236|P4|Overall Study|Adverse Event|2
1789944|NCT00599924|6229237|P3|Overall Study|Adverse Event|0
1789945|NCT00599924|6229238|P2|Overall Study|Adverse Event|0
1789946|NCT00599924|6229239|P1|Overall Study|Adverse Event|0
1789947|NCT00599924|6229233|P7|Overall Study|Lack of Efficacy|0
1789948|NCT00599924|6229234|P6|Overall Study|Lack of Efficacy|2
1789949|NCT00599924|6229235|P5|Overall Study|Lack of Efficacy|3
1789950|NCT00599924|6229236|P4|Overall Study|Lack of Efficacy|2
1789951|NCT00599924|6229237|P3|Overall Study|Lack of Efficacy|1
1789952|NCT00599924|6229238|P2|Overall Study|Lack of Efficacy|5
1789953|NCT00599924|6229239|P1|Overall Study|Lack of Efficacy|3
1789954|NCT00599755|6229343|P1|Overall Study|No data available|1
1789955|NCT00599755|6229343|P1|Overall Study|Other Reason|2
1789956|NCT00599755|6229343|P1|Overall Study|Progression of Disease|3
1789957|NCT00599755|6229343|P1|Overall Study|Withdrawal by Subject|2
1789958|NCT00599755|6229343|P1|Overall Study|Adverse Event|11
1789959|NCT00599521|6229354|P2|Overall Study|Pregnancy|2
1789960|NCT00599521|6229355|P1|Overall Study|Pregnancy|0
1789961|NCT00599521|6229354|P2|Overall Study|Lost to Follow-up|23
1789962|NCT00599521|6229355|P1|Overall Study|Lost to Follow-up|23
1789963|NCT00599521|6229354|P2|Overall Study|Protocol Violation|1
1789964|NCT00599521|6229355|P1|Overall Study|Protocol Violation|1
1789965|NCT00599521|6229354|P2|Overall Study|Withdrawal by Subject|34
1789966|NCT00599521|6229355|P1|Overall Study|Withdrawal by Subject|28
1789967|NCT00599521|6229354|P2|Overall Study|Adverse Event|1
1789968|NCT00599521|6229355|P1|Overall Study|Adverse Event|4
1789969|NCT00599521|6229354|P2|Overall Study|Lack of Efficacy|8
1789970|NCT00599521|6229355|P1|Overall Study|Lack of Efficacy|4
1789971|NCT00599339|6229369|P1|Overall Study|Study Termination Status Unknown|12
1789972|NCT00599339|6229369|P1|Overall Study|No valid data consent|36
1789973|NCT00599339|6229369|P1|Overall Study|Lost to Follow-up|221
1789974|NCT00599339|6229369|P1|Overall Study|Other Reason|179
1789975|NCT00599339|6229369|P1|Overall Study|Withdrawal by Subject|137
1789976|NCT00599339|6229369|P1|Overall Study|Adverse Event|79
1789977|NCT00599326|6229471|P1|Overall Study|Noncompliant|1
1789978|NCT00599326|6229471|P1|Overall Study|Lost to Follow-up|1
1789979|NCT00599313|6229476|P1|Overall Study|Ineligible|1
1789980|NCT00599313|6229476|P1|Overall Study|Patient Request|4
1789981|NCT00599313|6229476|P1|Overall Study|Disease Progression|12
1789982|NCT00599313|6229476|P1|Overall Study|Adverse Event|19
1789983|NCT00599196|6229518|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
1789984|NCT00599196|6229518|P1|Overall Study|Other: Patient Stopped Due To Moving|1
1789985|NCT00599196|6229518|P1|Overall Study|Other: Pt Moved To Australia|1
1789986|NCT00599196|6229518|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
1789987|NCT00599196|6229518|P1|Overall Study|Other: Spouse Withdrew Consent|1
1789988|NCT00599196|6229518|P1|Overall Study|Other: Patient Leaving For Israel|1
1789989|NCT00599196|6229518|P1|Overall Study|Lost to Follow-up|17
1789990|NCT00599196|6229518|P1|Overall Study|Study ended per sponsor|197
1789991|NCT00599196|6229518|P1|Overall Study|Subject withdrew consent|43
1789992|NCT00599196|6229518|P1|Overall Study|Unsatisfactory compliance of subject|3
1789993|NCT00599196|6229518|P1|Overall Study|Adverse Event|93
1789994|NCT00599196|6229518|P1|Overall Study|Lack of Efficacy|22
1789995|NCT00599027|6229549|P2|Overall Study|Treatment Failure|1
1789996|NCT00599027|6229550|P1|Overall Study|Treatment Failure|0
1789997|NCT00599027|6229549|P2|Overall Study|Adverse Event|1
1789998|NCT00599027|6229550|P1|Overall Study|Adverse Event|0
1789999|NCT00599027|6229549|P2|Overall Study|Withdrawal by Subject|1
1790000|NCT00599027|6229550|P1|Overall Study|Withdrawal by Subject|1
1790001|NCT00598871|6229563|P2|Overall Study|Adverse Event|1
1790002|NCT00598871|6229564|P1|Overall Study|Adverse Event|0
1790003|NCT00598832|6229574|P2|Overall Study|Non compliance|0
1790004|NCT00598832|6229575|P1|Overall Study|Non compliance|1
1790005|NCT00598832|6229574|P2|Overall Study|Physician Decision|4
1790006|NCT00598832|6229575|P1|Overall Study|Physician Decision|1
1790007|NCT00598832|6229574|P2|Overall Study|Pregnancy|2
1790008|NCT00598832|6229575|P1|Overall Study|Pregnancy|2
1790009|NCT00598832|6229574|P2|Overall Study|Lost to Follow-up|29
1790010|NCT00598832|6229575|P1|Overall Study|Lost to Follow-up|24
1790011|NCT00598832|6229574|P2|Overall Study|Protocol Violation|2
1790012|NCT00598832|6229575|P1|Overall Study|Protocol Violation|0
1790013|NCT00598832|6229574|P2|Overall Study|Withdrawal by Subject|36
1790014|NCT00598832|6229575|P1|Overall Study|Withdrawal by Subject|25
1790015|NCT00598832|6229574|P2|Overall Study|Adverse Event|2
1790016|NCT00598832|6229575|P1|Overall Study|Adverse Event|6
1790017|NCT00598832|6229574|P2|Overall Study|Lack of Efficacy|7
1790018|NCT00598832|6229575|P1|Overall Study|Lack of Efficacy|3
1790019|NCT00598702|6229628|P8|Overall Study|Dose limiting toxicity|0
1790020|NCT00598702|6229629|P7|Overall Study|Dose limiting toxicity|0
1790021|NCT00598702|6229630|P6|Overall Study|Dose limiting toxicity|1
1790022|NCT00598702|6229631|P5|Overall Study|Dose limiting toxicity|1
1790023|NCT00598702|6229632|P4|Overall Study|Dose limiting toxicity|1
1790024|NCT00598702|6229633|P3|Overall Study|Dose limiting toxicity|0
1790025|NCT00598702|6229634|P2|Overall Study|Dose limiting toxicity|0
1790026|NCT00598702|6229635|P1|Overall Study|Dose limiting toxicity|0
1790027|NCT00598702|6229628|P8|Overall Study|Physician Decision|0
1790028|NCT00598702|6229629|P7|Overall Study|Physician Decision|0
1790029|NCT00598702|6229630|P6|Overall Study|Physician Decision|0
1790030|NCT00598702|6229631|P5|Overall Study|Physician Decision|1
1790031|NCT00598702|6229632|P4|Overall Study|Physician Decision|0
1790032|NCT00598702|6229633|P3|Overall Study|Physician Decision|0
1790033|NCT00598702|6229634|P2|Overall Study|Physician Decision|0
1790034|NCT00598702|6229635|P1|Overall Study|Physician Decision|0
1790035|NCT00598702|6229628|P8|Overall Study|Withdrawal by Subject|0
1790036|NCT00598702|6229629|P7|Overall Study|Withdrawal by Subject|0
1790037|NCT00598702|6229630|P6|Overall Study|Withdrawal by Subject|0
1790038|NCT00598702|6229631|P5|Overall Study|Withdrawal by Subject|1
1790039|NCT00598702|6229632|P4|Overall Study|Withdrawal by Subject|1
1790040|NCT00598702|6229633|P3|Overall Study|Withdrawal by Subject|0
1790041|NCT00598702|6229634|P2|Overall Study|Withdrawal by Subject|0
1790042|NCT00598702|6229635|P1|Overall Study|Withdrawal by Subject|0
1790043|NCT00598702|6229628|P8|Overall Study|Adverse Event|0
1790044|NCT00598702|6229629|P7|Overall Study|Adverse Event|0
1790045|NCT00598702|6229630|P6|Overall Study|Adverse Event|0
1790046|NCT00598702|6229631|P5|Overall Study|Adverse Event|0
1790047|NCT00598702|6229632|P4|Overall Study|Adverse Event|1
1790048|NCT00598702|6229633|P3|Overall Study|Adverse Event|0
1790049|NCT00598702|6229634|P2|Overall Study|Adverse Event|0
1790050|NCT00598702|6229635|P1|Overall Study|Adverse Event|0
1790051|NCT00598702|6229628|P8|Overall Study|Early discharge from hospital|0
1790052|NCT00598702|6229629|P7|Overall Study|Early discharge from hospital|1
1790053|NCT00598702|6229630|P6|Overall Study|Early discharge from hospital|10
1790054|NCT00598702|6229631|P5|Overall Study|Early discharge from hospital|0
1790055|NCT00598702|6229632|P4|Overall Study|Early discharge from hospital|5
1790056|NCT00598702|6229633|P3|Overall Study|Early discharge from hospital|2
1790057|NCT00598702|6229634|P2|Overall Study|Early discharge from hospital|0
1790058|NCT00598702|6229635|P1|Overall Study|Early discharge from hospital|0
1790059|NCT00598702|6229628|P8|Overall Study|Other|0
1790060|NCT00598702|6229629|P7|Overall Study|Other|0
1790061|NCT00598702|6229630|P6|Overall Study|Other|1
1790062|NCT00598702|6229631|P5|Overall Study|Other|0
1790063|NCT00598702|6229632|P4|Overall Study|Other|0
1790064|NCT00598702|6229633|P3|Overall Study|Other|0
1790065|NCT00598702|6229634|P2|Overall Study|Other|2
1790066|NCT00598702|6229635|P1|Overall Study|Other|0
1790067|NCT00598650|6229711|P1|Overall Study|Physician Decision|2
1790068|NCT00598650|6229711|P1|Overall Study|Prohibited Concomitant Medication|2
1790069|NCT00598650|6229711|P1|Overall Study|Not eligible|1
1790070|NCT00598650|6229711|P1|Overall Study|No treatment for 3 weeks|1
1790071|NCT00598650|6229711|P1|Overall Study|Adverse Event|18
1790072|NCT00598650|6229711|P1|Overall Study|Withdrawal by Subject|3
1790073|NCT00598585|6229720|P2|Overall Study|Lost to Follow-up|0
1790074|NCT00598585|6229721|P1|Overall Study|Lost to Follow-up|1
1790075|NCT00598559|6229730|P3|Overall Study|Subject unable/unwilling to attend visit|0
1790076|NCT00598559|6229731|P2|Overall Study|Subject unable/unwilling to attend visit|7
1790077|NCT00598559|6229732|P1|Overall Study|Subject unable/unwilling to attend visit|4
1790078|NCT00598559|6229730|P3|Overall Study|Early discharge from hospital|3
1790079|NCT00598559|6229731|P2|Overall Study|Early discharge from hospital|12
1790080|NCT00598559|6229732|P1|Overall Study|Early discharge from hospital|9
1790081|NCT00598559|6229730|P3|Overall Study|Protocol Non-compliance|0
1790082|NCT00598559|6229731|P2|Overall Study|Protocol Non-compliance|0
1790083|NCT00598559|6229732|P1|Overall Study|Protocol Non-compliance|1
1790084|NCT00598559|6229730|P3|Overall Study|Withdrawal by Subject|0
1790085|NCT00598559|6229731|P2|Overall Study|Withdrawal by Subject|2
1790086|NCT00598559|6229732|P1|Overall Study|Withdrawal by Subject|2
1790087|NCT00598559|6229730|P3|Overall Study|Adverse Event|0
1790088|NCT00598559|6229731|P2|Overall Study|Adverse Event|7
1790089|NCT00598559|6229732|P1|Overall Study|Adverse Event|11
1790090|NCT00598442|6229759|P3|Overall Study|Started dialysis|0
1790091|NCT00598442|6229760|P2|Overall Study|Started dialysis|0
1790092|NCT00598442|6229761|P1|Overall Study|Started dialysis|1
1790093|NCT00598442|6229759|P3|Overall Study|Site closed by sponsor|1
1790094|NCT00598442|6229760|P2|Overall Study|Site closed by sponsor|2
1790095|NCT00598442|6229761|P1|Overall Study|Site closed by sponsor|5
1790096|NCT00598442|6229759|P3|Overall Study|Renal transplant|1
1790097|NCT00598442|6229760|P2|Overall Study|Renal transplant|0
1790098|NCT00598442|6229761|P1|Overall Study|Renal transplant|0
1790099|NCT00598442|6229759|P3|Overall Study|Relocation|0
1790100|NCT00598442|6229760|P2|Overall Study|Relocation|4
1790101|NCT00598442|6229761|P1|Overall Study|Relocation|1
1790102|NCT00598442|6229759|P3|Overall Study|Noncompliance|1
1790103|NCT00598442|6229760|P2|Overall Study|Noncompliance|2
1790104|NCT00598442|6229761|P1|Overall Study|Noncompliance|0
1790105|NCT00598442|6229759|P3|Overall Study|Withdrawal by Subject|6
1790106|NCT00598442|6229760|P2|Overall Study|Withdrawal by Subject|16
1790107|NCT00598442|6229761|P1|Overall Study|Withdrawal by Subject|8
1790108|NCT00598442|6229759|P3|Overall Study|Physician Decision|1
1790109|NCT00598442|6229760|P2|Overall Study|Physician Decision|1
1790110|NCT00598442|6229761|P1|Overall Study|Physician Decision|2
1790111|NCT00598442|6229759|P3|Overall Study|Lost to Follow-up|3
1790112|NCT00598442|6229760|P2|Overall Study|Lost to Follow-up|3
1790113|NCT00598442|6229761|P1|Overall Study|Lost to Follow-up|4
1790114|NCT00598442|6229759|P3|Overall Study|Death|11
1790115|NCT00598442|6229760|P2|Overall Study|Death|11
1790116|NCT00598442|6229761|P1|Overall Study|Death|19
1790117|NCT00598442|6229759|P3|Overall Study|Adverse Event|0
1790118|NCT00598442|6229760|P2|Overall Study|Adverse Event|0
1790119|NCT00598442|6229761|P1|Overall Study|Adverse Event|3
1790120|NCT00598273|6229778|P3|Overall Study|Started dialysis|5
1790121|NCT00598273|6229779|P2|Overall Study|Started dialysis|4
1790122|NCT00598273|6229780|P1|Overall Study|Started dialysis|6
1790123|NCT00598273|6229778|P3|Overall Study|Site elected to close|0
1790124|NCT00598273|6229779|P2|Overall Study|Site elected to close|0
1790125|NCT00598273|6229780|P1|Overall Study|Site elected to close|1
1790126|NCT00598273|6229778|P3|Overall Study|Renal transplant|1
1790127|NCT00598273|6229779|P2|Overall Study|Renal transplant|0
1790128|NCT00598273|6229780|P1|Overall Study|Renal transplant|1
1790129|NCT00598273|6229778|P3|Overall Study|Relocation|4
1790130|NCT00598273|6229779|P2|Overall Study|Relocation|2
1790131|NCT00598273|6229780|P1|Overall Study|Relocation|0
1790132|NCT00598273|6229778|P3|Overall Study|Noncompliance|3
1790133|NCT00598273|6229779|P2|Overall Study|Noncompliance|2
1790134|NCT00598273|6229780|P1|Overall Study|Noncompliance|3
1790135|NCT00598273|6229778|P3|Overall Study|Withdrawal by Subject|10
1790136|NCT00598273|6229779|P2|Overall Study|Withdrawal by Subject|10
1790137|NCT00598273|6229780|P1|Overall Study|Withdrawal by Subject|12
1790138|NCT00598273|6229778|P3|Overall Study|Physician Decision|1
1790139|NCT00598273|6229779|P2|Overall Study|Physician Decision|0
1790140|NCT00598273|6229780|P1|Overall Study|Physician Decision|0
1790141|NCT00598273|6229778|P3|Overall Study|Lost to Follow-up|5
1790142|NCT00598273|6229779|P2|Overall Study|Lost to Follow-up|3
1790143|NCT00598273|6229780|P1|Overall Study|Lost to Follow-up|8
1790144|NCT00598273|6229778|P3|Overall Study|Death|8
1790145|NCT00598273|6229779|P2|Overall Study|Death|12
1790146|NCT00598273|6229780|P1|Overall Study|Death|6
1790147|NCT00598273|6229778|P3|Overall Study|Adverse Event|2
1790148|NCT00598273|6229779|P2|Overall Study|Adverse Event|5
1790149|NCT00598273|6229780|P1|Overall Study|Adverse Event|4
1790150|NCT00598078|6229794|P2|Period 2 (Day 2)|Adverse Event|0
1790151|NCT00598078|6229795|P1|Period 2 (Day 2)|Adverse Event|1
1790152|NCT00597766|6229877|P3|Follow-up 2, Week 8|Lost to Follow-up|1
1790153|NCT00597766|6229878|P2|Follow-up 2, Week 8|Lost to Follow-up|0
1790154|NCT00597766|6229879|P1|Follow-up 2, Week 8|Lost to Follow-up|0
1790155|NCT00597766|6229877|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
1790156|NCT00597766|6229878|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
1790157|NCT00597766|6229879|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
1790158|NCT00597753|6229898|P2|Overall Study|Site elected to close|4
1790159|NCT00597753|6229899|P1|Overall Study|Site elected to close|2
1790160|NCT00597753|6229898|P2|Overall Study|Site closed by sponsor|7
1790161|NCT00597753|6229899|P1|Overall Study|Site closed by sponsor|19
1790162|NCT00597753|6229898|P2|Overall Study|Renal transplant|3
1790163|NCT00597753|6229899|P1|Overall Study|Renal transplant|10
1790164|NCT00597753|6229898|P2|Overall Study|Relocation|6
1790165|NCT00597753|6229899|P1|Overall Study|Relocation|17
1790166|NCT00597753|6229898|P2|Overall Study|Noncompliance|1
1790167|NCT00597753|6229899|P1|Overall Study|Noncompliance|2
1790168|NCT00597753|6229898|P2|Overall Study|Never dosed|0
1790169|NCT00597753|6229899|P1|Overall Study|Never dosed|2
1790170|NCT00597753|6229898|P2|Overall Study|Discontinued Dialysis|1
1790171|NCT00597753|6229899|P1|Overall Study|Discontinued Dialysis|0
1790172|NCT00597753|6229898|P2|Overall Study|Withdrawal by Subject|12
1790173|NCT00597753|6229899|P1|Overall Study|Withdrawal by Subject|35
1790174|NCT00597753|6229898|P2|Overall Study|Pregnancy|0
1790175|NCT00597753|6229899|P1|Overall Study|Pregnancy|1
1790176|NCT00597753|6229898|P2|Overall Study|Physician Decision|1
1790177|NCT00597753|6229899|P1|Overall Study|Physician Decision|5
1790178|NCT00597753|6229898|P2|Overall Study|Lost to Follow-up|3
1790179|NCT00597753|6229899|P1|Overall Study|Lost to Follow-up|10
1790180|NCT00597753|6229898|P2|Overall Study|Lack of Efficacy|0
1790181|NCT00597753|6229899|P1|Overall Study|Lack of Efficacy|2
1790182|NCT00597753|6229898|P2|Overall Study|Death|29
1790183|NCT00597753|6229899|P1|Overall Study|Death|55
1790184|NCT00597753|6229898|P2|Overall Study|Adverse Event|2
1790185|NCT00597753|6229899|P1|Overall Study|Adverse Event|6
1790186|NCT00597714|6229933|P3|Overall Study|Recipient death|10
1790187|NCT00597714|6229934|P2|Overall Study|Recipient death|0
1790188|NCT00597714|6229935|P1|Overall Study|Recipient death|0
1790189|NCT00597714|6229933|P3|Overall Study|Death|0
1790190|NCT00597714|6229934|P2|Overall Study|Death|46
1790191|NCT00597714|6229935|P1|Overall Study|Death|56
1790192|NCT00597701|6229947|P2|Overall Study|Did not start intervention (pharmacy er)|2
1790193|NCT00597701|6229948|P1|Overall Study|Did not start intervention (pharmacy er)|0
1790194|NCT00597701|6229947|P2|Overall Study|Physician Decision|0
1790195|NCT00597701|6229948|P1|Overall Study|Physician Decision|2
1790196|NCT00597701|6229947|P2|Overall Study|Death|1
1790197|NCT00597701|6229948|P1|Overall Study|Death|0
1790198|NCT00597701|6229947|P2|Overall Study|Withdrawal by Subject|5
1790199|NCT00597701|6229948|P1|Overall Study|Withdrawal by Subject|5
1790200|NCT00597584|6229970|P2|Overall Study|Renal transplant|7
1790201|NCT00597584|6229971|P1|Overall Study|Renal transplant|9
1790202|NCT00597584|6229970|P2|Overall Study|Relocation|6
1790203|NCT00597584|6229971|P1|Overall Study|Relocation|8
1790204|NCT00597584|6229970|P2|Overall Study|Never dosed|0
1790205|NCT00597584|6229971|P1|Overall Study|Never dosed|1
1790206|NCT00597584|6229970|P2|Overall Study|Lost ability to consent|1
1790207|NCT00597584|6229971|P1|Overall Study|Lost ability to consent|1
1790208|NCT00597584|6229970|P2|Overall Study|Discontinued Dialysis|1
1790209|NCT00597584|6229971|P1|Overall Study|Discontinued Dialysis|0
1790210|NCT00597584|6229970|P2|Overall Study|Withdrawal by Subject|12
1790211|NCT00597584|6229971|P1|Overall Study|Withdrawal by Subject|44
1790212|NCT00597584|6229970|P2|Overall Study|Pregnancy|0
1790213|NCT00597584|6229971|P1|Overall Study|Pregnancy|2
1790214|NCT00597584|6229970|P2|Overall Study|Physician Decision|0
1790215|NCT00597584|6229971|P1|Overall Study|Physician Decision|3
1790216|NCT00597584|6229970|P2|Overall Study|Lost to Follow-up|4
1790217|NCT00597584|6229971|P1|Overall Study|Lost to Follow-up|2
1790218|NCT00597584|6229970|P2|Overall Study|Lack of Efficacy|0
1790219|NCT00597584|6229971|P1|Overall Study|Lack of Efficacy|1
1790220|NCT00597584|6229970|P2|Overall Study|Death|30
1790221|NCT00597584|6229971|P1|Overall Study|Death|53
1790222|NCT00597584|6229970|P2|Overall Study|Adverse Event|2
1790223|NCT00597584|6229971|P1|Overall Study|Adverse Event|4
1790224|NCT00597519|6229996|P1|Overall Study|Death|1
1790225|NCT00597506|6230000|P1|Overall Study|Subject is being followed for survival|1
1790226|NCT00597376|6230050|P2|Overall Study|Adverse Event|1
1790227|NCT00597376|6230051|P1|Overall Study|Adverse Event|4
1790228|NCT00597376|6230050|P2|Overall Study|Withdrawal by Subject|3
1790229|NCT00597376|6230051|P1|Overall Study|Withdrawal by Subject|4
1790230|NCT00597207|6230092|P2|Overall Study|Lost to Follow-up|7
1790231|NCT00597207|6230093|P1|Overall Study|Lost to Follow-up|5
1790232|NCT00597116|6230101|P2|Overall Study|Progressive disease|6
1790233|NCT00597116|6230102|P1|Overall Study|Progressive disease|11
1790234|NCT00597116|6230101|P2|Overall Study|Lost to Follow-up|0
1790235|NCT00597116|6230102|P1|Overall Study|Lost to Follow-up|1
1790236|NCT00597116|6230101|P2|Overall Study|Death|1
1790237|NCT00597116|6230102|P1|Overall Study|Death|0
1790238|NCT00597116|6230101|P2|Overall Study|Physician Decision|1
1790239|NCT00597116|6230102|P1|Overall Study|Physician Decision|0
1790240|NCT00597116|6230101|P2|Overall Study|Withdrawal by Subject|2
1790241|NCT00597116|6230102|P1|Overall Study|Withdrawal by Subject|0
1790242|NCT00597116|6230101|P2|Overall Study|Adverse Event|1
1790243|NCT00597116|6230102|P1|Overall Study|Adverse Event|2
1790244|NCT00597012|6230128|P2|Overall Study|Lost to Follow-up|2
1790245|NCT00597012|6230129|P1|Overall Study|Lost to Follow-up|0
1790246|NCT00597012|6230128|P2|Overall Study|Ineligible|0
1790247|NCT00597012|6230129|P1|Overall Study|Ineligible|2
1790248|NCT00597012|6230128|P2|Overall Study|Withdrawal by Subject|4
1790249|NCT00597012|6230129|P1|Overall Study|Withdrawal by Subject|7
1790250|NCT00597012|6230128|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
1790251|NCT00597012|6230129|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
1790252|NCT00597012|6230128|P2|Overall Study|Death|1
1790253|NCT00597012|6230129|P1|Overall Study|Death|1
1790254|NCT00596960|6230141|P2|Overall Study|No alcohol use data|1
1790255|NCT00596960|6230142|P1|Overall Study|No alcohol use data|0
1790256|NCT00596960|6230141|P2|Overall Study|Protocol Violation|1
1790257|NCT00596960|6230142|P1|Overall Study|Protocol Violation|0
1790258|NCT00596960|6230141|P2|Overall Study|Physician Decision|0
1790259|NCT00596960|6230142|P1|Overall Study|Physician Decision|1
1790260|NCT00596960|6230141|P2|Overall Study|Incarcerated|0
1790261|NCT00596960|6230142|P1|Overall Study|Incarcerated|2
1790262|NCT00596960|6230141|P2|Overall Study|Withdrawal by Subject|0
1790263|NCT00596960|6230142|P1|Overall Study|Withdrawal by Subject|1
1790264|NCT00596960|6230141|P2|Overall Study|Lost to Follow-up|5
1790265|NCT00596960|6230142|P1|Overall Study|Lost to Follow-up|6
1790266|NCT00596960|6230141|P2|Overall Study|Death|2
1790267|NCT00596960|6230142|P1|Overall Study|Death|1
1790268|NCT00596947|6230154|P2|Overall Study|Lost to Follow-up|0
1790269|NCT00596947|6230155|P1|Overall Study|Lost to Follow-up|1
1790270|NCT00596947|6230154|P2|Overall Study|study halted due to low enrollment|3
1790271|NCT00596947|6230155|P1|Overall Study|study halted due to low enrollment|5
1790272|NCT00596934|6230195|P1|Overall Study|Withdrawal by Subject|1
1790273|NCT00596934|6230195|P1|Overall Study|Protocol Violation|1
1790274|NCT00596830|6230208|P2|Overall Study|Randomized but not treated|7
1790275|NCT00596830|6230209|P1|Overall Study|Randomized but not treated|3
1790276|NCT00596830|6230208|P2|Overall Study|Follow-up was discontinued|0
1790277|NCT00596830|6230209|P1|Overall Study|Follow-up was discontinued|1
1790278|NCT00596830|6230208|P2|Overall Study|Study terminated by sponsor|62
1790279|NCT00596830|6230209|P1|Overall Study|Study terminated by sponsor|51
1790280|NCT00596830|6230208|P2|Overall Study|Withdrawal by Subject|12
1790281|NCT00596830|6230209|P1|Overall Study|Withdrawal by Subject|22
1790282|NCT00596830|6230208|P2|Overall Study|Lost to Follow-up|11
1790283|NCT00596830|6230209|P1|Overall Study|Lost to Follow-up|7
1790284|NCT00596830|6230208|P2|Overall Study|Death|247
1790285|NCT00596830|6230209|P1|Overall Study|Death|258
1790286|NCT00596817|6230235|P2|Double-blind Period|Other Reasons|18
1790287|NCT00596817|6230236|P1|Double-blind Period|Other Reasons|10
1790288|NCT00596817|6230235|P2|Double-blind Period|Lost to Follow-up|2
1790289|NCT00596817|6230236|P1|Double-blind Period|Lost to Follow-up|0
1790290|NCT00596817|6230235|P2|Double-blind Period|Withdrawal of Consent|3
1790291|NCT00596817|6230236|P1|Double-blind Period|Withdrawal of Consent|7
1790292|NCT00596817|6230235|P2|Double-blind Period|Protocol Violation|8
1790293|NCT00596817|6230236|P1|Double-blind Period|Protocol Violation|11
1790294|NCT00596817|6230235|P2|Double-blind Period|Non-compliance With Study Product|4
1790295|NCT00596817|6230236|P1|Double-blind Period|Non-compliance With Study Product|3
1790296|NCT00596817|6230235|P2|Double-blind Period|Lack of Efficacy|28
1790297|NCT00596817|6230236|P1|Double-blind Period|Lack of Efficacy|52
1790298|NCT00596817|6230235|P2|Double-blind Period|Adverse Event|16
1790299|NCT00596817|6230236|P1|Double-blind Period|Adverse Event|5
1790300|NCT00596817|6230235|P2|Open-label Period to Double-blind Period|Other Reasons|14
1790301|NCT00596817|6230236|P1|Open-label Period to Double-blind Period|Other Reasons|0
1790302|NCT00596817|6230235|P2|Open-label Period to Double-blind Period|Not Eligible|49
1790303|NCT00596817|6230236|P1|Open-label Period to Double-blind Period|Not Eligible|0
1790304|NCT00596817|6230235|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
1790305|NCT00596817|6230236|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
1790306|NCT00596817|6230235|P2|Open-label Period to Double-blind Period|Adverse Event|5
1790307|NCT00596817|6230236|P1|Open-label Period to Double-blind Period|Adverse Event|0
1790308|NCT00596817|6230235|P2|Open-label Period|Other Reasons|65
1790309|NCT00596817|6230236|P1|Open-label Period|Other Reasons|0
1790310|NCT00596817|6230235|P2|Open-label Period|Lack of Efficacy|33
1790311|NCT00596817|6230236|P1|Open-label Period|Lack of Efficacy|0
1790312|NCT00596817|6230235|P2|Open-label Period|Adverse Event|49
1790313|NCT00596817|6230236|P1|Open-label Period|Adverse Event|0
1790314|NCT00596752|6230261|P2|Overall Study|Protocol Violation|0
1790315|NCT00596752|6230262|P1|Overall Study|Protocol Violation|1
1790316|NCT00596752|6230261|P2|Overall Study|Lack of Efficacy|7
1790317|NCT00596752|6230262|P1|Overall Study|Lack of Efficacy|4
1790318|NCT00596752|6230261|P2|Overall Study|Unsatisfactory Compliance|6
1790319|NCT00596752|6230262|P1|Overall Study|Unsatisfactory Compliance|9
1790320|NCT00596752|6230261|P2|Overall Study|Withdrawal by Subject|9
1790321|NCT00596752|6230262|P1|Overall Study|Withdrawal by Subject|12
1790322|NCT00596752|6230261|P2|Overall Study|Lost to Follow-up|38
1790323|NCT00596752|6230262|P1|Overall Study|Lost to Follow-up|22
1790324|NCT00596752|6230261|P2|Overall Study|Adverse Event|34
1790325|NCT00596752|6230262|P1|Overall Study|Adverse Event|34
1790326|NCT00596752|6230261|P2|Overall Study|Other Reason|49
1790327|NCT00596752|6230262|P1|Overall Study|Other Reason|44
1790328|NCT00596687|6230292|P2|Overall Study|cancelled surgery|1
1790329|NCT00596687|6230293|P1|Overall Study|cancelled surgery|1
1790330|NCT00596687|6230292|P2|Overall Study|Withdrawal by Subject|1
1790331|NCT00596687|6230293|P1|Overall Study|Withdrawal by Subject|3
1790332|NCT00596687|6230292|P2|Overall Study|continuous insulin infusion during TPN|1
1790333|NCT00596687|6230293|P1|Overall Study|continuous insulin infusion during TPN|2
1790334|NCT00596687|6230292|P2|Overall Study|< 24 hours of insulin treatment|6
1790335|NCT00596687|6230293|P1|Overall Study|< 24 hours of insulin treatment|8
1790336|NCT00596635|6230304|P3|Overall Study|Could not provide urine specimen|2
1790337|NCT00596635|6230305|P2|Overall Study|Could not provide urine specimen|2
1790338|NCT00596635|6230306|P1|Overall Study|Could not provide urine specimen|1
1790339|NCT00596635|6230304|P3|Overall Study|Hip fracture|3
1790340|NCT00596635|6230305|P2|Overall Study|Hip fracture|3
1790341|NCT00596635|6230306|P1|Overall Study|Hip fracture|2
1790342|NCT00596635|6230304|P3|Overall Study|Treatment for symptomatic UTI|3
1790343|NCT00596635|6230305|P2|Overall Study|Treatment for symptomatic UTI|6
1790344|NCT00596635|6230306|P1|Overall Study|Treatment for symptomatic UTI|4
1790345|NCT00596635|6230304|P3|Overall Study|Lost to Follow-up|0
1790346|NCT00596635|6230305|P2|Overall Study|Lost to Follow-up|2
1790347|NCT00596635|6230306|P1|Overall Study|Lost to Follow-up|0
1790348|NCT00596466|6230332|P1|Overall Study|Enrolled, not treated|2
1790349|NCT00596466|6230332|P1|Overall Study|Unpecified|2
1790350|NCT00596466|6230332|P1|Overall Study|Protocol Violation|2
1790351|NCT00596466|6230332|P1|Overall Study|Withdrawal by Subject|2
1790352|NCT00596466|6230332|P1|Overall Study|Adverse Event|4
1790353|NCT00596466|6230332|P1|Overall Study|Lack of Efficacy|5
1790354|NCT00596427|6230362|P2|Overall Study|Protocol Violation|0
1790355|NCT00596427|6230363|P1|Overall Study|Protocol Violation|1
1790356|NCT00596427|6230362|P2|Overall Study|Increased Fasting Triacylglycerol level|0
1790357|NCT00596427|6230363|P1|Overall Study|Increased Fasting Triacylglycerol level|1
1790358|NCT00596427|6230362|P2|Overall Study|Withdrawal by Subject|2
1790359|NCT00596427|6230363|P1|Overall Study|Withdrawal by Subject|2
1790360|NCT00596362|6230391|P1|Overall Study|Progressive Disease|1
1790361|NCT00596011|6230427|P2|Overall Study|Adverse Event|7
1790362|NCT00596011|6230428|P1|Overall Study|Adverse Event|11
1790363|NCT00596011|6230427|P2|Overall Study|Withdrawal by Subject|3
1790364|NCT00596011|6230428|P1|Overall Study|Withdrawal by Subject|2
1790365|NCT00595959|6230444|P1|Overall Study|Lost to Follow-up|1
1790366|NCT00595959|6230444|P1|Overall Study|Withdrawal by Subject|1
1790367|NCT00595920|6230478|P1|Overall Study|The OLTERMS study was discontinued by th|116
1790368|NCT00595868|6230489|P2|Overall Study|Lost to Follow-up|50
1790369|NCT00595868|6230490|P1|Overall Study|Lost to Follow-up|45
1790370|NCT00595764|6230513|P2|Overall Study|Withdrawal by Subject|0
1790371|NCT00595764|6230514|P1|Overall Study|Withdrawal by Subject|4
1790372|NCT00595764|6230513|P2|Overall Study|Missed 3 PM visits|7
1790373|NCT00595764|6230514|P1|Overall Study|Missed 3 PM visits|1
1790374|NCT00595764|6230513|P2|Overall Study|Missed Medication >1 week|17
1790375|NCT00595764|6230514|P1|Overall Study|Missed Medication >1 week|10
1790376|NCT00595764|6230513|P2|Overall Study|Protocol Violation|19
1790377|NCT00595764|6230514|P1|Overall Study|Protocol Violation|24
1790378|NCT00595621|6230530|P2|Randomization and Study|Withdrawal by Subject|1
1790379|NCT00595621|6230531|P1|Randomization and Study|Withdrawal by Subject|0
1790380|NCT00595621|6230530|P2|Randomization and Study|Adverse Event|0
1790381|NCT00595621|6230531|P1|Randomization and Study|Adverse Event|2
1790382|NCT00595621|6230530|P2|Open Label Run in|Withdrawal by Subject|0
1790383|NCT00595621|6230531|P1|Open Label Run in|Withdrawal by Subject|1
1790384|NCT00595621|6230530|P2|Open Label Run in|Physician Decision|0
1790385|NCT00595621|6230531|P1|Open Label Run in|Physician Decision|1
1790386|NCT00595621|6230530|P2|Open Label Run in|Adverse Event|0
1790387|NCT00595621|6230531|P1|Open Label Run in|Adverse Event|1
1790388|NCT00595582|6230548|P1|Overall Study|Physician Decision|5
1790389|NCT00595582|6230548|P1|Overall Study|Adverse Event|2
1790390|NCT00595582|6230548|P1|Overall Study|Lost to Follow-up|1
1790391|NCT00595582|6230548|P1|Overall Study|Pilot study that PI terminated|2
1790392|NCT00595517|6230574|P1|Overall Study|No intention to attend regularly|1
1790393|NCT00595517|6230574|P1|Overall Study|usage of prohibited treatment|1
1790394|NCT00595517|6230574|P1|Overall Study|Recurrence of ulcer|5
1790395|NCT00595517|6230574|P1|Overall Study|Protocol Violation|2
1790396|NCT00595517|6230574|P1|Overall Study|Withdrawal by Subject|4
1790397|NCT00595517|6230574|P1|Overall Study|Adverse Event|6
1790398|NCT00595504|6230583|P2|Overall Study|Physician Decision|0
1790399|NCT00595504|6230584|P1|Overall Study|Physician Decision|1
1790400|NCT00595504|6230583|P2|Overall Study|Withdrawal by Subject|3
1790401|NCT00595504|6230584|P1|Overall Study|Withdrawal by Subject|1
1790402|NCT00595478|6230596|P2|36-week Follow-up Period|Withdrawal by Subject|4
1790403|NCT00595478|6230597|P1|36-week Follow-up Period|Withdrawal by Subject|4
1790404|NCT00595478|6230596|P2|36-week Follow-up Period|Lost to Follow-up|4
1790405|NCT00595478|6230597|P1|36-week Follow-up Period|Lost to Follow-up|5
1790406|NCT00595465|6230608|P3|Overall Study|administrative reason|1
1790407|NCT00595465|6230609|P2|Overall Study|administrative reason|0
1790408|NCT00595465|6230610|P1|Overall Study|administrative reason|0
1790409|NCT00595465|6230608|P3|Overall Study|Lost to Follow-up|2
1790410|NCT00595465|6230609|P2|Overall Study|Lost to Follow-up|0
1790411|NCT00595465|6230610|P1|Overall Study|Lost to Follow-up|0
1790412|NCT00595465|6230608|P3|Overall Study|Protocol Violation|0
1790413|NCT00595465|6230609|P2|Overall Study|Protocol Violation|1
1790414|NCT00595465|6230610|P1|Overall Study|Protocol Violation|2
1790415|NCT00595465|6230608|P3|Overall Study|Pregnancy|1
1790416|NCT00595465|6230609|P2|Overall Study|Pregnancy|0
1790417|NCT00595465|6230610|P1|Overall Study|Pregnancy|0
1790418|NCT00595465|6230608|P3|Overall Study|Adverse Event|3
1790419|NCT00595465|6230609|P2|Overall Study|Adverse Event|3
1790420|NCT00595465|6230610|P1|Overall Study|Adverse Event|4
1790421|NCT00595413|6230622|P4|Overall Study|Other|0
1790422|NCT00595413|6230623|P3|Overall Study|Other|5
1790423|NCT00595413|6230624|P2|Overall Study|Other|1
1790424|NCT00595413|6230625|P1|Overall Study|Other|5
1790425|NCT00595413|6230622|P4|Overall Study|Death|0
1790426|NCT00595413|6230623|P3|Overall Study|Death|1
1790427|NCT00595413|6230624|P2|Overall Study|Death|0
1790428|NCT00595413|6230625|P1|Overall Study|Death|0
1790429|NCT00595413|6230622|P4|Overall Study|Lost to Follow-up|3
1790430|NCT00595413|6230623|P3|Overall Study|Lost to Follow-up|1
1790431|NCT00595413|6230624|P2|Overall Study|Lost to Follow-up|2
1790432|NCT00595413|6230625|P1|Overall Study|Lost to Follow-up|2
1790433|NCT00595413|6230622|P4|Overall Study|Adverse Event|1
1790434|NCT00595413|6230623|P3|Overall Study|Adverse Event|1
1790435|NCT00595413|6230624|P2|Overall Study|Adverse Event|2
1790436|NCT00595413|6230625|P1|Overall Study|Adverse Event|0
1790437|NCT00595335|6230666|P2|Six Months to Twelve Months|Disease Progression|0
1790438|NCT00595335|6230667|P1|Six Months to Twelve Months|Disease Progression|1
1790439|NCT00595335|6230666|P2|Six Months to Twelve Months|Withdrawal by Subject|1
1790440|NCT00595335|6230667|P1|Six Months to Twelve Months|Withdrawal by Subject|0
1790441|NCT00595335|6230666|P2|Baseline to Six Months|Adverse Event|0
1790442|NCT00595335|6230667|P1|Baseline to Six Months|Adverse Event|1
1790443|NCT00595335|6230666|P2|Baseline to Six Months|Disease Progression|1
1790444|NCT00595335|6230667|P1|Baseline to Six Months|Disease Progression|1
1790445|NCT00595335|6230666|P2|Baseline to Six Months|Withdrawal by Subject|1
1790446|NCT00595335|6230667|P1|Baseline to Six Months|Withdrawal by Subject|0
1790447|NCT00595309|6230687|P1|Overall Study|personal reason|1
1790448|NCT00595309|6230687|P1|Overall Study|acute infection after V0|1
1790449|NCT00595309|6230687|P1|Overall Study|planned vaccination against yellow fever|1
1790450|NCT00595309|6230687|P1|Overall Study|Lost to Follow-up|1
1790451|NCT00595127|6230736|P1|Overall Study|joined another trial|1
1790452|NCT00595127|6230736|P1|Overall Study|Relapsed|3
1790453|NCT00595127|6230736|P1|Overall Study|Death|6
1790454|NCT00595075|6230757|P2|Overall Study|Withdrawal by Subject|0
1790455|NCT00595075|6230758|P1|Overall Study|Withdrawal by Subject|1
1790456|NCT00594958|6230779|P3|Overall Study|administrative|2
1790457|NCT00594958|6230780|P2|Overall Study|administrative|0
1790458|NCT00594958|6230781|P1|Overall Study|administrative|3
1790459|NCT00594958|6230779|P3|Overall Study|Lost to Follow-up|3
1790460|NCT00594958|6230780|P2|Overall Study|Lost to Follow-up|0
1790461|NCT00594958|6230781|P1|Overall Study|Lost to Follow-up|5
1790462|NCT00594958|6230779|P3|Overall Study|Protocol Violation|2
1790463|NCT00594958|6230780|P2|Overall Study|Protocol Violation|0
1790464|NCT00594958|6230781|P1|Overall Study|Protocol Violation|1
1790465|NCT00594958|6230779|P3|Overall Study|Pregnancy|0
1790466|NCT00594958|6230780|P2|Overall Study|Pregnancy|2
1790467|NCT00594958|6230781|P1|Overall Study|Pregnancy|0
1790468|NCT00594958|6230779|P3|Overall Study|Adverse Event|2
1790469|NCT00594958|6230780|P2|Overall Study|Adverse Event|1
1790470|NCT00594958|6230781|P1|Overall Study|Adverse Event|4
1790471|NCT00594958|6230779|P3|Overall Study|Withdrawal by Subject|1
1790472|NCT00594958|6230780|P2|Overall Study|Withdrawal by Subject|0
1790473|NCT00594958|6230781|P1|Overall Study|Withdrawal by Subject|1
1790474|NCT00594906|6230802|P2|Overall Study|Death|1
1790475|NCT00594906|6230803|P1|Overall Study|Death|0
1790476|NCT00594906|6230802|P2|Overall Study|Physician Decision|1
1790477|NCT00594906|6230803|P1|Overall Study|Physician Decision|0
1790478|NCT00594906|6230802|P2|Overall Study|Physician Decision|0
1790479|NCT00594906|6230803|P1|Overall Study|Physician Decision|1
1790480|NCT00594880|6230811|P2|Overall Study|Lost to Follow-up|0
1790481|NCT00594880|6230812|P1|Overall Study|Lost to Follow-up|1
1790482|NCT00594880|6230811|P2|Overall Study|Withdrawal by Subject|1
1790483|NCT00594880|6230812|P1|Overall Study|Withdrawal by Subject|1
1790484|NCT00594854|6230824|P2|Overall Study|Study terminated|10
1790485|NCT00594854|6230825|P1|Overall Study|Study terminated|7
1790486|NCT00594815|6230835|P1|Overall Study|Toxicity|4
1790487|NCT00594815|6230835|P1|Overall Study|Withdrawal by Subject|2
1790488|NCT00594815|6230835|P1|Overall Study|Never Treated|3
1790489|NCT00594659|6230860|P3|Overall Study|Lost to Follow-up|7
1790490|NCT00594659|6230861|P2|Overall Study|Lost to Follow-up|9
1790491|NCT00594659|6230862|P1|Overall Study|Lost to Follow-up|13
1790492|NCT00594646|6230873|P1|Overall Study|Lost to Follow-up|15
1790493|NCT00594646|6230873|P1|Overall Study|Withdrawal by Subject|1
1790494|NCT00594568|6230881|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
1790495|NCT00594568|6230882|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
1790496|NCT00594568|6230883|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
1790497|NCT00594568|6230881|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
1790498|NCT00594568|6230882|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
1790499|NCT00594568|6230883|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
1790500|NCT00594568|6230881|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
1790501|NCT00594568|6230882|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
1790502|NCT00594568|6230883|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
1790503|NCT00594568|6230881|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
1790504|NCT00594568|6230882|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
1790505|NCT00594568|6230883|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
1790506|NCT00594568|6230881|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
1790507|NCT00594568|6230882|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
1790508|NCT00594568|6230883|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
1790509|NCT00594568|6230881|P3|Safety Follow Up (SFU)-Optional|Death|0
1790510|NCT00594568|6230882|P2|Safety Follow Up (SFU)-Optional|Death|1
1790511|NCT00594568|6230883|P1|Safety Follow Up (SFU)-Optional|Death|0
1790512|NCT00594568|6230881|P3|Delayed Start|Sponsor Decision|59
1790513|NCT00594568|6230882|P2|Delayed Start|Sponsor Decision|66
1790514|NCT00594568|6230883|P1|Delayed Start|Sponsor Decision|77
1790515|NCT00594568|6230881|P3|Delayed Start|Caregiver Decision|2
1790516|NCT00594568|6230882|P2|Delayed Start|Caregiver Decision|6
1790517|NCT00594568|6230883|P1|Delayed Start|Caregiver Decision|5
1790518|NCT00594568|6230881|P3|Delayed Start|Lost to Follow-up|1
1790519|NCT00594568|6230882|P2|Delayed Start|Lost to Follow-up|0
1790520|NCT00594568|6230883|P1|Delayed Start|Lost to Follow-up|0
1790521|NCT00594568|6230881|P3|Delayed Start|Physician Decision|1
1790522|NCT00594568|6230882|P2|Delayed Start|Physician Decision|0
1790523|NCT00594568|6230883|P1|Delayed Start|Physician Decision|0
1790524|NCT00594568|6230881|P3|Delayed Start|Withdrawal by Subject|0
1790525|NCT00594568|6230882|P2|Delayed Start|Withdrawal by Subject|3
1790526|NCT00594568|6230883|P1|Delayed Start|Withdrawal by Subject|4
1790527|NCT00594568|6230881|P3|Delayed Start|Adverse Event|2
1790528|NCT00594568|6230882|P2|Delayed Start|Adverse Event|2
1790529|NCT00594568|6230883|P1|Delayed Start|Adverse Event|12
1790530|NCT00594568|6230881|P3|Delayed Start|Death|1
1790531|NCT00594568|6230882|P2|Delayed Start|Death|0
1790532|NCT00594568|6230883|P1|Delayed Start|Death|0
1790533|NCT00594568|6230881|P3|Initial Treatment|Entry criteria exclusion|1
1790534|NCT00594568|6230882|P2|Initial Treatment|Entry criteria exclusion|1
1790535|NCT00594568|6230883|P1|Initial Treatment|Entry criteria exclusion|0
1790536|NCT00594568|6230881|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
1790537|NCT00594568|6230882|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
1790538|NCT00594568|6230883|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
1790539|NCT00594568|6230881|P3|Initial Treatment|Caregiver decision|36
1790540|NCT00594568|6230882|P2|Initial Treatment|Caregiver decision|36
1790541|NCT00594568|6230883|P1|Initial Treatment|Caregiver decision|21
1790542|NCT00594568|6230881|P3|Initial Treatment|Sponsor decision|147
1790543|NCT00594568|6230882|P2|Initial Treatment|Sponsor decision|142
1790544|NCT00594568|6230883|P1|Initial Treatment|Sponsor decision|193
1790545|NCT00594568|6230881|P3|Initial Treatment|Withdrawal by Subject|46
1790546|NCT00594568|6230882|P2|Initial Treatment|Withdrawal by Subject|31
1790547|NCT00594568|6230883|P1|Initial Treatment|Withdrawal by Subject|25
1790548|NCT00594568|6230881|P3|Initial Treatment|Protocol Violation|5
1790549|NCT00594568|6230882|P2|Initial Treatment|Protocol Violation|2
1790550|NCT00594568|6230883|P1|Initial Treatment|Protocol Violation|2
1790551|NCT00594568|6230881|P3|Initial Treatment|Physician Decision|4
1790552|NCT00594568|6230882|P2|Initial Treatment|Physician Decision|2
1790553|NCT00594568|6230883|P1|Initial Treatment|Physician Decision|3
1790554|NCT00594568|6230881|P3|Initial Treatment|Lost to Follow-up|4
1790555|NCT00594568|6230882|P2|Initial Treatment|Lost to Follow-up|1
1790556|NCT00594568|6230883|P1|Initial Treatment|Lost to Follow-up|4
1790557|NCT00594568|6230881|P3|Initial Treatment|Death|15
1790558|NCT00594568|6230882|P2|Initial Treatment|Death|11
1790559|NCT00594568|6230883|P1|Initial Treatment|Death|6
1790560|NCT00594568|6230881|P3|Initial Treatment|Adverse Event|144
1790561|NCT00594568|6230882|P2|Initial Treatment|Adverse Event|121
1790562|NCT00594568|6230883|P1|Initial Treatment|Adverse Event|51
1790563|NCT00594516|6230971|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
1790564|NCT00594516|6230972|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
1790565|NCT00594516|6230973|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
1790566|NCT00594516|6230971|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
1790567|NCT00594516|6230972|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
1790568|NCT00594516|6230973|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
1790818|NCT00592774|6231979|P4|Overall Study|Protocol Violation|0
1790569|NCT00594516|6230971|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
1790570|NCT00594516|6230972|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
1790571|NCT00594516|6230973|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
1790572|NCT00594516|6230971|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
1790573|NCT00594516|6230972|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
1790574|NCT00594516|6230973|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
1790575|NCT00594516|6230971|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
1790576|NCT00594516|6230972|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
1790577|NCT00594516|6230973|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
1790578|NCT00594516|6230971|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
1790579|NCT00594516|6230972|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
1790580|NCT00594516|6230973|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
1790581|NCT00594516|6230971|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
1790582|NCT00594516|6230972|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
1790583|NCT00594516|6230973|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
1790584|NCT00594516|6230971|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
1790585|NCT00594516|6230972|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
1790586|NCT00594516|6230973|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
1790587|NCT00594516|6230971|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
1790588|NCT00594516|6230972|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
1790589|NCT00594516|6230973|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
1790590|NCT00594464|6230981|P1|Overall Study|Delay in operation|2
1790591|NCT00594464|6230981|P1|Overall Study|Withdrawal by Subject|1
1790592|NCT00594399|6231110|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
1790593|NCT00594399|6231111|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
1790594|NCT00594399|6231112|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
1790595|NCT00594399|6231110|P3|Rerandomization Arm 1 Only|Death|0
1790596|NCT00594399|6231111|P2|Rerandomization Arm 1 Only|Death|1
1790597|NCT00594399|6231112|P1|Rerandomization Arm 1 Only|Death|2
1790598|NCT00594399|6231110|P3|Initial 3 Month Counseling|Family illness|0
1790599|NCT00594399|6231111|P2|Initial 3 Month Counseling|Family illness|0
1790600|NCT00594399|6231112|P1|Initial 3 Month Counseling|Family illness|1
1790601|NCT00594399|6231110|P3|Initial 3 Month Counseling|Moved|0
1790602|NCT00594399|6231111|P2|Initial 3 Month Counseling|Moved|0
1790603|NCT00594399|6231112|P1|Initial 3 Month Counseling|Moved|1
1790604|NCT00594399|6231110|P3|Initial 3 Month Counseling|Pain|0
1790605|NCT00594399|6231111|P2|Initial 3 Month Counseling|Pain|0
1790606|NCT00594399|6231112|P1|Initial 3 Month Counseling|Pain|2
1790607|NCT00594399|6231110|P3|Initial 3 Month Counseling|Too busy|0
1790608|NCT00594399|6231111|P2|Initial 3 Month Counseling|Too busy|1
1790609|NCT00594399|6231112|P1|Initial 3 Month Counseling|Too busy|7
1790610|NCT00594399|6231110|P3|Initial 3 Month Counseling|Personal issues|0
1790611|NCT00594399|6231111|P2|Initial 3 Month Counseling|Personal issues|0
1790612|NCT00594399|6231112|P1|Initial 3 Month Counseling|Personal issues|2
1790613|NCT00594399|6231110|P3|Initial 3 Month Counseling|Lack of Interest|0
1790614|NCT00594399|6231111|P2|Initial 3 Month Counseling|Lack of Interest|3
1790615|NCT00594399|6231112|P1|Initial 3 Month Counseling|Lack of Interest|3
1790616|NCT00594399|6231110|P3|Initial 3 Month Counseling|Not ready to exercise|0
1790617|NCT00594399|6231111|P2|Initial 3 Month Counseling|Not ready to exercise|0
1790618|NCT00594399|6231112|P1|Initial 3 Month Counseling|Not ready to exercise|1
1790619|NCT00594386|6231134|P1|Overall Study|Other: Loss of drivers license|1
1790620|NCT00594386|6231134|P1|Overall Study|Other: Patient wants prescription Neupro|1
1790621|NCT00594386|6231134|P1|Overall Study|Other: Site terminated participation|1
1790622|NCT00594386|6231134|P1|Overall Study|Other: Sponsor closure of study|1
1790623|NCT00594386|6231134|P1|Overall Study|Other: Study terminated per investigator|2
1790624|NCT00594386|6231134|P1|Overall Study|Other: Subject admitted to nursing home|1
1790625|NCT00594386|6231134|P1|Overall Study|Other: Subject moved to Seattle|1
1790626|NCT00594386|6231134|P1|Overall Study|Other: Patient went off patch (hospital)|1
1790627|NCT00594386|6231134|P1|Overall Study|Lost to Follow-up|6
1790628|NCT00594386|6231134|P1|Overall Study|Study ended per sponsor|115
1790629|NCT00594386|6231134|P1|Overall Study|Subject withdrew consent|35
1790630|NCT00594386|6231134|P1|Overall Study|Unsatisfactory compliance of subject|11
1790631|NCT00594386|6231134|P1|Overall Study|Adverse Event|68
1790632|NCT00594386|6231134|P1|Overall Study|Lack of Efficacy|12
1790633|NCT00594386|6231134|P1|Overall Study|Major protocol violation|2
1790634|NCT00594204|6231167|P2|Overall Study|Randomized but not treated|1
1790635|NCT00594204|6231168|P1|Overall Study|Randomized but not treated|4
1790636|NCT00594204|6231167|P2|Overall Study|Lack of Efficacy|4
1790637|NCT00594204|6231168|P1|Overall Study|Lack of Efficacy|3
1790638|NCT00594204|6231167|P2|Overall Study|Other|3
1790639|NCT00594204|6231168|P1|Overall Study|Other|4
1790640|NCT00594204|6231167|P2|Overall Study|Withdrawal by Subject|29
1790641|NCT00594204|6231168|P1|Overall Study|Withdrawal by Subject|23
1790642|NCT00594204|6231167|P2|Overall Study|Lost to Follow-up|5
1790643|NCT00594204|6231168|P1|Overall Study|Lost to Follow-up|9
1790644|NCT00594204|6231167|P2|Overall Study|Adverse Event|3
1790645|NCT00594204|6231168|P1|Overall Study|Adverse Event|15
1790646|NCT00594178|6231178|P1|Overall Study|Physician Decision|5
1790647|NCT00594165|6231183|P1|Overall Study|Other: Site terminated participation|2
1790648|NCT00594165|6231183|P1|Overall Study|Other: Subject enrolled in other trial|1
1790649|NCT00594165|6231183|P1|Overall Study|Other: House bound; can't get to clinic|1
1790650|NCT00594165|6231183|P1|Overall Study|Other: Brain surgery controlled symptoms|1
1790651|NCT00594165|6231183|P1|Overall Study|Other: Subject moving|3
1790652|NCT00594165|6231183|P1|Overall Study|Other: PI discretion|5
1790653|NCT00594165|6231183|P1|Overall Study|Lost to Follow-up|4
1790654|NCT00594165|6231183|P1|Overall Study|Study ended per sponsor|102
1790655|NCT00594165|6231183|P1|Overall Study|Subject withdrew consent|27
1790656|NCT00594165|6231183|P1|Overall Study|Unsatisfactory compliance of subject|6
1790657|NCT00594165|6231183|P1|Overall Study|Adverse Event|52
1790658|NCT00594165|6231183|P1|Overall Study|Lack of Efficacy|12
1790659|NCT00594165|6231183|P1|Overall Study|Major protocol violation|1
1790660|NCT00594100|6231189|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
1790661|NCT00594100|6231189|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
1790662|NCT00594100|6231189|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
1790663|NCT00594100|6231189|P1|Procedure|Technical Failure|9
1790664|NCT00594035|6231205|P2|Overall Study|Subject couldn't return due to job|1
1790665|NCT00594035|6231206|P1|Overall Study|Subject couldn't return due to job|0
1790666|NCT00594035|6231205|P2|Overall Study|Subject transferred to nursing home|1
1790667|NCT00594035|6231206|P1|Overall Study|Subject transferred to nursing home|0
1790668|NCT00594035|6231205|P2|Overall Study|Withdrawal by Subject|0
1790669|NCT00594035|6231206|P1|Overall Study|Withdrawal by Subject|1
1790670|NCT00594035|6231205|P2|Overall Study|Lost to Follow-up|1
1790671|NCT00594035|6231206|P1|Overall Study|Lost to Follow-up|1
1790672|NCT00593957|6231236|P3|Overall Study|Physician Decision|2
1790673|NCT00593957|6231237|P2|Overall Study|Physician Decision|1
1790674|NCT00593957|6231238|P1|Overall Study|Physician Decision|0
1790675|NCT00593918|6231262|P2|Overall Study|Withdrawal by Subject|24
1790676|NCT00593918|6231263|P1|Overall Study|Withdrawal by Subject|5
1790677|NCT00593840|6231276|P1|Overall Study|Withdrawal by Subject|1
1790678|NCT00593827|6231288|P2|Overall Study|On Active Treatment/Pending|2
1790679|NCT00593827|6231289|P1|Overall Study|On Active Treatment/Pending|0
1790680|NCT00593814|6231313|P2|Overall Study|Physician Decision|0
1790681|NCT00593814|6231314|P1|Overall Study|Physician Decision|3
1790682|NCT00593814|6231313|P2|Overall Study|Lost to Follow-up|0
1790683|NCT00593814|6231314|P1|Overall Study|Lost to Follow-up|7
1790684|NCT00593814|6231313|P2|Overall Study|Withdrawal by Subject|0
1790685|NCT00593814|6231314|P1|Overall Study|Withdrawal by Subject|7
1790686|NCT00593814|6231313|P2|Overall Study|Death|0
1790687|NCT00593814|6231314|P1|Overall Study|Death|7
1790688|NCT00593736|6231326|P4|Treatment Period and Placebo Run-out|Various|0
1790689|NCT00593736|6231327|P3|Treatment Period and Placebo Run-out|Various|1
1790690|NCT00593736|6231328|P2|Treatment Period and Placebo Run-out|Various|1
1790691|NCT00593736|6231329|P1|Treatment Period and Placebo Run-out|Various|1
1790692|NCT00593736|6231326|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
1790693|NCT00593736|6231327|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
1790694|NCT00593736|6231328|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
1790695|NCT00593736|6231329|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
1790696|NCT00593736|6231326|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
1790697|NCT00593736|6231327|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
1790698|NCT00593736|6231328|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
1790699|NCT00593736|6231329|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
1790700|NCT00593736|6231326|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
1790701|NCT00593736|6231327|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
1790702|NCT00593736|6231328|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
1790703|NCT00593736|6231329|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
1790704|NCT00593736|6231326|P4|Screening Period and Placebo Run-in|Various|25
1790705|NCT00593736|6231327|P3|Screening Period and Placebo Run-in|Various|0
1790706|NCT00593736|6231328|P2|Screening Period and Placebo Run-in|Various|0
1790707|NCT00593736|6231329|P1|Screening Period and Placebo Run-in|Various|0
1790708|NCT00593736|6231326|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
1790709|NCT00593736|6231327|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1790710|NCT00593736|6231328|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1790711|NCT00593736|6231329|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
1790712|NCT00593736|6231326|P4|Screening Period and Placebo Run-in|Study Termination|15
1790713|NCT00593736|6231327|P3|Screening Period and Placebo Run-in|Study Termination|0
1790714|NCT00593736|6231328|P2|Screening Period and Placebo Run-in|Study Termination|0
1790715|NCT00593736|6231329|P1|Screening Period and Placebo Run-in|Study Termination|0
1790716|NCT00593736|6231326|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
1790717|NCT00593736|6231327|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1790718|NCT00593736|6231328|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1790719|NCT00593736|6231329|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
1790720|NCT00593736|6231326|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
1790721|NCT00593736|6231327|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
1790722|NCT00593736|6231328|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
1790723|NCT00593736|6231329|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
1790724|NCT00593736|6231326|P4|Screening Period and Placebo Run-in|Adverse Event|3
1790725|NCT00593736|6231327|P3|Screening Period and Placebo Run-in|Adverse Event|0
1790726|NCT00593736|6231328|P2|Screening Period and Placebo Run-in|Adverse Event|0
1790727|NCT00593736|6231329|P1|Screening Period and Placebo Run-in|Adverse Event|0
1790728|NCT00593684|6231577|P2|Overall Study|Death|1
1790729|NCT00593684|6231578|P1|Overall Study|Death|2
1790730|NCT00593606|6231604|P1|Overall Study|Screen Failure|3
1790731|NCT00593606|6231604|P1|Overall Study|Run-In Failure|5
1790732|NCT00593606|6231604|P1|Overall Study|Lost to Follow-up|2
1790733|NCT00593606|6231604|P1|Overall Study|Protocol Violation|3
1790734|NCT00593606|6231604|P1|Overall Study|Withdrawal by Subject|1
1790735|NCT00593606|6231604|P1|Overall Study|Adverse Event|13
1790736|NCT00593554|6231702|P2|Overall Study|Disease Progression|2
1790737|NCT00593554|6231703|P1|Overall Study|Disease Progression|1
1790738|NCT00593554|6231702|P2|Overall Study|Withdrawal by Subject|0
1790739|NCT00593554|6231703|P1|Overall Study|Withdrawal by Subject|1
1790740|NCT00593554|6231702|P2|Overall Study|Physician Decision|1
1790741|NCT00593554|6231703|P1|Overall Study|Physician Decision|0
1790742|NCT00593554|6231702|P2|Overall Study|Death|2
1790743|NCT00593554|6231703|P1|Overall Study|Death|1
1790744|NCT00593385|6231798|P1|Overall Study|Withdrawal by Subject|9
1790745|NCT00593385|6231798|P1|Overall Study|Lost to Follow-up|17
1790746|NCT00593385|6231798|P1|Overall Study|Death|14
1790747|NCT00593333|6231859|P2|Overall Study|Lost to Follow-up|11
1790748|NCT00593333|6231860|P1|Overall Study|Lost to Follow-up|10
1790749|NCT00593112|6231883|P2|Overall Study|Withdrawal by Subject|0
1790750|NCT00593112|6231884|P1|Overall Study|Withdrawal by Subject|5
1790751|NCT00593112|6231883|P2|Overall Study|Unreadable Scan|0
1790752|NCT00593112|6231884|P1|Overall Study|Unreadable Scan|1
1790753|NCT00593112|6231883|P2|Overall Study|Abnormal Scan|0
1790754|NCT00593112|6231884|P1|Overall Study|Abnormal Scan|1
1790755|NCT00593112|6231883|P2|Overall Study|Scan Anxiety|0
1790756|NCT00593112|6231884|P1|Overall Study|Scan Anxiety|3
1790757|NCT00592904|6231911|P4|Overall Study|Other|0
1790758|NCT00592904|6231912|P3|Overall Study|Other|0
1790759|NCT00592904|6231913|P2|Overall Study|Other|3
1790760|NCT00592904|6231914|P1|Overall Study|Other|3
1790761|NCT00592904|6231911|P4|Overall Study|Physician Decision|0
1790762|NCT00592904|6231912|P3|Overall Study|Physician Decision|1
1790763|NCT00592904|6231913|P2|Overall Study|Physician Decision|3
1790764|NCT00592904|6231914|P1|Overall Study|Physician Decision|0
1790765|NCT00592904|6231911|P4|Overall Study|Lack of Efficacy|3
1790766|NCT00592904|6231912|P3|Overall Study|Lack of Efficacy|2
1790767|NCT00592904|6231913|P2|Overall Study|Lack of Efficacy|7
1790768|NCT00592904|6231914|P1|Overall Study|Lack of Efficacy|2
1790769|NCT00592904|6231911|P4|Overall Study|Withdrawal by Subject|2
1790770|NCT00592904|6231912|P3|Overall Study|Withdrawal by Subject|1
1790771|NCT00592904|6231913|P2|Overall Study|Withdrawal by Subject|16
1790772|NCT00592904|6231914|P1|Overall Study|Withdrawal by Subject|4
1790773|NCT00592904|6231911|P4|Overall Study|Protocol Violation|1
1790774|NCT00592904|6231912|P3|Overall Study|Protocol Violation|0
1790775|NCT00592904|6231913|P2|Overall Study|Protocol Violation|1
1790776|NCT00592904|6231914|P1|Overall Study|Protocol Violation|1
1790777|NCT00592904|6231911|P4|Overall Study|Adverse Event|5
1790778|NCT00592904|6231912|P3|Overall Study|Adverse Event|13
1790779|NCT00592904|6231913|P2|Overall Study|Adverse Event|25
1790780|NCT00592904|6231914|P1|Overall Study|Adverse Event|15
1790781|NCT00592852|6231940|P1|Overall Study|Withdrawal by Subject|1
1790782|NCT00592852|6231940|P1|Overall Study|Found ineligible|1
1790783|NCT00592852|6231940|P1|Overall Study|Adverse Event|3
1790784|NCT00592852|6231940|P1|Overall Study|Non-compliance|1
1790785|NCT00592839|6231948|P3|Overall Study|Lost to Follow-up|1
1790786|NCT00592839|6231949|P2|Overall Study|Lost to Follow-up|1
1790787|NCT00592839|6231950|P1|Overall Study|Lost to Follow-up|0
1790788|NCT00592839|6231948|P3|Overall Study|Adverse Event|0
1790789|NCT00592839|6231949|P2|Overall Study|Adverse Event|1
1790790|NCT00592839|6231950|P1|Overall Study|Adverse Event|0
1790791|NCT00592839|6231948|P3|Overall Study|Protocol Violation|2
1790792|NCT00592839|6231949|P2|Overall Study|Protocol Violation|1
1790793|NCT00592839|6231950|P1|Overall Study|Protocol Violation|1
1790794|NCT00592839|6231948|P3|Overall Study|Withdrawal by Subject|3
1790795|NCT00592839|6231949|P2|Overall Study|Withdrawal by Subject|1
1790796|NCT00592839|6231950|P1|Overall Study|Withdrawal by Subject|1
1790797|NCT00592774|6231978|P5|Overall Study|Other|2
1790798|NCT00592774|6231979|P4|Overall Study|Other|0
1790799|NCT00592774|6231980|P3|Overall Study|Other|1
1790800|NCT00592774|6231981|P2|Overall Study|Other|1
1790801|NCT00592774|6231982|P1|Overall Study|Other|0
1790802|NCT00592774|6231978|P5|Overall Study|Physician Decision|1
1790803|NCT00592774|6231979|P4|Overall Study|Physician Decision|0
1790804|NCT00592774|6231980|P3|Overall Study|Physician Decision|1
1790805|NCT00592774|6231981|P2|Overall Study|Physician Decision|1
1790806|NCT00592774|6231982|P1|Overall Study|Physician Decision|0
1790807|NCT00592774|6231978|P5|Overall Study|Lack of Efficacy|2
1790808|NCT00592774|6231979|P4|Overall Study|Lack of Efficacy|0
1790809|NCT00592774|6231980|P3|Overall Study|Lack of Efficacy|0
1790810|NCT00592774|6231981|P2|Overall Study|Lack of Efficacy|3
1790811|NCT00592774|6231982|P1|Overall Study|Lack of Efficacy|3
1790812|NCT00592774|6231978|P5|Overall Study|Withdrawal by Subject|0
1790813|NCT00592774|6231979|P4|Overall Study|Withdrawal by Subject|0
1790814|NCT00592774|6231980|P3|Overall Study|Withdrawal by Subject|0
1790815|NCT00592774|6231981|P2|Overall Study|Withdrawal by Subject|7
1790816|NCT00592774|6231982|P1|Overall Study|Withdrawal by Subject|3
1790817|NCT00592774|6231978|P5|Overall Study|Protocol Violation|1
1790819|NCT00592774|6231980|P3|Overall Study|Protocol Violation|0
1790820|NCT00592774|6231981|P2|Overall Study|Protocol Violation|1
1790821|NCT00592774|6231982|P1|Overall Study|Protocol Violation|0
1790822|NCT00592774|6231978|P5|Overall Study|Adverse Event|8
1790823|NCT00592774|6231979|P4|Overall Study|Adverse Event|14
1790824|NCT00592774|6231980|P3|Overall Study|Adverse Event|2
1790825|NCT00592774|6231981|P2|Overall Study|Adverse Event|19
1790826|NCT00592774|6231982|P1|Overall Study|Adverse Event|5
1790827|NCT00592683|6232054|P2|Overall Study|Lost to Follow-up|1
1790828|NCT00592683|6232055|P1|Overall Study|Lost to Follow-up|0
1790829|NCT00592683|6232054|P2|Overall Study|Other|0
1790830|NCT00592683|6232055|P1|Overall Study|Other|1
1790831|NCT00592683|6232054|P2|Overall Study|Study drug expired|0
1790832|NCT00592683|6232055|P1|Overall Study|Study drug expired|1
1790833|NCT00592683|6232054|P2|Overall Study|Protocol Violation|0
1790834|NCT00592683|6232055|P1|Overall Study|Protocol Violation|1
1790835|NCT00592683|6232054|P2|Overall Study|Adverse Event|2
1790836|NCT00592683|6232055|P1|Overall Study|Adverse Event|0
1790837|NCT00592683|6232054|P2|Overall Study|Withdrawal by Subject|0
1790838|NCT00592683|6232055|P1|Overall Study|Withdrawal by Subject|1
1790839|NCT00592683|6232054|P2|Overall Study|Found ineligible|1
1790840|NCT00592683|6232055|P1|Overall Study|Found ineligible|0
1790841|NCT00592631|6232065|P2|Overall Study|Lost to Follow-up|2
1790842|NCT00592631|6232066|P1|Overall Study|Lost to Follow-up|0
1790843|NCT00592384|6232115|P2|Overall Study|Withdrawal by Subject|6
1790844|NCT00592384|6232116|P1|Overall Study|Withdrawal by Subject|5
1790845|NCT00592358|6232124|P1|Overall Study|Inability to swallow pills|1
1790846|NCT00592358|6232124|P1|Overall Study|Lack of Efficacy|2
1790847|NCT00592358|6232124|P1|Overall Study|Adverse Event|1
1790848|NCT00592358|6232124|P1|Overall Study|Withdrawal by Subject|2
1790849|NCT00592319|6232131|P2|Overall Study|Lost to Follow-up|3
1790850|NCT00592319|6232132|P1|Overall Study|Lost to Follow-up|0
1790851|NCT00592072|6232207|P2|Wash Out Period|Lost to Follow-up|1
1790852|NCT00592072|6232208|P1|Wash Out Period|Lost to Follow-up|1
1790853|NCT00592007|6232230|P1|Overall Study|patient ineligible (out of lab range)|1
1790854|NCT00592007|6232230|P1|Overall Study|Withdrawal by Subject|1
1790855|NCT00591864|6232242|P1|Overall Study|Incomplete Imaging|5
1790856|NCT00591851|6232248|P1|Overall Study|Progressive Disease|1
1790857|NCT00591851|6232248|P1|Overall Study|Adverse Event|2
1790858|NCT00591851|6232248|P1|Overall Study|Withdrawal by Subject|3
1790859|NCT00591838|6232257|P5|Overall Study|Withdrawal by Subject|0
1790860|NCT00591838|6232258|P4|Overall Study|Withdrawal by Subject|1
1790861|NCT00591838|6232259|P3|Overall Study|Withdrawal by Subject|0
1790862|NCT00591838|6232260|P2|Overall Study|Withdrawal by Subject|0
1790863|NCT00591838|6232261|P1|Overall Study|Withdrawal by Subject|0
1790864|NCT00591786|6232325|P10|Overall Study|Withdrawal of Informed Consent|0
1790865|NCT00591786|6232326|P9|Overall Study|Withdrawal of Informed Consent|0
1790866|NCT00591786|6232327|P8|Overall Study|Withdrawal of Informed Consent|0
1790867|NCT00591786|6232328|P7|Overall Study|Withdrawal of Informed Consent|0
1790868|NCT00591786|6232329|P6|Overall Study|Withdrawal of Informed Consent|0
1790869|NCT00591786|6232330|P5|Overall Study|Withdrawal of Informed Consent|0
1790870|NCT00591786|6232331|P4|Overall Study|Withdrawal of Informed Consent|0
1790871|NCT00591786|6232332|P3|Overall Study|Withdrawal of Informed Consent|1
1790872|NCT00591786|6232333|P2|Overall Study|Withdrawal of Informed Consent|0
1790873|NCT00591786|6232334|P1|Overall Study|Withdrawal of Informed Consent|0
1790874|NCT00591773|6232379|P3|Overall Study|Other|4
1790875|NCT00591773|6232380|P2|Overall Study|Other|1
1790876|NCT00591773|6232381|P1|Overall Study|Other|1
1790877|NCT00591773|6232379|P3|Overall Study|Lack of Efficacy|2
1790878|NCT00591773|6232380|P2|Overall Study|Lack of Efficacy|2
1790879|NCT00591773|6232381|P1|Overall Study|Lack of Efficacy|1
1790880|NCT00591773|6232379|P3|Overall Study|Withdrawal by Subject|3
1790881|NCT00591773|6232380|P2|Overall Study|Withdrawal by Subject|5
1790882|NCT00591773|6232381|P1|Overall Study|Withdrawal by Subject|2
1790883|NCT00591773|6232379|P3|Overall Study|Lost to Follow-up|1
1790884|NCT00591773|6232380|P2|Overall Study|Lost to Follow-up|4
1790885|NCT00591773|6232381|P1|Overall Study|Lost to Follow-up|1
1790886|NCT00591773|6232379|P3|Overall Study|Protocol Violation|0
1790887|NCT00591773|6232380|P2|Overall Study|Protocol Violation|3
1790888|NCT00591773|6232381|P1|Overall Study|Protocol Violation|2
1790889|NCT00591773|6232379|P3|Overall Study|Adverse Event|6
1790890|NCT00591773|6232380|P2|Overall Study|Adverse Event|9
1790891|NCT00591773|6232381|P1|Overall Study|Adverse Event|9
1790892|NCT00591734|6232440|P1|Overall Study|Intercurrent Illness|8
1790893|NCT00591734|6232440|P1|Overall Study|Physician Decision|5
1790894|NCT00591734|6232440|P1|Overall Study|Adverse Event|5
1790895|NCT00591734|6232440|P1|Overall Study|Lack of Efficacy|35
1790896|NCT00591721|6232446|P2|Overall Study|Intervention not received|8
1790897|NCT00591721|6232447|P1|Overall Study|Intervention not received|10
1790898|NCT00591721|6232446|P2|Overall Study|Lost to Follow-up|4
1790899|NCT00591721|6232447|P1|Overall Study|Lost to Follow-up|1
1790900|NCT00591721|6232446|P2|Overall Study|Withdrawal by Subject|10
1790901|NCT00591721|6232447|P1|Overall Study|Withdrawal by Subject|10
1790902|NCT00591591|6232455|P2|Overall Study|Lack of Efficacy|2
1790903|NCT00591591|6232456|P1|Overall Study|Lack of Efficacy|10
1790904|NCT00591591|6232455|P2|Overall Study|Withdrawal by Subject|37
1790905|NCT00591591|6232456|P1|Overall Study|Withdrawal by Subject|1
1790906|NCT00591578|6232473|P3|Open-Label Extension Phase|Other|0
1790907|NCT00591578|6232474|P2|Open-Label Extension Phase|Other|0
1790908|NCT00591578|6232475|P1|Open-Label Extension Phase|Other|1
1790909|NCT00591578|6232473|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1790910|NCT00591578|6232474|P2|Open-Label Extension Phase|Withdrawal by Subject|1
1790911|NCT00591578|6232475|P1|Open-Label Extension Phase|Withdrawal by Subject|1
1790912|NCT00591578|6232473|P3|Open-Label Extension Phase|Lost to Follow-up|0
1790913|NCT00591578|6232474|P2|Open-Label Extension Phase|Lost to Follow-up|4
1790914|NCT00591578|6232475|P1|Open-Label Extension Phase|Lost to Follow-up|1
1790915|NCT00591578|6232473|P3|Open-Label Extension Phase|Adverse Event|0
1790916|NCT00591578|6232474|P2|Open-Label Extension Phase|Adverse Event|5
1790917|NCT00591578|6232475|P1|Open-Label Extension Phase|Adverse Event|3
1790918|NCT00591578|6232473|P3|Double-Blind Treatment Phase|Other|4
1790919|NCT00591578|6232474|P2|Double-Blind Treatment Phase|Other|9
1790920|NCT00591578|6232475|P1|Double-Blind Treatment Phase|Other|4
1790921|NCT00591578|6232473|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
1790922|NCT00591578|6232474|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
1790923|NCT00591578|6232475|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
1790924|NCT00591578|6232473|P3|Double-Blind Treatment Phase|Pregnancy|0
1790925|NCT00591578|6232474|P2|Double-Blind Treatment Phase|Pregnancy|0
1790926|NCT00591578|6232475|P1|Double-Blind Treatment Phase|Pregnancy|1
1790927|NCT00591578|6232473|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
1790928|NCT00591578|6232474|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
1790929|NCT00591578|6232475|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
1790930|NCT00591578|6232473|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
1790931|NCT00591578|6232474|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
1790932|NCT00591578|6232475|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
1790933|NCT00591578|6232473|P3|Double-Blind Treatment Phase|Protocol Violation|3
1790934|NCT00591578|6232474|P2|Double-Blind Treatment Phase|Protocol Violation|2
1790935|NCT00591578|6232475|P1|Double-Blind Treatment Phase|Protocol Violation|3
1790936|NCT00591578|6232473|P3|Double-Blind Treatment Phase|Adverse Event|19
1790937|NCT00591578|6232474|P2|Double-Blind Treatment Phase|Adverse Event|26
1790938|NCT00591578|6232475|P1|Double-Blind Treatment Phase|Adverse Event|20
1790939|NCT00591565|6232526|P1|Overall Study|lost follow up, withdrawn|5
1790940|NCT00591409|6232540|P10|Overall Study|Not Treated|1
1790941|NCT00591409|6232541|P9|Overall Study|Not Treated|0
1790942|NCT00591409|6232542|P8|Overall Study|Not Treated|0
1790943|NCT00591409|6232543|P7|Overall Study|Not Treated|0
1790944|NCT00591409|6232544|P6|Overall Study|Not Treated|0
1790945|NCT00591409|6232545|P5|Overall Study|Not Treated|1
1790946|NCT00591409|6232546|P4|Overall Study|Not Treated|0
1790947|NCT00591409|6232547|P3|Overall Study|Not Treated|0
1790948|NCT00591409|6232548|P2|Overall Study|Not Treated|0
1790949|NCT00591409|6232549|P1|Overall Study|Not Treated|0
1790950|NCT00591370|6232591|P1|Overall Study|Not Treated|2
1790951|NCT00591344|6232599|P2|Overall Study|Did not want to come off medication|1
1790952|NCT00591344|6232600|P1|Overall Study|Did not want to come off medication|0
1790953|NCT00591344|6232599|P2|Overall Study|Lost to Follow-up|1
1790954|NCT00591344|6232600|P1|Overall Study|Lost to Follow-up|0
1790955|NCT00591344|6232599|P2|Overall Study|Death|1
1790956|NCT00591344|6232600|P1|Overall Study|Death|0
1790957|NCT00591344|6232599|P2|Overall Study|Underwent DBS|2
1790958|NCT00591344|6232600|P1|Overall Study|Underwent DBS|2
1790959|NCT00591344|6232599|P2|Overall Study|Medical complications|3
1790960|NCT00591344|6232600|P1|Overall Study|Medical complications|1
1790961|NCT00591344|6232599|P2|Overall Study|Moved out of state|0
1790962|NCT00591344|6232600|P1|Overall Study|Moved out of state|1
1790963|NCT00591344|6232599|P2|Overall Study|Transportation issues|0
1790964|NCT00591344|6232600|P1|Overall Study|Transportation issues|1
1790965|NCT00591266|6232626|P3|Overall Study|Other|5
1790966|NCT00591266|6232627|P2|Overall Study|Other|4
1790967|NCT00591266|6232628|P1|Overall Study|Other|1
1790968|NCT00591266|6232626|P3|Overall Study|Lack of Efficacy|0
1790969|NCT00591266|6232627|P2|Overall Study|Lack of Efficacy|2
1790970|NCT00591266|6232628|P1|Overall Study|Lack of Efficacy|0
1790971|NCT00591266|6232626|P3|Overall Study|Withdrawal by Subject|5
1790972|NCT00591266|6232627|P2|Overall Study|Withdrawal by Subject|2
1790973|NCT00591266|6232628|P1|Overall Study|Withdrawal by Subject|6
1790974|NCT00591266|6232626|P3|Overall Study|Protocol Violation|1
1790975|NCT00591266|6232627|P2|Overall Study|Protocol Violation|0
1790976|NCT00591266|6232628|P1|Overall Study|Protocol Violation|0
1790977|NCT00591266|6232626|P3|Overall Study|Lost to Follow-up|0
1790978|NCT00591266|6232627|P2|Overall Study|Lost to Follow-up|1
1790979|NCT00591266|6232628|P1|Overall Study|Lost to Follow-up|0
1790980|NCT00591266|6232626|P3|Overall Study|Adverse Event|3
1790981|NCT00591266|6232627|P2|Overall Study|Adverse Event|2
1790982|NCT00591266|6232628|P1|Overall Study|Adverse Event|2
1790983|NCT00591253|6232681|P3|Overall Study|Other|3
1790984|NCT00591253|6232682|P2|Overall Study|Other|5
1790985|NCT00591253|6232683|P1|Overall Study|Other|5
1790986|NCT00591253|6232681|P3|Overall Study|Lack of Efficacy|3
1790987|NCT00591253|6232682|P2|Overall Study|Lack of Efficacy|0
1790988|NCT00591253|6232683|P1|Overall Study|Lack of Efficacy|1
1790989|NCT00591253|6232681|P3|Overall Study|Withdrawal by Subject|6
1790990|NCT00591253|6232682|P2|Overall Study|Withdrawal by Subject|7
1790991|NCT00591253|6232683|P1|Overall Study|Withdrawal by Subject|1
1790992|NCT00591253|6232681|P3|Overall Study|Lost to Follow-up|0
1790993|NCT00591253|6232682|P2|Overall Study|Lost to Follow-up|4
1790994|NCT00591253|6232683|P1|Overall Study|Lost to Follow-up|2
1790995|NCT00591253|6232681|P3|Overall Study|Protocol Violation|2
1790996|NCT00591253|6232682|P2|Overall Study|Protocol Violation|2
1790997|NCT00591253|6232683|P1|Overall Study|Protocol Violation|2
1790998|NCT00591253|6232681|P3|Overall Study|Adverse Event|1
1790999|NCT00591253|6232682|P2|Overall Study|Adverse Event|3
1791000|NCT00591253|6232683|P1|Overall Study|Adverse Event|3
1791001|NCT00591214|6232751|P1|Overall Study|Withdrawal by Subject|1
1791002|NCT00591214|6232751|P1|Overall Study|Physician Decision|7
1791003|NCT00591149|6232760|P1|Overall Study|Withdrawal by Subject|1
1791004|NCT00591149|6232760|P1|Overall Study|Adverse Event|4
1791005|NCT00591006|6232776|P24|Overall Study|Adverse Event|0
1791006|NCT00591006|6232777|P23|Overall Study|Adverse Event|1
1791007|NCT00591006|6232778|P22|Overall Study|Adverse Event|0
1791008|NCT00591006|6232779|P21|Overall Study|Adverse Event|0
1791009|NCT00591006|6232780|P20|Overall Study|Adverse Event|0
1791010|NCT00591006|6232781|P19|Overall Study|Adverse Event|0
1791011|NCT00591006|6232782|P18|Overall Study|Adverse Event|0
1791012|NCT00591006|6232783|P17|Overall Study|Adverse Event|0
1791013|NCT00591006|6232784|P16|Overall Study|Adverse Event|0
1791014|NCT00591006|6232785|P15|Overall Study|Adverse Event|0
1791015|NCT00591006|6232786|P14|Overall Study|Adverse Event|0
1791016|NCT00591006|6232787|P13|Overall Study|Adverse Event|0
1791017|NCT00591006|6232788|P12|Overall Study|Adverse Event|0
1791018|NCT00591006|6232789|P11|Overall Study|Adverse Event|0
1791019|NCT00591006|6232790|P10|Overall Study|Adverse Event|0
1791020|NCT00591006|6232791|P9|Overall Study|Adverse Event|0
1791021|NCT00591006|6232792|P8|Overall Study|Adverse Event|0
1791022|NCT00591006|6232793|P7|Overall Study|Adverse Event|0
1791023|NCT00591006|6232794|P6|Overall Study|Adverse Event|0
1791024|NCT00591006|6232795|P5|Overall Study|Adverse Event|0
1791025|NCT00591006|6232796|P4|Overall Study|Adverse Event|0
1791026|NCT00591006|6232797|P3|Overall Study|Adverse Event|0
1791027|NCT00591006|6232798|P2|Overall Study|Adverse Event|0
1791028|NCT00591006|6232799|P1|Overall Study|Adverse Event|0
1791029|NCT00591006|6232776|P24|Overall Study|Withdrawal by Subject|1
1791030|NCT00591006|6232777|P23|Overall Study|Withdrawal by Subject|0
1791031|NCT00591006|6232778|P22|Overall Study|Withdrawal by Subject|0
1791032|NCT00591006|6232779|P21|Overall Study|Withdrawal by Subject|0
1791033|NCT00591006|6232780|P20|Overall Study|Withdrawal by Subject|0
1791034|NCT00591006|6232781|P19|Overall Study|Withdrawal by Subject|0
1791035|NCT00591006|6232782|P18|Overall Study|Withdrawal by Subject|0
1791036|NCT00591006|6232783|P17|Overall Study|Withdrawal by Subject|0
1791037|NCT00591006|6232784|P16|Overall Study|Withdrawal by Subject|1
1791038|NCT00591006|6232785|P15|Overall Study|Withdrawal by Subject|0
1791039|NCT00591006|6232786|P14|Overall Study|Withdrawal by Subject|0
1791040|NCT00591006|6232787|P13|Overall Study|Withdrawal by Subject|0
1791041|NCT00591006|6232788|P12|Overall Study|Withdrawal by Subject|0
1791042|NCT00591006|6232789|P11|Overall Study|Withdrawal by Subject|0
1791043|NCT00591006|6232790|P10|Overall Study|Withdrawal by Subject|0
1791044|NCT00591006|6232791|P9|Overall Study|Withdrawal by Subject|0
1791045|NCT00591006|6232792|P8|Overall Study|Withdrawal by Subject|0
1791046|NCT00591006|6232793|P7|Overall Study|Withdrawal by Subject|0
1791047|NCT00591006|6232794|P6|Overall Study|Withdrawal by Subject|0
1791048|NCT00591006|6232795|P5|Overall Study|Withdrawal by Subject|0
1791049|NCT00591006|6232796|P4|Overall Study|Withdrawal by Subject|0
1791050|NCT00591006|6232797|P3|Overall Study|Withdrawal by Subject|0
1791051|NCT00591006|6232798|P2|Overall Study|Withdrawal by Subject|0
1791052|NCT00591006|6232799|P1|Overall Study|Withdrawal by Subject|0
1791053|NCT00590980|6232817|P1|Overall Study|Did not meet all inclusion criteria|10
1791054|NCT00590967|6232823|P2|Overall Study|Did not receive chemo per protocol|0
1791055|NCT00590967|6232824|P1|Overall Study|Did not receive chemo per protocol|1
1791056|NCT00590967|6232823|P2|Overall Study|Did not sign consent form|1
1791057|NCT00590967|6232824|P1|Overall Study|Did not sign consent form|0
1791058|NCT00590967|6232823|P2|Overall Study|Non-compliant|2
1791059|NCT00590967|6232824|P1|Overall Study|Non-compliant|0
1791060|NCT00590967|6232823|P2|Overall Study|Poor performance status|1
1791061|NCT00590967|6232824|P1|Overall Study|Poor performance status|0
1791062|NCT00590967|6232823|P2|Overall Study|Ineligible|0
1791063|NCT00590967|6232824|P1|Overall Study|Ineligible|1
1791064|NCT00590967|6232823|P2|Overall Study|Withdrawal by Subject|1
1791065|NCT00590967|6232824|P1|Overall Study|Withdrawal by Subject|1
1791066|NCT00590902|6232836|P1|Overall Study|Death|1
1791067|NCT00590824|6232869|P4|Overall Study|Adverse Event|1
1791068|NCT00590824|6232870|P3|Overall Study|Adverse Event|0
1791069|NCT00590824|6232871|P2|Overall Study|Adverse Event|0
1791070|NCT00590824|6232872|P1|Overall Study|Adverse Event|0
1791071|NCT00590824|6232869|P4|Overall Study|Disease could not be resected|0
1791072|NCT00590824|6232870|P3|Overall Study|Disease could not be resected|1
1791073|NCT00590824|6232871|P2|Overall Study|Disease could not be resected|2
1791074|NCT00590824|6232872|P1|Overall Study|Disease could not be resected|0
1791075|NCT00590759|6232898|P1|Overall Study|Lost to Follow-up|28
1791076|NCT00590759|6232898|P1|Overall Study|Death|52
1791077|NCT00590720|6232905|P2|Overall Study|Withdrawal by Subject|1
1791078|NCT00590720|6232906|P1|Overall Study|Withdrawal by Subject|0
1791079|NCT00590720|6232905|P2|Overall Study|Lost to Follow-up|0
1791080|NCT00590720|6232906|P1|Overall Study|Lost to Follow-up|1
1791081|NCT00590590|6232968|P3|Overall Study|Did not complete study|0
1791082|NCT00590590|6232969|P2|Overall Study|Did not complete study|1
1791083|NCT00590590|6232970|P1|Overall Study|Did not complete study|0
1791084|NCT00590590|6232968|P3|Overall Study|Did not complete due to study closure|1
1791085|NCT00590590|6232969|P2|Overall Study|Did not complete due to study closure|1
1791086|NCT00590590|6232970|P1|Overall Study|Did not complete due to study closure|1
1791087|NCT00590590|6232968|P3|Overall Study|Withdrawal by Subject|1
1791088|NCT00590590|6232969|P2|Overall Study|Withdrawal by Subject|1
1791089|NCT00590590|6232970|P1|Overall Study|Withdrawal by Subject|0
1791090|NCT00590590|6232968|P3|Overall Study|Lost to Follow-up|2
1791091|NCT00590590|6232969|P2|Overall Study|Lost to Follow-up|1
1791092|NCT00590590|6232970|P1|Overall Study|Lost to Follow-up|4
1791093|NCT00590590|6232968|P3|Overall Study|Protocol Violation|2
1791094|NCT00590590|6232969|P2|Overall Study|Protocol Violation|0
1791095|NCT00590590|6232970|P1|Overall Study|Protocol Violation|0
1791096|NCT00590590|6232968|P3|Overall Study|Adverse Event|0
1791097|NCT00590590|6232969|P2|Overall Study|Adverse Event|0
1791098|NCT00590590|6232970|P1|Overall Study|Adverse Event|1
1791099|NCT00590590|6232968|P3|Overall Study|Lack of Efficacy|0
1791100|NCT00590590|6232969|P2|Overall Study|Lack of Efficacy|2
1791101|NCT00590590|6232970|P1|Overall Study|Lack of Efficacy|1
1791102|NCT00590577|6232997|P4|Overall Study|Various reasons|2
1791103|NCT00590577|6232998|P3|Overall Study|Various reasons|1
1791104|NCT00590577|6232999|P2|Overall Study|Various reasons|3
1791105|NCT00590577|6233000|P1|Overall Study|Various reasons|1
1791106|NCT00590577|6232997|P4|Overall Study|Pregnancy|0
1791107|NCT00590577|6232998|P3|Overall Study|Pregnancy|0
1791108|NCT00590577|6232999|P2|Overall Study|Pregnancy|1
1791109|NCT00590577|6233000|P1|Overall Study|Pregnancy|0
1791110|NCT00590577|6232997|P4|Overall Study|Lost to Follow-up|9
1791111|NCT00590577|6232998|P3|Overall Study|Lost to Follow-up|6
1791112|NCT00590577|6232999|P2|Overall Study|Lost to Follow-up|6
1791113|NCT00590577|6233000|P1|Overall Study|Lost to Follow-up|12
1791114|NCT00590577|6232997|P4|Overall Study|Adverse Event|11
1791115|NCT00590577|6232998|P3|Overall Study|Adverse Event|13
1791116|NCT00590577|6232999|P2|Overall Study|Adverse Event|10
1791117|NCT00590577|6233000|P1|Overall Study|Adverse Event|10
1791118|NCT00590577|6232997|P4|Overall Study|Withdrawal by Subject|26
1791119|NCT00590577|6232998|P3|Overall Study|Withdrawal by Subject|30
1791120|NCT00590577|6232999|P2|Overall Study|Withdrawal by Subject|28
1791121|NCT00590577|6233000|P1|Overall Study|Withdrawal by Subject|23
1791122|NCT00590577|6232997|P4|Overall Study|Lack of Efficacy|45
1791123|NCT00590577|6232998|P3|Overall Study|Lack of Efficacy|23
1791124|NCT00590577|6232999|P2|Overall Study|Lack of Efficacy|28
1791125|NCT00590577|6233000|P1|Overall Study|Lack of Efficacy|31
1791126|NCT00590564|6233018|P1|Overall Study|Patient Non-compliance|6
1791127|NCT00590564|6233018|P1|Overall Study|Patient Found to be Ineligible|1
1791128|NCT00590564|6233018|P1|Overall Study|Protocol Violation|1
1791129|NCT00590564|6233018|P1|Overall Study|Lost to Follow-up|6
1791130|NCT00590564|6233018|P1|Overall Study|Withdrawal by Subject|4
1791131|NCT00590538|6233022|P1|Overall Study|Study terminated before completed|2
1791132|NCT00590317|6233068|P2|Overall Study|Lack of Efficacy|5
1791133|NCT00590317|6233069|P1|Overall Study|Lack of Efficacy|1
1791134|NCT00590135|6233099|P1|Overall Study|Primary endpoint measure not obtainable|59
1791135|NCT00590044|6233109|P2|Overall Study|Protocol Violation|0
1791136|NCT00590044|6233110|P1|Overall Study|Protocol Violation|1
1791137|NCT00590044|6233109|P2|Overall Study|wrong insulin arm assigned|0
1791138|NCT00590044|6233110|P1|Overall Study|wrong insulin arm assigned|1
1791139|NCT00590044|6233109|P2|Overall Study|Withdrawal by Subject|2
1791140|NCT00590044|6233110|P1|Overall Study|Withdrawal by Subject|2
1791141|NCT00590031|6233122|P1|Overall Study|Admin Hold|1
1791142|NCT00590031|6233122|P1|Overall Study|Metastatic Disease|1
1791143|NCT00590031|6233122|P1|Overall Study|Withdrawal by Subject|1
1791144|NCT00590031|6233122|P1|Overall Study|Adverse Event|3
1791145|NCT00589979|6233149|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
1791146|NCT00589979|6233150|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
1791147|NCT00589979|6233151|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
1791148|NCT00589979|6233149|P3|Double-Blind Treatment Period 3|Protocol Violation|0
1791149|NCT00589979|6233150|P2|Double-Blind Treatment Period 3|Protocol Violation|1
1791150|NCT00589979|6233151|P1|Double-Blind Treatment Period 3|Protocol Violation|0
1791151|NCT00589979|6233149|P3|Double-Blind Treatment Period 2|Other|1
1791152|NCT00589979|6233150|P2|Double-Blind Treatment Period 2|Other|0
1791153|NCT00589979|6233151|P1|Double-Blind Treatment Period 2|Other|0
1791154|NCT00589979|6233149|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
1791155|NCT00589979|6233150|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1791156|NCT00589979|6233151|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1791157|NCT00589979|6233149|P3|Double-Blind Treatment Period 2|Adverse Event|0
1791158|NCT00589979|6233150|P2|Double-Blind Treatment Period 2|Adverse Event|1
1791159|NCT00589979|6233151|P1|Double-Blind Treatment Period 2|Adverse Event|0
1791160|NCT00589979|6233149|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
1791161|NCT00589979|6233150|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
1791162|NCT00589979|6233151|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
1791163|NCT00589979|6233149|P3|Double-Blind Treatment Period 1|Protocol Violation|1
1791164|NCT00589979|6233150|P2|Double-Blind Treatment Period 1|Protocol Violation|1
1791165|NCT00589979|6233151|P1|Double-Blind Treatment Period 1|Protocol Violation|0
1791166|NCT00589979|6233149|P3|Double-Blind Treatment Period 1|Adverse Event|0
1791167|NCT00589979|6233150|P2|Double-Blind Treatment Period 1|Adverse Event|1
1791168|NCT00589979|6233151|P1|Double-Blind Treatment Period 1|Adverse Event|0
1791169|NCT00589979|6233149|P3|Run-In Period|Informed Consent Withdrawn|0
1791170|NCT00589979|6233150|P2|Run-In Period|Informed Consent Withdrawn|0
1791171|NCT00589979|6233151|P1|Run-In Period|Informed Consent Withdrawn|4
1791172|NCT00589979|6233149|P3|Run-In Period|Withdrawal by Subject|0
1791173|NCT00589979|6233150|P2|Run-In Period|Withdrawal by Subject|0
1791174|NCT00589979|6233151|P1|Run-In Period|Withdrawal by Subject|10
1791175|NCT00589979|6233149|P3|Run-In Period|Did not qualify for randomization|0
1791176|NCT00589979|6233150|P2|Run-In Period|Did not qualify for randomization|0
1791177|NCT00589979|6233151|P1|Run-In Period|Did not qualify for randomization|54
1791178|NCT00589979|6233149|P3|Run-In Period|Protocol Violation|0
1791179|NCT00589979|6233150|P2|Run-In Period|Protocol Violation|0
1791180|NCT00589979|6233151|P1|Run-In Period|Protocol Violation|3
1791181|NCT00589979|6233149|P3|Run-In Period|Adverse Event|0
1791182|NCT00589979|6233150|P2|Run-In Period|Adverse Event|0
1791183|NCT00589979|6233151|P1|Run-In Period|Adverse Event|5
1791184|NCT00589914|6233190|P2|Overall Study|Other|17
1791185|NCT00589914|6233191|P1|Overall Study|Other|22
1791186|NCT00589914|6233190|P2|Overall Study|Withdrawal by Subject|49
1791187|NCT00589914|6233191|P1|Overall Study|Withdrawal by Subject|55
1791188|NCT00589914|6233190|P2|Overall Study|Pregnancy|0
1791189|NCT00589914|6233191|P1|Overall Study|Pregnancy|1
1791190|NCT00589914|6233190|P2|Overall Study|Lost to Follow-up|18
1791191|NCT00589914|6233191|P1|Overall Study|Lost to Follow-up|11
1791192|NCT00589914|6233190|P2|Overall Study|Lack of Efficacy|43
1791193|NCT00589914|6233191|P1|Overall Study|Lack of Efficacy|40
1791194|NCT00589914|6233190|P2|Overall Study|Death|0
1791195|NCT00589914|6233191|P1|Overall Study|Death|2
1791196|NCT00589914|6233190|P2|Overall Study|Adverse Event|10
1791197|NCT00589914|6233191|P1|Overall Study|Adverse Event|19
1791198|NCT00589797|6233247|P2|Overall Study|Non-Randomized Training Subjects|6
1791199|NCT00589797|6233248|P1|Overall Study|Non-Randomized Training Subjects|46
1791200|NCT00589797|6233247|P2|Overall Study|Withdrawal by Subject|5
1791201|NCT00589797|6233248|P1|Overall Study|Withdrawal by Subject|6
1791202|NCT00589797|6233247|P2|Overall Study|Physician Decision|3
1791203|NCT00589797|6233248|P1|Overall Study|Physician Decision|8
1791204|NCT00589797|6233247|P2|Overall Study|Lost to Follow-up|9
1791205|NCT00589797|6233248|P1|Overall Study|Lost to Follow-up|12
1791206|NCT00589797|6233247|P2|Overall Study|Death|0
1791207|NCT00589797|6233248|P1|Overall Study|Death|1
1791208|NCT00589784|6233272|P2|Overall Study|Adverse Event|4
1791209|NCT00589784|6233273|P1|Overall Study|Adverse Event|0
1791210|NCT00589784|6233272|P2|Overall Study|Patient inevaluable|0
1791211|NCT00589784|6233273|P1|Overall Study|Patient inevaluable|1
1791212|NCT00589784|6233272|P2|Overall Study|Withdrawal by Subject|6
1791213|NCT00589784|6233273|P1|Overall Study|Withdrawal by Subject|0
1791214|NCT00589693|6233280|P2|Overall Study|Protocol Violation|1
1791215|NCT00589693|6233281|P1|Overall Study|Protocol Violation|1
1791216|NCT00589693|6233280|P2|Overall Study|Physician Decision|1
1791217|NCT00589693|6233281|P1|Overall Study|Physician Decision|0
1791218|NCT00589693|6233280|P2|Overall Study|Lost to Follow-up|0
1791219|NCT00589693|6233281|P1|Overall Study|Lost to Follow-up|1
1791220|NCT00589693|6233280|P2|Overall Study|Lack of Efficacy|1
1791221|NCT00589693|6233281|P1|Overall Study|Lack of Efficacy|0
1791222|NCT00589693|6233280|P2|Overall Study|Death|16
1791223|NCT00589693|6233281|P1|Overall Study|Death|26
1791224|NCT00589693|6233280|P2|Overall Study|Adverse Event|4
1791225|NCT00589693|6233281|P1|Overall Study|Adverse Event|4
1791226|NCT00589693|6233280|P2|Overall Study|randomized in error|6
1791227|NCT00589693|6233281|P1|Overall Study|randomized in error|12
1791228|NCT00589667|6233295|P1|Overall Study|Withdrawal by Subject|1
1791229|NCT00589667|6233295|P1|Overall Study|Adverse Event|2
1791230|NCT00589628|6233302|P2|Overall Study|Lost to Follow-up|1
1791231|NCT00589628|6233303|P1|Overall Study|Lost to Follow-up|0
1791232|NCT00589602|6233309|P1|Overall Study|Did not collect enough CD34+ cells|1
1791233|NCT00589472|6233344|P1|Overall Study|Adverse Event|1
1791234|NCT00589303|6233367|P2|Overall Study|Withdrawal by Subject|1
1791235|NCT00589303|6233368|P1|Overall Study|Withdrawal by Subject|2
1791236|NCT00589290|6233374|P1|Overall Study|Withdrawal by Subject|1
1791237|NCT00589121|6233397|P2|Overall Study|No protocol treatment received|1
1791238|NCT00589121|6233398|P1|Overall Study|No protocol treatment received|0
1791239|NCT00589121|6233397|P2|Overall Study|Protocol Violation|6
1791240|NCT00589121|6233398|P1|Overall Study|Protocol Violation|2
1791241|NCT00589108|6233420|P3|Overall Study|Death|4
1791242|NCT00589108|6233421|P2|Overall Study|Death|3
1791243|NCT00589108|6233422|P1|Overall Study|Death|3
1791244|NCT00589108|6233420|P3|Overall Study|Lost to Follow-up|1
1791245|NCT00589108|6233421|P2|Overall Study|Lost to Follow-up|1
1791246|NCT00589108|6233422|P1|Overall Study|Lost to Follow-up|1
1791247|NCT00588952|6233452|P2|Overall Study|Withdrawal by Subject|5
1791248|NCT00588952|6233453|P1|Overall Study|Withdrawal by Subject|3
1791249|NCT00588952|6233452|P2|Overall Study|Adverse Event|2
1791250|NCT00588952|6233453|P1|Overall Study|Adverse Event|0
1791251|NCT00588861|6233481|P2|10 Years|Incomplete due to study termination|114
1791252|NCT00588861|6233482|P1|10 Years|Incomplete due to study termination|107
1791253|NCT00588861|6233481|P2|8 Years|Patients did not return for follow-up|114
1791254|NCT00588861|6233482|P1|8 Years|Patients did not return for follow-up|105
1791255|NCT00588861|6233481|P2|6 Years|Patients did not return for follow-up|109
1791256|NCT00588861|6233482|P1|6 Years|Patients did not return for follow-up|104
1791257|NCT00588861|6233481|P2|4 Years|Patients did not return for follow-up|103
1791258|NCT00588861|6233482|P1|4 Years|Patients did not return for follow-up|91
1791259|NCT00588861|6233481|P2|2 Years|Patients did not return for follow-up|87
1791260|NCT00588861|6233482|P1|2 Years|Patients did not return for follow-up|92
1791261|NCT00588861|6233481|P2|1 Year|Patients did not return for follow-up|82
1791262|NCT00588861|6233482|P1|1 Year|Patients did not return for follow-up|89
1791263|NCT00588861|6233481|P2|6 Months|Patients did not return for follow-up|73
1791264|NCT00588861|6233482|P1|6 Months|Patients did not return for follow-up|98
1791265|NCT00588861|6233481|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
1791266|NCT00588861|6233482|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
1791267|NCT00588848|6233492|P2|Overall Study|Physician Decision|3
1791268|NCT00588848|6233493|P1|Overall Study|Physician Decision|0
1791269|NCT00588822|6233503|P1|Overall Study|progression of disease|8
1791290|NCT00588731|6233536|P2|Overall Study|Withdrawal by Subject|2
1791291|NCT00588731|6233537|P1|Overall Study|Withdrawal by Subject|3
1791292|NCT00588692|6233547|P2|Overall Study|Death|0
1791293|NCT00588692|6233548|P1|Overall Study|Death|1
1791294|NCT00588692|6233547|P2|Overall Study|Cancer|0
1791295|NCT00588692|6233548|P1|Overall Study|Cancer|1
1791296|NCT00588692|6233547|P2|Overall Study|Severe Peptic Ulcer Disease|0
1791297|NCT00588692|6233548|P1|Overall Study|Severe Peptic Ulcer Disease|1
1791298|NCT00588692|6233547|P2|Overall Study|Hip Surgery|1
1791299|NCT00588692|6233548|P1|Overall Study|Hip Surgery|0
1791300|NCT00588692|6233547|P2|Overall Study|Withdrawal by Subject|2
1791301|NCT00588692|6233548|P1|Overall Study|Withdrawal by Subject|4
1791302|NCT00588666|6233584|P1|Overall Study|Adverse Event|4
1791303|NCT00588640|6233589|P1|Overall Study|Ineligible Patient|1
1791304|NCT00588640|6233589|P1|Overall Study|Physician Decision|1
1791305|NCT00588445|6233608|P1|Overall Study|Not Treated|10
1791306|NCT00588445|6233608|P1|Overall Study|Disease Progression|1
1791307|NCT00588445|6233608|P1|Overall Study|Withdrawal by Subject|3
1791308|NCT00588445|6233608|P1|Overall Study|Protocol Violation|1
1791309|NCT00588354|6233632|P2|Baseline to 4 Weeks|Lost to Follow-up|1
1791310|NCT00588354|6233633|P1|Baseline to 4 Weeks|Lost to Follow-up|0
1791311|NCT00588354|6233632|P2|Baseline to 2 Weeks|Lack of Efficacy|0
1791312|NCT00588354|6233633|P1|Baseline to 2 Weeks|Lack of Efficacy|1
1791313|NCT00588354|6233632|P2|Baseline to 2 Weeks|Adverse Event|0
1791314|NCT00588354|6233633|P1|Baseline to 2 Weeks|Adverse Event|1
1791315|NCT00588341|6233653|P1|Overall Study|Patient ineligible|1
1791316|NCT00588341|6233653|P1|Overall Study|Not treated due to metastatic disease|1
1791317|NCT00588341|6233653|P1|Overall Study|Withdrawal by Subject|3
1791318|NCT00588237|6233657|P1|Overall Study|Patien not treated|1
1791319|NCT00588237|6233657|P1|Overall Study|Evaluable for toxicity only|3
1791320|NCT00588146|6233680|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
1791321|NCT00588146|6233681|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
1791322|NCT00588094|6233687|P1|Overall Study|Progression of Disease|2
1791323|NCT00588094|6233687|P1|Overall Study|Adverse Event|3
1791324|NCT00587990|6233694|P3|Overall Study|Death|1
1791325|NCT00587990|6233695|P2|Overall Study|Death|0
1791326|NCT00587990|6233696|P1|Overall Study|Death|0
1791327|NCT00587964|6233739|P1|Overall Study|Progression of Disease|4
1791328|NCT00587964|6233739|P1|Overall Study|Patient did not receive intervention|5
1791329|NCT00587964|6233739|P1|Overall Study|Patient found to be ineligible|1
1791330|NCT00587964|6233739|P1|Overall Study|Lost to Follow-up|1
1791331|NCT00587964|6233739|P1|Overall Study|Withdrawal by Subject|1
1791332|NCT00587860|6233745|P2|Overall Study|Withdrawal by Subject|3
1791333|NCT00587860|6233746|P1|Overall Study|Withdrawal by Subject|3
1791334|NCT00587860|6233745|P2|Overall Study|Lost to Follow-up|2
1791335|NCT00587860|6233746|P1|Overall Study|Lost to Follow-up|2
1791336|NCT00587847|6233766|P1|Overall Study|Adverse Event|2
1791337|NCT00587847|6233766|P1|Overall Study|Lack of Efficacy|5
1791338|NCT00587795|6233789|P2|Overall Study|Withdrawal by Subject|0
1791339|NCT00587795|6233790|P1|Overall Study|Withdrawal by Subject|1
1791340|NCT00587639|6233844|P1|Overall Study|Withdrawal by Subject|1
1791341|NCT00587587|6233851|P2|Overall Study|Lost to Follow-up|1
1791342|NCT00587587|6233852|P1|Overall Study|Lost to Follow-up|6
1791343|NCT00587457|6233906|P3|Overall Study|Development of neutralizing Abs|1
1791344|NCT00587457|6233907|P2|Overall Study|Development of neutralizing Abs|0
1791345|NCT00587457|6233908|P1|Overall Study|Development of neutralizing Abs|0
1791346|NCT00587457|6233906|P3|Overall Study|Undefined|1
1791347|NCT00587457|6233907|P2|Overall Study|Undefined|0
1791348|NCT00587457|6233908|P1|Overall Study|Undefined|0
1791349|NCT00587457|6233906|P3|Overall Study|Initiation of alternative therapy|0
1791350|NCT00587457|6233907|P2|Overall Study|Initiation of alternative therapy|1
1791351|NCT00587457|6233908|P1|Overall Study|Initiation of alternative therapy|0
1791352|NCT00587457|6233906|P3|Overall Study|Disease progression|2
1791353|NCT00587457|6233907|P2|Overall Study|Disease progression|0
1791354|NCT00587457|6233908|P1|Overall Study|Disease progression|2
1791355|NCT00587457|6233906|P3|Overall Study|Adverse Event|1
1791356|NCT00587457|6233907|P2|Overall Study|Adverse Event|2
1791357|NCT00587457|6233908|P1|Overall Study|Adverse Event|1
1791358|NCT00587431|6233945|P2|Overall Study|Withdrawal by Subject|1
1791359|NCT00587431|6233946|P1|Overall Study|Withdrawal by Subject|0
1791360|NCT00587431|6233945|P2|Overall Study|Adverse Event|0
1791361|NCT00587431|6233946|P1|Overall Study|Adverse Event|1
1791362|NCT00587288|6233957|P2|Overall Study|Protocol Violation|0
1791363|NCT00587288|6233958|P1|Overall Study|Protocol Violation|1
1791364|NCT00587288|6233957|P2|Overall Study|Lack of Efficacy|8
1791365|NCT00587288|6233958|P1|Overall Study|Lack of Efficacy|2
1791366|NCT00587288|6233957|P2|Overall Study|Adverse Event|1
1791367|NCT00587288|6233958|P1|Overall Study|Adverse Event|0
1791368|NCT00587223|6233976|P1|Overall Study|Adverse Event|1
1791369|NCT00587171|6233993|P2|Overall Study|Lost to Follow-up|1
1791370|NCT00587171|6233994|P1|Overall Study|Lost to Follow-up|1
1791371|NCT00587158|6234024|P2|Overall Study|Subject did not want to take study med|1
1791372|NCT00587158|6234025|P1|Overall Study|Subject did not want to take study med|0
1791373|NCT00587158|6234024|P2|Overall Study|Death|1
1791374|NCT00587158|6234025|P1|Overall Study|Death|0
1791375|NCT00587158|6234024|P2|Overall Study|Lost to Follow-up|2
1791376|NCT00587158|6234025|P1|Overall Study|Lost to Follow-up|1
1791377|NCT00587158|6234024|P2|Overall Study|Physician Decision|1
1791378|NCT00587158|6234025|P1|Overall Study|Physician Decision|0
1791379|NCT00587158|6234024|P2|Overall Study|Did not want to do 24 hr urine collect.|3
1791380|NCT00587158|6234025|P1|Overall Study|Did not want to do 24 hr urine collect.|4
1791381|NCT00587054|6234078|P1|Overall Study|Patient not treated|9
1791382|NCT00586924|6234104|P6|Overall Study|Other|6
1791383|NCT00586924|6234105|P5|Overall Study|Other|1
1791384|NCT00586924|6234106|P4|Overall Study|Other|1
1791385|NCT00586924|6234107|P3|Overall Study|Other|1
1791386|NCT00586924|6234108|P2|Overall Study|Other|0
1791387|NCT00586924|6234109|P1|Overall Study|Other|1
1791388|NCT00586924|6234104|P6|Overall Study|Complete response|2
1791389|NCT00586924|6234105|P5|Overall Study|Complete response|2
1791390|NCT00586924|6234106|P4|Overall Study|Complete response|0
1791391|NCT00586924|6234107|P3|Overall Study|Complete response|0
1791392|NCT00586924|6234108|P2|Overall Study|Complete response|1
1791393|NCT00586924|6234109|P1|Overall Study|Complete response|0
1791394|NCT00586924|6234104|P6|Overall Study|Development of neutralizing antibodies|22
1791395|NCT00586924|6234105|P5|Overall Study|Development of neutralizing antibodies|0
1791396|NCT00586924|6234106|P4|Overall Study|Development of neutralizing antibodies|0
1791397|NCT00586924|6234107|P3|Overall Study|Development of neutralizing antibodies|2
1791398|NCT00586924|6234108|P2|Overall Study|Development of neutralizing antibodies|2
1791399|NCT00586924|6234109|P1|Overall Study|Development of neutralizing antibodies|2
1791400|NCT00586924|6234104|P6|Overall Study|Disease progression|0
1791401|NCT00586924|6234105|P5|Overall Study|Disease progression|1
1791402|NCT00586924|6234106|P4|Overall Study|Disease progression|1
1791403|NCT00586924|6234107|P3|Overall Study|Disease progression|0
1791404|NCT00586924|6234108|P2|Overall Study|Disease progression|0
1791405|NCT00586924|6234109|P1|Overall Study|Disease progression|0
1791406|NCT00586924|6234104|P6|Overall Study|Initiation of alternative cancer therapy|1
1791407|NCT00586924|6234105|P5|Overall Study|Initiation of alternative cancer therapy|0
1791408|NCT00586924|6234106|P4|Overall Study|Initiation of alternative cancer therapy|0
1791409|NCT00586924|6234107|P3|Overall Study|Initiation of alternative cancer therapy|0
1791410|NCT00586924|6234108|P2|Overall Study|Initiation of alternative cancer therapy|0
1791411|NCT00586924|6234109|P1|Overall Study|Initiation of alternative cancer therapy|0
1791412|NCT00586924|6234104|P6|Overall Study|Adverse event/serious adverse event|2
1791413|NCT00586924|6234105|P5|Overall Study|Adverse event/serious adverse event|0
1791414|NCT00586924|6234106|P4|Overall Study|Adverse event/serious adverse event|1
1791415|NCT00586924|6234107|P3|Overall Study|Adverse event/serious adverse event|0
1791416|NCT00586924|6234108|P2|Overall Study|Adverse event/serious adverse event|0
1791417|NCT00586924|6234109|P1|Overall Study|Adverse event/serious adverse event|0
1791418|NCT00586898|6234309|P1|Overall Study|Evaluable for Toxicity Only|5
1791419|NCT00586898|6234309|P1|Overall Study|Patiemt Non-compliance|1
1791420|NCT00586898|6234309|P1|Overall Study|Adverse Event|1
1791421|NCT00586846|6234313|P1|Overall Study|Evaluable for Toxicity Only|4
1791422|NCT00586846|6234313|P1|Overall Study|Death|1
1791423|NCT00586846|6234313|P1|Overall Study|Physician Decision|1
1791424|NCT00586820|6234319|P2|Overall Study|Unsuccessful PCI|0
1791425|NCT00586820|6234320|P1|Overall Study|Unsuccessful PCI|1
1791426|NCT00586703|6234351|P1|Overall Study|Death|12
1791427|NCT00586690|6234358|P2|Overall Study|Lab can't accommodate|0
1791428|NCT00586690|6234359|P1|Overall Study|Lab can't accommodate|1
1791429|NCT00586690|6234358|P2|Overall Study|Lack of Efficacy|0
1791430|NCT00586690|6234359|P1|Overall Study|Lack of Efficacy|2
1791431|NCT00586690|6234358|P2|Overall Study|Adverse Event|0
1791432|NCT00586690|6234359|P1|Overall Study|Adverse Event|1
1791433|NCT00586690|6234358|P2|Overall Study|Disease Progression|0
1791434|NCT00586690|6234359|P1|Overall Study|Disease Progression|10
1791435|NCT00586690|6234358|P2|Overall Study|Death|0
1791436|NCT00586690|6234359|P1|Overall Study|Death|2
1791437|NCT00586664|6234369|P3|Overall Study|Exclusion criteria met|0
1791438|NCT00586664|6234370|P2|Overall Study|Exclusion criteria met|0
1791439|NCT00586664|6234371|P1|Overall Study|Exclusion criteria met|2
1791440|NCT00586664|6234369|P3|Overall Study|Withdrawal by Subject|1
1791441|NCT00586664|6234370|P2|Overall Study|Withdrawal by Subject|7
1791442|NCT00586664|6234371|P1|Overall Study|Withdrawal by Subject|3
1791443|NCT00586625|6234417|P2|Overall Study|Subject unable to return for visit|0
1791444|NCT00586625|6234418|P1|Overall Study|Subject unable to return for visit|2
1791445|NCT00586625|6234417|P2|Overall Study|Subject non-compliance|1
1791446|NCT00586625|6234418|P1|Overall Study|Subject non-compliance|0
1791447|NCT00586625|6234417|P2|Overall Study|Withdrawal by Subject|10
1791448|NCT00586625|6234418|P1|Overall Study|Withdrawal by Subject|32
1791449|NCT00586625|6234417|P2|Overall Study|Protocol Violation|0
1791450|NCT00586625|6234418|P1|Overall Study|Protocol Violation|3
1791451|NCT00586625|6234417|P2|Overall Study|Adverse Event|6
1791452|NCT00586625|6234418|P1|Overall Study|Adverse Event|6
1791453|NCT00586612|6234426|P2|Booster Phase|Lost to Follow-up|1
1791454|NCT00586612|6234427|P1|Booster Phase|Lost to Follow-up|3
1791455|NCT00586612|6234426|P2|Primary Phase|Withdrawal by Subject|2
1791456|NCT00586612|6234427|P1|Primary Phase|Withdrawal by Subject|0
1791457|NCT00586612|6234426|P2|Primary Phase|Lost to Follow-up|1
1791458|NCT00586612|6234427|P1|Primary Phase|Lost to Follow-up|0
1791459|NCT00586612|6234426|P2|Primary Phase|Protocol Violation|0
1791460|NCT00586612|6234427|P1|Primary Phase|Protocol Violation|1
1791461|NCT00586521|6234497|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
1791462|NCT00586495|6234504|P1|Follow-up|Switch to commercial drug|10
1791463|NCT00586495|6234504|P1|Follow-up|Protocol driven decision point|37
1791464|NCT00586495|6234504|P1|Follow-up|Withdrawal by Subject|4
1791465|NCT00586495|6234504|P1|Follow-up|Lost to Follow-up|1
1791466|NCT00586495|6234504|P1|Follow-up|Death|40
1791467|NCT00586495|6234504|P1|Treatment Period|Switch to commercial drug|10
1791468|NCT00586495|6234504|P1|Treatment Period|Disease progression, recurrence/relapse|71
1791469|NCT00586495|6234504|P1|Treatment Period|Withdrawal by Subject|1
1791470|NCT00586495|6234504|P1|Treatment Period|Protocol Violation|1
1791471|NCT00586495|6234504|P1|Treatment Period|Death|1
1791472|NCT00586495|6234504|P1|Treatment Period|Adverse Event|11
1791473|NCT00586469|6234533|P2|Overall Study|Adverse Event|1
1791474|NCT00586469|6234534|P1|Overall Study|Adverse Event|0
1791475|NCT00586339|6234561|P3|Overall Study|Lost to Follow-up|1
1791476|NCT00586339|6234562|P2|Overall Study|Lost to Follow-up|2
1791477|NCT00586339|6234563|P1|Overall Study|Lost to Follow-up|3
1791478|NCT00586339|6234561|P3|Overall Study|Migrated/moved from study area|4
1791479|NCT00586339|6234562|P2|Overall Study|Migrated/moved from study area|2
1791480|NCT00586339|6234563|P1|Overall Study|Migrated/moved from study area|3
1791481|NCT00586339|6234561|P3|Overall Study|Withdrawal by Subject|1
1791482|NCT00586339|6234562|P2|Overall Study|Withdrawal by Subject|3
1791483|NCT00586339|6234563|P1|Overall Study|Withdrawal by Subject|1
1791484|NCT00586326|6234664|P1|Treated Through 5-yr Follow Up-Treated|Other|2
1791485|NCT00586326|6234664|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
1791486|NCT00586326|6234664|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
1791487|NCT00586326|6234664|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
1791488|NCT00586326|6234664|P1|Treated Through 5-yr Follow Up-Treated|Death|2
1791489|NCT00586326|6234664|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
1791490|NCT00586326|6234664|P1|Device Placed toTreatment-ITT|Physician Decision|1
1791491|NCT00586326|6234664|P1|Device Placed toTreatment-ITT|Positive Margins|3
1791492|NCT00586326|6234664|P1|Device Placed toTreatment-ITT|Microinvasion|1
1791493|NCT00586326|6234664|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
1791494|NCT00586326|6234664|P1|Device Placed toTreatment-ITT|Skin Distance|7
1791495|NCT00586326|6234664|P1|Enrollment to Device Placement-Enrolled|Other|1
1791496|NCT00586326|6234664|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
1791497|NCT00586326|6234664|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
1791498|NCT00586326|6234664|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
1791499|NCT00586326|6234664|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
1791500|NCT00586326|6234664|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
1791501|NCT00586313|6234675|P1|Overall Study|Lack of Efficacy|2
1791502|NCT00586157|6234711|P2|Second Intervention|Adverse Event|1
1791503|NCT00586157|6234712|P1|Second Intervention|Adverse Event|0
1791504|NCT00586157|6234711|P2|Second Intervention|Worsening behavior|0
1791505|NCT00586157|6234712|P1|Second Intervention|Worsening behavior|1
1791506|NCT00586157|6234711|P2|Second Intervention|Withdrawal by Subject|0
1791507|NCT00586157|6234712|P1|Second Intervention|Withdrawal by Subject|1
1791508|NCT00586157|6234711|P2|First Intervention|Worsening behavior|0
1791509|NCT00586157|6234712|P1|First Intervention|Worsening behavior|1
1791510|NCT00586105|6234722|P1|Overall Study|Reason not reported|1
1791511|NCT00586105|6234722|P1|Overall Study|Switched to commercial drug|9
1791512|NCT00586105|6234722|P1|Overall Study|Disease progression|19
1791513|NCT00586105|6234722|P1|Overall Study|Withdrawal by Subject|3
1791514|NCT00586105|6234722|P1|Overall Study|Protocol Violation|1
1791515|NCT00586105|6234722|P1|Overall Study|Death|2
1791516|NCT00586105|6234722|P1|Overall Study|Adverse Event|4
1791517|NCT00586066|6234737|P2|Overall Study|Withdrawal of consent|2
1791518|NCT00586066|6234738|P1|Overall Study|Withdrawal of consent|4
1791519|NCT00586066|6234737|P2|Overall Study|Physician Decision|0
1791520|NCT00586066|6234738|P1|Overall Study|Physician Decision|1
1791521|NCT00586066|6234737|P2|Overall Study|Adverse Event|2
1791522|NCT00586066|6234738|P1|Overall Study|Adverse Event|2
1791523|NCT00586066|6234737|P2|Overall Study|Lack of Efficacy|3
1791524|NCT00586066|6234738|P1|Overall Study|Lack of Efficacy|5
1791525|NCT00586066|6234737|P2|Overall Study|Lost to Follow-up|3
1791526|NCT00586066|6234738|P1|Overall Study|Lost to Follow-up|6
1791527|NCT00585975|6234795|P2|Overall Study|Enrollment met/over-enrolled|9
1791528|NCT00585975|6234796|P1|Overall Study|Enrollment met/over-enrolled|10
1791529|NCT00585975|6234795|P2|Overall Study|Lost to Follow-up|1
1791530|NCT00585975|6234796|P1|Overall Study|Lost to Follow-up|2
1791531|NCT00585975|6234795|P2|Overall Study|Withdrawal by Subject|3
1791532|NCT00585975|6234796|P1|Overall Study|Withdrawal by Subject|3
1791533|NCT00585923|6234806|P2|Overall Study|Physician decided not to continue|33
1791534|NCT00585923|6234807|P1|Overall Study|Physician decided not to continue|31
1791535|NCT00585689|6234838|P1|Overall Study|Death|1
1791536|NCT00585689|6234838|P1|Overall Study|Patient had unresectable disease|1
1791537|NCT00585689|6234838|P1|Overall Study|Patient Declined Surgery|1
1791538|NCT00585689|6234838|P1|Overall Study|Adverse Event|1
1791539|NCT00585689|6234838|P1|Overall Study|Received different ABI-007 schedule|3
1791540|NCT00585585|6234897|P1|Overall Study|Adverse Event|1
1791541|NCT00585546|6234901|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
1791542|NCT00585546|6234901|P1|Clenbuterol Treatment - up to 12 Months|Death|1
1791543|NCT00585533|6234915|P1|Overall Study|objective or symptomatic progression|9
1791544|NCT00585468|6234924|P2|First Intervention|Withdrawal by Subject|1
1791545|NCT00585468|6234925|P1|First Intervention|Withdrawal by Subject|1
1791546|NCT00585351|6234957|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1791547|NCT00585351|6234958|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1791548|NCT00585351|6234959|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
1791549|NCT00585351|6234960|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
1791550|NCT00585351|6234961|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1791551|NCT00585351|6234962|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1791552|NCT00585351|6234963|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1791553|NCT00585351|6234964|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
1791554|NCT00585351|6234957|P8|Enrollment Period (Intervention)|Death|0
1791555|NCT00585351|6234958|P7|Enrollment Period (Intervention)|Death|1
1791556|NCT00585351|6234959|P6|Enrollment Period (Intervention)|Death|0
1791557|NCT00585351|6234960|P5|Enrollment Period (Intervention)|Death|1
1791558|NCT00585351|6234961|P4|Enrollment Period (Intervention)|Death|0
1791559|NCT00585351|6234962|P3|Enrollment Period (Intervention)|Death|0
1791560|NCT00585351|6234963|P2|Enrollment Period (Intervention)|Death|0
1791561|NCT00585351|6234964|P1|Enrollment Period (Intervention)|Death|0
1791562|NCT00585351|6234957|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
1791563|NCT00585351|6234958|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
1791564|NCT00585351|6234959|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
1791565|NCT00585351|6234960|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
1791566|NCT00585351|6234961|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
1791567|NCT00585351|6234962|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
1791568|NCT00585351|6234963|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
1791569|NCT00585351|6234964|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
1791570|NCT00585351|6234957|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1791571|NCT00585351|6234958|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1791572|NCT00585351|6234959|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1791573|NCT00585351|6234960|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1791574|NCT00585351|6234961|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1791575|NCT00585351|6234962|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
1791576|NCT00585351|6234963|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
1791577|NCT00585351|6234964|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
1791578|NCT00585351|6234957|P8|Notification Period (Informed Consent)|No study medication on flight|0
1791579|NCT00585351|6234958|P7|Notification Period (Informed Consent)|No study medication on flight|0
1791580|NCT00585351|6234959|P6|Notification Period (Informed Consent)|No study medication on flight|0
1791581|NCT00585351|6234960|P5|Notification Period (Informed Consent)|No study medication on flight|0
1791582|NCT00585351|6234961|P4|Notification Period (Informed Consent)|No study medication on flight|0
1791583|NCT00585351|6234962|P3|Notification Period (Informed Consent)|No study medication on flight|0
1791584|NCT00585351|6234963|P2|Notification Period (Informed Consent)|No study medication on flight|1
1791585|NCT00585351|6234964|P1|Notification Period (Informed Consent)|No study medication on flight|0
1791586|NCT00585351|6234957|P8|Notification Period (Informed Consent)|Flight aborted|0
1791587|NCT00585351|6234958|P7|Notification Period (Informed Consent)|Flight aborted|0
1791588|NCT00585351|6234959|P6|Notification Period (Informed Consent)|Flight aborted|0
1791589|NCT00585351|6234960|P5|Notification Period (Informed Consent)|Flight aborted|0
1791590|NCT00585351|6234961|P4|Notification Period (Informed Consent)|Flight aborted|0
1791591|NCT00585351|6234962|P3|Notification Period (Informed Consent)|Flight aborted|0
1791592|NCT00585351|6234963|P2|Notification Period (Informed Consent)|Flight aborted|1
1791593|NCT00585351|6234964|P1|Notification Period (Informed Consent)|Flight aborted|2
1791594|NCT00585351|6234957|P8|Notification Period (Informed Consent)|Physician Decision|0
1791595|NCT00585351|6234958|P7|Notification Period (Informed Consent)|Physician Decision|0
1791596|NCT00585351|6234959|P6|Notification Period (Informed Consent)|Physician Decision|0
1791597|NCT00585351|6234960|P5|Notification Period (Informed Consent)|Physician Decision|0
1791598|NCT00585351|6234961|P4|Notification Period (Informed Consent)|Physician Decision|0
1791599|NCT00585351|6234962|P3|Notification Period (Informed Consent)|Physician Decision|0
1791600|NCT00585351|6234963|P2|Notification Period (Informed Consent)|Physician Decision|2
1791601|NCT00585351|6234964|P1|Notification Period (Informed Consent)|Physician Decision|0
1791602|NCT00585325|6234980|P2|Overall Study|Withdrawal by Subject|1
1791603|NCT00585325|6234981|P1|Overall Study|Withdrawal by Subject|1
1791604|NCT00585312|6234989|P2|Overall Study|Study terminated by the sponsor|31
1791605|NCT00585312|6234990|P1|Overall Study|Study terminated by the sponsor|34
1791606|NCT00585312|6234989|P2|Overall Study|Withdrawal by Subject|1
1791607|NCT00585312|6234990|P1|Overall Study|Withdrawal by Subject|5
1791608|NCT00585312|6234989|P2|Overall Study|Reason not specified|0
1791609|NCT00585312|6234990|P1|Overall Study|Reason not specified|2
1791610|NCT00585312|6234989|P2|Overall Study|Lost to Follow-up|1
1791611|NCT00585312|6234990|P1|Overall Study|Lost to Follow-up|1
1791612|NCT00585312|6234989|P2|Overall Study|Lack of Efficacy|11
1791613|NCT00585312|6234990|P1|Overall Study|Lack of Efficacy|6
1791614|NCT00585312|6234989|P2|Overall Study|Adverse Event|0
1791615|NCT00585312|6234990|P1|Overall Study|Adverse Event|3
1791616|NCT00585286|6235002|P1|Overall Study|Lost to Follow-up|1
1791617|NCT00585221|6235018|P1|Overall Study|Protocol Violation|8
1791618|NCT00585169|6235028|P1|Overall Study|Withdrawal by Subject|1
1791619|NCT00585078|6235038|P1|Overall Study|Death|1
1791620|NCT00585078|6235038|P1|Overall Study|Adverse Event|10
1791621|NCT00585078|6235038|P1|Overall Study|Disease Progression|24
1791622|NCT00585078|6235038|P1|Overall Study|Poor performance status|1
1791623|NCT00585078|6235038|P1|Overall Study|Withdrawal by Subject|4
1791624|NCT00585052|6235045|P1|Overall Study|Withdrawal by Subject|1
1791625|NCT00585039|6235052|P2|Overall Study|medication spilled|0
1791626|NCT00585039|6235053|P1|Overall Study|medication spilled|2
1791627|NCT00584987|6235082|P4|Overall Study|Adverse Event|1
1791628|NCT00584987|6235083|P3|Overall Study|Adverse Event|0
1791629|NCT00584987|6235084|P2|Overall Study|Adverse Event|0
1791630|NCT00584987|6235085|P1|Overall Study|Adverse Event|0
1791631|NCT00584987|6235082|P4|Overall Study|Protocol Violation|0
1791632|NCT00584987|6235083|P3|Overall Study|Protocol Violation|1
1791633|NCT00584987|6235084|P2|Overall Study|Protocol Violation|1
1791634|NCT00584987|6235085|P1|Overall Study|Protocol Violation|1
1791635|NCT00584909|6235137|P1|Overall Study|Adverse Event|4
1791636|NCT00584844|6235147|P1|Overall Study|Screen Failure|20
1791637|NCT00584844|6235147|P1|Overall Study|Withdrawal by Subject|59
1791638|NCT00584805|6235197|P1|Overall Study|Screen failures|2
1791639|NCT00584805|6235197|P1|Overall Study|Lost to follow up|3
1791640|NCT00584805|6235197|P1|Overall Study|Non-compliance|1
1791641|NCT00584805|6235197|P1|Overall Study|Withdrawal by Subject|18
1791642|NCT00584805|6235197|P1|Overall Study|Relocation|36
1791643|NCT00584805|6235197|P1|Overall Study|No longer at risk of exposure|39
1791644|NCT00584740|6235210|P2|Overall Study|Lost to Follow-up|1
1791645|NCT00584740|6235211|P1|Overall Study|Lost to Follow-up|0
1791646|NCT00584740|6235210|P2|Overall Study|Withdrawal by Subject|2
1791647|NCT00584740|6235211|P1|Overall Study|Withdrawal by Subject|3
1791648|NCT00584740|6235210|P2|Overall Study|Lack of Efficacy|2
1791649|NCT00584740|6235211|P1|Overall Study|Lack of Efficacy|8
1791650|NCT00584740|6235210|P2|Overall Study|Adverse Event|1
1791651|NCT00584740|6235211|P1|Overall Study|Adverse Event|1
1791652|NCT00584727|6235229|P6|Third Intervention|Protocol Violation|2
1791653|NCT00584727|6235230|P5|Third Intervention|Protocol Violation|4
1791654|NCT00584727|6235231|P4|Third Intervention|Protocol Violation|0
1791655|NCT00584727|6235232|P3|Third Intervention|Protocol Violation|1
1791656|NCT00584727|6235233|P2|Third Intervention|Protocol Violation|0
1791657|NCT00584727|6235234|P1|Third Intervention|Protocol Violation|0
1791658|NCT00584727|6235229|P6|First Intervention|Discontinuation|0
1791659|NCT00584727|6235230|P5|First Intervention|Discontinuation|0
1791660|NCT00584727|6235231|P4|First Intervention|Discontinuation|0
1791661|NCT00584727|6235232|P3|First Intervention|Discontinuation|1
1791662|NCT00584727|6235233|P2|First Intervention|Discontinuation|0
1791663|NCT00584727|6235234|P1|First Intervention|Discontinuation|0
1791664|NCT00584454|6235272|P1|Overall Study|Clinical Hold|2
1791665|NCT00584454|6235272|P1|Overall Study|Relocation|1
1791666|NCT00584454|6235272|P1|Overall Study|Adverse Event|1
1791667|NCT00584415|6235276|P1|Overall Study|Adverse Event|7
1791668|NCT00584194|6235299|P1|Overall Study|Other|135
1791669|NCT00584012|6235312|P1|Overall Study|Withdrawal by Subject|1
1791670|NCT00583947|6235318|P2|Cross-over Period|Other|1
1791671|NCT00583947|6235319|P1|Cross-over Period|Other|1
1791672|NCT00583947|6235318|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
1791673|NCT00583947|6235319|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
1791674|NCT00583947|6235318|P2|Cross-over Period|Withdrawal by Subject|0
1791675|NCT00583947|6235319|P1|Cross-over Period|Withdrawal by Subject|2
1791676|NCT00583947|6235318|P2|Cross-over Period|Adverse Event|0
1791677|NCT00583947|6235319|P1|Cross-over Period|Adverse Event|2
1791678|NCT00583791|6235440|P1|Overall Study|Death|6
1791679|NCT00583791|6235440|P1|Overall Study|Other|67
1791680|NCT00583596|6235495|P1|Overall Study|Outside f-up window|26
1791681|NCT00583596|6235495|P1|Overall Study|Not consented|15
1791682|NCT00583596|6235495|P1|Overall Study|Data not complete|1
1791683|NCT00583596|6235495|P1|Overall Study|Lost to Follow-up|94
1791684|NCT00583596|6235495|P1|Overall Study|Withdrawal by Subject|6
1791685|NCT00583596|6235495|P1|Overall Study|Death|2
1791686|NCT00583596|6235495|P1|Overall Study|Excluded due to Hurricane Katrina|30
1791687|NCT00583596|6235495|P1|Overall Study|Lost to Follow-up|110
1791688|NCT00583557|6235500|P1|Overall Study|Did not receive belimumab in LBRA99|2
1791689|NCT00583557|6235500|P1|Overall Study|Other|5
1791690|NCT00583557|6235500|P1|Overall Study|Lack of Compliance|5
1791691|NCT00583557|6235500|P1|Overall Study|Lack of Efficacy|31
1791692|NCT00583557|6235500|P1|Overall Study|Adverse Event|9
1791693|NCT00583557|6235500|P1|Overall Study|Withdrawal by Subject|18
1791694|NCT00583453|6235531|P2|Overall Study|discontinued intervention|2
1791695|NCT00583453|6235532|P1|Overall Study|discontinued intervention|0
1791696|NCT00583362|6235569|P1|Overall Study|Withdrawal by Subject|57
1791697|NCT00583362|6235569|P1|Overall Study|Protocol Violation|2
1791698|NCT00583362|6235569|P1|Overall Study|Physician Decision|19
1791699|NCT00583362|6235569|P1|Overall Study|Sponsor request due to missed doses|1
1791700|NCT00583362|6235569|P1|Overall Study|Behavioral problems and non-compliance|1
1791701|NCT00583362|6235569|P1|Overall Study|Misunderstanding of protocol|1
1791702|NCT00583362|6235569|P1|Overall Study|Missed visits due to staff changes|1
1791703|NCT00583362|6235569|P1|Overall Study|Subject moved out of the country/state|2
1791704|NCT00583362|6235569|P1|Overall Study|Subject not dosed in LBSL99|1
1791705|NCT00583362|6235569|P1|Overall Study|Current site closed|7
1791706|NCT00583362|6235569|P1|Overall Study|Miscommunication of visit window|5
1791707|NCT00583362|6235569|P1|Overall Study|Pregnancy|7
1791708|NCT00583362|6235569|P1|Overall Study|Non-compliance with study drug|28
1791709|NCT00583362|6235569|P1|Overall Study|Lost to Follow-up|4
1791710|NCT00583362|6235569|P1|Overall Study|Lack of Efficacy|22
1791711|NCT00583362|6235569|P1|Overall Study|Adverse Event|44
1791712|NCT00583219|6235593|P1|Phase 2|Withdrawal by Subject|1
1791713|NCT00583115|6235610|P1|Overall Study|Death|1
1791714|NCT00583102|6235615|P1|Overall Study|Adverse Event|3
1791715|NCT00582972|6235628|P1|Overall Study|Protocol Violation|2
1791716|NCT00582933|6235637|P1|Overall Study|Physician Decision|3
1791717|NCT00582907|6235641|P4|2nd Course|Lack of Efficacy|0
1791718|NCT00582907|6235642|P3|2nd Course|Lack of Efficacy|0
1791719|NCT00582907|6235643|P2|2nd Course|Lack of Efficacy|0
1791720|NCT00582907|6235644|P1|2nd Course|Lack of Efficacy|1
1791721|NCT00582907|6235641|P4|1st Course|Lost to Follow-up|1
1791722|NCT00582907|6235642|P3|1st Course|Lost to Follow-up|0
1791723|NCT00582907|6235643|P2|1st Course|Lost to Follow-up|0
1791724|NCT00582907|6235644|P1|1st Course|Lost to Follow-up|0
1791725|NCT00582907|6235641|P4|1st Course|Withdrawal by Subject|0
1791726|NCT00582907|6235642|P3|1st Course|Withdrawal by Subject|0
1791727|NCT00582907|6235643|P2|1st Course|Withdrawal by Subject|0
1791728|NCT00582907|6235644|P1|1st Course|Withdrawal by Subject|1
1791729|NCT00582816|6235683|P1|Overall Study|Engraftment Failure|3
1791730|NCT00582790|6235693|P1|Overall Study|Rapid progression of disease|1
1791731|NCT00582738|6235702|P2|Overall Study|Withdrawal by Subject|3
1791732|NCT00582738|6235703|P1|Overall Study|Withdrawal by Subject|0
1791733|NCT00582738|6235702|P2|Overall Study|Protocol Violation|1
1791734|NCT00582738|6235703|P1|Overall Study|Protocol Violation|1
1791735|NCT00582738|6235702|P2|Overall Study|Other|0
1791736|NCT00582738|6235703|P1|Overall Study|Other|1
1791737|NCT00582738|6235702|P2|Overall Study|Graft Lost|1
1791738|NCT00582738|6235703|P1|Overall Study|Graft Lost|0
1791739|NCT00582738|6235702|P2|Overall Study|Adverse Event|5
1791740|NCT00582738|6235703|P1|Overall Study|Adverse Event|0
1791741|NCT00582738|6235702|P2|Overall Study|Administrative Problems|8
1791742|NCT00582738|6235703|P1|Overall Study|Administrative Problems|7
1791743|NCT00582712|6235727|P1|Overall Study|Complicating disease requiring treatment|1
1791744|NCT00582712|6235727|P1|Overall Study|Withdrawal by Subject|1
1791745|NCT00582712|6235727|P1|Overall Study|Lack of Efficacy|1
1791746|NCT00582712|6235727|P1|Overall Study|Adverse Event|1
1791747|NCT00582608|6235742|P1|Overall Study|Lack of accrual|4
1791748|NCT00582608|6235742|P1|Overall Study|Patient Ineligible|1
1791749|NCT00582608|6235742|P1|Overall Study|Not Treated|7
1791750|NCT00582556|6235749|P3|Overall Study|Physician Decision|1
1791751|NCT00582556|6235750|P2|Overall Study|Physician Decision|0
1791752|NCT00582556|6235751|P1|Overall Study|Physician Decision|0
1791753|NCT00582556|6235749|P3|Overall Study|Withdrawal by Subject|1
1791754|NCT00582556|6235750|P2|Overall Study|Withdrawal by Subject|1
1791755|NCT00582556|6235751|P1|Overall Study|Withdrawal by Subject|0
1791756|NCT00582491|6235779|P2|Overall Study|Withdrawal by Subject|0
1791757|NCT00582491|6235780|P1|Overall Study|Withdrawal by Subject|1
1791758|NCT00582426|6235804|P2|Overall Study|Use of illicit drugs|0
1791759|NCT00582426|6235805|P1|Overall Study|Use of illicit drugs|1
1791760|NCT00582426|6235804|P2|Overall Study|Disease Progression|2
1791761|NCT00582426|6235805|P1|Overall Study|Disease Progression|2
1791762|NCT00582426|6235804|P2|Overall Study|Withdrawal by Subject|2
1791763|NCT00582426|6235805|P1|Overall Study|Withdrawal by Subject|3
1791764|NCT00582426|6235804|P2|Overall Study|Death|3
1791765|NCT00582426|6235805|P1|Overall Study|Death|4
1791766|NCT00582426|6235804|P2|Overall Study|Protocol Violation|2
1791767|NCT00582426|6235805|P1|Overall Study|Protocol Violation|6
1791768|NCT00582426|6235804|P2|Overall Study|Adverse Event|2
1791769|NCT00582426|6235805|P1|Overall Study|Adverse Event|4
1791770|NCT00582426|6235804|P2|Overall Study|Lost to Follow-up|2
1791771|NCT00582426|6235805|P1|Overall Study|Lost to Follow-up|0
1791772|NCT00582309|6235852|P3|Overall Study|Protocol Violation|2
1791773|NCT00582309|6235853|P2|Overall Study|Protocol Violation|0
1791774|NCT00582309|6235854|P1|Overall Study|Protocol Violation|0
1791775|NCT00582166|6235867|P1|Overall Study|Ineligible pathology|1
1791776|NCT00582166|6235867|P1|Overall Study|Death|1
1791777|NCT00582114|6235877|P2|Overall Study|Stopped by data safety monitoring board|20
1791778|NCT00582114|6235878|P1|Overall Study|Stopped by data safety monitoring board|19
1791779|NCT00582114|6235877|P2|Overall Study|Physician Decision|6
1791780|NCT00582114|6235878|P1|Overall Study|Physician Decision|0
1791781|NCT00582114|6235877|P2|Overall Study|Adverse Event|1
1791782|NCT00582114|6235878|P1|Overall Study|Adverse Event|1
1791783|NCT00582114|6235877|P2|Overall Study|Withdrawal by Subject|16
1791784|NCT00582114|6235878|P1|Overall Study|Withdrawal by Subject|8
1791785|NCT00582114|6235877|P2|Overall Study|Lost to Follow-up|6
1791786|NCT00582114|6235878|P1|Overall Study|Lost to Follow-up|7
1791787|NCT00582114|6235877|P2|Overall Study|Kidney Transplant|1
1791788|NCT00582114|6235878|P1|Overall Study|Kidney Transplant|3
1791789|NCT00582114|6235877|P2|Overall Study|Death|4
1791790|NCT00582114|6235878|P1|Overall Study|Death|4
1791791|NCT00582036|6235893|P2|Overall Study|Withdrawal by Subject|1
1791792|NCT00582036|6235894|P1|Overall Study|Withdrawal by Subject|0
1791793|NCT00582010|6235902|P2|Overall Study|Death|1
1791794|NCT00582010|6235903|P1|Overall Study|Death|0
1791795|NCT00581945|6235932|P2|Overall Study|Death|0
1791796|NCT00581945|6235933|P1|Overall Study|Death|1
1791797|NCT00581945|6235932|P2|Overall Study|Withdrawal by Subject|6
1791798|NCT00581945|6235933|P1|Overall Study|Withdrawal by Subject|2
1791799|NCT00581945|6235932|P2|Overall Study|Unsatisfactory therapeutic effect|0
1791800|NCT00581945|6235933|P1|Overall Study|Unsatisfactory therapeutic effect|2
1791801|NCT00581945|6235932|P2|Overall Study|Adverse Event|4
1791802|NCT00581945|6235933|P1|Overall Study|Adverse Event|4
1791803|NCT00581919|6235949|P1|Overall Study|Withdrawal by Subject|1
1791804|NCT00581919|6235949|P1|Overall Study|Started Non-Protocol Therapy|2
1791805|NCT00581919|6235949|P1|Overall Study|Other Complicating Disease|1
1791806|NCT00581919|6235949|P1|Overall Study|Physician Decision|1
1791807|NCT00581919|6235949|P1|Overall Study|Disease Progression|10
1791808|NCT00581919|6235949|P1|Overall Study|Death|1
1791809|NCT00581919|6235949|P1|Overall Study|Adverse Event|8
1791810|NCT00581828|6235968|P1|Overall Study|Protocol Violation|1
1791811|NCT00581776|6235972|P1|Overall Study|Disease progression or no response|3
1791812|NCT00581555|6235990|P2|Overall Study|Other reasons|4
1791813|NCT00581555|6235991|P1|Overall Study|Other reasons|16
1791814|NCT00581555|6235990|P2|Overall Study|Lost to Follow-up|2
1791815|NCT00581555|6235991|P1|Overall Study|Lost to Follow-up|2
1791816|NCT00581555|6235990|P2|Overall Study|Withdrawal by Subject|9
1791817|NCT00581555|6235991|P1|Overall Study|Withdrawal by Subject|18
1791818|NCT00581555|6235990|P2|Overall Study|Physician Decision|2
1791819|NCT00581555|6235991|P1|Overall Study|Physician Decision|3
1791820|NCT00581555|6235990|P2|Overall Study|Adverse Event|3
1791821|NCT00581555|6235991|P1|Overall Study|Adverse Event|4
1791822|NCT00581542|6236015|P2|Overall Study|Lost to Follow-up|21
1791823|NCT00581542|6236016|P1|Overall Study|Lost to Follow-up|9
1791824|NCT00581542|6236015|P2|Overall Study|they met an exclusion criteria|2
1791825|NCT00581542|6236016|P1|Overall Study|they met an exclusion criteria|2
1791826|NCT00581360|6236070|P1|Overall Study|Withdrawal by Subject|1
1791827|NCT00581308|6236089|P1|Month 12|Other|1
1791828|NCT00581308|6236089|P1|Month 12|Device Removed|1
1791829|NCT00581308|6236089|P1|Month 12|Withdrawal by Subject|3
1791830|NCT00581308|6236089|P1|Month 12|Lost to Follow-up|14
1791831|NCT00581308|6236089|P1|Month 12|Death|1
1791832|NCT00581308|6236089|P1|Month 6|Withdrawal by Subject|2
1791833|NCT00581308|6236089|P1|Month 6|Lost to Follow-up|1
1791834|NCT00581308|6236089|P1|Month 1|Uknown|1
1791835|NCT00581308|6236089|P1|Month 1|Device Removed|2
1791836|NCT00581308|6236089|P1|Month 1|Withdrawal by Subject|2
1791837|NCT00581308|6236089|P1|Month 1|Lost to Follow-up|3
1791838|NCT00581308|6236089|P1|Pre Discharge|Device Removed|1
1791839|NCT00581308|6236089|P1|Pre Discharge|Lost to Follow-up|1
1791840|NCT00581113|6236120|P2|Overall Study|Withdrawal by Subject|1
1791841|NCT00581113|6236121|P1|Overall Study|Withdrawal by Subject|0
1791842|NCT00581100|6236131|P2|Overall Study|Other|0
1791843|NCT00581100|6236132|P1|Overall Study|Other|3
1791844|NCT00581100|6236131|P2|Overall Study|Withdrawal by Subject|4
1791845|NCT00581100|6236132|P1|Overall Study|Withdrawal by Subject|1
1791846|NCT00581100|6236131|P2|Overall Study|Adverse Event|1
1791847|NCT00581100|6236132|P1|Overall Study|Adverse Event|2
1791848|NCT00581100|6236131|P2|Overall Study|Death|0
1791849|NCT00581100|6236132|P1|Overall Study|Death|1
1791850|NCT00580983|6236185|P1|Overall Study|Did not complete 12 mon post RT studies|7
1791851|NCT00580970|6236192|P1|Treatment (Lovastatin)|Death|1
1791852|NCT00580970|6236192|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
1791853|NCT00580970|6236192|P1|Treatment (Lovastatin)|Physician Decision|4
1791854|NCT00580970|6236192|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
1791855|NCT00580970|6236192|P1|Treatment (Lovastatin)|Non-compliance|6
1791856|NCT00580970|6236192|P1|Pre-treatment|Non-compliance|1
1791857|NCT00580866|6236207|P2|Overall Study|Lost to Follow-up|2
1791858|NCT00580866|6236208|P1|Overall Study|Lost to Follow-up|2
1791859|NCT00580840|6236232|P4|Double-Blind|Other: Forbidden Medication|0
1791860|NCT00580840|6236233|P3|Double-Blind|Other: Forbidden Medication|1
1791861|NCT00580840|6236234|P2|Double-Blind|Other: Forbidden Medication|0
1791862|NCT00580840|6236235|P1|Double-Blind|Other: Forbidden Medication|0
1791863|NCT00580840|6236232|P4|Double-Blind|Other: Discontinued Methotrexate|0
1791864|NCT00580840|6236233|P3|Double-Blind|Other: Discontinued Methotrexate|0
1791865|NCT00580840|6236234|P2|Double-Blind|Other: Discontinued Methotrexate|1
1791866|NCT00580840|6236235|P1|Double-Blind|Other: Discontinued Methotrexate|0
1791867|NCT00580840|6236232|P4|Double-Blind|Withdrawal by Subject|2
1791868|NCT00580840|6236233|P3|Double-Blind|Withdrawal by Subject|2
1791869|NCT00580840|6236234|P2|Double-Blind|Withdrawal by Subject|1
1791870|NCT00580840|6236235|P1|Double-Blind|Withdrawal by Subject|0
1791871|NCT00580840|6236232|P4|Double-Blind|Lost to Follow-up|2
1791872|NCT00580840|6236233|P3|Double-Blind|Lost to Follow-up|0
1791873|NCT00580840|6236234|P2|Double-Blind|Lost to Follow-up|1
1791874|NCT00580840|6236235|P1|Double-Blind|Lost to Follow-up|0
1791875|NCT00580840|6236232|P4|Double-Blind|Loss of Efficacy|10
1791876|NCT00580840|6236233|P3|Double-Blind|Loss of Efficacy|2
1791877|NCT00580840|6236234|P2|Double-Blind|Loss of Efficacy|1
1791878|NCT00580840|6236235|P1|Double-Blind|Loss of Efficacy|0
1791879|NCT00580840|6236232|P4|Double-Blind|Adverse Event|1
1791880|NCT00580840|6236233|P3|Double-Blind|Adverse Event|4
1791881|NCT00580840|6236234|P2|Double-Blind|Adverse Event|3
1791882|NCT00580840|6236235|P1|Double-Blind|Adverse Event|0
1791883|NCT00580840|6236232|P4|Run-in|Other: Exclusionary Lab Value|0
1791884|NCT00580840|6236233|P3|Run-in|Other: Exclusionary Lab Value|0
1791885|NCT00580840|6236234|P2|Run-in|Other: Exclusionary Lab Value|0
1791886|NCT00580840|6236235|P1|Run-in|Other: Exclusionary Lab Value|1
1791887|NCT00580840|6236232|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
1791888|NCT00580840|6236233|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
1791889|NCT00580840|6236234|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
1791890|NCT00580840|6236235|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
1791891|NCT00580840|6236232|P4|Run-in|Other: Per Sponsor Request|0
1791892|NCT00580840|6236233|P3|Run-in|Other: Per Sponsor Request|0
1791893|NCT00580840|6236234|P2|Run-in|Other: Per Sponsor Request|0
1791894|NCT00580840|6236235|P1|Run-in|Other: Per Sponsor Request|2
1791895|NCT00580840|6236232|P4|Run-in|Withdrawal by Subject|0
1791896|NCT00580840|6236233|P3|Run-in|Withdrawal by Subject|0
1791897|NCT00580840|6236234|P2|Run-in|Withdrawal by Subject|0
1791898|NCT00580840|6236235|P1|Run-in|Withdrawal by Subject|5
1791899|NCT00580840|6236232|P4|Run-in|Lost to Follow-up|0
1791900|NCT00580840|6236233|P3|Run-in|Lost to Follow-up|0
1791901|NCT00580840|6236234|P2|Run-in|Lost to Follow-up|0
1791902|NCT00580840|6236235|P1|Run-in|Lost to Follow-up|4
1791903|NCT00580840|6236232|P4|Run-in|Loss of Efficacy|0
1791904|NCT00580840|6236233|P3|Run-in|Loss of Efficacy|0
1791905|NCT00580840|6236234|P2|Run-in|Loss of Efficacy|0
1791906|NCT00580840|6236235|P1|Run-in|Loss of Efficacy|1
1791907|NCT00580840|6236232|P4|Run-in|Lack of Efficacy|0
1791908|NCT00580840|6236233|P3|Run-in|Lack of Efficacy|0
1791909|NCT00580840|6236234|P2|Run-in|Lack of Efficacy|0
1791910|NCT00580840|6236235|P1|Run-in|Lack of Efficacy|93
1791911|NCT00580840|6236232|P4|Run-in|Adverse Event|0
1791912|NCT00580840|6236233|P3|Run-in|Adverse Event|0
1791913|NCT00580840|6236234|P2|Run-in|Adverse Event|0
1791914|NCT00580840|6236235|P1|Run-in|Adverse Event|17
1791915|NCT00580801|6236343|P3|Overall Study|Travel|0
1791916|NCT00580801|6236344|P2|Overall Study|Travel|0
1791917|NCT00580801|6236345|P1|Overall Study|Travel|1
1791918|NCT00580801|6236343|P3|Overall Study|Participant non-compliant|1
1791919|NCT00580801|6236344|P2|Overall Study|Participant non-compliant|0
1791920|NCT00580801|6236345|P1|Overall Study|Participant non-compliant|0
1791921|NCT00580801|6236343|P3|Overall Study|Reached a virologic endpoint|2
1791922|NCT00580801|6236344|P2|Overall Study|Reached a virologic endpoint|1
1791923|NCT00580801|6236345|P1|Overall Study|Reached a virologic endpoint|0
1791924|NCT00580801|6236343|P3|Overall Study|Lost to Follow-up|0
1791925|NCT00580801|6236344|P2|Overall Study|Lost to Follow-up|0
1791926|NCT00580801|6236345|P1|Overall Study|Lost to Follow-up|2
1791927|NCT00580801|6236343|P3|Overall Study|Adverse Event|0
1791928|NCT00580801|6236344|P2|Overall Study|Adverse Event|0
1791929|NCT00580801|6236345|P1|Overall Study|Adverse Event|2
1791930|NCT00580801|6236343|P3|Overall Study|Physician Decision|0
1791931|NCT00580801|6236344|P2|Overall Study|Physician Decision|0
1791932|NCT00580801|6236345|P1|Overall Study|Physician Decision|1
1791933|NCT00580788|6236384|P4|Overall Study|Adverse Event|1
1791934|NCT00580788|6236385|P3|Overall Study|Adverse Event|0
1791935|NCT00580788|6236386|P2|Overall Study|Adverse Event|0
1791936|NCT00580788|6236387|P1|Overall Study|Adverse Event|0
1791937|NCT00580723|6236445|P1|Overall Study|Lost to Follow-up|5
1791938|NCT00580723|6236445|P1|Overall Study|Did not want to participate in extension|3
1791939|NCT00580606|6236488|P2|Open Label (OL)|Needed Prohibited Medication|1
1791940|NCT00580606|6236489|P1|Open Label (OL)|Needed Prohibited Medication|0
1791941|NCT00580606|6236488|P2|Open Label (OL)|Physician Decision|1
1791942|NCT00580606|6236489|P1|Open Label (OL)|Physician Decision|1
1791943|NCT00580606|6236488|P2|Open Label (OL)|Non-compliance|0
1791944|NCT00580606|6236489|P1|Open Label (OL)|Non-compliance|2
1791945|NCT00580606|6236488|P2|Open Label (OL)|Pregnancy|1
1791946|NCT00580606|6236489|P1|Open Label (OL)|Pregnancy|0
1791947|NCT00580606|6236488|P2|Open Label (OL)|Lost to Follow-up|1
1791948|NCT00580606|6236489|P1|Open Label (OL)|Lost to Follow-up|0
1791949|NCT00580606|6236488|P2|Open Label (OL)|Dosing Symptoms|1
1791950|NCT00580606|6236489|P1|Open Label (OL)|Dosing Symptoms|0
1791951|NCT00580606|6236488|P2|Open Label (OL)|Withdrawal by Subject|6
1791952|NCT00580606|6236489|P1|Open Label (OL)|Withdrawal by Subject|4
1791953|NCT00580606|6236488|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
1791954|NCT00580606|6236489|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
1791955|NCT00580047|6236570|P3|Overall Study|Withdrawal by Subject|0
1791956|NCT00580047|6236571|P2|Overall Study|Withdrawal by Subject|0
1791957|NCT00580047|6236572|P1|Overall Study|Withdrawal by Subject|1
1791958|NCT00580047|6236570|P3|Overall Study|Withdrawal by Subject|2
1791959|NCT00580047|6236571|P2|Overall Study|Withdrawal by Subject|1
1791960|NCT00580047|6236572|P1|Overall Study|Withdrawal by Subject|1
1791961|NCT00580047|6236570|P3|Overall Study|Lost to Follow-up|0
1791962|NCT00580047|6236571|P2|Overall Study|Lost to Follow-up|1
1791963|NCT00580047|6236572|P1|Overall Study|Lost to Follow-up|1
1791964|NCT00580034|6236583|P2|Overall Study|Toxicity|0
1791965|NCT00580034|6236584|P1|Overall Study|Toxicity|10
1791966|NCT00579982|6236590|P1|Overall Study|Protocol Violation|4
1791967|NCT00579982|6236590|P1|Overall Study|Adverse Event|4
1791968|NCT00579826|6236624|P2|Overall Study|Withdrawal by Subject|3
1791969|NCT00579826|6236625|P1|Overall Study|Withdrawal by Subject|5
1791970|NCT00579670|6236659|P5|Overall Study|Withdrawal by Subject|0
1791971|NCT00579670|6236660|P4|Overall Study|Withdrawal by Subject|0
1791972|NCT00579670|6236661|P3|Overall Study|Withdrawal by Subject|1
1791973|NCT00579670|6236662|P2|Overall Study|Withdrawal by Subject|0
1791974|NCT00579670|6236663|P1|Overall Study|Withdrawal by Subject|0
1791975|NCT00579670|6236659|P5|Overall Study|Other|0
1791976|NCT00579670|6236660|P4|Overall Study|Other|2
1791977|NCT00579670|6236661|P3|Overall Study|Other|1
1791978|NCT00579670|6236662|P2|Overall Study|Other|0
1791979|NCT00579670|6236663|P1|Overall Study|Other|0
1791980|NCT00579670|6236659|P5|Overall Study|Lost to Follow-up|0
1791981|NCT00579670|6236660|P4|Overall Study|Lost to Follow-up|4
1791982|NCT00579670|6236661|P3|Overall Study|Lost to Follow-up|0
1791983|NCT00579670|6236662|P2|Overall Study|Lost to Follow-up|1
1791984|NCT00579670|6236663|P1|Overall Study|Lost to Follow-up|0
1791985|NCT00579670|6236659|P5|Overall Study|Lack of Efficacy|0
1791986|NCT00579670|6236660|P4|Overall Study|Lack of Efficacy|14
1791987|NCT00579670|6236661|P3|Overall Study|Lack of Efficacy|1
1791988|NCT00579670|6236662|P2|Overall Study|Lack of Efficacy|0
1791989|NCT00579670|6236663|P1|Overall Study|Lack of Efficacy|0
1791990|NCT00579670|6236659|P5|Overall Study|Adverse Event|0
1791991|NCT00579670|6236660|P4|Overall Study|Adverse Event|2
1791992|NCT00579670|6236661|P3|Overall Study|Adverse Event|1
1791993|NCT00579670|6236662|P2|Overall Study|Adverse Event|0
1791994|NCT00579670|6236663|P1|Overall Study|Adverse Event|1
1791995|NCT00579670|6236659|P5|Overall Study|Death|0
1791996|NCT00579670|6236660|P4|Overall Study|Death|0
1791997|NCT00579670|6236661|P3|Overall Study|Death|0
1791998|NCT00579670|6236662|P2|Overall Study|Death|0
1791999|NCT00579670|6236663|P1|Overall Study|Death|1
1792001|NCT00579501|6236887|P1|Overall Study|Radiation therapy before surgery|1
1792002|NCT00579501|6236887|P1|Overall Study|Secondary lesion|1
1792003|NCT00579501|6236887|P1|Overall Study|toxicity|1
1792004|NCT00579501|6236887|P1|Overall Study|End of neoadjuvant therapy|25
1792005|NCT00579501|6236887|P1|Overall Study|Death|1
1792006|NCT00579345|6236915|P8|Overall Study|Death|0
1792007|NCT00579345|6236916|P7|Overall Study|Death|0
1792008|NCT00579345|6236917|P6|Overall Study|Death|0
1792009|NCT00579345|6236918|P5|Overall Study|Death|0
1792010|NCT00579345|6236919|P4|Overall Study|Death|1
1792011|NCT00579345|6236920|P3|Overall Study|Death|1
1792012|NCT00579345|6236921|P2|Overall Study|Death|1
1792013|NCT00579345|6236922|P1|Overall Study|Death|1
1792014|NCT00579345|6236915|P8|Overall Study|Protocol Violation|1
1792015|NCT00579345|6236916|P7|Overall Study|Protocol Violation|0
1792016|NCT00579345|6236917|P6|Overall Study|Protocol Violation|0
1792017|NCT00579345|6236918|P5|Overall Study|Protocol Violation|0
1792018|NCT00579345|6236919|P4|Overall Study|Protocol Violation|0
1792019|NCT00579345|6236920|P3|Overall Study|Protocol Violation|0
1792020|NCT00579345|6236921|P2|Overall Study|Protocol Violation|0
1792021|NCT00579345|6236922|P1|Overall Study|Protocol Violation|1
1792022|NCT00579345|6236915|P8|Overall Study|Adverse Event|0
1792023|NCT00579345|6236916|P7|Overall Study|Adverse Event|0
1792024|NCT00579345|6236917|P6|Overall Study|Adverse Event|0
1792025|NCT00579345|6236918|P5|Overall Study|Adverse Event|0
1792026|NCT00579345|6236919|P4|Overall Study|Adverse Event|0
1792027|NCT00579345|6236920|P3|Overall Study|Adverse Event|1
1792028|NCT00579345|6236921|P2|Overall Study|Adverse Event|0
1792029|NCT00579345|6236922|P1|Overall Study|Adverse Event|0
1792030|NCT00579345|6236915|P8|Overall Study|Lost to Follow-up|0
1792031|NCT00579345|6236916|P7|Overall Study|Lost to Follow-up|0
1792032|NCT00579345|6236917|P6|Overall Study|Lost to Follow-up|0
1792033|NCT00579345|6236918|P5|Overall Study|Lost to Follow-up|0
1792034|NCT00579345|6236919|P4|Overall Study|Lost to Follow-up|0
1792035|NCT00579345|6236920|P3|Overall Study|Lost to Follow-up|0
1792036|NCT00579345|6236921|P2|Overall Study|Lost to Follow-up|0
1792037|NCT00579345|6236922|P1|Overall Study|Lost to Follow-up|1
1792038|NCT00579345|6236915|P8|Overall Study|Withdrawal by Subject|1
1792039|NCT00579345|6236916|P7|Overall Study|Withdrawal by Subject|0
1792040|NCT00579345|6236917|P6|Overall Study|Withdrawal by Subject|0
1792041|NCT00579345|6236918|P5|Overall Study|Withdrawal by Subject|0
1792042|NCT00579345|6236919|P4|Overall Study|Withdrawal by Subject|0
1792043|NCT00579345|6236920|P3|Overall Study|Withdrawal by Subject|0
1792044|NCT00579345|6236921|P2|Overall Study|Withdrawal by Subject|0
1792045|NCT00579345|6236922|P1|Overall Study|Withdrawal by Subject|2
1792046|NCT00579254|6236954|P1|Overall Study|Discontinued when study terminated|73
1792047|NCT00579254|6236954|P1|Overall Study|Lost to Follow-up|39
1792048|NCT00579098|6236978|P2|Overall Study|AF returned after ablation|2
1792049|NCT00579098|6236979|P1|Overall Study|AF returned after ablation|3
1792050|NCT00579098|6236978|P2|Overall Study|Withdrawal by Subject|3
1792051|NCT00579098|6236979|P1|Overall Study|Withdrawal by Subject|2
1792052|NCT00579098|6236978|P2|Overall Study|Adverse Event|3
1792053|NCT00579098|6236979|P1|Overall Study|Adverse Event|2
1792054|NCT00579098|6236978|P2|Overall Study|Lost to Follow-up|0
1792055|NCT00579098|6236979|P1|Overall Study|Lost to Follow-up|2
1792056|NCT00579059|6236995|P2|Overall Study|Study Canceled at 1 Year|10
1792057|NCT00579059|6236996|P1|Overall Study|Study Canceled at 1 Year|21
1792058|NCT00578942|6237070|P1|Overall Study|Lost to Follow-up|1
1792059|NCT00578877|6237109|P2|Overall Study|did not provide follow-up data|17
1792060|NCT00578877|6237110|P1|Overall Study|did not provide follow-up data|12
1792061|NCT00578877|6237109|P2|Overall Study|early discontinue|101
1792062|NCT00578877|6237110|P1|Overall Study|early discontinue|61
1792063|NCT00578877|6237109|P2|Overall Study|Lost to Follow-up|10
1792064|NCT00578877|6237110|P1|Overall Study|Lost to Follow-up|8
1792065|NCT00578864|6237118|P2|Overall Study|Death|0
1792066|NCT00578864|6237119|P1|Overall Study|Death|1
1792067|NCT00578812|6237135|P2|Overall Study|Not treated|7
1792068|NCT00578812|6237136|P1|Overall Study|Not treated|6
1792069|NCT00578786|6237175|P3|Overall Study|Qualified but Not Enrolled in Extension|0
1792070|NCT00578786|6237176|P2|Overall Study|Qualified but Not Enrolled in Extension|3
1792071|NCT00578786|6237177|P1|Overall Study|Qualified but Not Enrolled in Extension|0
1792072|NCT00578786|6237175|P3|Overall Study|Not Otherwise Specified|1
1792073|NCT00578786|6237176|P2|Overall Study|Not Otherwise Specified|4
1792074|NCT00578786|6237177|P1|Overall Study|Not Otherwise Specified|0
1792075|NCT00578786|6237175|P3|Overall Study|Pregnancy|0
1792076|NCT00578786|6237176|P2|Overall Study|Pregnancy|1
1792077|NCT00578786|6237177|P1|Overall Study|Pregnancy|0
1792078|NCT00578786|6237175|P3|Overall Study|Lost to Follow-up|0
1792079|NCT00578786|6237176|P2|Overall Study|Lost to Follow-up|4
1792080|NCT00578786|6237177|P1|Overall Study|Lost to Follow-up|0
1792081|NCT00578786|6237175|P3|Overall Study|Sponsor Decision|1
1792082|NCT00578786|6237176|P2|Overall Study|Sponsor Decision|0
1792083|NCT00578786|6237177|P1|Overall Study|Sponsor Decision|0
1792084|NCT00578786|6237175|P3|Overall Study|Physician Decision|1
1792085|NCT00578786|6237176|P2|Overall Study|Physician Decision|0
1792086|NCT00578786|6237177|P1|Overall Study|Physician Decision|1
1792087|NCT00578786|6237175|P3|Overall Study|Protocol Violation|1
1792088|NCT00578786|6237176|P2|Overall Study|Protocol Violation|3
1792089|NCT00578786|6237177|P1|Overall Study|Protocol Violation|0
1792090|NCT00578786|6237175|P3|Overall Study|Withdrawal by Subject|5
1792091|NCT00578786|6237176|P2|Overall Study|Withdrawal by Subject|8
1792092|NCT00578786|6237177|P1|Overall Study|Withdrawal by Subject|7
1792093|NCT00578786|6237175|P3|Overall Study|Early Escape from Prior Study|2
1792094|NCT00578786|6237176|P2|Overall Study|Early Escape from Prior Study|1
1792095|NCT00578786|6237177|P1|Overall Study|Early Escape from Prior Study|2
1792096|NCT00578786|6237175|P3|Overall Study|Lack of Efficacy|2
1792097|NCT00578786|6237176|P2|Overall Study|Lack of Efficacy|5
1792098|NCT00578786|6237177|P1|Overall Study|Lack of Efficacy|2
1792099|NCT00578786|6237175|P3|Overall Study|Adverse Event|17
1792100|NCT00578786|6237176|P2|Overall Study|Adverse Event|37
1792101|NCT00578786|6237177|P1|Overall Study|Adverse Event|27
1792102|NCT00578643|6237278|P1|Overall Study|Lost to Follow-up|1
1792103|NCT00578643|6237278|P1|Overall Study|Death|1
1792104|NCT00578565|6237294|P1|Overall Study|Adverse Event|3
1792105|NCT00578448|6237324|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
1792106|NCT00578448|6237324|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
1792107|NCT00578448|6237324|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
1792108|NCT00578448|6237324|P1|Day 1 up to 3 Years of Planned Study|Death|1
1792109|NCT00578318|6237388|P2|Overall Study|Physician Decision|0
1792110|NCT00578318|6237389|P1|Overall Study|Physician Decision|1
1792111|NCT00578318|6237388|P2|Overall Study|Lost to Follow-up|0
1792112|NCT00578318|6237389|P1|Overall Study|Lost to Follow-up|2
1792113|NCT00578227|6237471|P3|Overall Study|Withdrawal by Subject|3
1792114|NCT00578227|6237472|P2|Overall Study|Withdrawal by Subject|1
1792115|NCT00578227|6237473|P1|Overall Study|Withdrawal by Subject|5
1792116|NCT00578227|6237471|P3|Overall Study|Lost to Follow-up|1
1792117|NCT00578227|6237472|P2|Overall Study|Lost to Follow-up|1
1792118|NCT00578227|6237473|P1|Overall Study|Lost to Follow-up|0
1792119|NCT00578175|6237598|P3|Overall Study|Other reasons|23
1792120|NCT00578175|6237599|P2|Overall Study|Other reasons|42
1792121|NCT00578175|6237600|P1|Overall Study|Other reasons|70
1792122|NCT00578175|6237598|P3|Overall Study|Adverse Event|1
1792123|NCT00578175|6237599|P2|Overall Study|Adverse Event|1
1792124|NCT00578175|6237600|P1|Overall Study|Adverse Event|0
1792125|NCT00578136|6237679|P2|Overall Study|Not given intervention|1
1792126|NCT00578136|6237680|P1|Overall Study|Not given intervention|1
1792127|NCT00577889|6237698|P3|Overall Study|Withdrawal by Subject|0
1792128|NCT00577889|6237699|P2|Overall Study|Withdrawal by Subject|0
1792129|NCT00577889|6237700|P1|Overall Study|Withdrawal by Subject|1
1792130|NCT00577863|6237719|P2|Overall Study|Did Not Receive at Least One Injection|1
1792131|NCT00577863|6237720|P1|Overall Study|Did Not Receive at Least One Injection|0
1792132|NCT00577863|6237719|P2|Overall Study|Sponsor Decision|7
1792133|NCT00577863|6237720|P1|Overall Study|Sponsor Decision|2
1792134|NCT00577863|6237719|P2|Overall Study|Withdrawal by Subject|2
1792135|NCT00577863|6237720|P1|Overall Study|Withdrawal by Subject|0
1792136|NCT00577863|6237719|P2|Overall Study|Entry Criteria Exclusion|0
1792137|NCT00577863|6237720|P1|Overall Study|Entry Criteria Exclusion|1
1792138|NCT00577863|6237719|P2|Overall Study|Lost to Follow-up|2
1792139|NCT00577863|6237720|P1|Overall Study|Lost to Follow-up|2
1792140|NCT00577863|6237719|P2|Overall Study|Death|0
1792141|NCT00577863|6237720|P1|Overall Study|Death|1
1792142|NCT00577863|6237719|P2|Overall Study|Adverse Event|2
1792143|NCT00577863|6237720|P1|Overall Study|Adverse Event|4
1792144|NCT00577824|6237762|P3|Overall Study|Protocol Violation|0
1792145|NCT00577824|6237763|P2|Overall Study|Protocol Violation|1
1792146|NCT00577824|6237764|P1|Overall Study|Protocol Violation|1
1792147|NCT00577824|6237762|P3|Overall Study|Patient decision|1
1792148|NCT00577824|6237763|P2|Overall Study|Patient decision|1
1792149|NCT00577824|6237764|P1|Overall Study|Patient decision|0
1792150|NCT00577824|6237762|P3|Overall Study|Adverse Event|1
1792151|NCT00577824|6237763|P2|Overall Study|Adverse Event|18
1792152|NCT00577824|6237764|P1|Overall Study|Adverse Event|6
1792153|NCT00577772|6237822|P2|Overall Study|Lost to Follow-up|1
1792154|NCT00577772|6237823|P1|Overall Study|Lost to Follow-up|0
1792155|NCT00577720|6237833|P4|Overall Study|Withdrawal by Subject|2
1792156|NCT00577720|6237834|P3|Overall Study|Withdrawal by Subject|0
1792157|NCT00577720|6237835|P2|Overall Study|Withdrawal by Subject|0
1792158|NCT00577720|6237836|P1|Overall Study|Withdrawal by Subject|2
1792159|NCT00577720|6237833|P4|Overall Study|Protocol Violation|1
1792160|NCT00577720|6237834|P3|Overall Study|Protocol Violation|0
1792161|NCT00577720|6237835|P2|Overall Study|Protocol Violation|0
1792162|NCT00577720|6237836|P1|Overall Study|Protocol Violation|0
1792163|NCT00577720|6237833|P4|Overall Study|Lost to Follow-up|0
1792164|NCT00577720|6237834|P3|Overall Study|Lost to Follow-up|1
1792165|NCT00577720|6237835|P2|Overall Study|Lost to Follow-up|0
1792166|NCT00577720|6237836|P1|Overall Study|Lost to Follow-up|0
1792167|NCT00577720|6237833|P4|Overall Study|Adverse Event|4
1792168|NCT00577720|6237834|P3|Overall Study|Adverse Event|0
1792169|NCT00577720|6237835|P2|Overall Study|Adverse Event|1
1792170|NCT00577720|6237836|P1|Overall Study|Adverse Event|2
1792171|NCT00577707|6237854|P1|Overall Study|Withdrawal by Subject|3
1792172|NCT00577655|6237862|P2|Overall Study|Lost to Follow-up|1
1792173|NCT00577655|6237863|P1|Overall Study|Lost to Follow-up|1
1792174|NCT00577655|6237862|P2|Overall Study|Protocol Violation|1
1792175|NCT00577655|6237863|P1|Overall Study|Protocol Violation|0
1792176|NCT00577655|6237862|P2|Overall Study|Patient Request|2
1792177|NCT00577655|6237863|P1|Overall Study|Patient Request|0
1792178|NCT00577642|6237901|P1|Overall Study|Clinical Disease Progression|1
1792179|NCT00577629|6237905|P1|Long Term Follow-Up|Physician Decision|1
1792180|NCT00577629|6237905|P1|Long Term Follow-Up|Withdrawal by Subject|4
1792181|NCT00577629|6237905|P1|Long Term Follow-Up|Lost to Follow-up|5
1792182|NCT00577629|6237905|P1|Long Term Follow-Up|Death|15
1792183|NCT00577629|6237905|P1|Treatment Period|Death|1
1792184|NCT00577473|6237932|P2|Overall Study|Lack of Efficacy|7
1792185|NCT00577473|6237933|P1|Overall Study|Lack of Efficacy|8
1792186|NCT00577473|6237932|P2|Overall Study|Physician Decision|2
1792187|NCT00577473|6237933|P1|Overall Study|Physician Decision|2
1792188|NCT00577473|6237932|P2|Overall Study|Withdrawal by Subject|6
1792189|NCT00577473|6237933|P1|Overall Study|Withdrawal by Subject|2
1792190|NCT00577473|6237932|P2|Overall Study|Adverse Event|5
1792191|NCT00577473|6237933|P1|Overall Study|Adverse Event|8
1792192|NCT00577473|6237932|P2|Overall Study|Protocol Violation|4
1792193|NCT00577473|6237933|P1|Overall Study|Protocol Violation|1
1792194|NCT00577460|6237964|P3|Overall Study|Other|2
1792195|NCT00577460|6237965|P2|Overall Study|Other|3
1792196|NCT00577460|6237966|P1|Overall Study|Other|0
1792197|NCT00577460|6237964|P3|Overall Study|Withdrawal by Subject|6
1792198|NCT00577460|6237965|P2|Overall Study|Withdrawal by Subject|5
1792199|NCT00577460|6237966|P1|Overall Study|Withdrawal by Subject|5
1792200|NCT00577460|6237964|P3|Overall Study|Lost to Follow-up|4
1792201|NCT00577460|6237965|P2|Overall Study|Lost to Follow-up|3
1792202|NCT00577460|6237966|P1|Overall Study|Lost to Follow-up|0
1792203|NCT00577460|6237964|P3|Overall Study|Protocol Violation|1
1792204|NCT00577460|6237965|P2|Overall Study|Protocol Violation|1
1792205|NCT00577460|6237966|P1|Overall Study|Protocol Violation|0
1792206|NCT00577460|6237964|P3|Overall Study|Adverse Event|14
1792207|NCT00577460|6237965|P2|Overall Study|Adverse Event|7
1792208|NCT00577460|6237966|P1|Overall Study|Adverse Event|11
1792209|NCT00577408|6238075|P2|Overall Study|Psychiatric hospitalization|1
1792210|NCT00577408|6238076|P1|Overall Study|Psychiatric hospitalization|0
1792211|NCT00577408|6238075|P2|Overall Study|Death|1
1792212|NCT00577408|6238076|P1|Overall Study|Death|0
1792213|NCT00577408|6238075|P2|Overall Study|Scheduling Issues|3
1792214|NCT00577408|6238076|P1|Overall Study|Scheduling Issues|0
1792215|NCT00577408|6238075|P2|Overall Study|Moved out of state|1
1792216|NCT00577408|6238076|P1|Overall Study|Moved out of state|0
1792217|NCT00577408|6238075|P2|Overall Study|Refused Oral Naltrexone|1
1792218|NCT00577408|6238076|P1|Overall Study|Refused Oral Naltrexone|0
1792219|NCT00577408|6238075|P2|Overall Study|Non-compliance with study meds|3
1792220|NCT00577408|6238076|P1|Overall Study|Non-compliance with study meds|0
1792221|NCT00577408|6238075|P2|Overall Study|Continued opioid use|2
1792222|NCT00577408|6238076|P1|Overall Study|Continued opioid use|3
1792223|NCT00577408|6238075|P2|Overall Study|Stopped attending study visits|11
1792224|NCT00577408|6238076|P1|Overall Study|Stopped attending study visits|9
1792225|NCT00577395|6238084|P2|Overall Study|Study was terminated early by Sponsor|6
1792226|NCT00577395|6238085|P1|Overall Study|Study was terminated early by Sponsor|7
1792227|NCT00577382|6238095|P2|Overall Study|Lost to Follow-up|2
1792228|NCT00577382|6238096|P1|Overall Study|Lost to Follow-up|2
1792229|NCT00577382|6238095|P2|Overall Study|Death|1
1792230|NCT00577382|6238096|P1|Overall Study|Death|1
1792231|NCT00577382|6238095|P2|Overall Study|Intercurrent Illness|2
1792232|NCT00577382|6238096|P1|Overall Study|Intercurrent Illness|1
1792233|NCT00577382|6238095|P2|Overall Study|Progressive Disease|19
1792234|NCT00577382|6238096|P1|Overall Study|Progressive Disease|17
1792235|NCT00577382|6238095|P2|Overall Study|Withdrawal by Subject|1
1792236|NCT00577382|6238096|P1|Overall Study|Withdrawal by Subject|0
1792237|NCT00577382|6238095|P2|Overall Study|Adverse Event|6
1792238|NCT00577382|6238096|P1|Overall Study|Adverse Event|0
1792239|NCT00577122|6238239|P2|Overall Study|Alternative Therapy|1
1792240|NCT00577122|6238240|P1|Overall Study|Alternative Therapy|0
1792241|NCT00577122|6238239|P2|Overall Study|Prog, refract disease during active trt|5
1792242|NCT00577122|6238240|P1|Overall Study|Prog, refract disease during active trt|8
1792243|NCT00577122|6238239|P2|Overall Study|Progression, relapse during active trt|8
1792244|NCT00577122|6238240|P1|Overall Study|Progression, relapse during active trt|6
1792245|NCT00577122|6238239|P2|Overall Study|Adverse Event|2
1792246|NCT00577122|6238240|P1|Overall Study|Adverse Event|0
1792247|NCT00577096|6238254|P2|Short Term Participation|Death|1
1792248|NCT00577096|6238255|P1|Short Term Participation|Death|1
1792249|NCT00577096|6238254|P2|Short Term Participation|Withdrawal by Subject|5
1792250|NCT00577096|6238255|P1|Short Term Participation|Withdrawal by Subject|3
1792251|NCT00577096|6238254|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
1792252|NCT00577096|6238255|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
1792253|NCT00577031|6238294|P1|Overall Study|Death|6
1792254|NCT00577031|6238294|P1|Overall Study|Medical decision|14
1792255|NCT00577031|6238294|P1|Overall Study|Need for surgery|17
1792256|NCT00577031|6238294|P1|Overall Study|Participant non-compliance|5
1792257|NCT00577031|6238294|P1|Overall Study|Participant withdrew consent|13
1792258|NCT00577031|6238294|P1|Overall Study|Protocol Violation|5
1792259|NCT00577031|6238294|P1|Overall Study|Progression of disease|93
1792260|NCT00577031|6238294|P1|Overall Study|Adverse Event|52
1792261|NCT00577005|6238315|P2|Overall Study|Withdrawal by Subject|1
1792262|NCT00577005|6238316|P1|Overall Study|Withdrawal by Subject|2
1792263|NCT00577005|6238315|P2|Overall Study|Lost to Follow-up|2
1792264|NCT00577005|6238316|P1|Overall Study|Lost to Follow-up|3
1792265|NCT00576927|6238330|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
1792266|NCT00576927|6238330|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
1792267|NCT00576927|6238330|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
1792268|NCT00576927|6238330|P1|Sleep Hygiene Behavioral Intervention|Death|1
1792269|NCT00576927|6238330|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
1792270|NCT00576927|6238330|P1|Baseline|Withdrawal by Subject|3
1792271|NCT00576927|6238330|P1|Baseline|Medication Change by PCP of subject|1
1792272|NCT00576927|6238330|P1|Baseline|Physician Decision|9
1792273|NCT00576927|6238330|P1|Clinical Assessment|Physician Decision|1
1792274|NCT00576927|6238330|P1|Clinical Assessment|Withdrawal by Subject|10
1792275|NCT00576927|6238330|P1|Clinical Assessment|Death|1
1792276|NCT00576927|6238330|P1|Clinical Assessment|Lack of Efficacy|24
1792277|NCT00576901|6238342|P1|Overall Study|Protocol Violation|1
1792278|NCT00576901|6238342|P1|Overall Study|Disease course|1
1792279|NCT00576901|6238342|P1|Overall Study|Withdrawal by Subject|1
1792284|NCT00576823|6238366|P3|40-week Safety Extension Phase|Lack of Efficacy|0
1792285|NCT00576823|6238367|P2|40-week Safety Extension Phase|Lack of Efficacy|0
1792286|NCT00576823|6238368|P1|40-week Safety Extension Phase|Lack of Efficacy|1
1792287|NCT00576823|6238366|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
1792288|NCT00576823|6238367|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
1792289|NCT00576823|6238368|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
1792290|NCT00576758|6238384|P2|Follow-up Period|Withdrew consent|1
1792291|NCT00576758|6238385|P1|Follow-up Period|Withdrew consent|2
1792292|NCT00576758|6238384|P2|Follow-up Period|Insufficient therapeutic response|5
1792293|NCT00576758|6238385|P1|Follow-up Period|Insufficient therapeutic response|16
1792294|NCT00576758|6238384|P2|Follow-up Period|Death|3
1792295|NCT00576758|6238385|P1|Follow-up Period|Death|3
1792296|NCT00576758|6238384|P2|Follow-up Period|Administrative/Other|8
1792297|NCT00576758|6238385|P1|Follow-up Period|Administrative/Other|6
1792298|NCT00576758|6238384|P2|Extension Treatment Period|Administrative/Other|1
1792299|NCT00576758|6238385|P1|Extension Treatment Period|Administrative/Other|3
1792300|NCT00576758|6238384|P2|Extension Treatment Period|Insufficient therapeutic response|33
1792301|NCT00576758|6238385|P1|Extension Treatment Period|Insufficient therapeutic response|30
1792302|NCT00576758|6238384|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
1792303|NCT00576758|6238385|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
1792304|NCT00576758|6238384|P2|Extension Treatment Period|Death|1
1792305|NCT00576758|6238385|P1|Extension Treatment Period|Death|1
1792306|NCT00576758|6238384|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
1792307|NCT00576758|6238385|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
1792308|NCT00576758|6238384|P2|Induction Treatment Period|Withdrew consent|0
1792309|NCT00576758|6238385|P1|Induction Treatment Period|Withdrew consent|1
1792310|NCT00576758|6238384|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
1792311|NCT00576758|6238385|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
1792312|NCT00576758|6238384|P2|Induction Treatment Period|Death|0
1792313|NCT00576758|6238385|P1|Induction Treatment Period|Death|1
1792314|NCT00576758|6238384|P2|Induction Treatment Period|Violation of selection criteria at entry|1
1792315|NCT00576758|6238385|P1|Induction Treatment Period|Violation of selection criteria at entry|1
1792316|NCT00576758|6238384|P2|Induction Treatment Period|Insufficient therapeutic response|0
1792317|NCT00576758|6238385|P1|Induction Treatment Period|Insufficient therapeutic response|2
1792318|NCT00576758|6238384|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
1792319|NCT00576758|6238385|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
1792320|NCT00576732|6238431|P6|OPEN LABEL|Protocol Violation|0
1792321|NCT00576732|6238432|P5|OPEN LABEL|Protocol Violation|1
1792322|NCT00576732|6238433|P4|OPEN LABEL|Protocol Violation|2
1792323|NCT00576732|6238434|P3|OPEN LABEL|Protocol Violation|0
1792324|NCT00576732|6238435|P2|OPEN LABEL|Protocol Violation|0
1792325|NCT00576732|6238436|P1|OPEN LABEL|Protocol Violation|0
1792326|NCT00576732|6238431|P6|OPEN LABEL|Lack of Efficacy|3
1792327|NCT00576732|6238432|P5|OPEN LABEL|Lack of Efficacy|2
1792328|NCT00576732|6238433|P4|OPEN LABEL|Lack of Efficacy|2
1792329|NCT00576732|6238434|P3|OPEN LABEL|Lack of Efficacy|0
1792330|NCT00576732|6238435|P2|OPEN LABEL|Lack of Efficacy|0
1792331|NCT00576732|6238436|P1|OPEN LABEL|Lack of Efficacy|0
1792332|NCT00576732|6238431|P6|OPEN LABEL|OTHER|2
1792333|NCT00576732|6238432|P5|OPEN LABEL|OTHER|0
1792334|NCT00576732|6238433|P4|OPEN LABEL|OTHER|0
1792335|NCT00576732|6238434|P3|OPEN LABEL|OTHER|0
1792336|NCT00576732|6238435|P2|OPEN LABEL|OTHER|0
1792337|NCT00576732|6238436|P1|OPEN LABEL|OTHER|0
1792338|NCT00576732|6238431|P6|OPEN LABEL|Withdrawal by Subject|1
1792339|NCT00576732|6238432|P5|OPEN LABEL|Withdrawal by Subject|0
1792340|NCT00576732|6238433|P4|OPEN LABEL|Withdrawal by Subject|1
1792341|NCT00576732|6238434|P3|OPEN LABEL|Withdrawal by Subject|0
1792342|NCT00576732|6238435|P2|OPEN LABEL|Withdrawal by Subject|0
1792343|NCT00576732|6238436|P1|OPEN LABEL|Withdrawal by Subject|0
1792344|NCT00576732|6238431|P6|OPEN LABEL|Lost to Follow-up|1
1792345|NCT00576732|6238432|P5|OPEN LABEL|Lost to Follow-up|1
1792346|NCT00576732|6238433|P4|OPEN LABEL|Lost to Follow-up|2
1792347|NCT00576732|6238434|P3|OPEN LABEL|Lost to Follow-up|0
1792348|NCT00576732|6238435|P2|OPEN LABEL|Lost to Follow-up|0
1792349|NCT00576732|6238436|P1|OPEN LABEL|Lost to Follow-up|0
1792350|NCT00576732|6238431|P6|OPEN LABEL|Adverse Event|1
1792351|NCT00576732|6238432|P5|OPEN LABEL|Adverse Event|0
1792352|NCT00576732|6238433|P4|OPEN LABEL|Adverse Event|4
1792353|NCT00576732|6238434|P3|OPEN LABEL|Adverse Event|0
1792354|NCT00576732|6238435|P2|OPEN LABEL|Adverse Event|0
1792355|NCT00576732|6238436|P1|OPEN LABEL|Adverse Event|0
1792356|NCT00576732|6238431|P6|DOUBLE BLIND|Protocol Violation|0
1792357|NCT00576732|6238432|P5|DOUBLE BLIND|Protocol Violation|0
1792358|NCT00576732|6238433|P4|DOUBLE BLIND|Protocol Violation|0
1792359|NCT00576732|6238434|P3|DOUBLE BLIND|Protocol Violation|0
1792360|NCT00576732|6238435|P2|DOUBLE BLIND|Protocol Violation|0
1792361|NCT00576732|6238436|P1|DOUBLE BLIND|Protocol Violation|1
1792362|NCT00576732|6238431|P6|DOUBLE BLIND|Lack of Efficacy|0
1792363|NCT00576732|6238432|P5|DOUBLE BLIND|Lack of Efficacy|0
1792364|NCT00576732|6238433|P4|DOUBLE BLIND|Lack of Efficacy|0
1792365|NCT00576732|6238434|P3|DOUBLE BLIND|Lack of Efficacy|0
1792366|NCT00576732|6238435|P2|DOUBLE BLIND|Lack of Efficacy|1
1792367|NCT00576732|6238436|P1|DOUBLE BLIND|Lack of Efficacy|6
1792368|NCT00576732|6238431|P6|DOUBLE BLIND|OTHER|0
1792369|NCT00576732|6238432|P5|DOUBLE BLIND|OTHER|0
1792370|NCT00576732|6238433|P4|DOUBLE BLIND|OTHER|0
1792371|NCT00576732|6238434|P3|DOUBLE BLIND|OTHER|1
1792372|NCT00576732|6238435|P2|DOUBLE BLIND|OTHER|2
1792373|NCT00576732|6238436|P1|DOUBLE BLIND|OTHER|0
1792374|NCT00576732|6238431|P6|DOUBLE BLIND|Withdrawal by Subject|0
1792375|NCT00576732|6238432|P5|DOUBLE BLIND|Withdrawal by Subject|0
1792376|NCT00576732|6238433|P4|DOUBLE BLIND|Withdrawal by Subject|0
1792377|NCT00576732|6238434|P3|DOUBLE BLIND|Withdrawal by Subject|3
1792378|NCT00576732|6238435|P2|DOUBLE BLIND|Withdrawal by Subject|1
1792379|NCT00576732|6238436|P1|DOUBLE BLIND|Withdrawal by Subject|1
1792380|NCT00576732|6238431|P6|DOUBLE BLIND|Lost to Follow-up|0
1792381|NCT00576732|6238432|P5|DOUBLE BLIND|Lost to Follow-up|0
1792382|NCT00576732|6238433|P4|DOUBLE BLIND|Lost to Follow-up|0
1792383|NCT00576732|6238434|P3|DOUBLE BLIND|Lost to Follow-up|1
1792384|NCT00576732|6238435|P2|DOUBLE BLIND|Lost to Follow-up|1
1792385|NCT00576732|6238436|P1|DOUBLE BLIND|Lost to Follow-up|0
1792386|NCT00576732|6238431|P6|DOUBLE BLIND|Adverse Event|0
1792387|NCT00576732|6238432|P5|DOUBLE BLIND|Adverse Event|0
1792388|NCT00576732|6238433|P4|DOUBLE BLIND|Adverse Event|0
1792389|NCT00576732|6238434|P3|DOUBLE BLIND|Adverse Event|1
1792390|NCT00576732|6238435|P2|DOUBLE BLIND|Adverse Event|0
1792391|NCT00576732|6238436|P1|DOUBLE BLIND|Adverse Event|0
1792392|NCT00576693|6238468|P2|Overall Study|Withdrawal by Subject|13
1792393|NCT00576693|6238469|P1|Overall Study|Withdrawal by Subject|3
1792394|NCT00576693|6238468|P2|Overall Study|Lost to Follow-up|11
1792395|NCT00576693|6238469|P1|Overall Study|Lost to Follow-up|7
1792396|NCT00576628|6238475|P1|Overall Study|Dialysis|15
1792397|NCT00576628|6238475|P1|Overall Study|Transplantation|1
1792398|NCT00576628|6238475|P1|Overall Study|The patient move into other town|1
1792399|NCT00576628|6238475|P1|Overall Study|Progression of Renal Failure|1
1792400|NCT00576628|6238475|P1|Overall Study|Progression of Kidney Disease|1
1792401|NCT00576628|6238475|P1|Overall Study|RBC transfusion|1
1792402|NCT00576628|6238475|P1|Overall Study|Pregnancy|1
1792403|NCT00576628|6238475|P1|Overall Study|Refused Treatment|8
1792404|NCT00576628|6238475|P1|Overall Study|Failure to return|1
1792405|NCT00576628|6238475|P1|Overall Study|Death|2
1792406|NCT00576628|6238475|P1|Overall Study|Adverse Event|11
1792407|NCT00576576|6238495|P1|Overall Study|Protocol Violation|1
1792408|NCT00576576|6238495|P1|Overall Study|Lost to Follow-up|6
1792409|NCT00576472|6238529|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
1792410|NCT00576472|6238530|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
1792411|NCT00576472|6238531|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
1792412|NCT00576472|6238532|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
1792413|NCT00576472|6238533|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
1792414|NCT00576472|6238534|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
1792415|NCT00576472|6238535|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
1792416|NCT00576472|6238536|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
1792417|NCT00576472|6238537|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
1792418|NCT00576472|6238538|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
1792419|NCT00576472|6238539|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
1792420|NCT00576472|6238540|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
1792421|NCT00576472|6238541|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
1792422|NCT00576472|6238542|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
1792423|NCT00576472|6238543|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
1792424|NCT00576472|6238529|P15|MPH Home Maintenance Phase|Medical reasons|6
1792425|NCT00576472|6238530|P14|MPH Home Maintenance Phase|Medical reasons|0
1792426|NCT00576472|6238531|P13|MPH Home Maintenance Phase|Medical reasons|0
1792427|NCT00576472|6238532|P12|MPH Home Maintenance Phase|Medical reasons|0
1792428|NCT00576472|6238533|P11|MPH Home Maintenance Phase|Medical reasons|0
1792429|NCT00576472|6238534|P10|MPH Home Maintenance Phase|Medical reasons|0
1792430|NCT00576472|6238535|P9|MPH Home Maintenance Phase|Medical reasons|0
1792431|NCT00576472|6238536|P8|MPH Home Maintenance Phase|Medical reasons|0
1792432|NCT00576472|6238537|P7|MPH Home Maintenance Phase|Medical reasons|0
1792433|NCT00576472|6238538|P6|MPH Home Maintenance Phase|Medical reasons|0
1792434|NCT00576472|6238539|P5|MPH Home Maintenance Phase|Medical reasons|0
1792435|NCT00576472|6238540|P4|MPH Home Maintenance Phase|Medical reasons|0
1792436|NCT00576472|6238541|P3|MPH Home Maintenance Phase|Medical reasons|0
1792437|NCT00576472|6238542|P2|MPH Home Maintenance Phase|Medical reasons|0
1792438|NCT00576472|6238543|P1|MPH Home Maintenance Phase|Medical reasons|0
1792439|NCT00576472|6238529|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
1792440|NCT00576472|6238530|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792441|NCT00576472|6238531|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792442|NCT00576472|6238532|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792443|NCT00576472|6238533|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792444|NCT00576472|6238534|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792445|NCT00576472|6238535|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792446|NCT00576472|6238536|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792447|NCT00576472|6238537|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792448|NCT00576472|6238538|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792449|NCT00576472|6238539|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792450|NCT00576472|6238540|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792451|NCT00576472|6238541|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792452|NCT00576472|6238542|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792453|NCT00576472|6238543|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
1792454|NCT00576472|6238529|P15|MPH Home Maintenance Phase|Side effects|8
1792455|NCT00576472|6238530|P14|MPH Home Maintenance Phase|Side effects|0
1792456|NCT00576472|6238531|P13|MPH Home Maintenance Phase|Side effects|0
1792457|NCT00576472|6238532|P12|MPH Home Maintenance Phase|Side effects|0
1792458|NCT00576472|6238533|P11|MPH Home Maintenance Phase|Side effects|0
1792459|NCT00576472|6238534|P10|MPH Home Maintenance Phase|Side effects|0
1792460|NCT00576472|6238535|P9|MPH Home Maintenance Phase|Side effects|0
1792461|NCT00576472|6238536|P8|MPH Home Maintenance Phase|Side effects|0
1792462|NCT00576472|6238537|P7|MPH Home Maintenance Phase|Side effects|0
1792463|NCT00576472|6238538|P6|MPH Home Maintenance Phase|Side effects|0
1792464|NCT00576472|6238539|P5|MPH Home Maintenance Phase|Side effects|0
1792465|NCT00576472|6238540|P4|MPH Home Maintenance Phase|Side effects|0
1792466|NCT00576472|6238541|P3|MPH Home Maintenance Phase|Side effects|0
1792467|NCT00576472|6238542|P2|MPH Home Maintenance Phase|Side effects|0
1792468|NCT00576472|6238543|P1|MPH Home Maintenance Phase|Side effects|0
1792469|NCT00576472|6238529|P15|MPH Home Maintenance Phase|Insufficient data|0
1792470|NCT00576472|6238530|P14|MPH Home Maintenance Phase|Insufficient data|4
1792471|NCT00576472|6238531|P13|MPH Home Maintenance Phase|Insufficient data|0
1792472|NCT00576472|6238532|P12|MPH Home Maintenance Phase|Insufficient data|0
1792473|NCT00576472|6238533|P11|MPH Home Maintenance Phase|Insufficient data|0
1792474|NCT00576472|6238534|P10|MPH Home Maintenance Phase|Insufficient data|0
1792475|NCT00576472|6238535|P9|MPH Home Maintenance Phase|Insufficient data|0
1792476|NCT00576472|6238536|P8|MPH Home Maintenance Phase|Insufficient data|0
1792477|NCT00576472|6238537|P7|MPH Home Maintenance Phase|Insufficient data|0
1792478|NCT00576472|6238538|P6|MPH Home Maintenance Phase|Insufficient data|0
1792479|NCT00576472|6238539|P5|MPH Home Maintenance Phase|Insufficient data|0
1792480|NCT00576472|6238540|P4|MPH Home Maintenance Phase|Insufficient data|0
1792481|NCT00576472|6238541|P3|MPH Home Maintenance Phase|Insufficient data|0
1792482|NCT00576472|6238542|P2|MPH Home Maintenance Phase|Insufficient data|0
1792483|NCT00576472|6238543|P1|MPH Home Maintenance Phase|Insufficient data|0
1792484|NCT00576472|6238529|P15|MPH Home Maintenance Phase|Declined to participate|0
1792485|NCT00576472|6238530|P14|MPH Home Maintenance Phase|Declined to participate|7
1792486|NCT00576472|6238531|P13|MPH Home Maintenance Phase|Declined to participate|0
1792487|NCT00576472|6238532|P12|MPH Home Maintenance Phase|Declined to participate|0
1792488|NCT00576472|6238533|P11|MPH Home Maintenance Phase|Declined to participate|0
1792489|NCT00576472|6238534|P10|MPH Home Maintenance Phase|Declined to participate|0
1792490|NCT00576472|6238535|P9|MPH Home Maintenance Phase|Declined to participate|0
1792491|NCT00576472|6238536|P8|MPH Home Maintenance Phase|Declined to participate|0
1792492|NCT00576472|6238537|P7|MPH Home Maintenance Phase|Declined to participate|0
1792493|NCT00576472|6238538|P6|MPH Home Maintenance Phase|Declined to participate|0
1792494|NCT00576472|6238539|P5|MPH Home Maintenance Phase|Declined to participate|0
1792495|NCT00576472|6238540|P4|MPH Home Maintenance Phase|Declined to participate|0
1792496|NCT00576472|6238541|P3|MPH Home Maintenance Phase|Declined to participate|0
1792497|NCT00576472|6238542|P2|MPH Home Maintenance Phase|Declined to participate|0
1792498|NCT00576472|6238543|P1|MPH Home Maintenance Phase|Declined to participate|0
1792499|NCT00576472|6238529|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
1792500|NCT00576472|6238530|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
1792501|NCT00576472|6238531|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
1792502|NCT00576472|6238532|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
1792503|NCT00576472|6238533|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
1792504|NCT00576472|6238534|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
1792505|NCT00576472|6238535|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
1792506|NCT00576472|6238536|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
1792507|NCT00576472|6238537|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
1792508|NCT00576472|6238538|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
1792509|NCT00576472|6238539|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
1792510|NCT00576472|6238540|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
1792511|NCT00576472|6238541|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
1792512|NCT00576472|6238542|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
1792513|NCT00576472|6238543|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
1792514|NCT00576472|6238529|P15|MPH Cross Over Phase|Did not complete cross over phase|0
1792515|NCT00576472|6238530|P14|MPH Cross Over Phase|Did not complete cross over phase|0
1792516|NCT00576472|6238531|P13|MPH Cross Over Phase|Did not complete cross over phase|0
1792517|NCT00576472|6238532|P12|MPH Cross Over Phase|Did not complete cross over phase|1
1792518|NCT00576472|6238533|P11|MPH Cross Over Phase|Did not complete cross over phase|1
1792519|NCT00576472|6238534|P10|MPH Cross Over Phase|Did not complete cross over phase|0
1792520|NCT00576472|6238535|P9|MPH Cross Over Phase|Did not complete cross over phase|2
1792521|NCT00576472|6238536|P8|MPH Cross Over Phase|Did not complete cross over phase|0
1792522|NCT00576472|6238537|P7|MPH Cross Over Phase|Did not complete cross over phase|0
1792523|NCT00576472|6238538|P6|MPH Cross Over Phase|Did not complete cross over phase|0
1792524|NCT00576472|6238539|P5|MPH Cross Over Phase|Did not complete cross over phase|0
1792525|NCT00576472|6238540|P4|MPH Cross Over Phase|Did not complete cross over phase|0
1792526|NCT00576472|6238541|P3|MPH Cross Over Phase|Did not complete cross over phase|0
1792527|NCT00576472|6238542|P2|MPH Cross Over Phase|Did not complete cross over phase|0
1792528|NCT00576472|6238543|P1|MPH Cross Over Phase|Did not complete cross over phase|0
1792529|NCT00576472|6238529|P15|MPH Cross Over Phase|Physician Decision|0
1792530|NCT00576472|6238530|P14|MPH Cross Over Phase|Physician Decision|0
1792531|NCT00576472|6238531|P13|MPH Cross Over Phase|Physician Decision|0
1792532|NCT00576472|6238532|P12|MPH Cross Over Phase|Physician Decision|0
1792533|NCT00576472|6238533|P11|MPH Cross Over Phase|Physician Decision|0
1792534|NCT00576472|6238534|P10|MPH Cross Over Phase|Physician Decision|0
1792535|NCT00576472|6238535|P9|MPH Cross Over Phase|Physician Decision|0
1792536|NCT00576472|6238536|P8|MPH Cross Over Phase|Physician Decision|0
1792537|NCT00576472|6238537|P7|MPH Cross Over Phase|Physician Decision|4
1792538|NCT00576472|6238538|P6|MPH Cross Over Phase|Physician Decision|0
1792539|NCT00576472|6238539|P5|MPH Cross Over Phase|Physician Decision|0
1792540|NCT00576472|6238540|P4|MPH Cross Over Phase|Physician Decision|0
1792541|NCT00576472|6238541|P3|MPH Cross Over Phase|Physician Decision|0
1792542|NCT00576472|6238542|P2|MPH Cross Over Phase|Physician Decision|0
1792543|NCT00576472|6238543|P1|MPH Cross Over Phase|Physician Decision|0
1792544|NCT00576472|6238529|P15|MPH Cross Over Phase|Ineligible due to disease|0
1792545|NCT00576472|6238530|P14|MPH Cross Over Phase|Ineligible due to disease|0
1792546|NCT00576472|6238531|P13|MPH Cross Over Phase|Ineligible due to disease|0
1792547|NCT00576472|6238532|P12|MPH Cross Over Phase|Ineligible due to disease|0
1792548|NCT00576472|6238533|P11|MPH Cross Over Phase|Ineligible due to disease|0
1792549|NCT00576472|6238534|P10|MPH Cross Over Phase|Ineligible due to disease|0
1792550|NCT00576472|6238535|P9|MPH Cross Over Phase|Ineligible due to disease|0
1792551|NCT00576472|6238536|P8|MPH Cross Over Phase|Ineligible due to disease|0
1792552|NCT00576472|6238537|P7|MPH Cross Over Phase|Ineligible due to disease|2
1792553|NCT00576472|6238538|P6|MPH Cross Over Phase|Ineligible due to disease|0
1792554|NCT00576472|6238539|P5|MPH Cross Over Phase|Ineligible due to disease|0
1792555|NCT00576472|6238540|P4|MPH Cross Over Phase|Ineligible due to disease|0
1792556|NCT00576472|6238541|P3|MPH Cross Over Phase|Ineligible due to disease|0
1792557|NCT00576472|6238542|P2|MPH Cross Over Phase|Ineligible due to disease|0
1792558|NCT00576472|6238543|P1|MPH Cross Over Phase|Ineligible due to disease|0
1792559|NCT00576472|6238529|P15|MPH Cross Over Phase|Withdrawal by Subject|0
1792560|NCT00576472|6238530|P14|MPH Cross Over Phase|Withdrawal by Subject|0
1792561|NCT00576472|6238531|P13|MPH Cross Over Phase|Withdrawal by Subject|0
1792562|NCT00576472|6238532|P12|MPH Cross Over Phase|Withdrawal by Subject|0
1792563|NCT00576472|6238533|P11|MPH Cross Over Phase|Withdrawal by Subject|0
1792564|NCT00576472|6238534|P10|MPH Cross Over Phase|Withdrawal by Subject|0
1792565|NCT00576472|6238535|P9|MPH Cross Over Phase|Withdrawal by Subject|0
1792566|NCT00576472|6238536|P8|MPH Cross Over Phase|Withdrawal by Subject|0
1792567|NCT00576472|6238537|P7|MPH Cross Over Phase|Withdrawal by Subject|6
1792568|NCT00576472|6238538|P6|MPH Cross Over Phase|Withdrawal by Subject|0
1792569|NCT00576472|6238539|P5|MPH Cross Over Phase|Withdrawal by Subject|0
1792570|NCT00576472|6238540|P4|MPH Cross Over Phase|Withdrawal by Subject|0
1792571|NCT00576472|6238541|P3|MPH Cross Over Phase|Withdrawal by Subject|0
1792572|NCT00576472|6238542|P2|MPH Cross Over Phase|Withdrawal by Subject|0
1792573|NCT00576472|6238543|P1|MPH Cross Over Phase|Withdrawal by Subject|0
1792574|NCT00576472|6238529|P15|MPH In-Lab Phase|Psychiatric exclusion|0
1792575|NCT00576472|6238530|P14|MPH In-Lab Phase|Psychiatric exclusion|0
1792576|NCT00576472|6238531|P13|MPH In-Lab Phase|Psychiatric exclusion|0
1792577|NCT00576472|6238532|P12|MPH In-Lab Phase|Psychiatric exclusion|0
1792578|NCT00576472|6238533|P11|MPH In-Lab Phase|Psychiatric exclusion|0
1792579|NCT00576472|6238534|P10|MPH In-Lab Phase|Psychiatric exclusion|0
1792580|NCT00576472|6238535|P9|MPH In-Lab Phase|Psychiatric exclusion|0
1792581|NCT00576472|6238536|P8|MPH In-Lab Phase|Psychiatric exclusion|0
1792582|NCT00576472|6238537|P7|MPH In-Lab Phase|Psychiatric exclusion|0
1792583|NCT00576472|6238538|P6|MPH In-Lab Phase|Psychiatric exclusion|0
1792584|NCT00576472|6238539|P5|MPH In-Lab Phase|Psychiatric exclusion|0
1792585|NCT00576472|6238540|P4|MPH In-Lab Phase|Psychiatric exclusion|10
1792586|NCT00576472|6238541|P3|MPH In-Lab Phase|Psychiatric exclusion|0
1792587|NCT00576472|6238542|P2|MPH In-Lab Phase|Psychiatric exclusion|0
1792588|NCT00576472|6238543|P1|MPH In-Lab Phase|Psychiatric exclusion|0
1792589|NCT00576472|6238529|P15|MPH In-Lab Phase|No attention/academic problems|0
1792590|NCT00576472|6238530|P14|MPH In-Lab Phase|No attention/academic problems|0
1792591|NCT00576472|6238531|P13|MPH In-Lab Phase|No attention/academic problems|0
1792592|NCT00576472|6238532|P12|MPH In-Lab Phase|No attention/academic problems|0
1792593|NCT00576472|6238533|P11|MPH In-Lab Phase|No attention/academic problems|0
1792594|NCT00576472|6238534|P10|MPH In-Lab Phase|No attention/academic problems|0
1792595|NCT00576472|6238535|P9|MPH In-Lab Phase|No attention/academic problems|0
1792596|NCT00576472|6238536|P8|MPH In-Lab Phase|No attention/academic problems|0
1792597|NCT00576472|6238537|P7|MPH In-Lab Phase|No attention/academic problems|0
1792598|NCT00576472|6238538|P6|MPH In-Lab Phase|No attention/academic problems|0
1792599|NCT00576472|6238539|P5|MPH In-Lab Phase|No attention/academic problems|0
1792600|NCT00576472|6238540|P4|MPH In-Lab Phase|No attention/academic problems|245
1792601|NCT00576472|6238541|P3|MPH In-Lab Phase|No attention/academic problems|0
1792602|NCT00576472|6238542|P2|MPH In-Lab Phase|No attention/academic problems|0
1792603|NCT00576472|6238543|P1|MPH In-Lab Phase|No attention/academic problems|0
1792604|NCT00576472|6238529|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792605|NCT00576472|6238530|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792606|NCT00576472|6238531|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792607|NCT00576472|6238532|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792608|NCT00576472|6238533|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792609|NCT00576472|6238534|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792610|NCT00576472|6238535|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792611|NCT00576472|6238536|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792612|NCT00576472|6238537|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792613|NCT00576472|6238538|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792614|NCT00576472|6238539|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792615|NCT00576472|6238540|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
1792616|NCT00576472|6238541|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792617|NCT00576472|6238542|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792618|NCT00576472|6238543|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
1792619|NCT00576472|6238529|P15|MPH In-Lab Phase|Lost to Follow-up|0
1792620|NCT00576472|6238530|P14|MPH In-Lab Phase|Lost to Follow-up|0
1792621|NCT00576472|6238531|P13|MPH In-Lab Phase|Lost to Follow-up|0
1792622|NCT00576472|6238532|P12|MPH In-Lab Phase|Lost to Follow-up|0
1792623|NCT00576472|6238533|P11|MPH In-Lab Phase|Lost to Follow-up|0
1792624|NCT00576472|6238534|P10|MPH In-Lab Phase|Lost to Follow-up|0
1792625|NCT00576472|6238535|P9|MPH In-Lab Phase|Lost to Follow-up|0
1792626|NCT00576472|6238536|P8|MPH In-Lab Phase|Lost to Follow-up|0
1792627|NCT00576472|6238537|P7|MPH In-Lab Phase|Lost to Follow-up|0
1792628|NCT00576472|6238538|P6|MPH In-Lab Phase|Lost to Follow-up|0
1792629|NCT00576472|6238539|P5|MPH In-Lab Phase|Lost to Follow-up|0
1792630|NCT00576472|6238540|P4|MPH In-Lab Phase|Lost to Follow-up|1
1792631|NCT00576472|6238541|P3|MPH In-Lab Phase|Lost to Follow-up|0
1792632|NCT00576472|6238542|P2|MPH In-Lab Phase|Lost to Follow-up|0
1792633|NCT00576472|6238543|P1|MPH In-Lab Phase|Lost to Follow-up|0
1792634|NCT00576472|6238529|P15|MPH In-Lab Phase|Declined participation in medication pha|0
1792635|NCT00576472|6238530|P14|MPH In-Lab Phase|Declined participation in medication pha|0
1792636|NCT00576472|6238531|P13|MPH In-Lab Phase|Declined participation in medication pha|0
1792637|NCT00576472|6238532|P12|MPH In-Lab Phase|Declined participation in medication pha|0
1792638|NCT00576472|6238533|P11|MPH In-Lab Phase|Declined participation in medication pha|0
1792639|NCT00576472|6238534|P10|MPH In-Lab Phase|Declined participation in medication pha|0
1792640|NCT00576472|6238535|P9|MPH In-Lab Phase|Declined participation in medication pha|0
1792641|NCT00576472|6238536|P8|MPH In-Lab Phase|Declined participation in medication pha|0
1792642|NCT00576472|6238537|P7|MPH In-Lab Phase|Declined participation in medication pha|0
1792643|NCT00576472|6238538|P6|MPH In-Lab Phase|Declined participation in medication pha|0
1792644|NCT00576472|6238539|P5|MPH In-Lab Phase|Declined participation in medication pha|0
1792645|NCT00576472|6238540|P4|MPH In-Lab Phase|Declined participation in medication pha|75
1792646|NCT00576472|6238541|P3|MPH In-Lab Phase|Declined participation in medication pha|0
1792647|NCT00576472|6238542|P2|MPH In-Lab Phase|Declined participation in medication pha|0
1792648|NCT00576472|6238543|P1|MPH In-Lab Phase|Declined participation in medication pha|0
1792649|NCT00576420|6238636|P3|Overall Study|Death|1
1792650|NCT00576420|6238637|P2|Overall Study|Death|0
1792651|NCT00576420|6238638|P1|Overall Study|Death|0
1792654|NCT00576381|6238815|P1|Overall Study|Adverse Event|4
1792655|NCT00576381|6238815|P1|Overall Study|Reoperation|3
1792656|NCT00576316|6238819|P1|Overall Study|Protocol Violation|9
1792657|NCT00576316|6238819|P1|Overall Study|Withdrawal by Subject|2
1792658|NCT00576316|6238819|P1|Overall Study|Adverse Event|9
1792659|NCT00576303|6238824|P1|Long Term Safety Period|Early withdrawal|16
1792660|NCT00576303|6238824|P1|Efficacy Evaluation Period|Early withdrawal|5
1792661|NCT00576303|6238824|P1|Dose Titration Period|Early withdrawal|17
1792662|NCT00576199|6238842|P1|Overall Study|Reason Unspecified|2
1792663|NCT00576199|6238842|P1|Overall Study|Refused Treatment|2
1792664|NCT00576199|6238842|P1|Overall Study|Insufficient Therapeutic Response|14
1792665|NCT00576199|6238842|P1|Overall Study|Adverse Event|12
1792666|NCT00576056|6238855|P1|Overall Study|Physician Decision|1
1792667|NCT00576056|6238855|P1|Overall Study|did not meet eligibility criteria|8
1792668|NCT00576056|6238855|P1|Overall Study|Withdrawal by Subject|2
1792669|NCT00576056|6238855|P1|Overall Study|Lack of Efficacy|1
1792670|NCT00576056|6238855|P1|Overall Study|Death|1
1792671|NCT00576056|6238855|P1|Overall Study|Adverse Event|1
1792672|NCT00575666|6238871|P2|Overall Study|Physician Decision|1
1792673|NCT00575666|6238872|P1|Overall Study|Physician Decision|1
1792674|NCT00575666|6238871|P2|Overall Study|Withdrawal by Subject|2
1792675|NCT00575666|6238872|P1|Overall Study|Withdrawal by Subject|3
1792676|NCT00575588|6238912|P2|Overall Study|Impossible to determine HbA1c|1
1792677|NCT00575588|6238913|P1|Overall Study|Impossible to determine HbA1c|0
1792678|NCT00575588|6238912|P2|Overall Study|Patient moved|3
1792679|NCT00575588|6238913|P1|Overall Study|Patient moved|1
1792680|NCT00575588|6238912|P2|Overall Study|Elevated triglyceride|0
1792681|NCT00575588|6238913|P1|Overall Study|Elevated triglyceride|1
1792682|NCT00575588|6238912|P2|Overall Study|Safety reasons|1
1792683|NCT00575588|6238913|P1|Overall Study|Safety reasons|2
1792684|NCT00575588|6238912|P2|Overall Study|Severe non-compliance to protocol|7
1792685|NCT00575588|6238913|P1|Overall Study|Severe non-compliance to protocol|5
1792686|NCT00575588|6238912|P2|Overall Study|Study specific discontinuation criteria|218
1792687|NCT00575588|6238913|P1|Overall Study|Study specific discontinuation criteria|203
1792688|NCT00575588|6238912|P2|Overall Study|Incorrect enrollment|4
1792689|NCT00575588|6238913|P1|Overall Study|Incorrect enrollment|8
1792690|NCT00575588|6238912|P2|Overall Study|Death|2
1792691|NCT00575588|6238913|P1|Overall Study|Death|4
1792692|NCT00575588|6238912|P2|Overall Study|Lost to Follow-up|3
1792693|NCT00575588|6238913|P1|Overall Study|Lost to Follow-up|1
1792694|NCT00575588|6238912|P2|Overall Study|Withdrawal by Subject|31
1792695|NCT00575588|6238913|P1|Overall Study|Withdrawal by Subject|27
1792696|NCT00575588|6238912|P2|Overall Study|Adverse Event|13
1792697|NCT00575588|6238913|P1|Overall Study|Adverse Event|11
1792698|NCT00575510|6238936|P3|Overall Study|Pregnancy|1
1792699|NCT00575510|6238937|P2|Overall Study|Pregnancy|0
1792700|NCT00575510|6238938|P1|Overall Study|Pregnancy|0
1792701|NCT00575510|6238936|P3|Overall Study|Clinic Called Patient|7
1792702|NCT00575510|6238937|P2|Overall Study|Clinic Called Patient|7
1792703|NCT00575510|6238938|P1|Overall Study|Clinic Called Patient|7
1792704|NCT00575510|6238936|P3|Overall Study|Withdrawal by Subject|0
1792705|NCT00575510|6238937|P2|Overall Study|Withdrawal by Subject|0
1792706|NCT00575510|6238938|P1|Overall Study|Withdrawal by Subject|1
1792707|NCT00575510|6238936|P3|Overall Study|Lost to Follow-up|9
1792708|NCT00575510|6238937|P2|Overall Study|Lost to Follow-up|6
1792709|NCT00575510|6238938|P1|Overall Study|Lost to Follow-up|4
1792710|NCT00575380|6238951|P2|Overall Study|Various|2
1792711|NCT00575380|6238952|P1|Overall Study|Various|0
1792712|NCT00575380|6238951|P2|Overall Study|Adverse Event|1
1792713|NCT00575380|6238952|P1|Overall Study|Adverse Event|0
1792714|NCT00575380|6238951|P2|Overall Study|Withdrawal by Subject|0
1792715|NCT00575380|6238952|P1|Overall Study|Withdrawal by Subject|1
1792716|NCT00575094|6239094|P1|Overall Study|Withdrawal by Subject|1
1792717|NCT00575094|6239094|P1|Overall Study|Adverse Event|2
1792718|NCT00575042|6239098|P1|Overall Study|Lost to Follow-up|1
1792719|NCT00575042|6239098|P1|Overall Study|Adverse Event|2
1792720|NCT00574951|6239149|P1|Overall Study|Ineligible - improper prior treatment|1
1792721|NCT00574912|6239157|P1|Overall Study|Physician Decision|2
1792722|NCT00574912|6239157|P1|Overall Study|scheduling conflicts|3
1792723|NCT00574912|6239157|P1|Overall Study|Could not place IV lines.|3
1792724|NCT00574873|6239171|P2|Overall Study|Extension Study|0
1792725|NCT00574873|6239172|P1|Overall Study|Extension Study|126
1792726|NCT00574873|6239171|P2|Overall Study|Blank, site closed per local regulations|2
1792727|NCT00574873|6239172|P1|Overall Study|Blank, site closed per local regulations|2
1792728|NCT00574873|6239171|P2|Overall Study|Discontinuation of study by sponsor|199
1792729|NCT00574873|6239172|P1|Overall Study|Discontinuation of study by sponsor|5
1792730|NCT00574873|6239171|P2|Overall Study|Other|4
1792731|NCT00574873|6239172|P1|Overall Study|Other|40
1792732|NCT00574873|6239171|P2|Overall Study|Lost to Follow-up|5
1792733|NCT00574873|6239172|P1|Overall Study|Lost to Follow-up|14
1792734|NCT00574873|6239171|P2|Overall Study|Death|14
1792735|NCT00574873|6239172|P1|Overall Study|Death|15
1792736|NCT00574873|6239171|P2|Overall Study|Investigator request|8
1792737|NCT00574873|6239172|P1|Overall Study|Investigator request|18
1792738|NCT00574873|6239171|P2|Overall Study|Withdrawal by Subject|19
1792739|NCT00574873|6239172|P1|Overall Study|Withdrawal by Subject|18
1792740|NCT00574847|6239190|P2|Overall Study|Did not receive medication (declined)|5
1792741|NCT00574847|6239191|P1|Overall Study|Did not receive medication (declined)|2
1792742|NCT00574847|6239190|P2|Overall Study|Physician Decision|0
1792743|NCT00574847|6239191|P1|Overall Study|Physician Decision|1
1792744|NCT00574847|6239190|P2|Overall Study|Withdrawal by Subject|2
1792745|NCT00574847|6239191|P1|Overall Study|Withdrawal by Subject|2
1792746|NCT00574847|6239190|P2|Overall Study|Death|0
1792747|NCT00574847|6239191|P1|Overall Study|Death|1
1792748|NCT00574847|6239190|P2|Overall Study|Adverse Event|0
1792749|NCT00574847|6239191|P1|Overall Study|Adverse Event|2
1792750|NCT00574795|6239236|P1|Toddler Dose|Withdrawal by Subject|1
1792751|NCT00574795|6239236|P1|After Infant Series|Adverse Event|2
1792752|NCT00574795|6239236|P1|After Infant Series|Withdrawal by Subject|1
1792753|NCT00574795|6239236|P1|Infant Series|Adverse Event|1
1792754|NCT00574795|6239236|P1|Infant Series|Protocol Violation|2
1792755|NCT00574795|6239236|P1|Infant Series|Withdrawal by Subject|2
1792756|NCT00574405|6239319|P2|Overall Study|Withdrawal by Subject|2
1792757|NCT00574405|6239320|P1|Overall Study|Withdrawal by Subject|3
1792758|NCT00574288|6239340|P7|Overall Study|Other|0
1792759|NCT00574288|6239341|P6|Overall Study|Other|0
1792760|NCT00574288|6239342|P5|Overall Study|Other|0
1792761|NCT00574288|6239343|P4|Overall Study|Other|0
1792762|NCT00574288|6239344|P3|Overall Study|Other|0
1792763|NCT00574288|6239345|P2|Overall Study|Other|1
1792764|NCT00574288|6239346|P1|Overall Study|Other|1
1792765|NCT00574288|6239340|P7|Overall Study|Progressive Disease|0
1792766|NCT00574288|6239341|P6|Overall Study|Progressive Disease|0
1792767|NCT00574288|6239342|P5|Overall Study|Progressive Disease|1
1792768|NCT00574288|6239343|P4|Overall Study|Progressive Disease|2
1792769|NCT00574288|6239344|P3|Overall Study|Progressive Disease|3
1792770|NCT00574288|6239345|P2|Overall Study|Progressive Disease|2
1792771|NCT00574288|6239346|P1|Overall Study|Progressive Disease|17
1792772|NCT00574288|6239340|P7|Overall Study|Study Terminated By Sponsor|5
1792773|NCT00574288|6239341|P6|Overall Study|Study Terminated By Sponsor|0
1792774|NCT00574288|6239342|P5|Overall Study|Study Terminated By Sponsor|0
1792775|NCT00574288|6239343|P4|Overall Study|Study Terminated By Sponsor|0
1792776|NCT00574288|6239344|P3|Overall Study|Study Terminated By Sponsor|0
1792777|NCT00574288|6239345|P2|Overall Study|Study Terminated By Sponsor|0
1792778|NCT00574288|6239346|P1|Overall Study|Study Terminated By Sponsor|0
1792779|NCT00574288|6239340|P7|Overall Study|Lost to Follow-up|2
1792780|NCT00574288|6239341|P6|Overall Study|Lost to Follow-up|1
1792781|NCT00574288|6239342|P5|Overall Study|Lost to Follow-up|0
1792782|NCT00574288|6239343|P4|Overall Study|Lost to Follow-up|0
1792783|NCT00574288|6239344|P3|Overall Study|Lost to Follow-up|0
1792784|NCT00574288|6239345|P2|Overall Study|Lost to Follow-up|0
1792785|NCT00574288|6239346|P1|Overall Study|Lost to Follow-up|0
1792786|NCT00574288|6239340|P7|Overall Study|Death|21
1792787|NCT00574288|6239341|P6|Overall Study|Death|25
1792788|NCT00574288|6239342|P5|Overall Study|Death|0
1792789|NCT00574288|6239343|P4|Overall Study|Death|0
1792790|NCT00574288|6239344|P3|Overall Study|Death|0
1792791|NCT00574288|6239345|P2|Overall Study|Death|0
1792792|NCT00574288|6239346|P1|Overall Study|Death|0
1792793|NCT00574288|6239340|P7|Overall Study|Adverse Event|0
1792794|NCT00574288|6239341|P6|Overall Study|Adverse Event|0
1792795|NCT00574288|6239342|P5|Overall Study|Adverse Event|1
1792796|NCT00574288|6239343|P4|Overall Study|Adverse Event|0
1792797|NCT00574288|6239344|P3|Overall Study|Adverse Event|0
1792798|NCT00574288|6239345|P2|Overall Study|Adverse Event|0
1792799|NCT00574288|6239346|P1|Overall Study|Adverse Event|2
1792800|NCT00574275|6239384|P2|Overall Study|Operation for curative intent|1
1792801|NCT00574275|6239385|P1|Overall Study|Operation for curative intent|0
1792802|NCT00574275|6239384|P2|Overall Study|Insurance change|1
1792803|NCT00574275|6239385|P1|Overall Study|Insurance change|0
1792804|NCT00574275|6239384|P2|Overall Study|Patient and Investigator decision|1
1792805|NCT00574275|6239385|P1|Overall Study|Patient and Investigator decision|0
1792806|NCT00574275|6239384|P2|Overall Study|Protocol Violation|1
1792807|NCT00574275|6239385|P1|Overall Study|Protocol Violation|0
1792808|NCT00574275|6239384|P2|Overall Study|Physician Decision|1
1792809|NCT00574275|6239385|P1|Overall Study|Physician Decision|1
1792810|NCT00574275|6239384|P2|Overall Study|Error calculating tumor measurement|0
1792811|NCT00574275|6239385|P1|Overall Study|Error calculating tumor measurement|1
1792812|NCT00574275|6239384|P2|Overall Study|Withdrawal by Subject|17
1792813|NCT00574275|6239385|P1|Overall Study|Withdrawal by Subject|15
1792814|NCT00574275|6239384|P2|Overall Study|Study stopped based on DMC decision|23
1792815|NCT00574275|6239385|P1|Overall Study|Study stopped based on DMC decision|62
1792816|NCT00574275|6239384|P2|Overall Study|Lost to Follow-up|1
1792817|NCT00574275|6239385|P1|Overall Study|Lost to Follow-up|2
1792818|NCT00574275|6239384|P2|Overall Study|Disease progression|146
1792819|NCT00574275|6239385|P1|Overall Study|Disease progression|160
1792820|NCT00574275|6239384|P2|Overall Study|Adverse Event|76
1792821|NCT00574275|6239385|P1|Overall Study|Adverse Event|32
1792822|NCT00574275|6239384|P2|Overall Study|Randomized but not treated|3
1792823|NCT00574275|6239385|P1|Overall Study|Randomized but not treated|2
1792824|NCT00574249|6239403|P2|Overall Study|PPD test taken twice|1
1792825|NCT00574249|6239404|P1|Overall Study|PPD test taken twice|0
1792826|NCT00574249|6239403|P2|Overall Study|Excluded by company|1
1792827|NCT00574249|6239404|P1|Overall Study|Excluded by company|0
1792828|NCT00574249|6239403|P2|Overall Study|Pregnancy|0
1792829|NCT00574249|6239404|P1|Overall Study|Pregnancy|1
1792830|NCT00574249|6239403|P2|Overall Study|Physician Decision|0
1792831|NCT00574249|6239404|P1|Overall Study|Physician Decision|1
1792832|NCT00574249|6239403|P2|Overall Study|Withdrawal by Subject|0
1792833|NCT00574249|6239404|P1|Overall Study|Withdrawal by Subject|3
1792834|NCT00574249|6239403|P2|Overall Study|History of carcinoma|0
1792835|NCT00574249|6239404|P1|Overall Study|History of carcinoma|1
1792836|NCT00574249|6239403|P2|Overall Study|Protocol Violation|2
1792837|NCT00574249|6239404|P1|Overall Study|Protocol Violation|5
1792838|NCT00574249|6239403|P2|Overall Study|Lost to Follow-up|3
1792839|NCT00574249|6239404|P1|Overall Study|Lost to Follow-up|4
1792840|NCT00574249|6239403|P2|Overall Study|Lack of Efficacy|3
1792841|NCT00574249|6239404|P1|Overall Study|Lack of Efficacy|5
1792842|NCT00574249|6239403|P2|Overall Study|Adverse Event|18
1792843|NCT00574249|6239404|P1|Overall Study|Adverse Event|6
1792844|NCT00574145|6239455|P2|Overall Study|Withdrawal by Subject|1
1792845|NCT00574145|6239456|P1|Overall Study|Withdrawal by Subject|2
1792846|NCT00574119|6239466|P1|Overall Study|Physician Decision|1
1792847|NCT00574119|6239466|P1|Overall Study|Withdrawal by Subject|1
1792848|NCT00574119|6239466|P1|Overall Study|Protocol Violation|1
1792849|NCT00574119|6239466|P1|Overall Study|Adverse Event|1
1792850|NCT00574080|6239480|P2|Overall Study|Death|10
1792851|NCT00574080|6239481|P1|Overall Study|Death|10
1792852|NCT00573937|6239550|P2|Overall Study|Study Terminated|1
1792853|NCT00573937|6239551|P1|Overall Study|Study Terminated|0
1792854|NCT00573859|6239565|P1|Smoking Versus Abstinence|Scheduling conflicts|12
1792855|NCT00573859|6239565|P1|Medication Versus Placebo|Scheduling conflicts|12
1792856|NCT00573833|6239571|P1|Overall Study|Not Treated|2
1792857|NCT00573794|6239578|P1|Overall Study|Other|46
1792858|NCT00573794|6239578|P1|Overall Study|Lack of Efficacy|94
1792859|NCT00573794|6239578|P1|Overall Study|Protocol Violation|6
1792860|NCT00573794|6239578|P1|Overall Study|Lost to Follow-up|13
1792861|NCT00573794|6239578|P1|Overall Study|Withdrew Consent|90
1792862|NCT00573794|6239578|P1|Overall Study|Adverse Event|81
1792863|NCT00573768|6239609|P3|Overall Study|Lost to Follow-up|1
1792864|NCT00573768|6239610|P2|Overall Study|Lost to Follow-up|0
1792865|NCT00573768|6239611|P1|Overall Study|Lost to Follow-up|0
1792866|NCT00573768|6239609|P3|Overall Study|Withdrawal by Subject|0
1792867|NCT00573768|6239610|P2|Overall Study|Withdrawal by Subject|1
1792868|NCT00573768|6239611|P1|Overall Study|Withdrawal by Subject|0
1792869|NCT00573768|6239609|P3|Overall Study|Protocol Violation|1
1792870|NCT00573768|6239610|P2|Overall Study|Protocol Violation|0
1792871|NCT00573768|6239611|P1|Overall Study|Protocol Violation|1
1792872|NCT00573768|6239609|P3|Overall Study|Adverse Event|2
1792873|NCT00573768|6239610|P2|Overall Study|Adverse Event|1
1792874|NCT00573768|6239611|P1|Overall Study|Adverse Event|1
1792875|NCT00573755|6239621|P2|Overall Study|Still receiving treatment|0
1792876|NCT00573755|6239622|P1|Overall Study|Still receiving treatment|1
1792877|NCT00573534|6239638|P1|Overall Study|oppositional behavior|3
1792878|NCT00573469|6239679|P3|Overall Study|Other|3
1792879|NCT00573469|6239680|P2|Overall Study|Other|1
1792880|NCT00573469|6239681|P1|Overall Study|Other|5
1792881|NCT00573469|6239679|P3|Overall Study|Withdrawal by Subject|0
1792882|NCT00573469|6239680|P2|Overall Study|Withdrawal by Subject|2
1792883|NCT00573469|6239681|P1|Overall Study|Withdrawal by Subject|0
1792884|NCT00573469|6239679|P3|Overall Study|Adverse Event|1
1792885|NCT00573469|6239680|P2|Overall Study|Adverse Event|1
1792886|NCT00573469|6239681|P1|Overall Study|Adverse Event|1
1792887|NCT00573443|6239704|P3|Open-Label Extension Phase|Other|0
1792888|NCT00573443|6239705|P2|Open-Label Extension Phase|Other|0
1792889|NCT00573443|6239706|P1|Open-Label Extension Phase|Other|2
1792890|NCT00573443|6239704|P3|Open-Label Extension Phase|Protocol Violation|0
1792891|NCT00573443|6239705|P2|Open-Label Extension Phase|Protocol Violation|0
1792892|NCT00573443|6239706|P1|Open-Label Extension Phase|Protocol Violation|2
1792893|NCT00573443|6239704|P3|Open-Label Extension Phase|Withdrawal by Subject|0
1792894|NCT00573443|6239705|P2|Open-Label Extension Phase|Withdrawal by Subject|0
1792895|NCT00573443|6239706|P1|Open-Label Extension Phase|Withdrawal by Subject|3
1792896|NCT00573443|6239704|P3|Open-Label Extension Phase|Serious Adverse Event|0
1792897|NCT00573443|6239705|P2|Open-Label Extension Phase|Serious Adverse Event|0
1792898|NCT00573443|6239706|P1|Open-Label Extension Phase|Serious Adverse Event|5
1792899|NCT00573443|6239704|P3|Open-Label Extension Phase|Adverse Event|0
1792900|NCT00573443|6239705|P2|Open-Label Extension Phase|Adverse Event|0
1792901|NCT00573443|6239706|P1|Open-Label Extension Phase|Adverse Event|3
1792902|NCT00573443|6239704|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
1792903|NCT00573443|6239705|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
1792904|NCT00573443|6239706|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
1792905|NCT00573443|6239704|P3|Open-Label Extension Phase|Lost to Follow-up|0
1792906|NCT00573443|6239705|P2|Open-Label Extension Phase|Lost to Follow-up|0
1792907|NCT00573443|6239706|P1|Open-Label Extension Phase|Lost to Follow-up|1
1792908|NCT00573443|6239704|P3|Double-Blind Phase|Other|3
1792909|NCT00573443|6239705|P2|Double-Blind Phase|Other|2
1792910|NCT00573443|6239706|P1|Double-Blind Phase|Other|0
1792911|NCT00573443|6239704|P3|Double-Blind Phase|Protocol Violation|1
1792912|NCT00573443|6239705|P2|Double-Blind Phase|Protocol Violation|2
1792913|NCT00573443|6239706|P1|Double-Blind Phase|Protocol Violation|0
1792914|NCT00573443|6239704|P3|Double-Blind Phase|Withdrawal by Subject|7
1792915|NCT00573443|6239705|P2|Double-Blind Phase|Withdrawal by Subject|2
1792916|NCT00573443|6239706|P1|Double-Blind Phase|Withdrawal by Subject|2
1792917|NCT00573443|6239704|P3|Double-Blind Phase|Medication refusal due to AE|0
1792918|NCT00573443|6239705|P2|Double-Blind Phase|Medication refusal due to AE|2
1792919|NCT00573443|6239706|P1|Double-Blind Phase|Medication refusal due to AE|2
1792920|NCT00573443|6239704|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
1792921|NCT00573443|6239705|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
1792922|NCT00573443|6239706|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
1792923|NCT00573443|6239704|P3|Double-Blind Phase|Adverse Event|0
1792924|NCT00573443|6239705|P2|Double-Blind Phase|Adverse Event|5
1792925|NCT00573443|6239706|P1|Double-Blind Phase|Adverse Event|1
1792926|NCT00573443|6239704|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
1792927|NCT00573443|6239705|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
1792928|NCT00573443|6239706|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
1792929|NCT00573443|6239704|P3|Double-Blind Phase|Lost to Follow-up|2
1792930|NCT00573443|6239705|P2|Double-Blind Phase|Lost to Follow-up|3
1792931|NCT00573443|6239706|P1|Double-Blind Phase|Lost to Follow-up|1
1792932|NCT00573430|6239736|P3|Overall Study|Eligibility criteria not fulfilled|3
1792933|NCT00573430|6239737|P2|Overall Study|Eligibility criteria not fulfilled|0
1792934|NCT00573430|6239738|P1|Overall Study|Eligibility criteria not fulfilled|0
1792935|NCT00573430|6239736|P3|Overall Study|Protocol Violation|1
1792936|NCT00573430|6239737|P2|Overall Study|Protocol Violation|1
1792937|NCT00573430|6239738|P1|Overall Study|Protocol Violation|0
1792938|NCT00573430|6239736|P3|Overall Study|Withdrawal by Subject|1
1792939|NCT00573430|6239737|P2|Overall Study|Withdrawal by Subject|0
1792940|NCT00573430|6239738|P1|Overall Study|Withdrawal by Subject|1
1792941|NCT00573430|6239736|P3|Overall Study|Adverse Event|2
1792942|NCT00573430|6239737|P2|Overall Study|Adverse Event|0
1792943|NCT00573430|6239738|P1|Overall Study|Adverse Event|0
1792944|NCT00573430|6239736|P3|Overall Study|Incorrect enrollment of randomization|3
1792945|NCT00573430|6239737|P2|Overall Study|Incorrect enrollment of randomization|4
1792946|NCT00573430|6239738|P1|Overall Study|Incorrect enrollment of randomization|0
1792947|NCT00573391|6239760|P2|Overall Study|Death|0
1792948|NCT00573391|6239761|P1|Overall Study|Death|1
1792949|NCT00573391|6239760|P2|Overall Study|study stopped|2
1792950|NCT00573391|6239761|P1|Overall Study|study stopped|2
1792951|NCT00573313|6239771|P4|Overall Study|Protocol Violation|0
1792952|NCT00573313|6239772|P3|Overall Study|Protocol Violation|6
1792953|NCT00573313|6239773|P2|Overall Study|Protocol Violation|0
1792954|NCT00573313|6239774|P1|Overall Study|Protocol Violation|5
1792955|NCT00573248|6239824|P2|Overall Study|scheduling conflicts|11
1792956|NCT00573248|6239825|P1|Overall Study|scheduling conflicts|15
1792957|NCT00573183|6239839|P2|Overall Study|Other|2
1792958|NCT00573183|6239840|P1|Overall Study|Other|5
1792959|NCT00573183|6239839|P2|Overall Study|Incarceration|8
1792960|NCT00573183|6239840|P1|Overall Study|Incarceration|5
1792961|NCT00573183|6239839|P2|Overall Study|Adverse Event|0
1792962|NCT00573183|6239840|P1|Overall Study|Adverse Event|2
1792963|NCT00573183|6239839|P2|Overall Study|Death|1
1792964|NCT00573183|6239840|P1|Overall Study|Death|0
1792965|NCT00573183|6239839|P2|Overall Study|Withdrawal by Subject|2
1792966|NCT00573183|6239840|P1|Overall Study|Withdrawal by Subject|8
1792967|NCT00573183|6239839|P2|Overall Study|Lost to Follow-up|50
1792968|NCT00573183|6239840|P1|Overall Study|Lost to Follow-up|52
1792969|NCT00573170|6239848|P6|Third Treatment Period|Lost to Follow-up|2
1792970|NCT00573170|6239849|P5|Third Treatment Period|Lost to Follow-up|0
1792971|NCT00573170|6239850|P4|Third Treatment Period|Lost to Follow-up|0
1792972|NCT00573170|6239851|P3|Third Treatment Period|Lost to Follow-up|0
1792973|NCT00573170|6239852|P2|Third Treatment Period|Lost to Follow-up|0
1792974|NCT00573170|6239853|P1|Third Treatment Period|Lost to Follow-up|0
1792975|NCT00573170|6239848|P6|Third Treatment Period|Withdrawal by Subject|0
1792976|NCT00573170|6239849|P5|Third Treatment Period|Withdrawal by Subject|0
1792977|NCT00573170|6239850|P4|Third Treatment Period|Withdrawal by Subject|0
1792978|NCT00573170|6239851|P3|Third Treatment Period|Withdrawal by Subject|0
1792979|NCT00573170|6239852|P2|Third Treatment Period|Withdrawal by Subject|0
1792980|NCT00573170|6239853|P1|Third Treatment Period|Withdrawal by Subject|1
1792981|NCT00573170|6239848|P6|Second Washout Period|Other|2
1792982|NCT00573170|6239849|P5|Second Washout Period|Other|6
1792983|NCT00573170|6239850|P4|Second Washout Period|Other|4
1792984|NCT00573170|6239851|P3|Second Washout Period|Other|1
1792985|NCT00573170|6239852|P2|Second Washout Period|Other|2
1792986|NCT00573170|6239853|P1|Second Washout Period|Other|1
1792987|NCT00573170|6239848|P6|Second Washout Period|Lost to Follow-up|0
1792988|NCT00573170|6239849|P5|Second Washout Period|Lost to Follow-up|0
1792989|NCT00573170|6239850|P4|Second Washout Period|Lost to Follow-up|1
1792990|NCT00573170|6239851|P3|Second Washout Period|Lost to Follow-up|0
1792991|NCT00573170|6239852|P2|Second Washout Period|Lost to Follow-up|0
1792992|NCT00573170|6239853|P1|Second Washout Period|Lost to Follow-up|0
1792993|NCT00573170|6239848|P6|Second Washout Period|Withdrawal by Subject|0
1792994|NCT00573170|6239849|P5|Second Washout Period|Withdrawal by Subject|1
1792995|NCT00573170|6239850|P4|Second Washout Period|Withdrawal by Subject|0
1792996|NCT00573170|6239851|P3|Second Washout Period|Withdrawal by Subject|2
1792997|NCT00573170|6239852|P2|Second Washout Period|Withdrawal by Subject|1
1792998|NCT00573170|6239853|P1|Second Washout Period|Withdrawal by Subject|1
1792999|NCT00573170|6239848|P6|Second Washout Period|Protocol Violation|0
1793000|NCT00573170|6239849|P5|Second Washout Period|Protocol Violation|0
1793001|NCT00573170|6239850|P4|Second Washout Period|Protocol Violation|0
1793002|NCT00573170|6239851|P3|Second Washout Period|Protocol Violation|1
1793003|NCT00573170|6239852|P2|Second Washout Period|Protocol Violation|1
1793004|NCT00573170|6239853|P1|Second Washout Period|Protocol Violation|2
1793005|NCT00573170|6239848|P6|Second Washout Period|Adverse Event|0
1793006|NCT00573170|6239849|P5|Second Washout Period|Adverse Event|1
1793007|NCT00573170|6239850|P4|Second Washout Period|Adverse Event|0
1793008|NCT00573170|6239851|P3|Second Washout Period|Adverse Event|0
1793009|NCT00573170|6239852|P2|Second Washout Period|Adverse Event|0
1793010|NCT00573170|6239853|P1|Second Washout Period|Adverse Event|1
1793011|NCT00573170|6239848|P6|First Washout Period|Other|0
1793012|NCT00573170|6239849|P5|First Washout Period|Other|0
1793013|NCT00573170|6239850|P4|First Washout Period|Other|1
1793014|NCT00573170|6239851|P3|First Washout Period|Other|1
1793015|NCT00573170|6239852|P2|First Washout Period|Other|0
1793016|NCT00573170|6239853|P1|First Washout Period|Other|4
1793017|NCT00573170|6239848|P6|First Washout Period|Withdrawal by Subject|3
1793018|NCT00573170|6239849|P5|First Washout Period|Withdrawal by Subject|3
1793019|NCT00573170|6239850|P4|First Washout Period|Withdrawal by Subject|2
1793020|NCT00573170|6239851|P3|First Washout Period|Withdrawal by Subject|0
1793021|NCT00573170|6239852|P2|First Washout Period|Withdrawal by Subject|0
1793022|NCT00573170|6239853|P1|First Washout Period|Withdrawal by Subject|2
1793023|NCT00573170|6239848|P6|First Washout Period|Lost to Follow-up|2
1793024|NCT00573170|6239849|P5|First Washout Period|Lost to Follow-up|0
1793025|NCT00573170|6239850|P4|First Washout Period|Lost to Follow-up|2
1793026|NCT00573170|6239851|P3|First Washout Period|Lost to Follow-up|0
1793027|NCT00573170|6239852|P2|First Washout Period|Lost to Follow-up|1
1793028|NCT00573170|6239853|P1|First Washout Period|Lost to Follow-up|1
1793029|NCT00573170|6239848|P6|First Washout Period|Lack of Efficacy|1
1793030|NCT00573170|6239849|P5|First Washout Period|Lack of Efficacy|0
1793031|NCT00573170|6239850|P4|First Washout Period|Lack of Efficacy|0
1793032|NCT00573170|6239851|P3|First Washout Period|Lack of Efficacy|0
1793033|NCT00573170|6239852|P2|First Washout Period|Lack of Efficacy|0
1793034|NCT00573170|6239853|P1|First Washout Period|Lack of Efficacy|0
1793035|NCT00573170|6239848|P6|First Washout Period|Adverse Event|1
1793036|NCT00573170|6239849|P5|First Washout Period|Adverse Event|0
1793037|NCT00573170|6239850|P4|First Washout Period|Adverse Event|0
1793038|NCT00573170|6239851|P3|First Washout Period|Adverse Event|0
1793039|NCT00573170|6239852|P2|First Washout Period|Adverse Event|1
1793040|NCT00573170|6239853|P1|First Washout Period|Adverse Event|1
1793041|NCT00573170|6239848|P6|First Treatment Period|Did Not Treat Attack 1|0
1793042|NCT00573170|6239849|P5|First Treatment Period|Did Not Treat Attack 1|1
1793043|NCT00573170|6239850|P4|First Treatment Period|Did Not Treat Attack 1|0
1793044|NCT00573170|6239851|P3|First Treatment Period|Did Not Treat Attack 1|0
1793045|NCT00573170|6239852|P2|First Treatment Period|Did Not Treat Attack 1|0
1793046|NCT00573170|6239853|P1|First Treatment Period|Did Not Treat Attack 1|0
1793047|NCT00573157|6239929|P2|Overall Study|Other|1
1793048|NCT00573157|6239930|P1|Overall Study|Other|1
1793049|NCT00573157|6239929|P2|Overall Study|Adverse Event|1
1793050|NCT00573157|6239930|P1|Overall Study|Adverse Event|3
1793051|NCT00573144|6239942|P2|Overall Study|Withdrawal by Subject|3
1793052|NCT00573144|6239943|P1|Overall Study|Withdrawal by Subject|2
1793053|NCT00573131|6239955|P2|Overall Study|Withdrawal by Subject|8
1793054|NCT00573131|6239956|P1|Overall Study|Withdrawal by Subject|10
1793055|NCT00573066|6239962|P1|Overall Study|Postoperative bleeding|1
1793056|NCT00573066|6239962|P1|Overall Study|IV malfunction|1
1793057|NCT00573066|6239962|P1|Overall Study|Exclusion criteria|18
1793058|NCT00572910|6240006|P11|Overall Study|Withdrawal by Subject|1
1793059|NCT00572910|6240007|P10|Overall Study|Withdrawal by Subject|2
1793060|NCT00572910|6240008|P9|Overall Study|Withdrawal by Subject|2
1793061|NCT00572910|6240009|P8|Overall Study|Withdrawal by Subject|2
1793062|NCT00572910|6240010|P7|Overall Study|Withdrawal by Subject|0
1793063|NCT00572910|6240011|P6|Overall Study|Withdrawal by Subject|3
1793064|NCT00572910|6240012|P5|Overall Study|Withdrawal by Subject|1
1793065|NCT00572910|6240013|P4|Overall Study|Withdrawal by Subject|0
1793066|NCT00572910|6240014|P3|Overall Study|Withdrawal by Subject|1
1793067|NCT00572910|6240015|P2|Overall Study|Withdrawal by Subject|0
1793068|NCT00572910|6240016|P1|Overall Study|Withdrawal by Subject|3
1793069|NCT00572910|6240006|P11|Overall Study|Lost to Follow-up|0
1793070|NCT00572910|6240007|P10|Overall Study|Lost to Follow-up|1
1793071|NCT00572910|6240008|P9|Overall Study|Lost to Follow-up|0
1793072|NCT00572910|6240009|P8|Overall Study|Lost to Follow-up|0
1793073|NCT00572910|6240010|P7|Overall Study|Lost to Follow-up|0
1793074|NCT00572910|6240011|P6|Overall Study|Lost to Follow-up|0
1793075|NCT00572910|6240012|P5|Overall Study|Lost to Follow-up|1
1793076|NCT00572910|6240013|P4|Overall Study|Lost to Follow-up|2
1793077|NCT00572910|6240014|P3|Overall Study|Lost to Follow-up|1
1793078|NCT00572910|6240015|P2|Overall Study|Lost to Follow-up|1
1793079|NCT00572910|6240016|P1|Overall Study|Lost to Follow-up|0
1793080|NCT00572910|6240006|P11|Overall Study|Adverse Event|2
1793081|NCT00572910|6240007|P10|Overall Study|Adverse Event|3
1793082|NCT00572910|6240008|P9|Overall Study|Adverse Event|1
1793083|NCT00572910|6240009|P8|Overall Study|Adverse Event|2
1793084|NCT00572910|6240010|P7|Overall Study|Adverse Event|4
1793085|NCT00572910|6240011|P6|Overall Study|Adverse Event|0
1793086|NCT00572910|6240012|P5|Overall Study|Adverse Event|0
1793087|NCT00572910|6240013|P4|Overall Study|Adverse Event|2
1793088|NCT00572910|6240014|P3|Overall Study|Adverse Event|0
1793089|NCT00572910|6240015|P2|Overall Study|Adverse Event|2
1793090|NCT00572910|6240016|P1|Overall Study|Adverse Event|1
1793091|NCT00572832|6240083|P2|Overall Study|Pregnancy|1
1793092|NCT00572832|6240084|P1|Overall Study|Pregnancy|0
1793093|NCT00572832|6240083|P2|Overall Study|Lost to Follow-up|11
1793094|NCT00572832|6240084|P1|Overall Study|Lost to Follow-up|0
1793095|NCT00572728|6240090|P1|Overall Study|Pathology missing|1
1793096|NCT00572728|6240090|P1|Overall Study|FLT2 after second chemotherapy initiated|7
1793097|NCT00572728|6240090|P1|Overall Study|Second chemotherapy not initiated|1
1793098|NCT00572728|6240090|P1|Overall Study|FLT2 not completed|5
1793099|NCT00572728|6240090|P1|Overall Study|First Chemotherapy not initiated|2
1793100|NCT00572728|6240090|P1|Overall Study|FLT1 not completed|4
1793101|NCT00572728|6240090|P1|Overall Study|Offstudy due to complicating disease|1
1793102|NCT00572728|6240090|P1|Overall Study|Enrolled under Amendment 4|5
1793103|NCT00572728|6240090|P1|Overall Study|Ineligible|3
1793104|NCT00572728|6240090|P1|Overall Study|Withdrawal by Subject|10
1793105|NCT00572624|6240104|P2|Overall Study|Health issues unrelated to the study|0
1793106|NCT00572624|6240105|P1|Overall Study|Health issues unrelated to the study|1
1793107|NCT00572624|6240104|P2|Overall Study|Problem with vascular access|0
1793108|NCT00572624|6240105|P1|Overall Study|Problem with vascular access|1
1793109|NCT00572624|6240104|P2|Overall Study|Refused to do the stress test|0
1793110|NCT00572624|6240105|P1|Overall Study|Refused to do the stress test|1
1793111|NCT00572624|6240104|P2|Overall Study|Admitted to being a smoker|0
1793112|NCT00572624|6240105|P1|Overall Study|Admitted to being a smoker|1
1793113|NCT00572624|6240104|P2|Overall Study|Started a new job-- no time for study|0
1793114|NCT00572624|6240105|P1|Overall Study|Started a new job-- no time for study|1
1793115|NCT00572624|6240104|P2|Overall Study|Medication change|0
1793116|NCT00572624|6240105|P1|Overall Study|Medication change|1
1793117|NCT00572624|6240104|P2|Overall Study|Wanted to do a different diet program|0
1793118|NCT00572624|6240105|P1|Overall Study|Wanted to do a different diet program|1
1793119|NCT00572624|6240104|P2|Overall Study|Lost to Follow-up|4
1793120|NCT00572624|6240105|P1|Overall Study|Lost to Follow-up|10
1793121|NCT00572572|6240133|P2|Overall Study|Withdrawal by Subject|6
1793122|NCT00572572|6240134|P1|Overall Study|Withdrawal by Subject|3
1793123|NCT00572533|6240152|P2|Overall Study|Transfer out of Facility|1
1793124|NCT00572533|6240153|P1|Overall Study|Transfer out of Facility|0
1793125|NCT00572533|6240152|P2|Overall Study|Social Issues|0
1793126|NCT00572533|6240153|P1|Overall Study|Social Issues|1
1793127|NCT00572533|6240152|P2|Overall Study|Received Kidney Transplant|1
1793128|NCT00572533|6240153|P1|Overall Study|Received Kidney Transplant|2
1793129|NCT00572533|6240152|P2|Overall Study|Death|1
1793130|NCT00572533|6240153|P1|Overall Study|Death|4
1793131|NCT00572195|6240197|P1|Overall Study|Lost to Follow-up|5
1793132|NCT00572195|6240197|P1|Overall Study|Adverse Event|4
1793133|NCT00572195|6240197|P1|Overall Study|Death|9
1793134|NCT00572195|6240197|P1|Overall Study|Withdrawal by Subject|50
1793135|NCT00572156|6240209|P4|Overall Study|Sponsor Decision|19
1793136|NCT00572156|6240210|P3|Overall Study|Sponsor Decision|17
1793137|NCT00572156|6240211|P2|Overall Study|Sponsor Decision|16
1793138|NCT00572156|6240212|P1|Overall Study|Sponsor Decision|20
1793139|NCT00572156|6240209|P4|Overall Study|Patient/Parent Decision|3
1793140|NCT00572156|6240210|P3|Overall Study|Patient/Parent Decision|4
1793141|NCT00572156|6240211|P2|Overall Study|Patient/Parent Decision|6
1793142|NCT00572156|6240212|P1|Overall Study|Patient/Parent Decision|1
1793143|NCT00572156|6240209|P4|Overall Study|Protocol Violation|2
1793144|NCT00572156|6240210|P3|Overall Study|Protocol Violation|0
1793145|NCT00572156|6240211|P2|Overall Study|Protocol Violation|2
1793146|NCT00572156|6240212|P1|Overall Study|Protocol Violation|1
1793147|NCT00572156|6240209|P4|Overall Study|Lost to Follow-up|0
1793148|NCT00572156|6240210|P3|Overall Study|Lost to Follow-up|1
1793149|NCT00572156|6240211|P2|Overall Study|Lost to Follow-up|1
1793150|NCT00572156|6240212|P1|Overall Study|Lost to Follow-up|1
1793151|NCT00572156|6240209|P4|Overall Study|Adverse Event|1
1793152|NCT00572156|6240210|P3|Overall Study|Adverse Event|5
1793153|NCT00572156|6240211|P2|Overall Study|Adverse Event|1
1793154|NCT00572156|6240212|P1|Overall Study|Adverse Event|3
1793155|NCT00572039|6240283|P2|Overall Study|Ill|1
1793156|NCT00572039|6240284|P1|Overall Study|Ill|5
1793157|NCT00572039|6240283|P2|Overall Study|Death|3
1793158|NCT00572039|6240284|P1|Overall Study|Death|2
1793159|NCT00572039|6240283|P2|Overall Study|Withdrawal by Subject|6
1793160|NCT00572039|6240284|P1|Overall Study|Withdrawal by Subject|9
1793161|NCT00571948|6240316|P2|Overall Study|Parent were afraid of blood colection|5
1793162|NCT00571948|6240317|P1|Overall Study|Parent were afraid of blood colection|2
1793163|NCT00571948|6240316|P2|Overall Study|infant refused study meal|4
1793164|NCT00571948|6240317|P1|Overall Study|infant refused study meal|3
1793165|NCT00571948|6240316|P2|Overall Study|Protocol Violation|3
1793166|NCT00571948|6240317|P1|Overall Study|Protocol Violation|3
1793167|NCT00571948|6240316|P2|Overall Study|Withdrawal by Subject|2
1793168|NCT00571948|6240317|P1|Overall Study|Withdrawal by Subject|1
1793169|NCT00571948|6240316|P2|Overall Study|Lost to Follow-up|0
1793170|NCT00571948|6240317|P1|Overall Study|Lost to Follow-up|2
1793171|NCT00571922|6240325|P2|Overall Study|Completion unknown|36
1793172|NCT00571922|6240326|P1|Overall Study|Completion unknown|36
1793173|NCT00571701|6240336|P2|Second Intervention 12 Months|Withdrawal by Subject|0
1793174|NCT00571701|6240337|P1|Second Intervention 12 Months|Withdrawal by Subject|3
1793175|NCT00571701|6240336|P2|Second Intervention 12 Months|Adverse Event|1
1793176|NCT00571701|6240337|P1|Second Intervention 12 Months|Adverse Event|0
1793177|NCT00571701|6240336|P2|First Intervention 12 Months|Death|0
1793178|NCT00571701|6240337|P1|First Intervention 12 Months|Death|1
1793179|NCT00571701|6240336|P2|First Intervention 12 Months|Withdrawal by Subject|1
1793180|NCT00571701|6240337|P1|First Intervention 12 Months|Withdrawal by Subject|2
1793181|NCT00571688|6240363|P2|Overall Study|subject moved out of the area|0
1793182|NCT00571688|6240364|P1|Overall Study|subject moved out of the area|1
1793183|NCT00571688|6240363|P2|Overall Study|subject did not tolerate Consta|0
1793184|NCT00571688|6240364|P1|Overall Study|subject did not tolerate Consta|1
1793185|NCT00571688|6240363|P2|Overall Study|Lost to Follow-up|6
1793186|NCT00571688|6240364|P1|Overall Study|Lost to Follow-up|3
1793187|NCT00571662|6240370|P1|Overall Study|Adverse Event|5
1793188|NCT00571662|6240370|P1|Overall Study|psychiatric instability|1
1793189|NCT00571662|6240370|P1|Overall Study|Withdrawal by Subject|2
1793190|NCT00571649|6240381|P2|Follow-up Period|Protocol Violation|12
1793191|NCT00571649|6240382|P1|Follow-up Period|Protocol Violation|5
1793192|NCT00571649|6240381|P2|Follow-up Period|Patient convenience|121
1793193|NCT00571649|6240382|P1|Follow-up Period|Patient convenience|136
1793194|NCT00571649|6240381|P2|Follow-up Period|Lost to Follow-up|92
1793195|NCT00571649|6240382|P1|Follow-up Period|Lost to Follow-up|95
1793196|NCT00571649|6240381|P2|Follow-up Period|Physician Decision|13
1793197|NCT00571649|6240382|P1|Follow-up Period|Physician Decision|7
1793198|NCT00571649|6240381|P2|Follow-up Period|Death|133
1793199|NCT00571649|6240382|P1|Follow-up Period|Death|132
1793200|NCT00571649|6240381|P2|Follow-up Period|Withdrawal by Subject|115
1793201|NCT00571649|6240382|P1|Follow-up Period|Withdrawal by Subject|119
1793202|NCT00571649|6240381|P2|Follow-up Period|Clinical endpoint reached|2
1793203|NCT00571649|6240382|P1|Follow-up Period|Clinical endpoint reached|5
1793204|NCT00571649|6240381|P2|Follow-up Period|Adverse Event|40
1793205|NCT00571649|6240382|P1|Follow-up Period|Adverse Event|46
1793206|NCT00571649|6240381|P2|Treatment Period|Technical problems|5
1793207|NCT00571649|6240382|P1|Treatment Period|Technical problems|3
1793208|NCT00571649|6240381|P2|Treatment Period|Protocol Violation|92
1793209|NCT00571649|6240382|P1|Treatment Period|Protocol Violation|90
1793210|NCT00571649|6240381|P2|Treatment Period|Patient convenience|13
1793211|NCT00571649|6240382|P1|Treatment Period|Patient convenience|11
1793212|NCT00571649|6240381|P2|Treatment Period|Non-compliant with study medication|89
1793213|NCT00571649|6240382|P1|Treatment Period|Non-compliant with study medication|88
1793214|NCT00571649|6240381|P2|Treatment Period|Lost to Follow-up|41
1793215|NCT00571649|6240382|P1|Treatment Period|Lost to Follow-up|43
1793216|NCT00571649|6240381|P2|Treatment Period|Physician Decision|9
1793217|NCT00571649|6240382|P1|Treatment Period|Physician Decision|8
1793218|NCT00571649|6240381|P2|Treatment Period|Death|59
1793219|NCT00571649|6240382|P1|Treatment Period|Death|76
1793220|NCT00571649|6240381|P2|Treatment Period|Withdrawal by Subject|255
1793221|NCT00571649|6240382|P1|Treatment Period|Withdrawal by Subject|285
1793222|NCT00571649|6240381|P2|Treatment Period|Clinical endpoint reached|56
1793223|NCT00571649|6240382|P1|Treatment Period|Clinical endpoint reached|50
1793224|NCT00571649|6240381|P2|Treatment Period|Adverse Event|385
1793225|NCT00571649|6240382|P1|Treatment Period|Adverse Event|438
1793226|NCT00571103|6240480|P1|Overall Study|Lost to Follow-up|1
1793227|NCT00571103|6240480|P1|Overall Study|Withdrawal by Subject|1
1793228|NCT00571064|6240485|P1|Overall Study|Other|2
1793229|NCT00571064|6240485|P1|Overall Study|Withdrawal by Subject|2
1793230|NCT00571064|6240485|P1|Overall Study|Protocol Violation|4
1793231|NCT00571064|6240485|P1|Overall Study|Adverse Event|13
1793232|NCT00571038|6240500|P2|Overall Study|Moved out of state|2
1793233|NCT00571038|6240501|P1|Overall Study|Moved out of state|2
1793234|NCT00571038|6240500|P2|Overall Study|Withdrawal by Subject|3
1793235|NCT00571038|6240501|P1|Overall Study|Withdrawal by Subject|1
1793236|NCT00571038|6240500|P2|Overall Study|Death|5
1793237|NCT00571038|6240501|P1|Overall Study|Death|7
1793238|NCT00571038|6240500|P2|Overall Study|Lost to Follow-up|4
1793239|NCT00571038|6240501|P1|Overall Study|Lost to Follow-up|1
1793240|NCT00570921|6240556|P1|Overall Study|Physician Decision|1
1793241|NCT00570921|6240556|P1|Overall Study|Protocol Violation|1
1793242|NCT00570908|6240562|P1|Overall Study|Withdrawal by Subject|2
1793243|NCT00570908|6240562|P1|Overall Study|Adverse Event|5
1793244|NCT00570778|6240566|P4|Overall Study|Subject no longer requires study drug|0
1793245|NCT00570778|6240567|P3|Overall Study|Subject no longer requires study drug|0
1793246|NCT00570778|6240568|P2|Overall Study|Subject no longer requires study drug|1
1793247|NCT00570778|6240569|P1|Overall Study|Subject no longer requires study drug|0
1793248|NCT00570778|6240566|P4|Overall Study|Lost to Follow-up|0
1793249|NCT00570778|6240567|P3|Overall Study|Lost to Follow-up|1
1793250|NCT00570778|6240568|P2|Overall Study|Lost to Follow-up|0
1793251|NCT00570778|6240569|P1|Overall Study|Lost to Follow-up|0
1793252|NCT00570778|6240566|P4|Overall Study|Unsatisfactory therapeutic effect|0
1793253|NCT00570778|6240567|P3|Overall Study|Unsatisfactory therapeutic effect|0
1793254|NCT00570778|6240568|P2|Overall Study|Unsatisfactory therapeutic effect|0
1793255|NCT00570778|6240569|P1|Overall Study|Unsatisfactory therapeutic effect|1
1793256|NCT00570778|6240566|P4|Overall Study|Abnormal test procedure|0
1793257|NCT00570778|6240567|P3|Overall Study|Abnormal test procedure|0
1793258|NCT00570778|6240568|P2|Overall Study|Abnormal test procedure|0
1793259|NCT00570778|6240569|P1|Overall Study|Abnormal test procedure|1
1793260|NCT00570778|6240566|P4|Overall Study|Subject withdrew consent|1
1793261|NCT00570778|6240567|P3|Overall Study|Subject withdrew consent|0
1793262|NCT00570778|6240568|P2|Overall Study|Subject withdrew consent|1
1793263|NCT00570778|6240569|P1|Overall Study|Subject withdrew consent|0
1793264|NCT00570778|6240566|P4|Overall Study|Adverse Event|1
1793265|NCT00570778|6240567|P3|Overall Study|Adverse Event|4
1793266|NCT00570778|6240568|P2|Overall Study|Adverse Event|1
1793267|NCT00570778|6240569|P1|Overall Study|Adverse Event|0
1793268|NCT00570778|6240566|P4|Overall Study|Protocol deviation|2
1793269|NCT00570778|6240567|P3|Overall Study|Protocol deviation|2
1793270|NCT00570778|6240568|P2|Overall Study|Protocol deviation|1
1793271|NCT00570778|6240569|P1|Overall Study|Protocol deviation|2
1793272|NCT00570739|6240610|P4|Overall Study|Other|3
1793273|NCT00570739|6240611|P3|Overall Study|Other|5
1793274|NCT00570739|6240612|P2|Overall Study|Other|2
1793275|NCT00570739|6240613|P1|Overall Study|Other|0
1793276|NCT00570739|6240610|P4|Overall Study|Met discontinuation criteria|1
1793277|NCT00570739|6240611|P3|Overall Study|Met discontinuation criteria|1
1793278|NCT00570739|6240612|P2|Overall Study|Met discontinuation criteria|0
1793279|NCT00570739|6240613|P1|Overall Study|Met discontinuation criteria|1
1793280|NCT00570739|6240610|P4|Overall Study|Required restricted medication|0
1793281|NCT00570739|6240611|P3|Overall Study|Required restricted medication|1
1793282|NCT00570739|6240612|P2|Overall Study|Required restricted medication|0
1793283|NCT00570739|6240613|P1|Overall Study|Required restricted medication|0
1793284|NCT00570739|6240610|P4|Overall Study|Withdrawal by Subject|5
1793285|NCT00570739|6240611|P3|Overall Study|Withdrawal by Subject|3
1793286|NCT00570739|6240612|P2|Overall Study|Withdrawal by Subject|7
1793287|NCT00570739|6240613|P1|Overall Study|Withdrawal by Subject|7
1793288|NCT00570739|6240610|P4|Overall Study|Physician Decision|0
1793289|NCT00570739|6240611|P3|Overall Study|Physician Decision|0
1793290|NCT00570739|6240612|P2|Overall Study|Physician Decision|1
1793291|NCT00570739|6240613|P1|Overall Study|Physician Decision|1
1793292|NCT00570739|6240610|P4|Overall Study|Lost to Follow-up|1
1793293|NCT00570739|6240611|P3|Overall Study|Lost to Follow-up|4
1793294|NCT00570739|6240612|P2|Overall Study|Lost to Follow-up|5
1793295|NCT00570739|6240613|P1|Overall Study|Lost to Follow-up|4
1793296|NCT00570739|6240610|P4|Overall Study|Adverse Event|2
1793297|NCT00570739|6240611|P3|Overall Study|Adverse Event|2
1793298|NCT00570739|6240612|P2|Overall Study|Adverse Event|6
1793299|NCT00570739|6240613|P1|Overall Study|Adverse Event|8
1793300|NCT00570713|6240765|P2|Overall Study|Discontinuation of Study by the Sponsor|7
1793301|NCT00570713|6240766|P1|Overall Study|Discontinuation of Study by the Sponsor|10
1793302|NCT00570713|6240765|P2|Overall Study|Withdrawal by Subject|3
1793303|NCT00570713|6240766|P1|Overall Study|Withdrawal by Subject|3
1793304|NCT00570713|6240765|P2|Overall Study|Physician Decision|2
1793305|NCT00570713|6240766|P1|Overall Study|Physician Decision|2
1793306|NCT00570713|6240765|P2|Overall Study|Lack of Efficacy|49
1793307|NCT00570713|6240766|P1|Overall Study|Lack of Efficacy|40
1793308|NCT00570713|6240765|P2|Overall Study|Death|7
1793309|NCT00570713|6240766|P1|Overall Study|Death|7
1793310|NCT00570713|6240765|P2|Overall Study|Adverse Event|9
1793311|NCT00570713|6240766|P1|Overall Study|Adverse Event|16
1793312|NCT00570687|6240784|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793313|NCT00570687|6240785|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793314|NCT00570687|6240786|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793315|NCT00570687|6240787|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
1793316|NCT00570687|6240788|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793317|NCT00570687|6240789|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793318|NCT00570687|6240790|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793319|NCT00570687|6240791|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793320|NCT00570687|6240792|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793321|NCT00570687|6240793|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793322|NCT00570687|6240784|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793323|NCT00570687|6240785|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
1793324|NCT00570687|6240786|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793325|NCT00570687|6240787|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793326|NCT00570687|6240788|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793327|NCT00570687|6240789|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793328|NCT00570687|6240790|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793329|NCT00570687|6240791|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793330|NCT00570687|6240792|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793331|NCT00570687|6240793|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793332|NCT00570687|6240784|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1793333|NCT00570687|6240785|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
1793334|NCT00570687|6240786|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1793335|NCT00570687|6240787|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
1793336|NCT00570687|6240788|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1793337|NCT00570687|6240789|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
1793338|NCT00570687|6240790|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793339|NCT00570687|6240791|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793340|NCT00570687|6240792|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793341|NCT00570687|6240793|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
1793342|NCT00570674|6240819|P7|Overall Study|Withdrawal by Subject|0
1793343|NCT00570674|6240820|P6|Overall Study|Withdrawal by Subject|0
1793344|NCT00570674|6240821|P5|Overall Study|Withdrawal by Subject|0
1793345|NCT00570674|6240822|P4|Overall Study|Withdrawal by Subject|0
1793346|NCT00570674|6240823|P3|Overall Study|Withdrawal by Subject|1
1793347|NCT00570674|6240824|P2|Overall Study|Withdrawal by Subject|0
1793348|NCT00570674|6240825|P1|Overall Study|Withdrawal by Subject|0
1793349|NCT00570505|6240848|P1|Overall Study|Other loss to follow-up|4
1793350|NCT00570505|6240848|P1|Overall Study|Lost to Follow-up|23
1793351|NCT00570505|6240848|P1|Overall Study|Withdrawal by Subject|7
1793352|NCT00570505|6240848|P1|Overall Study|Adverse Event|7
1793353|NCT00570492|6240861|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
1793354|NCT00570492|6240862|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
1793355|NCT00570492|6240863|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
1793356|NCT00570492|6240861|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
1793357|NCT00570492|6240862|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
1793358|NCT00570492|6240863|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
1793359|NCT00570492|6240861|P3|52-week Double-blind Treatment Period|Physician Decision|4
1793360|NCT00570492|6240862|P2|52-week Double-blind Treatment Period|Physician Decision|2
1793361|NCT00570492|6240863|P1|52-week Double-blind Treatment Period|Physician Decision|0
1793362|NCT00570492|6240861|P3|52-week Double-blind Treatment Period|Adverse Event|5
1793363|NCT00570492|6240862|P2|52-week Double-blind Treatment Period|Adverse Event|5
1793364|NCT00570492|6240863|P1|52-week Double-blind Treatment Period|Adverse Event|0
1793365|NCT00570492|6240861|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
1793366|NCT00570492|6240862|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
1793367|NCT00570492|6240863|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
1793368|NCT00570492|6240861|P3|52-week Double-blind Treatment Period|Protocol Violation|15
1793369|NCT00570492|6240862|P2|52-week Double-blind Treatment Period|Protocol Violation|12
1793370|NCT00570492|6240863|P1|52-week Double-blind Treatment Period|Protocol Violation|0
1793371|NCT00570492|6240861|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
1793372|NCT00570492|6240862|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
1793373|NCT00570492|6240863|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
1793374|NCT00570492|6240861|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
1793375|NCT00570492|6240862|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
1793376|NCT00570492|6240863|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
1793377|NCT00570492|6240861|P3|16-week Single-blind Baseline Period|Adverse Event|0
1793378|NCT00570492|6240862|P2|16-week Single-blind Baseline Period|Adverse Event|0
1793379|NCT00570492|6240863|P1|16-week Single-blind Baseline Period|Adverse Event|1
1793380|NCT00570492|6240861|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
1793381|NCT00570492|6240862|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
1793382|NCT00570492|6240863|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
1793383|NCT00570492|6240861|P3|16-week Single-blind Baseline Period|Protocol Violation|0
1793384|NCT00570492|6240862|P2|16-week Single-blind Baseline Period|Protocol Violation|0
1793385|NCT00570492|6240863|P1|16-week Single-blind Baseline Period|Protocol Violation|15
1793386|NCT00570492|6240861|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
1793387|NCT00570492|6240862|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
1793388|NCT00570492|6240863|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
1793389|NCT00570492|6240861|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
1793390|NCT00570492|6240862|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
1793391|NCT00570492|6240863|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
1793392|NCT00570492|6240861|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
1793393|NCT00570492|6240862|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
1793394|NCT00570492|6240863|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
1793395|NCT00570401|6240901|P1|Overall Study|Adverse Event|2
1793396|NCT00570323|6240935|P2|Complete Study After Start|Physician Decision|0
1793397|NCT00570323|6240936|P1|Complete Study After Start|Physician Decision|1
1793398|NCT00570323|6240935|P2|Complete Study After Start|Withdrawal by Subject|0
1793399|NCT00570323|6240936|P1|Complete Study After Start|Withdrawal by Subject|2
1793400|NCT00570323|6240935|P2|Complete Study After Start|Lost to Follow-up|1
1793401|NCT00570323|6240936|P1|Complete Study After Start|Lost to Follow-up|0
1793402|NCT00570323|6240935|P2|Started Treatment After Randomization|Physician Decision|0
1793403|NCT00570323|6240936|P1|Started Treatment After Randomization|Physician Decision|1
1793404|NCT00570323|6240935|P2|Started Treatment After Randomization|Protocol Violation|0
1793405|NCT00570323|6240936|P1|Started Treatment After Randomization|Protocol Violation|1
1793406|NCT00570323|6240935|P2|Started Treatment After Randomization|Withdrawal by Subject|1
1793407|NCT00570323|6240936|P1|Started Treatment After Randomization|Withdrawal by Subject|0
1793408|NCT00570310|6240948|P2|Overall Study|Lack of Efficacy|4
1793409|NCT00570310|6240949|P1|Overall Study|Lack of Efficacy|1
1793410|NCT00570310|6240948|P2|Overall Study|Adverse Event|2
1793411|NCT00570310|6240949|P1|Overall Study|Adverse Event|1
1793412|NCT00570232|6240968|P1|Overall Study|discontinued due to noncompliance|2
1793413|NCT00570232|6240968|P1|Overall Study|discontinued due to recurrence|8
1793414|NCT00570232|6240968|P1|Overall Study|discontinued due to medical condition|3
1793415|NCT00570232|6240968|P1|Overall Study|Adverse Event|10
1793416|NCT00570141|6240974|P1|Overall Study|Lost to Follow-up|1
1793417|NCT00570141|6240974|P1|Overall Study|Missed visits|1
1793418|NCT00570141|6240974|P1|Overall Study|Adverse Event|1
1793419|NCT00570063|6240990|P2|Overall Study|Sponsor's Decision|3
1793420|NCT00570063|6240991|P1|Overall Study|Sponsor's Decision|7
1793421|NCT00570063|6240990|P2|Overall Study|Withdrawal by Subject|3
1793422|NCT00570063|6240991|P1|Overall Study|Withdrawal by Subject|4
1793423|NCT00570063|6240990|P2|Overall Study|Lack of Efficacy|1
1793424|NCT00570063|6240991|P1|Overall Study|Lack of Efficacy|0
1793425|NCT00570063|6240990|P2|Overall Study|Adverse Event|1
1793426|NCT00570063|6240991|P1|Overall Study|Adverse Event|4
1793427|NCT00570037|6241057|P2|Overall Study|Could not reach for 6-8 week contact|69
1793428|NCT00570037|6241058|P1|Overall Study|Could not reach for 6-8 week contact|44
1793429|NCT00569946|6241068|P1|Overall Study|Global Deterioration of Health Status|1
1793430|NCT00569946|6241068|P1|Overall Study|Objective Progression or Relapse|42
1793431|NCT00569946|6241068|P1|Overall Study|Adverse Event|16
1793432|NCT00569803|6241100|P8|Overall Study|Withdrawal by Subject|1
1793433|NCT00569803|6241101|P7|Overall Study|Withdrawal by Subject|0
1793434|NCT00569803|6241102|P6|Overall Study|Withdrawal by Subject|0
1793435|NCT00569803|6241103|P5|Overall Study|Withdrawal by Subject|0
1793436|NCT00569803|6241104|P4|Overall Study|Withdrawal by Subject|0
1793437|NCT00569803|6241105|P3|Overall Study|Withdrawal by Subject|0
1793438|NCT00569803|6241106|P2|Overall Study|Withdrawal by Subject|0
1793439|NCT00569803|6241107|P1|Overall Study|Withdrawal by Subject|0
1793440|NCT00569803|6241100|P8|Overall Study|injection syringe leaked during dosing|0
1793441|NCT00569803|6241101|P7|Overall Study|injection syringe leaked during dosing|0
1793442|NCT00569803|6241102|P6|Overall Study|injection syringe leaked during dosing|0
1793443|NCT00569803|6241103|P5|Overall Study|injection syringe leaked during dosing|0
1793444|NCT00569803|6241104|P4|Overall Study|injection syringe leaked during dosing|1
1793445|NCT00569803|6241105|P3|Overall Study|injection syringe leaked during dosing|0
1793446|NCT00569803|6241106|P2|Overall Study|injection syringe leaked during dosing|0
1793447|NCT00569803|6241107|P1|Overall Study|injection syringe leaked during dosing|0
1793448|NCT00569803|6241100|P8|Overall Study|Lost to Follow-up|0
1793449|NCT00569803|6241101|P7|Overall Study|Lost to Follow-up|0
1793450|NCT00569803|6241102|P6|Overall Study|Lost to Follow-up|0
1793451|NCT00569803|6241103|P5|Overall Study|Lost to Follow-up|0
1793452|NCT00569803|6241104|P4|Overall Study|Lost to Follow-up|0
1793453|NCT00569803|6241105|P3|Overall Study|Lost to Follow-up|0
1793454|NCT00569803|6241106|P2|Overall Study|Lost to Follow-up|0
1793455|NCT00569803|6241107|P1|Overall Study|Lost to Follow-up|1
1793456|NCT00569777|6241234|P2|Overall Study|pregnant|0
1793457|NCT00569777|6241235|P1|Overall Study|pregnant|1
1793458|NCT00569777|6241234|P2|Overall Study|did not meet exclusion criteria|2
1793459|NCT00569777|6241235|P1|Overall Study|did not meet exclusion criteria|1
1793460|NCT00569777|6241234|P2|Overall Study|scheduled eye surgery|1
1793461|NCT00569777|6241235|P1|Overall Study|scheduled eye surgery|0
1793462|NCT00569777|6241234|P2|Overall Study|Lost to Follow-up|0
1793463|NCT00569777|6241235|P1|Overall Study|Lost to Follow-up|1
1793464|NCT00569777|6241234|P2|Overall Study|Adverse Event|0
1793465|NCT00569777|6241235|P1|Overall Study|Adverse Event|3
1793466|NCT00569777|6241234|P2|Overall Study|Withdrawal by Subject|0
1793467|NCT00569777|6241235|P1|Overall Study|Withdrawal by Subject|4
1793468|NCT00569582|6241286|P1|Overall Study|Subject was non-compliant.|1
1793469|NCT00569582|6241286|P1|Overall Study|Subject was too ill to travel.|1
1793470|NCT00569582|6241286|P1|Overall Study|Adverse Event|7
1793471|NCT00569582|6241286|P1|Overall Study|Death|2
1793472|NCT00569582|6241286|P1|Overall Study|Withdrawal by Subject|5
1793473|NCT00569374|6241302|P1|Overall Study|Withdrawal by Subject|4
1793474|NCT00569270|6241321|P2|Period: First Intervention|Protocol Violation|1
1793475|NCT00569270|6241322|P1|Period: First Intervention|Protocol Violation|0
1793476|NCT00569231|6241357|P1|Overall Study|Non-compliance|2
1793477|NCT00569231|6241357|P1|Overall Study|Car accident injury|1
1793478|NCT00569231|6241357|P1|Overall Study|Withdrawal by Subject|1
1793479|NCT00569231|6241357|P1|Overall Study|Airfare expense|2
1793480|NCT00569231|6241357|P1|Overall Study|Study unrelated surgery|1
1793481|NCT00569166|6241395|P3|Overall Study|Lost to Follow-up|1
1793482|NCT00569166|6241396|P2|Overall Study|Lost to Follow-up|1
1793483|NCT00569166|6241397|P1|Overall Study|Lost to Follow-up|2
1793484|NCT00569166|6241395|P3|Overall Study|Withdrawal by Subject|3
1793485|NCT00569166|6241396|P2|Overall Study|Withdrawal by Subject|5
1793486|NCT00569166|6241397|P1|Overall Study|Withdrawal by Subject|7
1793487|NCT00569127|6241431|P2|Overall Study|Still on Treatment|3
1793488|NCT00569127|6241432|P1|Overall Study|Still on Treatment|7
1793489|NCT00569127|6241431|P2|Overall Study|Not Eligible|11
1793490|NCT00569127|6241432|P1|Overall Study|Not Eligible|14
1793491|NCT00569127|6241431|P2|Overall Study|Lost to Follow-up|3
1793492|NCT00569127|6241432|P1|Overall Study|Lost to Follow-up|0
1793493|NCT00569127|6241431|P2|Overall Study|Other|19
1793494|NCT00569127|6241432|P1|Overall Study|Other|20
1793495|NCT00569127|6241431|P2|Overall Study|Death|3
1793496|NCT00569127|6241432|P1|Overall Study|Death|4
1793497|NCT00569127|6241431|P2|Overall Study|Progression|100
1793498|NCT00569127|6241432|P1|Overall Study|Progression|99
1793499|NCT00569127|6241431|P2|Overall Study|Withdrawal by Subject|27
1793500|NCT00569127|6241432|P1|Overall Study|Withdrawal by Subject|13
1793501|NCT00569127|6241431|P2|Overall Study|Adverse Event|47
1793502|NCT00569127|6241432|P1|Overall Study|Adverse Event|57
1793503|NCT00568958|6241467|P2|Follow-Up|Adverse Event|0
1793504|NCT00568958|6241468|P1|Follow-Up|Adverse Event|1
1793505|NCT00568958|6241467|P2|Follow-Up|Family Emergency|0
1793506|NCT00568958|6241468|P1|Follow-Up|Family Emergency|1
1793507|NCT00568958|6241467|P2|Follow-Up|Physician Decision|1
1793508|NCT00568958|6241468|P1|Follow-Up|Physician Decision|1
1793509|NCT00568958|6241467|P2|Follow-Up|Withdrawal by Subject|6
1793510|NCT00568958|6241468|P1|Follow-Up|Withdrawal by Subject|6
1793511|NCT00568958|6241467|P2|Allocation|Physician Decision|0
1793512|NCT00568958|6241468|P1|Allocation|Physician Decision|2
1793513|NCT00568958|6241467|P2|Allocation|Withdrawal by Subject|3
1793514|NCT00568958|6241468|P1|Allocation|Withdrawal by Subject|7
1793515|NCT00568776|6241515|P4|Overall Study|Miscellaeneous|4
1793516|NCT00568776|6241516|P3|Overall Study|Miscellaeneous|1
1793517|NCT00568776|6241517|P2|Overall Study|Miscellaeneous|3
1793518|NCT00568776|6241518|P1|Overall Study|Miscellaeneous|3
1793519|NCT00568776|6241515|P4|Overall Study|Sponsor Decision|42
1793520|NCT00568776|6241516|P3|Overall Study|Sponsor Decision|41
1793521|NCT00568776|6241517|P2|Overall Study|Sponsor Decision|2
1793522|NCT00568776|6241518|P1|Overall Study|Sponsor Decision|2
1793523|NCT00568776|6241515|P4|Overall Study|Loss of Caregiver|2
1793524|NCT00568776|6241516|P3|Overall Study|Loss of Caregiver|1
1793525|NCT00568776|6241517|P2|Overall Study|Loss of Caregiver|2
1793526|NCT00568776|6241518|P1|Overall Study|Loss of Caregiver|0
1793527|NCT00568776|6241515|P4|Overall Study|Withdrawal by Subject|7
1793528|NCT00568776|6241516|P3|Overall Study|Withdrawal by Subject|13
1793529|NCT00568776|6241517|P2|Overall Study|Withdrawal by Subject|15
1793530|NCT00568776|6241518|P1|Overall Study|Withdrawal by Subject|13
1793531|NCT00568776|6241515|P4|Overall Study|Protocol Violation|1
1793532|NCT00568776|6241516|P3|Overall Study|Protocol Violation|1
1793533|NCT00568776|6241517|P2|Overall Study|Protocol Violation|0
1793534|NCT00568776|6241518|P1|Overall Study|Protocol Violation|1
1793535|NCT00568776|6241515|P4|Overall Study|Lost to Follow-up|1
1793536|NCT00568776|6241516|P3|Overall Study|Lost to Follow-up|1
1793537|NCT00568776|6241517|P2|Overall Study|Lost to Follow-up|1
1793538|NCT00568776|6241518|P1|Overall Study|Lost to Follow-up|1
1793539|NCT00568776|6241515|P4|Overall Study|Lack of Efficacy|4
1793540|NCT00568776|6241516|P3|Overall Study|Lack of Efficacy|2
1793541|NCT00568776|6241517|P2|Overall Study|Lack of Efficacy|2
1793542|NCT00568776|6241518|P1|Overall Study|Lack of Efficacy|2
1793543|NCT00568776|6241515|P4|Overall Study|Physician Decision|0
1793544|NCT00568776|6241516|P3|Overall Study|Physician Decision|0
1793545|NCT00568776|6241517|P2|Overall Study|Physician Decision|2
1793546|NCT00568776|6241518|P1|Overall Study|Physician Decision|0
1793547|NCT00568776|6241515|P4|Overall Study|Death|3
1793548|NCT00568776|6241516|P3|Overall Study|Death|4
1793549|NCT00568776|6241517|P2|Overall Study|Death|1
1793550|NCT00568776|6241518|P1|Overall Study|Death|0
1793551|NCT00568776|6241515|P4|Overall Study|Adverse Event|8
1793552|NCT00568776|6241516|P3|Overall Study|Adverse Event|10
1793553|NCT00568776|6241517|P2|Overall Study|Adverse Event|8
1793554|NCT00568776|6241518|P1|Overall Study|Adverse Event|8
1793555|NCT00568685|6241567|P3|Overall Study|Protocol Violation|0
1793556|NCT00568685|6241568|P2|Overall Study|Protocol Violation|0
1793557|NCT00568685|6241569|P1|Overall Study|Protocol Violation|1
1793558|NCT00568685|6241567|P3|Overall Study|Withdrawal by Subject|2
1793559|NCT00568685|6241568|P2|Overall Study|Withdrawal by Subject|2
1793560|NCT00568685|6241569|P1|Overall Study|Withdrawal by Subject|7
1793561|NCT00568685|6241567|P3|Overall Study|Adverse Event|3
1793562|NCT00568685|6241568|P2|Overall Study|Adverse Event|3
1793563|NCT00568685|6241569|P1|Overall Study|Adverse Event|2
1793564|NCT00568555|6241626|P2|Overall Study|Withdrawal by Subject|1
1793565|NCT00568555|6241627|P1|Overall Study|Withdrawal by Subject|1
1793566|NCT00568451|6241645|P4|Overall Study|Disease Progression|7
1793567|NCT00568451|6241646|P3|Overall Study|Disease Progression|2
1793568|NCT00568451|6241647|P2|Overall Study|Disease Progression|0
1793569|NCT00568451|6241648|P1|Overall Study|Disease Progression|0
1793570|NCT00568399|6241664|P1|Overall Study|Withdrawal by Subject|8
1793571|NCT00568399|6241664|P1|Overall Study|Adverse Event|5
1793572|NCT00568399|6241664|P1|Overall Study|Death|2
1793573|NCT00568334|6241679|P2|Overall Study|Lost to Follow-up|0
1793574|NCT00568334|6241680|P1|Overall Study|Lost to Follow-up|1
1793575|NCT00568334|6241679|P2|Overall Study|Withdrawal by Subject|1
1793576|NCT00568334|6241680|P1|Overall Study|Withdrawal by Subject|0
1793577|NCT00568178|6241706|P6|Open Label Extension|Withdrawal by Subject|4
1793578|NCT00568178|6241707|P5|Open Label Extension|Withdrawal by Subject|4
1793579|NCT00568178|6241708|P4|Open Label Extension|Withdrawal by Subject|0
1793580|NCT00568178|6241709|P3|Open Label Extension|Withdrawal by Subject|0
1793581|NCT00568178|6241710|P2|Open Label Extension|Withdrawal by Subject|0
1793582|NCT00568178|6241711|P1|Open Label Extension|Withdrawal by Subject|0
1793583|NCT00568178|6241706|P6|Open Label Extension|Termination of Trial|47
1793584|NCT00568178|6241707|P5|Open Label Extension|Termination of Trial|45
1793585|NCT00568178|6241708|P4|Open Label Extension|Termination of Trial|0
1793586|NCT00568178|6241709|P3|Open Label Extension|Termination of Trial|0
1793587|NCT00568178|6241710|P2|Open Label Extension|Termination of Trial|0
1793588|NCT00568178|6241711|P1|Open Label Extension|Termination of Trial|0
1793589|NCT00568178|6241706|P6|Open Label Extension|Progressive Disease|1
1793590|NCT00568178|6241707|P5|Open Label Extension|Progressive Disease|3
1793591|NCT00568178|6241708|P4|Open Label Extension|Progressive Disease|0
1793592|NCT00568178|6241709|P3|Open Label Extension|Progressive Disease|0
1793593|NCT00568178|6241710|P2|Open Label Extension|Progressive Disease|0
1793594|NCT00568178|6241711|P1|Open Label Extension|Progressive Disease|0
1793595|NCT00568178|6241706|P6|Open Label Extension|Pregnancy|1
1793596|NCT00568178|6241707|P5|Open Label Extension|Pregnancy|0
1793597|NCT00568178|6241708|P4|Open Label Extension|Pregnancy|0
1793598|NCT00568178|6241709|P3|Open Label Extension|Pregnancy|0
1793599|NCT00568178|6241710|P2|Open Label Extension|Pregnancy|0
1793600|NCT00568178|6241711|P1|Open Label Extension|Pregnancy|0
1793601|NCT00568178|6241706|P6|Open Label Extension|Physician Decision|8
1793602|NCT00568178|6241707|P5|Open Label Extension|Physician Decision|9
1793603|NCT00568178|6241708|P4|Open Label Extension|Physician Decision|0
1793604|NCT00568178|6241709|P3|Open Label Extension|Physician Decision|0
1793605|NCT00568178|6241710|P2|Open Label Extension|Physician Decision|0
1793606|NCT00568178|6241711|P1|Open Label Extension|Physician Decision|0
1793607|NCT00568178|6241706|P6|Open Label Extension|Lost to Follow-up|11
1793608|NCT00568178|6241707|P5|Open Label Extension|Lost to Follow-up|6
1793609|NCT00568178|6241708|P4|Open Label Extension|Lost to Follow-up|0
1793610|NCT00568178|6241709|P3|Open Label Extension|Lost to Follow-up|0
1793611|NCT00568178|6241710|P2|Open Label Extension|Lost to Follow-up|0
1793612|NCT00568178|6241711|P1|Open Label Extension|Lost to Follow-up|0
1793613|NCT00568178|6241706|P6|Open Label Extension|Protocol Violation|0
1793614|NCT00568178|6241707|P5|Open Label Extension|Protocol Violation|1
1793615|NCT00568178|6241708|P4|Open Label Extension|Protocol Violation|0
1793616|NCT00568178|6241709|P3|Open Label Extension|Protocol Violation|0
1793617|NCT00568178|6241710|P2|Open Label Extension|Protocol Violation|0
1793618|NCT00568178|6241711|P1|Open Label Extension|Protocol Violation|0
1793619|NCT00568178|6241706|P6|Open Label Extension|Adverse Event|8
1793620|NCT00568178|6241707|P5|Open Label Extension|Adverse Event|11
1793621|NCT00568178|6241708|P4|Open Label Extension|Adverse Event|0
1793622|NCT00568178|6241709|P3|Open Label Extension|Adverse Event|0
1793623|NCT00568178|6241710|P2|Open Label Extension|Adverse Event|0
1793624|NCT00568178|6241711|P1|Open Label Extension|Adverse Event|0
1793625|NCT00568178|6241706|P6|Double Blind Base Study|Progressive Disease|0
1793626|NCT00568178|6241707|P5|Double Blind Base Study|Progressive Disease|0
1793627|NCT00568178|6241708|P4|Double Blind Base Study|Progressive Disease|1
1793628|NCT00568178|6241709|P3|Double Blind Base Study|Progressive Disease|0
1793629|NCT00568178|6241710|P2|Double Blind Base Study|Progressive Disease|0
1793630|NCT00568178|6241711|P1|Double Blind Base Study|Progressive Disease|0
1793631|NCT00568178|6241706|P6|Double Blind Base Study|Withdrawal by Subject|0
1793632|NCT00568178|6241707|P5|Double Blind Base Study|Withdrawal by Subject|0
1793633|NCT00568178|6241708|P4|Double Blind Base Study|Withdrawal by Subject|0
1793634|NCT00568178|6241709|P3|Double Blind Base Study|Withdrawal by Subject|0
1793635|NCT00568178|6241710|P2|Double Blind Base Study|Withdrawal by Subject|1
1793636|NCT00568178|6241711|P1|Double Blind Base Study|Withdrawal by Subject|1
1793637|NCT00568178|6241706|P6|Double Blind Base Study|Protocol Violation|0
1793638|NCT00568178|6241707|P5|Double Blind Base Study|Protocol Violation|0
1793639|NCT00568178|6241708|P4|Double Blind Base Study|Protocol Violation|0
1793640|NCT00568178|6241709|P3|Double Blind Base Study|Protocol Violation|0
1793641|NCT00568178|6241710|P2|Double Blind Base Study|Protocol Violation|2
1793642|NCT00568178|6241711|P1|Double Blind Base Study|Protocol Violation|3
1793643|NCT00568178|6241706|P6|Double Blind Base Study|Physician Decision|0
1793644|NCT00568178|6241707|P5|Double Blind Base Study|Physician Decision|0
1793645|NCT00568178|6241708|P4|Double Blind Base Study|Physician Decision|1
1793646|NCT00568178|6241709|P3|Double Blind Base Study|Physician Decision|0
1793647|NCT00568178|6241710|P2|Double Blind Base Study|Physician Decision|1
1793648|NCT00568178|6241711|P1|Double Blind Base Study|Physician Decision|1
1793649|NCT00568178|6241706|P6|Double Blind Base Study|Lost to Follow-up|0
1793650|NCT00568178|6241707|P5|Double Blind Base Study|Lost to Follow-up|0
1793651|NCT00568178|6241708|P4|Double Blind Base Study|Lost to Follow-up|1
1793652|NCT00568178|6241709|P3|Double Blind Base Study|Lost to Follow-up|0
1793653|NCT00568178|6241710|P2|Double Blind Base Study|Lost to Follow-up|0
1793654|NCT00568178|6241711|P1|Double Blind Base Study|Lost to Follow-up|1
1793655|NCT00568178|6241706|P6|Double Blind Base Study|Adverse Event|0
1793656|NCT00568178|6241707|P5|Double Blind Base Study|Adverse Event|0
1793657|NCT00568178|6241708|P4|Double Blind Base Study|Adverse Event|2
1793658|NCT00568178|6241709|P3|Double Blind Base Study|Adverse Event|1
1793659|NCT00568178|6241710|P2|Double Blind Base Study|Adverse Event|2
1793660|NCT00568178|6241711|P1|Double Blind Base Study|Adverse Event|0
1793661|NCT00568061|6241742|P2|Overall Study|Adverse Event|1
1793662|NCT00568061|6241743|P1|Overall Study|Adverse Event|0
1793663|NCT00568061|6241742|P2|Overall Study|Inclusion / exclusion criteria|1
1793664|NCT00568061|6241743|P1|Overall Study|Inclusion / exclusion criteria|5
1793665|NCT00567996|6241806|P3|Overall Study|Patient's inability to use the device|0
1793666|NCT00567996|6241807|P2|Overall Study|Patient's inability to use the device|1
1793667|NCT00567996|6241808|P1|Overall Study|Patient's inability to use the device|0
1793668|NCT00567996|6241806|P3|Overall Study|Death|2
1793669|NCT00567996|6241807|P2|Overall Study|Death|0
1793670|NCT00567996|6241808|P1|Overall Study|Death|1
1793671|NCT00567996|6241806|P3|Overall Study|Administrative problems|0
1793672|NCT00567996|6241807|P2|Overall Study|Administrative problems|1
1793673|NCT00567996|6241808|P1|Overall Study|Administrative problems|1
1793674|NCT00567996|6241806|P3|Overall Study|Unsatisfactory therapeutic effect|15
1793675|NCT00567996|6241807|P2|Overall Study|Unsatisfactory therapeutic effect|2
1793676|NCT00567996|6241808|P1|Overall Study|Unsatisfactory therapeutic effect|1
1793677|NCT00567996|6241806|P3|Overall Study|Lost to Follow-up|2
1793678|NCT00567996|6241807|P2|Overall Study|Lost to Follow-up|5
1793679|NCT00567996|6241808|P1|Overall Study|Lost to Follow-up|2
1793680|NCT00567996|6241806|P3|Overall Study|Abnormal test procedure result(s)|1
1793681|NCT00567996|6241807|P2|Overall Study|Abnormal test procedure result(s)|1
1793682|NCT00567996|6241808|P1|Overall Study|Abnormal test procedure result(s)|2
1793683|NCT00567996|6241806|P3|Overall Study|Abnormal Lab value(s)|2
1793684|NCT00567996|6241807|P2|Overall Study|Abnormal Lab value(s)|1
1793685|NCT00567996|6241808|P1|Overall Study|Abnormal Lab value(s)|2
1793686|NCT00567996|6241806|P3|Overall Study|Withdrawal by Subject|22
1793687|NCT00567996|6241807|P2|Overall Study|Withdrawal by Subject|12
1793688|NCT00567996|6241808|P1|Overall Study|Withdrawal by Subject|8
1793689|NCT00567996|6241806|P3|Overall Study|Protocol Deviation|13
1793690|NCT00567996|6241807|P2|Overall Study|Protocol Deviation|11
1793691|NCT00567996|6241808|P1|Overall Study|Protocol Deviation|9
1793692|NCT00567996|6241806|P3|Overall Study|Adverse Event|13
1793693|NCT00567996|6241807|P2|Overall Study|Adverse Event|16
1793694|NCT00567996|6241808|P1|Overall Study|Adverse Event|18
1793695|NCT00567892|6241824|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
1793696|NCT00567892|6241825|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1793697|NCT00567892|6241826|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1793698|NCT00567892|6241827|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1793699|NCT00567892|6241824|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
1793700|NCT00567892|6241825|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
1793701|NCT00567892|6241826|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1793702|NCT00567892|6241827|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
1793703|NCT00567879|6241845|P6|Overall Study|Disease progression|3
1793704|NCT00567879|6241846|P5|Overall Study|Disease progression|11
1793705|NCT00567879|6241847|P4|Overall Study|Disease progression|5
1793706|NCT00567879|6241848|P3|Overall Study|Disease progression|15
1793707|NCT00567879|6241849|P2|Overall Study|Disease progression|7
1793708|NCT00567879|6241850|P1|Overall Study|Disease progression|5
1793709|NCT00567879|6241845|P6|Overall Study|New cancer therapy|0
1793710|NCT00567879|6241846|P5|Overall Study|New cancer therapy|0
1793711|NCT00567879|6241847|P4|Overall Study|New cancer therapy|0
1793712|NCT00567879|6241848|P3|Overall Study|New cancer therapy|1
1793713|NCT00567879|6241849|P2|Overall Study|New cancer therapy|0
1793714|NCT00567879|6241850|P1|Overall Study|New cancer therapy|0
1793715|NCT00567879|6241845|P6|Overall Study|Withdrawal by Subject|0
1793716|NCT00567879|6241846|P5|Overall Study|Withdrawal by Subject|0
1793717|NCT00567879|6241847|P4|Overall Study|Withdrawal by Subject|1
1793718|NCT00567879|6241848|P3|Overall Study|Withdrawal by Subject|3
1793719|NCT00567879|6241849|P2|Overall Study|Withdrawal by Subject|0
1793720|NCT00567879|6241850|P1|Overall Study|Withdrawal by Subject|0
1793721|NCT00567879|6241845|P6|Overall Study|Abnormal test procedure(s)|0
1793722|NCT00567879|6241846|P5|Overall Study|Abnormal test procedure(s)|0
1793723|NCT00567879|6241847|P4|Overall Study|Abnormal test procedure(s)|0
1793724|NCT00567879|6241848|P3|Overall Study|Abnormal test procedure(s)|1
1793725|NCT00567879|6241849|P2|Overall Study|Abnormal test procedure(s)|0
1793726|NCT00567879|6241850|P1|Overall Study|Abnormal test procedure(s)|0
1793727|NCT00567879|6241845|P6|Overall Study|Adverse Event|0
1793728|NCT00567879|6241846|P5|Overall Study|Adverse Event|1
1793729|NCT00567879|6241847|P4|Overall Study|Adverse Event|0
1793730|NCT00567879|6241848|P3|Overall Study|Adverse Event|1
1793731|NCT00567879|6241849|P2|Overall Study|Adverse Event|0
1793732|NCT00567879|6241850|P1|Overall Study|Adverse Event|2
1793733|NCT00567593|6241917|P1|Overall Study|Physician Decision|1
1793734|NCT00567593|6241917|P1|Overall Study|Adverse Event|1
1793735|NCT00567567|6241924|P3|Overall Study|Unable adequate stem cell for transplant|2
1793736|NCT00567567|6241925|P2|Overall Study|Unable adequate stem cell for transplant|0
1793737|NCT00567567|6241926|P1|Overall Study|Unable adequate stem cell for transplant|0
1793738|NCT00567567|6241924|P3|Overall Study|Enrolled another COG therapeutic study|0
1793739|NCT00567567|6241925|P2|Overall Study|Enrolled another COG therapeutic study|80
1793740|NCT00567567|6241926|P1|Overall Study|Enrolled another COG therapeutic study|99
1793741|NCT00567567|6241924|P3|Overall Study|Refusal by patient/parent/guardian|122
1793742|NCT00567567|6241925|P2|Overall Study|Refusal by patient/parent/guardian|16
1793743|NCT00567567|6241926|P1|Overall Study|Refusal by patient/parent/guardian|9
1793744|NCT00567567|6241924|P3|Overall Study|Ineligible|9
1793745|NCT00567567|6241925|P2|Overall Study|Ineligible|0
1793746|NCT00567567|6241926|P1|Overall Study|Ineligible|4
1793747|NCT00567567|6241924|P3|Overall Study|Withdrawal by Subject|2
1793748|NCT00567567|6241925|P2|Overall Study|Withdrawal by Subject|0
1793749|NCT00567567|6241926|P1|Overall Study|Withdrawal by Subject|0
1793750|NCT00567567|6241924|P3|Overall Study|Physician Decision|84
1793751|NCT00567567|6241925|P2|Overall Study|Physician Decision|18
1793752|NCT00567567|6241926|P1|Overall Study|Physician Decision|16
1793753|NCT00567567|6241924|P3|Overall Study|Lost to Follow-up|1
1793754|NCT00567567|6241925|P2|Overall Study|Lost to Follow-up|0
1793755|NCT00567567|6241926|P1|Overall Study|Lost to Follow-up|0
1793756|NCT00567567|6241924|P3|Overall Study|Lack of Efficacy|48
1793757|NCT00567567|6241925|P2|Overall Study|Lack of Efficacy|17
1793758|NCT00567567|6241926|P1|Overall Study|Lack of Efficacy|16
1793759|NCT00567567|6241924|P3|Overall Study|Death|5
1793760|NCT00567567|6241925|P2|Overall Study|Death|1
1793761|NCT00567567|6241926|P1|Overall Study|Death|8
1793762|NCT00567567|6241924|P3|Overall Study|Adverse Event|5
1793763|NCT00567567|6241925|P2|Overall Study|Adverse Event|2
1793764|NCT00567567|6241926|P1|Overall Study|Adverse Event|0
1793765|NCT00567541|6241974|P2|Overall Study|Adverse Event|1
1793766|NCT00567541|6241975|P1|Overall Study|Adverse Event|0
1793767|NCT00567502|6241985|P4|Overall Study|Never Initiated Treatment|72
1793768|NCT00567502|6241986|P3|Overall Study|Never Initiated Treatment|0
1793769|NCT00567502|6241987|P2|Overall Study|Never Initiated Treatment|0
1793770|NCT00567502|6241988|P1|Overall Study|Never Initiated Treatment|0
1793771|NCT00567502|6241985|P4|Overall Study|Sponsor request|1
1793772|NCT00567502|6241986|P3|Overall Study|Sponsor request|30
1793773|NCT00567502|6241987|P2|Overall Study|Sponsor request|0
1793774|NCT00567502|6241988|P1|Overall Study|Sponsor request|9
1793775|NCT00567502|6241985|P4|Overall Study|Participant request|1
1793776|NCT00567502|6241986|P3|Overall Study|Participant request|33
1793777|NCT00567502|6241987|P2|Overall Study|Participant request|1
1793778|NCT00567502|6241988|P1|Overall Study|Participant request|12
1793779|NCT00567502|6241985|P4|Overall Study|Other|6
1793780|NCT00567502|6241986|P3|Overall Study|Other|134
1793781|NCT00567502|6241987|P2|Overall Study|Other|2
1793782|NCT00567502|6241988|P1|Overall Study|Other|64
1793783|NCT00567502|6241985|P4|Overall Study|Death|5
1793784|NCT00567502|6241986|P3|Overall Study|Death|360
1793785|NCT00567502|6241987|P2|Overall Study|Death|16
1793786|NCT00567502|6241988|P1|Overall Study|Death|65
1793787|NCT00567502|6241985|P4|Overall Study|Lost to Follow-up|2
1793788|NCT00567502|6241986|P3|Overall Study|Lost to Follow-up|351
1793789|NCT00567502|6241987|P2|Overall Study|Lost to Follow-up|14
1793790|NCT00567502|6241988|P1|Overall Study|Lost to Follow-up|91
1793791|NCT00567489|6242025|P2|Overall Study|Other|0
1793792|NCT00567489|6242026|P1|Overall Study|Other|1
1793793|NCT00567489|6242025|P2|Overall Study|Renal Transplantation|3
1793794|NCT00567489|6242026|P1|Overall Study|Renal Transplantation|0
1793795|NCT00567489|6242025|P2|Overall Study|Withdrawal by Subject|2
1793796|NCT00567489|6242026|P1|Overall Study|Withdrawal by Subject|0
1793797|NCT00567489|6242025|P2|Overall Study|Physician Decision|4
1793798|NCT00567489|6242026|P1|Overall Study|Physician Decision|0
1793799|NCT00567489|6242025|P2|Overall Study|Adverse Event|14
1793800|NCT00567489|6242026|P1|Overall Study|Adverse Event|6
1793801|NCT00567476|6242076|P2|Overall Study|Non-adherence to protocol|1
1793802|NCT00567476|6242077|P1|Overall Study|Non-adherence to protocol|0
1793803|NCT00567476|6242076|P2|Overall Study|Medical Decision|1
1793804|NCT00567476|6242077|P1|Overall Study|Medical Decision|0
1793805|NCT00567476|6242076|P2|Overall Study|Administrative issues|0
1793806|NCT00567476|6242077|P1|Overall Study|Administrative issues|1
1793807|NCT00567476|6242076|P2|Overall Study|Lost to Follow-up|1
1793808|NCT00567476|6242077|P1|Overall Study|Lost to Follow-up|0
1793809|NCT00567476|6242076|P2|Overall Study|Protocol Violation|1
1793810|NCT00567476|6242077|P1|Overall Study|Protocol Violation|4
1793811|NCT00567476|6242076|P2|Overall Study|Pregnancy|0
1793812|NCT00567476|6242077|P1|Overall Study|Pregnancy|1
1793813|NCT00567476|6242076|P2|Overall Study|Adverse Event|0
1793814|NCT00567476|6242077|P1|Overall Study|Adverse Event|2
1793815|NCT00567398|6242103|P2|Overall Study|Other|0
1793816|NCT00567398|6242104|P1|Overall Study|Other|1
1793817|NCT00567398|6242103|P2|Overall Study|Renal Transplantation|3
1793818|NCT00567398|6242104|P1|Overall Study|Renal Transplantation|0
1793819|NCT00567398|6242103|P2|Overall Study|Withdrawal by Subject|2
1793820|NCT00567398|6242104|P1|Overall Study|Withdrawal by Subject|0
1793821|NCT00567398|6242103|P2|Overall Study|Physician Decision|4
1793822|NCT00567398|6242104|P1|Overall Study|Physician Decision|0
1793823|NCT00567398|6242103|P2|Overall Study|Adverse Event|14
1793824|NCT00567398|6242104|P1|Overall Study|Adverse Event|6
1793825|NCT00567359|6242152|P1|Overall Study|Withdrawal by Subject|1
1793826|NCT00567268|6242177|P1|Overall Study|"Safety Evaluation Not Assessable"|1
1793827|NCT00567268|6242177|P1|Overall Study|No Drug Administration|4
1793828|NCT00567268|6242177|P1|Overall Study|No Visit After First Day of Treatment|2
1793829|NCT00567268|6242177|P1|Overall Study|Lost to Follow-up|36
1793830|NCT00567268|6242177|P1|Overall Study|Protocol Violation|7
1793831|NCT00567255|6242228|P2|Overall Study|Drug noncompliance,moved,other|15
1793832|NCT00567255|6242229|P1|Overall Study|Drug noncompliance,moved,other|25
1793833|NCT00567255|6242228|P2|Overall Study|Pregnancy|0
1793834|NCT00567255|6242229|P1|Overall Study|Pregnancy|6
1793835|NCT00567255|6242228|P2|Overall Study|Protocol Violation|8
1793836|NCT00567255|6242229|P1|Overall Study|Protocol Violation|20
1793837|NCT00567255|6242228|P2|Overall Study|Lack of Efficacy|33
1793838|NCT00567255|6242229|P1|Overall Study|Lack of Efficacy|19
1793839|NCT00567255|6242228|P2|Overall Study|Withdrawal by Subject|56
1793840|NCT00567255|6242229|P1|Overall Study|Withdrawal by Subject|75
1793841|NCT00567255|6242228|P2|Overall Study|Lost to Follow-up|48
1793842|NCT00567255|6242229|P1|Overall Study|Lost to Follow-up|77
1793843|NCT00567255|6242228|P2|Overall Study|Adverse Event|68
1793844|NCT00567255|6242229|P1|Overall Study|Adverse Event|241
1793845|NCT00567190|6242292|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
1793846|NCT00567190|6242293|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
1793847|NCT00567190|6242292|P2|Overall Study|Death|280
1793848|NCT00567190|6242293|P1|Overall Study|Death|235
1793849|NCT00567164|6242344|P3|Overall Study|Missing|0
1793850|NCT00567164|6242345|P2|Overall Study|Missing|0
1793851|NCT00567164|6242346|P1|Overall Study|Missing|1
1793852|NCT00567164|6242344|P3|Overall Study|Primary Reason coded as 'Other'|16
1793853|NCT00567164|6242345|P2|Overall Study|Primary Reason coded as 'Other'|8
1793854|NCT00567164|6242346|P1|Overall Study|Primary Reason coded as 'Other'|37
1793855|NCT00567164|6242344|P3|Overall Study|Pregnancy|6
1793856|NCT00567164|6242345|P2|Overall Study|Pregnancy|4
1793857|NCT00567164|6242346|P1|Overall Study|Pregnancy|20
1793858|NCT00567164|6242344|P3|Overall Study|Lost to Follow-up|21
1793859|NCT00567164|6242345|P2|Overall Study|Lost to Follow-up|23
1793860|NCT00567164|6242346|P1|Overall Study|Lost to Follow-up|202
1793861|NCT00567164|6242344|P3|Overall Study|Death|1
1793862|NCT00567164|6242345|P2|Overall Study|Death|0
1793863|NCT00567164|6242346|P1|Overall Study|Death|0
1793864|NCT00567164|6242344|P3|Overall Study|Adverse Event|9
1793865|NCT00567164|6242345|P2|Overall Study|Adverse Event|13
1793866|NCT00567164|6242346|P1|Overall Study|Adverse Event|92
1793867|NCT00567164|6242344|P3|Overall Study|Protocol Violation|2
1793868|NCT00567164|6242345|P2|Overall Study|Protocol Violation|4
1793869|NCT00567164|6242346|P1|Overall Study|Protocol Violation|23
1793870|NCT00567164|6242344|P3|Overall Study|Withdrawal by Subject|17
1793871|NCT00567164|6242345|P2|Overall Study|Withdrawal by Subject|21
1793872|NCT00567164|6242346|P1|Overall Study|Withdrawal by Subject|171
1793873|NCT00567112|6242418|P3|Washout Period 3 (3 Days)|Protocol Violation|0
1793874|NCT00567112|6242419|P2|Washout Period 3 (3 Days)|Protocol Violation|0
1793875|NCT00567112|6242420|P1|Washout Period 3 (3 Days)|Protocol Violation|1
1793876|NCT00567112|6242418|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
1793877|NCT00567112|6242419|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
1793878|NCT00567112|6242420|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
1793879|NCT00567112|6242418|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
1793880|NCT00567112|6242419|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
1793881|NCT00567112|6242420|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
1793882|NCT00566995|6242451|P1|Overall Study|Withdrew consent|3
1793883|NCT00566995|6242451|P1|Overall Study|Toxicity|4
1793884|NCT00566982|6242466|P2|Overall Study|Other-family problems & doctor's request|2
1793885|NCT00566982|6242467|P1|Overall Study|Other-family problems & doctor's request|0
1793886|NCT00566982|6242466|P2|Overall Study|Lost to Follow-up|1
1793887|NCT00566982|6242467|P1|Overall Study|Lost to Follow-up|0
1793888|NCT00566982|6242466|P2|Overall Study|Protocol Violation|4
1793889|NCT00566982|6242467|P1|Overall Study|Protocol Violation|1
1793890|NCT00566982|6242466|P2|Overall Study|Withdrawal by Subject|14
1793891|NCT00566982|6242467|P1|Overall Study|Withdrawal by Subject|1
1793892|NCT00566982|6242466|P2|Overall Study|Adverse Event|48
1793893|NCT00566982|6242467|P1|Overall Study|Adverse Event|6
1793894|NCT00566852|6242532|P2|Overall Study|Missing reason not reported|20
1793895|NCT00566852|6242533|P1|Overall Study|Missing reason not reported|16
1793896|NCT00566852|6242532|P2|Overall Study|Missing reason not specified|2
1793897|NCT00566852|6242533|P1|Overall Study|Missing reason not specified|1
1793898|NCT00566852|6242532|P2|Overall Study|Not tested due to disability|12
1793899|NCT00566852|6242533|P1|Overall Study|Not tested due to disability|6
1793900|NCT00566852|6242532|P2|Overall Study|Patient refusal|37
1793901|NCT00566852|6242533|P1|Overall Study|Patient refusal|37
1793902|NCT00566852|6242532|P2|Overall Study|Withdrawal by Subject|25
1793903|NCT00566852|6242533|P1|Overall Study|Withdrawal by Subject|30
1793904|NCT00566852|6242532|P2|Overall Study|Death|78
1793905|NCT00566852|6242533|P1|Overall Study|Death|95
1793906|NCT00566852|6242532|P2|Overall Study|Protocol Violation|24
1793907|NCT00566852|6242533|P1|Overall Study|Protocol Violation|22
1793908|NCT00566735|6242564|P2|Overall Study|Switched into a manic episode|1
1793909|NCT00566735|6242565|P1|Overall Study|Switched into a manic episode|0
1793910|NCT00566735|6242564|P2|Overall Study|Refused neuropsychological testing|5
1793911|NCT00566735|6242565|P1|Overall Study|Refused neuropsychological testing|2
1793912|NCT00566735|6242564|P2|Overall Study|Withdrawal by Subject|1
1793913|NCT00566735|6242565|P1|Overall Study|Withdrawal by Subject|0
1793914|NCT00566722|6242578|P3|Overall Study|Noncompliant with drug administration|1
1793915|NCT00566722|6242579|P2|Overall Study|Noncompliant with drug administration|0
1793916|NCT00566722|6242580|P1|Overall Study|Noncompliant with drug administration|0
1793917|NCT00566722|6242578|P3|Overall Study|Serious adverse event|0
1793918|NCT00566722|6242579|P2|Overall Study|Serious adverse event|1
1793919|NCT00566722|6242580|P1|Overall Study|Serious adverse event|0
1793920|NCT00566722|6242578|P3|Overall Study|Did not meet exclusion criteria|2
1793921|NCT00566722|6242579|P2|Overall Study|Did not meet exclusion criteria|0
1793922|NCT00566722|6242580|P1|Overall Study|Did not meet exclusion criteria|0
1793923|NCT00566722|6242578|P3|Overall Study|Lack of Efficacy|4
1793924|NCT00566722|6242579|P2|Overall Study|Lack of Efficacy|2
1793925|NCT00566722|6242580|P1|Overall Study|Lack of Efficacy|1
1793926|NCT00566722|6242578|P3|Overall Study|Lost to Follow-up|1
1793927|NCT00566722|6242579|P2|Overall Study|Lost to Follow-up|1
1793928|NCT00566722|6242580|P1|Overall Study|Lost to Follow-up|1
1793929|NCT00566722|6242578|P3|Overall Study|Withdrawal by Subject|1
1793930|NCT00566722|6242579|P2|Overall Study|Withdrawal by Subject|0
1793931|NCT00566722|6242580|P1|Overall Study|Withdrawal by Subject|0
1793932|NCT00566722|6242578|P3|Overall Study|Adverse Event|0
1793933|NCT00566722|6242579|P2|Overall Study|Adverse Event|1
1793934|NCT00566722|6242580|P1|Overall Study|Adverse Event|0
1793935|NCT00566709|6242626|P2|Overall Study|Protocol Violation|0
1793936|NCT00566709|6242627|P1|Overall Study|Protocol Violation|5
1793937|NCT00566696|6242643|P1|Overall Study|Non-Patient Donors|37
1793938|NCT00566696|6242643|P1|Overall Study|Physician Decision|1
1793939|NCT00566696|6242643|P1|Overall Study|Health Status Change|1
1793940|NCT00566696|6242643|P1|Overall Study|Muromonab not available|1
1793941|NCT00566696|6242643|P1|Overall Study|Met Exclusion Criteria|2
1793942|NCT00566631|6242653|P1|Part 2: Extension Phase|Other|5
1793943|NCT00566631|6242653|P1|Part 2: Extension Phase|Death|1
1793944|NCT00566631|6242653|P1|Part 2: Extension Phase|Lost to Follow-up|6
1793945|NCT00566631|6242653|P1|Part 2: Extension Phase|Adverse Event|11
1793946|NCT00566631|6242653|P1|Part 2: Extension Phase|Withdrawal by Subject|34
1793947|NCT00566631|6242653|P1|Part 2: Extension Phase|Lack of Efficacy|25
1793948|NCT00566631|6242653|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
1793949|NCT00566631|6242653|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
1793950|NCT00566631|6242653|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
1793951|NCT00566631|6242653|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
1793952|NCT00566631|6242653|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
1793953|NCT00566631|6242653|P1|Part 1: Core Treatment Phase|Adverse Event|9
1793954|NCT00566631|6242653|P1|Part 1: Core Treatment Phase|Physician Decision|1
1793955|NCT00566631|6242653|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
1793956|NCT00566527|6242680|P3|Overall Study|Withdrawal by Subject|43
1793957|NCT00566527|6242681|P2|Overall Study|Withdrawal by Subject|43
1793958|NCT00566527|6242682|P1|Overall Study|Withdrawal by Subject|6
1793959|NCT00566527|6242680|P3|Overall Study|Lost to Follow-up|4
1793960|NCT00566527|6242681|P2|Overall Study|Lost to Follow-up|4
1793961|NCT00566527|6242682|P1|Overall Study|Lost to Follow-up|3
1793962|NCT00566527|6242680|P3|Overall Study|Physician Decision|20
1793963|NCT00566527|6242681|P2|Overall Study|Physician Decision|8
1793964|NCT00566527|6242682|P1|Overall Study|Physician Decision|3
1793965|NCT00566527|6242680|P3|Overall Study|Adverse Event|1
1793966|NCT00566527|6242681|P2|Overall Study|Adverse Event|0
1793967|NCT00566527|6242682|P1|Overall Study|Adverse Event|2
1793968|NCT00566527|6242680|P3|Overall Study|Reason not provided|10
1793969|NCT00566527|6242681|P2|Overall Study|Reason not provided|11
1793970|NCT00566527|6242682|P1|Overall Study|Reason not provided|3
1793971|NCT00566254|6242743|P2|Overall Study|Other|2
1793972|NCT00566254|6242744|P1|Overall Study|Other|0
1793973|NCT00566254|6242743|P2|Overall Study|Lack of Efficacy|6
1793974|NCT00566254|6242744|P1|Overall Study|Lack of Efficacy|5
1793975|NCT00566254|6242743|P2|Overall Study|Withdrawal by Subject|2
1793976|NCT00566254|6242744|P1|Overall Study|Withdrawal by Subject|1
1793977|NCT00566254|6242743|P2|Overall Study|Protocol Violation|3
1793978|NCT00566254|6242744|P1|Overall Study|Protocol Violation|1
1793979|NCT00566254|6242743|P2|Overall Study|Adverse Event|1
1793980|NCT00566254|6242744|P1|Overall Study|Adverse Event|3
1793981|NCT00566228|6242758|P2|Overall Study|progressed before infusion could occur|1
1793982|NCT00566228|6242759|P1|Overall Study|progressed before infusion could occur|0
1793983|NCT00566228|6242758|P2|Overall Study|Unable to collect sufficient CD34 cells|2
1793984|NCT00566228|6242759|P1|Overall Study|Unable to collect sufficient CD34 cells|3
1793985|NCT00566228|6242758|P2|Overall Study|Attempt to mobilize stem cells failed|2
1793986|NCT00566228|6242759|P1|Overall Study|Attempt to mobilize stem cells failed|2
1793987|NCT00566228|6242758|P2|Overall Study|Withdrawal by Subject|0
1793988|NCT00566228|6242759|P1|Overall Study|Withdrawal by Subject|1
1793989|NCT00566111|6242792|P2|Overall Study|Adverse Event|2
1793990|NCT00566111|6242793|P1|Overall Study|Adverse Event|0
1793991|NCT00566098|6242807|P1|Administration of ASCT+MILs|Lack of Efficacy|8
1793992|NCT00566098|6242807|P1|Administration of ASCT+MILs|Death|10
1793993|NCT00566098|6242807|P1|Generation of MILs Product|Relapsed|1
1793994|NCT00566098|6242807|P1|Collection of MILs|Relapsed|1
1793995|NCT00566098|6242807|P1|Collection of MILs|Withdrawal by Subject|1
1793996|NCT00566020|6242817|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
1793997|NCT00566020|6242818|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
1793998|NCT00566020|6242817|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
1793999|NCT00566020|6242818|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
1794000|NCT00566020|6242817|P2|46-week Long-term Administration Phase|Physician Decision|7
1794001|NCT00566020|6242818|P1|46-week Long-term Administration Phase|Physician Decision|0
1794002|NCT00566020|6242817|P2|46-week Long-term Administration Phase|Adverse Event|7
1794003|NCT00566020|6242818|P1|46-week Long-term Administration Phase|Adverse Event|0
1794004|NCT00566020|6242817|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
1794005|NCT00566020|6242818|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
1794006|NCT00566020|6242817|P2|6-week Dosage Adjustment Phase|Adverse Event|0
1794007|NCT00566020|6242818|P1|6-week Dosage Adjustment Phase|Adverse Event|5
1794008|NCT00565812|6242907|P3|Overall Study|Physician Decision|0
1794009|NCT00565812|6242908|P2|Overall Study|Physician Decision|0
1794010|NCT00565812|6242909|P1|Overall Study|Physician Decision|2
1794011|NCT00565812|6242907|P3|Overall Study|Follow-up Visit Not Completed|1
1794012|NCT00565812|6242908|P2|Overall Study|Follow-up Visit Not Completed|0
1794013|NCT00565812|6242909|P1|Overall Study|Follow-up Visit Not Completed|2
1794014|NCT00565812|6242907|P3|Overall Study|Low Compliance|1
1794015|NCT00565812|6242908|P2|Overall Study|Low Compliance|0
1794016|NCT00565812|6242909|P1|Overall Study|Low Compliance|1
1794017|NCT00565812|6242907|P3|Overall Study|Surgical Intervention|2
1794018|NCT00565812|6242908|P2|Overall Study|Surgical Intervention|1
1794019|NCT00565812|6242909|P1|Overall Study|Surgical Intervention|0
1794020|NCT00565812|6242907|P3|Overall Study|Research Site Closure|8
1794021|NCT00565812|6242908|P2|Overall Study|Research Site Closure|1
1794022|NCT00565812|6242909|P1|Overall Study|Research Site Closure|6
1794023|NCT00565812|6242907|P3|Overall Study|Domestic Reasons|3
1794024|NCT00565812|6242908|P2|Overall Study|Domestic Reasons|1
1794025|NCT00565812|6242909|P1|Overall Study|Domestic Reasons|7
1794026|NCT00565812|6242907|P3|Overall Study|Sponsor Decision|1
1794027|NCT00565812|6242908|P2|Overall Study|Sponsor Decision|5
1794028|NCT00565812|6242909|P1|Overall Study|Sponsor Decision|1
1794029|NCT00565812|6242907|P3|Overall Study|Relocated Out of Area|9
1794030|NCT00565812|6242908|P2|Overall Study|Relocated Out of Area|8
1794031|NCT00565812|6242909|P1|Overall Study|Relocated Out of Area|5
1794032|NCT00565812|6242907|P3|Overall Study|Jury Duty|0
1794033|NCT00565812|6242908|P2|Overall Study|Jury Duty|0
1794034|NCT00565812|6242909|P1|Overall Study|Jury Duty|1
1794035|NCT00565812|6242907|P3|Overall Study|Adverse Event|40
1794036|NCT00565812|6242908|P2|Overall Study|Adverse Event|54
1794037|NCT00565812|6242909|P1|Overall Study|Adverse Event|41
1794038|NCT00565812|6242907|P3|Overall Study|Protocol Violation|4
1794039|NCT00565812|6242908|P2|Overall Study|Protocol Violation|6
1794040|NCT00565812|6242909|P1|Overall Study|Protocol Violation|2
1794041|NCT00565812|6242907|P3|Overall Study|Work Schedule|1
1794042|NCT00565812|6242908|P2|Overall Study|Work Schedule|3
1794043|NCT00565812|6242909|P1|Overall Study|Work Schedule|5
1794044|NCT00565812|6242907|P3|Overall Study|Withdrawal by Subject|48
1794045|NCT00565812|6242908|P2|Overall Study|Withdrawal by Subject|47
1794046|NCT00565812|6242909|P1|Overall Study|Withdrawal by Subject|58
1794047|NCT00565812|6242907|P3|Overall Study|Lost to Follow-up|8
1794048|NCT00565812|6242908|P2|Overall Study|Lost to Follow-up|8
1794049|NCT00565812|6242909|P1|Overall Study|Lost to Follow-up|10
1794050|NCT00565812|6242907|P3|Overall Study|Did not Meet Entrance Criteria|1
1794051|NCT00565812|6242908|P2|Overall Study|Did not Meet Entrance Criteria|0
1794052|NCT00565812|6242909|P1|Overall Study|Did not Meet Entrance Criteria|1
1794053|NCT00565812|6242907|P3|Overall Study|Death|3
1794054|NCT00565812|6242908|P2|Overall Study|Death|1
1794055|NCT00565812|6242909|P1|Overall Study|Death|2
1794056|NCT00565773|6243046|P1|Overall Study|Physician Decision|1
1794057|NCT00565773|6243046|P1|Overall Study|Withdrawal by Subject|1
1794058|NCT00565747|6243058|P2|Overall Study|No embryo transfer|73
1794059|NCT00565747|6243059|P1|Overall Study|No embryo transfer|67
1794060|NCT00565721|6243069|P1|Overall Study|Other reasons|6
1794061|NCT00565721|6243069|P1|Overall Study|Physician Decision|2
1794062|NCT00565721|6243069|P1|Overall Study|Technical Problems|1
1794063|NCT00565721|6243069|P1|Overall Study|Lost to Follow-up|6
1794064|NCT00565721|6243069|P1|Overall Study|Screen Failure|2
1794065|NCT00565617|6243118|P1|Overall Study|Withdrawal by Subject|1
1794066|NCT00565604|6243122|P1|Overall Study|Lost to Follow-up|2
1794067|NCT00565604|6243122|P1|Overall Study|Failure to treat|2
1794068|NCT00565448|6243150|P2|Overall Study|Withdrawal by Subject|0
1794069|NCT00565448|6243151|P1|Overall Study|Withdrawal by Subject|1
1794070|NCT00565448|6243150|P2|Overall Study|Disease progression|0
1794071|NCT00565448|6243151|P1|Overall Study|Disease progression|1
1794072|NCT00565448|6243150|P2|Overall Study|Adverse Event|2
1794073|NCT00565448|6243151|P1|Overall Study|Adverse Event|1
1794074|NCT00565409|6243162|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
1794075|NCT00565409|6243163|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
1794076|NCT00565409|6243164|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
1794077|NCT00565409|6243165|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
1794078|NCT00565409|6243162|P4|Period 2 Double-Blind|Other|9
1794079|NCT00565409|6243163|P3|Period 2 Double-Blind|Other|5
1794080|NCT00565409|6243164|P2|Period 2 Double-Blind|Other|4
1794081|NCT00565409|6243165|P1|Period 2 Double-Blind|Other|0
1794082|NCT00565409|6243162|P4|Period 2 Double-Blind|Lost to Follow-up|0
1794083|NCT00565409|6243163|P3|Period 2 Double-Blind|Lost to Follow-up|1
1794084|NCT00565409|6243164|P2|Period 2 Double-Blind|Lost to Follow-up|0
1794085|NCT00565409|6243165|P1|Period 2 Double-Blind|Lost to Follow-up|0
1794086|NCT00565409|6243162|P4|Period 2 Double-Blind|Protocol Violation|2
1794087|NCT00565409|6243163|P3|Period 2 Double-Blind|Protocol Violation|6
1794088|NCT00565409|6243164|P2|Period 2 Double-Blind|Protocol Violation|4
1794089|NCT00565409|6243165|P1|Period 2 Double-Blind|Protocol Violation|0
1794090|NCT00565409|6243162|P4|Period 2 Double-Blind|Death|0
1794091|NCT00565409|6243163|P3|Period 2 Double-Blind|Death|0
1794092|NCT00565409|6243164|P2|Period 2 Double-Blind|Death|2
1794093|NCT00565409|6243165|P1|Period 2 Double-Blind|Death|0
1794094|NCT00565409|6243162|P4|Period 2 Double-Blind|Adverse Event|5
1794095|NCT00565409|6243163|P3|Period 2 Double-Blind|Adverse Event|4
1794096|NCT00565409|6243164|P2|Period 2 Double-Blind|Adverse Event|7
1794097|NCT00565409|6243165|P1|Period 2 Double-Blind|Adverse Event|0
1794098|NCT00565409|6243162|P4|After Period 1, Prior to Period 2|did not meet criteria|0
1794099|NCT00565409|6243163|P3|After Period 1, Prior to Period 2|did not meet criteria|0
1794100|NCT00565409|6243164|P2|After Period 1, Prior to Period 2|did not meet criteria|0
1794101|NCT00565409|6243165|P1|After Period 1, Prior to Period 2|did not meet criteria|152
1794102|NCT00565409|6243162|P4|Period 1 Open Label|no conclusion of participation record|0
1794103|NCT00565409|6243163|P3|Period 1 Open Label|no conclusion of participation record|0
1794104|NCT00565409|6243164|P2|Period 1 Open Label|no conclusion of participation record|0
1794105|NCT00565409|6243165|P1|Period 1 Open Label|no conclusion of participation record|1
1794106|NCT00565409|6243162|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1794107|NCT00565409|6243163|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1794108|NCT00565409|6243164|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
1794109|NCT00565409|6243165|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
1794110|NCT00565409|6243162|P4|Period 1 Open Label|Protocol Violation|0
1794111|NCT00565409|6243163|P3|Period 1 Open Label|Protocol Violation|0
1794112|NCT00565409|6243164|P2|Period 1 Open Label|Protocol Violation|0
1794113|NCT00565409|6243165|P1|Period 1 Open Label|Protocol Violation|14
1794114|NCT00565409|6243162|P4|Period 1 Open Label|Other|0
1794115|NCT00565409|6243163|P3|Period 1 Open Label|Other|0
1794116|NCT00565409|6243164|P2|Period 1 Open Label|Other|0
1794117|NCT00565409|6243165|P1|Period 1 Open Label|Other|21
1794118|NCT00565409|6243162|P4|Period 1 Open Label|Lost to Follow-up|0
1794119|NCT00565409|6243163|P3|Period 1 Open Label|Lost to Follow-up|0
1794120|NCT00565409|6243164|P2|Period 1 Open Label|Lost to Follow-up|0
1794121|NCT00565409|6243165|P1|Period 1 Open Label|Lost to Follow-up|1
1794122|NCT00565409|6243162|P4|Period 1 Open Label|Death|0
1794123|NCT00565409|6243163|P3|Period 1 Open Label|Death|0
1794124|NCT00565409|6243164|P2|Period 1 Open Label|Death|0
1794125|NCT00565409|6243165|P1|Period 1 Open Label|Death|2
1794126|NCT00565409|6243162|P4|Period 1 Open Label|Adverse Event|0
1794127|NCT00565409|6243163|P3|Period 1 Open Label|Adverse Event|0
1794128|NCT00565409|6243164|P2|Period 1 Open Label|Adverse Event|0
1794129|NCT00565409|6243165|P1|Period 1 Open Label|Adverse Event|17
1794130|NCT00565136|6243301|P1|Overall Study|Protocol Violation|1
1794131|NCT00565136|6243301|P1|Overall Study|Withdrawal by Subject|1
1794132|NCT00565136|6243301|P1|Overall Study|Lost to Follow-up|1
1794133|NCT00565058|6243342|P2|Overall Study|Adverse Event|0
1794134|NCT00565058|6243343|P1|Overall Study|Adverse Event|1
1794135|NCT00564902|6243390|P3|Overall Study|Death|0
1794136|NCT00564902|6243391|P2|Overall Study|Death|1
1794137|NCT00564902|6243392|P1|Overall Study|Death|1
1794138|NCT00564902|6243390|P3|Overall Study|Withdrawal by Subject|4
1794139|NCT00564902|6243391|P2|Overall Study|Withdrawal by Subject|3
1794140|NCT00564902|6243392|P1|Overall Study|Withdrawal by Subject|0
1794141|NCT00564889|6243424|P1|Overall Study|Other, not specified|4
1794142|NCT00564889|6243424|P1|Overall Study|Disease progression|3
1794143|NCT00564889|6243424|P1|Overall Study|Alternative treatment|3
1794144|NCT00564889|6243424|P1|Overall Study|Adverse Event|12
1794145|NCT00564889|6243424|P1|Overall Study|Death|7
1794146|NCT00564850|6243439|P1|Overall Study|Protocol Violation|2
1794147|NCT00564733|6243457|P1|Overall Study|Ineligible|5
1794148|NCT00564733|6243457|P1|Overall Study|Withdrawal by Subject|4
1794149|NCT00564629|6243491|P2|Overall Study|Vomited within 2 hours of receiving drug|9
1794150|NCT00564629|6243492|P1|Overall Study|Vomited within 2 hours of receiving drug|15
1794151|NCT00564486|6243517|P4|Overall Study|Lost to Follow-up|2
1794152|NCT00564486|6243518|P3|Overall Study|Lost to Follow-up|2
1794153|NCT00564486|6243519|P2|Overall Study|Lost to Follow-up|0
1794154|NCT00564486|6243520|P1|Overall Study|Lost to Follow-up|3
1794155|NCT00564486|6243517|P4|Overall Study|Subject refused to have blood drawn|0
1794156|NCT00564486|6243518|P3|Overall Study|Subject refused to have blood drawn|1
1794157|NCT00564486|6243519|P2|Overall Study|Subject refused to have blood drawn|0
1794158|NCT00564486|6243520|P1|Overall Study|Subject refused to have blood drawn|0
1794159|NCT00564486|6243517|P4|Overall Study|Withdrawal by Subject|5
1794160|NCT00564486|6243518|P3|Overall Study|Withdrawal by Subject|0
1794161|NCT00564486|6243519|P2|Overall Study|Withdrawal by Subject|0
1794162|NCT00564486|6243520|P1|Overall Study|Withdrawal by Subject|4
1794163|NCT00564486|6243517|P4|Overall Study|Adverse Event|0
1794164|NCT00564486|6243518|P3|Overall Study|Adverse Event|0
1794165|NCT00564486|6243519|P2|Overall Study|Adverse Event|1
1794166|NCT00564486|6243520|P1|Overall Study|Adverse Event|0
1794167|NCT00564395|6243569|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
1794168|NCT00564395|6243570|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
1794169|NCT00564395|6243569|P2|First Intervention (10 Days)|Withdrawal by Subject|0
1794170|NCT00564395|6243570|P1|First Intervention (10 Days)|Withdrawal by Subject|1
1794171|NCT00564278|6243578|P2|Overall Study|Withdrawal by Subject|7
1794172|NCT00564278|6243579|P1|Overall Study|Withdrawal by Subject|11
1794173|NCT00564278|6243578|P2|Overall Study|Physician Decision|2
1794174|NCT00564278|6243579|P1|Overall Study|Physician Decision|1
1794175|NCT00564278|6243578|P2|Overall Study|Lost to Follow-up|33
1794176|NCT00564278|6243579|P1|Overall Study|Lost to Follow-up|35
1794177|NCT00564070|6243601|P2|Overall Study|Worsening depression, referred to care|0
1794178|NCT00564070|6243602|P1|Overall Study|Worsening depression, referred to care|3
1794179|NCT00564070|6243601|P2|Overall Study|Lost to Follow-up|7
1794180|NCT00564070|6243602|P1|Overall Study|Lost to Follow-up|9
1794181|NCT00564018|6243629|P3|Overall Study|Withdrawal by Subject|1
1794182|NCT00564018|6243630|P2|Overall Study|Withdrawal by Subject|3
1794183|NCT00564018|6243631|P1|Overall Study|Withdrawal by Subject|2
1794184|NCT00563797|6243644|P2|Overall Study|Lost to Follow-up|2
1794185|NCT00563797|6243645|P1|Overall Study|Lost to Follow-up|7
1794186|NCT00563784|6243657|P1|Overall Study|Screen Failures|20
1794187|NCT00563784|6243657|P1|Overall Study|Withdrawal by Subject|2
1794188|NCT00563706|6243671|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
1794189|NCT00563706|6243672|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
1794190|NCT00563706|6243673|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
1794191|NCT00563706|6243674|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
1794192|NCT00563706|6243675|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
1794193|NCT00563706|6243676|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
1794194|NCT00563706|6243677|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
1794195|NCT00563706|6243678|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
1794196|NCT00563706|6243679|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
1794197|NCT00563706|6243671|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1794198|NCT00563706|6243672|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
1794199|NCT00563706|6243673|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1794200|NCT00563706|6243674|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1794201|NCT00563706|6243675|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1794202|NCT00563706|6243676|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1794203|NCT00563706|6243677|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1794204|NCT00563706|6243678|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
1794205|NCT00563706|6243679|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
1794206|NCT00563706|6243671|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1794207|NCT00563706|6243672|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
1794208|NCT00563706|6243673|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
1794209|NCT00563706|6243674|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1794210|NCT00563706|6243675|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
1794211|NCT00563706|6243676|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
1794212|NCT00563706|6243677|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
1794213|NCT00563706|6243678|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
1794214|NCT00563706|6243679|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
1794215|NCT00563706|6243671|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1794216|NCT00563706|6243672|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
1794217|NCT00563706|6243673|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1794218|NCT00563706|6243674|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1794219|NCT00563706|6243675|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1794220|NCT00563706|6243676|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
1794221|NCT00563706|6243677|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1794222|NCT00563706|6243678|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
1794223|NCT00563706|6243679|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
1794224|NCT00563706|6243671|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
1794225|NCT00563706|6243672|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1794226|NCT00563706|6243673|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1794227|NCT00563706|6243674|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1794228|NCT00563706|6243675|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
1794229|NCT00563706|6243676|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1794230|NCT00563706|6243677|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1794231|NCT00563706|6243678|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
1794232|NCT00563706|6243679|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
1794233|NCT00563381|6243797|P2|Overall Study|Individual different reasons|34
1794234|NCT00563381|6243798|P1|Overall Study|Individual different reasons|24
1794235|NCT00563381|6243797|P2|Overall Study|Lack of Efficacy|24
1794236|NCT00563381|6243798|P1|Overall Study|Lack of Efficacy|32
1794237|NCT00563381|6243797|P2|Overall Study|Withdrawal by Subject|209
1794238|NCT00563381|6243798|P1|Overall Study|Withdrawal by Subject|192
1794239|NCT00563381|6243797|P2|Overall Study|Lost to Follow-up|15
1794240|NCT00563381|6243798|P1|Overall Study|Lost to Follow-up|7
1794241|NCT00563381|6243797|P2|Overall Study|Protocol Violation|74
1794242|NCT00563381|6243798|P1|Overall Study|Protocol Violation|66
1794243|NCT00563381|6243797|P2|Overall Study|Adverse Event|292
1794244|NCT00563381|6243798|P1|Overall Study|Adverse Event|264
1794245|NCT00563368|6243871|P7|Overall Study|Other|0
1794246|NCT00563368|6243872|P6|Overall Study|Other|4
1794247|NCT00563368|6243873|P5|Overall Study|Other|4
1794248|NCT00563368|6243874|P4|Overall Study|Other|4
1794249|NCT00563368|6243875|P3|Overall Study|Other|3
1794250|NCT00563368|6243876|P2|Overall Study|Other|5
1794251|NCT00563368|6243877|P1|Overall Study|Other|5
1794252|NCT00563368|6243871|P7|Overall Study|requirement for restricted medication|0
1794253|NCT00563368|6243872|P6|Overall Study|requirement for restricted medication|0
1794254|NCT00563368|6243873|P5|Overall Study|requirement for restricted medication|0
1794255|NCT00563368|6243874|P4|Overall Study|requirement for restricted medication|0
1794256|NCT00563368|6243875|P3|Overall Study|requirement for restricted medication|2
1794257|NCT00563368|6243876|P2|Overall Study|requirement for restricted medication|0
1794258|NCT00563368|6243877|P1|Overall Study|requirement for restricted medication|0
1794259|NCT00563368|6243871|P7|Overall Study|Pregnancy|0
1794260|NCT00563368|6243872|P6|Overall Study|Pregnancy|2
1794261|NCT00563368|6243873|P5|Overall Study|Pregnancy|1
1794262|NCT00563368|6243874|P4|Overall Study|Pregnancy|2
1794263|NCT00563368|6243875|P3|Overall Study|Pregnancy|1
1794264|NCT00563368|6243876|P2|Overall Study|Pregnancy|0
1794265|NCT00563368|6243877|P1|Overall Study|Pregnancy|1
1794266|NCT00563368|6243871|P7|Overall Study|protocol non-compliance|3
1794267|NCT00563368|6243872|P6|Overall Study|protocol non-compliance|1
1794268|NCT00563368|6243873|P5|Overall Study|protocol non-compliance|0
1794269|NCT00563368|6243874|P4|Overall Study|protocol non-compliance|1
1794270|NCT00563368|6243875|P3|Overall Study|protocol non-compliance|2
1794271|NCT00563368|6243876|P2|Overall Study|protocol non-compliance|1
1794272|NCT00563368|6243877|P1|Overall Study|protocol non-compliance|1
1794273|NCT00563368|6243871|P7|Overall Study|Withdrawal by Subject|4
1794274|NCT00563368|6243872|P6|Overall Study|Withdrawal by Subject|5
1794275|NCT00563368|6243873|P5|Overall Study|Withdrawal by Subject|8
1794276|NCT00563368|6243874|P4|Overall Study|Withdrawal by Subject|7
1794277|NCT00563368|6243875|P3|Overall Study|Withdrawal by Subject|5
1794278|NCT00563368|6243876|P2|Overall Study|Withdrawal by Subject|6
1794279|NCT00563368|6243877|P1|Overall Study|Withdrawal by Subject|11
1794280|NCT00563368|6243871|P7|Overall Study|Adverse Event|17
1794281|NCT00563368|6243872|P6|Overall Study|Adverse Event|10
1794282|NCT00563368|6243873|P5|Overall Study|Adverse Event|6
1794283|NCT00563368|6243874|P4|Overall Study|Adverse Event|9
1794284|NCT00563368|6243875|P3|Overall Study|Adverse Event|5
1794285|NCT00563368|6243876|P2|Overall Study|Adverse Event|4
1794286|NCT00563368|6243877|P1|Overall Study|Adverse Event|3
1794287|NCT00563368|6243871|P7|Overall Study|Lost to Follow-up|9
1794288|NCT00563368|6243872|P6|Overall Study|Lost to Follow-up|8
1794289|NCT00563368|6243873|P5|Overall Study|Lost to Follow-up|9
1794290|NCT00563368|6243874|P4|Overall Study|Lost to Follow-up|6
1794291|NCT00563368|6243875|P3|Overall Study|Lost to Follow-up|12
1794292|NCT00563368|6243876|P2|Overall Study|Lost to Follow-up|14
1794293|NCT00563368|6243877|P1|Overall Study|Lost to Follow-up|14
1794294|NCT00563316|6243900|P1|Overall Study|Other|1
1794295|NCT00563316|6243900|P1|Overall Study|On-going in study as of 16 July 2009.|5
1794296|NCT00563316|6243900|P1|Overall Study|Death|1
1794297|NCT00563316|6243900|P1|Overall Study|Lost to Follow-up|2
1794298|NCT00563316|6243900|P1|Overall Study|Physician Decision|1
1794299|NCT00563316|6243900|P1|Overall Study|Adverse Event|2
1794300|NCT00563186|6243925|P2|Overall Study|Incomplete data|1
1794301|NCT00563186|6243926|P1|Overall Study|Incomplete data|1
1794302|NCT00563186|6243925|P2|Overall Study|LOS<48 hours|74
1794303|NCT00563186|6243926|P1|Overall Study|LOS<48 hours|97
1794304|NCT00562965|6243937|P2|Overall Study|Other|1
1794305|NCT00562965|6243938|P1|Overall Study|Other|0
1794306|NCT00562965|6243937|P2|Overall Study|Lost to Follow-up|0
1794307|NCT00562965|6243938|P1|Overall Study|Lost to Follow-up|1
1794308|NCT00562965|6243937|P2|Overall Study|Death|4
1794309|NCT00562965|6243938|P1|Overall Study|Death|2
1794310|NCT00562965|6243937|P2|Overall Study|Withdrawal by Subject|1
1794311|NCT00562965|6243938|P1|Overall Study|Withdrawal by Subject|0
1794312|NCT00562861|6243959|P2|Overall Study|Lost to Follow-up|3
1794313|NCT00562861|6243960|P1|Overall Study|Lost to Follow-up|7
1794314|NCT00562861|6243959|P2|Overall Study|noncompliance, moved|2
1794315|NCT00562861|6243960|P1|Overall Study|noncompliance, moved|7
1794316|NCT00562861|6243959|P2|Overall Study|Lack of Efficacy|5
1794317|NCT00562861|6243960|P1|Overall Study|Lack of Efficacy|5
1794318|NCT00562861|6243959|P2|Overall Study|Adverse Event|1
1794319|NCT00562861|6243960|P1|Overall Study|Adverse Event|1
1794320|NCT00562718|6243966|P1|Overall Study|not stated|1
1794321|NCT00562718|6243966|P1|Overall Study|Lack of Efficacy|2
1794322|NCT00562718|6243966|P1|Overall Study|Adverse Event|4
1794323|NCT00562718|6243966|P1|Overall Study|Withdrawal by Subject|3
1794324|NCT00562718|6243966|P1|Overall Study|Death|1
1794325|NCT00562627|6243975|P3|Overall Study|Protocol Violation|1
1794326|NCT00562627|6243976|P2|Overall Study|Protocol Violation|1
1794327|NCT00562627|6243977|P1|Overall Study|Protocol Violation|1
1794328|NCT00562588|6243993|P2|Overall Study|Other|2
1794329|NCT00562588|6243994|P1|Overall Study|Other|0
1794330|NCT00562588|6243993|P2|Overall Study|Withdrawal by Subject|9
1794331|NCT00562588|6243994|P1|Overall Study|Withdrawal by Subject|10
1794332|NCT00562588|6243993|P2|Overall Study|Lost to Follow-up|4
1794333|NCT00562588|6243994|P1|Overall Study|Lost to Follow-up|12
1794334|NCT00562588|6243993|P2|Overall Study|Protocol Violation|26
1794335|NCT00562588|6243994|P1|Overall Study|Protocol Violation|30
1794336|NCT00562588|6243993|P2|Overall Study|Adverse Event|58
1794337|NCT00562588|6243994|P1|Overall Study|Adverse Event|40
1794338|NCT00562484|6244024|P2|Overall Study|Reason not provided or not specified|12
1794339|NCT00562484|6244025|P1|Overall Study|Reason not provided or not specified|25
1794340|NCT00562484|6244024|P2|Overall Study|Lost to Follow-up|71
1794341|NCT00562484|6244025|P1|Overall Study|Lost to Follow-up|132
1794342|NCT00562484|6244024|P2|Overall Study|Moved away from the study area|9
1794343|NCT00562484|6244025|P1|Overall Study|Moved away from the study area|20
1794344|NCT00562484|6244024|P2|Overall Study|Withdrawal by Subject|9
1794345|NCT00562484|6244025|P1|Overall Study|Withdrawal by Subject|12
1794346|NCT00562484|6244024|P2|Overall Study|Protocol Violation|2
1794347|NCT00562484|6244025|P1|Overall Study|Protocol Violation|11
1794348|NCT00562484|6244024|P2|Overall Study|Adverse Event|1
1794349|NCT00562484|6244025|P1|Overall Study|Adverse Event|6
1794350|NCT00562354|6244057|P2|Overall Study|Lost to Follow-up|1
1794351|NCT00562354|6244058|P1|Overall Study|Lost to Follow-up|0
1794352|NCT00562354|6244057|P2|Overall Study|Physician Decision|1
1794353|NCT00562354|6244058|P1|Overall Study|Physician Decision|0
1794354|NCT00562302|6244124|P2|Overall Study|Not stated|4
1794355|NCT00562302|6244125|P1|Overall Study|Not stated|1
1794356|NCT00562302|6244124|P2|Overall Study|Lung resection prior to study completion|7
1794357|NCT00562302|6244125|P1|Overall Study|Lung resection prior to study completion|7
1794358|NCT00562302|6244124|P2|Overall Study|Death|2
1794359|NCT00562302|6244125|P1|Overall Study|Death|1
1794360|NCT00562302|6244124|P2|Overall Study|Withdrawal by Subject|8
1794361|NCT00562302|6244125|P1|Overall Study|Withdrawal by Subject|7
1794362|NCT00562302|6244124|P2|Overall Study|Non-compliance|2
1794363|NCT00562302|6244125|P1|Overall Study|Non-compliance|1
1794364|NCT00562302|6244124|P2|Overall Study|Adverse Event|6
1794365|NCT00562302|6244125|P1|Overall Study|Adverse Event|0
1794366|NCT00562302|6244124|P2|Overall Study|Lost to Follow-up|3
1794367|NCT00562302|6244125|P1|Overall Study|Lost to Follow-up|3
1794368|NCT00562159|6244147|P2|Overall Study|Did not meet protocol eligibility|1
1794369|NCT00562159|6244148|P1|Overall Study|Did not meet protocol eligibility|1
1794370|NCT00562159|6244147|P2|Overall Study|Protocol Violation|12
1794371|NCT00562159|6244148|P1|Overall Study|Protocol Violation|12
1794372|NCT00562159|6244147|P2|Overall Study|Withdrawal by Subject|8
1794373|NCT00562159|6244148|P1|Overall Study|Withdrawal by Subject|9
1794374|NCT00562159|6244147|P2|Overall Study|Lost to Follow-up|4
1794375|NCT00562159|6244148|P1|Overall Study|Lost to Follow-up|5
1794376|NCT00562159|6244147|P2|Overall Study|Adverse Event|8
1794377|NCT00562159|6244148|P1|Overall Study|Adverse Event|11
1794378|NCT00562120|6244160|P4|First Intervention Period|Randomized but not Treated|0
1794379|NCT00562120|6244161|P3|First Intervention Period|Randomized but not Treated|0
1794380|NCT00562120|6244162|P2|First Intervention Period|Randomized but not Treated|0
1794381|NCT00562120|6244163|P1|First Intervention Period|Randomized but not Treated|1
1794382|NCT00562120|6244160|P4|First Intervention Period|Adverse Event|0
1794383|NCT00562120|6244161|P3|First Intervention Period|Adverse Event|0
1794384|NCT00562120|6244162|P2|First Intervention Period|Adverse Event|0
1794385|NCT00562120|6244163|P1|First Intervention Period|Adverse Event|1
1794386|NCT00562094|6244195|P1|Overall Study|Lost to Follow-up|62
1794387|NCT00561977|6244210|P3|Overall Study|Pregnancy|1
1794388|NCT00561977|6244211|P2|Overall Study|Pregnancy|1
1794389|NCT00561977|6244212|P1|Overall Study|Pregnancy|0
1794390|NCT00561977|6244210|P3|Overall Study|Withdrawal by Subject|1
1794391|NCT00561977|6244211|P2|Overall Study|Withdrawal by Subject|2
1794392|NCT00561977|6244212|P1|Overall Study|Withdrawal by Subject|0
1794393|NCT00561951|6244238|P3|Overall Study|Adverse Event Occured Before Treatment|1
1794394|NCT00561951|6244239|P2|Overall Study|Adverse Event Occured Before Treatment|2
1794395|NCT00561951|6244240|P1|Overall Study|Adverse Event Occured Before Treatment|1
1794396|NCT00561951|6244238|P3|Overall Study|Meet Withdrawal Criterion|1
1794397|NCT00561951|6244239|P2|Overall Study|Meet Withdrawal Criterion|1
1794398|NCT00561951|6244240|P1|Overall Study|Meet Withdrawal Criterion|0
1794399|NCT00561951|6244238|P3|Overall Study|Pregnancy|0
1794400|NCT00561951|6244239|P2|Overall Study|Pregnancy|1
1794401|NCT00561951|6244240|P1|Overall Study|Pregnancy|0
1794402|NCT00561951|6244238|P3|Overall Study|Physician Decision|0
1794403|NCT00561951|6244239|P2|Overall Study|Physician Decision|0
1794404|NCT00561951|6244240|P1|Overall Study|Physician Decision|1
1794405|NCT00561951|6244238|P3|Overall Study|Protocol Violation|4
1794406|NCT00561951|6244239|P2|Overall Study|Protocol Violation|3
1794407|NCT00561951|6244240|P1|Overall Study|Protocol Violation|4
1794408|NCT00561951|6244238|P3|Overall Study|Withdrawal by Subject|10
1794409|NCT00561951|6244239|P2|Overall Study|Withdrawal by Subject|9
1794410|NCT00561951|6244240|P1|Overall Study|Withdrawal by Subject|10
1794411|NCT00561951|6244238|P3|Overall Study|Lost to Follow-up|0
1794412|NCT00561951|6244239|P2|Overall Study|Lost to Follow-up|1
1794413|NCT00561951|6244240|P1|Overall Study|Lost to Follow-up|1
1794414|NCT00561951|6244238|P3|Overall Study|Lack of Efficacy|2
1794415|NCT00561951|6244239|P2|Overall Study|Lack of Efficacy|3
1794416|NCT00561951|6244240|P1|Overall Study|Lack of Efficacy|5
1794417|NCT00561951|6244238|P3|Overall Study|Adverse Event|14
1794418|NCT00561951|6244239|P2|Overall Study|Adverse Event|14
1794419|NCT00561951|6244240|P1|Overall Study|Adverse Event|11
1794420|NCT00561925|6244296|P5|Open-Label Extension Period|Declined entry into extension period|50
1794421|NCT00561925|6244297|P4|Open-Label Extension Period|Declined entry into extension period|43
1794422|NCT00561925|6244298|P3|Open-Label Extension Period|Declined entry into extension period|0
1794423|NCT00561925|6244299|P2|Open-Label Extension Period|Declined entry into extension period|0
1794424|NCT00561925|6244300|P1|Open-Label Extension Period|Declined entry into extension period|0
1794425|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Other|0
1794426|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Other|0
1794427|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Other|11
1794428|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Other|8
1794429|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Other|0
1794430|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
1794431|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
1794432|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
1794433|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
1794434|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
1794435|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Death|0
1794436|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Death|0
1794437|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Death|3
1794438|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Death|6
1794439|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Death|0
1794440|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Pregnancy|0
1794441|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Pregnancy|0
1794442|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Pregnancy|9
1794443|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Pregnancy|1
1794444|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Pregnancy|0
1794445|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1794446|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1794447|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
1794448|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
1794449|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
1794450|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1794451|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1794452|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
1794453|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
1794454|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
1794455|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1794456|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1794457|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
1794458|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
1794459|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
1794460|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
1794461|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
1794462|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
1794463|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
1794464|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
1794465|NCT00561925|6244296|P5|144-week Double-blind, Double-dummy|Adverse Event|0
1794466|NCT00561925|6244297|P4|144-week Double-blind, Double-dummy|Adverse Event|0
1794467|NCT00561925|6244298|P3|144-week Double-blind, Double-dummy|Adverse Event|43
1794468|NCT00561925|6244299|P2|144-week Double-blind, Double-dummy|Adverse Event|48
1794469|NCT00561925|6244300|P1|144-week Double-blind, Double-dummy|Adverse Event|0
1794470|NCT00561925|6244296|P5|14 Day Lead-In Period|Other|0
1794471|NCT00561925|6244297|P4|14 Day Lead-In Period|Other|0
1794472|NCT00561925|6244298|P3|14 Day Lead-In Period|Other|0
1794473|NCT00561925|6244299|P2|14 Day Lead-In Period|Other|0
1794474|NCT00561925|6244300|P1|14 Day Lead-In Period|Other|5
1794475|NCT00561925|6244296|P5|14 Day Lead-In Period|Withdrawal by Subject|0
1794476|NCT00561925|6244297|P4|14 Day Lead-In Period|Withdrawal by Subject|0
1794477|NCT00561925|6244298|P3|14 Day Lead-In Period|Withdrawal by Subject|0
1794478|NCT00561925|6244299|P2|14 Day Lead-In Period|Withdrawal by Subject|0
1794479|NCT00561925|6244300|P1|14 Day Lead-In Period|Withdrawal by Subject|4
1794480|NCT00561925|6244296|P5|14 Day Lead-In Period|Lost to Follow-up|0
1794481|NCT00561925|6244297|P4|14 Day Lead-In Period|Lost to Follow-up|0
1794482|NCT00561925|6244298|P3|14 Day Lead-In Period|Lost to Follow-up|0
1794483|NCT00561925|6244299|P2|14 Day Lead-In Period|Lost to Follow-up|0
1794484|NCT00561925|6244300|P1|14 Day Lead-In Period|Lost to Follow-up|4
1794485|NCT00561925|6244296|P5|14 Day Lead-In Period|In/Exclusion criteria|0
1794486|NCT00561925|6244297|P4|14 Day Lead-In Period|In/Exclusion criteria|0
1794487|NCT00561925|6244298|P3|14 Day Lead-In Period|In/Exclusion criteria|0
1794488|NCT00561925|6244299|P2|14 Day Lead-In Period|In/Exclusion criteria|0
1794489|NCT00561925|6244300|P1|14 Day Lead-In Period|In/Exclusion criteria|4
1794490|NCT00561925|6244296|P5|14 Day Lead-In Period|Adverse Event|0
1794491|NCT00561925|6244297|P4|14 Day Lead-In Period|Adverse Event|0
1794492|NCT00561925|6244298|P3|14 Day Lead-In Period|Adverse Event|0
1794493|NCT00561925|6244299|P2|14 Day Lead-In Period|Adverse Event|0
1794494|NCT00561925|6244300|P1|14 Day Lead-In Period|Adverse Event|38
1794495|NCT00561912|6244349|P1|Overall Study|ineligible|1
1794496|NCT00561821|6244361|P4|Overall Study|Adverse Event|1
1794497|NCT00561821|6244362|P3|Overall Study|Adverse Event|1
1794498|NCT00561821|6244363|P2|Overall Study|Adverse Event|3
1794499|NCT00561821|6244364|P1|Overall Study|Adverse Event|2
1794500|NCT00561821|6244361|P4|Overall Study|Other (reason not specified)|0
1794501|NCT00561821|6244362|P3|Overall Study|Other (reason not specified)|0
1794502|NCT00561821|6244363|P2|Overall Study|Other (reason not specified)|1
1794503|NCT00561821|6244364|P1|Overall Study|Other (reason not specified)|1
1794504|NCT00561821|6244361|P4|Overall Study|Reasons not related to trial|0
1794505|NCT00561821|6244362|P3|Overall Study|Reasons not related to trial|0
1794506|NCT00561821|6244363|P2|Overall Study|Reasons not related to trial|1
1794507|NCT00561821|6244364|P1|Overall Study|Reasons not related to trial|2
1794508|NCT00561821|6244361|P4|Overall Study|Withdrawal by Subject|2
1794509|NCT00561821|6244362|P3|Overall Study|Withdrawal by Subject|0
1794510|NCT00561821|6244363|P2|Overall Study|Withdrawal by Subject|1
1794511|NCT00561821|6244364|P1|Overall Study|Withdrawal by Subject|0
1794512|NCT00561821|6244361|P4|Overall Study|Not treated|0
1794513|NCT00561821|6244362|P3|Overall Study|Not treated|1
1794514|NCT00561821|6244363|P2|Overall Study|Not treated|0
1794515|NCT00561821|6244364|P1|Overall Study|Not treated|0
1794516|NCT00561795|6244440|P4|Overall Study|Physician Decision|0
1794517|NCT00561795|6244441|P3|Overall Study|Physician Decision|0
1794518|NCT00561795|6244442|P2|Overall Study|Physician Decision|0
1794519|NCT00561795|6244443|P1|Overall Study|Physician Decision|1
1794520|NCT00561795|6244440|P4|Overall Study|Study Closed/Terminated|0
1794521|NCT00561795|6244441|P3|Overall Study|Study Closed/Terminated|0
1794522|NCT00561795|6244442|P2|Overall Study|Study Closed/Terminated|3
1794523|NCT00561795|6244443|P1|Overall Study|Study Closed/Terminated|0
1794524|NCT00561795|6244440|P4|Overall Study|Adverse Event|0
1794525|NCT00561795|6244441|P3|Overall Study|Adverse Event|0
1794526|NCT00561795|6244442|P2|Overall Study|Adverse Event|3
1794527|NCT00561795|6244443|P1|Overall Study|Adverse Event|3
1794528|NCT00561730|6244463|P1|Overall Study|Not specified reasons|1
1794529|NCT00561730|6244463|P1|Overall Study|Lost to Follow-up|5
1794530|NCT00561730|6244463|P1|Overall Study|Handling of the drug|1
1794531|NCT00561730|6244463|P1|Overall Study|Adverse Event|2
1794532|NCT00561678|6244479|P2|Overall Study|anesthesia provider refusal|0
1794533|NCT00561678|6244480|P1|Overall Study|anesthesia provider refusal|1
1794534|NCT00561678|6244479|P2|Overall Study|surgery rescheduled to different site|2
1794535|NCT00561678|6244480|P1|Overall Study|surgery rescheduled to different site|2
1794536|NCT00561678|6244479|P2|Overall Study|surgery cancelled|1
1794537|NCT00561678|6244480|P1|Overall Study|surgery cancelled|1
1794538|NCT00561678|6244479|P2|Overall Study|Withdrawal by Subject|3
1794539|NCT00561678|6244480|P1|Overall Study|Withdrawal by Subject|4
1794540|NCT00561652|6244498|P2|Overall Study|Withdrawal by Subject|1
1794541|NCT00561652|6244499|P1|Overall Study|Withdrawal by Subject|0
1794542|NCT00561574|6244582|P2|Overall Study|Other|7
1794543|NCT00561574|6244583|P1|Overall Study|Other|5
1794544|NCT00561574|6244582|P2|Overall Study|Lost to Follow-up|0
1794545|NCT00561574|6244583|P1|Overall Study|Lost to Follow-up|1
1794546|NCT00561574|6244582|P2|Overall Study|Reason Unrelated to Trial|2
1794547|NCT00561574|6244583|P1|Overall Study|Reason Unrelated to Trial|6
1794548|NCT00561574|6244582|P2|Overall Study|Withdrawal by Subject|4
1794549|NCT00561574|6244583|P1|Overall Study|Withdrawal by Subject|4
1794550|NCT00561574|6244582|P2|Overall Study|Lack of Efficacy|21
1794551|NCT00561574|6244583|P1|Overall Study|Lack of Efficacy|11
1794552|NCT00561574|6244582|P2|Overall Study|Adverse Event|24
1794553|NCT00561574|6244583|P1|Overall Study|Adverse Event|21
1794554|NCT00561470|6244609|P2|Overall Study|Ongoing Treatment|14
1794555|NCT00561470|6244610|P1|Overall Study|Ongoing Treatment|11
1794556|NCT00561470|6244609|P2|Overall Study|Planning surgery|1
1794557|NCT00561470|6244610|P1|Overall Study|Planning surgery|1
1794558|NCT00561470|6244609|P2|Overall Study|Missed visit window|4
1794559|NCT00561470|6244610|P1|Overall Study|Missed visit window|1
1794560|NCT00561470|6244609|P2|Overall Study|Randomized but not treated|5
1794561|NCT00561470|6244610|P1|Overall Study|Randomized but not treated|5
1794562|NCT00561470|6244609|P2|Overall Study|Unauthorized procedure|1
1794563|NCT00561470|6244610|P1|Overall Study|Unauthorized procedure|3
1794564|NCT00561470|6244609|P2|Overall Study|Metastatic surgery|12
1794565|NCT00561470|6244610|P1|Overall Study|Metastatic surgery|10
1794566|NCT00561470|6244609|P2|Overall Study|Subject request|77
1794567|NCT00561470|6244610|P1|Overall Study|Subject request|43
1794568|NCT00561470|6244609|P2|Overall Study|Consent Withdrawn|6
1794569|NCT00561470|6244610|P1|Overall Study|Consent Withdrawn|2
1794570|NCT00561470|6244609|P2|Overall Study|Physician Decision|20
1794571|NCT00561470|6244610|P1|Overall Study|Physician Decision|21
1794572|NCT00561470|6244609|P2|Overall Study|Lost to Follow-up|0
1794573|NCT00561470|6244610|P1|Overall Study|Lost to Follow-up|2
1794574|NCT00561470|6244609|P2|Overall Study|poor compliance to protocol|4
1794575|NCT00561470|6244610|P1|Overall Study|poor compliance to protocol|4
1794576|NCT00561470|6244609|P2|Overall Study|Disease progression|305
1794577|NCT00561470|6244610|P1|Overall Study|Disease progression|437
1794578|NCT00561470|6244609|P2|Overall Study|Adverse Event|163
1794579|NCT00561470|6244610|P1|Overall Study|Adverse Event|74
1794580|NCT00561392|6244646|P1|Overall Study|Administrative problems|4
1794581|NCT00561392|6244646|P1|Overall Study|Withdrawal by Subject|8
1794582|NCT00561392|6244646|P1|Overall Study|Protocol Violation|1
1794583|NCT00561392|6244646|P1|Overall Study|Lack of Efficacy|2
1794584|NCT00561392|6244646|P1|Overall Study|Adverse Event|38
1794585|NCT00561353|6244668|P10|Overall Study|Withdrawal by Subject|0
1794586|NCT00561353|6244669|P9|Overall Study|Withdrawal by Subject|0
1794587|NCT00561353|6244670|P8|Overall Study|Withdrawal by Subject|0
1794588|NCT00561353|6244671|P7|Overall Study|Withdrawal by Subject|0
1794589|NCT00561353|6244672|P6|Overall Study|Withdrawal by Subject|0
1794590|NCT00561353|6244673|P5|Overall Study|Withdrawal by Subject|0
1794591|NCT00561353|6244674|P4|Overall Study|Withdrawal by Subject|0
1794592|NCT00561353|6244675|P3|Overall Study|Withdrawal by Subject|0
1794593|NCT00561353|6244676|P2|Overall Study|Withdrawal by Subject|2
1794594|NCT00561353|6244677|P1|Overall Study|Withdrawal by Subject|0
1794595|NCT00561353|6244668|P10|Overall Study|Lost to Follow-up|0
1794596|NCT00561353|6244669|P9|Overall Study|Lost to Follow-up|0
1794597|NCT00561353|6244670|P8|Overall Study|Lost to Follow-up|0
1794598|NCT00561353|6244671|P7|Overall Study|Lost to Follow-up|0
1794599|NCT00561353|6244672|P6|Overall Study|Lost to Follow-up|0
1794600|NCT00561353|6244673|P5|Overall Study|Lost to Follow-up|0
1794601|NCT00561353|6244674|P4|Overall Study|Lost to Follow-up|0
1794602|NCT00561353|6244675|P3|Overall Study|Lost to Follow-up|1
1794603|NCT00561353|6244676|P2|Overall Study|Lost to Follow-up|0
1794604|NCT00561353|6244677|P1|Overall Study|Lost to Follow-up|2
1794605|NCT00561353|6244668|P10|Overall Study|Adverse Event|1
1794606|NCT00561353|6244669|P9|Overall Study|Adverse Event|0
1794607|NCT00561353|6244670|P8|Overall Study|Adverse Event|0
1794608|NCT00561353|6244671|P7|Overall Study|Adverse Event|1
1794609|NCT00561353|6244672|P6|Overall Study|Adverse Event|0
1794610|NCT00561353|6244673|P5|Overall Study|Adverse Event|0
1794611|NCT00561353|6244674|P4|Overall Study|Adverse Event|2
1794612|NCT00561353|6244675|P3|Overall Study|Adverse Event|0
1794613|NCT00561353|6244676|P2|Overall Study|Adverse Event|0
1794614|NCT00561353|6244677|P1|Overall Study|Adverse Event|0
1794615|NCT00561353|6244668|P10|Overall Study|Other|0
1794616|NCT00561353|6244669|P9|Overall Study|Other|0
1794617|NCT00561353|6244670|P8|Overall Study|Other|0
1794618|NCT00561353|6244671|P7|Overall Study|Other|0
1794619|NCT00561353|6244672|P6|Overall Study|Other|2
1794620|NCT00561353|6244673|P5|Overall Study|Other|0
1794621|NCT00561353|6244674|P4|Overall Study|Other|0
1794622|NCT00561353|6244675|P3|Overall Study|Other|1
1794623|NCT00561353|6244676|P2|Overall Study|Other|0
1794624|NCT00561353|6244677|P1|Overall Study|Other|1
1794625|NCT00561353|6244668|P10|Overall Study|Subject ineligible to continue the trial|1
1794626|NCT00561353|6244669|P9|Overall Study|Subject ineligible to continue the trial|2
1794627|NCT00561353|6244670|P8|Overall Study|Subject ineligible to continue the trial|0
1794628|NCT00561353|6244671|P7|Overall Study|Subject ineligible to continue the trial|1
1794629|NCT00561353|6244672|P6|Overall Study|Subject ineligible to continue the trial|1
1794630|NCT00561353|6244673|P5|Overall Study|Subject ineligible to continue the trial|0
1794631|NCT00561353|6244674|P4|Overall Study|Subject ineligible to continue the trial|0
1794632|NCT00561353|6244675|P3|Overall Study|Subject ineligible to continue the trial|0
1794633|NCT00561353|6244676|P2|Overall Study|Subject ineligible to continue the trial|0
1794634|NCT00561353|6244677|P1|Overall Study|Subject ineligible to continue the trial|0
1794635|NCT00561353|6244668|P10|Overall Study|Subject reached a virologic endpoint|0
1794636|NCT00561353|6244669|P9|Overall Study|Subject reached a virologic endpoint|5
1794637|NCT00561353|6244670|P8|Overall Study|Subject reached a virologic endpoint|4
1794638|NCT00561353|6244671|P7|Overall Study|Subject reached a virologic endpoint|4
1794639|NCT00561353|6244672|P6|Overall Study|Subject reached a virologic endpoint|3
1794640|NCT00561353|6244673|P5|Overall Study|Subject reached a virologic endpoint|1
1794641|NCT00561353|6244674|P4|Overall Study|Subject reached a virologic endpoint|4
1794642|NCT00561353|6244675|P3|Overall Study|Subject reached a virologic endpoint|1
1794643|NCT00561353|6244676|P2|Overall Study|Subject reached a virologic endpoint|1
1794644|NCT00561353|6244677|P1|Overall Study|Subject reached a virologic endpoint|2
1794645|NCT00561340|6244832|P2|Overall Study|refused to drink pediasure|0
1794646|NCT00561340|6244833|P1|Overall Study|refused to drink pediasure|6
1794647|NCT00561080|6244853|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
1794648|NCT00561080|6244854|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
1794649|NCT00561080|6244855|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
1794650|NCT00561080|6244853|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
1794651|NCT00561080|6244854|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
1794652|NCT00561080|6244855|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
1794653|NCT00561080|6244853|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
1794654|NCT00561080|6244854|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
1794655|NCT00561080|6244855|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
1794656|NCT00561080|6244853|P3|12-month Post Last Dose Follow-up|Adverse Event|1
1794657|NCT00561080|6244854|P2|12-month Post Last Dose Follow-up|Adverse Event|3
1794658|NCT00561080|6244855|P1|12-month Post Last Dose Follow-up|Adverse Event|3
1794659|NCT00561080|6244853|P3|Vaccination Period (up to Month 4)|Other|1
1794660|NCT00561080|6244854|P2|Vaccination Period (up to Month 4)|Other|2
1794661|NCT00561080|6244855|P1|Vaccination Period (up to Month 4)|Other|0
1794662|NCT00561080|6244853|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
1794663|NCT00561080|6244854|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
1794664|NCT00561080|6244855|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
1794665|NCT00561080|6244853|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
1794666|NCT00561080|6244854|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
1794667|NCT00561080|6244855|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
1794668|NCT00561080|6244853|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
1794669|NCT00561080|6244854|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
1794670|NCT00561080|6244855|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
1794671|NCT00561080|6244853|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
1794672|NCT00561080|6244854|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
1794673|NCT00561080|6244855|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
1794674|NCT00561080|6244853|P3|Vaccination Period (up to Month 4)|Adverse Event|6
1794675|NCT00561080|6244854|P2|Vaccination Period (up to Month 4)|Adverse Event|4
1794676|NCT00561080|6244855|P1|Vaccination Period (up to Month 4)|Adverse Event|0
1794677|NCT00561015|6244932|P6|Overall Study|Participant non-compliance|0
1794678|NCT00561015|6244933|P5|Overall Study|Participant non-compliance|0
1794679|NCT00561015|6244934|P4|Overall Study|Participant non-compliance|0
1794680|NCT00561015|6244935|P3|Overall Study|Participant non-compliance|0
1794681|NCT00561015|6244936|P2|Overall Study|Participant non-compliance|0
1794682|NCT00561015|6244937|P1|Overall Study|Participant non-compliance|2
1794683|NCT00561015|6244932|P6|Overall Study|Lost to Follow-up|3
1794684|NCT00561015|6244933|P5|Overall Study|Lost to Follow-up|0
1794685|NCT00561015|6244934|P4|Overall Study|Lost to Follow-up|1
1794686|NCT00561015|6244935|P3|Overall Study|Lost to Follow-up|0
1794687|NCT00561015|6244936|P2|Overall Study|Lost to Follow-up|0
1794688|NCT00561015|6244937|P1|Overall Study|Lost to Follow-up|2
1794689|NCT00561015|6244932|P6|Overall Study|Adverse Event|0
1794690|NCT00561015|6244933|P5|Overall Study|Adverse Event|1
1794691|NCT00561015|6244934|P4|Overall Study|Adverse Event|0
1794692|NCT00561015|6244935|P3|Overall Study|Adverse Event|0
1794693|NCT00561015|6244936|P2|Overall Study|Adverse Event|0
1794694|NCT00561015|6244937|P1|Overall Study|Adverse Event|0
1794695|NCT00560950|6245028|P2|Overall Study|Lost to Follow-up|0
1794696|NCT00560950|6245029|P1|Overall Study|Lost to Follow-up|1
1794697|NCT00560937|6245067|P2|Overall Study|Physician Decision|1
1794698|NCT00560937|6245068|P1|Overall Study|Physician Decision|1
1794699|NCT00560937|6245067|P2|Overall Study|Withdrawal by Subject|1
1794700|NCT00560937|6245068|P1|Overall Study|Withdrawal by Subject|0
1794701|NCT00560885|6245084|P1|Overall Study|Withdrawal by Subject|1
1794702|NCT00560885|6245084|P1|Overall Study|Death|7
1794703|NCT00560833|6245109|P5|Overall Study|Never received drug|1
1794704|NCT00560833|6245110|P4|Overall Study|Never received drug|0
1794705|NCT00560833|6245111|P3|Overall Study|Never received drug|0
1794706|NCT00560833|6245112|P2|Overall Study|Never received drug|1
1794707|NCT00560833|6245113|P1|Overall Study|Never received drug|0
1794708|NCT00560833|6245109|P5|Overall Study|Other|0
1794709|NCT00560833|6245110|P4|Overall Study|Other|0
1794710|NCT00560833|6245111|P3|Overall Study|Other|3
1794711|NCT00560833|6245112|P2|Overall Study|Other|1
1794712|NCT00560833|6245113|P1|Overall Study|Other|1
1794713|NCT00560833|6245109|P5|Overall Study|Participant uncooperative|2
1794714|NCT00560833|6245110|P4|Overall Study|Participant uncooperative|4
1794715|NCT00560833|6245111|P3|Overall Study|Participant uncooperative|4
1794716|NCT00560833|6245112|P2|Overall Study|Participant uncooperative|5
1794717|NCT00560833|6245113|P1|Overall Study|Participant uncooperative|5
1794718|NCT00560833|6245109|P5|Overall Study|Lack of Efficacy|4
1794719|NCT00560833|6245110|P4|Overall Study|Lack of Efficacy|4
1794720|NCT00560833|6245111|P3|Overall Study|Lack of Efficacy|6
1794721|NCT00560833|6245112|P2|Overall Study|Lack of Efficacy|9
1794722|NCT00560833|6245113|P1|Overall Study|Lack of Efficacy|22
1794723|NCT00560833|6245109|P5|Overall Study|Lost to Follow-up|0
1794724|NCT00560833|6245110|P4|Overall Study|Lost to Follow-up|0
1794725|NCT00560833|6245111|P3|Overall Study|Lost to Follow-up|1
1794726|NCT00560833|6245112|P2|Overall Study|Lost to Follow-up|0
1794727|NCT00560833|6245113|P1|Overall Study|Lost to Follow-up|0
1794728|NCT00560833|6245109|P5|Overall Study|Adverse Event|35
1794729|NCT00560833|6245110|P4|Overall Study|Adverse Event|23
1794730|NCT00560833|6245111|P3|Overall Study|Adverse Event|25
1794731|NCT00560833|6245112|P2|Overall Study|Adverse Event|10
1794732|NCT00560833|6245113|P1|Overall Study|Adverse Event|16
1794733|NCT00560794|6245145|P1|Overall Study|Received Bone Marrow Transplant|6
1794734|NCT00560794|6245145|P1|Overall Study|Hematological Relapse|1
1794735|NCT00560794|6245145|P1|Overall Study|Minimal Residual Disease Relapse|1
1794736|NCT00560794|6245145|P1|Overall Study|Patient was not Compliant|1
1794737|NCT00560794|6245145|P1|Overall Study|Adverse Event|2
1794738|NCT00560755|6245162|P1|Overall Study|Physician Decision|2
1794739|NCT00560755|6245162|P1|Overall Study|Adverse Event|8
1794740|NCT00560755|6245162|P1|Overall Study|Lost to Follow-up|9
1794741|NCT00560755|6245162|P1|Overall Study|Withdrawal by Subject|26
1794742|NCT00560755|6245162|P1|Overall Study|Protocol Violation|15
1794743|NCT00560703|6245183|P2|Overall Study|non-compliance|1
1794744|NCT00560703|6245184|P1|Overall Study|non-compliance|0
1794745|NCT00560703|6245183|P2|Overall Study|Withdrawal by Subject|1
1794746|NCT00560703|6245184|P1|Overall Study|Withdrawal by Subject|0
1794747|NCT00560703|6245183|P2|Overall Study|Protocol Violation|2
1794748|NCT00560703|6245184|P1|Overall Study|Protocol Violation|0
1794749|NCT00560703|6245183|P2|Overall Study|Adverse Event|2
1794750|NCT00560703|6245184|P1|Overall Study|Adverse Event|0
1794751|NCT00560573|6245207|P6|Overall Study|Enrolled, not treated|0
1794752|NCT00560573|6245208|P5|Overall Study|Enrolled, not treated|1
1794753|NCT00560573|6245209|P4|Overall Study|Enrolled, not treated|0
1794754|NCT00560573|6245210|P3|Overall Study|Enrolled, not treated|0
1794755|NCT00560573|6245211|P2|Overall Study|Enrolled, not treated|0
1794756|NCT00560573|6245212|P1|Overall Study|Enrolled, not treated|0
1794757|NCT00560573|6245207|P6|Overall Study|Other|3
1794758|NCT00560573|6245208|P5|Overall Study|Other|3
1794759|NCT00560573|6245209|P4|Overall Study|Other|3
1794760|NCT00560573|6245210|P3|Overall Study|Other|2
1794761|NCT00560573|6245211|P2|Overall Study|Other|2
1794762|NCT00560573|6245212|P1|Overall Study|Other|2
1794763|NCT00560573|6245207|P6|Overall Study|Withdrawal by Subject|0
1794764|NCT00560573|6245208|P5|Overall Study|Withdrawal by Subject|1
1794765|NCT00560573|6245209|P4|Overall Study|Withdrawal by Subject|1
1794766|NCT00560573|6245210|P3|Overall Study|Withdrawal by Subject|0
1794767|NCT00560573|6245211|P2|Overall Study|Withdrawal by Subject|0
1794768|NCT00560573|6245212|P1|Overall Study|Withdrawal by Subject|0
1794769|NCT00560573|6245207|P6|Overall Study|Lost to Follow-up|0
1794770|NCT00560573|6245208|P5|Overall Study|Lost to Follow-up|1
1794771|NCT00560573|6245209|P4|Overall Study|Lost to Follow-up|1
1794772|NCT00560573|6245210|P3|Overall Study|Lost to Follow-up|0
1794773|NCT00560573|6245211|P2|Overall Study|Lost to Follow-up|0
1794774|NCT00560573|6245212|P1|Overall Study|Lost to Follow-up|0
1794775|NCT00560573|6245207|P6|Overall Study|Death|10
1794776|NCT00560573|6245208|P5|Overall Study|Death|1
1794777|NCT00560573|6245209|P4|Overall Study|Death|5
1794778|NCT00560573|6245210|P3|Overall Study|Death|4
1794779|NCT00560573|6245211|P2|Overall Study|Death|1
1794780|NCT00560573|6245212|P1|Overall Study|Death|4
1794781|NCT00560508|6245289|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
1794782|NCT00560508|6245290|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
1794783|NCT00560508|6245289|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
1794784|NCT00560508|6245290|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
1794785|NCT00560508|6245289|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
1794786|NCT00560508|6245290|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
1794787|NCT00560508|6245289|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
1794788|NCT00560508|6245290|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
1794789|NCT00560508|6245289|P2|12 Week Double-blind Period|Withdrawal by Subject|1
1794790|NCT00560508|6245290|P1|12 Week Double-blind Period|Withdrawal by Subject|1
1794791|NCT00560508|6245289|P2|12 Week Double-blind Period|Protocol Violation|0
1794792|NCT00560508|6245290|P1|12 Week Double-blind Period|Protocol Violation|1
1794793|NCT00560508|6245289|P2|12 Week Double-blind Period|Adverse Event|2
1794794|NCT00560508|6245290|P1|12 Week Double-blind Period|Adverse Event|3
1794795|NCT00560417|6245349|P2|Overall Study|Withdrawal by Subject|3
1794796|NCT00560417|6245350|P1|Overall Study|Withdrawal by Subject|3
1794797|NCT00560417|6245349|P2|Overall Study|Sponsor Decision|0
1794798|NCT00560417|6245350|P1|Overall Study|Sponsor Decision|2
1794799|NCT00560417|6245349|P2|Overall Study|Protocol Violation|5
1794800|NCT00560417|6245350|P1|Overall Study|Protocol Violation|6
1794801|NCT00560417|6245349|P2|Overall Study|Physician Decision|6
1794802|NCT00560417|6245350|P1|Overall Study|Physician Decision|2
1794803|NCT00560417|6245349|P2|Overall Study|Lost to Follow-up|1
1794804|NCT00560417|6245350|P1|Overall Study|Lost to Follow-up|0
1794805|NCT00560417|6245349|P2|Overall Study|Entry Criteria Not Met|0
1794806|NCT00560417|6245350|P1|Overall Study|Entry Criteria Not Met|1
1794807|NCT00560417|6245349|P2|Overall Study|Adverse Event|2
1794808|NCT00560417|6245350|P1|Overall Study|Adverse Event|3
1794809|NCT00560404|6245378|P2|Overall Study|Other withdrawal reason|5
1794810|NCT00560404|6245379|P1|Overall Study|Other withdrawal reason|13
1794811|NCT00560404|6245378|P2|Overall Study|Failure to return|2
1794812|NCT00560404|6245379|P1|Overall Study|Failure to return|1
1794813|NCT00560404|6245378|P2|Overall Study|Withdrew Consent|0
1794814|NCT00560404|6245379|P1|Overall Study|Withdrew Consent|4
1794815|NCT00560404|6245378|P2|Overall Study|Administrative Reasons|1
1794816|NCT00560404|6245379|P1|Overall Study|Administrative Reasons|1
1794817|NCT00560404|6245378|P2|Overall Study|Protocol Violation|7
1794818|NCT00560404|6245379|P1|Overall Study|Protocol Violation|12
1794819|NCT00560404|6245378|P2|Overall Study|Death|3
1794820|NCT00560404|6245379|P1|Overall Study|Death|3
1794821|NCT00560404|6245378|P2|Overall Study|Adverse Event|3
1794822|NCT00560404|6245379|P1|Overall Study|Adverse Event|2
1794823|NCT00560391|6245426|P5|Overall Study|Still on treatment|2
1794824|NCT00560391|6245427|P4|Overall Study|Still on treatment|1
1794825|NCT00560391|6245428|P3|Overall Study|Still on treatment|0
1794826|NCT00560391|6245429|P2|Overall Study|Still on treatment|0
1794827|NCT00560391|6245430|P1|Overall Study|Still on treatment|0
1794828|NCT00560352|6245486|P3|Overall Study|Maximum clinical benefit|0
1794829|NCT00560352|6245487|P2|Overall Study|Maximum clinical benefit|0
1794830|NCT00560352|6245488|P1|Overall Study|Maximum clinical benefit|1
1794831|NCT00560352|6245486|P3|Overall Study|Withdrawal by Subject|1
1794832|NCT00560352|6245487|P2|Overall Study|Withdrawal by Subject|1
1794833|NCT00560352|6245488|P1|Overall Study|Withdrawal by Subject|1
1794834|NCT00560352|6245486|P3|Overall Study|Disease progression|1
1794835|NCT00560352|6245487|P2|Overall Study|Disease progression|1
1794836|NCT00560352|6245488|P1|Overall Study|Disease progression|0
1794837|NCT00560352|6245486|P3|Overall Study|Study drug toxicity|1
1794838|NCT00560352|6245487|P2|Overall Study|Study drug toxicity|0
1794839|NCT00560352|6245488|P1|Overall Study|Study drug toxicity|3
1794840|NCT00560352|6245486|P3|Overall Study|Adverse event unrelated to study drug|1
1794841|NCT00560352|6245487|P2|Overall Study|Adverse event unrelated to study drug|1
1794842|NCT00560352|6245488|P1|Overall Study|Adverse event unrelated to study drug|2
1794843|NCT00560313|6245505|P1|Overall Study|Protocol Violation|1
1794844|NCT00560313|6245505|P1|Overall Study|Lost to Follow-up|1
1794845|NCT00560313|6245505|P1|Overall Study|Withdrawal by Subject|2
1794846|NCT00560313|6245505|P1|Overall Study|Adverse Events or Death|2
1794847|NCT00560235|6245532|P3|Phase 2|Ongoing at Date of Cut-Off|1
1794848|NCT00560235|6245533|P2|Phase 2|Ongoing at Date of Cut-Off|0
1794849|NCT00560235|6245534|P1|Phase 2|Ongoing at Date of Cut-Off|0
1794850|NCT00560235|6245532|P3|Phase 2|Discontinued|96
1794851|NCT00560235|6245533|P2|Phase 2|Discontinued|0
1794852|NCT00560235|6245534|P1|Phase 2|Discontinued|0
1794853|NCT00560235|6245532|P3|Phase 1B|Discontinued|0
1794854|NCT00560235|6245533|P2|Phase 1B|Discontinued|19
1794855|NCT00560235|6245534|P1|Phase 1B|Discontinued|0
1794856|NCT00560235|6245532|P3|Phase 1|Discontinued|0
1794857|NCT00560235|6245533|P2|Phase 1|Discontinued|0
1794858|NCT00560235|6245534|P1|Phase 1|Discontinued|8
1794859|NCT00560105|6245565|P2|Overall Study|musculoskeletal chest discomfort with us|2
1794860|NCT00560105|6245566|P1|Overall Study|musculoskeletal chest discomfort with us|1
1794861|NCT00560066|6245580|P2|Overall Study|Missing primary reason|2
1794862|NCT00560066|6245581|P1|Overall Study|Missing primary reason|0
1794863|NCT00560066|6245580|P2|Overall Study|Administrative reason|5
1794864|NCT00560066|6245581|P1|Overall Study|Administrative reason|0
1794865|NCT00560066|6245580|P2|Overall Study|Protocol Violation|1
1794866|NCT00560066|6245581|P1|Overall Study|Protocol Violation|0
1794867|NCT00560066|6245580|P2|Overall Study|Lost to Follow-up|10
1794868|NCT00560066|6245581|P1|Overall Study|Lost to Follow-up|4
1794869|NCT00560066|6245580|P2|Overall Study|Withdrawal by Subject|3
1794870|NCT00560066|6245581|P1|Overall Study|Withdrawal by Subject|0
1794871|NCT00560066|6245580|P2|Overall Study|Death|1
1794872|NCT00560066|6245581|P1|Overall Study|Death|2
1794873|NCT00559988|6245613|P2|Overall Study|ICD device explanted|17
1794874|NCT00559988|6245614|P1|Overall Study|ICD device explanted|10
1794875|NCT00559988|6245613|P2|Overall Study|Lost to Follow-up|56
1794876|NCT00559988|6245614|P1|Overall Study|Lost to Follow-up|42
1794877|NCT00559988|6245613|P2|Overall Study|Withdrawal by Subject|139
1794878|NCT00559988|6245614|P1|Overall Study|Withdrawal by Subject|152
1794879|NCT00559988|6245613|P2|Overall Study|Death|140
1794880|NCT00559988|6245614|P1|Overall Study|Death|147
1794881|NCT00559962|6245644|P8|Overall Study|Inclusion/exclusion criteria not met|0
1794882|NCT00559962|6245645|P7|Overall Study|Inclusion/exclusion criteria not met|1
1794883|NCT00559962|6245646|P6|Overall Study|Inclusion/exclusion criteria not met|0
1794884|NCT00559962|6245647|P5|Overall Study|Inclusion/exclusion criteria not met|0
1794885|NCT00559962|6245648|P4|Overall Study|Inclusion/exclusion criteria not met|0
1794886|NCT00559962|6245649|P3|Overall Study|Inclusion/exclusion criteria not met|0
1794887|NCT00559962|6245650|P2|Overall Study|Inclusion/exclusion criteria not met|0
1794888|NCT00559962|6245651|P1|Overall Study|Inclusion/exclusion criteria not met|0
1794889|NCT00559962|6245644|P8|Overall Study|Withdrawal by Subject|2
1794890|NCT00559962|6245645|P7|Overall Study|Withdrawal by Subject|0
1794891|NCT00559962|6245646|P6|Overall Study|Withdrawal by Subject|1
1794892|NCT00559962|6245647|P5|Overall Study|Withdrawal by Subject|3
1794893|NCT00559962|6245648|P4|Overall Study|Withdrawal by Subject|0
1794894|NCT00559962|6245649|P3|Overall Study|Withdrawal by Subject|2
1794895|NCT00559962|6245650|P2|Overall Study|Withdrawal by Subject|1
1794896|NCT00559962|6245651|P1|Overall Study|Withdrawal by Subject|1
1794897|NCT00559962|6245644|P8|Overall Study|Lost to Follow-up|0
1794898|NCT00559962|6245645|P7|Overall Study|Lost to Follow-up|0
1794899|NCT00559962|6245646|P6|Overall Study|Lost to Follow-up|0
1794900|NCT00559962|6245647|P5|Overall Study|Lost to Follow-up|0
1794901|NCT00559962|6245648|P4|Overall Study|Lost to Follow-up|0
1794902|NCT00559962|6245649|P3|Overall Study|Lost to Follow-up|0
1794903|NCT00559962|6245650|P2|Overall Study|Lost to Follow-up|1
1794904|NCT00559962|6245651|P1|Overall Study|Lost to Follow-up|0
1794905|NCT00559962|6245644|P8|Overall Study|Adverse Event|2
1794906|NCT00559962|6245645|P7|Overall Study|Adverse Event|4
1794907|NCT00559962|6245646|P6|Overall Study|Adverse Event|4
1794908|NCT00559962|6245647|P5|Overall Study|Adverse Event|11
1794909|NCT00559962|6245648|P4|Overall Study|Adverse Event|5
1794910|NCT00559962|6245649|P3|Overall Study|Adverse Event|8
1794911|NCT00559962|6245650|P2|Overall Study|Adverse Event|7
1794912|NCT00559962|6245651|P1|Overall Study|Adverse Event|1
1794913|NCT00559949|6245671|P1|Overall Study|No disease evaluation per protocol|1
1794914|NCT00559949|6245671|P1|Overall Study|Withdrawal by Subject|4
1794915|NCT00559949|6245671|P1|Overall Study|Adverse Event|1
1794916|NCT00559949|6245671|P1|Overall Study|Progressive Disease during cycle 1|1
1794917|NCT00559845|6245687|P1|Overall Study|Premature Surgery-Investigator Decision|1
1794918|NCT00559845|6245687|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
1794919|NCT00559845|6245687|P1|Overall Study|Adverse Event|3
1794920|NCT00559845|6245687|P1|Overall Study|Disease Progression|1
1794921|NCT00559845|6245687|P1|Overall Study|Withdrew Consent|1
1794922|NCT00559754|6245696|P1|Overall Study|Withdrawal by Subject|2
1794923|NCT00559754|6245696|P1|Overall Study|Investigator criteria|2
1794924|NCT00559754|6245696|P1|Overall Study|Protocol Violation|1
1794925|NCT00559754|6245696|P1|Overall Study|Adverse Event|5
1794926|NCT00559754|6245696|P1|Overall Study|Disease progression|1
1794927|NCT00559637|6245720|P1|Overall Study|Inclusion or exclusion criteria violated|2
1794928|NCT00559637|6245720|P1|Overall Study|Change of home|1
1794929|NCT00559637|6245720|P1|Overall Study|Change of center|1
1794930|NCT00559637|6245720|P1|Overall Study|Delayed administration of C.E.R.A|1
1794931|NCT00559637|6245720|P1|Overall Study|Participation in another study|1
1794932|NCT00559637|6245720|P1|Overall Study|Suspected lung cancer|1
1794933|NCT00559637|6245720|P1|Overall Study|Started requiring dialysis after month 7|2
1794934|NCT00559637|6245720|P1|Overall Study|Insufficient response|3
1794935|NCT00559637|6245720|P1|Overall Study|Failure to return|6
1794936|NCT00559637|6245720|P1|Overall Study|Withdrawal criteria fulfilled|4
1794937|NCT00559637|6245720|P1|Overall Study|Protocol Violation|6
1794938|NCT00559637|6245720|P1|Overall Study|Withdrawal by Subject|4
1794939|NCT00559637|6245720|P1|Overall Study|Adverse Event|22
1794940|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
1794941|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
1794942|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|non-specified|0
1794943|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|non-specified|71
1794944|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
1794945|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
1794946|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
1794947|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
1794948|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
1794949|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
1794950|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Death|0
1794951|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Death|20
1794952|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
1794953|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
1794954|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
1794955|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
1794956|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
1794957|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
1794958|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
1794959|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
1794960|NCT00559585|6245733|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
1794961|NCT00559585|6245734|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
1794962|NCT00559585|6245733|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
1794963|NCT00559585|6245734|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
1794964|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
1794965|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
1794966|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Investigator Decision|1
1794967|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Investigator Decision|0
1794968|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
1794969|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
1794970|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
1794971|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
1794972|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Early Discontinuation|1
1794973|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Early Discontinuation|0
1794974|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
1794975|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
1794976|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
1794977|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
1794978|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Missed Doses|1
1794979|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Missed Doses|0
1794980|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
1794981|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
1794982|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
1794983|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
1794984|NCT00559585|6245733|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
1794985|NCT00559585|6245734|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
1794986|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Death|1
1794987|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Death|1
1794988|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
1794989|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
1794990|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
1794991|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
1794992|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
1794993|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
1794994|NCT00559585|6245733|P2|Double Blind ST Period Main Study|Adverse Event|25
1794995|NCT00559585|6245734|P1|Double Blind ST Period Main Study|Adverse Event|17
1794996|NCT00559507|6245794|P1|Overall Study|Not treated, patient ineligible|3
1794997|NCT00559377|6245813|P1|Overall Study|Withdrawal by Subject|9
1794998|NCT00559364|6245823|P2|Overall Study|Inclusion/exclusion criteria failure|0
1794999|NCT00559364|6245824|P1|Overall Study|Inclusion/exclusion criteria failure|1
1795000|NCT00559273|6245836|P2|Evaluation Period (8 Weeks)|Physician Decision|1
1795001|NCT00559273|6245837|P1|Evaluation Period (8 Weeks)|Physician Decision|0
1795002|NCT00559273|6245836|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
1795003|NCT00559273|6245837|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
1795004|NCT00559273|6245836|P2|Evaluation Period (8 Weeks)|Adverse Event|1
1795005|NCT00559273|6245837|P1|Evaluation Period (8 Weeks)|Adverse Event|0
1795006|NCT00559273|6245836|P2|Evaluation Period (8 Weeks)|Death|3
1795007|NCT00559273|6245837|P1|Evaluation Period (8 Weeks)|Death|1
1795008|NCT00559273|6245836|P2|Correction Period (20 Weeks)|Did not received study treatment|0
1795009|NCT00559273|6245837|P1|Correction Period (20 Weeks)|Did not received study treatment|2
1795010|NCT00559273|6245836|P2|Correction Period (20 Weeks)|Participant treated by another center|1
1795011|NCT00559273|6245837|P1|Correction Period (20 Weeks)|Participant treated by another center|0
1795012|NCT00559273|6245836|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
1795013|NCT00559273|6245837|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
1795014|NCT00559273|6245836|P2|Correction Period (20 Weeks)|Adverse Event|1
1795015|NCT00559273|6245837|P1|Correction Period (20 Weeks)|Adverse Event|2
1795016|NCT00559273|6245836|P2|Correction Period (20 Weeks)|Death|4
1795017|NCT00559273|6245837|P1|Correction Period (20 Weeks)|Death|3
1795018|NCT00559104|6245859|P2|Overall Study|Lack of Efficacy|0
1795019|NCT00559104|6245860|P1|Overall Study|Lack of Efficacy|9
1795020|NCT00558896|6245881|P7|Overall Study|Continues on treatment|6
1795021|NCT00558896|6245882|P6|Overall Study|Continues on treatment|25
1795022|NCT00558896|6245883|P5|Overall Study|Continues on treatment|9
1795023|NCT00558896|6245884|P4|Overall Study|Continues on treatment|1
1795024|NCT00558896|6245885|P3|Overall Study|Continues on treatment|0
1795025|NCT00558896|6245886|P2|Overall Study|Continues on treatment|1
1795026|NCT00558896|6245887|P1|Overall Study|Continues on treatment|10
1795027|NCT00558896|6245881|P7|Overall Study|Physician discretion|3
1795028|NCT00558896|6245882|P6|Overall Study|Physician discretion|3
1795029|NCT00558896|6245883|P5|Overall Study|Physician discretion|1
1795030|NCT00558896|6245884|P4|Overall Study|Physician discretion|2
1795031|NCT00558896|6245885|P3|Overall Study|Physician discretion|1
1795032|NCT00558896|6245886|P2|Overall Study|Physician discretion|2
1795033|NCT00558896|6245887|P1|Overall Study|Physician discretion|3
1795034|NCT00558896|6245881|P7|Overall Study|Alternative Treatment|1
1795035|NCT00558896|6245882|P6|Overall Study|Alternative Treatment|7
1795036|NCT00558896|6245883|P5|Overall Study|Alternative Treatment|6
1795037|NCT00558896|6245884|P4|Overall Study|Alternative Treatment|2
1795038|NCT00558896|6245885|P3|Overall Study|Alternative Treatment|0
1795039|NCT00558896|6245886|P2|Overall Study|Alternative Treatment|2
1795040|NCT00558896|6245887|P1|Overall Study|Alternative Treatment|2
1795041|NCT00558896|6245881|P7|Overall Study|Withdrawal by Subject|5
1795042|NCT00558896|6245882|P6|Overall Study|Withdrawal by Subject|5
1795043|NCT00558896|6245883|P5|Overall Study|Withdrawal by Subject|1
1795044|NCT00558896|6245884|P4|Overall Study|Withdrawal by Subject|1
1795045|NCT00558896|6245885|P3|Overall Study|Withdrawal by Subject|1
1795046|NCT00558896|6245886|P2|Overall Study|Withdrawal by Subject|1
1795047|NCT00558896|6245887|P1|Overall Study|Withdrawal by Subject|2
1795048|NCT00558896|6245881|P7|Overall Study|Death|6
1795049|NCT00558896|6245882|P6|Overall Study|Death|2
1795050|NCT00558896|6245883|P5|Overall Study|Death|2
1795051|NCT00558896|6245884|P4|Overall Study|Death|3
1795052|NCT00558896|6245885|P3|Overall Study|Death|2
1795053|NCT00558896|6245886|P2|Overall Study|Death|0
1795054|NCT00558896|6245887|P1|Overall Study|Death|3
1795055|NCT00558896|6245881|P7|Overall Study|Adverse Event|3
1795056|NCT00558896|6245882|P6|Overall Study|Adverse Event|10
1795057|NCT00558896|6245883|P5|Overall Study|Adverse Event|4
1795058|NCT00558896|6245884|P4|Overall Study|Adverse Event|3
1795059|NCT00558896|6245885|P3|Overall Study|Adverse Event|1
1795060|NCT00558896|6245886|P2|Overall Study|Adverse Event|1
1795061|NCT00558896|6245887|P1|Overall Study|Adverse Event|1
1795062|NCT00558831|6245989|P1|Overall Study|Lost to Follow-up|1
1795063|NCT00558753|6246046|P2|Overall Study|Lost to Follow-up|7
1795064|NCT00558753|6246047|P1|Overall Study|Lost to Follow-up|5
1795065|NCT00558701|6246059|P2|Overall Study|Protocol Deviations|4
1795066|NCT00558701|6246060|P1|Overall Study|Protocol Deviations|1
1795067|NCT00558636|6246068|P2|Follow-up|Premature termination of the study|7
1795068|NCT00558636|6246069|P1|Follow-up|Premature termination of the study|12
1795069|NCT00558636|6246068|P2|Treatment|Disease progression|5
1795070|NCT00558636|6246069|P1|Treatment|Disease progression|1
1795071|NCT00558636|6246068|P2|Treatment|Premature termination of the study|37
1795072|NCT00558636|6246069|P1|Treatment|Premature termination of the study|35
1795073|NCT00558636|6246068|P2|Treatment|Withdrawal by Subject|0
1795074|NCT00558636|6246069|P1|Treatment|Withdrawal by Subject|2
1795075|NCT00558636|6246068|P2|Treatment|Adverse Event|2
1795076|NCT00558636|6246069|P1|Treatment|Adverse Event|9
1795077|NCT00558558|6246169|P1|Overall Study|Lack of Efficacy|4
1795078|NCT00558558|6246169|P1|Overall Study|Withdrawal by Subject|1
1795079|NCT00558558|6246169|P1|Overall Study|Unable to swallow|1
1795080|NCT00558519|6246173|P1|Overall Study|Never received treatment|1
1795081|NCT00558519|6246173|P1|Overall Study|Insufficient data|1
1795082|NCT00558519|6246173|P1|Overall Study|Ineligible|1
1795083|NCT00558519|6246173|P1|Overall Study|Ph+|20
1795084|NCT00558467|6246183|P2|Overall Study|Patient moving out of state|1
1795085|NCT00558467|6246184|P1|Overall Study|Patient moving out of state|0
1795086|NCT00558467|6246183|P2|Overall Study|Lack of Efficacy|1
1795087|NCT00558467|6246184|P1|Overall Study|Lack of Efficacy|0
1795088|NCT00558467|6246183|P2|Overall Study|Adverse Event|2
1795089|NCT00558467|6246184|P1|Overall Study|Adverse Event|1
1795090|NCT00558428|6246244|P4|Overall Study|Other|1
1795091|NCT00558428|6246245|P3|Overall Study|Other|0
1795092|NCT00558428|6246246|P2|Overall Study|Other|0
1795093|NCT00558428|6246247|P1|Overall Study|Other|3
1795094|NCT00558428|6246244|P4|Overall Study|Consent withdrawn|1
1795095|NCT00558428|6246245|P3|Overall Study|Consent withdrawn|0
1795096|NCT00558428|6246246|P2|Overall Study|Consent withdrawn|1
1795097|NCT00558428|6246247|P1|Overall Study|Consent withdrawn|2
1795098|NCT00558428|6246244|P4|Overall Study|Non compliant with protocol|3
1795099|NCT00558428|6246245|P3|Overall Study|Non compliant with protocol|0
1795100|NCT00558428|6246246|P2|Overall Study|Non compliant with protocol|0
1795101|NCT00558428|6246247|P1|Overall Study|Non compliant with protocol|1
1795102|NCT00558428|6246244|P4|Overall Study|Lack of Efficacy|2
1795103|NCT00558428|6246245|P3|Overall Study|Lack of Efficacy|1
1795104|NCT00558428|6246246|P2|Overall Study|Lack of Efficacy|0
1795105|NCT00558428|6246247|P1|Overall Study|Lack of Efficacy|0
1795106|NCT00558428|6246244|P4|Overall Study|Lost to Follow-up|0
1795107|NCT00558428|6246245|P3|Overall Study|Lost to Follow-up|0
1795108|NCT00558428|6246246|P2|Overall Study|Lost to Follow-up|1
1795109|NCT00558428|6246247|P1|Overall Study|Lost to Follow-up|0
1795110|NCT00558428|6246244|P4|Overall Study|Adverse Event|4
1795111|NCT00558428|6246245|P3|Overall Study|Adverse Event|3
1795112|NCT00558428|6246246|P2|Overall Study|Adverse Event|22
1795113|NCT00558428|6246247|P1|Overall Study|Adverse Event|6
1795114|NCT00558363|6246287|P2|Overall Study|Hospitalized; Unable to Continue|1
1795115|NCT00558363|6246288|P1|Overall Study|Hospitalized; Unable to Continue|0
1795116|NCT00558363|6246287|P2|Overall Study|Randomized in Error|2
1795117|NCT00558363|6246288|P1|Overall Study|Randomized in Error|1
1795118|NCT00558363|6246287|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
1795119|NCT00558363|6246288|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
1795120|NCT00558363|6246287|P2|Overall Study|Lost to Follow-up|1
1795121|NCT00558363|6246288|P1|Overall Study|Lost to Follow-up|0
1795122|NCT00558363|6246287|P2|Overall Study|Protocol Violation|1
1795123|NCT00558363|6246288|P1|Overall Study|Protocol Violation|2
1795124|NCT00558363|6246287|P2|Overall Study|Lack of Efficacy|2
1795125|NCT00558363|6246288|P1|Overall Study|Lack of Efficacy|2
1795126|NCT00558363|6246287|P2|Overall Study|Adverse Event|5
1795127|NCT00558363|6246288|P1|Overall Study|Adverse Event|5
1795128|NCT00558363|6246287|P2|Overall Study|Withdrawal by Subject|4
1795129|NCT00558363|6246288|P1|Overall Study|Withdrawal by Subject|11
1795130|NCT00558363|6246287|P2|Overall Study|Physician Decision|4
1795131|NCT00558363|6246288|P1|Overall Study|Physician Decision|18
1795132|NCT00558285|6246343|P5|Overall Study|Protocol deviation|0
1795133|NCT00558285|6246344|P4|Overall Study|Protocol deviation|1
1795134|NCT00558285|6246345|P3|Overall Study|Protocol deviation|0
1795135|NCT00558285|6246346|P2|Overall Study|Protocol deviation|1
1795136|NCT00558285|6246347|P1|Overall Study|Protocol deviation|1
1795137|NCT00558285|6246343|P5|Overall Study|Administrative problems|1
1795138|NCT00558285|6246344|P4|Overall Study|Administrative problems|1
1795139|NCT00558285|6246345|P3|Overall Study|Administrative problems|0
1795140|NCT00558285|6246346|P2|Overall Study|Administrative problems|0
1795141|NCT00558285|6246347|P1|Overall Study|Administrative problems|0
1795142|NCT00558285|6246343|P5|Overall Study|Lost to Follow-up|0
1795143|NCT00558285|6246344|P4|Overall Study|Lost to Follow-up|0
1795144|NCT00558285|6246345|P3|Overall Study|Lost to Follow-up|0
1795145|NCT00558285|6246346|P2|Overall Study|Lost to Follow-up|1
1795146|NCT00558285|6246347|P1|Overall Study|Lost to Follow-up|1
1795147|NCT00558285|6246343|P5|Overall Study|Subject withdrew consent|1
1795148|NCT00558285|6246344|P4|Overall Study|Subject withdrew consent|1
1795149|NCT00558285|6246345|P3|Overall Study|Subject withdrew consent|1
1795150|NCT00558285|6246346|P2|Overall Study|Subject withdrew consent|0
1795151|NCT00558285|6246347|P1|Overall Study|Subject withdrew consent|2
1795152|NCT00558285|6246343|P5|Overall Study|Abnormal test procedure result(s)|0
1795153|NCT00558285|6246344|P4|Overall Study|Abnormal test procedure result(s)|0
1795154|NCT00558285|6246345|P3|Overall Study|Abnormal test procedure result(s)|0
1795155|NCT00558285|6246346|P2|Overall Study|Abnormal test procedure result(s)|0
1795156|NCT00558285|6246347|P1|Overall Study|Abnormal test procedure result(s)|1
1795157|NCT00558285|6246343|P5|Overall Study|Adverse Event|2
1795158|NCT00558285|6246344|P4|Overall Study|Adverse Event|1
1795159|NCT00558285|6246345|P3|Overall Study|Adverse Event|4
1795160|NCT00558285|6246346|P2|Overall Study|Adverse Event|1
1795161|NCT00558285|6246347|P1|Overall Study|Adverse Event|1
1795162|NCT00558272|6246391|P2|Overall Study|Withdrawal by Subject|1
1795163|NCT00558272|6246392|P1|Overall Study|Withdrawal by Subject|0
1795164|NCT00558272|6246391|P2|Overall Study|Incorrectly enrolled|0
1795165|NCT00558272|6246392|P1|Overall Study|Incorrectly enrolled|1
1795166|NCT00558272|6246391|P2|Overall Study|AZ study team decision|1
1795167|NCT00558272|6246392|P1|Overall Study|AZ study team decision|0
1795168|NCT00558272|6246391|P2|Overall Study|Dev. of study specific discon. criteria|0
1795169|NCT00558272|6246392|P1|Overall Study|Dev. of study specific discon. criteria|1
1795170|NCT00558272|6246391|P2|Overall Study|Death|0
1795171|NCT00558272|6246392|P1|Overall Study|Death|1
1795172|NCT00558272|6246391|P2|Overall Study|Adverse Event|0
1795173|NCT00558272|6246392|P1|Overall Study|Adverse Event|10
1795174|NCT00558259|6246432|P2|Overall Study|Withdrawal by Subject|13
1795175|NCT00558259|6246433|P1|Overall Study|Withdrawal by Subject|12
1795176|NCT00558259|6246432|P2|Overall Study|Protocol Violation|5
1795177|NCT00558259|6246433|P1|Overall Study|Protocol Violation|9
1795178|NCT00558259|6246432|P2|Overall Study|Adverse Event|81
1795179|NCT00558259|6246433|P1|Overall Study|Adverse Event|50
1795180|NCT00558103|6246473|P6|Monotherapy Extension Phase|Disease Progression|8
1795181|NCT00558103|6246474|P5|Monotherapy Extension Phase|Disease Progression|0
1795182|NCT00558103|6246475|P4|Monotherapy Extension Phase|Disease Progression|0
1795183|NCT00558103|6246476|P3|Monotherapy Extension Phase|Disease Progression|0
1795184|NCT00558103|6246477|P2|Monotherapy Extension Phase|Disease Progression|0
1795185|NCT00558103|6246478|P1|Monotherapy Extension Phase|Disease Progression|0
1795186|NCT00558103|6246473|P6|Monotherapy Extension Phase|Protocol Violation|1
1795187|NCT00558103|6246474|P5|Monotherapy Extension Phase|Protocol Violation|0
1795188|NCT00558103|6246475|P4|Monotherapy Extension Phase|Protocol Violation|0
1795189|NCT00558103|6246476|P3|Monotherapy Extension Phase|Protocol Violation|0
1795190|NCT00558103|6246477|P2|Monotherapy Extension Phase|Protocol Violation|0
1795191|NCT00558103|6246478|P1|Monotherapy Extension Phase|Protocol Violation|0
1795192|NCT00558103|6246473|P6|Randomized Treatment Phase|Adverse Event|0
1795193|NCT00558103|6246474|P5|Randomized Treatment Phase|Adverse Event|1
1795194|NCT00558103|6246475|P4|Randomized Treatment Phase|Adverse Event|1
1795195|NCT00558103|6246476|P3|Randomized Treatment Phase|Adverse Event|0
1795196|NCT00558103|6246477|P2|Randomized Treatment Phase|Adverse Event|0
1795197|NCT00558103|6246478|P1|Randomized Treatment Phase|Adverse Event|0
1795198|NCT00558103|6246473|P6|Randomized Treatment Phase|Disease Progression|0
1795199|NCT00558103|6246474|P5|Randomized Treatment Phase|Disease Progression|0
1795200|NCT00558103|6246475|P4|Randomized Treatment Phase|Disease Progression|0
1795201|NCT00558103|6246476|P3|Randomized Treatment Phase|Disease Progression|1
1795202|NCT00558103|6246477|P2|Randomized Treatment Phase|Disease Progression|0
1795203|NCT00558103|6246478|P1|Randomized Treatment Phase|Disease Progression|1
1795204|NCT00558103|6246473|P6|Randomized Treatment Phase|Withdrawal by Subject|0
1795205|NCT00558103|6246474|P5|Randomized Treatment Phase|Withdrawal by Subject|1
1795206|NCT00558103|6246475|P4|Randomized Treatment Phase|Withdrawal by Subject|0
1795207|NCT00558103|6246476|P3|Randomized Treatment Phase|Withdrawal by Subject|0
1795208|NCT00558103|6246477|P2|Randomized Treatment Phase|Withdrawal by Subject|2
1795209|NCT00558103|6246478|P1|Randomized Treatment Phase|Withdrawal by Subject|2
1795210|NCT00558103|6246473|P6|Randomized Treatment Phase|Lost to Follow-up|0
1795211|NCT00558103|6246474|P5|Randomized Treatment Phase|Lost to Follow-up|3
1795212|NCT00558103|6246475|P4|Randomized Treatment Phase|Lost to Follow-up|1
1795213|NCT00558103|6246476|P3|Randomized Treatment Phase|Lost to Follow-up|2
1795214|NCT00558103|6246477|P2|Randomized Treatment Phase|Lost to Follow-up|2
1795215|NCT00558103|6246478|P1|Randomized Treatment Phase|Lost to Follow-up|2
1795216|NCT00558064|6246508|P2|Overall Study|No visit within allowance period|0
1795217|NCT00558064|6246509|P1|Overall Study|No visit within allowance period|1
1795218|NCT00558064|6246508|P2|Overall Study|Withdrawal by Subject|1
1795219|NCT00558064|6246509|P1|Overall Study|Withdrawal by Subject|0
1795220|NCT00558064|6246508|P2|Overall Study|Lost to Follow-up|1
1795221|NCT00558064|6246509|P1|Overall Study|Lost to Follow-up|0
1795222|NCT00558064|6246508|P2|Overall Study|Protocol Violation|0
1795223|NCT00558064|6246509|P1|Overall Study|Protocol Violation|1
1795224|NCT00558064|6246508|P2|Overall Study|Lack of Efficacy|1
1795225|NCT00558064|6246509|P1|Overall Study|Lack of Efficacy|0
1795226|NCT00558064|6246508|P2|Overall Study|Adverse Event|2
1795227|NCT00558064|6246509|P1|Overall Study|Adverse Event|3
1795228|NCT00558025|6246531|P2|Overall Study|Protocol Violation|0
1795229|NCT00558025|6246532|P1|Overall Study|Protocol Violation|1
1795230|NCT00558025|6246531|P2|Overall Study|Withdrawal by Subject|2
1795231|NCT00558025|6246532|P1|Overall Study|Withdrawal by Subject|2
1795232|NCT00558025|6246531|P2|Overall Study|Adverse Event|1
1795233|NCT00558025|6246532|P1|Overall Study|Adverse Event|1
1795234|NCT00557856|6246579|P9|Part 2: Exploratory Phase|global deterioration of health status|1
1795235|NCT00557856|6246580|P8|Part 2: Exploratory Phase|global deterioration of health status|0
1795236|NCT00557856|6246581|P7|Part 2: Exploratory Phase|global deterioration of health status|0
1795237|NCT00557856|6246582|P6|Part 2: Exploratory Phase|global deterioration of health status|0
1795238|NCT00557856|6246583|P5|Part 2: Exploratory Phase|global deterioration of health status|0
1795239|NCT00557856|6246584|P4|Part 2: Exploratory Phase|global deterioration of health status|0
1795240|NCT00557856|6246585|P3|Part 2: Exploratory Phase|global deterioration of health status|0
1795241|NCT00557856|6246586|P2|Part 2: Exploratory Phase|global deterioration of health status|0
1795242|NCT00557856|6246587|P1|Part 2: Exploratory Phase|global deterioration of health status|0
1795243|NCT00557856|6246579|P9|Part 2: Exploratory Phase|Death|2
1795244|NCT00557856|6246580|P8|Part 2: Exploratory Phase|Death|0
1795245|NCT00557856|6246581|P7|Part 2: Exploratory Phase|Death|0
1795246|NCT00557856|6246582|P6|Part 2: Exploratory Phase|Death|0
1795247|NCT00557856|6246583|P5|Part 2: Exploratory Phase|Death|0
1795248|NCT00557856|6246584|P4|Part 2: Exploratory Phase|Death|0
1795249|NCT00557856|6246585|P3|Part 2: Exploratory Phase|Death|0
1795250|NCT00557856|6246586|P2|Part 2: Exploratory Phase|Death|0
1795251|NCT00557856|6246587|P1|Part 2: Exploratory Phase|Death|0
1795252|NCT00557856|6246579|P9|Part 2: Exploratory Phase|Other|1
1795253|NCT00557856|6246580|P8|Part 2: Exploratory Phase|Other|0
1795254|NCT00557856|6246581|P7|Part 2: Exploratory Phase|Other|0
1795255|NCT00557856|6246582|P6|Part 2: Exploratory Phase|Other|0
1795256|NCT00557856|6246583|P5|Part 2: Exploratory Phase|Other|0
1795257|NCT00557856|6246584|P4|Part 2: Exploratory Phase|Other|0
1795258|NCT00557856|6246585|P3|Part 2: Exploratory Phase|Other|0
1795259|NCT00557856|6246586|P2|Part 2: Exploratory Phase|Other|0
1795260|NCT00557856|6246587|P1|Part 2: Exploratory Phase|Other|0
1795261|NCT00557856|6246579|P9|Part 2: Exploratory Phase|Adverse Event|4
1795262|NCT00557856|6246580|P8|Part 2: Exploratory Phase|Adverse Event|0
1795263|NCT00557856|6246581|P7|Part 2: Exploratory Phase|Adverse Event|0
1795264|NCT00557856|6246582|P6|Part 2: Exploratory Phase|Adverse Event|0
1795265|NCT00557856|6246583|P5|Part 2: Exploratory Phase|Adverse Event|0
1795266|NCT00557856|6246584|P4|Part 2: Exploratory Phase|Adverse Event|0
1795267|NCT00557856|6246585|P3|Part 2: Exploratory Phase|Adverse Event|0
1795268|NCT00557856|6246586|P2|Part 2: Exploratory Phase|Adverse Event|0
1795269|NCT00557856|6246587|P1|Part 2: Exploratory Phase|Adverse Event|0
1795270|NCT00557856|6246579|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
1795271|NCT00557856|6246580|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795272|NCT00557856|6246581|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795273|NCT00557856|6246582|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795274|NCT00557856|6246583|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795275|NCT00557856|6246584|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795276|NCT00557856|6246585|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795277|NCT00557856|6246586|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795278|NCT00557856|6246587|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
1795279|NCT00557856|6246579|P9|Part 2: Exploratory Phase|objective progression or relapse|15
1795280|NCT00557856|6246580|P8|Part 2: Exploratory Phase|objective progression or relapse|0
1795281|NCT00557856|6246581|P7|Part 2: Exploratory Phase|objective progression or relapse|0
1795282|NCT00557856|6246582|P6|Part 2: Exploratory Phase|objective progression or relapse|0
1795283|NCT00557856|6246583|P5|Part 2: Exploratory Phase|objective progression or relapse|0
1795284|NCT00557856|6246584|P4|Part 2: Exploratory Phase|objective progression or relapse|0
1795285|NCT00557856|6246585|P3|Part 2: Exploratory Phase|objective progression or relapse|0
1795286|NCT00557856|6246586|P2|Part 2: Exploratory Phase|objective progression or relapse|0
1795287|NCT00557856|6246587|P1|Part 2: Exploratory Phase|objective progression or relapse|0
1795288|NCT00557856|6246579|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
1795289|NCT00557856|6246580|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
1795290|NCT00557856|6246581|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
1795291|NCT00557856|6246582|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
1795292|NCT00557856|6246583|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
1795293|NCT00557856|6246584|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
1795294|NCT00557856|6246585|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
1795295|NCT00557856|6246586|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
1795296|NCT00557856|6246587|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
1795297|NCT00557856|6246579|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
1795298|NCT00557856|6246580|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
1795299|NCT00557856|6246581|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
1795300|NCT00557856|6246582|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
1795301|NCT00557856|6246583|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
1795302|NCT00557856|6246584|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
1795303|NCT00557856|6246585|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
1795304|NCT00557856|6246586|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
1795305|NCT00557856|6246587|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
1795306|NCT00557856|6246579|P9|Part 1: Dose Escalation Phase|Death|0
1795307|NCT00557856|6246580|P8|Part 1: Dose Escalation Phase|Death|0
1795308|NCT00557856|6246581|P7|Part 1: Dose Escalation Phase|Death|0
1795309|NCT00557856|6246582|P6|Part 1: Dose Escalation Phase|Death|1
1795310|NCT00557856|6246583|P5|Part 1: Dose Escalation Phase|Death|0
1795311|NCT00557856|6246584|P4|Part 1: Dose Escalation Phase|Death|0
1795312|NCT00557856|6246585|P3|Part 1: Dose Escalation Phase|Death|0
1795313|NCT00557856|6246586|P2|Part 1: Dose Escalation Phase|Death|0
1795314|NCT00557856|6246587|P1|Part 1: Dose Escalation Phase|Death|0
1795315|NCT00557856|6246579|P9|Part 1: Dose Escalation Phase|Other|0
1795316|NCT00557856|6246580|P8|Part 1: Dose Escalation Phase|Other|1
1795317|NCT00557856|6246581|P7|Part 1: Dose Escalation Phase|Other|0
1795318|NCT00557856|6246582|P6|Part 1: Dose Escalation Phase|Other|0
1795319|NCT00557856|6246583|P5|Part 1: Dose Escalation Phase|Other|0
1795320|NCT00557856|6246584|P4|Part 1: Dose Escalation Phase|Other|1
1795321|NCT00557856|6246585|P3|Part 1: Dose Escalation Phase|Other|1
1795322|NCT00557856|6246586|P2|Part 1: Dose Escalation Phase|Other|0
1795323|NCT00557856|6246587|P1|Part 1: Dose Escalation Phase|Other|0
1795324|NCT00557856|6246579|P9|Part 1: Dose Escalation Phase|Adverse Event|0
1795325|NCT00557856|6246580|P8|Part 1: Dose Escalation Phase|Adverse Event|2
1795326|NCT00557856|6246581|P7|Part 1: Dose Escalation Phase|Adverse Event|1
1795327|NCT00557856|6246582|P6|Part 1: Dose Escalation Phase|Adverse Event|3
1795328|NCT00557856|6246583|P5|Part 1: Dose Escalation Phase|Adverse Event|1
1795329|NCT00557856|6246584|P4|Part 1: Dose Escalation Phase|Adverse Event|1
1795330|NCT00557856|6246585|P3|Part 1: Dose Escalation Phase|Adverse Event|1
1795331|NCT00557856|6246586|P2|Part 1: Dose Escalation Phase|Adverse Event|0
1795332|NCT00557856|6246587|P1|Part 1: Dose Escalation Phase|Adverse Event|1
1795333|NCT00557856|6246579|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1795334|NCT00557856|6246580|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1795335|NCT00557856|6246581|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1795336|NCT00557856|6246582|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1795337|NCT00557856|6246583|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1795338|NCT00557856|6246584|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1795339|NCT00557856|6246585|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
1795340|NCT00557856|6246586|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
1795341|NCT00557856|6246587|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
1795342|NCT00557856|6246579|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
1795343|NCT00557856|6246580|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
1795344|NCT00557856|6246581|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
1795345|NCT00557856|6246582|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
1795346|NCT00557856|6246583|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
1795347|NCT00557856|6246584|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
1795348|NCT00557856|6246585|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
1795349|NCT00557856|6246586|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
1795350|NCT00557856|6246587|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
1795351|NCT00557830|6246786|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
1795352|NCT00557830|6246787|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
1795353|NCT00557830|6246788|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
1795354|NCT00557830|6246786|P3|Screening Treatment Phase|Adverse Event|0
1795355|NCT00557830|6246787|P2|Screening Treatment Phase|Adverse Event|0
1795356|NCT00557830|6246788|P1|Screening Treatment Phase|Adverse Event|2
1795357|NCT00557830|6246786|P3|Screening Treatment Phase|Withdrawal by Subject|0
1795358|NCT00557830|6246787|P2|Screening Treatment Phase|Withdrawal by Subject|0
1795359|NCT00557830|6246788|P1|Screening Treatment Phase|Withdrawal by Subject|1
1795360|NCT00557622|6246810|P2|12-Week Treatment Phase|Lost to Follow-up|1
1795361|NCT00557622|6246811|P1|12-Week Treatment Phase|Lost to Follow-up|0
1795362|NCT00557622|6246810|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
1795363|NCT00557622|6246811|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
1795364|NCT00557622|6246810|P2|4-Week Run-in Phase|Withdrawal by Subject|0
1795365|NCT00557622|6246811|P1|4-Week Run-in Phase|Withdrawal by Subject|1
1795366|NCT00557505|6246840|P9|Overall Study|Withdrawal by Subject|1
1795367|NCT00557505|6246841|P8|Overall Study|Withdrawal by Subject|0
1795368|NCT00557505|6246842|P7|Overall Study|Withdrawal by Subject|0
1795369|NCT00557505|6246843|P6|Overall Study|Withdrawal by Subject|0
1795370|NCT00557505|6246844|P5|Overall Study|Withdrawal by Subject|0
1795371|NCT00557505|6246845|P4|Overall Study|Withdrawal by Subject|1
1795372|NCT00557505|6246846|P3|Overall Study|Withdrawal by Subject|0
1795373|NCT00557505|6246847|P2|Overall Study|Withdrawal by Subject|0
1795374|NCT00557505|6246848|P1|Overall Study|Withdrawal by Subject|0
1795375|NCT00557505|6246840|P9|Overall Study|Objective progression or relapse|15
1795376|NCT00557505|6246841|P8|Overall Study|Objective progression or relapse|5
1795377|NCT00557505|6246842|P7|Overall Study|Objective progression or relapse|2
1795378|NCT00557505|6246843|P6|Overall Study|Objective progression or relapse|3
1795379|NCT00557505|6246844|P5|Overall Study|Objective progression or relapse|2
1795380|NCT00557505|6246845|P4|Overall Study|Objective progression or relapse|2
1795381|NCT00557505|6246846|P3|Overall Study|Objective progression or relapse|3
1795382|NCT00557505|6246847|P2|Overall Study|Objective progression or relapse|3
1795383|NCT00557505|6246848|P1|Overall Study|Objective progression or relapse|2
1795384|NCT00557505|6246840|P9|Overall Study|Global deterioration of health|0
1795385|NCT00557505|6246841|P8|Overall Study|Global deterioration of health|0
1795386|NCT00557505|6246842|P7|Overall Study|Global deterioration of health|0
1795387|NCT00557505|6246843|P6|Overall Study|Global deterioration of health|0
1795388|NCT00557505|6246844|P5|Overall Study|Global deterioration of health|0
1795389|NCT00557505|6246845|P4|Overall Study|Global deterioration of health|0
1795390|NCT00557505|6246846|P3|Overall Study|Global deterioration of health|0
1795391|NCT00557505|6246847|P2|Overall Study|Global deterioration of health|0
1795392|NCT00557505|6246848|P1|Overall Study|Global deterioration of health|1
1795393|NCT00557505|6246840|P9|Overall Study|Adverse Event|0
1795394|NCT00557505|6246841|P8|Overall Study|Adverse Event|0
1795395|NCT00557505|6246842|P7|Overall Study|Adverse Event|1
1795396|NCT00557505|6246843|P6|Overall Study|Adverse Event|0
1795397|NCT00557505|6246844|P5|Overall Study|Adverse Event|0
1795398|NCT00557505|6246845|P4|Overall Study|Adverse Event|0
1795399|NCT00557505|6246846|P3|Overall Study|Adverse Event|1
1795400|NCT00557505|6246847|P2|Overall Study|Adverse Event|0
1795401|NCT00557505|6246848|P1|Overall Study|Adverse Event|0
1795402|NCT00557505|6246840|P9|Overall Study|Death|1
1795403|NCT00557505|6246841|P8|Overall Study|Death|0
1795404|NCT00557505|6246842|P7|Overall Study|Death|0
1795405|NCT00557505|6246843|P6|Overall Study|Death|0
1795406|NCT00557505|6246844|P5|Overall Study|Death|0
1795407|NCT00557505|6246845|P4|Overall Study|Death|0
1795408|NCT00557505|6246846|P3|Overall Study|Death|0
1795409|NCT00557505|6246847|P2|Overall Study|Death|0
1795410|NCT00557505|6246848|P1|Overall Study|Death|0
1795411|NCT00557492|6247012|P1|Overall Study|Change in health insurance|1
1795412|NCT00557466|6247030|P6|Overall Study|Lost to Follow-up|0
1795413|NCT00557466|6247031|P5|Overall Study|Lost to Follow-up|0
1795414|NCT00557466|6247032|P4|Overall Study|Lost to Follow-up|1
1795415|NCT00557466|6247033|P3|Overall Study|Lost to Follow-up|0
1795416|NCT00557466|6247034|P2|Overall Study|Lost to Follow-up|0
1795417|NCT00557466|6247035|P1|Overall Study|Lost to Follow-up|0
1795418|NCT00557466|6247030|P6|Overall Study|Abnormal test procedure results|0
1795419|NCT00557466|6247031|P5|Overall Study|Abnormal test procedure results|0
1795420|NCT00557466|6247032|P4|Overall Study|Abnormal test procedure results|0
1795421|NCT00557466|6247033|P3|Overall Study|Abnormal test procedure results|1
1795422|NCT00557466|6247034|P2|Overall Study|Abnormal test procedure results|0
1795423|NCT00557466|6247035|P1|Overall Study|Abnormal test procedure results|0
1795424|NCT00557466|6247030|P6|Overall Study|Administrative problems|0
1795425|NCT00557466|6247031|P5|Overall Study|Administrative problems|0
1795426|NCT00557466|6247032|P4|Overall Study|Administrative problems|0
1795427|NCT00557466|6247033|P3|Overall Study|Administrative problems|1
1795428|NCT00557466|6247034|P2|Overall Study|Administrative problems|1
1795429|NCT00557466|6247035|P1|Overall Study|Administrative problems|0
1795430|NCT00557466|6247030|P6|Overall Study|Subject withdrew consent|2
1795431|NCT00557466|6247031|P5|Overall Study|Subject withdrew consent|1
1795432|NCT00557466|6247032|P4|Overall Study|Subject withdrew consent|0
1795433|NCT00557466|6247033|P3|Overall Study|Subject withdrew consent|0
1795434|NCT00557466|6247034|P2|Overall Study|Subject withdrew consent|0
1795435|NCT00557466|6247035|P1|Overall Study|Subject withdrew consent|0
1795436|NCT00557466|6247030|P6|Overall Study|Protocol deviation|0
1795437|NCT00557466|6247031|P5|Overall Study|Protocol deviation|0
1795438|NCT00557466|6247032|P4|Overall Study|Protocol deviation|2
1795439|NCT00557466|6247033|P3|Overall Study|Protocol deviation|0
1795440|NCT00557466|6247034|P2|Overall Study|Protocol deviation|1
1795441|NCT00557466|6247035|P1|Overall Study|Protocol deviation|0
1795442|NCT00557466|6247030|P6|Overall Study|Abnormal laboratory value(s)|0
1795443|NCT00557466|6247031|P5|Overall Study|Abnormal laboratory value(s)|0
1795444|NCT00557466|6247032|P4|Overall Study|Abnormal laboratory value(s)|0
1795445|NCT00557466|6247033|P3|Overall Study|Abnormal laboratory value(s)|0
1795446|NCT00557466|6247034|P2|Overall Study|Abnormal laboratory value(s)|2
1795447|NCT00557466|6247035|P1|Overall Study|Abnormal laboratory value(s)|1
1795448|NCT00557466|6247030|P6|Overall Study|Adverse Event|4
1795449|NCT00557466|6247031|P5|Overall Study|Adverse Event|2
1795450|NCT00557466|6247032|P4|Overall Study|Adverse Event|1
1795451|NCT00557466|6247033|P3|Overall Study|Adverse Event|4
1795452|NCT00557466|6247034|P2|Overall Study|Adverse Event|1
1795453|NCT00557466|6247035|P1|Overall Study|Adverse Event|3
1795454|NCT00557440|6247088|P3|Treatment Period 1|Adverse Event|1
1795455|NCT00557440|6247089|P2|Treatment Period 1|Adverse Event|0
1795456|NCT00557440|6247090|P1|Treatment Period 1|Adverse Event|0
1795457|NCT00557323|6247144|P1|Overall Study|Administrative change|2
1795458|NCT00557323|6247144|P1|Overall Study|Withdrawal by Subject|2
1795459|NCT00557323|6247144|P1|Overall Study|Death|3
1795460|NCT00557310|6247149|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
1795461|NCT00557310|6247149|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
1795462|NCT00557310|6247149|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
1795463|NCT00557310|6247149|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
1795464|NCT00557310|6247149|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
1795465|NCT00557310|6247149|P1|Main Study (0 - 18 Months)|Adverse Event|4
1795466|NCT00557245|6247195|P3|Overall Study|Ineligible|2
1795467|NCT00557245|6247196|P2|Overall Study|Ineligible|4
1795468|NCT00557245|6247197|P1|Overall Study|Ineligible|5
1795469|NCT00557245|6247195|P3|Overall Study|Lost to Follow-up|10
1795470|NCT00557245|6247196|P2|Overall Study|Lost to Follow-up|8
1795471|NCT00557245|6247197|P1|Overall Study|Lost to Follow-up|7
1795472|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
1795473|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
1795474|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
1795475|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
1795476|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
1795477|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
1795478|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1795479|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1795480|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1795481|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
1795482|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1795483|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
1795484|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1795485|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1795486|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1795487|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
1795488|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1795489|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
1795490|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Relapse|20
1795491|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Relapse|1
1795492|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Relapse|3
1795493|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Relapse|16
1795494|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Relapse|5
1795495|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Relapse|0
1795496|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
1795497|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
1795498|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
1795499|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
1795500|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
1795501|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
1795502|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
1795503|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
1795504|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
1795505|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
1795506|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
1795507|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
1795508|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Death|2
1795509|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Death|2
1795510|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Death|0
1795511|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Death|2
1795512|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Death|0
1795513|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Death|0
1795514|NCT00557193|6247235|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
1795515|NCT00557193|6247236|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
1795516|NCT00557193|6247237|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
1795517|NCT00557193|6247238|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
1795518|NCT00557193|6247239|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
1795519|NCT00557193|6247240|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
1795520|NCT00557193|6247235|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
1795521|NCT00557193|6247236|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
1795522|NCT00557193|6247237|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
1795523|NCT00557193|6247238|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
1795524|NCT00557193|6247239|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
1795525|NCT00557193|6247240|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
1795526|NCT00557193|6247235|P6|Induction|Inevaluable for post Induction|0
1795527|NCT00557193|6247236|P5|Induction|Inevaluable for post Induction|0
1795528|NCT00557193|6247237|P4|Induction|Inevaluable for post Induction|0
1795529|NCT00557193|6247238|P3|Induction|Inevaluable for post Induction|0
1795530|NCT00557193|6247239|P2|Induction|Inevaluable for post Induction|0
1795531|NCT00557193|6247240|P1|Induction|Inevaluable for post Induction|2
1795532|NCT00557193|6247235|P6|Induction|Ineligible|0
1795533|NCT00557193|6247236|P5|Induction|Ineligible|0
1795534|NCT00557193|6247237|P4|Induction|Ineligible|0
1795535|NCT00557193|6247238|P3|Induction|Ineligible|0
1795536|NCT00557193|6247239|P2|Induction|Ineligible|0
1795537|NCT00557193|6247240|P1|Induction|Ineligible|8
1795538|NCT00557193|6247235|P6|Induction|Refusal of Further Protocol Therapy|0
1795539|NCT00557193|6247236|P5|Induction|Refusal of Further Protocol Therapy|0
1795540|NCT00557193|6247237|P4|Induction|Refusal of Further Protocol Therapy|0
1795541|NCT00557193|6247238|P3|Induction|Refusal of Further Protocol Therapy|0
1795542|NCT00557193|6247239|P2|Induction|Refusal of Further Protocol Therapy|0
1795543|NCT00557193|6247240|P1|Induction|Refusal of Further Protocol Therapy|2
1795544|NCT00557193|6247235|P6|Induction|Withdrawal by Subject|0
1795545|NCT00557193|6247236|P5|Induction|Withdrawal by Subject|0
1795546|NCT00557193|6247237|P4|Induction|Withdrawal by Subject|0
1795547|NCT00557193|6247238|P3|Induction|Withdrawal by Subject|0
1795548|NCT00557193|6247239|P2|Induction|Withdrawal by Subject|0
1795549|NCT00557193|6247240|P1|Induction|Withdrawal by Subject|1
1795550|NCT00557193|6247235|P6|Induction|Physician Decision|0
1795551|NCT00557193|6247236|P5|Induction|Physician Decision|0
1795552|NCT00557193|6247237|P4|Induction|Physician Decision|0
1795553|NCT00557193|6247238|P3|Induction|Physician Decision|0
1795554|NCT00557193|6247239|P2|Induction|Physician Decision|0
1795555|NCT00557193|6247240|P1|Induction|Physician Decision|3
1795556|NCT00557193|6247235|P6|Induction|Death|0
1795557|NCT00557193|6247236|P5|Induction|Death|0
1795558|NCT00557193|6247237|P4|Induction|Death|0
1795559|NCT00557193|6247238|P3|Induction|Death|0
1795560|NCT00557193|6247239|P2|Induction|Death|0
1795561|NCT00557193|6247240|P1|Induction|Death|6
1795562|NCT00557193|6247235|P6|Induction|Adverse Event|0
1795563|NCT00557193|6247236|P5|Induction|Adverse Event|0
1795564|NCT00557193|6247237|P4|Induction|Adverse Event|0
1795565|NCT00557193|6247238|P3|Induction|Adverse Event|0
1795566|NCT00557193|6247239|P2|Induction|Adverse Event|0
1795567|NCT00557193|6247240|P1|Induction|Adverse Event|2
1795568|NCT00557076|6247280|P2|Overall Study|Unblinding|1
1795569|NCT00557076|6247281|P1|Overall Study|Unblinding|0
1795570|NCT00556998|6247289|P1|Voriconazole Oral|Intolerant of oral treatment|1
1795571|NCT00556998|6247289|P1|Voriconazole Oral|Adverse Event|1
1795572|NCT00556998|6247289|P1|Voriconazole Intravenous (IV)|Other|4
1795573|NCT00556998|6247289|P1|Voriconazole Intravenous (IV)|Adverse Event|1
1795574|NCT00556933|6247324|P4|CNI Withdrawal vs. Minimization|Death|1
1795575|NCT00556933|6247325|P3|CNI Withdrawal vs. Minimization|Death|0
1795576|NCT00556933|6247326|P2|CNI Withdrawal vs. Minimization|Death|0
1795577|NCT00556933|6247327|P1|CNI Withdrawal vs. Minimization|Death|0
1795578|NCT00556933|6247324|P4|CNI Withdrawal vs. Minimization|Graft loss|0
1795579|NCT00556933|6247325|P3|CNI Withdrawal vs. Minimization|Graft loss|2
1795580|NCT00556933|6247326|P2|CNI Withdrawal vs. Minimization|Graft loss|1
1795581|NCT00556933|6247327|P1|CNI Withdrawal vs. Minimization|Graft loss|0
1795582|NCT00556933|6247324|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
1795583|NCT00556933|6247325|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
1795584|NCT00556933|6247326|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
1795585|NCT00556933|6247327|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
1795586|NCT00556933|6247324|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
1795587|NCT00556933|6247325|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
1795588|NCT00556933|6247326|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
1795589|NCT00556933|6247327|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
1795590|NCT00556933|6247324|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
1795591|NCT00556933|6247325|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
1795592|NCT00556933|6247326|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
1795593|NCT00556933|6247327|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
1795594|NCT00556933|6247324|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1795595|NCT00556933|6247325|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1795596|NCT00556933|6247326|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
1795597|NCT00556933|6247327|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
1795598|NCT00556933|6247324|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1795599|NCT00556933|6247325|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1795600|NCT00556933|6247326|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
1795601|NCT00556933|6247327|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
1795602|NCT00556933|6247324|P4|Single vs. Divided-dose rATG Induction|Death|0
1795603|NCT00556933|6247325|P3|Single vs. Divided-dose rATG Induction|Death|0
1795604|NCT00556933|6247326|P2|Single vs. Divided-dose rATG Induction|Death|1
1795605|NCT00556933|6247327|P1|Single vs. Divided-dose rATG Induction|Death|0
1795606|NCT00556933|6247324|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1795607|NCT00556933|6247325|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1795608|NCT00556933|6247326|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
1795609|NCT00556933|6247327|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
1795610|NCT00556933|6247324|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1795611|NCT00556933|6247325|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
1795612|NCT00556933|6247326|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1795613|NCT00556933|6247327|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
1795614|NCT00556933|6247324|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
1795615|NCT00556933|6247325|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
1795616|NCT00556933|6247326|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
1795617|NCT00556933|6247327|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
1795618|NCT00556894|6247384|P3|Overall Study|Withdrawal by Subject|1
1795619|NCT00556894|6247385|P2|Overall Study|Withdrawal by Subject|1
1795620|NCT00556894|6247386|P1|Overall Study|Withdrawal by Subject|1
1795621|NCT00556894|6247384|P3|Overall Study|Change in therapy|2
1795622|NCT00556894|6247385|P2|Overall Study|Change in therapy|1
1795623|NCT00556894|6247386|P1|Overall Study|Change in therapy|2
1795624|NCT00556894|6247384|P3|Overall Study|regulatory decision in Bulgaria|13
1795625|NCT00556894|6247385|P2|Overall Study|regulatory decision in Bulgaria|14
1795626|NCT00556894|6247386|P1|Overall Study|regulatory decision in Bulgaria|10
1795627|NCT00556894|6247384|P3|Overall Study|Death|0
1795628|NCT00556894|6247385|P2|Overall Study|Death|0
1795629|NCT00556894|6247386|P1|Overall Study|Death|1
1795630|NCT00556894|6247384|P3|Overall Study|Adverse Event|3
1795631|NCT00556894|6247385|P2|Overall Study|Adverse Event|3
1795632|NCT00556894|6247386|P1|Overall Study|Adverse Event|2
1795633|NCT00556712|6247396|P2|Overall Study|Ongoing at Data Cutoff|66
1795634|NCT00556712|6247397|P1|Overall Study|Ongoing at Data Cutoff|32
1795635|NCT00556712|6247396|P2|Overall Study|Other|2
1795636|NCT00556712|6247397|P1|Overall Study|Other|2
1795637|NCT00556712|6247396|P2|Overall Study|Failure to Return|3
1795638|NCT00556712|6247397|P1|Overall Study|Failure to Return|2
1795639|NCT00556712|6247396|P2|Overall Study|Refused Treatment|16
1795640|NCT00556712|6247397|P1|Overall Study|Refused Treatment|17
1795641|NCT00556712|6247396|P2|Overall Study|Protocol Violation|2
1795642|NCT00556712|6247397|P1|Overall Study|Protocol Violation|3
1795643|NCT00556712|6247396|P2|Overall Study|Progressive Disease|320
1795644|NCT00556712|6247397|P1|Overall Study|Progressive Disease|383
1795645|NCT00556712|6247396|P2|Overall Study|Death|10
1795646|NCT00556712|6247397|P1|Overall Study|Death|5
1795647|NCT00556712|6247396|P2|Overall Study|Adverse Event|19
1795648|NCT00556712|6247397|P1|Overall Study|Adverse Event|7
1795649|NCT00556673|6247475|P2|Overall Study|Protocol deviation|2
1795650|NCT00556673|6247476|P1|Overall Study|Protocol deviation|3
1795651|NCT00556439|6247612|P4|After Week 12 (Randomized Study Period)|Severe infection|0
1795652|NCT00556439|6247613|P3|After Week 12 (Randomized Study Period)|Severe infection|0
1795653|NCT00556439|6247614|P2|After Week 12 (Randomized Study Period)|Severe infection|0
1795654|NCT00556439|6247615|P1|After Week 12 (Randomized Study Period)|Severe infection|1
1795655|NCT00556439|6247612|P4|After Week 12 (Randomized Study Period)|Malignancy|1
1795656|NCT00556439|6247613|P3|After Week 12 (Randomized Study Period)|Malignancy|0
1795657|NCT00556439|6247614|P2|After Week 12 (Randomized Study Period)|Malignancy|1
1795658|NCT00556439|6247615|P1|After Week 12 (Randomized Study Period)|Malignancy|0
1795659|NCT00556439|6247612|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
1795660|NCT00556439|6247613|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
1795661|NCT00556439|6247614|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
1795662|NCT00556439|6247615|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
1795663|NCT00556439|6247612|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
1795664|NCT00556439|6247613|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
1795665|NCT00556439|6247614|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
1795666|NCT00556439|6247615|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
1795667|NCT00556439|6247612|P4|Study Entry to Week 12|Malignancy|0
1795668|NCT00556439|6247613|P3|Study Entry to Week 12|Malignancy|1
1795669|NCT00556439|6247614|P2|Study Entry to Week 12|Malignancy|0
1795670|NCT00556439|6247615|P1|Study Entry to Week 12|Malignancy|0
1795671|NCT00556439|6247612|P4|Study Entry to Week 12|Recurrent infection|0
1795672|NCT00556439|6247613|P3|Study Entry to Week 12|Recurrent infection|0
1795673|NCT00556439|6247614|P2|Study Entry to Week 12|Recurrent infection|0
1795674|NCT00556439|6247615|P1|Study Entry to Week 12|Recurrent infection|1
1795675|NCT00556439|6247612|P4|Study Entry to Week 12|Withdrawal by Subject|0
1795676|NCT00556439|6247613|P3|Study Entry to Week 12|Withdrawal by Subject|1
1795677|NCT00556439|6247614|P2|Study Entry to Week 12|Withdrawal by Subject|0
1795678|NCT00556439|6247615|P1|Study Entry to Week 12|Withdrawal by Subject|1
1795679|NCT00556439|6247612|P4|Study Entry to Week 12|Physician Decision|0
1795680|NCT00556439|6247613|P3|Study Entry to Week 12|Physician Decision|0
1795681|NCT00556439|6247614|P2|Study Entry to Week 12|Physician Decision|0
1795682|NCT00556439|6247615|P1|Study Entry to Week 12|Physician Decision|1
1795683|NCT00556439|6247612|P4|Study Entry to Week 12|Lack of Efficacy|0
1795684|NCT00556439|6247613|P3|Study Entry to Week 12|Lack of Efficacy|6
1795685|NCT00556439|6247614|P2|Study Entry to Week 12|Lack of Efficacy|0
1795686|NCT00556439|6247615|P1|Study Entry to Week 12|Lack of Efficacy|5
1795687|NCT00556426|6247625|P1|Overall Study|Death|6
1795688|NCT00556426|6247625|P1|Overall Study|Withdrawal by Subject|3
1795689|NCT00556374|6247647|P2|Overall Study|Lost to Follow-up|5
1795690|NCT00556374|6247648|P1|Overall Study|Lost to Follow-up|7
1795691|NCT00556374|6247647|P2|Overall Study|Death|43
1795692|NCT00556374|6247648|P1|Overall Study|Death|50
1795693|NCT00556374|6247647|P2|Overall Study|Withdrawal by Subject|172
1795694|NCT00556374|6247648|P1|Overall Study|Withdrawal by Subject|190
1795695|NCT00556322|6247668|P2|Overall Study|Death|14
1795696|NCT00556322|6247669|P1|Overall Study|Death|20
1795697|NCT00556322|6247668|P2|Overall Study|Ongoing at data cutoff|5
1795698|NCT00556322|6247669|P1|Overall Study|Ongoing at data cutoff|3
1795699|NCT00556322|6247668|P2|Overall Study|Protocol Violation|1
1795700|NCT00556322|6247669|P1|Overall Study|Protocol Violation|5
1795701|NCT00556322|6247668|P2|Overall Study|Withdrawal by Subject|7
1795702|NCT00556322|6247669|P1|Overall Study|Withdrawal by Subject|19
1795703|NCT00556322|6247668|P2|Overall Study|Lost to Follow-up|3
1795704|NCT00556322|6247669|P1|Overall Study|Lost to Follow-up|5
1795705|NCT00556322|6247668|P2|Overall Study|Other|1
1795706|NCT00556322|6247669|P1|Overall Study|Other|4
1795707|NCT00556322|6247668|P2|Overall Study|Adverse Event|4
1795708|NCT00556322|6247669|P1|Overall Study|Adverse Event|7
1795709|NCT00556322|6247668|P2|Overall Study|Insufficient therapeutic response|168
1795710|NCT00556322|6247669|P1|Overall Study|Insufficient therapeutic response|158
1795711|NCT00556166|6247717|P1|Overall Study|Withdrawal by Subject|1
1795712|NCT00556075|6247730|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1795713|NCT00556075|6247731|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
1795714|NCT00556075|6247732|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
1795715|NCT00556075|6247730|P3|Overall Study|Personal issues|0
1795716|NCT00556075|6247731|P2|Overall Study|Personal issues|1
1795717|NCT00556075|6247732|P1|Overall Study|Personal issues|4
1795718|NCT00556075|6247730|P3|Overall Study|Adverse Event|0
1795719|NCT00556075|6247731|P2|Overall Study|Adverse Event|2
1795720|NCT00556075|6247732|P1|Overall Study|Adverse Event|1
1795721|NCT00556075|6247730|P3|Overall Study|Not eligible|2
1795722|NCT00556075|6247731|P2|Overall Study|Not eligible|1
1795723|NCT00556075|6247732|P1|Overall Study|Not eligible|1
1795724|NCT00556075|6247730|P3|Overall Study|Protocol Violation|3
1795725|NCT00556075|6247731|P2|Overall Study|Protocol Violation|1
1795726|NCT00556075|6247732|P1|Overall Study|Protocol Violation|1
1795727|NCT00556075|6247730|P3|Overall Study|Withdrawal by Subject|0
1795728|NCT00556075|6247731|P2|Overall Study|Withdrawal by Subject|3
1795729|NCT00556075|6247732|P1|Overall Study|Withdrawal by Subject|3
1795730|NCT00556075|6247730|P3|Overall Study|Lost to Follow-up|3
1795731|NCT00556075|6247731|P2|Overall Study|Lost to Follow-up|0
1795732|NCT00556075|6247732|P1|Overall Study|Lost to Follow-up|3
1795733|NCT00555971|6247783|P2|Overall Study|Adverse Event|1
1795734|NCT00555971|6247784|P1|Overall Study|Adverse Event|1
1795735|NCT00555906|6247795|P5|Phase 2|Randomized but not Treated|2
1795736|NCT00555906|6247796|P4|Phase 2|Randomized but not Treated|0
1795737|NCT00555906|6247797|P3|Phase 2|Randomized but not Treated|0
1795738|NCT00555906|6247798|P2|Phase 2|Randomized but not Treated|0
1795739|NCT00555906|6247799|P1|Phase 2|Randomized but not Treated|0
1795740|NCT00555906|6247795|P5|Phase 2|Other|6
1795741|NCT00555906|6247796|P4|Phase 2|Other|0
1795742|NCT00555906|6247797|P3|Phase 2|Other|0
1795743|NCT00555906|6247798|P2|Phase 2|Other|0
1795744|NCT00555906|6247799|P1|Phase 2|Other|0
1795745|NCT00555906|6247795|P5|Phase 2|Withdrawal by Subject|2
1795746|NCT00555906|6247796|P4|Phase 2|Withdrawal by Subject|0
1795747|NCT00555906|6247797|P3|Phase 2|Withdrawal by Subject|0
1795748|NCT00555906|6247798|P2|Phase 2|Withdrawal by Subject|0
1795749|NCT00555906|6247799|P1|Phase 2|Withdrawal by Subject|0
1795750|NCT00555906|6247795|P5|Phase 2|Objective Progression or Relapse|16
1795751|NCT00555906|6247796|P4|Phase 2|Objective Progression or Relapse|0
1795752|NCT00555906|6247797|P3|Phase 2|Objective Progression or Relapse|0
1795753|NCT00555906|6247798|P2|Phase 2|Objective Progression or Relapse|0
1795754|NCT00555906|6247799|P1|Phase 2|Objective Progression or Relapse|0
1795755|NCT00555906|6247795|P5|Phase 2|Global Deterioration of Health Status|2
1795756|NCT00555906|6247796|P4|Phase 2|Global Deterioration of Health Status|0
1795757|NCT00555906|6247797|P3|Phase 2|Global Deterioration of Health Status|0
1795758|NCT00555906|6247798|P2|Phase 2|Global Deterioration of Health Status|0
1795759|NCT00555906|6247799|P1|Phase 2|Global Deterioration of Health Status|0
1795760|NCT00555906|6247795|P5|Phase 2|Adverse Event|4
1795761|NCT00555906|6247796|P4|Phase 2|Adverse Event|0
1795762|NCT00555906|6247797|P3|Phase 2|Adverse Event|0
1795763|NCT00555906|6247798|P2|Phase 2|Adverse Event|0
1795764|NCT00555906|6247799|P1|Phase 2|Adverse Event|0
1795765|NCT00555906|6247795|P5|Phase 1|Withdrawal by Subject|0
1795766|NCT00555906|6247796|P4|Phase 1|Withdrawal by Subject|1
1795767|NCT00555906|6247797|P3|Phase 1|Withdrawal by Subject|0
1795768|NCT00555906|6247798|P2|Phase 1|Withdrawal by Subject|0
1795769|NCT00555906|6247799|P1|Phase 1|Withdrawal by Subject|0
1795770|NCT00555906|6247795|P5|Phase 1|Adverse Event|0
1795771|NCT00555906|6247796|P4|Phase 1|Adverse Event|2
1795772|NCT00555906|6247797|P3|Phase 1|Adverse Event|3
1795773|NCT00555906|6247798|P2|Phase 1|Adverse Event|0
1795774|NCT00555906|6247799|P1|Phase 1|Adverse Event|0
1795775|NCT00555906|6247795|P5|Phase 1|Global Deterioration of Health Status|0
1795776|NCT00555906|6247796|P4|Phase 1|Global Deterioration of Health Status|1
1795777|NCT00555906|6247797|P3|Phase 1|Global Deterioration of Health Status|1
1795778|NCT00555906|6247798|P2|Phase 1|Global Deterioration of Health Status|1
1795779|NCT00555906|6247799|P1|Phase 1|Global Deterioration of Health Status|0
1795780|NCT00555906|6247795|P5|Phase 1|Objective Progression or Relapse|0
1795781|NCT00555906|6247796|P4|Phase 1|Objective Progression or Relapse|1
1795782|NCT00555906|6247797|P3|Phase 1|Objective Progression or Relapse|3
1795783|NCT00555906|6247798|P2|Phase 1|Objective Progression or Relapse|5
1795784|NCT00555906|6247799|P1|Phase 1|Objective Progression or Relapse|3
1795785|NCT00555672|6247921|P2|Overall Study|Participant refused|0
1795786|NCT00555672|6247922|P1|Overall Study|Participant refused|2
1795787|NCT00555672|6247921|P2|Overall Study|Other|1
1795788|NCT00555672|6247922|P1|Overall Study|Other|3
1795789|NCT00555672|6247921|P2|Overall Study|Objective progression or relapse|5
1795790|NCT00555672|6247922|P1|Overall Study|Objective progression or relapse|11
1795791|NCT00555672|6247921|P2|Overall Study|Adverse Event|2
1795792|NCT00555672|6247922|P1|Overall Study|Adverse Event|8
1795793|NCT00555672|6247921|P2|Overall Study|Death|2
1795794|NCT00555672|6247922|P1|Overall Study|Death|0
1795795|NCT00555620|6247947|P6|Overall Study|Other|3
1795796|NCT00555620|6247948|P5|Overall Study|Other|0
1795797|NCT00555620|6247949|P4|Overall Study|Other|1
1795798|NCT00555620|6247950|P3|Overall Study|Other|0
1795799|NCT00555620|6247951|P2|Overall Study|Other|0
1795800|NCT00555620|6247952|P1|Overall Study|Other|0
1795801|NCT00555620|6247947|P6|Overall Study|Participant refused treatment|1
1795802|NCT00555620|6247948|P5|Overall Study|Participant refused treatment|0
1795803|NCT00555620|6247949|P4|Overall Study|Participant refused treatment|0
1795804|NCT00555620|6247950|P3|Overall Study|Participant refused treatment|1
1795805|NCT00555620|6247951|P2|Overall Study|Participant refused treatment|1
1795806|NCT00555620|6247952|P1|Overall Study|Participant refused treatment|0
1795807|NCT00555620|6247947|P6|Overall Study|Objective progression or relapse|16
1795808|NCT00555620|6247948|P5|Overall Study|Objective progression or relapse|3
1795809|NCT00555620|6247949|P4|Overall Study|Objective progression or relapse|17
1795810|NCT00555620|6247950|P3|Overall Study|Objective progression or relapse|12
1795811|NCT00555620|6247951|P2|Overall Study|Objective progression or relapse|5
1795812|NCT00555620|6247952|P1|Overall Study|Objective progression or relapse|6
1795813|NCT00555620|6247947|P6|Overall Study|Adverse Event|1
1795814|NCT00555620|6247948|P5|Overall Study|Adverse Event|0
1795815|NCT00555620|6247949|P4|Overall Study|Adverse Event|5
1795816|NCT00555620|6247950|P3|Overall Study|Adverse Event|1
1795817|NCT00555620|6247951|P2|Overall Study|Adverse Event|0
1795818|NCT00555620|6247952|P1|Overall Study|Adverse Event|0
1795819|NCT00555620|6247947|P6|Overall Study|Study terminated by sponsor|0
1795820|NCT00555620|6247948|P5|Overall Study|Study terminated by sponsor|0
1795821|NCT00555620|6247949|P4|Overall Study|Study terminated by sponsor|0
1795822|NCT00555620|6247950|P3|Overall Study|Study terminated by sponsor|1
1795823|NCT00555620|6247951|P2|Overall Study|Study terminated by sponsor|0
1795824|NCT00555620|6247952|P1|Overall Study|Study terminated by sponsor|0
1795825|NCT00555620|6247947|P6|Overall Study|Death|1
1795826|NCT00555620|6247948|P5|Overall Study|Death|0
1795827|NCT00555620|6247949|P4|Overall Study|Death|0
1795828|NCT00555620|6247950|P3|Overall Study|Death|0
1795829|NCT00555620|6247951|P2|Overall Study|Death|1
1795830|NCT00555620|6247952|P1|Overall Study|Death|0
1795831|NCT00555568|6248076|P3|Overall Study|Lost to Follow-up|16
1795832|NCT00555568|6248077|P2|Overall Study|Lost to Follow-up|16
1795833|NCT00555568|6248078|P1|Overall Study|Lost to Follow-up|26
1795834|NCT00555477|6248100|P2|Overall Study|Physician Decision|2
1795835|NCT00555477|6248101|P1|Overall Study|Physician Decision|1
1795836|NCT00555477|6248100|P2|Overall Study|Withdrawal by Subject|2
1795837|NCT00555477|6248101|P1|Overall Study|Withdrawal by Subject|1
1795838|NCT00555477|6248100|P2|Overall Study|Adverse Event|9
1795839|NCT00555477|6248101|P1|Overall Study|Adverse Event|0
1795840|NCT00555438|6248117|P1|Between 10 Days and 30 Days Postoperativ|Death|5
1795841|NCT00555438|6248117|P1|10 Days Post-operative|Death|4
1795842|NCT00555425|6248127|P2|Overall Study|Became pregnant and transferred care|1
1795843|NCT00555425|6248128|P1|Overall Study|Became pregnant and transferred care|0
1795844|NCT00555425|6248127|P2|Overall Study|Met criteria for protective transfer|3
1795845|NCT00555425|6248128|P1|Overall Study|Met criteria for protective transfer|16
1795846|NCT00555425|6248127|P2|Overall Study|Missed 3 physician management visits|0
1795847|NCT00555425|6248128|P1|Overall Study|Missed 3 physician management visits|1
1795848|NCT00555425|6248127|P2|Overall Study|Missed Medication > 1 wk|15
1795849|NCT00555425|6248128|P1|Overall Study|Missed Medication > 1 wk|34
1795850|NCT00555321|6248164|P5|Long-term Extension Phase|Other Reason|0
1795851|NCT00555321|6248165|P4|Long-term Extension Phase|Other Reason|0
1795852|NCT00555321|6248166|P3|Long-term Extension Phase|Other Reason|2
1795853|NCT00555321|6248167|P2|Long-term Extension Phase|Other Reason|0
1795854|NCT00555321|6248168|P1|Long-term Extension Phase|Other Reason|1
1795855|NCT00555321|6248164|P5|Long-term Extension Phase|Participant did not meet study criteria|1
1795856|NCT00555321|6248165|P4|Long-term Extension Phase|Participant did not meet study criteria|0
1795857|NCT00555321|6248166|P3|Long-term Extension Phase|Participant did not meet study criteria|0
1795858|NCT00555321|6248167|P2|Long-term Extension Phase|Participant did not meet study criteria|0
1795859|NCT00555321|6248168|P1|Long-term Extension Phase|Participant did not meet study criteria|0
1795860|NCT00555321|6248164|P5|Long-term Extension Phase|Death|0
1795861|NCT00555321|6248165|P4|Long-term Extension Phase|Death|3
1795862|NCT00555321|6248166|P3|Long-term Extension Phase|Death|0
1795863|NCT00555321|6248167|P2|Long-term Extension Phase|Death|0
1795864|NCT00555321|6248168|P1|Long-term Extension Phase|Death|2
1795865|NCT00555321|6248164|P5|Long-term Extension Phase|Administrative reason by sponsor|23
1795866|NCT00555321|6248165|P4|Long-term Extension Phase|Administrative reason by sponsor|31
1795867|NCT00555321|6248166|P3|Long-term Extension Phase|Administrative reason by sponsor|18
1795868|NCT00555321|6248167|P2|Long-term Extension Phase|Administrative reason by sponsor|21
1795869|NCT00555321|6248168|P1|Long-term Extension Phase|Administrative reason by sponsor|23
1795870|NCT00555321|6248164|P5|Long-term Extension Phase|Withdrawal by Subject|2
1795871|NCT00555321|6248165|P4|Long-term Extension Phase|Withdrawal by Subject|3
1795872|NCT00555321|6248166|P3|Long-term Extension Phase|Withdrawal by Subject|2
1795873|NCT00555321|6248167|P2|Long-term Extension Phase|Withdrawal by Subject|1
1795874|NCT00555321|6248168|P1|Long-term Extension Phase|Withdrawal by Subject|2
1795875|NCT00555321|6248164|P5|Long-term Extension Phase|Adverse Event|0
1795876|NCT00555321|6248165|P4|Long-term Extension Phase|Adverse Event|1
1795877|NCT00555321|6248166|P3|Long-term Extension Phase|Adverse Event|2
1795878|NCT00555321|6248167|P2|Long-term Extension Phase|Adverse Event|5
1795879|NCT00555321|6248168|P1|Long-term Extension Phase|Adverse Event|2
1795880|NCT00555321|6248164|P5|Treatment Phase up to 12-months|Never treated|4
1795881|NCT00555321|6248165|P4|Treatment Phase up to 12-months|Never treated|0
1795882|NCT00555321|6248166|P3|Treatment Phase up to 12-months|Never treated|1
1795883|NCT00555321|6248167|P2|Treatment Phase up to 12-months|Never treated|3
1795884|NCT00555321|6248168|P1|Treatment Phase up to 12-months|Never treated|2
1795885|NCT00555321|6248164|P5|Treatment Phase up to 12-months|Other Reason|0
1795886|NCT00555321|6248165|P4|Treatment Phase up to 12-months|Other Reason|0
1795887|NCT00555321|6248166|P3|Treatment Phase up to 12-months|Other Reason|2
1795888|NCT00555321|6248167|P2|Treatment Phase up to 12-months|Other Reason|3
1795889|NCT00555321|6248168|P1|Treatment Phase up to 12-months|Other Reason|1
1795890|NCT00555321|6248164|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
1795891|NCT00555321|6248165|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
1795892|NCT00555321|6248166|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
1795893|NCT00555321|6248167|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
1795894|NCT00555321|6248168|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
1795895|NCT00555321|6248164|P5|Treatment Phase up to 12-months|Death|0
1795896|NCT00555321|6248165|P4|Treatment Phase up to 12-months|Death|0
1795897|NCT00555321|6248166|P3|Treatment Phase up to 12-months|Death|4
1795898|NCT00555321|6248167|P2|Treatment Phase up to 12-months|Death|1
1795899|NCT00555321|6248168|P1|Treatment Phase up to 12-months|Death|2
1795900|NCT00555321|6248164|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
1795901|NCT00555321|6248165|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
1795902|NCT00555321|6248166|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
1795903|NCT00555321|6248167|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
1795904|NCT00555321|6248168|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
1795905|NCT00555321|6248164|P5|Treatment Phase up to 12-months|Adverse Event|18
1795906|NCT00555321|6248165|P4|Treatment Phase up to 12-months|Adverse Event|7
1795907|NCT00555321|6248166|P3|Treatment Phase up to 12-months|Adverse Event|11
1795908|NCT00555321|6248167|P2|Treatment Phase up to 12-months|Adverse Event|7
1795909|NCT00555321|6248168|P1|Treatment Phase up to 12-months|Adverse Event|6
1795910|NCT00555217|6248472|P2|Overall Study|close out sites|17
1795911|NCT00555217|6248473|P1|Overall Study|close out sites|21
1795912|NCT00555217|6248472|P2|Overall Study|Lost to Follow-up|20
1795913|NCT00555217|6248473|P1|Overall Study|Lost to Follow-up|19
1795914|NCT00555217|6248472|P2|Overall Study|Withdrawal by Subject|31
1795915|NCT00555217|6248473|P1|Overall Study|Withdrawal by Subject|35
1795916|NCT00555061|6248510|P1|Overall Study|Participant enrolled, but never treated|1
1795917|NCT00555061|6248510|P1|Overall Study|Withdrawal by Subject|2
1795918|NCT00555061|6248510|P1|Overall Study|Lost to Follow-up|2
1795919|NCT00555061|6248510|P1|Overall Study|Protocol Violation|1
1795920|NCT00555061|6248510|P1|Overall Study|Adverse Event|3
1795921|NCT00555009|6248529|P2|Overall Study|Terminated by Sponsor|5
1795922|NCT00555009|6248530|P1|Overall Study|Terminated by Sponsor|2
1795923|NCT00555009|6248529|P2|Overall Study|Withdrawal by Subject|1
1795924|NCT00555009|6248530|P1|Overall Study|Withdrawal by Subject|0
1795925|NCT00554840|6248610|P2|Overall Study|Physician Decision|1
1795926|NCT00554840|6248611|P1|Overall Study|Physician Decision|0
1795927|NCT00554801|6248629|P2|Overall Study|Withdrawal by Subject|0
1795928|NCT00554801|6248630|P1|Overall Study|Withdrawal by Subject|14
1795929|NCT00554801|6248629|P2|Overall Study|left area before completion|0
1795930|NCT00554801|6248630|P1|Overall Study|left area before completion|5
1795931|NCT00554788|6248641|P3|Overall Study|Ineligible|1
1795932|NCT00554788|6248642|P2|Overall Study|Ineligible|0
1795933|NCT00554788|6248643|P1|Overall Study|Ineligible|2
1795934|NCT00554788|6248641|P3|Overall Study|Progressive disease|3
1795935|NCT00554788|6248642|P2|Overall Study|Progressive disease|0
1795936|NCT00554788|6248643|P1|Overall Study|Progressive disease|0
1795937|NCT00554788|6248641|P3|Overall Study|Refusal of further protocol therapy|1
1795938|NCT00554788|6248642|P2|Overall Study|Refusal of further protocol therapy|1
1795939|NCT00554788|6248643|P1|Overall Study|Refusal of further protocol therapy|0
1795940|NCT00554788|6248641|P3|Overall Study|Withdrawal by Subject|1
1795941|NCT00554788|6248642|P2|Overall Study|Withdrawal by Subject|0
1795942|NCT00554788|6248643|P1|Overall Study|Withdrawal by Subject|0
1795943|NCT00554788|6248641|P3|Overall Study|Physician Decision|3
1795944|NCT00554788|6248642|P2|Overall Study|Physician Decision|1
1795945|NCT00554788|6248643|P1|Overall Study|Physician Decision|1
1795946|NCT00554788|6248641|P3|Overall Study|Lost to Follow-up|3
1795947|NCT00554788|6248642|P2|Overall Study|Lost to Follow-up|3
1795948|NCT00554788|6248643|P1|Overall Study|Lost to Follow-up|4
1795949|NCT00554788|6248641|P3|Overall Study|Adverse Event|2
1795950|NCT00554788|6248642|P2|Overall Study|Adverse Event|1
1795951|NCT00554788|6248643|P1|Overall Study|Adverse Event|0
1795952|NCT00554619|6248675|P1|Overall Study|Liver Function Test Abnormality|1
1795953|NCT00554619|6248675|P1|Overall Study|Physician Decision|1
1795954|NCT00554619|6248675|P1|Overall Study|Adverse Event|1
1795955|NCT00554515|6248687|P1|Overall Study|Misc|15
1795956|NCT00554515|6248687|P1|Overall Study|Other|1
1795957|NCT00554515|6248687|P1|Overall Study|Achieved Stable Disease|7
1795958|NCT00554515|6248687|P1|Overall Study|Death|2
1795959|NCT00554515|6248687|P1|Overall Study|Adverse Event|9
1795960|NCT00554515|6248687|P1|Overall Study|Withdrawal by Subject|11
1795961|NCT00554515|6248687|P1|Overall Study|Physician Decision|18
1795962|NCT00554515|6248687|P1|Overall Study|Disease progression|52
1795963|NCT00554515|6248687|P1|Overall Study|Withdrawal by Subject|3
1795964|NCT00554229|6248750|P2|Overall Study|Randomised but no treatment received|0
1795965|NCT00554229|6248751|P1|Overall Study|Randomised but no treatment received|1
1795966|NCT00554229|6248750|P2|Overall Study|Reason not otherwise captured, eg; death|140
1795967|NCT00554229|6248751|P1|Overall Study|Reason not otherwise captured, eg; death|119
1795968|NCT00554229|6248750|P2|Overall Study|Protocol Violation|3
1795969|NCT00554229|6248751|P1|Overall Study|Protocol Violation|3
1795970|NCT00554229|6248750|P2|Overall Study|Adverse Event|39
1795971|NCT00554229|6248751|P1|Overall Study|Adverse Event|71
1795972|NCT00554229|6248750|P2|Overall Study|Withdrawal by Subject|37
1795973|NCT00554229|6248751|P1|Overall Study|Withdrawal by Subject|29
1795974|NCT00554229|6248750|P2|Overall Study|Lost to Follow-up|6
1795975|NCT00554229|6248751|P1|Overall Study|Lost to Follow-up|3
1795976|NCT00554216|6248776|P3|Overall Study|Lack of Efficacy|0
1795977|NCT00554216|6248777|P2|Overall Study|Lack of Efficacy|3
1795978|NCT00554216|6248778|P1|Overall Study|Lack of Efficacy|15
1795979|NCT00554216|6248776|P3|Overall Study|Other|10
1795980|NCT00554216|6248777|P2|Overall Study|Other|7
1795981|NCT00554216|6248778|P1|Overall Study|Other|12
1795982|NCT00554216|6248776|P3|Overall Study|Restricted med|1
1795983|NCT00554216|6248777|P2|Overall Study|Restricted med|1
1795984|NCT00554216|6248778|P1|Overall Study|Restricted med|3
1795985|NCT00554216|6248776|P3|Overall Study|Pregnancy|14
1795986|NCT00554216|6248777|P2|Overall Study|Pregnancy|1
1795987|NCT00554216|6248778|P1|Overall Study|Pregnancy|2
1795988|NCT00554216|6248776|P3|Overall Study|Non compliance|5
1795989|NCT00554216|6248777|P2|Overall Study|Non compliance|4
1795990|NCT00554216|6248778|P1|Overall Study|Non compliance|10
1795991|NCT00554216|6248776|P3|Overall Study|Withdrawal by Subject|43
1795992|NCT00554216|6248777|P2|Overall Study|Withdrawal by Subject|31
1795993|NCT00554216|6248778|P1|Overall Study|Withdrawal by Subject|92
1795994|NCT00554216|6248776|P3|Overall Study|Adverse Event|36
1795995|NCT00554216|6248777|P2|Overall Study|Adverse Event|16
1795996|NCT00554216|6248778|P1|Overall Study|Adverse Event|16
1795997|NCT00554216|6248776|P3|Overall Study|Lost to Follow-up|63
1795998|NCT00554216|6248777|P2|Overall Study|Lost to Follow-up|31
1795999|NCT00554216|6248778|P1|Overall Study|Lost to Follow-up|92
1796000|NCT00554190|6248789|P1|Overall Study|Termination forms not completed|10
1796001|NCT00554099|6248798|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
1796002|NCT00554099|6248799|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
1796003|NCT00554099|6248800|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
1796004|NCT00554099|6248798|P3|Non-Treatment Phase (9 Months)|Relapse|1
1796005|NCT00554099|6248799|P2|Non-Treatment Phase (9 Months)|Relapse|1
1796006|NCT00554099|6248800|P1|Non-Treatment Phase (9 Months)|Relapse|2
1796007|NCT00554099|6248798|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
1796008|NCT00554099|6248799|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
1796009|NCT00554099|6248800|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
1796010|NCT00554099|6248798|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
1796011|NCT00554099|6248799|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
1796012|NCT00554099|6248800|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
1796013|NCT00554099|6248798|P3|Treatment Period (12 Weeks)|Protocol Violation|2
1796014|NCT00554099|6248799|P2|Treatment Period (12 Weeks)|Protocol Violation|0
1796015|NCT00554099|6248800|P1|Treatment Period (12 Weeks)|Protocol Violation|0
1796016|NCT00554099|6248798|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
1796017|NCT00554099|6248799|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
1796018|NCT00554099|6248800|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
1796019|NCT00554099|6248798|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
1796020|NCT00554099|6248799|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
1796021|NCT00554099|6248800|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
1796022|NCT00554099|6248798|P3|Treatment Period (12 Weeks)|Physician Decision|0
1796023|NCT00554099|6248799|P2|Treatment Period (12 Weeks)|Physician Decision|0
1796024|NCT00554099|6248800|P1|Treatment Period (12 Weeks)|Physician Decision|3
1796025|NCT00554099|6248798|P3|Treatment Period (12 Weeks)|Adverse Event|1
1796026|NCT00554099|6248799|P2|Treatment Period (12 Weeks)|Adverse Event|5
1796027|NCT00554099|6248800|P1|Treatment Period (12 Weeks)|Adverse Event|3
1796028|NCT00553787|6248855|P3|Overall Study|Other|13
1796029|NCT00553787|6248856|P2|Overall Study|Other|10
1796030|NCT00553787|6248857|P1|Overall Study|Other|18
1796031|NCT00553787|6248855|P3|Overall Study|Requirement for restricted medication|5
1796032|NCT00553787|6248856|P2|Overall Study|Requirement for restricted medication|7
1796033|NCT00553787|6248857|P1|Overall Study|Requirement for restricted medication|8
1796034|NCT00553787|6248855|P3|Overall Study|non compliance|11
1796035|NCT00553787|6248856|P2|Overall Study|non compliance|0
1796036|NCT00553787|6248857|P1|Overall Study|non compliance|4
1796037|NCT00553787|6248855|P3|Overall Study|Pregnancy|2
1796038|NCT00553787|6248856|P2|Overall Study|Pregnancy|1
1796039|NCT00553787|6248857|P1|Overall Study|Pregnancy|0
1796040|NCT00553787|6248855|P3|Overall Study|Lack of Efficacy|3
1796041|NCT00553787|6248856|P2|Overall Study|Lack of Efficacy|1
1796042|NCT00553787|6248857|P1|Overall Study|Lack of Efficacy|31
1796043|NCT00553787|6248855|P3|Overall Study|Withdrawal by Subject|83
1796044|NCT00553787|6248856|P2|Overall Study|Withdrawal by Subject|40
1796045|NCT00553787|6248857|P1|Overall Study|Withdrawal by Subject|151
1796046|NCT00553787|6248855|P3|Overall Study|Lost to Follow-up|78
1796047|NCT00553787|6248856|P2|Overall Study|Lost to Follow-up|44
1796048|NCT00553787|6248857|P1|Overall Study|Lost to Follow-up|132
1796049|NCT00553787|6248855|P3|Overall Study|Adverse Event|67
1796050|NCT00553787|6248856|P2|Overall Study|Adverse Event|21
1796051|NCT00553787|6248857|P1|Overall Study|Adverse Event|34
1796052|NCT00553696|6248889|P4|Overall Study|Withdrawal by Subject|0
1796053|NCT00553696|6248890|P3|Overall Study|Withdrawal by Subject|0
1796054|NCT00553696|6248891|P2|Overall Study|Withdrawal by Subject|1
1796055|NCT00553696|6248892|P1|Overall Study|Withdrawal by Subject|0
1796056|NCT00553696|6248889|P4|Overall Study|Objective progression or relapse|0
1796057|NCT00553696|6248890|P3|Overall Study|Objective progression or relapse|6
1796058|NCT00553696|6248891|P2|Overall Study|Objective progression or relapse|9
1796059|NCT00553696|6248892|P1|Overall Study|Objective progression or relapse|2
1796060|NCT00553696|6248889|P4|Overall Study|Global deterioration of health status|0
1796061|NCT00553696|6248890|P3|Overall Study|Global deterioration of health status|0
1796062|NCT00553696|6248891|P2|Overall Study|Global deterioration of health status|2
1796063|NCT00553696|6248892|P1|Overall Study|Global deterioration of health status|0
1796064|NCT00553696|6248889|P4|Overall Study|Adverse Event|1
1796065|NCT00553696|6248890|P3|Overall Study|Adverse Event|0
1796066|NCT00553696|6248891|P2|Overall Study|Adverse Event|4
1796067|NCT00553696|6248892|P1|Overall Study|Adverse Event|2
1796068|NCT00553644|6248930|P1|Overall Study|Alternative therapy|6
1796069|NCT00553644|6248930|P1|Overall Study|Physician Decision|1
1796070|NCT00553644|6248930|P1|Overall Study|Withdrawal by Subject|4
1796071|NCT00553644|6248930|P1|Overall Study|Adverse Event|17
1796072|NCT00553631|6248939|P2|Overall Study|Lost to Follow-up|0
1796073|NCT00553631|6248940|P1|Overall Study|Lost to Follow-up|1
1796074|NCT00553631|6248939|P2|Overall Study|Withdrawal by Subject|1
1796075|NCT00553631|6248940|P1|Overall Study|Withdrawal by Subject|0
1796076|NCT00553605|6248962|P2|Overall Study|Randomized but not treated|0
1796077|NCT00553605|6248963|P1|Overall Study|Randomized but not treated|2
1796078|NCT00553605|6248962|P2|Overall Study|Did not receive full dose|0
1796079|NCT00553605|6248963|P1|Overall Study|Did not receive full dose|1
1796080|NCT00553605|6248962|P2|Overall Study|Did not meet entrance criteria|3
1796081|NCT00553605|6248963|P1|Overall Study|Did not meet entrance criteria|1
1796082|NCT00553540|6248989|P2|Overall Study|discharged after first visit|5
1796083|NCT00553540|6248990|P1|Overall Study|discharged after first visit|2
1796084|NCT00553514|6249001|P5|Overall Study|Other|1
1796085|NCT00553514|6249002|P4|Overall Study|Other|0
1796086|NCT00553514|6249003|P3|Overall Study|Other|0
1796087|NCT00553514|6249004|P2|Overall Study|Other|1
1796088|NCT00553514|6249005|P1|Overall Study|Other|1
1796089|NCT00553514|6249001|P5|Overall Study|Risk of multiple pregnancy|0
1796090|NCT00553514|6249002|P4|Overall Study|Risk of multiple pregnancy|1
1796091|NCT00553514|6249003|P3|Overall Study|Risk of multiple pregnancy|0
1796092|NCT00553514|6249004|P2|Overall Study|Risk of multiple pregnancy|2
1796093|NCT00553514|6249005|P1|Overall Study|Risk of multiple pregnancy|0
1796094|NCT00553514|6249001|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
1796095|NCT00553514|6249002|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
1796096|NCT00553514|6249003|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
1796097|NCT00553514|6249004|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
1796098|NCT00553514|6249005|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
1796099|NCT00553514|6249001|P5|Overall Study|Lack of ovarian response|6
1796100|NCT00553514|6249002|P4|Overall Study|Lack of ovarian response|5
1796101|NCT00553514|6249003|P3|Overall Study|Lack of ovarian response|5
1796102|NCT00553514|6249004|P2|Overall Study|Lack of ovarian response|5
1796103|NCT00553514|6249005|P1|Overall Study|Lack of ovarian response|4
1796104|NCT00553514|6249001|P5|Overall Study|Protocol deviation|0
1796105|NCT00553514|6249002|P4|Overall Study|Protocol deviation|1
1796106|NCT00553514|6249003|P3|Overall Study|Protocol deviation|0
1796107|NCT00553514|6249004|P2|Overall Study|Protocol deviation|0
1796108|NCT00553514|6249005|P1|Overall Study|Protocol deviation|0
1796109|NCT00553501|6249042|P1|Overall Study|Progression|1
1796110|NCT00553501|6249042|P1|Overall Study|Death|1
1796111|NCT00553501|6249042|P1|Overall Study|Adverse Event|2
1796112|NCT00553475|6249051|P3|Overall Study|Due to moving|0
1796113|NCT00553475|6249052|P2|Overall Study|Due to moving|1
1796114|NCT00553475|6249053|P1|Overall Study|Due to moving|0
1796115|NCT00553475|6249051|P3|Overall Study|Physician Decision|0
1796116|NCT00553475|6249052|P2|Overall Study|Physician Decision|0
1796117|NCT00553475|6249053|P1|Overall Study|Physician Decision|1
1796118|NCT00553475|6249051|P3|Overall Study|Withdrawal by Subject|0
1796119|NCT00553475|6249052|P2|Overall Study|Withdrawal by Subject|1
1796120|NCT00553475|6249053|P1|Overall Study|Withdrawal by Subject|1
1796121|NCT00553475|6249051|P3|Overall Study|Lack of Efficacy|0
1796122|NCT00553475|6249052|P2|Overall Study|Lack of Efficacy|1
1796123|NCT00553475|6249053|P1|Overall Study|Lack of Efficacy|7
1796124|NCT00553475|6249051|P3|Overall Study|Adverse Event|13
1796125|NCT00553475|6249052|P2|Overall Study|Adverse Event|17
1796126|NCT00553475|6249053|P1|Overall Study|Adverse Event|7
1796127|NCT00553462|6249175|P1|Overall Study|Physician Decision|1
1796128|NCT00553462|6249175|P1|Overall Study|Withdrawal by Subject|5
1796129|NCT00553462|6249175|P1|Overall Study|Progression|4
1796130|NCT00553462|6249175|P1|Overall Study|Adverse Event|4
1796131|NCT00553436|6249181|P1|Overall Study|Conversion to another procedure|1
1796132|NCT00553358|6249205|P3|Overall Study|Other: Reason Not Specified|20
1796133|NCT00553358|6249206|P2|Overall Study|Other: Reason Not Specified|4
1796134|NCT00553358|6249207|P1|Overall Study|Other: Reason Not Specified|15
1796135|NCT00553358|6249205|P3|Overall Study|Missing|1
1796136|NCT00553358|6249206|P2|Overall Study|Missing|1
1796137|NCT00553358|6249207|P1|Overall Study|Missing|1
1796138|NCT00553358|6249205|P3|Overall Study|Participant Withdrawal from Drug|3
1796139|NCT00553358|6249206|P2|Overall Study|Participant Withdrawal from Drug|0
1796140|NCT00553358|6249207|P1|Overall Study|Participant Withdrawal from Drug|0
1796141|NCT00553358|6249205|P3|Overall Study|Recurrence of Disease|1
1796142|NCT00553358|6249206|P2|Overall Study|Recurrence of Disease|4
1796143|NCT00553358|6249207|P1|Overall Study|Recurrence of Disease|3
1796144|NCT00553358|6249205|P3|Overall Study|Withdrawal by Subject|1
1796145|NCT00553358|6249206|P2|Overall Study|Withdrawal by Subject|0
1796146|NCT00553358|6249207|P1|Overall Study|Withdrawal by Subject|5
1796147|NCT00553358|6249205|P3|Overall Study|Protocol Violation|1
1796148|NCT00553358|6249206|P2|Overall Study|Protocol Violation|1
1796149|NCT00553358|6249207|P1|Overall Study|Protocol Violation|0
1796150|NCT00553358|6249205|P3|Overall Study|Lost to Follow-up|1
1796151|NCT00553358|6249206|P2|Overall Study|Lost to Follow-up|0
1796152|NCT00553358|6249207|P1|Overall Study|Lost to Follow-up|0
1796153|NCT00553358|6249205|P3|Overall Study|Adverse Event|32
1796154|NCT00553358|6249206|P2|Overall Study|Adverse Event|2
1796155|NCT00553358|6249207|P1|Overall Study|Adverse Event|29
1796156|NCT00553332|6249233|P1|Overall Study|ineligible, incorrect diagnosis|1
1796157|NCT00553319|6249245|P3|Overall Study|moved|1
1796158|NCT00553319|6249246|P2|Overall Study|moved|0
1796159|NCT00553319|6249247|P1|Overall Study|moved|1
1796160|NCT00553319|6249245|P3|Overall Study|incarceration|0
1796161|NCT00553319|6249246|P2|Overall Study|incarceration|0
1796162|NCT00553319|6249247|P1|Overall Study|incarceration|1
1796163|NCT00553319|6249245|P3|Overall Study|non-compliance|2
1796164|NCT00553319|6249246|P2|Overall Study|non-compliance|0
1796165|NCT00553319|6249247|P1|Overall Study|non-compliance|0
1796166|NCT00553319|6249245|P3|Overall Study|wanted treatment elsewhere|1
1796167|NCT00553319|6249246|P2|Overall Study|wanted treatment elsewhere|1
1796168|NCT00553319|6249247|P1|Overall Study|wanted treatment elsewhere|2
1796169|NCT00553319|6249245|P3|Overall Study|Lost to Follow-up|5
1796170|NCT00553319|6249246|P2|Overall Study|Lost to Follow-up|9
1796171|NCT00553319|6249247|P1|Overall Study|Lost to Follow-up|10
1796172|NCT00553280|6249258|P1|Overall Study|Physician Decision|1
1796173|NCT00553280|6249258|P1|Overall Study|Withdrawal by Subject|3
1796174|NCT00553280|6249258|P1|Overall Study|Lack of Efficacy|3
1796175|NCT00553280|6249258|P1|Overall Study|Adverse Event|19
1796176|NCT00553267|6249270|P3|Overall Study|Specified category|1
1796177|NCT00553267|6249271|P2|Overall Study|Specified category|2
1796178|NCT00553267|6249272|P1|Overall Study|Specified category|1
1796179|NCT00553267|6249270|P3|Overall Study|Consent withdrawn|1
1796180|NCT00553267|6249271|P2|Overall Study|Consent withdrawn|3
1796181|NCT00553267|6249272|P1|Overall Study|Consent withdrawn|2
1796182|NCT00553267|6249270|P3|Overall Study|Lost to Follow-up|1
1796183|NCT00553267|6249271|P2|Overall Study|Lost to Follow-up|0
1796184|NCT00553267|6249272|P1|Overall Study|Lost to Follow-up|0
1796185|NCT00553267|6249270|P3|Overall Study|Non compliant with protocol|2
1796186|NCT00553267|6249271|P2|Overall Study|Non compliant with protocol|3
1796187|NCT00553267|6249272|P1|Overall Study|Non compliant with protocol|3
1796188|NCT00553267|6249270|P3|Overall Study|Adverse Event|5
1796189|NCT00553267|6249271|P2|Overall Study|Adverse Event|10
1796190|NCT00553267|6249272|P1|Overall Study|Adverse Event|8
1796191|NCT00553202|6249307|P1|Overall Study|Fails to meet organ function|6
1796192|NCT00553202|6249307|P1|Overall Study|No donor identified|16
1796193|NCT00553202|6249307|P1|Overall Study|Withdrawal by Subject|1
1796194|NCT00553202|6249307|P1|Overall Study|Physician Decision|28
1796195|NCT00553202|6249307|P1|Overall Study|Lost to Follow-up|1
1796196|NCT00553202|6249307|P1|Overall Study|Death|16
1796197|NCT00553150|6249334|P4|Overall Study|Ineligible|1
1796198|NCT00553150|6249335|P3|Overall Study|Ineligible|0
1796199|NCT00553150|6249336|P2|Overall Study|Ineligible|0
1796200|NCT00553150|6249337|P1|Overall Study|Ineligible|0
1796201|NCT00553150|6249334|P4|Overall Study|Protocol Violation|1
1796202|NCT00553150|6249335|P3|Overall Study|Protocol Violation|0
1796203|NCT00553150|6249336|P2|Overall Study|Protocol Violation|0
1796204|NCT00553150|6249337|P1|Overall Study|Protocol Violation|0
1796205|NCT00553150|6249334|P4|Overall Study|Withdrawal by Subject|2
1796206|NCT00553150|6249335|P3|Overall Study|Withdrawal by Subject|0
1796207|NCT00553150|6249336|P2|Overall Study|Withdrawal by Subject|0
1796208|NCT00553150|6249337|P1|Overall Study|Withdrawal by Subject|0
1796209|NCT00552929|6249373|P10|Overall Study|Not Eligible|0
1796210|NCT00552929|6249374|P9|Overall Study|Not Eligible|0
1796211|NCT00552929|6249375|P8|Overall Study|Not Eligible|0
1796212|NCT00552929|6249376|P7|Overall Study|Not Eligible|0
1796213|NCT00552929|6249377|P6|Overall Study|Not Eligible|1
1796214|NCT00552929|6249378|P5|Overall Study|Not Eligible|0
1796215|NCT00552929|6249379|P4|Overall Study|Not Eligible|0
1796216|NCT00552929|6249380|P3|Overall Study|Not Eligible|0
1796217|NCT00552929|6249381|P2|Overall Study|Not Eligible|0
1796218|NCT00552929|6249382|P1|Overall Study|Not Eligible|0
1796219|NCT00552929|6249373|P10|Overall Study|Lost to Follow-up|0
1796220|NCT00552929|6249374|P9|Overall Study|Lost to Follow-up|1
1796221|NCT00552929|6249375|P8|Overall Study|Lost to Follow-up|0
1796222|NCT00552929|6249376|P7|Overall Study|Lost to Follow-up|0
1796223|NCT00552929|6249377|P6|Overall Study|Lost to Follow-up|0
1796224|NCT00552929|6249378|P5|Overall Study|Lost to Follow-up|0
1796225|NCT00552929|6249379|P4|Overall Study|Lost to Follow-up|0
1796226|NCT00552929|6249380|P3|Overall Study|Lost to Follow-up|0
1796227|NCT00552929|6249381|P2|Overall Study|Lost to Follow-up|0
1796228|NCT00552929|6249382|P1|Overall Study|Lost to Follow-up|0
1796229|NCT00552760|6249453|P2|Overall Study|Medication Change|0
1796230|NCT00552760|6249454|P1|Overall Study|Medication Change|1
1796231|NCT00552760|6249453|P2|Overall Study|Withdrawal by Subject|0
1796232|NCT00552760|6249454|P1|Overall Study|Withdrawal by Subject|3
1796233|NCT00552760|6249453|P2|Overall Study|Medical Condition|1
1796234|NCT00552760|6249454|P1|Overall Study|Medical Condition|1
1796235|NCT00552760|6249453|P2|Overall Study|Non-compliance|1
1796236|NCT00552760|6249454|P1|Overall Study|Non-compliance|1
1796237|NCT00552760|6249453|P2|Overall Study|Lost to Follow-up|1
1796238|NCT00552760|6249454|P1|Overall Study|Lost to Follow-up|1
1796239|NCT00552760|6249453|P2|Overall Study|Protocol Violation|1
1796240|NCT00552760|6249454|P1|Overall Study|Protocol Violation|0
1796241|NCT00552760|6249453|P2|Overall Study|Relapsed- Mixed Event|5
1796242|NCT00552760|6249454|P1|Overall Study|Relapsed- Mixed Event|3
1796243|NCT00552760|6249453|P2|Overall Study|Relapse- Manic Event|3
1796244|NCT00552760|6249454|P1|Overall Study|Relapse- Manic Event|3
1796245|NCT00552760|6249453|P2|Overall Study|Relapsed- Depressed Event|16
1796246|NCT00552760|6249454|P1|Overall Study|Relapsed- Depressed Event|10
1796247|NCT00552760|6249453|P2|Overall Study|Adverse Event|5
1796248|NCT00552760|6249454|P1|Overall Study|Adverse Event|3
1796249|NCT00552669|6249481|P2|Overall Study|Death|7
1796250|NCT00552669|6249482|P1|Overall Study|Death|3
1796251|NCT00552617|6249502|P10|Overall Study|Lost to Follow-up|0
1796252|NCT00552617|6249503|P9|Overall Study|Lost to Follow-up|2
1796253|NCT00552617|6249504|P8|Overall Study|Lost to Follow-up|0
1796254|NCT00552617|6249505|P7|Overall Study|Lost to Follow-up|0
1796255|NCT00552617|6249506|P6|Overall Study|Lost to Follow-up|2
1796256|NCT00552617|6249507|P5|Overall Study|Lost to Follow-up|0
1796257|NCT00552617|6249508|P4|Overall Study|Lost to Follow-up|1
1796258|NCT00552617|6249509|P3|Overall Study|Lost to Follow-up|0
1796259|NCT00552617|6249510|P2|Overall Study|Lost to Follow-up|0
1796260|NCT00552617|6249511|P1|Overall Study|Lost to Follow-up|0
1796261|NCT00552617|6249502|P10|Overall Study|Not Treated|1
1796262|NCT00552617|6249503|P9|Overall Study|Not Treated|0
1796263|NCT00552617|6249504|P8|Overall Study|Not Treated|0
1796264|NCT00552617|6249505|P7|Overall Study|Not Treated|0
1796265|NCT00552617|6249506|P6|Overall Study|Not Treated|0
1796266|NCT00552617|6249507|P5|Overall Study|Not Treated|0
1796267|NCT00552617|6249508|P4|Overall Study|Not Treated|0
1796268|NCT00552617|6249509|P3|Overall Study|Not Treated|1
1796269|NCT00552617|6249510|P2|Overall Study|Not Treated|0
1796270|NCT00552617|6249511|P1|Overall Study|Not Treated|0
1796271|NCT00552578|6249555|P2|Overall Study|Lost to Follow-up|1
1796272|NCT00552578|6249556|P1|Overall Study|Lost to Follow-up|1
1796273|NCT00552513|6249568|P2|Overall Study|Lost to Follow-up|1
1796274|NCT00552513|6249569|P1|Overall Study|Lost to Follow-up|5
1796275|NCT00552396|6249614|P7|Overall Study|protocol withdrawal criteria|9
1796276|NCT00552396|6249615|P6|Overall Study|protocol withdrawal criteria|3
1796277|NCT00552396|6249616|P5|Overall Study|protocol withdrawal criteria|3
1796278|NCT00552396|6249617|P4|Overall Study|protocol withdrawal criteria|6
1796279|NCT00552396|6249618|P3|Overall Study|protocol withdrawal criteria|3
1796280|NCT00552396|6249619|P2|Overall Study|protocol withdrawal criteria|3
1796281|NCT00552396|6249620|P1|Overall Study|protocol withdrawal criteria|3
1796282|NCT00552344|6249657|P1|Overall Study|Other Reason|22
1796283|NCT00552344|6249657|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
1796284|NCT00552344|6249657|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
1796285|NCT00552344|6249657|P1|Overall Study|AE, non-serious non-fatal|38
1796286|NCT00552344|6249657|P1|Overall Study|SAE, non-fatal|6
1796287|NCT00552344|6249657|P1|Overall Study|Withdrawal by Subject|48
1796288|NCT00552344|6249657|P1|Overall Study|Lost to Follow-up|8
1796289|NCT00552344|6249657|P1|Overall Study|Loss of efficacy|75
1796290|NCT00552344|6249657|P1|Overall Study|Lack of Efficacy|55
1796291|NCT00552305|6249666|P1|Overall Study|Other: Subject went to rehab|1
1796292|NCT00552305|6249666|P1|Overall Study|Other: Subject incarcerated|1
1796293|NCT00552305|6249666|P1|Overall Study|Other: Subject moved from area|2
1796294|NCT00552305|6249666|P1|Overall Study|Other: Health problems, not drug related|1
1796295|NCT00552305|6249666|P1|Overall Study|Other: Subject became pregnant|1
1796296|NCT00552305|6249666|P1|Overall Study|Other: Subject underwent surgery|4
1796297|NCT00552305|6249666|P1|Overall Study|Other: Unable to attend visits|1
1796298|NCT00552305|6249666|P1|Overall Study|Other: Personal problems|1
1796299|NCT00552305|6249666|P1|Overall Study|Other: Site closed|4
1796300|NCT00552305|6249666|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
1796301|NCT00552305|6249666|P1|Overall Study|AE/Other: prohibited drug required|1
1796302|NCT00552305|6249666|P1|Overall Study|Poor compliance/lost to follow-up|1
1796303|NCT00552305|6249666|P1|Overall Study|Unsatisfactory compliance|11
1796304|NCT00552305|6249666|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
1796305|NCT00552305|6249666|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
1796306|NCT00552305|6249666|P1|Overall Study|Lack of efficacy/withdrew consent|1
1796307|NCT00552305|6249666|P1|Overall Study|Withdrawal by Subject|44
1796308|NCT00552305|6249666|P1|Overall Study|Protocol Violation|3
1796309|NCT00552305|6249666|P1|Overall Study|Lost to Follow-up|4
1796310|NCT00552305|6249666|P1|Overall Study|Lack of Efficacy|120
1796311|NCT00552305|6249666|P1|Overall Study|Adverse Event|43
1796312|NCT00552279|6249676|P2|Overall Study|Other|1
1796313|NCT00552279|6249677|P1|Overall Study|Other|1
1796314|NCT00552279|6249676|P2|Overall Study|Lost to Follow-up|0
1796315|NCT00552279|6249677|P1|Overall Study|Lost to Follow-up|1
1796316|NCT00552279|6249676|P2|Overall Study|Withdrawal by Subject|1
1796317|NCT00552279|6249677|P1|Overall Study|Withdrawal by Subject|12
1796318|NCT00552279|6249676|P2|Overall Study|Adverse Event|1
1796319|NCT00552279|6249677|P1|Overall Study|Adverse Event|0
1796320|NCT00552240|6249703|P2|Overall Study|Other|0
1796321|NCT00552240|6249704|P1|Overall Study|Other|1
1796322|NCT00552240|6249703|P2|Overall Study|Lack of Efficacy|0
1796323|NCT00552240|6249704|P1|Overall Study|Lack of Efficacy|6
1796324|NCT00552240|6249703|P2|Overall Study|Withdrawal by Subject|2
1796325|NCT00552240|6249704|P1|Overall Study|Withdrawal by Subject|2
1796326|NCT00552240|6249703|P2|Overall Study|Lost to Follow-up|6
1796327|NCT00552240|6249704|P1|Overall Study|Lost to Follow-up|5
1796328|NCT00552240|6249703|P2|Overall Study|Protocol Violation|1
1796329|NCT00552240|6249704|P1|Overall Study|Protocol Violation|1
1796330|NCT00552240|6249703|P2|Overall Study|Adverse Event|9
1796331|NCT00552240|6249704|P1|Overall Study|Adverse Event|9
1796332|NCT00552188|6249806|P2|Overall Study|Subject returned to home country|1
1796333|NCT00552188|6249807|P1|Overall Study|Subject returned to home country|0
1796334|NCT00552188|6249806|P2|Overall Study|Withdrawal of consent|1
1796335|NCT00552188|6249807|P1|Overall Study|Withdrawal of consent|0
1796336|NCT00552188|6249806|P2|Overall Study|Lost to Follow-up|1
1796337|NCT00552188|6249807|P1|Overall Study|Lost to Follow-up|2
1796338|NCT00552188|6249806|P2|Overall Study|Adverse Event|2
1796339|NCT00552188|6249807|P1|Overall Study|Adverse Event|0
1796340|NCT00552175|6249818|P3|Overall Study|Reason Not Specified|1
1796341|NCT00552175|6249819|P2|Overall Study|Reason Not Specified|1
1796342|NCT00552175|6249820|P1|Overall Study|Reason Not Specified|3
1796343|NCT00552175|6249818|P3|Overall Study|Entry Criteria Not Met|0
1796344|NCT00552175|6249819|P2|Overall Study|Entry Criteria Not Met|1
1796345|NCT00552175|6249820|P1|Overall Study|Entry Criteria Not Met|1
1796346|NCT00552175|6249818|P3|Overall Study|Lost to Follow-up|1
1796347|NCT00552175|6249819|P2|Overall Study|Lost to Follow-up|0
1796348|NCT00552175|6249820|P1|Overall Study|Lost to Follow-up|0
1796349|NCT00552175|6249818|P3|Overall Study|Withdrawal by Subject|1
1796350|NCT00552175|6249819|P2|Overall Study|Withdrawal by Subject|2
1796351|NCT00552175|6249820|P1|Overall Study|Withdrawal by Subject|2
1796352|NCT00552175|6249818|P3|Overall Study|Adverse Event|10
1796353|NCT00552175|6249819|P2|Overall Study|Adverse Event|9
1796354|NCT00552175|6249820|P1|Overall Study|Adverse Event|9
1796355|NCT00552175|6249818|P3|Overall Study|Lack of Efficacy|1
1796356|NCT00552175|6249819|P2|Overall Study|Lack of Efficacy|0
1796357|NCT00552175|6249820|P1|Overall Study|Lack of Efficacy|2
1796358|NCT00552110|6249860|P5|Overall Study|Nonserious Adverse Event (AE)|0
1796359|NCT00552110|6249861|P4|Overall Study|Nonserious Adverse Event (AE)|1
1796360|NCT00552110|6249862|P3|Overall Study|Nonserious Adverse Event (AE)|0
1796361|NCT00552110|6249863|P2|Overall Study|Nonserious Adverse Event (AE)|0
1796362|NCT00552110|6249864|P1|Overall Study|Nonserious Adverse Event (AE)|1
1796363|NCT00552110|6249860|P5|Overall Study|Increased Blood Pressure at Visit 2|0
1796364|NCT00552110|6249861|P4|Overall Study|Increased Blood Pressure at Visit 2|1
1796365|NCT00552110|6249862|P3|Overall Study|Increased Blood Pressure at Visit 2|0
1796366|NCT00552110|6249863|P2|Overall Study|Increased Blood Pressure at Visit 2|0
1796367|NCT00552110|6249864|P1|Overall Study|Increased Blood Pressure at Visit 2|0
1796368|NCT00552110|6249860|P5|Overall Study|Delay of Study due to Relabeling|0
1796369|NCT00552110|6249861|P4|Overall Study|Delay of Study due to Relabeling|1
1796370|NCT00552110|6249862|P3|Overall Study|Delay of Study due to Relabeling|0
1796371|NCT00552110|6249863|P2|Overall Study|Delay of Study due to Relabeling|0
1796372|NCT00552110|6249864|P1|Overall Study|Delay of Study due to Relabeling|0
1796373|NCT00552110|6249860|P5|Overall Study|Use of Prohibited Medication|0
1796374|NCT00552110|6249861|P4|Overall Study|Use of Prohibited Medication|0
1796375|NCT00552110|6249862|P3|Overall Study|Use of Prohibited Medication|0
1796376|NCT00552110|6249863|P2|Overall Study|Use of Prohibited Medication|1
1796377|NCT00552110|6249864|P1|Overall Study|Use of Prohibited Medication|1
1796378|NCT00552110|6249860|P5|Overall Study|Withdrawn per Sponsor|1
1796379|NCT00552110|6249861|P4|Overall Study|Withdrawn per Sponsor|0
1796380|NCT00552110|6249862|P3|Overall Study|Withdrawn per Sponsor|0
1796381|NCT00552110|6249863|P2|Overall Study|Withdrawn per Sponsor|1
1796382|NCT00552110|6249864|P1|Overall Study|Withdrawn per Sponsor|0
1796383|NCT00552110|6249860|P5|Overall Study|Failed to Comply With Study Requirements|1
1796384|NCT00552110|6249861|P4|Overall Study|Failed to Comply With Study Requirements|0
1796385|NCT00552110|6249862|P3|Overall Study|Failed to Comply With Study Requirements|1
1796386|NCT00552110|6249863|P2|Overall Study|Failed to Comply With Study Requirements|1
1796387|NCT00552110|6249864|P1|Overall Study|Failed to Comply With Study Requirements|1
1796388|NCT00552110|6249860|P5|Overall Study|Lost to Follow-up|1
1796389|NCT00552110|6249861|P4|Overall Study|Lost to Follow-up|1
1796390|NCT00552110|6249862|P3|Overall Study|Lost to Follow-up|0
1796391|NCT00552110|6249863|P2|Overall Study|Lost to Follow-up|0
1796392|NCT00552110|6249864|P1|Overall Study|Lost to Follow-up|0
1796393|NCT00552110|6249860|P5|Overall Study|Withdrawal by Subject|2
1796394|NCT00552110|6249861|P4|Overall Study|Withdrawal by Subject|3
1796395|NCT00552110|6249862|P3|Overall Study|Withdrawal by Subject|0
1796396|NCT00552110|6249863|P2|Overall Study|Withdrawal by Subject|2
1796397|NCT00552110|6249864|P1|Overall Study|Withdrawal by Subject|0
1796398|NCT00552110|6249860|P5|Overall Study|Lack of Efficacy|4
1796399|NCT00552110|6249861|P4|Overall Study|Lack of Efficacy|1
1796400|NCT00552110|6249862|P3|Overall Study|Lack of Efficacy|0
1796401|NCT00552110|6249863|P2|Overall Study|Lack of Efficacy|0
1796402|NCT00552110|6249864|P1|Overall Study|Lack of Efficacy|1
1796403|NCT00552110|6249860|P5|Overall Study|Serious or Life-Threatening AE|0
1796404|NCT00552110|6249861|P4|Overall Study|Serious or Life-Threatening AE|0
1796405|NCT00552110|6249862|P3|Overall Study|Serious or Life-Threatening AE|1
1796406|NCT00552110|6249863|P2|Overall Study|Serious or Life-Threatening AE|0
1796407|NCT00552110|6249864|P1|Overall Study|Serious or Life-Threatening AE|0
1796408|NCT00552084|6249883|P2|Overall Study|change in anti-arrythmic drug|1
1796409|NCT00552084|6249884|P1|Overall Study|change in anti-arrythmic drug|1
1796410|NCT00552084|6249883|P2|Overall Study|Protocol Violation|0
1796411|NCT00552084|6249884|P1|Overall Study|Protocol Violation|1
1796412|NCT00552084|6249883|P2|Overall Study|Withdrawal by Subject|5
1796413|NCT00552084|6249884|P1|Overall Study|Withdrawal by Subject|4
1796414|NCT00552084|6249883|P2|Overall Study|Adverse Event|3
1796415|NCT00552084|6249884|P1|Overall Study|Adverse Event|2
1796416|NCT00552071|6249892|P2|Overall Study|Withdrawal by Subject|1
1796417|NCT00552071|6249893|P1|Overall Study|Withdrawal by Subject|0
1796418|NCT00552071|6249892|P2|Overall Study|Death|1
1796419|NCT00552071|6249893|P1|Overall Study|Death|0
1796420|NCT00552071|6249892|P2|Overall Study|Pregnancy|0
1796421|NCT00552071|6249893|P1|Overall Study|Pregnancy|1
1796422|NCT00552071|6249892|P2|Overall Study|Physician Decision|0
1796423|NCT00552071|6249893|P1|Overall Study|Physician Decision|1
1796424|NCT00552071|6249892|P2|Overall Study|Lack of Efficacy|0
1796425|NCT00552071|6249893|P1|Overall Study|Lack of Efficacy|1
1796426|NCT00552071|6249892|P2|Overall Study|Adverse Event|0
1796427|NCT00552071|6249893|P1|Overall Study|Adverse Event|1
1796428|NCT00552058|6249903|P2|Overall Study|Other: Early Roll Over|0
1796429|NCT00552058|6249904|P1|Overall Study|Other: Early Roll Over|1
1796430|NCT00552058|6249903|P2|Overall Study|Other: Sponsors Decision|1
1796431|NCT00552058|6249904|P1|Overall Study|Other: Sponsors Decision|0
1796432|NCT00552058|6249903|P2|Overall Study|Other: Randomized in error|1
1796433|NCT00552058|6249904|P1|Overall Study|Other: Randomized in error|0
1796434|NCT00552058|6249903|P2|Overall Study|Other: Positive Stool Result|1
1796435|NCT00552058|6249904|P1|Overall Study|Other: Positive Stool Result|0
1796436|NCT00552058|6249903|P2|Overall Study|Other: Low CDAI score, entry violation|1
1796437|NCT00552058|6249904|P1|Overall Study|Other: Low CDAI score, entry violation|0
1796438|NCT00552058|6249903|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
1796439|NCT00552058|6249904|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
1796440|NCT00552058|6249903|P2|Overall Study|Other: Non Compliance|2
1796441|NCT00552058|6249904|P1|Overall Study|Other: Non Compliance|1
1796442|NCT00552058|6249903|P2|Overall Study|Other: Protocol Violation|1
1796443|NCT00552058|6249904|P1|Overall Study|Other: Protocol Violation|0
1796444|NCT00552058|6249903|P2|Overall Study|Withdrawal by Subject|4
1796445|NCT00552058|6249904|P1|Overall Study|Withdrawal by Subject|4
1796446|NCT00552058|6249903|P2|Overall Study|Lost to Follow-up|0
1796447|NCT00552058|6249904|P1|Overall Study|Lost to Follow-up|1
1796448|NCT00552058|6249903|P2|Overall Study|Lack of Efficacy|5
1796449|NCT00552058|6249904|P1|Overall Study|Lack of Efficacy|1
1796450|NCT00552058|6249903|P2|Overall Study|Adverse Event|7
1796451|NCT00552058|6249904|P1|Overall Study|Adverse Event|8
1796452|NCT00552032|6249944|P2|Overall Study|Lost to Follow-up|5
1796453|NCT00552032|6249945|P1|Overall Study|Lost to Follow-up|8
1796454|NCT00552032|6249944|P2|Overall Study|Protocol Violation|12
1796455|NCT00552032|6249945|P1|Overall Study|Protocol Violation|7
1796456|NCT00552032|6249944|P2|Overall Study|Withdrawal by Subject|2
1796457|NCT00552032|6249945|P1|Overall Study|Withdrawal by Subject|2
1796458|NCT00551759|6249989|P1|Overall Study|Ineligible|1
1796459|NCT00551759|6249989|P1|Overall Study|Death|5
1796460|NCT00551759|6249989|P1|Overall Study|Adverse Event|7
1796461|NCT00551642|6250030|P2|Overall Study|Inclusion/Exclusion criteria|4
1796462|NCT00551642|6250031|P1|Overall Study|Inclusion/Exclusion criteria|4
1796463|NCT00551642|6250030|P2|Overall Study|Delivery device failure|3
1796464|NCT00551642|6250031|P1|Overall Study|Delivery device failure|1
1796465|NCT00551642|6250030|P2|Overall Study|Physician Decision|1
1796466|NCT00551642|6250031|P1|Overall Study|Physician Decision|0
1796467|NCT00551642|6250030|P2|Overall Study|Protocol Violation|11
1796468|NCT00551642|6250031|P1|Overall Study|Protocol Violation|6
1796469|NCT00551642|6250030|P2|Overall Study|Death|31
1796470|NCT00551642|6250031|P1|Overall Study|Death|33
1796471|NCT00551642|6250030|P2|Overall Study|Adverse Event|12
1796472|NCT00551642|6250031|P1|Overall Study|Adverse Event|15
1796473|NCT00551642|6250030|P2|Overall Study|Withdrawal by Subject|1
1796474|NCT00551642|6250031|P1|Overall Study|Withdrawal by Subject|2
1796475|NCT00551525|6250037|P1|Overall Study|Protocol Violation|5
1796476|NCT00551460|6250046|P1|Overall Study|Not analyzable (did not start treatment)|4
1796477|NCT00551460|6250046|P1|Overall Study|Ineligible|4
1796478|NCT00551460|6250046|P1|Overall Study|Death|7
1796479|NCT00551460|6250046|P1|Overall Study|Physician Decision|1
1796480|NCT00551460|6250046|P1|Overall Study|Withdrawal by Subject|1
1796481|NCT00551460|6250046|P1|Overall Study|Adverse Event|1
1796482|NCT00551421|6250052|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
1796483|NCT00551369|6250059|P1|Overall Study|Not treated per protocol and re|1
1796484|NCT00551369|6250059|P1|Overall Study|Withdrawal by Subject|1
1796485|NCT00551369|6250059|P1|Overall Study|Protocol Violation|5
1796486|NCT00551291|6250068|P1|Overall Study|Physician Decision|1
1796487|NCT00551213|6250076|P2|Overall Study|Not Treated|2
1796488|NCT00551213|6250077|P1|Overall Study|Not Treated|1
1796489|NCT00551213|6250076|P2|Overall Study|Withdrawal by Subject|0
1796490|NCT00551213|6250077|P1|Overall Study|Withdrawal by Subject|2
1796491|NCT00551213|6250076|P2|Overall Study|Progressive Disease|12
1796492|NCT00551213|6250077|P1|Overall Study|Progressive Disease|41
1796493|NCT00551213|6250076|P2|Overall Study|Adverse Event|3
1796494|NCT00551213|6250077|P1|Overall Study|Adverse Event|6
1796495|NCT00551161|6250121|P1|Overall Study|Withdrawal by Subject|1
1796496|NCT00551135|6250129|P4|Overall Study|Withdrawal by Subject|1
1796497|NCT00551135|6250130|P3|Overall Study|Withdrawal by Subject|3
1796498|NCT00551135|6250131|P2|Overall Study|Withdrawal by Subject|0
1796499|NCT00551135|6250132|P1|Overall Study|Withdrawal by Subject|1
1796500|NCT00551135|6250129|P4|Overall Study|Other|2
1796501|NCT00551135|6250130|P3|Overall Study|Other|1
1796502|NCT00551135|6250131|P2|Overall Study|Other|2
1796503|NCT00551135|6250132|P1|Overall Study|Other|3
1796504|NCT00551135|6250129|P4|Overall Study|Lost to Follow-up|1
1796505|NCT00551135|6250130|P3|Overall Study|Lost to Follow-up|0
1796506|NCT00551135|6250131|P2|Overall Study|Lost to Follow-up|0
1796507|NCT00551135|6250132|P1|Overall Study|Lost to Follow-up|0
1796508|NCT00551135|6250129|P4|Overall Study|Adverse Event|1
1796509|NCT00551135|6250130|P3|Overall Study|Adverse Event|1
1796510|NCT00551135|6250131|P2|Overall Study|Adverse Event|0
1796511|NCT00551135|6250132|P1|Overall Study|Adverse Event|1
1796512|NCT00551031|6250261|P5|Overall Study|Did not receive vaccine|0
1796513|NCT00551031|6250262|P4|Overall Study|Did not receive vaccine|0
1796514|NCT00551031|6250263|P3|Overall Study|Did not receive vaccine|0
1796515|NCT00551031|6250264|P2|Overall Study|Did not receive vaccine|2
1796516|NCT00551031|6250265|P1|Overall Study|Did not receive vaccine|1
1796517|NCT00551031|6250261|P5|Overall Study|Serious Adverse Event|0
1796518|NCT00551031|6250262|P4|Overall Study|Serious Adverse Event|0
1796519|NCT00551031|6250263|P3|Overall Study|Serious Adverse Event|1
1796520|NCT00551031|6250264|P2|Overall Study|Serious Adverse Event|2
1796521|NCT00551031|6250265|P1|Overall Study|Serious Adverse Event|0
1796522|NCT00551031|6250261|P5|Overall Study|Withdrawal by Subject|0
1796523|NCT00551031|6250262|P4|Overall Study|Withdrawal by Subject|2
1796524|NCT00551031|6250263|P3|Overall Study|Withdrawal by Subject|1
1796525|NCT00551031|6250264|P2|Overall Study|Withdrawal by Subject|4
1796526|NCT00551031|6250265|P1|Overall Study|Withdrawal by Subject|0
1796527|NCT00551031|6250261|P5|Overall Study|Lost to Follow-up|1
1796528|NCT00551031|6250262|P4|Overall Study|Lost to Follow-up|1
1796529|NCT00551031|6250263|P3|Overall Study|Lost to Follow-up|0
1796530|NCT00551031|6250264|P2|Overall Study|Lost to Follow-up|1
1796531|NCT00551031|6250265|P1|Overall Study|Lost to Follow-up|0
1796532|NCT00551031|6250261|P5|Overall Study|Protocol Violation|0
1796533|NCT00551031|6250262|P4|Overall Study|Protocol Violation|0
1796534|NCT00551031|6250263|P3|Overall Study|Protocol Violation|0
1796535|NCT00551031|6250264|P2|Overall Study|Protocol Violation|1
1796536|NCT00551031|6250265|P1|Overall Study|Protocol Violation|1
1796537|NCT00551031|6250261|P5|Overall Study|Adverse Event|0
1796538|NCT00551031|6250262|P4|Overall Study|Adverse Event|0
1796539|NCT00551031|6250263|P3|Overall Study|Adverse Event|0
1796540|NCT00551031|6250264|P2|Overall Study|Adverse Event|1
1796541|NCT00551031|6250265|P1|Overall Study|Adverse Event|0
1796542|NCT00550953|6250294|P2|Overall Study|Not able to visit the site|3
1796543|NCT00550953|6250295|P1|Overall Study|Not able to visit the site|2
1796544|NCT00550953|6250294|P2|Overall Study|Adverse Event|3
1796545|NCT00550953|6250295|P1|Overall Study|Adverse Event|4
1796546|NCT00550836|6250342|P2|Overall Study|Withdrawal by Subject|9
1796547|NCT00550836|6250343|P1|Overall Study|Withdrawal by Subject|3
1796548|NCT00550771|6250359|P2|Overall Study|Protocol Violation|5
1796549|NCT00550771|6250360|P1|Overall Study|Protocol Violation|4
1796550|NCT00550771|6250359|P2|Overall Study|Withdrawal by Subject|1
1796551|NCT00550771|6250360|P1|Overall Study|Withdrawal by Subject|0
1796552|NCT00550771|6250359|P2|Overall Study|Physician Decision|0
1796553|NCT00550771|6250360|P1|Overall Study|Physician Decision|2
1796554|NCT00550771|6250359|P2|Overall Study|Discontinued for study-related reasons|1
1796555|NCT00550771|6250360|P1|Overall Study|Discontinued for study-related reasons|0
1796556|NCT00550771|6250359|P2|Overall Study|Adverse Event|3
1796557|NCT00550771|6250360|P1|Overall Study|Adverse Event|11
1796558|NCT00550745|6250374|P2|Overall Study|Screen failure|0
1796559|NCT00550745|6250375|P1|Overall Study|Screen failure|1
1796560|NCT00550745|6250374|P2|Overall Study|Withdrawal by Subject|10
1796561|NCT00550745|6250375|P1|Overall Study|Withdrawal by Subject|17
1796562|NCT00550745|6250374|P2|Overall Study|Protocol Violation|2
1796563|NCT00550745|6250375|P1|Overall Study|Protocol Violation|4
1796564|NCT00550745|6250374|P2|Overall Study|Physician Decision|2
1796565|NCT00550745|6250375|P1|Overall Study|Physician Decision|0
1796566|NCT00550745|6250374|P2|Overall Study|Lost to Follow-up|30
1796567|NCT00550745|6250375|P1|Overall Study|Lost to Follow-up|45
1796568|NCT00550745|6250374|P2|Overall Study|Death|16
1796569|NCT00550745|6250375|P1|Overall Study|Death|20
1796570|NCT00550732|6250383|P1|Overall Study|Adverse Event|1
1796571|NCT00550732|6250383|P1|Overall Study|Palliative care|1
1796572|NCT00550732|6250383|P1|Overall Study|Lost to Follow-up|1
1796573|NCT00550732|6250383|P1|Overall Study|Physician Decision|2
1796574|NCT00550732|6250383|P1|Overall Study|Withdrawal by Subject|2
1796575|NCT00550732|6250383|P1|Overall Study|Death|4
1796576|NCT00550680|6250394|P1|Overall Study|Screen Failure|6
1796577|NCT00550680|6250394|P1|Overall Study|Refused Treatment|19
1796578|NCT00550680|6250394|P1|Overall Study|Protocol Violation|7
1796579|NCT00550680|6250394|P1|Overall Study|Other|10
1796580|NCT00550680|6250394|P1|Overall Study|Lack of Efficacy|1
1796581|NCT00550680|6250394|P1|Overall Study|Lost to Follow-up|3
1796582|NCT00550680|6250394|P1|Overall Study|Early Improvement|1
1796583|NCT00550680|6250394|P1|Overall Study|Death|3
1796584|NCT00550680|6250394|P1|Overall Study|Adverse Event|5
1796585|NCT00550680|6250394|P1|Overall Study|Administrative Reasons|1
1796586|NCT00550615|6250415|P4|Overall Study|Not evaluable|7
1796587|NCT00550615|6250416|P3|Overall Study|Not evaluable|2
1796588|NCT00550615|6250417|P2|Overall Study|Not evaluable|0
1796589|NCT00550615|6250418|P1|Overall Study|Not evaluable|0
1796590|NCT00550615|6250415|P4|Overall Study|Withdrawal by Subject|3
1796591|NCT00550615|6250416|P3|Overall Study|Withdrawal by Subject|2
1796592|NCT00550615|6250417|P2|Overall Study|Withdrawal by Subject|0
1796593|NCT00550615|6250418|P1|Overall Study|Withdrawal by Subject|0
1796594|NCT00550550|6250437|P2|Overall Study|Randomized But Not Treated|0
1796595|NCT00550550|6250438|P1|Overall Study|Randomized But Not Treated|1
1796596|NCT00550550|6250437|P2|Overall Study|Did Not Meet Protocol Eligibility|1
1796597|NCT00550550|6250438|P1|Overall Study|Did Not Meet Protocol Eligibility|1
1796598|NCT00550550|6250437|P2|Overall Study|Protocol Violation|14
1796599|NCT00550550|6250438|P1|Overall Study|Protocol Violation|5
1796600|NCT00550550|6250437|P2|Overall Study|Withdrawal by Subject|8
1796601|NCT00550550|6250438|P1|Overall Study|Withdrawal by Subject|10
1796602|NCT00550550|6250437|P2|Overall Study|Lost to Follow-up|0
1796603|NCT00550550|6250438|P1|Overall Study|Lost to Follow-up|4
1796604|NCT00550550|6250437|P2|Overall Study|Treatment Failure|1
1796605|NCT00550550|6250438|P1|Overall Study|Treatment Failure|0
1796606|NCT00550550|6250437|P2|Overall Study|Adverse Event|5
1796607|NCT00550550|6250438|P1|Overall Study|Adverse Event|13
1796608|NCT00550537|6250450|P1|Overall Study|Treated closer to home|4
1796609|NCT00550537|6250450|P1|Overall Study|Declining performance status|2
1796610|NCT00550537|6250450|P1|Overall Study|Other complicating ilness|3
1796611|NCT00550537|6250450|P1|Overall Study|Change in treatment plan|4
1796612|NCT00550537|6250450|P1|Overall Study|Withdrawal by Subject|7
1796613|NCT00550537|6250450|P1|Overall Study|Disease progression before|46
1796614|NCT00550537|6250450|P1|Overall Study|Adverse Event|20
1796615|NCT00550537|6250450|P1|Overall Study|Death|18
1796616|NCT00550459|6250467|P2|Overall Study|Withdrawal by Subject|1
1796617|NCT00550459|6250468|P1|Overall Study|Withdrawal by Subject|1
1796618|NCT00550459|6250467|P2|Overall Study|Adverse Event|2
1796619|NCT00550459|6250468|P1|Overall Study|Adverse Event|0
1796620|NCT00550446|6250537|P11|Post Week 12|Other|0
1796621|NCT00550446|6250538|P10|Post Week 12|Other|1
1796622|NCT00550446|6250539|P9|Post Week 12|Other|1
1796623|NCT00550446|6250540|P8|Post Week 12|Other|0
1796624|NCT00550446|6250541|P7|Post Week 12|Other|1
1796625|NCT00550446|6250542|P6|Post Week 12|Other|0
1796626|NCT00550446|6250543|P5|Post Week 12|Other|0
1796627|NCT00550446|6250544|P4|Post Week 12|Other|1
1796628|NCT00550446|6250545|P3|Post Week 12|Other|0
1796629|NCT00550446|6250546|P2|Post Week 12|Other|1
1796630|NCT00550446|6250547|P1|Post Week 12|Other|1
1796631|NCT00550446|6250537|P11|Post Week 12|Withdrawal by Subject|0
1796632|NCT00550446|6250538|P10|Post Week 12|Withdrawal by Subject|0
1796633|NCT00550446|6250539|P9|Post Week 12|Withdrawal by Subject|0
1796634|NCT00550446|6250540|P8|Post Week 12|Withdrawal by Subject|0
1796635|NCT00550446|6250541|P7|Post Week 12|Withdrawal by Subject|0
1796636|NCT00550446|6250542|P6|Post Week 12|Withdrawal by Subject|0
1796637|NCT00550446|6250543|P5|Post Week 12|Withdrawal by Subject|1
1796638|NCT00550446|6250544|P4|Post Week 12|Withdrawal by Subject|0
1796639|NCT00550446|6250545|P3|Post Week 12|Withdrawal by Subject|0
1796640|NCT00550446|6250546|P2|Post Week 12|Withdrawal by Subject|0
1796641|NCT00550446|6250547|P1|Post Week 12|Withdrawal by Subject|0
1796642|NCT00550446|6250537|P11|Post Week 12|Lost to Follow-up|0
1796643|NCT00550446|6250538|P10|Post Week 12|Lost to Follow-up|0
1796644|NCT00550446|6250539|P9|Post Week 12|Lost to Follow-up|0
1796645|NCT00550446|6250540|P8|Post Week 12|Lost to Follow-up|0
1796646|NCT00550446|6250541|P7|Post Week 12|Lost to Follow-up|1
1796647|NCT00550446|6250542|P6|Post Week 12|Lost to Follow-up|0
1796648|NCT00550446|6250543|P5|Post Week 12|Lost to Follow-up|0
1796649|NCT00550446|6250544|P4|Post Week 12|Lost to Follow-up|1
1796650|NCT00550446|6250545|P3|Post Week 12|Lost to Follow-up|1
1796651|NCT00550446|6250546|P2|Post Week 12|Lost to Follow-up|0
1796652|NCT00550446|6250547|P1|Post Week 12|Lost to Follow-up|0
1796653|NCT00550446|6250537|P11|Post Week 12|Lack of Efficacy|1
1796654|NCT00550446|6250538|P10|Post Week 12|Lack of Efficacy|2
1796655|NCT00550446|6250539|P9|Post Week 12|Lack of Efficacy|1
1796656|NCT00550446|6250540|P8|Post Week 12|Lack of Efficacy|1
1796657|NCT00550446|6250541|P7|Post Week 12|Lack of Efficacy|0
1796658|NCT00550446|6250542|P6|Post Week 12|Lack of Efficacy|0
1796659|NCT00550446|6250543|P5|Post Week 12|Lack of Efficacy|0
1796660|NCT00550446|6250544|P4|Post Week 12|Lack of Efficacy|0
1796661|NCT00550446|6250545|P3|Post Week 12|Lack of Efficacy|1
1796662|NCT00550446|6250546|P2|Post Week 12|Lack of Efficacy|0
1796663|NCT00550446|6250547|P1|Post Week 12|Lack of Efficacy|0
1796664|NCT00550446|6250537|P11|Post Week 12|Adverse Event|0
1796665|NCT00550446|6250538|P10|Post Week 12|Adverse Event|4
1796666|NCT00550446|6250539|P9|Post Week 12|Adverse Event|0
1796667|NCT00550446|6250540|P8|Post Week 12|Adverse Event|0
1796668|NCT00550446|6250541|P7|Post Week 12|Adverse Event|0
1796669|NCT00550446|6250542|P6|Post Week 12|Adverse Event|1
1796670|NCT00550446|6250543|P5|Post Week 12|Adverse Event|1
1796671|NCT00550446|6250544|P4|Post Week 12|Adverse Event|1
1796672|NCT00550446|6250545|P3|Post Week 12|Adverse Event|1
1796673|NCT00550446|6250546|P2|Post Week 12|Adverse Event|1
1796674|NCT00550446|6250547|P1|Post Week 12|Adverse Event|2
1796675|NCT00550446|6250537|P11|Up To Week 12|Randomized not treated|0
1796676|NCT00550446|6250538|P10|Up To Week 12|Randomized not treated|0
1796677|NCT00550446|6250539|P9|Up To Week 12|Randomized not treated|0
1796678|NCT00550446|6250540|P8|Up To Week 12|Randomized not treated|0
1796679|NCT00550446|6250541|P7|Up To Week 12|Randomized not treated|0
1796680|NCT00550446|6250542|P6|Up To Week 12|Randomized not treated|0
1796681|NCT00550446|6250543|P5|Up To Week 12|Randomized not treated|0
1796682|NCT00550446|6250544|P4|Up To Week 12|Randomized not treated|0
1796683|NCT00550446|6250545|P3|Up To Week 12|Randomized not treated|1
1796684|NCT00550446|6250546|P2|Up To Week 12|Randomized not treated|1
1796685|NCT00550446|6250547|P1|Up To Week 12|Randomized not treated|0
1796686|NCT00550446|6250537|P11|Up To Week 12|Other|0
1796687|NCT00550446|6250538|P10|Up To Week 12|Other|0
1796688|NCT00550446|6250539|P9|Up To Week 12|Other|0
1796689|NCT00550446|6250540|P8|Up To Week 12|Other|0
1796690|NCT00550446|6250541|P7|Up To Week 12|Other|4
1796691|NCT00550446|6250542|P6|Up To Week 12|Other|1
1796692|NCT00550446|6250543|P5|Up To Week 12|Other|0
1796693|NCT00550446|6250544|P4|Up To Week 12|Other|0
1796694|NCT00550446|6250545|P3|Up To Week 12|Other|0
1796695|NCT00550446|6250546|P2|Up To Week 12|Other|0
1796696|NCT00550446|6250547|P1|Up To Week 12|Other|3
1796697|NCT00550446|6250537|P11|Up To Week 12|Withdrawal by Subject|0
1796698|NCT00550446|6250538|P10|Up To Week 12|Withdrawal by Subject|0
1796699|NCT00550446|6250539|P9|Up To Week 12|Withdrawal by Subject|0
1796700|NCT00550446|6250540|P8|Up To Week 12|Withdrawal by Subject|0
1796701|NCT00550446|6250541|P7|Up To Week 12|Withdrawal by Subject|3
1796702|NCT00550446|6250542|P6|Up To Week 12|Withdrawal by Subject|1
1796703|NCT00550446|6250543|P5|Up To Week 12|Withdrawal by Subject|0
1796704|NCT00550446|6250544|P4|Up To Week 12|Withdrawal by Subject|2
1796705|NCT00550446|6250545|P3|Up To Week 12|Withdrawal by Subject|3
1796706|NCT00550446|6250546|P2|Up To Week 12|Withdrawal by Subject|0
1796707|NCT00550446|6250547|P1|Up To Week 12|Withdrawal by Subject|2
1796708|NCT00550446|6250537|P11|Up To Week 12|Lost to Follow-up|0
1796709|NCT00550446|6250538|P10|Up To Week 12|Lost to Follow-up|0
1796710|NCT00550446|6250539|P9|Up To Week 12|Lost to Follow-up|0
1796711|NCT00550446|6250540|P8|Up To Week 12|Lost to Follow-up|0
1796712|NCT00550446|6250541|P7|Up To Week 12|Lost to Follow-up|2
1796713|NCT00550446|6250542|P6|Up To Week 12|Lost to Follow-up|1
1796714|NCT00550446|6250543|P5|Up To Week 12|Lost to Follow-up|1
1796715|NCT00550446|6250544|P4|Up To Week 12|Lost to Follow-up|0
1796716|NCT00550446|6250545|P3|Up To Week 12|Lost to Follow-up|0
1796717|NCT00550446|6250546|P2|Up To Week 12|Lost to Follow-up|1
1796718|NCT00550446|6250547|P1|Up To Week 12|Lost to Follow-up|0
1796719|NCT00550446|6250537|P11|Up To Week 12|Lack of Efficacy|0
1796720|NCT00550446|6250538|P10|Up To Week 12|Lack of Efficacy|0
1796721|NCT00550446|6250539|P9|Up To Week 12|Lack of Efficacy|0
1796722|NCT00550446|6250540|P8|Up To Week 12|Lack of Efficacy|0
1796723|NCT00550446|6250541|P7|Up To Week 12|Lack of Efficacy|3
1796724|NCT00550446|6250542|P6|Up To Week 12|Lack of Efficacy|3
1796725|NCT00550446|6250543|P5|Up To Week 12|Lack of Efficacy|0
1796726|NCT00550446|6250544|P4|Up To Week 12|Lack of Efficacy|1
1796727|NCT00550446|6250545|P3|Up To Week 12|Lack of Efficacy|0
1796728|NCT00550446|6250546|P2|Up To Week 12|Lack of Efficacy|1
1796729|NCT00550446|6250547|P1|Up To Week 12|Lack of Efficacy|3
1796730|NCT00550446|6250537|P11|Up To Week 12|Adverse Event|0
1796731|NCT00550446|6250538|P10|Up To Week 12|Adverse Event|0
1796732|NCT00550446|6250539|P9|Up To Week 12|Adverse Event|0
1796733|NCT00550446|6250540|P8|Up To Week 12|Adverse Event|0
1796734|NCT00550446|6250541|P7|Up To Week 12|Adverse Event|1
1796735|NCT00550446|6250542|P6|Up To Week 12|Adverse Event|2
1796736|NCT00550446|6250543|P5|Up To Week 12|Adverse Event|2
1796737|NCT00550446|6250544|P4|Up To Week 12|Adverse Event|0
1796738|NCT00550446|6250545|P3|Up To Week 12|Adverse Event|0
1796739|NCT00550446|6250546|P2|Up To Week 12|Adverse Event|2
1796740|NCT00550446|6250547|P1|Up To Week 12|Adverse Event|2
1796741|NCT00550420|6250979|P1|Overall Study|Prohibited medicine|1
1796742|NCT00550420|6250979|P1|Overall Study|Exclusion criteria|1
1796743|NCT00550420|6250979|P1|Overall Study|Out of Electrocardiogram criteria|1
1796744|NCT00550420|6250979|P1|Overall Study|Caregiver's decision to withdraw|1
1796745|NCT00550420|6250979|P1|Overall Study|Unethical stop of enrollment|2
1796746|NCT00550420|6250979|P1|Overall Study|Lack of curative effect|1
1796747|NCT00550420|6250979|P1|Overall Study|Investigators opinion|1
1796748|NCT00550420|6250979|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
1796749|NCT00550420|6250979|P1|Overall Study|Missing|2
1796750|NCT00550420|6250979|P1|Overall Study|Still in study at termination|206
1796751|NCT00550420|6250979|P1|Overall Study|Withdrawal by Subject|30
1796752|NCT00550420|6250979|P1|Overall Study|Protocol Violation|11
1796753|NCT00550420|6250979|P1|Overall Study|Lost to Follow-up|8
1796754|NCT00550420|6250979|P1|Overall Study|Adverse Event|28
1796755|NCT00550407|6251002|P3|26-Week Randomized Phase|Withdrawal by Subject|3
1796756|NCT00550407|6251003|P2|26-Week Randomized Phase|Withdrawal by Subject|1
1796757|NCT00550407|6251004|P1|26-Week Randomized Phase|Withdrawal by Subject|0
1796758|NCT00550407|6251002|P3|26-Week Randomized Phase|Investigator Discretion|0
1796759|NCT00550407|6251003|P2|26-Week Randomized Phase|Investigator Discretion|1
1796760|NCT00550407|6251004|P1|26-Week Randomized Phase|Investigator Discretion|0
1796761|NCT00550407|6251002|P3|26-Week Randomized Phase|Lack of Efficacy|19
1796762|NCT00550407|6251003|P2|26-Week Randomized Phase|Lack of Efficacy|36
1796763|NCT00550407|6251004|P1|26-Week Randomized Phase|Lack of Efficacy|0
1796764|NCT00550407|6251002|P3|26-Week Randomized Phase|Adverse Event|2
1796765|NCT00550407|6251003|P2|26-Week Randomized Phase|Adverse Event|5
1796766|NCT00550407|6251004|P1|26-Week Randomized Phase|Adverse Event|0
1796767|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
1796768|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
1796769|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
1796770|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
1796771|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
1796772|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
1796773|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
1796774|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
1796775|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
1796776|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
1796777|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
1796778|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
1796779|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
1796780|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
1796781|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
1796782|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
1796783|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
1796784|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
1796785|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
1796786|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
1796787|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
1796788|NCT00550407|6251002|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
1796789|NCT00550407|6251003|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
1796790|NCT00550407|6251004|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
1796791|NCT00550238|6251076|P1|Overall Study|Sponsor decision|55
1796792|NCT00550238|6251076|P1|Overall Study|Lost to Follow-up|13
1796793|NCT00550238|6251076|P1|Overall Study|Patient noncompliance|25
1796794|NCT00550238|6251076|P1|Overall Study|Physician Decision|31
1796795|NCT00550238|6251076|P1|Overall Study|Withdrawal by Subject|167
1796796|NCT00550238|6251076|P1|Overall Study|Disease progression|46
1796797|NCT00550238|6251076|P1|Overall Study|Death|34
1796798|NCT00550238|6251076|P1|Overall Study|Adverse Event|88
1796799|NCT00550173|6251083|P3|Overall Study|Lost to Follow-up|3
1796800|NCT00550173|6251084|P2|Overall Study|Lost to Follow-up|4
1796801|NCT00550173|6251085|P1|Overall Study|Lost to Follow-up|4
1796802|NCT00550173|6251083|P3|Overall Study|Sponsor Decision|1
1796803|NCT00550173|6251084|P2|Overall Study|Sponsor Decision|7
1796804|NCT00550173|6251085|P1|Overall Study|Sponsor Decision|13
1796805|NCT00550173|6251083|P3|Overall Study|Withdrawal by Subject|17
1796806|NCT00550173|6251084|P2|Overall Study|Withdrawal by Subject|12
1796807|NCT00550173|6251085|P1|Overall Study|Withdrawal by Subject|9
1796808|NCT00550173|6251083|P3|Overall Study|Physician Decision|2
1796809|NCT00550173|6251084|P2|Overall Study|Physician Decision|2
1796810|NCT00550173|6251085|P1|Overall Study|Physician Decision|1
1796811|NCT00550173|6251083|P3|Overall Study|Death|50
1796812|NCT00550173|6251084|P2|Overall Study|Death|38
1796813|NCT00550173|6251085|P1|Overall Study|Death|45
1796814|NCT00550147|6251114|P1|Quetiapine Addition Treatment Period|Moved out of state|1
1796815|NCT00550147|6251114|P1|Quetiapine Addition Treatment Period|Noncompliance|2
1796816|NCT00550147|6251114|P1|Quetiapine Addition Treatment Period|Adverse Event|3
1796817|NCT00550147|6251114|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
1796818|NCT00550147|6251114|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
1796819|NCT00550043|6251137|P5|Overall Study|Other Reasons- Unspecified|0
1796820|NCT00550043|6251138|P4|Overall Study|Other Reasons- Unspecified|1
1796821|NCT00550043|6251139|P3|Overall Study|Other Reasons- Unspecified|0
1796822|NCT00550043|6251140|P2|Overall Study|Other Reasons- Unspecified|1
1796823|NCT00550043|6251141|P1|Overall Study|Other Reasons- Unspecified|0
1796824|NCT00550043|6251137|P5|Overall Study|Subject Withdrew Consent|0
1796825|NCT00550043|6251138|P4|Overall Study|Subject Withdrew Consent|0
1796826|NCT00550043|6251139|P3|Overall Study|Subject Withdrew Consent|1
1796827|NCT00550043|6251140|P2|Overall Study|Subject Withdrew Consent|2
1796828|NCT00550043|6251141|P1|Overall Study|Subject Withdrew Consent|0
1796829|NCT00550043|6251137|P5|Overall Study|Adverse Event|1
1796830|NCT00550043|6251138|P4|Overall Study|Adverse Event|1
1796831|NCT00550043|6251139|P3|Overall Study|Adverse Event|0
1796832|NCT00550043|6251140|P2|Overall Study|Adverse Event|0
1796833|NCT00550043|6251141|P1|Overall Study|Adverse Event|0
1796834|NCT00549939|6251196|P3|40-week Open Label Treatment Period|Other|4
1796835|NCT00549939|6251197|P2|40-week Open Label Treatment Period|Other|1
1796836|NCT00549939|6251198|P1|40-week Open Label Treatment Period|Other|0
1796837|NCT00549939|6251196|P3|40-week Open Label Treatment Period|Protocol Violation|0
1796838|NCT00549939|6251197|P2|40-week Open Label Treatment Period|Protocol Violation|1
1796839|NCT00549939|6251198|P1|40-week Open Label Treatment Period|Protocol Violation|0
1796840|NCT00549939|6251196|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
1796841|NCT00549939|6251197|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
1796842|NCT00549939|6251198|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
1796843|NCT00549939|6251196|P3|40-week Open Label Treatment Period|Adverse Event|1
1796844|NCT00549939|6251197|P2|40-week Open Label Treatment Period|Adverse Event|2
1796845|NCT00549939|6251198|P1|40-week Open Label Treatment Period|Adverse Event|0
1796846|NCT00549939|6251196|P3|12-week Double Blind Treatment Period|Too many blood draws|0
1796847|NCT00549939|6251197|P2|12-week Double Blind Treatment Period|Too many blood draws|1
1796848|NCT00549939|6251198|P1|12-week Double Blind Treatment Period|Too many blood draws|0
1796849|NCT00549939|6251196|P3|12-week Double Blind Treatment Period|Adverse Event|2
1796850|NCT00549939|6251197|P2|12-week Double Blind Treatment Period|Adverse Event|1
1796851|NCT00549939|6251198|P1|12-week Double Blind Treatment Period|Adverse Event|1
1796852|NCT00549900|6251225|P1|Overall Study|Adverse Event|1
1796853|NCT00549770|6251281|P8|Overall Study|Adverse Event|4
1796854|NCT00549770|6251282|P7|Overall Study|Adverse Event|5
1796855|NCT00549770|6251283|P6|Overall Study|Adverse Event|0
1796856|NCT00549770|6251284|P5|Overall Study|Adverse Event|1
1796857|NCT00549770|6251285|P4|Overall Study|Adverse Event|2
1796858|NCT00549770|6251286|P3|Overall Study|Adverse Event|1
1796859|NCT00549770|6251287|P2|Overall Study|Adverse Event|3
1796860|NCT00549770|6251288|P1|Overall Study|Adverse Event|1
1796861|NCT00549770|6251281|P8|Overall Study|Abnormal laboratory values|0
1796862|NCT00549770|6251282|P7|Overall Study|Abnormal laboratory values|0
1796863|NCT00549770|6251283|P6|Overall Study|Abnormal laboratory values|1
1796864|NCT00549770|6251284|P5|Overall Study|Abnormal laboratory values|0
1796865|NCT00549770|6251285|P4|Overall Study|Abnormal laboratory values|0
1796866|NCT00549770|6251286|P3|Overall Study|Abnormal laboratory values|0
1796867|NCT00549770|6251287|P2|Overall Study|Abnormal laboratory values|0
1796868|NCT00549770|6251288|P1|Overall Study|Abnormal laboratory values|0
1796869|NCT00549770|6251281|P8|Overall Study|Abnormal test procedure results|1
1796870|NCT00549770|6251282|P7|Overall Study|Abnormal test procedure results|1
1796871|NCT00549770|6251283|P6|Overall Study|Abnormal test procedure results|1
1796872|NCT00549770|6251284|P5|Overall Study|Abnormal test procedure results|0
1796873|NCT00549770|6251285|P4|Overall Study|Abnormal test procedure results|2
1796874|NCT00549770|6251286|P3|Overall Study|Abnormal test procedure results|0
1796875|NCT00549770|6251287|P2|Overall Study|Abnormal test procedure results|0
1796876|NCT00549770|6251288|P1|Overall Study|Abnormal test procedure results|0
1796877|NCT00549770|6251281|P8|Overall Study|Lack of Efficacy|8
1796878|NCT00549770|6251282|P7|Overall Study|Lack of Efficacy|3
1796879|NCT00549770|6251283|P6|Overall Study|Lack of Efficacy|1
1796880|NCT00549770|6251284|P5|Overall Study|Lack of Efficacy|5
1796881|NCT00549770|6251285|P4|Overall Study|Lack of Efficacy|3
1796882|NCT00549770|6251286|P3|Overall Study|Lack of Efficacy|2
1796883|NCT00549770|6251287|P2|Overall Study|Lack of Efficacy|0
1796884|NCT00549770|6251288|P1|Overall Study|Lack of Efficacy|1
1796885|NCT00549770|6251281|P8|Overall Study|Withdrawal by Subject|9
1796886|NCT00549770|6251282|P7|Overall Study|Withdrawal by Subject|4
1796887|NCT00549770|6251283|P6|Overall Study|Withdrawal by Subject|6
1796888|NCT00549770|6251284|P5|Overall Study|Withdrawal by Subject|6
1796889|NCT00549770|6251285|P4|Overall Study|Withdrawal by Subject|5
1796890|NCT00549770|6251286|P3|Overall Study|Withdrawal by Subject|4
1796891|NCT00549770|6251287|P2|Overall Study|Withdrawal by Subject|6
1796892|NCT00549770|6251288|P1|Overall Study|Withdrawal by Subject|4
1796893|NCT00549770|6251281|P8|Overall Study|Lost to Follow-up|0
1796894|NCT00549770|6251282|P7|Overall Study|Lost to Follow-up|0
1796895|NCT00549770|6251283|P6|Overall Study|Lost to Follow-up|2
1796896|NCT00549770|6251284|P5|Overall Study|Lost to Follow-up|3
1796897|NCT00549770|6251285|P4|Overall Study|Lost to Follow-up|2
1796898|NCT00549770|6251286|P3|Overall Study|Lost to Follow-up|2
1796899|NCT00549770|6251287|P2|Overall Study|Lost to Follow-up|0
1796900|NCT00549770|6251288|P1|Overall Study|Lost to Follow-up|0
1796901|NCT00549770|6251281|P8|Overall Study|Administrative problems|1
1796902|NCT00549770|6251282|P7|Overall Study|Administrative problems|0
1796903|NCT00549770|6251283|P6|Overall Study|Administrative problems|0
1796904|NCT00549770|6251284|P5|Overall Study|Administrative problems|0
1796905|NCT00549770|6251285|P4|Overall Study|Administrative problems|0
1796906|NCT00549770|6251286|P3|Overall Study|Administrative problems|0
1796907|NCT00549770|6251287|P2|Overall Study|Administrative problems|1
1796908|NCT00549770|6251288|P1|Overall Study|Administrative problems|0
1796909|NCT00549770|6251281|P8|Overall Study|Protocol deviation|2
1796910|NCT00549770|6251282|P7|Overall Study|Protocol deviation|1
1796911|NCT00549770|6251283|P6|Overall Study|Protocol deviation|2
1796912|NCT00549770|6251284|P5|Overall Study|Protocol deviation|2
1796913|NCT00549770|6251285|P4|Overall Study|Protocol deviation|2
1796914|NCT00549770|6251286|P3|Overall Study|Protocol deviation|1
1796915|NCT00549770|6251287|P2|Overall Study|Protocol deviation|1
1796916|NCT00549770|6251288|P1|Overall Study|Protocol deviation|1
1796917|NCT00549757|6251372|P2|Extension Period (in Average 9 Months)|Patient's request|436
1796918|NCT00549757|6251373|P1|Extension Period (in Average 9 Months)|Patient's request|421
1796919|NCT00549757|6251372|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
1796920|NCT00549757|6251373|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
1796921|NCT00549757|6251372|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
1796922|NCT00549757|6251373|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
1796923|NCT00549757|6251372|P2|Extension Period (in Average 9 Months)|Death|136
1796924|NCT00549757|6251373|P1|Extension Period (in Average 9 Months)|Death|143
1796925|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
1796926|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
1796927|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
1796928|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
1796929|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
1796930|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
1796931|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Death|200
1796932|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Death|188
1796933|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
1796934|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
1796935|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
1796936|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
1796937|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
1796938|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
1796939|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
1796940|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
1796941|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
1796942|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
1796943|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
1796944|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
1796945|NCT00549757|6251372|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
1796946|NCT00549757|6251373|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
1796947|NCT00549718|6251435|P4|Overall Study|Administrative|1
1796948|NCT00549718|6251436|P3|Overall Study|Administrative|2
1796949|NCT00549718|6251437|P2|Overall Study|Administrative|2
1796950|NCT00549718|6251438|P1|Overall Study|Administrative|2
1796951|NCT00549718|6251435|P4|Overall Study|Withdrawal by Subject|13
1796952|NCT00549718|6251436|P3|Overall Study|Withdrawal by Subject|12
1796953|NCT00549718|6251437|P2|Overall Study|Withdrawal by Subject|18
1796954|NCT00549718|6251438|P1|Overall Study|Withdrawal by Subject|9
1796955|NCT00549718|6251435|P4|Overall Study|Lost to Follow-up|6
1796956|NCT00549718|6251436|P3|Overall Study|Lost to Follow-up|0
1796957|NCT00549718|6251437|P2|Overall Study|Lost to Follow-up|2
1796958|NCT00549718|6251438|P1|Overall Study|Lost to Follow-up|4
1796959|NCT00549718|6251435|P4|Overall Study|Adverse Event|3
1796960|NCT00549718|6251436|P3|Overall Study|Adverse Event|7
1796961|NCT00549718|6251437|P2|Overall Study|Adverse Event|8
1796962|NCT00549718|6251438|P1|Overall Study|Adverse Event|6
1796963|NCT00549718|6251435|P4|Overall Study|Insufficient clinical response|32
1796964|NCT00549718|6251436|P3|Overall Study|Insufficient clinical response|18
1796965|NCT00549718|6251437|P2|Overall Study|Insufficient clinical response|7
1796966|NCT00549718|6251438|P1|Overall Study|Insufficient clinical response|20
1796967|NCT00549640|6251454|P2|Overall Study|Lost to Follow-up|4
1796968|NCT00549640|6251455|P1|Overall Study|Lost to Follow-up|7
1796969|NCT00549640|6251454|P2|Overall Study|Adverse Event|0
1796970|NCT00549640|6251455|P1|Overall Study|Adverse Event|5
1796971|NCT00549640|6251454|P2|Overall Study|Withdrawal by Subject|12
1796972|NCT00549640|6251455|P1|Overall Study|Withdrawal by Subject|6
1796973|NCT00549601|6251468|P3|Received Study Drug|Withdrawal by Subject|1
1796974|NCT00549601|6251469|P2|Received Study Drug|Withdrawal by Subject|0
1796975|NCT00549601|6251470|P1|Received Study Drug|Withdrawal by Subject|2
1796976|NCT00549601|6251468|P3|Received Study Drug|Protocol Violation|1
1796977|NCT00549601|6251469|P2|Received Study Drug|Protocol Violation|4
1796978|NCT00549601|6251470|P1|Received Study Drug|Protocol Violation|3
1796979|NCT00549601|6251468|P3|Received Study Drug|Lost to Follow-up|1
1796980|NCT00549601|6251469|P2|Received Study Drug|Lost to Follow-up|1
1796981|NCT00549601|6251470|P1|Received Study Drug|Lost to Follow-up|0
1796982|NCT00549601|6251468|P3|Received Study Drug|Death|0
1796983|NCT00549601|6251469|P2|Received Study Drug|Death|1
1796984|NCT00549601|6251470|P1|Received Study Drug|Death|0
1796985|NCT00549601|6251468|P3|Received Study Drug|Adverse Event|1
1796986|NCT00549601|6251469|P2|Received Study Drug|Adverse Event|5
1796987|NCT00549601|6251470|P1|Received Study Drug|Adverse Event|2
1796988|NCT00549601|6251468|P3|Randomized|Withdrawal by Subject|1
1796989|NCT00549601|6251469|P2|Randomized|Withdrawal by Subject|1
1796990|NCT00549601|6251470|P1|Randomized|Withdrawal by Subject|0
1796991|NCT00549601|6251468|P3|Randomized|Protocol Violation|1
1796992|NCT00549601|6251469|P2|Randomized|Protocol Violation|0
1796993|NCT00549601|6251470|P1|Randomized|Protocol Violation|0
1796994|NCT00549562|6251492|P1|Overall Study|Lack of Efficacy|1
1796995|NCT00549562|6251492|P1|Overall Study|Adverse Event|1
1796996|NCT00549549|6251504|P4|Overall Study|Randomized but not treated|1
1796997|NCT00549549|6251505|P3|Overall Study|Randomized but not treated|1
1796998|NCT00549549|6251506|P2|Overall Study|Randomized but not treated|0
1796999|NCT00549549|6251507|P1|Overall Study|Randomized but not treated|0
1797000|NCT00549549|6251504|P4|Overall Study|Other|11
1797001|NCT00549549|6251505|P3|Overall Study|Other|9
1797002|NCT00549549|6251506|P2|Overall Study|Other|9
1797003|NCT00549549|6251507|P1|Overall Study|Other|9
1797004|NCT00549549|6251504|P4|Overall Study|Withdrawal by Subject|0
1797005|NCT00549549|6251505|P3|Overall Study|Withdrawal by Subject|1
1797006|NCT00549549|6251506|P2|Overall Study|Withdrawal by Subject|4
1797007|NCT00549549|6251507|P1|Overall Study|Withdrawal by Subject|0
1797008|NCT00549549|6251504|P4|Overall Study|Lost to Follow-up|2
1797009|NCT00549549|6251505|P3|Overall Study|Lost to Follow-up|1
1797010|NCT00549549|6251506|P2|Overall Study|Lost to Follow-up|0
1797011|NCT00549549|6251507|P1|Overall Study|Lost to Follow-up|1
1797012|NCT00549549|6251504|P4|Overall Study|Lack of Efficacy|2
1797013|NCT00549549|6251505|P3|Overall Study|Lack of Efficacy|4
1797014|NCT00549549|6251506|P2|Overall Study|Lack of Efficacy|6
1797015|NCT00549549|6251507|P1|Overall Study|Lack of Efficacy|9
1797016|NCT00549549|6251504|P4|Overall Study|Adverse Event|9
1797017|NCT00549549|6251505|P3|Overall Study|Adverse Event|1
1797018|NCT00549549|6251506|P2|Overall Study|Adverse Event|3
1797019|NCT00549549|6251507|P1|Overall Study|Adverse Event|5
1797020|NCT00549445|6251575|P2|Overall Study|Sputum & Blood Samples Not Available|17
1797021|NCT00549445|6251576|P1|Overall Study|Sputum & Blood Samples Not Available|15
1797022|NCT00549328|6251595|P1|Overall Study|Use of Prohibited Medication|1
1797023|NCT00549328|6251595|P1|Overall Study|Death|1
1797024|NCT00549328|6251595|P1|Overall Study|Disease Progression|10
1797025|NCT00549328|6251595|P1|Overall Study|Adverse Event|2
1797026|NCT00549302|6251606|P3|Open-Label|Withdrawal by Subject|6
1797027|NCT00549302|6251607|P2|Open-Label|Withdrawal by Subject|0
1797028|NCT00549302|6251608|P1|Open-Label|Withdrawal by Subject|0
1797029|NCT00549302|6251606|P3|Open-Label|New drug pulmonary atrial hypertension|2
1797030|NCT00549302|6251607|P2|Open-Label|New drug pulmonary atrial hypertension|0
1797031|NCT00549302|6251608|P1|Open-Label|New drug pulmonary atrial hypertension|0
1797032|NCT00549302|6251606|P3|Open-Label|Other|3
1797033|NCT00549302|6251607|P2|Open-Label|Other|0
1797034|NCT00549302|6251608|P1|Open-Label|Other|0
1797035|NCT00549302|6251606|P3|Open-Label|Lost to Follow-up|2
1797036|NCT00549302|6251607|P2|Open-Label|Lost to Follow-up|0
1797037|NCT00549302|6251608|P1|Open-Label|Lost to Follow-up|0
1797038|NCT00549302|6251606|P3|Open-Label|Investigator Decision|5
1797039|NCT00549302|6251607|P2|Open-Label|Investigator Decision|0
1797040|NCT00549302|6251608|P1|Open-Label|Investigator Decision|0
1797041|NCT00549302|6251606|P3|Open-Label|Death|40
1797042|NCT00549302|6251607|P2|Open-Label|Death|0
1797043|NCT00549302|6251608|P1|Open-Label|Death|0
1797044|NCT00549302|6251606|P3|Open-Label|Adverse Event|11
1797045|NCT00549302|6251607|P2|Open-Label|Adverse Event|0
1797046|NCT00549302|6251608|P1|Open-Label|Adverse Event|0
1797047|NCT00549302|6251606|P3|Double-Blind|New condition or starts new therapy|0
1797048|NCT00549302|6251607|P2|Double-Blind|New condition or starts new therapy|2
1797049|NCT00549302|6251608|P1|Double-Blind|New condition or starts new therapy|0
1797050|NCT00549302|6251606|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
1797051|NCT00549302|6251607|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
1797052|NCT00549302|6251608|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
1797053|NCT00549302|6251606|P3|Double-Blind|Lost to Follow-up|0
1797054|NCT00549302|6251607|P2|Double-Blind|Lost to Follow-up|2
1797055|NCT00549302|6251608|P1|Double-Blind|Lost to Follow-up|1
1797056|NCT00549302|6251606|P3|Double-Blind|Sponsor Decision|0
1797057|NCT00549302|6251607|P2|Double-Blind|Sponsor Decision|1
1797058|NCT00549302|6251608|P1|Double-Blind|Sponsor Decision|0
1797059|NCT00549302|6251606|P3|Double-Blind|Investigator Decision|0
1797060|NCT00549302|6251607|P2|Double-Blind|Investigator Decision|5
1797061|NCT00549302|6251608|P1|Double-Blind|Investigator Decision|1
1797062|NCT00549302|6251606|P3|Double-Blind|Withdrawal by Subject|0
1797063|NCT00549302|6251607|P2|Double-Blind|Withdrawal by Subject|8
1797064|NCT00549302|6251608|P1|Double-Blind|Withdrawal by Subject|3
1797065|NCT00549302|6251606|P3|Double-Blind|Adverse Event|0
1797066|NCT00549302|6251607|P2|Double-Blind|Adverse Event|16
1797067|NCT00549302|6251608|P1|Double-Blind|Adverse Event|3
1797068|NCT00549302|6251606|P3|Double-Blind|Death|0
1797069|NCT00549302|6251607|P2|Double-Blind|Death|9
1797070|NCT00549302|6251608|P1|Double-Blind|Death|2
1797071|NCT00549198|6251620|P2|Overall Study|Not Exposed to Study Drug|4
1797072|NCT00549198|6251621|P1|Overall Study|Not Exposed to Study Drug|3
1797073|NCT00549198|6251620|P2|Overall Study|Pregnancy|3
1797074|NCT00549198|6251621|P1|Overall Study|Pregnancy|0
1797075|NCT00549198|6251620|P2|Overall Study|No scan facilities|2
1797076|NCT00549198|6251621|P1|Overall Study|No scan facilities|0
1797077|NCT00549198|6251620|P2|Overall Study|Participant overweight, no scan possible|0
1797078|NCT00549198|6251621|P1|Overall Study|Participant overweight, no scan possible|1
1797079|NCT00549198|6251620|P2|Overall Study|Participant planning pregnancy|0
1797080|NCT00549198|6251621|P1|Overall Study|Participant planning pregnancy|1
1797081|NCT00549198|6251620|P2|Overall Study|Prohibited Medication|2
1797082|NCT00549198|6251621|P1|Overall Study|Prohibited Medication|1
1797083|NCT00549198|6251620|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
1797084|NCT00549198|6251621|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
1797085|NCT00549198|6251620|P2|Overall Study|Participant not able to perform Week 96|0
1797086|NCT00549198|6251621|P1|Overall Study|Participant not able to perform Week 96|1
1797087|NCT00549198|6251620|P2|Overall Study|Participant Moved|0
1797088|NCT00549198|6251621|P1|Overall Study|Participant Moved|2
1797089|NCT00549198|6251620|P2|Overall Study|Disease Progression|0
1797090|NCT00549198|6251621|P1|Overall Study|Disease Progression|1
1797091|NCT00549198|6251620|P2|Overall Study|Withdrawal by Subject|7
1797092|NCT00549198|6251621|P1|Overall Study|Withdrawal by Subject|7
1797093|NCT00549198|6251620|P2|Overall Study|Investigator Decision|3
1797094|NCT00549198|6251621|P1|Overall Study|Investigator Decision|4
1797095|NCT00549198|6251620|P2|Overall Study|Protocol Violation|2
1797096|NCT00549198|6251621|P1|Overall Study|Protocol Violation|7
1797097|NCT00549198|6251620|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
1797098|NCT00549198|6251621|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
1797099|NCT00549198|6251620|P2|Overall Study|Lost to Follow-up|8
1797100|NCT00549198|6251621|P1|Overall Study|Lost to Follow-up|7
1797101|NCT00549198|6251620|P2|Overall Study|Non-compliance|4
1797102|NCT00549198|6251621|P1|Overall Study|Non-compliance|2
1797103|NCT00549198|6251620|P2|Overall Study|Protocol-defined Virological Failure|0
1797104|NCT00549198|6251621|P1|Overall Study|Protocol-defined Virological Failure|7
1797105|NCT00549198|6251620|P2|Overall Study|Insufficient Viral Load Response|2
1797106|NCT00549198|6251621|P1|Overall Study|Insufficient Viral Load Response|4
1797107|NCT00549198|6251620|P2|Overall Study|Adverse Event|26
1797108|NCT00549198|6251621|P1|Overall Study|Adverse Event|28
1797109|NCT00549055|6251758|P1|Overall Study|Very low visual acuity (VA)|1
1797110|NCT00549055|6251758|P1|Overall Study|Choroidal neovascularization|1
1797111|NCT00549055|6251758|P1|Overall Study|Growth choroidal neovascularisation|1
1797112|NCT00549055|6251758|P1|Overall Study|Vitreous hemorrhage|1
1797113|NCT00549055|6251758|P1|Overall Study|Active choroidal neovascula increased|1
1797114|NCT00549055|6251758|P1|Overall Study|Decrease of size|1
1797115|NCT00549055|6251758|P1|Overall Study|Progression to fibrosis|2
1797116|NCT00549055|6251758|P1|Overall Study|Stabilization|5
1797117|NCT00549055|6251758|P1|Overall Study|Lack of Efficacy|18
1797118|NCT00549055|6251758|P1|Overall Study|Adverse Event|4
1797119|NCT00548847|6251782|P1|Overall Study|Disease progression|7
1797120|NCT00548808|6251789|P2|Overall Study|Sponsor Decision|1
1797121|NCT00548808|6251790|P1|Overall Study|Sponsor Decision|1
1797122|NCT00548808|6251789|P2|Overall Study|Lack of Efficacy|0
1797123|NCT00548808|6251790|P1|Overall Study|Lack of Efficacy|2
1797124|NCT00548808|6251789|P2|Overall Study|Entry Criteria Not Met|2
1797125|NCT00548808|6251790|P1|Overall Study|Entry Criteria Not Met|2
1797126|NCT00548808|6251789|P2|Overall Study|Death|0
1797127|NCT00548808|6251790|P1|Overall Study|Death|2
1797128|NCT00548808|6251789|P2|Overall Study|Adverse Event|5
1797129|NCT00548808|6251790|P1|Overall Study|Adverse Event|4
1797130|NCT00548808|6251789|P2|Overall Study|Physician Decision|3
1797131|NCT00548808|6251790|P1|Overall Study|Physician Decision|6
1797132|NCT00548808|6251789|P2|Overall Study|Withdrawal by Subject|4
1797133|NCT00548808|6251790|P1|Overall Study|Withdrawal by Subject|8
1797134|NCT00548808|6251789|P2|Overall Study|Protocol Violation|8
1797135|NCT00548808|6251790|P1|Overall Study|Protocol Violation|8
1797136|NCT00548808|6251789|P2|Overall Study|Lost to Follow-up|3
1797137|NCT00548808|6251790|P1|Overall Study|Lost to Follow-up|9
1797138|NCT00548717|6251814|P2|Overall Study|Alternative treatment for GVHD|0
1797139|NCT00548717|6251815|P1|Overall Study|Alternative treatment for GVHD|1
1797140|NCT00548717|6251814|P2|Overall Study|Relapse|0
1797141|NCT00548717|6251815|P1|Overall Study|Relapse|3
1797142|NCT00548717|6251814|P2|Overall Study|Death|2
1797143|NCT00548717|6251815|P1|Overall Study|Death|5
1797144|NCT00548548|6251859|P2|Overall Study|Lost to Follow-up|18
1797145|NCT00548548|6251860|P1|Overall Study|Lost to Follow-up|17
1797146|NCT00548548|6251859|P2|Overall Study|Death|348
1797147|NCT00548548|6251860|P1|Overall Study|Death|345
1797148|NCT00548405|6251903|P3|Overall Study|Randomized but not treated|0
1797149|NCT00548405|6251904|P2|Overall Study|Randomized but not treated|0
1797150|NCT00548405|6251905|P1|Overall Study|Randomized but not treated|1
1797151|NCT00548405|6251903|P3|Overall Study|Sponsor decision|0
1797152|NCT00548405|6251904|P2|Overall Study|Sponsor decision|0
1797153|NCT00548405|6251905|P1|Overall Study|Sponsor decision|1
1797154|NCT00548405|6251903|P3|Overall Study|Death|1
1797155|NCT00548405|6251904|P2|Overall Study|Death|1
1797156|NCT00548405|6251905|P1|Overall Study|Death|0
1797157|NCT00548405|6251903|P3|Overall Study|Lost to Follow-up|2
1797158|NCT00548405|6251904|P2|Overall Study|Lost to Follow-up|1
1797159|NCT00548405|6251905|P1|Overall Study|Lost to Follow-up|1
1797160|NCT00548405|6251903|P3|Overall Study|Withdrawal by Subject|5
1797161|NCT00548405|6251904|P2|Overall Study|Withdrawal by Subject|12
1797162|NCT00548405|6251905|P1|Overall Study|Withdrawal by Subject|36
1797163|NCT00548405|6251903|P3|Overall Study|Protocol Violation|0
1797164|NCT00548405|6251904|P2|Overall Study|Protocol Violation|0
1797165|NCT00548405|6251905|P1|Overall Study|Protocol Violation|1
1797166|NCT00548405|6251903|P3|Overall Study|Pregnancy|0
1797167|NCT00548405|6251904|P2|Overall Study|Pregnancy|0
1797168|NCT00548405|6251905|P1|Overall Study|Pregnancy|1
1797169|NCT00548405|6251903|P3|Overall Study|Physician Decision|1
1797170|NCT00548405|6251904|P2|Overall Study|Physician Decision|4
1797171|NCT00548405|6251905|P1|Overall Study|Physician Decision|3
1797172|NCT00548405|6251903|P3|Overall Study|Lack of Efficacy|0
1797173|NCT00548405|6251904|P2|Overall Study|Lack of Efficacy|0
1797174|NCT00548405|6251905|P1|Overall Study|Lack of Efficacy|6
1797175|NCT00548405|6251903|P3|Overall Study|Adverse Event|0
1797176|NCT00548405|6251904|P2|Overall Study|Adverse Event|2
1797177|NCT00548405|6251905|P1|Overall Study|Adverse Event|6
1797178|NCT00548340|6251926|P3|Overall Study|Other|1
1797179|NCT00548340|6251927|P2|Overall Study|Other|1
1797180|NCT00548340|6251928|P1|Overall Study|Other|1
1797181|NCT00548340|6251926|P3|Overall Study|Withdrawal by Subject|3
1797182|NCT00548340|6251927|P2|Overall Study|Withdrawal by Subject|4
1797183|NCT00548340|6251928|P1|Overall Study|Withdrawal by Subject|2
1797184|NCT00548340|6251926|P3|Overall Study|Lost to Follow-up|0
1797185|NCT00548340|6251927|P2|Overall Study|Lost to Follow-up|1
1797186|NCT00548340|6251928|P1|Overall Study|Lost to Follow-up|1
1797187|NCT00548340|6251926|P3|Overall Study|Adverse Event|2
1797188|NCT00548340|6251927|P2|Overall Study|Adverse Event|2
1797189|NCT00548340|6251928|P1|Overall Study|Adverse Event|2
1797190|NCT00548340|6251926|P3|Overall Study|Protocol Violation|3
1797191|NCT00548340|6251927|P2|Overall Study|Protocol Violation|3
1797192|NCT00548340|6251928|P1|Overall Study|Protocol Violation|2
1797193|NCT00548327|6251947|P2|Overall Study|Adverse Event|1
1797194|NCT00548327|6251948|P1|Overall Study|Adverse Event|0
1797195|NCT00548262|6251966|P1|Overall Study|Withdrawal by Subject|1
1797196|NCT00548262|6251966|P1|Overall Study|Other|3
1797197|NCT00548262|6251966|P1|Overall Study|Lost to Follow-up|1
1797198|NCT00548262|6251966|P1|Overall Study|Lack of Efficacy|4
1797199|NCT00548262|6251966|P1|Overall Study|Adverse Event|2
1797200|NCT00548262|6251966|P1|Overall Study|Death|21
1797201|NCT00548249|6251996|P5|Overall Study|Sponsor's request|0
1797202|NCT00548249|6251997|P4|Overall Study|Sponsor's request|1
1797203|NCT00548249|6251998|P3|Overall Study|Sponsor's request|0
1797204|NCT00548249|6251999|P2|Overall Study|Sponsor's request|0
1797205|NCT00548249|6252000|P1|Overall Study|Sponsor's request|0
1797206|NCT00548249|6251996|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
1797207|NCT00548249|6251997|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1797208|NCT00548249|6251998|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1797209|NCT00548249|6251999|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
1797210|NCT00548249|6252000|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
1797211|NCT00548249|6251996|P5|Overall Study|Withdrawal by Subject|0
1797212|NCT00548249|6251997|P4|Overall Study|Withdrawal by Subject|0
1797213|NCT00548249|6251998|P3|Overall Study|Withdrawal by Subject|0
1797214|NCT00548249|6251999|P2|Overall Study|Withdrawal by Subject|0
1797215|NCT00548249|6252000|P1|Overall Study|Withdrawal by Subject|2
1797216|NCT00548249|6251996|P5|Overall Study|Prolonged hospitalization|0
1797217|NCT00548249|6251997|P4|Overall Study|Prolonged hospitalization|1
1797218|NCT00548249|6251998|P3|Overall Study|Prolonged hospitalization|2
1797219|NCT00548249|6251999|P2|Overall Study|Prolonged hospitalization|0
1797220|NCT00548249|6252000|P1|Overall Study|Prolonged hospitalization|0
1797221|NCT00548249|6251996|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
1797222|NCT00548249|6251997|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1797223|NCT00548249|6251998|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1797224|NCT00548249|6251999|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1797225|NCT00548249|6252000|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
1797226|NCT00548249|6251996|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
1797227|NCT00548249|6251997|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
1797228|NCT00548249|6251998|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
1797229|NCT00548249|6251999|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
1797230|NCT00548249|6252000|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
1797231|NCT00548249|6251996|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
1797232|NCT00548249|6251997|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
1797233|NCT00548249|6251998|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
1797234|NCT00548249|6251999|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
1797235|NCT00548249|6252000|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
1797236|NCT00548249|6251996|P5|Overall Study|Adverse Event|1
1797237|NCT00548249|6251997|P4|Overall Study|Adverse Event|1
1797238|NCT00548249|6251998|P3|Overall Study|Adverse Event|0
1797239|NCT00548249|6251999|P2|Overall Study|Adverse Event|2
1797240|NCT00548249|6252000|P1|Overall Study|Adverse Event|2
1797241|NCT00548249|6251996|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
1797242|NCT00548249|6251997|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
1797243|NCT00548249|6251998|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
1797244|NCT00548249|6251999|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
1797245|NCT00548249|6252000|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
1797246|NCT00548249|6251996|P5|Overall Study|Miscellaneous|2
1797247|NCT00548249|6251997|P4|Overall Study|Miscellaneous|0
1797248|NCT00548249|6251998|P3|Overall Study|Miscellaneous|2
1797249|NCT00548249|6251999|P2|Overall Study|Miscellaneous|3
1797250|NCT00548249|6252000|P1|Overall Study|Miscellaneous|2
1797251|NCT00548249|6251996|P5|Overall Study|Protocol Violation|3
1797252|NCT00548249|6251997|P4|Overall Study|Protocol Violation|0
1797253|NCT00548249|6251998|P3|Overall Study|Protocol Violation|4
1797254|NCT00548249|6251999|P2|Overall Study|Protocol Violation|1
1797255|NCT00548249|6252000|P1|Overall Study|Protocol Violation|1
1797256|NCT00548249|6251996|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
1797257|NCT00548249|6251997|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
1797258|NCT00548249|6251998|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
1797259|NCT00548249|6251999|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
1797260|NCT00548249|6252000|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
1797261|NCT00548249|6251996|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1797262|NCT00548249|6251997|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
1797263|NCT00548249|6251998|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1797264|NCT00548249|6251999|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
1797265|NCT00548249|6252000|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
1797266|NCT00548184|6252048|P1|Overall Study|Found Her2 negative|1
1797267|NCT00548184|6252048|P1|Overall Study|took other drug|1
1797268|NCT00548184|6252048|P1|Overall Study|Adverse Event|3
1797269|NCT00548145|6252096|P2|Overall Study|Physician Decision|1
1797270|NCT00548145|6252097|P1|Overall Study|Physician Decision|1
1797271|NCT00548145|6252096|P2|Overall Study|Withdrawal by Subject|2
1797272|NCT00548145|6252097|P1|Overall Study|Withdrawal by Subject|0
1797273|NCT00548145|6252096|P2|Overall Study|Death|1
1797274|NCT00548145|6252097|P1|Overall Study|Death|0
1797275|NCT00548093|6252116|P2|Overall Study|Completed post-treatment follow-up|0
1797276|NCT00548093|6252117|P1|Overall Study|Completed post-treatment follow-up|1
1797277|NCT00548093|6252116|P2|Overall Study|Withdrawal by Subject|0
1797278|NCT00548093|6252117|P1|Overall Study|Withdrawal by Subject|1
1797279|NCT00548093|6252116|P2|Overall Study|Other|1
1797280|NCT00548093|6252117|P1|Overall Study|Other|11
1797281|NCT00548093|6252116|P2|Overall Study|Objective progression or relapse|1
1797282|NCT00548093|6252117|P1|Overall Study|Objective progression or relapse|1
1797283|NCT00548093|6252116|P2|Overall Study|Lost to Follow-up|1
1797284|NCT00548093|6252117|P1|Overall Study|Lost to Follow-up|3
1797285|NCT00548093|6252116|P2|Overall Study|Death|13
1797286|NCT00548093|6252117|P1|Overall Study|Death|33
1797287|NCT00547911|6252155|P6|Overall Study|Adverse Event|0
1797288|NCT00547911|6252156|P5|Overall Study|Adverse Event|0
1797289|NCT00547911|6252157|P4|Overall Study|Adverse Event|1
1797290|NCT00547911|6252158|P3|Overall Study|Adverse Event|0
1797291|NCT00547911|6252159|P2|Overall Study|Adverse Event|0
1797292|NCT00547911|6252160|P1|Overall Study|Adverse Event|0
1797293|NCT00547703|6252191|P2|Overall Study|Lost to Follow-up|0
1797294|NCT00547703|6252192|P1|Overall Study|Lost to Follow-up|1
1797295|NCT00547534|6252217|P1|Overall Study|Disease Progression|4
1797296|NCT00547534|6252217|P1|Overall Study|Adverse Event|7
1797297|NCT00547521|6252225|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
1797298|NCT00547521|6252226|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
1797299|NCT00547521|6252225|P2|Long Term Extension (LTE) Study|Other|2
1797300|NCT00547521|6252226|P1|Long Term Extension (LTE) Study|Other|0
1797301|NCT00547521|6252225|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
1797302|NCT00547521|6252226|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
1797303|NCT00547521|6252225|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
1797304|NCT00547521|6252226|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
1797305|NCT00547521|6252225|P2|Long Term Extension (LTE) Study|Adverse Event|9
1797306|NCT00547521|6252226|P1|Long Term Extension (LTE) Study|Adverse Event|0
1797307|NCT00547521|6252225|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
1797308|NCT00547521|6252226|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
1797309|NCT00547521|6252225|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
1797310|NCT00547521|6252226|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
1797311|NCT00547521|6252225|P2|Short Term Study (4 Months)|Withdrawal of consent|1
1797312|NCT00547521|6252226|P1|Short Term Study (4 Months)|Withdrawal of consent|0
1797313|NCT00547521|6252225|P2|Short Term Study (4 Months)|Lack of Efficacy|2
1797314|NCT00547521|6252226|P1|Short Term Study (4 Months)|Lack of Efficacy|0
1797315|NCT00547521|6252225|P2|Short Term Study (4 Months)|Adverse Event|0
1797316|NCT00547521|6252226|P1|Short Term Study (4 Months)|Adverse Event|1
1797317|NCT00547378|6252303|P3|All Implanted Cohort|Other reasons|1
1797318|NCT00547378|6252304|P2|All Implanted Cohort|Other reasons|0
1797319|NCT00547378|6252305|P1|All Implanted Cohort|Other reasons|1
1797320|NCT00547378|6252303|P3|All Implanted Cohort|Site closure|1
1797321|NCT00547378|6252304|P2|All Implanted Cohort|Site closure|0
1797322|NCT00547378|6252305|P1|All Implanted Cohort|Site closure|2
1797323|NCT00547378|6252303|P3|All Implanted Cohort|Physician Decision|6
1797324|NCT00547378|6252304|P2|All Implanted Cohort|Physician Decision|2
1797325|NCT00547378|6252305|P1|All Implanted Cohort|Physician Decision|0
1797326|NCT00547378|6252303|P3|All Implanted Cohort|Death|4
1797327|NCT00547378|6252304|P2|All Implanted Cohort|Death|1
1797328|NCT00547378|6252305|P1|All Implanted Cohort|Death|3
1797329|NCT00547378|6252303|P3|All Implanted Cohort|Lost to Follow-up|14
1797330|NCT00547378|6252304|P2|All Implanted Cohort|Lost to Follow-up|1
1797331|NCT00547378|6252305|P1|All Implanted Cohort|Lost to Follow-up|0
1797332|NCT00547378|6252303|P3|All Implanted Cohort|Adverse Event|17
1797333|NCT00547378|6252304|P2|All Implanted Cohort|Adverse Event|10
1797334|NCT00547378|6252305|P1|All Implanted Cohort|Adverse Event|4
1797335|NCT00547378|6252303|P3|All Implanted Cohort|Withdrawal by Subject|27
1797336|NCT00547378|6252304|P2|All Implanted Cohort|Withdrawal by Subject|4
1797337|NCT00547378|6252305|P1|All Implanted Cohort|Withdrawal by Subject|5
1797338|NCT00547378|6252303|P3|Randomized Cohort|Other reasons|0
1797339|NCT00547378|6252304|P2|Randomized Cohort|Other reasons|0
1797340|NCT00547378|6252305|P1|Randomized Cohort|Other reasons|2
1797341|NCT00547378|6252303|P3|Randomized Cohort|Adverse Event|0
1797342|NCT00547378|6252304|P2|Randomized Cohort|Adverse Event|0
1797343|NCT00547378|6252305|P1|Randomized Cohort|Adverse Event|1
1797344|NCT00547378|6252303|P3|Randomized Cohort|Lost to Follow-up|0
1797345|NCT00547378|6252304|P2|Randomized Cohort|Lost to Follow-up|0
1797346|NCT00547378|6252305|P1|Randomized Cohort|Lost to Follow-up|1
1797347|NCT00547378|6252303|P3|Randomized Cohort|Death|0
1797348|NCT00547378|6252304|P2|Randomized Cohort|Death|1
1797349|NCT00547378|6252305|P1|Randomized Cohort|Death|0
1797350|NCT00547378|6252303|P3|Randomized Cohort|Withdrawal by Subject|0
1797351|NCT00547378|6252304|P2|Randomized Cohort|Withdrawal by Subject|5
1797352|NCT00547378|6252305|P1|Randomized Cohort|Withdrawal by Subject|7
1797353|NCT00547365|6252315|P1|Overall Study|death (not related to study)|4
1797354|NCT00547365|6252315|P1|Overall Study|Protocol Violation|2
1797355|NCT00547365|6252315|P1|Overall Study|Lost to Follow-up|1
1797356|NCT00547365|6252315|P1|Overall Study|Physician Decision|1
1797357|NCT00547300|6252322|P2|Overall Study|Did not Meet Entry Criteria|2
1797358|NCT00547300|6252323|P1|Overall Study|Did not Meet Entry Criteria|0
1797359|NCT00547300|6252322|P2|Overall Study|Study was Administratively Terminated|24
1797360|NCT00547300|6252323|P1|Overall Study|Study was Administratively Terminated|25
1797361|NCT00547248|6252337|P4|Overall Study|Withdrawal by Subject|1
1797362|NCT00547248|6252338|P3|Overall Study|Withdrawal by Subject|7
1797363|NCT00547248|6252339|P2|Overall Study|Withdrawal by Subject|0
1797364|NCT00547248|6252340|P1|Overall Study|Withdrawal by Subject|0
1797365|NCT00547248|6252337|P4|Overall Study|Migrated/moved from study area|0
1797366|NCT00547248|6252338|P3|Overall Study|Migrated/moved from study area|2
1797367|NCT00547248|6252339|P2|Overall Study|Migrated/moved from study area|0
1797368|NCT00547248|6252340|P1|Overall Study|Migrated/moved from study area|0
1797369|NCT00547248|6252337|P4|Overall Study|Protocol Violation|1
1797370|NCT00547248|6252338|P3|Overall Study|Protocol Violation|1
1797371|NCT00547248|6252339|P2|Overall Study|Protocol Violation|0
1797372|NCT00547248|6252340|P1|Overall Study|Protocol Violation|0
1797373|NCT00547157|6252458|P2|Overall Study|Lost to Follow-up|2
1797374|NCT00547157|6252459|P1|Overall Study|Lost to Follow-up|4
1797375|NCT00547157|6252458|P2|Overall Study|Administrative decision|2
1797376|NCT00547157|6252459|P1|Overall Study|Administrative decision|3
1797377|NCT00547157|6252458|P2|Overall Study|Withdrawal by Subject|1
1797378|NCT00547157|6252459|P1|Overall Study|Withdrawal by Subject|3
1797379|NCT00547157|6252458|P2|Overall Study|Death|18
1797380|NCT00547157|6252459|P1|Overall Study|Death|38
1797381|NCT00547157|6252458|P2|Overall Study|Other|0
1797382|NCT00547157|6252459|P1|Overall Study|Other|1
1797383|NCT00547118|6252477|P2|Overall Study|Study suspended|8
1797384|NCT00547118|6252478|P1|Overall Study|Study suspended|7
1797385|NCT00547118|6252477|P2|Overall Study|Did not qualify prior to starting drug|1
1797386|NCT00547118|6252478|P1|Overall Study|Did not qualify prior to starting drug|1
1797387|NCT00546910|6252522|P2|Overall Study|Withdrawal by Subject|0
1797388|NCT00546910|6252523|P1|Overall Study|Withdrawal by Subject|2
1797389|NCT00546910|6252522|P2|Overall Study|Physician Decision|1
1797390|NCT00546910|6252523|P1|Overall Study|Physician Decision|0
1797391|NCT00546910|6252522|P2|Overall Study|Lack of Efficacy|7
1797392|NCT00546910|6252523|P1|Overall Study|Lack of Efficacy|5
1797393|NCT00546910|6252522|P2|Overall Study|Adverse Event|3
1797394|NCT00546910|6252523|P1|Overall Study|Adverse Event|2
1797395|NCT00546871|6252589|P2|Study Extension Period|Withdrawal by Subject|1
1797396|NCT00546871|6252590|P1|Study Extension Period|Withdrawal by Subject|0
1797397|NCT00546871|6252589|P2|Study Extension Period|Protocol Violation|0
1797398|NCT00546871|6252590|P1|Study Extension Period|Protocol Violation|1
1797399|NCT00546871|6252589|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
1797400|NCT00546871|6252590|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
1797401|NCT00546871|6252589|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
1797402|NCT00546871|6252590|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
1797403|NCT00546871|6252589|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
1797404|NCT00546871|6252590|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
1797405|NCT00546819|6252695|P2|Overall Study|Withdrawal by Subject|2
1797406|NCT00546819|6252696|P1|Overall Study|Withdrawal by Subject|4
1797407|NCT00546819|6252695|P2|Overall Study|Lost to Follow-up|1
1797408|NCT00546819|6252696|P1|Overall Study|Lost to Follow-up|2
1797409|NCT00546819|6252695|P2|Overall Study|Adverse Event|3
1797410|NCT00546819|6252696|P1|Overall Study|Adverse Event|2
1797411|NCT00546754|6252708|P2|Overall Study|Missing|7
1797412|NCT00546754|6252709|P1|Overall Study|Missing|14
1797413|NCT00546754|6252708|P2|Overall Study|Patient's Decision|1
1797414|NCT00546754|6252709|P1|Overall Study|Patient's Decision|0
1797415|NCT00546754|6252708|P2|Overall Study|Elevated Creatinine and Potassium levels|1
1797416|NCT00546754|6252709|P1|Overall Study|Elevated Creatinine and Potassium levels|0
1797417|NCT00546754|6252708|P2|Overall Study|Missing Cooperation|0
1797418|NCT00546754|6252709|P1|Overall Study|Missing Cooperation|1
1797419|NCT00546754|6252708|P2|Overall Study|Suicide|0
1797420|NCT00546754|6252709|P1|Overall Study|Suicide|1
1797421|NCT00546754|6252708|P2|Overall Study|Hip Replacement|0
1797422|NCT00546754|6252709|P1|Overall Study|Hip Replacement|1
1797423|NCT00546754|6252708|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
1797424|NCT00546754|6252709|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
1797425|NCT00546754|6252708|P2|Overall Study|Dyspnea|0
1797426|NCT00546754|6252709|P1|Overall Study|Dyspnea|1
1797427|NCT00546754|6252708|P2|Overall Study|Withdrawal by Subject|7
1797428|NCT00546754|6252709|P1|Overall Study|Withdrawal by Subject|6
1797429|NCT00546754|6252708|P2|Overall Study|Protocol Violation|0
1797430|NCT00546754|6252709|P1|Overall Study|Protocol Violation|3
1797431|NCT00546754|6252708|P2|Overall Study|Lost to Follow-up|15
1797432|NCT00546754|6252709|P1|Overall Study|Lost to Follow-up|9
1797433|NCT00546754|6252708|P2|Overall Study|Lack of Efficacy|1
1797434|NCT00546754|6252709|P1|Overall Study|Lack of Efficacy|1
1797435|NCT00546754|6252708|P2|Overall Study|Adverse Event|16
1797436|NCT00546754|6252709|P1|Overall Study|Adverse Event|11
1797437|NCT00546754|6252708|P2|Overall Study|Serious Adverse Event|1
1797438|NCT00546754|6252709|P1|Overall Study|Serious Adverse Event|1
1797439|NCT00546715|6252752|P4|Overall Study|Withdrawal by Subject|0
1797440|NCT00546715|6252753|P3|Overall Study|Withdrawal by Subject|0
1797441|NCT00546715|6252754|P2|Overall Study|Withdrawal by Subject|1
1797442|NCT00546715|6252755|P1|Overall Study|Withdrawal by Subject|0
1797443|NCT00546637|6252810|P2|Overall Study|Randomized, but not treated|1
1797444|NCT00546637|6252811|P1|Overall Study|Randomized, but not treated|3
1797445|NCT00546637|6252810|P2|Overall Study|Withdrawal by Subject|9
1797446|NCT00546637|6252811|P1|Overall Study|Withdrawal by Subject|7
1797447|NCT00546637|6252810|P2|Overall Study|Other|12
1797448|NCT00546637|6252811|P1|Overall Study|Other|10
1797449|NCT00546637|6252810|P2|Overall Study|Lost to Follow-up|2
1797450|NCT00546637|6252811|P1|Overall Study|Lost to Follow-up|2
1797451|NCT00546637|6252810|P2|Overall Study|Lack of Efficacy|5
1797452|NCT00546637|6252811|P1|Overall Study|Lack of Efficacy|5
1797453|NCT00546637|6252810|P2|Overall Study|Adverse Event|20
1797454|NCT00546637|6252811|P1|Overall Study|Adverse Event|46
1797455|NCT00546572|6252885|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
1797456|NCT00546572|6252886|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
1797457|NCT00546572|6252885|P2|Vax 2 / Year 1|Adverse Event|0
1797458|NCT00546572|6252886|P1|Vax 2 / Year 1|Adverse Event|1
1797459|NCT00546572|6252885|P2|Vax 2 / Year 1|Other|1
1797460|NCT00546572|6252886|P1|Vax 2 / Year 1|Other|1
1797461|NCT00546572|6252885|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
1797462|NCT00546572|6252886|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
1797463|NCT00546572|6252885|P2|Vax 1 / Year 0|Lost to Follow-up|1
1797464|NCT00546572|6252886|P1|Vax 1 / Year 0|Lost to Follow-up|0
1797465|NCT00546572|6252885|P2|Vax 1 / Year 0|Adverse Event|1
1797466|NCT00546572|6252886|P1|Vax 1 / Year 0|Adverse Event|0
1797467|NCT00546572|6252885|P2|Vax 1 / Year 0|Death|2
1797468|NCT00546572|6252886|P1|Vax 1 / Year 0|Death|2
1797469|NCT00546572|6252885|P2|Vax 1 / Year 0|Protocol Violation|4
1797470|NCT00546572|6252886|P1|Vax 1 / Year 0|Protocol Violation|3
1797471|NCT00546572|6252885|P2|Vax 1 / Year 0|Withdrawal by Subject|2
1797472|NCT00546572|6252886|P1|Vax 1 / Year 0|Withdrawal by Subject|3
1797473|NCT00546572|6252885|P2|Vax 1 / Year 0|Randomized, not treated|1
1797474|NCT00546572|6252886|P1|Vax 1 / Year 0|Randomized, not treated|1
1797475|NCT00546481|6252930|P3|Maintenance Phase (CERA)|Other Reason|1
1797476|NCT00546481|6252931|P2|Maintenance Phase (CERA)|Other Reason|0
1797477|NCT00546481|6252932|P1|Maintenance Phase (CERA)|Other Reason|0
1797478|NCT00546481|6252930|P3|Maintenance Phase (CERA)|Kidney transplantation|1
1797479|NCT00546481|6252931|P2|Maintenance Phase (CERA)|Kidney transplantation|0
1797480|NCT00546481|6252932|P1|Maintenance Phase (CERA)|Kidney transplantation|0
1797481|NCT00546481|6252930|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
1797482|NCT00546481|6252931|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
1797483|NCT00546481|6252932|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
1797484|NCT00546481|6252930|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
1797485|NCT00546481|6252931|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
1797486|NCT00546481|6252932|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
1797487|NCT00546481|6252930|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
1797488|NCT00546481|6252931|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
1797489|NCT00546481|6252932|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
1797490|NCT00546481|6252930|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
1797491|NCT00546481|6252931|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
1797492|NCT00546481|6252932|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
1797493|NCT00546481|6252930|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
1797494|NCT00546481|6252931|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
1797495|NCT00546481|6252932|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
1797496|NCT00546481|6252930|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
1797497|NCT00546481|6252931|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
1797498|NCT00546481|6252932|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
1797499|NCT00546481|6252930|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
1797500|NCT00546481|6252931|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
1797501|NCT00546481|6252932|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
1797502|NCT00546377|6252970|P1|Overall Study|Adverse Event|6
1797503|NCT00546377|6252970|P1|Overall Study|Deemed ineligible|1
1797504|NCT00546364|6252978|P3|Overall Study|Sponsor decision|1
1797505|NCT00546364|6252979|P2|Overall Study|Sponsor decision|0
1797506|NCT00546364|6252980|P1|Overall Study|Sponsor decision|0
1797507|NCT00546364|6252978|P3|Overall Study|Physician Decision|1
1797508|NCT00546364|6252979|P2|Overall Study|Physician Decision|0
1797509|NCT00546364|6252980|P1|Overall Study|Physician Decision|0
1797510|NCT00546364|6252978|P3|Overall Study|Target lesions resected|0
1797511|NCT00546364|6252979|P2|Overall Study|Target lesions resected|0
1797512|NCT00546364|6252980|P1|Overall Study|Target lesions resected|1
1797513|NCT00546364|6252978|P3|Overall Study|Palliative treatment|1
1797514|NCT00546364|6252979|P2|Overall Study|Palliative treatment|0
1797515|NCT00546364|6252980|P1|Overall Study|Palliative treatment|1
1797516|NCT00546364|6252978|P3|Overall Study|Mixed response|0
1797517|NCT00546364|6252979|P2|Overall Study|Mixed response|0
1797518|NCT00546364|6252980|P1|Overall Study|Mixed response|1
1797519|NCT00546364|6252978|P3|Overall Study|Prior taxotere|0
1797520|NCT00546364|6252979|P2|Overall Study|Prior taxotere|0
1797521|NCT00546364|6252980|P1|Overall Study|Prior taxotere|1
1797522|NCT00546364|6252978|P3|Overall Study|Withdrawal by Subject|3
1797523|NCT00546364|6252979|P2|Overall Study|Withdrawal by Subject|6
1797524|NCT00546364|6252980|P1|Overall Study|Withdrawal by Subject|5
1797525|NCT00546364|6252978|P3|Overall Study|No longer meets study criteria|0
1797526|NCT00546364|6252979|P2|Overall Study|No longer meets study criteria|1
1797527|NCT00546364|6252980|P1|Overall Study|No longer meets study criteria|1
1797528|NCT00546364|6252978|P3|Overall Study|Poor compliance/noncompliance|1
1797529|NCT00546364|6252979|P2|Overall Study|Poor compliance/noncompliance|0
1797530|NCT00546364|6252980|P1|Overall Study|Poor compliance/noncompliance|0
1797531|NCT00546364|6252978|P3|Overall Study|Administrative reason by sponsor|0
1797532|NCT00546364|6252979|P2|Overall Study|Administrative reason by sponsor|0
1797533|NCT00546364|6252980|P1|Overall Study|Administrative reason by sponsor|1
1797534|NCT00546364|6252978|P3|Overall Study|Completed and off treatment|2
1797535|NCT00546364|6252979|P2|Overall Study|Completed and off treatment|0
1797536|NCT00546364|6252980|P1|Overall Study|Completed and off treatment|1
1797537|NCT00546364|6252978|P3|Overall Study|Disease progression|8
1797538|NCT00546364|6252979|P2|Overall Study|Disease progression|11
1797539|NCT00546364|6252980|P1|Overall Study|Disease progression|5
1797540|NCT00546351|6253015|P1|Overall Study|Other reasons for premature termination|17
1797541|NCT00546351|6253015|P1|Overall Study|Unsatisfactory compliance|9
1797542|NCT00546351|6253015|P1|Overall Study|Protocol Deviation|1
1797543|NCT00546351|6253015|P1|Overall Study|Lost to Follow-up|9
1797544|NCT00546351|6253015|P1|Overall Study|Withdrawal by Subject|109
1797545|NCT00546351|6253015|P1|Overall Study|Lack of Efficacy|15
1797546|NCT00546351|6253015|P1|Overall Study|Adverse Event|76
1797547|NCT00546260|6253061|P2|Overall Study|Drug not given pre diagnostic angiogr|2
1797548|NCT00546260|6253062|P1|Overall Study|Drug not given pre diagnostic angiogr|8
1797549|NCT00546117|6253084|P2|Overall Study|Inability to schedule follow-up visit|0
1797550|NCT00546117|6253085|P1|Overall Study|Inability to schedule follow-up visit|1
1797551|NCT00546117|6253084|P2|Overall Study|Withdrawal by Subject|0
1797552|NCT00546117|6253085|P1|Overall Study|Withdrawal by Subject|3
1797553|NCT00546078|6253110|P2|Overall Study|Other reason|1
1797554|NCT00546078|6253111|P1|Overall Study|Other reason|1
1797555|NCT00546078|6253110|P2|Overall Study|Withdrawal by Subject|3
1797556|NCT00546078|6253111|P1|Overall Study|Withdrawal by Subject|2
1797557|NCT00546078|6253110|P2|Overall Study|Lost to Follow-up|3
1797558|NCT00546078|6253111|P1|Overall Study|Lost to Follow-up|1
1797559|NCT00546052|6253149|P1|Overall Study|Non Compliance|7
1797560|NCT00546052|6253149|P1|Overall Study|Withdrawal by Subject|20
1797561|NCT00546052|6253149|P1|Overall Study|Protocol Violation|9
1797562|NCT00546052|6253149|P1|Overall Study|Lost to Follow-up|144
1797563|NCT00546052|6253149|P1|Overall Study|Adverse Event|47
1797564|NCT00546000|6253167|P1|Overall Study|Baseline HPA Axis Supression|2
1797565|NCT00546000|6253167|P1|Overall Study|Lost to Follow-up|1
1797566|NCT00546000|6253167|P1|Overall Study|Adverse Event|1
1797567|NCT00545948|6253186|P3|Overall Study|Not Treated|7
1797568|NCT00545948|6253187|P2|Overall Study|Not Treated|1
1797569|NCT00545948|6253188|P1|Overall Study|Not Treated|1
1797570|NCT00545844|6253198|P1|Overall Study|Withdrawal by Subject|2
1797571|NCT00545844|6253198|P1|Overall Study|Protocol Violation|1
1797572|NCT00545844|6253198|P1|Overall Study|Lost to Follow-up|9
1797573|NCT00545792|6253212|P1|Overall Study|Withdrawal by Subject|1
1797574|NCT00545779|6253217|P1|Overall Study|Failure to return|3
1797575|NCT00545779|6253217|P1|Overall Study|Adverse Event/intercurrent illness|5
1797576|NCT00545779|6253217|P1|Overall Study|Withdrawal by Subject|20
1797577|NCT00545779|6253217|P1|Overall Study|Did not cooperate|7
1797578|NCT00545779|6253217|P1|Overall Study|Other protocol violation|1
1797579|NCT00545779|6253217|P1|Overall Study|Violation of selection criteria at entry|8
1797580|NCT00545753|6253237|P3|Overall Study|Protocol Violation|4
1797581|NCT00545753|6253238|P2|Overall Study|Protocol Violation|1
1797582|NCT00545753|6253239|P1|Overall Study|Protocol Violation|3
1797583|NCT00545753|6253237|P3|Overall Study|Lost to Follow-up|12
1797584|NCT00545753|6253238|P2|Overall Study|Lost to Follow-up|3
1797585|NCT00545753|6253239|P1|Overall Study|Lost to Follow-up|13
1797586|NCT00545753|6253237|P3|Overall Study|Withdrawal by Subject|10
1797587|NCT00545753|6253238|P2|Overall Study|Withdrawal by Subject|1
1797588|NCT00545753|6253239|P1|Overall Study|Withdrawal by Subject|0
1797589|NCT00545740|6253252|P4|Overall Study|Husband against study|0
1797590|NCT00545740|6253253|P3|Overall Study|Husband against study|1
1797591|NCT00545740|6253254|P2|Overall Study|Husband against study|0
1797592|NCT00545740|6253255|P1|Overall Study|Husband against study|0
1797593|NCT00545740|6253252|P4|Overall Study|Patient difficulties|0
1797594|NCT00545740|6253253|P3|Overall Study|Patient difficulties|0
1797595|NCT00545740|6253254|P2|Overall Study|Patient difficulties|1
1797596|NCT00545740|6253255|P1|Overall Study|Patient difficulties|0
1797597|NCT00545740|6253252|P4|Overall Study|Non-adherence to visits|0
1797598|NCT00545740|6253253|P3|Overall Study|Non-adherence to visits|0
1797599|NCT00545740|6253254|P2|Overall Study|Non-adherence to visits|1
1797600|NCT00545740|6253255|P1|Overall Study|Non-adherence to visits|0
1797601|NCT00545740|6253252|P4|Overall Study|Lack of time|0
1797602|NCT00545740|6253253|P3|Overall Study|Lack of time|0
1797603|NCT00545740|6253254|P2|Overall Study|Lack of time|1
1797604|NCT00545740|6253255|P1|Overall Study|Lack of time|0
1797605|NCT00545740|6253252|P4|Overall Study|Sponsor decision|0
1797606|NCT00545740|6253253|P3|Overall Study|Sponsor decision|0
1797607|NCT00545740|6253254|P2|Overall Study|Sponsor decision|1
1797608|NCT00545740|6253255|P1|Overall Study|Sponsor decision|0
1797609|NCT00545740|6253252|P4|Overall Study|Accepted only monthly telephone calls|0
1797610|NCT00545740|6253253|P3|Overall Study|Accepted only monthly telephone calls|0
1797611|NCT00545740|6253254|P2|Overall Study|Accepted only monthly telephone calls|0
1797612|NCT00545740|6253255|P1|Overall Study|Accepted only monthly telephone calls|1
1797613|NCT00545740|6253252|P4|Overall Study|Physician Decision|0
1797614|NCT00545740|6253253|P3|Overall Study|Physician Decision|3
1797615|NCT00545740|6253254|P2|Overall Study|Physician Decision|0
1797616|NCT00545740|6253255|P1|Overall Study|Physician Decision|0
1797617|NCT00545740|6253252|P4|Overall Study|Missed visit|0
1797618|NCT00545740|6253253|P3|Overall Study|Missed visit|0
1797619|NCT00545740|6253254|P2|Overall Study|Missed visit|0
1797620|NCT00545740|6253255|P1|Overall Study|Missed visit|1
1797621|NCT00545740|6253252|P4|Overall Study|Site closure|0
1797622|NCT00545740|6253253|P3|Overall Study|Site closure|0
1797623|NCT00545740|6253254|P2|Overall Study|Site closure|0
1797624|NCT00545740|6253255|P1|Overall Study|Site closure|1
1797625|NCT00545740|6253252|P4|Overall Study|Suspected Diverticulitis Recurrence|1
1797626|NCT00545740|6253253|P3|Overall Study|Suspected Diverticulitis Recurrence|1
1797627|NCT00545740|6253254|P2|Overall Study|Suspected Diverticulitis Recurrence|1
1797628|NCT00545740|6253255|P1|Overall Study|Suspected Diverticulitis Recurrence|1
1797629|NCT00545740|6253252|P4|Overall Study|Diverticulitis attack|1
1797630|NCT00545740|6253253|P3|Overall Study|Diverticulitis attack|1
1797631|NCT00545740|6253254|P2|Overall Study|Diverticulitis attack|0
1797632|NCT00545740|6253255|P1|Overall Study|Diverticulitis attack|0
1797633|NCT00545740|6253252|P4|Overall Study|Moved|0
1797634|NCT00545740|6253253|P3|Overall Study|Moved|1
1797635|NCT00545740|6253254|P2|Overall Study|Moved|0
1797636|NCT00545740|6253255|P1|Overall Study|Moved|2
1797637|NCT00545740|6253252|P4|Overall Study|Non-compliance|0
1797638|NCT00545740|6253253|P3|Overall Study|Non-compliance|1
1797639|NCT00545740|6253254|P2|Overall Study|Non-compliance|2
1797640|NCT00545740|6253255|P1|Overall Study|Non-compliance|0
1797641|NCT00545740|6253252|P4|Overall Study|Protocol Violation|0
1797642|NCT00545740|6253253|P3|Overall Study|Protocol Violation|1
1797643|NCT00545740|6253254|P2|Overall Study|Protocol Violation|3
1797644|NCT00545740|6253255|P1|Overall Study|Protocol Violation|1
1797645|NCT00545740|6253252|P4|Overall Study|Lost to Follow-up|6
1797646|NCT00545740|6253253|P3|Overall Study|Lost to Follow-up|5
1797647|NCT00545740|6253254|P2|Overall Study|Lost to Follow-up|5
1797648|NCT00545740|6253255|P1|Overall Study|Lost to Follow-up|7
1797649|NCT00545740|6253252|P4|Overall Study|Adverse Event|9
1797650|NCT00545740|6253253|P3|Overall Study|Adverse Event|19
1797651|NCT00545740|6253254|P2|Overall Study|Adverse Event|18
1797652|NCT00545740|6253255|P1|Overall Study|Adverse Event|10
1797653|NCT00545740|6253252|P4|Overall Study|Withdrawal by Subject|18
1797654|NCT00545740|6253253|P3|Overall Study|Withdrawal by Subject|16
1797655|NCT00545740|6253254|P2|Overall Study|Withdrawal by Subject|15
1797656|NCT00545740|6253255|P1|Overall Study|Withdrawal by Subject|17
1797657|NCT00545740|6253252|P4|Overall Study|Lack of Efficacy|36
1797658|NCT00545740|6253253|P3|Overall Study|Lack of Efficacy|47
1797659|NCT00545740|6253254|P2|Overall Study|Lack of Efficacy|35
1797660|NCT00545740|6253255|P1|Overall Study|Lack of Efficacy|34
1797661|NCT00545714|6253289|P1|Maintenance Phase (36 Months)|Death|2
1797662|NCT00545714|6253289|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
1797663|NCT00545714|6253289|P1|Maintenance Phase (36 Months)|Protocol Violation|1
1797664|NCT00545714|6253289|P1|Maintenance Phase (36 Months)|Physician Decision|1
1797665|NCT00545714|6253289|P1|Maintenance Phase (36 Months)|Disease Progression|9
1797666|NCT00545714|6253289|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
1797667|NCT00545714|6253289|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
1797668|NCT00545714|6253289|P1|Induction Phase (6 Months)|Disease Progression|1
1797669|NCT00545714|6253289|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
1797670|NCT00545714|6253289|P1|Induction Phase (6 Months)|Physician Decision|3
1797671|NCT00545688|6253310|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
1797672|NCT00545688|6253311|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
1797673|NCT00545688|6253312|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
1797674|NCT00545688|6253313|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
1797675|NCT00545688|6253310|P4|Follow-Up Period|Unspecified Reason|8
1797676|NCT00545688|6253311|P3|Follow-Up Period|Unspecified Reason|6
1797677|NCT00545688|6253312|P2|Follow-Up Period|Unspecified Reason|5
1797678|NCT00545688|6253313|P1|Follow-Up Period|Unspecified Reason|2
1797679|NCT00545688|6253310|P4|Follow-Up Period|Lost to Follow-up|1
1797680|NCT00545688|6253311|P3|Follow-Up Period|Lost to Follow-up|3
1797681|NCT00545688|6253312|P2|Follow-Up Period|Lost to Follow-up|3
1797682|NCT00545688|6253313|P1|Follow-Up Period|Lost to Follow-up|3
1797683|NCT00545688|6253310|P4|Follow-Up Period|Refused Treatment|2
1797684|NCT00545688|6253311|P3|Follow-Up Period|Refused Treatment|0
1797685|NCT00545688|6253312|P2|Follow-Up Period|Refused Treatment|2
1797686|NCT00545688|6253313|P1|Follow-Up Period|Refused Treatment|6
1797687|NCT00545688|6253310|P4|Follow-Up Period|Disease Progression|9
1797688|NCT00545688|6253311|P3|Follow-Up Period|Disease Progression|9
1797689|NCT00545688|6253312|P2|Follow-Up Period|Disease Progression|5
1797690|NCT00545688|6253313|P1|Follow-Up Period|Disease Progression|6
1797691|NCT00545688|6253310|P4|Follow-Up Period|Death|6
1797692|NCT00545688|6253311|P3|Follow-Up Period|Death|2
1797693|NCT00545688|6253312|P2|Follow-Up Period|Death|2
1797694|NCT00545688|6253313|P1|Follow-Up Period|Death|4
1797695|NCT00545688|6253310|P4|Adjuvant Treatment Period|Unknown Reason|0
1797696|NCT00545688|6253311|P3|Adjuvant Treatment Period|Unknown Reason|0
1797697|NCT00545688|6253312|P2|Adjuvant Treatment Period|Unknown Reason|1
1797698|NCT00545688|6253313|P1|Adjuvant Treatment Period|Unknown Reason|0
1797699|NCT00545688|6253310|P4|Adjuvant Treatment Period|Adverse Event|2
1797700|NCT00545688|6253311|P3|Adjuvant Treatment Period|Adverse Event|2
1797701|NCT00545688|6253312|P2|Adjuvant Treatment Period|Adverse Event|3
1797702|NCT00545688|6253313|P1|Adjuvant Treatment Period|Adverse Event|0
1797703|NCT00545688|6253310|P4|Adjuvant Treatment Period|Lost to Follow-up|0
1797704|NCT00545688|6253311|P3|Adjuvant Treatment Period|Lost to Follow-up|1
1797705|NCT00545688|6253312|P2|Adjuvant Treatment Period|Lost to Follow-up|0
1797706|NCT00545688|6253313|P1|Adjuvant Treatment Period|Lost to Follow-up|1
1797707|NCT00545688|6253310|P4|Adjuvant Treatment Period|Refused Treatment|5
1797708|NCT00545688|6253311|P3|Adjuvant Treatment Period|Refused Treatment|1
1797709|NCT00545688|6253312|P2|Adjuvant Treatment Period|Refused Treatment|1
1797710|NCT00545688|6253313|P1|Adjuvant Treatment Period|Refused Treatment|1
1797711|NCT00545688|6253310|P4|Adjuvant Treatment Period|Disease Progression|7
1797712|NCT00545688|6253311|P3|Adjuvant Treatment Period|Disease Progression|0
1797713|NCT00545688|6253312|P2|Adjuvant Treatment Period|Disease Progression|3
1797714|NCT00545688|6253313|P1|Adjuvant Treatment Period|Disease Progression|3
1797715|NCT00545688|6253310|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
1797716|NCT00545688|6253311|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
1797717|NCT00545688|6253312|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
1797718|NCT00545688|6253313|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
1797719|NCT00545688|6253310|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
1797720|NCT00545688|6253311|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
1797721|NCT00545688|6253312|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
1797722|NCT00545688|6253313|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
1797723|NCT00545688|6253310|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
1797724|NCT00545688|6253311|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
1797725|NCT00545688|6253312|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
1797726|NCT00545688|6253313|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
1797727|NCT00545688|6253310|P4|Neo-Adjuvant Treatment Period|Death|0
1797728|NCT00545688|6253311|P3|Neo-Adjuvant Treatment Period|Death|0
1797729|NCT00545688|6253312|P2|Neo-Adjuvant Treatment Period|Death|1
1797730|NCT00545688|6253313|P1|Neo-Adjuvant Treatment Period|Death|0
1797731|NCT00545688|6253310|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1797732|NCT00545688|6253311|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1797733|NCT00545688|6253312|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
1797734|NCT00545688|6253313|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
1797735|NCT00545688|6253310|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
1797736|NCT00545688|6253311|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
1797737|NCT00545688|6253312|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
1797738|NCT00545688|6253313|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
1797739|NCT00545688|6253310|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
1797740|NCT00545688|6253311|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
1797741|NCT00545688|6253312|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
1797742|NCT00545688|6253313|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
1797743|NCT00545584|6253412|P3|Overall Study|Two or more reasons for discontinuation|8
1797744|NCT00545584|6253413|P2|Overall Study|Two or more reasons for discontinuation|19
1797745|NCT00545584|6253414|P1|Overall Study|Two or more reasons for discontinuation|17
1797746|NCT00545584|6253412|P3|Overall Study|Only one reason for discontinuation|48
1797747|NCT00545584|6253413|P2|Overall Study|Only one reason for discontinuation|61
1797748|NCT00545584|6253414|P1|Overall Study|Only one reason for discontinuation|62
1797749|NCT00545571|6253425|P1|Overall Study|Kidney Transplantation|3
1797750|NCT00545571|6253425|P1|Overall Study|Early Termination of Study|24
1797751|NCT00545571|6253425|P1|Overall Study|Transfusion|12
1797752|NCT00545571|6253425|P1|Overall Study|Screen Failure|16
1797753|NCT00545571|6253425|P1|Overall Study|Refused Treatment|1
1797754|NCT00545571|6253425|P1|Overall Study|Protocol Violation|2
1797755|NCT00545571|6253425|P1|Overall Study|Lack of Efficacy|1
1797756|NCT00545571|6253425|P1|Overall Study|Death|5
1797757|NCT00545571|6253425|P1|Overall Study|Adverse Event|2
1797758|NCT00545571|6253425|P1|Overall Study|Administrative Reasons|1
1797759|NCT00545532|6253440|P2|Overall Study|Death|1
1797760|NCT00545532|6253441|P1|Overall Study|Death|0
1797761|NCT00545532|6253440|P2|Overall Study|Lost to Follow-up|6
1797762|NCT00545532|6253441|P1|Overall Study|Lost to Follow-up|5
1797763|NCT00545532|6253440|P2|Overall Study|Withdrawal by Subject|3
1797764|NCT00545532|6253441|P1|Overall Study|Withdrawal by Subject|1
1797765|NCT00545441|6253532|P2|Overall Study|Patients were not treated|3
1797766|NCT00545441|6253533|P1|Overall Study|Patients were not treated|1
1797767|NCT00545441|6253532|P2|Overall Study|Persistence or recurrence of fistula|2
1797768|NCT00545441|6253533|P1|Overall Study|Persistence or recurrence of fistula|5
1797769|NCT00545441|6253532|P2|Overall Study|Withdrawal by Subject|1
1797770|NCT00545441|6253533|P1|Overall Study|Withdrawal by Subject|1
1797771|NCT00545441|6253532|P2|Overall Study|Technical failure|1
1797772|NCT00545441|6253533|P1|Overall Study|Technical failure|0
1797773|NCT00545441|6253532|P2|Overall Study|Lost to Follow-up|5
1797774|NCT00545441|6253533|P1|Overall Study|Lost to Follow-up|9
1797775|NCT00545441|6253532|P2|Overall Study|Fistula draining at 6 months|4
1797776|NCT00545441|6253533|P1|Overall Study|Fistula draining at 6 months|2
1797777|NCT00545402|6253541|P2|Overall Study|Reason not specified|1
1797778|NCT00545402|6253542|P1|Overall Study|Reason not specified|1
1797779|NCT00545402|6253541|P2|Overall Study|Protocol Violation|0
1797780|NCT00545402|6253542|P1|Overall Study|Protocol Violation|1
1797781|NCT00545402|6253541|P2|Overall Study|Withdrawal by Subject|1
1797782|NCT00545402|6253542|P1|Overall Study|Withdrawal by Subject|0
1797783|NCT00545402|6253541|P2|Overall Study|Graft loss|4
1797784|NCT00545402|6253542|P1|Overall Study|Graft loss|2
1797785|NCT00545402|6253541|P2|Overall Study|Death|7
1797786|NCT00545402|6253542|P1|Overall Study|Death|5
1797787|NCT00545402|6253541|P2|Overall Study|Use of unauthorized immunosuppressant|7
1797788|NCT00545402|6253542|P1|Overall Study|Use of unauthorized immunosuppressant|8
1797789|NCT00545402|6253541|P2|Overall Study|Discontinuation of treatment|9
1797790|NCT00545402|6253542|P1|Overall Study|Discontinuation of treatment|17
1797791|NCT00545363|6253560|P2|Overall Study|Other|1
1797792|NCT00545363|6253561|P1|Overall Study|Other|1
1797793|NCT00545363|6253560|P2|Overall Study|Lost to Follow-up|0
1797794|NCT00545363|6253561|P1|Overall Study|Lost to Follow-up|2
1797795|NCT00545363|6253560|P2|Overall Study|Did not meet entry criteria|1
1797796|NCT00545363|6253561|P1|Overall Study|Did not meet entry criteria|1
1797797|NCT00545363|6253560|P2|Overall Study|Non-compliance|1
1797798|NCT00545363|6253561|P1|Overall Study|Non-compliance|3
1797799|NCT00545363|6253560|P2|Overall Study|Withdrawal by Subject|5
1797800|NCT00545363|6253561|P1|Overall Study|Withdrawal by Subject|6
1797801|NCT00545363|6253560|P2|Overall Study|Adverse Event|7
1797802|NCT00545363|6253561|P1|Overall Study|Adverse Event|6
1797803|NCT00545298|6253576|P3|Overall Study|Issues with Standard of Care|1
1797804|NCT00545298|6253577|P2|Overall Study|Issues with Standard of Care|0
1797805|NCT00545298|6253578|P1|Overall Study|Issues with Standard of Care|2
1797806|NCT00545272|6253595|P6|Overall Study|Lost to Follow-up|0
1797807|NCT00545272|6253596|P5|Overall Study|Lost to Follow-up|1
1797808|NCT00545272|6253597|P4|Overall Study|Lost to Follow-up|0
1797809|NCT00545272|6253598|P3|Overall Study|Lost to Follow-up|0
1797810|NCT00545272|6253599|P2|Overall Study|Lost to Follow-up|0
1797811|NCT00545272|6253600|P1|Overall Study|Lost to Follow-up|0
1797812|NCT00545272|6253595|P6|Overall Study|Abnormal test procedure result(s)|0
1797813|NCT00545272|6253596|P5|Overall Study|Abnormal test procedure result(s)|1
1797814|NCT00545272|6253597|P4|Overall Study|Abnormal test procedure result(s)|0
1797815|NCT00545272|6253598|P3|Overall Study|Abnormal test procedure result(s)|0
1797816|NCT00545272|6253599|P2|Overall Study|Abnormal test procedure result(s)|0
1797817|NCT00545272|6253600|P1|Overall Study|Abnormal test procedure result(s)|0
1797818|NCT00545272|6253595|P6|Overall Study|Abnormal laboratory value(s)|1
1797819|NCT00545272|6253596|P5|Overall Study|Abnormal laboratory value(s)|0
1797820|NCT00545272|6253597|P4|Overall Study|Abnormal laboratory value(s)|0
1797821|NCT00545272|6253598|P3|Overall Study|Abnormal laboratory value(s)|0
1797822|NCT00545272|6253599|P2|Overall Study|Abnormal laboratory value(s)|0
1797823|NCT00545272|6253600|P1|Overall Study|Abnormal laboratory value(s)|0
1797824|NCT00545272|6253595|P6|Overall Study|Adverse Event|1
1797825|NCT00545272|6253596|P5|Overall Study|Adverse Event|0
1797826|NCT00545272|6253597|P4|Overall Study|Adverse Event|0
1797827|NCT00545272|6253598|P3|Overall Study|Adverse Event|1
1797828|NCT00545272|6253599|P2|Overall Study|Adverse Event|0
1797829|NCT00545272|6253600|P1|Overall Study|Adverse Event|0
1797830|NCT00545272|6253595|P6|Overall Study|Protocol deviation|1
1797831|NCT00545272|6253596|P5|Overall Study|Protocol deviation|0
1797832|NCT00545272|6253597|P4|Overall Study|Protocol deviation|1
1797833|NCT00545272|6253598|P3|Overall Study|Protocol deviation|0
1797834|NCT00545272|6253599|P2|Overall Study|Protocol deviation|1
1797835|NCT00545272|6253600|P1|Overall Study|Protocol deviation|0
1797836|NCT00545233|6253652|P2|Overall Study|Physician Decision|1
1797837|NCT00545233|6253653|P1|Overall Study|Physician Decision|2
1797838|NCT00545233|6253652|P2|Overall Study|Insufficient response|15
1797839|NCT00545233|6253653|P1|Overall Study|Insufficient response|14
1797840|NCT00545233|6253652|P2|Overall Study|Failure to Return|6
1797841|NCT00545233|6253653|P1|Overall Study|Failure to Return|4
1797842|NCT00545233|6253652|P2|Overall Study|Refused Treatment|7
1797843|NCT00545233|6253653|P1|Overall Study|Refused Treatment|9
1797844|NCT00545233|6253652|P2|Overall Study|Protocol Violation|0
1797845|NCT00545233|6253653|P1|Overall Study|Protocol Violation|2
1797846|NCT00545233|6253652|P2|Overall Study|Violation of Selection Criteria at Entry|1
1797847|NCT00545233|6253653|P1|Overall Study|Violation of Selection Criteria at Entry|5
1797848|NCT00545233|6253652|P2|Overall Study|Adverse Event|5
1797849|NCT00545233|6253653|P1|Overall Study|Adverse Event|10
1797850|NCT00545168|6253712|P3|Overall Study|Visit for Day 21 was not done in error|2
1797851|NCT00545168|6253713|P2|Overall Study|Visit for Day 21 was not done in error|0
1797852|NCT00545168|6253714|P1|Overall Study|Visit for Day 21 was not done in error|1
1797853|NCT00545168|6253712|P3|Overall Study|Protocol Violation|1
1797854|NCT00545168|6253713|P2|Overall Study|Protocol Violation|0
1797855|NCT00545168|6253714|P1|Overall Study|Protocol Violation|1
1797856|NCT00545168|6253712|P3|Overall Study|Withdrawal by Subject|13
1797857|NCT00545168|6253713|P2|Overall Study|Withdrawal by Subject|0
1797858|NCT00545168|6253714|P1|Overall Study|Withdrawal by Subject|9
1797859|NCT00545168|6253712|P3|Overall Study|Lost to Follow-up|5
1797860|NCT00545168|6253713|P2|Overall Study|Lost to Follow-up|5
1797861|NCT00545168|6253714|P1|Overall Study|Lost to Follow-up|5
1797862|NCT00545103|6253740|P4|Overall Study|Death|0
1797863|NCT00545103|6253741|P3|Overall Study|Death|0
1797864|NCT00545103|6253742|P2|Overall Study|Death|1
1797865|NCT00545103|6253743|P1|Overall Study|Death|0
1797866|NCT00545103|6253740|P4|Overall Study|Subject met endpoint under protocol v. 1|0
1797867|NCT00545103|6253741|P3|Overall Study|Subject met endpoint under protocol v. 1|1
1797868|NCT00545103|6253742|P2|Overall Study|Subject met endpoint under protocol v. 1|0
1797869|NCT00545103|6253743|P1|Overall Study|Subject met endpoint under protocol v. 1|0
1797870|NCT00545103|6253740|P4|Overall Study|Does not want to take study drug anymore|0
1797871|NCT00545103|6253741|P3|Overall Study|Does not want to take study drug anymore|1
1797872|NCT00545103|6253742|P2|Overall Study|Does not want to take study drug anymore|0
1797873|NCT00545103|6253743|P1|Overall Study|Does not want to take study drug anymore|1
1797874|NCT00545103|6253740|P4|Overall Study|Use of prohibited medication|0
1797875|NCT00545103|6253741|P3|Overall Study|Use of prohibited medication|1
1797876|NCT00545103|6253742|P2|Overall Study|Use of prohibited medication|0
1797877|NCT00545103|6253743|P1|Overall Study|Use of prohibited medication|0
1797878|NCT00545103|6253740|P4|Overall Study|Subject moved|0
1797879|NCT00545103|6253741|P3|Overall Study|Subject moved|0
1797880|NCT00545103|6253742|P2|Overall Study|Subject moved|1
1797881|NCT00545103|6253743|P1|Overall Study|Subject moved|0
1797882|NCT00545103|6253740|P4|Overall Study|Investigator decision|0
1797883|NCT00545103|6253741|P3|Overall Study|Investigator decision|1
1797884|NCT00545103|6253742|P2|Overall Study|Investigator decision|0
1797885|NCT00545103|6253743|P1|Overall Study|Investigator decision|0
1797886|NCT00545103|6253740|P4|Overall Study|Noncompliance|0
1797887|NCT00545103|6253741|P3|Overall Study|Noncompliance|0
1797888|NCT00545103|6253742|P2|Overall Study|Noncompliance|1
1797889|NCT00545103|6253743|P1|Overall Study|Noncompliance|0
1797890|NCT00545103|6253740|P4|Overall Study|Subject's decision|0
1797891|NCT00545103|6253741|P3|Overall Study|Subject's decision|0
1797892|NCT00545103|6253742|P2|Overall Study|Subject's decision|0
1797893|NCT00545103|6253743|P1|Overall Study|Subject's decision|1
1797894|NCT00545103|6253740|P4|Overall Study|Personal reasons|0
1797895|NCT00545103|6253741|P3|Overall Study|Personal reasons|0
1797896|NCT00545103|6253742|P2|Overall Study|Personal reasons|0
1797897|NCT00545103|6253743|P1|Overall Study|Personal reasons|1
1797898|NCT00545103|6253740|P4|Overall Study|Diverticulitis crisis|1
1797899|NCT00545103|6253741|P3|Overall Study|Diverticulitis crisis|0
1797900|NCT00545103|6253742|P2|Overall Study|Diverticulitis crisis|0
1797901|NCT00545103|6253743|P1|Overall Study|Diverticulitis crisis|0
1797902|NCT00545103|6253740|P4|Overall Study|Wish to start a family|1
1797903|NCT00545103|6253741|P3|Overall Study|Wish to start a family|0
1797904|NCT00545103|6253742|P2|Overall Study|Wish to start a family|0
1797905|NCT00545103|6253743|P1|Overall Study|Wish to start a family|0
1797906|NCT00545103|6253740|P4|Overall Study|Investigational product not taken|1
1797907|NCT00545103|6253741|P3|Overall Study|Investigational product not taken|0
1797908|NCT00545103|6253742|P2|Overall Study|Investigational product not taken|0
1797909|NCT00545103|6253743|P1|Overall Study|Investigational product not taken|1
1797910|NCT00545103|6253740|P4|Overall Study|Difficult to open package|1
1797911|NCT00545103|6253741|P3|Overall Study|Difficult to open package|0
1797912|NCT00545103|6253742|P2|Overall Study|Difficult to open package|0
1797913|NCT00545103|6253743|P1|Overall Study|Difficult to open package|0
1797914|NCT00545103|6253740|P4|Overall Study|Suspected recurrence of diverticulitis|3
1797915|NCT00545103|6253741|P3|Overall Study|Suspected recurrence of diverticulitis|0
1797916|NCT00545103|6253742|P2|Overall Study|Suspected recurrence of diverticulitis|0
1797917|NCT00545103|6253743|P1|Overall Study|Suspected recurrence of diverticulitis|1
1797918|NCT00545103|6253740|P4|Overall Study|Protocol Violation|0
1797919|NCT00545103|6253741|P3|Overall Study|Protocol Violation|3
1797920|NCT00545103|6253742|P2|Overall Study|Protocol Violation|2
1797921|NCT00545103|6253743|P1|Overall Study|Protocol Violation|1
1797922|NCT00545103|6253740|P4|Overall Study|Lost to Follow-up|4
1797923|NCT00545103|6253741|P3|Overall Study|Lost to Follow-up|3
1797924|NCT00545103|6253742|P2|Overall Study|Lost to Follow-up|6
1797925|NCT00545103|6253743|P1|Overall Study|Lost to Follow-up|4
1797926|NCT00545103|6253740|P4|Overall Study|Adverse Event|10
1797927|NCT00545103|6253741|P3|Overall Study|Adverse Event|17
1797928|NCT00545103|6253742|P2|Overall Study|Adverse Event|12
1797929|NCT00545103|6253743|P1|Overall Study|Adverse Event|11
1797930|NCT00545103|6253740|P4|Overall Study|Withdrawal by Subject|22
1797931|NCT00545103|6253741|P3|Overall Study|Withdrawal by Subject|18
1797932|NCT00545103|6253742|P2|Overall Study|Withdrawal by Subject|10
1797933|NCT00545103|6253743|P1|Overall Study|Withdrawal by Subject|6
1797934|NCT00545103|6253740|P4|Overall Study|Lack of Efficacy|27
1797935|NCT00545103|6253741|P3|Overall Study|Lack of Efficacy|31
1797936|NCT00545103|6253742|P2|Overall Study|Lack of Efficacy|45
1797937|NCT00545103|6253743|P1|Overall Study|Lack of Efficacy|48
1797938|NCT00545077|6253779|P2|Overall Study|Death|8
1797939|NCT00545077|6253780|P1|Overall Study|Death|0
1797940|NCT00545077|6253779|P2|Overall Study|Adverse Event|31
1797941|NCT00545077|6253780|P1|Overall Study|Adverse Event|0
1797942|NCT00545077|6253779|P2|Overall Study|Protocol Violation|0
1797943|NCT00545077|6253780|P1|Overall Study|Protocol Violation|1
1797944|NCT00545077|6253779|P2|Overall Study|Lost to Follow-up|0
1797945|NCT00545077|6253780|P1|Overall Study|Lost to Follow-up|2
1797946|NCT00545077|6253779|P2|Overall Study|Physician Decision|3
1797947|NCT00545077|6253780|P1|Overall Study|Physician Decision|6
1797948|NCT00545077|6253779|P2|Overall Study|Withdrawal by Subject|14
1797949|NCT00545077|6253780|P1|Overall Study|Withdrawal by Subject|3
1797950|NCT00545077|6253779|P2|Overall Study|Disease Progression|98
1797951|NCT00545077|6253780|P1|Overall Study|Disease Progression|131
1797952|NCT00545077|6253779|P2|Overall Study|Treatment not received|1
1797953|NCT00545077|6253780|P1|Overall Study|Treatment not received|5
1797954|NCT00545064|6253796|P1|Overall Study|inclement weather|1
1797955|NCT00545064|6253796|P1|Overall Study|cancel all appointments, no rebooking|1
1797956|NCT00545064|6253796|P1|Overall Study|did not complete course of treatment|1
1797957|NCT00545064|6253796|P1|Overall Study|Withdrawal by Subject|2
1797958|NCT00545064|6253796|P1|Overall Study|Lost to Follow-up|3
1797959|NCT00545051|6253807|P2|Overall Study|Administrative reasons|1
1797960|NCT00545051|6253808|P1|Overall Study|Administrative reasons|0
1797961|NCT00545051|6253807|P2|Overall Study|Withdrawal by Subject|1
1797962|NCT00545051|6253808|P1|Overall Study|Withdrawal by Subject|0
1797963|NCT00545051|6253807|P2|Overall Study|Protocol Violation|0
1797964|NCT00545051|6253808|P1|Overall Study|Protocol Violation|1
1797965|NCT00545051|6253807|P2|Overall Study|Violation of inclusion/exclusion|2
1797966|NCT00545051|6253808|P1|Overall Study|Violation of inclusion/exclusion|0
1797967|NCT00545051|6253807|P2|Overall Study|Death|0
1797968|NCT00545051|6253808|P1|Overall Study|Death|1
1797969|NCT00545051|6253807|P2|Overall Study|Adverse Event|3
1797970|NCT00545051|6253808|P1|Overall Study|Adverse Event|7
1797971|NCT00544882|6253852|P3|Cycle 3: Follow-up|Pregnancy|0
1797972|NCT00544882|6253853|P2|Cycle 3: Follow-up|Pregnancy|1
1797973|NCT00544882|6253854|P1|Cycle 3: Follow-up|Pregnancy|0
1797974|NCT00544882|6253852|P3|Cycle 3: Follow-up|Noncompliance|0
1797975|NCT00544882|6253853|P2|Cycle 3: Follow-up|Noncompliance|1
1797976|NCT00544882|6253854|P1|Cycle 3: Follow-up|Noncompliance|0
1797977|NCT00544882|6253852|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
1797978|NCT00544882|6253853|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
1797979|NCT00544882|6253854|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
1797980|NCT00544882|6253852|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
1797981|NCT00544882|6253853|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
1797982|NCT00544882|6253854|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
1797983|NCT00544882|6253852|P3|Cycle 1: Run-in Cycle|Adverse Event|0
1797984|NCT00544882|6253853|P2|Cycle 1: Run-in Cycle|Adverse Event|0
1797985|NCT00544882|6253854|P1|Cycle 1: Run-in Cycle|Adverse Event|1
1797986|NCT00544882|6253852|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
1797987|NCT00544882|6253853|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
1797988|NCT00544882|6253854|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
1797989|NCT00544869|6253879|P3|Overall Study|Physician Decision|0
1797990|NCT00544869|6253880|P2|Overall Study|Physician Decision|0
1797991|NCT00544869|6253881|P1|Overall Study|Physician Decision|2
1797992|NCT00544869|6253879|P3|Overall Study|Lack of Efficacy|0
1797993|NCT00544869|6253880|P2|Overall Study|Lack of Efficacy|1
1797994|NCT00544869|6253881|P1|Overall Study|Lack of Efficacy|1
1797995|NCT00544869|6253879|P3|Overall Study|Adverse Event|0
1797996|NCT00544869|6253880|P2|Overall Study|Adverse Event|1
1797997|NCT00544869|6253881|P1|Overall Study|Adverse Event|6
1797998|NCT00544869|6253879|P3|Overall Study|Rsolution of congenitive symptoms|0
1797999|NCT00544869|6253880|P2|Overall Study|Rsolution of congenitive symptoms|0
1798000|NCT00544869|6253881|P1|Overall Study|Rsolution of congenitive symptoms|3
1798001|NCT00544817|6253889|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
1798002|NCT00544817|6253889|P1|Follow-up Systemic Therapy|Physician Decision|3
1798003|NCT00544817|6253889|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
1798004|NCT00544817|6253889|P1|No Treatment Interval|Adverse Event|1
1798005|NCT00544817|6253889|P1|No Treatment Interval|Physician Decision|3
1798006|NCT00544817|6253889|P1|No Treatment Interval|Lack of Efficacy|8
1798007|NCT00544817|6253889|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
1798008|NCT00544817|6253889|P1|Combined Modality|Adverse Event|2
1798009|NCT00544817|6253889|P1|Combined Modality|Worsening Neurologic Symptoms|2
1798010|NCT00544817|6253889|P1|Combined Modality|Lack of Efficacy|2
1798011|NCT00544648|6253938|P2|Overall Study|progression of disease|0
1798012|NCT00544648|6253939|P1|Overall Study|progression of disease|1
1798013|NCT00544648|6253938|P2|Overall Study|Adverse Event|1
1798014|NCT00544648|6253939|P1|Overall Study|Adverse Event|1
1798015|NCT00544648|6253938|P2|Overall Study|Withdrawal by Subject|0
1798016|NCT00544648|6253939|P1|Overall Study|Withdrawal by Subject|1
1798017|NCT00544557|6253953|P1|Overall Study|Other|98
1798018|NCT00544557|6253953|P1|Overall Study|Lack of Efficacy|196
1798019|NCT00544557|6253953|P1|Overall Study|Adverse Event|140
1798020|NCT00544544|6253984|P1|Overall Study|Lost to Follow-up|1
1798021|NCT00544544|6253984|P1|Overall Study|Adverse Event|1
1798022|NCT00544544|6253984|P1|Overall Study|Withdrawal by Subject|1
1798023|NCT00544440|6253991|P1|Overall Study|Other|5
1798024|NCT00544440|6253991|P1|Overall Study|Progressive Disease|47
1798025|NCT00544440|6253991|P1|Overall Study|Subject Non-compliance|1
1798026|NCT00544440|6253991|P1|Overall Study|Withdrawal by Subject|2
1798027|NCT00544440|6253991|P1|Overall Study|Adverse Event|1
1798028|NCT00544440|6253991|P1|Overall Study|Other|1
1798029|NCT00544167|6253998|P1|Overall Study|Physician Decision|8
1798030|NCT00544167|6253998|P1|Overall Study|Adverse Event|21
1798031|NCT00543985|6254024|P1|Overall Study|Withdrawal by Subject|4
1798032|NCT00543855|6254035|P4|Overall Study|Protocol Violation|0
1798033|NCT00543855|6254036|P3|Overall Study|Protocol Violation|0
1798034|NCT00543855|6254037|P2|Overall Study|Protocol Violation|0
1798035|NCT00543855|6254038|P1|Overall Study|Protocol Violation|1
1798036|NCT00543855|6254035|P4|Overall Study|Withdrawal by Subject|0
1798037|NCT00543855|6254036|P3|Overall Study|Withdrawal by Subject|2
1798038|NCT00543855|6254037|P2|Overall Study|Withdrawal by Subject|1
1798039|NCT00543855|6254038|P1|Overall Study|Withdrawal by Subject|0
1798040|NCT00543855|6254035|P4|Overall Study|Lost to Follow-up|0
1798041|NCT00543855|6254036|P3|Overall Study|Lost to Follow-up|1
1798042|NCT00543855|6254037|P2|Overall Study|Lost to Follow-up|0
1798043|NCT00543855|6254038|P1|Overall Study|Lost to Follow-up|0
1798044|NCT00543855|6254035|P4|Overall Study|Adverse Event|4
1798045|NCT00543855|6254036|P3|Overall Study|Adverse Event|3
1798046|NCT00543855|6254037|P2|Overall Study|Adverse Event|1
1798047|NCT00543855|6254038|P1|Overall Study|Adverse Event|3
1798048|NCT00543803|6254060|P1|Overall Study|Other|86
1798049|NCT00543803|6254060|P1|Overall Study|Lost to Follow-up|20
1798050|NCT00543803|6254060|P1|Overall Study|Lack of Efficacy|22
1798051|NCT00543803|6254060|P1|Overall Study|Adverse Event|14
1798052|NCT00543725|6254088|P2|Overall Study|Other|3
1798053|NCT00543725|6254089|P1|Overall Study|Other|3
1798054|NCT00543725|6254088|P2|Overall Study|Lost to Follow-up|11
1798055|NCT00543725|6254089|P1|Overall Study|Lost to Follow-up|15
1798056|NCT00543725|6254088|P2|Overall Study|Withdrawal by Subject|13
1798057|NCT00543725|6254089|P1|Overall Study|Withdrawal by Subject|4
1798058|NCT00543725|6254088|P2|Overall Study|Protocol Violation|1
1798059|NCT00543725|6254089|P1|Overall Study|Protocol Violation|0
1798060|NCT00543725|6254088|P2|Overall Study|Subject Reached A Virologic Endpoint|14
1798061|NCT00543725|6254089|P1|Overall Study|Subject Reached A Virologic Endpoint|22
1798062|NCT00543725|6254088|P2|Overall Study|Subject Ineligible To Continue The Trial|0
1798063|NCT00543725|6254089|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1798064|NCT00543725|6254088|P2|Overall Study|Subject Non-Compliant|4
1798065|NCT00543725|6254089|P1|Overall Study|Subject Non-Compliant|4
1798066|NCT00543725|6254088|P2|Overall Study|Sponsor's Decision|1
1798067|NCT00543725|6254089|P1|Overall Study|Sponsor's Decision|0
1798068|NCT00543725|6254088|P2|Overall Study|Adverse Event|27
1798069|NCT00543725|6254089|P1|Overall Study|Adverse Event|18
1798070|NCT00543569|6254115|P4|Overall Study|Randomized but never received study drug|3
1798071|NCT00543569|6254116|P3|Overall Study|Randomized but never received study drug|5
1798072|NCT00543569|6254117|P2|Overall Study|Randomized but never received study drug|3
1798073|NCT00543569|6254118|P1|Overall Study|Randomized but never received study drug|3
1798074|NCT00543569|6254115|P4|Overall Study|Miscellaneous Reasons|4
1798075|NCT00543569|6254116|P3|Overall Study|Miscellaneous Reasons|11
1798076|NCT00543569|6254117|P2|Overall Study|Miscellaneous Reasons|3
1798077|NCT00543569|6254118|P1|Overall Study|Miscellaneous Reasons|7
1798078|NCT00543569|6254115|P4|Overall Study|Lost to Follow-up|1
1798079|NCT00543569|6254116|P3|Overall Study|Lost to Follow-up|1
1798080|NCT00543569|6254117|P2|Overall Study|Lost to Follow-up|0
1798081|NCT00543569|6254118|P1|Overall Study|Lost to Follow-up|0
1798082|NCT00543569|6254115|P4|Overall Study|Death|1
1798083|NCT00543569|6254116|P3|Overall Study|Death|3
1798084|NCT00543569|6254117|P2|Overall Study|Death|2
1798085|NCT00543569|6254118|P1|Overall Study|Death|2
1798086|NCT00543543|6254224|P4|Extension Study|Withdrawal by Subject|120
1798087|NCT00543543|6254225|P3|Extension Study|Withdrawal by Subject|0
1798088|NCT00543543|6254226|P2|Extension Study|Withdrawal by Subject|0
1798089|NCT00543543|6254227|P1|Extension Study|Withdrawal by Subject|0
1798090|NCT00543543|6254224|P4|Extension Study|Protocol Violation|11
1798091|NCT00543543|6254225|P3|Extension Study|Protocol Violation|0
1798092|NCT00543543|6254226|P2|Extension Study|Protocol Violation|0
1798093|NCT00543543|6254227|P1|Extension Study|Protocol Violation|0
1798094|NCT00543543|6254224|P4|Extension Study|Pregnancy|6
1798095|NCT00543543|6254225|P3|Extension Study|Pregnancy|0
1798096|NCT00543543|6254226|P2|Extension Study|Pregnancy|0
1798097|NCT00543543|6254227|P1|Extension Study|Pregnancy|0
1798098|NCT00543543|6254224|P4|Extension Study|Physician Decision|7
1798099|NCT00543543|6254225|P3|Extension Study|Physician Decision|0
1798100|NCT00543543|6254226|P2|Extension Study|Physician Decision|0
1798101|NCT00543543|6254227|P1|Extension Study|Physician Decision|0
1798102|NCT00543543|6254224|P4|Extension Study|Lost to Follow-up|77
1798103|NCT00543543|6254225|P3|Extension Study|Lost to Follow-up|0
1798104|NCT00543543|6254226|P2|Extension Study|Lost to Follow-up|0
1798105|NCT00543543|6254227|P1|Extension Study|Lost to Follow-up|0
1798106|NCT00543543|6254224|P4|Extension Study|Adverse Event|5
1798107|NCT00543543|6254225|P3|Extension Study|Adverse Event|0
1798108|NCT00543543|6254226|P2|Extension Study|Adverse Event|0
1798109|NCT00543543|6254227|P1|Extension Study|Adverse Event|0
1798110|NCT00543543|6254224|P4|Base Study|Withdrawal by Subject|503
1798111|NCT00543543|6254225|P3|Base Study|Withdrawal by Subject|5
1798112|NCT00543543|6254226|P2|Base Study|Withdrawal by Subject|482
1798113|NCT00543543|6254227|P1|Base Study|Withdrawal by Subject|7
1798114|NCT00543543|6254224|P4|Base Study|Protocol Violation|6
1798115|NCT00543543|6254225|P3|Base Study|Protocol Violation|0
1798116|NCT00543543|6254226|P2|Base Study|Protocol Violation|6
1798117|NCT00543543|6254227|P1|Base Study|Protocol Violation|0
1798118|NCT00543543|6254224|P4|Base Study|Physician Decision|7
1798119|NCT00543543|6254225|P3|Base Study|Physician Decision|0
1798120|NCT00543543|6254226|P2|Base Study|Physician Decision|4
1798121|NCT00543543|6254227|P1|Base Study|Physician Decision|0
1798122|NCT00543543|6254224|P4|Base Study|Lost to Follow-up|701
1798123|NCT00543543|6254225|P3|Base Study|Lost to Follow-up|9
1798124|NCT00543543|6254226|P2|Base Study|Lost to Follow-up|749
1798125|NCT00543543|6254227|P1|Base Study|Lost to Follow-up|12
1798126|NCT00543543|6254224|P4|Base Study|Adverse Event|5
1798127|NCT00543543|6254225|P3|Base Study|Adverse Event|0
1798128|NCT00543543|6254226|P2|Base Study|Adverse Event|11
1798129|NCT00543543|6254227|P1|Base Study|Adverse Event|1
1798130|NCT00543439|6254271|P3|Period 2|Adverse Event|1
1798131|NCT00543439|6254272|P2|Period 2|Adverse Event|1
1798132|NCT00543439|6254273|P1|Period 2|Adverse Event|0
1798133|NCT00543439|6254271|P3|Period 2|Protocol Violation|1
1798134|NCT00543439|6254272|P2|Period 2|Protocol Violation|0
1798135|NCT00543439|6254273|P1|Period 2|Protocol Violation|1
1798136|NCT00543439|6254271|P3|Period 1|Physician Decision|1
1798137|NCT00543439|6254272|P2|Period 1|Physician Decision|0
1798138|NCT00543439|6254273|P1|Period 1|Physician Decision|0
1798139|NCT00543439|6254271|P3|Period 1|Withdrawal by Subject|0
1798140|NCT00543439|6254272|P2|Period 1|Withdrawal by Subject|1
1798141|NCT00543439|6254273|P1|Period 1|Withdrawal by Subject|1
1798142|NCT00543439|6254271|P3|Period 1|Adverse Event|1
1798143|NCT00543439|6254272|P2|Period 1|Adverse Event|2
1798144|NCT00543439|6254273|P1|Period 1|Adverse Event|0
1798145|NCT00543387|6254342|P11|Crossover Participants|Study Terminated by Sponsor|1
1798146|NCT00543387|6254343|P10|Crossover Participants|Study Terminated by Sponsor|0
1798147|NCT00543387|6254344|P9|Crossover Participants|Study Terminated by Sponsor|0
1798148|NCT00543387|6254345|P8|Crossover Participants|Study Terminated by Sponsor|0
1798149|NCT00543387|6254346|P7|Crossover Participants|Study Terminated by Sponsor|0
1798150|NCT00543387|6254347|P6|Crossover Participants|Study Terminated by Sponsor|0
1798151|NCT00543387|6254348|P5|Crossover Participants|Study Terminated by Sponsor|0
1798152|NCT00543387|6254349|P4|Crossover Participants|Study Terminated by Sponsor|0
1798153|NCT00543387|6254350|P3|Crossover Participants|Study Terminated by Sponsor|0
1798154|NCT00543387|6254351|P2|Crossover Participants|Study Terminated by Sponsor|0
1798155|NCT00543387|6254352|P1|Crossover Participants|Study Terminated by Sponsor|0
1798156|NCT00543387|6254342|P11|Crossover Participants|Progressive Disease|2
1798157|NCT00543387|6254343|P10|Crossover Participants|Progressive Disease|1
1798158|NCT00543387|6254344|P9|Crossover Participants|Progressive Disease|0
1798159|NCT00543387|6254345|P8|Crossover Participants|Progressive Disease|0
1798160|NCT00543387|6254346|P7|Crossover Participants|Progressive Disease|0
1798161|NCT00543387|6254347|P6|Crossover Participants|Progressive Disease|0
1798162|NCT00543387|6254348|P5|Crossover Participants|Progressive Disease|0
1798163|NCT00543387|6254349|P4|Crossover Participants|Progressive Disease|0
1798164|NCT00543387|6254350|P3|Crossover Participants|Progressive Disease|0
1798165|NCT00543387|6254351|P2|Crossover Participants|Progressive Disease|0
1798166|NCT00543387|6254352|P1|Crossover Participants|Progressive Disease|0
1798167|NCT00543387|6254342|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
1798168|NCT00543387|6254343|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
1798169|NCT00543387|6254344|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
1798170|NCT00543387|6254345|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
1798171|NCT00543387|6254346|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
1798172|NCT00543387|6254347|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
1798173|NCT00543387|6254348|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
1798174|NCT00543387|6254349|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
1798175|NCT00543387|6254350|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
1798176|NCT00543387|6254351|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
1798177|NCT00543387|6254352|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
1798178|NCT00543387|6254342|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
1798179|NCT00543387|6254343|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
1798180|NCT00543387|6254344|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
1798181|NCT00543387|6254345|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
1798182|NCT00543387|6254346|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
1798183|NCT00543387|6254347|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
1798184|NCT00543387|6254348|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
1798185|NCT00543387|6254349|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
1798186|NCT00543387|6254350|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
1798187|NCT00543387|6254351|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
1798188|NCT00543387|6254352|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
1798189|NCT00543387|6254342|P11|Panel 1 + Panel 2|Physician Decision|0
1798190|NCT00543387|6254343|P10|Panel 1 + Panel 2|Physician Decision|0
1798191|NCT00543387|6254344|P9|Panel 1 + Panel 2|Physician Decision|0
1798192|NCT00543387|6254345|P8|Panel 1 + Panel 2|Physician Decision|1
1798193|NCT00543387|6254346|P7|Panel 1 + Panel 2|Physician Decision|0
1798194|NCT00543387|6254347|P6|Panel 1 + Panel 2|Physician Decision|0
1798195|NCT00543387|6254348|P5|Panel 1 + Panel 2|Physician Decision|0
1798196|NCT00543387|6254349|P4|Panel 1 + Panel 2|Physician Decision|0
1798197|NCT00543387|6254350|P3|Panel 1 + Panel 2|Physician Decision|1
1798198|NCT00543387|6254351|P2|Panel 1 + Panel 2|Physician Decision|0
1798199|NCT00543387|6254352|P1|Panel 1 + Panel 2|Physician Decision|0
1798200|NCT00543387|6254342|P11|Panel 1 + Panel 2|Adverse Event|0
1798201|NCT00543387|6254343|P10|Panel 1 + Panel 2|Adverse Event|0
1798202|NCT00543387|6254344|P9|Panel 1 + Panel 2|Adverse Event|1
1798203|NCT00543387|6254345|P8|Panel 1 + Panel 2|Adverse Event|1
1798204|NCT00543387|6254346|P7|Panel 1 + Panel 2|Adverse Event|0
1798205|NCT00543387|6254347|P6|Panel 1 + Panel 2|Adverse Event|0
1798206|NCT00543387|6254348|P5|Panel 1 + Panel 2|Adverse Event|0
1798207|NCT00543387|6254349|P4|Panel 1 + Panel 2|Adverse Event|0
1798208|NCT00543387|6254350|P3|Panel 1 + Panel 2|Adverse Event|0
1798209|NCT00543387|6254351|P2|Panel 1 + Panel 2|Adverse Event|1
1798210|NCT00543387|6254352|P1|Panel 1 + Panel 2|Adverse Event|0
1798211|NCT00543309|6254390|P3|Overall Study|Physician Decision|0
1798212|NCT00543309|6254391|P2|Overall Study|Physician Decision|1
1798213|NCT00543309|6254392|P1|Overall Study|Physician Decision|0
1798214|NCT00543296|6254442|P1|Overall Study|Physician Decision|7
1798215|NCT00543140|6254449|P1|Overall Study|Conversion to different procedure|1
1798216|NCT00543140|6254449|P1|Overall Study|Subject moved|1
1798217|NCT00543140|6254449|P1|Overall Study|Death|1
1798218|NCT00543140|6254449|P1|Overall Study|SAE leading to explant of SAGB|3
1798219|NCT00543140|6254449|P1|Overall Study|Insufficient weight loss|10
1798220|NCT00543140|6254449|P1|Overall Study|Protocol Violation|10
1798221|NCT00543140|6254449|P1|Overall Study|Withdrawal by Subject|13
1798222|NCT00543140|6254449|P1|Overall Study|Lost to Follow-up|33
1798223|NCT00543062|6254487|P4|Overall Study|Protocol Violation|0
1798224|NCT00543062|6254488|P3|Overall Study|Protocol Violation|0
1798225|NCT00543062|6254489|P2|Overall Study|Protocol Violation|0
1798226|NCT00543062|6254490|P1|Overall Study|Protocol Violation|1
1798227|NCT00543062|6254487|P4|Overall Study|Adverse Event|1
1798228|NCT00543062|6254488|P3|Overall Study|Adverse Event|1
1798229|NCT00543062|6254489|P2|Overall Study|Adverse Event|1
1798230|NCT00543062|6254490|P1|Overall Study|Adverse Event|0
1798231|NCT00543062|6254487|P4|Overall Study|Withdrawal by Subject|0
1798232|NCT00543062|6254488|P3|Overall Study|Withdrawal by Subject|2
1798233|NCT00543062|6254489|P2|Overall Study|Withdrawal by Subject|0
1798234|NCT00543062|6254490|P1|Overall Study|Withdrawal by Subject|1
1798235|NCT00542997|6254512|P1|Efficacy Period|Adverse Event|3
1798236|NCT00542997|6254512|P1|Wash in / Wash Out Period|Adverse Event|3
1798237|NCT00542997|6254512|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
1798238|NCT00542880|6254534|P2|Period 3|Adverse Event|2
1798239|NCT00542880|6254535|P1|Period 3|Adverse Event|0
1798240|NCT00542880|6254534|P2|Period 2|Other|1
1798241|NCT00542880|6254535|P1|Period 2|Other|0
1798242|NCT00542880|6254534|P2|Period 2|Severe non-compliance|1
1798243|NCT00542880|6254535|P1|Period 2|Severe non-compliance|0
1798244|NCT00542880|6254534|P2|Period 2|Discontinuation criteria|0
1798245|NCT00542880|6254535|P1|Period 2|Discontinuation criteria|2
1798246|NCT00542880|6254534|P2|Period 2|Eligibility not fulfilled|1
1798247|NCT00542880|6254535|P1|Period 2|Eligibility not fulfilled|0
1798248|NCT00542880|6254534|P2|Period 2|Adverse Event|7
1798249|NCT00542880|6254535|P1|Period 2|Adverse Event|5
1798250|NCT00542880|6254534|P2|Period 1|Protocol Violation|1
1798251|NCT00542880|6254535|P1|Period 1|Protocol Violation|0
1798252|NCT00542880|6254534|P2|Period 1|Withdrawal by Subject|1
1798253|NCT00542880|6254535|P1|Period 1|Withdrawal by Subject|1
1798254|NCT00542880|6254534|P2|Period 1|Development of study-specific criteria|2
1798255|NCT00542880|6254535|P1|Period 1|Development of study-specific criteria|1
1798256|NCT00542880|6254534|P2|Period 1|Adverse Event|2
1798257|NCT00542880|6254535|P1|Period 1|Adverse Event|2
1798258|NCT00542880|6254534|P2|Period 1|Eligibility criteria not fulfilled|6
1798259|NCT00542880|6254535|P1|Period 1|Eligibility criteria not fulfilled|2
1798260|NCT00542828|6254571|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
1798261|NCT00542828|6254571|P1|Overall Study|Study Prematurely Discontinued|7
1798262|NCT00542828|6254571|P1|Overall Study|Need for Prohibited Treatment|3
1798263|NCT00542828|6254571|P1|Overall Study|Physician Decision|1
1798264|NCT00542815|6254589|P3|Overall Study|Other reasons|10
1798265|NCT00542815|6254590|P2|Overall Study|Other reasons|10
1798266|NCT00542815|6254591|P1|Overall Study|Other reasons|24
1798267|NCT00542815|6254589|P3|Overall Study|Withdrawal by Subject|8
1798268|NCT00542815|6254590|P2|Overall Study|Withdrawal by Subject|5
1798269|NCT00542815|6254591|P1|Overall Study|Withdrawal by Subject|41
1798270|NCT00542815|6254589|P3|Overall Study|Protocol Violation|2
1798271|NCT00542815|6254590|P2|Overall Study|Protocol Violation|1
1798272|NCT00542815|6254591|P1|Overall Study|Protocol Violation|1
1798273|NCT00542815|6254589|P3|Overall Study|Physician Decision|0
1798274|NCT00542815|6254590|P2|Overall Study|Physician Decision|1
1798275|NCT00542815|6254591|P1|Overall Study|Physician Decision|2
1798276|NCT00542815|6254589|P3|Overall Study|Lack of Efficacy|0
1798277|NCT00542815|6254590|P2|Overall Study|Lack of Efficacy|2
1798278|NCT00542815|6254591|P1|Overall Study|Lack of Efficacy|9
1798279|NCT00542815|6254589|P3|Overall Study|Death|3
1798280|NCT00542815|6254590|P2|Overall Study|Death|7
1798281|NCT00542815|6254591|P1|Overall Study|Death|10
1798282|NCT00542815|6254589|P3|Overall Study|Adverse Event|9
1798283|NCT00542815|6254590|P2|Overall Study|Adverse Event|6
1798284|NCT00542815|6254591|P1|Overall Study|Adverse Event|19
1798285|NCT00542789|6254604|P2|Overall Study|Recurrence of Gastric Ulcer|57
1798286|NCT00542789|6254605|P1|Overall Study|Recurrence of Gastric Ulcer|8
1798287|NCT00542789|6254604|P2|Overall Study|Protocol Violation|1
1798288|NCT00542789|6254605|P1|Overall Study|Protocol Violation|8
1798289|NCT00542789|6254604|P2|Overall Study|Withdrawal by Subject|3
1798290|NCT00542789|6254605|P1|Overall Study|Withdrawal by Subject|7
1798291|NCT00542789|6254604|P2|Overall Study|Adverse Event|17
1798292|NCT00542789|6254605|P1|Overall Study|Adverse Event|18
1798293|NCT00542425|6254705|P5|Extended 24 Weeks of Treatment|Other|1
1798294|NCT00542425|6254706|P4|Extended 24 Weeks of Treatment|Other|0
1798295|NCT00542425|6254707|P3|Extended 24 Weeks of Treatment|Other|0
1798296|NCT00542425|6254708|P2|Extended 24 Weeks of Treatment|Other|1
1798297|NCT00542425|6254709|P1|Extended 24 Weeks of Treatment|Other|1
1798298|NCT00542425|6254705|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
1798299|NCT00542425|6254706|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
1798300|NCT00542425|6254707|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
1798301|NCT00542425|6254708|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
1798302|NCT00542425|6254709|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
1798303|NCT00542425|6254705|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
1798304|NCT00542425|6254706|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
1798305|NCT00542425|6254707|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
1798306|NCT00542425|6254708|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
1798307|NCT00542425|6254709|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
1798308|NCT00542425|6254705|P5|Extended 24 Weeks of Treatment|Adverse Event|0
1798309|NCT00542425|6254706|P4|Extended 24 Weeks of Treatment|Adverse Event|1
1798310|NCT00542425|6254707|P3|Extended 24 Weeks of Treatment|Adverse Event|1
1798311|NCT00542425|6254708|P2|Extended 24 Weeks of Treatment|Adverse Event|0
1798312|NCT00542425|6254709|P1|Extended 24 Weeks of Treatment|Adverse Event|0
1798313|NCT00542425|6254705|P5|Initial 24 Weeks|Other|0
1798314|NCT00542425|6254706|P4|Initial 24 Weeks|Other|0
1798315|NCT00542425|6254707|P3|Initial 24 Weeks|Other|1
1798316|NCT00542425|6254708|P2|Initial 24 Weeks|Other|2
1798317|NCT00542425|6254709|P1|Initial 24 Weeks|Other|0
1798318|NCT00542425|6254705|P5|Initial 24 Weeks|Refusal of treatment|1
1798319|NCT00542425|6254706|P4|Initial 24 Weeks|Refusal of treatment|4
1798320|NCT00542425|6254707|P3|Initial 24 Weeks|Refusal of treatment|1
1798321|NCT00542425|6254708|P2|Initial 24 Weeks|Refusal of treatment|2
1798322|NCT00542425|6254709|P1|Initial 24 Weeks|Refusal of treatment|2
1798323|NCT00542425|6254705|P5|Initial 24 Weeks|Protocol Violation|0
1798324|NCT00542425|6254706|P4|Initial 24 Weeks|Protocol Violation|1
1798325|NCT00542425|6254707|P3|Initial 24 Weeks|Protocol Violation|0
1798326|NCT00542425|6254708|P2|Initial 24 Weeks|Protocol Violation|0
1798327|NCT00542425|6254709|P1|Initial 24 Weeks|Protocol Violation|0
1798328|NCT00542425|6254705|P5|Initial 24 Weeks|Non-compliance|1
1798329|NCT00542425|6254706|P4|Initial 24 Weeks|Non-compliance|1
1798330|NCT00542425|6254707|P3|Initial 24 Weeks|Non-compliance|0
1798331|NCT00542425|6254708|P2|Initial 24 Weeks|Non-compliance|0
1798332|NCT00542425|6254709|P1|Initial 24 Weeks|Non-compliance|0
1798333|NCT00542425|6254705|P5|Initial 24 Weeks|Lost to Follow-up|0
1798334|NCT00542425|6254706|P4|Initial 24 Weeks|Lost to Follow-up|0
1798335|NCT00542425|6254707|P3|Initial 24 Weeks|Lost to Follow-up|1
1798336|NCT00542425|6254708|P2|Initial 24 Weeks|Lost to Follow-up|2
1798337|NCT00542425|6254709|P1|Initial 24 Weeks|Lost to Follow-up|2
1798338|NCT00542425|6254705|P5|Initial 24 Weeks|Inability to complete procedures|2
1798339|NCT00542425|6254706|P4|Initial 24 Weeks|Inability to complete procedures|1
1798340|NCT00542425|6254707|P3|Initial 24 Weeks|Inability to complete procedures|2
1798341|NCT00542425|6254708|P2|Initial 24 Weeks|Inability to complete procedures|3
1798342|NCT00542425|6254709|P1|Initial 24 Weeks|Inability to complete procedures|0
1798343|NCT00542425|6254705|P5|Initial 24 Weeks|Adverse Event|2
1798344|NCT00542425|6254706|P4|Initial 24 Weeks|Adverse Event|3
1798345|NCT00542425|6254707|P3|Initial 24 Weeks|Adverse Event|1
1798346|NCT00542425|6254708|P2|Initial 24 Weeks|Adverse Event|1
1798347|NCT00542425|6254709|P1|Initial 24 Weeks|Adverse Event|0
1798348|NCT00542425|6254705|P5|Initial 24 Weeks|Administrative reasons|0
1798349|NCT00542425|6254706|P4|Initial 24 Weeks|Administrative reasons|1
1798350|NCT00542425|6254707|P3|Initial 24 Weeks|Administrative reasons|1
1798351|NCT00542425|6254708|P2|Initial 24 Weeks|Administrative reasons|0
1798352|NCT00542425|6254709|P1|Initial 24 Weeks|Administrative reasons|0
1798353|NCT00542386|6254747|P6|Overall Study|Other Reasons|2
1798354|NCT00542386|6254748|P5|Overall Study|Other Reasons|4
1798355|NCT00542386|6254749|P4|Overall Study|Other Reasons|3
1798356|NCT00542386|6254750|P3|Overall Study|Other Reasons|4
1798357|NCT00542386|6254751|P2|Overall Study|Other Reasons|1
1798358|NCT00542386|6254752|P1|Overall Study|Other Reasons|4
1798359|NCT00542386|6254747|P6|Overall Study|Withdrawal by Subject|7
1798360|NCT00542386|6254748|P5|Overall Study|Withdrawal by Subject|15
1798361|NCT00542386|6254749|P4|Overall Study|Withdrawal by Subject|11
1798362|NCT00542386|6254750|P3|Overall Study|Withdrawal by Subject|10
1798363|NCT00542386|6254751|P2|Overall Study|Withdrawal by Subject|8
1798364|NCT00542386|6254752|P1|Overall Study|Withdrawal by Subject|5
1798365|NCT00542386|6254747|P6|Overall Study|Protocol Violation|4
1798366|NCT00542386|6254748|P5|Overall Study|Protocol Violation|0
1798367|NCT00542386|6254749|P4|Overall Study|Protocol Violation|0
1798368|NCT00542386|6254750|P3|Overall Study|Protocol Violation|1
1798369|NCT00542386|6254751|P2|Overall Study|Protocol Violation|0
1798370|NCT00542386|6254752|P1|Overall Study|Protocol Violation|0
1798371|NCT00542386|6254747|P6|Overall Study|Physician Decision|0
1798372|NCT00542386|6254748|P5|Overall Study|Physician Decision|0
1798373|NCT00542386|6254749|P4|Overall Study|Physician Decision|1
1798374|NCT00542386|6254750|P3|Overall Study|Physician Decision|0
1798375|NCT00542386|6254751|P2|Overall Study|Physician Decision|0
1798376|NCT00542386|6254752|P1|Overall Study|Physician Decision|1
1798377|NCT00542386|6254747|P6|Overall Study|Lack of Efficacy|31
1798378|NCT00542386|6254748|P5|Overall Study|Lack of Efficacy|7
1798379|NCT00542386|6254749|P4|Overall Study|Lack of Efficacy|13
1798380|NCT00542386|6254750|P3|Overall Study|Lack of Efficacy|10
1798381|NCT00542386|6254751|P2|Overall Study|Lack of Efficacy|12
1798382|NCT00542386|6254752|P1|Overall Study|Lack of Efficacy|32
1798383|NCT00542386|6254747|P6|Overall Study|Death|2
1798384|NCT00542386|6254748|P5|Overall Study|Death|1
1798385|NCT00542386|6254749|P4|Overall Study|Death|2
1798386|NCT00542386|6254750|P3|Overall Study|Death|1
1798387|NCT00542386|6254751|P2|Overall Study|Death|0
1798388|NCT00542386|6254752|P1|Overall Study|Death|0
1798389|NCT00542386|6254747|P6|Overall Study|Adverse Event|4
1798390|NCT00542386|6254748|P5|Overall Study|Adverse Event|13
1798391|NCT00542386|6254749|P4|Overall Study|Adverse Event|8
1798392|NCT00542386|6254750|P3|Overall Study|Adverse Event|7
1798393|NCT00542386|6254751|P2|Overall Study|Adverse Event|7
1798394|NCT00542386|6254752|P1|Overall Study|Adverse Event|1
1798395|NCT00542321|6254774|P2|Overall Study|Death|1
1798396|NCT00542321|6254775|P1|Overall Study|Death|0
1798397|NCT00542269|6254797|P3|Overall Study|Administrative problems|1
1798398|NCT00542269|6254798|P2|Overall Study|Administrative problems|1
1798399|NCT00542269|6254799|P1|Overall Study|Administrative problems|1
1798400|NCT00542269|6254797|P3|Overall Study|Withdrawal by Subject|0
1798401|NCT00542269|6254798|P2|Overall Study|Withdrawal by Subject|0
1798402|NCT00542269|6254799|P1|Overall Study|Withdrawal by Subject|1
1798403|NCT00542269|6254797|P3|Overall Study|Protocol Violation|0
1798404|NCT00542269|6254798|P2|Overall Study|Protocol Violation|1
1798405|NCT00542269|6254799|P1|Overall Study|Protocol Violation|1
1798406|NCT00542269|6254797|P3|Overall Study|Adverse Event|5
1798407|NCT00542269|6254798|P2|Overall Study|Adverse Event|4
1798408|NCT00542269|6254799|P1|Overall Study|Adverse Event|10
1798409|NCT00542191|6254828|P1|Overall Study|Death|3
1798410|NCT00542178|6254838|P8|Overall Study|did not complete year 4 follow-up|85
1798411|NCT00542178|6254839|P7|Overall Study|did not complete year 4 follow-up|87
1798412|NCT00542178|6254840|P6|Overall Study|did not complete year 4 follow-up|89
1798413|NCT00542178|6254841|P5|Overall Study|did not complete year 4 follow-up|64
1798414|NCT00542178|6254842|P4|Overall Study|did not complete year 4 follow-up|62
1798415|NCT00542178|6254843|P3|Overall Study|did not complete year 4 follow-up|74
1798416|NCT00542178|6254844|P2|Overall Study|did not complete year 4 follow-up|80
1798417|NCT00542178|6254845|P1|Overall Study|did not complete year 4 follow-up|75
1798418|NCT00541970|6254881|P4|Month 60|Protocol Violation|72
1798419|NCT00541970|6254882|P3|Month 60|Protocol Violation|82
1798420|NCT00541970|6254883|P2|Month 60|Protocol Violation|77
1798421|NCT00541970|6254884|P1|Month 60|Protocol Violation|78
1798422|NCT00541970|6254881|P4|Month 48|Lost to Follow-up|73
1798423|NCT00541970|6254882|P3|Month 48|Lost to Follow-up|68
1798424|NCT00541970|6254883|P2|Month 48|Lost to Follow-up|68
1798425|NCT00541970|6254884|P1|Month 48|Lost to Follow-up|66
1798426|NCT00541970|6254881|P4|Month 48|Other|0
1798427|NCT00541970|6254882|P3|Month 48|Other|1
1798428|NCT00541970|6254883|P2|Month 48|Other|1
1798429|NCT00541970|6254884|P1|Month 48|Other|3
1798430|NCT00541970|6254881|P4|Month 48|Withdrawal by Subject|2
1798431|NCT00541970|6254882|P3|Month 48|Withdrawal by Subject|4
1798432|NCT00541970|6254883|P2|Month 48|Withdrawal by Subject|4
1798433|NCT00541970|6254884|P1|Month 48|Withdrawal by Subject|2
1798434|NCT00541970|6254881|P4|Month 36|Protocol Violation|60
1798435|NCT00541970|6254882|P3|Month 36|Protocol Violation|66
1798436|NCT00541970|6254883|P2|Month 36|Protocol Violation|66
1798437|NCT00541970|6254884|P1|Month 36|Protocol Violation|61
1798438|NCT00541970|6254881|P4|Month 24|Protocol Violation|21
1798439|NCT00541970|6254882|P3|Month 24|Protocol Violation|31
1798440|NCT00541970|6254883|P2|Month 24|Protocol Violation|31
1798441|NCT00541970|6254884|P1|Month 24|Protocol Violation|29
1798442|NCT00541970|6254881|P4|Month 24|Adverse Event|1
1798443|NCT00541970|6254882|P3|Month 24|Adverse Event|1
1798444|NCT00541970|6254883|P2|Month 24|Adverse Event|1
1798445|NCT00541970|6254884|P1|Month 24|Adverse Event|0
1798446|NCT00541970|6254881|P4|Month 18|Protocol Violation|16
1798447|NCT00541970|6254882|P3|Month 18|Protocol Violation|24
1798448|NCT00541970|6254883|P2|Month 18|Protocol Violation|23
1798449|NCT00541970|6254884|P1|Month 18|Protocol Violation|14
1798450|NCT00541970|6254881|P4|Month 18|Adverse Event|1
1798451|NCT00541970|6254882|P3|Month 18|Adverse Event|1
1798452|NCT00541970|6254883|P2|Month 18|Adverse Event|1
1798453|NCT00541970|6254884|P1|Month 18|Adverse Event|0
1798454|NCT00541970|6254881|P4|Month 12|Protocol Violation|15
1798455|NCT00541970|6254882|P3|Month 12|Protocol Violation|20
1798456|NCT00541970|6254883|P2|Month 12|Protocol Violation|21
1798457|NCT00541970|6254884|P1|Month 12|Protocol Violation|12
1798458|NCT00541970|6254881|P4|Month 12|Adverse Event|1
1798459|NCT00541970|6254882|P3|Month 12|Adverse Event|1
1798460|NCT00541970|6254883|P2|Month 12|Adverse Event|1
1798461|NCT00541970|6254884|P1|Month 12|Adverse Event|0
1798462|NCT00541970|6254881|P4|Month 7|Protocol Violation|5
1798463|NCT00541970|6254882|P3|Month 7|Protocol Violation|11
1798464|NCT00541970|6254883|P2|Month 7|Protocol Violation|13
1798465|NCT00541970|6254884|P1|Month 7|Protocol Violation|9
1798466|NCT00541931|6255035|P2|Overall Study|Transportation Issue|1
1798467|NCT00541931|6255036|P1|Overall Study|Transportation Issue|0
1798468|NCT00541931|6255035|P2|Overall Study|Withdrawal by Subject|0
1798469|NCT00541931|6255036|P1|Overall Study|Withdrawal by Subject|1
1798470|NCT00541931|6255035|P2|Overall Study|Lost to Follow-up|3
1798471|NCT00541931|6255036|P1|Overall Study|Lost to Follow-up|3
1798472|NCT00541931|6255035|P2|Overall Study|Adverse Event|0
1798473|NCT00541931|6255036|P1|Overall Study|Adverse Event|1
1798474|NCT00541866|6255049|P5|Overall Study|Physician Decision|0
1798475|NCT00541866|6255050|P4|Overall Study|Physician Decision|1
1798476|NCT00541866|6255051|P3|Overall Study|Physician Decision|2
1798477|NCT00541866|6255052|P2|Overall Study|Physician Decision|0
1798478|NCT00541866|6255053|P1|Overall Study|Physician Decision|0
1798479|NCT00541866|6255049|P5|Overall Study|Not Reported or Other|1
1798480|NCT00541866|6255050|P4|Overall Study|Not Reported or Other|3
1798481|NCT00541866|6255051|P3|Overall Study|Not Reported or Other|3
1798482|NCT00541866|6255052|P2|Overall Study|Not Reported or Other|3
1798483|NCT00541866|6255053|P1|Overall Study|Not Reported or Other|11
1798484|NCT00541866|6255049|P5|Overall Study|Lack of Efficacy|14
1798485|NCT00541866|6255050|P4|Overall Study|Lack of Efficacy|12
1798486|NCT00541866|6255051|P3|Overall Study|Lack of Efficacy|10
1798487|NCT00541866|6255052|P2|Overall Study|Lack of Efficacy|15
1798488|NCT00541866|6255053|P1|Overall Study|Lack of Efficacy|19
1798489|NCT00541866|6255049|P5|Overall Study|Death|0
1798490|NCT00541866|6255050|P4|Overall Study|Death|0
1798491|NCT00541866|6255051|P3|Overall Study|Death|0
1798492|NCT00541866|6255052|P2|Overall Study|Death|0
1798493|NCT00541866|6255053|P1|Overall Study|Death|1
1798494|NCT00541866|6255049|P5|Overall Study|Adverse Event|0
1798495|NCT00541866|6255050|P4|Overall Study|Adverse Event|0
1798496|NCT00541866|6255051|P3|Overall Study|Adverse Event|0
1798497|NCT00541866|6255052|P2|Overall Study|Adverse Event|0
1798498|NCT00541866|6255053|P1|Overall Study|Adverse Event|3
1798499|NCT00541775|6255094|P3|Overall Study|Withdrawal by Subject and Other|2
1798500|NCT00541775|6255095|P2|Overall Study|Withdrawal by Subject and Other|0
1798501|NCT00541775|6255096|P1|Overall Study|Withdrawal by Subject and Other|5
1798502|NCT00541775|6255094|P3|Overall Study|Protocol Violation|0
1798503|NCT00541775|6255095|P2|Overall Study|Protocol Violation|0
1798504|NCT00541775|6255096|P1|Overall Study|Protocol Violation|1
1798505|NCT00541775|6255094|P3|Overall Study|Lost to Follow-up|2
1798506|NCT00541775|6255095|P2|Overall Study|Lost to Follow-up|0
1798507|NCT00541775|6255096|P1|Overall Study|Lost to Follow-up|0
1798508|NCT00541775|6255094|P3|Overall Study|Lack of Efficacy|3
1798509|NCT00541775|6255095|P2|Overall Study|Lack of Efficacy|0
1798510|NCT00541775|6255096|P1|Overall Study|Lack of Efficacy|0
1798511|NCT00541775|6255094|P3|Overall Study|Adverse Event|1
1798512|NCT00541775|6255095|P2|Overall Study|Adverse Event|2
1798513|NCT00541775|6255096|P1|Overall Study|Adverse Event|3
1798514|NCT00541658|6255122|P3|Overall Study|Took No Study Drug|0
1798515|NCT00541658|6255123|P2|Overall Study|Took No Study Drug|0
1798516|NCT00541658|6255124|P1|Overall Study|Took No Study Drug|1
1798517|NCT00541658|6255122|P3|Overall Study|Withdrawal by Subject|32
1798518|NCT00541658|6255123|P2|Overall Study|Withdrawal by Subject|32
1798519|NCT00541658|6255124|P1|Overall Study|Withdrawal by Subject|28
1798520|NCT00541658|6255122|P3|Overall Study|Protocol Violation|1
1798521|NCT00541658|6255123|P2|Overall Study|Protocol Violation|1
1798522|NCT00541658|6255124|P1|Overall Study|Protocol Violation|0
1798523|NCT00541658|6255122|P3|Overall Study|Lost to Follow-up|6
1798524|NCT00541658|6255123|P2|Overall Study|Lost to Follow-up|3
1798525|NCT00541658|6255124|P1|Overall Study|Lost to Follow-up|3
1798526|NCT00541658|6255122|P3|Overall Study|Physician Decision|4
1798527|NCT00541658|6255123|P2|Overall Study|Physician Decision|0
1798528|NCT00541658|6255124|P1|Overall Study|Physician Decision|0
1798529|NCT00541658|6255122|P3|Overall Study|Adverse Event|25
1798530|NCT00541658|6255123|P2|Overall Study|Adverse Event|37
1798531|NCT00541658|6255124|P1|Overall Study|Adverse Event|28
1798532|NCT00541450|6255287|P2|Phase B|Withdrawal by Subject|6
1798533|NCT00541450|6255288|P1|Phase B|Withdrawal by Subject|8
1798534|NCT00541450|6255287|P2|Phase B|Protocol Violation|3
1798535|NCT00541450|6255288|P1|Phase B|Protocol Violation|3
1798536|NCT00541450|6255287|P2|Phase B|Pregnancy|1
1798537|NCT00541450|6255288|P1|Phase B|Pregnancy|0
1798538|NCT00541450|6255287|P2|Phase B|Physician Decision|2
1798539|NCT00541450|6255288|P1|Phase B|Physician Decision|4
1798540|NCT00541450|6255287|P2|Phase B|Lost to Follow-up|4
1798541|NCT00541450|6255288|P1|Phase B|Lost to Follow-up|6
1798542|NCT00541450|6255287|P2|Phase B|Hyperglycemia|9
1798543|NCT00541450|6255288|P1|Phase B|Hyperglycemia|10
1798544|NCT00541450|6255287|P2|Phase B|Adverse Event|6
1798545|NCT00541450|6255288|P1|Phase B|Adverse Event|6
1798546|NCT00541450|6255287|P2|Phase A|Withdrawal by Subject|7
1798547|NCT00541450|6255288|P1|Phase A|Withdrawal by Subject|7
1798548|NCT00541450|6255287|P2|Phase A|Protocol Violation|3
1798549|NCT00541450|6255288|P1|Phase A|Protocol Violation|2
1798550|NCT00541450|6255287|P2|Phase A|Physician Decision|0
1798551|NCT00541450|6255288|P1|Phase A|Physician Decision|2
1798552|NCT00541450|6255287|P2|Phase A|Lost to Follow-up|4
1798553|NCT00541450|6255288|P1|Phase A|Lost to Follow-up|6
1798554|NCT00541450|6255287|P2|Phase A|Hyperglycemia|1
1798555|NCT00541450|6255288|P1|Phase A|Hyperglycemia|0
1798556|NCT00541450|6255287|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
1798557|NCT00541450|6255288|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
1798558|NCT00541450|6255287|P2|Phase A|Adverse Event|0
1798559|NCT00541450|6255288|P1|Phase A|Adverse Event|3
1798560|NCT00541346|6255306|P1|Follow-up|Adverse Event|1
1798561|NCT00541307|6255320|P1|Overall Study|Surgical Bypass|5
1798562|NCT00541307|6255320|P1|Overall Study|Subject returned early (outside window)|1
1798563|NCT00541307|6255320|P1|Overall Study|Lost to Follow-up|4
1798564|NCT00541307|6255320|P1|Overall Study|Withdrawal by Subject|6
1798565|NCT00541307|6255320|P1|Overall Study|Physician Decision|3
1798566|NCT00541307|6255320|P1|Overall Study|Death|5
1798567|NCT00541229|6255345|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1798568|NCT00541229|6255346|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1798569|NCT00541229|6255347|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1798570|NCT00541229|6255348|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
1798571|NCT00541229|6255349|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1798572|NCT00541229|6255350|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
1798573|NCT00541229|6255345|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
1798574|NCT00541229|6255346|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1798575|NCT00541229|6255347|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1798576|NCT00541229|6255348|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1798577|NCT00541229|6255349|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1798578|NCT00541229|6255350|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
1798579|NCT00541229|6255345|P6|Treatment Period III (Week 11)|Adverse Event|0
1798580|NCT00541229|6255346|P5|Treatment Period III (Week 11)|Adverse Event|1
1798581|NCT00541229|6255347|P4|Treatment Period III (Week 11)|Adverse Event|0
1798582|NCT00541229|6255348|P3|Treatment Period III (Week 11)|Adverse Event|0
1798583|NCT00541229|6255349|P2|Treatment Period III (Week 11)|Adverse Event|0
1798584|NCT00541229|6255350|P1|Treatment Period III (Week 11)|Adverse Event|0
1798585|NCT00541229|6255345|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1798586|NCT00541229|6255346|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1798587|NCT00541229|6255347|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
1798588|NCT00541229|6255348|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
1798589|NCT00541229|6255349|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
1798590|NCT00541229|6255350|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
1798591|NCT00541229|6255345|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1798592|NCT00541229|6255346|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
1798593|NCT00541229|6255347|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1798594|NCT00541229|6255348|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1798595|NCT00541229|6255349|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1798596|NCT00541229|6255350|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
1798597|NCT00541229|6255345|P6|Washout Period II (Week 7-10)|Protocol Violation|0
1798598|NCT00541229|6255346|P5|Washout Period II (Week 7-10)|Protocol Violation|0
1798599|NCT00541229|6255347|P4|Washout Period II (Week 7-10)|Protocol Violation|0
1798600|NCT00541229|6255348|P3|Washout Period II (Week 7-10)|Protocol Violation|0
1798601|NCT00541229|6255349|P2|Washout Period II (Week 7-10)|Protocol Violation|0
1798602|NCT00541229|6255350|P1|Washout Period II (Week 7-10)|Protocol Violation|1
1798603|NCT00541229|6255345|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
1798604|NCT00541229|6255346|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1798605|NCT00541229|6255347|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1798606|NCT00541229|6255348|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1798607|NCT00541229|6255349|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
1798608|NCT00541229|6255350|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
1798609|NCT00541229|6255345|P6|Treatment Period II (Week 6)|Protocol Violation|1
1798610|NCT00541229|6255346|P5|Treatment Period II (Week 6)|Protocol Violation|1
1798611|NCT00541229|6255347|P4|Treatment Period II (Week 6)|Protocol Violation|0
1798612|NCT00541229|6255348|P3|Treatment Period II (Week 6)|Protocol Violation|0
1798613|NCT00541229|6255349|P2|Treatment Period II (Week 6)|Protocol Violation|0
1798614|NCT00541229|6255350|P1|Treatment Period II (Week 6)|Protocol Violation|0
1798615|NCT00541229|6255345|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
1798616|NCT00541229|6255346|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
1798617|NCT00541229|6255347|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1798618|NCT00541229|6255348|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1798619|NCT00541229|6255349|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
1798620|NCT00541229|6255350|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
1798621|NCT00541229|6255345|P6|Washout Period I (Week 2-5)|Protocol Violation|1
1798622|NCT00541229|6255346|P5|Washout Period I (Week 2-5)|Protocol Violation|0
1798623|NCT00541229|6255347|P4|Washout Period I (Week 2-5)|Protocol Violation|0
1798624|NCT00541229|6255348|P3|Washout Period I (Week 2-5)|Protocol Violation|0
1798625|NCT00541229|6255349|P2|Washout Period I (Week 2-5)|Protocol Violation|0
1798626|NCT00541229|6255350|P1|Washout Period I (Week 2-5)|Protocol Violation|0
1798627|NCT00541229|6255345|P6|Washout Period I (Week 2-5)|Physician Decision|0
1798628|NCT00541229|6255346|P5|Washout Period I (Week 2-5)|Physician Decision|0
1798629|NCT00541229|6255347|P4|Washout Period I (Week 2-5)|Physician Decision|1
1798630|NCT00541229|6255348|P3|Washout Period I (Week 2-5)|Physician Decision|0
1798631|NCT00541229|6255349|P2|Washout Period I (Week 2-5)|Physician Decision|0
1798632|NCT00541229|6255350|P1|Washout Period I (Week 2-5)|Physician Decision|0
1798633|NCT00541229|6255345|P6|Washout Period I (Week 2-5)|Adverse Event|0
1798634|NCT00541229|6255346|P5|Washout Period I (Week 2-5)|Adverse Event|0
1798635|NCT00541229|6255347|P4|Washout Period I (Week 2-5)|Adverse Event|0
1798636|NCT00541229|6255348|P3|Washout Period I (Week 2-5)|Adverse Event|1
1798637|NCT00541229|6255349|P2|Washout Period I (Week 2-5)|Adverse Event|0
1798638|NCT00541229|6255350|P1|Washout Period I (Week 2-5)|Adverse Event|1
1798639|NCT00541229|6255345|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1798640|NCT00541229|6255346|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1798641|NCT00541229|6255347|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
1798642|NCT00541229|6255348|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
1798643|NCT00541229|6255349|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
1798644|NCT00541229|6255350|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
1798645|NCT00541229|6255345|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
1798646|NCT00541229|6255346|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1798647|NCT00541229|6255347|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1798648|NCT00541229|6255348|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1798649|NCT00541229|6255349|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1798650|NCT00541229|6255350|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
1798651|NCT00541229|6255345|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
1798652|NCT00541229|6255346|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
1798653|NCT00541229|6255347|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
1798654|NCT00541229|6255348|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
1798655|NCT00541229|6255349|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
1798656|NCT00541229|6255350|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
1798657|NCT00541229|6255345|P6|Treatment Period I (Week 1)|Physician Decision|0
1798658|NCT00541229|6255346|P5|Treatment Period I (Week 1)|Physician Decision|0
1798659|NCT00541229|6255347|P4|Treatment Period I (Week 1)|Physician Decision|0
1798660|NCT00541229|6255348|P3|Treatment Period I (Week 1)|Physician Decision|1
1798661|NCT00541229|6255349|P2|Treatment Period I (Week 1)|Physician Decision|0
1798662|NCT00541229|6255350|P1|Treatment Period I (Week 1)|Physician Decision|0
1798663|NCT00541099|6255369|P1|Overall Study|Ineligible|3
1798664|NCT00541034|6255377|P1|Overall Study|Non-Compliance|3
1798665|NCT00540644|6255426|P2|Overall Study|Noncomplilance|0
1798666|NCT00540644|6255427|P1|Overall Study|Noncomplilance|1
1798667|NCT00540644|6255426|P2|Overall Study|Withdrawal by Subject|2
1798668|NCT00540644|6255427|P1|Overall Study|Withdrawal by Subject|2
1798669|NCT00540644|6255426|P2|Overall Study|Physician Decision|5
1798670|NCT00540644|6255427|P1|Overall Study|Physician Decision|0
1798671|NCT00540644|6255426|P2|Overall Study|Disease Progression|1
1798672|NCT00540644|6255427|P1|Overall Study|Disease Progression|3
1798673|NCT00540644|6255426|P2|Overall Study|Adverse Event|1
1798674|NCT00540644|6255427|P1|Overall Study|Adverse Event|3
1798675|NCT00540592|6255447|P10|Overall Study|Withdrawal by Subject|0
1798676|NCT00540592|6255448|P9|Overall Study|Withdrawal by Subject|0
1798677|NCT00540592|6255449|P8|Overall Study|Withdrawal by Subject|0
1798678|NCT00540592|6255450|P7|Overall Study|Withdrawal by Subject|0
1798679|NCT00540592|6255451|P6|Overall Study|Withdrawal by Subject|0
1798680|NCT00540592|6255452|P5|Overall Study|Withdrawal by Subject|0
1798681|NCT00540592|6255453|P4|Overall Study|Withdrawal by Subject|1
1798682|NCT00540592|6255454|P3|Overall Study|Withdrawal by Subject|1
1798683|NCT00540592|6255455|P2|Overall Study|Withdrawal by Subject|0
1798684|NCT00540592|6255456|P1|Overall Study|Withdrawal by Subject|0
1798685|NCT00540592|6255447|P10|Overall Study|Lost to Follow-up|0
1798686|NCT00540592|6255448|P9|Overall Study|Lost to Follow-up|0
1798687|NCT00540592|6255449|P8|Overall Study|Lost to Follow-up|0
1798688|NCT00540592|6255450|P7|Overall Study|Lost to Follow-up|0
1798689|NCT00540592|6255451|P6|Overall Study|Lost to Follow-up|0
1798690|NCT00540592|6255452|P5|Overall Study|Lost to Follow-up|0
1798691|NCT00540592|6255453|P4|Overall Study|Lost to Follow-up|0
1798692|NCT00540592|6255454|P3|Overall Study|Lost to Follow-up|0
1798693|NCT00540592|6255455|P2|Overall Study|Lost to Follow-up|0
1798694|NCT00540592|6255456|P1|Overall Study|Lost to Follow-up|2
1798695|NCT00540592|6255447|P10|Overall Study|Adverse Event|2
1798696|NCT00540592|6255448|P9|Overall Study|Adverse Event|1
1798697|NCT00540592|6255449|P8|Overall Study|Adverse Event|1
1798698|NCT00540592|6255450|P7|Overall Study|Adverse Event|0
1798699|NCT00540592|6255451|P6|Overall Study|Adverse Event|0
1798700|NCT00540592|6255452|P5|Overall Study|Adverse Event|1
1798701|NCT00540592|6255453|P4|Overall Study|Adverse Event|0
1798702|NCT00540592|6255454|P3|Overall Study|Adverse Event|0
1798703|NCT00540592|6255455|P2|Overall Study|Adverse Event|1
1798704|NCT00540592|6255456|P1|Overall Study|Adverse Event|0
1798705|NCT00540514|6255695|P2|Overall Study|Paclitaxel not available|2
1798706|NCT00540514|6255696|P1|Overall Study|Paclitaxel not available|0
1798707|NCT00540514|6255695|P2|Overall Study|Excluded prior to treatment|7
1798708|NCT00540514|6255696|P1|Overall Study|Excluded prior to treatment|7
1798709|NCT00540514|6255695|P2|Overall Study|Withdrawal by Subject|67
1798710|NCT00540514|6255696|P1|Overall Study|Withdrawal by Subject|65
1798711|NCT00540514|6255695|P2|Overall Study|Lost to Follow-up|1
1798712|NCT00540514|6255696|P1|Overall Study|Lost to Follow-up|1
1798713|NCT00540514|6255695|P2|Overall Study|Protocol Deviation|4
1798714|NCT00540514|6255696|P1|Overall Study|Protocol Deviation|3
1798715|NCT00540514|6255695|P2|Overall Study|Physician Decision|99
1798716|NCT00540514|6255696|P1|Overall Study|Physician Decision|86
1798717|NCT00540514|6255695|P2|Overall Study|Adverse Event|24
1798718|NCT00540514|6255696|P1|Overall Study|Adverse Event|20
1798719|NCT00540514|6255695|P2|Overall Study|Unacceptable Toxicity|62
1798720|NCT00540514|6255696|P1|Overall Study|Unacceptable Toxicity|61
1798721|NCT00540514|6255695|P2|Overall Study|Still on treatment|0
1798722|NCT00540514|6255696|P1|Overall Study|Still on treatment|3
1798723|NCT00540449|6255728|P2|Overall Study|Other|4
1798724|NCT00540449|6255729|P1|Overall Study|Other|1
1798725|NCT00540449|6255728|P2|Overall Study|Withdrawal by Subject|10
1798726|NCT00540449|6255729|P1|Overall Study|Withdrawal by Subject|10
1798727|NCT00540449|6255728|P2|Overall Study|Subject Reached A Virologic Endpoint|8
1798728|NCT00540449|6255729|P1|Overall Study|Subject Reached A Virologic Endpoint|32
1798729|NCT00540449|6255728|P2|Overall Study|Subject Non-Compliant|5
1798730|NCT00540449|6255729|P1|Overall Study|Subject Non-Compliant|7
1798731|NCT00540449|6255728|P2|Overall Study|Lost to Follow-up|17
1798732|NCT00540449|6255729|P1|Overall Study|Lost to Follow-up|19
1798733|NCT00540449|6255728|P2|Overall Study|Subject Ineligible To Continue The Trial|1
1798734|NCT00540449|6255729|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1798735|NCT00540449|6255728|P2|Overall Study|Sponsor's Decision|1
1798736|NCT00540449|6255729|P1|Overall Study|Sponsor's Decision|1
1798737|NCT00540449|6255728|P2|Overall Study|Adverse Event|32
1798738|NCT00540449|6255729|P1|Overall Study|Adverse Event|12
1798739|NCT00540436|6255751|P1|Second 12-Week Treatment Period|Adverse Event|1
1798740|NCT00540436|6255751|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
1798741|NCT00540436|6255751|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
1798742|NCT00540436|6255751|P1|First 12-Week Treatment Period|Adverse Event|1
1798743|NCT00540423|6255766|P3|Open-Label Treatment Period|Lack of Efficacy|2
1798744|NCT00540423|6255767|P2|Open-Label Treatment Period|Lack of Efficacy|0
1798745|NCT00540423|6255768|P1|Open-Label Treatment Period|Lack of Efficacy|0
1798746|NCT00540423|6255766|P3|Double-Blind Treatment Period|Adverse Event|0
1798747|NCT00540423|6255767|P2|Double-Blind Treatment Period|Adverse Event|1
1798748|NCT00540423|6255768|P1|Double-Blind Treatment Period|Adverse Event|0
1798749|NCT00540293|6255818|P1|Overall Study|Protocol violation, & subject schedule|12
1798750|NCT00540293|6255818|P1|Overall Study|Withdrawal by Subject|6
1798751|NCT00540293|6255818|P1|Overall Study|Adverse event not related to study drug|7
1798752|NCT00540293|6255818|P1|Overall Study|Adverse event related to study drug|10
1798753|NCT00540228|6255866|P5|Overall Study|Lost to Follow-up|0
1798754|NCT00540228|6255867|P4|Overall Study|Lost to Follow-up|0
1798755|NCT00540228|6255868|P3|Overall Study|Lost to Follow-up|0
1798756|NCT00540228|6255869|P2|Overall Study|Lost to Follow-up|1
1798757|NCT00540228|6255870|P1|Overall Study|Lost to Follow-up|1
1798758|NCT00540228|6255866|P5|Overall Study|Adverse Event|0
1798759|NCT00540228|6255867|P4|Overall Study|Adverse Event|0
1798760|NCT00540228|6255868|P3|Overall Study|Adverse Event|0
1798761|NCT00540228|6255869|P2|Overall Study|Adverse Event|0
1798762|NCT00540228|6255870|P1|Overall Study|Adverse Event|2
1798763|NCT00540124|6255940|P3|Overall Study|Withdrawal by Subject|0
1798764|NCT00540124|6255941|P2|Overall Study|Withdrawal by Subject|1
1798765|NCT00540124|6255942|P1|Overall Study|Withdrawal by Subject|1
1798766|NCT00540124|6255940|P3|Overall Study|Lack of Efficacy|0
1798767|NCT00540124|6255941|P2|Overall Study|Lack of Efficacy|0
1798768|NCT00540124|6255942|P1|Overall Study|Lack of Efficacy|1
1798769|NCT00540124|6255940|P3|Overall Study|Entry Criteria Not Met|0
1798770|NCT00540124|6255941|P2|Overall Study|Entry Criteria Not Met|0
1798771|NCT00540124|6255942|P1|Overall Study|Entry Criteria Not Met|2
1798772|NCT00540124|6255940|P3|Overall Study|Adverse Event|1
1798773|NCT00540124|6255941|P2|Overall Study|Adverse Event|2
1798774|NCT00540124|6255942|P1|Overall Study|Adverse Event|0
1798775|NCT00540046|6255988|P2|Overall Study|Lost to Follow-up|23
1798776|NCT00540046|6255989|P1|Overall Study|Lost to Follow-up|33
1798777|NCT00539994|6256025|P3|Overall Study|Physician Decision|1
1798778|NCT00539994|6256026|P2|Overall Study|Physician Decision|0
1798779|NCT00539994|6256027|P1|Overall Study|Physician Decision|0
1798780|NCT00539994|6256025|P3|Overall Study|Withdrawal by Subject|1
1798781|NCT00539994|6256026|P2|Overall Study|Withdrawal by Subject|0
1798782|NCT00539994|6256027|P1|Overall Study|Withdrawal by Subject|1
1798783|NCT00539994|6256025|P3|Overall Study|Lost to Follow-up|0
1798784|NCT00539994|6256026|P2|Overall Study|Lost to Follow-up|1
1798785|NCT00539994|6256027|P1|Overall Study|Lost to Follow-up|2
1798786|NCT00539864|6256077|P2|Overall Study|Withdrawal by Subject|1
1798787|NCT00539864|6256078|P1|Overall Study|Withdrawal by Subject|1
1798788|NCT00539864|6256077|P2|Overall Study|Lost to Follow-up|1
1798789|NCT00539864|6256078|P1|Overall Study|Lost to Follow-up|0
1798790|NCT00539734|6256090|P1|Overall Study|Protocol Violation|1
1798791|NCT00539591|6256115|P3|Overall Study|Disease progression|3
1798792|NCT00539591|6256116|P2|Overall Study|Disease progression|2
1798793|NCT00539591|6256117|P1|Overall Study|Disease progression|2
1798794|NCT00539591|6256115|P3|Overall Study|Toxicity|0
1798795|NCT00539591|6256116|P2|Overall Study|Toxicity|0
1798796|NCT00539591|6256117|P1|Overall Study|Toxicity|3
1798797|NCT00539513|6256269|P2|Overall Study|Lost to Follow-up|1
1798798|NCT00539513|6256270|P1|Overall Study|Lost to Follow-up|0
1798799|NCT00539513|6256269|P2|Overall Study|Withdrawal by Subject|1
1798800|NCT00539513|6256270|P1|Overall Study|Withdrawal by Subject|2
1798801|NCT00539500|6256282|P1|Overall Study|Lost to Follow-up|2
1798802|NCT00539500|6256282|P1|Overall Study|Disease Progression|1
1798803|NCT00539305|6256290|P2|Overall Study|Withdrawal by Subject|1
1798804|NCT00539305|6256291|P1|Overall Study|Withdrawal by Subject|0
1798805|NCT00539305|6256290|P2|Overall Study|Substance Use|1
1798806|NCT00539305|6256291|P1|Overall Study|Substance Use|0
1798807|NCT00539305|6256290|P2|Overall Study|Adverse Event|0
1798808|NCT00539305|6256291|P1|Overall Study|Adverse Event|1
1798809|NCT00539279|6256305|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
1798810|NCT00539279|6256306|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
1798811|NCT00539279|6256305|P2|Post-Treatment Assessment|Lost to Follow-up|9
1798812|NCT00539279|6256306|P1|Post-Treatment Assessment|Lost to Follow-up|12
1798813|NCT00539279|6256305|P2|Treatment|Death|0
1798814|NCT00539279|6256306|P1|Treatment|Death|1
1798815|NCT00539279|6256305|P2|Treatment|Withdrawal by Subject|8
1798816|NCT00539279|6256306|P1|Treatment|Withdrawal by Subject|10
1798817|NCT00539240|6256332|P3|Overall Study|Adverse Event|10
1798818|NCT00539240|6256333|P2|Overall Study|Adverse Event|1
1798819|NCT00539240|6256334|P1|Overall Study|Adverse Event|3
1798820|NCT00539240|6256332|P3|Overall Study|Lost to Follow-up|1
1798821|NCT00539240|6256333|P2|Overall Study|Lost to Follow-up|3
1798822|NCT00539240|6256334|P1|Overall Study|Lost to Follow-up|2
1798823|NCT00539240|6256332|P3|Overall Study|Protocol Violation|4
1798824|NCT00539240|6256333|P2|Overall Study|Protocol Violation|1
1798825|NCT00539240|6256334|P1|Overall Study|Protocol Violation|1
1798826|NCT00539240|6256332|P3|Overall Study|Withdrawal by Subject|0
1798827|NCT00539240|6256333|P2|Overall Study|Withdrawal by Subject|2
1798828|NCT00539240|6256334|P1|Overall Study|Withdrawal by Subject|0
1798829|NCT00539188|6256353|P2|Overall Study|Lost to Follow-up|1
1798830|NCT00539188|6256354|P1|Overall Study|Lost to Follow-up|2
1798831|NCT00539188|6256353|P2|Overall Study|Withdrawal by Subject|0
1798832|NCT00539188|6256354|P1|Overall Study|Withdrawal by Subject|1
1798833|NCT00539032|6256377|P2|Overall Study|Withdrawal by Subject|1
1798834|NCT00539032|6256378|P1|Overall Study|Withdrawal by Subject|2
1798835|NCT00539006|6256392|P4|Treatment Period 2|Other|0
1798836|NCT00539006|6256393|P3|Treatment Period 2|Other|0
1798837|NCT00539006|6256394|P2|Treatment Period 2|Other|1
1798838|NCT00539006|6256395|P1|Treatment Period 2|Other|0
1798839|NCT00539006|6256392|P4|Treatment Period 2|Protocol Violation|0
1798840|NCT00539006|6256393|P3|Treatment Period 2|Protocol Violation|0
1798841|NCT00539006|6256394|P2|Treatment Period 2|Protocol Violation|0
1798842|NCT00539006|6256395|P1|Treatment Period 2|Protocol Violation|1
1798843|NCT00539006|6256392|P4|Washout|Other|3
1798844|NCT00539006|6256393|P3|Washout|Other|2
1798845|NCT00539006|6256394|P2|Washout|Other|1
1798846|NCT00539006|6256395|P1|Washout|Other|1
1798847|NCT00539006|6256392|P4|Washout|Failed to meet continuation criteria|6
1798848|NCT00539006|6256393|P3|Washout|Failed to meet continuation criteria|14
1798849|NCT00539006|6256394|P2|Washout|Failed to meet continuation criteria|5
1798850|NCT00539006|6256395|P1|Washout|Failed to meet continuation criteria|16
1798851|NCT00539006|6256392|P4|Washout|Withdrawal by Subject|0
1798852|NCT00539006|6256393|P3|Washout|Withdrawal by Subject|0
1798853|NCT00539006|6256394|P2|Washout|Withdrawal by Subject|2
1798854|NCT00539006|6256395|P1|Washout|Withdrawal by Subject|0
1798855|NCT00539006|6256392|P4|Washout|Protocol Violation|0
1798856|NCT00539006|6256393|P3|Washout|Protocol Violation|0
1798857|NCT00539006|6256394|P2|Washout|Protocol Violation|1
1798858|NCT00539006|6256395|P1|Washout|Protocol Violation|1
1798859|NCT00539006|6256392|P4|Washout|Adverse Event|0
1798860|NCT00539006|6256393|P3|Washout|Adverse Event|0
1798861|NCT00539006|6256394|P2|Washout|Adverse Event|1
1798862|NCT00539006|6256395|P1|Washout|Adverse Event|2
1798863|NCT00539006|6256392|P4|Treatment Period 1|Lack of Efficacy|1
1798864|NCT00539006|6256393|P3|Treatment Period 1|Lack of Efficacy|0
1798865|NCT00539006|6256394|P2|Treatment Period 1|Lack of Efficacy|0
1798866|NCT00539006|6256395|P1|Treatment Period 1|Lack of Efficacy|0
1798867|NCT00539006|6256392|P4|Treatment Period 1|Protocol Violation|0
1798868|NCT00539006|6256393|P3|Treatment Period 1|Protocol Violation|1
1798869|NCT00539006|6256394|P2|Treatment Period 1|Protocol Violation|0
1798870|NCT00539006|6256395|P1|Treatment Period 1|Protocol Violation|0
1798871|NCT00539006|6256392|P4|Treatment Period 1|Lost to Follow-up|0
1798872|NCT00539006|6256393|P3|Treatment Period 1|Lost to Follow-up|1
1798873|NCT00539006|6256394|P2|Treatment Period 1|Lost to Follow-up|0
1798874|NCT00539006|6256395|P1|Treatment Period 1|Lost to Follow-up|0
1798875|NCT00539006|6256392|P4|Pre-treatment|Other|0
1798876|NCT00539006|6256393|P3|Pre-treatment|Other|0
1798877|NCT00539006|6256394|P2|Pre-treatment|Other|1
1798878|NCT00539006|6256395|P1|Pre-treatment|Other|0
1798879|NCT00538902|6256440|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
1798880|NCT00538902|6256441|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
1798881|NCT00538902|6256442|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
1798882|NCT00538902|6256440|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
1798883|NCT00538902|6256441|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
1798884|NCT00538902|6256442|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
1798885|NCT00538902|6256440|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
1798886|NCT00538902|6256441|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
1798887|NCT00538902|6256442|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
1798888|NCT00538902|6256440|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
1798889|NCT00538902|6256441|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
1798890|NCT00538902|6256442|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
1798891|NCT00538902|6256440|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1798892|NCT00538902|6256441|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1798893|NCT00538902|6256442|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
1798894|NCT00538902|6256440|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
1798895|NCT00538902|6256441|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
1798896|NCT00538902|6256442|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
1798897|NCT00538902|6256440|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
1798898|NCT00538902|6256441|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
1798899|NCT00538902|6256442|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
1798900|NCT00538902|6256440|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
1798901|NCT00538902|6256441|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
1798902|NCT00538902|6256442|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
1798903|NCT00538785|6256503|P2|Overall Study|Lost to Follow-up|0
1798904|NCT00538785|6256504|P1|Overall Study|Lost to Follow-up|1
1798905|NCT00538785|6256503|P2|Overall Study|Withdrawal of consent|7
1798906|NCT00538785|6256504|P1|Overall Study|Withdrawal of consent|9
1798907|NCT00538785|6256503|P2|Overall Study|Death|10
1798908|NCT00538785|6256504|P1|Overall Study|Death|9
1798909|NCT00538733|6256546|P1|Overall Study|still on therapy|1
1798910|NCT00538733|6256546|P1|Overall Study|declined to participate|2
1798911|NCT00538733|6256546|P1|Overall Study|Death|1
1798912|NCT00538733|6256546|P1|Overall Study|Adverse Event|8
1798913|NCT00538629|6256596|P1|Overall Study|Subject's untimely distrust of medicine|1
1798914|NCT00538629|6256596|P1|Overall Study|Lost to Follow-up|6
1798915|NCT00538629|6256596|P1|Overall Study|Lack of Efficacy|12
1798916|NCT00538629|6256596|P1|Overall Study|Adverse Event|2
1798917|NCT00538629|6256596|P1|Overall Study|At subject's request|1
1798918|NCT00538590|6256652|P2|Overall Study|Death|0
1798919|NCT00538590|6256653|P1|Overall Study|Death|1
1798920|NCT00538473|6256691|P2|Overall Study|Adverse Event|0
1798921|NCT00538473|6256692|P1|Overall Study|Adverse Event|1
1798922|NCT00538291|6256772|P1|Overall Study|Withdrawal by Subject|1
1798923|NCT00538291|6256772|P1|Overall Study|Adverse Event|2
1798924|NCT00537979|6256830|P2|Overall Study|Heart failure|1
1798925|NCT00537979|6256831|P1|Overall Study|Heart failure|0
1798926|NCT00537979|6256830|P2|Overall Study|Kidney transplant|3
1798927|NCT00537979|6256831|P1|Overall Study|Kidney transplant|0
1798928|NCT00537979|6256830|P2|Overall Study|Death|3
1798929|NCT00537979|6256831|P1|Overall Study|Death|0
1798930|NCT00537979|6256830|P2|Overall Study|Non-compliance with treatment/procedure|2
1798931|NCT00537979|6256831|P1|Overall Study|Non-compliance with treatment/procedure|2
1798932|NCT00537979|6256830|P2|Overall Study|Lack of Efficacy|1
1798933|NCT00537979|6256831|P1|Overall Study|Lack of Efficacy|0
1798934|NCT00537979|6256830|P2|Overall Study|Lost to Follow-up|4
1798935|NCT00537979|6256831|P1|Overall Study|Lost to Follow-up|1
1798936|NCT00537979|6256830|P2|Overall Study|Withdrawal by Subject|4
1798937|NCT00537979|6256831|P1|Overall Study|Withdrawal by Subject|1
1798938|NCT00537979|6256830|P2|Overall Study|Adverse Event|2
1798939|NCT00537979|6256831|P1|Overall Study|Adverse Event|2
1798940|NCT00537940|6256847|P2|Overall Study|Other|12
1798941|NCT00537940|6256848|P1|Overall Study|Other|10
1798942|NCT00537940|6256847|P2|Overall Study|Study terminated by sponsor|3
1798943|NCT00537940|6256848|P1|Overall Study|Study terminated by sponsor|2
1798944|NCT00537940|6256847|P2|Overall Study|Pregnancy|1
1798945|NCT00537940|6256848|P1|Overall Study|Pregnancy|1
1798946|NCT00537940|6256847|P2|Overall Study|Protocol Violation|4
1798947|NCT00537940|6256848|P1|Overall Study|Protocol Violation|6
1798948|NCT00537940|6256847|P2|Overall Study|Withdrawal by Subject|95
1798949|NCT00537940|6256848|P1|Overall Study|Withdrawal by Subject|113
1798950|NCT00537940|6256847|P2|Overall Study|Lost to Follow-up|29
1798951|NCT00537940|6256848|P1|Overall Study|Lost to Follow-up|23
1798952|NCT00537940|6256847|P2|Overall Study|Lack of Efficacy|16
1798953|NCT00537940|6256848|P1|Overall Study|Lack of Efficacy|8
1798954|NCT00537940|6256847|P2|Overall Study|Adverse Event|19
1798955|NCT00537940|6256848|P1|Overall Study|Adverse Event|20
1798956|NCT00537823|6256872|P2|Overall Study|Adverse Event|0
1798957|NCT00537823|6256873|P1|Overall Study|Adverse Event|2
1798958|NCT00537810|6256899|P4|Overall Study|Medically withdrawn|1
1798959|NCT00537810|6256900|P3|Overall Study|Medically withdrawn|0
1798960|NCT00537810|6256901|P2|Overall Study|Medically withdrawn|2
1798961|NCT00537810|6256902|P1|Overall Study|Medically withdrawn|2
1798962|NCT00537810|6256899|P4|Overall Study|Withdrawal by Subject|3
1798963|NCT00537810|6256900|P3|Overall Study|Withdrawal by Subject|4
1798964|NCT00537810|6256901|P2|Overall Study|Withdrawal by Subject|11
1798965|NCT00537810|6256902|P1|Overall Study|Withdrawal by Subject|4
1798966|NCT00537771|6256918|P2|Overall Study|Severe Non-Compliance to Protocol|2
1798967|NCT00537771|6256919|P1|Overall Study|Severe Non-Compliance to Protocol|4
1798968|NCT00537771|6256918|P2|Overall Study|Protocol Violation|6
1798969|NCT00537771|6256919|P1|Overall Study|Protocol Violation|2
1798970|NCT00537771|6256918|P2|Overall Study|Lost to Follow-up|15
1798971|NCT00537771|6256919|P1|Overall Study|Lost to Follow-up|9
1798972|NCT00537771|6256918|P2|Overall Study|Adverse Event|15
1798973|NCT00537771|6256919|P1|Overall Study|Adverse Event|8
1798974|NCT00537771|6256918|P2|Overall Study|Withdrawal by Subject|23
1798975|NCT00537771|6256919|P1|Overall Study|Withdrawal by Subject|6
1798976|NCT00537745|6256929|P1|Overall Study|Subject unable to provide Interlock info|1
1798977|NCT00537745|6256929|P1|Overall Study|Withdrawal by Subject|2
1798978|NCT00537745|6256929|P1|Overall Study|Did not meet eligibility criteria|2
1798979|NCT00537485|6256974|P2|Overall Study|Physician Decision|0
1798980|NCT00537485|6256975|P1|Overall Study|Physician Decision|1
1798981|NCT00537485|6256974|P2|Overall Study|Withdrawal by Subject|3
1798982|NCT00537485|6256975|P1|Overall Study|Withdrawal by Subject|1
1798983|NCT00537485|6256974|P2|Overall Study|Withdrawal by Subject|2
1798984|NCT00537485|6256975|P1|Overall Study|Withdrawal by Subject|3
1798985|NCT00537485|6256974|P2|Overall Study|Adverse Event|5
1798986|NCT00537485|6256975|P1|Overall Study|Adverse Event|10
1798987|NCT00537394|6257048|P3|2nd Year of Follow-up|Clinic site closure|0
1798988|NCT00537394|6257049|P2|2nd Year of Follow-up|Clinic site closure|0
1798989|NCT00537394|6257050|P1|2nd Year of Follow-up|Clinic site closure|1
1798990|NCT00537394|6257048|P3|2nd Year of Follow-up|Lost to Follow-up|2
1798991|NCT00537394|6257049|P2|2nd Year of Follow-up|Lost to Follow-up|7
1798992|NCT00537394|6257050|P1|2nd Year of Follow-up|Lost to Follow-up|6
1798993|NCT00537394|6257048|P3|2nd Year of Follow-up|Withdrawal by Subject|2
1798994|NCT00537394|6257049|P2|2nd Year of Follow-up|Withdrawal by Subject|1
1798995|NCT00537394|6257050|P1|2nd Year of Follow-up|Withdrawal by Subject|0
1798996|NCT00537394|6257048|P3|2nd Year of Follow-up|Death|2
1798997|NCT00537394|6257049|P2|2nd Year of Follow-up|Death|1
1798998|NCT00537394|6257050|P1|2nd Year of Follow-up|Death|4
1798999|NCT00537394|6257048|P3|First Year of Follow-up|Lost to Follow-up|1
1799000|NCT00537394|6257049|P2|First Year of Follow-up|Lost to Follow-up|5
1799001|NCT00537394|6257050|P1|First Year of Follow-up|Lost to Follow-up|1
1799095|NCT00537316|6257128|P6|Part 1|Lost to Follow-up|0
1799002|NCT00537394|6257048|P3|First Year of Follow-up|Withdrawal by Subject|1
1799003|NCT00537394|6257049|P2|First Year of Follow-up|Withdrawal by Subject|6
1799004|NCT00537394|6257050|P1|First Year of Follow-up|Withdrawal by Subject|3
1799005|NCT00537394|6257048|P3|First Year of Follow-up|Severe debilitation|1
1799006|NCT00537394|6257049|P2|First Year of Follow-up|Severe debilitation|0
1799007|NCT00537394|6257050|P1|First Year of Follow-up|Severe debilitation|1
1799008|NCT00537394|6257048|P3|First Year of Follow-up|Death|0
1799009|NCT00537394|6257049|P2|First Year of Follow-up|Death|0
1799010|NCT00537394|6257050|P1|First Year of Follow-up|Death|7
1799011|NCT00537381|6257086|P2|Overall Study|Other|3
1799012|NCT00537381|6257087|P1|Overall Study|Other|5
1799013|NCT00537381|6257086|P2|Overall Study|Sponsor decision|9
1799014|NCT00537381|6257087|P1|Overall Study|Sponsor decision|14
1799015|NCT00537381|6257086|P2|Overall Study|Disease Progression|18
1799016|NCT00537381|6257087|P1|Overall Study|Disease Progression|9
1799017|NCT00537381|6257086|P2|Overall Study|Physician Decision|6
1799018|NCT00537381|6257087|P1|Overall Study|Physician Decision|7
1799019|NCT00537381|6257086|P2|Overall Study|Withdrawal by Subject|14
1799020|NCT00537381|6257087|P1|Overall Study|Withdrawal by Subject|5
1799021|NCT00537381|6257086|P2|Overall Study|Death|3
1799022|NCT00537381|6257087|P1|Overall Study|Death|3
1799023|NCT00537381|6257086|P2|Overall Study|Adverse Event|9
1799024|NCT00537381|6257087|P1|Overall Study|Adverse Event|13
1799025|NCT00537329|6257107|P1|Overall Study|Other|1
1799026|NCT00537329|6257107|P1|Overall Study|Withdrawal by Subject|4
1799027|NCT00537329|6257107|P1|Overall Study|Lost to Follow-up|6
1799028|NCT00537329|6257107|P1|Overall Study|Lack of Efficacy|2
1799029|NCT00537329|6257107|P1|Overall Study|Adverse Event|3
1799030|NCT00537329|6257107|P1|Overall Study|Death|10
1799031|NCT00537316|6257127|P7|Part 2|Administrative|1
1799032|NCT00537316|6257128|P6|Part 2|Administrative|4
1799033|NCT00537316|6257129|P5|Part 2|Administrative|1
1799034|NCT00537316|6257130|P4|Part 2|Administrative|3
1799035|NCT00537316|6257131|P3|Part 2|Administrative|24
1799036|NCT00537316|6257132|P2|Part 2|Administrative|8
1799037|NCT00537316|6257133|P1|Part 2|Administrative|16
1799038|NCT00537316|6257127|P7|Part 2|Withdrawal by Subject|0
1799039|NCT00537316|6257128|P6|Part 2|Withdrawal by Subject|0
1799040|NCT00537316|6257129|P5|Part 2|Withdrawal by Subject|0
1799041|NCT00537316|6257130|P4|Part 2|Withdrawal by Subject|0
1799042|NCT00537316|6257131|P3|Part 2|Withdrawal by Subject|4
1799043|NCT00537316|6257132|P2|Part 2|Withdrawal by Subject|1
1799044|NCT00537316|6257133|P1|Part 2|Withdrawal by Subject|5
1799045|NCT00537316|6257127|P7|Part 2|Lost to Follow-up|0
1799046|NCT00537316|6257128|P6|Part 2|Lost to Follow-up|0
1799047|NCT00537316|6257129|P5|Part 2|Lost to Follow-up|0
1799048|NCT00537316|6257130|P4|Part 2|Lost to Follow-up|0
1799049|NCT00537316|6257131|P3|Part 2|Lost to Follow-up|2
1799050|NCT00537316|6257132|P2|Part 2|Lost to Follow-up|0
1799051|NCT00537316|6257133|P1|Part 2|Lost to Follow-up|1
1799052|NCT00537316|6257127|P7|Part 2|Adverse Event|0
1799053|NCT00537316|6257128|P6|Part 2|Adverse Event|0
1799054|NCT00537316|6257129|P5|Part 2|Adverse Event|0
1799055|NCT00537316|6257130|P4|Part 2|Adverse Event|0
1799056|NCT00537316|6257131|P3|Part 2|Adverse Event|2
1799057|NCT00537316|6257132|P2|Part 2|Adverse Event|0
1799058|NCT00537316|6257133|P1|Part 2|Adverse Event|4
1799059|NCT00537316|6257127|P7|Part 2|Never entered follow-up|1
1799060|NCT00537316|6257128|P6|Part 2|Never entered follow-up|0
1799061|NCT00537316|6257129|P5|Part 2|Never entered follow-up|0
1799062|NCT00537316|6257130|P4|Part 2|Never entered follow-up|0
1799063|NCT00537316|6257131|P3|Part 2|Never entered follow-up|0
1799064|NCT00537316|6257132|P2|Part 2|Never entered follow-up|0
1799065|NCT00537316|6257133|P1|Part 2|Never entered follow-up|0
1799066|NCT00537316|6257127|P7|Part 1|Administrative|0
1799067|NCT00537316|6257128|P6|Part 1|Administrative|0
1799068|NCT00537316|6257129|P5|Part 1|Administrative|0
1799069|NCT00537316|6257130|P4|Part 1|Administrative|0
1799070|NCT00537316|6257131|P3|Part 1|Administrative|2
1799071|NCT00537316|6257132|P2|Part 1|Administrative|0
1799072|NCT00537316|6257133|P1|Part 1|Administrative|0
1799073|NCT00537316|6257127|P7|Part 1|Did not meet protocol eligibility|0
1799074|NCT00537316|6257128|P6|Part 1|Did not meet protocol eligibility|0
1799075|NCT00537316|6257129|P5|Part 1|Did not meet protocol eligibility|0
1799076|NCT00537316|6257130|P4|Part 1|Did not meet protocol eligibility|0
1799077|NCT00537316|6257131|P3|Part 1|Did not meet protocol eligibility|2
1799078|NCT00537316|6257132|P2|Part 1|Did not meet protocol eligibility|3
1799079|NCT00537316|6257133|P1|Part 1|Did not meet protocol eligibility|1
1799080|NCT00537316|6257127|P7|Part 1|Protocol Violation|0
1799081|NCT00537316|6257128|P6|Part 1|Protocol Violation|0
1799082|NCT00537316|6257129|P5|Part 1|Protocol Violation|0
1799083|NCT00537316|6257130|P4|Part 1|Protocol Violation|0
1799084|NCT00537316|6257131|P3|Part 1|Protocol Violation|1
1799085|NCT00537316|6257132|P2|Part 1|Protocol Violation|5
1799086|NCT00537316|6257133|P1|Part 1|Protocol Violation|1
1799087|NCT00537316|6257127|P7|Part 1|Withdrawal by Subject|0
1799088|NCT00537316|6257128|P6|Part 1|Withdrawal by Subject|0
1799089|NCT00537316|6257129|P5|Part 1|Withdrawal by Subject|0
1799090|NCT00537316|6257130|P4|Part 1|Withdrawal by Subject|0
1799091|NCT00537316|6257131|P3|Part 1|Withdrawal by Subject|4
1799092|NCT00537316|6257132|P2|Part 1|Withdrawal by Subject|8
1799093|NCT00537316|6257133|P1|Part 1|Withdrawal by Subject|3
1799094|NCT00537316|6257127|P7|Part 1|Lost to Follow-up|0
1799096|NCT00537316|6257129|P5|Part 1|Lost to Follow-up|0
1799097|NCT00537316|6257130|P4|Part 1|Lost to Follow-up|0
1799098|NCT00537316|6257131|P3|Part 1|Lost to Follow-up|0
1799099|NCT00537316|6257132|P2|Part 1|Lost to Follow-up|0
1799100|NCT00537316|6257133|P1|Part 1|Lost to Follow-up|1
1799101|NCT00537316|6257127|P7|Part 1|Protocol defined clinical event|0
1799102|NCT00537316|6257128|P6|Part 1|Protocol defined clinical event|0
1799103|NCT00537316|6257129|P5|Part 1|Protocol defined clinical event|0
1799104|NCT00537316|6257130|P4|Part 1|Protocol defined clinical event|0
1799105|NCT00537316|6257131|P3|Part 1|Protocol defined clinical event|0
1799106|NCT00537316|6257132|P2|Part 1|Protocol defined clinical event|0
1799107|NCT00537316|6257133|P1|Part 1|Protocol defined clinical event|1
1799108|NCT00537316|6257127|P7|Part 1|Adverse Event|0
1799109|NCT00537316|6257128|P6|Part 1|Adverse Event|0
1799110|NCT00537316|6257129|P5|Part 1|Adverse Event|0
1799111|NCT00537316|6257130|P4|Part 1|Adverse Event|0
1799112|NCT00537316|6257131|P3|Part 1|Adverse Event|8
1799113|NCT00537316|6257132|P2|Part 1|Adverse Event|11
1799114|NCT00537316|6257133|P1|Part 1|Adverse Event|7
1799115|NCT00537303|6257160|P2|Overall Study|Unclassified|7
1799116|NCT00537303|6257161|P1|Overall Study|Unclassified|8
1799117|NCT00537303|6257160|P2|Overall Study|Withdrawal criteria|3
1799118|NCT00537303|6257161|P1|Overall Study|Withdrawal criteria|3
1799119|NCT00537303|6257160|P2|Overall Study|Protocol Violation|4
1799120|NCT00537303|6257161|P1|Overall Study|Protocol Violation|8
1799121|NCT00537303|6257160|P2|Overall Study|Lack of Efficacy|7
1799122|NCT00537303|6257161|P1|Overall Study|Lack of Efficacy|6
1799123|NCT00537303|6257160|P2|Overall Study|Adverse Event|4
1799124|NCT00537303|6257161|P1|Overall Study|Adverse Event|1
1799125|NCT00537277|6257182|P1|Overall Study|Non-compliance with trial procedures|15
1799126|NCT00537277|6257182|P1|Overall Study|Inability to tolerate trial medication|4
1799127|NCT00537277|6257182|P1|Overall Study|Unclassified|4
1799128|NCT00537277|6257182|P1|Overall Study|Protocol Violation|11
1799129|NCT00537277|6257182|P1|Overall Study|Lost to Follow-up|12
1799130|NCT00537277|6257182|P1|Overall Study|Lack of Efficacy|2
1799131|NCT00537277|6257182|P1|Overall Study|Adverse Event|1
1799132|NCT00537238|6257193|P2|Overall Study|Other|52
1799133|NCT00537238|6257194|P1|Overall Study|Other|44
1799134|NCT00537238|6257193|P2|Overall Study|Does not meet entrance criteria|2
1799135|NCT00537238|6257194|P1|Overall Study|Does not meet entrance criteria|0
1799136|NCT00537238|6257193|P2|Overall Study|Protocol Violation|19
1799137|NCT00537238|6257194|P1|Overall Study|Protocol Violation|15
1799138|NCT00537238|6257193|P2|Overall Study|Withdrawal by Subject|47
1799139|NCT00537238|6257194|P1|Overall Study|Withdrawal by Subject|51
1799140|NCT00537238|6257193|P2|Overall Study|Lost to Follow-up|8
1799141|NCT00537238|6257194|P1|Overall Study|Lost to Follow-up|12
1799142|NCT00537238|6257193|P2|Overall Study|Lack of Efficacy|21
1799143|NCT00537238|6257194|P1|Overall Study|Lack of Efficacy|20
1799144|NCT00537238|6257193|P2|Overall Study|Adverse Event|22
1799145|NCT00537238|6257194|P1|Overall Study|Adverse Event|31
1799146|NCT00537238|6257193|P2|Overall Study|Death|2
1799147|NCT00537238|6257194|P1|Overall Study|Death|1
1799148|NCT00537199|6257214|P1|Overall Study|Study Terminated|1
1799149|NCT00537095|6257220|P2|Overall Study|Incorrect enrolment|1
1799150|NCT00537095|6257221|P1|Overall Study|Incorrect enrolment|0
1799151|NCT00537095|6257220|P2|Overall Study|subjective disease progression|1
1799152|NCT00537095|6257221|P1|Overall Study|subjective disease progression|0
1799153|NCT00537095|6257220|P2|Overall Study|Withdrawal by Subject|2
1799154|NCT00537095|6257221|P1|Overall Study|Withdrawal by Subject|2
1799155|NCT00537095|6257220|P2|Overall Study|Death|1
1799156|NCT00537095|6257221|P1|Overall Study|Death|3
1799157|NCT00537095|6257220|P2|Overall Study|disease progression|48
1799158|NCT00537095|6257221|P1|Overall Study|disease progression|21
1799159|NCT00537095|6257220|P2|Overall Study|Adverse Event|4
1799160|NCT00537095|6257221|P1|Overall Study|Adverse Event|24
1799161|NCT00537095|6257220|P2|Overall Study|surgery|0
1799162|NCT00537095|6257221|P1|Overall Study|surgery|1
1799163|NCT00537082|6257236|P3|Overall Study|Discontinued before initiating treatment|0
1799164|NCT00537082|6257237|P2|Overall Study|Discontinued before initiating treatment|0
1799165|NCT00537082|6257238|P1|Overall Study|Discontinued before initiating treatment|3
1799166|NCT00537082|6257236|P3|Overall Study|Withdrawal by Subject|0
1799167|NCT00537082|6257237|P2|Overall Study|Withdrawal by Subject|1
1799168|NCT00537082|6257238|P1|Overall Study|Withdrawal by Subject|0
1799169|NCT00537082|6257236|P3|Overall Study|Lack of Efficacy|2
1799170|NCT00537082|6257237|P2|Overall Study|Lack of Efficacy|0
1799171|NCT00537082|6257238|P1|Overall Study|Lack of Efficacy|0
1799172|NCT00537082|6257236|P3|Overall Study|Protocol Violation|1
1799173|NCT00537082|6257237|P2|Overall Study|Protocol Violation|2
1799174|NCT00537082|6257238|P1|Overall Study|Protocol Violation|0
1799175|NCT00537082|6257236|P3|Overall Study|Adverse Event|3
1799176|NCT00537082|6257237|P2|Overall Study|Adverse Event|6
1799177|NCT00537082|6257238|P1|Overall Study|Adverse Event|6
1799178|NCT00537056|6257255|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
1799179|NCT00537030|6257267|P1|Overall Study|Inevaluable|2
1799180|NCT00537030|6257267|P1|Overall Study|Ineligible|2
1799181|NCT00537030|6257267|P1|Overall Study|Disease progression/ relapse during Tx|1
1799182|NCT00537030|6257267|P1|Overall Study|≥ Grade 2 allergy|7
1799183|NCT00537030|6257267|P1|Overall Study|Withdrawal by Subject|2
1799184|NCT00537030|6257267|P1|Overall Study|Physician Decision|2
1799185|NCT00537017|6257274|P1|Follow-up Phase|Withdrawal by Subject|9
1799186|NCT00537017|6257274|P1|Treatment Phase|Protocol Violation|2
1799187|NCT00537017|6257274|P1|Treatment Phase|Withdrawal by Subject|13
1799188|NCT00537017|6257274|P1|Treatment Phase|Adverse Event|19
1799189|NCT00536991|6257285|P1|Overall Study|patient ineligible|2
1799190|NCT00536991|6257285|P1|Overall Study|Physician Decision|1
1799191|NCT00536991|6257285|P1|Overall Study|Withdrawal by Subject|10
1799192|NCT00536978|6257292|P1|Overall Study|Not eligible for Adback Infusion|22
1799193|NCT00536874|6257321|P1|Overall Study|Withdrawal by Subject|1
1799194|NCT00536874|6257321|P1|Overall Study|Death|2
1799195|NCT00536874|6257321|P1|Overall Study|Adverse Event|1
1799196|NCT00536809|6257331|P1|Phase II|Referred for surgical resection|1
1799197|NCT00536809|6257331|P1|Phase II|Adverse Event|1
1799198|NCT00536744|6257354|P2|Overall Study|PI tried alternative treatment|3
1799199|NCT00536744|6257355|P1|Overall Study|PI tried alternative treatment|1
1799200|NCT00536744|6257354|P2|Overall Study|Withdrawal by Subject|8
1799201|NCT00536744|6257355|P1|Overall Study|Withdrawal by Subject|7
1799202|NCT00536744|6257354|P2|Overall Study|Lost to Follow-up|5
1799203|NCT00536744|6257355|P1|Overall Study|Lost to Follow-up|3
1799204|NCT00536744|6257354|P2|Overall Study|Physician Decision|1
1799205|NCT00536744|6257355|P1|Overall Study|Physician Decision|3
1799206|NCT00536744|6257354|P2|Overall Study|Death|1
1799207|NCT00536744|6257355|P1|Overall Study|Death|2
1799208|NCT00536744|6257354|P2|Overall Study|Adverse Event|10
1799209|NCT00536744|6257355|P1|Overall Study|Adverse Event|13
1799210|NCT00536731|6257364|P3|Overall Study|Other|0
1799211|NCT00536731|6257365|P2|Overall Study|Other|1
1799212|NCT00536731|6257366|P1|Overall Study|Other|1
1799213|NCT00536731|6257364|P3|Overall Study|Safety reasons|1
1799214|NCT00536731|6257365|P2|Overall Study|Safety reasons|0
1799215|NCT00536731|6257366|P1|Overall Study|Safety reasons|0
1799216|NCT00536731|6257364|P3|Overall Study|Intake of prohibited conc. medication|1
1799217|NCT00536731|6257365|P2|Overall Study|Intake of prohibited conc. medication|0
1799218|NCT00536731|6257366|P1|Overall Study|Intake of prohibited conc. medication|0
1799219|NCT00536731|6257364|P3|Overall Study|Withdrawal by Subject|0
1799220|NCT00536731|6257365|P2|Overall Study|Withdrawal by Subject|2
1799221|NCT00536731|6257366|P1|Overall Study|Withdrawal by Subject|0
1799222|NCT00536731|6257364|P3|Overall Study|Adverse Event|3
1799223|NCT00536731|6257365|P2|Overall Study|Adverse Event|2
1799224|NCT00536731|6257366|P1|Overall Study|Adverse Event|3
1799225|NCT00536575|6257410|P1|Overall Study|Death|1
1799226|NCT00536575|6257410|P1|Overall Study|Withdrawal by Subject|1
1799227|NCT00536510|6257416|P2|Overall Study|Patient Discontinued for Other Reasons|2
1799228|NCT00536510|6257417|P1|Overall Study|Patient Discontinued for Other Reasons|2
1799229|NCT00536510|6257416|P2|Overall Study|Laboratory Adverse Event|1
1799230|NCT00536510|6257417|P1|Overall Study|Laboratory Adverse Event|2
1799231|NCT00536510|6257416|P2|Overall Study|Flushing with Product|0
1799232|NCT00536510|6257417|P1|Overall Study|Flushing with Product|20
1799233|NCT00536510|6257416|P2|Overall Study|Withdrawal by Subject|9
1799234|NCT00536510|6257417|P1|Overall Study|Withdrawal by Subject|16
1799235|NCT00536510|6257416|P2|Overall Study|Protocol Violation|5
1799236|NCT00536510|6257417|P1|Overall Study|Protocol Violation|4
1799237|NCT00536510|6257416|P2|Overall Study|Lost to Follow-up|8
1799238|NCT00536510|6257417|P1|Overall Study|Lost to Follow-up|11
1799239|NCT00536510|6257416|P2|Overall Study|Adverse Event|4
1799240|NCT00536510|6257417|P1|Overall Study|Adverse Event|27
1799241|NCT00536484|6257427|P2|Overall Study|Other|0
1799242|NCT00536484|6257428|P1|Overall Study|Other|4
1799243|NCT00536484|6257427|P2|Overall Study|Lack of Efficacy|5
1799244|NCT00536484|6257428|P1|Overall Study|Lack of Efficacy|16
1799245|NCT00536484|6257427|P2|Overall Study|Lost to Follow-up|6
1799246|NCT00536484|6257428|P1|Overall Study|Lost to Follow-up|8
1799247|NCT00536484|6257427|P2|Overall Study|Withdrawal by Subject|11
1799248|NCT00536484|6257428|P1|Overall Study|Withdrawal by Subject|11
1799249|NCT00536484|6257427|P2|Overall Study|Adverse Event|34
1799250|NCT00536484|6257428|P1|Overall Study|Adverse Event|21
1799251|NCT00536471|6257462|P4|Overall Study|Sponsor Decision|2
1799252|NCT00536471|6257463|P3|Overall Study|Sponsor Decision|3
1799253|NCT00536471|6257464|P2|Overall Study|Sponsor Decision|1
1799254|NCT00536471|6257465|P1|Overall Study|Sponsor Decision|0
1799255|NCT00536471|6257462|P4|Overall Study|Death|2
1799256|NCT00536471|6257463|P3|Overall Study|Death|1
1799257|NCT00536471|6257464|P2|Overall Study|Death|0
1799258|NCT00536471|6257465|P1|Overall Study|Death|0
1799259|NCT00536471|6257462|P4|Overall Study|Physician Decision|2
1799260|NCT00536471|6257463|P3|Overall Study|Physician Decision|3
1799261|NCT00536471|6257464|P2|Overall Study|Physician Decision|1
1799262|NCT00536471|6257465|P1|Overall Study|Physician Decision|11
1799263|NCT00536471|6257462|P4|Overall Study|Protocol Violation|3
1799264|NCT00536471|6257463|P3|Overall Study|Protocol Violation|2
1799265|NCT00536471|6257464|P2|Overall Study|Protocol Violation|1
1799266|NCT00536471|6257465|P1|Overall Study|Protocol Violation|8
1799267|NCT00536471|6257462|P4|Overall Study|Lack of Efficacy|9
1799268|NCT00536471|6257463|P3|Overall Study|Lack of Efficacy|11
1799269|NCT00536471|6257464|P2|Overall Study|Lack of Efficacy|18
1799270|NCT00536471|6257465|P1|Overall Study|Lack of Efficacy|17
1799271|NCT00536471|6257462|P4|Overall Study|Withdrawal by Subject|21
1799272|NCT00536471|6257463|P3|Overall Study|Withdrawal by Subject|43
1799273|NCT00536471|6257464|P2|Overall Study|Withdrawal by Subject|24
1799274|NCT00536471|6257465|P1|Overall Study|Withdrawal by Subject|40
1799275|NCT00536471|6257462|P4|Overall Study|Adverse Event|13
1799276|NCT00536471|6257463|P3|Overall Study|Adverse Event|28
1799277|NCT00536471|6257464|P2|Overall Study|Adverse Event|16
1799278|NCT00536471|6257465|P1|Overall Study|Adverse Event|32
1799279|NCT00536471|6257462|P4|Overall Study|Lost to Follow-up|22
1799280|NCT00536471|6257463|P3|Overall Study|Lost to Follow-up|48
1799281|NCT00536471|6257464|P2|Overall Study|Lost to Follow-up|23
1799282|NCT00536471|6257465|P1|Overall Study|Lost to Follow-up|48
1799283|NCT00536380|6257710|P3|Overall Study|Administrative|1
1799284|NCT00536380|6257711|P2|Overall Study|Administrative|0
1799285|NCT00536380|6257712|P1|Overall Study|Administrative|0
1799286|NCT00536380|6257710|P3|Overall Study|Did not meet protocol eligibility|1
1799287|NCT00536380|6257711|P2|Overall Study|Did not meet protocol eligibility|0
1799288|NCT00536380|6257712|P1|Overall Study|Did not meet protocol eligibility|0
1799289|NCT00536380|6257710|P3|Overall Study|Noncompliance with protocol|2
1799290|NCT00536380|6257711|P2|Overall Study|Noncompliance with protocol|2
1799291|NCT00536380|6257712|P1|Overall Study|Noncompliance with protocol|3
1799292|NCT00536380|6257710|P3|Overall Study|Withdrawal related to study drug|2
1799293|NCT00536380|6257711|P2|Overall Study|Withdrawal related to study drug|5
1799294|NCT00536380|6257712|P1|Overall Study|Withdrawal related to study drug|7
1799295|NCT00536380|6257710|P3|Overall Study|Withdrawal unrelated to study drug|1
1799296|NCT00536380|6257711|P2|Overall Study|Withdrawal unrelated to study drug|0
1799297|NCT00536380|6257712|P1|Overall Study|Withdrawal unrelated to study drug|2
1799298|NCT00536380|6257710|P3|Overall Study|Lost to Follow-up|1
1799299|NCT00536380|6257711|P2|Overall Study|Lost to Follow-up|0
1799300|NCT00536380|6257712|P1|Overall Study|Lost to Follow-up|0
1799301|NCT00536380|6257710|P3|Overall Study|Adverse Event|2
1799302|NCT00536380|6257711|P2|Overall Study|Adverse Event|2
1799303|NCT00536380|6257712|P1|Overall Study|Adverse Event|0
1799304|NCT00536263|6257736|P3|Overall Study|Did not meet protocol eligibility|2
1799305|NCT00536263|6257737|P2|Overall Study|Did not meet protocol eligibility|2
1799306|NCT00536263|6257738|P1|Overall Study|Did not meet protocol eligibility|1
1799307|NCT00536263|6257736|P3|Overall Study|Noncompliance with protocol|1
1799308|NCT00536263|6257737|P2|Overall Study|Noncompliance with protocol|0
1799309|NCT00536263|6257738|P1|Overall Study|Noncompliance with protocol|0
1799310|NCT00536263|6257736|P3|Overall Study|Subject withdrew - treatment related|2
1799311|NCT00536263|6257737|P2|Overall Study|Subject withdrew - treatment related|3
1799312|NCT00536263|6257738|P1|Overall Study|Subject withdrew - treatment related|0
1799313|NCT00536263|6257736|P3|Overall Study|Subject withdrew - not treatment related|5
1799314|NCT00536263|6257737|P2|Overall Study|Subject withdrew - not treatment related|0
1799315|NCT00536263|6257738|P1|Overall Study|Subject withdrew - not treatment related|2
1799316|NCT00536263|6257736|P3|Overall Study|Lost to Follow-up|4
1799317|NCT00536263|6257737|P2|Overall Study|Lost to Follow-up|4
1799318|NCT00536263|6257738|P1|Overall Study|Lost to Follow-up|3
1799319|NCT00536263|6257736|P3|Overall Study|Adverse Event|7
1799320|NCT00536263|6257737|P2|Overall Study|Adverse Event|5
1799321|NCT00536263|6257738|P1|Overall Study|Adverse Event|5
1799322|NCT00536198|6257778|P2|Overall Study|Protocol Violation|1
1799323|NCT00536198|6257779|P1|Overall Study|Protocol Violation|0
1799324|NCT00536198|6257778|P2|Overall Study|Pregnancy|1
1799325|NCT00536198|6257779|P1|Overall Study|Pregnancy|1
1799326|NCT00536198|6257778|P2|Overall Study|Rescue|9
1799327|NCT00536198|6257779|P1|Overall Study|Rescue|3
1799328|NCT00536198|6257778|P2|Overall Study|Adverse Event|2
1799329|NCT00536198|6257779|P1|Overall Study|Adverse Event|2
1799330|NCT00536198|6257778|P2|Overall Study|Withdrawal by Subject|12
1799331|NCT00536198|6257779|P1|Overall Study|Withdrawal by Subject|16
1799332|NCT00536198|6257778|P2|Overall Study|Lost to Follow-up|14
1799333|NCT00536198|6257779|P1|Overall Study|Lost to Follow-up|15
1799334|NCT00536120|6257818|P2|Overall Study|Missed Study Visit|1
1799335|NCT00536120|6257819|P1|Overall Study|Missed Study Visit|0
1799336|NCT00536120|6257818|P2|Overall Study|Steroid Use|2
1799337|NCT00536120|6257819|P1|Overall Study|Steroid Use|0
1799338|NCT00536120|6257818|P2|Overall Study|Sponsor Decision Due to Lab Values|0
1799339|NCT00536120|6257819|P1|Overall Study|Sponsor Decision Due to Lab Values|1
1799340|NCT00536120|6257818|P2|Overall Study|Non-compliance|0
1799341|NCT00536120|6257819|P1|Overall Study|Non-compliance|1
1799342|NCT00536120|6257818|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
1799343|NCT00536120|6257819|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
1799344|NCT00536120|6257818|P2|Overall Study|Lost to Follow-up|0
1799345|NCT00536120|6257819|P1|Overall Study|Lost to Follow-up|1
1799346|NCT00536107|6257833|P2|Overall Study|Study Termination|4
1799347|NCT00536107|6257834|P1|Overall Study|Study Termination|2
1799348|NCT00536107|6257833|P2|Overall Study|Withdrawal by Subject|1
1799349|NCT00536107|6257834|P1|Overall Study|Withdrawal by Subject|0
1799350|NCT00536107|6257833|P2|Overall Study|Incorrect enrolment|0
1799351|NCT00536107|6257834|P1|Overall Study|Incorrect enrolment|1
1799352|NCT00536107|6257833|P2|Overall Study|Death|1
1799353|NCT00536107|6257834|P1|Overall Study|Death|5
1799354|NCT00535847|6257888|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
1799355|NCT00535847|6257889|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
1799356|NCT00535847|6257890|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
1799357|NCT00535847|6257888|P3|Overall Study|Non compliance|0
1799358|NCT00535847|6257889|P2|Overall Study|Non compliance|1
1799359|NCT00535847|6257890|P1|Overall Study|Non compliance|1
1799360|NCT00535847|6257888|P3|Overall Study|Adverse Event|2
1799361|NCT00535847|6257889|P2|Overall Study|Adverse Event|3
1799362|NCT00535847|6257890|P1|Overall Study|Adverse Event|5
1799363|NCT00535730|6258125|P2|Overall Study|Withdrawal by Subject|4
1799364|NCT00535730|6258126|P1|Overall Study|Withdrawal by Subject|0
1799365|NCT00535730|6258125|P2|Overall Study|Protocol Violation|0
1799366|NCT00535730|6258126|P1|Overall Study|Protocol Violation|1
1799367|NCT00535730|6258125|P2|Overall Study|Physician Decision|1
1799368|NCT00535730|6258126|P1|Overall Study|Physician Decision|0
1799369|NCT00535730|6258125|P2|Overall Study|Lost to Follow-up|1
1799370|NCT00535730|6258126|P1|Overall Study|Lost to Follow-up|0
1799371|NCT00535730|6258125|P2|Overall Study|Adverse Event|1
1799372|NCT00535730|6258126|P1|Overall Study|Adverse Event|1
1799373|NCT00535626|6258147|P1|Overall Study|Unable to return|2
1799374|NCT00535626|6258147|P1|Overall Study|Subject terminated|31
1799375|NCT00535626|6258147|P1|Overall Study|Removal/revision of study component|8
1799376|NCT00535626|6258147|P1|Overall Study|Withdrawal by Subject|20
1799377|NCT00535626|6258147|P1|Overall Study|Lost to Follow-up|29
1799378|NCT00535626|6258147|P1|Overall Study|Death|15
1799379|NCT00535496|6258187|P4|Overall Study|Not treated with sugammadex|0
1799380|NCT00535496|6258188|P3|Overall Study|Not treated with sugammadex|0
1799381|NCT00535496|6258189|P2|Overall Study|Not treated with sugammadex|1
1799382|NCT00535496|6258190|P1|Overall Study|Not treated with sugammadex|0
1799383|NCT00535496|6258187|P4|Overall Study|Lost to Follow-up|0
1799384|NCT00535496|6258188|P3|Overall Study|Lost to Follow-up|0
1799385|NCT00535496|6258189|P2|Overall Study|Lost to Follow-up|1
1799386|NCT00535496|6258190|P1|Overall Study|Lost to Follow-up|0
1799387|NCT00535405|6258210|P5|Overall Study|Withdrawal by Subject|8
1799388|NCT00535405|6258211|P4|Overall Study|Withdrawal by Subject|10
1799389|NCT00535405|6258212|P3|Overall Study|Withdrawal by Subject|10
1799390|NCT00535405|6258213|P2|Overall Study|Withdrawal by Subject|11
1799391|NCT00535405|6258214|P1|Overall Study|Withdrawal by Subject|5
1799392|NCT00535405|6258210|P5|Overall Study|Protocol Violation|0
1799393|NCT00535405|6258211|P4|Overall Study|Protocol Violation|1
1799394|NCT00535405|6258212|P3|Overall Study|Protocol Violation|2
1799395|NCT00535405|6258213|P2|Overall Study|Protocol Violation|2
1799396|NCT00535405|6258214|P1|Overall Study|Protocol Violation|2
1799397|NCT00535405|6258210|P5|Overall Study|Physician Decision|1
1799398|NCT00535405|6258211|P4|Overall Study|Physician Decision|1
1799399|NCT00535405|6258212|P3|Overall Study|Physician Decision|0
1799400|NCT00535405|6258213|P2|Overall Study|Physician Decision|2
1799401|NCT00535405|6258214|P1|Overall Study|Physician Decision|3
1799402|NCT00535405|6258210|P5|Overall Study|Lost to Follow-up|1
1799403|NCT00535405|6258211|P4|Overall Study|Lost to Follow-up|2
1799404|NCT00535405|6258212|P3|Overall Study|Lost to Follow-up|3
1799405|NCT00535405|6258213|P2|Overall Study|Lost to Follow-up|3
1799406|NCT00535405|6258214|P1|Overall Study|Lost to Follow-up|1
1799407|NCT00535405|6258210|P5|Overall Study|Adverse Event|6
1799408|NCT00535405|6258211|P4|Overall Study|Adverse Event|8
1799409|NCT00535405|6258212|P3|Overall Study|Adverse Event|3
1799410|NCT00535405|6258213|P2|Overall Study|Adverse Event|8
1799411|NCT00535405|6258214|P1|Overall Study|Adverse Event|6
1799412|NCT00535288|6258275|P5|Overall Study|Other|1
1799413|NCT00535288|6258276|P4|Overall Study|Other|2
1799414|NCT00535288|6258277|P3|Overall Study|Other|1
1799415|NCT00535288|6258278|P2|Overall Study|Other|1
1799416|NCT00535288|6258279|P1|Overall Study|Other|2
1799417|NCT00535288|6258275|P5|Overall Study|Unwilling to cooperate|4
1799418|NCT00535288|6258276|P4|Overall Study|Unwilling to cooperate|3
1799419|NCT00535288|6258277|P3|Overall Study|Unwilling to cooperate|3
1799420|NCT00535288|6258278|P2|Overall Study|Unwilling to cooperate|6
1799421|NCT00535288|6258279|P1|Overall Study|Unwilling to cooperate|6
1799422|NCT00535288|6258275|P5|Overall Study|Lack of Efficacy|7
1799423|NCT00535288|6258276|P4|Overall Study|Lack of Efficacy|4
1799424|NCT00535288|6258277|P3|Overall Study|Lack of Efficacy|4
1799425|NCT00535288|6258278|P2|Overall Study|Lack of Efficacy|3
1799426|NCT00535288|6258279|P1|Overall Study|Lack of Efficacy|26
1799427|NCT00535288|6258275|P5|Overall Study|Lost to Follow-up|0
1799428|NCT00535288|6258276|P4|Overall Study|Lost to Follow-up|0
1799429|NCT00535288|6258277|P3|Overall Study|Lost to Follow-up|0
1799430|NCT00535288|6258278|P2|Overall Study|Lost to Follow-up|3
1799431|NCT00535288|6258279|P1|Overall Study|Lost to Follow-up|0
1799432|NCT00535288|6258275|P5|Overall Study|Adverse Event|30
1799433|NCT00535288|6258276|P4|Overall Study|Adverse Event|20
1799434|NCT00535288|6258277|P3|Overall Study|Adverse Event|25
1799435|NCT00535288|6258278|P2|Overall Study|Adverse Event|19
1799436|NCT00535288|6258279|P1|Overall Study|Adverse Event|20
1799437|NCT00535262|6258356|P1|Overall Study|No funding|3
1799438|NCT00535236|6258370|P10|Overall Study|Withdrawal by Subject|2
1799439|NCT00535236|6258371|P9|Overall Study|Withdrawal by Subject|4
1799440|NCT00535236|6258372|P8|Overall Study|Withdrawal by Subject|0
1799441|NCT00535236|6258373|P7|Overall Study|Withdrawal by Subject|5
1799442|NCT00535236|6258374|P6|Overall Study|Withdrawal by Subject|1
1799443|NCT00535236|6258375|P5|Overall Study|Withdrawal by Subject|6
1799444|NCT00535236|6258376|P4|Overall Study|Withdrawal by Subject|1
1799445|NCT00535236|6258377|P3|Overall Study|Withdrawal by Subject|2
1799446|NCT00535236|6258378|P2|Overall Study|Withdrawal by Subject|0
1799447|NCT00535236|6258379|P1|Overall Study|Withdrawal by Subject|3
1799448|NCT00535236|6258370|P10|Overall Study|Protocol Violation|0
1799449|NCT00535236|6258371|P9|Overall Study|Protocol Violation|1
1799450|NCT00535236|6258372|P8|Overall Study|Protocol Violation|0
1799451|NCT00535236|6258373|P7|Overall Study|Protocol Violation|0
1799452|NCT00535236|6258374|P6|Overall Study|Protocol Violation|0
1799453|NCT00535236|6258375|P5|Overall Study|Protocol Violation|0
1799454|NCT00535236|6258376|P4|Overall Study|Protocol Violation|0
1799455|NCT00535236|6258377|P3|Overall Study|Protocol Violation|1
1799456|NCT00535236|6258378|P2|Overall Study|Protocol Violation|0
1799457|NCT00535236|6258379|P1|Overall Study|Protocol Violation|2
1799458|NCT00535236|6258370|P10|Overall Study|Physician Decision|0
1799459|NCT00535236|6258371|P9|Overall Study|Physician Decision|0
1799460|NCT00535236|6258372|P8|Overall Study|Physician Decision|0
1799461|NCT00535236|6258373|P7|Overall Study|Physician Decision|1
1799462|NCT00535236|6258374|P6|Overall Study|Physician Decision|0
1799463|NCT00535236|6258375|P5|Overall Study|Physician Decision|1
1799464|NCT00535236|6258376|P4|Overall Study|Physician Decision|0
1799465|NCT00535236|6258377|P3|Overall Study|Physician Decision|0
1799466|NCT00535236|6258378|P2|Overall Study|Physician Decision|0
1799467|NCT00535236|6258379|P1|Overall Study|Physician Decision|0
1799468|NCT00535236|6258370|P10|Overall Study|Lost to Follow-up|1
1799469|NCT00535236|6258371|P9|Overall Study|Lost to Follow-up|6
1799470|NCT00535236|6258372|P8|Overall Study|Lost to Follow-up|0
1799471|NCT00535236|6258373|P7|Overall Study|Lost to Follow-up|0
1799472|NCT00535236|6258374|P6|Overall Study|Lost to Follow-up|0
1799473|NCT00535236|6258375|P5|Overall Study|Lost to Follow-up|2
1799474|NCT00535236|6258376|P4|Overall Study|Lost to Follow-up|0
1799475|NCT00535236|6258377|P3|Overall Study|Lost to Follow-up|0
1799476|NCT00535236|6258378|P2|Overall Study|Lost to Follow-up|2
1799477|NCT00535236|6258379|P1|Overall Study|Lost to Follow-up|1
1799478|NCT00535236|6258370|P10|Overall Study|Adverse Event|1
1799479|NCT00535236|6258371|P9|Overall Study|Adverse Event|2
1799480|NCT00535236|6258372|P8|Overall Study|Adverse Event|1
1799481|NCT00535236|6258373|P7|Overall Study|Adverse Event|5
1799482|NCT00535236|6258374|P6|Overall Study|Adverse Event|0
1799483|NCT00535236|6258375|P5|Overall Study|Adverse Event|3
1799484|NCT00535236|6258376|P4|Overall Study|Adverse Event|3
1799485|NCT00535236|6258377|P3|Overall Study|Adverse Event|9
1799486|NCT00535236|6258378|P2|Overall Study|Adverse Event|0
1799487|NCT00535236|6258379|P1|Overall Study|Adverse Event|1
1799488|NCT00535223|6258439|P2|Overall Study|Withdrawal by Subject|1
1799489|NCT00535223|6258440|P1|Overall Study|Withdrawal by Subject|4
1799490|NCT00535145|6258448|P1|Phase II|Subject non-compliance|2
1799491|NCT00535145|6258448|P1|Phase II|Withdrawal by Subject|5
1799492|NCT00535145|6258448|P1|Phase II|Lost to Follow-up|5
1799493|NCT00535145|6258448|P1|Phase II|Lack of Efficacy|1
1799494|NCT00535145|6258448|P1|Phase II|Adverse Event|2
1799495|NCT00535145|6258448|P1|Phase I|(diagnosis)|3
1799496|NCT00535145|6258448|P1|Phase I|(PI decision)|1
1799497|NCT00535145|6258448|P1|Phase I|(protocol violation)|1
1799498|NCT00535145|6258448|P1|Phase I|(eligibility)|8
1799499|NCT00535145|6258448|P1|Phase I|Withdrawal by Subject|6
1799500|NCT00535145|6258448|P1|Phase I|Lost to Follow-up|7
1799501|NCT00535145|6258448|P1|Phase I|Adverse Event|3
1799502|NCT00535132|6258460|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
1799503|NCT00535132|6258461|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
1799504|NCT00535132|6258460|P2|Safety Analysis Set|Did Not Receive Study Medication|2
1799505|NCT00535132|6258461|P1|Safety Analysis Set|Did Not Receive Study Medication|2
1799506|NCT00534976|6258542|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
1799507|NCT00534976|6258543|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
1799508|NCT00534976|6258542|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
1799509|NCT00534976|6258543|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
1799510|NCT00534976|6258542|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
1799511|NCT00534976|6258543|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
1799512|NCT00534638|6258623|P2|Overall Study|Other|902
1799513|NCT00534638|6258624|P1|Overall Study|Other|1685
1799514|NCT00534638|6258623|P2|Overall Study|Lost to follow-up, complete vaccination|10757
1799515|NCT00534638|6258624|P1|Overall Study|Lost to follow-up, complete vaccination|4707
1799516|NCT00534638|6258623|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
1799517|NCT00534638|6258624|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
1799518|NCT00534638|6258623|P2|Overall Study|Migrated/moved from study area|11
1799519|NCT00534638|6258624|P1|Overall Study|Migrated/moved from study area|13
1799520|NCT00534638|6258623|P2|Overall Study|Withdrawal by Subject|4
1799521|NCT00534638|6258624|P1|Overall Study|Withdrawal by Subject|3
1799522|NCT00534599|6258662|P2|Overall Study|Other|0
1799523|NCT00534599|6258663|P1|Overall Study|Other|7
1799524|NCT00534599|6258662|P2|Overall Study|Withdrawal by Subject|6
1799525|NCT00534599|6258663|P1|Overall Study|Withdrawal by Subject|4
1799526|NCT00534599|6258662|P2|Overall Study|Lost to Follow-up|14
1799527|NCT00534599|6258663|P1|Overall Study|Lost to Follow-up|11
1799528|NCT00534599|6258662|P2|Overall Study|Protocol Violation|3
1799529|NCT00534599|6258663|P1|Overall Study|Protocol Violation|1
1799530|NCT00534599|6258662|P2|Overall Study|Generalized anxiety disorder worsened|1
1799531|NCT00534599|6258663|P1|Overall Study|Generalized anxiety disorder worsened|0
1799532|NCT00534599|6258662|P2|Overall Study|Lack of Efficacy|1
1799533|NCT00534599|6258663|P1|Overall Study|Lack of Efficacy|0
1799534|NCT00534599|6258662|P2|Overall Study|Developed study-specific d/c criteria|0
1799535|NCT00534599|6258663|P1|Overall Study|Developed study-specific d/c criteria|5
1799536|NCT00534599|6258662|P2|Overall Study|Mis-randomization|2
1799537|NCT00534599|6258663|P1|Overall Study|Mis-randomization|2
1799538|NCT00534599|6258662|P2|Overall Study|Incorrect enrollment|1
1799539|NCT00534599|6258663|P1|Overall Study|Incorrect enrollment|2
1799540|NCT00534599|6258662|P2|Overall Study|Adverse Event|4
1799541|NCT00534599|6258663|P1|Overall Study|Adverse Event|25
1799542|NCT00534495|6258699|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
1799543|NCT00534495|6258700|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
1799544|NCT00534495|6258701|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
1799545|NCT00534495|6258699|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
1799546|NCT00534495|6258700|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
1799547|NCT00534495|6258701|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
1799548|NCT00534495|6258699|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
1799549|NCT00534495|6258700|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
1799550|NCT00534495|6258701|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
1799551|NCT00534495|6258699|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
1799552|NCT00534495|6258700|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
1799553|NCT00534495|6258701|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
1799554|NCT00534495|6258699|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
1799555|NCT00534495|6258700|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
1799556|NCT00534495|6258701|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
1799557|NCT00534495|6258699|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
1799558|NCT00534495|6258700|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
1799559|NCT00534495|6258701|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
1799560|NCT00534495|6258699|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
1799561|NCT00534495|6258700|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
1799562|NCT00534495|6258701|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
1799563|NCT00534495|6258699|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
1799564|NCT00534495|6258700|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
1799565|NCT00534495|6258701|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
1799566|NCT00534495|6258699|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
1799567|NCT00534495|6258700|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
1799568|NCT00534495|6258701|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
1799569|NCT00534404|6258739|P3|Overall Study|Lost to Follow-up|201
1799570|NCT00534404|6258740|P2|Overall Study|Lost to Follow-up|138
1799571|NCT00534404|6258741|P1|Overall Study|Lost to Follow-up|170
1799572|NCT00534404|6258739|P3|Overall Study|Removed by study staff|1
1799573|NCT00534404|6258740|P2|Overall Study|Removed by study staff|3
1799574|NCT00534404|6258741|P1|Overall Study|Removed by study staff|2
1799575|NCT00534404|6258739|P3|Overall Study|Withdrawal by Subject|38
1799576|NCT00534404|6258740|P2|Overall Study|Withdrawal by Subject|2
1799577|NCT00534404|6258741|P1|Overall Study|Withdrawal by Subject|8
1799578|NCT00534404|6258739|P3|Overall Study|Death|2
1799579|NCT00534404|6258740|P2|Overall Study|Death|0
1799580|NCT00534404|6258741|P1|Overall Study|Death|0
1799581|NCT00534352|6258772|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
1799582|NCT00534352|6258772|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
1799583|NCT00534352|6258772|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
1799584|NCT00534352|6258772|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
1799585|NCT00534352|6258772|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
1799586|NCT00534352|6258772|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
1799587|NCT00534313|6258816|P4|Long-term Period|Other|2
1799588|NCT00534313|6258817|P3|Long-term Period|Other|2
1799589|NCT00534313|6258818|P2|Long-term Period|Other|2
1799590|NCT00534313|6258819|P1|Long-term Period|Other|1
1799591|NCT00534313|6258816|P4|Long-term Period|Administrative reason by sponsor|18
1799592|NCT00534313|6258817|P3|Long-term Period|Administrative reason by sponsor|26
1799593|NCT00534313|6258818|P2|Long-term Period|Administrative reason by sponsor|15
1799594|NCT00534313|6258819|P1|Long-term Period|Administrative reason by sponsor|17
1799595|NCT00534313|6258816|P4|Long-term Period|Poor compliance/noncompliance|0
1799596|NCT00534313|6258817|P3|Long-term Period|Poor compliance/noncompliance|1
1799597|NCT00534313|6258818|P2|Long-term Period|Poor compliance/noncompliance|1
1799598|NCT00534313|6258819|P1|Long-term Period|Poor compliance/noncompliance|0
1799599|NCT00534313|6258816|P4|Long-term Period|No longer meets study criteria|0
1799600|NCT00534313|6258817|P3|Long-term Period|No longer meets study criteria|0
1799601|NCT00534313|6258818|P2|Long-term Period|No longer meets study criteria|1
1799602|NCT00534313|6258819|P1|Long-term Period|No longer meets study criteria|0
1799603|NCT00534313|6258816|P4|Long-term Period|Withdrawal by Subject|0
1799604|NCT00534313|6258817|P3|Long-term Period|Withdrawal by Subject|0
1799605|NCT00534313|6258818|P2|Long-term Period|Withdrawal by Subject|2
1799606|NCT00534313|6258819|P1|Long-term Period|Withdrawal by Subject|2
1799607|NCT00534313|6258816|P4|Long-term Period|Lost to Follow-up|0
1799608|NCT00534313|6258817|P3|Long-term Period|Lost to Follow-up|0
1799609|NCT00534313|6258818|P2|Long-term Period|Lost to Follow-up|2
1799610|NCT00534313|6258819|P1|Long-term Period|Lost to Follow-up|1
1799611|NCT00534313|6258816|P4|Long-term Period|Lack of Efficacy|12
1799612|NCT00534313|6258817|P3|Long-term Period|Lack of Efficacy|14
1799613|NCT00534313|6258818|P2|Long-term Period|Lack of Efficacy|10
1799614|NCT00534313|6258819|P1|Long-term Period|Lack of Efficacy|14
1799615|NCT00534313|6258816|P4|Long-term Period|Adverse Event|1
1799616|NCT00534313|6258817|P3|Long-term Period|Adverse Event|0
1799617|NCT00534313|6258818|P2|Long-term Period|Adverse Event|1
1799618|NCT00534313|6258819|P1|Long-term Period|Adverse Event|2
1799619|NCT00534313|6258816|P4|Short-term Period|Pregnancy|0
1799620|NCT00534313|6258817|P3|Short-term Period|Pregnancy|1
1799621|NCT00534313|6258818|P2|Short-term Period|Pregnancy|0
1799622|NCT00534313|6258819|P1|Short-term Period|Pregnancy|0
1799623|NCT00534313|6258816|P4|Short-term Period|Participant withdrew consent|2
1799624|NCT00534313|6258817|P3|Short-term Period|Participant withdrew consent|0
1799625|NCT00534313|6258818|P2|Short-term Period|Participant withdrew consent|0
1799626|NCT00534313|6258819|P1|Short-term Period|Participant withdrew consent|2
1799627|NCT00534313|6258816|P4|Short-term Period|Participant not meeting study criteria|1
1799628|NCT00534313|6258817|P3|Short-term Period|Participant not meeting study criteria|0
1799629|NCT00534313|6258818|P2|Short-term Period|Participant not meeting study criteria|0
1799630|NCT00534313|6258819|P1|Short-term Period|Participant not meeting study criteria|0
1799631|NCT00534313|6258816|P4|Short-term Period|Lack of Efficacy|3
1799632|NCT00534313|6258817|P3|Short-term Period|Lack of Efficacy|0
1799633|NCT00534313|6258818|P2|Short-term Period|Lack of Efficacy|4
1799634|NCT00534313|6258819|P1|Short-term Period|Lack of Efficacy|3
1799635|NCT00534313|6258816|P4|Short-term Period|Adverse Event|3
1799636|NCT00534313|6258817|P3|Short-term Period|Adverse Event|1
1799637|NCT00534313|6258818|P2|Short-term Period|Adverse Event|2
1799638|NCT00534313|6258819|P1|Short-term Period|Adverse Event|1
1799639|NCT00534248|6258914|P2|Overall Study|Withdrawal by Subject|255
1799640|NCT00534248|6258915|P1|Overall Study|Withdrawal by Subject|263
1799641|NCT00534248|6258914|P2|Overall Study|Protocol Violation|4
1799642|NCT00534248|6258915|P1|Overall Study|Protocol Violation|3
1799643|NCT00534248|6258914|P2|Overall Study|Physician Decision|7
1799644|NCT00534248|6258915|P1|Overall Study|Physician Decision|10
1799645|NCT00534248|6258914|P2|Overall Study|Other protocol specified criteria|3
1799646|NCT00534248|6258915|P1|Overall Study|Other protocol specified criteria|13
1799647|NCT00534248|6258914|P2|Overall Study|Lost to Follow-up|375
1799648|NCT00534248|6258915|P1|Overall Study|Lost to Follow-up|353
1799649|NCT00534248|6258914|P2|Overall Study|Adverse Event|29
1799650|NCT00534248|6258915|P1|Overall Study|Adverse Event|19
1799651|NCT00534105|6259072|P2|Overall Study|Lost to Follow-up|39
1799652|NCT00534105|6259073|P1|Overall Study|Lost to Follow-up|23
1799653|NCT00534092|6259087|P2|Overall Study|personal reasons/family concerns|0
1799654|NCT00534092|6259088|P1|Overall Study|personal reasons/family concerns|1
1799655|NCT00534092|6259087|P2|Overall Study|Lost to Follow-up|0
1799656|NCT00534092|6259088|P1|Overall Study|Lost to Follow-up|1
1799657|NCT00533949|6259126|P4|Overall Study|Withdrawal by Subject|1
1799658|NCT00533949|6259127|P3|Overall Study|Withdrawal by Subject|1
1799659|NCT00533949|6259128|P2|Overall Study|Withdrawal by Subject|2
1799660|NCT00533949|6259129|P1|Overall Study|Withdrawal by Subject|3
1799661|NCT00533949|6259126|P4|Overall Study|Protocol Violation|9
1799662|NCT00533949|6259127|P3|Overall Study|Protocol Violation|9
1799663|NCT00533949|6259128|P2|Overall Study|Protocol Violation|12
1799664|NCT00533949|6259129|P1|Overall Study|Protocol Violation|12
1799665|NCT00533897|6259170|P8|Long Term Extension (LTE)|Other|6
1799666|NCT00533897|6259171|P7|Long Term Extension (LTE)|Other|1
1799667|NCT00533897|6259172|P6|Long Term Extension (LTE)|Other|0
1799668|NCT00533897|6259173|P5|Long Term Extension (LTE)|Other|0
1799669|NCT00533897|6259174|P4|Long Term Extension (LTE)|Other|0
1799670|NCT00533897|6259175|P3|Long Term Extension (LTE)|Other|0
1799671|NCT00533897|6259176|P2|Long Term Extension (LTE)|Other|0
1799672|NCT00533897|6259177|P1|Long Term Extension (LTE)|Other|0
1799673|NCT00533897|6259170|P8|Long Term Extension (LTE)|Lost to Follow-up|1
1799674|NCT00533897|6259171|P7|Long Term Extension (LTE)|Lost to Follow-up|1
1799675|NCT00533897|6259172|P6|Long Term Extension (LTE)|Lost to Follow-up|0
1799676|NCT00533897|6259173|P5|Long Term Extension (LTE)|Lost to Follow-up|0
1799677|NCT00533897|6259174|P4|Long Term Extension (LTE)|Lost to Follow-up|0
1799678|NCT00533897|6259175|P3|Long Term Extension (LTE)|Lost to Follow-up|0
1799679|NCT00533897|6259176|P2|Long Term Extension (LTE)|Lost to Follow-up|0
1799680|NCT00533897|6259177|P1|Long Term Extension (LTE)|Lost to Follow-up|0
1799681|NCT00533897|6259170|P8|Long Term Extension (LTE)|Pregnancy|2
1799682|NCT00533897|6259171|P7|Long Term Extension (LTE)|Pregnancy|0
1799683|NCT00533897|6259172|P6|Long Term Extension (LTE)|Pregnancy|0
1799684|NCT00533897|6259173|P5|Long Term Extension (LTE)|Pregnancy|0
1799685|NCT00533897|6259174|P4|Long Term Extension (LTE)|Pregnancy|0
1799686|NCT00533897|6259175|P3|Long Term Extension (LTE)|Pregnancy|0
1799687|NCT00533897|6259176|P2|Long Term Extension (LTE)|Pregnancy|0
1799688|NCT00533897|6259177|P1|Long Term Extension (LTE)|Pregnancy|0
1799689|NCT00533897|6259170|P8|Long Term Extension (LTE)|Adverse Event|5
1799690|NCT00533897|6259171|P7|Long Term Extension (LTE)|Adverse Event|2
1799691|NCT00533897|6259172|P6|Long Term Extension (LTE)|Adverse Event|0
1799692|NCT00533897|6259173|P5|Long Term Extension (LTE)|Adverse Event|0
1799693|NCT00533897|6259174|P4|Long Term Extension (LTE)|Adverse Event|0
1799694|NCT00533897|6259175|P3|Long Term Extension (LTE)|Adverse Event|0
1799695|NCT00533897|6259176|P2|Long Term Extension (LTE)|Adverse Event|0
1799696|NCT00533897|6259177|P1|Long Term Extension (LTE)|Adverse Event|0
1799697|NCT00533897|6259170|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
1799698|NCT00533897|6259171|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
1799699|NCT00533897|6259172|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
1799700|NCT00533897|6259173|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
1799701|NCT00533897|6259174|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
1799702|NCT00533897|6259175|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
1799703|NCT00533897|6259176|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
1799704|NCT00533897|6259177|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
1799705|NCT00533897|6259170|P8|Long Term Extension (LTE)|Lack of Efficacy|3
1799706|NCT00533897|6259171|P7|Long Term Extension (LTE)|Lack of Efficacy|5
1799707|NCT00533897|6259172|P6|Long Term Extension (LTE)|Lack of Efficacy|0
1799708|NCT00533897|6259173|P5|Long Term Extension (LTE)|Lack of Efficacy|0
1799709|NCT00533897|6259174|P4|Long Term Extension (LTE)|Lack of Efficacy|0
1799710|NCT00533897|6259175|P3|Long Term Extension (LTE)|Lack of Efficacy|0
1799711|NCT00533897|6259176|P2|Long Term Extension (LTE)|Lack of Efficacy|0
1799712|NCT00533897|6259177|P1|Long Term Extension (LTE)|Lack of Efficacy|0
1799713|NCT00533897|6259170|P8|Long Term Extension (LTE)|Death|3
1799714|NCT00533897|6259171|P7|Long Term Extension (LTE)|Death|1
1799715|NCT00533897|6259172|P6|Long Term Extension (LTE)|Death|0
1799716|NCT00533897|6259173|P5|Long Term Extension (LTE)|Death|0
1799717|NCT00533897|6259174|P4|Long Term Extension (LTE)|Death|0
1799718|NCT00533897|6259175|P3|Long Term Extension (LTE)|Death|0
1799719|NCT00533897|6259176|P2|Long Term Extension (LTE)|Death|0
1799720|NCT00533897|6259177|P1|Long Term Extension (LTE)|Death|0
1799721|NCT00533897|6259170|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
1799722|NCT00533897|6259171|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
1799723|NCT00533897|6259172|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
1799724|NCT00533897|6259173|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
1799725|NCT00533897|6259174|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
1799726|NCT00533897|6259175|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
1799727|NCT00533897|6259176|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
1799728|NCT00533897|6259177|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
1799729|NCT00533897|6259170|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1799730|NCT00533897|6259171|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1799731|NCT00533897|6259172|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
1799732|NCT00533897|6259173|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1799733|NCT00533897|6259174|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1799734|NCT00533897|6259175|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1799735|NCT00533897|6259176|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1799736|NCT00533897|6259177|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
1799737|NCT00533897|6259170|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1799738|NCT00533897|6259171|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1799739|NCT00533897|6259172|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
1799740|NCT00533897|6259173|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1799741|NCT00533897|6259174|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1799742|NCT00533897|6259175|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1799743|NCT00533897|6259176|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1799744|NCT00533897|6259177|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
1799745|NCT00533897|6259170|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1799746|NCT00533897|6259171|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1799747|NCT00533897|6259172|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1799748|NCT00533897|6259173|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1799749|NCT00533897|6259174|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1799750|NCT00533897|6259175|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
1799751|NCT00533897|6259176|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1799752|NCT00533897|6259177|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
1799753|NCT00533897|6259170|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1799754|NCT00533897|6259171|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1799755|NCT00533897|6259172|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1799756|NCT00533897|6259173|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1799757|NCT00533897|6259174|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1799758|NCT00533897|6259175|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
1799759|NCT00533897|6259176|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
1799760|NCT00533897|6259177|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
1799761|NCT00533897|6259170|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1799762|NCT00533897|6259171|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1799763|NCT00533897|6259172|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1799764|NCT00533897|6259173|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1799765|NCT00533897|6259174|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1799766|NCT00533897|6259175|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1799767|NCT00533897|6259176|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
1799768|NCT00533897|6259177|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
1799769|NCT00533897|6259170|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
1799770|NCT00533897|6259171|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
1799771|NCT00533897|6259172|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
1799772|NCT00533897|6259173|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
1799773|NCT00533897|6259174|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
1799774|NCT00533897|6259175|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
1799775|NCT00533897|6259176|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
1799776|NCT00533897|6259177|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
1799777|NCT00533897|6259170|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1799778|NCT00533897|6259171|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1799779|NCT00533897|6259172|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1799780|NCT00533897|6259173|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1799781|NCT00533897|6259174|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1799782|NCT00533897|6259175|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1799783|NCT00533897|6259176|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
1799784|NCT00533897|6259177|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
1799785|NCT00533897|6259170|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
1799786|NCT00533897|6259171|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
1799787|NCT00533897|6259172|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
1799788|NCT00533897|6259173|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
1799789|NCT00533897|6259174|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
1799790|NCT00533897|6259175|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
1799791|NCT00533897|6259176|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
1799792|NCT00533897|6259177|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
1799793|NCT00533897|6259170|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1799794|NCT00533897|6259171|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1799795|NCT00533897|6259172|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1799796|NCT00533897|6259173|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1799797|NCT00533897|6259174|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1799798|NCT00533897|6259175|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1799799|NCT00533897|6259176|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
1799800|NCT00533897|6259177|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
1799801|NCT00533897|6259170|P8|Lead-in (LI) Period 1|Adverse Event|0
1799802|NCT00533897|6259171|P7|Lead-in (LI) Period 1|Adverse Event|0
1799803|NCT00533897|6259172|P6|Lead-in (LI) Period 1|Adverse Event|0
1799804|NCT00533897|6259173|P5|Lead-in (LI) Period 1|Adverse Event|0
1799805|NCT00533897|6259174|P4|Lead-in (LI) Period 1|Adverse Event|0
1799806|NCT00533897|6259175|P3|Lead-in (LI) Period 1|Adverse Event|0
1799807|NCT00533897|6259176|P2|Lead-in (LI) Period 1|Adverse Event|0
1799808|NCT00533897|6259177|P1|Lead-in (LI) Period 1|Adverse Event|1
1799809|NCT00533845|6259317|P2|Overall Study|Physician Decision|0
1799810|NCT00533845|6259318|P1|Overall Study|Physician Decision|1
1799811|NCT00533702|6259326|P2|Overall Study|Found ineligible after randomization|1
1799812|NCT00533702|6259327|P1|Overall Study|Found ineligible after randomization|2
1799813|NCT00533702|6259326|P2|Overall Study|Withdrawal by Subject|1
1799814|NCT00533702|6259327|P1|Overall Study|Withdrawal by Subject|3
1799815|NCT00533507|6259358|P1|Overall Study|Withdrawal by Subject|1
1799816|NCT00533273|6259403|P2|Open-label|Withdrawal by Subject|0
1799817|NCT00533273|6259404|P1|Open-label|Withdrawal by Subject|6
1799818|NCT00533273|6259403|P2|Double-blind|Withdrew consent|2
1799819|NCT00533273|6259404|P1|Double-blind|Withdrew consent|0
1799820|NCT00532948|6259455|P3|Overall Study|Failure to return|0
1799821|NCT00532948|6259456|P2|Overall Study|Failure to return|1
1799822|NCT00532948|6259457|P1|Overall Study|Failure to return|0
1799823|NCT00532948|6259455|P3|Overall Study|Violation of selection criteria at entry|0
1799824|NCT00532948|6259456|P2|Overall Study|Violation of selection criteria at entry|1
1799825|NCT00532948|6259457|P1|Overall Study|Violation of selection criteria at entry|0
1799826|NCT00532948|6259455|P3|Overall Study|Death|4
1799827|NCT00532948|6259456|P2|Overall Study|Death|3
1799828|NCT00532948|6259457|P1|Overall Study|Death|3
1799829|NCT00532948|6259455|P3|Overall Study|Protocol Violation|0
1799830|NCT00532948|6259456|P2|Overall Study|Protocol Violation|0
1799831|NCT00532948|6259457|P1|Overall Study|Protocol Violation|1
1799832|NCT00532935|6259489|P2|Overall Study|Protocol Specific Criteria|15
1799833|NCT00532935|6259490|P1|Overall Study|Protocol Specific Criteria|11
1799834|NCT00532935|6259489|P2|Overall Study|Withdrawal by Subject|9
1799835|NCT00532935|6259490|P1|Overall Study|Withdrawal by Subject|10
1799836|NCT00532935|6259489|P2|Overall Study|Protocol Violation|2
1799837|NCT00532935|6259490|P1|Overall Study|Protocol Violation|4
1799838|NCT00532935|6259489|P2|Overall Study|Pregnancy|0
1799839|NCT00532935|6259490|P1|Overall Study|Pregnancy|1
1799840|NCT00532935|6259489|P2|Overall Study|Physician Decision|5
1799841|NCT00532935|6259490|P1|Overall Study|Physician Decision|4
1799842|NCT00532935|6259489|P2|Overall Study|Lost to Follow-up|6
1799843|NCT00532935|6259490|P1|Overall Study|Lost to Follow-up|10
1799844|NCT00532935|6259489|P2|Overall Study|Lack of Efficacy|3
1799845|NCT00532935|6259490|P1|Overall Study|Lack of Efficacy|0
1799846|NCT00532935|6259489|P2|Overall Study|Adverse Event|12
1799847|NCT00532935|6259490|P1|Overall Study|Adverse Event|11
1799848|NCT00532883|6259508|P4|Overall Study|Early Study Termination|4
1799849|NCT00532883|6259509|P3|Overall Study|Early Study Termination|1
1799850|NCT00532883|6259510|P2|Overall Study|Early Study Termination|4
1799851|NCT00532883|6259511|P1|Overall Study|Early Study Termination|4
1799852|NCT00532883|6259508|P4|Overall Study|Subject was Nonadherent|0
1799853|NCT00532883|6259509|P3|Overall Study|Subject was Nonadherent|1
1799854|NCT00532883|6259510|P2|Overall Study|Subject was Nonadherent|1
1799855|NCT00532883|6259511|P1|Overall Study|Subject was Nonadherent|0
1799856|NCT00532883|6259508|P4|Overall Study|Withdrawal by Subject|0
1799857|NCT00532883|6259509|P3|Overall Study|Withdrawal by Subject|1
1799858|NCT00532883|6259510|P2|Overall Study|Withdrawal by Subject|1
1799859|NCT00532883|6259511|P1|Overall Study|Withdrawal by Subject|0
1799860|NCT00532883|6259508|P4|Overall Study|Lost to Follow-up|0
1799861|NCT00532883|6259509|P3|Overall Study|Lost to Follow-up|1
1799862|NCT00532883|6259510|P2|Overall Study|Lost to Follow-up|1
1799863|NCT00532883|6259511|P1|Overall Study|Lost to Follow-up|1
1799864|NCT00532883|6259508|P4|Overall Study|Adverse Event|1
1799865|NCT00532883|6259509|P3|Overall Study|Adverse Event|0
1799866|NCT00532883|6259510|P2|Overall Study|Adverse Event|0
1799867|NCT00532883|6259511|P1|Overall Study|Adverse Event|1
1799868|NCT00532779|6259524|P3|Overall Study|Drug noncompliance, moved, other|29
1799869|NCT00532779|6259525|P2|Overall Study|Drug noncompliance, moved, other|23
1799870|NCT00532779|6259526|P1|Overall Study|Drug noncompliance, moved, other|14
1799871|NCT00532779|6259524|P3|Overall Study|Death|0
1799872|NCT00532779|6259525|P2|Overall Study|Death|1
1799873|NCT00532779|6259526|P1|Overall Study|Death|0
1799874|NCT00532779|6259524|P3|Overall Study|Pregnancy|3
1799875|NCT00532779|6259525|P2|Overall Study|Pregnancy|5
1799876|NCT00532779|6259526|P1|Overall Study|Pregnancy|2
1799877|NCT00532779|6259524|P3|Overall Study|Protocol Violation|7
1799878|NCT00532779|6259525|P2|Overall Study|Protocol Violation|9
1799879|NCT00532779|6259526|P1|Overall Study|Protocol Violation|5
1799880|NCT00532779|6259524|P3|Overall Study|Lack of Efficacy|40
1799881|NCT00532779|6259525|P2|Overall Study|Lack of Efficacy|12
1799882|NCT00532779|6259526|P1|Overall Study|Lack of Efficacy|12
1799883|NCT00532779|6259524|P3|Overall Study|Withdrawal by Subject|90
1799884|NCT00532779|6259525|P2|Overall Study|Withdrawal by Subject|60
1799885|NCT00532779|6259526|P1|Overall Study|Withdrawal by Subject|63
1799886|NCT00532779|6259524|P3|Overall Study|Lost to Follow-up|66
1799887|NCT00532779|6259525|P2|Overall Study|Lost to Follow-up|65
1799888|NCT00532779|6259526|P1|Overall Study|Lost to Follow-up|76
1799889|NCT00532779|6259524|P3|Overall Study|Adverse Event|56
1799890|NCT00532779|6259525|P2|Overall Study|Adverse Event|112
1799891|NCT00532779|6259526|P1|Overall Study|Adverse Event|122
1799892|NCT00532493|6259587|P2|Overall Study|Contraindicative Medication|0
1799893|NCT00532493|6259588|P1|Overall Study|Contraindicative Medication|1
1799894|NCT00532493|6259587|P2|Overall Study|Subject Moved Away|1
1799895|NCT00532493|6259588|P1|Overall Study|Subject Moved Away|3
1799896|NCT00532493|6259587|P2|Overall Study|Protocol Deviation|0
1799897|NCT00532493|6259588|P1|Overall Study|Protocol Deviation|1
1799898|NCT00532493|6259587|P2|Overall Study|Adverse Event|5
1799899|NCT00532493|6259588|P1|Overall Study|Adverse Event|6
1799900|NCT00532493|6259587|P2|Overall Study|Physician Decision|6
1799901|NCT00532493|6259588|P1|Overall Study|Physician Decision|1
1799902|NCT00532493|6259587|P2|Overall Study|Withdrawal by Subject|9
1799903|NCT00532493|6259588|P1|Overall Study|Withdrawal by Subject|7
1799904|NCT00532493|6259587|P2|Overall Study|Lost to Follow-up|7
1799905|NCT00532493|6259588|P1|Overall Study|Lost to Follow-up|10
1799906|NCT00532493|6259587|P2|Overall Study|Death|1
1799907|NCT00532493|6259588|P1|Overall Study|Death|1
1799908|NCT00532441|6259622|P2|Overall Study|Death|0
1799909|NCT00532441|6259623|P1|Overall Study|Death|1
1799910|NCT00532298|6259638|P6|Overall Study|Lost to Follow-up|1
1799911|NCT00532298|6259639|P5|Overall Study|Lost to Follow-up|0
1799912|NCT00532298|6259640|P4|Overall Study|Lost to Follow-up|0
1799913|NCT00532298|6259641|P3|Overall Study|Lost to Follow-up|1
1799914|NCT00532298|6259642|P2|Overall Study|Lost to Follow-up|1
1799915|NCT00532298|6259643|P1|Overall Study|Lost to Follow-up|1
1799916|NCT00532298|6259638|P6|Overall Study|Adverse Event|1
1799917|NCT00532298|6259639|P5|Overall Study|Adverse Event|1
1799918|NCT00532298|6259640|P4|Overall Study|Adverse Event|0
1799919|NCT00532298|6259641|P3|Overall Study|Adverse Event|0
1799920|NCT00532298|6259642|P2|Overall Study|Adverse Event|0
1799921|NCT00532298|6259643|P1|Overall Study|Adverse Event|1
1799922|NCT00532259|6259723|P1|Overall Study|Protocol Violation|1
1799923|NCT00532259|6259723|P1|Overall Study|Physician Decision|3
1799924|NCT00532259|6259723|P1|Overall Study|Lost to Follow-up|3
1799925|NCT00532259|6259723|P1|Overall Study|Lack of Efficacy|21
1799926|NCT00532259|6259723|P1|Overall Study|Death|1
1799927|NCT00532259|6259723|P1|Overall Study|Adverse Event|1
1799928|NCT00532259|6259723|P1|Overall Study|Withdrawal by Subject|2
1799929|NCT00532155|6259730|P2|Overall Study|Did not receive study medication|6
1799930|NCT00532155|6259731|P1|Overall Study|Did not receive study medication|2
1799931|NCT00532155|6259730|P2|Overall Study|Study termination stop further treatment|0
1799932|NCT00532155|6259731|P1|Overall Study|Study termination stop further treatment|4
1799933|NCT00532155|6259730|P2|Overall Study|Study terminated by sponsor|0
1799934|NCT00532155|6259731|P1|Overall Study|Study terminated by sponsor|1
1799935|NCT00532155|6259730|P2|Overall Study|Study stopped|0
1799936|NCT00532155|6259731|P1|Overall Study|Study stopped|1
1799937|NCT00532155|6259730|P2|Overall Study|Had brain metastasis, was mis-randomized|0
1799938|NCT00532155|6259731|P1|Overall Study|Had brain metastasis, was mis-randomized|1
1799939|NCT00532155|6259730|P2|Overall Study|Progressive disease (by incorrect scan)|1
1799940|NCT00532155|6259731|P1|Overall Study|Progressive disease (by incorrect scan)|0
1799941|NCT00532155|6259730|P2|Overall Study|Promotor ended study|0
1799942|NCT00532155|6259731|P1|Overall Study|Promotor ended study|1
1799943|NCT00532155|6259730|P2|Overall Study|Occurence of a secondary cancer|1
1799944|NCT00532155|6259731|P1|Overall Study|Occurence of a secondary cancer|0
1799945|NCT00532155|6259730|P2|Overall Study|Occurence of a second cancer|1
1799946|NCT00532155|6259731|P1|Overall Study|Occurence of a second cancer|0
1799947|NCT00532155|6259730|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
1799948|NCT00532155|6259731|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
1799949|NCT00532155|6259730|P2|Overall Study|Moved|0
1799950|NCT00532155|6259731|P1|Overall Study|Moved|1
1799951|NCT00532155|6259730|P2|Overall Study|Consent withdrawn|7
1799952|NCT00532155|6259731|P1|Overall Study|Consent withdrawn|5
1799953|NCT00532155|6259730|P2|Overall Study|Withdrawal by Subject|44
1799954|NCT00532155|6259731|P1|Overall Study|Withdrawal by Subject|23
1799955|NCT00532155|6259730|P2|Overall Study|Physician Decision|15
1799956|NCT00532155|6259731|P1|Overall Study|Physician Decision|16
1799957|NCT00532155|6259730|P2|Overall Study|Lost to Follow-up|0
1799958|NCT00532155|6259731|P1|Overall Study|Lost to Follow-up|2
1799959|NCT00532155|6259730|P2|Overall Study|Protocol Violation|3
1799960|NCT00532155|6259731|P1|Overall Study|Protocol Violation|1
1799961|NCT00532155|6259730|P2|Overall Study|Lack of Efficacy|255
1799962|NCT00532155|6259731|P1|Overall Study|Lack of Efficacy|332
1799963|NCT00532155|6259730|P2|Overall Study|Adverse Event|123
1799964|NCT00532155|6259731|P1|Overall Study|Adverse Event|66
1799965|NCT00532129|6259745|P1|Follow-up Period|Other|6
1799966|NCT00532129|6259745|P1|Follow-up Period|Lost to Follow-up|1
1799967|NCT00532129|6259745|P1|Follow-up Period|Disease progression|57
1799968|NCT00532129|6259745|P1|Follow-up Period|Adverse event/Serious adverse event|1
1799969|NCT00532129|6259745|P1|Treatment Period|Other|5
1799970|NCT00532129|6259745|P1|Treatment Period|Protocol Violation|1
1799971|NCT00532129|6259745|P1|Treatment Period|Disease progression|3
1799972|NCT00532129|6259745|P1|Treatment Period|Physician Decision|15
1799973|NCT00532129|6259745|P1|Treatment Period|Adverse event/Serious adverse event|25
1799974|NCT00531960|6259765|P2|Overall Study|Other|10
1799975|NCT00531960|6259766|P1|Overall Study|Other|4
1799976|NCT00531960|6259765|P2|Overall Study|Refused Treatment|6
1799977|NCT00531960|6259766|P1|Overall Study|Refused Treatment|5
1799978|NCT00531960|6259765|P2|Overall Study|Violation of Selection Criteria|0
1799979|NCT00531960|6259766|P1|Overall Study|Violation of Selection Criteria|2
1799980|NCT00531960|6259765|P2|Overall Study|Lack of Efficacy|41
1799981|NCT00531960|6259766|P1|Overall Study|Lack of Efficacy|42
1799982|NCT00531960|6259765|P2|Overall Study|Death|2
1799983|NCT00531960|6259766|P1|Overall Study|Death|3
1799984|NCT00531960|6259765|P2|Overall Study|Adverse Event|4
1799985|NCT00531960|6259766|P1|Overall Study|Adverse Event|5
1799986|NCT00531947|6259784|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
1799987|NCT00531947|6259785|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
1799988|NCT00531947|6259784|P2|Overall Study|Non-Compliance|7
1799989|NCT00531947|6259785|P1|Overall Study|Non-Compliance|4
1799990|NCT00531947|6259784|P2|Overall Study|Protocol Violation|1
1799991|NCT00531947|6259785|P1|Overall Study|Protocol Violation|2
1799992|NCT00531947|6259784|P2|Overall Study|Withdrawal by Subject|19
1799993|NCT00531947|6259785|P1|Overall Study|Withdrawal by Subject|14
1799994|NCT00531947|6259784|P2|Overall Study|Lost to Follow-up|9
1799995|NCT00531947|6259785|P1|Overall Study|Lost to Follow-up|12
1799996|NCT00531947|6259784|P2|Overall Study|Adverse Event|10
1799997|NCT00531947|6259785|P1|Overall Study|Adverse Event|5
1799998|NCT00531934|6259829|P2|Overall Study|Other|2
1799999|NCT00531934|6259830|P1|Overall Study|Other|2
1800000|NCT00531934|6259829|P2|Overall Study|Withdrawal by Subject|1
1800001|NCT00531934|6259830|P1|Overall Study|Withdrawal by Subject|1
1800002|NCT00531934|6259829|P2|Overall Study|Death|10
1800003|NCT00531934|6259830|P1|Overall Study|Death|7
1800004|NCT00531934|6259829|P2|Overall Study|Progression|42
1800005|NCT00531934|6259830|P1|Overall Study|Progression|52
1800006|NCT00531934|6259829|P2|Overall Study|Adverse Event|8
1800007|NCT00531934|6259830|P1|Overall Study|Adverse Event|4
1800008|NCT00531752|6259958|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
1800009|NCT00531752|6259959|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
1800010|NCT00531752|6259960|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
1800011|NCT00531752|6259961|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
1800012|NCT00531752|6259958|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
1800013|NCT00531752|6259959|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
1800014|NCT00531752|6259960|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
1800015|NCT00531752|6259961|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
1800016|NCT00531752|6259958|P4|Second Double-blind Intervention Period|Other|0
1800017|NCT00531752|6259959|P3|Second Double-blind Intervention Period|Other|0
1800018|NCT00531752|6259960|P2|Second Double-blind Intervention Period|Other|1
1800019|NCT00531752|6259961|P1|Second Double-blind Intervention Period|Other|1
1800020|NCT00531752|6259958|P4|Second Double-blind Intervention Period|Adverse Event|0
1800021|NCT00531752|6259959|P3|Second Double-blind Intervention Period|Adverse Event|0
1800022|NCT00531752|6259960|P2|Second Double-blind Intervention Period|Adverse Event|1
1800023|NCT00531752|6259961|P1|Second Double-blind Intervention Period|Adverse Event|1
1800024|NCT00531752|6259958|P4|First Double-blind Intervention Period|Randomized but not treated|0
1800025|NCT00531752|6259959|P3|First Double-blind Intervention Period|Randomized but not treated|0
1800026|NCT00531752|6259960|P2|First Double-blind Intervention Period|Randomized but not treated|0
1800027|NCT00531752|6259961|P1|First Double-blind Intervention Period|Randomized but not treated|1
1800028|NCT00531752|6259958|P4|First Double-blind Intervention Period|Lost to Follow-up|1
1800029|NCT00531752|6259959|P3|First Double-blind Intervention Period|Lost to Follow-up|1
1800030|NCT00531752|6259960|P2|First Double-blind Intervention Period|Lost to Follow-up|0
1800031|NCT00531752|6259961|P1|First Double-blind Intervention Period|Lost to Follow-up|0
1800032|NCT00531752|6259958|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
1800033|NCT00531752|6259959|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
1800034|NCT00531752|6259960|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
1800035|NCT00531752|6259961|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
1800036|NCT00531752|6259958|P4|First Double-blind Intervention Period|Other|0
1800037|NCT00531752|6259959|P3|First Double-blind Intervention Period|Other|4
1800038|NCT00531752|6259960|P2|First Double-blind Intervention Period|Other|4
1800039|NCT00531752|6259961|P1|First Double-blind Intervention Period|Other|1
1800040|NCT00531752|6259958|P4|First Double-blind Intervention Period|Adverse Event|1
1800041|NCT00531752|6259959|P3|First Double-blind Intervention Period|Adverse Event|1
1800042|NCT00531752|6259960|P2|First Double-blind Intervention Period|Adverse Event|0
1800043|NCT00531752|6259961|P1|First Double-blind Intervention Period|Adverse Event|2
1800044|NCT00531479|6260072|P2|Overall Study|Did not receive treatment|3
1800045|NCT00531479|6260073|P1|Overall Study|Did not receive treatment|2
1800046|NCT00531479|6260072|P2|Overall Study|Withdrawal by Subject|6
1800047|NCT00531479|6260073|P1|Overall Study|Withdrawal by Subject|6
1800048|NCT00531479|6260072|P2|Overall Study|Other|1
1800049|NCT00531479|6260073|P1|Overall Study|Other|0
1800050|NCT00531479|6260072|P2|Overall Study|Lost to Follow-up|2
1800051|NCT00531479|6260073|P1|Overall Study|Lost to Follow-up|0
1800052|NCT00531479|6260072|P2|Overall Study|Death|71
1800053|NCT00531479|6260073|P1|Overall Study|Death|68
1800054|NCT00531427|6260104|P2|Overall Study|Administrative|9
1800055|NCT00531427|6260105|P1|Overall Study|Administrative|4
1800056|NCT00531427|6260104|P2|Overall Study|Lack of Efficacy|39
1800057|NCT00531427|6260105|P1|Overall Study|Lack of Efficacy|14
1800058|NCT00531427|6260104|P2|Overall Study|Lost to Follow-up|3
1800059|NCT00531427|6260105|P1|Overall Study|Lost to Follow-up|4
1800060|NCT00531427|6260104|P2|Overall Study|Adverse Event|30
1800061|NCT00531427|6260105|P1|Overall Study|Adverse Event|44
1800062|NCT00531427|6260104|P2|Overall Study|Withdrawal by Subject|13
1800063|NCT00531427|6260105|P1|Overall Study|Withdrawal by Subject|7
1800064|NCT00531284|6260133|P17|Overall Study|Other|0
1800065|NCT00531284|6260134|P16|Overall Study|Other|0
1800066|NCT00531284|6260135|P15|Overall Study|Other|1
1800067|NCT00531284|6260136|P14|Overall Study|Other|0
1800068|NCT00531284|6260137|P13|Overall Study|Other|0
1800069|NCT00531284|6260138|P12|Overall Study|Other|2
1800070|NCT00531284|6260139|P11|Overall Study|Other|0
1800071|NCT00531284|6260140|P10|Overall Study|Other|1
1800072|NCT00531284|6260141|P9|Overall Study|Other|2
1800073|NCT00531284|6260142|P8|Overall Study|Other|0
1800074|NCT00531284|6260143|P7|Overall Study|Other|0
1800075|NCT00531284|6260144|P6|Overall Study|Other|1
1800076|NCT00531284|6260145|P5|Overall Study|Other|2
1800077|NCT00531284|6260146|P4|Overall Study|Other|10
1800078|NCT00531284|6260147|P3|Overall Study|Other|0
1800079|NCT00531284|6260148|P2|Overall Study|Other|0
1800080|NCT00531284|6260149|P1|Overall Study|Other|1
1800081|NCT00531284|6260133|P17|Overall Study|Withdrawal by Subject|1
1800082|NCT00531284|6260134|P16|Overall Study|Withdrawal by Subject|1
1800083|NCT00531284|6260135|P15|Overall Study|Withdrawal by Subject|0
1800084|NCT00531284|6260136|P14|Overall Study|Withdrawal by Subject|1
1800085|NCT00531284|6260137|P13|Overall Study|Withdrawal by Subject|0
1800086|NCT00531284|6260138|P12|Overall Study|Withdrawal by Subject|3
1800087|NCT00531284|6260139|P11|Overall Study|Withdrawal by Subject|0
1800088|NCT00531284|6260140|P10|Overall Study|Withdrawal by Subject|0
1800089|NCT00531284|6260141|P9|Overall Study|Withdrawal by Subject|0
1800090|NCT00531284|6260142|P8|Overall Study|Withdrawal by Subject|0
1800091|NCT00531284|6260143|P7|Overall Study|Withdrawal by Subject|0
1800092|NCT00531284|6260144|P6|Overall Study|Withdrawal by Subject|0
1800093|NCT00531284|6260145|P5|Overall Study|Withdrawal by Subject|0
1800094|NCT00531284|6260146|P4|Overall Study|Withdrawal by Subject|4
1800095|NCT00531284|6260147|P3|Overall Study|Withdrawal by Subject|0
1800096|NCT00531284|6260148|P2|Overall Study|Withdrawal by Subject|0
1800097|NCT00531284|6260149|P1|Overall Study|Withdrawal by Subject|1
1800098|NCT00531284|6260133|P17|Overall Study|Adverse Event|2
1800099|NCT00531284|6260134|P16|Overall Study|Adverse Event|0
1800100|NCT00531284|6260135|P15|Overall Study|Adverse Event|1
1800101|NCT00531284|6260136|P14|Overall Study|Adverse Event|1
1800102|NCT00531284|6260137|P13|Overall Study|Adverse Event|0
1800103|NCT00531284|6260138|P12|Overall Study|Adverse Event|5
1800104|NCT00531284|6260139|P11|Overall Study|Adverse Event|0
1800105|NCT00531284|6260140|P10|Overall Study|Adverse Event|0
1800106|NCT00531284|6260141|P9|Overall Study|Adverse Event|3
1800107|NCT00531284|6260142|P8|Overall Study|Adverse Event|2
1800108|NCT00531284|6260143|P7|Overall Study|Adverse Event|3
1800109|NCT00531284|6260144|P6|Overall Study|Adverse Event|2
1800110|NCT00531284|6260145|P5|Overall Study|Adverse Event|0
1800111|NCT00531284|6260146|P4|Overall Study|Adverse Event|7
1800112|NCT00531284|6260147|P3|Overall Study|Adverse Event|1
1800113|NCT00531284|6260148|P2|Overall Study|Adverse Event|1
1800114|NCT00531284|6260149|P1|Overall Study|Adverse Event|0
1800115|NCT00531284|6260133|P17|Overall Study|Progressive Disease|5
1800116|NCT00531284|6260134|P16|Overall Study|Progressive Disease|11
1800117|NCT00531284|6260135|P15|Overall Study|Progressive Disease|2
1800118|NCT00531284|6260136|P14|Overall Study|Progressive Disease|1
1800119|NCT00531284|6260137|P13|Overall Study|Progressive Disease|2
1800120|NCT00531284|6260138|P12|Overall Study|Progressive Disease|14
1800121|NCT00531284|6260139|P11|Overall Study|Progressive Disease|3
1800122|NCT00531284|6260140|P10|Overall Study|Progressive Disease|3
1800123|NCT00531284|6260141|P9|Overall Study|Progressive Disease|6
1800124|NCT00531284|6260142|P8|Overall Study|Progressive Disease|8
1800125|NCT00531284|6260143|P7|Overall Study|Progressive Disease|3
1800126|NCT00531284|6260144|P6|Overall Study|Progressive Disease|4
1800127|NCT00531284|6260145|P5|Overall Study|Progressive Disease|4
1800128|NCT00531284|6260146|P4|Overall Study|Progressive Disease|42
1800129|NCT00531284|6260147|P3|Overall Study|Progressive Disease|5
1800130|NCT00531284|6260148|P2|Overall Study|Progressive Disease|3
1800131|NCT00531284|6260149|P1|Overall Study|Progressive Disease|1
1800132|NCT00531206|6260299|P1|Overall Study|including non-related adverse events|8
1800133|NCT00531206|6260299|P1|Overall Study|Lost to Follow-up|5
1800134|NCT00531206|6260299|P1|Overall Study|Lack of Efficacy|2
1800135|NCT00531206|6260299|P1|Overall Study|Adverse Event related|5
1800136|NCT00531050|6260329|P6|Part 2: Period 3|Abnormal test procedure|1
1800137|NCT00531050|6260330|P5|Part 2: Period 3|Abnormal test procedure|0
1800138|NCT00531050|6260331|P4|Part 2: Period 3|Abnormal test procedure|0
1800139|NCT00531050|6260332|P3|Part 2: Period 3|Abnormal test procedure|0
1800140|NCT00531050|6260333|P2|Part 2: Period 3|Abnormal test procedure|0
1800141|NCT00531050|6260334|P1|Part 2: Period 3|Abnormal test procedure|1
1800142|NCT00531050|6260329|P6|Part 2: Period 1|Adverse Event|1
1800143|NCT00531050|6260330|P5|Part 2: Period 1|Adverse Event|0
1800144|NCT00531050|6260331|P4|Part 2: Period 1|Adverse Event|0
1800145|NCT00531050|6260332|P3|Part 2: Period 1|Adverse Event|0
1800146|NCT00531050|6260333|P2|Part 2: Period 1|Adverse Event|0
1800147|NCT00531050|6260334|P1|Part 2: Period 1|Adverse Event|0
1800148|NCT00531050|6260329|P6|Part 1: Period 3|Adverse Event|0
1800149|NCT00531050|6260330|P5|Part 1: Period 3|Adverse Event|0
1800150|NCT00531050|6260331|P4|Part 1: Period 3|Adverse Event|0
1800151|NCT00531050|6260332|P3|Part 1: Period 3|Adverse Event|0
1800152|NCT00531050|6260333|P2|Part 1: Period 3|Adverse Event|0
1800153|NCT00531050|6260334|P1|Part 1: Period 3|Adverse Event|1
1800154|NCT00531050|6260329|P6|Part 1: Period 1|Protocol Deviation|0
1800155|NCT00531050|6260330|P5|Part 1: Period 1|Protocol Deviation|0
1800156|NCT00531050|6260331|P4|Part 1: Period 1|Protocol Deviation|1
1800157|NCT00531050|6260332|P3|Part 1: Period 1|Protocol Deviation|0
1800158|NCT00531050|6260333|P2|Part 1: Period 1|Protocol Deviation|0
1800159|NCT00531050|6260334|P1|Part 1: Period 1|Protocol Deviation|0
1800160|NCT00531050|6260329|P6|Part 1: Period 1|Adverse Event|0
1800161|NCT00531050|6260330|P5|Part 1: Period 1|Adverse Event|0
1800162|NCT00531050|6260331|P4|Part 1: Period 1|Adverse Event|0
1800163|NCT00531050|6260332|P3|Part 1: Period 1|Adverse Event|0
1800164|NCT00531050|6260333|P2|Part 1: Period 1|Adverse Event|1
1800165|NCT00531050|6260334|P1|Part 1: Period 1|Adverse Event|0
1800166|NCT00531011|6260363|P2|Overall Study|Physician Decision|3
1800167|NCT00531011|6260364|P1|Overall Study|Physician Decision|0
1800168|NCT00531011|6260363|P2|Overall Study|Lost to Follow-up|0
1800169|NCT00531011|6260364|P1|Overall Study|Lost to Follow-up|1
1800170|NCT00531011|6260363|P2|Overall Study|Death|0
1800171|NCT00531011|6260364|P1|Overall Study|Death|1
1800172|NCT00531011|6260363|P2|Overall Study|Withdrawal by Subject|4
1800173|NCT00531011|6260364|P1|Overall Study|Withdrawal by Subject|2
1800174|NCT00530946|6260410|P4|Overall Study|Noncompliance|0
1800175|NCT00530946|6260411|P3|Overall Study|Noncompliance|0
1800176|NCT00530946|6260412|P2|Overall Study|Noncompliance|0
1800177|NCT00530946|6260413|P1|Overall Study|Noncompliance|1
1800178|NCT00530946|6260410|P4|Overall Study|Protocol Violation|1
1800179|NCT00530946|6260411|P3|Overall Study|Protocol Violation|0
1800180|NCT00530946|6260412|P2|Overall Study|Protocol Violation|0
1800181|NCT00530946|6260413|P1|Overall Study|Protocol Violation|0
1800182|NCT00530946|6260410|P4|Overall Study|Adverse Event|1
1800183|NCT00530946|6260411|P3|Overall Study|Adverse Event|1
1800184|NCT00530946|6260412|P2|Overall Study|Adverse Event|2
1800185|NCT00530946|6260413|P1|Overall Study|Adverse Event|1
1800186|NCT00530920|6260466|P3|Overall Study|Withdrawal by Subject|1
1800187|NCT00530920|6260467|P2|Overall Study|Withdrawal by Subject|0
1800188|NCT00530920|6260468|P1|Overall Study|Withdrawal by Subject|0
1800189|NCT00530920|6260466|P3|Overall Study|Adverse Event|3
1800190|NCT00530920|6260467|P2|Overall Study|Adverse Event|0
1800191|NCT00530920|6260468|P1|Overall Study|Adverse Event|0
1800192|NCT00530920|6260466|P3|Overall Study|Randomized but not treated|0
1800193|NCT00530920|6260467|P2|Overall Study|Randomized but not treated|2
1800194|NCT00530920|6260468|P1|Overall Study|Randomized but not treated|0
1800195|NCT00530894|6260528|P4|Overall Study|Alive and censored prior to 1 year|0
1800196|NCT00530894|6260529|P3|Overall Study|Alive and censored prior to 1 year|0
1800197|NCT00530894|6260530|P2|Overall Study|Alive and censored prior to 1 year|0
1800198|NCT00530894|6260531|P1|Overall Study|Alive and censored prior to 1 year|2
1800199|NCT00530894|6260528|P4|Overall Study|Withdrawal by Subject|5
1800200|NCT00530894|6260529|P3|Overall Study|Withdrawal by Subject|0
1800201|NCT00530894|6260530|P2|Overall Study|Withdrawal by Subject|23
1800202|NCT00530894|6260531|P1|Overall Study|Withdrawal by Subject|1
1800203|NCT00530894|6260528|P4|Overall Study|Lost to Follow-up|0
1800204|NCT00530894|6260529|P3|Overall Study|Lost to Follow-up|0
1800205|NCT00530894|6260530|P2|Overall Study|Lost to Follow-up|3
1800206|NCT00530894|6260531|P1|Overall Study|Lost to Follow-up|1
1800207|NCT00530894|6260528|P4|Overall Study|Death|89
1800208|NCT00530894|6260529|P3|Overall Study|Death|55
1800209|NCT00530894|6260530|P2|Overall Study|Death|89
1800210|NCT00530894|6260531|P1|Overall Study|Death|84
1800211|NCT00530855|6260559|P1|Overall Study|Other reason for premature termination|17
1800212|NCT00530855|6260559|P1|Overall Study|Lost to Follow-up|9
1800213|NCT00530855|6260559|P1|Overall Study|Unsatisfactory compliance of subject|11
1800214|NCT00530855|6260559|P1|Overall Study|Protocol Violation|3
1800215|NCT00530855|6260559|P1|Overall Study|Non Fatal Non Serious AE|12
1800216|NCT00530855|6260559|P1|Overall Study|Non Fatal Serious AE|7
1800217|NCT00530855|6260559|P1|Overall Study|Fatal Serious AE|3
1800218|NCT00530855|6260559|P1|Overall Study|Withdrawal by Subject|30
1800219|NCT00530855|6260559|P1|Overall Study|Lack of Efficacy|20
1800220|NCT00530842|6260568|P2|Period 2|Individual different reasons|0
1800221|NCT00530842|6260569|P1|Period 2|Individual different reasons|2
1800222|NCT00530842|6260568|P2|Period 2|Withdrawal by Subject|2
1800223|NCT00530842|6260569|P1|Period 2|Withdrawal by Subject|1
1800224|NCT00530842|6260568|P2|Period 2|Protocol Violation|0
1800225|NCT00530842|6260569|P1|Period 2|Protocol Violation|1
1800226|NCT00530842|6260568|P2|Period 2|Lost to Follow-up|4
1800227|NCT00530842|6260569|P1|Period 2|Lost to Follow-up|0
1800228|NCT00530842|6260568|P2|Period 2|Lack of Efficacy|0
1800229|NCT00530842|6260569|P1|Period 2|Lack of Efficacy|1
1800230|NCT00530842|6260568|P2|Period 2|Adverse Event|3
1800231|NCT00530842|6260569|P1|Period 2|Adverse Event|3
1800232|NCT00530842|6260568|P2|Period 1|Individual different reasons|3
1800233|NCT00530842|6260569|P1|Period 1|Individual different reasons|2
1800234|NCT00530842|6260568|P2|Period 1|Withdrawal by Subject|3
1800235|NCT00530842|6260569|P1|Period 1|Withdrawal by Subject|2
1800236|NCT00530842|6260568|P2|Period 1|Protocol Violation|1
1800237|NCT00530842|6260569|P1|Period 1|Protocol Violation|2
1800238|NCT00530842|6260568|P2|Period 1|Lack of Efficacy|1
1800239|NCT00530842|6260569|P1|Period 1|Lack of Efficacy|1
1800240|NCT00530842|6260568|P2|Period 1|Adverse Event|3
1800241|NCT00530842|6260569|P1|Period 1|Adverse Event|7
1800242|NCT00530842|6260568|P2|Overall Study|Individual different reasons|3
1800243|NCT00530842|6260569|P1|Overall Study|Individual different reasons|4
1800244|NCT00530842|6260568|P2|Overall Study|Withdrawal by Subject|5
1800245|NCT00530842|6260569|P1|Overall Study|Withdrawal by Subject|4
1800246|NCT00530842|6260568|P2|Overall Study|Protocol Violation|2
1800247|NCT00530842|6260569|P1|Overall Study|Protocol Violation|3
1800248|NCT00530842|6260568|P2|Overall Study|Lost to Follow-up|4
1800249|NCT00530842|6260569|P1|Overall Study|Lost to Follow-up|0
1800250|NCT00530842|6260568|P2|Overall Study|Lack of Efficacy|1
1800251|NCT00530842|6260569|P1|Overall Study|Lack of Efficacy|2
1800252|NCT00530842|6260568|P2|Overall Study|Adverse Event|6
1800253|NCT00530842|6260569|P1|Overall Study|Adverse Event|10
1800254|NCT00530816|6260696|P3|Overall Study|Withdrawal by Subject|6
1800255|NCT00530816|6260697|P2|Overall Study|Withdrawal by Subject|2
1800256|NCT00530816|6260698|P1|Overall Study|Withdrawal by Subject|1
1800257|NCT00530816|6260696|P3|Overall Study|Other|4
1800258|NCT00530816|6260697|P2|Overall Study|Other|3
1800259|NCT00530816|6260698|P1|Overall Study|Other|3
1800260|NCT00530816|6260696|P3|Overall Study|Adverse Event|7
1800261|NCT00530816|6260697|P2|Overall Study|Adverse Event|13
1800262|NCT00530816|6260698|P1|Overall Study|Adverse Event|6
1800263|NCT00530816|6260696|P3|Overall Study|Progressive Disease|24
1800264|NCT00530816|6260697|P2|Overall Study|Progressive Disease|24
1800265|NCT00530816|6260698|P1|Overall Study|Progressive Disease|16
1800266|NCT00530790|6260741|P1|Overall Study|Physician Decision|1
1800267|NCT00530790|6260741|P1|Overall Study|Withdrawal by Subject|2
1800268|NCT00530790|6260741|P1|Overall Study|Adverse Event|2
1800269|NCT00530777|6260763|P2|Overall Study|Unable to adhere to visit schedule|1
1800270|NCT00530777|6260764|P1|Overall Study|Unable to adhere to visit schedule|5
1800271|NCT00530777|6260763|P2|Overall Study|Withdrawal by Subject|1
1800272|NCT00530777|6260764|P1|Overall Study|Withdrawal by Subject|0
1800273|NCT00530777|6260763|P2|Overall Study|Physician Decision|0
1800274|NCT00530777|6260764|P1|Overall Study|Physician Decision|1
1800275|NCT00530777|6260763|P2|Overall Study|Death|2
1800276|NCT00530777|6260764|P1|Overall Study|Death|1
1800277|NCT00530777|6260763|P2|Overall Study|Lost to Follow-up|1
1800278|NCT00530777|6260764|P1|Overall Study|Lost to Follow-up|0
1800279|NCT00530712|6260821|P1|12 Month Follow-up Visit|Death|9
1800280|NCT00530712|6260821|P1|12 Month Follow-up Visit|Lost to Follow-up|7
1800281|NCT00530712|6260821|P1|12 Month Follow-up Visit|Missed Visit|3
1800282|NCT00530712|6260821|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
1800283|NCT00530712|6260821|P1|6 Month Follow-up Visit|Death|2
1800284|NCT00530712|6260821|P1|6 Month Follow-up Visit|Lost to Follow-up|3
1800285|NCT00530712|6260821|P1|6 Month Follow-up Visit|Missed Visit|3
1800286|NCT00530712|6260821|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
1800287|NCT00530712|6260821|P1|30 Day Follow-up Visit|Missed Visit|5
1800288|NCT00530712|6260821|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
1800289|NCT00530504|6260842|P1|Overall Study|Exited study due to other reasons|33
1800290|NCT00530504|6260842|P1|Overall Study|Withdrawal by Subject|39
1800291|NCT00530504|6260842|P1|Overall Study|Lost to Follow-up|26
1800292|NCT00530504|6260842|P1|Overall Study|Death|54
1800293|NCT00530439|6260848|P2|Overall Study|Severe malformation/abortion|3
1800294|NCT00530439|6260849|P1|Overall Study|Severe malformation/abortion|0
1800295|NCT00530439|6260848|P2|Overall Study|Twin pregnancy|2
1800296|NCT00530439|6260849|P1|Overall Study|Twin pregnancy|0
1800297|NCT00530439|6260848|P2|Overall Study|Misclassification|0
1800298|NCT00530439|6260849|P1|Overall Study|Misclassification|2
1800299|NCT00530439|6260848|P2|Overall Study|Missed abortion|4
1800300|NCT00530439|6260849|P1|Overall Study|Missed abortion|1
1800301|NCT00530439|6260848|P2|Overall Study|Withdraw|14
1800302|NCT00530439|6260849|P1|Overall Study|Withdraw|18
1800303|NCT00530439|6260848|P2|Overall Study|GDM|3
1800304|NCT00530439|6260849|P1|Overall Study|GDM|9
1800305|NCT00530348|6260857|P2|Overall Study|Noncompliance with inclusion criterion 3|1
1800306|NCT00530348|6260858|P1|Overall Study|Noncompliance with inclusion criterion 3|0
1800307|NCT00530348|6260857|P2|Overall Study|Randomised in error|0
1800308|NCT00530348|6260858|P1|Overall Study|Randomised in error|1
1800309|NCT00530348|6260857|P2|Overall Study|Withdrawal by Subject|12
1800310|NCT00530348|6260858|P1|Overall Study|Withdrawal by Subject|12
1800311|NCT00530348|6260857|P2|Overall Study|Pregnancy|0
1800312|NCT00530348|6260858|P1|Overall Study|Pregnancy|1
1800313|NCT00530348|6260857|P2|Overall Study|Physician Decision|2
1800314|NCT00530348|6260858|P1|Overall Study|Physician Decision|1
1800315|NCT00530348|6260857|P2|Overall Study|Lost to Follow-up|2
1800316|NCT00530348|6260858|P1|Overall Study|Lost to Follow-up|0
1800317|NCT00530348|6260857|P2|Overall Study|Lack of Efficacy|0
1800318|NCT00530348|6260858|P1|Overall Study|Lack of Efficacy|2
1800319|NCT00530348|6260857|P2|Overall Study|Death|1
1800320|NCT00530348|6260858|P1|Overall Study|Death|0
1800321|NCT00530348|6260857|P2|Overall Study|Adverse Event|1
1800322|NCT00530348|6260858|P1|Overall Study|Adverse Event|5
1800323|NCT00530335|6260874|P1|Overall Study|Physician Decision|1
1800324|NCT00530335|6260874|P1|Overall Study|Withdrawal by Subject|1
1800325|NCT00530335|6260874|P1|Overall Study|Protocol Violation|1
1800326|NCT00530335|6260874|P1|Overall Study|Adverse Event|3
1800327|NCT00530270|6260891|P2|Overall Study|Protocol Violation|0
1800328|NCT00530270|6260892|P1|Overall Study|Protocol Violation|1
1800329|NCT00530257|6260906|P1|Overall Study|Lost to Follow-up|1
1800330|NCT00530218|6260934|P1|Overall Study|Death|12
1800331|NCT00530218|6260934|P1|Overall Study|CMV Not Detected|13
1800332|NCT00530088|6260941|P1|Overall Study|Other Not Specified|2
1800333|NCT00530088|6260941|P1|Overall Study|Physician Decision|4
1800334|NCT00530088|6260941|P1|Overall Study|Disease Progression|4
1800335|NCT00530075|6260946|P1|Overall Study|Withdrawal by Subject|1
1800336|NCT00530075|6260946|P1|Overall Study|Protocol Violation|1
1800337|NCT00530075|6260946|P1|Overall Study|Lack of Efficacy|3
1800338|NCT00530075|6260946|P1|Overall Study|Death|1
1800339|NCT00530075|6260946|P1|Overall Study|Adverse Event|1
1800340|NCT00530023|6260959|P2|Overall Study|Withdrawal by Subject|1
1800341|NCT00530023|6260960|P1|Overall Study|Withdrawal by Subject|0
1800342|NCT00529958|6260977|P3|5-Year Follow-up|Withdrawal by Subject|0
1800343|NCT00529958|6260978|P2|5-Year Follow-up|Withdrawal by Subject|0
1800344|NCT00529958|6260979|P1|5-Year Follow-up|Withdrawal by Subject|1
1800345|NCT00529958|6260977|P3|5-Year Follow-up|Lost to Follow-up|1
1800346|NCT00529958|6260978|P2|5-Year Follow-up|Lost to Follow-up|3
1800347|NCT00529958|6260979|P1|5-Year Follow-up|Lost to Follow-up|2
1800348|NCT00529958|6260977|P3|2-Year Follow-up|Withdrawal by Subject|0
1800349|NCT00529958|6260978|P2|2-Year Follow-up|Withdrawal by Subject|0
1800350|NCT00529958|6260979|P1|2-Year Follow-up|Withdrawal by Subject|3
1800351|NCT00529958|6260977|P3|2-Year Follow-up|Lost to Follow-up|2
1800352|NCT00529958|6260978|P2|2-Year Follow-up|Lost to Follow-up|2
1800353|NCT00529958|6260979|P1|2-Year Follow-up|Lost to Follow-up|1
1800354|NCT00529802|6261020|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
1800355|NCT00529802|6261020|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
1800356|NCT00529802|6261020|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
1800357|NCT00529802|6261020|P1|Evaluable for Primary Endpoint|Death|1
1800358|NCT00529802|6261020|P1|Evaluable for Primary Endpoint|Adverse Event|2
1800359|NCT00529802|6261020|P1|Evaluable for Primary Endpoint|Worsening performance status|2
1800360|NCT00529802|6261020|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
1800361|NCT00529789|6261026|P1|Study Period IV|Lost to Follow-up|3
1800362|NCT00529789|6261026|P1|Study Period IV|Lack of Efficacy|1
1800363|NCT00529789|6261026|P1|Study Period IV|Adverse Event|1
1800364|NCT00529789|6261026|P1|Study Period IV|Parent/Caregiver Decision|1
1800365|NCT00529789|6261026|P1|Study Period II/III|Lost to Follow-up|3
1800366|NCT00529789|6261026|P1|Study Period II/III|Physician Decision|3
1800367|NCT00529789|6261026|P1|Study Period II/III|Protocol Violation|3
1800368|NCT00529789|6261026|P1|Study Period II/III|Withdrawal by Subject|1
1800369|NCT00529789|6261026|P1|Study Period II/III|Lack of Efficacy|2
1800370|NCT00529789|6261026|P1|Study Period II/III|Adverse Event|3
1800371|NCT00529789|6261026|P1|Study Period II/III|Parent/Caregiver Decision|9
1800372|NCT00529763|6261051|P3|Overall Study|Patient Withdrew Consent|2
1800373|NCT00529763|6261052|P2|Overall Study|Patient Withdrew Consent|3
1800374|NCT00529763|6261053|P1|Overall Study|Patient Withdrew Consent|2
1800375|NCT00529763|6261051|P3|Overall Study|Study Drug Toxicity|1
1800376|NCT00529763|6261052|P2|Overall Study|Study Drug Toxicity|6
1800377|NCT00529763|6261053|P1|Overall Study|Study Drug Toxicity|1
1800378|NCT00529763|6261051|P3|Overall Study|Stem Cell Transplant|0
1800379|NCT00529763|6261052|P2|Overall Study|Stem Cell Transplant|3
1800380|NCT00529763|6261053|P1|Overall Study|Stem Cell Transplant|0
1800381|NCT00529763|6261051|P3|Overall Study|Lost to Follow-up|1
1800382|NCT00529763|6261052|P2|Overall Study|Lost to Follow-up|1
1800383|NCT00529763|6261053|P1|Overall Study|Lost to Follow-up|0
1800384|NCT00529763|6261051|P3|Overall Study|Disease Progression|1
1800385|NCT00529763|6261052|P2|Overall Study|Disease Progression|16
1800386|NCT00529763|6261053|P1|Overall Study|Disease Progression|6
1800387|NCT00529763|6261051|P3|Overall Study|Death|1
1800388|NCT00529763|6261052|P2|Overall Study|Death|1
1800389|NCT00529763|6261053|P1|Overall Study|Death|0
1800390|NCT00529763|6261051|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
1800391|NCT00529763|6261052|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
1800392|NCT00529763|6261053|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
1800393|NCT00529659|6261091|P2|Overall Study|Withdrawal by Subject|6
1800394|NCT00529659|6261092|P1|Overall Study|Withdrawal by Subject|1
1800395|NCT00529659|6261091|P2|Overall Study|Protocol Violation|6
1800396|NCT00529659|6261092|P1|Overall Study|Protocol Violation|2
1800397|NCT00529659|6261091|P2|Overall Study|Physician Decision|2
1800398|NCT00529659|6261092|P1|Overall Study|Physician Decision|0
1800399|NCT00529659|6261091|P2|Overall Study|Lost to Follow-up|2
1800400|NCT00529659|6261092|P1|Overall Study|Lost to Follow-up|0
1800401|NCT00529659|6261091|P2|Overall Study|Adverse Event|7
1800402|NCT00529659|6261092|P1|Overall Study|Adverse Event|8
1800403|NCT00529633|6261110|P2|Overall Study|Withdrawal by Subject|1
1800404|NCT00529633|6261111|P1|Overall Study|Withdrawal by Subject|1
1800405|NCT00529568|6261123|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
1800406|NCT00529568|6261124|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
1800407|NCT00529568|6261125|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
1800408|NCT00529568|6261123|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
1800409|NCT00529568|6261124|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
1800410|NCT00529568|6261125|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
1800411|NCT00529568|6261123|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
1800412|NCT00529568|6261124|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
1800413|NCT00529568|6261125|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
1800414|NCT00529568|6261123|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
1800415|NCT00529568|6261124|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
1800416|NCT00529568|6261125|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
1800417|NCT00529568|6261123|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
1800418|NCT00529568|6261124|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
1800419|NCT00529568|6261125|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
1800420|NCT00529568|6261123|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
1800421|NCT00529568|6261124|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
1800422|NCT00529568|6261125|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
1800423|NCT00529568|6261123|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
1800424|NCT00529568|6261124|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
1800425|NCT00529568|6261125|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
1800426|NCT00529568|6261123|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
1800427|NCT00529568|6261124|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
1800428|NCT00529568|6261125|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
1800429|NCT00529568|6261123|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
1800430|NCT00529568|6261124|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
1800431|NCT00529568|6261125|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
1800432|NCT00529568|6261123|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
1800433|NCT00529568|6261124|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
1800434|NCT00529568|6261125|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
1800435|NCT00529568|6261123|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
1800436|NCT00529568|6261124|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
1800437|NCT00529568|6261125|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
1800438|NCT00529542|6261188|P2|Overall Study|Lost to Follow-up|1
1800439|NCT00529542|6261189|P1|Overall Study|Lost to Follow-up|0
1800440|NCT00529542|6261188|P2|Overall Study|Withdrawal by Subject|0
1800441|NCT00529542|6261189|P1|Overall Study|Withdrawal by Subject|1
1800442|NCT00529529|6261232|P3|Overall Study|Administrative problems|3
1800443|NCT00529529|6261233|P2|Overall Study|Administrative problems|0
1800444|NCT00529529|6261234|P1|Overall Study|Administrative problems|1
1800445|NCT00529529|6261232|P3|Overall Study|Abnormal test procedure result(s)|0
1800446|NCT00529529|6261233|P2|Overall Study|Abnormal test procedure result(s)|0
1800447|NCT00529529|6261234|P1|Overall Study|Abnormal test procedure result(s)|1
1800448|NCT00529529|6261232|P3|Overall Study|Death|0
1800449|NCT00529529|6261233|P2|Overall Study|Death|0
1800450|NCT00529529|6261234|P1|Overall Study|Death|2
1800451|NCT00529529|6261232|P3|Overall Study|Unsatisfactory therapeutic effect|2
1800452|NCT00529529|6261233|P2|Overall Study|Unsatisfactory therapeutic effect|2
1800453|NCT00529529|6261234|P1|Overall Study|Unsatisfactory therapeutic effect|2
1800454|NCT00529529|6261232|P3|Overall Study|Lost to Follow-up|1
1800455|NCT00529529|6261233|P2|Overall Study|Lost to Follow-up|3
1800456|NCT00529529|6261234|P1|Overall Study|Lost to Follow-up|5
1800457|NCT00529529|6261232|P3|Overall Study|Protocol deviation|5
1800458|NCT00529529|6261233|P2|Overall Study|Protocol deviation|12
1800459|NCT00529529|6261234|P1|Overall Study|Protocol deviation|8
1800460|NCT00529529|6261232|P3|Overall Study|Subject withdrew consent|12
1800461|NCT00529529|6261233|P2|Overall Study|Subject withdrew consent|9
1800462|NCT00529529|6261234|P1|Overall Study|Subject withdrew consent|12
1800463|NCT00529529|6261232|P3|Overall Study|Adverse Event|8
1800464|NCT00529529|6261233|P2|Overall Study|Adverse Event|17
1800465|NCT00529529|6261234|P1|Overall Study|Adverse Event|12
1800466|NCT00529516|6261293|P3|Overall Study|Lost to Follow-up|1
1800467|NCT00529516|6261294|P2|Overall Study|Lost to Follow-up|0
1800468|NCT00529516|6261295|P1|Overall Study|Lost to Follow-up|0
1800469|NCT00529516|6261293|P3|Overall Study|Withdrawal by Subject|0
1800470|NCT00529516|6261294|P2|Overall Study|Withdrawal by Subject|1
1800471|NCT00529516|6261295|P1|Overall Study|Withdrawal by Subject|1
1800472|NCT00529516|6261293|P3|Overall Study|Adverse Event|0
1800473|NCT00529516|6261294|P2|Overall Study|Adverse Event|1
1800474|NCT00529516|6261295|P1|Overall Study|Adverse Event|2
1800475|NCT00529451|6261380|P4|Overall Study|Administrative problems|2
1800476|NCT00529451|6261381|P3|Overall Study|Administrative problems|0
1800477|NCT00529451|6261382|P2|Overall Study|Administrative problems|1
1800478|NCT00529451|6261383|P1|Overall Study|Administrative problems|1
1800479|NCT00529451|6261380|P4|Overall Study|Protocol deviation|1
1800480|NCT00529451|6261381|P3|Overall Study|Protocol deviation|4
1800481|NCT00529451|6261382|P2|Overall Study|Protocol deviation|1
1800482|NCT00529451|6261383|P1|Overall Study|Protocol deviation|1
1800483|NCT00529451|6261380|P4|Overall Study|Lost to Follow-up|4
1800484|NCT00529451|6261381|P3|Overall Study|Lost to Follow-up|4
1800485|NCT00529451|6261382|P2|Overall Study|Lost to Follow-up|7
1800486|NCT00529451|6261383|P1|Overall Study|Lost to Follow-up|4
1800487|NCT00529451|6261380|P4|Overall Study|Unsatisfactory therapeutic response|4
1800488|NCT00529451|6261381|P3|Overall Study|Unsatisfactory therapeutic response|5
1800489|NCT00529451|6261382|P2|Overall Study|Unsatisfactory therapeutic response|2
1800490|NCT00529451|6261383|P1|Overall Study|Unsatisfactory therapeutic response|6
1800491|NCT00529451|6261380|P4|Overall Study|Adverse Event|8
1800492|NCT00529451|6261381|P3|Overall Study|Adverse Event|14
1800493|NCT00529451|6261382|P2|Overall Study|Adverse Event|16
1800494|NCT00529451|6261383|P1|Overall Study|Adverse Event|9
1800495|NCT00529451|6261380|P4|Overall Study|Subject withdrew consent|12
1800496|NCT00529451|6261381|P3|Overall Study|Subject withdrew consent|13
1800497|NCT00529451|6261382|P2|Overall Study|Subject withdrew consent|21
1800498|NCT00529451|6261383|P1|Overall Study|Subject withdrew consent|16
1800499|NCT00529399|6261410|P3|Overall Study|Non-compliant|0
1800500|NCT00529399|6261411|P2|Overall Study|Non-compliant|1
1800501|NCT00529399|6261412|P1|Overall Study|Non-compliant|0
1800502|NCT00529399|6261410|P3|Overall Study|Withdrawal by Subject|1
1800503|NCT00529399|6261411|P2|Overall Study|Withdrawal by Subject|0
1800504|NCT00529399|6261412|P1|Overall Study|Withdrawal by Subject|1
1800505|NCT00529399|6261410|P3|Overall Study|Lost to Follow-up|1
1800506|NCT00529399|6261411|P2|Overall Study|Lost to Follow-up|0
1800507|NCT00529399|6261412|P1|Overall Study|Lost to Follow-up|1
1800508|NCT00529386|6261420|P1|Overall Study|Lost to Follow-up|1
1800509|NCT00529373|6261426|P2|Second Extension Study|Status Missing|5
1800510|NCT00529373|6261427|P1|Second Extension Study|Status Missing|5
1800511|NCT00529373|6261426|P2|Second Extension Study|Withdrawal by Subject|75
1800512|NCT00529373|6261427|P1|Second Extension Study|Withdrawal by Subject|97
1800513|NCT00529373|6261426|P2|Second Extension Study|Protocol Violation|1
1800514|NCT00529373|6261427|P1|Second Extension Study|Protocol Violation|2
1800515|NCT00529373|6261426|P2|Second Extension Study|Physician Decision|26
1800516|NCT00529373|6261427|P1|Second Extension Study|Physician Decision|63
1800517|NCT00529373|6261426|P2|Second Extension Study|Other|12
1800518|NCT00529373|6261427|P1|Second Extension Study|Other|7
1800519|NCT00529373|6261426|P2|Second Extension Study|Lost to Follow-up|12
1800520|NCT00529373|6261427|P1|Second Extension Study|Lost to Follow-up|18
1800521|NCT00529373|6261426|P2|Second Extension Study|Lack of Efficacy|15
1800522|NCT00529373|6261427|P1|Second Extension Study|Lack of Efficacy|7
1800523|NCT00529373|6261426|P2|Second Extension Study|Adverse Event|51
1800524|NCT00529373|6261427|P1|Second Extension Study|Adverse Event|101
1800525|NCT00529373|6261426|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
1800526|NCT00529373|6261427|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
1800527|NCT00529373|6261426|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
1800528|NCT00529373|6261427|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
1800529|NCT00529373|6261426|P2|First Extension Study|Discontinued after 5 years completion|346
1800530|NCT00529373|6261427|P1|First Extension Study|Discontinued after 5 years completion|208
1800531|NCT00529373|6261426|P2|First Extension Study|Disposition record non-existing|1
1800532|NCT00529373|6261427|P1|First Extension Study|Disposition record non-existing|0
1800533|NCT00529373|6261426|P2|First Extension Study|Withdrawal by Subject|287
1800534|NCT00529373|6261427|P1|First Extension Study|Withdrawal by Subject|296
1800535|NCT00529373|6261426|P2|First Extension Study|Protocol Violation|13
1800536|NCT00529373|6261427|P1|First Extension Study|Protocol Violation|16
1800537|NCT00529373|6261426|P2|First Extension Study|Physician Decision|45
1800538|NCT00529373|6261427|P1|First Extension Study|Physician Decision|50
1800539|NCT00529373|6261426|P2|First Extension Study|Other|47
1800540|NCT00529373|6261427|P1|First Extension Study|Other|27
1800541|NCT00529373|6261426|P2|First Extension Study|Lost to Follow-up|37
1800542|NCT00529373|6261427|P1|First Extension Study|Lost to Follow-up|41
1800543|NCT00529373|6261426|P2|First Extension Study|Lack of Efficacy|427
1800544|NCT00529373|6261427|P1|First Extension Study|Lack of Efficacy|65
1800545|NCT00529373|6261426|P2|First Extension Study|Adverse Event|142
1800546|NCT00529373|6261427|P1|First Extension Study|Adverse Event|162
1800547|NCT00529373|6261426|P2|Base Study|Did not continue into Extension|2238
1800548|NCT00529373|6261427|P1|Base Study|Did not continue into Extension|1795
1800549|NCT00529373|6261426|P2|Base Study|Withdrawal by Subject|967
1800550|NCT00529373|6261427|P1|Base Study|Withdrawal by Subject|1062
1800551|NCT00529373|6261426|P2|Base Study|Protocol Violation|38
1800552|NCT00529373|6261427|P1|Base Study|Protocol Violation|48
1800553|NCT00529373|6261426|P2|Base Study|Physician Decision|52
1800554|NCT00529373|6261427|P1|Base Study|Physician Decision|60
1800555|NCT00529373|6261426|P2|Base Study|Other Protocol Specified Criteria|20
1800556|NCT00529373|6261427|P1|Base Study|Other Protocol Specified Criteria|19
1800557|NCT00529373|6261426|P2|Base Study|Lost to Follow-up|208
1800558|NCT00529373|6261427|P1|Base Study|Lost to Follow-up|221
1800559|NCT00529373|6261426|P2|Base Study|Lack of Efficacy|75
1800560|NCT00529373|6261427|P1|Base Study|Lack of Efficacy|16
1800561|NCT00529373|6261426|P2|Base Study|Adverse Event|470
1800562|NCT00529373|6261427|P1|Base Study|Adverse Event|525
1800563|NCT00529308|6261621|P2|Overall Study|Withdrawal by Subject|1
1800564|NCT00529308|6261622|P1|Overall Study|Withdrawal by Subject|1
1800565|NCT00529243|6261651|P1|Overall Study|Relocated|1
1800566|NCT00529243|6261651|P1|Overall Study|Death|1
1800567|NCT00529243|6261651|P1|Overall Study|Adverse Event|1
1800568|NCT00529217|6261656|P1|Overall Study|Unable to adhere to study schedule|2
1800569|NCT00529217|6261656|P1|Overall Study|Lack of Efficacy|2
1800570|NCT00529152|6261692|P1|Overall Study|Lost to Follow-up|1
1800571|NCT00529152|6261692|P1|Overall Study|Withdrawal by Subject|2
1800572|NCT00529152|6261692|P1|Overall Study|Adverse Event|2
1800573|NCT00529100|6261716|P2|Overall Study|Participant Ineligibility|1
1800574|NCT00529100|6261717|P1|Overall Study|Participant Ineligibility|0
1800575|NCT00529100|6261716|P2|Overall Study|Withdrawal by Subject|1
1800576|NCT00529100|6261717|P1|Overall Study|Withdrawal by Subject|0
1800577|NCT00529100|6261716|P2|Overall Study|Progressive Disease|1
1800578|NCT00529100|6261717|P1|Overall Study|Progressive Disease|0
1800579|NCT00529100|6261716|P2|Overall Study|Protocol Violation|1
1800580|NCT00529100|6261717|P1|Overall Study|Protocol Violation|0
1800581|NCT00529100|6261716|P2|Overall Study|Adverse Event|5
1800582|NCT00529100|6261717|P1|Overall Study|Adverse Event|0
1800583|NCT00529087|6261734|P3|Overall Study|Protocol deviation|2
1800584|NCT00529087|6261735|P2|Overall Study|Protocol deviation|1
1800585|NCT00529087|6261736|P1|Overall Study|Protocol deviation|1
1800586|NCT00529087|6261734|P3|Overall Study|Withdrawal by Subject|3
1800587|NCT00529087|6261735|P2|Overall Study|Withdrawal by Subject|3
1800588|NCT00529087|6261736|P1|Overall Study|Withdrawal by Subject|3
1800589|NCT00529087|6261734|P3|Overall Study|Protocol Violation|6
1800590|NCT00529087|6261735|P2|Overall Study|Protocol Violation|7
1800591|NCT00529087|6261736|P1|Overall Study|Protocol Violation|8
1800592|NCT00529087|6261734|P3|Overall Study|Lost to Follow-up|1
1800593|NCT00529087|6261735|P2|Overall Study|Lost to Follow-up|4
1800594|NCT00529087|6261736|P1|Overall Study|Lost to Follow-up|6
1800595|NCT00529087|6261734|P3|Overall Study|Adverse Event|4
1800596|NCT00529087|6261735|P2|Overall Study|Adverse Event|13
1800597|NCT00529087|6261736|P1|Overall Study|Adverse Event|10
1800598|NCT00529035|6261800|P1|Overall Study|Withdrawal by Subject|1
1800599|NCT00528970|6261814|P3|Overall Study|Randomized but not treated|1
1800600|NCT00528970|6261815|P2|Overall Study|Randomized but not treated|0
1800601|NCT00528970|6261816|P1|Overall Study|Randomized but not treated|0
1800602|NCT00528970|6261814|P3|Overall Study|Withdrawal by Subject|5
1800603|NCT00528970|6261815|P2|Overall Study|Withdrawal by Subject|3
1800604|NCT00528970|6261816|P1|Overall Study|Withdrawal by Subject|4
1800605|NCT00528970|6261814|P3|Overall Study|Lack of Efficacy|1
1800606|NCT00528970|6261815|P2|Overall Study|Lack of Efficacy|0
1800607|NCT00528970|6261816|P1|Overall Study|Lack of Efficacy|0
1800608|NCT00528970|6261814|P3|Overall Study|Protocol Violation|4
1800609|NCT00528970|6261815|P2|Overall Study|Protocol Violation|1
1800610|NCT00528970|6261816|P1|Overall Study|Protocol Violation|2
1800611|NCT00528970|6261814|P3|Overall Study|Other than specified|3
1800612|NCT00528970|6261815|P2|Overall Study|Other than specified|3
1800613|NCT00528970|6261816|P1|Overall Study|Other than specified|2
1800614|NCT00528970|6261814|P3|Overall Study|Lost to Follow-up|1
1800615|NCT00528970|6261815|P2|Overall Study|Lost to Follow-up|0
1800616|NCT00528970|6261816|P1|Overall Study|Lost to Follow-up|0
1800617|NCT00528970|6261814|P3|Overall Study|Adverse Event|5
1800618|NCT00528970|6261815|P2|Overall Study|Adverse Event|8
1800619|NCT00528970|6261816|P1|Overall Study|Adverse Event|6
1800620|NCT00528957|6261835|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
1800621|NCT00528957|6261836|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
1800622|NCT00528957|6261835|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
1800623|NCT00528957|6261836|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
1800624|NCT00528957|6261835|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
1800625|NCT00528957|6261836|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
1800626|NCT00528957|6261835|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
1800627|NCT00528957|6261836|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
1800628|NCT00528957|6261835|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
1800629|NCT00528957|6261836|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
1800630|NCT00528957|6261835|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
1800631|NCT00528957|6261836|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
1800632|NCT00528957|6261835|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
1800633|NCT00528957|6261836|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
1800634|NCT00528957|6261835|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
1800635|NCT00528957|6261836|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
1800636|NCT00528957|6261835|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
1800637|NCT00528957|6261836|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
1800638|NCT00528957|6261835|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
1800639|NCT00528957|6261836|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
1800640|NCT00528957|6261835|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
1800641|NCT00528957|6261836|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
1800642|NCT00528957|6261835|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
1800643|NCT00528957|6261836|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
1800644|NCT00528957|6261835|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
1800645|NCT00528957|6261836|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
1800646|NCT00528957|6261835|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
1800647|NCT00528957|6261836|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
1800648|NCT00528957|6261835|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
1800649|NCT00528957|6261836|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
1800650|NCT00528957|6261835|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
1800651|NCT00528957|6261836|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
1800652|NCT00528931|6261977|P1|Overall Study|Lost to Follow-up|1
1800653|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
1800654|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1800655|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1800656|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
1800657|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1800658|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1800659|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
1800660|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
1800661|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
1800662|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
1800663|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
1800664|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
1800665|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
1800666|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
1800667|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
1800668|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
1800669|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|Death|0
1800670|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|Death|0
1800671|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|Death|1
1800672|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|Death|0
1800673|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
1800674|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
1800675|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
1800676|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
1800677|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
1800678|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
1800679|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
1800680|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
1800681|NCT00528879|6261989|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
1800682|NCT00528879|6261990|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
1800683|NCT00528879|6261991|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
1800684|NCT00528879|6261992|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
1800685|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|Other|1
1800686|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|Other|1
1800687|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|Other|0
1800688|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|Other|0
1800689|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1800690|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
1800691|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1800692|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
1800693|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
1800694|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
1800695|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
1800696|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
1800697|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1800698|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
1800699|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1800700|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
1800701|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
1800702|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1800703|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
1800704|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
1800705|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
1800706|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
1800707|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
1800708|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
1800709|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1800710|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
1800711|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1800712|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
1800713|NCT00528879|6261989|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
1800714|NCT00528879|6261990|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
1800715|NCT00528879|6261991|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
1800716|NCT00528879|6261992|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
1800717|NCT00528866|6262058|P1|Overall Study|Protocol Violation|6
1800718|NCT00528840|6262071|P1|Overall Study|Other|2
1800719|NCT00528840|6262071|P1|Overall Study|Administrative Reasons|1
1800720|NCT00528840|6262071|P1|Overall Study|Death|2
1800721|NCT00528840|6262071|P1|Overall Study|Withdrawal by Subject|17
1800722|NCT00528840|6262071|P1|Overall Study|Adverse Event|1
1800723|NCT00528840|6262071|P1|Overall Study|Lost to Follow-up|10
1800724|NCT00528801|6262085|P2|Overall Study|Administrative Reasons|1
1800725|NCT00528801|6262086|P1|Overall Study|Administrative Reasons|0
1800726|NCT00528801|6262085|P2|Overall Study|Lost to Follow-up|4
1800727|NCT00528801|6262086|P1|Overall Study|Lost to Follow-up|15
1800728|NCT00528801|6262085|P2|Overall Study|Protocol Violation|5
1800729|NCT00528801|6262086|P1|Overall Study|Protocol Violation|11
1800730|NCT00528801|6262085|P2|Overall Study|Withdrawal by Subject|1
1800731|NCT00528801|6262086|P1|Overall Study|Withdrawal by Subject|1
1800732|NCT00528775|6262100|P1|Overall Study|Other not specified|1
1800733|NCT00528645|6262108|P1|Overall Study|Adverse Event|3
1800734|NCT00528606|6262117|P2|Overall Study|Other|0
1800735|NCT00528606|6262118|P1|Overall Study|Other|2
1800736|NCT00528606|6262117|P2|Overall Study|Adverse Event|0
1800737|NCT00528606|6262118|P1|Overall Study|Adverse Event|3
1800738|NCT00528606|6262117|P2|Overall Study|Lost to Follow-up|1
1800739|NCT00528606|6262118|P1|Overall Study|Lost to Follow-up|4
1800740|NCT00528606|6262117|P2|Overall Study|Withdrew consent|3
1800741|NCT00528606|6262118|P1|Overall Study|Withdrew consent|4
1800742|NCT00528567|6262151|P2|Overall Study|Administrative/Other|75
1800743|NCT00528567|6262152|P1|Overall Study|Administrative/Other|22
1800744|NCT00528567|6262151|P2|Overall Study|Other Protocol Violation|21
1800745|NCT00528567|6262152|P1|Overall Study|Other Protocol Violation|5
1800746|NCT00528567|6262151|P2|Overall Study|Failure to Return|4
1800747|NCT00528567|6262152|P1|Overall Study|Failure to Return|1
1800748|NCT00528567|6262151|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
1800749|NCT00528567|6262152|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
1800750|NCT00528567|6262151|P2|Overall Study|Withdrew Consent|55
1800751|NCT00528567|6262152|P1|Overall Study|Withdrew Consent|59
1800752|NCT00528567|6262151|P2|Overall Study|Violation Criteria at Entry|17
1800753|NCT00528567|6262152|P1|Overall Study|Violation Criteria at Entry|3
1800754|NCT00528567|6262151|P2|Overall Study|Adverse Event/Intermittent Illness|29
1800755|NCT00528567|6262152|P1|Overall Study|Adverse Event/Intermittent Illness|255
1800756|NCT00528567|6262151|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
1800757|NCT00528567|6262152|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
1800758|NCT00528567|6262151|P2|Overall Study|Death|5
1800759|NCT00528567|6262152|P1|Overall Study|Death|4
1800760|NCT00528528|6262219|P4|Overall Study|Ongoing participant|0
1800761|NCT00528528|6262220|P3|Overall Study|Ongoing participant|1
1800762|NCT00528528|6262221|P2|Overall Study|Ongoing participant|0
1800763|NCT00528528|6262222|P1|Overall Study|Ongoing participant|0
1800764|NCT00528528|6262219|P4|Overall Study|Withdrawal by Subject|1
1800765|NCT00528528|6262220|P3|Overall Study|Withdrawal by Subject|1
1800766|NCT00528528|6262221|P2|Overall Study|Withdrawal by Subject|2
1800767|NCT00528528|6262222|P1|Overall Study|Withdrawal by Subject|3
1800768|NCT00528528|6262219|P4|Overall Study|Other|0
1800769|NCT00528528|6262220|P3|Overall Study|Other|0
1800770|NCT00528528|6262221|P2|Overall Study|Other|1
1800771|NCT00528528|6262222|P1|Overall Study|Other|0
1800772|NCT00528528|6262219|P4|Overall Study|Ineligible to continue the trial|1
1800773|NCT00528528|6262220|P3|Overall Study|Ineligible to continue the trial|0
1800774|NCT00528528|6262221|P2|Overall Study|Ineligible to continue the trial|0
1800775|NCT00528528|6262222|P1|Overall Study|Ineligible to continue the trial|0
1800776|NCT00528528|6262219|P4|Overall Study|Lost to Follow-up|1
1800777|NCT00528528|6262220|P3|Overall Study|Lost to Follow-up|1
1800778|NCT00528528|6262221|P2|Overall Study|Lost to Follow-up|0
1800779|NCT00528528|6262222|P1|Overall Study|Lost to Follow-up|0
1800780|NCT00528424|6262260|P1|Overall Study|Other|12
1800781|NCT00528424|6262260|P1|Overall Study|Administrative reason|2
1800782|NCT00528424|6262260|P1|Overall Study|Withdrew consent|2
1800783|NCT00528424|6262260|P1|Overall Study|Lost to Follow-up|13
1800784|NCT00528411|6262275|P3|Overall Study|Prior commitment medication|0
1800785|NCT00528411|6262276|P2|Overall Study|Prior commitment medication|1
1800786|NCT00528411|6262277|P1|Overall Study|Prior commitment medication|0
1800787|NCT00528411|6262275|P3|Overall Study|Severe non-compliance to protocol|0
1800788|NCT00528411|6262276|P2|Overall Study|Severe non-compliance to protocol|1
1800789|NCT00528411|6262277|P1|Overall Study|Severe non-compliance to protocol|0
1800790|NCT00528411|6262275|P3|Overall Study|Incorrect Enrolment|0
1800791|NCT00528411|6262276|P2|Overall Study|Incorrect Enrolment|1
1800792|NCT00528411|6262277|P1|Overall Study|Incorrect Enrolment|1
1800793|NCT00528411|6262275|P3|Overall Study|Adverse Event|1
1800794|NCT00528411|6262276|P2|Overall Study|Adverse Event|0
1800795|NCT00528411|6262277|P1|Overall Study|Adverse Event|4
1800796|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
1800797|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
1800798|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
1800799|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
1800800|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
1800801|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
1800802|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
1800803|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
1800804|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
1800805|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1800806|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1800807|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1800808|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1800809|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1800810|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1800811|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1800812|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
1800813|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
1800814|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1800815|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1800816|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1800817|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
1800818|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
1800819|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1800820|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1800821|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1800822|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
1800823|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1800824|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1800825|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1800826|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1800827|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1800828|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1800829|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1800830|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
1800831|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
1800832|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1800833|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
1800834|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
1800835|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
1800836|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
1800837|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1800838|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
1800839|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
1800840|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
1800841|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
1800842|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
1800843|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
1800844|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
1800845|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
1800846|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
1800847|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
1800848|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
1800849|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
1800850|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1800851|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1800852|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
1800853|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
1801010|NCT00527735|6262770|P2|Overall Study|Not identified|5
1800854|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
1800855|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
1800856|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
1800857|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
1800858|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
1800859|NCT00528372|6262414|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
1800860|NCT00528372|6262415|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
1800861|NCT00528372|6262416|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
1800862|NCT00528372|6262417|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1800863|NCT00528372|6262418|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1800864|NCT00528372|6262419|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
1800865|NCT00528372|6262420|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
1800866|NCT00528372|6262421|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
1800867|NCT00528372|6262422|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
1800868|NCT00528372|6262414|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
1800869|NCT00528372|6262415|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
1800870|NCT00528372|6262416|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
1800871|NCT00528372|6262417|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
1800872|NCT00528372|6262418|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
1800873|NCT00528372|6262419|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
1800874|NCT00528372|6262420|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
1800875|NCT00528372|6262421|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
1800876|NCT00528372|6262422|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
1800877|NCT00528372|6262414|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1800878|NCT00528372|6262415|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1800879|NCT00528372|6262416|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1800880|NCT00528372|6262417|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1800881|NCT00528372|6262418|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1800882|NCT00528372|6262419|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1800883|NCT00528372|6262420|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1800884|NCT00528372|6262421|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
1800885|NCT00528372|6262422|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
1800886|NCT00528372|6262414|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1800887|NCT00528372|6262415|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1800888|NCT00528372|6262416|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1800889|NCT00528372|6262417|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
1800890|NCT00528372|6262418|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1800891|NCT00528372|6262419|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
1800892|NCT00528372|6262420|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1800893|NCT00528372|6262421|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1800894|NCT00528372|6262422|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
1800895|NCT00528372|6262414|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
1800896|NCT00528372|6262415|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1800897|NCT00528372|6262416|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1800898|NCT00528372|6262417|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1800899|NCT00528372|6262418|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1800900|NCT00528372|6262419|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
1800901|NCT00528372|6262420|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
1800902|NCT00528372|6262421|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
1800903|NCT00528372|6262422|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
1800904|NCT00528372|6262414|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
1800905|NCT00528372|6262415|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
1800906|NCT00528372|6262416|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
1800907|NCT00528372|6262417|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
1800908|NCT00528372|6262418|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
1800909|NCT00528372|6262419|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
1800910|NCT00528372|6262420|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
1800911|NCT00528372|6262421|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
1800912|NCT00528372|6262422|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
1800913|NCT00528372|6262414|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1800914|NCT00528372|6262415|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1800915|NCT00528372|6262416|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
1800916|NCT00528372|6262417|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
1800917|NCT00528372|6262418|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1800918|NCT00528372|6262419|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
1800919|NCT00528372|6262420|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
1800920|NCT00528372|6262421|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
1800921|NCT00528372|6262422|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
1800922|NCT00528372|6262414|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800923|NCT00528372|6262415|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800924|NCT00528372|6262416|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800925|NCT00528372|6262417|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800926|NCT00528372|6262418|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800927|NCT00528372|6262419|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800928|NCT00528372|6262420|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800929|NCT00528372|6262421|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
1800930|NCT00528372|6262422|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
1800931|NCT00528112|6262554|P2|Extension Phase|Protocol Violation|2
1800932|NCT00528112|6262555|P1|Extension Phase|Protocol Violation|0
1800933|NCT00528112|6262554|P2|Extension Phase|Adverse Event|36
1800934|NCT00528112|6262555|P1|Extension Phase|Adverse Event|0
1800935|NCT00528112|6262554|P2|Extension Phase|Death|1
1800936|NCT00528112|6262555|P1|Extension Phase|Death|0
1800937|NCT00528112|6262554|P2|Extension Phase|Lost to Follow-up|12
1800938|NCT00528112|6262555|P1|Extension Phase|Lost to Follow-up|0
1800939|NCT00528112|6262554|P2|Extension Phase|Pregnancy|3
1800940|NCT00528112|6262555|P1|Extension Phase|Pregnancy|0
1800941|NCT00528112|6262554|P2|Extension Phase|Other reasons|100
1800942|NCT00528112|6262555|P1|Extension Phase|Other reasons|0
1800943|NCT00528112|6262554|P2|Extension Phase|Withdrawal by Subject|3
1800944|NCT00528112|6262555|P1|Extension Phase|Withdrawal by Subject|0
1800945|NCT00528112|6262554|P2|Treatment up to 3 Years|Other reasons|186
1800946|NCT00528112|6262555|P1|Treatment up to 3 Years|Other reasons|186
1800947|NCT00528112|6262554|P2|Treatment up to 3 Years|Pregnancy|10
1800948|NCT00528112|6262555|P1|Treatment up to 3 Years|Pregnancy|9
1800949|NCT00528112|6262554|P2|Treatment up to 3 Years|Lost to Follow-up|61
1800950|NCT00528112|6262555|P1|Treatment up to 3 Years|Lost to Follow-up|63
1800951|NCT00528112|6262554|P2|Treatment up to 3 Years|Death|1
1800952|NCT00528112|6262555|P1|Treatment up to 3 Years|Death|0
1800953|NCT00528112|6262554|P2|Treatment up to 3 Years|Protocol Violation|16
1800954|NCT00528112|6262555|P1|Treatment up to 3 Years|Protocol Violation|16
1800955|NCT00528112|6262554|P2|Treatment up to 3 Years|Withdrawal by Subject|31
1800956|NCT00528112|6262555|P1|Treatment up to 3 Years|Withdrawal by Subject|26
1800957|NCT00528112|6262554|P2|Treatment up to 3 Years|Adverse Event|278
1800958|NCT00528112|6262555|P1|Treatment up to 3 Years|Adverse Event|313
1800959|NCT00528021|6262613|P4|Overall Study|Lack of Efficacy|9
1800960|NCT00528021|6262614|P3|Overall Study|Lack of Efficacy|7
1800961|NCT00528021|6262615|P2|Overall Study|Lack of Efficacy|13
1800962|NCT00528021|6262616|P1|Overall Study|Lack of Efficacy|17
1800963|NCT00527982|6262628|P2|Overall Study|Physician Decision|0
1800964|NCT00527982|6262629|P1|Overall Study|Physician Decision|1
1800965|NCT00527904|6262670|P1|Overall Study|misc|22
1800966|NCT00527904|6262670|P1|Overall Study|Lost to Follow-up|8
1800967|NCT00527904|6262670|P1|Overall Study|Withdrawal by Subject|21
1800968|NCT00527904|6262670|P1|Overall Study|Adverse Event|45
1800969|NCT00527826|6262689|P2|Overall Study|Participant moved away|1
1800970|NCT00527826|6262690|P1|Overall Study|Participant moved away|0
1800971|NCT00527826|6262689|P2|Overall Study|Additional Intake of Viani forte|1
1800972|NCT00527826|6262690|P1|Overall Study|Additional Intake of Viani forte|0
1800973|NCT00527826|6262689|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
1800974|NCT00527826|6262690|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
1800975|NCT00527826|6262689|P2|Overall Study|Inclusion Criteria Not Met|3
1800976|NCT00527826|6262690|P1|Overall Study|Inclusion Criteria Not Met|3
1800977|NCT00527826|6262689|P2|Overall Study|Withdrawal by Subject|8
1800978|NCT00527826|6262690|P1|Overall Study|Withdrawal by Subject|5
1800979|NCT00527826|6262689|P2|Overall Study|Lost to Follow-up|2
1800980|NCT00527826|6262690|P1|Overall Study|Lost to Follow-up|3
1800981|NCT00527826|6262689|P2|Overall Study|Adverse Event|10
1800982|NCT00527826|6262690|P1|Overall Study|Adverse Event|10
1800983|NCT00527787|6262739|P2|Overall Study|misc|2
1800984|NCT00527787|6262740|P1|Overall Study|misc|5
1800985|NCT00527787|6262739|P2|Overall Study|Duodenal Ulcer|10
1800986|NCT00527787|6262740|P1|Overall Study|Duodenal Ulcer|1
1800987|NCT00527787|6262739|P2|Overall Study|Lost to Follow-up|2
1800988|NCT00527787|6262740|P1|Overall Study|Lost to Follow-up|5
1800989|NCT00527787|6262739|P2|Overall Study|Withdrawal by Subject|25
1800990|NCT00527787|6262740|P1|Overall Study|Withdrawal by Subject|13
1800991|NCT00527787|6262739|P2|Overall Study|Adverse Event|24
1800992|NCT00527787|6262740|P1|Overall Study|Adverse Event|14
1800993|NCT00527748|6262762|P1|Overall Study|Other|3
1800994|NCT00527735|6262769|P3|Overall Study|Completed treatment during maintenance|1
1800995|NCT00527735|6262770|P2|Overall Study|Completed treatment during maintenance|2
1800996|NCT00527735|6262771|P1|Overall Study|Completed treatment during maintenance|2
1800997|NCT00527735|6262769|P3|Overall Study|Poor compliance or noncompliance|1
1800998|NCT00527735|6262770|P2|Overall Study|Poor compliance or noncompliance|1
1800999|NCT00527735|6262771|P1|Overall Study|Poor compliance or noncompliance|0
1801000|NCT00527735|6262769|P3|Overall Study|Lost to Follow-up|3
1801001|NCT00527735|6262770|P2|Overall Study|Lost to Follow-up|0
1801002|NCT00527735|6262771|P1|Overall Study|Lost to Follow-up|0
1801003|NCT00527735|6262769|P3|Overall Study|No longer met study criteria|1
1801004|NCT00527735|6262770|P2|Overall Study|No longer met study criteria|2
1801005|NCT00527735|6262771|P1|Overall Study|No longer met study criteria|2
1801006|NCT00527735|6262769|P3|Overall Study|Withdrawal by Subject|3
1801007|NCT00527735|6262770|P2|Overall Study|Withdrawal by Subject|4
1801008|NCT00527735|6262771|P1|Overall Study|Withdrawal by Subject|5
1801009|NCT00527735|6262769|P3|Overall Study|Not identified|5
1801011|NCT00527735|6262771|P1|Overall Study|Not identified|5
1801012|NCT00527735|6262769|P3|Overall Study|Adverse Event|7
1801013|NCT00527735|6262770|P2|Overall Study|Adverse Event|6
1801014|NCT00527735|6262771|P1|Overall Study|Adverse Event|10
1801015|NCT00527735|6262769|P3|Overall Study|Completed treatment in treatment phase|18
1801016|NCT00527735|6262770|P2|Overall Study|Completed treatment in treatment phase|13
1801017|NCT00527735|6262771|P1|Overall Study|Completed treatment in treatment phase|14
1801018|NCT00527735|6262769|P3|Overall Study|Death|15
1801019|NCT00527735|6262770|P2|Overall Study|Death|13
1801020|NCT00527735|6262771|P1|Overall Study|Death|23
1801021|NCT00527735|6262769|P3|Overall Study|Disease progression|53
1801022|NCT00527735|6262770|P2|Overall Study|Disease progression|61
1801023|NCT00527735|6262771|P1|Overall Study|Disease progression|47
1801024|NCT00527618|6262857|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
1801025|NCT00527618|6262858|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
1801026|NCT00527618|6262857|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
1801027|NCT00527618|6262858|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
1801028|NCT00527618|6262857|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
1801029|NCT00527618|6262858|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
1801030|NCT00527618|6262857|P2|Week 13-14 (Washout)|Lost to Follow-up|0
1801031|NCT00527618|6262858|P1|Week 13-14 (Washout)|Lost to Follow-up|1
1801032|NCT00527618|6262857|P2|Week 1-12 (First Intervention)|Adverse Event|1
1801033|NCT00527618|6262858|P1|Week 1-12 (First Intervention)|Adverse Event|0
1801034|NCT00527618|6262857|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
1801035|NCT00527618|6262858|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
1801036|NCT00527605|6262873|P2|Overall Study|Protocol Violation|2
1801037|NCT00527605|6262874|P1|Overall Study|Protocol Violation|1
1801038|NCT00527605|6262873|P2|Overall Study|Lost to Follow-up|2
1801039|NCT00527605|6262874|P1|Overall Study|Lost to Follow-up|6
1801040|NCT00527605|6262873|P2|Overall Study|Withdrawal by Subject|7
1801041|NCT00527605|6262874|P1|Overall Study|Withdrawal by Subject|3
1801042|NCT00527605|6262873|P2|Overall Study|Adverse Event|0
1801043|NCT00527605|6262874|P1|Overall Study|Adverse Event|3
1801044|NCT00527514|6262925|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
1801045|NCT00527514|6262925|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
1801046|NCT00527514|6262925|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
1801047|NCT00527514|6262925|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
1801048|NCT00527514|6262925|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
1801049|NCT00527514|6262925|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
1801050|NCT00527514|6262925|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
1801051|NCT00527488|6262941|P4|Overall Study|Withdrawn prior to dosing|0
1801052|NCT00527488|6262942|P3|Overall Study|Withdrawn prior to dosing|1
1801053|NCT00527488|6262943|P2|Overall Study|Withdrawn prior to dosing|1
1801054|NCT00527488|6262944|P1|Overall Study|Withdrawn prior to dosing|0
1801055|NCT00527423|6263027|P1|Overall Study|Death|9
1801056|NCT00527423|6263027|P1|Overall Study|OTHER|4
1801057|NCT00527423|6263027|P1|Overall Study|Lost to Follow-up|4
1801058|NCT00527423|6263027|P1|Overall Study|Withdrawal by Subject|10
1801059|NCT00527423|6263027|P1|Overall Study|Physician Decision|4
1801060|NCT00527423|6263027|P1|Overall Study|Adverse Event|5
1801061|NCT00527423|6263027|P1|Overall Study|Protocol Violation|1
1801062|NCT00527397|6263033|P1|Overall Study|Study terminated by sponsor|13
1801063|NCT00527397|6263033|P1|Overall Study|Withdrawal by Subject|6
1801064|NCT00527397|6263033|P1|Overall Study|Protocol Violation|1
1801065|NCT00527397|6263033|P1|Overall Study|Lack of Efficacy|1
1801066|NCT00527397|6263033|P1|Overall Study|Adverse Event|3
1801067|NCT00527332|6263059|P2|Overall Study|Withdrew consent|1
1801068|NCT00527332|6263060|P1|Overall Study|Withdrew consent|5
1801069|NCT00527332|6263059|P2|Overall Study|Protocol Violation|8
1801070|NCT00527332|6263060|P1|Overall Study|Protocol Violation|4
1801071|NCT00527319|6263069|P3|Overall Study|Adverse Event|1
1801072|NCT00527319|6263070|P2|Overall Study|Adverse Event|0
1801073|NCT00527319|6263071|P1|Overall Study|Adverse Event|0
1801074|NCT00527319|6263069|P3|Overall Study|Intercurrent Medical Illness|3
1801075|NCT00527319|6263070|P2|Overall Study|Intercurrent Medical Illness|1
1801076|NCT00527319|6263071|P1|Overall Study|Intercurrent Medical Illness|0
1801077|NCT00527319|6263069|P3|Overall Study|Death|1
1801078|NCT00527319|6263070|P2|Overall Study|Death|3
1801079|NCT00527319|6263071|P1|Overall Study|Death|0
1801080|NCT00527319|6263069|P3|Overall Study|Lost to Follow-up|0
1801081|NCT00527319|6263070|P2|Overall Study|Lost to Follow-up|0
1801082|NCT00527319|6263071|P1|Overall Study|Lost to Follow-up|1
1801083|NCT00527319|6263069|P3|Overall Study|Withdrawal by Subject|1
1801084|NCT00527319|6263070|P2|Overall Study|Withdrawal by Subject|0
1801085|NCT00527319|6263071|P1|Overall Study|Withdrawal by Subject|5
1801086|NCT00527111|6263101|P2|Overall Study|Other|2
1801087|NCT00527111|6263102|P1|Overall Study|Other|2
1801088|NCT00527111|6263101|P2|Overall Study|Patient Request|5
1801089|NCT00527111|6263102|P1|Overall Study|Patient Request|2
1801090|NCT00527111|6263101|P2|Overall Study|Investigator Request|1
1801091|NCT00527111|6263102|P1|Overall Study|Investigator Request|2
1801092|NCT00527111|6263101|P2|Overall Study|Death|1
1801093|NCT00527111|6263102|P1|Overall Study|Death|0
1801094|NCT00527111|6263101|P2|Overall Study|Adverse Event|13
1801095|NCT00527111|6263102|P1|Overall Study|Adverse Event|14
1801096|NCT00527072|6263124|P1|Overall Study|Withdrawal by Subject|7
1801097|NCT00527072|6263124|P1|Overall Study|Protocol Violation|2
1801098|NCT00527072|6263124|P1|Overall Study|Lost to Follow-up|3
1801099|NCT00527072|6263124|P1|Overall Study|Lack of Efficacy|11
1801100|NCT00527072|6263124|P1|Overall Study|Adverse Event|13
1801101|NCT00526994|6263133|P3|Overall Study|incarcerated, impaired, incomplete|3
1801102|NCT00526994|6263134|P2|Overall Study|incarcerated, impaired, incomplete|3
1801103|NCT00526994|6263135|P1|Overall Study|incarcerated, impaired, incomplete|4
1801104|NCT00526994|6263133|P3|Overall Study|Withdrawal by Subject|5
1801105|NCT00526994|6263134|P2|Overall Study|Withdrawal by Subject|7
1801106|NCT00526994|6263135|P1|Overall Study|Withdrawal by Subject|2
1801107|NCT00526994|6263133|P3|Overall Study|Death|3
1801108|NCT00526994|6263134|P2|Overall Study|Death|3
1801109|NCT00526994|6263135|P1|Overall Study|Death|4
1801110|NCT00526994|6263133|P3|Overall Study|Lost to Follow-up|96
1801111|NCT00526994|6263134|P2|Overall Study|Lost to Follow-up|108
1801112|NCT00526994|6263135|P1|Overall Study|Lost to Follow-up|98
1801113|NCT00526890|6263152|P1|Overall Study|Adverse Event|2
1801114|NCT00526799|6263164|P2|Overall Study|Intercurrent Complicating Disease|1
1801115|NCT00526799|6263165|P1|Overall Study|Intercurrent Complicating Disease|0
1801116|NCT00526799|6263164|P2|Overall Study|Withdrawal by Subject|0
1801117|NCT00526799|6263165|P1|Overall Study|Withdrawal by Subject|1
1801118|NCT00526669|6263173|P2|Combined Treatment Phase|Death|2
1801119|NCT00526669|6263174|P1|Combined Treatment Phase|Death|0
1801120|NCT00526669|6263173|P2|Combined Treatment Phase|Sponsor Terminated Study|2
1801121|NCT00526669|6263174|P1|Combined Treatment Phase|Sponsor Terminated Study|0
1801122|NCT00526669|6263173|P2|Combined Treatment Phase|Withdrawal by Subject|2
1801123|NCT00526669|6263174|P1|Combined Treatment Phase|Withdrawal by Subject|0
1801124|NCT00526669|6263173|P2|Combined Treatment Phase|Lost to Follow-up|2
1801125|NCT00526669|6263174|P1|Combined Treatment Phase|Lost to Follow-up|0
1801126|NCT00526656|6263203|P1|Overall Study|Refused surgery|1
1801127|NCT00526656|6263203|P1|Overall Study|Death|1
1801128|NCT00526630|6263209|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
1801129|NCT00526630|6263210|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
1801130|NCT00526630|6263209|P2|First Intervention Period - 12 Weeks|Withdrawn|3
1801131|NCT00526630|6263210|P1|First Intervention Period - 12 Weeks|Withdrawn|0
1801132|NCT00526331|6263322|P1|Overall Study|Sponsor Termination|55
1801133|NCT00526227|6263330|P1|Overall Study|Death|1
1801134|NCT00526227|6263330|P1|Overall Study|Device not implanted|1
1801135|NCT00526162|6263341|P1|Overall Study|Device not implanted|3
1801136|NCT00526110|6263374|P2|Overall Study|Poor Tolerance|5
1801137|NCT00526110|6263375|P1|Overall Study|Poor Tolerance|0
1801138|NCT00526110|6263374|P2|Overall Study|Withdrawal by Subject|2
1801139|NCT00526110|6263375|P1|Overall Study|Withdrawal by Subject|0
1801140|NCT00526110|6263374|P2|Overall Study|Maximal Response|6
1801141|NCT00526110|6263375|P1|Overall Study|Maximal Response|0
1801142|NCT00526110|6263374|P2|Overall Study|Disease Progression|19
1801143|NCT00526110|6263375|P1|Overall Study|Disease Progression|0
1801144|NCT00526110|6263374|P2|Overall Study|Adverse Event|9
1801145|NCT00526110|6263375|P1|Overall Study|Adverse Event|2
1801146|NCT00526097|6263384|P2|Overall Study|Other|1
1801147|NCT00526097|6263385|P1|Overall Study|Other|2
1801148|NCT00526097|6263384|P2|Overall Study|Withdrawal by Subject|1
1801149|NCT00526097|6263385|P1|Overall Study|Withdrawal by Subject|3
1801150|NCT00526097|6263384|P2|Overall Study|Protocol Violation|10
1801151|NCT00526097|6263385|P1|Overall Study|Protocol Violation|4
1801152|NCT00526097|6263384|P2|Overall Study|Adverse Event|44
1801153|NCT00526097|6263385|P1|Overall Study|Adverse Event|6
1801154|NCT00526071|6263561|P1|Overall Study|Lack of Response to Study Drug|4
1801155|NCT00526071|6263561|P1|Overall Study|Withdrawal by Subject|1
1801156|NCT00526071|6263561|P1|Overall Study|Adverse Event|1
1801157|NCT00525915|6263587|P2|Overall Study|Unrelated illness|0
1801158|NCT00525915|6263588|P1|Overall Study|Unrelated illness|1
1801159|NCT00525915|6263587|P2|Overall Study|Refused Surgery|2
1801160|NCT00525915|6263588|P1|Overall Study|Refused Surgery|1
1801161|NCT00525915|6263587|P2|Overall Study|Withdrawal by Subject|0
1801162|NCT00525915|6263588|P1|Overall Study|Withdrawal by Subject|1
1801163|NCT00525915|6263587|P2|Overall Study|Disease Progression|6
1801164|NCT00525915|6263588|P1|Overall Study|Disease Progression|5
1801165|NCT00525915|6263587|P2|Overall Study|Non-Compliance|1
1801166|NCT00525915|6263588|P1|Overall Study|Non-Compliance|0
1801167|NCT00525902|6263594|P1|Overall Study|Lack of Efficacy|1
1801168|NCT00525824|6263618|P4|Overall Study|Other|1
1801169|NCT00525824|6263619|P3|Overall Study|Other|3
1801170|NCT00525824|6263620|P2|Overall Study|Other|3
1801171|NCT00525824|6263621|P1|Overall Study|Other|1
1801172|NCT00525824|6263618|P4|Overall Study|Safety reasons|0
1801173|NCT00525824|6263619|P3|Overall Study|Safety reasons|1
1801174|NCT00525824|6263620|P2|Overall Study|Safety reasons|0
1801175|NCT00525824|6263621|P1|Overall Study|Safety reasons|1
1801176|NCT00525824|6263618|P4|Overall Study|Severe non-compliance|1
1801177|NCT00525824|6263619|P3|Overall Study|Severe non-compliance|1
1801178|NCT00525824|6263620|P2|Overall Study|Severe non-compliance|1
1801179|NCT00525824|6263621|P1|Overall Study|Severe non-compliance|0
1801180|NCT00525824|6263618|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
1801181|NCT00525824|6263619|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
1801182|NCT00525824|6263620|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
1801183|NCT00525824|6263621|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
1801184|NCT00525824|6263618|P4|Overall Study|Lost to Follow-up|0
1801185|NCT00525824|6263619|P3|Overall Study|Lost to Follow-up|4
1801186|NCT00525824|6263620|P2|Overall Study|Lost to Follow-up|2
1801187|NCT00525824|6263621|P1|Overall Study|Lost to Follow-up|4
1801188|NCT00525824|6263618|P4|Overall Study|Withdrawal by Subject|4
1801189|NCT00525824|6263619|P3|Overall Study|Withdrawal by Subject|3
1801190|NCT00525824|6263620|P2|Overall Study|Withdrawal by Subject|9
1801191|NCT00525824|6263621|P1|Overall Study|Withdrawal by Subject|5
1801192|NCT00525824|6263618|P4|Overall Study|Adverse Event|7
1801193|NCT00525824|6263619|P3|Overall Study|Adverse Event|6
1801194|NCT00525824|6263620|P2|Overall Study|Adverse Event|11
1801195|NCT00525824|6263621|P1|Overall Study|Adverse Event|7
1801196|NCT00525785|6263694|P1|Overall Study|Physician Decision|1
1801197|NCT00525785|6263694|P1|Overall Study|Lack of Efficacy|1
1801198|NCT00525785|6263694|P1|Overall Study|Withdrawal by Subject|1
1801199|NCT00525512|6263730|P4|Open-Label Phase|Other reason (not specified)|5
1801200|NCT00525512|6263731|P3|Open-Label Phase|Other reason (not specified)|4
1801201|NCT00525512|6263732|P2|Open-Label Phase|Other reason (not specified)|0
1801202|NCT00525512|6263733|P1|Open-Label Phase|Other reason (not specified)|0
1801203|NCT00525512|6263730|P4|Open-Label Phase|Lost to Follow-up|0
1801204|NCT00525512|6263731|P3|Open-Label Phase|Lost to Follow-up|1
1801205|NCT00525512|6263732|P2|Open-Label Phase|Lost to Follow-up|0
1801206|NCT00525512|6263733|P1|Open-Label Phase|Lost to Follow-up|0
1801207|NCT00525512|6263730|P4|Open-Label Phase|Adverse Event|0
1801208|NCT00525512|6263731|P3|Open-Label Phase|Adverse Event|1
1801209|NCT00525512|6263732|P2|Open-Label Phase|Adverse Event|0
1801210|NCT00525512|6263733|P1|Open-Label Phase|Adverse Event|0
1801211|NCT00525512|6263730|P4|Double-Blind Phase|Other reason (not specified)|0
1801212|NCT00525512|6263731|P3|Double-Blind Phase|Other reason (not specified)|0
1801213|NCT00525512|6263732|P2|Double-Blind Phase|Other reason (not specified)|13
1801214|NCT00525512|6263733|P1|Double-Blind Phase|Other reason (not specified)|12
1801215|NCT00525512|6263730|P4|Double-Blind Phase|Lack of Efficacy|0
1801216|NCT00525512|6263731|P3|Double-Blind Phase|Lack of Efficacy|0
1801217|NCT00525512|6263732|P2|Double-Blind Phase|Lack of Efficacy|5
1801218|NCT00525512|6263733|P1|Double-Blind Phase|Lack of Efficacy|13
1801219|NCT00525512|6263730|P4|Double-Blind Phase|Withdrawal by Subject|0
1801220|NCT00525512|6263731|P3|Double-Blind Phase|Withdrawal by Subject|0
1801221|NCT00525512|6263732|P2|Double-Blind Phase|Withdrawal by Subject|12
1801222|NCT00525512|6263733|P1|Double-Blind Phase|Withdrawal by Subject|17
1801223|NCT00525512|6263730|P4|Double-Blind Phase|Lost to Follow-up|0
1801224|NCT00525512|6263731|P3|Double-Blind Phase|Lost to Follow-up|0
1801225|NCT00525512|6263732|P2|Double-Blind Phase|Lost to Follow-up|7
1801226|NCT00525512|6263733|P1|Double-Blind Phase|Lost to Follow-up|3
1801227|NCT00525512|6263730|P4|Double-Blind Phase|Protocol Violation|0
1801228|NCT00525512|6263731|P3|Double-Blind Phase|Protocol Violation|0
1801229|NCT00525512|6263732|P2|Double-Blind Phase|Protocol Violation|1
1801230|NCT00525512|6263733|P1|Double-Blind Phase|Protocol Violation|3
1801231|NCT00525512|6263730|P4|Double-Blind Phase|Adverse Event|0
1801232|NCT00525512|6263731|P3|Double-Blind Phase|Adverse Event|0
1801233|NCT00525512|6263732|P2|Double-Blind Phase|Adverse Event|28
1801234|NCT00525512|6263733|P1|Double-Blind Phase|Adverse Event|48
1801235|NCT00525499|6263875|P4|Overall Study|Protocol Violation|0
1801236|NCT00525499|6263876|P3|Overall Study|Protocol Violation|1
1801237|NCT00525499|6263877|P2|Overall Study|Protocol Violation|1
1801238|NCT00525499|6263878|P1|Overall Study|Protocol Violation|0
1801239|NCT00525499|6263875|P4|Overall Study|Withdrawal by Subject|2
1801240|NCT00525499|6263876|P3|Overall Study|Withdrawal by Subject|5
1801241|NCT00525499|6263877|P2|Overall Study|Withdrawal by Subject|1
1801242|NCT00525499|6263878|P1|Overall Study|Withdrawal by Subject|5
1801243|NCT00525499|6263875|P4|Overall Study|Adverse Event|1
1801244|NCT00525499|6263876|P3|Overall Study|Adverse Event|0
1801245|NCT00525499|6263877|P2|Overall Study|Adverse Event|1
1801246|NCT00525499|6263878|P1|Overall Study|Adverse Event|0
1801247|NCT00525499|6263875|P4|Overall Study|Lost to Follow-up|4
1801248|NCT00525499|6263876|P3|Overall Study|Lost to Follow-up|1
1801249|NCT00525499|6263877|P2|Overall Study|Lost to Follow-up|4
1801250|NCT00525499|6263878|P1|Overall Study|Lost to Follow-up|2
1801251|NCT00525265|6263905|P2|Overall Study|Protocol Violation|0
1801252|NCT00525265|6263906|P1|Overall Study|Protocol Violation|1
1801253|NCT00525161|6263963|P1|Overall Study|Adverse Event|1
1801254|NCT00525148|6263973|P4|Overall Study|Other than stated|3
1801255|NCT00525148|6263974|P3|Overall Study|Other than stated|0
1801256|NCT00525148|6263975|P2|Overall Study|Other than stated|1
1801257|NCT00525148|6263976|P1|Overall Study|Other than stated|2
1801258|NCT00525148|6263973|P4|Overall Study|Refused continuation of study medication|1
1801259|NCT00525148|6263974|P3|Overall Study|Refused continuation of study medication|0
1801260|NCT00525148|6263975|P2|Overall Study|Refused continuation of study medication|2
1801261|NCT00525148|6263976|P1|Overall Study|Refused continuation of study medication|0
1801262|NCT00525148|6263973|P4|Overall Study|Progressive disease|49
1801263|NCT00525148|6263974|P3|Overall Study|Progressive disease|6
1801264|NCT00525148|6263975|P2|Overall Study|Progressive disease|30
1801265|NCT00525148|6263976|P1|Overall Study|Progressive disease|18
1801266|NCT00525148|6263973|P4|Overall Study|Other Adverse Event|8
1801267|NCT00525148|6263974|P3|Overall Study|Other Adverse Event|1
1801268|NCT00525148|6263975|P2|Overall Study|Other Adverse Event|5
1801269|NCT00525148|6263976|P1|Overall Study|Other Adverse Event|3
1801270|NCT00525044|6264004|P2|Overall Study|Lost to Follow-up|1
1801271|NCT00525044|6264005|P1|Overall Study|Lost to Follow-up|0
1801272|NCT00525031|6264021|P2|Overall Study|Disease Progression|1
1801273|NCT00525031|6264022|P1|Overall Study|Disease Progression|1
1801274|NCT00524771|6264036|P2|Overall Study|Protocol Violation|585
1801275|NCT00524771|6264037|P1|Overall Study|Protocol Violation|220
1801276|NCT00524745|6264051|P4|Overall Study|subject withdrawal or lost to follow up|22
1801277|NCT00524745|6264052|P3|Overall Study|subject withdrawal or lost to follow up|29
1801278|NCT00524745|6264053|P2|Overall Study|subject withdrawal or lost to follow up|13
1801279|NCT00524745|6264054|P1|Overall Study|subject withdrawal or lost to follow up|34
1801280|NCT00524680|6264080|P4|Overall Study|Withdrawal by Subject|1
1801281|NCT00524680|6264081|P3|Overall Study|Withdrawal by Subject|1
1801282|NCT00524680|6264082|P2|Overall Study|Withdrawal by Subject|0
1801283|NCT00524680|6264083|P1|Overall Study|Withdrawal by Subject|1
1801284|NCT00524680|6264080|P4|Overall Study|Other|3
1801285|NCT00524680|6264081|P3|Overall Study|Other|2
1801286|NCT00524680|6264082|P2|Overall Study|Other|1
1801287|NCT00524680|6264083|P1|Overall Study|Other|0
1801288|NCT00524680|6264080|P4|Overall Study|Adverse Event|1
1801289|NCT00524680|6264081|P3|Overall Study|Adverse Event|0
1801290|NCT00524680|6264082|P2|Overall Study|Adverse Event|0
1801291|NCT00524680|6264083|P1|Overall Study|Adverse Event|2
1801292|NCT00524680|6264080|P4|Overall Study|progression|1
1801293|NCT00524680|6264081|P3|Overall Study|progression|0
1801294|NCT00524680|6264082|P2|Overall Study|progression|0
1801295|NCT00524680|6264083|P1|Overall Study|progression|0
1801296|NCT00524589|6264105|P1|Overall Study|Disease Progression|16
1801297|NCT00524589|6264105|P1|Overall Study|Withdrawal by Subject|2
1801298|NCT00524485|6264156|P1|Overall Study|Withdrawal by Subject|5
1801299|NCT00524459|6264185|P1|Overall Study|Other|1
1801300|NCT00524459|6264185|P1|Overall Study|Withdrawal by Subject|1
1801301|NCT00524420|6264195|P2|Overall Study|Lack of Efficacy|0
1801302|NCT00524420|6264196|P1|Overall Study|Lack of Efficacy|1
1801303|NCT00524368|6264214|P2|Overall Study|Other|2
1801304|NCT00524368|6264215|P1|Overall Study|Other|3
1801305|NCT00524368|6264214|P2|Overall Study|Ineligible to Continue the study|5
1801306|NCT00524368|6264215|P1|Overall Study|Ineligible to Continue the study|2
1801307|NCT00524368|6264214|P2|Overall Study|Sponsor's Decision|0
1801308|NCT00524368|6264215|P1|Overall Study|Sponsor's Decision|2
1801309|NCT00524368|6264214|P2|Overall Study|Reached a Virologic Endpoint|2
1801310|NCT00524368|6264215|P1|Overall Study|Reached a Virologic Endpoint|3
1801311|NCT00524368|6264214|P2|Overall Study|Non-compliant|9
1801312|NCT00524368|6264215|P1|Overall Study|Non-compliant|8
1801313|NCT00524368|6264214|P2|Overall Study|Withdrawal by Subject|5
1801314|NCT00524368|6264215|P1|Overall Study|Withdrawal by Subject|4
1801315|NCT00524368|6264214|P2|Overall Study|Lost to Follow-up|13
1801316|NCT00524368|6264215|P1|Overall Study|Lost to Follow-up|9
1801317|NCT00524368|6264214|P2|Overall Study|Adverse Event|12
1801318|NCT00524368|6264215|P1|Overall Study|Adverse Event|10
1801319|NCT00524316|6264249|P1|Overall Study|Disease Progression|7
1801320|NCT00524316|6264249|P1|Overall Study|Adverse Event|7
1801321|NCT00524316|6264249|P1|Overall Study|Withdrawal by Subject|2
1801322|NCT00524303|6264261|P3|Overall Study|Completed 5 years|1
1801323|NCT00524303|6264262|P2|Overall Study|Completed 5 years|0
1801324|NCT00524303|6264263|P1|Overall Study|Completed 5 years|0
1801325|NCT00524303|6264261|P3|Overall Study|Physician Decision|1
1801326|NCT00524303|6264262|P2|Overall Study|Physician Decision|0
1801327|NCT00524303|6264263|P1|Overall Study|Physician Decision|0
1801328|NCT00524303|6264261|P3|Overall Study|Sponsor Request|1
1801329|NCT00524303|6264262|P2|Overall Study|Sponsor Request|0
1801330|NCT00524303|6264263|P1|Overall Study|Sponsor Request|0
1801331|NCT00524303|6264261|P3|Overall Study|Disease Recurrence|0
1801332|NCT00524303|6264262|P2|Overall Study|Disease Recurrence|1
1801333|NCT00524303|6264263|P1|Overall Study|Disease Recurrence|0
1801334|NCT00524303|6264261|P3|Overall Study|Disease Progression|1
1801335|NCT00524303|6264262|P2|Overall Study|Disease Progression|4
1801336|NCT00524303|6264263|P1|Overall Study|Disease Progression|0
1801337|NCT00524303|6264261|P3|Overall Study|Worsening Peripheral Neuropathy|0
1801338|NCT00524303|6264262|P2|Overall Study|Worsening Peripheral Neuropathy|0
1801339|NCT00524303|6264263|P1|Overall Study|Worsening Peripheral Neuropathy|1
1801340|NCT00524303|6264261|P3|Overall Study|Did not Complete Study Dosing|0
1801341|NCT00524303|6264262|P2|Overall Study|Did not Complete Study Dosing|0
1801342|NCT00524303|6264263|P1|Overall Study|Did not Complete Study Dosing|1
1801343|NCT00524303|6264261|P3|Overall Study|Adverse Event|3
1801344|NCT00524303|6264262|P2|Overall Study|Adverse Event|2
1801345|NCT00524303|6264263|P1|Overall Study|Adverse Event|1
1801346|NCT00524303|6264261|P3|Overall Study|Death|3
1801347|NCT00524303|6264262|P2|Overall Study|Death|2
1801348|NCT00524303|6264263|P1|Overall Study|Death|0
1801349|NCT00524303|6264261|P3|Overall Study|Withdrawal by Subject|4
1801350|NCT00524303|6264262|P2|Overall Study|Withdrawal by Subject|0
1801351|NCT00524303|6264263|P1|Overall Study|Withdrawal by Subject|3
1801352|NCT00524303|6264261|P3|Overall Study|Protocol Violation|1
1801353|NCT00524303|6264262|P2|Overall Study|Protocol Violation|1
1801354|NCT00524303|6264263|P1|Overall Study|Protocol Violation|0
1801355|NCT00524303|6264261|P3|Overall Study|Lost to Follow-up|3
1801356|NCT00524303|6264262|P2|Overall Study|Lost to Follow-up|0
1801357|NCT00524303|6264263|P1|Overall Study|Lost to Follow-up|6
1801358|NCT00524173|6264315|P2|Overall Study|Had not reached endpoint at study close|1
1801359|NCT00524173|6264316|P1|Overall Study|Had not reached endpoint at study close|4
1801360|NCT00524173|6264315|P2|Overall Study|Death|0
1801361|NCT00524173|6264316|P1|Overall Study|Death|1
1801362|NCT00524173|6264315|P2|Overall Study|Lost to Follow-up|1
1801363|NCT00524173|6264316|P1|Overall Study|Lost to Follow-up|0
1801364|NCT00524134|6264328|P1|Overall Study|Physician Decision|1
1801365|NCT00524134|6264328|P1|Overall Study|Withdrawal by Subject|1
1801366|NCT00524121|6264335|P1|Overall Study|Not treated (changed mind)|1
1801367|NCT00524121|6264335|P1|Overall Study|Not treated (became ineligible)|4
1801368|NCT00524121|6264335|P1|Overall Study|Death|1
1801369|NCT00524121|6264335|P1|Overall Study|Other|1
1801370|NCT00524121|6264335|P1|Overall Study|Patient refused|2
1801371|NCT00524121|6264335|P1|Overall Study|Adverse Event|4
1801372|NCT00524121|6264335|P1|Overall Study|Disease progression|6
1801373|NCT00524043|6264355|P3|Overall Study|Various (eg, incarceration)|0
1801374|NCT00524043|6264356|P2|Overall Study|Various (eg, incarceration)|1
1801375|NCT00524043|6264357|P1|Overall Study|Various (eg, incarceration)|2
1801376|NCT00524043|6264355|P3|Overall Study|Lost to Follow-up|3
1801377|NCT00524043|6264356|P2|Overall Study|Lost to Follow-up|5
1801378|NCT00524043|6264357|P1|Overall Study|Lost to Follow-up|3
1801379|NCT00524043|6264355|P3|Overall Study|Adverse Event|7
1801380|NCT00524043|6264356|P2|Overall Study|Adverse Event|2
1801381|NCT00524043|6264357|P1|Overall Study|Adverse Event|5
1801382|NCT00524043|6264355|P3|Overall Study|Withdrawal by Subject|7
1801383|NCT00524043|6264356|P2|Overall Study|Withdrawal by Subject|7
1801384|NCT00524043|6264357|P1|Overall Study|Withdrawal by Subject|5
1801385|NCT00524043|6264355|P3|Overall Study|Lack of Efficacy|14
1801386|NCT00524043|6264356|P2|Overall Study|Lack of Efficacy|13
1801387|NCT00524043|6264357|P1|Overall Study|Lack of Efficacy|15
1801388|NCT00524030|6264379|P2|Overall Study|Death|1
1801389|NCT00524030|6264380|P1|Overall Study|Death|0
1801390|NCT00524030|6264379|P2|Overall Study|Adverse Event|21
1801391|NCT00524030|6264380|P1|Overall Study|Adverse Event|3
1801392|NCT00524030|6264379|P2|Overall Study|Pregnancy|0
1801393|NCT00524030|6264380|P1|Overall Study|Pregnancy|1
1801394|NCT00524030|6264379|P2|Overall Study|Protocol Violation|1
1801395|NCT00524030|6264380|P1|Overall Study|Protocol Violation|0
1801396|NCT00524030|6264379|P2|Overall Study|Noncompliance/Investigator discretion|2
1801397|NCT00524030|6264380|P1|Overall Study|Noncompliance/Investigator discretion|0
1801398|NCT00524030|6264379|P2|Overall Study|Withdrawal by Subject|8
1801399|NCT00524030|6264380|P1|Overall Study|Withdrawal by Subject|3
1801400|NCT00524030|6264379|P2|Overall Study|Lost to Follow-up|2
1801401|NCT00524030|6264380|P1|Overall Study|Lost to Follow-up|0
1801402|NCT00524030|6264379|P2|Overall Study|Lack of Efficacy|24
1801403|NCT00524030|6264380|P1|Overall Study|Lack of Efficacy|10
1801404|NCT00523991|6264400|P2|Overall Study|Other reason (not specified)|0
1801405|NCT00523991|6264401|P1|Overall Study|Other reason (not specified)|3
1801406|NCT00523991|6264400|P2|Overall Study|Withdrawal by Subject|17
1801407|NCT00523991|6264401|P1|Overall Study|Withdrawal by Subject|7
1801408|NCT00523991|6264400|P2|Overall Study|Lost to Follow-up|1
1801409|NCT00523991|6264401|P1|Overall Study|Lost to Follow-up|4
1801410|NCT00523991|6264400|P2|Overall Study|Protocol Violation|4
1801411|NCT00523991|6264401|P1|Overall Study|Protocol Violation|1
1801412|NCT00523991|6264400|P2|Overall Study|Adverse Event|5
1801413|NCT00523991|6264401|P1|Overall Study|Adverse Event|6
1801414|NCT00523978|6264681|P2|Overall Study|Death|0
1801415|NCT00523978|6264682|P1|Overall Study|Death|1
1801416|NCT00523978|6264681|P2|Overall Study|Screen Failures|1
1801417|NCT00523978|6264682|P1|Overall Study|Screen Failures|5
1801418|NCT00523978|6264681|P2|Overall Study|Withdrawal by Subject|7
1801419|NCT00523978|6264682|P1|Overall Study|Withdrawal by Subject|3
1801420|NCT00523848|6264704|P1|Overall Study|Other, unspecified|4
1801421|NCT00523848|6264704|P1|Overall Study|Disease Progression|5
1801422|NCT00523848|6264704|P1|Overall Study|NOT TREATED (Became ineligible)|2
1801423|NCT00523848|6264704|P1|Overall Study|Withdrawal by Subject|2
1801424|NCT00523848|6264704|P1|Overall Study|Adverse Event|11
1801425|NCT00523744|6264714|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
1801426|NCT00523744|6264714|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
1801427|NCT00523744|6264714|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
1801428|NCT00523744|6264714|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
1801429|NCT00523744|6264714|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
1801430|NCT00523744|6264714|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
1801431|NCT00523718|6264733|P2|Overall Study|Protocol Violation|0
1801432|NCT00523718|6264734|P1|Overall Study|Protocol Violation|2
1801433|NCT00523718|6264733|P2|Overall Study|Withdrawal by Subject|0
1801434|NCT00523718|6264734|P1|Overall Study|Withdrawal by Subject|1
1801435|NCT00523705|6264748|P2|Overall Study|No time for study.|1
1801436|NCT00523705|6264749|P1|Overall Study|No time for study.|0
1801437|NCT00523640|6264761|P1|Overall Study|Death|1
1801438|NCT00523549|6264778|P2|Overall Study|Lost to Follow-up|5
1801439|NCT00523549|6264779|P1|Overall Study|Lost to Follow-up|3
1801440|NCT00523549|6264778|P2|Overall Study|Patient withdrew consent|6
1801441|NCT00523549|6264779|P1|Overall Study|Patient withdrew consent|7
1801442|NCT00523549|6264778|P2|Overall Study|Protocol Deviation|1
1801443|NCT00523549|6264779|P1|Overall Study|Protocol Deviation|3
1801444|NCT00523549|6264778|P2|Overall Study|Unsatisfactory therapeutic effect|1
1801445|NCT00523549|6264779|P1|Overall Study|Unsatisfactory therapeutic effect|0
1801446|NCT00523549|6264778|P2|Overall Study|Adverse Event|3
1801447|NCT00523549|6264779|P1|Overall Study|Adverse Event|6
1801448|NCT00523419|6264797|P1|Overall Study|Death due to Adverse Event|2
1801449|NCT00523419|6264797|P1|Overall Study|Death due to Study Disease|4
1801450|NCT00523419|6264797|P1|Overall Study|Progressive Disease|22
1801451|NCT00523419|6264797|P1|Overall Study|Physician Decision|2
1801452|NCT00523419|6264797|P1|Overall Study|Withdrawal by Subject|1
1801453|NCT00523419|6264797|P1|Overall Study|Adverse Event|1
1801454|NCT00523367|6264807|P1|Overall Study|4 Withdrawn by PI|4
1801455|NCT00523367|6264807|P1|Overall Study|19 screen failures|19
1801456|NCT00523341|6264813|P2|Overall Study|Disease Progression|0
1801457|NCT00523341|6264814|P1|Overall Study|Disease Progression|1
1801458|NCT00523341|6264813|P2|Overall Study|Ineligibility Determined|4
1801459|NCT00523341|6264814|P1|Overall Study|Ineligibility Determined|3
1801460|NCT00523341|6264813|P2|Overall Study|Protocol Deviation|5
1801461|NCT00523341|6264814|P1|Overall Study|Protocol Deviation|6
1801462|NCT00523341|6264813|P2|Overall Study|Requirement for Alternative Therapy|14
1801463|NCT00523341|6264814|P1|Overall Study|Requirement for Alternative Therapy|4
1801464|NCT00523341|6264813|P2|Overall Study|Physician Decision|13
1801465|NCT00523341|6264814|P1|Overall Study|Physician Decision|14
1801466|NCT00523341|6264813|P2|Overall Study|Non-compliance|13
1801467|NCT00523341|6264814|P1|Overall Study|Non-compliance|20
1801468|NCT00523341|6264813|P2|Overall Study|Lost to Follow-up|61
1801469|NCT00523341|6264814|P1|Overall Study|Lost to Follow-up|73
1801470|NCT00523341|6264813|P2|Overall Study|Death|110
1801471|NCT00523341|6264814|P1|Overall Study|Death|101
1801472|NCT00523341|6264813|P2|Overall Study|Adverse Event|155
1801473|NCT00523341|6264814|P1|Overall Study|Adverse Event|122
1801474|NCT00523341|6264813|P2|Overall Study|Other|198
1801475|NCT00523341|6264814|P1|Overall Study|Other|181
1801476|NCT00523341|6264813|P2|Overall Study|Withdrawal by Subject|427
1801477|NCT00523341|6264814|P1|Overall Study|Withdrawal by Subject|399
1801478|NCT00522951|6264931|P2|Period 2|residual contrast medium|1
1801479|NCT00522951|6264932|P1|Period 2|residual contrast medium|1
1801480|NCT00522951|6264931|P2|Period 2|Withdrawal by Subject|0
1801481|NCT00522951|6264932|P1|Period 2|Withdrawal by Subject|1
1801482|NCT00522951|6264931|P2|Washout Period|Death|1
1801483|NCT00522951|6264932|P1|Washout Period|Death|0
1801484|NCT00522951|6264931|P2|Washout Period|Adverse Event|1
1801485|NCT00522951|6264932|P1|Washout Period|Adverse Event|0
1801486|NCT00522951|6264931|P2|Period 1|body motion|1
1801487|NCT00522951|6264932|P1|Period 1|body motion|0
1801488|NCT00522873|6264987|P2|Overall Study|Never Received Medication|0
1801489|NCT00522873|6264988|P1|Overall Study|Never Received Medication|1
1801490|NCT00522873|6264987|P2|Overall Study|Medication Errors|1
1801491|NCT00522873|6264988|P1|Overall Study|Medication Errors|1
1801492|NCT00522873|6264987|P2|Overall Study|Personal Reasons|1
1801493|NCT00522873|6264988|P1|Overall Study|Personal Reasons|8
1801494|NCT00522873|6264987|P2|Overall Study|Lost to Follow-up|3
1801495|NCT00522873|6264988|P1|Overall Study|Lost to Follow-up|11
1801496|NCT00522873|6264987|P2|Overall Study|Protocol Violation|4
1801497|NCT00522873|6264988|P1|Overall Study|Protocol Violation|14
1801498|NCT00522873|6264987|P2|Overall Study|Withdrawal by Subject|9
1801499|NCT00522873|6264988|P1|Overall Study|Withdrawal by Subject|20
1801500|NCT00522873|6264987|P2|Overall Study|Adverse Event|26
1801501|NCT00522873|6264988|P1|Overall Study|Adverse Event|41
1801502|NCT00522626|6265001|P1|Overall Study|Lost to Follow-up|7
1801503|NCT00522548|6265007|P2|Overall Study|Withdrawal by Subject|2
1801504|NCT00522548|6265008|P1|Overall Study|Withdrawal by Subject|0
1801505|NCT00522548|6265007|P2|Overall Study|Adverse Event|2
1801506|NCT00522548|6265008|P1|Overall Study|Adverse Event|2
1801507|NCT00522457|6265036|P1|Overall Study|Adverse Event|2
1801508|NCT00522457|6265036|P1|Overall Study|Due to disease progression|16
1801509|NCT00522431|6265042|P1|Overall Study|Other/unknown|1
1801510|NCT00522431|6265042|P1|Overall Study|Subject non-compliance|1
1801511|NCT00522431|6265042|P1|Overall Study|Withdrawal by Subject|2
1801512|NCT00522431|6265042|P1|Overall Study|Protocol Violation|2
1801513|NCT00522431|6265042|P1|Overall Study|Adverse Event|5
1801514|NCT00522418|6265049|P2|Overall Study|Lack of Efficacy|1
1801515|NCT00522418|6265050|P1|Overall Study|Lack of Efficacy|0
1801516|NCT00522418|6265049|P2|Overall Study|Consent Withdraw|2
1801517|NCT00522418|6265050|P1|Overall Study|Consent Withdraw|1
1801518|NCT00522418|6265049|P2|Overall Study|Reason Not Specified|1
1801519|NCT00522418|6265050|P1|Overall Study|Reason Not Specified|3
1801520|NCT00522418|6265049|P2|Overall Study|Noncompliance|2
1801521|NCT00522418|6265050|P1|Overall Study|Noncompliance|2
1801522|NCT00522418|6265049|P2|Overall Study|Early Study Termination|47
1801523|NCT00522418|6265050|P1|Overall Study|Early Study Termination|46
1801524|NCT00522418|6265049|P2|Overall Study|Local IRB Consent Violation|5
1801525|NCT00522418|6265050|P1|Overall Study|Local IRB Consent Violation|5
1801526|NCT00522392|6265098|P2|Overall Study|Non-compliance|1
1801527|NCT00522392|6265099|P1|Overall Study|Non-compliance|0
1801528|NCT00522392|6265098|P2|Overall Study|Physician Decision|1
1801529|NCT00522392|6265099|P1|Overall Study|Physician Decision|0
1801530|NCT00522392|6265098|P2|Overall Study|Withdrawal by Subject|1
1801531|NCT00522392|6265099|P1|Overall Study|Withdrawal by Subject|1
1801532|NCT00522392|6265098|P2|Overall Study|Adverse Event|7
1801533|NCT00522392|6265099|P1|Overall Study|Adverse Event|7
1801534|NCT00522392|6265098|P2|Overall Study|Disease progression|3
1801535|NCT00522392|6265099|P1|Overall Study|Disease progression|0
1801536|NCT00522379|6265116|P5|Overall Study|Subject Withdrawal|0
1801537|NCT00522379|6265117|P4|Overall Study|Subject Withdrawal|1
1801538|NCT00522379|6265118|P3|Overall Study|Subject Withdrawal|0
1801539|NCT00522379|6265119|P2|Overall Study|Subject Withdrawal|0
1801540|NCT00522379|6265120|P1|Overall Study|Subject Withdrawal|0
1801541|NCT00522379|6265116|P5|Overall Study|Site Closed|0
1801542|NCT00522379|6265117|P4|Overall Study|Site Closed|1
1801543|NCT00522379|6265118|P3|Overall Study|Site Closed|0
1801544|NCT00522379|6265119|P2|Overall Study|Site Closed|0
1801545|NCT00522379|6265120|P1|Overall Study|Site Closed|0
1801546|NCT00522379|6265116|P5|Overall Study|Family Problem|0
1801547|NCT00522379|6265117|P4|Overall Study|Family Problem|0
1801548|NCT00522379|6265118|P3|Overall Study|Family Problem|1
1801549|NCT00522379|6265119|P2|Overall Study|Family Problem|0
1801550|NCT00522379|6265120|P1|Overall Study|Family Problem|0
1801551|NCT00522379|6265116|P5|Overall Study|Sponsor Request|0
1801552|NCT00522379|6265117|P4|Overall Study|Sponsor Request|0
1801553|NCT00522379|6265118|P3|Overall Study|Sponsor Request|0
1801554|NCT00522379|6265119|P2|Overall Study|Sponsor Request|1
1801555|NCT00522379|6265120|P1|Overall Study|Sponsor Request|0
1801556|NCT00522379|6265116|P5|Overall Study|Subject Moved|0
1801557|NCT00522379|6265117|P4|Overall Study|Subject Moved|0
1801558|NCT00522379|6265118|P3|Overall Study|Subject Moved|0
1801559|NCT00522379|6265119|P2|Overall Study|Subject Moved|1
1801560|NCT00522379|6265120|P1|Overall Study|Subject Moved|1
1801561|NCT00522379|6265116|P5|Overall Study|Dispensing error|0
1801562|NCT00522379|6265117|P4|Overall Study|Dispensing error|1
1801563|NCT00522379|6265118|P3|Overall Study|Dispensing error|0
1801564|NCT00522379|6265119|P2|Overall Study|Dispensing error|0
1801565|NCT00522379|6265120|P1|Overall Study|Dispensing error|1
1801566|NCT00522379|6265116|P5|Overall Study|Randomization error|1
1801567|NCT00522379|6265117|P4|Overall Study|Randomization error|0
1801568|NCT00522379|6265118|P3|Overall Study|Randomization error|0
1801569|NCT00522379|6265119|P2|Overall Study|Randomization error|0
1801570|NCT00522379|6265120|P1|Overall Study|Randomization error|0
1801571|NCT00522379|6265116|P5|Overall Study|Lost to Follow-up|2
1801572|NCT00522379|6265117|P4|Overall Study|Lost to Follow-up|2
1801573|NCT00522379|6265118|P3|Overall Study|Lost to Follow-up|4
1801574|NCT00522379|6265119|P2|Overall Study|Lost to Follow-up|0
1801575|NCT00522379|6265120|P1|Overall Study|Lost to Follow-up|1
1801576|NCT00522379|6265116|P5|Overall Study|Unsatisfactory Subject Compliance|0
1801577|NCT00522379|6265117|P4|Overall Study|Unsatisfactory Subject Compliance|0
1801578|NCT00522379|6265118|P3|Overall Study|Unsatisfactory Subject Compliance|0
1801579|NCT00522379|6265119|P2|Overall Study|Unsatisfactory Subject Compliance|2
1801580|NCT00522379|6265120|P1|Overall Study|Unsatisfactory Subject Compliance|1
1801581|NCT00522379|6265116|P5|Overall Study|Protocol Violation|0
1801582|NCT00522379|6265117|P4|Overall Study|Protocol Violation|0
1801583|NCT00522379|6265118|P3|Overall Study|Protocol Violation|2
1801584|NCT00522379|6265119|P2|Overall Study|Protocol Violation|1
1801585|NCT00522379|6265120|P1|Overall Study|Protocol Violation|1
1801586|NCT00522379|6265116|P5|Overall Study|Withdrawal by Subject|0
1801587|NCT00522379|6265117|P4|Overall Study|Withdrawal by Subject|2
1801588|NCT00522379|6265118|P3|Overall Study|Withdrawal by Subject|1
1801589|NCT00522379|6265119|P2|Overall Study|Withdrawal by Subject|3
1801590|NCT00522379|6265120|P1|Overall Study|Withdrawal by Subject|2
1801591|NCT00522379|6265116|P5|Overall Study|Lack of Efficacy|7
1801592|NCT00522379|6265117|P4|Overall Study|Lack of Efficacy|2
1801593|NCT00522379|6265118|P3|Overall Study|Lack of Efficacy|2
1801594|NCT00522379|6265119|P2|Overall Study|Lack of Efficacy|0
1801595|NCT00522379|6265120|P1|Overall Study|Lack of Efficacy|3
1801596|NCT00522379|6265116|P5|Overall Study|Adverse Event|17
1801597|NCT00522379|6265117|P4|Overall Study|Adverse Event|5
1801598|NCT00522379|6265118|P3|Overall Study|Adverse Event|12
1801599|NCT00522379|6265119|P2|Overall Study|Adverse Event|15
1801600|NCT00522379|6265120|P1|Overall Study|Adverse Event|12
1801601|NCT00522301|6265222|P1|Overall Study|Adverse Event|5
1801602|NCT00522301|6265222|P1|Overall Study|Withdrawal by Subject|1
1801603|NCT00522275|6265226|P1|Overall Study|Other: Subject had surgery for epilepsy|2
1801604|NCT00522275|6265226|P1|Overall Study|Other: Subject ran out of medication|1
1801605|NCT00522275|6265226|P1|Overall Study|Other: Sponsor request|2
1801606|NCT00522275|6265226|P1|Overall Study|Other: Travel to / from site difficulty|3
1801607|NCT00522275|6265226|P1|Overall Study|Other: Site / clinic closed|4
1801608|NCT00522275|6265226|P1|Overall Study|Other: Subject arrested|1
1801609|NCT00522275|6265226|P1|Overall Study|Other: Subject relocated|2
1801610|NCT00522275|6265226|P1|Overall Study|Other: Subject is pregnant|2
1801611|NCT00522275|6265226|P1|Overall Study|Other: Subject wants to become pregnant|2
1801612|NCT00522275|6265226|P1|Overall Study|Lost to Follow-up|8
1801613|NCT00522275|6265226|P1|Overall Study|Unsatisfactory compliance|11
1801614|NCT00522275|6265226|P1|Overall Study|Protocol deviation|1
1801615|NCT00522275|6265226|P1|Overall Study|Subject withdrew consent|16
1801616|NCT00522275|6265226|P1|Overall Study|Lack of Efficacy|80
1801617|NCT00522275|6265226|P1|Overall Study|Adverse Event|35
1801618|NCT00522041|6265247|P2|Overall Study|Did not receive treatment|1
1801619|NCT00522041|6265248|P1|Overall Study|Did not receive treatment|0
1801620|NCT00522041|6265247|P2|Overall Study|Voluntary withdrawal|4
1801621|NCT00522041|6265248|P1|Overall Study|Voluntary withdrawal|5
1801622|NCT00522041|6265247|P2|Overall Study|Lost to Follow-up|4
1801623|NCT00522041|6265248|P1|Overall Study|Lost to Follow-up|1
1801624|NCT00522041|6265247|P2|Overall Study|Protocol Violation|0
1801625|NCT00522041|6265248|P1|Overall Study|Protocol Violation|2
1801626|NCT00522041|6265247|P2|Overall Study|Adverse Event|3
1801627|NCT00522041|6265248|P1|Overall Study|Adverse Event|9
1801628|NCT00521599|6265307|P3|Overall Study|Did not meet protocol eligibility|1
1801629|NCT00521599|6265308|P2|Overall Study|Did not meet protocol eligibility|2
1801630|NCT00521599|6265309|P1|Overall Study|Did not meet protocol eligibility|2
1801631|NCT00521599|6265307|P3|Overall Study|Protocol Violation|2
1801632|NCT00521599|6265308|P2|Overall Study|Protocol Violation|4
1801633|NCT00521599|6265309|P1|Overall Study|Protocol Violation|2
1801634|NCT00521599|6265307|P3|Overall Study|Withdrawal by subject treatment related|2
1801635|NCT00521599|6265308|P2|Overall Study|Withdrawal by subject treatment related|1
1801636|NCT00521599|6265309|P1|Overall Study|Withdrawal by subject treatment related|3
1801637|NCT00521599|6265307|P3|Overall Study|Withdrawal by Subject|1
1801638|NCT00521599|6265308|P2|Overall Study|Withdrawal by Subject|5
1801639|NCT00521599|6265309|P1|Overall Study|Withdrawal by Subject|3
1801640|NCT00521599|6265307|P3|Overall Study|Lost to Follow-up|2
1801641|NCT00521599|6265308|P2|Overall Study|Lost to Follow-up|1
1801642|NCT00521599|6265309|P1|Overall Study|Lost to Follow-up|2
1801643|NCT00521599|6265307|P3|Overall Study|Treatment Failure|22
1801644|NCT00521599|6265308|P2|Overall Study|Treatment Failure|9
1801645|NCT00521599|6265309|P1|Overall Study|Treatment Failure|8
1801646|NCT00521599|6265307|P3|Overall Study|Adverse Event|6
1801647|NCT00521599|6265308|P2|Overall Study|Adverse Event|7
1801648|NCT00521599|6265309|P1|Overall Study|Adverse Event|5
1801649|NCT00521586|6265320|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
1801650|NCT00521586|6265321|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
1801651|NCT00521586|6265320|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
1801652|NCT00521586|6265321|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
1801653|NCT00521586|6265320|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
1801654|NCT00521586|6265321|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
1801655|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
1801656|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
1801657|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
1801658|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
1801659|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
1801660|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
1801661|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
1801662|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
1801663|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
1801664|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
1801665|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
1801666|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
1801667|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
1801668|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
1801669|NCT00521586|6265320|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
1801670|NCT00521586|6265321|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
1801671|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Failed to return|1
1801672|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Failed to return|0
1801673|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Death|0
1801674|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Death|1
1801675|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Adverse Event|1
1801676|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Adverse Event|0
1801677|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Investigator request|0
1801678|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Investigator request|2
1801679|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Other, unspecified|1
1801680|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Other, unspecified|3
1801681|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Protocol Violation|5
1801682|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Protocol Violation|2
1801683|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
1801684|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
1801685|NCT00521586|6265320|P2|Initial Vaccination (Year 0)|Subject request|11
1801686|NCT00521586|6265321|P1|Initial Vaccination (Year 0)|Subject request|8
1801687|NCT00521365|6265394|P1|Overall Study|Usage of not allowed drugs|6
1801688|NCT00521365|6265394|P1|Overall Study|Drug compliance|3
1801689|NCT00521365|6265394|P1|Overall Study|Protocol deviation|2
1801690|NCT00521365|6265394|P1|Overall Study|Lost to Follow-up|6
1801691|NCT00521365|6265394|P1|Overall Study|Adverse Event|3
1801692|NCT00521339|6265424|P3|Treatment Extension Phase|Death|1
1801693|NCT00521339|6265425|P2|Treatment Extension Phase|Death|0
1801694|NCT00521339|6265426|P1|Treatment Extension Phase|Death|0
1801695|NCT00521339|6265424|P3|Treatment Extension Phase|Withdrawal by Subject|2
1801696|NCT00521339|6265425|P2|Treatment Extension Phase|Withdrawal by Subject|0
1801697|NCT00521339|6265426|P1|Treatment Extension Phase|Withdrawal by Subject|0
1801698|NCT00521339|6265424|P3|Treatment Phase|Protocol Violation|0
1801699|NCT00521339|6265425|P2|Treatment Phase|Protocol Violation|0
1801700|NCT00521339|6265426|P1|Treatment Phase|Protocol Violation|1
1801701|NCT00521339|6265424|P3|Treatment Phase|Lost to Follow-up|0
1801702|NCT00521339|6265425|P2|Treatment Phase|Lost to Follow-up|0
1801703|NCT00521339|6265426|P1|Treatment Phase|Lost to Follow-up|1
1801704|NCT00521339|6265424|P3|Treatment Phase|Withdrawal by Subject|0
1801705|NCT00521339|6265425|P2|Treatment Phase|Withdrawal by Subject|0
1801706|NCT00521339|6265426|P1|Treatment Phase|Withdrawal by Subject|3
1801707|NCT00521339|6265424|P3|Treatment Phase|Lack of Efficacy|0
1801708|NCT00521339|6265425|P2|Treatment Phase|Lack of Efficacy|0
1801709|NCT00521339|6265426|P1|Treatment Phase|Lack of Efficacy|3
1801710|NCT00521339|6265424|P3|Treatment Phase|Intolerability to study drug|0
1801711|NCT00521339|6265425|P2|Treatment Phase|Intolerability to study drug|0
1801712|NCT00521339|6265426|P1|Treatment Phase|Intolerability to study drug|2
1801713|NCT00521339|6265424|P3|Treatment Phase|Adverse Event|0
1801714|NCT00521339|6265425|P2|Treatment Phase|Adverse Event|0
1801715|NCT00521339|6265426|P1|Treatment Phase|Adverse Event|2
1801716|NCT00521144|6265494|P5|Overall Study|Progressive Disease|6
1801717|NCT00521144|6265495|P4|Overall Study|Progressive Disease|0
1801718|NCT00521144|6265496|P3|Overall Study|Progressive Disease|2
1801719|NCT00521144|6265497|P2|Overall Study|Progressive Disease|2
1801720|NCT00521144|6265498|P1|Overall Study|Progressive Disease|4
1801721|NCT00521144|6265494|P5|Overall Study|Adverse Event|1
1801722|NCT00521144|6265495|P4|Overall Study|Adverse Event|0
1801723|NCT00521144|6265496|P3|Overall Study|Adverse Event|0
1801724|NCT00521144|6265497|P2|Overall Study|Adverse Event|1
1801725|NCT00521144|6265498|P1|Overall Study|Adverse Event|0
1801726|NCT00521144|6265494|P5|Overall Study|Not Treated|0
1801727|NCT00521144|6265495|P4|Overall Study|Not Treated|1
1801728|NCT00521144|6265496|P3|Overall Study|Not Treated|0
1801729|NCT00521144|6265497|P2|Overall Study|Not Treated|0
1801730|NCT00521144|6265498|P1|Overall Study|Not Treated|0
1801731|NCT00521079|6265512|P2|Overall Study|Withdrawal by Subject|3
1801732|NCT00521079|6265513|P1|Overall Study|Withdrawal by Subject|5
1801733|NCT00521079|6265512|P2|Overall Study|Lost to Follow-up|1
1801734|NCT00521079|6265513|P1|Overall Study|Lost to Follow-up|2
1801735|NCT00521079|6265512|P2|Overall Study|Adverse Event|1
1801736|NCT00521079|6265513|P1|Overall Study|Adverse Event|7
1801737|NCT00521053|6265523|P1|Observation Phase|Physician Decision|1
1801738|NCT00521053|6265523|P1|Observation Phase|Other non-study melanoma treatment|1
1801739|NCT00521053|6265523|P1|Observation Phase|Adverse Event|1
1801740|NCT00521053|6265523|P1|Observation Phase|Death|2
1801741|NCT00521053|6265523|P1|Observation Phase|Additional PV-10 via alternate protocol|8
1801742|NCT00521053|6265523|P1|Observation Phase|Disease Progression|55
1801743|NCT00521014|6265533|P1|Overall Study|Inevaluable, not treated|1
1801744|NCT00521001|6265537|P1|Overall Study|Ineligible|1
1801745|NCT00520975|6265546|P2|Overall Study|Not start protocol therapy|2
1801746|NCT00520975|6265547|P1|Overall Study|Not start protocol therapy|1
1801747|NCT00520975|6265546|P2|Overall Study|Other reasons|2
1801748|NCT00520975|6265547|P1|Overall Study|Other reasons|4
1801749|NCT00520975|6265546|P2|Overall Study|Other therapy|4
1801750|NCT00520975|6265547|P1|Overall Study|Other therapy|2
1801751|NCT00520975|6265546|P2|Overall Study|Withdrawal by Subject|5
1801752|NCT00520975|6265547|P1|Overall Study|Withdrawal by Subject|3
1801753|NCT00520975|6265546|P2|Overall Study|Death|2
1801754|NCT00520975|6265547|P1|Overall Study|Death|0
1801755|NCT00520975|6265546|P2|Overall Study|Adverse Event|10
1801756|NCT00520975|6265547|P1|Overall Study|Adverse Event|7
1801757|NCT00520975|6265546|P2|Overall Study|Disease progression|23
1801758|NCT00520975|6265547|P1|Overall Study|Disease progression|31
1801759|NCT00520936|6265579|P8|Overall Study|Protocol Violation|0
1801760|NCT00520936|6265580|P7|Overall Study|Protocol Violation|1
1801761|NCT00520936|6265581|P6|Overall Study|Protocol Violation|0
1801762|NCT00520936|6265582|P5|Overall Study|Protocol Violation|1
1801763|NCT00520936|6265583|P4|Overall Study|Protocol Violation|0
1801764|NCT00520936|6265584|P3|Overall Study|Protocol Violation|1
1801765|NCT00520936|6265585|P2|Overall Study|Protocol Violation|1
1801766|NCT00520936|6265586|P1|Overall Study|Protocol Violation|0
1801767|NCT00520936|6265579|P8|Overall Study|Death|0
1801768|NCT00520936|6265580|P7|Overall Study|Death|1
1801769|NCT00520936|6265581|P6|Overall Study|Death|0
1801770|NCT00520936|6265582|P5|Overall Study|Death|0
1801771|NCT00520936|6265583|P4|Overall Study|Death|0
1801772|NCT00520936|6265584|P3|Overall Study|Death|0
1801773|NCT00520936|6265585|P2|Overall Study|Death|0
1801774|NCT00520936|6265586|P1|Overall Study|Death|0
1801775|NCT00520936|6265579|P8|Overall Study|Toxicity Requiring Removal from Study|0
1801776|NCT00520936|6265580|P7|Overall Study|Toxicity Requiring Removal from Study|2
1801777|NCT00520936|6265581|P6|Overall Study|Toxicity Requiring Removal from Study|0
1801778|NCT00520936|6265582|P5|Overall Study|Toxicity Requiring Removal from Study|0
1801779|NCT00520936|6265583|P4|Overall Study|Toxicity Requiring Removal from Study|0
1801780|NCT00520936|6265584|P3|Overall Study|Toxicity Requiring Removal from Study|0
1801781|NCT00520936|6265585|P2|Overall Study|Toxicity Requiring Removal from Study|1
1801782|NCT00520936|6265586|P1|Overall Study|Toxicity Requiring Removal from Study|0
1801783|NCT00520936|6265579|P8|Overall Study|Withdrawal by Subject|1
1801784|NCT00520936|6265580|P7|Overall Study|Withdrawal by Subject|0
1801785|NCT00520936|6265581|P6|Overall Study|Withdrawal by Subject|0
1801786|NCT00520936|6265582|P5|Overall Study|Withdrawal by Subject|0
1801787|NCT00520936|6265583|P4|Overall Study|Withdrawal by Subject|0
1801788|NCT00520936|6265584|P3|Overall Study|Withdrawal by Subject|0
1801789|NCT00520936|6265585|P2|Overall Study|Withdrawal by Subject|0
1801790|NCT00520936|6265586|P1|Overall Study|Withdrawal by Subject|0
1801791|NCT00520936|6265579|P8|Overall Study|Physician Decision|0
1801792|NCT00520936|6265580|P7|Overall Study|Physician Decision|0
1801793|NCT00520936|6265581|P6|Overall Study|Physician Decision|0
1801794|NCT00520936|6265582|P5|Overall Study|Physician Decision|0
1801795|NCT00520936|6265583|P4|Overall Study|Physician Decision|0
1801796|NCT00520936|6265584|P3|Overall Study|Physician Decision|1
1801797|NCT00520936|6265585|P2|Overall Study|Physician Decision|2
1801798|NCT00520936|6265586|P1|Overall Study|Physician Decision|0
1801799|NCT00520845|6265641|P1|Overall Study|Alternative Therapy|1
1801800|NCT00520845|6265641|P1|Overall Study|Withdrawal by Subject|1
1801801|NCT00520845|6265641|P1|Overall Study|Disease Progression, relapse|13
1801802|NCT00520845|6265641|P1|Overall Study|Adverse Event|4
1801803|NCT00520845|6265641|P1|Overall Study|Death|3
1801804|NCT00520767|6265649|P1|Overall Study|Death|2
1801805|NCT00520741|6265655|P2|Overall Study|Other reasons for premature termination|6
1801806|NCT00520741|6265656|P1|Overall Study|Other reasons for premature termination|0
1801807|NCT00520741|6265655|P2|Overall Study|Lost to Follow-up|4
1801808|NCT00520741|6265656|P1|Overall Study|Lost to Follow-up|4
1801809|NCT00520741|6265655|P2|Overall Study|Unsatisfactory compliance of subject|3
1801810|NCT00520741|6265656|P1|Overall Study|Unsatisfactory compliance of subject|4
1801811|NCT00520741|6265655|P2|Overall Study|Protocol Violation|15
1801812|NCT00520741|6265656|P1|Overall Study|Protocol Violation|2
1801813|NCT00520741|6265655|P2|Overall Study|Withdrawal by Subject|11
1801814|NCT00520741|6265656|P1|Overall Study|Withdrawal by Subject|0
1801815|NCT00520741|6265655|P2|Overall Study|Lack of Efficacy|30
1801816|NCT00520741|6265656|P1|Overall Study|Lack of Efficacy|11
1801817|NCT00520741|6265655|P2|Overall Study|Adverse Event|56
1801818|NCT00520741|6265656|P1|Overall Study|Adverse Event|16
1801819|NCT00520676|6265674|P2|Overall Study|Withdrawal by Subject|11
1801820|NCT00520676|6265675|P1|Overall Study|Withdrawal by Subject|7
1801821|NCT00520676|6265674|P2|Overall Study|Physician Decision|1
1801822|NCT00520676|6265675|P1|Overall Study|Physician Decision|4
1801823|NCT00520676|6265674|P2|Overall Study|Lost to Follow-up|10
1801824|NCT00520676|6265675|P1|Overall Study|Lost to Follow-up|6
1801825|NCT00520676|6265674|P2|Overall Study|Death|81
1801826|NCT00520676|6265675|P1|Overall Study|Death|84
1801827|NCT00520572|6265701|P6|Overall Study|Did not receive Treatment|0
1801828|NCT00520572|6265702|P5|Overall Study|Did not receive Treatment|0
1801829|NCT00520572|6265703|P4|Overall Study|Did not receive Treatment|0
1801830|NCT00520572|6265704|P3|Overall Study|Did not receive Treatment|1
1801831|NCT00520572|6265705|P2|Overall Study|Did not receive Treatment|0
1801832|NCT00520572|6265706|P1|Overall Study|Did not receive Treatment|1
1801833|NCT00520572|6265701|P6|Overall Study|Long break in taking Medication|0
1801834|NCT00520572|6265702|P5|Overall Study|Long break in taking Medication|0
1801835|NCT00520572|6265703|P4|Overall Study|Long break in taking Medication|1
1801836|NCT00520572|6265704|P3|Overall Study|Long break in taking Medication|0
1801837|NCT00520572|6265705|P2|Overall Study|Long break in taking Medication|0
1801838|NCT00520572|6265706|P1|Overall Study|Long break in taking Medication|0
1801839|NCT00520572|6265701|P6|Overall Study|Oral corticotherapy for acute urticaria|0
1801840|NCT00520572|6265702|P5|Overall Study|Oral corticotherapy for acute urticaria|0
1801841|NCT00520572|6265703|P4|Overall Study|Oral corticotherapy for acute urticaria|0
1801842|NCT00520572|6265704|P3|Overall Study|Oral corticotherapy for acute urticaria|0
1801843|NCT00520572|6265705|P2|Overall Study|Oral corticotherapy for acute urticaria|1
1801844|NCT00520572|6265706|P1|Overall Study|Oral corticotherapy for acute urticaria|0
1801845|NCT00520572|6265701|P6|Overall Study|Incorrect enrollment|0
1801846|NCT00520572|6265702|P5|Overall Study|Incorrect enrollment|1
1801847|NCT00520572|6265703|P4|Overall Study|Incorrect enrollment|0
1801848|NCT00520572|6265704|P3|Overall Study|Incorrect enrollment|1
1801849|NCT00520572|6265705|P2|Overall Study|Incorrect enrollment|0
1801850|NCT00520572|6265706|P1|Overall Study|Incorrect enrollment|1
1801851|NCT00520572|6265701|P6|Overall Study|Lost to Follow-up|0
1801852|NCT00520572|6265702|P5|Overall Study|Lost to Follow-up|1
1801853|NCT00520572|6265703|P4|Overall Study|Lost to Follow-up|0
1801854|NCT00520572|6265704|P3|Overall Study|Lost to Follow-up|0
1801855|NCT00520572|6265705|P2|Overall Study|Lost to Follow-up|0
1801856|NCT00520572|6265706|P1|Overall Study|Lost to Follow-up|0
1801857|NCT00520572|6265701|P6|Overall Study|Lack of Efficacy|0
1801858|NCT00520572|6265702|P5|Overall Study|Lack of Efficacy|1
1801859|NCT00520572|6265703|P4|Overall Study|Lack of Efficacy|2
1801860|NCT00520572|6265704|P3|Overall Study|Lack of Efficacy|1
1801861|NCT00520572|6265705|P2|Overall Study|Lack of Efficacy|1
1801862|NCT00520572|6265706|P1|Overall Study|Lack of Efficacy|1
1801863|NCT00520572|6265701|P6|Overall Study|Protocol Violation|0
1801864|NCT00520572|6265702|P5|Overall Study|Protocol Violation|0
1801865|NCT00520572|6265703|P4|Overall Study|Protocol Violation|0
1801866|NCT00520572|6265704|P3|Overall Study|Protocol Violation|1
1801867|NCT00520572|6265705|P2|Overall Study|Protocol Violation|0
1801868|NCT00520572|6265706|P1|Overall Study|Protocol Violation|0
1801869|NCT00520572|6265701|P6|Overall Study|Withdrawal by Subject|0
1801870|NCT00520572|6265702|P5|Overall Study|Withdrawal by Subject|2
1801871|NCT00520572|6265703|P4|Overall Study|Withdrawal by Subject|2
1801872|NCT00520572|6265704|P3|Overall Study|Withdrawal by Subject|5
1801873|NCT00520572|6265705|P2|Overall Study|Withdrawal by Subject|9
1801874|NCT00520572|6265706|P1|Overall Study|Withdrawal by Subject|0
1801875|NCT00520572|6265701|P6|Overall Study|Adverse Event|2
1801876|NCT00520572|6265702|P5|Overall Study|Adverse Event|7
1801877|NCT00520572|6265703|P4|Overall Study|Adverse Event|9
1801878|NCT00520572|6265704|P3|Overall Study|Adverse Event|6
1801879|NCT00520572|6265705|P2|Overall Study|Adverse Event|3
1801880|NCT00520572|6265706|P1|Overall Study|Adverse Event|9
1801881|NCT00520546|6265744|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
1801882|NCT00520546|6265744|P1|Overall Study|Withdrawal by Subject|1
1801883|NCT00520494|6265759|P1|Overall Study|Withdrawal by Subject|1
1801884|NCT00520481|6265784|P2|Overall Study|Withdrawal by Subject|0
1801885|NCT00520481|6265785|P1|Overall Study|Withdrawal by Subject|3
1801886|NCT00520481|6265784|P2|Overall Study|Adverse Event|1
1801887|NCT00520481|6265785|P1|Overall Study|Adverse Event|4
1801888|NCT00520403|6265809|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
1801889|NCT00520403|6265809|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
1801890|NCT00520403|6265809|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
1801891|NCT00520403|6265809|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
1801892|NCT00520403|6265809|P1|Bevacizumab + IFN/Vinblastine|Death|2
1801893|NCT00520403|6265809|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
1801894|NCT00520403|6265809|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
1801895|NCT00520403|6265809|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
1801896|NCT00520351|6265818|P2|First Intervention|Withdrawal by Subject|1
1801897|NCT00520351|6265819|P1|First Intervention|Withdrawal by Subject|1
1801898|NCT00520299|6265834|P3|Overall Study|Progressive disease|4
1801899|NCT00520299|6265835|P2|Overall Study|Progressive disease|3
1801900|NCT00520299|6265836|P1|Overall Study|Progressive disease|0
1801901|NCT00520299|6265834|P3|Overall Study|Withdrawal by Subject|2
1801902|NCT00520299|6265835|P2|Overall Study|Withdrawal by Subject|0
1801903|NCT00520299|6265836|P1|Overall Study|Withdrawal by Subject|0
1801904|NCT00520130|6265891|P2|Overall Study|Physician Decision|1
1801905|NCT00520130|6265892|P1|Overall Study|Physician Decision|1
1801906|NCT00520130|6265891|P2|Overall Study|Disease progression on study|0
1801907|NCT00520130|6265892|P1|Overall Study|Disease progression on study|4
1801908|NCT00520039|6265934|P2|Overall Study|Exclusion criteria met at first visit|5
1801909|NCT00520039|6265935|P1|Overall Study|Exclusion criteria met at first visit|7
1801910|NCT00520013|6265948|P3|Overall Study|Physician Decision|3
1801911|NCT00520013|6265949|P2|Overall Study|Physician Decision|0
1801912|NCT00520013|6265950|P1|Overall Study|Physician Decision|0
1801913|NCT00520013|6265948|P3|Overall Study|Death|0
1801914|NCT00520013|6265949|P2|Overall Study|Death|1
1801915|NCT00520013|6265950|P1|Overall Study|Death|0
1801916|NCT00520013|6265948|P3|Overall Study|Clinical Progression|0
1801917|NCT00520013|6265949|P2|Overall Study|Clinical Progression|1
1801918|NCT00520013|6265950|P1|Overall Study|Clinical Progression|3
1801919|NCT00520013|6265948|P3|Overall Study|Progressive Disease|0
1801920|NCT00520013|6265949|P2|Overall Study|Progressive Disease|3
1801921|NCT00520013|6265950|P1|Overall Study|Progressive Disease|7
1801922|NCT00520013|6265948|P3|Overall Study|Adverse Event|7
1801923|NCT00520013|6265949|P2|Overall Study|Adverse Event|10
1801924|NCT00520013|6265950|P1|Overall Study|Adverse Event|2
1801925|NCT00520013|6265948|P3|Overall Study|Withdrawal by Subject|1
1801926|NCT00520013|6265949|P2|Overall Study|Withdrawal by Subject|0
1801927|NCT00520013|6265950|P1|Overall Study|Withdrawal by Subject|0
1801928|NCT00519896|6265960|P1|Overall Study|Adverse Event|1
1801929|NCT00519896|6265960|P1|Overall Study|Protocol Violation|1
1801930|NCT00519831|6265966|P1|Overall Study|Adverse Event|3
1801931|NCT00519779|6265983|P2|Overall Study|Withdrawal by Subject|1
1801932|NCT00519779|6265984|P1|Overall Study|Withdrawal by Subject|0
1801933|NCT00519649|6266000|P1|Overall Study|Withdrawal by Subject|1
1801934|NCT00519636|6266013|P4|Post Study Period|Subject randomized in error|1
1801935|NCT00519636|6266014|P3|Post Study Period|Subject randomized in error|0
1801936|NCT00519636|6266015|P2|Post Study Period|Subject randomized in error|0
1801937|NCT00519636|6266016|P1|Post Study Period|Subject randomized in error|0
1801938|NCT00519636|6266013|P4|Treatment Period 2|Subject misrandomized|1
1801939|NCT00519636|6266014|P3|Treatment Period 2|Subject misrandomized|0
1801940|NCT00519636|6266015|P2|Treatment Period 2|Subject misrandomized|0
1801941|NCT00519636|6266016|P1|Treatment Period 2|Subject misrandomized|0
1801942|NCT00519636|6266013|P4|Treatment Period 2|Per doctors request|0
1801943|NCT00519636|6266014|P3|Treatment Period 2|Per doctors request|1
1801944|NCT00519636|6266015|P2|Treatment Period 2|Per doctors request|0
1801945|NCT00519636|6266016|P1|Treatment Period 2|Per doctors request|0
1801946|NCT00519636|6266013|P4|Treatment Period 2|Subject randomized in error|0
1801947|NCT00519636|6266014|P3|Treatment Period 2|Subject randomized in error|0
1801948|NCT00519636|6266015|P2|Treatment Period 2|Subject randomized in error|1
1801949|NCT00519636|6266016|P1|Treatment Period 2|Subject randomized in error|0
1801950|NCT00519636|6266013|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
1801951|NCT00519636|6266014|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
1801952|NCT00519636|6266015|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
1801953|NCT00519636|6266016|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
1801954|NCT00519636|6266013|P4|Washout Period|Prohibited medications|0
1801955|NCT00519636|6266014|P3|Washout Period|Prohibited medications|1
1801956|NCT00519636|6266015|P2|Washout Period|Prohibited medications|0
1801957|NCT00519636|6266016|P1|Washout Period|Prohibited medications|0
1801958|NCT00519636|6266013|P4|Washout Period|Subject randomized in error|0
1801959|NCT00519636|6266014|P3|Washout Period|Subject randomized in error|1
1801960|NCT00519636|6266015|P2|Washout Period|Subject randomized in error|0
1801961|NCT00519636|6266016|P1|Washout Period|Subject randomized in error|0
1801962|NCT00519636|6266013|P4|Washout Period|Per doctors request|0
1801963|NCT00519636|6266014|P3|Washout Period|Per doctors request|0
1801964|NCT00519636|6266015|P2|Washout Period|Per doctors request|1
1801965|NCT00519636|6266016|P1|Washout Period|Per doctors request|0
1801966|NCT00519636|6266013|P4|Washout Period|Non-compliant|0
1801967|NCT00519636|6266014|P3|Washout Period|Non-compliant|0
1801968|NCT00519636|6266015|P2|Washout Period|Non-compliant|1
1801969|NCT00519636|6266016|P1|Washout Period|Non-compliant|0
1801970|NCT00519636|6266013|P4|Washout Period|Participating in study at another site|0
1801971|NCT00519636|6266014|P3|Washout Period|Participating in study at another site|0
1801972|NCT00519636|6266015|P2|Washout Period|Participating in study at another site|0
1801973|NCT00519636|6266016|P1|Washout Period|Participating in study at another site|1
1801974|NCT00519636|6266013|P4|Washout Period|Out of pollen area > 48 hours|0
1801975|NCT00519636|6266014|P3|Washout Period|Out of pollen area > 48 hours|0
1801976|NCT00519636|6266015|P2|Washout Period|Out of pollen area > 48 hours|0
1801977|NCT00519636|6266016|P1|Washout Period|Out of pollen area > 48 hours|1
1801978|NCT00519636|6266013|P4|Washout Period|Failed to meet continuation criteria|3
1801979|NCT00519636|6266014|P3|Washout Period|Failed to meet continuation criteria|9
1801980|NCT00519636|6266015|P2|Washout Period|Failed to meet continuation criteria|11
1801981|NCT00519636|6266016|P1|Washout Period|Failed to meet continuation criteria|14
1801982|NCT00519636|6266013|P4|Washout Period|Withdrawal by Subject|0
1801983|NCT00519636|6266014|P3|Washout Period|Withdrawal by Subject|1
1801984|NCT00519636|6266015|P2|Washout Period|Withdrawal by Subject|0
1801985|NCT00519636|6266016|P1|Washout Period|Withdrawal by Subject|1
1801986|NCT00519636|6266013|P4|Washout Period|Protocol Violation|2
1801987|NCT00519636|6266014|P3|Washout Period|Protocol Violation|1
1801988|NCT00519636|6266015|P2|Washout Period|Protocol Violation|0
1801989|NCT00519636|6266016|P1|Washout Period|Protocol Violation|0
1801990|NCT00519636|6266013|P4|Washout Period|Lost to Follow-up|0
1801991|NCT00519636|6266014|P3|Washout Period|Lost to Follow-up|0
1801992|NCT00519636|6266015|P2|Washout Period|Lost to Follow-up|0
1801993|NCT00519636|6266016|P1|Washout Period|Lost to Follow-up|1
1801994|NCT00519636|6266013|P4|Washout Period|Adverse Event|0
1801995|NCT00519636|6266014|P3|Washout Period|Adverse Event|1
1801996|NCT00519636|6266015|P2|Washout Period|Adverse Event|1
1801997|NCT00519636|6266016|P1|Washout Period|Adverse Event|2
1801998|NCT00519636|6266013|P4|Treatment Period 1|Sponsor request due to missed visit|0
1801999|NCT00519636|6266014|P3|Treatment Period 1|Sponsor request due to missed visit|0
1802000|NCT00519636|6266015|P2|Treatment Period 1|Sponsor request due to missed visit|0
1802001|NCT00519636|6266016|P1|Treatment Period 1|Sponsor request due to missed visit|1
1802002|NCT00519636|6266013|P4|Treatment Period 1|Adverse Event|0
1802003|NCT00519636|6266014|P3|Treatment Period 1|Adverse Event|1
1802004|NCT00519636|6266015|P2|Treatment Period 1|Adverse Event|0
1802005|NCT00519636|6266016|P1|Treatment Period 1|Adverse Event|1
1802006|NCT00519623|6266046|P1|Overall Study|Adverse Event|1
1802007|NCT00519532|6266080|P1|Overall Study|Lost to Follow-up|2
1802008|NCT00519532|6266080|P1|Overall Study|Withdrawal by Subject|5
1802009|NCT00519532|6266080|P1|Overall Study|Adverse Event|11
1802010|NCT00519428|6266090|P3|Overall Study|unstated|2
1802011|NCT00519428|6266091|P2|Overall Study|unstated|3
1802012|NCT00519428|6266092|P1|Overall Study|unstated|1
1802013|NCT00519428|6266090|P3|Overall Study|Withdrawal by Subject|7
1802014|NCT00519428|6266091|P2|Overall Study|Withdrawal by Subject|3
1802015|NCT00519428|6266092|P1|Overall Study|Withdrawal by Subject|8
1802016|NCT00519428|6266090|P3|Overall Study|Lost to Follow-up|6
1802017|NCT00519428|6266091|P2|Overall Study|Lost to Follow-up|7
1802018|NCT00519428|6266092|P1|Overall Study|Lost to Follow-up|7
1802019|NCT00519428|6266090|P3|Overall Study|Adverse Event|10
1802020|NCT00519428|6266091|P2|Overall Study|Adverse Event|2
1802021|NCT00519428|6266092|P1|Overall Study|Adverse Event|5
1802022|NCT00519376|6266112|P16|Treatment Period 4|Lost to Follow-up|0
1802023|NCT00519376|6266113|P15|Treatment Period 4|Lost to Follow-up|0
1802024|NCT00519376|6266114|P14|Treatment Period 4|Lost to Follow-up|0
1802025|NCT00519376|6266115|P13|Treatment Period 4|Lost to Follow-up|0
1802026|NCT00519376|6266116|P12|Treatment Period 4|Lost to Follow-up|0
1802027|NCT00519376|6266117|P11|Treatment Period 4|Lost to Follow-up|0
1802028|NCT00519376|6266118|P10|Treatment Period 4|Lost to Follow-up|0
1802029|NCT00519376|6266119|P9|Treatment Period 4|Lost to Follow-up|0
1802030|NCT00519376|6266120|P8|Treatment Period 4|Lost to Follow-up|0
1802031|NCT00519376|6266121|P7|Treatment Period 4|Lost to Follow-up|0
1802032|NCT00519376|6266122|P6|Treatment Period 4|Lost to Follow-up|0
1802033|NCT00519376|6266123|P5|Treatment Period 4|Lost to Follow-up|0
1802034|NCT00519376|6266124|P4|Treatment Period 4|Lost to Follow-up|0
1802035|NCT00519376|6266125|P3|Treatment Period 4|Lost to Follow-up|1
1802036|NCT00519376|6266126|P2|Treatment Period 4|Lost to Follow-up|0
1802037|NCT00519376|6266127|P1|Treatment Period 4|Lost to Follow-up|0
1802038|NCT00519376|6266112|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802039|NCT00519376|6266113|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802040|NCT00519376|6266114|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802041|NCT00519376|6266115|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
1802042|NCT00519376|6266116|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802043|NCT00519376|6266117|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802044|NCT00519376|6266118|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802045|NCT00519376|6266119|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802046|NCT00519376|6266120|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802212|NCT00518323|6266896|P3|Overall Study|Adverse Event|1
1802047|NCT00519376|6266121|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802048|NCT00519376|6266122|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802049|NCT00519376|6266123|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802050|NCT00519376|6266124|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802051|NCT00519376|6266125|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802052|NCT00519376|6266126|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802053|NCT00519376|6266127|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
1802054|NCT00519285|6266251|P2|Overall Study|Treatment ongoing|2
1802055|NCT00519285|6266252|P1|Overall Study|Treatment ongoing|1
1802056|NCT00519285|6266251|P2|Overall Study|Not treated|7
1802057|NCT00519285|6266252|P1|Overall Study|Not treated|8
1802058|NCT00519285|6266251|P2|Overall Study|Reason unspecified|8
1802059|NCT00519285|6266252|P1|Overall Study|Reason unspecified|5
1802060|NCT00519285|6266251|P2|Overall Study|Poor compliance to protocol|7
1802061|NCT00519285|6266252|P1|Overall Study|Poor compliance to protocol|5
1802062|NCT00519285|6266251|P2|Overall Study|Consent withdrawn|5
1802063|NCT00519285|6266252|P1|Overall Study|Consent withdrawn|4
1802064|NCT00519285|6266251|P2|Overall Study|Participant's request|84
1802065|NCT00519285|6266252|P1|Overall Study|Participant's request|53
1802066|NCT00519285|6266251|P2|Overall Study|Physician Decision|47
1802067|NCT00519285|6266252|P1|Overall Study|Physician Decision|75
1802068|NCT00519285|6266251|P2|Overall Study|Disease progression|186
1802069|NCT00519285|6266252|P1|Overall Study|Disease progression|334
1802070|NCT00519285|6266251|P2|Overall Study|Adverse Event|266
1802071|NCT00519285|6266252|P1|Overall Study|Adverse Event|127
1802072|NCT00519194|6266278|P1|Overall Study|Lost to Follow-up|3
1802073|NCT00519194|6266278|P1|Overall Study|Death|9
1802074|NCT00519194|6266278|P1|Overall Study|Withdrawal by Subject|9
1802075|NCT00519077|6266293|P1|Overall Study|Other|2
1802076|NCT00519077|6266293|P1|Overall Study|Death|6
1802077|NCT00518986|6266300|P2|Overall Study|Non-Specific|1
1802078|NCT00518986|6266301|P1|Overall Study|Non-Specific|2
1802079|NCT00518986|6266300|P2|Overall Study|Withdrawal by Subject|4
1802080|NCT00518986|6266301|P1|Overall Study|Withdrawal by Subject|4
1802081|NCT00518986|6266300|P2|Overall Study|Protocol Violation|7
1802082|NCT00518986|6266301|P1|Overall Study|Protocol Violation|5
1802083|NCT00518986|6266300|P2|Overall Study|Physician Decision|3
1802084|NCT00518986|6266301|P1|Overall Study|Physician Decision|0
1802085|NCT00518986|6266300|P2|Overall Study|Lost to Follow-up|2
1802086|NCT00518986|6266301|P1|Overall Study|Lost to Follow-up|3
1802087|NCT00518986|6266300|P2|Overall Study|Lack of Efficacy|2
1802088|NCT00518986|6266301|P1|Overall Study|Lack of Efficacy|0
1802089|NCT00518986|6266300|P2|Overall Study|Adverse Event|7
1802090|NCT00518986|6266301|P1|Overall Study|Adverse Event|12
1802091|NCT00518973|6266427|P2|Overall Study|Withdrawal by Subject|2
1802092|NCT00518973|6266428|P1|Overall Study|Withdrawal by Subject|3
1802093|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
1802094|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
1802095|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Subject decision|0
1802096|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Subject decision|2
1802097|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
1802098|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
1802099|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
1802100|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
1802101|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Creatine increased|0
1802102|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Creatine increased|1
1802103|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Change in treatment|1
1802104|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Change in treatment|1
1802105|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
1802106|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
1802107|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
1802108|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
1802109|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
1802110|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
1802111|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
1802112|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
1802113|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
1802114|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
1802115|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
1802116|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
1802117|NCT00518882|6266444|P2|Open-Label Extension, Week 26-78|Adverse Event|9
1802118|NCT00518882|6266445|P1|Open-Label Extension, Week 26-78|Adverse Event|3
1802119|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Mutual consent|1
1802120|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Mutual consent|0
1802121|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
1802122|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
1802123|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
1802124|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
1802125|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Loss of trust|1
1802126|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Loss of trust|0
1802127|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
1802128|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
1802129|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Subject decision|1
1802130|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Subject decision|1
1802131|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Lost to follow up|1
1802132|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Lost to follow up|2
1802133|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
1802134|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
1802135|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Protocol Violation|3
1802136|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Protocol Violation|4
1802137|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
1802138|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
1802139|NCT00518882|6266444|P2|Double-Blind, Week 0-26|Adverse Event|31
1802140|NCT00518882|6266445|P1|Double-Blind, Week 0-26|Adverse Event|23
1802141|NCT00518687|6266626|P2|Overall Study|Withdrawal by Subject|110
1802142|NCT00518687|6266627|P1|Overall Study|Withdrawal by Subject|110
1802143|NCT00518687|6266626|P2|Overall Study|Study terminated by sponsor|918
1802144|NCT00518687|6266627|P1|Overall Study|Study terminated by sponsor|930
1802145|NCT00518687|6266626|P2|Overall Study|Protocol Violation|10
1802146|NCT00518687|6266627|P1|Overall Study|Protocol Violation|8
1802147|NCT00518687|6266626|P2|Overall Study|Progressive disease|2
1802148|NCT00518687|6266627|P1|Overall Study|Progressive disease|2
1802149|NCT00518687|6266626|P2|Overall Study|Physician Decision|48
1802150|NCT00518687|6266627|P1|Overall Study|Physician Decision|42
1802151|NCT00518687|6266626|P2|Overall Study|Lost to Follow-up|155
1802152|NCT00518687|6266627|P1|Overall Study|Lost to Follow-up|144
1802153|NCT00518687|6266626|P2|Overall Study|Adverse Event|177
1802154|NCT00518687|6266627|P1|Overall Study|Adverse Event|201
1802155|NCT00518622|6266647|P8|Overall Study|Study medication taken incorrectly|0
1802156|NCT00518622|6266648|P7|Overall Study|Study medication taken incorrectly|0
1802157|NCT00518622|6266649|P6|Overall Study|Study medication taken incorrectly|0
1802158|NCT00518622|6266650|P5|Overall Study|Study medication taken incorrectly|0
1802159|NCT00518622|6266651|P4|Overall Study|Study medication taken incorrectly|0
1802160|NCT00518622|6266652|P3|Overall Study|Study medication taken incorrectly|0
1802161|NCT00518622|6266653|P2|Overall Study|Study medication taken incorrectly|1
1802162|NCT00518622|6266654|P1|Overall Study|Study medication taken incorrectly|0
1802163|NCT00518622|6266647|P8|Overall Study|Lost to Follow-up|0
1802164|NCT00518622|6266648|P7|Overall Study|Lost to Follow-up|0
1802165|NCT00518622|6266649|P6|Overall Study|Lost to Follow-up|0
1802166|NCT00518622|6266650|P5|Overall Study|Lost to Follow-up|0
1802167|NCT00518622|6266651|P4|Overall Study|Lost to Follow-up|0
1802168|NCT00518622|6266652|P3|Overall Study|Lost to Follow-up|1
1802169|NCT00518622|6266653|P2|Overall Study|Lost to Follow-up|0
1802170|NCT00518622|6266654|P1|Overall Study|Lost to Follow-up|0
1802171|NCT00518531|6266682|P2|Treatment Period 2|Non-compliance|2
1802172|NCT00518531|6266683|P1|Treatment Period 2|Non-compliance|1
1802173|NCT00518531|6266682|P2|Treatment Period 2|Protocol-specified criteria|1
1802174|NCT00518531|6266683|P1|Treatment Period 2|Protocol-specified criteria|0
1802175|NCT00518531|6266682|P2|Treatment Period 2|Adverse Event|7
1802176|NCT00518531|6266683|P1|Treatment Period 2|Adverse Event|1
1802177|NCT00518531|6266682|P2|Treatment Period 2|Complete out of scheduled visit window|2
1802178|NCT00518531|6266683|P1|Treatment Period 2|Complete out of scheduled visit window|1
1802179|NCT00518531|6266682|P2|Treatment Period 2|Withdrawal by Subject|8
1802180|NCT00518531|6266683|P1|Treatment Period 2|Withdrawal by Subject|0
1802181|NCT00518531|6266682|P2|Treatment Period 1|Early crossover|3
1802182|NCT00518531|6266683|P1|Treatment Period 1|Early crossover|1
1802183|NCT00518531|6266682|P2|Treatment Period 1|Withdrawal by Subject|6
1802184|NCT00518531|6266683|P1|Treatment Period 1|Withdrawal by Subject|4
1802185|NCT00518531|6266682|P2|Treatment Period 1|Protocol Violation|0
1802186|NCT00518531|6266683|P1|Treatment Period 1|Protocol Violation|2
1802187|NCT00518531|6266682|P2|Treatment Period 1|Physician Decision|0
1802188|NCT00518531|6266683|P1|Treatment Period 1|Physician Decision|1
1802189|NCT00518531|6266682|P2|Treatment Period 1|Lost to Follow-up|3
1802190|NCT00518531|6266683|P1|Treatment Period 1|Lost to Follow-up|5
1802191|NCT00518531|6266682|P2|Treatment Period 1|Adverse Event|0
1802192|NCT00518531|6266683|P1|Treatment Period 1|Adverse Event|5
1802193|NCT00518336|6266728|P2|Year 9|Personal reasons|0
1802194|NCT00518336|6266729|P1|Year 9|Personal reasons|1
1802195|NCT00518336|6266728|P2|Year 9|Lost to Follow-up|0
1802196|NCT00518336|6266729|P1|Year 9|Lost to Follow-up|3
1802197|NCT00518336|6266728|P2|Year 9|Migrated/moved from study area|1
1802198|NCT00518336|6266729|P1|Year 9|Migrated/moved from study area|1
1802199|NCT00518336|6266728|P2|Year 8|Could not attend in time|1
1802200|NCT00518336|6266729|P1|Year 8|Could not attend in time|0
1802201|NCT00518336|6266728|P2|Year 8|Lost to Follow-up|1
1802202|NCT00518336|6266729|P1|Year 8|Lost to Follow-up|1
1802203|NCT00518336|6266728|P2|Year 7|Could not attend in time|3
1802204|NCT00518336|6266729|P1|Year 7|Could not attend in time|0
1802205|NCT00518336|6266728|P2|Year 7|Lost to Follow-up|0
1802206|NCT00518336|6266729|P1|Year 7|Lost to Follow-up|2
1802207|NCT00518323|6266895|P4|Overall Study|Prohibited medication and others|0
1802208|NCT00518323|6266896|P3|Overall Study|Prohibited medication and others|1
1802209|NCT00518323|6266897|P2|Overall Study|Prohibited medication and others|1
1802210|NCT00518323|6266898|P1|Overall Study|Prohibited medication and others|3
1802211|NCT00518323|6266895|P4|Overall Study|Adverse Event|0
1802213|NCT00518323|6266897|P2|Overall Study|Adverse Event|1
1802214|NCT00518323|6266898|P1|Overall Study|Adverse Event|1
1802215|NCT00518323|6266895|P4|Overall Study|Lost to Follow-up|3
1802216|NCT00518323|6266896|P3|Overall Study|Lost to Follow-up|1
1802217|NCT00518323|6266897|P2|Overall Study|Lost to Follow-up|2
1802218|NCT00518323|6266898|P1|Overall Study|Lost to Follow-up|0
1802219|NCT00518323|6266895|P4|Overall Study|Withdrawal by Subject|2
1802220|NCT00518323|6266896|P3|Overall Study|Withdrawal by Subject|4
1802221|NCT00518323|6266897|P2|Overall Study|Withdrawal by Subject|2
1802222|NCT00518323|6266898|P1|Overall Study|Withdrawal by Subject|1
1802223|NCT00518323|6266895|P4|Overall Study|Lack of Efficacy|20
1802224|NCT00518323|6266896|P3|Overall Study|Lack of Efficacy|4
1802225|NCT00518323|6266897|P2|Overall Study|Lack of Efficacy|2
1802226|NCT00518323|6266898|P1|Overall Study|Lack of Efficacy|14
1802227|NCT00518284|6266928|P4|Overall Study|Study Termination|2
1802228|NCT00518284|6266929|P3|Overall Study|Study Termination|1
1802229|NCT00518284|6266930|P2|Overall Study|Study Termination|2
1802230|NCT00518284|6266931|P1|Overall Study|Study Termination|0
1802231|NCT00518284|6266928|P4|Overall Study|Adverse Event|0
1802232|NCT00518284|6266929|P3|Overall Study|Adverse Event|0
1802233|NCT00518284|6266930|P2|Overall Study|Adverse Event|1
1802234|NCT00518284|6266931|P1|Overall Study|Adverse Event|0
1802235|NCT00518206|6266987|P2|Overall Study|Completion Status Unknown|0
1802236|NCT00518206|6266988|P1|Overall Study|Completion Status Unknown|1
1802237|NCT00518206|6266987|P2|Overall Study|Reason Unknown|0
1802238|NCT00518206|6266988|P1|Overall Study|Reason Unknown|1
1802239|NCT00518206|6266987|P2|Overall Study|Drug Supply Issue|0
1802240|NCT00518206|6266988|P1|Overall Study|Drug Supply Issue|1
1802241|NCT00518206|6266987|P2|Overall Study|Withdrawal by Subject|0
1802242|NCT00518206|6266988|P1|Overall Study|Withdrawal by Subject|2
1802243|NCT00518206|6266987|P2|Overall Study|Disease Progression Requiring Therapy|6
1802244|NCT00518206|6266988|P1|Overall Study|Disease Progression Requiring Therapy|6
1802245|NCT00518180|6267005|P3|Overall Study|Adverse Event|0
1802246|NCT00518180|6267006|P2|Overall Study|Adverse Event|0
1802247|NCT00518180|6267007|P1|Overall Study|Adverse Event|1
1802248|NCT00518180|6267005|P3|Overall Study|Unable to classify|0
1802249|NCT00518180|6267006|P2|Overall Study|Unable to classify|2
1802250|NCT00518180|6267007|P1|Overall Study|Unable to classify|0
1802251|NCT00518180|6267005|P3|Overall Study|Protocol Violation|4
1802252|NCT00518180|6267006|P2|Overall Study|Protocol Violation|7
1802253|NCT00518180|6267007|P1|Overall Study|Protocol Violation|5
1802254|NCT00518180|6267005|P3|Overall Study|Administrative reason|2
1802255|NCT00518180|6267006|P2|Overall Study|Administrative reason|2
1802256|NCT00518180|6267007|P1|Overall Study|Administrative reason|0
1802257|NCT00518180|6267005|P3|Overall Study|Lost to Follow-up|34
1802258|NCT00518180|6267006|P2|Overall Study|Lost to Follow-up|28
1802259|NCT00518180|6267007|P1|Overall Study|Lost to Follow-up|30
1802260|NCT00518180|6267005|P3|Overall Study|Withdrawal by Subject|42
1802261|NCT00518180|6267006|P2|Overall Study|Withdrawal by Subject|30
1802262|NCT00518180|6267007|P1|Overall Study|Withdrawal by Subject|29
1802263|NCT00518115|6267063|P10|Overall Study|Moved Out of State|1
1802264|NCT00518115|6267064|P9|Overall Study|Moved Out of State|0
1802265|NCT00518115|6267065|P8|Overall Study|Moved Out of State|0
1802266|NCT00518115|6267066|P7|Overall Study|Moved Out of State|0
1802267|NCT00518115|6267067|P6|Overall Study|Moved Out of State|0
1802268|NCT00518115|6267068|P5|Overall Study|Moved Out of State|0
1802269|NCT00518115|6267069|P4|Overall Study|Moved Out of State|0
1802270|NCT00518115|6267070|P3|Overall Study|Moved Out of State|0
1802271|NCT00518115|6267071|P2|Overall Study|Moved Out of State|0
1802272|NCT00518115|6267072|P1|Overall Study|Moved Out of State|0
1802273|NCT00518115|6267063|P10|Overall Study|Withdrew Consent|0
1802274|NCT00518115|6267064|P9|Overall Study|Withdrew Consent|0
1802275|NCT00518115|6267065|P8|Overall Study|Withdrew Consent|0
1802276|NCT00518115|6267066|P7|Overall Study|Withdrew Consent|0
1802277|NCT00518115|6267067|P6|Overall Study|Withdrew Consent|1
1802278|NCT00518115|6267068|P5|Overall Study|Withdrew Consent|0
1802279|NCT00518115|6267069|P4|Overall Study|Withdrew Consent|0
1802280|NCT00518115|6267070|P3|Overall Study|Withdrew Consent|0
1802281|NCT00518115|6267071|P2|Overall Study|Withdrew Consent|0
1802282|NCT00518115|6267072|P1|Overall Study|Withdrew Consent|0
1802283|NCT00518115|6267063|P10|Overall Study|Family Emergency; Had to Go to England|0
1802284|NCT00518115|6267064|P9|Overall Study|Family Emergency; Had to Go to England|0
1802285|NCT00518115|6267065|P8|Overall Study|Family Emergency; Had to Go to England|0
1802286|NCT00518115|6267066|P7|Overall Study|Family Emergency; Had to Go to England|0
1802287|NCT00518115|6267067|P6|Overall Study|Family Emergency; Had to Go to England|0
1802288|NCT00518115|6267068|P5|Overall Study|Family Emergency; Had to Go to England|1
1802289|NCT00518115|6267069|P4|Overall Study|Family Emergency; Had to Go to England|0
1802290|NCT00518115|6267070|P3|Overall Study|Family Emergency; Had to Go to England|0
1802291|NCT00518115|6267071|P2|Overall Study|Family Emergency; Had to Go to England|0
1802292|NCT00518115|6267072|P1|Overall Study|Family Emergency; Had to Go to England|0
1802293|NCT00518115|6267063|P10|Overall Study|Violation of Exclusion Criteria|0
1802294|NCT00518115|6267064|P9|Overall Study|Violation of Exclusion Criteria|0
1802295|NCT00518115|6267065|P8|Overall Study|Violation of Exclusion Criteria|0
1802296|NCT00518115|6267066|P7|Overall Study|Violation of Exclusion Criteria|1
1802297|NCT00518115|6267067|P6|Overall Study|Violation of Exclusion Criteria|0
1802298|NCT00518115|6267068|P5|Overall Study|Violation of Exclusion Criteria|0
1802299|NCT00518115|6267069|P4|Overall Study|Violation of Exclusion Criteria|1
1802300|NCT00518115|6267070|P3|Overall Study|Violation of Exclusion Criteria|0
1802301|NCT00518115|6267071|P2|Overall Study|Violation of Exclusion Criteria|0
1802302|NCT00518115|6267072|P1|Overall Study|Violation of Exclusion Criteria|0
1802303|NCT00518115|6267063|P10|Overall Study|Wrong Monotherapy Administered|0
1802304|NCT00518115|6267064|P9|Overall Study|Wrong Monotherapy Administered|0
1802305|NCT00518115|6267065|P8|Overall Study|Wrong Monotherapy Administered|0
1802306|NCT00518115|6267066|P7|Overall Study|Wrong Monotherapy Administered|1
1802307|NCT00518115|6267067|P6|Overall Study|Wrong Monotherapy Administered|0
1802308|NCT00518115|6267068|P5|Overall Study|Wrong Monotherapy Administered|0
1802309|NCT00518115|6267069|P4|Overall Study|Wrong Monotherapy Administered|0
1802310|NCT00518115|6267070|P3|Overall Study|Wrong Monotherapy Administered|1
1802311|NCT00518115|6267071|P2|Overall Study|Wrong Monotherapy Administered|0
1802312|NCT00518115|6267072|P1|Overall Study|Wrong Monotherapy Administered|0
1802313|NCT00518115|6267063|P10|Overall Study|Different Monotherapy Diabetic Drug|0
1802314|NCT00518115|6267064|P9|Overall Study|Different Monotherapy Diabetic Drug|1
1802315|NCT00518115|6267065|P8|Overall Study|Different Monotherapy Diabetic Drug|0
1802316|NCT00518115|6267066|P7|Overall Study|Different Monotherapy Diabetic Drug|0
1802317|NCT00518115|6267067|P6|Overall Study|Different Monotherapy Diabetic Drug|0
1802318|NCT00518115|6267068|P5|Overall Study|Different Monotherapy Diabetic Drug|0
1802319|NCT00518115|6267069|P4|Overall Study|Different Monotherapy Diabetic Drug|0
1802320|NCT00518115|6267070|P3|Overall Study|Different Monotherapy Diabetic Drug|1
1802321|NCT00518115|6267071|P2|Overall Study|Different Monotherapy Diabetic Drug|0
1802322|NCT00518115|6267072|P1|Overall Study|Different Monotherapy Diabetic Drug|0
1802323|NCT00518115|6267063|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802324|NCT00518115|6267064|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802325|NCT00518115|6267065|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802326|NCT00518115|6267066|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802327|NCT00518115|6267067|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802328|NCT00518115|6267068|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802329|NCT00518115|6267069|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802330|NCT00518115|6267070|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802331|NCT00518115|6267071|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
1802332|NCT00518115|6267072|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
1802333|NCT00518115|6267063|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
1802334|NCT00518115|6267064|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
1802335|NCT00518115|6267065|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
1802336|NCT00518115|6267066|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
1802337|NCT00518115|6267067|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
1802338|NCT00518115|6267068|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
1802339|NCT00518115|6267069|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
1802340|NCT00518115|6267070|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
1802341|NCT00518115|6267071|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
1802342|NCT00518115|6267072|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
1802343|NCT00518115|6267063|P10|Overall Study|Non-Compliance|1
1802344|NCT00518115|6267064|P9|Overall Study|Non-Compliance|0
1802345|NCT00518115|6267065|P8|Overall Study|Non-Compliance|1
1802346|NCT00518115|6267066|P7|Overall Study|Non-Compliance|1
1802347|NCT00518115|6267067|P6|Overall Study|Non-Compliance|1
1802348|NCT00518115|6267068|P5|Overall Study|Non-Compliance|1
1802349|NCT00518115|6267069|P4|Overall Study|Non-Compliance|0
1802350|NCT00518115|6267070|P3|Overall Study|Non-Compliance|1
1802351|NCT00518115|6267071|P2|Overall Study|Non-Compliance|0
1802352|NCT00518115|6267072|P1|Overall Study|Non-Compliance|1
1802353|NCT00518115|6267063|P10|Overall Study|Lack of Efficacy|0
1802354|NCT00518115|6267064|P9|Overall Study|Lack of Efficacy|0
1802355|NCT00518115|6267065|P8|Overall Study|Lack of Efficacy|1
1802356|NCT00518115|6267066|P7|Overall Study|Lack of Efficacy|0
1802357|NCT00518115|6267067|P6|Overall Study|Lack of Efficacy|0
1802358|NCT00518115|6267068|P5|Overall Study|Lack of Efficacy|0
1802359|NCT00518115|6267069|P4|Overall Study|Lack of Efficacy|1
1802360|NCT00518115|6267070|P3|Overall Study|Lack of Efficacy|1
1802361|NCT00518115|6267071|P2|Overall Study|Lack of Efficacy|0
1802362|NCT00518115|6267072|P1|Overall Study|Lack of Efficacy|1
1802363|NCT00518115|6267063|P10|Overall Study|Withdrawal by Subject|3
1802364|NCT00518115|6267064|P9|Overall Study|Withdrawal by Subject|1
1802365|NCT00518115|6267065|P8|Overall Study|Withdrawal by Subject|2
1802366|NCT00518115|6267066|P7|Overall Study|Withdrawal by Subject|0
1802367|NCT00518115|6267067|P6|Overall Study|Withdrawal by Subject|1
1802368|NCT00518115|6267068|P5|Overall Study|Withdrawal by Subject|2
1802369|NCT00518115|6267069|P4|Overall Study|Withdrawal by Subject|0
1802370|NCT00518115|6267070|P3|Overall Study|Withdrawal by Subject|5
1802371|NCT00518115|6267071|P2|Overall Study|Withdrawal by Subject|1
1802372|NCT00518115|6267072|P1|Overall Study|Withdrawal by Subject|1
1802373|NCT00518115|6267063|P10|Overall Study|Protocol Violation|0
1802374|NCT00518115|6267064|P9|Overall Study|Protocol Violation|0
1802375|NCT00518115|6267065|P8|Overall Study|Protocol Violation|0
1802376|NCT00518115|6267066|P7|Overall Study|Protocol Violation|0
1802377|NCT00518115|6267067|P6|Overall Study|Protocol Violation|0
1802378|NCT00518115|6267068|P5|Overall Study|Protocol Violation|0
1802379|NCT00518115|6267069|P4|Overall Study|Protocol Violation|0
1802380|NCT00518115|6267070|P3|Overall Study|Protocol Violation|1
1802381|NCT00518115|6267071|P2|Overall Study|Protocol Violation|3
1802382|NCT00518115|6267072|P1|Overall Study|Protocol Violation|1
1802383|NCT00518115|6267063|P10|Overall Study|Lost to Follow-up|1
1802384|NCT00518115|6267064|P9|Overall Study|Lost to Follow-up|1
1802385|NCT00518115|6267065|P8|Overall Study|Lost to Follow-up|1
1802386|NCT00518115|6267066|P7|Overall Study|Lost to Follow-up|0
1802387|NCT00518115|6267067|P6|Overall Study|Lost to Follow-up|3
1802388|NCT00518115|6267068|P5|Overall Study|Lost to Follow-up|1
1802389|NCT00518115|6267069|P4|Overall Study|Lost to Follow-up|3
1802390|NCT00518115|6267070|P3|Overall Study|Lost to Follow-up|2
1802391|NCT00518115|6267071|P2|Overall Study|Lost to Follow-up|0
1802392|NCT00518115|6267072|P1|Overall Study|Lost to Follow-up|0
1802393|NCT00518115|6267063|P10|Overall Study|Adverse Event|9
1802394|NCT00518115|6267064|P9|Overall Study|Adverse Event|2
1802395|NCT00518115|6267065|P8|Overall Study|Adverse Event|10
1802396|NCT00518115|6267066|P7|Overall Study|Adverse Event|5
1802397|NCT00518115|6267067|P6|Overall Study|Adverse Event|5
1802398|NCT00518115|6267068|P5|Overall Study|Adverse Event|5
1802399|NCT00518115|6267069|P4|Overall Study|Adverse Event|6
1802400|NCT00518115|6267070|P3|Overall Study|Adverse Event|5
1802401|NCT00518115|6267071|P2|Overall Study|Adverse Event|1
1802402|NCT00518115|6267072|P1|Overall Study|Adverse Event|6
1802403|NCT00518011|6267247|P2|Overall Study|Withdrawal by Subject|0
1802404|NCT00518011|6267248|P1|Overall Study|Withdrawal by Subject|1
1802405|NCT00518011|6267247|P2|Overall Study|Other Reasons|2
1802406|NCT00518011|6267248|P1|Overall Study|Other Reasons|3
1802407|NCT00518011|6267247|P2|Overall Study|Disease Progression|2
1802408|NCT00518011|6267248|P1|Overall Study|Disease Progression|2
1802409|NCT00518011|6267247|P2|Overall Study|Adverse Event|3
1802410|NCT00518011|6267248|P1|Overall Study|Adverse Event|2
1802411|NCT00518011|6267247|P2|Overall Study|Death|1
1802412|NCT00518011|6267248|P1|Overall Study|Death|1
1802413|NCT00517933|6267270|P2|Period 2|Underwent lung transplant|2
1802414|NCT00517933|6267271|P1|Period 2|Underwent lung transplant|0
1802415|NCT00517933|6267270|P2|Period 2|Withdrawal by Subject|3
1802416|NCT00517933|6267271|P1|Period 2|Withdrawal by Subject|1
1802417|NCT00517933|6267270|P2|Period 2|Physician Decision|0
1802418|NCT00517933|6267271|P1|Period 2|Physician Decision|1
1802419|NCT00517933|6267270|P2|Period 2|Adverse Event|4
1802420|NCT00517933|6267271|P1|Period 2|Adverse Event|2
1802421|NCT00517933|6267270|P2|Period 2|Death|4
1802422|NCT00517933|6267271|P1|Period 2|Death|2
1802423|NCT00517933|6267270|P2|Period 1|Underwent lung transplant|1
1802424|NCT00517933|6267271|P1|Period 1|Underwent lung transplant|0
1802425|NCT00517933|6267270|P2|Period 1|Lost to Follow-up|0
1802426|NCT00517933|6267271|P1|Period 1|Lost to Follow-up|2
1802427|NCT00517933|6267270|P2|Period 1|Adverse Event|4
1802428|NCT00517933|6267271|P1|Period 1|Adverse Event|4
1802429|NCT00517933|6267270|P2|Period 1|Death|1
1802430|NCT00517933|6267271|P1|Period 1|Death|2
1802431|NCT00517881|6267335|P1|Overall Study|Renal transplantation|2
1802432|NCT00517881|6267335|P1|Overall Study|Adverse Event|1
1802433|NCT00517881|6267335|P1|Overall Study|Protocol Violation|2
1802434|NCT00517829|6267347|P2|Overall Study|Other|1
1802435|NCT00517829|6267348|P1|Overall Study|Other|3
1802436|NCT00517829|6267347|P2|Overall Study|Investigator Request|3
1802437|NCT00517829|6267348|P1|Overall Study|Investigator Request|5
1802438|NCT00517829|6267347|P2|Overall Study|Patient Request|5
1802439|NCT00517829|6267348|P1|Overall Study|Patient Request|6
1802440|NCT00517829|6267347|P2|Overall Study|Disease Progression|32
1802441|NCT00517829|6267348|P1|Overall Study|Disease Progression|39
1802442|NCT00517829|6267347|P2|Overall Study|Adverse Event|34
1802443|NCT00517829|6267348|P1|Overall Study|Adverse Event|22
1802444|NCT00517751|6267362|P1|Overall Study|Missing|3
1802445|NCT00517751|6267362|P1|Overall Study|Patient not due for visit|76
1802446|NCT00517751|6267362|P1|Overall Study|patient not over due|6
1802447|NCT00517751|6267362|P1|Overall Study|Lost to Follow-up|4
1802448|NCT00517751|6267362|P1|Overall Study|Withdrawal by Subject|37
1802449|NCT00517751|6267362|P1|Overall Study|Death|3
1802450|NCT00517699|6267385|P1|Overall Study|Study terminated by Sponsor|2
1802451|NCT00517699|6267385|P1|Overall Study|Administrative error|1
1802452|NCT00517699|6267385|P1|Overall Study|Lack of Efficacy|1
1802453|NCT00517699|6267385|P1|Overall Study|Withdrawal by Subject|1
1802454|NCT00517634|6267393|P6|Second Treatment Period|Withdrawal by Subject|0
1802455|NCT00517634|6267394|P5|Second Treatment Period|Withdrawal by Subject|1
1802456|NCT00517634|6267395|P4|Second Treatment Period|Withdrawal by Subject|0
1802457|NCT00517634|6267396|P3|Second Treatment Period|Withdrawal by Subject|0
1802458|NCT00517634|6267397|P2|Second Treatment Period|Withdrawal by Subject|0
1802459|NCT00517634|6267398|P1|Second Treatment Period|Withdrawal by Subject|0
1802460|NCT00517413|6267500|P1|Overall Study|Other-Reasons|23
1802461|NCT00517413|6267500|P1|Overall Study|Failure to return|1
1802462|NCT00517413|6267500|P1|Overall Study|Withdrawal by Subject|2
1802463|NCT00517413|6267500|P1|Overall Study|Protocol Violation|15
1802464|NCT00517413|6267500|P1|Overall Study|Death|13
1802465|NCT00517413|6267500|P1|Overall Study|Adverse Event|7
1802466|NCT00517361|6267521|P1|Overall Study|The study was terminated|5
1802467|NCT00517361|6267521|P1|Overall Study|Death|6
1802468|NCT00517296|6267530|P2|Overall Study|Withdrawal by Subject|0
1802469|NCT00517296|6267531|P1|Overall Study|Withdrawal by Subject|1
1802470|NCT00517192|6267543|P2|Overall Study|Early termination of the trial|18
1802471|NCT00517192|6267544|P1|Overall Study|Early termination of the trial|16
1802472|NCT00517192|6267543|P2|Overall Study|Withdrawal by Subject|0
1802473|NCT00517192|6267544|P1|Overall Study|Withdrawal by Subject|1
1802474|NCT00517192|6267543|P2|Overall Study|Lost to Follow-up|1
1802475|NCT00517192|6267544|P1|Overall Study|Lost to Follow-up|1
1802476|NCT00517192|6267543|P2|Overall Study|Adverse Event|1
1802477|NCT00517192|6267544|P1|Overall Study|Adverse Event|1
1802478|NCT00516906|6267651|P2|Overall Study|Final Dressing Removal Data not captured|2
1802479|NCT00516906|6267652|P1|Overall Study|Final Dressing Removal Data not captured|6
1802480|NCT00516893|6267662|P1|Overall Study|Received Medication From Another Study|1
1802481|NCT00516893|6267662|P1|Overall Study|Pregnancy|1
1802482|NCT00516893|6267662|P1|Overall Study|Relocated|1
1802483|NCT00516893|6267662|P1|Overall Study|Persistent Antibodies per Protocol|6
1802484|NCT00516893|6267662|P1|Overall Study|Death|1
1802485|NCT00516893|6267662|P1|Overall Study|Noncompliance|2
1802486|NCT00516893|6267662|P1|Overall Study|Withdrawal by Subject|2
1802487|NCT00516893|6267662|P1|Overall Study|Adverse Event|3
1802488|NCT00516893|6267662|P1|Overall Study|Lost to Follow-up|4
1802489|NCT00516737|6267671|P2|Overall Study|Lack of Qualifying Event|6
1802490|NCT00516737|6267672|P1|Overall Study|Lack of Qualifying Event|9
1802491|NCT00516737|6267671|P2|Overall Study|Withdrawal by Subject|1
1802492|NCT00516737|6267672|P1|Overall Study|Withdrawal by Subject|0
1802493|NCT00516737|6267671|P2|Overall Study|Physician Decision|1
1802494|NCT00516737|6267672|P1|Overall Study|Physician Decision|0
1802495|NCT00516737|6267671|P2|Overall Study|Lost to Follow-up|0
1802496|NCT00516737|6267672|P1|Overall Study|Lost to Follow-up|2
1802497|NCT00516386|6267711|P1|Overall Study|Lost to Follow-up|2
1802498|NCT00516386|6267711|P1|Overall Study|not interested in the study|4
1802499|NCT00516321|6267718|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
1802500|NCT00516321|6267719|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
1802501|NCT00516321|6267720|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
1802502|NCT00516321|6267718|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
1802503|NCT00516321|6267719|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
1802504|NCT00516321|6267720|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
1802505|NCT00516321|6267718|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
1802506|NCT00516321|6267719|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
1802507|NCT00516321|6267720|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
1802508|NCT00516321|6267718|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
1802509|NCT00516321|6267719|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
1802510|NCT00516321|6267720|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
1802511|NCT00516321|6267718|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
1802512|NCT00516321|6267719|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
1802513|NCT00516321|6267720|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
1802514|NCT00516321|6267718|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
1802515|NCT00516321|6267719|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
1802516|NCT00516321|6267720|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
1802517|NCT00516321|6267718|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
1802518|NCT00516321|6267719|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
1802519|NCT00516321|6267720|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
1802520|NCT00516321|6267718|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
1802521|NCT00516321|6267719|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
1802522|NCT00516321|6267720|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
1802523|NCT00516321|6267718|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
1802524|NCT00516321|6267719|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
1802525|NCT00516321|6267720|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
1802526|NCT00516321|6267718|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
1802527|NCT00516321|6267719|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
1802528|NCT00516321|6267720|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
1802529|NCT00516321|6267718|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
1802530|NCT00516321|6267719|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
1802531|NCT00516321|6267720|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
1802532|NCT00516295|6267771|P3|Overall Study|Ineligible|0
1802533|NCT00516295|6267772|P2|Overall Study|Ineligible|0
1802534|NCT00516295|6267773|P1|Overall Study|Ineligible|1
1802535|NCT00516295|6267771|P3|Overall Study|Lack of Efficacy|0
1802536|NCT00516295|6267772|P2|Overall Study|Lack of Efficacy|0
1802537|NCT00516295|6267773|P1|Overall Study|Lack of Efficacy|2
1802538|NCT00516269|6267786|P2|Overall Study|Protocol Violation|1
1802539|NCT00516269|6267787|P1|Overall Study|Protocol Violation|0
1802540|NCT00516269|6267786|P2|Overall Study|Lost to Follow-up|1
1802541|NCT00516269|6267787|P1|Overall Study|Lost to Follow-up|0
1802542|NCT00516269|6267786|P2|Overall Study|Adverse Event|1
1802543|NCT00516269|6267787|P1|Overall Study|Adverse Event|2
1802544|NCT00516139|6267808|P1|Overall Study|Lack of Efficacy|1
1802545|NCT00516139|6267808|P1|Overall Study|Withdrawal by Subject|8
1802546|NCT00516139|6267808|P1|Overall Study|Protocol Violation|1
1802547|NCT00516139|6267808|P1|Overall Study|Lost to Follow-up|1
1802548|NCT00516139|6267808|P1|Overall Study|Adverse Event|27
1802549|NCT00516074|6267839|P2|Overall Study|Loss of Glucose Control|0
1802550|NCT00516074|6267840|P1|Overall Study|Loss of Glucose Control|2
1802551|NCT00516074|6267839|P2|Overall Study|Subject Decision|2
1802552|NCT00516074|6267840|P1|Overall Study|Subject Decision|4
1802553|NCT00516074|6267839|P2|Overall Study|Adverse Event|1
1802554|NCT00516074|6267840|P1|Overall Study|Adverse Event|0
1802555|NCT00516048|6267858|P3|Overall Study|Subject Decision|0
1802556|NCT00516048|6267859|P2|Overall Study|Subject Decision|2
1802557|NCT00516048|6267860|P1|Overall Study|Subject Decision|0
1802558|NCT00516048|6267858|P3|Overall Study|Death|1
1802559|NCT00516048|6267859|P2|Overall Study|Death|0
1802560|NCT00516048|6267860|P1|Overall Study|Death|0
1802561|NCT00515827|6267895|P2|Second Intervention (12 Weeks)|Consent withdraw|0
1802562|NCT00515827|6267896|P1|Second Intervention (12 Weeks)|Consent withdraw|1
1802563|NCT00515827|6267895|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
1802564|NCT00515827|6267896|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
1802565|NCT00515671|6267954|P2|Overall Study|incarcerated|2
1802566|NCT00515671|6267955|P1|Overall Study|incarcerated|1
1802567|NCT00515671|6267954|P2|Overall Study|Withdrawal by Subject|5
1802568|NCT00515671|6267955|P1|Overall Study|Withdrawal by Subject|3
1802569|NCT00515671|6267954|P2|Overall Study|Lost to Follow-up|10
1802570|NCT00515671|6267955|P1|Overall Study|Lost to Follow-up|13
1802571|NCT00515619|6267963|P1|Overall Study|Other: Subject interested in other AED|1
1802572|NCT00515619|6267963|P1|Overall Study|Other: Drug available on license|1
1802573|NCT00515619|6267963|P1|Overall Study|Other: Request from sponsor|1
1802574|NCT00515619|6267963|P1|Overall Study|Other: Subject became pregnant|1
1802575|NCT00515619|6267963|P1|Overall Study|Other: Investigator decision|1
1802576|NCT00515619|6267963|P1|Overall Study|Other: Subject moved to another country|1
1802577|NCT00515619|6267963|P1|Overall Study|Other: Subject required surgery|1
1802578|NCT00515619|6267963|P1|Overall Study|Other: Subject cannot attend visits|2
1802579|NCT00515619|6267963|P1|Overall Study|Other: Site discontinuing trials|2
1802580|NCT00515619|6267963|P1|Overall Study|Unsatisfactory compliance|6
1802581|NCT00515619|6267963|P1|Overall Study|Lost to Follow-up|4
1802582|NCT00515619|6267963|P1|Overall Study|Protocol Violation|3
1802583|NCT00515619|6267963|P1|Overall Study|Withdrawal by Subject|66
1802584|NCT00515619|6267963|P1|Overall Study|Lack of Efficacy|92
1802585|NCT00515619|6267963|P1|Overall Study|Adverse Event|34
1802586|NCT00515541|6267975|P4|Overall Study|Withdrawal by Subject|2
1802587|NCT00515541|6267976|P3|Overall Study|Withdrawal by Subject|0
1802588|NCT00515541|6267977|P2|Overall Study|Withdrawal by Subject|2
1802589|NCT00515541|6267978|P1|Overall Study|Withdrawal by Subject|0
1802590|NCT00515541|6267975|P4|Overall Study|No show for appointments|2
1802591|NCT00515541|6267976|P3|Overall Study|No show for appointments|0
1802592|NCT00515541|6267977|P2|Overall Study|No show for appointments|1
1802593|NCT00515541|6267978|P1|Overall Study|No show for appointments|0
1802594|NCT00515541|6267975|P4|Overall Study|Physician Decision|1
1802595|NCT00515541|6267976|P3|Overall Study|Physician Decision|0
1802596|NCT00515541|6267977|P2|Overall Study|Physician Decision|2
1802597|NCT00515541|6267978|P1|Overall Study|Physician Decision|0
1802598|NCT00515502|6268000|P12|Treatment Period 2|Adverse Event|0
1802599|NCT00515502|6268001|P11|Treatment Period 2|Adverse Event|0
1802600|NCT00515502|6268002|P10|Treatment Period 2|Adverse Event|0
1802601|NCT00515502|6268003|P9|Treatment Period 2|Adverse Event|0
1802602|NCT00515502|6268004|P8|Treatment Period 2|Adverse Event|0
1802603|NCT00515502|6268005|P7|Treatment Period 2|Adverse Event|0
1802604|NCT00515502|6268006|P6|Treatment Period 2|Adverse Event|0
1802605|NCT00515502|6268007|P5|Treatment Period 2|Adverse Event|0
1802606|NCT00515502|6268008|P4|Treatment Period 2|Adverse Event|0
1802607|NCT00515502|6268009|P3|Treatment Period 2|Adverse Event|0
1802608|NCT00515502|6268010|P2|Treatment Period 2|Adverse Event|1
1802609|NCT00515502|6268011|P1|Treatment Period 2|Adverse Event|0
1802610|NCT00515502|6268000|P12|Treatment Period 1|Adverse Event|1
1802611|NCT00515502|6268001|P11|Treatment Period 1|Adverse Event|0
1802612|NCT00515502|6268002|P10|Treatment Period 1|Adverse Event|0
1802613|NCT00515502|6268003|P9|Treatment Period 1|Adverse Event|1
1802614|NCT00515502|6268004|P8|Treatment Period 1|Adverse Event|0
1802615|NCT00515502|6268005|P7|Treatment Period 1|Adverse Event|1
1802616|NCT00515502|6268006|P6|Treatment Period 1|Adverse Event|0
1802617|NCT00515502|6268007|P5|Treatment Period 1|Adverse Event|0
1802618|NCT00515502|6268008|P4|Treatment Period 1|Adverse Event|0
1802619|NCT00515502|6268009|P3|Treatment Period 1|Adverse Event|0
1802620|NCT00515502|6268010|P2|Treatment Period 1|Adverse Event|0
1802621|NCT00515502|6268011|P1|Treatment Period 1|Adverse Event|0
1802622|NCT00515463|6268171|P2|Overall Study|Other|1
1802623|NCT00515463|6268172|P1|Overall Study|Other|0
1802624|NCT00515463|6268171|P2|Overall Study|Lost to Follow-up|5
1802625|NCT00515463|6268172|P1|Overall Study|Lost to Follow-up|6
1802626|NCT00515463|6268171|P2|Overall Study|Withdrawal by Subject|4
1802627|NCT00515463|6268172|P1|Overall Study|Withdrawal by Subject|3
1802628|NCT00515463|6268171|P2|Overall Study|Adverse Event|2
1802629|NCT00515463|6268172|P1|Overall Study|Adverse Event|1
1802630|NCT00515463|6268171|P2|Overall Study|Physician Decision|2
1802631|NCT00515463|6268172|P1|Overall Study|Physician Decision|4
1802632|NCT00515294|6268371|P4|Overall Study|Caffeine amount inaccurate|0
1802633|NCT00515294|6268372|P3|Overall Study|Caffeine amount inaccurate|7
1802634|NCT00515294|6268373|P2|Overall Study|Caffeine amount inaccurate|0
1802635|NCT00515294|6268374|P1|Overall Study|Caffeine amount inaccurate|5
1802636|NCT00515294|6268371|P4|Overall Study|Driver simulator problems|3
1802637|NCT00515294|6268372|P3|Overall Study|Driver simulator problems|1
1802638|NCT00515294|6268373|P2|Overall Study|Driver simulator problems|1
1802639|NCT00515294|6268374|P1|Overall Study|Driver simulator problems|1
1802640|NCT00515294|6268371|P4|Overall Study|Lost to Follow-up|1
1802641|NCT00515294|6268372|P3|Overall Study|Lost to Follow-up|3
1802642|NCT00515294|6268373|P2|Overall Study|Lost to Follow-up|2
1802643|NCT00515294|6268374|P1|Overall Study|Lost to Follow-up|3
1802644|NCT00515216|6268388|P1|Overall Study|Withdrawal by Subject|1
1802645|NCT00515112|6268450|P2|Overall Study|The study was terminated|2
1802646|NCT00515112|6268451|P1|Overall Study|The study was terminated|3
1802647|NCT00515112|6268450|P2|Overall Study|Death|1
1802648|NCT00515112|6268451|P1|Overall Study|Death|0
1802649|NCT00515099|6268461|P2|Overall Study|IRB Recommendation|0
1802650|NCT00515099|6268462|P1|Overall Study|IRB Recommendation|1
1802651|NCT00515099|6268461|P2|Overall Study|Withdrawal by Subject|0
1802652|NCT00515099|6268462|P1|Overall Study|Withdrawal by Subject|2
1802653|NCT00515099|6268461|P2|Overall Study|Lost to Follow-up|4
1802654|NCT00515099|6268462|P1|Overall Study|Lost to Follow-up|0
1802655|NCT00515086|6268484|P4|Overall Study|Death|0
1802656|NCT00515086|6268485|P3|Overall Study|Death|0
1802657|NCT00515086|6268486|P2|Overall Study|Death|0
1802658|NCT00515086|6268487|P1|Overall Study|Death|2
1802659|NCT00515086|6268484|P4|Overall Study|Study drug no longer required|0
1802660|NCT00515086|6268485|P3|Overall Study|Study drug no longer required|0
1802661|NCT00515086|6268486|P2|Overall Study|Study drug no longer required|1
1802662|NCT00515086|6268487|P1|Overall Study|Study drug no longer required|0
1802663|NCT00515086|6268484|P4|Overall Study|Lost to Follow-up|0
1802664|NCT00515086|6268485|P3|Overall Study|Lost to Follow-up|0
1802665|NCT00515086|6268486|P2|Overall Study|Lost to Follow-up|0
1802666|NCT00515086|6268487|P1|Overall Study|Lost to Follow-up|1
1802667|NCT00515086|6268484|P4|Overall Study|Unsatisfactory therapeutic effect|2
1802668|NCT00515086|6268485|P3|Overall Study|Unsatisfactory therapeutic effect|3
1802669|NCT00515086|6268486|P2|Overall Study|Unsatisfactory therapeutic effect|3
1802670|NCT00515086|6268487|P1|Overall Study|Unsatisfactory therapeutic effect|18
1802671|NCT00515086|6268484|P4|Overall Study|Withdrawal by Subject|1
1802672|NCT00515086|6268485|P3|Overall Study|Withdrawal by Subject|0
1802673|NCT00515086|6268486|P2|Overall Study|Withdrawal by Subject|0
1802674|NCT00515086|6268487|P1|Overall Study|Withdrawal by Subject|1
1802675|NCT00515086|6268484|P4|Overall Study|Administrative|0
1802676|NCT00515086|6268485|P3|Overall Study|Administrative|0
1802677|NCT00515086|6268486|P2|Overall Study|Administrative|1
1802678|NCT00515086|6268487|P1|Overall Study|Administrative|1
1802679|NCT00515086|6268484|P4|Overall Study|Adverse Event|3
1802680|NCT00515086|6268485|P3|Overall Study|Adverse Event|2
1802681|NCT00515086|6268486|P2|Overall Study|Adverse Event|1
1802682|NCT00515086|6268487|P1|Overall Study|Adverse Event|1
1802683|NCT00515073|6268514|P1|Overall Study|Physician Decision|1
1802684|NCT00515073|6268514|P1|Overall Study|Withdrawal by Subject|1
1802685|NCT00515034|6268522|P4|Overall Study|Other|1
1802686|NCT00515034|6268523|P3|Overall Study|Other|2
1802687|NCT00515034|6268524|P2|Overall Study|Other|0
1802688|NCT00515034|6268525|P1|Overall Study|Other|1
1802689|NCT00515034|6268522|P4|Overall Study|Physician Decision|1
1802690|NCT00515034|6268523|P3|Overall Study|Physician Decision|1
1802691|NCT00515034|6268524|P2|Overall Study|Physician Decision|0
1802692|NCT00515034|6268525|P1|Overall Study|Physician Decision|0
1802693|NCT00515034|6268522|P4|Overall Study|Withdrawal by Subject|0
1802694|NCT00515034|6268523|P3|Overall Study|Withdrawal by Subject|3
1802695|NCT00515034|6268524|P2|Overall Study|Withdrawal by Subject|0
1802696|NCT00515034|6268525|P1|Overall Study|Withdrawal by Subject|1
1802697|NCT00515034|6268522|P4|Overall Study|Death|3
1802698|NCT00515034|6268523|P3|Overall Study|Death|1
1802699|NCT00515034|6268524|P2|Overall Study|Death|2
1802700|NCT00515034|6268525|P1|Overall Study|Death|4
1802701|NCT00515034|6268522|P4|Overall Study|Adverse Event|0
1802702|NCT00515034|6268523|P3|Overall Study|Adverse Event|1
1802703|NCT00515034|6268524|P2|Overall Study|Adverse Event|0
1802704|NCT00515034|6268525|P1|Overall Study|Adverse Event|2
1802705|NCT00515008|6268556|P2|Overall Study|Scheduling conflict|0
1802706|NCT00515008|6268557|P1|Overall Study|Scheduling conflict|1
1802707|NCT00515008|6268556|P2|Overall Study|Left the Boston Area|1
1802708|NCT00515008|6268557|P1|Overall Study|Left the Boston Area|1
1802709|NCT00515008|6268556|P2|Overall Study|Declined|3
1802710|NCT00515008|6268557|P1|Overall Study|Declined|0
1802711|NCT00515008|6268556|P2|Overall Study|Lost to Follow-up|0
1802712|NCT00515008|6268557|P1|Overall Study|Lost to Follow-up|1
1802713|NCT00514943|6268581|P2|Stage 2|Other than stated above|2
1802714|NCT00514943|6268582|P1|Stage 2|Other than stated above|0
1802715|NCT00514943|6268581|P2|Stage 2|Patient refused to continue study meds|0
1802716|NCT00514943|6268582|P1|Stage 2|Patient refused to continue study meds|2
1802717|NCT00514943|6268581|P2|Stage 2|Other Adverse Event|10
1802718|NCT00514943|6268582|P1|Stage 2|Other Adverse Event|3
1802719|NCT00514943|6268581|P2|Stage 2|Progressive disease|24
1802720|NCT00514943|6268582|P1|Stage 2|Progressive disease|27
1802721|NCT00514943|6268581|P2|Stage 1|Other than stated above|7
1802722|NCT00514943|6268582|P1|Stage 1|Other than stated above|1
1802723|NCT00514943|6268581|P2|Stage 1|Patient refused to continue study meds|3
1802724|NCT00514943|6268582|P1|Stage 1|Patient refused to continue study meds|8
1802725|NCT00514943|6268581|P2|Stage 1|Not treated|2
1802726|NCT00514943|6268582|P1|Stage 1|Not treated|1
1802727|NCT00514943|6268581|P2|Stage 1|Other Adverse Event|6
1802728|NCT00514943|6268582|P1|Stage 1|Other Adverse Event|16
1802729|NCT00514943|6268581|P2|Stage 1|Progressive disease|8
1802730|NCT00514943|6268582|P1|Stage 1|Progressive disease|4
1802731|NCT00514917|6268640|P2|Overall Study|Undefined|5
1802732|NCT00514917|6268641|P1|Overall Study|Undefined|11
1802733|NCT00514917|6268640|P2|Overall Study|Discontinued due to study closure|81
1802734|NCT00514917|6268641|P1|Overall Study|Discontinued due to study closure|88
1802735|NCT00514917|6268640|P2|Overall Study|Withdrawal by Subject|16
1802736|NCT00514917|6268641|P1|Overall Study|Withdrawal by Subject|18
1802737|NCT00514917|6268640|P2|Overall Study|Lost to Follow-up|3
1802738|NCT00514917|6268641|P1|Overall Study|Lost to Follow-up|4
1802739|NCT00514917|6268640|P2|Overall Study|Protocol Violation|0
1802740|NCT00514917|6268641|P1|Overall Study|Protocol Violation|1
1802741|NCT00514917|6268640|P2|Overall Study|Death|10
1802742|NCT00514917|6268641|P1|Overall Study|Death|4
1802743|NCT00514904|6268669|P2|Overall Study|Lost to Follow-up|3
1802744|NCT00514904|6268670|P1|Overall Study|Lost to Follow-up|21
1802745|NCT00514904|6268669|P2|Overall Study|Withdrawal by Subject|2
1802746|NCT00514904|6268670|P1|Overall Study|Withdrawal by Subject|3
1802747|NCT00514813|6268735|P4|Overall Study|Death|2
1802748|NCT00514813|6268736|P3|Overall Study|Death|3
1802749|NCT00514813|6268737|P2|Overall Study|Death|2
1802750|NCT00514813|6268738|P1|Overall Study|Death|0
1802751|NCT00514813|6268735|P4|Overall Study|Kidney transplant|0
1802752|NCT00514813|6268736|P3|Overall Study|Kidney transplant|2
1802753|NCT00514813|6268737|P2|Overall Study|Kidney transplant|6
1802754|NCT00514813|6268738|P1|Overall Study|Kidney transplant|0
1802755|NCT00514813|6268735|P4|Overall Study|Lack of Efficacy|0
1802756|NCT00514813|6268736|P3|Overall Study|Lack of Efficacy|0
1802757|NCT00514813|6268737|P2|Overall Study|Lack of Efficacy|1
1802758|NCT00514813|6268738|P1|Overall Study|Lack of Efficacy|0
1802759|NCT00514813|6268735|P4|Overall Study|Withdrawal by Subject|0
1802760|NCT00514813|6268736|P3|Overall Study|Withdrawal by Subject|0
1802761|NCT00514813|6268737|P2|Overall Study|Withdrawal by Subject|1
1802762|NCT00514813|6268738|P1|Overall Study|Withdrawal by Subject|0
1802763|NCT00514813|6268735|P4|Overall Study|Protocol Violation|0
1802764|NCT00514813|6268736|P3|Overall Study|Protocol Violation|0
1802765|NCT00514813|6268737|P2|Overall Study|Protocol Violation|0
1802766|NCT00514813|6268738|P1|Overall Study|Protocol Violation|1
1802767|NCT00514813|6268735|P4|Overall Study|Adverse Event|0
1802768|NCT00514813|6268736|P3|Overall Study|Adverse Event|2
1802769|NCT00514813|6268737|P2|Overall Study|Adverse Event|2
1802770|NCT00514813|6268738|P1|Overall Study|Adverse Event|0
1802771|NCT00514813|6268735|P4|Overall Study|Study terminated|2
1802772|NCT00514813|6268736|P3|Overall Study|Study terminated|40
1802773|NCT00514813|6268737|P2|Overall Study|Study terminated|74
1802774|NCT00514813|6268738|P1|Overall Study|Study terminated|14
1802775|NCT00514735|6268758|P2|Overall Study|Lost to Follow-up|1
1802776|NCT00514735|6268759|P1|Overall Study|Lost to Follow-up|0
1802777|NCT00514735|6268758|P2|Overall Study|Death|0
1802778|NCT00514735|6268759|P1|Overall Study|Death|1
1802779|NCT00514735|6268758|P2|Overall Study|Withdrawal by Subject|5
1802780|NCT00514735|6268759|P1|Overall Study|Withdrawal by Subject|13
1802781|NCT00514683|6268795|P5|Overall Study|Reason other than listed above|1
1802782|NCT00514683|6268796|P4|Overall Study|Reason other than listed above|0
1802783|NCT00514683|6268797|P3|Overall Study|Reason other than listed above|2
1802784|NCT00514683|6268798|P2|Overall Study|Reason other than listed above|1
1802785|NCT00514683|6268799|P1|Overall Study|Reason other than listed above|0
1802786|NCT00514683|6268795|P5|Overall Study|Withdrawal by Subject|4
1802787|NCT00514683|6268796|P4|Overall Study|Withdrawal by Subject|0
1802788|NCT00514683|6268797|P3|Overall Study|Withdrawal by Subject|1
1802789|NCT00514683|6268798|P2|Overall Study|Withdrawal by Subject|2
1802790|NCT00514683|6268799|P1|Overall Study|Withdrawal by Subject|2
1802791|NCT00514683|6268795|P5|Overall Study|Protocol Violation|0
1802792|NCT00514683|6268796|P4|Overall Study|Protocol Violation|1
1802793|NCT00514683|6268797|P3|Overall Study|Protocol Violation|0
1802794|NCT00514683|6268798|P2|Overall Study|Protocol Violation|1
1802795|NCT00514683|6268799|P1|Overall Study|Protocol Violation|1
1802796|NCT00514683|6268795|P5|Overall Study|Adverse Event|27
1802797|NCT00514683|6268796|P4|Overall Study|Adverse Event|13
1802798|NCT00514683|6268797|P3|Overall Study|Adverse Event|15
1802799|NCT00514683|6268798|P2|Overall Study|Adverse Event|20
1802800|NCT00514683|6268799|P1|Overall Study|Adverse Event|21
1802801|NCT00514683|6268795|P5|Overall Study|Not treated|1
1802802|NCT00514683|6268796|P4|Overall Study|Not treated|0
1802803|NCT00514683|6268797|P3|Overall Study|Not treated|0
1802804|NCT00514683|6268798|P2|Overall Study|Not treated|1
1802805|NCT00514683|6268799|P1|Overall Study|Not treated|2
1802806|NCT00514514|6268998|P3|Extension - 4 Years|Adverse Event|3
1802807|NCT00514514|6268999|P2|Extension - 4 Years|Adverse Event|6
1802808|NCT00514514|6269000|P1|Extension - 4 Years|Adverse Event|9
1802809|NCT00514514|6268998|P3|Extension - 4 Years|Death|6
1802810|NCT00514514|6268999|P2|Extension - 4 Years|Death|3
1802811|NCT00514514|6269000|P1|Extension - 4 Years|Death|8
1802812|NCT00514514|6268998|P3|Extension - 4 Years|Administrative problems|1
1802813|NCT00514514|6268999|P2|Extension - 4 Years|Administrative problems|1
1802814|NCT00514514|6269000|P1|Extension - 4 Years|Administrative problems|3
1802815|NCT00514514|6268998|P3|Extension - 4 Years|Lost to Follow-up|9
1802816|NCT00514514|6268999|P2|Extension - 4 Years|Lost to Follow-up|10
1802817|NCT00514514|6269000|P1|Extension - 4 Years|Lost to Follow-up|12
1802818|NCT00514514|6268998|P3|Extension - 4 Years|Withdrawal by Subject|2
1802819|NCT00514514|6268999|P2|Extension - 4 Years|Withdrawal by Subject|2
1802820|NCT00514514|6269000|P1|Extension - 4 Years|Withdrawal by Subject|5
1802821|NCT00514514|6268998|P3|Randomized - 9 Month|Adverse Event|27
1802822|NCT00514514|6268999|P2|Randomized - 9 Month|Adverse Event|44
1802823|NCT00514514|6269000|P1|Randomized - 9 Month|Adverse Event|25
1802824|NCT00514514|6268998|P3|Randomized - 9 Month|Abnormal laboratory values|1
1802825|NCT00514514|6268999|P2|Randomized - 9 Month|Abnormal laboratory values|3
1802826|NCT00514514|6269000|P1|Randomized - 9 Month|Abnormal laboratory values|0
1802827|NCT00514514|6268998|P3|Randomized - 9 Month|Lack of Efficacy|1
1802828|NCT00514514|6268999|P2|Randomized - 9 Month|Lack of Efficacy|3
1802829|NCT00514514|6269000|P1|Randomized - 9 Month|Lack of Efficacy|2
1802830|NCT00514514|6268998|P3|Randomized - 9 Month|Protocol Violation|0
1802831|NCT00514514|6268999|P2|Randomized - 9 Month|Protocol Violation|1
1802832|NCT00514514|6269000|P1|Randomized - 9 Month|Protocol Violation|1
1802833|NCT00514514|6268998|P3|Randomized - 9 Month|Withdrawal by Subject|5
1802834|NCT00514514|6268999|P2|Randomized - 9 Month|Withdrawal by Subject|7
1802835|NCT00514514|6269000|P1|Randomized - 9 Month|Withdrawal by Subject|7
1802836|NCT00514514|6268998|P3|Randomized - 9 Month|Administrative problems|2
1802837|NCT00514514|6268999|P2|Randomized - 9 Month|Administrative problems|1
1802838|NCT00514514|6269000|P1|Randomized - 9 Month|Administrative problems|1
1802839|NCT00514514|6268998|P3|Randomized - 9 Month|Death|2
1802840|NCT00514514|6268999|P2|Randomized - 9 Month|Death|2
1802841|NCT00514514|6269000|P1|Randomized - 9 Month|Death|3
1802842|NCT00514514|6268998|P3|Pre-phase|Withdrawal by Subject|0
1802843|NCT00514514|6268999|P2|Pre-phase|Withdrawal by Subject|0
1802844|NCT00514514|6269000|P1|Pre-phase|Withdrawal by Subject|66
1802845|NCT00514514|6268998|P3|Pre-phase|Adverse Event|0
1802846|NCT00514514|6268999|P2|Pre-phase|Adverse Event|0
1802847|NCT00514514|6269000|P1|Pre-phase|Adverse Event|137
1802848|NCT00514514|6268998|P3|Pre-phase|Lack of Efficacy|0
1802849|NCT00514514|6268999|P2|Pre-phase|Lack of Efficacy|0
1802850|NCT00514514|6269000|P1|Pre-phase|Lack of Efficacy|35
1802851|NCT00514514|6268998|P3|Pre-phase|abnormal lab values|0
1802852|NCT00514514|6268999|P2|Pre-phase|abnormal lab values|0
1802853|NCT00514514|6269000|P1|Pre-phase|abnormal lab values|23
1802854|NCT00514514|6268998|P3|Pre-phase|Lost to Follow-up|0
1802855|NCT00514514|6268999|P2|Pre-phase|Lost to Follow-up|0
1802856|NCT00514514|6269000|P1|Pre-phase|Lost to Follow-up|2
1802857|NCT00514514|6268998|P3|Pre-phase|abnormal test procedure results|0
1802858|NCT00514514|6268999|P2|Pre-phase|abnormal test procedure results|0
1802859|NCT00514514|6269000|P1|Pre-phase|abnormal test procedure results|15
1802860|NCT00514514|6268998|P3|Pre-phase|condition no longer requires study drug|0
1802861|NCT00514514|6268999|P2|Pre-phase|condition no longer requires study drug|0
1802862|NCT00514514|6269000|P1|Pre-phase|condition no longer requires study drug|7
1802863|NCT00514514|6268998|P3|Pre-phase|Protocol Violation|0
1802864|NCT00514514|6268999|P2|Pre-phase|Protocol Violation|0
1802865|NCT00514514|6269000|P1|Pre-phase|Protocol Violation|6
1802866|NCT00514514|6268998|P3|Pre-phase|administrative problems|0
1802867|NCT00514514|6268999|P2|Pre-phase|administrative problems|0
1802868|NCT00514514|6269000|P1|Pre-phase|administrative problems|2
1802869|NCT00514514|6268998|P3|Pre-phase|Death|0
1802870|NCT00514514|6268999|P2|Pre-phase|Death|0
1802871|NCT00514514|6269000|P1|Pre-phase|Death|10
1802872|NCT00514449|6269052|P2|Overall Study|Lost to Follow-up|0
1802873|NCT00514449|6269053|P1|Overall Study|Lost to Follow-up|1
1802874|NCT00514449|6269052|P2|Overall Study|Protocol Violation|2
1802875|NCT00514449|6269053|P1|Overall Study|Protocol Violation|1
1802876|NCT00514449|6269052|P2|Overall Study|Withdrawal by Subject|2
1802877|NCT00514449|6269053|P1|Overall Study|Withdrawal by Subject|1
1802878|NCT00514020|6269077|P1|Overall Study|"patients moved to the no tx group"|6
1802879|NCT00514020|6269077|P1|Overall Study|patient went to radiation treatment|1
1802880|NCT00514020|6269077|P1|Overall Study|other complicating disease|2
1802881|NCT00514020|6269077|P1|Overall Study|disease progression|9
1802882|NCT00514020|6269077|P1|Overall Study|Physician Decision|1
1802883|NCT00514020|6269077|P1|Overall Study|Withdrawal by Subject|3
1802884|NCT00514020|6269077|P1|Overall Study|Adverse Event|6
1802885|NCT00513708|6269109|P3|Overall Study|Lost to Follow-up|4
1802886|NCT00513708|6269110|P2|Overall Study|Lost to Follow-up|4
1802887|NCT00513708|6269111|P1|Overall Study|Lost to Follow-up|4
1802888|NCT00513695|6269125|P1|Overall Study|Progression prior to surgery|3
1802889|NCT00513695|6269125|P1|Overall Study|Discontinued therapy|2
1802890|NCT00513682|6269134|P1|Washout Phase|Adverse Event|2
1802891|NCT00513604|6269164|P5|Overall Study|Death during treatment|0
1802892|NCT00513604|6269165|P4|Overall Study|Death during treatment|0
1802893|NCT00513604|6269166|P3|Overall Study|Death during treatment|2
1802894|NCT00513604|6269167|P2|Overall Study|Death during treatment|3
1802895|NCT00513604|6269168|P1|Overall Study|Death during treatment|0
1802896|NCT00513604|6269164|P5|Overall Study|Not treated|0
1802897|NCT00513604|6269165|P4|Overall Study|Not treated|0
1802898|NCT00513604|6269166|P3|Overall Study|Not treated|1
1802899|NCT00513604|6269167|P2|Overall Study|Not treated|0
1802900|NCT00513604|6269168|P1|Overall Study|Not treated|2
1802901|NCT00513500|6269202|P2|Overall Study|Hospitalized|14
1802902|NCT00513500|6269203|P1|Overall Study|Hospitalized|4
1802903|NCT00513500|6269202|P2|Overall Study|Death|1
1802904|NCT00513500|6269203|P1|Overall Study|Death|2
1802905|NCT00513500|6269202|P2|Overall Study|Lost to Follow-up|39
1802906|NCT00513500|6269203|P1|Overall Study|Lost to Follow-up|35
1802907|NCT00513474|6269215|P2|Overall Study|Participant Withdrew Consent|0
1802908|NCT00513474|6269216|P1|Overall Study|Participant Withdrew Consent|1
1802909|NCT00513474|6269215|P2|Overall Study|Death|9
1802910|NCT00513474|6269216|P1|Overall Study|Death|6
1802911|NCT00513409|6269272|P2|Overall Study|Visit 3 not done|2
1802912|NCT00513409|6269273|P1|Overall Study|Visit 3 not done|1
1802913|NCT00513409|6269272|P2|Overall Study|Physician Decision|0
1802914|NCT00513409|6269273|P1|Overall Study|Physician Decision|1
1802915|NCT00513409|6269272|P2|Overall Study|Lost to Follow-up|1
1802916|NCT00513409|6269273|P1|Overall Study|Lost to Follow-up|0
1802917|NCT00513409|6269272|P2|Overall Study|Withdrawal by Subject|2
1802918|NCT00513409|6269273|P1|Overall Study|Withdrawal by Subject|0
1802919|NCT00513409|6269272|P2|Overall Study|Adverse Event|1
1802920|NCT00513409|6269273|P1|Overall Study|Adverse Event|0
1802921|NCT00513357|6269329|P2|Overall Study|Disease Progression|1
1802922|NCT00513357|6269330|P1|Overall Study|Disease Progression|2
1802923|NCT00513357|6269329|P2|Overall Study|Withdrawal by Subject|4
1802924|NCT00513357|6269330|P1|Overall Study|Withdrawal by Subject|5
1802925|NCT00513357|6269329|P2|Overall Study|Death|0
1802926|NCT00513357|6269330|P1|Overall Study|Death|2
1802927|NCT00513357|6269329|P2|Overall Study|Adverse Event|2
1802928|NCT00513357|6269330|P1|Overall Study|Adverse Event|4
1802929|NCT00513357|6269329|P2|Overall Study|did not receive allocated placebo|3
1802930|NCT00513357|6269330|P1|Overall Study|did not receive allocated placebo|2
1802931|NCT00513305|6269349|P2|Overall Study|Sponsor Decision|2
1802932|NCT00513305|6269350|P1|Overall Study|Sponsor Decision|0
1802933|NCT00513305|6269349|P2|Overall Study|Persistent hypocellularity|1
1802934|NCT00513305|6269350|P1|Overall Study|Persistent hypocellularity|0
1802935|NCT00513305|6269349|P2|Overall Study|Physician Decision|0
1802936|NCT00513305|6269350|P1|Overall Study|Physician Decision|1
1802937|NCT00513305|6269349|P2|Overall Study|Hematologic counts did not recover|0
1802938|NCT00513305|6269350|P1|Overall Study|Hematologic counts did not recover|1
1802939|NCT00513305|6269349|P2|Overall Study|Eligible for stem cell transplant|0
1802940|NCT00513305|6269350|P1|Overall Study|Eligible for stem cell transplant|1
1802941|NCT00513305|6269349|P2|Overall Study|Disease progression|5
1802942|NCT00513305|6269350|P1|Overall Study|Disease progression|8
1802943|NCT00513305|6269349|P2|Overall Study|Withdrawal by Subject|2
1802944|NCT00513305|6269350|P1|Overall Study|Withdrawal by Subject|1
1802945|NCT00513305|6269349|P2|Overall Study|Lack of Efficacy|13
1802946|NCT00513305|6269350|P1|Overall Study|Lack of Efficacy|8
1802947|NCT00513305|6269349|P2|Overall Study|Death (through Consolidation Treatment)|2
1802948|NCT00513305|6269350|P1|Overall Study|Death (through Consolidation Treatment)|2
1802949|NCT00513305|6269349|P2|Overall Study|Adverse Event|2
1802950|NCT00513305|6269350|P1|Overall Study|Adverse Event|6
1802951|NCT00513240|6269393|P2|Overall Study|Withdrawal by Subject|4
1802952|NCT00513240|6269394|P1|Overall Study|Withdrawal by Subject|7
1802953|NCT00513240|6269393|P2|Overall Study|Death|3
1802954|NCT00513240|6269394|P1|Overall Study|Death|3
1802955|NCT00513240|6269393|P2|Overall Study|Did not have intended surgery|0
1802956|NCT00513240|6269394|P1|Overall Study|Did not have intended surgery|3
1802957|NCT00513071|6269407|P1|Overall Study|Physician Decision|3
1802958|NCT00513071|6269407|P1|Overall Study|Withdrawal by Subject|1
1802959|NCT00513071|6269407|P1|Overall Study|Adverse Event|1
1802960|NCT00513019|6269419|P2|Overall Study|Withdrawal by Subject|5
1802961|NCT00513019|6269420|P1|Overall Study|Withdrawal by Subject|4
1802962|NCT00513019|6269419|P2|Overall Study|Adverse Event|0
1802963|NCT00513019|6269420|P1|Overall Study|Adverse Event|1
1802964|NCT00512902|6269426|P1|Overall Study|Lost to Follow-up|1
1802965|NCT00512902|6269426|P1|Overall Study|Adverse Event|7
1802966|NCT00512798|6269441|P2|Overall Study|Withdrawal by Subject|0
1802967|NCT00512798|6269442|P1|Overall Study|Withdrawal by Subject|3
1802968|NCT00512798|6269441|P2|Overall Study|Progression of disease|20
1802969|NCT00512798|6269442|P1|Overall Study|Progression of disease|14
1802970|NCT00512798|6269441|P2|Overall Study|Adverse Event|4
1802971|NCT00512798|6269442|P1|Overall Study|Adverse Event|2
1802972|NCT00512798|6269441|P2|Overall Study|Death|3
1802973|NCT00512798|6269442|P1|Overall Study|Death|0
1802974|NCT00512707|6269453|P2|Overall Study|Unable to tolerate the smell of the gel|0
1802975|NCT00512707|6269454|P1|Overall Study|Unable to tolerate the smell of the gel|1
1802976|NCT00512707|6269453|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
1802977|NCT00512707|6269454|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
1802978|NCT00512707|6269453|P2|Overall Study|Developed skin irritation|1
1802979|NCT00512707|6269454|P1|Overall Study|Developed skin irritation|2
1802980|NCT00512707|6269453|P2|Overall Study|Lost to Follow-up|11
1802981|NCT00512707|6269454|P1|Overall Study|Lost to Follow-up|5
1802982|NCT00512252|6269504|P3|Overall Study|Death|1
1802983|NCT00512252|6269505|P2|Overall Study|Death|0
1802984|NCT00512252|6269506|P1|Overall Study|Death|0
1802985|NCT00512252|6269504|P3|Overall Study|Protocol Violation|1
1802986|NCT00512252|6269505|P2|Overall Study|Protocol Violation|0
1802987|NCT00512252|6269506|P1|Overall Study|Protocol Violation|0
1802988|NCT00512252|6269504|P3|Overall Study|Lost to Follow-up|1
1802989|NCT00512252|6269505|P2|Overall Study|Lost to Follow-up|0
1802990|NCT00512252|6269506|P1|Overall Study|Lost to Follow-up|0
1802991|NCT00512148|6269534|P1|Primay Study Period|Withdrawal by Subject|1
1802992|NCT00512096|6269540|P1|Overall Study|Lack of Efficacy|3
1802993|NCT00512096|6269540|P1|Overall Study|Withdrawal by Subject|2
1802994|NCT00512096|6269540|P1|Overall Study|Adverse Event|2
1802995|NCT00511901|6269568|P2|Overall Study|Withdrawal by Subject|3
1802996|NCT00511901|6269569|P1|Overall Study|Withdrawal by Subject|1
1802997|NCT00511875|6269591|P2|Overall Study|Missing variables|0
1802998|NCT00511875|6269592|P1|Overall Study|Missing variables|1
1802999|NCT00511875|6269591|P2|Overall Study|Lost to Follow-up|0
1803000|NCT00511875|6269592|P1|Overall Study|Lost to Follow-up|4
1803001|NCT00511836|6269632|P2|Double-blind Period|Lost to Follow-up|0
1803002|NCT00511836|6269633|P1|Double-blind Period|Lost to Follow-up|1
1803003|NCT00511810|6269650|P2|Overall Study|Refused second scn|1
1803004|NCT00511810|6269651|P1|Overall Study|Refused second scn|0
1803005|NCT00511810|6269650|P2|Overall Study|Lack of Efficacy|2
1803006|NCT00511810|6269651|P1|Overall Study|Lack of Efficacy|0
1803007|NCT00511810|6269650|P2|Overall Study|Lost to Follow-up|2
1803008|NCT00511810|6269651|P1|Overall Study|Lost to Follow-up|1
1803009|NCT00511797|6269661|P4|Overall Study|Other (moving etc)|2
1803010|NCT00511797|6269662|P3|Overall Study|Other (moving etc)|1
1803011|NCT00511797|6269663|P2|Overall Study|Other (moving etc)|0
1803012|NCT00511797|6269664|P1|Overall Study|Other (moving etc)|1
1803013|NCT00511797|6269661|P4|Overall Study|Partially missing diary|0
1803014|NCT00511797|6269662|P3|Overall Study|Partially missing diary|1
1803015|NCT00511797|6269663|P2|Overall Study|Partially missing diary|0
1803016|NCT00511797|6269664|P1|Overall Study|Partially missing diary|0
1803017|NCT00511797|6269661|P4|Overall Study|Study drug not taken|1
1803018|NCT00511797|6269662|P3|Overall Study|Study drug not taken|0
1803019|NCT00511797|6269663|P2|Overall Study|Study drug not taken|1
1803020|NCT00511797|6269664|P1|Overall Study|Study drug not taken|0
1803021|NCT00511797|6269661|P4|Overall Study|Never dispensed|3
1803022|NCT00511797|6269662|P3|Overall Study|Never dispensed|1
1803023|NCT00511797|6269663|P2|Overall Study|Never dispensed|0
1803024|NCT00511797|6269664|P1|Overall Study|Never dispensed|1
1803025|NCT00511797|6269661|P4|Overall Study|Withdrawal by Subject|2
1803026|NCT00511797|6269662|P3|Overall Study|Withdrawal by Subject|4
1803027|NCT00511797|6269663|P2|Overall Study|Withdrawal by Subject|3
1803028|NCT00511797|6269664|P1|Overall Study|Withdrawal by Subject|3
1803029|NCT00511797|6269661|P4|Overall Study|Protocol Violation|3
1803030|NCT00511797|6269662|P3|Overall Study|Protocol Violation|2
1803031|NCT00511797|6269663|P2|Overall Study|Protocol Violation|2
1803032|NCT00511797|6269664|P1|Overall Study|Protocol Violation|0
1803033|NCT00511797|6269661|P4|Overall Study|Pregnancy|1
1803034|NCT00511797|6269662|P3|Overall Study|Pregnancy|0
1803035|NCT00511797|6269663|P2|Overall Study|Pregnancy|0
1803036|NCT00511797|6269664|P1|Overall Study|Pregnancy|0
1803037|NCT00511797|6269661|P4|Overall Study|Lost to Follow-up|1
1803038|NCT00511797|6269662|P3|Overall Study|Lost to Follow-up|0
1803039|NCT00511797|6269663|P2|Overall Study|Lost to Follow-up|0
1803040|NCT00511797|6269664|P1|Overall Study|Lost to Follow-up|1
1803041|NCT00511797|6269661|P4|Overall Study|Adverse Event|2
1803042|NCT00511797|6269662|P3|Overall Study|Adverse Event|2
1803043|NCT00511797|6269663|P2|Overall Study|Adverse Event|2
1803044|NCT00511797|6269664|P1|Overall Study|Adverse Event|1
1803045|NCT00511667|6269783|P2|Overall Study|Other|1
1803046|NCT00511667|6269784|P1|Overall Study|Other|2
1803047|NCT00511667|6269783|P2|Overall Study|Site terminated|1
1803048|NCT00511667|6269784|P1|Overall Study|Site terminated|6
1803049|NCT00511667|6269783|P2|Overall Study|Withdrawal by Subject|0
1803050|NCT00511667|6269784|P1|Overall Study|Withdrawal by Subject|2
1803051|NCT00511667|6269783|P2|Overall Study|Protocol Violation|1
1803052|NCT00511667|6269784|P1|Overall Study|Protocol Violation|1
1803053|NCT00511667|6269783|P2|Overall Study|Adverse Event|0
1803054|NCT00511667|6269784|P1|Overall Study|Adverse Event|1
1803055|NCT00511472|6269819|P2|Overall Study|Not reported|2
1803056|NCT00511472|6269820|P1|Overall Study|Not reported|2
1803057|NCT00511472|6269819|P2|Overall Study|Laboratory Adverse Event|2
1803058|NCT00511472|6269820|P1|Overall Study|Laboratory Adverse Event|0
1803059|NCT00511472|6269819|P2|Overall Study|Clinical Adverse Event|2
1803060|NCT00511472|6269820|P1|Overall Study|Clinical Adverse Event|1
1803061|NCT00511433|6269839|P2|Overall Study|Other Reason|1
1803062|NCT00511433|6269840|P1|Overall Study|Other Reason|1
1803063|NCT00511433|6269839|P2|Overall Study|Adverse Event|0
1803064|NCT00511433|6269840|P1|Overall Study|Adverse Event|5
1803065|NCT00511355|6269880|P2|Overall Study|Other reason pre-treatment|1
1803066|NCT00511355|6269881|P1|Overall Study|Other reason pre-treatment|0
1803067|NCT00511355|6269880|P2|Overall Study|Withdrawal of informed consent|1
1803068|NCT00511355|6269881|P1|Overall Study|Withdrawal of informed consent|0
1803069|NCT00511355|6269880|P2|Overall Study|Pre-treatment (serious) adverse event|1
1803070|NCT00511355|6269881|P1|Overall Study|Pre-treatment (serious) adverse event|0
1803071|NCT00511355|6269880|P2|Overall Study|Other Reason|1
1803072|NCT00511355|6269881|P1|Overall Study|Other Reason|0
1803073|NCT00511355|6269880|P2|Overall Study|Lost to Follow-up|1
1803074|NCT00511355|6269881|P1|Overall Study|Lost to Follow-up|2
1803075|NCT00511355|6269880|P2|Overall Study|Pregnancy Wish|0
1803076|NCT00511355|6269881|P1|Overall Study|Pregnancy Wish|1
1803077|NCT00511355|6269880|P2|Overall Study|Adverse Event|4
1803078|NCT00511355|6269881|P1|Overall Study|Adverse Event|4
1803079|NCT00511342|6269981|P2|Overall Study|Other Reason|2
1803080|NCT00511342|6269982|P1|Overall Study|Other Reason|2
1803081|NCT00511342|6269981|P2|Overall Study|Lost to Follow-up|5
1803082|NCT00511342|6269982|P1|Overall Study|Lost to Follow-up|1
1803083|NCT00511342|6269981|P2|Overall Study|Pregnancy wish|1
1803084|NCT00511342|6269982|P1|Overall Study|Pregnancy wish|0
1803085|NCT00511342|6269981|P2|Overall Study|Pregnancy|1
1803086|NCT00511342|6269982|P1|Overall Study|Pregnancy|0
1803087|NCT00511342|6269981|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
1803088|NCT00511342|6269982|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
1803089|NCT00511342|6269981|P2|Overall Study|Unacceptable vaginal bleeding|1
1803090|NCT00511342|6269982|P1|Overall Study|Unacceptable vaginal bleeding|2
1803091|NCT00511238|6270013|P2|Overall Study|various reasons|14
1803092|NCT00511238|6270014|P1|Overall Study|various reasons|4
1803093|NCT00511238|6270013|P2|Overall Study|Progressive Disease|157
1803094|NCT00511238|6270014|P1|Overall Study|Progressive Disease|23
1803095|NCT00511238|6270013|P2|Overall Study|Withdrawal by Subject|22
1803096|NCT00511238|6270014|P1|Overall Study|Withdrawal by Subject|2
1803097|NCT00511238|6270013|P2|Overall Study|Adverse Event|33
1803098|NCT00511238|6270014|P1|Overall Study|Adverse Event|13
1803099|NCT00511199|6270033|P2|Overall Study|Other Reason|37
1803100|NCT00511199|6270034|P1|Overall Study|Other Reason|78
1803101|NCT00511199|6270033|P2|Overall Study|Lost to Follow-up|17
1803102|NCT00511199|6270034|P1|Overall Study|Lost to Follow-up|40
1803103|NCT00511199|6270033|P2|Overall Study|Pregnancy Wish|8
1803104|NCT00511199|6270034|P1|Overall Study|Pregnancy Wish|16
1803105|NCT00511199|6270033|P2|Overall Study|Pregnancy|3
1803106|NCT00511199|6270034|P1|Overall Study|Pregnancy|6
1803107|NCT00511199|6270033|P2|Overall Study|Withdrawal of Informed Consent|4
1803108|NCT00511199|6270034|P1|Overall Study|Withdrawal of Informed Consent|19
1803109|NCT00511199|6270033|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
1803110|NCT00511199|6270034|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
1803111|NCT00511199|6270033|P2|Overall Study|Unacceptable Vaginal Bleeding|4
1803112|NCT00511199|6270034|P1|Overall Study|Unacceptable Vaginal Bleeding|63
1803113|NCT00511147|6270063|P1|Overall Study|Required platelet transfusion|1
1803114|NCT00511147|6270063|P1|Overall Study|Disease progression|5
1803115|NCT00511147|6270063|P1|Overall Study|Withdrawal by Subject|1
1803116|NCT00511134|6270072|P2|Overall Study|Withdrawal by Subject|2
1803117|NCT00511134|6270073|P1|Overall Study|Withdrawal by Subject|0
1803118|NCT00511108|6270085|P4|Overall Study|Withdrawal by Subject|2
1803119|NCT00511108|6270086|P3|Overall Study|Withdrawal by Subject|3
1803120|NCT00511108|6270087|P2|Overall Study|Withdrawal by Subject|0
1803121|NCT00511108|6270088|P1|Overall Study|Withdrawal by Subject|4
1803122|NCT00511108|6270085|P4|Overall Study|Physician Decision|1
1803123|NCT00511108|6270086|P3|Overall Study|Physician Decision|0
1803124|NCT00511108|6270087|P2|Overall Study|Physician Decision|0
1803125|NCT00511108|6270088|P1|Overall Study|Physician Decision|0
1803126|NCT00511108|6270085|P4|Overall Study|Lost to Follow-up|0
1803127|NCT00511108|6270086|P3|Overall Study|Lost to Follow-up|1
1803128|NCT00511108|6270087|P2|Overall Study|Lost to Follow-up|2
1803129|NCT00511108|6270088|P1|Overall Study|Lost to Follow-up|0
1803130|NCT00511108|6270085|P4|Overall Study|Adverse Event|2
1803131|NCT00511108|6270086|P3|Overall Study|Adverse Event|1
1803132|NCT00511108|6270087|P2|Overall Study|Adverse Event|0
1803133|NCT00511108|6270088|P1|Overall Study|Adverse Event|2
1803134|NCT00511004|6270119|P3|Overall Study|Lost to Follow-up|4
1803135|NCT00511004|6270120|P2|Overall Study|Lost to Follow-up|0
1803136|NCT00511004|6270121|P1|Overall Study|Lost to Follow-up|0
1803137|NCT00510952|6270140|P2|Overall Study|Did Not Receive Study Drug|0
1803138|NCT00510952|6270141|P1|Overall Study|Did Not Receive Study Drug|2
1803139|NCT00510952|6270140|P2|Overall Study|Withdrawal by Subject|7
1803140|NCT00510952|6270141|P1|Overall Study|Withdrawal by Subject|6
1803141|NCT00510952|6270140|P2|Overall Study|Sponsor Decision|0
1803142|NCT00510952|6270141|P1|Overall Study|Sponsor Decision|1
1803143|NCT00510952|6270140|P2|Overall Study|Protocol Violation|4
1803144|NCT00510952|6270141|P1|Overall Study|Protocol Violation|7
1803145|NCT00510952|6270140|P2|Overall Study|Physician Decision|1
1803146|NCT00510952|6270141|P1|Overall Study|Physician Decision|1
1803147|NCT00510952|6270140|P2|Overall Study|Lost to Follow-up|3
1803148|NCT00510952|6270141|P1|Overall Study|Lost to Follow-up|5
1803149|NCT00510952|6270140|P2|Overall Study|Entry Criteria Not Met|1
1803150|NCT00510952|6270141|P1|Overall Study|Entry Criteria Not Met|3
1803151|NCT00510952|6270140|P2|Overall Study|Adverse Event|0
1803152|NCT00510952|6270141|P1|Overall Study|Adverse Event|1
1803153|NCT00510887|6270167|P1|Overall Study|Lost to Follow-up|1
1803154|NCT00510874|6270183|P7|Overall Study|Lost to Follow-up|1
1803155|NCT00510874|6270184|P6|Overall Study|Lost to Follow-up|0
1803156|NCT00510874|6270185|P5|Overall Study|Lost to Follow-up|4
1803157|NCT00510874|6270186|P4|Overall Study|Lost to Follow-up|3
1803158|NCT00510874|6270187|P3|Overall Study|Lost to Follow-up|1
1803159|NCT00510874|6270188|P2|Overall Study|Lost to Follow-up|3
1803160|NCT00510874|6270189|P1|Overall Study|Lost to Follow-up|2
1803161|NCT00510874|6270183|P7|Overall Study|Withdrawal by Subject|0
1803162|NCT00510874|6270184|P6|Overall Study|Withdrawal by Subject|0
1803163|NCT00510874|6270185|P5|Overall Study|Withdrawal by Subject|3
1803164|NCT00510874|6270186|P4|Overall Study|Withdrawal by Subject|0
1803165|NCT00510874|6270187|P3|Overall Study|Withdrawal by Subject|0
1803166|NCT00510874|6270188|P2|Overall Study|Withdrawal by Subject|1
1803167|NCT00510874|6270189|P1|Overall Study|Withdrawal by Subject|1
1803168|NCT00510835|6270292|P3|Overall Study|Withdrawal by Subject|2
1803169|NCT00510835|6270293|P2|Overall Study|Withdrawal by Subject|2
1803170|NCT00510835|6270294|P1|Overall Study|Withdrawal by Subject|6
1803171|NCT00510783|6270320|P2|Overall Study|Protocol Violation|1
1803172|NCT00510783|6270321|P1|Overall Study|Protocol Violation|0
1803173|NCT00510783|6270320|P2|Overall Study|Withdrawal by Subject|3
1803174|NCT00510783|6270321|P1|Overall Study|Withdrawal by Subject|2
1803175|NCT00510783|6270320|P2|Overall Study|Lost to Follow-up|25
1803176|NCT00510783|6270321|P1|Overall Study|Lost to Follow-up|29
1803177|NCT00510718|6270338|P2|Multiple Dose Period: 12 Weeks|Other|1
1803178|NCT00510718|6270339|P1|Multiple Dose Period: 12 Weeks|Other|1
1803179|NCT00510718|6270338|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
1803180|NCT00510718|6270339|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
1803181|NCT00510718|6270338|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
1803182|NCT00510718|6270339|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
1803183|NCT00510718|6270338|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
1803184|NCT00510718|6270339|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
1803185|NCT00510718|6270338|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
1803186|NCT00510718|6270339|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
1803187|NCT00510718|6270338|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
1803188|NCT00510718|6270339|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
1803189|NCT00510692|6270465|P2|Overall Study|Withdrawal by Subject|0
1803190|NCT00510692|6270466|P1|Overall Study|Withdrawal by Subject|1
1803191|NCT00510692|6270465|P2|Overall Study|Adverse Event|3
1803192|NCT00510692|6270466|P1|Overall Study|Adverse Event|1
1803193|NCT00510653|6270480|P1|Overall Study|Monetary|3
1803194|NCT00510653|6270480|P1|Overall Study|Withdrawal by Subject|8
1803195|NCT00510510|6270487|P3|Overall Study|Protocol Violation|4
1803196|NCT00510510|6270488|P2|Overall Study|Protocol Violation|3
1803197|NCT00510510|6270489|P1|Overall Study|Protocol Violation|0
1803198|NCT00510510|6270487|P3|Overall Study|Lost to Follow-up|1
1803199|NCT00510510|6270488|P2|Overall Study|Lost to Follow-up|0
1803200|NCT00510510|6270489|P1|Overall Study|Lost to Follow-up|0
1803201|NCT00510510|6270487|P3|Overall Study|Withdrawal by Subject|3
1803202|NCT00510510|6270488|P2|Overall Study|Withdrawal by Subject|2
1803203|NCT00510510|6270489|P1|Overall Study|Withdrawal by Subject|1
1803204|NCT00510510|6270487|P3|Overall Study|Subjects no longer requires study drug|2
1803205|NCT00510510|6270488|P2|Overall Study|Subjects no longer requires study drug|0
1803206|NCT00510510|6270489|P1|Overall Study|Subjects no longer requires study drug|0
1803207|NCT00510510|6270487|P3|Overall Study|Lack of Efficacy|1
1803208|NCT00510510|6270488|P2|Overall Study|Lack of Efficacy|1
1803209|NCT00510510|6270489|P1|Overall Study|Lack of Efficacy|0
1803210|NCT00510510|6270487|P3|Overall Study|Adverse Event|6
1803211|NCT00510510|6270488|P2|Overall Study|Adverse Event|3
1803212|NCT00510510|6270489|P1|Overall Study|Adverse Event|4
1803213|NCT00510484|6270507|P2|Wash-out Period|Adverse Event|1
1803214|NCT00510484|6270508|P1|Wash-out Period|Adverse Event|0
1803215|NCT00510458|6270528|P1|Overall Study|Revision|2
1803216|NCT00510458|6270528|P1|Overall Study|Withdrawal by Subject|3
1803217|NCT00510458|6270528|P1|Overall Study|Lost to Follow-up|6
1803218|NCT00510458|6270528|P1|Overall Study|Terminated|14
1803219|NCT00510458|6270528|P1|Overall Study|Death|1
1803220|NCT00510458|6270528|P1|Overall Study|5 year not evaluable/missed|21
1803221|NCT00510289|6270541|P1|Overall Study|Progressed prior to starting drug|2
1803222|NCT00510289|6270541|P1|Overall Study|Lost to Follow-up|1
1803223|NCT00510289|6270541|P1|Overall Study|Refused bone marrow biopsy|2
1803224|NCT00510289|6270541|P1|Overall Study|Withdrawal by Subject|7
1803225|NCT00510276|6270551|P2|Extension Open-Label Phase|Subject Decision|9
1803226|NCT00510276|6270552|P1|Extension Open-Label Phase|Subject Decision|7
1803227|NCT00510276|6270551|P2|Extension Open-Label Phase|Sponsor Decision|0
1803228|NCT00510276|6270552|P1|Extension Open-Label Phase|Sponsor Decision|1
1803229|NCT00510276|6270551|P2|Extension Open-Label Phase|Protocol Violation|1
1803230|NCT00510276|6270552|P1|Extension Open-Label Phase|Protocol Violation|0
1803231|NCT00510276|6270551|P2|Extension Open-Label Phase|Physician Decision|3
1803232|NCT00510276|6270552|P1|Extension Open-Label Phase|Physician Decision|2
1803233|NCT00510276|6270551|P2|Extension Open-Label Phase|Lost to Follow-up|10
1803234|NCT00510276|6270552|P1|Extension Open-Label Phase|Lost to Follow-up|12
1803235|NCT00510276|6270551|P2|Extension Open-Label Phase|Lack of Efficacy|7
1803236|NCT00510276|6270552|P1|Extension Open-Label Phase|Lack of Efficacy|2
1803237|NCT00510276|6270551|P2|Extension Open-Label Phase|Adverse Event|18
1803238|NCT00510276|6270552|P1|Extension Open-Label Phase|Adverse Event|9
1803239|NCT00510276|6270551|P2|Acute Double-Blind Phase|Subject Decision|28
1803240|NCT00510276|6270552|P1|Acute Double-Blind Phase|Subject Decision|26
1803241|NCT00510276|6270551|P2|Acute Double-Blind Phase|Sponsor Decision|1
1803242|NCT00510276|6270552|P1|Acute Double-Blind Phase|Sponsor Decision|2
1803243|NCT00510276|6270551|P2|Acute Double-Blind Phase|Protocol Violation|3
1803244|NCT00510276|6270552|P1|Acute Double-Blind Phase|Protocol Violation|4
1803245|NCT00510276|6270551|P2|Acute Double-Blind Phase|Physician Decision|3
1803246|NCT00510276|6270552|P1|Acute Double-Blind Phase|Physician Decision|0
1803247|NCT00510276|6270551|P2|Acute Double-Blind Phase|Lost to Follow-up|49
1803248|NCT00510276|6270552|P1|Acute Double-Blind Phase|Lost to Follow-up|48
1803249|NCT00510276|6270551|P2|Acute Double-Blind Phase|Lack of Efficacy|4
1803250|NCT00510276|6270552|P1|Acute Double-Blind Phase|Lack of Efficacy|3
1803251|NCT00510276|6270551|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
1803252|NCT00510276|6270552|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
1803253|NCT00510276|6270551|P2|Acute Double-Blind Phase|Adverse Event|6
1803254|NCT00510276|6270552|P1|Acute Double-Blind Phase|Adverse Event|21
1803255|NCT00510198|6270646|P2|Overall Study|Withdrawal by Subject|4
1803256|NCT00510198|6270647|P1|Overall Study|Withdrawal by Subject|5
1803257|NCT00510146|6270661|P2|Open-Label Treatment|Sponsor Decision|0
1803258|NCT00510146|6270662|P1|Open-Label Treatment|Sponsor Decision|2
1803259|NCT00510146|6270661|P2|Open-Label Treatment|Clinical Relapse|1
1803260|NCT00510146|6270662|P1|Open-Label Treatment|Clinical Relapse|1
1803261|NCT00510146|6270661|P2|Open-Label Treatment|Withdrawal by Subject|12
1803262|NCT00510146|6270662|P1|Open-Label Treatment|Withdrawal by Subject|24
1803263|NCT00510146|6270661|P2|Open-Label Treatment|Protocol Violation|2
1803264|NCT00510146|6270662|P1|Open-Label Treatment|Protocol Violation|4
1803265|NCT00510146|6270661|P2|Open-Label Treatment|Physician Decision|1
1803266|NCT00510146|6270662|P1|Open-Label Treatment|Physician Decision|3
1803267|NCT00510146|6270661|P2|Open-Label Treatment|Lost to Follow-up|1
1803268|NCT00510146|6270662|P1|Open-Label Treatment|Lost to Follow-up|10
1803269|NCT00510146|6270661|P2|Open-Label Treatment|Lack of Efficacy|0
1803270|NCT00510146|6270662|P1|Open-Label Treatment|Lack of Efficacy|4
1803271|NCT00510146|6270661|P2|Open-Label Treatment|Death|1
1803272|NCT00510146|6270662|P1|Open-Label Treatment|Death|1
1803273|NCT00510146|6270661|P2|Open-Label Treatment|Adverse Event|8
1803274|NCT00510146|6270662|P1|Open-Label Treatment|Adverse Event|22
1803275|NCT00510146|6270661|P2|Double-Blind Treatment|Entry Criteria Not Met|0
1803276|NCT00510146|6270662|P1|Double-Blind Treatment|Entry Criteria Not Met|3
1803277|NCT00510146|6270661|P2|Double-Blind Treatment|Clinical Relapse|1
1803278|NCT00510146|6270662|P1|Double-Blind Treatment|Clinical Relapse|0
1803279|NCT00510146|6270661|P2|Double-Blind Treatment|Withdrawal by Subject|13
1803280|NCT00510146|6270662|P1|Double-Blind Treatment|Withdrawal by Subject|27
1803281|NCT00510146|6270661|P2|Double-Blind Treatment|Protocol Violation|2
1803282|NCT00510146|6270662|P1|Double-Blind Treatment|Protocol Violation|1
1803283|NCT00510146|6270661|P2|Double-Blind Treatment|Physician Decision|0
1803284|NCT00510146|6270662|P1|Double-Blind Treatment|Physician Decision|6
1803285|NCT00510146|6270661|P2|Double-Blind Treatment|Lost to Follow-up|7
1803286|NCT00510146|6270662|P1|Double-Blind Treatment|Lost to Follow-up|3
1803287|NCT00510146|6270661|P2|Double-Blind Treatment|Lack of Efficacy|13
1803288|NCT00510146|6270662|P1|Double-Blind Treatment|Lack of Efficacy|6
1803289|NCT00510146|6270661|P2|Double-Blind Treatment|Adverse Event|13
1803290|NCT00510146|6270662|P1|Double-Blind Treatment|Adverse Event|30
1803291|NCT00510068|6270751|P2|Open-label Period|Abnormal laboratory value (s)|0
1803292|NCT00510068|6270752|P1|Open-label Period|Abnormal laboratory value (s)|1
1803293|NCT00510068|6270751|P2|Open-label Period|Protocol Violation|0
1803294|NCT00510068|6270752|P1|Open-label Period|Protocol Violation|2
1803295|NCT00510068|6270751|P2|Open-label Period|New cancer therapy|0
1803296|NCT00510068|6270752|P1|Open-label Period|New cancer therapy|7
1803297|NCT00510068|6270751|P2|Open-label Period|Death|0
1803298|NCT00510068|6270752|P1|Open-label Period|Death|7
1803299|NCT00510068|6270751|P2|Open-label Period|Administrative problems|0
1803300|NCT00510068|6270752|P1|Open-label Period|Administrative problems|17
1803301|NCT00510068|6270751|P2|Open-label Period|Withdrawal by Subject|0
1803302|NCT00510068|6270752|P1|Open-label Period|Withdrawal by Subject|21
1803303|NCT00510068|6270751|P2|Open-label Period|Adverse Event|0
1803304|NCT00510068|6270752|P1|Open-label Period|Adverse Event|46
1803305|NCT00510068|6270751|P2|Open-label Period|Disease Progression|0
1803306|NCT00510068|6270752|P1|Open-label Period|Disease Progression|124
1803307|NCT00510068|6270751|P2|Double-blind Period|Protocol Violation|0
1803308|NCT00510068|6270752|P1|Double-blind Period|Protocol Violation|6
1803309|NCT00510068|6270751|P2|Double-blind Period|Lost to Follow-up|0
1803310|NCT00510068|6270752|P1|Double-blind Period|Lost to Follow-up|1
1803311|NCT00510068|6270751|P2|Double-blind Period|Abnormal test result (s)|0
1803312|NCT00510068|6270752|P1|Double-blind Period|Abnormal test result (s)|1
1803313|NCT00510068|6270751|P2|Double-blind Period|Death|3
1803314|NCT00510068|6270752|P1|Double-blind Period|Death|4
1803315|NCT00510068|6270751|P2|Double-blind Period|Withdrawal by Subject|6
1803316|NCT00510068|6270752|P1|Double-blind Period|Withdrawal by Subject|8
1803317|NCT00510068|6270751|P2|Double-blind Period|Adverse Event|7
1803318|NCT00510068|6270752|P1|Double-blind Period|Adverse Event|37
1803319|NCT00510068|6270751|P2|Double-blind Period|Final primary analysis|18
1803320|NCT00510068|6270752|P1|Double-blind Period|Final primary analysis|52
1803321|NCT00510068|6270751|P2|Double-blind Period|Disease progression|169
1803322|NCT00510068|6270752|P1|Double-blind Period|Disease progression|98
1803323|NCT00509925|6270793|P2|Overall Study|Personal reasons|1
1803324|NCT00509925|6270794|P1|Overall Study|Personal reasons|0
1803325|NCT00509899|6270842|P8|Overall Study|Lack of Efficacy|0
1803326|NCT00509899|6270843|P7|Overall Study|Lack of Efficacy|0
1803327|NCT00509899|6270844|P6|Overall Study|Lack of Efficacy|1
1803328|NCT00509899|6270845|P5|Overall Study|Lack of Efficacy|0
1803329|NCT00509899|6270846|P4|Overall Study|Lack of Efficacy|0
1803330|NCT00509899|6270847|P3|Overall Study|Lack of Efficacy|2
1803331|NCT00509899|6270848|P2|Overall Study|Lack of Efficacy|0
1803332|NCT00509899|6270849|P1|Overall Study|Lack of Efficacy|1
1803333|NCT00509899|6270842|P8|Overall Study|Death|1
1803334|NCT00509899|6270843|P7|Overall Study|Death|1
1803335|NCT00509899|6270844|P6|Overall Study|Death|1
1803336|NCT00509899|6270845|P5|Overall Study|Death|1
1803337|NCT00509899|6270846|P4|Overall Study|Death|0
1803338|NCT00509899|6270847|P3|Overall Study|Death|3
1803339|NCT00509899|6270848|P2|Overall Study|Death|2
1803340|NCT00509899|6270849|P1|Overall Study|Death|2
1803341|NCT00509899|6270842|P8|Overall Study|Intercurrent Illness|0
1803342|NCT00509899|6270843|P7|Overall Study|Intercurrent Illness|0
1803343|NCT00509899|6270844|P6|Overall Study|Intercurrent Illness|1
1803344|NCT00509899|6270845|P5|Overall Study|Intercurrent Illness|0
1803345|NCT00509899|6270846|P4|Overall Study|Intercurrent Illness|1
1803346|NCT00509899|6270847|P3|Overall Study|Intercurrent Illness|0
1803347|NCT00509899|6270848|P2|Overall Study|Intercurrent Illness|0
1803348|NCT00509899|6270849|P1|Overall Study|Intercurrent Illness|1
1803349|NCT00509899|6270842|P8|Overall Study|Physician Decision|0
1803350|NCT00509899|6270843|P7|Overall Study|Physician Decision|0
1803351|NCT00509899|6270844|P6|Overall Study|Physician Decision|4
1803352|NCT00509899|6270845|P5|Overall Study|Physician Decision|1
1803353|NCT00509899|6270846|P4|Overall Study|Physician Decision|0
1803354|NCT00509899|6270847|P3|Overall Study|Physician Decision|7
1803355|NCT00509899|6270848|P2|Overall Study|Physician Decision|2
1803356|NCT00509899|6270849|P1|Overall Study|Physician Decision|4
1803357|NCT00509899|6270842|P8|Overall Study|Withdrawal by Subject|0
1803358|NCT00509899|6270843|P7|Overall Study|Withdrawal by Subject|0
1803359|NCT00509899|6270844|P6|Overall Study|Withdrawal by Subject|2
1803360|NCT00509899|6270845|P5|Overall Study|Withdrawal by Subject|3
1803361|NCT00509899|6270846|P4|Overall Study|Withdrawal by Subject|0
1803362|NCT00509899|6270847|P3|Overall Study|Withdrawal by Subject|3
1803363|NCT00509899|6270848|P2|Overall Study|Withdrawal by Subject|2
1803364|NCT00509899|6270849|P1|Overall Study|Withdrawal by Subject|6
1803365|NCT00509899|6270842|P8|Overall Study|Unacceptable Toxicity|0
1803366|NCT00509899|6270843|P7|Overall Study|Unacceptable Toxicity|0
1803367|NCT00509899|6270844|P6|Overall Study|Unacceptable Toxicity|0
1803368|NCT00509899|6270845|P5|Overall Study|Unacceptable Toxicity|0
1803369|NCT00509899|6270846|P4|Overall Study|Unacceptable Toxicity|2
1803370|NCT00509899|6270847|P3|Overall Study|Unacceptable Toxicity|0
1803371|NCT00509899|6270848|P2|Overall Study|Unacceptable Toxicity|0
1803372|NCT00509899|6270849|P1|Overall Study|Unacceptable Toxicity|1
1803373|NCT00509899|6270842|P8|Overall Study|Progressive disease|0
1803374|NCT00509899|6270843|P7|Overall Study|Progressive disease|0
1803375|NCT00509899|6270844|P6|Overall Study|Progressive disease|1
1803376|NCT00509899|6270845|P5|Overall Study|Progressive disease|0
1803377|NCT00509899|6270846|P4|Overall Study|Progressive disease|1
1803378|NCT00509899|6270847|P3|Overall Study|Progressive disease|5
1803379|NCT00509899|6270848|P2|Overall Study|Progressive disease|3
1803380|NCT00509899|6270849|P1|Overall Study|Progressive disease|1
1803381|NCT00509821|6270906|P2|Study Period 1 (Induction)|Progressive Disease|1
1803382|NCT00509821|6270907|P1|Study Period 1 (Induction)|Progressive Disease|0
1803383|NCT00509821|6270906|P2|Study Period 1 (Induction)|Adverse Event|2
1803384|NCT00509821|6270907|P1|Study Period 1 (Induction)|Adverse Event|0
1803385|NCT00509821|6270906|P2|Study Period 1 (Induction)|Death|1
1803386|NCT00509821|6270907|P1|Study Period 1 (Induction)|Death|0
1803387|NCT00509795|6270925|P4|Overall Study|Withdrawal by Subject|8
1803388|NCT00509795|6270926|P3|Overall Study|Withdrawal by Subject|7
1803389|NCT00509795|6270927|P2|Overall Study|Withdrawal by Subject|5
1803390|NCT00509795|6270928|P1|Overall Study|Withdrawal by Subject|10
1803391|NCT00509795|6270925|P4|Overall Study|Protocol Violation|1
1803392|NCT00509795|6270926|P3|Overall Study|Protocol Violation|3
1803393|NCT00509795|6270927|P2|Overall Study|Protocol Violation|0
1803394|NCT00509795|6270928|P1|Overall Study|Protocol Violation|3
1803395|NCT00509795|6270925|P4|Overall Study|OTHER|1
1803396|NCT00509795|6270926|P3|Overall Study|OTHER|4
1803397|NCT00509795|6270927|P2|Overall Study|OTHER|0
1803398|NCT00509795|6270928|P1|Overall Study|OTHER|1
1803399|NCT00509795|6270925|P4|Overall Study|Lost to Follow-up|4
1803400|NCT00509795|6270926|P3|Overall Study|Lost to Follow-up|4
1803401|NCT00509795|6270927|P2|Overall Study|Lost to Follow-up|2
1803402|NCT00509795|6270928|P1|Overall Study|Lost to Follow-up|1
1803403|NCT00509795|6270925|P4|Overall Study|Lack of Efficacy|2
1803404|NCT00509795|6270926|P3|Overall Study|Lack of Efficacy|2
1803405|NCT00509795|6270927|P2|Overall Study|Lack of Efficacy|0
1803406|NCT00509795|6270928|P1|Overall Study|Lack of Efficacy|0
1803407|NCT00509795|6270925|P4|Overall Study|Death|7
1803408|NCT00509795|6270926|P3|Overall Study|Death|2
1803409|NCT00509795|6270927|P2|Overall Study|Death|1
1803410|NCT00509795|6270928|P1|Overall Study|Death|3
1803411|NCT00509795|6270925|P4|Overall Study|Adverse Event|4
1803412|NCT00509795|6270926|P3|Overall Study|Adverse Event|5
1803413|NCT00509795|6270927|P2|Overall Study|Adverse Event|3
1803414|NCT00509795|6270928|P1|Overall Study|Adverse Event|4
1803415|NCT00509769|6270959|P1|Overall Study|Use of prohibited therapies during study|1
1803416|NCT00509769|6270959|P1|Overall Study|Physician Decision|8
1803417|NCT00509769|6270959|P1|Overall Study|Patient’s decision|1
1803418|NCT00509769|6270959|P1|Overall Study|Adverse Event|4
1803419|NCT00509769|6270959|P1|Overall Study|Progressive disease|77
1803420|NCT00509600|6270978|P1|Overall Study|Adverse Event|1
1803421|NCT00509366|6271057|P5|Overall Study|Not Treated (Screen Failure)|0
1803422|NCT00509366|6271058|P4|Overall Study|Not Treated (Screen Failure)|0
1803423|NCT00509366|6271059|P3|Overall Study|Not Treated (Screen Failure)|1
1803424|NCT00509366|6271060|P2|Overall Study|Not Treated (Screen Failure)|1
1803425|NCT00509366|6271061|P1|Overall Study|Not Treated (Screen Failure)|1
1803426|NCT00509262|6271085|P2|Overall Study|Withdrawal by Subject|11
1803427|NCT00509262|6271086|P1|Overall Study|Withdrawal by Subject|24
1803428|NCT00509262|6271085|P2|Overall Study|Protocol Violation|2
1803429|NCT00509262|6271086|P1|Overall Study|Protocol Violation|2
1803430|NCT00509262|6271085|P2|Overall Study|Physician Decision|3
1803431|NCT00509262|6271086|P1|Overall Study|Physician Decision|1
1803432|NCT00509262|6271085|P2|Overall Study|Lost to Follow-up|6
1803433|NCT00509262|6271086|P1|Overall Study|Lost to Follow-up|1
1803434|NCT00509262|6271085|P2|Overall Study|Lack of Efficacy|0
1803435|NCT00509262|6271086|P1|Overall Study|Lack of Efficacy|1
1803436|NCT00509262|6271085|P2|Overall Study|Other|2
1803437|NCT00509262|6271086|P1|Overall Study|Other|2
1803438|NCT00509262|6271085|P2|Overall Study|Adverse Event|18
1803439|NCT00509262|6271086|P1|Overall Study|Adverse Event|16
1803440|NCT00509236|6271104|P2|Overall Study|Scheduled Kidney Transplant|0
1803441|NCT00509236|6271105|P1|Overall Study|Scheduled Kidney Transplant|1
1803442|NCT00509236|6271104|P2|Overall Study|Excluded Medication|1
1803443|NCT00509236|6271105|P1|Overall Study|Excluded Medication|1
1803444|NCT00509236|6271104|P2|Overall Study|Protocol Violation|0
1803445|NCT00509236|6271105|P1|Overall Study|Protocol Violation|3
1803446|NCT00509236|6271104|P2|Overall Study|Withdrawal by Subject|10
1803447|NCT00509236|6271105|P1|Overall Study|Withdrawal by Subject|5
1803448|NCT00509236|6271104|P2|Overall Study|Adverse Event|9
1803449|NCT00509236|6271105|P1|Overall Study|Adverse Event|7
1803450|NCT00509223|6271120|P2|Overall Study|Did not meet revised inclusion criteria|62
1803451|NCT00509223|6271121|P1|Overall Study|Did not meet revised inclusion criteria|56
1803452|NCT00509223|6271120|P2|Overall Study|Including: subject change of address|2
1803453|NCT00509223|6271121|P1|Overall Study|Including: subject change of address|5
1803454|NCT00509223|6271120|P2|Overall Study|Withdrawal by Subject|6
1803455|NCT00509223|6271121|P1|Overall Study|Withdrawal by Subject|25
1803456|NCT00509223|6271120|P2|Overall Study|Adverse Event|1
1803457|NCT00509223|6271121|P1|Overall Study|Adverse Event|1
1803458|NCT00509223|6271120|P2|Overall Study|Lost to Follow-up|1
1803459|NCT00509223|6271121|P1|Overall Study|Lost to Follow-up|1
1803460|NCT00509106|6271144|P2|Overall Study|Death|6
1803461|NCT00509106|6271145|P1|Overall Study|Death|6
1803462|NCT00509106|6271144|P2|Overall Study|Other|0
1803463|NCT00509106|6271145|P1|Overall Study|Other|1
1803464|NCT00509106|6271144|P2|Overall Study|Lost to Follow-up|10
1803465|NCT00509106|6271145|P1|Overall Study|Lost to Follow-up|16
1803466|NCT00509106|6271144|P2|Overall Study|Withdrew consent|8
1803467|NCT00509106|6271145|P1|Overall Study|Withdrew consent|4
1803468|NCT00509106|6271144|P2|Overall Study|At the request of sponsor/investigator|2
1803469|NCT00509106|6271145|P1|Overall Study|At the request of sponsor/investigator|1
1803470|NCT00509106|6271144|P2|Overall Study|Noncompliance|1
1803471|NCT00509106|6271145|P1|Overall Study|Noncompliance|0
1803472|NCT00509106|6271144|P2|Overall Study|Adverse Event|2
1803473|NCT00509106|6271145|P1|Overall Study|Adverse Event|3
1803474|NCT00509067|6271153|P2|Overall Study|Protocol Violation|3
1803475|NCT00509067|6271154|P1|Overall Study|Protocol Violation|0
1803476|NCT00509067|6271153|P2|Overall Study|Adverse Event|1
1803477|NCT00509067|6271154|P1|Overall Study|Adverse Event|3
1803478|NCT00509067|6271153|P2|Overall Study|Lost to Follow-up|1
1803479|NCT00509067|6271154|P1|Overall Study|Lost to Follow-up|1
1803480|NCT00509028|6271173|P2|Overall Study|Non-compliance|1
1803481|NCT00509028|6271174|P1|Overall Study|Non-compliance|2
1803482|NCT00509028|6271173|P2|Overall Study|Protocol Violation|2
1803483|NCT00509028|6271174|P1|Overall Study|Protocol Violation|4
1803484|NCT00509028|6271173|P2|Overall Study|Lost to Follow-up|1
1803485|NCT00509028|6271174|P1|Overall Study|Lost to Follow-up|0
1803486|NCT00509028|6271173|P2|Overall Study|Withdrawal by Subject|3
1803487|NCT00509028|6271174|P1|Overall Study|Withdrawal by Subject|4
1803488|NCT00509028|6271173|P2|Overall Study|Adverse Event|0
1803489|NCT00509028|6271174|P1|Overall Study|Adverse Event|2
1803490|NCT00508924|6271214|P4|Overall Study|Protocol Violation|1
1803491|NCT00508924|6271215|P3|Overall Study|Protocol Violation|1
1803492|NCT00508924|6271216|P2|Overall Study|Protocol Violation|0
1803493|NCT00508924|6271217|P1|Overall Study|Protocol Violation|0
1803494|NCT00508872|6271231|P1|Overall Study|Physician Decision|1
1803495|NCT00508872|6271231|P1|Overall Study|Lost to Follow-up|1
1803496|NCT00508820|6271237|P2|Overall Study|Protocol-specified Criteria|12
1803497|NCT00508820|6271238|P1|Overall Study|Protocol-specified Criteria|3
1803498|NCT00508820|6271237|P2|Overall Study|Requirement for alternative therapy|15
1803499|NCT00508820|6271238|P1|Overall Study|Requirement for alternative therapy|7
1803500|NCT00508820|6271237|P2|Overall Study|Noncompliance|0
1803501|NCT00508820|6271238|P1|Overall Study|Noncompliance|1
1803502|NCT00508820|6271237|P2|Overall Study|Other|2
1803503|NCT00508820|6271238|P1|Overall Study|Other|11
1803504|NCT00508820|6271237|P2|Overall Study|Withdrawal by Subject|12
1803505|NCT00508820|6271238|P1|Overall Study|Withdrawal by Subject|10
1803506|NCT00508820|6271237|P2|Overall Study|Protocol Violation|0
1803507|NCT00508820|6271238|P1|Overall Study|Protocol Violation|2
1803508|NCT00508820|6271237|P2|Overall Study|Pregnancy|2
1803509|NCT00508820|6271238|P1|Overall Study|Pregnancy|0
1803510|NCT00508820|6271237|P2|Overall Study|Physician Decision|2
1803511|NCT00508820|6271238|P1|Overall Study|Physician Decision|8
1803512|NCT00508820|6271237|P2|Overall Study|Lost to Follow-up|1
1803513|NCT00508820|6271238|P1|Overall Study|Lost to Follow-up|1
1803514|NCT00508820|6271237|P2|Overall Study|Death|8
1803515|NCT00508820|6271238|P1|Overall Study|Death|6
1803516|NCT00508820|6271237|P2|Overall Study|Adverse Event|10
1803517|NCT00508820|6271238|P1|Overall Study|Adverse Event|6
1803518|NCT00508755|6271248|P1|Overall Study|Withdrawal by Subject|1
1803519|NCT00508742|6271256|P2|Period 3: Toddler Dose|Other|4
1803520|NCT00508742|6271257|P1|Period 3: Toddler Dose|Other|5
1803521|NCT00508742|6271256|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
1803522|NCT00508742|6271257|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
1803523|NCT00508742|6271256|P2|Period 3: Toddler Dose|Lost to Follow-up|3
1803524|NCT00508742|6271257|P1|Period 3: Toddler Dose|Lost to Follow-up|2
1803525|NCT00508742|6271256|P2|Period 3: Toddler Dose|Adverse Event|0
1803526|NCT00508742|6271257|P1|Period 3: Toddler Dose|Adverse Event|1
1803527|NCT00508742|6271256|P2|Period 2: After Infant Series|Other|1
1803528|NCT00508742|6271257|P1|Period 2: After Infant Series|Other|2
1803529|NCT00508742|6271256|P2|Period 2: After Infant Series|Failed to Return|0
1803530|NCT00508742|6271257|P1|Period 2: After Infant Series|Failed to Return|1
1803531|NCT00508742|6271256|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
1803532|NCT00508742|6271257|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
1803533|NCT00508742|6271256|P2|Period 2: After Infant Series|Protocol Violation|0
1803534|NCT00508742|6271257|P1|Period 2: After Infant Series|Protocol Violation|1
1803535|NCT00508742|6271256|P2|Period 2: After Infant Series|Lost to Follow-up|1
1803536|NCT00508742|6271257|P1|Period 2: After Infant Series|Lost to Follow-up|1
1803537|NCT00508742|6271256|P2|Period 2: After Infant Series|Adverse Event|6
1803538|NCT00508742|6271257|P1|Period 2: After Infant Series|Adverse Event|2
1803539|NCT00508742|6271256|P2|Period 1: Infant Series|Other|1
1803540|NCT00508742|6271257|P1|Period 1: Infant Series|Other|4
1803541|NCT00508742|6271256|P2|Period 1: Infant Series|Physician Decision|0
1803542|NCT00508742|6271257|P1|Period 1: Infant Series|Physician Decision|1
1803543|NCT00508742|6271256|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
1803544|NCT00508742|6271257|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
1803545|NCT00508742|6271256|P2|Period 1: Infant Series|Protocol Violation|0
1803546|NCT00508742|6271257|P1|Period 1: Infant Series|Protocol Violation|1
1803547|NCT00508742|6271256|P2|Period 1: Infant Series|Adverse Event|4
1803548|NCT00508742|6271257|P1|Period 1: Infant Series|Adverse Event|5
1803549|NCT00508651|6271282|P2|Overall Study|Withdrawal by Subject|1
1803550|NCT00508651|6271283|P1|Overall Study|Withdrawal by Subject|1
1803551|NCT00508651|6271282|P2|Overall Study|Lost to Follow-up|1
1803552|NCT00508651|6271283|P1|Overall Study|Lost to Follow-up|3
1803553|NCT00508482|6271364|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
1803554|NCT00508482|6271365|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
1803555|NCT00508482|6271366|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
1803556|NCT00508482|6271364|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
1803557|NCT00508482|6271365|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
1803558|NCT00508482|6271366|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
1803559|NCT00508482|6271364|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
1803560|NCT00508482|6271365|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
1803561|NCT00508482|6271366|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
1803562|NCT00508404|6271410|P1|Overall Study|Other - Not Specified|3
1803563|NCT00508404|6271410|P1|Overall Study|Lost to Follow-up|2
1803564|NCT00508404|6271410|P1|Overall Study|Protocol-specified Criteria|2
1803565|NCT00508404|6271410|P1|Overall Study|Withdrawal by Subject|3
1803566|NCT00508404|6271410|P1|Overall Study|Physician Decision|2
1803567|NCT00508404|6271410|P1|Overall Study|Death|16
1803568|NCT00508404|6271410|P1|Overall Study|Adverse Event|2
1803569|NCT00508404|6271410|P1|Overall Study|Ongoing at Data Cut-off|12
1803570|NCT00508391|6271437|P2|Second Treatment|Withdrawal by Subject|0
1803571|NCT00508391|6271438|P1|Second Treatment|Withdrawal by Subject|2
1803572|NCT00508391|6271437|P2|First Treatment|Withdrawal by Subject|3
1803573|NCT00508391|6271438|P1|First Treatment|Withdrawal by Subject|6
1803574|NCT00508274|6271458|P1|Overall Study|Withdrawal by Subject|1
1803575|NCT00508274|6271458|P1|Overall Study|Adverse Event|1
1803576|NCT00508261|6271471|P4|Overall Study|Lost to Follow-up|1
1803577|NCT00508261|6271472|P3|Overall Study|Lost to Follow-up|1
1803578|NCT00508261|6271473|P2|Overall Study|Lost to Follow-up|1
1803579|NCT00508261|6271474|P1|Overall Study|Lost to Follow-up|0
1803580|NCT00508261|6271471|P4|Overall Study|Migrated/ moved from study area|0
1803581|NCT00508261|6271472|P3|Overall Study|Migrated/ moved from study area|0
1803582|NCT00508261|6271473|P2|Overall Study|Migrated/ moved from study area|1
1803583|NCT00508261|6271474|P1|Overall Study|Migrated/ moved from study area|0
1803584|NCT00508261|6271471|P4|Overall Study|Withdrawal by Subject|0
1803585|NCT00508261|6271472|P3|Overall Study|Withdrawal by Subject|4
1803586|NCT00508261|6271473|P2|Overall Study|Withdrawal by Subject|4
1803587|NCT00508261|6271474|P1|Overall Study|Withdrawal by Subject|3
1803588|NCT00508261|6271471|P4|Overall Study|Serious Adverse Event|0
1803589|NCT00508261|6271472|P3|Overall Study|Serious Adverse Event|0
1803590|NCT00508261|6271473|P2|Overall Study|Serious Adverse Event|1
1803591|NCT00508261|6271474|P1|Overall Study|Serious Adverse Event|0
1803592|NCT00508261|6271471|P4|Overall Study|Other|0
1803593|NCT00508261|6271472|P3|Overall Study|Other|1
1803594|NCT00508261|6271473|P2|Overall Study|Other|1
1803595|NCT00508261|6271474|P1|Overall Study|Other|0
1803596|NCT00508157|6271614|P2|Overall Study|Other known cause|1
1803597|NCT00508157|6271615|P1|Overall Study|Other known cause|0
1803598|NCT00508157|6271614|P2|Overall Study|Subject no longer met study criteria|1
1803599|NCT00508157|6271615|P1|Overall Study|Subject no longer met study criteria|0
1803600|NCT00508157|6271614|P2|Overall Study|Lost to Follow-up|0
1803601|NCT00508157|6271615|P1|Overall Study|Lost to Follow-up|1
1803602|NCT00508157|6271614|P2|Overall Study|Subject Withdrew Consent|0
1803603|NCT00508157|6271615|P1|Overall Study|Subject Withdrew Consent|1
1803604|NCT00508157|6271614|P2|Overall Study|Adverse Event|1
1803605|NCT00508157|6271615|P1|Overall Study|Adverse Event|0
1803606|NCT00508144|6271637|P1|Overall Study|Death|5
1803607|NCT00508144|6271637|P1|Overall Study|Not eligible|6
1803608|NCT00508027|6271663|P1|Dose Level 2|Withdrawal by Subject|2
1803609|NCT00508027|6271663|P1|Dose Level 2|Lost to Follow-up|2
1803610|NCT00508027|6271663|P1|Dose Level 1|Physician Decision|2
1803611|NCT00508027|6271663|P1|Dose Level 1|Withdrawal by Subject|2
1803612|NCT00508027|6271663|P1|Dose Level 1|Lost to Follow-up|4
1803613|NCT00508001|6271704|P3|Overall Study|Withdrawal by Subject|1
1803614|NCT00508001|6271705|P2|Overall Study|Withdrawal by Subject|4
1803615|NCT00508001|6271706|P1|Overall Study|Withdrawal by Subject|4
1803616|NCT00508001|6271704|P3|Overall Study|Death|1
1803617|NCT00508001|6271705|P2|Overall Study|Death|1
1803618|NCT00508001|6271706|P1|Overall Study|Death|0
1803619|NCT00508001|6271704|P3|Overall Study|condition under investigation worsened|1
1803620|NCT00508001|6271705|P2|Overall Study|condition under investigation worsened|7
1803621|NCT00508001|6271706|P1|Overall Study|condition under investigation worsened|13
1803622|NCT00508001|6271704|P3|Overall Study|Adverse Event|4
1803623|NCT00508001|6271705|P2|Overall Study|Adverse Event|0
1803624|NCT00508001|6271706|P1|Overall Study|Adverse Event|2
1803625|NCT00507819|6271723|P2|Washout (6 Weeks)|Withdrawal by Subject|0
1803626|NCT00507819|6271724|P1|Washout (6 Weeks)|Withdrawal by Subject|1
1803627|NCT00507689|6271743|P2|Randomized Period|Withdrawal by Subject|1
1803628|NCT00507689|6271744|P1|Randomized Period|Withdrawal by Subject|0
1803629|NCT00507689|6271743|P2|Randomized Period|Adverse Event|1
1803630|NCT00507689|6271744|P1|Randomized Period|Adverse Event|1
1803631|NCT00507689|6271743|P2|Pre-Randomization Period|Withdrawal by Subject|0
1803632|NCT00507689|6271744|P1|Pre-Randomization Period|Withdrawal by Subject|1
1803633|NCT00507689|6271743|P2|Pre-Randomization Period|Physician Decision|0
1803634|NCT00507689|6271744|P1|Pre-Randomization Period|Physician Decision|1
1803635|NCT00507689|6271743|P2|Pre-Randomization Period|Adverse Event|0
1803636|NCT00507689|6271744|P1|Pre-Randomization Period|Adverse Event|1
1803637|NCT00507546|6271776|P2|Overall Study|Physician Decision|1
1803638|NCT00507546|6271777|P1|Overall Study|Physician Decision|0
1803639|NCT00507546|6271776|P2|Overall Study|Protocol Violation|0
1803640|NCT00507546|6271777|P1|Overall Study|Protocol Violation|1
1803641|NCT00507546|6271776|P2|Overall Study|Withdrawal by Subject|0
1803642|NCT00507546|6271777|P1|Overall Study|Withdrawal by Subject|1
1803643|NCT00507507|6271787|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
1803644|NCT00507507|6271788|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
1803645|NCT00507507|6271787|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
1803646|NCT00507507|6271788|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
1803647|NCT00507507|6271787|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
1803648|NCT00507507|6271788|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
1803649|NCT00507507|6271787|P2|Treatment Period|Withdrawal by Subject|47
1803650|NCT00507507|6271788|P1|Treatment Period|Withdrawal by Subject|46
1803651|NCT00507507|6271787|P2|Treatment Period|Adverse Event|1
1803652|NCT00507507|6271788|P1|Treatment Period|Adverse Event|1
1803653|NCT00507507|6271787|P2|Treatment Period|Protocol Violation|2
1803654|NCT00507507|6271788|P1|Treatment Period|Protocol Violation|1
1803655|NCT00507507|6271787|P2|Treatment Period|Physician Decision|1
1803656|NCT00507507|6271788|P1|Treatment Period|Physician Decision|4
1803657|NCT00507507|6271787|P2|Treatment Period|Lost to Follow-up|2
1803658|NCT00507507|6271788|P1|Treatment Period|Lost to Follow-up|0
1803659|NCT00507455|6271823|P3|Overall Study|Other - miscellaneous reason|1
1803660|NCT00507455|6271824|P2|Overall Study|Other - miscellaneous reason|0
1803661|NCT00507455|6271825|P1|Overall Study|Other - miscellaneous reason|1
1803662|NCT00507455|6271823|P3|Overall Study|Lack of Efficacy|0
1803663|NCT00507455|6271824|P2|Overall Study|Lack of Efficacy|1
1803664|NCT00507455|6271825|P1|Overall Study|Lack of Efficacy|0
1803665|NCT00507455|6271823|P3|Overall Study|Lost to Follow-up|2
1803666|NCT00507455|6271824|P2|Overall Study|Lost to Follow-up|0
1803667|NCT00507455|6271825|P1|Overall Study|Lost to Follow-up|2
1803668|NCT00507455|6271823|P3|Overall Study|Protocol Violation|1
1803669|NCT00507455|6271824|P2|Overall Study|Protocol Violation|1
1803670|NCT00507455|6271825|P1|Overall Study|Protocol Violation|4
1803671|NCT00507455|6271823|P3|Overall Study|Withdrawal by Subject|2
1803672|NCT00507455|6271824|P2|Overall Study|Withdrawal by Subject|1
1803673|NCT00507455|6271825|P1|Overall Study|Withdrawal by Subject|2
1803674|NCT00507455|6271823|P3|Overall Study|Adverse Event|6
1803675|NCT00507455|6271824|P2|Overall Study|Adverse Event|3
1803676|NCT00507455|6271825|P1|Overall Study|Adverse Event|3
1803677|NCT00507442|6271888|P4|Overall Study|Other|2
1803678|NCT00507442|6271889|P3|Overall Study|Other|2
1803679|NCT00507442|6271890|P2|Overall Study|Other|5
1803680|NCT00507442|6271891|P1|Overall Study|Other|2
1803681|NCT00507442|6271888|P4|Overall Study|Withdrawal by Subject|1
1803682|NCT00507442|6271889|P3|Overall Study|Withdrawal by Subject|2
1803683|NCT00507442|6271890|P2|Overall Study|Withdrawal by Subject|4
1803684|NCT00507442|6271891|P1|Overall Study|Withdrawal by Subject|4
1803685|NCT00507442|6271888|P4|Overall Study|Progressive Disease|0
1803686|NCT00507442|6271889|P3|Overall Study|Progressive Disease|2
1803687|NCT00507442|6271890|P2|Overall Study|Progressive Disease|4
1803688|NCT00507442|6271891|P1|Overall Study|Progressive Disease|2
1803689|NCT00507442|6271888|P4|Overall Study|Physician Decision|1
1803690|NCT00507442|6271889|P3|Overall Study|Physician Decision|4
1803691|NCT00507442|6271890|P2|Overall Study|Physician Decision|2
1803692|NCT00507442|6271891|P1|Overall Study|Physician Decision|0
1803693|NCT00507442|6271888|P4|Overall Study|Lost to Follow-up|0
1803694|NCT00507442|6271889|P3|Overall Study|Lost to Follow-up|1
1803695|NCT00507442|6271890|P2|Overall Study|Lost to Follow-up|0
1803696|NCT00507442|6271891|P1|Overall Study|Lost to Follow-up|0
1803697|NCT00507442|6271888|P4|Overall Study|Protocol Violation|0
1803698|NCT00507442|6271889|P3|Overall Study|Protocol Violation|0
1803699|NCT00507442|6271890|P2|Overall Study|Protocol Violation|1
1803700|NCT00507442|6271891|P1|Overall Study|Protocol Violation|0
1803701|NCT00507442|6271888|P4|Overall Study|Adverse Event|1
1803702|NCT00507442|6271889|P3|Overall Study|Adverse Event|4
1803703|NCT00507442|6271890|P2|Overall Study|Adverse Event|11
1803704|NCT00507442|6271891|P1|Overall Study|Adverse Event|8
1803705|NCT00507429|6271943|P2|Maintenance Phase|Progressive Disease|0
1803706|NCT00507429|6271944|P1|Maintenance Phase|Progressive Disease|14
1803707|NCT00507429|6271943|P2|Treatment Phase|Other|3
1803708|NCT00507429|6271944|P1|Treatment Phase|Other|6
1803709|NCT00507429|6271943|P2|Treatment Phase|Physician Decision|2
1803710|NCT00507429|6271944|P1|Treatment Phase|Physician Decision|4
1803711|NCT00507429|6271943|P2|Treatment Phase|Withdrawal by Subject|3
1803712|NCT00507429|6271944|P1|Treatment Phase|Withdrawal by Subject|3
1803713|NCT00507429|6271943|P2|Treatment Phase|Adverse Event|5
1803714|NCT00507429|6271944|P1|Treatment Phase|Adverse Event|12
1803715|NCT00507429|6271943|P2|Treatment Phase|Disease Progression|5
1803716|NCT00507429|6271944|P1|Treatment Phase|Disease Progression|12
1803717|NCT00507416|6271955|P3|Overall Study|Did not Receive Study Treatment|4
1803718|NCT00507416|6271956|P2|Overall Study|Did not Receive Study Treatment|9
1803719|NCT00507416|6271957|P1|Overall Study|Did not Receive Study Treatment|3
1803720|NCT00507416|6271955|P3|Overall Study|Other|13
1803721|NCT00507416|6271956|P2|Overall Study|Other|16
1803722|NCT00507416|6271957|P1|Overall Study|Other|11
1803723|NCT00507416|6271955|P3|Overall Study|Patient declined further treatment|11
1803724|NCT00507416|6271956|P2|Overall Study|Patient declined further treatment|14
1803725|NCT00507416|6271957|P1|Overall Study|Patient declined further treatment|18
1803726|NCT00507416|6271955|P3|Overall Study|Progressive Disease|13
1803727|NCT00507416|6271956|P2|Overall Study|Progressive Disease|10
1803728|NCT00507416|6271957|P1|Overall Study|Progressive Disease|20
1803729|NCT00507416|6271955|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
1803730|NCT00507416|6271956|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
1803731|NCT00507416|6271957|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
1803732|NCT00507416|6271955|P3|Overall Study|Protocol Violation|0
1803733|NCT00507416|6271956|P2|Overall Study|Protocol Violation|2
1803734|NCT00507416|6271957|P1|Overall Study|Protocol Violation|1
1803735|NCT00507416|6271955|P3|Overall Study|Adverse Event|65
1803736|NCT00507416|6271956|P2|Overall Study|Adverse Event|67
1803737|NCT00507416|6271957|P1|Overall Study|Adverse Event|58
1803738|NCT00507130|6271999|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1803739|NCT00507130|6272000|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1803740|NCT00507130|6272001|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
1803741|NCT00507130|6272002|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
1803742|NCT00507130|6271999|P4|Overall Study|Lost to Follow-up|1
1803743|NCT00507130|6272000|P3|Overall Study|Lost to Follow-up|1
1803744|NCT00507130|6272001|P2|Overall Study|Lost to Follow-up|0
1803745|NCT00507130|6272002|P1|Overall Study|Lost to Follow-up|0
1803746|NCT00506948|6272044|P1|Overall Study|Physician Decision|1
1803747|NCT00506948|6272044|P1|Overall Study|Adverse Event|5
1803748|NCT00506948|6272044|P1|Overall Study|Death|4
1803749|NCT00506922|6272053|P5|Overall Study|Withdrawal by Subject|1
1803750|NCT00506922|6272054|P4|Overall Study|Withdrawal by Subject|0
1803751|NCT00506922|6272055|P3|Overall Study|Withdrawal by Subject|0
1803752|NCT00506922|6272056|P2|Overall Study|Withdrawal by Subject|0
1803753|NCT00506922|6272057|P1|Overall Study|Withdrawal by Subject|0
1803754|NCT00506922|6272053|P5|Overall Study|Physician Decision|0
1803755|NCT00506922|6272054|P4|Overall Study|Physician Decision|2
1803756|NCT00506922|6272055|P3|Overall Study|Physician Decision|0
1803757|NCT00506922|6272056|P2|Overall Study|Physician Decision|0
1803758|NCT00506922|6272057|P1|Overall Study|Physician Decision|0
1803759|NCT00506883|6272084|P3|Overall Study|Other|1
1803760|NCT00506883|6272085|P2|Overall Study|Other|1
1803761|NCT00506883|6272086|P1|Overall Study|Other|5
1803762|NCT00506883|6272084|P3|Overall Study|Lack of Efficacy|1
1803763|NCT00506883|6272085|P2|Overall Study|Lack of Efficacy|1
1803764|NCT00506883|6272086|P1|Overall Study|Lack of Efficacy|0
1803765|NCT00506883|6272084|P3|Overall Study|Withdrawal by Subject|1
1803766|NCT00506883|6272085|P2|Overall Study|Withdrawal by Subject|0
1803767|NCT00506883|6272086|P1|Overall Study|Withdrawal by Subject|1
1803768|NCT00506883|6272084|P3|Overall Study|Lost to Follow-up|1
1803769|NCT00506883|6272085|P2|Overall Study|Lost to Follow-up|1
1803770|NCT00506883|6272086|P1|Overall Study|Lost to Follow-up|1
1803771|NCT00506831|6272099|P1|Overall Study|Withdrawal by Subject|1
1803772|NCT00506831|6272099|P1|Overall Study|Death|1
1803773|NCT00506753|6272112|P2|Overall Study|Lost to Follow-up|15
1803774|NCT00506753|6272113|P1|Overall Study|Lost to Follow-up|21
1803775|NCT00506662|6272151|P2|Overall Study|Not recorded|6
1803776|NCT00506662|6272152|P1|Overall Study|Not recorded|4
1803777|NCT00506662|6272151|P2|Overall Study|Trial terminated|16
1803778|NCT00506662|6272152|P1|Overall Study|Trial terminated|10
1803779|NCT00506662|6272151|P2|Overall Study|Protocol Violation|4
1803780|NCT00506662|6272152|P1|Overall Study|Protocol Violation|2
1803781|NCT00506662|6272151|P2|Overall Study|Lack of Efficacy|0
1803782|NCT00506662|6272152|P1|Overall Study|Lack of Efficacy|1
1803783|NCT00506662|6272151|P2|Overall Study|Adverse Event|2
1803784|NCT00506662|6272152|P1|Overall Study|Adverse Event|0
1803785|NCT00506493|6272186|P1|Overall Study|Withdrawal by Subject|5
1803786|NCT00506493|6272186|P1|Overall Study|Death|6
1803787|NCT00506454|6272195|P2|Overall Study|Withdrawal by Subject|1
1803788|NCT00506454|6272196|P1|Overall Study|Withdrawal by Subject|1
1803789|NCT00506441|6272202|P2|Period 2; Double-blind Period|Other Reason|1
1803790|NCT00506441|6272203|P1|Period 2; Double-blind Period|Other Reason|1
1803791|NCT00506441|6272202|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
1803792|NCT00506441|6272203|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
1803793|NCT00506441|6272202|P2|Period 2; Double-blind Period|Physician Decision|1
1803794|NCT00506441|6272203|P1|Period 2; Double-blind Period|Physician Decision|1
1803795|NCT00506441|6272202|P2|Period 2; Double-blind Period|Lack of Efficacy|2
1803796|NCT00506441|6272203|P1|Period 2; Double-blind Period|Lack of Efficacy|0
1803797|NCT00506441|6272202|P2|Period 2; Double-blind Period|Adverse Event|1
1803798|NCT00506441|6272203|P1|Period 2; Double-blind Period|Adverse Event|0
1803799|NCT00506441|6272202|P2|Period 1; Open-label Period|Other Reasons|0
1803800|NCT00506441|6272203|P1|Period 1; Open-label Period|Other Reasons|13
1803801|NCT00506441|6272202|P2|Period 1; Open-label Period|Withdrawal by Subject|0
1803802|NCT00506441|6272203|P1|Period 1; Open-label Period|Withdrawal by Subject|13
1803803|NCT00506441|6272202|P2|Period 1; Open-label Period|Protocol Violation|0
1803804|NCT00506441|6272203|P1|Period 1; Open-label Period|Protocol Violation|9
1803805|NCT00506441|6272202|P2|Period 1; Open-label Period|Physician Decision|0
1803806|NCT00506441|6272203|P1|Period 1; Open-label Period|Physician Decision|5
1803807|NCT00506441|6272202|P2|Period 1; Open-label Period|Lost to Follow-up|0
1803808|NCT00506441|6272203|P1|Period 1; Open-label Period|Lost to Follow-up|2
1803809|NCT00506441|6272202|P2|Period 1; Open-label Period|Lack of Efficacy|0
1803810|NCT00506441|6272203|P1|Period 1; Open-label Period|Lack of Efficacy|13
1803811|NCT00506441|6272202|P2|Period 1; Open-label Period|Adverse Event|0
1803812|NCT00506441|6272203|P1|Period 1; Open-label Period|Adverse Event|21
1803813|NCT00506415|6272211|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
1803814|NCT00506415|6272212|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
1803815|NCT00506415|6272213|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
1803816|NCT00506415|6272214|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
1803817|NCT00506415|6272211|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
1803818|NCT00506415|6272212|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1803819|NCT00506415|6272213|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1803820|NCT00506415|6272214|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1803821|NCT00506415|6272211|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
1803822|NCT00506415|6272212|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1803823|NCT00506415|6272213|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1803824|NCT00506415|6272214|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
1803825|NCT00506415|6272211|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
1803826|NCT00506415|6272212|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1803827|NCT00506415|6272213|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1803828|NCT00506415|6272214|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1803829|NCT00506415|6272211|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
1803830|NCT00506415|6272212|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1803831|NCT00506415|6272213|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1803832|NCT00506415|6272214|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1803833|NCT00506415|6272211|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
1803834|NCT00506415|6272212|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1803835|NCT00506415|6272213|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1803836|NCT00506415|6272214|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
1803837|NCT00506415|6272211|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
1803838|NCT00506415|6272212|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1803839|NCT00506415|6272213|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1803840|NCT00506415|6272214|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
1803841|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1803842|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
1803843|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1803844|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
1803845|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
1803846|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
1803847|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
1803848|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
1803849|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
1803850|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
1803851|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
1803852|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
1803853|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
1803854|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
1803855|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
1803856|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
1803857|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
1803858|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
1803859|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
1803860|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
1803861|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
1803862|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
1803863|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
1803864|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
1803865|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Death|0
1803866|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Death|3
1803867|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Death|5
1803868|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Death|0
1803869|NCT00506415|6272211|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
1803870|NCT00506415|6272212|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
1803871|NCT00506415|6272213|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
1803872|NCT00506415|6272214|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
1803873|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1803874|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1803875|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
1803876|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
1803877|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
1803878|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
1803879|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
1803880|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
1803881|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1803882|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1803883|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
1803884|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
1803885|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1803886|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1803887|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
1803888|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
1803889|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1803890|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1803891|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
1803892|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
1803893|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1803894|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1803895|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
1803896|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
1803897|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1803898|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1803899|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
1803900|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
1803901|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1803902|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1803903|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
1803904|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
1803905|NCT00506415|6272211|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1803906|NCT00506415|6272212|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1803907|NCT00506415|6272213|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
1803908|NCT00506415|6272214|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
1803909|NCT00506389|6272239|P3|In-treatment Period|Randomized but not treated|1
1803910|NCT00506389|6272240|P2|In-treatment Period|Randomized but not treated|1
1803911|NCT00506389|6272241|P1|In-treatment Period|Randomized but not treated|4
1803912|NCT00506389|6272239|P3|In-treatment Period|Adverse Event|2
1803913|NCT00506389|6272240|P2|In-treatment Period|Adverse Event|5
1803914|NCT00506389|6272241|P1|In-treatment Period|Adverse Event|11
1803915|NCT00506389|6272239|P3|In-treatment Period|Lack of Efficacy|0
1803916|NCT00506389|6272240|P2|In-treatment Period|Lack of Efficacy|2
1803917|NCT00506389|6272241|P1|In-treatment Period|Lack of Efficacy|0
1803918|NCT00506389|6272239|P3|In-treatment Period|Withdrawal by Subject|4
1803919|NCT00506389|6272240|P2|In-treatment Period|Withdrawal by Subject|3
1803920|NCT00506389|6272241|P1|In-treatment Period|Withdrawal by Subject|3
1803921|NCT00506389|6272239|P3|In-treatment Period|Reasons not related to trial|0
1803922|NCT00506389|6272240|P2|In-treatment Period|Reasons not related to trial|1
1803923|NCT00506389|6272241|P1|In-treatment Period|Reasons not related to trial|4
1803924|NCT00506389|6272239|P3|In-treatment Period|Lack of compliance|0
1803925|NCT00506389|6272240|P2|In-treatment Period|Lack of compliance|0
1803926|NCT00506389|6272241|P1|In-treatment Period|Lack of compliance|1
1803927|NCT00506389|6272239|P3|In-treatment Period|Lost to Follow-up|1
1803928|NCT00506389|6272240|P2|In-treatment Period|Lost to Follow-up|0
1803929|NCT00506389|6272241|P1|In-treatment Period|Lost to Follow-up|0
1803930|NCT00506389|6272239|P3|In-treatment Period|Other|4
1803931|NCT00506389|6272240|P2|In-treatment Period|Other|3
1803932|NCT00506389|6272241|P1|In-treatment Period|Other|3
1803933|NCT00506350|6272267|P9|Overall Study|Other|2
1803934|NCT00506350|6272268|P8|Overall Study|Other|2
1803935|NCT00506350|6272269|P7|Overall Study|Other|0
1803936|NCT00506350|6272270|P6|Overall Study|Other|0
1803937|NCT00506350|6272271|P5|Overall Study|Other|3
1803938|NCT00506350|6272272|P4|Overall Study|Other|0
1803939|NCT00506350|6272273|P3|Overall Study|Other|3
1803940|NCT00506350|6272274|P2|Overall Study|Other|1
1803941|NCT00506350|6272275|P1|Overall Study|Other|1
1803942|NCT00506350|6272267|P9|Overall Study|Medical Reason|0
1803943|NCT00506350|6272268|P8|Overall Study|Medical Reason|0
1803944|NCT00506350|6272269|P7|Overall Study|Medical Reason|0
1803945|NCT00506350|6272270|P6|Overall Study|Medical Reason|0
1803946|NCT00506350|6272271|P5|Overall Study|Medical Reason|1
1803947|NCT00506350|6272272|P4|Overall Study|Medical Reason|0
1803948|NCT00506350|6272273|P3|Overall Study|Medical Reason|0
1803949|NCT00506350|6272274|P2|Overall Study|Medical Reason|0
1803950|NCT00506350|6272275|P1|Overall Study|Medical Reason|0
1803951|NCT00506350|6272267|P9|Overall Study|Lost to Follow-up|2
1803952|NCT00506350|6272268|P8|Overall Study|Lost to Follow-up|0
1803953|NCT00506350|6272269|P7|Overall Study|Lost to Follow-up|0
1803954|NCT00506350|6272270|P6|Overall Study|Lost to Follow-up|1
1803955|NCT00506350|6272271|P5|Overall Study|Lost to Follow-up|2
1803956|NCT00506350|6272272|P4|Overall Study|Lost to Follow-up|1
1803957|NCT00506350|6272273|P3|Overall Study|Lost to Follow-up|1
1803958|NCT00506350|6272274|P2|Overall Study|Lost to Follow-up|1
1803959|NCT00506350|6272275|P1|Overall Study|Lost to Follow-up|1
1803960|NCT00506350|6272267|P9|Overall Study|Withdrawal by Subject|0
1803961|NCT00506350|6272268|P8|Overall Study|Withdrawal by Subject|2
1803962|NCT00506350|6272269|P7|Overall Study|Withdrawal by Subject|1
1803963|NCT00506350|6272270|P6|Overall Study|Withdrawal by Subject|1
1803964|NCT00506350|6272271|P5|Overall Study|Withdrawal by Subject|4
1803965|NCT00506350|6272272|P4|Overall Study|Withdrawal by Subject|1
1803966|NCT00506350|6272273|P3|Overall Study|Withdrawal by Subject|1
1803967|NCT00506350|6272274|P2|Overall Study|Withdrawal by Subject|1
1803968|NCT00506350|6272275|P1|Overall Study|Withdrawal by Subject|0
1803969|NCT00506350|6272267|P9|Overall Study|Protocol Violation|0
1803970|NCT00506350|6272268|P8|Overall Study|Protocol Violation|0
1803971|NCT00506350|6272269|P7|Overall Study|Protocol Violation|1
1803972|NCT00506350|6272270|P6|Overall Study|Protocol Violation|0
1803973|NCT00506350|6272271|P5|Overall Study|Protocol Violation|0
1803974|NCT00506350|6272272|P4|Overall Study|Protocol Violation|0
1803975|NCT00506350|6272273|P3|Overall Study|Protocol Violation|1
1803976|NCT00506350|6272274|P2|Overall Study|Protocol Violation|0
1803977|NCT00506350|6272275|P1|Overall Study|Protocol Violation|0
1803978|NCT00506350|6272267|P9|Overall Study|Adverse Event|1
1803979|NCT00506350|6272268|P8|Overall Study|Adverse Event|1
1803980|NCT00506350|6272269|P7|Overall Study|Adverse Event|0
1803981|NCT00506350|6272270|P6|Overall Study|Adverse Event|0
1803982|NCT00506350|6272271|P5|Overall Study|Adverse Event|0
1803983|NCT00506350|6272272|P4|Overall Study|Adverse Event|0
1803984|NCT00506350|6272273|P3|Overall Study|Adverse Event|0
1803985|NCT00506350|6272274|P2|Overall Study|Adverse Event|0
1803986|NCT00506350|6272275|P1|Overall Study|Adverse Event|0
1803987|NCT00506350|6272267|P9|Overall Study|Serious Adverse Event|0
1803988|NCT00506350|6272268|P8|Overall Study|Serious Adverse Event|0
1803989|NCT00506350|6272269|P7|Overall Study|Serious Adverse Event|0
1803990|NCT00506350|6272270|P6|Overall Study|Serious Adverse Event|0
1803991|NCT00506350|6272271|P5|Overall Study|Serious Adverse Event|0
1803992|NCT00506350|6272272|P4|Overall Study|Serious Adverse Event|0
1803993|NCT00506350|6272273|P3|Overall Study|Serious Adverse Event|0
1803994|NCT00506350|6272274|P2|Overall Study|Serious Adverse Event|0
1803995|NCT00506350|6272275|P1|Overall Study|Serious Adverse Event|1
1803996|NCT00506285|6272422|P2|6-month Open Label Phase|Withdrawal by Subject|5
1803997|NCT00506285|6272423|P1|6-month Open Label Phase|Withdrawal by Subject|9
1803998|NCT00506285|6272422|P2|6-month Open Label Phase|Lost to Follow-up|7
1803999|NCT00506285|6272423|P1|6-month Open Label Phase|Lost to Follow-up|1
1804000|NCT00506285|6272422|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
1804001|NCT00506285|6272423|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
1804002|NCT00506285|6272422|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
1804003|NCT00506285|6272423|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
1804004|NCT00506285|6272422|P2|3 Week Screening Phase|Withdrawal by Subject|10
1804005|NCT00506285|6272423|P1|3 Week Screening Phase|Withdrawal by Subject|17
1804006|NCT00506142|6272438|P2|Overall Study|New health condition|0
1804007|NCT00506142|6272439|P1|Overall Study|New health condition|1
1804008|NCT00506142|6272438|P2|Overall Study|Physician Decision|0
1804009|NCT00506142|6272439|P1|Overall Study|Physician Decision|1
1804010|NCT00506142|6272438|P2|Overall Study|Withdrawal by Subject|5
1804011|NCT00506142|6272439|P1|Overall Study|Withdrawal by Subject|4
1804012|NCT00506142|6272438|P2|Overall Study|Lack of Efficacy|7
1804013|NCT00506142|6272439|P1|Overall Study|Lack of Efficacy|21
1804014|NCT00506142|6272438|P2|Overall Study|Adverse Event|7
1804015|NCT00506142|6272439|P1|Overall Study|Adverse Event|8
1804016|NCT00506077|6272447|P2|Treatment Period 2|Withdrawal by Subject|0
1804017|NCT00506077|6272448|P1|Treatment Period 2|Withdrawal by Subject|1
1804018|NCT00506077|6272447|P2|Treatment Period 2|Adverse Event|1
1804019|NCT00506077|6272448|P1|Treatment Period 2|Adverse Event|0
1804020|NCT00506077|6272447|P2|Treatment Period 1|Withdrawal by Subject|0
1804021|NCT00506077|6272448|P1|Treatment Period 1|Withdrawal by Subject|2
1804022|NCT00506077|6272447|P2|Treatment Period 1|Lost to Follow-up|2
1804023|NCT00506077|6272448|P1|Treatment Period 1|Lost to Follow-up|0
1804024|NCT00506077|6272447|P2|Treatment Period 1|Adverse Event|1
1804025|NCT00506077|6272448|P1|Treatment Period 1|Adverse Event|2
1804026|NCT00505934|6272490|P1|Overall Study|Other: IV dose needed to be changed|1
1804027|NCT00505934|6272490|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
1804028|NCT00505934|6272490|P1|Overall Study|Adverse Event|1
1804029|NCT00505921|6272496|P1|Overall Study|Failed to Mobilize|8
1804030|NCT00505921|6272496|P1|Overall Study|Ineligible|1
1804031|NCT00505778|6272513|P2|Overall Study|Took No Study Drug|2
1804032|NCT00505778|6272514|P1|Overall Study|Took No Study Drug|2
1804033|NCT00505778|6272513|P2|Overall Study|Relapse|65
1804034|NCT00505778|6272514|P1|Overall Study|Relapse|65
1804035|NCT00505778|6272513|P2|Overall Study|Withdrawal by Subject|14
1804036|NCT00505778|6272514|P1|Overall Study|Withdrawal by Subject|29
1804037|NCT00505778|6272513|P2|Overall Study|Protocol Violation|9
1804038|NCT00505778|6272514|P1|Overall Study|Protocol Violation|7
1804039|NCT00505778|6272513|P2|Overall Study|Unable to Meet Protocol Criteria|1
1804040|NCT00505778|6272514|P1|Overall Study|Unable to Meet Protocol Criteria|4
1804041|NCT00505778|6272513|P2|Overall Study|Lost to Follow-up|23
1804042|NCT00505778|6272514|P1|Overall Study|Lost to Follow-up|17
1804043|NCT00505778|6272513|P2|Overall Study|Physician Decision|14
1804044|NCT00505778|6272514|P1|Overall Study|Physician Decision|8
1804045|NCT00505778|6272513|P2|Overall Study|Adverse Event|7
1804046|NCT00505778|6272514|P1|Overall Study|Adverse Event|2
1804047|NCT00505765|6272533|P3|Overall Study|Noncompliance|3
1804048|NCT00505765|6272534|P2|Overall Study|Noncompliance|1
1804049|NCT00505765|6272535|P1|Overall Study|Noncompliance|0
1804050|NCT00505765|6272533|P3|Overall Study|Adverse Event|0
1804051|NCT00505765|6272534|P2|Overall Study|Adverse Event|2
1804052|NCT00505765|6272535|P1|Overall Study|Adverse Event|1
1804053|NCT00505765|6272533|P3|Overall Study|Withdrawal by Subject|0
1804054|NCT00505765|6272534|P2|Overall Study|Withdrawal by Subject|0
1804055|NCT00505765|6272535|P1|Overall Study|Withdrawal by Subject|1
1804056|NCT00505752|6272562|P4|Overall Study|Other|2
1804057|NCT00505752|6272563|P3|Overall Study|Other|1
1804058|NCT00505752|6272564|P2|Overall Study|Other|2
1804059|NCT00505752|6272565|P1|Overall Study|Other|1
1804060|NCT00505752|6272562|P4|Overall Study|All embryos/blastocysts discarded|1
1804061|NCT00505752|6272563|P3|Overall Study|All embryos/blastocysts discarded|1
1804062|NCT00505752|6272564|P2|Overall Study|All embryos/blastocysts discarded|0
1804063|NCT00505752|6272565|P1|Overall Study|All embryos/blastocysts discarded|0
1804064|NCT00505752|6272562|P4|Overall Study|No Fertilization|1
1804065|NCT00505752|6272563|P3|Overall Study|No Fertilization|2
1804066|NCT00505752|6272564|P2|Overall Study|No Fertilization|1
1804067|NCT00505752|6272565|P1|Overall Study|No Fertilization|1
1804068|NCT00505752|6272562|P4|Overall Study|No oocytes retrieved|1
1804069|NCT00505752|6272563|P3|Overall Study|No oocytes retrieved|0
1804070|NCT00505752|6272564|P2|Overall Study|No oocytes retrieved|2
1804071|NCT00505752|6272565|P1|Overall Study|No oocytes retrieved|0
1804072|NCT00505752|6272562|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
1804073|NCT00505752|6272563|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
1804074|NCT00505752|6272564|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
1804075|NCT00505752|6272565|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
1804076|NCT00505752|6272562|P4|Overall Study|Lack of ovarian response|0
1804077|NCT00505752|6272563|P3|Overall Study|Lack of ovarian response|0
1804078|NCT00505752|6272564|P2|Overall Study|Lack of ovarian response|3
1804079|NCT00505752|6272565|P1|Overall Study|Lack of ovarian response|1
1804080|NCT00505752|6272562|P4|Overall Study|Lost to Follow-up|0
1804081|NCT00505752|6272563|P3|Overall Study|Lost to Follow-up|0
1804082|NCT00505752|6272564|P2|Overall Study|Lost to Follow-up|0
1804083|NCT00505752|6272565|P1|Overall Study|Lost to Follow-up|1
1804084|NCT00505752|6272562|P4|Overall Study|Adverse Event|0
1804085|NCT00505752|6272563|P3|Overall Study|Adverse Event|1
1804086|NCT00505752|6272564|P2|Overall Study|Adverse Event|0
1804087|NCT00505752|6272565|P1|Overall Study|Adverse Event|1
1804088|NCT00505687|6272579|P1|Overall Study|Other: As Per Sponsor|8
1804089|NCT00505687|6272579|P1|Overall Study|Other: Disease Progression|1
1804090|NCT00505687|6272579|P1|Overall Study|Other: Neupro Given In Hospital|1
1804091|NCT00505687|6272579|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
1804092|NCT00505687|6272579|P1|Overall Study|Other: Prolonged Hospitalization|1
1804093|NCT00505687|6272579|P1|Overall Study|Other: Scheduled DBS Surgery|1
1804094|NCT00505687|6272579|P1|Overall Study|Other: Underwent Implantation Of DBS|1
1804095|NCT00505687|6272579|P1|Overall Study|Lost to Follow-up|1
1804096|NCT00505687|6272579|P1|Overall Study|Subject withdrew consent|15
1804097|NCT00505687|6272579|P1|Overall Study|Adverse Event|48
1804098|NCT00505687|6272579|P1|Overall Study|Lack of Efficacy|15
1804099|NCT00505687|6272579|P1|Overall Study|Important protocol violation|2
1804100|NCT00505661|6272585|P1|Overall Study|Not Eligible|4
1804101|NCT00505622|6272596|P3|Overall Study|Study termination by sponsor|90
1804102|NCT00505622|6272597|P2|Overall Study|Study termination by sponsor|98
1804103|NCT00505622|6272598|P1|Overall Study|Study termination by sponsor|115
1804104|NCT00505622|6272596|P3|Overall Study|Withdrawal by Subject|2
1804105|NCT00505622|6272597|P2|Overall Study|Withdrawal by Subject|3
1804106|NCT00505622|6272598|P1|Overall Study|Withdrawal by Subject|0
1804107|NCT00505622|6272596|P3|Overall Study|Protocol Violation|0
1804108|NCT00505622|6272597|P2|Overall Study|Protocol Violation|1
1804109|NCT00505622|6272598|P1|Overall Study|Protocol Violation|1
1804110|NCT00505622|6272596|P3|Overall Study|Adverse Event|4
1804111|NCT00505622|6272597|P2|Overall Study|Adverse Event|6
1804112|NCT00505622|6272598|P1|Overall Study|Adverse Event|5
1804113|NCT00505414|6272623|P5|Maintenance Phase|underlying disease and therapy required|0
1804114|NCT00505414|6272624|P4|Maintenance Phase|underlying disease and therapy required|0
1804115|NCT00505414|6272625|P3|Maintenance Phase|underlying disease and therapy required|2
1804116|NCT00505414|6272626|P2|Maintenance Phase|underlying disease and therapy required|2
1804117|NCT00505414|6272627|P1|Maintenance Phase|underlying disease and therapy required|0
1804118|NCT00505414|6272623|P5|Maintenance Phase|Withdrawal by Subject|0
1804119|NCT00505414|6272624|P4|Maintenance Phase|Withdrawal by Subject|0
1804120|NCT00505414|6272625|P3|Maintenance Phase|Withdrawal by Subject|1
1804121|NCT00505414|6272626|P2|Maintenance Phase|Withdrawal by Subject|0
1804122|NCT00505414|6272627|P1|Maintenance Phase|Withdrawal by Subject|0
1804123|NCT00505414|6272623|P5|Maintenance Phase|Lack of Efficacy|0
1804124|NCT00505414|6272624|P4|Maintenance Phase|Lack of Efficacy|0
1804125|NCT00505414|6272625|P3|Maintenance Phase|Lack of Efficacy|1
1804126|NCT00505414|6272626|P2|Maintenance Phase|Lack of Efficacy|1
1804127|NCT00505414|6272627|P1|Maintenance Phase|Lack of Efficacy|2
1804128|NCT00505414|6272623|P5|Maintenance Phase|Death|0
1804129|NCT00505414|6272624|P4|Maintenance Phase|Death|0
1804130|NCT00505414|6272625|P3|Maintenance Phase|Death|1
1804131|NCT00505414|6272626|P2|Maintenance Phase|Death|0
1804132|NCT00505414|6272627|P1|Maintenance Phase|Death|2
1804133|NCT00505414|6272623|P5|Maintenance Phase|Adverse Event|0
1804134|NCT00505414|6272624|P4|Maintenance Phase|Adverse Event|0
1804135|NCT00505414|6272625|P3|Maintenance Phase|Adverse Event|3
1804136|NCT00505414|6272626|P2|Maintenance Phase|Adverse Event|2
1804137|NCT00505414|6272627|P1|Maintenance Phase|Adverse Event|2
1804138|NCT00505414|6272623|P5|Titration Phase|Underlying disease and therapy required|3
1804139|NCT00505414|6272624|P4|Titration Phase|Underlying disease and therapy required|7
1804140|NCT00505414|6272625|P3|Titration Phase|Underlying disease and therapy required|0
1804141|NCT00505414|6272626|P2|Titration Phase|Underlying disease and therapy required|0
1804142|NCT00505414|6272627|P1|Titration Phase|Underlying disease and therapy required|0
1804143|NCT00505414|6272623|P5|Titration Phase|Withdrawal by Subject|4
1804144|NCT00505414|6272624|P4|Titration Phase|Withdrawal by Subject|3
1804145|NCT00505414|6272625|P3|Titration Phase|Withdrawal by Subject|0
1804146|NCT00505414|6272626|P2|Titration Phase|Withdrawal by Subject|0
1804147|NCT00505414|6272627|P1|Titration Phase|Withdrawal by Subject|0
1804148|NCT00505414|6272623|P5|Titration Phase|Protocol Violation|1
1804149|NCT00505414|6272624|P4|Titration Phase|Protocol Violation|0
1804150|NCT00505414|6272625|P3|Titration Phase|Protocol Violation|0
1804151|NCT00505414|6272626|P2|Titration Phase|Protocol Violation|0
1804152|NCT00505414|6272627|P1|Titration Phase|Protocol Violation|0
1804153|NCT00505414|6272623|P5|Titration Phase|Lack of Efficacy|1
1804154|NCT00505414|6272624|P4|Titration Phase|Lack of Efficacy|10
1804155|NCT00505414|6272625|P3|Titration Phase|Lack of Efficacy|0
1804156|NCT00505414|6272626|P2|Titration Phase|Lack of Efficacy|0
1804157|NCT00505414|6272627|P1|Titration Phase|Lack of Efficacy|0
1804158|NCT00505414|6272623|P5|Titration Phase|Death|0
1804159|NCT00505414|6272624|P4|Titration Phase|Death|2
1804160|NCT00505414|6272625|P3|Titration Phase|Death|0
1804161|NCT00505414|6272626|P2|Titration Phase|Death|0
1804162|NCT00505414|6272627|P1|Titration Phase|Death|0
1804163|NCT00505414|6272623|P5|Titration Phase|Adverse Event|3
1804164|NCT00505414|6272624|P4|Titration Phase|Adverse Event|8
1804165|NCT00505414|6272625|P3|Titration Phase|Adverse Event|0
1804166|NCT00505414|6272626|P2|Titration Phase|Adverse Event|0
1804167|NCT00505414|6272627|P1|Titration Phase|Adverse Event|0
1804168|NCT00505375|6272644|P2|Overall Study|Travel issues|1
1804169|NCT00505375|6272645|P1|Overall Study|Travel issues|0
1804170|NCT00505375|6272644|P2|Overall Study|Pregnancy|0
1804171|NCT00505375|6272645|P1|Overall Study|Pregnancy|1
1804172|NCT00505375|6272644|P2|Overall Study|Lost to Follow-up|2
1804173|NCT00505375|6272645|P1|Overall Study|Lost to Follow-up|0
1804174|NCT00505375|6272644|P2|Overall Study|Withdrawal by Subject|2
1804175|NCT00505375|6272645|P1|Overall Study|Withdrawal by Subject|2
1804176|NCT00505375|6272644|P2|Overall Study|Death|0
1804177|NCT00505375|6272645|P1|Overall Study|Death|1
1804178|NCT00505284|6272667|P5|Overall Study|Other|4
1804179|NCT00505284|6272668|P4|Overall Study|Other|4
1804180|NCT00505284|6272669|P3|Overall Study|Other|0
1804181|NCT00505284|6272670|P2|Overall Study|Other|0
1804182|NCT00505284|6272671|P1|Overall Study|Other|5
1804183|NCT00505284|6272667|P5|Overall Study|Physician Decision|0
1804184|NCT00505284|6272668|P4|Overall Study|Physician Decision|0
1804185|NCT00505284|6272669|P3|Overall Study|Physician Decision|0
1804186|NCT00505284|6272670|P2|Overall Study|Physician Decision|1
1804187|NCT00505284|6272671|P1|Overall Study|Physician Decision|0
1804188|NCT00505284|6272667|P5|Overall Study|Lack of Efficacy|1
1804189|NCT00505284|6272668|P4|Overall Study|Lack of Efficacy|1
1804190|NCT00505284|6272669|P3|Overall Study|Lack of Efficacy|1
1804191|NCT00505284|6272670|P2|Overall Study|Lack of Efficacy|1
1804192|NCT00505284|6272671|P1|Overall Study|Lack of Efficacy|0
1804193|NCT00505284|6272667|P5|Overall Study|Withdrawal by Subject|6
1804194|NCT00505284|6272668|P4|Overall Study|Withdrawal by Subject|0
1804195|NCT00505284|6272669|P3|Overall Study|Withdrawal by Subject|1
1804196|NCT00505284|6272670|P2|Overall Study|Withdrawal by Subject|6
1804197|NCT00505284|6272671|P1|Overall Study|Withdrawal by Subject|2
1804198|NCT00505284|6272667|P5|Overall Study|Protocol Violation|0
1804199|NCT00505284|6272668|P4|Overall Study|Protocol Violation|0
1804200|NCT00505284|6272669|P3|Overall Study|Protocol Violation|1
1804201|NCT00505284|6272670|P2|Overall Study|Protocol Violation|1
1804202|NCT00505284|6272671|P1|Overall Study|Protocol Violation|0
1804203|NCT00505284|6272667|P5|Overall Study|Adverse Event|22
1804204|NCT00505284|6272668|P4|Overall Study|Adverse Event|14
1804205|NCT00505284|6272669|P3|Overall Study|Adverse Event|9
1804206|NCT00505284|6272670|P2|Overall Study|Adverse Event|7
1804207|NCT00505284|6272671|P1|Overall Study|Adverse Event|3
1804208|NCT00505076|6272741|P3|Overall Study|Withdrawal by Subject|2
1804209|NCT00505076|6272742|P2|Overall Study|Withdrawal by Subject|1
1804210|NCT00505076|6272743|P1|Overall Study|Withdrawal by Subject|0
1804211|NCT00505076|6272741|P3|Overall Study|Protocol Violation|2
1804212|NCT00505076|6272742|P2|Overall Study|Protocol Violation|1
1804213|NCT00505076|6272743|P1|Overall Study|Protocol Violation|2
1804214|NCT00505076|6272741|P3|Overall Study|Adverse Event|1
1804215|NCT00505076|6272742|P2|Overall Study|Adverse Event|0
1804216|NCT00505076|6272743|P1|Overall Study|Adverse Event|1
1804217|NCT00504881|6272772|P2|Overall Study|AE of unknown type|0
1804218|NCT00504881|6272773|P1|Overall Study|AE of unknown type|1
1804219|NCT00504881|6272772|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
1804220|NCT00504881|6272773|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1804221|NCT00504881|6272772|P2|Overall Study|AE, non-serious non-fatal|14
1804222|NCT00504881|6272773|P1|Overall Study|AE, non-serious non-fatal|4
1804223|NCT00504881|6272772|P2|Overall Study|SAE, non-fatal|6
1804224|NCT00504881|6272773|P1|Overall Study|SAE, non-fatal|2
1804225|NCT00504881|6272772|P2|Overall Study|AE, serious fatal|1
1804226|NCT00504881|6272773|P1|Overall Study|AE, serious fatal|0
1804227|NCT00504881|6272772|P2|Overall Study|Safety Visit not performed|1
1804228|NCT00504881|6272773|P1|Overall Study|Safety Visit not performed|0
1804229|NCT00504881|6272772|P2|Overall Study|No Birth Control|1
1804230|NCT00504881|6272773|P1|Overall Study|No Birth Control|0
1804231|NCT00504881|6272772|P2|Overall Study|Non-Compliance|0
1804232|NCT00504881|6272773|P1|Overall Study|Non-Compliance|1
1804233|NCT00504881|6272772|P2|Overall Study|Withdrawal by Subject|4
1804234|NCT00504881|6272773|P1|Overall Study|Withdrawal by Subject|1
1804235|NCT00504881|6272772|P2|Overall Study|Lost to Follow-up|2
1804236|NCT00504881|6272773|P1|Overall Study|Lost to Follow-up|0
1804237|NCT00504881|6272772|P2|Overall Study|Lack of Efficacy|5
1804238|NCT00504881|6272773|P1|Overall Study|Lack of Efficacy|1
1804242|NCT00504777|6272837|P1|Overall Study|Adverse Event|1
1804243|NCT00504725|6272850|P2|Overall Study|Protocol Violation|0
1804244|NCT00504725|6272851|P1|Overall Study|Protocol Violation|1
1804245|NCT00504595|6272874|P4|Overall Study|Other|0
1804246|NCT00504595|6272875|P3|Overall Study|Other|2
1804247|NCT00504595|6272876|P2|Overall Study|Other|0
1804248|NCT00504595|6272877|P1|Overall Study|Other|0
1804249|NCT00504595|6272874|P4|Overall Study|Lack of Efficacy|0
1804250|NCT00504595|6272875|P3|Overall Study|Lack of Efficacy|0
1804251|NCT00504595|6272876|P2|Overall Study|Lack of Efficacy|0
1804252|NCT00504595|6272877|P1|Overall Study|Lack of Efficacy|1
1804253|NCT00504556|6272894|P5|Overall Study|not in safety analysis set|1
1804254|NCT00504556|6272895|P4|Overall Study|not in safety analysis set|0
1804255|NCT00504556|6272896|P3|Overall Study|not in safety analysis set|1
1804256|NCT00504556|6272897|P2|Overall Study|not in safety analysis set|1
1804257|NCT00504556|6272898|P1|Overall Study|not in safety analysis set|0
1804258|NCT00504556|6272894|P5|Overall Study|Other|0
1804259|NCT00504556|6272895|P4|Overall Study|Other|3
1804260|NCT00504556|6272896|P3|Overall Study|Other|2
1804261|NCT00504556|6272897|P2|Overall Study|Other|2
1804262|NCT00504556|6272898|P1|Overall Study|Other|2
1804263|NCT00504556|6272894|P5|Overall Study|data monitor committee decision|0
1804264|NCT00504556|6272895|P4|Overall Study|data monitor committee decision|100
1804265|NCT00504556|6272896|P3|Overall Study|data monitor committee decision|0
1804266|NCT00504556|6272897|P2|Overall Study|data monitor committee decision|0
1804267|NCT00504556|6272898|P1|Overall Study|data monitor committee decision|0
1804268|NCT00504556|6272894|P5|Overall Study|did not meet entry criteria|0
1804269|NCT00504556|6272895|P4|Overall Study|did not meet entry criteria|1
1804270|NCT00504556|6272896|P3|Overall Study|did not meet entry criteria|1
1804271|NCT00504556|6272897|P2|Overall Study|did not meet entry criteria|0
1804272|NCT00504556|6272898|P1|Overall Study|did not meet entry criteria|2
1804273|NCT00504556|6272894|P5|Overall Study|administrative reasons|2
1804274|NCT00504556|6272895|P4|Overall Study|administrative reasons|1
1804275|NCT00504556|6272896|P3|Overall Study|administrative reasons|2
1804276|NCT00504556|6272897|P2|Overall Study|administrative reasons|2
1804277|NCT00504556|6272898|P1|Overall Study|administrative reasons|0
1804278|NCT00504556|6272894|P5|Overall Study|Withdrawal by Subject|12
1804279|NCT00504556|6272895|P4|Overall Study|Withdrawal by Subject|8
1804280|NCT00504556|6272896|P3|Overall Study|Withdrawal by Subject|7
1804281|NCT00504556|6272897|P2|Overall Study|Withdrawal by Subject|16
1804282|NCT00504556|6272898|P1|Overall Study|Withdrawal by Subject|16
1804283|NCT00504556|6272894|P5|Overall Study|Lost to Follow-up|1
1804284|NCT00504556|6272895|P4|Overall Study|Lost to Follow-up|1
1804285|NCT00504556|6272896|P3|Overall Study|Lost to Follow-up|1
1804286|NCT00504556|6272897|P2|Overall Study|Lost to Follow-up|0
1804287|NCT00504556|6272898|P1|Overall Study|Lost to Follow-up|0
1804288|NCT00504556|6272894|P5|Overall Study|Protocol Violation|2
1804289|NCT00504556|6272895|P4|Overall Study|Protocol Violation|1
1804290|NCT00504556|6272896|P3|Overall Study|Protocol Violation|2
1804291|NCT00504556|6272897|P2|Overall Study|Protocol Violation|3
1804292|NCT00504556|6272898|P1|Overall Study|Protocol Violation|1
1804293|NCT00504556|6272894|P5|Overall Study|Death|2
1804294|NCT00504556|6272895|P4|Overall Study|Death|0
1804295|NCT00504556|6272896|P3|Overall Study|Death|1
1804296|NCT00504556|6272897|P2|Overall Study|Death|3
1804297|NCT00504556|6272898|P1|Overall Study|Death|3
1804298|NCT00504556|6272894|P5|Overall Study|Adverse Event|5
1804299|NCT00504556|6272895|P4|Overall Study|Adverse Event|13
1804300|NCT00504556|6272896|P3|Overall Study|Adverse Event|14
1804301|NCT00504556|6272897|P2|Overall Study|Adverse Event|11
1804302|NCT00504556|6272898|P1|Overall Study|Adverse Event|11
1804303|NCT00504426|6272966|P4|Overall Study|Withdrawal by Subject|0
1804304|NCT00504426|6272967|P3|Overall Study|Withdrawal by Subject|0
1804305|NCT00504426|6272968|P2|Overall Study|Withdrawal by Subject|0
1804306|NCT00504426|6272969|P1|Overall Study|Withdrawal by Subject|2
1804307|NCT00504426|6272966|P4|Overall Study|Protocol Violation|0
1804308|NCT00504426|6272967|P3|Overall Study|Protocol Violation|2
1804309|NCT00504426|6272968|P2|Overall Study|Protocol Violation|1
1804310|NCT00504426|6272969|P1|Overall Study|Protocol Violation|1
1804311|NCT00504426|6272966|P4|Overall Study|Adverse Event|0
1804312|NCT00504426|6272967|P3|Overall Study|Adverse Event|2
1804313|NCT00504426|6272968|P2|Overall Study|Adverse Event|0
1804314|NCT00504426|6272969|P1|Overall Study|Adverse Event|0
1804315|NCT00504309|6272989|P6|Overall Study|Withdrawal by Subject|0
1804316|NCT00504309|6272990|P5|Overall Study|Withdrawal by Subject|0
1804317|NCT00504309|6272991|P4|Overall Study|Withdrawal by Subject|0
1804318|NCT00504309|6272992|P3|Overall Study|Withdrawal by Subject|1
1804319|NCT00504309|6272993|P2|Overall Study|Withdrawal by Subject|0
1804320|NCT00504309|6272994|P1|Overall Study|Withdrawal by Subject|0
1804321|NCT00504309|6272989|P6|Overall Study|Death|0
1804322|NCT00504309|6272990|P5|Overall Study|Death|1
1804323|NCT00504309|6272991|P4|Overall Study|Death|0
1804324|NCT00504309|6272992|P3|Overall Study|Death|0
1804325|NCT00504309|6272993|P2|Overall Study|Death|0
1804326|NCT00504309|6272994|P1|Overall Study|Death|0
1804327|NCT00504257|6273032|P1|Overall Study|ineligible histology|2
1804328|NCT00504257|6273032|P1|Overall Study|Withdrawal by Subject|2
1804329|NCT00504231|6273044|P4|Overall Study|Discrepant chart documentation re route|0
1804330|NCT00504231|6273045|P3|Overall Study|Discrepant chart documentation re route|1
1804331|NCT00504231|6273046|P2|Overall Study|Discrepant chart documentation re route|0
1804332|NCT00504231|6273047|P1|Overall Study|Discrepant chart documentation re route|0
1804333|NCT00504166|6273067|P2|Overall Study|Lost to Follow-up|3
1804334|NCT00504166|6273068|P1|Overall Study|Lost to Follow-up|1
1804335|NCT00504166|6273067|P2|Overall Study|Physician Decision|1
1804336|NCT00504166|6273068|P1|Overall Study|Physician Decision|1
1804337|NCT00504166|6273067|P2|Overall Study|Withdrawal by Subject|6
1804338|NCT00504166|6273068|P1|Overall Study|Withdrawal by Subject|3
1804339|NCT00504166|6273067|P2|Overall Study|Adverse Event|4
1804340|NCT00504166|6273068|P1|Overall Study|Adverse Event|1
1804341|NCT00504153|6273074|P1|Overall Study|Death|1
1804342|NCT00504153|6273074|P1|Overall Study|Adverse Event|4
1804343|NCT00504153|6273074|P1|Overall Study|Withdrawal by Subject|1
1804344|NCT00504075|6273082|P1|Overall Study|Required other therapeutic intervention|1
1804345|NCT00504075|6273082|P1|Overall Study|Withdrawal by Subject|1
1804346|NCT00504075|6273082|P1|Overall Study|Lost to Follow-up|5
1804347|NCT00504075|6273082|P1|Overall Study|Adverse Event|1
1804348|NCT00503997|6273092|P1|Overall Study|Withdrawal by Subject|1
1804349|NCT00503997|6273092|P1|Overall Study|Death|1
1804350|NCT00503997|6273092|P1|Overall Study|Adverse Event|5
1804351|NCT00503997|6273092|P1|Overall Study|disease progression|1
1804352|NCT00503984|6273098|P6|Overall Study|Death|0
1804353|NCT00503984|6273099|P5|Overall Study|Death|1
1804354|NCT00503984|6273100|P4|Overall Study|Death|0
1804355|NCT00503984|6273101|P3|Overall Study|Death|0
1804356|NCT00503984|6273102|P2|Overall Study|Death|0
1804357|NCT00503984|6273103|P1|Overall Study|Death|0
1804358|NCT00503984|6273098|P6|Overall Study|Adverse Event|0
1804359|NCT00503984|6273099|P5|Overall Study|Adverse Event|0
1804360|NCT00503984|6273100|P4|Overall Study|Adverse Event|0
1804361|NCT00503984|6273101|P3|Overall Study|Adverse Event|0
1804362|NCT00503984|6273102|P2|Overall Study|Adverse Event|1
1804363|NCT00503984|6273103|P1|Overall Study|Adverse Event|0
1804364|NCT00503984|6273098|P6|Overall Study|Protocol Violation|0
1804365|NCT00503984|6273099|P5|Overall Study|Protocol Violation|0
1804366|NCT00503984|6273100|P4|Overall Study|Protocol Violation|0
1804367|NCT00503984|6273101|P3|Overall Study|Protocol Violation|0
1804368|NCT00503984|6273102|P2|Overall Study|Protocol Violation|1
1804369|NCT00503984|6273103|P1|Overall Study|Protocol Violation|0
1804370|NCT00503906|6273129|P1|Overall Study|Withdrawal by Subject|1
1804371|NCT00503841|6273151|P1|Overall Study|All screen failures|44
1804372|NCT00503776|6273162|P4|Overall Study|Physician Decision|1
1804373|NCT00503776|6273163|P3|Overall Study|Physician Decision|1
1804374|NCT00503776|6273164|P2|Overall Study|Physician Decision|0
1804375|NCT00503776|6273165|P1|Overall Study|Physician Decision|0
1804376|NCT00503776|6273162|P4|Overall Study|Withdrawal by Subject|1
1804377|NCT00503776|6273163|P3|Overall Study|Withdrawal by Subject|1
1804378|NCT00503776|6273164|P2|Overall Study|Withdrawal by Subject|0
1804379|NCT00503776|6273165|P1|Overall Study|Withdrawal by Subject|1
1804380|NCT00503698|6273198|P2|Overall Study|Not exposed to trial drug|6
1804381|NCT00503698|6273199|P1|Overall Study|Not exposed to trial drug|11
1804382|NCT00503698|6273198|P2|Overall Study|Unclassified|32
1804383|NCT00503698|6273199|P1|Overall Study|Unclassified|48
1804384|NCT00503698|6273198|P2|Overall Study|Critically ill|0
1804385|NCT00503698|6273199|P1|Overall Study|Critically ill|2
1804386|NCT00503698|6273198|P2|Overall Study|Move to nonparticipating dialysis center|1
1804387|NCT00503698|6273199|P1|Overall Study|Move to nonparticipating dialysis center|2
1804388|NCT00503698|6273198|P2|Overall Study|Switch to peritoneal or home dialysis|2
1804389|NCT00503698|6273199|P1|Overall Study|Switch to peritoneal or home dialysis|2
1804390|NCT00503698|6273198|P2|Overall Study|Any condition in exclusion criteria|6
1804391|NCT00503698|6273199|P1|Overall Study|Any condition in exclusion criteria|4
1804392|NCT00503698|6273198|P2|Overall Study|Pregnancy/intention to become pregnant|0
1804393|NCT00503698|6273199|P1|Overall Study|Pregnancy/intention to become pregnant|1
1804394|NCT00503698|6273198|P2|Overall Study|End hemodialysis due to renal transplant|4
1804395|NCT00503698|6273199|P1|Overall Study|End hemodialysis due to renal transplant|10
1804396|NCT00503698|6273198|P2|Overall Study|Trial terminated|253
1804397|NCT00503698|6273199|P1|Overall Study|Trial terminated|216
1804398|NCT00503698|6273198|P2|Overall Study|Lack of Efficacy|4
1804399|NCT00503698|6273199|P1|Overall Study|Lack of Efficacy|3
1804400|NCT00503698|6273198|P2|Overall Study|Death|0
1804401|NCT00503698|6273199|P1|Overall Study|Death|1
1804402|NCT00503698|6273198|P2|Overall Study|Adverse Event|41
1804403|NCT00503698|6273199|P1|Overall Study|Adverse Event|52
1804404|NCT00503698|6273198|P2|Overall Study|Protocol Violation|6
1804405|NCT00503698|6273199|P1|Overall Study|Protocol Violation|5
1804406|NCT00503685|6273216|P3|Overall Study|Eligibility Criteria Not Met|0
1804407|NCT00503685|6273217|P2|Overall Study|Eligibility Criteria Not Met|1
1804408|NCT00503685|6273218|P1|Overall Study|Eligibility Criteria Not Met|0
1804409|NCT00503685|6273216|P3|Overall Study|Protocol Violation|0
1804410|NCT00503685|6273217|P2|Overall Study|Protocol Violation|1
1804411|NCT00503685|6273218|P1|Overall Study|Protocol Violation|0
1804412|NCT00503685|6273216|P3|Overall Study|Withdrawal by Subject|0
1804413|NCT00503685|6273217|P2|Overall Study|Withdrawal by Subject|1
1804414|NCT00503685|6273218|P1|Overall Study|Withdrawal by Subject|0
1804415|NCT00503685|6273216|P3|Overall Study|Adverse Event|2
1804416|NCT00503685|6273217|P2|Overall Study|Adverse Event|0
1804417|NCT00503685|6273218|P1|Overall Study|Adverse Event|0
1804418|NCT00503425|6273260|P1|Overall Study|Missing Data/Unknown|4
1804419|NCT00503425|6273260|P1|Overall Study|Death|3
1804420|NCT00503425|6273260|P1|Overall Study|Lost to Follow-up|3
1804421|NCT00503425|6273260|P1|Overall Study|Withdrawal by Subject|8
1804422|NCT00503425|6273260|P1|Overall Study|Lack of Efficacy|25
1804423|NCT00503425|6273260|P1|Overall Study|Adverse Event|5
1804424|NCT00503425|6273260|P1|Overall Study|Participant files lost|6
1804425|NCT00503399|6273270|P2|Overall Study|Lost to Follow-up|2
1804426|NCT00503399|6273271|P1|Overall Study|Lost to Follow-up|0
1804427|NCT00503399|6273270|P2|Overall Study|Adverse Event|3
1804428|NCT00503399|6273271|P1|Overall Study|Adverse Event|0
1804429|NCT00503399|6273270|P2|Overall Study|Withdrawal by Subject|2
1804430|NCT00503399|6273271|P1|Overall Study|Withdrawal by Subject|4
1804431|NCT00503399|6273270|P2|Overall Study|Protocol Violation|0
1804432|NCT00503399|6273271|P1|Overall Study|Protocol Violation|1
1804433|NCT00503399|6273270|P2|Overall Study|Death|1
1804434|NCT00503399|6273271|P1|Overall Study|Death|2
1804435|NCT00503308|6273295|P2|Overall Study|Protocol Violation|1
1804436|NCT00503308|6273296|P1|Overall Study|Protocol Violation|2
1804437|NCT00503139|6273302|P1|Overall Study|Protocol Violation|4
1804438|NCT00503139|6273302|P1|Overall Study|Case Report Forms were not collected|4
1804439|NCT00503009|6273350|P3|Overall Study|Physician Decision|1
1804440|NCT00503009|6273351|P2|Overall Study|Physician Decision|1
1804441|NCT00503009|6273352|P1|Overall Study|Physician Decision|0
1804442|NCT00503009|6273350|P3|Overall Study|Withdrawal by Subject|1
1804443|NCT00503009|6273351|P2|Overall Study|Withdrawal by Subject|1
1804444|NCT00503009|6273352|P1|Overall Study|Withdrawal by Subject|0
1804445|NCT00503009|6273350|P3|Overall Study|Protocol Violation|1
1804446|NCT00503009|6273351|P2|Overall Study|Protocol Violation|0
1804447|NCT00503009|6273352|P1|Overall Study|Protocol Violation|1
1804448|NCT00502996|6273369|P1|Overall Study|Adverse Event|2
1804449|NCT00502996|6273369|P1|Overall Study|Withdrawal Informed Consent|6
1804450|NCT00502996|6273369|P1|Overall Study|Treatment failure|25
1804451|NCT00502996|6273369|P1|Overall Study|Protocol Violation|2
1804452|NCT00502996|6273369|P1|Overall Study|Lost to Follow-up|9
1804453|NCT00502840|6273437|P1|Overall Study|Other|20
1804454|NCT00502840|6273437|P1|Overall Study|Administrative problems|1
1804455|NCT00502840|6273437|P1|Overall Study|Lost to Follow-up|6
1804456|NCT00502840|6273437|P1|Overall Study|Withdrawal by Subject|5
1804457|NCT00502840|6273437|P1|Overall Study|Protocol Violation|4
1804458|NCT00502840|6273437|P1|Overall Study|Lack of Efficacy|11
1804459|NCT00502840|6273437|P1|Overall Study|Additional or changed therapy|48
1804460|NCT00502840|6273437|P1|Overall Study|Adverse Event|5
1804461|NCT00502801|6273465|P1|End of Therapy to Test of Cure|OTHER|2
1804462|NCT00502801|6273465|P1|End of Therapy to Test of Cure|Death|3
1804463|NCT00502801|6273465|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
1804464|NCT00502801|6273465|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
1804465|NCT00502801|6273465|P1|Treatment Period|OTHER|30
1804466|NCT00502801|6273465|P1|Treatment Period|Death|14
1804467|NCT00502801|6273465|P1|Treatment Period|Adverse Event|7
1804468|NCT00502801|6273465|P1|Treatment Period|Withdrawal by Subject|3
1804469|NCT00502775|6273473|P3|Overall Study|Subject took disallowed drug|1
1804470|NCT00502775|6273474|P2|Overall Study|Subject took disallowed drug|0
1804471|NCT00502775|6273475|P1|Overall Study|Subject took disallowed drug|0
1804472|NCT00502775|6273473|P3|Overall Study|Subject in jail|0
1804473|NCT00502775|6273474|P2|Overall Study|Subject in jail|1
1804474|NCT00502775|6273475|P1|Overall Study|Subject in jail|0
1804475|NCT00502775|6273473|P3|Overall Study|Declining pollen counts|1
1804476|NCT00502775|6273474|P2|Overall Study|Declining pollen counts|1
1804477|NCT00502775|6273475|P1|Overall Study|Declining pollen counts|0
1804478|NCT00502775|6273473|P3|Overall Study|Outside pollen area more than 48 hours|0
1804479|NCT00502775|6273474|P2|Overall Study|Outside pollen area more than 48 hours|1
1804480|NCT00502775|6273475|P1|Overall Study|Outside pollen area more than 48 hours|0
1804481|NCT00502775|6273473|P3|Overall Study|Non-compliance|2
1804482|NCT00502775|6273474|P2|Overall Study|Non-compliance|2
1804483|NCT00502775|6273475|P1|Overall Study|Non-compliance|0
1804484|NCT00502775|6273473|P3|Overall Study|Randomized in error|1
1804485|NCT00502775|6273474|P2|Overall Study|Randomized in error|1
1804486|NCT00502775|6273475|P1|Overall Study|Randomized in error|0
1804487|NCT00502775|6273473|P3|Overall Study|Logpad compliance <80%|0
1804488|NCT00502775|6273474|P2|Overall Study|Logpad compliance <80%|0
1804489|NCT00502775|6273475|P1|Overall Study|Logpad compliance <80%|1
1804490|NCT00502775|6273473|P3|Overall Study|Subject unable to swallow capsule|1
1804491|NCT00502775|6273474|P2|Overall Study|Subject unable to swallow capsule|0
1804492|NCT00502775|6273475|P1|Overall Study|Subject unable to swallow capsule|1
1804493|NCT00502775|6273473|P3|Overall Study|Non-compliance with eDiary|1
1804494|NCT00502775|6273474|P2|Overall Study|Non-compliance with eDiary|1
1804495|NCT00502775|6273475|P1|Overall Study|Non-compliance with eDiary|4
1804496|NCT00502775|6273473|P3|Overall Study|Sponsor Terminated Study|1
1804497|NCT00502775|6273474|P2|Overall Study|Sponsor Terminated Study|0
1804498|NCT00502775|6273475|P1|Overall Study|Sponsor Terminated Study|1
1804499|NCT00502775|6273473|P3|Overall Study|Withdrawal by Subject|2
1804500|NCT00502775|6273474|P2|Overall Study|Withdrawal by Subject|1
1804501|NCT00502775|6273475|P1|Overall Study|Withdrawal by Subject|1
1804502|NCT00502775|6273473|P3|Overall Study|Protocol Violation|2
1804503|NCT00502775|6273474|P2|Overall Study|Protocol Violation|5
1804504|NCT00502775|6273475|P1|Overall Study|Protocol Violation|1
1804505|NCT00502775|6273473|P3|Overall Study|Adverse Event|1
1804506|NCT00502775|6273474|P2|Overall Study|Adverse Event|2
1804507|NCT00502775|6273475|P1|Overall Study|Adverse Event|1
1804508|NCT00502697|6273518|P2|Overall Study|did not meet assignment criteria|2
1804509|NCT00502697|6273519|P1|Overall Study|did not meet assignment criteria|4
1804510|NCT00502697|6273518|P2|Overall Study|found not to meet eligibility criteria|4
1804511|NCT00502697|6273519|P1|Overall Study|found not to meet eligibility criteria|3
1804512|NCT00502697|6273518|P2|Overall Study|disenrolled due to pregnancy loss|5
1804513|NCT00502697|6273519|P1|Overall Study|disenrolled due to pregnancy loss|3
1804514|NCT00502697|6273518|P2|Overall Study|Withdrawal by Subject|1
1804515|NCT00502697|6273519|P1|Overall Study|Withdrawal by Subject|3
1804516|NCT00502671|6273527|P1|Overall Study|Adverse Event|19
1804517|NCT00502671|6273527|P1|Overall Study|Protocol Violation|16
1804518|NCT00502671|6273527|P1|Overall Study|Lost to Follow-up|7
1804519|NCT00502671|6273527|P1|Overall Study|Personal Reasons|22
1804520|NCT00502671|6273527|P1|Overall Study|Disease Progression|13
1804521|NCT00502593|6273544|P12|Overall Study|Lost to Follow-up|0
1804522|NCT00502593|6273545|P11|Overall Study|Lost to Follow-up|1
1804523|NCT00502593|6273546|P10|Overall Study|Lost to Follow-up|0
1804524|NCT00502593|6273547|P9|Overall Study|Lost to Follow-up|3
1804525|NCT00502593|6273548|P8|Overall Study|Lost to Follow-up|0
1804526|NCT00502593|6273549|P7|Overall Study|Lost to Follow-up|0
1804527|NCT00502593|6273550|P6|Overall Study|Lost to Follow-up|0
1804528|NCT00502593|6273551|P5|Overall Study|Lost to Follow-up|0
1804529|NCT00502593|6273552|P4|Overall Study|Lost to Follow-up|1
1804530|NCT00502593|6273553|P3|Overall Study|Lost to Follow-up|1
1804531|NCT00502593|6273554|P2|Overall Study|Lost to Follow-up|1
1804532|NCT00502593|6273555|P1|Overall Study|Lost to Follow-up|2
1804533|NCT00502593|6273544|P12|Overall Study|Withdrawal by Subject|0
1804534|NCT00502593|6273545|P11|Overall Study|Withdrawal by Subject|1
1804535|NCT00502593|6273546|P10|Overall Study|Withdrawal by Subject|0
1804536|NCT00502593|6273547|P9|Overall Study|Withdrawal by Subject|3
1804537|NCT00502593|6273548|P8|Overall Study|Withdrawal by Subject|0
1804538|NCT00502593|6273549|P7|Overall Study|Withdrawal by Subject|3
1804539|NCT00502593|6273550|P6|Overall Study|Withdrawal by Subject|0
1804540|NCT00502593|6273551|P5|Overall Study|Withdrawal by Subject|2
1804541|NCT00502593|6273552|P4|Overall Study|Withdrawal by Subject|2
1804542|NCT00502593|6273553|P3|Overall Study|Withdrawal by Subject|6
1804543|NCT00502593|6273554|P2|Overall Study|Withdrawal by Subject|0
1804544|NCT00502593|6273555|P1|Overall Study|Withdrawal by Subject|0
1804545|NCT00502593|6273544|P12|Overall Study|Withdrawn unspecified reason|0
1804546|NCT00502593|6273545|P11|Overall Study|Withdrawn unspecified reason|0
1804547|NCT00502593|6273546|P10|Overall Study|Withdrawn unspecified reason|0
1804548|NCT00502593|6273547|P9|Overall Study|Withdrawn unspecified reason|0
1804549|NCT00502593|6273548|P8|Overall Study|Withdrawn unspecified reason|0
1804550|NCT00502593|6273549|P7|Overall Study|Withdrawn unspecified reason|2
1804551|NCT00502593|6273550|P6|Overall Study|Withdrawn unspecified reason|0
1804552|NCT00502593|6273551|P5|Overall Study|Withdrawn unspecified reason|2
1804553|NCT00502593|6273552|P4|Overall Study|Withdrawn unspecified reason|1
1804554|NCT00502593|6273553|P3|Overall Study|Withdrawn unspecified reason|3
1804555|NCT00502593|6273554|P2|Overall Study|Withdrawn unspecified reason|1
1804556|NCT00502593|6273555|P1|Overall Study|Withdrawn unspecified reason|1
1804557|NCT00502320|6274071|P2|Overall Study|Adverse Event|5
1804558|NCT00502320|6274072|P1|Overall Study|Adverse Event|3
1804559|NCT00502320|6274071|P2|Overall Study|Screen Failure|1
1804560|NCT00502320|6274072|P1|Overall Study|Screen Failure|0
1804561|NCT00502320|6274071|P2|Overall Study|No longer met criteria|0
1804562|NCT00502320|6274072|P1|Overall Study|No longer met criteria|1
1804563|NCT00502320|6274071|P2|Overall Study|Withdrew Consent|0
1804564|NCT00502320|6274072|P1|Overall Study|Withdrew Consent|1
1804565|NCT00502320|6274071|P2|Overall Study|Lost to Follow-up|1
1804566|NCT00502320|6274072|P1|Overall Study|Lost to Follow-up|1
1804567|NCT00502242|6274084|P2|Overall Study|Withdrawal by Subject|7
1804568|NCT00502242|6274085|P1|Overall Study|Withdrawal by Subject|6
1804569|NCT00502242|6274084|P2|Overall Study|Protocol Violation|1
1804570|NCT00502242|6274085|P1|Overall Study|Protocol Violation|3
1804571|NCT00502242|6274084|P2|Overall Study|Other - Unspecified|14
1804572|NCT00502242|6274085|P1|Overall Study|Other - Unspecified|8
1804573|NCT00502242|6274084|P2|Overall Study|Physician Decision|3
1804574|NCT00502242|6274085|P1|Overall Study|Physician Decision|2
1804575|NCT00502242|6274084|P2|Overall Study|Adverse Event|20
1804576|NCT00502242|6274085|P1|Overall Study|Adverse Event|31
1804577|NCT00502242|6274084|P2|Overall Study|Lack of Efficacy|11
1804578|NCT00502242|6274085|P1|Overall Study|Lack of Efficacy|1
1804579|NCT00502203|6274149|P1|Overall Study|Inevaluable|1
1804580|NCT00501969|6274158|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
1804581|NCT00501969|6274158|P1|Overall Study|Other: Admin Request from the Sponsor|3
1804582|NCT00501969|6274158|P1|Overall Study|Other: As Required by Local EC|2
1804583|NCT00501969|6274158|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
1804584|NCT00501969|6274158|P1|Overall Study|Other: Pat Pending Surgery for PD|1
1804585|NCT00501969|6274158|P1|Overall Study|Other: Patient is Going to Have DBS|1
1804586|NCT00501969|6274158|P1|Overall Study|Other: Patients + Investigator Agreement|1
1804587|NCT00501969|6274158|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
1804588|NCT00501969|6274158|P1|Overall Study|Other: Sponsor Stopped Study|12
1804589|NCT00501969|6274158|P1|Overall Study|Other: Sponsor Termination at Site|1
1804590|NCT00501969|6274158|P1|Overall Study|Other: Sponsors Request|10
1804591|NCT00501969|6274158|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
1804592|NCT00501969|6274158|P1|Overall Study|Lost to Follow-up|4
1804593|NCT00501969|6274158|P1|Overall Study|Subject withdrew consent|51
1804594|NCT00501969|6274158|P1|Overall Study|Unsatisfactory compliance of subject|7
1804595|NCT00501969|6274158|P1|Overall Study|Adverse Event|76
1804596|NCT00501969|6274158|P1|Overall Study|Lack of Efficacy|29
1804597|NCT00501969|6274158|P1|Overall Study|Major Protocol Violation|4
1804598|NCT00501852|6274190|P1|Overall Study|Withdrawal by Subject|2
1804599|NCT00501852|6274190|P1|Overall Study|Adverse Event|3
1804600|NCT00501644|6274210|P1|Overall Study|Withdrawal by Subject|1
1804601|NCT00501644|6274210|P1|Overall Study|Adverse Event|4
1804602|NCT00501540|6274239|P1|Overall Study|Death|5
1804603|NCT00501293|6274251|P2|Maintenance Period|Application site reaction|0
1804604|NCT00501293|6274252|P1|Maintenance Period|Application site reaction|1
1804605|NCT00501293|6274251|P2|Maintenance Period|Would not wear patch|0
1804606|NCT00501293|6274252|P1|Maintenance Period|Would not wear patch|1
1804607|NCT00501293|6274251|P2|Maintenance Period|Went into rehabilitation|0
1804608|NCT00501293|6274252|P1|Maintenance Period|Went into rehabilitation|1
1804609|NCT00501293|6274251|P2|Maintenance Period|Noncompliant with study medication|0
1804610|NCT00501293|6274252|P1|Maintenance Period|Noncompliant with study medication|5
1804611|NCT00501293|6274251|P2|Maintenance Period|Lack of Efficacy|1
1804612|NCT00501293|6274252|P1|Maintenance Period|Lack of Efficacy|4
1804613|NCT00501293|6274251|P2|Maintenance Period|Protocol Violation|1
1804614|NCT00501293|6274252|P1|Maintenance Period|Protocol Violation|2
1804615|NCT00501293|6274251|P2|Maintenance Period|Adverse Event|6
1804616|NCT00501293|6274252|P1|Maintenance Period|Adverse Event|6
1804617|NCT00501293|6274251|P2|Maintenance Period|Lost to Follow-up|7
1804618|NCT00501293|6274252|P1|Maintenance Period|Lost to Follow-up|12
1804619|NCT00501293|6274251|P2|Maintenance Period|Withdrawal by Subject|13
1804620|NCT00501293|6274252|P1|Maintenance Period|Withdrawal by Subject|14
1804621|NCT00501293|6274251|P2|Optimization Period|Enrolled in error|0
1804622|NCT00501293|6274252|P1|Optimization Period|Enrolled in error|1
1804623|NCT00501228|6274279|P1|Overall Study|Withdrawal by Subject|1
1804624|NCT00501085|6274283|P1|Overall Study|Other loss to follow-up|32
1804625|NCT00501085|6274283|P1|Overall Study|Study closed by sponsor|109
1804626|NCT00501085|6274283|P1|Overall Study|Non-Compliance|24
1804627|NCT00501085|6274283|P1|Overall Study|Adverse Event|4
1804628|NCT00501085|6274283|P1|Overall Study|Explantation Surgery|26
1804629|NCT00501085|6274283|P1|Overall Study|Revision Surgery|7
1804630|NCT00501085|6274283|P1|Overall Study|Subject Decision|1
1804631|NCT00501085|6274283|P1|Overall Study|Withdrawal by Subject|34
1804632|NCT00501085|6274283|P1|Overall Study|Lost to Follow-up|195
1804633|NCT00501059|6274293|P2|Overall Study|Not treated|17
1804634|NCT00501059|6274294|P1|Overall Study|Not treated|25
1804635|NCT00501059|6274293|P2|Overall Study|Lost to Follow-up|198
1804636|NCT00501059|6274294|P1|Overall Study|Lost to Follow-up|210
1804637|NCT00501059|6274293|P2|Overall Study|Adverse Event|122
1804638|NCT00501059|6274294|P1|Overall Study|Adverse Event|129
1804639|NCT00501059|6274293|P2|Overall Study|Reason not given|1
1804640|NCT00501059|6274294|P1|Overall Study|Reason not given|3
1804641|NCT00501059|6274293|P2|Overall Study|Non-compliant with study treatment|16
1804642|NCT00501059|6274294|P1|Overall Study|Non-compliant with study treatment|23
1804643|NCT00501059|6274293|P2|Overall Study|Consent withdrawn by subject|873
1804644|NCT00501059|6274294|P1|Overall Study|Consent withdrawn by subject|817
1804645|NCT00501059|6274293|P2|Overall Study|Insufficient therapeutic effect|5
1804646|NCT00501059|6274294|P1|Overall Study|Insufficient therapeutic effect|4
1804647|NCT00501059|6274293|P2|Overall Study|Clinical endpoint reached|123
1804648|NCT00501059|6274294|P1|Overall Study|Clinical endpoint reached|110
1804649|NCT00501059|6274293|P2|Overall Study|Missing end-of-study page|92
1804650|NCT00501059|6274294|P1|Overall Study|Missing end-of-study page|91
1804651|NCT00501059|6274293|P2|Overall Study|Other|239
1804652|NCT00501059|6274294|P1|Overall Study|Other|236
1804653|NCT00501059|6274293|P2|Overall Study|Death|137
1804654|NCT00501059|6274294|P1|Overall Study|Death|140
1804655|NCT00501059|6274293|P2|Overall Study|Protocol Violation|69
1804656|NCT00501059|6274294|P1|Overall Study|Protocol Violation|80
1804657|NCT00501046|6274318|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
1804658|NCT00501046|6274319|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
1804659|NCT00501046|6274318|P2|Overall Study|Withdrawal by Subject|83
1804660|NCT00501046|6274319|P1|Overall Study|Withdrawal by Subject|84
1804661|NCT00501046|6274318|P2|Overall Study|Protocol Violation|1
1804662|NCT00501046|6274319|P1|Overall Study|Protocol Violation|2
1804663|NCT00501046|6274318|P2|Overall Study|Pregnancy|3
1804664|NCT00501046|6274319|P1|Overall Study|Pregnancy|0
1804665|NCT00501046|6274318|P2|Overall Study|Physician Decision|2
1804666|NCT00501046|6274319|P1|Overall Study|Physician Decision|7
1804667|NCT00501046|6274318|P2|Overall Study|Lost to Follow-up|13
1804668|NCT00501046|6274319|P1|Overall Study|Lost to Follow-up|14
1804669|NCT00501046|6274318|P2|Overall Study|Death|30
1804670|NCT00501046|6274319|P1|Overall Study|Death|23
1804671|NCT00501046|6274318|P2|Overall Study|Adverse Event|25
1804672|NCT00501046|6274319|P1|Overall Study|Adverse Event|21
1804673|NCT00501007|6274325|P2|Overall Study|Inclusion criteria not met.|25
1804674|NCT00501007|6274326|P1|Overall Study|Inclusion criteria not met.|29
1804675|NCT00500903|6274335|P3|Overall Study|Reason Not Specified|2
1804676|NCT00500903|6274336|P2|Overall Study|Reason Not Specified|0
1804677|NCT00500903|6274337|P1|Overall Study|Reason Not Specified|10
1804678|NCT00500903|6274335|P3|Overall Study|Symptomatic Deterioration|0
1804679|NCT00500903|6274336|P2|Overall Study|Symptomatic Deterioration|0
1804680|NCT00500903|6274337|P1|Overall Study|Symptomatic Deterioration|2
1804681|NCT00500903|6274335|P3|Overall Study|Patient Declined Further Treatment|3
1804682|NCT00500903|6274336|P2|Overall Study|Patient Declined Further Treatment|0
1804683|NCT00500903|6274337|P1|Overall Study|Patient Declined Further Treatment|0
1804684|NCT00500903|6274335|P3|Overall Study|Progressive Disease|15
1804685|NCT00500903|6274336|P2|Overall Study|Progressive Disease|2
1804686|NCT00500903|6274337|P1|Overall Study|Progressive Disease|41
1804687|NCT00500903|6274335|P3|Overall Study|Unsatisfactory Therapeutic Response|0
1804688|NCT00500903|6274336|P2|Overall Study|Unsatisfactory Therapeutic Response|0
1804689|NCT00500903|6274337|P1|Overall Study|Unsatisfactory Therapeutic Response|2
1804690|NCT00500903|6274335|P3|Overall Study|Occurrence of Adverse Event(s)|0
1804691|NCT00500903|6274336|P2|Overall Study|Occurrence of Adverse Event(s)|0
1804692|NCT00500903|6274337|P1|Overall Study|Occurrence of Adverse Event(s)|10
1804693|NCT00500760|6274518|P2|Overall Study|Other|2
1804694|NCT00500760|6274519|P1|Overall Study|Other|1
1804695|NCT00500760|6274518|P2|Overall Study|Lost to Follow-up|0
1804696|NCT00500760|6274519|P1|Overall Study|Lost to Follow-up|3
1804697|NCT00500760|6274518|P2|Overall Study|Administrative decision|0
1804698|NCT00500760|6274519|P1|Overall Study|Administrative decision|2
1804699|NCT00500760|6274518|P2|Overall Study|Withdrawal by Subject|7
1804700|NCT00500760|6274519|P1|Overall Study|Withdrawal by Subject|5
1804701|NCT00500760|6274518|P2|Overall Study|Death|15
1804702|NCT00500760|6274519|P1|Overall Study|Death|32
1804703|NCT00500682|6274539|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
1804704|NCT00500682|6274540|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
1804705|NCT00500682|6274539|P2|Overall Study|Withdrawal by Subject|74
1804706|NCT00500682|6274540|P1|Overall Study|Withdrawal by Subject|80
1804707|NCT00500682|6274539|P2|Overall Study|Protocol Violation|3
1804708|NCT00500682|6274540|P1|Overall Study|Protocol Violation|1
1804709|NCT00500682|6274539|P2|Overall Study|Pregnancy|0
1804710|NCT00500682|6274540|P1|Overall Study|Pregnancy|2
1804711|NCT00500682|6274539|P2|Overall Study|Physician Decision|10
1804712|NCT00500682|6274540|P1|Overall Study|Physician Decision|6
1804713|NCT00500682|6274539|P2|Overall Study|Lost to Follow-up|11
1804714|NCT00500682|6274540|P1|Overall Study|Lost to Follow-up|11
1804715|NCT00500682|6274539|P2|Overall Study|Death|16
1804716|NCT00500682|6274540|P1|Overall Study|Death|25
1804717|NCT00500682|6274539|P2|Overall Study|Adverse Event|29
1804718|NCT00500682|6274540|P1|Overall Study|Adverse Event|37
1804719|NCT00500539|6274574|P1|Follow-up Period (16 Weeks)|Missing|3
1804720|NCT00500539|6274574|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
1804721|NCT00500539|6274574|P1|Follow-up Period (16 Weeks)|Death|1
1804722|NCT00500539|6274574|P1|Follow-up Period (16 Weeks)|Administrative problems|1
1804723|NCT00500539|6274574|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
1804724|NCT00500539|6274574|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
1804725|NCT00500539|6274574|P1|Follow-up Period (16 Weeks)|Adverse Event|1
1804726|NCT00500539|6274574|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
1804727|NCT00500539|6274574|P1|Treatment Period (24 Weeks)|Administrative problems|2
1804728|NCT00500539|6274574|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
1804729|NCT00500539|6274574|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
1804730|NCT00500539|6274574|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
1804731|NCT00500539|6274574|P1|Treatment Period (24 Weeks)|Adverse Event|4
1804732|NCT00500370|6274600|P2|Overall Study|Subject Decision|17
1804733|NCT00500370|6274601|P1|Overall Study|Subject Decision|10
1804734|NCT00500370|6274600|P2|Overall Study|Sponsor Decision|0
1804735|NCT00500370|6274601|P1|Overall Study|Sponsor Decision|2
1804736|NCT00500370|6274600|P2|Overall Study|Protocol Violation|4
1804737|NCT00500370|6274601|P1|Overall Study|Protocol Violation|2
1804738|NCT00500370|6274600|P2|Overall Study|Lost to Follow-up|10
1804739|NCT00500370|6274601|P1|Overall Study|Lost to Follow-up|10
1804740|NCT00500370|6274600|P2|Overall Study|Adverse Event|3
1804741|NCT00500370|6274601|P1|Overall Study|Adverse Event|9
1804742|NCT00500357|6274637|P1|Overall Study|Death|1
1804743|NCT00500331|6274663|P7|Overall Study|Protocol violated|0
1804744|NCT00500331|6274664|P6|Overall Study|Protocol violated|0
1804745|NCT00500331|6274665|P5|Overall Study|Protocol violated|0
1804746|NCT00500331|6274666|P4|Overall Study|Protocol violated|1
1804747|NCT00500331|6274667|P3|Overall Study|Protocol violated|0
1804748|NCT00500331|6274668|P2|Overall Study|Protocol violated|0
1804749|NCT00500331|6274669|P1|Overall Study|Protocol violated|0
1804750|NCT00500331|6274663|P7|Overall Study|State ban of biological samples export|0
1804751|NCT00500331|6274664|P6|Overall Study|State ban of biological samples export|0
1804752|NCT00500331|6274665|P5|Overall Study|State ban of biological samples export|0
1804753|NCT00500331|6274666|P4|Overall Study|State ban of biological samples export|1
1804754|NCT00500331|6274667|P3|Overall Study|State ban of biological samples export|0
1804755|NCT00500331|6274668|P2|Overall Study|State ban of biological samples export|0
1804756|NCT00500331|6274669|P1|Overall Study|State ban of biological samples export|0
1804757|NCT00500331|6274663|P7|Overall Study|Diabetologist nurse in the study|0
1804758|NCT00500331|6274664|P6|Overall Study|Diabetologist nurse in the study|0
1804759|NCT00500331|6274665|P5|Overall Study|Diabetologist nurse in the study|0
1804760|NCT00500331|6274666|P4|Overall Study|Diabetologist nurse in the study|0
1804761|NCT00500331|6274667|P3|Overall Study|Diabetologist nurse in the study|1
1804762|NCT00500331|6274668|P2|Overall Study|Diabetologist nurse in the study|0
1804763|NCT00500331|6274669|P1|Overall Study|Diabetologist nurse in the study|0
1804764|NCT00500331|6274663|P7|Overall Study|Participant was randomized by mistake|0
1804765|NCT00500331|6274664|P6|Overall Study|Participant was randomized by mistake|0
1804766|NCT00500331|6274665|P5|Overall Study|Participant was randomized by mistake|0
1804767|NCT00500331|6274666|P4|Overall Study|Participant was randomized by mistake|0
1804768|NCT00500331|6274667|P3|Overall Study|Participant was randomized by mistake|0
1804769|NCT00500331|6274668|P2|Overall Study|Participant was randomized by mistake|0
1804770|NCT00500331|6274669|P1|Overall Study|Participant was randomized by mistake|1
1804771|NCT00500331|6274663|P7|Overall Study|Sponsor decided to withdraw participant|0
1804772|NCT00500331|6274664|P6|Overall Study|Sponsor decided to withdraw participant|0
1804773|NCT00500331|6274665|P5|Overall Study|Sponsor decided to withdraw participant|0
1804774|NCT00500331|6274666|P4|Overall Study|Sponsor decided to withdraw participant|0
1804775|NCT00500331|6274667|P3|Overall Study|Sponsor decided to withdraw participant|0
1804776|NCT00500331|6274668|P2|Overall Study|Sponsor decided to withdraw participant|0
1804777|NCT00500331|6274669|P1|Overall Study|Sponsor decided to withdraw participant|1
1804778|NCT00500331|6274663|P7|Overall Study|Exclusion citeria not met on Visit 4|0
1804779|NCT00500331|6274664|P6|Overall Study|Exclusion citeria not met on Visit 4|0
1804780|NCT00500331|6274665|P5|Overall Study|Exclusion citeria not met on Visit 4|0
1804781|NCT00500331|6274666|P4|Overall Study|Exclusion citeria not met on Visit 4|0
1804782|NCT00500331|6274667|P3|Overall Study|Exclusion citeria not met on Visit 4|0
1804783|NCT00500331|6274668|P2|Overall Study|Exclusion citeria not met on Visit 4|0
1804784|NCT00500331|6274669|P1|Overall Study|Exclusion citeria not met on Visit 4|1
1804785|NCT00500331|6274663|P7|Overall Study|Didn't return for continuation of study|0
1804786|NCT00500331|6274664|P6|Overall Study|Didn't return for continuation of study|0
1804787|NCT00500331|6274665|P5|Overall Study|Didn't return for continuation of study|0
1804788|NCT00500331|6274666|P4|Overall Study|Didn't return for continuation of study|0
1804789|NCT00500331|6274667|P3|Overall Study|Didn't return for continuation of study|0
1804790|NCT00500331|6274668|P2|Overall Study|Didn't return for continuation of study|0
1804791|NCT00500331|6274669|P1|Overall Study|Didn't return for continuation of study|1
1804792|NCT00500331|6274663|P7|Overall Study|Increased serum creatinine from Baseline|0
1804793|NCT00500331|6274664|P6|Overall Study|Increased serum creatinine from Baseline|1
1804794|NCT00500331|6274665|P5|Overall Study|Increased serum creatinine from Baseline|0
1804795|NCT00500331|6274666|P4|Overall Study|Increased serum creatinine from Baseline|0
1804796|NCT00500331|6274667|P3|Overall Study|Increased serum creatinine from Baseline|0
1804797|NCT00500331|6274668|P2|Overall Study|Increased serum creatinine from Baseline|0
1804798|NCT00500331|6274669|P1|Overall Study|Increased serum creatinine from Baseline|0
1804799|NCT00500331|6274663|P7|Overall Study|Liver function test abnormality|0
1804800|NCT00500331|6274664|P6|Overall Study|Liver function test abnormality|0
1804801|NCT00500331|6274665|P5|Overall Study|Liver function test abnormality|0
1804802|NCT00500331|6274666|P4|Overall Study|Liver function test abnormality|0
1804803|NCT00500331|6274667|P3|Overall Study|Liver function test abnormality|1
1804804|NCT00500331|6274668|P2|Overall Study|Liver function test abnormality|0
1804805|NCT00500331|6274669|P1|Overall Study|Liver function test abnormality|0
1804806|NCT00500331|6274663|P7|Overall Study|Lack of Efficacy|0
1804807|NCT00500331|6274664|P6|Overall Study|Lack of Efficacy|0
1804808|NCT00500331|6274665|P5|Overall Study|Lack of Efficacy|0
1804809|NCT00500331|6274666|P4|Overall Study|Lack of Efficacy|0
1804810|NCT00500331|6274667|P3|Overall Study|Lack of Efficacy|0
1804811|NCT00500331|6274668|P2|Overall Study|Lack of Efficacy|1
1804812|NCT00500331|6274669|P1|Overall Study|Lack of Efficacy|3
1804813|NCT00500331|6274663|P7|Overall Study|Withdrawal by Subject|1
1804814|NCT00500331|6274664|P6|Overall Study|Withdrawal by Subject|1
1804815|NCT00500331|6274665|P5|Overall Study|Withdrawal by Subject|0
1804816|NCT00500331|6274666|P4|Overall Study|Withdrawal by Subject|5
1804817|NCT00500331|6274667|P3|Overall Study|Withdrawal by Subject|1
1804818|NCT00500331|6274668|P2|Overall Study|Withdrawal by Subject|0
1804819|NCT00500331|6274669|P1|Overall Study|Withdrawal by Subject|4
1804820|NCT00500331|6274663|P7|Overall Study|Protocol Violation|1
1804821|NCT00500331|6274664|P6|Overall Study|Protocol Violation|1
1804822|NCT00500331|6274665|P5|Overall Study|Protocol Violation|1
1804823|NCT00500331|6274666|P4|Overall Study|Protocol Violation|0
1804824|NCT00500331|6274667|P3|Overall Study|Protocol Violation|1
1804825|NCT00500331|6274668|P2|Overall Study|Protocol Violation|1
1804826|NCT00500331|6274669|P1|Overall Study|Protocol Violation|3
1804827|NCT00500331|6274663|P7|Overall Study|Lost to Follow-up|0
1804828|NCT00500331|6274664|P6|Overall Study|Lost to Follow-up|0
1804829|NCT00500331|6274665|P5|Overall Study|Lost to Follow-up|1
1804830|NCT00500331|6274666|P4|Overall Study|Lost to Follow-up|2
1804831|NCT00500331|6274667|P3|Overall Study|Lost to Follow-up|1
1804832|NCT00500331|6274668|P2|Overall Study|Lost to Follow-up|1
1804833|NCT00500331|6274669|P1|Overall Study|Lost to Follow-up|1
1804834|NCT00500331|6274663|P7|Overall Study|Adverse Event|0
1804835|NCT00500331|6274664|P6|Overall Study|Adverse Event|2
1804836|NCT00500331|6274665|P5|Overall Study|Adverse Event|2
1804837|NCT00500331|6274666|P4|Overall Study|Adverse Event|1
1804838|NCT00500331|6274667|P3|Overall Study|Adverse Event|0
1804839|NCT00500331|6274668|P2|Overall Study|Adverse Event|2
1804840|NCT00500331|6274669|P1|Overall Study|Adverse Event|0
1804841|NCT00500318|6274806|P2|Overall Study|Other Reason|1
1804842|NCT00500318|6274807|P1|Overall Study|Other Reason|0
1804843|NCT00500318|6274806|P2|Overall Study|Lack of Efficacy|3
1804844|NCT00500318|6274807|P1|Overall Study|Lack of Efficacy|0
1804845|NCT00500318|6274806|P2|Overall Study|Withdrawal by Subject|2
1804846|NCT00500318|6274807|P1|Overall Study|Withdrawal by Subject|1
1804847|NCT00500318|6274806|P2|Overall Study|Protocol Violation|3
1804848|NCT00500318|6274807|P1|Overall Study|Protocol Violation|1
1804849|NCT00500318|6274806|P2|Overall Study|Adverse Event|8
1804850|NCT00500318|6274807|P1|Overall Study|Adverse Event|3
1804851|NCT00500292|6274824|P3|Overall Study|Other|4
1804852|NCT00500292|6274825|P2|Overall Study|Other|1
1804853|NCT00500292|6274826|P1|Overall Study|Other|1
1804854|NCT00500292|6274824|P3|Overall Study|Withdrawal by Subject|0
1804855|NCT00500292|6274825|P2|Overall Study|Withdrawal by Subject|1
1804856|NCT00500292|6274826|P1|Overall Study|Withdrawal by Subject|0
1804857|NCT00500292|6274824|P3|Overall Study|Condition under investigation worsened|19
1804858|NCT00500292|6274825|P2|Overall Study|Condition under investigation worsened|23
1804859|NCT00500292|6274826|P1|Overall Study|Condition under investigation worsened|21
1804860|NCT00500292|6274824|P3|Overall Study|Adverse Event|4
1804861|NCT00500292|6274825|P2|Overall Study|Adverse Event|6
1804862|NCT00500292|6274826|P1|Overall Study|Adverse Event|3
1804863|NCT00500149|6274847|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
1804864|NCT00500149|6274848|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
1804865|NCT00500149|6274847|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
1804866|NCT00500149|6274848|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
1804867|NCT00500149|6274847|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
1804868|NCT00500149|6274848|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
1804869|NCT00500149|6274847|P2|First Intervention (Cross-over Phase)|Adverse Event|1
1804870|NCT00500149|6274848|P1|First Intervention (Cross-over Phase)|Adverse Event|0
1804871|NCT00500149|6274847|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
1804872|NCT00500149|6274848|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
1804873|NCT00500149|6274847|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
1804874|NCT00500149|6274848|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
1804875|NCT00500149|6274847|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
1804963|NCT00499369|6275169|P5|Overall Study|Not protocol specified|0
1804876|NCT00500149|6274848|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
1804877|NCT00500110|6274856|P1|Overall Study|Withdrawal by Subject|3
1804878|NCT00500071|6274860|P1|30-day Safety Follow-up|Lost to Follow-up|17
1804879|NCT00500071|6274860|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
1804880|NCT00500071|6274860|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
1804881|NCT00500071|6274860|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
1804882|NCT00500071|6274860|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
1804883|NCT00500071|6274860|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
1804884|NCT00500071|6274860|P1|Screening and Washout Phase|Protocol Violation|1
1804885|NCT00499889|6274883|P1|Overall Study|Infection prior to treatment|1
1804886|NCT00499863|6274891|P2|Overall Study|Lost to Follow-up|1
1804887|NCT00499863|6274892|P1|Overall Study|Lost to Follow-up|1
1804888|NCT00499863|6274891|P2|Overall Study|Sponsor decision|2
1804889|NCT00499863|6274892|P1|Overall Study|Sponsor decision|2
1804890|NCT00499863|6274891|P2|Overall Study|Adverse Event|2
1804891|NCT00499863|6274892|P1|Overall Study|Adverse Event|8
1804892|NCT00499863|6274891|P2|Overall Study|Withdrawal by Subject|4
1804893|NCT00499863|6274892|P1|Overall Study|Withdrawal by Subject|6
1804894|NCT00499863|6274891|P2|Overall Study|Protocol Violation|7
1804895|NCT00499863|6274892|P1|Overall Study|Protocol Violation|12
1804896|NCT00499863|6274891|P2|Overall Study|Lack of Efficacy|27
1804897|NCT00499863|6274892|P1|Overall Study|Lack of Efficacy|21
1804898|NCT00500266|6274920|P1|Overall Study|Assigned, not treated|4
1804899|NCT00500266|6274920|P1|Overall Study|Withdrawal by Subject|3
1804900|NCT00500266|6274920|P1|Overall Study|Lost to Follow-up|3
1804901|NCT00500266|6274920|P1|Overall Study|Death|3
1804902|NCT00499746|6274927|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
1804903|NCT00499746|6274927|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
1804904|NCT00499746|6274927|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
1804905|NCT00499746|6274927|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
1804906|NCT00499694|6274996|P1|Overall Study|Patient never received treatment.|1
1804907|NCT00499681|6275005|P2|Overall Study|disease progression|1
1804908|NCT00499681|6275006|P1|Overall Study|disease progression|0
1804909|NCT00499681|6275005|P2|Overall Study|toxicity|1
1804910|NCT00499681|6275006|P1|Overall Study|toxicity|0
1804911|NCT00499616|6275033|P4|Overall Study|Patient/Parent Refusal|0
1804912|NCT00499616|6275034|P3|Overall Study|Patient/Parent Refusal|3
1804913|NCT00499616|6275035|P2|Overall Study|Patient/Parent Refusal|5
1804914|NCT00499616|6275036|P1|Overall Study|Patient/Parent Refusal|1
1804915|NCT00499616|6275033|P4|Overall Study|Not evaluable|41
1804916|NCT00499616|6275034|P3|Overall Study|Not evaluable|0
1804917|NCT00499616|6275035|P2|Overall Study|Not evaluable|0
1804918|NCT00499616|6275036|P1|Overall Study|Not evaluable|0
1804919|NCT00499616|6275033|P4|Overall Study|Ineligible|15
1804920|NCT00499616|6275034|P3|Overall Study|Ineligible|0
1804921|NCT00499616|6275035|P2|Overall Study|Ineligible|2
1804922|NCT00499616|6275036|P1|Overall Study|Ineligible|1
1804923|NCT00499616|6275033|P4|Overall Study|Withdrawal by Subject|0
1804924|NCT00499616|6275034|P3|Overall Study|Withdrawal by Subject|1
1804925|NCT00499616|6275035|P2|Overall Study|Withdrawal by Subject|0
1804926|NCT00499616|6275036|P1|Overall Study|Withdrawal by Subject|1
1804927|NCT00499616|6275033|P4|Overall Study|Physician Decision|0
1804928|NCT00499616|6275034|P3|Overall Study|Physician Decision|9
1804929|NCT00499616|6275035|P2|Overall Study|Physician Decision|16
1804930|NCT00499616|6275036|P1|Overall Study|Physician Decision|6
1804931|NCT00499616|6275033|P4|Overall Study|Lost to Follow-up|0
1804932|NCT00499616|6275034|P3|Overall Study|Lost to Follow-up|1
1804933|NCT00499616|6275035|P2|Overall Study|Lost to Follow-up|0
1804934|NCT00499616|6275036|P1|Overall Study|Lost to Follow-up|0
1804935|NCT00499616|6275033|P4|Overall Study|Lack of Efficacy|0
1804936|NCT00499616|6275034|P3|Overall Study|Lack of Efficacy|19
1804937|NCT00499616|6275035|P2|Overall Study|Lack of Efficacy|0
1804938|NCT00499616|6275036|P1|Overall Study|Lack of Efficacy|5
1804939|NCT00499616|6275033|P4|Overall Study|Death|1
1804940|NCT00499616|6275034|P3|Overall Study|Death|3
1804941|NCT00499616|6275035|P2|Overall Study|Death|5
1804942|NCT00499616|6275036|P1|Overall Study|Death|1
1804943|NCT00499603|6275081|P2|Overall Study|Adverse Event|1
1804944|NCT00499603|6275082|P1|Overall Study|Adverse Event|0
1804945|NCT00499590|6275095|P3|Overall Study|Not treated|1
1804946|NCT00499590|6275096|P2|Overall Study|Not treated|0
1804947|NCT00499590|6275097|P1|Overall Study|Not treated|1
1804948|NCT00499590|6275095|P3|Overall Study|Study Terminated|112
1804949|NCT00499590|6275096|P2|Overall Study|Study Terminated|112
1804950|NCT00499590|6275097|P1|Overall Study|Study Terminated|112
1804951|NCT00499486|6275108|P1|Overall Study|Withdrawal by Subject|16
1804952|NCT00499460|6275135|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
1804953|NCT00499460|6275136|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
1804954|NCT00499460|6275135|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
1804955|NCT00499460|6275136|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
1804956|NCT00499460|6275135|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
1804957|NCT00499460|6275136|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
1804958|NCT00499369|6275169|P5|Overall Study|Ineligible|0
1804959|NCT00499369|6275170|P4|Overall Study|Ineligible|1
1804960|NCT00499369|6275171|P3|Overall Study|Ineligible|1
1804961|NCT00499369|6275172|P2|Overall Study|Ineligible|2
1804962|NCT00499369|6275173|P1|Overall Study|Ineligible|2
1804964|NCT00499369|6275170|P4|Overall Study|Not protocol specified|1
1804965|NCT00499369|6275171|P3|Overall Study|Not protocol specified|3
1804966|NCT00499369|6275172|P2|Overall Study|Not protocol specified|0
1804967|NCT00499369|6275173|P1|Overall Study|Not protocol specified|2
1804968|NCT00499369|6275169|P5|Overall Study|Death|0
1804969|NCT00499369|6275170|P4|Overall Study|Death|0
1804970|NCT00499369|6275171|P3|Overall Study|Death|0
1804971|NCT00499369|6275172|P2|Overall Study|Death|1
1804972|NCT00499369|6275173|P1|Overall Study|Death|0
1804973|NCT00499369|6275169|P5|Overall Study|Progression|10
1804974|NCT00499369|6275170|P4|Overall Study|Progression|6
1804975|NCT00499369|6275171|P3|Overall Study|Progression|9
1804976|NCT00499369|6275172|P2|Overall Study|Progression|12
1804977|NCT00499369|6275173|P1|Overall Study|Progression|10
1804978|NCT00499369|6275169|P5|Overall Study|Withdrawal by Subject|0
1804979|NCT00499369|6275170|P4|Overall Study|Withdrawal by Subject|0
1804980|NCT00499369|6275171|P3|Overall Study|Withdrawal by Subject|1
1804981|NCT00499369|6275172|P2|Overall Study|Withdrawal by Subject|1
1804982|NCT00499369|6275173|P1|Overall Study|Withdrawal by Subject|0
1804983|NCT00499369|6275169|P5|Overall Study|Adverse Event|2
1804984|NCT00499369|6275170|P4|Overall Study|Adverse Event|1
1804985|NCT00499369|6275171|P3|Overall Study|Adverse Event|3
1804986|NCT00499369|6275172|P2|Overall Study|Adverse Event|2
1804987|NCT00499369|6275173|P1|Overall Study|Adverse Event|2
1804988|NCT00499252|6275209|P1|Overall Study|<no further label>|3
1804989|NCT00499252|6275209|P1|Overall Study|Ineligible|4
1804990|NCT00499252|6275209|P1|Overall Study|Refused further treatment|2
1804991|NCT00499252|6275209|P1|Overall Study|Adverse Event|3
1804992|NCT00499122|6275219|P1|Overall Study|Withdrawal by Subject|2
1804993|NCT00499083|6275262|P1|Overall Study|Not evaluable|3
1804994|NCT00499031|6275269|P1|Overall Study|Never treated|1
1804995|NCT00499031|6275269|P1|Overall Study|Required test not done|1
1804996|NCT00499031|6275269|P1|Overall Study|Improper pre-protocol treatment|1
1804997|NCT00498797|6275292|P2|Overall Study|Other|1
1804998|NCT00498797|6275293|P1|Overall Study|Other|3
1804999|NCT00498797|6275292|P2|Overall Study|Condition under investigation worsened|21
1805000|NCT00498797|6275293|P1|Overall Study|Condition under investigation worsened|19
1805001|NCT00498797|6275292|P2|Overall Study|Adverse Event|5
1805002|NCT00498797|6275293|P1|Overall Study|Adverse Event|12
1805003|NCT00498797|6275292|P2|Overall Study|Withdrawal by Subject|2
1805004|NCT00498797|6275293|P1|Overall Study|Withdrawal by Subject|4
1805005|NCT00498602|6275377|P7|Overall Study|Other|0
1805006|NCT00498602|6275378|P6|Overall Study|Other|3
1805007|NCT00498602|6275379|P5|Overall Study|Other|0
1805008|NCT00498602|6275380|P4|Overall Study|Other|0
1805009|NCT00498602|6275381|P3|Overall Study|Other|1
1805010|NCT00498602|6275382|P2|Overall Study|Other|3
1805011|NCT00498602|6275383|P1|Overall Study|Other|2
1805012|NCT00498602|6275377|P7|Overall Study|Subject Request|1
1805013|NCT00498602|6275378|P6|Overall Study|Subject Request|4
1805014|NCT00498602|6275379|P5|Overall Study|Subject Request|1
1805015|NCT00498602|6275380|P4|Overall Study|Subject Request|1
1805016|NCT00498602|6275381|P3|Overall Study|Subject Request|1
1805017|NCT00498602|6275382|P2|Overall Study|Subject Request|0
1805018|NCT00498602|6275383|P1|Overall Study|Subject Request|3
1805019|NCT00498602|6275377|P7|Overall Study|Investigator Request|0
1805020|NCT00498602|6275378|P6|Overall Study|Investigator Request|0
1805021|NCT00498602|6275379|P5|Overall Study|Investigator Request|0
1805022|NCT00498602|6275380|P4|Overall Study|Investigator Request|0
1805023|NCT00498602|6275381|P3|Overall Study|Investigator Request|1
1805024|NCT00498602|6275382|P2|Overall Study|Investigator Request|0
1805025|NCT00498602|6275383|P1|Overall Study|Investigator Request|0
1805026|NCT00498602|6275377|P7|Overall Study|Caregiver Request|0
1805027|NCT00498602|6275378|P6|Overall Study|Caregiver Request|2
1805028|NCT00498602|6275379|P5|Overall Study|Caregiver Request|1
1805029|NCT00498602|6275380|P4|Overall Study|Caregiver Request|0
1805030|NCT00498602|6275381|P3|Overall Study|Caregiver Request|2
1805031|NCT00498602|6275382|P2|Overall Study|Caregiver Request|2
1805032|NCT00498602|6275383|P1|Overall Study|Caregiver Request|2
1805033|NCT00498602|6275377|P7|Overall Study|AE not related to Study Drug|1
1805034|NCT00498602|6275378|P6|Overall Study|AE not related to Study Drug|2
1805035|NCT00498602|6275379|P5|Overall Study|AE not related to Study Drug|2
1805036|NCT00498602|6275380|P4|Overall Study|AE not related to Study Drug|0
1805037|NCT00498602|6275381|P3|Overall Study|AE not related to Study Drug|0
1805038|NCT00498602|6275382|P2|Overall Study|AE not related to Study Drug|3
1805039|NCT00498602|6275383|P1|Overall Study|AE not related to Study Drug|1
1805040|NCT00498602|6275377|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
1805041|NCT00498602|6275378|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
1805042|NCT00498602|6275379|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
1805043|NCT00498602|6275380|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
1805044|NCT00498602|6275381|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
1805045|NCT00498602|6275382|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
1805046|NCT00498602|6275383|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
1805047|NCT00498602|6275377|P7|Overall Study|Lost to Follow-up|0
1805048|NCT00498602|6275378|P6|Overall Study|Lost to Follow-up|0
1805049|NCT00498602|6275379|P5|Overall Study|Lost to Follow-up|0
1805050|NCT00498602|6275380|P4|Overall Study|Lost to Follow-up|2
1805051|NCT00498602|6275381|P3|Overall Study|Lost to Follow-up|0
1805052|NCT00498602|6275382|P2|Overall Study|Lost to Follow-up|2
1805053|NCT00498602|6275383|P1|Overall Study|Lost to Follow-up|0
1805054|NCT00498602|6275377|P7|Overall Study|Lack of Efficacy|0
1805055|NCT00498602|6275378|P6|Overall Study|Lack of Efficacy|0
1805056|NCT00498602|6275379|P5|Overall Study|Lack of Efficacy|0
1805057|NCT00498602|6275380|P4|Overall Study|Lack of Efficacy|0
1805058|NCT00498602|6275381|P3|Overall Study|Lack of Efficacy|0
1805059|NCT00498602|6275382|P2|Overall Study|Lack of Efficacy|0
1805060|NCT00498602|6275383|P1|Overall Study|Lack of Efficacy|1
1805061|NCT00498602|6275377|P7|Overall Study|Death|0
1805062|NCT00498602|6275378|P6|Overall Study|Death|1
1805063|NCT00498602|6275379|P5|Overall Study|Death|0
1805064|NCT00498602|6275380|P4|Overall Study|Death|0
1805065|NCT00498602|6275381|P3|Overall Study|Death|0
1805066|NCT00498602|6275382|P2|Overall Study|Death|0
1805067|NCT00498602|6275383|P1|Overall Study|Death|0
1805068|NCT00498485|6275431|P2|Overall Study|Adverse Event|5
1805069|NCT00498485|6275432|P1|Overall Study|Adverse Event|1
1805070|NCT00498433|6275443|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
1805071|NCT00498433|6275444|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
1805072|NCT00498433|6275445|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
1805073|NCT00498433|6275443|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
1805074|NCT00498433|6275444|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
1805075|NCT00498433|6275445|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
1805076|NCT00498433|6275443|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
1805077|NCT00498433|6275444|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
1805078|NCT00498433|6275445|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
1805079|NCT00498433|6275443|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
1805080|NCT00498433|6275444|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
1805081|NCT00498433|6275445|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
1805082|NCT00498368|6275490|P2|Overall Study|Withdrawal by Subject|2
1805083|NCT00498368|6275491|P1|Overall Study|Withdrawal by Subject|3
1805084|NCT00498355|6275503|P1|Overall Study|Lost to Follow-up|1
1805085|NCT00498186|6275511|P1|Overall Study|Other|10
1805086|NCT00498186|6275511|P1|Overall Study|Lost to Follow-up|3
1805087|NCT00498186|6275511|P1|Overall Study|Withdrawal by Subject|18
1805088|NCT00498186|6275511|P1|Overall Study|Unsatisfactory compliance of subject|12
1805089|NCT00498186|6275511|P1|Overall Study|Adverse Event|89
1805090|NCT00498186|6275511|P1|Overall Study|Lack of Efficacy|31
1805091|NCT00498186|6275511|P1|Overall Study|Protocol Violation|10
1805092|NCT00498173|6275518|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
1805093|NCT00498173|6275519|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
1805094|NCT00498173|6275520|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
1805095|NCT00497874|6275550|P2|Overall Study|Unable to schedule|24
1805096|NCT00497874|6275551|P1|Overall Study|Unable to schedule|37
1805097|NCT00497874|6275550|P2|Overall Study|Unable to contact|67
1805098|NCT00497874|6275551|P1|Overall Study|Unable to contact|52
1805099|NCT00497874|6275550|P2|Overall Study|Death|4
1805100|NCT00497874|6275551|P1|Overall Study|Death|2
1805101|NCT00497874|6275550|P2|Overall Study|Illness|4
1805102|NCT00497874|6275551|P1|Overall Study|Illness|8
1805103|NCT00497874|6275550|P2|Overall Study|Withdrawal by Subject|17
1805104|NCT00497874|6275551|P1|Overall Study|Withdrawal by Subject|48
1805105|NCT00497796|6275569|P2|Overall Study|Not applicable (randomized not treated)|4
1805106|NCT00497796|6275570|P1|Overall Study|Not applicable (randomized not treated)|0
1805107|NCT00497796|6275569|P2|Overall Study|Lost to Follow-up|1
1805108|NCT00497796|6275570|P1|Overall Study|Lost to Follow-up|0
1805109|NCT00497796|6275569|P2|Overall Study|Investigator/sponsor discretion|34
1805110|NCT00497796|6275570|P1|Overall Study|Investigator/sponsor discretion|31
1805111|NCT00497796|6275569|P2|Overall Study|Consent withdrawn|3
1805112|NCT00497796|6275570|P1|Overall Study|Consent withdrawn|10
1805113|NCT00497796|6275569|P2|Overall Study|CMV infection or disease treatment|4
1805114|NCT00497796|6275570|P1|Overall Study|CMV infection or disease treatment|30
1805115|NCT00497796|6275569|P2|Overall Study|Adverse event (related)|4
1805116|NCT00497796|6275570|P1|Overall Study|Adverse event (related)|5
1805117|NCT00497796|6275569|P2|Overall Study|Adverse event (not related)|9
1805118|NCT00497796|6275570|P1|Overall Study|Adverse event (not related)|9
1805119|NCT00497198|6275657|P2|Overall Study|Withdrawal by Subject|1
1805120|NCT00497198|6275658|P1|Overall Study|Withdrawal by Subject|0
1805121|NCT00497198|6275657|P2|Overall Study|Physician Decision|2
1805122|NCT00497198|6275658|P1|Overall Study|Physician Decision|1
1805123|NCT00497198|6275657|P2|Overall Study|Adverse Event|2
1805124|NCT00497198|6275658|P1|Overall Study|Adverse Event|4
1805125|NCT00497146|6275674|P2|Long-term Follow-up Period|Other|1
1805126|NCT00497146|6275675|P1|Long-term Follow-up Period|Other|0
1805127|NCT00497146|6275674|P2|Long-term Follow-up Period|Lost to Follow-up|1
1805128|NCT00497146|6275675|P1|Long-term Follow-up Period|Lost to Follow-up|5
1805129|NCT00497146|6275674|P2|Long-term Follow-up Period|Withdrawal by Subject|2
1805130|NCT00497146|6275675|P1|Long-term Follow-up Period|Withdrawal by Subject|8
1805131|NCT00497146|6275674|P2|Long-term Follow-up Period|Adverse Event|2
1805132|NCT00497146|6275675|P1|Long-term Follow-up Period|Adverse Event|2
1805133|NCT00497146|6275674|P2|Treatment Period|Other Reason|3
1805134|NCT00497146|6275675|P1|Treatment Period|Other Reason|2
1805135|NCT00497146|6275674|P2|Treatment Period|Unable to dose reduce per protocol|1
1805136|NCT00497146|6275675|P1|Treatment Period|Unable to dose reduce per protocol|4
1805137|NCT00497146|6275674|P2|Treatment Period|Change in RAAS inhibitor therapy|2
1805138|NCT00497146|6275675|P1|Treatment Period|Change in RAAS inhibitor therapy|5
1805139|NCT00497146|6275674|P2|Treatment Period|Required dialysis|1
1805140|NCT00497146|6275675|P1|Treatment Period|Required dialysis|4
1805141|NCT00497146|6275674|P2|Treatment Period|Lost to Follow-up|3
1805142|NCT00497146|6275675|P1|Treatment Period|Lost to Follow-up|1
1805143|NCT00497146|6275674|P2|Treatment Period|Withdrawal by Subject|9
1805144|NCT00497146|6275675|P1|Treatment Period|Withdrawal by Subject|5
1805145|NCT00497146|6275674|P2|Treatment Period|Adverse Event|2
1805146|NCT00497146|6275675|P1|Treatment Period|Adverse Event|6
1805147|NCT00496964|6275743|P2|Overall Study|Withdrawal by Subject|1
1805148|NCT00496964|6275744|P1|Overall Study|Withdrawal by Subject|0
1805149|NCT00496873|6275762|P1|Overall Study|Withdrawal by Subject|3
1805150|NCT00496873|6275762|P1|Overall Study|Death|2
1805151|NCT00496873|6275762|P1|Overall Study|Ineligible|2
1805152|NCT00496834|6275795|P2|Overall Study|Blood Pressure control failure|1
1805153|NCT00496834|6275796|P1|Overall Study|Blood Pressure control failure|2
1805154|NCT00496834|6275795|P2|Overall Study|Lost to Follow-up|0
1805155|NCT00496834|6275796|P1|Overall Study|Lost to Follow-up|2
1805156|NCT00496834|6275795|P2|Overall Study|IP administration violation|0
1805157|NCT00496834|6275796|P1|Overall Study|IP administration violation|2
1805158|NCT00496834|6275795|P2|Overall Study|Adverse Event|3
1805159|NCT00496834|6275796|P1|Overall Study|Adverse Event|5
1805160|NCT00496834|6275795|P2|Overall Study|Inclusion/exclusion criteria not met|2
1805161|NCT00496834|6275796|P1|Overall Study|Inclusion/exclusion criteria not met|3
1805162|NCT00496834|6275795|P2|Overall Study|Contraindicated medication administered|1
1805163|NCT00496834|6275796|P1|Overall Study|Contraindicated medication administered|0
1805164|NCT00496834|6275795|P2|Overall Study|Withdrawal by Subject|6
1805165|NCT00496834|6275796|P1|Overall Study|Withdrawal by Subject|4
1805166|NCT00496782|6275815|P2|Overall Study|Protocol Violation|2
1805167|NCT00496782|6275816|P1|Overall Study|Protocol Violation|1
1805168|NCT00496769|6275850|P3|Open Label|>=1 reason assigned per patient|1011
1805169|NCT00496769|6275851|P2|Open Label|>=1 reason assigned per patient|0
1805170|NCT00496769|6275852|P1|Open Label|>=1 reason assigned per patient|0
1805171|NCT00496769|6275850|P3|Double Blind|>=1 reason assigned per patient|0
1805172|NCT00496769|6275851|P2|Double Blind|>=1 reason assigned per patient|649
1805173|NCT00496769|6275852|P1|Double Blind|>=1 reason assigned per patient|558
1805174|NCT00496730|6275882|P2|Overall Study|Withdrawal by Subject|2
1805175|NCT00496730|6275883|P1|Overall Study|Withdrawal by Subject|2
1805176|NCT00496730|6275882|P2|Overall Study|Lost to Follow-up|3
1805177|NCT00496730|6275883|P1|Overall Study|Lost to Follow-up|4
1805178|NCT00496626|6275895|P2|Overall Study|Relocated|1
1805179|NCT00496626|6275896|P1|Overall Study|Relocated|0
1805180|NCT00496626|6275895|P2|Overall Study|Withdrawal by Subject|4
1805181|NCT00496626|6275896|P1|Overall Study|Withdrawal by Subject|5
1805182|NCT00496626|6275895|P2|Overall Study|Protocol Violation|0
1805183|NCT00496626|6275896|P1|Overall Study|Protocol Violation|1
1805184|NCT00496626|6275895|P2|Overall Study|Lost to Follow-up|1
1805185|NCT00496626|6275896|P1|Overall Study|Lost to Follow-up|0
1805186|NCT00496587|6275908|P1|Overall Study|Complications unrelated|2
1805187|NCT00496587|6275908|P1|Overall Study|Death|1
1805188|NCT00496587|6275908|P1|Overall Study|Withdrawal by Subject|2
1805189|NCT00496587|6275908|P1|Overall Study|Progressive Disease|24
1805190|NCT00496587|6275908|P1|Overall Study|Adverse Event|2
1805191|NCT00496483|6275914|P1|Overall Study|Lack of Efficacy|1
1805192|NCT00496483|6275914|P1|Overall Study|Adverse Event|2
1805193|NCT00496483|6275914|P1|Overall Study|Not dosed|9
1805194|NCT00496470|6275931|P2|Overall Study|Other reason|2
1805195|NCT00496470|6275932|P1|Overall Study|Other reason|0
1805196|NCT00496470|6275931|P2|Overall Study|Incorrectly enrolled|5
1805197|NCT00496470|6275932|P1|Overall Study|Incorrectly enrolled|13
1805198|NCT00496470|6275931|P2|Overall Study|Withdrawal by Subject|12
1805199|NCT00496470|6275932|P1|Overall Study|Withdrawal by Subject|5
1805200|NCT00496470|6275931|P2|Overall Study|Adverse Event|10
1805201|NCT00496470|6275932|P1|Overall Study|Adverse Event|8
1805202|NCT00496366|6276018|P1|Overall Study|Death|1
1805203|NCT00496197|6276049|P1|Overall Study|Protocol Violation|8
1805204|NCT00496197|6276049|P1|Overall Study|Other|14
1805205|NCT00496197|6276049|P1|Overall Study|Pathogen not isolated baseline specimen|4
1805206|NCT00496197|6276049|P1|Overall Study|Withdrawal by Subject|11
1805207|NCT00496197|6276049|P1|Overall Study|Lost to Follow-up|11
1805208|NCT00496197|6276049|P1|Overall Study|Insufficient bacteriological response|10
1805209|NCT00496197|6276049|P1|Overall Study|Insufficient clinical response|3
1805210|NCT00496197|6276049|P1|Overall Study|Does not meet entrance criteria|5
1805211|NCT00496197|6276049|P1|Overall Study|Adverse Event|13
1805212|NCT00496197|6276049|P1|Overall Study|Discontinued study due to death|43
1805213|NCT00496080|6276076|P1|Overall Study|Physician Decision|6
1805214|NCT00496080|6276076|P1|Overall Study|Withdrawal by Subject|5
1805215|NCT00496080|6276076|P1|Overall Study|Surgical re-intervention|7
1805216|NCT00496080|6276076|P1|Overall Study|Lost to Follow-up|9
1805217|NCT00496054|6276086|P1|Overall Study|Lost to Follow-up|7
1805218|NCT00496054|6276086|P1|Overall Study|Adverse Event|1
1805219|NCT00496015|6276118|P5|Overall Study|Other|0
1805220|NCT00496015|6276119|P4|Overall Study|Other|1
1805221|NCT00496015|6276120|P3|Overall Study|Other|0
1805222|NCT00496015|6276121|P2|Overall Study|Other|0
1805223|NCT00496015|6276122|P1|Overall Study|Other|1
1805224|NCT00495820|6276246|P2|Overall Study|Adverse Event|1
1805225|NCT00495820|6276247|P1|Overall Study|Adverse Event|1
1805226|NCT00495794|6276259|P2|Overall Study|Pharmacist did not activate patient|0
1805227|NCT00495794|6276260|P1|Overall Study|Pharmacist did not activate patient|522
1805228|NCT00495755|6276270|P1|Overall Study|Adverse Event|3
1805229|NCT00495677|6276291|P7|Stage 1 (25 Days)|Adverse Event|0
1805230|NCT00495677|6276292|P6|Stage 1 (25 Days)|Adverse Event|0
1805231|NCT00495677|6276293|P5|Stage 1 (25 Days)|Adverse Event|0
1805232|NCT00495677|6276294|P4|Stage 1 (25 Days)|Adverse Event|0
1805233|NCT00495677|6276295|P3|Stage 1 (25 Days)|Adverse Event|1
1805234|NCT00495677|6276296|P2|Stage 1 (25 Days)|Adverse Event|0
1805235|NCT00495677|6276297|P1|Stage 1 (25 Days)|Adverse Event|0
1805236|NCT00495625|6276352|P1|Overall Study|Did not complete at least 1 42 day cycle|10
1805237|NCT00495612|6276363|P2|Overall Study|Subject's Decision to Withdraw|0
1805238|NCT00495612|6276364|P1|Overall Study|Subject's Decision to Withdraw|3
1805239|NCT00495612|6276363|P2|Overall Study|Lost to Follow-up|0
1805240|NCT00495612|6276364|P1|Overall Study|Lost to Follow-up|1
1805241|NCT00495586|6276382|P2|Overall Study|Withdrawal by Subject|4
1805242|NCT00495586|6276383|P1|Overall Study|Withdrawal by Subject|4
1805243|NCT00495521|6276393|P2|Overall Study|Physician Decision|1
1805244|NCT00495521|6276394|P1|Overall Study|Physician Decision|0
1805245|NCT00495495|6276424|P1|Overall Study|Protocol Violation|99
1805246|NCT00495469|6276444|P7|Overall Study|ST depression at randomisation in ECG|0
1805247|NCT00495469|6276445|P6|Overall Study|ST depression at randomisation in ECG|0
1805248|NCT00495469|6276446|P5|Overall Study|ST depression at randomisation in ECG|0
1805249|NCT00495469|6276447|P4|Overall Study|ST depression at randomisation in ECG|0
1805250|NCT00495469|6276448|P3|Overall Study|ST depression at randomisation in ECG|0
1805251|NCT00495469|6276449|P2|Overall Study|ST depression at randomisation in ECG|1
1805252|NCT00495469|6276450|P1|Overall Study|ST depression at randomisation in ECG|0
1805253|NCT00495469|6276444|P7|Overall Study|Liver function test abnormality|0
1805254|NCT00495469|6276445|P6|Overall Study|Liver function test abnormality|0
1805255|NCT00495469|6276446|P5|Overall Study|Liver function test abnormality|0
1805256|NCT00495469|6276447|P4|Overall Study|Liver function test abnormality|0
1805257|NCT00495469|6276448|P3|Overall Study|Liver function test abnormality|0
1805258|NCT00495469|6276449|P2|Overall Study|Liver function test abnormality|1
1805259|NCT00495469|6276450|P1|Overall Study|Liver function test abnormality|0
1805260|NCT00495469|6276444|P7|Overall Study|Lack of Efficacy|1
1805261|NCT00495469|6276445|P6|Overall Study|Lack of Efficacy|0
1805262|NCT00495469|6276446|P5|Overall Study|Lack of Efficacy|0
1805263|NCT00495469|6276447|P4|Overall Study|Lack of Efficacy|0
1805264|NCT00495469|6276448|P3|Overall Study|Lack of Efficacy|0
1805265|NCT00495469|6276449|P2|Overall Study|Lack of Efficacy|0
1805266|NCT00495469|6276450|P1|Overall Study|Lack of Efficacy|0
1805267|NCT00495469|6276444|P7|Overall Study|Withdrawal by Subject|3
1805268|NCT00495469|6276445|P6|Overall Study|Withdrawal by Subject|2
1805269|NCT00495469|6276446|P5|Overall Study|Withdrawal by Subject|3
1805270|NCT00495469|6276447|P4|Overall Study|Withdrawal by Subject|3
1805271|NCT00495469|6276448|P3|Overall Study|Withdrawal by Subject|1
1805272|NCT00495469|6276449|P2|Overall Study|Withdrawal by Subject|3
1805273|NCT00495469|6276450|P1|Overall Study|Withdrawal by Subject|5
1805274|NCT00495469|6276444|P7|Overall Study|Protocol Violation|0
1805275|NCT00495469|6276445|P6|Overall Study|Protocol Violation|2
1805276|NCT00495469|6276446|P5|Overall Study|Protocol Violation|1
1805277|NCT00495469|6276447|P4|Overall Study|Protocol Violation|0
1805278|NCT00495469|6276448|P3|Overall Study|Protocol Violation|0
1805279|NCT00495469|6276449|P2|Overall Study|Protocol Violation|0
1805280|NCT00495469|6276450|P1|Overall Study|Protocol Violation|0
1805281|NCT00495469|6276444|P7|Overall Study|Lost to Follow-up|0
1805282|NCT00495469|6276445|P6|Overall Study|Lost to Follow-up|0
1805283|NCT00495469|6276446|P5|Overall Study|Lost to Follow-up|0
1805284|NCT00495469|6276447|P4|Overall Study|Lost to Follow-up|1
1805285|NCT00495469|6276448|P3|Overall Study|Lost to Follow-up|3
1805286|NCT00495469|6276449|P2|Overall Study|Lost to Follow-up|1
1805287|NCT00495469|6276450|P1|Overall Study|Lost to Follow-up|1
1805288|NCT00495469|6276444|P7|Overall Study|Adverse Event|1
1805289|NCT00495469|6276445|P6|Overall Study|Adverse Event|1
1805290|NCT00495469|6276446|P5|Overall Study|Adverse Event|1
1805291|NCT00495469|6276447|P4|Overall Study|Adverse Event|0
1805292|NCT00495469|6276448|P3|Overall Study|Adverse Event|3
1805293|NCT00495469|6276449|P2|Overall Study|Adverse Event|1
1805294|NCT00495469|6276450|P1|Overall Study|Adverse Event|0
1805295|NCT00495391|6276594|P2|Overall Study|Withdrawal by Subject|3
1805296|NCT00495391|6276595|P1|Overall Study|Withdrawal by Subject|2
1805297|NCT00495391|6276594|P2|Overall Study|Lack of Efficacy|18
1805298|NCT00495391|6276595|P1|Overall Study|Lack of Efficacy|34
1805299|NCT00495170|6276618|P1|Overall Study|Inappropriate staging|8
1805300|NCT00495170|6276618|P1|Overall Study|Withdrawal by Subject|3
1805301|NCT00495170|6276618|P1|Overall Study|Lost to Follow-up|9
1805302|NCT00495131|6276637|P2|Overall Study|Withdrawal by Subject|0
1805303|NCT00495131|6276638|P1|Overall Study|Withdrawal by Subject|1
1805304|NCT00495131|6276637|P2|Overall Study|Lost to Follow-up|2
1805305|NCT00495131|6276638|P1|Overall Study|Lost to Follow-up|0
1805306|NCT00495131|6276637|P2|Overall Study|Lack of Efficacy|2
1805307|NCT00495131|6276638|P1|Overall Study|Lack of Efficacy|0
1805308|NCT00495131|6276637|P2|Overall Study|Adverse Event|2
1805309|NCT00495131|6276638|P1|Overall Study|Adverse Event|6
1805310|NCT00495040|6276655|P1|Overall Study|Withdrawal by Subject|3
1805311|NCT00494871|6276670|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
1805312|NCT00494871|6276671|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
1805313|NCT00494871|6276670|P2|Follow-up (FU) Period|Withdrawal by Subject|5
1805314|NCT00494871|6276671|P1|Follow-up (FU) Period|Withdrawal by Subject|5
1805315|NCT00494871|6276670|P2|Follow-up (FU) Period|Protocol Violation|0
1805316|NCT00494871|6276671|P1|Follow-up (FU) Period|Protocol Violation|1
1805317|NCT00494871|6276670|P2|Follow-up (FU) Period|Physician Decision|1
1805318|NCT00494871|6276671|P1|Follow-up (FU) Period|Physician Decision|0
1805319|NCT00494871|6276670|P2|Follow-up (FU) Period|Lost to Follow-up|2
1805320|NCT00494871|6276671|P1|Follow-up (FU) Period|Lost to Follow-up|6
1805321|NCT00494871|6276670|P2|Follow-up (FU) Period|Death|12
1805322|NCT00494871|6276671|P1|Follow-up (FU) Period|Death|13
1805323|NCT00494871|6276670|P2|Follow-up (FU) Period|Adverse Event|1
1805324|NCT00494871|6276671|P1|Follow-up (FU) Period|Adverse Event|1
1805325|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
1805326|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
1805327|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
1805328|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
1805329|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
1805330|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
1805331|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
1805332|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
1805333|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
1805334|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
1805335|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
1805336|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
1805337|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
1805338|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
1805339|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
1805340|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
1805341|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Physician Decision|13
1805342|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Physician Decision|4
1805343|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Death|3
1805344|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Death|8
1805345|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
1805346|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
1805347|NCT00494871|6276670|P2|Double-blind (DB) Treatment Period|Adverse Event|70
1805348|NCT00494871|6276671|P1|Double-blind (DB) Treatment Period|Adverse Event|73
1805349|NCT00494780|6276712|P2|Overall Study|Insurance Issues|1
1805350|NCT00494780|6276713|P1|Overall Study|Insurance Issues|0
1805351|NCT00494780|6276712|P2|Overall Study|Residual Tumour Mass|1
1805352|NCT00494780|6276713|P1|Overall Study|Residual Tumour Mass|0
1805353|NCT00494780|6276712|P2|Overall Study|Non-compliance|0
1805354|NCT00494780|6276713|P1|Overall Study|Non-compliance|1
1805355|NCT00494780|6276712|P2|Overall Study|New Treatment|2
1805356|NCT00494780|6276713|P1|Overall Study|New Treatment|2
1805357|NCT00494780|6276712|P2|Overall Study|Progression of Study Disease|8
1805358|NCT00494780|6276713|P1|Overall Study|Progression of Study Disease|7
1805359|NCT00494780|6276712|P2|Overall Study|Withdrew before Dosed|1
1805360|NCT00494780|6276713|P1|Overall Study|Withdrew before Dosed|0
1805361|NCT00494780|6276712|P2|Overall Study|Adverse Event|0
1805362|NCT00494780|6276713|P1|Overall Study|Adverse Event|1
1805363|NCT00494676|6276751|P2|Second Intervention|Withdrawal by Subject|1
1805364|NCT00494676|6276752|P1|Second Intervention|Withdrawal by Subject|1
1805365|NCT00494676|6276751|P2|First Intervention|Withdrawal by Subject|3
1805366|NCT00494676|6276752|P1|First Intervention|Withdrawal by Subject|1
1805367|NCT00494676|6276751|P2|Allocation|Withdrawal by Subject|4
1805368|NCT00494676|6276752|P1|Allocation|Withdrawal by Subject|2
1805369|NCT00494507|6276767|P4|Open-Label Phase|Worsening Disease|2
1805370|NCT00494507|6276768|P3|Open-Label Phase|Worsening Disease|0
1805371|NCT00494507|6276769|P2|Open-Label Phase|Worsening Disease|0
1805372|NCT00494507|6276770|P1|Open-Label Phase|Worsening Disease|0
1805373|NCT00494507|6276767|P4|Open-Label Phase|Adverse Event|3
1805374|NCT00494507|6276768|P3|Open-Label Phase|Adverse Event|5
1805375|NCT00494507|6276769|P2|Open-Label Phase|Adverse Event|1
1805376|NCT00494507|6276770|P1|Open-Label Phase|Adverse Event|0
1805377|NCT00494507|6276767|P4|Double-Blind Phase|Negative DNA test|1
1805378|NCT00494507|6276768|P3|Double-Blind Phase|Negative DNA test|0
1805379|NCT00494507|6276769|P2|Double-Blind Phase|Negative DNA test|0
1805380|NCT00494507|6276770|P1|Double-Blind Phase|Negative DNA test|0
1805381|NCT00494507|6276767|P4|Double-Blind Phase|Subject Non-compliance|0
1805382|NCT00494507|6276768|P3|Double-Blind Phase|Subject Non-compliance|1
1805383|NCT00494507|6276769|P2|Double-Blind Phase|Subject Non-compliance|0
1805384|NCT00494507|6276770|P1|Double-Blind Phase|Subject Non-compliance|0
1805385|NCT00494507|6276767|P4|Double-Blind Phase|Withdrawal by Subject|0
1805386|NCT00494507|6276768|P3|Double-Blind Phase|Withdrawal by Subject|0
1805387|NCT00494507|6276769|P2|Double-Blind Phase|Withdrawal by Subject|0
1805388|NCT00494507|6276770|P1|Double-Blind Phase|Withdrawal by Subject|1
1805389|NCT00494507|6276767|P4|Double-Blind Phase|Adverse Event|0
1805390|NCT00494507|6276768|P3|Double-Blind Phase|Adverse Event|1
1805391|NCT00494507|6276769|P2|Double-Blind Phase|Adverse Event|0
1805392|NCT00494507|6276770|P1|Double-Blind Phase|Adverse Event|2
1805393|NCT00494481|6276837|P2|Overall Study|Never received IP|0
1805394|NCT00494481|6276838|P1|Overall Study|Never received IP|2
1805395|NCT00494481|6276837|P2|Overall Study|Other|0
1805396|NCT00494481|6276838|P1|Overall Study|Other|1
1805397|NCT00494481|6276837|P2|Overall Study|Adverse Event|11
1805398|NCT00494481|6276838|P1|Overall Study|Adverse Event|15
1805399|NCT00494481|6276837|P2|Overall Study|Condition under investigation worsened|13
1805400|NCT00494481|6276838|P1|Overall Study|Condition under investigation worsened|11
1805401|NCT00494442|6276846|P2|Overall Study|Intercurrent illness|1
1805402|NCT00494442|6276847|P1|Overall Study|Intercurrent illness|0
1805403|NCT00494442|6276846|P2|Overall Study|Non-compliance|1
1805404|NCT00494442|6276847|P1|Overall Study|Non-compliance|0
1805405|NCT00494442|6276846|P2|Overall Study|Physician Decision|1
1805406|NCT00494442|6276847|P1|Overall Study|Physician Decision|0
1805407|NCT00494442|6276846|P2|Overall Study|Adverse Event|2
1805408|NCT00494442|6276847|P1|Overall Study|Adverse Event|0
1805409|NCT00494442|6276846|P2|Overall Study|Lack of Efficacy|10
1805410|NCT00494442|6276847|P1|Overall Study|Lack of Efficacy|16
1805411|NCT00494442|6276846|P2|Overall Study|Death|1
1805412|NCT00494442|6276847|P1|Overall Study|Death|1
1805413|NCT00494299|6276863|P2|Overall Study|Protocol Driven Decision Point|22
1805414|NCT00494299|6276864|P1|Overall Study|Protocol Driven Decision Point|11
1805415|NCT00494299|6276863|P2|Overall Study|Site Closed by Sponsor|0
1805416|NCT00494299|6276864|P1|Overall Study|Site Closed by Sponsor|6
1805417|NCT00494299|6276863|P2|Overall Study|Participant Did Not Take Study Drug|2
1805418|NCT00494299|6276864|P1|Overall Study|Participant Did Not Take Study Drug|0
1805419|NCT00494299|6276863|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
1805420|NCT00494299|6276864|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
1805421|NCT00494299|6276863|P2|Overall Study|Withdrawal by Subject|3
1805422|NCT00494299|6276864|P1|Overall Study|Withdrawal by Subject|8
1805423|NCT00494299|6276863|P2|Overall Study|Protocol Violation|2
1805424|NCT00494299|6276864|P1|Overall Study|Protocol Violation|1
1805425|NCT00494299|6276863|P2|Overall Study|Physician Decision|2
1805426|NCT00494299|6276864|P1|Overall Study|Physician Decision|0
1805427|NCT00494299|6276863|P2|Overall Study|Lost to Follow-up|0
1805428|NCT00494299|6276864|P1|Overall Study|Lost to Follow-up|1
1805429|NCT00494299|6276863|P2|Overall Study|Adverse Event|13
1805430|NCT00494299|6276864|P1|Overall Study|Adverse Event|93
1805431|NCT00494234|6276876|P2|Overall Study|Death|1
1805432|NCT00494234|6276877|P1|Overall Study|Death|2
1805433|NCT00494234|6276876|P2|Overall Study|Withdrawal by Subject|0
1805434|NCT00494234|6276877|P1|Overall Study|Withdrawal by Subject|1
1805435|NCT00494234|6276876|P2|Overall Study|Lack of Efficacy|9
1805436|NCT00494234|6276877|P1|Overall Study|Lack of Efficacy|12
1805437|NCT00494221|6276896|P3|Overall Study|Withdrawal by Subject|0
1805438|NCT00494221|6276897|P2|Overall Study|Withdrawal by Subject|2
1805439|NCT00494221|6276898|P1|Overall Study|Withdrawal by Subject|1
1805440|NCT00494221|6276896|P3|Overall Study|Death|14
1805441|NCT00494221|6276897|P2|Overall Study|Death|9
1805442|NCT00494221|6276898|P1|Overall Study|Death|15
1805443|NCT00494091|6276939|P2|Overall Study|Withdrawal by Subject|7
1805444|NCT00494091|6276940|P1|Overall Study|Withdrawal by Subject|0
1805445|NCT00494091|6276939|P2|Overall Study|Other|11
1805446|NCT00494091|6276940|P1|Overall Study|Other|1
1805447|NCT00494091|6276939|P2|Overall Study|Lost to Follow-up|4
1805448|NCT00494091|6276940|P1|Overall Study|Lost to Follow-up|0
1805449|NCT00494091|6276939|P2|Overall Study|Death|54
1805450|NCT00494091|6276940|P1|Overall Study|Death|5
1805451|NCT00494026|6276962|P1|Overall Study|Sponsor Decision|4
1805452|NCT00494013|6276972|P2|Overall Study|Sponsor Decision|1
1805453|NCT00494013|6276973|P1|Overall Study|Sponsor Decision|0
1805454|NCT00494013|6276972|P2|Overall Study|Withdrawal by Subject|14
1805455|NCT00494013|6276973|P1|Overall Study|Withdrawal by Subject|13
1805456|NCT00494013|6276972|P2|Overall Study|Protocol Violation|5
1805457|NCT00494013|6276973|P1|Overall Study|Protocol Violation|8
1805458|NCT00494013|6276972|P2|Overall Study|Physician Decision|5
1805459|NCT00494013|6276973|P1|Overall Study|Physician Decision|3
1805460|NCT00494013|6276972|P2|Overall Study|Lost to Follow-up|6
1805461|NCT00494013|6276973|P1|Overall Study|Lost to Follow-up|5
1805462|NCT00494013|6276972|P2|Overall Study|Entry Criteria Not Met|4
1805463|NCT00494013|6276973|P1|Overall Study|Entry Criteria Not Met|1
1805464|NCT00494013|6276972|P2|Overall Study|Adverse Event|1
1805465|NCT00494013|6276973|P1|Overall Study|Adverse Event|0
1805466|NCT00493974|6277003|P2|Overall Study|Lost to Follow-up|6
1805467|NCT00493974|6277004|P1|Overall Study|Lost to Follow-up|4
1805468|NCT00493974|6277003|P2|Overall Study|Withdrawal by Subject|6
1805469|NCT00493974|6277004|P1|Overall Study|Withdrawal by Subject|8
1805470|NCT00493974|6277003|P2|Overall Study|Death|2
1805471|NCT00493974|6277004|P1|Overall Study|Death|1
1805472|NCT00493779|6277031|P1|Overall Study|Logistical issue at site|1
1805473|NCT00493649|6277038|P1|Overall Study|Other|13
1805474|NCT00493649|6277038|P1|Overall Study|Lost to Follow-up|1
1805475|NCT00493649|6277038|P1|Overall Study|Disease Progression|1
1805476|NCT00493649|6277038|P1|Overall Study|Investigator Request|2
1805477|NCT00493649|6277038|P1|Overall Study|Patient Request|21
1805478|NCT00493649|6277038|P1|Overall Study|Adverse Event|44
1805479|NCT00493636|6277051|P2|Overall Study|Mis-randomization|1
1805480|NCT00493636|6277052|P1|Overall Study|Mis-randomization|1
1805481|NCT00493636|6277051|P2|Overall Study|Disease progression/recurrence/relapse|1
1805482|NCT00493636|6277052|P1|Overall Study|Disease progression/recurrence/relapse|0
1805483|NCT00493636|6277051|P2|Overall Study|Withdrawal by Subject|0
1805484|NCT00493636|6277052|P1|Overall Study|Withdrawal by Subject|1
1805485|NCT00493454|6277066|P1|Overall Study|Withdrawal by Subject|1
1805486|NCT00493311|6277072|P2|Overall Study|Need for rescue medication|2
1805487|NCT00493311|6277073|P1|Overall Study|Need for rescue medication|2
1805488|NCT00493285|6277093|P6|Overall Study|Lost to Follow-up|0
1805489|NCT00493285|6277094|P5|Overall Study|Lost to Follow-up|1
1805490|NCT00493285|6277095|P4|Overall Study|Lost to Follow-up|0
1805491|NCT00493285|6277096|P3|Overall Study|Lost to Follow-up|0
1805492|NCT00493285|6277097|P2|Overall Study|Lost to Follow-up|0
1805493|NCT00493285|6277098|P1|Overall Study|Lost to Follow-up|0
1805494|NCT00493246|6277330|P8|Overall Study|Lost to Follow-up|0
1805495|NCT00493246|6277331|P7|Overall Study|Lost to Follow-up|1
1805496|NCT00493246|6277332|P6|Overall Study|Lost to Follow-up|0
1805497|NCT00493246|6277333|P5|Overall Study|Lost to Follow-up|0
1805498|NCT00493246|6277334|P4|Overall Study|Lost to Follow-up|0
1805499|NCT00493246|6277335|P3|Overall Study|Lost to Follow-up|0
1805500|NCT00493246|6277336|P2|Overall Study|Lost to Follow-up|0
1805501|NCT00493246|6277337|P1|Overall Study|Lost to Follow-up|0
1805502|NCT00493246|6277330|P8|Overall Study|No access to draw blood|0
1805503|NCT00493246|6277331|P7|Overall Study|No access to draw blood|0
1805504|NCT00493246|6277332|P6|Overall Study|No access to draw blood|1
1805505|NCT00493246|6277333|P5|Overall Study|No access to draw blood|0
1805506|NCT00493246|6277334|P4|Overall Study|No access to draw blood|0
1805507|NCT00493246|6277335|P3|Overall Study|No access to draw blood|0
1805508|NCT00493246|6277336|P2|Overall Study|No access to draw blood|0
1805509|NCT00493246|6277337|P1|Overall Study|No access to draw blood|0
1805510|NCT00493246|6277330|P8|Overall Study|Withdrawal by Subject|0
1805511|NCT00493246|6277331|P7|Overall Study|Withdrawal by Subject|0
1805512|NCT00493246|6277332|P6|Overall Study|Withdrawal by Subject|0
1805513|NCT00493246|6277333|P5|Overall Study|Withdrawal by Subject|1
1805514|NCT00493246|6277334|P4|Overall Study|Withdrawal by Subject|0
1805515|NCT00493246|6277335|P3|Overall Study|Withdrawal by Subject|0
1805516|NCT00493246|6277336|P2|Overall Study|Withdrawal by Subject|0
1805517|NCT00493246|6277337|P1|Overall Study|Withdrawal by Subject|0
1805518|NCT00493220|6277401|P6|Third Intervention|Withdrawal by Subject|0
1805519|NCT00493220|6277402|P5|Third Intervention|Withdrawal by Subject|0
1805520|NCT00493220|6277403|P4|Third Intervention|Withdrawal by Subject|0
1805521|NCT00493220|6277404|P3|Third Intervention|Withdrawal by Subject|0
1805522|NCT00493220|6277405|P2|Third Intervention|Withdrawal by Subject|0
1805523|NCT00493220|6277406|P1|Third Intervention|Withdrawal by Subject|1
1805524|NCT00493038|6277434|P2|Follow-up|Lost to Follow-up|0
1805525|NCT00493038|6277435|P1|Follow-up|Lost to Follow-up|1
1805526|NCT00493038|6277434|P2|Treatment|Other|1
1805527|NCT00493038|6277435|P1|Treatment|Other|0
1805528|NCT00493038|6277434|P2|Treatment|Withdrawal by Subject|12
1805529|NCT00493038|6277435|P1|Treatment|Withdrawal by Subject|11
1805530|NCT00493038|6277434|P2|Treatment|Lost to Follow-up|3
1805531|NCT00493038|6277435|P1|Treatment|Lost to Follow-up|5
1805532|NCT00493038|6277434|P2|Treatment|Adverse Event|4
1805533|NCT00493038|6277435|P1|Treatment|Adverse Event|8
1805534|NCT00493025|6277449|P1|Overall Study|Physician Decision|19
1805535|NCT00493012|6277460|P2|Overall Study|Lost to Follow-up|17
1805536|NCT00493012|6277461|P1|Overall Study|Lost to Follow-up|18
1805537|NCT00492921|6277504|P3|Overall Study|Death|1
1805538|NCT00492921|6277505|P2|Overall Study|Death|0
1805539|NCT00492921|6277506|P1|Overall Study|Death|1
1805540|NCT00492856|6277517|P4|Post-consolidation|Observation Arm|0
1805541|NCT00492856|6277518|P3|Post-consolidation|Observation Arm|27
1805542|NCT00492856|6277519|P2|Post-consolidation|Observation Arm|0
1805543|NCT00492856|6277520|P1|Post-consolidation|Observation Arm|0
1805544|NCT00492856|6277517|P4|Post-consolidation|Lost to Follow-up|0
1805545|NCT00492856|6277518|P3|Post-consolidation|Lost to Follow-up|0
1805546|NCT00492856|6277519|P2|Post-consolidation|Lost to Follow-up|2
1805547|NCT00492856|6277520|P1|Post-consolidation|Lost to Follow-up|0
1805548|NCT00492856|6277517|P4|Post-consolidation|Not protocol specified|0
1805549|NCT00492856|6277518|P3|Post-consolidation|Not protocol specified|0
1805550|NCT00492856|6277519|P2|Post-consolidation|Not protocol specified|1
1805551|NCT00492856|6277520|P1|Post-consolidation|Not protocol specified|0
1805552|NCT00492856|6277517|P4|Post-consolidation|Death|0
1805553|NCT00492856|6277518|P3|Post-consolidation|Death|0
1805554|NCT00492856|6277519|P2|Post-consolidation|Death|1
1805555|NCT00492856|6277520|P1|Post-consolidation|Death|0
1805556|NCT00492856|6277517|P4|Post-consolidation|Withdrawal by Subject|0
1805557|NCT00492856|6277518|P3|Post-consolidation|Withdrawal by Subject|0
1805558|NCT00492856|6277519|P2|Post-consolidation|Withdrawal by Subject|4
1805559|NCT00492856|6277520|P1|Post-consolidation|Withdrawal by Subject|0
1805560|NCT00492856|6277517|P4|Post-consolidation|Adverse Event|1
1805561|NCT00492856|6277518|P3|Post-consolidation|Adverse Event|0
1805562|NCT00492856|6277519|P2|Post-consolidation|Adverse Event|4
1805563|NCT00492856|6277520|P1|Post-consolidation|Adverse Event|0
1805564|NCT00492856|6277517|P4|Consolidation|Lost to Follow-up|0
1805565|NCT00492856|6277518|P3|Consolidation|Lost to Follow-up|0
1805566|NCT00492856|6277519|P2|Consolidation|Lost to Follow-up|0
1805567|NCT00492856|6277520|P1|Consolidation|Lost to Follow-up|1
1805568|NCT00492856|6277517|P4|Consolidation|Not protocol specified|0
1805569|NCT00492856|6277518|P3|Consolidation|Not protocol specified|0
1805570|NCT00492856|6277519|P2|Consolidation|Not protocol specified|0
1805571|NCT00492856|6277520|P1|Consolidation|Not protocol specified|2
1805572|NCT00492856|6277517|P4|Consolidation|Adverse Event|0
1805573|NCT00492856|6277518|P3|Consolidation|Adverse Event|0
1805574|NCT00492856|6277519|P2|Consolidation|Adverse Event|0
1805575|NCT00492856|6277520|P1|Consolidation|Adverse Event|6
1805576|NCT00492856|6277517|P4|Induction|Death|0
1805577|NCT00492856|6277518|P3|Induction|Death|0
1805578|NCT00492856|6277519|P2|Induction|Death|0
1805579|NCT00492856|6277520|P1|Induction|Death|3
1805580|NCT00492856|6277517|P4|Induction|Withdrawal by Subject|0
1805581|NCT00492856|6277518|P3|Induction|Withdrawal by Subject|0
1805582|NCT00492856|6277519|P2|Induction|Withdrawal by Subject|0
1805583|NCT00492856|6277520|P1|Induction|Withdrawal by Subject|1
1805584|NCT00492856|6277517|P4|Induction|Adverse Event|0
1805585|NCT00492856|6277518|P3|Induction|Adverse Event|0
1805586|NCT00492856|6277519|P2|Induction|Adverse Event|0
1805587|NCT00492856|6277520|P1|Induction|Adverse Event|2
1805588|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1805589|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1805590|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
1805591|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
1805592|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1805593|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1805594|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
1805595|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
1805596|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
1805597|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1805598|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1805599|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
1805600|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
1805601|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
1805602|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
1805603|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
1805604|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
1805605|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
1805606|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
1805607|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
1805608|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
1805609|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
1805610|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
1805611|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
1805612|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Death|1
1805613|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Death|45
1805614|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Death|5
1805615|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Death|75
1805616|NCT00492752|6277534|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
1805617|NCT00492752|6277535|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
1805618|NCT00492752|6277536|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
1805619|NCT00492752|6277537|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
1805620|NCT00492752|6277534|P4|Double Blind Treatment|Protocol Violation|0
1805621|NCT00492752|6277535|P3|Double Blind Treatment|Protocol Violation|1
1805622|NCT00492752|6277536|P2|Double Blind Treatment|Protocol Violation|0
1805623|NCT00492752|6277537|P1|Double Blind Treatment|Protocol Violation|0
1805624|NCT00492752|6277534|P4|Double Blind Treatment|Adverse Event|0
1805625|NCT00492752|6277535|P3|Double Blind Treatment|Adverse Event|0
1805626|NCT00492752|6277536|P2|Double Blind Treatment|Adverse Event|0
1805627|NCT00492752|6277537|P1|Double Blind Treatment|Adverse Event|1
1805628|NCT00492752|6277534|P4|Double Blind Treatment|Death|0
1805629|NCT00492752|6277535|P3|Double Blind Treatment|Death|2
1805630|NCT00492752|6277536|P2|Double Blind Treatment|Death|0
1805631|NCT00492752|6277537|P1|Double Blind Treatment|Death|13
1805632|NCT00492726|6277572|P2|Overall Study|Non compliant with study medication|3
1805633|NCT00492726|6277573|P1|Overall Study|Non compliant with study medication|0
1805634|NCT00492726|6277572|P2|Overall Study|Withdrawal by Subject|3
1805635|NCT00492726|6277573|P1|Overall Study|Withdrawal by Subject|6
1805636|NCT00492726|6277572|P2|Overall Study|Physician Decision|1
1805637|NCT00492726|6277573|P1|Overall Study|Physician Decision|0
1805638|NCT00492726|6277572|P2|Overall Study|Lost to Follow-up|19
1805639|NCT00492726|6277573|P1|Overall Study|Lost to Follow-up|27
1805640|NCT00492726|6277572|P2|Overall Study|Lack of Efficacy|2
1805641|NCT00492726|6277573|P1|Overall Study|Lack of Efficacy|0
1805642|NCT00492726|6277572|P2|Overall Study|Death|2
1805643|NCT00492726|6277573|P1|Overall Study|Death|7
1805644|NCT00492726|6277572|P2|Overall Study|Adverse Event|6
1805645|NCT00492726|6277573|P1|Overall Study|Adverse Event|10
1805646|NCT00492648|6277599|P2|Month 30 (109671 Study)|Protocol Violation|1
1805647|NCT00492648|6277600|P1|Month 30 (109671 Study)|Protocol Violation|0
1805648|NCT00492557|6277647|P2|Overall Study|Lost to Follow-up|1
1805649|NCT00492557|6277648|P1|Overall Study|Lost to Follow-up|0
1805650|NCT00492557|6277647|P2|Overall Study|Failed to return|0
1805651|NCT00492557|6277648|P1|Overall Study|Failed to return|1
1805652|NCT00492557|6277647|P2|Overall Study|Adverse Event|0
1805653|NCT00492557|6277648|P1|Overall Study|Adverse Event|1
1805654|NCT00492557|6277647|P2|Overall Study|Death|1
1805655|NCT00492557|6277648|P1|Overall Study|Death|1
1805656|NCT00492557|6277647|P2|Overall Study|Other|2
1805657|NCT00492557|6277648|P1|Overall Study|Other|2
1805658|NCT00492557|6277647|P2|Overall Study|Protocol Violation|8
1805659|NCT00492557|6277648|P1|Overall Study|Protocol Violation|7
1805660|NCT00492557|6277647|P2|Overall Study|Subject request|11
1805661|NCT00492557|6277648|P1|Overall Study|Subject request|12
1805662|NCT00492531|6277678|P2|Overall Study|Withdrawn(More than one reason selected)|23
1805663|NCT00492531|6277679|P1|Overall Study|Withdrawn(More than one reason selected)|22
1805664|NCT00492297|6277752|P1|Survival Only Follow-up|Study terminated by sponsor|12
1805665|NCT00492297|6277752|P1|Survival Only Follow-up|Lack of Efficacy|1
1805666|NCT00492297|6277752|P1|Survival Only Follow-up|Death|46
1805667|NCT00492297|6277752|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
1805668|NCT00492297|6277752|P1|Active Follow-up 30(+4) Days Duration|Death|17
1805669|NCT00492297|6277752|P1|Treatment|Study terminated by sponsor|3
1805670|NCT00492297|6277752|P1|Treatment|Death|2
1805671|NCT00492284|6277770|P4|Overall Study|Withdrawal by Subject|2
1805672|NCT00492284|6277771|P3|Overall Study|Withdrawal by Subject|0
1805673|NCT00492284|6277772|P2|Overall Study|Withdrawal by Subject|0
1805674|NCT00492284|6277773|P1|Overall Study|Withdrawal by Subject|1
1805675|NCT00492284|6277770|P4|Overall Study|Death|5
1805676|NCT00492284|6277771|P3|Overall Study|Death|2
1805677|NCT00492284|6277772|P2|Overall Study|Death|3
1805678|NCT00492284|6277773|P1|Overall Study|Death|0
1805679|NCT00492284|6277770|P4|Overall Study|Lost to Follow-up|1
1805680|NCT00492284|6277771|P3|Overall Study|Lost to Follow-up|3
1805681|NCT00492284|6277772|P2|Overall Study|Lost to Follow-up|0
1805682|NCT00492284|6277773|P1|Overall Study|Lost to Follow-up|0
1805683|NCT00492284|6277770|P4|Overall Study|Adverse Event|2
1805684|NCT00492284|6277771|P3|Overall Study|Adverse Event|1
1805685|NCT00492284|6277772|P2|Overall Study|Adverse Event|1
1805686|NCT00492284|6277773|P1|Overall Study|Adverse Event|0
1805687|NCT00492232|6277817|P2|Open-Label Treatment|Withdrawal by Subject|0
1805688|NCT00492232|6277818|P1|Open-Label Treatment|Withdrawal by Subject|1
1805689|NCT00492232|6277817|P2|Double-Blind Treatment|Randomized not treated|0
1805690|NCT00492232|6277818|P1|Double-Blind Treatment|Randomized not treated|1
1805691|NCT00492232|6277817|P2|Double-Blind Treatment|Other|5
1805692|NCT00492232|6277818|P1|Double-Blind Treatment|Other|6
1805693|NCT00492232|6277817|P2|Double-Blind Treatment|Lack of Efficacy|0
1805694|NCT00492232|6277818|P1|Double-Blind Treatment|Lack of Efficacy|1
1805695|NCT00492232|6277817|P2|Double-Blind Treatment|Withdrawal by Subject|8
1805696|NCT00492232|6277818|P1|Double-Blind Treatment|Withdrawal by Subject|4
1805697|NCT00492232|6277817|P2|Double-Blind Treatment|Lost to Follow-up|3
1805698|NCT00492232|6277818|P1|Double-Blind Treatment|Lost to Follow-up|2
1805699|NCT00492232|6277817|P2|Double-Blind Treatment|Protocol Violation|7
1805700|NCT00492232|6277818|P1|Double-Blind Treatment|Protocol Violation|3
1805701|NCT00492232|6277817|P2|Double-Blind Treatment|Adverse Event|2
1805702|NCT00492232|6277818|P1|Double-Blind Treatment|Adverse Event|1
1805703|NCT00492232|6277817|P2|Placebo Run-in|Missing|2
1805704|NCT00492232|6277818|P1|Placebo Run-in|Missing|0
1805705|NCT00492232|6277817|P2|Placebo Run-in|Other|6
1805706|NCT00492232|6277818|P1|Placebo Run-in|Other|0
1805707|NCT00492232|6277817|P2|Placebo Run-in|Entrance criteria not met|45
1805708|NCT00492232|6277818|P1|Placebo Run-in|Entrance criteria not met|0
1805709|NCT00492232|6277817|P2|Placebo Run-in|Pregnancy|1
1805710|NCT00492232|6277818|P1|Placebo Run-in|Pregnancy|0
1805711|NCT00492232|6277817|P2|Placebo Run-in|Withdrawal by Subject|8
1805712|NCT00492232|6277818|P1|Placebo Run-in|Withdrawal by Subject|0
1805713|NCT00492232|6277817|P2|Placebo Run-in|Lost to Follow-up|3
1805714|NCT00492232|6277818|P1|Placebo Run-in|Lost to Follow-up|0
1805715|NCT00492232|6277817|P2|Placebo Run-in|Protocol Violation|3
1805716|NCT00492232|6277818|P1|Placebo Run-in|Protocol Violation|0
1805717|NCT00492232|6277817|P2|Placebo Run-in|Adverse Event|2
1805718|NCT00492232|6277818|P1|Placebo Run-in|Adverse Event|0
1805719|NCT00492115|6277859|P2|Overall Study|Withdrawal by Subject|4
1805720|NCT00492115|6277860|P1|Overall Study|Withdrawal by Subject|3
1805721|NCT00492063|6277881|P4|Overall Study|Protocol Violation|1
1805722|NCT00492063|6277882|P3|Overall Study|Protocol Violation|0
1805723|NCT00492063|6277883|P2|Overall Study|Protocol Violation|0
1805724|NCT00492063|6277884|P1|Overall Study|Protocol Violation|0
1805725|NCT00492063|6277881|P4|Overall Study|Lost to Follow-up|3
1805726|NCT00492063|6277882|P3|Overall Study|Lost to Follow-up|5
1805727|NCT00492063|6277883|P2|Overall Study|Lost to Follow-up|11
1805728|NCT00492063|6277884|P1|Overall Study|Lost to Follow-up|6
1805729|NCT00492063|6277881|P4|Overall Study|Withdrawal by Subject|4
1805730|NCT00492063|6277882|P3|Overall Study|Withdrawal by Subject|5
1805731|NCT00492063|6277883|P2|Overall Study|Withdrawal by Subject|3
1805732|NCT00492063|6277884|P1|Overall Study|Withdrawal by Subject|4
1805733|NCT00492063|6277881|P4|Overall Study|Death|2
1805734|NCT00492063|6277882|P3|Overall Study|Death|1
1805735|NCT00492063|6277883|P2|Overall Study|Death|0
1805736|NCT00492063|6277884|P1|Overall Study|Death|0
1805737|NCT00492024|6277908|P2|Follow up|Lost to Follow-up|1
1805738|NCT00492024|6277909|P1|Follow up|Lost to Follow-up|1
1805739|NCT00492024|6277908|P2|Follow up|Lack of Efficacy|1
1805740|NCT00492024|6277909|P1|Follow up|Lack of Efficacy|0
1805741|NCT00492024|6277908|P2|Treatment|Withdrawal by Subject|0
1805742|NCT00492024|6277909|P1|Treatment|Withdrawal by Subject|2
1805743|NCT00492024|6277908|P2|Treatment|Lost to Follow-up|1
1805744|NCT00492024|6277909|P1|Treatment|Lost to Follow-up|3
1805745|NCT00492024|6277908|P2|Treatment|Lack of Efficacy|20
1805746|NCT00492024|6277909|P1|Treatment|Lack of Efficacy|21
1805747|NCT00492024|6277908|P2|Treatment|Adverse Event|1
1805748|NCT00492024|6277909|P1|Treatment|Adverse Event|3
1805749|NCT00491894|6277925|P1|Overall Study|Other-Intake of prohibited medication|1
1805750|NCT00491894|6277925|P1|Overall Study|Protocol Violation|2
1805751|NCT00491894|6277925|P1|Overall Study|Physician Decision|2
1805752|NCT00491894|6277925|P1|Overall Study|Other-Failed to meet any criteria|2
1805753|NCT00491894|6277925|P1|Overall Study|Lack of Efficacy|2
1805754|NCT00491894|6277925|P1|Overall Study|Lost to Follow-up|3
1805755|NCT00491894|6277925|P1|Overall Study|Death|3
1805756|NCT00491894|6277925|P1|Overall Study|Withdrawal by Subject|5
1805757|NCT00491894|6277925|P1|Overall Study|Adverse Event|14
1805758|NCT00491764|6277952|P6|Overall Study|Administrative|0
1805759|NCT00491764|6277953|P5|Overall Study|Administrative|0
1805760|NCT00491764|6277954|P4|Overall Study|Administrative|1
1805761|NCT00491764|6277955|P3|Overall Study|Administrative|2
1805762|NCT00491764|6277956|P2|Overall Study|Administrative|0
1805763|NCT00491764|6277957|P1|Overall Study|Administrative|1
1805764|NCT00491764|6277952|P6|Overall Study|Did not Meet Protocol Eligibility|1
1805765|NCT00491764|6277953|P5|Overall Study|Did not Meet Protocol Eligibility|1
1805766|NCT00491764|6277954|P4|Overall Study|Did not Meet Protocol Eligibility|0
1805767|NCT00491764|6277955|P3|Overall Study|Did not Meet Protocol Eligibility|1
1805768|NCT00491764|6277956|P2|Overall Study|Did not Meet Protocol Eligibility|1
1805769|NCT00491764|6277957|P1|Overall Study|Did not Meet Protocol Eligibility|0
1805770|NCT00491764|6277952|P6|Overall Study|Non Compliance with the Protocol|0
1805771|NCT00491764|6277953|P5|Overall Study|Non Compliance with the Protocol|0
1805772|NCT00491764|6277954|P4|Overall Study|Non Compliance with the Protocol|0
1805773|NCT00491764|6277955|P3|Overall Study|Non Compliance with the Protocol|0
1805774|NCT00491764|6277956|P2|Overall Study|Non Compliance with the Protocol|0
1805775|NCT00491764|6277957|P1|Overall Study|Non Compliance with the Protocol|1
1805776|NCT00491764|6277952|P6|Overall Study|Withdrawal by Subject|4
1805777|NCT00491764|6277953|P5|Overall Study|Withdrawal by Subject|2
1805778|NCT00491764|6277954|P4|Overall Study|Withdrawal by Subject|2
1805779|NCT00491764|6277955|P3|Overall Study|Withdrawal by Subject|1
1805780|NCT00491764|6277956|P2|Overall Study|Withdrawal by Subject|3
1805781|NCT00491764|6277957|P1|Overall Study|Withdrawal by Subject|2
1805782|NCT00491764|6277952|P6|Overall Study|Lost to Follow-up|3
1805783|NCT00491764|6277953|P5|Overall Study|Lost to Follow-up|0
1805784|NCT00491764|6277954|P4|Overall Study|Lost to Follow-up|1
1805785|NCT00491764|6277955|P3|Overall Study|Lost to Follow-up|0
1805786|NCT00491764|6277956|P2|Overall Study|Lost to Follow-up|1
1805787|NCT00491764|6277957|P1|Overall Study|Lost to Follow-up|0
1805788|NCT00491764|6277952|P6|Overall Study|Adverse Event|1
1805789|NCT00491764|6277953|P5|Overall Study|Adverse Event|0
1805790|NCT00491764|6277954|P4|Overall Study|Adverse Event|4
1805791|NCT00491764|6277955|P3|Overall Study|Adverse Event|4
1805792|NCT00491764|6277956|P2|Overall Study|Adverse Event|2
1805793|NCT00491764|6277957|P1|Overall Study|Adverse Event|1
1805794|NCT00491608|6278005|P1|Overall Study|Withdrawal by Subject|1
1805795|NCT00491608|6278005|P1|Overall Study|Death|2
1805796|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
1805797|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
1805798|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
1805799|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
1805800|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
1805801|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
1805802|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
1805803|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
1805804|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
1805805|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
1805806|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
1805807|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
1805808|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
1805809|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
1805810|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
1805811|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
1805812|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
1805813|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
1805814|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
1805815|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
1805816|NCT00491556|6278016|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
1805817|NCT00491556|6278017|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
1805818|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
1805819|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
1805820|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
1805821|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
1805822|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
1805823|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
1805824|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
1805825|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
1805826|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
1805827|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
1805828|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
1805829|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
1805830|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
1805831|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
1805832|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
1805833|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
1805834|NCT00491556|6278016|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
1805835|NCT00491556|6278017|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
1805836|NCT00491530|6278076|P3|Overall Study|Use of Prohibited Medication|1
1805837|NCT00491530|6278077|P2|Overall Study|Use of Prohibited Medication|0
1805838|NCT00491530|6278078|P1|Overall Study|Use of Prohibited Medication|0
1805839|NCT00491530|6278076|P3|Overall Study|Patient Request|0
1805840|NCT00491530|6278077|P2|Overall Study|Patient Request|1
1805841|NCT00491530|6278078|P1|Overall Study|Patient Request|0
1805842|NCT00491530|6278076|P3|Overall Study|Investigator Discretion|0
1805843|NCT00491530|6278077|P2|Overall Study|Investigator Discretion|1
1805844|NCT00491530|6278078|P1|Overall Study|Investigator Discretion|0
1805845|NCT00491530|6278076|P3|Overall Study|Lack of Efficacy|0
1805846|NCT00491530|6278077|P2|Overall Study|Lack of Efficacy|1
1805847|NCT00491530|6278078|P1|Overall Study|Lack of Efficacy|0
1805848|NCT00491530|6278076|P3|Overall Study|Lost to Follow-up|2
1805849|NCT00491530|6278077|P2|Overall Study|Lost to Follow-up|2
1805850|NCT00491530|6278078|P1|Overall Study|Lost to Follow-up|3
1805851|NCT00491530|6278076|P3|Overall Study|Withdrawal by Subject|0
1805852|NCT00491530|6278077|P2|Overall Study|Withdrawal by Subject|0
1805853|NCT00491530|6278078|P1|Overall Study|Withdrawal by Subject|3
1805854|NCT00491530|6278076|P3|Overall Study|Adverse Event|2
1805855|NCT00491530|6278077|P2|Overall Study|Adverse Event|1
1805856|NCT00491530|6278078|P1|Overall Study|Adverse Event|6
1805857|NCT00491504|6278108|P4|Overall Study|Protocol Violation|2
1805858|NCT00491504|6278109|P3|Overall Study|Protocol Violation|3
1805859|NCT00491504|6278110|P2|Overall Study|Protocol Violation|0
1805860|NCT00491504|6278111|P1|Overall Study|Protocol Violation|0
1805861|NCT00491504|6278108|P4|Overall Study|Withdrawal by Subject|2
1805862|NCT00491504|6278109|P3|Overall Study|Withdrawal by Subject|1
1805863|NCT00491504|6278110|P2|Overall Study|Withdrawal by Subject|0
1805864|NCT00491504|6278111|P1|Overall Study|Withdrawal by Subject|0
1805865|NCT00491504|6278108|P4|Overall Study|Adverse Event|0
1805866|NCT00491504|6278109|P3|Overall Study|Adverse Event|0
1805867|NCT00491504|6278110|P2|Overall Study|Adverse Event|1
1805868|NCT00491504|6278111|P1|Overall Study|Adverse Event|0
1805869|NCT00491400|6278121|P2|Overall Study|Withdrawal by Subject|4
1805870|NCT00491400|6278122|P1|Overall Study|Withdrawal by Subject|5
1805871|NCT00491387|6278130|P1|Overall Study|study terminated|20
1805872|NCT00491322|6278145|P2|Overall Study|Pregnancy|1
1805873|NCT00491322|6278146|P1|Overall Study|Pregnancy|0
1805874|NCT00491322|6278145|P2|Overall Study|Protocol Violation|0
1805875|NCT00491322|6278146|P1|Overall Study|Protocol Violation|1
1805876|NCT00491179|6278165|P2|Overall Study|Withdrawal by Subject|1
1805877|NCT00491179|6278166|P1|Overall Study|Withdrawal by Subject|2
1805878|NCT00491179|6278165|P2|Overall Study|Adverse Event|1
1805879|NCT00491179|6278166|P1|Overall Study|Adverse Event|5
1805880|NCT00491075|6278174|P1|Overall Study|Physician Decision|1
1805881|NCT00491075|6278174|P1|Overall Study|Withdrawal by Subject|1
1805882|NCT00490971|6278180|P5|Maintenance|Other|3
1805883|NCT00490971|6278181|P4|Maintenance|Other|9
1805884|NCT00490971|6278182|P3|Maintenance|Other|11
1805885|NCT00490971|6278183|P2|Maintenance|Other|0
1805886|NCT00490971|6278184|P1|Maintenance|Other|0
1805887|NCT00490971|6278180|P5|Maintenance|Withdrawal by Subject|18
1805888|NCT00490971|6278181|P4|Maintenance|Withdrawal by Subject|28
1805889|NCT00490971|6278182|P3|Maintenance|Withdrawal by Subject|26
1805890|NCT00490971|6278183|P2|Maintenance|Withdrawal by Subject|0
1805891|NCT00490971|6278184|P1|Maintenance|Withdrawal by Subject|0
1805892|NCT00490971|6278180|P5|Maintenance|Protocol Violation|1
1805893|NCT00490971|6278181|P4|Maintenance|Protocol Violation|1
1805894|NCT00490971|6278182|P3|Maintenance|Protocol Violation|4
1805895|NCT00490971|6278183|P2|Maintenance|Protocol Violation|0
1805896|NCT00490971|6278184|P1|Maintenance|Protocol Violation|0
1805897|NCT00490971|6278180|P5|Maintenance|Pregnancy|0
1805898|NCT00490971|6278181|P4|Maintenance|Pregnancy|0
1805899|NCT00490971|6278182|P3|Maintenance|Pregnancy|1
1805900|NCT00490971|6278183|P2|Maintenance|Pregnancy|0
1805901|NCT00490971|6278184|P1|Maintenance|Pregnancy|0
1805902|NCT00490971|6278180|P5|Maintenance|Lost to Follow-up|10
1805903|NCT00490971|6278181|P4|Maintenance|Lost to Follow-up|8
1805904|NCT00490971|6278182|P3|Maintenance|Lost to Follow-up|5
1805905|NCT00490971|6278183|P2|Maintenance|Lost to Follow-up|0
1805906|NCT00490971|6278184|P1|Maintenance|Lost to Follow-up|0
1805907|NCT00490971|6278180|P5|Maintenance|Death|0
1805908|NCT00490971|6278181|P4|Maintenance|Death|2
1805909|NCT00490971|6278182|P3|Maintenance|Death|0
1805910|NCT00490971|6278183|P2|Maintenance|Death|0
1805911|NCT00490971|6278184|P1|Maintenance|Death|0
1805912|NCT00490971|6278180|P5|Maintenance|Adverse Event|7
1805913|NCT00490971|6278181|P4|Maintenance|Adverse Event|5
1805914|NCT00490971|6278182|P3|Maintenance|Adverse Event|4
1805915|NCT00490971|6278183|P2|Maintenance|Adverse Event|0
1805916|NCT00490971|6278184|P1|Maintenance|Adverse Event|0
1805917|NCT00490971|6278180|P5|Acute/Continuation|Other|0
1805918|NCT00490971|6278181|P4|Acute/Continuation|Other|0
1805919|NCT00490971|6278182|P3|Acute/Continuation|Other|0
1805920|NCT00490971|6278183|P2|Acute/Continuation|Other|4
1805921|NCT00490971|6278184|P1|Acute/Continuation|Other|11
1805922|NCT00490971|6278180|P5|Acute/Continuation|Withdrawal by Subject|0
1805923|NCT00490971|6278181|P4|Acute/Continuation|Withdrawal by Subject|0
1805924|NCT00490971|6278182|P3|Acute/Continuation|Withdrawal by Subject|0
1805925|NCT00490971|6278183|P2|Acute/Continuation|Withdrawal by Subject|24
1805926|NCT00490971|6278184|P1|Acute/Continuation|Withdrawal by Subject|92
1805927|NCT00490971|6278180|P5|Acute/Continuation|Protocol Violation|0
1805928|NCT00490971|6278181|P4|Acute/Continuation|Protocol Violation|0
1805929|NCT00490971|6278182|P3|Acute/Continuation|Protocol Violation|0
1805930|NCT00490971|6278183|P2|Acute/Continuation|Protocol Violation|2
1805931|NCT00490971|6278184|P1|Acute/Continuation|Protocol Violation|10
1805932|NCT00490971|6278180|P5|Acute/Continuation|Lost to Follow-up|0
1805933|NCT00490971|6278181|P4|Acute/Continuation|Lost to Follow-up|0
1805934|NCT00490971|6278182|P3|Acute/Continuation|Lost to Follow-up|0
1805935|NCT00490971|6278183|P2|Acute/Continuation|Lost to Follow-up|7
1805936|NCT00490971|6278184|P1|Acute/Continuation|Lost to Follow-up|23
1805937|NCT00490971|6278180|P5|Acute/Continuation|Lack of Efficacy|0
1805938|NCT00490971|6278181|P4|Acute/Continuation|Lack of Efficacy|0
1805939|NCT00490971|6278182|P3|Acute/Continuation|Lack of Efficacy|0
1805940|NCT00490971|6278183|P2|Acute/Continuation|Lack of Efficacy|12
1805941|NCT00490971|6278184|P1|Acute/Continuation|Lack of Efficacy|106
1805942|NCT00490971|6278180|P5|Acute/Continuation|Death|0
1805943|NCT00490971|6278181|P4|Acute/Continuation|Death|0
1805944|NCT00490971|6278182|P3|Acute/Continuation|Death|0
1805945|NCT00490971|6278183|P2|Acute/Continuation|Death|0
1805946|NCT00490971|6278184|P1|Acute/Continuation|Death|2
1805947|NCT00490971|6278180|P5|Acute/Continuation|Adverse Event|0
1805948|NCT00490971|6278181|P4|Acute/Continuation|Adverse Event|0
1805949|NCT00490971|6278182|P3|Acute/Continuation|Adverse Event|0
1805950|NCT00490971|6278183|P2|Acute/Continuation|Adverse Event|13
1805951|NCT00490971|6278184|P1|Acute/Continuation|Adverse Event|62
1805952|NCT00490945|6278231|P5|Overall Study|Adverse Event|0
1805953|NCT00490945|6278232|P4|Overall Study|Adverse Event|0
1805954|NCT00490945|6278233|P3|Overall Study|Adverse Event|0
1805955|NCT00490945|6278234|P2|Overall Study|Adverse Event|1
1805956|NCT00490945|6278235|P1|Overall Study|Adverse Event|0
1805957|NCT00490919|6278271|P3|Double-blind Phase|Administrative|6
1805958|NCT00490919|6278272|P2|Double-blind Phase|Administrative|6
1805959|NCT00490919|6278273|P1|Double-blind Phase|Administrative|0
1805960|NCT00490919|6278271|P3|Double-blind Phase|Lack of Efficacy|36
1805961|NCT00490919|6278272|P2|Double-blind Phase|Lack of Efficacy|22
1805962|NCT00490919|6278273|P1|Double-blind Phase|Lack of Efficacy|0
1805963|NCT00490919|6278271|P3|Double-blind Phase|Lost to Follow-up|11
1805964|NCT00490919|6278272|P2|Double-blind Phase|Lost to Follow-up|8
1805965|NCT00490919|6278273|P1|Double-blind Phase|Lost to Follow-up|0
1805966|NCT00490919|6278271|P3|Double-blind Phase|Withdrawal by Subject|11
1805967|NCT00490919|6278272|P2|Double-blind Phase|Withdrawal by Subject|10
1805968|NCT00490919|6278273|P1|Double-blind Phase|Withdrawal by Subject|0
1805969|NCT00490919|6278271|P3|Double-blind Phase|Adverse Event|20
1805970|NCT00490919|6278272|P2|Double-blind Phase|Adverse Event|40
1805971|NCT00490919|6278273|P1|Double-blind Phase|Adverse Event|0
1805972|NCT00490919|6278271|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
1805973|NCT00490919|6278272|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
1805974|NCT00490919|6278273|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
1805975|NCT00490919|6278271|P3|Open-label Run-in Period|Administrative|0
1805976|NCT00490919|6278272|P2|Open-label Run-in Period|Administrative|0
1805977|NCT00490919|6278273|P1|Open-label Run-in Period|Administrative|40
1805978|NCT00490919|6278271|P3|Open-label Run-in Period|Lack of Efficacy|0
1805979|NCT00490919|6278272|P2|Open-label Run-in Period|Lack of Efficacy|0
1805980|NCT00490919|6278273|P1|Open-label Run-in Period|Lack of Efficacy|143
1805981|NCT00490919|6278271|P3|Open-label Run-in Period|Lost to Follow-up|0
1805982|NCT00490919|6278272|P2|Open-label Run-in Period|Lost to Follow-up|0
1805983|NCT00490919|6278273|P1|Open-label Run-in Period|Lost to Follow-up|21
1805984|NCT00490919|6278271|P3|Open-label Run-in Period|Withdrawal by Subject|0
1805985|NCT00490919|6278272|P2|Open-label Run-in Period|Withdrawal by Subject|0
1805986|NCT00490919|6278273|P1|Open-label Run-in Period|Withdrawal by Subject|37
1805987|NCT00490919|6278271|P3|Open-label Run-in Period|Adverse Event|0
1805988|NCT00490919|6278272|P2|Open-label Run-in Period|Adverse Event|0
1805989|NCT00490919|6278273|P1|Open-label Run-in Period|Adverse Event|239
1805990|NCT00490841|6278284|P1|Overall Study|30 day f/u, only non-study stent used|3
1805991|NCT00490841|6278284|P1|Overall Study|Lost to Follow-up|1
1805992|NCT00490841|6278284|P1|Overall Study|Withdrawal by Subject|4
1805993|NCT00490841|6278284|P1|Overall Study|Death|5
1805994|NCT00490815|6278306|P2|Overall Study|Death|3
1805995|NCT00490815|6278307|P1|Overall Study|Death|1
1805996|NCT00490815|6278306|P2|Overall Study|Lost to Follow-up|3
1805997|NCT00490815|6278307|P1|Overall Study|Lost to Follow-up|1
1805998|NCT00490815|6278306|P2|Overall Study|Withdrawal by Subject|0
1805999|NCT00490815|6278307|P1|Overall Study|Withdrawal by Subject|4
1806000|NCT00490815|6278306|P2|Overall Study|Adverse Event|3
1806001|NCT00490815|6278307|P1|Overall Study|Adverse Event|2
1806002|NCT00490724|6278335|P3|Period II|Treatment Discontinuation|3
1806003|NCT00490724|6278336|P2|Period II|Treatment Discontinuation|1
1806004|NCT00490724|6278337|P1|Period II|Treatment Discontinuation|3
1806005|NCT00490724|6278335|P3|Period I|Physician Decision|1
1806006|NCT00490724|6278336|P2|Period I|Physician Decision|0
1806007|NCT00490724|6278337|P1|Period I|Physician Decision|0
1806008|NCT00490698|6278402|P1|Overall Study|Physician Decision|2
1806009|NCT00490698|6278402|P1|Overall Study|Disease Progression|7
1806010|NCT00490698|6278402|P1|Overall Study|Withdrawal by Subject|1
1806011|NCT00490646|6278408|P2|Overall Study|Never Treated (withdrew consent)|1
1806012|NCT00490646|6278409|P1|Overall Study|Never Treated (withdrew consent)|0
1806013|NCT00490646|6278408|P2|Overall Study|Never Treated (had an adverse event)|0
1806014|NCT00490646|6278409|P1|Overall Study|Never Treated (had an adverse event)|1
1806015|NCT00490646|6278408|P2|Overall Study|Still on trastuzumab monotherapy|1
1806016|NCT00490646|6278409|P1|Overall Study|Still on trastuzumab monotherapy|1
1806017|NCT00490568|6278429|P1|Overall Study|Participant withdrawal due to surgery|1
1806018|NCT00490568|6278429|P1|Overall Study|Participant died|1
1806019|NCT00490568|6278429|P1|Overall Study|Efficacy related|3
1806020|NCT00490568|6278429|P1|Overall Study|Non-Compliance|7
1806021|NCT00490568|6278429|P1|Overall Study|Investigator decision|3
1806022|NCT00490568|6278429|P1|Overall Study|Unmet inclusion-exclusion criteria|5
1806023|NCT00490568|6278429|P1|Overall Study|Disease progression|4
1806024|NCT00490568|6278429|P1|Overall Study|Legal representative withdrew consent|1
1806025|NCT00490568|6278429|P1|Overall Study|Participant refused follow-up|9
1806026|NCT00490568|6278429|P1|Overall Study|Abnormal ECG|25
1806027|NCT00490568|6278429|P1|Overall Study|Caregiver related|20
1806028|NCT00490568|6278429|P1|Overall Study|Exclusion criteria met|1
1806029|NCT00490568|6278429|P1|Overall Study|Other|1
1806030|NCT00490568|6278429|P1|Overall Study|Still in the study at termination|974
1806031|NCT00490568|6278429|P1|Overall Study|Withdrawal by Subject|135
1806032|NCT00490568|6278429|P1|Overall Study|Protocol Violation|45
1806033|NCT00490568|6278429|P1|Overall Study|Lost to Follow-up|13
1806034|NCT00490568|6278429|P1|Overall Study|Adverse Event|116
1806035|NCT00490555|6278453|P4|Overall Study|noncompliant with drug administration|0
1806036|NCT00490555|6278454|P3|Overall Study|noncompliant with drug administration|2
1806037|NCT00490555|6278455|P2|Overall Study|noncompliant with drug administration|0
1806038|NCT00490555|6278456|P1|Overall Study|noncompliant with drug administration|0
1806039|NCT00490542|6278484|P2|Overall Study|Lack of Efficacy|1
1806040|NCT00490542|6278485|P1|Overall Study|Lack of Efficacy|1
1806041|NCT00490542|6278484|P2|Overall Study|Adverse Event|3
1806042|NCT00490542|6278485|P1|Overall Study|Adverse Event|3
1806043|NCT00490542|6278484|P2|Overall Study|Lost to Follow-up|0
1806044|NCT00490542|6278485|P1|Overall Study|Lost to Follow-up|3
1806045|NCT00490529|6278491|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
1806046|NCT00490529|6278491|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
1806047|NCT00490529|6278491|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
1806048|NCT00490529|6278491|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
1806049|NCT00490529|6278491|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
1806050|NCT00490529|6278491|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
1806051|NCT00490490|6278499|P1|Completed Assessment for TTP|Lost to Follow-up|2
1806052|NCT00490490|6278499|P1|Completed Assessment for TTP|Withdrawal by Subject|1
1806053|NCT00490451|6278516|P2|Overall Study|Progressive Disease|34
1806054|NCT00490451|6278517|P1|Overall Study|Progressive Disease|53
1806055|NCT00490451|6278516|P2|Overall Study|Protocol Violation|0
1806056|NCT00490451|6278517|P1|Overall Study|Protocol Violation|1
1806057|NCT00490451|6278516|P2|Overall Study|Investigator Decision|0
1806058|NCT00490451|6278517|P1|Overall Study|Investigator Decision|1
1806059|NCT00490451|6278516|P2|Overall Study|Withdrawal by Subject|0
1806060|NCT00490451|6278517|P1|Overall Study|Withdrawal by Subject|2
1806061|NCT00490451|6278516|P2|Overall Study|Death|1
1806062|NCT00490451|6278517|P1|Overall Study|Death|3
1806063|NCT00490451|6278516|P2|Overall Study|Adverse Event|3
1806064|NCT00490451|6278517|P1|Overall Study|Adverse Event|3
1806065|NCT00490139|6278559|P4|Overall Study|Participant Withdrew Consent|116
1806066|NCT00490139|6278560|P3|Overall Study|Participant Withdrew Consent|208
1806067|NCT00490139|6278561|P2|Overall Study|Participant Withdrew Consent|110
1806068|NCT00490139|6278562|P1|Overall Study|Participant Withdrew Consent|146
1806069|NCT00490139|6278559|P4|Overall Study|Lost to Follow-up|56
1806070|NCT00490139|6278560|P3|Overall Study|Lost to Follow-up|58
1806071|NCT00490139|6278561|P2|Overall Study|Lost to Follow-up|46
1806072|NCT00490139|6278562|P1|Overall Study|Lost to Follow-up|56
1806073|NCT00490139|6278559|P4|Overall Study|Death|135
1806074|NCT00490139|6278560|P3|Overall Study|Death|168
1806075|NCT00490139|6278561|P2|Overall Study|Death|119
1806076|NCT00490139|6278562|P1|Overall Study|Death|106
1806077|NCT00490061|6278597|P1|Overall Study|Physician Decision|1
1806078|NCT00490035|6278606|P4|Overall Study|AE of unknown type|0
1806079|NCT00490035|6278607|P3|Overall Study|AE of unknown type|2
1806080|NCT00490035|6278608|P2|Overall Study|AE of unknown type|0
1806081|NCT00490035|6278609|P1|Overall Study|AE of unknown type|0
1806082|NCT00490035|6278606|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
1806083|NCT00490035|6278607|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
1806084|NCT00490035|6278608|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
1806085|NCT00490035|6278609|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
1806086|NCT00490035|6278606|P4|Overall Study|AE, serious fatal|0
1806087|NCT00490035|6278607|P3|Overall Study|AE, serious fatal|0
1806088|NCT00490035|6278608|P2|Overall Study|AE, serious fatal|0
1806089|NCT00490035|6278609|P1|Overall Study|AE, serious fatal|1
1806090|NCT00490035|6278606|P4|Overall Study|Other reason|1
1806091|NCT00490035|6278607|P3|Overall Study|Other reason|3
1806092|NCT00490035|6278608|P2|Overall Study|Other reason|1
1806093|NCT00490035|6278609|P1|Overall Study|Other reason|0
1806094|NCT00490035|6278606|P4|Overall Study|Withdrawal by Subject|0
1806095|NCT00490035|6278607|P3|Overall Study|Withdrawal by Subject|1
1806096|NCT00490035|6278608|P2|Overall Study|Withdrawal by Subject|1
1806097|NCT00490035|6278609|P1|Overall Study|Withdrawal by Subject|2
1806098|NCT00490035|6278606|P4|Overall Study|Lost to Follow-up|0
1806099|NCT00490035|6278607|P3|Overall Study|Lost to Follow-up|1
1806100|NCT00490035|6278608|P2|Overall Study|Lost to Follow-up|0
1806101|NCT00490035|6278609|P1|Overall Study|Lost to Follow-up|2
1806102|NCT00490035|6278606|P4|Overall Study|AE, non-serious non-fatal|5
1806103|NCT00490035|6278607|P3|Overall Study|AE, non-serious non-fatal|4
1806104|NCT00490035|6278608|P2|Overall Study|AE, non-serious non-fatal|4
1806105|NCT00490035|6278609|P1|Overall Study|AE, non-serious non-fatal|3
1806106|NCT00490022|6278709|P2|Overall Study|Subject failed to disclose concommitant|1
1806107|NCT00490022|6278710|P1|Overall Study|Subject failed to disclose concommitant|0
1806108|NCT00490022|6278709|P2|Overall Study|Withdrawal by Subject|0
1806109|NCT00490022|6278710|P1|Overall Study|Withdrawal by Subject|1
1806110|NCT00490022|6278709|P2|Overall Study|Adverse Event|2
1806111|NCT00490022|6278710|P1|Overall Study|Adverse Event|0
1806112|NCT00489970|6278727|P3|Persistence Year 9|Other|2
1806113|NCT00489970|6278728|P2|Persistence Year 9|Other|0
1806114|NCT00489970|6278729|P1|Persistence Year 9|Other|1
1806115|NCT00489970|6278727|P3|Persistence Year 9|Lost to Follow-up|3
1806116|NCT00489970|6278728|P2|Persistence Year 9|Lost to Follow-up|2
1806117|NCT00489970|6278729|P1|Persistence Year 9|Lost to Follow-up|2
1806118|NCT00489918|6278833|P5|Overall Study|Physician Decision|0
1806119|NCT00489918|6278834|P4|Overall Study|Physician Decision|0
1806120|NCT00489918|6278835|P3|Overall Study|Physician Decision|1
1806121|NCT00489918|6278836|P2|Overall Study|Physician Decision|0
1806122|NCT00489918|6278837|P1|Overall Study|Physician Decision|0
1806123|NCT00489918|6278833|P5|Overall Study|Lost to Follow-up|0
1806124|NCT00489918|6278834|P4|Overall Study|Lost to Follow-up|1
1806125|NCT00489918|6278835|P3|Overall Study|Lost to Follow-up|1
1806126|NCT00489918|6278836|P2|Overall Study|Lost to Follow-up|0
1806127|NCT00489918|6278837|P1|Overall Study|Lost to Follow-up|0
1806128|NCT00489918|6278833|P5|Overall Study|Adverse Event|0
1806129|NCT00489918|6278834|P4|Overall Study|Adverse Event|0
1806130|NCT00489918|6278835|P3|Overall Study|Adverse Event|1
1806131|NCT00489918|6278836|P2|Overall Study|Adverse Event|1
1806132|NCT00489918|6278837|P1|Overall Study|Adverse Event|0
1806133|NCT00489918|6278833|P5|Overall Study|Withdrawal by Subject|1
1806134|NCT00489918|6278834|P4|Overall Study|Withdrawal by Subject|0
1806135|NCT00489918|6278835|P3|Overall Study|Withdrawal by Subject|1
1806136|NCT00489918|6278836|P2|Overall Study|Withdrawal by Subject|1
1806137|NCT00489918|6278837|P1|Overall Study|Withdrawal by Subject|2
1806138|NCT00489853|6278886|P3|Treatment Period 3|Study specific discontinuation criteria|0
1806139|NCT00489853|6278887|P2|Treatment Period 3|Study specific discontinuation criteria|1
1806140|NCT00489853|6278888|P1|Treatment Period 3|Study specific discontinuation criteria|0
1806141|NCT00489853|6278886|P3|Wash-out Period 2|Study specific discontinuation criteria|2
1806142|NCT00489853|6278887|P2|Wash-out Period 2|Study specific discontinuation criteria|2
1806143|NCT00489853|6278888|P1|Wash-out Period 2|Study specific discontinuation criteria|3
1806144|NCT00489853|6278886|P3|Wash-out Period 2|Adverse Event|0
1806145|NCT00489853|6278887|P2|Wash-out Period 2|Adverse Event|1
1806146|NCT00489853|6278888|P1|Wash-out Period 2|Adverse Event|1
1806147|NCT00489853|6278886|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
1806148|NCT00489853|6278887|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
1806149|NCT00489853|6278888|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
1806150|NCT00489853|6278886|P3|Wash-out Period 1|Protocol Violation|1
1806151|NCT00489853|6278887|P2|Wash-out Period 1|Protocol Violation|1
1806152|NCT00489853|6278888|P1|Wash-out Period 1|Protocol Violation|0
1806153|NCT00489853|6278886|P3|Wash-out Period 1|Adverse Event|1
1806154|NCT00489853|6278887|P2|Wash-out Period 1|Adverse Event|1
1806155|NCT00489853|6278888|P1|Wash-out Period 1|Adverse Event|0
1806156|NCT00489853|6278886|P3|Wash-out Period 1|Withdrawal by Subject|0
1806157|NCT00489853|6278887|P2|Wash-out Period 1|Withdrawal by Subject|0
1806158|NCT00489853|6278888|P1|Wash-out Period 1|Withdrawal by Subject|1
1806159|NCT00489827|6278985|P2|Overall Study|Intraoperative exclusion criteria|1
1806160|NCT00489827|6278986|P1|Overall Study|Intraoperative exclusion criteria|1
1806161|NCT00489827|6278985|P2|Overall Study|Intraoperative exclusion criteria|1
1806162|NCT00489827|6278986|P1|Overall Study|Intraoperative exclusion criteria|1
1806163|NCT00489736|6279010|P2|Overall Study|Not coded/ Not pre-specified|8
1806164|NCT00489736|6279011|P1|Overall Study|Not coded/ Not pre-specified|5
1806165|NCT00489736|6279010|P2|Overall Study|Poor compliance|2
1806166|NCT00489736|6279011|P1|Overall Study|Poor compliance|6
1806167|NCT00489736|6279010|P2|Overall Study|Adverse Event|45
1806168|NCT00489736|6279011|P1|Overall Study|Adverse Event|32
1806169|NCT00489736|6279010|P2|Overall Study|Lack of Efficacy|14
1806170|NCT00489736|6279011|P1|Overall Study|Lack of Efficacy|53
1806171|NCT00489554|6279021|P1|Overall Study|Lost to Follow-up|1
1806172|NCT00489554|6279021|P1|Overall Study|Withdrawal by Subject|1
1806173|NCT00489554|6279021|P1|Overall Study|Adverse Event|2
1806174|NCT00489541|6279041|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
1806175|NCT00489541|6279042|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
1806176|NCT00489541|6279041|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
1806177|NCT00489541|6279042|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
1806178|NCT00489541|6279041|P2|12-Month Clinical Follow-up|Death|2
1806179|NCT00489541|6279042|P1|12-Month Clinical Follow-up|Death|3
1806180|NCT00489541|6279041|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
1806181|NCT00489541|6279042|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
1806182|NCT00489541|6279041|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
1806183|NCT00489541|6279042|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
1806184|NCT00489541|6279041|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
1806185|NCT00489541|6279042|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
1806186|NCT00489489|6279053|P3|Overall Study|Other than above|0
1806187|NCT00489489|6279054|P2|Overall Study|Other than above|1
1806188|NCT00489489|6279055|P1|Overall Study|Other than above|0
1806189|NCT00489489|6279053|P3|Overall Study|Participant did not wish to continue|0
1806190|NCT00489489|6279054|P2|Overall Study|Participant did not wish to continue|1
1806191|NCT00489489|6279055|P1|Overall Study|Participant did not wish to continue|1
1806192|NCT00489489|6279053|P3|Overall Study|Progressive disease|0
1806193|NCT00489489|6279054|P2|Overall Study|Progressive disease|1
1806194|NCT00489489|6279055|P1|Overall Study|Progressive disease|0
1806195|NCT00489489|6279053|P3|Overall Study|Protocol Violation|1
1806196|NCT00489489|6279054|P2|Overall Study|Protocol Violation|0
1806197|NCT00489489|6279055|P1|Overall Study|Protocol Violation|1
1806198|NCT00489489|6279053|P3|Overall Study|Adverse Event|1
1806199|NCT00489489|6279054|P2|Overall Study|Adverse Event|1
1806200|NCT00489489|6279055|P1|Overall Study|Adverse Event|1
1806201|NCT00489489|6279053|P3|Overall Study|Not treated due to protocol violation|1
1806202|NCT00489489|6279054|P2|Overall Study|Not treated due to protocol violation|1
1806203|NCT00489489|6279055|P1|Overall Study|Not treated due to protocol violation|0
1806204|NCT00489476|6279087|P4|Overall Study|Lost to Follow-up|0
1806205|NCT00489476|6279088|P3|Overall Study|Lost to Follow-up|0
1806206|NCT00489476|6279089|P2|Overall Study|Lost to Follow-up|1
1806207|NCT00489476|6279090|P1|Overall Study|Lost to Follow-up|0
1806208|NCT00489424|6279111|P3|Overall Study|Administrative problems|1
1806209|NCT00489424|6279112|P2|Overall Study|Administrative problems|2
1806210|NCT00489424|6279113|P1|Overall Study|Administrative problems|0
1806211|NCT00489424|6279111|P3|Overall Study|Lack of Efficacy|0
1806212|NCT00489424|6279112|P2|Overall Study|Lack of Efficacy|0
1806213|NCT00489424|6279113|P1|Overall Study|Lack of Efficacy|1
1806214|NCT00489424|6279111|P3|Overall Study|Adverse Event|4
1806215|NCT00489424|6279112|P2|Overall Study|Adverse Event|3
1806216|NCT00489424|6279113|P1|Overall Study|Adverse Event|3
1806217|NCT00489411|6279144|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
1806218|NCT00489411|6279145|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
1806219|NCT00489411|6279144|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
1806220|NCT00489411|6279145|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
1806221|NCT00489411|6279144|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
1806222|NCT00489411|6279145|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
1806223|NCT00489411|6279144|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
1806224|NCT00489411|6279145|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
1806225|NCT00489411|6279144|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
1806226|NCT00489411|6279145|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
1806227|NCT00489359|6279159|P2|Overall Study|Adverse Event|16
1806228|NCT00489359|6279160|P1|Overall Study|Adverse Event|0
1806229|NCT00489359|6279159|P2|Overall Study|Withdrawal by Subject|5
1806230|NCT00489359|6279160|P1|Overall Study|Withdrawal by Subject|1
1806231|NCT00489359|6279159|P2|Overall Study|Lost to Follow-up|0
1806232|NCT00489359|6279160|P1|Overall Study|Lost to Follow-up|1
1806233|NCT00489359|6279159|P2|Overall Study|Progressive Disease|6
1806234|NCT00489359|6279160|P1|Overall Study|Progressive Disease|5
1806235|NCT00489359|6279159|P2|Overall Study|Death|2
1806236|NCT00489359|6279160|P1|Overall Study|Death|0
1806237|NCT00489255|6279236|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
1806238|NCT00489255|6279237|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
1806239|NCT00489255|6279236|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
1806240|NCT00489255|6279237|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
1806241|NCT00489255|6279236|P2|Period 3: Days 57 to 84|Adverse Event|3
1806242|NCT00489255|6279237|P1|Period 3: Days 57 to 84|Adverse Event|3
1806243|NCT00489255|6279236|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
1806244|NCT00489255|6279237|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
1806245|NCT00489255|6279236|P2|Period 2: Days 29 to 56|Adverse Event|1
1806246|NCT00489255|6279237|P1|Period 2: Days 29 to 56|Adverse Event|3
1806247|NCT00489255|6279236|P2|Period 1: Days 1 to 28|Noncompliance|0
1806248|NCT00489255|6279237|P1|Period 1: Days 1 to 28|Noncompliance|2
1806249|NCT00489255|6279236|P2|Period 1: Days 1 to 28|Physician Decision|4
1806250|NCT00489255|6279237|P1|Period 1: Days 1 to 28|Physician Decision|1
1806251|NCT00489255|6279236|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
1806252|NCT00489255|6279237|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
1806253|NCT00489255|6279236|P2|Period 1: Days 1 to 28|Adverse Event|8
1806254|NCT00489255|6279237|P1|Period 1: Days 1 to 28|Adverse Event|21
1806255|NCT00489255|6279236|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
1806256|NCT00489255|6279237|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
1806257|NCT00489216|6279285|P1|Overall Study|Adverse Event|1
1806258|NCT00488982|6279298|P3|Course 1|Adverse Event|6
1806259|NCT00488982|6279299|P2|Course 1|Adverse Event|0
1806260|NCT00488982|6279300|P1|Course 1|Adverse Event|0
1806261|NCT00488982|6279298|P3|Course 1|nonprotocol therapy|2
1806262|NCT00488982|6279299|P2|Course 1|nonprotocol therapy|2
1806263|NCT00488982|6279300|P1|Course 1|nonprotocol therapy|0
1806264|NCT00488982|6279298|P3|Course 1|Withdrawal by Subject|2
1806265|NCT00488982|6279299|P2|Course 1|Withdrawal by Subject|8
1806266|NCT00488982|6279300|P1|Course 1|Withdrawal by Subject|0
1806267|NCT00488982|6279298|P3|Course 1|Physician Decision|4
1806268|NCT00488982|6279299|P2|Course 1|Physician Decision|2
1806269|NCT00488982|6279300|P1|Course 1|Physician Decision|0
1806270|NCT00488826|6279323|P3|Overall Study|Protocol Deviations|1
1806271|NCT00488826|6279324|P2|Overall Study|Protocol Deviations|1
1806272|NCT00488826|6279325|P1|Overall Study|Protocol Deviations|2
1806273|NCT00488826|6279323|P3|Overall Study|Lost to Follow-up|0
1806274|NCT00488826|6279324|P2|Overall Study|Lost to Follow-up|1
1806275|NCT00488826|6279325|P1|Overall Study|Lost to Follow-up|5
1806276|NCT00488826|6279323|P3|Overall Study|Adverse Event|4
1806277|NCT00488826|6279324|P2|Overall Study|Adverse Event|15
1806278|NCT00488826|6279325|P1|Overall Study|Adverse Event|9
1806279|NCT00488826|6279323|P3|Overall Study|Protocol Violation|2
1806280|NCT00488826|6279324|P2|Overall Study|Protocol Violation|0
1806281|NCT00488826|6279325|P1|Overall Study|Protocol Violation|0
1806282|NCT00488826|6279323|P3|Overall Study|Withdrawal by Subject|19
1806283|NCT00488826|6279324|P2|Overall Study|Withdrawal by Subject|35
1806284|NCT00488826|6279325|P1|Overall Study|Withdrawal by Subject|40
1806285|NCT00488774|6279340|P4|Overall Study|Lost to Follow-up|1
1806286|NCT00488774|6279341|P3|Overall Study|Lost to Follow-up|1
1806287|NCT00488774|6279342|P2|Overall Study|Lost to Follow-up|0
1806288|NCT00488774|6279343|P1|Overall Study|Lost to Follow-up|0
1806289|NCT00488774|6279340|P4|Overall Study|Other|2
1806290|NCT00488774|6279341|P3|Overall Study|Other|2
1806291|NCT00488774|6279342|P2|Overall Study|Other|3
1806292|NCT00488774|6279343|P1|Overall Study|Other|6
1806293|NCT00488774|6279340|P4|Overall Study|Withdrawal of consent|0
1806294|NCT00488774|6279341|P3|Overall Study|Withdrawal of consent|2
1806295|NCT00488774|6279342|P2|Overall Study|Withdrawal of consent|2
1806296|NCT00488774|6279343|P1|Overall Study|Withdrawal of consent|2
1806297|NCT00488683|6279360|P3|Overall Study|Unable to Classify|0
1806298|NCT00488683|6279361|P2|Overall Study|Unable to Classify|0
1806299|NCT00488683|6279362|P1|Overall Study|Unable to Classify|1
1806300|NCT00488683|6279360|P3|Overall Study|Protocol Violation|0
1806301|NCT00488683|6279361|P2|Overall Study|Protocol Violation|1
1806302|NCT00488683|6279362|P1|Overall Study|Protocol Violation|5
1806303|NCT00488683|6279360|P3|Overall Study|Lost to Follow-up|0
1806304|NCT00488683|6279361|P2|Overall Study|Lost to Follow-up|3
1806305|NCT00488683|6279362|P1|Overall Study|Lost to Follow-up|5
1806306|NCT00488683|6279360|P3|Overall Study|Withdrawal by Subject|2
1806307|NCT00488683|6279361|P2|Overall Study|Withdrawal by Subject|2
1806308|NCT00488683|6279362|P1|Overall Study|Withdrawal by Subject|1
1806309|NCT00488644|6279421|P1|Overall Study|Not Evaluable|1
1806310|NCT00488644|6279421|P1|Overall Study|Not Eligible|1
1806311|NCT00488631|6279431|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1806312|NCT00488631|6279432|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
1806313|NCT00488631|6279433|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
1806314|NCT00488631|6279434|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
1806315|NCT00488631|6279435|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1806316|NCT00488631|6279436|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1806317|NCT00488631|6279437|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1806318|NCT00488631|6279438|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1806319|NCT00488631|6279439|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1806320|NCT00488631|6279440|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
1806321|NCT00488631|6279431|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806322|NCT00488631|6279432|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
1806323|NCT00488631|6279433|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806324|NCT00488631|6279434|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
1806325|NCT00488631|6279435|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806326|NCT00488631|6279436|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806327|NCT00488631|6279437|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806328|NCT00488631|6279438|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806329|NCT00488631|6279439|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806330|NCT00488631|6279440|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
1806331|NCT00488631|6279431|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
1806332|NCT00488631|6279432|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
1806333|NCT00488631|6279433|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
1806334|NCT00488631|6279434|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
1806335|NCT00488631|6279435|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1806336|NCT00488631|6279436|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1806337|NCT00488631|6279437|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1806338|NCT00488631|6279438|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1806339|NCT00488631|6279439|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1806340|NCT00488631|6279440|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
1806341|NCT00488631|6279431|P10|Open Label Study Extension (Week 54-228)|Death|0
1806342|NCT00488631|6279432|P9|Open Label Study Extension (Week 54-228)|Death|1
1806343|NCT00488631|6279433|P8|Open Label Study Extension (Week 54-228)|Death|0
1806344|NCT00488631|6279434|P7|Open Label Study Extension (Week 54-228)|Death|0
1806345|NCT00488631|6279435|P6|Open Label Study Extension (Week 54-228)|Death|0
1806346|NCT00488631|6279436|P5|Open Label Study Extension (Week 54-228)|Death|0
1806347|NCT00488631|6279437|P4|Open Label Study Extension (Week 54-228)|Death|0
1806348|NCT00488631|6279438|P3|Open Label Study Extension (Week 54-228)|Death|0
1806349|NCT00488631|6279439|P2|Open Label Study Extension (Week 54-228)|Death|0
1806350|NCT00488631|6279440|P1|Open Label Study Extension (Week 54-228)|Death|0
1806351|NCT00488631|6279431|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
1806352|NCT00488631|6279432|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
1806353|NCT00488631|6279433|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
1806354|NCT00488631|6279434|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
1806355|NCT00488631|6279435|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
1806356|NCT00488631|6279436|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
1806357|NCT00488631|6279437|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
1806358|NCT00488631|6279438|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
1806359|NCT00488631|6279439|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
1806360|NCT00488631|6279440|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
1806361|NCT00488631|6279431|P10|Double Blind Period (Week 0-54)|Other|0
1806362|NCT00488631|6279432|P9|Double Blind Period (Week 0-54)|Other|0
1806363|NCT00488631|6279433|P8|Double Blind Period (Week 0-54)|Other|0
1806364|NCT00488631|6279434|P7|Double Blind Period (Week 0-54)|Other|0
1806365|NCT00488631|6279435|P6|Double Blind Period (Week 0-54)|Other|34
1806366|NCT00488631|6279436|P5|Double Blind Period (Week 0-54)|Other|14
1806367|NCT00488631|6279437|P4|Double Blind Period (Week 0-54)|Other|11
1806368|NCT00488631|6279438|P3|Double Blind Period (Week 0-54)|Other|10
1806369|NCT00488631|6279439|P2|Double Blind Period (Week 0-54)|Other|12
1806370|NCT00488631|6279440|P1|Double Blind Period (Week 0-54)|Other|6
1806371|NCT00488631|6279431|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1806372|NCT00488631|6279432|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1806373|NCT00488631|6279433|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1806374|NCT00488631|6279434|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1806375|NCT00488631|6279435|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
1806376|NCT00488631|6279436|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
1806377|NCT00488631|6279437|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
1806378|NCT00488631|6279438|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
1806379|NCT00488631|6279439|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
1806380|NCT00488631|6279440|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
1806381|NCT00488631|6279431|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1806382|NCT00488631|6279432|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1806383|NCT00488631|6279433|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1806384|NCT00488631|6279434|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
1806385|NCT00488631|6279435|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
1806386|NCT00488631|6279436|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
1806387|NCT00488631|6279437|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
1806388|NCT00488631|6279438|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
1806389|NCT00488631|6279439|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
1806390|NCT00488631|6279440|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
1806391|NCT00488631|6279431|P10|Double Blind Period (Week 0-54)|Death|0
1806392|NCT00488631|6279432|P9|Double Blind Period (Week 0-54)|Death|0
1806393|NCT00488631|6279433|P8|Double Blind Period (Week 0-54)|Death|0
1806394|NCT00488631|6279434|P7|Double Blind Period (Week 0-54)|Death|0
1806395|NCT00488631|6279435|P6|Double Blind Period (Week 0-54)|Death|1
1806396|NCT00488631|6279436|P5|Double Blind Period (Week 0-54)|Death|0
1806397|NCT00488631|6279437|P4|Double Blind Period (Week 0-54)|Death|0
1806398|NCT00488631|6279438|P3|Double Blind Period (Week 0-54)|Death|0
1806399|NCT00488631|6279439|P2|Double Blind Period (Week 0-54)|Death|0
1806400|NCT00488631|6279440|P1|Double Blind Period (Week 0-54)|Death|0
1806401|NCT00488631|6279431|P10|Double Blind Period (Week 0-54)|Adverse Event|0
1806402|NCT00488631|6279432|P9|Double Blind Period (Week 0-54)|Adverse Event|0
1806403|NCT00488631|6279433|P8|Double Blind Period (Week 0-54)|Adverse Event|0
1806404|NCT00488631|6279434|P7|Double Blind Period (Week 0-54)|Adverse Event|0
1806405|NCT00488631|6279435|P6|Double Blind Period (Week 0-54)|Adverse Event|50
1806406|NCT00488631|6279436|P5|Double Blind Period (Week 0-54)|Adverse Event|30
1806407|NCT00488631|6279437|P4|Double Blind Period (Week 0-54)|Adverse Event|12
1806408|NCT00488631|6279438|P3|Double Blind Period (Week 0-54)|Adverse Event|12
1806409|NCT00488631|6279439|P2|Double Blind Period (Week 0-54)|Adverse Event|12
1806410|NCT00488631|6279440|P1|Double Blind Period (Week 0-54)|Adverse Event|17
1806411|NCT00488618|6279477|P2|Overall Study|Lost to Follow-up|0
1806412|NCT00488618|6279478|P1|Overall Study|Lost to Follow-up|1
1806413|NCT00488618|6279477|P2|Overall Study|Withdrawal of Consent|13
1806414|NCT00488618|6279478|P1|Overall Study|Withdrawal of Consent|15
1806415|NCT00488618|6279477|P2|Overall Study|Protocol Violation|2
1806416|NCT00488618|6279478|P1|Overall Study|Protocol Violation|0
1806417|NCT00488618|6279477|P2|Overall Study|Insufficient Therapeutic Response|11
1806418|NCT00488618|6279478|P1|Overall Study|Insufficient Therapeutic Response|18
1806419|NCT00488618|6279477|P2|Overall Study|Adverse Event|17
1806420|NCT00488618|6279478|P1|Overall Study|Adverse Event|13
1806421|NCT00488592|6279486|P1|Overall Study|Enrolled but not treated|1
1806422|NCT00488592|6279486|P1|Overall Study|Disease progression|1
1806423|NCT00488592|6279486|P1|Overall Study|Withdrawal by Subject|1
1806424|NCT00488514|6279490|P1|Overall Study|Increased use of concomitant medication|1
1806425|NCT00488514|6279490|P1|Overall Study|Increase in number of migraines|2
1806426|NCT00488514|6279490|P1|Overall Study|Participant had too few migraines|5
1806427|NCT00488514|6279490|P1|Overall Study|Investigator decision|1
1806428|NCT00488514|6279490|P1|Overall Study|Withdrawn per medical monitor decision|2
1806429|NCT00488514|6279490|P1|Overall Study|Postive drug screen|1
1806430|NCT00488514|6279490|P1|Overall Study|Did not meet criteria for treatment|30
1806431|NCT00488514|6279490|P1|Overall Study|Lack of Efficacy|28
1806432|NCT00488514|6279490|P1|Overall Study|Withdrawal by Subject|106
1806433|NCT00488514|6279490|P1|Overall Study|Protocol Violation|32
1806434|NCT00488514|6279490|P1|Overall Study|Lost to Follow-up|44
1806435|NCT00488514|6279490|P1|Overall Study|Adverse Event|41
1806436|NCT00488475|6279578|P1|Overall Study|Other|1754
1806437|NCT00488345|6279607|P3|Overall Study|Parent/legal guardian request|1
1806438|NCT00488345|6279608|P2|Overall Study|Parent/legal guardian request|1
1806439|NCT00488345|6279609|P1|Overall Study|Parent/legal guardian request|0
1806440|NCT00488345|6279607|P3|Overall Study|Surgical team recommendation|0
1806441|NCT00488345|6279608|P2|Overall Study|Surgical team recommendation|1
1806442|NCT00488345|6279609|P1|Overall Study|Surgical team recommendation|0
1806443|NCT00488345|6279607|P3|Overall Study|Institutional Review Board review|1
1806444|NCT00488345|6279608|P2|Overall Study|Institutional Review Board review|0
1806445|NCT00488345|6279609|P1|Overall Study|Institutional Review Board review|0
1806446|NCT00488345|6279607|P3|Overall Study|Unable to administer antibiotics at home|0
1806447|NCT00488345|6279608|P2|Overall Study|Unable to administer antibiotics at home|1
1806448|NCT00488345|6279609|P1|Overall Study|Unable to administer antibiotics at home|0
1806449|NCT00488345|6279607|P3|Overall Study|Adverse Event|1
1806450|NCT00488345|6279608|P2|Overall Study|Adverse Event|1
1806451|NCT00488345|6279609|P1|Overall Study|Adverse Event|0
1806452|NCT00488319|6279635|P3|Overall Study|Other reasons for withdrawal|12
1806453|NCT00488319|6279636|P2|Overall Study|Other reasons for withdrawal|4
1806454|NCT00488319|6279637|P1|Overall Study|Other reasons for withdrawal|0
1806455|NCT00488319|6279635|P3|Overall Study|Withdrawal by Subject|44
1806456|NCT00488319|6279636|P2|Overall Study|Withdrawal by Subject|20
1806457|NCT00488319|6279637|P1|Overall Study|Withdrawal by Subject|5
1806458|NCT00488319|6279635|P3|Overall Study|Lost to Follow-up|16
1806459|NCT00488319|6279636|P2|Overall Study|Lost to Follow-up|5
1806460|NCT00488319|6279637|P1|Overall Study|Lost to Follow-up|3
1806461|NCT00488319|6279635|P3|Overall Study|Lack of Efficacy|27
1806462|NCT00488319|6279636|P2|Overall Study|Lack of Efficacy|12
1806463|NCT00488319|6279637|P1|Overall Study|Lack of Efficacy|6
1806464|NCT00488319|6279635|P3|Overall Study|Adverse Event|23
1806465|NCT00488319|6279636|P2|Overall Study|Adverse Event|2
1806466|NCT00488319|6279637|P1|Overall Study|Adverse Event|1
1806467|NCT00488293|6279724|P2|Overall Study|Misrandomization/Other Unspecified|1
1806468|NCT00488293|6279725|P1|Overall Study|Misrandomization/Other Unspecified|1
1806469|NCT00488293|6279724|P2|Overall Study|Death|1
1806470|NCT00488293|6279725|P1|Overall Study|Death|2
1806471|NCT00488293|6279724|P2|Overall Study|Withdrawal by Subject|3
1806472|NCT00488293|6279725|P1|Overall Study|Withdrawal by Subject|5
1806473|NCT00488293|6279724|P2|Overall Study|Lost to Follow-up|25
1806474|NCT00488293|6279725|P1|Overall Study|Lost to Follow-up|28
1806475|NCT00488033|6279770|P2|Overall Study|Withdrawal by Subject|0
1806476|NCT00488033|6279771|P1|Overall Study|Withdrawal by Subject|1
1806477|NCT00487981|6279787|P1|Overall Study|Hypothyroidism diagnosis|1
1806478|NCT00487942|6279795|P4|Overall Study|Withdrawal by Subject|0
1806479|NCT00487942|6279796|P3|Overall Study|Withdrawal by Subject|2
1806480|NCT00487942|6279797|P2|Overall Study|Withdrawal by Subject|1
1806481|NCT00487942|6279798|P1|Overall Study|Withdrawal by Subject|0
1806482|NCT00487942|6279795|P4|Overall Study|Protocol Violation|0
1806483|NCT00487942|6279796|P3|Overall Study|Protocol Violation|0
1806484|NCT00487942|6279797|P2|Overall Study|Protocol Violation|1
1806485|NCT00487942|6279798|P1|Overall Study|Protocol Violation|1
1806486|NCT00487942|6279795|P4|Overall Study|Lost to Follow-up|1
1806487|NCT00487942|6279796|P3|Overall Study|Lost to Follow-up|0
1806488|NCT00487942|6279797|P2|Overall Study|Lost to Follow-up|0
1806489|NCT00487942|6279798|P1|Overall Study|Lost to Follow-up|1
1806490|NCT00487942|6279795|P4|Overall Study|Adverse Event|1
1806491|NCT00487942|6279796|P3|Overall Study|Adverse Event|1
1806492|NCT00487942|6279797|P2|Overall Study|Adverse Event|1
1806493|NCT00487942|6279798|P1|Overall Study|Adverse Event|1
1806494|NCT00487825|6280182|P2|Overall Study|Other|2
1806495|NCT00487825|6280183|P1|Overall Study|Other|3
1806496|NCT00487825|6280182|P2|Overall Study|Lack of Efficacy|1
1806497|NCT00487825|6280183|P1|Overall Study|Lack of Efficacy|1
1806498|NCT00487825|6280182|P2|Overall Study|Adverse Event|2
1806499|NCT00487825|6280183|P1|Overall Study|Adverse Event|2
1806500|NCT00487747|6280195|P1|Overall Study|Lack of Efficacy|1
1806501|NCT00487747|6280195|P1|Overall Study|Lost to Follow-up|9
1806502|NCT00487747|6280195|P1|Overall Study|Adverse Event|1
1806503|NCT00487695|6280212|P2|Second Procedure|Withdrawal by Subject|2
1806504|NCT00487695|6280213|P1|Second Procedure|Withdrawal by Subject|1
1806505|NCT00487695|6280212|P2|Second Procedure|active wheezing|1
1806506|NCT00487695|6280213|P1|Second Procedure|active wheezing|0
1806507|NCT00487695|6280212|P2|First Procedure|esophageal stricture found (excl crit)|0
1806508|NCT00487695|6280213|P1|First Procedure|esophageal stricture found (excl crit)|1
1806509|NCT00487695|6280212|P2|First Procedure|active wheezing (did not have procedure)|0
1806510|NCT00487695|6280213|P1|First Procedure|active wheezing (did not have procedure)|1
1806511|NCT00487695|6280212|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
1806512|NCT00487695|6280213|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
1806513|NCT00487578|6280241|P2|Overall Study|Lost to Follow-up|1
1806514|NCT00487578|6280242|P1|Overall Study|Lost to Follow-up|0
1806515|NCT00487578|6280241|P2|Overall Study|Lack of Efficacy|1
1806516|NCT00487578|6280242|P1|Overall Study|Lack of Efficacy|0
1806517|NCT00487578|6280241|P2|Overall Study|Adverse Event|2
1806518|NCT00487578|6280242|P1|Overall Study|Adverse Event|1
1806519|NCT00487552|6280262|P1|Overall Study|Stent not placed|1
1806520|NCT00487552|6280262|P1|Overall Study|Death due to progressive malignancy|2
1806521|NCT00487552|6280262|P1|Overall Study|Unsuccessful magnet placements|3
1806522|NCT00487539|6280271|P4|Overall Study|Other|2
1806523|NCT00487539|6280272|P3|Overall Study|Other|2
1806524|NCT00487539|6280273|P2|Overall Study|Other|1
1806525|NCT00487539|6280274|P1|Overall Study|Other|3
1806526|NCT00487539|6280271|P4|Overall Study|Unsatisfactory therapeutic effect|1
1806527|NCT00487539|6280272|P3|Overall Study|Unsatisfactory therapeutic effect|0
1806528|NCT00487539|6280273|P2|Overall Study|Unsatisfactory therapeutic effect|0
1806529|NCT00487539|6280274|P1|Overall Study|Unsatisfactory therapeutic effect|1
1806530|NCT00487539|6280271|P4|Overall Study|Adverse Event|1
1806531|NCT00487539|6280272|P3|Overall Study|Adverse Event|1
1806532|NCT00487539|6280273|P2|Overall Study|Adverse Event|2
1806533|NCT00487539|6280274|P1|Overall Study|Adverse Event|3
1806534|NCT00487435|6280308|P1|Overall Study|Other|83
1806535|NCT00487435|6280308|P1|Overall Study|Study Medication Non-Compliant|32
1806536|NCT00487435|6280308|P1|Overall Study|Resolution Of Pain|1
1806537|NCT00487435|6280308|P1|Overall Study|Withdrawal by Subject|132
1806538|NCT00487435|6280308|P1|Overall Study|Pregnancy|2
1806539|NCT00487435|6280308|P1|Overall Study|Lost to Follow-up|54
1806540|NCT00487435|6280308|P1|Overall Study|Lack of Efficacy|33
1806541|NCT00487435|6280308|P1|Overall Study|Death|2
1806542|NCT00487435|6280308|P1|Overall Study|Adverse Event|146
1806543|NCT00487279|6280321|P2|Overall Study|Withdrawal by Subject|2
1806544|NCT00487279|6280322|P1|Overall Study|Withdrawal by Subject|0
1806545|NCT00487279|6280321|P2|Overall Study|Death|0
1806546|NCT00487279|6280322|P1|Overall Study|Death|1
1806547|NCT00487240|6280332|P2|Overall Study|Physician Decision|0
1806548|NCT00487240|6280333|P1|Overall Study|Physician Decision|2
1806549|NCT00487240|6280332|P2|Overall Study|Sponsor Decision|1
1806550|NCT00487240|6280333|P1|Overall Study|Sponsor Decision|2
1806551|NCT00487240|6280332|P2|Overall Study|Entry Criteria Not Met|4
1806552|NCT00487240|6280333|P1|Overall Study|Entry Criteria Not Met|3
1806553|NCT00487240|6280332|P2|Overall Study|Protocol Violation|5
1806554|NCT00487240|6280333|P1|Overall Study|Protocol Violation|5
1806555|NCT00487240|6280332|P2|Overall Study|Adverse Event|4
1806556|NCT00487240|6280333|P1|Overall Study|Adverse Event|0
1806557|NCT00487240|6280332|P2|Overall Study|Lost to Follow-up|6
1806558|NCT00487240|6280333|P1|Overall Study|Lost to Follow-up|7
1806559|NCT00487240|6280332|P2|Overall Study|Withdrawal by Subject|6
1806560|NCT00487240|6280333|P1|Overall Study|Withdrawal by Subject|12
1806561|NCT00487188|6280361|P3|Maintenance Phase|Administrative|1
1806562|NCT00487188|6280362|P2|Maintenance Phase|Administrative|0
1806563|NCT00487188|6280363|P1|Maintenance Phase|Administrative|0
1806564|NCT00487188|6280361|P3|Maintenance Phase|Lost to Follow-up|0
1806565|NCT00487188|6280362|P2|Maintenance Phase|Lost to Follow-up|0
1806566|NCT00487188|6280363|P1|Maintenance Phase|Lost to Follow-up|1
1806567|NCT00487188|6280361|P3|Maintenance Phase|Death|0
1806568|NCT00487188|6280362|P2|Maintenance Phase|Death|0
1806569|NCT00487188|6280363|P1|Maintenance Phase|Death|1
1806570|NCT00487188|6280361|P3|Maintenance Phase|Adverse Event|0
1806571|NCT00487188|6280362|P2|Maintenance Phase|Adverse Event|0
1806572|NCT00487188|6280363|P1|Maintenance Phase|Adverse Event|1
1806573|NCT00487188|6280361|P3|Induction Phase|Administrative|0
1806574|NCT00487188|6280362|P2|Induction Phase|Administrative|1
1806575|NCT00487188|6280363|P1|Induction Phase|Administrative|0
1806576|NCT00487188|6280361|P3|Induction Phase|Lost to Follow-up|0
1806577|NCT00487188|6280362|P2|Induction Phase|Lost to Follow-up|2
1806578|NCT00487188|6280363|P1|Induction Phase|Lost to Follow-up|2
1806579|NCT00487188|6280361|P3|Induction Phase|Refused Treatment|0
1806580|NCT00487188|6280362|P2|Induction Phase|Refused Treatment|2
1806581|NCT00487188|6280363|P1|Induction Phase|Refused Treatment|1
1806582|NCT00487188|6280361|P3|Induction Phase|Protocol Violation|0
1806583|NCT00487188|6280362|P2|Induction Phase|Protocol Violation|0
1806584|NCT00487188|6280363|P1|Induction Phase|Protocol Violation|1
1806585|NCT00487188|6280361|P3|Induction Phase|Lack of Efficacy|0
1806586|NCT00487188|6280362|P2|Induction Phase|Lack of Efficacy|1
1806587|NCT00487188|6280363|P1|Induction Phase|Lack of Efficacy|0
1806588|NCT00487188|6280361|P3|Induction Phase|Adverse Event|0
1806589|NCT00487188|6280362|P2|Induction Phase|Adverse Event|0
1806590|NCT00487188|6280363|P1|Induction Phase|Adverse Event|5
1806591|NCT00487188|6280361|P3|Induction Phase|Abnormality of Laboratory Test|0
1806592|NCT00487188|6280362|P2|Induction Phase|Abnormality of Laboratory Test|1
1806593|NCT00487188|6280363|P1|Induction Phase|Abnormality of Laboratory Test|0
1806594|NCT00487162|6280402|P2|Overall Study|Withdrawal by Subject|3
1806595|NCT00487162|6280403|P1|Overall Study|Withdrawal by Subject|2
1806596|NCT00487162|6280402|P2|Overall Study|Physician Decision|1
1806597|NCT00487162|6280403|P1|Overall Study|Physician Decision|0
1806598|NCT00487162|6280402|P2|Overall Study|Adverse Event|1
1806599|NCT00487162|6280403|P1|Overall Study|Adverse Event|0
1806600|NCT00487084|6280414|P3|Overall Study|Did not receive intervention|5
1806601|NCT00487084|6280415|P2|Overall Study|Did not receive intervention|3
1806602|NCT00487084|6280416|P1|Overall Study|Did not receive intervention|4
1806603|NCT00486954|6280437|P5|Randomized Part|Sponsor Terminated Study|13
1806604|NCT00486954|6280438|P4|Randomized Part|Sponsor Terminated Study|19
1806605|NCT00486954|6280439|P3|Randomized Part|Sponsor Terminated Study|0
1806606|NCT00486954|6280440|P2|Randomized Part|Sponsor Terminated Study|0
1806607|NCT00486954|6280441|P1|Randomized Part|Sponsor Terminated Study|0
1806608|NCT00486954|6280437|P5|Randomized Part|Withdrawal by Subject|0
1806609|NCT00486954|6280438|P4|Randomized Part|Withdrawal by Subject|1
1806610|NCT00486954|6280439|P3|Randomized Part|Withdrawal by Subject|0
1806611|NCT00486954|6280440|P2|Randomized Part|Withdrawal by Subject|0
1806612|NCT00486954|6280441|P1|Randomized Part|Withdrawal by Subject|0
1806613|NCT00486954|6280437|P5|Randomized Part|Lost to Follow-up|1
1806614|NCT00486954|6280438|P4|Randomized Part|Lost to Follow-up|0
1806615|NCT00486954|6280439|P3|Randomized Part|Lost to Follow-up|0
1806616|NCT00486954|6280440|P2|Randomized Part|Lost to Follow-up|0
1806617|NCT00486954|6280441|P1|Randomized Part|Lost to Follow-up|0
1806618|NCT00486954|6280437|P5|Pilot Part|Disease Progression|0
1806619|NCT00486954|6280438|P4|Pilot Part|Disease Progression|0
1806620|NCT00486954|6280439|P3|Pilot Part|Disease Progression|1
1806621|NCT00486954|6280440|P2|Pilot Part|Disease Progression|0
1806622|NCT00486954|6280441|P1|Pilot Part|Disease Progression|2
1806623|NCT00486954|6280437|P5|Pilot Part|Adverse Event|0
1806624|NCT00486954|6280438|P4|Pilot Part|Adverse Event|0
1806625|NCT00486954|6280439|P3|Pilot Part|Adverse Event|5
1806626|NCT00486954|6280440|P2|Pilot Part|Adverse Event|0
1806627|NCT00486954|6280441|P1|Pilot Part|Adverse Event|4
1806628|NCT00486902|6280539|P2|Overall Study|No toradol due to hemmorhage or allergy|1
1806629|NCT00486902|6280540|P1|Overall Study|No toradol due to hemmorhage or allergy|3
1806630|NCT00486902|6280539|P2|Overall Study|Did not meet inclusion criteria|0
1806631|NCT00486902|6280540|P1|Overall Study|Did not meet inclusion criteria|1
1806632|NCT00486902|6280539|P2|Overall Study|spinal anesthetic protocal violation|1
1806633|NCT00486902|6280540|P1|Overall Study|spinal anesthetic protocal violation|1
1806634|NCT00486902|6280539|P2|Overall Study|decision for postpartum tubal ligation|1
1806635|NCT00486902|6280540|P1|Overall Study|decision for postpartum tubal ligation|3
1806636|NCT00486902|6280539|P2|Overall Study|Withdrawal by Subject|2
1806637|NCT00486902|6280540|P1|Overall Study|Withdrawal by Subject|1
1806638|NCT00486837|6280607|P2|Overall Study|No sputum, devise issues, exacerbation|4
1806639|NCT00486837|6280608|P1|Overall Study|No sputum, devise issues, exacerbation|3
1806640|NCT00486837|6280607|P2|Overall Study|Protocol Violation|2
1806641|NCT00486837|6280608|P1|Overall Study|Protocol Violation|4
1806642|NCT00486837|6280607|P2|Overall Study|Adverse Event|1
1806643|NCT00486837|6280608|P1|Overall Study|Adverse Event|1
1806644|NCT00486837|6280607|P2|Overall Study|Withdrawal by Subject|0
1806645|NCT00486837|6280608|P1|Overall Study|Withdrawal by Subject|1
1806646|NCT00486811|6280648|P3|Overall Study|All other|7
1806647|NCT00486811|6280649|P2|Overall Study|All other|11
1806648|NCT00486811|6280650|P1|Overall Study|All other|18
1806649|NCT00486811|6280648|P3|Overall Study|Study drug non-compliant|3
1806650|NCT00486811|6280649|P2|Overall Study|Study drug non-compliant|6
1806651|NCT00486811|6280650|P1|Overall Study|Study drug non-compliant|5
1806652|NCT00486811|6280648|P3|Overall Study|Withdrawal by Subject|58
1806653|NCT00486811|6280649|P2|Overall Study|Withdrawal by Subject|44
1806654|NCT00486811|6280650|P1|Overall Study|Withdrawal by Subject|33
1806655|NCT00486811|6280648|P3|Overall Study|Lost to Follow-up|4
1806656|NCT00486811|6280649|P2|Overall Study|Lost to Follow-up|6
1806657|NCT00486811|6280650|P1|Overall Study|Lost to Follow-up|4
1806658|NCT00486811|6280648|P3|Overall Study|Lack of Efficacy|7
1806659|NCT00486811|6280649|P2|Overall Study|Lack of Efficacy|14
1806660|NCT00486811|6280650|P1|Overall Study|Lack of Efficacy|34
1806661|NCT00486811|6280648|P3|Overall Study|Adverse Event|135
1806662|NCT00486811|6280649|P2|Overall Study|Adverse Event|60
1806663|NCT00486811|6280650|P1|Overall Study|Adverse Event|28
1806664|NCT00486759|6280693|P2|Safety Follow-up|Adverse event/intercurrent illness|0
1806665|NCT00486759|6280694|P1|Safety Follow-up|Adverse event/intercurrent illness|4
1806666|NCT00486759|6280693|P2|Safety Follow-up|Refused treatment/did not cooperate|4
1806667|NCT00486759|6280694|P1|Safety Follow-up|Refused treatment/did not cooperate|6
1806668|NCT00486759|6280693|P2|Safety Follow-up|Administrative/not specified|6
1806669|NCT00486759|6280694|P1|Safety Follow-up|Administrative/not specified|8
1806670|NCT00486759|6280693|P2|Safety Follow-up|Failure to return|6
1806671|NCT00486759|6280694|P1|Safety Follow-up|Failure to return|9
1806672|NCT00486759|6280693|P2|Safety Follow-up|Withdrew consent|23
1806673|NCT00486759|6280694|P1|Safety Follow-up|Withdrew consent|32
1806674|NCT00486759|6280693|P2|Safety Follow-up|Death|29
1806675|NCT00486759|6280694|P1|Safety Follow-up|Death|40
1806676|NCT00486759|6280693|P2|Safety Follow-up|Insufficient therapeutic response|50
1806677|NCT00486759|6280694|P1|Safety Follow-up|Insufficient therapeutic response|40
1806678|NCT00486759|6280693|P2|Treatment|Failure to return|1
1806679|NCT00486759|6280694|P1|Treatment|Failure to return|1
1806680|NCT00486759|6280693|P2|Treatment|Other protocol violation|5
1806681|NCT00486759|6280694|P1|Treatment|Other protocol violation|1
1806682|NCT00486759|6280693|P2|Treatment|Violation of selection criteria at entry|3
1806683|NCT00486759|6280694|P1|Treatment|Violation of selection criteria at entry|3
1806684|NCT00486759|6280693|P2|Treatment|Refused treatment|7
1806685|NCT00486759|6280694|P1|Treatment|Refused treatment|10
1806686|NCT00486759|6280693|P2|Treatment|Administrative/reason not specified|21
1806687|NCT00486759|6280694|P1|Treatment|Administrative/reason not specified|17
1806688|NCT00486759|6280693|P2|Treatment|Withdrew consent|12
1806689|NCT00486759|6280694|P1|Treatment|Withdrew consent|15
1806690|NCT00486759|6280693|P2|Treatment|Death|10
1806691|NCT00486759|6280694|P1|Treatment|Death|17
1806692|NCT00486759|6280693|P2|Treatment|Insufficient therapeutic response|39
1806693|NCT00486759|6280694|P1|Treatment|Insufficient therapeutic response|37
1806694|NCT00486759|6280693|P2|Treatment|Adverse event/intercurrent illness|39
1806695|NCT00486759|6280694|P1|Treatment|Adverse event/intercurrent illness|86
1806696|NCT00486720|6280706|P2|Overall Study|Progressive Disease|1
1806697|NCT00486720|6280707|P1|Overall Study|Progressive Disease|0
1806698|NCT00486720|6280706|P2|Overall Study|Withdrawal by Subject|1
1806699|NCT00486720|6280707|P1|Overall Study|Withdrawal by Subject|3
1806700|NCT00486720|6280706|P2|Overall Study|Protocol Violation|0
1806701|NCT00486720|6280707|P1|Overall Study|Protocol Violation|1
1806702|NCT00486720|6280706|P2|Overall Study|Physician Decision|2
1806703|NCT00486720|6280707|P1|Overall Study|Physician Decision|1
1806704|NCT00486720|6280706|P2|Overall Study|Lack of Efficacy|6
1806705|NCT00486720|6280707|P1|Overall Study|Lack of Efficacy|4
1806706|NCT00486720|6280706|P2|Overall Study|Adverse Event|2
1806707|NCT00486720|6280707|P1|Overall Study|Adverse Event|1
1806708|NCT00486603|6280742|P5|Overall Study|Physician Decision|0
1806709|NCT00486603|6280743|P4|Overall Study|Physician Decision|0
1806710|NCT00486603|6280744|P3|Overall Study|Physician Decision|0
1806711|NCT00486603|6280745|P2|Overall Study|Physician Decision|1
1806712|NCT00486603|6280746|P1|Overall Study|Physician Decision|0
1806713|NCT00486603|6280742|P5|Overall Study|Withdrawal by Subject|0
1806714|NCT00486603|6280743|P4|Overall Study|Withdrawal by Subject|0
1806715|NCT00486603|6280744|P3|Overall Study|Withdrawal by Subject|0
1806716|NCT00486603|6280745|P2|Overall Study|Withdrawal by Subject|0
1806717|NCT00486603|6280746|P1|Overall Study|Withdrawal by Subject|1
1806718|NCT00486434|6280794|P2|Overall Study|Personal reasons|6
1806719|NCT00486434|6280795|P1|Overall Study|Personal reasons|5
1806720|NCT00486434|6280794|P2|Overall Study|Death|2
1806721|NCT00486434|6280795|P1|Overall Study|Death|1
1806722|NCT00486434|6280794|P2|Overall Study|Lost to Follow-up|3
1806723|NCT00486434|6280795|P1|Overall Study|Lost to Follow-up|2
1806724|NCT00486434|6280794|P2|Overall Study|Lack of Efficacy|19
1806725|NCT00486434|6280795|P1|Overall Study|Lack of Efficacy|12
1806726|NCT00486434|6280794|P2|Overall Study|Protocol Violation|21
1806727|NCT00486434|6280795|P1|Overall Study|Protocol Violation|22
1806728|NCT00486434|6280794|P2|Overall Study|Adverse Event|44
1806729|NCT00486434|6280795|P1|Overall Study|Adverse Event|118
1806730|NCT00486434|6280794|P2|Overall Study|Withdrawal by Subject|39
1806731|NCT00486434|6280795|P1|Overall Study|Withdrawal by Subject|34
1806732|NCT00486330|6280814|P1|Overall Study|Adverse Event|2
1806733|NCT00486291|6280820|P2|Overall Study|requirement for restricted medication|3
1806734|NCT00486291|6280821|P1|Overall Study|requirement for restricted medication|0
1806735|NCT00486291|6280820|P2|Overall Study|protocol non-compliance|15
1806736|NCT00486291|6280821|P1|Overall Study|protocol non-compliance|10
1806737|NCT00486291|6280820|P2|Overall Study|Lost to Follow-up|7
1806738|NCT00486291|6280821|P1|Overall Study|Lost to Follow-up|3
1806739|NCT00486291|6280820|P2|Overall Study|Adverse Event|4
1806740|NCT00486291|6280821|P1|Overall Study|Adverse Event|3
1806741|NCT00486278|6280829|P1|Overall Study|Physician Decision|2
1806742|NCT00486278|6280829|P1|Overall Study|Withdrawal by Subject|2
1806743|NCT00486278|6280829|P1|Overall Study|Adverse Event|5
1806744|NCT00486265|6280963|P1|Overall Study|Lack of Efficacy|8
1806745|NCT00486265|6280963|P1|Overall Study|Adverse Event|1
1806746|NCT00486252|6280967|P1|Overall Study|Other|18
1806747|NCT00486252|6280967|P1|Overall Study|Lost to Follow-up|24
1806748|NCT00486252|6280967|P1|Overall Study|Lack of Efficacy|9
1806749|NCT00486252|6280967|P1|Overall Study|Adverse Event|7
1806750|NCT00486226|6280982|P1|Overall Study|Lost to Follow-up|8
1806751|NCT00486226|6280982|P1|Overall Study|Withdrawal by Subject|1
1806752|NCT00486226|6280982|P1|Overall Study|Adverse Event|1
1806753|NCT00486226|6280982|P1|Overall Study|Death|3
1806754|NCT00486044|6280992|P2|Overall Study|Lost to Follow-up|1
1806755|NCT00486044|6280993|P1|Overall Study|Lost to Follow-up|0
1806756|NCT00486044|6280992|P2|Overall Study|Adverse Event|1
1806757|NCT00486044|6280993|P1|Overall Study|Adverse Event|0
1806758|NCT00486044|6280992|P2|Overall Study|Withdrawal by Subject|1
1806759|NCT00486044|6280993|P1|Overall Study|Withdrawal by Subject|2
1806760|NCT00485758|6281087|P2|Overall Study|Study Terminated by Sponsor|0
1806761|NCT00485758|6281088|P1|Overall Study|Study Terminated by Sponsor|3
1806762|NCT00485758|6281087|P2|Overall Study|Withdrawal by Subject|27
1806763|NCT00485758|6281088|P1|Overall Study|Withdrawal by Subject|32
1806764|NCT00485758|6281087|P2|Overall Study|Protocol Violation|2
1806765|NCT00485758|6281088|P1|Overall Study|Protocol Violation|11
1806766|NCT00485758|6281087|P2|Overall Study|Physician Decision|3
1806767|NCT00485758|6281088|P1|Overall Study|Physician Decision|3
1806768|NCT00485758|6281087|P2|Overall Study|Lost to Follow-up|1
1806769|NCT00485758|6281088|P1|Overall Study|Lost to Follow-up|5
1806770|NCT00485758|6281087|P2|Overall Study|Death|1
1806771|NCT00485758|6281088|P1|Overall Study|Death|0
1806772|NCT00485758|6281087|P2|Overall Study|Adverse Event|31
1806773|NCT00485758|6281088|P1|Overall Study|Adverse Event|102
1806774|NCT00485732|6281100|P2|Overall Study|Lost to Follow-up|2
1806775|NCT00485732|6281101|P1|Overall Study|Lost to Follow-up|2
1806776|NCT00485732|6281100|P2|Overall Study|Withdrawal by Subject|4
1806777|NCT00485732|6281101|P1|Overall Study|Withdrawal by Subject|5
1806778|NCT00485732|6281100|P2|Overall Study|Protocol Violation|3
1806779|NCT00485732|6281101|P1|Overall Study|Protocol Violation|1
1806780|NCT00485472|6281139|P2|Overall Study|Lost to Follow-up|1
1806781|NCT00485472|6281140|P1|Overall Study|Lost to Follow-up|0
1806782|NCT00485472|6281139|P2|Overall Study|Other|1
1806783|NCT00485472|6281140|P1|Overall Study|Other|2
1806784|NCT00485472|6281139|P2|Overall Study|Protocol Violation|1
1806785|NCT00485472|6281140|P1|Overall Study|Protocol Violation|0
1806786|NCT00485472|6281139|P2|Overall Study|Withdrawal by Subject|0
1806787|NCT00485472|6281140|P1|Overall Study|Withdrawal by Subject|1
1806788|NCT00485472|6281139|P2|Overall Study|Lack of Efficacy|4
1806789|NCT00485472|6281140|P1|Overall Study|Lack of Efficacy|5
1806790|NCT00485472|6281139|P2|Overall Study|Adverse Event|5
1806791|NCT00485472|6281140|P1|Overall Study|Adverse Event|8
1806792|NCT00485303|6281177|P1|Overall Study|Treatment ongoing at cutoff date|2
1806793|NCT00485303|6281177|P1|Overall Study|Initiation of new anti-cancer treatment|2
1806794|NCT00485303|6281177|P1|Overall Study|Other|3
1806795|NCT00485303|6281177|P1|Overall Study|Progressive Disease|44
1806796|NCT00485303|6281177|P1|Overall Study|Adverse Event|5
1806797|NCT00485264|6281195|P6|Overall Study|Other Reason|0
1806798|NCT00485264|6281196|P5|Overall Study|Other Reason|0
1806799|NCT00485264|6281197|P4|Overall Study|Other Reason|0
1806800|NCT00485264|6281198|P3|Overall Study|Other Reason|0
1806801|NCT00485264|6281199|P2|Overall Study|Other Reason|0
1806802|NCT00485264|6281200|P1|Overall Study|Other Reason|3
1806803|NCT00485264|6281195|P6|Overall Study|Lost to Follow-up|1
1806804|NCT00485264|6281196|P5|Overall Study|Lost to Follow-up|0
1806805|NCT00485264|6281197|P4|Overall Study|Lost to Follow-up|0
1806806|NCT00485264|6281198|P3|Overall Study|Lost to Follow-up|1
1806807|NCT00485264|6281199|P2|Overall Study|Lost to Follow-up|1
1806808|NCT00485264|6281200|P1|Overall Study|Lost to Follow-up|2
1806809|NCT00485264|6281195|P6|Overall Study|Non-Compliant|0
1806810|NCT00485264|6281196|P5|Overall Study|Non-Compliant|1
1806811|NCT00485264|6281197|P4|Overall Study|Non-Compliant|0
1806812|NCT00485264|6281198|P3|Overall Study|Non-Compliant|1
1806813|NCT00485264|6281199|P2|Overall Study|Non-Compliant|2
1806814|NCT00485264|6281200|P1|Overall Study|Non-Compliant|17
1806815|NCT00485264|6281195|P6|Overall Study|Not Able to Attend Clinic|2
1806816|NCT00485264|6281196|P5|Overall Study|Not Able to Attend Clinic|1
1806817|NCT00485264|6281197|P4|Overall Study|Not Able to Attend Clinic|1
1806818|NCT00485264|6281198|P3|Overall Study|Not Able to Attend Clinic|0
1806819|NCT00485264|6281199|P2|Overall Study|Not Able to Attend Clinic|0
1806820|NCT00485264|6281200|P1|Overall Study|Not Able to Attend Clinic|5
1806821|NCT00485264|6281195|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
1806822|NCT00485264|6281196|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
1806823|NCT00485264|6281197|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
1806824|NCT00485264|6281198|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
1806825|NCT00485264|6281199|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
1806826|NCT00485264|6281200|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
1806827|NCT00485264|6281195|P6|Overall Study|Physician Decision|0
1806828|NCT00485264|6281196|P5|Overall Study|Physician Decision|0
1806829|NCT00485264|6281197|P4|Overall Study|Physician Decision|0
1806830|NCT00485264|6281198|P3|Overall Study|Physician Decision|0
1806831|NCT00485264|6281199|P2|Overall Study|Physician Decision|2
1806832|NCT00485264|6281200|P1|Overall Study|Physician Decision|0
1806833|NCT00485264|6281195|P6|Overall Study|Guardian Consent Withdrawn|0
1806834|NCT00485264|6281196|P5|Overall Study|Guardian Consent Withdrawn|1
1806835|NCT00485264|6281197|P4|Overall Study|Guardian Consent Withdrawn|0
1806836|NCT00485264|6281198|P3|Overall Study|Guardian Consent Withdrawn|0
1806837|NCT00485264|6281199|P2|Overall Study|Guardian Consent Withdrawn|0
1806838|NCT00485264|6281200|P1|Overall Study|Guardian Consent Withdrawn|1
1806839|NCT00485264|6281195|P6|Overall Study|Lack of Efficacy|0
1806840|NCT00485264|6281196|P5|Overall Study|Lack of Efficacy|0
1806841|NCT00485264|6281197|P4|Overall Study|Lack of Efficacy|0
1806842|NCT00485264|6281198|P3|Overall Study|Lack of Efficacy|0
1806843|NCT00485264|6281199|P2|Overall Study|Lack of Efficacy|1
1806844|NCT00485264|6281200|P1|Overall Study|Lack of Efficacy|0
1806845|NCT00485264|6281195|P6|Overall Study|Number/Volume/Timing of Study Meds|0
1806846|NCT00485264|6281196|P5|Overall Study|Number/Volume/Timing of Study Meds|0
1806847|NCT00485264|6281197|P4|Overall Study|Number/Volume/Timing of Study Meds|0
1806848|NCT00485264|6281198|P3|Overall Study|Number/Volume/Timing of Study Meds|1
1806849|NCT00485264|6281199|P2|Overall Study|Number/Volume/Timing of Study Meds|1
1806850|NCT00485264|6281200|P1|Overall Study|Number/Volume/Timing of Study Meds|2
1806851|NCT00485264|6281195|P6|Overall Study|Disallowed Medication|1
1806852|NCT00485264|6281196|P5|Overall Study|Disallowed Medication|0
1806853|NCT00485264|6281197|P4|Overall Study|Disallowed Medication|0
1806854|NCT00485264|6281198|P3|Overall Study|Disallowed Medication|0
1806855|NCT00485264|6281199|P2|Overall Study|Disallowed Medication|0
1806856|NCT00485264|6281200|P1|Overall Study|Disallowed Medication|0
1806857|NCT00485264|6281195|P6|Overall Study|Pregnancy|0
1806858|NCT00485264|6281196|P5|Overall Study|Pregnancy|0
1806859|NCT00485264|6281197|P4|Overall Study|Pregnancy|0
1806860|NCT00485264|6281198|P3|Overall Study|Pregnancy|0
1806861|NCT00485264|6281199|P2|Overall Study|Pregnancy|0
1806862|NCT00485264|6281200|P1|Overall Study|Pregnancy|4
1806863|NCT00485264|6281195|P6|Overall Study|Adverse Event|3
1806864|NCT00485264|6281196|P5|Overall Study|Adverse Event|1
1806865|NCT00485264|6281197|P4|Overall Study|Adverse Event|3
1806866|NCT00485264|6281198|P3|Overall Study|Adverse Event|2
1806867|NCT00485264|6281199|P2|Overall Study|Adverse Event|0
1806868|NCT00485264|6281200|P1|Overall Study|Adverse Event|1
1806869|NCT00485264|6281195|P6|Overall Study|Death|0
1806870|NCT00485264|6281196|P5|Overall Study|Death|1
1806871|NCT00485264|6281197|P4|Overall Study|Death|0
1806872|NCT00485264|6281198|P3|Overall Study|Death|0
1806873|NCT00485264|6281199|P2|Overall Study|Death|0
1806874|NCT00485264|6281200|P1|Overall Study|Death|1
1806875|NCT00485264|6281195|P6|Overall Study|Enrolled But Not Given Treatment|0
1806876|NCT00485264|6281196|P5|Overall Study|Enrolled But Not Given Treatment|1
1806877|NCT00485264|6281197|P4|Overall Study|Enrolled But Not Given Treatment|0
1806878|NCT00485264|6281198|P3|Overall Study|Enrolled But Not Given Treatment|0
1806879|NCT00485264|6281199|P2|Overall Study|Enrolled But Not Given Treatment|0
1806880|NCT00485264|6281200|P1|Overall Study|Enrolled But Not Given Treatment|0
1806881|NCT00485173|6281288|P2|Overall Study|Lost to Follow-up|61
1806882|NCT00485173|6281289|P1|Overall Study|Lost to Follow-up|32
1806883|NCT00485173|6281288|P2|Overall Study|Death|3
1806884|NCT00485173|6281289|P1|Overall Study|Death|4
1806885|NCT00485134|6281337|P8|Overall Study|Pregnancy|0
1806886|NCT00485134|6281338|P7|Overall Study|Pregnancy|1
1806887|NCT00485134|6281339|P6|Overall Study|Pregnancy|0
1806888|NCT00485134|6281340|P5|Overall Study|Pregnancy|0
1806889|NCT00485134|6281341|P4|Overall Study|Pregnancy|0
1806890|NCT00485134|6281342|P3|Overall Study|Pregnancy|0
1806891|NCT00485134|6281343|P2|Overall Study|Pregnancy|0
1806892|NCT00485134|6281344|P1|Overall Study|Pregnancy|0
1806893|NCT00485134|6281337|P8|Overall Study|Unable to comply with study schedule|1
1806894|NCT00485134|6281338|P7|Overall Study|Unable to comply with study schedule|0
1806895|NCT00485134|6281339|P6|Overall Study|Unable to comply with study schedule|0
1806896|NCT00485134|6281340|P5|Overall Study|Unable to comply with study schedule|0
1806897|NCT00485134|6281341|P4|Overall Study|Unable to comply with study schedule|0
1806898|NCT00485134|6281342|P3|Overall Study|Unable to comply with study schedule|0
1806899|NCT00485134|6281343|P2|Overall Study|Unable to comply with study schedule|0
1806900|NCT00485134|6281344|P1|Overall Study|Unable to comply with study schedule|0
1806901|NCT00485134|6281337|P8|Overall Study|Non-compliance|0
1806902|NCT00485134|6281338|P7|Overall Study|Non-compliance|2
1806903|NCT00485134|6281339|P6|Overall Study|Non-compliance|2
1806904|NCT00485134|6281340|P5|Overall Study|Non-compliance|1
1806905|NCT00485134|6281341|P4|Overall Study|Non-compliance|0
1806906|NCT00485134|6281342|P3|Overall Study|Non-compliance|0
1806907|NCT00485134|6281343|P2|Overall Study|Non-compliance|0
1806908|NCT00485134|6281344|P1|Overall Study|Non-compliance|0
1806909|NCT00485134|6281337|P8|Overall Study|Positive drug test|0
1806910|NCT00485134|6281338|P7|Overall Study|Positive drug test|0
1806911|NCT00485134|6281339|P6|Overall Study|Positive drug test|1
1806912|NCT00485134|6281340|P5|Overall Study|Positive drug test|2
1806913|NCT00485134|6281341|P4|Overall Study|Positive drug test|0
1806914|NCT00485134|6281342|P3|Overall Study|Positive drug test|0
1806915|NCT00485134|6281343|P2|Overall Study|Positive drug test|0
1806916|NCT00485134|6281344|P1|Overall Study|Positive drug test|0
1806917|NCT00485134|6281337|P8|Overall Study|Withdrew for adverse event|0
1806918|NCT00485134|6281338|P7|Overall Study|Withdrew for adverse event|0
1806919|NCT00485134|6281339|P6|Overall Study|Withdrew for adverse event|0
1806920|NCT00485134|6281340|P5|Overall Study|Withdrew for adverse event|0
1806921|NCT00485134|6281341|P4|Overall Study|Withdrew for adverse event|0
1806922|NCT00485134|6281342|P3|Overall Study|Withdrew for adverse event|1
1806923|NCT00485134|6281343|P2|Overall Study|Withdrew for adverse event|0
1806924|NCT00485134|6281344|P1|Overall Study|Withdrew for adverse event|0
1806925|NCT00485134|6281337|P8|Overall Study|Change in health status|0
1806926|NCT00485134|6281338|P7|Overall Study|Change in health status|0
1806927|NCT00485134|6281339|P6|Overall Study|Change in health status|1
1806928|NCT00485134|6281340|P5|Overall Study|Change in health status|0
1806929|NCT00485134|6281341|P4|Overall Study|Change in health status|1
1806930|NCT00485134|6281342|P3|Overall Study|Change in health status|2
1806931|NCT00485134|6281343|P2|Overall Study|Change in health status|1
1806932|NCT00485134|6281344|P1|Overall Study|Change in health status|0
1806933|NCT00485134|6281337|P8|Overall Study|Withdrawal by Subject|0
1806934|NCT00485134|6281338|P7|Overall Study|Withdrawal by Subject|0
1806935|NCT00485134|6281339|P6|Overall Study|Withdrawal by Subject|0
1806936|NCT00485134|6281340|P5|Overall Study|Withdrawal by Subject|0
1806937|NCT00485134|6281341|P4|Overall Study|Withdrawal by Subject|0
1806938|NCT00485134|6281342|P3|Overall Study|Withdrawal by Subject|0
1806939|NCT00485134|6281343|P2|Overall Study|Withdrawal by Subject|1
1806940|NCT00485134|6281344|P1|Overall Study|Withdrawal by Subject|0
1806941|NCT00485134|6281337|P8|Overall Study|Lost to Follow-up|0
1806942|NCT00485134|6281338|P7|Overall Study|Lost to Follow-up|0
1806943|NCT00485134|6281339|P6|Overall Study|Lost to Follow-up|0
1806944|NCT00485134|6281340|P5|Overall Study|Lost to Follow-up|0
1806945|NCT00485134|6281341|P4|Overall Study|Lost to Follow-up|0
1806946|NCT00485134|6281342|P3|Overall Study|Lost to Follow-up|0
1806947|NCT00485134|6281343|P2|Overall Study|Lost to Follow-up|0
1806948|NCT00485134|6281344|P1|Overall Study|Lost to Follow-up|1
1806949|NCT00485069|6281366|P2|Overall Study|Withdrawal by Subject|6
1806950|NCT00485069|6281367|P1|Overall Study|Withdrawal by Subject|6
1806951|NCT00485069|6281366|P2|Overall Study|Protocol Violation|1
1806952|NCT00485069|6281367|P1|Overall Study|Protocol Violation|0
1806953|NCT00485069|6281366|P2|Overall Study|Lack of Efficacy|1
1806954|NCT00485069|6281367|P1|Overall Study|Lack of Efficacy|2
1806955|NCT00485069|6281366|P2|Overall Study|Adverse Event|4
1806956|NCT00485069|6281367|P1|Overall Study|Adverse Event|10
1806957|NCT00484939|6281412|P2|Overall Study|Reason Not Specified|6
1806958|NCT00484939|6281413|P1|Overall Study|Reason Not Specified|11
1806959|NCT00484939|6281412|P2|Overall Study|Screen Failure|2
1806960|NCT00484939|6281413|P1|Overall Study|Screen Failure|2
1806961|NCT00484939|6281412|P2|Overall Study|Disease progression|88
1806962|NCT00484939|6281413|P1|Overall Study|Disease progression|67
1806963|NCT00484939|6281412|P2|Overall Study|Discretion of Investigator or Sponsor|3
1806964|NCT00484939|6281413|P1|Overall Study|Discretion of Investigator or Sponsor|7
1806965|NCT00484939|6281412|P2|Overall Study|Lost to Follow-up|3
1806966|NCT00484939|6281413|P1|Overall Study|Lost to Follow-up|0
1806967|NCT00484939|6281412|P2|Overall Study|Protocol Violation|3
1806968|NCT00484939|6281413|P1|Overall Study|Protocol Violation|3
1806969|NCT00484939|6281412|P2|Overall Study|Patient Withdrew Consent|10
1806970|NCT00484939|6281413|P1|Overall Study|Patient Withdrew Consent|19
1806971|NCT00484939|6281412|P2|Overall Study|Adverse Event|12
1806972|NCT00484939|6281413|P1|Overall Study|Adverse Event|22
1806973|NCT00484939|6281412|P2|Overall Study|Death|13
1806974|NCT00484939|6281413|P1|Overall Study|Death|9
1806975|NCT00484679|6281440|P1|Overall Study|Withdrawal by Subject|3
1806976|NCT00484419|6281447|P3|Overall Study|sponsor decision, randomized in error|2
1806977|NCT00484419|6281448|P2|Overall Study|sponsor decision, randomized in error|0
1806978|NCT00484419|6281449|P1|Overall Study|sponsor decision, randomized in error|0
1806979|NCT00484419|6281447|P3|Overall Study|subject relocated|0
1806980|NCT00484419|6281448|P2|Overall Study|subject relocated|1
1806981|NCT00484419|6281449|P1|Overall Study|subject relocated|0
1806982|NCT00484419|6281447|P3|Overall Study|subject unable to receive medication|0
1806983|NCT00484419|6281448|P2|Overall Study|subject unable to receive medication|0
1806984|NCT00484419|6281449|P1|Overall Study|subject unable to receive medication|1
1806985|NCT00484419|6281447|P3|Overall Study|Physician Decision|1
1806986|NCT00484419|6281448|P2|Overall Study|Physician Decision|1
1806987|NCT00484419|6281449|P1|Overall Study|Physician Decision|1
1806988|NCT00484419|6281447|P3|Overall Study|required restricted medication|1
1806989|NCT00484419|6281448|P2|Overall Study|required restricted medication|0
1806990|NCT00484419|6281449|P1|Overall Study|required restricted medication|1
1806991|NCT00484419|6281447|P3|Overall Study|subject met discontinuation criteria|4
1806992|NCT00484419|6281448|P2|Overall Study|subject met discontinuation criteria|2
1806993|NCT00484419|6281449|P1|Overall Study|subject met discontinuation criteria|2
1806994|NCT00484419|6281447|P3|Overall Study|Withdrawal by Subject|1
1806995|NCT00484419|6281448|P2|Overall Study|Withdrawal by Subject|1
1806996|NCT00484419|6281449|P1|Overall Study|Withdrawal by Subject|3
1806997|NCT00484419|6281447|P3|Overall Study|Lost to Follow-up|2
1806998|NCT00484419|6281448|P2|Overall Study|Lost to Follow-up|0
1806999|NCT00484419|6281449|P1|Overall Study|Lost to Follow-up|1
1807000|NCT00484419|6281447|P3|Overall Study|Adverse Event|0
1807001|NCT00484419|6281448|P2|Overall Study|Adverse Event|0
1807002|NCT00484419|6281449|P1|Overall Study|Adverse Event|3
1807003|NCT00484315|6281533|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
1807004|NCT00484315|6281534|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
1807005|NCT00484315|6281533|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
1807006|NCT00484315|6281534|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
1807007|NCT00484315|6281533|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
1807008|NCT00484315|6281534|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
1807009|NCT00484315|6281533|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
1807010|NCT00484315|6281534|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
1807011|NCT00484315|6281533|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
1807012|NCT00484315|6281534|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
1807013|NCT00484315|6281533|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
1807014|NCT00484315|6281534|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
1807015|NCT00484315|6281533|P2|12-Month Clinical Follow-up|Death|2
1807016|NCT00484315|6281534|P1|12-Month Clinical Follow-up|Death|6
1807017|NCT00484289|6281545|P3|Post Marketing Phase|Adverse Event|0
1807018|NCT00484289|6281546|P2|Post Marketing Phase|Adverse Event|1
1807019|NCT00484289|6281547|P1|Post Marketing Phase|Adverse Event|0
1807020|NCT00484289|6281545|P3|Long Term Phase|Other Reason|1
1807021|NCT00484289|6281546|P2|Long Term Phase|Other Reason|5
1807022|NCT00484289|6281547|P1|Long Term Phase|Other Reason|0
1807023|NCT00484289|6281545|P3|Long Term Phase|Inadequate response|4
1807024|NCT00484289|6281546|P2|Long Term Phase|Inadequate response|7
1807025|NCT00484289|6281547|P1|Long Term Phase|Inadequate response|2
1807026|NCT00484289|6281545|P3|Long Term Phase|Withdrawal by Subject|6
1807027|NCT00484289|6281546|P2|Long Term Phase|Withdrawal by Subject|7
1807028|NCT00484289|6281547|P1|Long Term Phase|Withdrawal by Subject|0
1807029|NCT00484289|6281545|P3|Long Term Phase|Adverse Event|5
1807030|NCT00484289|6281546|P2|Long Term Phase|Adverse Event|17
1807031|NCT00484289|6281547|P1|Long Term Phase|Adverse Event|1
1807032|NCT00484185|6281619|P1|Overall Study|Death|2
1807033|NCT00484185|6281619|P1|Overall Study|Randomized but not treated|5
1807034|NCT00484185|6281619|P1|Overall Study|Other|20
1807035|NCT00484185|6281619|P1|Overall Study|Lost to Follow-up|44
1807036|NCT00484159|6281641|P3|Overall Study|Lost to Follow-up|0
1807037|NCT00484159|6281642|P2|Overall Study|Lost to Follow-up|1
1807038|NCT00484159|6281643|P1|Overall Study|Lost to Follow-up|1
1807039|NCT00484094|6281654|P1|Overall Study|Other|3
1807040|NCT00484094|6281654|P1|Overall Study|Discontinued|39
1807041|NCT00483938|6281670|P7|Overall Study|Other|32
1807042|NCT00483938|6281671|P6|Overall Study|Other|4
1807043|NCT00483938|6281672|P5|Overall Study|Other|0
1807044|NCT00483938|6281673|P4|Overall Study|Other|4
1807045|NCT00483938|6281674|P3|Overall Study|Other|0
1807046|NCT00483938|6281675|P2|Overall Study|Other|9
1807047|NCT00483938|6281676|P1|Overall Study|Other|3
1807048|NCT00483938|6281670|P7|Overall Study|Death|0
1807049|NCT00483938|6281671|P6|Overall Study|Death|0
1807050|NCT00483938|6281672|P5|Overall Study|Death|0
1807051|NCT00483938|6281673|P4|Overall Study|Death|0
1807052|NCT00483938|6281674|P3|Overall Study|Death|0
1807053|NCT00483938|6281675|P2|Overall Study|Death|2
1807054|NCT00483938|6281676|P1|Overall Study|Death|0
1807055|NCT00483938|6281670|P7|Overall Study|Lost to Follow-up|3
1807056|NCT00483938|6281671|P6|Overall Study|Lost to Follow-up|1
1807057|NCT00483938|6281672|P5|Overall Study|Lost to Follow-up|1
1807058|NCT00483938|6281673|P4|Overall Study|Lost to Follow-up|2
1807059|NCT00483938|6281674|P3|Overall Study|Lost to Follow-up|0
1807060|NCT00483938|6281675|P2|Overall Study|Lost to Follow-up|2
1807061|NCT00483938|6281676|P1|Overall Study|Lost to Follow-up|1
1807062|NCT00483938|6281670|P7|Overall Study|Withdrawal by Subject|2
1807063|NCT00483938|6281671|P6|Overall Study|Withdrawal by Subject|3
1807064|NCT00483938|6281672|P5|Overall Study|Withdrawal by Subject|1
1807065|NCT00483938|6281673|P4|Overall Study|Withdrawal by Subject|0
1807066|NCT00483938|6281674|P3|Overall Study|Withdrawal by Subject|0
1807067|NCT00483938|6281675|P2|Overall Study|Withdrawal by Subject|6
1807068|NCT00483938|6281676|P1|Overall Study|Withdrawal by Subject|1
1807069|NCT00483938|6281670|P7|Overall Study|Protocol Violation|3
1807070|NCT00483938|6281671|P6|Overall Study|Protocol Violation|0
1807071|NCT00483938|6281672|P5|Overall Study|Protocol Violation|0
1807072|NCT00483938|6281673|P4|Overall Study|Protocol Violation|0
1807073|NCT00483938|6281674|P3|Overall Study|Protocol Violation|0
1807074|NCT00483938|6281675|P2|Overall Study|Protocol Violation|0
1807075|NCT00483938|6281676|P1|Overall Study|Protocol Violation|0
1807076|NCT00483756|6281700|P3|Overall Study|Randomized, Not Treated|4
1807077|NCT00483756|6281701|P2|Overall Study|Randomized, Not Treated|4
1807078|NCT00483756|6281702|P1|Overall Study|Randomized, Not Treated|1
1807079|NCT00483756|6281700|P3|Overall Study|Other|3
1807080|NCT00483756|6281701|P2|Overall Study|Other|4
1807081|NCT00483756|6281702|P1|Overall Study|Other|2
1807082|NCT00483756|6281700|P3|Overall Study|Withdrawal by Subject|4
1807083|NCT00483756|6281701|P2|Overall Study|Withdrawal by Subject|3
1807084|NCT00483756|6281702|P1|Overall Study|Withdrawal by Subject|5
1807085|NCT00483756|6281700|P3|Overall Study|Lost to Follow-up|0
1807086|NCT00483756|6281701|P2|Overall Study|Lost to Follow-up|1
1807087|NCT00483756|6281702|P1|Overall Study|Lost to Follow-up|3
1807088|NCT00483756|6281700|P3|Overall Study|Lack of Efficacy|0
1807089|NCT00483756|6281701|P2|Overall Study|Lack of Efficacy|0
1807090|NCT00483756|6281702|P1|Overall Study|Lack of Efficacy|1
1807091|NCT00483756|6281700|P3|Overall Study|Adverse Event|40
1807092|NCT00483756|6281701|P2|Overall Study|Adverse Event|38
1807093|NCT00483756|6281702|P1|Overall Study|Adverse Event|19
1807094|NCT00483756|6281700|P3|Overall Study|Death|1
1807095|NCT00483756|6281701|P2|Overall Study|Death|0
1807096|NCT00483756|6281702|P1|Overall Study|Death|2
1807097|NCT00483717|6281766|P2|Overall Study|Withdrawal by Subject|0
1807098|NCT00483717|6281767|P1|Overall Study|Withdrawal by Subject|1
1807099|NCT00483717|6281766|P2|Overall Study|Lost to Follow-up|0
1807100|NCT00483717|6281767|P1|Overall Study|Lost to Follow-up|1
1807101|NCT00483717|6281766|P2|Overall Study|No treatment for migraine|13
1807102|NCT00483717|6281767|P1|Overall Study|No treatment for migraine|16
1807103|NCT00483717|6281766|P2|Overall Study|Time of dosing missing|1
1807104|NCT00483717|6281767|P1|Overall Study|Time of dosing missing|1
1807105|NCT00483717|6281766|P2|Overall Study|Protocol Violation|7
1807106|NCT00483717|6281767|P1|Overall Study|Protocol Violation|5
1807107|NCT00483704|6281790|P3|Treatment|Physician Decision|4
1807108|NCT00483704|6281791|P2|Treatment|Physician Decision|1
1807109|NCT00483704|6281792|P1|Treatment|Physician Decision|0
1807110|NCT00483704|6281790|P3|Treatment|Pregnancy|0
1807111|NCT00483704|6281791|P2|Treatment|Pregnancy|1
1807112|NCT00483704|6281792|P1|Treatment|Pregnancy|0
1807113|NCT00483704|6281790|P3|Treatment|Lack of Efficacy|1
1807114|NCT00483704|6281791|P2|Treatment|Lack of Efficacy|1
1807115|NCT00483704|6281792|P1|Treatment|Lack of Efficacy|1
1807116|NCT00483704|6281790|P3|Treatment|Lost to Follow-up|5
1807117|NCT00483704|6281791|P2|Treatment|Lost to Follow-up|7
1807118|NCT00483704|6281792|P1|Treatment|Lost to Follow-up|2
1807119|NCT00483704|6281790|P3|Treatment|Protocol Violation|5
1807120|NCT00483704|6281791|P2|Treatment|Protocol Violation|3
1807121|NCT00483704|6281792|P1|Treatment|Protocol Violation|6
1807122|NCT00483704|6281790|P3|Treatment|Withdrawal by Subject|21
1807123|NCT00483704|6281791|P2|Treatment|Withdrawal by Subject|12
1807124|NCT00483704|6281792|P1|Treatment|Withdrawal by Subject|16
1807125|NCT00483704|6281790|P3|Treatment|Adverse Event|4
1807126|NCT00483704|6281791|P2|Treatment|Adverse Event|5
1807127|NCT00483704|6281792|P1|Treatment|Adverse Event|3
1807128|NCT00483704|6281790|P3|Treatment|Lack of qualifying migraines|116
1807129|NCT00483704|6281791|P2|Treatment|Lack of qualifying migraines|99
1807130|NCT00483704|6281792|P1|Treatment|Lack of qualifying migraines|101
1807131|NCT00483704|6281790|P3|Randomization|Lack of qualifying migraines|31
1807132|NCT00483704|6281791|P2|Randomization|Lack of qualifying migraines|25
1807133|NCT00483704|6281792|P1|Randomization|Lack of qualifying migraines|21
1807134|NCT00483704|6281790|P3|Randomization|Progressive disease|1
1807135|NCT00483704|6281791|P2|Randomization|Progressive disease|0
1807136|NCT00483704|6281792|P1|Randomization|Progressive disease|0
1807137|NCT00483704|6281790|P3|Randomization|Physician Decision|0
1807138|NCT00483704|6281791|P2|Randomization|Physician Decision|4
1807139|NCT00483704|6281792|P1|Randomization|Physician Decision|2
1807140|NCT00483704|6281790|P3|Randomization|Pregnancy|0
1807141|NCT00483704|6281791|P2|Randomization|Pregnancy|0
1807142|NCT00483704|6281792|P1|Randomization|Pregnancy|1
1807143|NCT00483704|6281790|P3|Randomization|Lost to Follow-up|19
1807144|NCT00483704|6281791|P2|Randomization|Lost to Follow-up|14
1807145|NCT00483704|6281792|P1|Randomization|Lost to Follow-up|14
1807146|NCT00483704|6281790|P3|Randomization|Protocol Violation|22
1807147|NCT00483704|6281791|P2|Randomization|Protocol Violation|25
1807148|NCT00483704|6281792|P1|Randomization|Protocol Violation|14
1807149|NCT00483704|6281790|P3|Randomization|Withdrawal by Subject|18
1807150|NCT00483704|6281791|P2|Randomization|Withdrawal by Subject|28
1807151|NCT00483704|6281792|P1|Randomization|Withdrawal by Subject|19
1807152|NCT00483652|6281838|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
1807153|NCT00483652|6281839|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
1807154|NCT00483652|6281838|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
1807155|NCT00483652|6281839|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
1807156|NCT00483652|6281838|P2|Double-blind Treatment Period|Adverse Event|4
1807157|NCT00483652|6281839|P1|Double-blind Treatment Period|Adverse Event|3
1807158|NCT00483652|6281838|P2|Double-blind Treatment Period|Protocol Violation|1
1807159|NCT00483652|6281839|P1|Double-blind Treatment Period|Protocol Violation|2
1807160|NCT00483574|6281849|P2|Overall Study|Withdrawal by Subject|0
1807161|NCT00483574|6281850|P1|Overall Study|Withdrawal by Subject|52
1807162|NCT00483574|6281849|P2|Overall Study|Lost to Follow-up|4
1807163|NCT00483574|6281850|P1|Overall Study|Lost to Follow-up|16
1807164|NCT00483574|6281849|P2|Overall Study|Protocol Violation|9
1807165|NCT00483574|6281850|P1|Overall Study|Protocol Violation|28
1807166|NCT00483574|6281849|P2|Overall Study|Adverse Event|0
1807167|NCT00483574|6281850|P1|Overall Study|Adverse Event|6
1807168|NCT00483548|6281865|P2|Overall Study|Withdrawal by Subject|2
1807169|NCT00483548|6281866|P1|Overall Study|Withdrawal by Subject|5
1807170|NCT00483548|6281865|P2|Overall Study|Lost to Follow-up|4
1807171|NCT00483548|6281866|P1|Overall Study|Lost to Follow-up|3
1807172|NCT00483548|6281865|P2|Overall Study|Non-compliance with medication|0
1807173|NCT00483548|6281866|P1|Overall Study|Non-compliance with medication|2
1807174|NCT00483548|6281865|P2|Overall Study|Unable to comply with protocol schedule|0
1807175|NCT00483548|6281866|P1|Overall Study|Unable to comply with protocol schedule|1
1807176|NCT00483548|6281865|P2|Overall Study|Protocol required discontinuation|6
1807177|NCT00483548|6281866|P1|Overall Study|Protocol required discontinuation|6
1807178|NCT00483548|6281865|P2|Overall Study|Pregnancy|0
1807179|NCT00483548|6281866|P1|Overall Study|Pregnancy|1
1807180|NCT00483548|6281865|P2|Overall Study|Protocol Violation|7
1807181|NCT00483548|6281866|P1|Overall Study|Protocol Violation|11
1807182|NCT00483548|6281865|P2|Overall Study|Lack of Efficacy|8
1807183|NCT00483548|6281866|P1|Overall Study|Lack of Efficacy|4
1807184|NCT00483548|6281865|P2|Overall Study|Laboratory abnormality|2
1807185|NCT00483548|6281866|P1|Overall Study|Laboratory abnormality|1
1807186|NCT00483548|6281865|P2|Overall Study|Adverse Event|14
1807187|NCT00483548|6281866|P1|Overall Study|Adverse Event|25
1807188|NCT00483548|6281865|P2|Overall Study|Randomized; not treated with study drug|3
1807189|NCT00483548|6281866|P1|Overall Study|Randomized; not treated with study drug|1
1807190|NCT00483405|6281924|P1|Overall Study|Other complicating disease|1
1807191|NCT00483405|6281924|P1|Overall Study|Withdrawal by Subject|2
1807192|NCT00483405|6281924|P1|Overall Study|Death|3
1807193|NCT00483405|6281924|P1|Overall Study|Lack of Efficacy|14
1807194|NCT00483405|6281924|P1|Overall Study|Adverse Event|8
1807195|NCT00483379|6281933|P2|Treatment Period|Withdrawal by Subject|0
1807196|NCT00483379|6281934|P1|Treatment Period|Withdrawal by Subject|1
1807197|NCT00483379|6281933|P2|Treatment Period|Adverse Event|0
1807198|NCT00483379|6281934|P1|Treatment Period|Adverse Event|1
1807199|NCT00483327|6281970|P1|Overall Study|Patient Non Compliance|2
1807200|NCT00483327|6281970|P1|Overall Study|Lost to Follow-up|4
1807201|NCT00483327|6281970|P1|Overall Study|Withdrawal by Subject|3
1807202|NCT00483327|6281970|P1|Overall Study|Adverse Event|1
1807203|NCT00483184|6282002|P3|Overall Study|Protocol Violation|1
1807204|NCT00483184|6282003|P2|Overall Study|Protocol Violation|0
1807205|NCT00483184|6282004|P1|Overall Study|Protocol Violation|1
1807206|NCT00483184|6282002|P3|Overall Study|Adverse Event|2
1807207|NCT00483184|6282003|P2|Overall Study|Adverse Event|2
1807208|NCT00483184|6282004|P1|Overall Study|Adverse Event|1
1807209|NCT00483184|6282002|P3|Overall Study|Lost to Follow-up|0
1807210|NCT00483184|6282003|P2|Overall Study|Lost to Follow-up|0
1807211|NCT00483184|6282004|P1|Overall Study|Lost to Follow-up|1
1807212|NCT00483184|6282002|P3|Overall Study|Withdrawal by Subject|0
1807213|NCT00483184|6282003|P2|Overall Study|Withdrawal by Subject|2
1807214|NCT00483184|6282004|P1|Overall Study|Withdrawal by Subject|2
1807215|NCT00483119|6282014|P2|Overall Study|Physician Decision|0
1807216|NCT00483119|6282015|P1|Overall Study|Physician Decision|1
1807217|NCT00483119|6282014|P2|Overall Study|Adverse Event|1
1807218|NCT00483119|6282015|P1|Overall Study|Adverse Event|0
1807219|NCT00483041|6282029|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
1807220|NCT00483041|6282030|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
1807221|NCT00483002|6282060|P1|Overall Study|Other|967
1807222|NCT00483002|6282060|P1|Overall Study|Other|2
1807223|NCT00483002|6282060|P1|Overall Study|Lost to Follow-up|962
1807224|NCT00483002|6282060|P1|Overall Study|Lack of Efficacy|555
1807225|NCT00483002|6282060|P1|Overall Study|Adverse Event|68
1807226|NCT00482729|6282085|P2|Overall Study|Withdrawal by Subject|69
1807227|NCT00482729|6282086|P1|Overall Study|Withdrawal by Subject|67
1807228|NCT00482729|6282085|P2|Overall Study|Protocol Violation|18
1807229|NCT00482729|6282086|P1|Overall Study|Protocol Violation|10
1807230|NCT00482729|6282085|P2|Overall Study|Pregnancy|2
1807231|NCT00482729|6282086|P1|Overall Study|Pregnancy|4
1807232|NCT00482729|6282085|P2|Overall Study|Physician Decision|7
1807233|NCT00482729|6282086|P1|Overall Study|Physician Decision|10
1807234|NCT00482729|6282085|P2|Overall Study|Lost to Follow-up|66
1807235|NCT00482729|6282086|P1|Overall Study|Lost to Follow-up|86
1807236|NCT00482729|6282085|P2|Overall Study|Lack of Efficacy|16
1807237|NCT00482729|6282086|P1|Overall Study|Lack of Efficacy|4
1807238|NCT00482729|6282085|P2|Overall Study|Hyperglycemia Criteria|5
1807239|NCT00482729|6282086|P1|Overall Study|Hyperglycemia Criteria|7
1807240|NCT00482729|6282085|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
1807241|NCT00482729|6282086|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
1807242|NCT00482729|6282085|P2|Overall Study|Adverse Event|33
1807243|NCT00482729|6282086|P1|Overall Study|Adverse Event|29
1807244|NCT00482703|6282102|P2|Overall Study|Poor compliance|0
1807245|NCT00482703|6282103|P1|Overall Study|Poor compliance|1
1807246|NCT00482612|6282174|P4|Follow-up Period|Reasons not related to trial|3
1807247|NCT00482612|6282175|P3|Follow-up Period|Reasons not related to trial|1
1807248|NCT00482612|6282176|P2|Follow-up Period|Reasons not related to trial|0
1807249|NCT00482612|6282177|P1|Follow-up Period|Reasons not related to trial|1
1807250|NCT00482612|6282174|P4|Follow-up Period|Withdrawal by Subject|2
1807251|NCT00482612|6282175|P3|Follow-up Period|Withdrawal by Subject|7
1807252|NCT00482612|6282176|P2|Follow-up Period|Withdrawal by Subject|5
1807253|NCT00482612|6282177|P1|Follow-up Period|Withdrawal by Subject|3
1807254|NCT00482612|6282174|P4|Follow-up Period|Lack of Efficacy|0
1807255|NCT00482612|6282175|P3|Follow-up Period|Lack of Efficacy|1
1807256|NCT00482612|6282176|P2|Follow-up Period|Lack of Efficacy|0
1807257|NCT00482612|6282177|P1|Follow-up Period|Lack of Efficacy|2
1807258|NCT00482612|6282174|P4|Follow-up Period|Adverse Event|0
1807259|NCT00482612|6282175|P3|Follow-up Period|Adverse Event|9
1807260|NCT00482612|6282176|P2|Follow-up Period|Adverse Event|7
1807261|NCT00482612|6282177|P1|Follow-up Period|Adverse Event|4
1807262|NCT00482612|6282174|P4|Follow-up Period|Lost to Follow-up|1
1807263|NCT00482612|6282175|P3|Follow-up Period|Lost to Follow-up|2
1807264|NCT00482612|6282176|P2|Follow-up Period|Lost to Follow-up|4
1807265|NCT00482612|6282177|P1|Follow-up Period|Lost to Follow-up|0
1807266|NCT00482612|6282174|P4|Follow-up Period|Lack of compliance|0
1807267|NCT00482612|6282175|P3|Follow-up Period|Lack of compliance|1
1807268|NCT00482612|6282176|P2|Follow-up Period|Lack of compliance|0
1807269|NCT00482612|6282177|P1|Follow-up Period|Lack of compliance|0
1807270|NCT00482612|6282174|P4|Follow-up Period|Other|2
1807271|NCT00482612|6282175|P3|Follow-up Period|Other|1
1807272|NCT00482612|6282176|P2|Follow-up Period|Other|2
1807273|NCT00482612|6282177|P1|Follow-up Period|Other|4
1807274|NCT00482612|6282174|P4|In-treatment Period|No study medication administered|0
1807275|NCT00482612|6282175|P3|In-treatment Period|No study medication administered|1
1807276|NCT00482612|6282176|P2|In-treatment Period|No study medication administered|0
1807277|NCT00482612|6282177|P1|In-treatment Period|No study medication administered|0
1807278|NCT00482391|6282226|P1|Overall Study|Death|1
1807279|NCT00482391|6282226|P1|Overall Study|Adverse Event|1
1807280|NCT00482391|6282226|P1|Overall Study|Withdrawal by Subject|1
1807281|NCT00482274|6282231|P1|Overall Study|Adverse Event|1
1807282|NCT00482170|6282241|P2|Overall Study|Unspecified reason|2
1807283|NCT00482170|6282242|P1|Overall Study|Unspecified reason|0
1807284|NCT00482170|6282241|P2|Overall Study|Lost to Follow-up|0
1807285|NCT00482170|6282242|P1|Overall Study|Lost to Follow-up|2
1807286|NCT00482170|6282241|P2|Overall Study|Protocol Violation|3
1807287|NCT00482170|6282242|P1|Overall Study|Protocol Violation|2
1807288|NCT00482170|6282241|P2|Overall Study|Withdrawal by Subject|1
1807289|NCT00482170|6282242|P1|Overall Study|Withdrawal by Subject|6
1807290|NCT00482170|6282241|P2|Overall Study|Adverse Event|14
1807291|NCT00482170|6282242|P1|Overall Study|Adverse Event|5
1807292|NCT00482053|6282360|P1|Inter-treatment Period|Disease progression|1
1807293|NCT00482014|6282374|P4|Overall Study|Sponsor Decision|1
1807294|NCT00482014|6282375|P3|Overall Study|Sponsor Decision|1
1807295|NCT00482014|6282376|P2|Overall Study|Sponsor Decision|2
1807296|NCT00482014|6282377|P1|Overall Study|Sponsor Decision|1
1807297|NCT00482014|6282374|P4|Overall Study|Lack of Efficacy|6
1807298|NCT00482014|6282375|P3|Overall Study|Lack of Efficacy|4
1807299|NCT00482014|6282376|P2|Overall Study|Lack of Efficacy|0
1807300|NCT00482014|6282377|P1|Overall Study|Lack of Efficacy|1
1807301|NCT00482014|6282374|P4|Overall Study|Death|4
1807302|NCT00482014|6282375|P3|Overall Study|Death|1
1807303|NCT00482014|6282376|P2|Overall Study|Death|2
1807304|NCT00482014|6282377|P1|Overall Study|Death|1
1807305|NCT00482014|6282374|P4|Overall Study|Adverse Event|8
1807306|NCT00482014|6282375|P3|Overall Study|Adverse Event|2
1807307|NCT00482014|6282376|P2|Overall Study|Adverse Event|0
1807308|NCT00482014|6282377|P1|Overall Study|Adverse Event|3
1807309|NCT00482014|6282374|P4|Overall Study|Withdrawal by Subject|4
1807310|NCT00482014|6282375|P3|Overall Study|Withdrawal by Subject|3
1807311|NCT00482014|6282376|P2|Overall Study|Withdrawal by Subject|2
1807312|NCT00482014|6282377|P1|Overall Study|Withdrawal by Subject|1
1807313|NCT00482001|6282401|P2|Overall Study|Protocol Violation|1
1807314|NCT00482001|6282402|P1|Overall Study|Protocol Violation|1
1807315|NCT00481988|6282422|P2|Overall Study|Withdrawal by Subject|1
1807316|NCT00481988|6282423|P1|Overall Study|Withdrawal by Subject|1
1807317|NCT00481871|6282436|P5|Overall Study|Progressive Disease - pt withdrew|0
1807318|NCT00481871|6282437|P4|Overall Study|Progressive Disease - pt withdrew|0
1807319|NCT00481871|6282438|P3|Overall Study|Progressive Disease - pt withdrew|1
1807320|NCT00481871|6282439|P2|Overall Study|Progressive Disease - pt withdrew|0
1807321|NCT00481871|6282440|P1|Overall Study|Progressive Disease - pt withdrew|0
1807322|NCT00481832|6282465|P1|Inter-transplant Period|Lack of allogeneic donor|5
1807323|NCT00481832|6282465|P1|Inter-transplant Period|Disease relapse|11
1807324|NCT00481832|6282465|P1|Inter-transplant Period|Physician Decision|4
1807325|NCT00481832|6282465|P1|Inter-transplant Period|Death|3
1807326|NCT00481832|6282465|P1|Inter-transplant Period|Adverse Event|4
1807327|NCT00481832|6282465|P1|Enrollment|Unable to collect enough stem cells|2
1807328|NCT00481832|6282465|P1|Enrollment|Physician Decision|8
1807329|NCT00481767|6282480|P2|Overall Study|Lost to Follow-up|10
1807330|NCT00481767|6282481|P1|Overall Study|Lost to Follow-up|16
1807331|NCT00481767|6282480|P2|Overall Study|Withdrawal by Subject|11
1807332|NCT00481767|6282481|P1|Overall Study|Withdrawal by Subject|16
1807333|NCT00481676|6282515|P2|Overall Study|Administrative problem|0
1807334|NCT00481676|6282516|P1|Overall Study|Administrative problem|1
1807335|NCT00481676|6282515|P2|Overall Study|Unsatisfactory therapeutic effect|4
1807336|NCT00481676|6282516|P1|Overall Study|Unsatisfactory therapeutic effect|1
1807337|NCT00481676|6282515|P2|Overall Study|Adverse Event|1
1807338|NCT00481676|6282516|P1|Overall Study|Adverse Event|0
1807339|NCT00481247|6282568|P2|Overall Study|Did not receive treatment|2
1807340|NCT00481247|6282569|P1|Overall Study|Did not receive treatment|1
1807341|NCT00481247|6282568|P2|Overall Study|Varied|15
1807342|NCT00481247|6282569|P1|Overall Study|Varied|6
1807343|NCT00481247|6282568|P2|Overall Study|Administrative reason by sponsor|162
1807344|NCT00481247|6282569|P1|Overall Study|Administrative reason by sponsor|157
1807345|NCT00481247|6282568|P2|Overall Study|Poor compliance/noncompliance|7
1807346|NCT00481247|6282569|P1|Overall Study|Poor compliance/noncompliance|1
1807347|NCT00481247|6282568|P2|Overall Study|Lost to Follow-up|2
1807348|NCT00481247|6282569|P1|Overall Study|Lost to Follow-up|1
1807349|NCT00481247|6282568|P2|Overall Study|Pregnancy|1
1807350|NCT00481247|6282569|P1|Overall Study|Pregnancy|2
1807351|NCT00481247|6282568|P2|Overall Study|Withdrawal by Subject|13
1807352|NCT00481247|6282569|P1|Overall Study|Withdrawal by Subject|8
1807353|NCT00481247|6282568|P2|Overall Study|AE unrelated to study drug|4
1807354|NCT00481247|6282569|P1|Overall Study|AE unrelated to study drug|13
1807355|NCT00481247|6282568|P2|Overall Study|Treatment failure|14
1807356|NCT00481247|6282569|P1|Overall Study|Treatment failure|10
1807357|NCT00481247|6282568|P2|Overall Study|Intolerance|17
1807358|NCT00481247|6282569|P1|Overall Study|Intolerance|42
1807359|NCT00481247|6282568|P2|Overall Study|Disease progression|22
1807360|NCT00481247|6282569|P1|Overall Study|Disease progression|18
1807361|NCT00481247|6282568|P2|Overall Study|Death|1
1807362|NCT00481247|6282569|P1|Overall Study|Death|0
1807363|NCT00481195|6282593|P2|Overall Study|Miscellaneous|2
1807364|NCT00481195|6282594|P1|Overall Study|Miscellaneous|2
1807365|NCT00481195|6282593|P2|Overall Study|Withdrawal by Subject|9
1807366|NCT00481195|6282594|P1|Overall Study|Withdrawal by Subject|3
1807367|NCT00481195|6282593|P2|Overall Study|Protocol Violation|7
1807368|NCT00481195|6282594|P1|Overall Study|Protocol Violation|10
1807369|NCT00481195|6282593|P2|Overall Study|Physician Decision|1
1807370|NCT00481195|6282594|P1|Overall Study|Physician Decision|3
1807371|NCT00481195|6282593|P2|Overall Study|Lost to Follow-up|6
1807372|NCT00481195|6282594|P1|Overall Study|Lost to Follow-up|4
1807373|NCT00481195|6282593|P2|Overall Study|Lack of Efficacy|3
1807374|NCT00481195|6282594|P1|Overall Study|Lack of Efficacy|1
1807375|NCT00481195|6282593|P2|Overall Study|Adverse Event|11
1807376|NCT00481195|6282594|P1|Overall Study|Adverse Event|16
1807377|NCT00481078|6282680|P2|Overall Study|Brain metastasis|1
1807378|NCT00481078|6282681|P1|Overall Study|Brain metastasis|0
1807379|NCT00481078|6282680|P2|Overall Study|Received other treatment|1
1807380|NCT00481078|6282681|P1|Overall Study|Received other treatment|2
1807381|NCT00481078|6282680|P2|Overall Study|Information not available|0
1807382|NCT00481078|6282681|P1|Overall Study|Information not available|1
1807383|NCT00481078|6282680|P2|Overall Study|Withdrawal by Subject|1
1807384|NCT00481078|6282681|P1|Overall Study|Withdrawal by Subject|7
1807385|NCT00481078|6282680|P2|Overall Study|Intercurrent illness|0
1807386|NCT00481078|6282681|P1|Overall Study|Intercurrent illness|1
1807387|NCT00481078|6282680|P2|Overall Study|Death|3
1807388|NCT00481078|6282681|P1|Overall Study|Death|5
1807389|NCT00481078|6282680|P2|Overall Study|Adverse Event|3
1807390|NCT00481078|6282681|P1|Overall Study|Adverse Event|15
1807391|NCT00481078|6282680|P2|Overall Study|Progression of disease|11
1807392|NCT00481078|6282681|P1|Overall Study|Progression of disease|11
1807393|NCT00481065|6282699|P8|Overall Study|Unable to classify|0
1807394|NCT00481065|6282700|P7|Overall Study|Unable to classify|0
1807395|NCT00481065|6282701|P6|Overall Study|Unable to classify|0
1807396|NCT00481065|6282702|P5|Overall Study|Unable to classify|1
1807397|NCT00481065|6282703|P4|Overall Study|Unable to classify|0
1807398|NCT00481065|6282704|P3|Overall Study|Unable to classify|2
1807399|NCT00481065|6282705|P2|Overall Study|Unable to classify|1
1807400|NCT00481065|6282706|P1|Overall Study|Unable to classify|0
1807401|NCT00481065|6282699|P8|Overall Study|Protocol Violation|2
1807402|NCT00481065|6282700|P7|Overall Study|Protocol Violation|3
1807403|NCT00481065|6282701|P6|Overall Study|Protocol Violation|6
1807404|NCT00481065|6282702|P5|Overall Study|Protocol Violation|2
1807405|NCT00481065|6282703|P4|Overall Study|Protocol Violation|1
1807406|NCT00481065|6282704|P3|Overall Study|Protocol Violation|1
1807407|NCT00481065|6282705|P2|Overall Study|Protocol Violation|1
1807408|NCT00481065|6282706|P1|Overall Study|Protocol Violation|2
1807409|NCT00481065|6282699|P8|Overall Study|Administrative reason|0
1807410|NCT00481065|6282700|P7|Overall Study|Administrative reason|1
1807411|NCT00481065|6282701|P6|Overall Study|Administrative reason|2
1807412|NCT00481065|6282702|P5|Overall Study|Administrative reason|0
1807413|NCT00481065|6282703|P4|Overall Study|Administrative reason|0
1807414|NCT00481065|6282704|P3|Overall Study|Administrative reason|0
1807415|NCT00481065|6282705|P2|Overall Study|Administrative reason|0
1807416|NCT00481065|6282706|P1|Overall Study|Administrative reason|0
1807417|NCT00481065|6282699|P8|Overall Study|Inappropriate enrollment|1
1807418|NCT00481065|6282700|P7|Overall Study|Inappropriate enrollment|0
1807419|NCT00481065|6282701|P6|Overall Study|Inappropriate enrollment|1
1807420|NCT00481065|6282702|P5|Overall Study|Inappropriate enrollment|2
1807421|NCT00481065|6282703|P4|Overall Study|Inappropriate enrollment|0
1807422|NCT00481065|6282704|P3|Overall Study|Inappropriate enrollment|2
1807423|NCT00481065|6282705|P2|Overall Study|Inappropriate enrollment|0
1807424|NCT00481065|6282706|P1|Overall Study|Inappropriate enrollment|4
1807425|NCT00481065|6282699|P8|Overall Study|Lost to Follow-up|5
1807426|NCT00481065|6282700|P7|Overall Study|Lost to Follow-up|2
1807427|NCT00481065|6282701|P6|Overall Study|Lost to Follow-up|3
1807428|NCT00481065|6282702|P5|Overall Study|Lost to Follow-up|3
1807429|NCT00481065|6282703|P4|Overall Study|Lost to Follow-up|3
1807430|NCT00481065|6282704|P3|Overall Study|Lost to Follow-up|4
1807431|NCT00481065|6282705|P2|Overall Study|Lost to Follow-up|2
1807432|NCT00481065|6282706|P1|Overall Study|Lost to Follow-up|4
1807433|NCT00481065|6282699|P8|Overall Study|Withdrawal by Subject|10
1807434|NCT00481065|6282700|P7|Overall Study|Withdrawal by Subject|9
1807435|NCT00481065|6282701|P6|Overall Study|Withdrawal by Subject|12
1807436|NCT00481065|6282702|P5|Overall Study|Withdrawal by Subject|13
1807437|NCT00481065|6282703|P4|Overall Study|Withdrawal by Subject|11
1807438|NCT00481065|6282704|P3|Overall Study|Withdrawal by Subject|7
1807439|NCT00481065|6282705|P2|Overall Study|Withdrawal by Subject|12
1807440|NCT00481065|6282706|P1|Overall Study|Withdrawal by Subject|11
1807441|NCT00481065|6282699|P8|Overall Study|Adverse event or death|1
1807442|NCT00481065|6282700|P7|Overall Study|Adverse event or death|1
1807443|NCT00481065|6282701|P6|Overall Study|Adverse event or death|0
1807444|NCT00481065|6282702|P5|Overall Study|Adverse event or death|2
1807445|NCT00481065|6282703|P4|Overall Study|Adverse event or death|0
1807446|NCT00481065|6282704|P3|Overall Study|Adverse event or death|3
1807447|NCT00481065|6282705|P2|Overall Study|Adverse event or death|1
1807448|NCT00481065|6282706|P1|Overall Study|Adverse event or death|1
1807449|NCT00480857|6282796|P1|Overall Study|Lack of Efficacy|2
1807450|NCT00480779|6282806|P2|Overall Study|Job and Health-related|3
1807451|NCT00480779|6282807|P1|Overall Study|Job and Health-related|0
1807452|NCT00480779|6282806|P2|Overall Study|Other|0
1807453|NCT00480779|6282807|P1|Overall Study|Other|2
1807454|NCT00480636|6282844|P1|Overall Study|Lost to follow-up; subsequently died|1
1807455|NCT00480636|6282844|P1|Overall Study|Other|2
1807456|NCT00480636|6282844|P1|Overall Study|Lost to Follow-up|4
1807457|NCT00480636|6282844|P1|Overall Study|Death|12
1807458|NCT00480532|6282856|P4|Overall Study|Protocol Violation|0
1807459|NCT00480532|6282857|P3|Overall Study|Protocol Violation|1
1807460|NCT00480532|6282858|P2|Overall Study|Protocol Violation|0
1807461|NCT00480532|6282859|P1|Overall Study|Protocol Violation|0
1807462|NCT00480532|6282856|P4|Overall Study|Withdrawal by Subject|1
1807463|NCT00480532|6282857|P3|Overall Study|Withdrawal by Subject|3
1807464|NCT00480532|6282858|P2|Overall Study|Withdrawal by Subject|4
1807465|NCT00480532|6282859|P1|Overall Study|Withdrawal by Subject|2
1807466|NCT00480493|6282879|P2|Overall Study|moved|7
1807467|NCT00480493|6282880|P1|Overall Study|moved|2
1807468|NCT00480441|6282892|P3|Randomization|Lost to Follow-up|2
1807469|NCT00480441|6282893|P2|Randomization|Lost to Follow-up|7
1807470|NCT00480441|6282894|P1|Randomization|Lost to Follow-up|0
1807471|NCT00480441|6282892|P3|Baseline Functional MRI|physical contraindication|0
1807472|NCT00480441|6282893|P2|Baseline Functional MRI|physical contraindication|0
1807473|NCT00480441|6282894|P1|Baseline Functional MRI|physical contraindication|4
1807474|NCT00480441|6282892|P3|Baseline Functional MRI|Lost to Follow-up|0
1807475|NCT00480441|6282893|P2|Baseline Functional MRI|Lost to Follow-up|0
1807476|NCT00480441|6282894|P1|Baseline Functional MRI|Lost to Follow-up|4
1807477|NCT00480441|6282892|P3|Baseline Functional MRI|Functional MRI data not usable|0
1807478|NCT00480441|6282893|P2|Baseline Functional MRI|Functional MRI data not usable|0
1807479|NCT00480441|6282894|P1|Baseline Functional MRI|Functional MRI data not usable|4
1807480|NCT00480441|6282892|P3|Screening|Not Eligible|0
1807481|NCT00480441|6282893|P2|Screening|Not Eligible|0
1807482|NCT00480441|6282894|P1|Screening|Not Eligible|37
1807483|NCT00480324|6282903|P2|Overall Study|Subject’s mother pregnant|1
1807484|NCT00480324|6282904|P1|Overall Study|Subject’s mother pregnant|0
1807485|NCT00480324|6282903|P2|Overall Study|Lost to Follow-up|8
1807486|NCT00480324|6282904|P1|Overall Study|Lost to Follow-up|17
1807487|NCT00480324|6282903|P2|Overall Study|Withdrawal by Subject|5
1807488|NCT00480324|6282904|P1|Overall Study|Withdrawal by Subject|14
1807489|NCT00480324|6282903|P2|Overall Study|Protocol Violation|1
1807490|NCT00480324|6282904|P1|Overall Study|Protocol Violation|0
1807491|NCT00480324|6282903|P2|Overall Study|Adverse Event|1
1807492|NCT00480324|6282904|P1|Overall Study|Adverse Event|1
1807493|NCT00480077|6282932|P2|Overall Study|early exit|11
1807494|NCT00480077|6282933|P1|Overall Study|early exit|12
1807495|NCT00480077|6282932|P2|Overall Study|Death|15
1807496|NCT00480077|6282933|P1|Overall Study|Death|19
1807497|NCT00480025|6282941|P2|Overall Study|SAE including intercurrent illness|42
1807498|NCT00480025|6282942|P1|Overall Study|SAE including intercurrent illness|76
1807499|NCT00480025|6282941|P2|Overall Study|Other|29
1807500|NCT00480025|6282942|P1|Overall Study|Other|70
1807501|NCT00480025|6282941|P2|Overall Study|Adverse Event|12
1807502|NCT00480025|6282942|P1|Overall Study|Adverse Event|44
1807503|NCT00480025|6282941|P2|Overall Study|Disease Progression / Recurrence|224
1807504|NCT00480025|6282942|P1|Overall Study|Disease Progression / Recurrence|449
1807505|NCT00480025|6282941|P2|Overall Study|Patients remaining ongoing at Data Lock|55
1807506|NCT00480025|6282942|P1|Overall Study|Patients remaining ongoing at Data Lock|101
1807507|NCT00480025|6282941|P2|Overall Study|Protocol Violation|7
1807508|NCT00480025|6282942|P1|Overall Study|Protocol Violation|12
1807509|NCT00479882|6283014|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1807510|NCT00479882|6283015|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
1807511|NCT00479882|6283016|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1807512|NCT00479882|6283017|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
1807513|NCT00479882|6283014|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1807514|NCT00479882|6283015|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
1807515|NCT00479882|6283016|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1807516|NCT00479882|6283017|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
1807517|NCT00479882|6283014|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
1807518|NCT00479882|6283015|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
1807519|NCT00479882|6283016|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
1807520|NCT00479882|6283017|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
1807521|NCT00479882|6283014|P4|Crossover: Period III (Weeks 13-20)|Other|2
1807522|NCT00479882|6283015|P3|Crossover: Period III (Weeks 13-20)|Other|2
1807523|NCT00479882|6283016|P2|Crossover: Period III (Weeks 13-20)|Other|0
1807524|NCT00479882|6283017|P1|Crossover: Period III (Weeks 13-20)|Other|5
1807525|NCT00479882|6283014|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1807526|NCT00479882|6283015|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1807527|NCT00479882|6283016|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
1807528|NCT00479882|6283017|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
1807529|NCT00479882|6283014|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
1807530|NCT00479882|6283015|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
1807531|NCT00479882|6283016|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
1807532|NCT00479882|6283017|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
1807533|NCT00479882|6283014|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
1807534|NCT00479882|6283015|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
1807535|NCT00479882|6283016|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
1807536|NCT00479882|6283017|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
1807537|NCT00479882|6283014|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
1807538|NCT00479882|6283015|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
1807539|NCT00479882|6283016|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
1807540|NCT00479882|6283017|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
1807541|NCT00479882|6283014|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
1807542|NCT00479882|6283015|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
1807543|NCT00479882|6283016|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
1807544|NCT00479882|6283017|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
1807545|NCT00479882|6283014|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
1807546|NCT00479882|6283015|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
1807547|NCT00479882|6283016|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
1807548|NCT00479882|6283017|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
1807549|NCT00479882|6283014|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
1807550|NCT00479882|6283015|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
1807551|NCT00479882|6283016|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
1807552|NCT00479882|6283017|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
1807553|NCT00479882|6283014|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
1807554|NCT00479882|6283015|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
1807555|NCT00479882|6283016|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
1807556|NCT00479882|6283017|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
1807557|NCT00479882|6283014|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1807558|NCT00479882|6283015|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1807559|NCT00479882|6283016|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
1807560|NCT00479882|6283017|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
1807561|NCT00479882|6283014|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
1807562|NCT00479882|6283015|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
1807563|NCT00479882|6283016|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
1807564|NCT00479882|6283017|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
1807565|NCT00479856|6283147|P1|Overall Study|Physician Decision|1
1807566|NCT00479856|6283147|P1|Overall Study|Withdrawal by Subject|1
1807567|NCT00479856|6283147|P1|Overall Study|Adverse Event|1
1807568|NCT00479765|6283156|P1|Overall Study|study terminated|4
1807569|NCT00479713|6283162|P2|Overall Study|Withdrawal by Subject|1
1807570|NCT00479713|6283163|P1|Overall Study|Withdrawal by Subject|4
1807571|NCT00479713|6283162|P2|Overall Study|Protocol Violation|1
1807572|NCT00479713|6283163|P1|Overall Study|Protocol Violation|0
1807573|NCT00479713|6283162|P2|Overall Study|Lost to Follow-up|1
1807574|NCT00479713|6283163|P1|Overall Study|Lost to Follow-up|0
1807575|NCT00479713|6283162|P2|Overall Study|Death|0
1807576|NCT00479713|6283163|P1|Overall Study|Death|1
1807577|NCT00479713|6283162|P2|Overall Study|Adverse Event|6
1807578|NCT00479713|6283163|P1|Overall Study|Adverse Event|8
1807579|NCT00479674|6283187|P1|Overall Study|none provided|3
1807580|NCT00479674|6283187|P1|Overall Study|Physician Decision|14
1807581|NCT00479674|6283187|P1|Overall Study|Withdrawal by Subject|6
1807582|NCT00479674|6283187|P1|Overall Study|Adverse Event|18
1807583|NCT00479557|6283202|P7|Overall Study|Other|0
1807584|NCT00479557|6283203|P6|Overall Study|Other|3
1807585|NCT00479557|6283204|P5|Overall Study|Other|0
1807586|NCT00479557|6283205|P4|Overall Study|Other|0
1807587|NCT00479557|6283206|P3|Overall Study|Other|1
1807588|NCT00479557|6283207|P2|Overall Study|Other|3
1807589|NCT00479557|6283208|P1|Overall Study|Other|2
1807590|NCT00479557|6283202|P7|Overall Study|Subject Request|1
1807591|NCT00479557|6283203|P6|Overall Study|Subject Request|4
1807592|NCT00479557|6283204|P5|Overall Study|Subject Request|1
1807593|NCT00479557|6283205|P4|Overall Study|Subject Request|1
1807594|NCT00479557|6283206|P3|Overall Study|Subject Request|1
1807595|NCT00479557|6283207|P2|Overall Study|Subject Request|0
1807596|NCT00479557|6283208|P1|Overall Study|Subject Request|3
1807597|NCT00479557|6283202|P7|Overall Study|Investigator Request|0
1807598|NCT00479557|6283203|P6|Overall Study|Investigator Request|0
1807599|NCT00479557|6283204|P5|Overall Study|Investigator Request|0
1807600|NCT00479557|6283205|P4|Overall Study|Investigator Request|0
1807601|NCT00479557|6283206|P3|Overall Study|Investigator Request|1
1807602|NCT00479557|6283207|P2|Overall Study|Investigator Request|0
1807603|NCT00479557|6283208|P1|Overall Study|Investigator Request|0
1807604|NCT00479557|6283202|P7|Overall Study|Caregiver Request|0
1807605|NCT00479557|6283203|P6|Overall Study|Caregiver Request|2
1807606|NCT00479557|6283204|P5|Overall Study|Caregiver Request|1
1807607|NCT00479557|6283205|P4|Overall Study|Caregiver Request|0
1807608|NCT00479557|6283206|P3|Overall Study|Caregiver Request|2
1807609|NCT00479557|6283207|P2|Overall Study|Caregiver Request|2
1807610|NCT00479557|6283208|P1|Overall Study|Caregiver Request|2
1807611|NCT00479557|6283202|P7|Overall Study|AE not related to Study Drug|1
1807612|NCT00479557|6283203|P6|Overall Study|AE not related to Study Drug|2
1807613|NCT00479557|6283204|P5|Overall Study|AE not related to Study Drug|2
1807614|NCT00479557|6283205|P4|Overall Study|AE not related to Study Drug|0
1807615|NCT00479557|6283206|P3|Overall Study|AE not related to Study Drug|0
1807616|NCT00479557|6283207|P2|Overall Study|AE not related to Study Drug|3
1807617|NCT00479557|6283208|P1|Overall Study|AE not related to Study Drug|1
1807618|NCT00479557|6283202|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
1807619|NCT00479557|6283203|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
1807620|NCT00479557|6283204|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
1807621|NCT00479557|6283205|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
1807622|NCT00479557|6283206|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
1807623|NCT00479557|6283207|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
1807624|NCT00479557|6283208|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
1807625|NCT00479557|6283202|P7|Overall Study|Lost to Follow-up|0
1807626|NCT00479557|6283203|P6|Overall Study|Lost to Follow-up|0
1807627|NCT00479557|6283204|P5|Overall Study|Lost to Follow-up|0
1807628|NCT00479557|6283205|P4|Overall Study|Lost to Follow-up|2
1807629|NCT00479557|6283206|P3|Overall Study|Lost to Follow-up|0
1807630|NCT00479557|6283207|P2|Overall Study|Lost to Follow-up|2
1807631|NCT00479557|6283208|P1|Overall Study|Lost to Follow-up|0
1807632|NCT00479557|6283202|P7|Overall Study|Lack of Efficacy|0
1807633|NCT00479557|6283203|P6|Overall Study|Lack of Efficacy|0
1807634|NCT00479557|6283204|P5|Overall Study|Lack of Efficacy|0
1807635|NCT00479557|6283205|P4|Overall Study|Lack of Efficacy|0
1807636|NCT00479557|6283206|P3|Overall Study|Lack of Efficacy|0
1807637|NCT00479557|6283207|P2|Overall Study|Lack of Efficacy|0
1807638|NCT00479557|6283208|P1|Overall Study|Lack of Efficacy|1
1807639|NCT00479557|6283202|P7|Overall Study|Death|0
1807640|NCT00479557|6283203|P6|Overall Study|Death|1
1807641|NCT00479557|6283204|P5|Overall Study|Death|0
1807642|NCT00479557|6283205|P4|Overall Study|Death|0
1807643|NCT00479557|6283206|P3|Overall Study|Death|0
1807644|NCT00479557|6283207|P2|Overall Study|Death|0
1807645|NCT00479557|6283208|P1|Overall Study|Death|0
1807646|NCT00479466|6283251|P6|Overall Study|Withdrawal by Subject|1
1807647|NCT00479466|6283252|P5|Overall Study|Withdrawal by Subject|3
1807648|NCT00479466|6283253|P4|Overall Study|Withdrawal by Subject|2
1807649|NCT00479466|6283254|P3|Overall Study|Withdrawal by Subject|0
1807650|NCT00479466|6283255|P2|Overall Study|Withdrawal by Subject|5
1807651|NCT00479466|6283256|P1|Overall Study|Withdrawal by Subject|3
1807652|NCT00479466|6283251|P6|Overall Study|Protocol Violation|0
1807653|NCT00479466|6283252|P5|Overall Study|Protocol Violation|0
1807654|NCT00479466|6283253|P4|Overall Study|Protocol Violation|0
1807655|NCT00479466|6283254|P3|Overall Study|Protocol Violation|0
1807656|NCT00479466|6283255|P2|Overall Study|Protocol Violation|0
1807657|NCT00479466|6283256|P1|Overall Study|Protocol Violation|1
1807658|NCT00479466|6283251|P6|Overall Study|Pregnancy|0
1807659|NCT00479466|6283252|P5|Overall Study|Pregnancy|1
1807660|NCT00479466|6283253|P4|Overall Study|Pregnancy|0
1807661|NCT00479466|6283254|P3|Overall Study|Pregnancy|0
1807662|NCT00479466|6283255|P2|Overall Study|Pregnancy|0
1807663|NCT00479466|6283256|P1|Overall Study|Pregnancy|0
1807664|NCT00479466|6283251|P6|Overall Study|Physician Decision|0
1807665|NCT00479466|6283252|P5|Overall Study|Physician Decision|0
1807666|NCT00479466|6283253|P4|Overall Study|Physician Decision|0
1807667|NCT00479466|6283254|P3|Overall Study|Physician Decision|1
1807668|NCT00479466|6283255|P2|Overall Study|Physician Decision|1
1807669|NCT00479466|6283256|P1|Overall Study|Physician Decision|2
1807670|NCT00479466|6283251|P6|Overall Study|Lost to Follow-up|2
1807671|NCT00479466|6283252|P5|Overall Study|Lost to Follow-up|2
1807672|NCT00479466|6283253|P4|Overall Study|Lost to Follow-up|0
1807673|NCT00479466|6283254|P3|Overall Study|Lost to Follow-up|1
1807674|NCT00479466|6283255|P2|Overall Study|Lost to Follow-up|1
1807675|NCT00479466|6283256|P1|Overall Study|Lost to Follow-up|0
1807676|NCT00479466|6283251|P6|Overall Study|Lack of Efficacy|0
1807677|NCT00479466|6283252|P5|Overall Study|Lack of Efficacy|0
1807678|NCT00479466|6283253|P4|Overall Study|Lack of Efficacy|0
1807679|NCT00479466|6283254|P3|Overall Study|Lack of Efficacy|1
1807680|NCT00479466|6283255|P2|Overall Study|Lack of Efficacy|0
1807681|NCT00479466|6283256|P1|Overall Study|Lack of Efficacy|2
1807682|NCT00479466|6283251|P6|Overall Study|Hyperglycemia|1
1807683|NCT00479466|6283252|P5|Overall Study|Hyperglycemia|0
1807684|NCT00479466|6283253|P4|Overall Study|Hyperglycemia|0
1807685|NCT00479466|6283254|P3|Overall Study|Hyperglycemia|0
1807686|NCT00479466|6283255|P2|Overall Study|Hyperglycemia|0
1807687|NCT00479466|6283256|P1|Overall Study|Hyperglycemia|0
1807688|NCT00479466|6283251|P6|Overall Study|Adverse Event|0
1807689|NCT00479466|6283252|P5|Overall Study|Adverse Event|2
1807690|NCT00479466|6283253|P4|Overall Study|Adverse Event|1
1807691|NCT00479466|6283254|P3|Overall Study|Adverse Event|0
1807692|NCT00479466|6283255|P2|Overall Study|Adverse Event|1
1807693|NCT00479466|6283256|P1|Overall Study|Adverse Event|5
1807694|NCT00479401|6283285|P3|Overall Study|Exclusion criteria, relocation|0
1807695|NCT00479401|6283286|P2|Overall Study|Exclusion criteria, relocation|3
1807696|NCT00479401|6283287|P1|Overall Study|Exclusion criteria, relocation|4
1807697|NCT00479401|6283285|P3|Overall Study|Withdrawal by Subject|2
1807698|NCT00479401|6283286|P2|Overall Study|Withdrawal by Subject|10
1807699|NCT00479401|6283287|P1|Overall Study|Withdrawal by Subject|16
1807700|NCT00479401|6283285|P3|Overall Study|Lost to Follow-up|1
1807701|NCT00479401|6283286|P2|Overall Study|Lost to Follow-up|1
1807702|NCT00479401|6283287|P1|Overall Study|Lost to Follow-up|1
1807703|NCT00479401|6283285|P3|Overall Study|Protocol Violation|1
1807704|NCT00479401|6283286|P2|Overall Study|Protocol Violation|1
1807705|NCT00479401|6283287|P1|Overall Study|Protocol Violation|2
1807706|NCT00479401|6283285|P3|Overall Study|Lack of Efficacy|4
1807707|NCT00479401|6283286|P2|Overall Study|Lack of Efficacy|2
1807708|NCT00479401|6283287|P1|Overall Study|Lack of Efficacy|2
1807709|NCT00479401|6283285|P3|Overall Study|Adverse Event|4
1807710|NCT00479401|6283286|P2|Overall Study|Adverse Event|20
1807711|NCT00479401|6283287|P1|Overall Study|Adverse Event|24
1807712|NCT00479388|6283342|P2|Overall Study|Withdrawal by Subject|17
1807713|NCT00479388|6283343|P1|Overall Study|Withdrawal by Subject|32
1807714|NCT00479388|6283342|P2|Overall Study|Protocol Violation|9
1807715|NCT00479388|6283343|P1|Overall Study|Protocol Violation|10
1807716|NCT00479388|6283342|P2|Overall Study|Lost to Follow-up|2
1807717|NCT00479388|6283343|P1|Overall Study|Lost to Follow-up|0
1807718|NCT00479388|6283342|P2|Overall Study|Adverse Event|45
1807719|NCT00479388|6283343|P1|Overall Study|Adverse Event|90
1807720|NCT00479336|6283357|P4|Overall Study|Resolution of all hepatic edema findings|0
1807721|NCT00479336|6283358|P3|Overall Study|Resolution of all hepatic edema findings|0
1807722|NCT00479336|6283359|P2|Overall Study|Resolution of all hepatic edema findings|1
1807723|NCT00479336|6283360|P1|Overall Study|Resolution of all hepatic edema findings|1
1807724|NCT00479336|6283357|P4|Overall Study|Physician Decision|2
1807725|NCT00479336|6283358|P3|Overall Study|Physician Decision|0
1807726|NCT00479336|6283359|P2|Overall Study|Physician Decision|1
1807727|NCT00479336|6283360|P1|Overall Study|Physician Decision|0
1807728|NCT00479336|6283357|P4|Overall Study|Withdrawal by Subject|0
1807729|NCT00479336|6283358|P3|Overall Study|Withdrawal by Subject|0
1807730|NCT00479336|6283359|P2|Overall Study|Withdrawal by Subject|2
1807731|NCT00479336|6283360|P1|Overall Study|Withdrawal by Subject|1
1807732|NCT00479336|6283357|P4|Overall Study|Protocol Violation|0
1807733|NCT00479336|6283358|P3|Overall Study|Protocol Violation|0
1807734|NCT00479336|6283359|P2|Overall Study|Protocol Violation|1
1807735|NCT00479336|6283360|P1|Overall Study|Protocol Violation|0
1807736|NCT00479336|6283357|P4|Overall Study|Lack of Efficacy|0
1807737|NCT00479336|6283358|P3|Overall Study|Lack of Efficacy|0
1807738|NCT00479336|6283359|P2|Overall Study|Lack of Efficacy|0
1807739|NCT00479336|6283360|P1|Overall Study|Lack of Efficacy|1
1807740|NCT00479336|6283357|P4|Overall Study|Adverse Event|3
1807741|NCT00479336|6283358|P3|Overall Study|Adverse Event|1
1807742|NCT00479336|6283359|P2|Overall Study|Adverse Event|1
1807743|NCT00479336|6283360|P1|Overall Study|Adverse Event|1
1807744|NCT00479232|6283383|P6|Overall Study|Withdrew Consent|3
1807745|NCT00479232|6283384|P5|Overall Study|Withdrew Consent|1
1807746|NCT00479232|6283385|P4|Overall Study|Withdrew Consent|0
1807747|NCT00479232|6283386|P3|Overall Study|Withdrew Consent|6
1807748|NCT00479232|6283387|P2|Overall Study|Withdrew Consent|2
1807749|NCT00479232|6283388|P1|Overall Study|Withdrew Consent|0
1807750|NCT00479232|6283383|P6|Overall Study|Progressive Disease|12
1807751|NCT00479232|6283384|P5|Overall Study|Progressive Disease|3
1807752|NCT00479232|6283385|P4|Overall Study|Progressive Disease|3
1807753|NCT00479232|6283386|P3|Overall Study|Progressive Disease|12
1807754|NCT00479232|6283387|P2|Overall Study|Progressive Disease|1
1807755|NCT00479232|6283388|P1|Overall Study|Progressive Disease|3
1807756|NCT00479232|6283383|P6|Overall Study|Physician Decision|1
1807757|NCT00479232|6283384|P5|Overall Study|Physician Decision|0
1807758|NCT00479232|6283385|P4|Overall Study|Physician Decision|0
1807759|NCT00479232|6283386|P3|Overall Study|Physician Decision|2
1807760|NCT00479232|6283387|P2|Overall Study|Physician Decision|0
1807761|NCT00479232|6283388|P1|Overall Study|Physician Decision|0
1807762|NCT00479232|6283383|P6|Overall Study|Lack of Efficacy|4
1807763|NCT00479232|6283384|P5|Overall Study|Lack of Efficacy|0
1807764|NCT00479232|6283385|P4|Overall Study|Lack of Efficacy|0
1807765|NCT00479232|6283386|P3|Overall Study|Lack of Efficacy|2
1807766|NCT00479232|6283387|P2|Overall Study|Lack of Efficacy|0
1807767|NCT00479232|6283388|P1|Overall Study|Lack of Efficacy|0
1807768|NCT00479232|6283383|P6|Overall Study|Deviation from Protocol|0
1807769|NCT00479232|6283384|P5|Overall Study|Deviation from Protocol|0
1807770|NCT00479232|6283385|P4|Overall Study|Deviation from Protocol|0
1807771|NCT00479232|6283386|P3|Overall Study|Deviation from Protocol|1
1807772|NCT00479232|6283387|P2|Overall Study|Deviation from Protocol|0
1807773|NCT00479232|6283388|P1|Overall Study|Deviation from Protocol|0
1807774|NCT00479232|6283383|P6|Overall Study|Adverse Event|10
1807775|NCT00479232|6283384|P5|Overall Study|Adverse Event|0
1807776|NCT00479232|6283385|P4|Overall Study|Adverse Event|0
1807777|NCT00479232|6283386|P3|Overall Study|Adverse Event|5
1807778|NCT00479232|6283387|P2|Overall Study|Adverse Event|0
1807779|NCT00479232|6283388|P1|Overall Study|Adverse Event|0
1807780|NCT00478933|6283441|P1|Overall Study|Inadequate data available|53
1807781|NCT00478933|6283441|P1|Overall Study|Informed consent not verified|3
1807782|NCT00478933|6283441|P1|Overall Study|Protocol Violation|22
1807783|NCT00478881|6283467|P2|Overall Study|Non-Compliance with Study Medication|2
1807784|NCT00478881|6283468|P1|Overall Study|Non-Compliance with Study Medication|0
1807785|NCT00478881|6283467|P2|Overall Study|Withdrawal by Subject|2
1807786|NCT00478881|6283468|P1|Overall Study|Withdrawal by Subject|6
1807787|NCT00478881|6283467|P2|Overall Study|Protocol Violation|2
1807788|NCT00478881|6283468|P1|Overall Study|Protocol Violation|2
1807789|NCT00478881|6283467|P2|Overall Study|Lost to Follow-up|1
1807790|NCT00478881|6283468|P1|Overall Study|Lost to Follow-up|0
1807791|NCT00478881|6283467|P2|Overall Study|Lack of Efficacy|3
1807792|NCT00478881|6283468|P1|Overall Study|Lack of Efficacy|0
1807793|NCT00478881|6283467|P2|Overall Study|Adverse Event|12
1807794|NCT00478881|6283468|P1|Overall Study|Adverse Event|31
1807795|NCT00478777|6283492|P1|Overall Study|Not treated with lenalidomide|6
1807796|NCT00478777|6283492|P1|Overall Study|End of therapy|2
1807797|NCT00478777|6283492|P1|Overall Study|Lymphocytes infusion|1
1807798|NCT00478777|6283492|P1|Overall Study|Lack of compliance|1
1807799|NCT00478777|6283492|P1|Overall Study|Intolerance of therapy|1
1807800|NCT00478777|6283492|P1|Overall Study|Physician Decision|1
1807801|NCT00478777|6283492|P1|Overall Study|Lost to Follow-up|3
1807802|NCT00478777|6283492|P1|Overall Study|Protocol Violation|3
1807803|NCT00478777|6283492|P1|Overall Study|Death|3
1807804|NCT00478777|6283492|P1|Overall Study|Withdrawal by Subject|4
1807805|NCT00478777|6283492|P1|Overall Study|Lack of Efficacy|23
1807806|NCT00478777|6283492|P1|Overall Study|Adverse Event|29
1807807|NCT00478673|6283499|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
1807808|NCT00478673|6283499|P1|12-Months Post-Procedure|Missed Visit|25
1807809|NCT00478673|6283499|P1|12-Months Post-Procedure|Withdrawal by Subject|6
1807810|NCT00478673|6283499|P1|12-Months Post-Procedure|Lost to Follow-up|4
1807811|NCT00478673|6283499|P1|12-Months Post-Procedure|Death|23
1807812|NCT00478673|6283499|P1|30-Days Post-Procedure|Missed Visit|7
1807813|NCT00478673|6283499|P1|30-Days Post-Procedure|Withdrawal by Subject|1
1807814|NCT00478673|6283499|P1|30-Days Post-Procedure|Death|2
1807815|NCT00478647|6283504|P1|Overall Study|Withdrawal by Subject|1
1807816|NCT00478647|6283504|P1|Overall Study|Adverse Event|1
1807817|NCT00478608|6283512|P1|Overall Study|Protocol Violation|3
1807818|NCT00478608|6283512|P1|Overall Study|Withdrawal by Subject|2
1807819|NCT00478608|6283512|P1|Overall Study|Serious Adverse Event|14
1807820|NCT00478608|6283512|P1|Overall Study|Adverse Event|1
1807822|NCT00478257|6283564|P2|Overall Study|Withdrawal by Subject|3
1807823|NCT00478257|6283565|P1|Overall Study|Withdrawal by Subject|8
1807824|NCT00478244|6283571|P1|Overall Study|Did not receive transplant|1
1807825|NCT00478231|6283584|P1|Overall Study|Randomized, not treated|3
1807826|NCT00478231|6283584|P1|Overall Study|Adverse Event|5
1807827|NCT00478231|6283584|P1|Overall Study|Other|9
1807828|NCT00478231|6283584|P1|Overall Study|Withdrawal by Subject|6
1807829|NCT00478231|6283584|P1|Overall Study|Lost to Follow-up|7
1807830|NCT00478231|6283584|P1|Overall Study|Lack of Efficacy|47
1807831|NCT00478231|6283584|P1|Overall Study|Death|7
1807832|NCT00478205|6283620|P2|Overall Study|Other|12
1807833|NCT00478205|6283621|P1|Overall Study|Other|24
1807834|NCT00478205|6283620|P2|Overall Study|Lack of Efficacy|0
1807835|NCT00478205|6283621|P1|Overall Study|Lack of Efficacy|1
1807836|NCT00478205|6283620|P2|Overall Study|Withdrawal by Subject|22
1807837|NCT00478205|6283621|P1|Overall Study|Withdrawal by Subject|61
1807838|NCT00478205|6283620|P2|Overall Study|Request of Investigator or Sponsor|5
1807839|NCT00478205|6283621|P1|Overall Study|Request of Investigator or Sponsor|4
1807840|NCT00478205|6283620|P2|Overall Study|Protocol Violation|5
1807841|NCT00478205|6283621|P1|Overall Study|Protocol Violation|15
1807842|NCT00478205|6283620|P2|Overall Study|Medication Non-compliance|4
1807843|NCT00478205|6283621|P1|Overall Study|Medication Non-compliance|9
1807844|NCT00478205|6283620|P2|Overall Study|Adverse Event|39
1807845|NCT00478205|6283621|P1|Overall Study|Adverse Event|182
1807846|NCT00478140|6283665|P1|Overall Study|Clinical Disease Progression|1
1807847|NCT00478023|6283697|P5|Overall Study|Lack of pain, Technical difficulties|3
1807848|NCT00478023|6283698|P4|Overall Study|Lack of pain, Technical difficulties|6
1807849|NCT00478023|6283699|P3|Overall Study|Lack of pain, Technical difficulties|5
1807850|NCT00478023|6283700|P2|Overall Study|Lack of pain, Technical difficulties|3
1807851|NCT00478023|6283701|P1|Overall Study|Lack of pain, Technical difficulties|7
1807852|NCT00478023|6283697|P5|Overall Study|Withdrawal by Subject|5
1807853|NCT00478023|6283698|P4|Overall Study|Withdrawal by Subject|4
1807854|NCT00478023|6283699|P3|Overall Study|Withdrawal by Subject|2
1807855|NCT00478023|6283700|P2|Overall Study|Withdrawal by Subject|3
1807856|NCT00478023|6283701|P1|Overall Study|Withdrawal by Subject|2
1807857|NCT00478023|6283697|P5|Overall Study|Lost to Follow-up|0
1807858|NCT00478023|6283698|P4|Overall Study|Lost to Follow-up|1
1807859|NCT00478023|6283699|P3|Overall Study|Lost to Follow-up|1
1807860|NCT00478023|6283700|P2|Overall Study|Lost to Follow-up|1
1807861|NCT00478023|6283701|P1|Overall Study|Lost to Follow-up|3
1807862|NCT00478023|6283697|P5|Overall Study|Lack of Efficacy|41
1807863|NCT00478023|6283698|P4|Overall Study|Lack of Efficacy|5
1807864|NCT00478023|6283699|P3|Overall Study|Lack of Efficacy|4
1807865|NCT00478023|6283700|P2|Overall Study|Lack of Efficacy|10
1807866|NCT00478023|6283701|P1|Overall Study|Lack of Efficacy|11
1807867|NCT00478023|6283697|P5|Overall Study|Death|0
1807868|NCT00478023|6283698|P4|Overall Study|Death|0
1807869|NCT00478023|6283699|P3|Overall Study|Death|0
1807870|NCT00478023|6283700|P2|Overall Study|Death|0
1807871|NCT00478023|6283701|P1|Overall Study|Death|1
1807872|NCT00478023|6283697|P5|Overall Study|Adverse Event|6
1807873|NCT00478023|6283698|P4|Overall Study|Adverse Event|14
1807874|NCT00478023|6283699|P3|Overall Study|Adverse Event|8
1807875|NCT00478023|6283700|P2|Overall Study|Adverse Event|7
1807876|NCT00478023|6283701|P1|Overall Study|Adverse Event|11
1807877|NCT00477971|6283720|P2|Overall Study|Alternative treatment|1
1807878|NCT00477971|6283721|P1|Overall Study|Alternative treatment|3
1807879|NCT00477971|6283720|P2|Overall Study|Death|4
1807880|NCT00477971|6283721|P1|Overall Study|Death|2
1807881|NCT00477971|6283720|P2|Overall Study|Adverse Event|0
1807882|NCT00477971|6283721|P1|Overall Study|Adverse Event|3
1807883|NCT00477971|6283720|P2|Overall Study|Withdrawal by Subject|1
1807884|NCT00477971|6283721|P1|Overall Study|Withdrawal by Subject|3
1807885|NCT00477971|6283720|P2|Overall Study|Disease progression|0
1807886|NCT00477971|6283721|P1|Overall Study|Disease progression|6
1807887|NCT00477750|6283733|P1|Overall Study|Currently Receiving Treatment|11
1807888|NCT00477672|6283749|P3|Overall Study|Discretion of Sponsor|0
1807889|NCT00477672|6283750|P2|Overall Study|Discretion of Sponsor|2
1807890|NCT00477672|6283751|P1|Overall Study|Discretion of Sponsor|1
1807891|NCT00477672|6283749|P3|Overall Study|Consent withdrawn|10
1807892|NCT00477672|6283750|P2|Overall Study|Consent withdrawn|5
1807893|NCT00477672|6283751|P1|Overall Study|Consent withdrawn|2
1807894|NCT00477672|6283749|P3|Overall Study|Protocol noncompliance|0
1807895|NCT00477672|6283750|P2|Overall Study|Protocol noncompliance|2
1807896|NCT00477672|6283751|P1|Overall Study|Protocol noncompliance|0
1807897|NCT00477672|6283749|P3|Overall Study|Physician Decision|0
1807898|NCT00477672|6283750|P2|Overall Study|Physician Decision|0
1807899|NCT00477672|6283751|P1|Overall Study|Physician Decision|1
1807900|NCT00477672|6283749|P3|Overall Study|Disease progression|0
1807901|NCT00477672|6283750|P2|Overall Study|Disease progression|1
1807902|NCT00477672|6283751|P1|Overall Study|Disease progression|0
1807903|NCT00477672|6283749|P3|Overall Study|Death|0
1807904|NCT00477672|6283750|P2|Overall Study|Death|1
1807905|NCT00477672|6283751|P1|Overall Study|Death|0
1807906|NCT00477672|6283749|P3|Overall Study|Adverse Event|6
1807907|NCT00477672|6283750|P2|Overall Study|Adverse Event|5
1807908|NCT00477672|6283751|P1|Overall Study|Adverse Event|3
1807909|NCT00477633|6283762|P1|Overall Study|Various (Moving, Enrollment closed)|75
1807910|NCT00477633|6283762|P1|Overall Study|Protocol Violation|25
1807911|NCT00477633|6283762|P1|Overall Study|Withdrawal by Subject|149
1807912|NCT00477633|6283762|P1|Overall Study|Lost to Follow-up|271
1807913|NCT00477633|6283762|P1|Overall Study|Pregnancy|23
1807914|NCT00477633|6283762|P1|Overall Study|Adverse Event|143
1807915|NCT00477633|6283762|P1|Overall Study|Did not receive treatment|23
1807916|NCT00477607|6283770|P2|Overall Study|Lost to Follow-up|7
1807917|NCT00477607|6283771|P1|Overall Study|Lost to Follow-up|7
1807918|NCT00477594|6283783|P2|Follow-up Period|Other|0
1807919|NCT00477594|6283784|P1|Follow-up Period|Other|1
1807920|NCT00477594|6283783|P2|Follow-up Period|Withdrawal by Subject|1
1807921|NCT00477594|6283784|P1|Follow-up Period|Withdrawal by Subject|2
1807922|NCT00477594|6283783|P2|Year 3|Withdrawal by Subject|0
1807923|NCT00477594|6283784|P1|Year 3|Withdrawal by Subject|1
1807924|NCT00477594|6283783|P2|Year 3|Adverse Event|0
1807925|NCT00477594|6283784|P1|Year 3|Adverse Event|1
1807926|NCT00477594|6283783|P2|Year 1 and Year 2|Other|0
1807927|NCT00477594|6283784|P1|Year 1 and Year 2|Other|1
1807928|NCT00477594|6283783|P2|Year 1 and Year 2|Withdrawal by Subject|1
1807929|NCT00477594|6283784|P1|Year 1 and Year 2|Withdrawal by Subject|2
1807930|NCT00477594|6283783|P2|Year 1 and Year 2|Physician Decision|1
1807931|NCT00477594|6283784|P1|Year 1 and Year 2|Physician Decision|2
1807932|NCT00477594|6283783|P2|Year 1 and Year 2|Adverse Event|2
1807933|NCT00477594|6283784|P1|Year 1 and Year 2|Adverse Event|4
1807934|NCT00477490|6283845|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
1807935|NCT00477490|6283846|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
1807936|NCT00477490|6283847|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
1807937|NCT00477490|6283848|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
1807938|NCT00477490|6283849|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
1807939|NCT00477490|6283850|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
1807940|NCT00477490|6283851|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
1807941|NCT00477490|6283852|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
1807942|NCT00477490|6283853|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
1807943|NCT00477490|6283845|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1807944|NCT00477490|6283846|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
1807945|NCT00477490|6283847|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1807946|NCT00477490|6283848|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
1807947|NCT00477490|6283849|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
1807948|NCT00477490|6283850|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
1807949|NCT00477490|6283851|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
1807950|NCT00477490|6283852|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
1807951|NCT00477490|6283853|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
1807952|NCT00477490|6283845|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807953|NCT00477490|6283846|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807954|NCT00477490|6283847|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807955|NCT00477490|6283848|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807956|NCT00477490|6283849|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807957|NCT00477490|6283850|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807958|NCT00477490|6283851|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807959|NCT00477490|6283852|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
1807960|NCT00477490|6283853|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
1807961|NCT00477490|6283845|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1807962|NCT00477490|6283846|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1807963|NCT00477490|6283847|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1807964|NCT00477490|6283848|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1807965|NCT00477490|6283849|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
1807966|NCT00477490|6283850|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1807967|NCT00477490|6283851|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1807968|NCT00477490|6283852|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1807969|NCT00477490|6283853|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
1807970|NCT00477490|6283845|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1807971|NCT00477490|6283846|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1807972|NCT00477490|6283847|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
1807973|NCT00477490|6283848|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1807974|NCT00477490|6283849|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
1807975|NCT00477490|6283850|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1807976|NCT00477490|6283851|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
1807977|NCT00477490|6283852|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
1807978|NCT00477490|6283853|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
1807979|NCT00477490|6283845|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
1807980|NCT00477490|6283846|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1807981|NCT00477490|6283847|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1807982|NCT00477490|6283848|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1807983|NCT00477490|6283849|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1807984|NCT00477490|6283850|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
1807985|NCT00477490|6283851|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
1807986|NCT00477490|6283852|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
1807987|NCT00477490|6283853|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
1807988|NCT00477490|6283845|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
1807989|NCT00477490|6283846|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
1807990|NCT00477490|6283847|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
1807991|NCT00477490|6283848|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
1807992|NCT00477490|6283849|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
1807993|NCT00477490|6283850|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
1807994|NCT00477490|6283851|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
1807995|NCT00477490|6283852|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
1807996|NCT00477490|6283853|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
1807997|NCT00477490|6283845|P9|Part I: 4 Week Efficacy|Not Reported|0
1807998|NCT00477490|6283846|P8|Part I: 4 Week Efficacy|Not Reported|0
1807999|NCT00477490|6283847|P7|Part I: 4 Week Efficacy|Not Reported|0
1808000|NCT00477490|6283848|P6|Part I: 4 Week Efficacy|Not Reported|0
1808001|NCT00477490|6283849|P5|Part I: 4 Week Efficacy|Not Reported|1
1808002|NCT00477490|6283850|P4|Part I: 4 Week Efficacy|Not Reported|0
1808003|NCT00477490|6283851|P3|Part I: 4 Week Efficacy|Not Reported|3
1808004|NCT00477490|6283852|P2|Part I: 4 Week Efficacy|Not Reported|2
1808005|NCT00477490|6283853|P1|Part I: 4 Week Efficacy|Not Reported|1
1808006|NCT00477490|6283845|P9|Part I: 4 Week Efficacy|Other, not specified|0
1808007|NCT00477490|6283846|P8|Part I: 4 Week Efficacy|Other, not specified|0
1808008|NCT00477490|6283847|P7|Part I: 4 Week Efficacy|Other, not specified|0
1808009|NCT00477490|6283848|P6|Part I: 4 Week Efficacy|Other, not specified|0
1808010|NCT00477490|6283849|P5|Part I: 4 Week Efficacy|Other, not specified|1
1808011|NCT00477490|6283850|P4|Part I: 4 Week Efficacy|Other, not specified|1
1808012|NCT00477490|6283851|P3|Part I: 4 Week Efficacy|Other, not specified|0
1808013|NCT00477490|6283852|P2|Part I: 4 Week Efficacy|Other, not specified|4
1808014|NCT00477490|6283853|P1|Part I: 4 Week Efficacy|Other, not specified|2
1808015|NCT00477490|6283845|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
1808016|NCT00477490|6283846|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
1808017|NCT00477490|6283847|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
1808018|NCT00477490|6283848|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
1808019|NCT00477490|6283849|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
1808020|NCT00477490|6283850|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
1808021|NCT00477490|6283851|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
1808022|NCT00477490|6283852|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
1808023|NCT00477490|6283853|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
1808024|NCT00477490|6283845|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1808025|NCT00477490|6283846|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1808026|NCT00477490|6283847|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1808027|NCT00477490|6283848|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
1808028|NCT00477490|6283849|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
1808029|NCT00477490|6283850|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
1808030|NCT00477490|6283851|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
1808031|NCT00477490|6283852|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
1808032|NCT00477490|6283853|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
1808033|NCT00477490|6283845|P9|Part I: 4 Week Efficacy|Protocol Violation|0
1808034|NCT00477490|6283846|P8|Part I: 4 Week Efficacy|Protocol Violation|0
1808035|NCT00477490|6283847|P7|Part I: 4 Week Efficacy|Protocol Violation|0
1808036|NCT00477490|6283848|P6|Part I: 4 Week Efficacy|Protocol Violation|0
1808037|NCT00477490|6283849|P5|Part I: 4 Week Efficacy|Protocol Violation|1
1808038|NCT00477490|6283850|P4|Part I: 4 Week Efficacy|Protocol Violation|0
1808039|NCT00477490|6283851|P3|Part I: 4 Week Efficacy|Protocol Violation|0
1808040|NCT00477490|6283852|P2|Part I: 4 Week Efficacy|Protocol Violation|0
1808041|NCT00477490|6283853|P1|Part I: 4 Week Efficacy|Protocol Violation|2
1808042|NCT00477490|6283845|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1808043|NCT00477490|6283846|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1808044|NCT00477490|6283847|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1808045|NCT00477490|6283848|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1808046|NCT00477490|6283849|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
1808047|NCT00477490|6283850|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
1808048|NCT00477490|6283851|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1808049|NCT00477490|6283852|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
1808050|NCT00477490|6283853|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
1808051|NCT00477490|6283845|P9|Part I: 4 Week Efficacy|Adverse Event|0
1808052|NCT00477490|6283846|P8|Part I: 4 Week Efficacy|Adverse Event|0
1808053|NCT00477490|6283847|P7|Part I: 4 Week Efficacy|Adverse Event|0
1808054|NCT00477490|6283848|P6|Part I: 4 Week Efficacy|Adverse Event|0
1808055|NCT00477490|6283849|P5|Part I: 4 Week Efficacy|Adverse Event|6
1808056|NCT00477490|6283850|P4|Part I: 4 Week Efficacy|Adverse Event|5
1808057|NCT00477490|6283851|P3|Part I: 4 Week Efficacy|Adverse Event|0
1808058|NCT00477490|6283852|P2|Part I: 4 Week Efficacy|Adverse Event|4
1808059|NCT00477490|6283853|P1|Part I: 4 Week Efficacy|Adverse Event|1
1808060|NCT00477464|6283937|P1|Overall Study|Completion of protocol-defined follow-up|14
1808061|NCT00477464|6283937|P1|Overall Study|Death|36
1808062|NCT00477464|6283937|P1|Overall Study|Lost to Follow-up|1
1808063|NCT00477386|6283981|P2|Overall Study|Withdrawal by Subject|0
1808064|NCT00477386|6283982|P1|Overall Study|Withdrawal by Subject|1
1808065|NCT00477386|6283981|P2|Overall Study|Physician Decision|0
1808066|NCT00477386|6283982|P1|Overall Study|Physician Decision|1
1808067|NCT00477386|6283981|P2|Overall Study|Other|2
1808068|NCT00477386|6283982|P1|Overall Study|Other|1
1808069|NCT00477386|6283981|P2|Overall Study|Disease progression, refractory|3
1808070|NCT00477386|6283982|P1|Overall Study|Disease progression, refractory|1
1808071|NCT00477386|6283981|P2|Overall Study|Disease progression, relapse|4
1808072|NCT00477386|6283982|P1|Overall Study|Disease progression, relapse|3
1808073|NCT00477386|6283981|P2|Overall Study|Adverse Event|8
1808074|NCT00477386|6283982|P1|Overall Study|Adverse Event|4
1808075|NCT00477334|6283992|P2|Overall Study|Protocol Violation|1
1808076|NCT00477334|6283993|P1|Overall Study|Protocol Violation|7
1808077|NCT00477334|6283992|P2|Overall Study|Administrative Problems|15
1808078|NCT00477334|6283993|P1|Overall Study|Administrative Problems|39
1808079|NCT00477334|6283992|P2|Overall Study|Lost to Follow-up|4
1808080|NCT00477334|6283993|P1|Overall Study|Lost to Follow-up|15
1808081|NCT00477334|6283992|P2|Overall Study|Withdrawal by Subject|1
1808082|NCT00477334|6283993|P1|Overall Study|Withdrawal by Subject|2
1808083|NCT00477334|6283992|P2|Overall Study|Adverse Event|2
1808084|NCT00477334|6283993|P1|Overall Study|Adverse Event|1
1808085|NCT00477334|6283992|P2|Overall Study|Discontinued prior to taking study drug|53
1808086|NCT00477334|6283993|P1|Overall Study|Discontinued prior to taking study drug|106
1808087|NCT00477295|6284019|P2|Overall Study|Other|3
1808088|NCT00477295|6284020|P1|Overall Study|Other|4
1808089|NCT00477295|6284019|P2|Overall Study|Lost to Follow-up|11
1808090|NCT00477295|6284020|P1|Overall Study|Lost to Follow-up|21
1808091|NCT00477295|6284019|P2|Overall Study|Physician Decision|5
1808092|NCT00477295|6284020|P1|Overall Study|Physician Decision|4
1808093|NCT00477295|6284019|P2|Overall Study|Protocol Violation|8
1808094|NCT00477295|6284020|P1|Overall Study|Protocol Violation|3
1808095|NCT00477295|6284019|P2|Overall Study|Lack of Efficacy|23
1808096|NCT00477295|6284020|P1|Overall Study|Lack of Efficacy|23
1808097|NCT00477295|6284019|P2|Overall Study|Withdrawal by Subject|24
1808098|NCT00477295|6284020|P1|Overall Study|Withdrawal by Subject|35
1808099|NCT00477295|6284019|P2|Overall Study|Adverse Event|35
1808100|NCT00477295|6284020|P1|Overall Study|Adverse Event|31
1808101|NCT00477269|6284048|P3|Open Label Extension|Death|4
1808102|NCT00477269|6284049|P2|Open Label Extension|Death|0
1808103|NCT00477269|6284050|P1|Open Label Extension|Death|0
1808104|NCT00477269|6284048|P3|Open Label Extension|Adminiatrative problems|2
1808105|NCT00477269|6284049|P2|Open Label Extension|Adminiatrative problems|0
1808106|NCT00477269|6284050|P1|Open Label Extension|Adminiatrative problems|0
1808107|NCT00477269|6284048|P3|Open Label Extension|unsatisfactory therapeutic effects|2
1808108|NCT00477269|6284049|P2|Open Label Extension|unsatisfactory therapeutic effects|0
1808109|NCT00477269|6284050|P1|Open Label Extension|unsatisfactory therapeutic effects|0
1808110|NCT00477269|6284048|P3|Open Label Extension|Abnormal laboratory values|1
1808111|NCT00477269|6284049|P2|Open Label Extension|Abnormal laboratory values|0
1808112|NCT00477269|6284050|P1|Open Label Extension|Abnormal laboratory values|0
1808113|NCT00477269|6284048|P3|Open Label Extension|Adverse Event|4
1808114|NCT00477269|6284049|P2|Open Label Extension|Adverse Event|0
1808115|NCT00477269|6284050|P1|Open Label Extension|Adverse Event|0
1808116|NCT00477269|6284048|P3|Core Study|Withdrawn Consent|0
1808117|NCT00477269|6284049|P2|Core Study|Withdrawn Consent|1
1808118|NCT00477269|6284050|P1|Core Study|Withdrawn Consent|0
1808119|NCT00477269|6284048|P3|Core Study|Death|0
1808120|NCT00477269|6284049|P2|Core Study|Death|3
1808121|NCT00477269|6284050|P1|Core Study|Death|3
1808122|NCT00477269|6284048|P3|Core Study|Adverse Event|0
1808123|NCT00477269|6284049|P2|Core Study|Adverse Event|4
1808124|NCT00477269|6284050|P1|Core Study|Adverse Event|6
1808125|NCT00477165|6284129|P2|Overall Study|Adverse Event|2
1808126|NCT00477165|6284130|P1|Overall Study|Adverse Event|7
1808127|NCT00477152|6284142|P1|Overall Study|Adverse Event|1
1808128|NCT00477152|6284142|P1|Overall Study|Parent withdrew consent|2
1808129|NCT00476996|6284158|P4|OLE Phase (From Week 48)|Early termination of the study|578
1808130|NCT00476996|6284159|P3|OLE Phase (From Week 48)|Early termination of the study|0
1808131|NCT00476996|6284160|P2|OLE Phase (From Week 48)|Early termination of the study|0
1808132|NCT00476996|6284161|P1|OLE Phase (From Week 48)|Early termination of the study|0
1808133|NCT00476996|6284158|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
1808134|NCT00476996|6284159|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
1808135|NCT00476996|6284160|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
1808136|NCT00476996|6284161|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
1808137|NCT00476996|6284158|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
1808138|NCT00476996|6284159|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
1808139|NCT00476996|6284160|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
1808140|NCT00476996|6284161|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
1808141|NCT00476996|6284158|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
1808142|NCT00476996|6284159|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
1808143|NCT00476996|6284160|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
1808144|NCT00476996|6284161|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
1808145|NCT00476996|6284158|P4|OLE Phase (From Week 48)|Death|7
1808146|NCT00476996|6284159|P3|OLE Phase (From Week 48)|Death|0
1808147|NCT00476996|6284160|P2|OLE Phase (From Week 48)|Death|0
1808148|NCT00476996|6284161|P1|OLE Phase (From Week 48)|Death|0
1808149|NCT00476996|6284158|P4|OLE Phase (From Week 48)|Adverse Event|8
1808150|NCT00476996|6284159|P3|OLE Phase (From Week 48)|Adverse Event|0
1808151|NCT00476996|6284160|P2|OLE Phase (From Week 48)|Adverse Event|0
1808152|NCT00476996|6284161|P1|OLE Phase (From Week 48)|Adverse Event|0
1808153|NCT00476996|6284158|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
1808154|NCT00476996|6284159|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
1808155|NCT00476996|6284160|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
1808156|NCT00476996|6284161|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
1808157|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
1808158|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
1808159|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
1808160|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
1808161|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Death|0
1808162|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Death|1
1808163|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Death|1
1808164|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Death|2
1808165|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
1808166|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
1808167|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
1808168|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
1808169|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
1808170|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
1808171|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
1808172|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
1808173|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
1808174|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
1808175|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
1808176|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
1808177|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
1808178|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
1808179|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
1808180|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
1808181|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
1808182|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
1808183|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
1808184|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
1808185|NCT00476996|6284158|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
1808186|NCT00476996|6284159|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
1808187|NCT00476996|6284160|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
1808188|NCT00476996|6284161|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
1808189|NCT00476957|6284193|P2|Overall Study|Lost to Follow-up|193
1808190|NCT00476957|6284194|P1|Overall Study|Lost to Follow-up|176
1808191|NCT00476593|6284258|P4|Overall Study|Lost to Follow-up|22
1808192|NCT00476593|6284259|P3|Overall Study|Lost to Follow-up|8
1808193|NCT00476593|6284260|P2|Overall Study|Lost to Follow-up|2
1808194|NCT00476593|6284261|P1|Overall Study|Lost to Follow-up|10
1808195|NCT00476476|6284273|P2|Overall Study|Progressive Disease|17
1808196|NCT00476476|6284274|P1|Overall Study|Progressive Disease|0
1808197|NCT00476476|6284273|P2|Overall Study|Adverse Event|7
1808198|NCT00476476|6284274|P1|Overall Study|Adverse Event|2
1808199|NCT00476229|6284292|P1|Overall Study|Progressive shortness of breath|1
1808200|NCT00476151|6284298|P2|Overall Study|Physician Decision|2
1808201|NCT00476151|6284299|P1|Overall Study|Physician Decision|0
1808202|NCT00476151|6284298|P2|Overall Study|Withdrawal by Subject|0
1808203|NCT00476151|6284299|P1|Overall Study|Withdrawal by Subject|2
1808204|NCT00476151|6284298|P2|Overall Study|Protocol Violation|3
1808205|NCT00476151|6284299|P1|Overall Study|Protocol Violation|1
1808206|NCT00476151|6284298|P2|Overall Study|Adverse Event|2
1808207|NCT00476151|6284299|P1|Overall Study|Adverse Event|0
1808208|NCT00476086|6284305|P1|Overall Study|Progressive Disease|4
1808209|NCT00476086|6284305|P1|Overall Study|Alternative therapy|1
1808210|NCT00476047|6284311|P1|Overall Study|Lost to Follow-up|1
1808211|NCT00476008|6284337|P2|Overall Study|Death|0
1808212|NCT00476008|6284338|P1|Overall Study|Death|1
1808213|NCT00476008|6284337|P2|Overall Study|Withdrawal by Subject|1
1808214|NCT00476008|6284338|P1|Overall Study|Withdrawal by Subject|0
1808215|NCT00476008|6284337|P2|Overall Study|Physician Decision: Medication Noncompli|1
1808216|NCT00476008|6284338|P1|Overall Study|Physician Decision: Medication Noncompli|2
1808217|NCT00476008|6284337|P2|Overall Study|Placebo concerns|2
1808218|NCT00476008|6284338|P1|Overall Study|Placebo concerns|2
1808219|NCT00476008|6284337|P2|Overall Study|Adverse Event|4
1808220|NCT00476008|6284338|P1|Overall Study|Adverse Event|4
1808221|NCT00475982|6284364|P2|Overall Study|surgery rescheduled|3
1808222|NCT00475982|6284365|P1|Overall Study|surgery rescheduled|7
1808223|NCT00475865|6284413|P3|Overall Study|Other than above|0
1808224|NCT00475865|6284414|P2|Overall Study|Other than above|1
1808225|NCT00475865|6284415|P1|Overall Study|Other than above|0
1808226|NCT00475865|6284413|P3|Overall Study|Participant did not wish to continue|0
1808227|NCT00475865|6284414|P2|Overall Study|Participant did not wish to continue|0
1808228|NCT00475865|6284415|P1|Overall Study|Participant did not wish to continue|1
1808229|NCT00475865|6284413|P3|Overall Study|Progressive disease|2
1808230|NCT00475865|6284414|P2|Overall Study|Progressive disease|1
1808231|NCT00475865|6284415|P1|Overall Study|Progressive disease|0
1808232|NCT00475865|6284413|P3|Overall Study|Lack of Efficacy|0
1808233|NCT00475865|6284414|P2|Overall Study|Lack of Efficacy|0
1808234|NCT00475865|6284415|P1|Overall Study|Lack of Efficacy|1
1808235|NCT00475865|6284413|P3|Overall Study|Adverse Event|4
1808236|NCT00475865|6284414|P2|Overall Study|Adverse Event|3
1808237|NCT00475865|6284415|P1|Overall Study|Adverse Event|0
1808238|NCT00475852|6284445|P2|Overall Study|Lost to Follow-up|68
1808239|NCT00475852|6284446|P1|Overall Study|Lost to Follow-up|54
1808240|NCT00475852|6284445|P2|Overall Study|Withdrawal by Subject|24
1808241|NCT00475852|6284446|P1|Overall Study|Withdrawal by Subject|19
1808242|NCT00475852|6284445|P2|Overall Study|Death|456
1808243|NCT00475852|6284446|P1|Overall Study|Death|444
1808244|NCT00475735|6284497|P6|Treatment Period 2|Withdrawal by Subject|0
1808245|NCT00475735|6284498|P5|Treatment Period 2|Withdrawal by Subject|1
1808246|NCT00475735|6284499|P4|Treatment Period 2|Withdrawal by Subject|0
1808247|NCT00475735|6284500|P3|Treatment Period 2|Withdrawal by Subject|0
1808248|NCT00475735|6284501|P2|Treatment Period 2|Withdrawal by Subject|0
1808249|NCT00475735|6284502|P1|Treatment Period 2|Withdrawal by Subject|0
1808250|NCT00475735|6284497|P6|Treatment Period 2|Lack of Efficacy|1
1808251|NCT00475735|6284498|P5|Treatment Period 2|Lack of Efficacy|0
1808252|NCT00475735|6284499|P4|Treatment Period 2|Lack of Efficacy|0
1808253|NCT00475735|6284500|P3|Treatment Period 2|Lack of Efficacy|0
1808254|NCT00475735|6284501|P2|Treatment Period 2|Lack of Efficacy|0
1808255|NCT00475735|6284502|P1|Treatment Period 2|Lack of Efficacy|0
1808256|NCT00475735|6284497|P6|Treatment Period 2|Adverse Event|0
1808257|NCT00475735|6284498|P5|Treatment Period 2|Adverse Event|0
1808258|NCT00475735|6284499|P4|Treatment Period 2|Adverse Event|2
1808259|NCT00475735|6284500|P3|Treatment Period 2|Adverse Event|0
1808260|NCT00475735|6284501|P2|Treatment Period 2|Adverse Event|1
1808261|NCT00475735|6284502|P1|Treatment Period 2|Adverse Event|0
1808262|NCT00475735|6284497|P6|Treatment Washout|Protocol Violation|0
1808263|NCT00475735|6284498|P5|Treatment Washout|Protocol Violation|0
1808264|NCT00475735|6284499|P4|Treatment Washout|Protocol Violation|0
1808265|NCT00475735|6284500|P3|Treatment Washout|Protocol Violation|0
1808266|NCT00475735|6284501|P2|Treatment Washout|Protocol Violation|1
1808267|NCT00475735|6284502|P1|Treatment Washout|Protocol Violation|0
1808268|NCT00475735|6284497|P6|Treatment Washout|Lost to Follow-up|0
1808269|NCT00475735|6284498|P5|Treatment Washout|Lost to Follow-up|0
1808270|NCT00475735|6284499|P4|Treatment Washout|Lost to Follow-up|0
1808271|NCT00475735|6284500|P3|Treatment Washout|Lost to Follow-up|0
1808272|NCT00475735|6284501|P2|Treatment Washout|Lost to Follow-up|1
1808273|NCT00475735|6284502|P1|Treatment Washout|Lost to Follow-up|0
1808274|NCT00475735|6284497|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
1808275|NCT00475735|6284498|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
1808276|NCT00475735|6284499|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
1808277|NCT00475735|6284500|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
1808278|NCT00475735|6284501|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
1808279|NCT00475735|6284502|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
1808280|NCT00475735|6284497|P6|Treatment Period 1|DC due to AE but continuing|2
1808281|NCT00475735|6284498|P5|Treatment Period 1|DC due to AE but continuing|2
1808282|NCT00475735|6284499|P4|Treatment Period 1|DC due to AE but continuing|1
1808283|NCT00475735|6284500|P3|Treatment Period 1|DC due to AE but continuing|0
1808284|NCT00475735|6284501|P2|Treatment Period 1|DC due to AE but continuing|0
1808285|NCT00475735|6284502|P1|Treatment Period 1|DC due to AE but continuing|0
1808286|NCT00475735|6284497|P6|Treatment Period 1|Withdrawal by Subject|0
1808287|NCT00475735|6284498|P5|Treatment Period 1|Withdrawal by Subject|0
1808288|NCT00475735|6284499|P4|Treatment Period 1|Withdrawal by Subject|0
1808289|NCT00475735|6284500|P3|Treatment Period 1|Withdrawal by Subject|0
1808290|NCT00475735|6284501|P2|Treatment Period 1|Withdrawal by Subject|1
1808291|NCT00475735|6284502|P1|Treatment Period 1|Withdrawal by Subject|1
1808292|NCT00475735|6284497|P6|Treatment Period 1|Protocol Violation|0
1808293|NCT00475735|6284498|P5|Treatment Period 1|Protocol Violation|0
1808294|NCT00475735|6284499|P4|Treatment Period 1|Protocol Violation|1
1808295|NCT00475735|6284500|P3|Treatment Period 1|Protocol Violation|0
1808296|NCT00475735|6284501|P2|Treatment Period 1|Protocol Violation|0
1808297|NCT00475735|6284502|P1|Treatment Period 1|Protocol Violation|0
1808298|NCT00475735|6284497|P6|Treatment Period 1|Lost to Follow-up|1
1808299|NCT00475735|6284498|P5|Treatment Period 1|Lost to Follow-up|0
1808300|NCT00475735|6284499|P4|Treatment Period 1|Lost to Follow-up|0
1808301|NCT00475735|6284500|P3|Treatment Period 1|Lost to Follow-up|0
1808302|NCT00475735|6284501|P2|Treatment Period 1|Lost to Follow-up|0
1808303|NCT00475735|6284502|P1|Treatment Period 1|Lost to Follow-up|0
1808304|NCT00475735|6284497|P6|Treatment Period 1|Lack of Efficacy|0
1808305|NCT00475735|6284498|P5|Treatment Period 1|Lack of Efficacy|0
1808306|NCT00475735|6284499|P4|Treatment Period 1|Lack of Efficacy|0
1808307|NCT00475735|6284500|P3|Treatment Period 1|Lack of Efficacy|0
1808308|NCT00475735|6284501|P2|Treatment Period 1|Lack of Efficacy|0
1808309|NCT00475735|6284502|P1|Treatment Period 1|Lack of Efficacy|1
1808310|NCT00475735|6284497|P6|Treatment Period 1|Adverse Event|0
1808311|NCT00475735|6284498|P5|Treatment Period 1|Adverse Event|0
1808312|NCT00475735|6284499|P4|Treatment Period 1|Adverse Event|0
1808313|NCT00475735|6284500|P3|Treatment Period 1|Adverse Event|0
1808314|NCT00475735|6284501|P2|Treatment Period 1|Adverse Event|0
1808315|NCT00475735|6284502|P1|Treatment Period 1|Adverse Event|2
1808316|NCT00475722|6284515|P2|Overall Study|Protocol Violation|0
1808317|NCT00475722|6284516|P1|Overall Study|Protocol Violation|3
1808318|NCT00475722|6284515|P2|Overall Study|Withdrawal by Subject|12
1808319|NCT00475722|6284516|P1|Overall Study|Withdrawal by Subject|12
1808320|NCT00475709|6284522|P1|Overall Study|Lost to Follow-up|21
1808321|NCT00475709|6284522|P1|Overall Study|Device Explant|6
1808322|NCT00475709|6284522|P1|Overall Study|Death|41
1808323|NCT00475709|6284522|P1|Overall Study|Did not meet eligibility criteria|8
1808324|NCT00475670|6284530|P2|Overall Study|Other|3
1808325|NCT00475670|6284531|P1|Overall Study|Other|0
1808326|NCT00475670|6284530|P2|Overall Study|Failure to Return|1
1808327|NCT00475670|6284531|P1|Overall Study|Failure to Return|0
1808328|NCT00475670|6284530|P2|Overall Study|Refused treatment|2
1808329|NCT00475670|6284531|P1|Overall Study|Refused treatment|0
1808330|NCT00475670|6284530|P2|Overall Study|Lack of Efficacy|34
1808331|NCT00475670|6284531|P1|Overall Study|Lack of Efficacy|3
1808332|NCT00475670|6284530|P2|Overall Study|Death|1
1808333|NCT00475670|6284531|P1|Overall Study|Death|0
1808334|NCT00475657|6284555|P1|Overall Study|Sponsor's Decision|3
1808335|NCT00475657|6284555|P1|Overall Study|Death|1
1808336|NCT00475644|6284563|P1|Overall Study|Protocol Violation|13
1808337|NCT00475423|6284628|P1|Overall Study|Lost to Follow-up|7
1808338|NCT00475423|6284628|P1|Overall Study|Reason not specified|1
1808339|NCT00475423|6284628|P1|Overall Study|Death|1
1808340|NCT00475423|6284628|P1|Overall Study|Lack of Efficacy|8
1808341|NCT00475423|6284628|P1|Overall Study|Withdrawal by Subject|6
1808342|NCT00475423|6284628|P1|Overall Study|Adverse Event|4
1808343|NCT00475423|6284628|P1|Overall Study|Protocol Violation|5
1808344|NCT00475306|6284674|P4|Overall Study|Protocol Violation|1
1808345|NCT00475306|6284675|P3|Overall Study|Protocol Violation|0
1808346|NCT00475306|6284676|P2|Overall Study|Protocol Violation|1
1808347|NCT00475306|6284677|P1|Overall Study|Protocol Violation|1
1808348|NCT00475228|6284708|P2|Overall Study|Lost to Follow-up|17
1808349|NCT00475228|6284709|P1|Overall Study|Lost to Follow-up|17
1808350|NCT00475176|6284748|P1|Overall Study|Protocol Violation|1
1808351|NCT00475176|6284748|P1|Overall Study|Withdrawal by Subject|1
1808352|NCT00475176|6284748|P1|Overall Study|Adverse Event|2
1808353|NCT00475033|6284788|P2|Toddler Dose|Lost to Follow-up|0
1808354|NCT00475033|6284789|P1|Toddler Dose|Lost to Follow-up|1
1808355|NCT00475033|6284788|P2|Toddler Dose|Failed to return|0
1808356|NCT00475033|6284789|P1|Toddler Dose|Failed to return|1
1808357|NCT00475033|6284788|P2|Toddler Dose|Parent or legal guardian request|0
1808358|NCT00475033|6284789|P1|Toddler Dose|Parent or legal guardian request|2
1808359|NCT00475033|6284788|P2|After the Infant Series|Other|1
1808360|NCT00475033|6284789|P1|After the Infant Series|Other|0
1808361|NCT00475033|6284788|P2|After the Infant Series|Lost to Follow-up|0
1808362|NCT00475033|6284789|P1|After the Infant Series|Lost to Follow-up|1
1808363|NCT00475033|6284788|P2|After the Infant Series|Protocol Violation|0
1808364|NCT00475033|6284789|P1|After the Infant Series|Protocol Violation|1
1808365|NCT00475033|6284788|P2|After the Infant Series|Failed to return|1
1808366|NCT00475033|6284789|P1|After the Infant Series|Failed to return|2
1808367|NCT00475033|6284788|P2|After the Infant Series|Parent or legal guardian request|2
1808368|NCT00475033|6284789|P1|After the Infant Series|Parent or legal guardian request|2
1808369|NCT00475033|6284788|P2|After the Infant Series|Adverse Event|4
1808370|NCT00475033|6284789|P1|After the Infant Series|Adverse Event|0
1808371|NCT00475033|6284788|P2|Infant Series|Adverse Event|2
1808372|NCT00475033|6284789|P1|Infant Series|Adverse Event|0
1808373|NCT00475033|6284788|P2|Infant Series|Lost to Follow-up|0
1808374|NCT00475033|6284789|P1|Infant Series|Lost to Follow-up|2
1808375|NCT00475033|6284788|P2|Infant Series|Protocol Violation|2
1808376|NCT00475033|6284789|P1|Infant Series|Protocol Violation|1
1808377|NCT00475033|6284788|P2|Infant Series|Parent or legal guardian request|5
1808378|NCT00475033|6284789|P1|Infant Series|Parent or legal guardian request|1
1808379|NCT00475033|6284788|P2|Infant Series|Failed to return|4
1808380|NCT00475033|6284789|P1|Infant Series|Failed to return|3
1808381|NCT00475020|6284837|P1|Overall Study|Donor not able to donate the last minute|1
1808382|NCT00475020|6284837|P1|Overall Study|Insurance Denial|1
1808383|NCT00475020|6284837|P1|Overall Study|Physician Decision|3
1808384|NCT00474994|6284842|P1|Overall Study|Patient found to be ineligible|1
1808385|NCT00474994|6284842|P1|Overall Study|Patient evaluable for toxicity only|3
1808386|NCT00474994|6284842|P1|Overall Study|Patient Not treated|1
1808387|NCT00474968|6284848|P2|Overall Study|Sample not collected|1
1808388|NCT00474968|6284849|P1|Overall Study|Sample not collected|1
1808389|NCT00474968|6284848|P2|Overall Study|Protocol Violation|8
1808390|NCT00474968|6284849|P1|Overall Study|Protocol Violation|9
1808391|NCT00474968|6284848|P2|Overall Study|Withdrawal by Subject|7
1808392|NCT00474968|6284849|P1|Overall Study|Withdrawal by Subject|8
1808393|NCT00474955|6284859|P1|Overall Study|Personal reasons|5
1808394|NCT00474955|6284859|P1|Overall Study|Drug unavailability|1
1808395|NCT00474955|6284859|P1|Overall Study|Adverse Event|2
1808396|NCT00474929|6284875|P5|Overall Study|Physician Decision|0
1808397|NCT00474929|6284876|P4|Overall Study|Physician Decision|2
1808398|NCT00474929|6284877|P3|Overall Study|Physician Decision|1
1808399|NCT00474929|6284878|P2|Overall Study|Physician Decision|0
1808400|NCT00474929|6284879|P1|Overall Study|Physician Decision|0
1808401|NCT00474929|6284875|P5|Overall Study|Unrelated medical condition|0
1808402|NCT00474929|6284876|P4|Overall Study|Unrelated medical condition|0
1808403|NCT00474929|6284877|P3|Overall Study|Unrelated medical condition|1
1808404|NCT00474929|6284878|P2|Overall Study|Unrelated medical condition|0
1808405|NCT00474929|6284879|P1|Overall Study|Unrelated medical condition|0
1808406|NCT00474929|6284875|P5|Overall Study|Withdrawal by Subject|0
1808407|NCT00474929|6284876|P4|Overall Study|Withdrawal by Subject|0
1808408|NCT00474929|6284877|P3|Overall Study|Withdrawal by Subject|0
1808409|NCT00474929|6284878|P2|Overall Study|Withdrawal by Subject|1
1808410|NCT00474929|6284879|P1|Overall Study|Withdrawal by Subject|0
1808411|NCT00474903|6284896|P3|Overall Study|Protocol Violation|2
1808412|NCT00474903|6284897|P2|Overall Study|Protocol Violation|5
1808413|NCT00474903|6284898|P1|Overall Study|Protocol Violation|1
1808414|NCT00474812|6284920|P1|Overall Study|No Initiation of treatment|2
1808415|NCT00474812|6284920|P1|Overall Study|Withdrawal by Subject|5
1808416|NCT00474786|6284930|P2|Overall Study|Other|0
1808417|NCT00474786|6284931|P1|Overall Study|Other|5
1808418|NCT00474786|6284930|P2|Overall Study|Withdrawal by Subject|15
1808419|NCT00474786|6284931|P1|Overall Study|Withdrawal by Subject|15
1808420|NCT00474786|6284930|P2|Overall Study|Protocol Violation|0
1808421|NCT00474786|6284931|P1|Overall Study|Protocol Violation|2
1808422|NCT00474786|6284930|P2|Overall Study|Lost to Follow-up|7
1808423|NCT00474786|6284931|P1|Overall Study|Lost to Follow-up|4
1808424|NCT00474786|6284930|P2|Overall Study|Discontinuation of Study by Sponsor|59
1808425|NCT00474786|6284931|P1|Overall Study|Discontinuation of Study by Sponsor|42
1808426|NCT00474786|6284930|P2|Overall Study|Death|170
1808427|NCT00474786|6284931|P1|Overall Study|Death|189
1808428|NCT00474786|6284930|P2|Overall Study|Investigator Request|1
1808429|NCT00474786|6284931|P1|Overall Study|Investigator Request|2
1808430|NCT00474786|6284930|P2|Overall Study|Not Meeting Study Criteria|1
1808431|NCT00474786|6284931|P1|Overall Study|Not Meeting Study Criteria|0
1808432|NCT00474760|6284956|P7|Overall Study|Terminated by sponsor|2
1808433|NCT00474760|6284957|P6|Overall Study|Terminated by sponsor|0
1808434|NCT00474760|6284958|P5|Overall Study|Terminated by sponsor|0
1808435|NCT00474760|6284959|P4|Overall Study|Terminated by sponsor|0
1808436|NCT00474760|6284960|P3|Overall Study|Terminated by sponsor|0
1808437|NCT00474760|6284961|P2|Overall Study|Terminated by sponsor|0
1808438|NCT00474760|6284962|P1|Overall Study|Terminated by sponsor|0
1808439|NCT00474760|6284956|P7|Overall Study|Progressive disease|7
1808440|NCT00474760|6284957|P6|Overall Study|Progressive disease|20
1808441|NCT00474760|6284958|P5|Overall Study|Progressive disease|8
1808442|NCT00474760|6284959|P4|Overall Study|Progressive disease|2
1808443|NCT00474760|6284960|P3|Overall Study|Progressive disease|3
1808444|NCT00474760|6284961|P2|Overall Study|Progressive disease|2
1808445|NCT00474760|6284962|P1|Overall Study|Progressive disease|3
1808446|NCT00474760|6284956|P7|Overall Study|Other|0
1808447|NCT00474760|6284957|P6|Overall Study|Other|0
1808448|NCT00474760|6284958|P5|Overall Study|Other|1
1808449|NCT00474760|6284959|P4|Overall Study|Other|0
1808450|NCT00474760|6284960|P3|Overall Study|Other|0
1808451|NCT00474760|6284961|P2|Overall Study|Other|1
1808452|NCT00474760|6284962|P1|Overall Study|Other|0
1808453|NCT00474760|6284956|P7|Overall Study|Withdrawal by Subject|1
1808454|NCT00474760|6284957|P6|Overall Study|Withdrawal by Subject|1
1808455|NCT00474760|6284958|P5|Overall Study|Withdrawal by Subject|0
1808456|NCT00474760|6284959|P4|Overall Study|Withdrawal by Subject|1
1808457|NCT00474760|6284960|P3|Overall Study|Withdrawal by Subject|0
1808458|NCT00474760|6284961|P2|Overall Study|Withdrawal by Subject|0
1808459|NCT00474760|6284962|P1|Overall Study|Withdrawal by Subject|0
1808460|NCT00474760|6284956|P7|Overall Study|Laboratory abnormality|0
1808461|NCT00474760|6284957|P6|Overall Study|Laboratory abnormality|1
1808462|NCT00474760|6284958|P5|Overall Study|Laboratory abnormality|0
1808463|NCT00474760|6284959|P4|Overall Study|Laboratory abnormality|0
1808464|NCT00474760|6284960|P3|Overall Study|Laboratory abnormality|0
1808465|NCT00474760|6284961|P2|Overall Study|Laboratory abnormality|0
1808466|NCT00474760|6284962|P1|Overall Study|Laboratory abnormality|0
1808467|NCT00474760|6284956|P7|Overall Study|Adverse Event|0
1808468|NCT00474760|6284957|P6|Overall Study|Adverse Event|7
1808469|NCT00474760|6284958|P5|Overall Study|Adverse Event|1
1808470|NCT00474760|6284959|P4|Overall Study|Adverse Event|0
1808471|NCT00474760|6284960|P3|Overall Study|Adverse Event|0
1808472|NCT00474760|6284961|P2|Overall Study|Adverse Event|0
1808473|NCT00474760|6284962|P1|Overall Study|Adverse Event|0
1808474|NCT00474760|6284956|P7|Overall Study|Death|0
1808475|NCT00474760|6284957|P6|Overall Study|Death|0
1808476|NCT00474760|6284958|P5|Overall Study|Death|2
1808477|NCT00474760|6284959|P4|Overall Study|Death|0
1808478|NCT00474760|6284960|P3|Overall Study|Death|0
1808479|NCT00474760|6284961|P2|Overall Study|Death|0
1808480|NCT00474760|6284962|P1|Overall Study|Death|0
1808481|NCT00474708|6285069|P2|Overall Study|Physician Decision|6
1808482|NCT00474708|6285070|P1|Overall Study|Physician Decision|9
1808483|NCT00474708|6285069|P2|Overall Study|Lost to Follow-up|9
1808484|NCT00474708|6285070|P1|Overall Study|Lost to Follow-up|18
1808485|NCT00474708|6285069|P2|Overall Study|Lack of compliance|4
1808486|NCT00474708|6285070|P1|Overall Study|Lack of compliance|12
1808487|NCT00474708|6285069|P2|Overall Study|Withdrawal by Subject|0
1808488|NCT00474708|6285070|P1|Overall Study|Withdrawal by Subject|7
1808489|NCT00474708|6285069|P2|Overall Study|Suicide ideation/behavior|1
1808490|NCT00474708|6285070|P1|Overall Study|Suicide ideation/behavior|0
1808491|NCT00474708|6285069|P2|Overall Study|Lack of Efficacy|5
1808492|NCT00474708|6285070|P1|Overall Study|Lack of Efficacy|11
1808493|NCT00474630|6285080|P2|Overall Study|Drug noncompliance, other|4
1808494|NCT00474630|6285081|P1|Overall Study|Drug noncompliance, other|11
1808495|NCT00474630|6285080|P2|Overall Study|Lack of Efficacy|6
1808496|NCT00474630|6285081|P1|Overall Study|Lack of Efficacy|5
1808497|NCT00474630|6285080|P2|Overall Study|Protocol Violation|4
1808498|NCT00474630|6285081|P1|Overall Study|Protocol Violation|3
1808499|NCT00474630|6285080|P2|Overall Study|Withdrawal by Subject|15
1808500|NCT00474630|6285081|P1|Overall Study|Withdrawal by Subject|21
1808501|NCT00474630|6285080|P2|Overall Study|Lost to Follow-up|15
1808502|NCT00474630|6285081|P1|Overall Study|Lost to Follow-up|22
1808503|NCT00474630|6285080|P2|Overall Study|Adverse Event|26
1808504|NCT00474630|6285081|P1|Overall Study|Adverse Event|98
1808505|NCT00474539|6285174|P2|Toddler Dose|Protocol Violation|0
1808506|NCT00474539|6285175|P1|Toddler Dose|Protocol Violation|1
1808507|NCT00474539|6285174|P2|After Infant Series|Withdrawal by Subject|0
1808508|NCT00474539|6285175|P1|After Infant Series|Withdrawal by Subject|1
1808509|NCT00474539|6285174|P2|After Infant Series|Lost to Follow-up|0
1808510|NCT00474539|6285175|P1|After Infant Series|Lost to Follow-up|3
1808511|NCT00474539|6285174|P2|Infant Series|Protocol Violation|1
1808512|NCT00474539|6285175|P1|Infant Series|Protocol Violation|0
1808513|NCT00474539|6285174|P2|Infant Series|Lost to Follow-up|1
1808514|NCT00474539|6285175|P1|Infant Series|Lost to Follow-up|2
1808515|NCT00474539|6285174|P2|Infant Series|Randomization error|0
1808516|NCT00474539|6285175|P1|Infant Series|Randomization error|5
1808517|NCT00474539|6285174|P2|Infant Series|Withdrawal by Subject|4
1808518|NCT00474539|6285175|P1|Infant Series|Withdrawal by Subject|3
1808519|NCT00474526|6285240|P17|Overall Study|Withdrawal by Subject|1
1808520|NCT00474526|6285241|P16|Overall Study|Withdrawal by Subject|1
1808521|NCT00474526|6285242|P15|Overall Study|Withdrawal by Subject|22
1808522|NCT00474526|6285243|P14|Overall Study|Withdrawal by Subject|37
1808523|NCT00474526|6285244|P13|Overall Study|Withdrawal by Subject|4
1808524|NCT00474526|6285245|P12|Overall Study|Withdrawal by Subject|4
1808525|NCT00474526|6285246|P11|Overall Study|Withdrawal by Subject|5
1808526|NCT00474526|6285247|P10|Overall Study|Withdrawal by Subject|13
1808527|NCT00474526|6285248|P9|Overall Study|Withdrawal by Subject|4
1808528|NCT00474526|6285249|P8|Overall Study|Withdrawal by Subject|4
1808529|NCT00474526|6285250|P7|Overall Study|Withdrawal by Subject|12
1808530|NCT00474526|6285251|P6|Overall Study|Withdrawal by Subject|6
1808531|NCT00474526|6285252|P5|Overall Study|Withdrawal by Subject|38
1808532|NCT00474526|6285253|P4|Overall Study|Withdrawal by Subject|52
1808533|NCT00474526|6285254|P3|Overall Study|Withdrawal by Subject|21
1808534|NCT00474526|6285255|P2|Overall Study|Withdrawal by Subject|24
1808535|NCT00474526|6285256|P1|Overall Study|Withdrawal by Subject|9
1808536|NCT00474526|6285240|P17|Overall Study|UNABLE TO CLASSIFY|1
1808537|NCT00474526|6285241|P16|Overall Study|UNABLE TO CLASSIFY|6
1808538|NCT00474526|6285242|P15|Overall Study|UNABLE TO CLASSIFY|12
1808539|NCT00474526|6285243|P14|Overall Study|UNABLE TO CLASSIFY|20
1808540|NCT00474526|6285244|P13|Overall Study|UNABLE TO CLASSIFY|0
1808541|NCT00474526|6285245|P12|Overall Study|UNABLE TO CLASSIFY|0
1808542|NCT00474526|6285246|P11|Overall Study|UNABLE TO CLASSIFY|0
1808543|NCT00474526|6285247|P10|Overall Study|UNABLE TO CLASSIFY|3
1808544|NCT00474526|6285248|P9|Overall Study|UNABLE TO CLASSIFY|0
1808545|NCT00474526|6285249|P8|Overall Study|UNABLE TO CLASSIFY|1
1808546|NCT00474526|6285250|P7|Overall Study|UNABLE TO CLASSIFY|0
1808547|NCT00474526|6285251|P6|Overall Study|UNABLE TO CLASSIFY|2
1808548|NCT00474526|6285252|P5|Overall Study|UNABLE TO CLASSIFY|3
1808549|NCT00474526|6285253|P4|Overall Study|UNABLE TO CLASSIFY|1
1808550|NCT00474526|6285254|P3|Overall Study|UNABLE TO CLASSIFY|0
1808551|NCT00474526|6285255|P2|Overall Study|UNABLE TO CLASSIFY|0
1808552|NCT00474526|6285256|P1|Overall Study|UNABLE TO CLASSIFY|1
1808553|NCT00474526|6285240|P17|Overall Study|Protocol Violation|2
1808554|NCT00474526|6285241|P16|Overall Study|Protocol Violation|6
1808555|NCT00474526|6285242|P15|Overall Study|Protocol Violation|9
1808556|NCT00474526|6285243|P14|Overall Study|Protocol Violation|19
1808557|NCT00474526|6285244|P13|Overall Study|Protocol Violation|4
1808558|NCT00474526|6285245|P12|Overall Study|Protocol Violation|2
1808559|NCT00474526|6285246|P11|Overall Study|Protocol Violation|2
1808560|NCT00474526|6285247|P10|Overall Study|Protocol Violation|4
1808561|NCT00474526|6285248|P9|Overall Study|Protocol Violation|0
1808562|NCT00474526|6285249|P8|Overall Study|Protocol Violation|0
1808563|NCT00474526|6285250|P7|Overall Study|Protocol Violation|3
1808564|NCT00474526|6285251|P6|Overall Study|Protocol Violation|1
1808565|NCT00474526|6285252|P5|Overall Study|Protocol Violation|3
1808566|NCT00474526|6285253|P4|Overall Study|Protocol Violation|12
1808567|NCT00474526|6285254|P3|Overall Study|Protocol Violation|4
1808568|NCT00474526|6285255|P2|Overall Study|Protocol Violation|6
1808569|NCT00474526|6285256|P1|Overall Study|Protocol Violation|2
1808570|NCT00474526|6285240|P17|Overall Study|Lost to Follow-up|5
1808571|NCT00474526|6285241|P16|Overall Study|Lost to Follow-up|4
1808572|NCT00474526|6285242|P15|Overall Study|Lost to Follow-up|29
1808573|NCT00474526|6285243|P14|Overall Study|Lost to Follow-up|74
1808574|NCT00474526|6285244|P13|Overall Study|Lost to Follow-up|6
1808575|NCT00474526|6285245|P12|Overall Study|Lost to Follow-up|4
1808576|NCT00474526|6285246|P11|Overall Study|Lost to Follow-up|2
1808577|NCT00474526|6285247|P10|Overall Study|Lost to Follow-up|6
1808578|NCT00474526|6285248|P9|Overall Study|Lost to Follow-up|0
1808579|NCT00474526|6285249|P8|Overall Study|Lost to Follow-up|1
1808580|NCT00474526|6285250|P7|Overall Study|Lost to Follow-up|8
1808581|NCT00474526|6285251|P6|Overall Study|Lost to Follow-up|5
1808582|NCT00474526|6285252|P5|Overall Study|Lost to Follow-up|11
1808583|NCT00474526|6285253|P4|Overall Study|Lost to Follow-up|29
1808584|NCT00474526|6285254|P3|Overall Study|Lost to Follow-up|13
1808585|NCT00474526|6285255|P2|Overall Study|Lost to Follow-up|6
1808586|NCT00474526|6285256|P1|Overall Study|Lost to Follow-up|8
1808587|NCT00474526|6285240|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808588|NCT00474526|6285241|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808589|NCT00474526|6285242|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
1808590|NCT00474526|6285243|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
1808591|NCT00474526|6285244|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808592|NCT00474526|6285245|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808593|NCT00474526|6285246|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808594|NCT00474526|6285247|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808595|NCT00474526|6285248|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808596|NCT00474526|6285249|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808597|NCT00474526|6285250|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808598|NCT00474526|6285251|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808599|NCT00474526|6285252|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
1808600|NCT00474526|6285253|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
1808601|NCT00474526|6285254|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808602|NCT00474526|6285255|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
1808603|NCT00474526|6285256|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
1808604|NCT00474526|6285240|P17|Overall Study|Death|0
1808605|NCT00474526|6285241|P16|Overall Study|Death|0
1808606|NCT00474526|6285242|P15|Overall Study|Death|0
1808607|NCT00474526|6285243|P14|Overall Study|Death|3
1808608|NCT00474526|6285244|P13|Overall Study|Death|0
1808609|NCT00474526|6285245|P12|Overall Study|Death|0
1808610|NCT00474526|6285246|P11|Overall Study|Death|0
1808611|NCT00474526|6285247|P10|Overall Study|Death|0
1808612|NCT00474526|6285248|P9|Overall Study|Death|0
1808613|NCT00474526|6285249|P8|Overall Study|Death|0
1808614|NCT00474526|6285250|P7|Overall Study|Death|0
1808615|NCT00474526|6285251|P6|Overall Study|Death|0
1808616|NCT00474526|6285252|P5|Overall Study|Death|0
1808617|NCT00474526|6285253|P4|Overall Study|Death|0
1808618|NCT00474526|6285254|P3|Overall Study|Death|0
1808619|NCT00474526|6285255|P2|Overall Study|Death|0
1808620|NCT00474526|6285256|P1|Overall Study|Death|0
1808621|NCT00474526|6285240|P17|Overall Study|Adverse Event|0
1808622|NCT00474526|6285241|P16|Overall Study|Adverse Event|1
1808623|NCT00474526|6285242|P15|Overall Study|Adverse Event|1
1808624|NCT00474526|6285243|P14|Overall Study|Adverse Event|0
1808625|NCT00474526|6285244|P13|Overall Study|Adverse Event|0
1808626|NCT00474526|6285245|P12|Overall Study|Adverse Event|0
1808627|NCT00474526|6285246|P11|Overall Study|Adverse Event|0
1808628|NCT00474526|6285247|P10|Overall Study|Adverse Event|0
1808629|NCT00474526|6285248|P9|Overall Study|Adverse Event|0
1808630|NCT00474526|6285249|P8|Overall Study|Adverse Event|0
1808631|NCT00474526|6285250|P7|Overall Study|Adverse Event|1
1808632|NCT00474526|6285251|P6|Overall Study|Adverse Event|1
1808633|NCT00474526|6285252|P5|Overall Study|Adverse Event|2
1808634|NCT00474526|6285253|P4|Overall Study|Adverse Event|4
1808635|NCT00474526|6285254|P3|Overall Study|Adverse Event|2
1808636|NCT00474526|6285255|P2|Overall Study|Adverse Event|0
1808637|NCT00474526|6285256|P1|Overall Study|Adverse Event|2
1808638|NCT00474526|6285240|P17|Overall Study|ADMINISTRATIVE REASON|0
1808639|NCT00474526|6285241|P16|Overall Study|ADMINISTRATIVE REASON|0
1808640|NCT00474526|6285242|P15|Overall Study|ADMINISTRATIVE REASON|2
1808641|NCT00474526|6285243|P14|Overall Study|ADMINISTRATIVE REASON|1
1808642|NCT00474526|6285244|P13|Overall Study|ADMINISTRATIVE REASON|1
1808643|NCT00474526|6285245|P12|Overall Study|ADMINISTRATIVE REASON|1
1808644|NCT00474526|6285246|P11|Overall Study|ADMINISTRATIVE REASON|1
1808645|NCT00474526|6285247|P10|Overall Study|ADMINISTRATIVE REASON|1
1808646|NCT00474526|6285248|P9|Overall Study|ADMINISTRATIVE REASON|2
1808647|NCT00474526|6285249|P8|Overall Study|ADMINISTRATIVE REASON|0
1808648|NCT00474526|6285250|P7|Overall Study|ADMINISTRATIVE REASON|1
1808649|NCT00474526|6285251|P6|Overall Study|ADMINISTRATIVE REASON|1
1808650|NCT00474526|6285252|P5|Overall Study|ADMINISTRATIVE REASON|9
1808651|NCT00474526|6285253|P4|Overall Study|ADMINISTRATIVE REASON|20
1808652|NCT00474526|6285254|P3|Overall Study|ADMINISTRATIVE REASON|9
1808653|NCT00474526|6285255|P2|Overall Study|ADMINISTRATIVE REASON|9
1808654|NCT00474526|6285256|P1|Overall Study|ADMINISTRATIVE REASON|11
1808655|NCT00474487|6285421|P4|Overall Study|Death|0
1808656|NCT00474487|6285422|P3|Overall Study|Death|0
1808657|NCT00474487|6285423|P2|Overall Study|Death|1
1808658|NCT00474487|6285424|P1|Overall Study|Death|0
1808659|NCT00474487|6285421|P4|Overall Study|Inappropriate enrollment|0
1808660|NCT00474487|6285422|P3|Overall Study|Inappropriate enrollment|7
1808661|NCT00474487|6285423|P2|Overall Study|Inappropriate enrollment|0
1808662|NCT00474487|6285424|P1|Overall Study|Inappropriate enrollment|4
1808663|NCT00474487|6285421|P4|Overall Study|Lost to Follow-up|0
1808664|NCT00474487|6285422|P3|Overall Study|Lost to Follow-up|7
1808665|NCT00474487|6285423|P2|Overall Study|Lost to Follow-up|1
1808666|NCT00474487|6285424|P1|Overall Study|Lost to Follow-up|20
1808667|NCT00474487|6285421|P4|Overall Study|Withdrawal by Subject|0
1808668|NCT00474487|6285422|P3|Overall Study|Withdrawal by Subject|0
1808669|NCT00474487|6285423|P2|Overall Study|Withdrawal by Subject|0
1808670|NCT00474487|6285424|P1|Overall Study|Withdrawal by Subject|6
1808671|NCT00474383|6285444|P2|Extension|Progressive Disease|5
1808672|NCT00474383|6285445|P1|Extension|Progressive Disease|0
1808673|NCT00474383|6285444|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
1808674|NCT00474383|6285445|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
1808675|NCT00474383|6285444|P2|Main Study|Other|0
1808676|NCT00474383|6285445|P1|Main Study|Other|1
1808677|NCT00474383|6285444|P2|Main Study|Progressive Disease|0
1808678|NCT00474383|6285445|P1|Main Study|Progressive Disease|23
1808679|NCT00474383|6285444|P2|Main Study|Symptomatic Deterioration|0
1808680|NCT00474383|6285445|P1|Main Study|Symptomatic Deterioration|1
1808681|NCT00474383|6285444|P2|Main Study|Adverse Event|0
1808682|NCT00474383|6285445|P1|Main Study|Adverse Event|11
1808683|NCT00474266|6285460|P4|Overall Study|Withdrawal by Subject|7
1808684|NCT00474266|6285461|P3|Overall Study|Withdrawal by Subject|4
1808685|NCT00474266|6285462|P2|Overall Study|Withdrawal by Subject|20
1808686|NCT00474266|6285463|P1|Overall Study|Withdrawal by Subject|7
1808687|NCT00474253|6285567|P2|Overall Study|Discharged prior to study completion|1
1808688|NCT00474253|6285568|P1|Overall Study|Discharged prior to study completion|0
1808689|NCT00474253|6285567|P2|Overall Study|Lost to Follow-up|0
1808690|NCT00474253|6285568|P1|Overall Study|Lost to Follow-up|1
1808691|NCT00474253|6285567|P2|Overall Study|Withdrew due to surgery-related issues|3
1808692|NCT00474253|6285568|P1|Overall Study|Withdrew due to surgery-related issues|0
1808693|NCT00474253|6285567|P2|Overall Study|Withdrew consent|0
1808694|NCT00474253|6285568|P1|Overall Study|Withdrew consent|2
1808695|NCT00474240|6285592|P6|Overall Study|Removed due to lab value|1
1808696|NCT00474240|6285593|P5|Overall Study|Removed due to lab value|0
1808697|NCT00474240|6285594|P4|Overall Study|Removed due to lab value|0
1808698|NCT00474240|6285595|P3|Overall Study|Removed due to lab value|0
1808699|NCT00474240|6285596|P2|Overall Study|Removed due to lab value|0
1808700|NCT00474240|6285597|P1|Overall Study|Removed due to lab value|0
1808701|NCT00474240|6285592|P6|Overall Study|Adverse Event|16
1808702|NCT00474240|6285593|P5|Overall Study|Adverse Event|5
1808703|NCT00474240|6285594|P4|Overall Study|Adverse Event|14
1808704|NCT00474240|6285595|P3|Overall Study|Adverse Event|9
1808705|NCT00474240|6285596|P2|Overall Study|Adverse Event|0
1808706|NCT00474240|6285597|P1|Overall Study|Adverse Event|0
1808707|NCT00474240|6285592|P6|Overall Study|Withdrawal by Subject|1
1808708|NCT00474240|6285593|P5|Overall Study|Withdrawal by Subject|3
1808709|NCT00474240|6285594|P4|Overall Study|Withdrawal by Subject|2
1808710|NCT00474240|6285595|P3|Overall Study|Withdrawal by Subject|0
1808711|NCT00474240|6285596|P2|Overall Study|Withdrawal by Subject|1
1808712|NCT00474240|6285597|P1|Overall Study|Withdrawal by Subject|1
1808713|NCT00474188|6285622|P1|Overall Study|Study discontinued by sponsor|5
1808714|NCT00474188|6285622|P1|Overall Study|Withdrawal by Subject|1
1808715|NCT00474175|6285632|P3|Overall Study|Administrative|0
1808716|NCT00474175|6285633|P2|Overall Study|Administrative|1
1808717|NCT00474175|6285634|P1|Overall Study|Administrative|0
1808718|NCT00474175|6285632|P3|Overall Study|Protocol Violation|1
1808719|NCT00474175|6285633|P2|Overall Study|Protocol Violation|2
1808720|NCT00474175|6285634|P1|Overall Study|Protocol Violation|0
1808721|NCT00474175|6285632|P3|Overall Study|Ineligible|1
1808722|NCT00474175|6285633|P2|Overall Study|Ineligible|3
1808723|NCT00474175|6285634|P1|Overall Study|Ineligible|1
1808724|NCT00474175|6285632|P3|Overall Study|Withdrawal by Subject|1
1808725|NCT00474175|6285633|P2|Overall Study|Withdrawal by Subject|1
1808726|NCT00474175|6285634|P1|Overall Study|Withdrawal by Subject|0
1808727|NCT00474175|6285632|P3|Overall Study|Lack of Efficacy|1
1808728|NCT00474175|6285633|P2|Overall Study|Lack of Efficacy|0
1808729|NCT00474175|6285634|P1|Overall Study|Lack of Efficacy|0
1808730|NCT00474058|6285698|P2|Overall Study|Other|0
1808731|NCT00474058|6285699|P1|Overall Study|Other|2
1808732|NCT00474058|6285698|P2|Overall Study|Withdrawal by Subject|7
1808733|NCT00474058|6285699|P1|Overall Study|Withdrawal by Subject|11
1808734|NCT00474058|6285698|P2|Overall Study|Lack of Efficacy|4
1808735|NCT00474058|6285699|P1|Overall Study|Lack of Efficacy|0
1808736|NCT00474058|6285698|P2|Overall Study|Adverse Event|6
1808737|NCT00474058|6285699|P1|Overall Study|Adverse Event|11
1808738|NCT00474045|6285713|P2|Overall Study|Withdrawal criteria|50
1808739|NCT00474045|6285714|P1|Overall Study|Withdrawal criteria|60
1808740|NCT00474045|6285713|P2|Overall Study|Withdrawal by Subject|18
1808741|NCT00474045|6285714|P1|Overall Study|Withdrawal by Subject|16
1808742|NCT00474045|6285713|P2|Overall Study|Protocol Violation|12
1808743|NCT00474045|6285714|P1|Overall Study|Protocol Violation|10
1808744|NCT00474045|6285713|P2|Overall Study|Lost to Follow-up|1
1808745|NCT00474045|6285714|P1|Overall Study|Lost to Follow-up|1
1808746|NCT00474045|6285713|P2|Overall Study|Lack of Efficacy|9
1808747|NCT00474045|6285714|P1|Overall Study|Lack of Efficacy|0
1808748|NCT00474045|6285713|P2|Overall Study|Unclassified|3
1808749|NCT00474045|6285714|P1|Overall Study|Unclassified|1
1808750|NCT00474045|6285713|P2|Overall Study|Adverse Event|8
1808751|NCT00474045|6285714|P1|Overall Study|Adverse Event|18
1808752|NCT00473889|6285814|P2|Overall Study|Withdrawal by Subject|0
1808753|NCT00473889|6285815|P1|Overall Study|Withdrawal by Subject|5
1808754|NCT00473889|6285814|P2|Overall Study|Trial Terminated|6
1808755|NCT00473889|6285815|P1|Overall Study|Trial Terminated|3
1808756|NCT00473889|6285814|P2|Overall Study|Physician Decision|5
1808757|NCT00473889|6285815|P1|Overall Study|Physician Decision|10
1808758|NCT00473889|6285814|P2|Overall Study|Lost to Follow-up|1
1808759|NCT00473889|6285815|P1|Overall Study|Lost to Follow-up|2
1808760|NCT00473889|6285814|P2|Overall Study|Lack of Efficacy|29
1808761|NCT00473889|6285815|P1|Overall Study|Lack of Efficacy|28
1808762|NCT00473889|6285814|P2|Overall Study|Protocol Violation|2
1808763|NCT00473889|6285815|P1|Overall Study|Protocol Violation|4
1808764|NCT00473889|6285814|P2|Overall Study|Adverse Event|17
1808765|NCT00473889|6285815|P1|Overall Study|Adverse Event|30
1808766|NCT00473889|6285814|P2|Overall Study|Did not receive study medication|4
1808767|NCT00473889|6285815|P1|Overall Study|Did not receive study medication|1
1808768|NCT00473876|6285827|P2|Overall Study|Lost to Follow-up|1
1808769|NCT00473876|6285828|P1|Overall Study|Lost to Follow-up|3
1808770|NCT00473824|6285847|P2|Overall Study|Withdrawal by physician|0
1808771|NCT00473824|6285848|P1|Overall Study|Withdrawal by physician|1
1808772|NCT00473824|6285847|P2|Overall Study|Lost to Follow-up|0
1808773|NCT00473824|6285848|P1|Overall Study|Lost to Follow-up|1
1808774|NCT00473824|6285847|P2|Overall Study|Death|0
1808775|NCT00473824|6285848|P1|Overall Study|Death|1
1808776|NCT00473824|6285847|P2|Overall Study|Adverse Event|0
1808777|NCT00473824|6285848|P1|Overall Study|Adverse Event|1
1808778|NCT00473824|6285847|P2|Overall Study|Virologic Breakthrough|0
1808779|NCT00473824|6285848|P1|Overall Study|Virologic Breakthrough|1
1808780|NCT00473746|6285859|P5|Period 2 (Phase 2)|Reason not specified|3
1808781|NCT00473746|6285860|P4|Period 2 (Phase 2)|Reason not specified|0
1808782|NCT00473746|6285861|P3|Period 2 (Phase 2)|Reason not specified|0
1808783|NCT00473746|6285862|P2|Period 2 (Phase 2)|Reason not specified|0
1808784|NCT00473746|6285863|P1|Period 2 (Phase 2)|Reason not specified|0
1808785|NCT00473746|6285859|P5|Period 2 (Phase 2)|Progressive Disease|20
1808786|NCT00473746|6285860|P4|Period 2 (Phase 2)|Progressive Disease|0
1808787|NCT00473746|6285861|P3|Period 2 (Phase 2)|Progressive Disease|0
1808788|NCT00473746|6285862|P2|Period 2 (Phase 2)|Progressive Disease|0
1808789|NCT00473746|6285863|P1|Period 2 (Phase 2)|Progressive Disease|0
1808790|NCT00473746|6285859|P5|Period 2 (Phase 2)|Death|1
1808791|NCT00473746|6285860|P4|Period 2 (Phase 2)|Death|0
1808792|NCT00473746|6285861|P3|Period 2 (Phase 2)|Death|0
1808793|NCT00473746|6285862|P2|Period 2 (Phase 2)|Death|0
1808794|NCT00473746|6285863|P1|Period 2 (Phase 2)|Death|0
1808795|NCT00473746|6285859|P5|Period 2 (Phase 2)|Adverse Event|3
1808796|NCT00473746|6285860|P4|Period 2 (Phase 2)|Adverse Event|0
1808797|NCT00473746|6285861|P3|Period 2 (Phase 2)|Adverse Event|0
1808798|NCT00473746|6285862|P2|Period 2 (Phase 2)|Adverse Event|0
1808799|NCT00473746|6285863|P1|Period 2 (Phase 2)|Adverse Event|0
1808800|NCT00473746|6285859|P5|Period 1 (Phase 1)|Reason not specified|0
1808801|NCT00473746|6285860|P4|Period 1 (Phase 1)|Reason not specified|0
1808802|NCT00473746|6285861|P3|Period 1 (Phase 1)|Reason not specified|0
1808803|NCT00473746|6285862|P2|Period 1 (Phase 1)|Reason not specified|1
1808804|NCT00473746|6285863|P1|Period 1 (Phase 1)|Reason not specified|0
1808805|NCT00473746|6285859|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
1808806|NCT00473746|6285860|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
1808807|NCT00473746|6285861|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
1808808|NCT00473746|6285862|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
1808809|NCT00473746|6285863|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
1808810|NCT00473746|6285859|P5|Period 1 (Phase 1)|Progressive Disease|0
1808811|NCT00473746|6285860|P4|Period 1 (Phase 1)|Progressive Disease|10
1808812|NCT00473746|6285861|P3|Period 1 (Phase 1)|Progressive Disease|6
1808813|NCT00473746|6285862|P2|Period 1 (Phase 1)|Progressive Disease|6
1808814|NCT00473746|6285863|P1|Period 1 (Phase 1)|Progressive Disease|5
1808815|NCT00473746|6285859|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
1808816|NCT00473746|6285860|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
1808817|NCT00473746|6285861|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
1808818|NCT00473746|6285862|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
1808819|NCT00473746|6285863|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
1808820|NCT00473746|6285859|P5|Period 1 (Phase 1)|Adverse Event|0
1808821|NCT00473746|6285860|P4|Period 1 (Phase 1)|Adverse Event|0
1808822|NCT00473746|6285861|P3|Period 1 (Phase 1)|Adverse Event|0
1808823|NCT00473746|6285862|P2|Period 1 (Phase 1)|Adverse Event|0
1808824|NCT00473746|6285863|P1|Period 1 (Phase 1)|Adverse Event|1
1808825|NCT00473694|6285912|P4|Overall Study|Lost to Follow-up|1
1808826|NCT00473694|6285913|P3|Overall Study|Lost to Follow-up|0
1808827|NCT00473694|6285914|P2|Overall Study|Lost to Follow-up|0
1808828|NCT00473694|6285915|P1|Overall Study|Lost to Follow-up|0
1808829|NCT00473694|6285912|P4|Overall Study|Participants did not receive treatment|6
1808830|NCT00473694|6285913|P3|Overall Study|Participants did not receive treatment|5
1808831|NCT00473694|6285914|P2|Overall Study|Participants did not receive treatment|3
1808832|NCT00473694|6285915|P1|Overall Study|Participants did not receive treatment|11
1808833|NCT00473694|6285912|P4|Overall Study|Adverse Event|0
1808834|NCT00473694|6285913|P3|Overall Study|Adverse Event|0
1808835|NCT00473694|6285914|P2|Overall Study|Adverse Event|1
1808836|NCT00473694|6285915|P1|Overall Study|Adverse Event|0
1808837|NCT00473668|6285956|P3|Overall Study|Other|4
1808838|NCT00473668|6285957|P2|Overall Study|Other|3
1808839|NCT00473668|6285958|P1|Overall Study|Other|2
1808840|NCT00473668|6285956|P3|Overall Study|Lost to Follow-up|6
1808841|NCT00473668|6285957|P2|Overall Study|Lost to Follow-up|4
1808842|NCT00473668|6285958|P1|Overall Study|Lost to Follow-up|0
1808843|NCT00473668|6285956|P3|Overall Study|Migrated/moved from study area|0
1808844|NCT00473668|6285957|P2|Overall Study|Migrated/moved from study area|2
1808845|NCT00473668|6285958|P1|Overall Study|Migrated/moved from study area|3
1808846|NCT00473668|6285956|P3|Overall Study|Withdrawal by Subject|0
1808847|NCT00473668|6285957|P2|Overall Study|Withdrawal by Subject|2
1808848|NCT00473668|6285958|P1|Overall Study|Withdrawal by Subject|0
1808849|NCT00473655|6286011|P3|Overall Study|Lost to Follow-up|8
1808850|NCT00473655|6286012|P2|Overall Study|Lost to Follow-up|5
1808851|NCT00473655|6286013|P1|Overall Study|Lost to Follow-up|9
1808852|NCT00473590|6286060|P2|Overall Study|Other|1
1808853|NCT00473590|6286061|P1|Overall Study|Other|0
1808854|NCT00473590|6286060|P2|Overall Study|Withdrawal by Subject|3
1808855|NCT00473590|6286061|P1|Overall Study|Withdrawal by Subject|5
1808856|NCT00473590|6286060|P2|Overall Study|Physician Decision|4
1808857|NCT00473590|6286061|P1|Overall Study|Physician Decision|2
1808858|NCT00473590|6286060|P2|Overall Study|Non–protocol-specified therapy|5
1808859|NCT00473590|6286061|P1|Overall Study|Non–protocol-specified therapy|7
1808860|NCT00473590|6286060|P2|Overall Study|Progression not resulting in death|20
1808861|NCT00473590|6286061|P1|Overall Study|Progression not resulting in death|24
1808862|NCT00473590|6286060|P2|Overall Study|Death|2
1808863|NCT00473590|6286061|P1|Overall Study|Death|4
1808864|NCT00473590|6286060|P2|Overall Study|Adverse Event|3
1808865|NCT00473590|6286061|P1|Overall Study|Adverse Event|3
1808866|NCT00473564|6286077|P1|Overall Study|robot surgery aborted in OR|23
1808867|NCT00473512|6286087|P5|Period 2 (Phase 2)|Other|0
1808868|NCT00473512|6286088|P4|Period 2 (Phase 2)|Other|3
1808869|NCT00473512|6286089|P3|Period 2 (Phase 2)|Other|0
1808870|NCT00473512|6286090|P2|Period 2 (Phase 2)|Other|0
1808871|NCT00473512|6286091|P1|Period 2 (Phase 2)|Other|1
1808872|NCT00473512|6286087|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
1808873|NCT00473512|6286088|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
1808874|NCT00473512|6286089|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
1808875|NCT00473512|6286090|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
1808876|NCT00473512|6286091|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
1808877|NCT00473512|6286087|P5|Period 2 (Phase 2)|Disease Progression|1
1808878|NCT00473512|6286088|P4|Period 2 (Phase 2)|Disease Progression|17
1808879|NCT00473512|6286089|P3|Period 2 (Phase 2)|Disease Progression|2
1808880|NCT00473512|6286090|P2|Period 2 (Phase 2)|Disease Progression|2
1808881|NCT00473512|6286091|P1|Period 2 (Phase 2)|Disease Progression|0
1808882|NCT00473512|6286087|P5|Period 2 (Phase 2)|Death|1
1808883|NCT00473512|6286088|P4|Period 2 (Phase 2)|Death|1
1808884|NCT00473512|6286089|P3|Period 2 (Phase 2)|Death|0
1808885|NCT00473512|6286090|P2|Period 2 (Phase 2)|Death|0
1808886|NCT00473512|6286091|P1|Period 2 (Phase 2)|Death|0
1808887|NCT00473512|6286087|P5|Period 2 (Phase 2)|Adverse Event|0
1808888|NCT00473512|6286088|P4|Period 2 (Phase 2)|Adverse Event|1
1808889|NCT00473512|6286089|P3|Period 2 (Phase 2)|Adverse Event|0
1808890|NCT00473512|6286090|P2|Period 2 (Phase 2)|Adverse Event|0
1808891|NCT00473512|6286091|P1|Period 2 (Phase 2)|Adverse Event|0
1808892|NCT00473512|6286087|P5|Period 1 (Phase 1)|Other|0
1808893|NCT00473512|6286088|P4|Period 1 (Phase 1)|Other|1
1808894|NCT00473512|6286089|P3|Period 1 (Phase 1)|Other|0
1808895|NCT00473512|6286090|P2|Period 1 (Phase 1)|Other|0
1808896|NCT00473512|6286091|P1|Period 1 (Phase 1)|Other|0
1808897|NCT00473512|6286087|P5|Period 1 (Phase 1)|Disease Progression|1
1808898|NCT00473512|6286088|P4|Period 1 (Phase 1)|Disease Progression|10
1808899|NCT00473512|6286089|P3|Period 1 (Phase 1)|Disease Progression|0
1808900|NCT00473512|6286090|P2|Period 1 (Phase 1)|Disease Progression|1
1808901|NCT00473512|6286091|P1|Period 1 (Phase 1)|Disease Progression|1
1808902|NCT00473512|6286087|P5|Period 1 (Phase 1)|Death|0
1808903|NCT00473512|6286088|P4|Period 1 (Phase 1)|Death|1
1808904|NCT00473512|6286089|P3|Period 1 (Phase 1)|Death|0
1808905|NCT00473512|6286090|P2|Period 1 (Phase 1)|Death|0
1808906|NCT00473512|6286091|P1|Period 1 (Phase 1)|Death|0
1808907|NCT00473512|6286087|P5|Period 1 (Phase 1)|Adverse Event|0
1808908|NCT00473512|6286088|P4|Period 1 (Phase 1)|Adverse Event|5
1808909|NCT00473512|6286089|P3|Period 1 (Phase 1)|Adverse Event|0
1808910|NCT00473512|6286090|P2|Period 1 (Phase 1)|Adverse Event|0
1808911|NCT00473512|6286091|P1|Period 1 (Phase 1)|Adverse Event|0
1808912|NCT00473434|6286149|P1|Overall Study|No longer required|1
1808913|NCT00473434|6286149|P1|Overall Study|Switching to trial medication|1
1808914|NCT00473434|6286149|P1|Overall Study|Ceased in favor of Paliperidone|1
1808915|NCT00473434|6286149|P1|Overall Study|Reason not specified|6
1808916|NCT00473434|6286149|P1|Overall Study|Safety evaluation|1
1808917|NCT00473434|6286149|P1|Overall Study|Patient was selling medication to others|1
1808918|NCT00473434|6286149|P1|Overall Study|Adverse Event|3
1808919|NCT00473434|6286149|P1|Overall Study|Lack of Efficacy|3
1808920|NCT00473434|6286149|P1|Overall Study|Compliance|3
1808921|NCT00473434|6286149|P1|Overall Study|Withdrawal by Subject|9
1808922|NCT00473434|6286149|P1|Overall Study|Physician Decision|3
1808923|NCT00473382|6286214|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
1808924|NCT00473382|6286215|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
1808925|NCT00473382|6286216|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
1808926|NCT00473382|6286214|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
1808927|NCT00473382|6286215|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
1808928|NCT00473382|6286216|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
1808929|NCT00473382|6286214|P3|Open-label Extension Through Month 60|Subject's Decision|6
1808930|NCT00473382|6286215|P2|Open-label Extension Through Month 60|Subject's Decision|1
1808931|NCT00473382|6286216|P1|Open-label Extension Through Month 60|Subject's Decision|7
1808932|NCT00473382|6286214|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
1808933|NCT00473382|6286215|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
1808934|NCT00473382|6286216|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
1808935|NCT00473382|6286214|P3|Open-label Extension Through Month 60|Death|4
1808936|NCT00473382|6286215|P2|Open-label Extension Through Month 60|Death|7
1808937|NCT00473382|6286216|P1|Open-label Extension Through Month 60|Death|1
1808938|NCT00473382|6286214|P3|Open-label Extension Through Month 60|Adverse Event|2
1808939|NCT00473382|6286215|P2|Open-label Extension Through Month 60|Adverse Event|0
1808940|NCT00473382|6286216|P1|Open-label Extension Through Month 60|Adverse Event|0
1808941|NCT00473382|6286214|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
1808942|NCT00473382|6286215|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
1808943|NCT00473382|6286216|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
1808944|NCT00473382|6286214|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
1808945|NCT00473382|6286215|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
1808946|NCT00473382|6286216|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
1808947|NCT00473382|6286214|P3|Open-label Extension Through Month 48|Subject's Decision|6
1808948|NCT00473382|6286215|P2|Open-label Extension Through Month 48|Subject's Decision|1
1808949|NCT00473382|6286216|P1|Open-label Extension Through Month 48|Subject's Decision|5
1808950|NCT00473382|6286214|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
1808951|NCT00473382|6286215|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
1808952|NCT00473382|6286216|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
1808953|NCT00473382|6286214|P3|Open-label Extension Through Month 48|Death|3
1808954|NCT00473382|6286215|P2|Open-label Extension Through Month 48|Death|3
1808955|NCT00473382|6286216|P1|Open-label Extension Through Month 48|Death|1
1808956|NCT00473382|6286214|P3|Open-label Extension Through Month 48|Adverse Event|1
1808957|NCT00473382|6286215|P2|Open-label Extension Through Month 48|Adverse Event|0
1808958|NCT00473382|6286216|P1|Open-label Extension Through Month 48|Adverse Event|0
1808959|NCT00473382|6286214|P3|Core Study|Subject's decision|10
1808960|NCT00473382|6286215|P2|Core Study|Subject's decision|11
1808961|NCT00473382|6286216|P1|Core Study|Subject's decision|12
1808962|NCT00473382|6286214|P3|Core Study|Subject needed other treatment|2
1808963|NCT00473382|6286215|P2|Core Study|Subject needed other treatment|3
1808964|NCT00473382|6286216|P1|Core Study|Subject needed other treatment|1
1808965|NCT00473382|6286214|P3|Core Study|Subject non-compliance|1
1808966|NCT00473382|6286215|P2|Core Study|Subject non-compliance|2
1808967|NCT00473382|6286216|P1|Core Study|Subject non-compliance|5
1808968|NCT00473382|6286214|P3|Core Study|Physician Decision|2
1808969|NCT00473382|6286215|P2|Core Study|Physician Decision|2
1808970|NCT00473382|6286216|P1|Core Study|Physician Decision|1
1808971|NCT00473382|6286214|P3|Core Study|Lost to Follow-up|3
1808972|NCT00473382|6286215|P2|Core Study|Lost to Follow-up|3
1808973|NCT00473382|6286216|P1|Core Study|Lost to Follow-up|3
1808974|NCT00473382|6286214|P3|Core Study|Death|10
1808975|NCT00473382|6286215|P2|Core Study|Death|5
1808976|NCT00473382|6286216|P1|Core Study|Death|3
1808977|NCT00473382|6286214|P3|Core Study|Adverse Event|1
1808978|NCT00473382|6286215|P2|Core Study|Adverse Event|1
1808979|NCT00473382|6286216|P1|Core Study|Adverse Event|3
1808980|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
1808981|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
1808982|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
1808983|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
1808984|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
1808985|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
1808986|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
1808987|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
1808988|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
1808989|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Subject's Decision|4
1808990|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Subject's Decision|3
1808991|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Subject's Decision|1
1808992|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Physician's Decision|3
1808993|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Physician's Decision|1
1808994|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Physician's Decision|2
1808995|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
1808996|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
1808997|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
1808998|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Death|1
1808999|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Death|2
1809000|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Death|2
1809001|NCT00473330|6286274|P3|Open-label Extension Through Month 60|Adverse Event|2
1809002|NCT00473330|6286275|P2|Open-label Extension Through Month 60|Adverse Event|0
1809003|NCT00473330|6286276|P1|Open-label Extension Through Month 60|Adverse Event|0
1809004|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
1809005|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
1809006|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
1809007|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
1809008|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
1809009|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
1809010|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
1809011|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
1809012|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
1809013|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Subject's Decision|3
1809014|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Subject's Decision|3
1809015|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Subject's Decision|1
1809016|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Physician's Decision|3
1809017|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Physician's Decision|1
1809018|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Physician's Decision|2
1809019|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
1809020|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
1809021|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
1809022|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Death|0
1809023|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Death|0
1809024|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Death|2
1809025|NCT00473330|6286274|P3|Open-label Extension Through Month 48|Adverse Event|2
1809026|NCT00473330|6286275|P2|Open-label Extension Through Month 48|Adverse Event|0
1809027|NCT00473330|6286276|P1|Open-label Extension Through Month 48|Adverse Event|0
1809028|NCT00473330|6286274|P3|Core Study|Subject's Decision|19
1809029|NCT00473330|6286275|P2|Core Study|Subject's Decision|8
1809030|NCT00473330|6286276|P1|Core Study|Subject's Decision|9
1809031|NCT00473330|6286274|P3|Core Study|Subject Required Other Therapy|3
1809032|NCT00473330|6286275|P2|Core Study|Subject Required Other Therapy|1
1809033|NCT00473330|6286276|P1|Core Study|Subject Required Other Therapy|0
1809034|NCT00473330|6286274|P3|Core Study|Subject Non-compliance|1
1809035|NCT00473330|6286275|P2|Core Study|Subject Non-compliance|2
1809036|NCT00473330|6286276|P1|Core Study|Subject Non-compliance|1
1809037|NCT00473330|6286274|P3|Core Study|Physician Decision|3
1809038|NCT00473330|6286275|P2|Core Study|Physician Decision|1
1809039|NCT00473330|6286276|P1|Core Study|Physician Decision|2
1809040|NCT00473330|6286274|P3|Core Study|Lost to Follow-up|10
1809041|NCT00473330|6286275|P2|Core Study|Lost to Follow-up|5
1809042|NCT00473330|6286276|P1|Core Study|Lost to Follow-up|5
1809043|NCT00473330|6286274|P3|Core Study|Death|4
1809044|NCT00473330|6286275|P2|Core Study|Death|4
1809045|NCT00473330|6286276|P1|Core Study|Death|6
1809046|NCT00473330|6286274|P3|Core Study|Adverse Event|1
1809047|NCT00473330|6286275|P2|Core Study|Adverse Event|4
1809048|NCT00473330|6286276|P1|Core Study|Adverse Event|4
1809049|NCT00473265|6286331|P1|Overall Study|Off treatment early|15
1809050|NCT00473265|6286331|P1|Overall Study|Unrelated adverse event|5
1809051|NCT00473083|6286343|P3|Overall Study|Adverse Event|0
1809052|NCT00473083|6286344|P2|Overall Study|Adverse Event|0
1809053|NCT00473083|6286345|P1|Overall Study|Adverse Event|1
1809054|NCT00472641|6286420|P1|Overall Study|Lost to Follow-up|1
1809055|NCT00472641|6286420|P1|Overall Study|Adverse Event|3
1809056|NCT00472641|6286420|P1|Overall Study|Lack of Efficacy|3
1809057|NCT00472446|6286440|P4|Overall Study|Questionnaires not returned|4
1809058|NCT00472446|6286441|P3|Overall Study|Questionnaires not returned|6
1809059|NCT00472446|6286442|P2|Overall Study|Questionnaires not returned|6
1809060|NCT00472446|6286443|P1|Overall Study|Questionnaires not returned|5
1809061|NCT00472446|6286440|P4|Overall Study|Reintervention|1
1809062|NCT00472446|6286441|P3|Overall Study|Reintervention|1
1809063|NCT00472446|6286442|P2|Overall Study|Reintervention|0
1809064|NCT00472446|6286443|P1|Overall Study|Reintervention|0
1809065|NCT00472446|6286440|P4|Overall Study|Protocol Violation|1
1809066|NCT00472446|6286441|P3|Overall Study|Protocol Violation|0
1809067|NCT00472446|6286442|P2|Overall Study|Protocol Violation|0
1809068|NCT00472446|6286443|P1|Overall Study|Protocol Violation|0
1809069|NCT00472420|6286473|P1|Follow-up Period|Protocol Violation|1
1809070|NCT00472420|6286473|P1|Follow-up Period|Lost to Follow-up|2
1809071|NCT00472420|6286473|P1|Follow-up Period|Physician Decision|9
1809072|NCT00472420|6286473|P1|Follow-up Period|Death|5
1809073|NCT00472420|6286473|P1|Induction Treatment Period|Death|3
1809074|NCT00472420|6286473|P1|Induction Treatment Period|Non-compliance|1
1809075|NCT00472420|6286473|P1|Induction Treatment Period|Adverse Event|3
1809076|NCT00472420|6286473|P1|Induction Treatment Period|Physician Decision|9
1809077|NCT00472303|6286481|P3|Maintenance Phase|Other|0
1809078|NCT00472303|6286482|P2|Maintenance Phase|Other|1
1809079|NCT00472303|6286483|P1|Maintenance Phase|Other|1
1809080|NCT00472303|6286481|P3|Maintenance Phase|Resolution of pain|1
1809081|NCT00472303|6286482|P2|Maintenance Phase|Resolution of pain|0
1809082|NCT00472303|6286483|P1|Maintenance Phase|Resolution of pain|0
1809083|NCT00472303|6286481|P3|Maintenance Phase|Trial medication non-compliant|1
1809084|NCT00472303|6286482|P2|Maintenance Phase|Trial medication non-compliant|0
1809085|NCT00472303|6286483|P1|Maintenance Phase|Trial medication non-compliant|0
1809086|NCT00472303|6286481|P3|Maintenance Phase|Withdrawal by Subject|3
1809087|NCT00472303|6286482|P2|Maintenance Phase|Withdrawal by Subject|7
1809088|NCT00472303|6286483|P1|Maintenance Phase|Withdrawal by Subject|6
1809089|NCT00472303|6286481|P3|Maintenance Phase|Lack of Efficacy|4
1809090|NCT00472303|6286482|P2|Maintenance Phase|Lack of Efficacy|2
1809091|NCT00472303|6286483|P1|Maintenance Phase|Lack of Efficacy|2
1809092|NCT00472303|6286481|P3|Maintenance Phase|Death|2
1809093|NCT00472303|6286482|P2|Maintenance Phase|Death|0
1809094|NCT00472303|6286483|P1|Maintenance Phase|Death|3
1809095|NCT00472303|6286481|P3|Maintenance Phase|Adverse Event|6
1809096|NCT00472303|6286482|P2|Maintenance Phase|Adverse Event|6
1809097|NCT00472303|6286483|P1|Maintenance Phase|Adverse Event|5
1809098|NCT00472303|6286481|P3|Discontinuations After Titration Phase|Other|0
1809099|NCT00472303|6286482|P2|Discontinuations After Titration Phase|Other|0
1809100|NCT00472303|6286483|P1|Discontinuations After Titration Phase|Other|5
1809101|NCT00472303|6286481|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
1809102|NCT00472303|6286482|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
1809103|NCT00472303|6286483|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
1809104|NCT00472303|6286481|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
1809105|NCT00472303|6286482|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
1809106|NCT00472303|6286483|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
1809107|NCT00472303|6286481|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
1809108|NCT00472303|6286482|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
1809109|NCT00472303|6286483|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
1809110|NCT00472303|6286481|P3|Discontinuations After Titration Phase|Adverse Event|0
1809111|NCT00472303|6286482|P2|Discontinuations After Titration Phase|Adverse Event|0
1809112|NCT00472303|6286483|P1|Discontinuations After Titration Phase|Adverse Event|6
1809113|NCT00472303|6286481|P3|Titration Phase|Other|0
1809114|NCT00472303|6286482|P2|Titration Phase|Other|1
1809115|NCT00472303|6286483|P1|Titration Phase|Other|3
1809116|NCT00472303|6286481|P3|Titration Phase|Trial Medication non-compliant|0
1809117|NCT00472303|6286482|P2|Titration Phase|Trial Medication non-compliant|1
1809118|NCT00472303|6286483|P1|Titration Phase|Trial Medication non-compliant|4
1809119|NCT00472303|6286481|P3|Titration Phase|Withdrawal by Subject|0
1809120|NCT00472303|6286482|P2|Titration Phase|Withdrawal by Subject|13
1809121|NCT00472303|6286483|P1|Titration Phase|Withdrawal by Subject|16
1809122|NCT00472303|6286481|P3|Titration Phase|Lack of Efficacy|0
1809123|NCT00472303|6286482|P2|Titration Phase|Lack of Efficacy|0
1809124|NCT00472303|6286483|P1|Titration Phase|Lack of Efficacy|10
1809125|NCT00472303|6286481|P3|Titration Phase|Death|0
1809126|NCT00472303|6286482|P2|Titration Phase|Death|2
1809127|NCT00472303|6286483|P1|Titration Phase|Death|4
1809128|NCT00472303|6286481|P3|Titration Phase|Adverse Event|0
1809129|NCT00472303|6286482|P2|Titration Phase|Adverse Event|12
1809130|NCT00472303|6286483|P1|Titration Phase|Adverse Event|22
1809131|NCT00472290|6286546|P1|Overall Study|Requirement for alternative therapy|7
1809132|NCT00472290|6286546|P1|Overall Study|Adverse Event|6
1809133|NCT00472290|6286546|P1|Overall Study|Withdrawal by Subject|5
1809134|NCT00472290|6286546|P1|Overall Study|Disease Progression|4
1809135|NCT00472290|6286546|P1|Overall Study|Lack of Efficacy|1
1809136|NCT00472290|6286546|P1|Overall Study|Lost to Follow-up|1
1809137|NCT00472290|6286546|P1|Overall Study|Death|3
1809138|NCT00472290|6286546|P1|Overall Study|Administrative Decision|37
1809139|NCT00472290|6286546|P1|Overall Study|Protocol Specified Criteria|7
1809140|NCT00472290|6286546|P1|Overall Study|Progression of Therapy-Related MDS|1
1809141|NCT00472199|6286558|P2|Overall Study|patient was asymptomatic|0
1809142|NCT00472199|6286559|P1|Overall Study|patient was asymptomatic|1
1809143|NCT00472199|6286558|P2|Overall Study|personal reason|1
1809144|NCT00472199|6286559|P1|Overall Study|personal reason|0
1809145|NCT00472199|6286558|P2|Overall Study|Withdrawal by Subject|5
1809146|NCT00472199|6286559|P1|Overall Study|Withdrawal by Subject|6
1809147|NCT00472199|6286558|P2|Overall Study|Protocol Violation|2
1809148|NCT00472199|6286559|P1|Overall Study|Protocol Violation|3
1809149|NCT00472199|6286558|P2|Overall Study|Lost to Follow-up|4
1809150|NCT00472199|6286559|P1|Overall Study|Lost to Follow-up|2
1809151|NCT00472199|6286558|P2|Overall Study|Lack of Efficacy|25
1809152|NCT00472199|6286559|P1|Overall Study|Lack of Efficacy|4
1809153|NCT00472199|6286558|P2|Overall Study|Adverse Event|23
1809154|NCT00472199|6286559|P1|Overall Study|Adverse Event|19
1809155|NCT00472082|6286625|P1|Overall Study|Study prematurely terminated|5
1809156|NCT00472030|6286647|P2|Overall Study|Physician Decision|0
1809157|NCT00472030|6286648|P1|Overall Study|Physician Decision|1
1809158|NCT00471822|6286664|P1|Overall Study|Protocol Violation|2
1809159|NCT00471718|6286672|P1|Overall Study|Withdrawal by Subject|1
1809160|NCT00471718|6286672|P1|Overall Study|disease progression|22
1809161|NCT00471718|6286672|P1|Overall Study|other complicating disease|1
1809162|NCT00471718|6286672|P1|Overall Study|Adverse Event|3
1809163|NCT00471536|6286700|P1|Overall Study|Withdrawal by Subject|1
1809164|NCT00471497|6286712|P3|Overall Study|Sub optimal response or treat. failure|0
1809165|NCT00471497|6286713|P2|Overall Study|Sub optimal response or treat. failure|3
1809166|NCT00471497|6286714|P1|Overall Study|Sub optimal response or treat. failure|8
1809167|NCT00471497|6286712|P3|Overall Study|Protocol Violation|5
1809168|NCT00471497|6286713|P2|Overall Study|Protocol Violation|3
1809169|NCT00471497|6286714|P1|Overall Study|Protocol Violation|3
1809170|NCT00471497|6286712|P3|Overall Study|Disease Progression|2
1809171|NCT00471497|6286713|P2|Overall Study|Disease Progression|2
1809172|NCT00471497|6286714|P1|Overall Study|Disease Progression|8
1809173|NCT00471497|6286712|P3|Overall Study|Death|0
1809174|NCT00471497|6286713|P2|Overall Study|Death|2
1809175|NCT00471497|6286714|P1|Overall Study|Death|0
1809176|NCT00471497|6286712|P3|Overall Study|Lost to Follow-up|1
1809177|NCT00471497|6286713|P2|Overall Study|Lost to Follow-up|2
1809178|NCT00471497|6286714|P1|Overall Study|Lost to Follow-up|1
1809179|NCT00471497|6286712|P3|Overall Study|Withdrawal by Subject|5
1809180|NCT00471497|6286713|P2|Overall Study|Withdrawal by Subject|5
1809181|NCT00471497|6286714|P1|Overall Study|Withdrawal by Subject|3
1809182|NCT00471497|6286712|P3|Overall Study|Condition no longer requires study drug|0
1809183|NCT00471497|6286713|P2|Overall Study|Condition no longer requires study drug|1
1809184|NCT00471497|6286714|P1|Overall Study|Condition no longer requires study drug|0
1809185|NCT00471497|6286712|P3|Overall Study|Abnormal Test Procedure|1
1809186|NCT00471497|6286713|P2|Overall Study|Abnormal Test Procedure|0
1809187|NCT00471497|6286714|P1|Overall Study|Abnormal Test Procedure|1
1809188|NCT00471497|6286712|P3|Overall Study|Abnormal Laboratory Value|4
1809189|NCT00471497|6286713|P2|Overall Study|Abnormal Laboratory Value|6
1809190|NCT00471497|6286714|P1|Overall Study|Abnormal Laboratory Value|3
1809191|NCT00471497|6286712|P3|Overall Study|Adverse Event|22
1809192|NCT00471497|6286713|P2|Overall Study|Adverse Event|11
1809193|NCT00471497|6286714|P1|Overall Study|Adverse Event|19
1809194|NCT00471445|6286724|P2|Overall Study|Protocol Violation|1
1809195|NCT00471445|6286725|P1|Overall Study|Protocol Violation|0
1809196|NCT00471445|6286724|P2|Overall Study|Ineligible|0
1809197|NCT00471445|6286725|P1|Overall Study|Ineligible|1
1809198|NCT00471445|6286724|P2|Overall Study|Withdrawal by Subject|1
1809199|NCT00471445|6286725|P1|Overall Study|Withdrawal by Subject|1
1809200|NCT00471354|6286738|P1|Overall Study|Patient/Caregiver Decision|12
1809201|NCT00471354|6286738|P1|Overall Study|Lack of Efficacy|5
1809202|NCT00471354|6286738|P1|Overall Study|Lost to Follow-up|3
1809203|NCT00471354|6286738|P1|Overall Study|Sponsor Decision|1
1809204|NCT00471354|6286738|P1|Overall Study|Physician Decision|4
1809205|NCT00471354|6286738|P1|Overall Study|Withdrawal by Subject|1
1809206|NCT00471354|6286738|P1|Overall Study|Protocol Violation|12
1809207|NCT00471354|6286738|P1|Overall Study|Adverse Event|13
1809208|NCT00471354|6286738|P1|Overall Study|Protocol Entry Criteria Not Met|1
1809209|NCT00471328|6286750|P2|Extension Phase|Administrative Problem|0
1809210|NCT00471328|6286751|P1|Extension Phase|Administrative Problem|1
1809211|NCT00471328|6286750|P2|Extension Phase|New cancer Therapy|0
1809212|NCT00471328|6286751|P1|Extension Phase|New cancer Therapy|1
1809213|NCT00471328|6286750|P2|Extension Phase|Disease Progression|44
1809214|NCT00471328|6286751|P1|Extension Phase|Disease Progression|32
1809215|NCT00471328|6286750|P2|Extension Phase|Treatment duration as per protocol|1
1809216|NCT00471328|6286751|P1|Extension Phase|Treatment duration as per protocol|0
1809217|NCT00471328|6286750|P2|Extension Phase|Protocol Deviation|1
1809218|NCT00471328|6286751|P1|Extension Phase|Protocol Deviation|3
1809219|NCT00471328|6286750|P2|Extension Phase|Death|7
1809220|NCT00471328|6286751|P1|Extension Phase|Death|1
1809221|NCT00471328|6286750|P2|Extension Phase|Withdrawal by Subject|2
1809222|NCT00471328|6286751|P1|Extension Phase|Withdrawal by Subject|0
1809223|NCT00471328|6286750|P2|Extension Phase|Adverse Event|12
1809224|NCT00471328|6286751|P1|Extension Phase|Adverse Event|3
1809225|NCT00471328|6286750|P2|Core Phase|Protocol Deviation|1
1809226|NCT00471328|6286751|P1|Core Phase|Protocol Deviation|0
1809227|NCT00471328|6286750|P2|Core Phase|Administrative Problem|1
1809228|NCT00471328|6286751|P1|Core Phase|Administrative Problem|0
1809229|NCT00471328|6286750|P2|Core Phase|Disease Progression|53
1809230|NCT00471328|6286751|P1|Core Phase|Disease Progression|78
1809231|NCT00471328|6286750|P2|Core Phase|Abnormal laboratory value|0
1809232|NCT00471328|6286751|P1|Core Phase|Abnormal laboratory value|1
1809233|NCT00471328|6286750|P2|Core Phase|Withdrawal by Subject|2
1809234|NCT00471328|6286751|P1|Core Phase|Withdrawal by Subject|2
1809235|NCT00471328|6286750|P2|Core Phase|Death|4
1809236|NCT00471328|6286751|P1|Core Phase|Death|8
1809237|NCT00471328|6286750|P2|Core Phase|Adverse Event|6
1809238|NCT00471328|6286751|P1|Core Phase|Adverse Event|18
1809239|NCT00471315|6286770|P1|Overall Study|Withdrawal by Subject|1
1809240|NCT00471315|6286770|P1|Overall Study|Adverse Event|7
1809241|NCT00471276|6286775|P1|Overall Study|Refused treatment|6
1809242|NCT00471276|6286775|P1|Overall Study|Other|3
1809243|NCT00471276|6286775|P1|Overall Study|Global deterioration of health status|1
1809244|NCT00471276|6286775|P1|Overall Study|Objective progression or relapse|54
1809245|NCT00471276|6286775|P1|Overall Study|Protocol Violation|1
1809246|NCT00471276|6286775|P1|Overall Study|Adverse Event|16
1809247|NCT00471276|6286775|P1|Overall Study|Death|2
1809248|NCT00471237|6286805|P7|Overall Study|Participant's decision|0
1809249|NCT00471237|6286806|P6|Overall Study|Participant's decision|1
1809250|NCT00471237|6286807|P5|Overall Study|Participant's decision|0
1809251|NCT00471237|6286808|P4|Overall Study|Participant's decision|0
1809252|NCT00471237|6286809|P3|Overall Study|Participant's decision|0
1809253|NCT00471237|6286810|P2|Overall Study|Participant's decision|0
1809254|NCT00471237|6286811|P1|Overall Study|Participant's decision|0
1809255|NCT00471237|6286805|P7|Overall Study|Participant shifted residence|0
1809256|NCT00471237|6286806|P6|Overall Study|Participant shifted residence|0
1809257|NCT00471237|6286807|P5|Overall Study|Participant shifted residence|1
1809258|NCT00471237|6286808|P4|Overall Study|Participant shifted residence|0
1809259|NCT00471237|6286809|P3|Overall Study|Participant shifted residence|0
1809260|NCT00471237|6286810|P2|Overall Study|Participant shifted residence|0
1809261|NCT00471237|6286811|P1|Overall Study|Participant shifted residence|0
1809262|NCT00471237|6286805|P7|Overall Study|Administration of prohibited medicine|0
1809263|NCT00471237|6286806|P6|Overall Study|Administration of prohibited medicine|0
1809264|NCT00471237|6286807|P5|Overall Study|Administration of prohibited medicine|1
1809265|NCT00471237|6286808|P4|Overall Study|Administration of prohibited medicine|0
1809266|NCT00471237|6286809|P3|Overall Study|Administration of prohibited medicine|0
1809267|NCT00471237|6286810|P2|Overall Study|Administration of prohibited medicine|0
1809268|NCT00471237|6286811|P1|Overall Study|Administration of prohibited medicine|0
1809269|NCT00471237|6286805|P7|Overall Study|Participant lost medication|0
1809270|NCT00471237|6286806|P6|Overall Study|Participant lost medication|0
1809271|NCT00471237|6286807|P5|Overall Study|Participant lost medication|1
1809272|NCT00471237|6286808|P4|Overall Study|Participant lost medication|0
1809273|NCT00471237|6286809|P3|Overall Study|Participant lost medication|0
1809274|NCT00471237|6286810|P2|Overall Study|Participant lost medication|0
1809275|NCT00471237|6286811|P1|Overall Study|Participant lost medication|0
1809276|NCT00471237|6286805|P7|Overall Study|High parathyroid hormone|0
1809277|NCT00471237|6286806|P6|Overall Study|High parathyroid hormone|0
1809278|NCT00471237|6286807|P5|Overall Study|High parathyroid hormone|0
1809279|NCT00471237|6286808|P4|Overall Study|High parathyroid hormone|0
1809280|NCT00471237|6286809|P3|Overall Study|High parathyroid hormone|1
1809281|NCT00471237|6286810|P2|Overall Study|High parathyroid hormone|0
1809282|NCT00471237|6286811|P1|Overall Study|High parathyroid hormone|0
1809283|NCT00471237|6286805|P7|Overall Study|Participant planned to travel to abraod|0
1809284|NCT00471237|6286806|P6|Overall Study|Participant planned to travel to abraod|1
1809285|NCT00471237|6286807|P5|Overall Study|Participant planned to travel to abraod|0
1809286|NCT00471237|6286808|P4|Overall Study|Participant planned to travel to abraod|0
1809287|NCT00471237|6286809|P3|Overall Study|Participant planned to travel to abraod|0
1809288|NCT00471237|6286810|P2|Overall Study|Participant planned to travel to abraod|0
1809289|NCT00471237|6286811|P1|Overall Study|Participant planned to travel to abraod|1
1809290|NCT00471237|6286805|P7|Overall Study|Early stopping due to non-efficacy|0
1809291|NCT00471237|6286806|P6|Overall Study|Early stopping due to non-efficacy|0
1809292|NCT00471237|6286807|P5|Overall Study|Early stopping due to non-efficacy|1
1809293|NCT00471237|6286808|P4|Overall Study|Early stopping due to non-efficacy|0
1809294|NCT00471237|6286809|P3|Overall Study|Early stopping due to non-efficacy|0
1809295|NCT00471237|6286810|P2|Overall Study|Early stopping due to non-efficacy|0
1809296|NCT00471237|6286811|P1|Overall Study|Early stopping due to non-efficacy|1
1809297|NCT00471237|6286805|P7|Overall Study|Met serum creatinine withdrawal criteria|0
1809298|NCT00471237|6286806|P6|Overall Study|Met serum creatinine withdrawal criteria|0
1809299|NCT00471237|6286807|P5|Overall Study|Met serum creatinine withdrawal criteria|0
1809300|NCT00471237|6286808|P4|Overall Study|Met serum creatinine withdrawal criteria|2
1809301|NCT00471237|6286809|P3|Overall Study|Met serum creatinine withdrawal criteria|2
1809302|NCT00471237|6286810|P2|Overall Study|Met serum creatinine withdrawal criteria|0
1809303|NCT00471237|6286811|P1|Overall Study|Met serum creatinine withdrawal criteria|1
1809304|NCT00471237|6286805|P7|Overall Study|Non-compliance|0
1809305|NCT00471237|6286806|P6|Overall Study|Non-compliance|0
1809306|NCT00471237|6286807|P5|Overall Study|Non-compliance|0
1809307|NCT00471237|6286808|P4|Overall Study|Non-compliance|1
1809308|NCT00471237|6286809|P3|Overall Study|Non-compliance|0
1809309|NCT00471237|6286810|P2|Overall Study|Non-compliance|1
1809310|NCT00471237|6286811|P1|Overall Study|Non-compliance|0
1809311|NCT00471237|6286805|P7|Overall Study|Sponsor terminated study|0
1809312|NCT00471237|6286806|P6|Overall Study|Sponsor terminated study|24
1809313|NCT00471237|6286807|P5|Overall Study|Sponsor terminated study|18
1809314|NCT00471237|6286808|P4|Overall Study|Sponsor terminated study|22
1809315|NCT00471237|6286809|P3|Overall Study|Sponsor terminated study|19
1809316|NCT00471237|6286810|P2|Overall Study|Sponsor terminated study|23
1809317|NCT00471237|6286811|P1|Overall Study|Sponsor terminated study|20
1809318|NCT00471237|6286805|P7|Overall Study|Withdrawal by Subject|2
1809319|NCT00471237|6286806|P6|Overall Study|Withdrawal by Subject|4
1809320|NCT00471237|6286807|P5|Overall Study|Withdrawal by Subject|7
1809321|NCT00471237|6286808|P4|Overall Study|Withdrawal by Subject|8
1809322|NCT00471237|6286809|P3|Overall Study|Withdrawal by Subject|5
1809323|NCT00471237|6286810|P2|Overall Study|Withdrawal by Subject|6
1809324|NCT00471237|6286811|P1|Overall Study|Withdrawal by Subject|8
1809325|NCT00471237|6286805|P7|Overall Study|Protocol Violation|1
1809326|NCT00471237|6286806|P6|Overall Study|Protocol Violation|4
1809327|NCT00471237|6286807|P5|Overall Study|Protocol Violation|2
1809328|NCT00471237|6286808|P4|Overall Study|Protocol Violation|2
1809329|NCT00471237|6286809|P3|Overall Study|Protocol Violation|3
1809330|NCT00471237|6286810|P2|Overall Study|Protocol Violation|6
1809331|NCT00471237|6286811|P1|Overall Study|Protocol Violation|3
1809332|NCT00471237|6286805|P7|Overall Study|Lost to Follow-up|0
1809333|NCT00471237|6286806|P6|Overall Study|Lost to Follow-up|0
1809334|NCT00471237|6286807|P5|Overall Study|Lost to Follow-up|3
1809335|NCT00471237|6286808|P4|Overall Study|Lost to Follow-up|2
1809336|NCT00471237|6286809|P3|Overall Study|Lost to Follow-up|0
1809337|NCT00471237|6286810|P2|Overall Study|Lost to Follow-up|1
1809338|NCT00471237|6286811|P1|Overall Study|Lost to Follow-up|1
1809339|NCT00471237|6286805|P7|Overall Study|Adverse Event|0
1809340|NCT00471237|6286806|P6|Overall Study|Adverse Event|5
1809341|NCT00471237|6286807|P5|Overall Study|Adverse Event|7
1809342|NCT00471237|6286808|P4|Overall Study|Adverse Event|8
1809343|NCT00471237|6286809|P3|Overall Study|Adverse Event|4
1809344|NCT00471237|6286810|P2|Overall Study|Adverse Event|5
1809345|NCT00471237|6286811|P1|Overall Study|Adverse Event|6
1809346|NCT00471146|6286961|P2|Overall Study|Other|5
1809347|NCT00471146|6286962|P1|Overall Study|Other|4
1809348|NCT00471146|6286961|P2|Overall Study|Randomized but not treated|8
1809349|NCT00471146|6286962|P1|Overall Study|Randomized but not treated|9
1809350|NCT00471146|6286961|P2|Overall Study|Global deterioration of health status|14
1809351|NCT00471146|6286962|P1|Overall Study|Global deterioration of health status|12
1809352|NCT00471146|6286961|P2|Overall Study|Objective progression or relapse|87
1809353|NCT00471146|6286962|P1|Overall Study|Objective progression or relapse|84
1809354|NCT00471146|6286961|P2|Overall Study|Protocol Violation|2
1809355|NCT00471146|6286962|P1|Overall Study|Protocol Violation|2
1809356|NCT00471146|6286961|P2|Overall Study|Lost to Follow-up|2
1809357|NCT00471146|6286962|P1|Overall Study|Lost to Follow-up|4
1809358|NCT00471146|6286961|P2|Overall Study|Death|12
1809359|NCT00471146|6286962|P1|Overall Study|Death|11
1809360|NCT00471146|6286961|P2|Overall Study|Withdrawal by Subject|11
1809361|NCT00471146|6286962|P1|Overall Study|Withdrawal by Subject|14
1809362|NCT00471146|6286961|P2|Overall Study|Adverse Event|33
1809363|NCT00471146|6286962|P1|Overall Study|Adverse Event|32
1809364|NCT00471107|6286987|P3|Overall Study|Technical problems/data loss|3
1809365|NCT00471107|6286988|P2|Overall Study|Technical problems/data loss|1
1809366|NCT00471107|6286989|P1|Overall Study|Technical problems/data loss|3
1809367|NCT00471081|6286999|P2|Extended Safety Follow-Up|Missing confirmed|1
1809368|NCT00471081|6287000|P1|Extended Safety Follow-Up|Missing confirmed|0
1809369|NCT00471081|6286999|P2|Extended Safety Follow-Up|Lost to Follow-up|8
1809370|NCT00471081|6287000|P1|Extended Safety Follow-Up|Lost to Follow-up|1
1809371|NCT00471081|6286999|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
1809372|NCT00471081|6287000|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
1809373|NCT00471081|6286999|P2|Active Phase|Lost health plan/insurance|8
1809374|NCT00471081|6287000|P1|Active Phase|Lost health plan/insurance|1
1809375|NCT00471081|6286999|P2|Active Phase|Lost to Follow-up|1
1809376|NCT00471081|6287000|P1|Active Phase|Lost to Follow-up|0
1809377|NCT00471081|6286999|P2|Active Phase|Withdrawal by Subject|3
1809378|NCT00471081|6287000|P1|Active Phase|Withdrawal by Subject|0
1809379|NCT00471081|6286999|P2|Active Phase|Protocol Violation|1
1809380|NCT00471081|6287000|P1|Active Phase|Protocol Violation|1
1809381|NCT00470847|6287046|P1|Overall Study|Pt still receiving treatment|1
1809382|NCT00470834|6287059|P2|Extension Period (24 Months)|Disease Progression|1
1809383|NCT00470834|6287060|P1|Extension Period (24 Months)|Disease Progression|0
1809384|NCT00470834|6287059|P2|Extension Period (24 Months)|Non-compliance|1
1809385|NCT00470834|6287060|P1|Extension Period (24 Months)|Non-compliance|0
1809386|NCT00470834|6287059|P2|Extension Period (24 Months)|Lost to Follow-up|1
1809387|NCT00470834|6287060|P1|Extension Period (24 Months)|Lost to Follow-up|0
1809388|NCT00470834|6287059|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
1809389|NCT00470834|6287060|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
1809390|NCT00470834|6287059|P2|Extension Period (24 Months)|Physician Decision|3
1809391|NCT00470834|6287060|P1|Extension Period (24 Months)|Physician Decision|4
1809392|NCT00470834|6287059|P2|Extension Period (24 Months)|Withdrawal by Subject|5
1809393|NCT00470834|6287060|P1|Extension Period (24 Months)|Withdrawal by Subject|2
1809394|NCT00470834|6287059|P2|Extension Period (24 Months)|Adverse Event|4
1809395|NCT00470834|6287060|P1|Extension Period (24 Months)|Adverse Event|3
1809396|NCT00470834|6287059|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
1809397|NCT00470834|6287060|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
1809398|NCT00470834|6287059|P2|Treatment Period (18 Months)|Lack of Efficacy|0
1809399|NCT00470834|6287060|P1|Treatment Period (18 Months)|Lack of Efficacy|1
1809400|NCT00470834|6287059|P2|Treatment Period (18 Months)|Non-compliance|0
1809401|NCT00470834|6287060|P1|Treatment Period (18 Months)|Non-compliance|1
1809402|NCT00470834|6287059|P2|Treatment Period (18 Months)|Lost to Follow-up|0
1809403|NCT00470834|6287060|P1|Treatment Period (18 Months)|Lost to Follow-up|1
1809404|NCT00470834|6287059|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
1809405|NCT00470834|6287060|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
1809406|NCT00470834|6287059|P2|Treatment Period (18 Months)|Protocol Violation|1
1809407|NCT00470834|6287060|P1|Treatment Period (18 Months)|Protocol Violation|3
1809408|NCT00470834|6287059|P2|Treatment Period (18 Months)|Physician Decision|4
1809409|NCT00470834|6287060|P1|Treatment Period (18 Months)|Physician Decision|4
1809410|NCT00470834|6287059|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
1809411|NCT00470834|6287060|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
1809412|NCT00470834|6287059|P2|Treatment Period (18 Months)|Adverse Event|6
1809413|NCT00470834|6287060|P1|Treatment Period (18 Months)|Adverse Event|7
1809414|NCT00470834|6287059|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
1809415|NCT00470834|6287060|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
1809416|NCT00470626|6287074|P1|Overall Study|Withdrawal by Subject|7
1809417|NCT00470626|6287074|P1|Overall Study|Lost to Follow-up|10
1809418|NCT00470535|6287116|P1|Overall Study|Other|2
1809419|NCT00470535|6287116|P1|Overall Study|Death|1
1809420|NCT00470535|6287116|P1|Overall Study|Adverse Event|1
1809421|NCT00470535|6287116|P1|Overall Study|Withdrawal by Subject|1
1809422|NCT00470535|6287116|P1|Overall Study|Disease Progression|13
1809423|NCT00470470|6287125|P1|Overall Study|Not treated|1
1809424|NCT00470470|6287125|P1|Overall Study|Death|2
1809425|NCT00470470|6287125|P1|Overall Study|Adverse Event|2
1809426|NCT00470418|6287132|P2|Overall Study|Withdrawal by Subject|0
1809427|NCT00470418|6287133|P1|Overall Study|Withdrawal by Subject|1
1809428|NCT00470366|6287154|P1|Overall Study|Poor compliance|1
1809429|NCT00470366|6287154|P1|Overall Study|Adverse Event|3
1809430|NCT00470275|6287165|P1|Overall Study|Withdrawal by Subject|2
1809431|NCT00470275|6287165|P1|Overall Study|Lack of Efficacy|7
1809432|NCT00470275|6287165|P1|Overall Study|Death|1
1809433|NCT00470262|6287171|P2|Overall Study|Withdrawal by Subject|0
1809434|NCT00470262|6287172|P1|Overall Study|Withdrawal by Subject|2
1809435|NCT00470184|6287180|P1|Overall Study|recurrence|1
1809436|NCT00470184|6287180|P1|Overall Study|other|5
1809437|NCT00470184|6287180|P1|Overall Study|Withdrawal by Subject|4
1809438|NCT00470184|6287180|P1|Overall Study|Adverse Event|3
1809439|NCT00470184|6287180|P1|Overall Study|disease Progression|4
1809440|NCT00470184|6287180|P1|Overall Study|Not treated (other)|1
1809441|NCT00470184|6287180|P1|Overall Study|Not Treated(became ineligible)|4
1809442|NCT00470158|6287192|P5|Overall Study|Protocol Violation|0
1809443|NCT00470158|6287193|P4|Overall Study|Protocol Violation|0
1809444|NCT00470158|6287194|P3|Overall Study|Protocol Violation|0
1809445|NCT00470158|6287195|P2|Overall Study|Protocol Violation|0
1809446|NCT00470158|6287196|P1|Overall Study|Protocol Violation|1
1809447|NCT00470158|6287192|P5|Overall Study|Lost to Follow-up|4
1809448|NCT00470158|6287193|P4|Overall Study|Lost to Follow-up|5
1809449|NCT00470158|6287194|P3|Overall Study|Lost to Follow-up|8
1809450|NCT00470158|6287195|P2|Overall Study|Lost to Follow-up|8
1809451|NCT00470158|6287196|P1|Overall Study|Lost to Follow-up|7
1809452|NCT00470158|6287192|P5|Overall Study|Death|2
1809453|NCT00470158|6287193|P4|Overall Study|Death|0
1809454|NCT00470158|6287194|P3|Overall Study|Death|0
1809455|NCT00470158|6287195|P2|Overall Study|Death|0
1809456|NCT00470158|6287196|P1|Overall Study|Death|0
1809457|NCT00470093|6287229|P1|Overall Study|Adverse Event|2
1809458|NCT00470067|6287236|P1|Overall Study|Disease Progression|6
1809459|NCT00470067|6287236|P1|Overall Study|Death|1
1809460|NCT00470054|6287240|P1|Overall Study|Ineligible|1
1809461|NCT00469898|6287256|P1|Overall Study|Decreased performance status|1
1809462|NCT00469898|6287256|P1|Overall Study|Disease progression|9
1809463|NCT00469898|6287256|P1|Overall Study|Death|4
1809464|NCT00469898|6287256|P1|Overall Study|Withdrawal by Subject|4
1809465|NCT00469898|6287256|P1|Overall Study|Adverse Event|7
1809466|NCT00469859|6287265|P2|Overall Study|Inevaluable|2
1809467|NCT00469859|6287266|P1|Overall Study|Inevaluable|0
1809468|NCT00469833|6287274|P1|Overall Study|No IV access|2
1809469|NCT00469612|6287286|P2|Overall Study|Study terminated before data collected|0
1809470|NCT00469612|6287287|P1|Overall Study|Study terminated before data collected|2
1809471|NCT00469456|6287314|P2|Overall Study|Withdrawal by Subject|1
1809472|NCT00469456|6287315|P1|Overall Study|Withdrawal by Subject|4
1809473|NCT00469456|6287314|P2|Overall Study|Protocol Violation|0
1809474|NCT00469456|6287315|P1|Overall Study|Protocol Violation|1
1809475|NCT00469456|6287314|P2|Overall Study|Adverse Event|3
1809476|NCT00469456|6287315|P1|Overall Study|Adverse Event|4
1809477|NCT00469209|6287344|P3|Overall Study|Adverse Event|1
1809478|NCT00469209|6287345|P2|Overall Study|Adverse Event|0
1809479|NCT00469209|6287346|P1|Overall Study|Adverse Event|1
1809480|NCT00469092|6287356|P2|Overall Study|Use of Corticosteroid|0
1809481|NCT00469092|6287357|P1|Overall Study|Use of Corticosteroid|1
1809482|NCT00469092|6287356|P2|Overall Study|Abnormal lab value|0
1809483|NCT00469092|6287357|P1|Overall Study|Abnormal lab value|1
1809484|NCT00469092|6287356|P2|Overall Study|Hypoglycaemic Episodes|1
1809485|NCT00469092|6287357|P1|Overall Study|Hypoglycaemic Episodes|1
1809486|NCT00469092|6287356|P2|Overall Study|Use of lipid lowering drug|0
1809487|NCT00469092|6287357|P1|Overall Study|Use of lipid lowering drug|1
1809488|NCT00469092|6287356|P2|Overall Study|Contraindication metformin/glimepiride|0
1809489|NCT00469092|6287357|P1|Overall Study|Contraindication metformin/glimepiride|1
1809490|NCT00469092|6287356|P2|Overall Study|Incorrectly Randomised|3
1809491|NCT00469092|6287357|P1|Overall Study|Incorrectly Randomised|4
1809492|NCT00469092|6287356|P2|Overall Study|Withdrawal Criteria|4
1809493|NCT00469092|6287357|P1|Overall Study|Withdrawal Criteria|3
1809494|NCT00469092|6287356|P2|Overall Study|Withdrawal by Subject|4
1809495|NCT00469092|6287357|P1|Overall Study|Withdrawal by Subject|4
1809496|NCT00469092|6287356|P2|Overall Study|Protocol Violation|3
1809497|NCT00469092|6287357|P1|Overall Study|Protocol Violation|3
1809498|NCT00469092|6287356|P2|Overall Study|Lost to Follow-up|2
1809499|NCT00469092|6287357|P1|Overall Study|Lost to Follow-up|1
1809500|NCT00469092|6287356|P2|Overall Study|Lack of Efficacy|0
1809501|NCT00469092|6287357|P1|Overall Study|Lack of Efficacy|1
1809502|NCT00469092|6287356|P2|Overall Study|Adverse Event|4
1809503|NCT00469092|6287357|P1|Overall Study|Adverse Event|5
1809504|NCT00469079|6287376|P3|Overall Study|Ineligible|0
1809505|NCT00469079|6287377|P2|Overall Study|Ineligible|1
1809506|NCT00469079|6287378|P1|Overall Study|Ineligible|0
1809507|NCT00469079|6287376|P3|Overall Study|Withdrawal by Subject|2
1809508|NCT00469079|6287377|P2|Overall Study|Withdrawal by Subject|2
1809509|NCT00469079|6287378|P1|Overall Study|Withdrawal by Subject|1
1809510|NCT00469079|6287376|P3|Overall Study|Lost to Follow-up|10
1809511|NCT00469079|6287377|P2|Overall Study|Lost to Follow-up|8
1809512|NCT00469079|6287378|P1|Overall Study|Lost to Follow-up|4
1809513|NCT00469079|6287376|P3|Overall Study|Adverse Event|2
1809514|NCT00469079|6287377|P2|Overall Study|Adverse Event|3
1809515|NCT00469079|6287378|P1|Overall Study|Adverse Event|1
1809516|NCT00469079|6287376|P3|Overall Study|Lack of Efficacy|5
1809517|NCT00469079|6287377|P2|Overall Study|Lack of Efficacy|8
1809518|NCT00469079|6287378|P1|Overall Study|Lack of Efficacy|3
1809519|NCT00468910|6287397|P2|Overall Study|Medical Contraindication|1
1809520|NCT00468910|6287398|P1|Overall Study|Medical Contraindication|0
1809521|NCT00468910|6287397|P2|Overall Study|Withdrawal by Subject|1
1809522|NCT00468910|6287398|P1|Overall Study|Withdrawal by Subject|2
1809523|NCT00468910|6287397|P2|Overall Study|Lost to Follow-up|1
1809524|NCT00468910|6287398|P1|Overall Study|Lost to Follow-up|2
1809525|NCT00468858|6287417|P3|Overall Study|Other|1
1809526|NCT00468858|6287418|P2|Overall Study|Other|0
1809527|NCT00468858|6287419|P1|Overall Study|Other|0
1809528|NCT00468858|6287417|P3|Overall Study|Lost to Follow-up|5
1809529|NCT00468858|6287418|P2|Overall Study|Lost to Follow-up|2
1809530|NCT00468858|6287419|P1|Overall Study|Lost to Follow-up|1
1809531|NCT00468858|6287417|P3|Overall Study|Relocation|3
1809532|NCT00468858|6287418|P2|Overall Study|Relocation|3
1809533|NCT00468858|6287419|P1|Overall Study|Relocation|1
1809534|NCT00468858|6287417|P3|Overall Study|Withdrawal by Subject|5
1809535|NCT00468858|6287418|P2|Overall Study|Withdrawal by Subject|4
1809536|NCT00468858|6287419|P1|Overall Study|Withdrawal by Subject|7
1809537|NCT00468858|6287417|P3|Overall Study|Adverse Event|0
1809538|NCT00468858|6287418|P2|Overall Study|Adverse Event|1
1809539|NCT00468858|6287419|P1|Overall Study|Adverse Event|0
1809540|NCT00468845|6287540|P3|Overall Study|Randomized, not treated|2
1809541|NCT00468845|6287541|P2|Overall Study|Randomized, not treated|4
1809542|NCT00468845|6287542|P1|Overall Study|Randomized, not treated|1
1809543|NCT00468845|6287540|P3|Overall Study|No longer willing to participate|10
1809544|NCT00468845|6287541|P2|Overall Study|No longer willing to participate|6
1809545|NCT00468845|6287542|P1|Overall Study|No longer willing to participate|5
1809546|NCT00468845|6287540|P3|Overall Study|Other|5
1809547|NCT00468845|6287541|P2|Overall Study|Other|9
1809548|NCT00468845|6287542|P1|Overall Study|Other|4
1809549|NCT00468845|6287540|P3|Overall Study|Lost to Follow-up|2
1809550|NCT00468845|6287541|P2|Overall Study|Lost to Follow-up|1
1809551|NCT00468845|6287542|P1|Overall Study|Lost to Follow-up|2
1809552|NCT00468845|6287540|P3|Overall Study|Adverse Event|11
1809553|NCT00468845|6287541|P2|Overall Study|Adverse Event|14
1809554|NCT00468845|6287542|P1|Overall Study|Adverse Event|9
1809555|NCT00468819|6287679|P3|Overall Study|Drop-outs (Treatment never received)|0
1809556|NCT00468819|6287680|P2|Overall Study|Drop-outs (Treatment never received)|0
1809557|NCT00468819|6287681|P1|Overall Study|Drop-outs (Treatment never received)|2
1809558|NCT00468819|6287679|P3|Overall Study|Lost to Follow-up|1
1809559|NCT00468819|6287680|P2|Overall Study|Lost to Follow-up|0
1809560|NCT00468819|6287681|P1|Overall Study|Lost to Follow-up|0
1809561|NCT00468819|6287679|P3|Overall Study|Withdrawal by Subject|1
1809562|NCT00468819|6287680|P2|Overall Study|Withdrawal by Subject|0
1809563|NCT00468819|6287681|P1|Overall Study|Withdrawal by Subject|4
1809564|NCT00468728|6287761|P2|Follow-up|mITT failure|31
1809565|NCT00468728|6287762|P1|Follow-up|mITT failure|34
1809566|NCT00468728|6287761|P2|Treatment|criteria for mITT population|11
1809567|NCT00468728|6287762|P1|Treatment|criteria for mITT population|4
1809568|NCT00468676|6287774|P2|Overall Study|Death|1
1809569|NCT00468676|6287775|P1|Overall Study|Death|2
1809570|NCT00468676|6287774|P2|Overall Study|Lost to Follow-up|11
1809571|NCT00468676|6287775|P1|Overall Study|Lost to Follow-up|14
1809572|NCT00468650|6287792|P1|Overall Study|Protocol Violation|1
1809573|NCT00468650|6287792|P1|Overall Study|Withdrawal by Subject|2
1809574|NCT00468650|6287792|P1|Overall Study|Lost to Follow-up|4
1809575|NCT00468585|6287840|P4|Overall Study|Withdrawal by Subject|1
1809576|NCT00468585|6287841|P3|Overall Study|Withdrawal by Subject|2
1809577|NCT00468585|6287842|P2|Overall Study|Withdrawal by Subject|0
1809578|NCT00468585|6287843|P1|Overall Study|Withdrawal by Subject|0
1809579|NCT00468585|6287840|P4|Overall Study|Adverse Event|0
1809580|NCT00468585|6287841|P3|Overall Study|Adverse Event|1
1809581|NCT00468585|6287842|P2|Overall Study|Adverse Event|0
1809582|NCT00468585|6287843|P1|Overall Study|Adverse Event|0
1809583|NCT00468585|6287840|P4|Overall Study|Patient found to be ineligible|0
1809584|NCT00468585|6287841|P3|Overall Study|Patient found to be ineligible|1
1809585|NCT00468585|6287842|P2|Overall Study|Patient found to be ineligible|0
1809586|NCT00468585|6287843|P1|Overall Study|Patient found to be ineligible|0
1809587|NCT00468585|6287840|P4|Overall Study|Patient not treated|0
1809588|NCT00468585|6287841|P3|Overall Study|Patient not treated|1
1809589|NCT00468585|6287842|P2|Overall Study|Patient not treated|0
1809590|NCT00468585|6287843|P1|Overall Study|Patient not treated|1
1809591|NCT00468559|6287855|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
1809592|NCT00468559|6287856|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
1809593|NCT00468559|6287857|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
1809594|NCT00468559|6287855|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
1809595|NCT00468559|6287856|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
1809596|NCT00468559|6287857|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
1809597|NCT00468559|6287855|P3|Open-label Treatment Phase|Withdrawal by Subject|0
1809598|NCT00468559|6287856|P2|Open-label Treatment Phase|Withdrawal by Subject|0
1809599|NCT00468559|6287857|P1|Open-label Treatment Phase|Withdrawal by Subject|4
1809600|NCT00468559|6287855|P3|Open-label Treatment Phase|Lack of Efficacy|0
1809601|NCT00468559|6287856|P2|Open-label Treatment Phase|Lack of Efficacy|0
1809602|NCT00468559|6287857|P1|Open-label Treatment Phase|Lack of Efficacy|9
1809603|NCT00468559|6287855|P3|Open-label Treatment Phase|Adverse Event|0
1809604|NCT00468559|6287856|P2|Open-label Treatment Phase|Adverse Event|0
1809605|NCT00468559|6287857|P1|Open-label Treatment Phase|Adverse Event|5
1809606|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Other|14
1809607|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Other|17
1809608|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
1809609|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
1809610|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Failure to return|2
1809611|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Failure to return|1
1809612|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Refused treatment|7
1809613|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Refused treatment|4
1809614|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
1809615|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
1809616|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
1809617|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
1809618|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Death|0
1809619|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Death|1
1809620|NCT00468546|6287885|P2|Week 24 to Week 104 Analysis|Adverse Event|5
1809621|NCT00468546|6287886|P1|Week 24 to Week 104 Analysis|Adverse Event|2
1809622|NCT00468546|6287885|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
1809623|NCT00468546|6287886|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
1809624|NCT00468546|6287885|P2|Week 24 Analysis|Went onto rescue therapy|0
1809625|NCT00468546|6287886|P1|Week 24 Analysis|Went onto rescue therapy|1
1809626|NCT00468546|6287885|P2|Week 24 Analysis|Due to clinical hold|0
1809627|NCT00468546|6287886|P1|Week 24 Analysis|Due to clinical hold|1
1809628|NCT00468546|6287885|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
1809629|NCT00468546|6287886|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
1809630|NCT00468546|6287885|P2|Week 24 Analysis|Rescue therapy|0
1809631|NCT00468546|6287886|P1|Week 24 Analysis|Rescue therapy|2
1809632|NCT00468546|6287885|P2|Week 24 Analysis|Failure to return|4
1809633|NCT00468546|6287886|P1|Week 24 Analysis|Failure to return|3
1809634|NCT00468546|6287885|P2|Week 24 Analysis|Adverse Event|8
1809635|NCT00468546|6287886|P1|Week 24 Analysis|Adverse Event|1
1809636|NCT00468546|6287885|P2|Week 24 Analysis|Refused treatment|5
1809637|NCT00468546|6287886|P1|Week 24 Analysis|Refused treatment|5
1809638|NCT00468546|6287885|P2|Week 24 Analysis|Lack of Efficacy|37
1809639|NCT00468546|6287886|P1|Week 24 Analysis|Lack of Efficacy|83
1809640|NCT00468481|6287916|P2|Overall Study|Other|0
1809641|NCT00468481|6287917|P1|Overall Study|Other|6
1809642|NCT00468481|6287916|P2|Overall Study|Non-Compliance|0
1809643|NCT00468481|6287917|P1|Overall Study|Non-Compliance|5
1809644|NCT00468481|6287916|P2|Overall Study|Moved out of area|1
1809645|NCT00468481|6287917|P1|Overall Study|Moved out of area|4
1809646|NCT00468481|6287916|P2|Overall Study|Egg Donor|0
1809647|NCT00468481|6287917|P1|Overall Study|Egg Donor|1
1809648|NCT00468481|6287916|P2|Overall Study|Prohibited Medication|1
1809649|NCT00468481|6287917|P1|Overall Study|Prohibited Medication|1
1809650|NCT00468481|6287916|P2|Overall Study|susp/diag malignant/premalignant disease|0
1809651|NCT00468481|6287917|P1|Overall Study|susp/diag malignant/premalignant disease|1
1809652|NCT00468481|6287916|P2|Overall Study|Withdrawal by Subject|3
1809653|NCT00468481|6287917|P1|Overall Study|Withdrawal by Subject|12
1809654|NCT00468481|6287916|P2|Overall Study|Protocol Violation|8
1809655|NCT00468481|6287917|P1|Overall Study|Protocol Violation|18
1809656|NCT00468481|6287916|P2|Overall Study|Pregnancy|0
1809657|NCT00468481|6287917|P1|Overall Study|Pregnancy|2
1809658|NCT00468481|6287916|P2|Overall Study|Lost to Follow-up|8
1809659|NCT00468481|6287917|P1|Overall Study|Lost to Follow-up|25
1809660|NCT00468481|6287916|P2|Overall Study|Adverse Event|3
1809661|NCT00468481|6287917|P1|Overall Study|Adverse Event|13
1809662|NCT00468312|6288017|P2|Overall Study|Did not meet protocol eligibility|1
1809663|NCT00468312|6288018|P1|Overall Study|Did not meet protocol eligibility|0
1809664|NCT00468312|6288017|P2|Overall Study|Protocol Violation|1
1809665|NCT00468312|6288018|P1|Overall Study|Protocol Violation|2
1809666|NCT00468312|6288017|P2|Overall Study|Withdrawal by Subject|1
1809667|NCT00468312|6288018|P1|Overall Study|Withdrawal by Subject|0
1809668|NCT00468312|6288017|P2|Overall Study|Lack of Efficacy|1
1809669|NCT00468312|6288018|P1|Overall Study|Lack of Efficacy|0
1809670|NCT00468312|6288017|P2|Overall Study|Adverse Event|1
1809671|NCT00468312|6288018|P1|Overall Study|Adverse Event|2
1809672|NCT00468299|6288034|P2|Overall Study|Withdrawal by Subject|1
1809673|NCT00468299|6288035|P1|Overall Study|Withdrawal by Subject|0
1809674|NCT00468286|6288045|P2|Overall Study|Physician Decision|1
1809675|NCT00468286|6288046|P1|Overall Study|Physician Decision|0
1809676|NCT00468286|6288045|P2|Overall Study|Withdrawal by Subject|3
1809677|NCT00468286|6288046|P1|Overall Study|Withdrawal by Subject|4
1809678|NCT00468286|6288045|P2|Overall Study|Protocol Violation|2
1809679|NCT00468286|6288046|P1|Overall Study|Protocol Violation|2
1809680|NCT00468286|6288045|P2|Overall Study|Adverse Event|6
1809681|NCT00468286|6288046|P1|Overall Study|Adverse Event|1
1809682|NCT00468169|6288078|P2|Overall Study|Withdrawal by Subject|0
1809683|NCT00468169|6288079|P1|Overall Study|Withdrawal by Subject|1
1809684|NCT00468143|6288095|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
1809685|NCT00468143|6288096|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
1809686|NCT00468143|6288095|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
1809687|NCT00468143|6288096|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
1809688|NCT00468104|6288110|P2|Second Intervention|discarded for malposition of chest tube|2
1809689|NCT00468104|6288111|P1|Second Intervention|discarded for malposition of chest tube|0
1809690|NCT00468104|6288110|P2|Second Intervention|Withdrawal by Subject|2
1809691|NCT00468104|6288111|P1|Second Intervention|Withdrawal by Subject|5
1809692|NCT00468104|6288110|P2|First Intervention|trapped lung|0
1809693|NCT00468104|6288111|P1|First Intervention|trapped lung|1
1809694|NCT00468104|6288110|P2|First Intervention|associated prolonged pneumothorax|0
1809695|NCT00468104|6288111|P1|First Intervention|associated prolonged pneumothorax|1
1809696|NCT00468104|6288110|P2|First Intervention|large lung mass with minimal effusion|0
1809697|NCT00468104|6288111|P1|First Intervention|large lung mass with minimal effusion|1
1809698|NCT00468104|6288110|P2|First Intervention|malposition/blocked chest tube tube|0
1809699|NCT00468104|6288111|P1|First Intervention|malposition/blocked chest tube tube|2
1809700|NCT00468104|6288110|P2|First Intervention|died within 3 weeks|0
1809701|NCT00468104|6288111|P1|First Intervention|died within 3 weeks|1
1809702|NCT00468104|6288110|P2|First Intervention|bleeding at chest tube site--first dose|0
1809703|NCT00468104|6288111|P1|First Intervention|bleeding at chest tube site--first dose|1
1809704|NCT00468104|6288110|P2|First Intervention|Protocol Violation|1
1809705|NCT00468104|6288111|P1|First Intervention|Protocol Violation|2
1809706|NCT00468052|6288128|P2|Overall Study|Protocol Violation|8
1809707|NCT00468052|6288129|P1|Overall Study|Protocol Violation|7
1809708|NCT00467961|6288147|P1|Overall Study|Disease Progression|2
1809709|NCT00467961|6288147|P1|Overall Study|Technical Failures|5
1809710|NCT00467896|6288151|P1|Overall Study|Patient had no improvement|1
1809711|NCT00467896|6288151|P1|Overall Study|Started inhaled Remodulin|1
1809712|NCT00467896|6288151|P1|Overall Study|Started intravenous prostacyclin|1
1809713|NCT00467896|6288151|P1|Overall Study|Mainly used Prodose not I-neb® device|1
1809714|NCT00467896|6288151|P1|Overall Study|Patient weaned off iloprost|1
1809715|NCT00467896|6288151|P1|Overall Study|Patient had atrial septostomy|1
1809716|NCT00467896|6288151|P1|Overall Study|Patient received transplant|2
1809717|NCT00467896|6288151|P1|Overall Study|Changed therapy|2
1809718|NCT00467896|6288151|P1|Overall Study|Non-compliance|3
1809719|NCT00467896|6288151|P1|Overall Study|Serious Adverse Event|13
1809720|NCT00467896|6288151|P1|Overall Study|Adverse Event|7
1809721|NCT00467896|6288151|P1|Overall Study|Consent Withdrawal|18
1809722|NCT00467870|6288177|P6|Overall Study|Other/Unknown|0
1809723|NCT00467870|6288178|P5|Overall Study|Other/Unknown|4
1809724|NCT00467870|6288179|P4|Overall Study|Other/Unknown|5
1809725|NCT00467870|6288180|P3|Overall Study|Other/Unknown|1
1809726|NCT00467870|6288181|P2|Overall Study|Other/Unknown|5
1809727|NCT00467870|6288182|P1|Overall Study|Other/Unknown|8
1809728|NCT00467870|6288177|P6|Overall Study|Subject Non-compliance|0
1809729|NCT00467870|6288178|P5|Overall Study|Subject Non-compliance|5
1809730|NCT00467870|6288179|P4|Overall Study|Subject Non-compliance|1
1809731|NCT00467870|6288180|P3|Overall Study|Subject Non-compliance|0
1809732|NCT00467870|6288181|P2|Overall Study|Subject Non-compliance|4
1809733|NCT00467870|6288182|P1|Overall Study|Subject Non-compliance|3
1809734|NCT00467870|6288177|P6|Overall Study|Lost to Follow-up|0
1809735|NCT00467870|6288178|P5|Overall Study|Lost to Follow-up|3
1809736|NCT00467870|6288179|P4|Overall Study|Lost to Follow-up|1
1809737|NCT00467870|6288180|P3|Overall Study|Lost to Follow-up|1
1809738|NCT00467870|6288181|P2|Overall Study|Lost to Follow-up|3
1809739|NCT00467870|6288182|P1|Overall Study|Lost to Follow-up|5
1809740|NCT00467870|6288177|P6|Overall Study|Withdrawal by Subject|1
1809741|NCT00467870|6288178|P5|Overall Study|Withdrawal by Subject|10
1809742|NCT00467870|6288179|P4|Overall Study|Withdrawal by Subject|9
1809743|NCT00467870|6288180|P3|Overall Study|Withdrawal by Subject|0
1809744|NCT00467870|6288181|P2|Overall Study|Withdrawal by Subject|21
1809745|NCT00467870|6288182|P1|Overall Study|Withdrawal by Subject|14
1809746|NCT00467870|6288177|P6|Overall Study|Protocol Violation|0
1809747|NCT00467870|6288178|P5|Overall Study|Protocol Violation|0
1809748|NCT00467870|6288179|P4|Overall Study|Protocol Violation|2
1809749|NCT00467870|6288180|P3|Overall Study|Protocol Violation|1
1809750|NCT00467870|6288181|P2|Overall Study|Protocol Violation|1
1809751|NCT00467870|6288182|P1|Overall Study|Protocol Violation|2
1809752|NCT00467870|6288177|P6|Overall Study|Adverse Event|1
1809753|NCT00467870|6288178|P5|Overall Study|Adverse Event|15
1809754|NCT00467870|6288179|P4|Overall Study|Adverse Event|15
1809755|NCT00467870|6288180|P3|Overall Study|Adverse Event|1
1809756|NCT00467870|6288181|P2|Overall Study|Adverse Event|9
1809757|NCT00467870|6288182|P1|Overall Study|Adverse Event|13
1809758|NCT00467857|6288225|P2|Overall Study|Discontinuation reason missing|3
1809759|NCT00467857|6288226|P1|Overall Study|Discontinuation reason missing|0
1809760|NCT00467857|6288225|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
1809761|NCT00467857|6288226|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
1809762|NCT00467857|6288225|P2|Overall Study|Emergency care required|1
1809763|NCT00467857|6288226|P1|Overall Study|Emergency care required|0
1809764|NCT00467857|6288225|P2|Overall Study|Discharged from court service|1
1809765|NCT00467857|6288226|P1|Overall Study|Discharged from court service|0
1809766|NCT00467857|6288225|P2|Overall Study|Death|1
1809767|NCT00467857|6288226|P1|Overall Study|Death|0
1809768|NCT00467857|6288225|P2|Overall Study|Withdrew consent|0
1809769|NCT00467857|6288226|P1|Overall Study|Withdrew consent|2
1809770|NCT00467857|6288225|P2|Overall Study|Adverse Event|0
1809771|NCT00467857|6288226|P1|Overall Study|Adverse Event|1
1809772|NCT00467831|6288274|P1|Overall Study|Withdrawal by Subject|1
1809773|NCT00467831|6288274|P1|Overall Study|Death|2
1809774|NCT00467779|6288293|P15|Stage 3|Unspecified Reason|5
1809775|NCT00467779|6288294|P14|Stage 3|Unspecified Reason|0
1809776|NCT00467779|6288295|P13|Stage 3|Unspecified Reason|0
1809777|NCT00467779|6288296|P12|Stage 3|Unspecified Reason|0
1809778|NCT00467779|6288297|P11|Stage 3|Unspecified Reason|0
1809779|NCT00467779|6288298|P10|Stage 3|Unspecified Reason|0
1809780|NCT00467779|6288299|P9|Stage 3|Unspecified Reason|0
1809781|NCT00467779|6288300|P8|Stage 3|Unspecified Reason|0
1809782|NCT00467779|6288301|P7|Stage 3|Unspecified Reason|0
1809783|NCT00467779|6288302|P6|Stage 3|Unspecified Reason|0
1809784|NCT00467779|6288303|P5|Stage 3|Unspecified Reason|0
1809785|NCT00467779|6288304|P4|Stage 3|Unspecified Reason|0
1809786|NCT00467779|6288305|P3|Stage 3|Unspecified Reason|0
1809787|NCT00467779|6288306|P2|Stage 3|Unspecified Reason|0
1809788|NCT00467779|6288307|P1|Stage 3|Unspecified Reason|0
1809789|NCT00467779|6288293|P15|Stage 3|Disease Progression|9
1809790|NCT00467779|6288294|P14|Stage 3|Disease Progression|0
1809791|NCT00467779|6288295|P13|Stage 3|Disease Progression|0
1809792|NCT00467779|6288296|P12|Stage 3|Disease Progression|0
1809793|NCT00467779|6288297|P11|Stage 3|Disease Progression|0
1809794|NCT00467779|6288298|P10|Stage 3|Disease Progression|0
1809795|NCT00467779|6288299|P9|Stage 3|Disease Progression|0
1809796|NCT00467779|6288300|P8|Stage 3|Disease Progression|0
1809797|NCT00467779|6288301|P7|Stage 3|Disease Progression|0
1809798|NCT00467779|6288302|P6|Stage 3|Disease Progression|0
1809799|NCT00467779|6288303|P5|Stage 3|Disease Progression|0
1809800|NCT00467779|6288304|P4|Stage 3|Disease Progression|0
1809801|NCT00467779|6288305|P3|Stage 3|Disease Progression|0
1809802|NCT00467779|6288306|P2|Stage 3|Disease Progression|0
1809803|NCT00467779|6288307|P1|Stage 3|Disease Progression|0
1809804|NCT00467779|6288293|P15|Stage 3|Death|1
1809805|NCT00467779|6288294|P14|Stage 3|Death|0
1809806|NCT00467779|6288295|P13|Stage 3|Death|0
1809807|NCT00467779|6288296|P12|Stage 3|Death|0
1809808|NCT00467779|6288297|P11|Stage 3|Death|0
1809809|NCT00467779|6288298|P10|Stage 3|Death|0
1809810|NCT00467779|6288299|P9|Stage 3|Death|0
1809811|NCT00467779|6288300|P8|Stage 3|Death|0
1809812|NCT00467779|6288301|P7|Stage 3|Death|0
1809813|NCT00467779|6288302|P6|Stage 3|Death|0
1809814|NCT00467779|6288303|P5|Stage 3|Death|0
1809815|NCT00467779|6288304|P4|Stage 3|Death|0
1809816|NCT00467779|6288305|P3|Stage 3|Death|0
1809817|NCT00467779|6288306|P2|Stage 3|Death|0
1809818|NCT00467779|6288307|P1|Stage 3|Death|0
1809819|NCT00467779|6288293|P15|Stage 3|Adverse Event|2
1809820|NCT00467779|6288294|P14|Stage 3|Adverse Event|0
1809821|NCT00467779|6288295|P13|Stage 3|Adverse Event|0
1809822|NCT00467779|6288296|P12|Stage 3|Adverse Event|0
1809823|NCT00467779|6288297|P11|Stage 3|Adverse Event|0
1809824|NCT00467779|6288298|P10|Stage 3|Adverse Event|0
1809825|NCT00467779|6288299|P9|Stage 3|Adverse Event|0
1809826|NCT00467779|6288300|P8|Stage 3|Adverse Event|0
1809827|NCT00467779|6288301|P7|Stage 3|Adverse Event|0
1809828|NCT00467779|6288302|P6|Stage 3|Adverse Event|0
1809829|NCT00467779|6288303|P5|Stage 3|Adverse Event|0
1809830|NCT00467779|6288304|P4|Stage 3|Adverse Event|0
1809831|NCT00467779|6288305|P3|Stage 3|Adverse Event|0
1809832|NCT00467779|6288306|P2|Stage 3|Adverse Event|0
1809833|NCT00467779|6288307|P1|Stage 3|Adverse Event|0
1809834|NCT00467779|6288293|P15|Stage 2A|Withdrawal by Subject|0
1809835|NCT00467779|6288294|P14|Stage 2A|Withdrawal by Subject|1
1809836|NCT00467779|6288295|P13|Stage 2A|Withdrawal by Subject|0
1809837|NCT00467779|6288296|P12|Stage 2A|Withdrawal by Subject|0
1809838|NCT00467779|6288297|P11|Stage 2A|Withdrawal by Subject|0
1809839|NCT00467779|6288298|P10|Stage 2A|Withdrawal by Subject|0
1809840|NCT00467779|6288299|P9|Stage 2A|Withdrawal by Subject|0
1809841|NCT00467779|6288300|P8|Stage 2A|Withdrawal by Subject|0
1809842|NCT00467779|6288301|P7|Stage 2A|Withdrawal by Subject|0
1809843|NCT00467779|6288302|P6|Stage 2A|Withdrawal by Subject|0
1809844|NCT00467779|6288303|P5|Stage 2A|Withdrawal by Subject|0
1809845|NCT00467779|6288304|P4|Stage 2A|Withdrawal by Subject|0
1809846|NCT00467779|6288305|P3|Stage 2A|Withdrawal by Subject|0
1809847|NCT00467779|6288306|P2|Stage 2A|Withdrawal by Subject|0
1809848|NCT00467779|6288307|P1|Stage 2A|Withdrawal by Subject|0
1809849|NCT00467779|6288293|P15|Stage 2A|Unspecified Reason|0
1809850|NCT00467779|6288294|P14|Stage 2A|Unspecified Reason|7
1809851|NCT00467779|6288295|P13|Stage 2A|Unspecified Reason|0
1809852|NCT00467779|6288296|P12|Stage 2A|Unspecified Reason|0
1809853|NCT00467779|6288297|P11|Stage 2A|Unspecified Reason|0
1809854|NCT00467779|6288298|P10|Stage 2A|Unspecified Reason|0
1809855|NCT00467779|6288299|P9|Stage 2A|Unspecified Reason|0
1809856|NCT00467779|6288300|P8|Stage 2A|Unspecified Reason|0
1809857|NCT00467779|6288301|P7|Stage 2A|Unspecified Reason|0
1809858|NCT00467779|6288302|P6|Stage 2A|Unspecified Reason|0
1809859|NCT00467779|6288303|P5|Stage 2A|Unspecified Reason|0
1809860|NCT00467779|6288304|P4|Stage 2A|Unspecified Reason|0
1809861|NCT00467779|6288305|P3|Stage 2A|Unspecified Reason|0
1809862|NCT00467779|6288306|P2|Stage 2A|Unspecified Reason|0
1809863|NCT00467779|6288307|P1|Stage 2A|Unspecified Reason|0
1809864|NCT00467779|6288293|P15|Stage 2A|Disease Progression|0
1809865|NCT00467779|6288294|P14|Stage 2A|Disease Progression|10
1809866|NCT00467779|6288295|P13|Stage 2A|Disease Progression|0
1809867|NCT00467779|6288296|P12|Stage 2A|Disease Progression|0
1809868|NCT00467779|6288297|P11|Stage 2A|Disease Progression|0
1809869|NCT00467779|6288298|P10|Stage 2A|Disease Progression|0
1809870|NCT00467779|6288299|P9|Stage 2A|Disease Progression|0
1809871|NCT00467779|6288300|P8|Stage 2A|Disease Progression|0
1809872|NCT00467779|6288301|P7|Stage 2A|Disease Progression|0
1809873|NCT00467779|6288302|P6|Stage 2A|Disease Progression|0
1809874|NCT00467779|6288303|P5|Stage 2A|Disease Progression|0
1809875|NCT00467779|6288304|P4|Stage 2A|Disease Progression|0
1809876|NCT00467779|6288305|P3|Stage 2A|Disease Progression|0
1809877|NCT00467779|6288306|P2|Stage 2A|Disease Progression|0
1809878|NCT00467779|6288307|P1|Stage 2A|Disease Progression|0
1809879|NCT00467779|6288293|P15|Stage 2A|Death|0
1809880|NCT00467779|6288294|P14|Stage 2A|Death|1
1809881|NCT00467779|6288295|P13|Stage 2A|Death|0
1809882|NCT00467779|6288296|P12|Stage 2A|Death|0
1809883|NCT00467779|6288297|P11|Stage 2A|Death|0
1809884|NCT00467779|6288298|P10|Stage 2A|Death|0
1809885|NCT00467779|6288299|P9|Stage 2A|Death|0
1809886|NCT00467779|6288300|P8|Stage 2A|Death|0
1809887|NCT00467779|6288301|P7|Stage 2A|Death|0
1809888|NCT00467779|6288302|P6|Stage 2A|Death|0
1809889|NCT00467779|6288303|P5|Stage 2A|Death|0
1809890|NCT00467779|6288304|P4|Stage 2A|Death|0
1809891|NCT00467779|6288305|P3|Stage 2A|Death|0
1809892|NCT00467779|6288306|P2|Stage 2A|Death|0
1809893|NCT00467779|6288307|P1|Stage 2A|Death|0
1809894|NCT00467779|6288293|P15|Stage 2A|Adverse Event|0
1809895|NCT00467779|6288294|P14|Stage 2A|Adverse Event|2
1809896|NCT00467779|6288295|P13|Stage 2A|Adverse Event|0
1809897|NCT00467779|6288296|P12|Stage 2A|Adverse Event|0
1809898|NCT00467779|6288297|P11|Stage 2A|Adverse Event|0
1809899|NCT00467779|6288298|P10|Stage 2A|Adverse Event|0
1809900|NCT00467779|6288299|P9|Stage 2A|Adverse Event|0
1809901|NCT00467779|6288300|P8|Stage 2A|Adverse Event|0
1809902|NCT00467779|6288301|P7|Stage 2A|Adverse Event|0
1809903|NCT00467779|6288302|P6|Stage 2A|Adverse Event|0
1809904|NCT00467779|6288303|P5|Stage 2A|Adverse Event|0
1809905|NCT00467779|6288304|P4|Stage 2A|Adverse Event|0
1809906|NCT00467779|6288305|P3|Stage 2A|Adverse Event|0
1809907|NCT00467779|6288306|P2|Stage 2A|Adverse Event|0
1809908|NCT00467779|6288307|P1|Stage 2A|Adverse Event|0
1809909|NCT00467779|6288293|P15|Stage 2|Unspecified Reason|0
1809910|NCT00467779|6288294|P14|Stage 2|Unspecified Reason|0
1809911|NCT00467779|6288295|P13|Stage 2|Unspecified Reason|0
1809912|NCT00467779|6288296|P12|Stage 2|Unspecified Reason|0
1809913|NCT00467779|6288297|P11|Stage 2|Unspecified Reason|0
1809914|NCT00467779|6288298|P10|Stage 2|Unspecified Reason|0
1809915|NCT00467779|6288299|P9|Stage 2|Unspecified Reason|3
1809916|NCT00467779|6288300|P8|Stage 2|Unspecified Reason|0
1809917|NCT00467779|6288301|P7|Stage 2|Unspecified Reason|0
1809918|NCT00467779|6288302|P6|Stage 2|Unspecified Reason|0
1809919|NCT00467779|6288303|P5|Stage 2|Unspecified Reason|0
1809920|NCT00467779|6288304|P4|Stage 2|Unspecified Reason|0
1809921|NCT00467779|6288305|P3|Stage 2|Unspecified Reason|0
1809922|NCT00467779|6288306|P2|Stage 2|Unspecified Reason|0
1809923|NCT00467779|6288307|P1|Stage 2|Unspecified Reason|0
1809924|NCT00467779|6288293|P15|Stage 2|Disease Progression|0
1809925|NCT00467779|6288294|P14|Stage 2|Disease Progression|0
1809926|NCT00467779|6288295|P13|Stage 2|Disease Progression|0
1809927|NCT00467779|6288296|P12|Stage 2|Disease Progression|0
1809928|NCT00467779|6288297|P11|Stage 2|Disease Progression|0
1809929|NCT00467779|6288298|P10|Stage 2|Disease Progression|0
1809930|NCT00467779|6288299|P9|Stage 2|Disease Progression|16
1809931|NCT00467779|6288300|P8|Stage 2|Disease Progression|0
1809932|NCT00467779|6288301|P7|Stage 2|Disease Progression|0
1809933|NCT00467779|6288302|P6|Stage 2|Disease Progression|0
1809934|NCT00467779|6288303|P5|Stage 2|Disease Progression|0
1809935|NCT00467779|6288304|P4|Stage 2|Disease Progression|0
1809936|NCT00467779|6288305|P3|Stage 2|Disease Progression|0
1809937|NCT00467779|6288306|P2|Stage 2|Disease Progression|0
1809938|NCT00467779|6288307|P1|Stage 2|Disease Progression|0
1809939|NCT00467779|6288293|P15|Stage 2|Death|0
1809940|NCT00467779|6288294|P14|Stage 2|Death|0
1809941|NCT00467779|6288295|P13|Stage 2|Death|0
1809942|NCT00467779|6288296|P12|Stage 2|Death|0
1809943|NCT00467779|6288297|P11|Stage 2|Death|0
1809944|NCT00467779|6288298|P10|Stage 2|Death|0
1809945|NCT00467779|6288299|P9|Stage 2|Death|1
1809946|NCT00467779|6288300|P8|Stage 2|Death|0
1809947|NCT00467779|6288301|P7|Stage 2|Death|0
1809948|NCT00467779|6288302|P6|Stage 2|Death|0
1809949|NCT00467779|6288303|P5|Stage 2|Death|0
1809950|NCT00467779|6288304|P4|Stage 2|Death|0
1809951|NCT00467779|6288305|P3|Stage 2|Death|0
1809952|NCT00467779|6288306|P2|Stage 2|Death|0
1809953|NCT00467779|6288307|P1|Stage 2|Death|0
1809954|NCT00467779|6288293|P15|Stage 2|Adverse Event|0
1809955|NCT00467779|6288294|P14|Stage 2|Adverse Event|0
1809956|NCT00467779|6288295|P13|Stage 2|Adverse Event|0
1809957|NCT00467779|6288296|P12|Stage 2|Adverse Event|0
1809958|NCT00467779|6288297|P11|Stage 2|Adverse Event|0
1809959|NCT00467779|6288298|P10|Stage 2|Adverse Event|0
1809960|NCT00467779|6288299|P9|Stage 2|Adverse Event|1
1809961|NCT00467779|6288300|P8|Stage 2|Adverse Event|0
1809962|NCT00467779|6288301|P7|Stage 2|Adverse Event|0
1809963|NCT00467779|6288302|P6|Stage 2|Adverse Event|0
1809964|NCT00467779|6288303|P5|Stage 2|Adverse Event|0
1809965|NCT00467779|6288304|P4|Stage 2|Adverse Event|0
1809966|NCT00467779|6288305|P3|Stage 2|Adverse Event|0
1809967|NCT00467779|6288306|P2|Stage 2|Adverse Event|0
1809968|NCT00467779|6288307|P1|Stage 2|Adverse Event|0
1809969|NCT00467779|6288293|P15|Stage 1A|Unspecified Reason|0
1809970|NCT00467779|6288294|P14|Stage 1A|Unspecified Reason|0
1809971|NCT00467779|6288295|P13|Stage 1A|Unspecified Reason|1
1809972|NCT00467779|6288296|P12|Stage 1A|Unspecified Reason|1
1809973|NCT00467779|6288297|P11|Stage 1A|Unspecified Reason|0
1809974|NCT00467779|6288298|P10|Stage 1A|Unspecified Reason|0
1809975|NCT00467779|6288299|P9|Stage 1A|Unspecified Reason|0
1809976|NCT00467779|6288300|P8|Stage 1A|Unspecified Reason|0
1809977|NCT00467779|6288301|P7|Stage 1A|Unspecified Reason|0
1809978|NCT00467779|6288302|P6|Stage 1A|Unspecified Reason|0
1809979|NCT00467779|6288303|P5|Stage 1A|Unspecified Reason|0
1809980|NCT00467779|6288304|P4|Stage 1A|Unspecified Reason|0
1809981|NCT00467779|6288305|P3|Stage 1A|Unspecified Reason|0
1809982|NCT00467779|6288306|P2|Stage 1A|Unspecified Reason|0
1809983|NCT00467779|6288307|P1|Stage 1A|Unspecified Reason|0
1809984|NCT00467779|6288293|P15|Stage 1A|Withdrawal by Subject|0
1809985|NCT00467779|6288294|P14|Stage 1A|Withdrawal by Subject|0
1809986|NCT00467779|6288295|P13|Stage 1A|Withdrawal by Subject|1
1809987|NCT00467779|6288296|P12|Stage 1A|Withdrawal by Subject|1
1809988|NCT00467779|6288297|P11|Stage 1A|Withdrawal by Subject|1
1809989|NCT00467779|6288298|P10|Stage 1A|Withdrawal by Subject|0
1809990|NCT00467779|6288299|P9|Stage 1A|Withdrawal by Subject|0
1809991|NCT00467779|6288300|P8|Stage 1A|Withdrawal by Subject|0
1809992|NCT00467779|6288301|P7|Stage 1A|Withdrawal by Subject|0
1809993|NCT00467779|6288302|P6|Stage 1A|Withdrawal by Subject|0
1809994|NCT00467779|6288303|P5|Stage 1A|Withdrawal by Subject|0
1809995|NCT00467779|6288304|P4|Stage 1A|Withdrawal by Subject|0
1809996|NCT00467779|6288305|P3|Stage 1A|Withdrawal by Subject|0
1809997|NCT00467779|6288306|P2|Stage 1A|Withdrawal by Subject|0
1809998|NCT00467779|6288307|P1|Stage 1A|Withdrawal by Subject|0
1809999|NCT00467779|6288293|P15|Stage 1A|Physician Decision|0
1810000|NCT00467779|6288294|P14|Stage 1A|Physician Decision|0
1810001|NCT00467779|6288295|P13|Stage 1A|Physician Decision|0
1810002|NCT00467779|6288296|P12|Stage 1A|Physician Decision|0
1810003|NCT00467779|6288297|P11|Stage 1A|Physician Decision|0
1810004|NCT00467779|6288298|P10|Stage 1A|Physician Decision|1
1810005|NCT00467779|6288299|P9|Stage 1A|Physician Decision|0
1810006|NCT00467779|6288300|P8|Stage 1A|Physician Decision|0
1810007|NCT00467779|6288301|P7|Stage 1A|Physician Decision|0
1810008|NCT00467779|6288302|P6|Stage 1A|Physician Decision|0
1810009|NCT00467779|6288303|P5|Stage 1A|Physician Decision|0
1810010|NCT00467779|6288304|P4|Stage 1A|Physician Decision|0
1810011|NCT00467779|6288305|P3|Stage 1A|Physician Decision|0
1810012|NCT00467779|6288306|P2|Stage 1A|Physician Decision|0
1810013|NCT00467779|6288307|P1|Stage 1A|Physician Decision|0
1810014|NCT00467779|6288293|P15|Stage 1A|Disease Progression|0
1810015|NCT00467779|6288294|P14|Stage 1A|Disease Progression|0
1810016|NCT00467779|6288295|P13|Stage 1A|Disease Progression|2
1810017|NCT00467779|6288296|P12|Stage 1A|Disease Progression|5
1810018|NCT00467779|6288297|P11|Stage 1A|Disease Progression|2
1810019|NCT00467779|6288298|P10|Stage 1A|Disease Progression|2
1810020|NCT00467779|6288299|P9|Stage 1A|Disease Progression|0
1810021|NCT00467779|6288300|P8|Stage 1A|Disease Progression|0
1810022|NCT00467779|6288301|P7|Stage 1A|Disease Progression|0
1810023|NCT00467779|6288302|P6|Stage 1A|Disease Progression|0
1810024|NCT00467779|6288303|P5|Stage 1A|Disease Progression|0
1810025|NCT00467779|6288304|P4|Stage 1A|Disease Progression|0
1810026|NCT00467779|6288305|P3|Stage 1A|Disease Progression|0
1810027|NCT00467779|6288306|P2|Stage 1A|Disease Progression|0
1810028|NCT00467779|6288307|P1|Stage 1A|Disease Progression|0
1810029|NCT00467779|6288293|P15|Stage 1A|Death|0
1810030|NCT00467779|6288294|P14|Stage 1A|Death|0
1810031|NCT00467779|6288295|P13|Stage 1A|Death|1
1810032|NCT00467779|6288296|P12|Stage 1A|Death|1
1810033|NCT00467779|6288297|P11|Stage 1A|Death|0
1810034|NCT00467779|6288298|P10|Stage 1A|Death|0
1810035|NCT00467779|6288299|P9|Stage 1A|Death|0
1810036|NCT00467779|6288300|P8|Stage 1A|Death|0
1810037|NCT00467779|6288301|P7|Stage 1A|Death|0
1810038|NCT00467779|6288302|P6|Stage 1A|Death|0
1810039|NCT00467779|6288303|P5|Stage 1A|Death|0
1810040|NCT00467779|6288304|P4|Stage 1A|Death|0
1810041|NCT00467779|6288305|P3|Stage 1A|Death|0
1810042|NCT00467779|6288306|P2|Stage 1A|Death|0
1810043|NCT00467779|6288307|P1|Stage 1A|Death|0
1810044|NCT00467779|6288293|P15|Stage 1A|Adverse Event|0
1810045|NCT00467779|6288294|P14|Stage 1A|Adverse Event|0
1810046|NCT00467779|6288295|P13|Stage 1A|Adverse Event|1
1810047|NCT00467779|6288296|P12|Stage 1A|Adverse Event|0
1810048|NCT00467779|6288297|P11|Stage 1A|Adverse Event|0
1810049|NCT00467779|6288298|P10|Stage 1A|Adverse Event|0
1810050|NCT00467779|6288299|P9|Stage 1A|Adverse Event|0
1810051|NCT00467779|6288300|P8|Stage 1A|Adverse Event|0
1810052|NCT00467779|6288301|P7|Stage 1A|Adverse Event|0
1810053|NCT00467779|6288302|P6|Stage 1A|Adverse Event|0
1810054|NCT00467779|6288303|P5|Stage 1A|Adverse Event|0
1810055|NCT00467779|6288304|P4|Stage 1A|Adverse Event|0
1810056|NCT00467779|6288305|P3|Stage 1A|Adverse Event|0
1810057|NCT00467779|6288306|P2|Stage 1A|Adverse Event|0
1810058|NCT00467779|6288307|P1|Stage 1A|Adverse Event|0
1810059|NCT00467779|6288293|P15|Stage 1|Withdrawal by Subject|0
1810060|NCT00467779|6288294|P14|Stage 1|Withdrawal by Subject|0
1810061|NCT00467779|6288295|P13|Stage 1|Withdrawal by Subject|0
1810062|NCT00467779|6288296|P12|Stage 1|Withdrawal by Subject|0
1810063|NCT00467779|6288297|P11|Stage 1|Withdrawal by Subject|0
1810064|NCT00467779|6288298|P10|Stage 1|Withdrawal by Subject|0
1810065|NCT00467779|6288299|P9|Stage 1|Withdrawal by Subject|0
1810066|NCT00467779|6288300|P8|Stage 1|Withdrawal by Subject|1
1810067|NCT00467779|6288301|P7|Stage 1|Withdrawal by Subject|1
1810068|NCT00467779|6288302|P6|Stage 1|Withdrawal by Subject|0
1810069|NCT00467779|6288303|P5|Stage 1|Withdrawal by Subject|0
1810070|NCT00467779|6288304|P4|Stage 1|Withdrawal by Subject|0
1810071|NCT00467779|6288305|P3|Stage 1|Withdrawal by Subject|0
1810072|NCT00467779|6288306|P2|Stage 1|Withdrawal by Subject|0
1810073|NCT00467779|6288307|P1|Stage 1|Withdrawal by Subject|0
1810074|NCT00467779|6288293|P15|Stage 1|Physician Decision|0
1810075|NCT00467779|6288294|P14|Stage 1|Physician Decision|0
1810076|NCT00467779|6288295|P13|Stage 1|Physician Decision|0
1810077|NCT00467779|6288296|P12|Stage 1|Physician Decision|0
1810078|NCT00467779|6288297|P11|Stage 1|Physician Decision|0
1810079|NCT00467779|6288298|P10|Stage 1|Physician Decision|0
1810080|NCT00467779|6288299|P9|Stage 1|Physician Decision|0
1810081|NCT00467779|6288300|P8|Stage 1|Physician Decision|0
1810082|NCT00467779|6288301|P7|Stage 1|Physician Decision|0
1810083|NCT00467779|6288302|P6|Stage 1|Physician Decision|0
1810084|NCT00467779|6288303|P5|Stage 1|Physician Decision|0
1810085|NCT00467779|6288304|P4|Stage 1|Physician Decision|0
1810086|NCT00467779|6288305|P3|Stage 1|Physician Decision|0
1810087|NCT00467779|6288306|P2|Stage 1|Physician Decision|1
1810088|NCT00467779|6288307|P1|Stage 1|Physician Decision|0
1810089|NCT00467779|6288293|P15|Stage 1|Unspecified Reason|0
1810090|NCT00467779|6288294|P14|Stage 1|Unspecified Reason|0
1810091|NCT00467779|6288295|P13|Stage 1|Unspecified Reason|0
1810092|NCT00467779|6288296|P12|Stage 1|Unspecified Reason|0
1810093|NCT00467779|6288297|P11|Stage 1|Unspecified Reason|0
1810094|NCT00467779|6288298|P10|Stage 1|Unspecified Reason|0
1810095|NCT00467779|6288299|P9|Stage 1|Unspecified Reason|0
1810096|NCT00467779|6288300|P8|Stage 1|Unspecified Reason|0
1810097|NCT00467779|6288301|P7|Stage 1|Unspecified Reason|0
1810098|NCT00467779|6288302|P6|Stage 1|Unspecified Reason|2
1810099|NCT00467779|6288303|P5|Stage 1|Unspecified Reason|1
1810100|NCT00467779|6288304|P4|Stage 1|Unspecified Reason|0
1810101|NCT00467779|6288305|P3|Stage 1|Unspecified Reason|1
1810102|NCT00467779|6288306|P2|Stage 1|Unspecified Reason|0
1810103|NCT00467779|6288307|P1|Stage 1|Unspecified Reason|1
1810104|NCT00467779|6288293|P15|Stage 1|Disease Progression|0
1810105|NCT00467779|6288294|P14|Stage 1|Disease Progression|0
1810106|NCT00467779|6288295|P13|Stage 1|Disease Progression|0
1810107|NCT00467779|6288296|P12|Stage 1|Disease Progression|0
1810108|NCT00467779|6288297|P11|Stage 1|Disease Progression|0
1810109|NCT00467779|6288298|P10|Stage 1|Disease Progression|0
1810110|NCT00467779|6288299|P9|Stage 1|Disease Progression|0
1810111|NCT00467779|6288300|P8|Stage 1|Disease Progression|5
1810112|NCT00467779|6288301|P7|Stage 1|Disease Progression|4
1810113|NCT00467779|6288302|P6|Stage 1|Disease Progression|2
1810114|NCT00467779|6288303|P5|Stage 1|Disease Progression|2
1810115|NCT00467779|6288304|P4|Stage 1|Disease Progression|3
1810116|NCT00467779|6288305|P3|Stage 1|Disease Progression|2
1810117|NCT00467779|6288306|P2|Stage 1|Disease Progression|2
1810118|NCT00467779|6288307|P1|Stage 1|Disease Progression|2
1810119|NCT00467779|6288293|P15|Stage 1|Adverse Event|0
1810120|NCT00467779|6288294|P14|Stage 1|Adverse Event|0
1810121|NCT00467779|6288295|P13|Stage 1|Adverse Event|0
1810122|NCT00467779|6288296|P12|Stage 1|Adverse Event|0
1810123|NCT00467779|6288297|P11|Stage 1|Adverse Event|0
1810124|NCT00467779|6288298|P10|Stage 1|Adverse Event|0
1810125|NCT00467779|6288299|P9|Stage 1|Adverse Event|0
1810126|NCT00467779|6288300|P8|Stage 1|Adverse Event|1
1810127|NCT00467779|6288301|P7|Stage 1|Adverse Event|2
1810128|NCT00467779|6288302|P6|Stage 1|Adverse Event|1
1810129|NCT00467779|6288303|P5|Stage 1|Adverse Event|0
1810130|NCT00467779|6288304|P4|Stage 1|Adverse Event|0
1810131|NCT00467779|6288305|P3|Stage 1|Adverse Event|0
1810132|NCT00467779|6288306|P2|Stage 1|Adverse Event|0
1810133|NCT00467779|6288307|P1|Stage 1|Adverse Event|1
1810134|NCT00467753|6288481|P2|Overall Study|Adverse Event|0
1810135|NCT00467753|6288482|P1|Overall Study|Adverse Event|2
1810136|NCT00467753|6288481|P2|Overall Study|Lost to Follow-up|2
1810137|NCT00467753|6288482|P1|Overall Study|Lost to Follow-up|1
1810138|NCT00467740|6288493|P5|Overall Study|Lack of Efficacy|0
1810139|NCT00467740|6288494|P4|Overall Study|Lack of Efficacy|0
1810140|NCT00467740|6288495|P3|Overall Study|Lack of Efficacy|0
1810141|NCT00467740|6288496|P2|Overall Study|Lack of Efficacy|1
1810142|NCT00467740|6288497|P1|Overall Study|Lack of Efficacy|0
1810143|NCT00467740|6288493|P5|Overall Study|Withdrawal by Subject|0
1810144|NCT00467740|6288494|P4|Overall Study|Withdrawal by Subject|1
1810145|NCT00467740|6288495|P3|Overall Study|Withdrawal by Subject|0
1810146|NCT00467740|6288496|P2|Overall Study|Withdrawal by Subject|1
1810147|NCT00467740|6288497|P1|Overall Study|Withdrawal by Subject|1
1810148|NCT00467740|6288493|P5|Overall Study|Lost to Follow-up|0
1810149|NCT00467740|6288494|P4|Overall Study|Lost to Follow-up|0
1810150|NCT00467740|6288495|P3|Overall Study|Lost to Follow-up|0
1810151|NCT00467740|6288496|P2|Overall Study|Lost to Follow-up|1
1810152|NCT00467740|6288497|P1|Overall Study|Lost to Follow-up|0
1810153|NCT00467740|6288493|P5|Overall Study|Protocol Violation|0
1810154|NCT00467740|6288494|P4|Overall Study|Protocol Violation|0
1810155|NCT00467740|6288495|P3|Overall Study|Protocol Violation|1
1810156|NCT00467740|6288496|P2|Overall Study|Protocol Violation|0
1810157|NCT00467740|6288497|P1|Overall Study|Protocol Violation|0
1810158|NCT00467740|6288493|P5|Overall Study|Adverse Event|0
1810159|NCT00467740|6288494|P4|Overall Study|Adverse Event|0
1810160|NCT00467740|6288495|P3|Overall Study|Adverse Event|1
1810161|NCT00467740|6288496|P2|Overall Study|Adverse Event|0
1810162|NCT00467740|6288497|P1|Overall Study|Adverse Event|0
1810163|NCT00467649|6288686|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
1810164|NCT00467649|6288687|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1810165|NCT00467649|6288688|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1810166|NCT00467649|6288689|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1810167|NCT00467649|6288690|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1810168|NCT00467649|6288691|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
1810169|NCT00467649|6288686|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1810170|NCT00467649|6288687|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1810171|NCT00467649|6288688|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
1810172|NCT00467649|6288689|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1810173|NCT00467649|6288690|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1810174|NCT00467649|6288691|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
1810175|NCT00467649|6288686|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1810176|NCT00467649|6288687|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1810177|NCT00467649|6288688|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
1810178|NCT00467649|6288689|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1810179|NCT00467649|6288690|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1810180|NCT00467649|6288691|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
1810181|NCT00467649|6288686|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1810182|NCT00467649|6288687|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1810183|NCT00467649|6288688|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1810184|NCT00467649|6288689|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
1810185|NCT00467649|6288690|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
1810186|NCT00467649|6288691|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
1810187|NCT00467649|6288686|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
1810188|NCT00467649|6288687|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
1810189|NCT00467649|6288688|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
1810190|NCT00467649|6288689|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
1810191|NCT00467649|6288690|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
1810192|NCT00467649|6288691|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
1810193|NCT00467649|6288686|P6|Phase 1 (Randomized Population)|Investigator Decision|0
1810194|NCT00467649|6288687|P5|Phase 1 (Randomized Population)|Investigator Decision|0
1810195|NCT00467649|6288688|P4|Phase 1 (Randomized Population)|Investigator Decision|0
1810196|NCT00467649|6288689|P3|Phase 1 (Randomized Population)|Investigator Decision|0
1810197|NCT00467649|6288690|P2|Phase 1 (Randomized Population)|Investigator Decision|0
1810198|NCT00467649|6288691|P1|Phase 1 (Randomized Population)|Investigator Decision|1
1810199|NCT00467649|6288686|P6|Phase 1 (Randomized Population)|Adverse Event|0
1810200|NCT00467649|6288687|P5|Phase 1 (Randomized Population)|Adverse Event|0
1810201|NCT00467649|6288688|P4|Phase 1 (Randomized Population)|Adverse Event|0
1810202|NCT00467649|6288689|P3|Phase 1 (Randomized Population)|Adverse Event|0
1810203|NCT00467649|6288690|P2|Phase 1 (Randomized Population)|Adverse Event|0
1810204|NCT00467649|6288691|P1|Phase 1 (Randomized Population)|Adverse Event|2
1810205|NCT00467610|6288731|P1|Overall Study|Withdrawal by Subject|1
1810206|NCT00467597|6288742|P2|Overall Study|Withdrawal by Subject|0
1810207|NCT00467597|6288743|P1|Overall Study|Withdrawal by Subject|2
1810208|NCT00467584|6288756|P3|Overall Study|Withdrawal by Subject|1
1810209|NCT00467584|6288757|P2|Overall Study|Withdrawal by Subject|5
1810210|NCT00467584|6288758|P1|Overall Study|Withdrawal by Subject|4
1810211|NCT00467558|6288768|P2|Overall Study|Lost to Follow-up|0
1810212|NCT00467558|6288769|P1|Overall Study|Lost to Follow-up|2
1810213|NCT00467519|6288779|P2|Overall Study|Withdrawal by Subject|10
1810214|NCT00467519|6288780|P1|Overall Study|Withdrawal by Subject|4
1810215|NCT00467519|6288779|P2|Overall Study|Lost to Follow-up|9
1810216|NCT00467519|6288780|P1|Overall Study|Lost to Follow-up|2
1810217|NCT00467519|6288779|P2|Overall Study|Protocol Violation|4
1810218|NCT00467519|6288780|P1|Overall Study|Protocol Violation|8
1810219|NCT00467363|6288809|P2|Overall Study|Lost to Follow-up|70
1810220|NCT00467363|6288810|P1|Overall Study|Lost to Follow-up|80
1810221|NCT00467285|6288857|P2|Overall Study|Lost to Follow-up|4
1810222|NCT00467285|6288858|P1|Overall Study|Lost to Follow-up|4
1810223|NCT00467259|6288878|P2|Overall Study|Site Closed|1
1810224|NCT00467259|6288879|P1|Overall Study|Site Closed|2
1810225|NCT00467259|6288878|P2|Overall Study|Lost to Follow-up|34
1810226|NCT00467259|6288879|P1|Overall Study|Lost to Follow-up|14
1810227|NCT00467259|6288878|P2|Overall Study|Physician Decision|2
1810228|NCT00467259|6288879|P1|Overall Study|Physician Decision|0
1810229|NCT00467259|6288878|P2|Overall Study|Withdrawal by Subject|108
1810230|NCT00467259|6288879|P1|Overall Study|Withdrawal by Subject|34
1810231|NCT00467259|6288878|P2|Overall Study|Protocol Violation|7
1810232|NCT00467259|6288879|P1|Overall Study|Protocol Violation|1
1810233|NCT00467259|6288878|P2|Overall Study|Adverse Event|90
1810234|NCT00467259|6288879|P1|Overall Study|Adverse Event|24
1810235|NCT00467051|6288896|P1|Overall Study|Adverse Event|2
1810236|NCT00466947|6288923|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
1810237|NCT00466947|6288924|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
1810238|NCT00466947|6288923|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
1810239|NCT00466947|6288924|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
1810240|NCT00466947|6288923|P2|Study End Analysis Period|Other – Forbidden vaccination|10
1810241|NCT00466947|6288924|P1|Study End Analysis Period|Other – Forbidden vaccination|21
1810242|NCT00466947|6288923|P2|Study End Analysis Period|Withdrawal by Subject|1267
1810243|NCT00466947|6288924|P1|Study End Analysis Period|Withdrawal by Subject|1264
1810244|NCT00466947|6288923|P2|Study End Analysis Period|Protocol Violation|17
1810245|NCT00466947|6288924|P1|Study End Analysis Period|Protocol Violation|9
1810246|NCT00466947|6288923|P2|Study End Analysis Period|Physician Decision|29
1810247|NCT00466947|6288924|P1|Study End Analysis Period|Physician Decision|29
1810248|NCT00466947|6288923|P2|Study End Analysis Period|Lost to Follow-up|1167
1810249|NCT00466947|6288924|P1|Study End Analysis Period|Lost to Follow-up|1137
1810250|NCT00466947|6288923|P2|Study End Analysis Period|Adverse Event|43
1810251|NCT00466947|6288924|P1|Study End Analysis Period|Adverse Event|35
1810252|NCT00466947|6288923|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
1810253|NCT00466947|6288924|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
1810254|NCT00466726|6289115|P1|Overall Study|Not evaluable for response|14
1810255|NCT00466687|6289121|P1|Overall Study|Disease progression|29
1810256|NCT00466687|6289121|P1|Overall Study|Withdrawal by Subject|1
1810257|NCT00466687|6289121|P1|Overall Study|Other complicating illness|3
1810258|NCT00466687|6289121|P1|Overall Study|Adverse Event|1
1810259|NCT00466505|6289153|P1|Overall Study|Adverse Event|4
1810260|NCT00466505|6289153|P1|Overall Study|disease progression|13
1810261|NCT00466193|6289203|P2|Overall Study|Patient refused Visit 4 procedures|0
1810262|NCT00466193|6289204|P1|Overall Study|Patient refused Visit 4 procedures|1
1810263|NCT00466193|6289203|P2|Overall Study|Withdrawal by Subject|2
1810264|NCT00466193|6289204|P1|Overall Study|Withdrawal by Subject|7
1810265|NCT00466193|6289203|P2|Overall Study|Protocol Violation|1
1810266|NCT00466193|6289204|P1|Overall Study|Protocol Violation|1
1810267|NCT00466193|6289203|P2|Overall Study|Physician Decision|0
1810268|NCT00466193|6289204|P1|Overall Study|Physician Decision|1
1810269|NCT00466193|6289203|P2|Overall Study|Lost to Follow-up|4
1810270|NCT00466193|6289204|P1|Overall Study|Lost to Follow-up|2
1810271|NCT00466193|6289203|P2|Overall Study|Adverse Event|1
1810272|NCT00466193|6289204|P1|Overall Study|Adverse Event|0
1810273|NCT00466167|6289231|P3|Overall Study|Not treated|0
1810274|NCT00466167|6289232|P2|Overall Study|Not treated|0
1810275|NCT00466167|6289233|P1|Overall Study|Not treated|1
1810276|NCT00466167|6289231|P3|Overall Study|patient did not meet inclusion criteria|1
1810277|NCT00466167|6289232|P2|Overall Study|patient did not meet inclusion criteria|0
1810278|NCT00466167|6289233|P1|Overall Study|patient did not meet inclusion criteria|1
1810279|NCT00466167|6289231|P3|Overall Study|Withdrawal by Subject|6
1810280|NCT00466167|6289232|P2|Overall Study|Withdrawal by Subject|1
1810281|NCT00466167|6289233|P1|Overall Study|Withdrawal by Subject|4
1810282|NCT00466167|6289231|P3|Overall Study|Lost to Follow-up|2
1810283|NCT00466167|6289232|P2|Overall Study|Lost to Follow-up|2
1810284|NCT00466167|6289233|P1|Overall Study|Lost to Follow-up|3
1810285|NCT00466167|6289231|P3|Overall Study|Protocol Violation|2
1810286|NCT00466167|6289232|P2|Overall Study|Protocol Violation|1
1810287|NCT00466167|6289233|P1|Overall Study|Protocol Violation|1
1810288|NCT00466167|6289231|P3|Overall Study|Lack of Efficacy|3
1810289|NCT00466167|6289232|P2|Overall Study|Lack of Efficacy|0
1810290|NCT00466167|6289233|P1|Overall Study|Lack of Efficacy|2
1810291|NCT00466167|6289231|P3|Overall Study|Adverse Event|7
1810292|NCT00466167|6289232|P2|Overall Study|Adverse Event|8
1810293|NCT00466167|6289233|P1|Overall Study|Adverse Event|8
1810294|NCT00465985|6289294|P2|Part III - Open-label Treatment Period|Adverse Event|0
1810295|NCT00465985|6289295|P1|Part III - Open-label Treatment Period|Adverse Event|1
1810296|NCT00465985|6289294|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
1810297|NCT00465985|6289295|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
1810298|NCT00465985|6289294|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
1810299|NCT00465985|6289295|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
1810300|NCT00465985|6289294|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
1810301|NCT00465985|6289295|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
1810302|NCT00465972|6289318|P2|Overall Study|Withdrawal by Subject|1
1810303|NCT00465972|6289319|P1|Overall Study|Withdrawal by Subject|2
1810304|NCT00465894|6289329|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
1810305|NCT00465894|6289330|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
1810306|NCT00465894|6289329|P2|Treatment For 12 Weeks|Family Issues|1
1810307|NCT00465894|6289330|P1|Treatment For 12 Weeks|Family Issues|1
1810308|NCT00465894|6289329|P2|Treatment For 12 Weeks|Lost to Follow-up|1
1810309|NCT00465894|6289330|P1|Treatment For 12 Weeks|Lost to Follow-up|4
1810310|NCT00465816|6289363|P3|Overall Study|Lost to Follow-up|2
1810311|NCT00465816|6289364|P2|Overall Study|Lost to Follow-up|0
1810312|NCT00465816|6289365|P1|Overall Study|Lost to Follow-up|0
1810313|NCT00465738|6289428|P2|Overall Study|Other|5
1810314|NCT00465738|6289429|P1|Overall Study|Other|2
1810315|NCT00465738|6289428|P2|Overall Study|Withdrawal by Subject|0
1810316|NCT00465738|6289429|P1|Overall Study|Withdrawal by Subject|2
1810317|NCT00465738|6289428|P2|Overall Study|Adverse Event|1
1810318|NCT00465738|6289429|P1|Overall Study|Adverse Event|0
1810319|NCT00465738|6289428|P2|Overall Study|Lost to Follow-up|0
1810320|NCT00465738|6289429|P1|Overall Study|Lost to Follow-up|2
1810321|NCT00465647|6289523|P4|Overall Study|"The other reasons included loss of IV"|2
1810322|NCT00465647|6289524|P3|Overall Study|"The other reasons included loss of IV"|3
1810323|NCT00465647|6289525|P2|Overall Study|"The other reasons included loss of IV"|4
1810324|NCT00465647|6289526|P1|Overall Study|"The other reasons included loss of IV"|8
1810325|NCT00465647|6289523|P4|Overall Study|Withdrawal by Subject|7
1810326|NCT00465647|6289524|P3|Overall Study|Withdrawal by Subject|2
1810327|NCT00465647|6289525|P2|Overall Study|Withdrawal by Subject|2
1810328|NCT00465647|6289526|P1|Overall Study|Withdrawal by Subject|1
1810329|NCT00465647|6289523|P4|Overall Study|Adverse Event|2
1810330|NCT00465647|6289524|P3|Overall Study|Adverse Event|3
1810331|NCT00465647|6289525|P2|Overall Study|Adverse Event|0
1810332|NCT00465647|6289526|P1|Overall Study|Adverse Event|2
1810333|NCT00465647|6289523|P4|Overall Study|Administrative|2
1810334|NCT00465647|6289524|P3|Overall Study|Administrative|3
1810335|NCT00465647|6289525|P2|Overall Study|Administrative|2
1810336|NCT00465647|6289526|P1|Overall Study|Administrative|2
1810337|NCT00465569|6289574|P2|Overall Study|persistent eczema during dose escalation|0
1810338|NCT00465569|6289575|P1|Overall Study|persistent eczema during dose escalation|1
1810339|NCT00465361|6289598|P1|Baseline Assessment|Personal Issues/Scheduling|4
1810340|NCT00465270|6289604|P2|Overall Study|Investigator request|4
1810341|NCT00465270|6289605|P1|Overall Study|Investigator request|3
1810342|NCT00465270|6289604|P2|Overall Study|Lost to Follow-up|67
1810343|NCT00465270|6289605|P1|Overall Study|Lost to Follow-up|60
1810344|NCT00465270|6289604|P2|Overall Study|Withdrawal by Subject|78
1810345|NCT00465270|6289605|P1|Overall Study|Withdrawal by Subject|34
1810346|NCT00465270|6289604|P2|Overall Study|Death|11
1810347|NCT00465270|6289605|P1|Overall Study|Death|7
1810348|NCT00465179|6289614|P1|Overall Study|Progression of Disease|47
1810349|NCT00465179|6289614|P1|Overall Study|Withdrawal by Subject|2
1810350|NCT00465179|6289614|P1|Overall Study|Adverse Event|4
1810351|NCT00465101|6289620|P1|Overall Study|Withdrew consent prior to procedure|3
1810352|NCT00465101|6289620|P1|Overall Study|Physician Decision|1
1810353|NCT00465101|6289620|P1|Overall Study|Withdrawal by Subject|25
1810354|NCT00465101|6289620|P1|Overall Study|Death|3
1810355|NCT00465101|6289620|P1|Overall Study|Unable to obtain IRB approval|1
1810356|NCT00465101|6289620|P1|Overall Study|Site closed due to IRB expiration|1
1810357|NCT00465101|6289620|P1|Overall Study|Patient postponed procedure|1
1810358|NCT00465101|6289620|P1|Overall Study|Pt. Insurance not accepted at center|2
1810359|NCT00465101|6289620|P1|Overall Study|Other|6
1810360|NCT00465101|6289620|P1|Overall Study|Lost to Follow-up|5
1810361|NCT00465101|6289620|P1|Overall Study|Did not meet study criteria|4
1810362|NCT00465101|6289620|P1|Overall Study|Change in health precluded follow up|4
1810363|NCT00465101|6289620|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
1810364|NCT00464945|6289690|P2|Toddler Dose|Lost to Follow-up|1
1810365|NCT00464945|6289691|P1|Toddler Dose|Lost to Follow-up|0
1810366|NCT00464945|6289690|P2|After Infant Series|Withdrawal by Subject|2
1810367|NCT00464945|6289691|P1|After Infant Series|Withdrawal by Subject|0
1810368|NCT00464945|6289690|P2|Infant Series|Lost to Follow-up|0
1810369|NCT00464945|6289691|P1|Infant Series|Lost to Follow-up|1
1810370|NCT00464945|6289690|P2|Infant Series|Protocol Violation|0
1810371|NCT00464945|6289691|P1|Infant Series|Protocol Violation|1
1810372|NCT00464945|6289690|P2|Infant Series|Withdrawal by parent/guardian request|1
1810373|NCT00464945|6289691|P1|Infant Series|Withdrawal by parent/guardian request|2
1810374|NCT00464815|6289721|P2|Overall Study|Withdrawal by Subject|3
1810375|NCT00464815|6289722|P1|Overall Study|Withdrawal by Subject|6
1810376|NCT00464737|6289755|P3|Overall Study|Other: Subject's disability per sponsor|1
1810377|NCT00464737|6289756|P2|Overall Study|Other: Subject's disability per sponsor|0
1810378|NCT00464737|6289757|P1|Overall Study|Other: Subject's disability per sponsor|0
1810379|NCT00464737|6289755|P3|Overall Study|Other: Personal family reasons|1
1810380|NCT00464737|6289756|P2|Overall Study|Other: Personal family reasons|0
1810381|NCT00464737|6289757|P1|Overall Study|Other: Personal family reasons|0
1810382|NCT00464737|6289755|P3|Overall Study|Other: Study demands too great|0
1810383|NCT00464737|6289756|P2|Overall Study|Other: Study demands too great|1
1810384|NCT00464737|6289757|P1|Overall Study|Other: Study demands too great|0
1810385|NCT00464737|6289755|P3|Overall Study|Other: Subject left town; family illness|0
1810386|NCT00464737|6289756|P2|Overall Study|Other: Subject left town; family illness|0
1810387|NCT00464737|6289757|P1|Overall Study|Other: Subject left town; family illness|1
1810388|NCT00464737|6289755|P3|Overall Study|Other: Subject's schedule doesn't permit|0
1810389|NCT00464737|6289756|P2|Overall Study|Other: Subject's schedule doesn't permit|0
1810390|NCT00464737|6289757|P1|Overall Study|Other: Subject's schedule doesn't permit|1
1810391|NCT00464737|6289755|P3|Overall Study|Lost to Follow-up|5
1810392|NCT00464737|6289756|P2|Overall Study|Lost to Follow-up|2
1810393|NCT00464737|6289757|P1|Overall Study|Lost to Follow-up|5
1810394|NCT00464737|6289755|P3|Overall Study|Non-compliance|1
1810395|NCT00464737|6289756|P2|Overall Study|Non-compliance|1
1810396|NCT00464737|6289757|P1|Overall Study|Non-compliance|0
1810397|NCT00464737|6289755|P3|Overall Study|Protocol Violation|5
1810398|NCT00464737|6289756|P2|Overall Study|Protocol Violation|1
1810399|NCT00464737|6289757|P1|Overall Study|Protocol Violation|1
1810400|NCT00464737|6289755|P3|Overall Study|Withdrawal by Subject|5
1810401|NCT00464737|6289756|P2|Overall Study|Withdrawal by Subject|3
1810402|NCT00464737|6289757|P1|Overall Study|Withdrawal by Subject|5
1810403|NCT00464737|6289755|P3|Overall Study|Lack of Efficacy|4
1810404|NCT00464737|6289756|P2|Overall Study|Lack of Efficacy|7
1810405|NCT00464737|6289757|P1|Overall Study|Lack of Efficacy|7
1810406|NCT00464737|6289755|P3|Overall Study|Adverse Event|33
1810407|NCT00464737|6289756|P2|Overall Study|Adverse Event|17
1810408|NCT00464737|6289757|P1|Overall Study|Adverse Event|12
1810409|NCT00464672|6289837|P6|Overall Study|Lost to Follow-up|0
1810410|NCT00464672|6289838|P5|Overall Study|Lost to Follow-up|1
1810411|NCT00464672|6289839|P4|Overall Study|Lost to Follow-up|0
1810412|NCT00464672|6289840|P3|Overall Study|Lost to Follow-up|0
1810413|NCT00464672|6289841|P2|Overall Study|Lost to Follow-up|10
1810414|NCT00464672|6289842|P1|Overall Study|Lost to Follow-up|25
1810415|NCT00464672|6289837|P6|Overall Study|withdrawal of consent|4
1810416|NCT00464672|6289838|P5|Overall Study|withdrawal of consent|9
1810417|NCT00464672|6289839|P4|Overall Study|withdrawal of consent|1
1810418|NCT00464672|6289840|P3|Overall Study|withdrawal of consent|0
1810419|NCT00464672|6289841|P2|Overall Study|withdrawal of consent|0
1810420|NCT00464672|6289842|P1|Overall Study|withdrawal of consent|0
1810421|NCT00464620|6289921|P3|Overall Study|Use of prohibited concomitant medication|2
1810422|NCT00464620|6289922|P2|Overall Study|Use of prohibited concomitant medication|0
1810423|NCT00464620|6289923|P1|Overall Study|Use of prohibited concomitant medication|0
1810424|NCT00464620|6289921|P3|Overall Study|Ineligible sarcoma subtype|2
1810425|NCT00464620|6289922|P2|Overall Study|Ineligible sarcoma subtype|2
1810426|NCT00464620|6289923|P1|Overall Study|Ineligible sarcoma subtype|0
1810427|NCT00464620|6289921|P3|Overall Study|Withdrawal by Subject|3
1810428|NCT00464620|6289922|P2|Overall Study|Withdrawal by Subject|0
1810429|NCT00464620|6289923|P1|Overall Study|Withdrawal by Subject|1
1810430|NCT00464620|6289921|P3|Overall Study|Physician Decision|0
1810431|NCT00464620|6289922|P2|Overall Study|Physician Decision|0
1810432|NCT00464620|6289923|P1|Overall Study|Physician Decision|1
1810433|NCT00464568|6289950|P1|Overall Study|Adverse Event|2
1810434|NCT00464542|6290023|P1|Pre-treatment|Withdrawal by Subject|2
1810435|NCT00464490|6290030|P2|Overall Study|Physician Decision|11
1810436|NCT00464490|6290031|P1|Overall Study|Physician Decision|11
1810437|NCT00464334|6290078|P11|Overall Study|Withdrawal by Subject|0
1810438|NCT00464334|6290079|P10|Overall Study|Withdrawal by Subject|0
1810439|NCT00464334|6290080|P9|Overall Study|Withdrawal by Subject|3
1810440|NCT00464334|6290081|P8|Overall Study|Withdrawal by Subject|1
1810441|NCT00464334|6290082|P7|Overall Study|Withdrawal by Subject|2
1810442|NCT00464334|6290083|P6|Overall Study|Withdrawal by Subject|2
1810443|NCT00464334|6290084|P5|Overall Study|Withdrawal by Subject|2
1810444|NCT00464334|6290085|P4|Overall Study|Withdrawal by Subject|2
1810445|NCT00464334|6290086|P3|Overall Study|Withdrawal by Subject|4
1810446|NCT00464334|6290087|P2|Overall Study|Withdrawal by Subject|7
1810447|NCT00464334|6290088|P1|Overall Study|Withdrawal by Subject|1
1810448|NCT00464334|6290078|P11|Overall Study|Study Terminated by Sponsor|0
1810449|NCT00464334|6290079|P10|Overall Study|Study Terminated by Sponsor|0
1810450|NCT00464334|6290080|P9|Overall Study|Study Terminated by Sponsor|0
1810451|NCT00464334|6290081|P8|Overall Study|Study Terminated by Sponsor|0
1810452|NCT00464334|6290082|P7|Overall Study|Study Terminated by Sponsor|0
1810453|NCT00464334|6290083|P6|Overall Study|Study Terminated by Sponsor|0
1810454|NCT00464334|6290084|P5|Overall Study|Study Terminated by Sponsor|0
1810455|NCT00464334|6290085|P4|Overall Study|Study Terminated by Sponsor|1
1810456|NCT00464334|6290086|P3|Overall Study|Study Terminated by Sponsor|0
1810457|NCT00464334|6290087|P2|Overall Study|Study Terminated by Sponsor|0
1810458|NCT00464334|6290088|P1|Overall Study|Study Terminated by Sponsor|0
1810459|NCT00464334|6290078|P11|Overall Study|Progressive Disease|0
1810460|NCT00464334|6290079|P10|Overall Study|Progressive Disease|0
1810461|NCT00464334|6290080|P9|Overall Study|Progressive Disease|1
1810462|NCT00464334|6290081|P8|Overall Study|Progressive Disease|0
1810463|NCT00464334|6290082|P7|Overall Study|Progressive Disease|0
1810464|NCT00464334|6290083|P6|Overall Study|Progressive Disease|1
1810465|NCT00464334|6290084|P5|Overall Study|Progressive Disease|0
1810466|NCT00464334|6290085|P4|Overall Study|Progressive Disease|0
1810467|NCT00464334|6290086|P3|Overall Study|Progressive Disease|0
1810468|NCT00464334|6290087|P2|Overall Study|Progressive Disease|0
1810469|NCT00464334|6290088|P1|Overall Study|Progressive Disease|0
1810470|NCT00464334|6290078|P11|Overall Study|Lost to Follow-up|2
1810471|NCT00464334|6290079|P10|Overall Study|Lost to Follow-up|0
1810472|NCT00464334|6290080|P9|Overall Study|Lost to Follow-up|0
1810473|NCT00464334|6290081|P8|Overall Study|Lost to Follow-up|0
1810474|NCT00464334|6290082|P7|Overall Study|Lost to Follow-up|1
1810475|NCT00464334|6290083|P6|Overall Study|Lost to Follow-up|0
1810476|NCT00464334|6290084|P5|Overall Study|Lost to Follow-up|1
1810477|NCT00464334|6290085|P4|Overall Study|Lost to Follow-up|0
1810478|NCT00464334|6290086|P3|Overall Study|Lost to Follow-up|1
1810479|NCT00464334|6290087|P2|Overall Study|Lost to Follow-up|0
1810480|NCT00464334|6290088|P1|Overall Study|Lost to Follow-up|0
1810481|NCT00464334|6290078|P11|Overall Study|Lack of Efficacy|0
1810482|NCT00464334|6290079|P10|Overall Study|Lack of Efficacy|0
1810483|NCT00464334|6290080|P9|Overall Study|Lack of Efficacy|0
1810484|NCT00464334|6290081|P8|Overall Study|Lack of Efficacy|0
1810485|NCT00464334|6290082|P7|Overall Study|Lack of Efficacy|0
1810486|NCT00464334|6290083|P6|Overall Study|Lack of Efficacy|0
1810487|NCT00464334|6290084|P5|Overall Study|Lack of Efficacy|0
1810488|NCT00464334|6290085|P4|Overall Study|Lack of Efficacy|0
1810489|NCT00464334|6290086|P3|Overall Study|Lack of Efficacy|0
1810490|NCT00464334|6290087|P2|Overall Study|Lack of Efficacy|1
1810491|NCT00464334|6290088|P1|Overall Study|Lack of Efficacy|0
1810492|NCT00464334|6290078|P11|Overall Study|Adverse Event|2
1810493|NCT00464334|6290079|P10|Overall Study|Adverse Event|1
1810494|NCT00464334|6290080|P9|Overall Study|Adverse Event|2
1810495|NCT00464334|6290081|P8|Overall Study|Adverse Event|0
1810496|NCT00464334|6290082|P7|Overall Study|Adverse Event|0
1810497|NCT00464334|6290083|P6|Overall Study|Adverse Event|1
1810498|NCT00464334|6290084|P5|Overall Study|Adverse Event|1
1810499|NCT00464334|6290085|P4|Overall Study|Adverse Event|1
1810500|NCT00464334|6290086|P3|Overall Study|Adverse Event|0
1810501|NCT00464334|6290087|P2|Overall Study|Adverse Event|0
1810502|NCT00464334|6290088|P1|Overall Study|Adverse Event|0
1810503|NCT00464308|6290148|P3|Overall Study|Physician Decision|0
1810504|NCT00464308|6290149|P2|Overall Study|Physician Decision|0
1810505|NCT00464308|6290150|P1|Overall Study|Physician Decision|1
1810506|NCT00464308|6290148|P3|Overall Study|Patient discontinued and other reasons|23
1810507|NCT00464308|6290149|P2|Overall Study|Patient discontinued and other reasons|17
1810508|NCT00464308|6290150|P1|Overall Study|Patient discontinued and other reasons|17
1810509|NCT00464308|6290148|P3|Overall Study|Lost to Follow-up|20
1810510|NCT00464308|6290149|P2|Overall Study|Lost to Follow-up|19
1810511|NCT00464308|6290150|P1|Overall Study|Lost to Follow-up|29
1810512|NCT00464308|6290148|P3|Overall Study|Adverse Event|16
1810513|NCT00464308|6290149|P2|Overall Study|Adverse Event|27
1810514|NCT00464308|6290150|P1|Overall Study|Adverse Event|22
1810515|NCT00464269|6290180|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1810516|NCT00464269|6290181|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
1810517|NCT00464269|6290182|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1810518|NCT00464269|6290183|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
1810519|NCT00464269|6290180|P4|Overall Study|AE, non-serious non-fatal|4
1810520|NCT00464269|6290181|P3|Overall Study|AE, non-serious non-fatal|3
1810521|NCT00464269|6290182|P2|Overall Study|AE, non-serious non-fatal|8
1810522|NCT00464269|6290183|P1|Overall Study|AE, non-serious non-fatal|2
1810523|NCT00464269|6290180|P4|Overall Study|SAE, non-fatal|1
1810524|NCT00464269|6290181|P3|Overall Study|SAE, non-fatal|0
1810525|NCT00464269|6290182|P2|Overall Study|SAE, non-fatal|0
1810526|NCT00464269|6290183|P1|Overall Study|SAE, non-fatal|0
1810527|NCT00464269|6290180|P4|Overall Study|AE, serious fatal|1
1810528|NCT00464269|6290181|P3|Overall Study|AE, serious fatal|1
1810529|NCT00464269|6290182|P2|Overall Study|AE, serious fatal|0
1810530|NCT00464269|6290183|P1|Overall Study|AE, serious fatal|0
1810531|NCT00464269|6290180|P4|Overall Study|Other reason|1
1810532|NCT00464269|6290181|P3|Overall Study|Other reason|1
1810533|NCT00464269|6290182|P2|Overall Study|Other reason|3
1810534|NCT00464269|6290183|P1|Overall Study|Other reason|3
1810535|NCT00464269|6290180|P4|Overall Study|Withdrawal by Subject|1
1810536|NCT00464269|6290181|P3|Overall Study|Withdrawal by Subject|1
1810537|NCT00464269|6290182|P2|Overall Study|Withdrawal by Subject|2
1810538|NCT00464269|6290183|P1|Overall Study|Withdrawal by Subject|0
1810539|NCT00464269|6290180|P4|Overall Study|Lost to Follow-up|1
1810540|NCT00464269|6290181|P3|Overall Study|Lost to Follow-up|0
1810541|NCT00464269|6290182|P2|Overall Study|Lost to Follow-up|4
1810542|NCT00464269|6290183|P1|Overall Study|Lost to Follow-up|0
1810543|NCT00464269|6290180|P4|Overall Study|Lack of Efficacy|0
1810544|NCT00464269|6290181|P3|Overall Study|Lack of Efficacy|0
1810545|NCT00464269|6290182|P2|Overall Study|Lack of Efficacy|0
1810546|NCT00464269|6290183|P1|Overall Study|Lack of Efficacy|1
1810547|NCT00464087|6290321|P3|Overall Study|No PCI per inclusion criteria|29
1810548|NCT00464087|6290322|P2|Overall Study|No PCI per inclusion criteria|0
1810549|NCT00464087|6290323|P1|Overall Study|No PCI per inclusion criteria|0
1810550|NCT00463866|6290341|P2|Overall Study|Other|22
1810551|NCT00463866|6290342|P1|Overall Study|Other|22
1810552|NCT00463866|6290341|P2|Overall Study|Mis-Randomization of subject|1
1810553|NCT00463866|6290342|P1|Overall Study|Mis-Randomization of subject|0
1810554|NCT00463866|6290341|P2|Overall Study|Safety Reason|3
1810555|NCT00463866|6290342|P1|Overall Study|Safety Reason|1
1810556|NCT00463866|6290341|P2|Overall Study|Severe Non-Compliance to Protocol|21
1810557|NCT00463866|6290342|P1|Overall Study|Severe Non-Compliance to Protocol|25
1810558|NCT00463866|6290341|P2|Overall Study|Incorrect Enrolment|66
1810559|NCT00463866|6290342|P1|Overall Study|Incorrect Enrolment|64
1810560|NCT00463866|6290341|P2|Overall Study|Lost to Follow-up|55
1810561|NCT00463866|6290342|P1|Overall Study|Lost to Follow-up|46
1810562|NCT00463866|6290341|P2|Overall Study|Withdrawal by Subject|79
1810563|NCT00463866|6290342|P1|Overall Study|Withdrawal by Subject|81
1810564|NCT00463866|6290341|P2|Overall Study|Adverse Event|93
1810565|NCT00463866|6290342|P1|Overall Study|Adverse Event|70
1810566|NCT00463840|6290362|P1|Overall Study|Adverse Event|3
1810567|NCT00463840|6290362|P1|Overall Study|Withdrawal by Subject|2
1810568|NCT00463840|6290362|P1|Overall Study|Disease progression|7
1810569|NCT00463801|6290367|P1|Overall Study|No longer require therapy|1
1810570|NCT00463801|6290367|P1|Overall Study|Lost to Follow-up|5
1810571|NCT00463801|6290367|P1|Overall Study|Adverse Event|4
1810572|NCT00463801|6290367|P1|Overall Study|Lack of Efficacy|2
1810573|NCT00463801|6290367|P1|Overall Study|Protocol Violation|1
1810574|NCT00463788|6290373|P2|Overall Study|Randomized but not treated|1
1810575|NCT00463788|6290374|P1|Overall Study|Randomized but not treated|1
1810576|NCT00463788|6290373|P2|Overall Study|Other|0
1810577|NCT00463788|6290374|P1|Overall Study|Other|3
1810578|NCT00463788|6290373|P2|Overall Study|Protocol Violation|1
1810579|NCT00463788|6290374|P1|Overall Study|Protocol Violation|0
1810580|NCT00463788|6290373|P2|Overall Study|Lost to Follow-up|0
1810581|NCT00463788|6290374|P1|Overall Study|Lost to Follow-up|1
1810582|NCT00463788|6290373|P2|Overall Study|Symptomatic Deterioration|3
1810583|NCT00463788|6290374|P1|Overall Study|Symptomatic Deterioration|2
1810584|NCT00463788|6290373|P2|Overall Study|Death|3
1810585|NCT00463788|6290374|P1|Overall Study|Death|4
1810586|NCT00463788|6290373|P2|Overall Study|Withdrawal by Subject|2
1810587|NCT00463788|6290374|P1|Overall Study|Withdrawal by Subject|6
1810588|NCT00463788|6290373|P2|Overall Study|Adverse Event|2
1810589|NCT00463788|6290374|P1|Overall Study|Adverse Event|6
1810590|NCT00463788|6290373|P2|Overall Study|Progressive Disease|42
1810591|NCT00463788|6290374|P1|Overall Study|Progressive Disease|86
1810592|NCT00463684|6290389|P1|Overall Study|Lost to Follow-up|3
1810593|NCT00463684|6290389|P1|Overall Study|Withdrawal by Subject|1
1810594|NCT00463606|6290407|P3|Overall Study|Protocol Violation|1
1810595|NCT00463606|6290408|P2|Overall Study|Protocol Violation|0
1810596|NCT00463606|6290409|P1|Overall Study|Protocol Violation|0
1810597|NCT00463606|6290407|P3|Overall Study|Participation in another ABT-335 trial|0
1810598|NCT00463606|6290408|P2|Overall Study|Participation in another ABT-335 trial|0
1810599|NCT00463606|6290409|P1|Overall Study|Participation in another ABT-335 trial|1
1810600|NCT00463606|6290407|P3|Overall Study|Patient randomized in error|0
1810601|NCT00463606|6290408|P2|Overall Study|Patient randomized in error|0
1810602|NCT00463606|6290409|P1|Overall Study|Patient randomized in error|1
1810603|NCT00463606|6290407|P3|Overall Study|Coordinator error|0
1810604|NCT00463606|6290408|P2|Overall Study|Coordinator error|0
1810605|NCT00463606|6290409|P1|Overall Study|Coordinator error|1
1810606|NCT00463606|6290407|P3|Overall Study|Exclusion criteria violation|0
1810607|NCT00463606|6290408|P2|Overall Study|Exclusion criteria violation|0
1810608|NCT00463606|6290409|P1|Overall Study|Exclusion criteria violation|2
1810609|NCT00463606|6290407|P3|Overall Study|Sponsor request|0
1810610|NCT00463606|6290408|P2|Overall Study|Sponsor request|1
1810611|NCT00463606|6290409|P1|Overall Study|Sponsor request|0
1810612|NCT00463606|6290407|P3|Overall Study|Physician Decision|0
1810613|NCT00463606|6290408|P2|Overall Study|Physician Decision|1
1810614|NCT00463606|6290409|P1|Overall Study|Physician Decision|0
1810615|NCT00463606|6290407|P3|Overall Study|Subject moved out of town|0
1810616|NCT00463606|6290408|P2|Overall Study|Subject moved out of town|0
1810617|NCT00463606|6290409|P1|Overall Study|Subject moved out of town|1
1810618|NCT00463606|6290407|P3|Overall Study|Subject noncompliance|0
1810619|NCT00463606|6290408|P2|Overall Study|Subject noncompliance|1
1810620|NCT00463606|6290409|P1|Overall Study|Subject noncompliance|1
1810621|NCT00463606|6290407|P3|Overall Study|Lost to Follow-up|3
1810622|NCT00463606|6290408|P2|Overall Study|Lost to Follow-up|2
1810623|NCT00463606|6290409|P1|Overall Study|Lost to Follow-up|2
1810624|NCT00463606|6290407|P3|Overall Study|Withdrawal by Subject|5
1810625|NCT00463606|6290408|P2|Overall Study|Withdrawal by Subject|11
1810626|NCT00463606|6290409|P1|Overall Study|Withdrawal by Subject|11
1810627|NCT00463606|6290407|P3|Overall Study|Adverse Event|11
1810628|NCT00463606|6290408|P2|Overall Study|Adverse Event|18
1810629|NCT00463606|6290409|P1|Overall Study|Adverse Event|21
1810630|NCT00463580|6290434|P2|Overall Study|Medical/psychiatric complications|2
1810631|NCT00463580|6290435|P1|Overall Study|Medical/psychiatric complications|0
1810632|NCT00463580|6290434|P2|Overall Study|Schedule conflict|0
1810633|NCT00463580|6290435|P1|Overall Study|Schedule conflict|2
1810634|NCT00463580|6290434|P2|Overall Study|Lost to Follow-up|0
1810635|NCT00463580|6290435|P1|Overall Study|Lost to Follow-up|1
1810636|NCT00463567|6290468|P7|Overall Study|Death|0
1810637|NCT00463567|6290469|P6|Overall Study|Death|0
1810638|NCT00463567|6290470|P5|Overall Study|Death|0
1810639|NCT00463567|6290471|P4|Overall Study|Death|0
1810640|NCT00463567|6290472|P3|Overall Study|Death|2
1810641|NCT00463567|6290473|P2|Overall Study|Death|0
1810642|NCT00463567|6290474|P1|Overall Study|Death|1
1810643|NCT00463567|6290468|P7|Overall Study|Abnormal test procedure result(s)|0
1810644|NCT00463567|6290469|P6|Overall Study|Abnormal test procedure result(s)|2
1810645|NCT00463567|6290470|P5|Overall Study|Abnormal test procedure result(s)|0
1810646|NCT00463567|6290471|P4|Overall Study|Abnormal test procedure result(s)|2
1810647|NCT00463567|6290472|P3|Overall Study|Abnormal test procedure result(s)|6
1810648|NCT00463567|6290473|P2|Overall Study|Abnormal test procedure result(s)|1
1810649|NCT00463567|6290474|P1|Overall Study|Abnormal test procedure result(s)|1
1810650|NCT00463567|6290468|P7|Overall Study|Abnormal lab value(s)|0
1810651|NCT00463567|6290469|P6|Overall Study|Abnormal lab value(s)|0
1810652|NCT00463567|6290470|P5|Overall Study|Abnormal lab value(s)|1
1810653|NCT00463567|6290471|P4|Overall Study|Abnormal lab value(s)|1
1810654|NCT00463567|6290472|P3|Overall Study|Abnormal lab value(s)|2
1810655|NCT00463567|6290473|P2|Overall Study|Abnormal lab value(s)|1
1810656|NCT00463567|6290474|P1|Overall Study|Abnormal lab value(s)|1
1810657|NCT00463567|6290468|P7|Overall Study|Lack of Efficacy|1
1810658|NCT00463567|6290469|P6|Overall Study|Lack of Efficacy|0
1810659|NCT00463567|6290470|P5|Overall Study|Lack of Efficacy|1
1810660|NCT00463567|6290471|P4|Overall Study|Lack of Efficacy|17
1810661|NCT00463567|6290472|P3|Overall Study|Lack of Efficacy|9
1810662|NCT00463567|6290473|P2|Overall Study|Lack of Efficacy|9
1810663|NCT00463567|6290474|P1|Overall Study|Lack of Efficacy|4
1810664|NCT00463567|6290468|P7|Overall Study|Administrative problems|2
1810665|NCT00463567|6290469|P6|Overall Study|Administrative problems|2
1810666|NCT00463567|6290470|P5|Overall Study|Administrative problems|3
1810667|NCT00463567|6290471|P4|Overall Study|Administrative problems|9
1810668|NCT00463567|6290472|P3|Overall Study|Administrative problems|6
1810669|NCT00463567|6290473|P2|Overall Study|Administrative problems|3
1810670|NCT00463567|6290474|P1|Overall Study|Administrative problems|5
1810671|NCT00463567|6290468|P7|Overall Study|Lost to Follow-up|1
1810672|NCT00463567|6290469|P6|Overall Study|Lost to Follow-up|1
1810673|NCT00463567|6290470|P5|Overall Study|Lost to Follow-up|1
1810674|NCT00463567|6290471|P4|Overall Study|Lost to Follow-up|8
1810675|NCT00463567|6290472|P3|Overall Study|Lost to Follow-up|13
1810676|NCT00463567|6290473|P2|Overall Study|Lost to Follow-up|6
1810677|NCT00463567|6290474|P1|Overall Study|Lost to Follow-up|12
1810678|NCT00463567|6290468|P7|Overall Study|Protocol Deviation|2
1810679|NCT00463567|6290469|P6|Overall Study|Protocol Deviation|1
1810680|NCT00463567|6290470|P5|Overall Study|Protocol Deviation|1
1810681|NCT00463567|6290471|P4|Overall Study|Protocol Deviation|11
1810682|NCT00463567|6290472|P3|Overall Study|Protocol Deviation|14
1810683|NCT00463567|6290473|P2|Overall Study|Protocol Deviation|9
1810684|NCT00463567|6290474|P1|Overall Study|Protocol Deviation|13
1810685|NCT00463567|6290468|P7|Overall Study|Withdrawal by Subject|1
1810686|NCT00463567|6290469|P6|Overall Study|Withdrawal by Subject|5
1810687|NCT00463567|6290470|P5|Overall Study|Withdrawal by Subject|6
1810688|NCT00463567|6290471|P4|Overall Study|Withdrawal by Subject|37
1810689|NCT00463567|6290472|P3|Overall Study|Withdrawal by Subject|20
1810690|NCT00463567|6290473|P2|Overall Study|Withdrawal by Subject|22
1810691|NCT00463567|6290474|P1|Overall Study|Withdrawal by Subject|29
1810692|NCT00463567|6290468|P7|Overall Study|Adverse Event|4
1810693|NCT00463567|6290469|P6|Overall Study|Adverse Event|10
1810694|NCT00463567|6290470|P5|Overall Study|Adverse Event|10
1810695|NCT00463567|6290471|P4|Overall Study|Adverse Event|46
1810696|NCT00463567|6290472|P3|Overall Study|Adverse Event|17
1810697|NCT00463567|6290473|P2|Overall Study|Adverse Event|26
1810698|NCT00463567|6290474|P1|Overall Study|Adverse Event|29
1810699|NCT00463385|6290578|P4|Overall Study|1 participant received commercial drug|0
1810700|NCT00463385|6290579|P3|Overall Study|1 participant received commercial drug|0
1810701|NCT00463385|6290580|P2|Overall Study|1 participant received commercial drug|1
1810702|NCT00463385|6290581|P1|Overall Study|1 participant received commercial drug|0
1810703|NCT00463385|6290578|P4|Overall Study|Missing|2
1810704|NCT00463385|6290579|P3|Overall Study|Missing|0
1810705|NCT00463385|6290580|P2|Overall Study|Missing|0
1810706|NCT00463385|6290581|P1|Overall Study|Missing|2
1810707|NCT00463385|6290578|P4|Overall Study|Death|0
1810708|NCT00463385|6290579|P3|Overall Study|Death|2
1810709|NCT00463385|6290580|P2|Overall Study|Death|1
1810710|NCT00463385|6290581|P1|Overall Study|Death|2
1810711|NCT00463385|6290578|P4|Overall Study|Lost to Follow-up|1
1810712|NCT00463385|6290579|P3|Overall Study|Lost to Follow-up|0
1810713|NCT00463385|6290580|P2|Overall Study|Lost to Follow-up|0
1810714|NCT00463385|6290581|P1|Overall Study|Lost to Follow-up|0
1810715|NCT00463385|6290578|P4|Overall Study|Withdrawal by Subject|4
1810716|NCT00463385|6290579|P3|Overall Study|Withdrawal by Subject|3
1810717|NCT00463385|6290580|P2|Overall Study|Withdrawal by Subject|3
1810718|NCT00463385|6290581|P1|Overall Study|Withdrawal by Subject|3
1810719|NCT00463385|6290578|P4|Overall Study|Lack of Efficacy|9
1810720|NCT00463385|6290579|P3|Overall Study|Lack of Efficacy|7
1810721|NCT00463385|6290580|P2|Overall Study|Lack of Efficacy|6
1810722|NCT00463385|6290581|P1|Overall Study|Lack of Efficacy|6
1810723|NCT00463385|6290578|P4|Overall Study|Adverse Event|2
1810724|NCT00463385|6290579|P3|Overall Study|Adverse Event|4
1810725|NCT00463385|6290580|P2|Overall Study|Adverse Event|8
1810726|NCT00463385|6290581|P1|Overall Study|Adverse Event|5
1810727|NCT00463385|6290578|P4|Overall Study|Other|4
1810728|NCT00463385|6290579|P3|Overall Study|Other|6
1810729|NCT00463385|6290580|P2|Overall Study|Other|3
1810730|NCT00463385|6290581|P1|Overall Study|Other|4
1810731|NCT00463346|6290633|P2|Overall Study|Withdrawal by Subject|3
1810732|NCT00463346|6290634|P1|Overall Study|Withdrawal by Subject|3
1810733|NCT00463229|6290644|P2|Overall Study|Death|3
1810734|NCT00463229|6290645|P1|Overall Study|Death|4
1810735|NCT00463229|6290644|P2|Overall Study|Lost to Follow-up|7
1810736|NCT00463229|6290645|P1|Overall Study|Lost to Follow-up|5
1810737|NCT00463060|6290665|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
1810738|NCT00463060|6290665|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
1810739|NCT00463047|6290679|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
1810740|NCT00463047|6290680|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
1810741|NCT00463047|6290679|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
1810742|NCT00463047|6290680|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
1810743|NCT00463047|6290679|P2|Double-Blind Treatment Period 2|Adverse Event|1
1810744|NCT00463047|6290680|P1|Double-Blind Treatment Period 2|Adverse Event|0
1810745|NCT00463047|6290679|P2|Double-Blind Treatment Period 1|Other|0
1810746|NCT00463047|6290680|P1|Double-Blind Treatment Period 1|Other|1
1810747|NCT00463047|6290679|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
1810748|NCT00463047|6290680|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
1810749|NCT00463047|6290679|P2|Double-Blind Treatment Period 1|Protocol Violation|2
1810750|NCT00463047|6290680|P1|Double-Blind Treatment Period 1|Protocol Violation|1
1810751|NCT00463047|6290679|P2|Double-Blind Treatment Period 1|Adverse Event|2
1810752|NCT00463047|6290680|P1|Double-Blind Treatment Period 1|Adverse Event|0
1810753|NCT00463047|6290679|P2|Titration Period 2|Other|2
1810754|NCT00463047|6290680|P1|Titration Period 2|Other|3
1810755|NCT00463047|6290679|P2|Titration Period 2|Non-compliance procedures|1
1810756|NCT00463047|6290680|P1|Titration Period 2|Non-compliance procedures|4
1810757|NCT00463047|6290679|P2|Titration Period 2|Non-compliance study medication|2
1810758|NCT00463047|6290680|P1|Titration Period 2|Non-compliance study medication|4
1810759|NCT00463047|6290679|P2|Titration Period 2|Lost to Follow-up|2
1810760|NCT00463047|6290680|P1|Titration Period 2|Lost to Follow-up|1
1810761|NCT00463047|6290679|P2|Titration Period 2|Protocol Violation|3
1810762|NCT00463047|6290680|P1|Titration Period 2|Protocol Violation|2
1810763|NCT00463047|6290679|P2|Titration Period 2|Withdrawal by Subject|0
1810764|NCT00463047|6290680|P1|Titration Period 2|Withdrawal by Subject|1
1810765|NCT00463047|6290679|P2|Titration Period 2|Lack of Efficacy|4
1810766|NCT00463047|6290680|P1|Titration Period 2|Lack of Efficacy|6
1810767|NCT00463047|6290679|P2|Titration Period 2|Adverse Event|9
1810768|NCT00463047|6290680|P1|Titration Period 2|Adverse Event|9
1810769|NCT00463047|6290679|P2|Titration Period 1|Other|2
1810770|NCT00463047|6290680|P1|Titration Period 1|Other|0
1810771|NCT00463047|6290679|P2|Titration Period 1|Non-compliance procedures|10
1810772|NCT00463047|6290680|P1|Titration Period 1|Non-compliance procedures|4
1810773|NCT00463047|6290679|P2|Titration Period 1|Withdrawal by Subject|5
1810774|NCT00463047|6290680|P1|Titration Period 1|Withdrawal by Subject|3
1810775|NCT00463047|6290679|P2|Titration Period 1|Protocol Violation|5
1810776|NCT00463047|6290680|P1|Titration Period 1|Protocol Violation|5
1810777|NCT00463047|6290679|P2|Titration Period 1|Non-compliance with study medication|5
1810778|NCT00463047|6290680|P1|Titration Period 1|Non-compliance with study medication|3
1810779|NCT00463047|6290679|P2|Titration Period 1|Lost to Follow-up|0
1810780|NCT00463047|6290680|P1|Titration Period 1|Lost to Follow-up|2
1810781|NCT00463047|6290679|P2|Titration Period 1|Lack of Efficacy|4
1810782|NCT00463047|6290680|P1|Titration Period 1|Lack of Efficacy|10
1810783|NCT00463047|6290679|P2|Titration Period 1|Adverse Event|8
1810784|NCT00463047|6290680|P1|Titration Period 1|Adverse Event|10
1810785|NCT00462982|6290765|P1|Overall Study|Patient Not Treated|2
1810786|NCT00462982|6290765|P1|Overall Study|Adverse Event|1
1810787|NCT00462943|6290772|P3|Overall Study|Withdrawal by Subject|0
1810788|NCT00462943|6290773|P2|Overall Study|Withdrawal by Subject|1
1810789|NCT00462943|6290774|P1|Overall Study|Withdrawal by Subject|0
1810790|NCT00462943|6290772|P3|Overall Study|Physician Decision|0
1810791|NCT00462943|6290773|P2|Overall Study|Physician Decision|0
1810792|NCT00462943|6290774|P1|Overall Study|Physician Decision|1
1810793|NCT00462943|6290772|P3|Overall Study|Transplant - not specified|1
1810794|NCT00462943|6290773|P2|Overall Study|Transplant - not specified|0
1810795|NCT00462943|6290774|P1|Overall Study|Transplant - not specified|1
1810796|NCT00462943|6290772|P3|Overall Study|Required Lymphocyte Infusion|0
1810797|NCT00462943|6290773|P2|Overall Study|Required Lymphocyte Infusion|0
1810798|NCT00462943|6290774|P1|Overall Study|Required Lymphocyte Infusion|1
1810799|NCT00462943|6290772|P3|Overall Study|Bone Marrow Transplant|0
1810800|NCT00462943|6290773|P2|Overall Study|Bone Marrow Transplant|0
1810801|NCT00462943|6290774|P1|Overall Study|Bone Marrow Transplant|1
1810802|NCT00462943|6290772|P3|Overall Study|Stem Cell Transplant|0
1810803|NCT00462943|6290773|P2|Overall Study|Stem Cell Transplant|1
1810804|NCT00462943|6290774|P1|Overall Study|Stem Cell Transplant|1
1810805|NCT00462943|6290772|P3|Overall Study|Death|7
1810806|NCT00462943|6290773|P2|Overall Study|Death|2
1810807|NCT00462943|6290774|P1|Overall Study|Death|5
1810808|NCT00462943|6290772|P3|Overall Study|Disease Progression|9
1810809|NCT00462943|6290773|P2|Overall Study|Disease Progression|15
1810810|NCT00462943|6290774|P1|Overall Study|Disease Progression|15
1810811|NCT00462943|6290772|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
1810812|NCT00462943|6290773|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
1810813|NCT00462943|6290774|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
1810814|NCT00462943|6290772|P3|Overall Study|Protocol Violation|0
1810815|NCT00462943|6290773|P2|Overall Study|Protocol Violation|0
1810816|NCT00462943|6290774|P1|Overall Study|Protocol Violation|1
1810817|NCT00462943|6290772|P3|Overall Study|Adverse Event|1
1810818|NCT00462943|6290773|P2|Overall Study|Adverse Event|4
1810819|NCT00462943|6290774|P1|Overall Study|Adverse Event|6
1810820|NCT00462943|6290772|P3|Overall Study|Failure to achieve a response|1
1810821|NCT00462943|6290773|P2|Overall Study|Failure to achieve a response|5
1810822|NCT00462943|6290774|P1|Overall Study|Failure to achieve a response|5
1810823|NCT00462904|6290866|P1|Overall Study|Lost to Follow-up|1
1810824|NCT00462865|6290871|P1|Overall Study|Adverse Event|1
1810825|NCT00462826|6290891|P1|Overall Study|Never treated|1
1810826|NCT00462826|6290891|P1|Overall Study|Ineligible - wrong primary|2
1810827|NCT00462826|6290891|P1|Overall Study|Ineligible - wrong cell type|1
1810828|NCT00462826|6290891|P1|Overall Study|Ineligible - second primary|1
1810829|NCT00462748|6290907|P3|Overall Study|Discontinued after 41 days Rx|0
1810830|NCT00462748|6290908|P2|Overall Study|Discontinued after 41 days Rx|0
1810831|NCT00462748|6290909|P1|Overall Study|Discontinued after 41 days Rx|1
1810832|NCT00462748|6290907|P3|Overall Study|Lost to Follow-up|1
1810833|NCT00462748|6290908|P2|Overall Study|Lost to Follow-up|1
1810834|NCT00462748|6290909|P1|Overall Study|Lost to Follow-up|1
1810835|NCT00462748|6290907|P3|Overall Study|Withdrew consent|0
1810836|NCT00462748|6290908|P2|Overall Study|Withdrew consent|3
1810837|NCT00462748|6290909|P1|Overall Study|Withdrew consent|3
1810838|NCT00462748|6290907|P3|Overall Study|Protocol Violation|1
1810839|NCT00462748|6290908|P2|Overall Study|Protocol Violation|2
1810840|NCT00462748|6290909|P1|Overall Study|Protocol Violation|0
1810841|NCT00462748|6290907|P3|Overall Study|Adverse Event|9
1810842|NCT00462748|6290908|P2|Overall Study|Adverse Event|5
1810843|NCT00462748|6290909|P1|Overall Study|Adverse Event|7
1810844|NCT00462709|6290962|P1|Overall Study|Withdrew to start treatment with Cetor|1
1810845|NCT00462709|6290962|P1|Overall Study|Physician Decision|1
1810846|NCT00462709|6290962|P1|Overall Study|Logistical reasons|2
1810847|NCT00462709|6290962|P1|Overall Study|Death|2
1810848|NCT00462709|6290962|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
1810849|NCT00462709|6290962|P1|Overall Study|Withdrawal by Subject|8
1810850|NCT00462709|6290962|P1|Overall Study|Lost to Follow-up|10
1810851|NCT00462709|6290962|P1|Overall Study|Transitioned to commercial C1INH-nf|40
1810852|NCT00462670|6290971|P2|Overall Study|Resolution of signs and symptoms|2
1810853|NCT00462670|6290972|P1|Overall Study|Resolution of signs and symptoms|0
1810854|NCT00462670|6290971|P2|Overall Study|Protocol Violation|0
1810855|NCT00462670|6290972|P1|Overall Study|Protocol Violation|1
1810856|NCT00462670|6290971|P2|Overall Study|Lack of Efficacy|0
1810857|NCT00462670|6290972|P1|Overall Study|Lack of Efficacy|1
1810858|NCT00462670|6290971|P2|Overall Study|Adverse Event|5
1810859|NCT00462670|6290972|P1|Overall Study|Adverse Event|3
1810860|NCT00462501|6291009|P1|Overall Study|Adverse Event|2
1810861|NCT00462501|6291009|P1|Overall Study|Not treated|3
1810862|NCT00462462|6291015|P2|Overall Study|Physician Decision|1
1810863|NCT00462462|6291016|P1|Overall Study|Physician Decision|0
1810864|NCT00462384|6291044|P1|Overall Study|Other|4
1810865|NCT00462384|6291044|P1|Overall Study|Withdrawal by Subject|1
1810866|NCT00462384|6291044|P1|Overall Study|Death|2
1810867|NCT00462384|6291044|P1|Overall Study|Adverse Event|2
1810868|NCT00462345|6291052|P1|Overall Study|Did not complete second course|1
1810869|NCT00462345|6291052|P1|Overall Study|Withdrawal by Subject|2
1810870|NCT00462306|6291087|P2|Overall Study|insufficient data|13
1810871|NCT00462306|6291088|P1|Overall Study|insufficient data|0
1810872|NCT00461981|6291219|P2|Overall Study|Withdrawal by Subject|3
1810873|NCT00461981|6291220|P1|Overall Study|Withdrawal by Subject|2
1810874|NCT00461981|6291219|P2|Overall Study|Lost to Follow-up|6
1810875|NCT00461981|6291220|P1|Overall Study|Lost to Follow-up|9
1810876|NCT00461812|6291336|P1|Overall Study|study terminated|10
1810877|NCT00461786|6291341|P1|Overall Study|Inevaluable (Never Treated)|1
1810878|NCT00461786|6291341|P1|Overall Study|Entry Criteria Not Met|2
1810879|NCT00461708|6291386|P2|Overall Study|Death|1
1810880|NCT00461708|6291387|P1|Overall Study|Death|8
1810881|NCT00461708|6291386|P2|Overall Study|Other|4
1810882|NCT00461708|6291387|P1|Overall Study|Other|4
1810883|NCT00461708|6291386|P2|Overall Study|Withdrawal by Subject|2
1810884|NCT00461708|6291387|P1|Overall Study|Withdrawal by Subject|8
1810885|NCT00461708|6291386|P2|Overall Study|Physician Decision|4
1810886|NCT00461708|6291387|P1|Overall Study|Physician Decision|10
1810887|NCT00461708|6291386|P2|Overall Study|Lack of Efficacy|20
1810888|NCT00461708|6291387|P1|Overall Study|Lack of Efficacy|68
1810889|NCT00461708|6291386|P2|Overall Study|Adverse Event|7
1810890|NCT00461708|6291387|P1|Overall Study|Adverse Event|17
1810891|NCT00461682|6291413|P1|Overall Study|Protocol Violation|1
1810892|NCT00461630|6291441|P2|Overall Study|Lost to Follow-up|95
1810893|NCT00461630|6291442|P1|Overall Study|Lost to Follow-up|108
1810894|NCT00461630|6291441|P2|Overall Study|Death|732
1810895|NCT00461630|6291442|P1|Overall Study|Death|798
1810896|NCT00461552|6291481|P2|Overall Study|Drug Dispensing error|2
1810897|NCT00461552|6291482|P1|Overall Study|Drug Dispensing error|0
1810898|NCT00461500|6291505|P2|Overall Study|Lost to Follow-up|2
1810899|NCT00461500|6291506|P1|Overall Study|Lost to Follow-up|2
1810900|NCT00461500|6291505|P2|Overall Study|No Longer Willing to Take Part in Study|0
1810901|NCT00461500|6291506|P1|Overall Study|No Longer Willing to Take Part in Study|1
1810902|NCT00461500|6291505|P2|Overall Study|Drug Treatment Misuse|0
1810903|NCT00461500|6291506|P1|Overall Study|Drug Treatment Misuse|1
1810904|NCT00461500|6291505|P2|Overall Study|Study Stopped|2
1810905|NCT00461500|6291506|P1|Overall Study|Study Stopped|1
1810906|NCT00461500|6291505|P2|Overall Study|Expired Drug Treatment|1
1810907|NCT00461500|6291506|P1|Overall Study|Expired Drug Treatment|1
1810908|NCT00461500|6291505|P2|Overall Study|Lack of Efficacy|1
1810909|NCT00461500|6291506|P1|Overall Study|Lack of Efficacy|0
1810910|NCT00461500|6291505|P2|Overall Study|Adverse Event|0
1810911|NCT00461500|6291506|P1|Overall Study|Adverse Event|1
1810912|NCT00461305|6291549|P2|Continued Treatment|Other (missing drug etc)|0
1810913|NCT00461305|6291550|P1|Continued Treatment|Other (missing drug etc)|2
1810914|NCT00461305|6291549|P2|Continued Treatment|Partially missing diary|0
1810915|NCT00461305|6291550|P1|Continued Treatment|Partially missing diary|2
1810916|NCT00461305|6291549|P2|Continued Treatment|Withdrawal by Subject|0
1810917|NCT00461305|6291550|P1|Continued Treatment|Withdrawal by Subject|48
1810918|NCT00461305|6291549|P2|Continued Treatment|Protocol Violation|0
1810919|NCT00461305|6291550|P1|Continued Treatment|Protocol Violation|13
1810920|NCT00461305|6291549|P2|Continued Treatment|Lost to Follow-up|0
1810921|NCT00461305|6291550|P1|Continued Treatment|Lost to Follow-up|4
1810922|NCT00461305|6291549|P2|Continued Treatment|Adverse Event|0
1810923|NCT00461305|6291550|P1|Continued Treatment|Adverse Event|26
1810924|NCT00461305|6291549|P2|Treatment|Other (missing drug etc)|0
1810925|NCT00461305|6291550|P1|Treatment|Other (missing drug etc)|2
1810926|NCT00461305|6291549|P2|Treatment|Partially missing diary|0
1810927|NCT00461305|6291550|P1|Treatment|Partially missing diary|2
1810928|NCT00461305|6291549|P2|Treatment|Study drug not taken|0
1810929|NCT00461305|6291550|P1|Treatment|Study drug not taken|1
1810930|NCT00461305|6291549|P2|Treatment|Never dispensed|0
1810931|NCT00461305|6291550|P1|Treatment|Never dispensed|5
1810932|NCT00461305|6291549|P2|Treatment|Withdrawal by Subject|2
1810933|NCT00461305|6291550|P1|Treatment|Withdrawal by Subject|48
1810934|NCT00461305|6291549|P2|Treatment|Protocol Violation|2
1810935|NCT00461305|6291550|P1|Treatment|Protocol Violation|13
1810936|NCT00461305|6291549|P2|Treatment|Lost to Follow-up|2
1810937|NCT00461305|6291550|P1|Treatment|Lost to Follow-up|4
1810938|NCT00461305|6291549|P2|Treatment|Adverse Event|3
1810939|NCT00461305|6291550|P1|Treatment|Adverse Event|26
1810940|NCT00461253|6291634|P2|Overall Study|administrative|7773
1810941|NCT00461253|6291635|P1|Overall Study|administrative|773
1810942|NCT00461253|6291634|P2|Overall Study|no response|11789
1810943|NCT00461253|6291635|P1|Overall Study|no response|2609
1810944|NCT00461253|6291634|P2|Overall Study|Protocol Violation|236
1810945|NCT00461253|6291635|P1|Overall Study|Protocol Violation|613
1810946|NCT00461253|6291634|P2|Overall Study|Death|0
1810947|NCT00461253|6291635|P1|Overall Study|Death|985
1810948|NCT00461175|6291643|P2|Overall Study|Protocol Violation|365
1810949|NCT00461175|6291644|P1|Overall Study|Protocol Violation|522
1810950|NCT00461123|6291654|P2|Overall Study|Withdrawal by Subject|3
1810951|NCT00461123|6291655|P1|Overall Study|Withdrawal by Subject|1
1810952|NCT00461123|6291654|P2|Overall Study|Protocol Violation|2
1810953|NCT00461123|6291655|P1|Overall Study|Protocol Violation|3
1810954|NCT00461123|6291654|P2|Overall Study|Lost to Follow-up|1
1810955|NCT00461123|6291655|P1|Overall Study|Lost to Follow-up|1
1810956|NCT00461123|6291654|P2|Overall Study|Adverse Event|0
1810957|NCT00461123|6291655|P1|Overall Study|Adverse Event|1
1810958|NCT00461032|6291700|P2|Overall Study|Other|5
1810959|NCT00461032|6291701|P1|Overall Study|Other|7
1810960|NCT00461032|6291700|P2|Overall Study|Patient Moved or Relocated|1
1810961|NCT00461032|6291701|P1|Overall Study|Patient Moved or Relocated|2
1810962|NCT00461032|6291700|P2|Overall Study|Withdrawal by Subject|15
1810963|NCT00461032|6291701|P1|Overall Study|Withdrawal by Subject|7
1810964|NCT00461032|6291700|P2|Overall Study|Protocol Violation|4
1810965|NCT00461032|6291701|P1|Overall Study|Protocol Violation|4
1810966|NCT00461032|6291700|P2|Overall Study|Lost to Follow-up|12
1810967|NCT00461032|6291701|P1|Overall Study|Lost to Follow-up|7
1810968|NCT00461032|6291700|P2|Overall Study|Lack of Efficacy|1
1810969|NCT00461032|6291701|P1|Overall Study|Lack of Efficacy|5
1810970|NCT00461032|6291700|P2|Overall Study|Adverse Event|6
1810971|NCT00461032|6291701|P1|Overall Study|Adverse Event|5
1810972|NCT00460811|6291727|P5|Overall Study|Lost to Follow-up|6
1810973|NCT00460811|6291728|P4|Overall Study|Lost to Follow-up|3
1810974|NCT00460811|6291729|P3|Overall Study|Lost to Follow-up|5
1810975|NCT00460811|6291730|P2|Overall Study|Lost to Follow-up|2
1810976|NCT00460811|6291731|P1|Overall Study|Lost to Follow-up|3
1810977|NCT00460811|6291727|P5|Overall Study|Physician Decision|0
1810978|NCT00460811|6291728|P4|Overall Study|Physician Decision|0
1810979|NCT00460811|6291729|P3|Overall Study|Physician Decision|0
1810980|NCT00460811|6291730|P2|Overall Study|Physician Decision|0
1810981|NCT00460811|6291731|P1|Overall Study|Physician Decision|1
1810982|NCT00460811|6291727|P5|Overall Study|Withdrawal by Subject|11
1810983|NCT00460811|6291728|P4|Overall Study|Withdrawal by Subject|3
1810984|NCT00460811|6291729|P3|Overall Study|Withdrawal by Subject|6
1810985|NCT00460811|6291730|P2|Overall Study|Withdrawal by Subject|7
1810986|NCT00460811|6291731|P1|Overall Study|Withdrawal by Subject|7
1810987|NCT00460811|6291727|P5|Overall Study|Noncompliance|1
1810988|NCT00460811|6291728|P4|Overall Study|Noncompliance|2
1810989|NCT00460811|6291729|P3|Overall Study|Noncompliance|0
1810990|NCT00460811|6291730|P2|Overall Study|Noncompliance|0
1810991|NCT00460811|6291731|P1|Overall Study|Noncompliance|1
1810992|NCT00460811|6291727|P5|Overall Study|Adverse Event|2
1810993|NCT00460811|6291728|P4|Overall Study|Adverse Event|10
1810994|NCT00460811|6291729|P3|Overall Study|Adverse Event|3
1810995|NCT00460811|6291730|P2|Overall Study|Adverse Event|6
1810996|NCT00460811|6291731|P1|Overall Study|Adverse Event|4
1810997|NCT00460798|6291773|P1|Overall Study|Missing/Incomplete Dosing Information|27
1810998|NCT00460798|6291773|P1|Overall Study|Ongoing at Date of Cut-Off|82
1810999|NCT00460798|6291773|P1|Overall Study|Other|27
1811000|NCT00460798|6291773|P1|Overall Study|Progressive Disease|99
1811001|NCT00460798|6291773|P1|Overall Study|Lost to Follow-up|19
1811002|NCT00460798|6291773|P1|Overall Study|Adverse Event|27
1811003|NCT00460798|6291773|P1|Overall Study|Death|59
1811004|NCT00460746|6291781|P1|Overall Study|Lost to Follow-up|1
1811005|NCT00460746|6291781|P1|Overall Study|Adverse Event|1
1811006|NCT00460655|6291796|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
1811007|NCT00460655|6291797|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1811008|NCT00460655|6291798|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1811009|NCT00460655|6291799|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
1811010|NCT00460655|6291796|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
1811011|NCT00460655|6291797|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
1811012|NCT00460655|6291798|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811013|NCT00460655|6291799|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811014|NCT00460655|6291796|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
1811015|NCT00460655|6291797|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
1811016|NCT00460655|6291798|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
1811017|NCT00460655|6291799|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
1811018|NCT00460655|6291796|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1811019|NCT00460655|6291797|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1811020|NCT00460655|6291798|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
1811021|NCT00460655|6291799|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
1811022|NCT00460655|6291796|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811023|NCT00460655|6291797|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811024|NCT00460655|6291798|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811025|NCT00460655|6291799|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
1811026|NCT00460655|6291796|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811027|NCT00460655|6291797|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811028|NCT00460655|6291798|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811029|NCT00460655|6291799|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
1811030|NCT00460603|6291843|P12|Phase 2|Randomized, but not treated|0
1811031|NCT00460603|6291844|P11|Phase 2|Randomized, but not treated|0
1811032|NCT00460603|6291845|P10|Phase 2|Randomized, but not treated|3
1811033|NCT00460603|6291846|P9|Phase 2|Randomized, but not treated|0
1811034|NCT00460603|6291847|P8|Phase 2|Randomized, but not treated|0
1811035|NCT00460603|6291848|P7|Phase 2|Randomized, but not treated|0
1811036|NCT00460603|6291849|P6|Phase 2|Randomized, but not treated|0
1811037|NCT00460603|6291850|P5|Phase 2|Randomized, but not treated|0
1811038|NCT00460603|6291851|P4|Phase 2|Randomized, but not treated|0
1811039|NCT00460603|6291852|P3|Phase 2|Randomized, but not treated|0
1811040|NCT00460603|6291853|P2|Phase 2|Randomized, but not treated|0
1811041|NCT00460603|6291854|P1|Phase 2|Randomized, but not treated|0
1811042|NCT00460603|6291843|P12|Phase 2|Withdrawal by Subject|5
1811043|NCT00460603|6291844|P11|Phase 2|Withdrawal by Subject|4
1811044|NCT00460603|6291845|P10|Phase 2|Withdrawal by Subject|5
1811045|NCT00460603|6291846|P9|Phase 2|Withdrawal by Subject|0
1811046|NCT00460603|6291847|P8|Phase 2|Withdrawal by Subject|0
1811047|NCT00460603|6291848|P7|Phase 2|Withdrawal by Subject|0
1811048|NCT00460603|6291849|P6|Phase 2|Withdrawal by Subject|0
1811049|NCT00460603|6291850|P5|Phase 2|Withdrawal by Subject|0
1811050|NCT00460603|6291851|P4|Phase 2|Withdrawal by Subject|0
1811051|NCT00460603|6291852|P3|Phase 2|Withdrawal by Subject|0
1811052|NCT00460603|6291853|P2|Phase 2|Withdrawal by Subject|0
1811053|NCT00460603|6291854|P1|Phase 2|Withdrawal by Subject|0
1811054|NCT00460603|6291843|P12|Phase 2|Global Deterioration of Health Status|0
1811055|NCT00460603|6291844|P11|Phase 2|Global Deterioration of Health Status|1
1811056|NCT00460603|6291845|P10|Phase 2|Global Deterioration of Health Status|0
1811057|NCT00460603|6291846|P9|Phase 2|Global Deterioration of Health Status|0
1811058|NCT00460603|6291847|P8|Phase 2|Global Deterioration of Health Status|0
1811059|NCT00460603|6291848|P7|Phase 2|Global Deterioration of Health Status|0
1811060|NCT00460603|6291849|P6|Phase 2|Global Deterioration of Health Status|0
1811061|NCT00460603|6291850|P5|Phase 2|Global Deterioration of Health Status|0
1811062|NCT00460603|6291851|P4|Phase 2|Global Deterioration of Health Status|0
1811063|NCT00460603|6291852|P3|Phase 2|Global Deterioration of Health Status|0
1811064|NCT00460603|6291853|P2|Phase 2|Global Deterioration of Health Status|0
1811065|NCT00460603|6291854|P1|Phase 2|Global Deterioration of Health Status|0
1811066|NCT00460603|6291843|P12|Phase 2|Objective Progression or Relapse|17
1811067|NCT00460603|6291844|P11|Phase 2|Objective Progression or Relapse|10
1811068|NCT00460603|6291845|P10|Phase 2|Objective Progression or Relapse|9
1811069|NCT00460603|6291846|P9|Phase 2|Objective Progression or Relapse|0
1811070|NCT00460603|6291847|P8|Phase 2|Objective Progression or Relapse|0
1811071|NCT00460603|6291848|P7|Phase 2|Objective Progression or Relapse|0
1811072|NCT00460603|6291849|P6|Phase 2|Objective Progression or Relapse|0
1811073|NCT00460603|6291850|P5|Phase 2|Objective Progression or Relapse|0
1811074|NCT00460603|6291851|P4|Phase 2|Objective Progression or Relapse|0
1811075|NCT00460603|6291852|P3|Phase 2|Objective Progression or Relapse|0
1811076|NCT00460603|6291853|P2|Phase 2|Objective Progression or Relapse|0
1811077|NCT00460603|6291854|P1|Phase 2|Objective Progression or Relapse|0
1811078|NCT00460603|6291843|P12|Phase 2|Other|7
1811079|NCT00460603|6291844|P11|Phase 2|Other|16
1811080|NCT00460603|6291845|P10|Phase 2|Other|6
1811081|NCT00460603|6291846|P9|Phase 2|Other|0
1811082|NCT00460603|6291847|P8|Phase 2|Other|0
1811083|NCT00460603|6291848|P7|Phase 2|Other|0
1811084|NCT00460603|6291849|P6|Phase 2|Other|0
1811085|NCT00460603|6291850|P5|Phase 2|Other|0
1811086|NCT00460603|6291851|P4|Phase 2|Other|0
1811087|NCT00460603|6291852|P3|Phase 2|Other|0
1811088|NCT00460603|6291853|P2|Phase 2|Other|0
1811089|NCT00460603|6291854|P1|Phase 2|Other|0
1811090|NCT00460603|6291843|P12|Phase 2|Lost to Follow-up|0
1811091|NCT00460603|6291844|P11|Phase 2|Lost to Follow-up|0
1811092|NCT00460603|6291845|P10|Phase 2|Lost to Follow-up|1
1811093|NCT00460603|6291846|P9|Phase 2|Lost to Follow-up|0
1811094|NCT00460603|6291847|P8|Phase 2|Lost to Follow-up|0
1811095|NCT00460603|6291848|P7|Phase 2|Lost to Follow-up|0
1811096|NCT00460603|6291849|P6|Phase 2|Lost to Follow-up|0
1811097|NCT00460603|6291850|P5|Phase 2|Lost to Follow-up|0
1811098|NCT00460603|6291851|P4|Phase 2|Lost to Follow-up|0
1811099|NCT00460603|6291852|P3|Phase 2|Lost to Follow-up|0
1811100|NCT00460603|6291853|P2|Phase 2|Lost to Follow-up|0
1811101|NCT00460603|6291854|P1|Phase 2|Lost to Follow-up|0
1811102|NCT00460603|6291843|P12|Phase 2|Protocol Violation|0
1811103|NCT00460603|6291844|P11|Phase 2|Protocol Violation|1
1811104|NCT00460603|6291845|P10|Phase 2|Protocol Violation|1
1811105|NCT00460603|6291846|P9|Phase 2|Protocol Violation|0
1811106|NCT00460603|6291847|P8|Phase 2|Protocol Violation|0
1811107|NCT00460603|6291848|P7|Phase 2|Protocol Violation|0
1811108|NCT00460603|6291849|P6|Phase 2|Protocol Violation|0
1811109|NCT00460603|6291850|P5|Phase 2|Protocol Violation|0
1811110|NCT00460603|6291851|P4|Phase 2|Protocol Violation|0
1811111|NCT00460603|6291852|P3|Phase 2|Protocol Violation|0
1811112|NCT00460603|6291853|P2|Phase 2|Protocol Violation|0
1811113|NCT00460603|6291854|P1|Phase 2|Protocol Violation|0
1811114|NCT00460603|6291843|P12|Phase 2|Death|2
1811115|NCT00460603|6291844|P11|Phase 2|Death|2
1811116|NCT00460603|6291845|P10|Phase 2|Death|4
1811117|NCT00460603|6291846|P9|Phase 2|Death|0
1811118|NCT00460603|6291847|P8|Phase 2|Death|0
1811119|NCT00460603|6291848|P7|Phase 2|Death|0
1811120|NCT00460603|6291849|P6|Phase 2|Death|0
1811121|NCT00460603|6291850|P5|Phase 2|Death|0
1811122|NCT00460603|6291851|P4|Phase 2|Death|0
1811123|NCT00460603|6291852|P3|Phase 2|Death|0
1811124|NCT00460603|6291853|P2|Phase 2|Death|0
1811125|NCT00460603|6291854|P1|Phase 2|Death|0
1811126|NCT00460603|6291843|P12|Phase 2|Adverse Event|10
1811127|NCT00460603|6291844|P11|Phase 2|Adverse Event|9
1811128|NCT00460603|6291845|P10|Phase 2|Adverse Event|12
1811129|NCT00460603|6291846|P9|Phase 2|Adverse Event|0
1811130|NCT00460603|6291847|P8|Phase 2|Adverse Event|0
1811131|NCT00460603|6291848|P7|Phase 2|Adverse Event|0
1811132|NCT00460603|6291849|P6|Phase 2|Adverse Event|0
1811133|NCT00460603|6291850|P5|Phase 2|Adverse Event|0
1811134|NCT00460603|6291851|P4|Phase 2|Adverse Event|0
1811135|NCT00460603|6291852|P3|Phase 2|Adverse Event|0
1811136|NCT00460603|6291853|P2|Phase 2|Adverse Event|0
1811137|NCT00460603|6291854|P1|Phase 2|Adverse Event|0
1811138|NCT00460603|6291843|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811139|NCT00460603|6291844|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811140|NCT00460603|6291845|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
1811141|NCT00460603|6291846|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811142|NCT00460603|6291847|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811143|NCT00460603|6291848|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811144|NCT00460603|6291849|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811145|NCT00460603|6291850|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811146|NCT00460603|6291851|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811147|NCT00460603|6291852|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811148|NCT00460603|6291853|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811149|NCT00460603|6291854|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
1811150|NCT00460603|6291843|P12|Phase 1|Other|0
1811151|NCT00460603|6291844|P11|Phase 1|Other|0
1811152|NCT00460603|6291845|P10|Phase 1|Other|0
1811153|NCT00460603|6291846|P9|Phase 1|Other|0
1811154|NCT00460603|6291847|P8|Phase 1|Other|1
1811155|NCT00460603|6291848|P7|Phase 1|Other|0
1811156|NCT00460603|6291849|P6|Phase 1|Other|2
1811157|NCT00460603|6291850|P5|Phase 1|Other|1
1811158|NCT00460603|6291851|P4|Phase 1|Other|1
1811159|NCT00460603|6291852|P3|Phase 1|Other|1
1811160|NCT00460603|6291853|P2|Phase 1|Other|3
1811161|NCT00460603|6291854|P1|Phase 1|Other|0
1811162|NCT00460603|6291843|P12|Phase 1|Withdrawal by Subject|0
1811163|NCT00460603|6291844|P11|Phase 1|Withdrawal by Subject|0
1811164|NCT00460603|6291845|P10|Phase 1|Withdrawal by Subject|0
1811165|NCT00460603|6291846|P9|Phase 1|Withdrawal by Subject|2
1811166|NCT00460603|6291847|P8|Phase 1|Withdrawal by Subject|0
1811167|NCT00460603|6291848|P7|Phase 1|Withdrawal by Subject|1
1811168|NCT00460603|6291849|P6|Phase 1|Withdrawal by Subject|0
1811169|NCT00460603|6291850|P5|Phase 1|Withdrawal by Subject|3
1811170|NCT00460603|6291851|P4|Phase 1|Withdrawal by Subject|1
1811171|NCT00460603|6291852|P3|Phase 1|Withdrawal by Subject|1
1811172|NCT00460603|6291853|P2|Phase 1|Withdrawal by Subject|2
1811173|NCT00460603|6291854|P1|Phase 1|Withdrawal by Subject|1
1811174|NCT00460603|6291843|P12|Phase 1|Lack of Efficacy|0
1811175|NCT00460603|6291844|P11|Phase 1|Lack of Efficacy|0
1811176|NCT00460603|6291845|P10|Phase 1|Lack of Efficacy|0
1811177|NCT00460603|6291846|P9|Phase 1|Lack of Efficacy|11
1811178|NCT00460603|6291847|P8|Phase 1|Lack of Efficacy|2
1811179|NCT00460603|6291848|P7|Phase 1|Lack of Efficacy|2
1811180|NCT00460603|6291849|P6|Phase 1|Lack of Efficacy|2
1811181|NCT00460603|6291850|P5|Phase 1|Lack of Efficacy|2
1811182|NCT00460603|6291851|P4|Phase 1|Lack of Efficacy|2
1811183|NCT00460603|6291852|P3|Phase 1|Lack of Efficacy|1
1811184|NCT00460603|6291853|P2|Phase 1|Lack of Efficacy|0
1811185|NCT00460603|6291854|P1|Phase 1|Lack of Efficacy|1
1811186|NCT00460603|6291843|P12|Phase 1|Adverse Event|0
1811187|NCT00460603|6291844|P11|Phase 1|Adverse Event|0
1811188|NCT00460603|6291845|P10|Phase 1|Adverse Event|0
1811189|NCT00460603|6291846|P9|Phase 1|Adverse Event|4
1811190|NCT00460603|6291847|P8|Phase 1|Adverse Event|0
1811191|NCT00460603|6291848|P7|Phase 1|Adverse Event|3
1811192|NCT00460603|6291849|P6|Phase 1|Adverse Event|0
1811193|NCT00460603|6291850|P5|Phase 1|Adverse Event|0
1811194|NCT00460603|6291851|P4|Phase 1|Adverse Event|2
1811195|NCT00460603|6291852|P3|Phase 1|Adverse Event|1
1811196|NCT00460603|6291853|P2|Phase 1|Adverse Event|1
1811197|NCT00460603|6291854|P1|Phase 1|Adverse Event|3
1811198|NCT00460603|6291843|P12|Phase 1|Death|0
1811199|NCT00460603|6291844|P11|Phase 1|Death|0
1811200|NCT00460603|6291845|P10|Phase 1|Death|0
1811201|NCT00460603|6291846|P9|Phase 1|Death|1
1811202|NCT00460603|6291847|P8|Phase 1|Death|0
1811203|NCT00460603|6291848|P7|Phase 1|Death|0
1811204|NCT00460603|6291849|P6|Phase 1|Death|0
1811205|NCT00460603|6291850|P5|Phase 1|Death|0
1811206|NCT00460603|6291851|P4|Phase 1|Death|2
1811207|NCT00460603|6291852|P3|Phase 1|Death|0
1811208|NCT00460603|6291853|P2|Phase 1|Death|0
1811209|NCT00460603|6291854|P1|Phase 1|Death|1
1811210|NCT00460577|6291948|P2|Overall Study|Protocol Violation|6
1811211|NCT00460577|6291949|P1|Overall Study|Protocol Violation|2
1811212|NCT00460564|6291967|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1811213|NCT00460564|6291968|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1811214|NCT00460564|6291969|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1811215|NCT00460564|6291970|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
1811216|NCT00460564|6291971|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1811217|NCT00460564|6291972|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1811218|NCT00460564|6291973|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1811219|NCT00460564|6291974|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
1811220|NCT00460564|6291967|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811221|NCT00460564|6291968|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811222|NCT00460564|6291969|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
1811223|NCT00460564|6291970|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
1811224|NCT00460564|6291971|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811225|NCT00460564|6291972|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811226|NCT00460564|6291973|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811227|NCT00460564|6291974|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
1811228|NCT00460564|6291967|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
1811229|NCT00460564|6291968|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
1811230|NCT00460564|6291969|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
1811231|NCT00460564|6291970|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
1811232|NCT00460564|6291971|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
1811233|NCT00460564|6291972|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
1811234|NCT00460564|6291973|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
1811235|NCT00460564|6291974|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
1811236|NCT00460564|6291967|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811237|NCT00460564|6291968|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811238|NCT00460564|6291969|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811239|NCT00460564|6291970|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811240|NCT00460564|6291971|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811241|NCT00460564|6291972|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811242|NCT00460564|6291973|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
1811243|NCT00460564|6291974|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
1811244|NCT00460564|6291967|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811245|NCT00460564|6291968|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811246|NCT00460564|6291969|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811247|NCT00460564|6291970|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811248|NCT00460564|6291971|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811249|NCT00460564|6291972|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
1811250|NCT00460564|6291973|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
1811251|NCT00460564|6291974|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
1811252|NCT00460434|6292118|P2|Overall Study|Lost to Follow-up|7
1811253|NCT00460434|6292119|P1|Overall Study|Lost to Follow-up|3
1811254|NCT00460408|6292198|P4|Overall Study|Other|0
1811255|NCT00460408|6292199|P3|Overall Study|Other|0
1811256|NCT00460408|6292200|P2|Overall Study|Other|2
1811257|NCT00460408|6292201|P1|Overall Study|Other|12
1811258|NCT00460408|6292198|P4|Overall Study|Insufficient clinical response|0
1811259|NCT00460408|6292199|P3|Overall Study|Insufficient clinical response|5
1811260|NCT00460408|6292200|P2|Overall Study|Insufficient clinical response|1
1811261|NCT00460408|6292201|P1|Overall Study|Insufficient clinical response|5
1811262|NCT00460408|6292198|P4|Overall Study|Withdrawal by Subject|0
1811263|NCT00460408|6292199|P3|Overall Study|Withdrawal by Subject|0
1811264|NCT00460408|6292200|P2|Overall Study|Withdrawal by Subject|0
1811265|NCT00460408|6292201|P1|Overall Study|Withdrawal by Subject|31
1811266|NCT00460408|6292198|P4|Overall Study|Lost to Follow-up|0
1811267|NCT00460408|6292199|P3|Overall Study|Lost to Follow-up|1
1811268|NCT00460408|6292200|P2|Overall Study|Lost to Follow-up|0
1811269|NCT00460408|6292201|P1|Overall Study|Lost to Follow-up|11
1811270|NCT00460408|6292198|P4|Overall Study|Death|0
1811271|NCT00460408|6292199|P3|Overall Study|Death|0
1811272|NCT00460408|6292200|P2|Overall Study|Death|0
1811273|NCT00460408|6292201|P1|Overall Study|Death|7
1811274|NCT00460408|6292198|P4|Overall Study|Adverse Event|0
1811275|NCT00460408|6292199|P3|Overall Study|Adverse Event|0
1811276|NCT00460408|6292200|P2|Overall Study|Adverse Event|0
1811277|NCT00460408|6292201|P1|Overall Study|Adverse Event|1
1811278|NCT00460265|6292238|P2|Overall Study|Ongoing|47
1811279|NCT00460265|6292239|P1|Overall Study|Ongoing|60
1811280|NCT00460265|6292238|P2|Overall Study|Withdrawal by Subject|25
1811281|NCT00460265|6292239|P1|Overall Study|Withdrawal by Subject|10
1811282|NCT00460265|6292238|P2|Overall Study|Physician Decision|2
1811283|NCT00460265|6292239|P1|Overall Study|Physician Decision|1
1811284|NCT00460265|6292238|P2|Overall Study|Lost to Follow-up|15
1811285|NCT00460265|6292239|P1|Overall Study|Lost to Follow-up|14
1811286|NCT00460239|6292255|P9|Overall Study|Withdrawal by Subject|0
1811287|NCT00460239|6292256|P8|Overall Study|Withdrawal by Subject|0
1811288|NCT00460239|6292257|P7|Overall Study|Withdrawal by Subject|0
1811289|NCT00460239|6292258|P6|Overall Study|Withdrawal by Subject|1
1811290|NCT00460239|6292259|P5|Overall Study|Withdrawal by Subject|0
1811291|NCT00460239|6292260|P4|Overall Study|Withdrawal by Subject|0
1811292|NCT00460239|6292261|P3|Overall Study|Withdrawal by Subject|0
1811293|NCT00460239|6292262|P2|Overall Study|Withdrawal by Subject|0
1811294|NCT00460239|6292263|P1|Overall Study|Withdrawal by Subject|0
1811295|NCT00460239|6292255|P9|Overall Study|Physician Decision|0
1811296|NCT00460239|6292256|P8|Overall Study|Physician Decision|0
1811297|NCT00460239|6292257|P7|Overall Study|Physician Decision|0
1811298|NCT00460239|6292258|P6|Overall Study|Physician Decision|2
1811299|NCT00460239|6292259|P5|Overall Study|Physician Decision|0
1811300|NCT00460239|6292260|P4|Overall Study|Physician Decision|0
1811301|NCT00460239|6292261|P3|Overall Study|Physician Decision|0
1811302|NCT00460239|6292262|P2|Overall Study|Physician Decision|1
1811303|NCT00460239|6292263|P1|Overall Study|Physician Decision|0
1811304|NCT00460109|6292332|P1|Overall Study|Death|1
1811305|NCT00460031|6292340|P1|Overall Study|Death|1
1811306|NCT00460031|6292340|P1|Overall Study|Withdrawal by Subject|5
1811307|NCT00460031|6292340|P1|Overall Study|Adverse Event|5
1811308|NCT00459979|6292348|P1|Overall Study|Protocol Violation|1
1811309|NCT00459979|6292348|P1|Overall Study|Withdrawal by Subject|1
1811310|NCT00459953|6292360|P2|Overall Study|not analyzed-household member in study|1
1811311|NCT00459953|6292361|P1|Overall Study|not analyzed-household member in study|1
1811312|NCT00459875|6292367|P1|Overall Study|Adverse Event|2
1811313|NCT00459875|6292367|P1|Overall Study|Ineligible participant|1
1811314|NCT00459706|6292403|P2|Overall Study|Other|1
1811315|NCT00459706|6292404|P1|Overall Study|Other|0
1811316|NCT00459706|6292403|P2|Overall Study|Failed to Return|0
1811317|NCT00459706|6292404|P1|Overall Study|Failed to Return|1
1811318|NCT00459706|6292403|P2|Overall Study|Protocol Violation|1
1811319|NCT00459706|6292404|P1|Overall Study|Protocol Violation|2
1811320|NCT00459706|6292403|P2|Overall Study|Discontinuation of Study by Sponsor|0
1811321|NCT00459706|6292404|P1|Overall Study|Discontinuation of Study by Sponsor|1
1811322|NCT00459706|6292403|P2|Overall Study|Physician Decision|0
1811323|NCT00459706|6292404|P1|Overall Study|Physician Decision|2
1811324|NCT00459706|6292403|P2|Overall Study|Withdrawal by Subject|6
1811325|NCT00459706|6292404|P1|Overall Study|Withdrawal by Subject|1
1811326|NCT00459706|6292403|P2|Overall Study|Adverse Event|13
1811327|NCT00459706|6292404|P1|Overall Study|Adverse Event|19
1811328|NCT00459667|6292547|P3|Overall Study|No treatment administered|1
1811329|NCT00459667|6292548|P2|Overall Study|No treatment administered|3
1811330|NCT00459667|6292549|P1|Overall Study|No treatment administered|6
1811331|NCT00459667|6292547|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
1811332|NCT00459667|6292548|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
1811333|NCT00459667|6292549|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
1811334|NCT00459667|6292547|P3|Overall Study|Other disease modifying treatment|1
1811335|NCT00459667|6292548|P2|Overall Study|Other disease modifying treatment|2
1811336|NCT00459667|6292549|P1|Overall Study|Other disease modifying treatment|1
1811337|NCT00459667|6292547|P3|Overall Study|Withdrawal by Subject|5
1811338|NCT00459667|6292548|P2|Overall Study|Withdrawal by Subject|5
1811339|NCT00459667|6292549|P1|Overall Study|Withdrawal by Subject|3
1811340|NCT00459667|6292547|P3|Overall Study|Protocol Violation|0
1811341|NCT00459667|6292548|P2|Overall Study|Protocol Violation|0
1811342|NCT00459667|6292549|P1|Overall Study|Protocol Violation|1
1811343|NCT00459667|6292547|P3|Overall Study|Pregnancy|1
1811344|NCT00459667|6292548|P2|Overall Study|Pregnancy|1
1811345|NCT00459667|6292549|P1|Overall Study|Pregnancy|1
1811346|NCT00459667|6292547|P3|Overall Study|Lost to Follow-up|3
1811347|NCT00459667|6292548|P2|Overall Study|Lost to Follow-up|9
1811348|NCT00459667|6292549|P1|Overall Study|Lost to Follow-up|5
1811349|NCT00459667|6292547|P3|Overall Study|Adverse Event|8
1811350|NCT00459667|6292548|P2|Overall Study|Adverse Event|12
1811351|NCT00459667|6292549|P1|Overall Study|Adverse Event|9
1811352|NCT00459537|6292571|P2|Overall Study|Missing|0
1811353|NCT00459537|6292572|P1|Overall Study|Missing|1
1811354|NCT00459537|6292571|P2|Overall Study|Protocol Violation|3
1811355|NCT00459537|6292572|P1|Overall Study|Protocol Violation|4
1811356|NCT00459537|6292571|P2|Overall Study|Administrative problems|0
1811357|NCT00459537|6292572|P1|Overall Study|Administrative problems|3
1811358|NCT00459537|6292571|P2|Overall Study|Lost to Follow-up|30
1811359|NCT00459537|6292572|P1|Overall Study|Lost to Follow-up|27
1811360|NCT00459537|6292571|P2|Overall Study|Withdrawal by Subject|26
1811361|NCT00459537|6292572|P1|Overall Study|Withdrawal by Subject|20
1811362|NCT00459537|6292571|P2|Overall Study|Lack of Efficacy|11
1811363|NCT00459537|6292572|P1|Overall Study|Lack of Efficacy|10
1811364|NCT00459537|6292571|P2|Overall Study|Adverse Event|6
1811365|NCT00459537|6292572|P1|Overall Study|Adverse Event|1
1811366|NCT00459355|6292607|P2|Overall Study|Subject no longer met inc criteria|18
1811367|NCT00459355|6292608|P1|Overall Study|Subject no longer met inc criteria|20
1811368|NCT00459342|6292620|P1|Overall Study|Not eligible|1
1811369|NCT00459316|6292633|P3|Step 3|Withdrawal by Subject|1
1811370|NCT00459316|6292634|P2|Step 3|Withdrawal by Subject|0
1811371|NCT00459316|6292635|P1|Step 3|Withdrawal by Subject|3
1811372|NCT00459316|6292633|P3|Steps 1 & 2|Lost to Follow-up|2
1811373|NCT00459316|6292634|P2|Steps 1 & 2|Lost to Follow-up|0
1811374|NCT00459316|6292635|P1|Steps 1 & 2|Lost to Follow-up|5
1811375|NCT00459316|6292633|P3|Steps 1 & 2|Not willing to adhere to regulations|0
1811376|NCT00459316|6292634|P2|Steps 1 & 2|Not willing to adhere to regulations|0
1811377|NCT00459316|6292635|P1|Steps 1 & 2|Not willing to adhere to regulations|1
1811378|NCT00459316|6292633|P3|Steps 1 & 2|Withdrawal by Subject|0
1811379|NCT00459316|6292634|P2|Steps 1 & 2|Withdrawal by Subject|1
1811380|NCT00459316|6292635|P1|Steps 1 & 2|Withdrawal by Subject|6
1811381|NCT00459316|6292633|P3|Steps 1 & 2|Not able to get to clinic|0
1811382|NCT00459316|6292634|P2|Steps 1 & 2|Not able to get to clinic|4
1811383|NCT00459316|6292635|P1|Steps 1 & 2|Not able to get to clinic|7
1811384|NCT00459316|6292633|P3|Steps 1 & 2|Death|0
1811385|NCT00459316|6292634|P2|Steps 1 & 2|Death|1
1811386|NCT00459316|6292635|P1|Steps 1 & 2|Death|1
1811387|NCT00459316|6292633|P3|Steps 1 & 2|Other eligibility failure|0
1811388|NCT00459316|6292634|P2|Steps 1 & 2|Other eligibility failure|1
1811389|NCT00459316|6292635|P1|Steps 1 & 2|Other eligibility failure|1
1811390|NCT00459290|6292700|P1|Overall Study|Ineligible|2
1811391|NCT00459290|6292700|P1|Overall Study|Adverse Event|3
1811392|NCT00459186|6292715|P1|PET Imaging and Assessment|Adverse Event|3
1811393|NCT00459186|6292715|P1|Single Agent RAD001|Withdrawal by Subject|1
1811394|NCT00459134|6292722|P2|Overall Study|Multiple Reasons|3
1811395|NCT00459134|6292723|P1|Overall Study|Multiple Reasons|2
1811396|NCT00459134|6292722|P2|Overall Study|Progression|0
1811397|NCT00459134|6292723|P1|Overall Study|Progression|1
1811398|NCT00459134|6292722|P2|Overall Study|Toxicity|5
1811399|NCT00459134|6292723|P1|Overall Study|Toxicity|4
1811400|NCT00459134|6292722|P2|Overall Study|Surgery|2
1811401|NCT00459134|6292723|P1|Overall Study|Surgery|1
1811402|NCT00459134|6292722|P2|Overall Study|Lost to Follow-up|7
1811403|NCT00459134|6292723|P1|Overall Study|Lost to Follow-up|6
1811404|NCT00459134|6292722|P2|Overall Study|Withdrawal by Subject|7
1811405|NCT00459134|6292723|P1|Overall Study|Withdrawal by Subject|8
1811406|NCT00459134|6292722|P2|Overall Study|Physician Decision|1
1811407|NCT00459134|6292723|P1|Overall Study|Physician Decision|1
1811408|NCT00459108|6292739|P1|Overall Study|Progression|1
1811409|NCT00459108|6292739|P1|Overall Study|Death|2
1811410|NCT00459108|6292739|P1|Overall Study|Adverse Event|3
1811411|NCT00459108|6292739|P1|Overall Study|Withdrawal by Subject|5
1811412|NCT00459056|6292749|P2|First Intervention (First Three Months)|Lost to Follow-up|1
1811413|NCT00459056|6292750|P1|First Intervention (First Three Months)|Lost to Follow-up|1
1811414|NCT00459043|6292758|P2|Overall Study|Withdrawal by Subject|0
1811415|NCT00459043|6292759|P1|Overall Study|Withdrawal by Subject|1
1811416|NCT00458705|6292786|P1|Overall Study|Not Treated|1
1811417|NCT00458705|6292786|P1|Overall Study|Adverse Event|4
1811418|NCT00458536|6292790|P1|Overall Study|Progressive disease during treatment|2
1811419|NCT00458536|6292790|P1|Overall Study|Withdrawal by Subject|1
1811420|NCT00458536|6292790|P1|Overall Study|Ineligible due to toxicity|1
1811421|NCT00458536|6292790|P1|Overall Study|Patient did not have surgery|1
1811422|NCT00458536|6292790|P1|Overall Study|Did not have renal cell carcinoma|2
1811423|NCT00458536|6292790|P1|Overall Study|No measurable disease after surgery|2
1811424|NCT00458536|6292790|P1|Overall Study|Unable to make vaccine|3
1811425|NCT00458536|6292790|P1|Overall Study|Disease progression prior to treatment|7
1811426|NCT00458393|6292821|P2|Overall Study|Sites marked other on the form.|20
1811427|NCT00458393|6292822|P1|Overall Study|Sites marked other on the form.|19
1811428|NCT00458393|6292821|P2|Overall Study|Lost to Follow-up|92
1811429|NCT00458393|6292822|P1|Overall Study|Lost to Follow-up|115
1811430|NCT00458393|6292821|P2|Overall Study|Relocated|81
1811431|NCT00458393|6292822|P1|Overall Study|Relocated|77
1811432|NCT00458393|6292821|P2|Overall Study|Physician Decision|22
1811433|NCT00458393|6292822|P1|Overall Study|Physician Decision|31
1811434|NCT00458393|6292821|P2|Overall Study|Withdrawal by Subject|80
1811435|NCT00458393|6292822|P1|Overall Study|Withdrawal by Subject|67
1811436|NCT00458302|6292870|P2|Overall Study|Other|2
1811437|NCT00458302|6292871|P1|Overall Study|Other|4
1811438|NCT00458302|6292870|P2|Overall Study|Lost to Follow-up|0
1811439|NCT00458302|6292871|P1|Overall Study|Lost to Follow-up|2
1811440|NCT00458302|6292870|P2|Overall Study|Study Termination By Sponsor|0
1811441|NCT00458302|6292871|P1|Overall Study|Study Termination By Sponsor|1
1811442|NCT00458302|6292870|P2|Overall Study|Inc/Exc Criteria Not Met|1
1811443|NCT00458302|6292871|P1|Overall Study|Inc/Exc Criteria Not Met|1
1811444|NCT00458302|6292870|P2|Overall Study|Withdrawal by Subject|4
1811445|NCT00458302|6292871|P1|Overall Study|Withdrawal by Subject|6
1811446|NCT00458302|6292870|P2|Overall Study|Protocol Violation|2
1811447|NCT00458302|6292871|P1|Overall Study|Protocol Violation|0
1811448|NCT00458302|6292870|P2|Overall Study|Pregnancy|1
1811449|NCT00458302|6292871|P1|Overall Study|Pregnancy|2
1811450|NCT00458302|6292870|P2|Overall Study|Adverse Event|14
1811451|NCT00458302|6292871|P1|Overall Study|Adverse Event|4
1811452|NCT00458211|6292916|P1|Overall Study|Protocol Violation|2
1811453|NCT00458211|6292916|P1|Overall Study|Withdrawal by Subject|2
1811454|NCT00458211|6292916|P1|Overall Study|Lack of Efficacy|12
1811455|NCT00457821|6292958|P8|Part 2|Withdrawal by Subject|1
1811456|NCT00457821|6292959|P7|Part 2|Withdrawal by Subject|0
1811457|NCT00457821|6292960|P6|Part 2|Withdrawal by Subject|0
1811458|NCT00457821|6292961|P5|Part 2|Withdrawal by Subject|0
1811459|NCT00457821|6292962|P4|Part 2|Withdrawal by Subject|0
1811460|NCT00457821|6292963|P3|Part 2|Withdrawal by Subject|0
1811461|NCT00457821|6292964|P2|Part 2|Withdrawal by Subject|0
1811462|NCT00457821|6292965|P1|Part 2|Withdrawal by Subject|0
1811463|NCT00457743|6293004|P3|Overall Study|Lack of Efficacy|3
1811464|NCT00457743|6293005|P2|Overall Study|Lack of Efficacy|23
1811465|NCT00457743|6293006|P1|Overall Study|Lack of Efficacy|3
1811466|NCT00457743|6293004|P3|Overall Study|Adverse Event|0
1811467|NCT00457743|6293005|P2|Overall Study|Adverse Event|4
1811468|NCT00457743|6293006|P1|Overall Study|Adverse Event|0
1811469|NCT00457691|6293063|P2|Overall Study|Disease progression, study terminated|196
1811470|NCT00457691|6293064|P1|Overall Study|Disease progression, study terminated|180
1811471|NCT00457691|6293063|P2|Overall Study|Subject refused (reason other than AE)|19
1811472|NCT00457691|6293064|P1|Overall Study|Subject refused (reason other than AE)|14
1811473|NCT00457691|6293063|P2|Overall Study|Study terminated by Sponsor|1
1811474|NCT00457691|6293064|P1|Overall Study|Study terminated by Sponsor|1
1811475|NCT00457691|6293063|P2|Overall Study|Lost to Follow-up|14
1811476|NCT00457691|6293064|P1|Overall Study|Lost to Follow-up|23
1811477|NCT00457691|6293063|P2|Overall Study|Protocol Violation|3
1811478|NCT00457691|6293064|P1|Overall Study|Protocol Violation|1
1811479|NCT00457691|6293063|P2|Overall Study|Death|148
1811480|NCT00457691|6293064|P1|Overall Study|Death|163
1811481|NCT00457691|6293063|P2|Overall Study|Adverse Event|1
1811482|NCT00457691|6293064|P1|Overall Study|Adverse Event|4
1811483|NCT00457665|6293086|P2|24 Months|Abnormal liver function tests|5
1811484|NCT00457665|6293087|P1|24 Months|Abnormal liver function tests|1
1811485|NCT00457665|6293086|P2|24 Months|Lipodystrophy|1
1811486|NCT00457665|6293087|P1|24 Months|Lipodystrophy|1
1811487|NCT00457665|6293086|P2|24 Months|Withdrawal by Subject|2
1811488|NCT00457665|6293087|P1|24 Months|Withdrawal by Subject|3
1811489|NCT00457665|6293086|P2|12 Months|Abnormal Liver function tests|5
1811490|NCT00457665|6293087|P1|12 Months|Abnormal Liver function tests|0
1811491|NCT00457665|6293086|P2|12 Months|Withdrawal by Subject|2
1811492|NCT00457665|6293087|P1|12 Months|Withdrawal by Subject|0
1811493|NCT00457665|6293086|P2|12 Months|Lipodystrophy|0
1811494|NCT00457665|6293087|P1|12 Months|Lipodystrophy|2
1811495|NCT00457665|6293086|P2|12 Months|High HIV viral load|1
1811496|NCT00457665|6293087|P1|12 Months|High HIV viral load|5
1811497|NCT00457665|6293086|P2|12 Months|Drug allergy|1
1811498|NCT00457665|6293087|P1|12 Months|Drug allergy|1
1811499|NCT00457639|6293093|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
1811500|NCT00457639|6293094|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
1811501|NCT00457639|6293093|P2|Intervention 1 (6 Months)|unrelated illness|2
1811502|NCT00457639|6293094|P1|Intervention 1 (6 Months)|unrelated illness|0
1811503|NCT00457639|6293093|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
1811504|NCT00457639|6293094|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
1811505|NCT00457418|6293102|P1|Post PK Maintenance|Lost to Follow-up|1
1811506|NCT00457418|6293102|P1|Post PK Maintenance|Withdrawal by Subject|11
1811507|NCT00457418|6293102|P1|Post PK Maintenance|Progression of Disease|6
1811508|NCT00457418|6293102|P1|Post PK Maintenance|Adverse Event|10
1811509|NCT00457418|6293102|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
1811510|NCT00457418|6293102|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
1811511|NCT00457418|6293102|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
1811512|NCT00457392|6293114|P2|Overall Study|Randomized, Not Treated|3
1811513|NCT00457392|6293115|P1|Overall Study|Randomized, Not Treated|7
1811514|NCT00457392|6293114|P2|Overall Study|Study Terminated by Sponsor|4
1811515|NCT00457392|6293115|P1|Overall Study|Study Terminated by Sponsor|1
1811516|NCT00457392|6293114|P2|Overall Study|Other|4
1811517|NCT00457392|6293115|P1|Overall Study|Other|7
1811518|NCT00457392|6293114|P2|Overall Study|Protocol Violation|3
1811519|NCT00457392|6293115|P1|Overall Study|Protocol Violation|4
1811520|NCT00457392|6293114|P2|Overall Study|Lost to Follow-up|7
1811521|NCT00457392|6293115|P1|Overall Study|Lost to Follow-up|6
1811522|NCT00457392|6293114|P2|Overall Study|Withdrawal by Subject|8
1811523|NCT00457392|6293115|P1|Overall Study|Withdrawal by Subject|14
1811524|NCT00457392|6293114|P2|Overall Study|Global Deterioration of Health Status|8
1811525|NCT00457392|6293115|P1|Overall Study|Global Deterioration of Health Status|22
1811526|NCT00457392|6293114|P2|Overall Study|Adverse Event|41
1811527|NCT00457392|6293115|P1|Overall Study|Adverse Event|84
1811528|NCT00457392|6293114|P2|Overall Study|Death|106
1811529|NCT00457392|6293115|P1|Overall Study|Death|106
1811530|NCT00457392|6293114|P2|Overall Study|Objective Progression or Relapse|296
1811531|NCT00457392|6293115|P1|Overall Study|Objective Progression or Relapse|229
1811532|NCT00457301|6293142|P2|Overall Study|Death|7
1811533|NCT00457301|6293143|P1|Overall Study|Death|5
1811534|NCT00457301|6293142|P2|Overall Study|Censored out of the study|14
1811535|NCT00457301|6293143|P1|Overall Study|Censored out of the study|15
1811536|NCT00457301|6293142|P2|Overall Study|Withdrawal by Subject|3
1811537|NCT00457301|6293143|P1|Overall Study|Withdrawal by Subject|3
1811538|NCT00457249|6293157|P2|Overall Study|Serious Adverse Events|0
1811539|NCT00457249|6293158|P1|Overall Study|Serious Adverse Events|2
1811540|NCT00457249|6293157|P2|Overall Study|Withdrawal by Subject|1
1811541|NCT00457249|6293158|P1|Overall Study|Withdrawal by Subject|3
1811542|NCT00457249|6293157|P2|Overall Study|Protocol Violation|1
1811543|NCT00457249|6293158|P1|Overall Study|Protocol Violation|4
1811544|NCT00457249|6293157|P2|Overall Study|Lost to Follow-up|0
1811545|NCT00457249|6293158|P1|Overall Study|Lost to Follow-up|3
1811546|NCT00457015|6293197|P2|Overall Study|Left study site against medical advice|1
1811547|NCT00457015|6293198|P1|Overall Study|Left study site against medical advice|0
1811548|NCT00457002|6293214|P2|Overall Study|treated for 1 day; missing status/reason|0
1811549|NCT00457002|6293215|P1|Overall Study|treated for 1 day; missing status/reason|1
1811550|NCT00457002|6293214|P2|Overall Study|non-specified|38
1811551|NCT00457002|6293215|P1|Overall Study|non-specified|29
1811552|NCT00457002|6293214|P2|Overall Study|Administrative reason by Sponsor|0
1811553|NCT00457002|6293215|P1|Overall Study|Administrative reason by Sponsor|1
1811554|NCT00457002|6293214|P2|Overall Study|No longer met criteria|37
1811555|NCT00457002|6293215|P1|Overall Study|No longer met criteria|41
1811556|NCT00457002|6293214|P2|Overall Study|Poor/Non-compliance|33
1811557|NCT00457002|6293215|P1|Overall Study|Poor/Non-compliance|46
1811558|NCT00457002|6293214|P2|Overall Study|Lost to Follow-up|71
1811559|NCT00457002|6293215|P1|Overall Study|Lost to Follow-up|72
1811560|NCT00457002|6293214|P2|Overall Study|Withdrawal by Subject|271
1811561|NCT00457002|6293215|P1|Overall Study|Withdrawal by Subject|299
1811562|NCT00457002|6293214|P2|Overall Study|Adverse Event|260
1811563|NCT00457002|6293215|P1|Overall Study|Adverse Event|284
1811564|NCT00457002|6293214|P2|Overall Study|Death|47
1811565|NCT00457002|6293215|P1|Overall Study|Death|40
1811566|NCT00456846|6293320|P2|Overall Study|Other|2
1811567|NCT00456846|6293321|P1|Overall Study|Other|0
1811568|NCT00456846|6293320|P2|Overall Study|Participant Discretion|5
1811569|NCT00456846|6293321|P1|Overall Study|Participant Discretion|1
1811570|NCT00456846|6293320|P2|Overall Study|Protocol Deviation|0
1811571|NCT00456846|6293321|P1|Overall Study|Protocol Deviation|2
1811572|NCT00456846|6293320|P2|Overall Study|Physician Decision|6
1811573|NCT00456846|6293321|P1|Overall Study|Physician Decision|11
1811574|NCT00456846|6293320|P2|Overall Study|Adverse Event|15
1811575|NCT00456846|6293321|P1|Overall Study|Adverse Event|2
1811576|NCT00456755|6293362|P2|Overall Study|Lost to Follow-up|1
1811577|NCT00456755|6293363|P1|Overall Study|Lost to Follow-up|2
1811578|NCT00456612|6293377|P1|Overall Study|Withdrawal by Subject|3
1811579|NCT00456599|6293382|P1|Overall Study|Withdrawal by Subject|2
1811580|NCT00456599|6293382|P1|Overall Study|Non-compliance|1
1811581|NCT00456521|6293405|P2|Overall Study|Drug non-compliance, moved, other|11
1811582|NCT00456521|6293406|P1|Overall Study|Drug non-compliance, moved, other|26
1811583|NCT00456521|6293405|P2|Overall Study|Pregnancy|1
1811584|NCT00456521|6293406|P1|Overall Study|Pregnancy|1
1811585|NCT00456521|6293405|P2|Overall Study|Protocol Violation|0
1811586|NCT00456521|6293406|P1|Overall Study|Protocol Violation|4
1811587|NCT00456521|6293405|P2|Overall Study|Lack of Efficacy|6
1811588|NCT00456521|6293406|P1|Overall Study|Lack of Efficacy|3
1811589|NCT00456521|6293405|P2|Overall Study|Lost to Follow-up|17
1811590|NCT00456521|6293406|P1|Overall Study|Lost to Follow-up|22
1811591|NCT00456521|6293405|P2|Overall Study|Withdrawal by Subject|24
1811592|NCT00456521|6293406|P1|Overall Study|Withdrawal by Subject|43
1811593|NCT00456521|6293405|P2|Overall Study|Adverse Event|25
1811594|NCT00456521|6293406|P1|Overall Study|Adverse Event|150
1811595|NCT00456495|6293452|P1|Overall Study|Physician Decision|2
1811596|NCT00456365|6293459|P2|Overall Study|oncologic diagnosis|1
1811597|NCT00456365|6293460|P1|Overall Study|oncologic diagnosis|1
1811598|NCT00456365|6293459|P2|Overall Study|Pregnancy|1
1811599|NCT00456365|6293460|P1|Overall Study|Pregnancy|1
1811600|NCT00456365|6293459|P2|Overall Study|Withdrawal by Subject|7
1811601|NCT00456365|6293460|P1|Overall Study|Withdrawal by Subject|4
1811602|NCT00456365|6293459|P2|Overall Study|Lost to Follow-up|3
1811603|NCT00456365|6293460|P1|Overall Study|Lost to Follow-up|1
1811604|NCT00456300|6293472|P2|Overall Study|Adverse Event|0
1811605|NCT00456300|6293473|P1|Overall Study|Adverse Event|1
1811606|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Other|0
1811607|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Other|0
1811608|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Other|1
1811609|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Other|0
1811610|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Other|1
1811611|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
1811612|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
1811613|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
1811614|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
1811615|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
1811616|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
1811617|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
1811618|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
1811619|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
1811620|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
1811621|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
1811622|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
1811623|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
1811624|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
1811625|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
1811626|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
1811627|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
1811628|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
1811629|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
1811630|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
1811631|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
1811632|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
1811633|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
1811634|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
1811635|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
1811636|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
1811637|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
1811638|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
1811639|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
1811640|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
1811641|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
1811642|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
1811643|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
1811644|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
1811645|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
1811646|NCT00456092|6293497|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
1811647|NCT00456092|6293498|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
1811648|NCT00456092|6293499|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
1811649|NCT00456092|6293500|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
1811650|NCT00456092|6293501|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
1811651|NCT00456092|6293497|P5|Extension Phase|Other|1
1811652|NCT00456092|6293498|P4|Extension Phase|Other|1
1811653|NCT00456092|6293499|P3|Extension Phase|Other|0
1811654|NCT00456092|6293500|P2|Extension Phase|Other|0
1811655|NCT00456092|6293501|P1|Extension Phase|Other|2
1811656|NCT00456092|6293497|P5|Extension Phase|Lost to Follow-up|1
1811657|NCT00456092|6293498|P4|Extension Phase|Lost to Follow-up|0
1811658|NCT00456092|6293499|P3|Extension Phase|Lost to Follow-up|0
1811659|NCT00456092|6293500|P2|Extension Phase|Lost to Follow-up|1
1811660|NCT00456092|6293501|P1|Extension Phase|Lost to Follow-up|1
1811661|NCT00456092|6293497|P5|Extension Phase|Withdrew Consent|0
1811662|NCT00456092|6293498|P4|Extension Phase|Withdrew Consent|0
1811663|NCT00456092|6293499|P3|Extension Phase|Withdrew Consent|0
1811664|NCT00456092|6293500|P2|Extension Phase|Withdrew Consent|0
1811665|NCT00456092|6293501|P1|Extension Phase|Withdrew Consent|2
1811666|NCT00456092|6293497|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
1811667|NCT00456092|6293498|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
1811668|NCT00456092|6293499|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
1811669|NCT00456092|6293500|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
1811670|NCT00456092|6293501|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
1811671|NCT00456092|6293497|P5|Extension Phase|Flare of Psoriatic Arthritis|1
1811672|NCT00456092|6293498|P4|Extension Phase|Flare of Psoriatic Arthritis|0
1811673|NCT00456092|6293499|P3|Extension Phase|Flare of Psoriatic Arthritis|0
1811674|NCT00456092|6293500|P2|Extension Phase|Flare of Psoriatic Arthritis|0
1811675|NCT00456092|6293501|P1|Extension Phase|Flare of Psoriatic Arthritis|1
1811676|NCT00456092|6293497|P5|Extension Phase|Grade 2 or Greater AE|2
1811677|NCT00456092|6293498|P4|Extension Phase|Grade 2 or Greater AE|0
1811678|NCT00456092|6293499|P3|Extension Phase|Grade 2 or Greater AE|0
1811679|NCT00456092|6293500|P2|Extension Phase|Grade 2 or Greater AE|2
1811680|NCT00456092|6293501|P1|Extension Phase|Grade 2 or Greater AE|2
1811681|NCT00455923|6293683|P2|Overall Study|Other|1
1811682|NCT00455923|6293684|P1|Overall Study|Other|3
1811683|NCT00455923|6293683|P2|Overall Study|Pregnancy|2
1811684|NCT00455923|6293684|P1|Overall Study|Pregnancy|0
1811685|NCT00455858|6293700|P1|Overall Study|Withdrawal|1
1811686|NCT00455858|6293700|P1|Overall Study|Well controlled FPG without insulin|1
1811687|NCT00455858|6293700|P1|Overall Study|Lack of Efficacy|1
1811688|NCT00455858|6293700|P1|Overall Study|Protocol Violation|1
1811689|NCT00455858|6293700|P1|Overall Study|Lost to Follow-up|2
1811690|NCT00455741|6293710|P2|Overall Study|Physician Decision|1
1811691|NCT00455741|6293711|P1|Overall Study|Physician Decision|0
1811692|NCT00455533|6293807|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
1811693|NCT00455533|6293808|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
1811694|NCT00455533|6293809|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
1811695|NCT00455533|6293807|P3|Period Two: Randomized Period|Study Drug Toxicity|0
1811696|NCT00455533|6293808|P2|Period Two: Randomized Period|Study Drug Toxicity|2
1811697|NCT00455533|6293809|P1|Period Two: Randomized Period|Study Drug Toxicity|0
1811698|NCT00455533|6293807|P3|Period Two: Randomized Period|Other - need reasons|0
1811699|NCT00455533|6293808|P2|Period Two: Randomized Period|Other - need reasons|1
1811700|NCT00455533|6293809|P1|Period Two: Randomized Period|Other - need reasons|0
1811701|NCT00455533|6293807|P3|Period Two: Randomized Period|Lost to Follow-up|1
1811702|NCT00455533|6293808|P2|Period Two: Randomized Period|Lost to Follow-up|0
1811703|NCT00455533|6293809|P1|Period Two: Randomized Period|Lost to Follow-up|0
1811704|NCT00455533|6293807|P3|Period Two: Randomized Period|Disease Progression|1
1811705|NCT00455533|6293808|P2|Period Two: Randomized Period|Disease Progression|1
1811706|NCT00455533|6293809|P1|Period Two: Randomized Period|Disease Progression|0
1811707|NCT00455533|6293807|P3|Period Two: Randomized Period|Death|3
1811708|NCT00455533|6293808|P2|Period Two: Randomized Period|Death|0
1811709|NCT00455533|6293809|P1|Period Two: Randomized Period|Death|0
1811710|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
1811711|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
1811712|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
1811713|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
1811714|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
1811715|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
1811716|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
1811717|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
1811718|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
1811719|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
1811720|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
1811721|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
1811722|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
1811723|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
1811724|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
1811725|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Not Reported|0
1811726|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Not Reported|0
1811727|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Not Reported|1
1811728|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
1811729|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
1811730|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
1811731|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Disease Progression|0
1811732|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Disease Progression|0
1811733|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Disease Progression|5
1811734|NCT00455533|6293807|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
1811735|NCT00455533|6293808|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
1811736|NCT00455533|6293809|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
1811737|NCT00455520|6293858|P2|Double Blind Tapentadol ER vs Placebo|All other|6
1811738|NCT00455520|6293859|P1|Double Blind Tapentadol ER vs Placebo|All other|4
1811739|NCT00455520|6293858|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
1811740|NCT00455520|6293859|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
1811741|NCT00455520|6293858|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
1811742|NCT00455520|6293859|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
1811743|NCT00455520|6293858|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
1811744|NCT00455520|6293859|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
1811745|NCT00455520|6293858|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
1811746|NCT00455520|6293859|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
1811747|NCT00455520|6293858|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
1811748|NCT00455520|6293859|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
1811749|NCT00455520|6293858|P2|Open Label Tapentadol Extended Release|All other|0
1811750|NCT00455520|6293859|P1|Open Label Tapentadol Extended Release|All other|33
1811751|NCT00455520|6293858|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
1811752|NCT00455520|6293859|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
1811753|NCT00455520|6293858|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
1811754|NCT00455520|6293859|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
1811755|NCT00455520|6293858|P2|Open Label Tapentadol Extended Release|Adverse Event|0
1811756|NCT00455520|6293859|P1|Open Label Tapentadol Extended Release|Adverse Event|100
1811757|NCT00455520|6293858|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
1811758|NCT00455520|6293859|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
1811759|NCT00455520|6293858|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
1811760|NCT00455520|6293859|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
1811761|NCT00455455|6293875|P2|Washout|Withdrawal by Subject|0
1811762|NCT00455455|6293876|P1|Washout|Withdrawal by Subject|1
1811763|NCT00455455|6293875|P2|Washout|Withdrawal by Subject|1
1811764|NCT00455455|6293876|P1|Washout|Withdrawal by Subject|0
1811765|NCT00455429|6293896|P4|Overall Study|Other|1
1811766|NCT00455429|6293897|P3|Overall Study|Other|0
1811767|NCT00455429|6293898|P2|Overall Study|Other|2
1811768|NCT00455429|6293899|P1|Overall Study|Other|0
1811769|NCT00455429|6293896|P4|Overall Study|Non-compliance|1
1811770|NCT00455429|6293897|P3|Overall Study|Non-compliance|0
1811771|NCT00455429|6293898|P2|Overall Study|Non-compliance|0
1811772|NCT00455429|6293899|P1|Overall Study|Non-compliance|0
1811773|NCT00455429|6293896|P4|Overall Study|Personal Reason|0
1811774|NCT00455429|6293897|P3|Overall Study|Personal Reason|0
1811775|NCT00455429|6293898|P2|Overall Study|Personal Reason|0
1811776|NCT00455429|6293899|P1|Overall Study|Personal Reason|1
1811777|NCT00455429|6293896|P4|Overall Study|Randomly assigned but not treated|2
1811778|NCT00455429|6293897|P3|Overall Study|Randomly assigned but not treated|0
1811779|NCT00455429|6293898|P2|Overall Study|Randomly assigned but not treated|0
1811780|NCT00455429|6293899|P1|Overall Study|Randomly assigned but not treated|0
1811781|NCT00455429|6293896|P4|Overall Study|Adverse Event|3
1811782|NCT00455429|6293897|P3|Overall Study|Adverse Event|0
1811783|NCT00455429|6293898|P2|Overall Study|Adverse Event|1
1811784|NCT00455429|6293899|P1|Overall Study|Adverse Event|0
1811785|NCT00455429|6293896|P4|Overall Study|Lack of Efficacy|1
1811786|NCT00455429|6293897|P3|Overall Study|Lack of Efficacy|0
1811787|NCT00455429|6293898|P2|Overall Study|Lack of Efficacy|1
1811788|NCT00455429|6293899|P1|Overall Study|Lack of Efficacy|0
1811789|NCT00455429|6293896|P4|Overall Study|Withdrawal by Subject|0
1811790|NCT00455429|6293897|P3|Overall Study|Withdrawal by Subject|1
1811791|NCT00455429|6293898|P2|Overall Study|Withdrawal by Subject|1
1811792|NCT00455429|6293899|P1|Overall Study|Withdrawal by Subject|0
1811793|NCT00455429|6293896|P4|Overall Study|Lost to Follow-up|3
1811794|NCT00455429|6293897|P3|Overall Study|Lost to Follow-up|0
1811795|NCT00455429|6293898|P2|Overall Study|Lost to Follow-up|0
1811796|NCT00455429|6293899|P1|Overall Study|Lost to Follow-up|1
1811797|NCT00455429|6293896|P4|Overall Study|Study Terminated by Sponsor|3
1811798|NCT00455429|6293897|P3|Overall Study|Study Terminated by Sponsor|0
1811799|NCT00455429|6293898|P2|Overall Study|Study Terminated by Sponsor|0
1811800|NCT00455429|6293899|P1|Overall Study|Study Terminated by Sponsor|0
1811801|NCT00455312|6293958|P2|Overall Study|Death|1
1811802|NCT00455312|6293959|P1|Overall Study|Death|0
1811803|NCT00455195|6293985|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
1811804|NCT00455195|6293986|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
1811805|NCT00455195|6293985|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
1811806|NCT00455195|6293986|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
1811807|NCT00455195|6293985|P2|Double-blind Study AGLU02704|Death|0
1811808|NCT00455195|6293986|P1|Double-blind Study AGLU02704|Death|1
1811809|NCT00455195|6293985|P2|Double-blind Study AGLU02704|Adverse Event|1
1811810|NCT00455195|6293986|P1|Double-blind Study AGLU02704|Adverse Event|2
1811811|NCT00455143|6294000|P1|Overall Study|Surgical time, staff not available|1
1811812|NCT00455143|6294000|P1|Overall Study|No longer met Inclusion Criteria|1
1811813|NCT00455143|6294000|P1|Overall Study|Staff was not avail to follow patient|2
1811814|NCT00455143|6294000|P1|Overall Study|Withdrawal by Subject|1
1811815|NCT00455143|6294000|P1|Overall Study|Physician Decision|1
1811816|NCT00455013|6294024|P3|Long Term Extension (LTE)|non-specified|1
1811817|NCT00455013|6294025|P2|Long Term Extension (LTE)|non-specified|0
1811818|NCT00455013|6294026|P1|Long Term Extension (LTE)|non-specified|0
1811819|NCT00455013|6294024|P3|Long Term Extension (LTE)|Poor non-compliance|0
1811820|NCT00455013|6294025|P2|Long Term Extension (LTE)|Poor non-compliance|1
1811821|NCT00455013|6294026|P1|Long Term Extension (LTE)|Poor non-compliance|0
1811822|NCT00455013|6294024|P3|Long Term Extension (LTE)|Subject Request or refused|3
1811823|NCT00455013|6294025|P2|Long Term Extension (LTE)|Subject Request or refused|0
1811824|NCT00455013|6294026|P1|Long Term Extension (LTE)|Subject Request or refused|0
1811825|NCT00455013|6294024|P3|Long Term Extension (LTE)|No longer met criteria|1
1811826|NCT00455013|6294025|P2|Long Term Extension (LTE)|No longer met criteria|0
1811827|NCT00455013|6294026|P1|Long Term Extension (LTE)|No longer met criteria|0
1811828|NCT00455013|6294024|P3|Long Term Extension (LTE)|Death|0
1811829|NCT00455013|6294025|P2|Long Term Extension (LTE)|Death|1
1811830|NCT00455013|6294026|P1|Long Term Extension (LTE)|Death|1
1811831|NCT00455013|6294024|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
1811832|NCT00455013|6294025|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
1811833|NCT00455013|6294026|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
1811834|NCT00455013|6294024|P3|Long Term Extension (LTE)|Adverse Event|1
1811835|NCT00455013|6294025|P2|Long Term Extension (LTE)|Adverse Event|1
1811836|NCT00455013|6294026|P1|Long Term Extension (LTE)|Adverse Event|0
1811837|NCT00455013|6294024|P3|Short Term Period|Other|1
1811838|NCT00455013|6294025|P2|Short Term Period|Other|0
1811839|NCT00455013|6294026|P1|Short Term Period|Other|0
1811840|NCT00455013|6294024|P3|Short Term Period|Lack of Efficacy|0
1811841|NCT00455013|6294025|P2|Short Term Period|Lack of Efficacy|0
1811842|NCT00455013|6294026|P1|Short Term Period|Lack of Efficacy|4
1811843|NCT00455013|6294024|P3|Short Term Period|Withdrawal by Subject|1
1811844|NCT00455013|6294025|P2|Short Term Period|Withdrawal by Subject|0
1811845|NCT00455013|6294026|P1|Short Term Period|Withdrawal by Subject|0
1811846|NCT00455013|6294024|P3|Short Term Period|Adverse Event|0
1811847|NCT00455013|6294025|P2|Short Term Period|Adverse Event|5
1811848|NCT00455013|6294026|P1|Short Term Period|Adverse Event|2
1811849|NCT00454987|6294094|P3|Booster Period|Lost to Follow-up|0
1811850|NCT00454987|6294095|P2|Booster Period|Lost to Follow-up|0
1811851|NCT00454987|6294096|P1|Booster Period|Lost to Follow-up|1
1811852|NCT00454987|6294094|P3|Booster Period|Withdrawal by Subject|0
1811853|NCT00454987|6294095|P2|Booster Period|Withdrawal by Subject|1
1811854|NCT00454987|6294096|P1|Booster Period|Withdrawal by Subject|0
1811855|NCT00454987|6294094|P3|Booster Period|Adverse Event|0
1811856|NCT00454987|6294095|P2|Booster Period|Adverse Event|0
1811857|NCT00454987|6294096|P1|Booster Period|Adverse Event|1
1811858|NCT00454909|6294170|P3|Overall Study|Others|0
1811859|NCT00454909|6294171|P2|Overall Study|Others|0
1811860|NCT00454909|6294172|P1|Overall Study|Others|1
1811861|NCT00454909|6294170|P3|Overall Study|Lost to follow-up (complete vaccination)|1
1811862|NCT00454909|6294171|P2|Overall Study|Lost to follow-up (complete vaccination)|3
1811863|NCT00454909|6294172|P1|Overall Study|Lost to follow-up (complete vaccination)|5
1811864|NCT00454909|6294170|P3|Overall Study|Migrated/moved from study area|1
1811865|NCT00454909|6294171|P2|Overall Study|Migrated/moved from study area|0
1811866|NCT00454909|6294172|P1|Overall Study|Migrated/moved from study area|0
1811867|NCT00454909|6294170|P3|Overall Study|Withdrawal by Subject|0
1811868|NCT00454909|6294171|P2|Overall Study|Withdrawal by Subject|0
1811869|NCT00454909|6294172|P1|Overall Study|Withdrawal by Subject|1
1811870|NCT00454857|6294210|P1|Overall Study|Reason unknown|1
1811871|NCT00454857|6294210|P1|Overall Study|Other|11
1811872|NCT00454857|6294210|P1|Overall Study|Death|5
1811873|NCT00454857|6294210|P1|Overall Study|Noncompliance|6
1811874|NCT00454857|6294210|P1|Overall Study|Lost to Follow-up|16
1811875|NCT00454857|6294210|P1|Overall Study|Withdrawal by Subject|15
1811876|NCT00454818|6294235|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
1811877|NCT00454818|6294236|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1811878|NCT00454818|6294237|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
1811879|NCT00454818|6294238|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1811880|NCT00454818|6294239|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
1811881|NCT00454818|6294235|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
1811882|NCT00454818|6294236|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
1811883|NCT00454818|6294237|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
1811884|NCT00454818|6294238|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
1811885|NCT00454818|6294239|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
1811886|NCT00454818|6294235|P5|Phase 2: Randomized Double-blind|Death|1
1811887|NCT00454818|6294236|P4|Phase 2: Randomized Double-blind|Death|0
1811888|NCT00454818|6294237|P3|Phase 2: Randomized Double-blind|Death|0
1811889|NCT00454818|6294238|P2|Phase 2: Randomized Double-blind|Death|1
1811890|NCT00454818|6294239|P1|Phase 2: Randomized Double-blind|Death|0
1811891|NCT00454818|6294235|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1811892|NCT00454818|6294236|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
1811893|NCT00454818|6294237|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1811894|NCT00454818|6294238|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
1811895|NCT00454818|6294239|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
1811896|NCT00454818|6294235|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1811897|NCT00454818|6294236|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
1811898|NCT00454818|6294237|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
1811899|NCT00454818|6294238|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1811900|NCT00454818|6294239|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
1811901|NCT00454818|6294235|P5|Phase I: Open-label Dose-escalation|Death|0
1811902|NCT00454818|6294236|P4|Phase I: Open-label Dose-escalation|Death|0
1811903|NCT00454818|6294237|P3|Phase I: Open-label Dose-escalation|Death|0
1811904|NCT00454818|6294238|P2|Phase I: Open-label Dose-escalation|Death|1
1811905|NCT00454818|6294239|P1|Phase I: Open-label Dose-escalation|Death|0
1811906|NCT00454818|6294235|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
1811907|NCT00454818|6294236|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
1811908|NCT00454818|6294237|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
1811909|NCT00454818|6294238|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
1811910|NCT00454818|6294239|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
1811911|NCT00454805|6294318|P2|Overall Study|In order to begin radiotherapy|0
1811912|NCT00454805|6294319|P1|Overall Study|In order to begin radiotherapy|1
1811913|NCT00454805|6294318|P2|Overall Study|Disease progression|19
1811914|NCT00454805|6294319|P1|Overall Study|Disease progression|16
1811915|NCT00454805|6294318|P2|Overall Study|Death|2
1811916|NCT00454805|6294319|P1|Overall Study|Death|0
1811917|NCT00454805|6294318|P2|Overall Study|Withdrawal by Subject|2
1811918|NCT00454805|6294319|P1|Overall Study|Withdrawal by Subject|9
1811919|NCT00454779|6294335|P2|Second-line Treatment Phase|Ongoing|1
1811920|NCT00454779|6294336|P1|Second-line Treatment Phase|Ongoing|0
1811921|NCT00454779|6294335|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
1811922|NCT00454779|6294336|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
1811923|NCT00454779|6294335|P2|Second-line Treatment Phase|Withdrawal by Subject|1
1811924|NCT00454779|6294336|P1|Second-line Treatment Phase|Withdrawal by Subject|0
1811925|NCT00454779|6294335|P2|First-line Treatment Phase|Ongoing|0
1811926|NCT00454779|6294336|P1|First-line Treatment Phase|Ongoing|1
1811927|NCT00454779|6294335|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
1811928|NCT00454779|6294336|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
1811929|NCT00454779|6294335|P2|First-line Treatment Phase|Protocol Violation|1
1811930|NCT00454779|6294336|P1|First-line Treatment Phase|Protocol Violation|0
1811931|NCT00454779|6294335|P2|First-line Treatment Phase|Lost to Follow-up|0
1811932|NCT00454779|6294336|P1|First-line Treatment Phase|Lost to Follow-up|1
1811933|NCT00454779|6294335|P2|First-line Treatment Phase|Withdrawal by Subject|4
1811934|NCT00454779|6294336|P1|First-line Treatment Phase|Withdrawal by Subject|2
1811935|NCT00454779|6294335|P2|First-line Treatment Phase|Lack of Efficacy|2
1811936|NCT00454779|6294336|P1|First-line Treatment Phase|Lack of Efficacy|0
1811937|NCT00454649|6294374|P10|Overall Study|Withdrawal by Subject|0
1811938|NCT00454649|6294375|P9|Overall Study|Withdrawal by Subject|1
1811939|NCT00454649|6294376|P8|Overall Study|Withdrawal by Subject|2
1811940|NCT00454649|6294377|P7|Overall Study|Withdrawal by Subject|0
1811941|NCT00454649|6294378|P6|Overall Study|Withdrawal by Subject|1
1811942|NCT00454649|6294379|P5|Overall Study|Withdrawal by Subject|0
1811943|NCT00454649|6294380|P4|Overall Study|Withdrawal by Subject|0
1811944|NCT00454649|6294381|P3|Overall Study|Withdrawal by Subject|0
1811945|NCT00454649|6294382|P2|Overall Study|Withdrawal by Subject|0
1811946|NCT00454649|6294383|P1|Overall Study|Withdrawal by Subject|0
1811947|NCT00454649|6294374|P10|Overall Study|Other|1
1811948|NCT00454649|6294375|P9|Overall Study|Other|3
1811949|NCT00454649|6294376|P8|Overall Study|Other|0
1811950|NCT00454649|6294377|P7|Overall Study|Other|0
1811951|NCT00454649|6294378|P6|Overall Study|Other|0
1811952|NCT00454649|6294379|P5|Overall Study|Other|0
1811953|NCT00454649|6294380|P4|Overall Study|Other|3
1811954|NCT00454649|6294381|P3|Overall Study|Other|5
1811955|NCT00454649|6294382|P2|Overall Study|Other|1
1811956|NCT00454649|6294383|P1|Overall Study|Other|1
1811957|NCT00454649|6294374|P10|Overall Study|Lost to Follow-up|0
1811958|NCT00454649|6294375|P9|Overall Study|Lost to Follow-up|0
1811959|NCT00454649|6294376|P8|Overall Study|Lost to Follow-up|0
1811960|NCT00454649|6294377|P7|Overall Study|Lost to Follow-up|1
1811961|NCT00454649|6294378|P6|Overall Study|Lost to Follow-up|0
1811962|NCT00454649|6294379|P5|Overall Study|Lost to Follow-up|0
1811963|NCT00454649|6294380|P4|Overall Study|Lost to Follow-up|0
1811964|NCT00454649|6294381|P3|Overall Study|Lost to Follow-up|1
1811965|NCT00454649|6294382|P2|Overall Study|Lost to Follow-up|0
1811966|NCT00454649|6294383|P1|Overall Study|Lost to Follow-up|0
1811967|NCT00454649|6294374|P10|Overall Study|Adverse Event|2
1811968|NCT00454649|6294375|P9|Overall Study|Adverse Event|6
1811969|NCT00454649|6294376|P8|Overall Study|Adverse Event|4
1811970|NCT00454649|6294377|P7|Overall Study|Adverse Event|3
1811971|NCT00454649|6294378|P6|Overall Study|Adverse Event|2
1811972|NCT00454649|6294379|P5|Overall Study|Adverse Event|1
1811973|NCT00454649|6294380|P4|Overall Study|Adverse Event|0
1811974|NCT00454649|6294381|P3|Overall Study|Adverse Event|3
1811975|NCT00454649|6294382|P2|Overall Study|Adverse Event|1
1811976|NCT00454649|6294383|P1|Overall Study|Adverse Event|0
1811977|NCT00454649|6294374|P10|Overall Study|Lack of Efficacy|2
1811978|NCT00454649|6294375|P9|Overall Study|Lack of Efficacy|10
1811979|NCT00454649|6294376|P8|Overall Study|Lack of Efficacy|13
1811980|NCT00454649|6294377|P7|Overall Study|Lack of Efficacy|5
1811981|NCT00454649|6294378|P6|Overall Study|Lack of Efficacy|4
1811982|NCT00454649|6294379|P5|Overall Study|Lack of Efficacy|0
1811983|NCT00454649|6294380|P4|Overall Study|Lack of Efficacy|3
1811984|NCT00454649|6294381|P3|Overall Study|Lack of Efficacy|10
1811985|NCT00454649|6294382|P2|Overall Study|Lack of Efficacy|2
1811986|NCT00454649|6294383|P1|Overall Study|Lack of Efficacy|2
1811987|NCT00454636|6294512|P4|Overall Study|Lost to Follow-up|0
1811988|NCT00454636|6294513|P3|Overall Study|Lost to Follow-up|0
1811989|NCT00454636|6294514|P2|Overall Study|Lost to Follow-up|1
1811990|NCT00454636|6294515|P1|Overall Study|Lost to Follow-up|0
1811991|NCT00454636|6294512|P4|Overall Study|Patient refusal|2
1811992|NCT00454636|6294513|P3|Overall Study|Patient refusal|3
1811993|NCT00454636|6294514|P2|Overall Study|Patient refusal|1
1811994|NCT00454636|6294515|P1|Overall Study|Patient refusal|1
1811995|NCT00454636|6294512|P4|Overall Study|Death|1
1811996|NCT00454636|6294513|P3|Overall Study|Death|1
1811997|NCT00454636|6294514|P2|Overall Study|Death|1
1811998|NCT00454636|6294515|P1|Overall Study|Death|6
1811999|NCT00454636|6294512|P4|Overall Study|Protocol Violation|3
1812000|NCT00454636|6294513|P3|Overall Study|Protocol Violation|3
1812001|NCT00454636|6294514|P2|Overall Study|Protocol Violation|2
1812002|NCT00454636|6294515|P1|Overall Study|Protocol Violation|3
1812003|NCT00454636|6294512|P4|Overall Study|Disease Progression|11
1812004|NCT00454636|6294513|P3|Overall Study|Disease Progression|4
1812005|NCT00454636|6294514|P2|Overall Study|Disease Progression|12
1812006|NCT00454636|6294515|P1|Overall Study|Disease Progression|11
1812007|NCT00454636|6294512|P4|Overall Study|Adverse Event|15
1812008|NCT00454636|6294513|P3|Overall Study|Adverse Event|9
1812009|NCT00454636|6294514|P2|Overall Study|Adverse Event|6
1812010|NCT00454636|6294515|P1|Overall Study|Adverse Event|10
1812011|NCT00454584|6294548|P6|After Controlled Period|Other|17
1812012|NCT00454584|6294549|P5|After Controlled Period|Other|5
1812013|NCT00454584|6294550|P4|After Controlled Period|Other|13
1812014|NCT00454584|6294551|P3|After Controlled Period|Other|0
1812015|NCT00454584|6294552|P2|After Controlled Period|Other|0
1812016|NCT00454584|6294553|P1|After Controlled Period|Other|0
1812017|NCT00454584|6294548|P6|After Controlled Period|Other|0
1812018|NCT00454584|6294549|P5|After Controlled Period|Other|0
1812019|NCT00454584|6294550|P4|After Controlled Period|Other|1
1812020|NCT00454584|6294551|P3|After Controlled Period|Other|0
1812021|NCT00454584|6294552|P2|After Controlled Period|Other|0
1812022|NCT00454584|6294553|P1|After Controlled Period|Other|0
1812023|NCT00454584|6294548|P6|After Controlled Period|Lost to Follow-up|6
1812024|NCT00454584|6294549|P5|After Controlled Period|Lost to Follow-up|4
1812025|NCT00454584|6294550|P4|After Controlled Period|Lost to Follow-up|2
1812026|NCT00454584|6294551|P3|After Controlled Period|Lost to Follow-up|0
1812027|NCT00454584|6294552|P2|After Controlled Period|Lost to Follow-up|0
1812028|NCT00454584|6294553|P1|After Controlled Period|Lost to Follow-up|0
1812029|NCT00454584|6294548|P6|After Controlled Period|Lack of Efficacy|0
1812030|NCT00454584|6294549|P5|After Controlled Period|Lack of Efficacy|0
1812031|NCT00454584|6294550|P4|After Controlled Period|Lack of Efficacy|1
1812032|NCT00454584|6294551|P3|After Controlled Period|Lack of Efficacy|0
1812033|NCT00454584|6294552|P2|After Controlled Period|Lack of Efficacy|0
1812034|NCT00454584|6294553|P1|After Controlled Period|Lack of Efficacy|0
1812035|NCT00454584|6294548|P6|After Controlled Period|Adverse Event|9
1812036|NCT00454584|6294549|P5|After Controlled Period|Adverse Event|3
1812037|NCT00454584|6294550|P4|After Controlled Period|Adverse Event|9
1812038|NCT00454584|6294551|P3|After Controlled Period|Adverse Event|0
1812039|NCT00454584|6294552|P2|After Controlled Period|Adverse Event|0
1812040|NCT00454584|6294553|P1|After Controlled Period|Adverse Event|0
1812041|NCT00454584|6294548|P6|Controlled Period|Other|0
1812042|NCT00454584|6294549|P5|Controlled Period|Other|0
1812043|NCT00454584|6294550|P4|Controlled Period|Other|0
1812044|NCT00454584|6294551|P3|Controlled Period|Other|2
1812045|NCT00454584|6294552|P2|Controlled Period|Other|4
1812046|NCT00454584|6294553|P1|Controlled Period|Other|5
1812047|NCT00454584|6294548|P6|Controlled Period|Lost to Follow-up|0
1812048|NCT00454584|6294549|P5|Controlled Period|Lost to Follow-up|0
1812049|NCT00454584|6294550|P4|Controlled Period|Lost to Follow-up|0
1812050|NCT00454584|6294551|P3|Controlled Period|Lost to Follow-up|2
1812051|NCT00454584|6294552|P2|Controlled Period|Lost to Follow-up|2
1812052|NCT00454584|6294553|P1|Controlled Period|Lost to Follow-up|1
1812053|NCT00454584|6294548|P6|Controlled Period|Adverse Event|0
1812054|NCT00454584|6294549|P5|Controlled Period|Adverse Event|0
1812055|NCT00454584|6294550|P4|Controlled Period|Adverse Event|0
1812056|NCT00454584|6294551|P3|Controlled Period|Adverse Event|1
1812057|NCT00454584|6294552|P2|Controlled Period|Adverse Event|2
1812058|NCT00454584|6294553|P1|Controlled Period|Adverse Event|5
1812059|NCT00454571|6294575|P2|Overall Study|Withdrawal by Subject|5
1812060|NCT00454571|6294576|P1|Overall Study|Withdrawal by Subject|10
1812061|NCT00454571|6294575|P2|Overall Study|Protocol Violation|0
1812062|NCT00454571|6294576|P1|Overall Study|Protocol Violation|1
1812063|NCT00454571|6294575|P2|Overall Study|Physician Decision|1
1812064|NCT00454571|6294576|P1|Overall Study|Physician Decision|0
1812065|NCT00454571|6294575|P2|Overall Study|Adverse Event|0
1812066|NCT00454571|6294576|P1|Overall Study|Adverse Event|2
1812067|NCT00454363|6294611|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
1812068|NCT00454363|6294612|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
1812069|NCT00454363|6294611|P2|Overall Study|Adverse Event|2
1812070|NCT00454363|6294612|P1|Overall Study|Adverse Event|1
1812071|NCT00454246|6294637|P3|Overall Study|Early termination of study|9
1812072|NCT00454246|6294638|P2|Overall Study|Early termination of study|26
1812073|NCT00454246|6294639|P1|Overall Study|Early termination of study|62
1812074|NCT00454246|6294637|P3|Overall Study|Failure to return|0
1812075|NCT00454246|6294638|P2|Overall Study|Failure to return|0
1812076|NCT00454246|6294639|P1|Overall Study|Failure to return|1
1812077|NCT00454246|6294637|P3|Overall Study|Refused Treatment|0
1812078|NCT00454246|6294638|P2|Overall Study|Refused Treatment|1
1812079|NCT00454246|6294639|P1|Overall Study|Refused Treatment|1
1812080|NCT00454246|6294637|P3|Overall Study|Protocol Violation|0
1812081|NCT00454246|6294638|P2|Overall Study|Protocol Violation|0
1812082|NCT00454246|6294639|P1|Overall Study|Protocol Violation|1
1812083|NCT00454246|6294637|P3|Overall Study|Violation of selection criteria at entry|0
1812084|NCT00454246|6294638|P2|Overall Study|Violation of selection criteria at entry|0
1812085|NCT00454246|6294639|P1|Overall Study|Violation of selection criteria at entry|6
1812086|NCT00454246|6294637|P3|Overall Study|Adverse Event|0
1812087|NCT00454246|6294638|P2|Overall Study|Adverse Event|2
1812088|NCT00454246|6294639|P1|Overall Study|Adverse Event|2
1812089|NCT00454207|6294655|P2|Overall Study|Protocol Violation|1
1812090|NCT00454207|6294656|P1|Overall Study|Protocol Violation|0
1812091|NCT00454207|6294655|P2|Overall Study|Lack of Efficacy|0
1812092|NCT00454207|6294656|P1|Overall Study|Lack of Efficacy|1
1812093|NCT00454207|6294655|P2|Overall Study|Adverse Event|1
1812094|NCT00454207|6294656|P1|Overall Study|Adverse Event|3
1812095|NCT00454194|6294701|P2|Overall Study|Other Unspecified Reason|2
1812096|NCT00454194|6294702|P1|Overall Study|Other Unspecified Reason|2
1812097|NCT00454194|6294701|P2|Overall Study|Other Medical Problems|2
1812098|NCT00454194|6294702|P1|Overall Study|Other Medical Problems|1
1812099|NCT00454194|6294701|P2|Overall Study|Withdrawal by Subject|8
1812100|NCT00454194|6294702|P1|Overall Study|Withdrawal by Subject|12
1812101|NCT00454194|6294701|P2|Overall Study|Adverse Event|2
1812102|NCT00454194|6294702|P1|Overall Study|Adverse Event|7
1812103|NCT00454181|6294720|P2|Overall Study|Withdrawal by Subject|0
1812104|NCT00454181|6294721|P1|Overall Study|Withdrawal by Subject|2
1812105|NCT00454181|6294720|P2|Overall Study|Protocol Violation|1
1812106|NCT00454181|6294721|P1|Overall Study|Protocol Violation|1
1812107|NCT00454181|6294720|P2|Overall Study|Lost to Follow-up|1
1812108|NCT00454181|6294721|P1|Overall Study|Lost to Follow-up|11
1812109|NCT00454181|6294720|P2|Overall Study|Adverse Event|1
1812110|NCT00454181|6294721|P1|Overall Study|Adverse Event|1
1812111|NCT00454142|6294737|P1|Overall Study|Withdrawal by Subject|1
1812112|NCT00454116|6294755|P3|Overall Study|Other|0
1812113|NCT00454116|6294756|P2|Overall Study|Other|2
1812114|NCT00454116|6294757|P1|Overall Study|Other|2
1812115|NCT00454116|6294755|P3|Overall Study|Withdrawal by Subject|1
1812116|NCT00454116|6294756|P2|Overall Study|Withdrawal by Subject|3
1812117|NCT00454116|6294757|P1|Overall Study|Withdrawal by Subject|3
1812118|NCT00454116|6294755|P3|Overall Study|Condition under investigation worsened|18
1812119|NCT00454116|6294756|P2|Overall Study|Condition under investigation worsened|13
1812120|NCT00454116|6294757|P1|Overall Study|Condition under investigation worsened|17
1812121|NCT00454116|6294755|P3|Overall Study|Adverse Event|9
1812122|NCT00454116|6294756|P2|Overall Study|Adverse Event|11
1812123|NCT00454116|6294757|P1|Overall Study|Adverse Event|5
1812124|NCT00454051|6294767|P2|Overall Study|Protocol Violation|1
1812125|NCT00454051|6294768|P1|Overall Study|Protocol Violation|1
1812126|NCT00454051|6294767|P2|Overall Study|Withdrawal by Subject|0
1812127|NCT00454051|6294768|P1|Overall Study|Withdrawal by Subject|1
1812128|NCT00454051|6294767|P2|Overall Study|Adverse Event|2
1812129|NCT00454051|6294768|P1|Overall Study|Adverse Event|1
1812130|NCT00453999|6294801|P3|Overall Study|Subject Request|0
1812131|NCT00453999|6294802|P2|Overall Study|Subject Request|1
1812132|NCT00453999|6294803|P1|Overall Study|Subject Request|2
1812133|NCT00453999|6294801|P3|Overall Study|Withdrawal by Subject|1
1812134|NCT00453999|6294802|P2|Overall Study|Withdrawal by Subject|1
1812135|NCT00453999|6294803|P1|Overall Study|Withdrawal by Subject|2
1812136|NCT00453999|6294801|P3|Overall Study|Lost to Follow-up|1
1812137|NCT00453999|6294802|P2|Overall Study|Lost to Follow-up|1
1812138|NCT00453999|6294803|P1|Overall Study|Lost to Follow-up|0
1812139|NCT00453999|6294801|P3|Overall Study|Adverse Event|1
1812140|NCT00453999|6294802|P2|Overall Study|Adverse Event|2
1812141|NCT00453999|6294803|P1|Overall Study|Adverse Event|1
1812142|NCT00453986|6294831|P5|Overall Study|Lost to Follow-up|0
1812143|NCT00453986|6294832|P4|Overall Study|Lost to Follow-up|2
1812144|NCT00453986|6294833|P3|Overall Study|Lost to Follow-up|6
1812145|NCT00453986|6294834|P2|Overall Study|Lost to Follow-up|5
1812146|NCT00453986|6294835|P1|Overall Study|Lost to Follow-up|6
1812147|NCT00453973|6294928|P2|Overall Study|Sponsor Decision to Terminate Study|30
1812148|NCT00453973|6294929|P1|Overall Study|Sponsor Decision to Terminate Study|35
1812149|NCT00453973|6294928|P2|Overall Study|Site closed by sponsor|0
1812150|NCT00453973|6294929|P1|Overall Study|Site closed by sponsor|3
1812151|NCT00453973|6294928|P2|Overall Study|Renal transplant|1
1812152|NCT00453973|6294929|P1|Overall Study|Renal transplant|1
1812153|NCT00453973|6294928|P2|Overall Study|Relocation|0
1812154|NCT00453973|6294929|P1|Overall Study|Relocation|1
1812155|NCT00453973|6294928|P2|Overall Study|PI Decision|2
1812156|NCT00453973|6294929|P1|Overall Study|PI Decision|0
1812157|NCT00453973|6294928|P2|Overall Study|Withdrawal by Subject|6
1812158|NCT00453973|6294929|P1|Overall Study|Withdrawal by Subject|7
1812159|NCT00453973|6294928|P2|Overall Study|Adverse Event|9
1812160|NCT00453973|6294929|P1|Overall Study|Adverse Event|4
1812161|NCT00453921|6294939|P4|Overall Study|Lost to Follow-up|0
1812162|NCT00453921|6294940|P3|Overall Study|Lost to Follow-up|1
1812163|NCT00453921|6294941|P2|Overall Study|Lost to Follow-up|0
1812164|NCT00453921|6294942|P1|Overall Study|Lost to Follow-up|0
1812165|NCT00453921|6294939|P4|Overall Study|Withdrawal by Subject|1
1812166|NCT00453921|6294940|P3|Overall Study|Withdrawal by Subject|1
1812167|NCT00453921|6294941|P2|Overall Study|Withdrawal by Subject|1
1812168|NCT00453921|6294942|P1|Overall Study|Withdrawal by Subject|1
1812169|NCT00453362|6295089|P1|Overall Study|Screening Failure|14
1812170|NCT00453362|6295089|P1|Overall Study|Progression of disease|56
1812171|NCT00453362|6295089|P1|Overall Study|Withdrawal by Subject|3
1812172|NCT00453362|6295089|P1|Overall Study|Physician Decision|2
1812173|NCT00453362|6295089|P1|Overall Study|Death|7
1812174|NCT00453362|6295089|P1|Overall Study|Adverse Event|5
1812175|NCT00453349|6295115|P2|Completed Study|Lost to follow up after study treatment|11
1812176|NCT00453349|6295116|P1|Completed Study|Lost to follow up after study treatment|2
1812177|NCT00453349|6295115|P2|Completed Study|Withdrawal by Subject|5
1812178|NCT00453349|6295116|P1|Completed Study|Withdrawal by Subject|3
1812179|NCT00453349|6295115|P2|Completed Study|Protocol Violation|1
1812180|NCT00453349|6295116|P1|Completed Study|Protocol Violation|1
1812181|NCT00453349|6295115|P2|Completed Study|Lost to Follow-up|5
1812182|NCT00453349|6295116|P1|Completed Study|Lost to Follow-up|7
1812183|NCT00453349|6295115|P2|Completed Study|Lack of Efficacy|1
1812184|NCT00453349|6295116|P1|Completed Study|Lack of Efficacy|2
1812185|NCT00453349|6295115|P2|Completed Study|Adverse Event|11
1812186|NCT00453349|6295116|P1|Completed Study|Adverse Event|12
1812187|NCT00453349|6295115|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
1812188|NCT00453349|6295116|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
1812189|NCT00453349|6295115|P2|Randomized|Withdrawal by Subject|5
1812190|NCT00453349|6295116|P1|Randomized|Withdrawal by Subject|3
1812191|NCT00453349|6295115|P2|Randomized|Protocol Violation|1
1812192|NCT00453349|6295116|P1|Randomized|Protocol Violation|1
1812193|NCT00453349|6295115|P2|Randomized|Lost to Follow-up|5
1812194|NCT00453349|6295116|P1|Randomized|Lost to Follow-up|7
1812195|NCT00453349|6295115|P2|Randomized|Lack of Efficacy|1
1812196|NCT00453349|6295116|P1|Randomized|Lack of Efficacy|2
1812197|NCT00453349|6295115|P2|Randomized|Adverse Event|11
1812198|NCT00453349|6295116|P1|Randomized|Adverse Event|12
1812199|NCT00453310|6295147|P1|Overall Study|Progression of Disease|10
1812200|NCT00453206|6295151|P1|Overall Study|Death|1
1812201|NCT00453180|6295161|P2|Overall Study|Adverse Event|2
1812202|NCT00453180|6295162|P1|Overall Study|Adverse Event|1
1812203|NCT00453180|6295161|P2|Overall Study|Lost to Follow-up|1
1812204|NCT00453180|6295162|P1|Overall Study|Lost to Follow-up|2
1812205|NCT00453154|6295181|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
1812206|NCT00453154|6295182|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
1812207|NCT00453154|6295183|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
1812208|NCT00453154|6295184|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
1812209|NCT00453154|6295181|P4|Double BIind Maintenance|Medical Issues|1
1812210|NCT00453154|6295182|P3|Double BIind Maintenance|Medical Issues|3
1812211|NCT00453154|6295183|P2|Double BIind Maintenance|Medical Issues|0
1812212|NCT00453154|6295184|P1|Double BIind Maintenance|Medical Issues|0
1812213|NCT00453154|6295181|P4|Double BIind Maintenance|Progression|26
1812214|NCT00453154|6295182|P3|Double BIind Maintenance|Progression|29
1812215|NCT00453154|6295183|P2|Double BIind Maintenance|Progression|0
1812216|NCT00453154|6295184|P1|Double BIind Maintenance|Progression|0
1812217|NCT00453154|6295181|P4|Double BIind Maintenance|Withdrawal by Subject|4
1812218|NCT00453154|6295182|P3|Double BIind Maintenance|Withdrawal by Subject|4
1812219|NCT00453154|6295183|P2|Double BIind Maintenance|Withdrawal by Subject|0
1812220|NCT00453154|6295184|P1|Double BIind Maintenance|Withdrawal by Subject|0
1812221|NCT00453154|6295181|P4|Double BIind Maintenance|Death|1
1812222|NCT00453154|6295182|P3|Double BIind Maintenance|Death|2
1812223|NCT00453154|6295183|P2|Double BIind Maintenance|Death|0
1812224|NCT00453154|6295184|P1|Double BIind Maintenance|Death|0
1812225|NCT00453154|6295181|P4|Double BIind Maintenance|Adverse Event|12
1812226|NCT00453154|6295182|P3|Double BIind Maintenance|Adverse Event|3
1812227|NCT00453154|6295183|P2|Double BIind Maintenance|Adverse Event|0
1812228|NCT00453154|6295184|P1|Double BIind Maintenance|Adverse Event|0
1812229|NCT00453102|6295197|P1|Overall Study|Withdrawal by Subject|2
1812230|NCT00453063|6295208|P2|Overall Study|Protocol Violation|0
1812231|NCT00453063|6295209|P1|Overall Study|Protocol Violation|1
1812232|NCT00453063|6295208|P2|Overall Study|Withdrawal by Subject|1
1812233|NCT00453063|6295209|P1|Overall Study|Withdrawal by Subject|1
1812234|NCT00453063|6295208|P2|Overall Study|Adverse Event|2
1812235|NCT00453063|6295209|P1|Overall Study|Adverse Event|1
1812236|NCT00452790|6295229|P2|Toddler Dose|Parent/legal guardian request|1
1812237|NCT00452790|6295230|P1|Toddler Dose|Parent/legal guardian request|0
1812238|NCT00452790|6295229|P2|Toddler Dose|Failed to return|1
1812239|NCT00452790|6295230|P1|Toddler Dose|Failed to return|0
1812240|NCT00452790|6295229|P2|After Infant Series|Other reasons|0
1812241|NCT00452790|6295230|P1|After Infant Series|Other reasons|1
1812242|NCT00452790|6295229|P2|After Infant Series|Failed to return|0
1812243|NCT00452790|6295230|P1|After Infant Series|Failed to return|1
1812244|NCT00452790|6295229|P2|After Infant Series|Lost to Follow-up|0
1812245|NCT00452790|6295230|P1|After Infant Series|Lost to Follow-up|4
1812246|NCT00452790|6295229|P2|After Infant Series|Parent/legal guardian request|3
1812247|NCT00452790|6295230|P1|After Infant Series|Parent/legal guardian request|1
1812248|NCT00452790|6295229|P2|After Infant Series|Adverse Event|1
1812249|NCT00452790|6295230|P1|After Infant Series|Adverse Event|4
1812250|NCT00452790|6295229|P2|After Infant Series|Investigator request|10
1812251|NCT00452790|6295230|P1|After Infant Series|Investigator request|10
1812252|NCT00452790|6295229|P2|Infant Series|Death|1
1812253|NCT00452790|6295230|P1|Infant Series|Death|0
1812254|NCT00452790|6295229|P2|Infant Series|Investigator request|1
1812255|NCT00452790|6295230|P1|Infant Series|Investigator request|0
1812256|NCT00452790|6295229|P2|Infant Series|Other reasons|2
1812257|NCT00452790|6295230|P1|Infant Series|Other reasons|1
1812258|NCT00452790|6295229|P2|Infant Series|Adverse Event|2
1812259|NCT00452790|6295230|P1|Infant Series|Adverse Event|1
1812260|NCT00452790|6295229|P2|Infant Series|Lost to Follow-up|2
1812261|NCT00452790|6295230|P1|Infant Series|Lost to Follow-up|2
1812262|NCT00452790|6295229|P2|Infant Series|Protocol Violation|3
1812263|NCT00452790|6295230|P1|Infant Series|Protocol Violation|1
1812264|NCT00452790|6295229|P2|Infant Series|Failed to return|1
1812265|NCT00452790|6295230|P1|Infant Series|Failed to return|4
1812266|NCT00452790|6295229|P2|Infant Series|Parent/legal guardian request|6
1812267|NCT00452790|6295230|P1|Infant Series|Parent/legal guardian request|8
1812268|NCT00452790|6295229|P2|Infant Series|Clinical hold - consent withdrawn|123
1812269|NCT00452790|6295230|P1|Infant Series|Clinical hold - consent withdrawn|118
1812270|NCT00452699|6295266|P2|Overall Study|Other|7
1812271|NCT00452699|6295267|P1|Overall Study|Other|12
1812272|NCT00452699|6295266|P2|Overall Study|Withdrawal by Subject|25
1812273|NCT00452699|6295267|P1|Overall Study|Withdrawal by Subject|26
1812274|NCT00452699|6295266|P2|Overall Study|Protocol Violation|25
1812275|NCT00452699|6295267|P1|Overall Study|Protocol Violation|21
1812276|NCT00452699|6295266|P2|Overall Study|Lost to Follow-up|9
1812277|NCT00452699|6295267|P1|Overall Study|Lost to Follow-up|6
1812278|NCT00452699|6295266|P2|Overall Study|Lack of Efficacy|4
1812279|NCT00452699|6295267|P1|Overall Study|Lack of Efficacy|6
1812280|NCT00452699|6295266|P2|Overall Study|Adverse Event|3
1812281|NCT00452699|6295267|P1|Overall Study|Adverse Event|10
1812282|NCT00452673|6295283|P5|Dose Expansion Period|Other|2
1812283|NCT00452673|6295284|P4|Dose Expansion Period|Other|0
1812284|NCT00452673|6295285|P3|Dose Expansion Period|Other|0
1812285|NCT00452673|6295286|P2|Dose Expansion Period|Other|0
1812286|NCT00452673|6295287|P1|Dose Expansion Period|Other|0
1812287|NCT00452673|6295283|P5|Dose Expansion Period|Disease Progression|19
1812288|NCT00452673|6295284|P4|Dose Expansion Period|Disease Progression|0
1812289|NCT00452673|6295285|P3|Dose Expansion Period|Disease Progression|0
1812290|NCT00452673|6295286|P2|Dose Expansion Period|Disease Progression|0
1812291|NCT00452673|6295287|P1|Dose Expansion Period|Disease Progression|0
1812292|NCT00452673|6295283|P5|Dose Escalation Period|Withdrawal by Subject|0
1812293|NCT00452673|6295284|P4|Dose Escalation Period|Withdrawal by Subject|1
1812294|NCT00452673|6295285|P3|Dose Escalation Period|Withdrawal by Subject|0
1812295|NCT00452673|6295286|P2|Dose Escalation Period|Withdrawal by Subject|0
1812296|NCT00452673|6295287|P1|Dose Escalation Period|Withdrawal by Subject|0
1812297|NCT00452673|6295283|P5|Dose Escalation Period|Adverse Event|0
1812298|NCT00452673|6295284|P4|Dose Escalation Period|Adverse Event|1
1812299|NCT00452673|6295285|P3|Dose Escalation Period|Adverse Event|0
1812300|NCT00452673|6295286|P2|Dose Escalation Period|Adverse Event|0
1812301|NCT00452673|6295287|P1|Dose Escalation Period|Adverse Event|0
1812302|NCT00452673|6295283|P5|Dose Escalation Period|Other|0
1812303|NCT00452673|6295284|P4|Dose Escalation Period|Other|0
1812304|NCT00452673|6295285|P3|Dose Escalation Period|Other|1
1812305|NCT00452673|6295286|P2|Dose Escalation Period|Other|0
1812306|NCT00452673|6295287|P1|Dose Escalation Period|Other|0
1812307|NCT00452673|6295283|P5|Dose Escalation Period|study drug toxicity|0
1812308|NCT00452673|6295284|P4|Dose Escalation Period|study drug toxicity|1
1812309|NCT00452673|6295285|P3|Dose Escalation Period|study drug toxicity|3
1812310|NCT00452673|6295286|P2|Dose Escalation Period|study drug toxicity|3
1812311|NCT00452673|6295287|P1|Dose Escalation Period|study drug toxicity|1
1812312|NCT00452673|6295283|P5|Dose Escalation Period|Disease Progression|0
1812313|NCT00452673|6295284|P4|Dose Escalation Period|Disease Progression|6
1812314|NCT00452673|6295285|P3|Dose Escalation Period|Disease Progression|2
1812315|NCT00452673|6295286|P2|Dose Escalation Period|Disease Progression|6
1812316|NCT00452673|6295287|P1|Dose Escalation Period|Disease Progression|6
1812317|NCT00452530|6295334|P2|Overall Study|Other|11
1812318|NCT00452530|6295335|P1|Overall Study|Other|7
1812319|NCT00452530|6295334|P2|Overall Study|No longer met study criteria|22
1812320|NCT00452530|6295335|P1|Overall Study|No longer met study criteria|18
1812321|NCT00452530|6295334|P2|Overall Study|Poor compliance/noncompliance|2
1812322|NCT00452530|6295335|P1|Overall Study|Poor compliance/noncompliance|1
1812323|NCT00452530|6295334|P2|Overall Study|Lost to Follow-up|0
1812324|NCT00452530|6295335|P1|Overall Study|Lost to Follow-up|1
1812325|NCT00452530|6295334|P2|Overall Study|Withdrawal by Subject|57
1812326|NCT00452530|6295335|P1|Overall Study|Withdrawal by Subject|68
1812327|NCT00452530|6295334|P2|Overall Study|Adverse Event|44
1812328|NCT00452530|6295335|P1|Overall Study|Adverse Event|40
1812329|NCT00452530|6295334|P2|Overall Study|Death|0
1812330|NCT00452530|6295335|P1|Overall Study|Death|1
1812331|NCT00452452|6295356|P3|Overall Study|Lost to Follow-up|0
1812332|NCT00452452|6295357|P2|Overall Study|Lost to Follow-up|0
1812333|NCT00452452|6295358|P1|Overall Study|Lost to Follow-up|1
1812334|NCT00452452|6295356|P3|Overall Study|Withdrawal by Subject|0
1812335|NCT00452452|6295357|P2|Overall Study|Withdrawal by Subject|0
1812336|NCT00452452|6295358|P1|Overall Study|Withdrawal by Subject|1
1812337|NCT00452452|6295356|P3|Overall Study|Protocol Violation|1
1812338|NCT00452452|6295357|P2|Overall Study|Protocol Violation|0
1812339|NCT00452452|6295358|P1|Overall Study|Protocol Violation|0
1812340|NCT00452400|6295403|P5|Overall Study|Other reasons not listed above|1
1812341|NCT00452400|6295404|P4|Overall Study|Other reasons not listed above|1
1812342|NCT00452400|6295405|P3|Overall Study|Other reasons not listed above|0
1812343|NCT00452400|6295406|P2|Overall Study|Other reasons not listed above|0
1812344|NCT00452400|6295407|P1|Overall Study|Other reasons not listed above|0
1812345|NCT00452400|6295403|P5|Overall Study|Lack of Efficacy|0
1812346|NCT00452400|6295404|P4|Overall Study|Lack of Efficacy|0
1812347|NCT00452400|6295405|P3|Overall Study|Lack of Efficacy|0
1812348|NCT00452400|6295406|P2|Overall Study|Lack of Efficacy|0
1812349|NCT00452400|6295407|P1|Overall Study|Lack of Efficacy|2
1812350|NCT00452400|6295403|P5|Overall Study|Withdrawal by Subject|0
1812351|NCT00452400|6295404|P4|Overall Study|Withdrawal by Subject|0
1812352|NCT00452400|6295405|P3|Overall Study|Withdrawal by Subject|1
1812353|NCT00452400|6295406|P2|Overall Study|Withdrawal by Subject|0
1812354|NCT00452400|6295407|P1|Overall Study|Withdrawal by Subject|1
1812355|NCT00452400|6295403|P5|Overall Study|Lost to Follow-up|0
1812356|NCT00452400|6295404|P4|Overall Study|Lost to Follow-up|0
1812357|NCT00452400|6295405|P3|Overall Study|Lost to Follow-up|0
1812358|NCT00452400|6295406|P2|Overall Study|Lost to Follow-up|0
1812359|NCT00452400|6295407|P1|Overall Study|Lost to Follow-up|1
1812360|NCT00452400|6295403|P5|Overall Study|Protocol Violation|0
1812361|NCT00452400|6295404|P4|Overall Study|Protocol Violation|0
1812362|NCT00452400|6295405|P3|Overall Study|Protocol Violation|1
1812363|NCT00452400|6295406|P2|Overall Study|Protocol Violation|0
1812364|NCT00452400|6295407|P1|Overall Study|Protocol Violation|0
1812365|NCT00452400|6295403|P5|Overall Study|Adverse Event|2
1812366|NCT00452400|6295404|P4|Overall Study|Adverse Event|0
1812367|NCT00452400|6295405|P3|Overall Study|Adverse Event|5
1812368|NCT00452400|6295406|P2|Overall Study|Adverse Event|1
1812369|NCT00452400|6295407|P1|Overall Study|Adverse Event|1
1812370|NCT00452361|6295594|P2|Overall Study|Premature termination|9
1812371|NCT00452361|6295595|P1|Overall Study|Premature termination|13
1812372|NCT00452361|6295594|P2|Overall Study|Withdrawal by Subject|1
1812373|NCT00452361|6295595|P1|Overall Study|Withdrawal by Subject|0
1812374|NCT00452361|6295594|P2|Overall Study|Adverse Event|0
1812375|NCT00452361|6295595|P1|Overall Study|Adverse Event|8
1812376|NCT00452348|6295639|P2|Overall Study|Other|9
1812377|NCT00452348|6295640|P1|Overall Study|Other|9
1812378|NCT00452348|6295639|P2|Overall Study|Withdrawal by Subject|21
1812379|NCT00452348|6295640|P1|Overall Study|Withdrawal by Subject|18
1812380|NCT00452348|6295639|P2|Overall Study|Protocol Violation|28
1812381|NCT00452348|6295640|P1|Overall Study|Protocol Violation|22
1812382|NCT00452348|6295639|P2|Overall Study|Lost to Follow-up|8
1812383|NCT00452348|6295640|P1|Overall Study|Lost to Follow-up|14
1812384|NCT00452348|6295639|P2|Overall Study|Lack of Efficacy|9
1812385|NCT00452348|6295640|P1|Overall Study|Lack of Efficacy|10
1812386|NCT00452348|6295639|P2|Overall Study|Adverse Event|9
1812387|NCT00452348|6295640|P1|Overall Study|Adverse Event|6
1812388|NCT00452114|6295694|P2|Overall Study|Physician Decision|3
1812389|NCT00452114|6295695|P1|Overall Study|Physician Decision|3
1812390|NCT00451958|6295711|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
1812391|NCT00451958|6295712|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
1812392|NCT00451958|6295713|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
1812393|NCT00451958|6295714|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
1812394|NCT00451958|6295715|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
1812395|NCT00451958|6295711|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
1812396|NCT00451958|6295712|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
1812397|NCT00451958|6295713|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
1812398|NCT00451958|6295714|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
1812399|NCT00451958|6295715|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
1812400|NCT00451958|6295711|P5|CS21A (NCT00451958)|Physician Decision|0
1812401|NCT00451958|6295712|P4|CS21A (NCT00451958)|Physician Decision|4
1812402|NCT00451958|6295713|P3|CS21A (NCT00451958)|Physician Decision|4
1812403|NCT00451958|6295714|P2|CS21A (NCT00451958)|Physician Decision|4
1812404|NCT00451958|6295715|P1|CS21A (NCT00451958)|Physician Decision|2
1812405|NCT00451958|6295711|P5|CS21A (NCT00451958)|Protocol Violation|0
1812406|NCT00451958|6295712|P4|CS21A (NCT00451958)|Protocol Violation|0
1812407|NCT00451958|6295713|P3|CS21A (NCT00451958)|Protocol Violation|2
1812408|NCT00451958|6295714|P2|CS21A (NCT00451958)|Protocol Violation|3
1812409|NCT00451958|6295715|P1|CS21A (NCT00451958)|Protocol Violation|1
1812410|NCT00451958|6295711|P5|CS21A (NCT00451958)|Lost to Follow-up|0
1812411|NCT00451958|6295712|P4|CS21A (NCT00451958)|Lost to Follow-up|1
1812412|NCT00451958|6295713|P3|CS21A (NCT00451958)|Lost to Follow-up|1
1812413|NCT00451958|6295714|P2|CS21A (NCT00451958)|Lost to Follow-up|5
1812414|NCT00451958|6295715|P1|CS21A (NCT00451958)|Lost to Follow-up|6
1812415|NCT00451958|6295711|P5|CS21A (NCT00451958)|Adverse Event|0
1812416|NCT00451958|6295712|P4|CS21A (NCT00451958)|Adverse Event|17
1812417|NCT00451958|6295713|P3|CS21A (NCT00451958)|Adverse Event|14
1812418|NCT00451958|6295714|P2|CS21A (NCT00451958)|Adverse Event|34
1812419|NCT00451958|6295715|P1|CS21A (NCT00451958)|Adverse Event|21
1812420|NCT00451906|6295745|P1|Overall Study|Did not complete final visit|4
1812421|NCT00451906|6295745|P1|Overall Study|Other Reasons|121
1812422|NCT00451906|6295745|P1|Overall Study|Termination of the study|108
1812423|NCT00451906|6295745|P1|Overall Study|Progressive disease|1328
1812424|NCT00451906|6295745|P1|Overall Study|Protocol Violation|21
1812425|NCT00451906|6295745|P1|Overall Study|Withdrawal by Subject|111
1812426|NCT00451906|6295745|P1|Overall Study|Lost to Follow-up|31
1812427|NCT00451906|6295745|P1|Overall Study|Adverse Event|515
1812428|NCT00451555|6295773|P2|Overall Study|Physician Decision|1
1812429|NCT00451555|6295774|P1|Overall Study|Physician Decision|2
1812430|NCT00451555|6295773|P2|Overall Study|Withdrawal by Subject|0
1812431|NCT00451555|6295774|P1|Overall Study|Withdrawal by Subject|6
1812432|NCT00451555|6295773|P2|Overall Study|Adverse Event|1
1812433|NCT00451555|6295774|P1|Overall Study|Adverse Event|3
1812434|NCT00451555|6295773|P2|Overall Study|Protocol Violation|2
1812435|NCT00451555|6295774|P1|Overall Study|Protocol Violation|2
1812436|NCT00451451|6295808|P4|Overall Study|Other Reasons for Not Completing Study|14
1812437|NCT00451451|6295809|P3|Overall Study|Other Reasons for Not Completing Study|17
1812438|NCT00451451|6295810|P2|Overall Study|Other Reasons for Not Completing Study|30
1812439|NCT00451451|6295811|P1|Overall Study|Other Reasons for Not Completing Study|34
1812440|NCT00451451|6295808|P4|Overall Study|Death|1
1812441|NCT00451451|6295809|P3|Overall Study|Death|0
1812442|NCT00451451|6295810|P2|Overall Study|Death|0
1812443|NCT00451451|6295811|P1|Overall Study|Death|1
1812444|NCT00451451|6295808|P4|Overall Study|Subject Non-Compliance|3
1812445|NCT00451451|6295809|P3|Overall Study|Subject Non-Compliance|3
1812446|NCT00451451|6295810|P2|Overall Study|Subject Non-Compliance|4
1812447|NCT00451451|6295811|P1|Overall Study|Subject Non-Compliance|8
1812448|NCT00451451|6295808|P4|Overall Study|Investigator Decision|2
1812449|NCT00451451|6295809|P3|Overall Study|Investigator Decision|1
1812450|NCT00451451|6295810|P2|Overall Study|Investigator Decision|2
1812451|NCT00451451|6295811|P1|Overall Study|Investigator Decision|6
1812452|NCT00451451|6295808|P4|Overall Study|Consent Withdrawn|17
1812453|NCT00451451|6295809|P3|Overall Study|Consent Withdrawn|17
1812454|NCT00451451|6295810|P2|Overall Study|Consent Withdrawn|9
1812455|NCT00451451|6295811|P1|Overall Study|Consent Withdrawn|14
1812456|NCT00451451|6295808|P4|Overall Study|Lost to Follow-up|11
1812457|NCT00451451|6295809|P3|Overall Study|Lost to Follow-up|8
1812458|NCT00451451|6295810|P2|Overall Study|Lost to Follow-up|9
1812459|NCT00451451|6295811|P1|Overall Study|Lost to Follow-up|11
1812460|NCT00451451|6295808|P4|Overall Study|Adverse Event|10
1812461|NCT00451451|6295809|P3|Overall Study|Adverse Event|26
1812462|NCT00451451|6295810|P2|Overall Study|Adverse Event|21
1812463|NCT00451451|6295811|P1|Overall Study|Adverse Event|11
1812464|NCT00451321|6295846|P8|Overall Study|Sponsor decision to amend protocol|3
1812465|NCT00451321|6295847|P7|Overall Study|Sponsor decision to amend protocol|1
1812466|NCT00451321|6295848|P6|Overall Study|Sponsor decision to amend protocol|1
1812467|NCT00451321|6295849|P5|Overall Study|Sponsor decision to amend protocol|0
1812468|NCT00451321|6295850|P4|Overall Study|Sponsor decision to amend protocol|0
1812469|NCT00451321|6295851|P3|Overall Study|Sponsor decision to amend protocol|0
1812470|NCT00451321|6295852|P2|Overall Study|Sponsor decision to amend protocol|0
1812471|NCT00451321|6295853|P1|Overall Study|Sponsor decision to amend protocol|0
1812472|NCT00451321|6295846|P8|Overall Study|Study closed/terminated|3
1812473|NCT00451321|6295847|P7|Overall Study|Study closed/terminated|5
1812474|NCT00451321|6295848|P6|Overall Study|Study closed/terminated|7
1812475|NCT00451321|6295849|P5|Overall Study|Study closed/terminated|7
1812476|NCT00451321|6295850|P4|Overall Study|Study closed/terminated|5
1812477|NCT00451321|6295851|P3|Overall Study|Study closed/terminated|17
1812478|NCT00451321|6295852|P2|Overall Study|Study closed/terminated|1
1812479|NCT00451321|6295853|P1|Overall Study|Study closed/terminated|1
1812480|NCT00451321|6295846|P8|Overall Study|Withdrawal by Subject|0
1812481|NCT00451321|6295847|P7|Overall Study|Withdrawal by Subject|0
1812482|NCT00451321|6295848|P6|Overall Study|Withdrawal by Subject|0
1812483|NCT00451321|6295849|P5|Overall Study|Withdrawal by Subject|0
1812484|NCT00451321|6295850|P4|Overall Study|Withdrawal by Subject|4
1812485|NCT00451321|6295851|P3|Overall Study|Withdrawal by Subject|0
1812486|NCT00451321|6295852|P2|Overall Study|Withdrawal by Subject|1
1812487|NCT00451321|6295853|P1|Overall Study|Withdrawal by Subject|3
1812488|NCT00451321|6295846|P8|Overall Study|Lost to Follow-up|0
1812489|NCT00451321|6295847|P7|Overall Study|Lost to Follow-up|0
1812490|NCT00451321|6295848|P6|Overall Study|Lost to Follow-up|1
1812491|NCT00451321|6295849|P5|Overall Study|Lost to Follow-up|0
1812492|NCT00451321|6295850|P4|Overall Study|Lost to Follow-up|3
1812493|NCT00451321|6295851|P3|Overall Study|Lost to Follow-up|1
1812494|NCT00451321|6295852|P2|Overall Study|Lost to Follow-up|3
1812495|NCT00451321|6295853|P1|Overall Study|Lost to Follow-up|3
1812496|NCT00451282|6296025|P2|Overall Study|Lost to Follow-up|5
1812497|NCT00451282|6296026|P1|Overall Study|Lost to Follow-up|6
1812498|NCT00451217|6296042|P4|Overall Study|Not Treated|4
1812499|NCT00451217|6296043|P3|Overall Study|Not Treated|3
1812500|NCT00451217|6296044|P2|Overall Study|Not Treated|1
1812501|NCT00451217|6296045|P1|Overall Study|Not Treated|1
1812502|NCT00451217|6296042|P4|Overall Study|Withdrawal by Subject|0
1812503|NCT00451217|6296043|P3|Overall Study|Withdrawal by Subject|0
1812504|NCT00451217|6296044|P2|Overall Study|Withdrawal by Subject|0
1812505|NCT00451217|6296045|P1|Overall Study|Withdrawal by Subject|1
1812506|NCT00451217|6296042|P4|Overall Study|Lost to Follow-up|1
1812507|NCT00451217|6296043|P3|Overall Study|Lost to Follow-up|1
1812508|NCT00451217|6296044|P2|Overall Study|Lost to Follow-up|1
1812509|NCT00451217|6296045|P1|Overall Study|Lost to Follow-up|0
1812510|NCT00451204|6296073|P2|Overall Study|Other|2
1812511|NCT00451204|6296074|P1|Overall Study|Other|1
1812512|NCT00451204|6296073|P2|Overall Study|Patient refusal|4
1812513|NCT00451204|6296074|P1|Overall Study|Patient refusal|8
1812514|NCT00451204|6296073|P2|Overall Study|Protocol Violation|0
1812515|NCT00451204|6296074|P1|Overall Study|Protocol Violation|1
1812516|NCT00451204|6296073|P2|Overall Study|Lost to Follow-up|4
1812517|NCT00451204|6296074|P1|Overall Study|Lost to Follow-up|4
1812518|NCT00451204|6296073|P2|Overall Study|Lack of Efficacy|4
1812519|NCT00451204|6296074|P1|Overall Study|Lack of Efficacy|4
1812520|NCT00451204|6296073|P2|Overall Study|Adverse Event|6
1812521|NCT00451204|6296074|P1|Overall Study|Adverse Event|4
1812522|NCT00451191|6296092|P2|Overall Study|withdrawal or received alternate tx|11
1812523|NCT00451191|6296093|P1|Overall Study|withdrawal or received alternate tx|15
1812524|NCT00450866|6296120|P2|Overall Study|Physician Decision|0
1812525|NCT00450866|6296121|P1|Overall Study|Physician Decision|1
1812526|NCT00450866|6296120|P2|Overall Study|Death|0
1812527|NCT00450866|6296121|P1|Overall Study|Death|1
1812528|NCT00450866|6296120|P2|Overall Study|Withdrawal by Subject|2
1812529|NCT00450866|6296121|P1|Overall Study|Withdrawal by Subject|5
1812530|NCT00450866|6296120|P2|Overall Study|Adverse Event|1
1812531|NCT00450866|6296121|P1|Overall Study|Adverse Event|0
1812532|NCT00450814|6296141|P11|Overall Study|Patient withdrawal prior to treatment|0
1812533|NCT00450814|6296142|P10|Overall Study|Patient withdrawal prior to treatment|1
1812534|NCT00450814|6296143|P9|Overall Study|Patient withdrawal prior to treatment|0
1812535|NCT00450814|6296144|P8|Overall Study|Patient withdrawal prior to treatment|0
1812536|NCT00450814|6296145|P7|Overall Study|Patient withdrawal prior to treatment|0
1812537|NCT00450814|6296146|P6|Overall Study|Patient withdrawal prior to treatment|0
1812538|NCT00450814|6296147|P5|Overall Study|Patient withdrawal prior to treatment|0
1812539|NCT00450814|6296148|P4|Overall Study|Patient withdrawal prior to treatment|0
1812540|NCT00450814|6296149|P3|Overall Study|Patient withdrawal prior to treatment|0
1812541|NCT00450814|6296150|P2|Overall Study|Patient withdrawal prior to treatment|0
1812542|NCT00450814|6296151|P1|Overall Study|Patient withdrawal prior to treatment|0
1812543|NCT00450814|6296141|P11|Overall Study|Failed to complete the initial therapy|0
1812544|NCT00450814|6296142|P10|Overall Study|Failed to complete the initial therapy|0
1812545|NCT00450814|6296143|P9|Overall Study|Failed to complete the initial therapy|0
1812546|NCT00450814|6296144|P8|Overall Study|Failed to complete the initial therapy|0
1812547|NCT00450814|6296145|P7|Overall Study|Failed to complete the initial therapy|0
1812548|NCT00450814|6296146|P6|Overall Study|Failed to complete the initial therapy|1
1812549|NCT00450814|6296147|P5|Overall Study|Failed to complete the initial therapy|1
1812550|NCT00450814|6296148|P4|Overall Study|Failed to complete the initial therapy|1
1812551|NCT00450814|6296149|P3|Overall Study|Failed to complete the initial therapy|0
1812552|NCT00450814|6296150|P2|Overall Study|Failed to complete the initial therapy|0
1812553|NCT00450814|6296151|P1|Overall Study|Failed to complete the initial therapy|0
1812554|NCT00450801|6296185|P1|Overall Study|Death|1
1812555|NCT00450749|6296199|P3|Overall Study|Noncompliant|0
1812556|NCT00450749|6296200|P2|Overall Study|Noncompliant|1
1812557|NCT00450749|6296201|P1|Overall Study|Noncompliant|0
1812558|NCT00450749|6296199|P3|Overall Study|Withdrawal by Subject|2
1812559|NCT00450749|6296200|P2|Overall Study|Withdrawal by Subject|0
1812560|NCT00450749|6296201|P1|Overall Study|Withdrawal by Subject|0
1812561|NCT00450723|6296239|P1|Overall Study|Physician Decision|5
1812562|NCT00450658|6296247|P2|Overall Study|misc|10
1812563|NCT00450658|6296248|P1|Overall Study|misc|21
1812564|NCT00450658|6296247|P2|Overall Study|UGI ulcer|34
1812565|NCT00450658|6296248|P1|Overall Study|UGI ulcer|33
1812566|NCT00450658|6296247|P2|Overall Study|Lost to Follow-up|5
1812567|NCT00450658|6296248|P1|Overall Study|Lost to Follow-up|22
1812568|NCT00450658|6296247|P2|Overall Study|Withdrawal by Subject|26
1812569|NCT00450658|6296248|P1|Overall Study|Withdrawal by Subject|43
1812570|NCT00450658|6296247|P2|Overall Study|Adverse Event|15
1812571|NCT00450658|6296248|P1|Overall Study|Adverse Event|24
1812572|NCT00450619|6296262|P2|Overall Study|Adverse Event|0
1812573|NCT00450619|6296263|P1|Overall Study|Adverse Event|1
1812574|NCT00450619|6296262|P2|Overall Study|did not progress; refused further trmt|1
1812575|NCT00450619|6296263|P1|Overall Study|did not progress; refused further trmt|1
1812576|NCT00450619|6296262|P2|Overall Study|refused treatment after randomization|0
1812577|NCT00450619|6296263|P1|Overall Study|refused treatment after randomization|2
1812578|NCT00450580|6296289|P2|Overall Study|Withdrawal due to pregnancy|1
1812579|NCT00450580|6296290|P1|Overall Study|Withdrawal due to pregnancy|0
1812580|NCT00450580|6296289|P2|Overall Study|Patient could not swallow Norvir|0
1812581|NCT00450580|6296290|P1|Overall Study|Patient could not swallow Norvir|1
1812582|NCT00450580|6296289|P2|Overall Study|Patient went to Brazil|0
1812583|NCT00450580|6296290|P1|Overall Study|Patient went to Brazil|1
1812584|NCT00450580|6296289|P2|Overall Study|Could not comply with scheduled visits|0
1812585|NCT00450580|6296290|P1|Overall Study|Could not comply with scheduled visits|1
1812586|NCT00450580|6296289|P2|Overall Study|Protocol-defined virologic failure|0
1812587|NCT00450580|6296290|P1|Overall Study|Protocol-defined virologic failure|1
1812588|NCT00450580|6296289|P2|Overall Study|Protocol Violation|1
1812589|NCT00450580|6296290|P1|Overall Study|Protocol Violation|1
1812590|NCT00450580|6296289|P2|Overall Study|Withdrawal by Subject|2
1812591|NCT00450580|6296290|P1|Overall Study|Withdrawal by Subject|2
1812592|NCT00450580|6296289|P2|Overall Study|Lost to Follow-up|5
1812593|NCT00450580|6296290|P1|Overall Study|Lost to Follow-up|4
1812594|NCT00450580|6296289|P2|Overall Study|Adverse Event|7
1812595|NCT00450580|6296290|P1|Overall Study|Adverse Event|5
1812596|NCT00450450|6296327|P2|Overall Study|Missing Data|0
1812597|NCT00450450|6296328|P1|Overall Study|Missing Data|2
1812598|NCT00450450|6296327|P2|Overall Study|Relapse|0
1812599|NCT00450450|6296328|P1|Overall Study|Relapse|2
1812600|NCT00450450|6296327|P2|Overall Study|Death|3
1812601|NCT00450450|6296328|P1|Overall Study|Death|1
1812602|NCT00450437|6296352|P4|Overall Study|Unable to Classify|0
1812603|NCT00450437|6296353|P3|Overall Study|Unable to Classify|1
1812604|NCT00450437|6296354|P2|Overall Study|Unable to Classify|0
1812605|NCT00450437|6296355|P1|Overall Study|Unable to Classify|1
1812606|NCT00450437|6296352|P4|Overall Study|Administrative reason|0
1812607|NCT00450437|6296353|P3|Overall Study|Administrative reason|1
1812608|NCT00450437|6296354|P2|Overall Study|Administrative reason|0
1812609|NCT00450437|6296355|P1|Overall Study|Administrative reason|0
1812610|NCT00450437|6296352|P4|Overall Study|Inappropriate enrollment|0
1812611|NCT00450437|6296353|P3|Overall Study|Inappropriate enrollment|3
1812612|NCT00450437|6296354|P2|Overall Study|Inappropriate enrollment|1
1812613|NCT00450437|6296355|P1|Overall Study|Inappropriate enrollment|4
1812614|NCT00450437|6296352|P4|Overall Study|Protocol Violation|1
1812615|NCT00450437|6296353|P3|Overall Study|Protocol Violation|0
1812616|NCT00450437|6296354|P2|Overall Study|Protocol Violation|1
1812617|NCT00450437|6296355|P1|Overall Study|Protocol Violation|0
1812618|NCT00450437|6296352|P4|Overall Study|Lost to Follow-up|9
1812619|NCT00450437|6296353|P3|Overall Study|Lost to Follow-up|19
1812620|NCT00450437|6296354|P2|Overall Study|Lost to Follow-up|12
1812621|NCT00450437|6296355|P1|Overall Study|Lost to Follow-up|31
1812622|NCT00450437|6296352|P4|Overall Study|Withdrawal by Subject|1
1812623|NCT00450437|6296353|P3|Overall Study|Withdrawal by Subject|0
1812624|NCT00450437|6296354|P2|Overall Study|Withdrawal by Subject|2
1812625|NCT00450437|6296355|P1|Overall Study|Withdrawal by Subject|10
1812626|NCT00450411|6296386|P1|Overall Study|No protocol treatment|2
1812627|NCT00450411|6296386|P1|Overall Study|Protocol Violation|6
1812628|NCT00450385|6296391|P1|Overall Study|Other|3
1812629|NCT00450385|6296391|P1|Overall Study|Physician Decision|1
1812630|NCT00450385|6296391|P1|Overall Study|Adverse Event|1
1812631|NCT00450385|6296391|P1|Overall Study|Lack of Efficacy|2
1812632|NCT00450385|6296391|P1|Overall Study|Withdrawal by Subject|2
1812633|NCT00450385|6296391|P1|Overall Study|Protocol Violation|1
1812634|NCT00450385|6296391|P1|Overall Study|Death|3
1812635|NCT00450372|6296400|P1|Overall Study|Physician Decision|1
1812636|NCT00450333|6296413|P4|Overall Study|Death|2
1812637|NCT00450333|6296414|P3|Overall Study|Death|2
1812638|NCT00450333|6296415|P2|Overall Study|Death|2
1812639|NCT00450333|6296416|P1|Overall Study|Death|3
1812640|NCT00450333|6296413|P4|Overall Study|Kidney transplant|3
1812641|NCT00450333|6296414|P3|Overall Study|Kidney transplant|1
1812642|NCT00450333|6296415|P2|Overall Study|Kidney transplant|0
1812643|NCT00450333|6296416|P1|Overall Study|Kidney transplant|1
1812644|NCT00450333|6296413|P4|Overall Study|Withdrawal by Subject|0
1812645|NCT00450333|6296414|P3|Overall Study|Withdrawal by Subject|3
1812646|NCT00450333|6296415|P2|Overall Study|Withdrawal by Subject|0
1812647|NCT00450333|6296416|P1|Overall Study|Withdrawal by Subject|1
1812648|NCT00450333|6296413|P4|Overall Study|Protocol Violation|0
1812649|NCT00450333|6296414|P3|Overall Study|Protocol Violation|1
1812650|NCT00450333|6296415|P2|Overall Study|Protocol Violation|0
1812651|NCT00450333|6296416|P1|Overall Study|Protocol Violation|1
1812652|NCT00450333|6296413|P4|Overall Study|Adverse Event|2
1812653|NCT00450333|6296414|P3|Overall Study|Adverse Event|2
1812654|NCT00450333|6296415|P2|Overall Study|Adverse Event|7
1812655|NCT00450333|6296416|P1|Overall Study|Adverse Event|1
1812656|NCT00450333|6296413|P4|Overall Study|Study terminated|21
1812657|NCT00450333|6296414|P3|Overall Study|Study terminated|16
1812658|NCT00450333|6296415|P2|Overall Study|Study terminated|54
1812659|NCT00450333|6296416|P1|Overall Study|Study terminated|47
1812660|NCT00450255|6296439|P1|Overall Study|Prior RFA ablation of liver|1
1812661|NCT00450216|6296464|P2|Overall Study|misc|20
1812662|NCT00450216|6296465|P1|Overall Study|misc|21
1812663|NCT00450216|6296464|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
1812664|NCT00450216|6296465|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
1812665|NCT00450216|6296464|P2|Overall Study|Lost to Follow-up|9
1812666|NCT00450216|6296465|P1|Overall Study|Lost to Follow-up|16
1812667|NCT00450216|6296464|P2|Overall Study|Withdrawal by Subject|26
1812668|NCT00450216|6296465|P1|Overall Study|Withdrawal by Subject|48
1812669|NCT00450216|6296464|P2|Overall Study|Adverse Event|23
1812670|NCT00450216|6296465|P1|Overall Study|Adverse Event|38
1812671|NCT00450190|6296477|P1|Overall Study|Withdrawal by Subject|2
1812672|NCT00450177|6296487|P2|Overall Study|Withdrawal by Primary Team|1
1812673|NCT00450177|6296488|P1|Overall Study|Withdrawal by Primary Team|1
1812674|NCT00450177|6296487|P2|Overall Study|Withdrawal by Subject|6
1812675|NCT00450177|6296488|P1|Overall Study|Withdrawal by Subject|1
1812676|NCT00450177|6296487|P2|Overall Study|Adverse Event|4
1812677|NCT00450177|6296488|P1|Overall Study|Adverse Event|7
1812678|NCT00450112|6296514|P2|Overall Study|Others|3
1812679|NCT00450112|6296515|P1|Overall Study|Others|2
1812680|NCT00450112|6296514|P2|Overall Study|Lost to Follow-up|1
1812681|NCT00450112|6296515|P1|Overall Study|Lost to Follow-up|2
1812682|NCT00450112|6296514|P2|Overall Study|Withdrawal by Subject|1
1812683|NCT00450112|6296515|P1|Overall Study|Withdrawal by Subject|4
1812684|NCT00450112|6296514|P2|Overall Study|Other Treatment Required|1
1812685|NCT00450112|6296515|P1|Overall Study|Other Treatment Required|5
1812686|NCT00449956|6296553|P3|Overall Study|Physician Decision|1
1812687|NCT00449956|6296554|P2|Overall Study|Physician Decision|1
1812688|NCT00449956|6296555|P1|Overall Study|Physician Decision|2
1812689|NCT00449956|6296553|P3|Overall Study|Withdrawal by Subject|0
1812690|NCT00449956|6296554|P2|Overall Study|Withdrawal by Subject|1
1812691|NCT00449956|6296555|P1|Overall Study|Withdrawal by Subject|0
1812692|NCT00449956|6296553|P3|Overall Study|Protocol Violation|1
1812693|NCT00449956|6296554|P2|Overall Study|Protocol Violation|1
1812694|NCT00449956|6296555|P1|Overall Study|Protocol Violation|1
1812695|NCT00449956|6296553|P3|Overall Study|Lack of Efficacy|1
1812696|NCT00449956|6296554|P2|Overall Study|Lack of Efficacy|0
1812697|NCT00449956|6296555|P1|Overall Study|Lack of Efficacy|0
1812698|NCT00449956|6296553|P3|Overall Study|Adverse Event|6
1812699|NCT00449956|6296554|P2|Overall Study|Adverse Event|1
1812700|NCT00449956|6296555|P1|Overall Study|Adverse Event|7
1812701|NCT00449930|6296571|P2|Overall Study|Glycemic discontinuation criteria|1
1812702|NCT00449930|6296572|P1|Overall Study|Glycemic discontinuation criteria|1
1812703|NCT00449930|6296571|P2|Overall Study|Withdrawal by Subject|23
1812704|NCT00449930|6296572|P1|Overall Study|Withdrawal by Subject|16
1812705|NCT00449930|6296571|P2|Overall Study|Protocol Violation|15
1812706|NCT00449930|6296572|P1|Overall Study|Protocol Violation|14
1812707|NCT00449930|6296571|P2|Overall Study|Physician Decision|2
1812708|NCT00449930|6296572|P1|Overall Study|Physician Decision|1
1812709|NCT00449930|6296571|P2|Overall Study|Lost to Follow-up|14
1812710|NCT00449930|6296572|P1|Overall Study|Lost to Follow-up|9
1812711|NCT00449930|6296571|P2|Overall Study|Lack of Efficacy|1
1812712|NCT00449930|6296572|P1|Overall Study|Lack of Efficacy|10
1812713|NCT00449930|6296571|P2|Overall Study|Trial Terminated ( Site Closed)|0
1812714|NCT00449930|6296572|P1|Overall Study|Trial Terminated ( Site Closed)|1
1812715|NCT00449930|6296571|P2|Overall Study|Adverse Event|19
1812716|NCT00449930|6296572|P1|Overall Study|Adverse Event|9
1812717|NCT00449865|6296588|P2|Overall Study|Study was stopped|328
1812718|NCT00449865|6296589|P1|Overall Study|Study was stopped|324
1812719|NCT00449865|6296588|P2|Overall Study|Protocol Violation|7
1812720|NCT00449865|6296589|P1|Overall Study|Protocol Violation|8
1812721|NCT00449865|6296588|P2|Overall Study|Death|40
1812722|NCT00449865|6296589|P1|Overall Study|Death|31
1812723|NCT00449865|6296588|P2|Overall Study|Physician Decision|12
1812724|NCT00449865|6296589|P1|Overall Study|Physician Decision|13
1812725|NCT00449865|6296588|P2|Overall Study|Lost to Follow-up|37
1812726|NCT00449865|6296589|P1|Overall Study|Lost to Follow-up|36
1812727|NCT00449865|6296588|P2|Overall Study|Withdrawal by Subject|110
1812728|NCT00449865|6296589|P1|Overall Study|Withdrawal by Subject|110
1812729|NCT00449787|6296597|P2|Overall Study|Did not require medication|92
1812730|NCT00449787|6296598|P1|Overall Study|Did not require medication|95
1812731|NCT00449787|6296597|P2|Overall Study|Lost to Follow-up|8
1812732|NCT00449787|6296598|P1|Overall Study|Lost to Follow-up|10
1812733|NCT00449696|6296614|P2|Overall Study|Others|0
1812734|NCT00449696|6296615|P1|Overall Study|Others|7
1812735|NCT00449696|6296614|P2|Overall Study|Lost to Follow-up|3
1812736|NCT00449696|6296615|P1|Overall Study|Lost to Follow-up|2
1812737|NCT00449696|6296614|P2|Overall Study|Withdrawal by Subject|5
1812738|NCT00449696|6296615|P1|Overall Study|Withdrawal by Subject|5
1812739|NCT00449696|6296614|P2|Overall Study|Other Treatment Required|1
1812740|NCT00449696|6296615|P1|Overall Study|Other Treatment Required|6
1812741|NCT00449644|6296641|P4|Overall Study|Rolled-over to treatment with TMC207|1
1812742|NCT00449644|6296642|P3|Overall Study|Rolled-over to treatment with TMC207|0
1812743|NCT00449644|6296643|P2|Overall Study|Rolled-over to treatment with TMC207|0
1812744|NCT00449644|6296644|P1|Overall Study|Rolled-over to treatment with TMC207|0
1812745|NCT00449644|6296641|P4|Overall Study|Other|0
1812746|NCT00449644|6296642|P3|Overall Study|Other|1
1812747|NCT00449644|6296643|P2|Overall Study|Other|4
1812748|NCT00449644|6296644|P1|Overall Study|Other|1
1812749|NCT00449644|6296641|P4|Overall Study|Inclusion/exclusion criteria not met|6
1812750|NCT00449644|6296642|P3|Overall Study|Inclusion/exclusion criteria not met|2
1812751|NCT00449644|6296643|P2|Overall Study|Inclusion/exclusion criteria not met|0
1812752|NCT00449644|6296644|P1|Overall Study|Inclusion/exclusion criteria not met|0
1812753|NCT00449644|6296641|P4|Overall Study|Withdrawal by Subject|7
1812754|NCT00449644|6296642|P3|Overall Study|Withdrawal by Subject|6
1812755|NCT00449644|6296643|P2|Overall Study|Withdrawal by Subject|4
1812756|NCT00449644|6296644|P1|Overall Study|Withdrawal by Subject|3
1812757|NCT00449644|6296641|P4|Overall Study|Protocol Violation|7
1812758|NCT00449644|6296642|P3|Overall Study|Protocol Violation|3
1812759|NCT00449644|6296643|P2|Overall Study|Protocol Violation|4
1812760|NCT00449644|6296644|P1|Overall Study|Protocol Violation|4
1812761|NCT00449644|6296641|P4|Overall Study|Pregnancy|2
1812762|NCT00449644|6296642|P3|Overall Study|Pregnancy|3
1812763|NCT00449644|6296643|P2|Overall Study|Pregnancy|0
1812764|NCT00449644|6296644|P1|Overall Study|Pregnancy|0
1812765|NCT00449644|6296641|P4|Overall Study|Lost to Follow-up|3
1812766|NCT00449644|6296642|P3|Overall Study|Lost to Follow-up|5
1812767|NCT00449644|6296643|P2|Overall Study|Lost to Follow-up|1
1812768|NCT00449644|6296644|P1|Overall Study|Lost to Follow-up|1
1812769|NCT00449644|6296641|P4|Overall Study|Death|1
1812770|NCT00449644|6296642|P3|Overall Study|Death|6
1812771|NCT00449644|6296643|P2|Overall Study|Death|0
1812772|NCT00449644|6296644|P1|Overall Study|Death|1
1812773|NCT00449644|6296641|P4|Overall Study|Adverse Event|5
1812774|NCT00449644|6296642|P3|Overall Study|Adverse Event|3
1812775|NCT00449644|6296643|P2|Overall Study|Adverse Event|0
1812776|NCT00449644|6296644|P1|Overall Study|Adverse Event|0
1812777|NCT00449540|6296664|P3|Treatment Phase|did not experience or treat migraine|17
1812778|NCT00449540|6296665|P2|Treatment Phase|did not experience or treat migraine|20
1812779|NCT00449540|6296666|P1|Treatment Phase|did not experience or treat migraine|0
1812780|NCT00449540|6296664|P3|Pretreatment Phase|No migraine experienced|0
1812781|NCT00449540|6296665|P2|Pretreatment Phase|No migraine experienced|0
1812782|NCT00449540|6296666|P1|Pretreatment Phase|No migraine experienced|66
1812783|NCT00449176|6296683|P3|Overall Study|all other|20
1812784|NCT00449176|6296684|P2|Overall Study|all other|19
1812785|NCT00449176|6296685|P1|Overall Study|all other|22
1812786|NCT00449176|6296683|P3|Overall Study|Study drug non-compliant|11
1812787|NCT00449176|6296684|P2|Overall Study|Study drug non-compliant|11
1812788|NCT00449176|6296685|P1|Overall Study|Study drug non-compliant|14
1812789|NCT00449176|6296683|P3|Overall Study|Lack of Efficacy|50
1812790|NCT00449176|6296684|P2|Overall Study|Lack of Efficacy|7
1812791|NCT00449176|6296685|P1|Overall Study|Lack of Efficacy|13
1812792|NCT00449176|6296683|P3|Overall Study|Adverse Event|15
1812793|NCT00449176|6296684|P2|Overall Study|Adverse Event|107
1812794|NCT00449176|6296685|P1|Overall Study|Adverse Event|51
1812795|NCT00449176|6296683|P3|Overall Study|Lost to Follow-up|12
1812796|NCT00449176|6296684|P2|Overall Study|Lost to Follow-up|8
1812797|NCT00449176|6296685|P1|Overall Study|Lost to Follow-up|13
1812798|NCT00449176|6296683|P3|Overall Study|Withdrawal by Subject|59
1812799|NCT00449176|6296684|P2|Overall Study|Withdrawal by Subject|43
1812800|NCT00449176|6296685|P1|Overall Study|Withdrawal by Subject|39
1812801|NCT00449163|6296711|P1|Overall Study|Physician Decision|3
1812802|NCT00449150|6296721|P3|Overall Study|Protocol Violation|1
1812803|NCT00449150|6296722|P2|Overall Study|Protocol Violation|2
1812804|NCT00449150|6296723|P1|Overall Study|Protocol Violation|1
1812805|NCT00449150|6296721|P3|Overall Study|Withdrawal by Subject|21
1812806|NCT00449150|6296722|P2|Overall Study|Withdrawal by Subject|18
1812807|NCT00449150|6296723|P1|Overall Study|Withdrawal by Subject|17
1812808|NCT00449150|6296721|P3|Overall Study|Other|14
1812809|NCT00449150|6296722|P2|Overall Study|Other|13
1812810|NCT00449150|6296723|P1|Overall Study|Other|16
1812811|NCT00449150|6296721|P3|Overall Study|Lack of Efficacy|2
1812812|NCT00449150|6296722|P2|Overall Study|Lack of Efficacy|2
1812813|NCT00449150|6296723|P1|Overall Study|Lack of Efficacy|1
1812814|NCT00449150|6296721|P3|Overall Study|Adverse Event|9
1812815|NCT00449150|6296722|P2|Overall Study|Adverse Event|18
1812816|NCT00449150|6296723|P1|Overall Study|Adverse Event|11
1812817|NCT00449072|6296736|P2|Overall Study|Relocation|2
1812818|NCT00449072|6296737|P1|Overall Study|Relocation|3
1812819|NCT00449072|6296736|P2|Overall Study|Sponsor decision|3
1812820|NCT00449072|6296737|P1|Overall Study|Sponsor decision|1
1812821|NCT00449072|6296736|P2|Overall Study|Non-compliance|5
1812822|NCT00449072|6296737|P1|Overall Study|Non-compliance|2
1812823|NCT00449072|6296736|P2|Overall Study|Excluded medication|2
1812824|NCT00449072|6296737|P1|Overall Study|Excluded medication|0
1812825|NCT00449072|6296736|P2|Overall Study|Not treated|1
1812826|NCT00449072|6296737|P1|Overall Study|Not treated|0
1812827|NCT00449072|6296736|P2|Overall Study|Physician Decision|0
1812828|NCT00449072|6296737|P1|Overall Study|Physician Decision|1
1812829|NCT00449072|6296736|P2|Overall Study|Lack of Efficacy|1
1812830|NCT00449072|6296737|P1|Overall Study|Lack of Efficacy|1
1812831|NCT00449072|6296736|P2|Overall Study|Withdrawal by Subject|8
1812832|NCT00449072|6296737|P1|Overall Study|Withdrawal by Subject|11
1812833|NCT00449072|6296736|P2|Overall Study|Lost to Follow-up|7
1812834|NCT00449072|6296737|P1|Overall Study|Lost to Follow-up|5
1812835|NCT00449072|6296736|P2|Overall Study|Protocol Violation|12
1812836|NCT00449072|6296737|P1|Overall Study|Protocol Violation|14
1812837|NCT00449072|6296736|P2|Overall Study|Adverse Event|1
1812838|NCT00449072|6296737|P1|Overall Study|Adverse Event|3
1812839|NCT00449033|6296774|P2|Follow-up Period|Reason Missing|113
1812840|NCT00449033|6296775|P1|Follow-up Period|Reason Missing|120
1812841|NCT00449033|6296774|P2|Follow-up Period|Lost to Follow-up|10
1812842|NCT00449033|6296775|P1|Follow-up Period|Lost to Follow-up|6
1812843|NCT00449033|6296774|P2|Follow-up Period|Death|311
1812844|NCT00449033|6296775|P1|Follow-up Period|Death|299
1812845|NCT00449033|6296774|P2|Treatment Period|Treatment Ongoing|4
1812846|NCT00449033|6296775|P1|Treatment Period|Treatment Ongoing|6
1812847|NCT00449033|6296774|P2|Treatment Period|Reason Missing|4
1812848|NCT00449033|6296775|P1|Treatment Period|Reason Missing|0
1812849|NCT00449033|6296774|P2|Treatment Period|Second Malignancy|1
1812850|NCT00449033|6296775|P1|Treatment Period|Second Malignancy|0
1812851|NCT00449033|6296774|P2|Treatment Period|Non-compliance|8
1812852|NCT00449033|6296775|P1|Treatment Period|Non-compliance|7
1812853|NCT00449033|6296774|P2|Treatment Period|Amended Protocol Criteria|18
1812854|NCT00449033|6296775|P1|Treatment Period|Amended Protocol Criteria|22
1812855|NCT00449033|6296774|P2|Treatment Period|Consent Withdrawn|20
1812856|NCT00449033|6296775|P1|Treatment Period|Consent Withdrawn|36
1812857|NCT00449033|6296774|P2|Treatment Period|Disease Progression|288
1812858|NCT00449033|6296775|P1|Treatment Period|Disease Progression|231
1812859|NCT00449033|6296774|P2|Treatment Period|Protocol Violation|7
1812860|NCT00449033|6296775|P1|Treatment Period|Protocol Violation|8
1812861|NCT00449033|6296774|P2|Treatment Period|Physician Decision|5
1812862|NCT00449033|6296775|P1|Treatment Period|Physician Decision|4
1812863|NCT00449033|6296774|P2|Treatment Period|Lost to Follow-up|2
1812864|NCT00449033|6296775|P1|Treatment Period|Lost to Follow-up|0
1812865|NCT00449033|6296774|P2|Treatment Period|Death|12
1812866|NCT00449033|6296775|P1|Treatment Period|Death|21
1812867|NCT00449033|6296774|P2|Treatment Period|Adverse Event|83
1812868|NCT00449033|6296775|P1|Treatment Period|Adverse Event|117
1812869|NCT00448916|6296813|P4|Overall Study|Protocol Violation|1
1812870|NCT00448916|6296814|P3|Overall Study|Protocol Violation|0
1812871|NCT00448916|6296815|P2|Overall Study|Protocol Violation|0
1812872|NCT00448916|6296816|P1|Overall Study|Protocol Violation|0
1812873|NCT00448916|6296813|P4|Overall Study|Lost to Follow-up|1
1812874|NCT00448916|6296814|P3|Overall Study|Lost to Follow-up|0
1812875|NCT00448916|6296815|P2|Overall Study|Lost to Follow-up|1
1812876|NCT00448916|6296816|P1|Overall Study|Lost to Follow-up|0
1812877|NCT00448916|6296813|P4|Overall Study|Other|0
1812878|NCT00448916|6296814|P3|Overall Study|Other|0
1812879|NCT00448916|6296815|P2|Overall Study|Other|0
1812880|NCT00448916|6296816|P1|Overall Study|Other|1
1812881|NCT00448916|6296813|P4|Overall Study|Withdrawal by Subject|1
1812882|NCT00448916|6296814|P3|Overall Study|Withdrawal by Subject|1
1812883|NCT00448916|6296815|P2|Overall Study|Withdrawal by Subject|3
1812884|NCT00448916|6296816|P1|Overall Study|Withdrawal by Subject|3
1812885|NCT00448916|6296813|P4|Overall Study|Lack of Efficacy|1
1812886|NCT00448916|6296814|P3|Overall Study|Lack of Efficacy|2
1812887|NCT00448916|6296815|P2|Overall Study|Lack of Efficacy|0
1812888|NCT00448916|6296816|P1|Overall Study|Lack of Efficacy|1
1812889|NCT00448916|6296813|P4|Overall Study|Adverse Event|2
1812890|NCT00448916|6296814|P3|Overall Study|Adverse Event|3
1812891|NCT00448916|6296815|P2|Overall Study|Adverse Event|2
1812892|NCT00448916|6296816|P1|Overall Study|Adverse Event|2
1812893|NCT00448864|6296890|P3|Overall Study|Protocol Violation|0
1812894|NCT00448864|6296891|P2|Overall Study|Protocol Violation|2
1812895|NCT00448864|6296892|P1|Overall Study|Protocol Violation|0
1812896|NCT00448864|6296890|P3|Overall Study|Withdrawal by Subject|0
1812897|NCT00448864|6296891|P2|Overall Study|Withdrawal by Subject|2
1812898|NCT00448864|6296892|P1|Overall Study|Withdrawal by Subject|0
1812899|NCT00448864|6296890|P3|Overall Study|Physician Decision|1
1812900|NCT00448864|6296891|P2|Overall Study|Physician Decision|0
1812901|NCT00448864|6296892|P1|Overall Study|Physician Decision|1
1812902|NCT00448864|6296890|P3|Overall Study|Lost to Follow-up|0
1812903|NCT00448864|6296891|P2|Overall Study|Lost to Follow-up|1
1812904|NCT00448864|6296892|P1|Overall Study|Lost to Follow-up|3
1812905|NCT00448864|6296890|P3|Overall Study|Death|0
1812906|NCT00448864|6296891|P2|Overall Study|Death|0
1812907|NCT00448864|6296892|P1|Overall Study|Death|1
1812908|NCT00448760|6296908|P1|Overall Study|Death|3
1812909|NCT00448747|6296917|P2|Overall Study|collapsed veins|0
1812910|NCT00448747|6296918|P1|Overall Study|collapsed veins|1
1812911|NCT00448708|6296936|P2|Overall Study|not listed|2
1812912|NCT00448708|6296937|P1|Overall Study|not listed|0
1812913|NCT00448708|6296936|P2|Overall Study|Lost to Follow-up|8
1812914|NCT00448708|6296937|P1|Overall Study|Lost to Follow-up|6
1812915|NCT00448708|6296936|P2|Overall Study|Withdrawal by Subject|4
1812916|NCT00448708|6296937|P1|Overall Study|Withdrawal by Subject|8
1812917|NCT00448708|6296936|P2|Overall Study|Death|17
1812918|NCT00448708|6296937|P1|Overall Study|Death|21
1812919|NCT00448669|6296953|P2|Overall Study|Never started drug|7
1812920|NCT00448669|6296954|P1|Overall Study|Never started drug|9
1812921|NCT00448669|6296953|P2|Overall Study|HIV-infected at enrollment|2
1812922|NCT00448669|6296954|P1|Overall Study|HIV-infected at enrollment|1
1812923|NCT00448669|6296953|P2|Overall Study|Had other reasons|6
1812924|NCT00448669|6296954|P1|Overall Study|Had other reasons|5
1812925|NCT00448669|6296953|P2|Overall Study|Death|4
1812926|NCT00448669|6296954|P1|Overall Study|Death|2
1812927|NCT00448669|6296953|P2|Overall Study|Were withdrawn by investigator|6
1812928|NCT00448669|6296954|P1|Overall Study|Were withdrawn by investigator|10
1812929|NCT00448669|6296953|P2|Overall Study|Relocated|36
1812930|NCT00448669|6296954|P1|Overall Study|Relocated|49
1812931|NCT00448669|6296953|P2|Overall Study|Withdrawal by Subject|74
1812932|NCT00448669|6296954|P1|Overall Study|Withdrawal by Subject|90
1812933|NCT00448669|6296953|P2|Overall Study|Lost to Follow-up|63
1812934|NCT00448669|6296954|P1|Overall Study|Lost to Follow-up|52
1812935|NCT00448591|6297015|P1|Overall Study|Termination of Study|70
1812936|NCT00448591|6297015|P1|Overall Study|Other|154
1812937|NCT00448591|6297015|P1|Overall Study|Treatment Regimen Completed|70
1812938|NCT00448591|6297015|P1|Overall Study|Lost to Follow-up|19
1812939|NCT00448591|6297015|P1|Overall Study|Protocol Violation|41
1812940|NCT00448591|6297015|P1|Overall Study|Adverse Event|382
1812941|NCT00448591|6297015|P1|Overall Study|Progressive Disease|1382
1812942|NCT00448591|6297015|P1|Overall Study|Withdrawal by Subject|178
1812943|NCT00448539|6297026|P2|Overall Study|Lost to Follow-up|3
1812944|NCT00448539|6297027|P1|Overall Study|Lost to Follow-up|1
1812945|NCT00448539|6297026|P2|Overall Study|Change of meds|3
1812946|NCT00448539|6297027|P1|Overall Study|Change of meds|2
1812947|NCT00448539|6297026|P2|Overall Study|Miscellaneous|1
1812948|NCT00448539|6297027|P1|Overall Study|Miscellaneous|2
1812949|NCT00448539|6297026|P2|Overall Study|Lack of Efficacy|40
1812950|NCT00448539|6297027|P1|Overall Study|Lack of Efficacy|27
1812951|NCT00448539|6297026|P2|Overall Study|Adverse Event|26
1812952|NCT00448539|6297027|P1|Overall Study|Adverse Event|9
1812953|NCT00448539|6297026|P2|Overall Study|Diary non-compliance|0
1812954|NCT00448539|6297027|P1|Overall Study|Diary non-compliance|1
1812955|NCT00448539|6297026|P2|Overall Study|Withdrawal by Subject|24
1812956|NCT00448539|6297027|P1|Overall Study|Withdrawal by Subject|20
1812957|NCT00448539|6297026|P2|Overall Study|Request of the investigator or sponsor|54
1812958|NCT00448539|6297027|P1|Overall Study|Request of the investigator or sponsor|67
1812959|NCT00448539|6297026|P2|Overall Study|Protocol Violation|0
1812960|NCT00448539|6297027|P1|Overall Study|Protocol Violation|1
1812961|NCT00448539|6297026|P2|Overall Study|Medication non-compliance|1
1812962|NCT00448539|6297027|P1|Overall Study|Medication non-compliance|4
1812963|NCT00448448|6297035|P2|Overall Study|Signed consent lost|1
1812964|NCT00448448|6297036|P1|Overall Study|Signed consent lost|0
1812965|NCT00448448|6297035|P2|Overall Study|Wrong diagnosis (n=3) or other|1
1812966|NCT00448448|6297036|P1|Overall Study|Wrong diagnosis (n=3) or other|2
1812967|NCT00448448|6297035|P2|Overall Study|Lost to Follow-up|1
1812968|NCT00448448|6297036|P1|Overall Study|Lost to Follow-up|2
1812969|NCT00448448|6297035|P2|Overall Study|On protocol when study ended|36
1812970|NCT00448448|6297036|P1|Overall Study|On protocol when study ended|83
1812971|NCT00448448|6297035|P2|Overall Study|Withdrawal by Subject|2
1812972|NCT00448448|6297036|P1|Overall Study|Withdrawal by Subject|13
1812973|NCT00448435|6297042|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
1812974|NCT00448435|6297043|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
1812975|NCT00448344|6297094|P2|Overall Study|Physician Decision|2
1812976|NCT00448344|6297095|P1|Overall Study|Physician Decision|1
1812977|NCT00448344|6297094|P2|Overall Study|Death|4
1812978|NCT00448344|6297095|P1|Overall Study|Death|3
1812979|NCT00448344|6297094|P2|Overall Study|Withdrawal by Subject|8
1812980|NCT00448344|6297095|P1|Overall Study|Withdrawal by Subject|6
1812981|NCT00448344|6297094|P2|Overall Study|Lost to Follow-up|22
1812982|NCT00448344|6297095|P1|Overall Study|Lost to Follow-up|20
1812983|NCT00448279|6297105|P2|Overall Study|Protocol Violation|1
1812984|NCT00448279|6297106|P1|Overall Study|Protocol Violation|0
1812985|NCT00448279|6297105|P2|Overall Study|Other|4
1812986|NCT00448279|6297106|P1|Overall Study|Other|6
1812987|NCT00448279|6297105|P2|Overall Study|Withdrawal by Subject|3
1812988|NCT00448279|6297106|P1|Overall Study|Withdrawal by Subject|4
1812989|NCT00448279|6297105|P2|Overall Study|Disease progression|18
1812990|NCT00448279|6297106|P1|Overall Study|Disease progression|16
1812991|NCT00448279|6297105|P2|Overall Study|Adverse Event|1
1812992|NCT00448279|6297106|P1|Overall Study|Adverse Event|1
1812993|NCT00448279|6297105|P2|Overall Study|Lost to Follow-up|2
1812994|NCT00448279|6297106|P1|Overall Study|Lost to Follow-up|2
1812995|NCT00448136|6297169|P2|Overall Study|Investigator's decision (progression)|0
1812996|NCT00448136|6297170|P1|Overall Study|Investigator's decision (progression)|1
1812997|NCT00448136|6297169|P2|Overall Study|Death|8
1812998|NCT00448136|6297170|P1|Overall Study|Death|3
1812999|NCT00448123|6297208|P2|Overall Study|Physician Decision|6
1813000|NCT00448123|6297209|P1|Overall Study|Physician Decision|6
1813001|NCT00448123|6297208|P2|Overall Study|Lost to Follow-up|6
1813002|NCT00448123|6297209|P1|Overall Study|Lost to Follow-up|9
1813003|NCT00448019|6297219|P1|Overall Study|Insurance Issues|1
1813004|NCT00448019|6297219|P1|Overall Study|Death|2
1813005|NCT00448019|6297219|P1|Overall Study|Disease progression|1
1813006|NCT00448019|6297219|P1|Overall Study|Withdrawal by Subject|3
1813007|NCT00447902|6297227|P2|Overall Study|Lack of Efficacy|1
1813008|NCT00447902|6297228|P1|Overall Study|Lack of Efficacy|2
1813009|NCT00447902|6297227|P2|Overall Study|included patients who discontinued|1
1813010|NCT00447902|6297228|P1|Overall Study|included patients who discontinued|1
1813011|NCT00447902|6297227|P2|Overall Study|Withdrawal by Subject|1
1813012|NCT00447902|6297228|P1|Overall Study|Withdrawal by Subject|0
1813013|NCT00447902|6297227|P2|Overall Study|Protocol Violation|0
1813014|NCT00447902|6297228|P1|Overall Study|Protocol Violation|1
1813015|NCT00447902|6297227|P2|Overall Study|Adverse Event|3
1813016|NCT00447902|6297228|P1|Overall Study|Adverse Event|0
1813017|NCT00447876|6297270|P2|Overall Study|Deterioration of symptomology|0
1813018|NCT00447876|6297271|P1|Overall Study|Deterioration of symptomology|1
1813019|NCT00447876|6297270|P2|Overall Study|Lost to Follow-up|0
1813020|NCT00447876|6297271|P1|Overall Study|Lost to Follow-up|1
1813021|NCT00447876|6297270|P2|Overall Study|Withdrawal by Subject|4
1813022|NCT00447876|6297271|P1|Overall Study|Withdrawal by Subject|1
1813023|NCT00447772|6297301|P1|Overall Study|Premature re-injection required|1
1813024|NCT00447772|6297301|P1|Overall Study|Chemotherapy for lung cancer|1
1813025|NCT00447772|6297301|P1|Overall Study|Incomplete documentation at visit 1|1
1813026|NCT00447772|6297301|P1|Overall Study|Patient relocated|1
1813027|NCT00447772|6297301|P1|Overall Study|Adverse Event|1
1813028|NCT00447772|6297301|P1|Overall Study|Unable to attend all study visits|2
1813029|NCT00447772|6297301|P1|Overall Study|Withdrawal by Subject|1
1813030|NCT00447772|6297301|P1|Overall Study|Lost to Follow-up|9
1813031|NCT00447772|6297301|P1|Overall Study|Discontinuation of drug therapy|1
1813032|NCT00447772|6297301|P1|Overall Study|Insufficient compliance|6
1813033|NCT00447772|6297301|P1|Overall Study|Lack of Efficacy|3
1813034|NCT00447603|6297321|P3|Filter Period|Study terminated by Sponsor|10
1813035|NCT00447603|6297322|P2|Filter Period|Study terminated by Sponsor|1
1813036|NCT00447603|6297323|P1|Filter Period|Study terminated by Sponsor|0
1813037|NCT00447603|6297321|P3|Filter Period|Screen Failure|4
1813038|NCT00447603|6297322|P2|Filter Period|Screen Failure|3
1813039|NCT00447603|6297323|P1|Filter Period|Screen Failure|0
1813040|NCT00447603|6297321|P3|Filter Period|Adverse Event|1
1813041|NCT00447603|6297322|P2|Filter Period|Adverse Event|0
1813042|NCT00447603|6297323|P1|Filter Period|Adverse Event|0
1813043|NCT00447603|6297321|P3|Screening|Study Terminated by Sponsor|0
1813044|NCT00447603|6297322|P2|Screening|Study Terminated by Sponsor|0
1813045|NCT00447603|6297323|P1|Screening|Study Terminated by Sponsor|15
1813046|NCT00447603|6297321|P3|Screening|Screen Failure|0
1813047|NCT00447603|6297322|P2|Screening|Screen Failure|0
1813048|NCT00447603|6297323|P1|Screening|Screen Failure|4
1813049|NCT00447603|6297321|P3|Screening|Protocol Violation|0
1813050|NCT00447603|6297322|P2|Screening|Protocol Violation|0
1813051|NCT00447603|6297323|P1|Screening|Protocol Violation|1
1813052|NCT00447603|6297321|P3|Screening|Withdrawal by Subject|0
1813053|NCT00447603|6297322|P2|Screening|Withdrawal by Subject|0
1813054|NCT00447603|6297323|P1|Screening|Withdrawal by Subject|1
1813055|NCT00447590|6297343|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
1813056|NCT00447590|6297343|P1|Overall Study|Lost to Follow-up|24
1813057|NCT00447590|6297343|P1|Overall Study|Withdrawal by Subject|26
1813058|NCT00447499|6297352|P1|Overall Study|Physician Decision|1
1813059|NCT00447499|6297352|P1|Overall Study|Sponsor Decision|1
1813060|NCT00447499|6297352|P1|Overall Study|Patient Decision|4
1813061|NCT00447499|6297352|P1|Overall Study|Adverse Event|1
1813062|NCT00447421|6297362|P1|Overall Study|Sponsor Decision|2
1813063|NCT00447421|6297362|P1|Overall Study|Adverse Event|3
1813064|NCT00447421|6297362|P1|Overall Study|Lack of Efficacy|1
1813065|NCT00447382|6297374|P2|Overall Study|Unclassified|5
1813066|NCT00447382|6297375|P1|Overall Study|Unclassified|2
1813067|NCT00447382|6297374|P2|Overall Study|Protocol Violation|0
1813068|NCT00447382|6297375|P1|Overall Study|Protocol Violation|2
1813069|NCT00447382|6297374|P2|Overall Study|Lack of Efficacy|0
1813070|NCT00447382|6297375|P1|Overall Study|Lack of Efficacy|1
1813071|NCT00447382|6297374|P2|Overall Study|Adverse Event|1
1813072|NCT00447382|6297375|P1|Overall Study|Adverse Event|1
1813073|NCT00447278|6297436|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
1813074|NCT00447278|6297437|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
1813075|NCT00447278|6297436|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
1813076|NCT00447278|6297437|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
1813077|NCT00447278|6297436|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
1813078|NCT00447278|6297437|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
1813079|NCT00447278|6297436|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
1813080|NCT00447278|6297437|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
1813081|NCT00447278|6297436|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
1813082|NCT00447278|6297437|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
1813083|NCT00447278|6297436|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
1813084|NCT00447278|6297437|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
1813085|NCT00447278|6297436|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
1813086|NCT00447278|6297437|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
1813087|NCT00447278|6297436|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
1813088|NCT00447278|6297437|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
1813089|NCT00447278|6297436|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
1813090|NCT00447278|6297437|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
1813091|NCT00447278|6297436|P2|Period II (6 Month Open-Label)|Physician Decision|1
1813092|NCT00447278|6297437|P1|Period II (6 Month Open-Label)|Physician Decision|4
1813093|NCT00447278|6297436|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
1813094|NCT00447278|6297437|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
1813095|NCT00447278|6297436|P2|Period II (6 Month Open-Label)|Protocol Violation|7
1813096|NCT00447278|6297437|P1|Period II (6 Month Open-Label)|Protocol Violation|10
1813097|NCT00447278|6297436|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
1813098|NCT00447278|6297437|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
1813099|NCT00447278|6297436|P2|Period II (6 Month Open-Label)|Adverse Event|3
1813100|NCT00447278|6297437|P1|Period II (6 Month Open-Label)|Adverse Event|7
1813101|NCT00447265|6297458|P2|Overall Study|Physician Decision|0
1813102|NCT00447265|6297459|P1|Overall Study|Physician Decision|1
1813103|NCT00447226|6297472|P2|Double-blind Phase|Disease Progression|3
1813104|NCT00447226|6297473|P1|Double-blind Phase|Disease Progression|4
1813105|NCT00447226|6297472|P2|12-Week Open-label Phase|Physician Decision|1
1813106|NCT00447226|6297473|P1|12-Week Open-label Phase|Physician Decision|0
1813107|NCT00447226|6297472|P2|12-Week Open-label Phase|Disease Progression|20
1813108|NCT00447226|6297473|P1|12-Week Open-label Phase|Disease Progression|0
1813109|NCT00447226|6297472|P2|12-Week Open-label Phase|Protocol Violation|1
1813110|NCT00447226|6297473|P1|12-Week Open-label Phase|Protocol Violation|0
1813111|NCT00447226|6297472|P2|12-Week Open-label Phase|Adverse Event|3
1813112|NCT00447226|6297473|P1|12-Week Open-label Phase|Adverse Event|0
1813113|NCT00447057|6297516|P4|Overall Study|Death, study drug related|0
1813114|NCT00447057|6297517|P3|Overall Study|Death, study drug related|0
1813115|NCT00447057|6297518|P2|Overall Study|Death, study drug related|1
1813116|NCT00447057|6297519|P1|Overall Study|Death, study drug related|0
1813117|NCT00447057|6297516|P4|Overall Study|Death due to adverse event|2
1813118|NCT00447057|6297517|P3|Overall Study|Death due to adverse event|1
1813119|NCT00447057|6297518|P2|Overall Study|Death due to adverse event|0
1813120|NCT00447057|6297519|P1|Overall Study|Death due to adverse event|0
1813121|NCT00447057|6297516|P4|Overall Study|Progressive disease|18
1813122|NCT00447057|6297517|P3|Overall Study|Progressive disease|13
1813123|NCT00447057|6297518|P2|Overall Study|Progressive disease|43
1813124|NCT00447057|6297519|P1|Overall Study|Progressive disease|58
1813125|NCT00447057|6297516|P4|Overall Study|Sponsor decision|0
1813126|NCT00447057|6297517|P3|Overall Study|Sponsor decision|0
1813127|NCT00447057|6297518|P2|Overall Study|Sponsor decision|1
1813128|NCT00447057|6297519|P1|Overall Study|Sponsor decision|1
1813129|NCT00447057|6297516|P4|Overall Study|Physician Decision|1
1813130|NCT00447057|6297517|P3|Overall Study|Physician Decision|3
1813131|NCT00447057|6297518|P2|Overall Study|Physician Decision|6
1813132|NCT00447057|6297519|P1|Overall Study|Physician Decision|9
1813133|NCT00447057|6297516|P4|Overall Study|Withdrawal by Subject|1
1813134|NCT00447057|6297517|P3|Overall Study|Withdrawal by Subject|1
1813135|NCT00447057|6297518|P2|Overall Study|Withdrawal by Subject|5
1813136|NCT00447057|6297519|P1|Overall Study|Withdrawal by Subject|4
1813137|NCT00447057|6297516|P4|Overall Study|Protocol Violation|0
1813138|NCT00447057|6297517|P3|Overall Study|Protocol Violation|0
1813139|NCT00447057|6297518|P2|Overall Study|Protocol Violation|1
1813140|NCT00447057|6297519|P1|Overall Study|Protocol Violation|0
1813141|NCT00447057|6297516|P4|Overall Study|Entry criteria not met|0
1813142|NCT00447057|6297517|P3|Overall Study|Entry criteria not met|0
1813143|NCT00447057|6297518|P2|Overall Study|Entry criteria not met|1
1813144|NCT00447057|6297519|P1|Overall Study|Entry criteria not met|1
1813145|NCT00447057|6297516|P4|Overall Study|Lost to Follow-up|0
1813146|NCT00447057|6297517|P3|Overall Study|Lost to Follow-up|0
1813147|NCT00447057|6297518|P2|Overall Study|Lost to Follow-up|1
1813148|NCT00447057|6297519|P1|Overall Study|Lost to Follow-up|0
1813149|NCT00447057|6297516|P4|Overall Study|Death due to study disease|1
1813150|NCT00447057|6297517|P3|Overall Study|Death due to study disease|1
1813151|NCT00447057|6297518|P2|Overall Study|Death due to study disease|4
1813152|NCT00447057|6297519|P1|Overall Study|Death due to study disease|6
1813153|NCT00447057|6297516|P4|Overall Study|Adverse Event|3
1813154|NCT00447057|6297517|P3|Overall Study|Adverse Event|0
1813155|NCT00447057|6297518|P2|Overall Study|Adverse Event|10
1813156|NCT00447057|6297519|P1|Overall Study|Adverse Event|4
1813157|NCT00447005|6297537|P1|Overall Study|Lack of Efficacy|11
1813158|NCT00447005|6297537|P1|Overall Study|Adverse Event|1
1813159|NCT00446992|6297551|P1|Overall Study|Lost to Follow-up|5
1813160|NCT00446992|6297551|P1|Overall Study|Adverse Event|11
1813161|NCT00446966|6297565|P2|Overall Study|Lost to Follow-up|7
1813162|NCT00446966|6297566|P1|Overall Study|Lost to Follow-up|10
1813163|NCT00446849|6297572|P1|Maintenance Phase|concomitant medication use|1
1813164|NCT00446849|6297572|P1|Maintenance Phase|hydrocodone use|1
1813165|NCT00446849|6297572|P1|Maintenance Phase|study closure|1
1813166|NCT00446849|6297572|P1|Maintenance Phase|antibiotic use|1
1813167|NCT00446849|6297572|P1|Maintenance Phase|prohibited medication use|2
1813168|NCT00446849|6297572|P1|Maintenance Phase|noncompliance|2
1813169|NCT00446849|6297572|P1|Maintenance Phase|Pregnancy|1
1813170|NCT00446849|6297572|P1|Maintenance Phase|Lost to Follow-up|3
1813171|NCT00446849|6297572|P1|Maintenance Phase|Consent withdrawn|5
1813172|NCT00446849|6297572|P1|Maintenance Phase|Adverse Event|6
1813173|NCT00446849|6297572|P1|Maintenance Phase|Protocol Violation|7
1813174|NCT00446849|6297572|P1|Maintenance Phase|Lack of Efficacy|40
1813175|NCT00446849|6297572|P1|Acute Phase|noncompliance|1
1813176|NCT00446849|6297572|P1|Acute Phase|Physician Decision|1
1813177|NCT00446849|6297572|P1|Acute Phase|Lost to Follow-up|2
1813178|NCT00446849|6297572|P1|Acute Phase|Consent withdrawn|4
1813179|NCT00446849|6297572|P1|Acute Phase|Protocol Violation|10
1813180|NCT00446849|6297572|P1|Acute Phase|Lack of Efficacy|64
1813181|NCT00446797|6297584|P2|Overall Study|did not meet entrance criteria|1
1813182|NCT00446797|6297585|P1|Overall Study|did not meet entrance criteria|0
1813183|NCT00446797|6297584|P2|Overall Study|subject entered at another site|1
1813184|NCT00446797|6297585|P1|Overall Study|subject entered at another site|0
1813185|NCT00446797|6297584|P2|Overall Study|Protocol Violation|3
1813186|NCT00446797|6297585|P1|Overall Study|Protocol Violation|1
1813187|NCT00446797|6297584|P2|Overall Study|Withdrawal by Subject|2
1813188|NCT00446797|6297585|P1|Overall Study|Withdrawal by Subject|2
1813189|NCT00446797|6297584|P2|Overall Study|Lost to Follow-up|3
1813190|NCT00446797|6297585|P1|Overall Study|Lost to Follow-up|5
1813191|NCT00446797|6297584|P2|Overall Study|Lack of Efficacy|2
1813192|NCT00446797|6297585|P1|Overall Study|Lack of Efficacy|0
1813193|NCT00446654|6297631|P2|Overall Study|Adverse Event|0
1813194|NCT00446654|6297632|P1|Overall Study|Adverse Event|1
1813195|NCT00446654|6297631|P2|Overall Study|Withdrawal by Subject|0
1813196|NCT00446654|6297632|P1|Overall Study|Withdrawal by Subject|1
1813197|NCT00446641|6297640|P2|Overall Study|Lost to Follow-up|1
1813198|NCT00446641|6297641|P1|Overall Study|Lost to Follow-up|1
1813199|NCT00446641|6297640|P2|Overall Study|poor compliance|6
1813200|NCT00446641|6297641|P1|Overall Study|poor compliance|8
1813201|NCT00446641|6297640|P2|Overall Study|Withdrawal by Subject|3
1813202|NCT00446641|6297641|P1|Overall Study|Withdrawal by Subject|8
1813203|NCT00446563|6297661|P2|Overall Study|Administrative problems|1
1813204|NCT00446563|6297662|P1|Overall Study|Administrative problems|0
1813205|NCT00446563|6297661|P2|Overall Study|Withdrawal by Subject|1
1813206|NCT00446563|6297662|P1|Overall Study|Withdrawal by Subject|2
1813207|NCT00446563|6297661|P2|Overall Study|Unsatisfactory therapeutic effect|3
1813208|NCT00446563|6297662|P1|Overall Study|Unsatisfactory therapeutic effect|0
1813209|NCT00446563|6297661|P2|Overall Study|Abnormal test procedure result(s)|0
1813210|NCT00446563|6297662|P1|Overall Study|Abnormal test procedure result(s)|1
1813211|NCT00446563|6297661|P2|Overall Study|Abnormal laboratory value(s)|1
1813212|NCT00446563|6297662|P1|Overall Study|Abnormal laboratory value(s)|0
1813213|NCT00446563|6297661|P2|Overall Study|Adverse Event|3
1813214|NCT00446563|6297662|P1|Overall Study|Adverse Event|4
1813215|NCT00446550|6297698|P2|Overall Study|Adverse Event|0
1813216|NCT00446550|6297699|P1|Overall Study|Adverse Event|1
1813217|NCT00446511|6297711|P4|Overall Study|Administrative Problems|1
1813218|NCT00446511|6297712|P3|Overall Study|Administrative Problems|4
1813219|NCT00446511|6297713|P2|Overall Study|Administrative Problems|0
1813220|NCT00446511|6297714|P1|Overall Study|Administrative Problems|3
1813221|NCT00446511|6297711|P4|Overall Study|Withdrawal by Subject|3
1813222|NCT00446511|6297712|P3|Overall Study|Withdrawal by Subject|0
1813223|NCT00446511|6297713|P2|Overall Study|Withdrawal by Subject|0
1813224|NCT00446511|6297714|P1|Overall Study|Withdrawal by Subject|0
1813225|NCT00446511|6297711|P4|Overall Study|Protocol Violation|1
1813226|NCT00446511|6297712|P3|Overall Study|Protocol Violation|0
1813227|NCT00446511|6297713|P2|Overall Study|Protocol Violation|0
1813228|NCT00446511|6297714|P1|Overall Study|Protocol Violation|0
1813229|NCT00446511|6297711|P4|Overall Study|Adverse Event|1
1813230|NCT00446511|6297712|P3|Overall Study|Adverse Event|3
1813231|NCT00446511|6297713|P2|Overall Study|Adverse Event|2
1813232|NCT00446511|6297714|P1|Overall Study|Adverse Event|7
1813233|NCT00446459|6297738|P1|12 Months|14 subjects to MMF + Rituximab Study|14
1813234|NCT00446459|6297738|P1|12 Months|Protocol Violation|4
1813235|NCT00446459|6297738|P1|8 Months|Protocol Violation|12
1813236|NCT00446446|6297746|P1|Overall Study|On Treatment at Time of Data Cut-off|1
1813237|NCT00446446|6297746|P1|Overall Study|Adverse Event|1
1813238|NCT00446446|6297746|P1|Overall Study|Disease Progession|2
1813239|NCT00446446|6297746|P1|Overall Study|Other|4
1813240|NCT00446446|6297746|P1|Overall Study|Withdrawal by Subject|6
1813241|NCT00446446|6297746|P1|Overall Study|Death|10
1813242|NCT00446251|6297770|P1|Overall Study|Lost to Follow-up|1
1813243|NCT00446251|6297770|P1|Overall Study|Rituximab Infusion Reaction|2
1813244|NCT00446251|6297770|P1|Overall Study|On-study Transplants|2
1813245|NCT00446199|6297780|P4|Overall Study|Move|0
1813246|NCT00446199|6297781|P3|Overall Study|Move|0
1813247|NCT00446199|6297782|P2|Overall Study|Move|1
1813248|NCT00446199|6297783|P1|Overall Study|Move|0
1813249|NCT00446199|6297780|P4|Overall Study|In-/Exclusion criterion violated|1
1813250|NCT00446199|6297781|P3|Overall Study|In-/Exclusion criterion violated|2
1813251|NCT00446199|6297782|P2|Overall Study|In-/Exclusion criterion violated|1
1813252|NCT00446199|6297783|P1|Overall Study|In-/Exclusion criterion violated|2
1813253|NCT00446199|6297780|P4|Overall Study|Lost interest in study participation|0
1813254|NCT00446199|6297781|P3|Overall Study|Lost interest in study participation|0
1813255|NCT00446199|6297782|P2|Overall Study|Lost interest in study participation|1
1813256|NCT00446199|6297783|P1|Overall Study|Lost interest in study participation|0
1813257|NCT00446199|6297780|P4|Overall Study|Hormone fear|1
1813258|NCT00446199|6297781|P3|Overall Study|Hormone fear|0
1813259|NCT00446199|6297782|P2|Overall Study|Hormone fear|0
1813260|NCT00446199|6297783|P1|Overall Study|Hormone fear|0
1813261|NCT00446199|6297780|P4|Overall Study|Non-compliant with visit schedule|2
1813262|NCT00446199|6297781|P3|Overall Study|Non-compliant with visit schedule|1
1813263|NCT00446199|6297782|P2|Overall Study|Non-compliant with visit schedule|1
1813264|NCT00446199|6297783|P1|Overall Study|Non-compliant with visit schedule|1
1813265|NCT00446199|6297780|P4|Overall Study|Non-compliant with study drug|0
1813266|NCT00446199|6297781|P3|Overall Study|Non-compliant with study drug|5
1813267|NCT00446199|6297782|P2|Overall Study|Non-compliant with study drug|0
1813268|NCT00446199|6297783|P1|Overall Study|Non-compliant with study drug|1
1813269|NCT00446199|6297780|P4|Overall Study|Lack of Efficacy|1
1813270|NCT00446199|6297781|P3|Overall Study|Lack of Efficacy|0
1813271|NCT00446199|6297782|P2|Overall Study|Lack of Efficacy|0
1813272|NCT00446199|6297783|P1|Overall Study|Lack of Efficacy|1
1813273|NCT00446199|6297780|P4|Overall Study|Randomization in Error|1
1813274|NCT00446199|6297781|P3|Overall Study|Randomization in Error|1
1813275|NCT00446199|6297782|P2|Overall Study|Randomization in Error|0
1813276|NCT00446199|6297783|P1|Overall Study|Randomization in Error|2
1813277|NCT00446199|6297780|P4|Overall Study|Site termination|1
1813278|NCT00446199|6297781|P3|Overall Study|Site termination|0
1813279|NCT00446199|6297782|P2|Overall Study|Site termination|0
1813280|NCT00446199|6297783|P1|Overall Study|Site termination|2
1813281|NCT00446199|6297780|P4|Overall Study|Withdrawal by Subject|10
1813282|NCT00446199|6297781|P3|Overall Study|Withdrawal by Subject|9
1813283|NCT00446199|6297782|P2|Overall Study|Withdrawal by Subject|5
1813284|NCT00446199|6297783|P1|Overall Study|Withdrawal by Subject|2
1813285|NCT00446199|6297780|P4|Overall Study|Protocol Violation|3
1813286|NCT00446199|6297781|P3|Overall Study|Protocol Violation|1
1813287|NCT00446199|6297782|P2|Overall Study|Protocol Violation|2
1813288|NCT00446199|6297783|P1|Overall Study|Protocol Violation|1
1813289|NCT00446199|6297780|P4|Overall Study|Lost to Follow-up|6
1813290|NCT00446199|6297781|P3|Overall Study|Lost to Follow-up|2
1813291|NCT00446199|6297782|P2|Overall Study|Lost to Follow-up|5
1813292|NCT00446199|6297783|P1|Overall Study|Lost to Follow-up|4
1813293|NCT00446199|6297780|P4|Overall Study|Adverse Event|4
1813294|NCT00446199|6297781|P3|Overall Study|Adverse Event|6
1813295|NCT00446199|6297782|P2|Overall Study|Adverse Event|4
1813296|NCT00446199|6297783|P1|Overall Study|Adverse Event|7
1813297|NCT00446134|6297876|P4|Overall Study|Reason Not Completed|2
1813298|NCT00446134|6297877|P3|Overall Study|Reason Not Completed|1
1813299|NCT00446134|6297878|P2|Overall Study|Reason Not Completed|0
1813300|NCT00446134|6297879|P1|Overall Study|Reason Not Completed|3
1813301|NCT00446134|6297876|P4|Overall Study|Adverse Event-Diarrhea|0
1813302|NCT00446134|6297877|P3|Overall Study|Adverse Event-Diarrhea|2
1813303|NCT00446134|6297878|P2|Overall Study|Adverse Event-Diarrhea|1
1813304|NCT00446134|6297879|P1|Overall Study|Adverse Event-Diarrhea|1
1813305|NCT00446134|6297876|P4|Overall Study|Physician Decision|2
1813306|NCT00446134|6297877|P3|Overall Study|Physician Decision|0
1813307|NCT00446134|6297878|P2|Overall Study|Physician Decision|0
1813308|NCT00446134|6297879|P1|Overall Study|Physician Decision|0
1813309|NCT00446134|6297876|P4|Overall Study|Withdrawal by Subject|3
1813310|NCT00446134|6297877|P3|Overall Study|Withdrawal by Subject|1
1813311|NCT00446134|6297878|P2|Overall Study|Withdrawal by Subject|3
1813312|NCT00446134|6297879|P1|Overall Study|Withdrawal by Subject|3
1813313|NCT00446134|6297876|P4|Overall Study|Lost to Follow-up|1
1813314|NCT00446134|6297877|P3|Overall Study|Lost to Follow-up|1
1813315|NCT00446134|6297878|P2|Overall Study|Lost to Follow-up|3
1813316|NCT00446134|6297879|P1|Overall Study|Lost to Follow-up|1
1813317|NCT00446134|6297876|P4|Overall Study|Protocol Violation|0
1813318|NCT00446134|6297877|P3|Overall Study|Protocol Violation|1
1813319|NCT00446134|6297878|P2|Overall Study|Protocol Violation|2
1813320|NCT00446134|6297879|P1|Overall Study|Protocol Violation|0
1813321|NCT00446134|6297876|P4|Overall Study|Lack of Efficacy|19
1813322|NCT00446134|6297877|P3|Overall Study|Lack of Efficacy|24
1813323|NCT00446134|6297878|P2|Overall Study|Lack of Efficacy|19
1813324|NCT00446134|6297879|P1|Overall Study|Lack of Efficacy|19
1813325|NCT00446134|6297876|P4|Overall Study|Adverse Event|18
1813326|NCT00446134|6297877|P3|Overall Study|Adverse Event|13
1813327|NCT00446134|6297878|P2|Overall Study|Adverse Event|17
1813328|NCT00446134|6297879|P1|Overall Study|Adverse Event|7
1813329|NCT00446095|6297906|P5|Phase I (28 Days)|Lack of Efficacy|3
1813330|NCT00446095|6297907|P4|Phase I (28 Days)|Lack of Efficacy|0
1813331|NCT00446095|6297908|P3|Phase I (28 Days)|Lack of Efficacy|0
1813332|NCT00446095|6297909|P2|Phase I (28 Days)|Lack of Efficacy|0
1813333|NCT00446095|6297910|P1|Phase I (28 Days)|Lack of Efficacy|0
1813334|NCT00446095|6297906|P5|Phase I (28 Days)|Adverse Event|0
1813335|NCT00446095|6297907|P4|Phase I (28 Days)|Adverse Event|1
1813336|NCT00446095|6297908|P3|Phase I (28 Days)|Adverse Event|0
1813337|NCT00446095|6297909|P2|Phase I (28 Days)|Adverse Event|0
1813338|NCT00446095|6297910|P1|Phase I (28 Days)|Adverse Event|0
1813339|NCT00446095|6297906|P5|Phase II (8 Weeks)|Ongoing|0
1813340|NCT00446095|6297907|P4|Phase II (8 Weeks)|Ongoing|0
1813341|NCT00446095|6297908|P3|Phase II (8 Weeks)|Ongoing|1
1813342|NCT00446095|6297909|P2|Phase II (8 Weeks)|Ongoing|0
1813343|NCT00446095|6297910|P1|Phase II (8 Weeks)|Ongoing|0
1813344|NCT00446095|6297906|P5|Phase II (8 Weeks)|Lack of Efficacy|0
1813345|NCT00446095|6297907|P4|Phase II (8 Weeks)|Lack of Efficacy|0
1813346|NCT00446095|6297908|P3|Phase II (8 Weeks)|Lack of Efficacy|1
1813347|NCT00446095|6297909|P2|Phase II (8 Weeks)|Lack of Efficacy|2
1813348|NCT00446095|6297910|P1|Phase II (8 Weeks)|Lack of Efficacy|9
1813349|NCT00446095|6297906|P5|Phase II (8 Weeks)|Physician Decision|0
1813350|NCT00446095|6297907|P4|Phase II (8 Weeks)|Physician Decision|0
1813351|NCT00446095|6297908|P3|Phase II (8 Weeks)|Physician Decision|0
1813352|NCT00446095|6297909|P2|Phase II (8 Weeks)|Physician Decision|0
1813353|NCT00446095|6297910|P1|Phase II (8 Weeks)|Physician Decision|1
1813354|NCT00446095|6297906|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
1813355|NCT00446095|6297907|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
1813356|NCT00446095|6297908|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
1813357|NCT00446095|6297909|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
1813358|NCT00446095|6297910|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
1813359|NCT00446095|6297906|P5|Phase II (8 Weeks)|Adverse Event|0
1813360|NCT00446095|6297907|P4|Phase II (8 Weeks)|Adverse Event|0
1813361|NCT00446095|6297908|P3|Phase II (8 Weeks)|Adverse Event|1
1813362|NCT00446095|6297909|P2|Phase II (8 Weeks)|Adverse Event|1
1813363|NCT00446095|6297910|P1|Phase II (8 Weeks)|Adverse Event|0
1813364|NCT00446095|6297906|P5|Phase II (8 Weeks)|Lost to Follow-up|0
1813365|NCT00446095|6297907|P4|Phase II (8 Weeks)|Lost to Follow-up|0
1813366|NCT00446095|6297908|P3|Phase II (8 Weeks)|Lost to Follow-up|0
1813367|NCT00446095|6297909|P2|Phase II (8 Weeks)|Lost to Follow-up|0
1813368|NCT00446095|6297910|P1|Phase II (8 Weeks)|Lost to Follow-up|1
1813369|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
1813370|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
1813371|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
1813372|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
1813373|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
1813374|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
1813375|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
1813376|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
1813377|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
1813378|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
1813379|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
1813380|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
1813381|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
1813382|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
1813383|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Death|2
1813384|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Death|2
1813385|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
1813386|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
1813387|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
1813388|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
1813389|NCT00446030|6297933|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
1813390|NCT00446030|6297934|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
1813391|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
1813392|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
1813393|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
1813394|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
1813395|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
1813396|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
1813397|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
1813398|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
1813399|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
1813400|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
1813401|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
1813402|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
1813403|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
1813404|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
1813405|NCT00446030|6297933|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
1813406|NCT00446030|6297934|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
1813407|NCT00445939|6297945|P4|Period B - Week 4 - Week 8|Adverse Event|1
1813408|NCT00445939|6297946|P3|Period B - Week 4 - Week 8|Adverse Event|0
1813409|NCT00445939|6297947|P2|Period B - Week 4 - Week 8|Adverse Event|0
1813410|NCT00445939|6297948|P1|Period B - Week 4 - Week 8|Adverse Event|2
1813411|NCT00445939|6297945|P4|Period A - Week 0 - Week 4|Adverse Event|0
1813412|NCT00445939|6297946|P3|Period A - Week 0 - Week 4|Adverse Event|0
1813413|NCT00445939|6297947|P2|Period A - Week 0 - Week 4|Adverse Event|2
1813414|NCT00445939|6297948|P1|Period A - Week 0 - Week 4|Adverse Event|1
1813415|NCT00445848|6297996|P1|Overall Study|Other-Not protocol specified|5
1813416|NCT00445848|6297996|P1|Overall Study|Progression|62
1813417|NCT00445848|6297996|P1|Overall Study|Withdrawal by Subject|4
1813418|NCT00445848|6297996|P1|Overall Study|Adverse Event|14
1813419|NCT00445770|6298006|P3|Overall Study|Other|6
1813420|NCT00445770|6298007|P2|Overall Study|Other|5
1813421|NCT00445770|6298008|P1|Overall Study|Other|6
1813422|NCT00445770|6298006|P3|Overall Study|Lost to Follow-up|0
1813423|NCT00445770|6298007|P2|Overall Study|Lost to Follow-up|2
1813424|NCT00445770|6298008|P1|Overall Study|Lost to Follow-up|0
1813425|NCT00445770|6298006|P3|Overall Study|Lack of Efficacy|6
1813426|NCT00445770|6298007|P2|Overall Study|Lack of Efficacy|13
1813427|NCT00445770|6298008|P1|Overall Study|Lack of Efficacy|38
1813428|NCT00445770|6298006|P3|Overall Study|Adverse Event|19
1813429|NCT00445770|6298007|P2|Overall Study|Adverse Event|15
1813430|NCT00445770|6298008|P1|Overall Study|Adverse Event|9
1813431|NCT00445692|6298109|P1|Overall Study|Lack of Efficacy|5
1813432|NCT00445692|6298109|P1|Overall Study|Adverse Event|11
1813433|NCT00445679|6298119|P4|Overall Study|Lack of Efficacy|0
1813434|NCT00445679|6298120|P3|Overall Study|Lack of Efficacy|2
1813435|NCT00445679|6298121|P2|Overall Study|Lack of Efficacy|6
1813436|NCT00445679|6298122|P1|Overall Study|Lack of Efficacy|2
1813437|NCT00445679|6298119|P4|Overall Study|Withdrawal by Subject|18
1813438|NCT00445679|6298120|P3|Overall Study|Withdrawal by Subject|20
1813439|NCT00445679|6298121|P2|Overall Study|Withdrawal by Subject|14
1813440|NCT00445679|6298122|P1|Overall Study|Withdrawal by Subject|8
1813441|NCT00445679|6298119|P4|Overall Study|Protocol Violation|1
1813442|NCT00445679|6298120|P3|Overall Study|Protocol Violation|3
1813443|NCT00445679|6298121|P2|Overall Study|Protocol Violation|3
1813444|NCT00445679|6298122|P1|Overall Study|Protocol Violation|2
1813445|NCT00445679|6298119|P4|Overall Study|Withdrawal of Informed Consent|0
1813446|NCT00445679|6298120|P3|Overall Study|Withdrawal of Informed Consent|1
1813447|NCT00445679|6298121|P2|Overall Study|Withdrawal of Informed Consent|0
1813448|NCT00445679|6298122|P1|Overall Study|Withdrawal of Informed Consent|0
1813449|NCT00445679|6298119|P4|Overall Study|Compliance|2
1813450|NCT00445679|6298120|P3|Overall Study|Compliance|1
1813451|NCT00445679|6298121|P2|Overall Study|Compliance|2
1813452|NCT00445679|6298122|P1|Overall Study|Compliance|3
1813453|NCT00445679|6298119|P4|Overall Study|Lost to Follow-up|5
1813454|NCT00445679|6298120|P3|Overall Study|Lost to Follow-up|6
1813455|NCT00445679|6298121|P2|Overall Study|Lost to Follow-up|6
1813456|NCT00445679|6298122|P1|Overall Study|Lost to Follow-up|10
1813457|NCT00445679|6298119|P4|Overall Study|Physician Decision|0
1813458|NCT00445679|6298120|P3|Overall Study|Physician Decision|1
1813459|NCT00445679|6298121|P2|Overall Study|Physician Decision|0
1813460|NCT00445679|6298122|P1|Overall Study|Physician Decision|0
1813461|NCT00445679|6298119|P4|Overall Study|Failed to return|2
1813462|NCT00445679|6298120|P3|Overall Study|Failed to return|2
1813463|NCT00445679|6298121|P2|Overall Study|Failed to return|3
1813464|NCT00445679|6298122|P1|Overall Study|Failed to return|1
1813465|NCT00445679|6298119|P4|Overall Study|Adverse Event|19
1813466|NCT00445679|6298120|P3|Overall Study|Adverse Event|30
1813467|NCT00445679|6298121|P2|Overall Study|Adverse Event|12
1813468|NCT00445679|6298122|P1|Overall Study|Adverse Event|22
1813469|NCT00445601|6298158|P2|Overall Study|Death prior to TURBT|1
1813470|NCT00445601|6298159|P1|Overall Study|Death prior to TURBT|0
1813471|NCT00445601|6298158|P2|Overall Study|Adverse Event|0
1813472|NCT00445601|6298159|P1|Overall Study|Adverse Event|2
1813473|NCT00445601|6298158|P2|Overall Study|Drug Delivery Issue|2
1813474|NCT00445601|6298159|P1|Overall Study|Drug Delivery Issue|2
1813475|NCT00445601|6298158|P2|Overall Study|Incorrect Disease Status|6
1813476|NCT00445601|6298159|P1|Overall Study|Incorrect Disease Status|6
1813477|NCT00445601|6298158|P2|Overall Study|TURBT Complication|8
1813478|NCT00445601|6298159|P1|Overall Study|TURBT Complication|12
1813479|NCT00445601|6298158|P2|Overall Study|Withdrawal by Subject|11
1813480|NCT00445601|6298159|P1|Overall Study|Withdrawal by Subject|11
1813481|NCT00445549|6298176|P1|Overall Study|progressive disease|12
1813482|NCT00445458|6298200|P4|Overall Study|Surgery|0
1813483|NCT00445458|6298201|P3|Overall Study|Surgery|1
1813484|NCT00445458|6298202|P2|Overall Study|Surgery|0
1813485|NCT00445458|6298203|P1|Overall Study|Surgery|0
1813486|NCT00445458|6298200|P4|Overall Study|Physician Decision|1
1813487|NCT00445458|6298201|P3|Overall Study|Physician Decision|1
1813488|NCT00445458|6298202|P2|Overall Study|Physician Decision|0
1813489|NCT00445458|6298203|P1|Overall Study|Physician Decision|0
1813490|NCT00445458|6298200|P4|Overall Study|Death|0
1813491|NCT00445458|6298201|P3|Overall Study|Death|2
1813492|NCT00445458|6298202|P2|Overall Study|Death|1
1813493|NCT00445458|6298203|P1|Overall Study|Death|0
1813494|NCT00445458|6298200|P4|Overall Study|Adverse Event|0
1813495|NCT00445458|6298201|P3|Overall Study|Adverse Event|3
1813496|NCT00445458|6298202|P2|Overall Study|Adverse Event|0
1813497|NCT00445458|6298203|P1|Overall Study|Adverse Event|0
1813498|NCT00445458|6298200|P4|Overall Study|Withdrawal by Subject|0
1813499|NCT00445458|6298201|P3|Overall Study|Withdrawal by Subject|7
1813500|NCT00445458|6298202|P2|Overall Study|Withdrawal by Subject|0
1813501|NCT00445458|6298203|P1|Overall Study|Withdrawal by Subject|0
1813502|NCT00445458|6298200|P4|Overall Study|Disease Progression|27
1813503|NCT00445458|6298201|P3|Overall Study|Disease Progression|54
1813504|NCT00445458|6298202|P2|Overall Study|Disease Progression|4
1813505|NCT00445458|6298203|P1|Overall Study|Disease Progression|3
1813506|NCT00445432|6298221|P4|148 Weeks of Adalimumab Treatment|Other|9
1813507|NCT00445432|6298222|P3|148 Weeks of Adalimumab Treatment|Other|0
1813508|NCT00445432|6298223|P2|148 Weeks of Adalimumab Treatment|Other|0
1813509|NCT00445432|6298224|P1|148 Weeks of Adalimumab Treatment|Other|0
1813510|NCT00445432|6298221|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
1813511|NCT00445432|6298222|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1813512|NCT00445432|6298223|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1813513|NCT00445432|6298224|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
1813514|NCT00445432|6298221|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
1813515|NCT00445432|6298222|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
1813516|NCT00445432|6298223|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
1813517|NCT00445432|6298224|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
1813518|NCT00445432|6298221|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
1813519|NCT00445432|6298222|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
1813520|NCT00445432|6298223|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
1813521|NCT00445432|6298224|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
1813522|NCT00445432|6298221|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
1813523|NCT00445432|6298222|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
1813524|NCT00445432|6298223|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
1813525|NCT00445432|6298224|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
1813526|NCT00445432|6298221|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1813527|NCT00445432|6298222|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
1813528|NCT00445432|6298223|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1813529|NCT00445432|6298224|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
1813530|NCT00445432|6298221|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
1813531|NCT00445432|6298222|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
1813532|NCT00445432|6298223|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
1813533|NCT00445432|6298224|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
1813534|NCT00445341|6298257|P1|Overall Study|taken off treatment too early|1
1813535|NCT00445341|6298257|P1|Overall Study|refused further treatment|1
1813536|NCT00445328|6298264|P2|Overall Study|Protocol Violation|0
1813537|NCT00445328|6298265|P1|Overall Study|Protocol Violation|1
1813538|NCT00445328|6298264|P2|Overall Study|Withdrawal by Subject|0
1813539|NCT00445328|6298265|P1|Overall Study|Withdrawal by Subject|2
1813540|NCT00445328|6298264|P2|Overall Study|Other|2
1813541|NCT00445328|6298265|P1|Overall Study|Other|0
1813542|NCT00445328|6298264|P2|Overall Study|Adverse Event|3
1813543|NCT00445328|6298265|P1|Overall Study|Adverse Event|0
1813544|NCT00445328|6298264|P2|Overall Study|Death|1
1813545|NCT00445328|6298265|P1|Overall Study|Death|0
1813546|NCT00445224|6298426|P2|Specific Exercises|Withdrawal by Subject|0
1813547|NCT00445224|6298427|P1|Specific Exercises|Withdrawal by Subject|1
1813548|NCT00445224|6298426|P2|Specific Exercises|Withdrawal by Subject|3
1813549|NCT00445224|6298427|P1|Specific Exercises|Withdrawal by Subject|3
1813550|NCT00445146|6298454|P1|Overall Study|Pregnancy|1
1813551|NCT00445146|6298454|P1|Overall Study|Protocol Violation|4
1813552|NCT00445146|6298454|P1|Overall Study|Death|9
1813553|NCT00445146|6298454|P1|Overall Study|Lost to Follow-up|13
1813554|NCT00445146|6298454|P1|Overall Study|Adverse Event|13
1813555|NCT00445146|6298454|P1|Overall Study|Investigator’s Discretion|22
1813556|NCT00445146|6298454|P1|Overall Study|Lack of Efficacy|28
1813557|NCT00445146|6298454|P1|Overall Study|Withdrew Consent|29
1813558|NCT00445003|6298476|P3|Overall Study|Dropped|2
1813559|NCT00445003|6298477|P2|Overall Study|Dropped|3
1813560|NCT00445003|6298478|P1|Overall Study|Dropped|1
1813561|NCT00445003|6298476|P3|Overall Study|Missed Visit|1
1813562|NCT00445003|6298477|P2|Overall Study|Missed Visit|5
1813563|NCT00445003|6298478|P1|Overall Study|Missed Visit|3
1813564|NCT00445003|6298476|P3|Overall Study|Death|1
1813565|NCT00445003|6298477|P2|Overall Study|Death|2
1813566|NCT00445003|6298478|P1|Overall Study|Death|1
1813567|NCT00444951|6298510|P3|Overall Study|Withdrawal by Subject|3
1813568|NCT00444951|6298511|P2|Overall Study|Withdrawal by Subject|5
1813569|NCT00444951|6298512|P1|Overall Study|Withdrawal by Subject|4
1813570|NCT00444951|6298510|P3|Overall Study|Lost to Follow-up|0
1813571|NCT00444951|6298511|P2|Overall Study|Lost to Follow-up|1
1813572|NCT00444951|6298512|P1|Overall Study|Lost to Follow-up|1
1813573|NCT00444925|6298529|P3|Double-blind Treatment Period|Other|12
1813574|NCT00444925|6298530|P2|Double-blind Treatment Period|Other|7
1813575|NCT00444925|6298531|P1|Double-blind Treatment Period|Other|7
1813576|NCT00444925|6298529|P3|Double-blind Treatment Period|Withdrawal by Subject|7
1813577|NCT00444925|6298530|P2|Double-blind Treatment Period|Withdrawal by Subject|8
1813578|NCT00444925|6298531|P1|Double-blind Treatment Period|Withdrawal by Subject|6
1813579|NCT00444925|6298529|P3|Double-blind Treatment Period|Lost to Follow-up|5
1813580|NCT00444925|6298530|P2|Double-blind Treatment Period|Lost to Follow-up|8
1813581|NCT00444925|6298531|P1|Double-blind Treatment Period|Lost to Follow-up|4
1813582|NCT00444925|6298529|P3|Double-blind Treatment Period|Lack of Efficacy|13
1813583|NCT00444925|6298530|P2|Double-blind Treatment Period|Lack of Efficacy|5
1813584|NCT00444925|6298531|P1|Double-blind Treatment Period|Lack of Efficacy|5
1813585|NCT00444925|6298529|P3|Double-blind Treatment Period|Adverse Event|44
1813586|NCT00444925|6298530|P2|Double-blind Treatment Period|Adverse Event|28
1813587|NCT00444925|6298531|P1|Double-blind Treatment Period|Adverse Event|6
1813588|NCT00444925|6298529|P3|Double-blind Treatment Period|Death|0
1813589|NCT00444925|6298530|P2|Double-blind Treatment Period|Death|0
1813590|NCT00444925|6298531|P1|Double-blind Treatment Period|Death|2
1813591|NCT00444925|6298529|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
1813592|NCT00444925|6298530|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
1813593|NCT00444925|6298531|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
1813594|NCT00444912|6298595|P2|Overall Study|Participant Failed Mobilization|0
1813595|NCT00444912|6298596|P1|Overall Study|Participant Failed Mobilization|1
1813596|NCT00444912|6298595|P2|Overall Study|Lost to Follow-up|0
1813597|NCT00444912|6298596|P1|Overall Study|Lost to Follow-up|1
1813598|NCT00444912|6298595|P2|Overall Study|Death|2
1813599|NCT00444912|6298596|P1|Overall Study|Death|1
1813600|NCT00444795|6298637|P1|Overall Study|Treated Prior to the Contract Date|2
1813601|NCT00444795|6298637|P1|Overall Study|Not Treated|1
1813602|NCT00444626|6298642|P1|Initial Treatment Period|Lost to Follow-up|9
1813603|NCT00444626|6298642|P1|Initial Treatment Period|Adverse Event|1
1813604|NCT00444626|6298642|P1|Initial Treatment Period|Withdrawal by Subject|2
1813605|NCT00444600|6298672|P4|Overall Study|Missed visit|1
1813606|NCT00444600|6298673|P3|Overall Study|Missed visit|0
1813607|NCT00444600|6298674|P2|Overall Study|Missed visit|0
1813608|NCT00444600|6298675|P1|Overall Study|Missed visit|1
1813609|NCT00444600|6298672|P4|Overall Study|Dropped|7
1813610|NCT00444600|6298673|P3|Overall Study|Dropped|7
1813611|NCT00444600|6298674|P2|Overall Study|Dropped|11
1813612|NCT00444600|6298675|P1|Overall Study|Dropped|11
1813613|NCT00444600|6298672|P4|Overall Study|Death|2
1813614|NCT00444600|6298673|P3|Overall Study|Death|3
1813615|NCT00444600|6298674|P2|Overall Study|Death|5
1813616|NCT00444600|6298675|P1|Overall Study|Death|7
1813617|NCT00444587|6298767|P2|Overall Study|Missing|5
1813618|NCT00444587|6298768|P1|Overall Study|Missing|0
1813619|NCT00444587|6298767|P2|Overall Study|Protocol Violation|0
1813620|NCT00444587|6298768|P1|Overall Study|Protocol Violation|1
1813621|NCT00444587|6298767|P2|Overall Study|Investigator decision|0
1813622|NCT00444587|6298768|P1|Overall Study|Investigator decision|3
1813623|NCT00444587|6298767|P2|Overall Study|Refused treatment/did not cooperate|1
1813624|NCT00444587|6298768|P1|Overall Study|Refused treatment/did not cooperate|4
1813625|NCT00444587|6298767|P2|Overall Study|Progression of the disease|8
1813626|NCT00444587|6298768|P1|Overall Study|Progression of the disease|73
1813627|NCT00444587|6298767|P2|Overall Study|Death|1
1813628|NCT00444587|6298768|P1|Overall Study|Death|2
1813629|NCT00444535|6298789|P1|Overall Study|Adverse Event|3
1813630|NCT00444535|6298789|P1|Overall Study|Investigator decision|2
1813631|NCT00444535|6298789|P1|Overall Study|Withdrawal by Subject|3
1813632|NCT00444535|6298789|P1|Overall Study|Treatment is ongoing|16
1813633|NCT00444457|6298800|P4|Toddler Dose|Protocol Violation|1
1813634|NCT00444457|6298801|P3|Toddler Dose|Protocol Violation|0
1813635|NCT00444457|6298802|P2|Toddler Dose|Protocol Violation|0
1813636|NCT00444457|6298803|P1|Toddler Dose|Protocol Violation|1
1813637|NCT00444457|6298800|P4|Toddler Dose|Parent or legal guardian request|1
1813638|NCT00444457|6298801|P3|Toddler Dose|Parent or legal guardian request|2
1813639|NCT00444457|6298802|P2|Toddler Dose|Parent or legal guardian request|3
1813640|NCT00444457|6298803|P1|Toddler Dose|Parent or legal guardian request|0
1813641|NCT00444457|6298800|P4|Toddler Dose|Failed to return|3
1813642|NCT00444457|6298801|P3|Toddler Dose|Failed to return|1
1813643|NCT00444457|6298802|P2|Toddler Dose|Failed to return|2
1813644|NCT00444457|6298803|P1|Toddler Dose|Failed to return|2
1813645|NCT00444457|6298800|P4|Toddler Dose|Lost to Follow-up|3
1813646|NCT00444457|6298801|P3|Toddler Dose|Lost to Follow-up|1
1813647|NCT00444457|6298802|P2|Toddler Dose|Lost to Follow-up|1
1813648|NCT00444457|6298803|P1|Toddler Dose|Lost to Follow-up|4
1813649|NCT00444457|6298800|P4|After Infant Series|Other|0
1813650|NCT00444457|6298801|P3|After Infant Series|Other|0
1813651|NCT00444457|6298802|P2|After Infant Series|Other|1
1813652|NCT00444457|6298803|P1|After Infant Series|Other|0
1813653|NCT00444457|6298800|P4|After Infant Series|Investigator request|1
1813654|NCT00444457|6298801|P3|After Infant Series|Investigator request|0
1813655|NCT00444457|6298802|P2|After Infant Series|Investigator request|0
1813656|NCT00444457|6298803|P1|After Infant Series|Investigator request|0
1813657|NCT00444457|6298800|P4|After Infant Series|Adverse Event|0
1813658|NCT00444457|6298801|P3|After Infant Series|Adverse Event|0
1813659|NCT00444457|6298802|P2|After Infant Series|Adverse Event|2
1813660|NCT00444457|6298803|P1|After Infant Series|Adverse Event|2
1813661|NCT00444457|6298800|P4|After Infant Series|Protocol Violation|2
1813662|NCT00444457|6298801|P3|After Infant Series|Protocol Violation|2
1813663|NCT00444457|6298802|P2|After Infant Series|Protocol Violation|4
1813664|NCT00444457|6298803|P1|After Infant Series|Protocol Violation|2
1813665|NCT00444457|6298800|P4|After Infant Series|Lost to Follow-up|2
1813666|NCT00444457|6298801|P3|After Infant Series|Lost to Follow-up|5
1813667|NCT00444457|6298802|P2|After Infant Series|Lost to Follow-up|5
1813668|NCT00444457|6298803|P1|After Infant Series|Lost to Follow-up|5
1813669|NCT00444457|6298800|P4|After Infant Series|Failed to return|1
1813670|NCT00444457|6298801|P3|After Infant Series|Failed to return|5
1813671|NCT00444457|6298802|P2|After Infant Series|Failed to return|6
1813672|NCT00444457|6298803|P1|After Infant Series|Failed to return|7
1813673|NCT00444457|6298800|P4|After Infant Series|Parent or legal guardian request|3
1813674|NCT00444457|6298801|P3|After Infant Series|Parent or legal guardian request|6
1813675|NCT00444457|6298802|P2|After Infant Series|Parent or legal guardian request|11
1813676|NCT00444457|6298803|P1|After Infant Series|Parent or legal guardian request|4
1813677|NCT00444457|6298800|P4|After Infant Series|Other|1
1813678|NCT00444457|6298801|P3|After Infant Series|Other|1
1813679|NCT00444457|6298802|P2|After Infant Series|Other|1
1813680|NCT00444457|6298803|P1|After Infant Series|Other|0
1813681|NCT00444457|6298800|P4|Infant Series|Death|1
1813682|NCT00444457|6298801|P3|Infant Series|Death|1
1813683|NCT00444457|6298802|P2|Infant Series|Death|1
1813684|NCT00444457|6298803|P1|Infant Series|Death|0
1813685|NCT00444457|6298800|P4|Infant Series|Adverse Event|0
1813686|NCT00444457|6298801|P3|Infant Series|Adverse Event|2
1813687|NCT00444457|6298802|P2|Infant Series|Adverse Event|2
1813688|NCT00444457|6298803|P1|Infant Series|Adverse Event|1
1813689|NCT00444457|6298800|P4|Infant Series|Other|0
1813690|NCT00444457|6298801|P3|Infant Series|Other|4
1813691|NCT00444457|6298802|P2|Infant Series|Other|2
1813692|NCT00444457|6298803|P1|Infant Series|Other|0
1813693|NCT00444457|6298800|P4|Infant Series|Investigator request|2
1813694|NCT00444457|6298801|P3|Infant Series|Investigator request|3
1813695|NCT00444457|6298802|P2|Infant Series|Investigator request|3
1813696|NCT00444457|6298803|P1|Infant Series|Investigator request|4
1813697|NCT00444457|6298800|P4|Infant Series|Failed to return|2
1813698|NCT00444457|6298801|P3|Infant Series|Failed to return|4
1813699|NCT00444457|6298802|P2|Infant Series|Failed to return|4
1813700|NCT00444457|6298803|P1|Infant Series|Failed to return|5
1813701|NCT00444457|6298800|P4|Infant Series|Protocol Violation|3
1813702|NCT00444457|6298801|P3|Infant Series|Protocol Violation|6
1813703|NCT00444457|6298802|P2|Infant Series|Protocol Violation|8
1813704|NCT00444457|6298803|P1|Infant Series|Protocol Violation|16
1813705|NCT00444457|6298800|P4|Infant Series|Lost to Follow-up|6
1813706|NCT00444457|6298801|P3|Infant Series|Lost to Follow-up|7
1813707|NCT00444457|6298802|P2|Infant Series|Lost to Follow-up|11
1813708|NCT00444457|6298803|P1|Infant Series|Lost to Follow-up|10
1813709|NCT00444457|6298800|P4|Infant Series|Parent or legal guardian request|14
1813710|NCT00444457|6298801|P3|Infant Series|Parent or legal guardian request|34
1813711|NCT00444457|6298802|P2|Infant Series|Parent or legal guardian request|29
1813712|NCT00444457|6298803|P1|Infant Series|Parent or legal guardian request|18
1813713|NCT00444457|6298800|P4|Infant Series|Other|0
1813714|NCT00444457|6298801|P3|Infant Series|Other|0
1813715|NCT00444457|6298802|P2|Infant Series|Other|1
1813716|NCT00444457|6298803|P1|Infant Series|Other|0
1813717|NCT00444275|6298868|P5|Maintenance Treatment Phase|Ineffectiveness|14
1813718|NCT00444275|6298869|P4|Maintenance Treatment Phase|Ineffectiveness|3
1813719|NCT00444275|6298870|P3|Maintenance Treatment Phase|Ineffectiveness|5
1813720|NCT00444275|6298871|P2|Maintenance Treatment Phase|Ineffectiveness|0
1813721|NCT00444275|6298872|P1|Maintenance Treatment Phase|Ineffectiveness|0
1813722|NCT00444275|6298868|P5|Maintenance Treatment Phase|Protocol Violation|87
1813723|NCT00444275|6298869|P4|Maintenance Treatment Phase|Protocol Violation|88
1813724|NCT00444275|6298870|P3|Maintenance Treatment Phase|Protocol Violation|103
1813725|NCT00444275|6298871|P2|Maintenance Treatment Phase|Protocol Violation|0
1813726|NCT00444275|6298872|P1|Maintenance Treatment Phase|Protocol Violation|0
1813727|NCT00444275|6298868|P5|Maintenance Treatment Phase|Patient's wish|20
1813728|NCT00444275|6298869|P4|Maintenance Treatment Phase|Patient's wish|9
1813729|NCT00444275|6298870|P3|Maintenance Treatment Phase|Patient's wish|19
1813730|NCT00444275|6298871|P2|Maintenance Treatment Phase|Patient's wish|0
1813731|NCT00444275|6298872|P1|Maintenance Treatment Phase|Patient's wish|0
1813732|NCT00444275|6298868|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
1813733|NCT00444275|6298869|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
1813734|NCT00444275|6298870|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
1813735|NCT00444275|6298871|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
1813736|NCT00444275|6298872|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
1813737|NCT00444275|6298868|P5|Maintenance Treatment Phase|Adverse Event|13
1813738|NCT00444275|6298869|P4|Maintenance Treatment Phase|Adverse Event|2
1813739|NCT00444275|6298870|P3|Maintenance Treatment Phase|Adverse Event|3
1813740|NCT00444275|6298871|P2|Maintenance Treatment Phase|Adverse Event|0
1813741|NCT00444275|6298872|P1|Maintenance Treatment Phase|Adverse Event|0
1813742|NCT00444275|6298868|P5|Maintenance Treatment Phase|Lost to Follow-up|10
1813743|NCT00444275|6298869|P4|Maintenance Treatment Phase|Lost to Follow-up|14
1813744|NCT00444275|6298870|P3|Maintenance Treatment Phase|Lost to Follow-up|8
1813745|NCT00444275|6298871|P2|Maintenance Treatment Phase|Lost to Follow-up|0
1813746|NCT00444275|6298872|P1|Maintenance Treatment Phase|Lost to Follow-up|0
1813747|NCT00444275|6298868|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
1813748|NCT00444275|6298869|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
1813749|NCT00444275|6298870|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
1813750|NCT00444275|6298871|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
1813751|NCT00444275|6298872|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
1813752|NCT00444145|6298922|P1|Overall Study|Screen Failures|5
1813753|NCT00444145|6298922|P1|Overall Study|non-compliant|11
1813754|NCT00444145|6298922|P1|Overall Study|Lost to Follow-up|1
1813755|NCT00444145|6298922|P1|Overall Study|Withdrawal by Subject|2
1813756|NCT00444106|6298929|P3|Overall Study|Abnormal Test Procedure Results|1
1813757|NCT00444106|6298930|P2|Overall Study|Abnormal Test Procedure Results|0
1813758|NCT00444106|6298931|P1|Overall Study|Abnormal Test Procedure Results|0
1813759|NCT00444106|6298929|P3|Overall Study|Lost to Follow-up|0
1813760|NCT00444106|6298930|P2|Overall Study|Lost to Follow-up|1
1813761|NCT00444106|6298931|P1|Overall Study|Lost to Follow-up|2
1813762|NCT00444067|6298948|P2|Overall Study|Lost to Follow-up|1
1813763|NCT00444067|6298949|P1|Overall Study|Lost to Follow-up|0
1813764|NCT00443898|6299012|P4|Overall Study|Death|0
1813765|NCT00443898|6299013|P3|Overall Study|Death|0
1813766|NCT00443898|6299014|P2|Overall Study|Death|1
1813767|NCT00443898|6299015|P1|Overall Study|Death|0
1813768|NCT00443898|6299012|P4|Overall Study|Lost to Follow-up|10
1813769|NCT00443898|6299013|P3|Overall Study|Lost to Follow-up|14
1813770|NCT00443898|6299014|P2|Overall Study|Lost to Follow-up|10
1813771|NCT00443898|6299015|P1|Overall Study|Lost to Follow-up|10
1813772|NCT00443898|6299012|P4|Overall Study|Withdrawal by Subject|6
1813773|NCT00443898|6299013|P3|Overall Study|Withdrawal by Subject|10
1813774|NCT00443898|6299014|P2|Overall Study|Withdrawal by Subject|10
1813775|NCT00443898|6299015|P1|Overall Study|Withdrawal by Subject|11
1813776|NCT00443898|6299012|P4|Overall Study|Protocol Violation|0
1813777|NCT00443898|6299013|P3|Overall Study|Protocol Violation|1
1813778|NCT00443898|6299014|P2|Overall Study|Protocol Violation|1
1813779|NCT00443898|6299015|P1|Overall Study|Protocol Violation|1
1813780|NCT00443898|6299012|P4|Overall Study|Lack of Efficacy|1
1813781|NCT00443898|6299013|P3|Overall Study|Lack of Efficacy|3
1813782|NCT00443898|6299014|P2|Overall Study|Lack of Efficacy|3
1813783|NCT00443898|6299015|P1|Overall Study|Lack of Efficacy|2
1813784|NCT00443898|6299012|P4|Overall Study|Adverse Event|1
1813785|NCT00443898|6299013|P3|Overall Study|Adverse Event|1
1813786|NCT00443898|6299014|P2|Overall Study|Adverse Event|0
1813787|NCT00443898|6299015|P1|Overall Study|Adverse Event|0
1813788|NCT00443872|6299037|P1|Overall Study|Adverse Event|8
1813789|NCT00443872|6299037|P1|Overall Study|Lost to Follow-up|2
1813790|NCT00443872|6299037|P1|Overall Study|Protocol Violation|7
1813791|NCT00443846|6299052|P2|Overall Study|Lost to Follow-up|2
1813792|NCT00443846|6299053|P1|Overall Study|Lost to Follow-up|1
1813793|NCT00443846|6299052|P2|Overall Study|Personal reason|3
1813794|NCT00443846|6299053|P1|Overall Study|Personal reason|8
1813795|NCT00443846|6299052|P2|Overall Study|Adverse Event|1
1813796|NCT00443846|6299053|P1|Overall Study|Adverse Event|0
1813797|NCT00443846|6299052|P2|Overall Study|Not vaccinated, no blood sample drawn|0
1813798|NCT00443846|6299053|P1|Overall Study|Not vaccinated, no blood sample drawn|1
1813799|NCT00443846|6299052|P2|Overall Study|Withdrawn due to intercurrent disease|0
1813800|NCT00443846|6299053|P1|Overall Study|Withdrawn due to intercurrent disease|1
1813801|NCT00443820|6299063|P4|Overall Study|Death|0
1813802|NCT00443820|6299064|P3|Overall Study|Death|1
1813803|NCT00443820|6299065|P2|Overall Study|Death|0
1813804|NCT00443820|6299066|P1|Overall Study|Death|0
1813805|NCT00443820|6299063|P4|Overall Study|Administrative problems|1
1813806|NCT00443820|6299064|P3|Overall Study|Administrative problems|0
1813807|NCT00443820|6299065|P2|Overall Study|Administrative problems|0
1813808|NCT00443820|6299066|P1|Overall Study|Administrative problems|0
1813809|NCT00443820|6299063|P4|Overall Study|Lost to Follow-up|5
1813810|NCT00443820|6299064|P3|Overall Study|Lost to Follow-up|6
1813811|NCT00443820|6299065|P2|Overall Study|Lost to Follow-up|8
1813812|NCT00443820|6299066|P1|Overall Study|Lost to Follow-up|9
1813813|NCT00443820|6299063|P4|Overall Study|Withdrawal by Subject|9
1813814|NCT00443820|6299064|P3|Overall Study|Withdrawal by Subject|8
1813815|NCT00443820|6299065|P2|Overall Study|Withdrawal by Subject|7
1813816|NCT00443820|6299066|P1|Overall Study|Withdrawal by Subject|6
1813817|NCT00443820|6299063|P4|Overall Study|Protocol Violation|1
1813818|NCT00443820|6299064|P3|Overall Study|Protocol Violation|2
1813819|NCT00443820|6299065|P2|Overall Study|Protocol Violation|1
1813820|NCT00443820|6299066|P1|Overall Study|Protocol Violation|2
1813821|NCT00443820|6299063|P4|Overall Study|Lack of Efficacy|1
1813822|NCT00443820|6299064|P3|Overall Study|Lack of Efficacy|1
1813823|NCT00443820|6299065|P2|Overall Study|Lack of Efficacy|2
1813824|NCT00443820|6299066|P1|Overall Study|Lack of Efficacy|3
1813825|NCT00443820|6299063|P4|Overall Study|Adverse Event|0
1813826|NCT00443820|6299064|P3|Overall Study|Adverse Event|0
1813827|NCT00443820|6299065|P2|Overall Study|Adverse Event|1
1813828|NCT00443820|6299066|P1|Overall Study|Adverse Event|1
1813829|NCT00443781|6299088|P1|Overall Study|PD/FAD not done|1
1813830|NCT00443781|6299088|P1|Overall Study|Insurance not covered|2
1813831|NCT00443781|6299088|P1|Overall Study|Investigator terminated participation|1
1813832|NCT00443781|6299088|P1|Overall Study|Unable to comply with study follow up|2
1813833|NCT00443781|6299088|P1|Overall Study|Withdrawal by Subject|6
1813834|NCT00443781|6299088|P1|Overall Study|Protocol Violation|1
1813835|NCT00443781|6299088|P1|Overall Study|Physician Decision|2
1813836|NCT00443781|6299088|P1|Overall Study|Lost to Follow-up|10
1813837|NCT00443755|6299094|P2|Overall Study|Withdrawal by Subject|1
1813838|NCT00443755|6299095|P1|Overall Study|Withdrawal by Subject|2
1813839|NCT00443729|6299129|P2|Overall Study|Withdrawal by Subject|1
1813840|NCT00443729|6299130|P1|Overall Study|Withdrawal by Subject|3
1813841|NCT00443729|6299129|P2|Overall Study|Protocol Violation|1
1813842|NCT00443729|6299130|P1|Overall Study|Protocol Violation|1
1813843|NCT00443729|6299129|P2|Overall Study|Physician Decision|1
1813844|NCT00443729|6299130|P1|Overall Study|Physician Decision|2
1813845|NCT00443729|6299129|P2|Overall Study|Lost to Follow-up|1
1813846|NCT00443729|6299130|P1|Overall Study|Lost to Follow-up|0
1813847|NCT00443729|6299129|P2|Overall Study|Lack of Efficacy|2
1813848|NCT00443729|6299130|P1|Overall Study|Lack of Efficacy|4
1813849|NCT00443729|6299129|P2|Overall Study|Never Treated|1
1813850|NCT00443729|6299130|P1|Overall Study|Never Treated|0
1813851|NCT00443703|6299178|P2|Overall Study|Progressive Disease|0
1813852|NCT00443703|6299179|P1|Overall Study|Progressive Disease|1
1813853|NCT00443703|6299178|P2|Overall Study|Withdrawal by Subject|6
1813854|NCT00443703|6299179|P1|Overall Study|Withdrawal by Subject|9
1813855|NCT00443703|6299178|P2|Overall Study|Protocol Violation|1
1813856|NCT00443703|6299179|P1|Overall Study|Protocol Violation|1
1813857|NCT00443703|6299178|P2|Overall Study|Physician Decision|2
1813858|NCT00443703|6299179|P1|Overall Study|Physician Decision|4
1813859|NCT00443703|6299178|P2|Overall Study|Lost to Follow-up|4
1813860|NCT00443703|6299179|P1|Overall Study|Lost to Follow-up|0
1813861|NCT00443703|6299178|P2|Overall Study|Lack of Efficacy|1
1813862|NCT00443703|6299179|P1|Overall Study|Lack of Efficacy|3
1813863|NCT00443703|6299178|P2|Overall Study|Adverse Event|3
1813864|NCT00443703|6299179|P1|Overall Study|Adverse Event|7
1813865|NCT00443703|6299178|P2|Overall Study|Never Treated|1
1813866|NCT00443703|6299179|P1|Overall Study|Never Treated|3
1813867|NCT00443651|6299231|P2|Overall Study|Pregnancy|1
1813868|NCT00443651|6299232|P1|Overall Study|Pregnancy|0
1813869|NCT00443651|6299231|P2|Overall Study|Physician Decision|4
1813870|NCT00443651|6299232|P1|Overall Study|Physician Decision|13
1813871|NCT00443651|6299231|P2|Overall Study|Patient's/Guardian's Decision|30
1813872|NCT00443651|6299232|P1|Overall Study|Patient's/Guardian's Decision|58
1813873|NCT00443651|6299231|P2|Overall Study|Lost to Follow-up|12
1813874|NCT00443651|6299232|P1|Overall Study|Lost to Follow-up|18
1813875|NCT00443651|6299231|P2|Overall Study|Adverse Event|6
1813876|NCT00443651|6299232|P1|Overall Study|Adverse Event|5
1813877|NCT00443651|6299231|P2|Overall Study|Death|5
1813878|NCT00443651|6299232|P1|Overall Study|Death|1
1813885|NCT00443560|6299287|P2|Overall Study|Multiple pregnancies or fetal demise|4
1813886|NCT00443560|6299288|P1|Overall Study|Multiple pregnancies or fetal demise|2
1813887|NCT00443560|6299287|P2|Overall Study|No intrathecal dose|26
1813888|NCT00443560|6299288|P1|Overall Study|No intrathecal dose|58
1813889|NCT00443534|6299323|P1|Overall Study|Enrolled, Not Treated|1
1813890|NCT00443534|6299323|P1|Overall Study|Other|10
1813891|NCT00443534|6299323|P1|Overall Study|Study Terminated by Sponsor|12
1813892|NCT00443534|6299323|P1|Overall Study|Withdrawal by Subject|8
1813893|NCT00443534|6299323|P1|Overall Study|Death|9
1813894|NCT00443534|6299323|P1|Overall Study|Adverse Event|16
1813895|NCT00443534|6299323|P1|Overall Study|Lack of Efficacy|67
1813896|NCT00443456|6299330|P1|Overall Study|Withdrawal by Subject|1
1813897|NCT00443456|6299330|P1|Overall Study|Move|1
1813898|NCT00443456|6299330|P1|Overall Study|Adverse Event|16
1813899|NCT00443430|6299365|P2|Overall Study|Adverse Event|1
1813900|NCT00443430|6299366|P1|Overall Study|Adverse Event|1
1813901|NCT00443430|6299365|P2|Overall Study|Lack of Efficacy|3
1813902|NCT00443430|6299366|P1|Overall Study|Lack of Efficacy|3
1813903|NCT00443261|6299380|P1|Overall Study|Death|1
1813904|NCT00443209|6299386|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
1813905|NCT00443209|6299387|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
1813906|NCT00443209|6299386|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
1813907|NCT00443209|6299387|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
1813908|NCT00443209|6299386|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
1813909|NCT00443209|6299387|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
1813910|NCT00443209|6299386|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
1813911|NCT00443209|6299387|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
1813912|NCT00443209|6299386|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
1813913|NCT00443209|6299387|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
1813914|NCT00443209|6299386|P2|Months 13 to 18 Treatment Period|Adverse Event|0
1813915|NCT00443209|6299387|P1|Months 13 to 18 Treatment Period|Adverse Event|1
1813916|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Not Treated|43
1813917|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Not Treated|71
1813918|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Missing|1
1813919|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Missing|2
1813920|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
1813921|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
1813922|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
1813923|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
1813924|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Pregnancy|4
1813925|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Pregnancy|3
1813926|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Physician Decision|4
1813927|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Physician Decision|8
1813928|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
1813929|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
1813930|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
1813931|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
1813932|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
1813933|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
1813934|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
1813935|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
1813936|NCT00443209|6299386|P2|Months 1 to 12 Treatment Period|Adverse Event|11
1813937|NCT00443209|6299387|P1|Months 1 to 12 Treatment Period|Adverse Event|22
1813938|NCT00443118|6299404|P3|Overall Study|Withdrawal by Subject|0
1813939|NCT00443118|6299405|P2|Overall Study|Withdrawal by Subject|0
1813940|NCT00443118|6299406|P1|Overall Study|Withdrawal by Subject|1
1813941|NCT00443118|6299404|P3|Overall Study|unknown primary outcome|0
1813942|NCT00443118|6299405|P2|Overall Study|unknown primary outcome|1
1813943|NCT00443118|6299406|P1|Overall Study|unknown primary outcome|3
1813944|NCT00443053|6299455|P2|Overall Study|Physician Decision|4
1813945|NCT00443053|6299456|P1|Overall Study|Physician Decision|0
1813946|NCT00443053|6299455|P2|Overall Study|Other|4
1813947|NCT00443053|6299456|P1|Overall Study|Other|3
1813948|NCT00443053|6299455|P2|Overall Study|Noncompliance|1
1813949|NCT00443053|6299456|P1|Overall Study|Noncompliance|2
1813950|NCT00443053|6299455|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1813951|NCT00443053|6299456|P1|Overall Study|Did Not Meet Eligibility Criteria|1
1813952|NCT00443053|6299455|P2|Overall Study|Lost to Follow-up|5
1813953|NCT00443053|6299456|P1|Overall Study|Lost to Follow-up|4
1813954|NCT00443053|6299455|P2|Overall Study|Withdrawal by Subject|18
1813955|NCT00443053|6299456|P1|Overall Study|Withdrawal by Subject|9
1813956|NCT00443053|6299455|P2|Overall Study|Adverse Event|1
1813957|NCT00443053|6299456|P1|Overall Study|Adverse Event|2
1813958|NCT00443040|6299477|P3|Overall Study|Converted to an open laparotomy|1
1813959|NCT00443040|6299478|P2|Overall Study|Converted to an open laparotomy|0
1813960|NCT00443040|6299479|P1|Overall Study|Converted to an open laparotomy|3
1813961|NCT00443040|6299477|P3|Overall Study|Withdrawal by Subject|0
1813962|NCT00443040|6299478|P2|Overall Study|Withdrawal by Subject|0
1813963|NCT00443040|6299479|P1|Overall Study|Withdrawal by Subject|1
1813964|NCT00442962|6299487|P1|Overall Study|Lost to Follow-up|7
1813965|NCT00442962|6299487|P1|Overall Study|Pregnancy|1
1813966|NCT00442936|6299505|P4|Overall Study|Protocol Violation|1
1813967|NCT00442936|6299506|P3|Overall Study|Protocol Violation|1
1813968|NCT00442936|6299507|P2|Overall Study|Protocol Violation|0
1813969|NCT00442936|6299508|P1|Overall Study|Protocol Violation|1
1813970|NCT00442897|6299556|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
1813971|NCT00442897|6299557|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
1813972|NCT00442897|6299556|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
1813973|NCT00442897|6299557|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
1813974|NCT00442897|6299556|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
1813975|NCT00442897|6299557|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
1813976|NCT00442897|6299556|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
1813977|NCT00442897|6299557|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
1813978|NCT00442897|6299556|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
1813979|NCT00442897|6299557|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
1813980|NCT00442897|6299556|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
1813981|NCT00442897|6299557|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
1813982|NCT00442897|6299556|P2|Base Study (12 Week Follow-up)|Death|1
1813983|NCT00442897|6299557|P1|Base Study (12 Week Follow-up)|Death|0
1813984|NCT00442897|6299556|P2|Base Study (12 Week Follow-up)|Adverse Event|0
1813985|NCT00442897|6299557|P1|Base Study (12 Week Follow-up)|Adverse Event|1
1813986|NCT00442702|6299575|P2|Evaluation Period|Site closure|1
1813987|NCT00442702|6299576|P1|Evaluation Period|Site closure|0
1813988|NCT00442702|6299575|P2|Evaluation Period|Failure to return|0
1813989|NCT00442702|6299576|P1|Evaluation Period|Failure to return|1
1813990|NCT00442702|6299575|P2|Evaluation Period|Renal transplant|1
1813991|NCT00442702|6299576|P1|Evaluation Period|Renal transplant|0
1813992|NCT00442702|6299575|P2|Evaluation Period|Refused treatment|1
1813993|NCT00442702|6299576|P1|Evaluation Period|Refused treatment|1
1813994|NCT00442702|6299575|P2|Evaluation Period|Insufficient Therapeutic Response|0
1813995|NCT00442702|6299576|P1|Evaluation Period|Insufficient Therapeutic Response|1
1813996|NCT00442702|6299575|P2|Evaluation Period|Death|1
1813997|NCT00442702|6299576|P1|Evaluation Period|Death|1
1813998|NCT00442702|6299575|P2|Evaluation Period|Adverse Event|0
1813999|NCT00442702|6299576|P1|Evaluation Period|Adverse Event|1
1814000|NCT00442702|6299575|P2|Titration Period|Hospitalized in another hospital|0
1814001|NCT00442702|6299576|P1|Titration Period|Hospitalized in another hospital|1
1814002|NCT00442702|6299575|P2|Titration Period|Failure to return|0
1814003|NCT00442702|6299576|P1|Titration Period|Failure to return|1
1814004|NCT00442702|6299575|P2|Titration Period|Refused Treatment|1
1814005|NCT00442702|6299576|P1|Titration Period|Refused Treatment|4
1814006|NCT00442702|6299575|P2|Titration Period|Insufficient Therapeutic Response|0
1814007|NCT00442702|6299576|P1|Titration Period|Insufficient Therapeutic Response|1
1814008|NCT00442702|6299575|P2|Titration Period|Death|2
1814009|NCT00442702|6299576|P1|Titration Period|Death|3
1814010|NCT00442702|6299575|P2|Titration Period|Adverse Event|0
1814011|NCT00442702|6299576|P1|Titration Period|Adverse Event|2
1814012|NCT00442598|6299641|P3|Overall Study|Death|0
1814013|NCT00442598|6299642|P2|Overall Study|Death|1
1814014|NCT00442598|6299643|P1|Overall Study|Death|0
1814015|NCT00442598|6299641|P3|Overall Study|Reduced creatinine clearance|0
1814016|NCT00442598|6299642|P2|Overall Study|Reduced creatinine clearance|0
1814017|NCT00442598|6299643|P1|Overall Study|Reduced creatinine clearance|1
1814018|NCT00442598|6299641|P3|Overall Study|CA125 progression|0
1814019|NCT00442598|6299642|P2|Overall Study|CA125 progression|1
1814020|NCT00442598|6299643|P1|Overall Study|CA125 progression|0
1814021|NCT00442598|6299641|P3|Overall Study|Clinical deterioration|0
1814022|NCT00442598|6299642|P2|Overall Study|Clinical deterioration|2
1814023|NCT00442598|6299643|P1|Overall Study|Clinical deterioration|1
1814024|NCT00442598|6299641|P3|Overall Study|Tumor progression|0
1814025|NCT00442598|6299642|P2|Overall Study|Tumor progression|4
1814026|NCT00442598|6299643|P1|Overall Study|Tumor progression|3
1814027|NCT00442598|6299641|P3|Overall Study|Adverse Event|0
1814028|NCT00442598|6299642|P2|Overall Study|Adverse Event|0
1814029|NCT00442598|6299643|P1|Overall Study|Adverse Event|1
1814030|NCT00442572|6299661|P2|Overall Study|Withdrawal by Subject|1
1814031|NCT00442572|6299662|P1|Overall Study|Withdrawal by Subject|0
1814032|NCT00442572|6299661|P2|Overall Study|Lost to Follow-up|1
1814033|NCT00442572|6299662|P1|Overall Study|Lost to Follow-up|0
1814034|NCT00442572|6299661|P2|Overall Study|Relapse|1
1814035|NCT00442572|6299662|P1|Overall Study|Relapse|8
1814036|NCT00442559|6299702|P2|Overall Study|Withdrawal by Subject|0
1814037|NCT00442559|6299703|P1|Overall Study|Withdrawal by Subject|1
1814038|NCT00442559|6299702|P2|Overall Study|Protocol Violation|1
1814039|NCT00442559|6299703|P1|Overall Study|Protocol Violation|1
1814040|NCT00442559|6299702|P2|Overall Study|Lost to Follow-up|34
1814041|NCT00442559|6299703|P1|Overall Study|Lost to Follow-up|32
1814042|NCT00442546|6299718|P3|Overall Study|Randomized But Not Treated|6
1814043|NCT00442546|6299719|P2|Overall Study|Randomized But Not Treated|4
1814044|NCT00442546|6299720|P1|Overall Study|Randomized But Not Treated|5
1814045|NCT00442546|6299718|P3|Overall Study|Withdrawal by Subject|7
1814046|NCT00442546|6299719|P2|Overall Study|Withdrawal by Subject|5
1814047|NCT00442546|6299720|P1|Overall Study|Withdrawal by Subject|5
1814048|NCT00442546|6299718|P3|Overall Study|Other|6
1814049|NCT00442546|6299719|P2|Overall Study|Other|9
1814050|NCT00442546|6299720|P1|Overall Study|Other|4
1814051|NCT00442546|6299718|P3|Overall Study|Lost to Follow-up|1
1814052|NCT00442546|6299719|P2|Overall Study|Lost to Follow-up|2
1814053|NCT00442546|6299720|P1|Overall Study|Lost to Follow-up|1
1814054|NCT00442546|6299718|P3|Overall Study|Adverse Event|13
1814055|NCT00442546|6299719|P2|Overall Study|Adverse Event|17
1814056|NCT00442546|6299720|P1|Overall Study|Adverse Event|11
1814057|NCT00442468|6299849|P1|Overall Study|Did not complete all study procedures|88
1814058|NCT00442468|6299849|P1|Overall Study|Withdrawal by Subject|91
1814059|NCT00442468|6299849|P1|Overall Study|Adverse Event|4
1814060|NCT00442416|6299879|P2|Overall Study|Administrative/Other|33
1814061|NCT00442416|6299880|P1|Overall Study|Administrative/Other|27
1814062|NCT00442416|6299879|P2|Overall Study|Withdrew consent|2
1814063|NCT00442416|6299880|P1|Overall Study|Withdrew consent|1
1814064|NCT00442416|6299879|P2|Overall Study|Protocol Violation|3
1814065|NCT00442416|6299880|P1|Overall Study|Protocol Violation|2
1814066|NCT00442416|6299879|P2|Overall Study|Lack of Efficacy|0
1814067|NCT00442416|6299880|P1|Overall Study|Lack of Efficacy|2
1814068|NCT00442416|6299879|P2|Overall Study|Death|0
1814069|NCT00442416|6299880|P1|Overall Study|Death|1
1814070|NCT00442416|6299879|P2|Overall Study|Adverse Event|1
1814071|NCT00442416|6299880|P1|Overall Study|Adverse Event|4
1814072|NCT00442351|6299919|P2|Overall Study|Other|1
1814073|NCT00442351|6299920|P1|Overall Study|Other|0
1814074|NCT00442351|6299919|P2|Overall Study|Did not meet protocol eligibility|0
1814075|NCT00442351|6299920|P1|Overall Study|Did not meet protocol eligibility|1
1814076|NCT00442351|6299919|P2|Overall Study|Administrative|5
1814077|NCT00442351|6299920|P1|Overall Study|Administrative|6
1814078|NCT00442286|6299942|P2|Overall Study|Patient Injury|0
1814079|NCT00442286|6299943|P1|Overall Study|Patient Injury|1
1814080|NCT00442286|6299942|P2|Overall Study|System explanted|0
1814081|NCT00442286|6299943|P1|Overall Study|System explanted|1
1814082|NCT00442286|6299942|P2|Overall Study|Withdrawal by Subject|0
1814083|NCT00442286|6299943|P1|Overall Study|Withdrawal by Subject|2
1814084|NCT00442286|6299942|P2|Overall Study|Lost to Follow-up|0
1814085|NCT00442286|6299943|P1|Overall Study|Lost to Follow-up|1
1814086|NCT00442286|6299942|P2|Overall Study|Death|2
1814087|NCT00442286|6299943|P1|Overall Study|Death|2
1814088|NCT00442117|6300005|P2|Overall Study|Met Withdrawal Criteria|1
1814089|NCT00442117|6300006|P1|Overall Study|Met Withdrawal Criteria|2
1814090|NCT00442117|6300005|P2|Overall Study|Non compliance with protocol|5
1814091|NCT00442117|6300006|P1|Overall Study|Non compliance with protocol|3
1814092|NCT00442117|6300005|P2|Overall Study|Major Deviation|20
1814093|NCT00442117|6300006|P1|Overall Study|Major Deviation|25
1814094|NCT00442117|6300005|P2|Overall Study|Withdrawal by Subject|2
1814095|NCT00442117|6300006|P1|Overall Study|Withdrawal by Subject|2
1814096|NCT00442117|6300005|P2|Overall Study|Lost to Follow-up|2
1814097|NCT00442117|6300006|P1|Overall Study|Lost to Follow-up|1
1814098|NCT00442117|6300005|P2|Overall Study|Lack of Efficacy|6
1814099|NCT00442117|6300006|P1|Overall Study|Lack of Efficacy|2
1814100|NCT00442117|6300005|P2|Overall Study|Adverse Event|2
1814101|NCT00442117|6300006|P1|Overall Study|Adverse Event|3
1814102|NCT00441974|6300037|P1|Overall Study|Protocol Violation|7
1814103|NCT00441974|6300037|P1|Overall Study|Lost to Follow-up|80
1814104|NCT00441974|6300037|P1|Overall Study|Consent Withdrawn|35
1814105|NCT00441974|6300037|P1|Overall Study|Adverse Event|6
1814106|NCT00441792|6300053|P2|Overall Study|Lost to Follow-up|2
1814107|NCT00441792|6300054|P1|Overall Study|Lost to Follow-up|0
1814108|NCT00441727|6300094|P3|Overall Study|Various reason specified|5
1814109|NCT00441727|6300095|P2|Overall Study|Various reason specified|8
1814110|NCT00441727|6300096|P1|Overall Study|Various reason specified|6
1814111|NCT00441727|6300094|P3|Overall Study|Safety Reasons|3
1814112|NCT00441727|6300095|P2|Overall Study|Safety Reasons|1
1814113|NCT00441727|6300096|P1|Overall Study|Safety Reasons|3
1814114|NCT00441727|6300094|P3|Overall Study|Lost to Follow-up|5
1814115|NCT00441727|6300095|P2|Overall Study|Lost to Follow-up|6
1814116|NCT00441727|6300096|P1|Overall Study|Lost to Follow-up|5
1814117|NCT00441727|6300094|P3|Overall Study|Withdrawal by Subject|47
1814118|NCT00441727|6300095|P2|Overall Study|Withdrawal by Subject|34
1814119|NCT00441727|6300096|P1|Overall Study|Withdrawal by Subject|40
1814120|NCT00441727|6300094|P3|Overall Study|Lack of Efficacy|48
1814121|NCT00441727|6300095|P2|Overall Study|Lack of Efficacy|8
1814122|NCT00441727|6300096|P1|Overall Study|Lack of Efficacy|7
1814123|NCT00441727|6300094|P3|Overall Study|Adverse Event|28
1814124|NCT00441727|6300095|P2|Overall Study|Adverse Event|33
1814125|NCT00441727|6300096|P1|Overall Study|Adverse Event|26
1814126|NCT00441727|6300094|P3|Overall Study|Protocol Violation|32
1814127|NCT00441727|6300095|P2|Overall Study|Protocol Violation|28
1814128|NCT00441727|6300096|P1|Overall Study|Protocol Violation|19
1814129|NCT00441701|6300129|P10|Overall Study|Withdrawal by Subject|0
1814130|NCT00441701|6300130|P9|Overall Study|Withdrawal by Subject|0
1814131|NCT00441701|6300131|P8|Overall Study|Withdrawal by Subject|0
1814132|NCT00441701|6300132|P7|Overall Study|Withdrawal by Subject|0
1814133|NCT00441701|6300133|P6|Overall Study|Withdrawal by Subject|0
1814134|NCT00441701|6300134|P5|Overall Study|Withdrawal by Subject|0
1814135|NCT00441701|6300135|P4|Overall Study|Withdrawal by Subject|1
1814136|NCT00441701|6300136|P3|Overall Study|Withdrawal by Subject|1
1814137|NCT00441701|6300137|P2|Overall Study|Withdrawal by Subject|2
1814138|NCT00441701|6300138|P1|Overall Study|Withdrawal by Subject|0
1814139|NCT00441701|6300129|P10|Overall Study|Lack of Efficacy|0
1814140|NCT00441701|6300130|P9|Overall Study|Lack of Efficacy|0
1814141|NCT00441701|6300131|P8|Overall Study|Lack of Efficacy|0
1814142|NCT00441701|6300132|P7|Overall Study|Lack of Efficacy|0
1814143|NCT00441701|6300133|P6|Overall Study|Lack of Efficacy|1
1814144|NCT00441701|6300134|P5|Overall Study|Lack of Efficacy|0
1814145|NCT00441701|6300135|P4|Overall Study|Lack of Efficacy|2
1814146|NCT00441701|6300136|P3|Overall Study|Lack of Efficacy|2
1814147|NCT00441701|6300137|P2|Overall Study|Lack of Efficacy|0
1814148|NCT00441701|6300138|P1|Overall Study|Lack of Efficacy|2
1814149|NCT00441701|6300129|P10|Overall Study|Adverse Event|0
1814150|NCT00441701|6300130|P9|Overall Study|Adverse Event|0
1814151|NCT00441701|6300131|P8|Overall Study|Adverse Event|0
1814152|NCT00441701|6300132|P7|Overall Study|Adverse Event|0
1814153|NCT00441701|6300133|P6|Overall Study|Adverse Event|2
1814154|NCT00441701|6300134|P5|Overall Study|Adverse Event|2
1814155|NCT00441701|6300135|P4|Overall Study|Adverse Event|0
1814156|NCT00441701|6300136|P3|Overall Study|Adverse Event|1
1814157|NCT00441701|6300137|P2|Overall Study|Adverse Event|2
1814158|NCT00441701|6300138|P1|Overall Study|Adverse Event|3
1814159|NCT00441584|6300220|P1|Overall Study|Failure to meet eligibility criteria|3
1814160|NCT00441584|6300220|P1|Overall Study|Lost to Follow-up|4
1814161|NCT00441584|6300220|P1|Overall Study|Protocol Violation|5
1814162|NCT00441584|6300220|P1|Overall Study|Adverse Event|6
1814163|NCT00441584|6300220|P1|Overall Study|Withdrawal by Subject|8
1814164|NCT00441584|6300220|P1|Overall Study|Lack of Efficacy|79
1814165|NCT00441545|6300228|P2|Second Intervention|Subject moved|1
1814166|NCT00441545|6300229|P1|Second Intervention|Subject moved|0
1814167|NCT00441545|6300228|P2|Second Intervention|Subject exceeded safety criteria|0
1814168|NCT00441545|6300229|P1|Second Intervention|Subject exceeded safety criteria|1
1814169|NCT00441545|6300228|P2|Second Intervention|Lack of Efficacy|1
1814170|NCT00441545|6300229|P1|Second Intervention|Lack of Efficacy|0
1814171|NCT00441545|6300228|P2|Second Intervention|Kidney Transplant|1
1814172|NCT00441545|6300229|P1|Second Intervention|Kidney Transplant|1
1814173|NCT00441545|6300228|P2|Second Intervention|Withdrawal by Subject|1
1814174|NCT00441545|6300229|P1|Second Intervention|Withdrawal by Subject|1
1814175|NCT00441545|6300228|P2|Second Intervention|Protocol Violation|1
1814176|NCT00441545|6300229|P1|Second Intervention|Protocol Violation|4
1814177|NCT00441545|6300228|P2|Second Intervention|Adverse Event|2
1814178|NCT00441545|6300229|P1|Second Intervention|Adverse Event|5
1814179|NCT00441545|6300228|P2|First Intervention|Sponsor's request|0
1814180|NCT00441545|6300229|P1|First Intervention|Sponsor's request|1
1814181|NCT00441545|6300228|P2|First Intervention|Site error|0
1814182|NCT00441545|6300229|P1|First Intervention|Site error|1
1814183|NCT00441545|6300228|P2|First Intervention|Extended hospitalization|0
1814184|NCT00441545|6300229|P1|First Intervention|Extended hospitalization|1
1814185|NCT00441545|6300228|P2|First Intervention|Subject met an exclusionary criteria|0
1814186|NCT00441545|6300229|P1|First Intervention|Subject met an exclusionary criteria|1
1814187|NCT00441545|6300228|P2|First Intervention|Subject exceeded safety criteria|1
1814188|NCT00441545|6300229|P1|First Intervention|Subject exceeded safety criteria|0
1814189|NCT00441545|6300228|P2|First Intervention|Lack of Efficacy|0
1814190|NCT00441545|6300229|P1|First Intervention|Lack of Efficacy|2
1814191|NCT00441545|6300228|P2|First Intervention|Kidney transplant|1
1814192|NCT00441545|6300229|P1|First Intervention|Kidney transplant|1
1814193|NCT00441545|6300228|P2|First Intervention|Withdrawal by Subject|3
1814194|NCT00441545|6300229|P1|First Intervention|Withdrawal by Subject|3
1814195|NCT00441545|6300228|P2|First Intervention|Protocol Violation|2
1814196|NCT00441545|6300229|P1|First Intervention|Protocol Violation|2
1814197|NCT00441545|6300228|P2|First Intervention|Adverse Event|5
1814198|NCT00441545|6300229|P1|First Intervention|Adverse Event|6
1814199|NCT00441480|6300243|P2|Overall Study|Withdrawal by Subject|3
1814200|NCT00441480|6300244|P1|Overall Study|Withdrawal by Subject|2
1814201|NCT00441480|6300243|P2|Overall Study|Protocol Violation|1
1814202|NCT00441480|6300244|P1|Overall Study|Protocol Violation|1
1814203|NCT00441467|6300276|P1|Overall Study|Progressive disease|9
1814204|NCT00441467|6300276|P1|Overall Study|Withdrawal by Subject|3
1814205|NCT00441467|6300276|P1|Overall Study|Adverse Event|6
1814206|NCT00441441|6300284|P2|Overall Study|Other|3
1814207|NCT00441441|6300285|P1|Overall Study|Other|3
1814208|NCT00441441|6300284|P2|Overall Study|Withdrawal by Subject|2
1814209|NCT00441441|6300285|P1|Overall Study|Withdrawal by Subject|1
1814210|NCT00441441|6300284|P2|Overall Study|Exacerbation of asthma|2
1814211|NCT00441441|6300285|P1|Overall Study|Exacerbation of asthma|1
1814212|NCT00441441|6300284|P2|Overall Study|Protocol Violation|6
1814213|NCT00441441|6300285|P1|Overall Study|Protocol Violation|4
1814214|NCT00441441|6300284|P2|Overall Study|Adverse Event|1
1814215|NCT00441441|6300285|P1|Overall Study|Adverse Event|2
1814216|NCT00441363|6300345|P2|Overall Study|Other|0
1814217|NCT00441363|6300346|P1|Overall Study|Other|2
1814218|NCT00441363|6300345|P2|Overall Study|Lost to Follow-up|2
1814219|NCT00441363|6300346|P1|Overall Study|Lost to Follow-up|2
1814220|NCT00441363|6300345|P2|Overall Study|Physician Decision|7
1814221|NCT00441363|6300346|P1|Overall Study|Physician Decision|6
1814222|NCT00441363|6300345|P2|Overall Study|Withdrawal by Subject|4
1814223|NCT00441363|6300346|P1|Overall Study|Withdrawal by Subject|3
1814224|NCT00441363|6300345|P2|Overall Study|Adverse Event|2
1814225|NCT00441363|6300346|P1|Overall Study|Adverse Event|4
1814226|NCT00441337|6300358|P4|Overall Study|Did not meet inclusion criteria|0
1814227|NCT00441337|6300359|P3|Overall Study|Did not meet inclusion criteria|1
1814228|NCT00441337|6300360|P2|Overall Study|Did not meet inclusion criteria|0
1814229|NCT00441337|6300361|P1|Overall Study|Did not meet inclusion criteria|0
1814230|NCT00441337|6300358|P4|Overall Study|Sponsor Decision|2
1814231|NCT00441337|6300359|P3|Overall Study|Sponsor Decision|1
1814232|NCT00441337|6300360|P2|Overall Study|Sponsor Decision|0
1814233|NCT00441337|6300361|P1|Overall Study|Sponsor Decision|0
1814234|NCT00441337|6300358|P4|Overall Study|Lost to Follow-up|1
1814235|NCT00441337|6300359|P3|Overall Study|Lost to Follow-up|0
1814236|NCT00441337|6300360|P2|Overall Study|Lost to Follow-up|0
1814237|NCT00441337|6300361|P1|Overall Study|Lost to Follow-up|0
1814238|NCT00441337|6300358|P4|Overall Study|Disease Progression|18
1814239|NCT00441337|6300359|P3|Overall Study|Disease Progression|4
1814240|NCT00441337|6300360|P2|Overall Study|Disease Progression|6
1814241|NCT00441337|6300361|P1|Overall Study|Disease Progression|6
1814242|NCT00441272|6300474|P2|Overall Study|Study terminated prior to enrollment|25
1814243|NCT00441272|6300475|P1|Overall Study|Study terminated prior to enrollment|25
1814244|NCT00441168|6300502|P2|Follow-up Period|Other|3
1814245|NCT00441168|6300503|P1|Follow-up Period|Other|1
1814246|NCT00441168|6300502|P2|Follow-up Period|Withdrawal by Subject|0
1814247|NCT00441168|6300503|P1|Follow-up Period|Withdrawal by Subject|3
1814248|NCT00441168|6300502|P2|Follow-up Period|Lost to Follow-up|6
1814249|NCT00441168|6300503|P1|Follow-up Period|Lost to Follow-up|5
1814250|NCT00441168|6300502|P2|Follow-up Period|Death|0
1814251|NCT00441168|6300503|P1|Follow-up Period|Death|3
1814252|NCT00441168|6300502|P2|Treatment Period|refractory disease|0
1814253|NCT00441168|6300503|P1|Treatment Period|refractory disease|1
1814254|NCT00441168|6300502|P2|Treatment Period|qualified for stem-cell transplantation|0
1814255|NCT00441168|6300503|P1|Treatment Period|qualified for stem-cell transplantation|3
1814256|NCT00441168|6300502|P2|Treatment Period|Withdrawal by Subject|0
1814257|NCT00441168|6300503|P1|Treatment Period|Withdrawal by Subject|3
1814258|NCT00441168|6300502|P2|Treatment Period|Lost to Follow-up|1
1814259|NCT00441168|6300503|P1|Treatment Period|Lost to Follow-up|0
1814260|NCT00441168|6300502|P2|Treatment Period|Protocol Violation|1
1814261|NCT00441168|6300503|P1|Treatment Period|Protocol Violation|0
1814262|NCT00441168|6300502|P2|Treatment Period|Progressive Disease|2
1814263|NCT00441168|6300503|P1|Treatment Period|Progressive Disease|0
1814264|NCT00441168|6300502|P2|Treatment Period|Adverse Event|2
1814265|NCT00441168|6300503|P1|Treatment Period|Adverse Event|1
1814266|NCT00441168|6300502|P2|Treatment Period|Death|0
1814267|NCT00441168|6300503|P1|Treatment Period|Death|3
1814268|NCT00441142|6300517|P4|Overall Study|Death|1
1814269|NCT00441142|6300518|P3|Overall Study|Death|0
1814270|NCT00441142|6300519|P2|Overall Study|Death|0
1814271|NCT00441142|6300520|P1|Overall Study|Death|0
1814272|NCT00441142|6300517|P4|Overall Study|Physician Decision|1
1814273|NCT00441142|6300518|P3|Overall Study|Physician Decision|0
1814274|NCT00441142|6300519|P2|Overall Study|Physician Decision|1
1814275|NCT00441142|6300520|P1|Overall Study|Physician Decision|0
1814276|NCT00441142|6300517|P4|Overall Study|Patient still receiving active study tx|2
1814277|NCT00441142|6300518|P3|Overall Study|Patient still receiving active study tx|0
1814278|NCT00441142|6300519|P2|Overall Study|Patient still receiving active study tx|0
1814279|NCT00441142|6300520|P1|Overall Study|Patient still receiving active study tx|1
1814280|NCT00441142|6300517|P4|Overall Study|Withdrawal by Subject|10
1814281|NCT00441142|6300518|P3|Overall Study|Withdrawal by Subject|2
1814282|NCT00441142|6300519|P2|Overall Study|Withdrawal by Subject|0
1814283|NCT00441142|6300520|P1|Overall Study|Withdrawal by Subject|0
1814284|NCT00441142|6300517|P4|Overall Study|Lack of Efficacy|32
1814285|NCT00441142|6300518|P3|Overall Study|Lack of Efficacy|17
1814286|NCT00441142|6300519|P2|Overall Study|Lack of Efficacy|3
1814287|NCT00441142|6300520|P1|Overall Study|Lack of Efficacy|3
1814288|NCT00441142|6300517|P4|Overall Study|Adverse Event|22
1814289|NCT00441142|6300518|P3|Overall Study|Adverse Event|3
1814290|NCT00441142|6300519|P2|Overall Study|Adverse Event|3
1814291|NCT00441142|6300520|P1|Overall Study|Adverse Event|2
1814292|NCT00441129|6300542|P2|Overall Study|Withdrawal by Subject|14
1814293|NCT00441129|6300543|P1|Overall Study|Withdrawal by Subject|6
1814294|NCT00441116|6300555|P2|Overall Study|Did not meet Eligibility Criteria|1
1814295|NCT00441116|6300556|P1|Overall Study|Did not meet Eligibility Criteria|1
1814296|NCT00441116|6300555|P2|Overall Study|Withdrawal by Subject|0
1814297|NCT00441116|6300556|P1|Overall Study|Withdrawal by Subject|1
1814298|NCT00441116|6300555|P2|Overall Study|Adverse Event|1
1814299|NCT00441116|6300556|P1|Overall Study|Adverse Event|1
1814300|NCT00441103|6300624|P2|Overall Study|Participant decided to stop|1
1814301|NCT00441103|6300625|P1|Overall Study|Participant decided to stop|0
1814302|NCT00441103|6300624|P2|Overall Study|Participant's reason|1
1814303|NCT00441103|6300625|P1|Overall Study|Participant's reason|0
1814304|NCT00441103|6300624|P2|Overall Study|Participant decided to withdraw|0
1814305|NCT00441103|6300625|P1|Overall Study|Participant decided to withdraw|1
1814306|NCT00441103|6300624|P2|Overall Study|Non-compliant|1
1814307|NCT00441103|6300625|P1|Overall Study|Non-compliant|0
1814308|NCT00441103|6300624|P2|Overall Study|Inclusion criteria absent|0
1814309|NCT00441103|6300625|P1|Overall Study|Inclusion criteria absent|1
1814310|NCT00441103|6300624|P2|Overall Study|Participant refused MRI|0
1814311|NCT00441103|6300625|P1|Overall Study|Participant refused MRI|1
1814312|NCT00441103|6300624|P2|Overall Study|Participant unable to use Rebiject II|0
1814313|NCT00441103|6300625|P1|Overall Study|Participant unable to use Rebiject II|1
1814314|NCT00441103|6300624|P2|Overall Study|Protocol Violation|0
1814315|NCT00441103|6300625|P1|Overall Study|Protocol Violation|1
1814316|NCT00441103|6300624|P2|Overall Study|Lost to Follow-up|0
1814317|NCT00441103|6300625|P1|Overall Study|Lost to Follow-up|1
1814318|NCT00441103|6300624|P2|Overall Study|Disease Progression|0
1814319|NCT00441103|6300625|P1|Overall Study|Disease Progression|2
1814320|NCT00441103|6300624|P2|Overall Study|Death|0
1814321|NCT00441103|6300625|P1|Overall Study|Death|1
1814322|NCT00441103|6300624|P2|Overall Study|Adverse Event|1
1814323|NCT00441103|6300625|P1|Overall Study|Adverse Event|2
1814324|NCT00441090|6300641|P5|Overall Study|Lack of Efficacy|0
1814325|NCT00441090|6300642|P4|Overall Study|Lack of Efficacy|0
1814326|NCT00441090|6300643|P3|Overall Study|Lack of Efficacy|0
1814327|NCT00441090|6300644|P2|Overall Study|Lack of Efficacy|0
1814328|NCT00441090|6300645|P1|Overall Study|Lack of Efficacy|1
1814329|NCT00441090|6300641|P5|Overall Study|Withdrawal by Subject|0
1814330|NCT00441090|6300642|P4|Overall Study|Withdrawal by Subject|0
1814331|NCT00441090|6300643|P3|Overall Study|Withdrawal by Subject|1
1814332|NCT00441090|6300644|P2|Overall Study|Withdrawal by Subject|0
1814333|NCT00441090|6300645|P1|Overall Study|Withdrawal by Subject|1
1814334|NCT00441090|6300641|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
1814335|NCT00441090|6300642|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
1814336|NCT00441090|6300643|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
1814337|NCT00441090|6300644|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
1814338|NCT00441090|6300645|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
1814339|NCT00441090|6300641|P5|Overall Study|Adverse Event|0
1814340|NCT00441090|6300642|P4|Overall Study|Adverse Event|0
1814341|NCT00441090|6300643|P3|Overall Study|Adverse Event|1
1814342|NCT00441090|6300644|P2|Overall Study|Adverse Event|1
1814343|NCT00441090|6300645|P1|Overall Study|Adverse Event|0
1814344|NCT00441064|6300689|P2|Overall Study|Patient withdrew consent|2
1814345|NCT00441064|6300690|P1|Overall Study|Patient withdrew consent|5
1814346|NCT00441064|6300689|P2|Overall Study|Protocol Deviation|2
1814347|NCT00441064|6300690|P1|Overall Study|Protocol Deviation|3
1814348|NCT00441064|6300689|P2|Overall Study|Unsatisfactory therapeutic effect|0
1814349|NCT00441064|6300690|P1|Overall Study|Unsatisfactory therapeutic effect|1
1814350|NCT00441064|6300689|P2|Overall Study|Abnormal test procedure results|1
1814351|NCT00441064|6300690|P1|Overall Study|Abnormal test procedure results|0
1814352|NCT00441064|6300689|P2|Overall Study|Abnormal laboratory values|2
1814353|NCT00441064|6300690|P1|Overall Study|Abnormal laboratory values|0
1814354|NCT00441064|6300689|P2|Overall Study|Adverse Event|0
1814355|NCT00441064|6300690|P1|Overall Study|Adverse Event|1
1814356|NCT00441012|6300702|P2|Overall Study|Subject Randomized but Not Vaccinated|0
1814357|NCT00441012|6300703|P1|Overall Study|Subject Randomized but Not Vaccinated|1
1814358|NCT00441012|6300702|P2|Overall Study|Withdrawal by Subject|0
1814359|NCT00441012|6300703|P1|Overall Study|Withdrawal by Subject|4
1814360|NCT00441012|6300702|P2|Overall Study|Protocol Violation|9
1814361|NCT00441012|6300703|P1|Overall Study|Protocol Violation|10
1814362|NCT00441012|6300702|P2|Overall Study|Lost to Follow-up|3
1814363|NCT00441012|6300703|P1|Overall Study|Lost to Follow-up|3
1814364|NCT00441012|6300702|P2|Overall Study|Adverse Event|1
1814365|NCT00441012|6300703|P1|Overall Study|Adverse Event|0
1814366|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
1814367|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1814368|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1814369|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1814370|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
1814371|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Physician Decision|1
1814372|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Physician Decision|0
1814373|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Physician Decision|0
1814374|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Physician Decision|0
1814375|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Physician Decision|0
1814376|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Other|0
1814377|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Other|1
1814378|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Other|0
1814379|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Other|0
1814380|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Other|0
1814381|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
1814382|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
1814383|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1814384|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1814385|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
1814386|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Sponsor Request|1
1814387|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Sponsor Request|1
1814388|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Sponsor Request|0
1814389|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Sponsor Request|0
1814390|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Sponsor Request|0
1814391|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Participant Moved|1
1814392|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Participant Moved|1
1814393|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Participant Moved|0
1814394|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Participant Moved|0
1814395|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Participant Moved|0
1814396|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Pregnancy|0
1814397|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Pregnancy|3
1814398|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Pregnancy|0
1814399|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Pregnancy|0
1814400|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Pregnancy|0
1814401|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
1814402|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
1814403|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1814404|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1814405|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
1814406|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Protocol Violation|0
1814407|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Protocol Violation|1
1814408|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Protocol Violation|0
1814409|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Protocol Violation|0
1814410|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Protocol Violation|0
1814411|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
1814412|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
1814413|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
1814414|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
1814415|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
1814416|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Non-compliance|1
1814417|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Non-compliance|1
1814418|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Non-compliance|0
1814419|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Non-compliance|0
1814420|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Non-compliance|0
1814421|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
1814422|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
1814423|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1814424|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1814425|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
1814426|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
1814427|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
1814428|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1814429|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1814430|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
1814431|NCT00440947|6300717|P5|Optional 60-Week Extension Phase|Adverse Event|3
1814432|NCT00440947|6300718|P4|Optional 60-Week Extension Phase|Adverse Event|1
1814433|NCT00440947|6300719|P3|Optional 60-Week Extension Phase|Adverse Event|0
1814434|NCT00440947|6300720|P2|Optional 60-Week Extension Phase|Adverse Event|0
1814435|NCT00440947|6300721|P1|Optional 60-Week Extension Phase|Adverse Event|0
1814436|NCT00440947|6300717|P5|48-Week Randomization Phase|Physician Decision|0
1814437|NCT00440947|6300718|P4|48-Week Randomization Phase|Physician Decision|0
1814438|NCT00440947|6300719|P3|48-Week Randomization Phase|Physician Decision|0
1814439|NCT00440947|6300720|P2|48-Week Randomization Phase|Physician Decision|2
1814440|NCT00440947|6300721|P1|48-Week Randomization Phase|Physician Decision|0
1814441|NCT00440947|6300717|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
1814442|NCT00440947|6300718|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
1814443|NCT00440947|6300719|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
1814444|NCT00440947|6300720|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
1814445|NCT00440947|6300721|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
1814446|NCT00440947|6300717|P5|48-Week Randomization Phase|Incarceration|0
1814447|NCT00440947|6300718|P4|48-Week Randomization Phase|Incarceration|0
1814448|NCT00440947|6300719|P3|48-Week Randomization Phase|Incarceration|0
1814449|NCT00440947|6300720|P2|48-Week Randomization Phase|Incarceration|3
1814450|NCT00440947|6300721|P1|48-Week Randomization Phase|Incarceration|0
1814451|NCT00440947|6300717|P5|48-Week Randomization Phase|Pregnancy|0
1814452|NCT00440947|6300718|P4|48-Week Randomization Phase|Pregnancy|0
1814453|NCT00440947|6300719|P3|48-Week Randomization Phase|Pregnancy|1
1814454|NCT00440947|6300720|P2|48-Week Randomization Phase|Pregnancy|0
1814455|NCT00440947|6300721|P1|48-Week Randomization Phase|Pregnancy|0
1814456|NCT00440947|6300717|P5|48-Week Randomization Phase|Withdrawal by Subject|0
1814457|NCT00440947|6300718|P4|48-Week Randomization Phase|Withdrawal by Subject|0
1814458|NCT00440947|6300719|P3|48-Week Randomization Phase|Withdrawal by Subject|4
1814459|NCT00440947|6300720|P2|48-Week Randomization Phase|Withdrawal by Subject|2
1814460|NCT00440947|6300721|P1|48-Week Randomization Phase|Withdrawal by Subject|0
1814461|NCT00440947|6300717|P5|48-Week Randomization Phase|Protocol Violation|0
1814462|NCT00440947|6300718|P4|48-Week Randomization Phase|Protocol Violation|0
1814463|NCT00440947|6300719|P3|48-Week Randomization Phase|Protocol Violation|1
1814464|NCT00440947|6300720|P2|48-Week Randomization Phase|Protocol Violation|0
1814465|NCT00440947|6300721|P1|48-Week Randomization Phase|Protocol Violation|0
1814466|NCT00440947|6300717|P5|48-Week Randomization Phase|Lost to Follow-up|0
1814467|NCT00440947|6300718|P4|48-Week Randomization Phase|Lost to Follow-up|0
1814468|NCT00440947|6300719|P3|48-Week Randomization Phase|Lost to Follow-up|8
1814469|NCT00440947|6300720|P2|48-Week Randomization Phase|Lost to Follow-up|2
1814470|NCT00440947|6300721|P1|48-Week Randomization Phase|Lost to Follow-up|0
1814471|NCT00440947|6300717|P5|48-Week Randomization Phase|Non-compliance|0
1814472|NCT00440947|6300718|P4|48-Week Randomization Phase|Non-compliance|0
1814473|NCT00440947|6300719|P3|48-Week Randomization Phase|Non-compliance|4
1814474|NCT00440947|6300720|P2|48-Week Randomization Phase|Non-compliance|3
1814475|NCT00440947|6300721|P1|48-Week Randomization Phase|Non-compliance|0
1814476|NCT00440947|6300717|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1814477|NCT00440947|6300718|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1814478|NCT00440947|6300719|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
1814479|NCT00440947|6300720|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
1814480|NCT00440947|6300721|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
1814481|NCT00440947|6300717|P5|48-Week Randomization Phase|Adverse Event|0
1814482|NCT00440947|6300718|P4|48-Week Randomization Phase|Adverse Event|0
1814483|NCT00440947|6300719|P3|48-Week Randomization Phase|Adverse Event|5
1814484|NCT00440947|6300720|P2|48-Week Randomization Phase|Adverse Event|2
1814485|NCT00440947|6300721|P1|48-Week Randomization Phase|Adverse Event|0
1814486|NCT00440947|6300717|P5|36-Week Induction Phase|Pregnancy|0
1814487|NCT00440947|6300718|P4|36-Week Induction Phase|Pregnancy|0
1814488|NCT00440947|6300719|P3|36-Week Induction Phase|Pregnancy|0
1814489|NCT00440947|6300720|P2|36-Week Induction Phase|Pregnancy|0
1814490|NCT00440947|6300721|P1|36-Week Induction Phase|Pregnancy|1
1814491|NCT00440947|6300717|P5|36-Week Induction Phase|Incarceration|0
1814492|NCT00440947|6300718|P4|36-Week Induction Phase|Incarceration|0
1814493|NCT00440947|6300719|P3|36-Week Induction Phase|Incarceration|0
1814494|NCT00440947|6300720|P2|36-Week Induction Phase|Incarceration|0
1814495|NCT00440947|6300721|P1|36-Week Induction Phase|Incarceration|3
1814496|NCT00440947|6300717|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1814497|NCT00440947|6300718|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1814498|NCT00440947|6300719|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1814499|NCT00440947|6300720|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
1814500|NCT00440947|6300721|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
1814501|NCT00440947|6300717|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1814502|NCT00440947|6300718|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1814503|NCT00440947|6300719|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1814504|NCT00440947|6300720|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
1814505|NCT00440947|6300721|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
1814506|NCT00440947|6300717|P5|36-Week Induction Phase|Took Exclusionary Medications|0
1814507|NCT00440947|6300718|P4|36-Week Induction Phase|Took Exclusionary Medications|0
1814508|NCT00440947|6300719|P3|36-Week Induction Phase|Took Exclusionary Medications|0
1814509|NCT00440947|6300720|P2|36-Week Induction Phase|Took Exclusionary Medications|0
1814510|NCT00440947|6300721|P1|36-Week Induction Phase|Took Exclusionary Medications|1
1814511|NCT00440947|6300717|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1814512|NCT00440947|6300718|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1814513|NCT00440947|6300719|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1814514|NCT00440947|6300720|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
1814515|NCT00440947|6300721|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
1814516|NCT00440947|6300717|P5|36-Week Induction Phase|Withdrawal by Subject|0
1814517|NCT00440947|6300718|P4|36-Week Induction Phase|Withdrawal by Subject|0
1814518|NCT00440947|6300719|P3|36-Week Induction Phase|Withdrawal by Subject|0
1814519|NCT00440947|6300720|P2|36-Week Induction Phase|Withdrawal by Subject|0
1814520|NCT00440947|6300721|P1|36-Week Induction Phase|Withdrawal by Subject|7
1814521|NCT00440947|6300717|P5|36-Week Induction Phase|Lost to Follow-up|0
1814522|NCT00440947|6300718|P4|36-Week Induction Phase|Lost to Follow-up|0
1814523|NCT00440947|6300719|P3|36-Week Induction Phase|Lost to Follow-up|0
1814524|NCT00440947|6300720|P2|36-Week Induction Phase|Lost to Follow-up|0
1814525|NCT00440947|6300721|P1|36-Week Induction Phase|Lost to Follow-up|16
1814526|NCT00440947|6300717|P5|36-Week Induction Phase|Non-compliance|0
1814527|NCT00440947|6300718|P4|36-Week Induction Phase|Non-compliance|0
1814528|NCT00440947|6300719|P3|36-Week Induction Phase|Non-compliance|0
1814529|NCT00440947|6300720|P2|36-Week Induction Phase|Non-compliance|0
1814530|NCT00440947|6300721|P1|36-Week Induction Phase|Non-compliance|10
1814531|NCT00440947|6300717|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1814532|NCT00440947|6300718|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1814533|NCT00440947|6300719|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1814534|NCT00440947|6300720|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
1814535|NCT00440947|6300721|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
1814536|NCT00440947|6300717|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
1814537|NCT00440947|6300718|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
1814538|NCT00440947|6300719|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
1814539|NCT00440947|6300720|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
1814540|NCT00440947|6300721|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
1814541|NCT00440947|6300717|P5|36-Week Induction Phase|Adverse Event|0
1814542|NCT00440947|6300718|P4|36-Week Induction Phase|Adverse Event|0
1814543|NCT00440947|6300719|P3|36-Week Induction Phase|Adverse Event|0
1814544|NCT00440947|6300720|P2|36-Week Induction Phase|Adverse Event|0
1814545|NCT00440947|6300721|P1|36-Week Induction Phase|Adverse Event|16
1814558|NCT00440700|6300812|P3|Overall Study|Withdrawal by Subject|4
1814559|NCT00440700|6300813|P2|Overall Study|Withdrawal by Subject|8
1814560|NCT00440700|6300814|P1|Overall Study|Withdrawal by Subject|8
1814561|NCT00440557|6300837|P3|Overall Study|Patient had surgery|0
1814562|NCT00440557|6300838|P2|Overall Study|Patient had surgery|0
1814563|NCT00440557|6300839|P1|Overall Study|Patient had surgery|1
1814564|NCT00440557|6300837|P3|Overall Study|Patient transferred to nursing home|0
1814565|NCT00440557|6300838|P2|Overall Study|Patient transferred to nursing home|1
1814566|NCT00440557|6300839|P1|Overall Study|Patient transferred to nursing home|0
1814567|NCT00440557|6300837|P3|Overall Study|Principal Investigator's office closed|4
1814568|NCT00440557|6300838|P2|Overall Study|Principal Investigator's office closed|6
1814569|NCT00440557|6300839|P1|Overall Study|Principal Investigator's office closed|3
1814570|NCT00440557|6300837|P3|Overall Study|Patient moved|1
1814571|NCT00440557|6300838|P2|Overall Study|Patient moved|2
1814572|NCT00440557|6300839|P1|Overall Study|Patient moved|1
1814573|NCT00440557|6300837|P3|Overall Study|Principal Investigator decision|1
1814574|NCT00440557|6300838|P2|Overall Study|Principal Investigator decision|3
1814575|NCT00440557|6300839|P1|Overall Study|Principal Investigator decision|0
1814576|NCT00440557|6300837|P3|Overall Study|Began Dialysis|4
1814577|NCT00440557|6300838|P2|Overall Study|Began Dialysis|1
1814578|NCT00440557|6300839|P1|Overall Study|Began Dialysis|4
1814579|NCT00440557|6300837|P3|Overall Study|Death|3
1814580|NCT00440557|6300838|P2|Overall Study|Death|6
1814581|NCT00440557|6300839|P1|Overall Study|Death|2
1814582|NCT00440557|6300837|P3|Overall Study|Adverse Event|5
1814583|NCT00440557|6300838|P2|Overall Study|Adverse Event|3
1814584|NCT00440557|6300839|P1|Overall Study|Adverse Event|3
1814585|NCT00440557|6300837|P3|Overall Study|Lost to Follow-up|6
1814586|NCT00440557|6300838|P2|Overall Study|Lost to Follow-up|2
1814587|NCT00440557|6300839|P1|Overall Study|Lost to Follow-up|1
1814588|NCT00440557|6300837|P3|Overall Study|Withdrawal by Subject|11
1814589|NCT00440557|6300838|P2|Overall Study|Withdrawal by Subject|5
1814590|NCT00440557|6300839|P1|Overall Study|Withdrawal by Subject|10
1814591|NCT00440531|6300871|P3|Overall Study|see pre-assignment details|0
1814592|NCT00440531|6300872|P2|Overall Study|see pre-assignment details|0
1814593|NCT00440531|6300873|P1|Overall Study|see pre-assignment details|2
1814594|NCT00440531|6300871|P3|Overall Study|Lost to Follow-up|5
1814595|NCT00440531|6300872|P2|Overall Study|Lost to Follow-up|3
1814596|NCT00440531|6300873|P1|Overall Study|Lost to Follow-up|4
1814597|NCT00440531|6300871|P3|Overall Study|Protocol Violation|0
1814598|NCT00440531|6300872|P2|Overall Study|Protocol Violation|2
1814599|NCT00440531|6300873|P1|Overall Study|Protocol Violation|1
1814600|NCT00440531|6300871|P3|Overall Study|Withdrawal by Subject|0
1814601|NCT00440531|6300872|P2|Overall Study|Withdrawal by Subject|0
1814602|NCT00440531|6300873|P1|Overall Study|Withdrawal by Subject|2
1814603|NCT00440531|6300871|P3|Overall Study|Adverse Event|2
1814604|NCT00440531|6300872|P2|Overall Study|Adverse Event|0
1814605|NCT00440531|6300873|P1|Overall Study|Adverse Event|1
1814606|NCT00440518|6300890|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
1814607|NCT00440518|6300891|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
1814608|NCT00440518|6300892|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
1814609|NCT00440518|6300890|P3|Maintenance and Safety Follow-up Periods|Other|2
1814610|NCT00440518|6300891|P2|Maintenance and Safety Follow-up Periods|Other|0
1814611|NCT00440518|6300892|P1|Maintenance and Safety Follow-up Periods|Other|0
1814612|NCT00440518|6300890|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
1814613|NCT00440518|6300891|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
1814614|NCT00440518|6300892|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
1814615|NCT00440518|6300890|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
1814616|NCT00440518|6300891|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
1814617|NCT00440518|6300892|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
1814618|NCT00440518|6300890|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
1814619|NCT00440518|6300891|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
1814620|NCT00440518|6300892|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
1814621|NCT00440518|6300890|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
1814622|NCT00440518|6300891|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
1814623|NCT00440518|6300892|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
1814624|NCT00440518|6300890|P3|Randomized /Titration Period|Adverse Event|0
1814625|NCT00440518|6300891|P2|Randomized /Titration Period|Adverse Event|3
1814626|NCT00440518|6300892|P1|Randomized /Titration Period|Adverse Event|2
1814627|NCT00440518|6300890|P3|Randomized /Titration Period|Lost to Follow-up|1
1814628|NCT00440518|6300891|P2|Randomized /Titration Period|Lost to Follow-up|2
1814629|NCT00440518|6300892|P1|Randomized /Titration Period|Lost to Follow-up|2
1814630|NCT00440518|6300890|P3|Randomized /Titration Period|Other|0
1814631|NCT00440518|6300891|P2|Randomized /Titration Period|Other|0
1814632|NCT00440518|6300892|P1|Randomized /Titration Period|Other|1
1814633|NCT00440518|6300890|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
1814634|NCT00440518|6300891|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
1814635|NCT00440518|6300892|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
1814636|NCT00440518|6300890|P3|Randomized /Titration Period|Protocol Deviation|0
1814637|NCT00440518|6300891|P2|Randomized /Titration Period|Protocol Deviation|0
1814638|NCT00440518|6300892|P1|Randomized /Titration Period|Protocol Deviation|1
1814639|NCT00440518|6300890|P3|Randomized /Titration Period|Subject Withdrew Consent|0
1814640|NCT00440518|6300891|P2|Randomized /Titration Period|Subject Withdrew Consent|1
1814641|NCT00440518|6300892|P1|Randomized /Titration Period|Subject Withdrew Consent|4
1814642|NCT00440518|6300890|P3|Randomized /Titration Period|Lack of Efficacy|1
1814643|NCT00440518|6300891|P2|Randomized /Titration Period|Lack of Efficacy|0
1814644|NCT00440518|6300892|P1|Randomized /Titration Period|Lack of Efficacy|1
1814645|NCT00440466|6300937|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
1814646|NCT00440466|6300938|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
1814647|NCT00440466|6300939|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
1814648|NCT00440466|6300937|P3|Overall Study|Began Dialysis|1
1814649|NCT00440466|6300938|P2|Overall Study|Began Dialysis|0
1814650|NCT00440466|6300939|P1|Overall Study|Began Dialysis|0
1814651|NCT00440466|6300937|P3|Overall Study|Withdrawal by Subject|9
1814652|NCT00440466|6300938|P2|Overall Study|Withdrawal by Subject|5
1814653|NCT00440466|6300939|P1|Overall Study|Withdrawal by Subject|2
1814654|NCT00440466|6300937|P3|Overall Study|Protocol Violation|4
1814655|NCT00440466|6300938|P2|Overall Study|Protocol Violation|0
1814656|NCT00440466|6300939|P1|Overall Study|Protocol Violation|2
1814657|NCT00440466|6300937|P3|Overall Study|Physician Decision|1
1814658|NCT00440466|6300938|P2|Overall Study|Physician Decision|0
1814659|NCT00440466|6300939|P1|Overall Study|Physician Decision|2
1814660|NCT00440466|6300937|P3|Overall Study|Lost to Follow-up|2
1814661|NCT00440466|6300938|P2|Overall Study|Lost to Follow-up|0
1814662|NCT00440466|6300939|P1|Overall Study|Lost to Follow-up|1
1814663|NCT00440466|6300937|P3|Overall Study|Adverse Event|11
1814664|NCT00440466|6300938|P2|Overall Study|Adverse Event|4
1814665|NCT00440466|6300939|P1|Overall Study|Adverse Event|3
1814666|NCT00440466|6300937|P3|Overall Study|Death|9
1814667|NCT00440466|6300938|P2|Overall Study|Death|2
1814668|NCT00440466|6300939|P1|Overall Study|Death|3
1814669|NCT00440401|6300973|P2|Overall Study|Other|5
1814670|NCT00440401|6300974|P1|Overall Study|Other|2
1814671|NCT00440401|6300973|P2|Overall Study|Adverse Event|1
1814672|NCT00440401|6300974|P1|Overall Study|Adverse Event|2
1814673|NCT00440310|6300984|P2|Overall Study|Status Unknown|3
1814674|NCT00440310|6300985|P1|Overall Study|Status Unknown|1
1814675|NCT00440310|6300984|P2|Overall Study|Other|0
1814676|NCT00440310|6300985|P1|Overall Study|Other|1
1814677|NCT00440310|6300984|P2|Overall Study|No Reply at EOS|7
1814678|NCT00440310|6300985|P1|Overall Study|No Reply at EOS|7
1814679|NCT00440310|6300984|P2|Overall Study|Withdrawal by Subject|14
1814680|NCT00440310|6300985|P1|Overall Study|Withdrawal by Subject|15
1814681|NCT00440310|6300984|P2|Overall Study|Protocol Violation|1
1814682|NCT00440310|6300985|P1|Overall Study|Protocol Violation|0
1814683|NCT00440310|6300984|P2|Overall Study|Lost to Follow-up|5
1814684|NCT00440310|6300985|P1|Overall Study|Lost to Follow-up|4
1814685|NCT00440297|6300993|P2|Overall Study|Randomized by mistake|0
1814686|NCT00440297|6300994|P1|Overall Study|Randomized by mistake|1
1814687|NCT00440297|6300993|P2|Overall Study|Withdrawal by Subject|6
1814688|NCT00440297|6300994|P1|Overall Study|Withdrawal by Subject|1
1814689|NCT00440297|6300993|P2|Overall Study|Protocol Violation|7
1814690|NCT00440297|6300994|P1|Overall Study|Protocol Violation|11
1814691|NCT00440297|6300993|P2|Overall Study|Physician Decision|0
1814692|NCT00440297|6300994|P1|Overall Study|Physician Decision|1
1814693|NCT00440297|6300993|P2|Overall Study|Lost to Follow-up|0
1814694|NCT00440297|6300994|P1|Overall Study|Lost to Follow-up|1
1814695|NCT00440297|6300993|P2|Overall Study|Adverse Event|5
1814696|NCT00440297|6300994|P1|Overall Study|Adverse Event|8
1814697|NCT00440271|6301010|P2|Overall Study|Other|0
1814698|NCT00440271|6301011|P1|Overall Study|Other|2
1814699|NCT00440271|6301010|P2|Overall Study|Due to closure of trial|10
1814700|NCT00440271|6301011|P1|Overall Study|Due to closure of trial|8
1814701|NCT00440271|6301010|P2|Overall Study|Lack of Efficacy|1
1814702|NCT00440271|6301011|P1|Overall Study|Lack of Efficacy|0
1814703|NCT00440271|6301010|P2|Overall Study|Withdrawal by Subject|2
1814704|NCT00440271|6301011|P1|Overall Study|Withdrawal by Subject|0
1814705|NCT00440271|6301010|P2|Overall Study|Lost to Follow-up|0
1814706|NCT00440271|6301011|P1|Overall Study|Lost to Follow-up|1
1814707|NCT00440271|6301010|P2|Overall Study|Adverse Event|1
1814708|NCT00440271|6301011|P1|Overall Study|Adverse Event|0
1814709|NCT00440271|6301010|P2|Overall Study|Protocol Violation|1
1814710|NCT00440271|6301011|P1|Overall Study|Protocol Violation|1
1814711|NCT00440232|6301045|P2|Overall Study|Onset of headache within 4 hours of fast|2
1814712|NCT00440232|6301046|P1|Overall Study|Onset of headache within 4 hours of fast|2
1814713|NCT00440232|6301045|P2|Overall Study|Unable to treat within allowed time|1
1814714|NCT00440232|6301046|P1|Overall Study|Unable to treat within allowed time|0
1814715|NCT00440232|6301045|P2|Overall Study|Lost to Follow-up|1
1814716|NCT00440232|6301046|P1|Overall Study|Lost to Follow-up|1
1814717|NCT00440193|6301056|P2|Observational Period|Participant convenience|0
1814718|NCT00440193|6301057|P1|Observational Period|Participant convenience|2
1814719|NCT00440193|6301056|P2|Observational Period|Clinical endpoint reached|0
1814720|NCT00440193|6301057|P1|Observational Period|Clinical endpoint reached|1
1814721|NCT00440193|6301056|P2|Observational Period|Physician Decision|0
1814722|NCT00440193|6301057|P1|Observational Period|Physician Decision|1
1814723|NCT00440193|6301056|P2|Observational Period|Withdrawal by Subject|8
1814724|NCT00440193|6301057|P1|Observational Period|Withdrawal by Subject|11
1814725|NCT00440193|6301056|P2|Observational Period|Protocol Violation|0
1814726|NCT00440193|6301057|P1|Observational Period|Protocol Violation|1
1814727|NCT00440193|6301056|P2|Observational Period|Lost to Follow-up|8
1814728|NCT00440193|6301057|P1|Observational Period|Lost to Follow-up|12
1814729|NCT00440193|6301056|P2|Observational Period|Death|20
1814730|NCT00440193|6301057|P1|Observational Period|Death|15
1814731|NCT00440193|6301056|P2|Observational Period|Adverse Event|2
1814732|NCT00440193|6301057|P1|Observational Period|Adverse Event|2
1814733|NCT00440193|6301056|P2|Treatment Period|Site closed by investigator|2
1814734|NCT00440193|6301057|P1|Treatment Period|Site closed by investigator|0
1814735|NCT00440193|6301056|P2|Treatment Period|Participant did not receive treatment|13
1814736|NCT00440193|6301057|P1|Treatment Period|Participant did not receive treatment|7
1814737|NCT00440193|6301056|P2|Treatment Period|Participant convenience|2
1814738|NCT00440193|6301057|P1|Treatment Period|Participant convenience|5
1814739|NCT00440193|6301056|P2|Treatment Period|Technical problems|1
1814740|NCT00440193|6301057|P1|Treatment Period|Technical problems|1
1814741|NCT00440193|6301056|P2|Treatment Period|Switch to commercial drug|2
1814742|NCT00440193|6301057|P1|Treatment Period|Switch to commercial drug|0
1814743|NCT00440193|6301056|P2|Treatment Period|Protocol driven decision point|2
1814744|NCT00440193|6301057|P1|Treatment Period|Protocol driven decision point|2
1814745|NCT00440193|6301056|P2|Treatment Period|Study terminated by sponsor|94
1814746|NCT00440193|6301057|P1|Treatment Period|Study terminated by sponsor|102
1814747|NCT00440193|6301056|P2|Treatment Period|Clinical endpoint reached|25
1814748|NCT00440193|6301057|P1|Treatment Period|Clinical endpoint reached|28
1814749|NCT00440193|6301056|P2|Treatment Period|Withdrawal by Subject|77
1814750|NCT00440193|6301057|P1|Treatment Period|Withdrawal by Subject|36
1814751|NCT00440193|6301056|P2|Treatment Period|Protocol Violation|19
1814752|NCT00440193|6301057|P1|Treatment Period|Protocol Violation|16
1814753|NCT00440193|6301056|P2|Treatment Period|Physician Decision|6
1814754|NCT00440193|6301057|P1|Treatment Period|Physician Decision|3
1814755|NCT00440193|6301056|P2|Treatment Period|Lost to Follow-up|18
1814756|NCT00440193|6301057|P1|Treatment Period|Lost to Follow-up|12
1814757|NCT00440193|6301056|P2|Treatment Period|Lack of Efficacy|1
1814758|NCT00440193|6301057|P1|Treatment Period|Lack of Efficacy|0
1814759|NCT00440193|6301056|P2|Treatment Period|Death|22
1814760|NCT00440193|6301057|P1|Treatment Period|Death|19
1814761|NCT00440193|6301056|P2|Treatment Period|Adverse Event|67
1814762|NCT00440193|6301057|P1|Treatment Period|Adverse Event|74
1814763|NCT00440115|6301103|P3|Overall Study|Incarceration|1
1814764|NCT00440115|6301104|P2|Overall Study|Incarceration|2
1814765|NCT00440115|6301105|P1|Overall Study|Incarceration|0
1814766|NCT00440115|6301103|P3|Overall Study|Death|5
1814767|NCT00440115|6301104|P2|Overall Study|Death|9
1814768|NCT00440115|6301105|P1|Overall Study|Death|7
1814769|NCT00440037|6301134|P1|Overall Study|Administrative decision|3
1814770|NCT00440037|6301134|P1|Overall Study|Withdrawal by Subject|6
1814771|NCT00440011|6301144|P2|Overall Study|Withdrawal by Subject|0
1814772|NCT00440011|6301145|P1|Overall Study|Withdrawal by Subject|1
1814773|NCT00440011|6301144|P2|Overall Study|Protocol Violation|1
1814774|NCT00440011|6301145|P1|Overall Study|Protocol Violation|1
1814775|NCT00440011|6301144|P2|Overall Study|Lost to Follow-up|2
1814776|NCT00440011|6301145|P1|Overall Study|Lost to Follow-up|0
1814777|NCT00440011|6301144|P2|Overall Study|Adverse Event|0
1814778|NCT00440011|6301145|P1|Overall Study|Adverse Event|2
1814779|NCT00439777|6301172|P2|Observational Period|Technical problems|1
1814780|NCT00439777|6301173|P1|Observational Period|Technical problems|0
1814781|NCT00439777|6301172|P2|Observational Period|Lack of Efficacy|0
1814782|NCT00439777|6301173|P1|Observational Period|Lack of Efficacy|1
1814783|NCT00439777|6301172|P2|Observational Period|Protocol driven decision point|1
1814784|NCT00439777|6301173|P1|Observational Period|Protocol driven decision point|0
1814785|NCT00439777|6301172|P2|Observational Period|Study terminated by sponsor|1
1814786|NCT00439777|6301173|P1|Observational Period|Study terminated by sponsor|3
1814787|NCT00439777|6301172|P2|Observational Period|Death|20
1814788|NCT00439777|6301173|P1|Observational Period|Death|27
1814789|NCT00439777|6301172|P2|Observational Period|Lost to Follow-up|11
1814790|NCT00439777|6301173|P1|Observational Period|Lost to Follow-up|1
1814791|NCT00439777|6301172|P2|Observational Period|Withdrawal by Subject|5
1814792|NCT00439777|6301173|P1|Observational Period|Withdrawal by Subject|9
1814793|NCT00439777|6301172|P2|Observational Period|Protocol Violation|2
1814794|NCT00439777|6301173|P1|Observational Period|Protocol Violation|0
1814795|NCT00439777|6301172|P2|Treatment Period|Participant convenience|8
1814796|NCT00439777|6301173|P1|Treatment Period|Participant convenience|12
1814797|NCT00439777|6301172|P2|Treatment Period|Technical problems|1
1814798|NCT00439777|6301173|P1|Treatment Period|Technical problems|3
1814799|NCT00439777|6301172|P2|Treatment Period|Clinical endpoint reached|13
1814800|NCT00439777|6301173|P1|Treatment Period|Clinical endpoint reached|26
1814801|NCT00439777|6301172|P2|Treatment Period|Physician Decision|18
1814802|NCT00439777|6301173|P1|Treatment Period|Physician Decision|7
1814803|NCT00439777|6301172|P2|Treatment Period|Protocol driven decision point|3
1814804|NCT00439777|6301173|P1|Treatment Period|Protocol driven decision point|1
1814805|NCT00439777|6301172|P2|Treatment Period|Lost to Follow-up|10
1814806|NCT00439777|6301173|P1|Treatment Period|Lost to Follow-up|8
1814807|NCT00439777|6301172|P2|Treatment Period|Lack of Efficacy|4
1814808|NCT00439777|6301173|P1|Treatment Period|Lack of Efficacy|1
1814809|NCT00439777|6301172|P2|Treatment Period|Withdrawal by Subject|118
1814810|NCT00439777|6301173|P1|Treatment Period|Withdrawal by Subject|66
1814811|NCT00439777|6301172|P2|Treatment Period|Protocol Violation|30
1814812|NCT00439777|6301173|P1|Treatment Period|Protocol Violation|23
1814813|NCT00439777|6301172|P2|Treatment Period|Adverse Event|92
1814814|NCT00439777|6301173|P1|Treatment Period|Adverse Event|111
1814815|NCT00439777|6301172|P2|Treatment Period|Did not take study treatment|8
1814816|NCT00439777|6301173|P1|Treatment Period|Did not take study treatment|7
1814817|NCT00439777|6301172|P2|Treatment Period|Site closed by investigator|1
1814818|NCT00439777|6301173|P1|Treatment Period|Site closed by investigator|0
1814819|NCT00439777|6301172|P2|Treatment Period|Study terminated by sponsor|132
1814820|NCT00439777|6301173|P1|Treatment Period|Study terminated by sponsor|125
1814821|NCT00439777|6301172|P2|Treatment Period|Death|21
1814822|NCT00439777|6301173|P1|Treatment Period|Death|29
1814823|NCT00439738|6301211|P2|Overall Study|Abnormal Lab Values|0
1814824|NCT00439738|6301212|P1|Overall Study|Abnormal Lab Values|1
1814825|NCT00439738|6301211|P2|Overall Study|Lack of Efficacy|2
1814826|NCT00439738|6301212|P1|Overall Study|Lack of Efficacy|2
1814827|NCT00439738|6301211|P2|Overall Study|Protocol Violation|3
1814828|NCT00439738|6301212|P1|Overall Study|Protocol Violation|6
1814829|NCT00439738|6301211|P2|Overall Study|Lost to Follow-up|6
1814830|NCT00439738|6301212|P1|Overall Study|Lost to Follow-up|5
1814831|NCT00439738|6301211|P2|Overall Study|Adverse Event|4
1814832|NCT00439738|6301212|P1|Overall Study|Adverse Event|6
1814833|NCT00439738|6301211|P2|Overall Study|Withdrawal by Subject|13
1814834|NCT00439738|6301212|P1|Overall Study|Withdrawal by Subject|16
1814835|NCT00439725|6301230|P2|Observational Period|Participant convenience|0
1814836|NCT00439725|6301231|P1|Observational Period|Participant convenience|1
1814837|NCT00439725|6301230|P2|Observational Period|Technical problems|0
1814838|NCT00439725|6301231|P1|Observational Period|Technical problems|1
1814839|NCT00439725|6301230|P2|Observational Period|Clinical endpoint reached|1
1814840|NCT00439725|6301231|P1|Observational Period|Clinical endpoint reached|3
1814841|NCT00439725|6301230|P2|Observational Period|Study termination by sponsor|1
1814842|NCT00439725|6301231|P1|Observational Period|Study termination by sponsor|1
1814843|NCT00439725|6301230|P2|Observational Period|Death|2
1814844|NCT00439725|6301231|P1|Observational Period|Death|0
1814845|NCT00439725|6301230|P2|Observational Period|Lost to Follow-up|1
1814846|NCT00439725|6301231|P1|Observational Period|Lost to Follow-up|0
1814847|NCT00439725|6301230|P2|Observational Period|Withdrawal by Subject|2
1814848|NCT00439725|6301231|P1|Observational Period|Withdrawal by Subject|2
1814849|NCT00439725|6301230|P2|Treatment Period|Participant did not receive treatment|4
1814850|NCT00439725|6301231|P1|Treatment Period|Participant did not receive treatment|4
1814851|NCT00439725|6301230|P2|Treatment Period|Death|1
1814852|NCT00439725|6301231|P1|Treatment Period|Death|1
1814853|NCT00439725|6301230|P2|Treatment Period|Protocol driven decision point|1
1814854|NCT00439725|6301231|P1|Treatment Period|Protocol driven decision point|1
1814855|NCT00439725|6301230|P2|Treatment Period|Participant convenience|0
1814856|NCT00439725|6301231|P1|Treatment Period|Participant convenience|1
1814857|NCT00439725|6301230|P2|Treatment Period|Lost to Follow-up|1
1814858|NCT00439725|6301231|P1|Treatment Period|Lost to Follow-up|1
1814859|NCT00439725|6301230|P2|Treatment Period|Technical problems|0
1814860|NCT00439725|6301231|P1|Treatment Period|Technical problems|1
1814861|NCT00439725|6301230|P2|Treatment Period|Clinical endpoint reached|50
1814862|NCT00439725|6301231|P1|Treatment Period|Clinical endpoint reached|6
1814863|NCT00439725|6301230|P2|Treatment Period|Protocol Violation|1
1814864|NCT00439725|6301231|P1|Treatment Period|Protocol Violation|2
1814865|NCT00439725|6301230|P2|Treatment Period|Physician Decision|1
1814866|NCT00439725|6301231|P1|Treatment Period|Physician Decision|1
1814867|NCT00439725|6301230|P2|Treatment Period|Adverse Event|18
1814868|NCT00439725|6301231|P1|Treatment Period|Adverse Event|39
1814869|NCT00439725|6301230|P2|Treatment Period|Site closed by investigator|2
1814870|NCT00439725|6301231|P1|Treatment Period|Site closed by investigator|1
1814871|NCT00439725|6301230|P2|Treatment Period|Study terminated by sponsor|148
1814872|NCT00439725|6301231|P1|Treatment Period|Study terminated by sponsor|156
1814873|NCT00439725|6301230|P2|Treatment Period|Withdrawal by Subject|19
1814874|NCT00439725|6301231|P1|Treatment Period|Withdrawal by Subject|22
1814875|NCT00439647|6301282|P2|Overall Study|Lack of Efficacy|4
1814876|NCT00439647|6301283|P1|Overall Study|Lack of Efficacy|0
1814877|NCT00439647|6301282|P2|Overall Study|Protocol Violation|4
1814878|NCT00439647|6301283|P1|Overall Study|Protocol Violation|3
1814879|NCT00439647|6301282|P2|Overall Study|Lost to Follow-up|12
1814880|NCT00439647|6301283|P1|Overall Study|Lost to Follow-up|4
1814881|NCT00439647|6301282|P2|Overall Study|Adverse Event|11
1814882|NCT00439647|6301283|P1|Overall Study|Adverse Event|11
1814883|NCT00439647|6301282|P2|Overall Study|Death|18
1814884|NCT00439647|6301283|P1|Overall Study|Death|15
1814885|NCT00439647|6301282|P2|Overall Study|Withdrawal by Subject|22
1814886|NCT00439647|6301283|P1|Overall Study|Withdrawal by Subject|25
1814887|NCT00439569|6301320|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
1814888|NCT00439569|6301320|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
1814889|NCT00439569|6301320|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
1814890|NCT00439556|6301334|P3|Overall Study|Patient was taken off study for non-comp|0
1814891|NCT00439556|6301335|P2|Overall Study|Patient was taken off study for non-comp|1
1814892|NCT00439556|6301336|P1|Overall Study|Patient was taken off study for non-comp|0
1814893|NCT00439517|6301349|P2|Overall Study|Subject in survival follow-up|0
1814894|NCT00439517|6301350|P1|Overall Study|Subject in survival follow-up|1
1814895|NCT00439517|6301349|P2|Overall Study|Subject on treatment|0
1814896|NCT00439517|6301350|P1|Overall Study|Subject on treatment|1
1814897|NCT00439309|6301489|P2|Follow-Up|Late response by subject|1
1814898|NCT00439309|6301490|P1|Follow-Up|Late response by subject|0
1814899|NCT00439309|6301489|P2|Follow-Up|Withdrawal by Subject|1
1814900|NCT00439309|6301490|P1|Follow-Up|Withdrawal by Subject|0
1814901|NCT00439309|6301489|P2|Follow-Up|Lost to Follow-up|0
1814902|NCT00439309|6301490|P1|Follow-Up|Lost to Follow-up|2
1814903|NCT00439309|6301489|P2|Follow-Up|Death|0
1814904|NCT00439309|6301490|P1|Follow-Up|Death|1
1814905|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1814906|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
1814907|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1814908|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1814909|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
1814910|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1814911|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
1814912|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1814913|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1814914|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
1814915|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1814916|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
1814917|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1814918|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1814919|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
1814920|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
1814921|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
1814922|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
1814923|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
1814924|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
1814925|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1814926|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
1814927|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1814928|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1814929|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
1814930|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
1814931|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
1814932|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
1814933|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
1814934|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
1814935|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1814936|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
1814937|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1814938|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1814939|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
1814940|NCT00439270|6301509|P5|Phase 2 (51.6 Months)|Disease progression|0
1814941|NCT00439270|6301510|P4|Phase 2 (51.6 Months)|Disease progression|18
1814942|NCT00439270|6301511|P3|Phase 2 (51.6 Months)|Disease progression|0
1814943|NCT00439270|6301512|P2|Phase 2 (51.6 Months)|Disease progression|0
1814944|NCT00439270|6301513|P1|Phase 2 (51.6 Months)|Disease progression|0
1814945|NCT00439270|6301509|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
1814946|NCT00439270|6301510|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
1814947|NCT00439270|6301511|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
1814948|NCT00439270|6301512|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
1814949|NCT00439270|6301513|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
1814950|NCT00439270|6301509|P5|Phase 1 (18.1 Months)|Disease progression|3
1814951|NCT00439270|6301510|P4|Phase 1 (18.1 Months)|Disease progression|0
1814952|NCT00439270|6301511|P3|Phase 1 (18.1 Months)|Disease progression|3
1814953|NCT00439270|6301512|P2|Phase 1 (18.1 Months)|Disease progression|2
1814954|NCT00439270|6301513|P1|Phase 1 (18.1 Months)|Disease progression|3
1814955|NCT00439244|6301555|P3|Overall Study|Administrative problems|0
1814956|NCT00439244|6301556|P2|Overall Study|Administrative problems|0
1814957|NCT00439244|6301557|P1|Overall Study|Administrative problems|1
1814958|NCT00439244|6301555|P3|Overall Study|Protocol Violation|0
1814959|NCT00439244|6301556|P2|Overall Study|Protocol Violation|1
1814960|NCT00439244|6301557|P1|Overall Study|Protocol Violation|0
1814961|NCT00439244|6301555|P3|Overall Study|Death|0
1814962|NCT00439244|6301556|P2|Overall Study|Death|1
1814963|NCT00439244|6301557|P1|Overall Study|Death|0
1814964|NCT00439244|6301555|P3|Overall Study|Lost to Follow-up|2
1814965|NCT00439244|6301556|P2|Overall Study|Lost to Follow-up|1
1814966|NCT00439244|6301557|P1|Overall Study|Lost to Follow-up|2
1814967|NCT00439244|6301555|P3|Overall Study|Withdrawal by Subject|2
1814968|NCT00439244|6301556|P2|Overall Study|Withdrawal by Subject|1
1814969|NCT00439244|6301557|P1|Overall Study|Withdrawal by Subject|3
1814970|NCT00439244|6301555|P3|Overall Study|Adverse Event|3
1814971|NCT00439244|6301556|P2|Overall Study|Adverse Event|2
1814972|NCT00439244|6301557|P1|Overall Study|Adverse Event|5
1814973|NCT00439231|6301577|P1|Overall Study|Lack of Efficacy|28
1814974|NCT00439218|6301581|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
1814979|NCT00439140|6301616|P3|Treatment Cycle 2|Lost to Follow-up|0
1814980|NCT00439140|6301617|P2|Treatment Cycle 2|Lost to Follow-up|1
1814981|NCT00439140|6301618|P1|Treatment Cycle 2|Lost to Follow-up|1
1814982|NCT00439140|6301616|P3|Treatment Cycle 2|Withdrawal by Subject|0
1814983|NCT00439140|6301617|P2|Treatment Cycle 2|Withdrawal by Subject|0
1814984|NCT00439140|6301618|P1|Treatment Cycle 2|Withdrawal by Subject|1
1814985|NCT00439140|6301616|P3|Treatment Cycle 1|Withdrawal by Subject|0
1814986|NCT00439140|6301617|P2|Treatment Cycle 1|Withdrawal by Subject|1
1814987|NCT00439140|6301618|P1|Treatment Cycle 1|Withdrawal by Subject|0
1814988|NCT00439140|6301616|P3|Treatment Cycle 1|Personal reasons|0
1814989|NCT00439140|6301617|P2|Treatment Cycle 1|Personal reasons|2
1814990|NCT00439140|6301618|P1|Treatment Cycle 1|Personal reasons|0
1814991|NCT00439140|6301616|P3|Treatment Cycle 1|Lost to Follow-up|1
1814992|NCT00439140|6301617|P2|Treatment Cycle 1|Lost to Follow-up|1
1814993|NCT00439140|6301618|P1|Treatment Cycle 1|Lost to Follow-up|1
1814994|NCT00438815|6301701|P1|Overall Study|Death|1
1814995|NCT00438815|6301701|P1|Overall Study|Withdrawal by Subject|6
1814996|NCT00438815|6301701|P1|Overall Study|Lost to Follow-up|6
1814997|NCT00438815|6301701|P1|Overall Study|Transitioned to commercial C1INH-nf|6
1815167|NCT00437281|6302186|P4|Overall Study|Adverse Event|1
1814998|NCT00438815|6301701|P1|Overall Study|Noncompliance with protocol requirements|9
1814999|NCT00438815|6301701|P1|Overall Study|3-month follow-up no longer required|12
1815000|NCT00438815|6301701|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
1815001|NCT00438672|6301751|P2|Overall Study|Lost to Follow-up|9
1815002|NCT00438672|6301752|P1|Overall Study|Lost to Follow-up|7
1815003|NCT00438659|6301762|P2|Overall Study|Cancel|2
1815004|NCT00438659|6301763|P1|Overall Study|Cancel|5
1815005|NCT00438659|6301762|P2|Overall Study|Discontinued Mometasone/Placebo|2
1815006|NCT00438659|6301763|P1|Overall Study|Discontinued Mometasone/Placebo|1
1815007|NCT00438633|6301787|P2|Overall Study|Lost to Follow-up|17
1815008|NCT00438633|6301788|P1|Overall Study|Lost to Follow-up|15
1815009|NCT00438633|6301787|P2|Overall Study|Withdrawal by Subject|0
1815010|NCT00438633|6301788|P1|Overall Study|Withdrawal by Subject|1
1815011|NCT00438464|6301819|P2|Overall Study|Incomplete data submission|2
1815012|NCT00438464|6301820|P1|Overall Study|Incomplete data submission|0
1815013|NCT00438464|6301819|P2|Overall Study|Terminated Early|5
1815014|NCT00438464|6301820|P1|Overall Study|Terminated Early|14
1815015|NCT00438399|6301921|P6|Overall Study|Patien stopped study at visit 4 by error|0
1815016|NCT00438399|6301922|P5|Overall Study|Patien stopped study at visit 4 by error|0
1815017|NCT00438399|6301923|P4|Overall Study|Patien stopped study at visit 4 by error|0
1815018|NCT00438399|6301924|P3|Overall Study|Patien stopped study at visit 4 by error|0
1815019|NCT00438399|6301925|P2|Overall Study|Patien stopped study at visit 4 by error|0
1815020|NCT00438399|6301926|P1|Overall Study|Patien stopped study at visit 4 by error|1
1815021|NCT00438399|6301921|P6|Overall Study|Pregnancy|1
1815022|NCT00438399|6301922|P5|Overall Study|Pregnancy|0
1815023|NCT00438399|6301923|P4|Overall Study|Pregnancy|0
1815024|NCT00438399|6301924|P3|Overall Study|Pregnancy|0
1815025|NCT00438399|6301925|P2|Overall Study|Pregnancy|0
1815026|NCT00438399|6301926|P1|Overall Study|Pregnancy|0
1815027|NCT00438399|6301921|P6|Overall Study|Subje stopped study|0
1815028|NCT00438399|6301922|P5|Overall Study|Subje stopped study|0
1815029|NCT00438399|6301923|P4|Overall Study|Subje stopped study|0
1815030|NCT00438399|6301924|P3|Overall Study|Subje stopped study|1
1815031|NCT00438399|6301925|P2|Overall Study|Subje stopped study|0
1815032|NCT00438399|6301926|P1|Overall Study|Subje stopped study|0
1815033|NCT00438399|6301921|P6|Overall Study|Protocol Violation|1
1815034|NCT00438399|6301922|P5|Overall Study|Protocol Violation|0
1815035|NCT00438399|6301923|P4|Overall Study|Protocol Violation|0
1815036|NCT00438399|6301924|P3|Overall Study|Protocol Violation|1
1815037|NCT00438399|6301925|P2|Overall Study|Protocol Violation|0
1815038|NCT00438399|6301926|P1|Overall Study|Protocol Violation|0
1815039|NCT00438399|6301921|P6|Overall Study|Withdrawal by Subject|2
1815040|NCT00438399|6301922|P5|Overall Study|Withdrawal by Subject|2
1815041|NCT00438399|6301923|P4|Overall Study|Withdrawal by Subject|2
1815042|NCT00438399|6301924|P3|Overall Study|Withdrawal by Subject|3
1815043|NCT00438399|6301925|P2|Overall Study|Withdrawal by Subject|6
1815044|NCT00438399|6301926|P1|Overall Study|Withdrawal by Subject|5
1815045|NCT00438399|6301921|P6|Overall Study|Adverse Event|1
1815046|NCT00438399|6301922|P5|Overall Study|Adverse Event|0
1815047|NCT00438399|6301923|P4|Overall Study|Adverse Event|1
1815048|NCT00438399|6301924|P3|Overall Study|Adverse Event|1
1815049|NCT00438399|6301925|P2|Overall Study|Adverse Event|0
1815050|NCT00438399|6301926|P1|Overall Study|Adverse Event|0
1815051|NCT00438399|6301921|P6|Overall Study|Lost to Follow-up|1
1815052|NCT00438399|6301922|P5|Overall Study|Lost to Follow-up|1
1815053|NCT00438399|6301923|P4|Overall Study|Lost to Follow-up|1
1815054|NCT00438399|6301924|P3|Overall Study|Lost to Follow-up|1
1815055|NCT00438399|6301925|P2|Overall Study|Lost to Follow-up|2
1815056|NCT00438399|6301926|P1|Overall Study|Lost to Follow-up|2
1815057|NCT00438360|6301937|P2|Overall Study|Other|15
1815058|NCT00438360|6301938|P1|Overall Study|Other|24
1815059|NCT00438360|6301937|P2|Overall Study|Lack of Efficacy|27
1815060|NCT00438360|6301938|P1|Overall Study|Lack of Efficacy|42
1815061|NCT00438360|6301937|P2|Overall Study|Adverse Event|1
1815062|NCT00438360|6301938|P1|Overall Study|Adverse Event|6
1815063|NCT00438256|6301952|P4|Overall Study|Excluded final Diagnosis|2
1815064|NCT00438256|6301953|P3|Overall Study|Excluded final Diagnosis|0
1815065|NCT00438256|6301954|P2|Overall Study|Excluded final Diagnosis|0
1815066|NCT00438256|6301955|P1|Overall Study|Excluded final Diagnosis|0
1815067|NCT00438256|6301952|P4|Overall Study|Ineligible for Resection|7
1815068|NCT00438256|6301953|P3|Overall Study|Ineligible for Resection|1
1815069|NCT00438256|6301954|P2|Overall Study|Ineligible for Resection|1
1815070|NCT00438256|6301955|P1|Overall Study|Ineligible for Resection|2
1815071|NCT00437983|6302005|P2|Overall Study|Withdrawal by Subject|6
1815072|NCT00437983|6302006|P1|Overall Study|Withdrawal by Subject|5
1815073|NCT00437983|6302005|P2|Overall Study|Protocol Violation|1
1815074|NCT00437983|6302006|P1|Overall Study|Protocol Violation|2
1815075|NCT00437983|6302005|P2|Overall Study|Adverse Event|6
1815076|NCT00437983|6302006|P1|Overall Study|Adverse Event|6
1815077|NCT00437658|6302019|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
1815078|NCT00437658|6302020|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
1815079|NCT00437658|6302021|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
1815080|NCT00437658|6302019|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
1815081|NCT00437658|6302020|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
1815082|NCT00437658|6302021|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
1815083|NCT00437658|6302019|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
1815084|NCT00437658|6302020|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
1815085|NCT00437658|6302021|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
1815086|NCT00437658|6302019|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
1815087|NCT00437658|6302020|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
1815088|NCT00437658|6302021|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
1815089|NCT00437658|6302019|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
1815090|NCT00437658|6302020|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
1815091|NCT00437658|6302021|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
1815092|NCT00437658|6302019|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
1815093|NCT00437658|6302020|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
1815094|NCT00437658|6302021|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
1815095|NCT00437658|6302019|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
1815096|NCT00437658|6302020|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
1815097|NCT00437658|6302021|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
1815098|NCT00437658|6302019|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
1815099|NCT00437658|6302020|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
1815100|NCT00437658|6302021|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
1815101|NCT00437658|6302019|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
1815102|NCT00437658|6302020|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
1815103|NCT00437658|6302021|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
1815104|NCT00437658|6302019|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
1815105|NCT00437658|6302020|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
1815106|NCT00437658|6302021|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
1815107|NCT00437658|6302019|P3|Treatment Period (24 Weeks)|Non-compliance|4
1815108|NCT00437658|6302020|P2|Treatment Period (24 Weeks)|Non-compliance|1
1815109|NCT00437658|6302021|P1|Treatment Period (24 Weeks)|Non-compliance|1
1815110|NCT00437658|6302019|P3|Treatment Period (24 Weeks)|Adverse Event|14
1815111|NCT00437658|6302020|P2|Treatment Period (24 Weeks)|Adverse Event|7
1815112|NCT00437658|6302021|P1|Treatment Period (24 Weeks)|Adverse Event|4
1815113|NCT00437645|6302115|P2|Overall Study|Condition no longer requires study drug|1
1815114|NCT00437645|6302116|P1|Overall Study|Condition no longer requires study drug|1
1815115|NCT00437645|6302115|P2|Overall Study|Lack of Efficacy|1
1815116|NCT00437645|6302116|P1|Overall Study|Lack of Efficacy|2
1815117|NCT00437645|6302115|P2|Overall Study|Administrative problems|1
1815118|NCT00437645|6302116|P1|Overall Study|Administrative problems|2
1815119|NCT00437645|6302115|P2|Overall Study|Lost to Follow-up|3
1815120|NCT00437645|6302116|P1|Overall Study|Lost to Follow-up|2
1815121|NCT00437645|6302115|P2|Overall Study|Protocol Violation|3
1815122|NCT00437645|6302116|P1|Overall Study|Protocol Violation|3
1815123|NCT00437645|6302115|P2|Overall Study|Withdrawal by Subject|22
1815124|NCT00437645|6302116|P1|Overall Study|Withdrawal by Subject|10
1815125|NCT00437645|6302115|P2|Overall Study|Adverse Event|84
1815126|NCT00437645|6302116|P1|Overall Study|Adverse Event|15
1815127|NCT00437489|6302132|P2|Overall Study|Lost to Follow-up|1
1815128|NCT00437489|6302133|P1|Overall Study|Lost to Follow-up|0
1815129|NCT00437489|6302132|P2|Overall Study|Study terminated by sponsor|21
1815130|NCT00437489|6302133|P1|Overall Study|Study terminated by sponsor|23
1815131|NCT00437281|6302170|P20|Overall Study|Lost to Follow-up|1
1815132|NCT00437281|6302171|P19|Overall Study|Lost to Follow-up|0
1815133|NCT00437281|6302172|P18|Overall Study|Lost to Follow-up|0
1815134|NCT00437281|6302173|P17|Overall Study|Lost to Follow-up|0
1815135|NCT00437281|6302174|P16|Overall Study|Lost to Follow-up|0
1815136|NCT00437281|6302175|P15|Overall Study|Lost to Follow-up|0
1815137|NCT00437281|6302176|P14|Overall Study|Lost to Follow-up|0
1815138|NCT00437281|6302177|P13|Overall Study|Lost to Follow-up|0
1815139|NCT00437281|6302178|P12|Overall Study|Lost to Follow-up|0
1815140|NCT00437281|6302179|P11|Overall Study|Lost to Follow-up|0
1815141|NCT00437281|6302180|P10|Overall Study|Lost to Follow-up|0
1815142|NCT00437281|6302181|P9|Overall Study|Lost to Follow-up|0
1815143|NCT00437281|6302182|P8|Overall Study|Lost to Follow-up|0
1815144|NCT00437281|6302183|P7|Overall Study|Lost to Follow-up|0
1815145|NCT00437281|6302184|P6|Overall Study|Lost to Follow-up|0
1815146|NCT00437281|6302185|P5|Overall Study|Lost to Follow-up|0
1815147|NCT00437281|6302186|P4|Overall Study|Lost to Follow-up|0
1815148|NCT00437281|6302187|P3|Overall Study|Lost to Follow-up|0
1815149|NCT00437281|6302188|P2|Overall Study|Lost to Follow-up|0
1815150|NCT00437281|6302189|P1|Overall Study|Lost to Follow-up|0
1815151|NCT00437281|6302170|P20|Overall Study|Adverse Event|0
1815152|NCT00437281|6302171|P19|Overall Study|Adverse Event|1
1815153|NCT00437281|6302172|P18|Overall Study|Adverse Event|0
1815154|NCT00437281|6302173|P17|Overall Study|Adverse Event|0
1815155|NCT00437281|6302174|P16|Overall Study|Adverse Event|0
1815156|NCT00437281|6302175|P15|Overall Study|Adverse Event|1
1815157|NCT00437281|6302176|P14|Overall Study|Adverse Event|1
1815158|NCT00437281|6302177|P13|Overall Study|Adverse Event|0
1815159|NCT00437281|6302178|P12|Overall Study|Adverse Event|0
1815160|NCT00437281|6302179|P11|Overall Study|Adverse Event|0
1815161|NCT00437281|6302180|P10|Overall Study|Adverse Event|1
1815162|NCT00437281|6302181|P9|Overall Study|Adverse Event|0
1815163|NCT00437281|6302182|P8|Overall Study|Adverse Event|0
1815164|NCT00437281|6302183|P7|Overall Study|Adverse Event|0
1815165|NCT00437281|6302184|P6|Overall Study|Adverse Event|1
1815166|NCT00437281|6302185|P5|Overall Study|Adverse Event|0
1815168|NCT00437281|6302187|P3|Overall Study|Adverse Event|0
1815169|NCT00437281|6302188|P2|Overall Study|Adverse Event|0
1815170|NCT00437281|6302189|P1|Overall Study|Adverse Event|0
1815171|NCT00437203|6302493|P10|Overall Study|Other|0
1815172|NCT00437203|6302494|P9|Overall Study|Other|0
1815173|NCT00437203|6302495|P8|Overall Study|Other|0
1815174|NCT00437203|6302496|P7|Overall Study|Other|1
1815175|NCT00437203|6302497|P6|Overall Study|Other|0
1815176|NCT00437203|6302498|P5|Overall Study|Other|0
1815177|NCT00437203|6302499|P4|Overall Study|Other|0
1815178|NCT00437203|6302500|P3|Overall Study|Other|0
1815179|NCT00437203|6302501|P2|Overall Study|Other|1
1815180|NCT00437203|6302502|P1|Overall Study|Other|0
1815181|NCT00437203|6302493|P10|Overall Study|Objective progression or relapse|2
1815182|NCT00437203|6302494|P9|Overall Study|Objective progression or relapse|2
1815183|NCT00437203|6302495|P8|Overall Study|Objective progression or relapse|1
1815184|NCT00437203|6302496|P7|Overall Study|Objective progression or relapse|6
1815185|NCT00437203|6302497|P6|Overall Study|Objective progression or relapse|3
1815186|NCT00437203|6302498|P5|Overall Study|Objective progression or relapse|3
1815187|NCT00437203|6302499|P4|Overall Study|Objective progression or relapse|3
1815188|NCT00437203|6302500|P3|Overall Study|Objective progression or relapse|2
1815189|NCT00437203|6302501|P2|Overall Study|Objective progression or relapse|6
1815190|NCT00437203|6302502|P1|Overall Study|Objective progression or relapse|5
1815191|NCT00437203|6302493|P10|Overall Study|Study terminated by sponsor|0
1815192|NCT00437203|6302494|P9|Overall Study|Study terminated by sponsor|1
1815193|NCT00437203|6302495|P8|Overall Study|Study terminated by sponsor|0
1815194|NCT00437203|6302496|P7|Overall Study|Study terminated by sponsor|0
1815195|NCT00437203|6302497|P6|Overall Study|Study terminated by sponsor|0
1815196|NCT00437203|6302498|P5|Overall Study|Study terminated by sponsor|0
1815197|NCT00437203|6302499|P4|Overall Study|Study terminated by sponsor|0
1815198|NCT00437203|6302500|P3|Overall Study|Study terminated by sponsor|0
1815199|NCT00437203|6302501|P2|Overall Study|Study terminated by sponsor|0
1815200|NCT00437203|6302502|P1|Overall Study|Study terminated by sponsor|0
1815201|NCT00437203|6302493|P10|Overall Study|Adverse Event|1
1815202|NCT00437203|6302494|P9|Overall Study|Adverse Event|0
1815203|NCT00437203|6302495|P8|Overall Study|Adverse Event|1
1815204|NCT00437203|6302496|P7|Overall Study|Adverse Event|0
1815205|NCT00437203|6302497|P6|Overall Study|Adverse Event|0
1815206|NCT00437203|6302498|P5|Overall Study|Adverse Event|0
1815207|NCT00437203|6302499|P4|Overall Study|Adverse Event|0
1815208|NCT00437203|6302500|P3|Overall Study|Adverse Event|0
1815209|NCT00437203|6302501|P2|Overall Study|Adverse Event|1
1815210|NCT00437203|6302502|P1|Overall Study|Adverse Event|1
1815211|NCT00437203|6302493|P10|Overall Study|Death|1
1815212|NCT00437203|6302494|P9|Overall Study|Death|0
1815213|NCT00437203|6302495|P8|Overall Study|Death|1
1815214|NCT00437203|6302496|P7|Overall Study|Death|0
1815215|NCT00437203|6302497|P6|Overall Study|Death|0
1815216|NCT00437203|6302498|P5|Overall Study|Death|0
1815217|NCT00437203|6302499|P4|Overall Study|Death|0
1815218|NCT00437203|6302500|P3|Overall Study|Death|1
1815219|NCT00437203|6302501|P2|Overall Study|Death|0
1815220|NCT00437203|6302502|P1|Overall Study|Death|0
1815221|NCT00437125|6302606|P1|Overall Study|Physician Decision|1
1815222|NCT00437125|6302606|P1|Overall Study|Withdrawal by Caregiver|2
1815223|NCT00437125|6302606|P1|Overall Study|Withdrawal by Subject|13
1815224|NCT00437125|6302606|P1|Overall Study|Lost to Follow-up|1
1815225|NCT00437125|6302606|P1|Overall Study|Lack of Efficacy|1
1815226|NCT00437125|6302606|P1|Overall Study|Clinical Relapse|1
1815227|NCT00437125|6302606|P1|Overall Study|Death|1
1815228|NCT00437125|6302606|P1|Overall Study|Adverse Event|12
1815229|NCT00437073|6302627|P2|Overall Study|Physician Decision|1
1815230|NCT00437073|6302628|P1|Overall Study|Physician Decision|0
1815231|NCT00437073|6302627|P2|Overall Study|Sponsor Terminated Study|0
1815232|NCT00437073|6302628|P1|Overall Study|Sponsor Terminated Study|1
1815233|NCT00437034|6302656|P1|Overall Study|Disease progression during treatment|5
1815234|NCT00437034|6302656|P1|Overall Study|Adverse Event|1
1815235|NCT00436982|6302662|P2|Overall Study|no RSA data|2
1815236|NCT00436982|6302663|P1|Overall Study|no RSA data|1
1815237|NCT00436982|6302662|P2|Overall Study|Did not receive allocated intervention|1
1815238|NCT00436982|6302663|P1|Overall Study|Did not receive allocated intervention|0
1815239|NCT00436982|6302662|P2|Overall Study|Withdrawal by Subject|1
1815240|NCT00436982|6302663|P1|Overall Study|Withdrawal by Subject|3
1815241|NCT00436956|6302734|P2|Overall Study|Not evaluable|0
1815242|NCT00436956|6302735|P1|Overall Study|Not evaluable|1
1815243|NCT00436917|6302749|P1|Overall Study|Personal conflicts of patient|1
1815244|NCT00436917|6302749|P1|Overall Study|Increased creatinine|1
1815245|NCT00436917|6302749|P1|Overall Study|Treatment for polymyalgia rheumatic|1
1815246|NCT00436917|6302749|P1|Overall Study|Lost to Follow-up|1
1815247|NCT00436917|6302749|P1|Overall Study|Death|1
1815248|NCT00436917|6302749|P1|Overall Study|Physician Decision|1
1815249|NCT00436917|6302749|P1|Overall Study|Adverse Event|2
1815250|NCT00436917|6302749|P1|Overall Study|Withdrawal by Subject|13
1815251|NCT00436852|6302775|P2|Overall Study|Ineligible|0
1815252|NCT00436852|6302776|P1|Overall Study|Ineligible|1
1815253|NCT00436852|6302775|P2|Overall Study|Withdrawal by Subject|4
1815254|NCT00436852|6302776|P1|Overall Study|Withdrawal by Subject|2
1815255|NCT00436852|6302775|P2|Overall Study|Lack of Efficacy|7
1815256|NCT00436852|6302776|P1|Overall Study|Lack of Efficacy|9
1815257|NCT00436852|6302775|P2|Overall Study|Death|34
1815258|NCT00436852|6302776|P1|Overall Study|Death|23
1815259|NCT00436826|6302795|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
1815260|NCT00436826|6302796|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
1815261|NCT00436826|6302797|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1815262|NCT00436826|6302798|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1815263|NCT00436826|6302799|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1815264|NCT00436826|6302800|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
1815265|NCT00436826|6302795|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1815266|NCT00436826|6302796|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1815267|NCT00436826|6302797|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
1815268|NCT00436826|6302798|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
1815269|NCT00436826|6302799|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1815270|NCT00436826|6302800|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
1815271|NCT00436826|6302795|P6|Double Blind Period|Other|0
1815272|NCT00436826|6302796|P5|Double Blind Period|Other|0
1815273|NCT00436826|6302797|P4|Double Blind Period|Other|0
1815274|NCT00436826|6302798|P3|Double Blind Period|Other|0
1815275|NCT00436826|6302799|P2|Double Blind Period|Other|11
1815276|NCT00436826|6302800|P1|Double Blind Period|Other|10
1815277|NCT00436826|6302795|P6|Double Blind Period|Protocol Violation|0
1815278|NCT00436826|6302796|P5|Double Blind Period|Protocol Violation|0
1815279|NCT00436826|6302797|P4|Double Blind Period|Protocol Violation|0
1815280|NCT00436826|6302798|P3|Double Blind Period|Protocol Violation|0
1815281|NCT00436826|6302799|P2|Double Blind Period|Protocol Violation|0
1815282|NCT00436826|6302800|P1|Double Blind Period|Protocol Violation|1
1815283|NCT00436826|6302795|P6|Double Blind Period|Adverse Event|0
1815284|NCT00436826|6302796|P5|Double Blind Period|Adverse Event|0
1815285|NCT00436826|6302797|P4|Double Blind Period|Adverse Event|0
1815286|NCT00436826|6302798|P3|Double Blind Period|Adverse Event|0
1815287|NCT00436826|6302799|P2|Double Blind Period|Adverse Event|0
1815288|NCT00436826|6302800|P1|Double Blind Period|Adverse Event|2
1815289|NCT00436748|6302822|P2|Overall Study|Other|0
1815290|NCT00436748|6302823|P1|Overall Study|Other|3
1815291|NCT00436748|6302822|P2|Overall Study|Protocol-specified Criteria|4
1815292|NCT00436748|6302823|P1|Overall Study|Protocol-specified Criteria|5
1815293|NCT00436748|6302822|P2|Overall Study|Lost to Follow-up|1
1815294|NCT00436748|6302823|P1|Overall Study|Lost to Follow-up|0
1815295|NCT00436748|6302822|P2|Overall Study|Administrative Decision|0
1815296|NCT00436748|6302823|P1|Overall Study|Administrative Decision|1
1815297|NCT00436748|6302822|P2|Overall Study|Consent Withdrawn|4
1815298|NCT00436748|6302823|P1|Overall Study|Consent Withdrawn|1
1815299|NCT00436748|6302822|P2|Overall Study|Adverse Event|2
1815300|NCT00436748|6302823|P1|Overall Study|Adverse Event|0
1815301|NCT00436748|6302822|P2|Overall Study|Ineligibility Determined|1
1815302|NCT00436748|6302823|P1|Overall Study|Ineligibility Determined|1
1815303|NCT00436644|6302857|P1|Overall Study|Death|1
1815304|NCT00436644|6302857|P1|Overall Study|Adverse Event|2
1815305|NCT00436618|6302867|P3|Overall Study|Still on treatment|7
1815306|NCT00436618|6302868|P2|Overall Study|Still on treatment|2
1815307|NCT00436618|6302869|P1|Overall Study|Still on treatment|1
1815308|NCT00436618|6302867|P3|Overall Study|New Primary or Other Reasons|12
1815309|NCT00436618|6302868|P2|Overall Study|New Primary or Other Reasons|2
1815310|NCT00436618|6302869|P1|Overall Study|New Primary or Other Reasons|6
1815311|NCT00436618|6302867|P3|Overall Study|Death|3
1815312|NCT00436618|6302868|P2|Overall Study|Death|2
1815313|NCT00436618|6302869|P1|Overall Study|Death|4
1815314|NCT00436618|6302867|P3|Overall Study|Other Medical Problems|7
1815315|NCT00436618|6302868|P2|Overall Study|Other Medical Problems|1
1815316|NCT00436618|6302869|P1|Overall Study|Other Medical Problems|3
1815317|NCT00436618|6302867|P3|Overall Study|Alternate Treatment|12
1815318|NCT00436618|6302868|P2|Overall Study|Alternate Treatment|4
1815319|NCT00436618|6302869|P1|Overall Study|Alternate Treatment|3
1815320|NCT00436618|6302867|P3|Overall Study|Adverse Event|9
1815321|NCT00436618|6302868|P2|Overall Study|Adverse Event|8
1815322|NCT00436618|6302869|P1|Overall Study|Adverse Event|8
1815323|NCT00436618|6302867|P3|Overall Study|Withdrawal by Subject|11
1815324|NCT00436618|6302868|P2|Overall Study|Withdrawal by Subject|8
1815325|NCT00436618|6302869|P1|Overall Study|Withdrawal by Subject|5
1815326|NCT00436605|6302886|P1|Overall Study|Protocol Violation|3
1815327|NCT00436566|6302891|P1|Overall Study|Protocol Violation|1
1815328|NCT00436566|6302891|P1|Overall Study|Withdrawal by Subject|2
1815329|NCT00436553|6302898|P3|Overall Study|Withdrawal by Subject|3
1815330|NCT00436553|6302899|P2|Overall Study|Withdrawal by Subject|6
1815331|NCT00436553|6302900|P1|Overall Study|Withdrawal by Subject|5
1815332|NCT00436553|6302898|P3|Overall Study|Protocol Violation|0
1815333|NCT00436553|6302899|P2|Overall Study|Protocol Violation|0
1815334|NCT00436553|6302900|P1|Overall Study|Protocol Violation|1
1815335|NCT00436553|6302898|P3|Overall Study|Lost to Follow-up|0
1815336|NCT00436553|6302899|P2|Overall Study|Lost to Follow-up|2
1815337|NCT00436553|6302900|P1|Overall Study|Lost to Follow-up|0
1815338|NCT00436553|6302898|P3|Overall Study|Death|3
1815339|NCT00436553|6302899|P2|Overall Study|Death|1
1815340|NCT00436553|6302900|P1|Overall Study|Death|3
1815341|NCT00436553|6302898|P3|Overall Study|Adverse Event|4
1815342|NCT00436553|6302899|P2|Overall Study|Adverse Event|3
1815343|NCT00436553|6302900|P1|Overall Study|Adverse Event|4
1815344|NCT00436501|6302921|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
1815345|NCT00436501|6302922|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
1815346|NCT00436501|6302921|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
1815347|NCT00436501|6302922|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
1815348|NCT00436436|6302958|P1|Overall Study|Death|6
1815349|NCT00436436|6302958|P1|Overall Study|Adverse Event|2
1815350|NCT00436436|6302958|P1|Overall Study|Progression|4
1815351|NCT00436345|6302969|P2|Overall Study|ICU resident beyond follow-up period|0
1815352|NCT00436345|6302970|P1|Overall Study|ICU resident beyond follow-up period|3
1815353|NCT00436332|6303023|P1|Overall Study|Never Received Treatment|3
1815354|NCT00436332|6303023|P1|Overall Study|Ineligible|2
1815355|NCT00436332|6303023|P1|Overall Study|Not Protocol Specified|6
1815356|NCT00436332|6303023|P1|Overall Study|Death|2
1815357|NCT00436332|6303023|P1|Overall Study|Progression|59
1815358|NCT00436332|6303023|P1|Overall Study|Withdrawal by Subject|2
1815359|NCT00436332|6303023|P1|Overall Study|Adverse Event|9
1815360|NCT00436215|6303030|P1|Overall Study|Small bowel obstruction|1
1815361|NCT00436215|6303030|P1|Overall Study|Refused further treatment|3
1815362|NCT00436163|6303036|P1|Overall Study|Adverse Event|1
1815363|NCT00436163|6303036|P1|Overall Study|Lost to Follow-up|2
1815364|NCT00436007|6303084|P3|Overall Study|Other|1
1815365|NCT00436007|6303085|P2|Overall Study|Other|0
1815366|NCT00436007|6303086|P1|Overall Study|Other|0
1815367|NCT00436007|6303084|P3|Overall Study|Death|3
1815368|NCT00436007|6303085|P2|Overall Study|Death|1
1815369|NCT00436007|6303086|P1|Overall Study|Death|0
1815370|NCT00436007|6303084|P3|Overall Study|Physician Decision|2
1815371|NCT00436007|6303085|P2|Overall Study|Physician Decision|0
1815372|NCT00436007|6303086|P1|Overall Study|Physician Decision|0
1815373|NCT00436007|6303084|P3|Overall Study|Lost to Follow-up|13
1815374|NCT00436007|6303085|P2|Overall Study|Lost to Follow-up|10
1815375|NCT00436007|6303086|P1|Overall Study|Lost to Follow-up|14
1815376|NCT00436007|6303084|P3|Overall Study|Withdrawal by Subject|4
1815377|NCT00436007|6303085|P2|Overall Study|Withdrawal by Subject|3
1815378|NCT00436007|6303086|P1|Overall Study|Withdrawal by Subject|5
1815379|NCT00435994|6303134|P3|Overall Study|Lost to Follow-up|0
1815380|NCT00435994|6303135|P2|Overall Study|Lost to Follow-up|0
1815381|NCT00435994|6303136|P1|Overall Study|Lost to Follow-up|7
1815382|NCT00435942|6303147|P2|Overall Study|Other|1
1815383|NCT00435942|6303148|P1|Overall Study|Other|0
1815384|NCT00435942|6303147|P2|Overall Study|Technical Failure|0
1815385|NCT00435942|6303148|P1|Overall Study|Technical Failure|3
1815386|NCT00435942|6303147|P2|Overall Study|Conversion to Open Repair|0
1815387|NCT00435942|6303148|P1|Overall Study|Conversion to Open Repair|1
1815388|NCT00435942|6303147|P2|Overall Study|Lost to Follow-up|16
1815389|NCT00435942|6303148|P1|Overall Study|Lost to Follow-up|0
1815390|NCT00435942|6303147|P2|Overall Study|Withdrawal by Subject|0
1815391|NCT00435942|6303148|P1|Overall Study|Withdrawal by Subject|2
1815392|NCT00435942|6303147|P2|Overall Study|Death|10
1815393|NCT00435942|6303148|P1|Overall Study|Death|17
1815394|NCT00435825|6303188|P4|Overall Study|Did not complete full follow-up period|5
1815395|NCT00435825|6303189|P3|Overall Study|Did not complete full follow-up period|4
1815396|NCT00435825|6303190|P2|Overall Study|Did not complete full follow-up period|6
1815397|NCT00435825|6303191|P1|Overall Study|Did not complete full follow-up period|6
1815398|NCT00435825|6303188|P4|Overall Study|Did not enter follow-up|3
1815399|NCT00435825|6303189|P3|Overall Study|Did not enter follow-up|1
1815400|NCT00435825|6303190|P2|Overall Study|Did not enter follow-up|4
1815401|NCT00435825|6303191|P1|Overall Study|Did not enter follow-up|0
1815402|NCT00435825|6303188|P4|Overall Study|Did not receive study drug|0
1815403|NCT00435825|6303189|P3|Overall Study|Did not receive study drug|2
1815404|NCT00435825|6303190|P2|Overall Study|Did not receive study drug|0
1815405|NCT00435825|6303191|P1|Overall Study|Did not receive study drug|1
1815406|NCT00435825|6303188|P4|Overall Study|Failure to return|0
1815407|NCT00435825|6303189|P3|Overall Study|Failure to return|4
1815408|NCT00435825|6303190|P2|Overall Study|Failure to return|0
1815409|NCT00435825|6303191|P1|Overall Study|Failure to return|5
1815410|NCT00435825|6303188|P4|Overall Study|Refused treatment|5
1815411|NCT00435825|6303189|P3|Overall Study|Refused treatment|0
1815412|NCT00435825|6303190|P2|Overall Study|Refused treatment|0
1815413|NCT00435825|6303191|P1|Overall Study|Refused treatment|2
1815414|NCT00435825|6303188|P4|Overall Study|Other Protocol Violation|0
1815415|NCT00435825|6303189|P3|Overall Study|Other Protocol Violation|0
1815416|NCT00435825|6303190|P2|Overall Study|Other Protocol Violation|0
1815417|NCT00435825|6303191|P1|Overall Study|Other Protocol Violation|1
1815418|NCT00435825|6303188|P4|Overall Study|Insufficient Therapeutic Response|3
1815419|NCT00435825|6303189|P3|Overall Study|Insufficient Therapeutic Response|0
1815420|NCT00435825|6303190|P2|Overall Study|Insufficient Therapeutic Response|1
1815421|NCT00435825|6303191|P1|Overall Study|Insufficient Therapeutic Response|3
1815422|NCT00435825|6303188|P4|Overall Study|Abnormality of Laboratory Test|0
1815423|NCT00435825|6303189|P3|Overall Study|Abnormality of Laboratory Test|0
1815424|NCT00435825|6303190|P2|Overall Study|Abnormality of Laboratory Test|1
1815425|NCT00435825|6303191|P1|Overall Study|Abnormality of Laboratory Test|0
1815426|NCT00435487|6303314|P2|Overall Study|Received Drug in Other Treatment Group|1
1815427|NCT00435487|6303315|P1|Overall Study|Received Drug in Other Treatment Group|0
1815428|NCT00435487|6303314|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
1815429|NCT00435487|6303315|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
1815430|NCT00435487|6303314|P2|Overall Study|Withdrawal by Subject|1
1815431|NCT00435487|6303315|P1|Overall Study|Withdrawal by Subject|2
1815432|NCT00435487|6303314|P2|Overall Study|Other|2
1815433|NCT00435487|6303315|P1|Overall Study|Other|5
1815434|NCT00435487|6303314|P2|Overall Study|Lost to Follow-up|2
1815435|NCT00435487|6303315|P1|Overall Study|Lost to Follow-up|2
1815436|NCT00435487|6303314|P2|Overall Study|Adverse Event|3
1815437|NCT00435487|6303315|P1|Overall Study|Adverse Event|0
1815438|NCT00435487|6303314|P2|Overall Study|Death|4
1815439|NCT00435487|6303315|P1|Overall Study|Death|3
1815440|NCT00435461|6303334|P3|Overall Study|Lost to Follow-up|2
1815441|NCT00435461|6303335|P2|Overall Study|Lost to Follow-up|1
1815442|NCT00435461|6303336|P1|Overall Study|Lost to Follow-up|1
1815443|NCT00435461|6303334|P3|Overall Study|Non-Compliance of diary|1
1815444|NCT00435461|6303335|P2|Overall Study|Non-Compliance of diary|0
1815445|NCT00435461|6303336|P1|Overall Study|Non-Compliance of diary|2
1815446|NCT00435461|6303334|P3|Overall Study|Adverse Event|6
1815447|NCT00435461|6303335|P2|Overall Study|Adverse Event|2
1815448|NCT00435461|6303336|P1|Overall Study|Adverse Event|1
1815449|NCT00435461|6303334|P3|Overall Study|Noncompliance with study requirements|1
1815450|NCT00435461|6303335|P2|Overall Study|Noncompliance with study requirements|1
1815451|NCT00435461|6303336|P1|Overall Study|Noncompliance with study requirements|1
1815452|NCT00435461|6303334|P3|Overall Study|Participant ended study one day early|0
1815453|NCT00435461|6303335|P2|Overall Study|Participant ended study one day early|0
1815454|NCT00435461|6303336|P1|Overall Study|Participant ended study one day early|1
1815455|NCT00435461|6303334|P3|Overall Study|Participant moved eDiary,studymedication|0
1815456|NCT00435461|6303335|P2|Overall Study|Participant moved eDiary,studymedication|0
1815457|NCT00435461|6303336|P1|Overall Study|Participant moved eDiary,studymedication|1
1815458|NCT00435461|6303334|P3|Overall Study|Pregnancy|0
1815459|NCT00435461|6303335|P2|Overall Study|Pregnancy|0
1815460|NCT00435461|6303336|P1|Overall Study|Pregnancy|2
1815461|NCT00435461|6303334|P3|Overall Study|Participant could not swallow capsule|1
1815462|NCT00435461|6303335|P2|Overall Study|Participant could not swallow capsule|0
1815463|NCT00435461|6303336|P1|Overall Study|Participant could not swallow capsule|0
1815464|NCT00435461|6303334|P3|Overall Study|Participant could not tolerate symptoms|1
1815465|NCT00435461|6303335|P2|Overall Study|Participant could not tolerate symptoms|0
1815466|NCT00435461|6303336|P1|Overall Study|Participant could not tolerate symptoms|0
1815467|NCT00435461|6303334|P3|Overall Study|Randomized in error|0
1815468|NCT00435461|6303335|P2|Overall Study|Randomized in error|0
1815469|NCT00435461|6303336|P1|Overall Study|Randomized in error|1
1815470|NCT00435461|6303334|P3|Overall Study|Withdrawal by Subject|2
1815471|NCT00435461|6303335|P2|Overall Study|Withdrawal by Subject|0
1815472|NCT00435461|6303336|P1|Overall Study|Withdrawal by Subject|1
1815473|NCT00435461|6303334|P3|Overall Study|Lack of Efficacy|0
1815474|NCT00435461|6303335|P2|Overall Study|Lack of Efficacy|1
1815475|NCT00435461|6303336|P1|Overall Study|Lack of Efficacy|2
1815476|NCT00435461|6303334|P3|Overall Study|In error, two study medications switched|0
1815477|NCT00435461|6303335|P2|Overall Study|In error, two study medications switched|0
1815478|NCT00435461|6303336|P1|Overall Study|In error, two study medications switched|1
1815479|NCT00435461|6303334|P3|Overall Study|Compliance less than 80 percent|0
1815480|NCT00435461|6303335|P2|Overall Study|Compliance less than 80 percent|0
1815481|NCT00435461|6303336|P1|Overall Study|Compliance less than 80 percent|1
1815482|NCT00435461|6303334|P3|Overall Study|Participant randomized(inadequate score)|0
1815483|NCT00435461|6303335|P2|Overall Study|Participant randomized(inadequate score)|0
1815484|NCT00435461|6303336|P1|Overall Study|Participant randomized(inadequate score)|1
1815485|NCT00435461|6303334|P3|Overall Study|Protocol Violation|10
1815486|NCT00435461|6303335|P2|Overall Study|Protocol Violation|9
1815487|NCT00435461|6303336|P1|Overall Study|Protocol Violation|6
1815488|NCT00435461|6303334|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
1815489|NCT00435461|6303335|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
1815490|NCT00435461|6303336|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
1815491|NCT00435409|6303373|P3|Overall Study|Sponsor decision|0
1815492|NCT00435409|6303374|P2|Overall Study|Sponsor decision|3
1815493|NCT00435409|6303375|P1|Overall Study|Sponsor decision|0
1815494|NCT00435409|6303373|P3|Overall Study|Adverse Event|8
1815495|NCT00435409|6303374|P2|Overall Study|Adverse Event|0
1815496|NCT00435409|6303375|P1|Overall Study|Adverse Event|0
1815497|NCT00435409|6303373|P3|Overall Study|Other|1
1815498|NCT00435409|6303374|P2|Overall Study|Other|30
1815499|NCT00435409|6303375|P1|Overall Study|Other|45
1815500|NCT00435409|6303373|P3|Overall Study|Withdrawal by Subject|1
1815501|NCT00435409|6303374|P2|Overall Study|Withdrawal by Subject|7
1815502|NCT00435409|6303375|P1|Overall Study|Withdrawal by Subject|8
1815503|NCT00435409|6303373|P3|Overall Study|Global deterioration of health status|4
1815504|NCT00435409|6303374|P2|Overall Study|Global deterioration of health status|0
1815505|NCT00435409|6303375|P1|Overall Study|Global deterioration of health status|0
1815506|NCT00435409|6303373|P3|Overall Study|Objective progression or relapse|58
1815507|NCT00435409|6303374|P2|Overall Study|Objective progression or relapse|93
1815508|NCT00435409|6303375|P1|Overall Study|Objective progression or relapse|158
1815509|NCT00435409|6303373|P3|Overall Study|Death|6
1815510|NCT00435409|6303374|P2|Overall Study|Death|6
1815511|NCT00435409|6303375|P1|Overall Study|Death|8
1815512|NCT00435409|6303373|P3|Overall Study|Lost to Follow-up|0
1815513|NCT00435409|6303374|P2|Overall Study|Lost to Follow-up|2
1815514|NCT00435409|6303375|P1|Overall Study|Lost to Follow-up|1
1815515|NCT00435409|6303373|P3|Overall Study|Protocol Violation|0
1815516|NCT00435409|6303374|P2|Overall Study|Protocol Violation|2
1815517|NCT00435409|6303375|P1|Overall Study|Protocol Violation|1
1815518|NCT00435370|6303397|P2|Overall Study|Antipsychotic medication changed|2
1815519|NCT00435370|6303398|P1|Overall Study|Antipsychotic medication changed|4
1815520|NCT00435370|6303397|P2|Overall Study|Withdrawal by Subject|10
1815521|NCT00435370|6303398|P1|Overall Study|Withdrawal by Subject|10
1815522|NCT00435370|6303397|P2|Overall Study|Adverse Event|8
1815523|NCT00435370|6303398|P1|Overall Study|Adverse Event|8
1815524|NCT00435188|6303406|P2|Overall Study|Lost to Follow-up|6
1815525|NCT00435188|6303407|P1|Overall Study|Lost to Follow-up|5
1815526|NCT00435188|6303406|P2|Overall Study|Withdrawal by Subject|11
1815527|NCT00435188|6303407|P1|Overall Study|Withdrawal by Subject|16
1815528|NCT00435188|6303406|P2|Overall Study|Death|6
1815529|NCT00435188|6303407|P1|Overall Study|Death|1
1815530|NCT00435162|6303450|P6|Period 2 (2 Weeks)|Adverse Event|0
1815531|NCT00435162|6303451|P5|Period 2 (2 Weeks)|Adverse Event|0
1815532|NCT00435162|6303452|P4|Period 2 (2 Weeks)|Adverse Event|0
1815533|NCT00435162|6303453|P3|Period 2 (2 Weeks)|Adverse Event|0
1815534|NCT00435162|6303454|P2|Period 2 (2 Weeks)|Adverse Event|1
1815535|NCT00435162|6303455|P1|Period 2 (2 Weeks)|Adverse Event|0
1815536|NCT00435045|6303475|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
1815537|NCT00435045|6303476|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
1815538|NCT00435045|6303475|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
1815539|NCT00435045|6303476|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
1815540|NCT00435045|6303475|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
1815541|NCT00435045|6303476|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
1815542|NCT00435045|6303475|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
1815543|NCT00435045|6303476|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
1815544|NCT00435045|6303475|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
1815545|NCT00435045|6303476|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
1815546|NCT00435045|6303475|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
1815547|NCT00435045|6303476|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
1815548|NCT00435045|6303475|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
1815549|NCT00435045|6303476|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
1815550|NCT00435045|6303475|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
1815551|NCT00435045|6303476|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
1815552|NCT00435045|6303475|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
1815553|NCT00435045|6303476|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
1815554|NCT00435045|6303475|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
1815555|NCT00435045|6303476|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
1815556|NCT00435045|6303475|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
1815557|NCT00435045|6303476|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
1815558|NCT00435019|6303532|P2|Overall Study|Personal reasons for withdrawal|7
1815559|NCT00435019|6303533|P1|Overall Study|Personal reasons for withdrawal|8
1815560|NCT00435019|6303532|P2|Overall Study|Protocol Violation|1
1815561|NCT00435019|6303533|P1|Overall Study|Protocol Violation|3
1815562|NCT00435019|6303532|P2|Overall Study|Lack of Efficacy|2
1815563|NCT00435019|6303533|P1|Overall Study|Lack of Efficacy|1
1815564|NCT00435019|6303532|P2|Overall Study|Adverse Event|0
1815565|NCT00435019|6303533|P1|Overall Study|Adverse Event|1
1815566|NCT00434967|6303574|P4|Overall Study|Patient Disposition Challenges|3
1815567|NCT00434967|6303575|P3|Overall Study|Patient Disposition Challenges|0
1815568|NCT00434967|6303576|P2|Overall Study|Patient Disposition Challenges|0
1815569|NCT00434967|6303577|P1|Overall Study|Patient Disposition Challenges|2
1815570|NCT00434967|6303574|P4|Overall Study|Physician Decision|0
1815571|NCT00434967|6303575|P3|Overall Study|Physician Decision|1
1815572|NCT00434967|6303576|P2|Overall Study|Physician Decision|1
1815573|NCT00434967|6303577|P1|Overall Study|Physician Decision|1
1815574|NCT00434967|6303574|P4|Overall Study|Protocol Violation|1
1815575|NCT00434967|6303575|P3|Overall Study|Protocol Violation|0
1815576|NCT00434967|6303576|P2|Overall Study|Protocol Violation|1
1815577|NCT00434967|6303577|P1|Overall Study|Protocol Violation|0
1815578|NCT00434967|6303574|P4|Overall Study|Randomized in error|1
1815579|NCT00434967|6303575|P3|Overall Study|Randomized in error|0
1815580|NCT00434967|6303576|P2|Overall Study|Randomized in error|0
1815581|NCT00434967|6303577|P1|Overall Study|Randomized in error|0
1815582|NCT00434967|6303574|P4|Overall Study|Withdrawal by Subject|6
1815583|NCT00434967|6303575|P3|Overall Study|Withdrawal by Subject|4
1815584|NCT00434967|6303576|P2|Overall Study|Withdrawal by Subject|2
1815585|NCT00434967|6303577|P1|Overall Study|Withdrawal by Subject|2
1815586|NCT00434967|6303574|P4|Overall Study|Lost to Follow-up|0
1815587|NCT00434967|6303575|P3|Overall Study|Lost to Follow-up|1
1815588|NCT00434967|6303576|P2|Overall Study|Lost to Follow-up|0
1815589|NCT00434967|6303577|P1|Overall Study|Lost to Follow-up|0
1815590|NCT00434967|6303574|P4|Overall Study|Adverse Event|3
1815591|NCT00434967|6303575|P3|Overall Study|Adverse Event|3
1815592|NCT00434967|6303576|P2|Overall Study|Adverse Event|4
1815593|NCT00434967|6303577|P1|Overall Study|Adverse Event|2
1815594|NCT00434954|6303597|P2|Overall Study|Subject decision|22
1815595|NCT00434954|6303598|P1|Overall Study|Subject decision|8
1815596|NCT00434954|6303597|P2|Overall Study|Sponsor decision|0
1815597|NCT00434954|6303598|P1|Overall Study|Sponsor decision|1
1815598|NCT00434954|6303597|P2|Overall Study|Protocol Violation|27
1815599|NCT00434954|6303598|P1|Overall Study|Protocol Violation|36
1815600|NCT00434954|6303597|P2|Overall Study|Physician Decision|3
1815601|NCT00434954|6303598|P1|Overall Study|Physician Decision|6
1815602|NCT00434954|6303597|P2|Overall Study|Lost to Follow-up|1
1815603|NCT00434954|6303598|P1|Overall Study|Lost to Follow-up|0
1815604|NCT00434954|6303597|P2|Overall Study|Entry criteria not met|16
1815605|NCT00434954|6303598|P1|Overall Study|Entry criteria not met|14
1815606|NCT00434954|6303597|P2|Overall Study|Adverse Event|2
1815607|NCT00434954|6303598|P1|Overall Study|Adverse Event|17
1815608|NCT00434876|6303628|P2|Overall Study|Lost to Follow-up|1
1815609|NCT00434876|6303629|P1|Overall Study|Lost to Follow-up|1
1815610|NCT00434759|6303643|P2|Overall Study|family affairs|0
1815611|NCT00434759|6303644|P1|Overall Study|family affairs|2
1815612|NCT00434759|6303643|P2|Overall Study|Withdrawal by Subject|1
1815613|NCT00434759|6303644|P1|Overall Study|Withdrawal by Subject|17
1815614|NCT00434759|6303643|P2|Overall Study|Lack of Efficacy|4
1815615|NCT00434759|6303644|P1|Overall Study|Lack of Efficacy|5
1815616|NCT00434642|6303660|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
1815617|NCT00434642|6303661|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
1815618|NCT00434642|6303660|P2|Open-label Treatment Phase|Adverse Event|5
1815619|NCT00434642|6303661|P1|Open-label Treatment Phase|Adverse Event|0
1815620|NCT00434642|6303660|P2|Blinded Treatment Phase|Did not Receive Treatment|1
1815621|NCT00434642|6303661|P1|Blinded Treatment Phase|Did not Receive Treatment|4
1815622|NCT00434642|6303660|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
1815623|NCT00434642|6303661|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
1815624|NCT00434642|6303660|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
1815625|NCT00434642|6303661|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
1815626|NCT00434642|6303660|P2|Blinded Treatment Phase|Physician Decision|27
1815627|NCT00434642|6303661|P1|Blinded Treatment Phase|Physician Decision|19
1815628|NCT00434642|6303660|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
1815629|NCT00434642|6303661|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
1815630|NCT00434642|6303660|P2|Blinded Treatment Phase|Clinical Disease Progression|5
1815631|NCT00434642|6303661|P1|Blinded Treatment Phase|Clinical Disease Progression|4
1815632|NCT00434642|6303660|P2|Blinded Treatment Phase|Adverse Event|58
1815633|NCT00434642|6303661|P1|Blinded Treatment Phase|Adverse Event|12
1815634|NCT00434590|6303679|P2|Overall Study|Administrative problems|5
1815635|NCT00434590|6303680|P1|Overall Study|Administrative problems|5
1815636|NCT00434577|6303691|P5|Months 0-3|Withdrawal by Subject|1
1815637|NCT00434577|6303692|P4|Months 0-3|Withdrawal by Subject|1
1815638|NCT00434577|6303693|P3|Months 0-3|Withdrawal by Subject|1
1815639|NCT00434577|6303694|P2|Months 0-3|Withdrawal by Subject|1
1815640|NCT00434577|6303695|P1|Months 0-3|Withdrawal by Subject|2
1815641|NCT00434577|6303691|P5|Months 0-3|Protocol Violation|0
1815642|NCT00434577|6303692|P4|Months 0-3|Protocol Violation|0
1815643|NCT00434577|6303693|P3|Months 0-3|Protocol Violation|1
1815644|NCT00434577|6303694|P2|Months 0-3|Protocol Violation|0
1815645|NCT00434577|6303695|P1|Months 0-3|Protocol Violation|1
1815646|NCT00434577|6303691|P5|Months 0-3|Lost to Follow-up|2
1815647|NCT00434577|6303692|P4|Months 0-3|Lost to Follow-up|0
1815648|NCT00434577|6303693|P3|Months 0-3|Lost to Follow-up|0
1815649|NCT00434577|6303694|P2|Months 0-3|Lost to Follow-up|0
1815650|NCT00434577|6303695|P1|Months 0-3|Lost to Follow-up|0
1815651|NCT00434577|6303691|P5|Months 0-3|Adverse Event|0
1815652|NCT00434577|6303692|P4|Months 0-3|Adverse Event|0
1815653|NCT00434577|6303693|P3|Months 0-3|Adverse Event|1
1815654|NCT00434577|6303694|P2|Months 0-3|Adverse Event|1
1815655|NCT00434577|6303695|P1|Months 0-3|Adverse Event|0
1815656|NCT00434577|6303691|P5|Months 0-3|Serious Adverse Event|0
1815657|NCT00434577|6303692|P4|Months 0-3|Serious Adverse Event|0
1815658|NCT00434577|6303693|P3|Months 0-3|Serious Adverse Event|1
1815659|NCT00434577|6303694|P2|Months 0-3|Serious Adverse Event|0
1815660|NCT00434577|6303695|P1|Months 0-3|Serious Adverse Event|0
1815661|NCT00434512|6303873|P6|Overall Study|Other|0
1815662|NCT00434512|6303874|P5|Overall Study|Other|0
1815663|NCT00434512|6303875|P4|Overall Study|Other|0
1815664|NCT00434512|6303876|P3|Overall Study|Other|0
1815665|NCT00434512|6303877|P2|Overall Study|Other|1
1815666|NCT00434512|6303878|P1|Overall Study|Other|0
1815667|NCT00434512|6303873|P6|Overall Study|Migrated/moved from study area|1
1815668|NCT00434512|6303874|P5|Overall Study|Migrated/moved from study area|1
1815669|NCT00434512|6303875|P4|Overall Study|Migrated/moved from study area|1
1815670|NCT00434512|6303876|P3|Overall Study|Migrated/moved from study area|0
1815671|NCT00434512|6303877|P2|Overall Study|Migrated/moved from study area|0
1815672|NCT00434512|6303878|P1|Overall Study|Migrated/moved from study area|0
1815673|NCT00434421|6303992|P1|Overall Study|Non-compliance with study treatment|1
1815674|NCT00434421|6303992|P1|Overall Study|Withdrawal by Subject|1
1815675|NCT00434330|6304020|P6|Overall Study|Subject Not Compliant With Study|0
1815676|NCT00434330|6304021|P5|Overall Study|Subject Not Compliant With Study|0
1815677|NCT00434330|6304022|P4|Overall Study|Subject Not Compliant With Study|0
1815678|NCT00434330|6304023|P3|Overall Study|Subject Not Compliant With Study|1
1815679|NCT00434330|6304024|P2|Overall Study|Subject Not Compliant With Study|0
1815680|NCT00434330|6304025|P1|Overall Study|Subject Not Compliant With Study|0
1815681|NCT00434330|6304020|P6|Overall Study|Renal transplant|0
1815682|NCT00434330|6304021|P5|Overall Study|Renal transplant|0
1815683|NCT00434330|6304022|P4|Overall Study|Renal transplant|1
1815684|NCT00434330|6304023|P3|Overall Study|Renal transplant|0
1815685|NCT00434330|6304024|P2|Overall Study|Renal transplant|0
1815686|NCT00434330|6304025|P1|Overall Study|Renal transplant|0
1815687|NCT00434330|6304020|P6|Overall Study|Withdrawal by Subject|0
1815688|NCT00434330|6304021|P5|Overall Study|Withdrawal by Subject|0
1815689|NCT00434330|6304022|P4|Overall Study|Withdrawal by Subject|1
1815690|NCT00434330|6304023|P3|Overall Study|Withdrawal by Subject|1
1815691|NCT00434330|6304024|P2|Overall Study|Withdrawal by Subject|0
1815692|NCT00434330|6304025|P1|Overall Study|Withdrawal by Subject|0
1815693|NCT00434330|6304020|P6|Overall Study|Death|1
1815694|NCT00434330|6304021|P5|Overall Study|Death|1
1815695|NCT00434330|6304022|P4|Overall Study|Death|0
1815696|NCT00434330|6304023|P3|Overall Study|Death|0
1815697|NCT00434330|6304024|P2|Overall Study|Death|0
1815698|NCT00434330|6304025|P1|Overall Study|Death|1
1815699|NCT00434330|6304020|P6|Overall Study|Adverse Event|0
1815700|NCT00434330|6304021|P5|Overall Study|Adverse Event|0
1815701|NCT00434330|6304022|P4|Overall Study|Adverse Event|0
1815702|NCT00434330|6304023|P3|Overall Study|Adverse Event|1
1815703|NCT00434330|6304024|P2|Overall Study|Adverse Event|0
1815704|NCT00434330|6304025|P1|Overall Study|Adverse Event|0
1815705|NCT00434304|6304057|P1|Overall Study|Withdrawal by Subject|4
1815706|NCT00434304|6304057|P1|Overall Study|Lack of Efficacy|2
1815707|NCT00434304|6304057|P1|Overall Study|Adverse Event|14
1815708|NCT00434252|6304106|P2|Overall Study|Withdrawal by Subject|7
1815709|NCT00434252|6304107|P1|Overall Study|Withdrawal by Subject|3
1815710|NCT00434252|6304106|P2|Overall Study|Physician Decision|8
1815711|NCT00434252|6304107|P1|Overall Study|Physician Decision|4
1815712|NCT00434252|6304106|P2|Overall Study|Lost to Follow-up|1
1815713|NCT00434252|6304107|P1|Overall Study|Lost to Follow-up|0
1815714|NCT00434252|6304106|P2|Overall Study|Death|2
1815715|NCT00434252|6304107|P1|Overall Study|Death|1
1815716|NCT00434252|6304106|P2|Overall Study|Adverse Event|13
1815717|NCT00434252|6304107|P1|Overall Study|Adverse Event|6
1815718|NCT00434252|6304106|P2|Overall Study|Lack of Efficacy|100
1815719|NCT00434252|6304107|P1|Overall Study|Lack of Efficacy|50
1815720|NCT00434213|6304141|P1|Overall Study|Non-compliant to study schedule|1
1815721|NCT00434213|6304141|P1|Overall Study|Application site reaction|1
1815722|NCT00434213|6304141|P1|Overall Study|Unable to comply with study visit window|2
1815723|NCT00434213|6304141|P1|Overall Study|Protocol Violation|3
1815724|NCT00434213|6304141|P1|Overall Study|Withdrawal by Subject|7
1815725|NCT00434213|6304141|P1|Overall Study|Lost to Follow-up|14
1815726|NCT00434213|6304141|P1|Overall Study|Lack of Efficacy|9
1815727|NCT00434213|6304141|P1|Overall Study|Adverse Event|12
1815728|NCT00434161|6304149|P3|Overall Study|Logistical error study assessments|3
1815729|NCT00434161|6304150|P2|Overall Study|Logistical error study assessments|0
1815730|NCT00434161|6304151|P1|Overall Study|Logistical error study assessments|1
1815731|NCT00434161|6304149|P3|Overall Study|Withdrawal by Subject|3
1815732|NCT00434161|6304150|P2|Overall Study|Withdrawal by Subject|0
1815733|NCT00434161|6304151|P1|Overall Study|Withdrawal by Subject|2
1815734|NCT00434161|6304149|P3|Overall Study|Non-Compliance|0
1815735|NCT00434161|6304150|P2|Overall Study|Non-Compliance|1
1815736|NCT00434161|6304151|P1|Overall Study|Non-Compliance|1
1815737|NCT00434161|6304149|P3|Overall Study|Death|1
1815738|NCT00434161|6304150|P2|Overall Study|Death|0
1815739|NCT00434161|6304151|P1|Overall Study|Death|1
1815740|NCT00434161|6304149|P3|Overall Study|Lost to Follow-up|0
1815741|NCT00434161|6304150|P2|Overall Study|Lost to Follow-up|1
1815742|NCT00434161|6304151|P1|Overall Study|Lost to Follow-up|0
1815743|NCT00434161|6304149|P3|Overall Study|Adverse Event|4
1815744|NCT00434161|6304150|P2|Overall Study|Adverse Event|1
1815745|NCT00434161|6304151|P1|Overall Study|Adverse Event|5
1815746|NCT00434148|6304195|P2|Overall Study|Abnormal test procedure result|1
1815747|NCT00434148|6304196|P1|Overall Study|Abnormal test procedure result|0
1815748|NCT00434148|6304195|P2|Overall Study|Condition no longer requires study drug|0
1815749|NCT00434148|6304196|P1|Overall Study|Condition no longer requires study drug|1
1815750|NCT00434148|6304195|P2|Overall Study|Lost to Follow-up|1
1815751|NCT00434148|6304196|P1|Overall Study|Lost to Follow-up|0
1815752|NCT00434148|6304195|P2|Overall Study|Administrative problems|10
1815753|NCT00434148|6304196|P1|Overall Study|Administrative problems|6
1815754|NCT00434148|6304195|P2|Overall Study|Protocol Violation|0
1815755|NCT00434148|6304196|P1|Overall Study|Protocol Violation|4
1815756|NCT00434148|6304195|P2|Overall Study|Withdrawal by Subject|15
1815757|NCT00434148|6304196|P1|Overall Study|Withdrawal by Subject|15
1815758|NCT00434148|6304195|P2|Overall Study|Lack of Efficacy|28
1815759|NCT00434148|6304196|P1|Overall Study|Lack of Efficacy|25
1815760|NCT00434148|6304195|P2|Overall Study|Adverse Event|18
1815761|NCT00434148|6304196|P1|Overall Study|Adverse Event|18
1815762|NCT00434122|6304232|P2|Overall Study|Travelling of subject.|0
1815763|NCT00434122|6304233|P1|Overall Study|Travelling of subject.|1
1815764|NCT00434122|6304232|P2|Overall Study|Low follicular response.|2
1815765|NCT00434122|6304233|P1|Overall Study|Low follicular response.|1
1815766|NCT00434122|6304232|P2|Overall Study|Large follicle size|2
1815767|NCT00434122|6304233|P1|Overall Study|Large follicle size|2
1815768|NCT00434122|6304232|P2|Overall Study|Personal reasons|1
1815769|NCT00434122|6304233|P1|Overall Study|Personal reasons|1
1815770|NCT00434122|6304232|P2|Overall Study|loss of subject contact|1
1815771|NCT00434122|6304233|P1|Overall Study|loss of subject contact|1
1815772|NCT00434122|6304232|P2|Overall Study|Non-compliance with protocol|1
1815773|NCT00434122|6304233|P1|Overall Study|Non-compliance with protocol|0
1815774|NCT00434109|6304242|P1|Overall Study|had embolism, did not receive sunitinib|3
1815775|NCT00434109|6304242|P1|Overall Study|Protocol Violation|1
1815776|NCT00434109|6304242|P1|Overall Study|Adverse Event|5
1815777|NCT00434109|6304242|P1|Overall Study|Physician Decision|9
1815778|NCT00434057|6304251|P1|Overall Study|Withdrawal by Subject|1
1815779|NCT00433966|6304289|P4|Stent Intervention/Randomization|Lost to Follow-up|47
1815780|NCT00433966|6304290|P3|Stent Intervention/Randomization|Lost to Follow-up|113
1815781|NCT00433966|6304291|P2|Stent Intervention/Randomization|Lost to Follow-up|0
1815782|NCT00433966|6304292|P1|Stent Intervention/Randomization|Lost to Follow-up|0
1815783|NCT00433966|6304289|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
1815784|NCT00433966|6304290|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
1815785|NCT00433966|6304291|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
1815786|NCT00433966|6304292|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
1815787|NCT00433966|6304289|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
1815788|NCT00433966|6304290|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
1815789|NCT00433966|6304291|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
1815790|NCT00433966|6304292|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
1815791|NCT00433966|6304289|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
1815792|NCT00433966|6304290|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
1815793|NCT00433966|6304291|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
1815794|NCT00433966|6304292|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
1815795|NCT00433966|6304289|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
1815796|NCT00433966|6304290|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
1815797|NCT00433966|6304291|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
1815798|NCT00433966|6304292|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
1815799|NCT00433914|6304314|P2|Overall Study|Lost to Follow-up|1
1815800|NCT00433914|6304315|P1|Overall Study|Lost to Follow-up|0
1815801|NCT00433914|6304314|P2|Overall Study|Withdrawal by Subject|2
1815802|NCT00433914|6304315|P1|Overall Study|Withdrawal by Subject|0
1815803|NCT00433836|6304335|P2|Overall Study|Abnormal laboratory values|1
1815804|NCT00433836|6304336|P1|Overall Study|Abnormal laboratory values|0
1815805|NCT00433836|6304335|P2|Overall Study|Condition no longer requires study drug|1
1815806|NCT00433836|6304336|P1|Overall Study|Condition no longer requires study drug|0
1815807|NCT00433836|6304335|P2|Overall Study|Protocol Violation|2
1815808|NCT00433836|6304336|P1|Overall Study|Protocol Violation|0
1815809|NCT00433836|6304335|P2|Overall Study|Unsatisfactory therapeutic effect|1
1815810|NCT00433836|6304336|P1|Overall Study|Unsatisfactory therapeutic effect|1
1815811|NCT00433836|6304335|P2|Overall Study|Withdrawal by Subject|1
1815812|NCT00433836|6304336|P1|Overall Study|Withdrawal by Subject|2
1815813|NCT00433836|6304335|P2|Overall Study|Lost to Follow-up|0
1815814|NCT00433836|6304336|P1|Overall Study|Lost to Follow-up|3
1815815|NCT00433836|6304335|P2|Overall Study|Adverse Event|0
1815816|NCT00433836|6304336|P1|Overall Study|Adverse Event|7
1815817|NCT00433771|6304348|P1|Overall Study|Failure to deploy stent|1
1815818|NCT00433771|6304348|P1|Overall Study|Death|2
1815819|NCT00433771|6304348|P1|Overall Study|Treated and later found to be ineligible|2
1815820|NCT00433771|6304348|P1|Overall Study|screen fail|14
1815821|NCT00433654|6304371|P2|Overall Study|Withdrawal by Subject|2
1815822|NCT00433654|6304372|P1|Overall Study|Withdrawal by Subject|1
1815823|NCT00433654|6304371|P2|Overall Study|Subject not yet due for visit|0
1815824|NCT00433654|6304372|P1|Overall Study|Subject not yet due for visit|4
1815825|NCT00433654|6304371|P2|Overall Study|Missed visit|3
1815826|NCT00433654|6304372|P1|Overall Study|Missed visit|6
1815827|NCT00433654|6304371|P2|Overall Study|Death|0
1815828|NCT00433654|6304372|P1|Overall Study|Death|4
1815829|NCT00433537|6304418|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
1815830|NCT00433537|6304419|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
1815831|NCT00433537|6304420|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
1815832|NCT00433537|6304418|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
1815833|NCT00433537|6304419|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
1815834|NCT00433537|6304420|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
1815835|NCT00433537|6304418|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
1815836|NCT00433537|6304419|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
1815837|NCT00433537|6304420|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
1815838|NCT00433537|6304418|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
1815839|NCT00433537|6304419|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
1815840|NCT00433537|6304420|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
1815841|NCT00433537|6304418|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
1815842|NCT00433537|6304419|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
1815843|NCT00433537|6304420|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
1815844|NCT00433537|6304418|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
1815845|NCT00433537|6304419|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
1815846|NCT00433537|6304420|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
1815847|NCT00433537|6304418|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
1815848|NCT00433537|6304419|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
1815849|NCT00433537|6304420|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
1815850|NCT00433537|6304418|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
1815851|NCT00433537|6304419|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
1815852|NCT00433537|6304420|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
1815853|NCT00433537|6304418|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
1815854|NCT00433537|6304419|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
1815855|NCT00433537|6304420|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
1815922|NCT00433446|6304448|P1|Overall Study|Ineligible|9
1815923|NCT00433446|6304448|P1|Overall Study|Other - Not Protocol specified|3
1815924|NCT00433446|6304448|P1|Overall Study|Progression|44
1815925|NCT00433446|6304448|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1815926|NCT00433446|6304448|P1|Overall Study|Adverse Event|4
1815927|NCT00433381|6304458|P2|Overall Study|Ineligible / no protocol treatment|3
1815928|NCT00433381|6304459|P1|Overall Study|Ineligible / no protocol treatment|3
1815929|NCT00433329|6304478|P1|Overall Study|Physician Decision|1
1815930|NCT00433329|6304478|P1|Overall Study|Lost to Follow-up|1
1815931|NCT00433329|6304478|P1|Overall Study|Moved out of state|1
1815932|NCT00433329|6304478|P1|Overall Study|Discontinued sildenafil|2
1815933|NCT00433329|6304478|P1|Overall Study|Withdrew consent|3
1815934|NCT00433329|6304478|P1|Overall Study|Death|4
1815935|NCT00433329|6304478|P1|Overall Study|Adverse Event|9
1815936|NCT00433290|6304484|P2|Overall Study|Lost to Follow-up|0
1815937|NCT00433290|6304485|P1|Overall Study|Lost to Follow-up|1
1815938|NCT00433290|6304484|P2|Overall Study|Entry Criteria Not Met|1
1815939|NCT00433290|6304485|P1|Overall Study|Entry Criteria Not Met|0
1815940|NCT00433290|6304484|P2|Overall Study|Physician Decision|0
1815941|NCT00433290|6304485|P1|Overall Study|Physician Decision|2
1815942|NCT00433290|6304484|P2|Overall Study|Protocol Violation|2
1815943|NCT00433290|6304485|P1|Overall Study|Protocol Violation|3
1815944|NCT00433290|6304484|P2|Overall Study|Withdrawal by Subject|2
1815945|NCT00433290|6304485|P1|Overall Study|Withdrawal by Subject|4
1815946|NCT00433290|6304484|P2|Overall Study|Lack of Efficacy|5
1815947|NCT00433290|6304485|P1|Overall Study|Lack of Efficacy|1
1815948|NCT00433290|6304484|P2|Overall Study|Adverse Event|7
1815949|NCT00433290|6304485|P1|Overall Study|Adverse Event|24
1815950|NCT00433199|6304554|P2|Open-Label Period|Administrative|1
1815951|NCT00433199|6304555|P1|Open-Label Period|Administrative|0
1815952|NCT00433199|6304554|P2|Open-Label Period|Protocol Violation|2
1815953|NCT00433199|6304555|P1|Open-Label Period|Protocol Violation|0
1815954|NCT00433199|6304554|P2|Open-Label Period|Withdrawal by Subject|7
1815955|NCT00433199|6304555|P1|Open-Label Period|Withdrawal by Subject|0
1815956|NCT00433199|6304554|P2|Open-Label Period|Lost to Follow-up|3
1815957|NCT00433199|6304555|P1|Open-Label Period|Lost to Follow-up|0
1815958|NCT00433199|6304554|P2|Open-Label Period|Lack of Efficacy|2
1815959|NCT00433199|6304555|P1|Open-Label Period|Lack of Efficacy|0
1815960|NCT00433199|6304554|P2|Open-Label Period|Adverse Event|19
1815961|NCT00433199|6304555|P1|Open-Label Period|Adverse Event|0
1815962|NCT00433199|6304554|P2|Double-Blind Period|Administrative|5
1815963|NCT00433199|6304555|P1|Double-Blind Period|Administrative|1
1815964|NCT00433199|6304554|P2|Double-Blind Period|Protocol Violation|10
1815965|NCT00433199|6304555|P1|Double-Blind Period|Protocol Violation|1
1815966|NCT00433199|6304554|P2|Double-Blind Period|Withdrawal by Subject|19
1815967|NCT00433199|6304555|P1|Double-Blind Period|Withdrawal by Subject|8
1815968|NCT00433199|6304554|P2|Double-Blind Period|Lost to Follow-up|5
1815969|NCT00433199|6304555|P1|Double-Blind Period|Lost to Follow-up|2
1815970|NCT00433199|6304554|P2|Double-Blind Period|Lack of Efficacy|2
1815971|NCT00433199|6304555|P1|Double-Blind Period|Lack of Efficacy|0
1815972|NCT00433199|6304554|P2|Double-Blind Period|Adverse Event|25
1815973|NCT00433199|6304555|P1|Double-Blind Period|Adverse Event|0
1815974|NCT00433160|6304575|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
1815975|NCT00433160|6304576|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
1815976|NCT00433160|6304575|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
1815977|NCT00433160|6304576|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
1815978|NCT00433160|6304575|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
1815979|NCT00433160|6304576|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
1815980|NCT00433160|6304575|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
1815981|NCT00433160|6304576|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
1815982|NCT00433160|6304575|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
1815983|NCT00433160|6304576|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
1815984|NCT00433160|6304575|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
1815985|NCT00433160|6304576|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
1815986|NCT00433160|6304575|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
1815987|NCT00433160|6304576|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
1815988|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
1815989|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
1815990|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
1815991|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
1815992|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
1815993|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
1815994|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
1815995|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
1815996|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
1815997|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
1815998|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
1815999|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
1816000|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1816001|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
1816002|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Death|0
1816003|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Death|0
1816004|NCT00433160|6304575|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
1816005|NCT00433160|6304576|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
1816006|NCT00433147|6304628|P4|Overall Study|Adverse Event|0
1816007|NCT00433147|6304629|P3|Overall Study|Adverse Event|0
1816008|NCT00433147|6304630|P2|Overall Study|Adverse Event|1
1816009|NCT00433147|6304631|P1|Overall Study|Adverse Event|0
1816010|NCT00433017|6304647|P2|Overall Study|Subject no longer requires study drug|1
1816011|NCT00433017|6304648|P1|Overall Study|Subject no longer requires study drug|1
1816012|NCT00433017|6304647|P2|Overall Study|Death|2
1816013|NCT00433017|6304648|P1|Overall Study|Death|2
1816014|NCT00433017|6304647|P2|Overall Study|Protocol Violation|0
1816015|NCT00433017|6304648|P1|Overall Study|Protocol Violation|1
1816016|NCT00433017|6304647|P2|Overall Study|Administrative problems|86
1816017|NCT00433017|6304648|P1|Overall Study|Administrative problems|80
1816018|NCT00433017|6304647|P2|Overall Study|Lost to Follow-up|4
1816019|NCT00433017|6304648|P1|Overall Study|Lost to Follow-up|3
1816020|NCT00433017|6304647|P2|Overall Study|Withdrawal by Subject|5
1816021|NCT00433017|6304648|P1|Overall Study|Withdrawal by Subject|4
1816022|NCT00433017|6304647|P2|Overall Study|Adverse Event|3
1816023|NCT00433017|6304648|P1|Overall Study|Adverse Event|5
1816024|NCT00433004|6304664|P2|Overall Study|Lost to Follow-up|7
1816025|NCT00433004|6304665|P1|Overall Study|Lost to Follow-up|5
1816026|NCT00432991|6304677|P2|Overall Study|Protocol Violation|12
1816027|NCT00432991|6304678|P1|Overall Study|Protocol Violation|7
1816028|NCT00432965|6304690|P2|Overall Study|Incomplete Data|3
1816029|NCT00432965|6304691|P1|Overall Study|Incomplete Data|4
1816030|NCT00432965|6304690|P2|Overall Study|Exclusionary Methods|2
1816031|NCT00432965|6304691|P1|Overall Study|Exclusionary Methods|1
1816032|NCT00432965|6304690|P2|Overall Study|Death|4
1816033|NCT00432965|6304691|P1|Overall Study|Death|3
1816034|NCT00432965|6304690|P2|Overall Study|Adverse Event|19
1816035|NCT00432965|6304691|P1|Overall Study|Adverse Event|22
1816036|NCT00432965|6304690|P2|Overall Study|Non-compliance|0
1816037|NCT00432965|6304691|P1|Overall Study|Non-compliance|7
1816038|NCT00432965|6304690|P2|Overall Study|Lack of Efficacy|13
1816039|NCT00432965|6304691|P1|Overall Study|Lack of Efficacy|8
1816040|NCT00432965|6304690|P2|Overall Study|Physician Decision|13
1816041|NCT00432965|6304691|P1|Overall Study|Physician Decision|14
1816042|NCT00432965|6304690|P2|Overall Study|Withdrawal by Subject|13
1816043|NCT00432965|6304691|P1|Overall Study|Withdrawal by Subject|13
1816044|NCT00432965|6304690|P2|Overall Study|Lost to Follow-up|19
1816045|NCT00432965|6304691|P1|Overall Study|Lost to Follow-up|22
1816046|NCT00432835|6304699|P2|Overall Study|Adverse event: lead dislodgement.|7
1816047|NCT00432835|6304700|P1|Overall Study|Adverse event: lead dislodgement.|6
1816048|NCT00432809|6304713|P3|1 Year Follow-up|Withdrawal by Subject|1
1816049|NCT00432809|6304714|P2|1 Year Follow-up|Withdrawal by Subject|0
1816050|NCT00432809|6304715|P1|1 Year Follow-up|Withdrawal by Subject|7
1816051|NCT00432809|6304713|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
1816052|NCT00432809|6304714|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
1816053|NCT00432809|6304715|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
1816054|NCT00432744|6304788|P2|Months 7 - 12|Too disabled to score|1
1816055|NCT00432744|6304789|P1|Months 7 - 12|Too disabled to score|0
1816056|NCT00432744|6304788|P2|Months 7 - 12|Withdrawal by Subject|0
1816057|NCT00432744|6304789|P1|Months 7 - 12|Withdrawal by Subject|1
1816058|NCT00432744|6304788|P2|Months 0-6|Too disabled to score|0
1816059|NCT00432744|6304789|P1|Months 0-6|Too disabled to score|1
1816060|NCT00432744|6304788|P2|Months 0-6|Withdrawal by Subject|4
1816061|NCT00432744|6304789|P1|Months 0-6|Withdrawal by Subject|4
1816062|NCT00432679|6304801|P2|Overall Study|Withdrawal by Subject|2
1816063|NCT00432679|6304802|P1|Overall Study|Withdrawal by Subject|3
1816064|NCT00432679|6304801|P2|Overall Study|Adverse Event|1
1816065|NCT00432679|6304802|P1|Overall Study|Adverse Event|2
1816066|NCT00432666|6304826|P2|Open-Label Extension Period|Physician Decision|0
1816067|NCT00432666|6304827|P1|Open-Label Extension Period|Physician Decision|3
1816068|NCT00432666|6304826|P2|Open-Label Extension Period|Consent withdrawn|0
1816069|NCT00432666|6304827|P1|Open-Label Extension Period|Consent withdrawn|10
1816070|NCT00432666|6304826|P2|Open-Label Extension Period|Adverse Event|0
1816071|NCT00432666|6304827|P1|Open-Label Extension Period|Adverse Event|5
1816072|NCT00432666|6304826|P2|Open-Label Extension Period|Lack of Efficacy|0
1816073|NCT00432666|6304827|P1|Open-Label Extension Period|Lack of Efficacy|6
1816074|NCT00432666|6304826|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
1816075|NCT00432666|6304827|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
1816076|NCT00432666|6304826|P2|Main Period|Consent Withdrawn|0
1816077|NCT00432666|6304827|P1|Main Period|Consent Withdrawn|1
1816078|NCT00432666|6304826|P2|Main Period|Adverse Event|1
1816079|NCT00432666|6304827|P1|Main Period|Adverse Event|1
1816080|NCT00432562|6305000|P2|Overall Study|Death|0
1816081|NCT00432562|6305001|P1|Overall Study|Death|3
1816082|NCT00432380|6305053|P3|Overall Study|Adverse Event|0
1816083|NCT00432380|6305054|P2|Overall Study|Adverse Event|0
1816084|NCT00432380|6305055|P1|Overall Study|Adverse Event|1
1816085|NCT00432380|6305053|P3|Overall Study|Migrated/moved from study area|1
1816086|NCT00432380|6305054|P2|Overall Study|Migrated/moved from study area|4
1816087|NCT00432380|6305055|P1|Overall Study|Migrated/moved from study area|3
1816088|NCT00432276|6305108|P2|Overall Study|Other|3
1816089|NCT00432276|6305109|P1|Overall Study|Other|2
1816090|NCT00432276|6305108|P2|Overall Study|Physician Decision|8
1816091|NCT00432276|6305109|P1|Overall Study|Physician Decision|6
1816092|NCT00432276|6305108|P2|Overall Study|Withdrawal by Subject|20
1816093|NCT00432276|6305109|P1|Overall Study|Withdrawal by Subject|25
1816094|NCT00432276|6305108|P2|Overall Study|Lost to Follow-up|2
1816095|NCT00432276|6305109|P1|Overall Study|Lost to Follow-up|6
1816096|NCT00432276|6305108|P2|Overall Study|Protocol Violation|20
1816097|NCT00432276|6305109|P1|Overall Study|Protocol Violation|25
1816098|NCT00432276|6305108|P2|Overall Study|Adverse Event|16
1816099|NCT00432276|6305109|P1|Overall Study|Adverse Event|13
1816100|NCT00432276|6305108|P2|Overall Study|Hyperglycemic Rescue|87
1816101|NCT00432276|6305109|P1|Overall Study|Hyperglycemic Rescue|44
1816102|NCT00432237|6305199|P4|Overall Study|Lack of Qualifying Event|84
1816103|NCT00432237|6305200|P3|Overall Study|Lack of Qualifying Event|69
1816104|NCT00432237|6305201|P2|Overall Study|Lack of Qualifying Event|71
1816105|NCT00432237|6305202|P1|Overall Study|Lack of Qualifying Event|38
1816106|NCT00432237|6305199|P4|Overall Study|Withdrawal by Subject|11
1816107|NCT00432237|6305200|P3|Overall Study|Withdrawal by Subject|9
1816108|NCT00432237|6305201|P2|Overall Study|Withdrawal by Subject|6
1816109|NCT00432237|6305202|P1|Overall Study|Withdrawal by Subject|5
1816110|NCT00432237|6305199|P4|Overall Study|Protocol Violation|8
1816111|NCT00432237|6305200|P3|Overall Study|Protocol Violation|11
1816112|NCT00432237|6305201|P2|Overall Study|Protocol Violation|10
1816113|NCT00432237|6305202|P1|Overall Study|Protocol Violation|13
1816114|NCT00432237|6305199|P4|Overall Study|Pregnancy|0
1816115|NCT00432237|6305200|P3|Overall Study|Pregnancy|0
1816116|NCT00432237|6305201|P2|Overall Study|Pregnancy|1
1816117|NCT00432237|6305202|P1|Overall Study|Pregnancy|0
1816118|NCT00432237|6305199|P4|Overall Study|Physician Decision|1
1816119|NCT00432237|6305200|P3|Overall Study|Physician Decision|2
1816120|NCT00432237|6305201|P2|Overall Study|Physician Decision|3
1816121|NCT00432237|6305202|P1|Overall Study|Physician Decision|1
1816122|NCT00432237|6305199|P4|Overall Study|Lost to Follow-up|18
1816123|NCT00432237|6305200|P3|Overall Study|Lost to Follow-up|18
1816124|NCT00432237|6305201|P2|Overall Study|Lost to Follow-up|10
1816125|NCT00432237|6305202|P1|Overall Study|Lost to Follow-up|10
1816126|NCT00432237|6305199|P4|Overall Study|Lack of Efficacy|1
1816127|NCT00432237|6305200|P3|Overall Study|Lack of Efficacy|0
1816128|NCT00432237|6305201|P2|Overall Study|Lack of Efficacy|0
1816129|NCT00432237|6305202|P1|Overall Study|Lack of Efficacy|0
1816130|NCT00432237|6305199|P4|Overall Study|Adverse Event|1
1816131|NCT00432237|6305200|P3|Overall Study|Adverse Event|0
1816132|NCT00432237|6305201|P2|Overall Study|Adverse Event|0
1816133|NCT00432237|6305202|P1|Overall Study|Adverse Event|0
1816134|NCT00432172|6305244|P4|Overall Study|No treatment received|1
1816135|NCT00432172|6305245|P3|Overall Study|No treatment received|0
1816136|NCT00432172|6305246|P2|Overall Study|No treatment received|2
1816137|NCT00432172|6305247|P1|Overall Study|No treatment received|2
1816138|NCT00432172|6305244|P4|Overall Study|Withdrawal by Subject|2
1816139|NCT00432172|6305245|P3|Overall Study|Withdrawal by Subject|0
1816140|NCT00432172|6305246|P2|Overall Study|Withdrawal by Subject|1
1816141|NCT00432172|6305247|P1|Overall Study|Withdrawal by Subject|0
1816142|NCT00432172|6305244|P4|Overall Study|Disease progression|1
1816143|NCT00432172|6305245|P3|Overall Study|Disease progression|5
1816144|NCT00432172|6305246|P2|Overall Study|Disease progression|2
1816145|NCT00432172|6305247|P1|Overall Study|Disease progression|0
1816146|NCT00432172|6305244|P4|Overall Study|Adverse Event|3
1816147|NCT00432172|6305245|P3|Overall Study|Adverse Event|4
1816148|NCT00432172|6305246|P2|Overall Study|Adverse Event|2
1816149|NCT00432172|6305247|P1|Overall Study|Adverse Event|4
1816150|NCT00432172|6305244|P4|Overall Study|Physician Decision|0
1816151|NCT00432172|6305245|P3|Overall Study|Physician Decision|2
1816152|NCT00432172|6305246|P2|Overall Study|Physician Decision|0
1816153|NCT00432172|6305247|P1|Overall Study|Physician Decision|0
1816154|NCT00432159|6305272|P5|Overall Study|Missing NDI and/or neuro. assessment|7
1816155|NCT00432159|6305273|P4|Overall Study|Missing NDI and/or neuro. assessment|3
1816156|NCT00432159|6305274|P3|Overall Study|Missing NDI and/or neuro. assessment|1
1816157|NCT00432159|6305275|P2|Overall Study|Missing NDI and/or neuro. assessment|24
1816158|NCT00432159|6305276|P1|Overall Study|Missing NDI and/or neuro. assessment|13
1816159|NCT00432159|6305272|P5|Overall Study|Failure|3
1816160|NCT00432159|6305273|P4|Overall Study|Failure|2
1816161|NCT00432159|6305274|P3|Overall Study|Failure|3
1816162|NCT00432159|6305275|P2|Overall Study|Failure|5
1816163|NCT00432159|6305276|P1|Overall Study|Failure|9
1816164|NCT00432159|6305272|P5|Overall Study|Death|0
1816165|NCT00432159|6305273|P4|Overall Study|Death|0
1816166|NCT00432159|6305274|P3|Overall Study|Death|0
1816167|NCT00432159|6305275|P2|Overall Study|Death|1
1816168|NCT00432159|6305276|P1|Overall Study|Death|0
1816169|NCT00432042|6305383|P3|Overall Study|Lost to Follow-up|0
1816170|NCT00432042|6305384|P2|Overall Study|Lost to Follow-up|1
1816171|NCT00432042|6305385|P1|Overall Study|Lost to Follow-up|5
1816172|NCT00432042|6305383|P3|Overall Study|Withdrawal by Subject|2
1816173|NCT00432042|6305384|P2|Overall Study|Withdrawal by Subject|0
1816174|NCT00432042|6305385|P1|Overall Study|Withdrawal by Subject|0
1816175|NCT00432042|6305383|P3|Overall Study|Protocol Violation|0
1816176|NCT00432042|6305384|P2|Overall Study|Protocol Violation|0
1816177|NCT00432042|6305385|P1|Overall Study|Protocol Violation|2
1816178|NCT00431964|6305398|P2|Overall Study|Due to Unstable Health|1
1816179|NCT00431964|6305399|P1|Overall Study|Due to Unstable Health|0
1816180|NCT00431964|6305398|P2|Overall Study|Parental Consent Withdrawn|2
1816181|NCT00431964|6305399|P1|Overall Study|Parental Consent Withdrawn|0
1816182|NCT00431964|6305398|P2|Overall Study|Withdrawal by Subject|1
1816183|NCT00431964|6305399|P1|Overall Study|Withdrawal by Subject|2
1816184|NCT00431964|6305398|P2|Overall Study|Physician Decision|2
1816185|NCT00431964|6305399|P1|Overall Study|Physician Decision|2
1816186|NCT00431964|6305398|P2|Overall Study|Lost to Follow-up|2
1816187|NCT00431964|6305399|P1|Overall Study|Lost to Follow-up|1
1816188|NCT00431964|6305398|P2|Overall Study|Adverse Event|0
1816189|NCT00431964|6305399|P1|Overall Study|Adverse Event|1
1816190|NCT00431951|6305409|P4|Overall Study|Adverse Event|0
1816191|NCT00431951|6305410|P3|Overall Study|Adverse Event|1
1816192|NCT00431951|6305411|P2|Overall Study|Adverse Event|0
1816193|NCT00431951|6305412|P1|Overall Study|Adverse Event|0
1816194|NCT00431951|6305409|P4|Overall Study|Withdrawal by Subject|0
1816195|NCT00431951|6305410|P3|Overall Study|Withdrawal by Subject|0
1816196|NCT00431951|6305411|P2|Overall Study|Withdrawal by Subject|1
1816197|NCT00431951|6305412|P1|Overall Study|Withdrawal by Subject|0
1816198|NCT00431951|6305409|P4|Overall Study|Lost to Follow-up|0
1816199|NCT00431951|6305410|P3|Overall Study|Lost to Follow-up|0
1816200|NCT00431951|6305411|P2|Overall Study|Lost to Follow-up|1
1816201|NCT00431951|6305412|P1|Overall Study|Lost to Follow-up|0
1816202|NCT00431951|6305409|P4|Overall Study|Inability to follow study procedures|2
1816203|NCT00431951|6305410|P3|Overall Study|Inability to follow study procedures|1
1816204|NCT00431951|6305411|P2|Overall Study|Inability to follow study procedures|0
1816205|NCT00431951|6305412|P1|Overall Study|Inability to follow study procedures|1
1816206|NCT00431847|6305474|P5|Overall Study|Protocol Violation|1
1816207|NCT00431847|6305475|P4|Overall Study|Protocol Violation|0
1816208|NCT00431847|6305476|P3|Overall Study|Protocol Violation|0
1816209|NCT00431847|6305477|P2|Overall Study|Protocol Violation|0
1816210|NCT00431847|6305478|P1|Overall Study|Protocol Violation|0
1816211|NCT00431847|6305474|P5|Overall Study|completion of less than two study visits|0
1816212|NCT00431847|6305475|P4|Overall Study|completion of less than two study visits|14
1816213|NCT00431847|6305476|P3|Overall Study|completion of less than two study visits|4
1816214|NCT00431847|6305477|P2|Overall Study|completion of less than two study visits|3
1816215|NCT00431847|6305478|P1|Overall Study|completion of less than two study visits|6
1816216|NCT00431834|6305552|P1|Overall Study|Lost to Follow-up|1
1816217|NCT00431834|6305552|P1|Overall Study|Missed Endpoint Visit|2
1816218|NCT00431834|6305552|P1|Overall Study|Death|3
1816219|NCT00431834|6305552|P1|Overall Study|Withdrawal by Subject|7
1816220|NCT00431496|6305568|P1|Overall Study|Protocol-specified criteria|5
1816221|NCT00431496|6305568|P1|Overall Study|Withdrawal by Subject|2
1816222|NCT00431496|6305568|P1|Overall Study|Lost to Follow-up|1
1816223|NCT00431496|6305568|P1|Overall Study|Adverse Event|3
1816224|NCT00431444|6305579|P2|Overall Study|Administrative Problems|1
1816225|NCT00431444|6305580|P1|Overall Study|Administrative Problems|0
1816226|NCT00431444|6305579|P2|Overall Study|Lost to Follow-up|0
1816227|NCT00431444|6305580|P1|Overall Study|Lost to Follow-up|1
1816228|NCT00431444|6305579|P2|Overall Study|Withdrawal by Subject|1
1816229|NCT00431444|6305580|P1|Overall Study|Withdrawal by Subject|1
1816230|NCT00431444|6305579|P2|Overall Study|Adverse Event|1
1816231|NCT00431444|6305580|P1|Overall Study|Adverse Event|2
1816232|NCT00431444|6305579|P2|Overall Study|Protocol Violation|4
1816233|NCT00431444|6305580|P1|Overall Study|Protocol Violation|1
1816234|NCT00431067|6305620|P1|Overall Study|Non-compliance,lost to follow-up|2
1816235|NCT00431067|6305620|P1|Overall Study|Progressive disease|30
1816236|NCT00431067|6305620|P1|Overall Study|Other Adverse Event|9
1816237|NCT00430989|6305645|P2|Overall Study|Not eligible|6
1816238|NCT00430989|6305646|P1|Overall Study|Not eligible|13
1816239|NCT00430989|6305645|P2|Overall Study|Protocol Violation|37
1816240|NCT00430989|6305646|P1|Overall Study|Protocol Violation|30
1816241|NCT00430989|6305645|P2|Overall Study|Withdrawal by Subject|14
1816242|NCT00430989|6305646|P1|Overall Study|Withdrawal by Subject|15
1816243|NCT00430989|6305645|P2|Overall Study|Lost to Follow-up|3
1816244|NCT00430989|6305646|P1|Overall Study|Lost to Follow-up|2
1816245|NCT00430950|6305666|P2|Overall Study|concomitant medication,etc.|7
1816246|NCT00430950|6305667|P1|Overall Study|concomitant medication,etc.|5
1816247|NCT00430950|6305666|P2|Overall Study|Withdrawal by Subject|0
1816248|NCT00430950|6305667|P1|Overall Study|Withdrawal by Subject|1
1816249|NCT00430950|6305666|P2|Overall Study|Adverse Event|6
1816250|NCT00430950|6305667|P1|Overall Study|Adverse Event|7
1816251|NCT00430937|6305681|P2|Overall Study|Unable to classify|1
1816252|NCT00430937|6305682|P1|Overall Study|Unable to classify|0
1816253|NCT00430937|6305681|P2|Overall Study|Protocol discontinuation criteria met|2
1816254|NCT00430937|6305682|P1|Overall Study|Protocol discontinuation criteria met|1
1816255|NCT00430937|6305681|P2|Overall Study|Administrative reasons|0
1816256|NCT00430937|6305682|P1|Overall Study|Administrative reasons|1
1816257|NCT00430937|6305681|P2|Overall Study|Inappropriate enrollment|1
1816258|NCT00430937|6305682|P1|Overall Study|Inappropriate enrollment|2
1816259|NCT00430937|6305681|P2|Overall Study|Lack of Efficacy|5
1816260|NCT00430937|6305682|P1|Overall Study|Lack of Efficacy|6
1816261|NCT00430937|6305681|P2|Overall Study|Protocol Violation|2
1816262|NCT00430937|6305682|P1|Overall Study|Protocol Violation|3
1816263|NCT00430937|6305681|P2|Overall Study|Withdrawal by Subject|2
1816264|NCT00430937|6305682|P1|Overall Study|Withdrawal by Subject|5
1816265|NCT00430937|6305681|P2|Overall Study|Lost to Follow-up|6
1816266|NCT00430937|6305682|P1|Overall Study|Lost to Follow-up|6
1816267|NCT00430937|6305681|P2|Overall Study|Death|1
1816268|NCT00430937|6305682|P1|Overall Study|Death|0
1816269|NCT00430937|6305681|P2|Overall Study|Adverse Event|8
1816270|NCT00430937|6305682|P1|Overall Study|Adverse Event|3
1816271|NCT00430781|6305693|P3|End-of-Study Analysis; 28 July 2011|Other|0
1816272|NCT00430781|6305694|P2|End-of-Study Analysis; 28 July 2011|Other|1
1816273|NCT00430781|6305695|P1|End-of-Study Analysis; 28 July 2011|Other|4
1816274|NCT00430781|6305693|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
1816275|NCT00430781|6305694|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
1816276|NCT00430781|6305695|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
1816277|NCT00430781|6305693|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
1816278|NCT00430781|6305694|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
1816279|NCT00430781|6305695|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
1816280|NCT00430781|6305693|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
1816281|NCT00430781|6305694|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
1816282|NCT00430781|6305695|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
1816283|NCT00430781|6305693|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
1816284|NCT00430781|6305694|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
1816285|NCT00430781|6305695|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
1816286|NCT00430781|6305693|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
1816287|NCT00430781|6305694|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
1816288|NCT00430781|6305695|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
1816289|NCT00430781|6305693|P3|Final Analysis; 31 July 2008|Ongoing|32
1816290|NCT00430781|6305694|P2|Final Analysis; 31 July 2008|Ongoing|29
1816291|NCT00430781|6305695|P1|Final Analysis; 31 July 2008|Ongoing|0
1816292|NCT00430781|6305693|P3|Final Analysis; 31 July 2008|Other|0
1816293|NCT00430781|6305694|P2|Final Analysis; 31 July 2008|Other|1
1816294|NCT00430781|6305695|P1|Final Analysis; 31 July 2008|Other|0
1816295|NCT00430781|6305693|P3|Final Analysis; 31 July 2008|Physician Decision|6
1816296|NCT00430781|6305694|P2|Final Analysis; 31 July 2008|Physician Decision|6
1816297|NCT00430781|6305695|P1|Final Analysis; 31 July 2008|Physician Decision|0
1816298|NCT00430781|6305693|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
1816299|NCT00430781|6305694|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
1816300|NCT00430781|6305695|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
1816301|NCT00430781|6305693|P3|Final Analysis; 31 July 2008|Protocol Violation|0
1816302|NCT00430781|6305694|P2|Final Analysis; 31 July 2008|Protocol Violation|1
1816303|NCT00430781|6305695|P1|Final Analysis; 31 July 2008|Protocol Violation|0
1816304|NCT00430781|6305693|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
1816305|NCT00430781|6305694|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
1816306|NCT00430781|6305695|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
1816307|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Ongoing|25
1816308|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Ongoing|20
1816309|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Ongoing|23
1816310|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Physician Decision|3
1816311|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Physician Decision|3
1816312|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Physician Decision|2
1816313|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
1816314|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
1816315|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
1816316|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Death|0
1816317|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Death|1
1816318|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Death|0
1816319|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Disease Progression|22
1816320|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Disease Progression|30
1816321|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Disease Progression|16
1816322|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
1816323|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
1816324|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
1816325|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
1816326|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
1816327|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
1816328|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
1816329|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
1816330|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
1816331|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
1816332|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
1816333|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
1816334|NCT00430781|6305693|P3|Interim Analysis; 11 February 2008|Adverse Event|7
1816335|NCT00430781|6305694|P2|Interim Analysis; 11 February 2008|Adverse Event|3
1816336|NCT00430781|6305695|P1|Interim Analysis; 11 February 2008|Adverse Event|10
1816337|NCT00430755|6305737|P1|Overall Study|Withdrawal by Subject|53
1816338|NCT00430716|6305744|P3|Open Label Phase|Study terminated by sponsor|4
1816339|NCT00430716|6305745|P2|Open Label Phase|Study terminated by sponsor|5
1816340|NCT00430716|6305746|P1|Open Label Phase|Study terminated by sponsor|4
1816341|NCT00430716|6305744|P3|Open Label Phase|Protocol Violation|0
1816342|NCT00430716|6305745|P2|Open Label Phase|Protocol Violation|0
1816343|NCT00430716|6305746|P1|Open Label Phase|Protocol Violation|1
1816344|NCT00430716|6305744|P3|Open Label Phase|Other|1
1816345|NCT00430716|6305745|P2|Open Label Phase|Other|1
1816346|NCT00430716|6305746|P1|Open Label Phase|Other|3
1816347|NCT00430716|6305744|P3|Open Label Phase|No longer willing to participate|1
1816348|NCT00430716|6305745|P2|Open Label Phase|No longer willing to participate|1
1816349|NCT00430716|6305746|P1|Open Label Phase|No longer willing to participate|0
1816350|NCT00430716|6305744|P3|Open Label Phase|Lost to Follow-up|1
1816351|NCT00430716|6305745|P2|Open Label Phase|Lost to Follow-up|0
1816352|NCT00430716|6305746|P1|Open Label Phase|Lost to Follow-up|1
1816353|NCT00430716|6305744|P3|Double Blind Phase|Not met eligibility criteria|0
1816354|NCT00430716|6305745|P2|Double Blind Phase|Not met eligibility criteria|0
1816355|NCT00430716|6305746|P1|Double Blind Phase|Not met eligibility criteria|1
1816356|NCT00430716|6305744|P3|Double Blind Phase|Adverse Event|3
1816357|NCT00430716|6305745|P2|Double Blind Phase|Adverse Event|1
1816358|NCT00430716|6305746|P1|Double Blind Phase|Adverse Event|1
1816359|NCT00430716|6305744|P3|Double Blind Phase|Study terminated by sponsor|2
1816360|NCT00430716|6305745|P2|Double Blind Phase|Study terminated by sponsor|1
1816361|NCT00430716|6305746|P1|Double Blind Phase|Study terminated by sponsor|1
1816362|NCT00430716|6305744|P3|Double Blind Phase|Other|0
1816363|NCT00430716|6305745|P2|Double Blind Phase|Other|2
1816364|NCT00430716|6305746|P1|Double Blind Phase|Other|0
1816365|NCT00430716|6305744|P3|Double Blind Phase|No longer willing to participate|1
1816366|NCT00430716|6305745|P2|Double Blind Phase|No longer willing to participate|1
1816367|NCT00430716|6305746|P1|Double Blind Phase|No longer willing to participate|2
1816368|NCT00430716|6305744|P3|Double Blind Phase|Death|0
1816369|NCT00430716|6305745|P2|Double Blind Phase|Death|0
1816370|NCT00430716|6305746|P1|Double Blind Phase|Death|1
1816371|NCT00430677|6305778|P3|Long-term Extension Period|Poor compliance/noncompliance|0
1816372|NCT00430677|6305779|P2|Long-term Extension Period|Poor compliance/noncompliance|0
1816373|NCT00430677|6305780|P1|Long-term Extension Period|Poor compliance/noncompliance|1
1816374|NCT00430677|6305778|P3|Long-term Extension Period|Other|1
1816375|NCT00430677|6305779|P2|Long-term Extension Period|Other|1
1816376|NCT00430677|6305780|P1|Long-term Extension Period|Other|2
1816377|NCT00430677|6305778|P3|Long-term Extension Period|Administrative reason by sponsor|46
1816378|NCT00430677|6305779|P2|Long-term Extension Period|Administrative reason by sponsor|49
1816379|NCT00430677|6305780|P1|Long-term Extension Period|Administrative reason by sponsor|41
1816380|NCT00430677|6305778|P3|Long-term Extension Period|Pregnancy|0
1816381|NCT00430677|6305779|P2|Long-term Extension Period|Pregnancy|1
1816382|NCT00430677|6305780|P1|Long-term Extension Period|Pregnancy|1
1816383|NCT00430677|6305778|P3|Long-term Extension Period|Withdrawal by Subject|2
1816384|NCT00430677|6305779|P2|Long-term Extension Period|Withdrawal by Subject|1
1816385|NCT00430677|6305780|P1|Long-term Extension Period|Withdrawal by Subject|5
1816386|NCT00430677|6305778|P3|Long-term Extension Period|Lost to Follow-up|1
1816387|NCT00430677|6305779|P2|Long-term Extension Period|Lost to Follow-up|1
1816388|NCT00430677|6305780|P1|Long-term Extension Period|Lost to Follow-up|1
1816389|NCT00430677|6305778|P3|Long-term Extension Period|Lack of Efficacy|8
1816390|NCT00430677|6305779|P2|Long-term Extension Period|Lack of Efficacy|3
1816391|NCT00430677|6305780|P1|Long-term Extension Period|Lack of Efficacy|5
1816392|NCT00430677|6305778|P3|Long-term Extension Period|Adverse Event|5
1816393|NCT00430677|6305779|P2|Long-term Extension Period|Adverse Event|2
1816394|NCT00430677|6305780|P1|Long-term Extension Period|Adverse Event|3
1816395|NCT00430677|6305778|P3|Long-term Extension Period|Death|0
1816396|NCT00430677|6305779|P2|Long-term Extension Period|Death|0
1816397|NCT00430677|6305780|P1|Long-term Extension Period|Death|1
1816398|NCT00430677|6305778|P3|Short-term Period|Pregnancy|0
1816399|NCT00430677|6305779|P2|Short-term Period|Pregnancy|2
1816400|NCT00430677|6305780|P1|Short-term Period|Pregnancy|0
1816401|NCT00430677|6305778|P3|Short-term Period|Poor compliance/ noncompliance|0
1816402|NCT00430677|6305779|P2|Short-term Period|Poor compliance/ noncompliance|1
1816403|NCT00430677|6305780|P1|Short-term Period|Poor compliance/ noncompliance|0
1816404|NCT00430677|6305778|P3|Short-term Period|Participant no longer met study criteria|2
1816405|NCT00430677|6305779|P2|Short-term Period|Participant no longer met study criteria|1
1816406|NCT00430677|6305780|P1|Short-term Period|Participant no longer met study criteria|1
1816407|NCT00430677|6305778|P3|Short-term Period|Withdrawal by Subject|2
1816408|NCT00430677|6305779|P2|Short-term Period|Withdrawal by Subject|1
1816409|NCT00430677|6305780|P1|Short-term Period|Withdrawal by Subject|1
1816410|NCT00430677|6305778|P3|Short-term Period|Lack of Efficacy|4
1816411|NCT00430677|6305779|P2|Short-term Period|Lack of Efficacy|6
1816412|NCT00430677|6305780|P1|Short-term Period|Lack of Efficacy|5
1816413|NCT00430677|6305778|P3|Short-term Period|Adverse Event|9
1816414|NCT00430677|6305779|P2|Short-term Period|Adverse Event|13
1816415|NCT00430677|6305780|P1|Short-term Period|Adverse Event|15
1816416|NCT00430677|6305778|P3|Short-term Period|Death|5
1816417|NCT00430677|6305779|P2|Short-term Period|Death|1
1816418|NCT00430677|6305780|P1|Short-term Period|Death|1
1816419|NCT00430638|6305903|P2|Overall Study|Other|2
1816420|NCT00430638|6305904|P1|Overall Study|Other|2
1816421|NCT00430638|6305903|P2|Overall Study|Non-compliant|1
1816422|NCT00430638|6305904|P1|Overall Study|Non-compliant|2
1816423|NCT00430638|6305903|P2|Overall Study|Withdrawal by Subject|6
1816424|NCT00430638|6305904|P1|Overall Study|Withdrawal by Subject|4
1816425|NCT00430638|6305903|P2|Overall Study|Protocol Violation|4
1816426|NCT00430638|6305904|P1|Overall Study|Protocol Violation|6
1816427|NCT00430638|6305903|P2|Overall Study|Lost to Follow-up|7
1816428|NCT00430638|6305904|P1|Overall Study|Lost to Follow-up|1
1816429|NCT00430638|6305903|P2|Overall Study|Uncontrolled blood pressure|13
1816430|NCT00430638|6305904|P1|Overall Study|Uncontrolled blood pressure|48
1816431|NCT00430638|6305903|P2|Overall Study|Adverse Event|15
1816432|NCT00430638|6305904|P1|Overall Study|Adverse Event|15
1816433|NCT00430573|6305939|P1|Overall Study|Withdrawal by Subject|5
1816434|NCT00430521|6305952|P8|Overall Study|Withdrawal by Subject|2
1816435|NCT00430521|6305953|P7|Overall Study|Withdrawal by Subject|0
1816436|NCT00430521|6305954|P6|Overall Study|Withdrawal by Subject|0
1816437|NCT00430521|6305955|P5|Overall Study|Withdrawal by Subject|0
1816438|NCT00430521|6305956|P4|Overall Study|Withdrawal by Subject|3
1816439|NCT00430521|6305957|P3|Overall Study|Withdrawal by Subject|0
1816440|NCT00430521|6305958|P2|Overall Study|Withdrawal by Subject|1
1816441|NCT00430521|6305959|P1|Overall Study|Withdrawal by Subject|3
1816442|NCT00430521|6305952|P8|Overall Study|Protocol Violation|0
1816443|NCT00430521|6305953|P7|Overall Study|Protocol Violation|0
1816444|NCT00430521|6305954|P6|Overall Study|Protocol Violation|0
1816445|NCT00430521|6305955|P5|Overall Study|Protocol Violation|0
1816446|NCT00430521|6305956|P4|Overall Study|Protocol Violation|0
1816447|NCT00430521|6305957|P3|Overall Study|Protocol Violation|0
1816448|NCT00430521|6305958|P2|Overall Study|Protocol Violation|0
1816449|NCT00430521|6305959|P1|Overall Study|Protocol Violation|1
1816450|NCT00430521|6305952|P8|Overall Study|Vaccine Expired|0
1816451|NCT00430521|6305953|P7|Overall Study|Vaccine Expired|0
1816452|NCT00430521|6305954|P6|Overall Study|Vaccine Expired|1
1816453|NCT00430521|6305955|P5|Overall Study|Vaccine Expired|0
1816454|NCT00430521|6305956|P4|Overall Study|Vaccine Expired|0
1816455|NCT00430521|6305957|P3|Overall Study|Vaccine Expired|0
1816456|NCT00430521|6305958|P2|Overall Study|Vaccine Expired|0
1816457|NCT00430521|6305959|P1|Overall Study|Vaccine Expired|0
1816458|NCT00430521|6305952|P8|Overall Study|Pregnancy|0
1816459|NCT00430521|6305953|P7|Overall Study|Pregnancy|1
1816460|NCT00430521|6305954|P6|Overall Study|Pregnancy|0
1816461|NCT00430521|6305955|P5|Overall Study|Pregnancy|0
1816462|NCT00430521|6305956|P4|Overall Study|Pregnancy|0
1816463|NCT00430521|6305957|P3|Overall Study|Pregnancy|0
1816464|NCT00430521|6305958|P2|Overall Study|Pregnancy|0
1816465|NCT00430521|6305959|P1|Overall Study|Pregnancy|0
1816466|NCT00430521|6305952|P8|Overall Study|Lost to Follow-up|10
1816467|NCT00430521|6305953|P7|Overall Study|Lost to Follow-up|8
1816468|NCT00430521|6305954|P6|Overall Study|Lost to Follow-up|2
1816469|NCT00430521|6305955|P5|Overall Study|Lost to Follow-up|5
1816470|NCT00430521|6305956|P4|Overall Study|Lost to Follow-up|5
1816471|NCT00430521|6305957|P3|Overall Study|Lost to Follow-up|3
1816472|NCT00430521|6305958|P2|Overall Study|Lost to Follow-up|8
1816473|NCT00430521|6305959|P1|Overall Study|Lost to Follow-up|7
1816474|NCT00430521|6305952|P8|Overall Study|Adverse Event|0
1816475|NCT00430521|6305953|P7|Overall Study|Adverse Event|1
1816476|NCT00430521|6305954|P6|Overall Study|Adverse Event|2
1816477|NCT00430521|6305955|P5|Overall Study|Adverse Event|0
1816478|NCT00430521|6305956|P4|Overall Study|Adverse Event|0
1816479|NCT00430521|6305957|P3|Overall Study|Adverse Event|0
1816480|NCT00430521|6305958|P2|Overall Study|Adverse Event|0
1816481|NCT00430521|6305959|P1|Overall Study|Adverse Event|0
1816482|NCT00430508|6306201|P4|Overall Study|Other|0
1816483|NCT00430508|6306202|P3|Overall Study|Other|3
1816484|NCT00430508|6306203|P2|Overall Study|Other|1
1816485|NCT00430508|6306204|P1|Overall Study|Other|1
1816486|NCT00430508|6306201|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
1816487|NCT00430508|6306202|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
1816488|NCT00430508|6306203|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
1816489|NCT00430508|6306204|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
1816490|NCT00430508|6306201|P4|Overall Study|responder at visit 4|0
1816491|NCT00430508|6306202|P3|Overall Study|responder at visit 4|2
1816492|NCT00430508|6306203|P2|Overall Study|responder at visit 4|0
1816493|NCT00430508|6306204|P1|Overall Study|responder at visit 4|0
1816494|NCT00430508|6306201|P4|Overall Study|Withdrawal by Subject|1
1816495|NCT00430508|6306202|P3|Overall Study|Withdrawal by Subject|1
1816496|NCT00430508|6306203|P2|Overall Study|Withdrawal by Subject|1
1816497|NCT00430508|6306204|P1|Overall Study|Withdrawal by Subject|0
1816498|NCT00430508|6306201|P4|Overall Study|Adverse Event|3
1816499|NCT00430508|6306202|P3|Overall Study|Adverse Event|5
1816500|NCT00430508|6306203|P2|Overall Study|Adverse Event|3
1816501|NCT00430508|6306204|P1|Overall Study|Adverse Event|2
1816502|NCT00430495|6306242|P4|Overall Study|Randomized but not Treated|0
1816503|NCT00430495|6306243|P3|Overall Study|Randomized but not Treated|0
1816504|NCT00430495|6306244|P2|Overall Study|Randomized but not Treated|0
1816505|NCT00430495|6306245|P1|Overall Study|Randomized but not Treated|2
1816506|NCT00430495|6306242|P4|Overall Study|Other|4
1816507|NCT00430495|6306243|P3|Overall Study|Other|5
1816508|NCT00430495|6306244|P2|Overall Study|Other|2
1816509|NCT00430495|6306245|P1|Overall Study|Other|8
1816510|NCT00430495|6306242|P4|Overall Study|Disease Progression|0
1816511|NCT00430495|6306243|P3|Overall Study|Disease Progression|0
1816512|NCT00430495|6306244|P2|Overall Study|Disease Progression|1
1816513|NCT00430495|6306245|P1|Overall Study|Disease Progression|1
1816514|NCT00430495|6306242|P4|Overall Study|Protocol Violation|0
1816515|NCT00430495|6306243|P3|Overall Study|Protocol Violation|1
1816516|NCT00430495|6306244|P2|Overall Study|Protocol Violation|0
1816517|NCT00430495|6306245|P1|Overall Study|Protocol Violation|1
1816518|NCT00430495|6306242|P4|Overall Study|Lost to Follow-up|0
1816519|NCT00430495|6306243|P3|Overall Study|Lost to Follow-up|4
1816520|NCT00430495|6306244|P2|Overall Study|Lost to Follow-up|1
1816521|NCT00430495|6306245|P1|Overall Study|Lost to Follow-up|0
1816522|NCT00430495|6306242|P4|Overall Study|Death|0
1816523|NCT00430495|6306243|P3|Overall Study|Death|1
1816524|NCT00430495|6306244|P2|Overall Study|Death|0
1816525|NCT00430495|6306245|P1|Overall Study|Death|0
1816526|NCT00430495|6306242|P4|Overall Study|Adverse Event|0
1816527|NCT00430495|6306243|P3|Overall Study|Adverse Event|2
1816528|NCT00430495|6306244|P2|Overall Study|Adverse Event|3
1816529|NCT00430495|6306245|P1|Overall Study|Adverse Event|2
1816530|NCT00430482|6306285|P2|Completed Treatment|Insufficient Treatment|11
1816531|NCT00430482|6306286|P1|Completed Treatment|Insufficient Treatment|7
1816532|NCT00430352|6306294|P1|Overall Study|Other|48
1816533|NCT00430352|6306294|P1|Overall Study|Death|5
1816534|NCT00430352|6306294|P1|Overall Study|Adverse Event|16
1816535|NCT00430352|6306294|P1|Overall Study|Withdrawal by Subject|11
1816536|NCT00430352|6306294|P1|Overall Study|Disease progression|58
1816537|NCT00430300|6306312|P4|Overall Study|Other|1
1816538|NCT00430300|6306313|P3|Overall Study|Other|0
1816539|NCT00430300|6306314|P2|Overall Study|Other|0
1816540|NCT00430300|6306315|P1|Overall Study|Other|0
1816541|NCT00430300|6306312|P4|Overall Study|Laboratory abnormality|0
1816542|NCT00430300|6306313|P3|Overall Study|Laboratory abnormality|0
1816543|NCT00430300|6306314|P2|Overall Study|Laboratory abnormality|0
1816544|NCT00430300|6306315|P1|Overall Study|Laboratory abnormality|1
1816545|NCT00430300|6306312|P4|Overall Study|Withdrawal by Subject|0
1816546|NCT00430300|6306313|P3|Overall Study|Withdrawal by Subject|5
1816547|NCT00430300|6306314|P2|Overall Study|Withdrawal by Subject|0
1816548|NCT00430300|6306315|P1|Overall Study|Withdrawal by Subject|1
1816549|NCT00430300|6306312|P4|Overall Study|Adverse Event|1
1816550|NCT00430300|6306313|P3|Overall Study|Adverse Event|1
1816551|NCT00430300|6306314|P2|Overall Study|Adverse Event|2
1816552|NCT00430300|6306315|P1|Overall Study|Adverse Event|0
1816553|NCT00430248|6306420|P3|Overall Study|Reason Not Specified|11
1816554|NCT00430248|6306421|P2|Overall Study|Reason Not Specified|8
1816555|NCT00430248|6306422|P1|Overall Study|Reason Not Specified|8
1816556|NCT00430248|6306420|P3|Overall Study|Gout Flare|2
1816557|NCT00430248|6306421|P2|Overall Study|Gout Flare|7
1816558|NCT00430248|6306422|P1|Overall Study|Gout Flare|3
1816559|NCT00430248|6306420|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1816560|NCT00430248|6306421|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1816561|NCT00430248|6306422|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1816562|NCT00430248|6306420|P3|Overall Study|Withdrawal by Subject|16
1816563|NCT00430248|6306421|P2|Overall Study|Withdrawal by Subject|20
1816564|NCT00430248|6306422|P1|Overall Study|Withdrawal by Subject|14
1816565|NCT00430248|6306420|P3|Overall Study|Therapeutic Failure|1
1816566|NCT00430248|6306421|P2|Overall Study|Therapeutic Failure|1
1816567|NCT00430248|6306422|P1|Overall Study|Therapeutic Failure|1
1816568|NCT00430248|6306420|P3|Overall Study|Lost to Follow-up|28
1816569|NCT00430248|6306421|P2|Overall Study|Lost to Follow-up|33
1816570|NCT00430248|6306422|P1|Overall Study|Lost to Follow-up|28
1816571|NCT00430248|6306420|P3|Overall Study|Personal Reasons|9
1816572|NCT00430248|6306421|P2|Overall Study|Personal Reasons|24
1816573|NCT00430248|6306422|P1|Overall Study|Personal Reasons|12
1816574|NCT00430248|6306420|P3|Overall Study|Protocol Violation|4
1816575|NCT00430248|6306421|P2|Overall Study|Protocol Violation|2
1816576|NCT00430248|6306422|P1|Overall Study|Protocol Violation|10
1816577|NCT00430248|6306420|P3|Overall Study|Adverse Event|64
1816578|NCT00430248|6306421|P2|Overall Study|Adverse Event|61
1816579|NCT00430248|6306422|P1|Overall Study|Adverse Event|49
1816580|NCT00430092|6306490|P3|Overall Study|Withdrawal by Subject|1
1816581|NCT00430092|6306491|P2|Overall Study|Withdrawal by Subject|1
1816582|NCT00430092|6306492|P1|Overall Study|Withdrawal by Subject|0
1816583|NCT00430092|6306490|P3|Overall Study|Protocol Violation|1
1816584|NCT00430092|6306491|P2|Overall Study|Protocol Violation|1
1816585|NCT00430092|6306492|P1|Overall Study|Protocol Violation|0
1816586|NCT00430092|6306490|P3|Overall Study|Lost to Follow-up|0
1816587|NCT00430092|6306491|P2|Overall Study|Lost to Follow-up|0
1816588|NCT00430092|6306492|P1|Overall Study|Lost to Follow-up|1
1816589|NCT00430092|6306490|P3|Overall Study|Lack of Efficacy|54
1816590|NCT00430092|6306491|P2|Overall Study|Lack of Efficacy|2
1816591|NCT00430092|6306492|P1|Overall Study|Lack of Efficacy|5
1816592|NCT00430092|6306490|P3|Overall Study|Adverse Event|1
1816593|NCT00430092|6306491|P2|Overall Study|Adverse Event|0
1816594|NCT00430092|6306492|P1|Overall Study|Adverse Event|0
1816595|NCT00430027|6306497|P1|Overall Study|Study terminated|8
1816596|NCT00429923|6306514|P3|Overall Study|Early Termination|0
1816597|NCT00429923|6306515|P2|Overall Study|Early Termination|1
1816598|NCT00429923|6306516|P1|Overall Study|Early Termination|0
1816599|NCT00429923|6306514|P3|Overall Study|Withdrew Consent|1
1816600|NCT00429923|6306515|P2|Overall Study|Withdrew Consent|0
1816601|NCT00429923|6306516|P1|Overall Study|Withdrew Consent|1
1816602|NCT00429923|6306514|P3|Overall Study|Lost to Follow-up|2
1816603|NCT00429923|6306515|P2|Overall Study|Lost to Follow-up|0
1816604|NCT00429923|6306516|P1|Overall Study|Lost to Follow-up|0
1816605|NCT00429923|6306514|P3|Overall Study|Lack of Efficacy|33
1816606|NCT00429923|6306515|P2|Overall Study|Lack of Efficacy|1
1816607|NCT00429923|6306516|P1|Overall Study|Lack of Efficacy|4
1816608|NCT00429923|6306514|P3|Overall Study|Adverse Event|3
1816609|NCT00429923|6306515|P2|Overall Study|Adverse Event|2
1816610|NCT00429923|6306516|P1|Overall Study|Adverse Event|0
1816611|NCT00429793|6306521|P1|Overall Study|Non-measurable|1
1816612|NCT00429793|6306521|P1|Overall Study|Never treated|1
1816613|NCT00429793|6306521|P1|Overall Study|Required test not done|1
1816614|NCT00429793|6306521|P1|Overall Study|Improper pre-protocol treatment|3
1816615|NCT00429663|6306548|P2|Overall Study|Death|0
1816616|NCT00429663|6306549|P1|Overall Study|Death|4
1816617|NCT00429663|6306548|P2|Overall Study|Withdrawal by Subject|5
1816618|NCT00429663|6306549|P1|Overall Study|Withdrawal by Subject|2
1816619|NCT00429663|6306548|P2|Overall Study|Physician Decision|3
1816620|NCT00429663|6306549|P1|Overall Study|Physician Decision|6
1816621|NCT00429663|6306548|P2|Overall Study|Lost to Follow-up|31
1816622|NCT00429663|6306549|P1|Overall Study|Lost to Follow-up|24
1816623|NCT00429572|6306563|P1|Overall Study|Disease progression|1
1816624|NCT00429494|6306575|P1|Overall Study|Death|6
1816625|NCT00429494|6306575|P1|Overall Study|Withdrawal by Subject|9
1816626|NCT00429416|6306579|P1|Overall Study|Death|1
1816627|NCT00429364|6306598|P2|Overall Study|Pregnancy|1
1816628|NCT00429364|6306599|P1|Overall Study|Pregnancy|0
1816629|NCT00429364|6306598|P2|Overall Study|Underwent aortic root surgery|18
1816630|NCT00429364|6306599|P1|Overall Study|Underwent aortic root surgery|10
1816631|NCT00429364|6306598|P2|Overall Study|Death|1
1816632|NCT00429364|6306599|P1|Overall Study|Death|0
1816633|NCT00429364|6306598|P2|Overall Study|Lost to Follow-up|6
1816634|NCT00429364|6306599|P1|Overall Study|Lost to Follow-up|7
1816635|NCT00429364|6306598|P2|Overall Study|Physician Decision|2
1816636|NCT00429364|6306599|P1|Overall Study|Physician Decision|4
1816637|NCT00429364|6306598|P2|Overall Study|Withdrawal by Subject|5
1816638|NCT00429364|6306599|P1|Overall Study|Withdrawal by Subject|11
1816639|NCT00429299|6306658|P3|Overall Study|Withdrawal by Subject|3
1816640|NCT00429299|6306659|P2|Overall Study|Withdrawal by Subject|1
1816641|NCT00429299|6306660|P1|Overall Study|Withdrawal by Subject|0
1816642|NCT00429299|6306658|P3|Overall Study|Protocol Violation|0
1816643|NCT00429299|6306659|P2|Overall Study|Protocol Violation|0
1816644|NCT00429299|6306660|P1|Overall Study|Protocol Violation|1
1816645|NCT00429299|6306658|P3|Overall Study|Adverse Event|1
1816646|NCT00429299|6306659|P2|Overall Study|Adverse Event|5
1816647|NCT00429299|6306660|P1|Overall Study|Adverse Event|2
1816648|NCT00429299|6306658|P3|Overall Study|Disease Progression|0
1816649|NCT00429299|6306659|P2|Overall Study|Disease Progression|1
1816650|NCT00429299|6306660|P1|Overall Study|Disease Progression|1
1816651|NCT00429273|6306692|P3|Overall Study|Adverse Event|2
1816652|NCT00429273|6306693|P2|Overall Study|Adverse Event|1
1816653|NCT00429273|6306694|P1|Overall Study|Adverse Event|1
1816654|NCT00429273|6306692|P3|Overall Study|Physician Decision|5
1816655|NCT00429273|6306693|P2|Overall Study|Physician Decision|5
1816656|NCT00429273|6306694|P1|Overall Study|Physician Decision|6
1816657|NCT00429273|6306692|P3|Overall Study|Lost to Follow-up|2
1816658|NCT00429273|6306693|P2|Overall Study|Lost to Follow-up|2
1816659|NCT00429273|6306694|P1|Overall Study|Lost to Follow-up|1
1816660|NCT00429182|6306702|P1|Overall Study|Not eligible|5
1816661|NCT00429182|6306702|P1|Overall Study|Not evaluable, Disease Progression|2
1816662|NCT00429169|6306709|P2|Overall Study|Ineligibility discovered after entry|1
1816663|NCT00429169|6306710|P1|Overall Study|Ineligibility discovered after entry|2
1816664|NCT00429169|6306709|P2|Overall Study|Lost to Follow-up|1
1816665|NCT00429169|6306710|P1|Overall Study|Lost to Follow-up|0
1816666|NCT00429104|6306730|P1|Overall Study|Protocol Violation|1
1816667|NCT00429026|6306735|P1|Overall Study|Inevaluable for response.|40
1816668|NCT00428948|6306762|P2|Overall Study|Protocol Deviation|1
1816669|NCT00428948|6306763|P1|Overall Study|Protocol Deviation|1
1816670|NCT00428948|6306762|P2|Overall Study|Subject Withdrew Consent|30
1816671|NCT00428948|6306763|P1|Overall Study|Subject Withdrew Consent|50
1816672|NCT00428948|6306762|P2|Overall Study|Investigator Withdrew Subject|4
1816673|NCT00428948|6306763|P1|Overall Study|Investigator Withdrew Subject|3
1816674|NCT00428948|6306762|P2|Overall Study|Subject Met Withdrawal Criteria|0
1816675|NCT00428948|6306763|P1|Overall Study|Subject Met Withdrawal Criteria|4
1816676|NCT00428948|6306762|P2|Overall Study|Adverse Event|24
1816677|NCT00428948|6306763|P1|Overall Study|Adverse Event|148
1816678|NCT00428948|6306762|P2|Overall Study|Lost to Follow-up|8
1816679|NCT00428948|6306763|P1|Overall Study|Lost to Follow-up|15
1816680|NCT00428844|6306791|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
1816681|NCT00428844|6306792|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
1816682|NCT00428844|6306793|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
1816683|NCT00428844|6306791|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
1816684|NCT00428844|6306792|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
1816685|NCT00428844|6306793|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
1816686|NCT00428844|6306791|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
1816687|NCT00428844|6306792|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
1816688|NCT00428844|6306793|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
1816689|NCT00428844|6306791|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
1816690|NCT00428844|6306792|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
1816691|NCT00428844|6306793|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
1816692|NCT00428844|6306791|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
1816693|NCT00428844|6306792|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
1816694|NCT00428844|6306793|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
1816695|NCT00428844|6306791|P3|Completed Study Drug Treatment|Randomized Not Treated|1
1816696|NCT00428844|6306792|P2|Completed Study Drug Treatment|Randomized Not Treated|0
1816697|NCT00428844|6306793|P1|Completed Study Drug Treatment|Randomized Not Treated|0
1816698|NCT00428844|6306791|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
1816699|NCT00428844|6306792|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
1816700|NCT00428844|6306793|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
1816701|NCT00428844|6306791|P3|Completed Study Drug Treatment|Protocol Violation|1
1816702|NCT00428844|6306792|P2|Completed Study Drug Treatment|Protocol Violation|1
1816703|NCT00428844|6306793|P1|Completed Study Drug Treatment|Protocol Violation|0
1816704|NCT00428844|6306791|P3|Completed Study Drug Treatment|Adverse Event|4
1816705|NCT00428844|6306792|P2|Completed Study Drug Treatment|Adverse Event|4
1816706|NCT00428844|6306793|P1|Completed Study Drug Treatment|Adverse Event|2
1816707|NCT00428792|6306816|P2|Overall Study|Lost to Follow-up|1
1816708|NCT00428792|6306817|P1|Overall Study|Lost to Follow-up|0
1816709|NCT00428792|6306816|P2|Overall Study|Lack of Efficacy|3
1816710|NCT00428792|6306817|P1|Overall Study|Lack of Efficacy|1
1816711|NCT00428610|6306844|P3|Overall Study|Withdrawal by Subject|0
1816712|NCT00428610|6306845|P2|Overall Study|Withdrawal by Subject|0
1816713|NCT00428610|6306846|P1|Overall Study|Withdrawal by Subject|4
1816714|NCT00428610|6306844|P3|Overall Study|Progressive Disease|22
1816715|NCT00428610|6306845|P2|Overall Study|Progressive Disease|14
1816716|NCT00428610|6306846|P1|Overall Study|Progressive Disease|42
1816717|NCT00428610|6306844|P3|Overall Study|Investigator Decision|1
1816718|NCT00428610|6306845|P2|Overall Study|Investigator Decision|1
1816719|NCT00428610|6306846|P1|Overall Study|Investigator Decision|2
1816720|NCT00428610|6306844|P3|Overall Study|Adverse Event|2
1816721|NCT00428610|6306845|P2|Overall Study|Adverse Event|3
1816722|NCT00428610|6306846|P1|Overall Study|Adverse Event|2
1816723|NCT00428610|6306844|P3|Overall Study|Death Due to Progressive Disease|2
1816724|NCT00428610|6306845|P2|Overall Study|Death Due to Progressive Disease|0
1816725|NCT00428610|6306846|P1|Overall Study|Death Due to Progressive Disease|0
1816726|NCT00428610|6306844|P3|Overall Study|Death Due to Adverse Event|5
1816727|NCT00428610|6306845|P2|Overall Study|Death Due to Adverse Event|0
1816728|NCT00428610|6306846|P1|Overall Study|Death Due to Adverse Event|3
1816729|NCT00428597|6306880|P2|Overall Study|Death|3
1816730|NCT00428597|6306881|P1|Overall Study|Death|1
1816731|NCT00428597|6306880|P2|Overall Study|Pregnancy|0
1816732|NCT00428597|6306881|P1|Overall Study|Pregnancy|1
1816733|NCT00428597|6306880|P2|Overall Study|Lost to Follow-up|1
1816734|NCT00428597|6306881|P1|Overall Study|Lost to Follow-up|0
1816735|NCT00428597|6306880|P2|Overall Study|Other|1
1816736|NCT00428597|6306881|P1|Overall Study|Other|1
1816737|NCT00428597|6306880|P2|Overall Study|Withdrawal by Subject|1
1816738|NCT00428597|6306881|P1|Overall Study|Withdrawal by Subject|2
1816739|NCT00428597|6306880|P2|Overall Study|Protocol Violation|1
1816740|NCT00428597|6306881|P1|Overall Study|Protocol Violation|2
1816741|NCT00428597|6306880|P2|Overall Study|Global Deterioration of Health Status|5
1816742|NCT00428597|6306881|P1|Overall Study|Global Deterioration of Health Status|1
1816743|NCT00428597|6306880|P2|Overall Study|Adverse Event|7
1816744|NCT00428597|6306881|P1|Overall Study|Adverse Event|15
1816745|NCT00428597|6306880|P2|Overall Study|Study Terminated by Sponsor|16
1816746|NCT00428597|6306881|P1|Overall Study|Study Terminated by Sponsor|41
1816747|NCT00428597|6306880|P2|Overall Study|Objective Progression or Relapse|47
1816748|NCT00428597|6306881|P1|Overall Study|Objective Progression or Relapse|19
1816749|NCT00428597|6306880|P2|Overall Study|Randomized but not treated|3
1816750|NCT00428597|6306881|P1|Overall Study|Randomized but not treated|3
1816751|NCT00428441|6306948|P1|Overall Study|Lost to Follow-up|1
1816752|NCT00428389|6306954|P2|Extension Phase|Administrative problems|1
1816753|NCT00428389|6306955|P1|Extension Phase|Administrative problems|1
1816754|NCT00428389|6306954|P2|Extension Phase|Protocol Violation|2
1816755|NCT00428389|6306955|P1|Extension Phase|Protocol Violation|3
1816756|NCT00428389|6306954|P2|Extension Phase|Death|0
1816757|NCT00428389|6306955|P1|Extension Phase|Death|1
1816758|NCT00428389|6306954|P2|Extension Phase|Lost to Follow-up|3
1816759|NCT00428389|6306955|P1|Extension Phase|Lost to Follow-up|0
1816760|NCT00428389|6306954|P2|Extension Phase|Withdrawal by Subject|6
1816761|NCT00428389|6306955|P1|Extension Phase|Withdrawal by Subject|6
1816762|NCT00428389|6306954|P2|Extension Phase|Lack of Efficacy|3
1816763|NCT00428389|6306955|P1|Extension Phase|Lack of Efficacy|4
1816764|NCT00428389|6306954|P2|Extension Phase|Adverse Event|11
1816765|NCT00428389|6306955|P1|Extension Phase|Adverse Event|17
1816766|NCT00428389|6306954|P2|Core Phase|Protocol deviation|2
1816767|NCT00428389|6306955|P1|Core Phase|Protocol deviation|0
1816768|NCT00428389|6306954|P2|Core Phase|Withdrawal by Subject|4
1816769|NCT00428389|6306955|P1|Core Phase|Withdrawal by Subject|3
1816770|NCT00428389|6306954|P2|Core Phase|Abnormal test procedure result(s)|1
1816771|NCT00428389|6306955|P1|Core Phase|Abnormal test procedure result(s)|0
1816772|NCT00428389|6306954|P2|Core Phase|Lack of Efficacy|0
1816773|NCT00428389|6306955|P1|Core Phase|Lack of Efficacy|2
1816774|NCT00428389|6306954|P2|Core Phase|Adverse Event|4
1816775|NCT00428389|6306955|P1|Core Phase|Adverse Event|6
1816776|NCT00428246|6306989|P3|Overall Study|Adverse Event|0
1816777|NCT00428246|6306990|P2|Overall Study|Adverse Event|0
1816778|NCT00428246|6306991|P1|Overall Study|Adverse Event|1
1816779|NCT00428246|6306989|P3|Overall Study|Withdrawal by Subject|1
1816780|NCT00428246|6306990|P2|Overall Study|Withdrawal by Subject|0
1816781|NCT00428246|6306991|P1|Overall Study|Withdrawal by Subject|0
1816782|NCT00428220|6306999|P1|Overall Study|Other|23
1816783|NCT00428220|6306999|P1|Overall Study|Adverse Event|51
1816784|NCT00428220|6306999|P1|Overall Study|Participant refused continued treatment|7
1816785|NCT00428220|6306999|P1|Overall Study|Objective progression or relapse|123
1816786|NCT00428220|6306999|P1|Overall Study|Lost to Follow-up|4
1816787|NCT00428220|6306999|P1|Overall Study|Global deterioration of health status|7
1816788|NCT00428220|6306999|P1|Overall Study|Participant died|8
1816789|NCT00428116|6307024|P2|Overall Study|Lost to Follow-up|0
1816790|NCT00428116|6307025|P1|Overall Study|Lost to Follow-up|1
1816791|NCT00428116|6307024|P2|Overall Study|Withdrawal by Subject|0
1816792|NCT00428116|6307025|P1|Overall Study|Withdrawal by Subject|1
1816793|NCT00428116|6307024|P2|Overall Study|Death|0
1816794|NCT00428116|6307025|P1|Overall Study|Death|1
1816795|NCT00428090|6307037|P4|Overall Study|Raised Creatinine Value|1
1816796|NCT00428090|6307038|P3|Overall Study|Raised Creatinine Value|0
1816797|NCT00428090|6307039|P2|Overall Study|Raised Creatinine Value|0
1816798|NCT00428090|6307040|P1|Overall Study|Raised Creatinine Value|0
1816799|NCT00428090|6307037|P4|Overall Study|Excluded for heart insufficiency|0
1816800|NCT00428090|6307038|P3|Overall Study|Excluded for heart insufficiency|1
1816801|NCT00428090|6307039|P2|Overall Study|Excluded for heart insufficiency|0
1816802|NCT00428090|6307040|P1|Overall Study|Excluded for heart insufficiency|0
1816803|NCT00428090|6307037|P4|Overall Study|Serious adverse event|0
1816804|NCT00428090|6307038|P3|Overall Study|Serious adverse event|1
1816805|NCT00428090|6307039|P2|Overall Study|Serious adverse event|0
1816806|NCT00428090|6307040|P1|Overall Study|Serious adverse event|0
1816807|NCT00428090|6307037|P4|Overall Study|Deterioration of cognitive status|0
1816808|NCT00428090|6307038|P3|Overall Study|Deterioration of cognitive status|1
1816809|NCT00428090|6307039|P2|Overall Study|Deterioration of cognitive status|0
1816810|NCT00428090|6307040|P1|Overall Study|Deterioration of cognitive status|0
1816811|NCT00428090|6307037|P4|Overall Study|High MMSE scores|0
1816812|NCT00428090|6307038|P3|Overall Study|High MMSE scores|1
1816813|NCT00428090|6307039|P2|Overall Study|High MMSE scores|0
1816814|NCT00428090|6307040|P1|Overall Study|High MMSE scores|0
1816815|NCT00428090|6307037|P4|Overall Study|Insufficient AD documentation|0
1816816|NCT00428090|6307038|P3|Overall Study|Insufficient AD documentation|1
1816817|NCT00428090|6307039|P2|Overall Study|Insufficient AD documentation|0
1816818|NCT00428090|6307040|P1|Overall Study|Insufficient AD documentation|0
1816819|NCT00428090|6307037|P4|Overall Study|Excluded for concerning QTc value|0
1816820|NCT00428090|6307038|P3|Overall Study|Excluded for concerning QTc value|1
1816821|NCT00428090|6307039|P2|Overall Study|Excluded for concerning QTc value|0
1816822|NCT00428090|6307040|P1|Overall Study|Excluded for concerning QTc value|0
1816823|NCT00428090|6307037|P4|Overall Study|Worsening of AD|0
1816824|NCT00428090|6307038|P3|Overall Study|Worsening of AD|1
1816825|NCT00428090|6307039|P2|Overall Study|Worsening of AD|0
1816826|NCT00428090|6307040|P1|Overall Study|Worsening of AD|0
1816827|NCT00428090|6307037|P4|Overall Study|Mental status of par. was|0
1816828|NCT00428090|6307038|P3|Overall Study|Mental status of par. was|0
1816829|NCT00428090|6307039|P2|Overall Study|Mental status of par. was|1
1816830|NCT00428090|6307040|P1|Overall Study|Mental status of par. was|0
1816831|NCT00428090|6307037|P4|Overall Study|Medical monitor terminated par.|0
1816832|NCT00428090|6307038|P3|Overall Study|Medical monitor terminated par.|0
1816833|NCT00428090|6307039|P2|Overall Study|Medical monitor terminated par.|1
1816834|NCT00428090|6307040|P1|Overall Study|Medical monitor terminated par.|0
1816835|NCT00428090|6307037|P4|Overall Study|Visit 7 exceed the visit window|0
1816836|NCT00428090|6307038|P3|Overall Study|Visit 7 exceed the visit window|0
1816837|NCT00428090|6307039|P2|Overall Study|Visit 7 exceed the visit window|1
1816838|NCT00428090|6307040|P1|Overall Study|Visit 7 exceed the visit window|0
1816839|NCT00428090|6307037|P4|Overall Study|Death of par.|0
1816840|NCT00428090|6307038|P3|Overall Study|Death of par.|1
1816841|NCT00428090|6307039|P2|Overall Study|Death of par.|0
1816842|NCT00428090|6307040|P1|Overall Study|Death of par.|1
1816843|NCT00428090|6307037|P4|Overall Study|Prohibited medication used for SAE|0
1816844|NCT00428090|6307038|P3|Overall Study|Prohibited medication used for SAE|0
1816845|NCT00428090|6307039|P2|Overall Study|Prohibited medication used for SAE|0
1816846|NCT00428090|6307040|P1|Overall Study|Prohibited medication used for SAE|1
1816847|NCT00428090|6307037|P4|Overall Study|Follow-Up visit not possible|0
1816848|NCT00428090|6307038|P3|Overall Study|Follow-Up visit not possible|0
1816849|NCT00428090|6307039|P2|Overall Study|Follow-Up visit not possible|0
1816850|NCT00428090|6307040|P1|Overall Study|Follow-Up visit not possible|1
1816851|NCT00428090|6307037|P4|Overall Study|Par. did not returned to visit|1
1816852|NCT00428090|6307038|P3|Overall Study|Par. did not returned to visit|0
1816853|NCT00428090|6307039|P2|Overall Study|Par. did not returned to visit|0
1816854|NCT00428090|6307040|P1|Overall Study|Par. did not returned to visit|1
1816855|NCT00428090|6307037|P4|Overall Study|Non-compliance|3
1816856|NCT00428090|6307038|P3|Overall Study|Non-compliance|1
1816857|NCT00428090|6307039|P2|Overall Study|Non-compliance|0
1816858|NCT00428090|6307040|P1|Overall Study|Non-compliance|4
1816859|NCT00428090|6307037|P4|Overall Study|Sponsor terminated study|0
1816860|NCT00428090|6307038|P3|Overall Study|Sponsor terminated study|0
1816861|NCT00428090|6307039|P2|Overall Study|Sponsor terminated study|1
1816862|NCT00428090|6307040|P1|Overall Study|Sponsor terminated study|0
1816863|NCT00428090|6307037|P4|Overall Study|Withdrawal by Subject|5
1816864|NCT00428090|6307038|P3|Overall Study|Withdrawal by Subject|15
1816865|NCT00428090|6307039|P2|Overall Study|Withdrawal by Subject|12
1816866|NCT00428090|6307040|P1|Overall Study|Withdrawal by Subject|10
1816867|NCT00428090|6307037|P4|Overall Study|Protocol Violation|3
1816868|NCT00428090|6307038|P3|Overall Study|Protocol Violation|3
1816869|NCT00428090|6307039|P2|Overall Study|Protocol Violation|1
1816870|NCT00428090|6307040|P1|Overall Study|Protocol Violation|3
1816871|NCT00428090|6307037|P4|Overall Study|Lost to Follow-up|4
1816872|NCT00428090|6307038|P3|Overall Study|Lost to Follow-up|1
1816873|NCT00428090|6307039|P2|Overall Study|Lost to Follow-up|6
1816874|NCT00428090|6307040|P1|Overall Study|Lost to Follow-up|3
1816875|NCT00428090|6307037|P4|Overall Study|Adverse Event|11
1816876|NCT00428090|6307038|P3|Overall Study|Adverse Event|10
1816877|NCT00428090|6307039|P2|Overall Study|Adverse Event|8
1816878|NCT00428090|6307040|P1|Overall Study|Adverse Event|10
1816879|NCT00427999|6307158|P1|Overall Study|Death|1
1816880|NCT00427999|6307158|P1|Overall Study|Withdrawal by Subject|9
1816881|NCT00427999|6307158|P1|Overall Study|Protocol Violation|2
1816882|NCT00427999|6307158|P1|Overall Study|Unsatisfactory therapeutic effect|13
1816883|NCT00427999|6307158|P1|Overall Study|Abnormal laboratory values|1
1816884|NCT00427999|6307158|P1|Overall Study|Adverse Event|6
1816885|NCT00427960|6307176|P2|Overall Study|Other|1
1816886|NCT00427960|6307177|P1|Overall Study|Other|0
1816887|NCT00427960|6307176|P2|Overall Study|Withdrawal by Subject|3
1816888|NCT00427960|6307177|P1|Overall Study|Withdrawal by Subject|0
1816889|NCT00427960|6307176|P2|Overall Study|Adverse Event|0
1816890|NCT00427960|6307177|P1|Overall Study|Adverse Event|2
1816891|NCT00427934|6307215|P4|Overall Study|Withdrawal by Subject|3
1816892|NCT00427934|6307216|P3|Overall Study|Withdrawal by Subject|1
1816893|NCT00427934|6307217|P2|Overall Study|Withdrawal by Subject|0
1816894|NCT00427934|6307218|P1|Overall Study|Withdrawal by Subject|0
1816895|NCT00427934|6307215|P4|Overall Study|Other|5
1816896|NCT00427934|6307216|P3|Overall Study|Other|11
1816897|NCT00427934|6307217|P2|Overall Study|Other|0
1816898|NCT00427934|6307218|P1|Overall Study|Other|0
1816899|NCT00427934|6307215|P4|Overall Study|Randomized But Did Not Receive Treatment|1
1816900|NCT00427934|6307216|P3|Overall Study|Randomized But Did Not Receive Treatment|1
1816901|NCT00427934|6307217|P2|Overall Study|Randomized But Did Not Receive Treatment|0
1816902|NCT00427934|6307218|P1|Overall Study|Randomized But Did Not Receive Treatment|0
1816903|NCT00427934|6307215|P4|Overall Study|Lack of Efficacy|2
1816904|NCT00427934|6307216|P3|Overall Study|Lack of Efficacy|5
1816905|NCT00427934|6307217|P2|Overall Study|Lack of Efficacy|0
1816906|NCT00427934|6307218|P1|Overall Study|Lack of Efficacy|0
1816907|NCT00427934|6307215|P4|Overall Study|Adverse Event|4
1816908|NCT00427934|6307216|P3|Overall Study|Adverse Event|5
1816909|NCT00427934|6307217|P2|Overall Study|Adverse Event|0
1816910|NCT00427934|6307218|P1|Overall Study|Adverse Event|1
1816911|NCT00427921|6307286|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
1816912|NCT00427921|6307286|P1|Overall Study|Adverse Event + Withdrawn from Study|1
1816913|NCT00427921|6307286|P1|Overall Study|Adverse Event + Lost Response|1
1816914|NCT00427921|6307286|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
1816915|NCT00427921|6307286|P1|Overall Study|Adverse Event + Worsening of CD|1
1816916|NCT00427921|6307286|P1|Overall Study|Adverse Event + No Response|1
1816917|NCT00427921|6307286|P1|Overall Study|Adverse Event + Withdrew Consent|1
1816918|NCT00427921|6307286|P1|Overall Study|Adverse Event + Hospitalization|1
1816919|NCT00427921|6307286|P1|Overall Study|Other reason not specified|10
1816920|NCT00427921|6307286|P1|Overall Study|Lost to Follow-up|2
1816921|NCT00427921|6307286|P1|Overall Study|Withdrawal by Subject|4
1816922|NCT00427921|6307286|P1|Overall Study|Adverse Event|26
1816923|NCT00427908|6307309|P4|Primary Phase|Adverse Event|0
1816924|NCT00427908|6307310|P3|Primary Phase|Adverse Event|0
1816925|NCT00427908|6307311|P2|Primary Phase|Adverse Event|1
1816926|NCT00427908|6307312|P1|Primary Phase|Adverse Event|0
1816927|NCT00427908|6307309|P4|Primary Phase|Withdrawal by Subject|0
1816928|NCT00427908|6307310|P3|Primary Phase|Withdrawal by Subject|1
1816929|NCT00427908|6307311|P2|Primary Phase|Withdrawal by Subject|2
1816930|NCT00427908|6307312|P1|Primary Phase|Withdrawal by Subject|1
1816931|NCT00427908|6307309|P4|Primary Phase|Lost to Follow-up|0
1816932|NCT00427908|6307310|P3|Primary Phase|Lost to Follow-up|2
1816933|NCT00427908|6307311|P2|Primary Phase|Lost to Follow-up|0
1816934|NCT00427908|6307312|P1|Primary Phase|Lost to Follow-up|4
1816935|NCT00427895|6307512|P8|Vax 2/Year 3 to 4|Failed to Return|0
1816936|NCT00427895|6307513|P7|Vax 2/Year 3 to 4|Failed to Return|0
1816937|NCT00427895|6307514|P6|Vax 2/Year 3 to 4|Failed to Return|0
1816938|NCT00427895|6307515|P5|Vax 2/Year 3 to 4|Failed to Return|1
1816939|NCT00427895|6307516|P4|Vax 2/Year 3 to 4|Failed to Return|0
1816940|NCT00427895|6307517|P3|Vax 2/Year 3 to 4|Failed to Return|0
1816941|NCT00427895|6307518|P2|Vax 2/Year 3 to 4|Failed to Return|0
1816942|NCT00427895|6307519|P1|Vax 2/Year 3 to 4|Failed to Return|0
1816943|NCT00427895|6307512|P8|Vax 2/Year 3 to 4|Protocol Violation|1
1816944|NCT00427895|6307513|P7|Vax 2/Year 3 to 4|Protocol Violation|0
1816945|NCT00427895|6307514|P6|Vax 2/Year 3 to 4|Protocol Violation|0
1816946|NCT00427895|6307515|P5|Vax 2/Year 3 to 4|Protocol Violation|0
1816947|NCT00427895|6307516|P4|Vax 2/Year 3 to 4|Protocol Violation|0
1816948|NCT00427895|6307517|P3|Vax 2/Year 3 to 4|Protocol Violation|0
1816949|NCT00427895|6307518|P2|Vax 2/Year 3 to 4|Protocol Violation|0
1816950|NCT00427895|6307519|P1|Vax 2/Year 3 to 4|Protocol Violation|0
1816951|NCT00427895|6307512|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
1816952|NCT00427895|6307513|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
1816953|NCT00427895|6307514|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
1816954|NCT00427895|6307515|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
1816955|NCT00427895|6307516|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
1816956|NCT00427895|6307517|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
1816957|NCT00427895|6307518|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
1816958|NCT00427895|6307519|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
1816959|NCT00427895|6307512|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1816960|NCT00427895|6307513|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1816961|NCT00427895|6307514|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1816962|NCT00427895|6307515|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
1816963|NCT00427895|6307516|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
1816964|NCT00427895|6307517|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
1816965|NCT00427895|6307518|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
1816966|NCT00427895|6307519|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
1816967|NCT00427895|6307512|P8|Vax 1/Year 1 Follow-up|Other|0
1816968|NCT00427895|6307513|P7|Vax 1/Year 1 Follow-up|Other|0
1816969|NCT00427895|6307514|P6|Vax 1/Year 1 Follow-up|Other|0
1816970|NCT00427895|6307515|P5|Vax 1/Year 1 Follow-up|Other|0
1816971|NCT00427895|6307516|P4|Vax 1/Year 1 Follow-up|Other|2
1816972|NCT00427895|6307517|P3|Vax 1/Year 1 Follow-up|Other|0
1816973|NCT00427895|6307518|P2|Vax 1/Year 1 Follow-up|Other|0
1816974|NCT00427895|6307519|P1|Vax 1/Year 1 Follow-up|Other|0
1816975|NCT00427895|6307512|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
1816976|NCT00427895|6307513|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
1816977|NCT00427895|6307514|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
1816978|NCT00427895|6307515|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
1816979|NCT00427895|6307516|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
1816980|NCT00427895|6307517|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
1816981|NCT00427895|6307518|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
1816982|NCT00427895|6307519|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
1816983|NCT00427895|6307512|P8|Vax 1/Year 1 Follow-up|Death|0
1816984|NCT00427895|6307513|P7|Vax 1/Year 1 Follow-up|Death|0
1816985|NCT00427895|6307514|P6|Vax 1/Year 1 Follow-up|Death|0
1816986|NCT00427895|6307515|P5|Vax 1/Year 1 Follow-up|Death|0
1816987|NCT00427895|6307516|P4|Vax 1/Year 1 Follow-up|Death|0
1816988|NCT00427895|6307517|P3|Vax 1/Year 1 Follow-up|Death|0
1816989|NCT00427895|6307518|P2|Vax 1/Year 1 Follow-up|Death|0
1816990|NCT00427895|6307519|P1|Vax 1/Year 1 Follow-up|Death|1
1816991|NCT00427895|6307512|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
1816992|NCT00427895|6307513|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
1816993|NCT00427895|6307514|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
1816994|NCT00427895|6307515|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
1816995|NCT00427895|6307516|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
1816996|NCT00427895|6307517|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
1816997|NCT00427895|6307518|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
1816998|NCT00427895|6307519|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
1816999|NCT00427895|6307512|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1817000|NCT00427895|6307513|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1817001|NCT00427895|6307514|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1817002|NCT00427895|6307515|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
1817003|NCT00427895|6307516|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
1817004|NCT00427895|6307517|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
1817005|NCT00427895|6307518|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
1817006|NCT00427895|6307519|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
1817007|NCT00427895|6307512|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
1817008|NCT00427895|6307513|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
1817009|NCT00427895|6307514|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
1817010|NCT00427895|6307515|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
1817011|NCT00427895|6307516|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
1817012|NCT00427895|6307517|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
1817013|NCT00427895|6307518|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
1817014|NCT00427895|6307519|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
1817015|NCT00427895|6307512|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1817016|NCT00427895|6307513|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1817017|NCT00427895|6307514|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1817018|NCT00427895|6307515|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1817019|NCT00427895|6307516|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
1817020|NCT00427895|6307517|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
1817021|NCT00427895|6307518|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
1817022|NCT00427895|6307519|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
1817023|NCT00427895|6307512|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1817024|NCT00427895|6307513|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1817025|NCT00427895|6307514|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1817026|NCT00427895|6307515|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1817027|NCT00427895|6307516|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
1817028|NCT00427895|6307517|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1817029|NCT00427895|6307518|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1817030|NCT00427895|6307519|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
1817031|NCT00427895|6307512|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
1817032|NCT00427895|6307513|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
1817033|NCT00427895|6307514|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
1817034|NCT00427895|6307515|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
1817035|NCT00427895|6307516|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
1817036|NCT00427895|6307517|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
1817037|NCT00427895|6307518|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
1817038|NCT00427895|6307519|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
1817039|NCT00427895|6307512|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1817040|NCT00427895|6307513|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1817041|NCT00427895|6307514|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1817042|NCT00427895|6307515|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
1817043|NCT00427895|6307516|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1817044|NCT00427895|6307517|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
1817045|NCT00427895|6307518|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
1817046|NCT00427895|6307519|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
1817047|NCT00427895|6307512|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1817048|NCT00427895|6307513|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1817049|NCT00427895|6307514|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1817050|NCT00427895|6307515|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1817051|NCT00427895|6307516|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
1817052|NCT00427895|6307517|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1817053|NCT00427895|6307518|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1817054|NCT00427895|6307519|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
1817055|NCT00427895|6307512|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1817056|NCT00427895|6307513|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1817057|NCT00427895|6307514|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1817058|NCT00427895|6307515|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
1817059|NCT00427895|6307516|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
1817060|NCT00427895|6307517|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
1817061|NCT00427895|6307518|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1817062|NCT00427895|6307519|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
1817063|NCT00427895|6307512|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1817064|NCT00427895|6307513|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1817065|NCT00427895|6307514|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1817066|NCT00427895|6307515|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1817067|NCT00427895|6307516|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1817068|NCT00427895|6307517|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
1817069|NCT00427895|6307518|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1817070|NCT00427895|6307519|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
1817071|NCT00427895|6307512|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1817072|NCT00427895|6307513|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1817073|NCT00427895|6307514|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1817074|NCT00427895|6307515|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1817075|NCT00427895|6307516|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
1817076|NCT00427895|6307517|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
1817077|NCT00427895|6307518|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
1817078|NCT00427895|6307519|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
1817079|NCT00427895|6307512|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1817080|NCT00427895|6307513|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1817081|NCT00427895|6307514|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1817082|NCT00427895|6307515|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1817083|NCT00427895|6307516|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
1817084|NCT00427895|6307517|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
1817085|NCT00427895|6307518|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
1817086|NCT00427895|6307519|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
1817087|NCT00427778|6307594|P2|First Intervention (4 Weeks)|anxious about using ring|0
1817088|NCT00427778|6307595|P1|First Intervention (4 Weeks)|anxious about using ring|1
1817089|NCT00427778|6307594|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
1817090|NCT00427778|6307595|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
1817091|NCT00427778|6307594|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
1817092|NCT00427778|6307595|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
1817093|NCT00427778|6307594|P2|First Intervention (4 Weeks)|no longer interested|0
1817094|NCT00427778|6307595|P1|First Intervention (4 Weeks)|no longer interested|1
1817095|NCT00427700|6307620|P2|Overall Study|Pregnancy|2
1817096|NCT00427700|6307621|P1|Overall Study|Pregnancy|0
1817097|NCT00427700|6307620|P2|Overall Study|no induction of menses|4
1817098|NCT00427700|6307621|P1|Overall Study|no induction of menses|1
1817099|NCT00427700|6307620|P2|Overall Study|Lost to Follow-up|5
1817100|NCT00427700|6307621|P1|Overall Study|Lost to Follow-up|2
1817101|NCT00427635|6307637|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
1817102|NCT00427635|6307638|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
1817103|NCT00427635|6307637|P2|Treatment Phase|Withdrawal by Subject|0
1817104|NCT00427635|6307638|P1|Treatment Phase|Withdrawal by Subject|1
1817105|NCT00427349|6307670|P1|Overall Study|Never started therapy|1
1817106|NCT00427349|6307670|P1|Overall Study|Ineligible|1
1817107|NCT00427349|6307670|P1|Overall Study|Other|2
1817108|NCT00427349|6307670|P1|Overall Study|Alternative therapy|1
1817109|NCT00427349|6307670|P1|Overall Study|Withdrawal by Subject|3
1817110|NCT00427349|6307670|P1|Overall Study|Death|1
1817111|NCT00427349|6307670|P1|Overall Study|Adverse Event|14
1817112|NCT00427349|6307670|P1|Overall Study|Lack of Efficacy|23
1817113|NCT00427011|6307727|P1|Overall Study|Other|12
1817114|NCT00427011|6307727|P1|Overall Study|Lack of Efficacy|2
1817115|NCT00427011|6307727|P1|Overall Study|Withdrawal by Subject|1
1817116|NCT00427011|6307727|P1|Overall Study|Adverse Event|10
1817117|NCT00426842|6307742|P1|Overall Study|Lost to Follow-up|1
1817118|NCT00426764|6307748|P1|Overall Study|Other Reasons (Miscellaneous)|10
1817119|NCT00426764|6307748|P1|Overall Study|Death|1
1817120|NCT00426764|6307748|P1|Overall Study|Other|1
1817121|NCT00426764|6307748|P1|Overall Study|Adverse Event|24
1817122|NCT00426764|6307748|P1|Overall Study|Progressive Disease|83
1817123|NCT00426764|6307748|P1|Overall Study|Compassionate Use|1
1817124|NCT00426764|6307748|P1|Overall Study|Physician Decision|6
1817125|NCT00426764|6307748|P1|Overall Study|Withdrawal by Subject|4
1817126|NCT00426764|6307748|P1|Overall Study|Protocol Violation|1
1817127|NCT00426751|6307765|P2|Overall Study|Other Reasons|12
1817128|NCT00426751|6307766|P1|Overall Study|Other Reasons|7
1817129|NCT00426751|6307765|P2|Overall Study|Consent Withdrawn|1
1817130|NCT00426751|6307766|P1|Overall Study|Consent Withdrawn|0
1817131|NCT00426751|6307765|P2|Overall Study|Lost to Follow-up|6
1817132|NCT00426751|6307766|P1|Overall Study|Lost to Follow-up|7
1817133|NCT00426751|6307765|P2|Overall Study|Adverse Event|1
1817134|NCT00426751|6307766|P1|Overall Study|Adverse Event|8
1817135|NCT00426660|6307810|P1|Overall Study|Enrolled Not Treated|15
1817136|NCT00426660|6307810|P1|Overall Study|Protocol Violation|1
1817137|NCT00426660|6307810|P1|Overall Study|Withdrawal by Subject|18
1817138|NCT00426660|6307810|P1|Overall Study|Other|23
1817139|NCT00426660|6307810|P1|Overall Study|Lost to Follow-up|15
1817140|NCT00426660|6307810|P1|Overall Study|Insufficient Clinical Response|22
1817141|NCT00426660|6307810|P1|Overall Study|Adverse Event|23
1817142|NCT00426660|6307810|P1|Overall Study|Death|14
1817143|NCT00426556|6307841|P4|Phase II - Extension Phase|Adverse Event|2
1817144|NCT00426556|6307842|P3|Phase II - Extension Phase|Adverse Event|0
1817145|NCT00426556|6307843|P2|Phase II - Extension Phase|Adverse Event|0
1817146|NCT00426556|6307844|P1|Phase II - Extension Phase|Adverse Event|0
1817147|NCT00426556|6307841|P4|Phase II - Extension Phase|Disease Progression|21
1817148|NCT00426556|6307842|P3|Phase II - Extension Phase|Disease Progression|0
1817149|NCT00426556|6307843|P2|Phase II - Extension Phase|Disease Progression|0
1817150|NCT00426556|6307844|P1|Phase II - Extension Phase|Disease Progression|0
1817151|NCT00426556|6307841|P4|Phase II - Core Phase|Adverse Event|8
1817152|NCT00426556|6307842|P3|Phase II - Core Phase|Adverse Event|0
1817153|NCT00426556|6307843|P2|Phase II - Core Phase|Adverse Event|0
1817154|NCT00426556|6307844|P1|Phase II - Core Phase|Adverse Event|0
1817155|NCT00426556|6307841|P4|Phase II - Core Phase|Disease Progression|16
1817156|NCT00426556|6307842|P3|Phase II - Core Phase|Disease Progression|0
1817157|NCT00426556|6307843|P2|Phase II - Core Phase|Disease Progression|0
1817158|NCT00426556|6307844|P1|Phase II - Core Phase|Disease Progression|0
1817159|NCT00426556|6307841|P4|Phase II - Core Phase|Withdrawal by Subject|3
1817160|NCT00426556|6307842|P3|Phase II - Core Phase|Withdrawal by Subject|0
1817161|NCT00426556|6307843|P2|Phase II - Core Phase|Withdrawal by Subject|0
1817162|NCT00426556|6307844|P1|Phase II - Core Phase|Withdrawal by Subject|0
1817163|NCT00426556|6307841|P4|Phase I - Extension Phase|Disease Progression|0
1817164|NCT00426556|6307842|P3|Phase I - Extension Phase|Disease Progression|6
1817165|NCT00426556|6307843|P2|Phase I - Extension Phase|Disease Progression|5
1817166|NCT00426556|6307844|P1|Phase I - Extension Phase|Disease Progression|5
1817167|NCT00426556|6307841|P4|Phase I - Extension Phase|Adverse Event|0
1817168|NCT00426556|6307842|P3|Phase I - Extension Phase|Adverse Event|1
1817169|NCT00426556|6307843|P2|Phase I - Extension Phase|Adverse Event|1
1817170|NCT00426556|6307844|P1|Phase I - Extension Phase|Adverse Event|0
1817171|NCT00426556|6307841|P4|Phase I - Core Phase|Death|0
1817172|NCT00426556|6307842|P3|Phase I - Core Phase|Death|0
1817173|NCT00426556|6307843|P2|Phase I - Core Phase|Death|1
1817174|NCT00426556|6307844|P1|Phase I - Core Phase|Death|0
1817175|NCT00426556|6307841|P4|Phase I - Core Phase|Adverse Event|0
1817176|NCT00426556|6307842|P3|Phase I - Core Phase|Adverse Event|1
1817177|NCT00426556|6307843|P2|Phase I - Core Phase|Adverse Event|3
1817178|NCT00426556|6307844|P1|Phase I - Core Phase|Adverse Event|1
1817179|NCT00426556|6307841|P4|Phase I - Core Phase|Disease Progression|0
1817180|NCT00426556|6307842|P3|Phase I - Core Phase|Disease Progression|2
1817181|NCT00426556|6307843|P2|Phase I - Core Phase|Disease Progression|6
1817182|NCT00426556|6307844|P1|Phase I - Core Phase|Disease Progression|0
1817183|NCT00426361|6307869|P3|Overall Study|Withdrawal by Subject|0
1817184|NCT00426361|6307870|P2|Overall Study|Withdrawal by Subject|3
1817185|NCT00426361|6307871|P1|Overall Study|Withdrawal by Subject|1
1817186|NCT00426361|6307869|P3|Overall Study|Lost to Follow-up|5
1817187|NCT00426361|6307870|P2|Overall Study|Lost to Follow-up|2
1817188|NCT00426361|6307871|P1|Overall Study|Lost to Follow-up|3
1817189|NCT00426270|6307930|P1|Overall Study|Adverse Event|5
1817190|NCT00426270|6307930|P1|Overall Study|Incorrectly Enrolled in the Study|1
1817191|NCT00426231|6307940|P2|Overall Study|Withdrawal by Subject|12
1817192|NCT00426231|6307941|P1|Overall Study|Withdrawal by Subject|9
1817193|NCT00426127|6307964|P1|Overall Study|Removed due to disease progression|1
1817194|NCT00426127|6307964|P1|Overall Study|Adverse Event|1
1817195|NCT00425945|6307972|P2|Overall Study|Moved from area|1
1817196|NCT00425945|6307973|P1|Overall Study|Moved from area|0
1817197|NCT00425945|6307972|P2|Overall Study|Began cancer treatments|0
1817198|NCT00425945|6307973|P1|Overall Study|Began cancer treatments|1
1817199|NCT00425945|6307972|P2|Overall Study|Began hypertension medication|0
1817200|NCT00425945|6307973|P1|Overall Study|Began hypertension medication|1
1817201|NCT00425945|6307972|P2|Overall Study|Lost to Follow-up|2
1817202|NCT00425945|6307973|P1|Overall Study|Lost to Follow-up|0
1817203|NCT00425945|6307972|P2|Overall Study|Inconvenience|2
1817204|NCT00425945|6307973|P1|Overall Study|Inconvenience|0
1817205|NCT00425945|6307972|P2|Overall Study|Concern about Supplement|0
1817206|NCT00425945|6307973|P1|Overall Study|Concern about Supplement|2
1817207|NCT00425854|6308011|P2|Overall Study|Other Adverse Event|2
1817208|NCT00425854|6308012|P1|Overall Study|Other Adverse Event|2
1817209|NCT00425854|6308011|P2|Overall Study|Dose reduction toxicity AE|7
1817210|NCT00425854|6308012|P1|Overall Study|Dose reduction toxicity AE|8
1817211|NCT00425854|6308011|P2|Overall Study|Progressive Disease|12
1817212|NCT00425854|6308012|P1|Overall Study|Progressive Disease|19
1817213|NCT00425750|6308045|P1|Overall Study|Progression of disease|18
1817214|NCT00425750|6308045|P1|Overall Study|Adverse Event|3
1817215|NCT00425750|6308045|P1|Overall Study|Withdrawal by Subject|3
1817216|NCT00425750|6308045|P1|Overall Study|Death|1
1817217|NCT00425698|6308053|P2|Overall Study|Withdrawal by Subject|1
1817218|NCT00425698|6308054|P1|Overall Study|Withdrawal by Subject|0
1817219|NCT00425698|6308053|P2|Overall Study|Adverse Event|1
1817220|NCT00425698|6308054|P1|Overall Study|Adverse Event|3
1817221|NCT00425607|6308069|P1|Overall Study|Withdrawal by Subject|1
1817222|NCT00425607|6308069|P1|Overall Study|Death|1
1817223|NCT00425503|6308073|P1|Overall Study|Protocol Violation|1
1817224|NCT00425503|6308073|P1|Overall Study|Adverse Event|2
1817225|NCT00425438|6308085|P2|Overall Study|Termination by Sponsor|27
1817226|NCT00425438|6308086|P1|Overall Study|Termination by Sponsor|25
1817227|NCT00425373|6308120|P9|Overall Study|Lack of Efficacy|5
1817228|NCT00425373|6308121|P8|Overall Study|Lack of Efficacy|0
1817229|NCT00425373|6308122|P7|Overall Study|Lack of Efficacy|3
1817230|NCT00425373|6308123|P6|Overall Study|Lack of Efficacy|3
1817231|NCT00425373|6308124|P5|Overall Study|Lack of Efficacy|1
1817232|NCT00425373|6308125|P4|Overall Study|Lack of Efficacy|0
1817233|NCT00425373|6308126|P3|Overall Study|Lack of Efficacy|0
1817234|NCT00425373|6308127|P2|Overall Study|Lack of Efficacy|0
1817235|NCT00425373|6308128|P1|Overall Study|Lack of Efficacy|0
1817236|NCT00425373|6308120|P9|Overall Study|Withdrawal by Subject|2
1817237|NCT00425373|6308121|P8|Overall Study|Withdrawal by Subject|2
1817238|NCT00425373|6308122|P7|Overall Study|Withdrawal by Subject|2
1817239|NCT00425373|6308123|P6|Overall Study|Withdrawal by Subject|0
1817240|NCT00425373|6308124|P5|Overall Study|Withdrawal by Subject|4
1817241|NCT00425373|6308125|P4|Overall Study|Withdrawal by Subject|1
1817242|NCT00425373|6308126|P3|Overall Study|Withdrawal by Subject|2
1817243|NCT00425373|6308127|P2|Overall Study|Withdrawal by Subject|0
1817244|NCT00425373|6308128|P1|Overall Study|Withdrawal by Subject|2
1817245|NCT00425373|6308120|P9|Overall Study|Protocol Violation|3
1817246|NCT00425373|6308121|P8|Overall Study|Protocol Violation|5
1817247|NCT00425373|6308122|P7|Overall Study|Protocol Violation|0
1817248|NCT00425373|6308123|P6|Overall Study|Protocol Violation|0
1817249|NCT00425373|6308124|P5|Overall Study|Protocol Violation|0
1817250|NCT00425373|6308125|P4|Overall Study|Protocol Violation|0
1817251|NCT00425373|6308126|P3|Overall Study|Protocol Violation|1
1817252|NCT00425373|6308127|P2|Overall Study|Protocol Violation|0
1817253|NCT00425373|6308128|P1|Overall Study|Protocol Violation|1
1817254|NCT00425373|6308120|P9|Overall Study|Lost to Follow-up|0
1817255|NCT00425373|6308121|P8|Overall Study|Lost to Follow-up|0
1817256|NCT00425373|6308122|P7|Overall Study|Lost to Follow-up|0
1817257|NCT00425373|6308123|P6|Overall Study|Lost to Follow-up|0
1817258|NCT00425373|6308124|P5|Overall Study|Lost to Follow-up|1
1817259|NCT00425373|6308125|P4|Overall Study|Lost to Follow-up|0
1817260|NCT00425373|6308126|P3|Overall Study|Lost to Follow-up|0
1817261|NCT00425373|6308127|P2|Overall Study|Lost to Follow-up|1
1817262|NCT00425373|6308128|P1|Overall Study|Lost to Follow-up|0
1817263|NCT00425373|6308120|P9|Overall Study|Adverse Event|8
1817264|NCT00425373|6308121|P8|Overall Study|Adverse Event|3
1817265|NCT00425373|6308122|P7|Overall Study|Adverse Event|2
1817266|NCT00425373|6308123|P6|Overall Study|Adverse Event|6
1817267|NCT00425373|6308124|P5|Overall Study|Adverse Event|4
1817268|NCT00425373|6308125|P4|Overall Study|Adverse Event|1
1817269|NCT00425373|6308126|P3|Overall Study|Adverse Event|0
1817270|NCT00425373|6308127|P2|Overall Study|Adverse Event|2
1817271|NCT00425373|6308128|P1|Overall Study|Adverse Event|2
1817272|NCT00425308|6308186|P2|Overall Study|Death|0
1817273|NCT00425308|6308187|P1|Overall Study|Death|1
1817274|NCT00425308|6308186|P2|Overall Study|Withdrawal by Subject|0
1817275|NCT00425308|6308187|P1|Overall Study|Withdrawal by Subject|1
1817276|NCT00425308|6308186|P2|Overall Study|Adverse Event|1
1817277|NCT00425308|6308187|P1|Overall Study|Adverse Event|2
1817278|NCT00425269|6308217|P2|Overall Study|moved or medical reason|4
1817279|NCT00425269|6308218|P1|Overall Study|moved or medical reason|5
1817280|NCT00425269|6308217|P2|Overall Study|Lost to Follow-up|9
1817281|NCT00425269|6308218|P1|Overall Study|Lost to Follow-up|9
1817282|NCT00425269|6308217|P2|Overall Study|Pregnancy|7
1817283|NCT00425269|6308218|P1|Overall Study|Pregnancy|5
1817284|NCT00425113|6308296|P2|Overall Study|Withdrawal by Subject|0
1817285|NCT00425113|6308297|P1|Overall Study|Withdrawal by Subject|1
1817286|NCT00425113|6308296|P2|Overall Study|missing study drug more than 14 days|1
1817287|NCT00425113|6308297|P1|Overall Study|missing study drug more than 14 days|0
1817288|NCT00425113|6308296|P2|Overall Study|diagnosis of abdominal TB|1
1817289|NCT00425113|6308297|P1|Overall Study|diagnosis of abdominal TB|0
1817290|NCT00425113|6308296|P2|Overall Study|uncontrolled diabetes mellitus|0
1817291|NCT00425113|6308297|P1|Overall Study|uncontrolled diabetes mellitus|1
1817292|NCT00425100|6308305|P1|Overall Study|Withdrawal by Subject|7
1817293|NCT00425100|6308305|P1|Overall Study|Protocol Violation|4
1817294|NCT00425100|6308305|P1|Overall Study|Lost to Follow-up|2
1817295|NCT00425100|6308305|P1|Overall Study|Lack of Efficacy|4
1817296|NCT00425100|6308305|P1|Overall Study|Adverse Event|36
1817297|NCT00425061|6308349|P7|Overall Study|Other|1
1817298|NCT00425061|6308350|P6|Overall Study|Other|0
1817299|NCT00425061|6308351|P5|Overall Study|Other|3
1817300|NCT00425061|6308352|P4|Overall Study|Other|0
1817301|NCT00425061|6308353|P3|Overall Study|Other|0
1817302|NCT00425061|6308354|P2|Overall Study|Other|0
1817303|NCT00425061|6308355|P1|Overall Study|Other|0
1817304|NCT00425061|6308349|P7|Overall Study|Physician Decision|0
1817305|NCT00425061|6308350|P6|Overall Study|Physician Decision|0
1817306|NCT00425061|6308351|P5|Overall Study|Physician Decision|1
1817307|NCT00425061|6308352|P4|Overall Study|Physician Decision|0
1817308|NCT00425061|6308353|P3|Overall Study|Physician Decision|0
1817309|NCT00425061|6308354|P2|Overall Study|Physician Decision|0
1817310|NCT00425061|6308355|P1|Overall Study|Physician Decision|0
1817311|NCT00425061|6308349|P7|Overall Study|Sponsor's request|15
1817312|NCT00425061|6308350|P6|Overall Study|Sponsor's request|4
1817313|NCT00425061|6308351|P5|Overall Study|Sponsor's request|19
1817314|NCT00425061|6308352|P4|Overall Study|Sponsor's request|0
1817315|NCT00425061|6308353|P3|Overall Study|Sponsor's request|0
1817316|NCT00425061|6308354|P2|Overall Study|Sponsor's request|0
1817317|NCT00425061|6308355|P1|Overall Study|Sponsor's request|0
1817318|NCT00425061|6308349|P7|Overall Study|Withdrawal by Subject|3
1817319|NCT00425061|6308350|P6|Overall Study|Withdrawal by Subject|0
1817320|NCT00425061|6308351|P5|Overall Study|Withdrawal by Subject|1
1817321|NCT00425061|6308352|P4|Overall Study|Withdrawal by Subject|0
1817322|NCT00425061|6308353|P3|Overall Study|Withdrawal by Subject|0
1817323|NCT00425061|6308354|P2|Overall Study|Withdrawal by Subject|1
1817324|NCT00425061|6308355|P1|Overall Study|Withdrawal by Subject|0
1817325|NCT00425061|6308349|P7|Overall Study|Protocol Violation|0
1817326|NCT00425061|6308350|P6|Overall Study|Protocol Violation|0
1817327|NCT00425061|6308351|P5|Overall Study|Protocol Violation|0
1817328|NCT00425061|6308352|P4|Overall Study|Protocol Violation|0
1817329|NCT00425061|6308353|P3|Overall Study|Protocol Violation|0
1817330|NCT00425061|6308354|P2|Overall Study|Protocol Violation|0
1817331|NCT00425061|6308355|P1|Overall Study|Protocol Violation|1
1817332|NCT00425061|6308349|P7|Overall Study|Lost to Follow-up|0
1817333|NCT00425061|6308350|P6|Overall Study|Lost to Follow-up|0
1817334|NCT00425061|6308351|P5|Overall Study|Lost to Follow-up|0
1817335|NCT00425061|6308352|P4|Overall Study|Lost to Follow-up|0
1817336|NCT00425061|6308353|P3|Overall Study|Lost to Follow-up|0
1817337|NCT00425061|6308354|P2|Overall Study|Lost to Follow-up|1
1817338|NCT00425061|6308355|P1|Overall Study|Lost to Follow-up|0
1817339|NCT00425061|6308349|P7|Overall Study|Adverse Event|0
1817340|NCT00425061|6308350|P6|Overall Study|Adverse Event|0
1817341|NCT00425061|6308351|P5|Overall Study|Adverse Event|2
1817342|NCT00425061|6308352|P4|Overall Study|Adverse Event|2
1817343|NCT00425061|6308353|P3|Overall Study|Adverse Event|0
1817344|NCT00425061|6308354|P2|Overall Study|Adverse Event|0
1817345|NCT00425061|6308355|P1|Overall Study|Adverse Event|1
1817346|NCT00424827|6308479|P1|Overall Study|Adverse Event|1
1817347|NCT00424775|6308487|P2|Overall Study|Lack of Efficacy|0
1817348|NCT00424775|6308488|P1|Overall Study|Lack of Efficacy|1
1817349|NCT00424775|6308487|P2|Overall Study|Adverse Event|0
1817350|NCT00424775|6308488|P1|Overall Study|Adverse Event|2
1817351|NCT00424762|6308498|P2|Overall Study|Lost to Follow-up|3
1817352|NCT00424762|6308499|P1|Overall Study|Lost to Follow-up|2
1817353|NCT00424762|6308498|P2|Overall Study|Withdrawal by Subject|19
1817354|NCT00424762|6308499|P1|Overall Study|Withdrawal by Subject|18
1817355|NCT00424749|6308509|P1|Overall Study|Withdrawal by Subject|1
1817356|NCT00424645|6308516|P2|Overall Study|Death|0
1817357|NCT00424645|6308517|P1|Overall Study|Death|1
1817358|NCT00424632|6308525|P10|Overall Study|Other|0
1817359|NCT00424632|6308526|P9|Overall Study|Other|1
1817360|NCT00424632|6308527|P8|Overall Study|Other|0
1817361|NCT00424632|6308528|P7|Overall Study|Other|0
1817362|NCT00424632|6308529|P6|Overall Study|Other|0
1817363|NCT00424632|6308530|P5|Overall Study|Other|0
1817364|NCT00424632|6308531|P4|Overall Study|Other|1
1817365|NCT00424632|6308532|P3|Overall Study|Other|0
1817366|NCT00424632|6308533|P2|Overall Study|Other|0
1817367|NCT00424632|6308534|P1|Overall Study|Other|0
1817368|NCT00424632|6308525|P10|Overall Study|Objective progression or relapse|4
1817369|NCT00424632|6308526|P9|Overall Study|Objective progression or relapse|12
1817370|NCT00424632|6308527|P8|Overall Study|Objective progression or relapse|3
1817371|NCT00424632|6308528|P7|Overall Study|Objective progression or relapse|7
1817372|NCT00424632|6308529|P6|Overall Study|Objective progression or relapse|13
1817373|NCT00424632|6308530|P5|Overall Study|Objective progression or relapse|2
1817374|NCT00424632|6308531|P4|Overall Study|Objective progression or relapse|2
1817375|NCT00424632|6308532|P3|Overall Study|Objective progression or relapse|1
1817376|NCT00424632|6308533|P2|Overall Study|Objective progression or relapse|1
1817377|NCT00424632|6308534|P1|Overall Study|Objective progression or relapse|1
1817378|NCT00424632|6308525|P10|Overall Study|Global deterioration of health status|0
1817379|NCT00424632|6308526|P9|Overall Study|Global deterioration of health status|0
1817380|NCT00424632|6308527|P8|Overall Study|Global deterioration of health status|0
1817381|NCT00424632|6308528|P7|Overall Study|Global deterioration of health status|0
1817382|NCT00424632|6308529|P6|Overall Study|Global deterioration of health status|0
1817383|NCT00424632|6308530|P5|Overall Study|Global deterioration of health status|1
1817384|NCT00424632|6308531|P4|Overall Study|Global deterioration of health status|1
1817385|NCT00424632|6308532|P3|Overall Study|Global deterioration of health status|0
1817386|NCT00424632|6308533|P2|Overall Study|Global deterioration of health status|0
1817387|NCT00424632|6308534|P1|Overall Study|Global deterioration of health status|0
1817388|NCT00424632|6308525|P10|Overall Study|Adverse Event|2
1817389|NCT00424632|6308526|P9|Overall Study|Adverse Event|3
1817390|NCT00424632|6308527|P8|Overall Study|Adverse Event|0
1817391|NCT00424632|6308528|P7|Overall Study|Adverse Event|0
1817392|NCT00424632|6308529|P6|Overall Study|Adverse Event|0
1817393|NCT00424632|6308530|P5|Overall Study|Adverse Event|0
1817394|NCT00424632|6308531|P4|Overall Study|Adverse Event|0
1817395|NCT00424632|6308532|P3|Overall Study|Adverse Event|0
1817396|NCT00424632|6308533|P2|Overall Study|Adverse Event|0
1817397|NCT00424632|6308534|P1|Overall Study|Adverse Event|0
1817398|NCT00424632|6308525|P10|Overall Study|Death|0
1817399|NCT00424632|6308526|P9|Overall Study|Death|0
1817400|NCT00424632|6308527|P8|Overall Study|Death|0
1817401|NCT00424632|6308528|P7|Overall Study|Death|0
1817402|NCT00424632|6308529|P6|Overall Study|Death|2
1817403|NCT00424632|6308530|P5|Overall Study|Death|0
1817404|NCT00424632|6308531|P4|Overall Study|Death|0
1817405|NCT00424632|6308532|P3|Overall Study|Death|0
1817406|NCT00424632|6308533|P2|Overall Study|Death|0
1817407|NCT00424632|6308534|P1|Overall Study|Death|0
1817408|NCT00424593|6308704|P2|Dose-Blind Extension Period|Physician Decision|0
1817409|NCT00424593|6308705|P1|Dose-Blind Extension Period|Physician Decision|3
1817410|NCT00424593|6308704|P2|Dose-Blind Extension Period|Lost to Follow-up|0
1817411|NCT00424593|6308705|P1|Dose-Blind Extension Period|Lost to Follow-up|6
1817412|NCT00424593|6308704|P2|Dose-Blind Extension Period|Protocol Violation|0
1817413|NCT00424593|6308705|P1|Dose-Blind Extension Period|Protocol Violation|9
1817414|NCT00424593|6308704|P2|Dose-Blind Extension Period|Lack of Efficacy|0
1817415|NCT00424593|6308705|P1|Dose-Blind Extension Period|Lack of Efficacy|9
1817416|NCT00424593|6308704|P2|Dose-Blind Extension Period|Adverse Event|0
1817417|NCT00424593|6308705|P1|Dose-Blind Extension Period|Adverse Event|18
1817418|NCT00424593|6308704|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
1817419|NCT00424593|6308705|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
1817420|NCT00424593|6308704|P2|Acute Double-Blind Period|Lack of Efficacy|1
1817421|NCT00424593|6308705|P1|Acute Double-Blind Period|Lack of Efficacy|0
1817422|NCT00424593|6308704|P2|Acute Double-Blind Period|Lost to Follow-up|1
1817423|NCT00424593|6308705|P1|Acute Double-Blind Period|Lost to Follow-up|1
1817424|NCT00424593|6308704|P2|Acute Double-Blind Period|Physician Decision|2
1817425|NCT00424593|6308705|P1|Acute Double-Blind Period|Physician Decision|1
1817426|NCT00424593|6308704|P2|Acute Double-Blind Period|Protocol Violation|2
1817427|NCT00424593|6308705|P1|Acute Double-Blind Period|Protocol Violation|2
1817428|NCT00424593|6308704|P2|Acute Double-Blind Period|Withdrawal by Subject|10
1817429|NCT00424593|6308705|P1|Acute Double-Blind Period|Withdrawal by Subject|11
1817430|NCT00424593|6308704|P2|Acute Double-Blind Period|Adverse Event|7
1817431|NCT00424593|6308705|P1|Acute Double-Blind Period|Adverse Event|16
1817432|NCT00424528|6308769|P3|Overall Study|noncompliance with study requirements|2
1817433|NCT00424528|6308770|P2|Overall Study|noncompliance with study requirements|1
1817434|NCT00424528|6308771|P1|Overall Study|noncompliance with study requirements|2
1817435|NCT00424528|6308769|P3|Overall Study|Lost to Follow-up|0
1817436|NCT00424528|6308770|P2|Overall Study|Lost to Follow-up|1
1817437|NCT00424528|6308771|P1|Overall Study|Lost to Follow-up|0
1817438|NCT00424528|6308769|P3|Overall Study|Protocol Violation|0
1817439|NCT00424528|6308770|P2|Overall Study|Protocol Violation|1
1817440|NCT00424528|6308771|P1|Overall Study|Protocol Violation|1
1817441|NCT00424528|6308769|P3|Overall Study|Adverse Event|2
1817442|NCT00424528|6308770|P2|Overall Study|Adverse Event|1
1817443|NCT00424528|6308771|P1|Overall Study|Adverse Event|2
1817444|NCT00424515|6308826|P2|Overall Study|Withdrawal by Subject|0
1817445|NCT00424515|6308827|P1|Overall Study|Withdrawal by Subject|1
1817446|NCT00424515|6308826|P2|Overall Study|Intercurrent Illness|1
1817447|NCT00424515|6308827|P1|Overall Study|Intercurrent Illness|0
1817448|NCT00424515|6308826|P2|Overall Study|Adverse Event|1
1817449|NCT00424515|6308827|P1|Overall Study|Adverse Event|0
1817450|NCT00424515|6308826|P2|Overall Study|Progressive Disease|11
1817451|NCT00424515|6308827|P1|Overall Study|Progressive Disease|10
1817452|NCT00424489|6308846|P1|Overall Study|Death|3
1817453|NCT00424476|6308853|P3|Overall Study|Other|9
1817454|NCT00424476|6308854|P2|Overall Study|Other|3
1817455|NCT00424476|6308855|P1|Overall Study|Other|4
1817456|NCT00424476|6308853|P3|Overall Study|Physician Decision|3
1817457|NCT00424476|6308854|P2|Overall Study|Physician Decision|2
1817458|NCT00424476|6308855|P1|Overall Study|Physician Decision|3
1817459|NCT00424476|6308853|P3|Overall Study|Protocol Violation|3
1817460|NCT00424476|6308854|P2|Overall Study|Protocol Violation|2
1817461|NCT00424476|6308855|P1|Overall Study|Protocol Violation|7
1817462|NCT00424476|6308853|P3|Overall Study|Lost to Follow-up|3
1817463|NCT00424476|6308854|P2|Overall Study|Lost to Follow-up|6
1817464|NCT00424476|6308855|P1|Overall Study|Lost to Follow-up|4
1817465|NCT00424476|6308853|P3|Overall Study|Lack of Compliance|1
1817466|NCT00424476|6308854|P2|Overall Study|Lack of Compliance|1
1817467|NCT00424476|6308855|P1|Overall Study|Lack of Compliance|1
1817468|NCT00424476|6308853|P3|Overall Study|Lack of Efficacy|12
1817469|NCT00424476|6308854|P2|Overall Study|Lack of Efficacy|12
1817470|NCT00424476|6308855|P1|Overall Study|Lack of Efficacy|16
1817471|NCT00424476|6308853|P3|Overall Study|Adverse Event|15
1817472|NCT00424476|6308854|P2|Overall Study|Adverse Event|16
1817473|NCT00424476|6308855|P1|Overall Study|Adverse Event|19
1817474|NCT00424476|6308853|P3|Overall Study|Withdrawal by Subject|3
1817475|NCT00424476|6308854|P2|Overall Study|Withdrawal by Subject|6
1817476|NCT00424476|6308855|P1|Overall Study|Withdrawal by Subject|7
1817477|NCT00424463|6308881|P3|Overall Study|Patient’s convenience|1
1817478|NCT00424463|6308882|P2|Overall Study|Patient’s convenience|0
1817479|NCT00424463|6308883|P1|Overall Study|Patient’s convenience|0
1817480|NCT00424463|6308881|P3|Overall Study|Tracheotomy due to worsening of ALS|6
1817481|NCT00424463|6308882|P2|Overall Study|Tracheotomy due to worsening of ALS|7
1817482|NCT00424463|6308883|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1817483|NCT00424463|6308881|P3|Overall Study|Withdrawal by Subject|5
1817484|NCT00424463|6308882|P2|Overall Study|Withdrawal by Subject|2
1817485|NCT00424463|6308883|P1|Overall Study|Withdrawal by Subject|4
1817486|NCT00424463|6308881|P3|Overall Study|Physician Decision|2
1817487|NCT00424463|6308882|P2|Overall Study|Physician Decision|2
1817488|NCT00424463|6308883|P1|Overall Study|Physician Decision|0
1817489|NCT00424463|6308881|P3|Overall Study|Adverse Event|2
1817490|NCT00424463|6308882|P2|Overall Study|Adverse Event|3
1817491|NCT00424463|6308883|P1|Overall Study|Adverse Event|2
1817492|NCT00424398|6308912|P3|Overall Study|Subject met exclusion criteria|0
1817493|NCT00424398|6308913|P2|Overall Study|Subject met exclusion criteria|0
1817494|NCT00424398|6308914|P1|Overall Study|Subject met exclusion criteria|1
1817495|NCT00424398|6308912|P3|Overall Study|Withdrawal by Subject|0
1817496|NCT00424398|6308913|P2|Overall Study|Withdrawal by Subject|1
1817497|NCT00424398|6308914|P1|Overall Study|Withdrawal by Subject|2
1817498|NCT00424385|6308958|P1|Cohort 1|Withdrawal by Subject|1
1817499|NCT00424385|6308958|P1|Cohort 0|Physician Decision|1
1817500|NCT00424385|6308958|P1|Cohort 0|Withdrawal by Subject|5
1817501|NCT00424372|6308965|P1|Overall Study|Lack of Efficacy|6
1817502|NCT00424372|6308965|P1|Overall Study|Protocol Violation|1
1817503|NCT00424372|6308965|P1|Overall Study|Withdrawal by Subject|4
1817504|NCT00424372|6308965|P1|Overall Study|Health deterioration|1
1817505|NCT00424372|6308965|P1|Overall Study|Adverse Event|18
1817506|NCT00424372|6308965|P1|Overall Study|Death|1
1817507|NCT00424346|6308977|P4|Extension Phase|Protocol Violation|0
1817508|NCT00424346|6308978|P3|Extension Phase|Protocol Violation|1
1817509|NCT00424346|6308979|P2|Extension Phase|Protocol Violation|1
1817510|NCT00424346|6308980|P1|Extension Phase|Protocol Violation|0
1817511|NCT00424346|6308977|P4|Extension Phase|Death|1
1817512|NCT00424346|6308978|P3|Extension Phase|Death|0
1817513|NCT00424346|6308979|P2|Extension Phase|Death|0
1817514|NCT00424346|6308980|P1|Extension Phase|Death|0
1817515|NCT00424346|6308977|P4|Extension Phase|Administrative Problems|35
1817516|NCT00424346|6308978|P3|Extension Phase|Administrative Problems|32
1817517|NCT00424346|6308979|P2|Extension Phase|Administrative Problems|69
1817518|NCT00424346|6308980|P1|Extension Phase|Administrative Problems|0
1817519|NCT00424346|6308977|P4|Extension Phase|Lost to Follow-up|0
1817520|NCT00424346|6308978|P3|Extension Phase|Lost to Follow-up|0
1817521|NCT00424346|6308979|P2|Extension Phase|Lost to Follow-up|2
1817522|NCT00424346|6308980|P1|Extension Phase|Lost to Follow-up|0
1817523|NCT00424346|6308977|P4|Extension Phase|Withdrawal by Subject|4
1817524|NCT00424346|6308978|P3|Extension Phase|Withdrawal by Subject|3
1817525|NCT00424346|6308979|P2|Extension Phase|Withdrawal by Subject|5
1817526|NCT00424346|6308980|P1|Extension Phase|Withdrawal by Subject|0
1817527|NCT00424346|6308977|P4|Extension Phase|Lack of Efficacy|11
1817528|NCT00424346|6308978|P3|Extension Phase|Lack of Efficacy|14
1817529|NCT00424346|6308979|P2|Extension Phase|Lack of Efficacy|16
1817530|NCT00424346|6308980|P1|Extension Phase|Lack of Efficacy|0
1817531|NCT00424346|6308977|P4|Extension Phase|Adverse Event|4
1817532|NCT00424346|6308978|P3|Extension Phase|Adverse Event|5
1817533|NCT00424346|6308979|P2|Extension Phase|Adverse Event|9
1817534|NCT00424346|6308980|P1|Extension Phase|Adverse Event|0
1817535|NCT00424346|6308977|P4|Core Study|Protocol Violation|0
1817536|NCT00424346|6308978|P3|Core Study|Protocol Violation|2
1817537|NCT00424346|6308979|P2|Core Study|Protocol Violation|0
1817538|NCT00424346|6308980|P1|Core Study|Protocol Violation|0
1817539|NCT00424346|6308977|P4|Core Study|Administrative Problems|0
1817540|NCT00424346|6308978|P3|Core Study|Administrative Problems|1
1817541|NCT00424346|6308979|P2|Core Study|Administrative Problems|0
1817542|NCT00424346|6308980|P1|Core Study|Administrative Problems|1
1817543|NCT00424346|6308977|P4|Core Study|Lost to Follow-up|0
1817544|NCT00424346|6308978|P3|Core Study|Lost to Follow-up|0
1817545|NCT00424346|6308979|P2|Core Study|Lost to Follow-up|1
1817546|NCT00424346|6308980|P1|Core Study|Lost to Follow-up|1
1817547|NCT00424346|6308977|P4|Core Study|Withdrawal by Subject|2
1817548|NCT00424346|6308978|P3|Core Study|Withdrawal by Subject|0
1817549|NCT00424346|6308979|P2|Core Study|Withdrawal by Subject|0
1817550|NCT00424346|6308980|P1|Core Study|Withdrawal by Subject|1
1817551|NCT00424346|6308977|P4|Core Study|Lack of Efficacy|4
1817552|NCT00424346|6308978|P3|Core Study|Lack of Efficacy|0
1817553|NCT00424346|6308979|P2|Core Study|Lack of Efficacy|3
1817554|NCT00424346|6308980|P1|Core Study|Lack of Efficacy|1
1817555|NCT00424346|6308977|P4|Core Study|Abnormal Laboratory Values|0
1817556|NCT00424346|6308978|P3|Core Study|Abnormal Laboratory Values|0
1817557|NCT00424346|6308979|P2|Core Study|Abnormal Laboratory Values|1
1817558|NCT00424346|6308980|P1|Core Study|Abnormal Laboratory Values|0
1817559|NCT00424346|6308977|P4|Core Study|Adverse Event|1
1817560|NCT00424346|6308978|P3|Core Study|Adverse Event|1
1817561|NCT00424346|6308979|P2|Core Study|Adverse Event|3
1817562|NCT00424346|6308980|P1|Core Study|Adverse Event|5
1817563|NCT00424294|6309095|P2|Overall Study|Randomized but not Treated|0
1817564|NCT00424294|6309096|P1|Overall Study|Randomized but not Treated|1
1817565|NCT00424294|6309095|P2|Overall Study|Other|2
1817566|NCT00424294|6309096|P1|Overall Study|Other|0
1817567|NCT00424294|6309095|P2|Overall Study|Withdrawal by Subject|2
1817568|NCT00424294|6309096|P1|Overall Study|Withdrawal by Subject|1
1817569|NCT00424294|6309095|P2|Overall Study|Lack of Efficacy|1
1817570|NCT00424294|6309096|P1|Overall Study|Lack of Efficacy|2
1817571|NCT00424294|6309095|P2|Overall Study|Adverse Event|10
1817572|NCT00424294|6309096|P1|Overall Study|Adverse Event|4
1817573|NCT00424255|6309163|P2|Overall Study|Sponsor Terminated Study|167
1817574|NCT00424255|6309164|P1|Overall Study|Sponsor Terminated Study|161
1817575|NCT00424255|6309163|P2|Overall Study|Disease Progression|2
1817576|NCT00424255|6309164|P1|Overall Study|Disease Progression|0
1817577|NCT00424255|6309163|P2|Overall Study|Fatigue|0
1817578|NCT00424255|6309164|P1|Overall Study|Fatigue|1
1817579|NCT00424255|6309163|P2|Overall Study|Non-compliance by Participants|0
1817580|NCT00424255|6309164|P1|Overall Study|Non-compliance by Participants|1
1817581|NCT00424255|6309163|P2|Overall Study|Cognitive Disturbance|0
1817582|NCT00424255|6309164|P1|Overall Study|Cognitive Disturbance|1
1817583|NCT00424255|6309163|P2|Overall Study|Physician Decision|7
1817584|NCT00424255|6309164|P1|Overall Study|Physician Decision|3
1817585|NCT00424255|6309163|P2|Overall Study|Withdrawal by Subject|38
1817586|NCT00424255|6309164|P1|Overall Study|Withdrawal by Subject|34
1817587|NCT00424255|6309163|P2|Overall Study|Protocol Violation|1
1817588|NCT00424255|6309164|P1|Overall Study|Protocol Violation|0
1817589|NCT00424255|6309163|P2|Overall Study|Lost to Follow-up|20
1817590|NCT00424255|6309164|P1|Overall Study|Lost to Follow-up|26
1817591|NCT00424255|6309163|P2|Overall Study|Death|111
1817592|NCT00424255|6309164|P1|Overall Study|Death|115
1817593|NCT00424190|6309212|P2|Overall Study|Other|21
1817594|NCT00424190|6309213|P1|Overall Study|Other|15
1817595|NCT00424190|6309212|P2|Overall Study|Diagnosis of osteomyelitis|1
1817596|NCT00424190|6309213|P1|Overall Study|Diagnosis of osteomyelitis|0
1817597|NCT00424190|6309212|P2|Overall Study|Request of sponsor or investigator|2
1817598|NCT00424190|6309213|P1|Overall Study|Request of sponsor or investigator|0
1817599|NCT00424190|6309212|P2|Overall Study|Noncompliance|2
1817600|NCT00424190|6309213|P1|Overall Study|Noncompliance|1
1817601|NCT00424190|6309212|P2|Overall Study|Death|0
1817602|NCT00424190|6309213|P1|Overall Study|Death|3
1817603|NCT00424190|6309212|P2|Overall Study|Withdrew consent|4
1817604|NCT00424190|6309213|P1|Overall Study|Withdrew consent|3
1817605|NCT00424177|6309219|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
1817606|NCT00424177|6309219|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1817607|NCT00424177|6309219|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
1817608|NCT00424177|6309219|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
1817609|NCT00424177|6309219|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
1817610|NCT00424177|6309219|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
1817611|NCT00424177|6309219|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
1817612|NCT00424177|6309219|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
1817613|NCT00424177|6309219|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
1817614|NCT00424177|6309219|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
1817615|NCT00424047|6309248|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
1817616|NCT00424047|6309249|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
1817617|NCT00424047|6309248|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
1817618|NCT00424047|6309249|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
1817619|NCT00424047|6309248|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
1817620|NCT00424047|6309249|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
1817621|NCT00424047|6309248|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
1817622|NCT00424047|6309249|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
1817623|NCT00424047|6309248|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
1817624|NCT00424047|6309249|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
1817625|NCT00424047|6309248|P2|On Study at Time of Unblinding|Other|4
1817626|NCT00424047|6309249|P1|On Study at Time of Unblinding|Other|5
1817627|NCT00424047|6309248|P2|On Study at Time of Unblinding|Death|11
1817628|NCT00424047|6309249|P1|On Study at Time of Unblinding|Death|11
1817629|NCT00424047|6309248|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
1817630|NCT00424047|6309249|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
1817631|NCT00424047|6309248|P2|On Study at Time of Unblinding|Lack of Efficacy|3
1817632|NCT00424047|6309249|P1|On Study at Time of Unblinding|Lack of Efficacy|1
1817633|NCT00424047|6309248|P2|On Study at Time of Unblinding|Progression of disease|128
1817634|NCT00424047|6309249|P1|On Study at Time of Unblinding|Progression of disease|92
1817635|NCT00424047|6309248|P2|On Study at Time of Unblinding|Adverse Event|12
1817636|NCT00424047|6309249|P1|On Study at Time of Unblinding|Adverse Event|22
1817637|NCT00424047|6309248|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
1817638|NCT00424047|6309249|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
1817639|NCT00424047|6309248|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
1817640|NCT00424047|6309249|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
1817641|NCT00424047|6309248|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
1817642|NCT00424047|6309249|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
1817643|NCT00424047|6309248|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
1817644|NCT00424047|6309249|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
1817645|NCT00424047|6309248|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
1817646|NCT00424047|6309249|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
1817647|NCT00424047|6309248|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
1817648|NCT00424047|6309249|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
1817649|NCT00424021|6309281|P4|AMB-220-E Study Period|Physician Decision|1
1817650|NCT00424021|6309282|P3|AMB-220-E Study Period|Physician Decision|0
1817651|NCT00424021|6309283|P2|AMB-220-E Study Period|Physician Decision|0
1817652|NCT00424021|6309284|P1|AMB-220-E Study Period|Physician Decision|0
1817653|NCT00424021|6309281|P4|AMB-220-E Study Period|Lost to Follow-up|1
1817654|NCT00424021|6309282|P3|AMB-220-E Study Period|Lost to Follow-up|1
1817655|NCT00424021|6309283|P2|AMB-220-E Study Period|Lost to Follow-up|1
1817656|NCT00424021|6309284|P1|AMB-220-E Study Period|Lost to Follow-up|0
1817657|NCT00424021|6309281|P4|AMB-220-E Study Period|Death|1
1817658|NCT00424021|6309282|P3|AMB-220-E Study Period|Death|1
1817659|NCT00424021|6309283|P2|AMB-220-E Study Period|Death|0
1817660|NCT00424021|6309284|P1|AMB-220-E Study Period|Death|0
1817661|NCT00424021|6309281|P4|AMB-220-E Study Period|Adverse Event|7
1817662|NCT00424021|6309282|P3|AMB-220-E Study Period|Adverse Event|3
1817663|NCT00424021|6309283|P2|AMB-220-E Study Period|Adverse Event|1
1817664|NCT00424021|6309284|P1|AMB-220-E Study Period|Adverse Event|1
1817665|NCT00424021|6309281|P4|NCT00046319 Study Period|Lost to Follow-up|0
1817666|NCT00424021|6309282|P3|NCT00046319 Study Period|Lost to Follow-up|0
1817667|NCT00424021|6309283|P2|NCT00046319 Study Period|Lost to Follow-up|1
1817668|NCT00424021|6309284|P1|NCT00046319 Study Period|Lost to Follow-up|0
1817669|NCT00424021|6309281|P4|NCT00046319 Study Period|Sponsor discretion|0
1817670|NCT00424021|6309282|P3|NCT00046319 Study Period|Sponsor discretion|0
1817671|NCT00424021|6309283|P2|NCT00046319 Study Period|Sponsor discretion|1
1817672|NCT00424021|6309284|P1|NCT00046319 Study Period|Sponsor discretion|0
1817673|NCT00424021|6309281|P4|NCT00046319 Study Period|Withdrawal by Subject|0
1817674|NCT00424021|6309282|P3|NCT00046319 Study Period|Withdrawal by Subject|0
1817675|NCT00424021|6309283|P2|NCT00046319 Study Period|Withdrawal by Subject|1
1817676|NCT00424021|6309284|P1|NCT00046319 Study Period|Withdrawal by Subject|0
1817677|NCT00424021|6309281|P4|NCT00046319 Study Period|Adverse Event|1
1817678|NCT00424021|6309282|P3|NCT00046319 Study Period|Adverse Event|1
1817679|NCT00424021|6309283|P2|NCT00046319 Study Period|Adverse Event|0
1817680|NCT00424021|6309284|P1|NCT00046319 Study Period|Adverse Event|1
1817681|NCT00424008|6309327|P2|Overall Study|Administrative|257
1817682|NCT00424008|6309328|P1|Overall Study|Administrative|266
1817683|NCT00424008|6309327|P2|Overall Study|Did not meet protocol eligibility|21
1817684|NCT00424008|6309328|P1|Overall Study|Did not meet protocol eligibility|16
1817685|NCT00424008|6309327|P2|Overall Study|Noncompliance with protocol|7
1817686|NCT00424008|6309328|P1|Overall Study|Noncompliance with protocol|13
1817687|NCT00424008|6309327|P2|Overall Study|Withdrawal by Subject|8
1817688|NCT00424008|6309328|P1|Overall Study|Withdrawal by Subject|5
1817689|NCT00424008|6309327|P2|Overall Study|Lost to Follow-up|2
1817690|NCT00424008|6309328|P1|Overall Study|Lost to Follow-up|1
1817691|NCT00424008|6309327|P2|Overall Study|Lack of Efficacy|34
1817692|NCT00424008|6309328|P1|Overall Study|Lack of Efficacy|40
1817693|NCT00424008|6309327|P2|Overall Study|Adverse Event|6
1817694|NCT00424008|6309328|P1|Overall Study|Adverse Event|8
1817695|NCT00423943|6309343|P2|Overall Study|Withdrawal by Subject|1
1817696|NCT00423943|6309344|P1|Overall Study|Withdrawal by Subject|3
1817697|NCT00423930|6309358|P1|Overall Study|Withdrawal by Subject|2
1817698|NCT00423917|6309363|P1|Overall Study|Ineligible|1
1817699|NCT00423917|6309363|P1|Overall Study|Cancel|2
1817700|NCT00423891|6309376|P3|Post-Dosing Follow Up|Lost to Follow-up|0
1817701|NCT00423891|6309377|P2|Post-Dosing Follow Up|Lost to Follow-up|0
1817702|NCT00423891|6309378|P1|Post-Dosing Follow Up|Lost to Follow-up|2
1817703|NCT00423891|6309376|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
1817704|NCT00423891|6309377|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
1817705|NCT00423891|6309378|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
1817706|NCT00423891|6309376|P3|Treatment|Lost to Follow-up|0
1817707|NCT00423891|6309377|P2|Treatment|Lost to Follow-up|0
1817708|NCT00423891|6309378|P1|Treatment|Lost to Follow-up|1
1817709|NCT00423891|6309376|P3|Treatment|Withdrawal by Subject|0
1817710|NCT00423891|6309377|P2|Treatment|Withdrawal by Subject|0
1817711|NCT00423891|6309378|P1|Treatment|Withdrawal by Subject|1
1817712|NCT00423891|6309376|P3|Enrolled|No longer met criteria|1
1817713|NCT00423891|6309377|P2|Enrolled|No longer met criteria|2
1817714|NCT00423891|6309378|P1|Enrolled|No longer met criteria|11
1817715|NCT00423891|6309376|P3|Enrolled|Lost to Follow-up|1
1817716|NCT00423891|6309377|P2|Enrolled|Lost to Follow-up|0
1817717|NCT00423891|6309378|P1|Enrolled|Lost to Follow-up|0
1817718|NCT00423891|6309376|P3|Enrolled|Withdrawal by Subject|1
1817719|NCT00423891|6309377|P2|Enrolled|Withdrawal by Subject|0
1817720|NCT00423891|6309378|P1|Enrolled|Withdrawal by Subject|0
1817721|NCT00423852|6309456|P1|Overall Study|Removed pior to the high-dose portion|3
1817722|NCT00423813|6309464|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
1817723|NCT00423813|6309465|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
1817724|NCT00423813|6309466|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
1817725|NCT00423813|6309464|P3|Overall Study|Will start exclusionary medications|0
1817726|NCT00423813|6309465|P2|Overall Study|Will start exclusionary medications|1
1817727|NCT00423813|6309466|P1|Overall Study|Will start exclusionary medications|0
1817728|NCT00423813|6309464|P3|Overall Study|Subject started night shift work|0
1817729|NCT00423813|6309465|P2|Overall Study|Subject started night shift work|0
1817730|NCT00423813|6309466|P1|Overall Study|Subject started night shift work|1
1817731|NCT00423813|6309464|P3|Overall Study|Pregnancy|1
1817732|NCT00423813|6309465|P2|Overall Study|Pregnancy|0
1817733|NCT00423813|6309466|P1|Overall Study|Pregnancy|0
1817734|NCT00423813|6309464|P3|Overall Study|Protocol Violation|4
1817735|NCT00423813|6309465|P2|Overall Study|Protocol Violation|4
1817736|NCT00423813|6309466|P1|Overall Study|Protocol Violation|9
1817737|NCT00423813|6309464|P3|Overall Study|Sponsor Decision|0
1817738|NCT00423813|6309465|P2|Overall Study|Sponsor Decision|1
1817739|NCT00423813|6309466|P1|Overall Study|Sponsor Decision|0
1817740|NCT00423813|6309464|P3|Overall Study|Physician Decision|0
1817741|NCT00423813|6309465|P2|Overall Study|Physician Decision|0
1817742|NCT00423813|6309466|P1|Overall Study|Physician Decision|2
1817743|NCT00423813|6309464|P3|Overall Study|Lack of Efficacy|19
1817744|NCT00423813|6309465|P2|Overall Study|Lack of Efficacy|18
1817745|NCT00423813|6309466|P1|Overall Study|Lack of Efficacy|23
1817746|NCT00423813|6309464|P3|Overall Study|Lost to Follow-up|4
1817747|NCT00423813|6309465|P2|Overall Study|Lost to Follow-up|4
1817748|NCT00423813|6309466|P1|Overall Study|Lost to Follow-up|5
1817749|NCT00423813|6309464|P3|Overall Study|Withdrawal by Subject|5
1817750|NCT00423813|6309465|P2|Overall Study|Withdrawal by Subject|8
1817751|NCT00423813|6309466|P1|Overall Study|Withdrawal by Subject|6
1817752|NCT00423813|6309464|P3|Overall Study|Adverse Event|40
1817753|NCT00423813|6309465|P2|Overall Study|Adverse Event|30
1817754|NCT00423813|6309466|P1|Overall Study|Adverse Event|11
1817755|NCT00423800|6309476|P2|Overall Study|Protocol Violation|1
1817756|NCT00423800|6309477|P1|Overall Study|Protocol Violation|0
1817757|NCT00423735|6309489|P3|Overall Study|Ineligible / No protocol treatment|0
1817758|NCT00423735|6309490|P2|Overall Study|Ineligible / No protocol treatment|6
1817759|NCT00423735|6309491|P1|Overall Study|Ineligible / No protocol treatment|8
1817760|NCT00423722|6309514|P2|Overall Study|Withdrawal by Subject|2
1817761|NCT00423722|6309515|P1|Overall Study|Withdrawal by Subject|4
1817762|NCT00423722|6309514|P2|Overall Study|Unable to complete questionnaires|4
1817763|NCT00423722|6309515|P1|Overall Study|Unable to complete questionnaires|4
1817764|NCT00423722|6309514|P2|Overall Study|Declined to participate|3
1817765|NCT00423722|6309515|P1|Overall Study|Declined to participate|2
1817766|NCT00423722|6309514|P2|Overall Study|Death|4
1817767|NCT00423722|6309515|P1|Overall Study|Death|4
1817768|NCT00423670|6309557|P8|Follow-up Period|Non-compliance with protocol|2
1817769|NCT00423670|6309558|P7|Follow-up Period|Non-compliance with protocol|3
1817770|NCT00423670|6309559|P6|Follow-up Period|Non-compliance with protocol|0
1817771|NCT00423670|6309560|P5|Follow-up Period|Non-compliance with protocol|0
1817772|NCT00423670|6309561|P4|Follow-up Period|Non-compliance with protocol|1
1817773|NCT00423670|6309562|P3|Follow-up Period|Non-compliance with protocol|1
1817774|NCT00423670|6309563|P2|Follow-up Period|Non-compliance with protocol|0
1817775|NCT00423670|6309564|P1|Follow-up Period|Non-compliance with protocol|2
1817776|NCT00423670|6309557|P8|Follow-up Period|Subject withdrew (not treatment related)|1
1817777|NCT00423670|6309558|P7|Follow-up Period|Subject withdrew (not treatment related)|1
1817778|NCT00423670|6309559|P6|Follow-up Period|Subject withdrew (not treatment related)|0
1817779|NCT00423670|6309560|P5|Follow-up Period|Subject withdrew (not treatment related)|1
1817780|NCT00423670|6309561|P4|Follow-up Period|Subject withdrew (not treatment related)|1
1817781|NCT00423670|6309562|P3|Follow-up Period|Subject withdrew (not treatment related)|2
1817782|NCT00423670|6309563|P2|Follow-up Period|Subject withdrew (not treatment related)|4
1817783|NCT00423670|6309564|P1|Follow-up Period|Subject withdrew (not treatment related)|1
1817784|NCT00423670|6309557|P8|Follow-up Period|Lost to Follow-up|0
1817785|NCT00423670|6309558|P7|Follow-up Period|Lost to Follow-up|5
1817786|NCT00423670|6309559|P6|Follow-up Period|Lost to Follow-up|0
1817787|NCT00423670|6309560|P5|Follow-up Period|Lost to Follow-up|1
1817788|NCT00423670|6309561|P4|Follow-up Period|Lost to Follow-up|3
1817789|NCT00423670|6309562|P3|Follow-up Period|Lost to Follow-up|8
1817790|NCT00423670|6309563|P2|Follow-up Period|Lost to Follow-up|12
1817791|NCT00423670|6309564|P1|Follow-up Period|Lost to Follow-up|0
1817792|NCT00423670|6309557|P8|Treatment Period|Non-compliance with protocol|2
1817793|NCT00423670|6309558|P7|Treatment Period|Non-compliance with protocol|2
1817794|NCT00423670|6309559|P6|Treatment Period|Non-compliance with protocol|0
1817795|NCT00423670|6309560|P5|Treatment Period|Non-compliance with protocol|2
1817796|NCT00423670|6309561|P4|Treatment Period|Non-compliance with protocol|3
1817797|NCT00423670|6309562|P3|Treatment Period|Non-compliance with protocol|1
1817798|NCT00423670|6309563|P2|Treatment Period|Non-compliance with protocol|1
1817799|NCT00423670|6309564|P1|Treatment Period|Non-compliance with protocol|3
1817800|NCT00423670|6309557|P8|Treatment Period|Investigator decision|1
1817801|NCT00423670|6309558|P7|Treatment Period|Investigator decision|0
1817802|NCT00423670|6309559|P6|Treatment Period|Investigator decision|0
1817803|NCT00423670|6309560|P5|Treatment Period|Investigator decision|0
1817804|NCT00423670|6309561|P4|Treatment Period|Investigator decision|0
1817805|NCT00423670|6309562|P3|Treatment Period|Investigator decision|0
1817806|NCT00423670|6309563|P2|Treatment Period|Investigator decision|0
1817807|NCT00423670|6309564|P1|Treatment Period|Investigator decision|0
1817808|NCT00423670|6309557|P8|Treatment Period|Subject withdrew (not treatment related)|0
1817809|NCT00423670|6309558|P7|Treatment Period|Subject withdrew (not treatment related)|3
1817895|NCT00423449|6309674|P1|Overall Study|Progressive Disease|1
1817810|NCT00423670|6309559|P6|Treatment Period|Subject withdrew (not treatment related)|0
1817811|NCT00423670|6309560|P5|Treatment Period|Subject withdrew (not treatment related)|5
1817812|NCT00423670|6309561|P4|Treatment Period|Subject withdrew (not treatment related)|4
1817813|NCT00423670|6309562|P3|Treatment Period|Subject withdrew (not treatment related)|4
1817814|NCT00423670|6309563|P2|Treatment Period|Subject withdrew (not treatment related)|9
1817815|NCT00423670|6309564|P1|Treatment Period|Subject withdrew (not treatment related)|3
1817816|NCT00423670|6309557|P8|Treatment Period|Lost to Follow-up|1
1817817|NCT00423670|6309558|P7|Treatment Period|Lost to Follow-up|3
1817818|NCT00423670|6309559|P6|Treatment Period|Lost to Follow-up|0
1817819|NCT00423670|6309560|P5|Treatment Period|Lost to Follow-up|6
1817820|NCT00423670|6309561|P4|Treatment Period|Lost to Follow-up|1
1817821|NCT00423670|6309562|P3|Treatment Period|Lost to Follow-up|3
1817822|NCT00423670|6309563|P2|Treatment Period|Lost to Follow-up|1
1817823|NCT00423670|6309564|P1|Treatment Period|Lost to Follow-up|2
1817824|NCT00423670|6309557|P8|Treatment Period|Protocol-defined clinical event|15
1817825|NCT00423670|6309558|P7|Treatment Period|Protocol-defined clinical event|16
1817826|NCT00423670|6309559|P6|Treatment Period|Protocol-defined clinical event|4
1817827|NCT00423670|6309560|P5|Treatment Period|Protocol-defined clinical event|5
1817828|NCT00423670|6309561|P4|Treatment Period|Protocol-defined clinical event|12
1817829|NCT00423670|6309562|P3|Treatment Period|Protocol-defined clinical event|4
1817830|NCT00423670|6309563|P2|Treatment Period|Protocol-defined clinical event|7
1817831|NCT00423670|6309564|P1|Treatment Period|Protocol-defined clinical event|0
1817832|NCT00423670|6309557|P8|Treatment Period|Adverse Event|2
1817833|NCT00423670|6309558|P7|Treatment Period|Adverse Event|7
1817834|NCT00423670|6309559|P6|Treatment Period|Adverse Event|4
1817835|NCT00423670|6309560|P5|Treatment Period|Adverse Event|9
1817836|NCT00423670|6309561|P4|Treatment Period|Adverse Event|20
1817837|NCT00423670|6309562|P3|Treatment Period|Adverse Event|15
1817838|NCT00423670|6309563|P2|Treatment Period|Adverse Event|12
1817839|NCT00423670|6309564|P1|Treatment Period|Adverse Event|8
1817840|NCT00423670|6309557|P8|Treatment Period|Switched to Arm 8 at TW 24|0
1817841|NCT00423670|6309558|P7|Treatment Period|Switched to Arm 8 at TW 24|0
1817842|NCT00423670|6309559|P6|Treatment Period|Switched to Arm 8 at TW 24|0
1817843|NCT00423670|6309560|P5|Treatment Period|Switched to Arm 8 at TW 24|0
1817844|NCT00423670|6309561|P4|Treatment Period|Switched to Arm 8 at TW 24|0
1817845|NCT00423670|6309562|P3|Treatment Period|Switched to Arm 8 at TW 24|0
1817846|NCT00423670|6309563|P2|Treatment Period|Switched to Arm 8 at TW 24|0
1817847|NCT00423670|6309564|P1|Treatment Period|Switched to Arm 8 at TW 24|36
1817848|NCT00423657|6309622|P2|Overall Study|Request of sponsor/investigator|0
1817849|NCT00423657|6309623|P1|Overall Study|Request of sponsor/investigator|1
1817850|NCT00423657|6309622|P2|Overall Study|Other|16
1817851|NCT00423657|6309623|P1|Overall Study|Other|15
1817852|NCT00423657|6309622|P2|Overall Study|Non-compliance|1
1817853|NCT00423657|6309623|P1|Overall Study|Non-compliance|0
1817854|NCT00423657|6309622|P2|Overall Study|Withdrew consent|8
1817855|NCT00423657|6309623|P1|Overall Study|Withdrew consent|10
1817856|NCT00423605|6309629|P1|Overall Study|Not one of the pre-specified options|5
1817857|NCT00423605|6309629|P1|Overall Study|Protocol Violation|7
1817858|NCT00423605|6309629|P1|Overall Study|Physician Decision|8
1817859|NCT00423605|6309629|P1|Overall Study|Sponsor Decision|3
1817860|NCT00423605|6309629|P1|Overall Study|Lack of Efficacy|38
1817861|NCT00423605|6309629|P1|Overall Study|Lost to Follow-up|15
1817862|NCT00423605|6309629|P1|Overall Study|Withdrawal by Subject|36
1817863|NCT00423605|6309629|P1|Overall Study|Adverse Event|129
1817864|NCT00423592|6309633|P1|Overall Study|Adverse Event (post Week 12)|5
1817865|NCT00423592|6309633|P1|Overall Study|Adverse Event (through Week 12)|2
1817866|NCT00423579|6309654|P2|Overall Study|Diagnosis of diabetes|1
1817867|NCT00423579|6309655|P1|Overall Study|Diagnosis of diabetes|0
1817868|NCT00423579|6309654|P2|Overall Study|Protocol Violation|3
1817869|NCT00423579|6309655|P1|Overall Study|Protocol Violation|1
1817870|NCT00423579|6309654|P2|Overall Study|Lost to Follow-up|0
1817871|NCT00423579|6309655|P1|Overall Study|Lost to Follow-up|3
1817872|NCT00423488|6309663|P2|Overall Study|No post baseline data|0
1817873|NCT00423488|6309664|P1|Overall Study|No post baseline data|3
1817874|NCT00423488|6309663|P2|Overall Study|No evidence of study drug intake|1
1817875|NCT00423488|6309664|P1|Overall Study|No evidence of study drug intake|2
1817876|NCT00423449|6309670|P5|Overall Study|Protocol Violation|0
1817877|NCT00423449|6309671|P4|Overall Study|Protocol Violation|1
1817878|NCT00423449|6309672|P3|Overall Study|Protocol Violation|2
1817879|NCT00423449|6309673|P2|Overall Study|Protocol Violation|0
1817880|NCT00423449|6309674|P1|Overall Study|Protocol Violation|0
1817881|NCT00423449|6309670|P5|Overall Study|Other|0
1817882|NCT00423449|6309671|P4|Overall Study|Other|1
1817883|NCT00423449|6309672|P3|Overall Study|Other|0
1817884|NCT00423449|6309673|P2|Overall Study|Other|0
1817885|NCT00423449|6309674|P1|Overall Study|Other|0
1817886|NCT00423449|6309670|P5|Overall Study|Laboratory Adverse Event|0
1817887|NCT00423449|6309671|P4|Overall Study|Laboratory Adverse Event|0
1817888|NCT00423449|6309672|P3|Overall Study|Laboratory Adverse Event|2
1817889|NCT00423449|6309673|P2|Overall Study|Laboratory Adverse Event|1
1817890|NCT00423449|6309674|P1|Overall Study|Laboratory Adverse Event|0
1817891|NCT00423449|6309670|P5|Overall Study|Progressive Disease|4
1817892|NCT00423449|6309671|P4|Overall Study|Progressive Disease|11
1817893|NCT00423449|6309672|P3|Overall Study|Progressive Disease|8
1817894|NCT00423449|6309673|P2|Overall Study|Progressive Disease|3
1817896|NCT00423449|6309670|P5|Overall Study|Death|1
1817897|NCT00423449|6309671|P4|Overall Study|Death|1
1817898|NCT00423449|6309672|P3|Overall Study|Death|2
1817899|NCT00423449|6309673|P2|Overall Study|Death|0
1817900|NCT00423449|6309674|P1|Overall Study|Death|1
1817901|NCT00423449|6309670|P5|Overall Study|Clinical Adverse Event|2
1817902|NCT00423449|6309671|P4|Overall Study|Clinical Adverse Event|8
1817903|NCT00423449|6309672|P3|Overall Study|Clinical Adverse Event|1
1817904|NCT00423449|6309673|P2|Overall Study|Clinical Adverse Event|0
1817905|NCT00423449|6309674|P1|Overall Study|Clinical Adverse Event|1
1817906|NCT00423332|6309721|P2|Overall Study|Unblinded before 12 weeks|3
1817907|NCT00423332|6309722|P1|Overall Study|Unblinded before 12 weeks|1
1817908|NCT00423332|6309721|P2|Overall Study|Progressive at Week 6|1
1817909|NCT00423332|6309722|P1|Overall Study|Progressive at Week 6|0
1817910|NCT00423332|6309721|P2|Overall Study|Condition under investigation worsened|1
1817911|NCT00423332|6309722|P1|Overall Study|Condition under investigation worsened|1
1817912|NCT00423332|6309721|P2|Overall Study|Withdrawal by Subject|0
1817913|NCT00423332|6309722|P1|Overall Study|Withdrawal by Subject|1
1817914|NCT00423332|6309721|P2|Overall Study|Adverse Event|2
1817915|NCT00423332|6309722|P1|Overall Study|Adverse Event|6
1817916|NCT00423319|6309741|P2|Overall Study|Other|22
1817917|NCT00423319|6309742|P1|Overall Study|Other|23
1817918|NCT00423319|6309741|P2|Overall Study|No longer meets study criteria|15
1817919|NCT00423319|6309742|P1|Overall Study|No longer meets study criteria|15
1817920|NCT00423319|6309741|P2|Overall Study|Poor compliance or noncompliance|1
1817921|NCT00423319|6309742|P1|Overall Study|Poor compliance or noncompliance|1
1817922|NCT00423319|6309741|P2|Overall Study|Lost to Follow-up|3
1817923|NCT00423319|6309742|P1|Overall Study|Lost to Follow-up|4
1817924|NCT00423319|6309741|P2|Overall Study|Withdrawal by Subject|99
1817925|NCT00423319|6309742|P1|Overall Study|Withdrawal by Subject|86
1817926|NCT00423319|6309741|P2|Overall Study|Adverse Event|112
1817927|NCT00423319|6309742|P1|Overall Study|Adverse Event|93
1817928|NCT00423319|6309741|P2|Overall Study|Death|0
1817929|NCT00423319|6309742|P1|Overall Study|Death|2
1817930|NCT00423293|6309774|P1|Overall Study|Ineligible / No protocol treatment|11
1817931|NCT00423267|6309791|P2|Period A|Administrative|0
1817932|NCT00423267|6309792|P1|Period A|Administrative|1
1817933|NCT00423267|6309791|P2|Period A|Non-compliance with protocol|0
1817934|NCT00423267|6309792|P1|Period A|Non-compliance with protocol|1
1817935|NCT00423267|6309791|P2|Period A|Withdrawal by Subject|1
1817936|NCT00423267|6309792|P1|Period A|Withdrawal by Subject|0
1817937|NCT00423189|6309812|P3|Overall Study|Death|0
1817938|NCT00423189|6309813|P2|Overall Study|Death|1
1817939|NCT00423189|6309814|P1|Overall Study|Death|0
1817940|NCT00423176|6309836|P2|Overall Study|Did not meet protocol eligibility|4
1817941|NCT00423176|6309837|P1|Overall Study|Did not meet protocol eligibility|2
1817942|NCT00423176|6309836|P2|Overall Study|Protocol Violation|3
1817943|NCT00423176|6309837|P1|Overall Study|Protocol Violation|1
1817944|NCT00423176|6309836|P2|Overall Study|Withdrawal by Subject|3
1817945|NCT00423176|6309837|P1|Overall Study|Withdrawal by Subject|4
1817946|NCT00423176|6309836|P2|Overall Study|Lost to Follow-up|7
1817947|NCT00423176|6309837|P1|Overall Study|Lost to Follow-up|4
1817948|NCT00423176|6309836|P2|Overall Study|Treatment Failure|6
1817949|NCT00423176|6309837|P1|Overall Study|Treatment Failure|1
1817950|NCT00423176|6309836|P2|Overall Study|Adverse Event|6
1817951|NCT00423176|6309837|P1|Overall Study|Adverse Event|4
1817952|NCT00423150|6309845|P1|Overall Study|Administrative|4
1817953|NCT00423150|6309845|P1|Overall Study|Non-compliance with protocol|1
1817954|NCT00423150|6309845|P1|Overall Study|Withdrawal by Subject|1
1817955|NCT00423150|6309845|P1|Overall Study|Progression of disease being studied|69
1817956|NCT00423150|6309845|P1|Overall Study|Adverse Event|11
1817957|NCT00423098|6309851|P2|Overall Study|Death|0
1817958|NCT00423098|6309852|P1|Overall Study|Death|2
1817959|NCT00423098|6309851|P2|Overall Study|Administrative problems|1
1817960|NCT00423098|6309852|P1|Overall Study|Administrative problems|0
1817961|NCT00423098|6309851|P2|Overall Study|Unsatisfactory therapeutic effect|1
1817962|NCT00423098|6309852|P1|Overall Study|Unsatisfactory therapeutic effect|0
1817963|NCT00423098|6309851|P2|Overall Study|Adverse Event|2
1817964|NCT00423098|6309852|P1|Overall Study|Adverse Event|1
1817965|NCT00423085|6309879|P4|52-Week Open-Label Extension Phase|Death|2
1817966|NCT00423085|6309880|P3|52-Week Open-Label Extension Phase|Death|0
1817967|NCT00423085|6309881|P2|52-Week Open-Label Extension Phase|Death|0
1817968|NCT00423085|6309882|P1|52-Week Open-Label Extension Phase|Death|0
1817969|NCT00423085|6309879|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
1817970|NCT00423085|6309880|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
1817971|NCT00423085|6309881|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
1817972|NCT00423085|6309882|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
1817973|NCT00423085|6309879|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
1817974|NCT00423085|6309880|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1817975|NCT00423085|6309881|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1817976|NCT00423085|6309882|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
1817977|NCT00423085|6309879|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
1817978|NCT00423085|6309880|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1817979|NCT00423085|6309881|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1817980|NCT00423085|6309882|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
1817981|NCT00423085|6309879|P4|52-Week Open-Label Extension Phase|Adverse Event|97
1817982|NCT00423085|6309880|P3|52-Week Open-Label Extension Phase|Adverse Event|0
1817983|NCT00423085|6309881|P2|52-Week Open-Label Extension Phase|Adverse Event|0
1817984|NCT00423085|6309882|P1|52-Week Open-Label Extension Phase|Adverse Event|0
1817985|NCT00423085|6309879|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1817986|NCT00423085|6309880|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1817987|NCT00423085|6309881|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
1817988|NCT00423085|6309882|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
1817989|NCT00423085|6309879|P4|24-Week Double-Blind Treatment Phase|Death|0
1817990|NCT00423085|6309880|P3|24-Week Double-Blind Treatment Phase|Death|0
1817991|NCT00423085|6309881|P2|24-Week Double-Blind Treatment Phase|Death|1
1817992|NCT00423085|6309882|P1|24-Week Double-Blind Treatment Phase|Death|1
1817993|NCT00423085|6309879|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
1817994|NCT00423085|6309880|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
1817995|NCT00423085|6309881|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
1817996|NCT00423085|6309882|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
1817997|NCT00423085|6309879|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
1817998|NCT00423085|6309880|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1817999|NCT00423085|6309881|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
1818000|NCT00423085|6309882|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
1818001|NCT00423085|6309879|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
1818002|NCT00423085|6309880|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
1818003|NCT00423085|6309881|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
1818004|NCT00423085|6309882|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
1818005|NCT00423085|6309879|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
1818006|NCT00423085|6309880|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
1818007|NCT00423085|6309881|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
1818008|NCT00423085|6309882|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
1818009|NCT00423046|6309911|P2|Overall Study|Other|345
1818010|NCT00423046|6309912|P1|Overall Study|Other|340
1818011|NCT00422942|6309978|P1|Overall Study|Study terminated by Sponsor|3
1818012|NCT00422903|6309997|P2|Overall Study|Informed Consent Withdrawn|2
1818013|NCT00422903|6309998|P1|Overall Study|Informed Consent Withdrawn|1
1818014|NCT00422903|6309997|P2|Overall Study|Adverse Event|2
1818015|NCT00422903|6309998|P1|Overall Study|Adverse Event|0
1818016|NCT00422903|6309997|P2|Overall Study|Disease Progression|1
1818017|NCT00422903|6309998|P1|Overall Study|Disease Progression|3
1818018|NCT00422799|6310047|P1|Overall Study|Adverse Event|7
1818019|NCT00422799|6310047|P1|Overall Study|Withdrawal by Subject|6
1818020|NCT00422734|6310056|P2|Overall Study|Partner Decision|3
1818021|NCT00422734|6310057|P1|Overall Study|Partner Decision|0
1818022|NCT00422734|6310056|P2|Overall Study|Adverse Event|3
1818023|NCT00422734|6310057|P1|Overall Study|Adverse Event|0
1818024|NCT00422734|6310056|P2|Overall Study|Withdrawal by Subject|8
1818025|NCT00422734|6310057|P1|Overall Study|Withdrawal by Subject|12
1818026|NCT00422734|6310056|P2|Overall Study|Protocol Violation|6
1818027|NCT00422734|6310057|P1|Overall Study|Protocol Violation|1
1818028|NCT00422734|6310056|P2|Overall Study|Physician Decision|1
1818029|NCT00422734|6310057|P1|Overall Study|Physician Decision|1
1818030|NCT00422669|6310103|P3|Overall Study|The study was terminated early.|7
1818031|NCT00422669|6310104|P2|Overall Study|The study was terminated early.|100
1818032|NCT00422669|6310105|P1|Overall Study|The study was terminated early.|98
1818033|NCT00422591|6310133|P1|Overall Study|Withdrawal by Subject|2
1818034|NCT00422591|6310133|P1|Overall Study|Physician Decision|4
1818035|NCT00422513|6310141|P2|Overall Study|Death|7
1818036|NCT00422513|6310142|P1|Overall Study|Death|3
1818037|NCT00422513|6310141|P2|Overall Study|Adverse Event|4
1818038|NCT00422513|6310142|P1|Overall Study|Adverse Event|4
1818039|NCT00422513|6310141|P2|Overall Study|early termination of the study|80
1818040|NCT00422513|6310142|P1|Overall Study|early termination of the study|67
1818041|NCT00422513|6310141|P2|Overall Study|Withdrawal by Subject|1
1818042|NCT00422513|6310142|P1|Overall Study|Withdrawal by Subject|2
1818043|NCT00422513|6310141|P2|Overall Study|Refused Treatment|2
1818044|NCT00422513|6310142|P1|Overall Study|Refused Treatment|4
1818045|NCT00422513|6310141|P2|Overall Study|Protocol Violation|7
1818046|NCT00422513|6310142|P1|Overall Study|Protocol Violation|23
1818047|NCT00422513|6310141|P2|Overall Study|Lack of Efficacy|5
1818048|NCT00422513|6310142|P1|Overall Study|Lack of Efficacy|4
1818049|NCT00422422|6310159|P1|Overall Study|AE, non-serious non-fatal|5
1818050|NCT00422422|6310159|P1|Overall Study|SAE, non-fatal|1
1818051|NCT00422422|6310159|P1|Overall Study|Withdrawal by Subject|2
1818052|NCT00422422|6310159|P1|Overall Study|Protocol Violation|1
1818053|NCT00422422|6310159|P1|Overall Study|Lack of Efficacy|1
1818054|NCT00422383|6310176|P5|Overall Study|Withdrawal by Subject|1
1818055|NCT00422383|6310177|P4|Overall Study|Withdrawal by Subject|0
1818056|NCT00422383|6310178|P3|Overall Study|Withdrawal by Subject|0
1818057|NCT00422383|6310179|P2|Overall Study|Withdrawal by Subject|5
1818058|NCT00422383|6310180|P1|Overall Study|Withdrawal by Subject|5
1818059|NCT00422383|6310176|P5|Overall Study|Protocol Violation|0
1818060|NCT00422383|6310177|P4|Overall Study|Protocol Violation|0
1818061|NCT00422383|6310178|P3|Overall Study|Protocol Violation|1
1818062|NCT00422383|6310179|P2|Overall Study|Protocol Violation|1
1818063|NCT00422383|6310180|P1|Overall Study|Protocol Violation|1
1818064|NCT00422383|6310176|P5|Overall Study|Lost to Follow-up|1
1818065|NCT00422383|6310177|P4|Overall Study|Lost to Follow-up|0
1818066|NCT00422383|6310178|P3|Overall Study|Lost to Follow-up|0
1818067|NCT00422383|6310179|P2|Overall Study|Lost to Follow-up|1
1818068|NCT00422383|6310180|P1|Overall Study|Lost to Follow-up|0
1818069|NCT00422383|6310176|P5|Overall Study|Lack of Efficacy|1
1818070|NCT00422383|6310177|P4|Overall Study|Lack of Efficacy|1
1818071|NCT00422383|6310178|P3|Overall Study|Lack of Efficacy|2
1818072|NCT00422383|6310179|P2|Overall Study|Lack of Efficacy|4
1818073|NCT00422383|6310180|P1|Overall Study|Lack of Efficacy|4
1818074|NCT00422383|6310176|P5|Overall Study|Adverse Event|0
1818075|NCT00422383|6310177|P4|Overall Study|Adverse Event|1
1818076|NCT00422383|6310178|P3|Overall Study|Adverse Event|1
1818077|NCT00422383|6310179|P2|Overall Study|Adverse Event|3
1818078|NCT00422383|6310180|P1|Overall Study|Adverse Event|5
1818079|NCT00422292|6310323|P4|Overall Study|Withdrawal by Subject|13
1818080|NCT00422292|6310324|P3|Overall Study|Withdrawal by Subject|7
1818081|NCT00422292|6310325|P2|Overall Study|Withdrawal by Subject|25
1818082|NCT00422292|6310326|P1|Overall Study|Withdrawal by Subject|6
1818083|NCT00422292|6310323|P4|Overall Study|Lost to Follow-up|6
1818084|NCT00422292|6310324|P3|Overall Study|Lost to Follow-up|6
1818085|NCT00422292|6310325|P2|Overall Study|Lost to Follow-up|12
1818086|NCT00422292|6310326|P1|Overall Study|Lost to Follow-up|6
1818087|NCT00422292|6310323|P4|Overall Study|Protocol Violation|5
1818088|NCT00422292|6310324|P3|Overall Study|Protocol Violation|8
1818089|NCT00422292|6310325|P2|Overall Study|Protocol Violation|25
1818090|NCT00422292|6310326|P1|Overall Study|Protocol Violation|4
1818091|NCT00422292|6310323|P4|Overall Study|Adverse Event|0
1818092|NCT00422292|6310324|P3|Overall Study|Adverse Event|1
1818093|NCT00422292|6310325|P2|Overall Study|Adverse Event|0
1818094|NCT00422292|6310326|P1|Overall Study|Adverse Event|1
1818095|NCT00422292|6310323|P4|Overall Study|Serious adverse events|0
1818096|NCT00422292|6310324|P3|Overall Study|Serious adverse events|0
1818097|NCT00422292|6310325|P2|Overall Study|Serious adverse events|4
1818098|NCT00422292|6310326|P1|Overall Study|Serious adverse events|1
1818099|NCT00422227|6310365|P2|Overall Study|Withdrawal by Subject|4
1818100|NCT00422227|6310366|P1|Overall Study|Withdrawal by Subject|0
1818101|NCT00422227|6310365|P2|Overall Study|Lost to Follow-up|3
1818102|NCT00422227|6310366|P1|Overall Study|Lost to Follow-up|1
1818103|NCT00422227|6310365|P2|Overall Study|Adverse Event|8
1818104|NCT00422227|6310366|P1|Overall Study|Adverse Event|3
1818105|NCT00422162|6310397|P2|Overall Study|Didn't Receive Treatment|1
1818106|NCT00422162|6310398|P1|Overall Study|Didn't Receive Treatment|0
1818107|NCT00422162|6310397|P2|Overall Study|Other|1
1818108|NCT00422162|6310398|P1|Overall Study|Other|0
1818109|NCT00422162|6310397|P2|Overall Study|Non-Compliant with Protocol|1
1818110|NCT00422162|6310398|P1|Overall Study|Non-Compliant with Protocol|1
1818111|NCT00422162|6310397|P2|Overall Study|Lost to Follow-up|2
1818112|NCT00422162|6310398|P1|Overall Study|Lost to Follow-up|1
1818113|NCT00422162|6310397|P2|Overall Study|Withdrawal by Subject|6
1818114|NCT00422162|6310398|P1|Overall Study|Withdrawal by Subject|7
1818115|NCT00422162|6310397|P2|Overall Study|Lack of Efficacy|10
1818116|NCT00422162|6310398|P1|Overall Study|Lack of Efficacy|4
1818117|NCT00422162|6310397|P2|Overall Study|Adverse Event|9
1818118|NCT00422162|6310398|P1|Overall Study|Adverse Event|11
1818119|NCT00422097|6310458|P8|Dose Level 2|Still on treatment|0
1818120|NCT00422097|6310459|P7|Dose Level 2|Still on treatment|0
1818121|NCT00422097|6310460|P6|Dose Level 2|Still on treatment|0
1818122|NCT00422097|6310461|P5|Dose Level 2|Still on treatment|0
1818123|NCT00422097|6310462|P4|Dose Level 2|Still on treatment|0
1818124|NCT00422097|6310463|P3|Dose Level 2|Still on treatment|0
1818125|NCT00422097|6310464|P2|Dose Level 2|Still on treatment|1
1818126|NCT00422097|6310465|P1|Dose Level 2|Still on treatment|0
1818127|NCT00422058|6310530|P6|Open-Label Extension, Week 20-104|Other|18
1818128|NCT00422058|6310531|P5|Open-Label Extension, Week 20-104|Other|16
1818129|NCT00422058|6310532|P4|Open-Label Extension, Week 20-104|Other|13
1818130|NCT00422058|6310533|P3|Open-Label Extension, Week 20-104|Other|6
1818131|NCT00422058|6310534|P2|Open-Label Extension, Week 20-104|Other|14
1818132|NCT00422058|6310535|P1|Open-Label Extension, Week 20-104|Other|13
1818133|NCT00422058|6310530|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
1818134|NCT00422058|6310531|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
1818135|NCT00422058|6310532|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1818136|NCT00422058|6310533|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
1818137|NCT00422058|6310534|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
1818138|NCT00422058|6310535|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
1818139|NCT00422058|6310530|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
1818140|NCT00422058|6310531|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
1818141|NCT00422058|6310532|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
1818142|NCT00422058|6310533|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
1818143|NCT00422058|6310534|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
1818144|NCT00422058|6310535|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
1818145|NCT00422058|6310530|P6|Open-Label Extension, Week 20-104|Adverse Event|0
1818146|NCT00422058|6310531|P5|Open-Label Extension, Week 20-104|Adverse Event|4
1818147|NCT00422058|6310532|P4|Open-Label Extension, Week 20-104|Adverse Event|4
1818148|NCT00422058|6310533|P3|Open-Label Extension, Week 20-104|Adverse Event|7
1818149|NCT00422058|6310534|P2|Open-Label Extension, Week 20-104|Adverse Event|4
1818150|NCT00422058|6310535|P1|Open-Label Extension, Week 20-104|Adverse Event|3
1818151|NCT00422058|6310530|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1818152|NCT00422058|6310531|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
1818153|NCT00422058|6310532|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
1818154|NCT00422058|6310533|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
1818155|NCT00422058|6310534|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
1818156|NCT00422058|6310535|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
1818157|NCT00422058|6310530|P6|Double-Blind, Week 0-20|Other|10
1818158|NCT00422058|6310531|P5|Double-Blind, Week 0-20|Other|4
1818159|NCT00422058|6310532|P4|Double-Blind, Week 0-20|Other|8
1818160|NCT00422058|6310533|P3|Double-Blind, Week 0-20|Other|8
1818161|NCT00422058|6310534|P2|Double-Blind, Week 0-20|Other|3
1818162|NCT00422058|6310535|P1|Double-Blind, Week 0-20|Other|11
1818163|NCT00422058|6310530|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
1818164|NCT00422058|6310531|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
1818165|NCT00422058|6310532|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
1818166|NCT00422058|6310533|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
1818167|NCT00422058|6310534|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
1818168|NCT00422058|6310535|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
1818169|NCT00422058|6310530|P6|Double-Blind, Week 0-20|Protocol Violation|2
1818170|NCT00422058|6310531|P5|Double-Blind, Week 0-20|Protocol Violation|2
1818171|NCT00422058|6310532|P4|Double-Blind, Week 0-20|Protocol Violation|3
1818172|NCT00422058|6310533|P3|Double-Blind, Week 0-20|Protocol Violation|2
1818173|NCT00422058|6310534|P2|Double-Blind, Week 0-20|Protocol Violation|2
1818174|NCT00422058|6310535|P1|Double-Blind, Week 0-20|Protocol Violation|3
1818175|NCT00422058|6310530|P6|Double-Blind, Week 0-20|Adverse Event|3
1818176|NCT00422058|6310531|P5|Double-Blind, Week 0-20|Adverse Event|5
1818177|NCT00422058|6310532|P4|Double-Blind, Week 0-20|Adverse Event|9
1818178|NCT00422058|6310533|P3|Double-Blind, Week 0-20|Adverse Event|5
1818179|NCT00422058|6310534|P2|Double-Blind, Week 0-20|Adverse Event|4
1818180|NCT00422058|6310535|P1|Double-Blind, Week 0-20|Adverse Event|3
1818181|NCT00421993|6310676|P4|Overall Study|Subject transportation issues|1
1818182|NCT00421993|6310677|P3|Overall Study|Subject transportation issues|0
1818183|NCT00421993|6310678|P2|Overall Study|Subject transportation issues|0
1818184|NCT00421993|6310679|P1|Overall Study|Subject transportation issues|0
1818185|NCT00421993|6310676|P4|Overall Study|Pregnancy|2
1818186|NCT00421993|6310677|P3|Overall Study|Pregnancy|1
1818187|NCT00421993|6310678|P2|Overall Study|Pregnancy|1
1818188|NCT00421993|6310679|P1|Overall Study|Pregnancy|0
1818189|NCT00421993|6310676|P4|Overall Study|Lack of Efficacy|5
1818190|NCT00421993|6310677|P3|Overall Study|Lack of Efficacy|0
1818191|NCT00421993|6310678|P2|Overall Study|Lack of Efficacy|3
1818192|NCT00421993|6310679|P1|Overall Study|Lack of Efficacy|0
1818193|NCT00421993|6310676|P4|Overall Study|Protocol Violation|1
1818194|NCT00421993|6310677|P3|Overall Study|Protocol Violation|0
1818195|NCT00421993|6310678|P2|Overall Study|Protocol Violation|2
1818196|NCT00421993|6310679|P1|Overall Study|Protocol Violation|2
1818197|NCT00421993|6310676|P4|Overall Study|Adverse Event|4
1818198|NCT00421993|6310677|P3|Overall Study|Adverse Event|6
1818199|NCT00421993|6310678|P2|Overall Study|Adverse Event|1
1818200|NCT00421993|6310679|P1|Overall Study|Adverse Event|11
1818201|NCT00421993|6310676|P4|Overall Study|Lost to Follow-up|20
1818202|NCT00421993|6310677|P3|Overall Study|Lost to Follow-up|22
1818203|NCT00421993|6310678|P2|Overall Study|Lost to Follow-up|19
1818204|NCT00421993|6310679|P1|Overall Study|Lost to Follow-up|18
1818205|NCT00421993|6310676|P4|Overall Study|Withdrawal by Subject|24
1818206|NCT00421993|6310677|P3|Overall Study|Withdrawal by Subject|23
1818207|NCT00421993|6310678|P2|Overall Study|Withdrawal by Subject|23
1818208|NCT00421993|6310679|P1|Overall Study|Withdrawal by Subject|22
1818209|NCT00421928|6310716|P3|Overall Study|Death|0
1818210|NCT00421928|6310717|P2|Overall Study|Death|1
1818211|NCT00421928|6310718|P1|Overall Study|Death|0
1818212|NCT00421928|6310716|P3|Overall Study|All other|27
1818213|NCT00421928|6310717|P2|Overall Study|All other|21
1818214|NCT00421928|6310718|P1|Overall Study|All other|26
1818215|NCT00421928|6310716|P3|Overall Study|Study drug non-compliant|4
1818216|NCT00421928|6310717|P2|Overall Study|Study drug non-compliant|7
1818217|NCT00421928|6310718|P1|Overall Study|Study drug non-compliant|6
1818218|NCT00421928|6310716|P3|Overall Study|Lack of Efficacy|35
1818219|NCT00421928|6310717|P2|Overall Study|Lack of Efficacy|7
1818220|NCT00421928|6310718|P1|Overall Study|Lack of Efficacy|15
1818221|NCT00421928|6310716|P3|Overall Study|Withdrawal by Subject|43
1818222|NCT00421928|6310717|P2|Overall Study|Withdrawal by Subject|48
1818223|NCT00421928|6310718|P1|Overall Study|Withdrawal by Subject|50
1818224|NCT00421928|6310716|P3|Overall Study|Lost to Follow-up|3
1818225|NCT00421928|6310717|P2|Overall Study|Lost to Follow-up|0
1818226|NCT00421928|6310718|P1|Overall Study|Lost to Follow-up|5
1818227|NCT00421928|6310716|P3|Overall Study|Adverse Event|22
1818228|NCT00421928|6310717|P2|Overall Study|Adverse Event|140
1818229|NCT00421928|6310718|P1|Overall Study|Adverse Event|61
1818230|NCT00421889|6310753|P9|Overall Study|Lost to Follow-up|1
1818231|NCT00421889|6310754|P8|Overall Study|Lost to Follow-up|0
1818232|NCT00421889|6310755|P7|Overall Study|Lost to Follow-up|0
1818233|NCT00421889|6310756|P6|Overall Study|Lost to Follow-up|0
1818234|NCT00421889|6310757|P5|Overall Study|Lost to Follow-up|0
1818235|NCT00421889|6310758|P4|Overall Study|Lost to Follow-up|0
1818236|NCT00421889|6310759|P3|Overall Study|Lost to Follow-up|0
1818237|NCT00421889|6310760|P2|Overall Study|Lost to Follow-up|0
1818238|NCT00421889|6310761|P1|Overall Study|Lost to Follow-up|0
1818239|NCT00421889|6310753|P9|Overall Study|Patient/Investigator request|3
1818240|NCT00421889|6310754|P8|Overall Study|Patient/Investigator request|1
1818241|NCT00421889|6310755|P7|Overall Study|Patient/Investigator request|0
1818242|NCT00421889|6310756|P6|Overall Study|Patient/Investigator request|9
1818243|NCT00421889|6310757|P5|Overall Study|Patient/Investigator request|0
1818244|NCT00421889|6310758|P4|Overall Study|Patient/Investigator request|0
1818245|NCT00421889|6310759|P3|Overall Study|Patient/Investigator request|0
1818246|NCT00421889|6310760|P2|Overall Study|Patient/Investigator request|0
1818247|NCT00421889|6310761|P1|Overall Study|Patient/Investigator request|0
1818248|NCT00421889|6310753|P9|Overall Study|Progressive disease|5
1818249|NCT00421889|6310754|P8|Overall Study|Progressive disease|1
1818250|NCT00421889|6310755|P7|Overall Study|Progressive disease|3
1818251|NCT00421889|6310756|P6|Overall Study|Progressive disease|21
1818252|NCT00421889|6310757|P5|Overall Study|Progressive disease|2
1818253|NCT00421889|6310758|P4|Overall Study|Progressive disease|3
1818254|NCT00421889|6310759|P3|Overall Study|Progressive disease|2
1818255|NCT00421889|6310760|P2|Overall Study|Progressive disease|2
1818256|NCT00421889|6310761|P1|Overall Study|Progressive disease|3
1818257|NCT00421889|6310753|P9|Overall Study|Death|0
1818258|NCT00421889|6310754|P8|Overall Study|Death|0
1818259|NCT00421889|6310755|P7|Overall Study|Death|0
1818260|NCT00421889|6310756|P6|Overall Study|Death|1
1818261|NCT00421889|6310757|P5|Overall Study|Death|1
1818262|NCT00421889|6310758|P4|Overall Study|Death|0
1818263|NCT00421889|6310759|P3|Overall Study|Death|0
1818264|NCT00421889|6310760|P2|Overall Study|Death|0
1818265|NCT00421889|6310761|P1|Overall Study|Death|0
1818266|NCT00421889|6310753|P9|Overall Study|Withdrawal by Subject|0
1818267|NCT00421889|6310754|P8|Overall Study|Withdrawal by Subject|0
1818268|NCT00421889|6310755|P7|Overall Study|Withdrawal by Subject|0
1818269|NCT00421889|6310756|P6|Overall Study|Withdrawal by Subject|0
1818270|NCT00421889|6310757|P5|Overall Study|Withdrawal by Subject|2
1818271|NCT00421889|6310758|P4|Overall Study|Withdrawal by Subject|0
1818272|NCT00421889|6310759|P3|Overall Study|Withdrawal by Subject|0
1818273|NCT00421889|6310760|P2|Overall Study|Withdrawal by Subject|3
1818274|NCT00421889|6310761|P1|Overall Study|Withdrawal by Subject|1
1818275|NCT00421889|6310753|P9|Overall Study|Adverse Event|2
1818276|NCT00421889|6310754|P8|Overall Study|Adverse Event|0
1818277|NCT00421889|6310755|P7|Overall Study|Adverse Event|1
1818278|NCT00421889|6310756|P6|Overall Study|Adverse Event|4
1818279|NCT00421889|6310757|P5|Overall Study|Adverse Event|1
1818280|NCT00421889|6310758|P4|Overall Study|Adverse Event|1
1818281|NCT00421889|6310759|P3|Overall Study|Adverse Event|1
1818282|NCT00421889|6310760|P2|Overall Study|Adverse Event|0
1818283|NCT00421889|6310761|P1|Overall Study|Adverse Event|1
1818284|NCT00421733|6310806|P3|Overall Study|Protocol deviation|2
1818285|NCT00421733|6310807|P2|Overall Study|Protocol deviation|7
1818286|NCT00421733|6310808|P1|Overall Study|Protocol deviation|4
1818287|NCT00421733|6310806|P3|Overall Study|Sponsor request|3
1818288|NCT00421733|6310807|P2|Overall Study|Sponsor request|0
1818289|NCT00421733|6310808|P1|Overall Study|Sponsor request|1
1818290|NCT00421733|6310806|P3|Overall Study|Did not satisfy entry criteria|2
1818291|NCT00421733|6310807|P2|Overall Study|Did not satisfy entry criteria|3
1818292|NCT00421733|6310808|P1|Overall Study|Did not satisfy entry criteria|1
1818293|NCT00421733|6310806|P3|Overall Study|Administrative|0
1818294|NCT00421733|6310807|P2|Overall Study|Administrative|0
1818295|NCT00421733|6310808|P1|Overall Study|Administrative|2
1818296|NCT00421733|6310806|P3|Overall Study|Required dialysis|0
1818297|NCT00421733|6310807|P2|Overall Study|Required dialysis|0
1818298|NCT00421733|6310808|P1|Overall Study|Required dialysis|1
1818299|NCT00421733|6310806|P3|Overall Study|Death|0
1818300|NCT00421733|6310807|P2|Overall Study|Death|3
1818301|NCT00421733|6310808|P1|Overall Study|Death|0
1818302|NCT00421733|6310806|P3|Overall Study|Withdrawal by Subject|7
1818303|NCT00421733|6310807|P2|Overall Study|Withdrawal by Subject|2
1818304|NCT00421733|6310808|P1|Overall Study|Withdrawal by Subject|1
1818305|NCT00421733|6310806|P3|Overall Study|Lost to Follow-up|4
1818306|NCT00421733|6310807|P2|Overall Study|Lost to Follow-up|2
1818307|NCT00421733|6310808|P1|Overall Study|Lost to Follow-up|1
1818308|NCT00421733|6310806|P3|Overall Study|Adverse Event|2
1818309|NCT00421733|6310807|P2|Overall Study|Adverse Event|9
1818310|NCT00421733|6310808|P1|Overall Study|Adverse Event|4
1818311|NCT00421707|6310828|P2|Period 3:Treatment Period 2|Adverse Event|2
1818312|NCT00421707|6310829|P1|Period 3:Treatment Period 2|Adverse Event|0
1818313|NCT00421707|6310828|P2|Period 3:Treatment Period 2|Protocol Violation|0
1818314|NCT00421707|6310829|P1|Period 3:Treatment Period 2|Protocol Violation|1
1818315|NCT00421707|6310828|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
1818316|NCT00421707|6310829|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
1818317|NCT00421707|6310828|P2|Period 2: Washout|Other: Pregnancy|1
1818318|NCT00421707|6310829|P1|Period 2: Washout|Other: Pregnancy|0
1818319|NCT00421707|6310828|P2|Period 2: Washout|Lost to Follow-up|1
1818320|NCT00421707|6310829|P1|Period 2: Washout|Lost to Follow-up|0
1818321|NCT00421707|6310828|P2|Period 2: Washout|Withdrawal by Subject|1
1818322|NCT00421707|6310829|P1|Period 2: Washout|Withdrawal by Subject|0
1818323|NCT00421707|6310828|P2|Period 2: Washout|Adverse Event|1
1818324|NCT00421707|6310829|P1|Period 2: Washout|Adverse Event|1
1818325|NCT00421707|6310828|P2|Period 1: Treatment Period 1|Protocol Violation|0
1818326|NCT00421707|6310829|P1|Period 1: Treatment Period 1|Protocol Violation|1
1818327|NCT00421707|6310828|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
1818328|NCT00421707|6310829|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
1818329|NCT00421707|6310828|P2|Period 1: Treatment Period 1|Adverse Event|2
1818330|NCT00421707|6310829|P1|Period 1: Treatment Period 1|Adverse Event|7
1818331|NCT00421707|6310828|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
1818332|NCT00421707|6310829|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
1818333|NCT00421408|6310880|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
1818334|NCT00421408|6310881|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
1818335|NCT00421408|6310880|P2|Overall Study|Lost to Follow-up|20
1818336|NCT00421408|6310881|P1|Overall Study|Lost to Follow-up|30
1818337|NCT00421343|6310899|P1|Overall Study|Lost to Follow-up|3
1818338|NCT00421343|6310899|P1|Overall Study|Withdrawal by Subject|2
1818339|NCT00421343|6310899|P1|Overall Study|Death|1
1818340|NCT00421174|6310905|P2|Overall Study|Ineligible due to infection|0
1818341|NCT00421174|6310906|P1|Overall Study|Ineligible due to infection|2
1818342|NCT00421174|6310905|P2|Overall Study|Withdrawal by Subject|1
1818343|NCT00421174|6310906|P1|Overall Study|Withdrawal by Subject|0
1818344|NCT00421148|6310954|P20|Overall Study|Protocol Violation|0
1818345|NCT00421148|6310955|P19|Overall Study|Protocol Violation|1
1818346|NCT00421148|6310956|P18|Overall Study|Protocol Violation|0
1818347|NCT00421148|6310957|P17|Overall Study|Protocol Violation|0
1818348|NCT00421148|6310958|P16|Overall Study|Protocol Violation|0
1818349|NCT00421148|6310959|P15|Overall Study|Protocol Violation|0
1818350|NCT00421148|6310960|P14|Overall Study|Protocol Violation|0
1818351|NCT00421148|6310961|P13|Overall Study|Protocol Violation|0
1818352|NCT00421148|6310962|P12|Overall Study|Protocol Violation|0
1818353|NCT00421148|6310963|P11|Overall Study|Protocol Violation|0
1818354|NCT00421148|6310964|P10|Overall Study|Protocol Violation|0
1818355|NCT00421148|6310965|P9|Overall Study|Protocol Violation|0
1818356|NCT00421148|6310966|P8|Overall Study|Protocol Violation|0
1818357|NCT00421148|6310967|P7|Overall Study|Protocol Violation|0
1818358|NCT00421148|6310968|P6|Overall Study|Protocol Violation|1
1818359|NCT00421148|6310969|P5|Overall Study|Protocol Violation|0
1818360|NCT00421148|6310970|P4|Overall Study|Protocol Violation|0
1818361|NCT00421148|6310971|P3|Overall Study|Protocol Violation|0
1818362|NCT00421148|6310972|P2|Overall Study|Protocol Violation|0
1818363|NCT00421148|6310973|P1|Overall Study|Protocol Violation|0
1818364|NCT00421148|6310954|P20|Overall Study|Withdrawal by Subject|0
1818365|NCT00421148|6310955|P19|Overall Study|Withdrawal by Subject|0
1818366|NCT00421148|6310956|P18|Overall Study|Withdrawal by Subject|1
1818367|NCT00421148|6310957|P17|Overall Study|Withdrawal by Subject|0
1818368|NCT00421148|6310958|P16|Overall Study|Withdrawal by Subject|0
1818369|NCT00421148|6310959|P15|Overall Study|Withdrawal by Subject|0
1818370|NCT00421148|6310960|P14|Overall Study|Withdrawal by Subject|0
1818371|NCT00421148|6310961|P13|Overall Study|Withdrawal by Subject|0
1818372|NCT00421148|6310962|P12|Overall Study|Withdrawal by Subject|0
1818373|NCT00421148|6310963|P11|Overall Study|Withdrawal by Subject|0
1818374|NCT00421148|6310964|P10|Overall Study|Withdrawal by Subject|0
1818375|NCT00421148|6310965|P9|Overall Study|Withdrawal by Subject|0
1818376|NCT00421148|6310966|P8|Overall Study|Withdrawal by Subject|0
1818377|NCT00421148|6310967|P7|Overall Study|Withdrawal by Subject|0
1818378|NCT00421148|6310968|P6|Overall Study|Withdrawal by Subject|0
1818379|NCT00421148|6310969|P5|Overall Study|Withdrawal by Subject|0
1818380|NCT00421148|6310970|P4|Overall Study|Withdrawal by Subject|0
1818381|NCT00421148|6310971|P3|Overall Study|Withdrawal by Subject|0
1818382|NCT00421148|6310972|P2|Overall Study|Withdrawal by Subject|0
1818383|NCT00421148|6310973|P1|Overall Study|Withdrawal by Subject|0
1818384|NCT00421148|6310954|P20|Overall Study|Lost to Follow-up|0
1818385|NCT00421148|6310955|P19|Overall Study|Lost to Follow-up|0
1818386|NCT00421148|6310956|P18|Overall Study|Lost to Follow-up|1
1818387|NCT00421148|6310957|P17|Overall Study|Lost to Follow-up|0
1818388|NCT00421148|6310958|P16|Overall Study|Lost to Follow-up|0
1818389|NCT00421148|6310959|P15|Overall Study|Lost to Follow-up|0
1818390|NCT00421148|6310960|P14|Overall Study|Lost to Follow-up|0
1818391|NCT00421148|6310961|P13|Overall Study|Lost to Follow-up|0
1818392|NCT00421148|6310962|P12|Overall Study|Lost to Follow-up|0
1818393|NCT00421148|6310963|P11|Overall Study|Lost to Follow-up|0
1818394|NCT00421148|6310964|P10|Overall Study|Lost to Follow-up|0
1818395|NCT00421148|6310965|P9|Overall Study|Lost to Follow-up|0
1818396|NCT00421148|6310966|P8|Overall Study|Lost to Follow-up|0
1818397|NCT00421148|6310967|P7|Overall Study|Lost to Follow-up|0
1818398|NCT00421148|6310968|P6|Overall Study|Lost to Follow-up|0
1818399|NCT00421148|6310969|P5|Overall Study|Lost to Follow-up|0
1818400|NCT00421148|6310970|P4|Overall Study|Lost to Follow-up|0
1818401|NCT00421148|6310971|P3|Overall Study|Lost to Follow-up|0
1818402|NCT00421148|6310972|P2|Overall Study|Lost to Follow-up|0
1818403|NCT00421148|6310973|P1|Overall Study|Lost to Follow-up|0
1818404|NCT00420927|6311072|P7|Period 2|Took prohibited medication|0
1818405|NCT00420927|6311073|P6|Period 2|Took prohibited medication|0
1818406|NCT00420927|6311074|P5|Period 2|Took prohibited medication|1
1818407|NCT00420927|6311075|P4|Period 2|Took prohibited medication|0
1818408|NCT00420927|6311076|P3|Period 2|Took prohibited medication|0
1818409|NCT00420927|6311077|P2|Period 2|Took prohibited medication|0
1818410|NCT00420927|6311078|P1|Period 2|Took prohibited medication|0
1818411|NCT00420927|6311072|P7|Period 2|Methotrexate intolerance|1
1818412|NCT00420927|6311073|P6|Period 2|Methotrexate intolerance|0
1818413|NCT00420927|6311074|P5|Period 2|Methotrexate intolerance|0
1818414|NCT00420927|6311075|P4|Period 2|Methotrexate intolerance|0
1818415|NCT00420927|6311076|P3|Period 2|Methotrexate intolerance|0
1818416|NCT00420927|6311077|P2|Period 2|Methotrexate intolerance|0
1818417|NCT00420927|6311078|P1|Period 2|Methotrexate intolerance|0
1818418|NCT00420927|6311072|P7|Period 2|Noncompliant with study drug|2
1818419|NCT00420927|6311073|P6|Period 2|Noncompliant with study drug|0
1818420|NCT00420927|6311074|P5|Period 2|Noncompliant with study drug|0
1818421|NCT00420927|6311075|P4|Period 2|Noncompliant with study drug|1
1818422|NCT00420927|6311076|P3|Period 2|Noncompliant with study drug|0
1818423|NCT00420927|6311077|P2|Period 2|Noncompliant with study drug|0
1818424|NCT00420927|6311078|P1|Period 2|Noncompliant with study drug|0
1818425|NCT00420927|6311072|P7|Period 2|Randomization error|0
1818426|NCT00420927|6311073|P6|Period 2|Randomization error|1
1818427|NCT00420927|6311074|P5|Period 2|Randomization error|1
1818428|NCT00420927|6311075|P4|Period 2|Randomization error|0
1818429|NCT00420927|6311076|P3|Period 2|Randomization error|0
1818430|NCT00420927|6311077|P2|Period 2|Randomization error|0
1818431|NCT00420927|6311078|P1|Period 2|Randomization error|0
1818432|NCT00420927|6311072|P7|Period 2|Sponsor decision|1
1818433|NCT00420927|6311073|P6|Period 2|Sponsor decision|0
1818434|NCT00420927|6311074|P5|Period 2|Sponsor decision|0
1818435|NCT00420927|6311075|P4|Period 2|Sponsor decision|0
1818436|NCT00420927|6311076|P3|Period 2|Sponsor decision|1
1818437|NCT00420927|6311077|P2|Period 2|Sponsor decision|0
1818438|NCT00420927|6311078|P1|Period 2|Sponsor decision|0
1818439|NCT00420927|6311072|P7|Period 2|Physician Decision|0
1818440|NCT00420927|6311073|P6|Period 2|Physician Decision|1
1818441|NCT00420927|6311074|P5|Period 2|Physician Decision|1
1818442|NCT00420927|6311075|P4|Period 2|Physician Decision|0
1818443|NCT00420927|6311076|P3|Period 2|Physician Decision|0
1818444|NCT00420927|6311077|P2|Period 2|Physician Decision|0
1818445|NCT00420927|6311078|P1|Period 2|Physician Decision|0
1818446|NCT00420927|6311072|P7|Period 2|Subject unable to find transportation|1
1818447|NCT00420927|6311073|P6|Period 2|Subject unable to find transportation|0
1818448|NCT00420927|6311074|P5|Period 2|Subject unable to find transportation|0
1818449|NCT00420927|6311075|P4|Period 2|Subject unable to find transportation|0
1818450|NCT00420927|6311076|P3|Period 2|Subject unable to find transportation|0
1818451|NCT00420927|6311077|P2|Period 2|Subject unable to find transportation|0
1818452|NCT00420927|6311078|P1|Period 2|Subject unable to find transportation|0
1818453|NCT00420927|6311072|P7|Period 2|Received wrong treatment/incorrect dose|1
1818454|NCT00420927|6311073|P6|Period 2|Received wrong treatment/incorrect dose|0
1818455|NCT00420927|6311074|P5|Period 2|Received wrong treatment/incorrect dose|0
1818456|NCT00420927|6311075|P4|Period 2|Received wrong treatment/incorrect dose|0
1818457|NCT00420927|6311076|P3|Period 2|Received wrong treatment/incorrect dose|0
1818458|NCT00420927|6311077|P2|Period 2|Received wrong treatment/incorrect dose|0
1818459|NCT00420927|6311078|P1|Period 2|Received wrong treatment/incorrect dose|0
1818460|NCT00420927|6311072|P7|Period 2|Lack of efficacy/Loss of efficacy|6
1818461|NCT00420927|6311073|P6|Period 2|Lack of efficacy/Loss of efficacy|2
1818462|NCT00420927|6311074|P5|Period 2|Lack of efficacy/Loss of efficacy|6
1818463|NCT00420927|6311075|P4|Period 2|Lack of efficacy/Loss of efficacy|1
1818464|NCT00420927|6311076|P3|Period 2|Lack of efficacy/Loss of efficacy|2
1818465|NCT00420927|6311077|P2|Period 2|Lack of efficacy/Loss of efficacy|0
1818466|NCT00420927|6311078|P1|Period 2|Lack of efficacy/Loss of efficacy|0
1818467|NCT00420927|6311072|P7|Period 2|Lost to Follow-up|9
1818468|NCT00420927|6311073|P6|Period 2|Lost to Follow-up|3
1818469|NCT00420927|6311074|P5|Period 2|Lost to Follow-up|6
1818470|NCT00420927|6311075|P4|Period 2|Lost to Follow-up|2
1818471|NCT00420927|6311076|P3|Period 2|Lost to Follow-up|2
1818472|NCT00420927|6311077|P2|Period 2|Lost to Follow-up|0
1818473|NCT00420927|6311078|P1|Period 2|Lost to Follow-up|0
1818474|NCT00420927|6311072|P7|Period 2|Withdrawal by Subject|12
1818475|NCT00420927|6311073|P6|Period 2|Withdrawal by Subject|2
1818476|NCT00420927|6311074|P5|Period 2|Withdrawal by Subject|11
1818477|NCT00420927|6311075|P4|Period 2|Withdrawal by Subject|3
1818478|NCT00420927|6311076|P3|Period 2|Withdrawal by Subject|1
1818479|NCT00420927|6311077|P2|Period 2|Withdrawal by Subject|0
1818480|NCT00420927|6311078|P1|Period 2|Withdrawal by Subject|0
1818481|NCT00420927|6311072|P7|Period 2|Adverse Event|20
1818482|NCT00420927|6311073|P6|Period 2|Adverse Event|6
1818483|NCT00420927|6311074|P5|Period 2|Adverse Event|17
1818484|NCT00420927|6311075|P4|Period 2|Adverse Event|3
1818485|NCT00420927|6311076|P3|Period 2|Adverse Event|7
1818486|NCT00420927|6311077|P2|Period 2|Adverse Event|0
1818487|NCT00420927|6311078|P1|Period 2|Adverse Event|0
1818488|NCT00420927|6311072|P7|Period 1|Took prohibited medication|0
1818489|NCT00420927|6311073|P6|Period 1|Took prohibited medication|0
1818490|NCT00420927|6311074|P5|Period 1|Took prohibited medication|0
1818491|NCT00420927|6311075|P4|Period 1|Took prohibited medication|0
1818492|NCT00420927|6311076|P3|Period 1|Took prohibited medication|0
1818493|NCT00420927|6311077|P2|Period 1|Took prohibited medication|3
1818494|NCT00420927|6311078|P1|Period 1|Took prohibited medication|1
1818495|NCT00420927|6311072|P7|Period 1|Failed to meet entry criteria|0
1818496|NCT00420927|6311073|P6|Period 1|Failed to meet entry criteria|0
1818497|NCT00420927|6311074|P5|Period 1|Failed to meet entry criteria|0
1818498|NCT00420927|6311075|P4|Period 1|Failed to meet entry criteria|0
1818499|NCT00420927|6311076|P3|Period 1|Failed to meet entry criteria|0
1818500|NCT00420927|6311077|P2|Period 1|Failed to meet entry criteria|7
1818501|NCT00420927|6311078|P1|Period 1|Failed to meet entry criteria|8
1818502|NCT00420927|6311072|P7|Period 1|Received wrong treatment/incorrect dose|0
1818503|NCT00420927|6311073|P6|Period 1|Received wrong treatment/incorrect dose|0
1818504|NCT00420927|6311074|P5|Period 1|Received wrong treatment/incorrect dose|0
1818505|NCT00420927|6311075|P4|Period 1|Received wrong treatment/incorrect dose|0
1818506|NCT00420927|6311076|P3|Period 1|Received wrong treatment/incorrect dose|0
1818507|NCT00420927|6311077|P2|Period 1|Received wrong treatment/incorrect dose|1
1818508|NCT00420927|6311078|P1|Period 1|Received wrong treatment/incorrect dose|0
1818509|NCT00420927|6311072|P7|Period 1|Subject received new diagnosis|0
1818510|NCT00420927|6311073|P6|Period 1|Subject received new diagnosis|0
1818511|NCT00420927|6311074|P5|Period 1|Subject received new diagnosis|0
1818512|NCT00420927|6311075|P4|Period 1|Subject received new diagnosis|0
1818513|NCT00420927|6311076|P3|Period 1|Subject received new diagnosis|0
1818514|NCT00420927|6311077|P2|Period 1|Subject received new diagnosis|2
1818515|NCT00420927|6311078|P1|Period 1|Subject received new diagnosis|0
1818516|NCT00420927|6311072|P7|Period 1|Study site closure|0
1818517|NCT00420927|6311073|P6|Period 1|Study site closure|0
1818518|NCT00420927|6311074|P5|Period 1|Study site closure|0
1818519|NCT00420927|6311075|P4|Period 1|Study site closure|0
1818520|NCT00420927|6311076|P3|Period 1|Study site closure|0
1818521|NCT00420927|6311077|P2|Period 1|Study site closure|1
1818522|NCT00420927|6311078|P1|Period 1|Study site closure|0
1818523|NCT00420927|6311072|P7|Period 1|Suspected tuberculosis/positive test|0
1818524|NCT00420927|6311073|P6|Period 1|Suspected tuberculosis/positive test|0
1818525|NCT00420927|6311074|P5|Period 1|Suspected tuberculosis/positive test|0
1818526|NCT00420927|6311075|P4|Period 1|Suspected tuberculosis/positive test|0
1818527|NCT00420927|6311076|P3|Period 1|Suspected tuberculosis/positive test|0
1818528|NCT00420927|6311077|P2|Period 1|Suspected tuberculosis/positive test|1
1818529|NCT00420927|6311078|P1|Period 1|Suspected tuberculosis/positive test|1
1818530|NCT00420927|6311072|P7|Period 1|Randomization error|0
1818531|NCT00420927|6311073|P6|Period 1|Randomization error|0
1818532|NCT00420927|6311074|P5|Period 1|Randomization error|0
1818533|NCT00420927|6311075|P4|Period 1|Randomization error|0
1818534|NCT00420927|6311076|P3|Period 1|Randomization error|0
1818535|NCT00420927|6311077|P2|Period 1|Randomization error|0
1818536|NCT00420927|6311078|P1|Period 1|Randomization error|1
1818537|NCT00420927|6311072|P7|Period 1|Noncompliant with study drug|0
1818538|NCT00420927|6311073|P6|Period 1|Noncompliant with study drug|0
1818539|NCT00420927|6311074|P5|Period 1|Noncompliant with study drug|0
1818540|NCT00420927|6311075|P4|Period 1|Noncompliant with study drug|0
1818541|NCT00420927|6311076|P3|Period 1|Noncompliant with study drug|0
1818542|NCT00420927|6311077|P2|Period 1|Noncompliant with study drug|1
1818543|NCT00420927|6311078|P1|Period 1|Noncompliant with study drug|1
1818544|NCT00420927|6311072|P7|Period 1|Subject moved/relocated|0
1818545|NCT00420927|6311073|P6|Period 1|Subject moved/relocated|0
1818546|NCT00420927|6311074|P5|Period 1|Subject moved/relocated|0
1818547|NCT00420927|6311075|P4|Period 1|Subject moved/relocated|0
1818548|NCT00420927|6311076|P3|Period 1|Subject moved/relocated|0
1818549|NCT00420927|6311077|P2|Period 1|Subject moved/relocated|2
1818550|NCT00420927|6311078|P1|Period 1|Subject moved/relocated|0
1818551|NCT00420927|6311072|P7|Period 1|Death|0
1818552|NCT00420927|6311073|P6|Period 1|Death|0
1818553|NCT00420927|6311074|P5|Period 1|Death|0
1818554|NCT00420927|6311075|P4|Period 1|Death|0
1818555|NCT00420927|6311076|P3|Period 1|Death|0
1818556|NCT00420927|6311077|P2|Period 1|Death|0
1818557|NCT00420927|6311078|P1|Period 1|Death|2
1818558|NCT00420927|6311072|P7|Period 1|Lack of efficacy/Loss of efficacy|0
1818559|NCT00420927|6311073|P6|Period 1|Lack of efficacy/Loss of efficacy|0
1818560|NCT00420927|6311074|P5|Period 1|Lack of efficacy/Loss of efficacy|0
1818561|NCT00420927|6311075|P4|Period 1|Lack of efficacy/Loss of efficacy|0
1818562|NCT00420927|6311076|P3|Period 1|Lack of efficacy/Loss of efficacy|0
1818563|NCT00420927|6311077|P2|Period 1|Lack of efficacy/Loss of efficacy|6
1818564|NCT00420927|6311078|P1|Period 1|Lack of efficacy/Loss of efficacy|1
1818565|NCT00420927|6311072|P7|Period 1|Lost to Follow-up|0
1818566|NCT00420927|6311073|P6|Period 1|Lost to Follow-up|0
1818567|NCT00420927|6311074|P5|Period 1|Lost to Follow-up|0
1818568|NCT00420927|6311075|P4|Period 1|Lost to Follow-up|0
1818569|NCT00420927|6311076|P3|Period 1|Lost to Follow-up|0
1818570|NCT00420927|6311077|P2|Period 1|Lost to Follow-up|6
1818571|NCT00420927|6311078|P1|Period 1|Lost to Follow-up|8
1818572|NCT00420927|6311072|P7|Period 1|Withdrawal by Subject|0
1818573|NCT00420927|6311073|P6|Period 1|Withdrawal by Subject|0
1818574|NCT00420927|6311074|P5|Period 1|Withdrawal by Subject|0
1818575|NCT00420927|6311075|P4|Period 1|Withdrawal by Subject|0
1818576|NCT00420927|6311076|P3|Period 1|Withdrawal by Subject|0
1818577|NCT00420927|6311077|P2|Period 1|Withdrawal by Subject|12
1818578|NCT00420927|6311078|P1|Period 1|Withdrawal by Subject|7
1818579|NCT00420927|6311072|P7|Period 1|Adverse Event|0
1818580|NCT00420927|6311073|P6|Period 1|Adverse Event|0
1818581|NCT00420927|6311074|P5|Period 1|Adverse Event|0
1818582|NCT00420927|6311075|P4|Period 1|Adverse Event|0
1818583|NCT00420927|6311076|P3|Period 1|Adverse Event|0
1818584|NCT00420927|6311077|P2|Period 1|Adverse Event|15
1818585|NCT00420927|6311078|P1|Period 1|Adverse Event|19
1818586|NCT00420849|6311182|P1|Overall Study|Lost to Follow-up|1
1818587|NCT00420849|6311182|P1|Overall Study|Protocol Violation|1
1818588|NCT00420849|6311182|P1|Overall Study|Transplant|8
1818589|NCT00420849|6311182|P1|Overall Study|Other|14
1818590|NCT00420849|6311182|P1|Overall Study|Death|18
1818591|NCT00420849|6311182|P1|Overall Study|Withdrawal by Subject|28
1818592|NCT00420849|6311182|P1|Overall Study|Adverse Event|107
1818593|NCT00420849|6311182|P1|Overall Study|Lack of Efficacy|154
1818594|NCT00420784|6311251|P4|Overall Study|Other|5
1818595|NCT00420784|6311252|P3|Overall Study|Other|0
1818596|NCT00420784|6311253|P2|Overall Study|Other|2
1818597|NCT00420784|6311254|P1|Overall Study|Other|1
1818598|NCT00420784|6311251|P4|Overall Study|Virologic Stopping Rule|67
1818599|NCT00420784|6311252|P3|Overall Study|Virologic Stopping Rule|41
1818600|NCT00420784|6311253|P2|Overall Study|Virologic Stopping Rule|26
1818601|NCT00420784|6311254|P1|Overall Study|Virologic Stopping Rule|17
1818602|NCT00420784|6311251|P4|Overall Study|Lost to Follow-up|1
1818603|NCT00420784|6311252|P3|Overall Study|Lost to Follow-up|2
1818604|NCT00420784|6311253|P2|Overall Study|Lost to Follow-up|0
1818605|NCT00420784|6311254|P1|Overall Study|Lost to Follow-up|0
1818606|NCT00420784|6311251|P4|Overall Study|Withdrawal by Subject|0
1818607|NCT00420784|6311252|P3|Overall Study|Withdrawal by Subject|0
1818608|NCT00420784|6311253|P2|Overall Study|Withdrawal by Subject|1
1818609|NCT00420784|6311254|P1|Overall Study|Withdrawal by Subject|0
1818610|NCT00420784|6311251|P4|Overall Study|Adverse Event|5
1818611|NCT00420784|6311252|P3|Overall Study|Adverse Event|10
1818612|NCT00420784|6311253|P2|Overall Study|Adverse Event|29
1818613|NCT00420784|6311254|P1|Overall Study|Adverse Event|11
1818614|NCT00420745|6311292|P2|Overall Study|Age limit exceeded for Dose 2|0
1818615|NCT00420745|6311293|P1|Overall Study|Age limit exceeded for Dose 2|1
1818616|NCT00420745|6311292|P2|Overall Study|Recurrent pneumonia & bronchitis|1
1818617|NCT00420745|6311293|P1|Overall Study|Recurrent pneumonia & bronchitis|0
1818618|NCT00420745|6311292|P2|Overall Study|Physician Decision|1
1818619|NCT00420745|6311293|P1|Overall Study|Physician Decision|1
1818620|NCT00420745|6311292|P2|Overall Study|Protocol Violation|0
1818621|NCT00420745|6311293|P1|Overall Study|Protocol Violation|1
1818622|NCT00420745|6311292|P2|Overall Study|Lost to Follow-up|2
1818623|NCT00420745|6311293|P1|Overall Study|Lost to Follow-up|10
1818624|NCT00420745|6311292|P2|Overall Study|Adverse Event|2
1818625|NCT00420745|6311293|P1|Overall Study|Adverse Event|2
1818626|NCT00420641|6311312|P3|Overall Study|Other|3
1818627|NCT00420641|6311313|P2|Overall Study|Other|4
1818628|NCT00420641|6311314|P1|Overall Study|Other|4
1818629|NCT00420641|6311312|P3|Overall Study|Non-compliance|4
1818630|NCT00420641|6311313|P2|Overall Study|Non-compliance|5
1818631|NCT00420641|6311314|P1|Overall Study|Non-compliance|7
1818632|NCT00420641|6311312|P3|Overall Study|Lack of Efficacy|4
1818633|NCT00420641|6311313|P2|Overall Study|Lack of Efficacy|5
1818634|NCT00420641|6311314|P1|Overall Study|Lack of Efficacy|6
1818635|NCT00420641|6311312|P3|Overall Study|Withdrawal by Subject|14
1818636|NCT00420641|6311313|P2|Overall Study|Withdrawal by Subject|21
1818637|NCT00420641|6311314|P1|Overall Study|Withdrawal by Subject|15
1818638|NCT00420641|6311312|P3|Overall Study|Protocol Violation|7
1818639|NCT00420641|6311313|P2|Overall Study|Protocol Violation|8
1818640|NCT00420641|6311314|P1|Overall Study|Protocol Violation|8
1818641|NCT00420641|6311312|P3|Overall Study|Lost to Follow-up|2
1818642|NCT00420641|6311313|P2|Overall Study|Lost to Follow-up|4
1818643|NCT00420641|6311314|P1|Overall Study|Lost to Follow-up|2
1818644|NCT00420641|6311312|P3|Overall Study|Adverse Event|10
1818645|NCT00420641|6311313|P2|Overall Study|Adverse Event|25
1818646|NCT00420641|6311314|P1|Overall Study|Adverse Event|3
1818647|NCT00420628|6311390|P2|Overall Study|Adverse Event|0
1818648|NCT00420628|6311391|P1|Overall Study|Adverse Event|1
1818649|NCT00420628|6311390|P2|Overall Study|Lost to Follow-up|2
1818650|NCT00420628|6311391|P1|Overall Study|Lost to Follow-up|3
1818651|NCT00420628|6311390|P2|Overall Study|Withdrawn by parent or gaurdian|2
1818652|NCT00420628|6311391|P1|Overall Study|Withdrawn by parent or gaurdian|5
1818653|NCT00420511|6311407|P2|Overall Study|Lost to Follow-up|0
1818654|NCT00420511|6311408|P1|Overall Study|Lost to Follow-up|1
1818655|NCT00420511|6311407|P2|Overall Study|Adverse Event|1
1818656|NCT00420511|6311408|P1|Overall Study|Adverse Event|1
1818657|NCT00420420|6311429|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
1818658|NCT00420420|6311430|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
1818659|NCT00420420|6311429|P2|Overall Study|Withdrawal by Subject|0
1818660|NCT00420420|6311430|P1|Overall Study|Withdrawal by Subject|1
1818661|NCT00420420|6311429|P2|Overall Study|Protocol Violation|1
1818662|NCT00420420|6311430|P1|Overall Study|Protocol Violation|1
1818663|NCT00420420|6311429|P2|Overall Study|Adverse Event|3
1818664|NCT00420420|6311430|P1|Overall Study|Adverse Event|5
1818665|NCT00420407|6311448|P2|Overall Study|Withdrawal by Subject|2
1818666|NCT00420407|6311449|P1|Overall Study|Withdrawal by Subject|0
1818667|NCT00420407|6311448|P2|Overall Study|subject identified as Jehovah's witness|0
1818668|NCT00420407|6311449|P1|Overall Study|subject identified as Jehovah's witness|1
1818669|NCT00420407|6311448|P2|Overall Study|subject identified as detainee|0
1818670|NCT00420407|6311449|P1|Overall Study|subject identified as detainee|1
1818671|NCT00420407|6311448|P2|Overall Study|Physician Decision|1
1818672|NCT00420407|6311449|P1|Overall Study|Physician Decision|2
1818673|NCT00420407|6311448|P2|Overall Study|Lost to Follow-up|3
1818674|NCT00420407|6311449|P1|Overall Study|Lost to Follow-up|0
1818675|NCT00420342|6311459|P3|Overall Study|Withdrawal by Subject|0
1818676|NCT00420342|6311460|P2|Overall Study|Withdrawal by Subject|2
1818677|NCT00420342|6311461|P1|Overall Study|Withdrawal by Subject|0
1818678|NCT00420342|6311459|P3|Overall Study|Lost to Follow-up|1
1818679|NCT00420342|6311460|P2|Overall Study|Lost to Follow-up|0
1818680|NCT00420342|6311461|P1|Overall Study|Lost to Follow-up|1
1818681|NCT00420316|6311504|P2|Overall Study|Lost to Follow-up|8
1818682|NCT00420316|6311505|P1|Overall Study|Lost to Follow-up|12
1818683|NCT00420316|6311504|P2|Overall Study|Withdrawal by Subject|1
1818684|NCT00420316|6311505|P1|Overall Study|Withdrawal by Subject|0
1818685|NCT00420303|6311529|P2|Overall Study|Physician Decision|1
1818686|NCT00420303|6311530|P1|Overall Study|Physician Decision|0
1818687|NCT00420303|6311529|P2|Overall Study|Lack of Efficacy|3
1818688|NCT00420303|6311530|P1|Overall Study|Lack of Efficacy|0
1818689|NCT00420303|6311529|P2|Overall Study|Serious Adverse Event|0
1818690|NCT00420303|6311530|P1|Overall Study|Serious Adverse Event|1
1818691|NCT00420290|6311542|P2|Overall Study|did not meet inclusion/exclusion|1
1818692|NCT00420290|6311543|P1|Overall Study|did not meet inclusion/exclusion|1
1818693|NCT00420290|6311542|P2|Overall Study|Withdrawal by Subject|2
1818694|NCT00420290|6311543|P1|Overall Study|Withdrawal by Subject|0
1818695|NCT00420290|6311542|P2|Overall Study|Adverse Event|1
1818696|NCT00420290|6311543|P1|Overall Study|Adverse Event|3
1818697|NCT00420238|6311559|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1818698|NCT00420238|6311560|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
1818699|NCT00420238|6311559|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
1818700|NCT00420238|6311560|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
1818701|NCT00420238|6311559|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
1818702|NCT00420238|6311560|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
1818703|NCT00420238|6311559|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
1818704|NCT00420238|6311560|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
1818705|NCT00420238|6311559|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
1818706|NCT00420238|6311560|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
1818707|NCT00420238|6311559|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
1818708|NCT00420238|6311560|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
1818709|NCT00420212|6311699|P3|Overall Study|Other-Unspecified|18
1818710|NCT00420212|6311700|P2|Overall Study|Other-Unspecified|14
1818711|NCT00420212|6311701|P1|Overall Study|Other-Unspecified|21
1818712|NCT00420212|6311699|P3|Overall Study|Death|1
1818713|NCT00420212|6311700|P2|Overall Study|Death|0
1818714|NCT00420212|6311701|P1|Overall Study|Death|0
1818715|NCT00420212|6311699|P3|Overall Study|Protocol Violation|8
1818716|NCT00420212|6311700|P2|Overall Study|Protocol Violation|4
1818717|NCT00420212|6311701|P1|Overall Study|Protocol Violation|4
1818718|NCT00420212|6311699|P3|Overall Study|Physician Decision|3
1818719|NCT00420212|6311700|P2|Overall Study|Physician Decision|4
1818720|NCT00420212|6311701|P1|Overall Study|Physician Decision|4
1818721|NCT00420212|6311699|P3|Overall Study|Withdrawal by Subject|19
1818722|NCT00420212|6311700|P2|Overall Study|Withdrawal by Subject|22
1818723|NCT00420212|6311701|P1|Overall Study|Withdrawal by Subject|31
1818724|NCT00420212|6311699|P3|Overall Study|Lost to Follow-up|11
1818725|NCT00420212|6311700|P2|Overall Study|Lost to Follow-up|11
1818726|NCT00420212|6311701|P1|Overall Study|Lost to Follow-up|9
1818727|NCT00420212|6311699|P3|Overall Study|Adverse Event|36
1818728|NCT00420212|6311700|P2|Overall Study|Adverse Event|40
1818729|NCT00420212|6311701|P1|Overall Study|Adverse Event|22
1818730|NCT00420199|6311727|P2|Overall Study|Participant no longer met study criteria|0
1818731|NCT00420199|6311728|P1|Overall Study|Participant no longer met study criteria|1
1818732|NCT00420095|6311794|P2|Overall Study|Lost to Follow-up|0
1818733|NCT00420095|6311795|P1|Overall Study|Lost to Follow-up|1
1818734|NCT00420095|6311794|P2|Overall Study|Protocol Violation|1
1818735|NCT00420095|6311795|P1|Overall Study|Protocol Violation|1
1818736|NCT00420095|6311794|P2|Overall Study|Adverse Event|0
1818737|NCT00420095|6311795|P1|Overall Study|Adverse Event|1
1818738|NCT00420056|6311813|P1|Overall Study|Objective progression or relapse|17
1818739|NCT00420004|6311853|P3|Overall Study|Sponsor Decision|1
1818740|NCT00420004|6311854|P2|Overall Study|Sponsor Decision|3
1818741|NCT00420004|6311855|P1|Overall Study|Sponsor Decision|3
1818742|NCT00420004|6311853|P3|Overall Study|Withdrawal by Subject|14
1818743|NCT00420004|6311854|P2|Overall Study|Withdrawal by Subject|42
1818744|NCT00420004|6311855|P1|Overall Study|Withdrawal by Subject|67
1818745|NCT00420004|6311853|P3|Overall Study|Protocol Violation|3
1818746|NCT00420004|6311854|P2|Overall Study|Protocol Violation|4
1818747|NCT00420004|6311855|P1|Overall Study|Protocol Violation|5
1818748|NCT00420004|6311853|P3|Overall Study|Physician Decision|2
1818749|NCT00420004|6311854|P2|Overall Study|Physician Decision|4
1818750|NCT00420004|6311855|P1|Overall Study|Physician Decision|14
1818751|NCT00420004|6311853|P3|Overall Study|Entry Criteria Not Met|0
1818752|NCT00420004|6311854|P2|Overall Study|Entry Criteria Not Met|1
1818753|NCT00420004|6311855|P1|Overall Study|Entry Criteria Not Met|0
1818754|NCT00420004|6311853|P3|Overall Study|Lost to Follow-up|10
1818755|NCT00420004|6311854|P2|Overall Study|Lost to Follow-up|12
1818756|NCT00420004|6311855|P1|Overall Study|Lost to Follow-up|31
1818757|NCT00420004|6311853|P3|Overall Study|Lack of Efficacy|1
1818758|NCT00420004|6311854|P2|Overall Study|Lack of Efficacy|4
1818759|NCT00420004|6311855|P1|Overall Study|Lack of Efficacy|5
1818760|NCT00420004|6311853|P3|Overall Study|Adverse Event|1
1818761|NCT00420004|6311854|P2|Overall Study|Adverse Event|1
1818762|NCT00420004|6311855|P1|Overall Study|Adverse Event|4
1818763|NCT00419952|6311920|P2|Overall Study|Abnormal ECG|0
1818764|NCT00419952|6311921|P1|Overall Study|Abnormal ECG|1
1818765|NCT00419952|6311920|P2|Overall Study|Diary or medication non-compliance|4
1818766|NCT00419952|6311921|P1|Overall Study|Diary or medication non-compliance|2
1818767|NCT00419952|6311920|P2|Overall Study|Occurence of 2 or more exacerbations|0
1818768|NCT00419952|6311921|P1|Overall Study|Occurence of 2 or more exacerbations|2
1818769|NCT00419952|6311920|P2|Overall Study|Intake of prohibited medication|2
1818770|NCT00419952|6311921|P1|Overall Study|Intake of prohibited medication|2
1818771|NCT00419952|6311920|P2|Overall Study|Incorrectly enrolled|3
1818772|NCT00419952|6311921|P1|Overall Study|Incorrectly enrolled|10
1818773|NCT00419952|6311920|P2|Overall Study|Physician Decision|3
1818774|NCT00419952|6311921|P1|Overall Study|Physician Decision|1
1818775|NCT00419952|6311920|P2|Overall Study|Pregnancy|2
1818776|NCT00419952|6311921|P1|Overall Study|Pregnancy|4
1818777|NCT00419952|6311920|P2|Overall Study|Protocol Violation|24
1818778|NCT00419952|6311921|P1|Overall Study|Protocol Violation|32
1818779|NCT00419952|6311920|P2|Overall Study|Lost to Follow-up|34
1818780|NCT00419952|6311921|P1|Overall Study|Lost to Follow-up|43
1818781|NCT00419952|6311920|P2|Overall Study|Withdrawal by Subject|43
1818782|NCT00419952|6311921|P1|Overall Study|Withdrawal by Subject|44
1818783|NCT00419952|6311920|P2|Overall Study|Adverse Event|10
1818784|NCT00419952|6311921|P1|Overall Study|Adverse Event|8
1818785|NCT00419926|6311955|P2|Overall Study|Death|1
1818786|NCT00419926|6311956|P1|Overall Study|Death|2
1818787|NCT00419926|6311955|P2|Overall Study|Lost to Follow-up|2
1818788|NCT00419926|6311956|P1|Overall Study|Lost to Follow-up|1
1818789|NCT00419926|6311955|P2|Overall Study|Administrative Problem|4
1818790|NCT00419926|6311956|P1|Overall Study|Administrative Problem|4
1818791|NCT00419926|6311955|P2|Overall Study|Withdrawal by Subject|3
1818792|NCT00419926|6311956|P1|Overall Study|Withdrawal by Subject|7
1818793|NCT00419770|6311972|P2|Overall Study|Withdrawal by Subject|1
1818794|NCT00419770|6311973|P1|Overall Study|Withdrawal by Subject|5
1818795|NCT00419757|6311981|P2|Overall Study|Multiple reasons|1
1818796|NCT00419757|6311982|P1|Overall Study|Multiple reasons|3
1818797|NCT00419757|6311981|P2|Overall Study|Study specific discontinuation criteria|8
1818798|NCT00419757|6311982|P1|Overall Study|Study specific discontinuation criteria|4
1818799|NCT00419757|6311981|P2|Overall Study|Protocol Violation|3
1818800|NCT00419757|6311982|P1|Overall Study|Protocol Violation|2
1818801|NCT00419757|6311981|P2|Overall Study|Withdrawal by Subject|1
1818802|NCT00419757|6311982|P1|Overall Study|Withdrawal by Subject|7
1818803|NCT00419757|6311981|P2|Overall Study|Lost to Follow-up|4
1818804|NCT00419757|6311982|P1|Overall Study|Lost to Follow-up|1
1818805|NCT00419757|6311981|P2|Overall Study|Adverse Event|4
1818806|NCT00419757|6311982|P1|Overall Study|Adverse Event|1
1818807|NCT00419744|6312021|P3|Overall Study|Incorrect medication kit dispensed|1
1818808|NCT00419744|6312022|P2|Overall Study|Incorrect medication kit dispensed|0
1818809|NCT00419744|6312023|P1|Overall Study|Incorrect medication kit dispensed|0
1818810|NCT00419744|6312021|P3|Overall Study|Spirometry mouthpiece issues|2
1818811|NCT00419744|6312022|P2|Overall Study|Spirometry mouthpiece issues|1
1818812|NCT00419744|6312023|P1|Overall Study|Spirometry mouthpiece issues|0
1818813|NCT00419744|6312021|P3|Overall Study|Physician Decision|6
1818814|NCT00419744|6312022|P2|Overall Study|Physician Decision|5
1818815|NCT00419744|6312023|P1|Overall Study|Physician Decision|10
1818816|NCT00419744|6312021|P3|Overall Study|Moving out of state|1
1818817|NCT00419744|6312022|P2|Overall Study|Moving out of state|0
1818818|NCT00419744|6312023|P1|Overall Study|Moving out of state|2
1818819|NCT00419744|6312021|P3|Overall Study|Randomized in error|7
1818820|NCT00419744|6312022|P2|Overall Study|Randomized in error|6
1818821|NCT00419744|6312023|P1|Overall Study|Randomized in error|9
1818822|NCT00419744|6312021|P3|Overall Study|Protocol Violation|8
1818823|NCT00419744|6312022|P2|Overall Study|Protocol Violation|7
1818824|NCT00419744|6312023|P1|Overall Study|Protocol Violation|4
1818825|NCT00419744|6312021|P3|Overall Study|Lost to Follow-up|6
1818826|NCT00419744|6312022|P2|Overall Study|Lost to Follow-up|10
1818827|NCT00419744|6312023|P1|Overall Study|Lost to Follow-up|8
1818828|NCT00419744|6312021|P3|Overall Study|Withdrawal by Subject|52
1818829|NCT00419744|6312022|P2|Overall Study|Withdrawal by Subject|49
1818830|NCT00419744|6312023|P1|Overall Study|Withdrawal by Subject|45
1818831|NCT00419744|6312021|P3|Overall Study|Adverse Event|50
1818832|NCT00419744|6312022|P2|Overall Study|Adverse Event|40
1818833|NCT00419744|6312023|P1|Overall Study|Adverse Event|39
1818840|NCT00419393|6312090|P1|Overall Study|Other: Investigator decision|1
1818841|NCT00419393|6312090|P1|Overall Study|Other: Other health problems|1
1818842|NCT00419393|6312090|P1|Overall Study|Other: Site closure|1
1818843|NCT00419393|6312090|P1|Overall Study|Other: Subject had temporal lobectomy|1
1818844|NCT00419393|6312090|P1|Overall Study|Other: Sponsor request|3
1818845|NCT00419393|6312090|P1|Overall Study|Withdrawal by Subject|7
1818846|NCT00419393|6312090|P1|Overall Study|Protocol Violation|5
1818847|NCT00419393|6312090|P1|Overall Study|Adverse Event|5
1818848|NCT00419380|6312100|P2|Overall Study|Withdrawal by Subject|1
1818849|NCT00419380|6312101|P1|Overall Study|Withdrawal by Subject|0
1818850|NCT00419380|6312100|P2|Overall Study|Lost to Follow-up|1
1818851|NCT00419380|6312101|P1|Overall Study|Lost to Follow-up|0
1818852|NCT00419380|6312100|P2|Overall Study|Physician Decision|1
1818853|NCT00419380|6312101|P1|Overall Study|Physician Decision|0
1818854|NCT00419380|6312100|P2|Overall Study|Lack of Efficacy|7
1818855|NCT00419380|6312101|P1|Overall Study|Lack of Efficacy|1
1818856|NCT00419341|6312109|P1|Efficacy Period|Termination of study site|1
1818857|NCT00419341|6312109|P1|Efficacy Period|Non-compliance|1
1818858|NCT00419341|6312109|P1|Efficacy Period|Lost to Follow-up|1
1818859|NCT00419341|6312109|P1|Efficacy Period|Protocol Violation|1
1818860|NCT00419341|6312109|P1|Efficacy Period|Withdrawal by Subject|6
1818861|NCT00419341|6312109|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
1818862|NCT00419341|6312109|P1|Wash in/Wash Out Period|Adverse Event|2
1818863|NCT00419341|6312109|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
1818864|NCT00419263|6312144|P3|Overall Study|Withdrawal by Subject|1
1818865|NCT00419263|6312145|P2|Overall Study|Withdrawal by Subject|0
1818866|NCT00419263|6312146|P1|Overall Study|Withdrawal by Subject|0
1818867|NCT00419263|6312144|P3|Overall Study|Adverse Event|1
1818868|NCT00419263|6312145|P2|Overall Study|Adverse Event|0
1818869|NCT00419263|6312146|P1|Overall Study|Adverse Event|0
1818870|NCT00419263|6312144|P3|Overall Study|Randomized in Error, Not Treated|0
1818871|NCT00419263|6312145|P2|Overall Study|Randomized in Error, Not Treated|1
1818872|NCT00419263|6312146|P1|Overall Study|Randomized in Error, Not Treated|1
1818873|NCT00419263|6312144|P3|Overall Study|Lost to Follow-up|1
1818874|NCT00419263|6312145|P2|Overall Study|Lost to Follow-up|1
1818875|NCT00419263|6312146|P1|Overall Study|Lost to Follow-up|2
1818876|NCT00419159|6312175|P2|Overall Study|Disease progression|76
1818877|NCT00419159|6312176|P1|Overall Study|Disease progression|79
1818878|NCT00419159|6312175|P2|Overall Study|Death|2
1818879|NCT00419159|6312176|P1|Overall Study|Death|2
1818880|NCT00419159|6312175|P2|Overall Study|Lost to Follow-up|1
1818881|NCT00419159|6312176|P1|Overall Study|Lost to Follow-up|0
1818882|NCT00419159|6312175|P2|Overall Study|Withdrawal by Subject|3
1818883|NCT00419159|6312176|P1|Overall Study|Withdrawal by Subject|10
1818884|NCT00419159|6312175|P2|Overall Study|Protocol Violation|0
1818885|NCT00419159|6312176|P1|Overall Study|Protocol Violation|1
1818886|NCT00419159|6312175|P2|Overall Study|Subject's no longer requires study drug|1
1818887|NCT00419159|6312176|P1|Overall Study|Subject's no longer requires study drug|0
1818888|NCT00419159|6312175|P2|Overall Study|Abnormal laboratory value(s)|2
1818889|NCT00419159|6312176|P1|Overall Study|Abnormal laboratory value(s)|0
1818890|NCT00419159|6312175|P2|Overall Study|Adverse Event|15
1818891|NCT00419159|6312176|P1|Overall Study|Adverse Event|7
1818892|NCT00419120|6312206|P1|Long Term Follow up Period|study ongoing|10
1818893|NCT00419094|6312213|P2|Overall Study|Other: No contact for extended period|1
1818894|NCT00419094|6312214|P1|Overall Study|Other: No contact for extended period|0
1818895|NCT00419094|6312213|P2|Overall Study|Other: Patient non-compliant|1
1818896|NCT00419094|6312214|P1|Overall Study|Other: Patient non-compliant|0
1818897|NCT00419094|6312213|P2|Overall Study|Other: Error determining exit criteria|0
1818898|NCT00419094|6312214|P1|Overall Study|Other: Error determining exit criteria|1
1818899|NCT00419094|6312213|P2|Overall Study|Withdrawal of consent|5
1818900|NCT00419094|6312214|P1|Overall Study|Withdrawal of consent|1
1818901|NCT00419094|6312213|P2|Overall Study|Protocol Violation|14
1818902|NCT00419094|6312214|P1|Overall Study|Protocol Violation|1
1818903|NCT00419094|6312213|P2|Overall Study|Lost to Follow-up|2
1818904|NCT00419094|6312214|P1|Overall Study|Lost to Follow-up|0
1818905|NCT00419094|6312213|P2|Overall Study|Lack of Efficacy|0
1818906|NCT00419094|6312214|P1|Overall Study|Lack of Efficacy|1
1818907|NCT00419094|6312213|P2|Overall Study|Adverse Event|7
1818908|NCT00419094|6312214|P1|Overall Study|Adverse Event|3
1818909|NCT00419003|6312228|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
1818910|NCT00419003|6312229|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
1818911|NCT00419003|6312228|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
1818912|NCT00419003|6312229|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
1818913|NCT00418938|6312283|P2|Overall Study|Ineligibility Determined|0
1818914|NCT00418938|6312284|P1|Overall Study|Ineligibility Determined|1
1818915|NCT00418938|6312283|P2|Overall Study|On-going|1
1818916|NCT00418938|6312284|P1|Overall Study|On-going|1
1818917|NCT00418938|6312283|P2|Overall Study|Adverse Event|1
1818918|NCT00418938|6312284|P1|Overall Study|Adverse Event|1
1818919|NCT00418938|6312283|P2|Overall Study|Lost to Follow-up|3
1818920|NCT00418938|6312284|P1|Overall Study|Lost to Follow-up|1
1818921|NCT00418938|6312283|P2|Overall Study|Withdrawal by Subject|15
1818922|NCT00418938|6312284|P1|Overall Study|Withdrawal by Subject|16
1818923|NCT00418938|6312283|P2|Overall Study|Administrative decision|3
1818924|NCT00418938|6312284|P1|Overall Study|Administrative decision|3
1818925|NCT00418938|6312283|P2|Overall Study|Reimbursement|0
1818926|NCT00418938|6312284|P1|Overall Study|Reimbursement|1
1818927|NCT00418886|6312304|P2|Overall Study|randomised but no treatment received|1
1818928|NCT00418886|6312305|P1|Overall Study|randomised but no treatment received|0
1818929|NCT00418886|6312304|P2|Overall Study|withdrawn due to other reason|0
1818930|NCT00418886|6312305|P1|Overall Study|withdrawn due to other reason|1
1818931|NCT00418886|6312304|P2|Overall Study|Lost to Follow-up|6
1818932|NCT00418886|6312305|P1|Overall Study|Lost to Follow-up|4
1818933|NCT00418886|6312304|P2|Overall Study|Withdrawal by Subject|10
1818934|NCT00418886|6312305|P1|Overall Study|Withdrawal by Subject|9
1818935|NCT00418886|6312304|P2|Overall Study|Death|147
1818936|NCT00418886|6312305|P1|Overall Study|Death|122
1818937|NCT00418886|6312304|P2|Overall Study|discontinue treatment survival follow up|91
1818938|NCT00418886|6312305|P1|Overall Study|discontinue treatment survival follow up|90
1818939|NCT00418834|6312331|P2|Overall Study|Withdrawal by Subject|7
1818940|NCT00418834|6312332|P1|Overall Study|Withdrawal by Subject|3
1818941|NCT00418834|6312331|P2|Overall Study|Protocol Violation|3
1818942|NCT00418834|6312332|P1|Overall Study|Protocol Violation|4
1818943|NCT00418834|6312331|P2|Overall Study|Lost to Follow-up|1
1818944|NCT00418834|6312332|P1|Overall Study|Lost to Follow-up|0
1818945|NCT00418834|6312331|P2|Overall Study|Adverse Event|9
1818946|NCT00418834|6312332|P1|Overall Study|Adverse Event|16
1818947|NCT00418717|6312392|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
1818948|NCT00418717|6312392|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
1818949|NCT00418691|6312400|P3|Overall Study|Progressive Disease|1
1818950|NCT00418691|6312401|P2|Overall Study|Progressive Disease|0
1818951|NCT00418691|6312402|P1|Overall Study|Progressive Disease|1
1818952|NCT00418691|6312400|P3|Overall Study|Started new medication voiding entry|1
1818953|NCT00418691|6312401|P2|Overall Study|Started new medication voiding entry|0
1818954|NCT00418691|6312402|P1|Overall Study|Started new medication voiding entry|0
1818955|NCT00418691|6312400|P3|Overall Study|Lost to Follow-up|3
1818956|NCT00418691|6312401|P2|Overall Study|Lost to Follow-up|2
1818957|NCT00418691|6312402|P1|Overall Study|Lost to Follow-up|1
1818958|NCT00418665|6312413|P3|Treatment Extension|Death|1
1818959|NCT00418665|6312414|P2|Treatment Extension|Death|0
1818960|NCT00418665|6312415|P1|Treatment Extension|Death|0
1818961|NCT00418665|6312413|P3|Treatment Extension|Physician Decision|1
1818962|NCT00418665|6312414|P2|Treatment Extension|Physician Decision|2
1818963|NCT00418665|6312415|P1|Treatment Extension|Physician Decision|2
1818964|NCT00418665|6312413|P3|Treatment Extension|Requirement for alternative therapy|0
1818965|NCT00418665|6312414|P2|Treatment Extension|Requirement for alternative therapy|2
1818966|NCT00418665|6312415|P1|Treatment Extension|Requirement for alternative therapy|2
1818967|NCT00418665|6312413|P3|Treatment Extension|Withdrawal by Subject|0
1818968|NCT00418665|6312414|P2|Treatment Extension|Withdrawal by Subject|0
1818969|NCT00418665|6312415|P1|Treatment Extension|Withdrawal by Subject|1
1818970|NCT00418665|6312413|P3|Treatment Extension|Adverse Event|0
1818971|NCT00418665|6312414|P2|Treatment Extension|Adverse Event|0
1818972|NCT00418665|6312415|P1|Treatment Extension|Adverse Event|1
1818973|NCT00418665|6312413|P3|Treatment Period|Physician Decision|3
1818974|NCT00418665|6312414|P2|Treatment Period|Physician Decision|0
1818975|NCT00418665|6312415|P1|Treatment Period|Physician Decision|1
1818976|NCT00418665|6312413|P3|Treatment Period|Requirement for alternative therapy|0
1818977|NCT00418665|6312414|P2|Treatment Period|Requirement for alternative therapy|0
1818978|NCT00418665|6312415|P1|Treatment Period|Requirement for alternative therapy|1
1818979|NCT00418665|6312413|P3|Treatment Period|Withdrawal by Subject|1
1818980|NCT00418665|6312414|P2|Treatment Period|Withdrawal by Subject|3
1818981|NCT00418665|6312415|P1|Treatment Period|Withdrawal by Subject|0
1818982|NCT00418665|6312413|P3|Treatment Period|Adverse Event|0
1818983|NCT00418665|6312414|P2|Treatment Period|Adverse Event|2
1818984|NCT00418665|6312415|P1|Treatment Period|Adverse Event|2
1818985|NCT00418665|6312413|P3|Treatment Period|Ineligibility determined|0
1818986|NCT00418665|6312414|P2|Treatment Period|Ineligibility determined|1
1818987|NCT00418665|6312415|P1|Treatment Period|Ineligibility determined|1
1818988|NCT00418561|6312449|P3|Overall Study|Participant's (guardian's) decision|0
1818989|NCT00418561|6312450|P2|Overall Study|Participant's (guardian's) decision|1
1818990|NCT00418561|6312451|P1|Overall Study|Participant's (guardian's) decision|0
1818991|NCT00418522|6312521|P2|Overall Study|Randomized but did not receive treatment|4
1818992|NCT00418522|6312522|P1|Overall Study|Randomized but did not receive treatment|7
1818993|NCT00418522|6312521|P2|Overall Study|Other|23
1818994|NCT00418522|6312522|P1|Overall Study|Other|27
1818995|NCT00418522|6312521|P2|Overall Study|Withdrawal by Subject|7
1818996|NCT00418522|6312522|P1|Overall Study|Withdrawal by Subject|31
1818997|NCT00418522|6312521|P2|Overall Study|Lost to Follow-up|4
1818998|NCT00418522|6312522|P1|Overall Study|Lost to Follow-up|10
1818999|NCT00418522|6312521|P2|Overall Study|Lack of Efficacy|3
1819000|NCT00418522|6312522|P1|Overall Study|Lack of Efficacy|1
1819001|NCT00418522|6312521|P2|Overall Study|Adverse Event|1
1819002|NCT00418522|6312522|P1|Overall Study|Adverse Event|7
1819003|NCT00418379|6312569|P3|Year 5|Any other reason not above-mentioned|3
1819004|NCT00418379|6312570|P2|Year 5|Any other reason not above-mentioned|4
1819005|NCT00418379|6312571|P1|Year 5|Any other reason not above-mentioned|2
1819006|NCT00418379|6312569|P3|Year 5|Adverse Event|0
1819007|NCT00418379|6312570|P2|Year 5|Adverse Event|1
1819008|NCT00418379|6312571|P1|Year 5|Adverse Event|0
1819009|NCT00418379|6312569|P3|Year 4|Any other reason not above-mentioned|0
1819010|NCT00418379|6312570|P2|Year 4|Any other reason not above-mentioned|1
1819011|NCT00418379|6312571|P1|Year 4|Any other reason not above-mentioned|1
1819012|NCT00418379|6312569|P3|Year 4|Withdrawal by Subject|2
1819013|NCT00418379|6312570|P2|Year 4|Withdrawal by Subject|3
1819014|NCT00418379|6312571|P1|Year 4|Withdrawal by Subject|2
1819015|NCT00418379|6312569|P3|Year 4|Adverse Event|0
1819016|NCT00418379|6312570|P2|Year 4|Adverse Event|1
1819017|NCT00418379|6312571|P1|Year 4|Adverse Event|0
1819018|NCT00418379|6312569|P3|Year 3|Any other reason not above-mentioned|1
1819019|NCT00418379|6312570|P2|Year 3|Any other reason not above-mentioned|1
1819020|NCT00418379|6312571|P1|Year 3|Any other reason not above-mentioned|2
1819021|NCT00418379|6312569|P3|Year 3|Withdrawal by Subject|2
1819022|NCT00418379|6312570|P2|Year 3|Withdrawal by Subject|1
1819023|NCT00418379|6312571|P1|Year 3|Withdrawal by Subject|1
1819024|NCT00418379|6312569|P3|Year 2|Any other reason not above-mentioned|6
1819025|NCT00418379|6312570|P2|Year 2|Any other reason not above-mentioned|1
1819026|NCT00418379|6312571|P1|Year 2|Any other reason not above-mentioned|2
1819027|NCT00418379|6312569|P3|Year 2|Withdrawal by Subject|3
1819028|NCT00418379|6312570|P2|Year 2|Withdrawal by Subject|1
1819029|NCT00418379|6312571|P1|Year 2|Withdrawal by Subject|1
1819030|NCT00418379|6312569|P3|Year 2|Adverse Event|1
1819031|NCT00418379|6312570|P2|Year 2|Adverse Event|2
1819032|NCT00418379|6312571|P1|Year 2|Adverse Event|5
1819033|NCT00418379|6312569|P3|Year 1|Any other reason not above-mentioned|7
1819034|NCT00418379|6312570|P2|Year 1|Any other reason not above-mentioned|5
1819035|NCT00418379|6312571|P1|Year 1|Any other reason not above-mentioned|2
1819036|NCT00418379|6312569|P3|Year 1|Withdrawal by Subject|5
1819037|NCT00418379|6312570|P2|Year 1|Withdrawal by Subject|8
1819038|NCT00418379|6312571|P1|Year 1|Withdrawal by Subject|7
1819039|NCT00418379|6312569|P3|Year 1|Adverse Event|3
1819040|NCT00418379|6312570|P2|Year 1|Adverse Event|15
1819041|NCT00418379|6312571|P1|Year 1|Adverse Event|9
1819042|NCT00418314|6312581|P2|Overall Study|Withdrawal by Subject|2
1819043|NCT00418314|6312582|P1|Overall Study|Withdrawal by Subject|1
1819044|NCT00418184|6312612|P2|Double-blind Phase|Poor compliance|1
1819045|NCT00418184|6312613|P1|Double-blind Phase|Poor compliance|3
1819046|NCT00418184|6312612|P2|Double-blind Phase|Adverse Event|1
1819047|NCT00418184|6312613|P1|Double-blind Phase|Adverse Event|2
1819048|NCT00418184|6312612|P2|Double-blind Phase|Withdrawal by Subject|9
1819049|NCT00418184|6312613|P1|Double-blind Phase|Withdrawal by Subject|22
1819050|NCT00418145|6312621|P1|Overall Study|study terminated|6
1819051|NCT00417989|6312696|P2|Overall Study|Physician Decision|2
1819052|NCT00417989|6312697|P1|Overall Study|Physician Decision|5
1819053|NCT00417989|6312696|P2|Overall Study|Death|1
1819054|NCT00417989|6312697|P1|Overall Study|Death|0
1819055|NCT00417989|6312696|P2|Overall Study|Protocol Violation|0
1819056|NCT00417989|6312697|P1|Overall Study|Protocol Violation|1
1819057|NCT00417989|6312696|P2|Overall Study|Lost to Follow-up|6
1819058|NCT00417989|6312697|P1|Overall Study|Lost to Follow-up|1
1819059|NCT00417989|6312696|P2|Overall Study|Withdrawal by Subject|13
1819060|NCT00417989|6312697|P1|Overall Study|Withdrawal by Subject|13
1819061|NCT00417976|6312719|P1|Overall Study|Treatment -related toxicity|2
1819062|NCT00417976|6312719|P1|Overall Study|Non compliance unrelated to toxicity|1
1819063|NCT00417963|6312724|P1|Overall Study|Study device could not be deployed|3
1819064|NCT00417963|6312724|P1|Overall Study|Death|17
1819065|NCT00417963|6312724|P1|Overall Study|Withdrawal by Subject|18
1819066|NCT00417963|6312724|P1|Overall Study|Lost to Follow-up|3
1819067|NCT00417885|6312741|P1|Overall Study|Transferred to Another Sunitinib Study|2
1819068|NCT00417885|6312741|P1|Overall Study|Objective Progression or Relapse|3
1819069|NCT00417885|6312741|P1|Overall Study|Adverse Event|1
1819070|NCT00417612|6312752|P2|Overall Study|Lost to Follow-up|0
1819071|NCT00417612|6312753|P1|Overall Study|Lost to Follow-up|1
1819072|NCT00417612|6312752|P2|Overall Study|Protocol Violation|2
1819073|NCT00417612|6312753|P1|Overall Study|Protocol Violation|0
1819074|NCT00417612|6312752|P2|Overall Study|Adverse Event|0
1819075|NCT00417612|6312753|P1|Overall Study|Adverse Event|2
1819076|NCT00417612|6312752|P2|Overall Study|Errant diagnosis|1
1819077|NCT00417612|6312753|P1|Overall Study|Errant diagnosis|0
1819078|NCT00417482|6312779|P3|Phase B 2nd 16 Weeks|Death|0
1819079|NCT00417482|6312780|P2|Phase B 2nd 16 Weeks|Death|1
1819080|NCT00417482|6312781|P1|Phase B 2nd 16 Weeks|Death|1
1819081|NCT00417482|6312779|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1819082|NCT00417482|6312780|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
1819083|NCT00417482|6312781|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
1819084|NCT00417482|6312779|P3|Phase B 2nd 16 Weeks|Adverse Event|1
1819085|NCT00417482|6312780|P2|Phase B 2nd 16 Weeks|Adverse Event|0
1819086|NCT00417482|6312781|P1|Phase B 2nd 16 Weeks|Adverse Event|0
1819087|NCT00417482|6312779|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
1819088|NCT00417482|6312780|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
1819089|NCT00417482|6312781|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
1819090|NCT00417482|6312779|P3|Phase B 1st 16 Weeks|Death|0
1819091|NCT00417482|6312780|P2|Phase B 1st 16 Weeks|Death|0
1819092|NCT00417482|6312781|P1|Phase B 1st 16 Weeks|Death|1
1819093|NCT00417482|6312779|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1819094|NCT00417482|6312780|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
1819095|NCT00417482|6312781|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
1819096|NCT00417482|6312779|P3|Phase B 1st 16 Weeks|Adverse Event|1
1819097|NCT00417482|6312780|P2|Phase B 1st 16 Weeks|Adverse Event|0
1819098|NCT00417482|6312781|P1|Phase B 1st 16 Weeks|Adverse Event|2
1819099|NCT00417482|6312779|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
1819100|NCT00417482|6312780|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
1819101|NCT00417482|6312781|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
1819102|NCT00417248|6312820|P1|Overall Study|Lack of Efficacy|1
1819103|NCT00417248|6312820|P1|Overall Study|Death|1
1819104|NCT00417248|6312820|P1|Overall Study|Study Terminated|6
1819105|NCT00417170|6312827|P2|Overall Study|Lost to Follow-up|1
1819106|NCT00417170|6312828|P1|Overall Study|Lost to Follow-up|0
1819107|NCT00417170|6312827|P2|Overall Study|Withdrawal by Subject|1
1819108|NCT00417170|6312828|P1|Overall Study|Withdrawal by Subject|1
1819109|NCT00417170|6312827|P2|Overall Study|Adverse Event|1
1819110|NCT00417170|6312828|P1|Overall Study|Adverse Event|1
1819111|NCT00417079|6312844|P2|Overall Study|abnormal liver function tests|1
1819112|NCT00417079|6312845|P1|Overall Study|abnormal liver function tests|0
1819113|NCT00417079|6312844|P2|Overall Study|Patient unable to come to the clinic|1
1819114|NCT00417079|6312845|P1|Overall Study|Patient unable to come to the clinic|0
1819115|NCT00417079|6312844|P2|Overall Study|Withdrawal by subject's family|1
1819116|NCT00417079|6312845|P1|Overall Study|Withdrawal by subject's family|0
1819117|NCT00417079|6312844|P2|Overall Study|Screening error|1
1819118|NCT00417079|6312845|P1|Overall Study|Screening error|2
1819119|NCT00417079|6312844|P2|Overall Study|Clinical deterioration|0
1819120|NCT00417079|6312845|P1|Overall Study|Clinical deterioration|1
1819121|NCT00417079|6312844|P2|Overall Study|Non-confirmed Disease progression|1
1819122|NCT00417079|6312845|P1|Overall Study|Non-confirmed Disease progression|1
1819123|NCT00417079|6312844|P2|Overall Study|Investigator's decision|4
1819124|NCT00417079|6312845|P1|Overall Study|Investigator's decision|1
1819125|NCT00417079|6312844|P2|Overall Study|Screened failure|1
1819126|NCT00417079|6312845|P1|Overall Study|Screened failure|2
1819127|NCT00417079|6312844|P2|Overall Study|Not treated|7
1819128|NCT00417079|6312845|P1|Overall Study|Not treated|6
1819129|NCT00417079|6312844|P2|Overall Study|Withdrawal by Subject|8
1819130|NCT00417079|6312845|P1|Overall Study|Withdrawal by Subject|17
1819131|NCT00417079|6312844|P2|Overall Study|Lost to Follow-up|0
1819132|NCT00417079|6312845|P1|Overall Study|Lost to Follow-up|2
1819133|NCT00417079|6312844|P2|Overall Study|Non-compliance to protocol|1
1819134|NCT00417079|6312845|P1|Overall Study|Non-compliance to protocol|0
1819135|NCT00417079|6312844|P2|Overall Study|Adverse Event|67
1819136|NCT00417079|6312845|P1|Overall Study|Adverse Event|32
1819137|NCT00417079|6312844|P2|Overall Study|Disease progression|180
1819138|NCT00417079|6312845|P1|Overall Study|Disease progression|267
1819139|NCT00417027|6312868|P3|Overall Study|Protocol Violation|5
1819140|NCT00417027|6312869|P2|Overall Study|Protocol Violation|5
1819141|NCT00417027|6312870|P1|Overall Study|Protocol Violation|0
1819142|NCT00416949|6312896|P1|Overall Study|Patients refused to participate|5
1819143|NCT00416884|6312900|P1|Overall Study|Study terminated due to low accrual|1
1819144|NCT00416715|6312909|P1|Overall Study|Vitamin D levels not evaluable|8
1819145|NCT00416715|6312909|P1|Overall Study|Not evaluable for joint aches|7
1819146|NCT00416624|6312920|P4|Overall Study|Cancel|0
1819147|NCT00416624|6312921|P3|Overall Study|Cancel|0
1819148|NCT00416624|6312922|P2|Overall Study|Cancel|0
1819149|NCT00416624|6312923|P1|Overall Study|Cancel|1
1819150|NCT00416624|6312920|P4|Overall Study|Other|5
1819151|NCT00416624|6312921|P3|Overall Study|Other|5
1819152|NCT00416624|6312922|P2|Overall Study|Other|11
1819153|NCT00416624|6312923|P1|Overall Study|Other|8
1819154|NCT00416624|6312920|P4|Overall Study|Adverse Event|2
1819155|NCT00416624|6312921|P3|Overall Study|Adverse Event|2
1819156|NCT00416624|6312922|P2|Overall Study|Adverse Event|3
1819157|NCT00416624|6312923|P1|Overall Study|Adverse Event|8
1819158|NCT00416624|6312920|P4|Overall Study|Death|1
1819159|NCT00416624|6312921|P3|Overall Study|Death|7
1819160|NCT00416624|6312922|P2|Overall Study|Death|7
1819161|NCT00416624|6312923|P1|Overall Study|Death|4
1819162|NCT00416624|6312920|P4|Overall Study|Withdrawal by Subject|9
1819163|NCT00416624|6312921|P3|Overall Study|Withdrawal by Subject|4
1819164|NCT00416624|6312922|P2|Overall Study|Withdrawal by Subject|6
1819165|NCT00416624|6312923|P1|Overall Study|Withdrawal by Subject|1
1819166|NCT00416598|6312977|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
1819167|NCT00416598|6312977|P1|Decitabine Maintenance|Alternative treatment|2
1819168|NCT00416598|6312977|P1|Decitabine Maintenance|Progression/relapse|38
1819169|NCT00416598|6312977|P1|Decitabine Maintenance|Withdrawal by Subject|18
1819170|NCT00416598|6312977|P1|Decitabine Maintenance|Adverse Event|5
1819171|NCT00416598|6312977|P1|Induction & Intensification|Failed induction|87
1819172|NCT00416598|6312977|P1|Induction & Intensification|Relapse/progression|29
1819173|NCT00416598|6312977|P1|Induction & Intensification|Physician discretion/other medical issue|45
1819174|NCT00416598|6312977|P1|Induction & Intensification|Alternative Treatment|135
1819175|NCT00416598|6312977|P1|Induction & Intensification|Withdrawal by Subject|46
1819176|NCT00416598|6312977|P1|Induction & Intensification|Death|32
1819177|NCT00416598|6312977|P1|Induction & Intensification|Adverse Event|38
1819178|NCT00416520|6313003|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
1819179|NCT00416520|6313004|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
1819180|NCT00416520|6313005|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
1819181|NCT00416520|6313006|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
1819182|NCT00416520|6313003|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
1819183|NCT00416520|6313004|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1819184|NCT00416520|6313005|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1819185|NCT00416520|6313006|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
1819186|NCT00416520|6313003|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
1819187|NCT00416520|6313004|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
1819188|NCT00416520|6313005|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
1819189|NCT00416520|6313006|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
1819190|NCT00416520|6313003|P4|Open-label Period|Other Reasons|0
1819191|NCT00416520|6313004|P3|Open-label Period|Other Reasons|0
1819192|NCT00416520|6313005|P2|Open-label Period|Other Reasons|12
1819193|NCT00416520|6313006|P1|Open-label Period|Other Reasons|3
1819194|NCT00416520|6313003|P4|Open-label Period|Withdrawal by Subject|0
1819195|NCT00416520|6313004|P3|Open-label Period|Withdrawal by Subject|0
1819196|NCT00416520|6313005|P2|Open-label Period|Withdrawal by Subject|5
1819197|NCT00416520|6313006|P1|Open-label Period|Withdrawal by Subject|16
1819198|NCT00416520|6313003|P4|Open-label Period|Protocol Violation|0
1819199|NCT00416520|6313004|P3|Open-label Period|Protocol Violation|0
1819200|NCT00416520|6313005|P2|Open-label Period|Protocol Violation|3
1819201|NCT00416520|6313006|P1|Open-label Period|Protocol Violation|3
1819202|NCT00416520|6313003|P4|Open-label Period|Lack of Efficacy|0
1819203|NCT00416520|6313004|P3|Open-label Period|Lack of Efficacy|0
1819204|NCT00416520|6313005|P2|Open-label Period|Lack of Efficacy|1
1819205|NCT00416520|6313006|P1|Open-label Period|Lack of Efficacy|8
1819206|NCT00416520|6313003|P4|Open-label Period|Death|0
1819207|NCT00416520|6313004|P3|Open-label Period|Death|0
1819208|NCT00416520|6313005|P2|Open-label Period|Death|1
1819209|NCT00416520|6313006|P1|Open-label Period|Death|2
1819210|NCT00416520|6313003|P4|Open-label Period|Adverse Event|0
1819211|NCT00416520|6313004|P3|Open-label Period|Adverse Event|0
1819212|NCT00416520|6313005|P2|Open-label Period|Adverse Event|10
1819213|NCT00416520|6313006|P1|Open-label Period|Adverse Event|28
1819214|NCT00416455|6313035|P2|Overall Study|Inadequate pathology|2
1819215|NCT00416455|6313036|P1|Overall Study|Inadequate pathology|11
1819216|NCT00416455|6313035|P2|Overall Study|PET / CT poor quality|1
1819217|NCT00416455|6313036|P1|Overall Study|PET / CT poor quality|2
1819218|NCT00416455|6313035|P2|Overall Study|PET / CT not done|5
1819219|NCT00416455|6313036|P1|Overall Study|PET / CT not done|3
1819220|NCT00416312|6313071|P1|Overall Study|tumors not visible on imaging|2
1819221|NCT00416195|6313077|P2|Overall Study|Other|1
1819222|NCT00416195|6313078|P1|Overall Study|Other|0
1819223|NCT00416195|6313077|P2|Overall Study|Protocol Violation|1
1819224|NCT00416195|6313078|P1|Overall Study|Protocol Violation|1
1819225|NCT00416195|6313077|P2|Overall Study|Adverse Event|2
1819226|NCT00416195|6313078|P1|Overall Study|Adverse Event|1
1819227|NCT00416078|6313103|P2|Overall Study|Lost to Follow-up|2
1819228|NCT00416078|6313104|P1|Overall Study|Lost to Follow-up|4
1819229|NCT00416078|6313103|P2|Overall Study|Physician Decision|0
1819230|NCT00416078|6313104|P1|Overall Study|Physician Decision|1
1819231|NCT00416078|6313103|P2|Overall Study|Withdrawal by Subject|2
1819232|NCT00416078|6313104|P1|Overall Study|Withdrawal by Subject|3
1819233|NCT00416078|6313103|P2|Overall Study|Death|4
1819234|NCT00416078|6313104|P1|Overall Study|Death|3
1819235|NCT00415909|6313120|P1|Overall Study|Death|1
1819236|NCT00415909|6313120|P1|Overall Study|Withdrawal by Subject|2
1819237|NCT00415636|6313154|P6|Overall Study|Disease progression|1
1819238|NCT00415636|6313155|P5|Overall Study|Disease progression|0
1819239|NCT00415636|6313156|P4|Overall Study|Disease progression|3
1819240|NCT00415636|6313157|P3|Overall Study|Disease progression|0
1819241|NCT00415636|6313158|P2|Overall Study|Disease progression|0
1819242|NCT00415636|6313159|P1|Overall Study|Disease progression|0
1819243|NCT00415636|6313154|P6|Overall Study|Withdrawal by Subject|0
1819244|NCT00415636|6313155|P5|Overall Study|Withdrawal by Subject|1
1819245|NCT00415636|6313156|P4|Overall Study|Withdrawal by Subject|0
1819246|NCT00415636|6313157|P3|Overall Study|Withdrawal by Subject|0
1819247|NCT00415636|6313158|P2|Overall Study|Withdrawal by Subject|0
1819248|NCT00415636|6313159|P1|Overall Study|Withdrawal by Subject|0
1819249|NCT00415636|6313154|P6|Overall Study|Adverse Event|0
1819250|NCT00415636|6313155|P5|Overall Study|Adverse Event|1
1819251|NCT00415636|6313156|P4|Overall Study|Adverse Event|1
1819252|NCT00415636|6313157|P3|Overall Study|Adverse Event|0
1819253|NCT00415636|6313158|P2|Overall Study|Adverse Event|0
1819254|NCT00415636|6313159|P1|Overall Study|Adverse Event|0
1819255|NCT00415636|6313154|P6|Overall Study|Symptomatic deterioration|1
1819256|NCT00415636|6313155|P5|Overall Study|Symptomatic deterioration|0
1819257|NCT00415636|6313156|P4|Overall Study|Symptomatic deterioration|2
1819258|NCT00415636|6313157|P3|Overall Study|Symptomatic deterioration|1
1819259|NCT00415636|6313158|P2|Overall Study|Symptomatic deterioration|0
1819260|NCT00415636|6313159|P1|Overall Study|Symptomatic deterioration|1
1819261|NCT00415623|6313193|P2|Overall Study|Withdrawal by Subject|1
1819262|NCT00415623|6313194|P1|Overall Study|Withdrawal by Subject|1
1819263|NCT00415623|6313193|P2|Overall Study|Death|0
1819264|NCT00415623|6313194|P1|Overall Study|Death|1
1819265|NCT00415623|6313193|P2|Overall Study|Adverse Event|4
1819266|NCT00415623|6313194|P1|Overall Study|Adverse Event|3
1819267|NCT00415610|6313221|P3|Overall Study|Death|5
1819268|NCT00415610|6313222|P2|Overall Study|Death|2
1819269|NCT00415610|6313223|P1|Overall Study|Death|3
1819270|NCT00415597|6313243|P1|Treatment|Multiple Reasons|1
1819271|NCT00415597|6313243|P1|Treatment|Sponsor Decision|1
1819272|NCT00415597|6313243|P1|Treatment|Administrative|3
1819273|NCT00415597|6313243|P1|Treatment|Drug Screen|2
1819274|NCT00415597|6313243|P1|Treatment|Lost to Follow-up|28
1819275|NCT00415597|6313243|P1|Treatment|Withdrawal by Subject|51
1819276|NCT00415597|6313243|P1|Treatment|Physician Decision|3
1819277|NCT00415597|6313243|P1|Treatment|Protocol Violation|67
1819278|NCT00415597|6313243|P1|Treatment|Lack of Efficacy|39
1819279|NCT00415597|6313243|P1|Treatment|Adverse Event|110
1819280|NCT00415597|6313243|P1|Enrollment|Protocol Violation|1
1819281|NCT00415597|6313243|P1|Enrollment|Withdrawal by Subject|1
1819282|NCT00415532|6313251|P2|Safety Follow Up Period|Requirement for alternative therapy|1
1819283|NCT00415532|6313252|P1|Safety Follow Up Period|Requirement for alternative therapy|0
1819284|NCT00415532|6313251|P2|Safety Follow Up Period|Noncompliance|0
1819285|NCT00415532|6313252|P1|Safety Follow Up Period|Noncompliance|1
1819286|NCT00415532|6313251|P2|Safety Follow Up Period|Ineligibility determined|1
1819287|NCT00415532|6313252|P1|Safety Follow Up Period|Ineligibility determined|1
1819288|NCT00415532|6313251|P2|Safety Follow Up Period|Other|4
1819289|NCT00415532|6313252|P1|Safety Follow Up Period|Other|1
1819290|NCT00415532|6313251|P2|Safety Follow Up Period|Withdrawal by Subject|3
1819291|NCT00415532|6313252|P1|Safety Follow Up Period|Withdrawal by Subject|2
1819292|NCT00415532|6313251|P2|Safety Follow Up Period|Death|0
1819293|NCT00415532|6313252|P1|Safety Follow Up Period|Death|3
1819294|NCT00415532|6313251|P2|Safety Follow Up Period|Adverse Event|3
1819295|NCT00415532|6313252|P1|Safety Follow Up Period|Adverse Event|1
1819296|NCT00415532|6313251|P2|Treatment Period|Requirement for alternative therapy|0
1819297|NCT00415532|6313252|P1|Treatment Period|Requirement for alternative therapy|1
1819298|NCT00415532|6313251|P2|Treatment Period|Noncompliance|1
1819299|NCT00415532|6313252|P1|Treatment Period|Noncompliance|1
1819300|NCT00415532|6313251|P2|Treatment Period|Ineligibility determined|1
1819301|NCT00415532|6313252|P1|Treatment Period|Ineligibility determined|1
1819302|NCT00415532|6313251|P2|Treatment Period|Other|2
1819303|NCT00415532|6313252|P1|Treatment Period|Other|2
1819304|NCT00415532|6313251|P2|Treatment Period|Withdrawal by Subject|6
1819305|NCT00415532|6313252|P1|Treatment Period|Withdrawal by Subject|6
1819306|NCT00415532|6313251|P2|Treatment Period|Protocol Violation|0
1819307|NCT00415532|6313252|P1|Treatment Period|Protocol Violation|1
1819308|NCT00415532|6313251|P2|Treatment Period|Lost to Follow-up|1
1819309|NCT00415532|6313252|P1|Treatment Period|Lost to Follow-up|1
1819310|NCT00415532|6313251|P2|Treatment Period|Death|1
1819311|NCT00415532|6313252|P1|Treatment Period|Death|2
1819312|NCT00415532|6313251|P2|Treatment Period|Adverse Event|3
1819313|NCT00415532|6313252|P1|Treatment Period|Adverse Event|2
1819314|NCT00415519|6313274|P2|Overall Study|Patient’s convenience|0
1819315|NCT00415519|6313275|P1|Overall Study|Patient’s convenience|1
1819316|NCT00415519|6313274|P2|Overall Study|Withdrawal by Subject|0
1819317|NCT00415519|6313275|P1|Overall Study|Withdrawal by Subject|2
1819318|NCT00415519|6313274|P2|Overall Study|Adverse Event|0
1819319|NCT00415519|6313275|P1|Overall Study|Adverse Event|1
1819320|NCT00415194|6313315|P2|Overall Study|Death Due to AE (Other Causes)|15
1819321|NCT00415194|6313316|P1|Overall Study|Death Due to AE (Other Causes)|27
1819322|NCT00415194|6313315|P2|Overall Study|Death Due to Procedural Related AE|1
1819323|NCT00415194|6313316|P1|Overall Study|Death Due to Procedural Related AE|0
1819324|NCT00415194|6313315|P2|Overall Study|Death Due to Study Drug Related AE|1
1819325|NCT00415194|6313316|P1|Overall Study|Death Due to Study Drug Related AE|11
1819326|NCT00415194|6313315|P2|Overall Study|Death Due to Study Disease|29
1819327|NCT00415194|6313316|P1|Overall Study|Death Due to Study Disease|26
1819328|NCT00415194|6313315|P2|Overall Study|Withdrawal by Subject|21
1819329|NCT00415194|6313316|P1|Overall Study|Withdrawal by Subject|28
1819330|NCT00415194|6313315|P2|Overall Study|Protocol Violation|2
1819331|NCT00415194|6313316|P1|Overall Study|Protocol Violation|4
1819332|NCT00415194|6313315|P2|Overall Study|Progressive Disease|217
1819333|NCT00415194|6313316|P1|Overall Study|Progressive Disease|180
1819334|NCT00415194|6313315|P2|Overall Study|Physician Decision|16
1819335|NCT00415194|6313316|P1|Overall Study|Physician Decision|10
1819336|NCT00415194|6313315|P2|Overall Study|Lost to Follow-up|0
1819337|NCT00415194|6313316|P1|Overall Study|Lost to Follow-up|1
1819338|NCT00415194|6313315|P2|Overall Study|Entry Criteria Not Met|8
1819339|NCT00415194|6313316|P1|Overall Study|Entry Criteria Not Met|4
1819340|NCT00415194|6313315|P2|Overall Study|Adverse Event|32
1819341|NCT00415194|6313316|P1|Overall Study|Adverse Event|37
1819342|NCT00415168|6313332|P1|Overall Study|Withdrawal by Subject|6
1819343|NCT00415168|6313332|P1|Overall Study|Sponsor Decision|4
1819344|NCT00415168|6313332|P1|Overall Study|Physician Decision|13
1819345|NCT00415168|6313332|P1|Overall Study|Lost to Follow-up|3
1819346|NCT00415168|6313332|P1|Overall Study|Death|26
1819347|NCT00415051|6313342|P1|Overall Study|Protocol Violation|1
1819348|NCT00414973|6313353|P4|Overall Study|Death|0
1819349|NCT00414973|6313354|P3|Overall Study|Death|1
1819350|NCT00414973|6313355|P2|Overall Study|Death|0
1819351|NCT00414973|6313356|P1|Overall Study|Death|0
1819352|NCT00414973|6313353|P4|Overall Study|Sponsor Decision|0
1819353|NCT00414973|6313354|P3|Overall Study|Sponsor Decision|0
1819354|NCT00414973|6313355|P2|Overall Study|Sponsor Decision|0
1819355|NCT00414973|6313356|P1|Overall Study|Sponsor Decision|1
1819356|NCT00414973|6313353|P4|Overall Study|Lost to Follow-up|0
1819357|NCT00414973|6313354|P3|Overall Study|Lost to Follow-up|0
1819358|NCT00414973|6313355|P2|Overall Study|Lost to Follow-up|2
1819359|NCT00414973|6313356|P1|Overall Study|Lost to Follow-up|0
1819360|NCT00414973|6313353|P4|Overall Study|Protocol Violation|0
1819361|NCT00414973|6313354|P3|Overall Study|Protocol Violation|0
1819362|NCT00414973|6313355|P2|Overall Study|Protocol Violation|4
1819363|NCT00414973|6313356|P1|Overall Study|Protocol Violation|3
1819364|NCT00414973|6313353|P4|Overall Study|Adverse Event|0
1819365|NCT00414973|6313354|P3|Overall Study|Adverse Event|1
1819366|NCT00414973|6313355|P2|Overall Study|Adverse Event|0
1819367|NCT00414973|6313356|P1|Overall Study|Adverse Event|10
1819368|NCT00414973|6313353|P4|Overall Study|Withdrawal by Subject|0
1819369|NCT00414973|6313354|P3|Overall Study|Withdrawal by Subject|1
1819370|NCT00414973|6313355|P2|Overall Study|Withdrawal by Subject|4
1819371|NCT00414973|6313356|P1|Overall Study|Withdrawal by Subject|14
1819372|NCT00414908|6313376|P2|Overall Study|Protocol Violation|1
1819373|NCT00414908|6313377|P1|Overall Study|Protocol Violation|1
1819374|NCT00414726|6313414|P2|Overall Study|Withdrawal by Subject|1
1819375|NCT00414726|6313415|P1|Overall Study|Withdrawal by Subject|0
1819376|NCT00414661|6313450|P4|Overall Study|Other|0
1819377|NCT00414661|6313451|P3|Overall Study|Other|0
1819378|NCT00414661|6313452|P2|Overall Study|Other|3
1819379|NCT00414661|6313453|P1|Overall Study|Other|6
1819380|NCT00414661|6313450|P4|Overall Study|Withdrawal by Subject|2
1819381|NCT00414661|6313451|P3|Overall Study|Withdrawal by Subject|2
1819382|NCT00414661|6313452|P2|Overall Study|Withdrawal by Subject|2
1819383|NCT00414661|6313453|P1|Overall Study|Withdrawal by Subject|5
1819384|NCT00414661|6313450|P4|Overall Study|Lost to Follow-up|1
1819385|NCT00414661|6313451|P3|Overall Study|Lost to Follow-up|0
1819386|NCT00414661|6313452|P2|Overall Study|Lost to Follow-up|4
1819387|NCT00414661|6313453|P1|Overall Study|Lost to Follow-up|1
1819388|NCT00414661|6313450|P4|Overall Study|Death|0
1819389|NCT00414661|6313451|P3|Overall Study|Death|0
1819390|NCT00414661|6313452|P2|Overall Study|Death|5
1819391|NCT00414661|6313453|P1|Overall Study|Death|2
1819392|NCT00414609|6313498|P3|Extension Study|Death|17
1819393|NCT00414609|6313499|P2|Extension Study|Death|0
1819394|NCT00414609|6313500|P1|Extension Study|Death|0
1819395|NCT00414609|6313498|P3|Extension Study|Administrative problems|1
1819396|NCT00414609|6313499|P2|Extension Study|Administrative problems|0
1819397|NCT00414609|6313500|P1|Extension Study|Administrative problems|0
1819398|NCT00414609|6313498|P3|Extension Study|Lost to Follow-up|10
1819399|NCT00414609|6313499|P2|Extension Study|Lost to Follow-up|0
1819400|NCT00414609|6313500|P1|Extension Study|Lost to Follow-up|0
1819401|NCT00414609|6313498|P3|Extension Study|Withdrawal by Subject|13
1819402|NCT00414609|6313499|P2|Extension Study|Withdrawal by Subject|0
1819403|NCT00414609|6313500|P1|Extension Study|Withdrawal by Subject|0
1819404|NCT00414609|6313498|P3|Extension Study|Unsatisfactory therapeutic effect|2
1819405|NCT00414609|6313499|P2|Extension Study|Unsatisfactory therapeutic effect|0
1819406|NCT00414609|6313500|P1|Extension Study|Unsatisfactory therapeutic effect|0
1819407|NCT00414609|6313498|P3|Extension Study|Adverse Event|14
1819408|NCT00414609|6313499|P2|Extension Study|Adverse Event|0
1819409|NCT00414609|6313500|P1|Extension Study|Adverse Event|0
1819410|NCT00414609|6313498|P3|Core Study|Death|0
1819411|NCT00414609|6313499|P2|Core Study|Death|14
1819412|NCT00414609|6313500|P1|Core Study|Death|7
1819413|NCT00414609|6313498|P3|Core Study|Administrative problems|0
1819414|NCT00414609|6313499|P2|Core Study|Administrative problems|2
1819415|NCT00414609|6313500|P1|Core Study|Administrative problems|0
1819416|NCT00414609|6313498|P3|Core Study|Lost to Follow-up|0
1819417|NCT00414609|6313499|P2|Core Study|Lost to Follow-up|4
1819418|NCT00414609|6313500|P1|Core Study|Lost to Follow-up|7
1819419|NCT00414609|6313498|P3|Core Study|Patient withdrew consent|0
1819420|NCT00414609|6313499|P2|Core Study|Patient withdrew consent|11
1819421|NCT00414609|6313500|P1|Core Study|Patient withdrew consent|10
1819422|NCT00414609|6313498|P3|Core Study|Protocol deviation|0
1819423|NCT00414609|6313499|P2|Core Study|Protocol deviation|1
1819424|NCT00414609|6313500|P1|Core Study|Protocol deviation|0
1819425|NCT00414609|6313498|P3|Core Study|Abnormal test procedure results|0
1819426|NCT00414609|6313499|P2|Core Study|Abnormal test procedure results|1
1819427|NCT00414609|6313500|P1|Core Study|Abnormal test procedure results|1
1819428|NCT00414609|6313498|P3|Core Study|Abnormal laboratory values|0
1819429|NCT00414609|6313499|P2|Core Study|Abnormal laboratory values|1
1819430|NCT00414609|6313500|P1|Core Study|Abnormal laboratory values|0
1819431|NCT00414609|6313498|P3|Core Study|Adverse Event|0
1819432|NCT00414609|6313499|P2|Core Study|Adverse Event|11
1819433|NCT00414609|6313500|P1|Core Study|Adverse Event|9
1819434|NCT00414596|6313523|P1|Overall Study|Protocol Violation|2
1819435|NCT00414544|6313532|P1|Overall Study|Lost to Follow-up|14
1819436|NCT00414466|6313555|P4|Overall Study|Withdrawn by Sponsor|0
1819437|NCT00414466|6313556|P3|Overall Study|Withdrawn by Sponsor|0
1819438|NCT00414466|6313557|P2|Overall Study|Withdrawn by Sponsor|0
1819439|NCT00414466|6313558|P1|Overall Study|Withdrawn by Sponsor|1
1819440|NCT00414466|6313555|P4|Overall Study|Lack of Efficacy|0
1819441|NCT00414466|6313556|P3|Overall Study|Lack of Efficacy|0
1819442|NCT00414466|6313557|P2|Overall Study|Lack of Efficacy|0
1819443|NCT00414466|6313558|P1|Overall Study|Lack of Efficacy|1
1819444|NCT00414466|6313555|P4|Overall Study|Adverse Event|1
1819445|NCT00414466|6313556|P3|Overall Study|Adverse Event|1
1819446|NCT00414466|6313557|P2|Overall Study|Adverse Event|0
1819447|NCT00414466|6313558|P1|Overall Study|Adverse Event|0
1819448|NCT00414453|6313576|P1|Overall Study|Abnormal lab work|16
1819449|NCT00414440|6313624|P2|Extension Period|Not included in follow up period|8
1819450|NCT00414440|6313625|P1|Extension Period|Not included in follow up period|18
1819451|NCT00414440|6313624|P2|Extension Period|Withdrawal by Subject|7
1819452|NCT00414440|6313625|P1|Extension Period|Withdrawal by Subject|9
1819453|NCT00414440|6313624|P2|Extension Period|Death|2
1819454|NCT00414440|6313625|P1|Extension Period|Death|1
1819455|NCT00414440|6313624|P2|Extension Period|Administrative|16
1819456|NCT00414440|6313625|P1|Extension Period|Administrative|16
1819457|NCT00414440|6313624|P2|Extension Period|Other|1
1819458|NCT00414440|6313625|P1|Extension Period|Other|1
1819459|NCT00414440|6313624|P2|Extension Period|Did not consent to continue follow up|54
1819460|NCT00414440|6313625|P1|Extension Period|Did not consent to continue follow up|61
1819461|NCT00414440|6313624|P2|Extension Period|Lost to Follow-up|52
1819462|NCT00414440|6313625|P1|Extension Period|Lost to Follow-up|44
1819463|NCT00414440|6313624|P2|Core Period|Withdrawal by Subject|32
1819464|NCT00414440|6313625|P1|Core Period|Withdrawal by Subject|70
1819465|NCT00414388|6313639|P1|Overall Study|Adverse Event|1
1819466|NCT00414310|6313647|P2|Overall Study|Not treated|0
1819467|NCT00414310|6313648|P1|Overall Study|Not treated|1
1819468|NCT00414076|6313692|P2|Overall Study|Adverse Event|0
1819469|NCT00414076|6313693|P1|Overall Study|Adverse Event|1
1819470|NCT00414076|6313692|P2|Overall Study|Withdrawal by Subject|3
1819471|NCT00414076|6313693|P1|Overall Study|Withdrawal by Subject|1
1819472|NCT00414076|6313692|P2|Overall Study|Progression|2
1819473|NCT00414076|6313693|P1|Overall Study|Progression|1
1819474|NCT00414050|6313703|P4|Overall Study|Subject Moved|1
1819475|NCT00414050|6313704|P3|Overall Study|Subject Moved|0
1819476|NCT00414050|6313705|P2|Overall Study|Subject Moved|0
1819477|NCT00414050|6313706|P1|Overall Study|Subject Moved|0
1819478|NCT00414050|6313703|P4|Overall Study|Subject discontinued for other reason|1
1819479|NCT00414050|6313704|P3|Overall Study|Subject discontinued for other reason|2
1819480|NCT00414050|6313705|P2|Overall Study|Subject discontinued for other reason|2
1819481|NCT00414050|6313706|P1|Overall Study|Subject discontinued for other reason|1
1819482|NCT00414050|6313703|P4|Overall Study|Withdrawal by Subject|4
1819483|NCT00414050|6313704|P3|Overall Study|Withdrawal by Subject|2
1819484|NCT00414050|6313705|P2|Overall Study|Withdrawal by Subject|3
1819485|NCT00414050|6313706|P1|Overall Study|Withdrawal by Subject|5
1819486|NCT00414050|6313703|P4|Overall Study|Lost to Follow-up|1
1819487|NCT00414050|6313704|P3|Overall Study|Lost to Follow-up|1
1819488|NCT00414050|6313705|P2|Overall Study|Lost to Follow-up|2
1819489|NCT00414050|6313706|P1|Overall Study|Lost to Follow-up|2
1819490|NCT00414050|6313703|P4|Overall Study|Adverse Event|1
1819491|NCT00414050|6313704|P3|Overall Study|Adverse Event|1
1819492|NCT00414050|6313705|P2|Overall Study|Adverse Event|1
1819493|NCT00414050|6313706|P1|Overall Study|Adverse Event|1
1819494|NCT00414011|6313720|P1|Overall Study|Withdrawal by Subject|2
1819495|NCT00414011|6313720|P1|Overall Study|Physician Decision|3
1819496|NCT00413972|6313729|P4|Overall Study|Other|1
1819497|NCT00413972|6313730|P3|Overall Study|Other|0
1819498|NCT00413972|6313731|P2|Overall Study|Other|0
1819499|NCT00413972|6313732|P1|Overall Study|Other|0
1819500|NCT00413972|6313729|P4|Overall Study|Protocol Violation|0
1819501|NCT00413972|6313730|P3|Overall Study|Protocol Violation|2
1819502|NCT00413972|6313731|P2|Overall Study|Protocol Violation|0
1819503|NCT00413972|6313732|P1|Overall Study|Protocol Violation|0
1819504|NCT00413972|6313729|P4|Overall Study|Withdrawal by Subject|2
1819505|NCT00413972|6313730|P3|Overall Study|Withdrawal by Subject|7
1819506|NCT00413972|6313731|P2|Overall Study|Withdrawal by Subject|5
1819507|NCT00413972|6313732|P1|Overall Study|Withdrawal by Subject|4
1819508|NCT00413972|6313729|P4|Overall Study|Lost to Follow-up|0
1819509|NCT00413972|6313730|P3|Overall Study|Lost to Follow-up|1
1819510|NCT00413972|6313731|P2|Overall Study|Lost to Follow-up|2
1819511|NCT00413972|6313732|P1|Overall Study|Lost to Follow-up|1
1819512|NCT00413972|6313729|P4|Overall Study|Adverse Event|0
1819513|NCT00413972|6313730|P3|Overall Study|Adverse Event|0
1819514|NCT00413972|6313731|P2|Overall Study|Adverse Event|1
1819515|NCT00413972|6313732|P1|Overall Study|Adverse Event|2
1819516|NCT00413959|6313742|P1|Overall Study|Pt had only one cycle.|1
1819517|NCT00413920|6313749|P2|Overall Study|Graft Loss|3
1819518|NCT00413920|6313750|P1|Overall Study|Graft Loss|5
1819519|NCT00413920|6313749|P2|Overall Study|Death|5
1819520|NCT00413920|6313750|P1|Overall Study|Death|3
1819521|NCT00413920|6313749|P2|Overall Study|Lack of Efficacy|9
1819522|NCT00413920|6313750|P1|Overall Study|Lack of Efficacy|11
1819523|NCT00413920|6313749|P2|Overall Study|Adverse Event|11
1819524|NCT00413920|6313750|P1|Overall Study|Adverse Event|9
1819525|NCT00413894|6313765|P1|Overall Study|Other|18
1819526|NCT00413894|6313765|P1|Overall Study|Protocol Violation|11
1819527|NCT00413894|6313765|P1|Overall Study|Adverse Event|28
1819528|NCT00413894|6313765|P1|Overall Study|Hb <10 grams/deciliter|12
1819529|NCT00413894|6313765|P1|Overall Study|Administrative Reasons|1
1819530|NCT00413894|6313765|P1|Overall Study|Withdrawal by Subject|10
1819531|NCT00413777|6313782|P2|Fixed-dose Period|Withdrew Consent|1
1819532|NCT00413777|6313783|P1|Fixed-dose Period|Withdrew Consent|0
1819533|NCT00413777|6313782|P2|Fixed-dose Period|Met Withdrawal Criteria|0
1819534|NCT00413777|6313783|P1|Fixed-dose Period|Met Withdrawal Criteria|1
1819535|NCT00413777|6313782|P2|Fixed-dose Period|Adverse Event|1
1819536|NCT00413777|6313783|P1|Fixed-dose Period|Adverse Event|2
1819537|NCT00413777|6313782|P2|Fixed-dose Period|Lost to Follow-up|1
1819538|NCT00413777|6313783|P1|Fixed-dose Period|Lost to Follow-up|1
1819539|NCT00413699|6313831|P3|Extension Period|Adverse Event|2
1819540|NCT00413699|6313832|P2|Extension Period|Adverse Event|0
1819541|NCT00413699|6313833|P1|Extension Period|Adverse Event|0
1819542|NCT00413699|6313831|P3|Extension Period|Protocol Violation|1
1819543|NCT00413699|6313832|P2|Extension Period|Protocol Violation|0
1819544|NCT00413699|6313833|P1|Extension Period|Protocol Violation|0
1819545|NCT00413699|6313831|P3|Extension Period|No Longer Willing to Participate|2
1819546|NCT00413699|6313832|P2|Extension Period|No Longer Willing to Participate|0
1819547|NCT00413699|6313833|P1|Extension Period|No Longer Willing to Participate|0
1819548|NCT00413699|6313831|P3|Initial Period|No longer willing to participate|0
1819549|NCT00413699|6313832|P2|Initial Period|No longer willing to participate|368
1819550|NCT00413699|6313833|P1|Initial Period|No longer willing to participate|116
1819551|NCT00413699|6313831|P3|Initial Period|Missing end of study page|0
1819552|NCT00413699|6313832|P2|Initial Period|Missing end of study page|4
1819553|NCT00413699|6313833|P1|Initial Period|Missing end of study page|0
1819554|NCT00413699|6313831|P3|Initial Period|Adverse event not related to study drug|0
1819555|NCT00413699|6313832|P2|Initial Period|Adverse event not related to study drug|248
1819556|NCT00413699|6313833|P1|Initial Period|Adverse event not related to study drug|113
1819557|NCT00413699|6313831|P3|Initial Period|Adverse event related to study drug|0
1819558|NCT00413699|6313832|P2|Initial Period|Adverse event related to study drug|527
1819559|NCT00413699|6313833|P1|Initial Period|Adverse event related to study drug|178
1819560|NCT00413699|6313831|P3|Initial Period|Other|0
1819561|NCT00413699|6313832|P2|Initial Period|Other|211
1819562|NCT00413699|6313833|P1|Initial Period|Other|67
1819563|NCT00413699|6313831|P3|Initial Period|Study terminated by Sponsor|0
1819564|NCT00413699|6313832|P2|Initial Period|Study terminated by Sponsor|1
1819565|NCT00413699|6313833|P1|Initial Period|Study terminated by Sponsor|0
1819566|NCT00413699|6313831|P3|Initial Period|Medication error without adverse event|0
1819567|NCT00413699|6313832|P2|Initial Period|Medication error without adverse event|1
1819568|NCT00413699|6313833|P1|Initial Period|Medication error without adverse event|0
1819569|NCT00413699|6313831|P3|Initial Period|Did not meet entrance criteria|0
1819570|NCT00413699|6313832|P2|Initial Period|Did not meet entrance criteria|2
1819571|NCT00413699|6313833|P1|Initial Period|Did not meet entrance criteria|2
1819572|NCT00413699|6313831|P3|Initial Period|Pregnancy|0
1819573|NCT00413699|6313832|P2|Initial Period|Pregnancy|8
1819574|NCT00413699|6313833|P1|Initial Period|Pregnancy|10
1819575|NCT00413699|6313831|P3|Initial Period|Protocol Violation|0
1819576|NCT00413699|6313832|P2|Initial Period|Protocol Violation|89
1819577|NCT00413699|6313833|P1|Initial Period|Protocol Violation|38
1819578|NCT00413699|6313831|P3|Initial Period|Lost to Follow-up|0
1819579|NCT00413699|6313832|P2|Initial Period|Lost to Follow-up|101
1819580|NCT00413699|6313833|P1|Initial Period|Lost to Follow-up|31
1819581|NCT00413699|6313831|P3|Initial Period|Lack of Efficacy|0
1819582|NCT00413699|6313832|P2|Initial Period|Lack of Efficacy|115
1819583|NCT00413699|6313833|P1|Initial Period|Lack of Efficacy|59
1819584|NCT00413699|6313831|P3|Initial Period|Death|0
1819585|NCT00413699|6313832|P2|Initial Period|Death|30
1819586|NCT00413699|6313833|P1|Initial Period|Death|25
1819587|NCT00413660|6313915|P11|Post Week 12|Other|0
1819588|NCT00413660|6313916|P10|Post Week 12|Other|0
1819589|NCT00413660|6313917|P9|Post Week 12|Other|0
1819590|NCT00413660|6313918|P8|Post Week 12|Other|0
1819591|NCT00413660|6313919|P7|Post Week 12|Other|1
1819592|NCT00413660|6313920|P6|Post Week 12|Other|1
1819593|NCT00413660|6313921|P5|Post Week 12|Other|1
1819594|NCT00413660|6313922|P4|Post Week 12|Other|0
1819595|NCT00413660|6313923|P3|Post Week 12|Other|3
1819596|NCT00413660|6313924|P2|Post Week 12|Other|2
1819597|NCT00413660|6313925|P1|Post Week 12|Other|1
1819598|NCT00413660|6313915|P11|Post Week 12|Withdrawal by Subject|1
1819599|NCT00413660|6313916|P10|Post Week 12|Withdrawal by Subject|0
1819600|NCT00413660|6313917|P9|Post Week 12|Withdrawal by Subject|0
1819601|NCT00413660|6313918|P8|Post Week 12|Withdrawal by Subject|0
1819602|NCT00413660|6313919|P7|Post Week 12|Withdrawal by Subject|0
1819603|NCT00413660|6313920|P6|Post Week 12|Withdrawal by Subject|0
1819604|NCT00413660|6313921|P5|Post Week 12|Withdrawal by Subject|1
1819605|NCT00413660|6313922|P4|Post Week 12|Withdrawal by Subject|0
1819606|NCT00413660|6313923|P3|Post Week 12|Withdrawal by Subject|1
1819607|NCT00413660|6313924|P2|Post Week 12|Withdrawal by Subject|1
1819608|NCT00413660|6313925|P1|Post Week 12|Withdrawal by Subject|0
1819609|NCT00413660|6313915|P11|Post Week 12|Lost to Follow-up|0
1819610|NCT00413660|6313916|P10|Post Week 12|Lost to Follow-up|0
1819611|NCT00413660|6313917|P9|Post Week 12|Lost to Follow-up|0
1819612|NCT00413660|6313918|P8|Post Week 12|Lost to Follow-up|0
1819613|NCT00413660|6313919|P7|Post Week 12|Lost to Follow-up|0
1819614|NCT00413660|6313920|P6|Post Week 12|Lost to Follow-up|0
1819615|NCT00413660|6313921|P5|Post Week 12|Lost to Follow-up|0
1819616|NCT00413660|6313922|P4|Post Week 12|Lost to Follow-up|0
1819617|NCT00413660|6313923|P3|Post Week 12|Lost to Follow-up|1
1819618|NCT00413660|6313924|P2|Post Week 12|Lost to Follow-up|1
1819619|NCT00413660|6313925|P1|Post Week 12|Lost to Follow-up|0
1819620|NCT00413660|6313915|P11|Post Week 12|Lack of Efficacy|0
1819621|NCT00413660|6313916|P10|Post Week 12|Lack of Efficacy|1
1819622|NCT00413660|6313917|P9|Post Week 12|Lack of Efficacy|0
1819623|NCT00413660|6313918|P8|Post Week 12|Lack of Efficacy|0
1819624|NCT00413660|6313919|P7|Post Week 12|Lack of Efficacy|0
1819625|NCT00413660|6313920|P6|Post Week 12|Lack of Efficacy|0
1819626|NCT00413660|6313921|P5|Post Week 12|Lack of Efficacy|0
1819627|NCT00413660|6313922|P4|Post Week 12|Lack of Efficacy|0
1819628|NCT00413660|6313923|P3|Post Week 12|Lack of Efficacy|1
1819629|NCT00413660|6313924|P2|Post Week 12|Lack of Efficacy|0
1819630|NCT00413660|6313925|P1|Post Week 12|Lack of Efficacy|0
1819631|NCT00413660|6313915|P11|Post Week 12|Adverse Event|0
1819632|NCT00413660|6313916|P10|Post Week 12|Adverse Event|0
1819633|NCT00413660|6313917|P9|Post Week 12|Adverse Event|0
1819634|NCT00413660|6313918|P8|Post Week 12|Adverse Event|0
1819635|NCT00413660|6313919|P7|Post Week 12|Adverse Event|2
1819636|NCT00413660|6313920|P6|Post Week 12|Adverse Event|2
1819637|NCT00413660|6313921|P5|Post Week 12|Adverse Event|4
1819638|NCT00413660|6313922|P4|Post Week 12|Adverse Event|1
1819639|NCT00413660|6313923|P3|Post Week 12|Adverse Event|2
1819640|NCT00413660|6313924|P2|Post Week 12|Adverse Event|0
1819641|NCT00413660|6313925|P1|Post Week 12|Adverse Event|2
1819642|NCT00413660|6313915|P11|Up To Week 12|Other|0
1819643|NCT00413660|6313916|P10|Up To Week 12|Other|0
1819644|NCT00413660|6313917|P9|Up To Week 12|Other|0
1819645|NCT00413660|6313918|P8|Up To Week 12|Other|0
1819646|NCT00413660|6313919|P7|Up To Week 12|Other|3
1819647|NCT00413660|6313920|P6|Up To Week 12|Other|4
1819648|NCT00413660|6313921|P5|Up To Week 12|Other|2
1819649|NCT00413660|6313922|P4|Up To Week 12|Other|1
1819650|NCT00413660|6313923|P3|Up To Week 12|Other|6
1819651|NCT00413660|6313924|P2|Up To Week 12|Other|1
1819652|NCT00413660|6313925|P1|Up To Week 12|Other|3
1819653|NCT00413660|6313915|P11|Up To Week 12|Randomized, Not Treated|0
1819654|NCT00413660|6313916|P10|Up To Week 12|Randomized, Not Treated|0
1819655|NCT00413660|6313917|P9|Up To Week 12|Randomized, Not Treated|0
1819656|NCT00413660|6313918|P8|Up To Week 12|Randomized, Not Treated|0
1819657|NCT00413660|6313919|P7|Up To Week 12|Randomized, Not Treated|0
1819658|NCT00413660|6313920|P6|Up To Week 12|Randomized, Not Treated|0
1819659|NCT00413660|6313921|P5|Up To Week 12|Randomized, Not Treated|0
1819660|NCT00413660|6313922|P4|Up To Week 12|Randomized, Not Treated|1
1819661|NCT00413660|6313923|P3|Up To Week 12|Randomized, Not Treated|0
1819662|NCT00413660|6313924|P2|Up To Week 12|Randomized, Not Treated|0
1819663|NCT00413660|6313925|P1|Up To Week 12|Randomized, Not Treated|1
1819664|NCT00413660|6313915|P11|Up To Week 12|Withdrawal by Subject|0
1819665|NCT00413660|6313916|P10|Up To Week 12|Withdrawal by Subject|0
1819666|NCT00413660|6313917|P9|Up To Week 12|Withdrawal by Subject|0
1819667|NCT00413660|6313918|P8|Up To Week 12|Withdrawal by Subject|0
1819668|NCT00413660|6313919|P7|Up To Week 12|Withdrawal by Subject|2
1819669|NCT00413660|6313920|P6|Up To Week 12|Withdrawal by Subject|2
1819670|NCT00413660|6313921|P5|Up To Week 12|Withdrawal by Subject|0
1819671|NCT00413660|6313922|P4|Up To Week 12|Withdrawal by Subject|2
1819672|NCT00413660|6313923|P3|Up To Week 12|Withdrawal by Subject|0
1819673|NCT00413660|6313924|P2|Up To Week 12|Withdrawal by Subject|2
1819674|NCT00413660|6313925|P1|Up To Week 12|Withdrawal by Subject|0
1819675|NCT00413660|6313915|P11|Up To Week 12|Lost to Follow-up|0
1819676|NCT00413660|6313916|P10|Up To Week 12|Lost to Follow-up|0
1819677|NCT00413660|6313917|P9|Up To Week 12|Lost to Follow-up|0
1819678|NCT00413660|6313918|P8|Up To Week 12|Lost to Follow-up|0
1819679|NCT00413660|6313919|P7|Up To Week 12|Lost to Follow-up|0
1819680|NCT00413660|6313920|P6|Up To Week 12|Lost to Follow-up|0
1819681|NCT00413660|6313921|P5|Up To Week 12|Lost to Follow-up|1
1819682|NCT00413660|6313922|P4|Up To Week 12|Lost to Follow-up|0
1819683|NCT00413660|6313923|P3|Up To Week 12|Lost to Follow-up|0
1819684|NCT00413660|6313924|P2|Up To Week 12|Lost to Follow-up|1
1819685|NCT00413660|6313925|P1|Up To Week 12|Lost to Follow-up|0
1819686|NCT00413660|6313915|P11|Up To Week 12|Lack of Efficacy|0
1819687|NCT00413660|6313916|P10|Up To Week 12|Lack of Efficacy|0
1819688|NCT00413660|6313917|P9|Up To Week 12|Lack of Efficacy|0
1819689|NCT00413660|6313918|P8|Up To Week 12|Lack of Efficacy|0
1819690|NCT00413660|6313919|P7|Up To Week 12|Lack of Efficacy|5
1819691|NCT00413660|6313920|P6|Up To Week 12|Lack of Efficacy|0
1819692|NCT00413660|6313921|P5|Up To Week 12|Lack of Efficacy|0
1819693|NCT00413660|6313922|P4|Up To Week 12|Lack of Efficacy|0
1819694|NCT00413660|6313923|P3|Up To Week 12|Lack of Efficacy|0
1819695|NCT00413660|6313924|P2|Up To Week 12|Lack of Efficacy|0
1819696|NCT00413660|6313925|P1|Up To Week 12|Lack of Efficacy|2
1819697|NCT00413660|6313915|P11|Up To Week 12|Adverse Event|0
1819698|NCT00413660|6313916|P10|Up To Week 12|Adverse Event|0
1819699|NCT00413660|6313917|P9|Up To Week 12|Adverse Event|0
1819700|NCT00413660|6313918|P8|Up To Week 12|Adverse Event|0
1819701|NCT00413660|6313919|P7|Up To Week 12|Adverse Event|1
1819702|NCT00413660|6313920|P6|Up To Week 12|Adverse Event|4
1819703|NCT00413660|6313921|P5|Up To Week 12|Adverse Event|6
1819704|NCT00413660|6313922|P4|Up To Week 12|Adverse Event|4
1819705|NCT00413660|6313923|P3|Up To Week 12|Adverse Event|1
1819706|NCT00413660|6313924|P2|Up To Week 12|Adverse Event|3
1819707|NCT00413660|6313925|P1|Up To Week 12|Adverse Event|1
1819708|NCT00413413|6314328|P3|Double-Blind|Lost to Follow-up|2
1819709|NCT00413413|6314329|P2|Double-Blind|Lost to Follow-up|4
1819710|NCT00413413|6314330|P1|Double-Blind|Lost to Follow-up|3
1819711|NCT00413413|6314328|P3|Double-Blind|Subject withdrew consent|9
1819712|NCT00413413|6314329|P2|Double-Blind|Subject withdrew consent|6
1819713|NCT00413413|6314330|P1|Double-Blind|Subject withdrew consent|4
1819714|NCT00413413|6314328|P3|Double-Blind|Protocol deviation|1
1819715|NCT00413413|6314329|P2|Double-Blind|Protocol deviation|2
1819716|NCT00413413|6314330|P1|Double-Blind|Protocol deviation|1
1819717|NCT00413413|6314328|P3|Double-Blind|Unsatisfactory therapeutic effect|1
1819718|NCT00413413|6314329|P2|Double-Blind|Unsatisfactory therapeutic effect|2
1819719|NCT00413413|6314330|P1|Double-Blind|Unsatisfactory therapeutic effect|1
1819720|NCT00413413|6314328|P3|Double-Blind|Adverse Event|5
1819721|NCT00413413|6314329|P2|Double-Blind|Adverse Event|0
1819722|NCT00413413|6314330|P1|Double-Blind|Adverse Event|6
1819723|NCT00413413|6314328|P3|Single-Blind|Lost to Follow-up|0
1819724|NCT00413413|6314329|P2|Single-Blind|Lost to Follow-up|8
1819725|NCT00413413|6314330|P1|Single-Blind|Lost to Follow-up|0
1819726|NCT00413413|6314328|P3|Single-Blind|Withdrawal by Subject|0
1819727|NCT00413413|6314329|P2|Single-Blind|Withdrawal by Subject|27
1819728|NCT00413413|6314330|P1|Single-Blind|Withdrawal by Subject|0
1819729|NCT00413413|6314328|P3|Single-Blind|Protocol Violation|0
1819730|NCT00413413|6314329|P2|Single-Blind|Protocol Violation|16
1819731|NCT00413413|6314330|P1|Single-Blind|Protocol Violation|0
1819732|NCT00413413|6314328|P3|Single-Blind|Subject no longer requires study drug|0
1819733|NCT00413413|6314329|P2|Single-Blind|Subject no longer requires study drug|151
1819734|NCT00413413|6314330|P1|Single-Blind|Subject no longer requires study drug|0
1819735|NCT00413413|6314328|P3|Single-Blind|Lack of Efficacy|0
1819736|NCT00413413|6314329|P2|Single-Blind|Lack of Efficacy|5
1819737|NCT00413413|6314330|P1|Single-Blind|Lack of Efficacy|0
1819738|NCT00413413|6314328|P3|Single-Blind|Adverse Event|0
1819739|NCT00413413|6314329|P2|Single-Blind|Adverse Event|9
1819740|NCT00413413|6314330|P1|Single-Blind|Adverse Event|0
1819741|NCT00413374|6314383|P2|Overall Study|Surgery|0
1819742|NCT00413374|6314384|P1|Overall Study|Surgery|1
1819743|NCT00413374|6314383|P2|Overall Study|Lost to Follow-up|0
1819744|NCT00413374|6314384|P1|Overall Study|Lost to Follow-up|1
1819745|NCT00413374|6314383|P2|Overall Study|Adverse Event|0
1819746|NCT00413374|6314384|P1|Overall Study|Adverse Event|1
1819747|NCT00413374|6314383|P2|Overall Study|Ineligible due to screening criteria.|0
1819748|NCT00413374|6314384|P1|Overall Study|Ineligible due to screening criteria.|3
1819749|NCT00413283|6314415|P4|Overall Study|Other|0
1819750|NCT00413283|6314416|P3|Overall Study|Other|1
1819751|NCT00413283|6314417|P2|Overall Study|Other|0
1819752|NCT00413283|6314418|P1|Overall Study|Other|0
1819753|NCT00413283|6314415|P4|Overall Study|Requirement for alternative therapy|0
1819754|NCT00413283|6314416|P3|Overall Study|Requirement for alternative therapy|0
1819755|NCT00413283|6314417|P2|Overall Study|Requirement for alternative therapy|2
1819756|NCT00413283|6314418|P1|Overall Study|Requirement for alternative therapy|0
1819757|NCT00413283|6314415|P4|Overall Study|Protocol deviation|0
1819758|NCT00413283|6314416|P3|Overall Study|Protocol deviation|0
1819759|NCT00413283|6314417|P2|Overall Study|Protocol deviation|1
1819760|NCT00413283|6314418|P1|Overall Study|Protocol deviation|0
1819761|NCT00413283|6314415|P4|Overall Study|Ineligibility determined|1
1819762|NCT00413283|6314416|P3|Overall Study|Ineligibility determined|0
1819763|NCT00413283|6314417|P2|Overall Study|Ineligibility determined|0
1819764|NCT00413283|6314418|P1|Overall Study|Ineligibility determined|0
1819765|NCT00413283|6314415|P4|Overall Study|Adverse Event|1
1819766|NCT00413283|6314416|P3|Overall Study|Adverse Event|0
1819767|NCT00413283|6314417|P2|Overall Study|Adverse Event|0
1819768|NCT00413283|6314418|P1|Overall Study|Adverse Event|0
1819769|NCT00413283|6314415|P4|Overall Study|Death|1
1819770|NCT00413283|6314416|P3|Overall Study|Death|1
1819771|NCT00413283|6314417|P2|Overall Study|Death|0
1819772|NCT00413283|6314418|P1|Overall Study|Death|0
1819773|NCT00413283|6314415|P4|Overall Study|Withdrawal by Subject|1
1819774|NCT00413283|6314416|P3|Overall Study|Withdrawal by Subject|0
1819775|NCT00413283|6314417|P2|Overall Study|Withdrawal by Subject|0
1819776|NCT00413283|6314418|P1|Overall Study|Withdrawal by Subject|1
1819777|NCT00413244|6314450|P2|Overall Study|Withdrawal by Subject|1
1819778|NCT00413244|6314451|P1|Overall Study|Withdrawal by Subject|10
1819779|NCT00413231|6314479|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
1819780|NCT00413231|6314479|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
1819781|NCT00413231|6314479|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
1819782|NCT00413231|6314479|P1|365-day to 60-month Post Treatment|Death|36
1819783|NCT00413231|6314479|P1|30-day to 365-day Post Treatment|Death|13
1819784|NCT00413231|6314479|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
1819785|NCT00413231|6314479|P1|0 to 30-day Post Treatment|Death|5
1819786|NCT00413218|6314511|P2|Overall Study|Withdrawal by Subject|1
1819787|NCT00413218|6314512|P1|Overall Study|Withdrawal by Subject|9
1819788|NCT00413218|6314511|P2|Overall Study|Missing|0
1819789|NCT00413218|6314512|P1|Overall Study|Missing|1
1819790|NCT00413218|6314511|P2|Overall Study|Admin|14
1819791|NCT00413218|6314512|P1|Overall Study|Admin|20
1819792|NCT00413218|6314511|P2|Overall Study|Lost to Follow-up|17
1819793|NCT00413218|6314512|P1|Overall Study|Lost to Follow-up|14
1819794|NCT00413218|6314511|P2|Overall Study|Death|56
1819795|NCT00413218|6314512|P1|Overall Study|Death|57
1819796|NCT00413218|6314511|P2|Overall Study|Randomized but didn't receive study drug|8
1819797|NCT00413218|6314512|P1|Overall Study|Randomized but didn't receive study drug|2
1819798|NCT00413192|6314538|P4|Overall Study|Not treated|1
1819799|NCT00413192|6314539|P3|Overall Study|Not treated|0
1819800|NCT00413192|6314540|P2|Overall Study|Not treated|0
1819801|NCT00413192|6314541|P1|Overall Study|Not treated|0
1819802|NCT00413192|6314538|P4|Overall Study|Other|2
1819803|NCT00413192|6314539|P3|Overall Study|Other|1
1819804|NCT00413192|6314540|P2|Overall Study|Other|1
1819805|NCT00413192|6314541|P1|Overall Study|Other|5
1819806|NCT00413192|6314538|P4|Overall Study|Intercurrent death|0
1819807|NCT00413192|6314539|P3|Overall Study|Intercurrent death|0
1819808|NCT00413192|6314540|P2|Overall Study|Intercurrent death|1
1819809|NCT00413192|6314541|P1|Overall Study|Intercurrent death|0
1819810|NCT00413192|6314538|P4|Overall Study|Intercurrent illness|1
1819811|NCT00413192|6314539|P3|Overall Study|Intercurrent illness|0
1819812|NCT00413192|6314540|P2|Overall Study|Intercurrent illness|0
1819813|NCT00413192|6314541|P1|Overall Study|Intercurrent illness|0
1819814|NCT00413192|6314538|P4|Overall Study|Withdrawal by Subject|1
1819815|NCT00413192|6314539|P3|Overall Study|Withdrawal by Subject|0
1819816|NCT00413192|6314540|P2|Overall Study|Withdrawal by Subject|5
1819817|NCT00413192|6314541|P1|Overall Study|Withdrawal by Subject|3
1819818|NCT00413192|6314538|P4|Overall Study|Toxicity|2
1819819|NCT00413192|6314539|P3|Overall Study|Toxicity|2
1819820|NCT00413192|6314540|P2|Overall Study|Toxicity|2
1819821|NCT00413192|6314541|P1|Overall Study|Toxicity|3
1819822|NCT00413192|6314538|P4|Overall Study|Disease progression|25
1819823|NCT00413192|6314539|P3|Overall Study|Disease progression|16
1819824|NCT00413192|6314540|P2|Overall Study|Disease progression|31
1819825|NCT00413192|6314541|P1|Overall Study|Disease progression|26
1819826|NCT00413153|6314594|P2|Overall Study|Adverse Event|0
1819827|NCT00413153|6314595|P1|Overall Study|Adverse Event|1
1819828|NCT00413153|6314594|P2|Overall Study|Withdrawal by Subject|1
1819829|NCT00413153|6314595|P1|Overall Study|Withdrawal by Subject|1
1819830|NCT00413062|6314619|P2|Overall Study|Other reason|34
1819831|NCT00413062|6314620|P1|Overall Study|Other reason|70
1819832|NCT00413062|6314619|P2|Overall Study|Lost to Follow-up|73
1819833|NCT00413062|6314620|P1|Overall Study|Lost to Follow-up|175
1819834|NCT00413062|6314619|P2|Overall Study|Pregnancy wish|6
1819835|NCT00413062|6314620|P1|Overall Study|Pregnancy wish|17
1819836|NCT00413062|6314619|P2|Overall Study|Pregnancy|5
1819837|NCT00413062|6314620|P1|Overall Study|Pregnancy|15
1819838|NCT00413062|6314619|P2|Overall Study|Withdrawal of informed consent|36
1819839|NCT00413062|6314620|P1|Overall Study|Withdrawal of informed consent|111
1819840|NCT00413062|6314619|P2|Overall Study|Pre-treatment (serious) adverse event|0
1819841|NCT00413062|6314620|P1|Overall Study|Pre-treatment (serious) adverse event|1
1819842|NCT00413062|6314619|P2|Overall Study|Adverse event/serious adverse event|56
1819843|NCT00413062|6314620|P1|Overall Study|Adverse event/serious adverse event|289
1819844|NCT00413049|6314646|P2|Overall Study|Lack of Efficacy|0
1819845|NCT00413049|6314647|P1|Overall Study|Lack of Efficacy|1
1819846|NCT00413049|6314646|P2|Overall Study|Abnormal laboratory value(s)|0
1819847|NCT00413049|6314647|P1|Overall Study|Abnormal laboratory value(s)|1
1819848|NCT00413049|6314646|P2|Overall Study|Subject no longer requires study drug|1
1819849|NCT00413049|6314647|P1|Overall Study|Subject no longer requires study drug|0
1819850|NCT00413049|6314646|P2|Overall Study|Protocol Violation|1
1819851|NCT00413049|6314647|P1|Overall Study|Protocol Violation|3
1819852|NCT00413049|6314646|P2|Overall Study|Lost to Follow-up|3
1819853|NCT00413049|6314647|P1|Overall Study|Lost to Follow-up|2
1819854|NCT00413049|6314646|P2|Overall Study|Withdrawal by Subject|5
1819855|NCT00413049|6314647|P1|Overall Study|Withdrawal by Subject|7
1819856|NCT00413049|6314646|P2|Overall Study|Adverse Event|8
1819857|NCT00413049|6314647|P1|Overall Study|Adverse Event|10
1819858|NCT00413036|6314663|P1|Overall Study|Missing|2
1819859|NCT00413036|6314663|P1|Overall Study|Other|26
1819860|NCT00413036|6314663|P1|Overall Study|Death|9
1819861|NCT00413036|6314663|P1|Overall Study|Withdrawal by Subject|7
1819862|NCT00413036|6314663|P1|Overall Study|Lack of Efficacy|129
1819863|NCT00413036|6314663|P1|Overall Study|Adverse Event|44
1819864|NCT00413010|6314673|P2|Overall Study|Due to termination of the study|52
1819865|NCT00413010|6314674|P1|Overall Study|Due to termination of the study|54
1819866|NCT00413010|6314673|P2|Overall Study|Withdrawal by Subject|2
1819867|NCT00413010|6314674|P1|Overall Study|Withdrawal by Subject|7
1819868|NCT00413010|6314673|P2|Overall Study|Lost to Follow-up|0
1819869|NCT00413010|6314674|P1|Overall Study|Lost to Follow-up|3
1819870|NCT00413010|6314673|P2|Overall Study|Lack of Efficacy|3
1819871|NCT00413010|6314674|P1|Overall Study|Lack of Efficacy|0
1819872|NCT00413010|6314673|P2|Overall Study|Laboratory abnormality|2
1819873|NCT00413010|6314674|P1|Overall Study|Laboratory abnormality|0
1819874|NCT00413010|6314673|P2|Overall Study|Adverse Event|4
1819875|NCT00413010|6314674|P1|Overall Study|Adverse Event|8
1819876|NCT00412984|6314696|P2|Overall Study|Not Reported|12
1819877|NCT00412984|6314697|P1|Overall Study|Not Reported|11
1819878|NCT00412984|6314696|P2|Overall Study|Other Reason|92
1819879|NCT00412984|6314697|P1|Overall Study|Other Reason|80
1819880|NCT00412984|6314696|P2|Overall Study|Physician Refused to Continue Treatment|89
1819881|NCT00412984|6314697|P1|Overall Study|Physician Refused to Continue Treatment|81
1819882|NCT00412984|6314696|P2|Overall Study|Administrative Reason by Sponsor|8
1819883|NCT00412984|6314697|P1|Overall Study|Administrative Reason by Sponsor|11
1819884|NCT00412984|6314696|P2|Overall Study|Subject No Longer Meets Study Criteria|100
1819885|NCT00412984|6314697|P1|Overall Study|Subject No Longer Meets Study Criteria|87
1819886|NCT00412984|6314696|P2|Overall Study|Pregnancy|0
1819887|NCT00412984|6314697|P1|Overall Study|Pregnancy|1
1819888|NCT00412984|6314696|P2|Overall Study|Poor/Noncompliance|77
1819889|NCT00412984|6314697|P1|Overall Study|Poor/Noncompliance|57
1819890|NCT00412984|6314696|P2|Overall Study|Lost to Follow-up|39
1819891|NCT00412984|6314697|P1|Overall Study|Lost to Follow-up|51
1819892|NCT00412984|6314696|P2|Overall Study|Withdrawal by Subject|989
1819893|NCT00412984|6314697|P1|Overall Study|Withdrawal by Subject|921
1819894|NCT00412984|6314696|P2|Overall Study|Adverse Event|738
1819895|NCT00412984|6314697|P1|Overall Study|Adverse Event|679
1819896|NCT00412984|6314696|P2|Overall Study|Death|349
1819897|NCT00412984|6314697|P1|Overall Study|Death|331
1819898|NCT00412971|6314741|P2|Overall Study|Protocol Violation|1
1819899|NCT00412971|6314742|P1|Overall Study|Protocol Violation|13
1819900|NCT00412971|6314741|P2|Overall Study|Lost to Follow-up|9
1819901|NCT00412971|6314742|P1|Overall Study|Lost to Follow-up|17
1819902|NCT00412958|6314755|P4|Overall Study|Transport issue|0
1819903|NCT00412958|6314756|P3|Overall Study|Transport issue|0
1819904|NCT00412958|6314757|P2|Overall Study|Transport issue|1
1819905|NCT00412958|6314758|P1|Overall Study|Transport issue|0
1819906|NCT00412958|6314755|P4|Overall Study|Death|0
1819907|NCT00412958|6314756|P3|Overall Study|Death|0
1819908|NCT00412958|6314757|P2|Overall Study|Death|1
1819909|NCT00412958|6314758|P1|Overall Study|Death|0
1819910|NCT00412958|6314755|P4|Overall Study|Lost to Follow-up|0
1819911|NCT00412958|6314756|P3|Overall Study|Lost to Follow-up|0
1819912|NCT00412958|6314757|P2|Overall Study|Lost to Follow-up|1
1819913|NCT00412958|6314758|P1|Overall Study|Lost to Follow-up|0
1819914|NCT00412958|6314755|P4|Overall Study|Adverse Event|0
1819915|NCT00412958|6314756|P3|Overall Study|Adverse Event|0
1819916|NCT00412958|6314757|P2|Overall Study|Adverse Event|1
1819917|NCT00412958|6314758|P1|Overall Study|Adverse Event|0
1819918|NCT00412958|6314755|P4|Overall Study|Withdrawal by Subject|1
1819919|NCT00412958|6314756|P3|Overall Study|Withdrawal by Subject|0
1819920|NCT00412958|6314757|P2|Overall Study|Withdrawal by Subject|0
1819921|NCT00412958|6314758|P1|Overall Study|Withdrawal by Subject|3
1819922|NCT00412932|6314768|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1819923|NCT00412932|6314768|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
1819924|NCT00412932|6314768|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
1819925|NCT00412932|6314768|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
1819926|NCT00412932|6314768|P1|Olmesartan 40 mg|Withdrawal by Subject|1
1819927|NCT00412932|6314768|P1|Olmesartan 40 mg|Lack of Efficacy|3
1819928|NCT00412932|6314768|P1|Olmesartan 40 mg|Adverse Event|4
1819929|NCT00412932|6314768|P1|Olmesartan (Olm) 20 mg|Other|1
1819930|NCT00412932|6314768|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
1819931|NCT00412932|6314768|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
1819932|NCT00412932|6314768|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
1819933|NCT00412932|6314768|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
1819934|NCT00412893|6314779|P2|Overall Study|Randomized but Never Received Study Drug|6
1819935|NCT00412893|6314780|P1|Overall Study|Randomized but Never Received Study Drug|5
1819936|NCT00412893|6314779|P2|Overall Study|Administrative Reason|15
1819937|NCT00412893|6314780|P1|Overall Study|Administrative Reason|12
1819938|NCT00412893|6314779|P2|Overall Study|Did Not Cooperate|9
1819939|NCT00412893|6314780|P1|Overall Study|Did Not Cooperate|12
1819940|NCT00412893|6314779|P2|Overall Study|Other Protocol Violation|6
1819941|NCT00412893|6314780|P1|Overall Study|Other Protocol Violation|10
1819942|NCT00412893|6314779|P2|Overall Study|Violation of Selection at Entry|10
1819943|NCT00412893|6314780|P1|Overall Study|Violation of Selection at Entry|17
1819944|NCT00412893|6314779|P2|Overall Study|Lost to Follow-up|1
1819945|NCT00412893|6314780|P1|Overall Study|Lost to Follow-up|2
1819946|NCT00412893|6314779|P2|Overall Study|Insufficient Therapeutic Response|23
1819947|NCT00412893|6314780|P1|Overall Study|Insufficient Therapeutic Response|39
1819948|NCT00412893|6314779|P2|Overall Study|Death|21
1819949|NCT00412893|6314780|P1|Overall Study|Death|17
1819950|NCT00412893|6314779|P2|Overall Study|Adverse Event|53
1819951|NCT00412893|6314780|P1|Overall Study|Adverse Event|31
1819952|NCT00412854|6314818|P2|Overall Study|Withdrawn for other reasons|11
1819953|NCT00412854|6314819|P1|Overall Study|Withdrawn for other reasons|13
1819954|NCT00412854|6314818|P2|Overall Study|Withdrawn due to adverse events|5
1819955|NCT00412854|6314819|P1|Overall Study|Withdrawn due to adverse events|1
1819956|NCT00412750|6314863|P3|Overall Study|Lack of Efficacy|3
1819957|NCT00412750|6314864|P2|Overall Study|Lack of Efficacy|0
1819958|NCT00412750|6314865|P1|Overall Study|Lack of Efficacy|0
1819959|NCT00412750|6314863|P3|Overall Study|Withdrawal by Subject|2
1819960|NCT00412750|6314864|P2|Overall Study|Withdrawal by Subject|1
1819961|NCT00412750|6314865|P1|Overall Study|Withdrawal by Subject|0
1819962|NCT00412750|6314863|P3|Overall Study|Lost to Follow-up|1
1819963|NCT00412750|6314864|P2|Overall Study|Lost to Follow-up|0
1819964|NCT00412750|6314865|P1|Overall Study|Lost to Follow-up|1
1819965|NCT00412750|6314863|P3|Overall Study|Adverse Event|3
1819966|NCT00412750|6314864|P2|Overall Study|Adverse Event|3
1819967|NCT00412750|6314865|P1|Overall Study|Adverse Event|8
1819968|NCT00412750|6314863|P3|Overall Study|Administrative problems|14
1819969|NCT00412750|6314864|P2|Overall Study|Administrative problems|17
1819970|NCT00412750|6314865|P1|Overall Study|Administrative problems|21
1819971|NCT00412750|6314863|P3|Overall Study|Abnormal laboratory value(s)|0
1819972|NCT00412750|6314864|P2|Overall Study|Abnormal laboratory value(s)|0
1819973|NCT00412750|6314865|P1|Overall Study|Abnormal laboratory value(s)|1
1819974|NCT00412737|6314890|P2|Overall Study|Failure to Return|2
1819975|NCT00412737|6314891|P1|Overall Study|Failure to Return|6
1819976|NCT00412737|6314890|P2|Overall Study|Refused Treatment|2
1819977|NCT00412737|6314891|P1|Overall Study|Refused Treatment|6
1819978|NCT00412737|6314890|P2|Overall Study|Adverse Event|2
1819979|NCT00412737|6314891|P1|Overall Study|Adverse Event|3
1819980|NCT00412737|6314890|P2|Overall Study|Death|0
1819981|NCT00412737|6314891|P1|Overall Study|Death|1
1819982|NCT00412607|6314909|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
1819983|NCT00412607|6314909|P1|Overall Study|Death|61
1819984|NCT00412607|6314909|P1|Overall Study|Lost to Follow-up|19
1819985|NCT00412607|6314909|P1|Overall Study|Withdrawal by Subject|9
1819986|NCT00412542|6314922|P2|Overall Study|Not Eligible|1
1819987|NCT00412542|6314923|P1|Overall Study|Not Eligible|0
1819988|NCT00412542|6314922|P2|Overall Study|Withdrawal by Subject|2
1819989|NCT00412542|6314923|P1|Overall Study|Withdrawal by Subject|0
1819990|NCT00412373|6315008|P2|Overall Study|Other|2
1819991|NCT00412373|6315009|P1|Overall Study|Other|2
1819992|NCT00412373|6315008|P2|Overall Study|Withdrawal by Subject|27
1819993|NCT00412373|6315009|P1|Overall Study|Withdrawal by Subject|8
1819994|NCT00412373|6315008|P2|Overall Study|Lost to Follow-up|13
1819995|NCT00412373|6315009|P1|Overall Study|Lost to Follow-up|7
1819996|NCT00412373|6315008|P2|Overall Study|Lack of Efficacy|22
1819997|NCT00412373|6315009|P1|Overall Study|Lack of Efficacy|16
1819998|NCT00412373|6315008|P2|Overall Study|Adverse Event|13
1819999|NCT00412373|6315009|P1|Overall Study|Adverse Event|8
1820000|NCT00412360|6315051|P2|Overall Study|Not Transplanted|2
1820001|NCT00412360|6315052|P1|Overall Study|Not Transplanted|1
1820002|NCT00412360|6315051|P2|Overall Study|Lost to Follow-up|1
1820003|NCT00412360|6315052|P1|Overall Study|Lost to Follow-up|0
1820004|NCT00412217|6315082|P2|Overall Study|Other|1
1820005|NCT00412217|6315083|P1|Overall Study|Other|1
1820006|NCT00412217|6315082|P2|Overall Study|Study Terminated by Sponsor|33
1820007|NCT00412217|6315083|P1|Overall Study|Study Terminated by Sponsor|26
1820008|NCT00412217|6315082|P2|Overall Study|Lost to Follow-up|4
1820009|NCT00412217|6315083|P1|Overall Study|Lost to Follow-up|1
1820010|NCT00412217|6315082|P2|Overall Study|Withdrawal by Subject|0
1820011|NCT00412217|6315083|P1|Overall Study|Withdrawal by Subject|2
1820012|NCT00412217|6315082|P2|Overall Study|Investigator Decision|0
1820013|NCT00412217|6315083|P1|Overall Study|Investigator Decision|1
1820014|NCT00412217|6315082|P2|Overall Study|Disease Progression|3
1820015|NCT00412217|6315083|P1|Overall Study|Disease Progression|2
1820016|NCT00412217|6315082|P2|Overall Study|Death|4
1820017|NCT00412217|6315083|P1|Overall Study|Death|5
1820018|NCT00412217|6315082|P2|Overall Study|Insufficient Data Available|3
1820019|NCT00412217|6315083|P1|Overall Study|Insufficient Data Available|8
1820020|NCT00412113|6315097|P2|Overall Study|did not receive treatment|0
1820021|NCT00412113|6315098|P1|Overall Study|did not receive treatment|1
1820022|NCT00412113|6315097|P2|Overall Study|Adverse Event|15
1820023|NCT00412113|6315098|P1|Overall Study|Adverse Event|11
1820024|NCT00412061|6315182|P2|Open Label Phase|New Cancer Therapy|1
1820025|NCT00412061|6315183|P1|Open Label Phase|New Cancer Therapy|0
1820026|NCT00412061|6315182|P2|Open Label Phase|Lost to Follow-up|2
1820027|NCT00412061|6315183|P1|Open Label Phase|Lost to Follow-up|0
1820028|NCT00412061|6315182|P2|Open Label Phase|Death|7
1820029|NCT00412061|6315183|P1|Open Label Phase|Death|0
1820030|NCT00412061|6315182|P2|Open Label Phase|Administrative Problems|13
1820031|NCT00412061|6315183|P1|Open Label Phase|Administrative Problems|0
1820032|NCT00412061|6315182|P2|Open Label Phase|Withdrawal by Subject|15
1820033|NCT00412061|6315183|P1|Open Label Phase|Withdrawal by Subject|0
1820034|NCT00412061|6315182|P2|Open Label Phase|Adverse Event|46
1820035|NCT00412061|6315183|P1|Open Label Phase|Adverse Event|0
1820036|NCT00412061|6315182|P2|Open Label Phase|Disease Progression|86
1820037|NCT00412061|6315183|P1|Open Label Phase|Disease Progression|0
1820038|NCT00412061|6315182|P2|Double Blind Phase|Lost to Follow-up|1
1820039|NCT00412061|6315183|P1|Double Blind Phase|Lost to Follow-up|0
1820040|NCT00412061|6315182|P2|Double Blind Phase|New Cander Therapy|1
1820041|NCT00412061|6315183|P1|Double Blind Phase|New Cander Therapy|1
1820042|NCT00412061|6315182|P2|Double Blind Phase|Protocol Violation|4
1820043|NCT00412061|6315183|P1|Double Blind Phase|Protocol Violation|3
1820044|NCT00412061|6315182|P2|Double Blind Phase|Death|3
1820045|NCT00412061|6315183|P1|Double Blind Phase|Death|6
1820046|NCT00412061|6315182|P2|Double Blind Phase|Withdrawal by Subject|20
1820047|NCT00412061|6315183|P1|Double Blind Phase|Withdrawal by Subject|18
1820048|NCT00412061|6315182|P2|Double Blind Phase|Final Primary Analysis|14
1820049|NCT00412061|6315183|P1|Double Blind Phase|Final Primary Analysis|26
1820050|NCT00412061|6315182|P2|Double Blind Phase|Adverse Event|16
1820051|NCT00412061|6315183|P1|Double Blind Phase|Adverse Event|61
1820052|NCT00412061|6315182|P2|Double Blind Phase|Disease Progression|154
1820053|NCT00412061|6315183|P1|Double Blind Phase|Disease Progression|101
1820054|NCT00411788|6315201|P1|Overall Study|Adverse Event|1
1820055|NCT00411788|6315201|P1|Overall Study|Protocol Violation|1
1820056|NCT00411762|6315210|P1|Overall Study|Withdrawal by Subject|5
1820057|NCT00411671|6315234|P1|Overall Study|Lost to Follow-up|3
1820058|NCT00411671|6315234|P1|Overall Study|Death|2
1820059|NCT00411671|6315234|P1|Overall Study|Adverse Event|15
1820060|NCT00411645|6315242|P2|Overall Study|Lost to Follow-up|0
1820061|NCT00411645|6315243|P1|Overall Study|Lost to Follow-up|2
1820062|NCT00411645|6315242|P2|Overall Study|Investigator/Sponsor Decision|7
1820063|NCT00411645|6315243|P1|Overall Study|Investigator/Sponsor Decision|10
1820064|NCT00411645|6315242|P2|Overall Study|Death|135
1820065|NCT00411645|6315243|P1|Overall Study|Death|56
1820066|NCT00411645|6315242|P2|Overall Study|Consent Withdrawn|22
1820067|NCT00411645|6315243|P1|Overall Study|Consent Withdrawn|13
1820068|NCT00411632|6315267|P1|Overall Study|Death|1
1820069|NCT00411554|6315278|P2|Overall Study|Patient Moved|0
1820070|NCT00411554|6315279|P1|Overall Study|Patient Moved|1
1820071|NCT00411554|6315278|P2|Overall Study|Withdrawal by Subject|0
1820072|NCT00411554|6315279|P1|Overall Study|Withdrawal by Subject|3
1820073|NCT00411554|6315278|P2|Overall Study|Lack of Efficacy|5
1820074|NCT00411554|6315279|P1|Overall Study|Lack of Efficacy|2
1820075|NCT00411554|6315278|P2|Overall Study|Adverse Event|4
1820076|NCT00411554|6315279|P1|Overall Study|Adverse Event|2
1820077|NCT00411450|6315305|P1|Overall Study|Ongoing at time of data cut-off.|3
1820078|NCT00411216|6315348|P2|Overall Study|Ten participants were entered into the c|2
1820165|NCT00410410|6315561|P3|Open-Label Period (OL)|Lost to Follow-up|0
1820079|NCT00411216|6315349|P1|Overall Study|Ten participants were entered into the c|0
1820080|NCT00411151|6315355|P1|Overall Study|Trial prematurely closed|4
1820081|NCT00411151|6315355|P1|Overall Study|Protocol Violation|1
1820082|NCT00411151|6315355|P1|Overall Study|Lost to Follow-up|2
1820083|NCT00411151|6315355|P1|Overall Study|Withdrawal by Subject|2
1820084|NCT00411151|6315355|P1|Overall Study|Death|38
1820085|NCT00410813|6315399|P2|Overall Study|Death|2
1820086|NCT00410813|6315400|P1|Overall Study|Death|0
1820087|NCT00410813|6315399|P2|Overall Study|Ineligible|4
1820088|NCT00410813|6315400|P1|Overall Study|Ineligible|2
1820089|NCT00410813|6315399|P2|Overall Study|Not protocol specified|4
1820090|NCT00410813|6315400|P1|Overall Study|Not protocol specified|3
1820091|NCT00410813|6315399|P2|Overall Study|Progression|21
1820092|NCT00410813|6315400|P1|Overall Study|Progression|32
1820093|NCT00410813|6315399|P2|Overall Study|Adverse Event|11
1820094|NCT00410813|6315400|P1|Overall Study|Adverse Event|6
1820095|NCT00410761|6315437|P2|Overall Study|Never received randomised treatment|1
1820096|NCT00410761|6315438|P1|Overall Study|Never received randomised treatment|0
1820097|NCT00410761|6315437|P2|Overall Study|Other|9
1820098|NCT00410761|6315438|P1|Overall Study|Other|12
1820099|NCT00410761|6315437|P2|Overall Study|Withdrawal by Subject|4
1820100|NCT00410761|6315438|P1|Overall Study|Withdrawal by Subject|8
1820101|NCT00410761|6315437|P2|Overall Study|objective disease progression|55
1820102|NCT00410761|6315438|P1|Overall Study|objective disease progression|71
1820103|NCT00410761|6315437|P2|Overall Study|Adverse Event|3
1820104|NCT00410761|6315438|P1|Overall Study|Adverse Event|29
1820105|NCT00410605|6315458|P1|Overall Study|Transferred to another Institution|1
1820106|NCT00410605|6315458|P1|Overall Study|Stopped treatmen to collect stem cells|1
1820107|NCT00410605|6315458|P1|Overall Study|Started Non-Protocol Therapy|3
1820108|NCT00410605|6315458|P1|Overall Study|Withdrawal by Subject|5
1820109|NCT00410605|6315458|P1|Overall Study|Physician Decision|3
1820110|NCT00410605|6315458|P1|Overall Study|Adverse Event|12
1820111|NCT00410514|6315470|P3|Overall Study|Non-compliant with study procedures|2
1820112|NCT00410514|6315471|P2|Overall Study|Non-compliant with study procedures|0
1820113|NCT00410514|6315472|P1|Overall Study|Non-compliant with study procedures|0
1820114|NCT00410514|6315470|P3|Overall Study|Lost to Follow-up|2
1820115|NCT00410514|6315471|P2|Overall Study|Lost to Follow-up|0
1820116|NCT00410514|6315472|P1|Overall Study|Lost to Follow-up|0
1820117|NCT00410514|6315470|P3|Overall Study|Protocol Violation|1
1820118|NCT00410514|6315471|P2|Overall Study|Protocol Violation|1
1820119|NCT00410514|6315472|P1|Overall Study|Protocol Violation|0
1820120|NCT00410514|6315470|P3|Overall Study|Adverse Event|2
1820121|NCT00410514|6315471|P2|Overall Study|Adverse Event|2
1820122|NCT00410514|6315472|P1|Overall Study|Adverse Event|2
1820123|NCT00410410|6315555|P9|Open-Label Period (OL)|Other|7
1820124|NCT00410410|6315556|P8|Open-Label Period (OL)|Other|0
1820125|NCT00410410|6315557|P7|Open-Label Period (OL)|Other|0
1820126|NCT00410410|6315558|P6|Open-Label Period (OL)|Other|0
1820127|NCT00410410|6315559|P5|Open-Label Period (OL)|Other|0
1820128|NCT00410410|6315560|P4|Open-Label Period (OL)|Other|0
1820129|NCT00410410|6315561|P3|Open-Label Period (OL)|Other|0
1820130|NCT00410410|6315562|P2|Open-Label Period (OL)|Other|0
1820131|NCT00410410|6315563|P1|Open-Label Period (OL)|Other|0
1820132|NCT00410410|6315555|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
1820133|NCT00410410|6315556|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820134|NCT00410410|6315557|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820135|NCT00410410|6315558|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820136|NCT00410410|6315559|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820137|NCT00410410|6315560|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820138|NCT00410410|6315561|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820139|NCT00410410|6315562|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820140|NCT00410410|6315563|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
1820141|NCT00410410|6315555|P9|Open-Label Period (OL)|Pregnancy|1
1820142|NCT00410410|6315556|P8|Open-Label Period (OL)|Pregnancy|0
1820143|NCT00410410|6315557|P7|Open-Label Period (OL)|Pregnancy|0
1820144|NCT00410410|6315558|P6|Open-Label Period (OL)|Pregnancy|0
1820145|NCT00410410|6315559|P5|Open-Label Period (OL)|Pregnancy|0
1820146|NCT00410410|6315560|P4|Open-Label Period (OL)|Pregnancy|0
1820147|NCT00410410|6315561|P3|Open-Label Period (OL)|Pregnancy|0
1820148|NCT00410410|6315562|P2|Open-Label Period (OL)|Pregnancy|0
1820149|NCT00410410|6315563|P1|Open-Label Period (OL)|Pregnancy|0
1820150|NCT00410410|6315555|P9|Open-Label Period (OL)|Withdrawal by Subject|20
1820151|NCT00410410|6315556|P8|Open-Label Period (OL)|Withdrawal by Subject|0
1820152|NCT00410410|6315557|P7|Open-Label Period (OL)|Withdrawal by Subject|0
1820153|NCT00410410|6315558|P6|Open-Label Period (OL)|Withdrawal by Subject|0
1820154|NCT00410410|6315559|P5|Open-Label Period (OL)|Withdrawal by Subject|0
1820155|NCT00410410|6315560|P4|Open-Label Period (OL)|Withdrawal by Subject|0
1820156|NCT00410410|6315561|P3|Open-Label Period (OL)|Withdrawal by Subject|0
1820157|NCT00410410|6315562|P2|Open-Label Period (OL)|Withdrawal by Subject|0
1820158|NCT00410410|6315563|P1|Open-Label Period (OL)|Withdrawal by Subject|0
1820159|NCT00410410|6315555|P9|Open-Label Period (OL)|Lost to Follow-up|4
1820160|NCT00410410|6315556|P8|Open-Label Period (OL)|Lost to Follow-up|0
1820161|NCT00410410|6315557|P7|Open-Label Period (OL)|Lost to Follow-up|0
1820162|NCT00410410|6315558|P6|Open-Label Period (OL)|Lost to Follow-up|0
1820163|NCT00410410|6315559|P5|Open-Label Period (OL)|Lost to Follow-up|0
1820164|NCT00410410|6315560|P4|Open-Label Period (OL)|Lost to Follow-up|0
1820166|NCT00410410|6315562|P2|Open-Label Period (OL)|Lost to Follow-up|0
1820167|NCT00410410|6315563|P1|Open-Label Period (OL)|Lost to Follow-up|0
1820168|NCT00410410|6315555|P9|Open-Label Period (OL)|Lack of Efficacy|161
1820169|NCT00410410|6315556|P8|Open-Label Period (OL)|Lack of Efficacy|0
1820170|NCT00410410|6315557|P7|Open-Label Period (OL)|Lack of Efficacy|0
1820171|NCT00410410|6315558|P6|Open-Label Period (OL)|Lack of Efficacy|0
1820172|NCT00410410|6315559|P5|Open-Label Period (OL)|Lack of Efficacy|0
1820173|NCT00410410|6315560|P4|Open-Label Period (OL)|Lack of Efficacy|0
1820174|NCT00410410|6315561|P3|Open-Label Period (OL)|Lack of Efficacy|0
1820175|NCT00410410|6315562|P2|Open-Label Period (OL)|Lack of Efficacy|0
1820176|NCT00410410|6315563|P1|Open-Label Period (OL)|Lack of Efficacy|0
1820177|NCT00410410|6315555|P9|Open-Label Period (OL)|Adverse Event|10
1820178|NCT00410410|6315556|P8|Open-Label Period (OL)|Adverse Event|0
1820179|NCT00410410|6315557|P7|Open-Label Period (OL)|Adverse Event|0
1820180|NCT00410410|6315558|P6|Open-Label Period (OL)|Adverse Event|0
1820181|NCT00410410|6315559|P5|Open-Label Period (OL)|Adverse Event|0
1820182|NCT00410410|6315560|P4|Open-Label Period (OL)|Adverse Event|0
1820183|NCT00410410|6315561|P3|Open-Label Period (OL)|Adverse Event|0
1820184|NCT00410410|6315562|P2|Open-Label Period (OL)|Adverse Event|0
1820185|NCT00410410|6315563|P1|Open-Label Period (OL)|Adverse Event|0
1820186|NCT00410410|6315555|P9|Open-Label Period (OL)|Death|1
1820187|NCT00410410|6315556|P8|Open-Label Period (OL)|Death|0
1820188|NCT00410410|6315557|P7|Open-Label Period (OL)|Death|0
1820189|NCT00410410|6315558|P6|Open-Label Period (OL)|Death|0
1820190|NCT00410410|6315559|P5|Open-Label Period (OL)|Death|0
1820191|NCT00410410|6315560|P4|Open-Label Period (OL)|Death|0
1820192|NCT00410410|6315561|P3|Open-Label Period (OL)|Death|0
1820193|NCT00410410|6315562|P2|Open-Label Period (OL)|Death|0
1820194|NCT00410410|6315563|P1|Open-Label Period (OL)|Death|0
1820195|NCT00410410|6315555|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1820196|NCT00410410|6315556|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
1820197|NCT00410410|6315557|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
1820198|NCT00410410|6315558|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1820199|NCT00410410|6315559|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1820200|NCT00410410|6315560|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1820201|NCT00410410|6315561|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1820202|NCT00410410|6315562|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1820203|NCT00410410|6315563|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
1820204|NCT00410410|6315555|P9|Maintenance Period (MP)|Withdrawal by Subject|0
1820205|NCT00410410|6315556|P8|Maintenance Period (MP)|Withdrawal by Subject|1
1820206|NCT00410410|6315557|P7|Maintenance Period (MP)|Withdrawal by Subject|1
1820207|NCT00410410|6315558|P6|Maintenance Period (MP)|Withdrawal by Subject|0
1820208|NCT00410410|6315559|P5|Maintenance Period (MP)|Withdrawal by Subject|0
1820209|NCT00410410|6315560|P4|Maintenance Period (MP)|Withdrawal by Subject|0
1820210|NCT00410410|6315561|P3|Maintenance Period (MP)|Withdrawal by Subject|0
1820211|NCT00410410|6315562|P2|Maintenance Period (MP)|Withdrawal by Subject|0
1820212|NCT00410410|6315563|P1|Maintenance Period (MP)|Withdrawal by Subject|0
1820213|NCT00410410|6315555|P9|Maintenance Period (MP)|Lost to Follow-up|0
1820214|NCT00410410|6315556|P8|Maintenance Period (MP)|Lost to Follow-up|2
1820215|NCT00410410|6315557|P7|Maintenance Period (MP)|Lost to Follow-up|1
1820216|NCT00410410|6315558|P6|Maintenance Period (MP)|Lost to Follow-up|0
1820217|NCT00410410|6315559|P5|Maintenance Period (MP)|Lost to Follow-up|0
1820218|NCT00410410|6315560|P4|Maintenance Period (MP)|Lost to Follow-up|0
1820219|NCT00410410|6315561|P3|Maintenance Period (MP)|Lost to Follow-up|0
1820220|NCT00410410|6315562|P2|Maintenance Period (MP)|Lost to Follow-up|0
1820221|NCT00410410|6315563|P1|Maintenance Period (MP)|Lost to Follow-up|0
1820222|NCT00410410|6315555|P9|Maintenance Period (MP)|Lack of Efficacy|0
1820223|NCT00410410|6315556|P8|Maintenance Period (MP)|Lack of Efficacy|24
1820224|NCT00410410|6315557|P7|Maintenance Period (MP)|Lack of Efficacy|25
1820225|NCT00410410|6315558|P6|Maintenance Period (MP)|Lack of Efficacy|0
1820226|NCT00410410|6315559|P5|Maintenance Period (MP)|Lack of Efficacy|0
1820227|NCT00410410|6315560|P4|Maintenance Period (MP)|Lack of Efficacy|0
1820228|NCT00410410|6315561|P3|Maintenance Period (MP)|Lack of Efficacy|0
1820229|NCT00410410|6315562|P2|Maintenance Period (MP)|Lack of Efficacy|0
1820230|NCT00410410|6315563|P1|Maintenance Period (MP)|Lack of Efficacy|0
1820231|NCT00410410|6315555|P9|Maintenance Period (MP)|Adverse Event|0
1820232|NCT00410410|6315556|P8|Maintenance Period (MP)|Adverse Event|3
1820233|NCT00410410|6315557|P7|Maintenance Period (MP)|Adverse Event|1
1820234|NCT00410410|6315558|P6|Maintenance Period (MP)|Adverse Event|0
1820235|NCT00410410|6315559|P5|Maintenance Period (MP)|Adverse Event|0
1820236|NCT00410410|6315560|P4|Maintenance Period (MP)|Adverse Event|0
1820237|NCT00410410|6315561|P3|Maintenance Period (MP)|Adverse Event|0
1820238|NCT00410410|6315562|P2|Maintenance Period (MP)|Adverse Event|0
1820239|NCT00410410|6315563|P1|Maintenance Period (MP)|Adverse Event|0
1820240|NCT00410410|6315555|P9|Maintenance Period (MP)|Death|0
1820241|NCT00410410|6315556|P8|Maintenance Period (MP)|Death|0
1820242|NCT00410410|6315557|P7|Maintenance Period (MP)|Death|1
1820243|NCT00410410|6315558|P6|Maintenance Period (MP)|Death|0
1820244|NCT00410410|6315559|P5|Maintenance Period (MP)|Death|0
1820245|NCT00410410|6315560|P4|Maintenance Period (MP)|Death|0
1820246|NCT00410410|6315561|P3|Maintenance Period (MP)|Death|0
1820247|NCT00410410|6315562|P2|Maintenance Period (MP)|Death|0
1820248|NCT00410410|6315563|P1|Maintenance Period (MP)|Death|0
1820249|NCT00410410|6315555|P9|Induction Period (IP)|Other|0
1820250|NCT00410410|6315556|P8|Induction Period (IP)|Other|0
1820251|NCT00410410|6315557|P7|Induction Period (IP)|Other|0
1820252|NCT00410410|6315558|P6|Induction Period (IP)|Other|0
1820253|NCT00410410|6315559|P5|Induction Period (IP)|Other|0
1820254|NCT00410410|6315560|P4|Induction Period (IP)|Other|0
1820255|NCT00410410|6315561|P3|Induction Period (IP)|Other|1
1820256|NCT00410410|6315562|P2|Induction Period (IP)|Other|0
1820257|NCT00410410|6315563|P1|Induction Period (IP)|Other|0
1820258|NCT00410410|6315555|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
1820259|NCT00410410|6315556|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
1820260|NCT00410410|6315557|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
1820261|NCT00410410|6315558|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
1820262|NCT00410410|6315559|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
1820263|NCT00410410|6315560|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
1820264|NCT00410410|6315561|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
1820265|NCT00410410|6315562|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
1820266|NCT00410410|6315563|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
1820267|NCT00410410|6315555|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820268|NCT00410410|6315556|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820269|NCT00410410|6315557|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820270|NCT00410410|6315558|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820271|NCT00410410|6315559|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820272|NCT00410410|6315560|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820273|NCT00410410|6315561|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
1820274|NCT00410410|6315562|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820275|NCT00410410|6315563|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
1820276|NCT00410410|6315555|P9|Induction Period (IP)|Withdrawal by Subject|0
1820277|NCT00410410|6315556|P8|Induction Period (IP)|Withdrawal by Subject|0
1820278|NCT00410410|6315557|P7|Induction Period (IP)|Withdrawal by Subject|0
1820279|NCT00410410|6315558|P6|Induction Period (IP)|Withdrawal by Subject|0
1820280|NCT00410410|6315559|P5|Induction Period (IP)|Withdrawal by Subject|2
1820281|NCT00410410|6315560|P4|Induction Period (IP)|Withdrawal by Subject|5
1820282|NCT00410410|6315561|P3|Induction Period (IP)|Withdrawal by Subject|3
1820283|NCT00410410|6315562|P2|Induction Period (IP)|Withdrawal by Subject|5
1820284|NCT00410410|6315563|P1|Induction Period (IP)|Withdrawal by Subject|3
1820285|NCT00410410|6315555|P9|Induction Period (IP)|Lost to Follow-up|0
1820286|NCT00410410|6315556|P8|Induction Period (IP)|Lost to Follow-up|0
1820287|NCT00410410|6315557|P7|Induction Period (IP)|Lost to Follow-up|0
1820288|NCT00410410|6315558|P6|Induction Period (IP)|Lost to Follow-up|1
1820289|NCT00410410|6315559|P5|Induction Period (IP)|Lost to Follow-up|0
1820290|NCT00410410|6315560|P4|Induction Period (IP)|Lost to Follow-up|3
1820291|NCT00410410|6315561|P3|Induction Period (IP)|Lost to Follow-up|2
1820292|NCT00410410|6315562|P2|Induction Period (IP)|Lost to Follow-up|2
1820293|NCT00410410|6315563|P1|Induction Period (IP)|Lost to Follow-up|2
1820294|NCT00410410|6315555|P9|Induction Period (IP)|Lack of Efficacy|0
1820295|NCT00410410|6315556|P8|Induction Period (IP)|Lack of Efficacy|0
1820296|NCT00410410|6315557|P7|Induction Period (IP)|Lack of Efficacy|0
1820297|NCT00410410|6315558|P6|Induction Period (IP)|Lack of Efficacy|7
1820298|NCT00410410|6315559|P5|Induction Period (IP)|Lack of Efficacy|7
1820299|NCT00410410|6315560|P4|Induction Period (IP)|Lack of Efficacy|8
1820300|NCT00410410|6315561|P3|Induction Period (IP)|Lack of Efficacy|8
1820301|NCT00410410|6315562|P2|Induction Period (IP)|Lack of Efficacy|24
1820302|NCT00410410|6315563|P1|Induction Period (IP)|Lack of Efficacy|26
1820303|NCT00410410|6315555|P9|Induction Period (IP)|Adverse Event|0
1820304|NCT00410410|6315556|P8|Induction Period (IP)|Adverse Event|0
1820305|NCT00410410|6315557|P7|Induction Period (IP)|Adverse Event|0
1820306|NCT00410410|6315558|P6|Induction Period (IP)|Adverse Event|0
1820307|NCT00410410|6315559|P5|Induction Period (IP)|Adverse Event|1
1820308|NCT00410410|6315560|P4|Induction Period (IP)|Adverse Event|4
1820309|NCT00410410|6315561|P3|Induction Period (IP)|Adverse Event|2
1820310|NCT00410410|6315562|P2|Induction Period (IP)|Adverse Event|4
1820311|NCT00410410|6315563|P1|Induction Period (IP)|Adverse Event|3
1820312|NCT00410410|6315555|P9|Induction Period (IP)|Death|0
1820313|NCT00410410|6315556|P8|Induction Period (IP)|Death|0
1820314|NCT00410410|6315557|P7|Induction Period (IP)|Death|0
1820315|NCT00410410|6315558|P6|Induction Period (IP)|Death|0
1820316|NCT00410410|6315559|P5|Induction Period (IP)|Death|0
1820317|NCT00410410|6315560|P4|Induction Period (IP)|Death|0
1820318|NCT00410410|6315561|P3|Induction Period (IP)|Death|0
1820319|NCT00410410|6315562|P2|Induction Period (IP)|Death|0
1820320|NCT00410410|6315563|P1|Induction Period (IP)|Death|1
1820321|NCT00410384|6315724|P3|Overall Study|Other|4
1820322|NCT00410384|6315725|P2|Overall Study|Other|8
1820323|NCT00410384|6315726|P1|Overall Study|Other|3
1820324|NCT00410384|6315724|P3|Overall Study|Physician Decision|4
1820325|NCT00410384|6315725|P2|Overall Study|Physician Decision|3
1820326|NCT00410384|6315726|P1|Overall Study|Physician Decision|3
1820327|NCT00410384|6315724|P3|Overall Study|Protocol Violation|6
1820328|NCT00410384|6315725|P2|Overall Study|Protocol Violation|6
1820329|NCT00410384|6315726|P1|Overall Study|Protocol Violation|6
1820330|NCT00410384|6315724|P3|Overall Study|Lost to Follow-up|6
1820331|NCT00410384|6315725|P2|Overall Study|Lost to Follow-up|6
1820332|NCT00410384|6315726|P1|Overall Study|Lost to Follow-up|4
1820333|NCT00410384|6315724|P3|Overall Study|Lack of Compliance|2
1820334|NCT00410384|6315725|P2|Overall Study|Lack of Compliance|2
1820335|NCT00410384|6315726|P1|Overall Study|Lack of Compliance|2
1820336|NCT00410384|6315724|P3|Overall Study|Lack of Efficacy|17
1820337|NCT00410384|6315725|P2|Overall Study|Lack of Efficacy|12
1820338|NCT00410384|6315726|P1|Overall Study|Lack of Efficacy|20
1820339|NCT00410384|6315724|P3|Overall Study|Adverse Event|23
1820340|NCT00410384|6315725|P2|Overall Study|Adverse Event|18
1820341|NCT00410384|6315726|P1|Overall Study|Adverse Event|23
1820342|NCT00410384|6315724|P3|Overall Study|Withdrawal by Subject|20
1820343|NCT00410384|6315725|P2|Overall Study|Withdrawal by Subject|17
1820344|NCT00410384|6315726|P1|Overall Study|Withdrawal by Subject|28
1820345|NCT00410202|6315799|P3|Off-treatment Follow up|Lost to Follow-up|0
1820346|NCT00410202|6315800|P2|Off-treatment Follow up|Lost to Follow-up|0
1820347|NCT00410202|6315801|P1|Off-treatment Follow up|Lost to Follow-up|1
1820348|NCT00410202|6315799|P3|Off-treatment Follow up|Follow up not required per protocol|1
1820349|NCT00410202|6315800|P2|Off-treatment Follow up|Follow up not required per protocol|0
1820350|NCT00410202|6315801|P1|Off-treatment Follow up|Follow up not required per protocol|3
1820351|NCT00410202|6315799|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
1820352|NCT00410202|6315800|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
1820353|NCT00410202|6315801|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
1820354|NCT00410202|6315799|P3|On-Treatment|Other Reason|1
1820355|NCT00410202|6315800|P2|On-Treatment|Other Reason|0
1820356|NCT00410202|6315801|P1|On-Treatment|Other Reason|0
1820357|NCT00410202|6315799|P3|On-Treatment|Withdrawal by Subject|1
1820358|NCT00410202|6315800|P2|On-Treatment|Withdrawal by Subject|1
1820359|NCT00410202|6315801|P1|On-Treatment|Withdrawal by Subject|2
1820360|NCT00410202|6315799|P3|On-Treatment|Lack of Efficacy|0
1820361|NCT00410202|6315800|P2|On-Treatment|Lack of Efficacy|4
1820362|NCT00410202|6315801|P1|On-Treatment|Lack of Efficacy|1
1820363|NCT00410202|6315799|P3|On-Treatment|Lost to Follow-up|1
1820364|NCT00410202|6315800|P2|On-Treatment|Lost to Follow-up|0
1820365|NCT00410202|6315801|P1|On-Treatment|Lost to Follow-up|1
1820366|NCT00410202|6315799|P3|On-Treatment|Death|0
1820367|NCT00410202|6315800|P2|On-Treatment|Death|0
1820368|NCT00410202|6315801|P1|On-Treatment|Death|1
1820369|NCT00410202|6315799|P3|On-Treatment|Adverse Event|2
1820370|NCT00410202|6315800|P2|On-Treatment|Adverse Event|3
1820371|NCT00410202|6315801|P1|On-Treatment|Adverse Event|1
1820372|NCT00410202|6315799|P3|On-Treatment|Continuing treatment|66
1820373|NCT00410202|6315800|P2|On-Treatment|Continuing treatment|71
1820374|NCT00410202|6315801|P1|On-Treatment|Continuing treatment|69
1820375|NCT00410163|6315888|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
1820376|NCT00410163|6315889|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
1820377|NCT00410163|6315888|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
1820378|NCT00410163|6315889|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
1820379|NCT00410163|6315888|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
1820380|NCT00410163|6315889|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
1820381|NCT00410163|6315888|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1820382|NCT00410163|6315889|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
1820383|NCT00410163|6315888|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
1820384|NCT00410163|6315889|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
1820385|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
1820386|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
1820387|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
1820388|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
1820389|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1820390|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
1820391|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
1820392|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
1820393|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
1820394|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
1820395|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
1820396|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
1820397|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
1820398|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
1820399|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Death|1
1820400|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Death|1
1820401|NCT00410163|6315888|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
1820402|NCT00410163|6315889|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
1820403|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
1820404|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
1820405|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
1820406|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
1820407|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
1820408|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
1820409|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Death|10
1820410|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Death|2
1820411|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1820412|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
1820413|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
1820414|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
1820415|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
1820416|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
1820417|NCT00410124|6315942|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
1820418|NCT00410124|6315943|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
1820419|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
1820420|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
1820421|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Death|4
1820422|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Death|7
1820423|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
1820424|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
1820425|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
1820426|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
1820427|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
1820428|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
1820429|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
1820430|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
1820431|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
1820432|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
1820433|NCT00410124|6315942|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
1820434|NCT00410124|6315943|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
1820435|NCT00410072|6315974|P2|After Week 48 to Week 96|Withdrawal by Subject|1
1820436|NCT00410072|6315975|P1|After Week 48 to Week 96|Withdrawal by Subject|0
1820437|NCT00410072|6315974|P2|After Week 48 to Week 96|Pregnancy|2
1820438|NCT00410072|6315975|P1|After Week 48 to Week 96|Pregnancy|0
1820439|NCT00410072|6315974|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
1820440|NCT00410072|6315975|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
1820441|NCT00410072|6315974|P2|After Week 48 to Week 96|Other|0
1820442|NCT00410072|6315975|P1|After Week 48 to Week 96|Other|2
1820443|NCT00410072|6315974|P2|After Week 48 to Week 96|Lost to Follow-up|4
1820444|NCT00410072|6315975|P1|After Week 48 to Week 96|Lost to Follow-up|2
1820445|NCT00410072|6315974|P2|After Week 48 to Week 96|Lack of Efficacy|0
1820446|NCT00410072|6315975|P1|After Week 48 to Week 96|Lack of Efficacy|1
1820447|NCT00410072|6315974|P2|After Week 48 to Week 96|Death|1
1820448|NCT00410072|6315975|P1|After Week 48 to Week 96|Death|0
1820449|NCT00410072|6315974|P2|After Week 48 to Week 96|Adverse Event|2
1820450|NCT00410072|6315975|P1|After Week 48 to Week 96|Adverse Event|1
1820451|NCT00410072|6315974|P2|Day 1 to Week 48|Withdrawal by Subject|2
1820452|NCT00410072|6315975|P1|Day 1 to Week 48|Withdrawal by Subject|0
1820453|NCT00410072|6315974|P2|Day 1 to Week 48|Pregnancy|2
1820454|NCT00410072|6315975|P1|Day 1 to Week 48|Pregnancy|0
1820455|NCT00410072|6315974|P2|Day 1 to Week 48|poor compliance/noncompliance|3
1820456|NCT00410072|6315975|P1|Day 1 to Week 48|poor compliance/noncompliance|0
1820457|NCT00410072|6315974|P2|Day 1 to Week 48|Other|1
1820458|NCT00410072|6315975|P1|Day 1 to Week 48|Other|0
1820459|NCT00410072|6315974|P2|Day 1 to Week 48|Lost to Follow-up|2
1820460|NCT00410072|6315975|P1|Day 1 to Week 48|Lost to Follow-up|5
1820461|NCT00410072|6315974|P2|Day 1 to Week 48|Adverse Event|2
1820462|NCT00410072|6315975|P1|Day 1 to Week 48|Adverse Event|1
1820463|NCT00410046|6316015|P1|Overall Study|Lost to Follow-up|1
1820464|NCT00410046|6316015|P1|Overall Study|Withdrawal by Subject|1
1820465|NCT00410046|6316015|P1|Overall Study|Adverse Event|3
1820466|NCT00409838|6316046|P2|Long-term Extension Period|Pregnancy|0
1820467|NCT00409838|6316047|P1|Long-term Extension Period|Pregnancy|1
1820468|NCT00409838|6316046|P2|Long-term Extension Period|Poor compliance/noncompliance|0
1820469|NCT00409838|6316047|P1|Long-term Extension Period|Poor compliance/noncompliance|1
1820470|NCT00409838|6316046|P2|Long-term Extension Period|Withdrawal by Subject|0
1820471|NCT00409838|6316047|P1|Long-term Extension Period|Withdrawal by Subject|3
1820472|NCT00409838|6316046|P2|Long-term Extension Period|Lack of Efficacy|0
1820473|NCT00409838|6316047|P1|Long-term Extension Period|Lack of Efficacy|2
1820474|NCT00409838|6316046|P2|Long-term Extension Period|Death|0
1820475|NCT00409838|6316047|P1|Long-term Extension Period|Death|1
1820476|NCT00409838|6316046|P2|Long-term Extension Period|Adverse Event|0
1820477|NCT00409838|6316047|P1|Long-term Extension Period|Adverse Event|10
1820478|NCT00409838|6316046|P2|Short-term Period|Never Treated|0
1820479|NCT00409838|6316047|P1|Short-term Period|Never Treated|1
1820480|NCT00409838|6316046|P2|Short-term Period|Withdrawal by Subject|3
1820481|NCT00409838|6316047|P1|Short-term Period|Withdrawal by Subject|2
1820482|NCT00409838|6316046|P2|Short-term Period|Lost to Follow-up|1
1820483|NCT00409838|6316047|P1|Short-term Period|Lost to Follow-up|0
1820484|NCT00409838|6316046|P2|Short-term Period|Adverse Event|1
1820485|NCT00409838|6316047|P1|Short-term Period|Adverse Event|0
1820486|NCT00409786|6316112|P1|Overall Study|Withdrawal by Subject|3
1820487|NCT00409773|6316121|P5|Overall Study|Lack of Eligibility|1
1820488|NCT00409773|6316122|P4|Overall Study|Lack of Eligibility|0
1820489|NCT00409773|6316123|P3|Overall Study|Lack of Eligibility|0
1820490|NCT00409773|6316124|P2|Overall Study|Lack of Eligibility|0
1820491|NCT00409773|6316125|P1|Overall Study|Lack of Eligibility|0
1820492|NCT00409773|6316121|P5|Overall Study|Withdrawal by Subject|1
1820493|NCT00409773|6316122|P4|Overall Study|Withdrawal by Subject|2
1820494|NCT00409773|6316123|P3|Overall Study|Withdrawal by Subject|0
1820495|NCT00409773|6316124|P2|Overall Study|Withdrawal by Subject|0
1820496|NCT00409773|6316125|P1|Overall Study|Withdrawal by Subject|0
1820497|NCT00409773|6316121|P5|Overall Study|Protocol Violation|1
1820498|NCT00409773|6316122|P4|Overall Study|Protocol Violation|3
1820499|NCT00409773|6316123|P3|Overall Study|Protocol Violation|3
1820500|NCT00409773|6316124|P2|Overall Study|Protocol Violation|2
1820501|NCT00409773|6316125|P1|Overall Study|Protocol Violation|0
1820502|NCT00409773|6316121|P5|Overall Study|Physician Decision|0
1820503|NCT00409773|6316122|P4|Overall Study|Physician Decision|2
1820504|NCT00409773|6316123|P3|Overall Study|Physician Decision|0
1820505|NCT00409773|6316124|P2|Overall Study|Physician Decision|0
1820506|NCT00409773|6316125|P1|Overall Study|Physician Decision|0
1820507|NCT00409773|6316121|P5|Overall Study|Lost to Follow-up|1
1820508|NCT00409773|6316122|P4|Overall Study|Lost to Follow-up|3
1820509|NCT00409773|6316123|P3|Overall Study|Lost to Follow-up|2
1820510|NCT00409773|6316124|P2|Overall Study|Lost to Follow-up|1
1820511|NCT00409773|6316125|P1|Overall Study|Lost to Follow-up|6
1820512|NCT00409773|6316121|P5|Overall Study|Adverse Event|6
1820513|NCT00409773|6316122|P4|Overall Study|Adverse Event|2
1820514|NCT00409773|6316123|P3|Overall Study|Adverse Event|4
1820515|NCT00409773|6316124|P2|Overall Study|Adverse Event|4
1820516|NCT00409773|6316125|P1|Overall Study|Adverse Event|3
1820517|NCT00409747|6316207|P1|Overall Study|Withdrawal by Subject|1
1820518|NCT00409708|6316214|P2|Washout|Lost to Follow-up|3
1820519|NCT00409708|6316215|P1|Washout|Lost to Follow-up|1
1820520|NCT00409708|6316214|P2|Washout|Withdrawal by Subject|5
1820521|NCT00409708|6316215|P1|Washout|Withdrawal by Subject|11
1820522|NCT00409708|6316214|P2|Washout|Protocol Violation|1
1820523|NCT00409708|6316215|P1|Washout|Protocol Violation|0
1820524|NCT00409708|6316214|P2|Washout|Lack of Efficacy|1
1820525|NCT00409708|6316215|P1|Washout|Lack of Efficacy|9
1820526|NCT00409708|6316214|P2|Treatment|Administrative problems|0
1820527|NCT00409708|6316215|P1|Treatment|Administrative problems|5
1820528|NCT00409708|6316214|P2|Treatment|Lost to Follow-up|6
1820529|NCT00409708|6316215|P1|Treatment|Lost to Follow-up|0
1820530|NCT00409708|6316214|P2|Treatment|Withdrawal by Subject|8
1820531|NCT00409708|6316215|P1|Treatment|Withdrawal by Subject|3
1820532|NCT00409708|6316214|P2|Treatment|Protocol Violation|2
1820533|NCT00409708|6316215|P1|Treatment|Protocol Violation|6
1820534|NCT00409708|6316214|P2|Treatment|Lack of Efficacy|1
1820535|NCT00409708|6316215|P1|Treatment|Lack of Efficacy|0
1820536|NCT00409708|6316214|P2|Treatment|Abnormal test procedure result(s)|0
1820537|NCT00409708|6316215|P1|Treatment|Abnormal test procedure result(s)|1
1820538|NCT00409682|6316236|P3|EOW Double-blind Maintenance Period|Non-compliance|1
1820539|NCT00409682|6316237|P2|EOW Double-blind Maintenance Period|Non-compliance|0
1820540|NCT00409682|6316238|P1|EOW Double-blind Maintenance Period|Non-compliance|0
1820541|NCT00409682|6316236|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
1820542|NCT00409682|6316237|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
1820543|NCT00409682|6316238|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
1820544|NCT00409682|6316236|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
1820545|NCT00409682|6316237|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
1820546|NCT00409682|6316238|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
1820547|NCT00409682|6316236|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1820548|NCT00409682|6316237|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
1820549|NCT00409682|6316238|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
1820550|NCT00409682|6316236|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
1820551|NCT00409682|6316237|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
1820552|NCT00409682|6316238|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
1820553|NCT00409682|6316236|P3|EOW Double-blind Maintenance Period|Adverse Event|12
1820554|NCT00409682|6316237|P2|EOW Double-blind Maintenance Period|Adverse Event|10
1820555|NCT00409682|6316238|P1|EOW Double-blind Maintenance Period|Adverse Event|0
1820556|NCT00409682|6316236|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
1820557|NCT00409682|6316237|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
1820558|NCT00409682|6316238|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
1820559|NCT00409682|6316236|P3|Open-label Induction Period|Protocol Violation|0
1820560|NCT00409682|6316237|P2|Open-label Induction Period|Protocol Violation|0
1820561|NCT00409682|6316238|P1|Open-label Induction Period|Protocol Violation|1
1820562|NCT00409682|6316236|P3|Open-label Induction Period|Lack of Efficacy|0
1820563|NCT00409682|6316237|P2|Open-label Induction Period|Lack of Efficacy|0
1820564|NCT00409682|6316238|P1|Open-label Induction Period|Lack of Efficacy|1
1820565|NCT00409682|6316236|P3|Open-label Induction Period|Adverse Event|0
1820566|NCT00409682|6316237|P2|Open-label Induction Period|Adverse Event|0
1820567|NCT00409682|6316238|P1|Open-label Induction Period|Adverse Event|1
1820568|NCT00409617|6316255|P1|Overall Study|Not described|14
1820569|NCT00409617|6316255|P1|Overall Study|Administrative reasons|1
1820570|NCT00409617|6316255|P1|Overall Study|Withdrawal by Subject|8
1820571|NCT00409617|6316255|P1|Overall Study|Protocol Violation|24
1820572|NCT00409617|6316255|P1|Overall Study|Lost to Follow-up|2
1820573|NCT00409617|6316255|P1|Overall Study|Lack of Efficacy|54
1820574|NCT00409617|6316255|P1|Overall Study|Adverse Event|57
1820575|NCT00409578|6316271|P4|Overall Study|Missing|1
1820576|NCT00409578|6316272|P3|Overall Study|Missing|0
1820577|NCT00409578|6316273|P2|Overall Study|Missing|1
1820578|NCT00409578|6316274|P1|Overall Study|Missing|0
1820579|NCT00409578|6316271|P4|Overall Study|Protocol Violation|1
1820580|NCT00409578|6316272|P3|Overall Study|Protocol Violation|3
1820581|NCT00409578|6316273|P2|Overall Study|Protocol Violation|2
1820582|NCT00409578|6316274|P1|Overall Study|Protocol Violation|3
1820583|NCT00409578|6316271|P4|Overall Study|Death|2
1820584|NCT00409578|6316272|P3|Overall Study|Death|4
1820585|NCT00409578|6316273|P2|Overall Study|Death|4
1820586|NCT00409578|6316274|P1|Overall Study|Death|2
1820587|NCT00409578|6316271|P4|Overall Study|Administrative problems|4
1820588|NCT00409578|6316272|P3|Overall Study|Administrative problems|2
1820589|NCT00409578|6316273|P2|Overall Study|Administrative problems|9
1820590|NCT00409578|6316274|P1|Overall Study|Administrative problems|8
1820591|NCT00409578|6316271|P4|Overall Study|Lost to Follow-up|2
1820592|NCT00409578|6316272|P3|Overall Study|Lost to Follow-up|2
1820593|NCT00409578|6316273|P2|Overall Study|Lost to Follow-up|0
1820594|NCT00409578|6316274|P1|Overall Study|Lost to Follow-up|2
1820595|NCT00409578|6316271|P4|Overall Study|Withdrawal by Subject|17
1820596|NCT00409578|6316272|P3|Overall Study|Withdrawal by Subject|16
1820597|NCT00409578|6316273|P2|Overall Study|Withdrawal by Subject|15
1820598|NCT00409578|6316274|P1|Overall Study|Withdrawal by Subject|8
1820599|NCT00409578|6316271|P4|Overall Study|Subject no longer requires study drug|1
1820600|NCT00409578|6316272|P3|Overall Study|Subject no longer requires study drug|0
1820601|NCT00409578|6316273|P2|Overall Study|Subject no longer requires study drug|0
1820602|NCT00409578|6316274|P1|Overall Study|Subject no longer requires study drug|0
1820603|NCT00409578|6316271|P4|Overall Study|Lack of Efficacy|2
1820604|NCT00409578|6316272|P3|Overall Study|Lack of Efficacy|0
1820605|NCT00409578|6316273|P2|Overall Study|Lack of Efficacy|0
1820606|NCT00409578|6316274|P1|Overall Study|Lack of Efficacy|0
1820607|NCT00409578|6316271|P4|Overall Study|Abnormal laboratory value(s)|4
1820608|NCT00409578|6316272|P3|Overall Study|Abnormal laboratory value(s)|2
1820609|NCT00409578|6316273|P2|Overall Study|Abnormal laboratory value(s)|2
1820610|NCT00409578|6316274|P1|Overall Study|Abnormal laboratory value(s)|2
1820611|NCT00409578|6316271|P4|Overall Study|Adverse Event|33
1820612|NCT00409578|6316272|P3|Overall Study|Adverse Event|25
1820613|NCT00409578|6316273|P2|Overall Study|Adverse Event|37
1820614|NCT00409578|6316274|P1|Overall Study|Adverse Event|27
1820615|NCT00409409|6316332|P2|Overall Study|Any other reason not above-mentioned|1
1820616|NCT00409409|6316333|P1|Overall Study|Any other reason not above-mentioned|0
1820617|NCT00409409|6316332|P2|Overall Study|Withdrawal by Subject|1
1820618|NCT00409409|6316333|P1|Overall Study|Withdrawal by Subject|1
1820619|NCT00409409|6316332|P2|Overall Study|Adverse Event|2
1820620|NCT00409409|6316333|P1|Overall Study|Adverse Event|7
1820621|NCT00409344|6316341|P2|Overall Study|no enrollment|0
1820622|NCT00409344|6316342|P1|Overall Study|no enrollment|0
1820623|NCT00409331|6316360|P1|Overall Study|Physician Decision|1
1820624|NCT00409188|6316382|P2|Overall Study|Ongoing at data cut-off|175
1820625|NCT00409188|6316383|P1|Overall Study|Ongoing at data cut-off|383
1820626|NCT00409175|6316399|P2|Overall Study|Liver transplantation|13
1820627|NCT00409175|6316400|P1|Overall Study|Liver transplantation|13
1820628|NCT00409175|6316399|P2|Overall Study|Negative genotype|1
1820629|NCT00409175|6316400|P1|Overall Study|Negative genotype|0
1820630|NCT00409175|6316399|P2|Overall Study|Withdrawal by Subject|2
1820631|NCT00409175|6316400|P1|Overall Study|Withdrawal by Subject|1
1820632|NCT00409175|6316399|P2|Overall Study|Adverse Event|3
1820633|NCT00409175|6316400|P1|Overall Study|Adverse Event|4
1820634|NCT00409006|6316426|P2|Overall Study|Physician Decision|2
1820635|NCT00409006|6316427|P1|Overall Study|Physician Decision|1
1820636|NCT00409006|6316426|P2|Overall Study|Withdrawal by Subject|2
1820637|NCT00409006|6316427|P1|Overall Study|Withdrawal by Subject|3
1820638|NCT00409006|6316426|P2|Overall Study|Lost to Follow-up|2
1820639|NCT00409006|6316427|P1|Overall Study|Lost to Follow-up|1
1820640|NCT00409006|6316426|P2|Overall Study|Death|6
1820641|NCT00409006|6316427|P1|Overall Study|Death|15
1820642|NCT00408993|6316443|P2|Overall Study|Withdrawal by Subject|3
1820643|NCT00408993|6316444|P1|Overall Study|Withdrawal by Subject|2
1820644|NCT00408993|6316443|P2|Overall Study|Lack of Efficacy|4
1820645|NCT00408993|6316444|P1|Overall Study|Lack of Efficacy|1
1820646|NCT00408993|6316443|P2|Overall Study|Protocol Violation|6
1820647|NCT00408993|6316444|P1|Overall Study|Protocol Violation|1
1820648|NCT00408993|6316443|P2|Overall Study|Adverse Event|4
1820649|NCT00408993|6316444|P1|Overall Study|Adverse Event|15
1820650|NCT00408928|6316476|P1|Overall Study|Infection indistinguishable from GVHD|1
1820651|NCT00408928|6316476|P1|Overall Study|Death|1
1820652|NCT00408928|6316476|P1|Overall Study|Withdrawal by Subject|1
1820653|NCT00408902|6316481|P1|Overall Study|Adverse Event|3
1820654|NCT00408902|6316481|P1|Overall Study|Lack of Efficacy|7
1820655|NCT00408876|6316491|P4|Overall Study|Physician Decision|0
1820656|NCT00408876|6316492|P3|Overall Study|Physician Decision|3
1820657|NCT00408876|6316493|P2|Overall Study|Physician Decision|0
1820658|NCT00408876|6316494|P1|Overall Study|Physician Decision|1
1820659|NCT00408876|6316491|P4|Overall Study|Protocol Violation|3
1820660|NCT00408876|6316492|P3|Overall Study|Protocol Violation|4
1820661|NCT00408876|6316493|P2|Overall Study|Protocol Violation|3
1820662|NCT00408876|6316494|P1|Overall Study|Protocol Violation|0
1820663|NCT00408876|6316491|P4|Overall Study|Lost to Follow-up|2
1820664|NCT00408876|6316492|P3|Overall Study|Lost to Follow-up|5
1820665|NCT00408876|6316493|P2|Overall Study|Lost to Follow-up|6
1820666|NCT00408876|6316494|P1|Overall Study|Lost to Follow-up|1
1820667|NCT00408876|6316491|P4|Overall Study|Lack of Efficacy|6
1820668|NCT00408876|6316492|P3|Overall Study|Lack of Efficacy|5
1820669|NCT00408876|6316493|P2|Overall Study|Lack of Efficacy|4
1820670|NCT00408876|6316494|P1|Overall Study|Lack of Efficacy|2
1820671|NCT00408876|6316491|P4|Overall Study|Withdrawal by Subject|14
1820672|NCT00408876|6316492|P3|Overall Study|Withdrawal by Subject|6
1820673|NCT00408876|6316493|P2|Overall Study|Withdrawal by Subject|6
1820674|NCT00408876|6316494|P1|Overall Study|Withdrawal by Subject|3
1820675|NCT00408876|6316491|P4|Overall Study|Adverse Event|10
1820676|NCT00408876|6316492|P3|Overall Study|Adverse Event|27
1820677|NCT00408876|6316493|P2|Overall Study|Adverse Event|17
1820678|NCT00408876|6316494|P1|Overall Study|Adverse Event|9
1820679|NCT00408694|6316744|P1|Overall Study|No protocol treatment|1
1820680|NCT00408694|6316744|P1|Overall Study|Ineligible|1
1820681|NCT00408681|6316756|P1|Overall Study|Adverse Event|7
1820682|NCT00408681|6316756|P1|Overall Study|Lack of Efficacy|2
1820683|NCT00408629|6316775|P2|Overall Study|Miscellaneous|15
1820684|NCT00408629|6316776|P1|Overall Study|Miscellaneous|11
1820685|NCT00408629|6316775|P2|Overall Study|Protocol Violation|5
1820686|NCT00408629|6316776|P1|Overall Study|Protocol Violation|1
1820687|NCT00408629|6316775|P2|Overall Study|Lack of Efficacy|73
1820688|NCT00408629|6316776|P1|Overall Study|Lack of Efficacy|63
1820689|NCT00408629|6316775|P2|Overall Study|Lost to Follow-up|1
1820690|NCT00408629|6316776|P1|Overall Study|Lost to Follow-up|1
1820691|NCT00408629|6316775|P2|Overall Study|Withdrawal by Subject|4
1820692|NCT00408629|6316776|P1|Overall Study|Withdrawal by Subject|8
1820693|NCT00408629|6316775|P2|Overall Study|Adverse Event|27
1820694|NCT00408629|6316776|P1|Overall Study|Adverse Event|13
1820695|NCT00408499|6316872|P5|Phase II- MTD Expansion|treatment delay|3
1820696|NCT00408499|6316873|P4|Phase II- MTD Expansion|treatment delay|0
1820697|NCT00408499|6316874|P3|Phase II- MTD Expansion|treatment delay|0
1820698|NCT00408499|6316875|P2|Phase II- MTD Expansion|treatment delay|0
1820699|NCT00408499|6316876|P1|Phase II- MTD Expansion|treatment delay|0
1820700|NCT00408499|6316872|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
1820701|NCT00408499|6316873|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
1820702|NCT00408499|6316874|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
1820703|NCT00408499|6316875|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
1820704|NCT00408499|6316876|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
1820705|NCT00408499|6316872|P5|Phase II- MTD Expansion|Physician Decision|1
1820706|NCT00408499|6316873|P4|Phase II- MTD Expansion|Physician Decision|0
1820707|NCT00408499|6316874|P3|Phase II- MTD Expansion|Physician Decision|0
1820708|NCT00408499|6316875|P2|Phase II- MTD Expansion|Physician Decision|0
1820709|NCT00408499|6316876|P1|Phase II- MTD Expansion|Physician Decision|0
1820710|NCT00408499|6316872|P5|Phase II- MTD Expansion|Death|2
1820711|NCT00408499|6316873|P4|Phase II- MTD Expansion|Death|0
1820712|NCT00408499|6316874|P3|Phase II- MTD Expansion|Death|0
1820713|NCT00408499|6316875|P2|Phase II- MTD Expansion|Death|0
1820714|NCT00408499|6316876|P1|Phase II- MTD Expansion|Death|0
1820715|NCT00408499|6316872|P5|Phase II- MTD Expansion|Adverse Event|9
1820716|NCT00408499|6316873|P4|Phase II- MTD Expansion|Adverse Event|0
1820717|NCT00408499|6316874|P3|Phase II- MTD Expansion|Adverse Event|0
1820718|NCT00408499|6316875|P2|Phase II- MTD Expansion|Adverse Event|0
1820719|NCT00408499|6316876|P1|Phase II- MTD Expansion|Adverse Event|0
1820720|NCT00408499|6316872|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
1820721|NCT00408499|6316873|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
1820722|NCT00408499|6316874|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
1820723|NCT00408499|6316875|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
1820724|NCT00408499|6316876|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
1820725|NCT00408499|6316872|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1820726|NCT00408499|6316873|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1820727|NCT00408499|6316874|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
1820728|NCT00408499|6316875|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1820729|NCT00408499|6316876|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
1820730|NCT00408499|6316872|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
1820731|NCT00408499|6316873|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
1820732|NCT00408499|6316874|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
1820733|NCT00408499|6316875|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
1820734|NCT00408499|6316876|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
1820735|NCT00408421|6316893|P3|Treatment Re-Randomization|Withdrawal by Subject|0
1820736|NCT00408421|6316894|P2|Treatment Re-Randomization|Withdrawal by Subject|1
1820737|NCT00408421|6316895|P1|Treatment Re-Randomization|Withdrawal by Subject|2
1820738|NCT00408421|6316893|P3|Treatment Re-Randomization|Protocol Violation|0
1820739|NCT00408421|6316894|P2|Treatment Re-Randomization|Protocol Violation|1
1820740|NCT00408421|6316895|P1|Treatment Re-Randomization|Protocol Violation|1
1820741|NCT00408421|6316893|P3|Treatment Re-Randomization|Physician Decision|0
1820742|NCT00408421|6316894|P2|Treatment Re-Randomization|Physician Decision|3
1820743|NCT00408421|6316895|P1|Treatment Re-Randomization|Physician Decision|1
1820744|NCT00408421|6316893|P3|Treatment Re-Randomization|Lost to Follow-up|1
1820745|NCT00408421|6316894|P2|Treatment Re-Randomization|Lost to Follow-up|0
1820746|NCT00408421|6316895|P1|Treatment Re-Randomization|Lost to Follow-up|0
1820747|NCT00408421|6316893|P3|Treatment Re-Randomization|Lack of Efficacy|0
1820748|NCT00408421|6316894|P2|Treatment Re-Randomization|Lack of Efficacy|0
1820749|NCT00408421|6316895|P1|Treatment Re-Randomization|Lack of Efficacy|1
1820750|NCT00408421|6316893|P3|Treatment Re-Randomization|Adverse Event|4
1820751|NCT00408421|6316894|P2|Treatment Re-Randomization|Adverse Event|2
1820752|NCT00408421|6316895|P1|Treatment Re-Randomization|Adverse Event|2
1820753|NCT00408421|6316893|P3|Treatment Initial Randomization|Sponsor Decision|0
1820754|NCT00408421|6316894|P2|Treatment Initial Randomization|Sponsor Decision|0
1820755|NCT00408421|6316895|P1|Treatment Initial Randomization|Sponsor Decision|1
1820756|NCT00408421|6316893|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
1820757|NCT00408421|6316894|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
1820758|NCT00408421|6316895|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
1820759|NCT00408421|6316893|P3|Treatment Initial Randomization|Withdrawal by Subject|0
1820760|NCT00408421|6316894|P2|Treatment Initial Randomization|Withdrawal by Subject|7
1820761|NCT00408421|6316895|P1|Treatment Initial Randomization|Withdrawal by Subject|7
1820762|NCT00408421|6316893|P3|Treatment Initial Randomization|Protocol Violation|0
1820763|NCT00408421|6316894|P2|Treatment Initial Randomization|Protocol Violation|1
1820764|NCT00408421|6316895|P1|Treatment Initial Randomization|Protocol Violation|0
1820765|NCT00408421|6316893|P3|Treatment Initial Randomization|Physician Decision|0
1820766|NCT00408421|6316894|P2|Treatment Initial Randomization|Physician Decision|0
1820767|NCT00408421|6316895|P1|Treatment Initial Randomization|Physician Decision|1
1820768|NCT00408421|6316893|P3|Treatment Initial Randomization|Lost to Follow-up|0
1820769|NCT00408421|6316894|P2|Treatment Initial Randomization|Lost to Follow-up|3
1820770|NCT00408421|6316895|P1|Treatment Initial Randomization|Lost to Follow-up|0
1820771|NCT00408421|6316893|P3|Treatment Initial Randomization|Lack of Efficacy|0
1820772|NCT00408421|6316894|P2|Treatment Initial Randomization|Lack of Efficacy|2
1820773|NCT00408421|6316895|P1|Treatment Initial Randomization|Lack of Efficacy|2
1820774|NCT00408421|6316893|P3|Treatment Initial Randomization|Adverse Event|0
1820775|NCT00408421|6316894|P2|Treatment Initial Randomization|Adverse Event|9
1820776|NCT00408421|6316895|P1|Treatment Initial Randomization|Adverse Event|5
1820777|NCT00408408|6316975|P6|Overall Study|No follow up data|3
1820778|NCT00408408|6316976|P5|Overall Study|No follow up data|5
1820779|NCT00408408|6316977|P4|Overall Study|No follow up data|7
1820780|NCT00408408|6316978|P3|Overall Study|No follow up data|0
1820781|NCT00408408|6316979|P2|Overall Study|No follow up data|3
1820782|NCT00408408|6316980|P1|Overall Study|No follow up data|2
1820783|NCT00408317|6317042|P2|Second Intervention Period|Withdrawal of consent|1
1820784|NCT00408317|6317043|P1|Second Intervention Period|Withdrawal of consent|0
1820785|NCT00408317|6317042|P2|Second Intervention Period|Protocol Violation|1
1820786|NCT00408317|6317043|P1|Second Intervention Period|Protocol Violation|0
1820787|NCT00408317|6317042|P2|Second Intervention Period|Adverse Event|0
1820788|NCT00408317|6317043|P1|Second Intervention Period|Adverse Event|2
1820789|NCT00408317|6317042|P2|First Intervention Period|Adverse Event|1
1820790|NCT00408317|6317043|P1|First Intervention Period|Adverse Event|0
1820791|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
1820792|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
1820793|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
1820794|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
1820795|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
1820796|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
1820797|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
1820798|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
1820799|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
1820800|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
1820801|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
1820802|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
1820803|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
1820804|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
1820805|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
1820806|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
1820807|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
1820808|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
1820809|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
1820810|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
1820811|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
1820812|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
1820813|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
1821049|NCT00407537|6317265|P2|Overall Study|Withdrawal by Subject|16
1820814|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
1820815|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
1820816|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
1820817|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
1820818|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
1820819|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
1820820|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
1820821|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
1820822|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
1820823|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
1820824|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
1820825|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
1820826|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
1820827|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
1820828|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
1820829|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
1820830|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
1820831|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
1820832|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
1820833|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
1820834|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
1820835|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
1820836|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
1820837|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
1820838|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
1820839|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
1820840|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
1820841|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
1820842|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
1820843|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
1820844|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
1820845|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
1820846|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
1820847|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
1820848|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
1820849|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
1820850|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
1820851|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
1820852|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
1820853|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
1820854|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
1820855|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
1820856|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
1820857|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
1820858|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
1820859|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
1820860|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
1820861|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
1820862|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
1820863|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
1820864|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
1820865|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
1820866|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
1820867|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
1820868|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
1820869|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
1820870|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
1820871|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
1820872|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
1820873|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
1820874|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
1820875|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
1820876|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
1820877|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
1820878|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
1820879|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
1820880|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
1820881|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
1820882|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
1820883|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
1820884|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
1820885|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
1820886|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
1820887|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Death|1
1820888|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Death|3
1820889|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Death|5
1820890|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Death|5
1820891|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Death|0
1820892|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Death|3
1820893|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Death|0
1820894|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Death|0
1820895|NCT00408005|6317076|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
1820896|NCT00408005|6317077|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
1820897|NCT00408005|6317078|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
1820898|NCT00408005|6317079|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
1820899|NCT00408005|6317080|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
1820900|NCT00408005|6317081|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
1820901|NCT00408005|6317082|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
1820902|NCT00408005|6317083|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
1820903|NCT00408005|6317076|P8|Induction|Recurrent leukemia|0
1820904|NCT00408005|6317077|P7|Induction|Recurrent leukemia|0
1820905|NCT00408005|6317078|P6|Induction|Recurrent leukemia|0
1820906|NCT00408005|6317079|P5|Induction|Recurrent leukemia|0
1820907|NCT00408005|6317080|P4|Induction|Recurrent leukemia|0
1820908|NCT00408005|6317081|P3|Induction|Recurrent leukemia|0
1820909|NCT00408005|6317082|P2|Induction|Recurrent leukemia|0
1820910|NCT00408005|6317083|P1|Induction|Recurrent leukemia|1
1820911|NCT00408005|6317076|P8|Induction|Hematopoietic Stem Cell Transplantation|0
1820912|NCT00408005|6317077|P7|Induction|Hematopoietic Stem Cell Transplantation|0
1820913|NCT00408005|6317078|P6|Induction|Hematopoietic Stem Cell Transplantation|0
1820914|NCT00408005|6317079|P5|Induction|Hematopoietic Stem Cell Transplantation|0
1820915|NCT00408005|6317080|P4|Induction|Hematopoietic Stem Cell Transplantation|0
1820916|NCT00408005|6317081|P3|Induction|Hematopoietic Stem Cell Transplantation|0
1820917|NCT00408005|6317082|P2|Induction|Hematopoietic Stem Cell Transplantation|0
1820918|NCT00408005|6317083|P1|Induction|Hematopoietic Stem Cell Transplantation|1
1820919|NCT00408005|6317076|P8|Induction|Protocol Deviation|0
1820920|NCT00408005|6317077|P7|Induction|Protocol Deviation|0
1820921|NCT00408005|6317078|P6|Induction|Protocol Deviation|0
1820922|NCT00408005|6317079|P5|Induction|Protocol Deviation|0
1820923|NCT00408005|6317080|P4|Induction|Protocol Deviation|0
1820924|NCT00408005|6317081|P3|Induction|Protocol Deviation|0
1820925|NCT00408005|6317082|P2|Induction|Protocol Deviation|1
1820926|NCT00408005|6317083|P1|Induction|Protocol Deviation|3
1820927|NCT00408005|6317076|P8|Induction|Failed to Complete Randomization|0
1820928|NCT00408005|6317077|P7|Induction|Failed to Complete Randomization|0
1820929|NCT00408005|6317078|P6|Induction|Failed to Complete Randomization|0
1820930|NCT00408005|6317079|P5|Induction|Failed to Complete Randomization|0
1820931|NCT00408005|6317080|P4|Induction|Failed to Complete Randomization|0
1820932|NCT00408005|6317081|P3|Induction|Failed to Complete Randomization|0
1820933|NCT00408005|6317082|P2|Induction|Failed to Complete Randomization|2
1820934|NCT00408005|6317083|P1|Induction|Failed to Complete Randomization|3
1820935|NCT00408005|6317076|P8|Induction|Inevaluable|0
1820936|NCT00408005|6317077|P7|Induction|Inevaluable|0
1820937|NCT00408005|6317078|P6|Induction|Inevaluable|0
1820938|NCT00408005|6317079|P5|Induction|Inevaluable|0
1820939|NCT00408005|6317080|P4|Induction|Inevaluable|0
1820940|NCT00408005|6317081|P3|Induction|Inevaluable|0
1820941|NCT00408005|6317082|P2|Induction|Inevaluable|14
1820942|NCT00408005|6317083|P1|Induction|Inevaluable|18
1820943|NCT00408005|6317076|P8|Induction|Progressive Disease|0
1820944|NCT00408005|6317077|P7|Induction|Progressive Disease|0
1820945|NCT00408005|6317078|P6|Induction|Progressive Disease|0
1820946|NCT00408005|6317079|P5|Induction|Progressive Disease|0
1820947|NCT00408005|6317080|P4|Induction|Progressive Disease|0
1820948|NCT00408005|6317081|P3|Induction|Progressive Disease|0
1820949|NCT00408005|6317082|P2|Induction|Progressive Disease|1
1820950|NCT00408005|6317083|P1|Induction|Progressive Disease|0
1820951|NCT00408005|6317076|P8|Induction|Identified as Philadelphia Chr. Positive|0
1820952|NCT00408005|6317077|P7|Induction|Identified as Philadelphia Chr. Positive|0
1820953|NCT00408005|6317078|P6|Induction|Identified as Philadelphia Chr. Positive|0
1820954|NCT00408005|6317079|P5|Induction|Identified as Philadelphia Chr. Positive|0
1820955|NCT00408005|6317080|P4|Induction|Identified as Philadelphia Chr. Positive|0
1820956|NCT00408005|6317081|P3|Induction|Identified as Philadelphia Chr. Positive|0
1820957|NCT00408005|6317082|P2|Induction|Identified as Philadelphia Chr. Positive|0
1820958|NCT00408005|6317083|P1|Induction|Identified as Philadelphia Chr. Positive|6
1820959|NCT00408005|6317076|P8|Induction|Patient transferred Tx to Non-COG Site|0
1820960|NCT00408005|6317077|P7|Induction|Patient transferred Tx to Non-COG Site|0
1820961|NCT00408005|6317078|P6|Induction|Patient transferred Tx to Non-COG Site|0
1820962|NCT00408005|6317079|P5|Induction|Patient transferred Tx to Non-COG Site|0
1820963|NCT00408005|6317080|P4|Induction|Patient transferred Tx to Non-COG Site|0
1820964|NCT00408005|6317081|P3|Induction|Patient transferred Tx to Non-COG Site|0
1820965|NCT00408005|6317082|P2|Induction|Patient transferred Tx to Non-COG Site|2
1820966|NCT00408005|6317083|P1|Induction|Patient transferred Tx to Non-COG Site|3
1820967|NCT00408005|6317076|P8|Induction|Entered another COG therapeutic protocol|0
1820968|NCT00408005|6317077|P7|Induction|Entered another COG therapeutic protocol|0
1820969|NCT00408005|6317078|P6|Induction|Entered another COG therapeutic protocol|0
1820970|NCT00408005|6317079|P5|Induction|Entered another COG therapeutic protocol|0
1820971|NCT00408005|6317080|P4|Induction|Entered another COG therapeutic protocol|0
1820972|NCT00408005|6317081|P3|Induction|Entered another COG therapeutic protocol|0
1820973|NCT00408005|6317082|P2|Induction|Entered another COG therapeutic protocol|0
1820974|NCT00408005|6317083|P1|Induction|Entered another COG therapeutic protocol|4
1820975|NCT00408005|6317076|P8|Induction|Refusal of Further Protocol Therapy|0
1820976|NCT00408005|6317077|P7|Induction|Refusal of Further Protocol Therapy|0
1820977|NCT00408005|6317078|P6|Induction|Refusal of Further Protocol Therapy|0
1820978|NCT00408005|6317079|P5|Induction|Refusal of Further Protocol Therapy|0
1820979|NCT00408005|6317080|P4|Induction|Refusal of Further Protocol Therapy|0
1820980|NCT00408005|6317081|P3|Induction|Refusal of Further Protocol Therapy|0
1820981|NCT00408005|6317082|P2|Induction|Refusal of Further Protocol Therapy|44
1820982|NCT00408005|6317083|P1|Induction|Refusal of Further Protocol Therapy|225
1820983|NCT00408005|6317076|P8|Induction|Ineligible|0
1820984|NCT00408005|6317077|P7|Induction|Ineligible|0
1820985|NCT00408005|6317078|P6|Induction|Ineligible|0
1820986|NCT00408005|6317079|P5|Induction|Ineligible|0
1820987|NCT00408005|6317080|P4|Induction|Ineligible|0
1820988|NCT00408005|6317081|P3|Induction|Ineligible|0
1820989|NCT00408005|6317082|P2|Induction|Ineligible|14
1820990|NCT00408005|6317083|P1|Induction|Ineligible|33
1820991|NCT00408005|6317076|P8|Induction|Withdrawal by Subject|0
1820992|NCT00408005|6317077|P7|Induction|Withdrawal by Subject|0
1820993|NCT00408005|6317078|P6|Induction|Withdrawal by Subject|0
1820994|NCT00408005|6317079|P5|Induction|Withdrawal by Subject|0
1820995|NCT00408005|6317080|P4|Induction|Withdrawal by Subject|0
1820996|NCT00408005|6317081|P3|Induction|Withdrawal by Subject|0
1820997|NCT00408005|6317082|P2|Induction|Withdrawal by Subject|4
1820998|NCT00408005|6317083|P1|Induction|Withdrawal by Subject|2
1820999|NCT00408005|6317076|P8|Induction|Physician Decision|0
1821000|NCT00408005|6317077|P7|Induction|Physician Decision|0
1821001|NCT00408005|6317078|P6|Induction|Physician Decision|0
1821002|NCT00408005|6317079|P5|Induction|Physician Decision|0
1821003|NCT00408005|6317080|P4|Induction|Physician Decision|0
1821004|NCT00408005|6317081|P3|Induction|Physician Decision|0
1821005|NCT00408005|6317082|P2|Induction|Physician Decision|9
1821006|NCT00408005|6317083|P1|Induction|Physician Decision|83
1821007|NCT00408005|6317076|P8|Induction|Death|0
1821008|NCT00408005|6317077|P7|Induction|Death|0
1821009|NCT00408005|6317078|P6|Induction|Death|0
1821010|NCT00408005|6317079|P5|Induction|Death|0
1821011|NCT00408005|6317080|P4|Induction|Death|0
1821012|NCT00408005|6317081|P3|Induction|Death|0
1821013|NCT00408005|6317082|P2|Induction|Death|0
1821014|NCT00408005|6317083|P1|Induction|Death|6
1821015|NCT00408005|6317076|P8|Induction|Adverse Event|0
1821016|NCT00408005|6317077|P7|Induction|Adverse Event|0
1821017|NCT00408005|6317078|P6|Induction|Adverse Event|0
1821018|NCT00408005|6317079|P5|Induction|Adverse Event|0
1821019|NCT00408005|6317080|P4|Induction|Adverse Event|0
1821020|NCT00408005|6317081|P3|Induction|Adverse Event|0
1821021|NCT00408005|6317082|P2|Induction|Adverse Event|3
1821022|NCT00408005|6317083|P1|Induction|Adverse Event|19
1821023|NCT00407797|6317125|P1|Overall Study|Withdrawal by Subject|3
1821024|NCT00407797|6317125|P1|Overall Study|Other|7
1821025|NCT00407797|6317125|P1|Overall Study|Adverse Event|6
1821026|NCT00407797|6317125|P1|Overall Study|Lost to Follow-up|2
1821027|NCT00407758|6317140|P1|Overall Study|ineligible –improper prior treatment|1
1821028|NCT00407745|6317153|P2|Overall Study|Randomized, unknown if treated|1
1821029|NCT00407745|6317154|P1|Overall Study|Randomized, unknown if treated|0
1821030|NCT00407745|6317153|P2|Overall Study|Other|0
1821031|NCT00407745|6317154|P1|Overall Study|Other|2
1821032|NCT00407745|6317153|P2|Overall Study|Adverse Event|8
1821033|NCT00407745|6317154|P1|Overall Study|Adverse Event|8
1821034|NCT00407745|6317153|P2|Overall Study|Protocol Violation|3
1821035|NCT00407745|6317154|P1|Overall Study|Protocol Violation|5
1821036|NCT00407745|6317153|P2|Overall Study|Withdrawal by Subject|3
1821037|NCT00407745|6317154|P1|Overall Study|Withdrawal by Subject|3
1821038|NCT00407745|6317153|P2|Overall Study|Lack of Efficacy|2
1821039|NCT00407745|6317154|P1|Overall Study|Lack of Efficacy|1
1821040|NCT00407563|6317240|P1|Overall Study|Patient continues on treatment|1
1821041|NCT00407550|6317250|P2|Overall Study|Insurance or Other medical condition|1
1821042|NCT00407550|6317251|P1|Overall Study|Insurance or Other medical condition|2
1821043|NCT00407550|6317250|P2|Overall Study|Death|0
1821044|NCT00407550|6317251|P1|Overall Study|Death|1
1821045|NCT00407550|6317250|P2|Overall Study|Withdrawal by Subject|2
1821046|NCT00407550|6317251|P1|Overall Study|Withdrawal by Subject|0
1821047|NCT00407550|6317250|P2|Overall Study|Adverse Event|1
1821048|NCT00407550|6317251|P1|Overall Study|Adverse Event|0
1821050|NCT00407537|6317266|P1|Overall Study|Withdrawal by Subject|34
1821051|NCT00407537|6317265|P2|Overall Study|Other|7
1821052|NCT00407537|6317266|P1|Overall Study|Other|6
1821053|NCT00407537|6317265|P2|Overall Study|Lost to Follow-up|19
1821054|NCT00407537|6317266|P1|Overall Study|Lost to Follow-up|12
1821055|NCT00407537|6317265|P2|Overall Study|Adverse Event|0
1821056|NCT00407537|6317266|P1|Overall Study|Adverse Event|36
1821057|NCT00407537|6317265|P2|Overall Study|Death|2
1821058|NCT00407537|6317266|P1|Overall Study|Death|5
1821059|NCT00407511|6317314|P1|Overall Study|Withdrawal by Subject|4
1821060|NCT00407511|6317314|P1|Overall Study|Other|5
1821061|NCT00407511|6317314|P1|Overall Study|Lost to Follow-up|4
1821062|NCT00407511|6317314|P1|Overall Study|Adverse Event|9
1821063|NCT00407030|6317375|P3|Extension Period - up to 68 Weeks|Physician Decision|0
1821064|NCT00407030|6317376|P2|Extension Period - up to 68 Weeks|Physician Decision|2
1821065|NCT00407030|6317377|P1|Extension Period - up to 68 Weeks|Physician Decision|1
1821066|NCT00407030|6317375|P3|Extension Period - up to 68 Weeks|Patient Decision|0
1821067|NCT00407030|6317376|P2|Extension Period - up to 68 Weeks|Patient Decision|2
1821068|NCT00407030|6317377|P1|Extension Period - up to 68 Weeks|Patient Decision|1
1821069|NCT00407030|6317375|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
1821070|NCT00407030|6317376|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1821071|NCT00407030|6317377|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
1821072|NCT00407030|6317375|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
1821073|NCT00407030|6317376|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1821074|NCT00407030|6317377|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
1821075|NCT00407030|6317375|P3|Extension Period - up to 68 Weeks|Adverse Event|0
1821076|NCT00407030|6317376|P2|Extension Period - up to 68 Weeks|Adverse Event|0
1821077|NCT00407030|6317377|P1|Extension Period - up to 68 Weeks|Adverse Event|1
1821078|NCT00407030|6317375|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
1821079|NCT00407030|6317376|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1821080|NCT00407030|6317377|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
1821081|NCT00407030|6317375|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1821082|NCT00407030|6317376|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
1821083|NCT00407030|6317377|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1821084|NCT00407030|6317375|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
1821085|NCT00407030|6317376|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
1821086|NCT00407030|6317377|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
1821087|NCT00407030|6317375|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
1821088|NCT00407030|6317376|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1821089|NCT00407030|6317377|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
1821090|NCT00407030|6317375|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1821091|NCT00407030|6317376|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1821092|NCT00407030|6317377|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
1821093|NCT00407030|6317375|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1821094|NCT00407030|6317376|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1821095|NCT00407030|6317377|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
1821096|NCT00407030|6317375|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
1821097|NCT00407030|6317376|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1821098|NCT00407030|6317377|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
1821099|NCT00407030|6317375|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
1821100|NCT00407030|6317376|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
1821101|NCT00407030|6317377|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
1821102|NCT00406848|6317405|P2|Overall Study|Sponsor Decision|1
1821103|NCT00406848|6317406|P1|Overall Study|Sponsor Decision|1
1821104|NCT00406848|6317405|P2|Overall Study|Physician Decision|2
1821105|NCT00406848|6317406|P1|Overall Study|Physician Decision|2
1821106|NCT00406848|6317405|P2|Overall Study|Lost to Follow-up|2
1821107|NCT00406848|6317406|P1|Overall Study|Lost to Follow-up|6
1821108|NCT00406848|6317405|P2|Overall Study|Protocol Violation|6
1821109|NCT00406848|6317406|P1|Overall Study|Protocol Violation|10
1821110|NCT00406848|6317405|P2|Overall Study|Lack of Efficacy|14
1821111|NCT00406848|6317406|P1|Overall Study|Lack of Efficacy|9
1821112|NCT00406848|6317405|P2|Overall Study|Adverse Event|7
1821113|NCT00406848|6317406|P1|Overall Study|Adverse Event|38
1821114|NCT00406848|6317405|P2|Overall Study|Withdrawal by Subject|22
1821115|NCT00406848|6317406|P1|Overall Study|Withdrawal by Subject|27
1821116|NCT00406783|6317470|P2|Overall Study|Protocol Violation|4
1821117|NCT00406783|6317471|P1|Overall Study|Protocol Violation|4
1821118|NCT00406783|6317470|P2|Overall Study|Withdrawal by Subject|4
1821119|NCT00406783|6317471|P1|Overall Study|Withdrawal by Subject|1
1821120|NCT00406783|6317470|P2|Overall Study|Lost to Follow-up|0
1821121|NCT00406783|6317471|P1|Overall Study|Lost to Follow-up|3
1821122|NCT00406783|6317470|P2|Overall Study|Treatment Failure|3
1821123|NCT00406783|6317471|P1|Overall Study|Treatment Failure|2
1821124|NCT00406783|6317470|P2|Overall Study|Adverse Event|4
1821125|NCT00406783|6317471|P1|Overall Study|Adverse Event|4
1821126|NCT00406718|6317486|P3|Overall Study|Lost to Follow-up|4
1821127|NCT00406718|6317487|P2|Overall Study|Lost to Follow-up|5
1821128|NCT00406718|6317488|P1|Overall Study|Lost to Follow-up|2
1821129|NCT00406718|6317486|P3|Overall Study|Withdrawal by Subject|4
1821130|NCT00406718|6317487|P2|Overall Study|Withdrawal by Subject|9
1821131|NCT00406718|6317488|P1|Overall Study|Withdrawal by Subject|2
1821132|NCT00406692|6317502|P1|Overall Study|Lack of Efficacy|1
1821133|NCT00406692|6317502|P1|Overall Study|Adverse Event|1
1821134|NCT00406692|6317502|P1|Overall Study|Physician Decision|1
1821135|NCT00406692|6317502|P1|Overall Study|Withdrawal by Subject|4
1821136|NCT00406653|6317512|P7|Open-Label Period|Refused followup|1
1821137|NCT00406653|6317513|P6|Open-Label Period|Refused followup|0
1821138|NCT00406653|6317514|P5|Open-Label Period|Refused followup|0
1821139|NCT00406653|6317515|P4|Open-Label Period|Refused followup|0
1821140|NCT00406653|6317516|P3|Open-Label Period|Refused followup|0
1821141|NCT00406653|6317517|P2|Open-Label Period|Refused followup|0
1821142|NCT00406653|6317518|P1|Open-Label Period|Refused followup|0
1821143|NCT00406653|6317512|P7|Open-Label Period|Discontinued by Sponsor|1
1821144|NCT00406653|6317513|P6|Open-Label Period|Discontinued by Sponsor|0
1821145|NCT00406653|6317514|P5|Open-Label Period|Discontinued by Sponsor|0
1821146|NCT00406653|6317515|P4|Open-Label Period|Discontinued by Sponsor|0
1821147|NCT00406653|6317516|P3|Open-Label Period|Discontinued by Sponsor|0
1821148|NCT00406653|6317517|P2|Open-Label Period|Discontinued by Sponsor|0
1821149|NCT00406653|6317518|P1|Open-Label Period|Discontinued by Sponsor|0
1821150|NCT00406653|6317512|P7|Open-Label Period|Declined participation but followup done|8
1821151|NCT00406653|6317513|P6|Open-Label Period|Declined participation but followup done|0
1821152|NCT00406653|6317514|P5|Open-Label Period|Declined participation but followup done|0
1821153|NCT00406653|6317515|P4|Open-Label Period|Declined participation but followup done|0
1821154|NCT00406653|6317516|P3|Open-Label Period|Declined participation but followup done|0
1821155|NCT00406653|6317517|P2|Open-Label Period|Declined participation but followup done|0
1821156|NCT00406653|6317518|P1|Open-Label Period|Declined participation but followup done|0
1821157|NCT00406653|6317512|P7|Open-Label Period|Administrative Reason By Sponsor|115
1821158|NCT00406653|6317513|P6|Open-Label Period|Administrative Reason By Sponsor|0
1821159|NCT00406653|6317514|P5|Open-Label Period|Administrative Reason By Sponsor|0
1821160|NCT00406653|6317515|P4|Open-Label Period|Administrative Reason By Sponsor|0
1821161|NCT00406653|6317516|P3|Open-Label Period|Administrative Reason By Sponsor|0
1821162|NCT00406653|6317517|P2|Open-Label Period|Administrative Reason By Sponsor|0
1821163|NCT00406653|6317518|P1|Open-Label Period|Administrative Reason By Sponsor|0
1821164|NCT00406653|6317512|P7|Open-Label Period|Pregnancy|2
1821165|NCT00406653|6317513|P6|Open-Label Period|Pregnancy|0
1821166|NCT00406653|6317514|P5|Open-Label Period|Pregnancy|0
1821167|NCT00406653|6317515|P4|Open-Label Period|Pregnancy|0
1821168|NCT00406653|6317516|P3|Open-Label Period|Pregnancy|0
1821169|NCT00406653|6317517|P2|Open-Label Period|Pregnancy|0
1821170|NCT00406653|6317518|P1|Open-Label Period|Pregnancy|0
1821171|NCT00406653|6317512|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
1821172|NCT00406653|6317513|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
1821173|NCT00406653|6317514|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
1821174|NCT00406653|6317515|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
1821175|NCT00406653|6317516|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
1821176|NCT00406653|6317517|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
1821177|NCT00406653|6317518|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
1821178|NCT00406653|6317512|P7|Open-Label Period|Withdrawal of Consent|11
1821179|NCT00406653|6317513|P6|Open-Label Period|Withdrawal of Consent|0
1821180|NCT00406653|6317514|P5|Open-Label Period|Withdrawal of Consent|0
1821181|NCT00406653|6317515|P4|Open-Label Period|Withdrawal of Consent|0
1821182|NCT00406653|6317516|P3|Open-Label Period|Withdrawal of Consent|0
1821183|NCT00406653|6317517|P2|Open-Label Period|Withdrawal of Consent|0
1821184|NCT00406653|6317518|P1|Open-Label Period|Withdrawal of Consent|0
1821185|NCT00406653|6317512|P7|Open-Label Period|Lost to Follow-up|6
1821186|NCT00406653|6317513|P6|Open-Label Period|Lost to Follow-up|0
1821187|NCT00406653|6317514|P5|Open-Label Period|Lost to Follow-up|0
1821188|NCT00406653|6317515|P4|Open-Label Period|Lost to Follow-up|0
1821189|NCT00406653|6317516|P3|Open-Label Period|Lost to Follow-up|0
1821190|NCT00406653|6317517|P2|Open-Label Period|Lost to Follow-up|0
1821191|NCT00406653|6317518|P1|Open-Label Period|Lost to Follow-up|0
1821192|NCT00406653|6317512|P7|Open-Label Period|Lack of Efficacy|160
1821193|NCT00406653|6317513|P6|Open-Label Period|Lack of Efficacy|0
1821194|NCT00406653|6317514|P5|Open-Label Period|Lack of Efficacy|0
1821195|NCT00406653|6317515|P4|Open-Label Period|Lack of Efficacy|0
1821196|NCT00406653|6317516|P3|Open-Label Period|Lack of Efficacy|0
1821197|NCT00406653|6317517|P2|Open-Label Period|Lack of Efficacy|0
1821198|NCT00406653|6317518|P1|Open-Label Period|Lack of Efficacy|0
1821199|NCT00406653|6317512|P7|Open-Label Period|Adverse Event|18
1821200|NCT00406653|6317513|P6|Open-Label Period|Adverse Event|0
1821201|NCT00406653|6317514|P5|Open-Label Period|Adverse Event|0
1821202|NCT00406653|6317515|P4|Open-Label Period|Adverse Event|0
1821203|NCT00406653|6317516|P3|Open-Label Period|Adverse Event|0
1821204|NCT00406653|6317517|P2|Open-Label Period|Adverse Event|0
1821205|NCT00406653|6317518|P1|Open-Label Period|Adverse Event|0
1821206|NCT00406653|6317512|P7|Open-Label Period|Death|1
1821207|NCT00406653|6317513|P6|Open-Label Period|Death|0
1821208|NCT00406653|6317514|P5|Open-Label Period|Death|0
1821209|NCT00406653|6317515|P4|Open-Label Period|Death|0
1821210|NCT00406653|6317516|P3|Open-Label Period|Death|0
1821211|NCT00406653|6317517|P2|Open-Label Period|Death|0
1821212|NCT00406653|6317518|P1|Open-Label Period|Death|0
1821213|NCT00406653|6317512|P7|Maintenance Period|Error in disease score evaluation|0
1821214|NCT00406653|6317513|P6|Maintenance Period|Error in disease score evaluation|0
1821215|NCT00406653|6317514|P5|Maintenance Period|Error in disease score evaluation|1
1821216|NCT00406653|6317515|P4|Maintenance Period|Error in disease score evaluation|0
1821217|NCT00406653|6317516|P3|Maintenance Period|Error in disease score evaluation|0
1821218|NCT00406653|6317517|P2|Maintenance Period|Error in disease score evaluation|0
1821219|NCT00406653|6317518|P1|Maintenance Period|Error in disease score evaluation|0
1821220|NCT00406653|6317512|P7|Maintenance Period|Administrative Reason By Sponsor|0
1821221|NCT00406653|6317513|P6|Maintenance Period|Administrative Reason By Sponsor|7
1821222|NCT00406653|6317514|P5|Maintenance Period|Administrative Reason By Sponsor|4
1821223|NCT00406653|6317515|P4|Maintenance Period|Administrative Reason By Sponsor|0
1821224|NCT00406653|6317516|P3|Maintenance Period|Administrative Reason By Sponsor|0
1821225|NCT00406653|6317517|P2|Maintenance Period|Administrative Reason By Sponsor|0
1821226|NCT00406653|6317518|P1|Maintenance Period|Administrative Reason By Sponsor|0
1821227|NCT00406653|6317512|P7|Maintenance Period|Pregnancy|0
1821228|NCT00406653|6317513|P6|Maintenance Period|Pregnancy|1
1821229|NCT00406653|6317514|P5|Maintenance Period|Pregnancy|0
1821230|NCT00406653|6317515|P4|Maintenance Period|Pregnancy|0
1821231|NCT00406653|6317516|P3|Maintenance Period|Pregnancy|0
1821232|NCT00406653|6317517|P2|Maintenance Period|Pregnancy|0
1821233|NCT00406653|6317518|P1|Maintenance Period|Pregnancy|0
1821234|NCT00406653|6317512|P7|Maintenance Period|Withdrawal of Consent|0
1821235|NCT00406653|6317513|P6|Maintenance Period|Withdrawal of Consent|0
1821236|NCT00406653|6317514|P5|Maintenance Period|Withdrawal of Consent|2
1821237|NCT00406653|6317515|P4|Maintenance Period|Withdrawal of Consent|0
1821238|NCT00406653|6317516|P3|Maintenance Period|Withdrawal of Consent|0
1821239|NCT00406653|6317517|P2|Maintenance Period|Withdrawal of Consent|0
1821240|NCT00406653|6317518|P1|Maintenance Period|Withdrawal of Consent|0
1821241|NCT00406653|6317512|P7|Maintenance Period|Lost to Follow-up|0
1821242|NCT00406653|6317513|P6|Maintenance Period|Lost to Follow-up|1
1821243|NCT00406653|6317514|P5|Maintenance Period|Lost to Follow-up|2
1821244|NCT00406653|6317515|P4|Maintenance Period|Lost to Follow-up|0
1821245|NCT00406653|6317516|P3|Maintenance Period|Lost to Follow-up|0
1821246|NCT00406653|6317517|P2|Maintenance Period|Lost to Follow-up|0
1821247|NCT00406653|6317518|P1|Maintenance Period|Lost to Follow-up|0
1821248|NCT00406653|6317512|P7|Maintenance Period|Lack of Efficacy|0
1821249|NCT00406653|6317513|P6|Maintenance Period|Lack of Efficacy|26
1821250|NCT00406653|6317514|P5|Maintenance Period|Lack of Efficacy|20
1821251|NCT00406653|6317515|P4|Maintenance Period|Lack of Efficacy|0
1821252|NCT00406653|6317516|P3|Maintenance Period|Lack of Efficacy|0
1821253|NCT00406653|6317517|P2|Maintenance Period|Lack of Efficacy|0
1821254|NCT00406653|6317518|P1|Maintenance Period|Lack of Efficacy|0
1821255|NCT00406653|6317512|P7|Maintenance Period|Adverse Event|0
1821256|NCT00406653|6317513|P6|Maintenance Period|Adverse Event|1
1821257|NCT00406653|6317514|P5|Maintenance Period|Adverse Event|1
1821258|NCT00406653|6317515|P4|Maintenance Period|Adverse Event|0
1821259|NCT00406653|6317516|P3|Maintenance Period|Adverse Event|0
1821260|NCT00406653|6317517|P2|Maintenance Period|Adverse Event|0
1821261|NCT00406653|6317518|P1|Maintenance Period|Adverse Event|0
1821262|NCT00406653|6317512|P7|Induction Period|Patient relocated|0
1821263|NCT00406653|6317513|P6|Induction Period|Patient relocated|0
1821264|NCT00406653|6317514|P5|Induction Period|Patient relocated|0
1821265|NCT00406653|6317515|P4|Induction Period|Patient relocated|0
1821266|NCT00406653|6317516|P3|Induction Period|Patient relocated|1
1821267|NCT00406653|6317517|P2|Induction Period|Patient relocated|0
1821268|NCT00406653|6317518|P1|Induction Period|Patient relocated|0
1821269|NCT00406653|6317512|P7|Induction Period|Incarcerated|0
1821270|NCT00406653|6317513|P6|Induction Period|Incarcerated|0
1821271|NCT00406653|6317514|P5|Induction Period|Incarcerated|0
1821272|NCT00406653|6317515|P4|Induction Period|Incarcerated|0
1821273|NCT00406653|6317516|P3|Induction Period|Incarcerated|1
1821274|NCT00406653|6317517|P2|Induction Period|Incarcerated|0
1821275|NCT00406653|6317518|P1|Induction Period|Incarcerated|0
1821276|NCT00406653|6317512|P7|Induction Period|Given prohibited drug|0
1821277|NCT00406653|6317513|P6|Induction Period|Given prohibited drug|0
1821278|NCT00406653|6317514|P5|Induction Period|Given prohibited drug|0
1821279|NCT00406653|6317515|P4|Induction Period|Given prohibited drug|0
1821280|NCT00406653|6317516|P3|Induction Period|Given prohibited drug|2
1821281|NCT00406653|6317517|P2|Induction Period|Given prohibited drug|1
1821282|NCT00406653|6317518|P1|Induction Period|Given prohibited drug|0
1821283|NCT00406653|6317512|P7|Induction Period|Declined participation but followup done|0
1821284|NCT00406653|6317513|P6|Induction Period|Declined participation but followup done|0
1821285|NCT00406653|6317514|P5|Induction Period|Declined participation but followup done|0
1821286|NCT00406653|6317515|P4|Induction Period|Declined participation but followup done|1
1821287|NCT00406653|6317516|P3|Induction Period|Declined participation but followup done|1
1821288|NCT00406653|6317517|P2|Induction Period|Declined participation but followup done|2
1821289|NCT00406653|6317518|P1|Induction Period|Declined participation but followup done|0
1821290|NCT00406653|6317512|P7|Induction Period|Pregnancy|0
1821291|NCT00406653|6317513|P6|Induction Period|Pregnancy|0
1821292|NCT00406653|6317514|P5|Induction Period|Pregnancy|0
1821293|NCT00406653|6317515|P4|Induction Period|Pregnancy|0
1821294|NCT00406653|6317516|P3|Induction Period|Pregnancy|0
1821295|NCT00406653|6317517|P2|Induction Period|Pregnancy|0
1821296|NCT00406653|6317518|P1|Induction Period|Pregnancy|1
1821297|NCT00406653|6317512|P7|Induction Period|Subject No Longer Meets Study Criteria|0
1821298|NCT00406653|6317513|P6|Induction Period|Subject No Longer Meets Study Criteria|0
1821299|NCT00406653|6317514|P5|Induction Period|Subject No Longer Meets Study Criteria|0
1821300|NCT00406653|6317515|P4|Induction Period|Subject No Longer Meets Study Criteria|2
1821301|NCT00406653|6317516|P3|Induction Period|Subject No Longer Meets Study Criteria|0
1821302|NCT00406653|6317517|P2|Induction Period|Subject No Longer Meets Study Criteria|0
1821303|NCT00406653|6317518|P1|Induction Period|Subject No Longer Meets Study Criteria|0
1821304|NCT00406653|6317512|P7|Induction Period|Withdrawal of Consent|0
1821305|NCT00406653|6317513|P6|Induction Period|Withdrawal of Consent|0
1821306|NCT00406653|6317514|P5|Induction Period|Withdrawal of Consent|0
1821307|NCT00406653|6317515|P4|Induction Period|Withdrawal of Consent|2
1821308|NCT00406653|6317516|P3|Induction Period|Withdrawal of Consent|1
1821309|NCT00406653|6317517|P2|Induction Period|Withdrawal of Consent|5
1821310|NCT00406653|6317518|P1|Induction Period|Withdrawal of Consent|2
1821311|NCT00406653|6317512|P7|Induction Period|Lost to Follow-up|0
1821312|NCT00406653|6317513|P6|Induction Period|Lost to Follow-up|0
1821313|NCT00406653|6317514|P5|Induction Period|Lost to Follow-up|0
1821314|NCT00406653|6317515|P4|Induction Period|Lost to Follow-up|0
1821315|NCT00406653|6317516|P3|Induction Period|Lost to Follow-up|0
1821316|NCT00406653|6317517|P2|Induction Period|Lost to Follow-up|2
1821317|NCT00406653|6317518|P1|Induction Period|Lost to Follow-up|0
1821318|NCT00406653|6317512|P7|Induction Period|Lack of Efficacy|0
1821319|NCT00406653|6317513|P6|Induction Period|Lack of Efficacy|0
1821320|NCT00406653|6317514|P5|Induction Period|Lack of Efficacy|0
1821321|NCT00406653|6317515|P4|Induction Period|Lack of Efficacy|10
1821322|NCT00406653|6317516|P3|Induction Period|Lack of Efficacy|8
1821323|NCT00406653|6317517|P2|Induction Period|Lack of Efficacy|14
1821324|NCT00406653|6317518|P1|Induction Period|Lack of Efficacy|11
1821325|NCT00406653|6317512|P7|Induction Period|Adverse Event|0
1821326|NCT00406653|6317513|P6|Induction Period|Adverse Event|0
1821327|NCT00406653|6317514|P5|Induction Period|Adverse Event|0
1821328|NCT00406653|6317515|P4|Induction Period|Adverse Event|11
1821329|NCT00406653|6317516|P3|Induction Period|Adverse Event|4
1821330|NCT00406653|6317517|P2|Induction Period|Adverse Event|10
1821331|NCT00406653|6317518|P1|Induction Period|Adverse Event|1
1821332|NCT00406640|6317599|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
1821333|NCT00406640|6317600|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
1821334|NCT00406640|6317599|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
1821335|NCT00406640|6317600|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
1821336|NCT00406640|6317599|P2|OL Extension Phase for Non-Responders|non-compliance|2
1821337|NCT00406640|6317600|P1|OL Extension Phase for Non-Responders|non-compliance|3
1821338|NCT00406640|6317599|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
1821339|NCT00406640|6317600|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
1821340|NCT00406640|6317599|P2|OL Extension Phase for Non-Responders|Physician Decision|0
1821341|NCT00406640|6317600|P1|OL Extension Phase for Non-Responders|Physician Decision|1
1821342|NCT00406640|6317599|P2|OL Extension Phase for Non-Responders|Failed to Return|0
1821343|NCT00406640|6317600|P1|OL Extension Phase for Non-Responders|Failed to Return|1
1821344|NCT00406640|6317599|P2|OL Extension Phase for Non-Responders|Adverse Event|6
1821345|NCT00406640|6317600|P1|OL Extension Phase for Non-Responders|Adverse Event|6
1821346|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
1821347|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
1821348|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
1821349|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
1821350|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Protocol Violation|2
1821351|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Protocol Violation|2
1821352|NCT00406640|6317599|P2|DB Continuation Phase for Responders|non-compliance|5
1821353|NCT00406640|6317600|P1|DB Continuation Phase for Responders|non-compliance|7
1821354|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
1821355|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
1821356|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Physician Decision|3
1821357|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Physician Decision|2
1821358|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Failed to Return|2
1821359|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Failed to Return|0
1821360|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Death|0
1821361|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Death|1
1821362|NCT00406640|6317599|P2|DB Continuation Phase for Responders|Adverse Event|11
1821363|NCT00406640|6317600|P1|DB Continuation Phase for Responders|Adverse Event|11
1821364|NCT00406640|6317599|P2|Acute Phase|Lack of Efficacy|3
1821365|NCT00406640|6317600|P1|Acute Phase|Lack of Efficacy|3
1821366|NCT00406640|6317599|P2|Acute Phase|Withdrawal by Subject|9
1821367|NCT00406640|6317600|P1|Acute Phase|Withdrawal by Subject|11
1821368|NCT00406640|6317599|P2|Acute Phase|Protocol Violation|2
1821369|NCT00406640|6317600|P1|Acute Phase|Protocol Violation|3
1821370|NCT00406640|6317599|P2|Acute Phase|Protocol deviation|10
1821371|NCT00406640|6317600|P1|Acute Phase|Protocol deviation|4
1821372|NCT00406640|6317599|P2|Acute Phase|Lost to Follow-up|4
1821373|NCT00406640|6317600|P1|Acute Phase|Lost to Follow-up|7
1821374|NCT00406640|6317599|P2|Acute Phase|Physician Decision|1
1821375|NCT00406640|6317600|P1|Acute Phase|Physician Decision|0
1821376|NCT00406640|6317599|P2|Acute Phase|Failed to Return|1
1821377|NCT00406640|6317600|P1|Acute Phase|Failed to Return|5
1821378|NCT00406640|6317599|P2|Acute Phase|Adverse Event|13
1821379|NCT00406640|6317600|P1|Acute Phase|Adverse Event|18
1821380|NCT00406393|6317632|P2|Overall Study|Did not undergo transplantation|1
1821381|NCT00406393|6317633|P1|Overall Study|Did not undergo transplantation|2
1821382|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
1821383|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
1821384|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
1821385|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
1821386|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
1821387|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
1821388|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
1821389|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
1821390|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
1821391|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
1821392|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
1821393|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
1821394|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
1821395|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
1821396|NCT00406367|6317663|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
1821397|NCT00406367|6317664|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
1821398|NCT00406367|6317663|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
1821399|NCT00406367|6317664|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
1821400|NCT00406367|6317663|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
1821401|NCT00406367|6317664|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
1821402|NCT00406367|6317663|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
1821403|NCT00406367|6317664|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
1821404|NCT00406367|6317663|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
1821405|NCT00406367|6317664|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
1821406|NCT00406354|6317679|P3|All Randomized and Treated Patients|Physician Decision|1
1821407|NCT00406354|6317680|P2|All Randomized and Treated Patients|Physician Decision|0
1821408|NCT00406354|6317681|P1|All Randomized and Treated Patients|Physician Decision|0
1821409|NCT00406354|6317679|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
1821410|NCT00406354|6317680|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
1821411|NCT00406354|6317681|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
1821412|NCT00406354|6317679|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
1821413|NCT00406354|6317680|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
1821414|NCT00406354|6317681|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
1821415|NCT00406354|6317679|P3|All Randomized and Treated Patients|Adverse Event|1
1821416|NCT00406354|6317680|P2|All Randomized and Treated Patients|Adverse Event|2
1821417|NCT00406354|6317681|P1|All Randomized and Treated Patients|Adverse Event|6
1821418|NCT00406354|6317679|P3|All Randomized and Treated Patients|Lack of Efficacy|17
1821419|NCT00406354|6317680|P2|All Randomized and Treated Patients|Lack of Efficacy|4
1821420|NCT00406354|6317681|P1|All Randomized and Treated Patients|Lack of Efficacy|7
1821421|NCT00406354|6317679|P3|All Randomized Patients|Protocol Violation|1
1821422|NCT00406354|6317680|P2|All Randomized Patients|Protocol Violation|0
1821423|NCT00406354|6317681|P1|All Randomized Patients|Protocol Violation|0
1821424|NCT00406315|6317752|P1|Overall Study|Withdrawal by Subject|30
1821425|NCT00406315|6317752|P1|Overall Study|Lost to Follow-up|21
1821426|NCT00406315|6317752|P1|Overall Study|Other|33
1821427|NCT00406315|6317752|P1|Overall Study|Lack of Efficacy|13
1821428|NCT00406315|6317752|P1|Overall Study|Laboratory Abnormality|4
1821429|NCT00406315|6317752|P1|Overall Study|Adverse Event|39
1821430|NCT00406315|6317752|P1|Overall Study|Death|1
1821431|NCT00406029|6317862|P5|Overall Study|Randomized in Error|1
1821432|NCT00406029|6317863|P4|Overall Study|Randomized in Error|3
1821433|NCT00406029|6317864|P3|Overall Study|Randomized in Error|2
1821434|NCT00406029|6317865|P2|Overall Study|Randomized in Error|0
1821435|NCT00406029|6317866|P1|Overall Study|Randomized in Error|0
1821436|NCT00406029|6317862|P5|Overall Study|Did Not Meet Eligibility Criteria|0
1821437|NCT00406029|6317863|P4|Overall Study|Did Not Meet Eligibility Criteria|0
1821438|NCT00406029|6317864|P3|Overall Study|Did Not Meet Eligibility Criteria|1
1821439|NCT00406029|6317865|P2|Overall Study|Did Not Meet Eligibility Criteria|0
1821440|NCT00406029|6317866|P1|Overall Study|Did Not Meet Eligibility Criteria|0
1821441|NCT00406029|6317862|P5|Overall Study|Protocol Violation|0
1821442|NCT00406029|6317863|P4|Overall Study|Protocol Violation|2
1821443|NCT00406029|6317864|P3|Overall Study|Protocol Violation|0
1821444|NCT00406029|6317865|P2|Overall Study|Protocol Violation|2
1821445|NCT00406029|6317866|P1|Overall Study|Protocol Violation|1
1821446|NCT00406029|6317862|P5|Overall Study|Withdrawal by Subject|0
1821447|NCT00406029|6317863|P4|Overall Study|Withdrawal by Subject|2
1821448|NCT00406029|6317864|P3|Overall Study|Withdrawal by Subject|2
1821449|NCT00406029|6317865|P2|Overall Study|Withdrawal by Subject|4
1821450|NCT00406029|6317866|P1|Overall Study|Withdrawal by Subject|3
1821451|NCT00406029|6317862|P5|Overall Study|Adverse Event|7
1821452|NCT00406029|6317863|P4|Overall Study|Adverse Event|10
1821453|NCT00406029|6317864|P3|Overall Study|Adverse Event|5
1821454|NCT00406029|6317865|P2|Overall Study|Adverse Event|2
1821455|NCT00406029|6317866|P1|Overall Study|Adverse Event|12
1821456|NCT00405964|6317970|P2|Overall Study|Protocol Violation|6
1821457|NCT00405964|6317971|P1|Overall Study|Protocol Violation|11
1821458|NCT00405964|6317970|P2|Overall Study|Withdrawal by Subject|23
1821459|NCT00405964|6317971|P1|Overall Study|Withdrawal by Subject|19
1821460|NCT00405964|6317970|P2|Overall Study|Lost to Follow-up|5
1821461|NCT00405964|6317971|P1|Overall Study|Lost to Follow-up|5
1821462|NCT00405964|6317970|P2|Overall Study|Adverse Event|16
1821463|NCT00405964|6317971|P1|Overall Study|Adverse Event|7
1821464|NCT00405964|6317970|P2|Overall Study|Treatment Failure|45
1821465|NCT00405964|6317971|P1|Overall Study|Treatment Failure|17
1821466|NCT00405912|6317993|P3|Overall Study|Lost to Follow-up|4
1821467|NCT00405912|6317994|P2|Overall Study|Lost to Follow-up|8
1821468|NCT00405912|6317995|P1|Overall Study|Lost to Follow-up|4
1821469|NCT00405912|6317993|P3|Overall Study|Withdrawal by Subject|12
1821470|NCT00405912|6317994|P2|Overall Study|Withdrawal by Subject|11
1821471|NCT00405912|6317995|P1|Overall Study|Withdrawal by Subject|12
1821472|NCT00405821|6318008|P2|Overall Study|initiated ART|8
1821473|NCT00405821|6318009|P1|Overall Study|initiated ART|9
1821474|NCT00405821|6318008|P2|Overall Study|Protocol Violation|0
1821475|NCT00405821|6318009|P1|Overall Study|Protocol Violation|1
1821476|NCT00405821|6318008|P2|Overall Study|Lost to Follow-up|7
1821477|NCT00405821|6318009|P1|Overall Study|Lost to Follow-up|7
1821478|NCT00405821|6318008|P2|Overall Study|Death|7
1821479|NCT00405821|6318009|P1|Overall Study|Death|5
1821480|NCT00405756|6318022|P3|Follow-up|Lost to Follow-up|4
1821481|NCT00405756|6318023|P2|Follow-up|Lost to Follow-up|8
1821482|NCT00405756|6318024|P1|Follow-up|Lost to Follow-up|2
1821483|NCT00405756|6318022|P3|Follow-up|Death|24
1821484|NCT00405756|6318023|P2|Follow-up|Death|31
1821485|NCT00405756|6318024|P1|Follow-up|Death|21
1821486|NCT00405756|6318022|P3|Follow-up|Ongoing in Follow-up Period|60
1821487|NCT00405756|6318023|P2|Follow-up|Ongoing in Follow-up Period|51
1821488|NCT00405756|6318024|P1|Follow-up|Ongoing in Follow-up Period|52
1821489|NCT00405756|6318022|P3|Open-label Extension|Other|7
1821490|NCT00405756|6318023|P2|Open-label Extension|Other|1
1821491|NCT00405756|6318024|P1|Open-label Extension|Other|0
1821492|NCT00405756|6318022|P3|Open-label Extension|Death|4
1821493|NCT00405756|6318023|P2|Open-label Extension|Death|2
1821494|NCT00405756|6318024|P1|Open-label Extension|Death|1
1821495|NCT00405756|6318022|P3|Open-label Extension|Withdrawal by Subject|3
1821496|NCT00405756|6318023|P2|Open-label Extension|Withdrawal by Subject|3
1821497|NCT00405756|6318024|P1|Open-label Extension|Withdrawal by Subject|2
1821498|NCT00405756|6318022|P3|Open-label Extension|Disease Progression|26
1821499|NCT00405756|6318023|P2|Open-label Extension|Disease Progression|23
1821500|NCT00405756|6318024|P1|Open-label Extension|Disease Progression|8
1821501|NCT00405756|6318022|P3|Open-label Extension|Adverse Event|7
1821502|NCT00405756|6318023|P2|Open-label Extension|Adverse Event|3
1821503|NCT00405756|6318024|P1|Open-label Extension|Adverse Event|1
1821504|NCT00405756|6318022|P3|Open-label Extension|Ongoing in Open Label Period|25
1821505|NCT00405756|6318023|P2|Open-label Extension|Ongoing in Open Label Period|15
1821506|NCT00405756|6318024|P1|Open-label Extension|Ongoing in Open Label Period|7
1821507|NCT00405756|6318022|P3|Double-blind Treatment|Other|4
1821508|NCT00405756|6318023|P2|Double-blind Treatment|Other|4
1821509|NCT00405756|6318024|P1|Double-blind Treatment|Other|7
1821510|NCT00405756|6318022|P3|Double-blind Treatment|Protocol Violation|2
1821511|NCT00405756|6318023|P2|Double-blind Treatment|Protocol Violation|0
1821512|NCT00405756|6318024|P1|Double-blind Treatment|Protocol Violation|1
1821513|NCT00405756|6318022|P3|Double-blind Treatment|Death|4
1821514|NCT00405756|6318023|P2|Double-blind Treatment|Death|4
1821515|NCT00405756|6318024|P1|Double-blind Treatment|Death|4
1821516|NCT00405756|6318022|P3|Double-blind Treatment|Lost to Follow-up|0
1821517|NCT00405756|6318023|P2|Double-blind Treatment|Lost to Follow-up|0
1821518|NCT00405756|6318024|P1|Double-blind Treatment|Lost to Follow-up|1
1821519|NCT00405756|6318022|P3|Double-blind Treatment|Withdrawal by Subject|10
1821520|NCT00405756|6318023|P2|Double-blind Treatment|Withdrawal by Subject|9
1821521|NCT00405756|6318024|P1|Double-blind Treatment|Withdrawal by Subject|15
1821522|NCT00405756|6318022|P3|Double-blind Treatment|Lack of Efficacy|2
1821523|NCT00405756|6318023|P2|Double-blind Treatment|Lack of Efficacy|4
1821524|NCT00405756|6318024|P1|Double-blind Treatment|Lack of Efficacy|1
1821525|NCT00405756|6318022|P3|Double-blind Treatment|Disease Progression|102
1821526|NCT00405756|6318023|P2|Double-blind Treatment|Disease Progression|81
1821527|NCT00405756|6318024|P1|Double-blind Treatment|Disease Progression|47
1821528|NCT00405756|6318022|P3|Double-blind Treatment|Adverse Event|12
1821529|NCT00405756|6318023|P2|Double-blind Treatment|Adverse Event|27
1821530|NCT00405756|6318024|P1|Double-blind Treatment|Adverse Event|31
1821531|NCT00405756|6318022|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
1821532|NCT00405756|6318023|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
1821533|NCT00405756|6318024|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
1821534|NCT00405652|6318135|P1|Overall Study|Adverse Event|4
1821535|NCT00405639|6318142|P2|Overall Study|Seizure prior to receiving BNP|0
1821536|NCT00405639|6318143|P1|Overall Study|Seizure prior to receiving BNP|1
1821537|NCT00405639|6318142|P2|Overall Study|Adverse Event|0
1821538|NCT00405639|6318143|P1|Overall Study|Adverse Event|1
1821539|NCT00405639|6318142|P2|Overall Study|Withdrawal by Subject|0
1821540|NCT00405639|6318143|P1|Overall Study|Withdrawal by Subject|1
1821541|NCT00405587|6318159|P4|Overall Study|Participant not dosed|0
1821542|NCT00405587|6318160|P3|Overall Study|Participant not dosed|0
1821543|NCT00405587|6318161|P2|Overall Study|Participant not dosed|1
1821544|NCT00405587|6318162|P1|Overall Study|Participant not dosed|0
1821545|NCT00405587|6318159|P4|Overall Study|Withdrawal by Subject|2
1821546|NCT00405587|6318160|P3|Overall Study|Withdrawal by Subject|0
1821547|NCT00405587|6318161|P2|Overall Study|Withdrawal by Subject|0
1821548|NCT00405587|6318162|P1|Overall Study|Withdrawal by Subject|0
1821549|NCT00405587|6318159|P4|Overall Study|Radiation induced necrosis|0
1821550|NCT00405587|6318160|P3|Overall Study|Radiation induced necrosis|0
1821551|NCT00405587|6318161|P2|Overall Study|Radiation induced necrosis|1
1821552|NCT00405587|6318162|P1|Overall Study|Radiation induced necrosis|0
1821553|NCT00405587|6318159|P4|Overall Study|Lost to Follow-up|0
1821554|NCT00405587|6318160|P3|Overall Study|Lost to Follow-up|1
1821555|NCT00405587|6318161|P2|Overall Study|Lost to Follow-up|1
1821556|NCT00405587|6318162|P1|Overall Study|Lost to Follow-up|0
1821557|NCT00405587|6318159|P4|Overall Study|Adverse Event|0
1821558|NCT00405587|6318160|P3|Overall Study|Adverse Event|0
1821559|NCT00405587|6318161|P2|Overall Study|Adverse Event|0
1821560|NCT00405587|6318162|P1|Overall Study|Adverse Event|1
1821561|NCT00405587|6318159|P4|Overall Study|Physician Decision|0
1821562|NCT00405587|6318160|P3|Overall Study|Physician Decision|0
1821563|NCT00405587|6318161|P2|Overall Study|Physician Decision|2
1821564|NCT00405587|6318162|P1|Overall Study|Physician Decision|3
1821565|NCT00405587|6318159|P4|Overall Study|Disease Progression|17
1821566|NCT00405587|6318160|P3|Overall Study|Disease Progression|21
1821567|NCT00405587|6318161|P2|Overall Study|Disease Progression|23
1821568|NCT00405587|6318162|P1|Overall Study|Disease Progression|22
1821569|NCT00405587|6318159|P4|Overall Study|Death|1
1821570|NCT00405587|6318160|P3|Overall Study|Death|0
1821571|NCT00405587|6318161|P2|Overall Study|Death|0
1821572|NCT00405587|6318162|P1|Overall Study|Death|0
1821573|NCT00405548|6318280|P2|Overall Study|Withdrawal by Subject|0
1821574|NCT00405548|6318281|P1|Overall Study|Withdrawal by Subject|1
1821575|NCT00405548|6318280|P2|Overall Study|Venous access failed during study day|0
1821576|NCT00405548|6318281|P1|Overall Study|Venous access failed during study day|1
1821577|NCT00405548|6318280|P2|Overall Study|Unable to self-administer shots|0
1821578|NCT00405548|6318281|P1|Overall Study|Unable to self-administer shots|1
1821579|NCT00405548|6318280|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
1821580|NCT00405548|6318281|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
1821581|NCT00405548|6318280|P2|Overall Study|Cognitive Memory problems on study day|0
1821582|NCT00405548|6318281|P1|Overall Study|Cognitive Memory problems on study day|1
1821583|NCT00405392|6318325|P2|Overall Study|Other|5
1821584|NCT00405392|6318326|P1|Overall Study|Other|1
1821585|NCT00405392|6318325|P2|Overall Study|Non-compliance|1
1821586|NCT00405392|6318326|P1|Overall Study|Non-compliance|0
1821587|NCT00405392|6318325|P2|Overall Study|Data missing|0
1821588|NCT00405392|6318326|P1|Overall Study|Data missing|2
1821589|NCT00405392|6318325|P2|Overall Study|Lost to Follow-up|2
1821590|NCT00405392|6318326|P1|Overall Study|Lost to Follow-up|1
1821591|NCT00405392|6318325|P2|Overall Study|Withdrawal by Subject|3
1821592|NCT00405392|6318326|P1|Overall Study|Withdrawal by Subject|4
1821593|NCT00405392|6318325|P2|Overall Study|Did not meet Eligibility criteria|2
1821594|NCT00405392|6318326|P1|Overall Study|Did not meet Eligibility criteria|7
1821595|NCT00405392|6318325|P2|Overall Study|Adverse Event|14
1821596|NCT00405392|6318326|P1|Overall Study|Adverse Event|15
1821597|NCT00405275|6318373|P2|Overall Study|Unwilling to continue|9
1821598|NCT00405275|6318374|P1|Overall Study|Unwilling to continue|10
1821599|NCT00405275|6318373|P2|Overall Study|Withdrawal by Subject|9
1821600|NCT00405275|6318374|P1|Overall Study|Withdrawal by Subject|7
1821601|NCT00405275|6318373|P2|Overall Study|Lost to Follow-up|1
1821602|NCT00405275|6318374|P1|Overall Study|Lost to Follow-up|5
1821603|NCT00405275|6318373|P2|Overall Study|Death|0
1821604|NCT00405275|6318374|P1|Overall Study|Death|1
1821605|NCT00405067|6318383|P3|Overall Study|Lost to Follow-up|1
1821606|NCT00405067|6318384|P2|Overall Study|Lost to Follow-up|0
1821607|NCT00405067|6318385|P1|Overall Study|Lost to Follow-up|0
1821608|NCT00405067|6318383|P3|Overall Study|Adverse Event|4
1821609|NCT00405067|6318384|P2|Overall Study|Adverse Event|9
1821610|NCT00405067|6318385|P1|Overall Study|Adverse Event|4
1821611|NCT00404924|6318422|P2|Overall Study|Randomised but not received treatment|1
1821612|NCT00404924|6318423|P1|Overall Study|Randomised but not received treatment|1
1821613|NCT00404924|6318422|P2|Overall Study|Other|11
1821614|NCT00404924|6318423|P1|Overall Study|Other|25
1821615|NCT00404924|6318422|P2|Overall Study|Withdrawal by Subject|13
1821616|NCT00404924|6318423|P1|Overall Study|Withdrawal by Subject|26
1821617|NCT00404924|6318422|P2|Overall Study|Lost to Follow-up|1
1821618|NCT00404924|6318423|P1|Overall Study|Lost to Follow-up|1
1821619|NCT00404924|6318422|P2|Overall Study|Condition under investigation worsened|264
1821620|NCT00404924|6318423|P1|Overall Study|Condition under investigation worsened|475
1821621|NCT00404924|6318422|P2|Overall Study|Adverse Event|16
1821622|NCT00404924|6318423|P1|Overall Study|Adverse Event|75
1821623|NCT00404820|6318441|P2|Overall Study|Other|2
1821624|NCT00404820|6318442|P1|Overall Study|Other|0
1821625|NCT00404820|6318441|P2|Overall Study|Death|0
1821626|NCT00404820|6318442|P1|Overall Study|Death|1
1821627|NCT00404820|6318441|P2|Overall Study|Administrative problems|0
1821628|NCT00404820|6318442|P1|Overall Study|Administrative problems|2
1821629|NCT00404820|6318441|P2|Overall Study|Lost to Follow-up|3
1821630|NCT00404820|6318442|P1|Overall Study|Lost to Follow-up|7
1821631|NCT00404820|6318441|P2|Overall Study|Withdrawal by Subject|3
1821632|NCT00404820|6318442|P1|Overall Study|Withdrawal by Subject|5
1821633|NCT00404820|6318441|P2|Overall Study|Adverse Event|16
1821634|NCT00404820|6318442|P1|Overall Study|Adverse Event|4
1821635|NCT00404768|6318464|P4|Part C|Researcher suspended study medication|1
1821636|NCT00404768|6318465|P3|Part C|Researcher suspended study medication|0
1821637|NCT00404768|6318466|P2|Part C|Researcher suspended study medication|0
1821638|NCT00404768|6318467|P1|Part C|Researcher suspended study medication|0
1821639|NCT00404768|6318464|P4|Part C|Investigator discretion|1
1821640|NCT00404768|6318465|P3|Part C|Investigator discretion|0
1821641|NCT00404768|6318466|P2|Part C|Investigator discretion|0
1821642|NCT00404768|6318467|P1|Part C|Investigator discretion|0
1821643|NCT00404768|6318464|P4|Part C|Treatment failure|1
1821644|NCT00404768|6318465|P3|Part C|Treatment failure|0
1821645|NCT00404768|6318466|P2|Part C|Treatment failure|0
1821646|NCT00404768|6318467|P1|Part C|Treatment failure|0
1821647|NCT00404768|6318464|P4|Part C|Lack of Efficacy|2
1821648|NCT00404768|6318465|P3|Part C|Lack of Efficacy|0
1821649|NCT00404768|6318466|P2|Part C|Lack of Efficacy|0
1821650|NCT00404768|6318467|P1|Part C|Lack of Efficacy|0
1821651|NCT00404768|6318464|P4|Part C|Active labor|1
1821652|NCT00404768|6318465|P3|Part C|Active labor|0
1821653|NCT00404768|6318466|P2|Part C|Active labor|0
1821654|NCT00404768|6318467|P1|Part C|Active labor|0
1821655|NCT00404768|6318464|P4|Part C|Unsatisfactory uterine response to IP|1
1821656|NCT00404768|6318465|P3|Part C|Unsatisfactory uterine response to IP|0
1821657|NCT00404768|6318466|P2|Part C|Unsatisfactory uterine response to IP|0
1821658|NCT00404768|6318467|P1|Part C|Unsatisfactory uterine response to IP|0
1821659|NCT00404768|6318464|P4|Part C|Participant delivered baby|1
1821660|NCT00404768|6318465|P3|Part C|Participant delivered baby|0
1821661|NCT00404768|6318466|P2|Part C|Participant delivered baby|0
1821662|NCT00404768|6318467|P1|Part C|Participant delivered baby|0
1821663|NCT00404768|6318464|P4|Part C|Physician withdrew the study medication|0
1821664|NCT00404768|6318465|P3|Part C|Physician withdrew the study medication|1
1821665|NCT00404768|6318466|P2|Part C|Physician withdrew the study medication|0
1821666|NCT00404768|6318467|P1|Part C|Physician withdrew the study medication|0
1821667|NCT00404768|6318464|P4|Part C|Participant did not respond to therapy|1
1821668|NCT00404768|6318465|P3|Part C|Participant did not respond to therapy|1
1821669|NCT00404768|6318466|P2|Part C|Participant did not respond to therapy|0
1821670|NCT00404768|6318467|P1|Part C|Participant did not respond to therapy|0
1821671|NCT00404768|6318464|P4|Part C|Early withdrawal from study medication|0
1821672|NCT00404768|6318465|P3|Part C|Early withdrawal from study medication|1
1821673|NCT00404768|6318466|P2|Part C|Early withdrawal from study medication|0
1821674|NCT00404768|6318467|P1|Part C|Early withdrawal from study medication|0
1821675|NCT00404768|6318464|P4|Part C|Withdrawal by Subject|1
1821676|NCT00404768|6318465|P3|Part C|Withdrawal by Subject|2
1821677|NCT00404768|6318466|P2|Part C|Withdrawal by Subject|0
1821678|NCT00404768|6318467|P1|Part C|Withdrawal by Subject|0
1821679|NCT00404768|6318464|P4|Part C|Lost to Follow-up|1
1821680|NCT00404768|6318465|P3|Part C|Lost to Follow-up|3
1821681|NCT00404768|6318466|P2|Part C|Lost to Follow-up|0
1821682|NCT00404768|6318467|P1|Part C|Lost to Follow-up|0
1821683|NCT00404768|6318464|P4|Part C|Adverse Event|3
1821684|NCT00404768|6318465|P3|Part C|Adverse Event|0
1821685|NCT00404768|6318466|P2|Part C|Adverse Event|0
1821686|NCT00404768|6318467|P1|Part C|Adverse Event|0
1821687|NCT00404768|6318464|P4|Part A and B|Withdrawn as delivery imminemnt|0
1821688|NCT00404768|6318465|P3|Part A and B|Withdrawn as delivery imminemnt|0
1821689|NCT00404768|6318466|P2|Part A and B|Withdrawn as delivery imminemnt|1
1821690|NCT00404768|6318467|P1|Part A and B|Withdrawn as delivery imminemnt|0
1821691|NCT00404768|6318464|P4|Part A and B|Withdrawn due to labor progression|0
1821692|NCT00404768|6318465|P3|Part A and B|Withdrawn due to labor progression|0
1821693|NCT00404768|6318466|P2|Part A and B|Withdrawn due to labor progression|0
1821694|NCT00404768|6318467|P1|Part A and B|Withdrawn due to labor progression|1
1821695|NCT00404755|6318528|P1|Phase II (Escitalopram)|Lost to Follow-up|2
1821696|NCT00404755|6318528|P1|Phase I (Bupropion)|Other|1
1821697|NCT00404755|6318528|P1|Phase I (Bupropion)|Adverse Event|3
1821698|NCT00404651|6318543|P4|Overall Study|Withdrawal by Subject|6
1821699|NCT00404651|6318544|P3|Overall Study|Withdrawal by Subject|16
1821700|NCT00404651|6318545|P2|Overall Study|Withdrawal by Subject|12
1821701|NCT00404651|6318546|P1|Overall Study|Withdrawal by Subject|14
1821702|NCT00404651|6318543|P4|Overall Study|Lost to Follow-up|10
1821703|NCT00404651|6318544|P3|Overall Study|Lost to Follow-up|13
1821704|NCT00404651|6318545|P2|Overall Study|Lost to Follow-up|11
1821705|NCT00404651|6318546|P1|Overall Study|Lost to Follow-up|15
1821706|NCT00404651|6318543|P4|Overall Study|Protocol Violation|5
1821707|NCT00404651|6318544|P3|Overall Study|Protocol Violation|14
1821708|NCT00404651|6318545|P2|Overall Study|Protocol Violation|5
1821709|NCT00404651|6318546|P1|Overall Study|Protocol Violation|10
1821710|NCT00404651|6318543|P4|Overall Study|Serious Adverse Event|0
1821711|NCT00404651|6318544|P3|Overall Study|Serious Adverse Event|2
1821712|NCT00404651|6318545|P2|Overall Study|Serious Adverse Event|0
1821713|NCT00404651|6318546|P1|Overall Study|Serious Adverse Event|0
1821714|NCT00404547|6318574|P2|Overall Study|Reason not stated|6
1821715|NCT00404547|6318575|P1|Overall Study|Reason not stated|3
1821716|NCT00404547|6318574|P2|Overall Study|Other|0
1821717|NCT00404547|6318575|P1|Overall Study|Other|4
1821718|NCT00404547|6318574|P2|Overall Study|Lack of compliance|1
1821719|NCT00404547|6318575|P1|Overall Study|Lack of compliance|5
1821720|NCT00404547|6318574|P2|Overall Study|Lost to Follow-up|9
1821721|NCT00404547|6318575|P1|Overall Study|Lost to Follow-up|20
1821722|NCT00404547|6318574|P2|Overall Study|Protocol Violation|1
1821723|NCT00404547|6318575|P1|Overall Study|Protocol Violation|0
1821724|NCT00404547|6318574|P2|Overall Study|Withdrawal by Subject|2
1821725|NCT00404547|6318575|P1|Overall Study|Withdrawal by Subject|19
1821726|NCT00404547|6318574|P2|Overall Study|Adverse Event|6
1821727|NCT00404547|6318575|P1|Overall Study|Adverse Event|39
1821728|NCT00404495|6318585|P2|Overall Study|Withdrawal by Subject|0
1821729|NCT00404495|6318586|P1|Overall Study|Withdrawal by Subject|1
1821730|NCT00404495|6318585|P2|Overall Study|Other|0
1821731|NCT00404495|6318586|P1|Overall Study|Other|1
1821732|NCT00404495|6318585|P2|Overall Study|Lost to Follow-up|0
1821733|NCT00404495|6318586|P1|Overall Study|Lost to Follow-up|5
1821734|NCT00404495|6318585|P2|Overall Study|Death|11
1821735|NCT00404495|6318586|P1|Overall Study|Death|37
1821736|NCT00404352|6318605|P9|Open Label Extension (up to 36 Months)|Other|2
1821737|NCT00404352|6318606|P8|Open Label Extension (up to 36 Months)|Other|0
1821738|NCT00404352|6318607|P7|Open Label Extension (up to 36 Months)|Other|0
1821739|NCT00404352|6318608|P6|Open Label Extension (up to 36 Months)|Other|0
1821740|NCT00404352|6318609|P5|Open Label Extension (up to 36 Months)|Other|0
1821741|NCT00404352|6318610|P4|Open Label Extension (up to 36 Months)|Other|0
1821742|NCT00404352|6318611|P3|Open Label Extension (up to 36 Months)|Other|0
1821743|NCT00404352|6318612|P2|Open Label Extension (up to 36 Months)|Other|0
1821744|NCT00404352|6318613|P1|Open Label Extension (up to 36 Months)|Other|0
1821745|NCT00404352|6318605|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
1821746|NCT00404352|6318606|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
1821747|NCT00404352|6318607|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
1821748|NCT00404352|6318608|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
1821749|NCT00404352|6318609|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
1821750|NCT00404352|6318610|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
1821751|NCT00404352|6318611|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
1821752|NCT00404352|6318612|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
1821753|NCT00404352|6318613|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
1821754|NCT00404352|6318605|P9|Open Label (up to 24 Month)|Disease progression|0
1821755|NCT00404352|6318606|P8|Open Label (up to 24 Month)|Disease progression|0
1821756|NCT00404352|6318607|P7|Open Label (up to 24 Month)|Disease progression|0
1821757|NCT00404352|6318608|P6|Open Label (up to 24 Month)|Disease progression|0
1821758|NCT00404352|6318609|P5|Open Label (up to 24 Month)|Disease progression|0
1821759|NCT00404352|6318610|P4|Open Label (up to 24 Month)|Disease progression|1
1821760|NCT00404352|6318611|P3|Open Label (up to 24 Month)|Disease progression|0
1821761|NCT00404352|6318612|P2|Open Label (up to 24 Month)|Disease progression|0
1821762|NCT00404352|6318613|P1|Open Label (up to 24 Month)|Disease progression|0
1821763|NCT00404352|6318605|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821764|NCT00404352|6318606|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821765|NCT00404352|6318607|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821766|NCT00404352|6318608|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
1821767|NCT00404352|6318609|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821768|NCT00404352|6318610|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821769|NCT00404352|6318611|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821770|NCT00404352|6318612|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821771|NCT00404352|6318613|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
1821772|NCT00404352|6318605|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
1821773|NCT00404352|6318606|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
1821774|NCT00404352|6318607|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
1821775|NCT00404352|6318608|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
1821776|NCT00404352|6318609|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
1821777|NCT00404352|6318610|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
1821778|NCT00404352|6318611|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
1821779|NCT00404352|6318612|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
1821780|NCT00404352|6318613|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
1821781|NCT00404352|6318605|P9|Open Label (up to 24 Month)|Pregnancy|0
1821782|NCT00404352|6318606|P8|Open Label (up to 24 Month)|Pregnancy|0
1821783|NCT00404352|6318607|P7|Open Label (up to 24 Month)|Pregnancy|0
1821784|NCT00404352|6318608|P6|Open Label (up to 24 Month)|Pregnancy|1
1821785|NCT00404352|6318609|P5|Open Label (up to 24 Month)|Pregnancy|0
1821786|NCT00404352|6318610|P4|Open Label (up to 24 Month)|Pregnancy|0
1821787|NCT00404352|6318611|P3|Open Label (up to 24 Month)|Pregnancy|0
1821788|NCT00404352|6318612|P2|Open Label (up to 24 Month)|Pregnancy|0
1821789|NCT00404352|6318613|P1|Open Label (up to 24 Month)|Pregnancy|0
1821790|NCT00404352|6318605|P9|Open Label (up to 24 Month)|Adverse Event|0
1821791|NCT00404352|6318606|P8|Open Label (up to 24 Month)|Adverse Event|0
1821792|NCT00404352|6318607|P7|Open Label (up to 24 Month)|Adverse Event|0
1821793|NCT00404352|6318608|P6|Open Label (up to 24 Month)|Adverse Event|1
1821794|NCT00404352|6318609|P5|Open Label (up to 24 Month)|Adverse Event|1
1821795|NCT00404352|6318610|P4|Open Label (up to 24 Month)|Adverse Event|2
1821796|NCT00404352|6318611|P3|Open Label (up to 24 Month)|Adverse Event|0
1821797|NCT00404352|6318612|P2|Open Label (up to 24 Month)|Adverse Event|0
1821798|NCT00404352|6318613|P1|Open Label (up to 24 Month)|Adverse Event|0
1821799|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Other|0
1821800|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Other|0
1821801|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Other|0
1821802|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Other|0
1821803|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Other|0
1821804|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Other|0
1821805|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Other|0
1821806|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Other|1
1821807|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Other|0
1821808|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Physician Decision|0
1821809|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Physician Decision|0
1821810|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Physician Decision|0
1821811|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Physician Decision|0
1821812|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Physician Decision|0
1821813|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Physician Decision|0
1821814|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Physician Decision|1
1821815|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Physician Decision|0
1821816|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Physician Decision|0
1821817|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
1821818|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
1821819|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
1821820|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
1821821|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
1821822|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
1821823|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
1821824|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
1821825|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
1821826|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
1821827|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
1821828|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
1821829|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
1821830|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
1821831|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
1821832|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
1821833|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
1821834|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
1821835|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Poor compliance|0
1821836|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Poor compliance|0
1821837|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Poor compliance|0
1821838|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Poor compliance|0
1821839|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Poor compliance|0
1821840|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Poor compliance|0
1821841|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Poor compliance|0
1821842|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Poor compliance|0
1821843|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Poor compliance|1
1821844|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Disease progression|0
1821845|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Disease progression|0
1821846|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Disease progression|0
1821847|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Disease progression|0
1821848|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Disease progression|0
1821849|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Disease progression|0
1821850|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Disease progression|2
1821851|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Disease progression|0
1821852|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Disease progression|3
1821853|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1821854|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1821855|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1821856|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1821857|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1821858|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
1821859|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
1821860|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
1821861|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
1821862|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
1821863|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
1821864|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
1821865|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
1821866|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
1821867|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
1821868|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
1821869|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
1821870|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
1821871|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Death|0
1821872|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Death|0
1821873|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Death|0
1821874|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Death|0
1821875|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Death|0
1821876|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Death|0
1821877|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Death|1
1821878|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Death|0
1821879|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Death|0
1821880|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Pregnancy|0
1821881|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Pregnancy|0
1821882|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Pregnancy|0
1821883|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Pregnancy|0
1821884|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Pregnancy|0
1821885|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Pregnancy|0
1821886|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Pregnancy|2
1821887|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Pregnancy|0
1821888|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Pregnancy|0
1821889|NCT00404352|6318605|P9|Double Blind (up to 24 Month)|Adverse Event|0
1821890|NCT00404352|6318606|P8|Double Blind (up to 24 Month)|Adverse Event|0
1821891|NCT00404352|6318607|P7|Double Blind (up to 24 Month)|Adverse Event|0
1821892|NCT00404352|6318608|P6|Double Blind (up to 24 Month)|Adverse Event|0
1821893|NCT00404352|6318609|P5|Double Blind (up to 24 Month)|Adverse Event|0
1821894|NCT00404352|6318610|P4|Double Blind (up to 24 Month)|Adverse Event|0
1821895|NCT00404352|6318611|P3|Double Blind (up to 24 Month)|Adverse Event|6
1821896|NCT00404352|6318612|P2|Double Blind (up to 24 Month)|Adverse Event|4
1821897|NCT00404352|6318613|P1|Double Blind (up to 24 Month)|Adverse Event|5
1821898|NCT00404248|6318648|P9|Overall Study|pts declining status|0
1821899|NCT00404248|6318649|P8|Overall Study|pts declining status|0
1821900|NCT00404248|6318650|P7|Overall Study|pts declining status|0
1821901|NCT00404248|6318651|P6|Overall Study|pts declining status|0
1821902|NCT00404248|6318652|P5|Overall Study|pts declining status|0
1821903|NCT00404248|6318653|P4|Overall Study|pts declining status|0
1821904|NCT00404248|6318654|P3|Overall Study|pts declining status|0
1821905|NCT00404248|6318655|P2|Overall Study|pts declining status|1
1821906|NCT00404248|6318656|P1|Overall Study|pts declining status|0
1821907|NCT00404235|6318689|P2|Overall Study|Withdrawal by Subject|2
1821908|NCT00404235|6318690|P1|Overall Study|Withdrawal by Subject|1
1821909|NCT00404092|6318708|P4|Overall Study|Adverse Event|0
1821910|NCT00404092|6318709|P3|Overall Study|Adverse Event|1
1821911|NCT00404092|6318710|P2|Overall Study|Adverse Event|0
1821912|NCT00404092|6318711|P1|Overall Study|Adverse Event|0
1821913|NCT00404092|6318708|P4|Overall Study|Death|0
1821914|NCT00404092|6318709|P3|Overall Study|Death|0
1821915|NCT00404092|6318710|P2|Overall Study|Death|0
1821916|NCT00404092|6318711|P1|Overall Study|Death|1
1821917|NCT00404079|6318727|P2|Overall Study|Lost to follow up, adverse event etc|20
1821918|NCT00404079|6318728|P1|Overall Study|Lost to follow up, adverse event etc|22
1821919|NCT00404066|6318734|P1|Overall Study|Withdrawal by Subject - Adverse event|2
1821920|NCT00404066|6318734|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
1821921|NCT00403845|6318739|P4|Treatment Period 3|Adverse Event|1
1821922|NCT00403845|6318740|P3|Treatment Period 3|Adverse Event|0
1821923|NCT00403845|6318741|P2|Treatment Period 3|Adverse Event|0
1821924|NCT00403845|6318742|P1|Treatment Period 3|Adverse Event|0
1821925|NCT00403845|6318739|P4|Treatment Period 3|Subject withdrew consent|1
1821926|NCT00403845|6318740|P3|Treatment Period 3|Subject withdrew consent|0
1821927|NCT00403845|6318741|P2|Treatment Period 3|Subject withdrew consent|0
1821928|NCT00403845|6318742|P1|Treatment Period 3|Subject withdrew consent|0
1821929|NCT00403845|6318739|P4|Treatment Period 2|Subject withdrew consent|0
1821930|NCT00403845|6318740|P3|Treatment Period 2|Subject withdrew consent|0
1821931|NCT00403845|6318741|P2|Treatment Period 2|Subject withdrew consent|0
1821932|NCT00403845|6318742|P1|Treatment Period 2|Subject withdrew consent|1
1821933|NCT00403845|6318739|P4|Treatment Period 1|Subject no longer needs study drug|1
1821934|NCT00403845|6318740|P3|Treatment Period 1|Subject no longer needs study drug|0
1821935|NCT00403845|6318741|P2|Treatment Period 1|Subject no longer needs study drug|0
1821936|NCT00403845|6318742|P1|Treatment Period 1|Subject no longer needs study drug|0
1821937|NCT00403845|6318739|P4|Treatment Period 1|Subject withdrew consent|0
1821938|NCT00403845|6318740|P3|Treatment Period 1|Subject withdrew consent|0
1821939|NCT00403845|6318741|P2|Treatment Period 1|Subject withdrew consent|0
1821940|NCT00403845|6318742|P1|Treatment Period 1|Subject withdrew consent|1
1821941|NCT00403767|6318766|P2|Overall Study|Missing/incomplete data|1
1821942|NCT00403767|6318767|P1|Overall Study|Missing/incomplete data|1
1821943|NCT00403767|6318766|P2|Overall Study|Study terminated by sponsor|69
1821944|NCT00403767|6318767|P1|Overall Study|Study terminated by sponsor|82
1821945|NCT00403767|6318766|P2|Overall Study|Clinical efficacy endpoint reached|332
1821946|NCT00403767|6318767|P1|Overall Study|Clinical efficacy endpoint reached|300
1821947|NCT00403767|6318766|P2|Overall Study|Protocol Violation|124
1821948|NCT00403767|6318767|P1|Overall Study|Protocol Violation|142
1821949|NCT00403767|6318766|P2|Overall Study|Lost to Follow-up|8
1821950|NCT00403767|6318767|P1|Overall Study|Lost to Follow-up|6
1821951|NCT00403767|6318766|P2|Overall Study|Investigator dec./not protocol-related|178
1821952|NCT00403767|6318767|P1|Overall Study|Investigator dec./not protocol-related|191
1821953|NCT00403767|6318766|P2|Overall Study|Consent withdrawn|673
1821954|NCT00403767|6318767|P1|Overall Study|Consent withdrawn|671
1821955|NCT00403767|6318766|P2|Overall Study|Non-compliant with study medication|164
1821956|NCT00403767|6318767|P1|Overall Study|Non-compliant with study medication|134
1821957|NCT00403767|6318766|P2|Overall Study|Adverse Event|919
1821958|NCT00403767|6318767|P1|Overall Study|Adverse Event|993
1821959|NCT00403754|6318791|P4|Core Treatment Period 2|Lack of Efficacy|0
1821960|NCT00403754|6318792|P3|Core Treatment Period 2|Lack of Efficacy|1
1821961|NCT00403754|6318793|P2|Core Treatment Period 2|Lack of Efficacy|0
1821962|NCT00403754|6318794|P1|Core Treatment Period 2|Lack of Efficacy|0
1821963|NCT00403754|6318791|P4|Core Treatment Period 1|Withdrawal by Subject|0
1821964|NCT00403754|6318792|P3|Core Treatment Period 1|Withdrawal by Subject|0
1821965|NCT00403754|6318793|P2|Core Treatment Period 1|Withdrawal by Subject|1
1821966|NCT00403754|6318794|P1|Core Treatment Period 1|Withdrawal by Subject|0
1821967|NCT00403585|6318821|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
1821968|NCT00403585|6318821|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
1821969|NCT00403585|6318821|P1|Initial Treatment Phase|Lost to Follow-up|2
1821970|NCT00403546|6318832|P3|Randomized Trial|Early Terminations|16
1821971|NCT00403546|6318833|P2|Randomized Trial|Early Terminations|17
1821972|NCT00403546|6318834|P1|Randomized Trial|Early Terminations|0
1821973|NCT00403546|6318832|P3|Screening Phase|Terminated Prior to Randomization|0
1821974|NCT00403546|6318833|P2|Screening Phase|Terminated Prior to Randomization|0
1821975|NCT00403546|6318834|P1|Screening Phase|Terminated Prior to Randomization|5
1821976|NCT00403546|6318832|P3|Screening Phase|Adverse Event|0
1821977|NCT00403546|6318833|P2|Screening Phase|Adverse Event|0
1821978|NCT00403546|6318834|P1|Screening Phase|Adverse Event|1
1821979|NCT00403546|6318832|P3|Screening Phase|Screening Failure|0
1821980|NCT00403546|6318833|P2|Screening Phase|Screening Failure|0
1821981|NCT00403546|6318834|P1|Screening Phase|Screening Failure|22
1821982|NCT00403546|6318832|P3|Signed Informed Consent/Open-Label|Adverse Event|0
1821983|NCT00403546|6318833|P2|Signed Informed Consent/Open-Label|Adverse Event|0
1821984|NCT00403546|6318834|P1|Signed Informed Consent/Open-Label|Adverse Event|5
1821985|NCT00403546|6318832|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1821986|NCT00403546|6318833|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
1821987|NCT00403546|6318834|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
1821988|NCT00403546|6318832|P3|Signed Informed Consent/Open-Label|Early Termination|0
1821989|NCT00403546|6318833|P2|Signed Informed Consent/Open-Label|Early Termination|0
1821990|NCT00403546|6318834|P1|Signed Informed Consent/Open-Label|Early Termination|8
1821991|NCT00403546|6318832|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
1821992|NCT00403546|6318833|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
1821993|NCT00403546|6318834|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
1821994|NCT00403481|6318874|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
1821995|NCT00403481|6318874|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
1821996|NCT00403481|6318874|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
1821997|NCT00403481|6318874|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
1821998|NCT00403481|6318874|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
1821999|NCT00403481|6318874|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
1822000|NCT00403481|6318874|P1|Olm 40 mg|Other|1
1822001|NCT00403481|6318874|P1|Olm 40 mg|Withdrawal by Subject|1
1822002|NCT00403481|6318874|P1|Olm 40 mg|Protocol Violation|1
1822003|NCT00403481|6318874|P1|Olm 40 mg|Adverse Event|2
1822004|NCT00403481|6318874|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
1822005|NCT00403481|6318874|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
1822006|NCT00403481|6318874|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
1822007|NCT00403481|6318874|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
1822008|NCT00403455|6318889|P1|Overall Study|Withdrawal by Subject|1
1822009|NCT00403390|6318912|P2|Overall Study|non-compliant|0
1822010|NCT00403390|6318913|P1|Overall Study|non-compliant|1
1822011|NCT00403390|6318912|P2|Overall Study|samples lost|0
1822012|NCT00403390|6318913|P1|Overall Study|samples lost|1
1822013|NCT00403390|6318912|P2|Overall Study|Withdrawal by Subject|0
1822014|NCT00403390|6318913|P1|Overall Study|Withdrawal by Subject|1
1822015|NCT00403273|6318921|P2|Overall Study|pt. wanted to have a surgical procedure|1
1822016|NCT00403273|6318922|P1|Overall Study|pt. wanted to have a surgical procedure|0
1822017|NCT00403273|6318921|P2|Overall Study|Physician Decision|1
1822018|NCT00403273|6318922|P1|Overall Study|Physician Decision|0
1822019|NCT00403273|6318921|P2|Overall Study|Lost to Follow-up|2
1822020|NCT00403273|6318922|P1|Overall Study|Lost to Follow-up|3
1822021|NCT00403234|6318964|P4|Overall Study|Adverse Event|0
1822022|NCT00403234|6318965|P3|Overall Study|Adverse Event|1
1822023|NCT00403234|6318966|P2|Overall Study|Adverse Event|0
1822024|NCT00403234|6318967|P1|Overall Study|Adverse Event|1
1822025|NCT00403234|6318964|P4|Overall Study|Withdrawal by Subject|0
1822026|NCT00403234|6318965|P3|Overall Study|Withdrawal by Subject|0
1822027|NCT00403234|6318966|P2|Overall Study|Withdrawal by Subject|1
1822028|NCT00403234|6318967|P1|Overall Study|Withdrawal by Subject|0
1822029|NCT00403130|6318977|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
1822030|NCT00403130|6318977|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
1822031|NCT00403130|6318977|P1|2 Years From Start of Treatment|Lost to Follow up|1
1822032|NCT00403130|6318977|P1|2 Years From Start of Treatment|Not Eligible|3
1822033|NCT00402987|6319030|P4|Overall Study|Lack of Efficacy|0
1822034|NCT00402987|6319031|P3|Overall Study|Lack of Efficacy|1
1822035|NCT00402987|6319032|P2|Overall Study|Lack of Efficacy|0
1822036|NCT00402987|6319033|P1|Overall Study|Lack of Efficacy|0
1822037|NCT00402831|6319205|P2|Overall Study|Non-compliance with protocol|1
1822038|NCT00402831|6319206|P1|Overall Study|Non-compliance with protocol|0
1822039|NCT00402831|6319205|P2|Overall Study|Lost to Follow-up|2
1822040|NCT00402831|6319206|P1|Overall Study|Lost to Follow-up|1
1822041|NCT00402740|6319238|P1|Overall Study|Subject disposition unknown.|1
1822042|NCT00402740|6319238|P1|Overall Study|No stent. Completed FU at 30 days.|5
1822043|NCT00402740|6319238|P1|Overall Study|Lost to Follow-up|6
1822044|NCT00402740|6319238|P1|Overall Study|Death|50
1822045|NCT00402740|6319238|P1|Overall Study|Withdrawal by Subject|18
1822046|NCT00402727|6319250|P2|Overall Study|non-compliance|1
1822047|NCT00402727|6319251|P1|Overall Study|non-compliance|0
1822048|NCT00402727|6319250|P2|Overall Study|supply problems|1
1822049|NCT00402727|6319251|P1|Overall Study|supply problems|2
1822050|NCT00402727|6319250|P2|Overall Study|Withdrawal by Subject|7
1822051|NCT00402727|6319251|P1|Overall Study|Withdrawal by Subject|3
1822052|NCT00402727|6319250|P2|Overall Study|Protocol Violation|4
1822053|NCT00402727|6319251|P1|Overall Study|Protocol Violation|0
1822054|NCT00402727|6319250|P2|Overall Study|Physician Decision|1
1822055|NCT00402727|6319251|P1|Overall Study|Physician Decision|1
1822056|NCT00402727|6319250|P2|Overall Study|Lost to Follow-up|11
1822057|NCT00402727|6319251|P1|Overall Study|Lost to Follow-up|24
1822058|NCT00402727|6319250|P2|Overall Study|Lack of Efficacy|3
1822059|NCT00402727|6319251|P1|Overall Study|Lack of Efficacy|1
1822060|NCT00402727|6319250|P2|Overall Study|Death|0
1822061|NCT00402727|6319251|P1|Overall Study|Death|1
1822062|NCT00402727|6319250|P2|Overall Study|Adverse Event|6
1822063|NCT00402727|6319251|P1|Overall Study|Adverse Event|10
1822064|NCT00402688|6319293|P3|Overall Study|Patient Left Town and Forgot Medication|1
1822065|NCT00402688|6319294|P2|Overall Study|Patient Left Town and Forgot Medication|0
1822066|NCT00402688|6319295|P1|Overall Study|Patient Left Town and Forgot Medication|0
1822067|NCT00402688|6319293|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
1822068|NCT00402688|6319294|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1822069|NCT00402688|6319295|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
1822070|NCT00402688|6319293|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
1822071|NCT00402688|6319294|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
1822072|NCT00402688|6319295|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
1822073|NCT00402688|6319293|P3|Overall Study|Lost to Follow-up|2
1822074|NCT00402688|6319294|P2|Overall Study|Lost to Follow-up|0
1822075|NCT00402688|6319295|P1|Overall Study|Lost to Follow-up|1
1822076|NCT00402688|6319293|P3|Overall Study|Protocol Violation|1
1822077|NCT00402688|6319294|P2|Overall Study|Protocol Violation|1
1822078|NCT00402688|6319295|P1|Overall Study|Protocol Violation|1
1822079|NCT00402688|6319293|P3|Overall Study|Lack of Efficacy|5
1822080|NCT00402688|6319294|P2|Overall Study|Lack of Efficacy|4
1822081|NCT00402688|6319295|P1|Overall Study|Lack of Efficacy|4
1822082|NCT00402688|6319293|P3|Overall Study|Physician Decision|1
1822083|NCT00402688|6319294|P2|Overall Study|Physician Decision|0
1822084|NCT00402688|6319295|P1|Overall Study|Physician Decision|0
1822085|NCT00402688|6319293|P3|Overall Study|Withdrawal by Subject|1
1822086|NCT00402688|6319294|P2|Overall Study|Withdrawal by Subject|1
1822087|NCT00402688|6319295|P1|Overall Study|Withdrawal by Subject|3
1822088|NCT00402688|6319293|P3|Overall Study|Adverse Event|3
1822089|NCT00402688|6319294|P2|Overall Study|Adverse Event|9
1822090|NCT00402688|6319295|P1|Overall Study|Adverse Event|12
1822091|NCT00402649|6319318|P1|Overall Study|Withdrawal by Subject|1
1822092|NCT00402649|6319318|P1|Overall Study|Lost to Follow-up|1
1822093|NCT00402597|6319333|P5|Overall Study|reason not specified|20
1822094|NCT00402597|6319334|P4|Overall Study|reason not specified|14
1822095|NCT00402597|6319335|P3|Overall Study|reason not specified|27
1822096|NCT00402597|6319336|P2|Overall Study|reason not specified|4
1822097|NCT00402597|6319337|P1|Overall Study|reason not specified|30
1822098|NCT00402597|6319333|P5|Overall Study|Withdrawal by Subject|24
1822099|NCT00402597|6319334|P4|Overall Study|Withdrawal by Subject|15
1822100|NCT00402597|6319335|P3|Overall Study|Withdrawal by Subject|65
1822101|NCT00402597|6319336|P2|Overall Study|Withdrawal by Subject|16
1822102|NCT00402597|6319337|P1|Overall Study|Withdrawal by Subject|57
1822103|NCT00402597|6319333|P5|Overall Study|Lost to Follow-up|3
1822104|NCT00402597|6319334|P4|Overall Study|Lost to Follow-up|2
1822105|NCT00402597|6319335|P3|Overall Study|Lost to Follow-up|8
1822106|NCT00402597|6319336|P2|Overall Study|Lost to Follow-up|1
1822107|NCT00402597|6319337|P1|Overall Study|Lost to Follow-up|8
1822108|NCT00402597|6319333|P5|Overall Study|Adverse Event|71
1822109|NCT00402597|6319334|P4|Overall Study|Adverse Event|39
1822110|NCT00402597|6319335|P3|Overall Study|Adverse Event|106
1822111|NCT00402597|6319336|P2|Overall Study|Adverse Event|18
1822112|NCT00402597|6319337|P1|Overall Study|Adverse Event|81
1822113|NCT00402597|6319333|P5|Overall Study|Death|6
1822114|NCT00402597|6319334|P4|Overall Study|Death|4
1822115|NCT00402597|6319335|P3|Overall Study|Death|6
1822116|NCT00402597|6319336|P2|Overall Study|Death|7
1822117|NCT00402597|6319337|P1|Overall Study|Death|15
1822118|NCT00402363|6319378|P4|Overall Study|"Captured as Other"|2
1822119|NCT00402363|6319379|P3|Overall Study|"Captured as Other"|2
1822120|NCT00402363|6319380|P2|Overall Study|"Captured as Other"|2
1822121|NCT00402363|6319381|P1|Overall Study|"Captured as Other"|6
1822122|NCT00402363|6319378|P4|Overall Study|Lost to Follow-up|2
1822123|NCT00402363|6319379|P3|Overall Study|Lost to Follow-up|0
1822124|NCT00402363|6319380|P2|Overall Study|Lost to Follow-up|4
1822125|NCT00402363|6319381|P1|Overall Study|Lost to Follow-up|5
1822126|NCT00402363|6319378|P4|Overall Study|Protocol Violation|3
1822127|NCT00402363|6319379|P3|Overall Study|Protocol Violation|0
1822128|NCT00402363|6319380|P2|Overall Study|Protocol Violation|5
1822129|NCT00402363|6319381|P1|Overall Study|Protocol Violation|3
1822130|NCT00402363|6319378|P4|Overall Study|Withdrew Consent|1
1822131|NCT00402363|6319379|P3|Overall Study|Withdrew Consent|2
1822132|NCT00402363|6319380|P2|Overall Study|Withdrew Consent|5
1822133|NCT00402363|6319381|P1|Overall Study|Withdrew Consent|10
1822134|NCT00402363|6319378|P4|Overall Study|Adverse Event|2
1822135|NCT00402363|6319379|P3|Overall Study|Adverse Event|2
1822136|NCT00402363|6319380|P2|Overall Study|Adverse Event|14
1822137|NCT00402363|6319381|P1|Overall Study|Adverse Event|9
1822138|NCT00402337|6319444|P5|Overall Study|Other Reason|0
1822139|NCT00402337|6319445|P4|Overall Study|Other Reason|0
1822140|NCT00402337|6319446|P3|Overall Study|Other Reason|0
1822141|NCT00402337|6319447|P2|Overall Study|Other Reason|1
1822142|NCT00402337|6319448|P1|Overall Study|Other Reason|0
1822143|NCT00402337|6319444|P5|Overall Study|Physician Decision|0
1822144|NCT00402337|6319445|P4|Overall Study|Physician Decision|1
1822145|NCT00402337|6319446|P3|Overall Study|Physician Decision|0
1822146|NCT00402337|6319447|P2|Overall Study|Physician Decision|0
1822147|NCT00402337|6319448|P1|Overall Study|Physician Decision|0
1822148|NCT00402337|6319444|P5|Overall Study|Lost to Follow-up|0
1822149|NCT00402337|6319445|P4|Overall Study|Lost to Follow-up|2
1822150|NCT00402337|6319446|P3|Overall Study|Lost to Follow-up|1
1822151|NCT00402337|6319447|P2|Overall Study|Lost to Follow-up|0
1822152|NCT00402337|6319448|P1|Overall Study|Lost to Follow-up|0
1822153|NCT00402337|6319444|P5|Overall Study|Withdrawal by Subject|4
1822154|NCT00402337|6319445|P4|Overall Study|Withdrawal by Subject|6
1822155|NCT00402337|6319446|P3|Overall Study|Withdrawal by Subject|1
1822156|NCT00402337|6319447|P2|Overall Study|Withdrawal by Subject|3
1822157|NCT00402337|6319448|P1|Overall Study|Withdrawal by Subject|5
1822158|NCT00402337|6319444|P5|Overall Study|Noncompliance|2
1822159|NCT00402337|6319445|P4|Overall Study|Noncompliance|0
1822160|NCT00402337|6319446|P3|Overall Study|Noncompliance|0
1822161|NCT00402337|6319447|P2|Overall Study|Noncompliance|0
1822162|NCT00402337|6319448|P1|Overall Study|Noncompliance|0
1822163|NCT00402337|6319444|P5|Overall Study|Adverse Event|2
1822164|NCT00402337|6319445|P4|Overall Study|Adverse Event|3
1822165|NCT00402337|6319446|P3|Overall Study|Adverse Event|2
1822166|NCT00402337|6319447|P2|Overall Study|Adverse Event|2
1822167|NCT00402337|6319448|P1|Overall Study|Adverse Event|0
1822168|NCT00402324|6319487|P2|Overall Study|Death|0
1822169|NCT00402324|6319488|P1|Overall Study|Death|1
1822170|NCT00402324|6319487|P2|Overall Study|Adverse Event|4
1822171|NCT00402324|6319488|P1|Overall Study|Adverse Event|6
1822172|NCT00402324|6319487|P2|Overall Study|Lack of Efficacy|4
1822173|NCT00402324|6319488|P1|Overall Study|Lack of Efficacy|1
1822174|NCT00402324|6319487|P2|Overall Study|Sponsor Decision|5
1822175|NCT00402324|6319488|P1|Overall Study|Sponsor Decision|4
1822176|NCT00402324|6319487|P2|Overall Study|Physician Decision|4
1822177|NCT00402324|6319488|P1|Overall Study|Physician Decision|2
1822178|NCT00402324|6319487|P2|Overall Study|Withdrawal by Subject|2
1822179|NCT00402324|6319488|P1|Overall Study|Withdrawal by Subject|5
1822180|NCT00402324|6319487|P2|Overall Study|Protocol Violation|7
1822181|NCT00402324|6319488|P1|Overall Study|Protocol Violation|8
1822182|NCT00402324|6319487|P2|Overall Study|Protocol Entry Criteria Not Met|4
1822183|NCT00402324|6319488|P1|Overall Study|Protocol Entry Criteria Not Met|5
1822184|NCT00402324|6319487|P2|Overall Study|Lost to Follow-up|11
1822185|NCT00402324|6319488|P1|Overall Study|Lost to Follow-up|11
1822186|NCT00402285|6319521|P3|Overall Study|insufficient RNA quality|2
1822187|NCT00402285|6319522|P2|Overall Study|insufficient RNA quality|6
1822188|NCT00402285|6319523|P1|Overall Study|insufficient RNA quality|7
1822189|NCT00402246|6319531|P2|Overall Study|Deterioriating Condition|2
1822190|NCT00402246|6319532|P1|Overall Study|Deterioriating Condition|3
1822191|NCT00402246|6319531|P2|Overall Study|Center Closure|3
1822192|NCT00402246|6319532|P1|Overall Study|Center Closure|5
1822193|NCT00402246|6319531|P2|Overall Study|Patient's device explanted|2
1822194|NCT00402246|6319532|P1|Overall Study|Patient's device explanted|6
1822195|NCT00402246|6319531|P2|Overall Study|Heart Transplant|1
1822196|NCT00402246|6319532|P1|Overall Study|Heart Transplant|0
1822197|NCT00402246|6319531|P2|Overall Study|Insurance Issues|1
1822198|NCT00402246|6319532|P1|Overall Study|Insurance Issues|2
1822199|NCT00402246|6319531|P2|Overall Study|Missed Final Visit|2
1822200|NCT00402246|6319532|P1|Overall Study|Missed Final Visit|1
1822201|NCT00402246|6319531|P2|Overall Study|Protocol Violation|24
1822202|NCT00402246|6319532|P1|Overall Study|Protocol Violation|25
1822203|NCT00402246|6319531|P2|Overall Study|Physician Decision|26
1822204|NCT00402246|6319532|P1|Overall Study|Physician Decision|24
1822205|NCT00402246|6319531|P2|Overall Study|Withdrawal by Subject|87
1822206|NCT00402246|6319532|P1|Overall Study|Withdrawal by Subject|72
1822207|NCT00402246|6319531|P2|Overall Study|Lost to Follow-up|28
1822208|NCT00402246|6319532|P1|Overall Study|Lost to Follow-up|20
1822209|NCT00402246|6319531|P2|Overall Study|Death|58
1822210|NCT00402246|6319532|P1|Overall Study|Death|62
1822211|NCT00402233|6319566|P4|Overall Study|Worsening of other pre-existing disease|0
1822212|NCT00402233|6319567|P3|Overall Study|Worsening of other pre-existing disease|0
1822213|NCT00402233|6319568|P2|Overall Study|Worsening of other pre-existing disease|1
1822214|NCT00402233|6319569|P1|Overall Study|Worsening of other pre-existing disease|0
1822215|NCT00402233|6319566|P4|Overall Study|Worsening of disease under study|0
1822216|NCT00402233|6319567|P3|Overall Study|Worsening of disease under study|0
1822217|NCT00402233|6319568|P2|Overall Study|Worsening of disease under study|0
1822218|NCT00402233|6319569|P1|Overall Study|Worsening of disease under study|2
1822219|NCT00402233|6319566|P4|Overall Study|Withdrawal by Subject|2
1822220|NCT00402233|6319567|P3|Overall Study|Withdrawal by Subject|2
1822221|NCT00402233|6319568|P2|Overall Study|Withdrawal by Subject|1
1822222|NCT00402233|6319569|P1|Overall Study|Withdrawal by Subject|2
1822223|NCT00402233|6319566|P4|Overall Study|Protocol Violation|0
1822224|NCT00402233|6319567|P3|Overall Study|Protocol Violation|0
1822225|NCT00402233|6319568|P2|Overall Study|Protocol Violation|1
1822226|NCT00402233|6319569|P1|Overall Study|Protocol Violation|0
1822227|NCT00402233|6319566|P4|Overall Study|Adverse Event|9
1822228|NCT00402233|6319567|P3|Overall Study|Adverse Event|9
1822229|NCT00402233|6319568|P2|Overall Study|Adverse Event|7
1822230|NCT00402233|6319569|P1|Overall Study|Adverse Event|1
1822231|NCT00402168|6319604|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
1822232|NCT00402168|6319605|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
1822233|NCT00402168|6319604|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
1822234|NCT00402168|6319605|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
1822235|NCT00402168|6319604|P2|Long Term (LT)|non-specified|2
1822236|NCT00402168|6319605|P1|Long Term (LT)|non-specified|1
1822237|NCT00402168|6319604|P2|Long Term (LT)|Lack of Efficacy|2
1822238|NCT00402168|6319605|P1|Long Term (LT)|Lack of Efficacy|0
1822239|NCT00402168|6319604|P2|Long Term (LT)|Death|0
1822240|NCT00402168|6319605|P1|Long Term (LT)|Death|4
1822241|NCT00402168|6319604|P2|Long Term (LT)|Lost to Follow-up|0
1822242|NCT00402168|6319605|P1|Long Term (LT)|Lost to Follow-up|1
1822243|NCT00402168|6319604|P2|Long Term (LT)|Pregnancy|1
1822244|NCT00402168|6319605|P1|Long Term (LT)|Pregnancy|0
1822245|NCT00402168|6319604|P2|Long Term (LT)|Withdrawal by Subject|7
1822246|NCT00402168|6319605|P1|Long Term (LT)|Withdrawal by Subject|4
1822247|NCT00402168|6319604|P2|Long Term (LT)|Adverse Event|5
1822248|NCT00402168|6319605|P1|Long Term (LT)|Adverse Event|1
1822249|NCT00402168|6319604|P2|Treatment (up to 12 Months)|non-specified|1
1822250|NCT00402168|6319605|P1|Treatment (up to 12 Months)|non-specified|0
1822251|NCT00402168|6319604|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
1822252|NCT00402168|6319605|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
1822253|NCT00402168|6319604|P2|Treatment (up to 12 Months)|Death|1
1822254|NCT00402168|6319605|P1|Treatment (up to 12 Months)|Death|0
1822255|NCT00402168|6319604|P2|Randomized|Withdrawal by Subject|1
1822256|NCT00402168|6319605|P1|Randomized|Withdrawal by Subject|0
1822257|NCT00402168|6319604|P2|Randomized|Lost to Follow-up|0
1822258|NCT00402168|6319605|P1|Randomized|Lost to Follow-up|1
1822259|NCT00402103|6319662|P2|Overall Study|Administrative problems|0
1822260|NCT00402103|6319663|P1|Overall Study|Administrative problems|2
1822261|NCT00402103|6319662|P2|Overall Study|Lost to Follow-up|3
1822262|NCT00402103|6319663|P1|Overall Study|Lost to Follow-up|6
1822263|NCT00402103|6319662|P2|Overall Study|Patient withdrew consent|1
1822264|NCT00402103|6319663|P1|Overall Study|Patient withdrew consent|12
1822265|NCT00402103|6319662|P2|Overall Study|Protocol Deviation|0
1822266|NCT00402103|6319663|P1|Overall Study|Protocol Deviation|8
1822267|NCT00402103|6319662|P2|Overall Study|Condition no longer requires study drug|0
1822268|NCT00402103|6319663|P1|Overall Study|Condition no longer requires study drug|2
1822269|NCT00402103|6319662|P2|Overall Study|Unsatisfactory therapeutic effect|2
1822270|NCT00402103|6319663|P1|Overall Study|Unsatisfactory therapeutic effect|1
1822271|NCT00402103|6319662|P2|Overall Study|Adverse Event|7
1822272|NCT00402103|6319663|P1|Overall Study|Adverse Event|60
1822273|NCT00402051|6319679|P2|Overall Study|Lost to Follow-up|0
1822274|NCT00402051|6319680|P1|Overall Study|Lost to Follow-up|1
1822275|NCT00402051|6319679|P2|Overall Study|Death Due to Adverse Event|2
1822276|NCT00402051|6319680|P1|Overall Study|Death Due to Adverse Event|0
1822277|NCT00402051|6319679|P2|Overall Study|Death Due to Study Disease|1
1822278|NCT00402051|6319680|P1|Overall Study|Death Due to Study Disease|2
1822279|NCT00402051|6319679|P2|Overall Study|Death - Related to Study Drug|2
1822280|NCT00402051|6319680|P1|Overall Study|Death - Related to Study Drug|1
1822281|NCT00402051|6319679|P2|Overall Study|Withdrawal by Subject|3
1822282|NCT00402051|6319680|P1|Overall Study|Withdrawal by Subject|3
1822283|NCT00402051|6319679|P2|Overall Study|Physician Decision|3
1822284|NCT00402051|6319680|P1|Overall Study|Physician Decision|7
1822285|NCT00402051|6319679|P2|Overall Study|Adverse Event|4
1822286|NCT00402051|6319680|P1|Overall Study|Adverse Event|11
1822287|NCT00402051|6319679|P2|Overall Study|Progressive Disease|20
1822288|NCT00402051|6319680|P1|Overall Study|Progressive Disease|13
1822289|NCT00402025|6319697|P3|Overall Study|Participant Decision|1
1822290|NCT00402025|6319698|P2|Overall Study|Participant Decision|0
1822291|NCT00402025|6319699|P1|Overall Study|Participant Decision|0
1822292|NCT00402025|6319697|P3|Overall Study|Physician Decision|0
1822293|NCT00402025|6319698|P2|Overall Study|Physician Decision|1
1822294|NCT00402025|6319699|P1|Overall Study|Physician Decision|1
1822295|NCT00402025|6319697|P3|Overall Study|Disease Progression|2
1822296|NCT00402025|6319698|P2|Overall Study|Disease Progression|1
1822297|NCT00402025|6319699|P1|Overall Study|Disease Progression|1
1822298|NCT00402025|6319697|P3|Overall Study|Death|5
1822299|NCT00402025|6319698|P2|Overall Study|Death|1
1822300|NCT00402025|6319699|P1|Overall Study|Death|0
1822301|NCT00402025|6319697|P3|Overall Study|Adverse Event|2
1822302|NCT00402025|6319698|P2|Overall Study|Adverse Event|0
1822303|NCT00402025|6319699|P1|Overall Study|Adverse Event|0
1822304|NCT00401973|6319725|P3|Overall Study|Withdrawal by Subject|9
1822305|NCT00401973|6319726|P2|Overall Study|Withdrawal by Subject|12
1822306|NCT00401973|6319727|P1|Overall Study|Withdrawal by Subject|4
1822307|NCT00401973|6319725|P3|Overall Study|Sponsor Decision|0
1822308|NCT00401973|6319726|P2|Overall Study|Sponsor Decision|1
1822309|NCT00401973|6319727|P1|Overall Study|Sponsor Decision|0
1822310|NCT00401973|6319725|P3|Overall Study|Protocol Violation|3
1822311|NCT00401973|6319726|P2|Overall Study|Protocol Violation|2
1822312|NCT00401973|6319727|P1|Overall Study|Protocol Violation|1
1822313|NCT00401973|6319725|P3|Overall Study|Physician Decision|1
1822314|NCT00401973|6319726|P2|Overall Study|Physician Decision|0
1822315|NCT00401973|6319727|P1|Overall Study|Physician Decision|2
1822316|NCT00401973|6319725|P3|Overall Study|Lost to Follow-up|2
1822317|NCT00401973|6319726|P2|Overall Study|Lost to Follow-up|2
1822318|NCT00401973|6319727|P1|Overall Study|Lost to Follow-up|2
1822319|NCT00401973|6319725|P3|Overall Study|Lack of Efficacy|3
1822320|NCT00401973|6319726|P2|Overall Study|Lack of Efficacy|0
1822321|NCT00401973|6319727|P1|Overall Study|Lack of Efficacy|0
1822322|NCT00401973|6319725|P3|Overall Study|Clinical Relapse|1
1822323|NCT00401973|6319726|P2|Overall Study|Clinical Relapse|1
1822324|NCT00401973|6319727|P1|Overall Study|Clinical Relapse|0
1822325|NCT00401973|6319725|P3|Overall Study|Adverse Event|4
1822326|NCT00401973|6319726|P2|Overall Study|Adverse Event|8
1822327|NCT00401973|6319727|P1|Overall Study|Adverse Event|2
1822328|NCT00401960|6319766|P2|Overall Study|Death|0
1822329|NCT00401960|6319767|P1|Overall Study|Death|2
1822330|NCT00401960|6319766|P2|Overall Study|Lost to Follow-up|0
1822331|NCT00401960|6319767|P1|Overall Study|Lost to Follow-up|3
1822332|NCT00401843|6319797|P3|Overall Study|Received incorrect treatment|0
1822333|NCT00401843|6319798|P2|Overall Study|Received incorrect treatment|3
1822334|NCT00401843|6319799|P1|Overall Study|Received incorrect treatment|0
1822335|NCT00401843|6319797|P3|Overall Study|Randomized but not Treated|3
1822336|NCT00401843|6319798|P2|Overall Study|Randomized but not Treated|2
1822337|NCT00401843|6319799|P1|Overall Study|Randomized but not Treated|0
1822338|NCT00401843|6319797|P3|Overall Study|Withdrawal of consent to study agent|17
1822339|NCT00401843|6319798|P2|Overall Study|Withdrawal of consent to study agent|15
1822340|NCT00401843|6319799|P1|Overall Study|Withdrawal of consent to study agent|1
1822341|NCT00401843|6319797|P3|Overall Study|Withdrawal by Subject|5
1822342|NCT00401843|6319798|P2|Overall Study|Withdrawal by Subject|5
1822343|NCT00401843|6319799|P1|Overall Study|Withdrawal by Subject|1
1822344|NCT00401843|6319797|P3|Overall Study|Protocol Violation|1
1822345|NCT00401843|6319798|P2|Overall Study|Protocol Violation|0
1822346|NCT00401843|6319799|P1|Overall Study|Protocol Violation|0
1822347|NCT00401843|6319797|P3|Overall Study|Physician Decision|10
1822348|NCT00401843|6319798|P2|Overall Study|Physician Decision|16
1822349|NCT00401843|6319799|P1|Overall Study|Physician Decision|0
1822350|NCT00401843|6319797|P3|Overall Study|Other Unspecified|5
1822351|NCT00401843|6319798|P2|Overall Study|Other Unspecified|3
1822352|NCT00401843|6319799|P1|Overall Study|Other Unspecified|0
1822353|NCT00401843|6319797|P3|Overall Study|Lost to Follow-up|2
1822354|NCT00401843|6319798|P2|Overall Study|Lost to Follow-up|0
1822355|NCT00401843|6319799|P1|Overall Study|Lost to Follow-up|0
1822356|NCT00401843|6319797|P3|Overall Study|End of Study|2
1822357|NCT00401843|6319798|P2|Overall Study|End of Study|1
1822358|NCT00401843|6319799|P1|Overall Study|End of Study|1
1822359|NCT00401843|6319797|P3|Overall Study|Disease progression|49
1822360|NCT00401843|6319798|P2|Overall Study|Disease progression|60
1822361|NCT00401843|6319799|P1|Overall Study|Disease progression|10
1822362|NCT00401843|6319797|P3|Overall Study|Death|10
1822363|NCT00401843|6319798|P2|Overall Study|Death|8
1822364|NCT00401843|6319799|P1|Overall Study|Death|0
1822365|NCT00401843|6319797|P3|Overall Study|Adverse Event|27
1822366|NCT00401843|6319798|P2|Overall Study|Adverse Event|26
1822367|NCT00401843|6319799|P1|Overall Study|Adverse Event|7
1822368|NCT00401843|6319797|P3|Overall Study|Achieved Complete Response|11
1822369|NCT00401843|6319798|P2|Overall Study|Achieved Complete Response|5
1822370|NCT00401843|6319799|P1|Overall Study|Achieved Complete Response|1
1822371|NCT00401830|6319817|P2|Overall Study|Other: Personal / Family problems|0
1822372|NCT00401830|6319818|P1|Overall Study|Other: Personal / Family problems|1
1822373|NCT00401830|6319817|P2|Overall Study|Lost to Follow-up|3
1822374|NCT00401830|6319818|P1|Overall Study|Lost to Follow-up|1
1822375|NCT00401830|6319817|P2|Overall Study|Non-compliance with drug study|0
1822376|NCT00401830|6319818|P1|Overall Study|Non-compliance with drug study|1
1822377|NCT00401830|6319817|P2|Overall Study|Protocol Violation|3
1822378|NCT00401830|6319818|P1|Overall Study|Protocol Violation|3
1822379|NCT00401830|6319817|P2|Overall Study|Withdrawal by Subject|3
1822380|NCT00401830|6319818|P1|Overall Study|Withdrawal by Subject|4
1822381|NCT00401830|6319817|P2|Overall Study|Lack of Efficacy|5
1822382|NCT00401830|6319818|P1|Overall Study|Lack of Efficacy|11
1822383|NCT00401830|6319817|P2|Overall Study|Adverse Event|18
1822384|NCT00401830|6319818|P1|Overall Study|Adverse Event|10
1822385|NCT00401752|6319876|P2|Overall Study|Physician Decision|1
1822386|NCT00401752|6319877|P1|Overall Study|Physician Decision|1
1822387|NCT00401752|6319876|P2|Overall Study|Development of any exclusion criteria|2
1822388|NCT00401752|6319877|P1|Overall Study|Development of any exclusion criteria|4
1822389|NCT00401752|6319876|P2|Overall Study|Lost to Follow-up|4
1822390|NCT00401752|6319877|P1|Overall Study|Lost to Follow-up|1
1822391|NCT00401752|6319876|P2|Overall Study|Withdrawal by Subject|6
1822392|NCT00401752|6319877|P1|Overall Study|Withdrawal by Subject|2
1822393|NCT00401752|6319876|P2|Overall Study|Adverse Event|5
1822394|NCT00401752|6319877|P1|Overall Study|Adverse Event|2
1822395|NCT00401726|6319895|P2|Overall Study|Protocol Deviation|4
1822396|NCT00401726|6319896|P1|Overall Study|Protocol Deviation|9
1822397|NCT00401726|6319895|P2|Overall Study|Lack of Efficacy|6
1822398|NCT00401726|6319896|P1|Overall Study|Lack of Efficacy|4
1822399|NCT00401726|6319895|P2|Overall Study|Withdrawal by Subject|24
1822400|NCT00401726|6319896|P1|Overall Study|Withdrawal by Subject|18
1822401|NCT00401726|6319895|P2|Overall Study|Protocol Violation|3
1822402|NCT00401726|6319896|P1|Overall Study|Protocol Violation|6
1822403|NCT00401726|6319895|P2|Overall Study|Lost to Follow-up|20
1822404|NCT00401726|6319896|P1|Overall Study|Lost to Follow-up|23
1822405|NCT00401726|6319895|P2|Overall Study|Physician Decision|6
1822406|NCT00401726|6319896|P1|Overall Study|Physician Decision|3
1822407|NCT00401726|6319895|P2|Overall Study|Sponsor Request|1
1822408|NCT00401726|6319896|P1|Overall Study|Sponsor Request|0
1822409|NCT00401726|6319895|P2|Overall Study|Death|3
1822410|NCT00401726|6319896|P1|Overall Study|Death|0
1822411|NCT00401726|6319895|P2|Overall Study|Adverse Event|45
1822412|NCT00401726|6319896|P1|Overall Study|Adverse Event|34
1822413|NCT00401544|6319931|P4|Overall Study|Other|2
1822414|NCT00401544|6319932|P3|Overall Study|Other|2
1822415|NCT00401544|6319933|P2|Overall Study|Other|0
1822416|NCT00401544|6319934|P1|Overall Study|Other|0
1822417|NCT00401544|6319931|P4|Overall Study|Disease progression|0
1822418|NCT00401544|6319932|P3|Overall Study|Disease progression|0
1822419|NCT00401544|6319933|P2|Overall Study|Disease progression|1
1822420|NCT00401544|6319934|P1|Overall Study|Disease progression|0
1822421|NCT00401544|6319931|P4|Overall Study|Ineligibility determined|2
1822422|NCT00401544|6319932|P3|Overall Study|Ineligibility determined|0
1822423|NCT00401544|6319933|P2|Overall Study|Ineligibility determined|1
1822424|NCT00401544|6319934|P1|Overall Study|Ineligibility determined|0
1822425|NCT00401544|6319931|P4|Overall Study|Physician Decision|0
1822426|NCT00401544|6319932|P3|Overall Study|Physician Decision|0
1822427|NCT00401544|6319933|P2|Overall Study|Physician Decision|3
1822428|NCT00401544|6319934|P1|Overall Study|Physician Decision|1
1822429|NCT00401544|6319931|P4|Overall Study|Withdrawal by Subject|5
1822430|NCT00401544|6319932|P3|Overall Study|Withdrawal by Subject|6
1822431|NCT00401544|6319933|P2|Overall Study|Withdrawal by Subject|6
1822432|NCT00401544|6319934|P1|Overall Study|Withdrawal by Subject|7
1822433|NCT00401544|6319931|P4|Overall Study|Lost to Follow-up|1
1822434|NCT00401544|6319932|P3|Overall Study|Lost to Follow-up|1
1822435|NCT00401544|6319933|P2|Overall Study|Lost to Follow-up|0
1822436|NCT00401544|6319934|P1|Overall Study|Lost to Follow-up|2
1822437|NCT00401544|6319931|P4|Overall Study|Death|5
1822438|NCT00401544|6319932|P3|Overall Study|Death|2
1822439|NCT00401544|6319933|P2|Overall Study|Death|6
1822440|NCT00401544|6319934|P1|Overall Study|Death|3
1822441|NCT00401544|6319931|P4|Overall Study|Adverse Event|1
1822442|NCT00401544|6319932|P3|Overall Study|Adverse Event|1
1822443|NCT00401544|6319933|P2|Overall Study|Adverse Event|1
1822444|NCT00401544|6319934|P1|Overall Study|Adverse Event|5
1822445|NCT00401531|6319974|P2|Overall Study|Withdrawal by Subject|2
1822446|NCT00401531|6319975|P1|Overall Study|Withdrawal by Subject|3
1822447|NCT00401531|6319974|P2|Overall Study|Lost to Follow-up|1
1822448|NCT00401531|6319975|P1|Overall Study|Lost to Follow-up|1
1822449|NCT00401531|6319974|P2|Overall Study|Protocol Violation|7
1822450|NCT00401531|6319975|P1|Overall Study|Protocol Violation|3
1822451|NCT00401531|6319974|P2|Overall Study|Adverse Event|0
1822452|NCT00401531|6319975|P1|Overall Study|Adverse Event|2
1822453|NCT00401375|6320048|P3|Overall Study|Randomized but not treated|3
1822454|NCT00401375|6320049|P2|Overall Study|Randomized but not treated|3
1822455|NCT00401375|6320050|P1|Overall Study|Randomized but not treated|3
1822456|NCT00401375|6320048|P3|Overall Study|Other than specified|3
1822457|NCT00401375|6320049|P2|Overall Study|Other than specified|1
1822458|NCT00401375|6320050|P1|Overall Study|Other than specified|2
1822459|NCT00401375|6320048|P3|Overall Study|Lost to Follow-up|1
1822460|NCT00401375|6320049|P2|Overall Study|Lost to Follow-up|1
1822461|NCT00401375|6320050|P1|Overall Study|Lost to Follow-up|0
1822462|NCT00401375|6320048|P3|Overall Study|Withdrawal by Subject|7
1822463|NCT00401375|6320049|P2|Overall Study|Withdrawal by Subject|7
1822464|NCT00401375|6320050|P1|Overall Study|Withdrawal by Subject|9
1822465|NCT00401375|6320048|P3|Overall Study|Adverse Event|10
1822466|NCT00401375|6320049|P2|Overall Study|Adverse Event|11
1822467|NCT00401375|6320050|P1|Overall Study|Adverse Event|6
1822468|NCT00401375|6320048|P3|Overall Study|Protocol Violation|1
1822469|NCT00401375|6320049|P2|Overall Study|Protocol Violation|2
1822470|NCT00401375|6320050|P1|Overall Study|Protocol Violation|2
1822471|NCT00401258|6320067|P1|Overall Study|Adverse Event|7
1822472|NCT00401245|6320082|P8|Double Blind Tapering Phase|Lack of Efficacy|0
1822473|NCT00401245|6320083|P7|Double Blind Tapering Phase|Lack of Efficacy|0
1822474|NCT00401245|6320084|P6|Double Blind Tapering Phase|Lack of Efficacy|1
1822475|NCT00401245|6320085|P5|Double Blind Tapering Phase|Lack of Efficacy|0
1822476|NCT00401245|6320086|P4|Double Blind Tapering Phase|Lack of Efficacy|0
1822477|NCT00401245|6320087|P3|Double Blind Tapering Phase|Lack of Efficacy|0
1822478|NCT00401245|6320088|P2|Double Blind Tapering Phase|Lack of Efficacy|0
1822479|NCT00401245|6320089|P1|Double Blind Tapering Phase|Lack of Efficacy|0
1822480|NCT00401245|6320082|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
1822481|NCT00401245|6320083|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
1822482|NCT00401245|6320084|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
1822483|NCT00401245|6320085|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
1822484|NCT00401245|6320086|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
1822485|NCT00401245|6320087|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
1822486|NCT00401245|6320088|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
1822487|NCT00401245|6320089|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
1822488|NCT00401245|6320082|P8|Double Blind Tapering Phase|Other|2
1822489|NCT00401245|6320083|P7|Double Blind Tapering Phase|Other|2
1822490|NCT00401245|6320084|P6|Double Blind Tapering Phase|Other|0
1822491|NCT00401245|6320085|P5|Double Blind Tapering Phase|Other|1
1822492|NCT00401245|6320086|P4|Double Blind Tapering Phase|Other|0
1822493|NCT00401245|6320087|P3|Double Blind Tapering Phase|Other|0
1822494|NCT00401245|6320088|P2|Double Blind Tapering Phase|Other|0
1822495|NCT00401245|6320089|P1|Double Blind Tapering Phase|Other|0
1822496|NCT00401245|6320082|P8|Double Blind Tapering Phase|Investigator request|1
1822497|NCT00401245|6320083|P7|Double Blind Tapering Phase|Investigator request|0
1822498|NCT00401245|6320084|P6|Double Blind Tapering Phase|Investigator request|0
1822499|NCT00401245|6320085|P5|Double Blind Tapering Phase|Investigator request|0
1822500|NCT00401245|6320086|P4|Double Blind Tapering Phase|Investigator request|0
1822501|NCT00401245|6320087|P3|Double Blind Tapering Phase|Investigator request|0
1822502|NCT00401245|6320088|P2|Double Blind Tapering Phase|Investigator request|0
1822503|NCT00401245|6320089|P1|Double Blind Tapering Phase|Investigator request|0
1822504|NCT00401245|6320082|P8|Double Blind Tapering Phase|Adverse Event|4
1822505|NCT00401245|6320083|P7|Double Blind Tapering Phase|Adverse Event|2
1822506|NCT00401245|6320084|P6|Double Blind Tapering Phase|Adverse Event|1
1822507|NCT00401245|6320085|P5|Double Blind Tapering Phase|Adverse Event|1
1822508|NCT00401245|6320086|P4|Double Blind Tapering Phase|Adverse Event|0
1822509|NCT00401245|6320087|P3|Double Blind Tapering Phase|Adverse Event|0
1822510|NCT00401245|6320088|P2|Double Blind Tapering Phase|Adverse Event|0
1822511|NCT00401245|6320089|P1|Double Blind Tapering Phase|Adverse Event|0
1822512|NCT00401245|6320082|P8|Open Label Phase|Lack of Efficacy|0
1822513|NCT00401245|6320083|P7|Open Label Phase|Lack of Efficacy|0
1822514|NCT00401245|6320084|P6|Open Label Phase|Lack of Efficacy|0
1822515|NCT00401245|6320085|P5|Open Label Phase|Lack of Efficacy|0
1822516|NCT00401245|6320086|P4|Open Label Phase|Lack of Efficacy|0
1822517|NCT00401245|6320087|P3|Open Label Phase|Lack of Efficacy|3
1822518|NCT00401245|6320088|P2|Open Label Phase|Lack of Efficacy|2
1822519|NCT00401245|6320089|P1|Open Label Phase|Lack of Efficacy|4
1822520|NCT00401245|6320082|P8|Open Label Phase|Withdrawal by Subject|0
1822521|NCT00401245|6320083|P7|Open Label Phase|Withdrawal by Subject|0
1822522|NCT00401245|6320084|P6|Open Label Phase|Withdrawal by Subject|0
1822523|NCT00401245|6320085|P5|Open Label Phase|Withdrawal by Subject|0
1822524|NCT00401245|6320086|P4|Open Label Phase|Withdrawal by Subject|1
1822525|NCT00401245|6320087|P3|Open Label Phase|Withdrawal by Subject|2
1822526|NCT00401245|6320088|P2|Open Label Phase|Withdrawal by Subject|3
1822527|NCT00401245|6320089|P1|Open Label Phase|Withdrawal by Subject|3
1822528|NCT00401245|6320082|P8|Open Label Phase|Protocol Violation|0
1822529|NCT00401245|6320083|P7|Open Label Phase|Protocol Violation|0
1822530|NCT00401245|6320084|P6|Open Label Phase|Protocol Violation|0
1822531|NCT00401245|6320085|P5|Open Label Phase|Protocol Violation|0
1822532|NCT00401245|6320086|P4|Open Label Phase|Protocol Violation|1
1822533|NCT00401245|6320087|P3|Open Label Phase|Protocol Violation|0
1822534|NCT00401245|6320088|P2|Open Label Phase|Protocol Violation|1
1822535|NCT00401245|6320089|P1|Open Label Phase|Protocol Violation|0
1822536|NCT00401245|6320082|P8|Open Label Phase|Other|0
1822537|NCT00401245|6320083|P7|Open Label Phase|Other|0
1822538|NCT00401245|6320084|P6|Open Label Phase|Other|0
1822539|NCT00401245|6320085|P5|Open Label Phase|Other|0
1822540|NCT00401245|6320086|P4|Open Label Phase|Other|8
1822541|NCT00401245|6320087|P3|Open Label Phase|Other|7
1822542|NCT00401245|6320088|P2|Open Label Phase|Other|8
1822543|NCT00401245|6320089|P1|Open Label Phase|Other|4
1822544|NCT00401245|6320082|P8|Open Label Phase|Lost to Follow-up|0
1822545|NCT00401245|6320083|P7|Open Label Phase|Lost to Follow-up|0
1822546|NCT00401245|6320084|P6|Open Label Phase|Lost to Follow-up|0
1822547|NCT00401245|6320085|P5|Open Label Phase|Lost to Follow-up|0
1822548|NCT00401245|6320086|P4|Open Label Phase|Lost to Follow-up|4
1822549|NCT00401245|6320087|P3|Open Label Phase|Lost to Follow-up|5
1822550|NCT00401245|6320088|P2|Open Label Phase|Lost to Follow-up|7
1822551|NCT00401245|6320089|P1|Open Label Phase|Lost to Follow-up|5
1822552|NCT00401245|6320082|P8|Open Label Phase|Adverse Event|0
1822553|NCT00401245|6320083|P7|Open Label Phase|Adverse Event|0
1822554|NCT00401245|6320084|P6|Open Label Phase|Adverse Event|0
1822555|NCT00401245|6320085|P5|Open Label Phase|Adverse Event|0
1822556|NCT00401245|6320086|P4|Open Label Phase|Adverse Event|7
1822557|NCT00401245|6320087|P3|Open Label Phase|Adverse Event|6
1822558|NCT00401245|6320088|P2|Open Label Phase|Adverse Event|14
1822559|NCT00401245|6320089|P1|Open Label Phase|Adverse Event|5
1822560|NCT00401245|6320082|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
1822561|NCT00401245|6320083|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
1822562|NCT00401245|6320084|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
1822563|NCT00401245|6320085|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
1822564|NCT00401245|6320086|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
1822565|NCT00401245|6320087|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
1822652|NCT00400946|6320189|P2|Overall Study|Lost to Follow-up|1
1822566|NCT00401245|6320088|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
1822567|NCT00401245|6320089|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
1822568|NCT00401245|6320082|P8|Double Blind Titration Phase|Withdrawal by Subject|0
1822569|NCT00401245|6320083|P7|Double Blind Titration Phase|Withdrawal by Subject|0
1822570|NCT00401245|6320084|P6|Double Blind Titration Phase|Withdrawal by Subject|0
1822571|NCT00401245|6320085|P5|Double Blind Titration Phase|Withdrawal by Subject|0
1822572|NCT00401245|6320086|P4|Double Blind Titration Phase|Withdrawal by Subject|2
1822573|NCT00401245|6320087|P3|Double Blind Titration Phase|Withdrawal by Subject|0
1822574|NCT00401245|6320088|P2|Double Blind Titration Phase|Withdrawal by Subject|1
1822575|NCT00401245|6320089|P1|Double Blind Titration Phase|Withdrawal by Subject|1
1822576|NCT00401245|6320082|P8|Double Blind Titration Phase|Protocol Violation|0
1822577|NCT00401245|6320083|P7|Double Blind Titration Phase|Protocol Violation|0
1822578|NCT00401245|6320084|P6|Double Blind Titration Phase|Protocol Violation|0
1822579|NCT00401245|6320085|P5|Double Blind Titration Phase|Protocol Violation|0
1822580|NCT00401245|6320086|P4|Double Blind Titration Phase|Protocol Violation|1
1822581|NCT00401245|6320087|P3|Double Blind Titration Phase|Protocol Violation|0
1822582|NCT00401245|6320088|P2|Double Blind Titration Phase|Protocol Violation|0
1822583|NCT00401245|6320089|P1|Double Blind Titration Phase|Protocol Violation|0
1822584|NCT00401245|6320082|P8|Double Blind Titration Phase|Other|0
1822585|NCT00401245|6320083|P7|Double Blind Titration Phase|Other|0
1822586|NCT00401245|6320084|P6|Double Blind Titration Phase|Other|0
1822587|NCT00401245|6320085|P5|Double Blind Titration Phase|Other|0
1822588|NCT00401245|6320086|P4|Double Blind Titration Phase|Other|0
1822589|NCT00401245|6320087|P3|Double Blind Titration Phase|Other|1
1822590|NCT00401245|6320088|P2|Double Blind Titration Phase|Other|0
1822591|NCT00401245|6320089|P1|Double Blind Titration Phase|Other|0
1822592|NCT00401245|6320082|P8|Double Blind Titration Phase|Adverse Event|0
1822593|NCT00401245|6320083|P7|Double Blind Titration Phase|Adverse Event|0
1822594|NCT00401245|6320084|P6|Double Blind Titration Phase|Adverse Event|0
1822595|NCT00401245|6320085|P5|Double Blind Titration Phase|Adverse Event|0
1822596|NCT00401245|6320086|P4|Double Blind Titration Phase|Adverse Event|12
1822597|NCT00401245|6320087|P3|Double Blind Titration Phase|Adverse Event|5
1822598|NCT00401245|6320088|P2|Double Blind Titration Phase|Adverse Event|2
1822599|NCT00401245|6320089|P1|Double Blind Titration Phase|Adverse Event|3
1822600|NCT00401193|6320157|P3|Overall Study|Other Event|2
1822601|NCT00401193|6320158|P2|Overall Study|Other Event|2
1822602|NCT00401193|6320159|P1|Overall Study|Other Event|3
1822603|NCT00401193|6320157|P3|Overall Study|Withdrawal by Subject|1
1822604|NCT00401193|6320158|P2|Overall Study|Withdrawal by Subject|0
1822605|NCT00401193|6320159|P1|Overall Study|Withdrawal by Subject|2
1822606|NCT00401193|6320157|P3|Overall Study|Lost to Follow-up|1
1822607|NCT00401193|6320158|P2|Overall Study|Lost to Follow-up|5
1822608|NCT00401193|6320159|P1|Overall Study|Lost to Follow-up|6
1822609|NCT00401193|6320157|P3|Overall Study|Protocol Violation|1
1822610|NCT00401193|6320158|P2|Overall Study|Protocol Violation|1
1822611|NCT00401193|6320159|P1|Overall Study|Protocol Violation|3
1822612|NCT00401193|6320157|P3|Overall Study|Adverse Event|1
1822613|NCT00401193|6320158|P2|Overall Study|Adverse Event|3
1822614|NCT00401193|6320159|P1|Overall Study|Adverse Event|1
1822615|NCT00400985|6320177|P1|Overall Study|Lost to Follow-up|9
1822616|NCT00400985|6320177|P1|Overall Study|Death|30
1822617|NCT00400985|6320177|P1|Overall Study|system modification|8
1822618|NCT00400985|6320177|P1|Overall Study|Withdrawal by Subject|5
1822619|NCT00400946|6320186|P5|Overall Study|Other|1
1822620|NCT00400946|6320187|P4|Overall Study|Other|0
1822621|NCT00400946|6320188|P3|Overall Study|Other|0
1822622|NCT00400946|6320189|P2|Overall Study|Other|0
1822623|NCT00400946|6320190|P1|Overall Study|Other|0
1822624|NCT00400946|6320186|P5|Overall Study|Clinical|9
1822625|NCT00400946|6320187|P4|Overall Study|Clinical|2
1822626|NCT00400946|6320188|P3|Overall Study|Clinical|0
1822627|NCT00400946|6320189|P2|Overall Study|Clinical|2
1822628|NCT00400946|6320190|P1|Overall Study|Clinical|1
1822629|NCT00400946|6320186|P5|Overall Study|Withdrawal by Subject|8
1822630|NCT00400946|6320187|P4|Overall Study|Withdrawal by Subject|5
1822631|NCT00400946|6320188|P3|Overall Study|Withdrawal by Subject|1
1822632|NCT00400946|6320189|P2|Overall Study|Withdrawal by Subject|5
1822633|NCT00400946|6320190|P1|Overall Study|Withdrawal by Subject|2
1822634|NCT00400946|6320186|P5|Overall Study|Transplant in CR1|1
1822635|NCT00400946|6320187|P4|Overall Study|Transplant in CR1|10
1822636|NCT00400946|6320188|P3|Overall Study|Transplant in CR1|0
1822637|NCT00400946|6320189|P2|Overall Study|Transplant in CR1|0
1822638|NCT00400946|6320190|P1|Overall Study|Transplant in CR1|0
1822639|NCT00400946|6320186|P5|Overall Study|Relapse|5
1822640|NCT00400946|6320187|P4|Overall Study|Relapse|1
1822641|NCT00400946|6320188|P3|Overall Study|Relapse|1
1822642|NCT00400946|6320189|P2|Overall Study|Relapse|2
1822643|NCT00400946|6320190|P1|Overall Study|Relapse|9
1822644|NCT00400946|6320186|P5|Overall Study|Remission Death|1
1822645|NCT00400946|6320187|P4|Overall Study|Remission Death|0
1822646|NCT00400946|6320188|P3|Overall Study|Remission Death|0
1822647|NCT00400946|6320189|P2|Overall Study|Remission Death|1
1822648|NCT00400946|6320190|P1|Overall Study|Remission Death|1
1822649|NCT00400946|6320186|P5|Overall Study|Lost to Follow-up|1
1822650|NCT00400946|6320187|P4|Overall Study|Lost to Follow-up|0
1822651|NCT00400946|6320188|P3|Overall Study|Lost to Follow-up|0
1822653|NCT00400946|6320190|P1|Overall Study|Lost to Follow-up|1
1822654|NCT00400946|6320186|P5|Overall Study|Induction Death|3
1822655|NCT00400946|6320187|P4|Overall Study|Induction Death|13
1822656|NCT00400946|6320188|P3|Overall Study|Induction Death|0
1822657|NCT00400946|6320189|P2|Overall Study|Induction Death|0
1822658|NCT00400946|6320190|P1|Overall Study|Induction Death|0
1822659|NCT00400946|6320186|P5|Overall Study|Induction Failure|8
1822660|NCT00400946|6320187|P4|Overall Study|Induction Failure|11
1822661|NCT00400946|6320188|P3|Overall Study|Induction Failure|0
1822662|NCT00400946|6320189|P2|Overall Study|Induction Failure|0
1822663|NCT00400946|6320190|P1|Overall Study|Induction Failure|0
1822664|NCT00400946|6320186|P5|Overall Study|Ineligible|1
1822665|NCT00400946|6320187|P4|Overall Study|Ineligible|5
1822666|NCT00400946|6320188|P3|Overall Study|Ineligible|0
1822667|NCT00400946|6320189|P2|Overall Study|Ineligible|0
1822668|NCT00400946|6320190|P1|Overall Study|Ineligible|0
1822669|NCT00400764|6320249|P5|Phase II|Withdrawal by Subject|0
1822670|NCT00400764|6320250|P4|Phase II|Withdrawal by Subject|1
1822671|NCT00400764|6320251|P3|Phase II|Withdrawal by Subject|1
1822672|NCT00400764|6320252|P2|Phase II|Withdrawal by Subject|0
1822673|NCT00400764|6320253|P1|Phase II|Withdrawal by Subject|0
1822674|NCT00400764|6320249|P5|Phase II|Patient began new, non-protocol, therapy|0
1822675|NCT00400764|6320250|P4|Phase II|Patient began new, non-protocol, therapy|0
1822676|NCT00400764|6320251|P3|Phase II|Patient began new, non-protocol, therapy|1
1822677|NCT00400764|6320252|P2|Phase II|Patient began new, non-protocol, therapy|0
1822678|NCT00400764|6320253|P1|Phase II|Patient began new, non-protocol, therapy|0
1822679|NCT00400764|6320249|P5|Phase II|Sponsor’s decision to terminate|11
1822680|NCT00400764|6320250|P4|Phase II|Sponsor’s decision to terminate|22
1822681|NCT00400764|6320251|P3|Phase II|Sponsor’s decision to terminate|18
1822682|NCT00400764|6320252|P2|Phase II|Sponsor’s decision to terminate|0
1822683|NCT00400764|6320253|P1|Phase II|Sponsor’s decision to terminate|0
1822684|NCT00400764|6320249|P5|Phase II|Physician Decision|0
1822685|NCT00400764|6320250|P4|Phase II|Physician Decision|1
1822686|NCT00400764|6320251|P3|Phase II|Physician Decision|1
1822687|NCT00400764|6320252|P2|Phase II|Physician Decision|0
1822688|NCT00400764|6320253|P1|Phase II|Physician Decision|0
1822689|NCT00400764|6320249|P5|Phase II|Lost to Follow-up|0
1822690|NCT00400764|6320250|P4|Phase II|Lost to Follow-up|0
1822691|NCT00400764|6320251|P3|Phase II|Lost to Follow-up|1
1822692|NCT00400764|6320252|P2|Phase II|Lost to Follow-up|0
1822693|NCT00400764|6320253|P1|Phase II|Lost to Follow-up|0
1822694|NCT00400764|6320249|P5|Phase II|Death|0
1822695|NCT00400764|6320250|P4|Phase II|Death|2
1822696|NCT00400764|6320251|P3|Phase II|Death|1
1822697|NCT00400764|6320252|P2|Phase II|Death|0
1822698|NCT00400764|6320253|P1|Phase II|Death|0
1822699|NCT00400764|6320249|P5|Phase Ib|Disease Progression|0
1822700|NCT00400764|6320250|P4|Phase Ib|Disease Progression|0
1822701|NCT00400764|6320251|P3|Phase Ib|Disease Progression|0
1822702|NCT00400764|6320252|P2|Phase Ib|Disease Progression|4
1822703|NCT00400764|6320253|P1|Phase Ib|Disease Progression|4
1822704|NCT00400764|6320249|P5|Phase Ib|Death|0
1822705|NCT00400764|6320250|P4|Phase Ib|Death|0
1822706|NCT00400764|6320251|P3|Phase Ib|Death|0
1822707|NCT00400764|6320252|P2|Phase Ib|Death|0
1822708|NCT00400764|6320253|P1|Phase Ib|Death|1
1822709|NCT00400764|6320249|P5|Phase Ib|Adverse Event|0
1822710|NCT00400764|6320250|P4|Phase Ib|Adverse Event|0
1822711|NCT00400764|6320251|P3|Phase Ib|Adverse Event|0
1822712|NCT00400764|6320252|P2|Phase Ib|Adverse Event|0
1822713|NCT00400764|6320253|P1|Phase Ib|Adverse Event|1
1822714|NCT00400712|6320306|P2|Overall Study|Physician Decision|4
1822715|NCT00400712|6320307|P1|Overall Study|Physician Decision|5
1822716|NCT00400712|6320306|P2|Overall Study|Withdrawal by Subject|12
1822717|NCT00400712|6320307|P1|Overall Study|Withdrawal by Subject|11
1822718|NCT00400712|6320306|P2|Overall Study|Death|0
1822719|NCT00400712|6320307|P1|Overall Study|Death|1
1822720|NCT00400569|6320342|P1|Overall Study|Death|1
1822721|NCT00400517|6320353|P1|Overall Study|Physician Decision|1
1822722|NCT00400517|6320353|P1|Overall Study|Withdrawal by Subject|1
1822723|NCT00400400|6320373|P2|Overall Study|Did not receive study drug|3
1822724|NCT00400400|6320374|P1|Overall Study|Did not receive study drug|1
1822725|NCT00400400|6320373|P2|Overall Study|Lost to Follow-up|1
1822726|NCT00400400|6320374|P1|Overall Study|Lost to Follow-up|0
1822727|NCT00400400|6320373|P2|Overall Study|Administrative Problem|0
1822728|NCT00400400|6320374|P1|Overall Study|Administrative Problem|1
1822729|NCT00400400|6320373|P2|Overall Study|Withdrawal by Subject|3
1822730|NCT00400400|6320374|P1|Overall Study|Withdrawal by Subject|1
1822731|NCT00400400|6320373|P2|Overall Study|Protocol Violation|0
1822732|NCT00400400|6320374|P1|Overall Study|Protocol Violation|2
1822733|NCT00400400|6320373|P2|Overall Study|Adverse Event|8
1822734|NCT00400400|6320374|P1|Overall Study|Adverse Event|9
1822735|NCT00400179|6320399|P2|Overall Study|Randomization error/patient ineligible|6
1822736|NCT00400179|6320400|P1|Overall Study|Randomization error/patient ineligible|1
1822737|NCT00400179|6320399|P2|Overall Study|Investigator judgment|1
1822738|NCT00400179|6320400|P1|Overall Study|Investigator judgment|0
1822739|NCT00400179|6320399|P2|Overall Study|Intercurrent illness|1
1822740|NCT00400179|6320400|P1|Overall Study|Intercurrent illness|0
1822741|NCT00400179|6320399|P2|Overall Study|Disease progression|1
1822742|NCT00400179|6320400|P1|Overall Study|Disease progression|1
1822743|NCT00400179|6320399|P2|Overall Study|Withdrew Consent|5
1822744|NCT00400179|6320400|P1|Overall Study|Withdrew Consent|1
1822745|NCT00400179|6320399|P2|Overall Study|Death|2
1822746|NCT00400179|6320400|P1|Overall Study|Death|1
1822747|NCT00400179|6320399|P2|Overall Study|Adverse Event|2
1822748|NCT00400179|6320400|P1|Overall Study|Adverse Event|2
1822749|NCT00400153|6320417|P3|Overall Study|Other reasons - not mentioned above|3
1822750|NCT00400153|6320418|P2|Overall Study|Other reasons - not mentioned above|5
1822751|NCT00400153|6320419|P1|Overall Study|Other reasons - not mentioned above|8
1822752|NCT00400153|6320417|P3|Overall Study|Withdrawal by Subject|10
1822753|NCT00400153|6320418|P2|Overall Study|Withdrawal by Subject|11
1822754|NCT00400153|6320419|P1|Overall Study|Withdrawal by Subject|12
1822755|NCT00400153|6320417|P3|Overall Study|Lost to Follow-up|4
1822756|NCT00400153|6320418|P2|Overall Study|Lost to Follow-up|1
1822757|NCT00400153|6320419|P1|Overall Study|Lost to Follow-up|2
1822758|NCT00400153|6320417|P3|Overall Study|Protocol Violation|9
1822759|NCT00400153|6320418|P2|Overall Study|Protocol Violation|4
1822760|NCT00400153|6320419|P1|Overall Study|Protocol Violation|7
1822761|NCT00400153|6320417|P3|Overall Study|AE due to other condition|15
1822762|NCT00400153|6320418|P2|Overall Study|AE due to other condition|14
1822763|NCT00400153|6320419|P1|Overall Study|AE due to other condition|3
1822764|NCT00400153|6320417|P3|Overall Study|AE due to other disease worsening|0
1822765|NCT00400153|6320418|P2|Overall Study|AE due to other disease worsening|1
1822766|NCT00400153|6320419|P1|Overall Study|AE due to other disease worsening|2
1822767|NCT00400153|6320417|P3|Overall Study|AE due to study disease worsening|20
1822768|NCT00400153|6320418|P2|Overall Study|AE due to study disease worsening|19
1822769|NCT00400153|6320419|P1|Overall Study|AE due to study disease worsening|14
1822770|NCT00399893|6320666|P2|Overall Study|Withdrawal by Subject|0
1822771|NCT00399893|6320667|P1|Overall Study|Withdrawal by Subject|1
1822772|NCT00399802|6320706|P2|Overall Study|Participant discontinued by mistake|1
1822773|NCT00399802|6320707|P1|Overall Study|Participant discontinued by mistake|0
1822774|NCT00399802|6320706|P2|Overall Study|Adverse Event|2
1822775|NCT00399802|6320707|P1|Overall Study|Adverse Event|0
1822776|NCT00399763|6320721|P2|Overall Study|Lost to Follow-up|3
1822777|NCT00399763|6320722|P1|Overall Study|Lost to Follow-up|2
1822778|NCT00399568|6320734|P2|Overall Study|Lost to Follow-up|2
1822779|NCT00399568|6320735|P1|Overall Study|Lost to Follow-up|2
1822780|NCT00399568|6320734|P2|Overall Study|Protocol non-compliance|2
1822781|NCT00399568|6320735|P1|Overall Study|Protocol non-compliance|2
1822782|NCT00399568|6320734|P2|Overall Study|Withdrawal by Subject|3
1822783|NCT00399568|6320735|P1|Overall Study|Withdrawal by Subject|7
1822784|NCT00399568|6320734|P2|Overall Study|Adverse Event|2
1822785|NCT00399568|6320735|P1|Overall Study|Adverse Event|1
1822786|NCT00399542|6320749|P2|Overall Study|Physician Decision|1
1822787|NCT00399542|6320750|P1|Overall Study|Physician Decision|0
1822788|NCT00399542|6320749|P2|Overall Study|Other|0
1822789|NCT00399542|6320750|P1|Overall Study|Other|1
1822790|NCT00399542|6320749|P2|Overall Study|Lost to Follow-up|6
1822791|NCT00399542|6320750|P1|Overall Study|Lost to Follow-up|6
1822792|NCT00399542|6320749|P2|Overall Study|Lack of Efficacy|8
1822793|NCT00399542|6320750|P1|Overall Study|Lack of Efficacy|18
1822794|NCT00399542|6320749|P2|Overall Study|Withdrawal by Subject|10
1822795|NCT00399542|6320750|P1|Overall Study|Withdrawal by Subject|28
1822796|NCT00399542|6320749|P2|Overall Study|Protocol Violation|3
1822797|NCT00399542|6320750|P1|Overall Study|Protocol Violation|13
1822798|NCT00399542|6320749|P2|Overall Study|Adverse Event|15
1822799|NCT00399542|6320750|P1|Overall Study|Adverse Event|18
1822800|NCT00399516|6320812|P1|Overall Study|Lost to Follow-up|2
1822801|NCT00399360|6320820|P4|Overall Study|Withdrawal by Subject|2
1822802|NCT00399360|6320821|P3|Overall Study|Withdrawal by Subject|0
1822803|NCT00399360|6320822|P2|Overall Study|Withdrawal by Subject|2
1822804|NCT00399360|6320823|P1|Overall Study|Withdrawal by Subject|0
1822805|NCT00399360|6320820|P4|Overall Study|Adverse Event|0
1822806|NCT00399360|6320821|P3|Overall Study|Adverse Event|1
1822807|NCT00399360|6320822|P2|Overall Study|Adverse Event|0
1822808|NCT00399360|6320823|P1|Overall Study|Adverse Event|0
1822809|NCT00399360|6320820|P4|Overall Study|Lost to Follow-up|4
1822810|NCT00399360|6320821|P3|Overall Study|Lost to Follow-up|2
1822811|NCT00399360|6320822|P2|Overall Study|Lost to Follow-up|1
1822812|NCT00399360|6320823|P1|Overall Study|Lost to Follow-up|2
1822813|NCT00399035|6320894|P3|Overall Study|Severe non-compliance with protocol|0
1822814|NCT00399035|6320895|P2|Overall Study|Severe non-compliance with protocol|1
1822815|NCT00399035|6320896|P1|Overall Study|Severe non-compliance with protocol|2
1822816|NCT00399035|6320894|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1822817|NCT00399035|6320895|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
1822818|NCT00399035|6320896|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
1822819|NCT00399035|6320894|P3|Overall Study|Withdrawal by Subject|12
1822820|NCT00399035|6320895|P2|Overall Study|Withdrawal by Subject|15
1822821|NCT00399035|6320896|P1|Overall Study|Withdrawal by Subject|19
1822822|NCT00399035|6320894|P3|Overall Study|Lost to Follow-up|5
1822823|NCT00399035|6320895|P2|Overall Study|Lost to Follow-up|1
1822824|NCT00399035|6320896|P1|Overall Study|Lost to Follow-up|2
1822825|NCT00399035|6320894|P3|Overall Study|Death|234
1822826|NCT00399035|6320895|P2|Overall Study|Death|141
1822827|NCT00399035|6320896|P1|Overall Study|Death|289
1822828|NCT00398866|6320932|P3|Overall Study|Unable to complete requirements of study|1
1822829|NCT00398866|6320933|P2|Overall Study|Unable to complete requirements of study|1
1822830|NCT00398866|6320934|P1|Overall Study|Unable to complete requirements of study|1
1822831|NCT00398866|6320932|P3|Overall Study|Withdrawal by Subject|2
1822832|NCT00398866|6320933|P2|Overall Study|Withdrawal by Subject|1
1822833|NCT00398866|6320934|P1|Overall Study|Withdrawal by Subject|5
1822834|NCT00398866|6320932|P3|Overall Study|Lost to Follow-up|4
1822835|NCT00398866|6320933|P2|Overall Study|Lost to Follow-up|6
1822836|NCT00398866|6320934|P1|Overall Study|Lost to Follow-up|7
1822837|NCT00398866|6320932|P3|Overall Study|Lack of Efficacy|1
1822838|NCT00398866|6320933|P2|Overall Study|Lack of Efficacy|0
1822839|NCT00398866|6320934|P1|Overall Study|Lack of Efficacy|0
1822840|NCT00398866|6320932|P3|Overall Study|Adverse Event|0
1822841|NCT00398866|6320933|P2|Overall Study|Adverse Event|0
1822842|NCT00398866|6320934|P1|Overall Study|Adverse Event|1
1822843|NCT00398632|6320945|P1|Overall Study|Lack of Efficacy|1
1822844|NCT00398632|6320945|P1|Overall Study|Withdrawal by Subject|1
1822845|NCT00398567|6320953|P3|Overall Study|Protocol Violation|1
1822846|NCT00398567|6320954|P2|Overall Study|Protocol Violation|0
1822847|NCT00398567|6320955|P1|Overall Study|Protocol Violation|0
1822848|NCT00398567|6320953|P3|Overall Study|Adverse Event|2
1822849|NCT00398567|6320954|P2|Overall Study|Adverse Event|0
1822850|NCT00398567|6320955|P1|Overall Study|Adverse Event|0
1822851|NCT00398567|6320953|P3|Overall Study|Withdrawal by Subject|4
1822852|NCT00398567|6320954|P2|Overall Study|Withdrawal by Subject|0
1822853|NCT00398567|6320955|P1|Overall Study|Withdrawal by Subject|1
1822854|NCT00398567|6320953|P3|Overall Study|Disease Progression|27
1822855|NCT00398567|6320954|P2|Overall Study|Disease Progression|4
1822856|NCT00398567|6320955|P1|Overall Study|Disease Progression|3
1822857|NCT00398411|6321009|P2|Overall Study|Death|1
1822858|NCT00398411|6321010|P1|Overall Study|Death|0
1822859|NCT00398320|6321033|P1|Overall Study|Physician Decision|1
1822860|NCT00398320|6321033|P1|Overall Study|Adverse Event|4
1822861|NCT00398320|6321033|P1|Overall Study|Death|1
1822862|NCT00398216|6321046|P5|Overall Study|entrance criteria|2
1822863|NCT00398216|6321047|P4|Overall Study|entrance criteria|0
1822864|NCT00398216|6321048|P3|Overall Study|entrance criteria|0
1822865|NCT00398216|6321049|P2|Overall Study|entrance criteria|0
1822866|NCT00398216|6321050|P1|Overall Study|entrance criteria|0
1822867|NCT00398216|6321046|P5|Overall Study|administrative reasons|3
1822868|NCT00398216|6321047|P4|Overall Study|administrative reasons|3
1822869|NCT00398216|6321048|P3|Overall Study|administrative reasons|4
1822870|NCT00398216|6321049|P2|Overall Study|administrative reasons|4
1822871|NCT00398216|6321050|P1|Overall Study|administrative reasons|3
1822872|NCT00398216|6321046|P5|Overall Study|Withdrawal by Subject|2
1822873|NCT00398216|6321047|P4|Overall Study|Withdrawal by Subject|1
1822874|NCT00398216|6321048|P3|Overall Study|Withdrawal by Subject|3
1822875|NCT00398216|6321049|P2|Overall Study|Withdrawal by Subject|0
1822876|NCT00398216|6321050|P1|Overall Study|Withdrawal by Subject|1
1822877|NCT00398216|6321046|P5|Overall Study|Death|0
1822878|NCT00398216|6321047|P4|Overall Study|Death|0
1822879|NCT00398216|6321048|P3|Overall Study|Death|0
1822880|NCT00398216|6321049|P2|Overall Study|Death|3
1822881|NCT00398216|6321050|P1|Overall Study|Death|0
1822882|NCT00398216|6321046|P5|Overall Study|Lost to Follow-up|1
1822883|NCT00398216|6321047|P4|Overall Study|Lost to Follow-up|4
1822884|NCT00398216|6321048|P3|Overall Study|Lost to Follow-up|4
1822885|NCT00398216|6321049|P2|Overall Study|Lost to Follow-up|6
1822886|NCT00398216|6321050|P1|Overall Study|Lost to Follow-up|1
1822887|NCT00398216|6321046|P5|Overall Study|Protocol Violation|5
1822888|NCT00398216|6321047|P4|Overall Study|Protocol Violation|7
1822889|NCT00398216|6321048|P3|Overall Study|Protocol Violation|5
1822890|NCT00398216|6321049|P2|Overall Study|Protocol Violation|4
1822891|NCT00398216|6321050|P1|Overall Study|Protocol Violation|2
1822892|NCT00398216|6321046|P5|Overall Study|Adverse Event|2
1822893|NCT00398216|6321047|P4|Overall Study|Adverse Event|7
1822894|NCT00398216|6321048|P3|Overall Study|Adverse Event|5
1822895|NCT00398216|6321049|P2|Overall Study|Adverse Event|2
1822896|NCT00398216|6321050|P1|Overall Study|Adverse Event|4
1822897|NCT00398138|6321077|P1|Overall Study|Adverse Event|2
1822898|NCT00398112|6321082|P1|Overall Study|Death|1
1822899|NCT00398112|6321082|P1|Overall Study|Withdrawal by Subject|3
1822900|NCT00398112|6321082|P1|Overall Study|Alternative treatment|1
1822901|NCT00398112|6321082|P1|Overall Study|Disease progression|9
1822902|NCT00398112|6321082|P1|Overall Study|Adverse Event|4
1822903|NCT00398086|6321093|P3|Overall Study|Withdrawal by Subject|0
1822904|NCT00398086|6321094|P2|Overall Study|Withdrawal by Subject|7
1822905|NCT00398086|6321095|P1|Overall Study|Withdrawal by Subject|5
1822906|NCT00398086|6321093|P3|Overall Study|Physician Decision|0
1822907|NCT00398086|6321094|P2|Overall Study|Physician Decision|4
1822908|NCT00398086|6321095|P1|Overall Study|Physician Decision|1
1822909|NCT00398086|6321093|P3|Overall Study|Adverse Event|0
1822910|NCT00398086|6321094|P2|Overall Study|Adverse Event|4
1822911|NCT00398086|6321095|P1|Overall Study|Adverse Event|1
1822912|NCT00398086|6321093|P3|Overall Study|Unacceptable Toxicity|2
1822913|NCT00398086|6321094|P2|Overall Study|Unacceptable Toxicity|8
1822914|NCT00398086|6321095|P1|Overall Study|Unacceptable Toxicity|2
1822915|NCT00398073|6321129|P2|Overall Study|Withdrawal by Subject|0
1822916|NCT00398073|6321130|P1|Overall Study|Withdrawal by Subject|1
1822917|NCT00398047|6321140|P1|Overall Study|all patient progressed before completion|3
1822918|NCT00397982|6321150|P1|Overall Study|Unrelated health issues|1
1822919|NCT00397982|6321150|P1|Overall Study|noncompliance|1
1822920|NCT00397982|6321150|P1|Overall Study|Adverse Event|1
1822921|NCT00397982|6321150|P1|Overall Study|Withdrawal by Subject|1
1822922|NCT00397943|6321164|P5|Overall Study|Unspecified reasons|0
1822923|NCT00397943|6321165|P4|Overall Study|Unspecified reasons|0
1822924|NCT00397943|6321166|P3|Overall Study|Unspecified reasons|0
1822925|NCT00397943|6321167|P2|Overall Study|Unspecified reasons|9
1822926|NCT00397943|6321168|P1|Overall Study|Unspecified reasons|12
1822927|NCT00397930|6321324|P2|Overall Study|Missing data|4
1822928|NCT00397930|6321325|P1|Overall Study|Missing data|0
1822929|NCT00397930|6321324|P2|Overall Study|Withdrawal by Subject|8
1822930|NCT00397930|6321325|P1|Overall Study|Withdrawal by Subject|0
1822931|NCT00397930|6321324|P2|Overall Study|Did not want to be in control group|1
1822932|NCT00397930|6321325|P1|Overall Study|Did not want to be in control group|0
1822933|NCT00397930|6321324|P2|Overall Study|Started own yoga program|1
1822934|NCT00397930|6321325|P1|Overall Study|Started own yoga program|1
1822935|NCT00397930|6321324|P2|Overall Study|Too time-consuming|9
1822936|NCT00397930|6321325|P1|Overall Study|Too time-consuming|2
1822937|NCT00397930|6321324|P2|Overall Study|Noncompliant|2
1822938|NCT00397930|6321325|P1|Overall Study|Noncompliant|3
1822939|NCT00397930|6321324|P2|Overall Study|Unknown reasons|14
1822940|NCT00397930|6321325|P1|Overall Study|Unknown reasons|9
1822941|NCT00397930|6321324|P2|Overall Study|Other medical|4
1822942|NCT00397930|6321325|P1|Overall Study|Other medical|9
1822943|NCT00397930|6321324|P2|Overall Study|Personal reasons|8
1822944|NCT00397930|6321325|P1|Overall Study|Personal reasons|14
1822945|NCT00397891|6321340|P5|Overall Study|Withdrawal by Subject|1
1822946|NCT00397891|6321341|P4|Overall Study|Withdrawal by Subject|0
1822947|NCT00397891|6321342|P3|Overall Study|Withdrawal by Subject|0
1822948|NCT00397891|6321343|P2|Overall Study|Withdrawal by Subject|0
1822949|NCT00397891|6321344|P1|Overall Study|Withdrawal by Subject|1
1822950|NCT00397631|6321517|P2|Overall Study|protocol discontinuation criteria|4
1822951|NCT00397631|6321518|P1|Overall Study|protocol discontinuation criteria|1
1822952|NCT00397631|6321517|P2|Overall Study|Withdrawal by Subject|14
1822953|NCT00397631|6321518|P1|Overall Study|Withdrawal by Subject|7
1822954|NCT00397631|6321517|P2|Overall Study|Protocol Violation|1
1822955|NCT00397631|6321518|P1|Overall Study|Protocol Violation|0
1822956|NCT00397631|6321517|P2|Overall Study|Physician Decision|0
1822957|NCT00397631|6321518|P1|Overall Study|Physician Decision|2
1822958|NCT00397631|6321517|P2|Overall Study|Lost to Follow-up|9
1822959|NCT00397631|6321518|P1|Overall Study|Lost to Follow-up|8
1822960|NCT00397631|6321517|P2|Overall Study|Lack of Efficacy|10
1822961|NCT00397631|6321518|P1|Overall Study|Lack of Efficacy|7
1822962|NCT00397631|6321517|P2|Overall Study|Adverse Event|6
1822963|NCT00397631|6321518|P1|Overall Study|Adverse Event|5
1822964|NCT00397540|6321534|P2|Overall Study|short follow-up duration < 12 months|0
1822965|NCT00397540|6321535|P1|Overall Study|short follow-up duration < 12 months|1
1822966|NCT00397514|6321543|P1|Overall Study|poor echocardiographic windows|1
1822967|NCT00397514|6321543|P1|Overall Study|early extubation|2
1822968|NCT00397514|6321543|P1|Overall Study|Not able to capture & pace LV intraoper.|4
1822969|NCT00397514|6321543|P1|Overall Study|Pacing wire malfunction|1
1822970|NCT00397514|6321543|P1|Overall Study|Withdrawal by Subject|1
1822971|NCT00397488|6321553|P1|Overall Study|Death|1
1822972|NCT00397488|6321553|P1|Overall Study|Adverse Event|3
1822973|NCT00397488|6321553|P1|Overall Study|Withdrawal by Subject|3
1822974|NCT00397254|6321573|P2|Overall Study|Lost to Follow-up|2
1822975|NCT00397254|6321574|P1|Overall Study|Lost to Follow-up|2
1822976|NCT00397215|6321596|P4|Month 6 (Day 180)|Other|0
1822977|NCT00397215|6321597|P3|Month 6 (Day 180)|Other|3
1822978|NCT00397215|6321598|P2|Month 6 (Day 180)|Other|0
1822979|NCT00397215|6321599|P1|Month 6 (Day 180)|Other|2
1822980|NCT00397215|6321596|P4|Month 6 (Day 180)|Adverse Event|0
1822981|NCT00397215|6321597|P3|Month 6 (Day 180)|Adverse Event|2
1822982|NCT00397215|6321598|P2|Month 6 (Day 180)|Adverse Event|3
1822983|NCT00397215|6321599|P1|Month 6 (Day 180)|Adverse Event|0
1822984|NCT00397215|6321596|P4|Month 0 (Day 0)|Other|3
1822985|NCT00397215|6321597|P3|Month 0 (Day 0)|Other|3
1822986|NCT00397215|6321598|P2|Month 0 (Day 0)|Other|1
1822987|NCT00397215|6321599|P1|Month 0 (Day 0)|Other|4
1822988|NCT00397215|6321596|P4|Month 0 (Day 0)|Withdrawal by Subject|1
1822989|NCT00397215|6321597|P3|Month 0 (Day 0)|Withdrawal by Subject|3
1822990|NCT00397215|6321598|P2|Month 0 (Day 0)|Withdrawal by Subject|3
1822991|NCT00397215|6321599|P1|Month 0 (Day 0)|Withdrawal by Subject|3
1822992|NCT00397215|6321596|P4|Month 0 (Day 0)|Adverse Event|0
1822993|NCT00397215|6321597|P3|Month 0 (Day 0)|Adverse Event|0
1822994|NCT00397215|6321598|P2|Month 0 (Day 0)|Adverse Event|1
1822995|NCT00397215|6321599|P1|Month 0 (Day 0)|Adverse Event|0
1822996|NCT00397189|6321735|P2|3 Weeks Period|Other|2
1822997|NCT00397189|6321736|P1|3 Weeks Period|Other|0
1822998|NCT00397189|6321735|P2|3 Weeks Period|Protocol Violation|3
1822999|NCT00397189|6321736|P1|3 Weeks Period|Protocol Violation|0
1823000|NCT00397189|6321735|P2|3 Weeks Period|Physician Decision|2
1823001|NCT00397189|6321736|P1|3 Weeks Period|Physician Decision|0
1823002|NCT00397189|6321735|P2|3 Weeks Period|Withdrawal by Subject|9
1823003|NCT00397189|6321736|P1|3 Weeks Period|Withdrawal by Subject|13
1823004|NCT00397189|6321735|P2|3 Weeks Period|Adverse Event|2
1823005|NCT00397189|6321736|P1|3 Weeks Period|Adverse Event|3
1823006|NCT00397189|6321735|P2|3 Weeks Period|Lost to Follow-up|4
1823007|NCT00397189|6321736|P1|3 Weeks Period|Lost to Follow-up|5
1823008|NCT00397046|6321763|P4|Overall Study|Disease Progression|5
1823009|NCT00397046|6321764|P3|Overall Study|Disease Progression|10
1823010|NCT00397046|6321765|P2|Overall Study|Disease Progression|3
1823011|NCT00397046|6321766|P1|Overall Study|Disease Progression|3
1823012|NCT00397033|6321788|P3|Overall Study|Other|2
1823013|NCT00397033|6321789|P2|Overall Study|Other|5
1823014|NCT00397033|6321790|P1|Overall Study|Other|0
1823015|NCT00397033|6321788|P3|Overall Study|Withdrawal by Subject|5
1823016|NCT00397033|6321789|P2|Overall Study|Withdrawal by Subject|7
1823017|NCT00397033|6321790|P1|Overall Study|Withdrawal by Subject|12
1823018|NCT00397033|6321788|P3|Overall Study|Lost to Follow-up|3
1823019|NCT00397033|6321789|P2|Overall Study|Lost to Follow-up|3
1823020|NCT00397033|6321790|P1|Overall Study|Lost to Follow-up|3
1823021|NCT00397033|6321788|P3|Overall Study|Lack of Efficacy|9
1823022|NCT00397033|6321789|P2|Overall Study|Lack of Efficacy|12
1823023|NCT00397033|6321790|P1|Overall Study|Lack of Efficacy|22
1823024|NCT00397033|6321788|P3|Overall Study|Adverse Event|4
1823025|NCT00397033|6321789|P2|Overall Study|Adverse Event|10
1823026|NCT00397033|6321790|P1|Overall Study|Adverse Event|7
1823027|NCT00396877|6321881|P2|Overall Study|Parent(s)/guardian(s)'s request|7
1823028|NCT00396877|6321882|P1|Overall Study|Parent(s)/guardian(s)'s request|4
1823029|NCT00396877|6321881|P2|Overall Study|Lost to Follow-up|1
1823030|NCT00396877|6321882|P1|Overall Study|Lost to Follow-up|2
1823031|NCT00396812|6321892|P1|Overall Study|Physician Decision|1
1823032|NCT00396656|6321904|P2|Second Treatment Period|Adverse Event|1
1823033|NCT00396656|6321905|P1|Second Treatment Period|Adverse Event|0
1823034|NCT00396656|6321904|P2|First Treatment Period|Withdrawal by Subject|2
1823035|NCT00396656|6321905|P1|First Treatment Period|Withdrawal by Subject|0
1823036|NCT00396630|6321923|P2|Overall Study|Not vaccinated at Visit 3|3
1823037|NCT00396630|6321924|P1|Overall Study|Not vaccinated at Visit 3|3
1823038|NCT00396630|6321923|P2|Overall Study|Withdrawal by Subject|1
1823039|NCT00396630|6321924|P1|Overall Study|Withdrawal by Subject|1
1823040|NCT00396630|6321923|P2|Overall Study|Lost to Follow-up|1
1823041|NCT00396630|6321924|P1|Overall Study|Lost to Follow-up|1
1823042|NCT00396591|6321944|P1|Overall Study|Participant request|1
1823043|NCT00396591|6321944|P1|Overall Study|Adverse Event|2
1823044|NCT00396591|6321944|P1|Overall Study|Disease Progression|13
1823045|NCT00396565|6321957|P3|Overall Study|Lack of Efficacy|11
1823046|NCT00396565|6321958|P2|Overall Study|Lack of Efficacy|64
1823047|NCT00396565|6321959|P1|Overall Study|Lack of Efficacy|32
1823048|NCT00396565|6321957|P3|Overall Study|Withdrawal by Subject|1
1823049|NCT00396565|6321958|P2|Overall Study|Withdrawal by Subject|13
1823050|NCT00396565|6321959|P1|Overall Study|Withdrawal by Subject|8
1823051|NCT00396565|6321957|P3|Overall Study|Adverse Event|3
1823052|NCT00396565|6321958|P2|Overall Study|Adverse Event|13
1823053|NCT00396565|6321959|P1|Overall Study|Adverse Event|5
1823054|NCT00396565|6321957|P3|Overall Study|Physician Decision|2
1823055|NCT00396565|6321958|P2|Overall Study|Physician Decision|1
1823056|NCT00396565|6321959|P1|Overall Study|Physician Decision|3
1823057|NCT00396409|6321984|P2|Period 2 - 2008|Lost to Follow-up|1
1823058|NCT00396409|6321985|P1|Period 2 - 2008|Lost to Follow-up|3
1823059|NCT00396409|6321984|P2|Period 2 - 2008|Withdrawal by Subject|1
1823060|NCT00396409|6321985|P1|Period 2 - 2008|Withdrawal by Subject|3
1823061|NCT00396409|6321984|P2|Period 2 - 2008|Protocol Violation|0
1823062|NCT00396409|6321985|P1|Period 2 - 2008|Protocol Violation|1
1823063|NCT00396409|6321984|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
1823064|NCT00396409|6321985|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
1823065|NCT00396409|6321984|P2|Period 1 - 2007|Lost to Follow-up|3
1823066|NCT00396409|6321985|P1|Period 1 - 2007|Lost to Follow-up|2
1823067|NCT00396409|6321984|P2|Period 1 - 2007|Withdrawal by Subject|1
1823068|NCT00396409|6321985|P1|Period 1 - 2007|Withdrawal by Subject|1
1823069|NCT00396409|6321984|P2|Period 1 - 2007|Lack of Efficacy|1
1823070|NCT00396409|6321985|P1|Period 1 - 2007|Lack of Efficacy|0
1823071|NCT00396409|6321984|P2|Period 1 - 2007|Adverse Event|1
1823072|NCT00396409|6321985|P1|Period 1 - 2007|Adverse Event|0
1823073|NCT00396383|6322015|P1|Overall Study|Lost to Follow-up|1
1823074|NCT00396383|6322015|P1|Overall Study|Death|2
1823075|NCT00396331|6322028|P1|Overall Study|Death|16
1823076|NCT00396331|6322028|P1|Overall Study|Lost to Follow-up|3
1823077|NCT00396331|6322028|P1|Overall Study|Did not go on to transplant|5
1823078|NCT00396331|6322028|P1|Overall Study|Failed to mobilize - no transplant|8
1823079|NCT00396318|6322081|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
1823080|NCT00396279|6322101|P1|Overall Study|Physician Decision|1
1823081|NCT00396279|6322101|P1|Overall Study|Withdrawal by Subject|1
1823082|NCT00396279|6322101|P1|Overall Study|Disease progression|2
1823083|NCT00396279|6322101|P1|Overall Study|Ongoing in study|26
1823084|NCT00396253|6322134|P1|Overall Study|Change in eligibility status|1
1823085|NCT00396253|6322134|P1|Overall Study|Physician Decision|1
1823086|NCT00396253|6322134|P1|Overall Study|Death|3
1823087|NCT00396253|6322134|P1|Overall Study|Withdrawal by Subject|7
1823088|NCT00396253|6322134|P1|Overall Study|Protocol Violation|1
1823089|NCT00396162|6322165|P2|Overall Study|Withdrawal by Subject|3
1823090|NCT00396162|6322166|P1|Overall Study|Withdrawal by Subject|2
1823091|NCT00396136|6322178|P1|Overall Study|Study device explanted|8
1823092|NCT00396136|6322178|P1|Overall Study|Lost to Follow-up|15
1823093|NCT00396136|6322178|P1|Overall Study|Withdrawal by Subject|59
1823094|NCT00396136|6322178|P1|Overall Study|Death|43
1823095|NCT00396097|6322185|P2|Overall Study|Insufficient Clinical Response|4
1823096|NCT00396097|6322186|P1|Overall Study|Insufficient Clinical Response|1
1823097|NCT00396097|6322185|P2|Overall Study|Adverse Event|5
1823098|NCT00396097|6322186|P1|Overall Study|Adverse Event|1
1823099|NCT00396097|6322185|P2|Overall Study|Protocol Violation|6
1823100|NCT00396097|6322186|P1|Overall Study|Protocol Violation|0
1823101|NCT00396097|6322185|P2|Overall Study|Other|5
1823102|NCT00396097|6322186|P1|Overall Study|Other|3
1823103|NCT00396097|6322185|P2|Overall Study|Lost to Follow-up|9
1823104|NCT00396097|6322186|P1|Overall Study|Lost to Follow-up|4
1823105|NCT00396097|6322185|P2|Overall Study|Withdrawal by Subject|17
1823106|NCT00396097|6322186|P1|Overall Study|Withdrawal by Subject|17
1823107|NCT00396084|6322214|P6|Overall Study|Withdrawal by Subject|0
1823108|NCT00396084|6322215|P5|Overall Study|Withdrawal by Subject|0
1823109|NCT00396084|6322216|P4|Overall Study|Withdrawal by Subject|1
1823110|NCT00396084|6322217|P3|Overall Study|Withdrawal by Subject|0
1823111|NCT00396084|6322218|P2|Overall Study|Withdrawal by Subject|0
1823112|NCT00396084|6322219|P1|Overall Study|Withdrawal by Subject|0
1823113|NCT00396084|6322214|P6|Overall Study|Adverse Event|2
1823114|NCT00396084|6322215|P5|Overall Study|Adverse Event|1
1823115|NCT00396084|6322216|P4|Overall Study|Adverse Event|0
1823116|NCT00396084|6322217|P3|Overall Study|Adverse Event|0
1823117|NCT00396084|6322218|P2|Overall Study|Adverse Event|0
1823118|NCT00396084|6322219|P1|Overall Study|Adverse Event|0
1823119|NCT00395967|6322348|P1|Follow-up Period|Lost to Follow-up|1
1823120|NCT00395967|6322348|P1|Follow-up Period|Death|1
1823121|NCT00395967|6322348|P1|Treatment Period|Failed Mobilization|1
1823122|NCT00395863|6322388|P2|Overall Study|Patients did not complete both exams|3
1823123|NCT00395863|6322389|P1|Overall Study|Patients did not complete both exams|2
1823124|NCT00395850|6322424|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1823125|NCT00395850|6322425|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1823126|NCT00395850|6322426|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
1823127|NCT00395850|6322427|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
1823128|NCT00395850|6322424|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1823129|NCT00395850|6322425|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1823130|NCT00395850|6322426|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
1823131|NCT00395850|6322427|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
1823132|NCT00395850|6322424|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1823133|NCT00395850|6322425|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1823134|NCT00395850|6322426|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
1823135|NCT00395850|6322427|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
1823136|NCT00395850|6322424|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
1823137|NCT00395850|6322425|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
1823138|NCT00395850|6322426|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1823139|NCT00395850|6322427|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
1823140|NCT00395850|6322424|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1823141|NCT00395850|6322425|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1823142|NCT00395850|6322426|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
1823143|NCT00395850|6322427|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
1823144|NCT00395850|6322424|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1823145|NCT00395850|6322425|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1823146|NCT00395850|6322426|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
1823147|NCT00395850|6322427|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
1823148|NCT00395850|6322424|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1823149|NCT00395850|6322425|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1823150|NCT00395850|6322426|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
1823151|NCT00395850|6322427|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
1823152|NCT00395746|6322444|P3|Overall Study|Unable to visit site on schedule|0
1823153|NCT00395746|6322445|P2|Overall Study|Unable to visit site on schedule|0
1823154|NCT00395746|6322446|P1|Overall Study|Unable to visit site on schedule|1
1823155|NCT00395746|6322444|P3|Overall Study|Difficultulty in use of device|1
1823156|NCT00395746|6322445|P2|Overall Study|Difficultulty in use of device|0
1823157|NCT00395746|6322446|P1|Overall Study|Difficultulty in use of device|0
1823158|NCT00395746|6322444|P3|Overall Study|Withdrawal of consent|1
1823159|NCT00395746|6322445|P2|Overall Study|Withdrawal of consent|0
1823160|NCT00395746|6322446|P1|Overall Study|Withdrawal of consent|0
1823161|NCT00395746|6322444|P3|Overall Study|Subject decision|1
1823162|NCT00395746|6322445|P2|Overall Study|Subject decision|0
1823163|NCT00395746|6322446|P1|Overall Study|Subject decision|0
1823164|NCT00395746|6322444|P3|Overall Study|Hypoglycaemia|0
1823165|NCT00395746|6322445|P2|Overall Study|Hypoglycaemia|1
1823166|NCT00395746|6322446|P1|Overall Study|Hypoglycaemia|2
1823167|NCT00395746|6322444|P3|Overall Study|Lack of Efficacy|17
1823168|NCT00395746|6322445|P2|Overall Study|Lack of Efficacy|0
1823169|NCT00395746|6322446|P1|Overall Study|Lack of Efficacy|2
1823170|NCT00395746|6322444|P3|Overall Study|Protocol Violation|0
1823171|NCT00395746|6322445|P2|Overall Study|Protocol Violation|1
1823172|NCT00395746|6322446|P1|Overall Study|Protocol Violation|0
1823173|NCT00395746|6322444|P3|Overall Study|Adverse Event|2
1823174|NCT00395746|6322445|P2|Overall Study|Adverse Event|2
1823175|NCT00395746|6322446|P1|Overall Study|Adverse Event|5
1823176|NCT00395733|6322492|P2|Period 2|Technical problems|0
1823177|NCT00395733|6322493|P1|Period 2|Technical problems|1
1823178|NCT00395733|6322492|P2|Period 2|Adverse Event|2
1823179|NCT00395733|6322493|P1|Period 2|Adverse Event|0
1823180|NCT00395733|6322492|P2|Period 2|Protocol Violation|1
1823181|NCT00395733|6322493|P1|Period 2|Protocol Violation|0
1823182|NCT00395733|6322492|P2|Period 2|Withdrawal by Subject|2
1823183|NCT00395733|6322493|P1|Period 2|Withdrawal by Subject|1
1823184|NCT00395694|6322517|P2|Continuation Phase|Withdrawal by Subject|2
1823185|NCT00395694|6322518|P1|Continuation Phase|Withdrawal by Subject|0
1823186|NCT00395694|6322517|P2|Continuation Phase|Poor Compliance|0
1823187|NCT00395694|6322518|P1|Continuation Phase|Poor Compliance|1
1823188|NCT00395694|6322517|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
1823189|NCT00395694|6322518|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
1823190|NCT00395694|6322517|P2|Continuation Phase|Lack of Efficacy|11
1823191|NCT00395694|6322518|P1|Continuation Phase|Lack of Efficacy|12
1823192|NCT00395694|6322517|P2|Continuation Phase|Adverse Event|0
1823193|NCT00395694|6322518|P1|Continuation Phase|Adverse Event|1
1823194|NCT00395694|6322517|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
1823195|NCT00395694|6322518|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
1823196|NCT00395642|6322549|P1|Overall Study|Withdrawal by Subject|1
1823197|NCT00395642|6322549|P1|Overall Study|Physician Decision|7
1823198|NCT00395642|6322549|P1|Overall Study|Lost to Follow-up|1
1823199|NCT00395642|6322549|P1|Overall Study|Death|4
1823200|NCT00395629|6322556|P3|Extension Study|Administrative problems|1
1823201|NCT00395629|6322557|P2|Extension Study|Administrative problems|0
1823202|NCT00395629|6322558|P1|Extension Study|Administrative problems|0
1823203|NCT00395629|6322556|P3|Extension Study|Adverse Event|2
1823204|NCT00395629|6322557|P2|Extension Study|Adverse Event|0
1823205|NCT00395629|6322558|P1|Extension Study|Adverse Event|0
1823206|NCT00395629|6322556|P3|Core Study|Lost to Follow-up|1
1823207|NCT00395629|6322557|P2|Core Study|Lost to Follow-up|0
1823208|NCT00395629|6322558|P1|Core Study|Lost to Follow-up|0
1823209|NCT00395629|6322556|P3|Core Study|Withdrawal by Subject|1
1823210|NCT00395629|6322557|P2|Core Study|Withdrawal by Subject|1
1823211|NCT00395629|6322558|P1|Core Study|Withdrawal by Subject|0
1823212|NCT00395629|6322556|P3|Core Study|Protocol Violation|0
1823213|NCT00395629|6322557|P2|Core Study|Protocol Violation|0
1823214|NCT00395629|6322558|P1|Core Study|Protocol Violation|1
1823215|NCT00395629|6322556|P3|Core Study|Abnormal laboratory value(s)|1
1823216|NCT00395629|6322557|P2|Core Study|Abnormal laboratory value(s)|0
1823217|NCT00395629|6322558|P1|Core Study|Abnormal laboratory value(s)|0
1823218|NCT00395629|6322556|P3|Core Study|Adverse Event|4
1823219|NCT00395629|6322557|P2|Core Study|Adverse Event|3
1823220|NCT00395629|6322558|P1|Core Study|Adverse Event|0
1823221|NCT00395538|6322575|P3|Overall Study|Participant elected to discontinue|1
1823222|NCT00395538|6322576|P2|Overall Study|Participant elected to discontinue|0
1823223|NCT00395538|6322577|P1|Overall Study|Participant elected to discontinue|0
1823224|NCT00395538|6322575|P3|Overall Study|Partial recovery of parathyroid function|1
1823225|NCT00395538|6322576|P2|Overall Study|Partial recovery of parathyroid function|0
1823226|NCT00395538|6322577|P1|Overall Study|Partial recovery of parathyroid function|0
1823227|NCT00395538|6322575|P3|Overall Study|Pregnancy|0
1823228|NCT00395538|6322576|P2|Overall Study|Pregnancy|0
1823229|NCT00395538|6322577|P1|Overall Study|Pregnancy|1
1823230|NCT00395538|6322575|P3|Overall Study|PTH resistance|1
1823231|NCT00395538|6322576|P2|Overall Study|PTH resistance|0
1823232|NCT00395538|6322577|P1|Overall Study|PTH resistance|0
1823233|NCT00395538|6322575|P3|Overall Study|Non-compliance with study protocol|0
1823234|NCT00395538|6322576|P2|Overall Study|Non-compliance with study protocol|1
1823235|NCT00395538|6322577|P1|Overall Study|Non-compliance with study protocol|0
1823236|NCT00395538|6322575|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
1823237|NCT00395538|6322576|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
1823238|NCT00395538|6322577|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
1823239|NCT00395538|6322575|P3|Overall Study|Adverse Event|2
1823240|NCT00395538|6322576|P2|Overall Study|Adverse Event|0
1823241|NCT00395538|6322577|P1|Overall Study|Adverse Event|1
1823242|NCT00395538|6322575|P3|Overall Study|Switch to Natpara|3
1823243|NCT00395538|6322576|P2|Overall Study|Switch to Natpara|0
1823244|NCT00395538|6322577|P1|Overall Study|Switch to Natpara|0
1823245|NCT00395538|6322575|P3|Overall Study|Failed screening|4
1823246|NCT00395538|6322576|P2|Overall Study|Failed screening|0
1823247|NCT00395538|6322577|P1|Overall Study|Failed screening|0
1823248|NCT00395538|6322575|P3|Overall Study|FDA partial hold on PTH|11
1823249|NCT00395538|6322576|P2|Overall Study|FDA partial hold on PTH|0
1823250|NCT00395538|6322577|P1|Overall Study|FDA partial hold on PTH|0
1823251|NCT00395538|6322575|P3|Overall Study|Did not re-consent to revised protocol|0
1823252|NCT00395538|6322576|P2|Overall Study|Did not re-consent to revised protocol|10
1823253|NCT00395538|6322577|P1|Overall Study|Did not re-consent to revised protocol|1
1823254|NCT00395512|6322650|P4|Overall Study|Hyperglycemic Rescue|6
1823255|NCT00395512|6322651|P3|Overall Study|Hyperglycemic Rescue|4
1823256|NCT00395512|6322652|P2|Overall Study|Hyperglycemic Rescue|10
1823257|NCT00395512|6322653|P1|Overall Study|Hyperglycemic Rescue|18
1823258|NCT00395512|6322650|P4|Overall Study|Other|0
1823259|NCT00395512|6322651|P3|Overall Study|Other|0
1823260|NCT00395512|6322652|P2|Overall Study|Other|1
1823261|NCT00395512|6322653|P1|Overall Study|Other|1
1823262|NCT00395512|6322650|P4|Overall Study|Physician Decision|2
1823263|NCT00395512|6322651|P3|Overall Study|Physician Decision|2
1823264|NCT00395512|6322652|P2|Overall Study|Physician Decision|4
1823265|NCT00395512|6322653|P1|Overall Study|Physician Decision|6
1823266|NCT00395512|6322650|P4|Overall Study|Withdrawal by Subject|12
1823267|NCT00395512|6322651|P3|Overall Study|Withdrawal by Subject|5
1823268|NCT00395512|6322652|P2|Overall Study|Withdrawal by Subject|5
1823269|NCT00395512|6322653|P1|Overall Study|Withdrawal by Subject|6
1823270|NCT00395512|6322650|P4|Overall Study|Lost to Follow-up|5
1823271|NCT00395512|6322651|P3|Overall Study|Lost to Follow-up|5
1823272|NCT00395512|6322652|P2|Overall Study|Lost to Follow-up|6
1823273|NCT00395512|6322653|P1|Overall Study|Lost to Follow-up|2
1823274|NCT00395512|6322650|P4|Overall Study|Protocol Violation|7
1823275|NCT00395512|6322651|P3|Overall Study|Protocol Violation|6
1823276|NCT00395512|6322652|P2|Overall Study|Protocol Violation|3
1823277|NCT00395512|6322653|P1|Overall Study|Protocol Violation|2
1823278|NCT00395512|6322650|P4|Overall Study|Adverse Event|6
1823279|NCT00395512|6322651|P3|Overall Study|Adverse Event|6
1823280|NCT00395512|6322652|P2|Overall Study|Adverse Event|8
1823281|NCT00395512|6322653|P1|Overall Study|Adverse Event|3
1823282|NCT00395486|6322825|P2|Overall Study|Lost to Follow-up|1
1823283|NCT00395486|6322826|P1|Overall Study|Lost to Follow-up|0
1823284|NCT00395486|6322825|P2|Overall Study|Withdrawal by Subject|2
1823285|NCT00395486|6322826|P1|Overall Study|Withdrawal by Subject|5
1823286|NCT00395486|6322825|P2|Overall Study|Adverse Event|2
1823287|NCT00395486|6322826|P1|Overall Study|Adverse Event|1
1823288|NCT00395460|6322856|P2|Overall Study|Withdrawal by Subject|0
1823289|NCT00395460|6322857|P1|Overall Study|Withdrawal by Subject|1
1823290|NCT00395447|6322881|P2|Overall Study|Withdrawl - Other (not subject)|17
1823291|NCT00395447|6322882|P1|Overall Study|Withdrawl - Other (not subject)|8
1823292|NCT00395447|6322881|P2|Overall Study|Withdrawal by Subject|19
1823293|NCT00395447|6322882|P1|Overall Study|Withdrawal by Subject|24
1823294|NCT00395447|6322881|P2|Overall Study|Lost to Follow-up|43
1823295|NCT00395447|6322882|P1|Overall Study|Lost to Follow-up|52
1823296|NCT00395447|6322881|P2|Overall Study|Death|32
1823297|NCT00395447|6322882|P1|Overall Study|Death|37
1823298|NCT00395343|6322890|P2|Overall Study|Other|2
1823299|NCT00395343|6322891|P1|Overall Study|Other|5
1823300|NCT00395343|6322890|P2|Overall Study|Withdrawal by Subject|12
1823301|NCT00395343|6322891|P1|Overall Study|Withdrawal by Subject|11
1823302|NCT00395343|6322890|P2|Overall Study|Protocol Violation|8
1823303|NCT00395343|6322891|P1|Overall Study|Protocol Violation|6
1823304|NCT00395343|6322890|P2|Overall Study|Physician Decision|4
1823305|NCT00395343|6322891|P1|Overall Study|Physician Decision|2
1823306|NCT00395343|6322890|P2|Overall Study|Lost to Follow-up|4
1823307|NCT00395343|6322891|P1|Overall Study|Lost to Follow-up|4
1823308|NCT00395343|6322890|P2|Overall Study|Lack of Efficacy|1
1823309|NCT00395343|6322891|P1|Overall Study|Lack of Efficacy|0
1823310|NCT00395343|6322890|P2|Overall Study|Adverse Event|5
1823311|NCT00395343|6322891|P1|Overall Study|Adverse Event|13
1823312|NCT00395304|6322909|P6|Treatment Period 3|Other|0
1823313|NCT00395304|6322910|P5|Treatment Period 3|Other|0
1823314|NCT00395304|6322911|P4|Treatment Period 3|Other|1
1823315|NCT00395304|6322912|P3|Treatment Period 3|Other|0
1823316|NCT00395304|6322913|P2|Treatment Period 3|Other|0
1823317|NCT00395304|6322914|P1|Treatment Period 3|Other|0
1823318|NCT00395304|6322909|P6|Treatment Period 3|Physician Decision|0
1823319|NCT00395304|6322910|P5|Treatment Period 3|Physician Decision|0
1823320|NCT00395304|6322911|P4|Treatment Period 3|Physician Decision|0
1823321|NCT00395304|6322912|P3|Treatment Period 3|Physician Decision|0
1823322|NCT00395304|6322913|P2|Treatment Period 3|Physician Decision|1
1823323|NCT00395304|6322914|P1|Treatment Period 3|Physician Decision|0
1823324|NCT00395304|6322909|P6|Treatment Period 3|Lost to Follow-up|0
1823325|NCT00395304|6322910|P5|Treatment Period 3|Lost to Follow-up|0
1823326|NCT00395304|6322911|P4|Treatment Period 3|Lost to Follow-up|0
1823327|NCT00395304|6322912|P3|Treatment Period 3|Lost to Follow-up|0
1823328|NCT00395304|6322913|P2|Treatment Period 3|Lost to Follow-up|1
1823329|NCT00395304|6322914|P1|Treatment Period 3|Lost to Follow-up|1
1823330|NCT00395304|6322909|P6|Treatment Period 3|Withdrawal by Subject|1
1823331|NCT00395304|6322910|P5|Treatment Period 3|Withdrawal by Subject|0
1823332|NCT00395304|6322911|P4|Treatment Period 3|Withdrawal by Subject|1
1823333|NCT00395304|6322912|P3|Treatment Period 3|Withdrawal by Subject|0
1823334|NCT00395304|6322913|P2|Treatment Period 3|Withdrawal by Subject|0
1823335|NCT00395304|6322914|P1|Treatment Period 3|Withdrawal by Subject|0
1823336|NCT00395304|6322909|P6|Treatment Period 2|Other|0
1823337|NCT00395304|6322910|P5|Treatment Period 2|Other|0
1823338|NCT00395304|6322911|P4|Treatment Period 2|Other|0
1823339|NCT00395304|6322912|P3|Treatment Period 2|Other|0
1823340|NCT00395304|6322913|P2|Treatment Period 2|Other|1
1823341|NCT00395304|6322914|P1|Treatment Period 2|Other|0
1823342|NCT00395304|6322909|P6|Treatment Period 2|Physician Decision|0
1823343|NCT00395304|6322910|P5|Treatment Period 2|Physician Decision|0
1823344|NCT00395304|6322911|P4|Treatment Period 2|Physician Decision|0
1823345|NCT00395304|6322912|P3|Treatment Period 2|Physician Decision|1
1823346|NCT00395304|6322913|P2|Treatment Period 2|Physician Decision|0
1823347|NCT00395304|6322914|P1|Treatment Period 2|Physician Decision|0
1823348|NCT00395304|6322909|P6|Treatment Period 2|Lost to Follow-up|0
1823349|NCT00395304|6322910|P5|Treatment Period 2|Lost to Follow-up|0
1823350|NCT00395304|6322911|P4|Treatment Period 2|Lost to Follow-up|0
1823351|NCT00395304|6322912|P3|Treatment Period 2|Lost to Follow-up|0
1823352|NCT00395304|6322913|P2|Treatment Period 2|Lost to Follow-up|3
1823353|NCT00395304|6322914|P1|Treatment Period 2|Lost to Follow-up|0
1823354|NCT00395304|6322909|P6|Treatment Period 2|Withdrawal by Subject|2
1823355|NCT00395304|6322910|P5|Treatment Period 2|Withdrawal by Subject|0
1823356|NCT00395304|6322911|P4|Treatment Period 2|Withdrawal by Subject|1
1823357|NCT00395304|6322912|P3|Treatment Period 2|Withdrawal by Subject|0
1823358|NCT00395304|6322913|P2|Treatment Period 2|Withdrawal by Subject|0
1823359|NCT00395304|6322914|P1|Treatment Period 2|Withdrawal by Subject|0
1823360|NCT00395304|6322909|P6|Treatment Period 1|Physician Decision|0
1823361|NCT00395304|6322910|P5|Treatment Period 1|Physician Decision|0
1823362|NCT00395304|6322911|P4|Treatment Period 1|Physician Decision|0
1823363|NCT00395304|6322912|P3|Treatment Period 1|Physician Decision|0
1823364|NCT00395304|6322913|P2|Treatment Period 1|Physician Decision|1
1823365|NCT00395304|6322914|P1|Treatment Period 1|Physician Decision|0
1823366|NCT00395304|6322909|P6|Treatment Period 1|Lost to Follow-up|1
1823367|NCT00395304|6322910|P5|Treatment Period 1|Lost to Follow-up|0
1823368|NCT00395304|6322911|P4|Treatment Period 1|Lost to Follow-up|1
1823369|NCT00395304|6322912|P3|Treatment Period 1|Lost to Follow-up|0
1823370|NCT00395304|6322913|P2|Treatment Period 1|Lost to Follow-up|0
1823371|NCT00395304|6322914|P1|Treatment Period 1|Lost to Follow-up|1
1823372|NCT00395304|6322909|P6|Treatment Period 1|Withdrawal by Subject|1
1823373|NCT00395304|6322910|P5|Treatment Period 1|Withdrawal by Subject|1
1823374|NCT00395304|6322911|P4|Treatment Period 1|Withdrawal by Subject|2
1823375|NCT00395304|6322912|P3|Treatment Period 1|Withdrawal by Subject|0
1823376|NCT00395304|6322913|P2|Treatment Period 1|Withdrawal by Subject|3
1823377|NCT00395304|6322914|P1|Treatment Period 1|Withdrawal by Subject|0
1823378|NCT00395226|6322990|P2|Overall Study|Lost to Follow-up|1
1823379|NCT00395226|6322991|P1|Overall Study|Lost to Follow-up|0
1823380|NCT00395226|6322990|P2|Overall Study|Withdrawal by Subject|1
1823381|NCT00395226|6322991|P1|Overall Study|Withdrawal by Subject|0
1823382|NCT00395226|6322990|P2|Overall Study|Adverse Event|3
1823383|NCT00395226|6322991|P1|Overall Study|Adverse Event|4
1823384|NCT00395083|6323038|P2|Overall Study|Developed another disease|3
1823385|NCT00395083|6323039|P1|Overall Study|Developed another disease|4
1823386|NCT00395083|6323038|P2|Overall Study|Withdrawal by Subject|5
1823387|NCT00395083|6323039|P1|Overall Study|Withdrawal by Subject|6
1823388|NCT00395018|6323105|P1|Off-Treatment Follow-up|Poor/non-compliance|1
1823389|NCT00395018|6323105|P1|Off-Treatment Follow-up|Lost to Follow-up|2
1823390|NCT00395018|6323105|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
1823391|NCT00395018|6323105|P1|On-Treatment|Subject no longer meets study criteria|2
1823392|NCT00395018|6323105|P1|On-Treatment|Poor/non-compliance|2
1823393|NCT00395018|6323105|P1|On-Treatment|Other Reason|2
1823394|NCT00395018|6323105|P1|On-Treatment|Death|4
1823395|NCT00394953|6323126|P2|Second Treatment Period|Not defined|8
1823396|NCT00394953|6323127|P1|Second Treatment Period|Not defined|3
1823397|NCT00394953|6323126|P2|Second Treatment Period|Renal transplant|6
1823398|NCT00394953|6323127|P1|Second Treatment Period|Renal transplant|4
1823399|NCT00394953|6323126|P2|Second Treatment Period|Lost to Follow-up|1
1823400|NCT00394953|6323127|P1|Second Treatment Period|Lost to Follow-up|0
1823401|NCT00394953|6323126|P2|Second Treatment Period|Withdrawal by Subject|3
1823402|NCT00394953|6323127|P1|Second Treatment Period|Withdrawal by Subject|3
1823403|NCT00394953|6323126|P2|Second Treatment Period|Lack of Efficacy|47
1823404|NCT00394953|6323127|P1|Second Treatment Period|Lack of Efficacy|9
1823405|NCT00394953|6323126|P2|Second Treatment Period|Death|4
1823406|NCT00394953|6323127|P1|Second Treatment Period|Death|8
1823407|NCT00394953|6323126|P2|Second Treatment Period|Adverse Event|5
1823408|NCT00394953|6323127|P1|Second Treatment Period|Adverse Event|2
1823409|NCT00394953|6323126|P2|First Treatment Period|Not defined|1
1823410|NCT00394953|6323127|P1|First Treatment Period|Not defined|4
1823411|NCT00394953|6323126|P2|First Treatment Period|Renal transplant|7
1823412|NCT00394953|6323127|P1|First Treatment Period|Renal transplant|11
1823413|NCT00394953|6323126|P2|First Treatment Period|Lost to Follow-up|1
1823414|NCT00394953|6323127|P1|First Treatment Period|Lost to Follow-up|0
1823415|NCT00394953|6323126|P2|First Treatment Period|Withdrawal by Subject|3
1823416|NCT00394953|6323127|P1|First Treatment Period|Withdrawal by Subject|6
1823417|NCT00394953|6323126|P2|First Treatment Period|Lack of Efficacy|1
1823418|NCT00394953|6323127|P1|First Treatment Period|Lack of Efficacy|1
1823419|NCT00394953|6323126|P2|First Treatment Period|Death|7
1823420|NCT00394953|6323127|P1|First Treatment Period|Death|6
1823421|NCT00394953|6323126|P2|First Treatment Period|Adverse Event|2
1823422|NCT00394953|6323127|P1|First Treatment Period|Adverse Event|1
1823423|NCT00394914|6323145|P3|Treatment Period|Did not meet protocol eligibility|1
1823424|NCT00394914|6323146|P2|Treatment Period|Did not meet protocol eligibility|1
1823425|NCT00394914|6323147|P1|Treatment Period|Did not meet protocol eligibility|0
1823426|NCT00394914|6323145|P3|Treatment Period|Noncompliance with protocol|2
1823427|NCT00394914|6323146|P2|Treatment Period|Noncompliance with protocol|3
1823428|NCT00394914|6323147|P1|Treatment Period|Noncompliance with protocol|0
1823429|NCT00394914|6323145|P3|Treatment Period|Withdrawal by Subject|2
1823430|NCT00394914|6323146|P2|Treatment Period|Withdrawal by Subject|2
1823431|NCT00394914|6323147|P1|Treatment Period|Withdrawal by Subject|0
1823432|NCT00394914|6323145|P3|Treatment Period|Lost to Follow-up|0
1823433|NCT00394914|6323146|P2|Treatment Period|Lost to Follow-up|1
1823434|NCT00394914|6323147|P1|Treatment Period|Lost to Follow-up|0
1823435|NCT00394914|6323145|P3|Treatment Period|Adverse Event|1
1823436|NCT00394914|6323146|P2|Treatment Period|Adverse Event|3
1823437|NCT00394914|6323147|P1|Treatment Period|Adverse Event|0
1823438|NCT00394901|6323175|P4|Double-blind Phase|Found not to meet entrance criteria|1
1823439|NCT00394901|6323176|P3|Double-blind Phase|Found not to meet entrance criteria|0
1823440|NCT00394901|6323177|P2|Double-blind Phase|Found not to meet entrance criteria|0
1823441|NCT00394901|6323178|P1|Double-blind Phase|Found not to meet entrance criteria|0
1823442|NCT00394901|6323175|P4|Double-blind Phase|Entry into another study was found|0
1823443|NCT00394901|6323176|P3|Double-blind Phase|Entry into another study was found|1
1823444|NCT00394901|6323177|P2|Double-blind Phase|Entry into another study was found|0
1823445|NCT00394901|6323178|P1|Double-blind Phase|Entry into another study was found|0
1823446|NCT00394901|6323175|P4|Double-blind Phase|Lack of Compliance|0
1823447|NCT00394901|6323176|P3|Double-blind Phase|Lack of Compliance|0
1823448|NCT00394901|6323177|P2|Double-blind Phase|Lack of Compliance|3
1823449|NCT00394901|6323178|P1|Double-blind Phase|Lack of Compliance|0
1823450|NCT00394901|6323175|P4|Double-blind Phase|Subject's Personal Reason|1
1823451|NCT00394901|6323176|P3|Double-blind Phase|Subject's Personal Reason|0
1823452|NCT00394901|6323177|P2|Double-blind Phase|Subject's Personal Reason|0
1823453|NCT00394901|6323178|P1|Double-blind Phase|Subject's Personal Reason|1
1823454|NCT00394901|6323175|P4|Double-blind Phase|Death|0
1823455|NCT00394901|6323176|P3|Double-blind Phase|Death|0
1823456|NCT00394901|6323177|P2|Double-blind Phase|Death|0
1823457|NCT00394901|6323178|P1|Double-blind Phase|Death|1
1823458|NCT00394901|6323175|P4|Double-blind Phase|Protocol Violation|1
1823459|NCT00394901|6323176|P3|Double-blind Phase|Protocol Violation|0
1823460|NCT00394901|6323177|P2|Double-blind Phase|Protocol Violation|0
1823461|NCT00394901|6323178|P1|Double-blind Phase|Protocol Violation|0
1823462|NCT00394901|6323175|P4|Double-blind Phase|Lost to Follow-up|1
1823463|NCT00394901|6323176|P3|Double-blind Phase|Lost to Follow-up|0
1823464|NCT00394901|6323177|P2|Double-blind Phase|Lost to Follow-up|0
1823465|NCT00394901|6323178|P1|Double-blind Phase|Lost to Follow-up|0
1823466|NCT00394901|6323175|P4|Double-blind Phase|Withdrawal by Subject|0
1823467|NCT00394901|6323176|P3|Double-blind Phase|Withdrawal by Subject|0
1823468|NCT00394901|6323177|P2|Double-blind Phase|Withdrawal by Subject|0
1823469|NCT00394901|6323178|P1|Double-blind Phase|Withdrawal by Subject|2
1823470|NCT00394901|6323175|P4|Double-blind Phase|Lack of Efficacy|3
1823471|NCT00394901|6323176|P3|Double-blind Phase|Lack of Efficacy|1
1823472|NCT00394901|6323177|P2|Double-blind Phase|Lack of Efficacy|4
1823473|NCT00394901|6323178|P1|Double-blind Phase|Lack of Efficacy|6
1823474|NCT00394901|6323175|P4|Double-blind Phase|Adverse Event|20
1823475|NCT00394901|6323176|P3|Double-blind Phase|Adverse Event|16
1823476|NCT00394901|6323177|P2|Double-blind Phase|Adverse Event|7
1823477|NCT00394901|6323178|P1|Double-blind Phase|Adverse Event|5
1823478|NCT00394901|6323175|P4|Baseline Phase|Protocol Violation|0
1823479|NCT00394901|6323176|P3|Baseline Phase|Protocol Violation|1
1823480|NCT00394901|6323177|P2|Baseline Phase|Protocol Violation|0
1823481|NCT00394901|6323178|P1|Baseline Phase|Protocol Violation|0
1823482|NCT00394836|6323421|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
1823483|NCT00394836|6323422|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
1823484|NCT00394836|6323421|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
1823485|NCT00394836|6323422|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
1823486|NCT00394836|6323421|P2|Extended Follow-up Phase (2-5 Years)|Death|1
1823487|NCT00394836|6323422|P1|Extended Follow-up Phase (2-5 Years)|Death|0
1823488|NCT00394836|6323421|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
1823489|NCT00394836|6323422|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
1823490|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Non compliance|1
1823491|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Non compliance|0
1823492|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
1823493|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
1823494|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Physician Decision|1
1823495|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Physician Decision|0
1823496|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
1823497|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
1823498|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Started alternative treatment|6
1823499|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Started alternative treatment|0
1823500|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
1823501|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
1823502|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Death|1
1823503|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Death|0
1823504|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Patient Refusal|2
1823505|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Patient Refusal|1
1823506|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Disease Progression|60
1823507|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Disease Progression|27
1823508|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Protocol Violation|2
1823509|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Protocol Violation|0
1823510|NCT00394836|6323421|P2|Teatment or Follow-up Phase|Adverse Event|2
1823511|NCT00394836|6323422|P1|Teatment or Follow-up Phase|Adverse Event|0
1823512|NCT00394771|6323468|P4|Overall Study|Other|0
1823513|NCT00394771|6323469|P3|Overall Study|Other|1
1823514|NCT00394771|6323470|P2|Overall Study|Other|3
1823515|NCT00394771|6323471|P1|Overall Study|Other|3
1823516|NCT00394771|6323468|P4|Overall Study|Lost to Follow-up|10
1823517|NCT00394771|6323469|P3|Overall Study|Lost to Follow-up|13
1823518|NCT00394771|6323470|P2|Overall Study|Lost to Follow-up|15
1823519|NCT00394771|6323471|P1|Overall Study|Lost to Follow-up|15
1823520|NCT00394771|6323468|P4|Overall Study|Participant pregnant|2
1823521|NCT00394771|6323469|P3|Overall Study|Participant pregnant|2
1823522|NCT00394771|6323470|P2|Overall Study|Participant pregnant|1
1823523|NCT00394771|6323471|P1|Overall Study|Participant pregnant|0
1823524|NCT00394771|6323468|P4|Overall Study|Adverse Event|8
1823525|NCT00394771|6323469|P3|Overall Study|Adverse Event|12
1823526|NCT00394771|6323470|P2|Overall Study|Adverse Event|5
1823527|NCT00394771|6323471|P1|Overall Study|Adverse Event|10
1823528|NCT00394771|6323468|P4|Overall Study|Withdrawal by Subject|12
1823529|NCT00394771|6323469|P3|Overall Study|Withdrawal by Subject|8
1823530|NCT00394771|6323470|P2|Overall Study|Withdrawal by Subject|6
1823531|NCT00394771|6323471|P1|Overall Study|Withdrawal by Subject|10
1823532|NCT00394771|6323468|P4|Overall Study|Protocol Violation|7
1823533|NCT00394771|6323469|P3|Overall Study|Protocol Violation|9
1823534|NCT00394771|6323470|P2|Overall Study|Protocol Violation|4
1823535|NCT00394771|6323471|P1|Overall Study|Protocol Violation|2
1823536|NCT00394771|6323468|P4|Overall Study|Did not meet protocol requirements|0
1823537|NCT00394771|6323469|P3|Overall Study|Did not meet protocol requirements|2
1823538|NCT00394771|6323470|P2|Overall Study|Did not meet protocol requirements|0
1823539|NCT00394771|6323471|P1|Overall Study|Did not meet protocol requirements|1
1823540|NCT00394706|6323541|P8|Overall Study|Lost to Follow-up|0
1823541|NCT00394706|6323542|P7|Overall Study|Lost to Follow-up|2
1823542|NCT00394706|6323543|P6|Overall Study|Lost to Follow-up|5
1823543|NCT00394706|6323544|P5|Overall Study|Lost to Follow-up|2
1823544|NCT00394706|6323545|P4|Overall Study|Lost to Follow-up|1
1823545|NCT00394706|6323546|P3|Overall Study|Lost to Follow-up|8
1823546|NCT00394706|6323547|P2|Overall Study|Lost to Follow-up|2
1823547|NCT00394706|6323548|P1|Overall Study|Lost to Follow-up|2
1823548|NCT00394706|6323541|P8|Overall Study|Withdrawal by Subject|0
1823549|NCT00394706|6323542|P7|Overall Study|Withdrawal by Subject|1
1823550|NCT00394706|6323543|P6|Overall Study|Withdrawal by Subject|2
1823551|NCT00394706|6323544|P5|Overall Study|Withdrawal by Subject|0
1823552|NCT00394706|6323545|P4|Overall Study|Withdrawal by Subject|0
1823553|NCT00394706|6323546|P3|Overall Study|Withdrawal by Subject|1
1823554|NCT00394706|6323547|P2|Overall Study|Withdrawal by Subject|0
1823555|NCT00394706|6323548|P1|Overall Study|Withdrawal by Subject|2
1823556|NCT00394654|6323580|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
1823557|NCT00394654|6323581|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
1823558|NCT00394654|6323580|P2|Overall Study|Lost to Follow-up|0
1823559|NCT00394654|6323581|P1|Overall Study|Lost to Follow-up|1
1823560|NCT00394589|6323646|P3|Overall Study|Protocol Violation|2
1823561|NCT00394589|6323647|P2|Overall Study|Protocol Violation|0
1823562|NCT00394589|6323648|P1|Overall Study|Protocol Violation|4
1823563|NCT00394589|6323646|P3|Overall Study|Lack of Efficacy|3
1823564|NCT00394589|6323647|P2|Overall Study|Lack of Efficacy|2
1823565|NCT00394589|6323648|P1|Overall Study|Lack of Efficacy|2
1823566|NCT00394589|6323646|P3|Overall Study|Adverse Event|2
1823567|NCT00394589|6323647|P2|Overall Study|Adverse Event|1
1823568|NCT00394589|6323648|P1|Overall Study|Adverse Event|2
1823569|NCT00394524|6323658|P2|Overall Study|Withdrawal by Subject|1
1823570|NCT00394524|6323659|P1|Overall Study|Withdrawal by Subject|0
1823571|NCT00394524|6323658|P2|Overall Study|Death|0
1823572|NCT00394524|6323659|P1|Overall Study|Death|1
1823573|NCT00394524|6323658|P2|Overall Study|Protocol Violation|3
1823574|NCT00394524|6323659|P1|Overall Study|Protocol Violation|2
1823575|NCT00394472|6323673|P2|Overall Study|Lost to Follow-up|1
1823576|NCT00394472|6323674|P1|Overall Study|Lost to Follow-up|0
1823577|NCT00394472|6323673|P2|Overall Study|Physician Decision|1
1823578|NCT00394472|6323674|P1|Overall Study|Physician Decision|0
1823579|NCT00394472|6323673|P2|Overall Study|Withdrawal by Subject|2
1823580|NCT00394472|6323674|P1|Overall Study|Withdrawal by Subject|0
1823581|NCT00394472|6323673|P2|Overall Study|Adverse Event|2
1823582|NCT00394472|6323674|P1|Overall Study|Adverse Event|4
1823583|NCT00394472|6323673|P2|Overall Study|incorrect enrolment|2
1823584|NCT00394472|6323674|P1|Overall Study|incorrect enrolment|4
1823585|NCT00394472|6323673|P2|Overall Study|Protocol Violation|3
1823586|NCT00394472|6323674|P1|Overall Study|Protocol Violation|1
1823587|NCT00394433|6323682|P1|Overall Study|Alternative Therapy|1
1823588|NCT00394433|6323682|P1|Overall Study|Adverse Event|2
1823589|NCT00394355|6323693|P4|Overall Study|Lack of Efficacy|3
1823590|NCT00394355|6323694|P3|Overall Study|Lack of Efficacy|2
1823591|NCT00394355|6323695|P2|Overall Study|Lack of Efficacy|0
1823592|NCT00394355|6323696|P1|Overall Study|Lack of Efficacy|0
1823593|NCT00394355|6323693|P4|Overall Study|Administrative|1
1823594|NCT00394355|6323694|P3|Overall Study|Administrative|1
1823595|NCT00394355|6323695|P2|Overall Study|Administrative|1
1823596|NCT00394355|6323696|P1|Overall Study|Administrative|0
1823597|NCT00394355|6323693|P4|Overall Study|Noncompliance with protocol|8
1823598|NCT00394355|6323694|P3|Overall Study|Noncompliance with protocol|10
1823599|NCT00394355|6323695|P2|Overall Study|Noncompliance with protocol|3
1823600|NCT00394355|6323696|P1|Overall Study|Noncompliance with protocol|4
1823601|NCT00394355|6323693|P4|Overall Study|Lost to Follow-up|3
1823602|NCT00394355|6323694|P3|Overall Study|Lost to Follow-up|4
1823603|NCT00394355|6323695|P2|Overall Study|Lost to Follow-up|5
1823604|NCT00394355|6323696|P1|Overall Study|Lost to Follow-up|7
1823605|NCT00394355|6323693|P4|Overall Study|Subject withdrawal - related to drug|0
1823606|NCT00394355|6323694|P3|Overall Study|Subject withdrawal - related to drug|0
1823607|NCT00394355|6323695|P2|Overall Study|Subject withdrawal - related to drug|0
1823608|NCT00394355|6323696|P1|Overall Study|Subject withdrawal - related to drug|1
1823609|NCT00394355|6323693|P4|Overall Study|Subject withdrawal - unrelated to drug|6
1823610|NCT00394355|6323694|P3|Overall Study|Subject withdrawal - unrelated to drug|10
1823611|NCT00394355|6323695|P2|Overall Study|Subject withdrawal - unrelated to drug|14
1823612|NCT00394355|6323696|P1|Overall Study|Subject withdrawal - unrelated to drug|12
1823613|NCT00394355|6323693|P4|Overall Study|Did not meet protocol eligibility|2
1823614|NCT00394355|6323694|P3|Overall Study|Did not meet protocol eligibility|4
1823615|NCT00394355|6323695|P2|Overall Study|Did not meet protocol eligibility|5
1823616|NCT00394355|6323696|P1|Overall Study|Did not meet protocol eligibility|1
1823617|NCT00394355|6323693|P4|Overall Study|Adverse Event|8
1823618|NCT00394355|6323694|P3|Overall Study|Adverse Event|7
1823619|NCT00394355|6323695|P2|Overall Study|Adverse Event|6
1823620|NCT00394355|6323696|P1|Overall Study|Adverse Event|10
1823621|NCT00394251|6323802|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1823622|NCT00394251|6323803|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
1823623|NCT00394251|6323802|P2|Overall Study|Withdrawal by Subject|11
1823624|NCT00394251|6323803|P1|Overall Study|Withdrawal by Subject|7
1823625|NCT00394251|6323802|P2|Overall Study|Protocol Violation|1
1823626|NCT00394251|6323803|P1|Overall Study|Protocol Violation|0
1823627|NCT00394251|6323802|P2|Overall Study|Physician Decision|1
1823628|NCT00394251|6323803|P1|Overall Study|Physician Decision|1
1823629|NCT00394251|6323802|P2|Overall Study|Unacceptable Toxicity|18
1823630|NCT00394251|6323803|P1|Overall Study|Unacceptable Toxicity|20
1823631|NCT00394251|6323802|P2|Overall Study|Adverse Event|5
1823632|NCT00394251|6323803|P1|Overall Study|Adverse Event|7
1823633|NCT00394212|6323831|P2|Overall Study|Withdrawal by Subject|1
1823634|NCT00394212|6323832|P1|Overall Study|Withdrawal by Subject|4
1823635|NCT00394212|6323831|P2|Overall Study|Lost to Follow-up|0
1823636|NCT00394212|6323832|P1|Overall Study|Lost to Follow-up|3
1823637|NCT00394095|6323846|P2|Overall Study|Adverse Event|0
1823638|NCT00394095|6323847|P1|Overall Study|Adverse Event|1
1823639|NCT00394082|6323855|P1|Overall Study|Other|1
1823640|NCT00394082|6323855|P1|Overall Study|Withdrawal by Subject|2
1823641|NCT00394082|6323855|P1|Overall Study|Physician Decision|4
1823642|NCT00394082|6323855|P1|Overall Study|Adverse Event|4
1823643|NCT00394082|6323855|P1|Overall Study|Unacceptable toxicity|15
1823644|NCT00393939|6323877|P2|Overall Study|Other|45
1823645|NCT00393939|6323878|P1|Overall Study|Other|37
1823646|NCT00393939|6323877|P2|Overall Study|Withdrawal by Subject|7
1823647|NCT00393939|6323878|P1|Overall Study|Withdrawal by Subject|2
1823648|NCT00393939|6323877|P2|Overall Study|Objective progression or relapse|223
1823649|NCT00393939|6323878|P1|Overall Study|Objective progression or relapse|239
1823650|NCT00393939|6323877|P2|Overall Study|Sponsor|13
1823651|NCT00393939|6323878|P1|Overall Study|Sponsor|5
1823652|NCT00393939|6323877|P2|Overall Study|Death|4
1823653|NCT00393939|6323878|P1|Overall Study|Death|10
1823654|NCT00393939|6323877|P2|Overall Study|Lost to Follow-up|4
1823655|NCT00393939|6323878|P1|Overall Study|Lost to Follow-up|2
1823656|NCT00393939|6323877|P2|Overall Study|Protocol Violation|1
1823657|NCT00393939|6323878|P1|Overall Study|Protocol Violation|1
1823658|NCT00393913|6323896|P1|CPAP|TEchnical problem with CPAP|3
1823659|NCT00393913|6323896|P1|CPAP|Physician Decision|1
1823660|NCT00393913|6323896|P1|CPAP|Withdrawal by Subject|3
1823661|NCT00393913|6323896|P1|Initial Assessment|Withdrawal by Subject|16
1823662|NCT00393913|6323896|P1|Initial Assessment|diagnosed with other sleep disorder|21
1823663|NCT00393887|6323904|P2|Overall Study|Lost to Follow-up|9
1823664|NCT00393887|6323905|P1|Overall Study|Lost to Follow-up|11
1823665|NCT00393887|6323904|P2|Overall Study|Physician Decision|0
1823666|NCT00393887|6323905|P1|Overall Study|Physician Decision|5
1823667|NCT00393861|6323933|P1|Overall Study|Disease Progression|24
1823668|NCT00393861|6323933|P1|Overall Study|Adverse Event|2
1823669|NCT00393848|6323944|P4|Overall Study|Personal reasons|0
1823670|NCT00393848|6323945|P3|Overall Study|Personal reasons|2
1823671|NCT00393848|6323946|P2|Overall Study|Personal reasons|0
1823672|NCT00393848|6323947|P1|Overall Study|Personal reasons|0
1823673|NCT00393848|6323944|P4|Overall Study|Surgical schedule|1
1823674|NCT00393848|6323945|P3|Overall Study|Surgical schedule|0
1823675|NCT00393848|6323946|P2|Overall Study|Surgical schedule|0
1823676|NCT00393848|6323947|P1|Overall Study|Surgical schedule|0
1823677|NCT00393718|6323970|P2|Overall Study|Move|0
1823678|NCT00393718|6323971|P1|Overall Study|Move|1
1823679|NCT00393718|6323970|P2|Overall Study|Missed measurement|0
1823680|NCT00393718|6323971|P1|Overall Study|Missed measurement|1
1823681|NCT00393718|6323970|P2|Overall Study|Withdrawal of consent|1
1823682|NCT00393718|6323971|P1|Overall Study|Withdrawal of consent|2
1823683|NCT00393718|6323970|P2|Overall Study|Subject decision|0
1823684|NCT00393718|6323971|P1|Overall Study|Subject decision|5
1823685|NCT00393718|6323970|P2|Overall Study|Hypoglycaemia|2
1823686|NCT00393718|6323971|P1|Overall Study|Hypoglycaemia|3
1823687|NCT00393718|6323970|P2|Overall Study|Lack of Efficacy|9
1823688|NCT00393718|6323971|P1|Overall Study|Lack of Efficacy|10
1823689|NCT00393718|6323970|P2|Overall Study|Protocol Violation|2
1823690|NCT00393718|6323971|P1|Overall Study|Protocol Violation|1
1823691|NCT00393718|6323970|P2|Overall Study|Adverse Event|8
1823692|NCT00393718|6323971|P1|Overall Study|Adverse Event|20
1823693|NCT00393705|6324003|P2|Overall Study|Physician Decision|2
1823694|NCT00393705|6324004|P1|Overall Study|Physician Decision|2
1823695|NCT00393705|6324003|P2|Overall Study|Withdrawal by Subject|3
1823696|NCT00393705|6324004|P1|Overall Study|Withdrawal by Subject|5
1823697|NCT00393705|6324003|P2|Overall Study|Protocol Violation|3
1823698|NCT00393705|6324004|P1|Overall Study|Protocol Violation|4
1823699|NCT00393705|6324003|P2|Overall Study|Entry Criteria Not Met|10
1823700|NCT00393705|6324004|P1|Overall Study|Entry Criteria Not Met|10
1823701|NCT00393705|6324003|P2|Overall Study|Lost to Follow-up|2
1823702|NCT00393705|6324004|P1|Overall Study|Lost to Follow-up|2
1823703|NCT00393705|6324003|P2|Overall Study|Death|1
1823704|NCT00393705|6324004|P1|Overall Study|Death|0
1823705|NCT00393705|6324003|P2|Overall Study|Adverse Event|2
1823706|NCT00393705|6324004|P1|Overall Study|Adverse Event|0
1823707|NCT00393523|6324033|P5|Overall Study|Vaccine supply issue|0
1823708|NCT00393523|6324034|P4|Overall Study|Vaccine supply issue|0
1823709|NCT00393523|6324035|P3|Overall Study|Vaccine supply issue|1
1823710|NCT00393523|6324036|P2|Overall Study|Vaccine supply issue|0
1823711|NCT00393523|6324037|P1|Overall Study|Vaccine supply issue|0
1823712|NCT00393523|6324033|P5|Overall Study|Difficulties in specimen collection|0
1823713|NCT00393523|6324034|P4|Overall Study|Difficulties in specimen collection|0
1823714|NCT00393523|6324035|P3|Overall Study|Difficulties in specimen collection|1
1823715|NCT00393523|6324036|P2|Overall Study|Difficulties in specimen collection|0
1823716|NCT00393523|6324037|P1|Overall Study|Difficulties in specimen collection|0
1823717|NCT00393523|6324033|P5|Overall Study|Withdrawal by Subject|0
1823718|NCT00393523|6324034|P4|Overall Study|Withdrawal by Subject|3
1823719|NCT00393523|6324035|P3|Overall Study|Withdrawal by Subject|2
1823720|NCT00393523|6324036|P2|Overall Study|Withdrawal by Subject|7
1823721|NCT00393523|6324037|P1|Overall Study|Withdrawal by Subject|6
1823722|NCT00393523|6324033|P5|Overall Study|Protocol Violation|0
1823723|NCT00393523|6324034|P4|Overall Study|Protocol Violation|1
1823724|NCT00393523|6324035|P3|Overall Study|Protocol Violation|0
1823725|NCT00393523|6324036|P2|Overall Study|Protocol Violation|2
1823726|NCT00393523|6324037|P1|Overall Study|Protocol Violation|6
1823727|NCT00393523|6324033|P5|Overall Study|Lost to Follow-up|1
1823728|NCT00393523|6324034|P4|Overall Study|Lost to Follow-up|2
1823729|NCT00393523|6324035|P3|Overall Study|Lost to Follow-up|0
1823730|NCT00393523|6324036|P2|Overall Study|Lost to Follow-up|0
1823731|NCT00393523|6324037|P1|Overall Study|Lost to Follow-up|0
1823732|NCT00393510|6324054|P2|Overall Study|Physician Decision|9
1823733|NCT00393510|6324055|P1|Overall Study|Physician Decision|3
1823734|NCT00393484|6324067|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
1823735|NCT00393484|6324068|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
1823736|NCT00393484|6324067|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1823737|NCT00393484|6324068|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
1823738|NCT00393484|6324067|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
1823739|NCT00393484|6324068|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
1823740|NCT00393484|6324067|P2|Open-label Period (Weeks 96 to 240)|Death|0
1823741|NCT00393484|6324068|P1|Open-label Period (Weeks 96 to 240)|Death|1
1823742|NCT00393484|6324067|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
1823743|NCT00393484|6324068|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
1823744|NCT00393484|6324067|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
1823745|NCT00393484|6324068|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
1823746|NCT00393484|6324067|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
1823747|NCT00393484|6324068|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
1823748|NCT00393484|6324067|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
1823749|NCT00393484|6324068|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
1823750|NCT00393484|6324067|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
1823751|NCT00393484|6324068|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
1823752|NCT00393484|6324067|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
1823753|NCT00393484|6324068|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
1823754|NCT00393458|6324104|P4|Overall Study|Subject no longer requires study drug|0
1823755|NCT00393458|6324105|P3|Overall Study|Subject no longer requires study drug|0
1823756|NCT00393458|6324106|P2|Overall Study|Subject no longer requires study drug|1
1823757|NCT00393458|6324107|P1|Overall Study|Subject no longer requires study drug|0
1823758|NCT00393458|6324104|P4|Overall Study|Abnormal test procedure result(s)|2
1823759|NCT00393458|6324105|P3|Overall Study|Abnormal test procedure result(s)|1
1823760|NCT00393458|6324106|P2|Overall Study|Abnormal test procedure result(s)|1
1823761|NCT00393458|6324107|P1|Overall Study|Abnormal test procedure result(s)|0
1823762|NCT00393458|6324104|P4|Overall Study|Death|5
1823763|NCT00393458|6324105|P3|Overall Study|Death|5
1823764|NCT00393458|6324106|P2|Overall Study|Death|1
1823765|NCT00393458|6324107|P1|Overall Study|Death|1
1823766|NCT00393458|6324104|P4|Overall Study|Abnormal laboratory value(s)|0
1823767|NCT00393458|6324105|P3|Overall Study|Abnormal laboratory value(s)|0
1823768|NCT00393458|6324106|P2|Overall Study|Abnormal laboratory value(s)|1
1823769|NCT00393458|6324107|P1|Overall Study|Abnormal laboratory value(s)|1
1823770|NCT00393458|6324104|P4|Overall Study|Lost to Follow-up|3
1823771|NCT00393458|6324105|P3|Overall Study|Lost to Follow-up|5
1823772|NCT00393458|6324106|P2|Overall Study|Lost to Follow-up|6
1823773|NCT00393458|6324107|P1|Overall Study|Lost to Follow-up|5
1823774|NCT00393458|6324104|P4|Overall Study|Administrative problems|2
1823775|NCT00393458|6324105|P3|Overall Study|Administrative problems|5
1823776|NCT00393458|6324106|P2|Overall Study|Administrative problems|8
1823777|NCT00393458|6324107|P1|Overall Study|Administrative problems|7
1823778|NCT00393458|6324104|P4|Overall Study|Protocol deviation|10
1823779|NCT00393458|6324105|P3|Overall Study|Protocol deviation|11
1823780|NCT00393458|6324106|P2|Overall Study|Protocol deviation|11
1823781|NCT00393458|6324107|P1|Overall Study|Protocol deviation|11
1823782|NCT00393458|6324104|P4|Overall Study|Unsatisfactory therapeutic effect|30
1823783|NCT00393458|6324105|P3|Overall Study|Unsatisfactory therapeutic effect|12
1823784|NCT00393458|6324106|P2|Overall Study|Unsatisfactory therapeutic effect|9
1823785|NCT00393458|6324107|P1|Overall Study|Unsatisfactory therapeutic effect|12
1823786|NCT00393458|6324104|P4|Overall Study|Subject withdrew consent|50
1823787|NCT00393458|6324105|P3|Overall Study|Subject withdrew consent|33
1823788|NCT00393458|6324106|P2|Overall Study|Subject withdrew consent|40
1823789|NCT00393458|6324107|P1|Overall Study|Subject withdrew consent|27
1823790|NCT00393458|6324104|P4|Overall Study|Adverse Event|35
1823791|NCT00393458|6324105|P3|Overall Study|Adverse Event|40
1823792|NCT00393458|6324106|P2|Overall Study|Adverse Event|24
1823793|NCT00393458|6324107|P1|Overall Study|Adverse Event|35
1823794|NCT00393367|6324134|P2|Overall Study|Withdrawal by Subject|2
1823795|NCT00393367|6324135|P1|Overall Study|Withdrawal by Subject|0
1823796|NCT00393367|6324134|P2|Overall Study|Protocol Violation|5
1823797|NCT00393367|6324135|P1|Overall Study|Protocol Violation|2
1823798|NCT00393094|6324163|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
1823799|NCT00393094|6324163|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
1823800|NCT00393042|6324174|P2|Second Intervetion|Protocol Violation|1
1823801|NCT00393042|6324175|P1|Second Intervetion|Protocol Violation|1
1823802|NCT00393042|6324174|P2|Second Intervetion|Lost to Follow-up|2
1823803|NCT00393042|6324175|P1|Second Intervetion|Lost to Follow-up|0
1823804|NCT00393042|6324174|P2|Second Intervetion|Lack of Efficacy|0
1823805|NCT00393042|6324175|P1|Second Intervetion|Lack of Efficacy|1
1823806|NCT00393042|6324174|P2|Second Intervetion|Withdrawal by Subject|2
1823807|NCT00393042|6324175|P1|Second Intervetion|Withdrawal by Subject|0
1823808|NCT00393042|6324174|P2|Second Intervetion|Adverse Event|3
1823809|NCT00393042|6324175|P1|Second Intervetion|Adverse Event|0
1823810|NCT00393042|6324174|P2|First Intervention|Adverse Event|1
1823811|NCT00393042|6324175|P1|First Intervention|Adverse Event|0
1823812|NCT00393042|6324174|P2|First Intervention|Protocol Violation|0
1823813|NCT00393042|6324175|P1|First Intervention|Protocol Violation|1
1823814|NCT00393042|6324174|P2|First Intervention|Lost to Follow-up|3
1823815|NCT00393042|6324175|P1|First Intervention|Lost to Follow-up|3
1823816|NCT00393042|6324174|P2|First Intervention|Withdrawal by Subject|2
1823817|NCT00393042|6324175|P1|First Intervention|Withdrawal by Subject|1
1823818|NCT00393029|6324247|P2|Overall Study|Not treated|1
1823819|NCT00393029|6324248|P1|Overall Study|Not treated|0
1823820|NCT00392990|6324259|P2|Follow up for 2 Years|Death|0
1823821|NCT00392990|6324260|P1|Follow up for 2 Years|Death|4
1823822|NCT00392990|6324259|P2|Treatment on Study|Adverse Event|1
1823823|NCT00392990|6324260|P1|Treatment on Study|Adverse Event|3
1823824|NCT00392925|6324284|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
1823825|NCT00392925|6324285|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
1823826|NCT00392925|6324286|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
1823827|NCT00392925|6324287|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
1823828|NCT00392925|6324284|P4|Randomization to Treatment Group Period|Protocol Violation|1
1823829|NCT00392925|6324285|P3|Randomization to Treatment Group Period|Protocol Violation|2
1823830|NCT00392925|6324286|P2|Randomization to Treatment Group Period|Protocol Violation|0
1823831|NCT00392925|6324287|P1|Randomization to Treatment Group Period|Protocol Violation|0
1823832|NCT00392925|6324284|P4|Randomization to Treatment Group Period|Adverse Event|5
1823833|NCT00392925|6324285|P3|Randomization to Treatment Group Period|Adverse Event|3
1823834|NCT00392925|6324286|P2|Randomization to Treatment Group Period|Adverse Event|3
1823835|NCT00392925|6324287|P1|Randomization to Treatment Group Period|Adverse Event|0
1823836|NCT00392925|6324284|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
1823837|NCT00392925|6324285|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
1823838|NCT00392925|6324286|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
1823839|NCT00392925|6324287|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
1823840|NCT00392925|6324284|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1823841|NCT00392925|6324285|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1823842|NCT00392925|6324286|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
1823843|NCT00392925|6324287|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
1823844|NCT00392925|6324284|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1823845|NCT00392925|6324285|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1823846|NCT00392925|6324286|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
1823847|NCT00392925|6324287|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
1823848|NCT00392925|6324284|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1823849|NCT00392925|6324285|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1823850|NCT00392925|6324286|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
1823851|NCT00392925|6324287|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
1823852|NCT00392925|6324284|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1823853|NCT00392925|6324285|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1823854|NCT00392925|6324286|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
1823855|NCT00392925|6324287|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
1823856|NCT00392925|6324284|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1823857|NCT00392925|6324285|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1823858|NCT00392925|6324286|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
1823859|NCT00392925|6324287|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
1823860|NCT00392808|6324401|P4|Overall Study|Unable to withdraw blood|2
1823861|NCT00392808|6324402|P3|Overall Study|Unable to withdraw blood|1
1823862|NCT00392808|6324403|P2|Overall Study|Unable to withdraw blood|1
1823863|NCT00392808|6324404|P1|Overall Study|Unable to withdraw blood|3
1823864|NCT00392808|6324401|P4|Overall Study|Lost to Follow-up|2
1823865|NCT00392808|6324402|P3|Overall Study|Lost to Follow-up|1
1823866|NCT00392808|6324403|P2|Overall Study|Lost to Follow-up|2
1823867|NCT00392808|6324404|P1|Overall Study|Lost to Follow-up|3
1823868|NCT00392769|6324428|P1|Overall Study|Adverse Event|1
1823869|NCT00392769|6324428|P1|Overall Study|Clinical Deterioration|9
1823870|NCT00392665|6324480|P2|Overall Study|Lost to Follow-up|1
1823871|NCT00392665|6324481|P1|Overall Study|Lost to Follow-up|1
1823872|NCT00392665|6324480|P2|Overall Study|Death|14
1823873|NCT00392665|6324481|P1|Overall Study|Death|16
1823874|NCT00392379|6324507|P2|Overall Study|Adverse Event|1
1823875|NCT00392379|6324508|P1|Overall Study|Adverse Event|1
1823876|NCT00392379|6324507|P2|Overall Study|Lost to Follow-up|9
1823877|NCT00392379|6324508|P1|Overall Study|Lost to Follow-up|4
1823878|NCT00392379|6324507|P2|Overall Study|Withdrawal by Subject|28
1823879|NCT00392379|6324508|P1|Overall Study|Withdrawal by Subject|17
1823880|NCT00392288|6324521|P3|Overall Study|Other|1
1823881|NCT00392288|6324522|P2|Overall Study|Other|4
1823882|NCT00392288|6324523|P1|Overall Study|Other|3
1823883|NCT00392288|6324521|P3|Overall Study|Parent/legal guardian withdrawal|1
1823884|NCT00392288|6324522|P2|Overall Study|Parent/legal guardian withdrawal|2
1823885|NCT00392288|6324523|P1|Overall Study|Parent/legal guardian withdrawal|1
1823886|NCT00392288|6324521|P3|Overall Study|Withdrawal by Subject|2
1823887|NCT00392288|6324522|P2|Overall Study|Withdrawal by Subject|0
1823888|NCT00392288|6324523|P1|Overall Study|Withdrawal by Subject|1
1823889|NCT00392288|6324521|P3|Overall Study|Lost to Follow-up|1
1823890|NCT00392288|6324522|P2|Overall Study|Lost to Follow-up|1
1823891|NCT00392288|6324523|P1|Overall Study|Lost to Follow-up|1
1823892|NCT00392288|6324521|P3|Overall Study|Protocol Violation|1
1823893|NCT00392288|6324522|P2|Overall Study|Protocol Violation|3
1823894|NCT00392288|6324523|P1|Overall Study|Protocol Violation|1
1823895|NCT00392288|6324521|P3|Overall Study|Lack of Efficacy|3
1823896|NCT00392288|6324522|P2|Overall Study|Lack of Efficacy|5
1823897|NCT00392288|6324523|P1|Overall Study|Lack of Efficacy|8
1823898|NCT00392288|6324521|P3|Overall Study|Adverse Event|8
1823899|NCT00392288|6324522|P2|Overall Study|Adverse Event|7
1823900|NCT00392288|6324523|P1|Overall Study|Adverse Event|17
1823901|NCT00392223|6324548|P2|Overall Study|Withdrawal by Subject|2
1823902|NCT00392223|6324549|P1|Overall Study|Withdrawal by Subject|3
1823903|NCT00392223|6324548|P2|Overall Study|Protocol Violation|3
1823904|NCT00392223|6324549|P1|Overall Study|Protocol Violation|0
1823905|NCT00392223|6324548|P2|Overall Study|Lost to Follow-up|4
1823906|NCT00392223|6324549|P1|Overall Study|Lost to Follow-up|1
1823907|NCT00392223|6324548|P2|Overall Study|Adverse Event|4
1823908|NCT00392223|6324549|P1|Overall Study|Adverse Event|5
1823909|NCT00392210|6324567|P2|First Voiding Trial|Physician Decision|2
1823910|NCT00392210|6324568|P1|First Voiding Trial|Physician Decision|2
1823911|NCT00392197|6324576|P2|Overall Study|Withdrawal by Subject|6
1823912|NCT00392197|6324577|P1|Overall Study|Withdrawal by Subject|4
1823913|NCT00392197|6324576|P2|Overall Study|Protocol Violation|5
1823914|NCT00392197|6324577|P1|Overall Study|Protocol Violation|7
1823915|NCT00392197|6324576|P2|Overall Study|Physician Decision|2
1823916|NCT00392197|6324577|P1|Overall Study|Physician Decision|3
1823917|NCT00392197|6324576|P2|Overall Study|Lost to Follow-up|1
1823918|NCT00392197|6324577|P1|Overall Study|Lost to Follow-up|0
1823919|NCT00392197|6324576|P2|Overall Study|Lack of Efficacy|4
1823920|NCT00392197|6324577|P1|Overall Study|Lack of Efficacy|3
1823921|NCT00392197|6324576|P2|Overall Study|Adverse Event|12
1823922|NCT00392197|6324577|P1|Overall Study|Adverse Event|4
1823923|NCT00392171|6324585|P1|Overall Study|Disease progression|101
1823924|NCT00392171|6324585|P1|Overall Study|Did not meet inclusion criteria|4
1823925|NCT00391976|6324619|P3|Overall Study|Positive P. aeruginosa antibody test|31
1823926|NCT00391976|6324620|P2|Overall Study|Positive P. aeruginosa antibody test|0
1823927|NCT00391976|6324621|P1|Overall Study|Positive P. aeruginosa antibody test|0
1823928|NCT00391976|6324619|P3|Overall Study|Unable to classify|1
1823929|NCT00391976|6324620|P2|Overall Study|Unable to classify|0
1823930|NCT00391976|6324621|P1|Overall Study|Unable to classify|0
1823931|NCT00391976|6324619|P3|Overall Study|Recurrence/no eradication of infection|0
1823932|NCT00391976|6324620|P2|Overall Study|Recurrence/no eradication of infection|19
1823933|NCT00391976|6324621|P1|Overall Study|Recurrence/no eradication of infection|21
1823934|NCT00391976|6324619|P3|Overall Study|Protocol deviation/violation|1
1823935|NCT00391976|6324620|P2|Overall Study|Protocol deviation/violation|2
1823936|NCT00391976|6324621|P1|Overall Study|Protocol deviation/violation|4
1823937|NCT00391976|6324619|P3|Overall Study|Inappropriate enrollment|0
1823938|NCT00391976|6324620|P2|Overall Study|Inappropriate enrollment|1
1823939|NCT00391976|6324621|P1|Overall Study|Inappropriate enrollment|1
1823940|NCT00391976|6324619|P3|Overall Study|Lost to Follow-up|0
1823941|NCT00391976|6324620|P2|Overall Study|Lost to Follow-up|2
1823942|NCT00391976|6324621|P1|Overall Study|Lost to Follow-up|1
1823943|NCT00391976|6324619|P3|Overall Study|Withdrawal of consent|1
1823944|NCT00391976|6324620|P2|Overall Study|Withdrawal of consent|1
1823945|NCT00391976|6324621|P1|Overall Study|Withdrawal of consent|0
1823946|NCT00391976|6324619|P3|Overall Study|Adverse Event|1
1823947|NCT00391976|6324620|P2|Overall Study|Adverse Event|0
1823948|NCT00391976|6324621|P1|Overall Study|Adverse Event|0
1823949|NCT00391898|6324645|P2|Overall Study|Other|10
1823950|NCT00391898|6324646|P1|Overall Study|Other|8
1823951|NCT00391898|6324645|P2|Overall Study|Adverse Event|0
1823952|NCT00391898|6324646|P1|Overall Study|Adverse Event|3
1823953|NCT00391872|6324666|P2|Overall Study|Lost to Follow-up|0
1823954|NCT00391872|6324667|P1|Overall Study|Lost to Follow-up|2
1823955|NCT00391872|6324666|P2|Overall Study|Reason unknown|4
1823956|NCT00391872|6324667|P1|Overall Study|Reason unknown|2
1823957|NCT00391872|6324666|P2|Overall Study|Withdrawal by Subject|249
1823958|NCT00391872|6324667|P1|Overall Study|Withdrawal by Subject|296
1823959|NCT00391872|6324666|P2|Overall Study|Protocol Violation|2
1823960|NCT00391872|6324667|P1|Overall Study|Protocol Violation|7
1823961|NCT00391846|6324705|P2|Overall Study|Developed study specific DC criteria|1
1823962|NCT00391846|6324706|P1|Overall Study|Developed study specific DC criteria|0
1823963|NCT00391846|6324705|P2|Overall Study|Withdrawal by Subject|3
1823964|NCT00391846|6324706|P1|Overall Study|Withdrawal by Subject|2
1823965|NCT00391846|6324705|P2|Overall Study|Did not meet the required elig. crit|2
1823966|NCT00391846|6324706|P1|Overall Study|Did not meet the required elig. crit|2
1823967|NCT00391846|6324705|P2|Overall Study|Adverse Event|1
1823968|NCT00391846|6324706|P1|Overall Study|Adverse Event|4
1823969|NCT00391807|6324726|P1|Overall Study|Various|96
1823970|NCT00391807|6324726|P1|Overall Study|Protocol Violation|20
1823971|NCT00391807|6324726|P1|Overall Study|Withdrawal by Subject|147
1823972|NCT00391807|6324726|P1|Overall Study|Lost to Follow-up|227
1823973|NCT00391807|6324726|P1|Overall Study|Pregnancy|25
1823974|NCT00391807|6324726|P1|Overall Study|Adverse Event|177
1823975|NCT00391807|6324726|P1|Overall Study|Did not receive study medication|23
1823976|NCT00391768|6324753|P7|Overall Study|Lost to Follow-up|3
1823977|NCT00391768|6324754|P6|Overall Study|Lost to Follow-up|2
1823978|NCT00391768|6324755|P5|Overall Study|Lost to Follow-up|2
1823979|NCT00391768|6324756|P4|Overall Study|Lost to Follow-up|1
1823980|NCT00391768|6324757|P3|Overall Study|Lost to Follow-up|0
1823981|NCT00391768|6324758|P2|Overall Study|Lost to Follow-up|0
1823982|NCT00391768|6324759|P1|Overall Study|Lost to Follow-up|0
1823983|NCT00391768|6324753|P7|Overall Study|Withdrawal by Subject|1
1823984|NCT00391768|6324754|P6|Overall Study|Withdrawal by Subject|1
1823985|NCT00391768|6324755|P5|Overall Study|Withdrawal by Subject|0
1823986|NCT00391768|6324756|P4|Overall Study|Withdrawal by Subject|0
1823987|NCT00391768|6324757|P3|Overall Study|Withdrawal by Subject|1
1823988|NCT00391768|6324758|P2|Overall Study|Withdrawal by Subject|0
1823989|NCT00391768|6324759|P1|Overall Study|Withdrawal by Subject|0
1823990|NCT00391625|6324846|P1|Month 50|Physician Decision|1
1823991|NCT00391625|6324846|P1|Month 14|Withdrawal by Subject|1
1823992|NCT00391586|6324899|P1|Overall Study|Death|4
1823993|NCT00391586|6324899|P1|Overall Study|Physician Decision|2
1823994|NCT00391586|6324899|P1|Overall Study|Adverse Event|5
1823995|NCT00391586|6324899|P1|Overall Study|Progressive disease|13
1823996|NCT00391391|6324936|P4|Overall Study|Withdrawal by Subject|7
1823997|NCT00391391|6324937|P3|Overall Study|Withdrawal by Subject|10
1823998|NCT00391391|6324938|P2|Overall Study|Withdrawal by Subject|4
1823999|NCT00391391|6324939|P1|Overall Study|Withdrawal by Subject|6
1824000|NCT00391391|6324936|P4|Overall Study|Protocol Violation|7
1824001|NCT00391391|6324937|P3|Overall Study|Protocol Violation|6
1824002|NCT00391391|6324938|P2|Overall Study|Protocol Violation|3
1824003|NCT00391391|6324939|P1|Overall Study|Protocol Violation|2
1824004|NCT00391391|6324936|P4|Overall Study|Lost to Follow-up|4
1824005|NCT00391391|6324937|P3|Overall Study|Lost to Follow-up|7
1824006|NCT00391391|6324938|P2|Overall Study|Lost to Follow-up|3
1824007|NCT00391391|6324939|P1|Overall Study|Lost to Follow-up|1
1824008|NCT00391391|6324936|P4|Overall Study|Adverse Event|1
1824009|NCT00391391|6324937|P3|Overall Study|Adverse Event|0
1824010|NCT00391391|6324938|P2|Overall Study|Adverse Event|0
1824011|NCT00391391|6324939|P1|Overall Study|Adverse Event|0
1824012|NCT00391274|6324984|P2|Overall Study|Death Not Study Related|1
1824013|NCT00391274|6324985|P1|Overall Study|Death Not Study Related|0
1824014|NCT00391274|6324984|P2|Overall Study|Death Due to Indeterminate Cause|0
1824015|NCT00391274|6324985|P1|Overall Study|Death Due to Indeterminate Cause|1
1824016|NCT00391274|6324984|P2|Overall Study|Death Due to Adverse Event|3
1824017|NCT00391274|6324985|P1|Overall Study|Death Due to Adverse Event|1
1824018|NCT00391274|6324984|P2|Overall Study|Withdrawal by Subject|3
1824019|NCT00391274|6324985|P1|Overall Study|Withdrawal by Subject|0
1824020|NCT00391274|6324984|P2|Overall Study|Physician Decision|2
1824021|NCT00391274|6324985|P1|Overall Study|Physician Decision|4
1824022|NCT00391274|6324984|P2|Overall Study|Lost to Follow-up|3
1824023|NCT00391274|6324985|P1|Overall Study|Lost to Follow-up|0
1824024|NCT00391274|6324984|P2|Overall Study|Death Due to Study Disease|45
1824025|NCT00391274|6324985|P1|Overall Study|Death Due to Study Disease|55
1824026|NCT00391222|6325004|P4|Period III (Double-Blind Treatment)|Other|0
1824027|NCT00391222|6325005|P3|Period III (Double-Blind Treatment)|Other|6
1824028|NCT00391222|6325006|P2|Period III (Double-Blind Treatment)|Other|1
1824029|NCT00391222|6325007|P1|Period III (Double-Blind Treatment)|Other|6
1824030|NCT00391222|6325004|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1824031|NCT00391222|6325005|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
1824032|NCT00391222|6325006|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
1824033|NCT00391222|6325007|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
1824034|NCT00391222|6325004|P4|Period III (Double-Blind Treatment)|Pregnancy|0
1824035|NCT00391222|6325005|P3|Period III (Double-Blind Treatment)|Pregnancy|0
1824036|NCT00391222|6325006|P2|Period III (Double-Blind Treatment)|Pregnancy|2
1824037|NCT00391222|6325007|P1|Period III (Double-Blind Treatment)|Pregnancy|0
1824038|NCT00391222|6325004|P4|Period III (Double-Blind Treatment)|Adverse Event|0
1824039|NCT00391222|6325005|P3|Period III (Double-Blind Treatment)|Adverse Event|4
1824040|NCT00391222|6325006|P2|Period III (Double-Blind Treatment)|Adverse Event|2
1824041|NCT00391222|6325007|P1|Period III (Double-Blind Treatment)|Adverse Event|5
1824042|NCT00391222|6325004|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
1824043|NCT00391222|6325005|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1824044|NCT00391222|6325006|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
1824045|NCT00391222|6325007|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
1824046|NCT00391222|6325004|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
1824047|NCT00391222|6325005|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
1824048|NCT00391222|6325006|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
1824049|NCT00391222|6325007|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
1824050|NCT00391222|6325004|P4|Period II (Open-label Risperidone LAI)|Other|24
1824051|NCT00391222|6325005|P3|Period II (Open-label Risperidone LAI)|Other|0
1824052|NCT00391222|6325006|P2|Period II (Open-label Risperidone LAI)|Other|0
1824053|NCT00391222|6325007|P1|Period II (Open-label Risperidone LAI)|Other|0
1824054|NCT00391222|6325004|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
1824055|NCT00391222|6325005|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
1824056|NCT00391222|6325006|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
1824057|NCT00391222|6325007|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
1824058|NCT00391222|6325004|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
1824059|NCT00391222|6325005|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
1824060|NCT00391222|6325006|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
1824061|NCT00391222|6325007|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
1824062|NCT00391222|6325004|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
1824063|NCT00391222|6325005|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1824064|NCT00391222|6325006|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1824065|NCT00391222|6325007|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
1824066|NCT00391222|6325004|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
1824067|NCT00391222|6325005|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1824068|NCT00391222|6325006|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1824069|NCT00391222|6325007|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
1824070|NCT00391092|6325033|P2|Overall Study|Alive in follow-up|84
1824071|NCT00391092|6325034|P1|Overall Study|Alive in follow-up|88
1824072|NCT00391092|6325033|P2|Overall Study|Alive on treatment|33
1824073|NCT00391092|6325034|P1|Overall Study|Alive on treatment|29
1824074|NCT00391092|6325033|P2|Overall Study|Lost to Follow-up|18
1824075|NCT00391092|6325034|P1|Overall Study|Lost to Follow-up|13
1824076|NCT00391092|6325033|P2|Overall Study|Death|81
1824077|NCT00391092|6325034|P1|Overall Study|Death|78
1824078|NCT00391053|6325077|P4|Overall Study|Withdrawal by Subject|1
1824079|NCT00391053|6325078|P3|Overall Study|Withdrawal by Subject|1
1824080|NCT00391053|6325079|P2|Overall Study|Withdrawal by Subject|1
1824081|NCT00391053|6325080|P1|Overall Study|Withdrawal by Subject|5
1824082|NCT00391053|6325077|P4|Overall Study|Lost to Follow-up|5
1824083|NCT00391053|6325078|P3|Overall Study|Lost to Follow-up|0
1824084|NCT00391053|6325079|P2|Overall Study|Lost to Follow-up|0
1824085|NCT00391053|6325080|P1|Overall Study|Lost to Follow-up|1
1824086|NCT00391053|6325077|P4|Overall Study|Protocol Violation|0
1824087|NCT00391053|6325078|P3|Overall Study|Protocol Violation|0
1824088|NCT00391053|6325079|P2|Overall Study|Protocol Violation|0
1824089|NCT00391053|6325080|P1|Overall Study|Protocol Violation|2
1824090|NCT00391053|6325077|P4|Overall Study|Serious Adverse Events|4
1824091|NCT00391053|6325078|P3|Overall Study|Serious Adverse Events|1
1824092|NCT00391053|6325079|P2|Overall Study|Serious Adverse Events|0
1824093|NCT00391053|6325080|P1|Overall Study|Serious Adverse Events|1
1824094|NCT00391027|6325104|P2|Overall Study|Other|3
1824095|NCT00391027|6325105|P1|Overall Study|Other|4
1824096|NCT00391027|6325104|P2|Overall Study|Withdrawal by Subject|1
1824097|NCT00391027|6325105|P1|Overall Study|Withdrawal by Subject|10
1824098|NCT00391027|6325104|P2|Overall Study|Lack of Efficacy|0
1824099|NCT00391027|6325105|P1|Overall Study|Lack of Efficacy|3
1824100|NCT00391027|6325104|P2|Overall Study|Adverse Event|8
1824101|NCT00391027|6325105|P1|Overall Study|Adverse Event|8
1824102|NCT00390910|6325155|P3|Overall Study|Migrated/moved from study area|3
1824103|NCT00390910|6325156|P2|Overall Study|Migrated/moved from study area|0
1824104|NCT00390910|6325157|P1|Overall Study|Migrated/moved from study area|0
1824105|NCT00390910|6325155|P3|Overall Study|Withdrawal by Subject|2
1824106|NCT00390910|6325156|P2|Overall Study|Withdrawal by Subject|3
1824107|NCT00390910|6325157|P1|Overall Study|Withdrawal by Subject|1
1824108|NCT00390910|6325155|P3|Overall Study|Lost to Follow-up|5
1824109|NCT00390910|6325156|P2|Overall Study|Lost to Follow-up|1
1824110|NCT00390910|6325157|P1|Overall Study|Lost to Follow-up|0
1824111|NCT00390910|6325155|P3|Overall Study|Adverse Event|0
1824112|NCT00390910|6325156|P2|Overall Study|Adverse Event|0
1824113|NCT00390910|6325157|P1|Overall Study|Adverse Event|1
1824114|NCT00390884|6325245|P2|Overall Study|Withdrawal by Subject|2
1824115|NCT00390884|6325246|P1|Overall Study|Withdrawal by Subject|2
1824116|NCT00390858|6325258|P2|Overall Study|Withdrawal by Subject|4
1824117|NCT00390858|6325259|P1|Overall Study|Withdrawal by Subject|3
1824118|NCT00390858|6325258|P2|Overall Study|Lack of Efficacy|1
1824119|NCT00390858|6325259|P1|Overall Study|Lack of Efficacy|0
1824120|NCT00390858|6325258|P2|Overall Study|Adverse Event|2
1824121|NCT00390858|6325259|P1|Overall Study|Adverse Event|6
1824122|NCT00390806|6325273|P2|Overall Study|Ongoing|2
1824123|NCT00390806|6325274|P1|Overall Study|Ongoing|4
1824124|NCT00390806|6325273|P2|Overall Study|Physician Decision|1
1824125|NCT00390806|6325274|P1|Overall Study|Physician Decision|0
1824126|NCT00390806|6325273|P2|Overall Study|Death|0
1824127|NCT00390806|6325274|P1|Overall Study|Death|1
1824128|NCT00390806|6325273|P2|Overall Study|Investigator Decision|6
1824129|NCT00390806|6325274|P1|Overall Study|Investigator Decision|4
1824130|NCT00390806|6325273|P2|Overall Study|Withdrawal by Subject|15
1824131|NCT00390806|6325274|P1|Overall Study|Withdrawal by Subject|12
1824132|NCT00390806|6325273|P2|Overall Study|Protocol Violation|2
1824133|NCT00390806|6325274|P1|Overall Study|Protocol Violation|2
1824134|NCT00390806|6325273|P2|Overall Study|Lost to Follow-up|6
1824135|NCT00390806|6325274|P1|Overall Study|Lost to Follow-up|7
1824136|NCT00390780|6325342|P2|Overall Study|SAE, death|1
1824137|NCT00390780|6325343|P1|Overall Study|SAE, death|0
1824138|NCT00390780|6325342|P2|Overall Study|Investigator decision, SAE, other reason|1
1824139|NCT00390780|6325343|P1|Overall Study|Investigator decision, SAE, other reason|0
1824140|NCT00390780|6325342|P2|Overall Study|Lost to follow up and other reasons|1
1824141|NCT00390780|6325343|P1|Overall Study|Lost to follow up and other reasons|0
1824142|NCT00390780|6325342|P2|Overall Study|Inclusion criteria not satisfied|2
1824143|NCT00390780|6325343|P1|Overall Study|Inclusion criteria not satisfied|0
1824144|NCT00390780|6325342|P2|Overall Study|Withdrawal by Subject|2
1824145|NCT00390780|6325343|P1|Overall Study|Withdrawal by Subject|1
1824146|NCT00390780|6325342|P2|Overall Study|Death|3
1824147|NCT00390780|6325343|P1|Overall Study|Death|1
1824148|NCT00390780|6325342|P2|Overall Study|Adverse Event|3
1824149|NCT00390780|6325343|P1|Overall Study|Adverse Event|2
1824150|NCT00390780|6325342|P2|Overall Study|Lost to Follow-up|6
1824151|NCT00390780|6325343|P1|Overall Study|Lost to Follow-up|3
1824152|NCT00390780|6325342|P2|Overall Study|Protocol Violation|4
1824153|NCT00390780|6325343|P1|Overall Study|Protocol Violation|6
1824154|NCT00390780|6325342|P2|Overall Study|Not completed|4
1824155|NCT00390780|6325343|P1|Overall Study|Not completed|10
1824156|NCT00390689|6325376|P3|Overall Study|Investigator's judgement|0
1824157|NCT00390689|6325377|P2|Overall Study|Investigator's judgement|0
1824158|NCT00390689|6325378|P1|Overall Study|Investigator's judgement|2
1824159|NCT00390689|6325376|P3|Overall Study|Protocol Violation|0
1824160|NCT00390689|6325377|P2|Overall Study|Protocol Violation|0
1824161|NCT00390689|6325378|P1|Overall Study|Protocol Violation|1
1824162|NCT00390689|6325376|P3|Overall Study|Lack of Efficacy|1
1824163|NCT00390689|6325377|P2|Overall Study|Lack of Efficacy|0
1824164|NCT00390689|6325378|P1|Overall Study|Lack of Efficacy|0
1824165|NCT00390689|6325376|P3|Overall Study|Adverse Event|2
1824166|NCT00390689|6325377|P2|Overall Study|Adverse Event|5
1824167|NCT00390689|6325378|P1|Overall Study|Adverse Event|2
1824168|NCT00390572|6325453|P2|Overall Study|health condition|1
1824169|NCT00390572|6325454|P1|Overall Study|health condition|0
1824170|NCT00390572|6325453|P2|Overall Study|Lost to Follow-up|4
1824171|NCT00390572|6325454|P1|Overall Study|Lost to Follow-up|8
1824172|NCT00390546|6325480|P2|Overall Study|Physician Decision|5
1824173|NCT00390546|6325481|P1|Overall Study|Physician Decision|5
1824174|NCT00390546|6325480|P2|Overall Study|Renal impairment|0
1824175|NCT00390546|6325481|P1|Overall Study|Renal impairment|1
1824176|NCT00390468|6325491|P1|Overall Study|Lack of Efficacy|1
1824177|NCT00390468|6325491|P1|Overall Study|Protocol Violation|2
1824178|NCT00390455|6325497|P2|Overall Study|Other Medical Reasons|11
1824179|NCT00390455|6325498|P1|Overall Study|Other Medical Reasons|7
1824180|NCT00390455|6325497|P2|Overall Study|Alternate Treatment|1
1824181|NCT00390455|6325498|P1|Overall Study|Alternate Treatment|0
1824182|NCT00390455|6325497|P2|Overall Study|Withdrawal by Subject|8
1824183|NCT00390455|6325498|P1|Overall Study|Withdrawal by Subject|8
1824184|NCT00390455|6325497|P2|Overall Study|Adverse Event|3
1824185|NCT00390455|6325498|P1|Overall Study|Adverse Event|17
1824186|NCT00390416|6325543|P1|Overall Study|Not treated|3
1824187|NCT00390416|6325543|P1|Overall Study|Withdrawal by Subject|1
1824188|NCT00390299|6325581|P5|Overall Study|Cancellation|0
1824189|NCT00390299|6325582|P4|Overall Study|Cancellation|0
1824190|NCT00390299|6325583|P3|Overall Study|Cancellation|0
1824191|NCT00390299|6325584|P2|Overall Study|Cancellation|0
1824192|NCT00390299|6325585|P1|Overall Study|Cancellation|1
1824193|NCT00390221|6325616|P3|Overall Study|Other|2
1824194|NCT00390221|6325617|P2|Overall Study|Other|4
1824195|NCT00390221|6325618|P1|Overall Study|Other|3
1824196|NCT00390221|6325616|P3|Overall Study|Subject Non-compliance|2
1824197|NCT00390221|6325617|P2|Overall Study|Subject Non-compliance|0
1824198|NCT00390221|6325618|P1|Overall Study|Subject Non-compliance|1
1824199|NCT00390221|6325616|P3|Overall Study|Withdrawal by Subject|7
1824200|NCT00390221|6325617|P2|Overall Study|Withdrawal by Subject|9
1824201|NCT00390221|6325618|P1|Overall Study|Withdrawal by Subject|13
1824202|NCT00390221|6325616|P3|Overall Study|Investigator Decision|1
1824203|NCT00390221|6325617|P2|Overall Study|Investigator Decision|0
1824204|NCT00390221|6325618|P1|Overall Study|Investigator Decision|0
1824205|NCT00390221|6325616|P3|Overall Study|Adverse Event|3
1824206|NCT00390221|6325617|P2|Overall Study|Adverse Event|4
1824207|NCT00390221|6325618|P1|Overall Study|Adverse Event|1
1824208|NCT00390221|6325616|P3|Overall Study|Lost to Follow-up|0
1824209|NCT00390221|6325617|P2|Overall Study|Lost to Follow-up|3
1824210|NCT00390221|6325618|P1|Overall Study|Lost to Follow-up|0
1824211|NCT00390013|6325648|P4|Phase 2 First Treatment|Withdrawal by Subject|0
1824212|NCT00390013|6325649|P3|Phase 2 First Treatment|Withdrawal by Subject|0
1824213|NCT00390013|6325650|P2|Phase 2 First Treatment|Withdrawal by Subject|1
1824214|NCT00390013|6325651|P1|Phase 2 First Treatment|Withdrawal by Subject|0
1824215|NCT00390013|6325648|P4|Phase 2 First Treatment|tired|0
1824216|NCT00390013|6325649|P3|Phase 2 First Treatment|tired|0
1824217|NCT00390013|6325650|P2|Phase 2 First Treatment|tired|0
1824218|NCT00390013|6325651|P1|Phase 2 First Treatment|tired|1
1824219|NCT00390013|6325648|P4|Phase 1|tired|1
1824220|NCT00390013|6325649|P3|Phase 1|tired|0
1824221|NCT00390013|6325650|P2|Phase 1|tired|0
1824222|NCT00390013|6325651|P1|Phase 1|tired|0
1824223|NCT00389831|6325676|P2|Overall Study|Lost to Follow-up|1
1824224|NCT00389831|6325677|P1|Overall Study|Lost to Follow-up|0
1824225|NCT00389831|6325676|P2|Overall Study|Other reasons|2
1824226|NCT00389831|6325677|P1|Overall Study|Other reasons|0
1824227|NCT00389831|6325676|P2|Overall Study|Did not receive treatment.|2
1824228|NCT00389831|6325677|P1|Overall Study|Did not receive treatment.|0
1824229|NCT00389831|6325676|P2|Overall Study|Lack of Efficacy|2
1824230|NCT00389831|6325677|P1|Overall Study|Lack of Efficacy|0
1824231|NCT00389597|6325740|P4|Overall Study|Lost to Follow-up|6
1824232|NCT00389597|6325741|P3|Overall Study|Lost to Follow-up|4
1824233|NCT00389597|6325742|P2|Overall Study|Lost to Follow-up|6
1824234|NCT00389597|6325743|P1|Overall Study|Lost to Follow-up|8
1824235|NCT00389519|6325768|P4|Treated|Reason not specified|2
1824236|NCT00389519|6325769|P3|Treated|Reason not specified|0
1824237|NCT00389519|6325770|P2|Treated|Reason not specified|1
1824238|NCT00389519|6325771|P1|Treated|Reason not specified|1
1824239|NCT00389519|6325768|P4|Treated|Adverse Event|2
1824240|NCT00389519|6325769|P3|Treated|Adverse Event|0
1824241|NCT00389519|6325770|P2|Treated|Adverse Event|0
1824242|NCT00389519|6325771|P1|Treated|Adverse Event|1
1824243|NCT00389519|6325768|P4|Randomized|Did not receive study drug|0
1824244|NCT00389519|6325769|P3|Randomized|Did not receive study drug|0
1824245|NCT00389519|6325770|P2|Randomized|Did not receive study drug|0
1824246|NCT00389519|6325771|P1|Randomized|Did not receive study drug|2
1824247|NCT00389519|6325768|P4|Placebo Run-In|Reason not specified|0
1824248|NCT00389519|6325769|P3|Placebo Run-In|Reason not specified|0
1824249|NCT00389519|6325770|P2|Placebo Run-In|Reason not specified|0
1824250|NCT00389519|6325771|P1|Placebo Run-In|Reason not specified|40
1824251|NCT00389519|6325768|P4|Placebo Run-In|Withdrawal by Subject|0
1824252|NCT00389519|6325769|P3|Placebo Run-In|Withdrawal by Subject|0
1824253|NCT00389519|6325770|P2|Placebo Run-In|Withdrawal by Subject|0
1824254|NCT00389519|6325771|P1|Placebo Run-In|Withdrawal by Subject|19
1824255|NCT00389519|6325768|P4|Placebo Run-In|Did not meet blood pressure criteria|0
1824256|NCT00389519|6325769|P3|Placebo Run-In|Did not meet blood pressure criteria|0
1824257|NCT00389519|6325770|P2|Placebo Run-In|Did not meet blood pressure criteria|0
1824258|NCT00389519|6325771|P1|Placebo Run-In|Did not meet blood pressure criteria|119
1824259|NCT00389441|6325848|P1|Overall Study|Clinical progression|1
1824260|NCT00389441|6325848|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
1824261|NCT00389441|6325848|P1|Overall Study|Objective progression or relapse|26
1824262|NCT00389441|6325848|P1|Overall Study|Global deterioration of health status|4
1824263|NCT00389441|6325848|P1|Overall Study|Protocol Violation|1
1824264|NCT00389441|6325848|P1|Overall Study|Physician Decision|1
1824265|NCT00389441|6325848|P1|Overall Study|Withdrawal by Subject|4
1824266|NCT00389441|6325848|P1|Overall Study|Lost to Follow-up|2
1824267|NCT00389441|6325848|P1|Overall Study|Death|4
1824268|NCT00389441|6325848|P1|Overall Study|Adverse Event|7
1824269|NCT00389324|6325857|P1|Subcutaneous Phase|Lost to Follow-up|1
1824270|NCT00389324|6325857|P1|Subcutaneous Phase|Withdrawal by Subject|2
1824271|NCT00389324|6325857|P1|Subcutaneous Phase|Non-compliance with study medication|2
1824272|NCT00389324|6325857|P1|Subcutaneous Phase|Adverse Event|2
1824273|NCT00389324|6325857|P1|Run-In Phase|Withdrawal by Subject|1
1824274|NCT00389324|6325857|P1|Run-In Phase|Lost to Follow-up|1
1824275|NCT00389324|6325857|P1|Run-In Phase|Adverse Event|1
1824276|NCT00389207|6325867|P3|Overall Study|Other|9
1824277|NCT00389207|6325868|P2|Overall Study|Other|23
1824278|NCT00389207|6325869|P1|Overall Study|Other|17
1824279|NCT00389207|6325867|P3|Overall Study|Withdrawal by Subject|11
1824280|NCT00389207|6325868|P2|Overall Study|Withdrawal by Subject|7
1824281|NCT00389207|6325869|P1|Overall Study|Withdrawal by Subject|5
1824282|NCT00389207|6325867|P3|Overall Study|Lost to Follow-up|7
1824283|NCT00389207|6325868|P2|Overall Study|Lost to Follow-up|9
1824284|NCT00389207|6325869|P1|Overall Study|Lost to Follow-up|12
1824285|NCT00389207|6325867|P3|Overall Study|Protocol Violation|4
1824286|NCT00389207|6325868|P2|Overall Study|Protocol Violation|1
1824287|NCT00389207|6325869|P1|Overall Study|Protocol Violation|3
1824288|NCT00389207|6325867|P3|Overall Study|Adverse Event|10
1824289|NCT00389207|6325868|P2|Overall Study|Adverse Event|32
1824290|NCT00389207|6325869|P1|Overall Study|Adverse Event|26
1824291|NCT00389064|6325992|P2|Overall Study|Multiple Reasons|11
1824292|NCT00389064|6325993|P1|Overall Study|Multiple Reasons|9
1824293|NCT00389064|6325992|P2|Overall Study|Protocol Violation|0
1824294|NCT00389064|6325993|P1|Overall Study|Protocol Violation|2
1824295|NCT00389064|6325992|P2|Overall Study|Lost to Follow-up|2
1824296|NCT00389064|6325993|P1|Overall Study|Lost to Follow-up|1
1824297|NCT00389064|6325992|P2|Overall Study|Physician Decision|2
1824298|NCT00389064|6325993|P1|Overall Study|Physician Decision|2
1824299|NCT00389064|6325992|P2|Overall Study|Withdrawal by Subject|27
1824300|NCT00389064|6325993|P1|Overall Study|Withdrawal by Subject|17
1824301|NCT00389064|6325992|P2|Overall Study|Lack of Efficacy|14
1824302|NCT00389064|6325993|P1|Overall Study|Lack of Efficacy|3
1824303|NCT00389064|6325992|P2|Overall Study|Adverse Event|3
1824304|NCT00389064|6325993|P1|Overall Study|Adverse Event|11
1824305|NCT00388973|6326021|P2|Overall Study|Did not complete 2-week follow-up visit|17
1824306|NCT00388973|6326022|P1|Overall Study|Did not complete 2-week follow-up visit|17
1824307|NCT00388973|6326021|P2|Overall Study|Left region|1
1824308|NCT00388973|6326022|P1|Overall Study|Left region|0
1824309|NCT00388973|6326021|P2|Overall Study|Did not complete 61 days of treatment|4
1824310|NCT00388973|6326022|P1|Overall Study|Did not complete 61 days of treatment|5
1824311|NCT00388973|6326021|P2|Overall Study|Study specific Discontinuation Criteria|1
1824312|NCT00388973|6326022|P1|Overall Study|Study specific Discontinuation Criteria|0
1824313|NCT00388973|6326021|P2|Overall Study|Withdrawal by Subject|17
1824314|NCT00388973|6326022|P1|Overall Study|Withdrawal by Subject|14
1824315|NCT00388973|6326021|P2|Overall Study|Protocol Violation|0
1824316|NCT00388973|6326022|P1|Overall Study|Protocol Violation|3
1824317|NCT00388973|6326021|P2|Overall Study|Lack of Efficacy|12
1824318|NCT00388973|6326022|P1|Overall Study|Lack of Efficacy|1
1824319|NCT00388973|6326021|P2|Overall Study|Adverse Event|6
1824320|NCT00388973|6326022|P1|Overall Study|Adverse Event|16
1824321|NCT00388947|6326042|P1|Overall Study|Protocol Violation|47
1824322|NCT00388726|6326058|P2|Overall Study|Death|2
1824323|NCT00388726|6326059|P1|Overall Study|Death|3
1824324|NCT00388726|6326058|P2|Overall Study|Physician Decision|13
1824325|NCT00388726|6326059|P1|Overall Study|Physician Decision|18
1824326|NCT00388726|6326058|P2|Overall Study|Administrative|9
1824327|NCT00388726|6326059|P1|Overall Study|Administrative|6
1824328|NCT00388726|6326058|P2|Overall Study|Withdrawal by Subject|7
1824329|NCT00388726|6326059|P1|Overall Study|Withdrawal by Subject|10
1824330|NCT00388726|6326058|P2|Overall Study|Clinical Progression|36
1824331|NCT00388726|6326059|P1|Overall Study|Clinical Progression|61
1824332|NCT00388726|6326058|P2|Overall Study|Progressive Disease|153
1824333|NCT00388726|6326059|P1|Overall Study|Progressive Disease|336
1824334|NCT00388726|6326058|P2|Overall Study|Adverse Event|24
1824335|NCT00388726|6326059|P1|Overall Study|Adverse Event|50
1824336|NCT00388674|6326075|P2|End of Study|Not Reported|1
1824337|NCT00388674|6326076|P1|End of Study|Not Reported|0
1824338|NCT00388674|6326075|P2|End of Study|No Off-Treatment Status Data|30
1824339|NCT00388674|6326076|P1|End of Study|No Off-Treatment Status Data|22
1824340|NCT00388674|6326075|P2|End of Study|Participant Withdrew Consent|673
1824341|NCT00388674|6326076|P1|End of Study|Participant Withdrew Consent|437
1824342|NCT00388674|6326075|P2|End of Study|Not Defined|214
1824343|NCT00388674|6326076|P1|End of Study|Not Defined|135
1824344|NCT00388674|6326075|P2|End of Study|Non-Study Related Comorbidities|4
1824345|NCT00388674|6326076|P1|End of Study|Non-Study Related Comorbidities|3
1824346|NCT00388674|6326075|P2|End of Study|Malignancy (Non-HCC)|1
1824347|NCT00388674|6326076|P1|End of Study|Malignancy (Non-HCC)|1
1824348|NCT00388674|6326075|P2|End of Study|Lost to Follow-up|715
1824349|NCT00388674|6326076|P1|End of Study|Lost to Follow-up|587
1824350|NCT00388674|6326075|P2|End of Study|HCC|7
1824351|NCT00388674|6326076|P1|End of Study|HCC|8
1824352|NCT00388674|6326075|P2|End of Study|HBV Disease Progression (Non-HCC)|9
1824353|NCT00388674|6326076|P1|End of Study|HBV Disease Progression (Non-HCC)|3
1824354|NCT00388674|6326075|P2|End of Study|Death|262
1824355|NCT00388674|6326076|P1|End of Study|Death|239
1824356|NCT00388674|6326075|P2|End of Study|Administrative Reason By Sponsor|253
1824357|NCT00388674|6326076|P1|End of Study|Administrative Reason By Sponsor|299
1824358|NCT00388674|6326075|P2|Initial Treatment|Not Reported|12
1824359|NCT00388674|6326076|P1|Initial Treatment|Not Reported|10
1824360|NCT00388674|6326075|P2|Initial Treatment|No Off-Treatment Status Data|13
1824361|NCT00388674|6326076|P1|Initial Treatment|No Off-Treatment Status Data|11
1824362|NCT00388674|6326075|P2|Initial Treatment|Participant Request|673
1824363|NCT00388674|6326076|P1|Initial Treatment|Participant Request|501
1824364|NCT00388674|6326075|P2|Initial Treatment|Study Drug Toxicity|92
1824365|NCT00388674|6326076|P1|Initial Treatment|Study Drug Toxicity|5
1824366|NCT00388674|6326075|P2|Initial Treatment|Pregnancy|16
1824367|NCT00388674|6326076|P1|Initial Treatment|Pregnancy|26
1824368|NCT00388674|6326075|P2|Initial Treatment|Partial or inadequate Treatment|472
1824369|NCT00388674|6326076|P1|Initial Treatment|Partial or inadequate Treatment|112
1824370|NCT00388674|6326075|P2|Initial Treatment|Not Defined|172
1824371|NCT00388674|6326076|P1|Initial Treatment|Not Defined|125
1824372|NCT00388674|6326075|P2|Initial Treatment|Non-Study related Comorbidities|4
1824373|NCT00388674|6326076|P1|Initial Treatment|Non-Study related Comorbidities|3
1824374|NCT00388674|6326075|P2|Initial Treatment|Never Treated with Study Medication|7
1824375|NCT00388674|6326076|P1|Initial Treatment|Never Treated with Study Medication|1
1824376|NCT00388674|6326075|P2|Initial Treatment|Malignancy (Non-HCC)|3
1824377|NCT00388674|6326076|P1|Initial Treatment|Malignancy (Non-HCC)|7
1824378|NCT00388674|6326075|P2|Initial Treatment|Lost to Follow-up|624
1824379|NCT00388674|6326076|P1|Initial Treatment|Lost to Follow-up|526
1824380|NCT00388674|6326075|P2|Initial Treatment|HCC|20
1824381|NCT00388674|6326076|P1|Initial Treatment|HCC|12
1824382|NCT00388674|6326075|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
1824383|NCT00388674|6326076|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
1824384|NCT00388674|6326075|P2|Initial Treatment|Death|216
1824385|NCT00388674|6326076|P1|Initial Treatment|Death|215
1824386|NCT00388674|6326075|P2|Initial Treatment|Adverse Event|87
1824387|NCT00388674|6326076|P1|Initial Treatment|Adverse Event|22
1824388|NCT00388674|6326075|P2|Initial Treatment|Administrative Reason by Sponsor|158
1824389|NCT00388674|6326076|P1|Initial Treatment|Administrative Reason by Sponsor|241
1824390|NCT00388583|6326094|P2|Overall Study|Did not receive vaccine|1
1824391|NCT00388583|6326095|P1|Overall Study|Did not receive vaccine|0
1824392|NCT00388583|6326094|P2|Overall Study|Serious Adverse Event|0
1824393|NCT00388583|6326095|P1|Overall Study|Serious Adverse Event|2
1824394|NCT00388583|6326094|P2|Overall Study|Withdrawal by Subject|3
1824395|NCT00388583|6326095|P1|Overall Study|Withdrawal by Subject|3
1824396|NCT00388583|6326094|P2|Overall Study|Protocol Violation|0
1824397|NCT00388583|6326095|P1|Overall Study|Protocol Violation|1
1824398|NCT00388505|6326109|P2|Overall Study|Unable to classify|3
1824399|NCT00388505|6326110|P1|Overall Study|Unable to classify|4
1824400|NCT00388505|6326109|P2|Overall Study|Protocol Violation|5
1824401|NCT00388505|6326110|P1|Overall Study|Protocol Violation|6
1824402|NCT00388505|6326109|P2|Overall Study|Administrative Reason|0
1824403|NCT00388505|6326110|P1|Overall Study|Administrative Reason|1
1824404|NCT00388505|6326109|P2|Overall Study|Inappropriate Enrollment|1
1824405|NCT00388505|6326110|P1|Overall Study|Inappropriate Enrollment|0
1824406|NCT00388505|6326109|P2|Overall Study|Lost to Follow-up|3
1824407|NCT00388505|6326110|P1|Overall Study|Lost to Follow-up|5
1824408|NCT00388505|6326109|P2|Overall Study|Withdrawal by Subject|9
1824409|NCT00388505|6326110|P1|Overall Study|Withdrawal by Subject|24
1824410|NCT00388505|6326109|P2|Overall Study|Adverse Event or Death|17
1824411|NCT00388505|6326110|P1|Overall Study|Adverse Event or Death|43
1824412|NCT00388362|6326165|P1|Remained on Study Median of 514 Days|Death|2
1824413|NCT00388362|6326165|P1|Enrolled|Withdrawal by Subject|1
1824414|NCT00388362|6326165|P1|Enrolled|Loss insurance|1
1824415|NCT00388362|6326165|P1|Enrolled|Death|1
1824416|NCT00388362|6326165|P1|Enrolled|Adverse Event|9
1824417|NCT00388362|6326165|P1|Enrolled|Ineligible|1
1824418|NCT00388349|6326170|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
1824419|NCT00388349|6326171|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
1824420|NCT00388297|6326184|P4|Overall Study|Lost to Follow-up|8
1824421|NCT00388297|6326185|P3|Overall Study|Lost to Follow-up|11
1824422|NCT00388297|6326186|P2|Overall Study|Lost to Follow-up|12
1824423|NCT00388297|6326187|P1|Overall Study|Lost to Follow-up|16
1824424|NCT00388154|6326297|P1|Overall Study|Withdrawal by Subject|1
1824425|NCT00388037|6326302|P1|Overall Study|Protocol Violation|1
1824426|NCT00387894|6326310|P1|Overall Study|Withdrawal by Subject|1
1824427|NCT00387881|6326317|P2|Overall Study|Not otherwise specified|7
1824428|NCT00387881|6326318|P1|Overall Study|Not otherwise specified|11
1824429|NCT00387881|6326317|P2|Overall Study|No opportunity to treat headache|34
1824430|NCT00387881|6326318|P1|Overall Study|No opportunity to treat headache|32
1824431|NCT00387881|6326317|P2|Overall Study|Not eligible|7
1824432|NCT00387881|6326318|P1|Overall Study|Not eligible|6
1824433|NCT00387881|6326317|P2|Overall Study|Sponsor terminated Study|1
1824434|NCT00387881|6326318|P1|Overall Study|Sponsor terminated Study|0
1824435|NCT00387881|6326317|P2|Overall Study|Withdrawal by Subject|18
1824436|NCT00387881|6326318|P1|Overall Study|Withdrawal by Subject|15
1824437|NCT00387881|6326317|P2|Overall Study|Protocol Violation|12
1824438|NCT00387881|6326318|P1|Overall Study|Protocol Violation|2
1824439|NCT00387881|6326317|P2|Overall Study|Lost to Follow-up|23
1824440|NCT00387881|6326318|P1|Overall Study|Lost to Follow-up|23
1824441|NCT00387790|6326351|P1|Overall Study|Ineligible for study|2
1824442|NCT00387790|6326351|P1|Overall Study|Withdrawal by Subject|3
1824443|NCT00387790|6326351|P1|Overall Study|Physician Decision|2
1824444|NCT00387790|6326351|P1|Overall Study|Lack of Efficacy|2
1824445|NCT00387790|6326351|P1|Overall Study|Adverse Event|5
1824446|NCT00387764|6326357|P1|Overall Study|Death|7
1824447|NCT00387764|6326357|P1|Overall Study|Other|2
1824448|NCT00387764|6326357|P1|Overall Study|Physician Decision|1
1824449|NCT00387764|6326357|P1|Overall Study|Sponsor Terminated Study|1
1824450|NCT00387764|6326357|P1|Overall Study|Withdrawal by Subject|8
1824451|NCT00387764|6326357|P1|Overall Study|Adverse Event|12
1824452|NCT00387725|6326385|P4|Overall Study|Parent/legal guardian request|1
1824453|NCT00387725|6326386|P3|Overall Study|Parent/legal guardian request|1
1824454|NCT00387725|6326387|P2|Overall Study|Parent/legal guardian request|0
1824455|NCT00387725|6326388|P1|Overall Study|Parent/legal guardian request|0
1824456|NCT00387725|6326385|P4|Overall Study|Withdrawal by Subject|0
1824457|NCT00387725|6326386|P3|Overall Study|Withdrawal by Subject|1
1824458|NCT00387725|6326387|P2|Overall Study|Withdrawal by Subject|0
1824459|NCT00387725|6326388|P1|Overall Study|Withdrawal by Subject|1
1824460|NCT00387725|6326385|P4|Overall Study|Protocol Violation|0
1824461|NCT00387725|6326386|P3|Overall Study|Protocol Violation|0
1824462|NCT00387725|6326387|P2|Overall Study|Protocol Violation|1
1824463|NCT00387725|6326388|P1|Overall Study|Protocol Violation|0
1824464|NCT00387725|6326385|P4|Overall Study|Adverse Event|1
1824465|NCT00387725|6326386|P3|Overall Study|Adverse Event|0
1824466|NCT00387725|6326387|P2|Overall Study|Adverse Event|0
1824467|NCT00387725|6326388|P1|Overall Study|Adverse Event|0
1824468|NCT00387712|6326408|P2|Overall Study|Withdrawal by Subject|12
1824469|NCT00387712|6326409|P1|Overall Study|Withdrawal by Subject|6
1824470|NCT00387712|6326408|P2|Overall Study|Lost to Follow-up|20
1824471|NCT00387712|6326409|P1|Overall Study|Lost to Follow-up|17
1824472|NCT00387712|6326408|P2|Overall Study|Physician Decision|4
1824473|NCT00387712|6326409|P1|Overall Study|Physician Decision|6
1824474|NCT00387647|6326440|P1|Overall Study|Death|18
1824475|NCT00387465|6326483|P3|Overall Study|Withdrawal by Subject|0
1824476|NCT00387465|6326484|P2|Overall Study|Withdrawal by Subject|1
1824477|NCT00387465|6326485|P1|Overall Study|Withdrawal by Subject|0
1824478|NCT00387426|6326502|P1|Overall Study|Disease Progression|3
1824479|NCT00387426|6326502|P1|Overall Study|Toxicities|4
1824480|NCT00387426|6326502|P1|Overall Study|Lack of Response|7
1824481|NCT00387348|6326509|P3|Overall Study|Adverse Event|1
1824482|NCT00387348|6326510|P2|Overall Study|Adverse Event|0
1824483|NCT00387348|6326511|P1|Overall Study|Adverse Event|1
1824484|NCT00387348|6326509|P3|Overall Study|Withdrawal by Subject|2
1824485|NCT00387348|6326510|P2|Overall Study|Withdrawal by Subject|2
1824486|NCT00387348|6326511|P1|Overall Study|Withdrawal by Subject|0
1824487|NCT00387348|6326509|P3|Overall Study|Physician Decision|1
1824488|NCT00387348|6326510|P2|Overall Study|Physician Decision|0
1824489|NCT00387348|6326511|P1|Overall Study|Physician Decision|1
1824490|NCT00387348|6326509|P3|Overall Study|Death|0
1824491|NCT00387348|6326510|P2|Overall Study|Death|1
1824492|NCT00387348|6326511|P1|Overall Study|Death|1
1824493|NCT00387153|6326540|P1|Overall Study|Lack of Response|4
1824494|NCT00387153|6326540|P1|Overall Study|Disease Progression|3
1824495|NCT00387153|6326540|P1|Overall Study|Adverse Event|1
1824496|NCT00387127|6326546|P2|Overall Study|Sponsor Unblinded|0
1824497|NCT00387127|6326547|P1|Overall Study|Sponsor Unblinded|1
1824498|NCT00387127|6326546|P2|Overall Study|Serious Adverse Event|1
1824499|NCT00387127|6326547|P1|Overall Study|Serious Adverse Event|1
1824500|NCT00387127|6326546|P2|Overall Study|Required by Protocol Amendment #4|10
1824501|NCT00387127|6326547|P1|Overall Study|Required by Protocol Amendment #4|12
1824502|NCT00387127|6326546|P2|Overall Study|Withdrawal by Subject|2
1824503|NCT00387127|6326547|P1|Overall Study|Withdrawal by Subject|3
1824504|NCT00387127|6326546|P2|Overall Study|Physician Decision|1
1824505|NCT00387127|6326547|P1|Overall Study|Physician Decision|0
1824506|NCT00387127|6326546|P2|Overall Study|Death|16
1824507|NCT00387127|6326547|P1|Overall Study|Death|16
1824508|NCT00387127|6326546|P2|Overall Study|Lost to Follow-up|4
1824509|NCT00387127|6326547|P1|Overall Study|Lost to Follow-up|0
1824510|NCT00387088|6326589|P2|Overall Study|Other|52
1824511|NCT00387088|6326590|P1|Overall Study|Other|58
1824512|NCT00387088|6326589|P2|Overall Study|Lost to Follow-up|28
1824513|NCT00387088|6326590|P1|Overall Study|Lost to Follow-up|22
1824514|NCT00387088|6326589|P2|Overall Study|Lack of Efficacy|67
1824515|NCT00387088|6326590|P1|Overall Study|Lack of Efficacy|28
1824516|NCT00387088|6326589|P2|Overall Study|Withdrawal by Subject|35
1824517|NCT00387088|6326590|P1|Overall Study|Withdrawal by Subject|20
1824518|NCT00387088|6326589|P2|Overall Study|Protocol Violation|35
1824519|NCT00387088|6326590|P1|Overall Study|Protocol Violation|47
1824520|NCT00387088|6326589|P2|Overall Study|Adverse Event|156
1824521|NCT00387088|6326590|P1|Overall Study|Adverse Event|143
1824522|NCT00387010|6326647|P1|Treatment Period|Participant reported study drug stolen|1
1824523|NCT00387010|6326647|P1|Treatment Period|Noncompliance with study procedures|3
1824524|NCT00387010|6326647|P1|Treatment Period|Noncompliance with study medication|2
1824525|NCT00387010|6326647|P1|Treatment Period|Withdrawal by Subject|1
1824526|NCT00387010|6326647|P1|Treatment Period|Adverse Event|4
1824527|NCT00387010|6326647|P1|Dose Titration Period|Noncompliance with study procedures|7
1824528|NCT00387010|6326647|P1|Dose Titration Period|Noncompliance with study medication|8
1824529|NCT00387010|6326647|P1|Dose Titration Period|Lost to Follow-up|2
1824530|NCT00387010|6326647|P1|Dose Titration Period|Protocol Violation|1
1824531|NCT00387010|6326647|P1|Dose Titration Period|Withdrawal by Subject|3
1824532|NCT00387010|6326647|P1|Dose Titration Period|Lack of Efficacy|5
1824533|NCT00387010|6326647|P1|Dose Titration Period|Adverse Event|12
1824534|NCT00386776|6326674|P1|Overall Study|Withdrawal by Subject|8
1824535|NCT00386607|6326684|P2|Extension|Unsatisfactory therapeutic effect|1
1824536|NCT00386607|6326685|P1|Extension|Unsatisfactory therapeutic effect|0
1824537|NCT00386607|6326684|P2|Extension|Patient withdrew consent|5
1824538|NCT00386607|6326685|P1|Extension|Patient withdrew consent|0
1824539|NCT00386607|6326684|P2|Extension|Lost to Follow-up|3
1824540|NCT00386607|6326685|P1|Extension|Lost to Follow-up|0
1824541|NCT00386607|6326684|P2|Extension|Administrative problems|1
1824542|NCT00386607|6326685|P1|Extension|Administrative problems|0
1824543|NCT00386607|6326684|P2|Extension|Abnormal laboratory value(s)|1
1824544|NCT00386607|6326685|P1|Extension|Abnormal laboratory value(s)|0
1824545|NCT00386607|6326684|P2|Extension|Adverse Event|6
1824546|NCT00386607|6326685|P1|Extension|Adverse Event|0
1824547|NCT00386607|6326684|P2|Core|Protocol Deviation|0
1824548|NCT00386607|6326685|P1|Core|Protocol Deviation|6
1824549|NCT00386607|6326684|P2|Core|Administrative problems|0
1824550|NCT00386607|6326685|P1|Core|Administrative problems|1
1824551|NCT00386607|6326684|P2|Core|Lost to Follow-up|0
1824552|NCT00386607|6326685|P1|Core|Lost to Follow-up|23
1824553|NCT00386607|6326684|P2|Core|Patient withdrew consent|0
1824554|NCT00386607|6326685|P1|Core|Patient withdrew consent|15
1824555|NCT00386607|6326684|P2|Core|Condition no longer requires study drug|0
1824556|NCT00386607|6326685|P1|Core|Condition no longer requires study drug|4
1824557|NCT00386607|6326684|P2|Core|Unsatisfactory therapeutic effect|0
1824558|NCT00386607|6326685|P1|Core|Unsatisfactory therapeutic effect|23
1824559|NCT00386607|6326684|P2|Core|Abnormal laboratory value(s)|0
1824560|NCT00386607|6326685|P1|Core|Abnormal laboratory value(s)|3
1824561|NCT00386607|6326684|P2|Core|Adverse Event|0
1824562|NCT00386607|6326685|P1|Core|Adverse Event|40
1824563|NCT00386425|6326713|P3|Overall Study|Withdrawal by Subject|0
1824564|NCT00386425|6326714|P2|Overall Study|Withdrawal by Subject|1
1824565|NCT00386425|6326715|P1|Overall Study|Withdrawal by Subject|0
1824566|NCT00386425|6326713|P3|Overall Study|Physician Decision|0
1824567|NCT00386425|6326714|P2|Overall Study|Physician Decision|0
1824568|NCT00386425|6326715|P1|Overall Study|Physician Decision|3
1824569|NCT00386360|6326741|P2|Overall Study|Did not take any study medication|2
1824570|NCT00386360|6326742|P1|Overall Study|Did not take any study medication|0
1824571|NCT00386360|6326741|P2|Overall Study|Withdrawal by Subject|6
1824572|NCT00386360|6326742|P1|Overall Study|Withdrawal by Subject|3
1824573|NCT00386360|6326741|P2|Overall Study|Protocol Violation|3
1824574|NCT00386360|6326742|P1|Overall Study|Protocol Violation|0
1824575|NCT00386360|6326741|P2|Overall Study|Lost to Follow-up|2
1824576|NCT00386360|6326742|P1|Overall Study|Lost to Follow-up|0
1824577|NCT00386360|6326741|P2|Overall Study|Physician Decision|2
1824578|NCT00386360|6326742|P1|Overall Study|Physician Decision|2
1824579|NCT00386360|6326741|P2|Overall Study|Adverse Event|2
1824580|NCT00386360|6326742|P1|Overall Study|Adverse Event|4
1824581|NCT00386334|6326776|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
1824582|NCT00386334|6326777|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
1824583|NCT00386334|6326776|P2|Double Blind Period|Other|3
1824584|NCT00386334|6326777|P1|Double Blind Period|Other|3
1824585|NCT00386334|6326776|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
1824586|NCT00386334|6326777|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
1824587|NCT00386334|6326776|P2|Double Blind Period|Lack of Efficacy|11
1824588|NCT00386334|6326777|P1|Double Blind Period|Lack of Efficacy|20
1824589|NCT00386334|6326776|P2|Double Blind Period|Withdrawal by Subject|13
1824590|NCT00386334|6326777|P1|Double Blind Period|Withdrawal by Subject|9
1824591|NCT00386334|6326776|P2|Double Blind Period|Protocol Violation|1
1824592|NCT00386334|6326777|P1|Double Blind Period|Protocol Violation|1
1824593|NCT00386334|6326776|P2|Double Blind Period|Adverse Event|14
1824594|NCT00386334|6326777|P1|Double Blind Period|Adverse Event|9
1824595|NCT00386308|6326921|P2|Overall Study|Other Event|1
1824596|NCT00386308|6326922|P1|Overall Study|Other Event|8
1824597|NCT00386308|6326921|P2|Overall Study|Withdrawal by Subject|2
1824598|NCT00386308|6326922|P1|Overall Study|Withdrawal by Subject|6
1824599|NCT00386308|6326921|P2|Overall Study|Lost to Follow-up|6
1824600|NCT00386308|6326922|P1|Overall Study|Lost to Follow-up|10
1824601|NCT00386308|6326921|P2|Overall Study|Lack of Efficacy|2
1824602|NCT00386308|6326922|P1|Overall Study|Lack of Efficacy|0
1824603|NCT00386308|6326921|P2|Overall Study|Protocol Violation|5
1824604|NCT00386308|6326922|P1|Overall Study|Protocol Violation|2
1824605|NCT00386308|6326921|P2|Overall Study|Adverse Event|3
1824606|NCT00386308|6326922|P1|Overall Study|Adverse Event|3
1824607|NCT00386152|6326979|P3|Overall Study|Withdrawal by Subject|10
1824608|NCT00386152|6326980|P2|Overall Study|Withdrawal by Subject|6
1824609|NCT00386152|6326981|P1|Overall Study|Withdrawal by Subject|3
1824610|NCT00386152|6326979|P3|Overall Study|Protocol Violation|2
1824611|NCT00386152|6326980|P2|Overall Study|Protocol Violation|5
1824612|NCT00386152|6326981|P1|Overall Study|Protocol Violation|3
1824613|NCT00386152|6326979|P3|Overall Study|Completed chemotherapy|1
1824614|NCT00386152|6326980|P2|Overall Study|Completed chemotherapy|5
1824615|NCT00386152|6326981|P1|Overall Study|Completed chemotherapy|4
1824616|NCT00386152|6326979|P3|Overall Study|Lost to Follow-up|0
1824617|NCT00386152|6326980|P2|Overall Study|Lost to Follow-up|0
1824618|NCT00386152|6326981|P1|Overall Study|Lost to Follow-up|1
1824619|NCT00386152|6326979|P3|Overall Study|Physician Decision|4
1824620|NCT00386152|6326980|P2|Overall Study|Physician Decision|10
1824621|NCT00386152|6326981|P1|Overall Study|Physician Decision|13
1824622|NCT00386152|6326979|P3|Overall Study|Disease progression|5
1824623|NCT00386152|6326980|P2|Overall Study|Disease progression|4
1824624|NCT00386152|6326981|P1|Overall Study|Disease progression|7
1824625|NCT00386152|6326979|P3|Overall Study|Death|1
1824626|NCT00386152|6326980|P2|Overall Study|Death|0
1824627|NCT00386152|6326981|P1|Overall Study|Death|3
1824628|NCT00386152|6326979|P3|Overall Study|Chang from original chemo stratification|6
1824629|NCT00386152|6326980|P2|Overall Study|Chang from original chemo stratification|5
1824630|NCT00386152|6326981|P1|Overall Study|Chang from original chemo stratification|4
1824631|NCT00386152|6326979|P3|Overall Study|Adverse Event|4
1824632|NCT00386152|6326980|P2|Overall Study|Adverse Event|5
1824633|NCT00386152|6326981|P1|Overall Study|Adverse Event|6
1824634|NCT00386100|6327000|P2|Overall Study|Participant randomized in error|0
1824635|NCT00386100|6327001|P1|Overall Study|Participant randomized in error|1
1824636|NCT00386100|6327000|P2|Overall Study|Hb1Ac >8%|1
1824637|NCT00386100|6327001|P1|Overall Study|Hb1Ac >8%|0
1824638|NCT00386100|6327000|P2|Overall Study|Out of country for 5 months|0
1824639|NCT00386100|6327001|P1|Overall Study|Out of country for 5 months|1
1824640|NCT00386100|6327000|P2|Overall Study|Positive pregnancy test|3
1824641|NCT00386100|6327001|P1|Overall Study|Positive pregnancy test|1
1824642|NCT00386100|6327000|P2|Overall Study|Osteoporosis|1
1824643|NCT00386100|6327001|P1|Overall Study|Osteoporosis|0
1824644|NCT00386100|6327000|P2|Overall Study|7.6% bone loss|0
1824645|NCT00386100|6327001|P1|Overall Study|7.6% bone loss|1
1824646|NCT00386100|6327000|P2|Overall Study|DBP 93 mmHg at randomization|0
1824647|NCT00386100|6327001|P1|Overall Study|DBP 93 mmHg at randomization|1
1824648|NCT00386100|6327000|P2|Overall Study|Bone loss by DXA bone scan|0
1824649|NCT00386100|6327001|P1|Overall Study|Bone loss by DXA bone scan|1
1824650|NCT00386100|6327000|P2|Overall Study|Bad metabolic control & patient security|0
1824651|NCT00386100|6327001|P1|Overall Study|Bad metabolic control & patient security|1
1824652|NCT00386100|6327000|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
1824653|NCT00386100|6327001|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
1824654|NCT00386100|6327000|P2|Overall Study|Participant's PCP wanted to stop drug|0
1824655|NCT00386100|6327001|P1|Overall Study|Participant's PCP wanted to stop drug|1
1824656|NCT00386100|6327000|P2|Overall Study|Didn't meet entry criteria|1
1824657|NCT00386100|6327001|P1|Overall Study|Didn't meet entry criteria|1
1824658|NCT00386100|6327000|P2|Overall Study|Excessive bone loss vs. baseline value|1
1824659|NCT00386100|6327001|P1|Overall Study|Excessive bone loss vs. baseline value|0
1824660|NCT00386100|6327000|P2|Overall Study|Participant moving out of state|0
1824661|NCT00386100|6327001|P1|Overall Study|Participant moving out of state|2
1824662|NCT00386100|6327000|P2|Overall Study|Participant's concern due to CPK levels|0
1824663|NCT00386100|6327001|P1|Overall Study|Participant's concern due to CPK levels|1
1824664|NCT00386100|6327000|P2|Overall Study|Laboratory findings|0
1824665|NCT00386100|6327001|P1|Overall Study|Laboratory findings|1
1824666|NCT00386100|6327000|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
1824667|NCT00386100|6327001|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
1824668|NCT00386100|6327000|P2|Overall Study|Consecutive elevated Hba1C|0
1824669|NCT00386100|6327001|P1|Overall Study|Consecutive elevated Hba1C|1
1824670|NCT00386100|6327000|P2|Overall Study|BMD <2.5|0
1824671|NCT00386100|6327001|P1|Overall Study|BMD <2.5|1
1824672|NCT00386100|6327000|P2|Overall Study|Bone mass density (BMD) loss >6%|4
1824673|NCT00386100|6327001|P1|Overall Study|Bone mass density (BMD) loss >6%|4
1824674|NCT00386100|6327000|P2|Overall Study|Withdrawal by Subject|31
1824675|NCT00386100|6327001|P1|Overall Study|Withdrawal by Subject|32
1824676|NCT00386100|6327000|P2|Overall Study|Protocol Violation|3
1824677|NCT00386100|6327001|P1|Overall Study|Protocol Violation|5
1824678|NCT00386100|6327000|P2|Overall Study|Non-compliance|19
1824679|NCT00386100|6327001|P1|Overall Study|Non-compliance|18
1824680|NCT00386100|6327000|P2|Overall Study|Lost to Follow-up|29
1824681|NCT00386100|6327001|P1|Overall Study|Lost to Follow-up|29
1824682|NCT00386100|6327000|P2|Overall Study|Insufficient therapeutic effect|6
1824683|NCT00386100|6327001|P1|Overall Study|Insufficient therapeutic effect|30
1824684|NCT00386100|6327000|P2|Overall Study|Death|1
1824685|NCT00386100|6327001|P1|Overall Study|Death|0
1824686|NCT00386100|6327000|P2|Overall Study|Adverse Event|25
1824687|NCT00386100|6327001|P1|Overall Study|Adverse Event|15
1824688|NCT00386100|6327000|P2|Overall Study|Did not receive study medication|4
1824689|NCT00386100|6327001|P1|Overall Study|Did not receive study medication|6
1824690|NCT00386022|6327065|P2|Plus Estrogen|Adverse Event|1
1824691|NCT00386022|6327066|P1|Plus Estrogen|Adverse Event|0
1824692|NCT00386022|6327065|P2|Plus Estrogen|Lost to Follow-up|0
1824693|NCT00386022|6327066|P1|Plus Estrogen|Lost to Follow-up|2
1824694|NCT00386009|6327076|P2|Overall Study|Withdrawal by Subject|4
1824695|NCT00386009|6327077|P1|Overall Study|Withdrawal by Subject|5
1824696|NCT00386009|6327076|P2|Overall Study|Sponsor Decision|1
1824697|NCT00386009|6327077|P1|Overall Study|Sponsor Decision|1
1824698|NCT00386009|6327076|P2|Overall Study|Protocol Violation|0
1824699|NCT00386009|6327077|P1|Overall Study|Protocol Violation|1
1824700|NCT00386009|6327076|P2|Overall Study|Lost to Follow-up|1
1824701|NCT00386009|6327077|P1|Overall Study|Lost to Follow-up|1
1824702|NCT00386009|6327076|P2|Overall Study|Entry Criteria Not Met|2
1824703|NCT00386009|6327077|P1|Overall Study|Entry Criteria Not Met|0
1824704|NCT00386009|6327076|P2|Overall Study|Death|0
1824705|NCT00386009|6327077|P1|Overall Study|Death|1
1824706|NCT00386009|6327076|P2|Overall Study|Adverse Event|2
1824707|NCT00386009|6327077|P1|Overall Study|Adverse Event|0
1824708|NCT00385944|6327124|P3|2nd Maintenance Dose Period|Invalid PD Data|0
1824709|NCT00385944|6327125|P2|2nd Maintenance Dose Period|Invalid PD Data|3
1824710|NCT00385944|6327126|P1|2nd Maintenance Dose Period|Invalid PD Data|2
1824711|NCT00385944|6327124|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1824712|NCT00385944|6327125|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
1824713|NCT00385944|6327126|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
1824714|NCT00385944|6327124|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1824715|NCT00385944|6327125|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
1824716|NCT00385944|6327126|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
1824717|NCT00385944|6327124|P3|1st Maintenance Dose Period|Physician Decision|0
1824718|NCT00385944|6327125|P2|1st Maintenance Dose Period|Physician Decision|0
1824719|NCT00385944|6327126|P1|1st Maintenance Dose Period|Physician Decision|1
1824720|NCT00385918|6327169|P3|Intervention Phase After Randomization|Lost to Follow-up|0
1824721|NCT00385918|6327170|P2|Intervention Phase After Randomization|Lost to Follow-up|0
1824722|NCT00385918|6327171|P1|Intervention Phase After Randomization|Lost to Follow-up|1
1824723|NCT00385918|6327169|P3|Intervention Phase After Randomization|Physician Decision|0
1824724|NCT00385918|6327170|P2|Intervention Phase After Randomization|Physician Decision|0
1824725|NCT00385918|6327171|P1|Intervention Phase After Randomization|Physician Decision|1
1824726|NCT00385918|6327169|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
1824727|NCT00385918|6327170|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
1824728|NCT00385918|6327171|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
1824729|NCT00385918|6327169|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
1824730|NCT00385918|6327170|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
1824731|NCT00385918|6327171|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
1824732|NCT00385918|6327169|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
1824733|NCT00385918|6327170|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1824734|NCT00385918|6327171|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
1824735|NCT00385918|6327169|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
1824736|NCT00385918|6327170|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1824737|NCT00385918|6327171|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
1824738|NCT00385840|6327195|P2|Overall Study|Lost to Follow-up|13
1824739|NCT00385840|6327196|P1|Overall Study|Lost to Follow-up|3
1824740|NCT00385840|6327195|P2|Overall Study|Adverse Event|1
1824741|NCT00385840|6327196|P1|Overall Study|Adverse Event|1
1824742|NCT00385827|6327219|P3|Part 2|Other|21
1824743|NCT00385827|6327220|P2|Part 2|Other|11
1824744|NCT00385827|6327221|P1|Part 2|Other|0
1824745|NCT00385827|6327219|P3|Part 2|Randomized but not treated|2
1824746|NCT00385827|6327220|P2|Part 2|Randomized but not treated|2
1824747|NCT00385827|6327221|P1|Part 2|Randomized but not treated|0
1824748|NCT00385827|6327219|P3|Part 2|Lack of Efficacy|13
1824749|NCT00385827|6327220|P2|Part 2|Lack of Efficacy|14
1824750|NCT00385827|6327221|P1|Part 2|Lack of Efficacy|0
1824751|NCT00385827|6327219|P3|Part 2|Death|2
1824752|NCT00385827|6327220|P2|Part 2|Death|0
1824753|NCT00385827|6327221|P1|Part 2|Death|0
1824754|NCT00385827|6327219|P3|Part 2|Adverse Event|10
1824755|NCT00385827|6327220|P2|Part 2|Adverse Event|6
1824756|NCT00385827|6327221|P1|Part 2|Adverse Event|0
1824757|NCT00385827|6327219|P3|Part 1|Other|0
1824758|NCT00385827|6327220|P2|Part 1|Other|0
1824759|NCT00385827|6327221|P1|Part 1|Other|1
1824760|NCT00385827|6327219|P3|Part 1|Lack of Efficacy|0
1824761|NCT00385827|6327220|P2|Part 1|Lack of Efficacy|0
1824762|NCT00385827|6327221|P1|Part 1|Lack of Efficacy|5
1824763|NCT00385827|6327219|P3|Part 1|Death|0
1824764|NCT00385827|6327220|P2|Part 1|Death|0
1824765|NCT00385827|6327221|P1|Part 1|Death|2
1824766|NCT00385827|6327219|P3|Part 1|Adverse Event|0
1824767|NCT00385827|6327220|P2|Part 1|Adverse Event|0
1824768|NCT00385827|6327221|P1|Part 1|Adverse Event|1
1824769|NCT00385762|6327265|P1|Overall Study|Lost to Follow-up|1
1824770|NCT00385762|6327265|P1|Overall Study|Adverse Event|1
1824771|NCT00385736|6327275|P3|Safety Analysis Set|Other|4
1824772|NCT00385736|6327276|P2|Safety Analysis Set|Other|4
1824773|NCT00385736|6327277|P1|Safety Analysis Set|Other|1
1824774|NCT00385736|6327275|P3|Safety Analysis Set|Protocol Violation|6
1824775|NCT00385736|6327276|P2|Safety Analysis Set|Protocol Violation|1
1824776|NCT00385736|6327277|P1|Safety Analysis Set|Protocol Violation|2
1824777|NCT00385736|6327275|P3|Safety Analysis Set|Lack of Efficacy|31
1824778|NCT00385736|6327276|P2|Safety Analysis Set|Lack of Efficacy|16
1824779|NCT00385736|6327277|P1|Safety Analysis Set|Lack of Efficacy|38
1824780|NCT00385736|6327275|P3|Safety Analysis Set|Lost to Follow-up|2
1824781|NCT00385736|6327276|P2|Safety Analysis Set|Lost to Follow-up|2
1824782|NCT00385736|6327277|P1|Safety Analysis Set|Lost to Follow-up|0
1824783|NCT00385736|6327275|P3|Safety Analysis Set|Withdrawal by Subject|14
1824784|NCT00385736|6327276|P2|Safety Analysis Set|Withdrawal by Subject|6
1824785|NCT00385736|6327277|P1|Safety Analysis Set|Withdrawal by Subject|6
1824786|NCT00385736|6327275|P3|Safety Analysis Set|Adverse Event|23
1824787|NCT00385736|6327276|P2|Safety Analysis Set|Adverse Event|15
1824788|NCT00385736|6327277|P1|Safety Analysis Set|Adverse Event|23
1824789|NCT00385736|6327275|P3|Efficacy Analysis Set - Maintenance|Other|4
1824790|NCT00385736|6327276|P2|Efficacy Analysis Set - Maintenance|Other|4
1824791|NCT00385736|6327277|P1|Efficacy Analysis Set - Maintenance|Other|0
1824792|NCT00385736|6327275|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
1824793|NCT00385736|6327276|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
1824794|NCT00385736|6327277|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
1824795|NCT00385736|6327275|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
1824796|NCT00385736|6327276|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
1824797|NCT00385736|6327277|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
1824798|NCT00385736|6327275|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1824799|NCT00385736|6327276|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
1824800|NCT00385736|6327277|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
1824801|NCT00385736|6327275|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
1824802|NCT00385736|6327276|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1824803|NCT00385736|6327277|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
1824804|NCT00385736|6327275|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
1824805|NCT00385736|6327276|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
1824806|NCT00385736|6327277|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
1824807|NCT00385736|6327275|P3|Efficacy Analysis Set - Induction|Other|1
1824808|NCT00385736|6327276|P2|Efficacy Analysis Set - Induction|Other|0
1824809|NCT00385736|6327277|P1|Efficacy Analysis Set - Induction|Other|0
1824810|NCT00385736|6327275|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
1824811|NCT00385736|6327276|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
1824812|NCT00385736|6327277|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
1824813|NCT00385736|6327275|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
1824814|NCT00385736|6327276|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
1824815|NCT00385736|6327277|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
1824816|NCT00385736|6327275|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1824817|NCT00385736|6327276|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
1824818|NCT00385736|6327277|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
1824819|NCT00385736|6327275|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
1824820|NCT00385736|6327276|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
1824821|NCT00385736|6327277|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
1824822|NCT00385736|6327275|P3|Efficacy Analysis Set - Induction|Adverse Event|4
1824823|NCT00385736|6327276|P2|Efficacy Analysis Set - Induction|Adverse Event|6
1824824|NCT00385736|6327277|P1|Efficacy Analysis Set - Induction|Adverse Event|5
1824825|NCT00385723|6327322|P3|Overall Study|Withdrawal by Subject|2
1824826|NCT00385723|6327323|P2|Overall Study|Withdrawal by Subject|0
1824827|NCT00385723|6327324|P1|Overall Study|Withdrawal by Subject|1
1824828|NCT00385723|6327322|P3|Overall Study|Lost to Follow-up|0
1824829|NCT00385723|6327323|P2|Overall Study|Lost to Follow-up|1
1824830|NCT00385723|6327324|P1|Overall Study|Lost to Follow-up|1
1824831|NCT00385684|6327338|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
1824832|NCT00385684|6327339|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
1824833|NCT00385684|6327338|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
1824834|NCT00385684|6327339|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
1824835|NCT00385684|6327338|P2|FIRST INTERVENTION OF PHASE A|Death|0
1824836|NCT00385684|6327339|P1|FIRST INTERVENTION OF PHASE A|Death|1
1824837|NCT00385671|6327348|P3|Overall Study|Withdrawal by Subject|4
1824838|NCT00385671|6327349|P2|Overall Study|Withdrawal by Subject|4
1824839|NCT00385671|6327350|P1|Overall Study|Withdrawal by Subject|4
1824840|NCT00385671|6327348|P3|Overall Study|Sponsor Decision|1
1824841|NCT00385671|6327349|P2|Overall Study|Sponsor Decision|2
1824842|NCT00385671|6327350|P1|Overall Study|Sponsor Decision|2
1824843|NCT00385671|6327348|P3|Overall Study|Protocol Violation|1
1824844|NCT00385671|6327349|P2|Overall Study|Protocol Violation|2
1824845|NCT00385671|6327350|P1|Overall Study|Protocol Violation|5
1824846|NCT00385671|6327348|P3|Overall Study|Physician Decision|2
1824847|NCT00385671|6327349|P2|Overall Study|Physician Decision|1
1824848|NCT00385671|6327350|P1|Overall Study|Physician Decision|2
1824849|NCT00385671|6327348|P3|Overall Study|Lost to Follow-up|5
1824850|NCT00385671|6327349|P2|Overall Study|Lost to Follow-up|6
1824851|NCT00385671|6327350|P1|Overall Study|Lost to Follow-up|6
1824852|NCT00385671|6327348|P3|Overall Study|Lack of Efficacy|5
1824853|NCT00385671|6327349|P2|Overall Study|Lack of Efficacy|9
1824854|NCT00385671|6327350|P1|Overall Study|Lack of Efficacy|5
1824855|NCT00385671|6327348|P3|Overall Study|Adverse Event|18
1824856|NCT00385671|6327349|P2|Overall Study|Adverse Event|27
1824857|NCT00385671|6327350|P1|Overall Study|Adverse Event|14
1824858|NCT00385593|6327506|P2|Overall Study|Incorrect randomization|1
1824859|NCT00385593|6327507|P1|Overall Study|Incorrect randomization|0
1824860|NCT00385593|6327506|P2|Overall Study|Incorrect inclusion|0
1824861|NCT00385593|6327507|P1|Overall Study|Incorrect inclusion|2
1824862|NCT00385593|6327506|P2|Overall Study|Several reasons|15
1824863|NCT00385593|6327507|P1|Overall Study|Several reasons|17
1824864|NCT00385593|6327506|P2|Overall Study|Protocol Violation|4
1824865|NCT00385593|6327507|P1|Overall Study|Protocol Violation|7
1824866|NCT00385593|6327506|P2|Overall Study|Lost to Follow-up|8
1824867|NCT00385593|6327507|P1|Overall Study|Lost to Follow-up|12
1824868|NCT00385593|6327506|P2|Overall Study|Withdrawal by Subject|7
1824869|NCT00385593|6327507|P1|Overall Study|Withdrawal by Subject|17
1824870|NCT00385593|6327506|P2|Overall Study|Adverse Event|2
1824871|NCT00385593|6327507|P1|Overall Study|Adverse Event|3
1824872|NCT00385541|6327617|P2|Overall Study|severe pain, clinician requested unblind|1
1824873|NCT00385541|6327618|P1|Overall Study|severe pain, clinician requested unblind|0
1824874|NCT00385255|6327654|P2|Overall Study|Lost to Follow-up|58
1824875|NCT00385255|6327655|P1|Overall Study|Lost to Follow-up|20
1824876|NCT00385255|6327654|P2|Overall Study|Migrated/moved from study area|1
1824877|NCT00385255|6327655|P1|Overall Study|Migrated/moved from study area|0
1824878|NCT00385255|6327654|P2|Overall Study|Withdrawal by Subject|8
1824879|NCT00385255|6327655|P1|Overall Study|Withdrawal by Subject|0
1824880|NCT00385255|6327654|P2|Overall Study|Protocol Violation|4
1824881|NCT00385255|6327655|P1|Overall Study|Protocol Violation|0
1824882|NCT00385255|6327654|P2|Overall Study|Serious Adverse Event|2
1824883|NCT00385255|6327655|P1|Overall Study|Serious Adverse Event|1
1824884|NCT00385203|6327734|P2|Overall Study|Incorrect enrollment|0
1824885|NCT00385203|6327735|P1|Overall Study|Incorrect enrollment|2
1824886|NCT00385203|6327734|P2|Overall Study|Condition under investigation worsened|3
1824887|NCT00385203|6327735|P1|Overall Study|Condition under investigation worsened|18
1824888|NCT00385203|6327734|P2|Overall Study|Death|0
1824889|NCT00385203|6327735|P1|Overall Study|Death|1
1824890|NCT00385203|6327734|P2|Overall Study|Adverse Event|4
1824891|NCT00385203|6327735|P1|Overall Study|Adverse Event|5
1824892|NCT00384956|6327823|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
1824893|NCT00384930|6327840|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
1824894|NCT00384930|6327841|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
1824895|NCT00384930|6327842|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
1824896|NCT00384930|6327843|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
1824897|NCT00384930|6327844|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
1824898|NCT00384930|6327840|P5|Overall Study|Withdrawal by Subject|16
1824899|NCT00384930|6327841|P4|Overall Study|Withdrawal by Subject|6
1824900|NCT00384930|6327842|P3|Overall Study|Withdrawal by Subject|7
1824901|NCT00384930|6327843|P2|Overall Study|Withdrawal by Subject|7
1824902|NCT00384930|6327844|P1|Overall Study|Withdrawal by Subject|9
1824903|NCT00384930|6327840|P5|Overall Study|Sponsor Decision|0
1824904|NCT00384930|6327841|P4|Overall Study|Sponsor Decision|5
1824905|NCT00384930|6327842|P3|Overall Study|Sponsor Decision|0
1824906|NCT00384930|6327843|P2|Overall Study|Sponsor Decision|4
1824907|NCT00384930|6327844|P1|Overall Study|Sponsor Decision|3
1824908|NCT00384930|6327840|P5|Overall Study|Protocol Violation|4
1824909|NCT00384930|6327841|P4|Overall Study|Protocol Violation|6
1824910|NCT00384930|6327842|P3|Overall Study|Protocol Violation|1
1824911|NCT00384930|6327843|P2|Overall Study|Protocol Violation|0
1824912|NCT00384930|6327844|P1|Overall Study|Protocol Violation|1
1824913|NCT00384930|6327840|P5|Overall Study|Physician Decision|1
1824914|NCT00384930|6327841|P4|Overall Study|Physician Decision|0
1824915|NCT00384930|6327842|P3|Overall Study|Physician Decision|1
1824916|NCT00384930|6327843|P2|Overall Study|Physician Decision|1
1824917|NCT00384930|6327844|P1|Overall Study|Physician Decision|0
1824918|NCT00384930|6327840|P5|Overall Study|Lost to Follow-up|6
1824919|NCT00384930|6327841|P4|Overall Study|Lost to Follow-up|4
1824920|NCT00384930|6327842|P3|Overall Study|Lost to Follow-up|0
1824921|NCT00384930|6327843|P2|Overall Study|Lost to Follow-up|3
1824922|NCT00384930|6327844|P1|Overall Study|Lost to Follow-up|5
1824923|NCT00384930|6327840|P5|Overall Study|Lack of Efficacy|2
1824924|NCT00384930|6327841|P4|Overall Study|Lack of Efficacy|1
1824925|NCT00384930|6327842|P3|Overall Study|Lack of Efficacy|2
1824926|NCT00384930|6327843|P2|Overall Study|Lack of Efficacy|1
1824927|NCT00384930|6327844|P1|Overall Study|Lack of Efficacy|1
1824928|NCT00384930|6327840|P5|Overall Study|Entry Criteria Not Met|4
1824929|NCT00384930|6327841|P4|Overall Study|Entry Criteria Not Met|8
1824930|NCT00384930|6327842|P3|Overall Study|Entry Criteria Not Met|7
1824931|NCT00384930|6327843|P2|Overall Study|Entry Criteria Not Met|6
1824932|NCT00384930|6327844|P1|Overall Study|Entry Criteria Not Met|2
1824933|NCT00384930|6327840|P5|Overall Study|Adverse Event|14
1824934|NCT00384930|6327841|P4|Overall Study|Adverse Event|11
1824935|NCT00384930|6327842|P3|Overall Study|Adverse Event|12
1824936|NCT00384930|6327843|P2|Overall Study|Adverse Event|4
1824937|NCT00384930|6327844|P1|Overall Study|Adverse Event|5
1824938|NCT00384839|6327923|P1|Overall Study|Ineligible|2
1824939|NCT00384839|6327923|P1|Overall Study|Patient Request|1
1824940|NCT00384839|6327923|P1|Overall Study|Investigator Request|1
1824941|NCT00384839|6327923|P1|Overall Study|Adverse Event|4
1824942|NCT00384397|6328056|P3|Overall Study|Withdrawal by Subject|15
1824943|NCT00384397|6328057|P2|Overall Study|Withdrawal by Subject|17
1824944|NCT00384397|6328058|P1|Overall Study|Withdrawal by Subject|14
1824945|NCT00384397|6328056|P3|Overall Study|Lost to Follow-up|3
1824946|NCT00384397|6328057|P2|Overall Study|Lost to Follow-up|13
1824947|NCT00384397|6328058|P1|Overall Study|Lost to Follow-up|11
1824948|NCT00384397|6328056|P3|Overall Study|Protocol Violation|13
1824949|NCT00384397|6328057|P2|Overall Study|Protocol Violation|15
1824950|NCT00384397|6328058|P1|Overall Study|Protocol Violation|7
1824951|NCT00384397|6328056|P3|Overall Study|Adverse Event|2
1824952|NCT00384397|6328057|P2|Overall Study|Adverse Event|1
1824953|NCT00384397|6328058|P1|Overall Study|Adverse Event|0
1824954|NCT00384332|6328077|P2|Overall Study|Lost to Follow-up|0
1824955|NCT00384332|6328078|P1|Overall Study|Lost to Follow-up|4
1824956|NCT00384293|6328088|P3|Post-randomization Period|Patient Randomized in Error|1
1824957|NCT00384293|6328089|P2|Post-randomization Period|Patient Randomized in Error|0
1824958|NCT00384293|6328090|P1|Post-randomization Period|Patient Randomized in Error|0
1824959|NCT00384293|6328088|P3|Post-randomization Period|Trial Termination|204
1824960|NCT00384293|6328089|P2|Post-randomization Period|Trial Termination|180
1824961|NCT00384293|6328090|P1|Post-randomization Period|Trial Termination|0
1824962|NCT00384293|6328088|P3|Post-randomization Period|Withdrawal by Subject|6
1824963|NCT00384293|6328089|P2|Post-randomization Period|Withdrawal by Subject|8
1824964|NCT00384293|6328090|P1|Post-randomization Period|Withdrawal by Subject|0
1824965|NCT00384293|6328088|P3|Post-randomization Period|Protocol Violation|0
1824966|NCT00384293|6328089|P2|Post-randomization Period|Protocol Violation|1
1824967|NCT00384293|6328090|P1|Post-randomization Period|Protocol Violation|0
1824968|NCT00384293|6328088|P3|Post-randomization Period|Lost to Follow-up|1
1824969|NCT00384293|6328089|P2|Post-randomization Period|Lost to Follow-up|2
1824970|NCT00384293|6328090|P1|Post-randomization Period|Lost to Follow-up|0
1824971|NCT00384293|6328088|P3|Post-randomization Period|Adverse Event|7
1824972|NCT00384293|6328089|P2|Post-randomization Period|Adverse Event|23
1824973|NCT00384293|6328090|P1|Post-randomization Period|Adverse Event|0
1824974|NCT00384293|6328088|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1824975|NCT00384293|6328089|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
1824976|NCT00384293|6328090|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
1824977|NCT00384293|6328088|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1824978|NCT00384293|6328089|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
1824979|NCT00384293|6328090|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
1824980|NCT00384293|6328088|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1824981|NCT00384293|6328089|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
1824982|NCT00384293|6328090|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
1824983|NCT00384293|6328088|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1824984|NCT00384293|6328089|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
1824985|NCT00384293|6328090|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
1824986|NCT00384293|6328088|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1824987|NCT00384293|6328089|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
1824988|NCT00384293|6328090|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
1824989|NCT00384293|6328088|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1824990|NCT00384293|6328089|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
1824991|NCT00384293|6328090|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
1824992|NCT00384293|6328088|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1824993|NCT00384293|6328089|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
1824994|NCT00384293|6328090|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
1824995|NCT00384189|6328114|P4|Overall Study|Reason Not Specified|40
1824996|NCT00384189|6328115|P3|Overall Study|Reason Not Specified|58
1824997|NCT00384189|6328116|P2|Overall Study|Reason Not Specified|57
1824998|NCT00384189|6328117|P1|Overall Study|Reason Not Specified|50
1824999|NCT00384176|6328178|P3|Overall Study|Liver metastases, colon resec. planned|0
1825000|NCT00384176|6328179|P2|Overall Study|Liver metastases, colon resec. planned|0
1825001|NCT00384176|6328180|P1|Overall Study|Liver metastases, colon resec. planned|1
1825002|NCT00384176|6328178|P3|Overall Study|Physician Decision|0
1825003|NCT00384176|6328179|P2|Overall Study|Physician Decision|2
1825004|NCT00384176|6328180|P1|Overall Study|Physician Decision|0
1825005|NCT00384176|6328178|P3|Overall Study|Did not receive study treatment|1
1825006|NCT00384176|6328179|P2|Overall Study|Did not receive study treatment|1
1825007|NCT00384176|6328180|P1|Overall Study|Did not receive study treatment|0
1825008|NCT00384176|6328178|P3|Overall Study|Toxicity of treatment|0
1825009|NCT00384176|6328179|P2|Overall Study|Toxicity of treatment|0
1825010|NCT00384176|6328180|P1|Overall Study|Toxicity of treatment|1
1825011|NCT00384176|6328178|P3|Overall Study|Longer QTC as Visit 1|0
1825012|NCT00384176|6328179|P2|Overall Study|Longer QTC as Visit 1|0
1825013|NCT00384176|6328180|P1|Overall Study|Longer QTC as Visit 1|1
1825014|NCT00384176|6328178|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
1825015|NCT00384176|6328179|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
1825016|NCT00384176|6328180|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
1825017|NCT00384176|6328178|P3|Overall Study|Lost to Follow-up|4
1825018|NCT00384176|6328179|P2|Overall Study|Lost to Follow-up|18
1825019|NCT00384176|6328180|P1|Overall Study|Lost to Follow-up|16
1825020|NCT00384176|6328178|P3|Overall Study|Withdrawal by Subject|22
1825021|NCT00384176|6328179|P2|Overall Study|Withdrawal by Subject|48
1825022|NCT00384176|6328180|P1|Overall Study|Withdrawal by Subject|52
1825023|NCT00384176|6328178|P3|Overall Study|Death|105
1825024|NCT00384176|6328179|P2|Overall Study|Death|247
1825025|NCT00384176|6328180|P1|Overall Study|Death|239
1825026|NCT00384085|6328206|P3|Overall Study|Patient required surgery|0
1825027|NCT00384085|6328207|P2|Overall Study|Patient required surgery|1
1825028|NCT00384085|6328208|P1|Overall Study|Patient required surgery|0
1825029|NCT00384085|6328206|P3|Overall Study|Patient moved|1
1825030|NCT00384085|6328207|P2|Overall Study|Patient moved|0
1825031|NCT00384085|6328208|P1|Overall Study|Patient moved|1
1825032|NCT00384085|6328206|P3|Overall Study|Sponsor decision|1
1825033|NCT00384085|6328207|P2|Overall Study|Sponsor decision|2
1825034|NCT00384085|6328208|P1|Overall Study|Sponsor decision|1
1825035|NCT00384085|6328206|P3|Overall Study|Loss of site personnel|1
1825036|NCT00384085|6328207|P2|Overall Study|Loss of site personnel|0
1825037|NCT00384085|6328208|P1|Overall Study|Loss of site personnel|1
1825038|NCT00384085|6328206|P3|Overall Study|Physician Decision|0
1825039|NCT00384085|6328207|P2|Overall Study|Physician Decision|0
1825040|NCT00384085|6328208|P1|Overall Study|Physician Decision|1
1825041|NCT00384085|6328206|P3|Overall Study|Patient non-compliant|5
1825042|NCT00384085|6328207|P2|Overall Study|Patient non-compliant|4
1825043|NCT00384085|6328208|P1|Overall Study|Patient non-compliant|4
1825044|NCT00384085|6328206|P3|Overall Study|Withdrawal by Subject|29
1825045|NCT00384085|6328207|P2|Overall Study|Withdrawal by Subject|19
1825046|NCT00384085|6328208|P1|Overall Study|Withdrawal by Subject|14
1825047|NCT00384085|6328206|P3|Overall Study|Progressive Disease|0
1825048|NCT00384085|6328207|P2|Overall Study|Progressive Disease|1
1825049|NCT00384085|6328208|P1|Overall Study|Progressive Disease|0
1825050|NCT00384085|6328206|P3|Overall Study|Lost to Follow-up|10
1825051|NCT00384085|6328207|P2|Overall Study|Lost to Follow-up|9
1825052|NCT00384085|6328208|P1|Overall Study|Lost to Follow-up|9
1825053|NCT00384085|6328206|P3|Overall Study|Protocol Violation|2
1825054|NCT00384085|6328207|P2|Overall Study|Protocol Violation|2
1825055|NCT00384085|6328208|P1|Overall Study|Protocol Violation|2
1825056|NCT00384085|6328206|P3|Overall Study|No longer Requires Study Treatment|1
1825057|NCT00384085|6328207|P2|Overall Study|No longer Requires Study Treatment|0
1825058|NCT00384085|6328208|P1|Overall Study|No longer Requires Study Treatment|1
1825059|NCT00384085|6328206|P3|Overall Study|Lack of Efficacy|2
1825060|NCT00384085|6328207|P2|Overall Study|Lack of Efficacy|3
1825061|NCT00384085|6328208|P1|Overall Study|Lack of Efficacy|0
1825062|NCT00384085|6328206|P3|Overall Study|Adverse Event|4
1825063|NCT00384085|6328207|P2|Overall Study|Adverse Event|5
1825064|NCT00384085|6328208|P1|Overall Study|Adverse Event|5
1825065|NCT00384059|6328234|P2|Toddler Dose|Failed to return|1
1825066|NCT00384059|6328235|P1|Toddler Dose|Failed to return|0
1825067|NCT00384059|6328234|P2|Toddler Dose|Lost to Follow-up|1
1825068|NCT00384059|6328235|P1|Toddler Dose|Lost to Follow-up|1
1825069|NCT00384059|6328234|P2|After Infant Series|Lost to Follow-up|1
1825070|NCT00384059|6328235|P1|After Infant Series|Lost to Follow-up|0
1825071|NCT00384059|6328234|P2|After Infant Series|Physician Decision|1
1825072|NCT00384059|6328235|P1|After Infant Series|Physician Decision|0
1825073|NCT00384059|6328234|P2|After Infant Series|Adverse Event|1
1825074|NCT00384059|6328235|P1|After Infant Series|Adverse Event|0
1825075|NCT00384059|6328234|P2|After Infant Series|Failed to Return|2
1825076|NCT00384059|6328235|P1|After Infant Series|Failed to Return|0
1825077|NCT00384059|6328234|P2|After Infant Series|Withdrawal by Subject|2
1825078|NCT00384059|6328235|P1|After Infant Series|Withdrawal by Subject|2
1825079|NCT00384059|6328234|P2|After Infant Series|Protocol Violation|3
1825080|NCT00384059|6328235|P1|After Infant Series|Protocol Violation|2
1825081|NCT00384059|6328234|P2|Infant Series|Lost to Follow-up|1
1825082|NCT00384059|6328235|P1|Infant Series|Lost to Follow-up|0
1825083|NCT00384059|6328234|P2|Infant Series|Protocol Violation|2
1825084|NCT00384059|6328235|P1|Infant Series|Protocol Violation|1
1825085|NCT00384059|6328234|P2|Infant Series|Adverse Event|2
1825086|NCT00384059|6328235|P1|Infant Series|Adverse Event|1
1825087|NCT00384059|6328234|P2|Infant Series|Withdrawal by Subject|2
1825088|NCT00384059|6328235|P1|Infant Series|Withdrawal by Subject|2
1825089|NCT00384059|6328234|P2|Infant Series|Not consented|6
1825090|NCT00384059|6328235|P1|Infant Series|Not consented|2
1825091|NCT00384033|6328285|P4|Overall Study|Randomized but not treated|2
1825092|NCT00384033|6328286|P3|Overall Study|Randomized but not treated|10
1825093|NCT00384033|6328287|P2|Overall Study|Randomized but not treated|7
1825094|NCT00384033|6328288|P1|Overall Study|Randomized but not treated|3
1825095|NCT00384033|6328285|P4|Overall Study|Lack of Efficacy|1
1825096|NCT00384033|6328286|P3|Overall Study|Lack of Efficacy|3
1825097|NCT00384033|6328287|P2|Overall Study|Lack of Efficacy|3
1825098|NCT00384033|6328288|P1|Overall Study|Lack of Efficacy|7
1825099|NCT00384033|6328285|P4|Overall Study|Withdrawal by Subject|2
1825100|NCT00384033|6328286|P3|Overall Study|Withdrawal by Subject|5
1825101|NCT00384033|6328287|P2|Overall Study|Withdrawal by Subject|2
1825102|NCT00384033|6328288|P1|Overall Study|Withdrawal by Subject|6
1825103|NCT00384033|6328285|P4|Overall Study|Protocol Violation|6
1825104|NCT00384033|6328286|P3|Overall Study|Protocol Violation|5
1825105|NCT00384033|6328287|P2|Overall Study|Protocol Violation|0
1825106|NCT00384033|6328288|P1|Overall Study|Protocol Violation|5
1825107|NCT00384033|6328285|P4|Overall Study|Other|0
1825108|NCT00384033|6328286|P3|Overall Study|Other|0
1825109|NCT00384033|6328287|P2|Overall Study|Other|0
1825110|NCT00384033|6328288|P1|Overall Study|Other|2
1825111|NCT00384033|6328285|P4|Overall Study|Lost to Follow-up|7
1825112|NCT00384033|6328286|P3|Overall Study|Lost to Follow-up|7
1825113|NCT00384033|6328287|P2|Overall Study|Lost to Follow-up|12
1825114|NCT00384033|6328288|P1|Overall Study|Lost to Follow-up|6
1825115|NCT00384033|6328285|P4|Overall Study|Physician Decision|0
1825116|NCT00384033|6328286|P3|Overall Study|Physician Decision|0
1825117|NCT00384033|6328287|P2|Overall Study|Physician Decision|0
1825118|NCT00384033|6328288|P1|Overall Study|Physician Decision|1
1825119|NCT00384033|6328285|P4|Overall Study|Failed to return|2
1825120|NCT00384033|6328286|P3|Overall Study|Failed to return|2
1825121|NCT00384033|6328287|P2|Overall Study|Failed to return|3
1825122|NCT00384033|6328288|P1|Overall Study|Failed to return|1
1825123|NCT00384033|6328285|P4|Overall Study|Adverse Event|20
1825124|NCT00384033|6328286|P3|Overall Study|Adverse Event|11
1825125|NCT00384033|6328287|P2|Overall Study|Adverse Event|8
1825126|NCT00384033|6328288|P1|Overall Study|Adverse Event|10
1825127|NCT00383786|6328341|P2|Overall Study|Physician Decision|1
1825128|NCT00383786|6328342|P1|Overall Study|Physician Decision|0
1825129|NCT00383786|6328341|P2|Overall Study|Withdrawal by Subject|5
1825130|NCT00383786|6328342|P1|Overall Study|Withdrawal by Subject|2
1825131|NCT00383786|6328341|P2|Overall Study|Protocol Violation|6
1825132|NCT00383786|6328342|P1|Overall Study|Protocol Violation|2
1825133|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Administrative|0
1825134|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Administrative|1
1825135|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Administrative|3
1825136|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Administrative|2
1825137|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Administrative|1
1825138|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1825139|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1825140|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1825141|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1825142|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1825143|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1825144|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1825145|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1825146|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1825147|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
1825148|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
1825149|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
1825150|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
1825151|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
1825152|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1825153|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1825154|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
1825155|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1825156|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
1825157|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1825158|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
1825159|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
1825160|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1825161|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
1825162|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
1825163|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1825164|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1825165|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
1825166|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
1825167|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
1825168|NCT00383721|6328392|P5|26-Week Treatment Safety Extension|Adverse Event|0
1825169|NCT00383721|6328393|P4|26-Week Treatment Safety Extension|Adverse Event|1
1825170|NCT00383721|6328394|P3|26-Week Treatment Safety Extension|Adverse Event|10
1825171|NCT00383721|6328395|P2|26-Week Treatment Safety Extension|Adverse Event|7
1825172|NCT00383721|6328396|P1|26-Week Treatment Safety Extension|Adverse Event|6
1825173|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Ongoing|0
1825174|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Ongoing|0
1825175|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Ongoing|0
1825176|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Ongoing|0
1825177|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Ongoing|1
1825178|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Administrative|3
1825179|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Administrative|3
1825180|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Administrative|3
1825181|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Administrative|3
1825182|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Administrative|1
1825183|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
1825184|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
1825185|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
1825186|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1825187|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1825188|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1825189|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
1825190|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1825191|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1825192|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
1825193|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
1825194|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
1825195|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
1825196|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1825197|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
1825198|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
1825199|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1825200|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
1825201|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1825202|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
1825203|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
1825204|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1825205|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1825206|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1825207|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
1825208|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1825209|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
1825210|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1825211|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1825212|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
1825213|NCT00383721|6328392|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
1825214|NCT00383721|6328393|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
1825215|NCT00383721|6328394|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
1825216|NCT00383721|6328395|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
1825217|NCT00383721|6328396|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
1825218|NCT00383708|6328433|P1|Co-administration Period|Adverse Event|5
1825219|NCT00383708|6328433|P1|Run-in Period|Claustrophobia|1
1825220|NCT00383708|6328433|P1|Run-in Period|Adverse Event|2
1825221|NCT00383708|6328433|P1|Run-in Period|Protocol Violation|4
1825222|NCT00383708|6328433|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
1825223|NCT00383708|6328433|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
1825224|NCT00383552|6328508|P4|Overall Study|Administrative|1
1825225|NCT00383552|6328509|P3|Overall Study|Administrative|1
1825226|NCT00383552|6328510|P2|Overall Study|Administrative|0
1825227|NCT00383552|6328511|P1|Overall Study|Administrative|1
1825228|NCT00383552|6328508|P4|Overall Study|Did not meet protocol eligibility|3
1825229|NCT00383552|6328509|P3|Overall Study|Did not meet protocol eligibility|2
1825230|NCT00383552|6328510|P2|Overall Study|Did not meet protocol eligibility|6
1825231|NCT00383552|6328511|P1|Overall Study|Did not meet protocol eligibility|8
1825232|NCT00383552|6328508|P4|Overall Study|Noncompliance with the protocol|10
1825233|NCT00383552|6328509|P3|Overall Study|Noncompliance with the protocol|8
1825234|NCT00383552|6328510|P2|Overall Study|Noncompliance with the protocol|6
1825235|NCT00383552|6328511|P1|Overall Study|Noncompliance with the protocol|11
1825236|NCT00383552|6328508|P4|Overall Study|Did not wish to continue (related)|3
1825237|NCT00383552|6328509|P3|Overall Study|Did not wish to continue (related)|2
1825238|NCT00383552|6328510|P2|Overall Study|Did not wish to continue (related)|0
1825239|NCT00383552|6328511|P1|Overall Study|Did not wish to continue (related)|1
1825240|NCT00383552|6328508|P4|Overall Study|Did not wish to continue (unrelated)|6
1825241|NCT00383552|6328509|P3|Overall Study|Did not wish to continue (unrelated)|5
1825242|NCT00383552|6328510|P2|Overall Study|Did not wish to continue (unrelated)|9
1825243|NCT00383552|6328511|P1|Overall Study|Did not wish to continue (unrelated)|4
1825244|NCT00383552|6328508|P4|Overall Study|Lost to Follow-up|1
1825245|NCT00383552|6328509|P3|Overall Study|Lost to Follow-up|5
1825246|NCT00383552|6328510|P2|Overall Study|Lost to Follow-up|1
1825247|NCT00383552|6328511|P1|Overall Study|Lost to Follow-up|0
1825248|NCT00383552|6328508|P4|Overall Study|Lack of Efficacy|42
1825249|NCT00383552|6328509|P3|Overall Study|Lack of Efficacy|29
1825250|NCT00383552|6328510|P2|Overall Study|Lack of Efficacy|13
1825251|NCT00383552|6328511|P1|Overall Study|Lack of Efficacy|4
1825252|NCT00383552|6328508|P4|Overall Study|Adverse Event|6
1825253|NCT00383552|6328509|P3|Overall Study|Adverse Event|9
1825254|NCT00383552|6328510|P2|Overall Study|Adverse Event|6
1825255|NCT00383552|6328511|P1|Overall Study|Adverse Event|7
1825256|NCT00383500|6328553|P3|Overall Study|Lost to Follow-up|2
1825257|NCT00383500|6328554|P2|Overall Study|Lost to Follow-up|0
1825258|NCT00383500|6328555|P1|Overall Study|Lost to Follow-up|0
1825259|NCT00383500|6328553|P3|Overall Study|Withdrawal by Subject|0
1825260|NCT00383500|6328554|P2|Overall Study|Withdrawal by Subject|3
1825261|NCT00383500|6328555|P1|Overall Study|Withdrawal by Subject|8
1825262|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Administrative|0
1825263|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Administrative|1
1825264|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Administrative|0
1825265|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Administrative|1
1825266|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Administrative|1
1825267|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1825268|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1825269|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1825270|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
1825271|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
1825272|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
1825273|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1825274|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1825275|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
1825276|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
1825277|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
1825278|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
1825279|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
1825280|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
1825281|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
1825282|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
1825283|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1825284|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
1825285|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1825286|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
1825287|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
1825288|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
1825289|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
1825290|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
1825291|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
1825292|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
1825293|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
1825294|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
1825295|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
1825296|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
1825297|NCT00383435|6328579|P5|26-Week Treatment Safety Extension|Adverse Event|1
1825298|NCT00383435|6328580|P4|26-Week Treatment Safety Extension|Adverse Event|5
1825299|NCT00383435|6328581|P3|26-Week Treatment Safety Extension|Adverse Event|5
1825300|NCT00383435|6328582|P2|26-Week Treatment Safety Extension|Adverse Event|2
1825301|NCT00383435|6328583|P1|26-Week Treatment Safety Extension|Adverse Event|4
1825302|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Administrative|1
1825303|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Administrative|1
1825304|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Administrative|1
1825305|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Administrative|3
1825306|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Administrative|5
1825307|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
1825308|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
1825309|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
1825310|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
1825311|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
1825312|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
1825313|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1825314|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
1825315|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
1825316|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
1825317|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1825318|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1825319|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
1825320|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
1825321|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
1825322|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
1825323|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
1825324|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
1825325|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
1825326|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
1825327|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1825328|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
1825329|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
1825330|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1825331|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
1825332|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
1825333|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
1825334|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1825335|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
1825336|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
1825337|NCT00383435|6328579|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
1825338|NCT00383435|6328580|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
1825339|NCT00383435|6328581|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
1825340|NCT00383435|6328582|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
1825341|NCT00383435|6328583|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
1825342|NCT00383331|6328622|P2|Overall Study|Protocol Violation|1
1825343|NCT00383331|6328623|P1|Overall Study|Protocol Violation|0
1825344|NCT00383292|6328642|P3|Overall Study|Other|0
1825345|NCT00383292|6328643|P2|Overall Study|Other|0
1825346|NCT00383292|6328644|P1|Overall Study|Other|1
1825347|NCT00383292|6328642|P3|Overall Study|Withdrawal by Subject|2
1825348|NCT00383292|6328643|P2|Overall Study|Withdrawal by Subject|2
1825349|NCT00383292|6328644|P1|Overall Study|Withdrawal by Subject|3
1825350|NCT00383292|6328642|P3|Overall Study|Physician Decision|1
1825351|NCT00383292|6328643|P2|Overall Study|Physician Decision|0
1825352|NCT00383292|6328644|P1|Overall Study|Physician Decision|4
1825353|NCT00383292|6328642|P3|Overall Study|Death|3
1825354|NCT00383292|6328643|P2|Overall Study|Death|3
1825355|NCT00383292|6328644|P1|Overall Study|Death|3
1825356|NCT00383292|6328642|P3|Overall Study|Adverse Event|2
1825357|NCT00383292|6328643|P2|Overall Study|Adverse Event|1
1825358|NCT00383292|6328644|P1|Overall Study|Adverse Event|4
1825359|NCT00383240|6328685|P4|Overall Study|Administrative|0
1825360|NCT00383240|6328686|P3|Overall Study|Administrative|0
1825361|NCT00383240|6328687|P2|Overall Study|Administrative|1
1825362|NCT00383240|6328688|P1|Overall Study|Administrative|1
1825363|NCT00383240|6328685|P4|Overall Study|Did not meet protocol eligibility|3
1825364|NCT00383240|6328686|P3|Overall Study|Did not meet protocol eligibility|9
1825365|NCT00383240|6328687|P2|Overall Study|Did not meet protocol eligibility|4
1825366|NCT00383240|6328688|P1|Overall Study|Did not meet protocol eligibility|9
1825367|NCT00383240|6328685|P4|Overall Study|Protocol Violation|6
1825368|NCT00383240|6328686|P3|Overall Study|Protocol Violation|9
1825369|NCT00383240|6328687|P2|Overall Study|Protocol Violation|5
1825370|NCT00383240|6328688|P1|Overall Study|Protocol Violation|4
1825371|NCT00383240|6328685|P4|Overall Study|Withdrawal by subjects, reasons related|5
1825372|NCT00383240|6328686|P3|Overall Study|Withdrawal by subjects, reasons related|3
1825373|NCT00383240|6328687|P2|Overall Study|Withdrawal by subjects, reasons related|1
1825374|NCT00383240|6328688|P1|Overall Study|Withdrawal by subjects, reasons related|0
1825375|NCT00383240|6328685|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
1825376|NCT00383240|6328686|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
1825377|NCT00383240|6328687|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
1825378|NCT00383240|6328688|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
1825379|NCT00383240|6328685|P4|Overall Study|Lost to Follow-up|2
1825380|NCT00383240|6328686|P3|Overall Study|Lost to Follow-up|0
1825381|NCT00383240|6328687|P2|Overall Study|Lost to Follow-up|0
1825382|NCT00383240|6328688|P1|Overall Study|Lost to Follow-up|3
1825383|NCT00383240|6328685|P4|Overall Study|Treatment Failure|46
1825384|NCT00383240|6328686|P3|Overall Study|Treatment Failure|47
1825385|NCT00383240|6328687|P2|Overall Study|Treatment Failure|13
1825386|NCT00383240|6328688|P1|Overall Study|Treatment Failure|8
1825387|NCT00383240|6328685|P4|Overall Study|Adverse Event|7
1825388|NCT00383240|6328686|P3|Overall Study|Adverse Event|9
1825389|NCT00383240|6328687|P2|Overall Study|Adverse Event|6
1825390|NCT00383240|6328688|P1|Overall Study|Adverse Event|4
1825391|NCT00383162|6328719|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
1825392|NCT00383162|6328720|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
1825393|NCT00383162|6328719|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
1825394|NCT00383162|6328720|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
1825395|NCT00383162|6328719|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1825396|NCT00383162|6328720|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1825397|NCT00383162|6328719|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
1825398|NCT00383162|6328720|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
1825399|NCT00383162|6328719|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
1825400|NCT00383162|6328720|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
1825401|NCT00383162|6328719|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
1825402|NCT00383162|6328720|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
1825403|NCT00383162|6328719|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
1825404|NCT00383162|6328720|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
1825405|NCT00383162|6328719|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1825406|NCT00383162|6328720|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
1825407|NCT00383162|6328719|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
1825408|NCT00383162|6328720|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
1825409|NCT00383149|6328762|P1|Overall Study|Participant Withdrew Consent|1
1825410|NCT00383149|6328762|P1|Overall Study|Request to Discontinue Treatment|4
1825411|NCT00383149|6328762|P1|Overall Study|Study Drug Toxicity|4
1825412|NCT00383149|6328762|P1|Overall Study|Other|1
1825413|NCT00383149|6328762|P1|Overall Study|Lost to Follow-up|1
1825414|NCT00383149|6328762|P1|Overall Study|Disease Progression|38
1825415|NCT00383149|6328762|P1|Overall Study|Death|2
1825416|NCT00383149|6328762|P1|Overall Study|Adverse Event not Related to Study Drug|3
1825417|NCT00383123|6328781|P2|Overall Study|Other reason|6
1825418|NCT00383123|6328782|P1|Overall Study|Other reason|10
1825419|NCT00383123|6328781|P2|Overall Study|Withdrawal by Subject|18
1825420|NCT00383123|6328782|P1|Overall Study|Withdrawal by Subject|27
1825421|NCT00383123|6328781|P2|Overall Study|Protocol Violation|1
1825422|NCT00383123|6328782|P1|Overall Study|Protocol Violation|5
1825423|NCT00383123|6328781|P2|Overall Study|Lost to Follow-up|61
1825424|NCT00383123|6328782|P1|Overall Study|Lost to Follow-up|68
1825425|NCT00383123|6328781|P2|Overall Study|Adverse Event|0
1825426|NCT00383123|6328782|P1|Overall Study|Adverse Event|1
1825427|NCT00383084|6328823|P2|Overall Study|Withdrawal by Subject|10
1825428|NCT00383084|6328824|P1|Overall Study|Withdrawal by Subject|12
1825429|NCT00383019|6328855|P2|Overall Study|Withdrawal by Subject|1
1825430|NCT00383019|6328856|P1|Overall Study|Withdrawal by Subject|0
1825431|NCT00383019|6328855|P2|Overall Study|Adverse Event|1
1825432|NCT00383019|6328856|P1|Overall Study|Adverse Event|5
1825433|NCT00382993|6328878|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1825434|NCT00382993|6328879|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
1825435|NCT00382993|6328878|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
1825436|NCT00382993|6328879|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
1825437|NCT00382993|6328878|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
1825438|NCT00382993|6328879|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
1825439|NCT00382993|6328878|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
1825440|NCT00382993|6328879|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
1825441|NCT00382993|6328878|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
1825442|NCT00382993|6328879|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
1825443|NCT00382993|6328878|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
1825444|NCT00382993|6328879|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
1825445|NCT00382993|6328878|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1825446|NCT00382993|6328879|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
1825447|NCT00382993|6328878|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
1825448|NCT00382993|6328879|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
1825449|NCT00382993|6328878|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
1825450|NCT00382993|6328879|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
1825451|NCT00382993|6328878|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
1825452|NCT00382993|6328879|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
1825453|NCT00382967|6328923|P2|Overall Study|Protocol Violation|1
1825454|NCT00382967|6328924|P1|Overall Study|Protocol Violation|1
1825455|NCT00382863|6328949|P2|Overall Study|Withdrawal by Subject|25
1825456|NCT00382863|6328950|P1|Overall Study|Withdrawal by Subject|5
1825457|NCT00382863|6328949|P2|Overall Study|Lost to Follow-up|2
1825458|NCT00382863|6328950|P1|Overall Study|Lost to Follow-up|1
1825459|NCT00382863|6328949|P2|Overall Study|Death|9
1825460|NCT00382863|6328950|P1|Overall Study|Death|9
1825461|NCT00382733|6329034|P5|Overall Study|Withdrawal by Subject|0
1825462|NCT00382733|6329035|P4|Overall Study|Withdrawal by Subject|0
1825463|NCT00382733|6329036|P3|Overall Study|Withdrawal by Subject|0
1825464|NCT00382733|6329037|P2|Overall Study|Withdrawal by Subject|1
1825465|NCT00382733|6329038|P1|Overall Study|Withdrawal by Subject|0
1825466|NCT00382720|6329059|P3|Overall Study|Discontinued at end of study|2
1825467|NCT00382720|6329060|P2|Overall Study|Discontinued at end of study|1
1825468|NCT00382720|6329061|P1|Overall Study|Discontinued at end of study|0
1825469|NCT00382720|6329059|P3|Overall Study|Investigator/Clinical decision|6
1825470|NCT00382720|6329060|P2|Overall Study|Investigator/Clinical decision|6
1825471|NCT00382720|6329061|P1|Overall Study|Investigator/Clinical decision|5
1825472|NCT00382720|6329059|P3|Overall Study|Good prognosis|0
1825473|NCT00382720|6329060|P2|Overall Study|Good prognosis|1
1825474|NCT00382720|6329061|P1|Overall Study|Good prognosis|0
1825475|NCT00382720|6329059|P3|Overall Study|Clinically progressive disease|0
1825476|NCT00382720|6329060|P2|Overall Study|Clinically progressive disease|1
1825477|NCT00382720|6329061|P1|Overall Study|Clinically progressive disease|0
1825478|NCT00382720|6329059|P3|Overall Study|Patient did not receive study medication|4
1825479|NCT00382720|6329060|P2|Overall Study|Patient did not receive study medication|1
1825480|NCT00382720|6329061|P1|Overall Study|Patient did not receive study medication|1
1825481|NCT00382720|6329059|P3|Overall Study|Surgery|4
1825482|NCT00382720|6329060|P2|Overall Study|Surgery|1
1825483|NCT00382720|6329061|P1|Overall Study|Surgery|1
1825484|NCT00382720|6329059|P3|Overall Study|Withdrawal by Subject|12
1825485|NCT00382720|6329060|P2|Overall Study|Withdrawal by Subject|20
1825486|NCT00382720|6329061|P1|Overall Study|Withdrawal by Subject|11
1825487|NCT00382720|6329059|P3|Overall Study|Withdrew consent|2
1825488|NCT00382720|6329060|P2|Overall Study|Withdrew consent|1
1825489|NCT00382720|6329061|P1|Overall Study|Withdrew consent|1
1825490|NCT00382720|6329059|P3|Overall Study|Progressive disease|38
1825491|NCT00382720|6329060|P2|Overall Study|Progressive disease|28
1825492|NCT00382720|6329061|P1|Overall Study|Progressive disease|37
1825493|NCT00382720|6329059|P3|Overall Study|Death|2
1825494|NCT00382720|6329060|P2|Overall Study|Death|1
1825495|NCT00382720|6329061|P1|Overall Study|Death|0
1825496|NCT00382720|6329059|P3|Overall Study|Protocol Violation|1
1825497|NCT00382720|6329060|P2|Overall Study|Protocol Violation|5
1825498|NCT00382720|6329061|P1|Overall Study|Protocol Violation|2
1825499|NCT00382720|6329059|P3|Overall Study|Adverse Event|15
1825500|NCT00382720|6329060|P2|Overall Study|Adverse Event|23
1825501|NCT00382720|6329061|P1|Overall Study|Adverse Event|21
1825502|NCT00382408|6329086|P2|Overall Study|Other|35
1825503|NCT00382408|6329087|P1|Overall Study|Other|100
1825504|NCT00382408|6329086|P2|Overall Study|Lost to Follow-up|8
1825505|NCT00382408|6329087|P1|Overall Study|Lost to Follow-up|19
1825506|NCT00382408|6329086|P2|Overall Study|Pregnancy|0
1825507|NCT00382408|6329087|P1|Overall Study|Pregnancy|2
1825508|NCT00382408|6329086|P2|Overall Study|Withdrawal by Subject|6
1825509|NCT00382408|6329087|P1|Overall Study|Withdrawal by Subject|17
1825510|NCT00382408|6329086|P2|Overall Study|Physician Decision|0
1825511|NCT00382408|6329087|P1|Overall Study|Physician Decision|1
1825512|NCT00382408|6329086|P2|Overall Study|Protocol Violation|2
1825513|NCT00382408|6329087|P1|Overall Study|Protocol Violation|2
1825514|NCT00382408|6329086|P2|Overall Study|Did not meet protocol requirement|3
1825515|NCT00382408|6329087|P1|Overall Study|Did not meet protocol requirement|3
1825516|NCT00382291|6329114|P3|Overall Study|Lack of Efficacy|1
1825517|NCT00382291|6329115|P2|Overall Study|Lack of Efficacy|0
1825518|NCT00382291|6329116|P1|Overall Study|Lack of Efficacy|0
1825519|NCT00382291|6329114|P3|Overall Study|Physician Decision|0
1825520|NCT00382291|6329115|P2|Overall Study|Physician Decision|1
1825521|NCT00382291|6329116|P1|Overall Study|Physician Decision|0
1825522|NCT00382291|6329114|P3|Overall Study|Withdrawal by Subject|0
1825523|NCT00382291|6329115|P2|Overall Study|Withdrawal by Subject|2
1825524|NCT00382291|6329116|P1|Overall Study|Withdrawal by Subject|0
1825525|NCT00382291|6329114|P3|Overall Study|Temporary study suspension|5
1825526|NCT00382291|6329115|P2|Overall Study|Temporary study suspension|2
1825527|NCT00382291|6329116|P1|Overall Study|Temporary study suspension|2
1825528|NCT00382291|6329114|P3|Overall Study|Protocol Violation|0
1825529|NCT00382291|6329115|P2|Overall Study|Protocol Violation|0
1825530|NCT00382291|6329116|P1|Overall Study|Protocol Violation|1
1825531|NCT00382291|6329114|P3|Overall Study|Adverse Event|2
1825532|NCT00382291|6329115|P2|Overall Study|Adverse Event|2
1825533|NCT00382291|6329116|P1|Overall Study|Adverse Event|1
1825534|NCT00382174|6329148|P3|Overall Study|Wounds merged|2
1825535|NCT00382174|6329149|P2|Overall Study|Wounds merged|2
1825536|NCT00382174|6329150|P1|Overall Study|Wounds merged|0
1825537|NCT00382174|6329148|P3|Overall Study|Failed to meet criteria|1
1825538|NCT00382174|6329149|P2|Overall Study|Failed to meet criteria|1
1825539|NCT00382174|6329150|P1|Overall Study|Failed to meet criteria|0
1825540|NCT00382174|6329148|P3|Overall Study|Physician Decision|2
1825541|NCT00382174|6329149|P2|Overall Study|Physician Decision|2
1825542|NCT00382174|6329150|P1|Overall Study|Physician Decision|0
1825543|NCT00382174|6329148|P3|Overall Study|Non compliance|1
1825544|NCT00382174|6329149|P2|Overall Study|Non compliance|0
1825545|NCT00382174|6329150|P1|Overall Study|Non compliance|1
1825546|NCT00382174|6329148|P3|Overall Study|Withdrawal by Subject|5
1825547|NCT00382174|6329149|P2|Overall Study|Withdrawal by Subject|4
1825548|NCT00382174|6329150|P1|Overall Study|Withdrawal by Subject|1
1825549|NCT00382174|6329148|P3|Overall Study|Adverse Event|5
1825550|NCT00382174|6329149|P2|Overall Study|Adverse Event|4
1825551|NCT00382174|6329150|P1|Overall Study|Adverse Event|1
1825552|NCT00382174|6329148|P3|Overall Study|Lost to Follow-up|5
1825553|NCT00382174|6329149|P2|Overall Study|Lost to Follow-up|4
1825554|NCT00382174|6329150|P1|Overall Study|Lost to Follow-up|1
1825555|NCT00382109|6329178|P2|Overall Study|consent withdrawal|1
1825556|NCT00382109|6329179|P1|Overall Study|consent withdrawal|0
1825557|NCT00382109|6329178|P2|Overall Study|Other|2
1825558|NCT00382109|6329179|P1|Overall Study|Other|0
1825559|NCT00382109|6329178|P2|Overall Study|ineligible|0
1825560|NCT00382109|6329179|P1|Overall Study|ineligible|2
1825561|NCT00382109|6329178|P2|Overall Study|Withdrawal by Subject|0
1825562|NCT00382109|6329179|P1|Overall Study|Withdrawal by Subject|1
1825563|NCT00382109|6329178|P2|Overall Study|Physician Decision|1
1825564|NCT00382109|6329179|P1|Overall Study|Physician Decision|6
1825565|NCT00382109|6329178|P2|Overall Study|Adverse Event|0
1825566|NCT00382109|6329179|P1|Overall Study|Adverse Event|3
1825567|NCT00382018|6329218|P4|Overall Study|Other, not protocol specified|1
1825568|NCT00382018|6329219|P3|Overall Study|Other, not protocol specified|3
1825569|NCT00382018|6329220|P2|Overall Study|Other, not protocol specified|16
1825570|NCT00382018|6329221|P1|Overall Study|Other, not protocol specified|0
1825571|NCT00382018|6329218|P4|Overall Study|Withdrawal by Subject|4
1825572|NCT00382018|6329219|P3|Overall Study|Withdrawal by Subject|3
1825573|NCT00382018|6329220|P2|Overall Study|Withdrawal by Subject|4
1825574|NCT00382018|6329221|P1|Overall Study|Withdrawal by Subject|0
1825575|NCT00382018|6329218|P4|Overall Study|Death|11
1825576|NCT00382018|6329219|P3|Overall Study|Death|7
1825577|NCT00382018|6329220|P2|Overall Study|Death|9
1825578|NCT00382018|6329221|P1|Overall Study|Death|0
1825579|NCT00382018|6329218|P4|Overall Study|Progression|43
1825580|NCT00382018|6329219|P3|Overall Study|Progression|51
1825581|NCT00382018|6329220|P2|Overall Study|Progression|136
1825582|NCT00382018|6329221|P1|Overall Study|Progression|0
1825583|NCT00381940|6329244|P1|Overall Study|Ineligible|1
1825584|NCT00381940|6329244|P1|Overall Study|Protocol Violation|1
1825585|NCT00381940|6329244|P1|Overall Study|Lack of Efficacy|3
1825586|NCT00381888|6329248|P1|Overall Study|Adverse Event|1
1825587|NCT00381888|6329248|P1|Overall Study|Surgery was cancelled|2
1825588|NCT00381888|6329248|P1|Overall Study|Had laparoscopic surgery|2
1825589|NCT00381888|6329248|P1|Overall Study|Protocol Violation|9
1825590|NCT00381888|6329248|P1|Overall Study|Physician Decision|1
1825591|NCT00381888|6329248|P1|Overall Study|Withdrawal by Subject|1
1825592|NCT00381888|6329248|P1|Overall Study|Death|1
1825593|NCT00381849|6329259|P2|Wash Out|Withdrawal by Subject|1
1825594|NCT00381849|6329260|P1|Wash Out|Withdrawal by Subject|0
1825595|NCT00381797|6329287|P5|Overall Study|Ineligible|0
1825596|NCT00381797|6329288|P4|Overall Study|Ineligible|1
1825597|NCT00381797|6329289|P3|Overall Study|Ineligible|0
1825598|NCT00381797|6329290|P2|Overall Study|Ineligible|0
1825599|NCT00381797|6329291|P1|Overall Study|Ineligible|0
1825600|NCT00381797|6329287|P5|Overall Study|Withdrawal by Subject|2
1825601|NCT00381797|6329288|P4|Overall Study|Withdrawal by Subject|0
1825602|NCT00381797|6329289|P3|Overall Study|Withdrawal by Subject|0
1825603|NCT00381797|6329290|P2|Overall Study|Withdrawal by Subject|1
1825604|NCT00381797|6329291|P1|Overall Study|Withdrawal by Subject|1
1825605|NCT00381706|6329366|P3|Overall Study|Never treated|1
1825606|NCT00381706|6329367|P2|Overall Study|Never treated|2
1825607|NCT00381706|6329368|P1|Overall Study|Never treated|7
1825608|NCT00381693|6329391|P1|Overall Study|Progression|2
1825609|NCT00381693|6329391|P1|Overall Study|Patient Choice|1
1825610|NCT00381693|6329391|P1|Overall Study|Adverse Event|4
1825611|NCT00381693|6329391|P1|Overall Study|Death|1
1825612|NCT00381680|6329400|P2|Overall Study|Ineligible|1
1825613|NCT00381680|6329401|P1|Overall Study|Ineligible|3
1825614|NCT00381680|6329400|P2|Overall Study|Other not otherwise specified|2
1825615|NCT00381680|6329401|P1|Overall Study|Other not otherwise specified|7
1825616|NCT00381680|6329400|P2|Overall Study|Progression|1
1825617|NCT00381680|6329401|P1|Overall Study|Progression|1
1825618|NCT00381680|6329400|P2|Overall Study|Induction Failure|1
1825619|NCT00381680|6329401|P1|Overall Study|Induction Failure|4
1825620|NCT00381680|6329400|P2|Overall Study|Relapse|9
1825621|NCT00381680|6329401|P1|Overall Study|Relapse|18
1825622|NCT00381680|6329400|P2|Overall Study|Stem Cell Transplant|10
1825623|NCT00381680|6329401|P1|Overall Study|Stem Cell Transplant|26
1825624|NCT00381680|6329400|P2|Overall Study|Delay initiation|0
1825625|NCT00381680|6329401|P1|Overall Study|Delay initiation|1
1825626|NCT00381680|6329400|P2|Overall Study|Secondary Malignancy|0
1825627|NCT00381680|6329401|P1|Overall Study|Secondary Malignancy|3
1825628|NCT00381680|6329400|P2|Overall Study|Alternative Therapy|5
1825629|NCT00381680|6329401|P1|Overall Study|Alternative Therapy|11
1825630|NCT00381680|6329400|P2|Overall Study|Entry onto another COG Trial|2
1825631|NCT00381680|6329401|P1|Overall Study|Entry onto another COG Trial|1
1825632|NCT00381680|6329400|P2|Overall Study|Withdrawal by Subject|1
1825633|NCT00381680|6329401|P1|Overall Study|Withdrawal by Subject|3
1825634|NCT00381680|6329400|P2|Overall Study|Physician Decision|6
1825635|NCT00381680|6329401|P1|Overall Study|Physician Decision|25
1825636|NCT00381680|6329400|P2|Overall Study|Lost to Follow-up|2
1825637|NCT00381680|6329401|P1|Overall Study|Lost to Follow-up|3
1825638|NCT00381680|6329400|P2|Overall Study|Death|7
1825639|NCT00381680|6329401|P1|Overall Study|Death|10
1825640|NCT00381680|6329400|P2|Overall Study|Adverse Event|3
1825641|NCT00381680|6329401|P1|Overall Study|Adverse Event|9
1825642|NCT00381641|6329418|P2|Overall Study|Withdrawal by Subject|2
1825643|NCT00381641|6329419|P1|Overall Study|Withdrawal by Subject|0
1825644|NCT00381615|6329452|P4|Overall Study|Protocol Violation|0
1825645|NCT00381615|6329453|P3|Overall Study|Protocol Violation|1
1825646|NCT00381615|6329454|P2|Overall Study|Protocol Violation|0
1825647|NCT00381615|6329455|P1|Overall Study|Protocol Violation|0
1825648|NCT00381615|6329452|P4|Overall Study|Lost to Follow-up|1
1825649|NCT00381615|6329453|P3|Overall Study|Lost to Follow-up|0
1825650|NCT00381615|6329454|P2|Overall Study|Lost to Follow-up|2
1825651|NCT00381615|6329455|P1|Overall Study|Lost to Follow-up|3
1825652|NCT00381615|6329452|P4|Overall Study|Withdrawal by Subject|1
1825653|NCT00381615|6329453|P3|Overall Study|Withdrawal by Subject|0
1825654|NCT00381615|6329454|P2|Overall Study|Withdrawal by Subject|3
1825655|NCT00381615|6329455|P1|Overall Study|Withdrawal by Subject|1
1825656|NCT00381563|6329507|P2|Overall Study|Protocol Violation|1
1825657|NCT00381563|6329508|P1|Overall Study|Protocol Violation|0
1825658|NCT00381563|6329507|P2|Overall Study|Lost to Follow-up|0
1825659|NCT00381563|6329508|P1|Overall Study|Lost to Follow-up|2
1825660|NCT00381563|6329507|P2|Overall Study|Withdrawal by Subject|5
1825661|NCT00381563|6329508|P1|Overall Study|Withdrawal by Subject|5
1825662|NCT00381485|6329523|P4|Double-Blind Treatment Period|Administrative|1
1825663|NCT00381485|6329524|P3|Double-Blind Treatment Period|Administrative|0
1825664|NCT00381485|6329525|P2|Double-Blind Treatment Period|Administrative|1
1825665|NCT00381485|6329526|P1|Double-Blind Treatment Period|Administrative|0
1825666|NCT00381485|6329523|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
1825667|NCT00381485|6329524|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1825668|NCT00381485|6329525|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1825669|NCT00381485|6329526|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
1825670|NCT00381485|6329523|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
1825671|NCT00381485|6329524|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
1825672|NCT00381485|6329525|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
1825673|NCT00381485|6329526|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
1825674|NCT00381485|6329523|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1825675|NCT00381485|6329524|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
1825676|NCT00381485|6329525|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
1825677|NCT00381485|6329526|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
1825678|NCT00381485|6329523|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
1825679|NCT00381485|6329524|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
1825680|NCT00381485|6329525|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
1825681|NCT00381485|6329526|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
1825682|NCT00381485|6329523|P4|Double-Blind Treatment Period|Lost to Follow-up|1
1825683|NCT00381485|6329524|P3|Double-Blind Treatment Period|Lost to Follow-up|1
1825684|NCT00381485|6329525|P2|Double-Blind Treatment Period|Lost to Follow-up|0
1825685|NCT00381485|6329526|P1|Double-Blind Treatment Period|Lost to Follow-up|0
1825686|NCT00381485|6329523|P4|Double-Blind Treatment Period|Lack of Efficacy|13
1825687|NCT00381485|6329524|P3|Double-Blind Treatment Period|Lack of Efficacy|11
1825688|NCT00381485|6329525|P2|Double-Blind Treatment Period|Lack of Efficacy|8
1825689|NCT00381485|6329526|P1|Double-Blind Treatment Period|Lack of Efficacy|0
1825690|NCT00381485|6329523|P4|Double-Blind Treatment Period|Adverse Event|5
1825691|NCT00381485|6329524|P3|Double-Blind Treatment Period|Adverse Event|2
1825692|NCT00381485|6329525|P2|Double-Blind Treatment Period|Adverse Event|2
1825693|NCT00381485|6329526|P1|Double-Blind Treatment Period|Adverse Event|0
1825694|NCT00381485|6329523|P4|Open-Label Run-In Period|Treatment failure|0
1825695|NCT00381485|6329524|P3|Open-Label Run-In Period|Treatment failure|0
1825696|NCT00381485|6329525|P2|Open-Label Run-In Period|Treatment failure|0
1825697|NCT00381485|6329526|P1|Open-Label Run-In Period|Treatment failure|1
1825698|NCT00381485|6329523|P4|Open-Label Run-In Period|Lost to Follow-up|0
1825699|NCT00381485|6329524|P3|Open-Label Run-In Period|Lost to Follow-up|0
1825700|NCT00381485|6329525|P2|Open-Label Run-In Period|Lost to Follow-up|0
1825701|NCT00381485|6329526|P1|Open-Label Run-In Period|Lost to Follow-up|3
1825702|NCT00381485|6329523|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1825703|NCT00381485|6329524|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1825704|NCT00381485|6329525|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
1825705|NCT00381485|6329526|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
1825706|NCT00381485|6329523|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1825707|NCT00381485|6329524|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1825708|NCT00381485|6329525|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
1825709|NCT00381485|6329526|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
1825710|NCT00381485|6329523|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
1825711|NCT00381485|6329524|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
1825712|NCT00381485|6329525|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
1825713|NCT00381485|6329526|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
1825714|NCT00381485|6329523|P4|Open-Label Run-In Period|Adverse Event|0
1825715|NCT00381485|6329524|P3|Open-Label Run-In Period|Adverse Event|0
1825716|NCT00381485|6329525|P2|Open-Label Run-In Period|Adverse Event|0
1825717|NCT00381485|6329526|P1|Open-Label Run-In Period|Adverse Event|9
1825718|NCT00381381|6329544|P1|Overall Study|Withdrawal by Subject|9
1825719|NCT00381381|6329544|P1|Overall Study|Lost to Follow-up|52
1825720|NCT00381381|6329544|P1|Overall Study|Adverse Event|3
1825721|NCT00381303|6329553|P2|Overall Study|Subject primary physician's decision|0
1825722|NCT00381303|6329554|P1|Overall Study|Subject primary physician's decision|1
1825723|NCT00381303|6329553|P2|Overall Study|Subject did not continue visits|0
1825724|NCT00381303|6329554|P1|Overall Study|Subject did not continue visits|1
1825725|NCT00381303|6329553|P2|Overall Study|Subject was too busy for appointments|0
1825726|NCT00381303|6329554|P1|Overall Study|Subject was too busy for appointments|1
1825727|NCT00381303|6329553|P2|Overall Study|No virologic response by week 12|0
1825728|NCT00381303|6329554|P1|Overall Study|No virologic response by week 12|1
1825729|NCT00381303|6329553|P2|Overall Study|Subject taking too many different meds|0
1825730|NCT00381303|6329554|P1|Overall Study|Subject taking too many different meds|1
1825731|NCT00381303|6329553|P2|Overall Study|Subject moved out of state|0
1825732|NCT00381303|6329554|P1|Overall Study|Subject moved out of state|2
1825733|NCT00381303|6329553|P2|Overall Study|Physician's decision to close the site|1
1825734|NCT00381303|6329554|P1|Overall Study|Physician's decision to close the site|3
1825735|NCT00381303|6329553|P2|Overall Study|Physician Decision|0
1825736|NCT00381303|6329554|P1|Overall Study|Physician Decision|1
1825737|NCT00381303|6329553|P2|Overall Study|Pregnancy|0
1825738|NCT00381303|6329554|P1|Overall Study|Pregnancy|2
1825739|NCT00381303|6329553|P2|Overall Study|Ineligible to continue the trial|1
1825740|NCT00381303|6329554|P1|Overall Study|Ineligible to continue the trial|2
1825741|NCT00381303|6329553|P2|Overall Study|Virologic failure|4
1825742|NCT00381303|6329554|P1|Overall Study|Virologic failure|6
1825743|NCT00381303|6329553|P2|Overall Study|Withdrawal by Subject|6
1825744|NCT00381303|6329554|P1|Overall Study|Withdrawal by Subject|13
1825745|NCT00381303|6329553|P2|Overall Study|Non-Adherence|6
1825746|NCT00381303|6329554|P1|Overall Study|Non-Adherence|13
1825747|NCT00381303|6329553|P2|Overall Study|AE/HIV-related event|6
1825748|NCT00381303|6329554|P1|Overall Study|AE/HIV-related event|22
1825749|NCT00381303|6329553|P2|Overall Study|Lost to Follow-up|9
1825750|NCT00381303|6329554|P1|Overall Study|Lost to Follow-up|25
1825751|NCT00381238|6329614|P1|Overall Study|Disease progression|1
1825752|NCT00381238|6329614|P1|Overall Study|Withdrew by physician|1
1825753|NCT00381238|6329614|P1|Overall Study|Lack of Efficacy|2
1825754|NCT00381238|6329614|P1|Overall Study|Withdrawal by Subject|4
1825755|NCT00381238|6329614|P1|Overall Study|Protocol Violation|1
1825756|NCT00381238|6329614|P1|Overall Study|Adverse Event|3
1825757|NCT00381095|6329630|P2|Overall Study|Adverse Event|7
1825758|NCT00381095|6329631|P1|Overall Study|Adverse Event|2
1825759|NCT00381095|6329630|P2|Overall Study|Withdrawal by Subject|3
1825760|NCT00381095|6329631|P1|Overall Study|Withdrawal by Subject|3
1825761|NCT00381095|6329630|P2|Overall Study|Protocol Violation|1
1825762|NCT00381095|6329631|P1|Overall Study|Protocol Violation|1
1825763|NCT00381095|6329630|P2|Overall Study|Other|2
1825764|NCT00381095|6329631|P1|Overall Study|Other|2
1825765|NCT00381095|6329630|P2|Overall Study|Lack of Efficacy|4
1825766|NCT00381095|6329631|P1|Overall Study|Lack of Efficacy|2
1825767|NCT00381095|6329630|P2|Overall Study|Death|4
1825768|NCT00381095|6329631|P1|Overall Study|Death|3
1825769|NCT00381043|6329663|P2|Overall Study|incarcerated|0
1825770|NCT00381043|6329664|P1|Overall Study|incarcerated|1
1825771|NCT00381043|6329663|P2|Overall Study|wanted more care|1
1825772|NCT00381043|6329664|P1|Overall Study|wanted more care|0
1825773|NCT00381043|6329663|P2|Overall Study|Withdrawal by Subject|1
1825774|NCT00381043|6329664|P1|Overall Study|Withdrawal by Subject|3
1825775|NCT00381043|6329663|P2|Overall Study|Lost to Follow-up|6
1825776|NCT00381043|6329664|P1|Overall Study|Lost to Follow-up|8
1825777|NCT00380978|6329690|P2|Overall Study|Parous patient|0
1825778|NCT00380978|6329691|P1|Overall Study|Parous patient|1
1825779|NCT00380978|6329690|P2|Overall Study|Allocation prior to analgesia request|2
1825780|NCT00380978|6329691|P1|Overall Study|Allocation prior to analgesia request|1
1825781|NCT00380978|6329690|P2|Overall Study|Wrong study envelope|2
1825782|NCT00380978|6329691|P1|Overall Study|Wrong study envelope|0
1825783|NCT00380978|6329690|P2|Overall Study|Refused allocated intervention|6
1825784|NCT00380978|6329691|P1|Overall Study|Refused allocated intervention|0
1825785|NCT00380874|6329713|P2|Overall Study|Not related to study drug|2
1825786|NCT00380874|6329714|P1|Overall Study|Not related to study drug|3
1825787|NCT00380874|6329713|P2|Overall Study|Withdrawal by Subject|1
1825788|NCT00380874|6329714|P1|Overall Study|Withdrawal by Subject|2
1825789|NCT00380874|6329713|P2|Overall Study|Death|0
1825790|NCT00380874|6329714|P1|Overall Study|Death|1
1825791|NCT00380874|6329713|P2|Overall Study|Adverse Event|7
1825792|NCT00380874|6329714|P1|Overall Study|Adverse Event|7
1825793|NCT00380744|6329746|P7|Overall Study|Withdrawal by Subject|0
1825794|NCT00380744|6329747|P6|Overall Study|Withdrawal by Subject|0
1825795|NCT00380744|6329748|P5|Overall Study|Withdrawal by Subject|0
1825796|NCT00380744|6329749|P4|Overall Study|Withdrawal by Subject|0
1825797|NCT00380744|6329750|P3|Overall Study|Withdrawal by Subject|0
1825798|NCT00380744|6329751|P2|Overall Study|Withdrawal by Subject|0
1825799|NCT00380744|6329752|P1|Overall Study|Withdrawal by Subject|1
1825800|NCT00380744|6329746|P7|Overall Study|Death|1
1825801|NCT00380744|6329747|P6|Overall Study|Death|0
1825802|NCT00380744|6329748|P5|Overall Study|Death|0
1825803|NCT00380744|6329749|P4|Overall Study|Death|0
1825804|NCT00380744|6329750|P3|Overall Study|Death|0
1825805|NCT00380744|6329751|P2|Overall Study|Death|0
1825806|NCT00380744|6329752|P1|Overall Study|Death|0
1825807|NCT00380718|6329802|P1|Overall Study|Death after 30-day post-therapy followup|17
1825808|NCT00380718|6329802|P1|Overall Study|Adverse Event|1
1825809|NCT00380692|6329814|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
1825810|NCT00380692|6329815|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
1825811|NCT00380692|6329814|P2|Study Period III - Open Label|Lack of Efficacy|4
1825812|NCT00380692|6329815|P1|Study Period III - Open Label|Lack of Efficacy|0
1825813|NCT00380692|6329814|P2|Study Period III - Open Label|Physician Decision|3
1825814|NCT00380692|6329815|P1|Study Period III - Open Label|Physician Decision|0
1825815|NCT00380692|6329814|P2|Study Period III - Open Label|Withdrawal by Subject|1
1825816|NCT00380692|6329815|P1|Study Period III - Open Label|Withdrawal by Subject|0
1825817|NCT00380692|6329814|P2|Study Period III - Open Label|Protocol Violation|0
1825818|NCT00380692|6329815|P1|Study Period III - Open Label|Protocol Violation|0
1825819|NCT00380692|6329814|P2|Study Period III - Open Label|Adverse Event|3
1825820|NCT00380692|6329815|P1|Study Period III - Open Label|Adverse Event|5
1825821|NCT00380692|6329814|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
1825822|NCT00380692|6329815|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
1825823|NCT00380692|6329814|P2|Study Period II - Double Blind|Lack of Efficacy|0
1825824|NCT00380692|6329815|P1|Study Period II - Double Blind|Lack of Efficacy|1
1825825|NCT00380692|6329814|P2|Study Period II - Double Blind|Physician Decision|1
1825826|NCT00380692|6329815|P1|Study Period II - Double Blind|Physician Decision|0
1825827|NCT00380692|6329814|P2|Study Period II - Double Blind|Withdrawal by Subject|0
1825828|NCT00380692|6329815|P1|Study Period II - Double Blind|Withdrawal by Subject|0
1825829|NCT00380692|6329814|P2|Study Period II - Double Blind|Protocol Violation|2
1825830|NCT00380692|6329815|P1|Study Period II - Double Blind|Protocol Violation|2
1825831|NCT00380692|6329814|P2|Study Period II - Double Blind|Adverse Event|0
1825832|NCT00380692|6329815|P1|Study Period II - Double Blind|Adverse Event|1
1825833|NCT00380588|6329863|P2|Overall Study|Physician Decision|0
1825834|NCT00380588|6329864|P1|Overall Study|Physician Decision|2
1825835|NCT00380588|6329863|P2|Overall Study|Withdrawal by Subject|3
1825836|NCT00380588|6329864|P1|Overall Study|Withdrawal by Subject|1
1825837|NCT00380588|6329863|P2|Overall Study|Adverse Event|3
1825838|NCT00380588|6329864|P1|Overall Study|Adverse Event|7
1825839|NCT00380588|6329863|P2|Overall Study|Next Cycle Not Started|0
1825840|NCT00380588|6329864|P1|Overall Study|Next Cycle Not Started|4
1825841|NCT00380588|6329863|P2|Overall Study|Unequivocal Disease Progression|34
1825842|NCT00380588|6329864|P1|Overall Study|Unequivocal Disease Progression|25
1825843|NCT00380393|6329878|P2|Month 14|Others|6
1825844|NCT00380393|6329879|P1|Month 14|Others|6
1825845|NCT00380393|6329878|P2|Month 14|Protocol Violation|0
1825846|NCT00380393|6329879|P1|Month 14|Protocol Violation|2
1825847|NCT00380393|6329878|P2|Month 14|Migrated/moved from study area|42
1825848|NCT00380393|6329879|P1|Month 14|Migrated/moved from study area|39
1825849|NCT00380393|6329878|P2|Month 14|Lost to Follow-up|1
1825850|NCT00380393|6329879|P1|Month 14|Lost to Follow-up|0
1825851|NCT00380393|6329878|P2|Month 14|Death|0
1825852|NCT00380393|6329879|P1|Month 14|Death|1
1825853|NCT00380393|6329878|P2|Month 14|Withdrawal by Subject|7
1825854|NCT00380393|6329879|P1|Month 14|Withdrawal by Subject|9
1825855|NCT00380393|6329878|P2|Month 8 (Cross-sectional Visit)|Others|4
1825856|NCT00380393|6329879|P1|Month 8 (Cross-sectional Visit)|Others|5
1825857|NCT00380393|6329878|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1825858|NCT00380393|6329879|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
1825859|NCT00380393|6329878|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
1825945|NCT00379795|6330317|P4|Overall Study|Subject non-compliance|0
1825860|NCT00380393|6329879|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
1825861|NCT00380393|6329878|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
1825862|NCT00380393|6329879|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
1825863|NCT00380393|6329878|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
1825864|NCT00380393|6329879|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
1825865|NCT00380367|6329927|P1|Overall Study|Withdrawal by Subject|1
1825866|NCT00380367|6329927|P1|Overall Study|Lost to Follow-up|1
1825867|NCT00380250|6329934|P2|Overall Study|Physician Decision|0
1825868|NCT00380250|6329935|P1|Overall Study|Physician Decision|1
1825869|NCT00380250|6329934|P2|Overall Study|Lost to Follow-up|5
1825870|NCT00380250|6329935|P1|Overall Study|Lost to Follow-up|14
1825871|NCT00380250|6329934|P2|Overall Study|Protocol Violation|5
1825872|NCT00380250|6329935|P1|Overall Study|Protocol Violation|15
1825873|NCT00380250|6329934|P2|Overall Study|Lack of Efficacy|8
1825874|NCT00380250|6329935|P1|Overall Study|Lack of Efficacy|10
1825875|NCT00380250|6329934|P2|Overall Study|Adverse Event|9
1825876|NCT00380250|6329935|P1|Overall Study|Adverse Event|20
1825877|NCT00380250|6329934|P2|Overall Study|Withdrawal by Subject|28
1825878|NCT00380250|6329935|P1|Overall Study|Withdrawal by Subject|39
1825879|NCT00380081|6330003|P6|Overall Study|Family Emergency|1
1825880|NCT00380081|6330004|P5|Overall Study|Family Emergency|0
1825881|NCT00380081|6330005|P4|Overall Study|Family Emergency|0
1825882|NCT00380081|6330006|P3|Overall Study|Family Emergency|0
1825883|NCT00380081|6330007|P2|Overall Study|Family Emergency|0
1825884|NCT00380081|6330008|P1|Overall Study|Family Emergency|0
1825885|NCT00380081|6330003|P6|Overall Study|Withdrawal by Subject|0
1825886|NCT00380081|6330004|P5|Overall Study|Withdrawal by Subject|1
1825887|NCT00380081|6330005|P4|Overall Study|Withdrawal by Subject|0
1825888|NCT00380081|6330006|P3|Overall Study|Withdrawal by Subject|0
1825889|NCT00380081|6330007|P2|Overall Study|Withdrawal by Subject|0
1825890|NCT00380081|6330008|P1|Overall Study|Withdrawal by Subject|0
1825891|NCT00380068|6330058|P1|Overall Study|Lack of Efficacy|5
1825892|NCT00380068|6330058|P1|Overall Study|Partipant moved away|1
1825893|NCT00380068|6330058|P1|Overall Study|Physician Decision|2
1825894|NCT00380068|6330058|P1|Overall Study|Lung transplant|3
1825895|NCT00380068|6330058|P1|Overall Study|Addition of other PAH therapeutic agent|1
1825896|NCT00380068|6330058|P1|Overall Study|Lost to Follow-up|1
1825897|NCT00380068|6330058|P1|Overall Study|Not compliant|6
1825898|NCT00380068|6330058|P1|Overall Study|Withdrawal by Subject|10
1825899|NCT00380068|6330058|P1|Overall Study|Adverse Event|40
1825900|NCT00379912|6330090|P2|Overall Study|Lack of Efficacy|0
1825901|NCT00379912|6330091|P1|Overall Study|Lack of Efficacy|1
1825902|NCT00379899|6330113|P2|Overall Study|Other|1
1825903|NCT00379899|6330114|P1|Overall Study|Other|3
1825904|NCT00379899|6330113|P2|Overall Study|Other protocol-specified criteria|4
1825905|NCT00379899|6330114|P1|Overall Study|Other protocol-specified criteria|3
1825906|NCT00379899|6330113|P2|Overall Study|Coronary artery bypass graft|1
1825907|NCT00379899|6330114|P1|Overall Study|Coronary artery bypass graft|1
1825908|NCT00379899|6330113|P2|Overall Study|Renal transplantation|4
1825909|NCT00379899|6330114|P1|Overall Study|Renal transplantation|5
1825910|NCT00379899|6330113|P2|Overall Study|Parathyroidectomy|2
1825911|NCT00379899|6330114|P1|Overall Study|Parathyroidectomy|0
1825912|NCT00379899|6330113|P2|Overall Study|Noncompliance|1
1825913|NCT00379899|6330114|P1|Overall Study|Noncompliance|1
1825914|NCT00379899|6330113|P2|Overall Study|Ineligibility determined|1
1825915|NCT00379899|6330114|P1|Overall Study|Ineligibility determined|0
1825916|NCT00379899|6330113|P2|Overall Study|Withdrawal by Subject|5
1825917|NCT00379899|6330114|P1|Overall Study|Withdrawal by Subject|5
1825918|NCT00379899|6330113|P2|Overall Study|Physician Decision|4
1825919|NCT00379899|6330114|P1|Overall Study|Physician Decision|3
1825920|NCT00379899|6330113|P2|Overall Study|Lost to Follow-up|4
1825921|NCT00379899|6330114|P1|Overall Study|Lost to Follow-up|2
1825922|NCT00379899|6330113|P2|Overall Study|Death|10
1825923|NCT00379899|6330114|P1|Overall Study|Death|10
1825924|NCT00379899|6330113|P2|Overall Study|Adverse Event|3
1825925|NCT00379899|6330114|P1|Overall Study|Adverse Event|7
1825926|NCT00379834|6330142|P1|Overall Study|Time constraints|2
1825927|NCT00379808|6330294|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
1825928|NCT00379808|6330295|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
1825929|NCT00379795|6330316|P5|Overall Study|Sponsor's decision|10
1825930|NCT00379795|6330317|P4|Overall Study|Sponsor's decision|47
1825931|NCT00379795|6330318|P3|Overall Study|Sponsor's decision|54
1825932|NCT00379795|6330319|P2|Overall Study|Sponsor's decision|17
1825933|NCT00379795|6330320|P1|Overall Study|Sponsor's decision|257
1825934|NCT00379795|6330316|P5|Overall Study|Subjects condition mandated intervention|7
1825935|NCT00379795|6330317|P4|Overall Study|Subjects condition mandated intervention|5
1825936|NCT00379795|6330318|P3|Overall Study|Subjects condition mandated intervention|7
1825937|NCT00379795|6330319|P2|Overall Study|Subjects condition mandated intervention|9
1825938|NCT00379795|6330320|P1|Overall Study|Subjects condition mandated intervention|34
1825939|NCT00379795|6330316|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
1825940|NCT00379795|6330317|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
1825941|NCT00379795|6330318|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
1825942|NCT00379795|6330319|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
1825943|NCT00379795|6330320|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
1825944|NCT00379795|6330316|P5|Overall Study|Subject non-compliance|1
1825946|NCT00379795|6330318|P3|Overall Study|Subject non-compliance|0
1825947|NCT00379795|6330319|P2|Overall Study|Subject non-compliance|2
1825948|NCT00379795|6330320|P1|Overall Study|Subject non-compliance|7
1825949|NCT00379795|6330316|P5|Overall Study|Withdrawal by Subject|14
1825950|NCT00379795|6330317|P4|Overall Study|Withdrawal by Subject|7
1825951|NCT00379795|6330318|P3|Overall Study|Withdrawal by Subject|19
1825952|NCT00379795|6330319|P2|Overall Study|Withdrawal by Subject|11
1825953|NCT00379795|6330320|P1|Overall Study|Withdrawal by Subject|94
1825954|NCT00379795|6330316|P5|Overall Study|Physician Decision|2
1825955|NCT00379795|6330317|P4|Overall Study|Physician Decision|2
1825956|NCT00379795|6330318|P3|Overall Study|Physician Decision|2
1825957|NCT00379795|6330319|P2|Overall Study|Physician Decision|0
1825958|NCT00379795|6330320|P1|Overall Study|Physician Decision|25
1825959|NCT00379795|6330316|P5|Overall Study|Lost to Follow-up|4
1825960|NCT00379795|6330317|P4|Overall Study|Lost to Follow-up|1
1825961|NCT00379795|6330318|P3|Overall Study|Lost to Follow-up|2
1825962|NCT00379795|6330319|P2|Overall Study|Lost to Follow-up|1
1825963|NCT00379795|6330320|P1|Overall Study|Lost to Follow-up|8
1825964|NCT00379795|6330316|P5|Overall Study|Adverse Event|4
1825965|NCT00379795|6330317|P4|Overall Study|Adverse Event|1
1825966|NCT00379795|6330318|P3|Overall Study|Adverse Event|3
1825967|NCT00379795|6330319|P2|Overall Study|Adverse Event|3
1825968|NCT00379795|6330320|P1|Overall Study|Adverse Event|17
1825969|NCT00379795|6330316|P5|Overall Study|Death|7
1825970|NCT00379795|6330317|P4|Overall Study|Death|4
1825971|NCT00379795|6330318|P3|Overall Study|Death|6
1825972|NCT00379795|6330319|P2|Overall Study|Death|8
1825973|NCT00379795|6330320|P1|Overall Study|Death|31
1825974|NCT00379769|6330350|P6|Observational Follow-up|Unknown; Reason Not Provided|1
1825975|NCT00379769|6330351|P5|Observational Follow-up|Unknown; Reason Not Provided|1
1825976|NCT00379769|6330352|P4|Observational Follow-up|Unknown; Reason Not Provided|0
1825977|NCT00379769|6330353|P3|Observational Follow-up|Unknown; Reason Not Provided|0
1825978|NCT00379769|6330354|P2|Observational Follow-up|Unknown; Reason Not Provided|0
1825979|NCT00379769|6330355|P1|Observational Follow-up|Unknown; Reason Not Provided|0
1825980|NCT00379769|6330350|P6|Observational Follow-up|Participant Moved|1
1825981|NCT00379769|6330351|P5|Observational Follow-up|Participant Moved|0
1825982|NCT00379769|6330352|P4|Observational Follow-up|Participant Moved|0
1825983|NCT00379769|6330353|P3|Observational Follow-up|Participant Moved|0
1825984|NCT00379769|6330354|P2|Observational Follow-up|Participant Moved|0
1825985|NCT00379769|6330355|P1|Observational Follow-up|Participant Moved|0
1825986|NCT00379769|6330350|P6|Observational Follow-up|Site Closed Early|7
1825987|NCT00379769|6330351|P5|Observational Follow-up|Site Closed Early|6
1825988|NCT00379769|6330352|P4|Observational Follow-up|Site Closed Early|0
1825989|NCT00379769|6330353|P3|Observational Follow-up|Site Closed Early|0
1825990|NCT00379769|6330354|P2|Observational Follow-up|Site Closed Early|0
1825991|NCT00379769|6330355|P1|Observational Follow-up|Site Closed Early|0
1825992|NCT00379769|6330350|P6|Observational Follow-up|Physician Decision|8
1825993|NCT00379769|6330351|P5|Observational Follow-up|Physician Decision|8
1825994|NCT00379769|6330352|P4|Observational Follow-up|Physician Decision|0
1825995|NCT00379769|6330353|P3|Observational Follow-up|Physician Decision|0
1825996|NCT00379769|6330354|P2|Observational Follow-up|Physician Decision|0
1825997|NCT00379769|6330355|P1|Observational Follow-up|Physician Decision|0
1825998|NCT00379769|6330350|P6|Observational Follow-up|Entered into Another Clinical Trial|22
1825999|NCT00379769|6330351|P5|Observational Follow-up|Entered into Another Clinical Trial|18
1826000|NCT00379769|6330352|P4|Observational Follow-up|Entered into Another Clinical Trial|0
1826001|NCT00379769|6330353|P3|Observational Follow-up|Entered into Another Clinical Trial|0
1826002|NCT00379769|6330354|P2|Observational Follow-up|Entered into Another Clinical Trial|0
1826003|NCT00379769|6330355|P1|Observational Follow-up|Entered into Another Clinical Trial|0
1826004|NCT00379769|6330350|P6|Observational Follow-up|Withdrawal by Subject|12
1826005|NCT00379769|6330351|P5|Observational Follow-up|Withdrawal by Subject|12
1826006|NCT00379769|6330352|P4|Observational Follow-up|Withdrawal by Subject|0
1826007|NCT00379769|6330353|P3|Observational Follow-up|Withdrawal by Subject|0
1826008|NCT00379769|6330354|P2|Observational Follow-up|Withdrawal by Subject|0
1826009|NCT00379769|6330355|P1|Observational Follow-up|Withdrawal by Subject|0
1826010|NCT00379769|6330350|P6|Observational Follow-up|Lost to Follow-up|27
1826011|NCT00379769|6330351|P5|Observational Follow-up|Lost to Follow-up|25
1826012|NCT00379769|6330352|P4|Observational Follow-up|Lost to Follow-up|0
1826013|NCT00379769|6330353|P3|Observational Follow-up|Lost to Follow-up|0
1826014|NCT00379769|6330354|P2|Observational Follow-up|Lost to Follow-up|0
1826015|NCT00379769|6330355|P1|Observational Follow-up|Lost to Follow-up|0
1826016|NCT00379769|6330350|P6|Observational Follow-up|Adverse Event|0
1826017|NCT00379769|6330351|P5|Observational Follow-up|Adverse Event|1
1826018|NCT00379769|6330352|P4|Observational Follow-up|Adverse Event|0
1826019|NCT00379769|6330353|P3|Observational Follow-up|Adverse Event|0
1826020|NCT00379769|6330354|P2|Observational Follow-up|Adverse Event|0
1826021|NCT00379769|6330355|P1|Observational Follow-up|Adverse Event|0
1826022|NCT00379769|6330350|P6|Observational Follow-up|Death|70
1826023|NCT00379769|6330351|P5|Observational Follow-up|Death|78
1826024|NCT00379769|6330352|P4|Observational Follow-up|Death|0
1826025|NCT00379769|6330353|P3|Observational Follow-up|Death|0
1826026|NCT00379769|6330354|P2|Observational Follow-up|Death|0
1826027|NCT00379769|6330355|P1|Observational Follow-up|Death|0
1826028|NCT00379769|6330350|P6|Main Study|Reason unspecified|0
1826029|NCT00379769|6330351|P5|Main Study|Reason unspecified|0
1826030|NCT00379769|6330352|P4|Main Study|Reason unspecified|0
1826031|NCT00379769|6330353|P3|Main Study|Reason unspecified|1
1826032|NCT00379769|6330354|P2|Main Study|Reason unspecified|0
1826033|NCT00379769|6330355|P1|Main Study|Reason unspecified|0
1826034|NCT00379769|6330350|P6|Main Study|Investigator refused to log temperature|0
1826035|NCT00379769|6330351|P5|Main Study|Investigator refused to log temperature|0
1826036|NCT00379769|6330352|P4|Main Study|Investigator refused to log temperature|0
1826037|NCT00379769|6330353|P3|Main Study|Investigator refused to log temperature|1
1826038|NCT00379769|6330354|P2|Main Study|Investigator refused to log temperature|0
1826039|NCT00379769|6330355|P1|Main Study|Investigator refused to log temperature|0
1826040|NCT00379769|6330350|P6|Main Study|Risk of heart failure|0
1826041|NCT00379769|6330351|P5|Main Study|Risk of heart failure|0
1826042|NCT00379769|6330352|P4|Main Study|Risk of heart failure|0
1826043|NCT00379769|6330353|P3|Main Study|Risk of heart failure|0
1826044|NCT00379769|6330354|P2|Main Study|Risk of heart failure|1
1826045|NCT00379769|6330355|P1|Main Study|Risk of heart failure|0
1826046|NCT00379769|6330350|P6|Main Study|Personal reasons|0
1826047|NCT00379769|6330351|P5|Main Study|Personal reasons|0
1826048|NCT00379769|6330352|P4|Main Study|Personal reasons|0
1826049|NCT00379769|6330353|P3|Main Study|Personal reasons|0
1826050|NCT00379769|6330354|P2|Main Study|Personal reasons|0
1826051|NCT00379769|6330355|P1|Main Study|Personal reasons|1
1826052|NCT00379769|6330350|P6|Main Study|Participant completed study at visit 27|0
1826053|NCT00379769|6330351|P5|Main Study|Participant completed study at visit 27|0
1826054|NCT00379769|6330352|P4|Main Study|Participant completed study at visit 27|0
1826055|NCT00379769|6330353|P3|Main Study|Participant completed study at visit 27|0
1826056|NCT00379769|6330354|P2|Main Study|Participant completed study at visit 27|0
1826057|NCT00379769|6330355|P1|Main Study|Participant completed study at visit 27|1
1826058|NCT00379769|6330350|P6|Main Study|Physician Decision|0
1826059|NCT00379769|6330351|P5|Main Study|Physician Decision|0
1826060|NCT00379769|6330352|P4|Main Study|Physician Decision|1
1826061|NCT00379769|6330353|P3|Main Study|Physician Decision|1
1826062|NCT00379769|6330354|P2|Main Study|Physician Decision|2
1826063|NCT00379769|6330355|P1|Main Study|Physician Decision|2
1826064|NCT00379769|6330350|P6|Main Study|Participant did not take study drug|0
1826065|NCT00379769|6330351|P5|Main Study|Participant did not take study drug|0
1826066|NCT00379769|6330352|P4|Main Study|Participant did not take study drug|0
1826067|NCT00379769|6330353|P3|Main Study|Participant did not take study drug|1
1826068|NCT00379769|6330354|P2|Main Study|Participant did not take study drug|0
1826069|NCT00379769|6330355|P1|Main Study|Participant did not take study drug|0
1826070|NCT00379769|6330350|P6|Main Study|Entry criteria violation|0
1826071|NCT00379769|6330351|P5|Main Study|Entry criteria violation|0
1826072|NCT00379769|6330352|P4|Main Study|Entry criteria violation|1
1826073|NCT00379769|6330353|P3|Main Study|Entry criteria violation|1
1826074|NCT00379769|6330354|P2|Main Study|Entry criteria violation|0
1826075|NCT00379769|6330355|P1|Main Study|Entry criteria violation|0
1826076|NCT00379769|6330350|P6|Main Study|Site closed|0
1826077|NCT00379769|6330351|P5|Main Study|Site closed|0
1826078|NCT00379769|6330352|P4|Main Study|Site closed|8
1826079|NCT00379769|6330353|P3|Main Study|Site closed|4
1826080|NCT00379769|6330354|P2|Main Study|Site closed|4
1826081|NCT00379769|6330355|P1|Main Study|Site closed|4
1826082|NCT00379769|6330350|P6|Main Study|Prohibited glucose lowering medication|0
1826083|NCT00379769|6330351|P5|Main Study|Prohibited glucose lowering medication|0
1826084|NCT00379769|6330352|P4|Main Study|Prohibited glucose lowering medication|1
1826085|NCT00379769|6330353|P3|Main Study|Prohibited glucose lowering medication|0
1826086|NCT00379769|6330354|P2|Main Study|Prohibited glucose lowering medication|3
1826087|NCT00379769|6330355|P1|Main Study|Prohibited glucose lowering medication|0
1826088|NCT00379769|6330350|P6|Main Study|Poor compliance|0
1826089|NCT00379769|6330351|P5|Main Study|Poor compliance|0
1826090|NCT00379769|6330352|P4|Main Study|Poor compliance|1
1826091|NCT00379769|6330353|P3|Main Study|Poor compliance|2
1826092|NCT00379769|6330354|P2|Main Study|Poor compliance|2
1826093|NCT00379769|6330355|P1|Main Study|Poor compliance|3
1826094|NCT00379769|6330350|P6|Main Study|Participant moved|0
1826095|NCT00379769|6330351|P5|Main Study|Participant moved|0
1826096|NCT00379769|6330352|P4|Main Study|Participant moved|3
1826097|NCT00379769|6330353|P3|Main Study|Participant moved|3
1826098|NCT00379769|6330354|P2|Main Study|Participant moved|2
1826099|NCT00379769|6330355|P1|Main Study|Participant moved|3
1826100|NCT00379769|6330350|P6|Main Study|Moved to survival status follow-up only|0
1826101|NCT00379769|6330351|P5|Main Study|Moved to survival status follow-up only|0
1826102|NCT00379769|6330352|P4|Main Study|Moved to survival status follow-up only|36
1826103|NCT00379769|6330353|P3|Main Study|Moved to survival status follow-up only|32
1826104|NCT00379769|6330354|P2|Main Study|Moved to survival status follow-up only|25
1826105|NCT00379769|6330355|P1|Main Study|Moved to survival status follow-up only|27
1826106|NCT00379769|6330350|P6|Main Study|Withdrawal by Subject|0
1826107|NCT00379769|6330351|P5|Main Study|Withdrawal by Subject|0
1826108|NCT00379769|6330352|P4|Main Study|Withdrawal by Subject|70
1826109|NCT00379769|6330353|P3|Main Study|Withdrawal by Subject|72
1826110|NCT00379769|6330354|P2|Main Study|Withdrawal by Subject|56
1826111|NCT00379769|6330355|P1|Main Study|Withdrawal by Subject|46
1826112|NCT00379769|6330350|P6|Main Study|Lost to Follow-up|0
1826113|NCT00379769|6330351|P5|Main Study|Lost to Follow-up|0
1826114|NCT00379769|6330352|P4|Main Study|Lost to Follow-up|26
1826115|NCT00379769|6330353|P3|Main Study|Lost to Follow-up|25
1826116|NCT00379769|6330354|P2|Main Study|Lost to Follow-up|29
1826117|NCT00379769|6330355|P1|Main Study|Lost to Follow-up|29
1826118|NCT00379769|6330350|P6|Main Study|Adverse Event|0
1826119|NCT00379769|6330351|P5|Main Study|Adverse Event|0
1826120|NCT00379769|6330352|P4|Main Study|Adverse Event|11
1826121|NCT00379769|6330353|P3|Main Study|Adverse Event|10
1826122|NCT00379769|6330354|P2|Main Study|Adverse Event|8
1826123|NCT00379769|6330355|P1|Main Study|Adverse Event|5
1826124|NCT00379769|6330350|P6|Main Study|Death|0
1826125|NCT00379769|6330351|P5|Main Study|Death|0
1826126|NCT00379769|6330352|P4|Main Study|Death|72
1826127|NCT00379769|6330353|P3|Main Study|Death|54
1826128|NCT00379769|6330354|P2|Main Study|Death|67
1826129|NCT00379769|6330355|P1|Main Study|Death|57
1826130|NCT00379639|6330514|P5|Overall Study|Other|0
1826131|NCT00379639|6330515|P4|Overall Study|Other|0
1826132|NCT00379639|6330516|P3|Overall Study|Other|3
1826133|NCT00379639|6330517|P2|Overall Study|Other|0
1826134|NCT00379639|6330518|P1|Overall Study|Other|0
1826135|NCT00379639|6330514|P5|Overall Study|Lost to Follow-up|0
1826136|NCT00379639|6330515|P4|Overall Study|Lost to Follow-up|1
1826137|NCT00379639|6330516|P3|Overall Study|Lost to Follow-up|0
1826138|NCT00379639|6330517|P2|Overall Study|Lost to Follow-up|0
1826139|NCT00379639|6330518|P1|Overall Study|Lost to Follow-up|0
1826140|NCT00379639|6330514|P5|Overall Study|Adverse Event|1
1826141|NCT00379639|6330515|P4|Overall Study|Adverse Event|0
1826142|NCT00379639|6330516|P3|Overall Study|Adverse Event|1
1826143|NCT00379639|6330517|P2|Overall Study|Adverse Event|0
1826144|NCT00379639|6330518|P1|Overall Study|Adverse Event|0
1826145|NCT00379639|6330514|P5|Overall Study|Symptomatic Deterioration|1
1826146|NCT00379639|6330515|P4|Overall Study|Symptomatic Deterioration|0
1826147|NCT00379639|6330516|P3|Overall Study|Symptomatic Deterioration|1
1826148|NCT00379639|6330517|P2|Overall Study|Symptomatic Deterioration|0
1826149|NCT00379639|6330518|P1|Overall Study|Symptomatic Deterioration|0
1826150|NCT00379639|6330514|P5|Overall Study|Physician Decision|0
1826151|NCT00379639|6330515|P4|Overall Study|Physician Decision|1
1826152|NCT00379639|6330516|P3|Overall Study|Physician Decision|1
1826153|NCT00379639|6330517|P2|Overall Study|Physician Decision|2
1826154|NCT00379639|6330518|P1|Overall Study|Physician Decision|0
1826155|NCT00379639|6330514|P5|Overall Study|Disease Progression|4
1826156|NCT00379639|6330515|P4|Overall Study|Disease Progression|4
1826157|NCT00379639|6330516|P3|Overall Study|Disease Progression|3
1826158|NCT00379639|6330517|P2|Overall Study|Disease Progression|3
1826159|NCT00379639|6330518|P1|Overall Study|Disease Progression|3
1826160|NCT00379587|6330540|P1|Overall Study|Lost to Follow-up|2
1826161|NCT00379353|6330554|P2|Overall Study|Conflicting drug treatment|1
1826162|NCT00379353|6330555|P1|Overall Study|Conflicting drug treatment|0
1826163|NCT00379353|6330554|P2|Overall Study|Non-compliance|0
1826164|NCT00379353|6330555|P1|Overall Study|Non-compliance|1
1826165|NCT00379353|6330554|P2|Overall Study|Cardiac Tamponade|0
1826166|NCT00379353|6330555|P1|Overall Study|Cardiac Tamponade|1
1826167|NCT00379353|6330554|P2|Overall Study|Death|0
1826168|NCT00379353|6330555|P1|Overall Study|Death|1
1826169|NCT00379353|6330554|P2|Overall Study|Withdrawal by Subject|2
1826170|NCT00379353|6330555|P1|Overall Study|Withdrawal by Subject|5
1826171|NCT00379353|6330554|P2|Overall Study|Hospitalization|3
1826172|NCT00379353|6330555|P1|Overall Study|Hospitalization|3
1826173|NCT00379340|6330590|P5|Overall Study|Delayed nephrectomy and anaplasia|1
1826174|NCT00379340|6330591|P4|Overall Study|Delayed nephrectomy and anaplasia|1
1826175|NCT00379340|6330592|P3|Overall Study|Delayed nephrectomy and anaplasia|0
1826176|NCT00379340|6330593|P2|Overall Study|Delayed nephrectomy and anaplasia|0
1826177|NCT00379340|6330594|P1|Overall Study|Delayed nephrectomy and anaplasia|0
1826178|NCT00379340|6330590|P5|Overall Study|On more than 1 tumor therapeutic study|0
1826179|NCT00379340|6330591|P4|Overall Study|On more than 1 tumor therapeutic study|2
1826180|NCT00379340|6330592|P3|Overall Study|On more than 1 tumor therapeutic study|0
1826181|NCT00379340|6330593|P2|Overall Study|On more than 1 tumor therapeutic study|0
1826182|NCT00379340|6330594|P1|Overall Study|On more than 1 tumor therapeutic study|0
1826183|NCT00379340|6330590|P5|Overall Study|Refusal of further protocol therapy|7
1826184|NCT00379340|6330591|P4|Overall Study|Refusal of further protocol therapy|1
1826185|NCT00379340|6330592|P3|Overall Study|Refusal of further protocol therapy|1
1826186|NCT00379340|6330593|P2|Overall Study|Refusal of further protocol therapy|0
1826187|NCT00379340|6330594|P1|Overall Study|Refusal of further protocol therapy|1
1826188|NCT00379340|6330590|P5|Overall Study|Withdrawal by Subject|0
1826189|NCT00379340|6330591|P4|Overall Study|Withdrawal by Subject|1
1826190|NCT00379340|6330592|P3|Overall Study|Withdrawal by Subject|0
1826191|NCT00379340|6330593|P2|Overall Study|Withdrawal by Subject|0
1826192|NCT00379340|6330594|P1|Overall Study|Withdrawal by Subject|0
1826193|NCT00379340|6330590|P5|Overall Study|Physician Decision|3
1826194|NCT00379340|6330591|P4|Overall Study|Physician Decision|2
1826195|NCT00379340|6330592|P3|Overall Study|Physician Decision|1
1826196|NCT00379340|6330593|P2|Overall Study|Physician Decision|2
1826197|NCT00379340|6330594|P1|Overall Study|Physician Decision|6
1826198|NCT00379340|6330590|P5|Overall Study|Lack of Efficacy|3
1826199|NCT00379340|6330591|P4|Overall Study|Lack of Efficacy|4
1826200|NCT00379340|6330592|P3|Overall Study|Lack of Efficacy|0
1826201|NCT00379340|6330593|P2|Overall Study|Lack of Efficacy|1
1826202|NCT00379340|6330594|P1|Overall Study|Lack of Efficacy|6
1826203|NCT00379340|6330590|P5|Overall Study|Death|0
1826204|NCT00379340|6330591|P4|Overall Study|Death|2
1826205|NCT00379340|6330592|P3|Overall Study|Death|0
1826206|NCT00379340|6330593|P2|Overall Study|Death|0
1826207|NCT00379340|6330594|P1|Overall Study|Death|0
1826208|NCT00379288|6330611|P4|Overall Study|Administrative|1
1826209|NCT00379288|6330612|P3|Overall Study|Administrative|0
1826210|NCT00379288|6330613|P2|Overall Study|Administrative|2
1826211|NCT00379288|6330614|P1|Overall Study|Administrative|2
1826212|NCT00379288|6330611|P4|Overall Study|Did not meet protocol eligibility|2
1826213|NCT00379288|6330612|P3|Overall Study|Did not meet protocol eligibility|0
1826214|NCT00379288|6330613|P2|Overall Study|Did not meet protocol eligibility|1
1826215|NCT00379288|6330614|P1|Overall Study|Did not meet protocol eligibility|0
1826216|NCT00379288|6330611|P4|Overall Study|Noncompliance with protocol|1
1826217|NCT00379288|6330612|P3|Overall Study|Noncompliance with protocol|2
1826218|NCT00379288|6330613|P2|Overall Study|Noncompliance with protocol|6
1826219|NCT00379288|6330614|P1|Overall Study|Noncompliance with protocol|8
1826220|NCT00379288|6330611|P4|Overall Study|Subject withdrew-related to study drug|1
1826221|NCT00379288|6330612|P3|Overall Study|Subject withdrew-related to study drug|0
1826222|NCT00379288|6330613|P2|Overall Study|Subject withdrew-related to study drug|0
1826223|NCT00379288|6330614|P1|Overall Study|Subject withdrew-related to study drug|1
1826224|NCT00379288|6330611|P4|Overall Study|Subject withdrew-unrelated to study drug|2
1826225|NCT00379288|6330612|P3|Overall Study|Subject withdrew-unrelated to study drug|4
1826226|NCT00379288|6330613|P2|Overall Study|Subject withdrew-unrelated to study drug|3
1826227|NCT00379288|6330614|P1|Overall Study|Subject withdrew-unrelated to study drug|0
1826228|NCT00379288|6330611|P4|Overall Study|Lost to Follow-up|0
1826229|NCT00379288|6330612|P3|Overall Study|Lost to Follow-up|2
1826230|NCT00379288|6330613|P2|Overall Study|Lost to Follow-up|3
1826231|NCT00379288|6330614|P1|Overall Study|Lost to Follow-up|3
1826232|NCT00379288|6330611|P4|Overall Study|Treatment Failure|1
1826233|NCT00379288|6330612|P3|Overall Study|Treatment Failure|0
1826234|NCT00379288|6330613|P2|Overall Study|Treatment Failure|1
1826235|NCT00379288|6330614|P1|Overall Study|Treatment Failure|0
1826236|NCT00379288|6330611|P4|Overall Study|Adverse Event|0
1826237|NCT00379288|6330612|P3|Overall Study|Adverse Event|2
1826238|NCT00379288|6330613|P2|Overall Study|Adverse Event|6
1826239|NCT00379288|6330614|P1|Overall Study|Adverse Event|5
1826240|NCT00379236|6330626|P3|Open-label Extension|Other|7
1826241|NCT00379236|6330627|P2|Open-label Extension|Other|0
1826242|NCT00379236|6330628|P1|Open-label Extension|Other|0
1826243|NCT00379236|6330626|P3|Open-label Extension|Use of exclusionary medication|3
1826244|NCT00379236|6330627|P2|Open-label Extension|Use of exclusionary medication|0
1826245|NCT00379236|6330628|P1|Open-label Extension|Use of exclusionary medication|0
1826246|NCT00379236|6330626|P3|Open-label Extension|Lost to Follow-up|12
1826247|NCT00379236|6330627|P2|Open-label Extension|Lost to Follow-up|0
1826248|NCT00379236|6330628|P1|Open-label Extension|Lost to Follow-up|0
1826249|NCT00379236|6330626|P3|Open-label Extension|Withdrawal by Subject|13
1826250|NCT00379236|6330627|P2|Open-label Extension|Withdrawal by Subject|0
1826251|NCT00379236|6330628|P1|Open-label Extension|Withdrawal by Subject|0
1826252|NCT00379236|6330626|P3|Open-label Extension|Protocol Violation|7
1826253|NCT00379236|6330627|P2|Open-label Extension|Protocol Violation|0
1826254|NCT00379236|6330628|P1|Open-label Extension|Protocol Violation|0
1826255|NCT00379236|6330626|P3|Open-label Extension|Adverse Event|13
1826256|NCT00379236|6330627|P2|Open-label Extension|Adverse Event|0
1826257|NCT00379236|6330628|P1|Open-label Extension|Adverse Event|0
1826258|NCT00379236|6330626|P3|Double-blind|Data could not be retrieved|0
1826259|NCT00379236|6330627|P2|Double-blind|Data could not be retrieved|2
1826260|NCT00379236|6330628|P1|Double-blind|Data could not be retrieved|2
1826261|NCT00379236|6330626|P3|Double-blind|Other|0
1826262|NCT00379236|6330627|P2|Double-blind|Other|7
1826263|NCT00379236|6330628|P1|Double-blind|Other|3
1826264|NCT00379236|6330626|P3|Double-blind|Use of exclusionary medication|0
1826265|NCT00379236|6330627|P2|Double-blind|Use of exclusionary medication|2
1826266|NCT00379236|6330628|P1|Double-blind|Use of exclusionary medication|1
1826267|NCT00379236|6330626|P3|Double-blind|Lost to Follow-up|0
1826268|NCT00379236|6330627|P2|Double-blind|Lost to Follow-up|3
1826269|NCT00379236|6330628|P1|Double-blind|Lost to Follow-up|4
1826270|NCT00379236|6330626|P3|Double-blind|Withdrawal by Subject|0
1826271|NCT00379236|6330627|P2|Double-blind|Withdrawal by Subject|13
1826272|NCT00379236|6330628|P1|Double-blind|Withdrawal by Subject|12
1826273|NCT00379236|6330626|P3|Double-blind|Protocol Violation|0
1826274|NCT00379236|6330627|P2|Double-blind|Protocol Violation|3
1826275|NCT00379236|6330628|P1|Double-blind|Protocol Violation|3
1826276|NCT00379236|6330626|P3|Double-blind|Adverse Event|0
1826277|NCT00379236|6330627|P2|Double-blind|Adverse Event|6
1826278|NCT00379236|6330628|P1|Double-blind|Adverse Event|11
1826279|NCT00379210|6330673|P2|Overall Study|Withdrawal by Subject|7
1826280|NCT00379210|6330674|P1|Overall Study|Withdrawal by Subject|10
1826281|NCT00379080|6330697|P3|Overall Study|Withdrawal by Subject|0
1826282|NCT00379080|6330698|P2|Overall Study|Withdrawal by Subject|4
1826283|NCT00379080|6330699|P1|Overall Study|Withdrawal by Subject|0
1826284|NCT00378898|6330744|P2|Overall Study|Protocol Violation|1
1826285|NCT00378898|6330745|P1|Overall Study|Protocol Violation|1
1826286|NCT00378898|6330744|P2|Overall Study|Withdrawal by Subject|5
1826287|NCT00378898|6330745|P1|Overall Study|Withdrawal by Subject|10
1826288|NCT00378703|6330757|P4|Overall Study|Other|3
1826289|NCT00378703|6330758|P3|Overall Study|Other|2
1826290|NCT00378703|6330759|P2|Overall Study|Other|1
1826291|NCT00378703|6330760|P1|Overall Study|Other|1
1826292|NCT00378703|6330757|P4|Overall Study|Never started treatment|0
1826293|NCT00378703|6330758|P3|Overall Study|Never started treatment|0
1826294|NCT00378703|6330759|P2|Overall Study|Never started treatment|4
1826295|NCT00378703|6330760|P1|Overall Study|Never started treatment|1
1826296|NCT00378703|6330757|P4|Overall Study|Ineligible|7
1826297|NCT00378703|6330758|P3|Overall Study|Ineligible|7
1826298|NCT00378703|6330759|P2|Overall Study|Ineligible|7
1826299|NCT00378703|6330760|P1|Overall Study|Ineligible|4
1826300|NCT00378703|6330757|P4|Overall Study|Relocation|0
1826301|NCT00378703|6330758|P3|Overall Study|Relocation|1
1826302|NCT00378703|6330759|P2|Overall Study|Relocation|0
1826303|NCT00378703|6330760|P1|Overall Study|Relocation|0
1826304|NCT00378703|6330757|P4|Overall Study|Adverse events and progressive disease|1
1826305|NCT00378703|6330758|P3|Overall Study|Adverse events and progressive disease|0
1826306|NCT00378703|6330759|P2|Overall Study|Adverse events and progressive disease|0
1826307|NCT00378703|6330760|P1|Overall Study|Adverse events and progressive disease|0
1826308|NCT00378703|6330757|P4|Overall Study|Joint decision of physician and patient|0
1826309|NCT00378703|6330758|P3|Overall Study|Joint decision of physician and patient|0
1826310|NCT00378703|6330759|P2|Overall Study|Joint decision of physician and patient|0
1826311|NCT00378703|6330760|P1|Overall Study|Joint decision of physician and patient|1
1826312|NCT00378703|6330757|P4|Overall Study|Surgery|1
1826313|NCT00378703|6330758|P3|Overall Study|Surgery|0
1826314|NCT00378703|6330759|P2|Overall Study|Surgery|0
1826315|NCT00378703|6330760|P1|Overall Study|Surgery|1
1826316|NCT00378703|6330757|P4|Overall Study|Symptomatic deterioration|2
1826317|NCT00378703|6330758|P3|Overall Study|Symptomatic deterioration|0
1826318|NCT00378703|6330759|P2|Overall Study|Symptomatic deterioration|1
1826319|NCT00378703|6330760|P1|Overall Study|Symptomatic deterioration|0
1826320|NCT00378703|6330757|P4|Overall Study|Other complicated disease|0
1826321|NCT00378703|6330758|P3|Overall Study|Other complicated disease|2
1826322|NCT00378703|6330759|P2|Overall Study|Other complicated disease|2
1826323|NCT00378703|6330760|P1|Overall Study|Other complicated disease|0
1826324|NCT00378703|6330757|P4|Overall Study|Alternative therapy|0
1826325|NCT00378703|6330758|P3|Overall Study|Alternative therapy|0
1826326|NCT00378703|6330759|P2|Overall Study|Alternative therapy|2
1826327|NCT00378703|6330760|P1|Overall Study|Alternative therapy|4
1826328|NCT00378703|6330757|P4|Overall Study|Physician Decision|0
1826329|NCT00378703|6330758|P3|Overall Study|Physician Decision|1
1826330|NCT00378703|6330759|P2|Overall Study|Physician Decision|4
1826331|NCT00378703|6330760|P1|Overall Study|Physician Decision|1
1826332|NCT00378703|6330757|P4|Overall Study|Withdrawal by Subject|7
1826333|NCT00378703|6330758|P3|Overall Study|Withdrawal by Subject|5
1826334|NCT00378703|6330759|P2|Overall Study|Withdrawal by Subject|8
1826335|NCT00378703|6330760|P1|Overall Study|Withdrawal by Subject|4
1826336|NCT00378703|6330757|P4|Overall Study|Death|3
1826337|NCT00378703|6330758|P3|Overall Study|Death|4
1826338|NCT00378703|6330759|P2|Overall Study|Death|2
1826339|NCT00378703|6330760|P1|Overall Study|Death|2
1826340|NCT00378703|6330757|P4|Overall Study|Adverse Event|18
1826341|NCT00378703|6330758|P3|Overall Study|Adverse Event|20
1826342|NCT00378703|6330759|P2|Overall Study|Adverse Event|17
1826343|NCT00378703|6330760|P1|Overall Study|Adverse Event|11
1826344|NCT00378703|6330757|P4|Overall Study|Disease progression|49
1826345|NCT00378703|6330758|P3|Overall Study|Disease progression|48
1826346|NCT00378703|6330759|P2|Overall Study|Disease progression|43
1826347|NCT00378703|6330760|P1|Overall Study|Disease progression|59
1826348|NCT00378599|6330782|P1|Overall Study|Withdrawal by Subject|5
1826349|NCT00378599|6330782|P1|Overall Study|Treatment failure|7
1826350|NCT00378599|6330782|P1|Overall Study|Protocol Violation|2
1826351|NCT00378599|6330782|P1|Overall Study|Adverse Event|38
1826352|NCT00378573|6330786|P1|Follow-up|Withdrawal by Subject|1
1826353|NCT00378573|6330786|P1|Follow-up|Lost to Follow-up|1
1826354|NCT00378573|6330786|P1|Follow-up|Death|12
1826355|NCT00378573|6330786|P1|Treatment Period|Sponsor decision to close study|1
1826356|NCT00378573|6330786|P1|Treatment Period|Disease Progression|4
1826357|NCT00378573|6330786|P1|Treatment Period|Withdrawal by Subject|2
1826358|NCT00378573|6330786|P1|Treatment Period|Physician Decision|1
1826359|NCT00378573|6330786|P1|Treatment Period|Adverse Event|9
1826360|NCT00378560|6330794|P2|Overall Study|Laboratory test values abnormal|0
1826361|NCT00378560|6330795|P1|Overall Study|Laboratory test values abnormal|1
1826362|NCT00378560|6330794|P2|Overall Study|Pregnancy|5
1826363|NCT00378560|6330795|P1|Overall Study|Pregnancy|7
1826364|NCT00378560|6330794|P2|Overall Study|Moved|3
1826365|NCT00378560|6330795|P1|Overall Study|Moved|4
1826366|NCT00378560|6330794|P2|Overall Study|Withdrawal by Subject|21
1826367|NCT00378560|6330795|P1|Overall Study|Withdrawal by Subject|17
1826368|NCT00378560|6330794|P2|Overall Study|Protocol Violation|0
1826369|NCT00378560|6330795|P1|Overall Study|Protocol Violation|2
1826370|NCT00378560|6330794|P2|Overall Study|Lost to Follow-up|29
1826371|NCT00378560|6330795|P1|Overall Study|Lost to Follow-up|24
1826372|NCT00378560|6330794|P2|Overall Study|Adverse Event|0
1826373|NCT00378560|6330795|P1|Overall Study|Adverse Event|1
1826374|NCT00378534|6330809|P1|Overall Study|Subjects did not receive a transplant|3
1826375|NCT00378534|6330809|P1|Overall Study|Donors|57
1826376|NCT00378508|6330815|P2|Overall Study|Lost to Follow-up|0
1826377|NCT00378508|6330816|P1|Overall Study|Lost to Follow-up|1
1826378|NCT00378508|6330815|P2|Overall Study|Withdrawal by Subject|3
1826379|NCT00378508|6330816|P1|Overall Study|Withdrawal by Subject|1
1826380|NCT00378378|6330835|P3|Overall Study|Non-compliance with protocol|1
1826381|NCT00378378|6330836|P2|Overall Study|Non-compliance with protocol|0
1826382|NCT00378378|6330837|P1|Overall Study|Non-compliance with protocol|0
1826383|NCT00378378|6330835|P3|Overall Study|Treatment Failure|1
1826384|NCT00378378|6330836|P2|Overall Study|Treatment Failure|0
1826385|NCT00378378|6330837|P1|Overall Study|Treatment Failure|0
1826386|NCT00378378|6330835|P3|Overall Study|Withdrawal by Subject|0
1826387|NCT00378378|6330836|P2|Overall Study|Withdrawal by Subject|1
1826388|NCT00378378|6330837|P1|Overall Study|Withdrawal by Subject|0
1826389|NCT00378209|6330883|P1|Overall Study|Treatment delay|1
1826390|NCT00378209|6330883|P1|Overall Study|Death|1
1826391|NCT00378209|6330883|P1|Overall Study|Physician Decision|3
1826392|NCT00378209|6330883|P1|Overall Study|Initiation of non-protocol therapy|3
1826393|NCT00378209|6330883|P1|Overall Study|Adverse Event|3
1826394|NCT00378209|6330883|P1|Overall Study|Progressive disease|11
1826395|NCT00378105|6330893|P2|Overall Study|necessity to increase lenalidomide dose|1
1826396|NCT00378105|6330894|P1|Overall Study|necessity to increase lenalidomide dose|0
1826397|NCT00378105|6330893|P2|Overall Study|Going non-protocol therapy|1
1826398|NCT00378105|6330894|P1|Overall Study|Going non-protocol therapy|0
1826399|NCT00378105|6330893|P2|Overall Study|Physician Decision|2
1826400|NCT00378105|6330894|P1|Overall Study|Physician Decision|0
1826401|NCT00378105|6330893|P2|Overall Study|remain on study|11
1826402|NCT00378105|6330894|P1|Overall Study|remain on study|3
1826403|NCT00378105|6330893|P2|Overall Study|Progressive disease|3
1826404|NCT00378105|6330894|P1|Overall Study|Progressive disease|3
1826405|NCT00378105|6330893|P2|Overall Study|Going to transplant|8
1826406|NCT00378105|6330894|P1|Overall Study|Going to transplant|7
1826407|NCT00378105|6330893|P2|Overall Study|Death|0
1826408|NCT00378105|6330894|P1|Overall Study|Death|1
1826409|NCT00378105|6330893|P2|Overall Study|Withdrawal by Subject|3
1826410|NCT00378105|6330894|P1|Overall Study|Withdrawal by Subject|3
1826411|NCT00378105|6330893|P2|Overall Study|Adverse Event|1
1826412|NCT00378105|6330894|P1|Overall Study|Adverse Event|3
1826413|NCT00378079|6330906|P3|Overall Study|Lost to Follow-up|0
1826414|NCT00378079|6330907|P2|Overall Study|Lost to Follow-up|1
1826415|NCT00378079|6330908|P1|Overall Study|Lost to Follow-up|6
1826416|NCT00378014|6330930|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
1826417|NCT00378014|6330931|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
1826418|NCT00378014|6330930|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
1826419|NCT00378014|6330931|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
1826420|NCT00378014|6330930|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1826421|NCT00378014|6330931|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
1826422|NCT00378014|6330930|P2|Extension (Month 12 to Month 59)|Administrative problems|0
1826423|NCT00378014|6330931|P1|Extension (Month 12 to Month 59)|Administrative problems|1
1826424|NCT00378014|6330930|P2|Extension (Month 12 to Month 59)|Death|2
1826425|NCT00378014|6330931|P1|Extension (Month 12 to Month 59)|Death|1
1826426|NCT00378014|6330930|P2|Extension (Month 12 to Month 59)|Adverse Event|7
1826427|NCT00378014|6330931|P1|Extension (Month 12 to Month 59)|Adverse Event|8
1826428|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
1826429|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
1826430|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Protocol deviation|1
1826431|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Protocol deviation|0
1826432|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
1826433|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
1826434|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
1826435|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
1826436|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Administrative Problems|2
1826437|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Administrative Problems|2
1826438|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Death|3
1826439|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Death|5
1826440|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Graft loss|2
1826441|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Graft loss|1
1826442|NCT00378014|6330930|P2|Core (Randomization to Month 11)|Adverse Event|0
1826443|NCT00378014|6330931|P1|Core (Randomization to Month 11)|Adverse Event|1
1826444|NCT00377962|6330957|P2|Extension Study: 12-24 Months|Unspecified reason|3
1826445|NCT00377962|6330958|P1|Extension Study: 12-24 Months|Unspecified reason|0
1826446|NCT00377962|6330957|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
1826447|NCT00377962|6330958|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
1826448|NCT00377962|6330957|P2|Extension Study: 12-24 Months|Adverse Event|0
1826449|NCT00377962|6330958|P1|Extension Study: 12-24 Months|Adverse Event|8
1826450|NCT00377962|6330957|P2|Extension Study: 12-24 Months|Death|1
1826451|NCT00377962|6330958|P1|Extension Study: 12-24 Months|Death|1
1826452|NCT00377962|6330957|P2|Core Study: 0-12 Months|Unspecified reasons|4
1826453|NCT00377962|6330958|P1|Core Study: 0-12 Months|Unspecified reasons|1
1826454|NCT00377962|6330957|P2|Core Study: 0-12 Months|Administrative Reason|1
1826455|NCT00377962|6330958|P1|Core Study: 0-12 Months|Administrative Reason|1
1826456|NCT00377962|6330957|P2|Core Study: 0-12 Months|Withdrew Consent|2
1826457|NCT00377962|6330958|P1|Core Study: 0-12 Months|Withdrew Consent|5
1826458|NCT00377962|6330957|P2|Core Study: 0-12 Months|Death|0
1826459|NCT00377962|6330958|P1|Core Study: 0-12 Months|Death|3
1826460|NCT00377962|6330957|P2|Core Study: 0-12 Months|Adverse Event|2
1826461|NCT00377962|6330958|P1|Core Study: 0-12 Months|Adverse Event|18
1826462|NCT00377858|6330994|P2|Overall Study|Death|3
1826463|NCT00377858|6330995|P1|Overall Study|Death|0
1826464|NCT00377858|6330994|P2|Overall Study|Sponsor Decision|2
1826465|NCT00377858|6330995|P1|Overall Study|Sponsor Decision|1
1826466|NCT00377858|6330994|P2|Overall Study|Entry Criteria Not Met|0
1826467|NCT00377858|6330995|P1|Overall Study|Entry Criteria Not Met|2
1826468|NCT00377858|6330994|P2|Overall Study|Adverse Event|1
1826469|NCT00377858|6330995|P1|Overall Study|Adverse Event|2
1826470|NCT00377858|6330994|P2|Overall Study|Protocol Violation|4
1826471|NCT00377858|6330995|P1|Overall Study|Protocol Violation|3
1826472|NCT00377858|6330994|P2|Overall Study|Physician Decision|5
1826473|NCT00377858|6330995|P1|Overall Study|Physician Decision|5
1826474|NCT00377858|6330994|P2|Overall Study|Lost to Follow-up|1
1826475|NCT00377858|6330995|P1|Overall Study|Lost to Follow-up|6
1826476|NCT00377858|6330994|P2|Overall Study|Withdrawal by Subject|11
1826477|NCT00377858|6330995|P1|Overall Study|Withdrawal by Subject|12
1826478|NCT00377819|6331048|P2|Overall Study|Protocol Violation|1
1826479|NCT00377819|6331049|P1|Overall Study|Protocol Violation|1
1826480|NCT00377819|6331048|P2|Overall Study|Lost to Follow-up|1
1826481|NCT00377819|6331049|P1|Overall Study|Lost to Follow-up|0
1826482|NCT00377819|6331048|P2|Overall Study|Death|1
1826483|NCT00377819|6331049|P1|Overall Study|Death|0
1826484|NCT00377819|6331048|P2|Overall Study|Withdrawal by Subject|4
1826485|NCT00377819|6331049|P1|Overall Study|Withdrawal by Subject|10
1826486|NCT00377819|6331048|P2|Overall Study|Adverse Event|3
1826487|NCT00377819|6331049|P1|Overall Study|Adverse Event|2
1826488|NCT00377676|6331078|P2|Overall Study|Other|58
1826489|NCT00377676|6331079|P1|Overall Study|Other|118
1826490|NCT00377676|6331078|P2|Overall Study|Lost to Follow-up|56
1826491|NCT00377676|6331079|P1|Overall Study|Lost to Follow-up|120
1826492|NCT00377676|6331078|P2|Overall Study|Withdrawal by Subject|72
1826493|NCT00377676|6331079|P1|Overall Study|Withdrawal by Subject|187
1826494|NCT00377676|6331078|P2|Overall Study|Death|2
1826495|NCT00377676|6331079|P1|Overall Study|Death|5
1826496|NCT00377676|6331078|P2|Overall Study|Protocol Violation|27
1826497|NCT00377676|6331079|P1|Overall Study|Protocol Violation|33
1826498|NCT00377676|6331078|P2|Overall Study|Adverse Event|107
1826499|NCT00377676|6331079|P1|Overall Study|Adverse Event|498
1826500|NCT00377637|6331095|P4|Maintenance Phase|Death|1
1826501|NCT00377637|6331096|P3|Maintenance Phase|Death|0
1826502|NCT00377637|6331097|P2|Maintenance Phase|Death|0
1826503|NCT00377637|6331098|P1|Maintenance Phase|Death|0
1826504|NCT00377637|6331095|P4|Maintenance Phase|Study medication stopped > 14 days|1
1826505|NCT00377637|6331096|P3|Maintenance Phase|Study medication stopped > 14 days|0
1826506|NCT00377637|6331097|P2|Maintenance Phase|Study medication stopped > 14 days|0
1826507|NCT00377637|6331098|P1|Maintenance Phase|Study medication stopped > 14 days|0
1826508|NCT00377637|6331095|P4|Maintenance Phase|Non-compliance|1
1826509|NCT00377637|6331096|P3|Maintenance Phase|Non-compliance|1
1826510|NCT00377637|6331097|P2|Maintenance Phase|Non-compliance|0
1826511|NCT00377637|6331098|P1|Maintenance Phase|Non-compliance|0
1826512|NCT00377637|6331095|P4|Maintenance Phase|Sponsor decision|3
1826513|NCT00377637|6331096|P3|Maintenance Phase|Sponsor decision|2
1826514|NCT00377637|6331097|P2|Maintenance Phase|Sponsor decision|0
1826515|NCT00377637|6331098|P1|Maintenance Phase|Sponsor decision|0
1826516|NCT00377637|6331095|P4|Maintenance Phase|Withdrawal by Subject|3
1826517|NCT00377637|6331096|P3|Maintenance Phase|Withdrawal by Subject|3
1826518|NCT00377637|6331097|P2|Maintenance Phase|Withdrawal by Subject|0
1826519|NCT00377637|6331098|P1|Maintenance Phase|Withdrawal by Subject|0
1826520|NCT00377637|6331095|P4|Maintenance Phase|Lost to Follow-up|1
1826521|NCT00377637|6331096|P3|Maintenance Phase|Lost to Follow-up|3
1826522|NCT00377637|6331097|P2|Maintenance Phase|Lost to Follow-up|0
1826523|NCT00377637|6331098|P1|Maintenance Phase|Lost to Follow-up|0
1826524|NCT00377637|6331095|P4|Maintenance Phase|Physician Decision|4
1826525|NCT00377637|6331096|P3|Maintenance Phase|Physician Decision|5
1826526|NCT00377637|6331097|P2|Maintenance Phase|Physician Decision|0
1826527|NCT00377637|6331098|P1|Maintenance Phase|Physician Decision|0
1826528|NCT00377637|6331095|P4|Maintenance Phase|Adverse Event|43
1826529|NCT00377637|6331096|P3|Maintenance Phase|Adverse Event|29
1826530|NCT00377637|6331097|P2|Maintenance Phase|Adverse Event|0
1826531|NCT00377637|6331098|P1|Maintenance Phase|Adverse Event|0
1826532|NCT00377637|6331095|P4|Induction Phase|Reason for withdrawal is not noted|0
1826533|NCT00377637|6331096|P3|Induction Phase|Reason for withdrawal is not noted|0
1826534|NCT00377637|6331097|P2|Induction Phase|Reason for withdrawal is not noted|0
1826535|NCT00377637|6331098|P1|Induction Phase|Reason for withdrawal is not noted|2
1826536|NCT00377637|6331095|P4|Induction Phase|Non-Compliance|0
1826537|NCT00377637|6331096|P3|Induction Phase|Non-Compliance|0
1826538|NCT00377637|6331097|P2|Induction Phase|Non-Compliance|0
1826539|NCT00377637|6331098|P1|Induction Phase|Non-Compliance|1
1826540|NCT00377637|6331095|P4|Induction Phase|Sponsor decision|0
1826541|NCT00377637|6331096|P3|Induction Phase|Sponsor decision|0
1826542|NCT00377637|6331097|P2|Induction Phase|Sponsor decision|2
1826543|NCT00377637|6331098|P1|Induction Phase|Sponsor decision|1
1826544|NCT00377637|6331095|P4|Induction Phase|Physician Decision|0
1826545|NCT00377637|6331096|P3|Induction Phase|Physician Decision|0
1826546|NCT00377637|6331097|P2|Induction Phase|Physician Decision|1
1826547|NCT00377637|6331098|P1|Induction Phase|Physician Decision|3
1826548|NCT00377637|6331095|P4|Induction Phase|Withdrawal by Subject|0
1826549|NCT00377637|6331096|P3|Induction Phase|Withdrawal by Subject|0
1826550|NCT00377637|6331097|P2|Induction Phase|Withdrawal by Subject|6
1826551|NCT00377637|6331098|P1|Induction Phase|Withdrawal by Subject|5
1826552|NCT00377637|6331095|P4|Induction Phase|Death|0
1826553|NCT00377637|6331096|P3|Induction Phase|Death|0
1826554|NCT00377637|6331097|P2|Induction Phase|Death|3
1826555|NCT00377637|6331098|P1|Induction Phase|Death|1
1826556|NCT00377637|6331095|P4|Induction Phase|Lost to Follow-up|0
1826557|NCT00377637|6331096|P3|Induction Phase|Lost to Follow-up|0
1826558|NCT00377637|6331097|P2|Induction Phase|Lost to Follow-up|1
1826559|NCT00377637|6331098|P1|Induction Phase|Lost to Follow-up|2
1826560|NCT00377637|6331095|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1826561|NCT00377637|6331096|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1826562|NCT00377637|6331097|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
1826563|NCT00377637|6331098|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
1826564|NCT00377637|6331095|P4|Induction Phase|Deterioration/serum creatinine|0
1826565|NCT00377637|6331096|P3|Induction Phase|Deterioration/serum creatinine|0
1826566|NCT00377637|6331097|P2|Induction Phase|Deterioration/serum creatinine|0
1826567|NCT00377637|6331098|P1|Induction Phase|Deterioration/serum creatinine|2
1826568|NCT00377637|6331095|P4|Induction Phase|Adverse Event|0
1826569|NCT00377637|6331096|P3|Induction Phase|Adverse Event|0
1826570|NCT00377637|6331097|P2|Induction Phase|Adverse Event|21
1826571|NCT00377637|6331098|P1|Induction Phase|Adverse Event|12
1826572|NCT00377611|6331134|P2|Overall Study|Other|3
1826573|NCT00377611|6331135|P1|Overall Study|Other|0
1826574|NCT00377611|6331134|P2|Overall Study|Lost to Follow-up|16
1826575|NCT00377611|6331135|P1|Overall Study|Lost to Follow-up|18
1826576|NCT00377611|6331134|P2|Overall Study|Withdrawal by Subject|5
1826577|NCT00377611|6331135|P1|Overall Study|Withdrawal by Subject|0
1826578|NCT00377611|6331134|P2|Overall Study|Protocol Violation|0
1826579|NCT00377611|6331135|P1|Overall Study|Protocol Violation|2
1826580|NCT00377611|6331134|P2|Overall Study|Adverse Event|9
1826581|NCT00377611|6331135|P1|Overall Study|Adverse Event|2
1826582|NCT00377520|6331237|P1|Overall Study|Ineligible (Prior radiation)|1
1826583|NCT00377455|6331242|P1|Overall Study|Withdrawal by Subject|1
1826584|NCT00377429|6331250|P1|Overall Study|Patient non-compliance|1
1826585|NCT00377429|6331250|P1|Overall Study|Physician Decision|1
1826586|NCT00377429|6331250|P1|Overall Study|Adverse Event|8
1826587|NCT00377429|6331250|P1|Overall Study|Withdrawal by Subject|5
1826588|NCT00377403|6331261|P2|Overall Study|Unable to contact for telephone intervie|7
1826589|NCT00377403|6331262|P1|Overall Study|Unable to contact for telephone intervie|4
1826590|NCT00377364|6331270|P2|Overall Study|Withdrawal by Subject|0
1826591|NCT00377364|6331271|P1|Overall Study|Withdrawal by Subject|1
1826592|NCT00377364|6331270|P2|Overall Study|Lost to Follow-up|0
1826593|NCT00377364|6331271|P1|Overall Study|Lost to Follow-up|1
1826594|NCT00377312|6331297|P2|Overall Study|Adverse Event|1
1826595|NCT00377312|6331298|P1|Overall Study|Adverse Event|1
1826596|NCT00377299|6331330|P2|Overall Study|Withdrawal by Subject|4
1826597|NCT00377299|6331331|P1|Overall Study|Withdrawal by Subject|5
1826598|NCT00377299|6331330|P2|Overall Study|Adverse Event|1
1826599|NCT00377299|6331331|P1|Overall Study|Adverse Event|0
1826600|NCT00377299|6331330|P2|Overall Study|Lost to Follow-up|19
1826601|NCT00377299|6331331|P1|Overall Study|Lost to Follow-up|14
1826602|NCT00377260|6331347|P2|Overall Study|Withdrawal by Subject|4
1826603|NCT00377260|6331348|P1|Overall Study|Withdrawal by Subject|2
1826604|NCT00377260|6331347|P2|Overall Study|Lost to Follow-up|1
1826605|NCT00377260|6331348|P1|Overall Study|Lost to Follow-up|0
1826606|NCT00377234|6331402|P2|Overall Study|Not assigned|2
1826607|NCT00377234|6331403|P1|Overall Study|Not assigned|3
1826608|NCT00377234|6331402|P2|Overall Study|Administrative|1
1826609|NCT00377234|6331403|P1|Overall Study|Administrative|2
1826610|NCT00377234|6331402|P2|Overall Study|Lost to Follow-up|2
1826611|NCT00377234|6331403|P1|Overall Study|Lost to Follow-up|4
1826612|NCT00377234|6331402|P2|Overall Study|Withdrawal by Subject|9
1826613|NCT00377234|6331403|P1|Overall Study|Withdrawal by Subject|11
1826614|NCT00377234|6331402|P2|Overall Study|Adverse Event|17
1826615|NCT00377234|6331403|P1|Overall Study|Adverse Event|14
1826616|NCT00377156|6331421|P2|Overall Study|Other|2
1826617|NCT00377156|6331422|P1|Overall Study|Other|5
1826618|NCT00377156|6331421|P2|Overall Study|Disability or language problem|1
1826619|NCT00377156|6331422|P1|Overall Study|Disability or language problem|0
1826620|NCT00377156|6331421|P2|Overall Study|Ineligible|1
1826621|NCT00377156|6331422|P1|Overall Study|Ineligible|0
1826622|NCT00377156|6331421|P2|Overall Study|Refused testing|1
1826623|NCT00377156|6331422|P1|Overall Study|Refused testing|0
1826624|NCT00377156|6331421|P2|Overall Study|Cancellation|0
1826625|NCT00377156|6331422|P1|Overall Study|Cancellation|1
1826626|NCT00377156|6331421|P2|Overall Study|Had follow-up <90 d|6
1826627|NCT00377156|6331422|P1|Overall Study|Had follow-up <90 d|3
1826628|NCT00377156|6331421|P2|Overall Study|Withdrawal by Subject|24
1826629|NCT00377156|6331422|P1|Overall Study|Withdrawal by Subject|16
1826630|NCT00377156|6331421|P2|Overall Study|Death|19
1826631|NCT00377156|6331422|P1|Overall Study|Death|23
1826632|NCT00376961|6331436|P2|Maintenance|Ineligible|3
1826633|NCT00376961|6331437|P1|Maintenance|Ineligible|0
1826634|NCT00376961|6331436|P2|Maintenance|Progression/relapse|18
1826635|NCT00376961|6331437|P1|Maintenance|Progression/relapse|0
1826636|NCT00376961|6331436|P2|Maintenance|Refusal Unrelated to Adverse Event|1
1826637|NCT00376961|6331437|P1|Maintenance|Refusal Unrelated to Adverse Event|0
1826638|NCT00376961|6331436|P2|Maintenance|Adverse Event|1
1826639|NCT00376961|6331437|P1|Maintenance|Adverse Event|0
1826640|NCT00376961|6331436|P2|Initial Registration|Ineligible|0
1826641|NCT00376961|6331437|P1|Initial Registration|Ineligible|3
1826642|NCT00376961|6331436|P2|Initial Registration|Progression/relapse|0
1826643|NCT00376961|6331437|P1|Initial Registration|Progression/relapse|1
1826644|NCT00376961|6331436|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
1826645|NCT00376961|6331437|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
1826646|NCT00376961|6331436|P2|Initial Registration|Adverse Event|0
1826647|NCT00376961|6331437|P1|Initial Registration|Adverse Event|1
1826650|NCT00376675|6331509|P2|Overall Study|Other Reason|7
1826651|NCT00376675|6331510|P1|Overall Study|Other Reason|1
1826652|NCT00376675|6331509|P2|Overall Study|Adverse Event|5
1826653|NCT00376675|6331510|P1|Overall Study|Adverse Event|10
1826654|NCT00376675|6331509|P2|Overall Study|Withdrawal by Subject|2
1826655|NCT00376675|6331510|P1|Overall Study|Withdrawal by Subject|9
1826656|NCT00376532|6331559|P2|Overall Study|Lack sufficient blood sample|6
1826657|NCT00376532|6331560|P1|Overall Study|Lack sufficient blood sample|6
1826658|NCT00376506|6331570|P2|Overall Study|Death|2
1826659|NCT00376506|6331571|P1|Overall Study|Death|0
1826660|NCT00376259|6331602|P2|Overall Study|Patient request|0
1826661|NCT00376259|6331603|P1|Overall Study|Patient request|1
1826662|NCT00376259|6331602|P2|Overall Study|Sponsor request - study termination|21
1826663|NCT00376259|6331603|P1|Overall Study|Sponsor request - study termination|21
1826664|NCT00376246|6331615|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
1826665|NCT00376246|6331616|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
1826666|NCT00376246|6331615|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
1826667|NCT00376246|6331616|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
1826668|NCT00376246|6331615|P2|First Intervention (2 Weeks)|Adverse Event|0
1826669|NCT00376246|6331616|P1|First Intervention (2 Weeks)|Adverse Event|2
1826670|NCT00376220|6331626|P2|Overall Study|Withdrawal by Subject|2
1826671|NCT00376220|6331627|P1|Overall Study|Withdrawal by Subject|3
1826672|NCT00376220|6331626|P2|Overall Study|Lost to Follow-up|10
1826673|NCT00376220|6331627|P1|Overall Study|Lost to Follow-up|7
1826674|NCT00376168|6331635|P2|Overall Study|Pregnancy|0
1826675|NCT00376168|6331636|P1|Overall Study|Pregnancy|1
1826676|NCT00376168|6331635|P2|Overall Study|Adverse Event|1
1826677|NCT00376168|6331636|P1|Overall Study|Adverse Event|1
1826678|NCT00375934|6331677|P2|Overall Study|Physician Decision|1
1826679|NCT00375934|6331678|P1|Overall Study|Physician Decision|0
1826680|NCT00375934|6331677|P2|Overall Study|Lack of Efficacy|2
1826681|NCT00375934|6331678|P1|Overall Study|Lack of Efficacy|0
1826682|NCT00375934|6331677|P2|Overall Study|Withdrawal by Subject|2
1826683|NCT00375934|6331678|P1|Overall Study|Withdrawal by Subject|2
1826684|NCT00375934|6331677|P2|Overall Study|Adverse Event|1
1826685|NCT00375934|6331678|P1|Overall Study|Adverse Event|1
1826686|NCT00375752|6331736|P2|Overall Study|Administrative Problems|1
1826687|NCT00375752|6331737|P1|Overall Study|Administrative Problems|0
1826688|NCT00375752|6331736|P2|Overall Study|Protocol Violation|2
1826689|NCT00375752|6331737|P1|Overall Study|Protocol Violation|0
1826690|NCT00375752|6331736|P2|Overall Study|Abnormal Laboratory Value(s)|1
1826691|NCT00375752|6331737|P1|Overall Study|Abnormal Laboratory Value(s)|1
1826692|NCT00375752|6331736|P2|Overall Study|Withdrawal by Subject|1
1826693|NCT00375752|6331737|P1|Overall Study|Withdrawal by Subject|6
1826694|NCT00375752|6331736|P2|Overall Study|Adverse Event|6
1826695|NCT00375752|6331737|P1|Overall Study|Adverse Event|1
1826696|NCT00375752|6331736|P2|Overall Study|Lack of Efficacy|4
1826697|NCT00375752|6331737|P1|Overall Study|Lack of Efficacy|4
1826698|NCT00375674|6331768|P2|Overall Study|Enrolled but not treated|2
1826699|NCT00375674|6331769|P1|Overall Study|Enrolled but not treated|3
1826700|NCT00375674|6331768|P2|Overall Study|Lost to Follow-up|15
1826701|NCT00375674|6331769|P1|Overall Study|Lost to Follow-up|17
1826702|NCT00375674|6331768|P2|Overall Study|Participants refused further follow-up|30
1826703|NCT00375674|6331769|P1|Overall Study|Participants refused further follow-up|31
1826704|NCT00375674|6331768|P2|Overall Study|Death|76
1826705|NCT00375674|6331769|P1|Overall Study|Death|67
1826706|NCT00375674|6331768|P2|Overall Study|Other|18
1826707|NCT00375674|6331769|P1|Overall Study|Other|26
1826708|NCT00375609|6331798|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
1826709|NCT00375609|6331799|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
1826710|NCT00375609|6331800|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
1826711|NCT00375609|6331798|P3|Overall Study|Withdrawal by Subject|0
1826712|NCT00375609|6331799|P2|Overall Study|Withdrawal by Subject|4
1826713|NCT00375609|6331800|P1|Overall Study|Withdrawal by Subject|1
1826714|NCT00375609|6331798|P3|Overall Study|Physician Decision|1
1826715|NCT00375609|6331799|P2|Overall Study|Physician Decision|0
1826716|NCT00375609|6331800|P1|Overall Study|Physician Decision|0
1826717|NCT00375609|6331798|P3|Overall Study|Lost to Follow-up|0
1826718|NCT00375609|6331799|P2|Overall Study|Lost to Follow-up|0
1826719|NCT00375609|6331800|P1|Overall Study|Lost to Follow-up|1
1826720|NCT00375609|6331798|P3|Overall Study|Adverse Event|0
1826721|NCT00375609|6331799|P2|Overall Study|Adverse Event|3
1826722|NCT00375609|6331800|P1|Overall Study|Adverse Event|0
1826723|NCT00375609|6331798|P3|Overall Study|Did not receive treatment|0
1826724|NCT00375609|6331799|P2|Overall Study|Did not receive treatment|0
1826725|NCT00375609|6331800|P1|Overall Study|Did not receive treatment|1
1826726|NCT00375518|6331816|P2|Overall Study|Death|1
1826727|NCT00375518|6331817|P1|Overall Study|Death|0
1826728|NCT00375518|6331816|P2|Overall Study|Patient Not Treated|6
1826729|NCT00375518|6331817|P1|Overall Study|Patient Not Treated|6
1826730|NCT00375518|6331816|P2|Overall Study|Withdrawal by Subject|10
1826731|NCT00375518|6331817|P1|Overall Study|Withdrawal by Subject|2
1826732|NCT00375505|6331825|P2|Overall Study|Adverse Event|2
1826733|NCT00375505|6331826|P1|Overall Study|Adverse Event|1
1826734|NCT00375492|6331870|P2|Overall Study|Withdrawal by Subject|6
1826735|NCT00375492|6331871|P1|Overall Study|Withdrawal by Subject|6
1826736|NCT00375492|6331870|P2|Overall Study|Sponsor Decision|1
1826737|NCT00375492|6331871|P1|Overall Study|Sponsor Decision|0
1826738|NCT00375492|6331870|P2|Overall Study|Protocol Violation|3
1826739|NCT00375492|6331871|P1|Overall Study|Protocol Violation|6
1826740|NCT00375492|6331870|P2|Overall Study|Physician Decision|4
1826741|NCT00375492|6331871|P1|Overall Study|Physician Decision|0
1826742|NCT00375492|6331870|P2|Overall Study|Lost to Follow-up|5
1826743|NCT00375492|6331871|P1|Overall Study|Lost to Follow-up|10
1826744|NCT00375492|6331870|P2|Overall Study|Loss of Glucose Control|1
1826745|NCT00375492|6331871|P1|Overall Study|Loss of Glucose Control|0
1826746|NCT00375492|6331870|P2|Overall Study|Entry Criteria Not Met|1
1826747|NCT00375492|6331871|P1|Overall Study|Entry Criteria Not Met|0
1826748|NCT00375492|6331870|P2|Overall Study|Adverse Event|5
1826749|NCT00375492|6331871|P1|Overall Study|Adverse Event|4
1826750|NCT00375427|6331901|P2|Overall Study|Death|10
1826751|NCT00375427|6331902|P1|Overall Study|Death|11
1826752|NCT00375427|6331901|P2|Overall Study|Administrative reasons|1
1826753|NCT00375427|6331902|P1|Overall Study|Administrative reasons|0
1826754|NCT00375427|6331901|P2|Overall Study|Lost to Follow-up|1
1826755|NCT00375427|6331902|P1|Overall Study|Lost to Follow-up|1
1826756|NCT00375427|6331901|P2|Overall Study|Withdrawal by Subject|13
1826757|NCT00375427|6331902|P1|Overall Study|Withdrawal by Subject|9
1826758|NCT00375427|6331901|P2|Overall Study|Protocol Violation|8
1826759|NCT00375427|6331902|P1|Overall Study|Protocol Violation|10
1826760|NCT00375427|6331901|P2|Overall Study|Patient no longer requires study drug|7
1826761|NCT00375427|6331902|P1|Overall Study|Patient no longer requires study drug|3
1826762|NCT00375427|6331901|P2|Overall Study|Unsatisfactory therapeutic effect|4
1826763|NCT00375427|6331902|P1|Overall Study|Unsatisfactory therapeutic effect|4
1826764|NCT00375427|6331901|P2|Overall Study|Abnormal laboratory value(s)|2
1826765|NCT00375427|6331902|P1|Overall Study|Abnormal laboratory value(s)|1
1826766|NCT00375427|6331901|P2|Overall Study|Abnormal test procedure result(s)|1
1826767|NCT00375427|6331902|P1|Overall Study|Abnormal test procedure result(s)|0
1826768|NCT00375427|6331901|P2|Overall Study|Adverse Event|27
1826769|NCT00375427|6331902|P1|Overall Study|Adverse Event|21
1826770|NCT00375219|6331927|P3|Overall Study|Withdrawal by Subject|0
1826771|NCT00375219|6331928|P2|Overall Study|Withdrawal by Subject|0
1826772|NCT00375219|6331929|P1|Overall Study|Withdrawal by Subject|1
1826773|NCT00375219|6331927|P3|Overall Study|Cord blood transplantation|0
1826774|NCT00375219|6331928|P2|Overall Study|Cord blood transplantation|0
1826775|NCT00375219|6331929|P1|Overall Study|Cord blood transplantation|1
1826776|NCT00375219|6331927|P3|Overall Study|Allograft|0
1826777|NCT00375219|6331928|P2|Overall Study|Allograft|0
1826778|NCT00375219|6331929|P1|Overall Study|Allograft|2
1826779|NCT00375219|6331927|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
1826780|NCT00375219|6331928|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
1826781|NCT00375219|6331929|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
1826782|NCT00375219|6331927|P3|Overall Study|Hematologic resistance|0
1826783|NCT00375219|6331928|P2|Overall Study|Hematologic resistance|0
1826784|NCT00375219|6331929|P1|Overall Study|Hematologic resistance|1
1826785|NCT00375219|6331927|P3|Overall Study|Death|7
1826786|NCT00375219|6331928|P2|Overall Study|Death|3
1826787|NCT00375219|6331929|P1|Overall Study|Death|4
1826788|NCT00375219|6331927|P3|Overall Study|Disease progression|12
1826789|NCT00375219|6331928|P2|Overall Study|Disease progression|9
1826790|NCT00375219|6331929|P1|Overall Study|Disease progression|18
1826791|NCT00375219|6331927|P3|Overall Study|Lost to Follow-up|0
1826792|NCT00375219|6331928|P2|Overall Study|Lost to Follow-up|1
1826793|NCT00375219|6331929|P1|Overall Study|Lost to Follow-up|1
1826794|NCT00375219|6331927|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
1826795|NCT00375219|6331928|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
1826796|NCT00375219|6331929|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
1826797|NCT00375219|6331927|P3|Overall Study|Protocol Violation|1
1826798|NCT00375219|6331928|P2|Overall Study|Protocol Violation|0
1826799|NCT00375219|6331929|P1|Overall Study|Protocol Violation|1
1826800|NCT00375219|6331927|P3|Overall Study|Adverse Event|1
1826801|NCT00375219|6331928|P2|Overall Study|Adverse Event|2
1826802|NCT00375219|6331929|P1|Overall Study|Adverse Event|8
1826803|NCT00375219|6331927|P3|Overall Study|Failure to achieve a response|0
1826804|NCT00375219|6331928|P2|Overall Study|Failure to achieve a response|2
1826805|NCT00375219|6331929|P1|Overall Study|Failure to achieve a response|16
1826806|NCT00374907|6332012|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1826807|NCT00374907|6332013|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
1826808|NCT00374907|6332012|P2|116-Week Short-term + Long-term Period|Adverse Event|2
1826809|NCT00374907|6332013|P1|116-Week Short-term + Long-term Period|Adverse Event|0
1826810|NCT00374907|6332012|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
1826811|NCT00374907|6332013|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
1826812|NCT00374907|6332012|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
1826813|NCT00374907|6332013|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
1826814|NCT00374907|6332012|P2|12-Week Short-term Period|Subject Withdrew Consent|1
1826815|NCT00374907|6332013|P1|12-Week Short-term Period|Subject Withdrew Consent|3
1826816|NCT00374868|6332025|P1|Overall Study|Other - Not Specified|1
1826817|NCT00374868|6332025|P1|Overall Study|Death|2
1826818|NCT00374868|6332025|P1|Overall Study|Lost to Follow-up|1
1826819|NCT00374868|6332025|P1|Overall Study|Physician Decision|13
1826820|NCT00374868|6332025|P1|Overall Study|Progressive Disease|7
1826821|NCT00374868|6332025|P1|Overall Study|Adverse Event|12
1826822|NCT00374556|6332089|P2|Overall Study|Removed at baseline due to medical cond|1
1826823|NCT00374556|6332090|P1|Overall Study|Removed at baseline due to medical cond|0
1826824|NCT00374556|6332089|P2|Overall Study|Lost to Follow-up|0
1826825|NCT00374556|6332090|P1|Overall Study|Lost to Follow-up|1
1826826|NCT00374452|6332151|P2|Overall Study|Withdrawal by Subject|2
1826827|NCT00374452|6332152|P1|Overall Study|Withdrawal by Subject|0
1826828|NCT00374452|6332151|P2|Overall Study|Left clinic after intervention started|1
1826829|NCT00374452|6332152|P1|Overall Study|Left clinic after intervention started|1
1826830|NCT00374452|6332151|P2|Overall Study|Change in job role before intervention|1
1826831|NCT00374452|6332152|P1|Overall Study|Change in job role before intervention|0
1826832|NCT00374452|6332151|P2|Overall Study|Left clinic before intervention started|1
1826833|NCT00374452|6332152|P1|Overall Study|Left clinic before intervention started|4
1826834|NCT00374322|6332165|P2|Overall Study|Did Not Receive Study Medication|6
1826835|NCT00374322|6332166|P1|Overall Study|Did Not Receive Study Medication|8
1826836|NCT00374322|6332165|P2|Overall Study|Withdrew Consent During Follow-up|5
1826837|NCT00374322|6332166|P1|Overall Study|Withdrew Consent During Follow-up|0
1826838|NCT00374322|6332165|P2|Overall Study|Noncompliance with Study Requirements|1
1826839|NCT00374322|6332166|P1|Overall Study|Noncompliance with Study Requirements|0
1826840|NCT00374322|6332165|P2|Overall Study|Started Another Chemotherapy Regimen|1
1826841|NCT00374322|6332166|P1|Overall Study|Started Another Chemotherapy Regimen|0
1826842|NCT00374322|6332165|P2|Overall Study|Participant Changed Physician|0
1826843|NCT00374322|6332166|P1|Overall Study|Participant Changed Physician|1
1826844|NCT00374322|6332165|P2|Overall Study|Site Closed|2
1826845|NCT00374322|6332166|P1|Overall Study|Site Closed|2
1826846|NCT00374322|6332165|P2|Overall Study|Severe Toxicity|0
1826847|NCT00374322|6332166|P1|Overall Study|Severe Toxicity|1
1826848|NCT00374322|6332165|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
1826849|NCT00374322|6332166|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
1826850|NCT00374322|6332165|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
1826851|NCT00374322|6332166|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
1826852|NCT00374322|6332165|P2|Overall Study|Sponsor Decision|3
1826853|NCT00374322|6332166|P1|Overall Study|Sponsor Decision|2
1826854|NCT00374322|6332165|P2|Overall Study|Par. Consented to Survival FU Only|1
1826855|NCT00374322|6332166|P1|Overall Study|Par. Consented to Survival FU Only|3
1826856|NCT00374322|6332165|P2|Overall Study|Physician Decision|32
1826857|NCT00374322|6332166|P1|Overall Study|Physician Decision|36
1826858|NCT00374322|6332165|P2|Overall Study|Sponsor Terminated Study|990
1826859|NCT00374322|6332166|P1|Overall Study|Sponsor Terminated Study|866
1826860|NCT00374322|6332165|P2|Overall Study|Withdrawal by Subject|167
1826861|NCT00374322|6332166|P1|Overall Study|Withdrawal by Subject|235
1826862|NCT00374322|6332165|P2|Overall Study|Protocol Violation|3
1826863|NCT00374322|6332166|P1|Overall Study|Protocol Violation|8
1826864|NCT00374322|6332165|P2|Overall Study|Lost to Follow-up|90
1826865|NCT00374322|6332166|P1|Overall Study|Lost to Follow-up|92
1826866|NCT00374140|6332257|P1|Overall Study|Protocol Violation|1
1826867|NCT00374140|6332257|P1|Overall Study|Lost to Follow-up|1
1826868|NCT00374127|6332264|P1|Overall Study|Pregnancy|1
1826869|NCT00374127|6332264|P1|Overall Study|Protocol Violation|5
1826870|NCT00374127|6332264|P1|Overall Study|Blood could not be drawn.|2
1826871|NCT00374127|6332264|P1|Overall Study|Did not inhale during smoking procedure.|3
1826872|NCT00373958|6332313|P2|Toddler Dose|Withdrawn after infant series|25
1826873|NCT00373958|6332314|P1|Toddler Dose|Withdrawn after infant series|22
1826874|NCT00373958|6332313|P2|Toddler Dose|Protocol Violation|1
1826875|NCT00373958|6332314|P1|Toddler Dose|Protocol Violation|0
1826876|NCT00373958|6332313|P2|Toddler Dose|Failed to return|2
1826877|NCT00373958|6332314|P1|Toddler Dose|Failed to return|1
1826878|NCT00373958|6332313|P2|Toddler Dose|Withdrawal by Subject|2
1826879|NCT00373958|6332314|P1|Toddler Dose|Withdrawal by Subject|2
1826880|NCT00373958|6332313|P2|Toddler Dose|Lost to Follow-up|8
1826881|NCT00373958|6332314|P1|Toddler Dose|Lost to Follow-up|5
1826882|NCT00373958|6332313|P2|Infant Series|Physician Decision|1
1826883|NCT00373958|6332314|P1|Infant Series|Physician Decision|1
1826884|NCT00373958|6332313|P2|Infant Series|Adverse Event|1
1826885|NCT00373958|6332314|P1|Infant Series|Adverse Event|3
1826886|NCT00373958|6332313|P2|Infant Series|Consent was not received|0
1826887|NCT00373958|6332314|P1|Infant Series|Consent was not received|1
1826888|NCT00373958|6332313|P2|Infant Series|Child relocated|0
1826889|NCT00373958|6332314|P1|Infant Series|Child relocated|1
1826890|NCT00373958|6332313|P2|Infant Series|Lost Kaiser coverage|0
1826891|NCT00373958|6332314|P1|Infant Series|Lost Kaiser coverage|4
1826892|NCT00373958|6332313|P2|Infant Series|Protocol Violation|7
1826893|NCT00373958|6332314|P1|Infant Series|Protocol Violation|3
1826894|NCT00373958|6332313|P2|Infant Series|Lost to Follow-up|5
1826895|NCT00373958|6332314|P1|Infant Series|Lost to Follow-up|6
1826896|NCT00373958|6332313|P2|Infant Series|Failed to return|13
1826897|NCT00373958|6332314|P1|Infant Series|Failed to return|8
1826898|NCT00373958|6332313|P2|Infant Series|Withdrawal by Subject|15
1826899|NCT00373958|6332314|P1|Infant Series|Withdrawal by Subject|13
1826900|NCT00373880|6332362|P1|Overall Study|Protocol Violation|14
1826901|NCT00373880|6332362|P1|Overall Study|Arrested|1
1826902|NCT00373880|6332362|P1|Overall Study|Physician Decision|3
1826903|NCT00373685|6332407|P2|Overall Study|Randomized, not treated|77
1826904|NCT00373685|6332408|P1|Overall Study|Randomized, not treated|51
1826905|NCT00373685|6332407|P2|Overall Study|Final Status Unknown|4
1826906|NCT00373685|6332408|P1|Overall Study|Final Status Unknown|12
1826907|NCT00373685|6332407|P2|Overall Study|Protocol Violation|182
1826908|NCT00373685|6332408|P1|Overall Study|Protocol Violation|191
1826909|NCT00373685|6332407|P2|Overall Study|Other|146
1826910|NCT00373685|6332408|P1|Overall Study|Other|149
1826911|NCT00373685|6332407|P2|Overall Study|No longer willing to participate|352
1826912|NCT00373685|6332408|P1|Overall Study|No longer willing to participate|337
1826913|NCT00373685|6332407|P2|Overall Study|Lost to follow up|103
1826914|NCT00373685|6332408|P1|Overall Study|Lost to follow up|83
1826915|NCT00373685|6332407|P2|Overall Study|Did not meet entrance criteria|184
1826916|NCT00373685|6332408|P1|Overall Study|Did not meet entrance criteria|167
1826917|NCT00373685|6332407|P2|Overall Study|Insufficient clinical response|119
1826918|NCT00373685|6332408|P1|Overall Study|Insufficient clinical response|169
1826919|NCT00373685|6332407|P2|Overall Study|Adverse Event|253
1826920|NCT00373685|6332408|P1|Overall Study|Adverse Event|278
1826921|NCT00373685|6332407|P2|Overall Study|Death|1
1826922|NCT00373685|6332408|P1|Overall Study|Death|2
1826923|NCT00373529|6332442|P1|Overall Study|Consent violation|1
1826924|NCT00373529|6332442|P1|Overall Study|Failed independent confirmation of AML|3
1826925|NCT00373529|6332442|P1|Overall Study|Other|8
1826926|NCT00373529|6332442|P1|Overall Study|Need for treatment prohibited by study|1
1826927|NCT00373529|6332442|P1|Overall Study|Death|16
1826928|NCT00373529|6332442|P1|Overall Study|Disease recurrence|10
1826929|NCT00373529|6332442|P1|Overall Study|Treatment failure|36
1826930|NCT00373529|6332442|P1|Overall Study|Adverse Event|7
1826931|NCT00373529|6332442|P1|Overall Study|Withdrawal by Subject|7
1826932|NCT00373529|6332442|P1|Overall Study|Physician Decision|19
1826933|NCT00373490|6332454|P2|Overall Study|Withdrawal by Subject|1
1826934|NCT00373490|6332455|P1|Overall Study|Withdrawal by Subject|0
1826935|NCT00373490|6332454|P2|Overall Study|Lack of Efficacy|4
1826936|NCT00373490|6332455|P1|Overall Study|Lack of Efficacy|9
1826937|NCT00373490|6332454|P2|Overall Study|Adverse Event|1
1826938|NCT00373490|6332455|P1|Overall Study|Adverse Event|0
1826939|NCT00373425|6332478|P5|Overall Study|Death|0
1826940|NCT00373425|6332479|P4|Overall Study|Death|1
1826941|NCT00373425|6332480|P3|Overall Study|Death|3
1826942|NCT00373425|6332481|P2|Overall Study|Death|0
1826943|NCT00373425|6332482|P1|Overall Study|Death|7
1826944|NCT00373425|6332478|P5|Overall Study|Medical/ethical/noncompliance reason|5
1826945|NCT00373425|6332479|P4|Overall Study|Medical/ethical/noncompliance reason|2
1826946|NCT00373425|6332480|P3|Overall Study|Medical/ethical/noncompliance reason|10
1826947|NCT00373425|6332481|P2|Overall Study|Medical/ethical/noncompliance reason|9
1826948|NCT00373425|6332482|P1|Overall Study|Medical/ethical/noncompliance reason|21
1826949|NCT00373425|6332478|P5|Overall Study|Patient request|7
1826950|NCT00373425|6332479|P4|Overall Study|Patient request|6
1826951|NCT00373425|6332480|P3|Overall Study|Patient request|43
1826952|NCT00373425|6332481|P2|Overall Study|Patient request|18
1826953|NCT00373425|6332482|P1|Overall Study|Patient request|35
1826954|NCT00373425|6332478|P5|Overall Study|Adverse Event|34
1826955|NCT00373425|6332479|P4|Overall Study|Adverse Event|0
1826956|NCT00373425|6332480|P3|Overall Study|Adverse Event|59
1826957|NCT00373425|6332481|P2|Overall Study|Adverse Event|22
1826958|NCT00373425|6332482|P1|Overall Study|Adverse Event|191
1826959|NCT00373425|6332478|P5|Overall Study|Relapse of NSCLC|26
1826960|NCT00373425|6332479|P4|Overall Study|Relapse of NSCLC|2
1826961|NCT00373425|6332480|P3|Overall Study|Relapse of NSCLC|19
1826962|NCT00373425|6332481|P2|Overall Study|Relapse of NSCLC|104
1826963|NCT00373425|6332482|P1|Overall Study|Relapse of NSCLC|116
1826964|NCT00373295|6332577|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
1826965|NCT00373295|6332578|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
1826966|NCT00373295|6332579|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
1826967|NCT00373295|6332580|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
1826968|NCT00373295|6332581|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
1826969|NCT00373295|6332582|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
1826970|NCT00373256|6332603|P2|Overall Study|Study Terminated by Sponsor|13
1826971|NCT00373256|6332604|P1|Overall Study|Study Terminated by Sponsor|41
1826972|NCT00373256|6332603|P2|Overall Study|Protocol Violation|2
1826973|NCT00373256|6332604|P1|Overall Study|Protocol Violation|0
1826974|NCT00373256|6332603|P2|Overall Study|Other|107
1826975|NCT00373256|6332604|P1|Overall Study|Other|73
1826976|NCT00373256|6332603|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
1826977|NCT00373256|6332604|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
1826978|NCT00373256|6332603|P2|Overall Study|Objective Progression or Relapse|104
1826979|NCT00373256|6332604|P1|Overall Study|Objective Progression or Relapse|111
1826980|NCT00373256|6332603|P2|Overall Study|Death|8
1826981|NCT00373256|6332604|P1|Overall Study|Death|9
1826982|NCT00373256|6332603|P2|Overall Study|Lost to Follow-up|1
1826983|NCT00373256|6332604|P1|Overall Study|Lost to Follow-up|2
1826984|NCT00373256|6332603|P2|Overall Study|Adverse Event (AE)|5
1826985|NCT00373256|6332604|P1|Overall Study|Adverse Event (AE)|1
1826986|NCT00373113|6332630|P2|Overall Study|Withdrawal by Subject|15
1826987|NCT00373113|6332631|P1|Overall Study|Withdrawal by Subject|10
1826988|NCT00373113|6332630|P2|Overall Study|Protocol Violation|1
1826989|NCT00373113|6332631|P1|Overall Study|Protocol Violation|5
1826990|NCT00373113|6332630|P2|Overall Study|Other|17
1826991|NCT00373113|6332631|P1|Overall Study|Other|14
1826992|NCT00373113|6332630|P2|Overall Study|Objective progression or relapse|169
1826993|NCT00373113|6332631|P1|Overall Study|Objective progression or relapse|150
1826994|NCT00373113|6332630|P2|Overall Study|Lost to Follow-up|3
1826995|NCT00373113|6332631|P1|Overall Study|Lost to Follow-up|1
1826996|NCT00373113|6332630|P2|Overall Study|Global deterioration of health status|7
1826997|NCT00373113|6332631|P1|Overall Study|Global deterioration of health status|10
1826998|NCT00373113|6332630|P2|Overall Study|Study terminated by sponsor|1
1826999|NCT00373113|6332631|P1|Overall Study|Study terminated by sponsor|9
1827000|NCT00373113|6332630|P2|Overall Study|Adverse Event|24
1827001|NCT00373113|6332631|P1|Overall Study|Adverse Event|38
1827002|NCT00373113|6332630|P2|Overall Study|Death|7
1827003|NCT00373113|6332631|P1|Overall Study|Death|1
1827004|NCT00372996|6332653|P4|Overall Study|Other|7
1827005|NCT00372996|6332654|P3|Overall Study|Other|7
1827006|NCT00372996|6332655|P2|Overall Study|Other|2
1827007|NCT00372996|6332656|P1|Overall Study|Other|10
1827008|NCT00372996|6332653|P4|Overall Study|Study Terminated by Sponsor|0
1827009|NCT00372996|6332654|P3|Overall Study|Study Terminated by Sponsor|4
1827010|NCT00372996|6332655|P2|Overall Study|Study Terminated by Sponsor|0
1827011|NCT00372996|6332656|P1|Overall Study|Study Terminated by Sponsor|4
1827012|NCT00372996|6332653|P4|Overall Study|Withdrawal by Subject|5
1827013|NCT00372996|6332654|P3|Overall Study|Withdrawal by Subject|9
1827014|NCT00372996|6332655|P2|Overall Study|Withdrawal by Subject|6
1827015|NCT00372996|6332656|P1|Overall Study|Withdrawal by Subject|12
1827016|NCT00372996|6332653|P4|Overall Study|Lost to Follow-up|1
1827017|NCT00372996|6332654|P3|Overall Study|Lost to Follow-up|0
1827018|NCT00372996|6332655|P2|Overall Study|Lost to Follow-up|2
1827019|NCT00372996|6332656|P1|Overall Study|Lost to Follow-up|0
1827020|NCT00372996|6332653|P4|Overall Study|Death|7
1827021|NCT00372996|6332654|P3|Overall Study|Death|8
1827022|NCT00372996|6332655|P2|Overall Study|Death|4
1827023|NCT00372996|6332656|P1|Overall Study|Death|11
1827024|NCT00372905|6332741|P4|Follow up Until Relapse or Progression|Other|0
1827025|NCT00372905|6332742|P3|Follow up Until Relapse or Progression|Other|0
1827026|NCT00372905|6332743|P2|Follow up Until Relapse or Progression|Other|1
1827027|NCT00372905|6332744|P1|Follow up Until Relapse or Progression|Other|0
1827028|NCT00372905|6332741|P4|Follow up Until Relapse or Progression|Study closed|3
1827029|NCT00372905|6332742|P3|Follow up Until Relapse or Progression|Study closed|0
1827030|NCT00372905|6332743|P2|Follow up Until Relapse or Progression|Study closed|0
1827031|NCT00372905|6332744|P1|Follow up Until Relapse or Progression|Study closed|0
1827032|NCT00372905|6332741|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
1827033|NCT00372905|6332742|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1827034|NCT00372905|6332743|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1827035|NCT00372905|6332744|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
1827036|NCT00372905|6332741|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1827037|NCT00372905|6332742|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
1827038|NCT00372905|6332743|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1827039|NCT00372905|6332744|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
1827040|NCT00372905|6332741|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1827041|NCT00372905|6332742|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
1827042|NCT00372905|6332743|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1827043|NCT00372905|6332744|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
1827044|NCT00372905|6332741|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1827045|NCT00372905|6332742|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1827046|NCT00372905|6332743|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
1827047|NCT00372905|6332744|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
1827048|NCT00372775|6332756|P1|Overall Study|Not Treated|2
1827049|NCT00372775|6332756|P1|Overall Study|Other|1
1827050|NCT00372775|6332756|P1|Overall Study|Withdrawal by Subject|1
1827051|NCT00372775|6332756|P1|Overall Study|Global deterioration of health status|6
1827052|NCT00372775|6332756|P1|Overall Study|Objective progression or relapse|30
1827053|NCT00372775|6332756|P1|Overall Study|Death|15
1827054|NCT00372775|6332756|P1|Overall Study|Adverse Event|8
1827055|NCT00372697|6332778|P2|Overall Study|Protocol Violation|1
1827056|NCT00372697|6332779|P1|Overall Study|Protocol Violation|1
1827057|NCT00372619|6332804|P7|Overall Study|Inevaluable|0
1827058|NCT00372619|6332805|P6|Overall Study|Inevaluable|1
1827059|NCT00372619|6332806|P5|Overall Study|Inevaluable|0
1827060|NCT00372619|6332807|P4|Overall Study|Inevaluable|0
1827061|NCT00372619|6332808|P3|Overall Study|Inevaluable|0
1827062|NCT00372619|6332809|P2|Overall Study|Inevaluable|0
1827063|NCT00372619|6332810|P1|Overall Study|Inevaluable|0
1827064|NCT00372619|6332804|P7|Overall Study|Ineligible|0
1827065|NCT00372619|6332805|P6|Overall Study|Ineligible|2
1827066|NCT00372619|6332806|P5|Overall Study|Ineligible|0
1827067|NCT00372619|6332807|P4|Overall Study|Ineligible|0
1827068|NCT00372619|6332808|P3|Overall Study|Ineligible|0
1827069|NCT00372619|6332809|P2|Overall Study|Ineligible|0
1827070|NCT00372619|6332810|P1|Overall Study|Ineligible|0
1827071|NCT00372593|6332843|P3|Overall Study|Ineligible|1
1827072|NCT00372593|6332844|P2|Overall Study|Ineligible|21
1827073|NCT00372593|6332845|P1|Overall Study|Ineligible|20
1827074|NCT00372593|6332843|P3|Overall Study|Physician Decision|0
1827075|NCT00372593|6332844|P2|Overall Study|Physician Decision|41
1827076|NCT00372593|6332845|P1|Overall Study|Physician Decision|42
1827077|NCT00372593|6332843|P3|Overall Study|Lost to Follow-up|0
1827078|NCT00372593|6332844|P2|Overall Study|Lost to Follow-up|0
1827079|NCT00372593|6332845|P1|Overall Study|Lost to Follow-up|1
1827080|NCT00372593|6332843|P3|Overall Study|Lack of Efficacy|2
1827081|NCT00372593|6332844|P2|Overall Study|Lack of Efficacy|71
1827082|NCT00372593|6332845|P1|Overall Study|Lack of Efficacy|82
1827083|NCT00372593|6332843|P3|Overall Study|Death|1
1827084|NCT00372593|6332844|P2|Overall Study|Death|20
1827085|NCT00372593|6332845|P1|Overall Study|Death|16
1827086|NCT00372593|6332843|P3|Overall Study|Adverse Event|0
1827087|NCT00372593|6332844|P2|Overall Study|Adverse Event|45
1827088|NCT00372593|6332845|P1|Overall Study|Adverse Event|43
1827089|NCT00372567|6332874|P3|Phase 3 Study|study terminated by sponsor|5
1827090|NCT00372567|6332875|P2|Phase 3 Study|study terminated by sponsor|8
1827091|NCT00372567|6332876|P1|Phase 3 Study|study terminated by sponsor|13
1827092|NCT00372567|6332874|P3|Phase 3 Study|Other|1
1827093|NCT00372567|6332875|P2|Phase 3 Study|Other|2
1827094|NCT00372567|6332876|P1|Phase 3 Study|Other|2
1827095|NCT00372567|6332874|P3|Phase 3 Study|Global deterioration of health status|0
1827096|NCT00372567|6332875|P2|Phase 3 Study|Global deterioration of health status|1
1827097|NCT00372567|6332876|P1|Phase 3 Study|Global deterioration of health status|0
1827098|NCT00372567|6332874|P3|Phase 3 Study|Objective progression or relapse|4
1827099|NCT00372567|6332875|P2|Phase 3 Study|Objective progression or relapse|13
1827100|NCT00372567|6332876|P1|Phase 3 Study|Objective progression or relapse|10
1827101|NCT00372567|6332874|P3|Phase 3 Study|Protocol Violation|1
1827102|NCT00372567|6332875|P2|Phase 3 Study|Protocol Violation|0
1827103|NCT00372567|6332876|P1|Phase 3 Study|Protocol Violation|0
1827104|NCT00372567|6332874|P3|Phase 3 Study|Death|0
1827105|NCT00372567|6332875|P2|Phase 3 Study|Death|1
1827106|NCT00372567|6332876|P1|Phase 3 Study|Death|1
1827107|NCT00372567|6332874|P3|Phase 3 Study|Adverse Event|1
1827108|NCT00372567|6332875|P2|Phase 3 Study|Adverse Event|1
1827109|NCT00372567|6332876|P1|Phase 3 Study|Adverse Event|5
1827110|NCT00372528|6332904|P1|Overall Study|Other|1
1827111|NCT00372528|6332904|P1|Overall Study|Study Terminated by Sponsor|18
1827112|NCT00372528|6332904|P1|Overall Study|Adverse Event|1
1827113|NCT00372528|6332904|P1|Overall Study|Lack of Efficacy|1
1827114|NCT00372489|6332909|P1|Overall Study|Sponsor Decision to Terminate Study|41
1827115|NCT00372489|6332909|P1|Overall Study|Renal transplant|6
1827116|NCT00372489|6332909|P1|Overall Study|Patient Relocation|2
1827117|NCT00372489|6332909|P1|Overall Study|Withdrawal by Subject|5
1827118|NCT00372489|6332909|P1|Overall Study|Physician Decision|3
1827119|NCT00372489|6332909|P1|Overall Study|Lost to Follow-up|3
1827120|NCT00372489|6332909|P1|Overall Study|Lack of Efficacy|1
1827121|NCT00372489|6332909|P1|Overall Study|Adverse Event|18
1827122|NCT00372424|6332913|P1|Overall Study|Enrolled, Not Treated|1
1827123|NCT00372424|6332913|P1|Overall Study|Other|7
1827124|NCT00372424|6332913|P1|Overall Study|Objective Progression or Relapse|14
1827125|NCT00372424|6332913|P1|Overall Study|Death|1
1827126|NCT00372424|6332913|P1|Overall Study|Withdrawal by Subject|1
1827127|NCT00372424|6332913|P1|Overall Study|Adverse Event|2
1827128|NCT00372411|6332927|P3|Overall Study|Adverse Event|0
1827129|NCT00372411|6332928|P2|Overall Study|Adverse Event|1
1827130|NCT00372411|6332929|P1|Overall Study|Adverse Event|1
1827131|NCT00372411|6332927|P3|Overall Study|Lost to Follow-up|1
1827132|NCT00372411|6332928|P2|Overall Study|Lost to Follow-up|1
1827133|NCT00372411|6332929|P1|Overall Study|Lost to Follow-up|1
1827134|NCT00372411|6332927|P3|Overall Study|Death|1
1827135|NCT00372411|6332928|P2|Overall Study|Death|2
1827136|NCT00372411|6332929|P1|Overall Study|Death|0
1827137|NCT00372411|6332927|P3|Overall Study|Withdrawal by Subject|1
1827138|NCT00372411|6332928|P2|Overall Study|Withdrawal by Subject|4
1827139|NCT00372411|6332929|P1|Overall Study|Withdrawal by Subject|3
1827140|NCT00372385|6332953|P4|Overall Study|Virologic Stopping Rule|0
1827141|NCT00372385|6332954|P3|Overall Study|Virologic Stopping Rule|0
1827142|NCT00372385|6332955|P2|Overall Study|Virologic Stopping Rule|0
1827143|NCT00372385|6332956|P1|Overall Study|Virologic Stopping Rule|17
1827144|NCT00372385|6332953|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
1827145|NCT00372385|6332954|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
1827146|NCT00372385|6332955|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
1827147|NCT00372385|6332956|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
1827148|NCT00372385|6332953|P4|Overall Study|No Response|0
1827149|NCT00372385|6332954|P3|Overall Study|No Response|0
1827150|NCT00372385|6332955|P2|Overall Study|No Response|1
1827151|NCT00372385|6332956|P1|Overall Study|No Response|1
1827152|NCT00372385|6332953|P4|Overall Study|Refusal of Treatment|0
1827153|NCT00372385|6332954|P3|Overall Study|Refusal of Treatment|0
1827154|NCT00372385|6332955|P2|Overall Study|Refusal of Treatment|6
1827155|NCT00372385|6332956|P1|Overall Study|Refusal of Treatment|3
1827156|NCT00372385|6332953|P4|Overall Study|Withdrawal by Subject|0
1827157|NCT00372385|6332954|P3|Overall Study|Withdrawal by Subject|0
1827158|NCT00372385|6332955|P2|Overall Study|Withdrawal by Subject|1
1827159|NCT00372385|6332956|P1|Overall Study|Withdrawal by Subject|2
1827160|NCT00372385|6332953|P4|Overall Study|Lost to Follow-up|0
1827161|NCT00372385|6332954|P3|Overall Study|Lost to Follow-up|0
1827162|NCT00372385|6332955|P2|Overall Study|Lost to Follow-up|0
1827163|NCT00372385|6332956|P1|Overall Study|Lost to Follow-up|2
1827164|NCT00372385|6332953|P4|Overall Study|Physician Decision|0
1827165|NCT00372385|6332954|P3|Overall Study|Physician Decision|0
1827166|NCT00372385|6332955|P2|Overall Study|Physician Decision|0
1827167|NCT00372385|6332956|P1|Overall Study|Physician Decision|1
1827168|NCT00372385|6332953|P4|Overall Study|Noncompliance|1
1827169|NCT00372385|6332954|P3|Overall Study|Noncompliance|1
1827170|NCT00372385|6332955|P2|Overall Study|Noncompliance|1
1827171|NCT00372385|6332956|P1|Overall Study|Noncompliance|0
1827172|NCT00372385|6332953|P4|Overall Study|Adverse Event|7
1827173|NCT00372385|6332954|P3|Overall Study|Adverse Event|9
1827174|NCT00372385|6332955|P2|Overall Study|Adverse Event|11
1827175|NCT00372385|6332956|P1|Overall Study|Adverse Event|6
1827176|NCT00372255|6332985|P2|Overall Study|Withdrawn for other reasons|1
1827177|NCT00372255|6332986|P1|Overall Study|Withdrawn for other reasons|2
1827178|NCT00372190|6333008|P2|Overall Study|Lost to Follow-up|1
1827179|NCT00372190|6333009|P1|Overall Study|Lost to Follow-up|3
1827180|NCT00372112|6333025|P4|Overall Study|Other-protocol violation|0
1827181|NCT00372112|6333026|P3|Overall Study|Other-protocol violation|1
1827182|NCT00372112|6333027|P2|Overall Study|Other-protocol violation|0
1827183|NCT00372112|6333028|P1|Overall Study|Other-protocol violation|0
1827184|NCT00372112|6333025|P4|Overall Study|Hepatitis B|0
1827185|NCT00372112|6333026|P3|Overall Study|Hepatitis B|0
1827186|NCT00372112|6333027|P2|Overall Study|Hepatitis B|0
1827187|NCT00372112|6333028|P1|Overall Study|Hepatitis B|1
1827188|NCT00372112|6333025|P4|Overall Study|PR >240 at Visit 3|1
1827189|NCT00372112|6333026|P3|Overall Study|PR >240 at Visit 3|0
1827190|NCT00372112|6333027|P2|Overall Study|PR >240 at Visit 3|0
1827191|NCT00372112|6333028|P1|Overall Study|PR >240 at Visit 3|0
1827192|NCT00372112|6333025|P4|Overall Study|Exacerbation|1
1827193|NCT00372112|6333026|P3|Overall Study|Exacerbation|0
1827194|NCT00372112|6333027|P2|Overall Study|Exacerbation|0
1827195|NCT00372112|6333028|P1|Overall Study|Exacerbation|0
1827196|NCT00372112|6333025|P4|Overall Study|Withdrawal by Subject|1
1827197|NCT00372112|6333026|P3|Overall Study|Withdrawal by Subject|2
1827198|NCT00372112|6333027|P2|Overall Study|Withdrawal by Subject|0
1827199|NCT00372112|6333028|P1|Overall Study|Withdrawal by Subject|0
1827200|NCT00372112|6333025|P4|Overall Study|Adverse Event|1
1827201|NCT00372112|6333026|P3|Overall Study|Adverse Event|1
1827202|NCT00372112|6333027|P2|Overall Study|Adverse Event|1
1827203|NCT00372112|6333028|P1|Overall Study|Adverse Event|0
1827204|NCT00372060|6333159|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
1827205|NCT00372060|6333160|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
1827206|NCT00372060|6333159|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
1827207|NCT00372060|6333160|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
1827208|NCT00372060|6333159|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
1827209|NCT00372060|6333160|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
1827210|NCT00372060|6333159|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
1827211|NCT00372060|6333160|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
1827212|NCT00372060|6333159|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
1827213|NCT00372060|6333160|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
1827214|NCT00372060|6333159|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
1827215|NCT00372060|6333160|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
1827216|NCT00371865|6333175|P2|Overall Study|Withdrawal by Subject|10
1827217|NCT00371865|6333176|P1|Overall Study|Withdrawal by Subject|12
1827218|NCT00371865|6333175|P2|Overall Study|Protocol Violation|2
1827219|NCT00371865|6333176|P1|Overall Study|Protocol Violation|3
1827220|NCT00371865|6333175|P2|Overall Study|Lack of Efficacy|2
1827221|NCT00371865|6333176|P1|Overall Study|Lack of Efficacy|0
1827222|NCT00371839|6333193|P3|Overall Study|Lost to Follow-up|2
1827223|NCT00371839|6333194|P2|Overall Study|Lost to Follow-up|3
1827224|NCT00371839|6333195|P1|Overall Study|Lost to Follow-up|6
1827225|NCT00371839|6333193|P3|Overall Study|Withdrawal by Subject|0
1827226|NCT00371839|6333194|P2|Overall Study|Withdrawal by Subject|4
1827227|NCT00371839|6333195|P1|Overall Study|Withdrawal by Subject|7
1827228|NCT00371839|6333193|P3|Overall Study|Death|0
1827229|NCT00371839|6333194|P2|Overall Study|Death|0
1827230|NCT00371839|6333195|P1|Overall Study|Death|4
1827231|NCT00371826|6333204|P3|Extension Phase (24 Months)|Administrative problems|2
1827232|NCT00371826|6333205|P2|Extension Phase (24 Months)|Administrative problems|0
1827233|NCT00371826|6333206|P1|Extension Phase (24 Months)|Administrative problems|0
1827234|NCT00371826|6333204|P3|Extension Phase (24 Months)|Subject withdrew consent|0
1827235|NCT00371826|6333205|P2|Extension Phase (24 Months)|Subject withdrew consent|2
1827236|NCT00371826|6333206|P1|Extension Phase (24 Months)|Subject withdrew consent|1
1827237|NCT00371826|6333204|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1827238|NCT00371826|6333205|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
1827239|NCT00371826|6333206|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
1827240|NCT00371826|6333204|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1827241|NCT00371826|6333205|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
1827242|NCT00371826|6333206|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
1827243|NCT00371826|6333204|P3|Extension Phase (24 Months)|Adverse Event|0
1827244|NCT00371826|6333205|P2|Extension Phase (24 Months)|Adverse Event|5
1827245|NCT00371826|6333206|P1|Extension Phase (24 Months)|Adverse Event|4
1827246|NCT00371826|6333204|P3|Core Phase (12 Months)|Graft Loss|0
1827247|NCT00371826|6333205|P2|Core Phase (12 Months)|Graft Loss|1
1827248|NCT00371826|6333206|P1|Core Phase (12 Months)|Graft Loss|0
1827249|NCT00371826|6333204|P3|Core Phase (12 Months)|Administrative problems|8
1827250|NCT00371826|6333205|P2|Core Phase (12 Months)|Administrative problems|0
1827251|NCT00371826|6333206|P1|Core Phase (12 Months)|Administrative problems|1
1827252|NCT00371826|6333204|P3|Core Phase (12 Months)|Subject withdrew consent|3
1827253|NCT00371826|6333205|P2|Core Phase (12 Months)|Subject withdrew consent|0
1827254|NCT00371826|6333206|P1|Core Phase (12 Months)|Subject withdrew consent|0
1827255|NCT00371826|6333204|P3|Core Phase (12 Months)|Protocol Violation|1
1827256|NCT00371826|6333205|P2|Core Phase (12 Months)|Protocol Violation|0
1827257|NCT00371826|6333206|P1|Core Phase (12 Months)|Protocol Violation|1
1827258|NCT00371826|6333204|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
1827259|NCT00371826|6333205|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
1827260|NCT00371826|6333206|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
1827261|NCT00371826|6333204|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1827262|NCT00371826|6333205|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
1827263|NCT00371826|6333206|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
1827264|NCT00371826|6333204|P3|Core Phase (12 Months)|Adverse Event|9
1827265|NCT00371826|6333205|P2|Core Phase (12 Months)|Adverse Event|4
1827266|NCT00371826|6333206|P1|Core Phase (12 Months)|Adverse Event|15
1827267|NCT00371787|6333330|P2|Overall Study|Withdrawal by Subject|1
1827268|NCT00371787|6333331|P1|Overall Study|Withdrawal by Subject|3
1827269|NCT00371761|6333345|P2|Overall Study|Study termination|3
1827270|NCT00371761|6333346|P1|Overall Study|Study termination|4
1827271|NCT00371761|6333345|P2|Overall Study|Investigator Judgment|3
1827272|NCT00371761|6333346|P1|Overall Study|Investigator Judgment|2
1827273|NCT00371761|6333345|P2|Overall Study|Withdrawal by Subject|3
1827274|NCT00371761|6333346|P1|Overall Study|Withdrawal by Subject|1
1827275|NCT00371761|6333345|P2|Overall Study|Adverse Event|1
1827276|NCT00371761|6333346|P1|Overall Study|Adverse Event|1
1827277|NCT00371683|6333354|P2|Follow-Up Period - Randomized Patients|non-specified|12
1827278|NCT00371683|6333355|P1|Follow-Up Period - Randomized Patients|non-specified|6
1827279|NCT00371683|6333354|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
1827280|NCT00371683|6333355|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
1827281|NCT00371683|6333354|P2|Follow-Up Period - Randomized Patients|Death|2
1827282|NCT00371683|6333355|P1|Follow-Up Period - Randomized Patients|Death|0
1827283|NCT00371683|6333354|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
1827284|NCT00371683|6333355|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
1827285|NCT00371683|6333354|P2|DB Treatment Period-Randomized Patients|non-specified|8
1827286|NCT00371683|6333355|P1|DB Treatment Period-Randomized Patients|non-specified|9
1827287|NCT00371683|6333354|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
1827288|NCT00371683|6333355|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
1827289|NCT00371683|6333354|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
1827290|NCT00371683|6333355|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
1827291|NCT00371683|6333354|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
1827292|NCT00371683|6333355|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
1827293|NCT00371683|6333354|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
1827294|NCT00371683|6333355|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
1827295|NCT00371683|6333354|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
1827296|NCT00371683|6333355|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
1827297|NCT00371683|6333354|P2|DB Treatment Period-Randomized Patients|Death|1
1827298|NCT00371683|6333355|P1|DB Treatment Period-Randomized Patients|Death|1
1827299|NCT00371566|6333423|P2|Follow Up Phase|Lost to Follow-up|0
1827300|NCT00371566|6333424|P1|Follow Up Phase|Lost to Follow-up|1
1827301|NCT00371566|6333423|P2|Follow Up Phase|Physician Decision|1
1827302|NCT00371566|6333424|P1|Follow Up Phase|Physician Decision|1
1827303|NCT00371566|6333423|P2|Follow Up Phase|Withdrawal by Subject|1
1827304|NCT00371566|6333424|P1|Follow Up Phase|Withdrawal by Subject|0
1827305|NCT00371566|6333423|P2|Follow Up Phase|Disease progression|0
1827306|NCT00371566|6333424|P1|Follow Up Phase|Disease progression|1
1827307|NCT00371566|6333423|P2|Follow Up Phase|Death|5
1827308|NCT00371566|6333424|P1|Follow Up Phase|Death|0
1827309|NCT00371566|6333423|P2|Chemoradiation Phase|Death|0
1827310|NCT00371566|6333424|P1|Chemoradiation Phase|Death|2
1827311|NCT00371566|6333423|P2|Chemoradiation Phase|Progressive Disease|1
1827312|NCT00371566|6333424|P1|Chemoradiation Phase|Progressive Disease|1
1827313|NCT00371566|6333423|P2|Chemoradiation Phase|Non compliant|1
1827314|NCT00371566|6333424|P1|Chemoradiation Phase|Non compliant|0
1827315|NCT00371566|6333423|P2|Chemoradiation Phase|Withdrawal by Subject|1
1827316|NCT00371566|6333424|P1|Chemoradiation Phase|Withdrawal by Subject|0
1827317|NCT00371566|6333423|P2|Chemoradiation Phase|Physician Decision|0
1827318|NCT00371566|6333424|P1|Chemoradiation Phase|Physician Decision|2
1827319|NCT00371566|6333423|P2|Treatment Phase|Protocol Violation|1
1827320|NCT00371566|6333424|P1|Treatment Phase|Protocol Violation|0
1827321|NCT00371566|6333423|P2|Treatment Phase|Adverse Event|1
1827322|NCT00371566|6333424|P1|Treatment Phase|Adverse Event|0
1827323|NCT00371566|6333423|P2|Treatment Phase|Withdrawal by Subject|1
1827324|NCT00371566|6333424|P1|Treatment Phase|Withdrawal by Subject|0
1827325|NCT00371462|6333509|P2|Overall Study|Other|8
1827326|NCT00371462|6333510|P1|Overall Study|Other|7
1827327|NCT00371462|6333509|P2|Overall Study|Withdrawal by Subject|0
1827328|NCT00371462|6333510|P1|Overall Study|Withdrawal by Subject|1
1827329|NCT00371397|6333534|P12|Session 1|Withdrawal by Subject|0
1827330|NCT00371397|6333535|P11|Session 1|Withdrawal by Subject|0
1827331|NCT00371397|6333536|P10|Session 1|Withdrawal by Subject|0
1827332|NCT00371397|6333537|P9|Session 1|Withdrawal by Subject|0
1827333|NCT00371397|6333538|P8|Session 1|Withdrawal by Subject|1
1827334|NCT00371397|6333539|P7|Session 1|Withdrawal by Subject|0
1827335|NCT00371397|6333540|P6|Session 1|Withdrawal by Subject|0
1827336|NCT00371397|6333541|P5|Session 1|Withdrawal by Subject|0
1827337|NCT00371397|6333542|P4|Session 1|Withdrawal by Subject|0
1827338|NCT00371397|6333543|P3|Session 1|Withdrawal by Subject|0
1827339|NCT00371397|6333544|P2|Session 1|Withdrawal by Subject|0
1827340|NCT00371397|6333545|P1|Session 1|Withdrawal by Subject|1
1827341|NCT00371345|6333553|P2|Overall Study|Participant Withdrew Consent|1
1827342|NCT00371345|6333554|P1|Overall Study|Participant Withdrew Consent|0
1827343|NCT00371345|6333553|P2|Overall Study|Participant Request|1
1827344|NCT00371345|6333554|P1|Overall Study|Participant Request|1
1827345|NCT00371345|6333553|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
1827346|NCT00371345|6333554|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
1827347|NCT00371345|6333553|P2|Overall Study|Study Drug Toxicity|7
1827348|NCT00371345|6333554|P1|Overall Study|Study Drug Toxicity|1
1827349|NCT00371345|6333553|P2|Overall Study|Disease Progression|35
1827350|NCT00371345|6333554|P1|Overall Study|Disease Progression|21
1827351|NCT00371254|6333655|P2|Overall Study|Withdrawal by Subject|1
1827352|NCT00371254|6333656|P1|Overall Study|Withdrawal by Subject|0
1827353|NCT00371254|6333655|P2|Overall Study|Lost to Follow-up|1
1827354|NCT00371254|6333656|P1|Overall Study|Lost to Follow-up|0
1827355|NCT00371254|6333655|P2|Overall Study|Adverse event unrelated to study drug|1
1827356|NCT00371254|6333656|P1|Overall Study|Adverse event unrelated to study drug|0
1827357|NCT00371254|6333655|P2|Overall Study|Investigator Decision|0
1827358|NCT00371254|6333656|P1|Overall Study|Investigator Decision|2
1827359|NCT00371254|6333655|P2|Overall Study|Subject request|0
1827360|NCT00371254|6333656|P1|Overall Study|Subject request|5
1827361|NCT00371254|6333655|P2|Overall Study|Study drug toxicity|5
1827362|NCT00371254|6333656|P1|Overall Study|Study drug toxicity|3
1827363|NCT00371254|6333655|P2|Overall Study|Disease progression|13
1827364|NCT00371254|6333656|P1|Overall Study|Disease progression|13
1827365|NCT00371150|6333739|P2|Overall Study|Lost to Follow-up|2
1827366|NCT00371150|6333740|P1|Overall Study|Lost to Follow-up|3
1827367|NCT00371137|6333775|P3|Overall Study|Protocol Violation|1
1827368|NCT00371137|6333776|P2|Overall Study|Protocol Violation|1
1827369|NCT00371137|6333777|P1|Overall Study|Protocol Violation|2
1827370|NCT00371137|6333775|P3|Overall Study|Physician Decision|1
1827371|NCT00371137|6333776|P2|Overall Study|Physician Decision|1
1827372|NCT00371137|6333777|P1|Overall Study|Physician Decision|1
1827373|NCT00371137|6333775|P3|Overall Study|Sponsor Decision|2
1827374|NCT00371137|6333776|P2|Overall Study|Sponsor Decision|1
1827375|NCT00371137|6333777|P1|Overall Study|Sponsor Decision|2
1827376|NCT00371137|6333775|P3|Overall Study|Lack of Efficacy|13
1827377|NCT00371137|6333776|P2|Overall Study|Lack of Efficacy|12
1827378|NCT00371137|6333777|P1|Overall Study|Lack of Efficacy|30
1827379|NCT00371137|6333775|P3|Overall Study|Lost to Follow-up|5
1827380|NCT00371137|6333776|P2|Overall Study|Lost to Follow-up|3
1827381|NCT00371137|6333777|P1|Overall Study|Lost to Follow-up|6
1827382|NCT00371137|6333775|P3|Overall Study|Withdrawal by Subject|15
1827383|NCT00371137|6333776|P2|Overall Study|Withdrawal by Subject|10
1827384|NCT00371137|6333777|P1|Overall Study|Withdrawal by Subject|11
1827385|NCT00371137|6333775|P3|Overall Study|Adverse Event|42
1827386|NCT00371137|6333776|P2|Overall Study|Adverse Event|35
1827387|NCT00371137|6333777|P1|Overall Study|Adverse Event|20
1827388|NCT00370682|6333820|P3|Overall Study|Lost to Follow-up|1
1827389|NCT00370682|6333821|P2|Overall Study|Lost to Follow-up|1
1827390|NCT00370682|6333822|P1|Overall Study|Lost to Follow-up|0
1827391|NCT00370682|6333820|P3|Overall Study|Moved from area|0
1827392|NCT00370682|6333821|P2|Overall Study|Moved from area|2
1827393|NCT00370682|6333822|P1|Overall Study|Moved from area|0
1827394|NCT00370552|6333864|P3|Overall Study|Planned radiation for palliation|0
1827395|NCT00370552|6333865|P2|Overall Study|Planned radiation for palliation|1
1827396|NCT00370552|6333866|P1|Overall Study|Planned radiation for palliation|0
1827397|NCT00370552|6333864|P3|Overall Study|High risk of allergic reaction|0
1827398|NCT00370552|6333865|P2|Overall Study|High risk of allergic reaction|1
1827399|NCT00370552|6333866|P1|Overall Study|High risk of allergic reaction|0
1827400|NCT00370552|6333864|P3|Overall Study|Investigator decision|0
1827401|NCT00370552|6333865|P2|Overall Study|Investigator decision|1
1827402|NCT00370552|6333866|P1|Overall Study|Investigator decision|2
1827403|NCT00370552|6333864|P3|Overall Study|Physician Decision|0
1827404|NCT00370552|6333865|P2|Overall Study|Physician Decision|1
1827405|NCT00370552|6333866|P1|Overall Study|Physician Decision|1
1827406|NCT00370552|6333864|P3|Overall Study|Never treated|0
1827407|NCT00370552|6333865|P2|Overall Study|Never treated|0
1827408|NCT00370552|6333866|P1|Overall Study|Never treated|1
1827409|NCT00370552|6333864|P3|Overall Study|Still on treatment|2
1827410|NCT00370552|6333865|P2|Overall Study|Still on treatment|3
1827411|NCT00370552|6333866|P1|Overall Study|Still on treatment|1
1827412|NCT00370552|6333864|P3|Overall Study|Withdrawal by Subject|1
1827413|NCT00370552|6333865|P2|Overall Study|Withdrawal by Subject|0
1827414|NCT00370552|6333866|P1|Overall Study|Withdrawal by Subject|2
1827415|NCT00370552|6333864|P3|Overall Study|Study drug toxicity|6
1827416|NCT00370552|6333865|P2|Overall Study|Study drug toxicity|8
1827417|NCT00370552|6333866|P1|Overall Study|Study drug toxicity|11
1827418|NCT00370552|6333864|P3|Overall Study|Poor or noncompliance|1
1827419|NCT00370552|6333865|P2|Overall Study|Poor or noncompliance|0
1827420|NCT00370552|6333866|P1|Overall Study|Poor or noncompliance|0
1827421|NCT00370552|6333864|P3|Overall Study|Maximum clinical benefit|5
1827422|NCT00370552|6333865|P2|Overall Study|Maximum clinical benefit|5
1827423|NCT00370552|6333866|P1|Overall Study|Maximum clinical benefit|3
1827424|NCT00370552|6333864|P3|Overall Study|Disease progression|15
1827425|NCT00370552|6333865|P2|Overall Study|Disease progression|23
1827426|NCT00370552|6333866|P1|Overall Study|Disease progression|23
1827427|NCT00370552|6333864|P3|Overall Study|Adverse Event|2
1827428|NCT00370552|6333865|P2|Overall Study|Adverse Event|2
1827429|NCT00370552|6333866|P1|Overall Study|Adverse Event|2
1827430|NCT00370396|6333907|P3|Overall Study|Lost to Follow-up|0
1827431|NCT00370396|6333908|P2|Overall Study|Lost to Follow-up|1
1827432|NCT00370396|6333909|P1|Overall Study|Lost to Follow-up|11
1827433|NCT00370396|6333907|P3|Overall Study|Withdrawal by Subject|1
1827434|NCT00370396|6333908|P2|Overall Study|Withdrawal by Subject|0
1827435|NCT00370396|6333909|P1|Overall Study|Withdrawal by Subject|0
1827436|NCT00370331|6333963|P2|Overall Study|Protocol Violation|1
1827437|NCT00370331|6333964|P1|Overall Study|Protocol Violation|1
1827438|NCT00370331|6333963|P2|Overall Study|Non-compliance|1
1827439|NCT00370331|6333964|P1|Overall Study|Non-compliance|0
1827440|NCT00370331|6333963|P2|Overall Study|Lack of Efficacy|1
1827441|NCT00370331|6333964|P1|Overall Study|Lack of Efficacy|0
1827442|NCT00370331|6333963|P2|Overall Study|Lost to Follow-up|3
1827443|NCT00370331|6333964|P1|Overall Study|Lost to Follow-up|0
1827444|NCT00370331|6333963|P2|Overall Study|Withdrawal by Subject|4
1827445|NCT00370331|6333964|P1|Overall Study|Withdrawal by Subject|2
1827446|NCT00370331|6333963|P2|Overall Study|Adverse Event|13
1827447|NCT00370331|6333964|P1|Overall Study|Adverse Event|4
1827448|NCT00370292|6333990|P1|Overall Study|Physician Decision|2
1827449|NCT00370292|6333990|P1|Overall Study|Adverse Event|7
1827450|NCT00370292|6333990|P1|Overall Study|Disease Progression|4
1827451|NCT00370149|6334003|P2|Overall Study|Antibiotic coated dressing placed|1
1827452|NCT00370149|6334004|P1|Overall Study|Antibiotic coated dressing placed|0
1827453|NCT00370149|6334003|P2|Overall Study|Pre-existing infection|1
1827454|NCT00370149|6334004|P1|Overall Study|Pre-existing infection|0
1827455|NCT00370149|6334003|P2|Overall Study|Catheter inserted in wrong vessel-|1
1827456|NCT00370149|6334004|P1|Overall Study|Catheter inserted in wrong vessel-|2
1827457|NCT00370149|6334003|P2|Overall Study|Protocol Violation|0
1827458|NCT00370149|6334004|P1|Overall Study|Protocol Violation|1
1827459|NCT00370149|6334003|P2|Overall Study|Physician Decision|16
1827460|NCT00370149|6334004|P1|Overall Study|Physician Decision|16
1827461|NCT00370071|6334014|P1|Overall Study|Withdrawal by Subject|2
1827462|NCT00370032|6334031|P2|Follow-up Period|Withdrawal by Subject|0
1827463|NCT00370032|6334032|P1|Follow-up Period|Withdrawal by Subject|1
1827464|NCT00370032|6334031|P2|Washout Period|Adverse Event|0
1827465|NCT00370032|6334032|P1|Washout Period|Adverse Event|1
1827466|NCT00370032|6334031|P2|Washout Period|Lost to Follow-up|1
1827467|NCT00370032|6334032|P1|Washout Period|Lost to Follow-up|0
1827468|NCT00370032|6334031|P2|Washout Period|Withdrawal by Subject|1
1827469|NCT00370032|6334032|P1|Washout Period|Withdrawal by Subject|0
1827470|NCT00370032|6334031|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
1827471|NCT00370032|6334032|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
1827472|NCT00369967|6334052|P2|Overall Study|Lost to Follow-up|12
1827473|NCT00369967|6334053|P1|Overall Study|Lost to Follow-up|23
1827474|NCT00369941|6334071|P2|Overall Study|Miscellaneous|3
1827475|NCT00369941|6334072|P1|Overall Study|Miscellaneous|3
1827476|NCT00369941|6334071|P2|Overall Study|Study Site Terminated|0
1827477|NCT00369941|6334072|P1|Overall Study|Study Site Terminated|2
1827478|NCT00369941|6334071|P2|Overall Study|Employment Interfered with Study Visits|0
1827479|NCT00369941|6334072|P1|Overall Study|Employment Interfered with Study Visits|1
1827480|NCT00369941|6334071|P2|Overall Study|Treatment with Prohibited Medication|1
1827481|NCT00369941|6334072|P1|Overall Study|Treatment with Prohibited Medication|3
1827482|NCT00369941|6334071|P2|Overall Study|Moved|5
1827483|NCT00369941|6334072|P1|Overall Study|Moved|11
1827484|NCT00369941|6334071|P2|Overall Study|Completed, Did Not Enter Extension|6
1827485|NCT00369941|6334072|P1|Overall Study|Completed, Did Not Enter Extension|5
1827486|NCT00369941|6334071|P2|Overall Study|Pregnancy|2
1827487|NCT00369941|6334072|P1|Overall Study|Pregnancy|4
1827488|NCT00369941|6334071|P2|Overall Study|Withdrawal by Subject|18
1827489|NCT00369941|6334072|P1|Overall Study|Withdrawal by Subject|5
1827490|NCT00369941|6334071|P2|Overall Study|Protocol Violation|3
1827491|NCT00369941|6334072|P1|Overall Study|Protocol Violation|5
1827492|NCT00369941|6334071|P2|Overall Study|Lost to Follow-up|22
1827493|NCT00369941|6334072|P1|Overall Study|Lost to Follow-up|12
1827494|NCT00369941|6334071|P2|Overall Study|Lack of Efficacy|10
1827495|NCT00369941|6334072|P1|Overall Study|Lack of Efficacy|6
1827496|NCT00369941|6334071|P2|Overall Study|Adverse Event|28
1827497|NCT00369941|6334072|P1|Overall Study|Adverse Event|14
1827498|NCT00369941|6334071|P2|Overall Study|Never Treated|2
1827499|NCT00369941|6334072|P1|Overall Study|Never Treated|1
1827500|NCT00369915|6334237|P2|Overall Study|W/drawl by investigators|1
1827501|NCT00369915|6334238|P1|Overall Study|W/drawl by investigators|0
1827502|NCT00369915|6334237|P2|Overall Study|Withdrawal by Subject|1
1827503|NCT00369915|6334238|P1|Overall Study|Withdrawal by Subject|4
1827504|NCT00369915|6334237|P2|Overall Study|expected side effects|1
1827505|NCT00369915|6334238|P1|Overall Study|expected side effects|2
1827506|NCT00369824|6334252|P6|Overall Study|Other|3
1827507|NCT00369824|6334253|P5|Overall Study|Other|1
1827508|NCT00369824|6334254|P4|Overall Study|Other|2
1827509|NCT00369824|6334255|P3|Overall Study|Other|0
1827510|NCT00369824|6334256|P2|Overall Study|Other|0
1827511|NCT00369824|6334257|P1|Overall Study|Other|0
1827512|NCT00369824|6334252|P6|Overall Study|Lost to Follow-up|6
1827513|NCT00369824|6334253|P5|Overall Study|Lost to Follow-up|9
1827514|NCT00369824|6334254|P4|Overall Study|Lost to Follow-up|8
1827515|NCT00369824|6334255|P3|Overall Study|Lost to Follow-up|7
1827516|NCT00369824|6334256|P2|Overall Study|Lost to Follow-up|11
1827517|NCT00369824|6334257|P1|Overall Study|Lost to Follow-up|6
1827518|NCT00369824|6334252|P6|Overall Study|Withdrawal by Subject|2
1827519|NCT00369824|6334253|P5|Overall Study|Withdrawal by Subject|6
1827520|NCT00369824|6334254|P4|Overall Study|Withdrawal by Subject|4
1827521|NCT00369824|6334255|P3|Overall Study|Withdrawal by Subject|5
1827522|NCT00369824|6334256|P2|Overall Study|Withdrawal by Subject|5
1827523|NCT00369824|6334257|P1|Overall Study|Withdrawal by Subject|9
1827524|NCT00369824|6334252|P6|Overall Study|Protocol Violation|0
1827525|NCT00369824|6334253|P5|Overall Study|Protocol Violation|1
1827526|NCT00369824|6334254|P4|Overall Study|Protocol Violation|1
1827527|NCT00369824|6334255|P3|Overall Study|Protocol Violation|0
1827528|NCT00369824|6334256|P2|Overall Study|Protocol Violation|1
1827529|NCT00369824|6334257|P1|Overall Study|Protocol Violation|0
1827530|NCT00369824|6334252|P6|Overall Study|Adverse Event|0
1827531|NCT00369824|6334253|P5|Overall Study|Adverse Event|1
1827532|NCT00369824|6334254|P4|Overall Study|Adverse Event|0
1827533|NCT00369824|6334255|P3|Overall Study|Adverse Event|0
1827534|NCT00369824|6334256|P2|Overall Study|Adverse Event|2
1827535|NCT00369824|6334257|P1|Overall Study|Adverse Event|0
1827536|NCT00369785|6334357|P2|Overall Study|Multiple reasons|5
1827537|NCT00369785|6334358|P1|Overall Study|Multiple reasons|6
1827538|NCT00369785|6334357|P2|Overall Study|Progression|4
1827539|NCT00369785|6334358|P1|Overall Study|Progression|4
1827540|NCT00369785|6334357|P2|Overall Study|Never started|2
1827541|NCT00369785|6334358|P1|Overall Study|Never started|0
1827542|NCT00369785|6334357|P2|Overall Study|Toxicity|4
1827543|NCT00369785|6334358|P1|Overall Study|Toxicity|6
1827544|NCT00369785|6334357|P2|Overall Study|Withdrawal by Subject|6
1827545|NCT00369785|6334358|P1|Overall Study|Withdrawal by Subject|7
1827546|NCT00369785|6334357|P2|Overall Study|Death|2
1827547|NCT00369785|6334358|P1|Overall Study|Death|1
1827548|NCT00369785|6334357|P2|Overall Study|Physician Decision|2
1827549|NCT00369785|6334358|P1|Overall Study|Physician Decision|3
1827550|NCT00369707|6334379|P1|Follow up for 2 Years After Treatment|Other|2
1827551|NCT00369707|6334379|P1|Follow up for 2 Years After Treatment|Death|1
1827552|NCT00369707|6334379|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
1827553|NCT00369707|6334379|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
1827554|NCT00369707|6334379|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
1827555|NCT00369707|6334379|P1|Induction Part B (2 Cycles)|Progressive disease|1
1827556|NCT00369707|6334379|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
1827557|NCT00369707|6334379|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
1827558|NCT00369707|6334379|P1|Induction Part B (2 Cycles)|Adverse Event|3
1827559|NCT00369681|6334392|P1|Overall Study|Death|1
1827560|NCT00369668|6334402|P3|Overall Study|Lack of Efficacy|7
1827561|NCT00369668|6334403|P2|Overall Study|Lack of Efficacy|5
1827562|NCT00369668|6334404|P1|Overall Study|Lack of Efficacy|4
1827563|NCT00369655|6334418|P1|Overall Study|Refusal of further treatment|2
1827564|NCT00369629|6334427|P4|Follow up for 1 Year|stopped being followed as study closed|0
1827565|NCT00369629|6334428|P3|Follow up for 1 Year|stopped being followed as study closed|2
1827566|NCT00369629|6334429|P2|Follow up for 1 Year|stopped being followed as study closed|0
1827567|NCT00369629|6334430|P1|Follow up for 1 Year|stopped being followed as study closed|0
1827568|NCT00369629|6334427|P4|Follow up for 1 Year|Lost to Follow-up|0
1827569|NCT00369629|6334428|P3|Follow up for 1 Year|Lost to Follow-up|0
1827570|NCT00369629|6334429|P2|Follow up for 1 Year|Lost to Follow-up|1
1827571|NCT00369629|6334430|P1|Follow up for 1 Year|Lost to Follow-up|0
1827572|NCT00369629|6334427|P4|Follow up for 1 Year|Death|0
1827573|NCT00369629|6334428|P3|Follow up for 1 Year|Death|1
1827574|NCT00369629|6334429|P2|Follow up for 1 Year|Death|1
1827575|NCT00369629|6334430|P1|Follow up for 1 Year|Death|2
1827576|NCT00369629|6334427|P4|Completed 4 More Cycles|Progressive disease|0
1827577|NCT00369629|6334428|P3|Completed 4 More Cycles|Progressive disease|2
1827578|NCT00369629|6334429|P2|Completed 4 More Cycles|Progressive disease|1
1827579|NCT00369629|6334430|P1|Completed 4 More Cycles|Progressive disease|2
1827580|NCT00369629|6334427|P4|Completed 4 More Cycles|Withdrawal by Subject|0
1827581|NCT00369629|6334428|P3|Completed 4 More Cycles|Withdrawal by Subject|0
1827582|NCT00369629|6334429|P2|Completed 4 More Cycles|Withdrawal by Subject|1
1827583|NCT00369629|6334430|P1|Completed 4 More Cycles|Withdrawal by Subject|2
1827584|NCT00369629|6334427|P4|Moved on to 4 More Cycles|Progressive Disease|0
1827585|NCT00369629|6334428|P3|Moved on to 4 More Cycles|Progressive Disease|1
1827586|NCT00369629|6334429|P2|Moved on to 4 More Cycles|Progressive Disease|0
1827587|NCT00369629|6334430|P1|Moved on to 4 More Cycles|Progressive Disease|0
1827588|NCT00369629|6334427|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
1827589|NCT00369629|6334428|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
1827590|NCT00369629|6334429|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
1827591|NCT00369629|6334430|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
1827592|NCT00369629|6334427|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
1827593|NCT00369629|6334428|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
1827594|NCT00369629|6334429|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
1827595|NCT00369629|6334430|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
1827596|NCT00369629|6334427|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
1827597|NCT00369629|6334428|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
1827598|NCT00369629|6334429|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
1827599|NCT00369629|6334430|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
1827600|NCT00369577|6334461|P3|Overall Study|Withdrawal by Subject|1
1827601|NCT00369577|6334462|P2|Overall Study|Withdrawal by Subject|0
1827602|NCT00369577|6334463|P1|Overall Study|Withdrawal by Subject|0
1827603|NCT00369486|6334500|P5|34-Week Visit|Dropped|3
1827604|NCT00369486|6334501|P4|34-Week Visit|Dropped|3
1827605|NCT00369486|6334502|P3|34-Week Visit|Dropped|1
1827606|NCT00369486|6334503|P2|34-Week Visit|Dropped|1
1827607|NCT00369486|6334504|P1|34-Week Visit|Dropped|0
1827608|NCT00369486|6334500|P5|17-Week Visit|Missed visit|1
1827609|NCT00369486|6334501|P4|17-Week Visit|Missed visit|1
1827610|NCT00369486|6334502|P3|17-Week Visit|Missed visit|1
1827611|NCT00369486|6334503|P2|17-Week Visit|Missed visit|0
1827612|NCT00369486|6334504|P1|17-Week Visit|Missed visit|0
1827613|NCT00369486|6334500|P5|8-Week Visit|Dropped|0
1827614|NCT00369486|6334501|P4|8-Week Visit|Dropped|1
1827615|NCT00369486|6334502|P3|8-Week Visit|Dropped|0
1827616|NCT00369486|6334503|P2|8-Week Visit|Dropped|0
1827617|NCT00369486|6334504|P1|8-Week Visit|Dropped|0
1827618|NCT00369486|6334500|P5|8-Week Visit|Missed visit|1
1827619|NCT00369486|6334501|P4|8-Week Visit|Missed visit|0
1827620|NCT00369486|6334502|P3|8-Week Visit|Missed visit|0
1827621|NCT00369486|6334503|P2|8-Week Visit|Missed visit|1
1827622|NCT00369486|6334504|P1|8-Week Visit|Missed visit|0
1827623|NCT00369486|6334500|P5|4-Week Visit|Dropped|0
1827624|NCT00369486|6334501|P4|4-Week Visit|Dropped|0
1827625|NCT00369486|6334502|P3|4-Week Visit|Dropped|1
1827626|NCT00369486|6334503|P2|4-Week Visit|Dropped|0
1827627|NCT00369486|6334504|P1|4-Week Visit|Dropped|0
1827628|NCT00369486|6334500|P5|4-Week Visit|Missed visit|1
1827629|NCT00369486|6334501|P4|4-Week Visit|Missed visit|2
1827630|NCT00369486|6334502|P3|4-Week Visit|Missed visit|0
1827631|NCT00369486|6334503|P2|4-Week Visit|Missed visit|2
1827632|NCT00369486|6334504|P1|4-Week Visit|Missed visit|2
1827633|NCT00369382|6334543|P2|Overall Study|Other|0
1827634|NCT00369382|6334544|P1|Overall Study|Other|1
1827635|NCT00369382|6334543|P2|Overall Study|Randomized, not treated|0
1827636|NCT00369382|6334544|P1|Overall Study|Randomized, not treated|2
1827637|NCT00369382|6334543|P2|Overall Study|Withdrawal by Subject|0
1827638|NCT00369382|6334544|P1|Overall Study|Withdrawal by Subject|5
1827639|NCT00369382|6334543|P2|Overall Study|Physician Decision|1
1827640|NCT00369382|6334544|P1|Overall Study|Physician Decision|2
1827641|NCT00369382|6334543|P2|Overall Study|Death|2
1827642|NCT00369382|6334544|P1|Overall Study|Death|0
1827643|NCT00369343|6334577|P2|Open-label Phase|did not take study drug|2
1827644|NCT00369343|6334578|P1|Open-label Phase|did not take study drug|1
1827645|NCT00369343|6334577|P2|Open-label Phase|Lack of continuance tolerability|4
1827646|NCT00369343|6334578|P1|Open-label Phase|Lack of continuance tolerability|3
1827647|NCT00369343|6334577|P2|Open-label Phase|Lack of Efficacy|3
1827648|NCT00369343|6334578|P1|Open-label Phase|Lack of Efficacy|4
1827649|NCT00369343|6334577|P2|Open-label Phase|Withdrawal by Subject|6
1827650|NCT00369343|6334578|P1|Open-label Phase|Withdrawal by Subject|15
1827651|NCT00369343|6334577|P2|Open-label Phase|Protocol Violation|3
1827652|NCT00369343|6334578|P1|Open-label Phase|Protocol Violation|1
1827653|NCT00369343|6334577|P2|Open-label Phase|inadvertently reported study completers|2
1827654|NCT00369343|6334578|P1|Open-label Phase|inadvertently reported study completers|3
1827655|NCT00369343|6334577|P2|Open-label Phase|Lost to Follow-up|3
1827656|NCT00369343|6334578|P1|Open-label Phase|Lost to Follow-up|5
1827657|NCT00369343|6334577|P2|Open-label Phase|Physician Decision|0
1827658|NCT00369343|6334578|P1|Open-label Phase|Physician Decision|2
1827659|NCT00369343|6334577|P2|Open-label Phase|Failed to return|0
1827660|NCT00369343|6334578|P1|Open-label Phase|Failed to return|4
1827661|NCT00369343|6334577|P2|Open-label Phase|Adverse Event|7
1827662|NCT00369343|6334578|P1|Open-label Phase|Adverse Event|19
1827663|NCT00369343|6334577|P2|Double-blind Phase|Protocol deviation|0
1827664|NCT00369343|6334578|P1|Double-blind Phase|Protocol deviation|4
1827665|NCT00369343|6334577|P2|Double-blind Phase|Lack of Efficacy|4
1827666|NCT00369343|6334578|P1|Double-blind Phase|Lack of Efficacy|0
1827667|NCT00369343|6334577|P2|Double-blind Phase|Withdrawal by Subject|6
1827668|NCT00369343|6334578|P1|Double-blind Phase|Withdrawal by Subject|8
1827669|NCT00369343|6334577|P2|Double-blind Phase|Protocol Violation|0
1827670|NCT00369343|6334578|P1|Double-blind Phase|Protocol Violation|2
1827671|NCT00369343|6334577|P2|Double-blind Phase|Lost to Follow-up|2
1827672|NCT00369343|6334578|P1|Double-blind Phase|Lost to Follow-up|9
1827673|NCT00369343|6334577|P2|Double-blind Phase|Failed to return|0
1827674|NCT00369343|6334578|P1|Double-blind Phase|Failed to return|2
1827675|NCT00369343|6334577|P2|Double-blind Phase|Adverse Event|4
1827676|NCT00369343|6334578|P1|Double-blind Phase|Adverse Event|19
1827677|NCT00369317|6334611|P1|Overall Study|Ineligible|1
1827678|NCT00369317|6334611|P1|Overall Study|Withdrawal by Subject|8
1827679|NCT00369317|6334611|P1|Overall Study|Physician Decision|2
1827680|NCT00369317|6334611|P1|Overall Study|Lack of Efficacy|5
1827681|NCT00369317|6334611|P1|Overall Study|Death|1
1827682|NCT00369317|6334611|P1|Overall Study|Adverse Event|3
1827683|NCT00369278|6334627|P2|Overall Study|Graft loss|2
1827684|NCT00369278|6334628|P1|Overall Study|Graft loss|1
1827685|NCT00369278|6334627|P2|Overall Study|Lost to Follow-up|0
1827686|NCT00369278|6334628|P1|Overall Study|Lost to Follow-up|1
1827687|NCT00369278|6334627|P2|Overall Study|Withdrawal by Subject|2
1827688|NCT00369278|6334628|P1|Overall Study|Withdrawal by Subject|2
1827689|NCT00369278|6334627|P2|Overall Study|Protocol Violation|1
1827690|NCT00369278|6334628|P1|Overall Study|Protocol Violation|2
1827691|NCT00369278|6334627|P2|Overall Study|Unsatisfactory therapeutic effect|5
1827692|NCT00369278|6334628|P1|Overall Study|Unsatisfactory therapeutic effect|4
1827693|NCT00369278|6334627|P2|Overall Study|Adverse Event|11
1827694|NCT00369278|6334628|P1|Overall Study|Adverse Event|14
1827695|NCT00369265|6334644|P2|Overall Study|Study terminated|7
1827696|NCT00369265|6334645|P1|Overall Study|Study terminated|4
1827697|NCT00369161|6334666|P2|Overall Study|Administrative Problem|2
1827698|NCT00369161|6334667|P1|Overall Study|Administrative Problem|2
1827699|NCT00369161|6334666|P2|Overall Study|Graft loss|0
1827700|NCT00369161|6334667|P1|Overall Study|Graft loss|4
1827701|NCT00369161|6334666|P2|Overall Study|Death|2
1827702|NCT00369161|6334667|P1|Overall Study|Death|1
1827703|NCT00369161|6334666|P2|Overall Study|Withdrawal by Subject|3
1827704|NCT00369161|6334667|P1|Overall Study|Withdrawal by Subject|2
1827705|NCT00369161|6334666|P2|Overall Study|Protocol Violation|2
1827706|NCT00369161|6334667|P1|Overall Study|Protocol Violation|0
1827707|NCT00369161|6334666|P2|Overall Study|Lack of Efficacy|1
1827708|NCT00369161|6334667|P1|Overall Study|Lack of Efficacy|3
1827709|NCT00369161|6334666|P2|Overall Study|Abnormal laboratory value|1
1827710|NCT00369161|6334667|P1|Overall Study|Abnormal laboratory value|0
1827711|NCT00369161|6334666|P2|Overall Study|Adverse Event|13
1827712|NCT00369161|6334667|P1|Overall Study|Adverse Event|15
1827713|NCT00369122|6334677|P1|Overall Study|No protocol treatment|1
1827714|NCT00369122|6334677|P1|Overall Study|Ineligible|10
1827715|NCT00368992|6334684|P1|Overall Study|Other|9
1827716|NCT00368992|6334684|P1|Overall Study|Death|4
1827717|NCT00368992|6334684|P1|Overall Study|Adverse Event|26
1827718|NCT00368992|6334684|P1|Overall Study|Lack of Efficacy|63
1827719|NCT00368992|6334684|P1|Overall Study|Refused treatment|3
1827720|NCT00368992|6334684|P1|Overall Study|Ineligible|5
1827721|NCT00368979|6334693|P2|Overall Study|Withdrawal by Subject|9
1827722|NCT00368979|6334694|P1|Overall Study|Withdrawal by Subject|5
1827723|NCT00368979|6334693|P2|Overall Study|Protocol Violation|1
1827724|NCT00368979|6334694|P1|Overall Study|Protocol Violation|2
1827725|NCT00368979|6334693|P2|Overall Study|Lost to Follow-up|0
1827726|NCT00368979|6334694|P1|Overall Study|Lost to Follow-up|1
1827727|NCT00368979|6334693|P2|Overall Study|Other|1
1827728|NCT00368979|6334694|P1|Overall Study|Other|3
1827729|NCT00368979|6334693|P2|Overall Study|Lack of Efficacy|3
1827730|NCT00368979|6334694|P1|Overall Study|Lack of Efficacy|5
1827731|NCT00368979|6334693|P2|Overall Study|Adverse Event|16
1827732|NCT00368979|6334694|P1|Overall Study|Adverse Event|9
1827733|NCT00368966|6334710|P2|Toddler Dose|Lost to Follow-up|2
1827734|NCT00368966|6334711|P1|Toddler Dose|Lost to Follow-up|0
1827735|NCT00368966|6334710|P2|Toddler Dose|Withdrawal by Subject|1
1827736|NCT00368966|6334711|P1|Toddler Dose|Withdrawal by Subject|1
1827737|NCT00368966|6334710|P2|After Infant|Lost to Follow-up|1
1827738|NCT00368966|6334711|P1|After Infant|Lost to Follow-up|0
1827739|NCT00368966|6334710|P2|After Infant|Death|0
1827740|NCT00368966|6334711|P1|After Infant|Death|1
1827741|NCT00368966|6334710|P2|After Infant|Withdrawal by Subject|1
1827742|NCT00368966|6334711|P1|After Infant|Withdrawal by Subject|1
1827743|NCT00368966|6334710|P2|After Infant|Adverse Event|2
1827744|NCT00368966|6334711|P1|After Infant|Adverse Event|1
1827745|NCT00368966|6334710|P2|After Infant|Failed to return|1
1827746|NCT00368966|6334711|P1|After Infant|Failed to return|3
1827747|NCT00368966|6334710|P2|Infant Series|Failed to return|0
1827748|NCT00368966|6334711|P1|Infant Series|Failed to return|1
1827749|NCT00368966|6334710|P2|Infant Series|Adverse Event|1
1827750|NCT00368966|6334711|P1|Infant Series|Adverse Event|0
1827751|NCT00368966|6334710|P2|Infant Series|Failed to meet eligibility criteria|1
1827752|NCT00368966|6334711|P1|Infant Series|Failed to meet eligibility criteria|0
1827753|NCT00368966|6334710|P2|Infant Series|Randomization error|1
1827754|NCT00368966|6334711|P1|Infant Series|Randomization error|0
1827755|NCT00368966|6334710|P2|Infant Series|Lost to Follow-up|0
1827756|NCT00368966|6334711|P1|Infant Series|Lost to Follow-up|2
1827757|NCT00368966|6334710|P2|Infant Series|Protocol Violation|1
1827758|NCT00368966|6334711|P1|Infant Series|Protocol Violation|2
1827759|NCT00368966|6334710|P2|Infant Series|Withdrawal by Subject|6
1827760|NCT00368966|6334711|P1|Infant Series|Withdrawal by Subject|11
1827761|NCT00368927|6334782|P2|Overall Study|Physician Decision|0
1827762|NCT00368927|6334783|P1|Overall Study|Physician Decision|1
1827763|NCT00368927|6334782|P2|Overall Study|Withdrawal by Subject|2
1827764|NCT00368927|6334783|P1|Overall Study|Withdrawal by Subject|1
1827765|NCT00368927|6334782|P2|Overall Study|Adverse Event|1
1827766|NCT00368927|6334783|P1|Overall Study|Adverse Event|1
1827767|NCT00368927|6334782|P2|Overall Study|Lost to Follow-up|0
1827768|NCT00368927|6334783|P1|Overall Study|Lost to Follow-up|2
1827769|NCT00368875|6334791|P2|Overall Study|Alternative Therapy|1
1827770|NCT00368875|6334792|P1|Overall Study|Alternative Therapy|1
1827771|NCT00368875|6334791|P2|Overall Study|Other Reason|2
1827772|NCT00368875|6334792|P1|Overall Study|Other Reason|0
1827773|NCT00368875|6334791|P2|Overall Study|Withdrawal by Subject|6
1827774|NCT00368875|6334792|P1|Overall Study|Withdrawal by Subject|2
1827775|NCT00368875|6334791|P2|Overall Study|Progressive disease|27
1827776|NCT00368875|6334792|P1|Overall Study|Progressive disease|3
1827777|NCT00368875|6334791|P2|Overall Study|Adverse Event|12
1827778|NCT00368875|6334792|P1|Overall Study|Adverse Event|0
1827779|NCT00368849|6334800|P2|Overall Study|Physician Decision|1
1827780|NCT00368849|6334801|P1|Overall Study|Physician Decision|0
1827781|NCT00368849|6334800|P2|Overall Study|Withdrawal by Subject|1
1827782|NCT00368849|6334801|P1|Overall Study|Withdrawal by Subject|0
1827783|NCT00368745|6334817|P2|Double-blind Treatment Period|Other|6
1827784|NCT00368745|6334818|P1|Double-blind Treatment Period|Other|7
1827785|NCT00368745|6334817|P2|Double-blind Treatment Period|Withdrawal by Subject|3
1827786|NCT00368745|6334818|P1|Double-blind Treatment Period|Withdrawal by Subject|5
1827787|NCT00368745|6334817|P2|Double-blind Treatment Period|Lost to Follow-up|0
1827788|NCT00368745|6334818|P1|Double-blind Treatment Period|Lost to Follow-up|1
1827789|NCT00368745|6334817|P2|Double-blind Treatment Period|Lack of Efficacy|16
1827790|NCT00368745|6334818|P1|Double-blind Treatment Period|Lack of Efficacy|7
1827791|NCT00368745|6334817|P2|Double-blind Treatment Period|Adverse Event|6
1827792|NCT00368745|6334818|P1|Double-blind Treatment Period|Adverse Event|6
1827793|NCT00368641|6334871|P2|Overall Study|Sponsor decision to terminate study|5
1827794|NCT00368641|6334872|P1|Overall Study|Sponsor decision to terminate study|2
1827795|NCT00368641|6334871|P2|Overall Study|Withdrawal by Subject|0
1827796|NCT00368641|6334872|P1|Overall Study|Withdrawal by Subject|1
1827797|NCT00368641|6334871|P2|Overall Study|Death|0
1827798|NCT00368641|6334872|P1|Overall Study|Death|1
1827799|NCT00368641|6334871|P2|Overall Study|Adverse Event|1
1827800|NCT00368641|6334872|P1|Overall Study|Adverse Event|2
1827801|NCT00368550|6334880|P2|Overall Study|Withdrawal by Subject|10
1827802|NCT00368550|6334881|P1|Overall Study|Withdrawal by Subject|17
1827803|NCT00368550|6334880|P2|Overall Study|Lack of Efficacy|9
1827804|NCT00368550|6334881|P1|Overall Study|Lack of Efficacy|4
1827805|NCT00368550|6334880|P2|Overall Study|Adverse Event|4
1827806|NCT00368550|6334881|P1|Overall Study|Adverse Event|7
1827807|NCT00368537|6334893|P2|Baseline Participants|Patient uncompliant|1
1827808|NCT00368537|6334894|P1|Baseline Participants|Patient uncompliant|0
1827809|NCT00368537|6334893|P2|Baseline Participants|No susceptibility|0
1827810|NCT00368537|6334894|P1|Baseline Participants|No susceptibility|1
1827811|NCT00368537|6334893|P2|Baseline Participants|Death|2
1827812|NCT00368537|6334894|P1|Baseline Participants|Death|1
1827813|NCT00368537|6334893|P2|Baseline Participants|Withdrawal by Subject|4
1827814|NCT00368537|6334894|P1|Baseline Participants|Withdrawal by Subject|6
1827815|NCT00368537|6334893|P2|Baseline Participants|Lost to Follow-up|17
1827816|NCT00368537|6334894|P1|Baseline Participants|Lost to Follow-up|16
1827817|NCT00368537|6334893|P2|Randomization|No study drug dosed|6
1827818|NCT00368537|6334894|P1|Randomization|No study drug dosed|13
1827819|NCT00368472|6334908|P1|Overall Study|Missing Final Disposition Date|1
1827820|NCT00368472|6334908|P1|Overall Study|Other|32
1827821|NCT00368472|6334908|P1|Overall Study|Diary non-compliance|1
1827822|NCT00368472|6334908|P1|Overall Study|Withdrawal by Subject|40
1827823|NCT00368472|6334908|P1|Overall Study|Request of Investigator or Sponsor|3
1827824|NCT00368472|6334908|P1|Overall Study|Protocol Violation|2
1827825|NCT00368472|6334908|P1|Overall Study|Medication non-compliance|4
1827826|NCT00368472|6334908|P1|Overall Study|Adverse Event|22
1827827|NCT00368355|6334943|P2|Overall Study|Treatment - hematopoietic cell product|0
1827828|NCT00368355|6334944|P1|Overall Study|Treatment - hematopoietic cell product|2
1827829|NCT00368355|6334943|P2|Overall Study|Subsequent transplant|3
1827830|NCT00368355|6334944|P1|Overall Study|Subsequent transplant|0
1827831|NCT00368355|6334943|P2|Overall Study|Relapse|10
1827832|NCT00368355|6334944|P1|Overall Study|Relapse|6
1827833|NCT00368355|6334943|P2|Overall Study|Death|4
1827834|NCT00368355|6334944|P1|Overall Study|Death|2
1827835|NCT00368355|6334943|P2|Overall Study|Adverse Event|0
1827836|NCT00368355|6334944|P1|Overall Study|Adverse Event|1
1827837|NCT00368277|6334984|P2|Overall Study|Lost to Follow-up|6
1827838|NCT00368277|6334985|P1|Overall Study|Lost to Follow-up|8
1827839|NCT00368277|6334984|P2|Overall Study|Patient withdrew consent|28
1827840|NCT00368277|6334985|P1|Overall Study|Patient withdrew consent|32
1827841|NCT00368277|6334984|P2|Overall Study|Protocol deviation|0
1827842|NCT00368277|6334985|P1|Overall Study|Protocol deviation|7
1827843|NCT00368277|6334984|P2|Overall Study|Unsatisfactory therapeutic effect|24
1827844|NCT00368277|6334985|P1|Overall Study|Unsatisfactory therapeutic effect|31
1827845|NCT00368277|6334984|P2|Overall Study|Death|1
1827846|NCT00368277|6334985|P1|Overall Study|Death|2
1827847|NCT00368277|6334984|P2|Overall Study|Adverse Event|49
1827848|NCT00368277|6334985|P1|Overall Study|Adverse Event|33
1827849|NCT00368251|6335000|P3|Overall Study|AE, non-serious non-fatal|1
1827850|NCT00368251|6335001|P2|Overall Study|AE, non-serious non-fatal|0
1827851|NCT00368251|6335002|P1|Overall Study|AE, non-serious non-fatal|0
1827852|NCT00368251|6335000|P3|Overall Study|SAE, non-fatal|0
1827853|NCT00368251|6335001|P2|Overall Study|SAE, non-fatal|0
1827854|NCT00368251|6335002|P1|Overall Study|SAE, non-fatal|1
1827855|NCT00368108|6335025|P3|Overall Study|Other|1
1827856|NCT00368108|6335026|P2|Overall Study|Other|7
1827857|NCT00368108|6335027|P1|Overall Study|Other|3
1827858|NCT00368108|6335025|P3|Overall Study|Physician Decision|1
1827859|NCT00368108|6335026|P2|Overall Study|Physician Decision|0
1827860|NCT00368108|6335027|P1|Overall Study|Physician Decision|2
1827861|NCT00368108|6335025|P3|Overall Study|Lack of Efficacy|5
1827862|NCT00368108|6335026|P2|Overall Study|Lack of Efficacy|8
1827863|NCT00368108|6335027|P1|Overall Study|Lack of Efficacy|7
1827864|NCT00368108|6335025|P3|Overall Study|Withdrawal by Subject|5
1827865|NCT00368108|6335026|P2|Overall Study|Withdrawal by Subject|3
1827866|NCT00368108|6335027|P1|Overall Study|Withdrawal by Subject|9
1827867|NCT00368108|6335025|P3|Overall Study|Protocol Violation|9
1827868|NCT00368108|6335026|P2|Overall Study|Protocol Violation|9
1827869|NCT00368108|6335027|P1|Overall Study|Protocol Violation|5
1827870|NCT00368108|6335025|P3|Overall Study|Abnormal Laboratory Value|3
1827871|NCT00368108|6335026|P2|Overall Study|Abnormal Laboratory Value|0
1827872|NCT00368108|6335027|P1|Overall Study|Abnormal Laboratory Value|0
1827873|NCT00368108|6335025|P3|Overall Study|Adverse Event|44
1827874|NCT00368108|6335026|P2|Overall Study|Adverse Event|26
1827875|NCT00368108|6335027|P1|Overall Study|Adverse Event|38
1827876|NCT00368069|6335046|P2|Overall Study|no blood sampling possible|1
1827877|NCT00368069|6335047|P1|Overall Study|no blood sampling possible|0
1827878|NCT00368069|6335046|P2|Overall Study|Withdrawal of Consent|1
1827879|NCT00368069|6335047|P1|Overall Study|Withdrawal of Consent|2
1827880|NCT00368069|6335046|P2|Overall Study|Protocol Violation|2
1827881|NCT00368069|6335047|P1|Overall Study|Protocol Violation|0
1827882|NCT00368069|6335046|P2|Overall Study|Lost to Follow-up|0
1827883|NCT00368069|6335047|P1|Overall Study|Lost to Follow-up|1
1827884|NCT00368069|6335046|P2|Overall Study|Lack of Efficacy|1
1827885|NCT00368069|6335047|P1|Overall Study|Lack of Efficacy|0
1827886|NCT00368069|6335046|P2|Overall Study|Adverse Event|2
1827887|NCT00368069|6335047|P1|Overall Study|Adverse Event|5
1827888|NCT00367991|6335065|P2|Overall Study|Adverse Event|1
1827889|NCT00367991|6335066|P1|Overall Study|Adverse Event|1
1827890|NCT00367991|6335065|P2|Overall Study|Withdrawal by Subject|1
1827891|NCT00367991|6335066|P1|Overall Study|Withdrawal by Subject|1
1827892|NCT00367835|6335084|P2|Overall Study|History of lead poisoning|1
1827893|NCT00367835|6335085|P1|Overall Study|History of lead poisoning|0
1827894|NCT00367835|6335084|P2|Overall Study|Did not respond to calls|0
1827895|NCT00367835|6335085|P1|Overall Study|Did not respond to calls|1
1827896|NCT00367835|6335084|P2|Overall Study|refused blood collection|0
1827897|NCT00367835|6335085|P1|Overall Study|refused blood collection|1
1827898|NCT00367835|6335084|P2|Overall Study|Subject in juvenile detention center|0
1827899|NCT00367835|6335085|P1|Overall Study|Subject in juvenile detention center|1
1827900|NCT00367835|6335084|P2|Overall Study|Lack of Efficacy|12
1827901|NCT00367835|6335085|P1|Overall Study|Lack of Efficacy|3
1827902|NCT00367835|6335084|P2|Overall Study|Lost to Follow-up|4
1827903|NCT00367835|6335085|P1|Overall Study|Lost to Follow-up|1
1827904|NCT00367835|6335084|P2|Overall Study|Withdrawal by Subject|6
1827905|NCT00367835|6335085|P1|Overall Study|Withdrawal by Subject|7
1827906|NCT00367835|6335084|P2|Overall Study|Protocol Violation|7
1827907|NCT00367835|6335085|P1|Overall Study|Protocol Violation|1
1827908|NCT00367835|6335084|P2|Overall Study|Adverse Event|1
1827909|NCT00367835|6335085|P1|Overall Study|Adverse Event|14
1827910|NCT00367770|6335111|P1|Overall Study|Withdrawal by Subject|1
1827911|NCT00367770|6335111|P1|Overall Study|Adverse Event|1
1827912|NCT00367744|6335119|P2|Overall Study|Lost to Follow-up|5
1827913|NCT00367744|6335120|P1|Overall Study|Lost to Follow-up|4
1827914|NCT00367640|6335149|P4|Overall Study|Any other reason not above-mentioned|4
1827915|NCT00367640|6335150|P3|Overall Study|Any other reason not above-mentioned|3
1827916|NCT00367640|6335151|P2|Overall Study|Any other reason not above-mentioned|5
1827917|NCT00367640|6335152|P1|Overall Study|Any other reason not above-mentioned|7
1827918|NCT00367640|6335149|P4|Overall Study|Withdrawal by Subject|6
1827919|NCT00367640|6335150|P3|Overall Study|Withdrawal by Subject|8
1827920|NCT00367640|6335151|P2|Overall Study|Withdrawal by Subject|11
1827921|NCT00367640|6335152|P1|Overall Study|Withdrawal by Subject|8
1827922|NCT00367640|6335149|P4|Overall Study|Adverse Event|0
1827923|NCT00367640|6335150|P3|Overall Study|Adverse Event|8
1827924|NCT00367640|6335151|P2|Overall Study|Adverse Event|6
1827925|NCT00367640|6335152|P1|Overall Study|Adverse Event|3
1827926|NCT00367484|6335168|P1|Overall Study|Lack of Efficacy|1
1827927|NCT00367484|6335168|P1|Overall Study|The choice of the patient|1
1827928|NCT00367484|6335168|P1|Overall Study|Protocol Violation|1
1827929|NCT00367484|6335168|P1|Overall Study|Lost to Follow-up|1
1827930|NCT00367484|6335168|P1|Overall Study|Travel to USA|1
1827931|NCT00367484|6335168|P1|Overall Study|Withdrew informed consent|5
1827932|NCT00367484|6335168|P1|Overall Study|Adverse Event|7
1827933|NCT00367432|6335172|P2|Second Period (up to 54 Months)|Other Reason|2
1827934|NCT00367432|6335173|P1|Second Period (up to 54 Months)|Other Reason|6
1827935|NCT00367432|6335172|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
1827936|NCT00367432|6335173|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
1827937|NCT00367432|6335172|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
1827938|NCT00367432|6335173|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
1827939|NCT00367432|6335172|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
1827940|NCT00367432|6335173|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
1827941|NCT00367432|6335172|P2|Second Period (up to 54 Months)|Adverse Event|3
1827942|NCT00367432|6335173|P1|Second Period (up to 54 Months)|Adverse Event|14
1827943|NCT00367432|6335172|P2|First Period (16 Weeks)|Other Reason|0
1827944|NCT00367432|6335173|P1|First Period (16 Weeks)|Other Reason|2
1827945|NCT00367432|6335172|P2|First Period (16 Weeks)|Withdrawal by Subject|0
1827946|NCT00367432|6335173|P1|First Period (16 Weeks)|Withdrawal by Subject|6
1827947|NCT00367432|6335172|P2|First Period (16 Weeks)|Lack of Efficacy|0
1827948|NCT00367432|6335173|P1|First Period (16 Weeks)|Lack of Efficacy|24
1827949|NCT00367432|6335172|P2|First Period (16 Weeks)|Adverse Event|0
1827950|NCT00367432|6335173|P1|First Period (16 Weeks)|Adverse Event|6
1827951|NCT00367341|6335200|P2|Overall Study|Protocol Violation|0
1827952|NCT00367341|6335201|P1|Overall Study|Protocol Violation|1
1827953|NCT00367341|6335200|P2|Overall Study|Physician Decision|0
1827954|NCT00367341|6335201|P1|Overall Study|Physician Decision|1
1827955|NCT00367237|6335211|P2|Overall Study|Protocol Violation|5
1827956|NCT00367237|6335212|P1|Overall Study|Protocol Violation|2
1827957|NCT00367237|6335211|P2|Overall Study|Withdrawal by Subject|4
1827958|NCT00367237|6335212|P1|Overall Study|Withdrawal by Subject|0
1827959|NCT00367237|6335211|P2|Overall Study|Lost to Follow-up|0
1827960|NCT00367237|6335212|P1|Overall Study|Lost to Follow-up|1
1827961|NCT00367237|6335211|P2|Overall Study|Adverse Event|2
1827962|NCT00367237|6335212|P1|Overall Study|Adverse Event|7
1827963|NCT00367133|6335221|P3|2 Years|Missed visit|4
1827964|NCT00367133|6335222|P2|2 Years|Missed visit|5
1827965|NCT00367133|6335223|P1|2 Years|Missed visit|4
1827966|NCT00367133|6335221|P3|2 Years|Dropped|33
1827967|NCT00367133|6335222|P2|2 Years|Dropped|19
1827968|NCT00367133|6335223|P1|2 Years|Dropped|34
1827969|NCT00367133|6335221|P3|2 Years|Death|12
1827970|NCT00367133|6335222|P2|2 Years|Death|12
1827971|NCT00367133|6335223|P1|2 Years|Death|20
1827972|NCT00367055|6335275|P2|Overall Study|Participant Living too Far from Hospital|1
1827973|NCT00367055|6335276|P1|Overall Study|Participant Living too Far from Hospital|0
1827974|NCT00367055|6335275|P2|Overall Study|Stopping Criterion Met|1
1827975|NCT00367055|6335276|P1|Overall Study|Stopping Criterion Met|0
1827976|NCT00367055|6335275|P2|Overall Study|Protocol Violation|1
1827977|NCT00367055|6335276|P1|Overall Study|Protocol Violation|0
1827978|NCT00367055|6335275|P2|Overall Study|Lost to Follow-up|1
1827979|NCT00367055|6335276|P1|Overall Study|Lost to Follow-up|1
1827980|NCT00367055|6335275|P2|Overall Study|Lack of Efficacy|2
1827981|NCT00367055|6335276|P1|Overall Study|Lack of Efficacy|1
1827982|NCT00367055|6335275|P2|Overall Study|Patient's Willing|2
1827983|NCT00367055|6335276|P1|Overall Study|Patient's Willing|3
1827984|NCT00367055|6335275|P2|Overall Study|Adverse Event|3
1827985|NCT00367055|6335276|P1|Overall Study|Adverse Event|6
1827986|NCT00366899|6335292|P2|Toddler Dose|Protocol Violation|0
1827987|NCT00366899|6335293|P1|Toddler Dose|Protocol Violation|1
1827988|NCT00366899|6335292|P2|Toddler Dose|Withdrawal by Subject|1
1827989|NCT00366899|6335293|P1|Toddler Dose|Withdrawal by Subject|1
1827990|NCT00366899|6335292|P2|After Infant Series|Protocol Violation|0
1827991|NCT00366899|6335293|P1|After Infant Series|Protocol Violation|1
1827992|NCT00366899|6335292|P2|After Infant Series|Adverse Event|2
1827993|NCT00366899|6335293|P1|After Infant Series|Adverse Event|1
1827994|NCT00366899|6335292|P2|After Infant Series|Withdrawal by Subject|4
1827995|NCT00366899|6335293|P1|After Infant Series|Withdrawal by Subject|1
1827996|NCT00366899|6335292|P2|After Infant Series|Lost to Follow-up|3
1827997|NCT00366899|6335293|P1|After Infant Series|Lost to Follow-up|4
1827998|NCT00366899|6335292|P2|Infant Series|Randomized but not consented|0
1827999|NCT00366899|6335293|P1|Infant Series|Randomized but not consented|1
1828000|NCT00366899|6335292|P2|Infant Series|Physician Decision|0
1828001|NCT00366899|6335293|P1|Infant Series|Physician Decision|1
1828002|NCT00366899|6335292|P2|Infant Series|Adverse Event|1
1828003|NCT00366899|6335293|P1|Infant Series|Adverse Event|0
1828004|NCT00366899|6335292|P2|Infant Series|Lost to Follow-up|2
1828005|NCT00366899|6335293|P1|Infant Series|Lost to Follow-up|0
1828006|NCT00366899|6335292|P2|Infant Series|Failed to return|1
1828007|NCT00366899|6335293|P1|Infant Series|Failed to return|1
1828008|NCT00366899|6335292|P2|Infant Series|Protocol Violation|1
1828009|NCT00366899|6335293|P1|Infant Series|Protocol Violation|2
1828010|NCT00366899|6335292|P2|Infant Series|Withdrawal by Subject|7
1828011|NCT00366899|6335293|P1|Infant Series|Withdrawal by Subject|4
1828012|NCT00366678|6335353|P3|Toddler Dose|protocol deviation|0
1828013|NCT00366678|6335354|P2|Toddler Dose|protocol deviation|0
1828014|NCT00366678|6335355|P1|Toddler Dose|protocol deviation|1
1828015|NCT00366678|6335353|P3|Toddler Dose|Withdrawal by Subject|0
1828016|NCT00366678|6335354|P2|Toddler Dose|Withdrawal by Subject|0
1828017|NCT00366678|6335355|P1|Toddler Dose|Withdrawal by Subject|1
1828018|NCT00366678|6335353|P3|Toddler Dose|Failed to return|0
1828019|NCT00366678|6335354|P2|Toddler Dose|Failed to return|0
1828020|NCT00366678|6335355|P1|Toddler Dose|Failed to return|1
1828021|NCT00366678|6335353|P3|Toddler Dose|Protocol Violation|0
1828022|NCT00366678|6335354|P2|Toddler Dose|Protocol Violation|1
1828023|NCT00366678|6335355|P1|Toddler Dose|Protocol Violation|2
1828024|NCT00366678|6335353|P3|After Infant|Protocol Violation|0
1828025|NCT00366678|6335354|P2|After Infant|Protocol Violation|0
1828026|NCT00366678|6335355|P1|After Infant|Protocol Violation|1
1828027|NCT00366678|6335353|P3|After Infant|Adverse Event|0
1828028|NCT00366678|6335354|P2|After Infant|Adverse Event|0
1828029|NCT00366678|6335355|P1|After Infant|Adverse Event|1
1828030|NCT00366678|6335353|P3|After Infant|Failed to return|0
1828031|NCT00366678|6335354|P2|After Infant|Failed to return|5
1828032|NCT00366678|6335355|P1|After Infant|Failed to return|5
1828033|NCT00366678|6335353|P3|After Infant|Lost to Follow-up|0
1828034|NCT00366678|6335354|P2|After Infant|Lost to Follow-up|1
1828035|NCT00366678|6335355|P1|After Infant|Lost to Follow-up|2
1828036|NCT00366678|6335353|P3|After Infant|Withdrawal by Subject|0
1828037|NCT00366678|6335354|P2|After Infant|Withdrawal by Subject|4
1828038|NCT00366678|6335355|P1|After Infant|Withdrawal by Subject|8
1828039|NCT00366678|6335353|P3|Infant Series|Adverse Event|0
1828040|NCT00366678|6335354|P2|Infant Series|Adverse Event|0
1828041|NCT00366678|6335355|P1|Infant Series|Adverse Event|1
1828042|NCT00366678|6335353|P3|Infant Series|Failed to return|0
1828043|NCT00366678|6335354|P2|Infant Series|Failed to return|1
1828044|NCT00366678|6335355|P1|Infant Series|Failed to return|1
1828045|NCT00366678|6335353|P3|Infant Series|Protocol Violation|0
1828046|NCT00366678|6335354|P2|Infant Series|Protocol Violation|3
1828047|NCT00366678|6335355|P1|Infant Series|Protocol Violation|4
1828048|NCT00366678|6335353|P3|Infant Series|Withdrawal by Subject|0
1828049|NCT00366678|6335354|P2|Infant Series|Withdrawal by Subject|6
1828050|NCT00366678|6335355|P1|Infant Series|Withdrawal by Subject|8
1828051|NCT00366548|6335437|P2|After Infant Series|Lost to Follow-up|0
1828052|NCT00366548|6335438|P1|After Infant Series|Lost to Follow-up|1
1828053|NCT00366548|6335437|P2|After Infant Series|Adverse Event|0
1828054|NCT00366548|6335438|P1|After Infant Series|Adverse Event|2
1828055|NCT00366548|6335437|P2|After Infant Series|Withdrawal by Subject|1
1828056|NCT00366548|6335438|P1|After Infant Series|Withdrawal by Subject|3
1828057|NCT00366548|6335437|P2|Infant Series|Withdrawal by Subject|1
1828058|NCT00366548|6335438|P1|Infant Series|Withdrawal by Subject|3
1828059|NCT00366548|6335437|P2|Infant Series|Protocol Violation|1
1828060|NCT00366548|6335438|P1|Infant Series|Protocol Violation|0
1828061|NCT00366548|6335437|P2|Infant Series|Adverse Event|3
1828062|NCT00366548|6335438|P1|Infant Series|Adverse Event|1
1828063|NCT00366535|6335474|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
1828064|NCT00366535|6335475|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
1828065|NCT00366535|6335474|P2|Second Phase: 12 Weeks|Adverse Event|1
1828066|NCT00366535|6335475|P1|Second Phase: 12 Weeks|Adverse Event|1
1828067|NCT00366535|6335474|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
1828068|NCT00366535|6335475|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
1828069|NCT00366535|6335474|P2|First Phase: 12 Weeks|Adverse Event|3
1828070|NCT00366535|6335475|P1|First Phase: 12 Weeks|Adverse Event|1
1828071|NCT00366457|6335489|P1|Overall Study|never began study therapy|2
1828072|NCT00366444|6335498|P2|Overall Study|Lack of Efficacy|1
1828073|NCT00366444|6335499|P1|Overall Study|Lack of Efficacy|0
1828074|NCT00366444|6335498|P2|Overall Study|Withdrawal by Subject|1
1828075|NCT00366444|6335499|P1|Overall Study|Withdrawal by Subject|1
1828076|NCT00366340|6335527|P2|Toddler Dose|Parent/legal guardian request|1
1828077|NCT00366340|6335528|P1|Toddler Dose|Parent/legal guardian request|0
1828078|NCT00366340|6335527|P2|Toddler Dose|Failed to return|0
1828079|NCT00366340|6335528|P1|Toddler Dose|Failed to return|1
1828080|NCT00366340|6335527|P2|After the Infant Series|Lost to Follow-up|1
1828081|NCT00366340|6335528|P1|After the Infant Series|Lost to Follow-up|0
1828082|NCT00366340|6335527|P2|After the Infant Series|Adverse Event|1
1828083|NCT00366340|6335528|P1|After the Infant Series|Adverse Event|0
1828084|NCT00366340|6335527|P2|After the Infant Series|Protocol Violation|2
1828085|NCT00366340|6335528|P1|After the Infant Series|Protocol Violation|2
1828086|NCT00366340|6335527|P2|After the Infant Series|Failed to return|1
1828087|NCT00366340|6335528|P1|After the Infant Series|Failed to return|0
1828088|NCT00366340|6335527|P2|After the Infant Series|Parent/legal guardian request|1
1828089|NCT00366340|6335528|P1|After the Infant Series|Parent/legal guardian request|1
1828090|NCT00366340|6335527|P2|Infant Series|Failure to return|0
1828091|NCT00366340|6335528|P1|Infant Series|Failure to return|1
1828092|NCT00366340|6335527|P2|Infant Series|Lost to Follow-up|1
1828093|NCT00366340|6335528|P1|Infant Series|Lost to Follow-up|1
1828094|NCT00366340|6335527|P2|Infant Series|Adverse Event|2
1828095|NCT00366340|6335528|P1|Infant Series|Adverse Event|0
1828096|NCT00366340|6335527|P2|Infant Series|Withdrawal by Subject|3
1828097|NCT00366340|6335528|P1|Infant Series|Withdrawal by Subject|3
1828098|NCT00366340|6335527|P2|Infant Series|Protocol Violation|4
1828099|NCT00366340|6335528|P1|Infant Series|Protocol Violation|3
1828100|NCT00366301|6335586|P4|Overall Study|Withdrawal by Subject|1
1828101|NCT00366301|6335587|P3|Overall Study|Withdrawal by Subject|1
1828102|NCT00366301|6335588|P2|Overall Study|Withdrawal by Subject|2
1828103|NCT00366301|6335589|P1|Overall Study|Withdrawal by Subject|4
1828104|NCT00366301|6335586|P4|Overall Study|Lost to Follow-up|7
1828105|NCT00366301|6335587|P3|Overall Study|Lost to Follow-up|3
1828106|NCT00366301|6335588|P2|Overall Study|Lost to Follow-up|4
1828107|NCT00366301|6335589|P1|Overall Study|Lost to Follow-up|4
1828108|NCT00366249|6335605|P2|Overall Study|Most due to osteomylitis status|20
1828109|NCT00366249|6335606|P1|Overall Study|Most due to osteomylitis status|31
1828110|NCT00366249|6335605|P2|Overall Study|Lack of Efficacy|21
1828111|NCT00366249|6335606|P1|Overall Study|Lack of Efficacy|21
1828112|NCT00366249|6335605|P2|Overall Study|Withdrawal by Subject|4
1828113|NCT00366249|6335606|P1|Overall Study|Withdrawal by Subject|18
1828114|NCT00366249|6335605|P2|Overall Study|Protocol Violation|2
1828115|NCT00366249|6335606|P1|Overall Study|Protocol Violation|1
1828116|NCT00366249|6335605|P2|Overall Study|Lost to Follow-up|0
1828117|NCT00366249|6335606|P1|Overall Study|Lost to Follow-up|2
1828118|NCT00366249|6335605|P2|Overall Study|Physician Decision|2
1828119|NCT00366249|6335606|P1|Overall Study|Physician Decision|5
1828120|NCT00366249|6335605|P2|Overall Study|Death|1
1828121|NCT00366249|6335606|P1|Overall Study|Death|0
1828122|NCT00366249|6335605|P2|Overall Study|Adverse Event|28
1828123|NCT00366249|6335606|P1|Overall Study|Adverse Event|53
1828124|NCT00365989|6335638|P1|Overall Study|Non-compliance|1
1828125|NCT00365989|6335638|P1|Overall Study|Withdrawal by Subject|1
1828126|NCT00365976|6335646|P2|Overall Study|Withdrawal by Subject|5
1828127|NCT00365976|6335647|P1|Overall Study|Withdrawal by Subject|1
1828128|NCT00365846|6335785|P1|Overall Study|Lost to Follow-up|1
1828129|NCT00365794|6335794|P1|Overall Study|Withdrawal by Subject|2
1828130|NCT00365716|6335823|P7|Extension 2|Withdrawal by Subject|5
1828131|NCT00365716|6335824|P6|Extension 2|Withdrawal by Subject|0
1828132|NCT00365716|6335825|P5|Extension 2|Withdrawal by Subject|0
1828133|NCT00365716|6335826|P4|Extension 2|Withdrawal by Subject|0
1828134|NCT00365716|6335827|P3|Extension 2|Withdrawal by Subject|0
1828135|NCT00365716|6335828|P2|Extension 2|Withdrawal by Subject|0
1828136|NCT00365716|6335829|P1|Extension 2|Withdrawal by Subject|0
1828137|NCT00365716|6335823|P7|Extension 2|Other|3
1828138|NCT00365716|6335824|P6|Extension 2|Other|0
1828139|NCT00365716|6335825|P5|Extension 2|Other|0
1828140|NCT00365716|6335826|P4|Extension 2|Other|0
1828141|NCT00365716|6335827|P3|Extension 2|Other|0
1828142|NCT00365716|6335828|P2|Extension 2|Other|0
1828143|NCT00365716|6335829|P1|Extension 2|Other|0
1828144|NCT00365716|6335823|P7|Extension 2|Lost to Follow-up|2
1828145|NCT00365716|6335824|P6|Extension 2|Lost to Follow-up|0
1828146|NCT00365716|6335825|P5|Extension 2|Lost to Follow-up|0
1828147|NCT00365716|6335826|P4|Extension 2|Lost to Follow-up|0
1828148|NCT00365716|6335827|P3|Extension 2|Lost to Follow-up|0
1828149|NCT00365716|6335828|P2|Extension 2|Lost to Follow-up|0
1828150|NCT00365716|6335829|P1|Extension 2|Lost to Follow-up|0
1828151|NCT00365716|6335823|P7|Extension 1|Protocol Violation|0
1828152|NCT00365716|6335824|P6|Extension 1|Protocol Violation|1
1828153|NCT00365716|6335825|P5|Extension 1|Protocol Violation|0
1828154|NCT00365716|6335826|P4|Extension 1|Protocol Violation|0
1828155|NCT00365716|6335827|P3|Extension 1|Protocol Violation|0
1828156|NCT00365716|6335828|P2|Extension 1|Protocol Violation|0
1828157|NCT00365716|6335829|P1|Extension 1|Protocol Violation|0
1828158|NCT00365716|6335823|P7|Extension 1|Pregnancy|0
1828159|NCT00365716|6335824|P6|Extension 1|Pregnancy|4
1828160|NCT00365716|6335825|P5|Extension 1|Pregnancy|0
1828161|NCT00365716|6335826|P4|Extension 1|Pregnancy|0
1828162|NCT00365716|6335827|P3|Extension 1|Pregnancy|0
1828163|NCT00365716|6335828|P2|Extension 1|Pregnancy|0
1828164|NCT00365716|6335829|P1|Extension 1|Pregnancy|0
1828165|NCT00365716|6335823|P7|Extension 1|Withdrawal by Subject|0
1828166|NCT00365716|6335824|P6|Extension 1|Withdrawal by Subject|3
1828167|NCT00365716|6335825|P5|Extension 1|Withdrawal by Subject|0
1828168|NCT00365716|6335826|P4|Extension 1|Withdrawal by Subject|0
1828169|NCT00365716|6335827|P3|Extension 1|Withdrawal by Subject|0
1828170|NCT00365716|6335828|P2|Extension 1|Withdrawal by Subject|0
1828171|NCT00365716|6335829|P1|Extension 1|Withdrawal by Subject|0
1828172|NCT00365716|6335823|P7|Extension 1|Moved|0
1828173|NCT00365716|6335824|P6|Extension 1|Moved|4
1828174|NCT00365716|6335825|P5|Extension 1|Moved|0
1828175|NCT00365716|6335826|P4|Extension 1|Moved|0
1828176|NCT00365716|6335827|P3|Extension 1|Moved|0
1828177|NCT00365716|6335828|P2|Extension 1|Moved|0
1828178|NCT00365716|6335829|P1|Extension 1|Moved|0
1828179|NCT00365716|6335823|P7|Extension 1|Other|0
1828180|NCT00365716|6335824|P6|Extension 1|Other|9
1828181|NCT00365716|6335825|P5|Extension 1|Other|0
1828182|NCT00365716|6335826|P4|Extension 1|Other|0
1828183|NCT00365716|6335827|P3|Extension 1|Other|0
1828184|NCT00365716|6335828|P2|Extension 1|Other|0
1828185|NCT00365716|6335829|P1|Extension 1|Other|0
1828186|NCT00365716|6335823|P7|Extension 1|Lost to Follow-up|0
1828187|NCT00365716|6335824|P6|Extension 1|Lost to Follow-up|1
1828188|NCT00365716|6335825|P5|Extension 1|Lost to Follow-up|0
1828189|NCT00365716|6335826|P4|Extension 1|Lost to Follow-up|0
1828190|NCT00365716|6335827|P3|Extension 1|Lost to Follow-up|0
1828191|NCT00365716|6335828|P2|Extension 1|Lost to Follow-up|0
1828192|NCT00365716|6335829|P1|Extension 1|Lost to Follow-up|0
1828193|NCT00365716|6335823|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1828194|NCT00365716|6335824|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
1828195|NCT00365716|6335825|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
1828196|NCT00365716|6335826|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1828197|NCT00365716|6335827|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
1828198|NCT00365716|6335828|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
1828199|NCT00365716|6335829|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
1828200|NCT00365716|6335823|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1828201|NCT00365716|6335824|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1828202|NCT00365716|6335825|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1828203|NCT00365716|6335826|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1828204|NCT00365716|6335827|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1828205|NCT00365716|6335828|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
1828206|NCT00365716|6335829|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
1828207|NCT00365716|6335823|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1828208|NCT00365716|6335824|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1828209|NCT00365716|6335825|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
1828210|NCT00365716|6335826|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1828211|NCT00365716|6335827|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1828212|NCT00365716|6335828|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
1828213|NCT00365716|6335829|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
1828214|NCT00365716|6335823|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1828215|NCT00365716|6335824|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1828216|NCT00365716|6335825|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
1828217|NCT00365716|6335826|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1828218|NCT00365716|6335827|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
1828219|NCT00365716|6335828|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
1828220|NCT00365716|6335829|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
1828221|NCT00365716|6335823|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1828222|NCT00365716|6335824|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
1828223|NCT00365716|6335825|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
1828224|NCT00365716|6335826|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
1828225|NCT00365716|6335827|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
1828226|NCT00365716|6335828|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
1828227|NCT00365716|6335829|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
1828228|NCT00365716|6335823|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1828229|NCT00365716|6335824|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1828230|NCT00365716|6335825|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
1828231|NCT00365716|6335826|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
1828232|NCT00365716|6335827|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1828233|NCT00365716|6335828|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
1828234|NCT00365716|6335829|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
1828235|NCT00365716|6335823|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1828236|NCT00365716|6335824|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
1828237|NCT00365716|6335825|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
1828238|NCT00365716|6335826|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
1828239|NCT00365716|6335827|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1828240|NCT00365716|6335828|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
1828241|NCT00365716|6335829|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
1828242|NCT00365716|6335823|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
1828243|NCT00365716|6335824|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
1828244|NCT00365716|6335825|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
1828245|NCT00365716|6335826|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
1828246|NCT00365716|6335827|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
1828247|NCT00365716|6335828|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
1828248|NCT00365716|6335829|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
1828249|NCT00365716|6335823|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
1828250|NCT00365716|6335824|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
1828251|NCT00365716|6335825|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
1828252|NCT00365716|6335826|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
1828253|NCT00365716|6335827|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
1828254|NCT00365716|6335828|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
1828255|NCT00365716|6335829|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
1828256|NCT00365716|6335823|P7|Base Study (Day 1 to Month 7)|Other|0
1828257|NCT00365716|6335824|P6|Base Study (Day 1 to Month 7)|Other|0
1828258|NCT00365716|6335825|P5|Base Study (Day 1 to Month 7)|Other|0
1828259|NCT00365716|6335826|P4|Base Study (Day 1 to Month 7)|Other|0
1828260|NCT00365716|6335827|P3|Base Study (Day 1 to Month 7)|Other|0
1828261|NCT00365716|6335828|P2|Base Study (Day 1 to Month 7)|Other|1
1828262|NCT00365716|6335829|P1|Base Study (Day 1 to Month 7)|Other|0
1828263|NCT00365716|6335823|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1828264|NCT00365716|6335824|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1828265|NCT00365716|6335825|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
1828266|NCT00365716|6335826|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1828267|NCT00365716|6335827|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1828268|NCT00365716|6335828|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
1828269|NCT00365716|6335829|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
1828270|NCT00365716|6335823|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
1828271|NCT00365716|6335824|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
1828272|NCT00365716|6335825|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
1828273|NCT00365716|6335826|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
1828274|NCT00365716|6335827|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
1828275|NCT00365716|6335828|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
1828276|NCT00365716|6335829|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
1828277|NCT00365716|6335823|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1828278|NCT00365716|6335824|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1828279|NCT00365716|6335825|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1828280|NCT00365716|6335826|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1828281|NCT00365716|6335827|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
1828282|NCT00365716|6335828|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
1828283|NCT00365716|6335829|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
1828284|NCT00365547|6335850|P1|Overall Study|Withdrawal by Subject|1
1828285|NCT00365547|6335850|P1|Overall Study|Screen failure|1
1828286|NCT00365547|6335850|P1|Overall Study|Insurance did not cover Avastin|1
1828287|NCT00365508|6335860|P2|Overall Study|Lost to Follow-up|154
1828288|NCT00365508|6335861|P1|Overall Study|Lost to Follow-up|139
1828289|NCT00365456|6335869|P2|Trial Period III (12 Months)|Other|1
1828290|NCT00365456|6335870|P1|Trial Period III (12 Months)|Other|1
1828291|NCT00365456|6335869|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
1828292|NCT00365456|6335870|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
1828293|NCT00365456|6335869|P2|Trial Period III (12 Months)|Adverse Event|3
1828294|NCT00365456|6335870|P1|Trial Period III (12 Months)|Adverse Event|13
1828295|NCT00365456|6335869|P2|Trial Period II (12 Months)|Other|1
1828296|NCT00365456|6335870|P1|Trial Period II (12 Months)|Other|0
1828297|NCT00365456|6335869|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
1828298|NCT00365456|6335870|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
1828299|NCT00365456|6335869|P2|Trial Period II (12 Months)|Non-compliance|2
1828300|NCT00365456|6335870|P1|Trial Period II (12 Months)|Non-compliance|0
1828301|NCT00365456|6335869|P2|Trial Period II (12 Months)|Adverse Event|6
1828302|NCT00365456|6335870|P1|Trial Period II (12 Months)|Adverse Event|0
1828303|NCT00365456|6335869|P2|Trial Period I (12 Months)|Other|0
1828304|NCT00365456|6335870|P1|Trial Period I (12 Months)|Other|11
1828305|NCT00365456|6335869|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
1828306|NCT00365456|6335870|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
1828307|NCT00365456|6335869|P2|Trial Period I (12 Months)|Non-compliance|0
1828308|NCT00365456|6335870|P1|Trial Period I (12 Months)|Non-compliance|3
1828309|NCT00365456|6335869|P2|Trial Period I (12 Months)|Adverse Event|0
1828310|NCT00365456|6335870|P1|Trial Period I (12 Months)|Adverse Event|84
1828311|NCT00365378|6335897|P3|Extension|Other|31
1828312|NCT00365378|6335898|P2|Extension|Other|0
1828313|NCT00365378|6335899|P1|Extension|Other|0
1828314|NCT00365378|6335897|P3|Extension|Withdrawal by Subject|98
1828315|NCT00365378|6335898|P2|Extension|Withdrawal by Subject|0
1828316|NCT00365378|6335899|P1|Extension|Withdrawal by Subject|0
1828317|NCT00365378|6335897|P3|Extension|Protocol Violation|2
1828318|NCT00365378|6335898|P2|Extension|Protocol Violation|0
1828319|NCT00365378|6335899|P1|Extension|Protocol Violation|0
1828320|NCT00365378|6335897|P3|Extension|Lost to Follow-up|57
1828321|NCT00365378|6335898|P2|Extension|Lost to Follow-up|0
1828322|NCT00365378|6335899|P1|Extension|Lost to Follow-up|0
1828323|NCT00365378|6335897|P3|Extension|Moved|8
1828324|NCT00365378|6335898|P2|Extension|Moved|0
1828325|NCT00365378|6335899|P1|Extension|Moved|0
1828326|NCT00365378|6335897|P3|Extension|Adverse Event|1
1828327|NCT00365378|6335898|P2|Extension|Adverse Event|0
1828328|NCT00365378|6335899|P1|Extension|Adverse Event|0
1828329|NCT00365378|6335897|P3|Follow-up (Month 7 Though Month 48)|Other|0
1828330|NCT00365378|6335898|P2|Follow-up (Month 7 Though Month 48)|Other|21
1828331|NCT00365378|6335899|P1|Follow-up (Month 7 Though Month 48)|Other|11
1828332|NCT00365378|6335897|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
1828333|NCT00365378|6335898|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
1828334|NCT00365378|6335899|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
1828335|NCT00365378|6335897|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
1828336|NCT00365378|6335898|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
1828337|NCT00365378|6335899|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
1828338|NCT00365378|6335897|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1828339|NCT00365378|6335898|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
1828340|NCT00365378|6335899|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
1828341|NCT00365378|6335897|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
1828342|NCT00365378|6335898|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
1828343|NCT00365378|6335899|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
1828344|NCT00365378|6335897|P3|Follow-up (Month 7 Though Month 48)|Moved|0
1828345|NCT00365378|6335898|P2|Follow-up (Month 7 Though Month 48)|Moved|5
1828346|NCT00365378|6335899|P1|Follow-up (Month 7 Though Month 48)|Moved|6
1828347|NCT00365378|6335897|P3|Vaccination (Day 1 to Month 7)|Other|0
1828348|NCT00365378|6335898|P2|Vaccination (Day 1 to Month 7)|Other|9
1828349|NCT00365378|6335899|P1|Vaccination (Day 1 to Month 7)|Other|17
1828350|NCT00365378|6335897|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
1828351|NCT00365378|6335898|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
1828352|NCT00365378|6335899|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
1828353|NCT00365378|6335897|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
1828354|NCT00365378|6335898|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
1828355|NCT00365378|6335899|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
1828356|NCT00365378|6335897|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
1828357|NCT00365378|6335898|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
1828358|NCT00365378|6335899|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
1828359|NCT00365378|6335897|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
1828360|NCT00365378|6335898|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
1828361|NCT00365378|6335899|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
1828362|NCT00365378|6335897|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
1828363|NCT00365378|6335898|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
1828364|NCT00365378|6335899|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
1828365|NCT00365378|6335897|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
1828366|NCT00365378|6335898|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
1828367|NCT00365378|6335899|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
1828368|NCT00365365|6335913|P3|Overall Study|Patient/physician decision|1
1828369|NCT00365365|6335914|P2|Overall Study|Patient/physician decision|0
1828370|NCT00365365|6335915|P1|Overall Study|Patient/physician decision|0
1828371|NCT00365365|6335913|P3|Overall Study|Second malignancy|0
1828372|NCT00365365|6335914|P2|Overall Study|Second malignancy|1
1828373|NCT00365365|6335915|P1|Overall Study|Second malignancy|0
1828374|NCT00365365|6335913|P3|Overall Study|Withdrew consent|0
1828375|NCT00365365|6335914|P2|Overall Study|Withdrew consent|1
1828376|NCT00365365|6335915|P1|Overall Study|Withdrew consent|1
1828377|NCT00365365|6335913|P3|Overall Study|New cancer|0
1828378|NCT00365365|6335914|P2|Overall Study|New cancer|0
1828379|NCT00365365|6335915|P1|Overall Study|New cancer|1
1828380|NCT00365365|6335913|P3|Overall Study|Moved|0
1828381|NCT00365365|6335914|P2|Overall Study|Moved|0
1828382|NCT00365365|6335915|P1|Overall Study|Moved|2
1828383|NCT00365365|6335913|P3|Overall Study|Adverse Event|3
1828384|NCT00365365|6335914|P2|Overall Study|Adverse Event|6
1828385|NCT00365365|6335915|P1|Overall Study|Adverse Event|6
1828386|NCT00365365|6335913|P3|Overall Study|Disease progression/relapse|7
1828387|NCT00365365|6335914|P2|Overall Study|Disease progression/relapse|6
1828388|NCT00365365|6335915|P1|Overall Study|Disease progression/relapse|9
1828389|NCT00365365|6335913|P3|Overall Study|Subject's request|1
1828390|NCT00365365|6335914|P2|Overall Study|Subject's request|13
1828391|NCT00365365|6335915|P1|Overall Study|Subject's request|11
1828392|NCT00365365|6335913|P3|Overall Study|Death|0
1828393|NCT00365365|6335914|P2|Overall Study|Death|3
1828394|NCT00365365|6335915|P1|Overall Study|Death|1
1828395|NCT00365365|6335913|P3|Overall Study|Lost to Follow-up|3
1828396|NCT00365365|6335914|P2|Overall Study|Lost to Follow-up|3
1828397|NCT00365365|6335915|P1|Overall Study|Lost to Follow-up|3
1828398|NCT00365365|6335913|P3|Overall Study|Poor compliance to protocol|0
1828399|NCT00365365|6335914|P2|Overall Study|Poor compliance to protocol|1
1828400|NCT00365365|6335915|P1|Overall Study|Poor compliance to protocol|0
1828401|NCT00365365|6335913|P3|Overall Study|Randomized but not treated|0
1828402|NCT00365365|6335914|P2|Overall Study|Randomized but not treated|2
1828403|NCT00365365|6335915|P1|Overall Study|Randomized but not treated|0
1828404|NCT00365352|6335932|P3|Overall Study|Withdrawal of Participant by Sponsor|0
1828405|NCT00365352|6335933|P2|Overall Study|Withdrawal of Participant by Sponsor|0
1828406|NCT00365352|6335934|P1|Overall Study|Withdrawal of Participant by Sponsor|1
1828407|NCT00365352|6335932|P3|Overall Study|Lost to Follow-up|0
1828408|NCT00365352|6335933|P2|Overall Study|Lost to Follow-up|1
1828409|NCT00365352|6335934|P1|Overall Study|Lost to Follow-up|1
1828410|NCT00365352|6335932|P3|Overall Study|Non-Compliance (after Randomization)|1
1828411|NCT00365352|6335933|P2|Overall Study|Non-Compliance (after Randomization)|0
1828412|NCT00365352|6335934|P1|Overall Study|Non-Compliance (after Randomization)|1
1828413|NCT00365352|6335932|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
1828414|NCT00365352|6335933|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1828415|NCT00365352|6335934|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
1828416|NCT00365352|6335932|P3|Overall Study|Lack of Efficacy|0
1828417|NCT00365352|6335933|P2|Overall Study|Lack of Efficacy|0
1828418|NCT00365352|6335934|P1|Overall Study|Lack of Efficacy|3
1828419|NCT00365352|6335932|P3|Overall Study|Participant Withdrew Consent|4
1828420|NCT00365352|6335933|P2|Overall Study|Participant Withdrew Consent|3
1828421|NCT00365352|6335934|P1|Overall Study|Participant Withdrew Consent|8
1828422|NCT00365352|6335932|P3|Overall Study|Adverse Event|8
1828423|NCT00365352|6335933|P2|Overall Study|Adverse Event|7
1828424|NCT00365352|6335934|P1|Overall Study|Adverse Event|6
1828425|NCT00365300|6336018|P2|Double-blind Phase|Lack of Efficacy|6
1828426|NCT00365300|6336019|P1|Double-blind Phase|Lack of Efficacy|6
1828427|NCT00365300|6336018|P2|Double-blind Phase|Protocol Violation|1
1828428|NCT00365300|6336019|P1|Double-blind Phase|Protocol Violation|3
1828429|NCT00365300|6336018|P2|Double-blind Phase|Withdrawal by Subject|1
1828430|NCT00365300|6336019|P1|Double-blind Phase|Withdrawal by Subject|0
1828431|NCT00365300|6336018|P2|Double-blind Phase|Noncompliance|1
1828432|NCT00365300|6336019|P1|Double-blind Phase|Noncompliance|1
1828433|NCT00365300|6336018|P2|Double-blind Phase|Failed to return|0
1828434|NCT00365300|6336019|P1|Double-blind Phase|Failed to return|1
1828435|NCT00365300|6336018|P2|Open-label Phase|Patient skipped open label phase|0
1828436|NCT00365300|6336019|P1|Open-label Phase|Patient skipped open label phase|1
1828437|NCT00365300|6336018|P2|Open-label Phase|Lack of Efficacy|0
1828438|NCT00365300|6336019|P1|Open-label Phase|Lack of Efficacy|1
1828439|NCT00365300|6336018|P2|Open-label Phase|Protocol Violation|0
1828440|NCT00365300|6336019|P1|Open-label Phase|Protocol Violation|1
1828441|NCT00365300|6336018|P2|Open-label Phase|Parent/Legal Guardian Request|0
1828442|NCT00365300|6336019|P1|Open-label Phase|Parent/Legal Guardian Request|4
1828443|NCT00365300|6336018|P2|Open-label Phase|Noncompliance|0
1828444|NCT00365300|6336019|P1|Open-label Phase|Noncompliance|9
1828445|NCT00365300|6336018|P2|Open-label Phase|Physician Decision|0
1828446|NCT00365300|6336019|P1|Open-label Phase|Physician Decision|1
1828447|NCT00365300|6336018|P2|Open-label Phase|Failed to Return|0
1828448|NCT00365300|6336019|P1|Open-label Phase|Failed to Return|1
1828449|NCT00365300|6336018|P2|Open-label Phase|Adverse Event|0
1828450|NCT00365300|6336019|P1|Open-label Phase|Adverse Event|4
1828451|NCT00365105|6336084|P2|Overall Study|Protocol Violation|8
1828452|NCT00365105|6336085|P1|Overall Study|Protocol Violation|5
1828453|NCT00364923|6336131|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
1828454|NCT00364923|6336131|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
1828455|NCT00364858|6336140|P2|Overall Study|Clinical baseline issue|1
1828456|NCT00364858|6336141|P1|Overall Study|Clinical baseline issue|0
1828457|NCT00364858|6336140|P2|Overall Study|Return to Q2 regimen|1
1828458|NCT00364858|6336141|P1|Overall Study|Return to Q2 regimen|0
1828459|NCT00364858|6336140|P2|Overall Study|Non-compliant|0
1828460|NCT00364858|6336141|P1|Overall Study|Non-compliant|1
1828461|NCT00364858|6336140|P2|Overall Study|Discontinuation at baseline|0
1828462|NCT00364858|6336141|P1|Overall Study|Discontinuation at baseline|1
1828463|NCT00364858|6336140|P2|Overall Study|Clinical failure|13
1828464|NCT00364858|6336141|P1|Overall Study|Clinical failure|2
1828465|NCT00364858|6336140|P2|Overall Study|Pregnancy|1
1828466|NCT00364858|6336141|P1|Overall Study|Pregnancy|1
1828467|NCT00364858|6336140|P2|Overall Study|Withdrawal by Subject|1
1828468|NCT00364858|6336141|P1|Overall Study|Withdrawal by Subject|1
1828469|NCT00364858|6336140|P2|Overall Study|Adverse Event|5
1828470|NCT00364858|6336141|P1|Overall Study|Adverse Event|1
1828471|NCT00364845|6336156|P2|Overall Study|Death|1
1828472|NCT00364845|6336157|P1|Overall Study|Death|0
1828473|NCT00364845|6336156|P2|Overall Study|Lost to Follow-up|1
1828474|NCT00364845|6336157|P1|Overall Study|Lost to Follow-up|0
1828475|NCT00364845|6336156|P2|Overall Study|Physician Decision|8
1828476|NCT00364845|6336157|P1|Overall Study|Physician Decision|8
1828477|NCT00364845|6336156|P2|Overall Study|Withdrawal by Subject|1
1828478|NCT00364845|6336157|P1|Overall Study|Withdrawal by Subject|2
1828479|NCT00364845|6336156|P2|Overall Study|Adverse Event|0
1828480|NCT00364845|6336157|P1|Overall Study|Adverse Event|1
1828481|NCT00364832|6336178|P12|Extension Year 2|Early Withdrawals|3
1828482|NCT00364832|6336179|P11|Extension Year 2|Early Withdrawals|5
1828483|NCT00364832|6336180|P10|Extension Year 2|Early Withdrawals|5
1828484|NCT00364832|6336181|P9|Extension Year 2|Early Withdrawals|0
1828485|NCT00364832|6336182|P8|Extension Year 2|Early Withdrawals|0
1828486|NCT00364832|6336183|P7|Extension Year 2|Early Withdrawals|0
1828487|NCT00364832|6336184|P6|Extension Year 2|Early Withdrawals|0
1828488|NCT00364832|6336185|P5|Extension Year 2|Early Withdrawals|0
1828489|NCT00364832|6336186|P4|Extension Year 2|Early Withdrawals|0
1828490|NCT00364832|6336187|P3|Extension Year 2|Early Withdrawals|0
1828491|NCT00364832|6336188|P2|Extension Year 2|Early Withdrawals|0
1828492|NCT00364832|6336189|P1|Extension Year 2|Early Withdrawals|0
1828493|NCT00364832|6336178|P12|Extension Year 1|Early Withdrawals|10
1828494|NCT00364832|6336179|P11|Extension Year 1|Early Withdrawals|2
1828495|NCT00364832|6336180|P10|Extension Year 1|Early Withdrawals|4
1828496|NCT00364832|6336181|P9|Extension Year 1|Early Withdrawals|0
1828497|NCT00364832|6336182|P8|Extension Year 1|Early Withdrawals|0
1828498|NCT00364832|6336183|P7|Extension Year 1|Early Withdrawals|0
1828499|NCT00364832|6336184|P6|Extension Year 1|Early Withdrawals|0
1828500|NCT00364832|6336185|P5|Extension Year 1|Early Withdrawals|0
1828501|NCT00364832|6336186|P4|Extension Year 1|Early Withdrawals|0
1828502|NCT00364832|6336187|P3|Extension Year 1|Early Withdrawals|0
1828503|NCT00364832|6336188|P2|Extension Year 1|Early Withdrawals|0
1828504|NCT00364832|6336189|P1|Extension Year 1|Early Withdrawals|0
1828505|NCT00364832|6336178|P12|Core Period|Early Withdrawals|0
1828506|NCT00364832|6336179|P11|Core Period|Early Withdrawals|0
1828507|NCT00364832|6336180|P10|Core Period|Early Withdrawals|0
1828508|NCT00364832|6336181|P9|Core Period|Early Withdrawals|0
1828509|NCT00364832|6336182|P8|Core Period|Early Withdrawals|1
1828510|NCT00364832|6336183|P7|Core Period|Early Withdrawals|4
1828511|NCT00364832|6336184|P6|Core Period|Early Withdrawals|0
1828512|NCT00364832|6336185|P5|Core Period|Early Withdrawals|0
1828513|NCT00364832|6336186|P4|Core Period|Early Withdrawals|1
1828514|NCT00364832|6336187|P3|Core Period|Early Withdrawals|1
1828515|NCT00364832|6336188|P2|Core Period|Early Withdrawals|2
1828516|NCT00364832|6336189|P1|Core Period|Early Withdrawals|2
1828517|NCT00364793|6336254|P4|Overall Study|Withdrawal by Subject|0
1828518|NCT00364793|6336255|P3|Overall Study|Withdrawal by Subject|0
1828519|NCT00364793|6336256|P2|Overall Study|Withdrawal by Subject|1
1828520|NCT00364793|6336257|P1|Overall Study|Withdrawal by Subject|0
1828521|NCT00364793|6336254|P4|Overall Study|No longer meets criteria|1
1828522|NCT00364793|6336255|P3|Overall Study|No longer meets criteria|0
1828523|NCT00364793|6336256|P2|Overall Study|No longer meets criteria|0
1828524|NCT00364793|6336257|P1|Overall Study|No longer meets criteria|0
1828525|NCT00364793|6336254|P4|Overall Study|Poor or non-compliance|1
1828526|NCT00364793|6336255|P3|Overall Study|Poor or non-compliance|0
1828527|NCT00364793|6336256|P2|Overall Study|Poor or non-compliance|1
1828528|NCT00364793|6336257|P1|Overall Study|Poor or non-compliance|1
1828529|NCT00364793|6336254|P4|Overall Study|Lost to Follow-up|0
1828530|NCT00364793|6336255|P3|Overall Study|Lost to Follow-up|2
1828531|NCT00364793|6336256|P2|Overall Study|Lost to Follow-up|0
1828532|NCT00364793|6336257|P1|Overall Study|Lost to Follow-up|1
1828533|NCT00364793|6336254|P4|Overall Study|Lack of Efficacy|1
1828534|NCT00364793|6336255|P3|Overall Study|Lack of Efficacy|1
1828535|NCT00364793|6336256|P2|Overall Study|Lack of Efficacy|3
1828536|NCT00364793|6336257|P1|Overall Study|Lack of Efficacy|3
1828537|NCT00364793|6336254|P4|Overall Study|Death|0
1828538|NCT00364793|6336255|P3|Overall Study|Death|1
1828539|NCT00364793|6336256|P2|Overall Study|Death|0
1828540|NCT00364793|6336257|P1|Overall Study|Death|1
1828541|NCT00364793|6336254|P4|Overall Study|Adverse Event|0
1828542|NCT00364793|6336255|P3|Overall Study|Adverse Event|0
1828543|NCT00364793|6336256|P2|Overall Study|Adverse Event|0
1828544|NCT00364793|6336257|P1|Overall Study|Adverse Event|2
1828545|NCT00364689|6336394|P1|Overall Study|Lost to Follow-up|1
1828546|NCT00364611|6336414|P2|Overall Study|Receiving Liver Ablation|1
1828547|NCT00364611|6336415|P1|Overall Study|Receiving Liver Ablation|0
1828548|NCT00364611|6336414|P2|Overall Study|Presumed CR on Study|1
1828549|NCT00364611|6336415|P1|Overall Study|Presumed CR on Study|0
1828550|NCT00364611|6336414|P2|Overall Study|Found Ineligible|0
1828551|NCT00364611|6336415|P1|Overall Study|Found Ineligible|1
1828552|NCT00364611|6336414|P2|Overall Study|Investigator decision|2
1828553|NCT00364611|6336415|P1|Overall Study|Investigator decision|2
1828554|NCT00364611|6336414|P2|Overall Study|Disease Progression|8
1828555|NCT00364611|6336415|P1|Overall Study|Disease Progression|38
1828556|NCT00364611|6336414|P2|Overall Study|Participant's Request|4
1828557|NCT00364611|6336415|P1|Overall Study|Participant's Request|3
1828558|NCT00364611|6336414|P2|Overall Study|Adverse Event|4
1828559|NCT00364611|6336415|P1|Overall Study|Adverse Event|7
1828560|NCT00364611|6336414|P2|Overall Study|Did not receive study medication|1
1828561|NCT00364611|6336415|P1|Overall Study|Did not receive study medication|0
1828562|NCT00364533|6336438|P5|Overall Study|Protocol Violation|0
1828563|NCT00364533|6336439|P4|Overall Study|Protocol Violation|0
1828564|NCT00364533|6336440|P3|Overall Study|Protocol Violation|0
1828565|NCT00364533|6336441|P2|Overall Study|Protocol Violation|1
1828566|NCT00364533|6336442|P1|Overall Study|Protocol Violation|1
1828567|NCT00364533|6336438|P5|Overall Study|Non-compliance|0
1828568|NCT00364533|6336439|P4|Overall Study|Non-compliance|0
1828569|NCT00364533|6336440|P3|Overall Study|Non-compliance|0
1828570|NCT00364533|6336441|P2|Overall Study|Non-compliance|0
1828571|NCT00364533|6336442|P1|Overall Study|Non-compliance|1
1828572|NCT00364533|6336438|P5|Overall Study|Variations in drug compliance|0
1828573|NCT00364533|6336439|P4|Overall Study|Variations in drug compliance|0
1828574|NCT00364533|6336440|P3|Overall Study|Variations in drug compliance|1
1828575|NCT00364533|6336441|P2|Overall Study|Variations in drug compliance|1
1828576|NCT00364533|6336442|P1|Overall Study|Variations in drug compliance|2
1828577|NCT00364533|6336438|P5|Overall Study|Subject discharged from hospital|1
1828578|NCT00364533|6336439|P4|Overall Study|Subject discharged from hospital|3
1828579|NCT00364533|6336440|P3|Overall Study|Subject discharged from hospital|2
1828580|NCT00364533|6336441|P2|Overall Study|Subject discharged from hospital|1
1828581|NCT00364533|6336442|P1|Overall Study|Subject discharged from hospital|4
1828582|NCT00364533|6336438|P5|Overall Study|Lack of Efficacy|42
1828583|NCT00364533|6336439|P4|Overall Study|Lack of Efficacy|17
1828584|NCT00364533|6336440|P3|Overall Study|Lack of Efficacy|21
1828585|NCT00364533|6336441|P2|Overall Study|Lack of Efficacy|22
1828586|NCT00364533|6336442|P1|Overall Study|Lack of Efficacy|22
1828587|NCT00364533|6336438|P5|Overall Study|Withdrawal by Subject|6
1828588|NCT00364533|6336439|P4|Overall Study|Withdrawal by Subject|6
1828589|NCT00364533|6336440|P3|Overall Study|Withdrawal by Subject|6
1828590|NCT00364533|6336441|P2|Overall Study|Withdrawal by Subject|8
1828591|NCT00364533|6336442|P1|Overall Study|Withdrawal by Subject|4
1828592|NCT00364533|6336438|P5|Overall Study|Adverse Event|2
1828593|NCT00364533|6336439|P4|Overall Study|Adverse Event|5
1828594|NCT00364533|6336440|P3|Overall Study|Adverse Event|15
1828595|NCT00364533|6336441|P2|Overall Study|Adverse Event|7
1828596|NCT00364533|6336442|P1|Overall Study|Adverse Event|8
1828597|NCT00364351|6336475|P2|Overall Study|Randomised treatment not started|3
1828598|NCT00364351|6336476|P1|Overall Study|Randomised treatment not started|0
1828599|NCT00364351|6336475|P2|Overall Study|Patient could not travel to site|1
1828600|NCT00364351|6336476|P1|Overall Study|Patient could not travel to site|0
1828601|NCT00364351|6336475|P2|Overall Study|Investigator error|2
1828602|NCT00364351|6336476|P1|Overall Study|Investigator error|0
1828603|NCT00364351|6336475|P2|Overall Study|Poor treatment compliance|3
1828604|NCT00364351|6336476|P1|Overall Study|Poor treatment compliance|0
1828605|NCT00364351|6336475|P2|Overall Study|Sponsor decision|0
1828606|NCT00364351|6336476|P1|Overall Study|Sponsor decision|1
1828607|NCT00364351|6336475|P2|Overall Study|Incorrect enrollment|1
1828608|NCT00364351|6336476|P1|Overall Study|Incorrect enrollment|1
1828609|NCT00364351|6336475|P2|Overall Study|Withdrawal by Subject|29
1828610|NCT00364351|6336476|P1|Overall Study|Withdrawal by Subject|30
1828611|NCT00364351|6336475|P2|Overall Study|Lost to Follow-up|1
1828612|NCT00364351|6336476|P1|Overall Study|Lost to Follow-up|1
1828613|NCT00364351|6336475|P2|Overall Study|Prohibited concomitant medication|2
1828614|NCT00364351|6336476|P1|Overall Study|Prohibited concomitant medication|0
1828615|NCT00364351|6336475|P2|Overall Study|Condition under investigation worsened|497
1828616|NCT00364351|6336476|P1|Overall Study|Condition under investigation worsened|469
1828617|NCT00364351|6336475|P2|Overall Study|Adverse Event|44
1828618|NCT00364351|6336476|P1|Overall Study|Adverse Event|90
1828619|NCT00364286|6336494|P1|Overall Study|Adverse Event|2
1828620|NCT00364286|6336494|P1|Overall Study|Withdrawal by Subject|1
1828621|NCT00364182|6336501|P3|Third Intervention|Lost to Follow-up|1
1828622|NCT00364182|6336502|P2|Third Intervention|Lost to Follow-up|0
1828623|NCT00364182|6336503|P1|Third Intervention|Lost to Follow-up|0
1828624|NCT00364182|6336501|P3|Third Intervention|non-compliance|0
1828625|NCT00364182|6336502|P2|Third Intervention|non-compliance|1
1828626|NCT00364182|6336503|P1|Third Intervention|non-compliance|0
1828627|NCT00364182|6336501|P3|Second Intervention|Adverse Event|1
1828628|NCT00364182|6336502|P2|Second Intervention|Adverse Event|0
1828629|NCT00364182|6336503|P1|Second Intervention|Adverse Event|0
1828630|NCT00364182|6336501|P3|Second Intervention|Protocol Violation|0
1828631|NCT00364182|6336502|P2|Second Intervention|Protocol Violation|1
1828632|NCT00364182|6336503|P1|Second Intervention|Protocol Violation|0
1828633|NCT00364182|6336501|P3|Second Intervention|non-compliance|1
1828634|NCT00364182|6336502|P2|Second Intervention|non-compliance|1
1828635|NCT00364182|6336503|P1|Second Intervention|non-compliance|0
1828636|NCT00364182|6336501|P3|First Intervention|Withdrawal by Subject|0
1828637|NCT00364182|6336502|P2|First Intervention|Withdrawal by Subject|0
1828638|NCT00364182|6336503|P1|First Intervention|Withdrawal by Subject|2
1828639|NCT00364182|6336501|P3|First Intervention|Secondary prophylaxis|0
1828640|NCT00364182|6336502|P2|First Intervention|Secondary prophylaxis|0
1828641|NCT00364182|6336503|P1|First Intervention|Secondary prophylaxis|1
1828642|NCT00364156|6336537|P2|Overall Study|Protocol Violation|1
1828643|NCT00364156|6336538|P1|Overall Study|Protocol Violation|6
1828644|NCT00364156|6336537|P2|Overall Study|Withdrawal by Subject|80
1828645|NCT00364156|6336538|P1|Overall Study|Withdrawal by Subject|73
1828646|NCT00364130|6336546|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
1828647|NCT00364130|6336547|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
1828648|NCT00364130|6336546|P2|Intervention Period|Withdrawal by Subject|5
1828649|NCT00364130|6336547|P1|Intervention Period|Withdrawal by Subject|4
1828650|NCT00364130|6336546|P2|Intervention Period|Pregnancy|0
1828651|NCT00364130|6336547|P1|Intervention Period|Pregnancy|1
1828652|NCT00364130|6336546|P2|Intervention Period|Lost to Follow-up|3
1828653|NCT00364130|6336547|P1|Intervention Period|Lost to Follow-up|4
1828654|NCT00364013|6336569|P2|Overall Study|Ongoing|13
1828655|NCT00364013|6336570|P1|Overall Study|Ongoing|20
1828656|NCT00364013|6336569|P2|Overall Study|Other|47
1828657|NCT00364013|6336570|P1|Overall Study|Other|41
1828658|NCT00364013|6336569|P2|Overall Study|Protocol-specified criteria|6
1828659|NCT00364013|6336570|P1|Overall Study|Protocol-specified criteria|6
1828660|NCT00364013|6336569|P2|Overall Study|Lost to Follow-up|3
1828661|NCT00364013|6336570|P1|Overall Study|Lost to Follow-up|10
1828662|NCT00364013|6336569|P2|Overall Study|Physician Decision|3
1828663|NCT00364013|6336570|P1|Overall Study|Physician Decision|3
1828664|NCT00364013|6336569|P2|Overall Study|Withdrawal by Subject|18
1828665|NCT00364013|6336570|P1|Overall Study|Withdrawal by Subject|13
1828666|NCT00364013|6336569|P2|Overall Study|Adverse Event|3
1828667|NCT00364013|6336570|P1|Overall Study|Adverse Event|4
1828668|NCT00364013|6336569|P2|Overall Study|Ineligibility determined|2
1828669|NCT00364013|6336570|P1|Overall Study|Ineligibility determined|4
1828670|NCT00363896|6336598|P2|Overall Study|Other|2
1828671|NCT00363896|6336599|P1|Overall Study|Other|1
1828672|NCT00363896|6336598|P2|Overall Study|Non-fulfilment of entry criteria|0
1828673|NCT00363896|6336599|P1|Overall Study|Non-fulfilment of entry criteria|1
1828674|NCT00363896|6336598|P2|Overall Study|Lost to Follow-up|0
1828675|NCT00363896|6336599|P1|Overall Study|Lost to Follow-up|3
1828676|NCT00363896|6336598|P2|Overall Study|Protocol Violation|1
1828677|NCT00363896|6336599|P1|Overall Study|Protocol Violation|6
1828678|NCT00363896|6336598|P2|Overall Study|Lack of Efficacy|8
1828679|NCT00363896|6336599|P1|Overall Study|Lack of Efficacy|12
1828680|NCT00363896|6336598|P2|Overall Study|COPD exacerbation|7
1828681|NCT00363896|6336599|P1|Overall Study|COPD exacerbation|13
1828682|NCT00363896|6336598|P2|Overall Study|Adverse Event|13
1828683|NCT00363896|6336599|P1|Overall Study|Adverse Event|24
1828684|NCT00363896|6336598|P2|Overall Study|Withdrawal by Subject|16
1828685|NCT00363896|6336599|P1|Overall Study|Withdrawal by Subject|29
1828686|NCT00363766|6336640|P2|Overall Study|Physician Decision|2
1828687|NCT00363766|6336641|P1|Overall Study|Physician Decision|1
1828688|NCT00363766|6336640|P2|Overall Study|Withdrawal by Subject|0
1828689|NCT00363766|6336641|P1|Overall Study|Withdrawal by Subject|2
1828690|NCT00363766|6336640|P2|Overall Study|Not Disease Related Death|4
1828691|NCT00363766|6336641|P1|Overall Study|Not Disease Related Death|3
1828692|NCT00363766|6336640|P2|Overall Study|Disease Related Death|3
1828693|NCT00363766|6336641|P1|Overall Study|Disease Related Death|1
1828694|NCT00363766|6336640|P2|Overall Study|Adverse Event|2
1828695|NCT00363766|6336641|P1|Overall Study|Adverse Event|10
1828696|NCT00363766|6336640|P2|Overall Study|Progressive Disease|9
1828697|NCT00363766|6336641|P1|Overall Study|Progressive Disease|15
1828698|NCT00363649|6336670|P2|Overall Study|Adverse Event|0
1828699|NCT00363649|6336671|P1|Overall Study|Adverse Event|6
1828700|NCT00363649|6336670|P2|Overall Study|Withdrawal by Subject|1
1828701|NCT00363649|6336671|P1|Overall Study|Withdrawal by Subject|1
1828702|NCT00363545|6336687|P2|Overall Study|Others|0
1828703|NCT00363545|6336688|P1|Overall Study|Others|1
1828704|NCT00363545|6336687|P2|Overall Study|Lost to follow-up (complete vaccination)|17
1828705|NCT00363545|6336688|P1|Overall Study|Lost to follow-up (complete vaccination)|14
1828706|NCT00363545|6336687|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
1828707|NCT00363545|6336688|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
1828708|NCT00363545|6336687|P2|Overall Study|Migrated/moved from study area|6
1828709|NCT00363545|6336688|P1|Overall Study|Migrated/moved from study area|3
1828710|NCT00363545|6336687|P2|Overall Study|Withdrawal by Subject|15
1828711|NCT00363545|6336688|P1|Overall Study|Withdrawal by Subject|12
1828712|NCT00363545|6336687|P2|Overall Study|Serious Adverse Event|1
1828713|NCT00363545|6336688|P1|Overall Study|Serious Adverse Event|0
1828714|NCT00363480|6336706|P1|Overall Study|Participant discontinued on its own|1
1828715|NCT00363480|6336706|P1|Overall Study|Non-compliance of subject|1
1828716|NCT00363480|6336706|P1|Overall Study|Withdrawal by Subject|5
1828717|NCT00363480|6336706|P1|Overall Study|Lost to Follow-up|5
1828718|NCT00363480|6336706|P1|Overall Study|Adverse Event|4
1828719|NCT00363480|6336706|P1|Overall Study|Criteria for treatment period not fulfil|1
1828720|NCT00363467|6336726|P1|Overall Study|Physician Decision|1
1828721|NCT00363415|6336736|P2|Overall Study|Protocol Violation|4
1828722|NCT00363415|6336737|P1|Overall Study|Protocol Violation|1
1828723|NCT00363415|6336736|P2|Overall Study|Lost to Follow-up|3
1828724|NCT00363415|6336737|P1|Overall Study|Lost to Follow-up|3
1828725|NCT00363415|6336736|P2|Overall Study|Withdrawal by Subject|15
1828726|NCT00363415|6336737|P1|Overall Study|Withdrawal by Subject|9
1828727|NCT00363415|6336736|P2|Overall Study|Entry Criteria Not Met|10
1828728|NCT00363415|6336737|P1|Overall Study|Entry Criteria Not Met|11
1828729|NCT00363415|6336736|P2|Overall Study|Physician Decision|35
1828730|NCT00363415|6336737|P1|Overall Study|Physician Decision|18
1828731|NCT00363415|6336736|P2|Overall Study|Adverse Event|15
1828732|NCT00363415|6336737|P1|Overall Study|Adverse Event|24
1828733|NCT00363415|6336736|P2|Overall Study|Death|29
1828734|NCT00363415|6336737|P1|Overall Study|Death|32
1828735|NCT00363415|6336736|P2|Overall Study|Sponsor Decision|31
1828736|NCT00363415|6336737|P1|Overall Study|Sponsor Decision|67
1828737|NCT00363415|6336736|P2|Overall Study|Progressive Disease|107
1828738|NCT00363415|6336737|P1|Overall Study|Progressive Disease|196
1828739|NCT00363311|6336755|P2|Overall Study|Participant Moved to Louisiana|1
1828740|NCT00363311|6336756|P1|Overall Study|Participant Moved to Louisiana|0
1828741|NCT00363311|6336755|P2|Overall Study|Withdrawn per Instructions of Monitor|1
1828742|NCT00363311|6336756|P1|Overall Study|Withdrawn per Instructions of Monitor|0
1828743|NCT00363311|6336755|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
1828744|NCT00363311|6336756|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
1828745|NCT00363311|6336755|P2|Overall Study|Participant Moved to Another Country|0
1828746|NCT00363311|6336756|P1|Overall Study|Participant Moved to Another Country|1
1828747|NCT00363311|6336755|P2|Overall Study|Participant Opted for Treatment|0
1828748|NCT00363311|6336756|P1|Overall Study|Participant Opted for Treatment|1
1828749|NCT00363311|6336755|P2|Overall Study|Prostate Volume/PSA Doubled|0
1828750|NCT00363311|6336756|P1|Overall Study|Prostate Volume/PSA Doubled|1
1828751|NCT00363311|6336755|P2|Overall Study|Participant Refused Biopsy|0
1828752|NCT00363311|6336756|P1|Overall Study|Participant Refused Biopsy|1
1828753|NCT00363311|6336755|P2|Overall Study|Non-Compliance|1
1828754|NCT00363311|6336756|P1|Overall Study|Non-Compliance|1
1828755|NCT00363311|6336755|P2|Overall Study|Disease Progression|26
1828756|NCT00363311|6336756|P1|Overall Study|Disease Progression|46
1828757|NCT00363311|6336755|P2|Overall Study|Sponsor Terminated Study|2
1828758|NCT00363311|6336756|P1|Overall Study|Sponsor Terminated Study|2
1828759|NCT00363311|6336755|P2|Overall Study|Physician Decision|1
1828760|NCT00363311|6336756|P1|Overall Study|Physician Decision|1
1828761|NCT00363311|6336755|P2|Overall Study|Withdrawal by Subject|6
1828762|NCT00363311|6336756|P1|Overall Study|Withdrawal by Subject|12
1828763|NCT00363311|6336755|P2|Overall Study|Protocol Violation|2
1828764|NCT00363311|6336756|P1|Overall Study|Protocol Violation|1
1828765|NCT00363311|6336755|P2|Overall Study|Lost to Follow-up|0
1828766|NCT00363311|6336756|P1|Overall Study|Lost to Follow-up|3
1828767|NCT00363311|6336755|P2|Overall Study|Adverse Event|4
1828768|NCT00363311|6336756|P1|Overall Study|Adverse Event|6
1828769|NCT00363298|6336822|P2|4-week Study Continuation Phase|Lack of Efficacy|0
1828770|NCT00363298|6336823|P1|4-week Study Continuation Phase|Lack of Efficacy|1
1828771|NCT00363298|6336822|P2|First Study Week|Lack of Efficacy|5
1828772|NCT00363298|6336823|P1|First Study Week|Lack of Efficacy|6
1828773|NCT00363246|6336831|P1|Overall Study|Eligibility changed due to Hospice move|5
1828774|NCT00363246|6336831|P1|Overall Study|Subject expressed security concerns|2
1828775|NCT00363246|6336831|P1|Overall Study|Stopped using wheelchair|11
1828776|NCT00363246|6336831|P1|Overall Study|Bad health|6
1828777|NCT00363246|6336831|P1|Overall Study|Lost to Follow-up|14
1828778|NCT00363246|6336831|P1|Overall Study|Withdrawal by Subject|19
1828779|NCT00363246|6336831|P1|Overall Study|Death|40
1828780|NCT00363142|6336849|P2|Overall Study|Withdrawal by Subject|1
1828781|NCT00363142|6336850|P1|Overall Study|Withdrawal by Subject|3
1828782|NCT00363142|6336849|P2|Overall Study|Non-compliance|1
1828783|NCT00363142|6336850|P1|Overall Study|Non-compliance|1
1828784|NCT00363142|6336849|P2|Overall Study|Lost to Follow-up|0
1828785|NCT00363142|6336850|P1|Overall Study|Lost to Follow-up|1
1828786|NCT00363142|6336849|P2|Overall Study|Lack of Efficacy|1
1828787|NCT00363142|6336850|P1|Overall Study|Lack of Efficacy|0
1828788|NCT00363142|6336849|P2|Overall Study|Adverse Event|0
1828789|NCT00363142|6336850|P1|Overall Study|Adverse Event|2
1828790|NCT00363129|6336879|P2|Overall Study|Other Reasons|3
1828791|NCT00363129|6336880|P1|Overall Study|Other Reasons|6
1828792|NCT00363129|6336879|P2|Overall Study|Death|1
1828793|NCT00363129|6336880|P1|Overall Study|Death|0
1828794|NCT00363129|6336879|P2|Overall Study|Other Medical Problems|4
1828795|NCT00363129|6336880|P1|Overall Study|Other Medical Problems|2
1828796|NCT00363129|6336879|P2|Overall Study|Alternate Treatment|4
1828797|NCT00363129|6336880|P1|Overall Study|Alternate Treatment|2
1828798|NCT00363129|6336879|P2|Overall Study|Adverse Event|3
1828799|NCT00363129|6336880|P1|Overall Study|Adverse Event|8
1828800|NCT00363129|6336879|P2|Overall Study|Withdrawal by Subject|18
1828801|NCT00363129|6336880|P1|Overall Study|Withdrawal by Subject|11
1828802|NCT00363051|6336923|P2|Overall Study|Death|2
1828803|NCT00363051|6336924|P1|Overall Study|Death|3
1828804|NCT00363051|6336923|P2|Overall Study|Protocol Violation|2
1828805|NCT00363051|6336924|P1|Overall Study|Protocol Violation|0
1828806|NCT00363051|6336923|P2|Overall Study|Lost to Follow-up|1
1828807|NCT00363051|6336924|P1|Overall Study|Lost to Follow-up|0
1828808|NCT00363051|6336923|P2|Overall Study|Withdrawal by Subject|3
1828809|NCT00363051|6336924|P1|Overall Study|Withdrawal by Subject|11
1828810|NCT00363051|6336923|P2|Overall Study|New Cancer Therapy|1
1828811|NCT00363051|6336924|P1|Overall Study|New Cancer Therapy|2
1828812|NCT00363051|6336923|P2|Overall Study|Adverse Event|12
1828813|NCT00363051|6336924|P1|Overall Study|Adverse Event|21
1828814|NCT00363051|6336923|P2|Overall Study|Adminstrative problems|1
1828815|NCT00363051|6336924|P1|Overall Study|Adminstrative problems|1
1828816|NCT00362648|6336973|P4|Overall Study|Withdrawal by Subject|6
1828817|NCT00362648|6336974|P3|Overall Study|Withdrawal by Subject|2
1828818|NCT00362648|6336975|P2|Overall Study|Withdrawal by Subject|42
1828819|NCT00362648|6336976|P1|Overall Study|Withdrawal by Subject|48
1828820|NCT00362648|6336973|P4|Overall Study|Protocol Violation|2
1828821|NCT00362648|6336974|P3|Overall Study|Protocol Violation|2
1828822|NCT00362648|6336975|P2|Overall Study|Protocol Violation|2
1828823|NCT00362648|6336976|P1|Overall Study|Protocol Violation|4
1828824|NCT00362648|6336973|P4|Overall Study|Lost to Follow-up|3
1828825|NCT00362648|6336974|P3|Overall Study|Lost to Follow-up|4
1828826|NCT00362648|6336975|P2|Overall Study|Lost to Follow-up|69
1828827|NCT00362648|6336976|P1|Overall Study|Lost to Follow-up|62
1828828|NCT00362648|6336973|P4|Overall Study|Adverse Event|0
1828829|NCT00362648|6336974|P3|Overall Study|Adverse Event|1
1828830|NCT00362648|6336975|P2|Overall Study|Adverse Event|21
1828831|NCT00362648|6336976|P1|Overall Study|Adverse Event|12
1828832|NCT00362609|6336994|P2|Overall Study|Protocol Violation|1
1828833|NCT00362609|6336995|P1|Overall Study|Protocol Violation|0
1828834|NCT00362609|6336994|P2|Overall Study|Withdrawal by Subject|1
1828835|NCT00362609|6336995|P1|Overall Study|Withdrawal by Subject|0
1828836|NCT00362414|6337076|P1|Overall Study|Adverse Event|1
1828837|NCT00362414|6337076|P1|Overall Study|Death|2
1828838|NCT00362375|6337105|P2|Overall Study|Lost to Follow-up|35
1828839|NCT00362375|6337106|P1|Overall Study|Lost to Follow-up|40
1828840|NCT00362336|6337123|P3|Overall Study|Withdrawal by Subject|1
1828841|NCT00362336|6337124|P2|Overall Study|Withdrawal by Subject|3
1828842|NCT00362336|6337125|P1|Overall Study|Withdrawal by Subject|3
1828843|NCT00362336|6337123|P3|Overall Study|Lost to Follow-up|0
1828844|NCT00362336|6337124|P2|Overall Study|Lost to Follow-up|4
1828845|NCT00362336|6337125|P1|Overall Study|Lost to Follow-up|6
1828846|NCT00362336|6337123|P3|Overall Study|Protocol Violation|1
1828847|NCT00362336|6337124|P2|Overall Study|Protocol Violation|0
1828848|NCT00362336|6337125|P1|Overall Study|Protocol Violation|0
1828849|NCT00362336|6337123|P3|Overall Study|Serious Adverse Event|1
1828850|NCT00362336|6337124|P2|Overall Study|Serious Adverse Event|0
1828851|NCT00362336|6337125|P1|Overall Study|Serious Adverse Event|1
1828852|NCT00362297|6337153|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
1828853|NCT00362297|6337154|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
1828854|NCT00362232|6337162|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
1828855|NCT00362232|6337163|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
1828856|NCT00362232|6337162|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
1828857|NCT00362232|6337163|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
1828858|NCT00362232|6337162|P2|Follow-up (30 (+ 5) Days)|Death|1
1828859|NCT00362232|6337163|P1|Follow-up (30 (+ 5) Days)|Death|1
1828860|NCT00362232|6337162|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
1828861|NCT00362232|6337163|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
1828862|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
1828863|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
1828864|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
1828865|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
1828866|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
1828867|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
1828868|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
1828869|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
1828870|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
1828871|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
1828872|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
1828873|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
1828874|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
1828875|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
1828876|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Death|3
1828877|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Death|1
1828878|NCT00362232|6337162|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
1828879|NCT00362232|6337163|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
1828880|NCT00362180|6337208|P9|Treated Period|Adverse Event|0
1828881|NCT00362180|6337209|P8|Treated Period|Adverse Event|1
1828882|NCT00362180|6337210|P7|Treated Period|Adverse Event|0
1828883|NCT00362180|6337211|P6|Treated Period|Adverse Event|1
1828884|NCT00362180|6337212|P5|Treated Period|Adverse Event|0
1828885|NCT00362180|6337213|P4|Treated Period|Adverse Event|0
1828886|NCT00362180|6337214|P3|Treated Period|Adverse Event|0
1828887|NCT00362180|6337215|P2|Treated Period|Adverse Event|0
1828888|NCT00362180|6337216|P1|Treated Period|Adverse Event|0
1828889|NCT00362180|6337208|P9|Treated Period|Withdrawal by Subject|0
1828890|NCT00362180|6337209|P8|Treated Period|Withdrawal by Subject|0
1828891|NCT00362180|6337210|P7|Treated Period|Withdrawal by Subject|0
1828892|NCT00362180|6337211|P6|Treated Period|Withdrawal by Subject|0
1828893|NCT00362180|6337212|P5|Treated Period|Withdrawal by Subject|0
1828894|NCT00362180|6337213|P4|Treated Period|Withdrawal by Subject|0
1828895|NCT00362180|6337214|P3|Treated Period|Withdrawal by Subject|0
1828896|NCT00362180|6337215|P2|Treated Period|Withdrawal by Subject|0
1828897|NCT00362180|6337216|P1|Treated Period|Withdrawal by Subject|1
1828898|NCT00362115|6337288|P7|Overall Study|Other|0
1828899|NCT00362115|6337289|P6|Overall Study|Other|1
1828900|NCT00362115|6337290|P5|Overall Study|Other|0
1828901|NCT00362115|6337291|P4|Overall Study|Other|1
1828902|NCT00362115|6337292|P3|Overall Study|Other|0
1828903|NCT00362115|6337293|P2|Overall Study|Other|1
1828904|NCT00362115|6337294|P1|Overall Study|Other|0
1828905|NCT00362115|6337288|P7|Overall Study|Physician Decision|3
1828906|NCT00362115|6337289|P6|Overall Study|Physician Decision|0
1828907|NCT00362115|6337290|P5|Overall Study|Physician Decision|0
1828908|NCT00362115|6337291|P4|Overall Study|Physician Decision|0
1828909|NCT00362115|6337292|P3|Overall Study|Physician Decision|0
1828910|NCT00362115|6337293|P2|Overall Study|Physician Decision|0
1828911|NCT00362115|6337294|P1|Overall Study|Physician Decision|0
1828912|NCT00362115|6337288|P7|Overall Study|Lack of Efficacy|3
1828913|NCT00362115|6337289|P6|Overall Study|Lack of Efficacy|0
1828914|NCT00362115|6337290|P5|Overall Study|Lack of Efficacy|2
1828915|NCT00362115|6337291|P4|Overall Study|Lack of Efficacy|2
1828916|NCT00362115|6337292|P3|Overall Study|Lack of Efficacy|5
1828917|NCT00362115|6337293|P2|Overall Study|Lack of Efficacy|0
1828918|NCT00362115|6337294|P1|Overall Study|Lack of Efficacy|1
1828919|NCT00362115|6337288|P7|Overall Study|Withdrawal by Subject|4
1828920|NCT00362115|6337289|P6|Overall Study|Withdrawal by Subject|3
1828921|NCT00362115|6337290|P5|Overall Study|Withdrawal by Subject|1
1828922|NCT00362115|6337291|P4|Overall Study|Withdrawal by Subject|0
1828923|NCT00362115|6337292|P3|Overall Study|Withdrawal by Subject|1
1828924|NCT00362115|6337293|P2|Overall Study|Withdrawal by Subject|3
1828925|NCT00362115|6337294|P1|Overall Study|Withdrawal by Subject|1
1828926|NCT00362115|6337288|P7|Overall Study|Lost to Follow-up|1
1828927|NCT00362115|6337289|P6|Overall Study|Lost to Follow-up|0
1828928|NCT00362115|6337290|P5|Overall Study|Lost to Follow-up|2
1828929|NCT00362115|6337291|P4|Overall Study|Lost to Follow-up|0
1828930|NCT00362115|6337292|P3|Overall Study|Lost to Follow-up|0
1828931|NCT00362115|6337293|P2|Overall Study|Lost to Follow-up|1
1828932|NCT00362115|6337294|P1|Overall Study|Lost to Follow-up|0
1828933|NCT00362115|6337288|P7|Overall Study|Protocol Violation|0
1828934|NCT00362115|6337289|P6|Overall Study|Protocol Violation|1
1828935|NCT00362115|6337290|P5|Overall Study|Protocol Violation|0
1828936|NCT00362115|6337291|P4|Overall Study|Protocol Violation|0
1828937|NCT00362115|6337292|P3|Overall Study|Protocol Violation|0
1828938|NCT00362115|6337293|P2|Overall Study|Protocol Violation|0
1828939|NCT00362115|6337294|P1|Overall Study|Protocol Violation|0
1828940|NCT00362115|6337288|P7|Overall Study|Adverse Event|1
1828941|NCT00362115|6337289|P6|Overall Study|Adverse Event|2
1828942|NCT00362115|6337290|P5|Overall Study|Adverse Event|2
1828943|NCT00362115|6337291|P4|Overall Study|Adverse Event|1
1828944|NCT00362115|6337292|P3|Overall Study|Adverse Event|1
1828945|NCT00362115|6337293|P2|Overall Study|Adverse Event|1
1828946|NCT00362115|6337294|P1|Overall Study|Adverse Event|0
1828947|NCT00361634|6337467|P1|Overall Study|Withdrawal by Subject|1
1828948|NCT00361634|6337467|P1|Overall Study|Lost to Follow-up|1
1828949|NCT00361569|6337496|P4|Overall Study|Not specified by investigator|1
1828950|NCT00361569|6337497|P3|Overall Study|Not specified by investigator|0
1828951|NCT00361569|6337498|P2|Overall Study|Not specified by investigator|0
1828952|NCT00361569|6337499|P1|Overall Study|Not specified by investigator|2
1828953|NCT00361569|6337496|P4|Overall Study|Lost to Follow-up|2
1828954|NCT00361569|6337497|P3|Overall Study|Lost to Follow-up|3
1828955|NCT00361569|6337498|P2|Overall Study|Lost to Follow-up|3
1828956|NCT00361569|6337499|P1|Overall Study|Lost to Follow-up|2
1828957|NCT00361569|6337496|P4|Overall Study|Adverse Event|2
1828958|NCT00361569|6337497|P3|Overall Study|Adverse Event|2
1828959|NCT00361569|6337498|P2|Overall Study|Adverse Event|5
1828960|NCT00361569|6337499|P1|Overall Study|Adverse Event|3
1828961|NCT00361569|6337496|P4|Overall Study|Withdrawal by Subject|14
1828962|NCT00361569|6337497|P3|Overall Study|Withdrawal by Subject|9
1828963|NCT00361569|6337498|P2|Overall Study|Withdrawal by Subject|1
1828964|NCT00361569|6337499|P1|Overall Study|Withdrawal by Subject|2
1828965|NCT00361569|6337496|P4|Overall Study|Protocol Violation|2
1828966|NCT00361569|6337497|P3|Overall Study|Protocol Violation|4
1828967|NCT00361569|6337498|P2|Overall Study|Protocol Violation|2
1828968|NCT00361569|6337499|P1|Overall Study|Protocol Violation|3
1828969|NCT00361504|6337523|P2|Overall Study|All other|3
1828970|NCT00361504|6337524|P1|Overall Study|All other|28
1828971|NCT00361504|6337523|P2|Overall Study|Study medication non compliant|15
1828972|NCT00361504|6337524|P1|Overall Study|Study medication non compliant|42
1828973|NCT00361504|6337523|P2|Overall Study|Resolution of Pain|0
1828974|NCT00361504|6337524|P1|Overall Study|Resolution of Pain|2
1828975|NCT00361504|6337523|P2|Overall Study|Lack of Efficacy|7
1828976|NCT00361504|6337524|P1|Overall Study|Lack of Efficacy|72
1828977|NCT00361504|6337523|P2|Overall Study|Adverse Event|82
1828978|NCT00361504|6337524|P1|Overall Study|Adverse Event|203
1828979|NCT00361504|6337523|P2|Overall Study|Lost to Follow-up|7
1828980|NCT00361504|6337524|P1|Overall Study|Lost to Follow-up|40
1828981|NCT00361504|6337523|P2|Overall Study|Withdrawal by Subject|31
1828982|NCT00361504|6337524|P1|Overall Study|Withdrawal by Subject|94
1828983|NCT00361335|6337565|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
1828984|NCT00361335|6337566|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1828985|NCT00361335|6337567|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1828986|NCT00361335|6337568|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1828987|NCT00361335|6337569|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
1828988|NCT00361335|6337570|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1828989|NCT00361335|6337571|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
1828990|NCT00361335|6337565|P7|SC Period: Week E0 to Week E24|Other|2
1828991|NCT00361335|6337566|P6|SC Period: Week E0 to Week E24|Other|1
1828992|NCT00361335|6337567|P5|SC Period: Week E0 to Week E24|Other|0
1828993|NCT00361335|6337568|P4|SC Period: Week E0 to Week E24|Other|1
1828994|NCT00361335|6337569|P3|SC Period: Week E0 to Week E24|Other|0
1828995|NCT00361335|6337570|P2|SC Period: Week E0 to Week E24|Other|0
1828996|NCT00361335|6337571|P1|SC Period: Week E0 to Week E24|Other|1
1828997|NCT00361335|6337565|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
1828998|NCT00361335|6337566|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
1828999|NCT00361335|6337567|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
1829000|NCT00361335|6337568|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
1829001|NCT00361335|6337569|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
1829002|NCT00361335|6337570|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
1829003|NCT00361335|6337571|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
1829004|NCT00361335|6337565|P7|SC Period: Week E0 to Week E24|Death|1
1829005|NCT00361335|6337566|P6|SC Period: Week E0 to Week E24|Death|0
1829006|NCT00361335|6337567|P5|SC Period: Week E0 to Week E24|Death|0
1829007|NCT00361335|6337568|P4|SC Period: Week E0 to Week E24|Death|0
1829008|NCT00361335|6337569|P3|SC Period: Week E0 to Week E24|Death|0
1829009|NCT00361335|6337570|P2|SC Period: Week E0 to Week E24|Death|0
1829010|NCT00361335|6337571|P1|SC Period: Week E0 to Week E24|Death|0
1829011|NCT00361335|6337565|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1829012|NCT00361335|6337566|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1829013|NCT00361335|6337567|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1829014|NCT00361335|6337568|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1829015|NCT00361335|6337569|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1829016|NCT00361335|6337570|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
1829017|NCT00361335|6337571|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
1829018|NCT00361335|6337565|P7|SC Period: Week E0 to Week E24|Adverse Event|2
1829019|NCT00361335|6337566|P6|SC Period: Week E0 to Week E24|Adverse Event|0
1829020|NCT00361335|6337567|P5|SC Period: Week E0 to Week E24|Adverse Event|0
1829021|NCT00361335|6337568|P4|SC Period: Week E0 to Week E24|Adverse Event|2
1829022|NCT00361335|6337569|P3|SC Period: Week E0 to Week E24|Adverse Event|1
1829023|NCT00361335|6337570|P2|SC Period: Week E0 to Week E24|Adverse Event|2
1829024|NCT00361335|6337571|P1|SC Period: Week E0 to Week E24|Adverse Event|0
1829025|NCT00361335|6337565|P7|IV Period: Baseline to E0|Lack of Efficacy|0
1829026|NCT00361335|6337566|P6|IV Period: Baseline to E0|Lack of Efficacy|0
1829027|NCT00361335|6337567|P5|IV Period: Baseline to E0|Lack of Efficacy|8
1829028|NCT00361335|6337568|P4|IV Period: Baseline to E0|Lack of Efficacy|7
1829029|NCT00361335|6337569|P3|IV Period: Baseline to E0|Lack of Efficacy|3
1829030|NCT00361335|6337570|P2|IV Period: Baseline to E0|Lack of Efficacy|9
1829031|NCT00361335|6337571|P1|IV Period: Baseline to E0|Lack of Efficacy|5
1829032|NCT00361335|6337565|P7|IV Period: Baseline to E0|Other|0
1829033|NCT00361335|6337566|P6|IV Period: Baseline to E0|Other|0
1829034|NCT00361335|6337567|P5|IV Period: Baseline to E0|Other|2
1829035|NCT00361335|6337568|P4|IV Period: Baseline to E0|Other|3
1829036|NCT00361335|6337569|P3|IV Period: Baseline to E0|Other|9
1829037|NCT00361335|6337570|P2|IV Period: Baseline to E0|Other|9
1829038|NCT00361335|6337571|P1|IV Period: Baseline to E0|Other|2
1829039|NCT00361335|6337565|P7|IV Period: Baseline to E0|Worsening of RA|0
1829040|NCT00361335|6337566|P6|IV Period: Baseline to E0|Worsening of RA|0
1829041|NCT00361335|6337567|P5|IV Period: Baseline to E0|Worsening of RA|2
1829042|NCT00361335|6337568|P4|IV Period: Baseline to E0|Worsening of RA|4
1829043|NCT00361335|6337569|P3|IV Period: Baseline to E0|Worsening of RA|1
1829044|NCT00361335|6337570|P2|IV Period: Baseline to E0|Worsening of RA|5
1829045|NCT00361335|6337571|P1|IV Period: Baseline to E0|Worsening of RA|0
1829046|NCT00361335|6337565|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
1829047|NCT00361335|6337566|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
1829048|NCT00361335|6337567|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
1829049|NCT00361335|6337568|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
1829050|NCT00361335|6337569|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
1829051|NCT00361335|6337570|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
1829052|NCT00361335|6337571|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
1829053|NCT00361335|6337565|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
1829054|NCT00361335|6337566|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
1829055|NCT00361335|6337567|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
1829056|NCT00361335|6337568|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
1829057|NCT00361335|6337569|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
1829058|NCT00361335|6337570|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
1829059|NCT00361335|6337571|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
1829060|NCT00361335|6337565|P7|IV Period: Baseline to E0|Death|0
1829061|NCT00361335|6337566|P6|IV Period: Baseline to E0|Death|0
1829062|NCT00361335|6337567|P5|IV Period: Baseline to E0|Death|0
1829063|NCT00361335|6337568|P4|IV Period: Baseline to E0|Death|1
1829064|NCT00361335|6337569|P3|IV Period: Baseline to E0|Death|1
1829065|NCT00361335|6337570|P2|IV Period: Baseline to E0|Death|1
1829066|NCT00361335|6337571|P1|IV Period: Baseline to E0|Death|1
1829067|NCT00361335|6337565|P7|IV Period: Baseline to E0|Lost to Follow-up|0
1829068|NCT00361335|6337566|P6|IV Period: Baseline to E0|Lost to Follow-up|0
1829069|NCT00361335|6337567|P5|IV Period: Baseline to E0|Lost to Follow-up|2
1829070|NCT00361335|6337568|P4|IV Period: Baseline to E0|Lost to Follow-up|2
1829071|NCT00361335|6337569|P3|IV Period: Baseline to E0|Lost to Follow-up|0
1829072|NCT00361335|6337570|P2|IV Period: Baseline to E0|Lost to Follow-up|0
1829073|NCT00361335|6337571|P1|IV Period: Baseline to E0|Lost to Follow-up|1
1829074|NCT00361335|6337565|P7|IV Period: Baseline to E0|Adverse Event|0
1829075|NCT00361335|6337566|P6|IV Period: Baseline to E0|Adverse Event|0
1829076|NCT00361335|6337567|P5|IV Period: Baseline to E0|Adverse Event|8
1829077|NCT00361335|6337568|P4|IV Period: Baseline to E0|Adverse Event|9
1829078|NCT00361335|6337569|P3|IV Period: Baseline to E0|Adverse Event|5
1829079|NCT00361335|6337570|P2|IV Period: Baseline to E0|Adverse Event|4
1829080|NCT00361335|6337571|P1|IV Period: Baseline to E0|Adverse Event|9
1829081|NCT00361296|6337615|P1|Overall Study|Lack of Efficacy|2
1829082|NCT00361296|6337615|P1|Overall Study|Physician Decision|1
1829083|NCT00361283|6337622|P1|Overall Study|Lost to Follow-up|27
1829084|NCT00361270|6337630|P4|Overall Study|Adverse Event|0
1829085|NCT00361270|6337631|P3|Overall Study|Adverse Event|1
1829086|NCT00361270|6337632|P2|Overall Study|Adverse Event|1
1829087|NCT00361270|6337633|P1|Overall Study|Adverse Event|0
1829088|NCT00361270|6337630|P4|Overall Study|Problems with Transportation|0
1829089|NCT00361270|6337631|P3|Overall Study|Problems with Transportation|0
1829090|NCT00361270|6337632|P2|Overall Study|Problems with Transportation|0
1829091|NCT00361270|6337633|P1|Overall Study|Problems with Transportation|4
1829092|NCT00361270|6337630|P4|Overall Study|Afraid of Hypnosis|0
1829093|NCT00361270|6337631|P3|Overall Study|Afraid of Hypnosis|0
1829094|NCT00361270|6337632|P2|Overall Study|Afraid of Hypnosis|2
1829095|NCT00361270|6337633|P1|Overall Study|Afraid of Hypnosis|1
1829096|NCT00361270|6337630|P4|Overall Study|Withdrawal by Subject|7
1829097|NCT00361270|6337631|P3|Overall Study|Withdrawal by Subject|3
1829098|NCT00361270|6337632|P2|Overall Study|Withdrawal by Subject|6
1829099|NCT00361270|6337633|P1|Overall Study|Withdrawal by Subject|6
1829100|NCT00361270|6337630|P4|Overall Study|Protocol Violation|4
1829101|NCT00361270|6337631|P3|Overall Study|Protocol Violation|5
1829102|NCT00361270|6337632|P2|Overall Study|Protocol Violation|4
1829103|NCT00361270|6337633|P1|Overall Study|Protocol Violation|9
1829104|NCT00361270|6337630|P4|Overall Study|Physician Decision|0
1829105|NCT00361270|6337631|P3|Overall Study|Physician Decision|1
1829106|NCT00361270|6337632|P2|Overall Study|Physician Decision|0
1829107|NCT00361270|6337633|P1|Overall Study|Physician Decision|0
1829108|NCT00361270|6337630|P4|Overall Study|Lost to Follow-up|0
1829109|NCT00361270|6337631|P3|Overall Study|Lost to Follow-up|0
1829110|NCT00361270|6337632|P2|Overall Study|Lost to Follow-up|1
1829111|NCT00361270|6337633|P1|Overall Study|Lost to Follow-up|4
1829112|NCT00361270|6337630|P4|Overall Study|Death|2
1829113|NCT00361270|6337631|P3|Overall Study|Death|0
1829114|NCT00361270|6337632|P2|Overall Study|Death|0
1829115|NCT00361270|6337633|P1|Overall Study|Death|0
1829116|NCT00361231|6337706|P1|Overall Study|Adverse Event|6
1829117|NCT00361231|6337706|P1|Overall Study|Withdrawal by Subject|4
1829118|NCT00361231|6337706|P1|Overall Study|Radiographic disease progression|16
1829119|NCT00361231|6337706|P1|Overall Study|Symptomatic deterioration|5
1829120|NCT00361231|6337706|P1|Overall Study|Physician Decision|3
1829121|NCT00361218|6337711|P1|Overall Study|terminated / withdrawn due to toxicity /|5
1829122|NCT00361218|6337711|P1|Overall Study|Personal Reasons|7
1829123|NCT00361218|6337711|P1|Overall Study|Lost to Follow-up|11
1829124|NCT00360698|6337790|P2|Treatment Period|Early termination by error|1
1829125|NCT00360698|6337791|P1|Treatment Period|Early termination by error|0
1829126|NCT00360698|6337790|P2|Treatment Period|Non compliance with treatment procedure|0
1829127|NCT00360698|6337791|P1|Treatment Period|Non compliance with treatment procedure|1
1829128|NCT00360698|6337790|P2|Run-In|Need of insulin with meals|1
1829129|NCT00360698|6337791|P1|Run-In|Need of insulin with meals|0
1829130|NCT00360698|6337790|P2|Run-In|Patient personal reasons|2
1829131|NCT00360698|6337791|P1|Run-In|Patient personal reasons|0
1829132|NCT00360698|6337790|P2|Run-In|Patient did not meet inclusion criteria|1
1829133|NCT00360698|6337791|P1|Run-In|Patient did not meet inclusion criteria|0
1829134|NCT00360698|6337790|P2|Run-In|Sponsor request|2
1829135|NCT00360698|6337791|P1|Run-In|Sponsor request|0
1829136|NCT00360698|6337790|P2|Run-In|Non compliance with treatment procedure|1
1829137|NCT00360698|6337791|P1|Run-In|Non compliance with treatment procedure|0
1829138|NCT00360698|6337790|P2|Run-In|Withdrawal by Subject|2
1829139|NCT00360698|6337791|P1|Run-In|Withdrawal by Subject|0
1829140|NCT00360698|6337790|P2|Run-In|Physician Decision|1
1829141|NCT00360698|6337791|P1|Run-In|Physician Decision|0
1829142|NCT00360568|6337836|P2|Overall Study|Withdrawal by Subject|3
1829143|NCT00360568|6337837|P1|Overall Study|Withdrawal by Subject|0
1829144|NCT00360568|6337836|P2|Overall Study|Lack of Efficacy|0
1829145|NCT00360568|6337837|P1|Overall Study|Lack of Efficacy|1
1829146|NCT00360568|6337836|P2|Overall Study|Adverse Event|2
1829147|NCT00360568|6337837|P1|Overall Study|Adverse Event|1
1829148|NCT00360529|6337968|P3|Overall Study|Reason discontinued not explained above|11
1829149|NCT00360529|6337969|P2|Overall Study|Reason discontinued not explained above|9
1829150|NCT00360529|6337970|P1|Overall Study|Reason discontinued not explained above|4
1829151|NCT00360529|6337968|P3|Overall Study|Lack of Efficacy|5
1829152|NCT00360529|6337969|P2|Overall Study|Lack of Efficacy|6
1829153|NCT00360529|6337970|P1|Overall Study|Lack of Efficacy|8
1829154|NCT00360529|6337968|P3|Overall Study|Withdrawal by Subject|18
1829155|NCT00360529|6337969|P2|Overall Study|Withdrawal by Subject|14
1829156|NCT00360529|6337970|P1|Overall Study|Withdrawal by Subject|22
1829157|NCT00360529|6337968|P3|Overall Study|Lost to Follow-up|13
1829158|NCT00360529|6337969|P2|Overall Study|Lost to Follow-up|10
1829159|NCT00360529|6337970|P1|Overall Study|Lost to Follow-up|14
1829160|NCT00360529|6337968|P3|Overall Study|Protocol Violation|11
1829161|NCT00360529|6337969|P2|Overall Study|Protocol Violation|3
1829162|NCT00360529|6337970|P1|Overall Study|Protocol Violation|3
1829163|NCT00360529|6337968|P3|Overall Study|Adverse Event|33
1829164|NCT00360529|6337969|P2|Overall Study|Adverse Event|23
1829165|NCT00360529|6337970|P1|Overall Study|Adverse Event|10
1829166|NCT00360490|6337998|P2|Overall Study|Withdrawal by Subject|3
1829167|NCT00360490|6337999|P1|Overall Study|Withdrawal by Subject|1
1829168|NCT00360490|6337998|P2|Overall Study|Protocol Violation|4
1829169|NCT00360490|6337999|P1|Overall Study|Protocol Violation|0
1829170|NCT00360490|6337998|P2|Overall Study|Physician Decision|1
1829171|NCT00360490|6337999|P1|Overall Study|Physician Decision|2
1829172|NCT00360490|6337998|P2|Overall Study|Lost to Follow-up|1
1829173|NCT00360490|6337999|P1|Overall Study|Lost to Follow-up|2
1829174|NCT00360490|6337998|P2|Overall Study|Adverse Event|2
1829175|NCT00360490|6337999|P1|Overall Study|Adverse Event|4
1829176|NCT00360412|6338034|P2|Overall Study|Study termination by Sponsor|469
1829177|NCT00360412|6338035|P1|Overall Study|Study termination by Sponsor|214
1829178|NCT00360412|6338034|P2|Overall Study|Other|6
1829179|NCT00360412|6338035|P1|Overall Study|Other|5
1829180|NCT00360412|6338034|P2|Overall Study|Physician Decision|4
1829181|NCT00360412|6338035|P1|Overall Study|Physician Decision|2
1829182|NCT00360412|6338034|P2|Overall Study|Lack of therapeutic efficacy|61
1829183|NCT00360412|6338035|P1|Overall Study|Lack of therapeutic efficacy|46
1829184|NCT00360412|6338034|P2|Overall Study|Patient withdrew consent|52
1829185|NCT00360412|6338035|P1|Overall Study|Patient withdrew consent|27
1829186|NCT00360412|6338034|P2|Overall Study|Protocol Violation|5
1829187|NCT00360412|6338035|P1|Overall Study|Protocol Violation|2
1829188|NCT00360412|6338034|P2|Overall Study|Adverse Event|65
1829189|NCT00360412|6338035|P1|Overall Study|Adverse Event|37
1829190|NCT00360334|6338082|P2|Overall Study|Subject decision|2
1829191|NCT00360334|6338083|P1|Overall Study|Subject decision|8
1829192|NCT00360334|6338082|P2|Overall Study|Entry criterion not met|2
1829193|NCT00360334|6338083|P1|Overall Study|Entry criterion not met|1
1829194|NCT00360334|6338082|P2|Overall Study|Lack of Efficacy|1
1829195|NCT00360334|6338083|P1|Overall Study|Lack of Efficacy|0
1829196|NCT00360334|6338082|P2|Overall Study|Physician Decision|3
1829197|NCT00360334|6338083|P1|Overall Study|Physician Decision|2
1829198|NCT00360334|6338082|P2|Overall Study|Protocol Violation|1
1829199|NCT00360334|6338083|P1|Overall Study|Protocol Violation|1
1829200|NCT00360334|6338082|P2|Overall Study|Adverse Event|4
1829201|NCT00360334|6338083|P1|Overall Study|Adverse Event|7
1829202|NCT00360308|6338146|P3|Overall Study|Study termination by sponsor|44
1829203|NCT00360308|6338147|P2|Overall Study|Study termination by sponsor|55
1829204|NCT00360308|6338148|P1|Overall Study|Study termination by sponsor|43
1829205|NCT00360308|6338146|P3|Overall Study|Other|1
1829206|NCT00360308|6338147|P2|Overall Study|Other|1
1829207|NCT00360308|6338148|P1|Overall Study|Other|2
1829208|NCT00360308|6338146|P3|Overall Study|Lack of Efficacy|2
1829209|NCT00360308|6338147|P2|Overall Study|Lack of Efficacy|0
1829210|NCT00360308|6338148|P1|Overall Study|Lack of Efficacy|3
1829211|NCT00360308|6338146|P3|Overall Study|Withdrawal by Subject|14
1829212|NCT00360308|6338147|P2|Overall Study|Withdrawal by Subject|7
1829213|NCT00360308|6338148|P1|Overall Study|Withdrawal by Subject|11
1829214|NCT00360308|6338146|P3|Overall Study|Protocol Violation|2
1829215|NCT00360308|6338147|P2|Overall Study|Protocol Violation|1
1829216|NCT00360308|6338148|P1|Overall Study|Protocol Violation|2
1829217|NCT00360308|6338146|P3|Overall Study|Abnormal Laboratory Value(s)|0
1829218|NCT00360308|6338147|P2|Overall Study|Abnormal Laboratory Value(s)|1
1829219|NCT00360308|6338148|P1|Overall Study|Abnormal Laboratory Value(s)|0
1829220|NCT00360308|6338146|P3|Overall Study|Adverse Event|25
1829221|NCT00360308|6338147|P2|Overall Study|Adverse Event|14
1829222|NCT00360308|6338148|P1|Overall Study|Adverse Event|15
1829223|NCT00360282|6338165|P4|Second Intervention|Adverse Event|0
1829224|NCT00360282|6338166|P3|Second Intervention|Adverse Event|0
1829225|NCT00360282|6338167|P2|Second Intervention|Adverse Event|1
1829226|NCT00360282|6338168|P1|Second Intervention|Adverse Event|0
1829227|NCT00360282|6338165|P4|Washout 1-3 Weeks|Lost to Follow-up|0
1829228|NCT00360282|6338166|P3|Washout 1-3 Weeks|Lost to Follow-up|1
1829229|NCT00360282|6338167|P2|Washout 1-3 Weeks|Lost to Follow-up|0
1829230|NCT00360282|6338168|P1|Washout 1-3 Weeks|Lost to Follow-up|0
1829231|NCT00360269|6338180|P2|Overall Study|Withdrawal by Subject|1
1829232|NCT00360269|6338181|P1|Overall Study|Withdrawal by Subject|1
1829233|NCT00360269|6338180|P2|Overall Study|Adverse Event|0
1829234|NCT00360269|6338181|P1|Overall Study|Adverse Event|1
1829235|NCT00360269|6338180|P2|Overall Study|Physician Decision|2
1829236|NCT00360269|6338181|P1|Overall Study|Physician Decision|1
1829237|NCT00360269|6338180|P2|Overall Study|Lost to Follow-up|9
1829238|NCT00360269|6338181|P1|Overall Study|Lost to Follow-up|7
1829239|NCT00360230|6338223|P7|Overall Study|Death|1
1829240|NCT00360230|6338224|P6|Overall Study|Death|1
1829241|NCT00360230|6338225|P5|Overall Study|Death|0
1829242|NCT00360230|6338226|P4|Overall Study|Death|0
1829243|NCT00360230|6338227|P3|Overall Study|Death|0
1829244|NCT00360230|6338228|P2|Overall Study|Death|1
1829245|NCT00360230|6338229|P1|Overall Study|Death|0
1829246|NCT00360230|6338223|P7|Overall Study|Protocol Violation|0
1829247|NCT00360230|6338224|P6|Overall Study|Protocol Violation|1
1829248|NCT00360230|6338225|P5|Overall Study|Protocol Violation|0
1829249|NCT00360230|6338226|P4|Overall Study|Protocol Violation|0
1829250|NCT00360230|6338227|P3|Overall Study|Protocol Violation|0
1829251|NCT00360230|6338228|P2|Overall Study|Protocol Violation|0
1829252|NCT00360230|6338229|P1|Overall Study|Protocol Violation|0
1829253|NCT00360230|6338223|P7|Overall Study|Other|0
1829254|NCT00360230|6338224|P6|Overall Study|Other|0
1829255|NCT00360230|6338225|P5|Overall Study|Other|0
1829256|NCT00360230|6338226|P4|Overall Study|Other|0
1829257|NCT00360230|6338227|P3|Overall Study|Other|0
1829258|NCT00360230|6338228|P2|Overall Study|Other|0
1829259|NCT00360230|6338229|P1|Overall Study|Other|1
1829260|NCT00360230|6338223|P7|Overall Study|Migrated|1
1829261|NCT00360230|6338224|P6|Overall Study|Migrated|1
1829262|NCT00360230|6338225|P5|Overall Study|Migrated|4
1829263|NCT00360230|6338226|P4|Overall Study|Migrated|1
1829264|NCT00360230|6338227|P3|Overall Study|Migrated|3
1829265|NCT00360230|6338228|P2|Overall Study|Migrated|1
1829266|NCT00360230|6338229|P1|Overall Study|Migrated|4
1829267|NCT00360230|6338223|P7|Overall Study|Withdrawal by Subject|0
1829268|NCT00360230|6338224|P6|Overall Study|Withdrawal by Subject|1
1829269|NCT00360230|6338225|P5|Overall Study|Withdrawal by Subject|1
1829270|NCT00360230|6338226|P4|Overall Study|Withdrawal by Subject|1
1829271|NCT00360230|6338227|P3|Overall Study|Withdrawal by Subject|0
1829272|NCT00360230|6338228|P2|Overall Study|Withdrawal by Subject|1
1829273|NCT00360230|6338229|P1|Overall Study|Withdrawal by Subject|1
1829274|NCT00359801|6338385|P2|Overall Study|Sponsor Decision|16
1829275|NCT00359801|6338386|P1|Overall Study|Sponsor Decision|17
1829276|NCT00359801|6338385|P2|Overall Study|Final Status Unknown: missing data|4
1829277|NCT00359801|6338386|P1|Overall Study|Final Status Unknown: missing data|7
1829278|NCT00359801|6338385|P2|Overall Study|Other|46
1829279|NCT00359801|6338386|P1|Overall Study|Other|66
1829280|NCT00359801|6338385|P2|Overall Study|Withdrawal by Subject|96
1829281|NCT00359801|6338386|P1|Overall Study|Withdrawal by Subject|143
1829282|NCT00359801|6338385|P2|Overall Study|Lost to Follow-up|58
1829283|NCT00359801|6338386|P1|Overall Study|Lost to Follow-up|72
1829284|NCT00359788|6338420|P2|Overall Study|Protocol Violation|2
1829285|NCT00359788|6338421|P1|Overall Study|Protocol Violation|4
1829286|NCT00359788|6338420|P2|Overall Study|Withdrawal by Subject|1
1829287|NCT00359788|6338421|P1|Overall Study|Withdrawal by Subject|4
1829288|NCT00359788|6338420|P2|Overall Study|Lost to Follow-up|2
1829289|NCT00359788|6338421|P1|Overall Study|Lost to Follow-up|3
1829290|NCT00359788|6338420|P2|Overall Study|Lack of Efficacy|2
1829291|NCT00359788|6338421|P1|Overall Study|Lack of Efficacy|1
1829292|NCT00359788|6338420|P2|Overall Study|Adverse Event|10
1829293|NCT00359788|6338421|P1|Overall Study|Adverse Event|11
1829294|NCT00359762|6338655|P5|Period III|Subject Decision|0
1829295|NCT00359762|6338656|P4|Period III|Subject Decision|20
1829296|NCT00359762|6338657|P3|Period III|Subject Decision|8
1829297|NCT00359762|6338658|P2|Period III|Subject Decision|7
1829298|NCT00359762|6338659|P1|Period III|Subject Decision|0
1829299|NCT00359762|6338655|P5|Period III|Entry Criteria Not Met|0
1829300|NCT00359762|6338656|P4|Period III|Entry Criteria Not Met|1
1829301|NCT00359762|6338657|P3|Period III|Entry Criteria Not Met|0
1829302|NCT00359762|6338658|P2|Period III|Entry Criteria Not Met|1
1829303|NCT00359762|6338659|P1|Period III|Entry Criteria Not Met|0
1829304|NCT00359762|6338655|P5|Period III|Lost to follow up|0
1829305|NCT00359762|6338656|P4|Period III|Lost to follow up|2
1829306|NCT00359762|6338657|P3|Period III|Lost to follow up|1
1829307|NCT00359762|6338658|P2|Period III|Lost to follow up|1
1829308|NCT00359762|6338659|P1|Period III|Lost to follow up|0
1829309|NCT00359762|6338655|P5|Period III|Lack of Efficacy|0
1829310|NCT00359762|6338656|P4|Period III|Lack of Efficacy|9
1829311|NCT00359762|6338657|P3|Period III|Lack of Efficacy|5
1829312|NCT00359762|6338658|P2|Period III|Lack of Efficacy|7
1829313|NCT00359762|6338659|P1|Period III|Lack of Efficacy|0
1829314|NCT00359762|6338655|P5|Period III|Physician Decision|0
1829315|NCT00359762|6338656|P4|Period III|Physician Decision|15
1829316|NCT00359762|6338657|P3|Period III|Physician Decision|9
1829317|NCT00359762|6338658|P2|Period III|Physician Decision|5
1829318|NCT00359762|6338659|P1|Period III|Physician Decision|0
1829319|NCT00359762|6338655|P5|Period III|Adverse Event|0
1829320|NCT00359762|6338656|P4|Period III|Adverse Event|10
1829321|NCT00359762|6338657|P3|Period III|Adverse Event|4
1829322|NCT00359762|6338658|P2|Period III|Adverse Event|3
1829323|NCT00359762|6338659|P1|Period III|Adverse Event|0
1829324|NCT00359762|6338655|P5|Period III|Protocol Violation|0
1829325|NCT00359762|6338656|P4|Period III|Protocol Violation|8
1829326|NCT00359762|6338657|P3|Period III|Protocol Violation|3
1829327|NCT00359762|6338658|P2|Period III|Protocol Violation|5
1829328|NCT00359762|6338659|P1|Period III|Protocol Violation|0
1829329|NCT00359762|6338655|P5|Period II|Subject Decision|70
1829330|NCT00359762|6338656|P4|Period II|Subject Decision|0
1829331|NCT00359762|6338657|P3|Period II|Subject Decision|0
1829332|NCT00359762|6338658|P2|Period II|Subject Decision|0
1829333|NCT00359762|6338659|P1|Period II|Subject Decision|50
1829334|NCT00359762|6338655|P5|Period II|Entry Criteria Not Met|4
1829335|NCT00359762|6338656|P4|Period II|Entry Criteria Not Met|0
1829336|NCT00359762|6338657|P3|Period II|Entry Criteria Not Met|0
1829337|NCT00359762|6338658|P2|Period II|Entry Criteria Not Met|0
1829338|NCT00359762|6338659|P1|Period II|Entry Criteria Not Met|8
1829339|NCT00359762|6338655|P5|Period II|Lost to follow up|5
1829340|NCT00359762|6338656|P4|Period II|Lost to follow up|0
1829341|NCT00359762|6338657|P3|Period II|Lost to follow up|0
1829342|NCT00359762|6338658|P2|Period II|Lost to follow up|0
1829343|NCT00359762|6338659|P1|Period II|Lost to follow up|5
1829344|NCT00359762|6338655|P5|Period II|Lack of Efficacy|8
1829345|NCT00359762|6338656|P4|Period II|Lack of Efficacy|0
1829346|NCT00359762|6338657|P3|Period II|Lack of Efficacy|0
1829347|NCT00359762|6338658|P2|Period II|Lack of Efficacy|0
1829348|NCT00359762|6338659|P1|Period II|Lack of Efficacy|11
1829349|NCT00359762|6338655|P5|Period II|Death|4
1829350|NCT00359762|6338656|P4|Period II|Death|0
1829351|NCT00359762|6338657|P3|Period II|Death|0
1829352|NCT00359762|6338658|P2|Period II|Death|0
1829353|NCT00359762|6338659|P1|Period II|Death|2
1829354|NCT00359762|6338655|P5|Period II|Physician Decision|23
1829355|NCT00359762|6338656|P4|Period II|Physician Decision|0
1829356|NCT00359762|6338657|P3|Period II|Physician Decision|0
1829357|NCT00359762|6338658|P2|Period II|Physician Decision|0
1829358|NCT00359762|6338659|P1|Period II|Physician Decision|17
1829359|NCT00359762|6338655|P5|Period II|Protocol Violation|11
1829360|NCT00359762|6338656|P4|Period II|Protocol Violation|0
1829361|NCT00359762|6338657|P3|Period II|Protocol Violation|0
1829362|NCT00359762|6338658|P2|Period II|Protocol Violation|0
1829363|NCT00359762|6338659|P1|Period II|Protocol Violation|18
1829364|NCT00359762|6338655|P5|Period II|Adverse Event|49
1829365|NCT00359762|6338656|P4|Period II|Adverse Event|0
1829366|NCT00359762|6338657|P3|Period II|Adverse Event|0
1829367|NCT00359762|6338658|P2|Period II|Adverse Event|0
1829368|NCT00359762|6338659|P1|Period II|Adverse Event|17
1829369|NCT00359632|6338733|P2|Overall Study|Non-compliance with visit schedule|0
1829370|NCT00359632|6338734|P1|Overall Study|Non-compliance with visit schedule|1
1829371|NCT00359632|6338733|P2|Overall Study|Adverse Event|0
1829372|NCT00359632|6338734|P1|Overall Study|Adverse Event|1
1829373|NCT00359632|6338733|P2|Overall Study|Death|0
1829374|NCT00359632|6338734|P1|Overall Study|Death|2
1829375|NCT00359619|6338748|P7|Overall Study|Lost to Follow-up|0
1829376|NCT00359619|6338749|P6|Overall Study|Lost to Follow-up|5
1829377|NCT00359619|6338750|P5|Overall Study|Lost to Follow-up|1
1829378|NCT00359619|6338751|P4|Overall Study|Lost to Follow-up|1
1829379|NCT00359619|6338752|P3|Overall Study|Lost to Follow-up|2
1829380|NCT00359619|6338753|P2|Overall Study|Lost to Follow-up|4
1829381|NCT00359619|6338754|P1|Overall Study|Lost to Follow-up|4
1829382|NCT00359619|6338748|P7|Overall Study|Other|0
1829383|NCT00359619|6338749|P6|Overall Study|Other|0
1829384|NCT00359619|6338750|P5|Overall Study|Other|0
1829385|NCT00359619|6338751|P4|Overall Study|Other|0
1829386|NCT00359619|6338752|P3|Overall Study|Other|0
1829387|NCT00359619|6338753|P2|Overall Study|Other|0
1829388|NCT00359619|6338754|P1|Overall Study|Other|1
1829389|NCT00359619|6338748|P7|Overall Study|Withdrawal by Subject|3
1829390|NCT00359619|6338749|P6|Overall Study|Withdrawal by Subject|0
1829391|NCT00359619|6338750|P5|Overall Study|Withdrawal by Subject|2
1829392|NCT00359619|6338751|P4|Overall Study|Withdrawal by Subject|2
1829393|NCT00359619|6338752|P3|Overall Study|Withdrawal by Subject|4
1829394|NCT00359619|6338753|P2|Overall Study|Withdrawal by Subject|1
1829395|NCT00359619|6338754|P1|Overall Study|Withdrawal by Subject|3
1829396|NCT00359619|6338748|P7|Overall Study|Adverse Event|1
1829397|NCT00359619|6338749|P6|Overall Study|Adverse Event|0
1829398|NCT00359619|6338750|P5|Overall Study|Adverse Event|0
1829399|NCT00359619|6338751|P4|Overall Study|Adverse Event|0
1829400|NCT00359619|6338752|P3|Overall Study|Adverse Event|1
1829401|NCT00359619|6338753|P2|Overall Study|Adverse Event|0
1829402|NCT00359619|6338754|P1|Overall Study|Adverse Event|0
1829403|NCT00359424|6338884|P2|Overall Study|follow up not conducted|0
1829404|NCT00359424|6338885|P1|Overall Study|follow up not conducted|2
1829405|NCT00359424|6338884|P2|Overall Study|Withdrawal by Subject|2
1829406|NCT00359424|6338885|P1|Overall Study|Withdrawal by Subject|10
1829407|NCT00359424|6338884|P2|Overall Study|Lost to Follow-up|7
1829408|NCT00359424|6338885|P1|Overall Study|Lost to Follow-up|19
1829409|NCT00359424|6338884|P2|Overall Study|Death|58
1829410|NCT00359424|6338885|P1|Overall Study|Death|99
1829411|NCT00359281|6338924|P9|Overall Study|Withdrawal by Subject|0
1829412|NCT00359281|6338925|P8|Overall Study|Withdrawal by Subject|0
1829413|NCT00359281|6338926|P7|Overall Study|Withdrawal by Subject|1
1829414|NCT00359281|6338927|P6|Overall Study|Withdrawal by Subject|0
1829415|NCT00359281|6338928|P5|Overall Study|Withdrawal by Subject|0
1829416|NCT00359281|6338929|P4|Overall Study|Withdrawal by Subject|0
1829417|NCT00359281|6338930|P3|Overall Study|Withdrawal by Subject|0
1829418|NCT00359281|6338931|P2|Overall Study|Withdrawal by Subject|0
1829419|NCT00359281|6338932|P1|Overall Study|Withdrawal by Subject|0
1829420|NCT00359281|6338924|P9|Overall Study|Adverse Event|0
1829421|NCT00359281|6338925|P8|Overall Study|Adverse Event|0
1829422|NCT00359281|6338926|P7|Overall Study|Adverse Event|1
1829423|NCT00359281|6338927|P6|Overall Study|Adverse Event|0
1829424|NCT00359281|6338928|P5|Overall Study|Adverse Event|0
1829425|NCT00359281|6338929|P4|Overall Study|Adverse Event|0
1829426|NCT00359281|6338930|P3|Overall Study|Adverse Event|0
1829427|NCT00359281|6338931|P2|Overall Study|Adverse Event|0
1829428|NCT00359281|6338932|P1|Overall Study|Adverse Event|1
1829429|NCT00359073|6338995|P2|Overall Study|developed RV16 antibody|1
1829430|NCT00359073|6338996|P1|Overall Study|developed RV16 antibody|0
1829431|NCT00359073|6338995|P2|Overall Study|Eligibility criteria no longer met|0
1829432|NCT00359073|6338996|P1|Overall Study|Eligibility criteria no longer met|3
1829433|NCT00359073|6338995|P2|Overall Study|Withdrawal by Subject|1
1829434|NCT00359073|6338996|P1|Overall Study|Withdrawal by Subject|1
1829435|NCT00359021|6339008|P2|Overall Study|Pregnancy|0
1829436|NCT00359021|6339009|P1|Overall Study|Pregnancy|1
1829437|NCT00359021|6339008|P2|Overall Study|Other|1
1829438|NCT00359021|6339009|P1|Overall Study|Other|4
1829439|NCT00359021|6339008|P2|Overall Study|Lost to Follow-up|0
1829440|NCT00359021|6339009|P1|Overall Study|Lost to Follow-up|1
1829441|NCT00359021|6339008|P2|Overall Study|Withdrawal by Subject|9
1829442|NCT00359021|6339009|P1|Overall Study|Withdrawal by Subject|2
1829443|NCT00359021|6339008|P2|Overall Study|Subject Reached A Virologic Endpoint|32
1829444|NCT00359021|6339009|P1|Overall Study|Subject Reached A Virologic Endpoint|45
1829445|NCT00359021|6339008|P2|Overall Study|Subject Ineligible To Continue The Trial|0
1829446|NCT00359021|6339009|P1|Overall Study|Subject Ineligible To Continue The Trial|1
1829447|NCT00359021|6339008|P2|Overall Study|Subject Non-Compliant|2
1829448|NCT00359021|6339009|P1|Overall Study|Subject Non-Compliant|1
1829449|NCT00359021|6339008|P2|Overall Study|Adverse Event|8
1829450|NCT00359021|6339009|P1|Overall Study|Adverse Event|26
1829451|NCT00358956|6339021|P1|Overall Study|Withdrawal by Subject|1
1829452|NCT00358956|6339021|P1|Overall Study|condition under investigation worsened|4
1829453|NCT00358956|6339021|P1|Overall Study|Adverse Event|3
1829454|NCT00358917|6339033|P2|Overall Study|Unable to Continue Participation|2
1829455|NCT00358917|6339034|P1|Overall Study|Unable to Continue Participation|2
1829456|NCT00358917|6339033|P2|Overall Study|Virologic failure|8
1829457|NCT00358917|6339034|P1|Overall Study|Virologic failure|11
1829458|NCT00358917|6339033|P2|Overall Study|Death|3
1829459|NCT00358917|6339034|P1|Overall Study|Death|2
1829460|NCT00358917|6339033|P2|Overall Study|Noncompliance|11
1829461|NCT00358917|6339034|P1|Overall Study|Noncompliance|12
1829462|NCT00358917|6339033|P2|Overall Study|Lost to Follow-up|17
1829463|NCT00358917|6339034|P1|Overall Study|Lost to Follow-up|20
1829464|NCT00358917|6339033|P2|Overall Study|Withdrawal by Subject|7
1829465|NCT00358917|6339034|P1|Overall Study|Withdrawal by Subject|5
1829466|NCT00358917|6339033|P2|Overall Study|Adverse Event|21
1829467|NCT00358917|6339034|P1|Overall Study|Adverse Event|14
1829468|NCT00358826|6339052|P8|MDCT Substudy|Withdrawal by Subject|0
1829469|NCT00358826|6339053|P7|MDCT Substudy|Withdrawal by Subject|0
1829470|NCT00358826|6339054|P6|MDCT Substudy|Withdrawal by Subject|1
1829471|NCT00358826|6339055|P5|MDCT Substudy|Withdrawal by Subject|0
1829472|NCT00358826|6339056|P4|MDCT Substudy|Withdrawal by Subject|0
1829473|NCT00358826|6339057|P3|MDCT Substudy|Withdrawal by Subject|0
1829474|NCT00358826|6339058|P2|MDCT Substudy|Withdrawal by Subject|0
1829475|NCT00358826|6339059|P1|MDCT Substudy|Withdrawal by Subject|0
1829476|NCT00358826|6339052|P8|MDCT Substudy|Lost to Follow-up|0
1829477|NCT00358826|6339053|P7|MDCT Substudy|Lost to Follow-up|0
1829478|NCT00358826|6339054|P6|MDCT Substudy|Lost to Follow-up|1
1829479|NCT00358826|6339055|P5|MDCT Substudy|Lost to Follow-up|0
1829480|NCT00358826|6339056|P4|MDCT Substudy|Lost to Follow-up|0
1829481|NCT00358826|6339057|P3|MDCT Substudy|Lost to Follow-up|0
1829482|NCT00358826|6339058|P2|MDCT Substudy|Lost to Follow-up|0
1829483|NCT00358826|6339059|P1|MDCT Substudy|Lost to Follow-up|0
1829484|NCT00358826|6339052|P8|MDCT Substudy|Adverse Event|0
1829485|NCT00358826|6339053|P7|MDCT Substudy|Adverse Event|0
1829486|NCT00358826|6339054|P6|MDCT Substudy|Adverse Event|0
1829487|NCT00358826|6339055|P5|MDCT Substudy|Adverse Event|1
1829488|NCT00358826|6339056|P4|MDCT Substudy|Adverse Event|0
1829489|NCT00358826|6339057|P3|MDCT Substudy|Adverse Event|0
1829490|NCT00358826|6339058|P2|MDCT Substudy|Adverse Event|0
1829491|NCT00358826|6339059|P1|MDCT Substudy|Adverse Event|0
1829492|NCT00358826|6339052|P8|Core Study|Physician Decision|0
1829493|NCT00358826|6339053|P7|Core Study|Physician Decision|0
1829494|NCT00358826|6339054|P6|Core Study|Physician Decision|0
1829495|NCT00358826|6339055|P5|Core Study|Physician Decision|0
1829496|NCT00358826|6339056|P4|Core Study|Physician Decision|0
1829497|NCT00358826|6339057|P3|Core Study|Physician Decision|1
1829498|NCT00358826|6339058|P2|Core Study|Physician Decision|0
1829499|NCT00358826|6339059|P1|Core Study|Physician Decision|0
1829500|NCT00358826|6339052|P8|Core Study|Lost to Follow-up|0
1829501|NCT00358826|6339053|P7|Core Study|Lost to Follow-up|0
1829502|NCT00358826|6339054|P6|Core Study|Lost to Follow-up|0
1829503|NCT00358826|6339055|P5|Core Study|Lost to Follow-up|0
1829504|NCT00358826|6339056|P4|Core Study|Lost to Follow-up|1
1829505|NCT00358826|6339057|P3|Core Study|Lost to Follow-up|0
1829506|NCT00358826|6339058|P2|Core Study|Lost to Follow-up|0
1829507|NCT00358826|6339059|P1|Core Study|Lost to Follow-up|0
1829508|NCT00358826|6339052|P8|Core Study|Withdrawal by Subject|0
1829509|NCT00358826|6339053|P7|Core Study|Withdrawal by Subject|0
1829510|NCT00358826|6339054|P6|Core Study|Withdrawal by Subject|0
1829511|NCT00358826|6339055|P5|Core Study|Withdrawal by Subject|0
1829512|NCT00358826|6339056|P4|Core Study|Withdrawal by Subject|0
1829513|NCT00358826|6339057|P3|Core Study|Withdrawal by Subject|0
1829514|NCT00358826|6339058|P2|Core Study|Withdrawal by Subject|2
1829515|NCT00358826|6339059|P1|Core Study|Withdrawal by Subject|2
1829516|NCT00358826|6339052|P8|Core Study|Adverse Event|0
1829517|NCT00358826|6339053|P7|Core Study|Adverse Event|0
1829518|NCT00358826|6339054|P6|Core Study|Adverse Event|0
1829519|NCT00358826|6339055|P5|Core Study|Adverse Event|0
1829520|NCT00358826|6339056|P4|Core Study|Adverse Event|1
1829521|NCT00358826|6339057|P3|Core Study|Adverse Event|1
1829522|NCT00358826|6339058|P2|Core Study|Adverse Event|3
1829523|NCT00358826|6339059|P1|Core Study|Adverse Event|1
1829524|NCT00358670|6339126|P2|Overall Study|Administrative|125
1829525|NCT00358670|6339127|P1|Overall Study|Administrative|153
1829526|NCT00358670|6339126|P2|Overall Study|Did Not Meet Protocol Eligibility|3
1829527|NCT00358670|6339127|P1|Overall Study|Did Not Meet Protocol Eligibility|0
1829528|NCT00358670|6339126|P2|Overall Study|Protocol Defined Clinical Event|1
1829529|NCT00358670|6339127|P1|Overall Study|Protocol Defined Clinical Event|0
1829530|NCT00358670|6339126|P2|Overall Study|Withdrawal by Subject|24
1829531|NCT00358670|6339127|P1|Overall Study|Withdrawal by Subject|13
1829532|NCT00358670|6339126|P2|Overall Study|Lost to Follow-up|5
1829533|NCT00358670|6339127|P1|Overall Study|Lost to Follow-up|4
1829534|NCT00358670|6339126|P2|Overall Study|Protocol Violation|9
1829535|NCT00358670|6339127|P1|Overall Study|Protocol Violation|6
1829536|NCT00358670|6339126|P2|Overall Study|Lack of Efficacy|23
1829537|NCT00358670|6339127|P1|Overall Study|Lack of Efficacy|20
1829538|NCT00358670|6339126|P2|Overall Study|Adverse Event|29
1829539|NCT00358670|6339127|P1|Overall Study|Adverse Event|26
1829540|NCT00358644|6339141|P1|Overall Study|Patient not eligible for study|1
1829541|NCT00358644|6339141|P1|Overall Study|Physician Decision|6
1829542|NCT00358644|6339141|P1|Overall Study|Withdrawal by Subject|4
1829543|NCT00358644|6339141|P1|Overall Study|Death|11
1829544|NCT00358644|6339141|P1|Overall Study|Adverse Event|7
1829545|NCT00358644|6339141|P1|Overall Study|Progressive Disease|21
1829546|NCT00358527|6339164|P2|Overall Study|Administrative|1
1829547|NCT00358527|6339165|P1|Overall Study|Administrative|2
1829548|NCT00358527|6339164|P2|Overall Study|Non-compliance with protocol|1
1829549|NCT00358527|6339165|P1|Overall Study|Non-compliance with protocol|6
1829550|NCT00358527|6339164|P2|Overall Study|Withdrawal by Subject|1
1829551|NCT00358527|6339165|P1|Overall Study|Withdrawal by Subject|1
1829552|NCT00358527|6339164|P2|Overall Study|Adverse Event|0
1829553|NCT00358527|6339165|P1|Overall Study|Adverse Event|4
1829554|NCT00358449|6339215|P3|Overall Study|Steriod Inhaler was Increased|1
1829555|NCT00358449|6339216|P2|Overall Study|Steriod Inhaler was Increased|0
1829556|NCT00358449|6339217|P1|Overall Study|Steriod Inhaler was Increased|0
1829557|NCT00358449|6339215|P3|Overall Study|Lack of Efficacy|0
1829558|NCT00358449|6339216|P2|Overall Study|Lack of Efficacy|1
1829559|NCT00358449|6339217|P1|Overall Study|Lack of Efficacy|0
1829560|NCT00358449|6339215|P3|Overall Study|Withdrawal by Subject|0
1829561|NCT00358449|6339216|P2|Overall Study|Withdrawal by Subject|0
1829562|NCT00358449|6339217|P1|Overall Study|Withdrawal by Subject|2
1829563|NCT00358449|6339215|P3|Overall Study|Lost to Follow-up|0
1829564|NCT00358449|6339216|P2|Overall Study|Lost to Follow-up|0
1829565|NCT00358449|6339217|P1|Overall Study|Lost to Follow-up|1
1829566|NCT00358449|6339215|P3|Overall Study|Adverse Event|1
1829567|NCT00358449|6339216|P2|Overall Study|Adverse Event|0
1829568|NCT00358449|6339217|P1|Overall Study|Adverse Event|1
1829569|NCT00358436|6339320|P2|Overall Study|Other|1
1829570|NCT00358436|6339321|P1|Overall Study|Other|6
1829571|NCT00358436|6339320|P2|Overall Study|COPD exacerbation|10
1829572|NCT00358436|6339321|P1|Overall Study|COPD exacerbation|22
1829573|NCT00358436|6339320|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
1829574|NCT00358436|6339321|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
1829575|NCT00358436|6339320|P2|Overall Study|Withdrawal by Subject|17
1829576|NCT00358436|6339321|P1|Overall Study|Withdrawal by Subject|40
1829577|NCT00358436|6339320|P2|Overall Study|Protocol Violation|3
1829578|NCT00358436|6339321|P1|Overall Study|Protocol Violation|8
1829579|NCT00358436|6339320|P2|Overall Study|Lost to Follow-up|6
1829580|NCT00358436|6339321|P1|Overall Study|Lost to Follow-up|11
1829581|NCT00358436|6339320|P2|Overall Study|Lack of Efficacy|36
1829582|NCT00358436|6339321|P1|Overall Study|Lack of Efficacy|34
1829583|NCT00358436|6339320|P2|Overall Study|Adverse Event|13
1829584|NCT00358436|6339321|P1|Overall Study|Adverse Event|29
1829585|NCT00358215|6339392|P2|Overall Study|Did not receive investigational product|3
1829586|NCT00358215|6339393|P1|Overall Study|Did not receive investigational product|2
1829587|NCT00358215|6339392|P2|Overall Study|Other|14
1829588|NCT00358215|6339393|P1|Overall Study|Other|21
1829589|NCT00358215|6339392|P2|Overall Study|Pregnancy|0
1829590|NCT00358215|6339393|P1|Overall Study|Pregnancy|1
1829591|NCT00358215|6339392|P2|Overall Study|Protocol Violation|59
1829592|NCT00358215|6339393|P1|Overall Study|Protocol Violation|64
1829593|NCT00358215|6339392|P2|Overall Study|Death|281
1829594|NCT00358215|6339393|P1|Overall Study|Death|265
1829595|NCT00358215|6339392|P2|Overall Study|Lost to Follow-up|22
1829596|NCT00358215|6339393|P1|Overall Study|Lost to Follow-up|16
1829597|NCT00358215|6339392|P2|Overall Study|Physician Decision|39
1829598|NCT00358215|6339393|P1|Overall Study|Physician Decision|47
1829599|NCT00358215|6339392|P2|Overall Study|Participant request|64
1829600|NCT00358215|6339393|P1|Overall Study|Participant request|65
1829601|NCT00358215|6339392|P2|Overall Study|Withdrawal by Subject|102
1829602|NCT00358215|6339393|P1|Overall Study|Withdrawal by Subject|111
1829603|NCT00358215|6339392|P2|Overall Study|Adverse Event|65
1829604|NCT00358215|6339393|P1|Overall Study|Adverse Event|83
1829605|NCT00358215|6339392|P2|Overall Study|Ineligibility determined|3
1829606|NCT00358215|6339393|P1|Overall Study|Ineligibility determined|4
1829607|NCT00358150|6339407|P1|Overall Study|Undefined|3
1829608|NCT00358150|6339407|P1|Overall Study|Withdrawal by Subject|1
1829609|NCT00358150|6339407|P1|Overall Study|Adverse Event|3
1829610|NCT00357994|6339436|P2|Overall Study|Protocol Violation|0
1829611|NCT00357994|6339437|P1|Overall Study|Protocol Violation|1
1829612|NCT00357994|6339436|P2|Overall Study|Lack of Efficacy|1
1829613|NCT00357994|6339437|P1|Overall Study|Lack of Efficacy|0
1829614|NCT00357994|6339436|P2|Overall Study|Adverse Event|2
1829615|NCT00357994|6339437|P1|Overall Study|Adverse Event|1
1829616|NCT00357968|6339491|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
1829617|NCT00357968|6339492|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
1829618|NCT00357968|6339491|P2|First Maintenance Dose Phase|Not a PCI patient|42
1829619|NCT00357968|6339492|P1|First Maintenance Dose Phase|Not a PCI patient|47
1829620|NCT00357903|6339545|P2|Overall Study|Other|10
1829621|NCT00357903|6339546|P1|Overall Study|Other|49
1829622|NCT00357903|6339545|P2|Overall Study|Response status|9
1829623|NCT00357903|6339546|P1|Overall Study|Response status|61
1829624|NCT00357903|6339545|P2|Overall Study|Protocol issues|3
1829625|NCT00357903|6339546|P1|Overall Study|Protocol issues|14
1829626|NCT00357903|6339545|P2|Overall Study|Completed month 12 only|1
1829627|NCT00357903|6339546|P1|Overall Study|Completed month 12 only|0
1829628|NCT00357903|6339545|P2|Overall Study|Withdrawal by Subject|7
1829629|NCT00357903|6339546|P1|Overall Study|Withdrawal by Subject|57
1829630|NCT00357903|6339545|P2|Overall Study|Physician Decision|5
1829631|NCT00357903|6339546|P1|Overall Study|Physician Decision|39
1829632|NCT00357903|6339545|P2|Overall Study|Lost to Follow-up|4
1829633|NCT00357903|6339546|P1|Overall Study|Lost to Follow-up|23
1829634|NCT00357903|6339545|P2|Overall Study|Death|0
1829635|NCT00357903|6339546|P1|Overall Study|Death|33
1829636|NCT00357903|6339545|P2|Overall Study|Adverse Event|4
1829637|NCT00357903|6339546|P1|Overall Study|Adverse Event|87
1829638|NCT00357877|6339586|P2|Overall Study|Other|2
1829639|NCT00357877|6339587|P1|Overall Study|Other|0
1829640|NCT00357877|6339586|P2|Overall Study|Administrative withdrawal|1
1829641|NCT00357877|6339587|P1|Overall Study|Administrative withdrawal|1
1829642|NCT00357877|6339586|P2|Overall Study|Withdrawal by Subject|3
1829643|NCT00357877|6339587|P1|Overall Study|Withdrawal by Subject|3
1829644|NCT00357877|6339586|P2|Overall Study|Lost to Follow-up|23
1829645|NCT00357877|6339587|P1|Overall Study|Lost to Follow-up|20
1829646|NCT00357877|6339586|P2|Overall Study|Death|1
1829647|NCT00357877|6339587|P1|Overall Study|Death|2
1829648|NCT00357760|6339601|P2|Overall Study|To receive hospice care|1
1829649|NCT00357760|6339602|P1|Overall Study|To receive hospice care|0
1829650|NCT00357760|6339601|P2|Overall Study|Protocol Violation|1
1829651|NCT00357760|6339602|P1|Overall Study|Protocol Violation|0
1829652|NCT00357760|6339601|P2|Overall Study|Physician Decision|1
1829653|NCT00357760|6339602|P1|Overall Study|Physician Decision|2
1829654|NCT00357760|6339601|P2|Overall Study|Ineligible|2
1829655|NCT00357760|6339602|P1|Overall Study|Ineligible|0
1829656|NCT00357760|6339601|P2|Overall Study|Never started treatment|1
1829657|NCT00357760|6339602|P1|Overall Study|Never started treatment|2
1829658|NCT00357760|6339601|P2|Overall Study|Withdrawal by Subject|2
1829659|NCT00357760|6339602|P1|Overall Study|Withdrawal by Subject|0
1829660|NCT00357760|6339601|P2|Overall Study|Alternative therapy|0
1829661|NCT00357760|6339602|P1|Overall Study|Alternative therapy|1
1829662|NCT00357760|6339601|P2|Overall Study|Death|3
1829663|NCT00357760|6339602|P1|Overall Study|Death|0
1829664|NCT00357760|6339601|P2|Overall Study|Adverse Event|7
1829665|NCT00357760|6339602|P1|Overall Study|Adverse Event|10
1829666|NCT00357760|6339601|P2|Overall Study|Disease progression|17
1829667|NCT00357760|6339602|P1|Overall Study|Disease progression|44
1829668|NCT00357656|6339623|P2|Overall Study|Other, No surgery performed|3
1829669|NCT00357656|6339624|P1|Overall Study|Other, No surgery performed|0
1829670|NCT00357552|6339675|P1|Weeks 24 to 104|Not able to get to clinic|2
1829671|NCT00357552|6339675|P1|Weeks 24 to 104|Death|3
1829672|NCT00357552|6339675|P1|Weeks 0 to 24|Death|1
1829673|NCT00357552|6339675|P1|Screening|Did not meet eligibility criteria|84
1829674|NCT00357500|6339690|P1|Overall Study|Not Started Protocol Therapy|4
1829675|NCT00357500|6339690|P1|Overall Study|Progressive Disease|65
1829676|NCT00357500|6339690|P1|Overall Study|Withdrawal by Subject|5
1829677|NCT00357500|6339690|P1|Overall Study|Adverse Event|3
1829678|NCT00357396|6339699|P2|Overall Study|Adverse Event|0
1829679|NCT00357396|6339700|P1|Overall Study|Adverse Event|1
1829680|NCT00357370|6339708|P3|Cohort 2|Withdrawal by Subject|0
1829681|NCT00357370|6339709|P2|Cohort 2|Withdrawal by Subject|2
1829682|NCT00357370|6339710|P1|Cohort 2|Withdrawal by Subject|0
1829683|NCT00357370|6339708|P3|Cohort 2|non-compliance, not met criteria, etc|0
1829684|NCT00357370|6339709|P2|Cohort 2|non-compliance, not met criteria, etc|1
1829685|NCT00357370|6339710|P1|Cohort 2|non-compliance, not met criteria, etc|1
1829686|NCT00357370|6339708|P3|Cohort 2|Lost to Follow-up|0
1829687|NCT00357370|6339709|P2|Cohort 2|Lost to Follow-up|1
1829688|NCT00357370|6339710|P1|Cohort 2|Lost to Follow-up|0
1829689|NCT00357370|6339708|P3|Cohort 2|Adverse Event|1
1829690|NCT00357370|6339709|P2|Cohort 2|Adverse Event|1
1829691|NCT00357370|6339710|P1|Cohort 2|Adverse Event|1
1829692|NCT00357370|6339708|P3|Cohort 2|Lack of Efficacy|1
1829693|NCT00357370|6339709|P2|Cohort 2|Lack of Efficacy|2
1829694|NCT00357370|6339710|P1|Cohort 2|Lack of Efficacy|0
1829695|NCT00357110|6339773|P2|Overall Study|Early study termination|5
1829696|NCT00357110|6339774|P1|Overall Study|Early study termination|5
1829697|NCT00357097|6339782|P2|Overall Study|Increase of RLS Symptoms|1
1829698|NCT00357097|6339783|P1|Overall Study|Increase of RLS Symptoms|0
1829699|NCT00357097|6339782|P2|Overall Study|Other|1
1829700|NCT00357097|6339783|P1|Overall Study|Other|1
1829701|NCT00357097|6339782|P2|Overall Study|Met Exclusion Criteria|1
1829702|NCT00357097|6339783|P1|Overall Study|Met Exclusion Criteria|3
1829703|NCT00357097|6339782|P2|Overall Study|Lack of Efficacy|8
1829704|NCT00357097|6339783|P1|Overall Study|Lack of Efficacy|2
1829705|NCT00357097|6339782|P2|Overall Study|Non-compliance|2
1829706|NCT00357097|6339783|P1|Overall Study|Non-compliance|1
1829707|NCT00357097|6339782|P2|Overall Study|Withdrawal by Subject|7
1829708|NCT00357097|6339783|P1|Overall Study|Withdrawal by Subject|8
1829709|NCT00357097|6339782|P2|Overall Study|Adverse Event|6
1829710|NCT00357097|6339783|P1|Overall Study|Adverse Event|34
1829711|NCT00357097|6339782|P2|Overall Study|Did not meet inclusion criteria|3
1829712|NCT00357097|6339783|P1|Overall Study|Did not meet inclusion criteria|5
1829713|NCT00357006|6339837|P3|Overall Study|Withdrawal by Subject|2
1829714|NCT00357006|6339838|P2|Overall Study|Withdrawal by Subject|3
1829715|NCT00357006|6339839|P1|Overall Study|Withdrawal by Subject|1
1829716|NCT00357006|6339837|P3|Overall Study|Lost to Follow-up|1
1829717|NCT00357006|6339838|P2|Overall Study|Lost to Follow-up|2
1829718|NCT00357006|6339839|P1|Overall Study|Lost to Follow-up|1
1829719|NCT00356915|6339854|P3|Overall Study|Miscellaneous reasons|3
1829720|NCT00356915|6339855|P2|Overall Study|Miscellaneous reasons|8
1829721|NCT00356915|6339856|P1|Overall Study|Miscellaneous reasons|11
1829722|NCT00356915|6339854|P3|Overall Study|Adverse Event|8
1829723|NCT00356915|6339855|P2|Overall Study|Adverse Event|31
1829724|NCT00356915|6339856|P1|Overall Study|Adverse Event|21
1829725|NCT00356915|6339854|P3|Overall Study|Physician Decision|0
1829726|NCT00356915|6339855|P2|Overall Study|Physician Decision|2
1829727|NCT00356915|6339856|P1|Overall Study|Physician Decision|0
1829728|NCT00356915|6339854|P3|Overall Study|Administrative Decision|1
1829729|NCT00356915|6339855|P2|Overall Study|Administrative Decision|0
1829730|NCT00356915|6339856|P1|Overall Study|Administrative Decision|0
1829731|NCT00356915|6339854|P3|Overall Study|Lost to Follow-up|14
1829732|NCT00356915|6339855|P2|Overall Study|Lost to Follow-up|34
1829733|NCT00356915|6339856|P1|Overall Study|Lost to Follow-up|27
1829734|NCT00356915|6339854|P3|Overall Study|Lack of Efficacy|3
1829735|NCT00356915|6339855|P2|Overall Study|Lack of Efficacy|0
1829736|NCT00356915|6339856|P1|Overall Study|Lack of Efficacy|0
1829737|NCT00356915|6339854|P3|Overall Study|Withdrawal by Subject|10
1829738|NCT00356915|6339855|P2|Overall Study|Withdrawal by Subject|14
1829739|NCT00356915|6339856|P1|Overall Study|Withdrawal by Subject|14
1829740|NCT00356915|6339854|P3|Overall Study|Protocol Violation|2
1829741|NCT00356915|6339855|P2|Overall Study|Protocol Violation|3
1829742|NCT00356915|6339856|P1|Overall Study|Protocol Violation|2
1829743|NCT00356915|6339854|P3|Overall Study|Non compliance|1
1829744|NCT00356915|6339855|P2|Overall Study|Non compliance|2
1829745|NCT00356915|6339856|P1|Overall Study|Non compliance|1
1829746|NCT00356889|6339873|P1|Overall Study|Adverse Event|1
1829747|NCT00356889|6339873|P1|Overall Study|Protocol Violation|2
1829748|NCT00356863|6339882|P2|Overall Study|Lost to Follow-up|43
1829749|NCT00356863|6339883|P1|Overall Study|Lost to Follow-up|76
1829750|NCT00356863|6339882|P2|Overall Study|Death|32
1829751|NCT00356863|6339883|P1|Overall Study|Death|16
1829752|NCT00356811|6339909|P1|Overall Study|Site Closed during Follow-up|2
1829753|NCT00356811|6339909|P1|Overall Study|Study Is Terminating|3
1829754|NCT00356811|6339909|P1|Overall Study|Participant Could Not Make a Checkup|1
1829755|NCT00356811|6339909|P1|Overall Study|Withdrawal by Subject|6
1829756|NCT00356811|6339909|P1|Overall Study|Lost to Follow-up|2
1829757|NCT00356811|6339909|P1|Overall Study|Death|35
1829758|NCT00356759|6339924|P2|Overall Study|Intercurrent disease or persistent extre|2
1829759|NCT00356759|6339925|P1|Overall Study|Intercurrent disease or persistent extre|5
1829760|NCT00356759|6339924|P2|Overall Study|Lost to Follow-up|1
1829761|NCT00356759|6339925|P1|Overall Study|Lost to Follow-up|1
1829762|NCT00356759|6339924|P2|Overall Study|Adverse Event|3
1829763|NCT00356759|6339925|P1|Overall Study|Adverse Event|1
1829764|NCT00356759|6339924|P2|Overall Study|Withdrawal by Subject|2
1829765|NCT00356759|6339925|P1|Overall Study|Withdrawal by Subject|2
1829766|NCT00356759|6339924|P2|Overall Study|Death|2
1829767|NCT00356759|6339925|P1|Overall Study|Death|5
1829768|NCT00356603|6339943|P2|Overall Study|Other|3
1829769|NCT00356603|6339944|P1|Overall Study|Other|6
1829770|NCT00356590|6339958|P1|Overall Study|Other|52
1829771|NCT00356590|6339958|P1|Overall Study|Response status|28
1829772|NCT00356590|6339958|P1|Overall Study|Protocol issues|6
1829773|NCT00356590|6339958|P1|Overall Study|Completed month 12 only|2
1829774|NCT00356590|6339958|P1|Overall Study|Withdrawal by Subject|41
1829775|NCT00356590|6339958|P1|Overall Study|Physician Decision|46
1829776|NCT00356590|6339958|P1|Overall Study|Lost to Follow-up|35
1829777|NCT00356590|6339958|P1|Overall Study|Death|10
1829778|NCT00356590|6339958|P1|Overall Study|Adverse Event|54
1829779|NCT00356525|6339994|P4|Overall Study|Sponsor Decision|1
1829780|NCT00356525|6339995|P3|Overall Study|Sponsor Decision|0
1829781|NCT00356525|6339996|P2|Overall Study|Sponsor Decision|0
1829782|NCT00356525|6339997|P1|Overall Study|Sponsor Decision|0
1829783|NCT00356525|6339994|P4|Overall Study|Death|1
1829784|NCT00356525|6339995|P3|Overall Study|Death|0
1829785|NCT00356525|6339996|P2|Overall Study|Death|0
1829786|NCT00356525|6339997|P1|Overall Study|Death|0
1829787|NCT00356525|6339994|P4|Overall Study|Withdrawal by Subject|3
1829788|NCT00356525|6339995|P3|Overall Study|Withdrawal by Subject|0
1829789|NCT00356525|6339996|P2|Overall Study|Withdrawal by Subject|1
1829790|NCT00356525|6339997|P1|Overall Study|Withdrawal by Subject|1
1829791|NCT00356525|6339994|P4|Overall Study|Protocol Entry Criteria Not Met|0
1829792|NCT00356525|6339995|P3|Overall Study|Protocol Entry Criteria Not Met|0
1829793|NCT00356525|6339996|P2|Overall Study|Protocol Entry Criteria Not Met|0
1829794|NCT00356525|6339997|P1|Overall Study|Protocol Entry Criteria Not Met|1
1829795|NCT00356525|6339994|P4|Overall Study|Physician Decision|1
1829796|NCT00356525|6339995|P3|Overall Study|Physician Decision|2
1829797|NCT00356525|6339996|P2|Overall Study|Physician Decision|2
1829798|NCT00356525|6339997|P1|Overall Study|Physician Decision|2
1829799|NCT00356525|6339994|P4|Overall Study|Lost to Follow-up|0
1829800|NCT00356525|6339995|P3|Overall Study|Lost to Follow-up|0
1829801|NCT00356525|6339996|P2|Overall Study|Lost to Follow-up|0
1829802|NCT00356525|6339997|P1|Overall Study|Lost to Follow-up|1
1829803|NCT00356525|6339994|P4|Overall Study|Adverse Event|1
1829804|NCT00356525|6339995|P3|Overall Study|Adverse Event|1
1829805|NCT00356525|6339996|P2|Overall Study|Adverse Event|3
1829806|NCT00356525|6339997|P1|Overall Study|Adverse Event|1
1829807|NCT00356525|6339994|P4|Overall Study|Progressive Disease|2
1829808|NCT00356525|6339995|P3|Overall Study|Progressive Disease|4
1829809|NCT00356525|6339996|P2|Overall Study|Progressive Disease|5
1829810|NCT00356525|6339997|P1|Overall Study|Progressive Disease|8
1829811|NCT00356421|6340038|P2|Overall Study|Not related to study drug|3
1829812|NCT00356421|6340039|P1|Overall Study|Not related to study drug|5
1829813|NCT00356421|6340038|P2|Overall Study|Related to study drug|12
1829814|NCT00356421|6340039|P1|Overall Study|Related to study drug|15
1829815|NCT00356421|6340038|P2|Overall Study|Withdrawal by Subject|2
1829816|NCT00356421|6340039|P1|Overall Study|Withdrawal by Subject|9
1829817|NCT00356421|6340038|P2|Overall Study|Lack of Efficacy|0
1829818|NCT00356421|6340039|P1|Overall Study|Lack of Efficacy|3
1829819|NCT00356408|6340079|P1|Overall Study|Other: Subject chose commerical dosing|1
1829820|NCT00356408|6340079|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
1829821|NCT00356408|6340079|P1|Overall Study|Other: Azathioprine stopped|1
1829822|NCT00356408|6340079|P1|Overall Study|Other: Sponsor request|1
1829823|NCT00356408|6340079|P1|Overall Study|Other: Principal investigator discretion|3
1829824|NCT00356408|6340079|P1|Overall Study|Withdrawal by Subject|6
1829825|NCT00356408|6340079|P1|Overall Study|Lost to Follow-up|2
1829826|NCT00356408|6340079|P1|Overall Study|Lack of Efficacy|36
1829827|NCT00356408|6340079|P1|Overall Study|Adverse Event|9
1829828|NCT00356369|6340096|P2|Active Phase|Withdrawal by Subject|1
1829829|NCT00356369|6340097|P1|Active Phase|Withdrawal by Subject|2
1829830|NCT00356278|6340179|P3|Overall Study|Withdrawal by Subject|19
1829831|NCT00356278|6340180|P2|Overall Study|Withdrawal by Subject|15
1829832|NCT00356278|6340181|P1|Overall Study|Withdrawal by Subject|25
1829833|NCT00356265|6340219|P3|Overall Study|Withdrawal by Subject|1
1829834|NCT00356265|6340220|P2|Overall Study|Withdrawal by Subject|0
1829835|NCT00356265|6340221|P1|Overall Study|Withdrawal by Subject|0
1829836|NCT00356200|6340233|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
1829837|NCT00356200|6340234|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
1829838|NCT00356200|6340233|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
1829839|NCT00356200|6340234|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
1829840|NCT00356148|6340263|P2|Overall Study|Reoperation within 30 days|1
1829841|NCT00356148|6340264|P1|Overall Study|Reoperation within 30 days|2
1829842|NCT00356135|6340275|P3|Overall Study|Subject non-compliance|3
1829843|NCT00356135|6340276|P2|Overall Study|Subject non-compliance|1
1829844|NCT00356135|6340277|P1|Overall Study|Subject non-compliance|1
1829845|NCT00356135|6340275|P3|Overall Study|Physician Decision|1
1829846|NCT00356135|6340276|P2|Overall Study|Physician Decision|1
1829847|NCT00356135|6340277|P1|Overall Study|Physician Decision|1
1829848|NCT00356135|6340275|P3|Overall Study|Lost to Follow-up|1
1829849|NCT00356135|6340276|P2|Overall Study|Lost to Follow-up|0
1829850|NCT00356135|6340277|P1|Overall Study|Lost to Follow-up|0
1829851|NCT00356135|6340275|P3|Overall Study|Adverse Event|0
1829852|NCT00356135|6340276|P2|Overall Study|Adverse Event|0
1829853|NCT00356135|6340277|P1|Overall Study|Adverse Event|1
1829854|NCT00356135|6340275|P3|Overall Study|Protocol Violation|0
1829855|NCT00356135|6340276|P2|Overall Study|Protocol Violation|0
1829856|NCT00356135|6340277|P1|Overall Study|Protocol Violation|1
1829857|NCT00356122|6340299|P1|FOLLOW-UP|Other|2
1829858|NCT00356122|6340299|P1|FOLLOW-UP|Lost to Follow-up|2
1829859|NCT00356122|6340299|P1|FOLLOW-UP|Death|37
1829860|NCT00356122|6340299|P1|TREATMENT|Did not receive study medication|1
1829861|NCT00356122|6340299|P1|TREATMENT|Other|4
1829862|NCT00356122|6340299|P1|TREATMENT|Subject's request|4
1829863|NCT00356122|6340299|P1|TREATMENT|Adverse Event|10
1829864|NCT00356122|6340299|P1|TREATMENT|Lack of Efficacy|26
1829865|NCT00355784|6340407|P3|Overall Study|Withdrawal by Subject|2
1829866|NCT00355784|6340408|P2|Overall Study|Withdrawal by Subject|0
1829867|NCT00355784|6340409|P1|Overall Study|Withdrawal by Subject|0
1829868|NCT00355615|6340458|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
1829869|NCT00355615|6340459|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
1829870|NCT00355615|6340460|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
1829871|NCT00355615|6340461|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
1829872|NCT00355615|6340462|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
1829873|NCT00355615|6340458|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
1829874|NCT00355615|6340459|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1829875|NCT00355615|6340460|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1829876|NCT00355615|6340461|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1829877|NCT00355615|6340462|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
1829878|NCT00355615|6340458|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
1829879|NCT00355615|6340459|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1829880|NCT00355615|6340460|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1829881|NCT00355615|6340461|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1829882|NCT00355615|6340462|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
1829883|NCT00355615|6340458|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
1829884|NCT00355615|6340459|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
1829885|NCT00355615|6340460|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
1829886|NCT00355615|6340461|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
1829887|NCT00355615|6340462|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
1829888|NCT00355615|6340458|P5|Randomized Double Blind Period|Protocol Violation|0
1829889|NCT00355615|6340459|P4|Randomized Double Blind Period|Protocol Violation|1
1829890|NCT00355615|6340460|P3|Randomized Double Blind Period|Protocol Violation|1
1829891|NCT00355615|6340461|P2|Randomized Double Blind Period|Protocol Violation|0
1829892|NCT00355615|6340462|P1|Randomized Double Blind Period|Protocol Violation|0
1829893|NCT00355615|6340458|P5|Randomized Double Blind Period|Adverse Event|0
1829894|NCT00355615|6340459|P4|Randomized Double Blind Period|Adverse Event|0
1829895|NCT00355615|6340460|P3|Randomized Double Blind Period|Adverse Event|0
1829896|NCT00355615|6340461|P2|Randomized Double Blind Period|Adverse Event|0
1829897|NCT00355615|6340462|P1|Randomized Double Blind Period|Adverse Event|1
1829898|NCT00355472|6340521|P1|Overall Study|Physician Decision|1
1829899|NCT00355368|6340567|P2|Overall Study|cardiac arrest prior to intubation|2
1829900|NCT00355368|6340568|P1|Overall Study|cardiac arrest prior to intubation|2
1829901|NCT00355368|6340567|P2|Overall Study|Protocol Violation|7
1829902|NCT00355368|6340568|P1|Overall Study|Protocol Violation|8
1829903|NCT00355342|6340582|P2|Overall Study|Use of protocol excluded medication|1
1829904|NCT00355342|6340583|P1|Overall Study|Use of protocol excluded medication|0
1829905|NCT00355342|6340582|P2|Overall Study|Protocol Violation|1
1829906|NCT00355342|6340583|P1|Overall Study|Protocol Violation|0
1829907|NCT00355342|6340582|P2|Overall Study|Study management|1
1829908|NCT00355342|6340583|P1|Overall Study|Study management|0
1829909|NCT00355342|6340582|P2|Overall Study|Participant discontinued study drug|1
1829910|NCT00355342|6340583|P1|Overall Study|Participant discontinued study drug|0
1829911|NCT00355342|6340582|P2|Overall Study|Participant relocated|1
1829912|NCT00355342|6340583|P1|Overall Study|Participant relocated|0
1829913|NCT00355342|6340582|P2|Overall Study|Withdrawal by participant and physician|0
1829914|NCT00355342|6340583|P1|Overall Study|Withdrawal by participant and physician|1
1829915|NCT00355342|6340582|P2|Overall Study|Non-compliance with Dexa scans|0
1829916|NCT00355342|6340583|P1|Overall Study|Non-compliance with Dexa scans|1
1829917|NCT00355342|6340582|P2|Overall Study|Dispensed wrong study drug kit|0
1829918|NCT00355342|6340583|P1|Overall Study|Dispensed wrong study drug kit|1
1829919|NCT00355342|6340582|P2|Overall Study|COPD exacerbation|1
1829920|NCT00355342|6340583|P1|Overall Study|COPD exacerbation|1
1829921|NCT00355342|6340582|P2|Overall Study|Use of prohibited medication|0
1829922|NCT00355342|6340583|P1|Overall Study|Use of prohibited medication|1
1829923|NCT00355342|6340582|P2|Overall Study|Overcompliant-PI discretion|0
1829924|NCT00355342|6340583|P1|Overall Study|Overcompliant-PI discretion|1
1829925|NCT00355342|6340582|P2|Overall Study|Sponsor terminated study|2
1829926|NCT00355342|6340583|P1|Overall Study|Sponsor terminated study|2
1829927|NCT00355342|6340582|P2|Overall Study|Withdrawal by Subject|11
1829928|NCT00355342|6340583|P1|Overall Study|Withdrawal by Subject|14
1829929|NCT00355342|6340582|P2|Overall Study|Lost to Follow-up|2
1829930|NCT00355342|6340583|P1|Overall Study|Lost to Follow-up|4
1829931|NCT00355342|6340582|P2|Overall Study|Adverse Event|15
1829932|NCT00355342|6340583|P1|Overall Study|Adverse Event|13
1829933|NCT00355147|6340610|P2|Overall Study|Withdrawal by Subject|12
1829934|NCT00355147|6340611|P1|Overall Study|Withdrawal by Subject|8
1829935|NCT00355147|6340610|P2|Overall Study|Lost to Follow-up|8
1829936|NCT00355147|6340611|P1|Overall Study|Lost to Follow-up|10
1829937|NCT00355134|6340630|P5|Extension Phase|Protocol Violation|0
1829938|NCT00355134|6340631|P4|Extension Phase|Protocol Violation|1
1829939|NCT00355134|6340632|P3|Extension Phase|Protocol Violation|0
1829940|NCT00355134|6340633|P2|Extension Phase|Protocol Violation|0
1829941|NCT00355134|6340634|P1|Extension Phase|Protocol Violation|0
1829942|NCT00355134|6340630|P5|Extension Phase|Abnormal test procedure result(s)|1
1829943|NCT00355134|6340631|P4|Extension Phase|Abnormal test procedure result(s)|0
1829944|NCT00355134|6340632|P3|Extension Phase|Abnormal test procedure result(s)|0
1829945|NCT00355134|6340633|P2|Extension Phase|Abnormal test procedure result(s)|1
1829946|NCT00355134|6340634|P1|Extension Phase|Abnormal test procedure result(s)|0
1829947|NCT00355134|6340630|P5|Extension Phase|Unsatisfactory therapeutic effect|1
1829948|NCT00355134|6340631|P4|Extension Phase|Unsatisfactory therapeutic effect|0
1829949|NCT00355134|6340632|P3|Extension Phase|Unsatisfactory therapeutic effect|0
1829950|NCT00355134|6340633|P2|Extension Phase|Unsatisfactory therapeutic effect|4
1829951|NCT00355134|6340634|P1|Extension Phase|Unsatisfactory therapeutic effect|3
1829952|NCT00355134|6340630|P5|Extension Phase|Administrative problems|1
1829953|NCT00355134|6340631|P4|Extension Phase|Administrative problems|1
1829954|NCT00355134|6340632|P3|Extension Phase|Administrative problems|0
1829955|NCT00355134|6340633|P2|Extension Phase|Administrative problems|4
1829956|NCT00355134|6340634|P1|Extension Phase|Administrative problems|2
1829957|NCT00355134|6340630|P5|Extension Phase|Abnormal laboratory value(s)|2
1829958|NCT00355134|6340631|P4|Extension Phase|Abnormal laboratory value(s)|2
1829959|NCT00355134|6340632|P3|Extension Phase|Abnormal laboratory value(s)|0
1829960|NCT00355134|6340633|P2|Extension Phase|Abnormal laboratory value(s)|2
1829961|NCT00355134|6340634|P1|Extension Phase|Abnormal laboratory value(s)|4
1829962|NCT00355134|6340630|P5|Extension Phase|Lost to Follow-up|4
1829963|NCT00355134|6340631|P4|Extension Phase|Lost to Follow-up|2
1829964|NCT00355134|6340632|P3|Extension Phase|Lost to Follow-up|0
1829965|NCT00355134|6340633|P2|Extension Phase|Lost to Follow-up|6
1829966|NCT00355134|6340634|P1|Extension Phase|Lost to Follow-up|2
1829967|NCT00355134|6340630|P5|Extension Phase|Adverse Event|5
1829968|NCT00355134|6340631|P4|Extension Phase|Adverse Event|3
1829969|NCT00355134|6340632|P3|Extension Phase|Adverse Event|0
1829970|NCT00355134|6340633|P2|Extension Phase|Adverse Event|9
1829971|NCT00355134|6340634|P1|Extension Phase|Adverse Event|13
1829972|NCT00355134|6340630|P5|Extension Phase|Withdrawal by Subject|5
1829973|NCT00355134|6340631|P4|Extension Phase|Withdrawal by Subject|7
1829974|NCT00355134|6340632|P3|Extension Phase|Withdrawal by Subject|0
1829975|NCT00355134|6340633|P2|Extension Phase|Withdrawal by Subject|11
1829976|NCT00355134|6340634|P1|Extension Phase|Withdrawal by Subject|7
1829977|NCT00355134|6340630|P5|Core Phase|Condition no longer requires study drug|0
1829978|NCT00355134|6340631|P4|Core Phase|Condition no longer requires study drug|0
1829979|NCT00355134|6340632|P3|Core Phase|Condition no longer requires study drug|1
1829980|NCT00355134|6340633|P2|Core Phase|Condition no longer requires study drug|0
1829981|NCT00355134|6340634|P1|Core Phase|Condition no longer requires study drug|1
1829982|NCT00355134|6340630|P5|Core Phase|Abnormal test procedure result(s)|0
1829983|NCT00355134|6340631|P4|Core Phase|Abnormal test procedure result(s)|0
1829984|NCT00355134|6340632|P3|Core Phase|Abnormal test procedure result(s)|1
1829985|NCT00355134|6340633|P2|Core Phase|Abnormal test procedure result(s)|2
1829986|NCT00355134|6340634|P1|Core Phase|Abnormal test procedure result(s)|1
1829987|NCT00355134|6340630|P5|Core Phase|Protocol Violation|0
1829988|NCT00355134|6340631|P4|Core Phase|Protocol Violation|0
1829989|NCT00355134|6340632|P3|Core Phase|Protocol Violation|2
1829990|NCT00355134|6340633|P2|Core Phase|Protocol Violation|2
1829991|NCT00355134|6340634|P1|Core Phase|Protocol Violation|3
1829992|NCT00355134|6340630|P5|Core Phase|Administrative problems|0
1829993|NCT00355134|6340631|P4|Core Phase|Administrative problems|0
1829994|NCT00355134|6340632|P3|Core Phase|Administrative problems|5
1829995|NCT00355134|6340633|P2|Core Phase|Administrative problems|3
1829996|NCT00355134|6340634|P1|Core Phase|Administrative problems|5
1829997|NCT00355134|6340630|P5|Core Phase|Unsatisfactory therapeutic effect|0
1829998|NCT00355134|6340631|P4|Core Phase|Unsatisfactory therapeutic effect|0
1829999|NCT00355134|6340632|P3|Core Phase|Unsatisfactory therapeutic effect|17
1830000|NCT00355134|6340633|P2|Core Phase|Unsatisfactory therapeutic effect|6
1830001|NCT00355134|6340634|P1|Core Phase|Unsatisfactory therapeutic effect|10
1830002|NCT00355134|6340630|P5|Core Phase|Abnormal laboratory value(s)|0
1830003|NCT00355134|6340631|P4|Core Phase|Abnormal laboratory value(s)|0
1830004|NCT00355134|6340632|P3|Core Phase|Abnormal laboratory value(s)|2
1830005|NCT00355134|6340633|P2|Core Phase|Abnormal laboratory value(s)|14
1830006|NCT00355134|6340634|P1|Core Phase|Abnormal laboratory value(s)|19
1830007|NCT00355134|6340630|P5|Core Phase|Lost to Follow-up|0
1830008|NCT00355134|6340631|P4|Core Phase|Lost to Follow-up|0
1830009|NCT00355134|6340632|P3|Core Phase|Lost to Follow-up|21
1830010|NCT00355134|6340633|P2|Core Phase|Lost to Follow-up|13
1830011|NCT00355134|6340634|P1|Core Phase|Lost to Follow-up|17
1830012|NCT00355134|6340630|P5|Core Phase|Adverse Event|0
1830013|NCT00355134|6340631|P4|Core Phase|Adverse Event|0
1830014|NCT00355134|6340632|P3|Core Phase|Adverse Event|16
1830015|NCT00355134|6340633|P2|Core Phase|Adverse Event|22
1830016|NCT00355134|6340634|P1|Core Phase|Adverse Event|28
1830017|NCT00355134|6340630|P5|Core Phase|Withdrawal by Subject|0
1830018|NCT00355134|6340631|P4|Core Phase|Withdrawal by Subject|0
1830019|NCT00355134|6340632|P3|Core Phase|Withdrawal by Subject|35
1830020|NCT00355134|6340633|P2|Core Phase|Withdrawal by Subject|24
1830021|NCT00355134|6340634|P1|Core Phase|Withdrawal by Subject|35
1830022|NCT00355121|6340677|P3|Overall Study|Serious adverse events|0
1830023|NCT00355121|6340678|P2|Overall Study|Serious adverse events|2
1830024|NCT00355121|6340679|P1|Overall Study|Serious adverse events|0
1830025|NCT00355121|6340677|P3|Overall Study|Withdrawal by Subject|2
1830026|NCT00355121|6340678|P2|Overall Study|Withdrawal by Subject|10
1830027|NCT00355121|6340679|P1|Overall Study|Withdrawal by Subject|9
1830028|NCT00355121|6340677|P3|Overall Study|Lost to Follow-up|1
1830029|NCT00355121|6340678|P2|Overall Study|Lost to Follow-up|7
1830030|NCT00355121|6340679|P1|Overall Study|Lost to Follow-up|4
1830031|NCT00355121|6340677|P3|Overall Study|Protocol Violation|1
1830032|NCT00355121|6340678|P2|Overall Study|Protocol Violation|9
1830033|NCT00355121|6340679|P1|Overall Study|Protocol Violation|7
1830034|NCT00355121|6340677|P3|Overall Study|Adverse Event|0
1830035|NCT00355121|6340678|P2|Overall Study|Adverse Event|1
1830036|NCT00355121|6340679|P1|Overall Study|Adverse Event|0
1830037|NCT00355121|6340677|P3|Overall Study|Did not receive study vaccine|1
1830038|NCT00355121|6340678|P2|Overall Study|Did not receive study vaccine|0
1830039|NCT00355121|6340679|P1|Overall Study|Did not receive study vaccine|1
1830040|NCT00355082|6340710|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
1830041|NCT00355082|6340711|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
1830042|NCT00355082|6340712|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
1830043|NCT00355082|6340710|P3|Continuation Phase|Scheduling Error|0
1830044|NCT00355082|6340711|P2|Continuation Phase|Scheduling Error|0
1830045|NCT00355082|6340712|P1|Continuation Phase|Scheduling Error|1
1830046|NCT00355082|6340710|P3|Continuation Phase|Site Closed by Sponsor|0
1830047|NCT00355082|6340711|P2|Continuation Phase|Site Closed by Sponsor|0
1830048|NCT00355082|6340712|P1|Continuation Phase|Site Closed by Sponsor|8
1830049|NCT00355082|6340710|P3|Continuation Phase|Lack of Efficacy|0
1830050|NCT00355082|6340711|P2|Continuation Phase|Lack of Efficacy|0
1830051|NCT00355082|6340712|P1|Continuation Phase|Lack of Efficacy|5
1830052|NCT00355082|6340710|P3|Continuation Phase|Withdrawal by Subject|0
1830053|NCT00355082|6340711|P2|Continuation Phase|Withdrawal by Subject|0
1830054|NCT00355082|6340712|P1|Continuation Phase|Withdrawal by Subject|4
1830055|NCT00355082|6340710|P3|Continuation Phase|Protocol Violation|1
1830056|NCT00355082|6340711|P2|Continuation Phase|Protocol Violation|0
1830057|NCT00355082|6340712|P1|Continuation Phase|Protocol Violation|1
1830058|NCT00355082|6340710|P3|Continuation Phase|Lost to Follow-up|1
1830059|NCT00355082|6340711|P2|Continuation Phase|Lost to Follow-up|0
1830060|NCT00355082|6340712|P1|Continuation Phase|Lost to Follow-up|2
1830061|NCT00355082|6340710|P3|Continuation Phase|Adverse Event|1
1830062|NCT00355082|6340711|P2|Continuation Phase|Adverse Event|0
1830063|NCT00355082|6340712|P1|Continuation Phase|Adverse Event|2
1830064|NCT00355082|6340710|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
1830065|NCT00355082|6340711|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
1830066|NCT00355082|6340712|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
1830067|NCT00355082|6340710|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1830068|NCT00355082|6340711|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
1830069|NCT00355082|6340712|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
1830070|NCT00355082|6340710|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1830071|NCT00355082|6340711|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
1830072|NCT00355082|6340712|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
1830073|NCT00355082|6340710|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
1830074|NCT00355082|6340711|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
1830075|NCT00355082|6340712|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
1830076|NCT00355082|6340710|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
1830077|NCT00355082|6340711|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
1830078|NCT00355082|6340712|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
1830079|NCT00355082|6340710|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
1830080|NCT00355082|6340711|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
1830081|NCT00355082|6340712|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
1830082|NCT00355030|6340734|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1830083|NCT00355030|6340735|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
1830084|NCT00355030|6340734|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
1830085|NCT00355030|6340735|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
1830086|NCT00355030|6340734|P2|Study Period 1 Treatment|Other|6
1830087|NCT00355030|6340735|P1|Study Period 1 Treatment|Other|2
1830088|NCT00355030|6340734|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
1830089|NCT00355030|6340735|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
1830090|NCT00355030|6340734|P2|Study Period 1 Treatment|Sponsor Decision|32
1830091|NCT00355030|6340735|P1|Study Period 1 Treatment|Sponsor Decision|34
1830092|NCT00355030|6340734|P2|Study Period 1 Treatment|Physician Decision|1
1830093|NCT00355030|6340735|P1|Study Period 1 Treatment|Physician Decision|0
1830094|NCT00355030|6340734|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
1830095|NCT00355030|6340735|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
1830096|NCT00355030|6340734|P2|Study Period 1 Treatment|Withdrawal by Subject|1
1830097|NCT00355030|6340735|P1|Study Period 1 Treatment|Withdrawal by Subject|4
1830098|NCT00355030|6340734|P2|Study Period 1 Treatment|Lost to Follow-up|0
1830099|NCT00355030|6340735|P1|Study Period 1 Treatment|Lost to Follow-up|3
1830100|NCT00355030|6340734|P2|Study Period 1 Treatment|Adverse Event|1
1830101|NCT00355030|6340735|P1|Study Period 1 Treatment|Adverse Event|1
1830102|NCT00354835|6340774|P2|Overall Study|Refusal of further therapy|8
1830103|NCT00354835|6340775|P1|Overall Study|Refusal of further therapy|3
1830104|NCT00354835|6340774|P2|Overall Study|Adverse Event|0
1830105|NCT00354835|6340775|P1|Overall Study|Adverse Event|6
1830106|NCT00354835|6340774|P2|Overall Study|Disease progression or relapse|22
1830107|NCT00354835|6340775|P1|Overall Study|Disease progression or relapse|15
1830108|NCT00354835|6340774|P2|Overall Study|Ineligible|16
1830109|NCT00354835|6340775|P1|Overall Study|Ineligible|17
1830110|NCT00354835|6340774|P2|Overall Study|Withdrawal by Subject|1
1830111|NCT00354835|6340775|P1|Overall Study|Withdrawal by Subject|2
1830112|NCT00354835|6340774|P2|Overall Study|Physician Decision|13
1830113|NCT00354835|6340775|P1|Overall Study|Physician Decision|8
1830114|NCT00354835|6340774|P2|Overall Study|Death|1
1830115|NCT00354835|6340775|P1|Overall Study|Death|1
1830116|NCT00354744|6340814|P1|Overall Study|Withdrawal by Subject|14
1830117|NCT00354744|6340814|P1|Overall Study|Physician Decision|11
1830118|NCT00354744|6340814|P1|Overall Study|Lost to Follow-up|2
1830119|NCT00354744|6340814|P1|Overall Study|Lack of Efficacy|11
1830120|NCT00354744|6340814|P1|Overall Study|Death|2
1830121|NCT00354744|6340814|P1|Overall Study|Adverse Event|2
1830122|NCT00354679|6340820|P1|Overall Study|Patient Not Treated|1
1830123|NCT00354614|6340829|P1|Overall Study|Lack of Efficacy|28
1830124|NCT00354601|6340833|P1|Overall Study|progression|1
1830125|NCT00354601|6340833|P1|Overall Study|Protocol Violation|1
1830126|NCT00354432|6340853|P4|Overall Study|Off/Toxicity|5
1830127|NCT00354432|6340854|P3|Overall Study|Off/Toxicity|5
1830128|NCT00354432|6340855|P2|Overall Study|Off/Toxicity|7
1830129|NCT00354432|6340856|P1|Overall Study|Off/Toxicity|3
1830130|NCT00354432|6340853|P4|Overall Study|Adverse Event|5
1830131|NCT00354432|6340854|P3|Overall Study|Adverse Event|5
1830132|NCT00354432|6340855|P2|Overall Study|Adverse Event|1
1830133|NCT00354432|6340856|P1|Overall Study|Adverse Event|3
1830134|NCT00354341|6340872|P2|Overall Study|Other|2
1830135|NCT00354341|6340873|P1|Overall Study|Other|1
1830136|NCT00354341|6340872|P2|Overall Study|Failure to return|1
1830137|NCT00354341|6340873|P1|Overall Study|Failure to return|0
1830138|NCT00354341|6340872|P2|Overall Study|Refused treatment|2
1830139|NCT00354341|6340873|P1|Overall Study|Refused treatment|1
1830140|NCT00354341|6340872|P2|Overall Study|Death|2
1830141|NCT00354341|6340873|P1|Overall Study|Death|0
1830142|NCT00354341|6340872|P2|Overall Study|Adverse Event|0
1830143|NCT00354341|6340873|P1|Overall Study|Adverse Event|1
1830144|NCT00354172|6340895|P1|Overall Study|Did not receive transplant|1
1830145|NCT00354159|6340915|P2|Long-term Follow-up|Study Closed|34
1830146|NCT00354159|6340916|P1|Long-term Follow-up|Study Closed|29
1830147|NCT00354159|6340915|P2|Long-term Follow-up|Death|11
1830148|NCT00354159|6340916|P1|Long-term Follow-up|Death|14
1830149|NCT00354159|6340915|P2|Long-term Follow-up|Lost to Follow-up|0
1830150|NCT00354159|6340916|P1|Long-term Follow-up|Lost to Follow-up|1
1830151|NCT00354159|6340915|P2|Long-term Follow-up|Physician Decision|122
1830152|NCT00354159|6340916|P1|Long-term Follow-up|Physician Decision|127
1830153|NCT00354159|6340915|P2|Long-term Follow-up|Withdrawal by Subject|9
1830154|NCT00354159|6340916|P1|Long-term Follow-up|Withdrawal by Subject|9
1830155|NCT00354159|6340915|P2|Randomized Study Period|Death|9
1830156|NCT00354159|6340916|P1|Randomized Study Period|Death|7
1830157|NCT00354159|6340915|P2|Randomized Study Period|Lost to Follow-up|0
1830158|NCT00354159|6340916|P1|Randomized Study Period|Lost to Follow-up|4
1830159|NCT00354159|6340915|P2|Randomized Study Period|Physician Decision|10
1830160|NCT00354159|6340916|P1|Randomized Study Period|Physician Decision|6
1830161|NCT00354159|6340915|P2|Randomized Study Period|Withdrawal by Subject|3
1830162|NCT00354159|6340916|P1|Randomized Study Period|Withdrawal by Subject|5
1830163|NCT00354107|6340959|P1|Overall Study|Withdrawal by Subject|1
1830164|NCT00354107|6340959|P1|Overall Study|Physician Decision|2
1830165|NCT00354107|6340959|P1|Overall Study|Adverse Event|2
1830166|NCT00354029|6340969|P2|Overall Study|Protocol Violation|2
1830167|NCT00354029|6340970|P1|Overall Study|Protocol Violation|4
1830168|NCT00353873|6340982|P2|Overall Study|Withdrawal by Subject|1
1830169|NCT00353873|6340983|P1|Overall Study|Withdrawal by Subject|1
1830170|NCT00353873|6340982|P2|Overall Study|Physician Decision|0
1830171|NCT00353873|6340983|P1|Overall Study|Physician Decision|2
1830172|NCT00353873|6340982|P2|Overall Study|Adverse Event|0
1830173|NCT00353873|6340983|P1|Overall Study|Adverse Event|1
1830174|NCT00353873|6340982|P2|Overall Study|Exacerbation|0
1830175|NCT00353873|6340983|P1|Overall Study|Exacerbation|1
1830176|NCT00353873|6340982|P2|Overall Study|Protocol Violation|2
1830177|NCT00353873|6340983|P1|Overall Study|Protocol Violation|1
1830178|NCT00353704|6341012|P2|Overall Study|Protocol Violation|1
1830179|NCT00353704|6341013|P1|Overall Study|Protocol Violation|3
1830180|NCT00353496|6341083|P2|Overall Study|Not otherwise specified|2
1830181|NCT00353496|6341084|P1|Overall Study|Not otherwise specified|4
1830182|NCT00353496|6341083|P2|Overall Study|Physician Decision|9
1830183|NCT00353496|6341084|P1|Overall Study|Physician Decision|6
1830184|NCT00353496|6341083|P2|Overall Study|Withdrawal by Subject|4
1830185|NCT00353496|6341084|P1|Overall Study|Withdrawal by Subject|3
1830186|NCT00353496|6341083|P2|Overall Study|Protocol Violation|2
1830187|NCT00353496|6341084|P1|Overall Study|Protocol Violation|2
1830188|NCT00353496|6341083|P2|Overall Study|Adverse Event|0
1830189|NCT00353496|6341084|P1|Overall Study|Adverse Event|1
1830190|NCT00353366|6341137|P1|Overall Study|Other|135
1830191|NCT00353366|6341137|P1|Overall Study|Adverse Event|8
1830192|NCT00353262|6341164|P1|Overall Study|Break from Chemotherapy|1
1830193|NCT00353262|6341164|P1|Overall Study|Surgery|4
1830194|NCT00353262|6341164|P1|Overall Study|Progression|1
1830195|NCT00353262|6341164|P1|Overall Study|Insufficient Therapeutic Response|13
1830196|NCT00353262|6341164|P1|Overall Study|Withdrawal by Subject|2
1830197|NCT00353262|6341164|P1|Overall Study|Adverse Event|8
1830198|NCT00352885|6341205|P2|Overall Study|Side effects of IL-2 administration|0
1830199|NCT00352885|6341206|P1|Overall Study|Side effects of IL-2 administration|1
1830200|NCT00352885|6341205|P2|Overall Study|Progression of metastatic melanoma|3
1830201|NCT00352885|6341206|P1|Overall Study|Progression of metastatic melanoma|5
1830202|NCT00352885|6341205|P2|Overall Study|Development of major depression|1
1830203|NCT00352885|6341206|P1|Overall Study|Development of major depression|0
1830204|NCT00352885|6341205|P2|Overall Study|Withdrawal by Subject|3
1830205|NCT00352885|6341206|P1|Overall Study|Withdrawal by Subject|0
1830206|NCT00352846|6341224|P2|Overall Study|Death|1
1830207|NCT00352846|6341225|P1|Overall Study|Death|0
1830208|NCT00352846|6341224|P2|Overall Study|Non-compliance|0
1830209|NCT00352846|6341225|P1|Overall Study|Non-compliance|2
1830210|NCT00352846|6341224|P2|Overall Study|Ineligible|2
1830211|NCT00352846|6341225|P1|Overall Study|Ineligible|3
1830212|NCT00352846|6341224|P2|Overall Study|Withdrawal by Subject|8
1830213|NCT00352846|6341225|P1|Overall Study|Withdrawal by Subject|3
1830214|NCT00352846|6341224|P2|Overall Study|Disease progression|2
1830215|NCT00352846|6341225|P1|Overall Study|Disease progression|0
1830216|NCT00352755|6341240|P1|Overall Study|Adverse Event|1
1830217|NCT00352755|6341240|P1|Overall Study|Physician Decision|1
1830218|NCT00352690|6341250|P2|Overall Study|Determined to be ineligible|0
1830219|NCT00352690|6341251|P1|Overall Study|Determined to be ineligible|2
1830220|NCT00352664|6341271|P2|Overall Study|Withdrawal by Subject|0
1830221|NCT00352664|6341272|P1|Overall Study|Withdrawal by Subject|7
1830222|NCT00352534|6341289|P7|Final Risk Group Assignment|Death|0
1830223|NCT00352534|6341290|P6|Final Risk Group Assignment|Death|2
1830224|NCT00352534|6341291|P5|Final Risk Group Assignment|Death|0
1830225|NCT00352534|6341292|P4|Final Risk Group Assignment|Death|0
1830226|NCT00352534|6341293|P3|Final Risk Group Assignment|Death|0
1830227|NCT00352534|6341294|P2|Final Risk Group Assignment|Death|0
1830228|NCT00352534|6341295|P1|Final Risk Group Assignment|Death|0
1830229|NCT00352534|6341289|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
1830230|NCT00352534|6341290|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1830231|NCT00352534|6341291|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1830232|NCT00352534|6341292|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1830233|NCT00352534|6341293|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1830234|NCT00352534|6341294|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1830235|NCT00352534|6341295|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
1830236|NCT00352534|6341289|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
1830237|NCT00352534|6341290|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
1830238|NCT00352534|6341291|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
1830239|NCT00352534|6341292|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
1830240|NCT00352534|6341293|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
1830241|NCT00352534|6341294|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
1830242|NCT00352534|6341295|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
1830243|NCT00352534|6341289|P7|Final Risk Group Assignment|Ineligible|0
1830244|NCT00352534|6341290|P6|Final Risk Group Assignment|Ineligible|13
1830245|NCT00352534|6341291|P5|Final Risk Group Assignment|Ineligible|0
1830246|NCT00352534|6341292|P4|Final Risk Group Assignment|Ineligible|1
1830247|NCT00352534|6341293|P3|Final Risk Group Assignment|Ineligible|3
1830248|NCT00352534|6341294|P2|Final Risk Group Assignment|Ineligible|0
1830249|NCT00352534|6341295|P1|Final Risk Group Assignment|Ineligible|0
1830250|NCT00352534|6341289|P7|Final Risk Group Assignment|Withdrawal by Subject|0
1830251|NCT00352534|6341290|P6|Final Risk Group Assignment|Withdrawal by Subject|3
1830252|NCT00352534|6341291|P5|Final Risk Group Assignment|Withdrawal by Subject|0
1830253|NCT00352534|6341292|P4|Final Risk Group Assignment|Withdrawal by Subject|0
1830254|NCT00352534|6341293|P3|Final Risk Group Assignment|Withdrawal by Subject|0
1830255|NCT00352534|6341294|P2|Final Risk Group Assignment|Withdrawal by Subject|0
1830256|NCT00352534|6341295|P1|Final Risk Group Assignment|Withdrawal by Subject|0
1830257|NCT00352534|6341289|P7|Final Risk Group Assignment|Physician Decision|0
1830258|NCT00352534|6341290|P6|Final Risk Group Assignment|Physician Decision|8
1830259|NCT00352534|6341291|P5|Final Risk Group Assignment|Physician Decision|0
1830260|NCT00352534|6341292|P4|Final Risk Group Assignment|Physician Decision|0
1830261|NCT00352534|6341293|P3|Final Risk Group Assignment|Physician Decision|0
1830262|NCT00352534|6341294|P2|Final Risk Group Assignment|Physician Decision|0
1830263|NCT00352534|6341295|P1|Final Risk Group Assignment|Physician Decision|0
1830264|NCT00352534|6341289|P7|Final Risk Group Assignment|Lack of Efficacy|0
1830265|NCT00352534|6341290|P6|Final Risk Group Assignment|Lack of Efficacy|19
1830266|NCT00352534|6341291|P5|Final Risk Group Assignment|Lack of Efficacy|1
1830267|NCT00352534|6341292|P4|Final Risk Group Assignment|Lack of Efficacy|2
1830268|NCT00352534|6341293|P3|Final Risk Group Assignment|Lack of Efficacy|0
1830269|NCT00352534|6341294|P2|Final Risk Group Assignment|Lack of Efficacy|0
1830270|NCT00352534|6341295|P1|Final Risk Group Assignment|Lack of Efficacy|0
1830271|NCT00352534|6341289|P7|Initial Staging|Ineligible|0
1830272|NCT00352534|6341290|P6|Initial Staging|Ineligible|0
1830273|NCT00352534|6341291|P5|Initial Staging|Ineligible|0
1830274|NCT00352534|6341292|P4|Initial Staging|Ineligible|0
1830275|NCT00352534|6341293|P3|Initial Staging|Ineligible|0
1830276|NCT00352534|6341294|P2|Initial Staging|Ineligible|9
1830277|NCT00352534|6341295|P1|Initial Staging|Ineligible|8
1830278|NCT00352417|6341312|P2|Overall Study|Schedule Change|1
1830279|NCT00352417|6341313|P1|Overall Study|Schedule Change|2
1830280|NCT00352417|6341312|P2|Overall Study|Lost to Follow-up|0
1830281|NCT00352417|6341313|P1|Overall Study|Lost to Follow-up|1
1830282|NCT00352417|6341312|P2|Overall Study|Withdrawal by Subject|2
1830283|NCT00352417|6341313|P1|Overall Study|Withdrawal by Subject|1
1830284|NCT00352417|6341312|P2|Overall Study|Protocol Violation|2
1830285|NCT00352417|6341313|P1|Overall Study|Protocol Violation|0
1830286|NCT00352417|6341312|P2|Overall Study|Adverse Event|0
1830287|NCT00352417|6341313|P1|Overall Study|Adverse Event|1
1830288|NCT00352365|6341327|P1|Maintenance Therapy|Not eligible|4
1830289|NCT00352365|6341327|P1|Maintenance Therapy|Not protocol specified|3
1830290|NCT00352365|6341327|P1|Maintenance Therapy|Death|2
1830291|NCT00352365|6341327|P1|Maintenance Therapy|Progression/Relapse|3
1830292|NCT00352365|6341327|P1|Induction Therapy|Death before starting protocol therapy|1
1830293|NCT00352365|6341327|P1|Induction Therapy|Not eligible|3
1830294|NCT00352365|6341327|P1|Induction Therapy|Not protocol specified|1
1830295|NCT00352365|6341327|P1|Induction Therapy|Death|7
1830296|NCT00352365|6341327|P1|Induction Therapy|Progression/Relapse|8
1830297|NCT00352365|6341327|P1|Induction Therapy|Adverse Event|7
1830298|NCT00352118|6341337|P1|Overall Study|Physician Decision|4
1830299|NCT00352105|6341347|P1|Overall Study|Protocol Violation|2
1830300|NCT00352105|6341347|P1|Overall Study|Adverse Event|19
1830301|NCT00352105|6341347|P1|Overall Study|Lack of Efficacy|9
1830302|NCT00352105|6341347|P1|Overall Study|Withdrawal by Subject|5
1830303|NCT00352105|6341347|P1|Overall Study|Death|5
1830304|NCT00352053|6341358|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
1830305|NCT00352053|6341359|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
1830306|NCT00352053|6341358|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1830307|NCT00352053|6341359|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
1830308|NCT00352053|6341358|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1830309|NCT00352053|6341359|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
1830310|NCT00352053|6341358|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1830311|NCT00352053|6341359|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
1830312|NCT00352053|6341358|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
1830313|NCT00352053|6341359|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
1830314|NCT00352053|6341358|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
1830315|NCT00352053|6341359|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
1830316|NCT00352053|6341358|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
1830317|NCT00352053|6341359|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
1830318|NCT00352053|6341358|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
1830319|NCT00352053|6341359|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
1830320|NCT00352053|6341358|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
1830321|NCT00352053|6341359|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
1830322|NCT00352053|6341358|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
1830323|NCT00352053|6341359|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
1830324|NCT00352053|6341358|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
1830325|NCT00352053|6341359|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
1830326|NCT00352053|6341358|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
1830327|NCT00352053|6341359|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
1830328|NCT00352053|6341358|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
1830329|NCT00352053|6341359|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
1830330|NCT00352027|6341526|P1|Overall Study|Progressive disease|3
1830331|NCT00351819|6341825|P2|Overall Study|Enrolled in another trial|1
1830332|NCT00351819|6341826|P1|Overall Study|Enrolled in another trial|0
1830333|NCT00351819|6341825|P2|Overall Study|Incarcerated|1
1830334|NCT00351819|6341826|P1|Overall Study|Incarcerated|0
1830335|NCT00351819|6341825|P2|Overall Study|Non-compliance|1
1830336|NCT00351819|6341826|P1|Overall Study|Non-compliance|0
1830337|NCT00351819|6341825|P2|Overall Study|Unprofessional behavior|0
1830338|NCT00351819|6341826|P1|Overall Study|Unprofessional behavior|1
1830339|NCT00351819|6341825|P2|Overall Study|Traumatic ankle fracture|0
1830340|NCT00351819|6341826|P1|Overall Study|Traumatic ankle fracture|1
1830341|NCT00351819|6341825|P2|Overall Study|Elevated PSA|1
1830342|NCT00351819|6341826|P1|Overall Study|Elevated PSA|1
1830343|NCT00351819|6341825|P2|Overall Study|Withdrawal by Subject|4
1830344|NCT00351819|6341826|P1|Overall Study|Withdrawal by Subject|0
1830345|NCT00351819|6341825|P2|Overall Study|Lost to Follow-up|4
1830346|NCT00351819|6341826|P1|Overall Study|Lost to Follow-up|4
1830347|NCT00351533|6341897|P2|Overall Study|Withdrawal by Subject|1
1830348|NCT00351533|6341898|P1|Overall Study|Withdrawal by Subject|0
1830349|NCT00351533|6341897|P2|Overall Study|Physician Decision|1
1830350|NCT00351533|6341898|P1|Overall Study|Physician Decision|0
1830351|NCT00351533|6341897|P2|Overall Study|Lost to Follow-up|3
1830352|NCT00351533|6341898|P1|Overall Study|Lost to Follow-up|1
1830353|NCT00351533|6341897|P2|Overall Study|Extubated before first BAL|0
1830354|NCT00351533|6341898|P1|Overall Study|Extubated before first BAL|1
1830355|NCT00351468|6341958|P1|Overall Study|Protocol Violation|3
1830356|NCT00351468|6341958|P1|Overall Study|Lost to Follow-up|4
1830357|NCT00351468|6341958|P1|Overall Study|Non-compliance|8
1830358|NCT00351468|6341958|P1|Overall Study|Lack of Efficacy|32
1830359|NCT00351468|6341958|P1|Overall Study|Various -follow up w clinical team|39
1830360|NCT00351468|6341958|P1|Overall Study|Withdrawal by Subject|39
1830361|NCT00351468|6341958|P1|Overall Study|Adverse Event|42
1830362|NCT00351377|6341982|P1|Overall Study|Unsatisfactory therapeutic effect|1
1830363|NCT00351377|6341982|P1|Overall Study|Death|1
1830364|NCT00351377|6341982|P1|Overall Study|Adverse Event|5
1830365|NCT00351351|6341996|P2|Overall Study|surgical access pbs; device issues|4
1830366|NCT00351351|6341997|P1|Overall Study|surgical access pbs; device issues|9
1830367|NCT00351273|6342023|P3|Overall Study|Lost to Follow-up|5
1830368|NCT00351273|6342024|P2|Overall Study|Lost to Follow-up|2
1830369|NCT00351273|6342025|P1|Overall Study|Lost to Follow-up|1
1830370|NCT00350870|6342068|P4|Overall Study|Physician Decision|1
1830371|NCT00350870|6342069|P3|Overall Study|Physician Decision|1
1830372|NCT00350870|6342070|P2|Overall Study|Physician Decision|0
1830373|NCT00350870|6342071|P1|Overall Study|Physician Decision|1
1830374|NCT00350870|6342068|P4|Overall Study|Withdrawal by Subject|14
1830375|NCT00350870|6342069|P3|Overall Study|Withdrawal by Subject|15
1830376|NCT00350870|6342070|P2|Overall Study|Withdrawal by Subject|17
1830377|NCT00350870|6342071|P1|Overall Study|Withdrawal by Subject|21
1830378|NCT00350844|6342085|P1|Overall Study|Lost to Follow-up|1
1830379|NCT00350792|6342089|P1|Overall Study|Lack of Efficacy|11
1830380|NCT00350792|6342089|P1|Overall Study|Physician Decision|2
1830381|NCT00350792|6342089|P1|Overall Study|Withdrawal by Subject|4
1830382|NCT00350792|6342089|P1|Overall Study|Protocol Violation|1
1830383|NCT00350792|6342089|P1|Overall Study|Death Not Study Drug Related|2
1830384|NCT00350792|6342089|P1|Overall Study|Death from Study Drug Toxicity|1
1830385|NCT00350792|6342089|P1|Overall Study|Death from Study Disease|1
1830386|NCT00350792|6342089|P1|Overall Study|Adverse Event|11
1830387|NCT00350779|6342099|P2|Overall Study|Non-compliance with study procedures|1
1830388|NCT00350779|6342100|P1|Overall Study|Non-compliance with study procedures|0
1830389|NCT00350779|6342099|P2|Overall Study|Patient Moved|1
1830390|NCT00350779|6342100|P1|Overall Study|Patient Moved|2
1830391|NCT00350779|6342099|P2|Overall Study|Withdrawal by Subject|8
1830392|NCT00350779|6342100|P1|Overall Study|Withdrawal by Subject|9
1830393|NCT00350779|6342099|P2|Overall Study|Protocol Violation|1
1830394|NCT00350779|6342100|P1|Overall Study|Protocol Violation|3
1830395|NCT00350779|6342099|P2|Overall Study|Physician Decision|4
1830396|NCT00350779|6342100|P1|Overall Study|Physician Decision|2
1830397|NCT00350779|6342099|P2|Overall Study|Lost to Follow-up|0
1830398|NCT00350779|6342100|P1|Overall Study|Lost to Follow-up|2
1830399|NCT00350779|6342099|P2|Overall Study|Lack of Efficacy|4
1830400|NCT00350779|6342100|P1|Overall Study|Lack of Efficacy|0
1830401|NCT00350779|6342099|P2|Overall Study|Adverse Event|2
1830402|NCT00350779|6342100|P1|Overall Study|Adverse Event|4
1830403|NCT00350727|6342121|P3|Phase II|Enrolled in Rollover Study|1
1830404|NCT00350727|6342122|P2|Phase II|Enrolled in Rollover Study|0
1830405|NCT00350727|6342123|P1|Phase II|Enrolled in Rollover Study|0
1830406|NCT00350727|6342121|P3|Phase II|Sponsor Terminated Study|1
1830407|NCT00350727|6342122|P2|Phase II|Sponsor Terminated Study|0
1830408|NCT00350727|6342123|P1|Phase II|Sponsor Terminated Study|0
1830409|NCT00350727|6342121|P3|Phase II|Death|2
1830410|NCT00350727|6342122|P2|Phase II|Death|0
1830411|NCT00350727|6342123|P1|Phase II|Death|0
1830412|NCT00350727|6342121|P3|Phase II|Adverse Event|1
1830413|NCT00350727|6342122|P2|Phase II|Adverse Event|1
1830414|NCT00350727|6342123|P1|Phase II|Adverse Event|0
1830415|NCT00350727|6342121|P3|Phase II|Withdrawal by Subject|1
1830416|NCT00350727|6342122|P2|Phase II|Withdrawal by Subject|2
1830417|NCT00350727|6342123|P1|Phase II|Withdrawal by Subject|0
1830418|NCT00350727|6342121|P3|Phase II|Clinical Deterioration|0
1830419|NCT00350727|6342122|P2|Phase II|Clinical Deterioration|1
1830420|NCT00350727|6342123|P1|Phase II|Clinical Deterioration|0
1830421|NCT00350727|6342121|P3|Phase II|Disease Progression|16
1830422|NCT00350727|6342122|P2|Phase II|Disease Progression|15
1830423|NCT00350727|6342123|P1|Phase II|Disease Progression|0
1830424|NCT00350727|6342121|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
1830425|NCT00350727|6342122|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
1830426|NCT00350727|6342123|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
1830427|NCT00350727|6342121|P3|Phase I: Dose Escalation|Physician Decision|0
1830428|NCT00350727|6342122|P2|Phase I: Dose Escalation|Physician Decision|0
1830429|NCT00350727|6342123|P1|Phase I: Dose Escalation|Physician Decision|1
1830430|NCT00350727|6342121|P3|Phase I: Dose Escalation|Death|0
1830431|NCT00350727|6342122|P2|Phase I: Dose Escalation|Death|0
1830432|NCT00350727|6342123|P1|Phase I: Dose Escalation|Death|1
1830433|NCT00350727|6342121|P3|Phase I: Dose Escalation|Lack of Efficacy|0
1830434|NCT00350727|6342122|P2|Phase I: Dose Escalation|Lack of Efficacy|0
1830435|NCT00350727|6342123|P1|Phase I: Dose Escalation|Lack of Efficacy|25
1830436|NCT00350727|6342121|P3|Phase I: Dose Escalation|Adverse Event|0
1830437|NCT00350727|6342122|P2|Phase I: Dose Escalation|Adverse Event|0
1830438|NCT00350727|6342123|P1|Phase I: Dose Escalation|Adverse Event|4
1830439|NCT00350636|6342267|P2|Overall Study|Other|2
1830440|NCT00350636|6342268|P1|Overall Study|Other|1
1830441|NCT00350636|6342267|P2|Overall Study|Physician Decision|2
1830442|NCT00350636|6342268|P1|Overall Study|Physician Decision|0
1830443|NCT00350636|6342267|P2|Overall Study|Lost to Follow-up|8
1830444|NCT00350636|6342268|P1|Overall Study|Lost to Follow-up|9
1830445|NCT00350636|6342267|P2|Overall Study|Withdrawal by Subject|17
1830446|NCT00350636|6342268|P1|Overall Study|Withdrawal by Subject|13
1830447|NCT00350636|6342267|P2|Overall Study|Protocol Violation|3
1830448|NCT00350636|6342268|P1|Overall Study|Protocol Violation|1
1830449|NCT00350636|6342267|P2|Overall Study|Adverse Event|13
1830450|NCT00350636|6342268|P1|Overall Study|Adverse Event|19
1830451|NCT00350623|6342287|P3|Overall Study|patient traveling outside the country|1
1830452|NCT00350623|6342288|P2|Overall Study|patient traveling outside the country|0
1830453|NCT00350623|6342289|P1|Overall Study|patient traveling outside the country|0
1830454|NCT00350623|6342287|P3|Overall Study|Withdrawal by Subject|1
1830455|NCT00350623|6342288|P2|Overall Study|Withdrawal by Subject|1
1830456|NCT00350623|6342289|P1|Overall Study|Withdrawal by Subject|0
1830457|NCT00350623|6342287|P3|Overall Study|Lost to Follow-up|4
1830458|NCT00350623|6342288|P2|Overall Study|Lost to Follow-up|3
1830459|NCT00350623|6342289|P1|Overall Study|Lost to Follow-up|8
1830460|NCT00350545|6342297|P1|Overall Study|Withdrawal by Subject|2
1830461|NCT00350519|6342316|P2|Overall Study|Withdrawal by Subject|2
1830462|NCT00350519|6342317|P1|Overall Study|Withdrawal by Subject|3
1830463|NCT00350519|6342316|P2|Overall Study|Protocol Violation|2
1830464|NCT00350519|6342317|P1|Overall Study|Protocol Violation|1
1830465|NCT00350519|6342316|P2|Overall Study|Physician Decision|1
1830466|NCT00350519|6342317|P1|Overall Study|Physician Decision|0
1830467|NCT00350519|6342316|P2|Overall Study|Death|1
1830468|NCT00350519|6342317|P1|Overall Study|Death|0
1830469|NCT00350402|6342331|P2|Overall Study|Lost to Follow-up|1
1830470|NCT00350402|6342332|P1|Overall Study|Lost to Follow-up|1
1830471|NCT00350272|6342405|P2|Open-Label 84 Week Treatment|Sponsor decision|1
1830472|NCT00350272|6342406|P1|Open-Label 84 Week Treatment|Sponsor decision|2
1830473|NCT00350272|6342405|P2|Open-Label 84 Week Treatment|Physician Decision|2
1830474|NCT00350272|6342406|P1|Open-Label 84 Week Treatment|Physician Decision|1
1830475|NCT00350272|6342405|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
1830476|NCT00350272|6342406|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
1830477|NCT00350272|6342405|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
1830478|NCT00350272|6342406|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
1830479|NCT00350272|6342405|P2|Open-Label 84 Week Treatment|Adverse Event|1
1830480|NCT00350272|6342406|P1|Open-Label 84 Week Treatment|Adverse Event|2
1830481|NCT00350272|6342405|P2|Blinded 12 Week Treatment|Sponsor decision|1
1830482|NCT00350272|6342406|P1|Blinded 12 Week Treatment|Sponsor decision|0
1830483|NCT00350272|6342405|P2|Blinded 12 Week Treatment|Physician Decision|1
1830484|NCT00350272|6342406|P1|Blinded 12 Week Treatment|Physician Decision|2
1830485|NCT00350272|6342405|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
1830486|NCT00350272|6342406|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
1830487|NCT00350272|6342405|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
1830488|NCT00350272|6342406|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
1830489|NCT00350272|6342405|P2|Blinded 12 Week Treatment|Death|0
1830490|NCT00350272|6342406|P1|Blinded 12 Week Treatment|Death|1
1830491|NCT00350272|6342405|P2|Blinded 12 Week Treatment|Adverse Event|0
1830492|NCT00350272|6342406|P1|Blinded 12 Week Treatment|Adverse Event|1
1830493|NCT00350207|6342428|P3|Overall Study|Other|1
1830494|NCT00350207|6342429|P2|Overall Study|Other|3
1830495|NCT00350207|6342430|P1|Overall Study|Other|1
1830496|NCT00350207|6342428|P3|Overall Study|Withdrawal by Subject|1
1830497|NCT00350207|6342429|P2|Overall Study|Withdrawal by Subject|1
1830498|NCT00350207|6342430|P1|Overall Study|Withdrawal by Subject|0
1830499|NCT00350207|6342428|P3|Overall Study|Lost to Follow-up|1
1830500|NCT00350207|6342429|P2|Overall Study|Lost to Follow-up|0
1830501|NCT00350207|6342430|P1|Overall Study|Lost to Follow-up|1
1830502|NCT00350207|6342428|P3|Overall Study|Lack of Efficacy|2
1830503|NCT00350207|6342429|P2|Overall Study|Lack of Efficacy|0
1830504|NCT00350207|6342430|P1|Overall Study|Lack of Efficacy|1
1830505|NCT00350207|6342428|P3|Overall Study|Adverse Event|2
1830506|NCT00350207|6342429|P2|Overall Study|Adverse Event|2
1830507|NCT00350207|6342430|P1|Overall Study|Adverse Event|5
1830508|NCT00349973|6342642|P2|Overall Study|Withdrawal by Subject|0
1830509|NCT00349973|6342643|P1|Overall Study|Withdrawal by Subject|1
1830510|NCT00349973|6342642|P2|Overall Study|Adverse Event|3
1830511|NCT00349973|6342643|P1|Overall Study|Adverse Event|3
1830512|NCT00349921|6342657|P4|First Spinal Injection|Adverse Event|0
1830513|NCT00349921|6342658|P3|First Spinal Injection|Adverse Event|1
1830514|NCT00349921|6342659|P2|First Spinal Injection|Adverse Event|0
1830515|NCT00349921|6342660|P1|First Spinal Injection|Adverse Event|0
1830516|NCT00349921|6342657|P4|First Spinal Injection|Physician Decision|0
1830517|NCT00349921|6342658|P3|First Spinal Injection|Physician Decision|0
1830518|NCT00349921|6342659|P2|First Spinal Injection|Physician Decision|0
1830519|NCT00349921|6342660|P1|First Spinal Injection|Physician Decision|1
1830520|NCT00349908|6342671|P2|Overall Study|Withdrawal by Subject|4
1830521|NCT00349908|6342672|P1|Overall Study|Withdrawal by Subject|0
1830522|NCT00349752|6342698|P2|Overall Study|Other:History of squamous cell carcinoma|0
1830523|NCT00349752|6342699|P1|Overall Study|Other:History of squamous cell carcinoma|1
1830524|NCT00349752|6342698|P2|Overall Study|Other: Inadvertently unblinded|0
1830525|NCT00349752|6342699|P1|Overall Study|Other: Inadvertently unblinded|1
1830526|NCT00349752|6342698|P2|Overall Study|Other: Ineligible|0
1830527|NCT00349752|6342699|P1|Overall Study|Other: Ineligible|1
1830528|NCT00349752|6342698|P2|Overall Study|Other: Patient's steroid use|0
1830529|NCT00349752|6342699|P1|Overall Study|Other: Patient's steroid use|1
1830530|NCT00349752|6342698|P2|Overall Study|Other: Patient stopped steroids|1
1830531|NCT00349752|6342699|P1|Overall Study|Other: Patient stopped steroids|0
1830532|NCT00349752|6342698|P2|Overall Study|Other: Non compliance|1
1830533|NCT00349752|6342699|P1|Overall Study|Other: Non compliance|0
1830534|NCT00349752|6342698|P2|Overall Study|Other: Required exclusionary medication|1
1830535|NCT00349752|6342699|P1|Overall Study|Other: Required exclusionary medication|0
1830536|NCT00349752|6342698|P2|Overall Study|Personal reasons|5
1830537|NCT00349752|6342699|P1|Overall Study|Personal reasons|6
1830538|NCT00349752|6342698|P2|Overall Study|Lost to Follow-up|2
1830539|NCT00349752|6342699|P1|Overall Study|Lost to Follow-up|4
1830540|NCT00349752|6342698|P2|Overall Study|Lack of Efficacy|42
1830541|NCT00349752|6342699|P1|Overall Study|Lack of Efficacy|37
1830542|NCT00349752|6342698|P2|Overall Study|Adverse Event|12
1830543|NCT00349752|6342699|P1|Overall Study|Adverse Event|8
1830544|NCT00349622|6342752|P2|Overall Study|Withdrawal by Subject|9
1830545|NCT00349622|6342753|P1|Overall Study|Withdrawal by Subject|5
1830546|NCT00349622|6342752|P2|Overall Study|Lost to Follow-up|1
1830547|NCT00349622|6342753|P1|Overall Study|Lost to Follow-up|5
1830548|NCT00349622|6342752|P2|Overall Study|Death|86
1830549|NCT00349622|6342753|P1|Overall Study|Death|168
1830550|NCT00349349|6342792|P3|Overall Study|New Malignancy (Bladder Cancer)|0
1830551|NCT00349349|6342793|P2|Overall Study|New Malignancy (Bladder Cancer)|1
1830552|NCT00349349|6342794|P1|Overall Study|New Malignancy (Bladder Cancer)|0
1830553|NCT00349349|6342792|P3|Overall Study|No Response|0
1830554|NCT00349349|6342793|P2|Overall Study|No Response|3
1830555|NCT00349349|6342794|P1|Overall Study|No Response|0
1830556|NCT00349349|6342792|P3|Overall Study|Physician Decision|1
1830557|NCT00349349|6342793|P2|Overall Study|Physician Decision|2
1830558|NCT00349349|6342794|P1|Overall Study|Physician Decision|1
1830559|NCT00349349|6342792|P3|Overall Study|Participant Reduced General Condition|0
1830560|NCT00349349|6342793|P2|Overall Study|Participant Reduced General Condition|1
1830561|NCT00349349|6342794|P1|Overall Study|Participant Reduced General Condition|0
1830562|NCT00349349|6342792|P3|Overall Study|Other Treatment Selected|0
1830563|NCT00349349|6342793|P2|Overall Study|Other Treatment Selected|0
1830564|NCT00349349|6342794|P1|Overall Study|Other Treatment Selected|2
1830565|NCT00349349|6342792|P3|Overall Study|Death|1
1830566|NCT00349349|6342793|P2|Overall Study|Death|10
1830567|NCT00349349|6342794|P1|Overall Study|Death|13
1830568|NCT00349349|6342792|P3|Overall Study|Withdrawn due to Disease Progression|1
1830569|NCT00349349|6342793|P2|Overall Study|Withdrawn due to Disease Progression|37
1830570|NCT00349349|6342794|P1|Overall Study|Withdrawn due to Disease Progression|27
1830571|NCT00349349|6342792|P3|Overall Study|Withdrawal by Subject|1
1830572|NCT00349349|6342793|P2|Overall Study|Withdrawal by Subject|2
1830573|NCT00349349|6342794|P1|Overall Study|Withdrawal by Subject|5
1830574|NCT00349349|6342792|P3|Overall Study|Adverse Event|2
1830575|NCT00349349|6342793|P2|Overall Study|Adverse Event|6
1830576|NCT00349349|6342794|P1|Overall Study|Adverse Event|5
1830577|NCT00348933|6342883|P1|Overall Study|Adverse Event|7
1830578|NCT00348933|6342883|P1|Overall Study|Protocol Violation|2
1830579|NCT00348933|6342883|P1|Overall Study|Lost to Follow-up|6
1830580|NCT00348933|6342883|P1|Overall Study|Withdrawal by Subject|10
1830581|NCT00348881|6342891|P2|Overall Study|Serious Adverse Event|2
1830582|NCT00348881|6342892|P1|Overall Study|Serious Adverse Event|0
1830583|NCT00348881|6342891|P2|Overall Study|Adverse Event|0
1830584|NCT00348881|6342892|P1|Overall Study|Adverse Event|2
1830585|NCT00348881|6342891|P2|Overall Study|Withdrawal by Subject|4
1830586|NCT00348881|6342892|P1|Overall Study|Withdrawal by Subject|3
1830587|NCT00348881|6342891|P2|Overall Study|Lost to Follow-up|6
1830588|NCT00348881|6342892|P1|Overall Study|Lost to Follow-up|12
1830589|NCT00348816|6342904|P1|Overall Study|Noncompliance with radiation treatment|1
1830590|NCT00348790|6342911|P1|Completed Treatment|Unable to travel to study site|1
1830591|NCT00348790|6342911|P1|Completed Treatment|Required surgery|2
1830592|NCT00348790|6342911|P1|Completed Treatment|Adverse Event|4
1830593|NCT00348790|6342911|P1|Completed Treatment|Disease progression|14
1830594|NCT00348790|6342911|P1|Completed Treatment|Withdrawal by Subject|4
1830595|NCT00348686|6342923|P1|Overall Study|Multiple Reasons|8
1830596|NCT00348686|6342923|P1|Overall Study|Lost to Follow-up|2
1830597|NCT00348686|6342923|P1|Overall Study|Protocol Violation|6
1830598|NCT00348686|6342923|P1|Overall Study|Adverse Event|5
1830599|NCT00348686|6342923|P1|Overall Study|Withdrawal by Subject|45
1830600|NCT00348673|6342940|P9|Stage 1|Randomized but not Treated|0
1830601|NCT00348673|6342941|P8|Stage 1|Randomized but not Treated|0
1830602|NCT00348673|6342942|P7|Stage 1|Randomized but not Treated|0
1830603|NCT00348673|6342943|P6|Stage 1|Randomized but not Treated|0
1830604|NCT00348673|6342944|P5|Stage 1|Randomized but not Treated|0
1830605|NCT00348673|6342945|P4|Stage 1|Randomized but not Treated|0
1830606|NCT00348673|6342946|P3|Stage 1|Randomized but not Treated|1
1830607|NCT00348673|6342947|P2|Stage 1|Randomized but not Treated|0
1830608|NCT00348673|6342948|P1|Stage 1|Randomized but not Treated|0
1830609|NCT00348595|6342997|P2|Overall Study|Adverse Event|8
1830610|NCT00348595|6342998|P1|Overall Study|Adverse Event|5
1830611|NCT00348556|6343010|P1|Overall Study|Adverse Event|1
1830612|NCT00348374|6343017|P2|Overall Study|randomized but did not receive treatment|7
1830613|NCT00348374|6343018|P1|Overall Study|randomized but did not receive treatment|0
1830614|NCT00348374|6343017|P2|Overall Study|ongoing at date of cutoff|1
1830615|NCT00348374|6343018|P1|Overall Study|ongoing at date of cutoff|1
1830616|NCT00348374|6343017|P2|Overall Study|Other|12
1830617|NCT00348374|6343018|P1|Overall Study|Other|11
1830618|NCT00348374|6343017|P2|Overall Study|Withdrawal by Subject|5
1830619|NCT00348374|6343018|P1|Overall Study|Withdrawal by Subject|5
1830620|NCT00348374|6343017|P2|Overall Study|Lost to Follow-up|3
1830621|NCT00348374|6343018|P1|Overall Study|Lost to Follow-up|1
1830622|NCT00348374|6343017|P2|Overall Study|Adverse Event|4
1830623|NCT00348374|6343018|P1|Overall Study|Adverse Event|1
1830624|NCT00348348|6343065|P2|Overall Study|Adverse event probably related to study|0
1830625|NCT00348348|6343066|P1|Overall Study|Adverse event probably related to study|1
1830626|NCT00348348|6343065|P2|Overall Study|Worsening of BC - Unlikely related|2
1830627|NCT00348348|6343066|P1|Overall Study|Worsening of BC - Unlikely related|1
1830628|NCT00348348|6343065|P2|Overall Study|Worsening of BC - Unrelated to study|3
1830629|NCT00348348|6343066|P1|Overall Study|Worsening of BC - Unrelated to study|0
1830630|NCT00348348|6343065|P2|Overall Study|Dissallowed Meds - possibly releated|1
1830631|NCT00348348|6343066|P1|Overall Study|Dissallowed Meds - possibly releated|1
1830632|NCT00348348|6343065|P2|Overall Study|Dissallowed Meds - unlikley related|1
1830633|NCT00348348|6343066|P1|Overall Study|Dissallowed Meds - unlikley related|1
1830634|NCT00348348|6343065|P2|Overall Study|Dissallowed Meds - unrelated to study|3
1830635|NCT00348348|6343066|P1|Overall Study|Dissallowed Meds - unrelated to study|1
1830636|NCT00348348|6343065|P2|Overall Study|Other|4
1830637|NCT00348348|6343066|P1|Overall Study|Other|7
1830638|NCT00348348|6343065|P2|Overall Study|Withdrawal by Subject|1
1830639|NCT00348348|6343066|P1|Overall Study|Withdrawal by Subject|4
1830640|NCT00348348|6343065|P2|Overall Study|Lost to Follow-up|10
1830641|NCT00348348|6343066|P1|Overall Study|Lost to Follow-up|8
1830642|NCT00348348|6343065|P2|Overall Study|Lack of Efficacy|1
1830643|NCT00348348|6343066|P1|Overall Study|Lack of Efficacy|1
1830644|NCT00348348|6343065|P2|Overall Study|Adverse event - unrelated to study drug|1
1830645|NCT00348348|6343066|P1|Overall Study|Adverse event - unrelated to study drug|0
1830646|NCT00348309|6343081|P3|Overall Study|HCV career|1
1830647|NCT00348309|6343082|P2|Overall Study|HCV career|0
1830648|NCT00348309|6343083|P1|Overall Study|HCV career|0
1830649|NCT00348309|6343081|P3|Overall Study|Cardiologist recommendations|1
1830650|NCT00348309|6343082|P2|Overall Study|Cardiologist recommendations|0
1830651|NCT00348309|6343083|P1|Overall Study|Cardiologist recommendations|0
1830652|NCT00348309|6343081|P3|Overall Study|ECG abnormal|2
1830653|NCT00348309|6343082|P2|Overall Study|ECG abnormal|0
1830654|NCT00348309|6343083|P1|Overall Study|ECG abnormal|0
1830655|NCT00348309|6343081|P3|Overall Study|Adverse event not attended|1
1830656|NCT00348309|6343082|P2|Overall Study|Adverse event not attended|0
1830657|NCT00348309|6343083|P1|Overall Study|Adverse event not attended|0
1830658|NCT00348309|6343081|P3|Overall Study|Site closure|1
1830659|NCT00348309|6343082|P2|Overall Study|Site closure|0
1830660|NCT00348309|6343083|P1|Overall Study|Site closure|0
1830661|NCT00348309|6343081|P3|Overall Study|Increased dose of Aricept|1
1830662|NCT00348309|6343082|P2|Overall Study|Increased dose of Aricept|0
1830663|NCT00348309|6343083|P1|Overall Study|Increased dose of Aricept|0
1830664|NCT00348309|6343081|P3|Overall Study|Medical Monitor decision|1
1830665|NCT00348309|6343082|P2|Overall Study|Medical Monitor decision|0
1830666|NCT00348309|6343083|P1|Overall Study|Medical Monitor decision|0
1830667|NCT00348309|6343081|P3|Overall Study|Forgot often medication|0
1830668|NCT00348309|6343082|P2|Overall Study|Forgot often medication|1
1830669|NCT00348309|6343083|P1|Overall Study|Forgot often medication|0
1830670|NCT00348309|6343081|P3|Overall Study|Sponsor refuseal|1
1830671|NCT00348309|6343082|P2|Overall Study|Sponsor refuseal|1
1830672|NCT00348309|6343083|P1|Overall Study|Sponsor refuseal|0
1830673|NCT00348309|6343081|P3|Overall Study|Participant was hospitalized|0
1830674|NCT00348309|6343082|P2|Overall Study|Participant was hospitalized|1
1830675|NCT00348309|6343083|P1|Overall Study|Participant was hospitalized|0
1830676|NCT00348309|6343081|P3|Overall Study|A foul of exclusion criteria|0
1830677|NCT00348309|6343082|P2|Overall Study|A foul of exclusion criteria|1
1830678|NCT00348309|6343083|P1|Overall Study|A foul of exclusion criteria|0
1830679|NCT00348309|6343081|P3|Overall Study|Ineffectiveness of treatment|0
1830680|NCT00348309|6343082|P2|Overall Study|Ineffectiveness of treatment|1
1830681|NCT00348309|6343083|P1|Overall Study|Ineffectiveness of treatment|0
1830682|NCT00348309|6343081|P3|Overall Study|Decision of sponsor|0
1830683|NCT00348309|6343082|P2|Overall Study|Decision of sponsor|0
1830684|NCT00348309|6343083|P1|Overall Study|Decision of sponsor|1
1830685|NCT00348309|6343081|P3|Overall Study|Participant died|1
1830686|NCT00348309|6343082|P2|Overall Study|Participant died|1
1830687|NCT00348309|6343083|P1|Overall Study|Participant died|2
1830688|NCT00348309|6343081|P3|Overall Study|Did not appear in time for Visit 3|0
1830689|NCT00348309|6343082|P2|Overall Study|Did not appear in time for Visit 3|0
1830690|NCT00348309|6343083|P1|Overall Study|Did not appear in time for Visit 3|1
1830691|NCT00348309|6343081|P3|Overall Study|Worsening of alzheimer|1
1830692|NCT00348309|6343082|P2|Overall Study|Worsening of alzheimer|0
1830693|NCT00348309|6343083|P1|Overall Study|Worsening of alzheimer|1
1830694|NCT00348309|6343081|P3|Overall Study|Cognitive and behaviour worsening|0
1830695|NCT00348309|6343082|P2|Overall Study|Cognitive and behaviour worsening|0
1830696|NCT00348309|6343083|P1|Overall Study|Cognitive and behaviour worsening|2
1830697|NCT00348309|6343081|P3|Overall Study|Worsened neurodegenerative disease|0
1830698|NCT00348309|6343082|P2|Overall Study|Worsened neurodegenerative disease|0
1830699|NCT00348309|6343083|P1|Overall Study|Worsened neurodegenerative disease|1
1830700|NCT00348309|6343081|P3|Overall Study|No disponibility of medication|0
1830701|NCT00348309|6343082|P2|Overall Study|No disponibility of medication|0
1830702|NCT00348309|6343083|P1|Overall Study|No disponibility of medication|1
1830703|NCT00348309|6343081|P3|Overall Study|Principal investigator's decision|0
1830704|NCT00348309|6343082|P2|Overall Study|Principal investigator's decision|0
1830705|NCT00348309|6343083|P1|Overall Study|Principal investigator's decision|1
1830706|NCT00348309|6343081|P3|Overall Study|PI closing medical practice|0
1830707|NCT00348309|6343082|P2|Overall Study|PI closing medical practice|0
1830708|NCT00348309|6343083|P1|Overall Study|PI closing medical practice|1
1830709|NCT00348309|6343081|P3|Overall Study|Unable to complete ET visit|0
1830710|NCT00348309|6343082|P2|Overall Study|Unable to complete ET visit|0
1830711|NCT00348309|6343083|P1|Overall Study|Unable to complete ET visit|1
1830712|NCT00348309|6343081|P3|Overall Study|Caregiver withdrawal|7
1830713|NCT00348309|6343082|P2|Overall Study|Caregiver withdrawal|0
1830714|NCT00348309|6343083|P1|Overall Study|Caregiver withdrawal|3
1830715|NCT00348309|6343081|P3|Overall Study|Use of prohibited medication|2
1830716|NCT00348309|6343082|P2|Overall Study|Use of prohibited medication|2
1830717|NCT00348309|6343083|P1|Overall Study|Use of prohibited medication|5
1830718|NCT00348309|6343081|P3|Overall Study|Caregiver sick|0
1830719|NCT00348309|6343082|P2|Overall Study|Caregiver sick|0
1830720|NCT00348309|6343083|P1|Overall Study|Caregiver sick|1
1830721|NCT00348309|6343081|P3|Overall Study|Wrong bottle allocated|0
1830722|NCT00348309|6343082|P2|Overall Study|Wrong bottle allocated|0
1830723|NCT00348309|6343083|P1|Overall Study|Wrong bottle allocated|1
1830724|NCT00348309|6343081|P3|Overall Study|Lack of insight, dementia|0
1830725|NCT00348309|6343082|P2|Overall Study|Lack of insight, dementia|0
1830726|NCT00348309|6343083|P1|Overall Study|Lack of insight, dementia|1
1830727|NCT00348309|6343081|P3|Overall Study|Death of caregiver|1
1830728|NCT00348309|6343082|P2|Overall Study|Death of caregiver|0
1830729|NCT00348309|6343083|P1|Overall Study|Death of caregiver|1
1830730|NCT00348309|6343081|P3|Overall Study|Non-compliance|8
1830731|NCT00348309|6343082|P2|Overall Study|Non-compliance|6
1830732|NCT00348309|6343083|P1|Overall Study|Non-compliance|8
1830733|NCT00348309|6343081|P3|Overall Study|Withdrawal by Subject|40
1830734|NCT00348309|6343082|P2|Overall Study|Withdrawal by Subject|37
1830735|NCT00348309|6343083|P1|Overall Study|Withdrawal by Subject|33
1830736|NCT00348309|6343081|P3|Overall Study|Protocol Violation|7
1830737|NCT00348309|6343082|P2|Overall Study|Protocol Violation|12
1830738|NCT00348309|6343083|P1|Overall Study|Protocol Violation|7
1830739|NCT00348309|6343081|P3|Overall Study|Lost to Follow-up|4
1830740|NCT00348309|6343082|P2|Overall Study|Lost to Follow-up|7
1830741|NCT00348309|6343083|P1|Overall Study|Lost to Follow-up|6
1830742|NCT00348309|6343081|P3|Overall Study|Adverse Event|63
1830743|NCT00348309|6343082|P2|Overall Study|Adverse Event|28
1830744|NCT00348309|6343083|P1|Overall Study|Adverse Event|56
1830745|NCT00348283|6343156|P2|Open Label|Sponsor decision|1
1830746|NCT00348283|6343157|P1|Open Label|Sponsor decision|0
1830747|NCT00348283|6343156|P2|Open Label|Pregnancy|1
1830748|NCT00348283|6343157|P1|Open Label|Pregnancy|0
1830749|NCT00348283|6343156|P2|Open Label|Subject moved to the United States|1
1830750|NCT00348283|6343157|P1|Open Label|Subject moved to the United States|0
1830751|NCT00348283|6343156|P2|Open Label|Administrative reasons|5
1830752|NCT00348283|6343157|P1|Open Label|Administrative reasons|0
1830753|NCT00348283|6343156|P2|Open Label|Lack of Efficacy|13
1830754|NCT00348283|6343157|P1|Open Label|Lack of Efficacy|0
1830755|NCT00348283|6343156|P2|Open Label|Lost to Follow-up|1
1830756|NCT00348283|6343157|P1|Open Label|Lost to Follow-up|0
1830757|NCT00348283|6343156|P2|Open Label|Withdrawal by Subject|4
1830758|NCT00348283|6343157|P1|Open Label|Withdrawal by Subject|0
1830759|NCT00348283|6343156|P2|Open Label|Adverse Event|8
1830760|NCT00348283|6343157|P1|Open Label|Adverse Event|0
1830761|NCT00348283|6343156|P2|Double Blind|Pregnancy|1
1830762|NCT00348283|6343157|P1|Double Blind|Pregnancy|0
1830763|NCT00348283|6343156|P2|Double Blind|Lack of Efficacy|2
1830764|NCT00348283|6343157|P1|Double Blind|Lack of Efficacy|2
1830765|NCT00348283|6343156|P2|Double Blind|Protocol Violation|1
1830766|NCT00348283|6343157|P1|Double Blind|Protocol Violation|0
1830767|NCT00348283|6343156|P2|Double Blind|Withdrawal by Subject|1
1830768|NCT00348283|6343157|P1|Double Blind|Withdrawal by Subject|1
1830769|NCT00348283|6343156|P2|Double Blind|Adverse Event|5
1830770|NCT00348283|6343157|P1|Double Blind|Adverse Event|2
1830771|NCT00348283|6343156|P2|Induction|Protocol Violation|4
1830772|NCT00348283|6343157|P1|Induction|Protocol Violation|0
1830773|NCT00348283|6343156|P2|Induction|Adverse Event|2
1830774|NCT00348283|6343157|P1|Induction|Adverse Event|0
1830775|NCT00348140|6343176|P3|Overall Study|Memory declined|1
1830776|NCT00348140|6343177|P2|Overall Study|Memory declined|0
1830777|NCT00348140|6343178|P1|Overall Study|Memory declined|0
1830778|NCT00348140|6343176|P3|Overall Study|Exclusion criteria met|1
1830779|NCT00348140|6343177|P2|Overall Study|Exclusion criteria met|0
1830780|NCT00348140|6343178|P1|Overall Study|Exclusion criteria met|0
1830781|NCT00348140|6343176|P3|Overall Study|Participant died|0
1830782|NCT00348140|6343177|P2|Overall Study|Participant died|1
1830783|NCT00348140|6343178|P1|Overall Study|Participant died|0
1830784|NCT00348140|6343176|P3|Overall Study|Abnormal ECG|3
1830785|NCT00348140|6343177|P2|Overall Study|Abnormal ECG|1
1830786|NCT00348140|6343178|P1|Overall Study|Abnormal ECG|0
1830787|NCT00348140|6343176|P3|Overall Study|Serious adverse event|0
1830788|NCT00348140|6343177|P2|Overall Study|Serious adverse event|1
1830789|NCT00348140|6343178|P1|Overall Study|Serious adverse event|0
1830790|NCT00348140|6343176|P3|Overall Study|Increased risk of cardiac infarction|0
1830791|NCT00348140|6343177|P2|Overall Study|Increased risk of cardiac infarction|1
1830792|NCT00348140|6343178|P1|Overall Study|Increased risk of cardiac infarction|0
1830793|NCT00348140|6343176|P3|Overall Study|Disease progression|5
1830794|NCT00348140|6343177|P2|Overall Study|Disease progression|2
1830795|NCT00348140|6343178|P1|Overall Study|Disease progression|1
1830796|NCT00348140|6343176|P3|Overall Study|Use of prohibited drug|2
1830797|NCT00348140|6343177|P2|Overall Study|Use of prohibited drug|0
1830798|NCT00348140|6343178|P1|Overall Study|Use of prohibited drug|1
1830799|NCT00348140|6343176|P3|Overall Study|Decided to discontinue on their own|1
1830800|NCT00348140|6343177|P2|Overall Study|Decided to discontinue on their own|4
1830801|NCT00348140|6343178|P1|Overall Study|Decided to discontinue on their own|1
1830802|NCT00348140|6343176|P3|Overall Study|Investigator decided to discontinue|4
1830803|NCT00348140|6343177|P2|Overall Study|Investigator decided to discontinue|1
1830804|NCT00348140|6343178|P1|Overall Study|Investigator decided to discontinue|4
1830805|NCT00348140|6343176|P3|Overall Study|Screen failure|0
1830806|NCT00348140|6343177|P2|Overall Study|Screen failure|0
1830807|NCT00348140|6343178|P1|Overall Study|Screen failure|1
1830808|NCT00348140|6343176|P3|Overall Study|Participant unwell|0
1830809|NCT00348140|6343177|P2|Overall Study|Participant unwell|0
1830810|NCT00348140|6343178|P1|Overall Study|Participant unwell|1
1830811|NCT00348140|6343176|P3|Overall Study|Unmet inclusion-exclusion criteria|1
1830812|NCT00348140|6343177|P2|Overall Study|Unmet inclusion-exclusion criteria|0
1830813|NCT00348140|6343178|P1|Overall Study|Unmet inclusion-exclusion criteria|1
1830814|NCT00348140|6343176|P3|Overall Study|Administration related|1
1830815|NCT00348140|6343177|P2|Overall Study|Administration related|1
1830816|NCT00348140|6343178|P1|Overall Study|Administration related|3
1830817|NCT00348140|6343176|P3|Overall Study|Efficacy related|0
1830818|NCT00348140|6343177|P2|Overall Study|Efficacy related|1
1830819|NCT00348140|6343178|P1|Overall Study|Efficacy related|1
1830820|NCT00348140|6343176|P3|Overall Study|Participant hospitalised|0
1830821|NCT00348140|6343177|P2|Overall Study|Participant hospitalised|0
1830822|NCT00348140|6343178|P1|Overall Study|Participant hospitalised|3
1830823|NCT00348140|6343176|P3|Overall Study|Caregiver related|3
1830824|NCT00348140|6343177|P2|Overall Study|Caregiver related|7
1830825|NCT00348140|6343178|P1|Overall Study|Caregiver related|4
1830826|NCT00348140|6343176|P3|Overall Study|Conditional medication increased dose|0
1830827|NCT00348140|6343177|P2|Overall Study|Conditional medication increased dose|0
1830828|NCT00348140|6343178|P1|Overall Study|Conditional medication increased dose|1
1830829|NCT00348140|6343176|P3|Overall Study|Participant at risk due to study drug|0
1830830|NCT00348140|6343177|P2|Overall Study|Participant at risk due to study drug|0
1830831|NCT00348140|6343178|P1|Overall Study|Participant at risk due to study drug|2
1830832|NCT00348140|6343176|P3|Overall Study|Non-compliance|5
1830833|NCT00348140|6343177|P2|Overall Study|Non-compliance|13
1830834|NCT00348140|6343178|P1|Overall Study|Non-compliance|8
1830835|NCT00348140|6343176|P3|Overall Study|Withdrawal by Subject|40
1830836|NCT00348140|6343177|P2|Overall Study|Withdrawal by Subject|40
1830837|NCT00348140|6343178|P1|Overall Study|Withdrawal by Subject|32
1830838|NCT00348140|6343176|P3|Overall Study|Protocol Violation|14
1830839|NCT00348140|6343177|P2|Overall Study|Protocol Violation|13
1830840|NCT00348140|6343178|P1|Overall Study|Protocol Violation|12
1830841|NCT00348140|6343176|P3|Overall Study|Lost to Follow-up|4
1830842|NCT00348140|6343177|P2|Overall Study|Lost to Follow-up|4
1830843|NCT00348140|6343178|P1|Overall Study|Lost to Follow-up|4
1830844|NCT00348140|6343176|P3|Overall Study|Adverse Event|78
1830845|NCT00348140|6343177|P2|Overall Study|Adverse Event|49
1830846|NCT00348140|6343178|P1|Overall Study|Adverse Event|46
1830847|NCT00347958|6343276|P1|Overall Study|Withdrawal by Subject|1
1830848|NCT00347958|6343276|P1|Overall Study|Protocol Violation|2
1830849|NCT00347958|6343276|P1|Overall Study|Adverse Event|1
1830850|NCT00347932|6343285|P2|Overall Study|Did not meet inclusion criteria|8
1830851|NCT00347932|6343286|P1|Overall Study|Did not meet inclusion criteria|4
1830852|NCT00347932|6343285|P2|Overall Study|Withdrawal by Subject|16
1830853|NCT00347932|6343286|P1|Overall Study|Withdrawal by Subject|10
1830854|NCT00347932|6343285|P2|Overall Study|Lost to Follow-up|9
1830855|NCT00347932|6343286|P1|Overall Study|Lost to Follow-up|10
1830856|NCT00347932|6343285|P2|Overall Study|Lack of Efficacy|14
1830857|NCT00347932|6343286|P1|Overall Study|Lack of Efficacy|3
1830858|NCT00347932|6343285|P2|Overall Study|Adverse Event|5
1830859|NCT00347932|6343286|P1|Overall Study|Adverse Event|4
1830860|NCT00347919|6343301|P3|Overall Study|Missing|2
1830861|NCT00347919|6343302|P2|Overall Study|Missing|1
1830862|NCT00347919|6343303|P1|Overall Study|Missing|2
1830863|NCT00347919|6343301|P3|Overall Study|Par. Started Other Treatment|1
1830864|NCT00347919|6343302|P2|Overall Study|Par. Started Other Treatment|1
1830865|NCT00347919|6343303|P1|Overall Study|Par. Started Other Treatment|1
1830866|NCT00347919|6343301|P3|Overall Study|Death|19
1830867|NCT00347919|6343302|P2|Overall Study|Death|42
1830868|NCT00347919|6343303|P1|Overall Study|Death|35
1830869|NCT00347919|6343301|P3|Overall Study|Sponsor terminated study|16
1830870|NCT00347919|6343302|P2|Overall Study|Sponsor terminated study|10
1830871|NCT00347919|6343303|P1|Overall Study|Sponsor terminated study|15
1830872|NCT00347919|6343301|P3|Overall Study|Physician Decision|0
1830873|NCT00347919|6343302|P2|Overall Study|Physician Decision|1
1830874|NCT00347919|6343303|P1|Overall Study|Physician Decision|1
1830875|NCT00347919|6343301|P3|Overall Study|Withdrawal by Subject|0
1830876|NCT00347919|6343302|P2|Overall Study|Withdrawal by Subject|8
1830877|NCT00347919|6343303|P1|Overall Study|Withdrawal by Subject|6
1830878|NCT00347919|6343301|P3|Overall Study|Lost to Follow-up|0
1830879|NCT00347919|6343302|P2|Overall Study|Lost to Follow-up|13
1830880|NCT00347919|6343303|P1|Overall Study|Lost to Follow-up|11
1830881|NCT00347776|6343326|P3|12 Month Follow-up|Reached endpoint|9
1830882|NCT00347776|6343327|P2|12 Month Follow-up|Reached endpoint|6
1830883|NCT00347776|6343328|P1|12 Month Follow-up|Reached endpoint|13
1830884|NCT00347776|6343326|P3|12 Month Follow-up|Death|4
1830885|NCT00347776|6343327|P2|12 Month Follow-up|Death|4
1830886|NCT00347776|6343328|P1|12 Month Follow-up|Death|3
1830887|NCT00347776|6343326|P3|12 Month Follow-up|Lost to Follow-up|6
1830888|NCT00347776|6343327|P2|12 Month Follow-up|Lost to Follow-up|6
1830889|NCT00347776|6343328|P1|12 Month Follow-up|Lost to Follow-up|7
1830890|NCT00347776|6343326|P3|6 Month Follow-up|reached endpont|15
1830891|NCT00347776|6343327|P2|6 Month Follow-up|reached endpont|12
1830892|NCT00347776|6343328|P1|6 Month Follow-up|reached endpont|20
1830893|NCT00347776|6343326|P3|6 Month Follow-up|Death|3
1830894|NCT00347776|6343327|P2|6 Month Follow-up|Death|1
1830895|NCT00347776|6343328|P1|6 Month Follow-up|Death|2
1830896|NCT00347776|6343326|P3|1.5 Month Follow-up|reached the endpoint|12
1830897|NCT00347776|6343327|P2|1.5 Month Follow-up|reached the endpoint|8
1830898|NCT00347776|6343328|P1|1.5 Month Follow-up|reached the endpoint|12
1830899|NCT00347776|6343326|P3|1.5 Month Follow-up|Death|0
1830900|NCT00347776|6343327|P2|1.5 Month Follow-up|Death|0
1830901|NCT00347776|6343328|P1|1.5 Month Follow-up|Death|2
1830902|NCT00347438|6343340|P1|Overall Study|Physician Decision|1
1830903|NCT00347438|6343340|P1|Overall Study|Withdrawal by Subject|1
1830904|NCT00347360|6343362|P15|Overall Study|Visits conflicted with new job|0
1830905|NCT00347360|6343363|P14|Overall Study|Visits conflicted with new job|0
1830906|NCT00347360|6343364|P13|Overall Study|Visits conflicted with new job|0
1830907|NCT00347360|6343365|P12|Overall Study|Visits conflicted with new job|0
1830908|NCT00347360|6343366|P11|Overall Study|Visits conflicted with new job|0
1830909|NCT00347360|6343367|P10|Overall Study|Visits conflicted with new job|0
1830910|NCT00347360|6343368|P9|Overall Study|Visits conflicted with new job|0
1830911|NCT00347360|6343369|P8|Overall Study|Visits conflicted with new job|0
1830912|NCT00347360|6343370|P7|Overall Study|Visits conflicted with new job|1
1830913|NCT00347360|6343371|P6|Overall Study|Visits conflicted with new job|0
1830914|NCT00347360|6343372|P5|Overall Study|Visits conflicted with new job|0
1830915|NCT00347360|6343373|P4|Overall Study|Visits conflicted with new job|0
1830916|NCT00347360|6343374|P3|Overall Study|Visits conflicted with new job|0
1830917|NCT00347360|6343375|P2|Overall Study|Visits conflicted with new job|0
1830918|NCT00347360|6343376|P1|Overall Study|Visits conflicted with new job|0
1830919|NCT00347360|6343362|P15|Overall Study|Subject refuse to sign updated consent|1
1830920|NCT00347360|6343363|P14|Overall Study|Subject refuse to sign updated consent|0
1830921|NCT00347360|6343364|P13|Overall Study|Subject refuse to sign updated consent|0
1830922|NCT00347360|6343365|P12|Overall Study|Subject refuse to sign updated consent|0
1830923|NCT00347360|6343366|P11|Overall Study|Subject refuse to sign updated consent|0
1830924|NCT00347360|6343367|P10|Overall Study|Subject refuse to sign updated consent|0
1830925|NCT00347360|6343368|P9|Overall Study|Subject refuse to sign updated consent|0
1830926|NCT00347360|6343369|P8|Overall Study|Subject refuse to sign updated consent|0
1830927|NCT00347360|6343370|P7|Overall Study|Subject refuse to sign updated consent|0
1830928|NCT00347360|6343371|P6|Overall Study|Subject refuse to sign updated consent|0
1830929|NCT00347360|6343372|P5|Overall Study|Subject refuse to sign updated consent|0
1830930|NCT00347360|6343373|P4|Overall Study|Subject refuse to sign updated consent|0
1830931|NCT00347360|6343374|P3|Overall Study|Subject refuse to sign updated consent|0
1830932|NCT00347360|6343375|P2|Overall Study|Subject refuse to sign updated consent|0
1830933|NCT00347360|6343376|P1|Overall Study|Subject refuse to sign updated consent|0
1830934|NCT00347360|6343362|P15|Overall Study|Subject left town, ran out of study drug|0
1830935|NCT00347360|6343363|P14|Overall Study|Subject left town, ran out of study drug|1
1830936|NCT00347360|6343364|P13|Overall Study|Subject left town, ran out of study drug|0
1830937|NCT00347360|6343365|P12|Overall Study|Subject left town, ran out of study drug|0
1830938|NCT00347360|6343366|P11|Overall Study|Subject left town, ran out of study drug|0
1830939|NCT00347360|6343367|P10|Overall Study|Subject left town, ran out of study drug|0
1830940|NCT00347360|6343368|P9|Overall Study|Subject left town, ran out of study drug|0
1830941|NCT00347360|6343369|P8|Overall Study|Subject left town, ran out of study drug|0
1830942|NCT00347360|6343370|P7|Overall Study|Subject left town, ran out of study drug|0
1830943|NCT00347360|6343371|P6|Overall Study|Subject left town, ran out of study drug|0
1830944|NCT00347360|6343372|P5|Overall Study|Subject left town, ran out of study drug|0
1830945|NCT00347360|6343373|P4|Overall Study|Subject left town, ran out of study drug|0
1830946|NCT00347360|6343374|P3|Overall Study|Subject left town, ran out of study drug|0
1830947|NCT00347360|6343375|P2|Overall Study|Subject left town, ran out of study drug|0
1830948|NCT00347360|6343376|P1|Overall Study|Subject left town, ran out of study drug|0
1830949|NCT00347360|6343362|P15|Overall Study|Prolonged duration between visits|0
1830950|NCT00347360|6343363|P14|Overall Study|Prolonged duration between visits|0
1830951|NCT00347360|6343364|P13|Overall Study|Prolonged duration between visits|1
1830952|NCT00347360|6343365|P12|Overall Study|Prolonged duration between visits|0
1830953|NCT00347360|6343366|P11|Overall Study|Prolonged duration between visits|0
1830954|NCT00347360|6343367|P10|Overall Study|Prolonged duration between visits|0
1830955|NCT00347360|6343368|P9|Overall Study|Prolonged duration between visits|0
1830956|NCT00347360|6343369|P8|Overall Study|Prolonged duration between visits|0
1830957|NCT00347360|6343370|P7|Overall Study|Prolonged duration between visits|0
1830958|NCT00347360|6343371|P6|Overall Study|Prolonged duration between visits|0
1830959|NCT00347360|6343372|P5|Overall Study|Prolonged duration between visits|0
1830960|NCT00347360|6343373|P4|Overall Study|Prolonged duration between visits|0
1830961|NCT00347360|6343374|P3|Overall Study|Prolonged duration between visits|0
1830962|NCT00347360|6343375|P2|Overall Study|Prolonged duration between visits|0
1830963|NCT00347360|6343376|P1|Overall Study|Prolonged duration between visits|0
1830964|NCT00347360|6343362|P15|Overall Study|Failed inclusion criteria #4|0
1830965|NCT00347360|6343363|P14|Overall Study|Failed inclusion criteria #4|0
1830966|NCT00347360|6343364|P13|Overall Study|Failed inclusion criteria #4|0
1830967|NCT00347360|6343365|P12|Overall Study|Failed inclusion criteria #4|1
1830968|NCT00347360|6343366|P11|Overall Study|Failed inclusion criteria #4|0
1830969|NCT00347360|6343367|P10|Overall Study|Failed inclusion criteria #4|0
1830970|NCT00347360|6343368|P9|Overall Study|Failed inclusion criteria #4|0
1830971|NCT00347360|6343369|P8|Overall Study|Failed inclusion criteria #4|0
1830972|NCT00347360|6343370|P7|Overall Study|Failed inclusion criteria #4|0
1830973|NCT00347360|6343371|P6|Overall Study|Failed inclusion criteria #4|0
1830974|NCT00347360|6343372|P5|Overall Study|Failed inclusion criteria #4|0
1830975|NCT00347360|6343373|P4|Overall Study|Failed inclusion criteria #4|0
1830976|NCT00347360|6343374|P3|Overall Study|Failed inclusion criteria #4|0
1830977|NCT00347360|6343375|P2|Overall Study|Failed inclusion criteria #4|0
1830978|NCT00347360|6343376|P1|Overall Study|Failed inclusion criteria #4|0
1830979|NCT00347360|6343362|P15|Overall Study|Randomized in error|0
1830980|NCT00347360|6343363|P14|Overall Study|Randomized in error|0
1830981|NCT00347360|6343364|P13|Overall Study|Randomized in error|0
1830982|NCT00347360|6343365|P12|Overall Study|Randomized in error|1
1830983|NCT00347360|6343366|P11|Overall Study|Randomized in error|0
1830984|NCT00347360|6343367|P10|Overall Study|Randomized in error|0
1830985|NCT00347360|6343368|P9|Overall Study|Randomized in error|0
1830986|NCT00347360|6343369|P8|Overall Study|Randomized in error|0
1830987|NCT00347360|6343370|P7|Overall Study|Randomized in error|0
1830988|NCT00347360|6343371|P6|Overall Study|Randomized in error|0
1830989|NCT00347360|6343372|P5|Overall Study|Randomized in error|0
1830990|NCT00347360|6343373|P4|Overall Study|Randomized in error|0
1830991|NCT00347360|6343374|P3|Overall Study|Randomized in error|0
1830992|NCT00347360|6343375|P2|Overall Study|Randomized in error|0
1830993|NCT00347360|6343376|P1|Overall Study|Randomized in error|0
1830994|NCT00347360|6343362|P15|Overall Study|Did not meet criteria before ABPM|0
1830995|NCT00347360|6343363|P14|Overall Study|Did not meet criteria before ABPM|0
1830996|NCT00347360|6343364|P13|Overall Study|Did not meet criteria before ABPM|0
1830997|NCT00347360|6343365|P12|Overall Study|Did not meet criteria before ABPM|0
1830998|NCT00347360|6343366|P11|Overall Study|Did not meet criteria before ABPM|1
1830999|NCT00347360|6343367|P10|Overall Study|Did not meet criteria before ABPM|0
1831000|NCT00347360|6343368|P9|Overall Study|Did not meet criteria before ABPM|0
1831001|NCT00347360|6343369|P8|Overall Study|Did not meet criteria before ABPM|0
1831002|NCT00347360|6343370|P7|Overall Study|Did not meet criteria before ABPM|0
1831003|NCT00347360|6343371|P6|Overall Study|Did not meet criteria before ABPM|0
1831004|NCT00347360|6343372|P5|Overall Study|Did not meet criteria before ABPM|0
1831005|NCT00347360|6343373|P4|Overall Study|Did not meet criteria before ABPM|0
1831006|NCT00347360|6343374|P3|Overall Study|Did not meet criteria before ABPM|0
1831007|NCT00347360|6343375|P2|Overall Study|Did not meet criteria before ABPM|0
1831008|NCT00347360|6343376|P1|Overall Study|Did not meet criteria before ABPM|0
1831009|NCT00347360|6343362|P15|Overall Study|PI recommended early withdrawal|0
1831010|NCT00347360|6343363|P14|Overall Study|PI recommended early withdrawal|0
1831011|NCT00347360|6343364|P13|Overall Study|PI recommended early withdrawal|0
1831012|NCT00347360|6343365|P12|Overall Study|PI recommended early withdrawal|0
1831013|NCT00347360|6343366|P11|Overall Study|PI recommended early withdrawal|0
1831014|NCT00347360|6343367|P10|Overall Study|PI recommended early withdrawal|1
1831015|NCT00347360|6343368|P9|Overall Study|PI recommended early withdrawal|0
1831016|NCT00347360|6343369|P8|Overall Study|PI recommended early withdrawal|0
1831017|NCT00347360|6343370|P7|Overall Study|PI recommended early withdrawal|0
1831018|NCT00347360|6343371|P6|Overall Study|PI recommended early withdrawal|0
1831019|NCT00347360|6343372|P5|Overall Study|PI recommended early withdrawal|0
1831020|NCT00347360|6343373|P4|Overall Study|PI recommended early withdrawal|0
1831021|NCT00347360|6343374|P3|Overall Study|PI recommended early withdrawal|0
1831022|NCT00347360|6343375|P2|Overall Study|PI recommended early withdrawal|0
1831023|NCT00347360|6343376|P1|Overall Study|PI recommended early withdrawal|0
1831024|NCT00347360|6343362|P15|Overall Study|Abnormal lab values|0
1831025|NCT00347360|6343363|P14|Overall Study|Abnormal lab values|0
1831026|NCT00347360|6343364|P13|Overall Study|Abnormal lab values|0
1831027|NCT00347360|6343365|P12|Overall Study|Abnormal lab values|0
1831028|NCT00347360|6343366|P11|Overall Study|Abnormal lab values|0
1831029|NCT00347360|6343367|P10|Overall Study|Abnormal lab values|0
1831030|NCT00347360|6343368|P9|Overall Study|Abnormal lab values|0
1831031|NCT00347360|6343369|P8|Overall Study|Abnormal lab values|0
1831032|NCT00347360|6343370|P7|Overall Study|Abnormal lab values|1
1831033|NCT00347360|6343371|P6|Overall Study|Abnormal lab values|0
1831034|NCT00347360|6343372|P5|Overall Study|Abnormal lab values|0
1831035|NCT00347360|6343373|P4|Overall Study|Abnormal lab values|0
1831036|NCT00347360|6343374|P3|Overall Study|Abnormal lab values|0
1831037|NCT00347360|6343375|P2|Overall Study|Abnormal lab values|0
1831038|NCT00347360|6343376|P1|Overall Study|Abnormal lab values|0
1831039|NCT00347360|6343362|P15|Overall Study|Subject did not meet end of study ABPM|0
1831040|NCT00347360|6343363|P14|Overall Study|Subject did not meet end of study ABPM|1
1831041|NCT00347360|6343364|P13|Overall Study|Subject did not meet end of study ABPM|1
1831042|NCT00347360|6343365|P12|Overall Study|Subject did not meet end of study ABPM|0
1831043|NCT00347360|6343366|P11|Overall Study|Subject did not meet end of study ABPM|1
1831044|NCT00347360|6343367|P10|Overall Study|Subject did not meet end of study ABPM|0
1831045|NCT00347360|6343368|P9|Overall Study|Subject did not meet end of study ABPM|0
1831046|NCT00347360|6343369|P8|Overall Study|Subject did not meet end of study ABPM|0
1831047|NCT00347360|6343370|P7|Overall Study|Subject did not meet end of study ABPM|1
1831048|NCT00347360|6343371|P6|Overall Study|Subject did not meet end of study ABPM|0
1831049|NCT00347360|6343372|P5|Overall Study|Subject did not meet end of study ABPM|0
1831050|NCT00347360|6343373|P4|Overall Study|Subject did not meet end of study ABPM|0
1831051|NCT00347360|6343374|P3|Overall Study|Subject did not meet end of study ABPM|0
1831052|NCT00347360|6343375|P2|Overall Study|Subject did not meet end of study ABPM|0
1831053|NCT00347360|6343376|P1|Overall Study|Subject did not meet end of study ABPM|0
1831054|NCT00347360|6343362|P15|Overall Study|P.I. recommended due to blood pressure|0
1831055|NCT00347360|6343363|P14|Overall Study|P.I. recommended due to blood pressure|0
1831056|NCT00347360|6343364|P13|Overall Study|P.I. recommended due to blood pressure|0
1831057|NCT00347360|6343365|P12|Overall Study|P.I. recommended due to blood pressure|0
1831058|NCT00347360|6343366|P11|Overall Study|P.I. recommended due to blood pressure|0
1831059|NCT00347360|6343367|P10|Overall Study|P.I. recommended due to blood pressure|0
1831060|NCT00347360|6343368|P9|Overall Study|P.I. recommended due to blood pressure|0
1831061|NCT00347360|6343369|P8|Overall Study|P.I. recommended due to blood pressure|0
1831062|NCT00347360|6343370|P7|Overall Study|P.I. recommended due to blood pressure|0
1831063|NCT00347360|6343371|P6|Overall Study|P.I. recommended due to blood pressure|0
1831064|NCT00347360|6343372|P5|Overall Study|P.I. recommended due to blood pressure|1
1831065|NCT00347360|6343373|P4|Overall Study|P.I. recommended due to blood pressure|0
1831066|NCT00347360|6343374|P3|Overall Study|P.I. recommended due to blood pressure|0
1831067|NCT00347360|6343375|P2|Overall Study|P.I. recommended due to blood pressure|0
1831068|NCT00347360|6343376|P1|Overall Study|P.I. recommended due to blood pressure|0
1831069|NCT00347360|6343362|P15|Overall Study|Per sponsors instruction|0
1831070|NCT00347360|6343363|P14|Overall Study|Per sponsors instruction|0
1831071|NCT00347360|6343364|P13|Overall Study|Per sponsors instruction|0
1831072|NCT00347360|6343365|P12|Overall Study|Per sponsors instruction|0
1831073|NCT00347360|6343366|P11|Overall Study|Per sponsors instruction|0
1831074|NCT00347360|6343367|P10|Overall Study|Per sponsors instruction|0
1831075|NCT00347360|6343368|P9|Overall Study|Per sponsors instruction|0
1831076|NCT00347360|6343369|P8|Overall Study|Per sponsors instruction|0
1831077|NCT00347360|6343370|P7|Overall Study|Per sponsors instruction|0
1831078|NCT00347360|6343371|P6|Overall Study|Per sponsors instruction|0
1831079|NCT00347360|6343372|P5|Overall Study|Per sponsors instruction|0
1831080|NCT00347360|6343373|P4|Overall Study|Per sponsors instruction|0
1831081|NCT00347360|6343374|P3|Overall Study|Per sponsors instruction|0
1831082|NCT00347360|6343375|P2|Overall Study|Per sponsors instruction|1
1831083|NCT00347360|6343376|P1|Overall Study|Per sponsors instruction|0
1831084|NCT00347360|6343362|P15|Overall Study|Reason not listed/blank|0
1831085|NCT00347360|6343363|P14|Overall Study|Reason not listed/blank|1
1831086|NCT00347360|6343364|P13|Overall Study|Reason not listed/blank|0
1831087|NCT00347360|6343365|P12|Overall Study|Reason not listed/blank|0
1831088|NCT00347360|6343366|P11|Overall Study|Reason not listed/blank|0
1831089|NCT00347360|6343367|P10|Overall Study|Reason not listed/blank|0
1831090|NCT00347360|6343368|P9|Overall Study|Reason not listed/blank|0
1831091|NCT00347360|6343369|P8|Overall Study|Reason not listed/blank|0
1831092|NCT00347360|6343370|P7|Overall Study|Reason not listed/blank|1
1831093|NCT00347360|6343371|P6|Overall Study|Reason not listed/blank|0
1831094|NCT00347360|6343372|P5|Overall Study|Reason not listed/blank|0
1831095|NCT00347360|6343373|P4|Overall Study|Reason not listed/blank|0
1831096|NCT00347360|6343374|P3|Overall Study|Reason not listed/blank|0
1831097|NCT00347360|6343375|P2|Overall Study|Reason not listed/blank|0
1831098|NCT00347360|6343376|P1|Overall Study|Reason not listed/blank|1
1831099|NCT00347360|6343362|P15|Overall Study|Lack of Efficacy|0
1831100|NCT00347360|6343363|P14|Overall Study|Lack of Efficacy|0
1831101|NCT00347360|6343364|P13|Overall Study|Lack of Efficacy|0
1831102|NCT00347360|6343365|P12|Overall Study|Lack of Efficacy|0
1831103|NCT00347360|6343366|P11|Overall Study|Lack of Efficacy|0
1831104|NCT00347360|6343367|P10|Overall Study|Lack of Efficacy|0
1831105|NCT00347360|6343368|P9|Overall Study|Lack of Efficacy|1
1831106|NCT00347360|6343369|P8|Overall Study|Lack of Efficacy|1
1831107|NCT00347360|6343370|P7|Overall Study|Lack of Efficacy|0
1831108|NCT00347360|6343371|P6|Overall Study|Lack of Efficacy|1
1831109|NCT00347360|6343372|P5|Overall Study|Lack of Efficacy|0
1831110|NCT00347360|6343373|P4|Overall Study|Lack of Efficacy|1
1831111|NCT00347360|6343374|P3|Overall Study|Lack of Efficacy|3
1831112|NCT00347360|6343375|P2|Overall Study|Lack of Efficacy|1
1831113|NCT00347360|6343376|P1|Overall Study|Lack of Efficacy|1
1831114|NCT00347360|6343362|P15|Overall Study|Withdrawal by Subject|1
1831115|NCT00347360|6343363|P14|Overall Study|Withdrawal by Subject|2
1831116|NCT00347360|6343364|P13|Overall Study|Withdrawal by Subject|4
1831117|NCT00347360|6343365|P12|Overall Study|Withdrawal by Subject|3
1831118|NCT00347360|6343366|P11|Overall Study|Withdrawal by Subject|0
1831119|NCT00347360|6343367|P10|Overall Study|Withdrawal by Subject|1
1831120|NCT00347360|6343368|P9|Overall Study|Withdrawal by Subject|1
1831121|NCT00347360|6343369|P8|Overall Study|Withdrawal by Subject|1
1831122|NCT00347360|6343370|P7|Overall Study|Withdrawal by Subject|1
1831123|NCT00347360|6343371|P6|Overall Study|Withdrawal by Subject|2
1831124|NCT00347360|6343372|P5|Overall Study|Withdrawal by Subject|1
1831125|NCT00347360|6343373|P4|Overall Study|Withdrawal by Subject|4
1831126|NCT00347360|6343374|P3|Overall Study|Withdrawal by Subject|2
1831127|NCT00347360|6343375|P2|Overall Study|Withdrawal by Subject|1
1831128|NCT00347360|6343376|P1|Overall Study|Withdrawal by Subject|0
1831129|NCT00347360|6343362|P15|Overall Study|Protocol Violation|0
1831130|NCT00347360|6343363|P14|Overall Study|Protocol Violation|1
1831131|NCT00347360|6343364|P13|Overall Study|Protocol Violation|0
1831132|NCT00347360|6343365|P12|Overall Study|Protocol Violation|0
1831133|NCT00347360|6343366|P11|Overall Study|Protocol Violation|0
1831134|NCT00347360|6343367|P10|Overall Study|Protocol Violation|2
1831135|NCT00347360|6343368|P9|Overall Study|Protocol Violation|1
1831136|NCT00347360|6343369|P8|Overall Study|Protocol Violation|0
1831137|NCT00347360|6343370|P7|Overall Study|Protocol Violation|0
1831138|NCT00347360|6343371|P6|Overall Study|Protocol Violation|2
1831139|NCT00347360|6343372|P5|Overall Study|Protocol Violation|1
1831140|NCT00347360|6343373|P4|Overall Study|Protocol Violation|2
1831141|NCT00347360|6343374|P3|Overall Study|Protocol Violation|1
1831142|NCT00347360|6343375|P2|Overall Study|Protocol Violation|3
1831143|NCT00347360|6343376|P1|Overall Study|Protocol Violation|2
1831144|NCT00347360|6343362|P15|Overall Study|Lost to Follow-up|0
1831145|NCT00347360|6343363|P14|Overall Study|Lost to Follow-up|0
1831146|NCT00347360|6343364|P13|Overall Study|Lost to Follow-up|1
1831147|NCT00347360|6343365|P12|Overall Study|Lost to Follow-up|0
1831148|NCT00347360|6343366|P11|Overall Study|Lost to Follow-up|0
1831149|NCT00347360|6343367|P10|Overall Study|Lost to Follow-up|2
1831150|NCT00347360|6343368|P9|Overall Study|Lost to Follow-up|1
1831151|NCT00347360|6343369|P8|Overall Study|Lost to Follow-up|1
1831152|NCT00347360|6343370|P7|Overall Study|Lost to Follow-up|0
1831153|NCT00347360|6343371|P6|Overall Study|Lost to Follow-up|1
1831154|NCT00347360|6343372|P5|Overall Study|Lost to Follow-up|1
1831155|NCT00347360|6343373|P4|Overall Study|Lost to Follow-up|2
1831156|NCT00347360|6343374|P3|Overall Study|Lost to Follow-up|0
1831157|NCT00347360|6343375|P2|Overall Study|Lost to Follow-up|0
1831158|NCT00347360|6343376|P1|Overall Study|Lost to Follow-up|0
1831159|NCT00347360|6343362|P15|Overall Study|Adverse Event|2
1831160|NCT00347360|6343363|P14|Overall Study|Adverse Event|2
1831161|NCT00347360|6343364|P13|Overall Study|Adverse Event|3
1831162|NCT00347360|6343365|P12|Overall Study|Adverse Event|1
1831163|NCT00347360|6343366|P11|Overall Study|Adverse Event|3
1831164|NCT00347360|6343367|P10|Overall Study|Adverse Event|3
1831165|NCT00347360|6343368|P9|Overall Study|Adverse Event|2
1831166|NCT00347360|6343369|P8|Overall Study|Adverse Event|0
1831167|NCT00347360|6343370|P7|Overall Study|Adverse Event|2
1831168|NCT00347360|6343371|P6|Overall Study|Adverse Event|2
1831169|NCT00347360|6343372|P5|Overall Study|Adverse Event|1
1831170|NCT00347360|6343373|P4|Overall Study|Adverse Event|4
1831171|NCT00347360|6343374|P3|Overall Study|Adverse Event|0
1831172|NCT00347360|6343375|P2|Overall Study|Adverse Event|2
1831173|NCT00347360|6343376|P1|Overall Study|Adverse Event|1
1831174|NCT00347269|6343564|P2|Overall Study|Death|3
1831175|NCT00347269|6343565|P1|Overall Study|Death|2
1831176|NCT00347269|6343564|P2|Overall Study|Withdrawal by Subject|38
1831177|NCT00347269|6343565|P1|Overall Study|Withdrawal by Subject|18
1831178|NCT00347269|6343564|P2|Overall Study|Lost to Follow-up|65
1831179|NCT00347269|6343565|P1|Overall Study|Lost to Follow-up|74
1831180|NCT00347009|6343580|P1|Overall Study|Serious Adverse Event|1
1831181|NCT00347009|6343580|P1|Overall Study|Increased ALT/HBV DNA|1
1831182|NCT00347009|6343580|P1|Overall Study|Insufficient Viral Suppression|3
1831183|NCT00347009|6343580|P1|Overall Study|Adverse Laboratory Experience|1
1831184|NCT00347009|6343580|P1|Overall Study|Protocol Violation|2
1831185|NCT00347009|6343580|P1|Overall Study|Lost to Follow-up|4
1831186|NCT00347009|6343580|P1|Overall Study|Physician Decision|5
1831187|NCT00347009|6343580|P1|Overall Study|Withdrawal by Subject|3
1831188|NCT00347009|6343580|P1|Overall Study|Adverse Event|6
1831189|NCT00347009|6343580|P1|Overall Study|Death|1
1831190|NCT00346775|6343601|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
1831191|NCT00346775|6343602|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
1831192|NCT00346775|6343601|P2|Period 1: Intervention Period 1|Protocol Violation|2
1831193|NCT00346775|6343602|P1|Period 1: Intervention Period 1|Protocol Violation|3
1831194|NCT00346775|6343601|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
1831195|NCT00346775|6343602|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
1831196|NCT00346697|6343614|P2|Overall Study|Lost to Follow-up|1
1831197|NCT00346697|6343615|P1|Overall Study|Lost to Follow-up|0
1831198|NCT00346632|6343651|P10|Overall Study|Not Stated|1
1831199|NCT00346632|6343652|P9|Overall Study|Not Stated|2
1831200|NCT00346632|6343653|P8|Overall Study|Not Stated|2
1831201|NCT00346632|6343654|P7|Overall Study|Not Stated|0
1831202|NCT00346632|6343655|P6|Overall Study|Not Stated|0
1831203|NCT00346632|6343656|P5|Overall Study|Not Stated|0
1831204|NCT00346632|6343657|P4|Overall Study|Not Stated|0
1831205|NCT00346632|6343658|P3|Overall Study|Not Stated|0
1831206|NCT00346632|6343659|P2|Overall Study|Not Stated|1
1831207|NCT00346632|6343660|P1|Overall Study|Not Stated|1
1831208|NCT00346632|6343651|P10|Overall Study|Switched to alternative treatment|0
1831209|NCT00346632|6343652|P9|Overall Study|Switched to alternative treatment|0
1831210|NCT00346632|6343653|P8|Overall Study|Switched to alternative treatment|0
1831211|NCT00346632|6343654|P7|Overall Study|Switched to alternative treatment|0
1831212|NCT00346632|6343655|P6|Overall Study|Switched to alternative treatment|0
1831213|NCT00346632|6343656|P5|Overall Study|Switched to alternative treatment|0
1831214|NCT00346632|6343657|P4|Overall Study|Switched to alternative treatment|0
1831215|NCT00346632|6343658|P3|Overall Study|Switched to alternative treatment|1
1831216|NCT00346632|6343659|P2|Overall Study|Switched to alternative treatment|0
1831217|NCT00346632|6343660|P1|Overall Study|Switched to alternative treatment|0
1831218|NCT00346632|6343651|P10|Overall Study|Withdrawal by Subject|0
1831219|NCT00346632|6343652|P9|Overall Study|Withdrawal by Subject|0
1831220|NCT00346632|6343653|P8|Overall Study|Withdrawal by Subject|0
1831221|NCT00346632|6343654|P7|Overall Study|Withdrawal by Subject|1
1831222|NCT00346632|6343655|P6|Overall Study|Withdrawal by Subject|0
1831223|NCT00346632|6343656|P5|Overall Study|Withdrawal by Subject|0
1831224|NCT00346632|6343657|P4|Overall Study|Withdrawal by Subject|0
1831225|NCT00346632|6343658|P3|Overall Study|Withdrawal by Subject|0
1831226|NCT00346632|6343659|P2|Overall Study|Withdrawal by Subject|0
1831227|NCT00346632|6343660|P1|Overall Study|Withdrawal by Subject|0
1831228|NCT00346632|6343651|P10|Overall Study|Protocol Violation|0
1831229|NCT00346632|6343652|P9|Overall Study|Protocol Violation|0
1831230|NCT00346632|6343653|P8|Overall Study|Protocol Violation|0
1831231|NCT00346632|6343654|P7|Overall Study|Protocol Violation|1
1831232|NCT00346632|6343655|P6|Overall Study|Protocol Violation|0
1831233|NCT00346632|6343656|P5|Overall Study|Protocol Violation|0
1831234|NCT00346632|6343657|P4|Overall Study|Protocol Violation|0
1831235|NCT00346632|6343658|P3|Overall Study|Protocol Violation|0
1831236|NCT00346632|6343659|P2|Overall Study|Protocol Violation|0
1831237|NCT00346632|6343660|P1|Overall Study|Protocol Violation|0
1831238|NCT00346632|6343651|P10|Overall Study|Death|0
1831239|NCT00346632|6343652|P9|Overall Study|Death|0
1831240|NCT00346632|6343653|P8|Overall Study|Death|0
1831241|NCT00346632|6343654|P7|Overall Study|Death|0
1831242|NCT00346632|6343655|P6|Overall Study|Death|0
1831243|NCT00346632|6343656|P5|Overall Study|Death|0
1831244|NCT00346632|6343657|P4|Overall Study|Death|0
1831245|NCT00346632|6343658|P3|Overall Study|Death|1
1831246|NCT00346632|6343659|P2|Overall Study|Death|0
1831247|NCT00346632|6343660|P1|Overall Study|Death|0
1831248|NCT00346632|6343651|P10|Overall Study|Adverse Event|0
1831249|NCT00346632|6343652|P9|Overall Study|Adverse Event|0
1831250|NCT00346632|6343653|P8|Overall Study|Adverse Event|0
1831251|NCT00346632|6343654|P7|Overall Study|Adverse Event|1
1831252|NCT00346632|6343655|P6|Overall Study|Adverse Event|1
1831253|NCT00346632|6343656|P5|Overall Study|Adverse Event|1
1831254|NCT00346632|6343657|P4|Overall Study|Adverse Event|0
1831255|NCT00346632|6343658|P3|Overall Study|Adverse Event|0
1831256|NCT00346632|6343659|P2|Overall Study|Adverse Event|0
1831257|NCT00346632|6343660|P1|Overall Study|Adverse Event|0
1831258|NCT00346632|6343651|P10|Overall Study|Progressive Disease|2
1831259|NCT00346632|6343652|P9|Overall Study|Progressive Disease|2
1831260|NCT00346632|6343653|P8|Overall Study|Progressive Disease|2
1831261|NCT00346632|6343654|P7|Overall Study|Progressive Disease|2
1831262|NCT00346632|6343655|P6|Overall Study|Progressive Disease|1
1831263|NCT00346632|6343656|P5|Overall Study|Progressive Disease|3
1831264|NCT00346632|6343657|P4|Overall Study|Progressive Disease|3
1831265|NCT00346632|6343658|P3|Overall Study|Progressive Disease|4
1831266|NCT00346632|6343659|P2|Overall Study|Progressive Disease|2
1831267|NCT00346632|6343660|P1|Overall Study|Progressive Disease|2
1831268|NCT00346398|6343810|P2|Overall Study|Withdrawal by Subject|2
1831269|NCT00346398|6343811|P1|Overall Study|Withdrawal by Subject|0
1831270|NCT00346398|6343810|P2|Overall Study|Lost to Follow-up|0
1831271|NCT00346398|6343811|P1|Overall Study|Lost to Follow-up|3
1831272|NCT00346333|6343823|P2|Overall Study|unwilling or unable to continue|8
1831273|NCT00346333|6343824|P1|Overall Study|unwilling or unable to continue|4
1831274|NCT00346333|6343823|P2|Overall Study|Death|0
1831275|NCT00346333|6343824|P1|Overall Study|Death|1
1831276|NCT00346268|6343840|P2|Overall Study|Participant refused|3
1831277|NCT00346268|6343841|P1|Overall Study|Participant refused|0
1831278|NCT00346268|6343840|P2|Overall Study|Protocol Violation|0
1831279|NCT00346268|6343841|P1|Overall Study|Protocol Violation|1
1831280|NCT00346268|6343840|P2|Overall Study|Adverse Event|0
1831281|NCT00346268|6343841|P1|Overall Study|Adverse Event|1
1831282|NCT00346216|6343876|P3|Overall Study|Missing Subject Summary Status|62
1831283|NCT00346216|6343877|P2|Overall Study|Missing Subject Summary Status|61
1831284|NCT00346216|6343878|P1|Overall Study|Missing Subject Summary Status|62
1831285|NCT00346216|6343876|P3|Overall Study|Study terminated by sponsor|8
1831286|NCT00346216|6343877|P2|Overall Study|Study terminated by sponsor|4
1831287|NCT00346216|6343878|P1|Overall Study|Study terminated by sponsor|11
1831288|NCT00346216|6343876|P3|Overall Study|Death|228
1831289|NCT00346216|6343877|P2|Overall Study|Death|192
1831290|NCT00346216|6343878|P1|Overall Study|Death|189
1831291|NCT00346216|6343876|P3|Overall Study|Does not meet entrance criteria|8
1831292|NCT00346216|6343877|P2|Overall Study|Does not meet entrance criteria|10
1831293|NCT00346216|6343878|P1|Overall Study|Does not meet entrance criteria|13
1831294|NCT00346216|6343876|P3|Overall Study|Physician Decision|59
1831295|NCT00346216|6343877|P2|Overall Study|Physician Decision|76
1831296|NCT00346216|6343878|P1|Overall Study|Physician Decision|80
1831297|NCT00346216|6343876|P3|Overall Study|Lost to Follow-up|542
1831298|NCT00346216|6343877|P2|Overall Study|Lost to Follow-up|588
1831299|NCT00346216|6343878|P1|Overall Study|Lost to Follow-up|611
1831300|NCT00346216|6343876|P3|Overall Study|Withdrawal by Subject|651
1831301|NCT00346216|6343877|P2|Overall Study|Withdrawal by Subject|692
1831302|NCT00346216|6343878|P1|Overall Study|Withdrawal by Subject|661
1831303|NCT00346216|6343876|P3|Overall Study|No longer willing to participate|585
1831304|NCT00346216|6343877|P2|Overall Study|No longer willing to participate|606
1831305|NCT00346216|6343878|P1|Overall Study|No longer willing to participate|600
1831306|NCT00346216|6343876|P3|Overall Study|Other|205
1831307|NCT00346216|6343877|P2|Overall Study|Other|231
1831308|NCT00346216|6343878|P1|Overall Study|Other|181
1831309|NCT00346164|6343899|P4|Overall Study|Inability to start week 16 tx on time|11
1831310|NCT00346164|6343900|P3|Overall Study|Inability to start week 16 tx on time|0
1831311|NCT00346164|6343901|P2|Overall Study|Inability to start week 16 tx on time|0
1831312|NCT00346164|6343902|P1|Overall Study|Inability to start week 16 tx on time|0
1831313|NCT00346164|6343899|P4|Overall Study|Refusal of further protocol therapy|15
1831314|NCT00346164|6343900|P3|Overall Study|Refusal of further protocol therapy|3
1831315|NCT00346164|6343901|P2|Overall Study|Refusal of further protocol therapy|1
1831316|NCT00346164|6343902|P1|Overall Study|Refusal of further protocol therapy|0
1831317|NCT00346164|6343899|P4|Overall Study|Ineligible|23
1831318|NCT00346164|6343900|P3|Overall Study|Ineligible|2
1831319|NCT00346164|6343901|P2|Overall Study|Ineligible|2
1831320|NCT00346164|6343902|P1|Overall Study|Ineligible|11
1831321|NCT00346164|6343899|P4|Overall Study|Withdrawal by Subject|0
1831322|NCT00346164|6343900|P3|Overall Study|Withdrawal by Subject|2
1831323|NCT00346164|6343901|P2|Overall Study|Withdrawal by Subject|0
1831324|NCT00346164|6343902|P1|Overall Study|Withdrawal by Subject|0
1831325|NCT00346164|6343899|P4|Overall Study|Protocol Violation|4
1831326|NCT00346164|6343900|P3|Overall Study|Protocol Violation|10
1831327|NCT00346164|6343901|P2|Overall Study|Protocol Violation|2
1831328|NCT00346164|6343902|P1|Overall Study|Protocol Violation|6
1831329|NCT00346164|6343899|P4|Overall Study|Physician Decision|27
1831330|NCT00346164|6343900|P3|Overall Study|Physician Decision|2
1831331|NCT00346164|6343901|P2|Overall Study|Physician Decision|1
1831332|NCT00346164|6343902|P1|Overall Study|Physician Decision|0
1831333|NCT00346164|6343899|P4|Overall Study|Lack of Efficacy|25
1831334|NCT00346164|6343900|P3|Overall Study|Lack of Efficacy|7
1831335|NCT00346164|6343901|P2|Overall Study|Lack of Efficacy|1
1831336|NCT00346164|6343902|P1|Overall Study|Lack of Efficacy|0
1831337|NCT00346164|6343899|P4|Overall Study|Adverse Event|1
1831338|NCT00346164|6343900|P3|Overall Study|Adverse Event|0
1831339|NCT00346164|6343901|P2|Overall Study|Adverse Event|0
1831340|NCT00346164|6343902|P1|Overall Study|Adverse Event|0
1831341|NCT00346151|6343937|P1|Overall Study|Withdrawal by Subject|3
1831342|NCT00346073|6343957|P2|Overall Study|Lost to Follow-up|24
1831343|NCT00346073|6343958|P1|Overall Study|Lost to Follow-up|39
1831344|NCT00346073|6343957|P2|Overall Study|Serious Adverse Event|0
1831345|NCT00346073|6343958|P1|Overall Study|Serious Adverse Event|2
1831346|NCT00346034|6343992|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
1831347|NCT00346034|6343992|P1|Overall Study|Patient Stopped Taking Study Drug|1
1831348|NCT00346034|6343992|P1|Overall Study|Withdrawal by Subject|13
1831349|NCT00346034|6343992|P1|Overall Study|Lack of Efficacy|8
1831350|NCT00346034|6343992|P1|Overall Study|Adverse Event|34
1831351|NCT00345878|6344032|P2|Overall Study|Other|0
1831352|NCT00345878|6344033|P1|Overall Study|Other|1
1831353|NCT00345878|6344032|P2|Overall Study|Lost to Follow-up|1
1831354|NCT00345878|6344033|P1|Overall Study|Lost to Follow-up|2
1831355|NCT00345878|6344032|P2|Overall Study|Adverse Event|0
1831356|NCT00345878|6344033|P1|Overall Study|Adverse Event|1
1831357|NCT00345839|6344051|P2|Overall Study|Lost to Follow-up|61
1831358|NCT00345839|6344052|P1|Overall Study|Lost to Follow-up|58
1831359|NCT00345839|6344051|P2|Overall Study|Withdrawal by Subject|98
1831360|NCT00345839|6344052|P1|Overall Study|Withdrawal by Subject|91
1831361|NCT00345683|6344078|P2|Overall Study|Other|2
1831362|NCT00345683|6344079|P1|Overall Study|Other|6
1831363|NCT00345683|6344078|P2|Overall Study|Lost to Follow-up|7
1831364|NCT00345683|6344079|P1|Overall Study|Lost to Follow-up|19
1831365|NCT00345631|6344102|P3|Overall Study|Other reasons|1
1831366|NCT00345631|6344103|P2|Overall Study|Other reasons|0
1831367|NCT00345631|6344104|P1|Overall Study|Other reasons|0
1831368|NCT00345631|6344102|P3|Overall Study|Lost to Follow-up|4
1831369|NCT00345631|6344103|P2|Overall Study|Lost to Follow-up|7
1831370|NCT00345631|6344104|P1|Overall Study|Lost to Follow-up|3
1831371|NCT00345631|6344102|P3|Overall Study|Adverse Event|0
1831372|NCT00345631|6344103|P2|Overall Study|Adverse Event|1
1831373|NCT00345631|6344104|P1|Overall Study|Adverse Event|0
1831374|NCT00345631|6344102|P3|Overall Study|Withdrawal by Subject|1
1831375|NCT00345631|6344103|P2|Overall Study|Withdrawal by Subject|0
1831376|NCT00345631|6344104|P1|Overall Study|Withdrawal by Subject|1
1831377|NCT00345605|6344136|P2|Arm 2, Opposite Treatment|Adverse Event|0
1831378|NCT00345605|6344137|P1|Arm 2, Opposite Treatment|Adverse Event|1
1831379|NCT00345605|6344136|P2|Arm 1|Adverse Event|1
1831380|NCT00345605|6344137|P1|Arm 1|Adverse Event|0
1831381|NCT00345592|6344157|P2|Overall Study|Withdrawal by Subject|8
1831382|NCT00345592|6344158|P1|Overall Study|Withdrawal by Subject|11
1831383|NCT00345592|6344157|P2|Overall Study|Death|16
1831384|NCT00345592|6344158|P1|Overall Study|Death|14
1831385|NCT00345579|6344166|P2|Overall Study|Other|1
1831386|NCT00345579|6344167|P1|Overall Study|Other|9
1831387|NCT00345579|6344166|P2|Overall Study|Lost to Follow-up|36
1831388|NCT00345579|6344167|P1|Overall Study|Lost to Follow-up|82
1831389|NCT00345579|6344166|P2|Overall Study|Withdrawal by Subject|17
1831390|NCT00345579|6344167|P1|Overall Study|Withdrawal by Subject|50
1831391|NCT00345579|6344166|P2|Overall Study|Protocol Violation|5
1831392|NCT00345579|6344167|P1|Overall Study|Protocol Violation|14
1831393|NCT00345579|6344166|P2|Overall Study|Adverse Event|6
1831394|NCT00345579|6344167|P1|Overall Study|Adverse Event|9
1831395|NCT00345540|6344187|P1|Overall Study|Withdrawal by Subject|1
1831396|NCT00345397|6344193|P1|Overall Study|Death|1
1831397|NCT00345358|6344224|P4|Booster Vaccination Phase|Lost to Follow-up|0
1831398|NCT00345358|6344225|P3|Booster Vaccination Phase|Lost to Follow-up|0
1831399|NCT00345358|6344226|P2|Booster Vaccination Phase|Lost to Follow-up|0
1831400|NCT00345358|6344227|P1|Booster Vaccination Phase|Lost to Follow-up|3
1831401|NCT00345358|6344224|P4|Booster Vaccination Phase|Withdrawal by Subject|0
1831402|NCT00345358|6344225|P3|Booster Vaccination Phase|Withdrawal by Subject|0
1831403|NCT00345358|6344226|P2|Booster Vaccination Phase|Withdrawal by Subject|0
1831404|NCT00345358|6344227|P1|Booster Vaccination Phase|Withdrawal by Subject|1
1831405|NCT00345358|6344224|P4|Primary Vaccination Phase|Lost to Follow-up|2
1831406|NCT00345358|6344225|P3|Primary Vaccination Phase|Lost to Follow-up|2
1831407|NCT00345358|6344226|P2|Primary Vaccination Phase|Lost to Follow-up|0
1831408|NCT00345358|6344227|P1|Primary Vaccination Phase|Lost to Follow-up|1
1831409|NCT00345358|6344224|P4|Primary Vaccination Phase|Withdrawal by Subject|0
1831410|NCT00345358|6344225|P3|Primary Vaccination Phase|Withdrawal by Subject|4
1831411|NCT00345358|6344226|P2|Primary Vaccination Phase|Withdrawal by Subject|2
1831412|NCT00345358|6344227|P1|Primary Vaccination Phase|Withdrawal by Subject|1
1831413|NCT00345358|6344224|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
1831414|NCT00345358|6344225|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
1831415|NCT00345358|6344226|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
1831416|NCT00345358|6344227|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
1831417|NCT00345358|6344224|P4|Primary Vaccination Phase|Other|0
1831418|NCT00345358|6344225|P3|Primary Vaccination Phase|Other|1
1831419|NCT00345358|6344226|P2|Primary Vaccination Phase|Other|1
1831420|NCT00345358|6344227|P1|Primary Vaccination Phase|Other|0
1831421|NCT00345293|6344317|P2|Overall Study|Withdrawal by Subject|0
1831422|NCT00345293|6344318|P1|Overall Study|Withdrawal by Subject|1
1831423|NCT00345293|6344317|P2|Overall Study|Unable to access line for sample|0
1831424|NCT00345293|6344318|P1|Overall Study|Unable to access line for sample|1
1831425|NCT00345046|6344364|P3|Overall Study|Protocol Violation|2
1831426|NCT00345046|6344365|P2|Overall Study|Protocol Violation|1
1831427|NCT00345046|6344366|P1|Overall Study|Protocol Violation|1
1831428|NCT00344968|6344396|P3|Overall Study|Other|0
1831429|NCT00344968|6344397|P2|Overall Study|Other|1
1831430|NCT00344968|6344398|P1|Overall Study|Other|0
1831431|NCT00344968|6344396|P3|Overall Study|Death|31
1831432|NCT00344968|6344397|P2|Overall Study|Death|27
1831433|NCT00344968|6344398|P1|Overall Study|Death|11
1831434|NCT00344968|6344396|P3|Overall Study|Lost to Follow-up|37
1831435|NCT00344968|6344397|P2|Overall Study|Lost to Follow-up|37
1831436|NCT00344968|6344398|P1|Overall Study|Lost to Follow-up|24
1831437|NCT00344968|6344396|P3|Overall Study|Withdrawal by Subject|27
1831438|NCT00344968|6344397|P2|Overall Study|Withdrawal by Subject|31
1831439|NCT00344968|6344398|P1|Overall Study|Withdrawal by Subject|14
1831440|NCT00344968|6344396|P3|Overall Study|Protocol Violation|5
1831441|NCT00344968|6344397|P2|Overall Study|Protocol Violation|2
1831442|NCT00344968|6344398|P1|Overall Study|Protocol Violation|2
1831443|NCT00344968|6344396|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
1831444|NCT00344968|6344397|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
1831445|NCT00344968|6344398|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
1831446|NCT00344968|6344396|P3|Overall Study|Adverse Event|15
1831447|NCT00344968|6344397|P2|Overall Study|Adverse Event|4
1831448|NCT00344968|6344398|P1|Overall Study|Adverse Event|5
1831449|NCT00344773|6344409|P1|Overall Study|Not Eligible for the study|2
1831450|NCT00344773|6344409|P1|Overall Study|Withdrawal by Subject|1
1831451|NCT00344773|6344409|P1|Overall Study|Objective Disease Progression|16
1831452|NCT00344773|6344409|P1|Overall Study|Adverse Event|2
1831453|NCT00344500|6344432|P3|Overall Study|Not Noted|0
1831454|NCT00344500|6344433|P2|Overall Study|Not Noted|3
1831455|NCT00344500|6344434|P1|Overall Study|Not Noted|1
1831456|NCT00344500|6344432|P3|Overall Study|Protocol Violation|1
1831457|NCT00344500|6344433|P2|Overall Study|Protocol Violation|7
1831458|NCT00344500|6344434|P1|Overall Study|Protocol Violation|4
1831459|NCT00344500|6344432|P3|Overall Study|Withdrawal by Subject|0
1831460|NCT00344500|6344433|P2|Overall Study|Withdrawal by Subject|10
1831461|NCT00344500|6344434|P1|Overall Study|Withdrawal by Subject|7
1831462|NCT00344500|6344432|P3|Overall Study|Lost to Follow-up|1
1831463|NCT00344500|6344433|P2|Overall Study|Lost to Follow-up|13
1831464|NCT00344500|6344434|P1|Overall Study|Lost to Follow-up|5
1831465|NCT00344500|6344432|P3|Overall Study|Adverse Event|0
1831466|NCT00344500|6344433|P2|Overall Study|Adverse Event|2
1831467|NCT00344500|6344434|P1|Overall Study|Adverse Event|6
1831468|NCT00344487|6344445|P1|Overall Study|immunologic failure|1
1831469|NCT00344461|6344449|P1|Overall Study|Withdrawal by Subject|2
1831470|NCT00344461|6344449|P1|Overall Study|Protocol Violation|6
1831471|NCT00344461|6344449|P1|Overall Study|Physician Decision|2
1831472|NCT00344461|6344449|P1|Overall Study|Lost to Follow-up|2
1831473|NCT00344461|6344449|P1|Overall Study|Lack of Efficacy|2
1831474|NCT00344461|6344449|P1|Overall Study|Death|1
1831475|NCT00344461|6344449|P1|Overall Study|Adverse Event|6
1831476|NCT00344448|6344460|P2|Open Label|Study terminated|0
1831477|NCT00344448|6344461|P1|Open Label|Study terminated|1
1831478|NCT00344448|6344460|P2|Open Label|Withdrawal by Subject|1
1831479|NCT00344448|6344461|P1|Open Label|Withdrawal by Subject|1
1831480|NCT00344448|6344460|P2|Double Blind, Placebo Controlled|Study terminated|0
1831481|NCT00344448|6344461|P1|Double Blind, Placebo Controlled|Study terminated|1
1831482|NCT00344448|6344460|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
1831483|NCT00344448|6344461|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
1831484|NCT00344448|6344460|P2|Screening|Withdrawal by Subject|1
1831485|NCT00344448|6344461|P1|Screening|Withdrawal by Subject|0
1831486|NCT00344318|6344482|P4|Overall Study|Lost to Follow-up|0
1831487|NCT00344318|6344483|P3|Overall Study|Lost to Follow-up|1
1831488|NCT00344318|6344484|P2|Overall Study|Lost to Follow-up|0
1831489|NCT00344318|6344485|P1|Overall Study|Lost to Follow-up|2
1831490|NCT00344318|6344482|P4|Overall Study|Withdrawal by Subject|2
1831491|NCT00344318|6344483|P3|Overall Study|Withdrawal by Subject|0
1831492|NCT00344318|6344484|P2|Overall Study|Withdrawal by Subject|2
1831493|NCT00344318|6344485|P1|Overall Study|Withdrawal by Subject|2
1831494|NCT00344318|6344482|P4|Overall Study|Adverse Event|1
1831495|NCT00344318|6344483|P3|Overall Study|Adverse Event|0
1831496|NCT00344318|6344484|P2|Overall Study|Adverse Event|3
1831497|NCT00344318|6344485|P1|Overall Study|Adverse Event|0
1831498|NCT00344305|6344607|P2|Overall Study|Participant was not contacted in window|1
1831499|NCT00344305|6344608|P1|Overall Study|Participant was not contacted in window|0
1831500|NCT00344305|6344607|P2|Overall Study|Lost to Follow-up|0
1831501|NCT00344305|6344608|P1|Overall Study|Lost to Follow-up|2
1831502|NCT00344032|6344658|P2|Overall Study|Physician Decision|1
1831503|NCT00344032|6344659|P1|Overall Study|Physician Decision|4
1831504|NCT00344032|6344658|P2|Overall Study|Lost to Follow-up|6
1831505|NCT00344032|6344659|P1|Overall Study|Lost to Follow-up|4
1831506|NCT00344032|6344658|P2|Overall Study|Withdrawal by Subject|2
1831507|NCT00344032|6344659|P1|Overall Study|Withdrawal by Subject|6
1831508|NCT00344032|6344658|P2|Overall Study|Adverse Event|1
1831509|NCT00344032|6344659|P1|Overall Study|Adverse Event|0
1831510|NCT00344019|6344678|P3|Overall Study|did not meet final inclusion criteria|74
1831511|NCT00344019|6344679|P2|Overall Study|did not meet final inclusion criteria|0
1831512|NCT00344019|6344680|P1|Overall Study|did not meet final inclusion criteria|0
1831513|NCT00343915|6344698|P2|Primary Study|Other|0
1831514|NCT00343915|6344699|P1|Primary Study|Other|1
1831515|NCT00343915|6344698|P2|Primary Study|Lost to Follow-up|3
1831516|NCT00343915|6344699|P1|Primary Study|Lost to Follow-up|2
1831517|NCT00343915|6344698|P2|Primary Study|Withdrawal by Subject|0
1831518|NCT00343915|6344699|P1|Primary Study|Withdrawal by Subject|1
1831519|NCT00343889|6344725|P2|Overall Study|Protocol Violation|0
1831520|NCT00343889|6344726|P1|Overall Study|Protocol Violation|1
1831521|NCT00343889|6344725|P2|Overall Study|Withdrawal by Subject|1
1831522|NCT00343889|6344726|P1|Overall Study|Withdrawal by Subject|0
1831523|NCT00343889|6344725|P2|Overall Study|Lost to Follow-up|0
1831524|NCT00343889|6344726|P1|Overall Study|Lost to Follow-up|2
1831525|NCT00343512|6344890|P1|Overall Study|Withdrawal by Subject|2
1831526|NCT00343382|6344978|P3|Overall Study|Other Reason Not Specified|4
1831527|NCT00343382|6344979|P2|Overall Study|Other Reason Not Specified|2
1831528|NCT00343382|6344980|P1|Overall Study|Other Reason Not Specified|1
1831529|NCT00343382|6344978|P3|Overall Study|Withdrawal by Subject|6
1831530|NCT00343382|6344979|P2|Overall Study|Withdrawal by Subject|2
1831531|NCT00343382|6344980|P1|Overall Study|Withdrawal by Subject|1
1831532|NCT00343382|6344978|P3|Overall Study|Adverse Event|7
1831533|NCT00343382|6344979|P2|Overall Study|Adverse Event|10
1831534|NCT00343382|6344980|P1|Overall Study|Adverse Event|2
1831535|NCT00343291|6344999|P2|Overall Study|Other|5
1831536|NCT00343291|6345000|P1|Overall Study|Other|8
1831537|NCT00343291|6344999|P2|Overall Study|Withdrawal by Subject|2
1831538|NCT00343291|6345000|P1|Overall Study|Withdrawal by Subject|0
1831539|NCT00343291|6344999|P2|Overall Study|Progressive disease|34
1831540|NCT00343291|6345000|P1|Overall Study|Progressive disease|33
1831541|NCT00343291|6344999|P2|Overall Study|Death|2
1831542|NCT00343291|6345000|P1|Overall Study|Death|3
1831543|NCT00343291|6344999|P2|Overall Study|Adverse Event|13
1831544|NCT00343291|6345000|P1|Overall Study|Adverse Event|13
1831545|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
1831546|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
1831547|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Sponsor Decision|5
1831548|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Sponsor Decision|8
1831549|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Protocol Violation|3
1831550|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Protocol Violation|3
1831551|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Physician Decision|7
1831552|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Physician Decision|4
1831553|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
1831554|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
1831555|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
1831556|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
1831557|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
1831558|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
1831559|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Death|5
1831560|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Death|4
1831561|NCT00343252|6345016|P2|18 Months (All Treated Participants)|Adverse Event|23
1831562|NCT00343252|6345017|P1|18 Months (All Treated Participants)|Adverse Event|31
1831563|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
1831564|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
1831565|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Sponsor Decision|6
1831566|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Sponsor Decision|9
1831567|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Protocol Violation|2
1831568|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Protocol Violation|3
1831569|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Physician Decision|5
1831570|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Physician Decision|4
1831571|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
1831572|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
1831573|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
1831574|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
1831575|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1831576|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
1831577|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Death|3
1831578|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Death|3
1831579|NCT00343252|6345016|P2|12 Months (All Treated Participants)|Adverse Event|20
1831580|NCT00343252|6345017|P1|12 Months (All Treated Participants)|Adverse Event|22
1831581|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
1831582|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
1831583|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Sponsor Decision|4
1831584|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Sponsor Decision|7
1831585|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Protocol Violation|2
1831586|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Protocol Violation|2
1831587|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Physician Decision|3
1831588|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Physician Decision|1
1831589|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
1831590|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
1831591|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
1831592|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
1831593|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
1831594|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
1831595|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Death|2
1831596|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Death|0
1831597|NCT00343252|6345016|P2|6 Months (All Treated Participants)|Adverse Event|11
1831598|NCT00343252|6345017|P1|6 Months (All Treated Participants)|Adverse Event|17
1831599|NCT00342628|6345082|P3|Overall Study|moved residence|1
1831600|NCT00342628|6345083|P2|Overall Study|moved residence|1
1831601|NCT00342628|6345084|P1|Overall Study|moved residence|0
1831602|NCT00342628|6345082|P3|Overall Study|Death|0
1831603|NCT00342628|6345083|P2|Overall Study|Death|1
1831604|NCT00342628|6345084|P1|Overall Study|Death|1
1831605|NCT00342628|6345082|P3|Overall Study|Withdrawal by Subject|18
1831606|NCT00342628|6345083|P2|Overall Study|Withdrawal by Subject|19
1831607|NCT00342628|6345084|P1|Overall Study|Withdrawal by Subject|19
1831608|NCT00340834|6345150|P5|Extension Phase of Study|Death|1
1831609|NCT00340834|6345151|P4|Extension Phase of Study|Death|0
1831610|NCT00340834|6345152|P3|Extension Phase of Study|Death|0
1831611|NCT00340834|6345153|P2|Extension Phase of Study|Death|0
1831612|NCT00340834|6345154|P1|Extension Phase of Study|Death|0
1831613|NCT00340834|6345150|P5|Extension Phase of Study|Protocol Violation|0
1831614|NCT00340834|6345151|P4|Extension Phase of Study|Protocol Violation|0
1831615|NCT00340834|6345152|P3|Extension Phase of Study|Protocol Violation|0
1831616|NCT00340834|6345153|P2|Extension Phase of Study|Protocol Violation|0
1831617|NCT00340834|6345154|P1|Extension Phase of Study|Protocol Violation|3
1831618|NCT00340834|6345150|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
1831619|NCT00340834|6345151|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
1831620|NCT00340834|6345152|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
1831621|NCT00340834|6345153|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
1831622|NCT00340834|6345154|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
1831623|NCT00340834|6345150|P5|Extension Phase of Study|Administrative problems|1
1831624|NCT00340834|6345151|P4|Extension Phase of Study|Administrative problems|1
1831625|NCT00340834|6345152|P3|Extension Phase of Study|Administrative problems|0
1831626|NCT00340834|6345153|P2|Extension Phase of Study|Administrative problems|0
1831627|NCT00340834|6345154|P1|Extension Phase of Study|Administrative problems|3
1831628|NCT00340834|6345150|P5|Extension Phase of Study|Subject no longer requires study drug|2
1831629|NCT00340834|6345151|P4|Extension Phase of Study|Subject no longer requires study drug|0
1831630|NCT00340834|6345152|P3|Extension Phase of Study|Subject no longer requires study drug|0
1831631|NCT00340834|6345153|P2|Extension Phase of Study|Subject no longer requires study drug|0
1831632|NCT00340834|6345154|P1|Extension Phase of Study|Subject no longer requires study drug|4
1831633|NCT00340834|6345150|P5|Extension Phase of Study|Lost to Follow-up|3
1831634|NCT00340834|6345151|P4|Extension Phase of Study|Lost to Follow-up|2
1831635|NCT00340834|6345152|P3|Extension Phase of Study|Lost to Follow-up|0
1831636|NCT00340834|6345153|P2|Extension Phase of Study|Lost to Follow-up|1
1831637|NCT00340834|6345154|P1|Extension Phase of Study|Lost to Follow-up|1
1831638|NCT00340834|6345150|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
1831639|NCT00340834|6345151|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
1831640|NCT00340834|6345152|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
1831641|NCT00340834|6345153|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
1831642|NCT00340834|6345154|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
1831643|NCT00340834|6345150|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
1831644|NCT00340834|6345151|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
1831645|NCT00340834|6345152|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
1831646|NCT00340834|6345153|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
1831647|NCT00340834|6345154|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
1831648|NCT00340834|6345150|P5|Extension Phase of Study|Adverse Event|7
1831649|NCT00340834|6345151|P4|Extension Phase of Study|Adverse Event|19
1831650|NCT00340834|6345152|P3|Extension Phase of Study|Adverse Event|0
1831651|NCT00340834|6345153|P2|Extension Phase of Study|Adverse Event|22
1831652|NCT00340834|6345154|P1|Extension Phase of Study|Adverse Event|21
1831653|NCT00340834|6345150|P5|Extension Phase of Study|Subject withdrew consent|15
1831654|NCT00340834|6345151|P4|Extension Phase of Study|Subject withdrew consent|12
1831655|NCT00340834|6345152|P3|Extension Phase of Study|Subject withdrew consent|0
1831656|NCT00340834|6345153|P2|Extension Phase of Study|Subject withdrew consent|31
1831657|NCT00340834|6345154|P1|Extension Phase of Study|Subject withdrew consent|26
1831658|NCT00340834|6345150|P5|Extension Phase of Study|Subject did not receive study drug|0
1831659|NCT00340834|6345151|P4|Extension Phase of Study|Subject did not receive study drug|2
1831660|NCT00340834|6345152|P3|Extension Phase of Study|Subject did not receive study drug|0
1831661|NCT00340834|6345153|P2|Extension Phase of Study|Subject did not receive study drug|1
1831662|NCT00340834|6345154|P1|Extension Phase of Study|Subject did not receive study drug|0
1831663|NCT00340834|6345150|P5|Core Phase of Study|Protocol Violation|0
1831664|NCT00340834|6345151|P4|Core Phase of Study|Protocol Violation|0
1831665|NCT00340834|6345152|P3|Core Phase of Study|Protocol Violation|2
1831666|NCT00340834|6345153|P2|Core Phase of Study|Protocol Violation|0
1831667|NCT00340834|6345154|P1|Core Phase of Study|Protocol Violation|0
1831668|NCT00340834|6345150|P5|Core Phase of Study|Death|0
1831669|NCT00340834|6345151|P4|Core Phase of Study|Death|0
1831670|NCT00340834|6345152|P3|Core Phase of Study|Death|0
1831671|NCT00340834|6345153|P2|Core Phase of Study|Death|0
1831672|NCT00340834|6345154|P1|Core Phase of Study|Death|2
1831673|NCT00340834|6345150|P5|Core Phase of Study|Lost to Follow-up|0
1831674|NCT00340834|6345151|P4|Core Phase of Study|Lost to Follow-up|0
1831675|NCT00340834|6345152|P3|Core Phase of Study|Lost to Follow-up|4
1831676|NCT00340834|6345153|P2|Core Phase of Study|Lost to Follow-up|1
1831677|NCT00340834|6345154|P1|Core Phase of Study|Lost to Follow-up|1
1831678|NCT00340834|6345150|P5|Core Phase of Study|Abnormal test procedure result(s)|0
1831679|NCT00340834|6345151|P4|Core Phase of Study|Abnormal test procedure result(s)|0
1831680|NCT00340834|6345152|P3|Core Phase of Study|Abnormal test procedure result(s)|3
1831681|NCT00340834|6345153|P2|Core Phase of Study|Abnormal test procedure result(s)|3
1831682|NCT00340834|6345154|P1|Core Phase of Study|Abnormal test procedure result(s)|4
1831683|NCT00340834|6345150|P5|Core Phase of Study|Abnormal laboratory value(s)|0
1831684|NCT00340834|6345151|P4|Core Phase of Study|Abnormal laboratory value(s)|0
1831685|NCT00340834|6345152|P3|Core Phase of Study|Abnormal laboratory value(s)|1
1831686|NCT00340834|6345153|P2|Core Phase of Study|Abnormal laboratory value(s)|6
1831687|NCT00340834|6345154|P1|Core Phase of Study|Abnormal laboratory value(s)|4
1831688|NCT00340834|6345150|P5|Core Phase of Study|Lack of Efficacy|0
1831689|NCT00340834|6345151|P4|Core Phase of Study|Lack of Efficacy|0
1831690|NCT00340834|6345152|P3|Core Phase of Study|Lack of Efficacy|7
1831691|NCT00340834|6345153|P2|Core Phase of Study|Lack of Efficacy|3
1831692|NCT00340834|6345154|P1|Core Phase of Study|Lack of Efficacy|3
1831693|NCT00340834|6345150|P5|Core Phase of Study|Administrative Problems|0
1831694|NCT00340834|6345151|P4|Core Phase of Study|Administrative Problems|0
1831695|NCT00340834|6345152|P3|Core Phase of Study|Administrative Problems|7
1831696|NCT00340834|6345153|P2|Core Phase of Study|Administrative Problems|2
1831697|NCT00340834|6345154|P1|Core Phase of Study|Administrative Problems|6
1831698|NCT00340834|6345150|P5|Core Phase of Study|Withdrawal by Subject|0
1831699|NCT00340834|6345151|P4|Core Phase of Study|Withdrawal by Subject|0
1831700|NCT00340834|6345152|P3|Core Phase of Study|Withdrawal by Subject|16
1831701|NCT00340834|6345153|P2|Core Phase of Study|Withdrawal by Subject|9
1831702|NCT00340834|6345154|P1|Core Phase of Study|Withdrawal by Subject|11
1831703|NCT00340834|6345150|P5|Core Phase of Study|Adverse Event|0
1831704|NCT00340834|6345151|P4|Core Phase of Study|Adverse Event|0
1831705|NCT00340834|6345152|P3|Core Phase of Study|Adverse Event|9
1831706|NCT00340834|6345153|P2|Core Phase of Study|Adverse Event|9
1831707|NCT00340834|6345154|P1|Core Phase of Study|Adverse Event|26
1831708|NCT00340704|6345188|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
1831709|NCT00340704|6345189|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
1831710|NCT00340704|6345190|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
1831711|NCT00340704|6345191|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
1831712|NCT00340704|6345192|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1831713|NCT00340704|6345193|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1831714|NCT00340704|6345194|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1831715|NCT00340704|6345195|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1831716|NCT00340704|6345196|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
1831717|NCT00340704|6345188|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1831718|NCT00340704|6345189|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1831719|NCT00340704|6345190|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1831720|NCT00340704|6345191|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
1831721|NCT00340704|6345192|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
1831722|NCT00340704|6345193|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1831723|NCT00340704|6345194|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1831724|NCT00340704|6345195|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1831725|NCT00340704|6345196|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
1831726|NCT00340704|6345188|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831727|NCT00340704|6345189|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831728|NCT00340704|6345190|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831729|NCT00340704|6345191|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
1831730|NCT00340704|6345192|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831731|NCT00340704|6345193|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831732|NCT00340704|6345194|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831733|NCT00340704|6345195|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831734|NCT00340704|6345196|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
1831735|NCT00340704|6345188|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1831736|NCT00340704|6345189|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
1831737|NCT00340704|6345190|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1831738|NCT00340704|6345191|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1831739|NCT00340704|6345192|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
1831740|NCT00340704|6345193|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
1831741|NCT00340704|6345194|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1831742|NCT00340704|6345195|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1831743|NCT00340704|6345196|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
1831744|NCT00340704|6345188|P9|PK Study|Not treated|0
1831745|NCT00340704|6345189|P8|PK Study|Not treated|0
1831746|NCT00340704|6345190|P7|PK Study|Not treated|0
1831747|NCT00340704|6345191|P6|PK Study|Not treated|0
1831748|NCT00340704|6345192|P5|PK Study|Not treated|0
1831749|NCT00340704|6345193|P4|PK Study|Not treated|0
1831750|NCT00340704|6345194|P3|PK Study|Not treated|1
1831751|NCT00340704|6345195|P2|PK Study|Not treated|0
1831752|NCT00340704|6345196|P1|PK Study|Not treated|0
1831753|NCT00340704|6345188|P9|PK Study|Adverse Event|0
1831754|NCT00340704|6345189|P8|PK Study|Adverse Event|0
1831755|NCT00340704|6345190|P7|PK Study|Adverse Event|0
1831756|NCT00340704|6345191|P6|PK Study|Adverse Event|0
1831757|NCT00340704|6345192|P5|PK Study|Adverse Event|0
1831758|NCT00340704|6345193|P4|PK Study|Adverse Event|0
1831759|NCT00340704|6345194|P3|PK Study|Adverse Event|0
1831760|NCT00340704|6345195|P2|PK Study|Adverse Event|1
1831761|NCT00340704|6345196|P1|PK Study|Adverse Event|0
1831762|NCT00340678|6345302|P4|Overall Study|Lost to Follow-up|0
1831763|NCT00340678|6345303|P3|Overall Study|Lost to Follow-up|0
1831764|NCT00340678|6345304|P2|Overall Study|Lost to Follow-up|0
1831765|NCT00340678|6345305|P1|Overall Study|Lost to Follow-up|1
1831766|NCT00339833|6345332|P2|Overall Study|Error in data records|0
1831767|NCT00339833|6345333|P1|Overall Study|Error in data records|1
1831768|NCT00339833|6345332|P2|Overall Study|anaemia or excess drop in glycaemia|0
1831769|NCT00339833|6345333|P1|Overall Study|anaemia or excess drop in glycaemia|2
1831770|NCT00339833|6345332|P2|Overall Study|Poor venous access|2
1831771|NCT00339833|6345333|P1|Overall Study|Poor venous access|2
1831772|NCT00339833|6345332|P2|Overall Study|minor infection|1
1831773|NCT00339833|6345333|P1|Overall Study|minor infection|0
1831774|NCT00339833|6345332|P2|Overall Study|Chest pain|1
1831775|NCT00339833|6345333|P1|Overall Study|Chest pain|0
1831776|NCT00339833|6345332|P2|Overall Study|indigestion|1
1831777|NCT00339833|6345333|P1|Overall Study|indigestion|0
1831778|NCT00339833|6345332|P2|Overall Study|toothache|1
1831779|NCT00339833|6345333|P1|Overall Study|toothache|0
1831780|NCT00339833|6345332|P2|Overall Study|Withdrawal by Subject|2
1831781|NCT00339833|6345333|P1|Overall Study|Withdrawal by Subject|1
1831782|NCT00339183|6345343|P2|Overall Study|Ongoing|13
1831783|NCT00339183|6345344|P1|Overall Study|Ongoing|20
1831784|NCT00339183|6345343|P2|Overall Study|Other|40
1831785|NCT00339183|6345344|P1|Overall Study|Other|46
1831786|NCT00339183|6345343|P2|Overall Study|Missing reason|1
1831787|NCT00339183|6345344|P1|Overall Study|Missing reason|3
1831788|NCT00339183|6345343|P2|Overall Study|Protocol-specified criteria|8
1831789|NCT00339183|6345344|P1|Overall Study|Protocol-specified criteria|12
1831790|NCT00339183|6345343|P2|Overall Study|Lost to Follow-up|17
1831791|NCT00339183|6345344|P1|Overall Study|Lost to Follow-up|17
1831792|NCT00339183|6345343|P2|Overall Study|Physician Decision|4
1831793|NCT00339183|6345344|P1|Overall Study|Physician Decision|2
1831794|NCT00339183|6345343|P2|Overall Study|Withdrawal by Subject|19
1831795|NCT00339183|6345344|P1|Overall Study|Withdrawal by Subject|16
1831796|NCT00339183|6345343|P2|Overall Study|Adverse Event|3
1831797|NCT00339183|6345344|P1|Overall Study|Adverse Event|5
1831798|NCT00339144|6345373|P3|Overall Study|Participant's request to discontinuation|1
1831799|NCT00339144|6345374|P2|Overall Study|Participant's request to discontinuation|0
1831800|NCT00339144|6345375|P1|Overall Study|Participant's request to discontinuation|1
1831801|NCT00339144|6345373|P3|Overall Study|Study drug toxicity|1
1831802|NCT00339144|6345374|P2|Overall Study|Study drug toxicity|1
1831803|NCT00339144|6345375|P1|Overall Study|Study drug toxicity|3
1831804|NCT00339144|6345373|P3|Overall Study|Disease progression|2
1831805|NCT00339144|6345374|P2|Overall Study|Disease progression|2
1831806|NCT00339144|6345375|P1|Overall Study|Disease progression|5
1831807|NCT00339040|6345480|P2|Stage II|Site closing|0
1831808|NCT00339040|6345481|P1|Stage II|Site closing|2
1831809|NCT00339040|6345480|P2|Stage II|Not able to attend clinic|0
1831810|NCT00339040|6345481|P1|Stage II|Not able to attend clinic|1
1831811|NCT00339040|6345480|P2|Stage II|Protocol Violation|0
1831812|NCT00339040|6345481|P1|Stage II|Protocol Violation|3
1831813|NCT00339040|6345480|P2|Stage II|Withdrawal by Subject|2
1831814|NCT00339040|6345481|P1|Stage II|Withdrawal by Subject|1
1831815|NCT00339040|6345480|P2|Stage II|Lost to Follow-up|0
1831816|NCT00339040|6345481|P1|Stage II|Lost to Follow-up|3
1831817|NCT00339040|6345480|P2|Stage I|Protocol Violation|1
1831818|NCT00339040|6345481|P1|Stage I|Protocol Violation|1
1831819|NCT00339040|6345480|P2|Stage I|Not able to attend clinic|0
1831820|NCT00339040|6345481|P1|Stage I|Not able to attend clinic|1
1831821|NCT00338962|6345508|P4|Overall Study|Poor Compliance|0
1831822|NCT00338962|6345509|P3|Overall Study|Poor Compliance|2
1831823|NCT00338962|6345510|P2|Overall Study|Poor Compliance|0
1831824|NCT00338962|6345511|P1|Overall Study|Poor Compliance|0
1831825|NCT00338962|6345508|P4|Overall Study|Adverse Event|0
1831826|NCT00338962|6345509|P3|Overall Study|Adverse Event|2
1831827|NCT00338962|6345510|P2|Overall Study|Adverse Event|0
1831828|NCT00338962|6345511|P1|Overall Study|Adverse Event|0
1831829|NCT00338962|6345508|P4|Overall Study|Moved|0
1831830|NCT00338962|6345509|P3|Overall Study|Moved|0
1831831|NCT00338962|6345510|P2|Overall Study|Moved|1
1831832|NCT00338962|6345511|P1|Overall Study|Moved|0
1831833|NCT00338962|6345508|P4|Overall Study|Time Constraint|0
1831834|NCT00338962|6345509|P3|Overall Study|Time Constraint|0
1831835|NCT00338962|6345510|P2|Overall Study|Time Constraint|0
1831836|NCT00338962|6345511|P1|Overall Study|Time Constraint|2
1831837|NCT00338962|6345508|P4|Overall Study|No Transportation|0
1831838|NCT00338962|6345509|P3|Overall Study|No Transportation|0
1831839|NCT00338962|6345510|P2|Overall Study|No Transportation|0
1831840|NCT00338962|6345511|P1|Overall Study|No Transportation|2
1831841|NCT00338962|6345508|P4|Overall Study|Withdrawal by Subject|0
1831842|NCT00338962|6345509|P3|Overall Study|Withdrawal by Subject|0
1831843|NCT00338962|6345510|P2|Overall Study|Withdrawal by Subject|0
1831844|NCT00338962|6345511|P1|Overall Study|Withdrawal by Subject|1
1831845|NCT00338962|6345508|P4|Overall Study|Lost to Follow-up|3
1831846|NCT00338962|6345509|P3|Overall Study|Lost to Follow-up|2
1831847|NCT00338962|6345510|P2|Overall Study|Lost to Follow-up|3
1831848|NCT00338962|6345511|P1|Overall Study|Lost to Follow-up|3
1831849|NCT00338884|6345533|P1|Overall Study|Randomized But Did Not Receive Treatment|1
1831850|NCT00338884|6345533|P1|Overall Study|Lost to Follow-up|1
1831851|NCT00338884|6345533|P1|Overall Study|Withdrawal by Subject|3
1831852|NCT00338884|6345533|P1|Overall Study|Global Deterioration of Health Status|3
1831853|NCT00338884|6345533|P1|Overall Study|Other|4
1831854|NCT00338884|6345533|P1|Overall Study|Death|8
1831855|NCT00338884|6345533|P1|Overall Study|Adverse Event|14
1831856|NCT00338884|6345533|P1|Overall Study|Objective Disease Progression or Relapse|44
1831857|NCT00338806|6345567|P2|Follow-up|Lost to Follow-up|3
1831858|NCT00338806|6345568|P1|Follow-up|Lost to Follow-up|1
1831859|NCT00338806|6345567|P2|Acute Phase|Withdrawal by Subject|1
1831860|NCT00338806|6345568|P1|Acute Phase|Withdrawal by Subject|0
1831861|NCT00338741|6345630|P2|Overall Study|Lost to Follow-up|0
1831862|NCT00338741|6345631|P1|Overall Study|Lost to Follow-up|2
1831863|NCT00338728|6345639|P1|Overall Study|Screen Failure|14
1831864|NCT00338455|6345667|P2|Overall Study|Physician Decision|0
1831865|NCT00338455|6345668|P1|Overall Study|Physician Decision|1
1831866|NCT00338455|6345667|P2|Overall Study|Death|1
1831867|NCT00338455|6345668|P1|Overall Study|Death|2
1831868|NCT00338286|6345682|P2|Overall Study|Other|93
1831869|NCT00338286|6345683|P1|Overall Study|Other|103
1831870|NCT00338286|6345682|P2|Overall Study|Lost to Follow-up|66
1831871|NCT00338286|6345683|P1|Overall Study|Lost to Follow-up|80
1831872|NCT00338286|6345682|P2|Overall Study|Withdrawal by Subject|54
1831873|NCT00338286|6345683|P1|Overall Study|Withdrawal by Subject|50
1831874|NCT00338104|6345700|P3|Overall Study|Protocol Violation|3
1831875|NCT00338104|6345701|P2|Overall Study|Protocol Violation|1
1831876|NCT00338104|6345702|P1|Overall Study|Protocol Violation|2
1831877|NCT00337935|6345725|P2|Overall Study|Lack of Efficacy|1
1831878|NCT00337935|6345726|P1|Overall Study|Lack of Efficacy|0
1831879|NCT00337935|6345725|P2|Overall Study|Other|1
1831880|NCT00337935|6345726|P1|Overall Study|Other|0
1831881|NCT00337935|6345725|P2|Overall Study|Withdrawal by Subject|7
1831882|NCT00337935|6345726|P1|Overall Study|Withdrawal by Subject|1
1831883|NCT00337935|6345725|P2|Overall Study|Protocol Violation|3
1831884|NCT00337935|6345726|P1|Overall Study|Protocol Violation|4
1831885|NCT00337935|6345725|P2|Overall Study|Lost to Follow-up|1
1831886|NCT00337935|6345726|P1|Overall Study|Lost to Follow-up|0
1831887|NCT00337935|6345725|P2|Overall Study|Physician Decision|1
1831888|NCT00337935|6345726|P1|Overall Study|Physician Decision|1
1831889|NCT00337935|6345725|P2|Overall Study|Death|8
1831890|NCT00337935|6345726|P1|Overall Study|Death|2
1831891|NCT00337935|6345725|P2|Overall Study|Adverse Event|5
1831892|NCT00337935|6345726|P1|Overall Study|Adverse Event|2
1831893|NCT00337818|6345739|P3|Overall Study|Lost to Follow-up|107
1831894|NCT00337818|6345740|P2|Overall Study|Lost to Follow-up|91
1831895|NCT00337818|6345741|P1|Overall Study|Lost to Follow-up|289
1831896|NCT00337779|6345763|P2|Overall Study|Death|1
1831897|NCT00337779|6345764|P1|Overall Study|Death|0
1831898|NCT00337779|6345763|P2|Overall Study|Pregnancy|2
1831899|NCT00337779|6345764|P1|Overall Study|Pregnancy|3
1831900|NCT00337779|6345763|P2|Overall Study|Adverse Event|51
1831901|NCT00337779|6345764|P1|Overall Study|Adverse Event|28
1831902|NCT00337779|6345763|P2|Overall Study|Lost to Follow-up|5
1831903|NCT00337779|6345764|P1|Overall Study|Lost to Follow-up|6
1831904|NCT00337779|6345763|P2|Overall Study|Protocol Violation|1
1831905|NCT00337779|6345764|P1|Overall Study|Protocol Violation|1
1831906|NCT00337779|6345763|P2|Overall Study|Physician Decision|6
1831907|NCT00337779|6345764|P1|Overall Study|Physician Decision|3
1831908|NCT00337779|6345763|P2|Overall Study|Sponsor decision|1
1831909|NCT00337779|6345764|P1|Overall Study|Sponsor decision|1
1831910|NCT00337779|6345763|P2|Overall Study|Withdrawal by Subject|12
1831911|NCT00337779|6345764|P1|Overall Study|Withdrawal by Subject|10
1831912|NCT00337727|6345776|P2|Overall Study|Withdrawal by Subject|5
1831913|NCT00337727|6345777|P1|Overall Study|Withdrawal by Subject|3
1831914|NCT00337727|6345776|P2|Overall Study|Protocol Violation|0
1831915|NCT00337727|6345777|P1|Overall Study|Protocol Violation|4
1831916|NCT00337727|6345776|P2|Overall Study|Physician Decision|0
1831917|NCT00337727|6345777|P1|Overall Study|Physician Decision|1
1831918|NCT00337727|6345776|P2|Overall Study|Lost to Follow-up|4
1831919|NCT00337727|6345777|P1|Overall Study|Lost to Follow-up|5
1831920|NCT00337727|6345776|P2|Overall Study|Adverse Event|3
1831921|NCT00337727|6345777|P1|Overall Study|Adverse Event|5
1831922|NCT00337675|6345788|P3|Overall Study|Trial Terminated|2
1831923|NCT00337675|6345789|P2|Overall Study|Trial Terminated|0
1831924|NCT00337675|6345790|P1|Overall Study|Trial Terminated|0
1831925|NCT00337675|6345788|P3|Overall Study|Progressive Disease|0
1831926|NCT00337675|6345789|P2|Overall Study|Progressive Disease|2
1831927|NCT00337675|6345790|P1|Overall Study|Progressive Disease|0
1831928|NCT00337675|6345788|P3|Overall Study|Withdrawal by Subject|19
1831929|NCT00337675|6345789|P2|Overall Study|Withdrawal by Subject|25
1831930|NCT00337675|6345790|P1|Overall Study|Withdrawal by Subject|25
1831931|NCT00337675|6345788|P3|Overall Study|Protocol Violation|19
1831932|NCT00337675|6345789|P2|Overall Study|Protocol Violation|24
1831933|NCT00337675|6345790|P1|Overall Study|Protocol Violation|21
1831934|NCT00337675|6345788|P3|Overall Study|Physician Decision|14
1831935|NCT00337675|6345789|P2|Overall Study|Physician Decision|17
1831936|NCT00337675|6345790|P1|Overall Study|Physician Decision|9
1831937|NCT00337675|6345788|P3|Overall Study|Lost to Follow-up|17
1831938|NCT00337675|6345789|P2|Overall Study|Lost to Follow-up|19
1831939|NCT00337675|6345790|P1|Overall Study|Lost to Follow-up|22
1831940|NCT00337675|6345788|P3|Overall Study|Lack of Efficacy|9
1831941|NCT00337675|6345789|P2|Overall Study|Lack of Efficacy|7
1831942|NCT00337675|6345790|P1|Overall Study|Lack of Efficacy|10
1831943|NCT00337675|6345788|P3|Overall Study|Adverse Event|19
1831944|NCT00337675|6345789|P2|Overall Study|Adverse Event|9
1831945|NCT00337675|6345790|P1|Overall Study|Adverse Event|10
1831946|NCT00337662|6345807|P4|Study Period III|Clinical Relapse|0
1831947|NCT00337662|6345808|P3|Study Period III|Clinical Relapse|0
1831948|NCT00337662|6345809|P2|Study Period III|Clinical Relapse|0
1831949|NCT00337662|6345810|P1|Study Period III|Clinical Relapse|1
1831950|NCT00337662|6345807|P4|Study Period III|Sponsor Decision|0
1831951|NCT00337662|6345808|P3|Study Period III|Sponsor Decision|1
1831952|NCT00337662|6345809|P2|Study Period III|Sponsor Decision|0
1831953|NCT00337662|6345810|P1|Study Period III|Sponsor Decision|1
1831954|NCT00337662|6345807|P4|Study Period III|Parent/Caregiver Decision|0
1831955|NCT00337662|6345808|P3|Study Period III|Parent/Caregiver Decision|2
1831956|NCT00337662|6345809|P2|Study Period III|Parent/Caregiver Decision|0
1831957|NCT00337662|6345810|P1|Study Period III|Parent/Caregiver Decision|0
1831958|NCT00337662|6345807|P4|Study Period III|Lack of Efficacy|0
1831959|NCT00337662|6345808|P3|Study Period III|Lack of Efficacy|2
1831960|NCT00337662|6345809|P2|Study Period III|Lack of Efficacy|4
1831961|NCT00337662|6345810|P1|Study Period III|Lack of Efficacy|4
1831962|NCT00337662|6345807|P4|Study Period III|Entry Criteria Not Met|0
1831963|NCT00337662|6345808|P3|Study Period III|Entry Criteria Not Met|3
1831964|NCT00337662|6345809|P2|Study Period III|Entry Criteria Not Met|1
1831965|NCT00337662|6345810|P1|Study Period III|Entry Criteria Not Met|4
1831966|NCT00337662|6345807|P4|Study Period III|Physician Decision|0
1831967|NCT00337662|6345808|P3|Study Period III|Physician Decision|0
1831968|NCT00337662|6345809|P2|Study Period III|Physician Decision|5
1831969|NCT00337662|6345810|P1|Study Period III|Physician Decision|6
1831970|NCT00337662|6345807|P4|Study Period III|Protocol Violation|0
1831971|NCT00337662|6345808|P3|Study Period III|Protocol Violation|2
1831972|NCT00337662|6345809|P2|Study Period III|Protocol Violation|8
1831973|NCT00337662|6345810|P1|Study Period III|Protocol Violation|3
1831974|NCT00337662|6345807|P4|Study Period III|Adverse Event|0
1831975|NCT00337662|6345808|P3|Study Period III|Adverse Event|8
1831976|NCT00337662|6345809|P2|Study Period III|Adverse Event|10
1831977|NCT00337662|6345810|P1|Study Period III|Adverse Event|9
1831978|NCT00337662|6345807|P4|Study Period III|Withdrawal by Subject|0
1831979|NCT00337662|6345808|P3|Study Period III|Withdrawal by Subject|12
1831980|NCT00337662|6345809|P2|Study Period III|Withdrawal by Subject|14
1831981|NCT00337662|6345810|P1|Study Period III|Withdrawal by Subject|18
1831982|NCT00337662|6345807|P4|Study Period III|Lost to Follow-up|0
1831983|NCT00337662|6345808|P3|Study Period III|Lost to Follow-up|14
1831984|NCT00337662|6345809|P2|Study Period III|Lost to Follow-up|16
1831985|NCT00337662|6345810|P1|Study Period III|Lost to Follow-up|14
1831986|NCT00337662|6345807|P4|Study Period II|Parent/Caregiver Decision|1
1831987|NCT00337662|6345808|P3|Study Period II|Parent/Caregiver Decision|0
1831988|NCT00337662|6345809|P2|Study Period II|Parent/Caregiver Decision|0
1831989|NCT00337662|6345810|P1|Study Period II|Parent/Caregiver Decision|0
1831990|NCT00337662|6345807|P4|Study Period II|Sponsor Decision|2
1831991|NCT00337662|6345808|P3|Study Period II|Sponsor Decision|0
1831992|NCT00337662|6345809|P2|Study Period II|Sponsor Decision|0
1831993|NCT00337662|6345810|P1|Study Period II|Sponsor Decision|0
1831994|NCT00337662|6345807|P4|Study Period II|Lack of Efficacy|7
1831995|NCT00337662|6345808|P3|Study Period II|Lack of Efficacy|0
1831996|NCT00337662|6345809|P2|Study Period II|Lack of Efficacy|0
1831997|NCT00337662|6345810|P1|Study Period II|Lack of Efficacy|0
1831998|NCT00337662|6345807|P4|Study Period II|Protocol Violation|6
1831999|NCT00337662|6345808|P3|Study Period II|Protocol Violation|0
1832000|NCT00337662|6345809|P2|Study Period II|Protocol Violation|0
1832001|NCT00337662|6345810|P1|Study Period II|Protocol Violation|0
1832002|NCT00337662|6345807|P4|Study Period II|Entry Criteria Not Met|6
1832003|NCT00337662|6345808|P3|Study Period II|Entry Criteria Not Met|0
1832004|NCT00337662|6345809|P2|Study Period II|Entry Criteria Not Met|0
1832005|NCT00337662|6345810|P1|Study Period II|Entry Criteria Not Met|0
1832006|NCT00337662|6345807|P4|Study Period II|Physician Decision|13
1832007|NCT00337662|6345808|P3|Study Period II|Physician Decision|0
1832008|NCT00337662|6345809|P2|Study Period II|Physician Decision|0
1832009|NCT00337662|6345810|P1|Study Period II|Physician Decision|0
1832010|NCT00337662|6345807|P4|Study Period II|Adverse Event|16
1832011|NCT00337662|6345808|P3|Study Period II|Adverse Event|0
1832012|NCT00337662|6345809|P2|Study Period II|Adverse Event|0
1832013|NCT00337662|6345810|P1|Study Period II|Adverse Event|0
1832014|NCT00337662|6345807|P4|Study Period II|Withdrawal by Subject|20
1832015|NCT00337662|6345808|P3|Study Period II|Withdrawal by Subject|0
1832016|NCT00337662|6345809|P2|Study Period II|Withdrawal by Subject|0
1832017|NCT00337662|6345810|P1|Study Period II|Withdrawal by Subject|0
1832018|NCT00337662|6345807|P4|Study Period II|Lost to Follow-up|35
1832019|NCT00337662|6345808|P3|Study Period II|Lost to Follow-up|0
1832020|NCT00337662|6345809|P2|Study Period II|Lost to Follow-up|0
1832021|NCT00337662|6345810|P1|Study Period II|Lost to Follow-up|0
1832022|NCT00337610|6345864|P2|Overall Study|Withdrawal by Subject|5
1832023|NCT00337610|6345865|P1|Overall Study|Withdrawal by Subject|6
1832024|NCT00337610|6345864|P2|Overall Study|Lost to Follow-up|3
1832025|NCT00337610|6345865|P1|Overall Study|Lost to Follow-up|3
1832026|NCT00337610|6345864|P2|Overall Study|Lack of Efficacy|3
1832027|NCT00337610|6345865|P1|Overall Study|Lack of Efficacy|6
1832028|NCT00337610|6345864|P2|Overall Study|Death|1
1832029|NCT00337610|6345865|P1|Overall Study|Death|0
1832030|NCT00337610|6345864|P2|Overall Study|Adverse Event|2
1832031|NCT00337610|6345865|P1|Overall Study|Adverse Event|2
1832032|NCT00337571|6345881|P4|Overall Study|High Potassium level|1
1832033|NCT00337571|6345882|P3|Overall Study|High Potassium level|0
1832034|NCT00337571|6345883|P2|Overall Study|High Potassium level|0
1832035|NCT00337571|6345884|P1|Overall Study|High Potassium level|0
1832036|NCT00337571|6345881|P4|Overall Study|No longer met study criteria|0
1832037|NCT00337571|6345882|P3|Overall Study|No longer met study criteria|0
1832038|NCT00337571|6345883|P2|Overall Study|No longer met study criteria|0
1832039|NCT00337571|6345884|P1|Overall Study|No longer met study criteria|1
1832040|NCT00337571|6345881|P4|Overall Study|Poor/noncompliance|1
1832041|NCT00337571|6345882|P3|Overall Study|Poor/noncompliance|1
1832042|NCT00337571|6345883|P2|Overall Study|Poor/noncompliance|1
1832043|NCT00337571|6345884|P1|Overall Study|Poor/noncompliance|1
1832044|NCT00337571|6345881|P4|Overall Study|Lost to Follow-up|1
1832045|NCT00337571|6345882|P3|Overall Study|Lost to Follow-up|0
1832046|NCT00337571|6345883|P2|Overall Study|Lost to Follow-up|1
1832047|NCT00337571|6345884|P1|Overall Study|Lost to Follow-up|3
1832048|NCT00337571|6345881|P4|Overall Study|Withdrawal by Subject|0
1832049|NCT00337571|6345882|P3|Overall Study|Withdrawal by Subject|1
1832050|NCT00337571|6345883|P2|Overall Study|Withdrawal by Subject|2
1832051|NCT00337571|6345884|P1|Overall Study|Withdrawal by Subject|2
1832052|NCT00337571|6345881|P4|Overall Study|Adverse Event|4
1832053|NCT00337571|6345882|P3|Overall Study|Adverse Event|8
1832054|NCT00337571|6345883|P2|Overall Study|Adverse Event|5
1832055|NCT00337571|6345884|P1|Overall Study|Adverse Event|4
1832056|NCT00337571|6345881|P4|Overall Study|Lack of Efficacy|0
1832057|NCT00337571|6345882|P3|Overall Study|Lack of Efficacy|0
1832058|NCT00337571|6345883|P2|Overall Study|Lack of Efficacy|0
1832059|NCT00337571|6345884|P1|Overall Study|Lack of Efficacy|3
1832060|NCT00337467|6345922|P1|Overall Study|Subject No Longer Met Study Criteria|2
1832061|NCT00337467|6345922|P1|Overall Study|Lost to Follow-up|2
1832062|NCT00337467|6345922|P1|Overall Study|Pregnancy|1
1832063|NCT00337467|6345922|P1|Overall Study|Subject Withdrew Consent|2
1832064|NCT00337467|6345922|P1|Overall Study|Adverse Event|3
1832065|NCT00337428|6345941|P2|Overall Study|Anorexia|0
1832066|NCT00337428|6345942|P1|Overall Study|Anorexia|1
1832067|NCT00337428|6345941|P2|Overall Study|Unwilling to Continue|0
1832068|NCT00337428|6345942|P1|Overall Study|Unwilling to Continue|1
1832069|NCT00337428|6345941|P2|Overall Study|Lack of Time|1
1832070|NCT00337428|6345942|P1|Overall Study|Lack of Time|1
1832071|NCT00337428|6345941|P2|Overall Study|Withdrawal by Subject|2
1832072|NCT00337428|6345942|P1|Overall Study|Withdrawal by Subject|1
1832073|NCT00337285|6345993|P1|Overall Study|Lack of protocol compliance|7
1832074|NCT00337285|6345993|P1|Overall Study|Physician Decision|1
1832075|NCT00337285|6345993|P1|Overall Study|Death|1
1832076|NCT00337285|6345993|P1|Overall Study|Lack of Efficacy|11
1832077|NCT00337285|6345993|P1|Overall Study|Protocol Violation|27
1832078|NCT00337285|6345993|P1|Overall Study|Adverse Event|28
1832079|NCT00337285|6345993|P1|Overall Study|Lost to Follow-up|41
1832080|NCT00337285|6345993|P1|Overall Study|Withdrawal by Subject|42
1832081|NCT00337272|6346001|P2|Withdrawal Period|Non-compliance|1
1832082|NCT00337272|6346002|P1|Withdrawal Period|Non-compliance|0
1832083|NCT00337272|6346001|P2|Treatment Period|Withdrawal by Subject|1
1832084|NCT00337272|6346002|P1|Treatment Period|Withdrawal by Subject|0
1832085|NCT00337272|6346001|P2|Treatment Period|Non-compliance|1
1832086|NCT00337272|6346002|P1|Treatment Period|Non-compliance|1
1832087|NCT00337272|6346001|P2|Screening Period (Pre-randomization)|Screen failure|0
1832088|NCT00337272|6346002|P1|Screening Period (Pre-randomization)|Screen failure|3
1832089|NCT00337272|6346001|P2|Screening Period (Pre-randomization)|Non-compliance|0
1832090|NCT00337272|6346002|P1|Screening Period (Pre-randomization)|Non-compliance|1
1832091|NCT00337272|6346001|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
1832092|NCT00337272|6346002|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
1832093|NCT00337207|6346022|P1|Overall Study|Withdrawal by Subject|3
1832094|NCT00337194|6346030|P2|Overall Study|Subsequent non-protocol therapy|1
1832095|NCT00337194|6346031|P1|Overall Study|Subsequent non-protocol therapy|3
1832096|NCT00337194|6346030|P2|Overall Study|Disease progression|2
1832097|NCT00337194|6346031|P1|Overall Study|Disease progression|1
1832098|NCT00337194|6346030|P2|Overall Study|Withdrawal by Subject|0
1832099|NCT00337194|6346031|P1|Overall Study|Withdrawal by Subject|1
1832100|NCT00337194|6346030|P2|Overall Study|Death|0
1832101|NCT00337194|6346031|P1|Overall Study|Death|2
1832102|NCT00337194|6346030|P2|Overall Study|Adverse Event|1
1832103|NCT00337194|6346031|P1|Overall Study|Adverse Event|5
1832104|NCT00337168|6346055|P1|Overall Study|Did not start therapy|1
1832105|NCT00337168|6346055|P1|Overall Study|Not protocol specified|2
1832106|NCT00337168|6346055|P1|Overall Study|Death|5
1832107|NCT00337129|6346062|P1|Overall Study|not protocol specified|1
1832108|NCT00337129|6346062|P1|Overall Study|Death|2
1832109|NCT00337129|6346062|P1|Overall Study|Lack of Efficacy|32
1832110|NCT00337129|6346062|P1|Overall Study|Withdrawal by Subject|1
1832111|NCT00337129|6346062|P1|Overall Study|Adverse Event|4
1832112|NCT00337103|6346071|P2|Overall Study|Death|0
1832113|NCT00337103|6346072|P1|Overall Study|Death|1
1832114|NCT00337103|6346071|P2|Overall Study|Lost to Follow-up|2
1832115|NCT00337103|6346072|P1|Overall Study|Lost to Follow-up|1
1832116|NCT00337103|6346071|P2|Overall Study|Entry Criteria Not Met|1
1832117|NCT00337103|6346072|P1|Overall Study|Entry Criteria Not Met|4
1832118|NCT00337103|6346071|P2|Overall Study|Other|6
1832119|NCT00337103|6346072|P1|Overall Study|Other|5
1832120|NCT00337103|6346071|P2|Overall Study|Withdrawal by Subject|5
1832121|NCT00337103|6346072|P1|Overall Study|Withdrawal by Subject|8
1832122|NCT00337103|6346071|P2|Overall Study|Physician Decision|14
1832123|NCT00337103|6346072|P1|Overall Study|Physician Decision|15
1832124|NCT00337103|6346071|P2|Overall Study|Clinical Progression|24
1832125|NCT00337103|6346072|P1|Overall Study|Clinical Progression|27
1832126|NCT00337103|6346071|P2|Overall Study|Subject Choice|27
1832127|NCT00337103|6346072|P1|Overall Study|Subject Choice|34
1832128|NCT00337103|6346071|P2|Overall Study|Adverse Event|59
1832129|NCT00337103|6346072|P1|Overall Study|Adverse Event|45
1832130|NCT00337103|6346071|P2|Overall Study|Progressive Disease|405
1832131|NCT00337103|6346072|P1|Overall Study|Progressive Disease|409
1832132|NCT00337077|6346083|P3|Overall Study|Ineligible|1
1832133|NCT00337077|6346084|P2|Overall Study|Ineligible|1
1832134|NCT00337077|6346085|P1|Overall Study|Ineligible|1
1832135|NCT00337077|6346083|P3|Overall Study|Never started treatment|0
1832136|NCT00337077|6346084|P2|Overall Study|Never started treatment|1
1832137|NCT00337077|6346085|P1|Overall Study|Never started treatment|1
1832138|NCT00337077|6346083|P3|Overall Study|Physician Decision|2
1832139|NCT00337077|6346084|P2|Overall Study|Physician Decision|4
1832140|NCT00337077|6346085|P1|Overall Study|Physician Decision|1
1832141|NCT00337077|6346083|P3|Overall Study|Alternative therapy|0
1832142|NCT00337077|6346084|P2|Overall Study|Alternative therapy|0
1832143|NCT00337077|6346085|P1|Overall Study|Alternative therapy|1
1832144|NCT00337077|6346083|P3|Overall Study|Withdrawal by Subject|2
1832145|NCT00337077|6346084|P2|Overall Study|Withdrawal by Subject|2
1832146|NCT00337077|6346085|P1|Overall Study|Withdrawal by Subject|7
1832147|NCT00337077|6346083|P3|Overall Study|Death|0
1832148|NCT00337077|6346084|P2|Overall Study|Death|1
1832149|NCT00337077|6346085|P1|Overall Study|Death|0
1832150|NCT00337077|6346083|P3|Overall Study|Adverse Event|1
1832151|NCT00337077|6346084|P2|Overall Study|Adverse Event|7
1832152|NCT00337077|6346085|P1|Overall Study|Adverse Event|7
1832153|NCT00337077|6346083|P3|Overall Study|Progressive disease|19
1832154|NCT00337077|6346084|P2|Overall Study|Progressive disease|37
1832155|NCT00337077|6346085|P1|Overall Study|Progressive disease|25
1832156|NCT00336895|6346100|P1|Overall Study|screen failed|1
1832157|NCT00336895|6346100|P1|Overall Study|Physician Decision|1
1832158|NCT00336895|6346100|P1|Overall Study|nausea and upset stomach|1
1832159|NCT00336895|6346100|P1|Overall Study|diarrhea|1
1832160|NCT00336856|6346106|P1|Overall Study|Found ineligible at time of analysis|1
1832161|NCT00336856|6346106|P1|Overall Study|Withdrawal by Subject|3
1832162|NCT00336583|6346154|P1|Overall Study|Death|1
1832163|NCT00336583|6346154|P1|Overall Study|Lost to Follow-up|1
1832164|NCT00336544|6346161|P2|Overall Study|Other|5
1832165|NCT00336544|6346162|P1|Overall Study|Other|3
1832166|NCT00336544|6346161|P2|Overall Study|Withdrawal by Subject|3
1832167|NCT00336544|6346162|P1|Overall Study|Withdrawal by Subject|4
1832168|NCT00336544|6346161|P2|Overall Study|Adverse Event|9
1832169|NCT00336544|6346162|P1|Overall Study|Adverse Event|4
1832170|NCT00336544|6346161|P2|Overall Study|Lack of Efficacy|5
1832171|NCT00336544|6346162|P1|Overall Study|Lack of Efficacy|8
1832172|NCT00336505|6346176|P2|Overall Study|Other|7
1832173|NCT00336505|6346177|P1|Overall Study|Other|7
1832174|NCT00336505|6346176|P2|Overall Study|Withdrawal by Subject|3
1832175|NCT00336505|6346177|P1|Overall Study|Withdrawal by Subject|5
1832176|NCT00336505|6346176|P2|Overall Study|Lost to Follow-up|4
1832177|NCT00336505|6346177|P1|Overall Study|Lost to Follow-up|7
1832178|NCT00336505|6346176|P2|Overall Study|Lack of Efficacy|4
1832179|NCT00336505|6346177|P1|Overall Study|Lack of Efficacy|8
1832180|NCT00336505|6346176|P2|Overall Study|Adverse Event|9
1832181|NCT00336505|6346177|P1|Overall Study|Adverse Event|10
1832182|NCT00336492|6346192|P3|Overall Study|Other|1
1832183|NCT00336492|6346193|P2|Overall Study|Other|0
1832184|NCT00336492|6346194|P1|Overall Study|Other|5
1832185|NCT00336492|6346192|P3|Overall Study|Lack of Efficacy|4
1832186|NCT00336492|6346193|P2|Overall Study|Lack of Efficacy|1
1832187|NCT00336492|6346194|P1|Overall Study|Lack of Efficacy|6
1832188|NCT00336492|6346192|P3|Overall Study|Adverse Event|6
1832189|NCT00336492|6346193|P2|Overall Study|Adverse Event|3
1832190|NCT00336492|6346194|P1|Overall Study|Adverse Event|4
1832191|NCT00336479|6346206|P4|Overall Study|Virologic Stopping Rule|0
1832192|NCT00336479|6346207|P3|Overall Study|Virologic Stopping Rule|0
1832193|NCT00336479|6346208|P2|Overall Study|Virologic Stopping Rule|0
1832194|NCT00336479|6346209|P1|Overall Study|Virologic Stopping Rule|20
1832195|NCT00336479|6346206|P4|Overall Study|Other|0
1832196|NCT00336479|6346207|P3|Overall Study|Other|1
1832197|NCT00336479|6346208|P2|Overall Study|Other|0
1832198|NCT00336479|6346209|P1|Overall Study|Other|0
1832199|NCT00336479|6346206|P4|Overall Study|Withdrawal by Subject|0
1832200|NCT00336479|6346207|P3|Overall Study|Withdrawal by Subject|3
1832201|NCT00336479|6346208|P2|Overall Study|Withdrawal by Subject|2
1832202|NCT00336479|6346209|P1|Overall Study|Withdrawal by Subject|3
1832203|NCT00336479|6346206|P4|Overall Study|Lost to Follow-up|0
1832204|NCT00336479|6346207|P3|Overall Study|Lost to Follow-up|0
1832205|NCT00336479|6346208|P2|Overall Study|Lost to Follow-up|2
1832206|NCT00336479|6346209|P1|Overall Study|Lost to Follow-up|3
1832207|NCT00336479|6346206|P4|Overall Study|Physician Decision|0
1832208|NCT00336479|6346207|P3|Overall Study|Physician Decision|1
1832209|NCT00336479|6346208|P2|Overall Study|Physician Decision|3
1832210|NCT00336479|6346209|P1|Overall Study|Physician Decision|2
1832211|NCT00336479|6346206|P4|Overall Study|Noncompliant|0
1832212|NCT00336479|6346207|P3|Overall Study|Noncompliant|3
1832213|NCT00336479|6346208|P2|Overall Study|Noncompliant|7
1832214|NCT00336479|6346209|P1|Overall Study|Noncompliant|1
1832215|NCT00336479|6346206|P4|Overall Study|Adverse Event|4
1832216|NCT00336479|6346207|P3|Overall Study|Adverse Event|18
1832217|NCT00336479|6346208|P2|Overall Study|Adverse Event|11
1832218|NCT00336479|6346209|P1|Overall Study|Adverse Event|8
1832219|NCT00336284|6346298|P2|Overall Study|Withdrawal by Physician or Subject|64
1832220|NCT00336284|6346299|P1|Overall Study|Withdrawal by Physician or Subject|102
1832221|NCT00336284|6346298|P2|Overall Study|Lost to Follow-up|61
1832222|NCT00336284|6346299|P1|Overall Study|Lost to Follow-up|82
1832223|NCT00336284|6346298|P2|Overall Study|Death|26
1832224|NCT00336284|6346299|P1|Overall Study|Death|52
1832225|NCT00336024|6346317|P2|Overall Study|Ineligible|7
1832226|NCT00336024|6346318|P1|Overall Study|Ineligible|7
1832227|NCT00336024|6346317|P2|Overall Study|Progressive Disease|7
1832228|NCT00336024|6346318|P1|Overall Study|Progressive Disease|4
1832229|NCT00336024|6346317|P2|Overall Study|Failure to fulfill consolidation|1
1832230|NCT00336024|6346318|P1|Overall Study|Failure to fulfill consolidation|1
1832231|NCT00336024|6346317|P2|Overall Study|Withdrawal by Subject|2
1832232|NCT00336024|6346318|P1|Overall Study|Withdrawal by Subject|1
1832233|NCT00336024|6346317|P2|Overall Study|Protocol Violation|0
1832234|NCT00336024|6346318|P1|Overall Study|Protocol Violation|1
1832235|NCT00336024|6346317|P2|Overall Study|Physician Decision|1
1832236|NCT00336024|6346318|P1|Overall Study|Physician Decision|4
1832237|NCT00336024|6346317|P2|Overall Study|Death|1
1832238|NCT00336024|6346318|P1|Overall Study|Death|2
1832239|NCT00335972|6346352|P2|Overall Study|not given treatments|3
1832240|NCT00335972|6346353|P1|Overall Study|not given treatments|0
1832241|NCT00335959|6346363|P1|Overall Study|Ineligible|1
1832242|NCT00335959|6346363|P1|Overall Study|Adverse Event|2
1832243|NCT00335829|6346368|P1|Overall Study|Adverse Event|1
1832244|NCT00335829|6346368|P1|Overall Study|Lost to Follow-up|1
1832245|NCT00335829|6346368|P1|Overall Study|Withdrawal by Subject|1
1832246|NCT00335777|6346382|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
1832247|NCT00335777|6346382|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
1832248|NCT00335777|6346382|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
1832249|NCT00335777|6346382|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
1832250|NCT00335777|6346382|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
1832251|NCT00335764|6346392|P5|Overall Study|wrong histology|1
1832252|NCT00335764|6346393|P4|Overall Study|wrong histology|0
1832253|NCT00335764|6346394|P3|Overall Study|wrong histology|0
1832254|NCT00335764|6346395|P2|Overall Study|wrong histology|0
1832255|NCT00335764|6346396|P1|Overall Study|wrong histology|1
1832256|NCT00335738|6346445|P2|Overall Study|Ineligible|4
1832257|NCT00335738|6346446|P1|Overall Study|Ineligible|3
1832258|NCT00335738|6346445|P2|Overall Study|Withdrawal by Subject|0
1832259|NCT00335738|6346446|P1|Overall Study|Withdrawal by Subject|2
1832260|NCT00335738|6346445|P2|Overall Study|Physician Decision|0
1832261|NCT00335738|6346446|P1|Overall Study|Physician Decision|6
1832262|NCT00335556|6346478|P6|Overall Study|Refusal of further protocol therapy|0
1832263|NCT00335556|6346479|P5|Overall Study|Refusal of further protocol therapy|0
1832264|NCT00335556|6346480|P4|Overall Study|Refusal of further protocol therapy|1
1832265|NCT00335556|6346481|P3|Overall Study|Refusal of further protocol therapy|0
1832266|NCT00335556|6346482|P2|Overall Study|Refusal of further protocol therapy|4
1832267|NCT00335556|6346483|P1|Overall Study|Refusal of further protocol therapy|0
1832268|NCT00335556|6346478|P6|Overall Study|Ineligible|0
1832269|NCT00335556|6346479|P5|Overall Study|Ineligible|0
1832270|NCT00335556|6346480|P4|Overall Study|Ineligible|0
1832271|NCT00335556|6346481|P3|Overall Study|Ineligible|0
1832272|NCT00335556|6346482|P2|Overall Study|Ineligible|0
1832273|NCT00335556|6346483|P1|Overall Study|Ineligible|2
1832274|NCT00335556|6346478|P6|Overall Study|Physician Decision|0
1832275|NCT00335556|6346479|P5|Overall Study|Physician Decision|0
1832276|NCT00335556|6346480|P4|Overall Study|Physician Decision|1
1832277|NCT00335556|6346481|P3|Overall Study|Physician Decision|2
1832278|NCT00335556|6346482|P2|Overall Study|Physician Decision|6
1832279|NCT00335556|6346483|P1|Overall Study|Physician Decision|0
1832280|NCT00335556|6346478|P6|Overall Study|Lack of Efficacy|1
1832281|NCT00335556|6346479|P5|Overall Study|Lack of Efficacy|0
1832282|NCT00335556|6346480|P4|Overall Study|Lack of Efficacy|3
1832283|NCT00335556|6346481|P3|Overall Study|Lack of Efficacy|3
1832284|NCT00335556|6346482|P2|Overall Study|Lack of Efficacy|19
1832285|NCT00335556|6346483|P1|Overall Study|Lack of Efficacy|0
1832286|NCT00335556|6346478|P6|Overall Study|Death|0
1832287|NCT00335556|6346479|P5|Overall Study|Death|1
1832288|NCT00335556|6346480|P4|Overall Study|Death|0
1832289|NCT00335556|6346481|P3|Overall Study|Death|0
1832290|NCT00335556|6346482|P2|Overall Study|Death|5
1832291|NCT00335556|6346483|P1|Overall Study|Death|0
1832292|NCT00335452|6346545|P4|Overall Study|Lost to Follow-up|2
1832293|NCT00335452|6346546|P3|Overall Study|Lost to Follow-up|1
1832294|NCT00335452|6346547|P2|Overall Study|Lost to Follow-up|3
1832295|NCT00335452|6346548|P1|Overall Study|Lost to Follow-up|2
1832296|NCT00335452|6346545|P4|Overall Study|Death|129
1832297|NCT00335452|6346546|P3|Overall Study|Death|158
1832298|NCT00335452|6346547|P2|Overall Study|Death|144
1832299|NCT00335452|6346548|P1|Overall Study|Death|156
1832300|NCT00335322|6346573|P3|Overall Study|Randomised but withdrew prior to ART sta|2
1832301|NCT00335322|6346574|P2|Overall Study|Randomised but withdrew prior to ART sta|2
1832302|NCT00335322|6346575|P1|Overall Study|Randomised but withdrew prior to ART sta|1
1832303|NCT00335153|6346623|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
1832304|NCT00335153|6346623|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
1832305|NCT00335153|6346623|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
1832306|NCT00335153|6346623|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
1832307|NCT00335153|6346623|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
1832308|NCT00335153|6346623|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
1832309|NCT00335153|6346623|P1|Nasojejunal (NJ) Test Period|Administrative|1
1832310|NCT00335153|6346623|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
1832311|NCT00335153|6346623|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
1832312|NCT00335153|6346623|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
1832313|NCT00335140|6346660|P1|Overall Study|Ineligible|1
1832314|NCT00334958|6346666|P2|Overall Study|Other|2
1832315|NCT00334958|6346667|P1|Overall Study|Other|1
1832316|NCT00334958|6346666|P2|Overall Study|Adverse Event|12
1832317|NCT00334958|6346667|P1|Overall Study|Adverse Event|27
1832318|NCT00334958|6346666|P2|Overall Study|Withdrawal by Subject|4
1832319|NCT00334958|6346667|P1|Overall Study|Withdrawal by Subject|7
1832320|NCT00334958|6346666|P2|Overall Study|Request of the investigator or sponsor|1
1832321|NCT00334958|6346667|P1|Overall Study|Request of the investigator or sponsor|0
1832322|NCT00334958|6346666|P2|Overall Study|Protocol Violation|2
1832323|NCT00334958|6346667|P1|Overall Study|Protocol Violation|2
1832324|NCT00334958|6346666|P2|Overall Study|Medication Noncompliance|3
1832325|NCT00334958|6346667|P1|Overall Study|Medication Noncompliance|0
1832326|NCT00334893|6346681|P2|Overall Study|Not Treated|0
1832327|NCT00334893|6346682|P1|Overall Study|Not Treated|1
1832328|NCT00334815|6346692|P2|Overall Study|Physician Decision|4
1832329|NCT00334815|6346693|P1|Overall Study|Physician Decision|2
1832330|NCT00334815|6346692|P2|Overall Study|patient refused treatment|1
1832331|NCT00334815|6346693|P1|Overall Study|patient refused treatment|0
1832332|NCT00334815|6346692|P2|Overall Study|ineligible|1
1832333|NCT00334815|6346693|P1|Overall Study|ineligible|1
1832334|NCT00334815|6346692|P2|Overall Study|Progression|0
1832335|NCT00334815|6346693|P1|Overall Study|Progression|1
1832336|NCT00334815|6346692|P2|Overall Study|Death|2
1832337|NCT00334815|6346693|P1|Overall Study|Death|0
1832338|NCT00334815|6346692|P2|Overall Study|Adverse Event|2
1832339|NCT00334815|6346693|P1|Overall Study|Adverse Event|3
1832340|NCT00334802|6346707|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
1832341|NCT00334802|6346708|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
1832342|NCT00334802|6346707|P2|Overall Study|Adverse Event|3
1832343|NCT00334802|6346708|P1|Overall Study|Adverse Event|0
1832344|NCT00334802|6346707|P2|Overall Study|Withdrawal by Subject|4
1832345|NCT00334802|6346708|P1|Overall Study|Withdrawal by Subject|0
1832346|NCT00334802|6346707|P2|Overall Study|Physician Decision|0
1832347|NCT00334802|6346708|P1|Overall Study|Physician Decision|1
1832348|NCT00334802|6346707|P2|Overall Study|Patient Condition Aggrevated|0
1832349|NCT00334802|6346708|P1|Overall Study|Patient Condition Aggrevated|1
1832350|NCT00334802|6346707|P2|Overall Study|Lack of Efficacy|3
1832351|NCT00334802|6346708|P1|Overall Study|Lack of Efficacy|1
1832352|NCT00334802|6346707|P2|Overall Study|Toxicity|5
1832353|NCT00334802|6346708|P1|Overall Study|Toxicity|1
1832354|NCT00334802|6346707|P2|Overall Study|Progressive Disease|24
1832355|NCT00334802|6346708|P1|Overall Study|Progressive Disease|2
1832356|NCT00334737|6346728|P3|Follow up Phase|Lost to Follow-up|6
1832357|NCT00334737|6346729|P2|Follow up Phase|Lost to Follow-up|3
1832358|NCT00334737|6346730|P1|Follow up Phase|Lost to Follow-up|5
1832359|NCT00334737|6346728|P3|Hospital Phase|Did not receive study drug|0
1832360|NCT00334737|6346729|P2|Hospital Phase|Did not receive study drug|0
1832361|NCT00334737|6346730|P1|Hospital Phase|Did not receive study drug|1
1832362|NCT00334737|6346728|P3|Hospital Phase|Withdrawal by Subject|1
1832363|NCT00334737|6346729|P2|Hospital Phase|Withdrawal by Subject|0
1832364|NCT00334737|6346730|P1|Hospital Phase|Withdrawal by Subject|0
1832365|NCT00334737|6346728|P3|Hospital Phase|Death|3
1832366|NCT00334737|6346729|P2|Hospital Phase|Death|2
1832367|NCT00334737|6346730|P1|Hospital Phase|Death|1
1832368|NCT00334542|6346778|P1|Overall Study|New cancer diagnosis|1
1832369|NCT00334542|6346778|P1|Overall Study|Withdrawal by Subject|1
1832370|NCT00334542|6346778|P1|Overall Study|Adverse Event|3
1832371|NCT00334295|6346785|P1|Overall Study|Patients received fewer than 3 injection|5
1832372|NCT00334282|6346795|P2|Overall Study|Death|100
1832373|NCT00334282|6346796|P1|Overall Study|Death|194
1832374|NCT00334282|6346795|P2|Overall Study|Withdrawal by Subject|3
1832375|NCT00334282|6346796|P1|Overall Study|Withdrawal by Subject|17
1832376|NCT00334282|6346795|P2|Overall Study|Lost to Follow-up|5
1832377|NCT00334282|6346796|P1|Overall Study|Lost to Follow-up|11
1832378|NCT00334113|6346827|P2|Overall Study|Withdrawal by Subject|1
1832379|NCT00334113|6346828|P1|Overall Study|Withdrawal by Subject|0
1832380|NCT00334113|6346827|P2|Overall Study|Lost to Follow-up|2
1832381|NCT00334113|6346828|P1|Overall Study|Lost to Follow-up|2
1832382|NCT00333983|6346851|P3|Overall Study|Withdrawal by Subject|1
1832383|NCT00333983|6346852|P2|Overall Study|Withdrawal by Subject|3
1832384|NCT00333983|6346853|P1|Overall Study|Withdrawal by Subject|0
1832385|NCT00333983|6346851|P3|Overall Study|Adverse Event|1
1832386|NCT00333983|6346852|P2|Overall Study|Adverse Event|1
1832387|NCT00333983|6346853|P1|Overall Study|Adverse Event|1
1832388|NCT00333983|6346851|P3|Overall Study|Lost to Follow-up|0
1832389|NCT00333983|6346852|P2|Overall Study|Lost to Follow-up|1
1832390|NCT00333983|6346853|P1|Overall Study|Lost to Follow-up|2
1832391|NCT00333970|6346863|P2|Overall Study|Withdrawal by Subject|7
1832392|NCT00333970|6346864|P1|Overall Study|Withdrawal by Subject|13
1832393|NCT00333866|6346879|P4|Overall Study|Randomized but not Treated|1
1832394|NCT00333866|6346880|P3|Overall Study|Randomized but not Treated|2
1832395|NCT00333866|6346881|P2|Overall Study|Randomized but not Treated|3
1832396|NCT00333866|6346882|P1|Overall Study|Randomized but not Treated|5
1832397|NCT00333866|6346879|P4|Overall Study|Withdrawal by Subject|9
1832398|NCT00333866|6346880|P3|Overall Study|Withdrawal by Subject|4
1832399|NCT00333866|6346881|P2|Overall Study|Withdrawal by Subject|14
1832400|NCT00333866|6346882|P1|Overall Study|Withdrawal by Subject|8
1832401|NCT00333866|6346879|P4|Overall Study|Lost to Follow-up|2
1832402|NCT00333866|6346880|P3|Overall Study|Lost to Follow-up|2
1832403|NCT00333866|6346881|P2|Overall Study|Lost to Follow-up|2
1832404|NCT00333866|6346882|P1|Overall Study|Lost to Follow-up|1
1832405|NCT00333866|6346879|P4|Overall Study|Lack of Efficacy|5
1832406|NCT00333866|6346880|P3|Overall Study|Lack of Efficacy|3
1832407|NCT00333866|6346881|P2|Overall Study|Lack of Efficacy|6
1832408|NCT00333866|6346882|P1|Overall Study|Lack of Efficacy|8
1832409|NCT00333866|6346879|P4|Overall Study|Other|2
1832410|NCT00333866|6346880|P3|Overall Study|Other|2
1832411|NCT00333866|6346881|P2|Overall Study|Other|2
1832412|NCT00333866|6346882|P1|Overall Study|Other|3
1832413|NCT00333866|6346879|P4|Overall Study|Adverse Event|47
1832414|NCT00333866|6346880|P3|Overall Study|Adverse Event|38
1832415|NCT00333866|6346881|P2|Overall Study|Adverse Event|37
1832416|NCT00333866|6346882|P1|Overall Study|Adverse Event|23
1832417|NCT00333840|6346942|P4|Second-line Treatment Period|Death|9
1832418|NCT00333840|6346943|P3|Second-line Treatment Period|Death|0
1832419|NCT00333840|6346944|P2|Second-line Treatment Period|Death|0
1832420|NCT00333840|6346945|P1|Second-line Treatment Period|Death|0
1832421|NCT00333840|6346942|P4|Second-line Treatment Period|Administrative problems|7
1832422|NCT00333840|6346943|P3|Second-line Treatment Period|Administrative problems|0
1832423|NCT00333840|6346944|P2|Second-line Treatment Period|Administrative problems|0
1832424|NCT00333840|6346945|P1|Second-line Treatment Period|Administrative problems|0
1832425|NCT00333840|6346942|P4|Second-line Treatment Period|Lost to Follow-up|6
1832426|NCT00333840|6346943|P3|Second-line Treatment Period|Lost to Follow-up|0
1832427|NCT00333840|6346944|P2|Second-line Treatment Period|Lost to Follow-up|0
1832428|NCT00333840|6346945|P1|Second-line Treatment Period|Lost to Follow-up|0
1832429|NCT00333840|6346942|P4|Second-line Treatment Period|Subject withdrew consent|34
1832430|NCT00333840|6346943|P3|Second-line Treatment Period|Subject withdrew consent|0
1832431|NCT00333840|6346944|P2|Second-line Treatment Period|Subject withdrew consent|0
1832432|NCT00333840|6346945|P1|Second-line Treatment Period|Subject withdrew consent|0
1832433|NCT00333840|6346942|P4|Second-line Treatment Period|Protocol Violation|10
1832434|NCT00333840|6346943|P3|Second-line Treatment Period|Protocol Violation|1
1832435|NCT00333840|6346944|P2|Second-line Treatment Period|Protocol Violation|0
1832436|NCT00333840|6346945|P1|Second-line Treatment Period|Protocol Violation|0
1832437|NCT00333840|6346942|P4|Second-line Treatment Period|No longer required study drug|14
1832438|NCT00333840|6346943|P3|Second-line Treatment Period|No longer required study drug|1
1832439|NCT00333840|6346944|P2|Second-line Treatment Period|No longer required study drug|0
1832440|NCT00333840|6346945|P1|Second-line Treatment Period|No longer required study drug|0
1832441|NCT00333840|6346942|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
1832442|NCT00333840|6346943|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
1832443|NCT00333840|6346944|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1832444|NCT00333840|6346945|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
1832445|NCT00333840|6346942|P4|Second-line Treatment Period|Abnormal procedure|1
1832446|NCT00333840|6346943|P3|Second-line Treatment Period|Abnormal procedure|0
1832447|NCT00333840|6346944|P2|Second-line Treatment Period|Abnormal procedure|0
1832448|NCT00333840|6346945|P1|Second-line Treatment Period|Abnormal procedure|0
1832449|NCT00333840|6346942|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
1832450|NCT00333840|6346943|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
1832451|NCT00333840|6346944|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
1832452|NCT00333840|6346945|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
1832453|NCT00333840|6346942|P4|Second-line Treatment Period|Adverse Event|34
1832454|NCT00333840|6346943|P3|Second-line Treatment Period|Adverse Event|3
1832455|NCT00333840|6346944|P2|Second-line Treatment Period|Adverse Event|0
1832456|NCT00333840|6346945|P1|Second-line Treatment Period|Adverse Event|0
1832457|NCT00333840|6346942|P4|First-line Treatment Period|Crossed over to other treatment arm|0
1832458|NCT00333840|6346943|P3|First-line Treatment Period|Crossed over to other treatment arm|0
1832459|NCT00333840|6346944|P2|First-line Treatment Period|Crossed over to other treatment arm|363
1832460|NCT00333840|6346945|P1|First-line Treatment Period|Crossed over to other treatment arm|14
1832461|NCT00333840|6346942|P4|First-line Treatment Period|Death|0
1832462|NCT00333840|6346943|P3|First-line Treatment Period|Death|0
1832463|NCT00333840|6346944|P2|First-line Treatment Period|Death|2
1832464|NCT00333840|6346945|P1|First-line Treatment Period|Death|19
1832465|NCT00333840|6346942|P4|First-line Treatment Period|Administrative problems|0
1832466|NCT00333840|6346943|P3|First-line Treatment Period|Administrative problems|0
1832467|NCT00333840|6346944|P2|First-line Treatment Period|Administrative problems|6
1832468|NCT00333840|6346945|P1|First-line Treatment Period|Administrative problems|12
1832469|NCT00333840|6346942|P4|First-line Treatment Period|Lost to Follow-up|0
1832470|NCT00333840|6346943|P3|First-line Treatment Period|Lost to Follow-up|0
1832471|NCT00333840|6346944|P2|First-line Treatment Period|Lost to Follow-up|6
1832472|NCT00333840|6346945|P1|First-line Treatment Period|Lost to Follow-up|15
1832473|NCT00333840|6346942|P4|First-line Treatment Period|Subject withdrew consent|0
1832474|NCT00333840|6346943|P3|First-line Treatment Period|Subject withdrew consent|0
1832475|NCT00333840|6346944|P2|First-line Treatment Period|Subject withdrew consent|77
1832476|NCT00333840|6346945|P1|First-line Treatment Period|Subject withdrew consent|57
1832477|NCT00333840|6346942|P4|First-line Treatment Period|Protocol Violation|0
1832478|NCT00333840|6346943|P3|First-line Treatment Period|Protocol Violation|0
1832479|NCT00333840|6346944|P2|First-line Treatment Period|Protocol Violation|17
1832480|NCT00333840|6346945|P1|First-line Treatment Period|Protocol Violation|17
1832481|NCT00333840|6346942|P4|First-line Treatment Period|No longer required study drug|0
1832482|NCT00333840|6346943|P3|First-line Treatment Period|No longer required study drug|0
1832483|NCT00333840|6346944|P2|First-line Treatment Period|No longer required study drug|8
1832484|NCT00333840|6346945|P1|First-line Treatment Period|No longer required study drug|21
1832485|NCT00333840|6346942|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1832486|NCT00333840|6346943|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
1832487|NCT00333840|6346944|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
1832488|NCT00333840|6346945|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
1832489|NCT00333840|6346942|P4|First-line Treatment Period|Abnormal procedure|0
1832490|NCT00333840|6346943|P3|First-line Treatment Period|Abnormal procedure|0
1832491|NCT00333840|6346944|P2|First-line Treatment Period|Abnormal procedure|0
1832492|NCT00333840|6346945|P1|First-line Treatment Period|Abnormal procedure|2
1832493|NCT00333840|6346942|P4|First-line Treatment Period|Abnormal laboratory values|0
1832494|NCT00333840|6346943|P3|First-line Treatment Period|Abnormal laboratory values|0
1832495|NCT00333840|6346944|P2|First-line Treatment Period|Abnormal laboratory values|1
1832496|NCT00333840|6346945|P1|First-line Treatment Period|Abnormal laboratory values|3
1832497|NCT00333840|6346942|P4|First-line Treatment Period|Adverse Event|0
1832498|NCT00333840|6346943|P3|First-line Treatment Period|Adverse Event|0
1832499|NCT00333840|6346944|P2|First-line Treatment Period|Adverse Event|37
1832500|NCT00333840|6346945|P1|First-line Treatment Period|Adverse Event|38
1832501|NCT00333801|6346991|P2|Overall Study|Withdrawal by Subject|1
1832502|NCT00333801|6346992|P1|Overall Study|Withdrawal by Subject|0
1832503|NCT00333801|6346991|P2|Overall Study|Incarcerated|2
1832504|NCT00333801|6346992|P1|Overall Study|Incarcerated|1
1832505|NCT00333801|6346991|P2|Overall Study|Lost to Follow-up|0
1832506|NCT00333801|6346992|P1|Overall Study|Lost to Follow-up|2
1832507|NCT00333801|6346991|P2|Overall Study|Moved to another state|3
1832508|NCT00333801|6346992|P1|Overall Study|Moved to another state|5
1832509|NCT00333788|6347010|P1|Overall Study|Other: Signed consent for another study|1
1832510|NCT00333788|6347010|P1|Overall Study|Other: Physician decision|1
1832511|NCT00333788|6347010|P1|Overall Study|Other: Medical monitor decision|1
1832512|NCT00333788|6347010|P1|Overall Study|Other: Subject in need of an Entocort|1
1832513|NCT00333788|6347010|P1|Overall Study|Other: Sponsor decision|1
1832514|NCT00333788|6347010|P1|Overall Study|Other: Quality of life concern|1
1832515|NCT00333788|6347010|P1|Overall Study|Other: Investigator decision|1
1832516|NCT00333788|6347010|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
1832517|NCT00333788|6347010|P1|Overall Study|Other: Moved|2
1832518|NCT00333788|6347010|P1|Overall Study|Other: Non-compliance|2
1832519|NCT00333788|6347010|P1|Overall Study|Withdrawal by Subject|24
1832520|NCT00333788|6347010|P1|Overall Study|Lost to Follow-up|2
1832521|NCT00333788|6347010|P1|Overall Study|Lack of Efficacy|80
1832522|NCT00333788|6347010|P1|Overall Study|Adverse Event|44
1832523|NCT00333775|6347040|P3|Overall Study|Lost to Follow-up|8
1832524|NCT00333775|6347041|P2|Overall Study|Lost to Follow-up|7
1832525|NCT00333775|6347042|P1|Overall Study|Lost to Follow-up|10
1832526|NCT00333775|6347040|P3|Overall Study|In Follow−up When Study Stopped|96
1832527|NCT00333775|6347041|P2|Overall Study|In Follow−up When Study Stopped|92
1832528|NCT00333775|6347042|P1|Overall Study|In Follow−up When Study Stopped|87
1832529|NCT00333775|6347040|P3|Overall Study|Death|143
1832530|NCT00333775|6347041|P2|Overall Study|Death|149
1832531|NCT00333775|6347042|P1|Overall Study|Death|144
1832532|NCT00333619|6347081|P2|Overall Study|Lost to Follow-up|3
1832533|NCT00333619|6347082|P1|Overall Study|Lost to Follow-up|3
1832534|NCT00333619|6347081|P2|Overall Study|Withdrawal by Subject|1
1832535|NCT00333619|6347082|P1|Overall Study|Withdrawal by Subject|6
1832536|NCT00333619|6347081|P2|Overall Study|Death|6
1832537|NCT00333619|6347082|P1|Overall Study|Death|12
1832538|NCT00333359|6347111|P2|Overall Study|Withdrew before Receiving One Dose|6
1832539|NCT00333359|6347112|P1|Overall Study|Withdrew before Receiving One Dose|2
1832540|NCT00333359|6347111|P2|Overall Study|Treatment Failure|8
1832541|NCT00333359|6347112|P1|Overall Study|Treatment Failure|3
1832542|NCT00333359|6347111|P2|Overall Study|Termination or Withdrawal by Sponsor|1
1832543|NCT00333359|6347112|P1|Overall Study|Termination or Withdrawal by Sponsor|1
1832544|NCT00333359|6347111|P2|Overall Study|Lost to Follow-up|25
1832545|NCT00333359|6347112|P1|Overall Study|Lost to Follow-up|15
1832546|NCT00333359|6347111|P2|Overall Study|Protocol Non-compliance|8
1832547|NCT00333359|6347112|P1|Overall Study|Protocol Non-compliance|2
1832548|NCT00333359|6347111|P2|Overall Study|Physician Decision|2
1832549|NCT00333359|6347112|P1|Overall Study|Physician Decision|2
1832550|NCT00333359|6347111|P2|Overall Study|Withdrawal by Subject|37
1832551|NCT00333359|6347112|P1|Overall Study|Withdrawal by Subject|19
1832552|NCT00333359|6347111|P2|Overall Study|Adverse Event|35
1832553|NCT00333359|6347112|P1|Overall Study|Adverse Event|29
1832554|NCT00333229|6347155|P2|Overall Study|Lack of Efficacy|1
1832555|NCT00333229|6347156|P1|Overall Study|Lack of Efficacy|0
1832556|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Death|0
1832557|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Death|1
1832558|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Death|0
1832559|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
1832560|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1832561|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
1832562|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
1832563|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
1832564|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
1832565|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1832566|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
1832567|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
1832568|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1832569|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
1832570|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
1832571|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
1832572|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
1832573|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
1832574|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
1832575|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
1832576|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
1832577|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
1832578|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
1832579|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
1832580|NCT00333138|6347173|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1832581|NCT00333138|6347174|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
1832582|NCT00333138|6347175|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
1832583|NCT00333138|6347173|P3|Core Study (6 Months)|Laboratory abnormality|1
1832584|NCT00333138|6347174|P2|Core Study (6 Months)|Laboratory abnormality|0
1832585|NCT00333138|6347175|P1|Core Study (6 Months)|Laboratory abnormality|0
1832586|NCT00333138|6347173|P3|Core Study (6 Months)|Protocol Violation|1
1832587|NCT00333138|6347174|P2|Core Study (6 Months)|Protocol Violation|0
1832588|NCT00333138|6347175|P1|Core Study (6 Months)|Protocol Violation|1
1832589|NCT00333138|6347173|P3|Core Study (6 Months)|Lack of Efficacy|0
1832590|NCT00333138|6347174|P2|Core Study (6 Months)|Lack of Efficacy|0
1832591|NCT00333138|6347175|P1|Core Study (6 Months)|Lack of Efficacy|1
1832592|NCT00333138|6347173|P3|Core Study (6 Months)|Withdrawal by Subject|2
1832593|NCT00333138|6347174|P2|Core Study (6 Months)|Withdrawal by Subject|1
1832594|NCT00333138|6347175|P1|Core Study (6 Months)|Withdrawal by Subject|1
1832595|NCT00333138|6347173|P3|Core Study (6 Months)|Adverse Event|8
1832596|NCT00333138|6347174|P2|Core Study (6 Months)|Adverse Event|5
1832597|NCT00333138|6347175|P1|Core Study (6 Months)|Adverse Event|4
1832598|NCT00332839|6347214|P2|Follow-up (Months 12 - 60)|Death|1
1832599|NCT00332839|6347215|P1|Follow-up (Months 12 - 60)|Death|1
1832600|NCT00332839|6347214|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
1832601|NCT00332839|6347215|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
1832602|NCT00332839|6347214|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1832603|NCT00332839|6347215|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
1832604|NCT00332839|6347214|P2|Core (Months 0 - 12)|Adverse Event|15
1832605|NCT00332839|6347215|P1|Core (Months 0 - 12)|Adverse Event|5
1832606|NCT00332839|6347214|P2|Core (Months 0 - 12)|Protocol deviation|1
1832607|NCT00332839|6347215|P1|Core (Months 0 - 12)|Protocol deviation|1
1832608|NCT00332839|6347214|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
1832609|NCT00332839|6347215|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
1832610|NCT00332839|6347214|P2|Core (Months 0 - 12)|Administrative problems|1
1832611|NCT00332839|6347215|P1|Core (Months 0 - 12)|Administrative problems|1
1832612|NCT00332709|6347246|P2|Overall Study|Abnormal test procedure result|0
1832613|NCT00332709|6347247|P1|Overall Study|Abnormal test procedure result|1
1832614|NCT00332709|6347246|P2|Overall Study|Administrative Problems|3
1832615|NCT00332709|6347247|P1|Overall Study|Administrative Problems|0
1832616|NCT00332709|6347246|P2|Overall Study|Lost to Follow-up|0
1832617|NCT00332709|6347247|P1|Overall Study|Lost to Follow-up|2
1832618|NCT00332709|6347246|P2|Overall Study|Withdrawal by Subject|3
1832619|NCT00332709|6347247|P1|Overall Study|Withdrawal by Subject|2
1832620|NCT00332709|6347246|P2|Overall Study|Adverse Event|14
1832621|NCT00332709|6347247|P1|Overall Study|Adverse Event|11
1832622|NCT00332696|6347271|P2|Overall Study|Withdrawal by Subject|0
1832623|NCT00332696|6347272|P1|Overall Study|Withdrawal by Subject|1
1832624|NCT00332696|6347271|P2|Overall Study|Lost to Follow-up|1
1832625|NCT00332696|6347272|P1|Overall Study|Lost to Follow-up|0
1832626|NCT00332696|6347271|P2|Overall Study|Condition does not justify treatment|2
1832627|NCT00332696|6347272|P1|Overall Study|Condition does not justify treatment|0
1832628|NCT00332696|6347271|P2|Overall Study|Adverse Event|2
1832629|NCT00332696|6347272|P1|Overall Study|Adverse Event|1
1832630|NCT00332696|6347271|P2|Overall Study|Insufficient therapeutic effect|11
1832631|NCT00332696|6347272|P1|Overall Study|Insufficient therapeutic effect|4
1832632|NCT00332696|6347271|P2|Overall Study|Death|14
1832633|NCT00332696|6347272|P1|Overall Study|Death|24
1832634|NCT00332488|6347348|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
1832635|NCT00332488|6347349|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1832636|NCT00332488|6347350|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
1832637|NCT00332488|6347348|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
1832638|NCT00332488|6347349|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1832720|NCT00331864|6347474|P1|Overall Study|Administrative Problems|1
1832639|NCT00332488|6347350|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
1832640|NCT00332488|6347348|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
1832641|NCT00332488|6347349|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1832642|NCT00332488|6347350|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
1832643|NCT00332488|6347348|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
1832644|NCT00332488|6347349|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1832645|NCT00332488|6347350|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
1832646|NCT00332488|6347348|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
1832647|NCT00332488|6347349|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1832648|NCT00332488|6347350|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
1832649|NCT00332488|6347348|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
1832650|NCT00332488|6347349|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1832651|NCT00332488|6347350|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
1832652|NCT00332488|6347348|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
1832653|NCT00332488|6347349|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
1832654|NCT00332488|6347350|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
1832655|NCT00332488|6347348|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
1832656|NCT00332488|6347349|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
1832657|NCT00332488|6347350|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
1832658|NCT00332488|6347348|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
1832659|NCT00332488|6347349|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
1832660|NCT00332488|6347350|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
1832661|NCT00332488|6347348|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
1832662|NCT00332488|6347349|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
1832663|NCT00332488|6347350|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
1832664|NCT00332488|6347348|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
1832665|NCT00332488|6347349|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
1832666|NCT00332488|6347350|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
1832667|NCT00332488|6347348|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
1832668|NCT00332488|6347349|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
1832669|NCT00332488|6347350|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
1832670|NCT00332462|6347362|P1|Overall Study|Graft Loss|2
1832671|NCT00332462|6347362|P1|Overall Study|Death|3
1832672|NCT00332462|6347362|P1|Overall Study|no longer requires study drug|1
1832673|NCT00332462|6347362|P1|Overall Study|Unsatisfactory therapeutic effect|4
1832674|NCT00332462|6347362|P1|Overall Study|Abnormal Lab Value|1
1832675|NCT00332462|6347362|P1|Overall Study|Adverse Event|5
1832676|NCT00332332|6347369|P1|Overall Study|Did not receive study treatment|16
1832677|NCT00332332|6347369|P1|Overall Study|Other|18
1832678|NCT00332332|6347369|P1|Overall Study|Disease progression|2
1832679|NCT00332332|6347369|P1|Overall Study|Noncompliance|2
1832680|NCT00332332|6347369|P1|Overall Study|Protocol deviation|4
1832681|NCT00332332|6347369|P1|Overall Study|Lost to Follow-up|3
1832682|NCT00332332|6347369|P1|Overall Study|Physician Decision|1
1832683|NCT00332332|6347369|P1|Overall Study|Withdrawal by Subject|8
1832684|NCT00332332|6347369|P1|Overall Study|Death|1
1832685|NCT00332332|6347369|P1|Overall Study|Adverse Event|13
1832686|NCT00332241|6347378|P2|Overall Study|Lost to Follow-up|1
1832687|NCT00332241|6347379|P1|Overall Study|Lost to Follow-up|4
1832688|NCT00332241|6347378|P2|Overall Study|Withdrawal by Subject|1
1832689|NCT00332241|6347379|P1|Overall Study|Withdrawal by Subject|2
1832690|NCT00332241|6347378|P2|Overall Study|Adverse Event|5
1832691|NCT00332241|6347379|P1|Overall Study|Adverse Event|3
1832692|NCT00332241|6347378|P2|Overall Study|Lack of Efficacy|1
1832693|NCT00332241|6347379|P1|Overall Study|Lack of Efficacy|6
1832694|NCT00332202|6347401|P2|Overall Study|Death|2
1832695|NCT00332202|6347402|P1|Overall Study|Death|5
1832696|NCT00332202|6347401|P2|Overall Study|Progressive Disease|60
1832697|NCT00332202|6347402|P1|Overall Study|Progressive Disease|106
1832698|NCT00332202|6347401|P2|Overall Study|Withdrawal by Subject|17
1832699|NCT00332202|6347402|P1|Overall Study|Withdrawal by Subject|36
1832700|NCT00332202|6347401|P2|Overall Study|Sponsor Decision|2
1832701|NCT00332202|6347402|P1|Overall Study|Sponsor Decision|1
1832702|NCT00332202|6347401|P2|Overall Study|Protocol Violation|2
1832703|NCT00332202|6347402|P1|Overall Study|Protocol Violation|7
1832704|NCT00332202|6347401|P2|Overall Study|Protocol Entry Criteria Not Met|5
1832705|NCT00332202|6347402|P1|Overall Study|Protocol Entry Criteria Not Met|6
1832706|NCT00332202|6347401|P2|Overall Study|Physician Decision|8
1832707|NCT00332202|6347402|P1|Overall Study|Physician Decision|6
1832708|NCT00332202|6347401|P2|Overall Study|Lost to Follow-up|1
1832709|NCT00332202|6347402|P1|Overall Study|Lost to Follow-up|2
1832710|NCT00332202|6347401|P2|Overall Study|Adverse Event|28
1832711|NCT00332202|6347402|P1|Overall Study|Adverse Event|72
1832712|NCT00332189|6347431|P1|Overall Study|Moved out of country|2
1832713|NCT00332189|6347431|P1|Overall Study|Lack of Efficacy|4
1832714|NCT00332189|6347431|P1|Overall Study|Withdrawal by Subject|9
1832715|NCT00332189|6347431|P1|Overall Study|Uncooperative/Noncompliant|3
1832716|NCT00332189|6347431|P1|Overall Study|Adverse Event|3
1832717|NCT00331864|6347473|P2|Overall Study|Death|0
1832718|NCT00331864|6347474|P1|Overall Study|Death|6
1832719|NCT00331864|6347473|P2|Overall Study|Administrative Problems|0
1832721|NCT00331864|6347473|P2|Overall Study|Lost to Follow-up|3
1832722|NCT00331864|6347474|P1|Overall Study|Lost to Follow-up|4
1832723|NCT00331864|6347473|P2|Overall Study|Withdrawal by Subject|0
1832724|NCT00331864|6347474|P1|Overall Study|Withdrawal by Subject|10
1832725|NCT00331864|6347473|P2|Overall Study|Protocol Violation|0
1832726|NCT00331864|6347474|P1|Overall Study|Protocol Violation|3
1832727|NCT00331864|6347473|P2|Overall Study|Lack of Efficacy|0
1832728|NCT00331864|6347474|P1|Overall Study|Lack of Efficacy|4
1832729|NCT00331864|6347473|P2|Overall Study|Adverse Event|1
1832730|NCT00331864|6347474|P1|Overall Study|Adverse Event|30
1832731|NCT00331799|6347493|P1|Overall Study|Sedation|1
1832732|NCT00331799|6347493|P1|Overall Study|Withdrawal by Subject|2
1832733|NCT00331773|6347499|P2|Overall Study|Protocol Violation|3
1832734|NCT00331773|6347500|P1|Overall Study|Protocol Violation|10
1832735|NCT00331773|6347499|P2|Overall Study|Withdrawal by Subject|4
1832736|NCT00331773|6347500|P1|Overall Study|Withdrawal by Subject|6
1832737|NCT00331760|6347530|P2|Overall Study|Ineligible / no protocol treatment|8
1832738|NCT00331760|6347531|P1|Overall Study|Ineligible / no protocol treatment|15
1832739|NCT00331682|6347552|P1|Overall Study|Adverse Event|1
1832740|NCT00331552|6347560|P2|Period 3: Phase II|Severe Nausea|0
1832741|NCT00331552|6347561|P1|Period 3: Phase II|Severe Nausea|1
1832742|NCT00331552|6347560|P2|Period 3: Phase II|Neurological Symptoms|0
1832743|NCT00331552|6347561|P1|Period 3: Phase II|Neurological Symptoms|1
1832744|NCT00331422|6347575|P1|Overall Study|Did not receive entire study regimen|5
1832745|NCT00331409|6347584|P1|Overall Study|Lack of Efficacy|4
1832746|NCT00331344|6347592|P9|Phase II|Death|4
1832747|NCT00331344|6347593|P8|Phase II|Death|0
1832748|NCT00331344|6347594|P7|Phase II|Death|0
1832749|NCT00331344|6347595|P6|Phase II|Death|0
1832750|NCT00331344|6347596|P5|Phase II|Death|0
1832751|NCT00331344|6347597|P4|Phase II|Death|0
1832752|NCT00331344|6347598|P3|Phase II|Death|0
1832753|NCT00331344|6347599|P2|Phase II|Death|0
1832754|NCT00331344|6347600|P1|Phase II|Death|0
1832755|NCT00331344|6347592|P9|Phase I|Adverse Event|0
1832756|NCT00331344|6347593|P8|Phase I|Adverse Event|1
1832757|NCT00331344|6347594|P7|Phase I|Adverse Event|0
1832758|NCT00331344|6347595|P6|Phase I|Adverse Event|2
1832759|NCT00331344|6347596|P5|Phase I|Adverse Event|2
1832760|NCT00331344|6347597|P4|Phase I|Adverse Event|1
1832761|NCT00331344|6347598|P3|Phase I|Adverse Event|0
1832762|NCT00331344|6347599|P2|Phase I|Adverse Event|0
1832763|NCT00331344|6347600|P1|Phase I|Adverse Event|0
1832764|NCT00331006|6347637|P1|Follow-Up Phase II|Lost to Follow-up|3
1832765|NCT00331006|6347637|P1|Follow-Up Phase I|Lost to Follow-up|1
1832766|NCT00331006|6347637|P1|Treatment Phase|Withdrawal by Subject|1
1832767|NCT00331006|6347637|P1|Screening Phase|Ineligible for treatment phase|4
1832768|NCT00331006|6347637|P1|Screening Phase|Lost to Follow-up|1
1832769|NCT00331006|6347637|P1|Screening Phase|enrollment halted|1
1832770|NCT00331006|6347637|P1|Screening Phase|Withdrawal by Subject|1
1832771|NCT00330967|6347650|P2|Overall Study|Physician Decision|9
1832772|NCT00330967|6347651|P1|Overall Study|Physician Decision|0
1832773|NCT00330967|6347650|P2|Overall Study|Withdrawal by Subject|5
1832774|NCT00330967|6347651|P1|Overall Study|Withdrawal by Subject|0
1832775|NCT00330928|6347662|P1|Overall Study|IVUS could not be performed.|1
1832776|NCT00330928|6347662|P1|Overall Study|Death|1
1832777|NCT00330928|6347662|P1|Overall Study|Physician Decision|9
1832778|NCT00330928|6347662|P1|Overall Study|Lost to Follow-up|6
1832779|NCT00330759|6347704|P2|Overall Study|Other|44
1832780|NCT00330759|6347705|P1|Overall Study|Other|36
1832781|NCT00330759|6347704|P2|Overall Study|Ineligibility determined|1
1832782|NCT00330759|6347705|P1|Overall Study|Ineligibility determined|2
1832783|NCT00330759|6347704|P2|Overall Study|Protocol deviation|2
1832784|NCT00330759|6347705|P1|Overall Study|Protocol deviation|0
1832785|NCT00330759|6347704|P2|Overall Study|Physician Decision|2
1832786|NCT00330759|6347705|P1|Overall Study|Physician Decision|1
1832787|NCT00330759|6347704|P2|Overall Study|Noncompliance|17
1832788|NCT00330759|6347705|P1|Overall Study|Noncompliance|15
1832789|NCT00330759|6347704|P2|Overall Study|Lost to Follow-up|22
1832790|NCT00330759|6347705|P1|Overall Study|Lost to Follow-up|16
1832791|NCT00330759|6347704|P2|Overall Study|Participant request|22
1832792|NCT00330759|6347705|P1|Overall Study|Participant request|31
1832793|NCT00330759|6347704|P2|Overall Study|Adverse Event|36
1832794|NCT00330759|6347705|P1|Overall Study|Adverse Event|48
1832795|NCT00330759|6347704|P2|Overall Study|Withdrawal by Subject|124
1832796|NCT00330759|6347705|P1|Overall Study|Withdrawal by Subject|143
1832797|NCT00330759|6347704|P2|Overall Study|Disease progression|126
1832798|NCT00330759|6347705|P1|Overall Study|Disease progression|104
1832799|NCT00330759|6347704|P2|Overall Study|Death|310
1832800|NCT00330759|6347705|P1|Overall Study|Death|316
1832801|NCT00330681|6347738|P2|Overall Study|Tracheotomy due to worsening of ALS|2
1832802|NCT00330681|6347739|P1|Overall Study|Tracheotomy due to worsening of ALS|1
1832803|NCT00330681|6347738|P2|Overall Study|Withdrawal by Subject|5
1832804|NCT00330681|6347739|P1|Overall Study|Withdrawal by Subject|5
1832805|NCT00330681|6347738|P2|Overall Study|Protocol Violation|1
1832806|NCT00330681|6347739|P1|Overall Study|Protocol Violation|0
1832807|NCT00330681|6347738|P2|Overall Study|Adverse Event|6
1832808|NCT00330681|6347739|P1|Overall Study|Adverse Event|3
1832809|NCT00330668|6347761|P1|Overall Study|Patient started Lupron|1
1832810|NCT00330668|6347761|P1|Overall Study|Use of exclusionary medication|1
1832811|NCT00330668|6347761|P1|Overall Study|Lack of Efficacy|1
1832812|NCT00330668|6347761|P1|Overall Study|Sponsor's decision|76
1832813|NCT00330668|6347761|P1|Overall Study|Withdrawal by Subject|20
1832814|NCT00330668|6347761|P1|Overall Study|Non-Compliance|5
1832815|NCT00330668|6347761|P1|Overall Study|Lost to Follow-up|9
1832816|NCT00330668|6347761|P1|Overall Study|Adverse Event|1
1832817|NCT00330616|6347768|P1|Overall Study|Other|1
1832818|NCT00330616|6347768|P1|Overall Study|Withdrawal by Subject|4
1832819|NCT00330616|6347768|P1|Overall Study|Lost to Follow-up|2
1832820|NCT00330616|6347768|P1|Overall Study|Lack of Efficacy|1
1832821|NCT00330616|6347768|P1|Overall Study|Adverse Event|13
1832822|NCT00330460|6347794|P2|Overall Study|Other|0
1832823|NCT00330460|6347795|P1|Overall Study|Other|1
1832824|NCT00330460|6347794|P2|Overall Study|Noncompliance|1
1832825|NCT00330460|6347795|P1|Overall Study|Noncompliance|2
1832826|NCT00330460|6347794|P2|Overall Study|Lost to Follow-up|3
1832827|NCT00330460|6347795|P1|Overall Study|Lost to Follow-up|8
1832828|NCT00330460|6347794|P2|Overall Study|Ineligibility determined|3
1832829|NCT00330460|6347795|P1|Overall Study|Ineligibility determined|1
1832830|NCT00330460|6347794|P2|Overall Study|Death|1
1832831|NCT00330460|6347795|P1|Overall Study|Death|1
1832832|NCT00330460|6347794|P2|Overall Study|Withdrawal by Subject|17
1832833|NCT00330460|6347795|P1|Overall Study|Withdrawal by Subject|18
1832834|NCT00330460|6347794|P2|Overall Study|Adverse Event|8
1832835|NCT00330460|6347795|P1|Overall Study|Adverse Event|10
1832836|NCT00330460|6347794|P2|Overall Study|Physician Decision|0
1832837|NCT00330460|6347795|P1|Overall Study|Physician Decision|1
1832838|NCT00330343|6347838|P1|Overall Study|Lost to Follow-up|5
1832839|NCT00330187|6347846|P4|Overall Study|Withdrawal by Subject|4
1832840|NCT00330187|6347847|P3|Overall Study|Withdrawal by Subject|4
1832841|NCT00330187|6347848|P2|Overall Study|Withdrawal by Subject|5
1832842|NCT00330187|6347849|P1|Overall Study|Withdrawal by Subject|8
1832843|NCT00330187|6347846|P4|Overall Study|Lost to Follow-up|10
1832844|NCT00330187|6347847|P3|Overall Study|Lost to Follow-up|14
1832845|NCT00330187|6347848|P2|Overall Study|Lost to Follow-up|13
1832846|NCT00330187|6347849|P1|Overall Study|Lost to Follow-up|12
1832847|NCT00330174|6347861|P2|Overall Study|Miscellaneous reasons|1
1832848|NCT00330174|6347862|P1|Overall Study|Miscellaneous reasons|7
1832849|NCT00330174|6347861|P2|Overall Study|Excessive missed visits|8
1832850|NCT00330174|6347862|P1|Overall Study|Excessive missed visits|3
1832851|NCT00330174|6347861|P2|Overall Study|Clinical deterioration|2
1832852|NCT00330174|6347862|P1|Overall Study|Clinical deterioration|1
1832853|NCT00330174|6347861|P2|Overall Study|Lost to Follow-up|1
1832854|NCT00330174|6347862|P1|Overall Study|Lost to Follow-up|4
1832855|NCT00330174|6347861|P2|Overall Study|Withdrawal by Subject|7
1832856|NCT00330174|6347862|P1|Overall Study|Withdrawal by Subject|7
1832857|NCT00329901|6347886|P3|Overall Study|Unable to classify|0
1832858|NCT00329901|6347887|P2|Overall Study|Unable to classify|2
1832859|NCT00329901|6347888|P1|Overall Study|Unable to classify|2
1832860|NCT00329901|6347886|P3|Overall Study|Protocol Violation|1
1832861|NCT00329901|6347887|P2|Overall Study|Protocol Violation|0
1832862|NCT00329901|6347888|P1|Overall Study|Protocol Violation|1
1832863|NCT00329901|6347886|P3|Overall Study|Lost to Follow-up|1
1832864|NCT00329901|6347887|P2|Overall Study|Lost to Follow-up|0
1832865|NCT00329901|6347888|P1|Overall Study|Lost to Follow-up|2
1832866|NCT00329901|6347886|P3|Overall Study|Withdrawal by Subject|2
1832867|NCT00329901|6347887|P2|Overall Study|Withdrawal by Subject|3
1832868|NCT00329901|6347888|P1|Overall Study|Withdrawal by Subject|4
1832869|NCT00329849|6347918|P2|Overall Study|Withdrawal by Subject|4
1832870|NCT00329849|6347919|P1|Overall Study|Withdrawal by Subject|6
1832871|NCT00329797|6347945|P2|Overall Study|Withdrawal by Subject|6
1832872|NCT00329797|6347946|P1|Overall Study|Withdrawal by Subject|6
1832873|NCT00329797|6347945|P2|Overall Study|Protocol Violation|0
1832874|NCT00329797|6347946|P1|Overall Study|Protocol Violation|1
1832875|NCT00329784|6347962|P4|Overall Study|Other|0
1832876|NCT00329784|6347963|P3|Overall Study|Other|0
1832877|NCT00329784|6347964|P2|Overall Study|Other|2
1832878|NCT00329784|6347965|P1|Overall Study|Other|1
1832879|NCT00329784|6347962|P4|Overall Study|Withdrawal by Subject|0
1832880|NCT00329784|6347963|P3|Overall Study|Withdrawal by Subject|0
1832881|NCT00329784|6347964|P2|Overall Study|Withdrawal by Subject|2
1832882|NCT00329784|6347965|P1|Overall Study|Withdrawal by Subject|4
1832883|NCT00329784|6347962|P4|Overall Study|Lost to Follow-up|0
1832884|NCT00329784|6347963|P3|Overall Study|Lost to Follow-up|0
1832885|NCT00329784|6347964|P2|Overall Study|Lost to Follow-up|1
1832886|NCT00329784|6347965|P1|Overall Study|Lost to Follow-up|0
1832887|NCT00329745|6347993|P2|Overall Study|Lost to Follow-up|101
1832888|NCT00329745|6347994|P1|Overall Study|Lost to Follow-up|86
1832889|NCT00329745|6347993|P2|Overall Study|Withdrawal by Subject|1
1832890|NCT00329745|6347994|P1|Overall Study|Withdrawal by Subject|0
1832891|NCT00329745|6347993|P2|Overall Study|Protocol Violation|0
1832892|NCT00329745|6347994|P1|Overall Study|Protocol Violation|1
1832893|NCT00329719|6348014|P4|Overall Study|Lost to Follow-up|1
1832894|NCT00329719|6348015|P3|Overall Study|Lost to Follow-up|0
1832895|NCT00329719|6348016|P2|Overall Study|Lost to Follow-up|0
1832896|NCT00329719|6348017|P1|Overall Study|Lost to Follow-up|0
1832897|NCT00329641|6348039|P1|Overall Study|Other reason, not protocol specified|1
1832898|NCT00329641|6348039|P1|Overall Study|Adverse Event|3
1832899|NCT00329641|6348039|P1|Overall Study|Not eligible|1
1832900|NCT00329641|6348039|P1|Overall Study|Did not start treatment|1
1832901|NCT00329602|6348048|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
1832902|NCT00329602|6348049|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
1832903|NCT00329602|6348050|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
1832904|NCT00329602|6348048|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
1832905|NCT00329602|6348049|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1832906|NCT00329602|6348050|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
1832907|NCT00329602|6348048|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
1832908|NCT00329602|6348049|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
1832909|NCT00329602|6348050|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
1832910|NCT00329602|6348048|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
1832911|NCT00329602|6348049|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1832912|NCT00329602|6348050|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
1832913|NCT00329602|6348048|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
1832914|NCT00329602|6348049|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
1832915|NCT00329602|6348050|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
1832916|NCT00329602|6348048|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
1832917|NCT00329602|6348049|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
1832918|NCT00329602|6348050|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
1832919|NCT00329550|6348088|P3|Overall Study|Due to Relocation|1
1832920|NCT00329550|6348089|P2|Overall Study|Due to Relocation|0
1832921|NCT00329550|6348090|P1|Overall Study|Due to Relocation|0
1832922|NCT00329550|6348088|P3|Overall Study|Withdrawal of Consent|1
1832923|NCT00329550|6348089|P2|Overall Study|Withdrawal of Consent|0
1832924|NCT00329550|6348090|P1|Overall Study|Withdrawal of Consent|1
1832925|NCT00329550|6348088|P3|Overall Study|Adverse Event|2
1832926|NCT00329550|6348089|P2|Overall Study|Adverse Event|4
1832927|NCT00329550|6348090|P1|Overall Study|Adverse Event|3
1832928|NCT00329420|6348359|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1832929|NCT00329420|6348360|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
1832930|NCT00329420|6348361|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
1832931|NCT00329420|6348359|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
1832932|NCT00329420|6348360|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1832933|NCT00329420|6348361|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
1832934|NCT00329420|6348359|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1832935|NCT00329420|6348360|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
1832936|NCT00329420|6348361|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
1832937|NCT00329420|6348359|P3|Re-induction Phase|Did not respond to re-induction|7
1832938|NCT00329420|6348360|P2|Re-induction Phase|Did not respond to re-induction|5
1832939|NCT00329420|6348361|P1|Re-induction Phase|Did not respond to re-induction|6
1832940|NCT00329420|6348359|P3|Re-induction Phase|Withdrawal of Consent|1
1832941|NCT00329420|6348360|P2|Re-induction Phase|Withdrawal of Consent|0
1832942|NCT00329420|6348361|P1|Re-induction Phase|Withdrawal of Consent|0
1832943|NCT00329420|6348359|P3|Re-induction Phase|Lack of Efficacy|0
1832944|NCT00329420|6348360|P2|Re-induction Phase|Lack of Efficacy|1
1832945|NCT00329420|6348361|P1|Re-induction Phase|Lack of Efficacy|0
1832946|NCT00329407|6348740|P1|Overall Study|Withdrawal by Subject|1
1832947|NCT00329303|6348747|P2|Overall Study|Patient relocated|1
1832948|NCT00329303|6348748|P1|Overall Study|Patient relocated|0
1832949|NCT00329303|6348747|P2|Overall Study|Patient no longer available|0
1832950|NCT00329303|6348748|P1|Overall Study|Patient no longer available|1
1832951|NCT00329303|6348747|P2|Overall Study|Decision of the sponsor|1
1832952|NCT00329303|6348748|P1|Overall Study|Decision of the sponsor|0
1832953|NCT00329303|6348747|P2|Overall Study|Lack of Efficacy|0
1832954|NCT00329303|6348748|P1|Overall Study|Lack of Efficacy|1
1832955|NCT00329238|6348910|P2|Overall Study|Other reason (not specified)|54
1832956|NCT00329238|6348911|P1|Overall Study|Other reason (not specified)|40
1832957|NCT00329238|6348910|P2|Overall Study|Withdrawal by Subject|58
1832958|NCT00329238|6348911|P1|Overall Study|Withdrawal by Subject|64
1832959|NCT00329238|6348910|P2|Overall Study|Lost to Follow-up|6
1832960|NCT00329238|6348911|P1|Overall Study|Lost to Follow-up|2
1832961|NCT00329238|6348910|P2|Overall Study|Protocol Violation|34
1832962|NCT00329238|6348911|P1|Overall Study|Protocol Violation|23
1832963|NCT00329238|6348910|P2|Overall Study|Adverse Event|129
1832964|NCT00329238|6348911|P1|Overall Study|Adverse Event|147
1832965|NCT00329160|6348947|P1|Overall Study|Incomplete IVUS|45
1832966|NCT00329160|6348947|P1|Overall Study|Did not Receive Study Drug|1
1832967|NCT00329160|6348947|P1|Overall Study|Protocol Violation|2
1832968|NCT00329160|6348947|P1|Overall Study|Withdrawal by Subject|13
1832969|NCT00329160|6348947|P1|Overall Study|Adverse Event|27
1832970|NCT00329108|6348956|P2|Overall Study|Protocol Violation|2
1832971|NCT00329108|6348957|P1|Overall Study|Protocol Violation|0
1832972|NCT00329108|6348956|P2|Overall Study|withdrew patient after SAE resolved|0
1832973|NCT00329108|6348957|P1|Overall Study|withdrew patient after SAE resolved|1
1832974|NCT00329108|6348956|P2|Overall Study|study terminated by sponsor|0
1832975|NCT00329108|6348957|P1|Overall Study|study terminated by sponsor|1
1832976|NCT00329108|6348956|P2|Overall Study|Subject no longer willing to participate|2
1832977|NCT00329108|6348957|P1|Overall Study|Subject no longer willing to participate|2
1832978|NCT00329108|6348956|P2|Overall Study|symptomatic deterioration|1
1832979|NCT00329108|6348957|P1|Overall Study|symptomatic deterioration|1
1832980|NCT00329108|6348956|P2|Overall Study|Withdrawal by Subject|2
1832981|NCT00329108|6348957|P1|Overall Study|Withdrawal by Subject|0
1832982|NCT00329108|6348956|P2|Overall Study|Lack of Efficacy|3
1832983|NCT00329108|6348957|P1|Overall Study|Lack of Efficacy|3
1832984|NCT00329108|6348956|P2|Overall Study|Adverse Event|2
1832985|NCT00329108|6348957|P1|Overall Study|Adverse Event|2
1832986|NCT00329030|6348965|P2|Overall Study|Ineligible Pathology|1
1832987|NCT00329030|6348966|P1|Overall Study|Ineligible Pathology|1
1832988|NCT00329030|6348965|P2|Overall Study|Progressive Disease|2
1832989|NCT00329030|6348966|P1|Overall Study|Progressive Disease|6
1832990|NCT00329030|6348965|P2|Overall Study|Withdrawal by Subject|3
1832991|NCT00329030|6348966|P1|Overall Study|Withdrawal by Subject|1
1832992|NCT00328926|6348997|P3|Overall Study|Lack of ovarian response|0
1832993|NCT00328926|6348998|P2|Overall Study|Lack of ovarian response|1
1832994|NCT00328926|6348999|P1|Overall Study|Lack of ovarian response|0
1832995|NCT00328926|6348997|P3|Overall Study|In vitro fertilization treatment|1
1832996|NCT00328926|6348998|P2|Overall Study|In vitro fertilization treatment|0
1832997|NCT00328926|6348999|P1|Overall Study|In vitro fertilization treatment|0
1832998|NCT00328926|6348997|P3|Overall Study|Death|1
1832999|NCT00328926|6348998|P2|Overall Study|Death|0
1833000|NCT00328926|6348999|P1|Overall Study|Death|0
1833001|NCT00328926|6348997|P3|Overall Study|Lost to Follow-up|0
1833002|NCT00328926|6348998|P2|Overall Study|Lost to Follow-up|1
1833003|NCT00328926|6348999|P1|Overall Study|Lost to Follow-up|0
1833004|NCT00328926|6348997|P3|Overall Study|Pregnancy|0
1833005|NCT00328926|6348998|P2|Overall Study|Pregnancy|1
1833006|NCT00328926|6348999|P1|Overall Study|Pregnancy|2
1833007|NCT00328783|6349024|P1|Overall Study|Withdrawal by Subject|1
1833008|NCT00328783|6349024|P1|Overall Study|No heart in RT field|4
1833009|NCT00328783|6349024|P1|Overall Study|Could not tolerate ABC|21
1833010|NCT00328627|6349050|P12|Overall Study|Other|0
1833011|NCT00328627|6349051|P11|Overall Study|Other|1
1833012|NCT00328627|6349052|P10|Overall Study|Other|1
1833013|NCT00328627|6349053|P9|Overall Study|Other|0
1833014|NCT00328627|6349054|P8|Overall Study|Other|0
1833015|NCT00328627|6349055|P7|Overall Study|Other|1
1833016|NCT00328627|6349056|P6|Overall Study|Other|0
1833017|NCT00328627|6349057|P5|Overall Study|Other|0
1833018|NCT00328627|6349058|P4|Overall Study|Other|1
1833019|NCT00328627|6349059|P3|Overall Study|Other|0
1833020|NCT00328627|6349060|P2|Overall Study|Other|0
1833021|NCT00328627|6349061|P1|Overall Study|Other|0
1833022|NCT00328627|6349050|P12|Overall Study|Physician Decision|0
1833023|NCT00328627|6349051|P11|Overall Study|Physician Decision|1
1833024|NCT00328627|6349052|P10|Overall Study|Physician Decision|2
1833025|NCT00328627|6349053|P9|Overall Study|Physician Decision|3
1833026|NCT00328627|6349054|P8|Overall Study|Physician Decision|0
1833027|NCT00328627|6349055|P7|Overall Study|Physician Decision|1
1833028|NCT00328627|6349056|P6|Overall Study|Physician Decision|1
1833029|NCT00328627|6349057|P5|Overall Study|Physician Decision|1
1833030|NCT00328627|6349058|P4|Overall Study|Physician Decision|2
1833031|NCT00328627|6349059|P3|Overall Study|Physician Decision|1
1833032|NCT00328627|6349060|P2|Overall Study|Physician Decision|3
1833033|NCT00328627|6349061|P1|Overall Study|Physician Decision|4
1833034|NCT00328627|6349050|P12|Overall Study|Pregnancy|0
1833035|NCT00328627|6349051|P11|Overall Study|Pregnancy|0
1833036|NCT00328627|6349052|P10|Overall Study|Pregnancy|0
1833037|NCT00328627|6349053|P9|Overall Study|Pregnancy|0
1833038|NCT00328627|6349054|P8|Overall Study|Pregnancy|0
1833039|NCT00328627|6349055|P7|Overall Study|Pregnancy|0
1833040|NCT00328627|6349056|P6|Overall Study|Pregnancy|0
1833041|NCT00328627|6349057|P5|Overall Study|Pregnancy|0
1833042|NCT00328627|6349058|P4|Overall Study|Pregnancy|0
1833043|NCT00328627|6349059|P3|Overall Study|Pregnancy|0
1833044|NCT00328627|6349060|P2|Overall Study|Pregnancy|1
1833045|NCT00328627|6349061|P1|Overall Study|Pregnancy|0
1833046|NCT00328627|6349050|P12|Overall Study|Withdrawal by Subject|7
1833047|NCT00328627|6349051|P11|Overall Study|Withdrawal by Subject|2
1833048|NCT00328627|6349052|P10|Overall Study|Withdrawal by Subject|5
1833049|NCT00328627|6349053|P9|Overall Study|Withdrawal by Subject|4
1833050|NCT00328627|6349054|P8|Overall Study|Withdrawal by Subject|4
1833051|NCT00328627|6349055|P7|Overall Study|Withdrawal by Subject|4
1833052|NCT00328627|6349056|P6|Overall Study|Withdrawal by Subject|5
1833053|NCT00328627|6349057|P5|Overall Study|Withdrawal by Subject|2
1833054|NCT00328627|6349058|P4|Overall Study|Withdrawal by Subject|6
1833055|NCT00328627|6349059|P3|Overall Study|Withdrawal by Subject|5
1833056|NCT00328627|6349060|P2|Overall Study|Withdrawal by Subject|4
1833057|NCT00328627|6349061|P1|Overall Study|Withdrawal by Subject|5
1833058|NCT00328627|6349050|P12|Overall Study|Lost to Follow-up|1
1833059|NCT00328627|6349051|P11|Overall Study|Lost to Follow-up|0
1833060|NCT00328627|6349052|P10|Overall Study|Lost to Follow-up|2
1833061|NCT00328627|6349053|P9|Overall Study|Lost to Follow-up|3
1833062|NCT00328627|6349054|P8|Overall Study|Lost to Follow-up|0
1833063|NCT00328627|6349055|P7|Overall Study|Lost to Follow-up|3
1833064|NCT00328627|6349056|P6|Overall Study|Lost to Follow-up|2
1833065|NCT00328627|6349057|P5|Overall Study|Lost to Follow-up|0
1833066|NCT00328627|6349058|P4|Overall Study|Lost to Follow-up|4
1833067|NCT00328627|6349059|P3|Overall Study|Lost to Follow-up|2
1833068|NCT00328627|6349060|P2|Overall Study|Lost to Follow-up|2
1833069|NCT00328627|6349061|P1|Overall Study|Lost to Follow-up|4
1833070|NCT00328627|6349050|P12|Overall Study|Protocol Violation|2
1833071|NCT00328627|6349051|P11|Overall Study|Protocol Violation|6
1833072|NCT00328627|6349052|P10|Overall Study|Protocol Violation|4
1833073|NCT00328627|6349053|P9|Overall Study|Protocol Violation|1
1833074|NCT00328627|6349054|P8|Overall Study|Protocol Violation|2
1833075|NCT00328627|6349055|P7|Overall Study|Protocol Violation|6
1833076|NCT00328627|6349056|P6|Overall Study|Protocol Violation|5
1833077|NCT00328627|6349057|P5|Overall Study|Protocol Violation|5
1833078|NCT00328627|6349058|P4|Overall Study|Protocol Violation|8
1833079|NCT00328627|6349059|P3|Overall Study|Protocol Violation|2
1833080|NCT00328627|6349060|P2|Overall Study|Protocol Violation|2
1833081|NCT00328627|6349061|P1|Overall Study|Protocol Violation|2
1833082|NCT00328627|6349050|P12|Overall Study|Adverse Event|4
1833083|NCT00328627|6349051|P11|Overall Study|Adverse Event|5
1833084|NCT00328627|6349052|P10|Overall Study|Adverse Event|7
1833085|NCT00328627|6349053|P9|Overall Study|Adverse Event|0
1833086|NCT00328627|6349054|P8|Overall Study|Adverse Event|2
1833087|NCT00328627|6349055|P7|Overall Study|Adverse Event|1
1833088|NCT00328627|6349056|P6|Overall Study|Adverse Event|2
1833089|NCT00328627|6349057|P5|Overall Study|Adverse Event|1
1833090|NCT00328627|6349058|P4|Overall Study|Adverse Event|3
1833091|NCT00328627|6349059|P3|Overall Study|Adverse Event|2
1833092|NCT00328627|6349060|P2|Overall Study|Adverse Event|1
1833093|NCT00328627|6349061|P1|Overall Study|Adverse Event|3
1833094|NCT00328627|6349050|P12|Overall Study|Hyperglycemic Rescue|2
1833095|NCT00328627|6349051|P11|Overall Study|Hyperglycemic Rescue|3
1833096|NCT00328627|6349052|P10|Overall Study|Hyperglycemic Rescue|11
1833097|NCT00328627|6349053|P9|Overall Study|Hyperglycemic Rescue|6
1833098|NCT00328627|6349054|P8|Overall Study|Hyperglycemic Rescue|6
1833099|NCT00328627|6349055|P7|Overall Study|Hyperglycemic Rescue|19
1833100|NCT00328627|6349056|P6|Overall Study|Hyperglycemic Rescue|5
1833101|NCT00328627|6349057|P5|Overall Study|Hyperglycemic Rescue|6
1833102|NCT00328627|6349058|P4|Overall Study|Hyperglycemic Rescue|13
1833103|NCT00328627|6349059|P3|Overall Study|Hyperglycemic Rescue|16
1833104|NCT00328627|6349060|P2|Overall Study|Hyperglycemic Rescue|18
1833105|NCT00328627|6349061|P1|Overall Study|Hyperglycemic Rescue|41
1833106|NCT00328562|6350598|P1|Overall Study|Disease progression|1
1833107|NCT00328510|6350607|P2|Overall Study|Treatment changed to a single fraction|1
1833108|NCT00328510|6350608|P1|Overall Study|Treatment changed to a single fraction|1
1833109|NCT00328510|6350607|P2|Overall Study|Severe kyphosis, could not use mask|1
1833110|NCT00328510|6350608|P1|Overall Study|Severe kyphosis, could not use mask|0
1833111|NCT00328510|6350607|P2|Overall Study|Withdrawal by Subject|2
1833112|NCT00328510|6350608|P1|Overall Study|Withdrawal by Subject|4
1833113|NCT00328510|6350607|P2|Overall Study|Dentition problems, could not use frame|0
1833114|NCT00328510|6350608|P1|Overall Study|Dentition problems, could not use frame|1
1833115|NCT00328510|6350607|P2|Overall Study|Gag disorder, could not use frame|0
1833116|NCT00328510|6350608|P1|Overall Study|Gag disorder, could not use frame|4
1833117|NCT00328198|6350623|P1|Follow-up|Death|31
1833118|NCT00328198|6350623|P1|Follow-up|Lost to Follow-up|4
1833119|NCT00328198|6350623|P1|Treatment|Confirmed complete response, MRD -|3
1833120|NCT00328198|6350623|P1|Treatment|Non-compliance|1
1833121|NCT00328198|6350623|P1|Treatment|Evidence of disease progression|2
1833122|NCT00328198|6350623|P1|Treatment|Withdrawal by Subject|5
1833123|NCT00328198|6350623|P1|Treatment|Physician Decision|5
1833124|NCT00328198|6350623|P1|Treatment|Death|1
1833125|NCT00328198|6350623|P1|Treatment|Adverse Event|21
1833126|NCT00328172|6350638|P5|Overall Study|Other reason (not specified)|0
1833127|NCT00328172|6350639|P4|Overall Study|Other reason (not specified)|0
1833128|NCT00328172|6350640|P3|Overall Study|Other reason (not specified)|1
1833129|NCT00328172|6350641|P2|Overall Study|Other reason (not specified)|0
1833130|NCT00328172|6350642|P1|Overall Study|Other reason (not specified)|3
1833131|NCT00328172|6350638|P5|Overall Study|Lack of Efficacy|3
1833132|NCT00328172|6350639|P4|Overall Study|Lack of Efficacy|4
1833133|NCT00328172|6350640|P3|Overall Study|Lack of Efficacy|4
1833134|NCT00328172|6350641|P2|Overall Study|Lack of Efficacy|9
1833135|NCT00328172|6350642|P1|Overall Study|Lack of Efficacy|14
1833136|NCT00328172|6350638|P5|Overall Study|Withdrawal by Subject|0
1833137|NCT00328172|6350639|P4|Overall Study|Withdrawal by Subject|6
1833138|NCT00328172|6350640|P3|Overall Study|Withdrawal by Subject|1
1833139|NCT00328172|6350641|P2|Overall Study|Withdrawal by Subject|1
1833140|NCT00328172|6350642|P1|Overall Study|Withdrawal by Subject|1
1833141|NCT00328172|6350638|P5|Overall Study|Lost to Follow-up|1
1833142|NCT00328172|6350639|P4|Overall Study|Lost to Follow-up|1
1833143|NCT00328172|6350640|P3|Overall Study|Lost to Follow-up|2
1833144|NCT00328172|6350641|P2|Overall Study|Lost to Follow-up|1
1833145|NCT00328172|6350642|P1|Overall Study|Lost to Follow-up|1
1833146|NCT00328172|6350638|P5|Overall Study|Protocol Violation|0
1833147|NCT00328172|6350639|P4|Overall Study|Protocol Violation|0
1833148|NCT00328172|6350640|P3|Overall Study|Protocol Violation|1
1833149|NCT00328172|6350641|P2|Overall Study|Protocol Violation|1
1833150|NCT00328172|6350642|P1|Overall Study|Protocol Violation|0
1833151|NCT00328172|6350638|P5|Overall Study|Adverse Event|1
1833152|NCT00328172|6350639|P4|Overall Study|Adverse Event|2
1833153|NCT00328172|6350640|P3|Overall Study|Adverse Event|1
1833154|NCT00328172|6350641|P2|Overall Study|Adverse Event|2
1833155|NCT00328172|6350642|P1|Overall Study|Adverse Event|3
1833156|NCT00328094|6350666|P2|Overall Study|Physician Decision|3
1833157|NCT00328094|6350667|P1|Overall Study|Physician Decision|3
1833158|NCT00327717|6350701|P2|Overall Study|Withdrawal by Subject|7
1833159|NCT00327717|6350702|P1|Overall Study|Withdrawal by Subject|3
1833160|NCT00327717|6350701|P2|Overall Study|Lack of Efficacy|1
1833161|NCT00327717|6350702|P1|Overall Study|Lack of Efficacy|0
1833162|NCT00327717|6350701|P2|Overall Study|Adverse Event|6
1833163|NCT00327717|6350702|P1|Overall Study|Adverse Event|6
1833164|NCT00327470|6350728|P2|Overall Study|Death|4
1833165|NCT00327470|6350729|P1|Overall Study|Death|1
1833166|NCT00327470|6350728|P2|Overall Study|Withdrawal by Subject|12
1833167|NCT00327470|6350729|P1|Overall Study|Withdrawal by Subject|6
1833168|NCT00327470|6350728|P2|Overall Study|Lost to Follow-up|3
1833169|NCT00327470|6350729|P1|Overall Study|Lost to Follow-up|1
1833170|NCT00327470|6350728|P2|Overall Study|Other|9
1833171|NCT00327470|6350729|P1|Overall Study|Other|5
1833172|NCT00327470|6350728|P2|Overall Study|Lack of Efficacy|19
1833173|NCT00327470|6350729|P1|Overall Study|Lack of Efficacy|7
1833174|NCT00327470|6350728|P2|Overall Study|Adverse Event|14
1833175|NCT00327470|6350729|P1|Overall Study|Adverse Event|9
1833176|NCT00327470|6350728|P2|Overall Study|Randomized, but not treated|2
1833177|NCT00327470|6350729|P1|Overall Study|Randomized, but not treated|0
1833178|NCT00327444|6350749|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
1833179|NCT00327444|6350750|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
1833180|NCT00327444|6350749|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
1833181|NCT00327444|6350750|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
1833182|NCT00327444|6350749|P2|Open Label Treatment (OL) Period|Adverse Event|2
1833183|NCT00327444|6350750|P1|Open Label Treatment (OL) Period|Adverse Event|2
1833184|NCT00327444|6350749|P2|Open Label Treatment (OL) Period|Disease progression|7
1833185|NCT00327444|6350750|P1|Open Label Treatment (OL) Period|Disease progression|8
1833186|NCT00327444|6350749|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
1833187|NCT00327444|6350750|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
1833188|NCT00327444|6350749|P2|Double Blind Treatment (DB) Period|Subject request|1
1833189|NCT00327444|6350750|P1|Double Blind Treatment (DB) Period|Subject request|0
1833190|NCT00327444|6350749|P2|Double Blind Treatment (DB) Period|Adverse Event|5
1833191|NCT00327444|6350750|P1|Double Blind Treatment (DB) Period|Adverse Event|5
1833192|NCT00327444|6350749|P2|Double Blind Treatment (DB) Period|Disease progression|13
1833193|NCT00327444|6350750|P1|Double Blind Treatment (DB) Period|Disease progression|10
1833194|NCT00327340|6350768|P2|Overall Study|Adverse Event|3
1833195|NCT00327340|6350769|P1|Overall Study|Adverse Event|3
1833196|NCT00327340|6350768|P2|Overall Study|Symptomatic Disease|2
1833197|NCT00327340|6350769|P1|Overall Study|Symptomatic Disease|0
1833198|NCT00327340|6350768|P2|Overall Study|Disease Progression|19
1833199|NCT00327340|6350769|P1|Overall Study|Disease Progression|10
1833200|NCT00327340|6350768|P2|Overall Study|Physician Decision|1
1833201|NCT00327340|6350769|P1|Overall Study|Physician Decision|1
1833202|NCT00327340|6350768|P2|Overall Study|Withdrawal by Subject|5
1833203|NCT00327340|6350769|P1|Overall Study|Withdrawal by Subject|1
1833204|NCT00327171|6350783|P2|Overall Study|Other|0
1833205|NCT00327171|6350784|P1|Overall Study|Other|1
1833206|NCT00327171|6350783|P2|Overall Study|Undisclosed history of ischemia|1
1833207|NCT00327171|6350784|P1|Overall Study|Undisclosed history of ischemia|0
1833208|NCT00327171|6350783|P2|Overall Study|Clinical progression|8
1833209|NCT00327171|6350784|P1|Overall Study|Clinical progression|12
1833210|NCT00327171|6350783|P2|Overall Study|Investigator/participant request|8
1833211|NCT00327171|6350784|P1|Overall Study|Investigator/participant request|1
1833212|NCT00327171|6350783|P2|Overall Study|Disease progression/lack of efficacy|69
1833213|NCT00327171|6350784|P1|Overall Study|Disease progression/lack of efficacy|68
1833214|NCT00327171|6350783|P2|Overall Study|Adverse Event|23
1833215|NCT00327171|6350784|P1|Overall Study|Adverse Event|23
1833216|NCT00327171|6350783|P2|Overall Study|Did not receive study medication|0
1833217|NCT00327171|6350784|P1|Overall Study|Did not receive study medication|3
1833218|NCT00327015|6350816|P4|Overall Study|Administrative Reason by Sponsor|1
1833219|NCT00327015|6350817|P3|Overall Study|Administrative Reason by Sponsor|2
1833220|NCT00327015|6350818|P2|Overall Study|Administrative Reason by Sponsor|2
1833221|NCT00327015|6350819|P1|Overall Study|Administrative Reason by Sponsor|1
1833222|NCT00327015|6350816|P4|Overall Study|Pregnancy|1
1833223|NCT00327015|6350817|P3|Overall Study|Pregnancy|1
1833224|NCT00327015|6350818|P2|Overall Study|Pregnancy|2
1833225|NCT00327015|6350819|P1|Overall Study|Pregnancy|0
1833226|NCT00327015|6350816|P4|Overall Study|Death|3
1833227|NCT00327015|6350817|P3|Overall Study|Death|2
1833228|NCT00327015|6350818|P2|Overall Study|Death|2
1833229|NCT00327015|6350819|P1|Overall Study|Death|1
1833230|NCT00327015|6350816|P4|Overall Study|Physician Decision|2
1833231|NCT00327015|6350817|P3|Overall Study|Physician Decision|3
1833232|NCT00327015|6350818|P2|Overall Study|Physician Decision|1
1833233|NCT00327015|6350819|P1|Overall Study|Physician Decision|0
1833234|NCT00327015|6350816|P4|Overall Study|Poor/Noncompliance|5
1833235|NCT00327015|6350817|P3|Overall Study|Poor/Noncompliance|4
1833236|NCT00327015|6350818|P2|Overall Study|Poor/Noncompliance|8
1833237|NCT00327015|6350819|P1|Overall Study|Poor/Noncompliance|11
1833238|NCT00327015|6350816|P4|Overall Study|Subject no longer meets study criteria|7
1833239|NCT00327015|6350817|P3|Overall Study|Subject no longer meets study criteria|8
1833240|NCT00327015|6350818|P2|Overall Study|Subject no longer meets study criteria|2
1833241|NCT00327015|6350819|P1|Overall Study|Subject no longer meets study criteria|4
1833242|NCT00327015|6350816|P4|Overall Study|Adverse Event|14
1833243|NCT00327015|6350817|P3|Overall Study|Adverse Event|14
1833244|NCT00327015|6350818|P2|Overall Study|Adverse Event|10
1833245|NCT00327015|6350819|P1|Overall Study|Adverse Event|14
1833246|NCT00327015|6350816|P4|Overall Study|Lost to Follow-up|22
1833247|NCT00327015|6350817|P3|Overall Study|Lost to Follow-up|29
1833248|NCT00327015|6350818|P2|Overall Study|Lost to Follow-up|23
1833249|NCT00327015|6350819|P1|Overall Study|Lost to Follow-up|22
1833250|NCT00327015|6350816|P4|Overall Study|Withdrawal of Consent by Subject|25
1833251|NCT00327015|6350817|P3|Overall Study|Withdrawal of Consent by Subject|28
1833252|NCT00327015|6350818|P2|Overall Study|Withdrawal of Consent by Subject|24
1833253|NCT00327015|6350819|P1|Overall Study|Withdrawal of Consent by Subject|20
1833254|NCT00327015|6350816|P4|Overall Study|Lack of Efficacy|29
1833255|NCT00327015|6350817|P3|Overall Study|Lack of Efficacy|35
1833256|NCT00327015|6350818|P2|Overall Study|Lack of Efficacy|18
1833257|NCT00327015|6350819|P1|Overall Study|Lack of Efficacy|18
1833258|NCT00326963|6350861|P1|Overall Study|Administrative / other|1
1833259|NCT00326963|6350861|P1|Overall Study|Other protocol violation|1
1833260|NCT00326963|6350861|P1|Overall Study|Violation of selection criteria at entry|2
1833261|NCT00326963|6350861|P1|Overall Study|Refused treatment / did not cooperate|5
1833262|NCT00326963|6350861|P1|Overall Study|Withdrawal by Subject|10
1833263|NCT00326963|6350861|P1|Overall Study|Failure to return|10
1833264|NCT00326963|6350861|P1|Overall Study|Death|1
1833265|NCT00326963|6350861|P1|Overall Study|Injection site reaction|1
1833266|NCT00326963|6350861|P1|Overall Study|Adverse Event|2
1833267|NCT00326950|6350881|P1|Overall Study|Progressive Disease|1
1833268|NCT00326911|6350903|P2|Overall Study|Withdrawal by subject prior to treatment|1
1833269|NCT00326911|6350904|P1|Overall Study|Withdrawal by subject prior to treatment|0
1833270|NCT00326911|6350903|P2|Overall Study|Physician decision prior to treatment|0
1833271|NCT00326911|6350904|P1|Overall Study|Physician decision prior to treatment|1
1833272|NCT00326911|6350903|P2|Overall Study|Hospitalization prior to treatment|1
1833273|NCT00326911|6350904|P1|Overall Study|Hospitalization prior to treatment|0
1833274|NCT00326898|6350957|P3|Overall Study|Other/Missing/Unknown|32
1833275|NCT00326898|6350958|P2|Overall Study|Other/Missing/Unknown|28
1833276|NCT00326898|6350959|P1|Overall Study|Other/Missing/Unknown|33
1833277|NCT00326898|6350957|P3|Overall Study|Other complicating disease|4
1833278|NCT00326898|6350958|P2|Overall Study|Other complicating disease|5
1833279|NCT00326898|6350959|P1|Overall Study|Other complicating disease|5
1833280|NCT00326898|6350957|P3|Overall Study|Alternative therapy|0
1833281|NCT00326898|6350958|P2|Overall Study|Alternative therapy|0
1833282|NCT00326898|6350959|P1|Overall Study|Alternative therapy|1
1833283|NCT00326898|6350957|P3|Overall Study|Withdrawal by Subject|32
1833284|NCT00326898|6350958|P2|Overall Study|Withdrawal by Subject|128
1833285|NCT00326898|6350959|P1|Overall Study|Withdrawal by Subject|134
1833286|NCT00326898|6350957|P3|Overall Study|Death|0
1833287|NCT00326898|6350958|P2|Overall Study|Death|0
1833288|NCT00326898|6350959|P1|Overall Study|Death|2
1833289|NCT00326898|6350957|P3|Overall Study|Adverse Event|33
1833290|NCT00326898|6350958|P2|Overall Study|Adverse Event|128
1833291|NCT00326898|6350959|P1|Overall Study|Adverse Event|124
1833292|NCT00326898|6350957|P3|Overall Study|Disease progression|102
1833293|NCT00326898|6350958|P2|Overall Study|Disease progression|54
1833294|NCT00326898|6350959|P1|Overall Study|Disease progression|52
1833295|NCT00326885|6350976|P1|Overall Study|Hospice withdrew consent|2
1833296|NCT00326885|6350976|P1|Overall Study|Physician Decision|1
1833297|NCT00326885|6350976|P1|Overall Study|Withdrawal by Subject|3
1833298|NCT00326885|6350976|P1|Overall Study|Adverse Event|1
1833299|NCT00326716|6351007|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1833300|NCT00326716|6351008|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
1833301|NCT00326716|6351009|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
1833302|NCT00326716|6351010|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
1833303|NCT00326612|6351082|P2|Overall Study|They did not have a seizure requiring tx|137
1833304|NCT00326612|6351083|P1|Overall Study|They did not have a seizure requiring tx|129
1833305|NCT00326599|6351105|P4|Overall Study|Other Unspecified Reason|1
1833306|NCT00326599|6351106|P3|Overall Study|Other Unspecified Reason|2
1833307|NCT00326599|6351107|P2|Overall Study|Other Unspecified Reason|0
1833308|NCT00326599|6351108|P1|Overall Study|Other Unspecified Reason|0
1833309|NCT00326599|6351105|P4|Overall Study|Death|2
1833310|NCT00326599|6351106|P3|Overall Study|Death|1
1833311|NCT00326599|6351107|P2|Overall Study|Death|0
1833312|NCT00326599|6351108|P1|Overall Study|Death|0
1833313|NCT00326599|6351105|P4|Overall Study|Alternate Treatment|0
1833314|NCT00326599|6351106|P3|Overall Study|Alternate Treatment|0
1833315|NCT00326599|6351107|P2|Overall Study|Alternate Treatment|0
1833316|NCT00326599|6351108|P1|Overall Study|Alternate Treatment|1
1833317|NCT00326599|6351105|P4|Overall Study|Disease Progression|11
1833318|NCT00326599|6351106|P3|Overall Study|Disease Progression|13
1833319|NCT00326599|6351107|P2|Overall Study|Disease Progression|1
1833320|NCT00326599|6351108|P1|Overall Study|Disease Progression|3
1833321|NCT00326599|6351105|P4|Overall Study|Adverse Event|3
1833322|NCT00326599|6351106|P3|Overall Study|Adverse Event|32
1833323|NCT00326599|6351107|P2|Overall Study|Adverse Event|0
1833324|NCT00326599|6351108|P1|Overall Study|Adverse Event|1
1833325|NCT00326599|6351105|P4|Overall Study|Withdrawal by Subject|2
1833326|NCT00326599|6351106|P3|Overall Study|Withdrawal by Subject|5
1833327|NCT00326599|6351107|P2|Overall Study|Withdrawal by Subject|0
1833328|NCT00326599|6351108|P1|Overall Study|Withdrawal by Subject|1
1833329|NCT00326495|6351127|P1|Overall Study|Subject off study before assessment|1
1833330|NCT00326495|6351127|P1|Overall Study|Refused further treatment|2
1833331|NCT00326495|6351127|P1|Overall Study|Disease progression before treatment|1
1833505|NCT00324805|6351705|P2|Overall Study|Progression|35
1833332|NCT00326495|6351127|P1|Overall Study|Switched to alternative treatment|1
1833333|NCT00326417|6351134|P4|Overall Study|Death|0
1833334|NCT00326417|6351135|P3|Overall Study|Death|0
1833335|NCT00326417|6351136|P2|Overall Study|Death|0
1833336|NCT00326417|6351137|P1|Overall Study|Death|7
1833337|NCT00326417|6351134|P4|Overall Study|Arm Closed|3
1833338|NCT00326417|6351135|P3|Overall Study|Arm Closed|0
1833339|NCT00326417|6351136|P2|Overall Study|Arm Closed|0
1833340|NCT00326417|6351137|P1|Overall Study|Arm Closed|7
1833341|NCT00326417|6351134|P4|Overall Study|Withdrawal by Subject|0
1833342|NCT00326417|6351135|P3|Overall Study|Withdrawal by Subject|1
1833343|NCT00326417|6351136|P2|Overall Study|Withdrawal by Subject|0
1833344|NCT00326417|6351137|P1|Overall Study|Withdrawal by Subject|0
1833345|NCT00326209|6351153|P1|Overall Study|Pregnancy|1
1833346|NCT00326209|6351153|P1|Overall Study|Withdrawn in error|1
1833347|NCT00326209|6351153|P1|Overall Study|Violation of entry criteria|1
1833348|NCT00326209|6351153|P1|Overall Study|Prohibited medication use|1
1833349|NCT00326209|6351153|P1|Overall Study|Sponsor closed study|173
1833350|NCT00326209|6351153|P1|Overall Study|Participant non-compliant|6
1833351|NCT00326209|6351153|P1|Overall Study|Lost to Follow-up|18
1833352|NCT00326209|6351153|P1|Overall Study|Lack of Efficacy|31
1833353|NCT00326209|6351153|P1|Overall Study|Withdrawal by Subject|22
1833354|NCT00326209|6351153|P1|Overall Study|Adverse Event|28
1833355|NCT00326183|6351171|P2|Overall Study|Adverse Event|0
1833356|NCT00326183|6351172|P1|Overall Study|Adverse Event|1
1833357|NCT00326183|6351171|P2|Overall Study|Other|13
1833358|NCT00326183|6351172|P1|Overall Study|Other|47
1833359|NCT00326183|6351171|P2|Overall Study|Subject Moved|4
1833360|NCT00326183|6351172|P1|Overall Study|Subject Moved|7
1833361|NCT00326183|6351171|P2|Overall Study|Withdrawal by Subject|7
1833362|NCT00326183|6351172|P1|Overall Study|Withdrawal by Subject|35
1833363|NCT00326183|6351171|P2|Overall Study|Protocol Violation|3
1833364|NCT00326183|6351172|P1|Overall Study|Protocol Violation|6
1833365|NCT00326183|6351171|P2|Overall Study|Lost to Follow-up|56
1833366|NCT00326183|6351172|P1|Overall Study|Lost to Follow-up|104
1833367|NCT00326118|6351204|P2|Active Phase|Withdrawal by Subject|1
1833368|NCT00326118|6351205|P1|Active Phase|Withdrawal by Subject|4
1833369|NCT00326001|6351241|P2|Overall Study|Physician Decision|3
1833370|NCT00326001|6351242|P1|Overall Study|Physician Decision|3
1833371|NCT00326001|6351241|P2|Overall Study|Adverse Event|5
1833372|NCT00326001|6351242|P1|Overall Study|Adverse Event|4
1833373|NCT00325897|6351256|P2|Overall Study|Lost to Follow-up|13
1833374|NCT00325897|6351257|P1|Overall Study|Lost to Follow-up|12
1833375|NCT00325819|6351277|P2|Overall Study|Lost to Follow-up|3
1833376|NCT00325819|6351278|P1|Overall Study|Lost to Follow-up|3
1833377|NCT00325819|6351277|P2|Overall Study|Did not take a dose of study product|9
1833378|NCT00325819|6351278|P1|Overall Study|Did not take a dose of study product|4
1833379|NCT00325819|6351277|P2|Overall Study|Study product lost in mail|1
1833380|NCT00325819|6351278|P1|Overall Study|Study product lost in mail|2
1833381|NCT00325754|6351305|P2|Overall Study|Adverse Event|1
1833382|NCT00325754|6351306|P1|Overall Study|Adverse Event|4
1833383|NCT00325468|6351361|P5|Overall Study|site closure etc|1
1833384|NCT00325468|6351362|P4|Overall Study|site closure etc|8
1833385|NCT00325468|6351363|P3|Overall Study|site closure etc|1
1833386|NCT00325468|6351364|P2|Overall Study|site closure etc|2
1833387|NCT00325468|6351365|P1|Overall Study|site closure etc|4
1833388|NCT00325468|6351361|P5|Overall Study|Withdrawal by Subject|4
1833389|NCT00325468|6351362|P4|Overall Study|Withdrawal by Subject|14
1833390|NCT00325468|6351363|P3|Overall Study|Withdrawal by Subject|0
1833391|NCT00325468|6351364|P2|Overall Study|Withdrawal by Subject|1
1833392|NCT00325468|6351365|P1|Overall Study|Withdrawal by Subject|3
1833393|NCT00325468|6351361|P5|Overall Study|Physician Decision|0
1833394|NCT00325468|6351362|P4|Overall Study|Physician Decision|1
1833395|NCT00325468|6351363|P3|Overall Study|Physician Decision|0
1833396|NCT00325468|6351364|P2|Overall Study|Physician Decision|1
1833397|NCT00325468|6351365|P1|Overall Study|Physician Decision|1
1833398|NCT00325468|6351361|P5|Overall Study|Lost to Follow-up|2
1833399|NCT00325468|6351362|P4|Overall Study|Lost to Follow-up|2
1833400|NCT00325468|6351363|P3|Overall Study|Lost to Follow-up|1
1833401|NCT00325468|6351364|P2|Overall Study|Lost to Follow-up|0
1833402|NCT00325468|6351365|P1|Overall Study|Lost to Follow-up|0
1833403|NCT00325468|6351361|P5|Overall Study|Death|0
1833404|NCT00325468|6351362|P4|Overall Study|Death|4
1833405|NCT00325468|6351363|P3|Overall Study|Death|2
1833406|NCT00325468|6351364|P2|Overall Study|Death|0
1833407|NCT00325468|6351365|P1|Overall Study|Death|2
1833408|NCT00325468|6351361|P5|Overall Study|Adverse Event|1
1833409|NCT00325468|6351362|P4|Overall Study|Adverse Event|5
1833410|NCT00325468|6351363|P3|Overall Study|Adverse Event|0
1833411|NCT00325468|6351364|P2|Overall Study|Adverse Event|1
1833412|NCT00325468|6351365|P1|Overall Study|Adverse Event|1
1833413|NCT00325416|6351448|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
1833414|NCT00325416|6351449|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
1833415|NCT00325416|6351448|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
1833416|NCT00325416|6351449|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
1833417|NCT00325416|6351448|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
1833418|NCT00325416|6351449|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
1833419|NCT00325416|6351448|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
1833420|NCT00325416|6351449|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
1833421|NCT00325416|6351448|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
1833422|NCT00325416|6351449|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
1833423|NCT00325416|6351448|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
1833424|NCT00325416|6351449|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
1833425|NCT00325234|6351502|P2|Overall Study|Progressive Disease|37
1833426|NCT00325234|6351503|P1|Overall Study|Progressive Disease|34
1833427|NCT00325234|6351502|P2|Overall Study|Physician Decision|12
1833428|NCT00325234|6351503|P1|Overall Study|Physician Decision|17
1833429|NCT00325234|6351502|P2|Overall Study|Subject Decision|8
1833430|NCT00325234|6351503|P1|Overall Study|Subject Decision|6
1833431|NCT00325234|6351502|P2|Overall Study|Entry Criteria Not Met|2
1833432|NCT00325234|6351503|P1|Overall Study|Entry Criteria Not Met|1
1833433|NCT00325234|6351502|P2|Overall Study|Death due to Study Disease|0
1833434|NCT00325234|6351503|P1|Overall Study|Death due to Study Disease|1
1833435|NCT00325234|6351502|P2|Overall Study|Adverse Event|7
1833436|NCT00325234|6351503|P1|Overall Study|Adverse Event|10
1833437|NCT00325195|6351522|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
1833438|NCT00325195|6351523|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1833439|NCT00325195|6351524|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
1833440|NCT00325195|6351522|P3|Received Intervention: ITT Population|Lost to Follow-up|2
1833441|NCT00325195|6351523|P2|Received Intervention: ITT Population|Lost to Follow-up|0
1833442|NCT00325195|6351524|P1|Received Intervention: ITT Population|Lost to Follow-up|0
1833443|NCT00325195|6351522|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
1833444|NCT00325195|6351523|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
1833445|NCT00325195|6351524|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
1833446|NCT00325195|6351522|P3|Received Intervention: ITT Population|Death|0
1833447|NCT00325195|6351523|P2|Received Intervention: ITT Population|Death|1
1833448|NCT00325195|6351524|P1|Received Intervention: ITT Population|Death|3
1833449|NCT00325195|6351522|P3|Received Intervention: ITT Population|Adverse Event|1
1833450|NCT00325195|6351523|P2|Received Intervention: ITT Population|Adverse Event|17
1833451|NCT00325195|6351524|P1|Received Intervention: ITT Population|Adverse Event|15
1833452|NCT00325195|6351522|P3|Randomized|Not dosed|3
1833453|NCT00325195|6351523|P2|Randomized|Not dosed|5
1833454|NCT00325195|6351524|P1|Randomized|Not dosed|5
1833455|NCT00325156|6351547|P1|Overall Study|Withdrawal by Subject|31
1833456|NCT00325156|6351547|P1|Overall Study|Other|1
1833457|NCT00325156|6351547|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
1833458|NCT00325156|6351547|P1|Overall Study|Adverse event, non-fatal|3
1833459|NCT00325156|6351547|P1|Overall Study|Migrated/moved from study area|12
1833460|NCT00325156|6351547|P1|Overall Study|Lost to follow-up (complete vaccination)|41
1833461|NCT00325156|6351547|P1|Overall Study|Protocol Violation|8
1833462|NCT00325143|6351554|P1|Overall Study|Withdrawal by Subject|8
1833463|NCT00325143|6351554|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
1833464|NCT00325143|6351554|P1|Overall Study|Migrated/moved from study area|1
1833465|NCT00325143|6351554|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
1833466|NCT00325130|6351564|P2|Overall Study|Patient Discontinued for Other|0
1833467|NCT00325130|6351565|P1|Overall Study|Patient Discontinued for Other|1
1833468|NCT00325130|6351564|P2|Overall Study|Moved|1
1833469|NCT00325130|6351565|P1|Overall Study|Moved|0
1833470|NCT00325130|6351564|P2|Overall Study|Protocol Deviation|1
1833471|NCT00325130|6351565|P1|Overall Study|Protocol Deviation|0
1833472|NCT00325130|6351564|P2|Overall Study|Withdrawal by Subject|14
1833473|NCT00325130|6351565|P1|Overall Study|Withdrawal by Subject|12
1833474|NCT00325130|6351564|P2|Overall Study|Lost to Follow-up|14
1833475|NCT00325130|6351565|P1|Overall Study|Lost to Follow-up|6
1833476|NCT00325039|6351622|P2|Overall Study|Lost to Follow-up|14
1833477|NCT00325039|6351623|P1|Overall Study|Lost to Follow-up|18
1833478|NCT00324987|6351639|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
1833479|NCT00324987|6351640|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
1833480|NCT00324987|6351639|P2|Overall Study|Progression|1
1833481|NCT00324987|6351640|P1|Overall Study|Progression|1
1833482|NCT00324987|6351639|P2|Overall Study|Withdrawal by Subject|1
1833483|NCT00324987|6351640|P1|Overall Study|Withdrawal by Subject|1
1833484|NCT00324987|6351639|P2|Overall Study|Adverse Event|1
1833485|NCT00324987|6351640|P1|Overall Study|Adverse Event|2
1833486|NCT00324961|6351654|P1|Overall Study|Other|2
1833487|NCT00324961|6351654|P1|Overall Study|Protocol Violation|3
1833488|NCT00324961|6351654|P1|Overall Study|Lost to Follow-up|22
1833489|NCT00324961|6351654|P1|Overall Study|Consent Withdrawn|11
1833490|NCT00324961|6351654|P1|Overall Study|Adverse Event|5
1833491|NCT00324805|6351705|P2|Overall Study|Did not start therapy|17
1833492|NCT00324805|6351706|P1|Overall Study|Did not start therapy|12
1833493|NCT00324805|6351705|P2|Overall Study|Other|2
1833494|NCT00324805|6351706|P1|Overall Study|Other|0
1833495|NCT00324805|6351705|P2|Overall Study|Other reasons|26
1833496|NCT00324805|6351706|P1|Overall Study|Other reasons|7
1833497|NCT00324805|6351705|P2|Overall Study|Other complicating disease|9
1833498|NCT00324805|6351706|P1|Overall Study|Other complicating disease|1
1833499|NCT00324805|6351705|P2|Overall Study|Alternative therapy|8
1833500|NCT00324805|6351706|P1|Overall Study|Alternative therapy|4
1833501|NCT00324805|6351705|P2|Overall Study|Death|9
1833502|NCT00324805|6351706|P1|Overall Study|Death|6
1833503|NCT00324805|6351705|P2|Overall Study|Withdrawal by Subject|174
1833504|NCT00324805|6351706|P1|Overall Study|Withdrawal by Subject|51
1833506|NCT00324805|6351706|P1|Overall Study|Progression|7
1833507|NCT00324805|6351705|P2|Overall Study|Adverse Event|203
1833508|NCT00324805|6351706|P1|Overall Study|Adverse Event|62
1833509|NCT00324740|6351731|P3|Overall Study|Withdrawal by Subject|1
1833510|NCT00324740|6351732|P2|Overall Study|Withdrawal by Subject|0
1833511|NCT00324740|6351733|P1|Overall Study|Withdrawal by Subject|1
1833512|NCT00324675|6351753|P2|Overall Study|Adverse Event|0
1833513|NCT00324675|6351754|P1|Overall Study|Adverse Event|1
1833514|NCT00324649|6351762|P2|Overall Study|Noncompliance|0
1833515|NCT00324649|6351763|P1|Overall Study|Noncompliance|1
1833516|NCT00324649|6351762|P2|Overall Study|Withdrawal by Subject|1
1833517|NCT00324649|6351763|P1|Overall Study|Withdrawal by Subject|0
1833518|NCT00324649|6351762|P2|Overall Study|Adverse Event|4
1833519|NCT00324649|6351763|P1|Overall Study|Adverse Event|1
1833520|NCT00324233|6351894|P2|Second Period|Protocol Violation|6
1833521|NCT00324233|6351895|P1|Second Period|Protocol Violation|4
1833522|NCT00324233|6351894|P2|Second Period|unable to insert catheter|1
1833523|NCT00324233|6351895|P1|Second Period|unable to insert catheter|1
1833524|NCT00324233|6351894|P2|First Period|unable to insert catheter|0
1833525|NCT00324233|6351895|P1|First Period|unable to insert catheter|1
1833526|NCT00324168|6351903|P2|Overall Study|Patient did not visit in f/u window|9
1833527|NCT00324168|6351904|P1|Overall Study|Patient did not visit in f/u window|6
1833528|NCT00324168|6351903|P2|Overall Study|Death|3
1833529|NCT00324168|6351904|P1|Overall Study|Death|3
1833530|NCT00324168|6351903|P2|Overall Study|Lost to Follow-up|18
1833531|NCT00324168|6351904|P1|Overall Study|Lost to Follow-up|19
1833532|NCT00324155|6351932|P2|Follow-up Phase|On-going participants still on drug|6
1833533|NCT00324155|6351933|P1|Follow-up Phase|On-going participants still on drug|11
1833534|NCT00324155|6351932|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
1833535|NCT00324155|6351933|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
1833536|NCT00324155|6351932|P2|Received Treatment in Maintenance Phase|Adverse Event|3
1833537|NCT00324155|6351933|P1|Received Treatment in Maintenance Phase|Adverse Event|0
1833538|NCT00324155|6351932|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
1833539|NCT00324155|6351933|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
1833540|NCT00324155|6351932|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
1833541|NCT00324155|6351933|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
1833542|NCT00324155|6351932|P2|Received Treatment in Maintenance Phase|Disease Progression|41
1833543|NCT00324155|6351933|P1|Received Treatment in Maintenance Phase|Disease Progression|26
1833544|NCT00324155|6351932|P2|Received Treatment in Induction Phase|Physician Decision|0
1833545|NCT00324155|6351933|P1|Received Treatment in Induction Phase|Physician Decision|2
1833546|NCT00324155|6351932|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
1833547|NCT00324155|6351933|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
1833548|NCT00324155|6351932|P2|Received Treatment in Induction Phase|Adverse Event|7
1833549|NCT00324155|6351933|P1|Received Treatment in Induction Phase|Adverse Event|6
1833550|NCT00324155|6351932|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
1833551|NCT00324155|6351933|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
1833552|NCT00324155|6351932|P2|Received Treatment in Induction Phase|Death|15
1833553|NCT00324155|6351933|P1|Received Treatment in Induction Phase|Death|8
1833554|NCT00324155|6351932|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
1833555|NCT00324155|6351933|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
1833556|NCT00324155|6351932|P2|Received Treatment in Induction Phase|Disease Progression|152
1833557|NCT00324155|6351933|P1|Received Treatment in Induction Phase|Disease Progression|88
1833558|NCT00324155|6351932|P2|Enrolled and Randomized|Lost to Follow-up|1
1833559|NCT00324155|6351933|P1|Enrolled and Randomized|Lost to Follow-up|0
1833560|NCT00324155|6351932|P2|Enrolled and Randomized|No longer met study criteria|0
1833561|NCT00324155|6351933|P1|Enrolled and Randomized|No longer met study criteria|3
1833562|NCT00324116|6351963|P1|Overall Study|Other|5
1833563|NCT00324116|6351963|P1|Overall Study|Withdrawal by Subject|5
1833564|NCT00324116|6351963|P1|Overall Study|Lack of Efficacy|17
1833565|NCT00324116|6351963|P1|Overall Study|Adverse Event|5
1833566|NCT00324038|6351975|P2|Overall Study|Other|13
1833567|NCT00324038|6351976|P1|Overall Study|Other|6
1833568|NCT00324038|6351975|P2|Overall Study|Lost to Follow-up|2
1833569|NCT00324038|6351976|P1|Overall Study|Lost to Follow-up|0
1833570|NCT00324038|6351975|P2|Overall Study|Lack of Efficacy|13
1833571|NCT00324038|6351976|P1|Overall Study|Lack of Efficacy|5
1833572|NCT00324038|6351975|P2|Overall Study|Adverse Event|23
1833573|NCT00324038|6351976|P1|Overall Study|Adverse Event|38
1833574|NCT00323882|6351987|P5|Overall Study|Other|1
1833575|NCT00323882|6351988|P4|Overall Study|Other|1
1833576|NCT00323882|6351989|P3|Overall Study|Other|0
1833577|NCT00323882|6351990|P2|Overall Study|Other|0
1833578|NCT00323882|6351991|P1|Overall Study|Other|0
1833579|NCT00323882|6351987|P5|Overall Study|Lost to Follow-up|1
1833580|NCT00323882|6351988|P4|Overall Study|Lost to Follow-up|0
1833581|NCT00323882|6351989|P3|Overall Study|Lost to Follow-up|1
1833582|NCT00323882|6351990|P2|Overall Study|Lost to Follow-up|0
1833583|NCT00323882|6351991|P1|Overall Study|Lost to Follow-up|0
1833584|NCT00323882|6351987|P5|Overall Study|Death|5
1833585|NCT00323882|6351988|P4|Overall Study|Death|0
1833586|NCT00323882|6351989|P3|Overall Study|Death|1
1833587|NCT00323882|6351990|P2|Overall Study|Death|1
1833588|NCT00323882|6351991|P1|Overall Study|Death|0
1833589|NCT00323882|6351987|P5|Overall Study|Disease Progression|22
1833590|NCT00323882|6351988|P4|Overall Study|Disease Progression|5
1833591|NCT00323882|6351989|P3|Overall Study|Disease Progression|10
1833592|NCT00323882|6351990|P2|Overall Study|Disease Progression|4
1833593|NCT00323882|6351991|P1|Overall Study|Disease Progression|6
1833594|NCT00323882|6351987|P5|Overall Study|Adverse Event|3
1833595|NCT00323882|6351988|P4|Overall Study|Adverse Event|1
1833596|NCT00323882|6351989|P3|Overall Study|Adverse Event|1
1833597|NCT00323882|6351990|P2|Overall Study|Adverse Event|1
1833598|NCT00323882|6351991|P1|Overall Study|Adverse Event|2
1833599|NCT00323869|6352062|P1|Overall Study|Death|1
1833600|NCT00323622|6352118|P8|Overall Study|Death|2
1833601|NCT00323622|6352119|P7|Overall Study|Death|0
1833602|NCT00323622|6352120|P6|Overall Study|Death|0
1833603|NCT00323622|6352121|P5|Overall Study|Death|7
1833604|NCT00323622|6352122|P4|Overall Study|Death|0
1833605|NCT00323622|6352123|P3|Overall Study|Death|0
1833606|NCT00323622|6352124|P2|Overall Study|Death|1
1833607|NCT00323622|6352125|P1|Overall Study|Death|1
1833608|NCT00323622|6352118|P8|Overall Study|Other|13
1833609|NCT00323622|6352119|P7|Overall Study|Other|5
1833610|NCT00323622|6352120|P6|Overall Study|Other|74
1833611|NCT00323622|6352121|P5|Overall Study|Other|32
1833612|NCT00323622|6352122|P4|Overall Study|Other|12
1833613|NCT00323622|6352123|P3|Overall Study|Other|4
1833614|NCT00323622|6352124|P2|Overall Study|Other|91
1833615|NCT00323622|6352125|P1|Overall Study|Other|30
1833616|NCT00323609|6352167|P4|Overall Study|Other reason|9
1833617|NCT00323609|6352168|P3|Overall Study|Other reason|4
1833618|NCT00323609|6352169|P2|Overall Study|Other reason|8
1833619|NCT00323609|6352170|P1|Overall Study|Other reason|11
1833620|NCT00323609|6352167|P4|Overall Study|Logistical withdrawal|1
1833621|NCT00323609|6352168|P3|Overall Study|Logistical withdrawal|0
1833622|NCT00323609|6352169|P2|Overall Study|Logistical withdrawal|5
1833623|NCT00323609|6352170|P1|Overall Study|Logistical withdrawal|9
1833624|NCT00323609|6352167|P4|Overall Study|Unrelenting or severe back pain|0
1833625|NCT00323609|6352168|P3|Overall Study|Unrelenting or severe back pain|0
1833626|NCT00323609|6352169|P2|Overall Study|Unrelenting or severe back pain|1
1833627|NCT00323609|6352170|P1|Overall Study|Unrelenting or severe back pain|1
1833628|NCT00323609|6352167|P4|Overall Study|Sponsor discontinued trial|0
1833629|NCT00323609|6352168|P3|Overall Study|Sponsor discontinued trial|0
1833630|NCT00323609|6352169|P2|Overall Study|Sponsor discontinued trial|29
1833631|NCT00323609|6352170|P1|Overall Study|Sponsor discontinued trial|29
1833632|NCT00323609|6352167|P4|Overall Study|Other non-VCF-related medical condition|0
1833633|NCT00323609|6352168|P3|Overall Study|Other non-VCF-related medical condition|0
1833634|NCT00323609|6352169|P2|Overall Study|Other non-VCF-related medical condition|2
1833635|NCT00323609|6352170|P1|Overall Study|Other non-VCF-related medical condition|3
1833636|NCT00323609|6352167|P4|Overall Study|Withdrawal by Subject|4
1833637|NCT00323609|6352168|P3|Overall Study|Withdrawal by Subject|4
1833638|NCT00323609|6352169|P2|Overall Study|Withdrawal by Subject|23
1833639|NCT00323609|6352170|P1|Overall Study|Withdrawal by Subject|11
1833640|NCT00323609|6352167|P4|Overall Study|Physician Decision|1
1833641|NCT00323609|6352168|P3|Overall Study|Physician Decision|0
1833642|NCT00323609|6352169|P2|Overall Study|Physician Decision|0
1833643|NCT00323609|6352170|P1|Overall Study|Physician Decision|2
1833644|NCT00323609|6352167|P4|Overall Study|Lost to Follow-up|0
1833645|NCT00323609|6352168|P3|Overall Study|Lost to Follow-up|0
1833646|NCT00323609|6352169|P2|Overall Study|Lost to Follow-up|10
1833647|NCT00323609|6352170|P1|Overall Study|Lost to Follow-up|9
1833648|NCT00323609|6352167|P4|Overall Study|Death|0
1833649|NCT00323609|6352168|P3|Overall Study|Death|0
1833650|NCT00323609|6352169|P2|Overall Study|Death|21
1833651|NCT00323609|6352170|P1|Overall Study|Death|16
1833652|NCT00323557|6352206|P2|Overall Study|Physician Decision|0
1833653|NCT00323557|6352207|P1|Overall Study|Physician Decision|1
1833654|NCT00323492|6352216|P3|Study Phase 2|Protocol Violation|0
1833655|NCT00323492|6352217|P2|Study Phase 2|Protocol Violation|0
1833656|NCT00323492|6352218|P1|Study Phase 2|Protocol Violation|1
1833657|NCT00323492|6352216|P3|Study Phase 2|Noncompliance with study schedule|1
1833658|NCT00323492|6352217|P2|Study Phase 2|Noncompliance with study schedule|0
1833659|NCT00323492|6352218|P1|Study Phase 2|Noncompliance with study schedule|0
1833660|NCT00323492|6352216|P3|Study Phase 2|Withdrawal by Subject|0
1833661|NCT00323492|6352217|P2|Study Phase 2|Withdrawal by Subject|1
1833662|NCT00323492|6352218|P1|Study Phase 2|Withdrawal by Subject|0
1833663|NCT00323492|6352216|P3|Study Phase 2|Lost to Follow-up|0
1833664|NCT00323492|6352217|P2|Study Phase 2|Lost to Follow-up|0
1833665|NCT00323492|6352218|P1|Study Phase 2|Lost to Follow-up|1
1833666|NCT00323492|6352216|P3|Study Phase 2|Physician Decision|0
1833667|NCT00323492|6352217|P2|Study Phase 2|Physician Decision|0
1833668|NCT00323492|6352218|P1|Study Phase 2|Physician Decision|1
1833669|NCT00323492|6352216|P3|Study Phase 2|Adverse Event|0
1833670|NCT00323492|6352217|P2|Study Phase 2|Adverse Event|0
1833671|NCT00323492|6352218|P1|Study Phase 2|Adverse Event|1
1833672|NCT00323492|6352216|P3|Study Phase 1|Adverse Event|0
1833673|NCT00323492|6352217|P2|Study Phase 1|Adverse Event|0
1833674|NCT00323492|6352218|P1|Study Phase 1|Adverse Event|2
1833675|NCT00323479|6352249|P1|Overall Study|house moving|1
1833676|NCT00323479|6352249|P1|Overall Study|Protocol Violation|3
1833677|NCT00323479|6352249|P1|Overall Study|Withdrawal by Subject|2
1833678|NCT00323479|6352249|P1|Overall Study|Adverse Event|2
1833679|NCT00323414|6352282|P2|Overall Study|Withdrawal by Subject|1
1833680|NCT00323414|6352283|P1|Overall Study|Withdrawal by Subject|0
1833681|NCT00323310|6352305|P1|Overall Study|did not complete the 24-hr f-up visit|1
1833682|NCT00323310|6352305|P1|Overall Study|a parent refused blood draw|1
1833683|NCT00323310|6352305|P1|Overall Study|Withdrawal by Subject|1
1833684|NCT00323297|6352320|P2|Part B (Open-label)|Protocol Violation|1
1833685|NCT00323297|6352321|P1|Part B (Open-label)|Protocol Violation|0
1833686|NCT00323297|6352320|P2|Part B (Open-label)|Adverse Event|5
1833687|NCT00323297|6352321|P1|Part B (Open-label)|Adverse Event|5
1833688|NCT00323297|6352320|P2|Part B (Open-label)|Lack of Efficacy|1
1833689|NCT00323297|6352321|P1|Part B (Open-label)|Lack of Efficacy|3
1833690|NCT00323297|6352320|P2|Part B (Open-label)|Withdrawal by Subject|3
1833691|NCT00323297|6352321|P1|Part B (Open-label)|Withdrawal by Subject|1
1833692|NCT00323297|6352320|P2|Part B (Open-label)|Reason unspecified|1
1833693|NCT00323297|6352321|P1|Part B (Open-label)|Reason unspecified|0
1833694|NCT00323297|6352320|P2|Part B (Open-label)|Death|1
1833695|NCT00323297|6352321|P1|Part B (Open-label)|Death|0
1833696|NCT00323297|6352320|P2|Part A (Double Blind Randomized)|Related adverse event|2
1833697|NCT00323297|6352321|P1|Part A (Double Blind Randomized)|Related adverse event|2
1833698|NCT00323297|6352320|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
1833699|NCT00323297|6352321|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
1833700|NCT00323297|6352320|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
1833701|NCT00323297|6352321|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
1833702|NCT00323297|6352320|P2|Part A (Double Blind Randomized)|Protocol Violation|3
1833703|NCT00323297|6352321|P1|Part A (Double Blind Randomized)|Protocol Violation|1
1833704|NCT00323297|6352320|P2|Part A (Double Blind Randomized)|Death|1
1833705|NCT00323297|6352321|P1|Part A (Double Blind Randomized)|Death|0
1833706|NCT00323297|6352320|P2|Part A (Double Blind Randomized)|Reason unspecified|1
1833707|NCT00323297|6352321|P1|Part A (Double Blind Randomized)|Reason unspecified|0
1833708|NCT00323258|6352361|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
1833709|NCT00323258|6352362|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
1833710|NCT00323258|6352361|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
1833711|NCT00323258|6352362|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
1833712|NCT00323258|6352361|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
1833713|NCT00323258|6352362|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
1833714|NCT00323258|6352361|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
1833715|NCT00323258|6352362|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
1833716|NCT00323258|6352361|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
1833717|NCT00323258|6352362|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
1833718|NCT00323258|6352361|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
1833719|NCT00323258|6352362|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
1833720|NCT00323258|6352361|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
1833721|NCT00323258|6352362|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
1833722|NCT00323115|6352387|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
1833723|NCT00323115|6352387|P1|Vaccine Administration|Adverse Event|1
1833724|NCT00323063|6352414|P2|Overall Study|brain mets discovered prior to treatment|0
1833725|NCT00323063|6352415|P1|Overall Study|brain mets discovered prior to treatment|1
1833726|NCT00323063|6352414|P2|Overall Study|Adverse Event|0
1833727|NCT00323063|6352415|P1|Overall Study|Adverse Event|1
1833728|NCT00322881|6352432|P1|Overall Study|Disease Progression|2
1833729|NCT00322881|6352432|P1|Overall Study|Adverse Event|1
1833730|NCT00322881|6352432|P1|Overall Study|Death|2
1833731|NCT00322868|6352436|P1|Overall Study|disease progression|1
1833732|NCT00322842|6352461|P2|Overall Study|Death|0
1833733|NCT00322842|6352462|P1|Overall Study|Death|1
1833734|NCT00322842|6352461|P2|Overall Study|Refused transplant|0
1833735|NCT00322842|6352462|P1|Overall Study|Refused transplant|1
1833736|NCT00322842|6352461|P2|Overall Study|Lost to Follow-up|1
1833737|NCT00322842|6352462|P1|Overall Study|Lost to Follow-up|0
1833738|NCT00322842|6352461|P2|Overall Study|Withdrawal by Subject|1
1833739|NCT00322842|6352462|P1|Overall Study|Withdrawal by Subject|0
1833740|NCT00322712|6352500|P1|Overall Study|treated with bevacizumab not cetuximab|1
1833741|NCT00322621|6352504|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1833742|NCT00322621|6352505|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
1833743|NCT00322621|6352506|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
1833744|NCT00322621|6352504|P3|Period III - Maintenance / Rescue Phase|Death|0
1833745|NCT00322621|6352505|P2|Period III - Maintenance / Rescue Phase|Death|1
1833746|NCT00322621|6352506|P1|Period III - Maintenance / Rescue Phase|Death|0
1833747|NCT00322621|6352504|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
1833748|NCT00322621|6352505|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
1833749|NCT00322621|6352506|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
1833750|NCT00322621|6352504|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
1833751|NCT00322621|6352505|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
1833752|NCT00322621|6352506|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
1833753|NCT00322621|6352504|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
1833754|NCT00322621|6352505|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
1833755|NCT00322621|6352506|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
1833756|NCT00322621|6352504|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
1833842|NCT00322153|6352897|P2|Overall Study|Lost to Follow-up|4
1833757|NCT00322621|6352505|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
1833758|NCT00322621|6352506|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
1833759|NCT00322621|6352504|P3|Period II - Acute Therapy Phase|Physician Decision|0
1833760|NCT00322621|6352505|P2|Period II - Acute Therapy Phase|Physician Decision|0
1833761|NCT00322621|6352506|P1|Period II - Acute Therapy Phase|Physician Decision|1
1833762|NCT00322621|6352504|P3|Period II - Acute Therapy Phase|Protocol Violation|0
1833763|NCT00322621|6352505|P2|Period II - Acute Therapy Phase|Protocol Violation|0
1833764|NCT00322621|6352506|P1|Period II - Acute Therapy Phase|Protocol Violation|2
1833765|NCT00322621|6352504|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1833766|NCT00322621|6352505|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
1833767|NCT00322621|6352506|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
1833768|NCT00322621|6352504|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
1833769|NCT00322621|6352505|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
1833770|NCT00322621|6352506|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
1833771|NCT00322621|6352504|P3|Period II - Acute Therapy Phase|Adverse Event|0
1833772|NCT00322621|6352505|P2|Period II - Acute Therapy Phase|Adverse Event|0
1833773|NCT00322621|6352506|P1|Period II - Acute Therapy Phase|Adverse Event|20
1833774|NCT00322556|6352558|P1|Overall Study|Other Reason|7
1833775|NCT00322556|6352558|P1|Overall Study|Lost to Follow-up|3
1833776|NCT00322556|6352558|P1|Overall Study|Withdrawal by Subject|1
1833777|NCT00322556|6352558|P1|Overall Study|Adverse Event|1
1833778|NCT00322491|6352574|P2|Overall Study|Death|2
1833779|NCT00322491|6352575|P1|Overall Study|Death|1
1833780|NCT00322491|6352574|P2|Overall Study|Adverse Event|0
1833781|NCT00322491|6352575|P1|Overall Study|Adverse Event|1
1833782|NCT00322452|6352665|P2|Overall Study|Death|227
1833783|NCT00322452|6352666|P1|Overall Study|Death|223
1833784|NCT00322452|6352665|P2|Overall Study|Withdrawal by Subject|46
1833785|NCT00322452|6352666|P1|Overall Study|Withdrawal by Subject|19
1833786|NCT00322452|6352665|P2|Overall Study|Lost to Follow-up|2
1833787|NCT00322452|6352666|P1|Overall Study|Lost to Follow-up|5
1833788|NCT00322452|6352665|P2|Overall Study|Eligibility criteria not fulfilled|1
1833789|NCT00322452|6352666|P1|Overall Study|Eligibility criteria not fulfilled|0
1833790|NCT00322387|6352717|P2|Follow-up Period|Death|0
1833791|NCT00322387|6352718|P1|Follow-up Period|Death|1
1833792|NCT00322387|6352717|P2|Follow-up Period|Final assessment not done|3
1833793|NCT00322387|6352718|P1|Follow-up Period|Final assessment not done|1
1833794|NCT00322387|6352717|P2|Treatment Period|Adverse Event|1
1833795|NCT00322387|6352718|P1|Treatment Period|Adverse Event|0
1833796|NCT00322374|6352752|P4|Second Escalation|Study Drug Toxicity|0
1833797|NCT00322374|6352753|P3|Second Escalation|Study Drug Toxicity|1
1833798|NCT00322374|6352754|P2|Second Escalation|Study Drug Toxicity|0
1833799|NCT00322374|6352755|P1|Second Escalation|Study Drug Toxicity|0
1833800|NCT00322374|6352752|P4|Second Escalation|Physician Decision|0
1833801|NCT00322374|6352753|P3|Second Escalation|Physician Decision|5
1833802|NCT00322374|6352754|P2|Second Escalation|Physician Decision|0
1833803|NCT00322374|6352755|P1|Second Escalation|Physician Decision|0
1833804|NCT00322374|6352752|P4|First Escalation|Participant Request|0
1833805|NCT00322374|6352753|P3|First Escalation|Participant Request|0
1833806|NCT00322374|6352754|P2|First Escalation|Participant Request|1
1833807|NCT00322374|6352755|P1|First Escalation|Participant Request|0
1833808|NCT00322374|6352752|P4|First Escalation|Study Drug Toxicity|0
1833809|NCT00322374|6352753|P3|First Escalation|Study Drug Toxicity|0
1833810|NCT00322374|6352754|P2|First Escalation|Study Drug Toxicity|11
1833811|NCT00322374|6352755|P1|First Escalation|Study Drug Toxicity|0
1833812|NCT00322374|6352752|P4|First Escalation|Physician Decision|0
1833813|NCT00322374|6352753|P3|First Escalation|Physician Decision|0
1833814|NCT00322374|6352754|P2|First Escalation|Physician Decision|12
1833815|NCT00322374|6352755|P1|First Escalation|Physician Decision|0
1833816|NCT00322374|6352752|P4|First Escalation|Documented Disease Progression|0
1833817|NCT00322374|6352753|P3|First Escalation|Documented Disease Progression|0
1833818|NCT00322374|6352754|P2|First Escalation|Documented Disease Progression|6
1833819|NCT00322374|6352755|P1|First Escalation|Documented Disease Progression|0
1833820|NCT00322374|6352752|P4|Starting Dose|Study Drug Toxicity|0
1833821|NCT00322374|6352753|P3|Starting Dose|Study Drug Toxicity|0
1833822|NCT00322374|6352754|P2|Starting Dose|Study Drug Toxicity|0
1833823|NCT00322374|6352755|P1|Starting Dose|Study Drug Toxicity|4
1833824|NCT00322374|6352752|P4|Starting Dose|Physician Decision|0
1833825|NCT00322374|6352753|P3|Starting Dose|Physician Decision|0
1833826|NCT00322374|6352754|P2|Starting Dose|Physician Decision|0
1833827|NCT00322374|6352755|P1|Starting Dose|Physician Decision|2
1833828|NCT00322348|6352805|P2|Overall Study|Reasons not specified|1
1833829|NCT00322348|6352806|P1|Overall Study|Reasons not specified|5
1833830|NCT00322348|6352805|P2|Overall Study|Disease Progression|25
1833831|NCT00322348|6352806|P1|Overall Study|Disease Progression|30
1833832|NCT00322348|6352805|P2|Overall Study|Death|2
1833833|NCT00322348|6352806|P1|Overall Study|Death|0
1833834|NCT00322348|6352805|P2|Overall Study|Lost to Follow-up|0
1833835|NCT00322348|6352806|P1|Overall Study|Lost to Follow-up|1
1833836|NCT00322348|6352805|P2|Overall Study|Withdrawal by Subject|4
1833837|NCT00322348|6352806|P1|Overall Study|Withdrawal by Subject|1
1833838|NCT00322348|6352805|P2|Overall Study|Adverse Event|1
1833839|NCT00322348|6352806|P1|Overall Study|Adverse Event|0
1833840|NCT00322153|6352897|P2|Overall Study|Withdrawn for other reasons|4
1833841|NCT00322153|6352898|P1|Overall Study|Withdrawn for other reasons|5
1833843|NCT00322153|6352898|P1|Overall Study|Lost to Follow-up|5
1833844|NCT00322153|6352897|P2|Overall Study|Lack of Efficacy|3
1833845|NCT00322153|6352898|P1|Overall Study|Lack of Efficacy|8
1833846|NCT00322153|6352897|P2|Overall Study|Withdrawal by Subject|10
1833847|NCT00322153|6352898|P1|Overall Study|Withdrawal by Subject|18
1833848|NCT00322153|6352897|P2|Overall Study|Protocol Violation|14
1833849|NCT00322153|6352898|P1|Overall Study|Protocol Violation|6
1833850|NCT00322153|6352897|P2|Overall Study|Adverse Event|34
1833851|NCT00322153|6352898|P1|Overall Study|Adverse Event|21
1833852|NCT00322049|6352931|P4|Overall Study|Infected with Dengue during study|0
1833853|NCT00322049|6352932|P3|Overall Study|Infected with Dengue during study|0
1833854|NCT00322049|6352933|P2|Overall Study|Infected with Dengue during study|1
1833855|NCT00322049|6352934|P1|Overall Study|Infected with Dengue during study|0
1833856|NCT00322049|6352931|P4|Overall Study|Moved out of area|1
1833857|NCT00322049|6352932|P3|Overall Study|Moved out of area|0
1833858|NCT00322049|6352933|P2|Overall Study|Moved out of area|0
1833859|NCT00322049|6352934|P1|Overall Study|Moved out of area|0
1833860|NCT00321984|6352967|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1833861|NCT00321984|6352968|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
1833862|NCT00321984|6352969|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
1833863|NCT00321984|6352967|P3|Overall Study|Per Investigator Request|0
1833864|NCT00321984|6352968|P2|Overall Study|Per Investigator Request|0
1833865|NCT00321984|6352969|P1|Overall Study|Per Investigator Request|1
1833866|NCT00321984|6352967|P3|Overall Study|Per Subject Request|0
1833867|NCT00321984|6352968|P2|Overall Study|Per Subject Request|0
1833868|NCT00321984|6352969|P1|Overall Study|Per Subject Request|1
1833869|NCT00321984|6352967|P3|Overall Study|Pregnancy|0
1833870|NCT00321984|6352968|P2|Overall Study|Pregnancy|1
1833871|NCT00321984|6352969|P1|Overall Study|Pregnancy|0
1833872|NCT00321984|6352967|P3|Overall Study|Noncompliant|2
1833873|NCT00321984|6352968|P2|Overall Study|Noncompliant|0
1833874|NCT00321984|6352969|P1|Overall Study|Noncompliant|0
1833875|NCT00321984|6352967|P3|Overall Study|Lack of Efficacy|3
1833876|NCT00321984|6352968|P2|Overall Study|Lack of Efficacy|1
1833877|NCT00321984|6352969|P1|Overall Study|Lack of Efficacy|3
1833878|NCT00321984|6352967|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1833879|NCT00321984|6352968|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1833880|NCT00321984|6352969|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
1833881|NCT00321984|6352967|P3|Overall Study|Withdrawal by Subject|5
1833882|NCT00321984|6352968|P2|Overall Study|Withdrawal by Subject|6
1833883|NCT00321984|6352969|P1|Overall Study|Withdrawal by Subject|8
1833884|NCT00321984|6352967|P3|Overall Study|Lost to Follow-up|2
1833885|NCT00321984|6352968|P2|Overall Study|Lost to Follow-up|4
1833886|NCT00321984|6352969|P1|Overall Study|Lost to Follow-up|2
1833887|NCT00321984|6352967|P3|Overall Study|Protocol Violation|1
1833888|NCT00321984|6352968|P2|Overall Study|Protocol Violation|1
1833889|NCT00321984|6352969|P1|Overall Study|Protocol Violation|0
1833890|NCT00321984|6352967|P3|Overall Study|Adverse Event|8
1833891|NCT00321984|6352968|P2|Overall Study|Adverse Event|6
1833892|NCT00321984|6352969|P1|Overall Study|Adverse Event|9
1833893|NCT00321932|6352997|P2|Overall Study|Missing data|1
1833894|NCT00321932|6352998|P1|Overall Study|Missing data|2
1833895|NCT00321932|6352997|P2|Overall Study|Early relapse|8
1833896|NCT00321932|6352998|P1|Overall Study|Early relapse|2
1833897|NCT00321932|6352997|P2|Overall Study|Withdrawal by Subject|6
1833898|NCT00321932|6352998|P1|Overall Study|Withdrawal by Subject|3
1833899|NCT00321932|6352997|P2|Overall Study|Death|6
1833900|NCT00321932|6352998|P1|Overall Study|Death|3
1833901|NCT00321919|6353022|P2|Overall Study|Other withdrawal reason|6
1833902|NCT00321919|6353023|P1|Overall Study|Other withdrawal reason|7
1833903|NCT00321919|6353022|P2|Overall Study|Failure to Return|1
1833904|NCT00321919|6353023|P1|Overall Study|Failure to Return|3
1833905|NCT00321919|6353022|P2|Overall Study|Other Protocol Violation|3
1833906|NCT00321919|6353023|P1|Overall Study|Other Protocol Violation|2
1833907|NCT00321919|6353022|P2|Overall Study|Refused Treatment|14
1833908|NCT00321919|6353023|P1|Overall Study|Refused Treatment|23
1833909|NCT00321919|6353022|P2|Overall Study|Violation of Selection Criteria at Entry|1
1833910|NCT00321919|6353023|P1|Overall Study|Violation of Selection Criteria at Entry|1
1833911|NCT00321919|6353022|P2|Overall Study|Insufficient Therapeutic Response|0
1833912|NCT00321919|6353023|P1|Overall Study|Insufficient Therapeutic Response|1
1833913|NCT00321919|6353022|P2|Overall Study|Death|17
1833914|NCT00321919|6353023|P1|Overall Study|Death|21
1833915|NCT00321919|6353022|P2|Overall Study|Adverse Event|10
1833916|NCT00321919|6353023|P1|Overall Study|Adverse Event|17
1833917|NCT00321906|6353065|P2|Overall Study|Withdrawal by Subject|4
1833918|NCT00321906|6353066|P1|Overall Study|Withdrawal by Subject|0
1833919|NCT00321906|6353065|P2|Overall Study|Lost to Follow-up|2
1833920|NCT00321906|6353066|P1|Overall Study|Lost to Follow-up|1
1833921|NCT00321906|6353065|P2|Overall Study|Death|6
1833922|NCT00321906|6353066|P1|Overall Study|Death|9
1833923|NCT00321906|6353065|P2|Overall Study|Adverse Event|44
1833924|NCT00321906|6353066|P1|Overall Study|Adverse Event|36
1833925|NCT00321893|6353088|P2|Overall Study|Adverse Event|3
1833926|NCT00321893|6353089|P1|Overall Study|Adverse Event|6
1833927|NCT00321893|6353088|P2|Overall Study|Lost to Follow-up|1
1833928|NCT00321893|6353089|P1|Overall Study|Lost to Follow-up|2
1833929|NCT00321893|6353088|P2|Overall Study|Non-Compliance/Refusal|10
1833930|NCT00321893|6353089|P1|Overall Study|Non-Compliance/Refusal|16
1833931|NCT00321854|6353103|P2|Overall Study|Other|1
1833932|NCT00321854|6353104|P1|Overall Study|Other|1
1833933|NCT00321854|6353103|P2|Overall Study|Withdrawal by Subject|17
1833934|NCT00321854|6353104|P1|Overall Study|Withdrawal by Subject|6
1833935|NCT00321854|6353103|P2|Overall Study|Lost to Follow-up|2
1833936|NCT00321854|6353104|P1|Overall Study|Lost to Follow-up|0
1833937|NCT00321854|6353103|P2|Overall Study|Protocol Violation|5
1833938|NCT00321854|6353104|P1|Overall Study|Protocol Violation|6
1833939|NCT00321854|6353103|P2|Overall Study|Lack of Efficacy|14
1833940|NCT00321854|6353104|P1|Overall Study|Lack of Efficacy|9
1833941|NCT00321854|6353103|P2|Overall Study|Adverse Event|43
1833942|NCT00321854|6353104|P1|Overall Study|Adverse Event|41
1833943|NCT00321828|6353222|P1|Overall Study|No follow up data|1
1833944|NCT00321828|6353222|P1|Overall Study|Ineligible|3
1833945|NCT00321789|6353228|P2|Overall Study|Protocol Violation|3
1833946|NCT00321789|6353229|P1|Overall Study|Protocol Violation|5
1833947|NCT00321789|6353228|P2|Overall Study|Withdrawal by Subject|6
1833948|NCT00321789|6353229|P1|Overall Study|Withdrawal by Subject|6
1833949|NCT00321789|6353228|P2|Overall Study|Lost to Follow-up|7
1833950|NCT00321789|6353229|P1|Overall Study|Lost to Follow-up|4
1833951|NCT00321763|6353261|P4|Overall Study|Lost to Follow-up|4
1833952|NCT00321763|6353262|P3|Overall Study|Lost to Follow-up|5
1833953|NCT00321763|6353263|P2|Overall Study|Lost to Follow-up|1
1833954|NCT00321763|6353264|P1|Overall Study|Lost to Follow-up|3
1833955|NCT00321763|6353261|P4|Overall Study|Withdrawal by Subject|0
1833956|NCT00321763|6353262|P3|Overall Study|Withdrawal by Subject|1
1833957|NCT00321763|6353263|P2|Overall Study|Withdrawal by Subject|0
1833958|NCT00321763|6353264|P1|Overall Study|Withdrawal by Subject|2
1833959|NCT00321763|6353261|P4|Overall Study|Adverse Event|1
1833960|NCT00321763|6353262|P3|Overall Study|Adverse Event|0
1833961|NCT00321763|6353263|P2|Overall Study|Adverse Event|1
1833962|NCT00321763|6353264|P1|Overall Study|Adverse Event|1
1833963|NCT00321737|6353324|P3|Overall Study|Subject Request/ Subject Unavailable|2
1833964|NCT00321737|6353325|P2|Overall Study|Subject Request/ Subject Unavailable|0
1833965|NCT00321737|6353326|P1|Overall Study|Subject Request/ Subject Unavailable|0
1833966|NCT00321737|6353324|P3|Overall Study|Noncompliance|0
1833967|NCT00321737|6353325|P2|Overall Study|Noncompliance|0
1833968|NCT00321737|6353326|P1|Overall Study|Noncompliance|2
1833969|NCT00321737|6353324|P3|Overall Study|Pregnancy|0
1833970|NCT00321737|6353325|P2|Overall Study|Pregnancy|2
1833971|NCT00321737|6353326|P1|Overall Study|Pregnancy|0
1833972|NCT00321737|6353324|P3|Overall Study|Therapeutic Failure|2
1833973|NCT00321737|6353325|P2|Overall Study|Therapeutic Failure|0
1833974|NCT00321737|6353326|P1|Overall Study|Therapeutic Failure|6
1833975|NCT00321737|6353324|P3|Overall Study|Possible Barrett's Esophagus|1
1833976|NCT00321737|6353325|P2|Overall Study|Possible Barrett's Esophagus|1
1833977|NCT00321737|6353326|P1|Overall Study|Possible Barrett's Esophagus|2
1833978|NCT00321737|6353324|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1833979|NCT00321737|6353325|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1833980|NCT00321737|6353326|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
1833981|NCT00321737|6353324|P3|Overall Study|Protocol Violation|1
1833982|NCT00321737|6353325|P2|Overall Study|Protocol Violation|0
1833983|NCT00321737|6353326|P1|Overall Study|Protocol Violation|0
1833984|NCT00321737|6353324|P3|Overall Study|Withdrawal by Subject|17
1833985|NCT00321737|6353325|P2|Overall Study|Withdrawal by Subject|12
1833986|NCT00321737|6353326|P1|Overall Study|Withdrawal by Subject|19
1833987|NCT00321737|6353324|P3|Overall Study|Lost to Follow-up|6
1833988|NCT00321737|6353325|P2|Overall Study|Lost to Follow-up|5
1833989|NCT00321737|6353326|P1|Overall Study|Lost to Follow-up|5
1833990|NCT00321737|6353324|P3|Overall Study|Adverse Event|6
1833991|NCT00321737|6353325|P2|Overall Study|Adverse Event|3
1833992|NCT00321737|6353326|P1|Overall Study|Adverse Event|11
1833993|NCT00321737|6353324|P3|Overall Study|Relapse of Erosive Esophagitis|19
1833994|NCT00321737|6353325|P2|Overall Study|Relapse of Erosive Esophagitis|25
1833995|NCT00321737|6353326|P1|Overall Study|Relapse of Erosive Esophagitis|76
1833996|NCT00321711|6353354|P5|Part B|Death|1
1833997|NCT00321711|6353355|P4|Part B|Death|2
1833998|NCT00321711|6353356|P3|Part B|Death|0
1833999|NCT00321711|6353357|P2|Part B|Death|0
1834000|NCT00321711|6353358|P1|Part B|Death|0
1834001|NCT00321711|6353354|P5|Part B|Physician Decision|2
1834002|NCT00321711|6353355|P4|Part B|Physician Decision|1
1834003|NCT00321711|6353356|P3|Part B|Physician Decision|0
1834004|NCT00321711|6353357|P2|Part B|Physician Decision|0
1834005|NCT00321711|6353358|P1|Part B|Physician Decision|0
1834006|NCT00321711|6353354|P5|Part B|Disease progression|0
1834007|NCT00321711|6353355|P4|Part B|Disease progression|1
1834008|NCT00321711|6353356|P3|Part B|Disease progression|0
1834009|NCT00321711|6353357|P2|Part B|Disease progression|0
1834010|NCT00321711|6353358|P1|Part B|Disease progression|0
1834011|NCT00321711|6353354|P5|Part B|Adverse Event|1
1834012|NCT00321711|6353355|P4|Part B|Adverse Event|2
1834013|NCT00321711|6353356|P3|Part B|Adverse Event|0
1834014|NCT00321711|6353357|P2|Part B|Adverse Event|0
1834015|NCT00321711|6353358|P1|Part B|Adverse Event|0
1834016|NCT00321711|6353354|P5|Part B|Noncompliance|1
1834017|NCT00321711|6353355|P4|Part B|Noncompliance|0
1834018|NCT00321711|6353356|P3|Part B|Noncompliance|0
1834019|NCT00321711|6353357|P2|Part B|Noncompliance|0
1834020|NCT00321711|6353358|P1|Part B|Noncompliance|0
1834021|NCT00321711|6353354|P5|Part A|Protocol deviation|0
1834022|NCT00321711|6353355|P4|Part A|Protocol deviation|0
1834023|NCT00321711|6353356|P3|Part A|Protocol deviation|1
1834024|NCT00321711|6353357|P2|Part A|Protocol deviation|0
1834025|NCT00321711|6353358|P1|Part A|Protocol deviation|0
1834026|NCT00321711|6353354|P5|Part A|Other|0
1834027|NCT00321711|6353355|P4|Part A|Other|0
1834028|NCT00321711|6353356|P3|Part A|Other|3
1834029|NCT00321711|6353357|P2|Part A|Other|2
1834030|NCT00321711|6353358|P1|Part A|Other|1
1834031|NCT00321711|6353354|P5|Part A|Physician Decision|0
1834032|NCT00321711|6353355|P4|Part A|Physician Decision|0
1834033|NCT00321711|6353356|P3|Part A|Physician Decision|3
1834034|NCT00321711|6353357|P2|Part A|Physician Decision|1
1834035|NCT00321711|6353358|P1|Part A|Physician Decision|0
1834036|NCT00321711|6353354|P5|Part A|Requirement for alternative therapy|0
1834037|NCT00321711|6353355|P4|Part A|Requirement for alternative therapy|0
1834038|NCT00321711|6353356|P3|Part A|Requirement for alternative therapy|1
1834039|NCT00321711|6353357|P2|Part A|Requirement for alternative therapy|2
1834040|NCT00321711|6353358|P1|Part A|Requirement for alternative therapy|0
1834041|NCT00321711|6353354|P5|Part A|Disease progression|0
1834042|NCT00321711|6353355|P4|Part A|Disease progression|0
1834043|NCT00321711|6353356|P3|Part A|Disease progression|0
1834044|NCT00321711|6353357|P2|Part A|Disease progression|1
1834045|NCT00321711|6353358|P1|Part A|Disease progression|0
1834046|NCT00321711|6353354|P5|Part A|Withdrawal by Subject|0
1834047|NCT00321711|6353355|P4|Part A|Withdrawal by Subject|0
1834048|NCT00321711|6353356|P3|Part A|Withdrawal by Subject|1
1834049|NCT00321711|6353357|P2|Part A|Withdrawal by Subject|1
1834050|NCT00321711|6353358|P1|Part A|Withdrawal by Subject|1
1834051|NCT00321711|6353354|P5|Part A|Adverse Event|0
1834052|NCT00321711|6353355|P4|Part A|Adverse Event|0
1834053|NCT00321711|6353356|P3|Part A|Adverse Event|2
1834054|NCT00321711|6353357|P2|Part A|Adverse Event|3
1834055|NCT00321711|6353358|P1|Part A|Adverse Event|3
1834056|NCT00321685|6353408|P1|Overall Study|Ineligible|2
1834057|NCT00321685|6353408|P1|Overall Study|Not start protocol therapy|2
1834058|NCT00321685|6353408|P1|Overall Study|Other|5
1834059|NCT00321685|6353408|P1|Overall Study|Complicating disese|1
1834060|NCT00321685|6353408|P1|Overall Study|Alternative therapy|1
1834061|NCT00321685|6353408|P1|Overall Study|Withdrawal by Subject|8
1834062|NCT00321685|6353408|P1|Overall Study|Death|2
1834063|NCT00321685|6353408|P1|Overall Study|Adverse Event|18
1834064|NCT00321672|6353420|P4|Overall Study|Extensive travel required for new job|0
1834065|NCT00321672|6353421|P3|Overall Study|Extensive travel required for new job|0
1834066|NCT00321672|6353422|P2|Overall Study|Extensive travel required for new job|1
1834067|NCT00321672|6353423|P1|Overall Study|Extensive travel required for new job|0
1834068|NCT00321672|6353420|P4|Overall Study|Diagnosis of testicular cancer|0
1834069|NCT00321672|6353421|P3|Overall Study|Diagnosis of testicular cancer|0
1834070|NCT00321672|6353422|P2|Overall Study|Diagnosis of testicular cancer|1
1834071|NCT00321672|6353423|P1|Overall Study|Diagnosis of testicular cancer|0
1834072|NCT00321672|6353420|P4|Overall Study|Protocol Violation|0
1834073|NCT00321672|6353421|P3|Overall Study|Protocol Violation|1
1834074|NCT00321672|6353422|P2|Overall Study|Protocol Violation|0
1834075|NCT00321672|6353423|P1|Overall Study|Protocol Violation|0
1834076|NCT00321672|6353420|P4|Overall Study|Moved out of state|0
1834077|NCT00321672|6353421|P3|Overall Study|Moved out of state|1
1834078|NCT00321672|6353422|P2|Overall Study|Moved out of state|1
1834079|NCT00321672|6353423|P1|Overall Study|Moved out of state|0
1834080|NCT00321672|6353420|P4|Overall Study|Incarcerated|0
1834081|NCT00321672|6353421|P3|Overall Study|Incarcerated|2
1834082|NCT00321672|6353422|P2|Overall Study|Incarcerated|0
1834083|NCT00321672|6353423|P1|Overall Study|Incarcerated|0
1834084|NCT00321672|6353420|P4|Overall Study|Too far to travel for visits|0
1834085|NCT00321672|6353421|P3|Overall Study|Too far to travel for visits|0
1834086|NCT00321672|6353422|P2|Overall Study|Too far to travel for visits|0
1834087|NCT00321672|6353423|P1|Overall Study|Too far to travel for visits|1
1834088|NCT00321672|6353420|P4|Overall Study|Death|0
1834089|NCT00321672|6353421|P3|Overall Study|Death|0
1834090|NCT00321672|6353422|P2|Overall Study|Death|0
1834091|NCT00321672|6353423|P1|Overall Study|Death|1
1834092|NCT00321672|6353420|P4|Overall Study|Lost to Follow-up|2
1834093|NCT00321672|6353421|P3|Overall Study|Lost to Follow-up|4
1834094|NCT00321672|6353422|P2|Overall Study|Lost to Follow-up|0
1834095|NCT00321672|6353423|P1|Overall Study|Lost to Follow-up|2
1834096|NCT00321672|6353420|P4|Overall Study|Lack of Efficacy|0
1834097|NCT00321672|6353421|P3|Overall Study|Lack of Efficacy|0
1834098|NCT00321672|6353422|P2|Overall Study|Lack of Efficacy|1
1834099|NCT00321672|6353423|P1|Overall Study|Lack of Efficacy|1
1834100|NCT00321672|6353420|P4|Overall Study|Adverse Event|0
1834101|NCT00321672|6353421|P3|Overall Study|Adverse Event|0
1834102|NCT00321672|6353422|P2|Overall Study|Adverse Event|1
1834103|NCT00321672|6353423|P1|Overall Study|Adverse Event|1
1834104|NCT00321672|6353420|P4|Overall Study|Noncompliance|0
1834105|NCT00321672|6353421|P3|Overall Study|Noncompliance|1
1834106|NCT00321672|6353422|P2|Overall Study|Noncompliance|2
1834107|NCT00321672|6353423|P1|Overall Study|Noncompliance|1
1834108|NCT00321672|6353420|P4|Overall Study|Withdrawal by Subject|0
1834109|NCT00321672|6353421|P3|Overall Study|Withdrawal by Subject|2
1834110|NCT00321672|6353422|P2|Overall Study|Withdrawal by Subject|1
1834111|NCT00321672|6353423|P1|Overall Study|Withdrawal by Subject|5
1834112|NCT00321646|6353449|P1|Neoadjuvant Chemotherapy|Disease progression|1
1834113|NCT00321646|6353449|P1|Neoadjuvant Chemotherapy|Adverse Event|2
1834114|NCT00321646|6353449|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1834115|NCT00321620|6353456|P2|Overall Study|Other|33
1834116|NCT00321620|6353457|P1|Overall Study|Other|42
1834117|NCT00321620|6353456|P2|Overall Study|Participant request|52
1834118|NCT00321620|6353457|P1|Overall Study|Participant request|75
1834119|NCT00321620|6353456|P2|Overall Study|Ineligibility determined|3
1834120|NCT00321620|6353457|P1|Overall Study|Ineligibility determined|2
1834121|NCT00321620|6353456|P2|Overall Study|Protocol deviation|3
1834122|NCT00321620|6353457|P1|Overall Study|Protocol deviation|4
1834123|NCT00321620|6353456|P2|Overall Study|Noncompliance|7
1834124|NCT00321620|6353457|P1|Overall Study|Noncompliance|14
1834125|NCT00321620|6353456|P2|Overall Study|Physician Decision|1
1834126|NCT00321620|6353457|P1|Overall Study|Physician Decision|4
1834127|NCT00321620|6353456|P2|Overall Study|Lost to Follow-up|9
1834128|NCT00321620|6353457|P1|Overall Study|Lost to Follow-up|13
1834129|NCT00321620|6353456|P2|Overall Study|Adverse Event|56
1834130|NCT00321620|6353457|P1|Overall Study|Adverse Event|43
1834131|NCT00321620|6353456|P2|Overall Study|Disease progression|117
1834132|NCT00321620|6353457|P1|Overall Study|Disease progression|113
1834133|NCT00321620|6353456|P2|Overall Study|Withdrawal by Subject|147
1834134|NCT00321620|6353457|P1|Overall Study|Withdrawal by Subject|164
1834135|NCT00321620|6353456|P2|Overall Study|Death|294
1834136|NCT00321620|6353457|P1|Overall Study|Death|269
1834137|NCT00321555|6353485|P1|Overall Study|Disease progression on study|1
1834138|NCT00321555|6353485|P1|Overall Study|Physician Decision|1
1834139|NCT00321555|6353485|P1|Overall Study|Switched to alternative treatment|3
1834140|NCT00321555|6353485|P1|Overall Study|Developed antibodies|1
1834141|NCT00321464|6353493|P2|Overall Study|Other|18
1834142|NCT00321464|6353494|P1|Overall Study|Other|21
1834143|NCT00321464|6353493|P2|Overall Study|Ineligibility determined|1
1834144|NCT00321464|6353494|P1|Overall Study|Ineligibility determined|2
1834145|NCT00321464|6353493|P2|Overall Study|Protocol deviation|2
1834146|NCT00321464|6353494|P1|Overall Study|Protocol deviation|0
1834147|NCT00321464|6353493|P2|Overall Study|Lost to Follow-up|8
1834148|NCT00321464|6353494|P1|Overall Study|Lost to Follow-up|7
1834149|NCT00321464|6353493|P2|Overall Study|Noncompliance|10
1834150|NCT00321464|6353494|P1|Overall Study|Noncompliance|4
1834151|NCT00321464|6353493|P2|Overall Study|Physician Decision|14
1834152|NCT00321464|6353494|P1|Overall Study|Physician Decision|15
1834153|NCT00321464|6353493|P2|Overall Study|Adverse Event|28
1834154|NCT00321464|6353494|P1|Overall Study|Adverse Event|43
1834155|NCT00321464|6353493|P2|Overall Study|Participant request|61
1834156|NCT00321464|6353494|P1|Overall Study|Participant request|57
1834157|NCT00321464|6353493|P2|Overall Study|Withdrawal by Subject|118
1834158|NCT00321464|6353494|P1|Overall Study|Withdrawal by Subject|117
1834159|NCT00321464|6353493|P2|Overall Study|Disease progression|124
1834160|NCT00321464|6353494|P1|Overall Study|Disease progression|124
1834161|NCT00321464|6353493|P2|Overall Study|Death|174
1834162|NCT00321464|6353494|P1|Overall Study|Death|169
1834163|NCT00321373|6353507|P3|Overall Study|Other|1
1834164|NCT00321373|6353508|P2|Overall Study|Other|0
1834165|NCT00321373|6353509|P1|Overall Study|Other|0
1834166|NCT00321373|6353507|P3|Overall Study|Withdrawal by Subject|0
1834167|NCT00321373|6353508|P2|Overall Study|Withdrawal by Subject|0
1834168|NCT00321373|6353509|P1|Overall Study|Withdrawal by Subject|1
1834169|NCT00321373|6353507|P3|Overall Study|Lost to Follow-up|1
1834170|NCT00321373|6353508|P2|Overall Study|Lost to Follow-up|0
1834171|NCT00321373|6353509|P1|Overall Study|Lost to Follow-up|1
1834172|NCT00321373|6353507|P3|Overall Study|Adverse Event|1
1834173|NCT00321373|6353508|P2|Overall Study|Adverse Event|0
1834174|NCT00321373|6353509|P1|Overall Study|Adverse Event|0
1834175|NCT00321048|6353549|P2|Overall Study|Withdrawal by Subject|8
1834176|NCT00321048|6353550|P1|Overall Study|Withdrawal by Subject|6
1834177|NCT00320801|6353558|P4|Extension Phase|Lost to Follow-up|3
1834178|NCT00320801|6353559|P3|Extension Phase|Lost to Follow-up|0
1834179|NCT00320801|6353560|P2|Extension Phase|Lost to Follow-up|0
1834180|NCT00320801|6353561|P1|Extension Phase|Lost to Follow-up|0
1834181|NCT00320801|6353558|P4|Extension Phase|Lack of Efficacy|2
1834182|NCT00320801|6353559|P3|Extension Phase|Lack of Efficacy|0
1834183|NCT00320801|6353560|P2|Extension Phase|Lack of Efficacy|0
1834184|NCT00320801|6353561|P1|Extension Phase|Lack of Efficacy|0
1834185|NCT00320801|6353558|P4|Extension Phase|Administrative|29
1834186|NCT00320801|6353559|P3|Extension Phase|Administrative|0
1834187|NCT00320801|6353560|P2|Extension Phase|Administrative|0
1834188|NCT00320801|6353561|P1|Extension Phase|Administrative|0
1834189|NCT00320801|6353558|P4|Extension Phase|Adverse Event|8
1834190|NCT00320801|6353559|P3|Extension Phase|Adverse Event|0
1834191|NCT00320801|6353560|P2|Extension Phase|Adverse Event|0
1834192|NCT00320801|6353561|P1|Extension Phase|Adverse Event|0
1834193|NCT00320801|6353558|P4|Extension Phase|Withdrawal by Subject|6
1834194|NCT00320801|6353559|P3|Extension Phase|Withdrawal by Subject|0
1834195|NCT00320801|6353560|P2|Extension Phase|Withdrawal by Subject|0
1834196|NCT00320801|6353561|P1|Extension Phase|Withdrawal by Subject|0
1834197|NCT00320801|6353558|P4|Double-blind Phase|Lack of Efficacy|0
1834198|NCT00320801|6353559|P3|Double-blind Phase|Lack of Efficacy|1
1834199|NCT00320801|6353560|P2|Double-blind Phase|Lack of Efficacy|9
1834200|NCT00320801|6353561|P1|Double-blind Phase|Lack of Efficacy|0
1834201|NCT00320801|6353558|P4|Double-blind Phase|Administrative|0
1834202|NCT00320801|6353559|P3|Double-blind Phase|Administrative|4
1834203|NCT00320801|6353560|P2|Double-blind Phase|Administrative|0
1834204|NCT00320801|6353561|P1|Double-blind Phase|Administrative|0
1834205|NCT00320801|6353558|P4|Double-blind Phase|Adverse Event|0
1834206|NCT00320801|6353559|P3|Double-blind Phase|Adverse Event|8
1834207|NCT00320801|6353560|P2|Double-blind Phase|Adverse Event|2
1834208|NCT00320801|6353561|P1|Double-blind Phase|Adverse Event|0
1834209|NCT00320801|6353558|P4|Double-blind Phase|Withdrawal by Subject|0
1834210|NCT00320801|6353559|P3|Double-blind Phase|Withdrawal by Subject|1
1834211|NCT00320801|6353560|P2|Double-blind Phase|Withdrawal by Subject|0
1834212|NCT00320801|6353561|P1|Double-blind Phase|Withdrawal by Subject|0
1834213|NCT00320801|6353558|P4|Open-label Run-in Period|Did not qualify|0
1834214|NCT00320801|6353559|P3|Open-label Run-in Period|Did not qualify|0
1834215|NCT00320801|6353560|P2|Open-label Run-in Period|Did not qualify|0
1834216|NCT00320801|6353561|P1|Open-label Run-in Period|Did not qualify|1
1834217|NCT00320801|6353558|P4|Open-label Run-in Period|Lost to Follow-up|0
1834218|NCT00320801|6353559|P3|Open-label Run-in Period|Lost to Follow-up|0
1834219|NCT00320801|6353560|P2|Open-label Run-in Period|Lost to Follow-up|0
1834220|NCT00320801|6353561|P1|Open-label Run-in Period|Lost to Follow-up|2
1834221|NCT00320801|6353558|P4|Open-label Run-in Period|Lack of Efficacy|0
1834222|NCT00320801|6353559|P3|Open-label Run-in Period|Lack of Efficacy|0
1834223|NCT00320801|6353560|P2|Open-label Run-in Period|Lack of Efficacy|0
1834224|NCT00320801|6353561|P1|Open-label Run-in Period|Lack of Efficacy|44
1834225|NCT00320801|6353558|P4|Open-label Run-in Period|Administrative|0
1834226|NCT00320801|6353559|P3|Open-label Run-in Period|Administrative|0
1834227|NCT00320801|6353560|P2|Open-label Run-in Period|Administrative|0
1834228|NCT00320801|6353561|P1|Open-label Run-in Period|Administrative|10
1834229|NCT00320801|6353558|P4|Open-label Run-in Period|Adverse Event|0
1834230|NCT00320801|6353559|P3|Open-label Run-in Period|Adverse Event|0
1834231|NCT00320801|6353560|P2|Open-label Run-in Period|Adverse Event|0
1834232|NCT00320801|6353561|P1|Open-label Run-in Period|Adverse Event|33
1834233|NCT00320801|6353558|P4|Open-label Run-in Period|Withdrawal by Subject|0
1834234|NCT00320801|6353559|P3|Open-label Run-in Period|Withdrawal by Subject|0
1834235|NCT00320801|6353560|P2|Open-label Run-in Period|Withdrawal by Subject|0
1834236|NCT00320801|6353561|P1|Open-label Run-in Period|Withdrawal by Subject|2
1834237|NCT00320788|6353576|P5|Overall Study|Withdrawal by Subject|1
1834238|NCT00320788|6353577|P4|Overall Study|Withdrawal by Subject|3
1834239|NCT00320788|6353578|P3|Overall Study|Withdrawal by Subject|0
1834240|NCT00320788|6353579|P2|Overall Study|Withdrawal by Subject|0
1834241|NCT00320788|6353580|P1|Overall Study|Withdrawal by Subject|3
1834242|NCT00320788|6353576|P5|Overall Study|Protocol Violation|1
1834243|NCT00320788|6353577|P4|Overall Study|Protocol Violation|0
1834244|NCT00320788|6353578|P3|Overall Study|Protocol Violation|0
1834245|NCT00320788|6353579|P2|Overall Study|Protocol Violation|0
1834246|NCT00320788|6353580|P1|Overall Study|Protocol Violation|0
1834247|NCT00320788|6353576|P5|Overall Study|Physician Decision|0
1834248|NCT00320788|6353577|P4|Overall Study|Physician Decision|0
1834249|NCT00320788|6353578|P3|Overall Study|Physician Decision|0
1834250|NCT00320788|6353579|P2|Overall Study|Physician Decision|1
1834251|NCT00320788|6353580|P1|Overall Study|Physician Decision|1
1834252|NCT00320788|6353576|P5|Overall Study|Other|1
1834253|NCT00320788|6353577|P4|Overall Study|Other|1
1834254|NCT00320788|6353578|P3|Overall Study|Other|1
1834255|NCT00320788|6353579|P2|Overall Study|Other|2
1834256|NCT00320788|6353580|P1|Overall Study|Other|1
1834257|NCT00320788|6353576|P5|Overall Study|Decision by the Sponsor|1
1834258|NCT00320788|6353577|P4|Overall Study|Decision by the Sponsor|0
1834259|NCT00320788|6353578|P3|Overall Study|Decision by the Sponsor|0
1834260|NCT00320788|6353579|P2|Overall Study|Decision by the Sponsor|1
1834261|NCT00320788|6353580|P1|Overall Study|Decision by the Sponsor|1
1834262|NCT00320788|6353576|P5|Overall Study|Lost to Follow-up|0
1834263|NCT00320788|6353577|P4|Overall Study|Lost to Follow-up|0
1834264|NCT00320788|6353578|P3|Overall Study|Lost to Follow-up|1
1834265|NCT00320788|6353579|P2|Overall Study|Lost to Follow-up|2
1834266|NCT00320788|6353580|P1|Overall Study|Lost to Follow-up|0
1834267|NCT00320788|6353576|P5|Overall Study|Death|1
1834268|NCT00320788|6353577|P4|Overall Study|Death|0
1834269|NCT00320788|6353578|P3|Overall Study|Death|1
1834270|NCT00320788|6353579|P2|Overall Study|Death|0
1834271|NCT00320788|6353580|P1|Overall Study|Death|0
1834272|NCT00320788|6353576|P5|Overall Study|Adverse Event|0
1834273|NCT00320788|6353577|P4|Overall Study|Adverse Event|1
1834274|NCT00320788|6353578|P3|Overall Study|Adverse Event|0
1834275|NCT00320788|6353579|P2|Overall Study|Adverse Event|0
1834276|NCT00320788|6353580|P1|Overall Study|Adverse Event|0
1834277|NCT00320710|6353634|P3|Overall Study|Lost to Follow-up|0
1834278|NCT00320710|6353635|P2|Overall Study|Lost to Follow-up|0
1834279|NCT00320710|6353636|P1|Overall Study|Lost to Follow-up|1
1834280|NCT00320710|6353634|P3|Overall Study|Adverse Event|1
1834281|NCT00320710|6353635|P2|Overall Study|Adverse Event|14
1834282|NCT00320710|6353636|P1|Overall Study|Adverse Event|18
1834283|NCT00320710|6353634|P3|Overall Study|Abnormal laboratory value(s)|0
1834284|NCT00320710|6353635|P2|Overall Study|Abnormal laboratory value(s)|3
1834285|NCT00320710|6353636|P1|Overall Study|Abnormal laboratory value(s)|12
1834286|NCT00320710|6353634|P3|Overall Study|Abnormal test procedure result(s)|0
1834287|NCT00320710|6353635|P2|Overall Study|Abnormal test procedure result(s)|0
1834288|NCT00320710|6353636|P1|Overall Study|Abnormal test procedure result(s)|2
1834289|NCT00320710|6353634|P3|Overall Study|Protocol Violation|0
1834290|NCT00320710|6353635|P2|Overall Study|Protocol Violation|5
1834291|NCT00320710|6353636|P1|Overall Study|Protocol Violation|6
1834292|NCT00320710|6353634|P3|Overall Study|Withdrawal by Subject|1
1834293|NCT00320710|6353635|P2|Overall Study|Withdrawal by Subject|26
1834294|NCT00320710|6353636|P1|Overall Study|Withdrawal by Subject|20
1834295|NCT00320710|6353634|P3|Overall Study|Administrative problems|0
1834296|NCT00320710|6353635|P2|Overall Study|Administrative problems|2
1834297|NCT00320710|6353636|P1|Overall Study|Administrative problems|1
1834298|NCT00320710|6353634|P3|Overall Study|Death|1
1834299|NCT00320710|6353635|P2|Overall Study|Death|7
1834300|NCT00320710|6353636|P1|Overall Study|Death|10
1834301|NCT00320710|6353634|P3|Overall Study|Disease progression|2
1834302|NCT00320710|6353635|P2|Overall Study|Disease progression|19
1834303|NCT00320710|6353636|P1|Overall Study|Disease progression|24
1834304|NCT00320606|6353666|P1|Overall Study|Withdrawal by Subject|1
1834305|NCT00320606|6353666|P1|Overall Study|Protocol Violation|1
1834306|NCT00320606|6353666|P1|Overall Study|Adverse Event|1
1834307|NCT00320593|6353682|P2|Overall Study|Withdrawal by clinical center|0
1834308|NCT00320593|6353683|P1|Overall Study|Withdrawal by clinical center|1
1834309|NCT00320593|6353682|P2|Overall Study|Withdrawal by Subject|1
1834310|NCT00320593|6353683|P1|Overall Study|Withdrawal by Subject|2
1834311|NCT00320593|6353682|P2|Overall Study|Moved to another state|0
1834312|NCT00320593|6353683|P1|Overall Study|Moved to another state|1
1834313|NCT00320593|6353682|P2|Overall Study|Lost to Follow-up|0
1834314|NCT00320593|6353683|P1|Overall Study|Lost to Follow-up|3
1834315|NCT00320541|6353707|P2|Overall Study|Protocol Entry Criterion Not Met|0
1834316|NCT00320541|6353708|P1|Overall Study|Protocol Entry Criterion Not Met|1
1834317|NCT00320541|6353707|P2|Overall Study|Death due to Adverse Event(s)|0
1834318|NCT00320541|6353708|P1|Overall Study|Death due to Adverse Event(s)|1
1834319|NCT00320541|6353707|P2|Overall Study|Death due to Study Disease|3
1834320|NCT00320541|6353708|P1|Overall Study|Death due to Study Disease|1
1834321|NCT00320541|6353707|P2|Overall Study|Sponsor Decision|1
1834322|NCT00320541|6353708|P1|Overall Study|Sponsor Decision|2
1834323|NCT00320541|6353707|P2|Overall Study|Other|4
1834324|NCT00320541|6353708|P1|Overall Study|Other|3
1834325|NCT00320541|6353707|P2|Overall Study|Physician Decision|13
1834326|NCT00320541|6353708|P1|Overall Study|Physician Decision|9
1834327|NCT00320541|6353707|P2|Overall Study|Withdrawal by Subject|16
1834328|NCT00320541|6353708|P1|Overall Study|Withdrawal by Subject|12
1834329|NCT00320541|6353707|P2|Overall Study|Protocol Violation|1
1834330|NCT00320541|6353708|P1|Overall Study|Protocol Violation|0
1834331|NCT00320541|6353707|P2|Overall Study|Adverse Event|19
1834332|NCT00320541|6353708|P1|Overall Study|Adverse Event|21
1834333|NCT00320528|6353735|P3|Study Period III|Atomoxetine Commercially Available|90
1834334|NCT00320528|6353736|P2|Study Period III|Atomoxetine Commercially Available|25
1834335|NCT00320528|6353737|P1|Study Period III|Atomoxetine Commercially Available|68
1834336|NCT00320528|6353735|P3|Study Period III|Sponsor Decision|1
1834337|NCT00320528|6353736|P2|Study Period III|Sponsor Decision|0
1834338|NCT00320528|6353737|P1|Study Period III|Sponsor Decision|0
1834339|NCT00320528|6353735|P3|Study Period III|Physician Decision|2
1834340|NCT00320528|6353736|P2|Study Period III|Physician Decision|1
1834341|NCT00320528|6353737|P1|Study Period III|Physician Decision|0
1834342|NCT00320528|6353735|P3|Study Period III|Protocol Violation|0
1834343|NCT00320528|6353736|P2|Study Period III|Protocol Violation|1
1834344|NCT00320528|6353737|P1|Study Period III|Protocol Violation|0
1834345|NCT00320528|6353735|P3|Study Period III|Parent/Caregiver Decision|11
1834346|NCT00320528|6353736|P2|Study Period III|Parent/Caregiver Decision|3
1834347|NCT00320528|6353737|P1|Study Period III|Parent/Caregiver Decision|14
1834348|NCT00320528|6353735|P3|Study Period III|Lack of Efficacy|0
1834349|NCT00320528|6353736|P2|Study Period III|Lack of Efficacy|0
1834350|NCT00320528|6353737|P1|Study Period III|Lack of Efficacy|2
1834351|NCT00320528|6353735|P3|Study Period III|Withdrawal by Subject|2
1834352|NCT00320528|6353736|P2|Study Period III|Withdrawal by Subject|1
1834353|NCT00320528|6353737|P1|Study Period III|Withdrawal by Subject|1
1834354|NCT00320528|6353735|P3|Study Period III|Lost to Follow-up|0
1834355|NCT00320528|6353736|P2|Study Period III|Lost to Follow-up|0
1834356|NCT00320528|6353737|P1|Study Period III|Lost to Follow-up|1
1834357|NCT00320528|6353735|P3|Study Period III|Adverse Event|0
1834358|NCT00320528|6353736|P2|Study Period III|Adverse Event|0
1834359|NCT00320528|6353737|P1|Study Period III|Adverse Event|1
1834360|NCT00320528|6353735|P3|Study Period II|Entry Criteria Exclusion|2
1834361|NCT00320528|6353736|P2|Study Period II|Entry Criteria Exclusion|2
1834362|NCT00320528|6353737|P1|Study Period II|Entry Criteria Exclusion|0
1834363|NCT00320528|6353735|P3|Study Period II|Withdrawal by Subject|1
1834364|NCT00320528|6353736|P2|Study Period II|Withdrawal by Subject|1
1834365|NCT00320528|6353737|P1|Study Period II|Withdrawal by Subject|0
1834366|NCT00320528|6353735|P3|Study Period II|Parent/Caregiver Decision|11
1834367|NCT00320528|6353736|P2|Study Period II|Parent/Caregiver Decision|3
1834368|NCT00320528|6353737|P1|Study Period II|Parent/Caregiver Decision|8
1834369|NCT00320528|6353735|P3|Study Period II|Adverse Event|8
1834370|NCT00320528|6353736|P2|Study Period II|Adverse Event|4
1834371|NCT00320528|6353737|P1|Study Period II|Adverse Event|3
1834372|NCT00320515|6353772|P1|Overall Study|Withdrawal by Subject|8
1834373|NCT00320515|6353772|P1|Overall Study|Physician Decision|2
1834374|NCT00320515|6353772|P1|Overall Study|Lost to Follow-up|6
1834375|NCT00320515|6353772|P1|Overall Study|Death|33
1834376|NCT00320489|6353781|P2|Overall Study|Withdrawal by Subject|41
1834377|NCT00320489|6353782|P1|Overall Study|Withdrawal by Subject|39
1834378|NCT00320489|6353781|P2|Overall Study|Sponsor Decision|3
1834379|NCT00320489|6353782|P1|Overall Study|Sponsor Decision|3
1834380|NCT00320489|6353781|P2|Overall Study|Protocol Violation|4
1834381|NCT00320489|6353782|P1|Overall Study|Protocol Violation|4
1834382|NCT00320489|6353781|P2|Overall Study|Physician Decision|8
1834383|NCT00320489|6353782|P1|Overall Study|Physician Decision|8
1834384|NCT00320489|6353781|P2|Overall Study|Lost to Follow-up|22
1834385|NCT00320489|6353782|P1|Overall Study|Lost to Follow-up|21
1834386|NCT00320489|6353781|P2|Overall Study|Lack of Efficacy|7
1834387|NCT00320489|6353782|P1|Overall Study|Lack of Efficacy|16
1834388|NCT00320489|6353781|P2|Overall Study|Entry Criteria Exclusion|4
1834389|NCT00320489|6353782|P1|Overall Study|Entry Criteria Exclusion|2
1834390|NCT00320489|6353781|P2|Overall Study|Death|2
1834391|NCT00320489|6353782|P1|Overall Study|Death|0
1834392|NCT00320489|6353781|P2|Overall Study|Clinical Relapse|20
1834393|NCT00320489|6353782|P1|Overall Study|Clinical Relapse|26
1834394|NCT00320489|6353781|P2|Overall Study|Adverse Event|25
1834395|NCT00320489|6353782|P1|Overall Study|Adverse Event|26
1834396|NCT00320424|6353838|P1|Overall Study|Other|3
1834397|NCT00320424|6353838|P1|Overall Study|Adverse Event|3
1834398|NCT00320411|6353852|P1|Overall Study|No investigational product admin.|4
1834399|NCT00320398|6353875|P2|Overall Study|Other|0
1834400|NCT00320398|6353876|P1|Overall Study|Other|1
1834401|NCT00320398|6353875|P2|Overall Study|Adverse Event|4
1834402|NCT00320398|6353876|P1|Overall Study|Adverse Event|1
1834403|NCT00320385|6353904|P2|Overall Study|Adverse Event|1
1834404|NCT00320385|6353905|P1|Overall Study|Adverse Event|0
1834405|NCT00320385|6353904|P2|Overall Study|Withdrew Consent|0
1834406|NCT00320385|6353905|P1|Overall Study|Withdrew Consent|1
1834407|NCT00320385|6353904|P2|Overall Study|Serious Adverse Event|0
1834408|NCT00320385|6353905|P1|Overall Study|Serious Adverse Event|1
1834409|NCT00320385|6353904|P2|Overall Study|Death|2
1834410|NCT00320385|6353905|P1|Overall Study|Death|1
1834411|NCT00320385|6353904|P2|Overall Study|Investigator Decision|1
1834412|NCT00320385|6353905|P1|Overall Study|Investigator Decision|0
1834413|NCT00320385|6353904|P2|Overall Study|Sponsor Terminated Study|1
1834414|NCT00320385|6353905|P1|Overall Study|Sponsor Terminated Study|2
1834415|NCT00320385|6353904|P2|Overall Study|Withdrawal by Subject|7
1834416|NCT00320385|6353905|P1|Overall Study|Withdrawal by Subject|6
1834417|NCT00320385|6353904|P2|Overall Study|Lost to Follow-up|10
1834418|NCT00320385|6353905|P1|Overall Study|Lost to Follow-up|7
1834419|NCT00320372|6353928|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
1834420|NCT00320372|6353929|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
1834421|NCT00320372|6353928|P2|Overall Study|Did not Meet (I/E)|1
1834422|NCT00320372|6353929|P1|Overall Study|Did not Meet (I/E)|3
1834423|NCT00320372|6353928|P2|Overall Study|Non-Compliance|39
1834424|NCT00320372|6353929|P1|Overall Study|Non-Compliance|40
1834425|NCT00320372|6353928|P2|Overall Study|Withdrawal by Subject|37
1834426|NCT00320372|6353929|P1|Overall Study|Withdrawal by Subject|55
1834427|NCT00320372|6353928|P2|Overall Study|Death|8
1834428|NCT00320372|6353929|P1|Overall Study|Death|7
1834429|NCT00320372|6353928|P2|Overall Study|Physician Decision|7
1834430|NCT00320372|6353929|P1|Overall Study|Physician Decision|4
1834431|NCT00320255|6353969|P6|Overall Study|Other|0
1834432|NCT00320255|6353970|P5|Overall Study|Other|0
1834433|NCT00320255|6353971|P4|Overall Study|Other|0
1834434|NCT00320255|6353972|P3|Overall Study|Other|1
1834435|NCT00320255|6353973|P2|Overall Study|Other|2
1834436|NCT00320255|6353974|P1|Overall Study|Other|3
1834437|NCT00320255|6353969|P6|Overall Study|No longer meets study criteria|0
1834438|NCT00320255|6353970|P5|Overall Study|No longer meets study criteria|0
1834439|NCT00320255|6353971|P4|Overall Study|No longer meets study criteria|1
1834440|NCT00320255|6353972|P3|Overall Study|No longer meets study criteria|0
1834441|NCT00320255|6353973|P2|Overall Study|No longer meets study criteria|0
1834442|NCT00320255|6353974|P1|Overall Study|No longer meets study criteria|0
1834443|NCT00320255|6353969|P6|Overall Study|Poor compliance/noncompliance|0
1834444|NCT00320255|6353970|P5|Overall Study|Poor compliance/noncompliance|0
1834445|NCT00320255|6353971|P4|Overall Study|Poor compliance/noncompliance|1
1834446|NCT00320255|6353972|P3|Overall Study|Poor compliance/noncompliance|0
1834447|NCT00320255|6353973|P2|Overall Study|Poor compliance/noncompliance|1
1834448|NCT00320255|6353974|P1|Overall Study|Poor compliance/noncompliance|1
1834449|NCT00320255|6353969|P6|Overall Study|Withdrawal by Subject|0
1834450|NCT00320255|6353970|P5|Overall Study|Withdrawal by Subject|0
1834451|NCT00320255|6353971|P4|Overall Study|Withdrawal by Subject|4
1834452|NCT00320255|6353972|P3|Overall Study|Withdrawal by Subject|2
1834453|NCT00320255|6353973|P2|Overall Study|Withdrawal by Subject|2
1834454|NCT00320255|6353974|P1|Overall Study|Withdrawal by Subject|1
1834455|NCT00320255|6353969|P6|Overall Study|Adverse Event|0
1834456|NCT00320255|6353970|P5|Overall Study|Adverse Event|0
1834457|NCT00320255|6353971|P4|Overall Study|Adverse Event|2
1834458|NCT00320255|6353972|P3|Overall Study|Adverse Event|3
1834459|NCT00320255|6353973|P2|Overall Study|Adverse Event|2
1834460|NCT00320255|6353974|P1|Overall Study|Adverse Event|5
1834461|NCT00320255|6353969|P6|Overall Study|Lack of Efficacy|0
1834462|NCT00320255|6353970|P5|Overall Study|Lack of Efficacy|0
1834463|NCT00320255|6353971|P4|Overall Study|Lack of Efficacy|0
1834464|NCT00320255|6353972|P3|Overall Study|Lack of Efficacy|0
1834465|NCT00320255|6353973|P2|Overall Study|Lack of Efficacy|0
1834466|NCT00320255|6353974|P1|Overall Study|Lack of Efficacy|1
1834467|NCT00320216|6354067|P5|Overall Study|Other|3
1834468|NCT00320216|6354068|P4|Overall Study|Other|1
1834469|NCT00320216|6354069|P3|Overall Study|Other|5
1834470|NCT00320216|6354070|P2|Overall Study|Other|2
1834471|NCT00320216|6354071|P1|Overall Study|Other|7
1834472|NCT00320216|6354067|P5|Overall Study|Lost to Follow-up|0
1834473|NCT00320216|6354068|P4|Overall Study|Lost to Follow-up|0
1834474|NCT00320216|6354069|P3|Overall Study|Lost to Follow-up|0
1834475|NCT00320216|6354070|P2|Overall Study|Lost to Follow-up|0
1834476|NCT00320216|6354071|P1|Overall Study|Lost to Follow-up|3
1834477|NCT00320216|6354067|P5|Overall Study|Lack of Efficacy|1
1834478|NCT00320216|6354068|P4|Overall Study|Lack of Efficacy|0
1834479|NCT00320216|6354069|P3|Overall Study|Lack of Efficacy|1
1834480|NCT00320216|6354070|P2|Overall Study|Lack of Efficacy|2
1834481|NCT00320216|6354071|P1|Overall Study|Lack of Efficacy|6
1834482|NCT00320216|6354067|P5|Overall Study|Adverse Event|2
1834483|NCT00320216|6354068|P4|Overall Study|Adverse Event|2
1834484|NCT00320216|6354069|P3|Overall Study|Adverse Event|0
1834485|NCT00320216|6354070|P2|Overall Study|Adverse Event|6
1834486|NCT00320216|6354071|P1|Overall Study|Adverse Event|0
1834487|NCT00320190|6354105|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
1834488|NCT00320190|6354106|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
1834489|NCT00320190|6354105|P2|Long-term (12-month) Extension|Lack of major molecular response|2
1834490|NCT00320190|6354106|P1|Long-term (12-month) Extension|Lack of major molecular response|1
1834491|NCT00320190|6354105|P2|Long-term (12-month) Extension|Sponsor terminated study|0
1834492|NCT00320190|6354106|P1|Long-term (12-month) Extension|Sponsor terminated study|7
1834493|NCT00320190|6354105|P2|First 12 Months|Withdrawal by Subject|1
1834494|NCT00320190|6354106|P1|First 12 Months|Withdrawal by Subject|0
1834495|NCT00320190|6354105|P2|First 12 Months|Study drug toxicity|1
1834496|NCT00320190|6354106|P1|First 12 Months|Study drug toxicity|0
1834497|NCT00320190|6354105|P2|First 12 Months|Investigator request|1
1834498|NCT00320190|6354106|P1|First 12 Months|Investigator request|0
1834499|NCT00320190|6354105|P2|First 12 Months|Adverse event unrelated to study drug|0
1834500|NCT00320190|6354106|P1|First 12 Months|Adverse event unrelated to study drug|1
1834501|NCT00320190|6354105|P2|First 12 Months|Enrollment failure|1
1834502|NCT00320190|6354106|P1|First 12 Months|Enrollment failure|0
1834503|NCT00320190|6354105|P2|First 12 Months|Lost to Follow-up|1
1834504|NCT00320190|6354106|P1|First 12 Months|Lost to Follow-up|0
1834505|NCT00320190|6354105|P2|First 12 Months|Sponsor terminated study|2
1834506|NCT00320190|6354106|P1|First 12 Months|Sponsor terminated study|2
1834507|NCT00320190|6354105|P2|First 12 Months|Completed but did not enter extension|3
1834508|NCT00320190|6354106|P1|First 12 Months|Completed but did not enter extension|5
1834509|NCT00320112|6354126|P2|Overall Study|Death|1
1834510|NCT00320112|6354127|P1|Overall Study|Death|2
1834511|NCT00320112|6354126|P2|Overall Study|Withdrawal by Subject|0
1834512|NCT00320112|6354127|P1|Overall Study|Withdrawal by Subject|3
1834513|NCT00320112|6354126|P2|Overall Study|Lost to Follow-up|4
1834514|NCT00320112|6354127|P1|Overall Study|Lost to Follow-up|3
1834515|NCT00319982|6354141|P2|Overall Study|Withdrawal by Subject|0
1834516|NCT00319982|6354142|P1|Overall Study|Withdrawal by Subject|1
1834517|NCT00319956|6354162|P2|Overall Study|Death|24
1834518|NCT00319956|6354163|P1|Overall Study|Death|20
1834519|NCT00319839|6354175|P1|Overall Study|Withdrawal by Subject|1
1834520|NCT00319839|6354175|P1|Overall Study|Adverse Event|5
1834521|NCT00319735|6354191|P1|Overall Study|Death|2
1834522|NCT00319696|6354204|P1|Overall Study|Lost to Follow-up|3
1834523|NCT00319696|6354204|P1|Overall Study|administrative|7
1834524|NCT00319696|6354204|P1|Overall Study|withdrawal of consent|14
1834525|NCT00319696|6354204|P1|Overall Study|Adverse Event|36
1834526|NCT00319592|6354241|P2|Overall Study|Physician Decision|1
1834527|NCT00319592|6354242|P1|Overall Study|Physician Decision|0
1834528|NCT00319592|6354241|P2|Overall Study|Protocol Violation|0
1834529|NCT00319592|6354242|P1|Overall Study|Protocol Violation|1
1834530|NCT00319553|6354258|P2|Overall Study|Withdrawal by Subject|1
1834531|NCT00319553|6354259|P1|Overall Study|Withdrawal by Subject|1
1834532|NCT00319553|6354258|P2|Overall Study|Lost to Follow-up|1
1834533|NCT00319553|6354259|P1|Overall Study|Lost to Follow-up|2
1834534|NCT00319553|6354258|P2|Overall Study|Protocol Violation|2
1834535|NCT00319553|6354259|P1|Overall Study|Protocol Violation|1
1834536|NCT00319501|6354273|P2|Open-label Extension Period|Withdrawal by Subject|0
1834537|NCT00319501|6354274|P1|Open-label Extension Period|Withdrawal by Subject|2
1834538|NCT00319501|6354273|P2|Open-label Extension Period|Sponsor request|0
1834539|NCT00319501|6354274|P1|Open-label Extension Period|Sponsor request|26
1834540|NCT00319501|6354273|P2|Open-label Extension Period|Principal investigator decision|0
1834541|NCT00319501|6354274|P1|Open-label Extension Period|Principal investigator decision|2
1834542|NCT00319501|6354273|P2|Open-label Extension Period|Other|0
1834543|NCT00319501|6354274|P1|Open-label Extension Period|Other|1
1834544|NCT00319501|6354273|P2|Open-label Extension Period|Did not receive treatment|0
1834545|NCT00319501|6354274|P1|Open-label Extension Period|Did not receive treatment|18
1834546|NCT00319501|6354273|P2|Open-label Extension Period|Adverse Event|0
1834547|NCT00319501|6354274|P1|Open-label Extension Period|Adverse Event|2
1834548|NCT00319501|6354273|P2|Open-label Period|Other|0
1834549|NCT00319501|6354274|P1|Open-label Period|Other|11
1834550|NCT00319501|6354273|P2|Open-label Period|Did not receive treatment|0
1834551|NCT00319501|6354274|P1|Open-label Period|Did not receive treatment|33
1834552|NCT00319501|6354273|P2|Open-label Period|Lost to Follow-up|0
1834553|NCT00319501|6354274|P1|Open-label Period|Lost to Follow-up|5
1834554|NCT00319501|6354273|P2|Open-label Period|Sponsor request|0
1834555|NCT00319501|6354274|P1|Open-label Period|Sponsor request|12
1834556|NCT00319501|6354273|P2|Open-label Period|Principal Investigator decision|0
1834557|NCT00319501|6354274|P1|Open-label Period|Principal Investigator decision|6
1834558|NCT00319501|6354273|P2|Open-label Period|Withdrawal by Subject|0
1834559|NCT00319501|6354274|P1|Open-label Period|Withdrawal by Subject|38
1834560|NCT00319501|6354273|P2|Open-label Period|Protocol Violation|0
1834561|NCT00319501|6354274|P1|Open-label Period|Protocol Violation|6
1834562|NCT00319501|6354273|P2|Open-label Period|Adverse Event|0
1834563|NCT00319501|6354274|P1|Open-label Period|Adverse Event|5
1834564|NCT00319501|6354273|P2|Double-blind Period|Did not receive treatment|29
1834565|NCT00319501|6354274|P1|Double-blind Period|Did not receive treatment|42
1834566|NCT00319501|6354273|P2|Double-blind Period|Sponsor Request|0
1834567|NCT00319501|6354274|P1|Double-blind Period|Sponsor Request|1
1834568|NCT00319501|6354273|P2|Double-blind Period|Withdrawal by Subject|3
1834569|NCT00319501|6354274|P1|Double-blind Period|Withdrawal by Subject|0
1834570|NCT00319449|6354300|P2|Overall Study|Noncompliance with the protocol|0
1834571|NCT00319449|6354301|P1|Overall Study|Noncompliance with the protocol|1
1834572|NCT00319449|6354300|P2|Overall Study|Subject did not wish to continue|0
1834573|NCT00319449|6354301|P1|Overall Study|Subject did not wish to continue|1
1834574|NCT00319436|6354313|P2|Overall Study|Withdrawal by Subject|7
1834575|NCT00319436|6354314|P1|Overall Study|Withdrawal by Subject|6
1834576|NCT00319254|6354332|P1|Overall Study|Enrolled, Not Treated|2
1834577|NCT00319254|6354332|P1|Overall Study|Lost to Follow-up|2
1834578|NCT00319254|6354332|P1|Overall Study|Death|46
1834579|NCT00319254|6354332|P1|Overall Study|Withdrawal by Subject|4
1834580|NCT00319111|6354345|P1|Overall Study|Treatment failure|1
1834581|NCT00319111|6354345|P1|Overall Study|Administrative|2
1834582|NCT00319111|6354345|P1|Overall Study|Lack of clinical improvement|4
1834583|NCT00319111|6354345|P1|Overall Study|Death|9
1834584|NCT00319111|6354345|P1|Overall Study|Withdrawal of consent|11
1834585|NCT00319111|6354345|P1|Overall Study|Adverse Event|20
1834586|NCT00319098|6354359|P2|Overall Study|Protocol Violation|1
1834587|NCT00319098|6354360|P1|Overall Study|Protocol Violation|3
1834588|NCT00319098|6354359|P2|Overall Study|Others|8
1834589|NCT00319098|6354360|P1|Overall Study|Others|33
1834590|NCT00319098|6354359|P2|Overall Study|Lost to Follow-up|13
1834591|NCT00319098|6354360|P1|Overall Study|Lost to Follow-up|37
1834592|NCT00319098|6354359|P2|Overall Study|Migrated/moved from study area|1
1834593|NCT00319098|6354360|P1|Overall Study|Migrated/moved from study area|2
1834594|NCT00319098|6354359|P2|Overall Study|Withdrawal by Subject|8
1834595|NCT00319098|6354360|P1|Overall Study|Withdrawal by Subject|37
1834596|NCT00319098|6354359|P2|Overall Study|Adverse Event|1
1834597|NCT00319098|6354360|P1|Overall Study|Adverse Event|20
1834598|NCT00319098|6354359|P2|Overall Study|Serious adverse event|0
1834599|NCT00319098|6354360|P1|Overall Study|Serious adverse event|3
1834600|NCT00319046|6354418|P1|Overall Study|administrative reason|1
1834601|NCT00319046|6354418|P1|Overall Study|withdrawal of subject's consent|7
1834602|NCT00319020|6354427|P2|Overall Study|Adverse Event|1
1834603|NCT00319020|6354428|P1|Overall Study|Adverse Event|0
1834604|NCT00319020|6354427|P2|Overall Study|Treatment failure|1
1834605|NCT00319020|6354428|P1|Overall Study|Treatment failure|0
1834606|NCT00319020|6354427|P2|Overall Study|Transplant|1
1834607|NCT00319020|6354428|P1|Overall Study|Transplant|0
1834608|NCT00319020|6354427|P2|Overall Study|Disease progression|2
1834609|NCT00319020|6354428|P1|Overall Study|Disease progression|0
1834610|NCT00319020|6354427|P2|Overall Study|Administrative reason|5
1834611|NCT00319020|6354428|P1|Overall Study|Administrative reason|0
1834612|NCT00319020|6354427|P2|Overall Study|F-1 completed but not enrolled in F-2|0
1834613|NCT00319020|6354428|P1|Overall Study|F-1 completed but not enrolled in F-2|1
1834614|NCT00319020|6354427|P2|Overall Study|Withdrawal by Subject|1
1834615|NCT00319020|6354428|P1|Overall Study|Withdrawal by Subject|4
1834616|NCT00319020|6354427|P2|Overall Study|Death|2
1834617|NCT00319020|6354428|P1|Overall Study|Death|2
1834618|NCT00318656|6354500|P2|Overall Study|Did not receive any treatment|1
1834619|NCT00318656|6354501|P1|Overall Study|Did not receive any treatment|0
1834620|NCT00318656|6354500|P2|Overall Study|Took Avandamet instead of Glim/Met|1
1834621|NCT00318656|6354501|P1|Overall Study|Took Avandamet instead of Glim/Met|0
1834622|NCT00318565|6354558|P1|Overall Study|Excluded per protocol|24
1834623|NCT00318474|6354565|P2|Overall Study|Trial terminated|7
1834624|NCT00318474|6354566|P1|Overall Study|Trial terminated|10
1834625|NCT00318474|6354565|P2|Overall Study|Post-therapy hyperflycemia|1
1834626|NCT00318474|6354566|P1|Overall Study|Post-therapy hyperflycemia|0
1834627|NCT00318474|6354565|P2|Overall Study|Fall in GFR|3
1834628|NCT00318474|6354566|P1|Overall Study|Fall in GFR|3
1834629|NCT00318474|6354565|P2|Overall Study|Withdrawal by Subject|2
1834630|NCT00318474|6354566|P1|Overall Study|Withdrawal by Subject|3
1834631|NCT00318474|6354565|P2|Overall Study|Protocol Violation|0
1834632|NCT00318474|6354566|P1|Overall Study|Protocol Violation|1
1834633|NCT00318474|6354565|P2|Overall Study|Pregnancy|2
1834634|NCT00318474|6354566|P1|Overall Study|Pregnancy|0
1834635|NCT00318474|6354565|P2|Overall Study|Lost to Follow-up|1
1834636|NCT00318474|6354566|P1|Overall Study|Lost to Follow-up|0
1834637|NCT00318474|6354565|P2|Overall Study|Adverse Event|1
1834638|NCT00318474|6354566|P1|Overall Study|Adverse Event|1
1834639|NCT00318461|6354577|P5|Open-Label Extension, 18 Months|Protocol Violation|6
1834640|NCT00318461|6354578|P4|Open-Label Extension, 18 Months|Protocol Violation|4
1834641|NCT00318461|6354579|P3|Open-Label Extension, 18 Months|Protocol Violation|3
1834642|NCT00318461|6354580|P2|Open-Label Extension, 18 Months|Protocol Violation|5
1834643|NCT00318461|6354581|P1|Open-Label Extension, 18 Months|Protocol Violation|7
1834644|NCT00318461|6354577|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
1834645|NCT00318461|6354578|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
1834646|NCT00318461|6354579|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
1834647|NCT00318461|6354580|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
1834648|NCT00318461|6354581|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
1834649|NCT00318461|6354577|P5|Open-Label Extension, 18 Months|Adverse Event|6
1834650|NCT00318461|6354578|P4|Open-Label Extension, 18 Months|Adverse Event|1
1834651|NCT00318461|6354579|P3|Open-Label Extension, 18 Months|Adverse Event|6
1834652|NCT00318461|6354580|P2|Open-Label Extension, 18 Months|Adverse Event|8
1834653|NCT00318461|6354581|P1|Open-Label Extension, 18 Months|Adverse Event|11
1834654|NCT00318461|6354577|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
1834655|NCT00318461|6354578|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
1834656|NCT00318461|6354579|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
1834657|NCT00318461|6354580|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
1834658|NCT00318461|6354581|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
1834659|NCT00318461|6354577|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
1834660|NCT00318461|6354578|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
1834661|NCT00318461|6354579|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
1834662|NCT00318461|6354580|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
1834663|NCT00318461|6354581|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
1834664|NCT00318461|6354577|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
1834665|NCT00318461|6354578|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1834666|NCT00318461|6354579|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1834667|NCT00318461|6354580|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1834668|NCT00318461|6354581|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
1834669|NCT00318461|6354577|P5|Double-Blind, 6 Months|Hyperglicaemia|0
1834670|NCT00318461|6354578|P4|Double-Blind, 6 Months|Hyperglicaemia|1
1834671|NCT00318461|6354579|P3|Double-Blind, 6 Months|Hyperglicaemia|0
1834672|NCT00318461|6354580|P2|Double-Blind, 6 Months|Hyperglicaemia|0
1834673|NCT00318461|6354581|P1|Double-Blind, 6 Months|Hyperglicaemia|0
1834674|NCT00318461|6354577|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
1834675|NCT00318461|6354578|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1834676|NCT00318461|6354579|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1834677|NCT00318461|6354580|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1834678|NCT00318461|6354581|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
1834679|NCT00318461|6354577|P5|Double-Blind, 6 Months|Lack of time|0
1834680|NCT00318461|6354578|P4|Double-Blind, 6 Months|Lack of time|0
1834681|NCT00318461|6354579|P3|Double-Blind, 6 Months|Lack of time|0
1834682|NCT00318461|6354580|P2|Double-Blind, 6 Months|Lack of time|0
1834683|NCT00318461|6354581|P1|Double-Blind, 6 Months|Lack of time|1
1834684|NCT00318461|6354577|P5|Double-Blind, 6 Months|Investigator decision|1
1834685|NCT00318461|6354578|P4|Double-Blind, 6 Months|Investigator decision|0
1834686|NCT00318461|6354579|P3|Double-Blind, 6 Months|Investigator decision|0
1834687|NCT00318461|6354580|P2|Double-Blind, 6 Months|Investigator decision|0
1834688|NCT00318461|6354581|P1|Double-Blind, 6 Months|Investigator decision|0
1834689|NCT00318461|6354577|P5|Double-Blind, 6 Months|Work commitment|1
1834690|NCT00318461|6354578|P4|Double-Blind, 6 Months|Work commitment|0
1834691|NCT00318461|6354579|P3|Double-Blind, 6 Months|Work commitment|0
1834692|NCT00318461|6354580|P2|Double-Blind, 6 Months|Work commitment|0
1834693|NCT00318461|6354581|P1|Double-Blind, 6 Months|Work commitment|0
1834694|NCT00318461|6354577|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1834695|NCT00318461|6354578|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
1834696|NCT00318461|6354579|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1834697|NCT00318461|6354580|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
1834698|NCT00318461|6354581|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
1834699|NCT00318461|6354577|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
1834700|NCT00318461|6354578|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1834701|NCT00318461|6354579|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1834702|NCT00318461|6354580|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1834703|NCT00318461|6354581|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
1834704|NCT00318461|6354577|P5|Double-Blind, 6 Months|Move|0
1834705|NCT00318461|6354578|P4|Double-Blind, 6 Months|Move|0
1834706|NCT00318461|6354579|P3|Double-Blind, 6 Months|Move|0
1834707|NCT00318461|6354580|P2|Double-Blind, 6 Months|Move|1
1834708|NCT00318461|6354581|P1|Double-Blind, 6 Months|Move|0
1834709|NCT00318461|6354577|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1834710|NCT00318461|6354578|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1834711|NCT00318461|6354579|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
1834712|NCT00318461|6354580|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
1834713|NCT00318461|6354581|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
1834714|NCT00318461|6354577|P5|Double-Blind, 6 Months|Consent withdrawn|4
1834715|NCT00318461|6354578|P4|Double-Blind, 6 Months|Consent withdrawn|10
1834716|NCT00318461|6354579|P3|Double-Blind, 6 Months|Consent withdrawn|4
1834717|NCT00318461|6354580|P2|Double-Blind, 6 Months|Consent withdrawn|3
1834718|NCT00318461|6354581|P1|Double-Blind, 6 Months|Consent withdrawn|0
1834719|NCT00318461|6354577|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1834720|NCT00318461|6354578|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1834721|NCT00318461|6354579|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1834722|NCT00318461|6354580|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
1834723|NCT00318461|6354581|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
1834724|NCT00318461|6354577|P5|Double-Blind, 6 Months|Lost to follow up|0
1834725|NCT00318461|6354578|P4|Double-Blind, 6 Months|Lost to follow up|0
1834726|NCT00318461|6354579|P3|Double-Blind, 6 Months|Lost to follow up|0
1834727|NCT00318461|6354580|P2|Double-Blind, 6 Months|Lost to follow up|1
1834728|NCT00318461|6354581|P1|Double-Blind, 6 Months|Lost to follow up|0
1834729|NCT00318461|6354577|P5|Double-Blind, 6 Months|Protocol Violation|5
1834730|NCT00318461|6354578|P4|Double-Blind, 6 Months|Protocol Violation|4
1834731|NCT00318461|6354579|P3|Double-Blind, 6 Months|Protocol Violation|4
1834732|NCT00318461|6354580|P2|Double-Blind, 6 Months|Protocol Violation|4
1834733|NCT00318461|6354581|P1|Double-Blind, 6 Months|Protocol Violation|2
1834734|NCT00318461|6354577|P5|Double-Blind, 6 Months|Lack of Efficacy|9
1834735|NCT00318461|6354578|P4|Double-Blind, 6 Months|Lack of Efficacy|29
1834736|NCT00318461|6354579|P3|Double-Blind, 6 Months|Lack of Efficacy|13
1834737|NCT00318461|6354580|P2|Double-Blind, 6 Months|Lack of Efficacy|8
1834738|NCT00318461|6354581|P1|Double-Blind, 6 Months|Lack of Efficacy|19
1834739|NCT00318461|6354577|P5|Double-Blind, 6 Months|Adverse Event|8
1834740|NCT00318461|6354578|P4|Double-Blind, 6 Months|Adverse Event|2
1834741|NCT00318461|6354579|P3|Double-Blind, 6 Months|Adverse Event|29
1834742|NCT00318461|6354580|P2|Double-Blind, 6 Months|Adverse Event|23
1834743|NCT00318461|6354581|P1|Double-Blind, 6 Months|Adverse Event|11
1834744|NCT00318370|6354680|P3|Period 3|Other|3
1834745|NCT00318370|6354681|P2|Period 3|Other|0
1834746|NCT00318370|6354682|P1|Period 3|Other|0
1834747|NCT00318370|6354680|P3|Period 3|Withdrawal by Subject|3
1834748|NCT00318370|6354681|P2|Period 3|Withdrawal by Subject|0
1834749|NCT00318370|6354682|P1|Period 3|Withdrawal by Subject|0
1834750|NCT00318370|6354680|P3|Period 3|Physician Decision|1
1834751|NCT00318370|6354681|P2|Period 3|Physician Decision|0
1834752|NCT00318370|6354682|P1|Period 3|Physician Decision|0
1834753|NCT00318370|6354680|P3|Period 3|Death|1
1834754|NCT00318370|6354681|P2|Period 3|Death|0
1834755|NCT00318370|6354682|P1|Period 3|Death|0
1834756|NCT00318370|6354680|P3|Period 3|Lack of Efficacy|24
1834757|NCT00318370|6354681|P2|Period 3|Lack of Efficacy|0
1834758|NCT00318370|6354682|P1|Period 3|Lack of Efficacy|0
1834759|NCT00318370|6354680|P3|Period 3|Adverse Event|1
1834760|NCT00318370|6354681|P2|Period 3|Adverse Event|0
1834761|NCT00318370|6354682|P1|Period 3|Adverse Event|0
1834762|NCT00318370|6354680|P3|Period 2|Other|0
1834763|NCT00318370|6354681|P2|Period 2|Other|1
1834764|NCT00318370|6354682|P1|Period 2|Other|0
1834765|NCT00318370|6354680|P3|Period 2|Withdrawal by Subject|0
1834766|NCT00318370|6354681|P2|Period 2|Withdrawal by Subject|1
1834767|NCT00318370|6354682|P1|Period 2|Withdrawal by Subject|0
1834768|NCT00318370|6354680|P3|Period 2|Physician Decision|0
1834769|NCT00318370|6354681|P2|Period 2|Physician Decision|1
1834770|NCT00318370|6354682|P1|Period 2|Physician Decision|0
1834771|NCT00318370|6354680|P3|Period 2|Lack of Efficacy|0
1834772|NCT00318370|6354681|P2|Period 2|Lack of Efficacy|5
1834773|NCT00318370|6354682|P1|Period 2|Lack of Efficacy|0
1834774|NCT00318370|6354680|P3|Period 2|Adverse Event|0
1834775|NCT00318370|6354681|P2|Period 2|Adverse Event|3
1834776|NCT00318370|6354682|P1|Period 2|Adverse Event|0
1834777|NCT00318370|6354680|P3|Period 1|Withdrawal by Subject|0
1834778|NCT00318370|6354681|P2|Period 1|Withdrawal by Subject|0
1834779|NCT00318370|6354682|P1|Period 1|Withdrawal by Subject|1
1834780|NCT00318370|6354680|P3|Period 1|Physician Decision|0
1834781|NCT00318370|6354681|P2|Period 1|Physician Decision|0
1834782|NCT00318370|6354682|P1|Period 1|Physician Decision|1
1834783|NCT00318370|6354680|P3|Period 1|Lack of Efficacy|0
1834784|NCT00318370|6354681|P2|Period 1|Lack of Efficacy|0
1834785|NCT00318370|6354682|P1|Period 1|Lack of Efficacy|5
1834786|NCT00318149|6354716|P6|Overall Study|Adverse Event|2
1834787|NCT00318149|6354717|P5|Overall Study|Adverse Event|0
1834788|NCT00318149|6354718|P4|Overall Study|Adverse Event|0
1834789|NCT00318149|6354719|P3|Overall Study|Adverse Event|0
1834790|NCT00318149|6354720|P2|Overall Study|Adverse Event|0
1834791|NCT00318149|6354721|P1|Overall Study|Adverse Event|0
1834792|NCT00317642|6354867|P2|Overall Study|AML Not Centrally Confirmed|5
1834793|NCT00317642|6354868|P1|Overall Study|AML Not Centrally Confirmed|1
1834794|NCT00317642|6354867|P2|Overall Study|Referred For Transplantation|0
1834795|NCT00317642|6354868|P1|Overall Study|Referred For Transplantation|1
1834796|NCT00317642|6354867|P2|Overall Study|Withdrawal by Subject|1
1834797|NCT00317642|6354868|P1|Overall Study|Withdrawal by Subject|0
1834798|NCT00317642|6354867|P2|Overall Study|Not Continue to Consolidation|0
1834799|NCT00317642|6354868|P1|Overall Study|Not Continue to Consolidation|2
1834800|NCT00317642|6354867|P2|Overall Study|Death|7
1834801|NCT00317642|6354868|P1|Overall Study|Death|14
1834802|NCT00317642|6354867|P2|Overall Study|Disease Recurrence|2
1834803|NCT00317642|6354868|P1|Overall Study|Disease Recurrence|1
1834804|NCT00317642|6354867|P2|Overall Study|Treatment Failure|102
1834805|NCT00317642|6354868|P1|Overall Study|Treatment Failure|56
1834806|NCT00317642|6354867|P2|Overall Study|Adverse Event|5
1834807|NCT00317642|6354868|P1|Overall Study|Adverse Event|17
1834808|NCT00317642|6354867|P2|Overall Study|Participant declined treatment|3
1834809|NCT00317642|6354868|P1|Overall Study|Participant declined treatment|14
1834810|NCT00317642|6354867|P2|Overall Study|Physician Decision|7
1834811|NCT00317642|6354868|P1|Overall Study|Physician Decision|15
1834812|NCT00317642|6354867|P2|Overall Study|Not Received Either Study Drug|3
1834813|NCT00317642|6354868|P1|Overall Study|Not Received Either Study Drug|1
1834814|NCT00317473|6354947|P6|Overall Study|Other|0
1834815|NCT00317473|6354948|P5|Overall Study|Other|0
1834816|NCT00317473|6354949|P4|Overall Study|Other|0
1834817|NCT00317473|6354950|P3|Overall Study|Other|0
1834818|NCT00317473|6354951|P2|Overall Study|Other|2
1834819|NCT00317473|6354952|P1|Overall Study|Other|0
1834820|NCT00317473|6354947|P6|Overall Study|Death|0
1834821|NCT00317473|6354948|P5|Overall Study|Death|0
1834822|NCT00317473|6354949|P4|Overall Study|Death|0
1834823|NCT00317473|6354950|P3|Overall Study|Death|0
1834824|NCT00317473|6354951|P2|Overall Study|Death|0
1834825|NCT00317473|6354952|P1|Overall Study|Death|1
1834826|NCT00317473|6354947|P6|Overall Study|Relocation|2
1834827|NCT00317473|6354948|P5|Overall Study|Relocation|5
1834828|NCT00317473|6354949|P4|Overall Study|Relocation|1
1834829|NCT00317473|6354950|P3|Overall Study|Relocation|1
1834830|NCT00317473|6354951|P2|Overall Study|Relocation|0
1834831|NCT00317473|6354952|P1|Overall Study|Relocation|1
1834832|NCT00317473|6354947|P6|Overall Study|Withdrawal by Subject|1
1834833|NCT00317473|6354948|P5|Overall Study|Withdrawal by Subject|3
1834834|NCT00317473|6354949|P4|Overall Study|Withdrawal by Subject|1
1834835|NCT00317473|6354950|P3|Overall Study|Withdrawal by Subject|2
1834836|NCT00317473|6354951|P2|Overall Study|Withdrawal by Subject|1
1834837|NCT00317473|6354952|P1|Overall Study|Withdrawal by Subject|2
1834838|NCT00317109|6354991|P2|Overall Study|Migated/moved from study area|0
1834839|NCT00317109|6354992|P1|Overall Study|Migated/moved from study area|1
1834840|NCT00317109|6354991|P2|Overall Study|Withdrawal by Subject|0
1834841|NCT00317109|6354992|P1|Overall Study|Withdrawal by Subject|2
1834842|NCT00317044|6355029|P3|Overall Study|Multiple Reasons|6
1834843|NCT00317044|6355030|P2|Overall Study|Multiple Reasons|2
1834844|NCT00317044|6355031|P1|Overall Study|Multiple Reasons|6
1834845|NCT00317044|6355029|P3|Overall Study|Lost to Follow-up|3
1834846|NCT00317044|6355030|P2|Overall Study|Lost to Follow-up|2
1834847|NCT00317044|6355031|P1|Overall Study|Lost to Follow-up|0
1834848|NCT00317044|6355029|P3|Overall Study|Withdrawal by Subject|12
1834849|NCT00317044|6355030|P2|Overall Study|Withdrawal by Subject|7
1834850|NCT00317044|6355031|P1|Overall Study|Withdrawal by Subject|10
1834851|NCT00317044|6355029|P3|Overall Study|Adverse Event|4
1834852|NCT00317044|6355030|P2|Overall Study|Adverse Event|7
1834853|NCT00317044|6355031|P1|Overall Study|Adverse Event|4
1834854|NCT00317044|6355029|P3|Overall Study|Protocol Violation|20
1834855|NCT00317044|6355030|P2|Overall Study|Protocol Violation|22
1834856|NCT00317044|6355031|P1|Overall Study|Protocol Violation|28
1834857|NCT00316914|6355077|P2|Overall Study|Missing end of treatment documentation|15
1834858|NCT00316914|6355078|P1|Overall Study|Missing end of treatment documentation|14
1834859|NCT00316914|6355077|P2|Overall Study|Other Problems|11
1834860|NCT00316914|6355078|P1|Overall Study|Other Problems|6
1834861|NCT00316914|6355077|P2|Overall Study|Adverse Event|7
1834862|NCT00316914|6355078|P1|Overall Study|Adverse Event|8
1834863|NCT00316914|6355077|P2|Overall Study|Withdrawal by Subject|3
1834864|NCT00316914|6355078|P1|Overall Study|Withdrawal by Subject|5
1834865|NCT00316888|6355108|P2|Overall Study|Not start protocol therapy|1
1834866|NCT00316888|6355109|P1|Overall Study|Not start protocol therapy|0
1834867|NCT00316888|6355108|P2|Overall Study|Withdrawal by Subject|2
1834868|NCT00316888|6355109|P1|Overall Study|Withdrawal by Subject|2
1834869|NCT00316888|6355108|P2|Overall Study|Adverse Event|5
1834870|NCT00316888|6355109|P1|Overall Study|Adverse Event|4
1834871|NCT00316719|6355131|P2|Overall Study|Consent withdrawn|0
1834872|NCT00316719|6355132|P1|Overall Study|Consent withdrawn|2
1834873|NCT00316719|6355131|P2|Overall Study|Adverse Event|6
1834874|NCT00316719|6355132|P1|Overall Study|Adverse Event|0
1834875|NCT00316706|6355158|P2|Overall Study|Lost to Follow-up|48
1834876|NCT00316706|6355159|P1|Overall Study|Lost to Follow-up|38
1834877|NCT00316693|6355175|P2|Overall Study|Other|44
1834878|NCT00316693|6355176|P1|Overall Study|Other|38
1834879|NCT00316693|6355175|P2|Overall Study|Lost to Follow-up|34
1834880|NCT00316693|6355176|P1|Overall Study|Lost to Follow-up|26
1834881|NCT00316693|6355175|P2|Overall Study|Withdrawal by Subject|6
1834882|NCT00316693|6355176|P1|Overall Study|Withdrawal by Subject|6
1834883|NCT00316693|6355175|P2|Overall Study|Protocol Violation|0
1834884|NCT00316693|6355176|P1|Overall Study|Protocol Violation|1
1834885|NCT00316693|6355175|P2|Overall Study|Adverse Event|1
1834886|NCT00316693|6355176|P1|Overall Study|Adverse Event|6
1834887|NCT00316602|6355218|P2|Overall Study|Other|6
1834888|NCT00316602|6355219|P1|Overall Study|Other|3
1834889|NCT00316602|6355218|P2|Overall Study|Adverse Event|0
1834890|NCT00316602|6355219|P1|Overall Study|Adverse Event|1
1834891|NCT00316602|6355218|P2|Overall Study|Subject unwilling/unable to comply with|17
1834892|NCT00316602|6355219|P1|Overall Study|Subject unwilling/unable to comply with|3
1834893|NCT00316602|6355218|P2|Overall Study|Withdrawal by Subject|2
1834894|NCT00316602|6355219|P1|Overall Study|Withdrawal by Subject|3
1834895|NCT00316589|6355251|P4|Overall Study|Other reason|1
1834896|NCT00316589|6355252|P3|Overall Study|Other reason|1
1834897|NCT00316589|6355253|P2|Overall Study|Other reason|12
1834898|NCT00316589|6355254|P1|Overall Study|Other reason|0
1834899|NCT00316589|6355251|P4|Overall Study|Physician Decision|0
1834900|NCT00316589|6355252|P3|Overall Study|Physician Decision|0
1834901|NCT00316589|6355253|P2|Overall Study|Physician Decision|1
1834902|NCT00316589|6355254|P1|Overall Study|Physician Decision|0
1834903|NCT00316589|6355251|P4|Overall Study|Adverse Event|1
1834904|NCT00316589|6355252|P3|Overall Study|Adverse Event|0
1834905|NCT00316589|6355253|P2|Overall Study|Adverse Event|0
1834906|NCT00316589|6355254|P1|Overall Study|Adverse Event|1
1834907|NCT00316589|6355251|P4|Overall Study|Subject unwilling/unable to comply|2
1834908|NCT00316589|6355252|P3|Overall Study|Subject unwilling/unable to comply|0
1834909|NCT00316589|6355253|P2|Overall Study|Subject unwilling/unable to comply|6
1834910|NCT00316589|6355254|P1|Overall Study|Subject unwilling/unable to comply|0
1834911|NCT00316589|6355251|P4|Overall Study|Withdrawal by Subject|1
1834912|NCT00316589|6355252|P3|Overall Study|Withdrawal by Subject|0
1834913|NCT00316589|6355253|P2|Overall Study|Withdrawal by Subject|5
1834914|NCT00316589|6355254|P1|Overall Study|Withdrawal by Subject|0
1834915|NCT00316303|6355388|P2|Overall Study|Lost to Follow-up|16
1834916|NCT00316303|6355389|P1|Overall Study|Lost to Follow-up|11
1834917|NCT00316277|6355405|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
1834918|NCT00316277|6355406|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
1834919|NCT00316277|6355405|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
1834920|NCT00316277|6355406|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
1834921|NCT00316277|6355405|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
1834922|NCT00316277|6355406|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
1834923|NCT00316277|6355405|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
1834924|NCT00316277|6355406|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
1834925|NCT00316277|6355405|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
1834926|NCT00316277|6355406|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
1834927|NCT00316264|6355427|P3|Overall Study|Other|0
1834928|NCT00316264|6355428|P2|Overall Study|Other|1
1834929|NCT00316264|6355429|P1|Overall Study|Other|1
1834930|NCT00316264|6355427|P3|Overall Study|Death|0
1834931|NCT00316264|6355428|P2|Overall Study|Death|0
1834932|NCT00316264|6355429|P1|Overall Study|Death|2
1834933|NCT00316264|6355427|P3|Overall Study|Withdrawal of Consent|6
1834934|NCT00316264|6355428|P2|Overall Study|Withdrawal of Consent|5
1834935|NCT00316264|6355429|P1|Overall Study|Withdrawal of Consent|3
1834936|NCT00316264|6355427|P3|Overall Study|Lost to Follow-up|0
1834937|NCT00316264|6355428|P2|Overall Study|Lost to Follow-up|1
1834938|NCT00316264|6355429|P1|Overall Study|Lost to Follow-up|0
1834939|NCT00316225|6355497|P1|Overall Study|Death|2
1834940|NCT00316225|6355497|P1|Overall Study|Withdrawal by Subject|3
1834941|NCT00316225|6355497|P1|Overall Study|Progressive Disease|15
1834942|NCT00316225|6355497|P1|Overall Study|Physician Decision|3
1834943|NCT00316225|6355497|P1|Overall Study|Adverse Event|2
1834944|NCT00316199|6355506|P1|Overall Study|Lost to Follow-up|2
1834945|NCT00316199|6355506|P1|Overall Study|Death|8
1834946|NCT00316199|6355506|P1|Overall Study|Adverse Event|2
1834947|NCT00316186|6355514|P1|Overall Study|Other|1
1834948|NCT00316186|6355514|P1|Overall Study|Lost to Follow-up|1
1834949|NCT00316186|6355514|P1|Overall Study|Disease Progression|4
1834950|NCT00316186|6355514|P1|Overall Study|Adverse Event|6
1834951|NCT00316173|6355528|P2|Treatment Phase|Study Follow-up Stopped|34
1834952|NCT00316173|6355529|P1|Treatment Phase|Study Follow-up Stopped|0
1834953|NCT00316173|6355528|P2|Treatment Phase|Withdrawal by Subject|1
1834954|NCT00316173|6355529|P1|Treatment Phase|Withdrawal by Subject|0
1834955|NCT00316173|6355528|P2|Treatment Phase|Lost to Follow-up|3
1834956|NCT00316173|6355529|P1|Treatment Phase|Lost to Follow-up|0
1834957|NCT00316173|6355528|P2|Treatment Phase|Lack of Efficacy|3
1834958|NCT00316173|6355529|P1|Treatment Phase|Lack of Efficacy|0
1834959|NCT00316173|6355528|P2|Treatment Phase|Adverse Event|1
1834960|NCT00316173|6355529|P1|Treatment Phase|Adverse Event|0
1834961|NCT00316173|6355528|P2|Run-in Phase|Study Follow-up Stopped|0
1834962|NCT00316173|6355529|P1|Run-in Phase|Study Follow-up Stopped|5
1834963|NCT00316173|6355528|P2|Run-in Phase|Protocol Violation|0
1834964|NCT00316173|6355529|P1|Run-in Phase|Protocol Violation|1
1834965|NCT00316173|6355528|P2|Run-in Phase|Adverse Event|0
1834966|NCT00316173|6355529|P1|Run-in Phase|Adverse Event|1
1834967|NCT00316121|6355542|P2|Overall Study|Subject did not have 24 month visit|0
1834968|NCT00316121|6355543|P1|Overall Study|Subject did not have 24 month visit|1
1834969|NCT00316121|6355542|P2|Overall Study|Subject no show for visit x 3|0
1834970|NCT00316121|6355543|P1|Overall Study|Subject no show for visit x 3|1
1834971|NCT00316121|6355542|P2|Overall Study|Subject refused to return|0
1834972|NCT00316121|6355543|P1|Overall Study|Subject refused to return|1
1834973|NCT00316121|6355542|P2|Overall Study|Subject relocated|1
1834974|NCT00316121|6355543|P1|Overall Study|Subject relocated|1
1834975|NCT00316121|6355542|P2|Overall Study|Reason is missing|0
1834976|NCT00316121|6355543|P1|Overall Study|Reason is missing|1
1834977|NCT00316121|6355542|P2|Overall Study|Withdrawal by Subject|0
1834978|NCT00316121|6355543|P1|Overall Study|Withdrawal by Subject|2
1834979|NCT00316121|6355542|P2|Overall Study|Lost to Follow-up|8
1834980|NCT00316121|6355543|P1|Overall Study|Lost to Follow-up|14
1834981|NCT00316121|6355542|P2|Overall Study|Death|0
1834982|NCT00316121|6355543|P1|Overall Study|Death|1
1834983|NCT00316082|6355554|P5|Overall Study|Administrative reason by sponsor|0
1834984|NCT00316082|6355555|P4|Overall Study|Administrative reason by sponsor|0
1834985|NCT00316082|6355556|P3|Overall Study|Administrative reason by sponsor|1
1834986|NCT00316082|6355557|P2|Overall Study|Administrative reason by sponsor|0
1834987|NCT00316082|6355558|P1|Overall Study|Administrative reason by sponsor|0
1834988|NCT00316082|6355554|P5|Overall Study|Death|0
1834989|NCT00316082|6355555|P4|Overall Study|Death|0
1834990|NCT00316082|6355556|P3|Overall Study|Death|1
1834991|NCT00316082|6355557|P2|Overall Study|Death|0
1834992|NCT00316082|6355558|P1|Overall Study|Death|0
1834993|NCT00316082|6355554|P5|Overall Study|Physician Decision|1
1834994|NCT00316082|6355555|P4|Overall Study|Physician Decision|1
1834995|NCT00316082|6355556|P3|Overall Study|Physician Decision|2
1834996|NCT00316082|6355557|P2|Overall Study|Physician Decision|1
1834997|NCT00316082|6355558|P1|Overall Study|Physician Decision|1
1834998|NCT00316082|6355554|P5|Overall Study|Subject no longer meets study criteria|1
1834999|NCT00316082|6355555|P4|Overall Study|Subject no longer meets study criteria|2
1835000|NCT00316082|6355556|P3|Overall Study|Subject no longer meets study criteria|2
1835001|NCT00316082|6355557|P2|Overall Study|Subject no longer meets study criteria|1
1835002|NCT00316082|6355558|P1|Overall Study|Subject no longer meets study criteria|3
1835003|NCT00316082|6355554|P5|Overall Study|Adverse Event|3
1835004|NCT00316082|6355555|P4|Overall Study|Adverse Event|1
1835005|NCT00316082|6355556|P3|Overall Study|Adverse Event|5
1835006|NCT00316082|6355557|P2|Overall Study|Adverse Event|2
1835007|NCT00316082|6355558|P1|Overall Study|Adverse Event|4
1835008|NCT00316082|6355554|P5|Overall Study|Poor/noncompliance|4
1835009|NCT00316082|6355555|P4|Overall Study|Poor/noncompliance|1
1835010|NCT00316082|6355556|P3|Overall Study|Poor/noncompliance|4
1835011|NCT00316082|6355557|P2|Overall Study|Poor/noncompliance|1
1835012|NCT00316082|6355558|P1|Overall Study|Poor/noncompliance|6
1835013|NCT00316082|6355554|P5|Overall Study|Lost to Follow-up|6
1835014|NCT00316082|6355555|P4|Overall Study|Lost to Follow-up|8
1835015|NCT00316082|6355556|P3|Overall Study|Lost to Follow-up|7
1835016|NCT00316082|6355557|P2|Overall Study|Lost to Follow-up|6
1835017|NCT00316082|6355558|P1|Overall Study|Lost to Follow-up|7
1835018|NCT00316082|6355554|P5|Overall Study|Withdrawal of Consent by Subject|5
1835019|NCT00316082|6355555|P4|Overall Study|Withdrawal of Consent by Subject|9
1835020|NCT00316082|6355556|P3|Overall Study|Withdrawal of Consent by Subject|2
1835021|NCT00316082|6355557|P2|Overall Study|Withdrawal of Consent by Subject|8
1835022|NCT00316082|6355558|P1|Overall Study|Withdrawal of Consent by Subject|10
1835023|NCT00316082|6355554|P5|Overall Study|Lack of Efficacy|6
1835024|NCT00316082|6355555|P4|Overall Study|Lack of Efficacy|4
1835025|NCT00316082|6355556|P3|Overall Study|Lack of Efficacy|3
1835026|NCT00316082|6355557|P2|Overall Study|Lack of Efficacy|3
1835027|NCT00316082|6355558|P1|Overall Study|Lack of Efficacy|2
1835028|NCT00316017|6355589|P3|Overall Study|Protocol Violation|19
1835029|NCT00316017|6355590|P2|Overall Study|Protocol Violation|13
1835030|NCT00316017|6355591|P1|Overall Study|Protocol Violation|11
1835031|NCT00316004|6355665|P3|Overall Study|Subject was not given study fluid.|21
1835032|NCT00316004|6355666|P2|Overall Study|Subject was not given study fluid.|14
1835033|NCT00316004|6355667|P1|Overall Study|Subject was not given study fluid.|14
1835034|NCT00315731|6355738|P1|Overall Study|Death|5
1835035|NCT00315731|6355738|P1|Overall Study|Lost to Follow-up|1
1835036|NCT00315705|6355766|P1|Phase 2|Death|7
1835037|NCT00315705|6355766|P1|Phase 2|Other|1
1835038|NCT00315705|6355766|P1|Phase 2|Scheduled for transplant|8
1835039|NCT00315705|6355766|P1|Phase 2|Disease relapse|1
1835040|NCT00315705|6355766|P1|Phase 2|Failure to achieve response|3
1835041|NCT00315705|6355766|P1|Phase 2|Adverse Event|1
1835042|NCT00315705|6355766|P1|Phase 2|Physician Decision|4
1835043|NCT00315705|6355766|P1|Phase 1|Death|3
1835044|NCT00315705|6355766|P1|Phase 1|Scheduled for transplant|9
1835045|NCT00315705|6355766|P1|Phase 1|Disease relapse|4
1835046|NCT00315705|6355766|P1|Phase 1|Failure to achieve response|8
1835047|NCT00315705|6355766|P1|Phase 1|Refused further treatment|1
1835048|NCT00315458|6355827|P4|Overall Study|Did not qualify|0
1835049|NCT00315458|6355828|P3|Overall Study|Did not qualify|1
1835050|NCT00315458|6355829|P2|Overall Study|Did not qualify|0
1835051|NCT00315458|6355830|P1|Overall Study|Did not qualify|0
1835052|NCT00315458|6355827|P4|Overall Study|Lack of Efficacy|1
1835053|NCT00315458|6355828|P3|Overall Study|Lack of Efficacy|20
1835054|NCT00315458|6355829|P2|Overall Study|Lack of Efficacy|0
1835055|NCT00315458|6355830|P1|Overall Study|Lack of Efficacy|0
1835056|NCT00315458|6355827|P4|Overall Study|Withdrawal by Subject|2
1835057|NCT00315458|6355828|P3|Overall Study|Withdrawal by Subject|0
1835058|NCT00315458|6355829|P2|Overall Study|Withdrawal by Subject|3
1835059|NCT00315458|6355830|P1|Overall Study|Withdrawal by Subject|0
1835060|NCT00315458|6355827|P4|Overall Study|Lost to Follow-up|2
1835061|NCT00315458|6355828|P3|Overall Study|Lost to Follow-up|0
1835062|NCT00315458|6355829|P2|Overall Study|Lost to Follow-up|2
1835063|NCT00315458|6355830|P1|Overall Study|Lost to Follow-up|1
1835064|NCT00315458|6355827|P4|Overall Study|Adverse Event|3
1835065|NCT00315458|6355828|P3|Overall Study|Adverse Event|23
1835066|NCT00315458|6355829|P2|Overall Study|Adverse Event|4
1835067|NCT00315458|6355830|P1|Overall Study|Adverse Event|2
1835068|NCT00315458|6355827|P4|Overall Study|Administrative|21
1835069|NCT00315458|6355828|P3|Overall Study|Administrative|8
1835070|NCT00315458|6355829|P2|Overall Study|Administrative|3
1835071|NCT00315458|6355830|P1|Overall Study|Administrative|0
1835072|NCT00315445|6355843|P3|Overall Study|Other|0
1835073|NCT00315445|6355844|P2|Overall Study|Other|3
1835074|NCT00315445|6355845|P1|Overall Study|Other|1
1835075|NCT00315445|6355843|P3|Overall Study|Protocol Violation|1
1835076|NCT00315445|6355844|P2|Overall Study|Protocol Violation|0
1835077|NCT00315445|6355845|P1|Overall Study|Protocol Violation|2
1835078|NCT00315445|6355843|P3|Overall Study|Lost to Follow-up|1
1835079|NCT00315445|6355844|P2|Overall Study|Lost to Follow-up|0
1835080|NCT00315445|6355845|P1|Overall Study|Lost to Follow-up|1
1835081|NCT00315445|6355843|P3|Overall Study|Lack of Efficacy|7
1835082|NCT00315445|6355844|P2|Overall Study|Lack of Efficacy|1
1835083|NCT00315445|6355845|P1|Overall Study|Lack of Efficacy|16
1835084|NCT00315445|6355843|P3|Overall Study|Adverse Event|15
1835085|NCT00315445|6355844|P2|Overall Study|Adverse Event|12
1835086|NCT00315445|6355845|P1|Overall Study|Adverse Event|7
1835087|NCT00315055|6356135|P2|Overall Study|Lost to Follow-up|1
1835088|NCT00315055|6356136|P1|Overall Study|Lost to Follow-up|1
1835089|NCT00315055|6356135|P2|Overall Study|Protocol Violation|4
1835090|NCT00315055|6356136|P1|Overall Study|Protocol Violation|2
1835091|NCT00314951|6356154|P2|Follow-up|mITT failure|34
1835092|NCT00314951|6356155|P1|Follow-up|mITT failure|44
1835093|NCT00314951|6356154|P2|Treatment|Didn't meet criteria for mITT population|11
1835094|NCT00314951|6356155|P1|Treatment|Didn't meet criteria for mITT population|16
1835095|NCT00314808|6356165|P1|Overall Study|Withdrawal by Subject/PI without AE|4
1835096|NCT00314808|6356165|P1|Overall Study|Disease Progression without AE|4
1835097|NCT00314795|6356173|P1|Overall Study|Participants Withdrew Consent|2
1835098|NCT00314795|6356173|P1|Overall Study|Renal Transplant|3
1835099|NCT00314795|6356173|P1|Overall Study|Reason not Specified|3
1835100|NCT00314795|6356173|P1|Overall Study|Death|4
1835101|NCT00314795|6356173|P1|Overall Study|Adverse Event|8
1835102|NCT00314574|6356183|P2|Overall Study|Data unknown at database lock|1
1835103|NCT00314574|6356184|P1|Overall Study|Data unknown at database lock|0
1835104|NCT00314574|6356183|P2|Overall Study|Pregnancy|4
1835105|NCT00314574|6356184|P1|Overall Study|Pregnancy|6
1835106|NCT00314574|6356183|P2|Overall Study|Physician Decision|15
1835107|NCT00314574|6356184|P1|Overall Study|Physician Decision|22
1835108|NCT00314574|6356183|P2|Overall Study|Withdrawal by Subject|22
1835109|NCT00314574|6356184|P1|Overall Study|Withdrawal by Subject|33
1835110|NCT00314574|6356183|P2|Overall Study|Lost to Follow-up|25
1835111|NCT00314574|6356184|P1|Overall Study|Lost to Follow-up|19
1835112|NCT00314574|6356183|P2|Overall Study|Adverse Event|16
1835113|NCT00314574|6356184|P1|Overall Study|Adverse Event|11
1835114|NCT00314574|6356183|P2|Overall Study|Death|0
1835115|NCT00314574|6356184|P1|Overall Study|Death|3
1835116|NCT00314366|6356200|P2|Overall Study|not treated due to patient medical condi|0
1835117|NCT00314366|6356201|P1|Overall Study|not treated due to patient medical condi|1
1835118|NCT00314340|6356246|P1|Overall Study|lost interest|1
1835119|NCT00314327|6356252|P1|Overall Study|Withdrawal by Subject|1
1835120|NCT00314262|6356257|P1|Overall Study|Physician Decision|1
1835121|NCT00314262|6356257|P1|Overall Study|Withdrawal by Subject|2
1835122|NCT00314262|6356257|P1|Overall Study|Adverse Event|2
1835123|NCT00314249|6356265|P2|Overall Study|Non-Compliant|6
1835124|NCT00314249|6356266|P1|Overall Study|Non-Compliant|5
1835125|NCT00314249|6356265|P2|Overall Study|Withdrawn for other reasons|1
1835126|NCT00314249|6356266|P1|Overall Study|Withdrawn for other reasons|4
1835127|NCT00314249|6356265|P2|Overall Study|Physician Decision|1
1835128|NCT00314249|6356266|P1|Overall Study|Physician Decision|1
1835129|NCT00314249|6356265|P2|Overall Study|Lost to Follow-up|9
1835130|NCT00314249|6356266|P1|Overall Study|Lost to Follow-up|15
1835131|NCT00314249|6356265|P2|Overall Study|Withdrawal by Subject|28
1835132|NCT00314249|6356266|P1|Overall Study|Withdrawal by Subject|21
1835133|NCT00314249|6356265|P2|Overall Study|Lack of Efficacy|24
1835134|NCT00314249|6356266|P1|Overall Study|Lack of Efficacy|33
1835135|NCT00314249|6356265|P2|Overall Study|Adverse Event|94
1835136|NCT00314249|6356266|P1|Overall Study|Adverse Event|73
1835137|NCT00314145|6356299|P2|Overall Study|Sponsor Decision|0
1835138|NCT00314145|6356300|P1|Overall Study|Sponsor Decision|2
1835139|NCT00314145|6356299|P2|Overall Study|Protocol Violation|0
1835140|NCT00314145|6356300|P1|Overall Study|Protocol Violation|3
1835141|NCT00314145|6356299|P2|Overall Study|Adverse Event|3
1835142|NCT00314145|6356300|P1|Overall Study|Adverse Event|0
1835143|NCT00314145|6356299|P2|Overall Study|Physician Decision|4
1835144|NCT00314145|6356300|P1|Overall Study|Physician Decision|3
1835145|NCT00314145|6356299|P2|Overall Study|Lost to Follow-up|12
1835146|NCT00314145|6356300|P1|Overall Study|Lost to Follow-up|5
1835147|NCT00314145|6356299|P2|Overall Study|Withdrawal by Subject|10
1835148|NCT00314145|6356300|P1|Overall Study|Withdrawal by Subject|8
1835149|NCT00314132|6356314|P2|Overall Study|Physician Decision|0
1835150|NCT00314132|6356315|P1|Overall Study|Physician Decision|1
1835151|NCT00314132|6356314|P2|Overall Study|Adverse Event|0
1835152|NCT00314132|6356315|P1|Overall Study|Adverse Event|1
1835153|NCT00314132|6356314|P2|Overall Study|Withdrawal by Subject|5
1835154|NCT00314132|6356315|P1|Overall Study|Withdrawal by Subject|3
1835155|NCT00314132|6356314|P2|Overall Study|Lost to Follow-up|13
1835156|NCT00314132|6356315|P1|Overall Study|Lost to Follow-up|3
1835157|NCT00313911|6356342|P2|Overall Study|Did not meet age criteria|1
1835158|NCT00313911|6356343|P1|Overall Study|Did not meet age criteria|1
1835159|NCT00313911|6356342|P2|Overall Study|Withdrawal by Subject|12
1835160|NCT00313911|6356343|P1|Overall Study|Withdrawal by Subject|39
1835161|NCT00313911|6356342|P2|Overall Study|Lost to Follow-up|14
1835162|NCT00313911|6356343|P1|Overall Study|Lost to Follow-up|27
1835163|NCT00313911|6356342|P2|Overall Study|Protocol Violation|10
1835164|NCT00313911|6356343|P1|Overall Study|Protocol Violation|19
1835165|NCT00313911|6356342|P2|Overall Study|Adverse Event|3
1835166|NCT00313911|6356343|P1|Overall Study|Adverse Event|2
1835167|NCT00313911|6356342|P2|Overall Study|Serious adverse event|1
1835168|NCT00313911|6356343|P1|Overall Study|Serious adverse event|6
1835169|NCT00313846|6356357|P2|Overall Study|Administrative|3
1835170|NCT00313846|6356358|P1|Overall Study|Administrative|2
1835171|NCT00313846|6356357|P2|Overall Study|Adverse Event|8
1835172|NCT00313846|6356358|P1|Overall Study|Adverse Event|1
1835173|NCT00313846|6356357|P2|Overall Study|Withdrawal by Subject|0
1835174|NCT00313846|6356358|P1|Overall Study|Withdrawal by Subject|2
1835175|NCT00313820|6356369|P2|Pregabalin or Placebo Treatment Period|Other|3
1835176|NCT00313820|6356370|P1|Pregabalin or Placebo Treatment Period|Other|2
1835177|NCT00313820|6356369|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
1835178|NCT00313820|6356370|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
1835179|NCT00313820|6356369|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
1835180|NCT00313820|6356370|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
1835181|NCT00313820|6356369|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
1835182|NCT00313820|6356370|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
1835183|NCT00313820|6356369|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
1835184|NCT00313820|6356370|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
1835185|NCT00313820|6356369|P2|Assigned to Treatment|Other|0
1835186|NCT00313820|6356370|P1|Assigned to Treatment|Other|1
1835187|NCT00313781|6356408|P3|After Crossover|Other|18
1835188|NCT00313781|6356409|P2|After Crossover|Other|0
1835189|NCT00313781|6356410|P1|After Crossover|Other|0
1835190|NCT00313781|6356408|P3|After Crossover|Withdrawal by Subject|3
1835191|NCT00313781|6356409|P2|After Crossover|Withdrawal by Subject|0
1835192|NCT00313781|6356410|P1|After Crossover|Withdrawal by Subject|0
1835193|NCT00313781|6356408|P3|After Crossover|Death|6
1835194|NCT00313781|6356409|P2|After Crossover|Death|0
1835195|NCT00313781|6356410|P1|After Crossover|Death|0
1835196|NCT00313781|6356408|P3|Before Crossover|Randomized, not treated|0
1835197|NCT00313781|6356409|P2|Before Crossover|Randomized, not treated|0
1835198|NCT00313781|6356410|P1|Before Crossover|Randomized, not treated|5
1835199|NCT00313781|6356408|P3|Before Crossover|Crossover|0
1835200|NCT00313781|6356409|P2|Before Crossover|Crossover|37
1835201|NCT00313781|6356410|P1|Before Crossover|Crossover|0
1835202|NCT00313781|6356408|P3|Before Crossover|Other|0
1835203|NCT00313781|6356409|P2|Before Crossover|Other|30
1835204|NCT00313781|6356410|P1|Before Crossover|Other|45
1835205|NCT00313781|6356408|P3|Before Crossover|Withdrawal by Subject|0
1835206|NCT00313781|6356409|P2|Before Crossover|Withdrawal by Subject|1
1835207|NCT00313781|6356410|P1|Before Crossover|Withdrawal by Subject|3
1835208|NCT00313781|6356408|P3|Before Crossover|Lost to Follow-up|0
1835209|NCT00313781|6356409|P2|Before Crossover|Lost to Follow-up|3
1835210|NCT00313781|6356410|P1|Before Crossover|Lost to Follow-up|0
1835211|NCT00313781|6356408|P3|Before Crossover|Death|0
1835212|NCT00313781|6356409|P2|Before Crossover|Death|8
1835213|NCT00313781|6356410|P1|Before Crossover|Death|22
1835214|NCT00313716|6356456|P6|Overall Study|Withdrawal by Subject|0
1835215|NCT00313716|6356457|P5|Overall Study|Withdrawal by Subject|1
1835216|NCT00313716|6356458|P4|Overall Study|Withdrawal by Subject|0
1835217|NCT00313716|6356459|P3|Overall Study|Withdrawal by Subject|1
1835218|NCT00313716|6356460|P2|Overall Study|Withdrawal by Subject|1
1835219|NCT00313716|6356461|P1|Overall Study|Withdrawal by Subject|0
1835220|NCT00313716|6356456|P6|Overall Study|Lost to Follow-up|4
1835221|NCT00313716|6356457|P5|Overall Study|Lost to Follow-up|0
1835222|NCT00313716|6356458|P4|Overall Study|Lost to Follow-up|1
1835223|NCT00313716|6356459|P3|Overall Study|Lost to Follow-up|2
1835224|NCT00313716|6356460|P2|Overall Study|Lost to Follow-up|5
1835225|NCT00313716|6356461|P1|Overall Study|Lost to Follow-up|2
1835226|NCT00313716|6356456|P6|Overall Study|Death|9
1835227|NCT00313716|6356457|P5|Overall Study|Death|5
1835228|NCT00313716|6356458|P4|Overall Study|Death|3
1835229|NCT00313716|6356459|P3|Overall Study|Death|9
1835230|NCT00313716|6356460|P2|Overall Study|Death|2
1835231|NCT00313716|6356461|P1|Overall Study|Death|3
1835232|NCT00313703|6356488|P4|Overall Study|Lost to Follow-up|12
1835233|NCT00313703|6356489|P3|Overall Study|Lost to Follow-up|5
1835234|NCT00313703|6356490|P2|Overall Study|Lost to Follow-up|2
1835235|NCT00313703|6356491|P1|Overall Study|Lost to Follow-up|11
1835236|NCT00313612|6356507|P2|Overall Study|Patient never received treatment|1
1835237|NCT00313612|6356508|P1|Overall Study|Patient never received treatment|0
1835238|NCT00313586|6356520|P4|Overall Study|Death before starting treatment|0
1835239|NCT00313586|6356521|P3|Overall Study|Death before starting treatment|0
1835240|NCT00313586|6356522|P2|Overall Study|Death before starting treatment|0
1835241|NCT00313586|6356523|P1|Overall Study|Death before starting treatment|1
1835242|NCT00313586|6356520|P4|Overall Study|Moved|0
1835243|NCT00313586|6356521|P3|Overall Study|Moved|0
1835244|NCT00313586|6356522|P2|Overall Study|Moved|1
1835245|NCT00313586|6356523|P1|Overall Study|Moved|0
1835246|NCT00313586|6356520|P4|Overall Study|Lost insurance|0
1835247|NCT00313586|6356521|P3|Overall Study|Lost insurance|0
1835248|NCT00313586|6356522|P2|Overall Study|Lost insurance|1
1835249|NCT00313586|6356523|P1|Overall Study|Lost insurance|0
1835250|NCT00313586|6356520|P4|Overall Study|Absolute neutrophil count not recovered|0
1835251|NCT00313586|6356521|P3|Overall Study|Absolute neutrophil count not recovered|0
1835252|NCT00313586|6356522|P2|Overall Study|Absolute neutrophil count not recovered|1
1835253|NCT00313586|6356523|P1|Overall Study|Absolute neutrophil count not recovered|2
1835254|NCT00313586|6356520|P4|Overall Study|Physician Decision|0
1835255|NCT00313586|6356521|P3|Overall Study|Physician Decision|0
1835256|NCT00313586|6356522|P2|Overall Study|Physician Decision|1
1835257|NCT00313586|6356523|P1|Overall Study|Physician Decision|2
1835258|NCT00313586|6356520|P4|Overall Study|Did not achieve HI-major/better response|1
1835259|NCT00313586|6356521|P3|Overall Study|Did not achieve HI-major/better response|2
1835260|NCT00313586|6356522|P2|Overall Study|Did not achieve HI-major/better response|7
1835261|NCT00313586|6356523|P1|Overall Study|Did not achieve HI-major/better response|10
1835262|NCT00313586|6356520|P4|Overall Study|Other complicating disease|0
1835263|NCT00313586|6356521|P3|Overall Study|Other complicating disease|0
1835264|NCT00313586|6356522|P2|Overall Study|Other complicating disease|2
1835265|NCT00313586|6356523|P1|Overall Study|Other complicating disease|2
1835266|NCT00313586|6356520|P4|Overall Study|Alternative therapy|0
1835267|NCT00313586|6356521|P3|Overall Study|Alternative therapy|2
1835268|NCT00313586|6356522|P2|Overall Study|Alternative therapy|6
1835269|NCT00313586|6356523|P1|Overall Study|Alternative therapy|3
1835270|NCT00313586|6356520|P4|Overall Study|Withdrawal by Subject|2
1835271|NCT00313586|6356521|P3|Overall Study|Withdrawal by Subject|6
1835272|NCT00313586|6356522|P2|Overall Study|Withdrawal by Subject|6
1835273|NCT00313586|6356523|P1|Overall Study|Withdrawal by Subject|13
1835274|NCT00313586|6356520|P4|Overall Study|Death|7
1835275|NCT00313586|6356521|P3|Overall Study|Death|1
1835276|NCT00313586|6356522|P2|Overall Study|Death|8
1835277|NCT00313586|6356523|P1|Overall Study|Death|11
1835278|NCT00313586|6356520|P4|Overall Study|Adverse Event|10
1835279|NCT00313586|6356521|P3|Overall Study|Adverse Event|3
1835280|NCT00313586|6356522|P2|Overall Study|Adverse Event|18
1835281|NCT00313586|6356523|P1|Overall Study|Adverse Event|12
1835282|NCT00313586|6356520|P4|Overall Study|Disease progression|3
1835283|NCT00313586|6356521|P3|Overall Study|Disease progression|10
1835284|NCT00313586|6356522|P2|Overall Study|Disease progression|19
1835285|NCT00313586|6356523|P1|Overall Study|Disease progression|14
1835286|NCT00313313|6356546|P3|Overall Study|Subject No Longer Meets Study Criteria|2
1835287|NCT00313313|6356547|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1835288|NCT00313313|6356548|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1835289|NCT00313313|6356546|P3|Overall Study|Death|2
1835290|NCT00313313|6356547|P2|Overall Study|Death|0
1835291|NCT00313313|6356548|P1|Overall Study|Death|0
1835292|NCT00313313|6356546|P3|Overall Study|Pregnancy|0
1835293|NCT00313313|6356547|P2|Overall Study|Pregnancy|2
1835294|NCT00313313|6356548|P1|Overall Study|Pregnancy|1
1835295|NCT00313313|6356546|P3|Overall Study|Poor/Noncompliance|2
1835296|NCT00313313|6356547|P2|Overall Study|Poor/Noncompliance|6
1835297|NCT00313313|6356548|P1|Overall Study|Poor/Noncompliance|3
1835298|NCT00313313|6356546|P3|Overall Study|Physician Decision|4
1835299|NCT00313313|6356547|P2|Overall Study|Physician Decision|6
1835300|NCT00313313|6356548|P1|Overall Study|Physician Decision|2
1835301|NCT00313313|6356546|P3|Overall Study|Adverse Event|12
1835302|NCT00313313|6356547|P2|Overall Study|Adverse Event|16
1835303|NCT00313313|6356548|P1|Overall Study|Adverse Event|15
1835304|NCT00313313|6356546|P3|Overall Study|Lost to Follow-up|9
1835305|NCT00313313|6356547|P2|Overall Study|Lost to Follow-up|7
1835306|NCT00313313|6356548|P1|Overall Study|Lost to Follow-up|10
1835307|NCT00313313|6356546|P3|Overall Study|Withdrawal of consent by subject|31
1835308|NCT00313313|6356547|P2|Overall Study|Withdrawal of consent by subject|17
1835309|NCT00313313|6356548|P1|Overall Study|Withdrawal of consent by subject|18
1835310|NCT00313313|6356546|P3|Overall Study|Lack of Efficacy|20
1835311|NCT00313313|6356547|P2|Overall Study|Lack of Efficacy|9
1835312|NCT00313313|6356548|P1|Overall Study|Lack of Efficacy|14
1835313|NCT00313300|6356570|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1835314|NCT00313300|6356571|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
1835315|NCT00313300|6356572|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1835316|NCT00313300|6356573|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
1835317|NCT00313300|6356574|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
1835318|NCT00313300|6356570|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
1835319|NCT00313300|6356571|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
1835320|NCT00313300|6356572|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1835321|NCT00313300|6356573|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1835322|NCT00313300|6356574|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
1835323|NCT00313300|6356570|P5|Follow-Up(30days)-Randomized Phase B|Death|0
1835324|NCT00313300|6356571|P4|Follow-Up(30days)-Randomized Phase B|Death|0
1835325|NCT00313300|6356572|P3|Follow-Up(30days)-Randomized Phase B|Death|0
1835326|NCT00313300|6356573|P2|Follow-Up(30days)-Randomized Phase B|Death|0
1835327|NCT00313300|6356574|P1|Follow-Up(30days)-Randomized Phase B|Death|1
1835328|NCT00313300|6356570|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1835329|NCT00313300|6356571|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1835330|NCT00313300|6356572|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
1835331|NCT00313300|6356573|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
1835332|NCT00313300|6356574|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
1835333|NCT00313300|6356570|P5|Follow-Up(30days)-Randomized Phase A|Death|0
1835334|NCT00313300|6356571|P4|Follow-Up(30days)-Randomized Phase A|Death|0
1835335|NCT00313300|6356572|P3|Follow-Up(30days)-Randomized Phase A|Death|0
1835336|NCT00313300|6356573|P2|Follow-Up(30days)-Randomized Phase A|Death|1
1835337|NCT00313300|6356574|P1|Follow-Up(30days)-Randomized Phase A|Death|0
1835338|NCT00313300|6356570|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1835339|NCT00313300|6356571|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
1835340|NCT00313300|6356572|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
1835341|NCT00313300|6356573|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1835342|NCT00313300|6356574|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
1835343|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|non-specified|0
1835344|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|non-specified|0
1835345|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|non-specified|0
1835346|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|non-specified|0
1835347|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|non-specified|1
1835348|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
1835349|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
1835350|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
1835351|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
1835352|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
1835353|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1835354|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
1835355|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
1835356|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
1835357|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
1835358|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1835359|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
1835360|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1835361|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
1835362|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
1835363|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1835364|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1835365|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
1835366|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
1835367|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
1835368|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|Death|1
1835369|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|Death|0
1835370|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|Death|1
1835371|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|Death|3
1835372|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|Death|5
1835373|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1835374|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
1835375|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
1835376|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
1835377|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
1835378|NCT00313300|6356570|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
1835379|NCT00313300|6356571|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
1835380|NCT00313300|6356572|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
1835381|NCT00313300|6356573|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
1835382|NCT00313300|6356574|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
1835383|NCT00313300|6356570|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1835384|NCT00313300|6356571|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1835385|NCT00313300|6356572|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1835386|NCT00313300|6356573|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
1835387|NCT00313300|6356574|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
1835388|NCT00313300|6356570|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1835389|NCT00313300|6356571|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
1835390|NCT00313300|6356572|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
1835391|NCT00313300|6356573|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
1835392|NCT00313300|6356574|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
1835393|NCT00313300|6356570|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1835394|NCT00313300|6356571|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
1835395|NCT00313300|6356572|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
1835396|NCT00313300|6356573|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
1835397|NCT00313300|6356574|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
1835398|NCT00313300|6356570|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1835399|NCT00313300|6356571|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
1835400|NCT00313300|6356572|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
1835401|NCT00313300|6356573|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1835402|NCT00313300|6356574|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
1835403|NCT00313300|6356570|P5|Randomized in Phase A (26 Weeks)|Death|0
1835404|NCT00313300|6356571|P4|Randomized in Phase A (26 Weeks)|Death|0
1835405|NCT00313300|6356572|P3|Randomized in Phase A (26 Weeks)|Death|0
1835406|NCT00313300|6356573|P2|Randomized in Phase A (26 Weeks)|Death|4
1835407|NCT00313300|6356574|P1|Randomized in Phase A (26 Weeks)|Death|3
1835408|NCT00313300|6356570|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1835496|NCT00312845|6356867|P1|Overall Study|Withdrawal by Subject|14
1835409|NCT00313300|6356571|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
1835410|NCT00313300|6356572|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
1835411|NCT00313300|6356573|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
1835412|NCT00313300|6356574|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
1835413|NCT00313300|6356570|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
1835414|NCT00313300|6356571|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
1835415|NCT00313300|6356572|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
1835416|NCT00313300|6356573|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
1835417|NCT00313300|6356574|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
1835418|NCT00313170|6356644|P3|Overall Study|Progression (investigators opinion)|0
1835419|NCT00313170|6356645|P2|Overall Study|Progression (investigators opinion)|0
1835420|NCT00313170|6356646|P1|Overall Study|Progression (investigators opinion)|1
1835421|NCT00313170|6356644|P3|Overall Study|Lost to Follow-up|1
1835422|NCT00313170|6356645|P2|Overall Study|Lost to Follow-up|0
1835423|NCT00313170|6356646|P1|Overall Study|Lost to Follow-up|0
1835424|NCT00313170|6356644|P3|Overall Study|Incorrect enrollment|1
1835425|NCT00313170|6356645|P2|Overall Study|Incorrect enrollment|2
1835426|NCT00313170|6356646|P1|Overall Study|Incorrect enrollment|0
1835427|NCT00313170|6356644|P3|Overall Study|Withdrawal by Subject|1
1835428|NCT00313170|6356645|P2|Overall Study|Withdrawal by Subject|0
1835429|NCT00313170|6356646|P1|Overall Study|Withdrawal by Subject|1
1835430|NCT00313170|6356644|P3|Overall Study|Disease progression|27
1835431|NCT00313170|6356645|P2|Overall Study|Disease progression|26
1835432|NCT00313170|6356646|P1|Overall Study|Disease progression|31
1835433|NCT00313170|6356644|P3|Overall Study|Adverse Event|0
1835434|NCT00313170|6356645|P2|Overall Study|Adverse Event|2
1835435|NCT00313170|6356646|P1|Overall Study|Adverse Event|1
1835436|NCT00313170|6356644|P3|Overall Study|Death|2
1835437|NCT00313170|6356645|P2|Overall Study|Death|4
1835438|NCT00313170|6356646|P1|Overall Study|Death|2
1835439|NCT00313144|6356665|P1|Overall Study|Due to termination of the study|66
1835440|NCT00313144|6356665|P1|Overall Study|Change to different product|1
1835441|NCT00313144|6356665|P1|Overall Study|Insurance (homecare provider) change|1
1835442|NCT00313144|6356665|P1|Overall Study|Liver transplant|1
1835443|NCT00313144|6356665|P1|Overall Study|Adverse event - transient|5
1835444|NCT00313144|6356665|P1|Overall Study|Physician Decision|4
1835445|NCT00313144|6356665|P1|Overall Study|Terminated by sponsor/ homecare provider|4
1835446|NCT00313144|6356665|P1|Overall Study|Withdrawal by Subject|4
1835447|NCT00313144|6356665|P1|Overall Study|Lost to Follow-up|5
1835448|NCT00313144|6356665|P1|Overall Study|Death|7
1835449|NCT00313144|6356665|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
1835450|NCT00313014|6356752|P3|Overall Study|Lack of Efficacy|16
1835451|NCT00313014|6356753|P2|Overall Study|Lack of Efficacy|25
1835452|NCT00313014|6356754|P1|Overall Study|Lack of Efficacy|52
1835453|NCT00313014|6356752|P3|Overall Study|Administrative|14
1835454|NCT00313014|6356753|P2|Overall Study|Administrative|6
1835455|NCT00313014|6356754|P1|Overall Study|Administrative|9
1835456|NCT00313014|6356752|P3|Overall Study|Lost to Follow-up|10
1835457|NCT00313014|6356753|P2|Overall Study|Lost to Follow-up|6
1835458|NCT00313014|6356754|P1|Overall Study|Lost to Follow-up|7
1835459|NCT00313014|6356752|P3|Overall Study|Adverse Event|16
1835460|NCT00313014|6356753|P2|Overall Study|Adverse Event|29
1835461|NCT00313014|6356754|P1|Overall Study|Adverse Event|14
1835462|NCT00313014|6356752|P3|Overall Study|Withdrawal by Subject|5
1835463|NCT00313014|6356753|P2|Overall Study|Withdrawal by Subject|7
1835464|NCT00313014|6356754|P1|Overall Study|Withdrawal by Subject|11
1835465|NCT00312897|6356785|P2|Overall Study|discontinued prior to getting treatment|3
1835466|NCT00312897|6356786|P1|Overall Study|discontinued prior to getting treatment|0
1835467|NCT00312897|6356785|P2|Overall Study|Pregnancy|0
1835468|NCT00312897|6356786|P1|Overall Study|Pregnancy|1
1835469|NCT00312897|6356785|P2|Overall Study|Withdrawal by Subject|3
1835470|NCT00312897|6356786|P1|Overall Study|Withdrawal by Subject|1
1835471|NCT00312897|6356785|P2|Overall Study|Physician Decision|0
1835472|NCT00312897|6356786|P1|Overall Study|Physician Decision|1
1835473|NCT00312897|6356785|P2|Overall Study|Lost to Follow-up|0
1835474|NCT00312897|6356786|P1|Overall Study|Lost to Follow-up|2
1835475|NCT00312897|6356785|P2|Overall Study|Adverse Event|0
1835476|NCT00312897|6356786|P1|Overall Study|Adverse Event|1
1835477|NCT00312858|6356811|P2|Overall Study|Other|12
1835478|NCT00312858|6356812|P1|Overall Study|Other|9
1835479|NCT00312858|6356811|P2|Overall Study|Participant Moved|10
1835480|NCT00312858|6356812|P1|Overall Study|Participant Moved|11
1835481|NCT00312858|6356811|P2|Overall Study|Withdraw by Participant|20
1835482|NCT00312858|6356812|P1|Overall Study|Withdraw by Participant|20
1835483|NCT00312858|6356811|P2|Overall Study|Protocol Violation|8
1835484|NCT00312858|6356812|P1|Overall Study|Protocol Violation|3
1835485|NCT00312858|6356811|P2|Overall Study|Lost to Follow-up|42
1835486|NCT00312858|6356812|P1|Overall Study|Lost to Follow-up|25
1835487|NCT00312858|6356811|P2|Overall Study|Adverse Event|1
1835488|NCT00312858|6356812|P1|Overall Study|Adverse Event|0
1835489|NCT00312845|6356866|P2|Overall Study|Other|5
1835490|NCT00312845|6356867|P1|Overall Study|Other|6
1835491|NCT00312845|6356866|P2|Overall Study|Lost to Follow-up|0
1835492|NCT00312845|6356867|P1|Overall Study|Lost to Follow-up|2
1835493|NCT00312845|6356866|P2|Overall Study|Disease Progression|77
1835494|NCT00312845|6356867|P1|Overall Study|Disease Progression|56
1835495|NCT00312845|6356866|P2|Overall Study|Withdrawal by Subject|6
1835497|NCT00312845|6356866|P2|Overall Study|Death|2
1835498|NCT00312845|6356867|P1|Overall Study|Death|2
1835499|NCT00312845|6356866|P2|Overall Study|Adverse Event|5
1835500|NCT00312845|6356867|P1|Overall Study|Adverse Event|19
1835501|NCT00312728|6356875|P1|Overall Study|Other|1
1835502|NCT00312728|6356875|P1|Overall Study|Other|10
1835503|NCT00312728|6356875|P1|Overall Study|Protocol Violation|2
1835504|NCT00312728|6356875|P1|Overall Study|Required non-protocol cancer treatment|2
1835505|NCT00312728|6356875|P1|Overall Study|Withdrawal by Subject|10
1835506|NCT00312728|6356875|P1|Overall Study|Adverse Event|32
1835507|NCT00312728|6356875|P1|Overall Study|Progressive disease|53
1835508|NCT00312702|6356887|P3|Immunization Phase|Lost to Follow-up|0
1835509|NCT00312702|6356888|P2|Immunization Phase|Lost to Follow-up|1
1835510|NCT00312702|6356889|P1|Immunization Phase|Lost to Follow-up|0
1835511|NCT00312663|6356902|P3|Immunization Phase|Adverse Event|0
1835512|NCT00312663|6356903|P2|Immunization Phase|Adverse Event|1
1835513|NCT00312663|6356904|P1|Immunization Phase|Adverse Event|0
1835514|NCT00312572|6356917|P2|Overall Study|Lack of Efficacy|2
1835515|NCT00312572|6356918|P1|Overall Study|Lack of Efficacy|1
1835516|NCT00312572|6356917|P2|Overall Study|Administrative|2
1835517|NCT00312572|6356918|P1|Overall Study|Administrative|4
1835518|NCT00312572|6356917|P2|Overall Study|Lost to Follow-up|1
1835519|NCT00312572|6356918|P1|Overall Study|Lost to Follow-up|1
1835520|NCT00312572|6356917|P2|Overall Study|Adverse Event|16
1835521|NCT00312572|6356918|P1|Overall Study|Adverse Event|10
1835522|NCT00312494|6356929|P3|Overall Study|Other|1
1835523|NCT00312494|6356930|P2|Overall Study|Other|10
1835524|NCT00312494|6356931|P1|Overall Study|Other|10
1835525|NCT00312494|6356929|P3|Overall Study|Withdrawal by Subject|10
1835526|NCT00312494|6356930|P2|Overall Study|Withdrawal by Subject|9
1835527|NCT00312494|6356931|P1|Overall Study|Withdrawal by Subject|6
1835528|NCT00312494|6356929|P3|Overall Study|Lost to Follow-up|8
1835529|NCT00312494|6356930|P2|Overall Study|Lost to Follow-up|8
1835530|NCT00312494|6356931|P1|Overall Study|Lost to Follow-up|8
1835531|NCT00312494|6356929|P3|Overall Study|Laboratory abnormality|0
1835532|NCT00312494|6356930|P2|Overall Study|Laboratory abnormality|0
1835533|NCT00312494|6356931|P1|Overall Study|Laboratory abnormality|1
1835534|NCT00312494|6356929|P3|Overall Study|Lack of Efficacy|8
1835535|NCT00312494|6356930|P2|Overall Study|Lack of Efficacy|6
1835536|NCT00312494|6356931|P1|Overall Study|Lack of Efficacy|4
1835537|NCT00312494|6356929|P3|Overall Study|Adverse Event|11
1835538|NCT00312494|6356930|P2|Overall Study|Adverse Event|15
1835539|NCT00312494|6356931|P1|Overall Study|Adverse Event|33
1835540|NCT00312494|6356929|P3|Overall Study|Randomized; not treated with study drug|5
1835541|NCT00312494|6356930|P2|Overall Study|Randomized; not treated with study drug|10
1835542|NCT00312494|6356931|P1|Overall Study|Randomized; not treated with study drug|9
1835543|NCT00312377|6356965|P2|Overall Study|Site ended participation in study|0
1835544|NCT00312377|6356966|P1|Overall Study|Site ended participation in study|1
1835545|NCT00312377|6356965|P2|Overall Study|Discontinue treatment survival follow up|200
1835546|NCT00312377|6356966|P1|Overall Study|Discontinue treatment survival follow up|202
1835547|NCT00312377|6356965|P2|Overall Study|Randomised but never received treatment|6
1835548|NCT00312377|6356966|P1|Overall Study|Randomised but never received treatment|6
1835549|NCT00312377|6356965|P2|Overall Study|Non-compliance|2
1835550|NCT00312377|6356966|P1|Overall Study|Non-compliance|0
1835551|NCT00312377|6356965|P2|Overall Study|Lost to Follow-up|12
1835552|NCT00312377|6356966|P1|Overall Study|Lost to Follow-up|9
1835553|NCT00312377|6356965|P2|Overall Study|Withdrawal by Subject|30
1835554|NCT00312377|6356966|P1|Overall Study|Withdrawal by Subject|23
1835555|NCT00312377|6356965|P2|Overall Study|Death|418
1835556|NCT00312377|6356966|P1|Overall Study|Death|403
1835557|NCT00312338|6356990|P2|Overall Study|Subsequent infection|0
1835558|NCT00312338|6356991|P1|Overall Study|Subsequent infection|2
1835559|NCT00312338|6356990|P2|Overall Study|Withdrawal by Subject|0
1835560|NCT00312338|6356991|P1|Overall Study|Withdrawal by Subject|4
1835561|NCT00312338|6356990|P2|Overall Study|Lost to Follow-up|1
1835562|NCT00312338|6356991|P1|Overall Study|Lost to Follow-up|9
1835563|NCT00312338|6356990|P2|Overall Study|Adverse Event|2
1835564|NCT00312338|6356991|P1|Overall Study|Adverse Event|7
1835565|NCT00312221|6357004|P4|Double-blind Phase|Lack of Efficacy|10
1835566|NCT00312221|6357005|P3|Double-blind Phase|Lack of Efficacy|6
1835567|NCT00312221|6357006|P2|Double-blind Phase|Lack of Efficacy|17
1835568|NCT00312221|6357007|P1|Double-blind Phase|Lack of Efficacy|0
1835569|NCT00312221|6357004|P4|Double-blind Phase|Administrative|33
1835570|NCT00312221|6357005|P3|Double-blind Phase|Administrative|37
1835571|NCT00312221|6357006|P2|Double-blind Phase|Administrative|26
1835572|NCT00312221|6357007|P1|Double-blind Phase|Administrative|0
1835573|NCT00312221|6357004|P4|Double-blind Phase|Lost to Follow-up|2
1835574|NCT00312221|6357005|P3|Double-blind Phase|Lost to Follow-up|2
1835575|NCT00312221|6357006|P2|Double-blind Phase|Lost to Follow-up|0
1835576|NCT00312221|6357007|P1|Double-blind Phase|Lost to Follow-up|0
1835577|NCT00312221|6357004|P4|Double-blind Phase|Adverse Event|18
1835578|NCT00312221|6357005|P3|Double-blind Phase|Adverse Event|19
1835579|NCT00312221|6357006|P2|Double-blind Phase|Adverse Event|10
1835580|NCT00312221|6357007|P1|Double-blind Phase|Adverse Event|0
1835581|NCT00312221|6357004|P4|Double-blind Phase|Withdrawal by Subject|7
1835582|NCT00312221|6357005|P3|Double-blind Phase|Withdrawal by Subject|8
1835583|NCT00312221|6357006|P2|Double-blind Phase|Withdrawal by Subject|6
1835584|NCT00312221|6357007|P1|Double-blind Phase|Withdrawal by Subject|0
1835585|NCT00312221|6357004|P4|Open-label Run-in Period|Did not qualify|0
1835586|NCT00312221|6357005|P3|Open-label Run-in Period|Did not qualify|0
1835587|NCT00312221|6357006|P2|Open-label Run-in Period|Did not qualify|0
1835588|NCT00312221|6357007|P1|Open-label Run-in Period|Did not qualify|5
1835589|NCT00312221|6357004|P4|Open-label Run-in Period|Lack of Efficacy|0
1835590|NCT00312221|6357005|P3|Open-label Run-in Period|Lack of Efficacy|0
1835591|NCT00312221|6357006|P2|Open-label Run-in Period|Lack of Efficacy|0
1835592|NCT00312221|6357007|P1|Open-label Run-in Period|Lack of Efficacy|102
1835593|NCT00312221|6357004|P4|Open-label Run-in Period|Administrative|0
1835594|NCT00312221|6357005|P3|Open-label Run-in Period|Administrative|0
1835595|NCT00312221|6357006|P2|Open-label Run-in Period|Administrative|0
1835596|NCT00312221|6357007|P1|Open-label Run-in Period|Administrative|42
1835597|NCT00312221|6357004|P4|Open-label Run-in Period|Lost to Follow-up|0
1835598|NCT00312221|6357005|P3|Open-label Run-in Period|Lost to Follow-up|0
1835599|NCT00312221|6357006|P2|Open-label Run-in Period|Lost to Follow-up|0
1835600|NCT00312221|6357007|P1|Open-label Run-in Period|Lost to Follow-up|5
1835601|NCT00312221|6357004|P4|Open-label Run-in Period|Adverse Event|0
1835602|NCT00312221|6357005|P3|Open-label Run-in Period|Adverse Event|0
1835603|NCT00312221|6357006|P2|Open-label Run-in Period|Adverse Event|0
1835604|NCT00312221|6357007|P1|Open-label Run-in Period|Adverse Event|74
1835605|NCT00312221|6357004|P4|Open-label Run-in Period|Withdrawal by Subject|0
1835606|NCT00312221|6357005|P3|Open-label Run-in Period|Withdrawal by Subject|0
1835607|NCT00312221|6357006|P2|Open-label Run-in Period|Withdrawal by Subject|0
1835608|NCT00312221|6357007|P1|Open-label Run-in Period|Withdrawal by Subject|6
1835609|NCT00312208|6357027|P2|Overall Study|Other|7
1835610|NCT00312208|6357028|P1|Overall Study|Other|5
1835611|NCT00312208|6357027|P2|Overall Study|Withdrawal by Subject|42
1835612|NCT00312208|6357028|P1|Overall Study|Withdrawal by Subject|53
1835613|NCT00312208|6357027|P2|Overall Study|Lost to Follow-up|5
1835614|NCT00312208|6357028|P1|Overall Study|Lost to Follow-up|3
1835615|NCT00312208|6357027|P2|Overall Study|Lack of Efficacy|4
1835616|NCT00312208|6357028|P1|Overall Study|Lack of Efficacy|7
1835617|NCT00312208|6357027|P2|Overall Study|Death|1
1835618|NCT00312208|6357028|P1|Overall Study|Death|2
1835619|NCT00312208|6357027|P2|Overall Study|Protocol Violation|3
1835620|NCT00312208|6357028|P1|Overall Study|Protocol Violation|5
1835621|NCT00312208|6357027|P2|Overall Study|Adverse Event|61
1835622|NCT00312208|6357028|P1|Overall Study|Adverse Event|97
1835623|NCT00312195|6357038|P2|Overall Study|Protocol Violation|0
1835624|NCT00312195|6357039|P1|Overall Study|Protocol Violation|1
1835625|NCT00312195|6357038|P2|Overall Study|Lost to Follow-up|0
1835626|NCT00312195|6357039|P1|Overall Study|Lost to Follow-up|1
1835627|NCT00312195|6357038|P2|Overall Study|Adverse Event|6
1835628|NCT00312195|6357039|P1|Overall Study|Adverse Event|4
1835629|NCT00311623|6357067|P3|Overall Study|Physician Decision|2
1835630|NCT00311623|6357068|P2|Overall Study|Physician Decision|0
1835631|NCT00311623|6357069|P1|Overall Study|Physician Decision|0
1835632|NCT00311584|6357111|P2|Overall Study|ineligible|2
1835633|NCT00311584|6357112|P1|Overall Study|ineligible|2
1835634|NCT00311584|6357111|P2|Overall Study|Withdrawal by Subject|1
1835635|NCT00311584|6357112|P1|Overall Study|Withdrawal by Subject|1
1835636|NCT00311584|6357111|P2|Overall Study|Physician Decision|5
1835637|NCT00311584|6357112|P1|Overall Study|Physician Decision|4
1835638|NCT00311584|6357111|P2|Overall Study|Lack of Efficacy|15
1835639|NCT00311584|6357112|P1|Overall Study|Lack of Efficacy|12
1835640|NCT00311584|6357111|P2|Overall Study|Death|0
1835641|NCT00311584|6357112|P1|Overall Study|Death|1
1835642|NCT00311402|6357120|P2|Overall Study|IRB's rejection etc.|3
1835643|NCT00311402|6357121|P1|Overall Study|IRB's rejection etc.|10
1835644|NCT00311402|6357120|P2|Overall Study|Protocol Violation|6
1835645|NCT00311402|6357121|P1|Overall Study|Protocol Violation|7
1835646|NCT00311402|6357120|P2|Overall Study|Lack of Efficacy|42
1835647|NCT00311402|6357121|P1|Overall Study|Lack of Efficacy|58
1835648|NCT00311402|6357120|P2|Overall Study|Withdrawal by Subject|18
1835649|NCT00311402|6357121|P1|Overall Study|Withdrawal by Subject|17
1835650|NCT00311402|6357120|P2|Overall Study|Lost to Follow-up|3
1835651|NCT00311402|6357121|P1|Overall Study|Lost to Follow-up|0
1835652|NCT00311402|6357120|P2|Overall Study|Adverse Event|105
1835653|NCT00311402|6357121|P1|Overall Study|Adverse Event|118
1835654|NCT00311363|6357170|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1835655|NCT00311363|6357171|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
1835656|NCT00311363|6357172|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
1835657|NCT00311363|6357170|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
1835658|NCT00311363|6357171|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
1835659|NCT00311363|6357172|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
1835660|NCT00311363|6357170|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
1835661|NCT00311363|6357171|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
1835662|NCT00311363|6357172|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
1835663|NCT00311363|6357170|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
1835664|NCT00311363|6357171|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
1835665|NCT00311363|6357172|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
1835666|NCT00311363|6357170|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
1835667|NCT00311363|6357171|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
1835668|NCT00311363|6357172|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
1835669|NCT00311363|6357170|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
1835670|NCT00311363|6357171|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
1835671|NCT00311363|6357172|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
1835672|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Death|0
1835673|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Death|0
1835674|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Death|1
1835675|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
1835676|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
1835677|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
1835678|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1835679|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
1835680|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
1835681|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
1835682|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
1835683|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
1835684|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
1835685|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
1835686|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
1835687|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1835688|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
1835689|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
1835690|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1835691|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
1835692|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
1835693|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1835694|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
1835695|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
1835696|NCT00311363|6357170|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
1835697|NCT00311363|6357171|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
1835698|NCT00311363|6357172|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
1835699|NCT00311311|6357232|P2|Overall Study|Lack of ancillary assistance|1
1835700|NCT00311311|6357233|P1|Overall Study|Lack of ancillary assistance|0
1835701|NCT00311311|6357232|P2|Overall Study|Death|0
1835702|NCT00311311|6357233|P1|Overall Study|Death|1
1835703|NCT00311311|6357232|P2|Overall Study|Study Termination by Sponsor|4
1835704|NCT00311311|6357233|P1|Overall Study|Study Termination by Sponsor|3
1835705|NCT00311311|6357232|P2|Overall Study|Noncompliance|1
1835706|NCT00311311|6357233|P1|Overall Study|Noncompliance|0
1835707|NCT00311311|6357232|P2|Overall Study|Withdrawal by Subject|1
1835708|NCT00311311|6357233|P1|Overall Study|Withdrawal by Subject|1
1835709|NCT00311311|6357232|P2|Overall Study|Adverse Event|2
1835710|NCT00311311|6357233|P1|Overall Study|Adverse Event|3
1835711|NCT00311181|6357283|P1|Overall Study|Final DFTs were not obtained|96
1835712|NCT00311155|6357289|P1|Overall Study|Did not meet entry criteria|55
1835713|NCT00311155|6357289|P1|Overall Study|Withdrawal by Subject|17
1835714|NCT00311155|6357289|P1|Overall Study|Adverse Event|21
1835715|NCT00310856|6357301|P3|Overall Study|Unable to classify|0
1835716|NCT00310856|6357302|P2|Overall Study|Unable to classify|0
1835717|NCT00310856|6357303|P1|Overall Study|Unable to classify|1
1835718|NCT00310856|6357301|P3|Overall Study|Inappropriate enrollment|0
1835719|NCT00310856|6357302|P2|Overall Study|Inappropriate enrollment|1
1835720|NCT00310856|6357303|P1|Overall Study|Inappropriate enrollment|1
1835721|NCT00310856|6357301|P3|Overall Study|Lost to Follow-up|6
1835722|NCT00310856|6357302|P2|Overall Study|Lost to Follow-up|2
1835723|NCT00310856|6357303|P1|Overall Study|Lost to Follow-up|1
1835724|NCT00310856|6357301|P3|Overall Study|Withdrawal by Subject|2
1835725|NCT00310856|6357302|P2|Overall Study|Withdrawal by Subject|2
1835726|NCT00310856|6357303|P1|Overall Study|Withdrawal by Subject|2
1835727|NCT00310817|6357327|P4|Overall Study|Unable to classify|0
1835728|NCT00310817|6357328|P3|Overall Study|Unable to classify|0
1835729|NCT00310817|6357329|P2|Overall Study|Unable to classify|1
1835730|NCT00310817|6357330|P1|Overall Study|Unable to classify|3
1835731|NCT00310817|6357327|P4|Overall Study|Protocol Violation|1
1835732|NCT00310817|6357328|P3|Overall Study|Protocol Violation|1
1835733|NCT00310817|6357329|P2|Overall Study|Protocol Violation|1
1835734|NCT00310817|6357330|P1|Overall Study|Protocol Violation|1
1835735|NCT00310817|6357327|P4|Overall Study|Inappropriate Enrollment|0
1835736|NCT00310817|6357328|P3|Overall Study|Inappropriate Enrollment|1
1835737|NCT00310817|6357329|P2|Overall Study|Inappropriate Enrollment|0
1835738|NCT00310817|6357330|P1|Overall Study|Inappropriate Enrollment|1
1835739|NCT00310817|6357327|P4|Overall Study|Lost to Follow-up|0
1835740|NCT00310817|6357328|P3|Overall Study|Lost to Follow-up|0
1835741|NCT00310817|6357329|P2|Overall Study|Lost to Follow-up|1
1835742|NCT00310817|6357330|P1|Overall Study|Lost to Follow-up|2
1835743|NCT00310817|6357327|P4|Overall Study|Withdrawal by Subject|7
1835744|NCT00310817|6357328|P3|Overall Study|Withdrawal by Subject|6
1835745|NCT00310817|6357329|P2|Overall Study|Withdrawal by Subject|4
1835746|NCT00310817|6357330|P1|Overall Study|Withdrawal by Subject|1
1835747|NCT00310817|6357327|P4|Overall Study|AE or Death|0
1835748|NCT00310817|6357328|P3|Overall Study|AE or Death|0
1835749|NCT00310817|6357329|P2|Overall Study|AE or Death|1
1835750|NCT00310817|6357330|P1|Overall Study|AE or Death|3
1835751|NCT00310804|6357418|P2|Overall Study|Withdrawal by Subject|0
1835752|NCT00310804|6357419|P1|Overall Study|Withdrawal by Subject|3
1835753|NCT00310804|6357418|P2|Overall Study|Lost to Follow-up|0
1835754|NCT00310804|6357419|P1|Overall Study|Lost to Follow-up|2
1835755|NCT00310440|6357478|P2|Overall Study|Missed 12 Month Visit|4
1835756|NCT00310440|6357479|P1|Overall Study|Missed 12 Month Visit|7
1835757|NCT00310440|6357478|P2|Overall Study|Withdrawal by Subject|1
1835758|NCT00310440|6357479|P1|Overall Study|Withdrawal by Subject|2
1835759|NCT00310440|6357478|P2|Overall Study|Lost to Follow-up|8
1835760|NCT00310440|6357479|P1|Overall Study|Lost to Follow-up|17
1835761|NCT00310388|6357543|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
1835762|NCT00310388|6357544|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
1835763|NCT00310388|6357543|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
1835764|NCT00310388|6357544|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
1835765|NCT00310388|6357543|P2|Safety Follow-up Continuation Phase|Adverse Event|1
1835766|NCT00310388|6357544|P1|Safety Follow-up Continuation Phase|Adverse Event|0
1835767|NCT00310388|6357543|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
1835768|NCT00310388|6357544|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
1835769|NCT00310388|6357543|P2|Primary Reporting Phase|Other|0
1835770|NCT00310388|6357544|P1|Primary Reporting Phase|Other|1
1835771|NCT00310388|6357543|P2|Primary Reporting Phase|Missing|0
1835772|NCT00310388|6357544|P1|Primary Reporting Phase|Missing|1
1835773|NCT00310388|6357543|P2|Primary Reporting Phase|Participant retired the informed consent|0
1835774|NCT00310388|6357544|P1|Primary Reporting Phase|Participant retired the informed consent|1
1835775|NCT00310388|6357543|P2|Primary Reporting Phase|Participant passed away|0
1835776|NCT00310388|6357544|P1|Primary Reporting Phase|Participant passed away|1
1835777|NCT00310388|6357543|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
1835778|NCT00310388|6357544|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
1835779|NCT00310388|6357543|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
1835780|NCT00310388|6357544|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
1835781|NCT00310388|6357543|P2|Primary Reporting Phase|Termination of study at sponsor request|0
1835782|NCT00310388|6357544|P1|Primary Reporting Phase|Termination of study at sponsor request|3
1835783|NCT00310388|6357543|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
1835784|NCT00310388|6357544|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
1835785|NCT00310388|6357543|P2|Primary Reporting Phase|Discontinuation of study|0
1835786|NCT00310388|6357544|P1|Primary Reporting Phase|Discontinuation of study|1
1835787|NCT00310388|6357543|P2|Primary Reporting Phase|Ministry of Health decision|0
1835788|NCT00310388|6357544|P1|Primary Reporting Phase|Ministry of Health decision|25
1835789|NCT00310388|6357543|P2|Primary Reporting Phase|Participant request|0
1835790|NCT00310388|6357544|P1|Primary Reporting Phase|Participant request|2
1835791|NCT00310388|6357543|P2|Primary Reporting Phase|Participant request unrelated to study|0
1835792|NCT00310388|6357544|P1|Primary Reporting Phase|Participant request unrelated to study|2
1835793|NCT00310388|6357543|P2|Primary Reporting Phase|Failed to return|0
1835794|NCT00310388|6357544|P1|Primary Reporting Phase|Failed to return|8
1835795|NCT00310388|6357543|P2|Primary Reporting Phase|Request of the sponsor|0
1835796|NCT00310388|6357544|P1|Primary Reporting Phase|Request of the sponsor|19
1835797|NCT00310388|6357543|P2|Primary Reporting Phase|Physician Decision|0
1835798|NCT00310388|6357544|P1|Primary Reporting Phase|Physician Decision|2
1835799|NCT00310388|6357543|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
1835800|NCT00310388|6357544|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
1835801|NCT00310388|6357543|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
1835802|NCT00310388|6357544|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
1835803|NCT00310388|6357543|P2|Primary Reporting Phase|Change in participant medical condition|0
1835804|NCT00310388|6357544|P1|Primary Reporting Phase|Change in participant medical condition|3
1835805|NCT00310388|6357543|P2|Primary Reporting Phase|Pregnancy|0
1835806|NCT00310388|6357544|P1|Primary Reporting Phase|Pregnancy|3
1835807|NCT00310388|6357543|P2|Primary Reporting Phase|Protocol Violation|0
1835808|NCT00310388|6357544|P1|Primary Reporting Phase|Protocol Violation|10
1835809|NCT00310388|6357543|P2|Primary Reporting Phase|Withdrawal by Subject|0
1835810|NCT00310388|6357544|P1|Primary Reporting Phase|Withdrawal by Subject|97
1835811|NCT00310388|6357543|P2|Primary Reporting Phase|Lack of Efficacy|0
1835812|NCT00310388|6357544|P1|Primary Reporting Phase|Lack of Efficacy|56
1835813|NCT00310388|6357543|P2|Primary Reporting Phase|Adverse Event|0
1835814|NCT00310388|6357544|P1|Primary Reporting Phase|Adverse Event|101
1835815|NCT00310375|6357586|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
1835816|NCT00310375|6357587|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1835817|NCT00310375|6357588|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
1835818|NCT00310375|6357586|P3|Primary Reporting Phase|Request of Ethics Committee|0
1835819|NCT00310375|6357587|P2|Primary Reporting Phase|Request of Ethics Committee|1
1835820|NCT00310375|6357588|P1|Primary Reporting Phase|Request of Ethics Committee|0
1835821|NCT00310375|6357586|P3|Primary Reporting Phase|Par. switched to commercial product|0
1835822|NCT00310375|6357587|P2|Primary Reporting Phase|Par. switched to commercial product|1
1835823|NCT00310375|6357588|P1|Primary Reporting Phase|Par. switched to commercial product|0
1835824|NCT00310375|6357586|P3|Primary Reporting Phase|Missed study drug for 2 months|0
1835825|NCT00310375|6357587|P2|Primary Reporting Phase|Missed study drug for 2 months|0
1835826|NCT00310375|6357588|P1|Primary Reporting Phase|Missed study drug for 2 months|1
1835827|NCT00310375|6357586|P3|Primary Reporting Phase|Site closure|0
1835828|NCT00310375|6357587|P2|Primary Reporting Phase|Site closure|0
1835829|NCT00310375|6357588|P1|Primary Reporting Phase|Site closure|3
1835830|NCT00310375|6357586|P3|Primary Reporting Phase|Missed study drug >5 days|0
1835831|NCT00310375|6357587|P2|Primary Reporting Phase|Missed study drug >5 days|0
1835832|NCT00310375|6357588|P1|Primary Reporting Phase|Missed study drug >5 days|1
1835833|NCT00310375|6357586|P3|Primary Reporting Phase|Going for temporal lobectomy|0
1835834|NCT00310375|6357587|P2|Primary Reporting Phase|Going for temporal lobectomy|0
1835835|NCT00310375|6357588|P1|Primary Reporting Phase|Going for temporal lobectomy|1
1835836|NCT00310375|6357586|P3|Primary Reporting Phase|Participant request unrelated to study|0
1835837|NCT00310375|6357587|P2|Primary Reporting Phase|Participant request unrelated to study|2
1835838|NCT00310375|6357588|P1|Primary Reporting Phase|Participant request unrelated to study|1
1835839|NCT00310375|6357586|P3|Primary Reporting Phase|Failed to return|0
1835840|NCT00310375|6357587|P2|Primary Reporting Phase|Failed to return|3
1835841|NCT00310375|6357588|P1|Primary Reporting Phase|Failed to return|1
1835842|NCT00310375|6357586|P3|Primary Reporting Phase|Request of the sponsor|0
1835843|NCT00310375|6357587|P2|Primary Reporting Phase|Request of the sponsor|2
1835844|NCT00310375|6357588|P1|Primary Reporting Phase|Request of the sponsor|2
1835845|NCT00310375|6357586|P3|Primary Reporting Phase|Physician Decision|0
1835846|NCT00310375|6357587|P2|Primary Reporting Phase|Physician Decision|3
1835847|NCT00310375|6357588|P1|Primary Reporting Phase|Physician Decision|5
1835848|NCT00310375|6357586|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
1835849|NCT00310375|6357587|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
1835850|NCT00310375|6357588|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
1835851|NCT00310375|6357586|P3|Primary Reporting Phase|Change in Par medical condition|0
1835852|NCT00310375|6357587|P2|Primary Reporting Phase|Change in Par medical condition|0
1835853|NCT00310375|6357588|P1|Primary Reporting Phase|Change in Par medical condition|2
1835854|NCT00310375|6357586|P3|Primary Reporting Phase|Protocol Violation|0
1835855|NCT00310375|6357587|P2|Primary Reporting Phase|Protocol Violation|5
1835856|NCT00310375|6357588|P1|Primary Reporting Phase|Protocol Violation|8
1835857|NCT00310375|6357586|P3|Primary Reporting Phase|Withdrawal by Subject|0
1835858|NCT00310375|6357587|P2|Primary Reporting Phase|Withdrawal by Subject|7
1835859|NCT00310375|6357588|P1|Primary Reporting Phase|Withdrawal by Subject|10
1835860|NCT00310375|6357586|P3|Primary Reporting Phase|Pregnancy|0
1835861|NCT00310375|6357587|P2|Primary Reporting Phase|Pregnancy|2
1835862|NCT00310375|6357588|P1|Primary Reporting Phase|Pregnancy|2
1835863|NCT00310375|6357586|P3|Primary Reporting Phase|Lack of Efficacy|0
1835864|NCT00310375|6357587|P2|Primary Reporting Phase|Lack of Efficacy|19
1835865|NCT00310375|6357588|P1|Primary Reporting Phase|Lack of Efficacy|24
1835866|NCT00310375|6357586|P3|Primary Reporting Phase|Adverse Event|0
1835867|NCT00310375|6357587|P2|Primary Reporting Phase|Adverse Event|22
1835868|NCT00310375|6357588|P1|Primary Reporting Phase|Adverse Event|28
1835869|NCT00310037|6357724|P2|Overall Study|Non-protocol treatment|0
1835870|NCT00310037|6357725|P1|Overall Study|Non-protocol treatment|1
1835871|NCT00310037|6357724|P2|Overall Study|Progression|0
1835872|NCT00310037|6357725|P1|Overall Study|Progression|6
1835873|NCT00310037|6357724|P2|Overall Study|Withdrawal by Subject|3
1835874|NCT00310037|6357725|P1|Overall Study|Withdrawal by Subject|4
1835875|NCT00310037|6357724|P2|Overall Study|Adverse Event|14
1835876|NCT00310037|6357725|P1|Overall Study|Adverse Event|7
1835877|NCT00309985|6357739|P2|Overall Study|Chemotherapy discontinued only|0
1835878|NCT00309985|6357740|P1|Overall Study|Chemotherapy discontinued only|1
1835879|NCT00309985|6357739|P2|Overall Study|Non-compliance|0
1835880|NCT00309985|6357740|P1|Overall Study|Non-compliance|1
1835881|NCT00309985|6357739|P2|Overall Study|Complicating disease|0
1835882|NCT00309985|6357740|P1|Overall Study|Complicating disease|1
1835883|NCT00309985|6357739|P2|Overall Study|Never started treatment|0
1835884|NCT00309985|6357740|P1|Overall Study|Never started treatment|7
1835885|NCT00309985|6357739|P2|Overall Study|Physician Decision|0
1835886|NCT00309985|6357740|P1|Overall Study|Physician Decision|3
1835887|NCT00309985|6357739|P2|Overall Study|Withdrawal by Subject|1
1835888|NCT00309985|6357740|P1|Overall Study|Withdrawal by Subject|5
1835889|NCT00309985|6357739|P2|Overall Study|Death|0
1835890|NCT00309985|6357740|P1|Overall Study|Death|2
1835891|NCT00309985|6357739|P2|Overall Study|Adverse Event|0
1835892|NCT00309985|6357740|P1|Overall Study|Adverse Event|30
1835893|NCT00309985|6357739|P2|Overall Study|Disease progression|0
1835894|NCT00309985|6357740|P1|Overall Study|Disease progression|12
1835895|NCT00309959|6357756|P1|Overall Study|Ineligible - no prior chemotherapy|2
1835896|NCT00309946|6357765|P1|Overall Study|Withdrawal by Subject|1
1835897|NCT00309907|6357771|P1|Overall Study|Major infectious event|4
1835898|NCT00309907|6357771|P1|Overall Study|Ineligible|11
1835899|NCT00309907|6357771|P1|Overall Study|Physician Decision|1
1835900|NCT00309907|6357771|P1|Overall Study|Death|4
1835901|NCT00309777|6357784|P4|Overall Study|Death|0
1835902|NCT00309777|6357785|P3|Overall Study|Death|0
1835903|NCT00309777|6357786|P2|Overall Study|Death|1
1835904|NCT00309777|6357787|P1|Overall Study|Death|0
1835905|NCT00309777|6357784|P4|Overall Study|Lost to Follow-up|0
1835906|NCT00309777|6357785|P3|Overall Study|Lost to Follow-up|1
1835907|NCT00309777|6357786|P2|Overall Study|Lost to Follow-up|0
1835908|NCT00309777|6357787|P1|Overall Study|Lost to Follow-up|0
1835909|NCT00309777|6357784|P4|Overall Study|Withdrawal by Subject|2
1835910|NCT00309777|6357785|P3|Overall Study|Withdrawal by Subject|7
1835911|NCT00309777|6357786|P2|Overall Study|Withdrawal by Subject|5
1835912|NCT00309777|6357787|P1|Overall Study|Withdrawal by Subject|6
1835913|NCT00309777|6357784|P4|Overall Study|Protocol Violation|1
1835914|NCT00309777|6357785|P3|Overall Study|Protocol Violation|3
1835915|NCT00309777|6357786|P2|Overall Study|Protocol Violation|1
1835916|NCT00309777|6357787|P1|Overall Study|Protocol Violation|4
1835917|NCT00309777|6357784|P4|Overall Study|Adverse Event|1
1835918|NCT00309777|6357785|P3|Overall Study|Adverse Event|8
1835919|NCT00309777|6357786|P2|Overall Study|Adverse Event|2
1835920|NCT00309777|6357787|P1|Overall Study|Adverse Event|13
1835921|NCT00309608|6357828|P5|Overall Study|Other incl. Lack of efficacy|0
1835922|NCT00309608|6357829|P4|Overall Study|Other incl. Lack of efficacy|4
1835923|NCT00309608|6357830|P3|Overall Study|Other incl. Lack of efficacy|3
1835924|NCT00309608|6357831|P2|Overall Study|Other incl. Lack of efficacy|4
1835925|NCT00309608|6357832|P1|Overall Study|Other incl. Lack of efficacy|10
1835926|NCT00309608|6357828|P5|Overall Study|Withdrawal by Subject|0
1835927|NCT00309608|6357829|P4|Overall Study|Withdrawal by Subject|0
1835928|NCT00309608|6357830|P3|Overall Study|Withdrawal by Subject|2
1835929|NCT00309608|6357831|P2|Overall Study|Withdrawal by Subject|4
1835930|NCT00309608|6357832|P1|Overall Study|Withdrawal by Subject|1
1835931|NCT00309608|6357828|P5|Overall Study|Lost to Follow-up|1
1835932|NCT00309608|6357829|P4|Overall Study|Lost to Follow-up|0
1835933|NCT00309608|6357830|P3|Overall Study|Lost to Follow-up|2
1835934|NCT00309608|6357831|P2|Overall Study|Lost to Follow-up|0
1835935|NCT00309608|6357832|P1|Overall Study|Lost to Follow-up|0
1835936|NCT00309608|6357828|P5|Overall Study|Protocol Violation|0
1835937|NCT00309608|6357829|P4|Overall Study|Protocol Violation|0
1835938|NCT00309608|6357830|P3|Overall Study|Protocol Violation|0
1835939|NCT00309608|6357831|P2|Overall Study|Protocol Violation|0
1835940|NCT00309608|6357832|P1|Overall Study|Protocol Violation|2
1835941|NCT00309608|6357828|P5|Overall Study|Adverse Event|3
1835942|NCT00309608|6357829|P4|Overall Study|Adverse Event|2
1835943|NCT00309608|6357830|P3|Overall Study|Adverse Event|3
1835944|NCT00309608|6357831|P2|Overall Study|Adverse Event|5
1835945|NCT00309608|6357832|P1|Overall Study|Adverse Event|1
1835946|NCT00309452|6357880|P2|Overall Study|Withdrawal by Subject|0
1835947|NCT00309452|6357881|P1|Overall Study|Withdrawal by Subject|3
1835948|NCT00309387|6357909|P2|Overall Study|Lost to Follow-up|86
1835949|NCT00309387|6357910|P1|Overall Study|Lost to Follow-up|70
1835950|NCT00309387|6357909|P2|Overall Study|Death|73
1835951|NCT00309387|6357910|P1|Overall Study|Death|72
1835952|NCT00309244|6357928|P2|Overall Study|Death|1
1835953|NCT00309244|6357929|P1|Overall Study|Death|4
1835954|NCT00309244|6357928|P2|Overall Study|Randomized but not dosed|12
1835955|NCT00309244|6357929|P1|Overall Study|Randomized but not dosed|11
1835956|NCT00309244|6357928|P2|Overall Study|Various|7
1835957|NCT00309244|6357929|P1|Overall Study|Various|7
1835958|NCT00309244|6357928|P2|Overall Study|Withdrawal by Subject|32
1835959|NCT00309244|6357929|P1|Overall Study|Withdrawal by Subject|50
1835960|NCT00309244|6357928|P2|Overall Study|Protocol Violation|3
1835961|NCT00309244|6357929|P1|Overall Study|Protocol Violation|6
1835962|NCT00309244|6357928|P2|Overall Study|Physician Decision|8
1835963|NCT00309244|6357929|P1|Overall Study|Physician Decision|5
1835964|NCT00309244|6357928|P2|Overall Study|Lost to Follow-up|22
1835965|NCT00309244|6357929|P1|Overall Study|Lost to Follow-up|6
1835966|NCT00309244|6357928|P2|Overall Study|Adverse Event|12
1835967|NCT00309244|6357929|P1|Overall Study|Adverse Event|29
1835968|NCT00309166|6357951|P2|Overall Study|Withdrawal by Subject|3
1835969|NCT00309166|6357952|P1|Overall Study|Withdrawal by Subject|4
1835970|NCT00309166|6357951|P2|Overall Study|Adverse event, non-fatal|0
1835971|NCT00309166|6357952|P1|Overall Study|Adverse event, non-fatal|1
1835972|NCT00308997|6357980|P2|Overall Study|Unable to tolerate intervention|0
1835973|NCT00308997|6357981|P1|Overall Study|Unable to tolerate intervention|1
1835974|NCT00308997|6357980|P2|Overall Study|Subject feigned clinical data|1
1835975|NCT00308997|6357981|P1|Overall Study|Subject feigned clinical data|0
1835976|NCT00308737|6358000|P3|Overall Study|Various|8
1835977|NCT00308737|6358001|P2|Overall Study|Various|20
1835978|NCT00308737|6358002|P1|Overall Study|Various|32
1835979|NCT00308737|6358000|P3|Overall Study|Withdrawal by Subject|18
1835980|NCT00308737|6358001|P2|Overall Study|Withdrawal by Subject|166
1835981|NCT00308737|6358002|P1|Overall Study|Withdrawal by Subject|218
1835982|NCT00308737|6358000|P3|Overall Study|Protocol Violation|5
1835983|NCT00308737|6358001|P2|Overall Study|Protocol Violation|9
1835984|NCT00308737|6358002|P1|Overall Study|Protocol Violation|34
1835985|NCT00308737|6358000|P3|Overall Study|Physician Decision|1
1835986|NCT00308737|6358001|P2|Overall Study|Physician Decision|2
1835987|NCT00308737|6358002|P1|Overall Study|Physician Decision|15
1835988|NCT00308737|6358000|P3|Overall Study|Lost to Follow-up|5
1835989|NCT00308737|6358001|P2|Overall Study|Lost to Follow-up|80
1835990|NCT00308737|6358002|P1|Overall Study|Lost to Follow-up|56
1835991|NCT00308737|6358000|P3|Overall Study|Death|0
1835992|NCT00308737|6358001|P2|Overall Study|Death|3
1835993|NCT00308737|6358002|P1|Overall Study|Death|4
1835994|NCT00308737|6358000|P3|Overall Study|Adverse Event|0
1835995|NCT00308737|6358001|P2|Overall Study|Adverse Event|9
1835996|NCT00308737|6358002|P1|Overall Study|Adverse Event|104
1835997|NCT00308711|6358042|P3|Overall Study|Subject incarcerated, data not allowed|1
1835998|NCT00308711|6358043|P2|Overall Study|Subject incarcerated, data not allowed|0
1835999|NCT00308711|6358044|P1|Overall Study|Subject incarcerated, data not allowed|0
1836000|NCT00308711|6358042|P3|Overall Study|Baby not born within 7 days of treatment|2
1836001|NCT00308711|6358043|P2|Overall Study|Baby not born within 7 days of treatment|2
1836002|NCT00308711|6358044|P1|Overall Study|Baby not born within 7 days of treatment|1
1836003|NCT00308711|6358042|P3|Overall Study|Lost to Follow-up|0
1836004|NCT00308711|6358043|P2|Overall Study|Lost to Follow-up|1
1836005|NCT00308711|6358044|P1|Overall Study|Lost to Follow-up|0
1836006|NCT00308711|6358042|P3|Overall Study|Protocol Violation|1
1836007|NCT00308711|6358043|P2|Overall Study|Protocol Violation|1
1836008|NCT00308711|6358044|P1|Overall Study|Protocol Violation|0
1836009|NCT00308711|6358042|P3|Overall Study|Withdrawal by Subject|1
1836010|NCT00308711|6358043|P2|Overall Study|Withdrawal by Subject|0
1836011|NCT00308711|6358044|P1|Overall Study|Withdrawal by Subject|1
1836012|NCT00308620|6358079|P3|Overall Study|Lost to Follow-up|1
1836013|NCT00308620|6358080|P2|Overall Study|Lost to Follow-up|0
1836014|NCT00308620|6358081|P1|Overall Study|Lost to Follow-up|0
1836015|NCT00308620|6358079|P3|Overall Study|Death|0
1836016|NCT00308620|6358080|P2|Overall Study|Death|1
1836017|NCT00308620|6358081|P1|Overall Study|Death|1
1836018|NCT00308581|6358090|P3|Randomized Maintenance Phase|Unknown reason|0
1836019|NCT00308581|6358091|P2|Randomized Maintenance Phase|Unknown reason|0
1836020|NCT00308581|6358092|P1|Randomized Maintenance Phase|Unknown reason|3
1836021|NCT00308581|6358090|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
1836022|NCT00308581|6358091|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
1836023|NCT00308581|6358092|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
1836024|NCT00308581|6358090|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
1836025|NCT00308581|6358091|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
1836026|NCT00308581|6358092|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
1836027|NCT00308581|6358090|P3|Randomized Maintenance Phase|Lost to Follow-up|0
1836028|NCT00308581|6358091|P2|Randomized Maintenance Phase|Lost to Follow-up|2
1836029|NCT00308581|6358092|P1|Randomized Maintenance Phase|Lost to Follow-up|0
1836030|NCT00308581|6358090|P3|Randomized Maintenance Phase|Lack of Efficacy|0
1836031|NCT00308581|6358091|P2|Randomized Maintenance Phase|Lack of Efficacy|21
1836032|NCT00308581|6358092|P1|Randomized Maintenance Phase|Lack of Efficacy|9
1836033|NCT00308581|6358090|P3|Randomized Maintenance Phase|Adverse Event|0
1836034|NCT00308581|6358091|P2|Randomized Maintenance Phase|Adverse Event|17
1836035|NCT00308581|6358092|P1|Randomized Maintenance Phase|Adverse Event|10
1836036|NCT00308581|6358090|P3|Induction Phase|Unknown reason|3
1836037|NCT00308581|6358091|P2|Induction Phase|Unknown reason|0
1836038|NCT00308581|6358092|P1|Induction Phase|Unknown reason|0
1836039|NCT00308581|6358090|P3|Induction Phase|Withdrawal by Subject|5
1836040|NCT00308581|6358091|P2|Induction Phase|Withdrawal by Subject|0
1836041|NCT00308581|6358092|P1|Induction Phase|Withdrawal by Subject|0
1836042|NCT00308581|6358090|P3|Induction Phase|Lack of Efficacy|121
1836043|NCT00308581|6358091|P2|Induction Phase|Lack of Efficacy|0
1836044|NCT00308581|6358092|P1|Induction Phase|Lack of Efficacy|0
1836045|NCT00308581|6358090|P3|Induction Phase|Adverse Event|37
1836046|NCT00308581|6358091|P2|Induction Phase|Adverse Event|0
1836047|NCT00308581|6358092|P1|Induction Phase|Adverse Event|0
1836048|NCT00308555|6358218|P2|Overall Study|Physician Decision|0
1836049|NCT00308555|6358219|P1|Overall Study|Physician Decision|2
1836050|NCT00308555|6358218|P2|Overall Study|Withdrawal by Subject|0
1836051|NCT00308555|6358219|P1|Overall Study|Withdrawal by Subject|1
1836052|NCT00308308|6358236|P2|Overall Study|Other|0
1836053|NCT00308308|6358237|P1|Overall Study|Other|1
1836054|NCT00308308|6358236|P2|Overall Study|Randomized but not dosed|16
1836055|NCT00308308|6358237|P1|Overall Study|Randomized but not dosed|8
1836056|NCT00308308|6358236|P2|Overall Study|Various|5
1836057|NCT00308308|6358237|P1|Overall Study|Various|7
1836058|NCT00308308|6358236|P2|Overall Study|Withdrawal by Subject|19
1836059|NCT00308308|6358237|P1|Overall Study|Withdrawal by Subject|47
1836060|NCT00308308|6358236|P2|Overall Study|Protocol Violation|14
1836061|NCT00308308|6358237|P1|Overall Study|Protocol Violation|3
1836062|NCT00308308|6358236|P2|Overall Study|Physician Decision|7
1836063|NCT00308308|6358237|P1|Overall Study|Physician Decision|15
1836064|NCT00308308|6358236|P2|Overall Study|Lost to Follow-up|5
1836065|NCT00308308|6358237|P1|Overall Study|Lost to Follow-up|5
1836066|NCT00308308|6358236|P2|Overall Study|Adverse Event|2
1836067|NCT00308308|6358237|P1|Overall Study|Adverse Event|17
1836068|NCT00308139|6358316|P2|Overall Study|Other|0
1836069|NCT00308139|6358317|P1|Overall Study|Other|1
1836070|NCT00308139|6358316|P2|Overall Study|Administrative|4
1836071|NCT00308139|6358317|P1|Overall Study|Administrative|1
1836072|NCT00308139|6358316|P2|Overall Study|Loss of Glucose Control|7
1836073|NCT00308139|6358317|P1|Overall Study|Loss of Glucose Control|5
1836074|NCT00308139|6358316|P2|Overall Study|Investigator Decision|10
1836075|NCT00308139|6358317|P1|Overall Study|Investigator Decision|11
1836076|NCT00308139|6358316|P2|Overall Study|Withdrawal of Consent|42
1836077|NCT00308139|6358317|P1|Overall Study|Withdrawal of Consent|40
1836078|NCT00308139|6358316|P2|Overall Study|Protocol Violation|2
1836079|NCT00308139|6358317|P1|Overall Study|Protocol Violation|3
1836080|NCT00308139|6358316|P2|Overall Study|Lost to Follow-up|8
1836081|NCT00308139|6358317|P1|Overall Study|Lost to Follow-up|13
1836082|NCT00308139|6358316|P2|Overall Study|Adverse Event|14
1836083|NCT00308139|6358317|P1|Overall Study|Adverse Event|20
1836084|NCT00308113|6358391|P4|Overall Study|Protocol closure|1
1836085|NCT00308113|6358392|P3|Overall Study|Protocol closure|0
1836086|NCT00308113|6358393|P2|Overall Study|Protocol closure|0
1836087|NCT00308113|6358394|P1|Overall Study|Protocol closure|0
1836088|NCT00308087|6358414|P2|Overall Study|Other|3
1836089|NCT00308087|6358415|P1|Overall Study|Other|4
1836090|NCT00308087|6358414|P2|Overall Study|Withdrawal by Subject|1
1836091|NCT00308087|6358415|P1|Overall Study|Withdrawal by Subject|2
1836092|NCT00308087|6358414|P2|Overall Study|Study Closure|12
1836093|NCT00308087|6358415|P1|Overall Study|Study Closure|11
1836094|NCT00308087|6358414|P2|Overall Study|Progressive Disease|21
1836095|NCT00308087|6358415|P1|Overall Study|Progressive Disease|19
1836096|NCT00308074|6358431|P1|Overall Study|Withdrawal by Subject|1
1836097|NCT00307931|6358448|P1|Overall Study|Adverse Event|1
1836098|NCT00307801|6358465|P2|Overall Study|Pregnancy|1
1836099|NCT00307801|6358466|P1|Overall Study|Pregnancy|0
1836100|NCT00307801|6358465|P2|Overall Study|No reason specified|0
1836101|NCT00307801|6358466|P1|Overall Study|No reason specified|2
1836102|NCT00307801|6358465|P2|Overall Study|Protocol Violation|2
1836103|NCT00307801|6358466|P1|Overall Study|Protocol Violation|3
1836104|NCT00307801|6358465|P2|Overall Study|Frustration with e-diary|0
1836105|NCT00307801|6358466|P1|Overall Study|Frustration with e-diary|1
1836106|NCT00307801|6358465|P2|Overall Study|Lost to Follow-up, moved abroad|1
1836107|NCT00307801|6358466|P1|Overall Study|Lost to Follow-up, moved abroad|1
1836108|NCT00307801|6358465|P2|Overall Study|Lack of Efficacy|2
1836109|NCT00307801|6358466|P1|Overall Study|Lack of Efficacy|0
1836110|NCT00307801|6358465|P2|Overall Study|Wrong Randomization|0
1836111|NCT00307801|6358466|P1|Overall Study|Wrong Randomization|1
1836112|NCT00307801|6358465|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
1836113|NCT00307801|6358466|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
1836114|NCT00307801|6358465|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
1836115|NCT00307801|6358466|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
1836116|NCT00307801|6358465|P2|Overall Study|Non-compliance, not taken all tablets|2
1836117|NCT00307801|6358466|P1|Overall Study|Non-compliance, not taken all tablets|1
1836118|NCT00307801|6358465|P2|Overall Study|Withdrawal by Subject|4
1836119|NCT00307801|6358466|P1|Overall Study|Withdrawal by Subject|9
1836120|NCT00307801|6358465|P2|Overall Study|Adverse Event|4
1836121|NCT00307801|6358466|P1|Overall Study|Adverse Event|12
1836122|NCT00307736|6358578|P4|Overall Study|Withdrawal by Subject|0
1836123|NCT00307736|6358579|P3|Overall Study|Withdrawal by Subject|2
1836124|NCT00307736|6358580|P2|Overall Study|Withdrawal by Subject|0
1836125|NCT00307736|6358581|P1|Overall Study|Withdrawal by Subject|0
1836126|NCT00307736|6358578|P4|Overall Study|Adverse Event|3
1836127|NCT00307736|6358579|P3|Overall Study|Adverse Event|1
1836128|NCT00307736|6358580|P2|Overall Study|Adverse Event|0
1836129|NCT00307736|6358581|P1|Overall Study|Adverse Event|0
1836130|NCT00307684|6358592|P3|Double Blind Phase|Lack of Efficacy|0
1836131|NCT00307684|6358593|P2|Double Blind Phase|Lack of Efficacy|5
1836132|NCT00307684|6358594|P1|Double Blind Phase|Lack of Efficacy|2
1836133|NCT00307684|6358592|P3|Open Label Phase|other|6
1836134|NCT00307684|6358593|P2|Open Label Phase|other|0
1836135|NCT00307684|6358594|P1|Open Label Phase|other|0
1836136|NCT00307684|6358592|P3|Open Label Phase|non compliance|5
1836137|NCT00307684|6358593|P2|Open Label Phase|non compliance|0
1836138|NCT00307684|6358594|P1|Open Label Phase|non compliance|0
1836139|NCT00307684|6358592|P3|Open Label Phase|Lost to Follow-up|11
1836140|NCT00307684|6358593|P2|Open Label Phase|Lost to Follow-up|0
1836141|NCT00307684|6358594|P1|Open Label Phase|Lost to Follow-up|0
1836142|NCT00307684|6358592|P3|Open Label Phase|Withdrawal by Subject|15
1836143|NCT00307684|6358593|P2|Open Label Phase|Withdrawal by Subject|0
1836144|NCT00307684|6358594|P1|Open Label Phase|Withdrawal by Subject|0
1836145|NCT00307684|6358592|P3|Open Label Phase|Adverse Event|16
1836146|NCT00307684|6358593|P2|Open Label Phase|Adverse Event|0
1836147|NCT00307684|6358594|P1|Open Label Phase|Adverse Event|0
1836148|NCT00307684|6358592|P3|Open Label Phase|Lack of Efficacy|3
1836149|NCT00307684|6358593|P2|Open Label Phase|Lack of Efficacy|0
1836150|NCT00307684|6358594|P1|Open Label Phase|Lack of Efficacy|0
1836151|NCT00307489|6358622|P2|Week 48 Through Week 168|Seroconversion|0
1836152|NCT00307489|6358623|P1|Week 48 Through Week 168|Seroconversion|1
1836153|NCT00307489|6358622|P2|Week 48 Through Week 168|Lost to Follow-up|1
1836154|NCT00307489|6358623|P1|Week 48 Through Week 168|Lost to Follow-up|0
1836155|NCT00307489|6358622|P2|Week 48 Through Week 168|Death|1
1836156|NCT00307489|6358623|P1|Week 48 Through Week 168|Death|0
1836157|NCT00307489|6358622|P2|Week 48 Through Week 168|Lack of Efficacy|2
1836158|NCT00307489|6358623|P1|Week 48 Through Week 168|Lack of Efficacy|2
1836159|NCT00307489|6358622|P2|Week 48 Through Week 168|Withdrawal by Subject|2
1836160|NCT00307489|6358623|P1|Week 48 Through Week 168|Withdrawal by Subject|1
1836161|NCT00307489|6358622|P2|Week 48 Through Week 168|Physician Decision|0
1836162|NCT00307489|6358623|P1|Week 48 Through Week 168|Physician Decision|1
1836163|NCT00307489|6358622|P2|Week 48 Through Week 168|Adverse Event|0
1836164|NCT00307489|6358623|P1|Week 48 Through Week 168|Adverse Event|1
1836165|NCT00307489|6358622|P2|Baseline Through Week 48|Withdrawal by Subject|1
1836166|NCT00307489|6358623|P1|Baseline Through Week 48|Withdrawal by Subject|0
1836167|NCT00307489|6358622|P2|Baseline Through Week 48|Physician Decision|0
1836168|NCT00307489|6358623|P1|Baseline Through Week 48|Physician Decision|1
1836169|NCT00307489|6358622|P2|Baseline Through Week 48|Lost to Follow-up|1
1836170|NCT00307489|6358623|P1|Baseline Through Week 48|Lost to Follow-up|0
1836171|NCT00307437|6358668|P7|After Controlled Period|Other|28
1836172|NCT00307437|6358669|P6|After Controlled Period|Other|40
1836173|NCT00307437|6358670|P5|After Controlled Period|Other|9
1836174|NCT00307437|6358671|P4|After Controlled Period|Other|15
1836175|NCT00307437|6358672|P3|After Controlled Period|Other|0
1836176|NCT00307437|6358673|P2|After Controlled Period|Other|0
1836177|NCT00307437|6358674|P1|After Controlled Period|Other|0
1836178|NCT00307437|6358668|P7|After Controlled Period|Lost to Follow-up|18
1836179|NCT00307437|6358669|P6|After Controlled Period|Lost to Follow-up|13
1836180|NCT00307437|6358670|P5|After Controlled Period|Lost to Follow-up|12
1836181|NCT00307437|6358671|P4|After Controlled Period|Lost to Follow-up|7
1836182|NCT00307437|6358672|P3|After Controlled Period|Lost to Follow-up|0
1836183|NCT00307437|6358673|P2|After Controlled Period|Lost to Follow-up|0
1836184|NCT00307437|6358674|P1|After Controlled Period|Lost to Follow-up|0
1836185|NCT00307437|6358668|P7|After Controlled Period|Lack of Efficacy|24
1836186|NCT00307437|6358669|P6|After Controlled Period|Lack of Efficacy|37
1836187|NCT00307437|6358670|P5|After Controlled Period|Lack of Efficacy|17
1836188|NCT00307437|6358671|P4|After Controlled Period|Lack of Efficacy|15
1836189|NCT00307437|6358672|P3|After Controlled Period|Lack of Efficacy|0
1836190|NCT00307437|6358673|P2|After Controlled Period|Lack of Efficacy|0
1836191|NCT00307437|6358674|P1|After Controlled Period|Lack of Efficacy|0
1836192|NCT00307437|6358668|P7|After Controlled Period|Death|3
1836193|NCT00307437|6358669|P6|After Controlled Period|Death|1
1836194|NCT00307437|6358670|P5|After Controlled Period|Death|1
1836195|NCT00307437|6358671|P4|After Controlled Period|Death|3
1836196|NCT00307437|6358672|P3|After Controlled Period|Death|0
1836197|NCT00307437|6358673|P2|After Controlled Period|Death|0
1836198|NCT00307437|6358674|P1|After Controlled Period|Death|0
1836199|NCT00307437|6358668|P7|After Controlled Period|Adverse Event|40
1836200|NCT00307437|6358669|P6|After Controlled Period|Adverse Event|31
1836201|NCT00307437|6358670|P5|After Controlled Period|Adverse Event|16
1836202|NCT00307437|6358671|P4|After Controlled Period|Adverse Event|18
1836203|NCT00307437|6358672|P3|After Controlled Period|Adverse Event|0
1836204|NCT00307437|6358673|P2|After Controlled Period|Adverse Event|0
1836205|NCT00307437|6358674|P1|After Controlled Period|Adverse Event|0
1836206|NCT00307437|6358668|P7|Controlled Period|Other|0
1836207|NCT00307437|6358669|P6|Controlled Period|Other|0
1836208|NCT00307437|6358670|P5|Controlled Period|Other|0
1836209|NCT00307437|6358671|P4|Controlled Period|Other|0
1836210|NCT00307437|6358672|P3|Controlled Period|Other|3
1836211|NCT00307437|6358673|P2|Controlled Period|Other|1
1836212|NCT00307437|6358674|P1|Controlled Period|Other|5
1836213|NCT00307437|6358668|P7|Controlled Period|Lost to Follow-up|0
1836214|NCT00307437|6358669|P6|Controlled Period|Lost to Follow-up|0
1836215|NCT00307437|6358670|P5|Controlled Period|Lost to Follow-up|0
1836216|NCT00307437|6358671|P4|Controlled Period|Lost to Follow-up|0
1836217|NCT00307437|6358672|P3|Controlled Period|Lost to Follow-up|0
1836218|NCT00307437|6358673|P2|Controlled Period|Lost to Follow-up|3
1836219|NCT00307437|6358674|P1|Controlled Period|Lost to Follow-up|2
1836220|NCT00307437|6358668|P7|Controlled Period|Lack of Efficacy|0
1836221|NCT00307437|6358669|P6|Controlled Period|Lack of Efficacy|0
1836222|NCT00307437|6358670|P5|Controlled Period|Lack of Efficacy|0
1836223|NCT00307437|6358671|P4|Controlled Period|Lack of Efficacy|0
1836224|NCT00307437|6358672|P3|Controlled Period|Lack of Efficacy|0
1836225|NCT00307437|6358673|P2|Controlled Period|Lack of Efficacy|0
1836226|NCT00307437|6358674|P1|Controlled Period|Lack of Efficacy|2
1836227|NCT00307437|6358668|P7|Controlled Period|Death|0
1836228|NCT00307437|6358669|P6|Controlled Period|Death|0
1836229|NCT00307437|6358670|P5|Controlled Period|Death|0
1836230|NCT00307437|6358671|P4|Controlled Period|Death|0
1836231|NCT00307437|6358672|P3|Controlled Period|Death|1
1836232|NCT00307437|6358673|P2|Controlled Period|Death|0
1836233|NCT00307437|6358674|P1|Controlled Period|Death|0
1836234|NCT00307437|6358668|P7|Controlled Period|Adverse Event|0
1836235|NCT00307437|6358669|P6|Controlled Period|Adverse Event|0
1836236|NCT00307437|6358670|P5|Controlled Period|Adverse Event|0
1836237|NCT00307437|6358671|P4|Controlled Period|Adverse Event|0
1836238|NCT00307437|6358672|P3|Controlled Period|Adverse Event|5
1836239|NCT00307437|6358673|P2|Controlled Period|Adverse Event|2
1836240|NCT00307437|6358674|P1|Controlled Period|Adverse Event|7
1836241|NCT00307333|6358700|P2|Overall Study|Lost to Follow-up|3
1836242|NCT00307333|6358701|P1|Overall Study|Lost to Follow-up|11
1836243|NCT00307294|6358713|P1|Overall Study|Withdrawal by Subject|1
1836244|NCT00307164|6358722|P2|Overall Study|Lost to Follow-up|1
1836245|NCT00307164|6358723|P1|Overall Study|Lost to Follow-up|6
1836246|NCT00307164|6358722|P2|Overall Study|Not compliant with requirements|4
1836247|NCT00307164|6358723|P1|Overall Study|Not compliant with requirements|4
1836248|NCT00307164|6358722|P2|Overall Study|Withdrawal by Subject|8
1836249|NCT00307164|6358723|P1|Overall Study|Withdrawal by Subject|1
1836250|NCT00307164|6358722|P2|Overall Study|Subject/parent not able to get to clinic|1
1836251|NCT00307164|6358723|P1|Overall Study|Subject/parent not able to get to clinic|2
1836252|NCT00307164|6358722|P2|Overall Study|Severe debilitation, unable to continue|0
1836253|NCT00307164|6358723|P1|Overall Study|Severe debilitation, unable to continue|1
1836254|NCT00307164|6358722|P2|Overall Study|Death|0
1836255|NCT00307164|6358723|P1|Overall Study|Death|1
1836256|NCT00307151|6358763|P4|Overall Study|Clinic unable to contact subject|1
1836257|NCT00307151|6358764|P3|Overall Study|Clinic unable to contact subject|1
1836258|NCT00307151|6358765|P2|Overall Study|Clinic unable to contact subject|3
1836259|NCT00307151|6358766|P1|Overall Study|Clinic unable to contact subject|3
1836260|NCT00307151|6358763|P4|Overall Study|Not willing to adhere to study reqs|2
1836261|NCT00307151|6358764|P3|Overall Study|Not willing to adhere to study reqs|2
1836262|NCT00307151|6358765|P2|Overall Study|Not willing to adhere to study reqs|0
1836263|NCT00307151|6358766|P1|Overall Study|Not willing to adhere to study reqs|2
1836264|NCT00307151|6358763|P4|Overall Study|Withdrew consent|3
1836265|NCT00307151|6358764|P3|Overall Study|Withdrew consent|1
1836266|NCT00307151|6358765|P2|Overall Study|Withdrew consent|1
1836267|NCT00307151|6358766|P1|Overall Study|Withdrew consent|0
1836268|NCT00307151|6358763|P4|Overall Study|Subject unable to get to clinic|2
1836269|NCT00307151|6358764|P3|Overall Study|Subject unable to get to clinic|6
1836270|NCT00307151|6358765|P2|Overall Study|Subject unable to get to clinic|0
1836271|NCT00307151|6358766|P1|Overall Study|Subject unable to get to clinic|1
1836272|NCT00307151|6358763|P4|Overall Study|Severe debilitation, unable to continue|0
1836273|NCT00307151|6358764|P3|Overall Study|Severe debilitation, unable to continue|0
1836274|NCT00307151|6358765|P2|Overall Study|Severe debilitation, unable to continue|0
1836275|NCT00307151|6358766|P1|Overall Study|Severe debilitation, unable to continue|1
1836276|NCT00307151|6358763|P4|Overall Study|Death|3
1836277|NCT00307151|6358764|P3|Overall Study|Death|10
1836278|NCT00307151|6358765|P2|Overall Study|Death|3
1836279|NCT00307151|6358766|P1|Overall Study|Death|4
1836280|NCT00307125|6358810|P3|Pilot Phase|Withdrawal by Subject|1
1836281|NCT00307125|6358811|P2|Pilot Phase|Withdrawal by Subject|1
1836282|NCT00307125|6358812|P1|Pilot Phase|Withdrawal by Subject|0
1836283|NCT00307125|6358810|P3|Pilot Phase|Lost to Follow-up|0
1836284|NCT00307125|6358811|P2|Pilot Phase|Lost to Follow-up|1
1836285|NCT00307125|6358812|P1|Pilot Phase|Lost to Follow-up|0
1836286|NCT00307125|6358810|P3|Screening Phase|Coronary artery bypass|0
1836287|NCT00307125|6358811|P2|Screening Phase|Coronary artery bypass|0
1836288|NCT00307125|6358812|P1|Screening Phase|Coronary artery bypass|1
1836289|NCT00307125|6358810|P3|Screening Phase|AMR and treated with rituximab|0
1836290|NCT00307125|6358811|P2|Screening Phase|AMR and treated with rituximab|0
1836291|NCT00307125|6358812|P1|Screening Phase|AMR and treated with rituximab|1
1836292|NCT00307125|6358810|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1836293|NCT00307125|6358811|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
1836294|NCT00307125|6358812|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
1836295|NCT00307125|6358810|P3|Screening Phase|Screen Error|0
1836296|NCT00307125|6358811|P2|Screening Phase|Screen Error|0
1836297|NCT00307125|6358812|P1|Screening Phase|Screen Error|1
1836298|NCT00307125|6358810|P3|Screening Phase|Ineligible|0
1836299|NCT00307125|6358811|P2|Screening Phase|Ineligible|0
1836300|NCT00307125|6358812|P1|Screening Phase|Ineligible|1
1836301|NCT00307125|6358810|P3|Screening Phase|PAK|0
1836302|NCT00307125|6358811|P2|Screening Phase|PAK|0
1836303|NCT00307125|6358812|P1|Screening Phase|PAK|1
1836304|NCT00307125|6358810|P3|Screening Phase|Malignancy|0
1836305|NCT00307125|6358811|P2|Screening Phase|Malignancy|0
1836306|NCT00307125|6358812|P1|Screening Phase|Malignancy|1
1836307|NCT00307125|6358810|P3|Screening Phase|Metastatic colon cancer|0
1836308|NCT00307125|6358811|P2|Screening Phase|Metastatic colon cancer|0
1836309|NCT00307125|6358812|P1|Screening Phase|Metastatic colon cancer|1
1836310|NCT00307125|6358810|P3|Screening Phase|Developed acute leukemia|0
1836311|NCT00307125|6358811|P2|Screening Phase|Developed acute leukemia|0
1836312|NCT00307125|6358812|P1|Screening Phase|Developed acute leukemia|1
1836313|NCT00307125|6358810|P3|Screening Phase|Try to get pregnant|0
1836314|NCT00307125|6358811|P2|Screening Phase|Try to get pregnant|0
1836315|NCT00307125|6358812|P1|Screening Phase|Try to get pregnant|1
1836316|NCT00307125|6358810|P3|Screening Phase|Ineligible for pilot|0
1836317|NCT00307125|6358811|P2|Screening Phase|Ineligible for pilot|0
1836318|NCT00307125|6358812|P1|Screening Phase|Ineligible for pilot|4
1836319|NCT00307125|6358810|P3|Screening Phase|Received Pancreas Transplant|0
1836320|NCT00307125|6358811|P2|Screening Phase|Received Pancreas Transplant|0
1836321|NCT00307125|6358812|P1|Screening Phase|Received Pancreas Transplant|8
1836322|NCT00307125|6358810|P3|Screening Phase|Moved or transferred facilities|0
1836323|NCT00307125|6358811|P2|Screening Phase|Moved or transferred facilities|0
1836324|NCT00307125|6358812|P1|Screening Phase|Moved or transferred facilities|34
1836325|NCT00307125|6358810|P3|Screening Phase|Scheduling issues/Non-compliance|0
1836326|NCT00307125|6358811|P2|Screening Phase|Scheduling issues/Non-compliance|0
1836327|NCT00307125|6358812|P1|Screening Phase|Scheduling issues/Non-compliance|55
1836328|NCT00307125|6358810|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1836329|NCT00307125|6358811|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
1836330|NCT00307125|6358812|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
1836331|NCT00307125|6358810|P3|Screening Phase|Graft Failure|0
1836332|NCT00307125|6358811|P2|Screening Phase|Graft Failure|0
1836333|NCT00307125|6358812|P1|Screening Phase|Graft Failure|8
1836334|NCT00307125|6358810|P3|Screening Phase|Graft Loss|0
1836335|NCT00307125|6358811|P2|Screening Phase|Graft Loss|0
1836336|NCT00307125|6358812|P1|Screening Phase|Graft Loss|3
1836337|NCT00307125|6358810|P3|Screening Phase|Study Terminated|0
1836338|NCT00307125|6358811|P2|Screening Phase|Study Terminated|0
1836339|NCT00307125|6358812|P1|Screening Phase|Study Terminated|17
1836340|NCT00307125|6358810|P3|Screening Phase|Sponsor Decision|0
1836341|NCT00307125|6358811|P2|Screening Phase|Sponsor Decision|0
1836342|NCT00307125|6358812|P1|Screening Phase|Sponsor Decision|4
1836343|NCT00307125|6358810|P3|Screening Phase|Physician Decision|0
1836344|NCT00307125|6358811|P2|Screening Phase|Physician Decision|0
1836345|NCT00307125|6358812|P1|Screening Phase|Physician Decision|26
1836346|NCT00307125|6358810|P3|Screening Phase|Withdrawal by Subject|0
1836347|NCT00307125|6358811|P2|Screening Phase|Withdrawal by Subject|0
1836348|NCT00307125|6358812|P1|Screening Phase|Withdrawal by Subject|77
1836349|NCT00307125|6358810|P3|Screening Phase|Death|0
1836350|NCT00307125|6358811|P2|Screening Phase|Death|0
1836351|NCT00307125|6358812|P1|Screening Phase|Death|10
1836352|NCT00307125|6358810|P3|Screening Phase|Lost to Follow-up|0
1836353|NCT00307125|6358811|P2|Screening Phase|Lost to Follow-up|0
1836354|NCT00307125|6358812|P1|Screening Phase|Lost to Follow-up|87
1836355|NCT00307125|6358810|P3|Screening Phase|Protocol Violation|0
1836356|NCT00307125|6358811|P2|Screening Phase|Protocol Violation|0
1836357|NCT00307125|6358812|P1|Screening Phase|Protocol Violation|27
1836358|NCT00307125|6358810|P3|Screening Phase|Adverse Event|0
1836359|NCT00307125|6358811|P2|Screening Phase|Adverse Event|0
1836360|NCT00307125|6358812|P1|Screening Phase|Adverse Event|1
1836361|NCT00307086|6358834|P1|Overall Study|ineligible|5
1836362|NCT00307047|6358840|P2|Overall Study|All death, all MI, all Revascularization|16
1836363|NCT00307047|6358841|P1|Overall Study|All death, all MI, all Revascularization|27
1836364|NCT00307047|6358840|P2|Overall Study|Lost to follow-up for other reasons|1
1836365|NCT00307047|6358841|P1|Overall Study|Lost to follow-up for other reasons|0
1836366|NCT00307047|6358840|P2|Overall Study|Physician Decision|2
1836367|NCT00307047|6358841|P1|Overall Study|Physician Decision|1
1836368|NCT00307047|6358840|P2|Overall Study|Withdrawal by Subject|6
1836369|NCT00307047|6358841|P1|Overall Study|Withdrawal by Subject|6
1836370|NCT00307047|6358840|P2|Overall Study|Lost to Follow-up|24
1836371|NCT00307047|6358841|P1|Overall Study|Lost to Follow-up|35
1836372|NCT00307034|6358979|P2|Overall Study|Lost to Follow-up|3
1836373|NCT00307034|6358980|P1|Overall Study|Lost to Follow-up|0
1836374|NCT00307034|6358979|P2|Overall Study|Withdrawal by Subject|2
1836375|NCT00307034|6358980|P1|Overall Study|Withdrawal by Subject|1
1836376|NCT00307034|6358979|P2|Overall Study|Adverse Event|2
1836377|NCT00307034|6358980|P1|Overall Study|Adverse Event|1
1836378|NCT00306995|6359025|P7|Study Part II for Subset 2|Serious Adverse Event|0
1836379|NCT00306995|6359026|P6|Study Part II for Subset 2|Serious Adverse Event|0
1836380|NCT00306995|6359027|P5|Study Part II for Subset 2|Serious Adverse Event|0
1836381|NCT00306995|6359028|P4|Study Part II for Subset 2|Serious Adverse Event|0
1836382|NCT00306995|6359029|P3|Study Part II for Subset 2|Serious Adverse Event|0
1836383|NCT00306995|6359030|P2|Study Part II for Subset 2|Serious Adverse Event|1
1836384|NCT00306995|6359031|P1|Study Part II for Subset 2|Serious Adverse Event|0
1836385|NCT00306995|6359025|P7|Study Part I|Withdrawal by Subject|1
1836386|NCT00306995|6359026|P6|Study Part I|Withdrawal by Subject|0
1836387|NCT00306995|6359027|P5|Study Part I|Withdrawal by Subject|0
1836388|NCT00306995|6359028|P4|Study Part I|Withdrawal by Subject|0
1836389|NCT00306995|6359029|P3|Study Part I|Withdrawal by Subject|0
1836390|NCT00306995|6359030|P2|Study Part I|Withdrawal by Subject|0
1836391|NCT00306995|6359031|P1|Study Part I|Withdrawal by Subject|0
1836392|NCT00306891|6359424|P4|Part B|Development of study specific disc crit.|1
1836393|NCT00306891|6359425|P3|Part B|Development of study specific disc crit.|0
1836394|NCT00306891|6359426|P2|Part B|Development of study specific disc crit.|0
1836395|NCT00306891|6359427|P1|Part B|Development of study specific disc crit.|0
1836396|NCT00306891|6359424|P4|Part B|Condition under investigation worsened|8
1836397|NCT00306891|6359425|P3|Part B|Condition under investigation worsened|2
1836398|NCT00306891|6359426|P2|Part B|Condition under investigation worsened|0
1836399|NCT00306891|6359427|P1|Part B|Condition under investigation worsened|0
1836400|NCT00306891|6359424|P4|Part B|Withdrawal by Subject|1
1836401|NCT00306891|6359425|P3|Part B|Withdrawal by Subject|3
1836402|NCT00306891|6359426|P2|Part B|Withdrawal by Subject|0
1836403|NCT00306891|6359427|P1|Part B|Withdrawal by Subject|0
1836404|NCT00306891|6359424|P4|Part B|Adverse Event|5
1836405|NCT00306891|6359425|P3|Part B|Adverse Event|5
1836406|NCT00306891|6359426|P2|Part B|Adverse Event|0
1836407|NCT00306891|6359427|P1|Part B|Adverse Event|0
1836408|NCT00306891|6359424|P4|Part B|Death|2
1836409|NCT00306891|6359425|P3|Part B|Death|1
1836410|NCT00306891|6359426|P2|Part B|Death|0
1836411|NCT00306891|6359427|P1|Part B|Death|0
1836412|NCT00306891|6359424|P4|Part A|QTC interval outwith elig. criteria|0
1836413|NCT00306891|6359425|P3|Part A|QTC interval outwith elig. criteria|0
1836414|NCT00306891|6359426|P2|Part A|QTC interval outwith elig. criteria|0
1836415|NCT00306891|6359427|P1|Part A|QTC interval outwith elig. criteria|1
1836416|NCT00306891|6359424|P4|Part A|Suspicion of second malignancy|0
1836417|NCT00306891|6359425|P3|Part A|Suspicion of second malignancy|0
1836418|NCT00306891|6359426|P2|Part A|Suspicion of second malignancy|1
1836419|NCT00306891|6359427|P1|Part A|Suspicion of second malignancy|0
1836420|NCT00306891|6359424|P4|Part A|Reaccumul. of ascites following drainage|0
1836421|NCT00306891|6359425|P3|Part A|Reaccumul. of ascites following drainage|0
1836422|NCT00306891|6359426|P2|Part A|Reaccumul. of ascites following drainage|1
1836423|NCT00306891|6359427|P1|Part A|Reaccumul. of ascites following drainage|0
1836424|NCT00306891|6359424|P4|Part A|Partial bowel obstruction|0
1836425|NCT00306891|6359425|P3|Part A|Partial bowel obstruction|0
1836426|NCT00306891|6359426|P2|Part A|Partial bowel obstruction|0
1836427|NCT00306891|6359427|P1|Part A|Partial bowel obstruction|1
1836428|NCT00306891|6359424|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
1836429|NCT00306891|6359425|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
1836430|NCT00306891|6359426|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
1836431|NCT00306891|6359427|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
1836432|NCT00306891|6359424|P4|Part A|Condition under investigation worsened|0
1836433|NCT00306891|6359425|P3|Part A|Condition under investigation worsened|0
1836434|NCT00306891|6359426|P2|Part A|Condition under investigation worsened|2
1836435|NCT00306891|6359427|P1|Part A|Condition under investigation worsened|2
1836436|NCT00306891|6359424|P4|Part A|Withdrawal by Subject|0
1836437|NCT00306891|6359425|P3|Part A|Withdrawal by Subject|0
1836438|NCT00306891|6359426|P2|Part A|Withdrawal by Subject|1
1836439|NCT00306891|6359427|P1|Part A|Withdrawal by Subject|1
1836440|NCT00306852|6359450|P2|Overall Study|Lost to Follow-up|24
1836441|NCT00306852|6359451|P1|Overall Study|Lost to Follow-up|15
1836442|NCT00306852|6359450|P2|Overall Study|Death|14
1836443|NCT00306852|6359451|P1|Overall Study|Death|14
1836444|NCT00306787|6359469|P2|Overall Study|Abnormal laboratory value(s)|0
1836445|NCT00306787|6359470|P1|Overall Study|Abnormal laboratory value(s)|1
1836446|NCT00306787|6359469|P2|Overall Study|Administrative problems|0
1836447|NCT00306787|6359470|P1|Overall Study|Administrative problems|4
1836448|NCT00306787|6359469|P2|Overall Study|Lost to Follow-up|6
1836449|NCT00306787|6359470|P1|Overall Study|Lost to Follow-up|9
1836450|NCT00306787|6359469|P2|Overall Study|Withdrawal by Subject|9
1836451|NCT00306787|6359470|P1|Overall Study|Withdrawal by Subject|2
1836452|NCT00306787|6359469|P2|Overall Study|Protocol Violation|10
1836453|NCT00306787|6359470|P1|Overall Study|Protocol Violation|8
1836454|NCT00306787|6359469|P2|Overall Study|Lack of Efficacy|0
1836455|NCT00306787|6359470|P1|Overall Study|Lack of Efficacy|1
1836456|NCT00306787|6359469|P2|Overall Study|Adverse Event|1
1836457|NCT00306787|6359470|P1|Overall Study|Adverse Event|1
1836458|NCT00306787|6359469|P2|Overall Study|Discontinued without taking study drug|215
1836459|NCT00306787|6359470|P1|Overall Study|Discontinued without taking study drug|208
1836460|NCT00306670|6359488|P2|Overall Study|patients recruited; Genentech, the st|2
1836461|NCT00306670|6359489|P1|Overall Study|patients recruited; Genentech, the st|0
1836462|NCT00306592|6359495|P2|Overall Study|48-week Treatment Period Ongoing|20
1836463|NCT00306592|6359496|P1|Overall Study|48-week Treatment Period Ongoing|0
1836464|NCT00306592|6359495|P2|Overall Study|Other|2
1836465|NCT00306592|6359496|P1|Overall Study|Other|1
1836466|NCT00306592|6359495|P2|Overall Study|Other|10
1836467|NCT00306592|6359496|P1|Overall Study|Other|5
1836468|NCT00306592|6359495|P2|Overall Study|Voluntary|6
1836469|NCT00306592|6359496|P1|Overall Study|Voluntary|10
1836470|NCT00306592|6359495|P2|Overall Study|Persistent Antibodies|3
1836471|NCT00306592|6359496|P1|Overall Study|Persistent Antibodies|6
1836472|NCT00306592|6359495|P2|Overall Study|Noncompliance|2
1836473|NCT00306592|6359496|P1|Overall Study|Noncompliance|0
1836474|NCT00306592|6359495|P2|Overall Study|Lost to Follow-up|0
1836475|NCT00306592|6359496|P1|Overall Study|Lost to Follow-up|1
1836476|NCT00306592|6359495|P2|Overall Study|Adverse Event|15
1836477|NCT00306592|6359496|P1|Overall Study|Adverse Event|8
1836478|NCT00306527|6359506|P4|Overall Study|Death|2
1836479|NCT00306527|6359507|P3|Overall Study|Death|1
1836480|NCT00306527|6359508|P2|Overall Study|Death|0
1836481|NCT00306527|6359509|P1|Overall Study|Death|1
1836482|NCT00306527|6359506|P4|Overall Study|Adverse Event|1
1836483|NCT00306527|6359507|P3|Overall Study|Adverse Event|1
1836484|NCT00306527|6359508|P2|Overall Study|Adverse Event|0
1836485|NCT00306527|6359509|P1|Overall Study|Adverse Event|0
1836486|NCT00306527|6359506|P4|Overall Study|Withdrawal by Subject|3
1836487|NCT00306527|6359507|P3|Overall Study|Withdrawal by Subject|0
1836488|NCT00306527|6359508|P2|Overall Study|Withdrawal by Subject|3
1836489|NCT00306527|6359509|P1|Overall Study|Withdrawal by Subject|2
1836490|NCT00306527|6359506|P4|Overall Study|Lost to Follow-up|0
1836491|NCT00306527|6359507|P3|Overall Study|Lost to Follow-up|3
1836492|NCT00306527|6359508|P2|Overall Study|Lost to Follow-up|4
1836493|NCT00306527|6359509|P1|Overall Study|Lost to Follow-up|3
1836494|NCT00306384|6359578|P3|Overall Study|Site closure|0
1836495|NCT00306384|6359579|P2|Overall Study|Site closure|0
1836496|NCT00306384|6359580|P1|Overall Study|Site closure|2
1836497|NCT00306384|6359578|P3|Overall Study|Other|32
1836498|NCT00306384|6359579|P2|Overall Study|Other|70
1836499|NCT00306384|6359580|P1|Overall Study|Other|80
1836500|NCT00306384|6359578|P3|Overall Study|Investigator discretion|21
1836501|NCT00306384|6359579|P2|Overall Study|Investigator discretion|31
1836502|NCT00306384|6359580|P1|Overall Study|Investigator discretion|28
1836503|NCT00306384|6359578|P3|Overall Study|Lack of Efficacy|38
1836504|NCT00306384|6359579|P2|Overall Study|Lack of Efficacy|40
1836505|NCT00306384|6359580|P1|Overall Study|Lack of Efficacy|26
1836506|NCT00306384|6359578|P3|Overall Study|Pregnancy|1
1836507|NCT00306384|6359579|P2|Overall Study|Pregnancy|1
1836508|NCT00306384|6359580|P1|Overall Study|Pregnancy|3
1836509|NCT00306384|6359578|P3|Overall Study|Study termination|1
1836510|NCT00306384|6359579|P2|Overall Study|Study termination|0
1836511|NCT00306384|6359580|P1|Overall Study|Study termination|1
1836512|NCT00306384|6359578|P3|Overall Study|Voluntary withdrawal|91
1836513|NCT00306384|6359579|P2|Overall Study|Voluntary withdrawal|187
1836514|NCT00306384|6359580|P1|Overall Study|Voluntary withdrawal|199
1836515|NCT00306384|6359578|P3|Overall Study|Lost to Follow-up|35
1836516|NCT00306384|6359579|P2|Overall Study|Lost to Follow-up|41
1836517|NCT00306384|6359580|P1|Overall Study|Lost to Follow-up|57
1836518|NCT00306384|6359578|P3|Overall Study|Major protocol deviation|18
1836519|NCT00306384|6359579|P2|Overall Study|Major protocol deviation|51
1836520|NCT00306384|6359580|P1|Overall Study|Major protocol deviation|43
1836521|NCT00306384|6359578|P3|Overall Study|Adverse Event|40
1836522|NCT00306384|6359579|P2|Overall Study|Adverse Event|87
1836523|NCT00306384|6359580|P1|Overall Study|Adverse Event|103
1836524|NCT00306293|6359612|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
1836525|NCT00306293|6359613|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
1836526|NCT00306293|6359612|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
1836527|NCT00306293|6359613|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
1836528|NCT00306293|6359612|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
1836529|NCT00306293|6359613|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
1836530|NCT00306293|6359612|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
1836531|NCT00306293|6359613|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
1836532|NCT00306293|6359612|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1836533|NCT00306293|6359613|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
1836534|NCT00306293|6359612|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1836535|NCT00306293|6359613|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
1836536|NCT00306293|6359612|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
1836537|NCT00306293|6359613|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
1836538|NCT00306293|6359612|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
1836539|NCT00306293|6359613|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
1836540|NCT00306202|6359634|P3|Overall Study|Still on treatment|0
1836541|NCT00306202|6359635|P2|Overall Study|Still on treatment|1
1836542|NCT00306202|6359636|P1|Overall Study|Still on treatment|6
1836543|NCT00306189|6359796|P4|Overall Study|Other|0
1836544|NCT00306189|6359797|P3|Overall Study|Other|0
1836545|NCT00306189|6359798|P2|Overall Study|Other|0
1836546|NCT00306189|6359799|P1|Overall Study|Other|1
1836547|NCT00306189|6359796|P4|Overall Study|Ineligibility determined|1
1836548|NCT00306189|6359797|P3|Overall Study|Ineligibility determined|1
1836549|NCT00306189|6359798|P2|Overall Study|Ineligibility determined|1
1836550|NCT00306189|6359799|P1|Overall Study|Ineligibility determined|1
1836551|NCT00306189|6359796|P4|Overall Study|Withdrawal by Subject|1
1836552|NCT00306189|6359797|P3|Overall Study|Withdrawal by Subject|8
1836553|NCT00306189|6359798|P2|Overall Study|Withdrawal by Subject|2
1836554|NCT00306189|6359799|P1|Overall Study|Withdrawal by Subject|4
1836555|NCT00306189|6359796|P4|Overall Study|Adverse Event|2
1836556|NCT00306189|6359797|P3|Overall Study|Adverse Event|2
1836557|NCT00306189|6359798|P2|Overall Study|Adverse Event|3
1836558|NCT00306189|6359799|P1|Overall Study|Adverse Event|3
1836559|NCT00306189|6359796|P4|Overall Study|Physician Decision|1
1836560|NCT00306189|6359797|P3|Overall Study|Physician Decision|0
1836561|NCT00306189|6359798|P2|Overall Study|Physician Decision|0
1836562|NCT00306189|6359799|P1|Overall Study|Physician Decision|0
1836563|NCT00305877|6359826|P2|Overall Study|Transportation issue with daily RT|1
1836564|NCT00305877|6359827|P1|Overall Study|Transportation issue with daily RT|0
1836565|NCT00305877|6359826|P2|Overall Study|Ineligible|1
1836566|NCT00305877|6359827|P1|Overall Study|Ineligible|2
1836567|NCT00305877|6359826|P2|Overall Study|Never start treatment|5
1836568|NCT00305877|6359827|P1|Overall Study|Never start treatment|2
1836569|NCT00305877|6359826|P2|Overall Study|Physician Decision|1
1836570|NCT00305877|6359827|P1|Overall Study|Physician Decision|1
1836571|NCT00305877|6359826|P2|Overall Study|Withdrawal by Subject|2
1836572|NCT00305877|6359827|P1|Overall Study|Withdrawal by Subject|4
1836573|NCT00305877|6359826|P2|Overall Study|Death|1
1836574|NCT00305877|6359827|P1|Overall Study|Death|0
1836575|NCT00305877|6359826|P2|Overall Study|Adverse Event|14
1836576|NCT00305877|6359827|P1|Overall Study|Adverse Event|9
1836577|NCT00305877|6359826|P2|Overall Study|Lack of Efficacy|9
1836578|NCT00305877|6359827|P1|Overall Study|Lack of Efficacy|6
1836579|NCT00305864|6359841|P4|Overall Study|Ineligible / No protocol treatment|13
1836580|NCT00305864|6359842|P3|Overall Study|Ineligible / No protocol treatment|1
1836581|NCT00305864|6359843|P2|Overall Study|Ineligible / No protocol treatment|1
1836582|NCT00305864|6359844|P1|Overall Study|Ineligible / No protocol treatment|0
1836583|NCT00305773|6359857|P2|Overall Study|All other reasons|2
1836584|NCT00305773|6359858|P1|Overall Study|All other reasons|3
1836585|NCT00305773|6359857|P2|Overall Study|Disease Progression|3
1836586|NCT00305773|6359858|P1|Overall Study|Disease Progression|1
1836587|NCT00305773|6359857|P2|Overall Study|Withdrawal by Subject|4
1836588|NCT00305773|6359858|P1|Overall Study|Withdrawal by Subject|1
1836589|NCT00305773|6359857|P2|Overall Study|Physician Decision|1
1836590|NCT00305773|6359858|P1|Overall Study|Physician Decision|1
1836591|NCT00305773|6359857|P2|Overall Study|Alternative Treatment|4
1836592|NCT00305773|6359858|P1|Overall Study|Alternative Treatment|4
1836593|NCT00305773|6359857|P2|Overall Study|Adverse Event|2
1836594|NCT00305773|6359858|P1|Overall Study|Adverse Event|1
1836595|NCT00305773|6359857|P2|Overall Study|Death|2
1836596|NCT00305773|6359858|P1|Overall Study|Death|3
1836597|NCT00305604|6359889|P2|Overall Study|Patient moved|0
1836598|NCT00305604|6359890|P1|Overall Study|Patient moved|1
1836599|NCT00305604|6359889|P2|Overall Study|Withdrawal by Subject|21
1836600|NCT00305604|6359890|P1|Overall Study|Withdrawal by Subject|12
1836601|NCT00305604|6359889|P2|Overall Study|Protocol Violation|1
1836602|NCT00305604|6359890|P1|Overall Study|Protocol Violation|2
1836603|NCT00305604|6359889|P2|Overall Study|Lost to Follow-up|4
1836604|NCT00305604|6359890|P1|Overall Study|Lost to Follow-up|0
1836605|NCT00305604|6359889|P2|Overall Study|Lack of Efficacy|18
1836606|NCT00305604|6359890|P1|Overall Study|Lack of Efficacy|11
1836607|NCT00305604|6359889|P2|Overall Study|Adverse Event|3
1836608|NCT00305604|6359890|P1|Overall Study|Adverse Event|6
1836609|NCT00305448|6360034|P3|Overall Study|Tumor Marker Elevation|1
1836610|NCT00305448|6360035|P2|Overall Study|Tumor Marker Elevation|0
1836611|NCT00305448|6360036|P1|Overall Study|Tumor Marker Elevation|0
1836612|NCT00305448|6360034|P3|Overall Study|Subjective Disease Progression|2
1836613|NCT00305448|6360035|P2|Overall Study|Subjective Disease Progression|2
1836614|NCT00305448|6360036|P1|Overall Study|Subjective Disease Progression|1
1836615|NCT00305448|6360034|P3|Overall Study|Disease Progression|28
1836616|NCT00305448|6360035|P2|Overall Study|Disease Progression|31
1836617|NCT00305448|6360036|P1|Overall Study|Disease Progression|27
1836618|NCT00305448|6360034|P3|Overall Study|Adverse Event|1
1836619|NCT00305448|6360035|P2|Overall Study|Adverse Event|0
1836620|NCT00305448|6360036|P1|Overall Study|Adverse Event|1
1836621|NCT00305448|6360034|P3|Overall Study|Withdrawal by Subject|1
1836622|NCT00305448|6360035|P2|Overall Study|Withdrawal by Subject|0
1836623|NCT00305448|6360036|P1|Overall Study|Withdrawal by Subject|2
1836624|NCT00305448|6360034|P3|Overall Study|Protocol Violation|0
1836625|NCT00305448|6360035|P2|Overall Study|Protocol Violation|1
1836626|NCT00305448|6360036|P1|Overall Study|Protocol Violation|0
1836627|NCT00305253|6360058|P2|Overall Study|Withdrawal by Subject|1
1836628|NCT00305253|6360059|P1|Overall Study|Withdrawal by Subject|0
1836629|NCT00305227|6360071|P2|Overall Study|Lost to Follow-up|6
1836630|NCT00305227|6360072|P1|Overall Study|Lost to Follow-up|7
1836631|NCT00305110|6360119|P1|Overall Study|Missing data|29
1836632|NCT00305058|6360192|P2|Overall Study|Missing outcome data|2
1836633|NCT00305058|6360193|P1|Overall Study|Missing outcome data|3
1836634|NCT00305058|6360192|P2|Overall Study|Missing data collection instrument|2
1836635|NCT00305058|6360193|P1|Overall Study|Missing data collection instrument|3
1836636|NCT00305058|6360192|P2|Overall Study|Participant too young|0
1836637|NCT00305058|6360193|P1|Overall Study|Participant too young|1
1836638|NCT00304954|6360209|P4|Overall Study|Adverse Event|0
1836639|NCT00304954|6360210|P3|Overall Study|Adverse Event|0
1836640|NCT00304954|6360211|P2|Overall Study|Adverse Event|0
1836641|NCT00304954|6360212|P1|Overall Study|Adverse Event|1
1836642|NCT00304954|6360209|P4|Overall Study|Withdrawal by Subject|0
1836643|NCT00304954|6360210|P3|Overall Study|Withdrawal by Subject|1
1836644|NCT00304954|6360211|P2|Overall Study|Withdrawal by Subject|0
1836645|NCT00304954|6360212|P1|Overall Study|Withdrawal by Subject|0
1836646|NCT00304915|6360232|P2|Overall Study|Withdrawal by Subject|0
1836647|NCT00304915|6360233|P1|Overall Study|Withdrawal by Subject|3
1836648|NCT00304915|6360232|P2|Overall Study|Death|5
1836649|NCT00304915|6360233|P1|Overall Study|Death|4
1836650|NCT00304915|6360232|P2|Overall Study|Lost to Follow-up|11
1836651|NCT00304915|6360233|P1|Overall Study|Lost to Follow-up|11
1836652|NCT00304356|6360278|P1|Nitazoxanide|Physician Decision|1
1836653|NCT00304356|6360278|P1|Nitazoxanide|Physician Decision|1
1836654|NCT00304356|6360278|P1|Nitazoxanide|Physician Decision|1
1836655|NCT00304356|6360278|P1|Nitazoxanide|number is 0|1
1836656|NCT00304356|6360278|P1|Nitazoxanide|Physician Decision|1
1836657|NCT00304356|6360278|P1|Nitazoxanide|Physician Decision|5
1836658|NCT00304278|6360282|P1|Overall Study|PT had medical condition preventing TX|1
1836659|NCT00304278|6360282|P1|Overall Study|lack of insurance coverage for chemoRT|1
1836660|NCT00304083|6360331|P2|Overall Study|Other|2
1836661|NCT00304083|6360332|P1|Overall Study|Other|5
1836662|NCT00304083|6360331|P2|Overall Study|Disease Progression|1
1836663|NCT00304083|6360332|P1|Overall Study|Disease Progression|5
1836664|NCT00304083|6360331|P2|Overall Study|Physician Decision|3
1836665|NCT00304083|6360332|P1|Overall Study|Physician Decision|8
1836666|NCT00304083|6360331|P2|Overall Study|Withdrawal by Subject|2
1836667|NCT00304083|6360332|P1|Overall Study|Withdrawal by Subject|4
1836668|NCT00304070|6360351|P3|Overall Study|Progressive Disease|4
1836669|NCT00304070|6360352|P2|Overall Study|Progressive Disease|7
1836670|NCT00304070|6360353|P1|Overall Study|Progressive Disease|3
1836671|NCT00304070|6360351|P3|Overall Study|Withdrawal by Subject|1
1836672|NCT00304070|6360352|P2|Overall Study|Withdrawal by Subject|0
1836673|NCT00304070|6360353|P1|Overall Study|Withdrawal by Subject|0
1836674|NCT00304070|6360351|P3|Overall Study|Physician Decision|3
1836675|NCT00304070|6360352|P2|Overall Study|Physician Decision|0
1836676|NCT00304070|6360353|P1|Overall Study|Physician Decision|0
1836677|NCT00304070|6360351|P3|Overall Study|Lost to Follow-up|1
1836678|NCT00304070|6360352|P2|Overall Study|Lost to Follow-up|0
1836679|NCT00304070|6360353|P1|Overall Study|Lost to Follow-up|0
1836680|NCT00304070|6360351|P3|Overall Study|Death|3
1836681|NCT00304070|6360352|P2|Overall Study|Death|0
1836682|NCT00304070|6360353|P1|Overall Study|Death|0
1836683|NCT00304031|6360368|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
1836684|NCT00304031|6360369|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1836685|NCT00304031|6360370|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
1836686|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1836687|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
1836688|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
1836855|NCT00303446|6360661|P1|Overall Study|Death|0
1836689|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1836690|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
1836691|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
1836692|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
1836693|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
1836694|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
1836695|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
1836696|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
1836697|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
1836698|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Death|0
1836699|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Death|0
1836700|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Death|18
1836701|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1836702|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
1836703|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
1836704|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
1836705|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
1836706|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
1836707|NCT00304031|6360368|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1836708|NCT00304031|6360369|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
1836709|NCT00304031|6360370|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
1836710|NCT00304031|6360368|P3|Registration|Ineligible|0
1836711|NCT00304031|6360369|P2|Registration|Ineligible|0
1836712|NCT00304031|6360370|P1|Registration|Ineligible|48
1836713|NCT00303953|6360409|P1|Overall Study|Physician Decision|1
1836714|NCT00303953|6360409|P1|Overall Study|Lack of Efficacy|12
1836715|NCT00303953|6360409|P1|Overall Study|Adverse Event|4
1836716|NCT00303953|6360409|P1|Overall Study|Death|1
1836717|NCT00303953|6360409|P1|Overall Study|Ineligible|1
1836718|NCT00303667|6360444|P2|Overall Study|Death|4
1836719|NCT00303667|6360445|P1|Overall Study|Death|0
1836720|NCT00303628|6360469|P2|Overall Study|Other|9
1836721|NCT00303628|6360470|P1|Overall Study|Other|8
1836722|NCT00303628|6360469|P2|Overall Study|Not start protocol therapy|5
1836723|NCT00303628|6360470|P1|Overall Study|Not start protocol therapy|3
1836724|NCT00303628|6360469|P2|Overall Study|Other complicating disease|1
1836725|NCT00303628|6360470|P1|Overall Study|Other complicating disease|0
1836726|NCT00303628|6360469|P2|Overall Study|Alternative therapy|0
1836727|NCT00303628|6360470|P1|Overall Study|Alternative therapy|2
1836728|NCT00303628|6360469|P2|Overall Study|Withdrawal by Subject|20
1836729|NCT00303628|6360470|P1|Overall Study|Withdrawal by Subject|11
1836730|NCT00303628|6360469|P2|Overall Study|Death|1
1836731|NCT00303628|6360470|P1|Overall Study|Death|0
1836732|NCT00303628|6360469|P2|Overall Study|Adverse Event|36
1836733|NCT00303628|6360470|P1|Overall Study|Adverse Event|26
1836734|NCT00303628|6360469|P2|Overall Study|Disease progression|1
1836735|NCT00303628|6360470|P1|Overall Study|Disease progression|0
1836736|NCT00303602|6360488|P2|Overall Study|Protocol Violation|0
1836737|NCT00303602|6360489|P1|Overall Study|Protocol Violation|1
1836738|NCT00303602|6360488|P2|Overall Study|Noncompliance|2
1836739|NCT00303602|6360489|P1|Overall Study|Noncompliance|2
1836740|NCT00303602|6360488|P2|Overall Study|Physician Decision|1
1836741|NCT00303602|6360489|P1|Overall Study|Physician Decision|2
1836742|NCT00303602|6360488|P2|Overall Study|Protocol entry criteria not met|2
1836743|NCT00303602|6360489|P1|Overall Study|Protocol entry criteria not met|2
1836744|NCT00303602|6360488|P2|Overall Study|Lost to Follow-up|2
1836745|NCT00303602|6360489|P1|Overall Study|Lost to Follow-up|5
1836746|NCT00303602|6360488|P2|Overall Study|Withdrawal by Subject|6
1836747|NCT00303602|6360489|P1|Overall Study|Withdrawal by Subject|5
1836748|NCT00303602|6360488|P2|Overall Study|Adverse Event|2
1836749|NCT00303602|6360489|P1|Overall Study|Adverse Event|2
1836750|NCT00303485|6360535|P2|Overall Study|Withdrawal by Subject|0
1836751|NCT00303485|6360536|P1|Overall Study|Withdrawal by Subject|1
1836752|NCT00303485|6360535|P2|Overall Study|Failure to return|1
1836753|NCT00303485|6360536|P1|Overall Study|Failure to return|0
1836754|NCT00303485|6360535|P2|Overall Study|Adverse Event/Intercurrent Illness|1
1836755|NCT00303485|6360536|P1|Overall Study|Adverse Event/Intercurrent Illness|0
1836756|NCT00303472|6360567|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
1836757|NCT00303472|6360568|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
1836758|NCT00303472|6360569|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
1836759|NCT00303472|6360570|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
1836760|NCT00303472|6360571|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
1836761|NCT00303472|6360572|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
1836762|NCT00303472|6360573|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
1836763|NCT00303472|6360567|P7|Treatment Extension (Optional)|Other|0
1836764|NCT00303472|6360568|P6|Treatment Extension (Optional)|Other|0
1836765|NCT00303472|6360569|P5|Treatment Extension (Optional)|Other|1
1836766|NCT00303472|6360570|P4|Treatment Extension (Optional)|Other|2
1836767|NCT00303472|6360571|P3|Treatment Extension (Optional)|Other|4
1836768|NCT00303472|6360572|P2|Treatment Extension (Optional)|Other|2
1836769|NCT00303472|6360573|P1|Treatment Extension (Optional)|Other|0
1836770|NCT00303472|6360567|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
1836771|NCT00303472|6360568|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
1836772|NCT00303472|6360569|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
1836773|NCT00303472|6360570|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
1836774|NCT00303472|6360571|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
1836775|NCT00303472|6360572|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
1836776|NCT00303472|6360573|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
1836777|NCT00303472|6360567|P7|Treatment Extension (Optional)|Physician Decision|0
1836778|NCT00303472|6360568|P6|Treatment Extension (Optional)|Physician Decision|0
1836779|NCT00303472|6360569|P5|Treatment Extension (Optional)|Physician Decision|2
1836780|NCT00303472|6360570|P4|Treatment Extension (Optional)|Physician Decision|3
1836781|NCT00303472|6360571|P3|Treatment Extension (Optional)|Physician Decision|2
1836782|NCT00303472|6360572|P2|Treatment Extension (Optional)|Physician Decision|4
1836783|NCT00303472|6360573|P1|Treatment Extension (Optional)|Physician Decision|0
1836784|NCT00303472|6360567|P7|Treatment Extension (Optional)|Lost to Follow-up|0
1836785|NCT00303472|6360568|P6|Treatment Extension (Optional)|Lost to Follow-up|0
1836786|NCT00303472|6360569|P5|Treatment Extension (Optional)|Lost to Follow-up|0
1836787|NCT00303472|6360570|P4|Treatment Extension (Optional)|Lost to Follow-up|1
1836788|NCT00303472|6360571|P3|Treatment Extension (Optional)|Lost to Follow-up|0
1836789|NCT00303472|6360572|P2|Treatment Extension (Optional)|Lost to Follow-up|0
1836790|NCT00303472|6360573|P1|Treatment Extension (Optional)|Lost to Follow-up|0
1836791|NCT00303472|6360567|P7|Treatment Extension (Optional)|Death|0
1836792|NCT00303472|6360568|P6|Treatment Extension (Optional)|Death|0
1836793|NCT00303472|6360569|P5|Treatment Extension (Optional)|Death|0
1836794|NCT00303472|6360570|P4|Treatment Extension (Optional)|Death|0
1836795|NCT00303472|6360571|P3|Treatment Extension (Optional)|Death|1
1836796|NCT00303472|6360572|P2|Treatment Extension (Optional)|Death|0
1836797|NCT00303472|6360573|P1|Treatment Extension (Optional)|Death|2
1836798|NCT00303472|6360567|P7|Treatment Extension (Optional)|Adverse Event|0
1836799|NCT00303472|6360568|P6|Treatment Extension (Optional)|Adverse Event|0
1836800|NCT00303472|6360569|P5|Treatment Extension (Optional)|Adverse Event|0
1836801|NCT00303472|6360570|P4|Treatment Extension (Optional)|Adverse Event|0
1836802|NCT00303472|6360571|P3|Treatment Extension (Optional)|Adverse Event|1
1836803|NCT00303472|6360572|P2|Treatment Extension (Optional)|Adverse Event|0
1836804|NCT00303472|6360573|P1|Treatment Extension (Optional)|Adverse Event|1
1836805|NCT00303472|6360567|P7|Treatment Period|Disease Progression (to AML)|0
1836806|NCT00303472|6360568|P6|Treatment Period|Disease Progression (to AML)|0
1836807|NCT00303472|6360569|P5|Treatment Period|Disease Progression (to AML)|1
1836808|NCT00303472|6360570|P4|Treatment Period|Disease Progression (to AML)|0
1836809|NCT00303472|6360571|P3|Treatment Period|Disease Progression (to AML)|0
1836810|NCT00303472|6360572|P2|Treatment Period|Disease Progression (to AML)|0
1836811|NCT00303472|6360573|P1|Treatment Period|Disease Progression (to AML)|0
1836812|NCT00303472|6360567|P7|Treatment Period|Other|1
1836813|NCT00303472|6360568|P6|Treatment Period|Other|0
1836814|NCT00303472|6360569|P5|Treatment Period|Other|1
1836815|NCT00303472|6360570|P4|Treatment Period|Other|0
1836816|NCT00303472|6360571|P3|Treatment Period|Other|0
1836817|NCT00303472|6360572|P2|Treatment Period|Other|0
1836818|NCT00303472|6360573|P1|Treatment Period|Other|0
1836819|NCT00303472|6360567|P7|Treatment Period|Withdrawal by Subject|0
1836820|NCT00303472|6360568|P6|Treatment Period|Withdrawal by Subject|1
1836821|NCT00303472|6360569|P5|Treatment Period|Withdrawal by Subject|0
1836822|NCT00303472|6360570|P4|Treatment Period|Withdrawal by Subject|1
1836823|NCT00303472|6360571|P3|Treatment Period|Withdrawal by Subject|0
1836824|NCT00303472|6360572|P2|Treatment Period|Withdrawal by Subject|0
1836825|NCT00303472|6360573|P1|Treatment Period|Withdrawal by Subject|0
1836826|NCT00303472|6360567|P7|Treatment Period|Death|1
1836827|NCT00303472|6360568|P6|Treatment Period|Death|0
1836828|NCT00303472|6360569|P5|Treatment Period|Death|0
1836829|NCT00303472|6360570|P4|Treatment Period|Death|1
1836830|NCT00303472|6360571|P3|Treatment Period|Death|0
1836831|NCT00303472|6360572|P2|Treatment Period|Death|0
1836832|NCT00303472|6360573|P1|Treatment Period|Death|0
1836833|NCT00303472|6360567|P7|Treatment Period|Adverse Event|0
1836834|NCT00303472|6360568|P6|Treatment Period|Adverse Event|0
1836835|NCT00303472|6360569|P5|Treatment Period|Adverse Event|1
1836836|NCT00303472|6360570|P4|Treatment Period|Adverse Event|0
1836837|NCT00303472|6360571|P3|Treatment Period|Adverse Event|0
1836838|NCT00303472|6360572|P2|Treatment Period|Adverse Event|0
1836839|NCT00303472|6360573|P1|Treatment Period|Adverse Event|0
1836840|NCT00303459|6360633|P2|Overall Study|Lung transplantation|1
1836841|NCT00303459|6360634|P1|Overall Study|Lung transplantation|1
1836842|NCT00303459|6360633|P2|Overall Study|Decision by the investigator|7
1836843|NCT00303459|6360634|P1|Overall Study|Decision by the investigator|5
1836844|NCT00303459|6360633|P2|Overall Study|Administrative reason|7
1836845|NCT00303459|6360634|P1|Overall Study|Administrative reason|7
1836846|NCT00303459|6360633|P2|Overall Study|Lost to Follow-up|4
1836847|NCT00303459|6360634|P1|Overall Study|Lost to Follow-up|5
1836848|NCT00303459|6360633|P2|Overall Study|Withdrawal of consent|26
1836849|NCT00303459|6360634|P1|Overall Study|Withdrawal of consent|32
1836850|NCT00303459|6360633|P2|Overall Study|Death|44
1836851|NCT00303459|6360634|P1|Overall Study|Death|33
1836852|NCT00303446|6360660|P2|Overall Study|Physician Decision|1
1836853|NCT00303446|6360661|P1|Overall Study|Physician Decision|0
1836854|NCT00303446|6360660|P2|Overall Study|Death|1
1836856|NCT00303446|6360660|P2|Overall Study|Withdrawal by Subject|2
1836857|NCT00303446|6360661|P1|Overall Study|Withdrawal by Subject|2
1836858|NCT00303329|6360697|P2|Overall Study|Stopped at end of extension 1|0
1836859|NCT00303329|6360698|P1|Overall Study|Stopped at end of extension 1|1
1836860|NCT00303329|6360697|P2|Overall Study|Stopped at end of core|9
1836861|NCT00303329|6360698|P1|Overall Study|Stopped at end of core|3
1836862|NCT00303329|6360697|P2|Overall Study|Death|12
1836863|NCT00303329|6360698|P1|Overall Study|Death|2
1836864|NCT00303329|6360697|P2|Overall Study|Administrative problems|0
1836865|NCT00303329|6360698|P1|Overall Study|Administrative problems|1
1836866|NCT00303329|6360697|P2|Overall Study|Lost to Follow-up|1
1836867|NCT00303329|6360698|P1|Overall Study|Lost to Follow-up|0
1836868|NCT00303329|6360697|P2|Overall Study|Withdrawal by Subject|15
1836869|NCT00303329|6360698|P1|Overall Study|Withdrawal by Subject|9
1836870|NCT00303329|6360697|P2|Overall Study|Protocol Violation|0
1836871|NCT00303329|6360698|P1|Overall Study|Protocol Violation|3
1836872|NCT00303329|6360697|P2|Overall Study|Condition no longer requires study drug|8
1836873|NCT00303329|6360698|P1|Overall Study|Condition no longer requires study drug|0
1836874|NCT00303329|6360697|P2|Overall Study|Unsatisfactory therapeutic effect|2
1836875|NCT00303329|6360698|P1|Overall Study|Unsatisfactory therapeutic effect|9
1836876|NCT00303329|6360697|P2|Overall Study|Abnormal Laboratory Values|1
1836877|NCT00303329|6360698|P1|Overall Study|Abnormal Laboratory Values|0
1836878|NCT00303329|6360697|P2|Overall Study|Adverse Event|14
1836879|NCT00303329|6360698|P1|Overall Study|Adverse Event|7
1836880|NCT00303316|6360712|P2|Overall Study|Withdrawal by Subject|2
1836881|NCT00303316|6360713|P1|Overall Study|Withdrawal by Subject|1
1836882|NCT00303316|6360712|P2|Overall Study|Lost to Follow-up|1
1836883|NCT00303316|6360713|P1|Overall Study|Lost to Follow-up|0
1836884|NCT00303316|6360712|P2|Overall Study|Protocol Violation|0
1836885|NCT00303316|6360713|P1|Overall Study|Protocol Violation|1
1836886|NCT00303186|6360725|P1|Overall Study|Other|52
1836887|NCT00303108|6360759|P3|Overall Study|ineligible|0
1836888|NCT00303108|6360760|P2|Overall Study|ineligible|1
1836889|NCT00303108|6360761|P1|Overall Study|ineligible|2
1836890|NCT00303108|6360759|P3|Overall Study|Failed Entry|1
1836891|NCT00303108|6360760|P2|Overall Study|Failed Entry|0
1836892|NCT00303108|6360761|P1|Overall Study|Failed Entry|1
1836893|NCT00303108|6360759|P3|Overall Study|Patient Request|8
1836894|NCT00303108|6360760|P2|Overall Study|Patient Request|2
1836895|NCT00303108|6360761|P1|Overall Study|Patient Request|4
1836896|NCT00303108|6360759|P3|Overall Study|Adverse Event|7
1836897|NCT00303108|6360760|P2|Overall Study|Adverse Event|6
1836898|NCT00303108|6360761|P1|Overall Study|Adverse Event|5
1836899|NCT00303069|6360781|P4|Overall Study|Recruitment into Army Reserves|0
1836900|NCT00303069|6360782|P3|Overall Study|Recruitment into Army Reserves|1
1836901|NCT00303069|6360783|P2|Overall Study|Recruitment into Army Reserves|0
1836902|NCT00303069|6360784|P1|Overall Study|Recruitment into Army Reserves|0
1836903|NCT00303069|6360781|P4|Overall Study|subject moved|0
1836904|NCT00303069|6360782|P3|Overall Study|subject moved|0
1836905|NCT00303069|6360783|P2|Overall Study|subject moved|0
1836906|NCT00303069|6360784|P1|Overall Study|subject moved|1
1836907|NCT00303069|6360781|P4|Overall Study|Lost to Follow-up|2
1836908|NCT00303069|6360782|P3|Overall Study|Lost to Follow-up|0
1836909|NCT00303069|6360783|P2|Overall Study|Lost to Follow-up|0
1836910|NCT00303069|6360784|P1|Overall Study|Lost to Follow-up|1
1836911|NCT00302952|6360804|P2|Overall Study|Elevated SGOT (AST) lab value|1
1836912|NCT00302952|6360805|P1|Overall Study|Elevated SGOT (AST) lab value|0
1836913|NCT00302952|6360804|P2|Overall Study|Withdrawal by Subject|3
1836914|NCT00302952|6360805|P1|Overall Study|Withdrawal by Subject|2
1836915|NCT00302952|6360804|P2|Overall Study|Physician Decision|1
1836916|NCT00302952|6360805|P1|Overall Study|Physician Decision|1
1836917|NCT00302731|6360855|P4|Overall Study|cancer unrelated to study discovered|0
1836918|NCT00302731|6360856|P3|Overall Study|cancer unrelated to study discovered|1
1836919|NCT00302731|6360857|P2|Overall Study|cancer unrelated to study discovered|0
1836920|NCT00302731|6360858|P1|Overall Study|cancer unrelated to study discovered|1
1836921|NCT00302731|6360855|P4|Overall Study|Protocol Violation|0
1836922|NCT00302731|6360856|P3|Overall Study|Protocol Violation|0
1836923|NCT00302731|6360857|P2|Overall Study|Protocol Violation|0
1836924|NCT00302731|6360858|P1|Overall Study|Protocol Violation|1
1836925|NCT00302731|6360855|P4|Overall Study|Withdrawal by Subject|0
1836926|NCT00302731|6360856|P3|Overall Study|Withdrawal by Subject|0
1836927|NCT00302731|6360857|P2|Overall Study|Withdrawal by Subject|1
1836928|NCT00302731|6360858|P1|Overall Study|Withdrawal by Subject|1
1836929|NCT00302731|6360855|P4|Overall Study|Adverse Event|0
1836930|NCT00302731|6360856|P3|Overall Study|Adverse Event|2
1836931|NCT00302731|6360857|P2|Overall Study|Adverse Event|2
1836932|NCT00302731|6360858|P1|Overall Study|Adverse Event|0
1836933|NCT00302731|6360855|P4|Overall Study|Lost to Follow-up|0
1836934|NCT00302731|6360856|P3|Overall Study|Lost to Follow-up|0
1836935|NCT00302731|6360857|P2|Overall Study|Lost to Follow-up|2
1836936|NCT00302731|6360858|P1|Overall Study|Lost to Follow-up|1
1836937|NCT00302718|6360884|P4|Overall Study|Participant left primary care setting|1
1836938|NCT00302718|6360885|P3|Overall Study|Participant left primary care setting|2
1836939|NCT00302718|6360886|P2|Overall Study|Participant left primary care setting|0
1836940|NCT00302718|6360887|P1|Overall Study|Participant left primary care setting|0
1836941|NCT00302718|6360884|P4|Overall Study|Withdrawal by Subject|0
1836942|NCT00302718|6360885|P3|Overall Study|Withdrawal by Subject|0
1836943|NCT00302718|6360886|P2|Overall Study|Withdrawal by Subject|1
1836944|NCT00302718|6360887|P1|Overall Study|Withdrawal by Subject|0
1836945|NCT00302718|6360884|P4|Overall Study|Participant left the hospital|1
1836946|NCT00302718|6360885|P3|Overall Study|Participant left the hospital|0
1836947|NCT00302718|6360886|P2|Overall Study|Participant left the hospital|0
1836948|NCT00302718|6360887|P1|Overall Study|Participant left the hospital|1
1836949|NCT00302458|6360953|P1|Overall Study|Withdrawal by Subject|1
1836950|NCT00302458|6360953|P1|Overall Study|Ineligible after screening|1
1836951|NCT00302458|6360953|P1|Overall Study|Lost to Follow-up|1
1836952|NCT00302328|6360964|P3|Overall Study|Physician Decision|0
1836953|NCT00302328|6360965|P2|Overall Study|Physician Decision|1
1836954|NCT00302328|6360966|P1|Overall Study|Physician Decision|0
1836955|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1836956|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
1836957|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1836958|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1836959|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
1836960|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
1836961|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1836962|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1836963|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1836964|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
1836965|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
1836966|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1836967|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1836968|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1836969|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
1836970|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|Death|1
1836971|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|Death|1
1836972|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|Death|0
1836973|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|Death|0
1836974|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|Death|0
1836975|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|Disease progression|2
1836976|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|Disease progression|1
1836977|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|Disease progression|0
1836978|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|Disease progression|0
1836979|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|Disease progression|0
1836980|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
1836981|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
1836982|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
1836983|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
1836984|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
1836985|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|Adverse Event|0
1836986|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|Adverse Event|1
1836987|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|Adverse Event|0
1836988|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|Adverse Event|0
1836989|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|Adverse Event|0
1836990|NCT00302211|6360983|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1836991|NCT00302211|6360984|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
1836992|NCT00302211|6360985|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1836993|NCT00302211|6360986|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1836994|NCT00302211|6360987|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
1836995|NCT00302211|6360983|P5|Double Blind Period (New Patients)|Disease progression|0
1836996|NCT00302211|6360984|P4|Double Blind Period (New Patients)|Disease progression|0
1836997|NCT00302211|6360985|P3|Double Blind Period (New Patients)|Disease progression|1
1836998|NCT00302211|6360986|P2|Double Blind Period (New Patients)|Disease progression|1
1836999|NCT00302211|6360987|P1|Double Blind Period (New Patients)|Disease progression|0
1837000|NCT00302211|6360983|P5|Double Blind Period (New Patients)|Investigator's judgement|0
1837001|NCT00302211|6360984|P4|Double Blind Period (New Patients)|Investigator's judgement|0
1837002|NCT00302211|6360985|P3|Double Blind Period (New Patients)|Investigator's judgement|0
1837003|NCT00302211|6360986|P2|Double Blind Period (New Patients)|Investigator's judgement|0
1837004|NCT00302211|6360987|P1|Double Blind Period (New Patients)|Investigator's judgement|1
1837005|NCT00302211|6360983|P5|Double Blind Period (New Patients)|Adverse Event|0
1837006|NCT00302211|6360984|P4|Double Blind Period (New Patients)|Adverse Event|0
1837007|NCT00302211|6360985|P3|Double Blind Period (New Patients)|Adverse Event|3
1837008|NCT00302211|6360986|P2|Double Blind Period (New Patients)|Adverse Event|0
1837009|NCT00302211|6360987|P1|Double Blind Period (New Patients)|Adverse Event|0
1837010|NCT00302211|6360983|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
1837011|NCT00302211|6360984|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
1837012|NCT00302211|6360985|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
1837013|NCT00302211|6360986|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
1837014|NCT00302211|6360987|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
1837015|NCT00302159|6361013|P1|Overall Study|pt started Avastin|1
1837016|NCT00302159|6361013|P1|Overall Study|pt declined before treatment started|1
1837017|NCT00302107|6361035|P2|Overall Study|Adverse Event|0
1837018|NCT00302107|6361036|P1|Overall Study|Adverse Event|1
1837019|NCT00302107|6361035|P2|Overall Study|Withdrawal by Subject|3
1837020|NCT00302107|6361036|P1|Overall Study|Withdrawal by Subject|0
1837021|NCT00302107|6361035|P2|Overall Study|Relocation|1
1837022|NCT00302107|6361036|P1|Overall Study|Relocation|0
1837023|NCT00302107|6361035|P2|Overall Study|Protocol Violation|0
1837024|NCT00302107|6361036|P1|Overall Study|Protocol Violation|1
1837025|NCT00302107|6361035|P2|Overall Study|Lost to Follow-up|5
1837026|NCT00302107|6361036|P1|Overall Study|Lost to Follow-up|6
1837027|NCT00302081|6361045|P3|Overall Study|Other|5
1837028|NCT00302081|6361046|P2|Overall Study|Other|6
1837029|NCT00302081|6361047|P1|Overall Study|Other|13
1837030|NCT00302081|6361045|P3|Overall Study|Death|0
1837031|NCT00302081|6361046|P2|Overall Study|Death|1
1837032|NCT00302081|6361047|P1|Overall Study|Death|2
1837033|NCT00302081|6361045|P3|Overall Study|Lack of Efficacy|5
1837034|NCT00302081|6361046|P2|Overall Study|Lack of Efficacy|0
1837035|NCT00302081|6361047|P1|Overall Study|Lack of Efficacy|1
1837036|NCT00302081|6361045|P3|Overall Study|Protocol Violation|2
1837037|NCT00302081|6361046|P2|Overall Study|Protocol Violation|1
1837038|NCT00302081|6361047|P1|Overall Study|Protocol Violation|5
1837039|NCT00302081|6361045|P3|Overall Study|Withdrawal by Subject|8
1837040|NCT00302081|6361046|P2|Overall Study|Withdrawal by Subject|12
1837041|NCT00302081|6361047|P1|Overall Study|Withdrawal by Subject|8
1837042|NCT00302081|6361045|P3|Overall Study|Lost to Follow-up|28
1837043|NCT00302081|6361046|P2|Overall Study|Lost to Follow-up|18
1837044|NCT00302081|6361047|P1|Overall Study|Lost to Follow-up|21
1837045|NCT00302081|6361045|P3|Overall Study|Adverse Event|4
1837046|NCT00302081|6361046|P2|Overall Study|Adverse Event|5
1837047|NCT00302081|6361047|P1|Overall Study|Adverse Event|6
1837048|NCT00302003|6361104|P1|Overall Study|Protocol Violation|1
1837049|NCT00302003|6361104|P1|Overall Study|Ineligible|9
1837050|NCT00302003|6361104|P1|Overall Study|Withdrawal by Subject|5
1837051|NCT00302003|6361104|P1|Overall Study|Physician Decision|2
1837052|NCT00302003|6361104|P1|Overall Study|Lost to Follow-up|1
1837053|NCT00302003|6361104|P1|Overall Study|Lack of Efficacy|62
1837054|NCT00301964|6361111|P1|Overall Study|Inadequate pathology|1
1837055|NCT00301964|6361111|P1|Overall Study|Wrong primary|1
1837056|NCT00301964|6361111|P1|Overall Study|Second primary|2
1837057|NCT00301834|6361132|P1|Overall Study|Death|1
1837058|NCT00301821|6361141|P1|Overall Study|Cancel|1
1837059|NCT00301821|6361141|P1|Overall Study|Ineligible|25
1837060|NCT00301808|6361148|P1|Overall Study|Lack of Efficacy|4
1837061|NCT00301808|6361148|P1|Overall Study|Death|3
1837062|NCT00301808|6361148|P1|Overall Study|Adverse Event|5
1837063|NCT00301366|6361173|P1|Overall Study|Adverse Event|1
1837064|NCT00301262|6361179|P2|Open Label Phase (OL)|Other|0
1837065|NCT00301262|6361180|P1|Open Label Phase (OL)|Other|2
1837066|NCT00301262|6361179|P2|Open Label Phase (OL)|Lost to Follow-up|2
1837067|NCT00301262|6361180|P1|Open Label Phase (OL)|Lost to Follow-up|1
1837068|NCT00301262|6361179|P2|Open Label Phase (OL)|Adverse Event|0
1837069|NCT00301262|6361180|P1|Open Label Phase (OL)|Adverse Event|1
1837070|NCT00301262|6361179|P2|Double Blind Phase (DB)|Other|4
1837071|NCT00301262|6361180|P1|Double Blind Phase (DB)|Other|1
1837072|NCT00301262|6361179|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
1837073|NCT00301262|6361180|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
1837074|NCT00301262|6361179|P2|Double Blind Phase (DB)|Lost to Follow-up|3
1837075|NCT00301262|6361180|P1|Double Blind Phase (DB)|Lost to Follow-up|3
1837076|NCT00301262|6361179|P2|Double Blind Phase (DB)|Lack of Efficacy|1
1837077|NCT00301262|6361180|P1|Double Blind Phase (DB)|Lack of Efficacy|0
1837078|NCT00301262|6361179|P2|Double Blind Phase (DB)|Adverse Event|0
1837079|NCT00301262|6361180|P1|Double Blind Phase (DB)|Adverse Event|1
1837080|NCT00301080|6361338|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1837081|NCT00301080|6361339|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1837082|NCT00301080|6361340|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1837083|NCT00301080|6361341|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
1837084|NCT00301080|6361342|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
1837085|NCT00301067|6361371|P4|Follow up Until Death|Alive at last data cut point|1
1837086|NCT00301067|6361372|P3|Follow up Until Death|Alive at last data cut point|0
1837087|NCT00301067|6361373|P2|Follow up Until Death|Alive at last data cut point|0
1837088|NCT00301067|6361374|P1|Follow up Until Death|Alive at last data cut point|1
1837089|NCT00301067|6361371|P4|Completed 12 Cycles of Treatment|Adverse Event|1
1837090|NCT00301067|6361372|P3|Completed 12 Cycles of Treatment|Adverse Event|0
1837091|NCT00301067|6361373|P2|Completed 12 Cycles of Treatment|Adverse Event|0
1837092|NCT00301067|6361374|P1|Completed 12 Cycles of Treatment|Adverse Event|0
1837093|NCT00301067|6361371|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
1837094|NCT00301067|6361372|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
1837095|NCT00301067|6361373|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
1837096|NCT00301067|6361374|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
1837097|NCT00301067|6361371|P4|Completed 4 Cycles of Treatment|Progressive disease|5
1837098|NCT00301067|6361372|P3|Completed 4 Cycles of Treatment|Progressive disease|2
1837099|NCT00301067|6361373|P2|Completed 4 Cycles of Treatment|Progressive disease|1
1837100|NCT00301067|6361374|P1|Completed 4 Cycles of Treatment|Progressive disease|1
1837101|NCT00301067|6361371|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
1837102|NCT00301067|6361372|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
1837103|NCT00301067|6361373|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
1837104|NCT00301067|6361374|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
1837105|NCT00301067|6361371|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
1837106|NCT00301067|6361372|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
1837107|NCT00301067|6361373|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
1837108|NCT00301067|6361374|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
1837109|NCT00300885|6361399|P2|Follow-up|Withdrawal by Subject|25
1837110|NCT00300885|6361400|P1|Follow-up|Withdrawal by Subject|26
1837111|NCT00300885|6361399|P2|Follow-up|Lost to Follow-up|7
1837112|NCT00300885|6361400|P1|Follow-up|Lost to Follow-up|11
1837113|NCT00300885|6361399|P2|Follow-up|Death|163
1837114|NCT00300885|6361400|P1|Follow-up|Death|141
1837115|NCT00300885|6361399|P2|Treatment|Non-compliant with study medication|4
1837116|NCT00300885|6361400|P1|Treatment|Non-compliant with study medication|3
1837117|NCT00300885|6361399|P2|Treatment|Random code broken (subject died)|1
1837118|NCT00300885|6361400|P1|Treatment|Random code broken (subject died)|0
1837119|NCT00300885|6361399|P2|Treatment|Disease progression|238
1837120|NCT00300885|6361400|P1|Treatment|Disease progression|171
1837121|NCT00300885|6361399|P2|Treatment|Withdrawal by Subject|23
1837122|NCT00300885|6361400|P1|Treatment|Withdrawal by Subject|26
1837123|NCT00300885|6361399|P2|Treatment|Protocol Violation|11
1837124|NCT00300885|6361400|P1|Treatment|Protocol Violation|11
1837125|NCT00300885|6361399|P2|Treatment|Physician Decision|5
1837126|NCT00300885|6361400|P1|Treatment|Physician Decision|4
1837127|NCT00300885|6361399|P2|Treatment|Lost to Follow-up|2
1837128|NCT00300885|6361400|P1|Treatment|Lost to Follow-up|3
1837129|NCT00300885|6361399|P2|Treatment|Lack of Efficacy|1
1837130|NCT00300885|6361400|P1|Treatment|Lack of Efficacy|1
1837131|NCT00300885|6361399|P2|Treatment|Death|7
1837132|NCT00300885|6361400|P1|Treatment|Death|20
1837133|NCT00300885|6361399|P2|Treatment|Adverse Event|82
1837134|NCT00300885|6361400|P1|Treatment|Adverse Event|134
1837135|NCT00300781|6361418|P2|Overall Study|Lost to Follow-up|1
1837136|NCT00300781|6361419|P1|Overall Study|Lost to Follow-up|0
1837137|NCT00300781|6361418|P2|Overall Study|Symptomatic Deterioration|0
1837138|NCT00300781|6361419|P1|Overall Study|Symptomatic Deterioration|1
1837139|NCT00300781|6361418|P2|Overall Study|Not Recorded|1
1837140|NCT00300781|6361419|P1|Overall Study|Not Recorded|0
1837141|NCT00300781|6361418|P2|Overall Study|Physician Decision|0
1837142|NCT00300781|6361419|P1|Overall Study|Physician Decision|1
1837143|NCT00300781|6361418|P2|Overall Study|Withdrawal by Subject|2
1837144|NCT00300781|6361419|P1|Overall Study|Withdrawal by Subject|1
1837145|NCT00300781|6361418|P2|Overall Study|Adverse Event|6
1837146|NCT00300781|6361419|P1|Overall Study|Adverse Event|5
1837147|NCT00300781|6361418|P2|Overall Study|Disease Progression|52
1837148|NCT00300781|6361419|P1|Overall Study|Disease Progression|55
1837149|NCT00300755|6361434|P3|Overall Study|Protocol Violation|1
1837150|NCT00300755|6361435|P2|Overall Study|Protocol Violation|0
1837151|NCT00300755|6361436|P1|Overall Study|Protocol Violation|0
1837152|NCT00300755|6361434|P3|Overall Study|Withdrawal by Subject|0
1837153|NCT00300755|6361435|P2|Overall Study|Withdrawal by Subject|2
1837154|NCT00300755|6361436|P1|Overall Study|Withdrawal by Subject|0
1837155|NCT00300755|6361434|P3|Overall Study|Adverse Event|1
1837156|NCT00300755|6361435|P2|Overall Study|Adverse Event|2
1837157|NCT00300755|6361436|P1|Overall Study|Adverse Event|1
1837158|NCT00300495|6361470|P2|Overall Study|Protocol Violation|1
1837159|NCT00300495|6361471|P1|Overall Study|Protocol Violation|4
1837160|NCT00300365|6361738|P2|Overall Study|Adverse Event|2
1837161|NCT00300365|6361739|P1|Overall Study|Adverse Event|0
1837162|NCT00300365|6361738|P2|Overall Study|Withdrawal by Subject|0
1837163|NCT00300365|6361739|P1|Overall Study|Withdrawal by Subject|1
1837164|NCT00300365|6361738|P2|Overall Study|Physician Decision|0
1837165|NCT00300365|6361739|P1|Overall Study|Physician Decision|2
1837166|NCT00300365|6361738|P2|Overall Study|Lost to Follow-up|0
1837167|NCT00300365|6361739|P1|Overall Study|Lost to Follow-up|1
1837168|NCT00300274|6361748|P3|Overall Study|Re-transplant|1
1837169|NCT00300274|6361749|P2|Overall Study|Re-transplant|0
1837170|NCT00300274|6361750|P1|Overall Study|Re-transplant|0
1837171|NCT00300274|6361748|P3|Overall Study|Death|25
1837172|NCT00300274|6361749|P2|Overall Study|Death|20
1837173|NCT00300274|6361750|P1|Overall Study|Death|31
1837174|NCT00300274|6361748|P3|Overall Study|Lost to Follow-up|5
1837175|NCT00300274|6361749|P2|Overall Study|Lost to Follow-up|4
1837176|NCT00300274|6361750|P1|Overall Study|Lost to Follow-up|3
1837177|NCT00300274|6361748|P3|Overall Study|Withdrawal by Subject|14
1837178|NCT00300274|6361749|P2|Overall Study|Withdrawal by Subject|3
1837179|NCT00300274|6361750|P1|Overall Study|Withdrawal by Subject|12
1837180|NCT00299975|6361820|P3|Overall Study|Physician Decision|1
1837181|NCT00299975|6361821|P2|Overall Study|Physician Decision|0
1837182|NCT00299975|6361822|P1|Overall Study|Physician Decision|0
1837183|NCT00299975|6361820|P3|Overall Study|Withdrawal by Subject|3
1837184|NCT00299975|6361821|P2|Overall Study|Withdrawal by Subject|1
1837185|NCT00299975|6361822|P1|Overall Study|Withdrawal by Subject|0
1837186|NCT00299975|6361820|P3|Overall Study|Lost to Follow-up|0
1837187|NCT00299975|6361821|P2|Overall Study|Lost to Follow-up|0
1837188|NCT00299975|6361822|P1|Overall Study|Lost to Follow-up|1
1837189|NCT00299975|6361820|P3|Overall Study|Lack of Efficacy|1
1837190|NCT00299975|6361821|P2|Overall Study|Lack of Efficacy|0
1837191|NCT00299975|6361822|P1|Overall Study|Lack of Efficacy|1
1837192|NCT00299975|6361820|P3|Overall Study|Pregnancy|1
1837193|NCT00299975|6361821|P2|Overall Study|Pregnancy|0
1837194|NCT00299975|6361822|P1|Overall Study|Pregnancy|0
1837195|NCT00299975|6361820|P3|Overall Study|Adverse Event|2
1837196|NCT00299975|6361821|P2|Overall Study|Adverse Event|0
1837197|NCT00299975|6361822|P1|Overall Study|Adverse Event|1
1837198|NCT00299702|6361879|P2|Overall Study|Admin issues, sponsor decision, etc.|9
1837199|NCT00299702|6361880|P1|Overall Study|Admin issues, sponsor decision, etc.|5
1837200|NCT00299702|6361879|P2|Overall Study|Insufficient Response|3
1837201|NCT00299702|6361880|P1|Overall Study|Insufficient Response|4
1837202|NCT00299702|6361879|P2|Overall Study|Pregnancy|1
1837203|NCT00299702|6361880|P1|Overall Study|Pregnancy|0
1837204|NCT00299702|6361879|P2|Overall Study|Withdrawal by Subject|23
1837205|NCT00299702|6361880|P1|Overall Study|Withdrawal by Subject|25
1837206|NCT00299702|6361879|P2|Overall Study|Lost to Follow-up|10
1837207|NCT00299702|6361880|P1|Overall Study|Lost to Follow-up|18
1837208|NCT00299702|6361879|P2|Overall Study|Adverse Event|4
1837209|NCT00299702|6361880|P1|Overall Study|Adverse Event|0
1837210|NCT00299702|6361879|P2|Overall Study|Death|0
1837211|NCT00299702|6361880|P1|Overall Study|Death|1
1837212|NCT00299546|6361895|P3|Overall Study|Not treated|1
1837213|NCT00299546|6361896|P2|Overall Study|Not treated|1
1837214|NCT00299546|6361897|P1|Overall Study|Not treated|0
1837215|NCT00299546|6361895|P3|Overall Study|Other|19
1837216|NCT00299546|6361896|P2|Overall Study|Other|26
1837217|NCT00299546|6361897|P1|Overall Study|Other|24
1837218|NCT00299546|6361895|P3|Overall Study|Unsatisfactory therapeutic effect|34
1837219|NCT00299546|6361896|P2|Overall Study|Unsatisfactory therapeutic effect|39
1837220|NCT00299546|6361897|P1|Overall Study|Unsatisfactory therapeutic effect|34
1837221|NCT00299546|6361895|P3|Overall Study|Adverse Event|27
1837222|NCT00299546|6361896|P2|Overall Study|Adverse Event|22
1837223|NCT00299546|6361897|P1|Overall Study|Adverse Event|37
1837224|NCT00299546|6361895|P3|Overall Study|Lost to Follow-up|5
1837225|NCT00299546|6361896|P2|Overall Study|Lost to Follow-up|2
1837226|NCT00299546|6361897|P1|Overall Study|Lost to Follow-up|2
1837227|NCT00299546|6361895|P3|Overall Study|Death|0
1837228|NCT00299546|6361896|P2|Overall Study|Death|2
1837229|NCT00299546|6361897|P1|Overall Study|Death|3
1837230|NCT00299494|6361928|P6|Overall Study|Other - site closure|1
1837231|NCT00299494|6361929|P5|Overall Study|Other - site closure|1
1837232|NCT00299494|6361930|P4|Overall Study|Other - site closure|1
1837233|NCT00299494|6361931|P3|Overall Study|Other - site closure|0
1837234|NCT00299494|6361932|P2|Overall Study|Other - site closure|0
1837235|NCT00299494|6361933|P1|Overall Study|Other - site closure|0
1837236|NCT00299494|6361928|P6|Overall Study|Other - Unspecified|1
1837237|NCT00299494|6361929|P5|Overall Study|Other - Unspecified|3
1837238|NCT00299494|6361930|P4|Overall Study|Other - Unspecified|0
1837239|NCT00299494|6361931|P3|Overall Study|Other - Unspecified|0
1837240|NCT00299494|6361932|P2|Overall Study|Other - Unspecified|0
1837241|NCT00299494|6361933|P1|Overall Study|Other - Unspecified|0
1837242|NCT00299494|6361928|P6|Overall Study|Lost to Follow-up|1
1837243|NCT00299494|6361929|P5|Overall Study|Lost to Follow-up|3
1837244|NCT00299494|6361930|P4|Overall Study|Lost to Follow-up|0
1837245|NCT00299494|6361931|P3|Overall Study|Lost to Follow-up|0
1837246|NCT00299494|6361932|P2|Overall Study|Lost to Follow-up|0
1837247|NCT00299494|6361933|P1|Overall Study|Lost to Follow-up|0
1837248|NCT00299494|6361928|P6|Overall Study|Death|19
1837249|NCT00299494|6361929|P5|Overall Study|Death|18
1837250|NCT00299494|6361930|P4|Overall Study|Death|6
1837251|NCT00299494|6361931|P3|Overall Study|Death|4
1837252|NCT00299494|6361932|P2|Overall Study|Death|1
1837253|NCT00299494|6361933|P1|Overall Study|Death|3
1837254|NCT00299494|6361928|P6|Overall Study|Physician Decision|0
1837255|NCT00299494|6361929|P5|Overall Study|Physician Decision|1
1837256|NCT00299494|6361930|P4|Overall Study|Physician Decision|0
1837257|NCT00299494|6361931|P3|Overall Study|Physician Decision|0
1837258|NCT00299494|6361932|P2|Overall Study|Physician Decision|0
1837259|NCT00299494|6361933|P1|Overall Study|Physician Decision|0
1837260|NCT00299494|6361928|P6|Overall Study|Withdrawal by Subject|4
1837261|NCT00299494|6361929|P5|Overall Study|Withdrawal by Subject|1
1837262|NCT00299494|6361930|P4|Overall Study|Withdrawal by Subject|3
1837263|NCT00299494|6361931|P3|Overall Study|Withdrawal by Subject|0
1837264|NCT00299494|6361932|P2|Overall Study|Withdrawal by Subject|0
1837265|NCT00299494|6361933|P1|Overall Study|Withdrawal by Subject|0
1837266|NCT00299156|6362062|P3|Period 2 (Randomized)|Screen Failure|0
1837267|NCT00299156|6362063|P2|Period 2 (Randomized)|Screen Failure|1
1837268|NCT00299156|6362064|P1|Period 2 (Randomized)|Screen Failure|0
1837269|NCT00299130|6362075|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
1837270|NCT00299130|6362076|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
1837271|NCT00299130|6362077|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
1837272|NCT00299130|6362075|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1837273|NCT00299130|6362076|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
1837274|NCT00299130|6362077|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
1837275|NCT00299130|6362075|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1837276|NCT00299130|6362076|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
1837277|NCT00299130|6362077|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
1837278|NCT00299130|6362075|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
1837353|NCT00299104|6362182|P3|Treatment Period|Protocol Violation|0
1837279|NCT00299130|6362076|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1837280|NCT00299130|6362077|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
1837281|NCT00299130|6362075|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1837282|NCT00299130|6362076|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
1837283|NCT00299130|6362077|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
1837284|NCT00299130|6362075|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
1837285|NCT00299130|6362076|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
1837286|NCT00299130|6362077|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
1837287|NCT00299130|6362075|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
1837288|NCT00299130|6362076|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1837289|NCT00299130|6362077|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
1837290|NCT00299130|6362075|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
1837291|NCT00299130|6362076|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
1837292|NCT00299130|6362077|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
1837293|NCT00299130|6362075|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1837294|NCT00299130|6362076|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
1837295|NCT00299130|6362077|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
1837296|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1837297|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
1837298|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
1837299|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
1837300|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
1837301|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
1837302|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Failure to Return|6
1837303|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Failure to Return|6
1837304|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Failure to Return|4
1837305|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
1837306|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
1837307|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
1837308|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
1837309|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
1837310|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
1837311|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1837312|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
1837313|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
1837314|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Death|1
1837315|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Death|3
1837316|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Death|1
1837317|NCT00299130|6362075|P3|Treatment Period (up to 5 Years)|Adverse Event|13
1837318|NCT00299130|6362076|P2|Treatment Period (up to 5 Years)|Adverse Event|8
1837319|NCT00299130|6362077|P1|Treatment Period (up to 5 Years)|Adverse Event|13
1837320|NCT00299104|6362182|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1837321|NCT00299104|6362183|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
1837322|NCT00299104|6362184|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
1837323|NCT00299104|6362182|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
1837324|NCT00299104|6362183|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
1837325|NCT00299104|6362184|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
1837326|NCT00299104|6362182|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1837327|NCT00299104|6362183|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1837328|NCT00299104|6362184|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
1837329|NCT00299104|6362182|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
1837330|NCT00299104|6362183|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
1837331|NCT00299104|6362184|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
1837332|NCT00299104|6362182|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
1837333|NCT00299104|6362183|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
1837334|NCT00299104|6362184|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
1837335|NCT00299104|6362182|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
1837336|NCT00299104|6362183|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
1837337|NCT00299104|6362184|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
1837338|NCT00299104|6362182|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
1837339|NCT00299104|6362183|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
1837340|NCT00299104|6362184|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
1837341|NCT00299104|6362182|P3|Safety Follow-Up (SFU) Period|Death|1
1837342|NCT00299104|6362183|P2|Safety Follow-Up (SFU) Period|Death|2
1837343|NCT00299104|6362184|P1|Safety Follow-Up (SFU) Period|Death|3
1837344|NCT00299104|6362182|P3|Treatment Period|Administrative reasons|137
1837345|NCT00299104|6362183|P2|Treatment Period|Administrative reasons|120
1837346|NCT00299104|6362184|P1|Treatment Period|Administrative reasons|106
1837347|NCT00299104|6362182|P3|Treatment Period|Withdrew consent|9
1837348|NCT00299104|6362183|P2|Treatment Period|Withdrew consent|19
1837349|NCT00299104|6362184|P1|Treatment Period|Withdrew consent|14
1837350|NCT00299104|6362182|P3|Treatment Period|Refused treatment|2
1837351|NCT00299104|6362183|P2|Treatment Period|Refused treatment|2
1837352|NCT00299104|6362184|P1|Treatment Period|Refused treatment|9
1837354|NCT00299104|6362183|P2|Treatment Period|Protocol Violation|1
1837355|NCT00299104|6362184|P1|Treatment Period|Protocol Violation|1
1837356|NCT00299104|6362182|P3|Treatment Period|Violation of selection criteria|0
1837357|NCT00299104|6362183|P2|Treatment Period|Violation of selection criteria|2
1837358|NCT00299104|6362184|P1|Treatment Period|Violation of selection criteria|1
1837359|NCT00299104|6362182|P3|Treatment Period|Failure to return|8
1837360|NCT00299104|6362183|P2|Treatment Period|Failure to return|8
1837361|NCT00299104|6362184|P1|Treatment Period|Failure to return|9
1837362|NCT00299104|6362182|P3|Treatment Period|Insufficient therapeutic response|8
1837363|NCT00299104|6362183|P2|Treatment Period|Insufficient therapeutic response|13
1837364|NCT00299104|6362184|P1|Treatment Period|Insufficient therapeutic response|34
1837365|NCT00299104|6362182|P3|Treatment Period|Death|1
1837366|NCT00299104|6362183|P2|Treatment Period|Death|1
1837367|NCT00299104|6362184|P1|Treatment Period|Death|1
1837368|NCT00299104|6362182|P3|Treatment Period|Adverse Event|7
1837369|NCT00299104|6362183|P2|Treatment Period|Adverse Event|9
1837370|NCT00299104|6362184|P1|Treatment Period|Adverse Event|14
1837371|NCT00298896|6362294|P1|Overall Study|Assigned to treatment in error|1
1837372|NCT00298896|6362294|P1|Overall Study|Withdrawal by Subject|2
1837373|NCT00298896|6362294|P1|Overall Study|Disease Progression|41
1837374|NCT00298896|6362294|P1|Overall Study|Intercurrent Illness|1
1837375|NCT00298896|6362294|P1|Overall Study|Physician Decision|2
1837376|NCT00298896|6362294|P1|Overall Study|Death|3
1837377|NCT00298831|6362299|P1|Overall Study|Participants did not receive treatment|27
1837378|NCT00298831|6362299|P1|Overall Study|Withdrawal by Subject|1
1837379|NCT00298831|6362299|P1|Overall Study|Lost to Follow-up|3
1837380|NCT00298831|6362299|P1|Overall Study|Adverse Event|1
1837381|NCT00298766|6362308|P1|Overall Study|Other|4
1837382|NCT00298766|6362308|P1|Overall Study|Subjects overall condition deterioration|4
1837383|NCT00298766|6362308|P1|Overall Study|Deterioration in KPS and organ function|1
1837384|NCT00298766|6362308|P1|Overall Study|Progression of amyloid markers|4
1837385|NCT00298766|6362308|P1|Overall Study|Treatment ongoing|4
1837386|NCT00298766|6362308|P1|Overall Study|Withdrawal by Subject|9
1837387|NCT00298766|6362308|P1|Overall Study|Death|2
1837388|NCT00298766|6362308|P1|Overall Study|Adverse Event|18
1837389|NCT00298740|6362317|P1|Overall Study|Withdrawal by Subject|3
1837390|NCT00298740|6362317|P1|Overall Study|Lack of Efficacy|6
1837391|NCT00298363|6362387|P3|Overall Study|Lack of Efficacy|0
1837392|NCT00298363|6362388|P2|Overall Study|Lack of Efficacy|3
1837393|NCT00298363|6362389|P1|Overall Study|Lack of Efficacy|2
1837394|NCT00298363|6362387|P3|Overall Study|Adverse Event|2
1837395|NCT00298363|6362388|P2|Overall Study|Adverse Event|2
1837396|NCT00298363|6362389|P1|Overall Study|Adverse Event|5
1837397|NCT00298363|6362387|P3|Overall Study|Withdrawal by Subject|3
1837398|NCT00298363|6362388|P2|Overall Study|Withdrawal by Subject|1
1837399|NCT00298363|6362389|P1|Overall Study|Withdrawal by Subject|5
1837400|NCT00298363|6362387|P3|Overall Study|Protocol Violation|0
1837401|NCT00298363|6362388|P2|Overall Study|Protocol Violation|1
1837402|NCT00298363|6362389|P1|Overall Study|Protocol Violation|1
1837403|NCT00298363|6362387|P3|Overall Study|Physician Decision|0
1837404|NCT00298363|6362388|P2|Overall Study|Physician Decision|1
1837405|NCT00298363|6362389|P1|Overall Study|Physician Decision|4
1837406|NCT00298363|6362387|P3|Overall Study|Lost to Follow-up|1
1837407|NCT00298363|6362388|P2|Overall Study|Lost to Follow-up|0
1837408|NCT00298363|6362389|P1|Overall Study|Lost to Follow-up|0
1837409|NCT00298272|6362547|P2|Safety Follow-up Phase|Administrative/Other Reason|1
1837410|NCT00298272|6362548|P1|Safety Follow-up Phase|Administrative/Other Reason|1
1837411|NCT00298272|6362547|P2|Safety Follow-up Phase|Withdrawal by Subject|2
1837412|NCT00298272|6362548|P1|Safety Follow-up Phase|Withdrawal by Subject|2
1837413|NCT00298272|6362547|P2|Safety Follow-up Phase|Failure to Return|1
1837414|NCT00298272|6362548|P1|Safety Follow-up Phase|Failure to Return|1
1837415|NCT00298272|6362547|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
1837416|NCT00298272|6362548|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
1837417|NCT00298272|6362547|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
1837418|NCT00298272|6362548|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
1837419|NCT00298272|6362547|P2|Open Label Retreatment Phase|Protocol Violation|1
1837420|NCT00298272|6362548|P1|Open Label Retreatment Phase|Protocol Violation|2
1837421|NCT00298272|6362547|P2|Open Label Retreatment Phase|Failure to Return|0
1837422|NCT00298272|6362548|P1|Open Label Retreatment Phase|Failure to Return|1
1837423|NCT00298272|6362547|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
1837424|NCT00298272|6362548|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
1837425|NCT00298272|6362547|P2|Open Label Retreatment Phase|Adverse Event|2
1837426|NCT00298272|6362548|P1|Open Label Retreatment Phase|Adverse Event|1
1837427|NCT00298272|6362547|P2|Double-blind Phase|Withdrawal by Subject|0
1837428|NCT00298272|6362548|P1|Double-blind Phase|Withdrawal by Subject|2
1837429|NCT00298272|6362547|P2|Double-blind Phase|Protocol Violation|0
1837430|NCT00298272|6362548|P1|Double-blind Phase|Protocol Violation|2
1837431|NCT00298272|6362547|P2|Double-blind Phase|Failure to Return|0
1837432|NCT00298272|6362548|P1|Double-blind Phase|Failure to Return|2
1837433|NCT00298272|6362547|P2|Double-blind Phase|Adverse Event|0
1837434|NCT00298272|6362548|P1|Double-blind Phase|Adverse Event|2
1837435|NCT00298038|6362612|P2|Overall Study|Severe Gastrointestinal Bleed|0
1837436|NCT00298038|6362613|P1|Overall Study|Severe Gastrointestinal Bleed|1
1837437|NCT00298038|6362612|P2|Overall Study|Cocaine Abuse|0
1837438|NCT00298038|6362613|P1|Overall Study|Cocaine Abuse|1
1837439|NCT00298038|6362612|P2|Overall Study|Noncompliance|0
1837440|NCT00298038|6362613|P1|Overall Study|Noncompliance|1
1837441|NCT00298038|6362612|P2|Overall Study|Breakthrough overt HE episode|69
1837442|NCT00298038|6362613|P1|Overall Study|Breakthrough overt HE episode|28
1837443|NCT00298038|6362612|P2|Overall Study|Adverse Event|7
1837444|NCT00298038|6362613|P1|Overall Study|Adverse Event|8
1837445|NCT00298038|6362612|P2|Overall Study|Withdrawal by Subject|9
1837446|NCT00298038|6362613|P1|Overall Study|Withdrawal by Subject|6
1837447|NCT00298038|6362612|P2|Overall Study|Death|3
1837448|NCT00298038|6362613|P1|Overall Study|Death|6
1837449|NCT00298038|6362612|P2|Overall Study|Protocol Violation|3
1837450|NCT00298038|6362613|P1|Overall Study|Protocol Violation|1
1837451|NCT00298038|6362612|P2|Overall Study|Liver Transplant|1
1837452|NCT00298038|6362613|P1|Overall Study|Liver Transplant|0
1837453|NCT00298038|6362612|P2|Overall Study|Lost to Follow-up|1
1837454|NCT00298038|6362613|P1|Overall Study|Lost to Follow-up|0
1837455|NCT00297830|6362632|P3|12 Month Visit|Withdrawal by Subject|0
1837456|NCT00297830|6362633|P2|12 Month Visit|Withdrawal by Subject|3
1837457|NCT00297830|6362634|P1|12 Month Visit|Withdrawal by Subject|0
1837458|NCT00297830|6362632|P3|12 Month Visit|Adverse Event|0
1837459|NCT00297830|6362633|P2|12 Month Visit|Adverse Event|3
1837460|NCT00297830|6362634|P1|12 Month Visit|Adverse Event|0
1837461|NCT00297830|6362632|P3|12 Month Visit|Lost to Follow-up|0
1837462|NCT00297830|6362633|P2|12 Month Visit|Lost to Follow-up|0
1837463|NCT00297830|6362634|P1|12 Month Visit|Lost to Follow-up|1
1837464|NCT00297830|6362632|P3|6 Month Visit|Adverse Event|0
1837465|NCT00297830|6362633|P2|6 Month Visit|Adverse Event|1
1837466|NCT00297830|6362634|P1|6 Month Visit|Adverse Event|0
1837467|NCT00297830|6362632|P3|6 Month Visit|Withdrawal by Subject|1
1837468|NCT00297830|6362633|P2|6 Month Visit|Withdrawal by Subject|1
1837469|NCT00297830|6362634|P1|6 Month Visit|Withdrawal by Subject|2
1837470|NCT00297830|6362632|P3|6 Month Visit|Death|2
1837471|NCT00297830|6362633|P2|6 Month Visit|Death|0
1837472|NCT00297830|6362634|P1|6 Month Visit|Death|1
1837473|NCT00297778|6362653|P2|Overall Study|Other|1
1837474|NCT00297778|6362654|P1|Overall Study|Other|0
1837475|NCT00297778|6362653|P2|Overall Study|Non-compliant with trial protocol|3
1837476|NCT00297778|6362654|P1|Overall Study|Non-compliant with trial protocol|0
1837477|NCT00297778|6362653|P2|Overall Study|Lack of Efficacy|1
1837478|NCT00297778|6362654|P1|Overall Study|Lack of Efficacy|2
1837479|NCT00297778|6362653|P2|Overall Study|Withdrawal by Subject|5
1837480|NCT00297778|6362654|P1|Overall Study|Withdrawal by Subject|1
1837481|NCT00297778|6362653|P2|Overall Study|Adverse Event|10
1837482|NCT00297778|6362654|P1|Overall Study|Adverse Event|16
1837483|NCT00297648|6362688|P1|Overall Study|Other: Incompliance|1
1837484|NCT00297648|6362688|P1|Overall Study|Withdrawal by Subject|3
1837485|NCT00297648|6362688|P1|Overall Study|Lost to Follow-up|1
1837486|NCT00297648|6362688|P1|Overall Study|Lack of Efficacy|18
1837487|NCT00297648|6362688|P1|Overall Study|Adverse Event|13
1837488|NCT00297492|6362734|P3|6 Month Follow-up|Lost to Follow-up|27
1837489|NCT00297492|6362735|P2|6 Month Follow-up|Lost to Follow-up|49
1837490|NCT00297492|6362736|P1|6 Month Follow-up|Lost to Follow-up|63
1837491|NCT00297492|6362734|P3|Set Quit Date|Lost to Follow-up|5
1837492|NCT00297492|6362735|P2|Set Quit Date|Lost to Follow-up|13
1837493|NCT00297492|6362736|P1|Set Quit Date|Lost to Follow-up|7
1837494|NCT00297427|6362746|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
1837495|NCT00297427|6362747|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
1837496|NCT00297427|6362746|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
1837497|NCT00297427|6362747|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
1837498|NCT00297427|6362746|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
1837499|NCT00297427|6362747|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
1837500|NCT00297427|6362746|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
1837501|NCT00297427|6362747|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
1837502|NCT00297427|6362746|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
1837503|NCT00297427|6362747|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
1837504|NCT00297427|6362746|P2|Phase 1: Initial Intervention|Death|1
1837505|NCT00297427|6362747|P1|Phase 1: Initial Intervention|Death|0
1837506|NCT00297427|6362746|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
1837507|NCT00297427|6362747|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
1837508|NCT00297427|6362746|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
1837509|NCT00297427|6362747|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
1837510|NCT00297258|6362788|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
1837511|NCT00297258|6362788|P1|Overall Study|Switch to Commercial Treatment|1
1837512|NCT00297258|6362788|P1|Overall Study|Surgery Performed on Target Lesion|1
1837513|NCT00297258|6362788|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
1837514|NCT00297258|6362788|P1|Overall Study|Deteriorization of General Condition|1
1837515|NCT00297258|6362788|P1|Overall Study|Intercurrent Death|2
1837516|NCT00297258|6362788|P1|Overall Study|Intercurrent Illness|3
1837517|NCT00297258|6362788|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
1837518|NCT00297258|6362788|P1|Overall Study|Toxicity (or Toxic Death)|10
1837519|NCT00297258|6362788|P1|Overall Study|Disease Progression, Relapse, Death|120
1837520|NCT00297232|6362807|P1|Overall Study|Other|1
1837521|NCT00297232|6362807|P1|Overall Study|No data available after Week 264|161
1837522|NCT00297232|6362807|P1|Overall Study|Did Not Enroll to Week 480|17
1837523|NCT00297232|6362807|P1|Overall Study|Did Not Enroll to Week 264|34
1837524|NCT00297232|6362807|P1|Overall Study|Investigator Withdrew From Program|19
1837525|NCT00297232|6362807|P1|Overall Study|Persistently Positive Antibodies|11
1837526|NCT00297232|6362807|P1|Overall Study|Subject Withdrew Consent|37
1837527|NCT00297232|6362807|P1|Overall Study|Subject Relocated|7
1837528|NCT00297232|6362807|P1|Overall Study|Sponsor Decision|34
1837529|NCT00297232|6362807|P1|Overall Study|Miscellaneous|5
1837530|NCT00297232|6362807|P1|Overall Study|Anti-JCV Antibody Positive|13
1837531|NCT00297232|6362807|P1|Overall Study|Fear of PML|10
1837532|NCT00297232|6362807|P1|Overall Study|Disease Progression|8
1837533|NCT00297232|6362807|P1|Overall Study|Switched to Commercial Tysabri|22
1837534|NCT00297232|6362807|P1|Overall Study|Anti-natalizumab Positive|8
1837535|NCT00297232|6362807|P1|Overall Study|Death|9
1837536|NCT00297232|6362807|P1|Overall Study|Subject was Noncompliant|9
1837537|NCT00297232|6362807|P1|Overall Study|Voluntary Withdrawal|120
1837538|NCT00297232|6362807|P1|Overall Study|Adverse Event|63
1837539|NCT00297232|6362807|P1|Overall Study|Lost to Follow-up|10
1837540|NCT00297232|6362807|P1|Overall Study|Lack of Efficacy|7
1837541|NCT00297167|6362813|P3|Second Double-blind Intervention Period|Protocol Violation|0
1837542|NCT00297167|6362814|P2|Second Double-blind Intervention Period|Protocol Violation|0
1837543|NCT00297167|6362815|P1|Second Double-blind Intervention Period|Protocol Violation|1
1837544|NCT00297167|6362813|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
1837545|NCT00297167|6362814|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1837546|NCT00297167|6362815|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
1837547|NCT00297037|6362879|P2|Overall Study|Withdrawal by Subject|0
1837548|NCT00297037|6362880|P1|Overall Study|Withdrawal by Subject|2
1837549|NCT00296816|6362892|P1|Overall Study|ineligibility due to radiation treatment|1
1837550|NCT00296816|6362892|P1|Overall Study|Proteinuria|1
1837551|NCT00296816|6362892|P1|Overall Study|Neuropathy/patient preference|1
1837552|NCT00296816|6362892|P1|Overall Study|Urine protein/creatinine ratio delay|1
1837553|NCT00296816|6362892|P1|Overall Study|Noncompliance/decision to discontinue|1
1837554|NCT00296816|6362892|P1|Overall Study|Relocation to Florida|1
1837555|NCT00296816|6362892|P1|Overall Study|Poor performance status|1
1837556|NCT00296816|6362892|P1|Overall Study|Progression based on CA-125 (biomarker)|2
1837557|NCT00296816|6362892|P1|Overall Study|Missing for end of treatment|4
1837558|NCT00296816|6362892|P1|Overall Study|Non-compliance|1
1837559|NCT00296816|6362892|P1|Overall Study|Investigator/Participant request|5
1837560|NCT00296816|6362892|P1|Overall Study|Adverse Event|18
1837561|NCT00296816|6362892|P1|Overall Study|Disease Progression|37
1837562|NCT00296725|6362904|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
1837563|NCT00296725|6362904|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
1837564|NCT00296725|6362904|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
1837565|NCT00296647|6362917|P5|Overall Study|Withdrawal by Subject|19
1837566|NCT00296647|6362918|P4|Overall Study|Withdrawal by Subject|16
1837567|NCT00296647|6362919|P3|Overall Study|Withdrawal by Subject|32
1837568|NCT00296647|6362920|P2|Overall Study|Withdrawal by Subject|27
1837569|NCT00296647|6362921|P1|Overall Study|Withdrawal by Subject|28
1837570|NCT00296647|6362917|P5|Overall Study|Death|1
1837571|NCT00296647|6362918|P4|Overall Study|Death|1
1837572|NCT00296647|6362919|P3|Overall Study|Death|2
1837573|NCT00296647|6362920|P2|Overall Study|Death|1
1837574|NCT00296647|6362921|P1|Overall Study|Death|4
1837575|NCT00296517|6362935|P2|Dose Level 3 - Weeks 3-12|Other|2
1837576|NCT00296517|6362936|P1|Dose Level 3 - Weeks 3-12|Other|0
1837577|NCT00296517|6362935|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
1837578|NCT00296517|6362936|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
1837579|NCT00296517|6362935|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
1837580|NCT00296517|6362936|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
1837581|NCT00296517|6362935|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
1837582|NCT00296517|6362936|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
1837583|NCT00296517|6362935|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
1837584|NCT00296517|6362936|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
1837585|NCT00296517|6362935|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
1837586|NCT00296517|6362936|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
1837587|NCT00296517|6362935|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
1837588|NCT00296517|6362936|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
1837589|NCT00296517|6362935|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
1837590|NCT00296517|6362936|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
1837591|NCT00296517|6362935|P2|Dose Level 2 - Week 2|Adverse Event|5
1837592|NCT00296517|6362936|P1|Dose Level 2 - Week 2|Adverse Event|1
1837593|NCT00296504|6362972|P9|Final Analysis|Poor Adherence|1
1837594|NCT00296504|6362973|P8|Final Analysis|Poor Adherence|0
1837595|NCT00296504|6362974|P7|Final Analysis|Poor Adherence|0
1837596|NCT00296504|6362975|P6|Final Analysis|Poor Adherence|0
1837597|NCT00296504|6362976|P5|Final Analysis|Poor Adherence|0
1837598|NCT00296504|6362977|P4|Final Analysis|Poor Adherence|0
1837599|NCT00296504|6362978|P3|Final Analysis|Poor Adherence|0
1837600|NCT00296504|6362979|P2|Final Analysis|Poor Adherence|0
1837601|NCT00296504|6362980|P1|Final Analysis|Poor Adherence|0
1837602|NCT00296504|6362972|P9|Final Analysis|Participant Moved to Another Country|1
1837603|NCT00296504|6362973|P8|Final Analysis|Participant Moved to Another Country|0
1837604|NCT00296504|6362974|P7|Final Analysis|Participant Moved to Another Country|0
1837605|NCT00296504|6362975|P6|Final Analysis|Participant Moved to Another Country|0
1837606|NCT00296504|6362976|P5|Final Analysis|Participant Moved to Another Country|0
1837607|NCT00296504|6362977|P4|Final Analysis|Participant Moved to Another Country|0
1837608|NCT00296504|6362978|P3|Final Analysis|Participant Moved to Another Country|0
1837609|NCT00296504|6362979|P2|Final Analysis|Participant Moved to Another Country|0
1837610|NCT00296504|6362980|P1|Final Analysis|Participant Moved to Another Country|0
1837611|NCT00296504|6362972|P9|Final Analysis|Tuberculosis|1
1837612|NCT00296504|6362973|P8|Final Analysis|Tuberculosis|0
1837613|NCT00296504|6362974|P7|Final Analysis|Tuberculosis|0
1837614|NCT00296504|6362975|P6|Final Analysis|Tuberculosis|0
1837615|NCT00296504|6362976|P5|Final Analysis|Tuberculosis|0
1837616|NCT00296504|6362977|P4|Final Analysis|Tuberculosis|0
1837617|NCT00296504|6362978|P3|Final Analysis|Tuberculosis|0
1837618|NCT00296504|6362979|P2|Final Analysis|Tuberculosis|0
1837619|NCT00296504|6362980|P1|Final Analysis|Tuberculosis|0
1837620|NCT00296504|6362972|P9|Final Analysis|Pregnancy|4
1837621|NCT00296504|6362973|P8|Final Analysis|Pregnancy|0
1837622|NCT00296504|6362974|P7|Final Analysis|Pregnancy|0
1837623|NCT00296504|6362975|P6|Final Analysis|Pregnancy|0
1837624|NCT00296504|6362976|P5|Final Analysis|Pregnancy|0
1837625|NCT00296504|6362977|P4|Final Analysis|Pregnancy|0
1837626|NCT00296504|6362978|P3|Final Analysis|Pregnancy|0
1837627|NCT00296504|6362979|P2|Final Analysis|Pregnancy|0
1837628|NCT00296504|6362980|P1|Final Analysis|Pregnancy|0
1837629|NCT00296504|6362972|P9|Final Analysis|Adverse Event|2
1837630|NCT00296504|6362973|P8|Final Analysis|Adverse Event|0
1837631|NCT00296504|6362974|P7|Final Analysis|Adverse Event|0
1837632|NCT00296504|6362975|P6|Final Analysis|Adverse Event|0
1837633|NCT00296504|6362976|P5|Final Analysis|Adverse Event|0
1837634|NCT00296504|6362977|P4|Final Analysis|Adverse Event|0
1837635|NCT00296504|6362978|P3|Final Analysis|Adverse Event|0
1837636|NCT00296504|6362979|P2|Final Analysis|Adverse Event|0
1837637|NCT00296504|6362980|P1|Final Analysis|Adverse Event|0
1837638|NCT00296504|6362972|P9|Final Analysis|Insufficient Viral Load Response|6
1837639|NCT00296504|6362973|P8|Final Analysis|Insufficient Viral Load Response|0
1837640|NCT00296504|6362974|P7|Final Analysis|Insufficient Viral Load Response|0
1837641|NCT00296504|6362975|P6|Final Analysis|Insufficient Viral Load Response|0
1837642|NCT00296504|6362976|P5|Final Analysis|Insufficient Viral Load Response|0
1837643|NCT00296504|6362977|P4|Final Analysis|Insufficient Viral Load Response|0
1837644|NCT00296504|6362978|P3|Final Analysis|Insufficient Viral Load Response|0
1837645|NCT00296504|6362979|P2|Final Analysis|Insufficient Viral Load Response|0
1837646|NCT00296504|6362980|P1|Final Analysis|Insufficient Viral Load Response|0
1837647|NCT00296504|6362972|P9|Final Analysis|Lost to Follow-up|5
1837648|NCT00296504|6362973|P8|Final Analysis|Lost to Follow-up|0
1837649|NCT00296504|6362974|P7|Final Analysis|Lost to Follow-up|0
1837650|NCT00296504|6362975|P6|Final Analysis|Lost to Follow-up|0
1837651|NCT00296504|6362976|P5|Final Analysis|Lost to Follow-up|0
1837652|NCT00296504|6362977|P4|Final Analysis|Lost to Follow-up|0
1837653|NCT00296504|6362978|P3|Final Analysis|Lost to Follow-up|0
1837654|NCT00296504|6362979|P2|Final Analysis|Lost to Follow-up|0
1837655|NCT00296504|6362980|P1|Final Analysis|Lost to Follow-up|0
1837656|NCT00296504|6362972|P9|Final Analysis|Withdrawal by Subject|1
1837657|NCT00296504|6362973|P8|Final Analysis|Withdrawal by Subject|0
1837658|NCT00296504|6362974|P7|Final Analysis|Withdrawal by Subject|0
1837659|NCT00296504|6362975|P6|Final Analysis|Withdrawal by Subject|0
1837660|NCT00296504|6362976|P5|Final Analysis|Withdrawal by Subject|0
1837661|NCT00296504|6362977|P4|Final Analysis|Withdrawal by Subject|0
1837662|NCT00296504|6362978|P3|Final Analysis|Withdrawal by Subject|0
1837663|NCT00296504|6362979|P2|Final Analysis|Withdrawal by Subject|0
1837664|NCT00296504|6362980|P1|Final Analysis|Withdrawal by Subject|0
1837665|NCT00296504|6362972|P9|Interim Analysis|Ongoing|0
1837666|NCT00296504|6362973|P8|Interim Analysis|Ongoing|1
1837667|NCT00296504|6362974|P7|Interim Analysis|Ongoing|30
1837668|NCT00296504|6362975|P6|Interim Analysis|Ongoing|0
1837669|NCT00296504|6362976|P5|Interim Analysis|Ongoing|0
1837670|NCT00296504|6362977|P4|Interim Analysis|Ongoing|22
1837671|NCT00296504|6362978|P3|Interim Analysis|Ongoing|16
1837672|NCT00296504|6362979|P2|Interim Analysis|Ongoing|12
1837673|NCT00296504|6362980|P1|Interim Analysis|Ongoing|32
1837674|NCT00296504|6362972|P9|Interim Analysis|Participant Needed Interferon|0
1837675|NCT00296504|6362973|P8|Interim Analysis|Participant Needed Interferon|1
1837676|NCT00296504|6362974|P7|Interim Analysis|Participant Needed Interferon|0
1837677|NCT00296504|6362975|P6|Interim Analysis|Participant Needed Interferon|0
1837678|NCT00296504|6362976|P5|Interim Analysis|Participant Needed Interferon|0
1837679|NCT00296504|6362977|P4|Interim Analysis|Participant Needed Interferon|0
1837680|NCT00296504|6362978|P3|Interim Analysis|Participant Needed Interferon|0
1837681|NCT00296504|6362979|P2|Interim Analysis|Participant Needed Interferon|0
1837682|NCT00296504|6362980|P1|Interim Analysis|Participant Needed Interferon|0
1837683|NCT00296504|6362972|P9|Interim Analysis|Study Ended|0
1837684|NCT00296504|6362973|P8|Interim Analysis|Study Ended|0
1837685|NCT00296504|6362974|P7|Interim Analysis|Study Ended|1
1837686|NCT00296504|6362975|P6|Interim Analysis|Study Ended|0
1837687|NCT00296504|6362976|P5|Interim Analysis|Study Ended|0
1837688|NCT00296504|6362977|P4|Interim Analysis|Study Ended|0
1837689|NCT00296504|6362978|P3|Interim Analysis|Study Ended|0
1837690|NCT00296504|6362979|P2|Interim Analysis|Study Ended|0
1837691|NCT00296504|6362980|P1|Interim Analysis|Study Ended|0
1837692|NCT00296504|6362972|P9|Interim Analysis|Participant Stopped HIV Medications|0
1837693|NCT00296504|6362973|P8|Interim Analysis|Participant Stopped HIV Medications|0
1837694|NCT00296504|6362974|P7|Interim Analysis|Participant Stopped HIV Medications|1
1837695|NCT00296504|6362975|P6|Interim Analysis|Participant Stopped HIV Medications|0
1837696|NCT00296504|6362976|P5|Interim Analysis|Participant Stopped HIV Medications|0
1837697|NCT00296504|6362977|P4|Interim Analysis|Participant Stopped HIV Medications|0
1837698|NCT00296504|6362978|P3|Interim Analysis|Participant Stopped HIV Medications|0
1837699|NCT00296504|6362979|P2|Interim Analysis|Participant Stopped HIV Medications|0
1837700|NCT00296504|6362980|P1|Interim Analysis|Participant Stopped HIV Medications|0
1837701|NCT00296504|6362972|P9|Interim Analysis|Physician and Participant Decision|0
1837702|NCT00296504|6362973|P8|Interim Analysis|Physician and Participant Decision|0
1837703|NCT00296504|6362974|P7|Interim Analysis|Physician and Participant Decision|0
1837704|NCT00296504|6362975|P6|Interim Analysis|Physician and Participant Decision|1
1837705|NCT00296504|6362976|P5|Interim Analysis|Physician and Participant Decision|0
1837706|NCT00296504|6362977|P4|Interim Analysis|Physician and Participant Decision|0
1837707|NCT00296504|6362978|P3|Interim Analysis|Physician and Participant Decision|0
1837708|NCT00296504|6362979|P2|Interim Analysis|Physician and Participant Decision|0
1837709|NCT00296504|6362980|P1|Interim Analysis|Physician and Participant Decision|0
1837710|NCT00296504|6362972|P9|Interim Analysis|Participant Stopped|0
1837711|NCT00296504|6362973|P8|Interim Analysis|Participant Stopped|0
1837712|NCT00296504|6362974|P7|Interim Analysis|Participant Stopped|0
1837713|NCT00296504|6362975|P6|Interim Analysis|Participant Stopped|0
1837714|NCT00296504|6362976|P5|Interim Analysis|Participant Stopped|1
1837715|NCT00296504|6362977|P4|Interim Analysis|Participant Stopped|0
1837716|NCT00296504|6362978|P3|Interim Analysis|Participant Stopped|0
1837717|NCT00296504|6362979|P2|Interim Analysis|Participant Stopped|0
1837718|NCT00296504|6362980|P1|Interim Analysis|Participant Stopped|0
1837719|NCT00296504|6362972|P9|Interim Analysis|Inclusion in Other Protocol|0
1837720|NCT00296504|6362973|P8|Interim Analysis|Inclusion in Other Protocol|0
1837721|NCT00296504|6362974|P7|Interim Analysis|Inclusion in Other Protocol|0
1837722|NCT00296504|6362975|P6|Interim Analysis|Inclusion in Other Protocol|0
1837723|NCT00296504|6362976|P5|Interim Analysis|Inclusion in Other Protocol|0
1837724|NCT00296504|6362977|P4|Interim Analysis|Inclusion in Other Protocol|1
1837725|NCT00296504|6362978|P3|Interim Analysis|Inclusion in Other Protocol|0
1837726|NCT00296504|6362979|P2|Interim Analysis|Inclusion in Other Protocol|0
1837727|NCT00296504|6362980|P1|Interim Analysis|Inclusion in Other Protocol|0
1837728|NCT00296504|6362972|P9|Interim Analysis|Missed Schedule Date|0
1837729|NCT00296504|6362973|P8|Interim Analysis|Missed Schedule Date|0
1837730|NCT00296504|6362974|P7|Interim Analysis|Missed Schedule Date|0
1837731|NCT00296504|6362975|P6|Interim Analysis|Missed Schedule Date|0
1837732|NCT00296504|6362976|P5|Interim Analysis|Missed Schedule Date|0
1837733|NCT00296504|6362977|P4|Interim Analysis|Missed Schedule Date|0
1837734|NCT00296504|6362978|P3|Interim Analysis|Missed Schedule Date|0
1837735|NCT00296504|6362979|P2|Interim Analysis|Missed Schedule Date|0
1837736|NCT00296504|6362980|P1|Interim Analysis|Missed Schedule Date|1
1837737|NCT00296504|6362972|P9|Interim Analysis|Lack of Personnel at Site|0
1837738|NCT00296504|6362973|P8|Interim Analysis|Lack of Personnel at Site|0
1837739|NCT00296504|6362974|P7|Interim Analysis|Lack of Personnel at Site|0
1837740|NCT00296504|6362975|P6|Interim Analysis|Lack of Personnel at Site|0
1837741|NCT00296504|6362976|P5|Interim Analysis|Lack of Personnel at Site|0
1837742|NCT00296504|6362977|P4|Interim Analysis|Lack of Personnel at Site|0
1837743|NCT00296504|6362978|P3|Interim Analysis|Lack of Personnel at Site|0
1837744|NCT00296504|6362979|P2|Interim Analysis|Lack of Personnel at Site|0
1837745|NCT00296504|6362980|P1|Interim Analysis|Lack of Personnel at Site|1
1837746|NCT00296504|6362972|P9|Interim Analysis|Site Closing|0
1837747|NCT00296504|6362973|P8|Interim Analysis|Site Closing|0
1837748|NCT00296504|6362974|P7|Interim Analysis|Site Closing|2
1837749|NCT00296504|6362975|P6|Interim Analysis|Site Closing|1
1837750|NCT00296504|6362976|P5|Interim Analysis|Site Closing|0
1837751|NCT00296504|6362977|P4|Interim Analysis|Site Closing|0
1837752|NCT00296504|6362978|P3|Interim Analysis|Site Closing|0
1837753|NCT00296504|6362979|P2|Interim Analysis|Site Closing|0
1837754|NCT00296504|6362980|P1|Interim Analysis|Site Closing|1
1837755|NCT00296504|6362972|P9|Interim Analysis|Non-adherence|0
1837756|NCT00296504|6362973|P8|Interim Analysis|Non-adherence|1
1837757|NCT00296504|6362974|P7|Interim Analysis|Non-adherence|0
1837758|NCT00296504|6362975|P6|Interim Analysis|Non-adherence|0
1837759|NCT00296504|6362976|P5|Interim Analysis|Non-adherence|1
1837760|NCT00296504|6362977|P4|Interim Analysis|Non-adherence|0
1837761|NCT00296504|6362978|P3|Interim Analysis|Non-adherence|0
1837762|NCT00296504|6362979|P2|Interim Analysis|Non-adherence|0
1837763|NCT00296504|6362980|P1|Interim Analysis|Non-adherence|2
1837764|NCT00296504|6362972|P9|Interim Analysis|Principle Investigator Terminated Study|0
1837765|NCT00296504|6362973|P8|Interim Analysis|Principle Investigator Terminated Study|0
1837766|NCT00296504|6362974|P7|Interim Analysis|Principle Investigator Terminated Study|0
1837767|NCT00296504|6362975|P6|Interim Analysis|Principle Investigator Terminated Study|0
1837768|NCT00296504|6362976|P5|Interim Analysis|Principle Investigator Terminated Study|0
1837769|NCT00296504|6362977|P4|Interim Analysis|Principle Investigator Terminated Study|0
1837770|NCT00296504|6362978|P3|Interim Analysis|Principle Investigator Terminated Study|1
1837771|NCT00296504|6362979|P2|Interim Analysis|Principle Investigator Terminated Study|0
1837772|NCT00296504|6362980|P1|Interim Analysis|Principle Investigator Terminated Study|0
1837773|NCT00296504|6362972|P9|Interim Analysis|Principle Investigator Discretion|0
1837853|NCT00296504|6362980|P1|Interim Analysis|Participant Non-compliant|0
1837774|NCT00296504|6362973|P8|Interim Analysis|Principle Investigator Discretion|0
1837775|NCT00296504|6362974|P7|Interim Analysis|Principle Investigator Discretion|0
1837776|NCT00296504|6362975|P6|Interim Analysis|Principle Investigator Discretion|0
1837777|NCT00296504|6362976|P5|Interim Analysis|Principle Investigator Discretion|0
1837778|NCT00296504|6362977|P4|Interim Analysis|Principle Investigator Discretion|1
1837779|NCT00296504|6362978|P3|Interim Analysis|Principle Investigator Discretion|1
1837780|NCT00296504|6362979|P2|Interim Analysis|Principle Investigator Discretion|0
1837781|NCT00296504|6362980|P1|Interim Analysis|Principle Investigator Discretion|2
1837782|NCT00296504|6362972|P9|Interim Analysis|Physician Decision|0
1837783|NCT00296504|6362973|P8|Interim Analysis|Physician Decision|0
1837784|NCT00296504|6362974|P7|Interim Analysis|Physician Decision|0
1837785|NCT00296504|6362975|P6|Interim Analysis|Physician Decision|0
1837786|NCT00296504|6362976|P5|Interim Analysis|Physician Decision|0
1837787|NCT00296504|6362977|P4|Interim Analysis|Physician Decision|0
1837788|NCT00296504|6362978|P3|Interim Analysis|Physician Decision|1
1837789|NCT00296504|6362979|P2|Interim Analysis|Physician Decision|0
1837790|NCT00296504|6362980|P1|Interim Analysis|Physician Decision|0
1837791|NCT00296504|6362972|P9|Interim Analysis|Resistance to FPV|0
1837792|NCT00296504|6362973|P8|Interim Analysis|Resistance to FPV|0
1837793|NCT00296504|6362974|P7|Interim Analysis|Resistance to FPV|0
1837794|NCT00296504|6362975|P6|Interim Analysis|Resistance to FPV|0
1837795|NCT00296504|6362976|P5|Interim Analysis|Resistance to FPV|0
1837796|NCT00296504|6362977|P4|Interim Analysis|Resistance to FPV|0
1837797|NCT00296504|6362978|P3|Interim Analysis|Resistance to FPV|1
1837798|NCT00296504|6362979|P2|Interim Analysis|Resistance to FPV|0
1837799|NCT00296504|6362980|P1|Interim Analysis|Resistance to FPV|0
1837800|NCT00296504|6362972|P9|Interim Analysis|Participant Was Incarcerated|0
1837801|NCT00296504|6362973|P8|Interim Analysis|Participant Was Incarcerated|0
1837802|NCT00296504|6362974|P7|Interim Analysis|Participant Was Incarcerated|0
1837803|NCT00296504|6362975|P6|Interim Analysis|Participant Was Incarcerated|0
1837804|NCT00296504|6362976|P5|Interim Analysis|Participant Was Incarcerated|0
1837805|NCT00296504|6362977|P4|Interim Analysis|Participant Was Incarcerated|0
1837806|NCT00296504|6362978|P3|Interim Analysis|Participant Was Incarcerated|1
1837807|NCT00296504|6362979|P2|Interim Analysis|Participant Was Incarcerated|0
1837808|NCT00296504|6362980|P1|Interim Analysis|Participant Was Incarcerated|2
1837809|NCT00296504|6362972|P9|Interim Analysis|Participant Moved|0
1837810|NCT00296504|6362973|P8|Interim Analysis|Participant Moved|0
1837811|NCT00296504|6362974|P7|Interim Analysis|Participant Moved|1
1837812|NCT00296504|6362975|P6|Interim Analysis|Participant Moved|1
1837813|NCT00296504|6362976|P5|Interim Analysis|Participant Moved|0
1837814|NCT00296504|6362977|P4|Interim Analysis|Participant Moved|0
1837815|NCT00296504|6362978|P3|Interim Analysis|Participant Moved|1
1837816|NCT00296504|6362979|P2|Interim Analysis|Participant Moved|0
1837817|NCT00296504|6362980|P1|Interim Analysis|Participant Moved|1
1837818|NCT00296504|6362972|P9|Interim Analysis|Participant Had Problems with Alcohol|0
1837819|NCT00296504|6362973|P8|Interim Analysis|Participant Had Problems with Alcohol|0
1837820|NCT00296504|6362974|P7|Interim Analysis|Participant Had Problems with Alcohol|0
1837821|NCT00296504|6362975|P6|Interim Analysis|Participant Had Problems with Alcohol|0
1837822|NCT00296504|6362976|P5|Interim Analysis|Participant Had Problems with Alcohol|0
1837823|NCT00296504|6362977|P4|Interim Analysis|Participant Had Problems with Alcohol|0
1837824|NCT00296504|6362978|P3|Interim Analysis|Participant Had Problems with Alcohol|1
1837825|NCT00296504|6362979|P2|Interim Analysis|Participant Had Problems with Alcohol|0
1837826|NCT00296504|6362980|P1|Interim Analysis|Participant Had Problems with Alcohol|0
1837827|NCT00296504|6362972|P9|Interim Analysis|To Simplify Treatment|0
1837828|NCT00296504|6362973|P8|Interim Analysis|To Simplify Treatment|0
1837829|NCT00296504|6362974|P7|Interim Analysis|To Simplify Treatment|2
1837830|NCT00296504|6362975|P6|Interim Analysis|To Simplify Treatment|0
1837831|NCT00296504|6362976|P5|Interim Analysis|To Simplify Treatment|0
1837832|NCT00296504|6362977|P4|Interim Analysis|To Simplify Treatment|0
1837833|NCT00296504|6362978|P3|Interim Analysis|To Simplify Treatment|1
1837834|NCT00296504|6362979|P2|Interim Analysis|To Simplify Treatment|0
1837835|NCT00296504|6362980|P1|Interim Analysis|To Simplify Treatment|0
1837836|NCT00296504|6362972|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
1837837|NCT00296504|6362973|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
1837838|NCT00296504|6362974|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
1837839|NCT00296504|6362975|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
1837840|NCT00296504|6362976|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
1837841|NCT00296504|6362977|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
1837842|NCT00296504|6362978|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
1837843|NCT00296504|6362979|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
1837844|NCT00296504|6362980|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
1837845|NCT00296504|6362972|P9|Interim Analysis|Participant Non-compliant|0
1837846|NCT00296504|6362973|P8|Interim Analysis|Participant Non-compliant|2
1837847|NCT00296504|6362974|P7|Interim Analysis|Participant Non-compliant|6
1837848|NCT00296504|6362975|P6|Interim Analysis|Participant Non-compliant|3
1837849|NCT00296504|6362976|P5|Interim Analysis|Participant Non-compliant|1
1837850|NCT00296504|6362977|P4|Interim Analysis|Participant Non-compliant|1
1837851|NCT00296504|6362978|P3|Interim Analysis|Participant Non-compliant|2
1837852|NCT00296504|6362979|P2|Interim Analysis|Participant Non-compliant|1
1837854|NCT00296504|6362972|P9|Interim Analysis|Death|0
1837855|NCT00296504|6362973|P8|Interim Analysis|Death|0
1837856|NCT00296504|6362974|P7|Interim Analysis|Death|0
1837857|NCT00296504|6362975|P6|Interim Analysis|Death|0
1837858|NCT00296504|6362976|P5|Interim Analysis|Death|0
1837859|NCT00296504|6362977|P4|Interim Analysis|Death|0
1837860|NCT00296504|6362978|P3|Interim Analysis|Death|3
1837861|NCT00296504|6362979|P2|Interim Analysis|Death|0
1837862|NCT00296504|6362980|P1|Interim Analysis|Death|1
1837863|NCT00296504|6362972|P9|Interim Analysis|Pregnancy|0
1837864|NCT00296504|6362973|P8|Interim Analysis|Pregnancy|1
1837865|NCT00296504|6362974|P7|Interim Analysis|Pregnancy|1
1837866|NCT00296504|6362975|P6|Interim Analysis|Pregnancy|1
1837867|NCT00296504|6362976|P5|Interim Analysis|Pregnancy|0
1837868|NCT00296504|6362977|P4|Interim Analysis|Pregnancy|2
1837869|NCT00296504|6362978|P3|Interim Analysis|Pregnancy|4
1837870|NCT00296504|6362979|P2|Interim Analysis|Pregnancy|1
1837871|NCT00296504|6362980|P1|Interim Analysis|Pregnancy|4
1837872|NCT00296504|6362972|P9|Interim Analysis|Switched to Commercially Available Drug|0
1837873|NCT00296504|6362973|P8|Interim Analysis|Switched to Commercially Available Drug|4
1837874|NCT00296504|6362974|P7|Interim Analysis|Switched to Commercially Available Drug|3
1837875|NCT00296504|6362975|P6|Interim Analysis|Switched to Commercially Available Drug|5
1837876|NCT00296504|6362976|P5|Interim Analysis|Switched to Commercially Available Drug|0
1837877|NCT00296504|6362977|P4|Interim Analysis|Switched to Commercially Available Drug|1
1837878|NCT00296504|6362978|P3|Interim Analysis|Switched to Commercially Available Drug|4
1837879|NCT00296504|6362979|P2|Interim Analysis|Switched to Commercially Available Drug|0
1837880|NCT00296504|6362980|P1|Interim Analysis|Switched to Commercially Available Drug|2
1837881|NCT00296504|6362972|P9|Interim Analysis|Insufficient CD4 Response|0
1837882|NCT00296504|6362973|P8|Interim Analysis|Insufficient CD4 Response|0
1837883|NCT00296504|6362974|P7|Interim Analysis|Insufficient CD4 Response|0
1837884|NCT00296504|6362975|P6|Interim Analysis|Insufficient CD4 Response|1
1837885|NCT00296504|6362976|P5|Interim Analysis|Insufficient CD4 Response|1
1837886|NCT00296504|6362977|P4|Interim Analysis|Insufficient CD4 Response|0
1837887|NCT00296504|6362978|P3|Interim Analysis|Insufficient CD4 Response|0
1837888|NCT00296504|6362979|P2|Interim Analysis|Insufficient CD4 Response|0
1837889|NCT00296504|6362980|P1|Interim Analysis|Insufficient CD4 Response|0
1837890|NCT00296504|6362972|P9|Interim Analysis|Protocol Violation|0
1837891|NCT00296504|6362973|P8|Interim Analysis|Protocol Violation|1
1837892|NCT00296504|6362974|P7|Interim Analysis|Protocol Violation|0
1837893|NCT00296504|6362975|P6|Interim Analysis|Protocol Violation|0
1837894|NCT00296504|6362976|P5|Interim Analysis|Protocol Violation|1
1837895|NCT00296504|6362977|P4|Interim Analysis|Protocol Violation|0
1837896|NCT00296504|6362978|P3|Interim Analysis|Protocol Violation|2
1837897|NCT00296504|6362979|P2|Interim Analysis|Protocol Violation|0
1837898|NCT00296504|6362980|P1|Interim Analysis|Protocol Violation|0
1837899|NCT00296504|6362972|P9|Interim Analysis|Adverse Event|0
1837900|NCT00296504|6362973|P8|Interim Analysis|Adverse Event|5
1837901|NCT00296504|6362974|P7|Interim Analysis|Adverse Event|4
1837902|NCT00296504|6362975|P6|Interim Analysis|Adverse Event|3
1837903|NCT00296504|6362976|P5|Interim Analysis|Adverse Event|6
1837904|NCT00296504|6362977|P4|Interim Analysis|Adverse Event|4
1837905|NCT00296504|6362978|P3|Interim Analysis|Adverse Event|13
1837906|NCT00296504|6362979|P2|Interim Analysis|Adverse Event|0
1837907|NCT00296504|6362980|P1|Interim Analysis|Adverse Event|0
1837908|NCT00296504|6362972|P9|Interim Analysis|Insufficient Viral Load Response|0
1837909|NCT00296504|6362973|P8|Interim Analysis|Insufficient Viral Load Response|24
1837910|NCT00296504|6362974|P7|Interim Analysis|Insufficient Viral Load Response|2
1837911|NCT00296504|6362975|P6|Interim Analysis|Insufficient Viral Load Response|9
1837912|NCT00296504|6362976|P5|Interim Analysis|Insufficient Viral Load Response|7
1837913|NCT00296504|6362977|P4|Interim Analysis|Insufficient Viral Load Response|2
1837914|NCT00296504|6362978|P3|Interim Analysis|Insufficient Viral Load Response|12
1837915|NCT00296504|6362979|P2|Interim Analysis|Insufficient Viral Load Response|1
1837916|NCT00296504|6362980|P1|Interim Analysis|Insufficient Viral Load Response|5
1837917|NCT00296504|6362972|P9|Interim Analysis|Clinical Progression|0
1837918|NCT00296504|6362973|P8|Interim Analysis|Clinical Progression|2
1837919|NCT00296504|6362974|P7|Interim Analysis|Clinical Progression|1
1837920|NCT00296504|6362975|P6|Interim Analysis|Clinical Progression|2
1837921|NCT00296504|6362976|P5|Interim Analysis|Clinical Progression|0
1837922|NCT00296504|6362977|P4|Interim Analysis|Clinical Progression|1
1837923|NCT00296504|6362978|P3|Interim Analysis|Clinical Progression|1
1837924|NCT00296504|6362979|P2|Interim Analysis|Clinical Progression|0
1837925|NCT00296504|6362980|P1|Interim Analysis|Clinical Progression|1
1837926|NCT00296504|6362972|P9|Interim Analysis|Lost to Follow-up|0
1837927|NCT00296504|6362973|P8|Interim Analysis|Lost to Follow-up|4
1837928|NCT00296504|6362974|P7|Interim Analysis|Lost to Follow-up|11
1837929|NCT00296504|6362975|P6|Interim Analysis|Lost to Follow-up|4
1837930|NCT00296504|6362976|P5|Interim Analysis|Lost to Follow-up|14
1837931|NCT00296504|6362977|P4|Interim Analysis|Lost to Follow-up|8
1837932|NCT00296504|6362978|P3|Interim Analysis|Lost to Follow-up|26
1837933|NCT00296504|6362979|P2|Interim Analysis|Lost to Follow-up|3
1837934|NCT00296504|6362980|P1|Interim Analysis|Lost to Follow-up|13
1837935|NCT00296504|6362972|P9|Interim Analysis|Withdrawal by Subject|0
1837936|NCT00296504|6362973|P8|Interim Analysis|Withdrawal by Subject|3
1837937|NCT00296504|6362974|P7|Interim Analysis|Withdrawal by Subject|9
1837938|NCT00296504|6362975|P6|Interim Analysis|Withdrawal by Subject|5
1837939|NCT00296504|6362976|P5|Interim Analysis|Withdrawal by Subject|5
1837940|NCT00296504|6362977|P4|Interim Analysis|Withdrawal by Subject|0
1837941|NCT00296504|6362978|P3|Interim Analysis|Withdrawal by Subject|12
1837942|NCT00296504|6362979|P2|Interim Analysis|Withdrawal by Subject|0
1837943|NCT00296504|6362980|P1|Interim Analysis|Withdrawal by Subject|8
1837944|NCT00296491|6363073|P4|Overall Study|Lost to Follow-up|0
1837945|NCT00296491|6363074|P3|Overall Study|Lost to Follow-up|2
1837946|NCT00296491|6363075|P2|Overall Study|Lost to Follow-up|2
1837947|NCT00296491|6363076|P1|Overall Study|Lost to Follow-up|0
1837948|NCT00296491|6363073|P4|Overall Study|Non-Compliance|14
1837949|NCT00296491|6363074|P3|Overall Study|Non-Compliance|10
1837950|NCT00296491|6363075|P2|Overall Study|Non-Compliance|13
1837951|NCT00296491|6363076|P1|Overall Study|Non-Compliance|12
1837952|NCT00296491|6363073|P4|Overall Study|Withdrawal by Subject|2
1837953|NCT00296491|6363074|P3|Overall Study|Withdrawal by Subject|3
1837954|NCT00296491|6363075|P2|Overall Study|Withdrawal by Subject|3
1837955|NCT00296491|6363076|P1|Overall Study|Withdrawal by Subject|7
1837956|NCT00296491|6363073|P4|Overall Study|Withdrawn due to Asthma|4
1837957|NCT00296491|6363074|P3|Overall Study|Withdrawn due to Asthma|0
1837958|NCT00296491|6363075|P2|Overall Study|Withdrawn due to Asthma|0
1837959|NCT00296491|6363076|P1|Overall Study|Withdrawn due to Asthma|0
1837960|NCT00296491|6363073|P4|Overall Study|Adverse Event|4
1837961|NCT00296491|6363074|P3|Overall Study|Adverse Event|1
1837962|NCT00296491|6363075|P2|Overall Study|Adverse Event|3
1837963|NCT00296491|6363076|P1|Overall Study|Adverse Event|1
1837964|NCT00296491|6363073|P4|Overall Study|Protocol Violation|3
1837965|NCT00296491|6363074|P3|Overall Study|Protocol Violation|2
1837966|NCT00296491|6363075|P2|Overall Study|Protocol Violation|6
1837967|NCT00296491|6363076|P1|Overall Study|Protocol Violation|4
1837968|NCT00296491|6363073|P4|Overall Study|Low Pollen Counts|16
1837969|NCT00296491|6363074|P3|Overall Study|Low Pollen Counts|25
1837970|NCT00296491|6363075|P2|Overall Study|Low Pollen Counts|26
1837971|NCT00296491|6363076|P1|Overall Study|Low Pollen Counts|18
1837972|NCT00296400|6363105|P3|Overall Study|Pregnancy|0
1837973|NCT00296400|6363106|P2|Overall Study|Pregnancy|2
1837974|NCT00296400|6363107|P1|Overall Study|Pregnancy|1
1837975|NCT00296400|6363105|P3|Overall Study|Visit 10 was performed earlier|0
1837976|NCT00296400|6363106|P2|Overall Study|Visit 10 was performed earlier|1
1837977|NCT00296400|6363107|P1|Overall Study|Visit 10 was performed earlier|0
1837978|NCT00296400|6363105|P3|Overall Study|Study specific discontinuation criteria|1
1837979|NCT00296400|6363106|P2|Overall Study|Study specific discontinuation criteria|0
1837980|NCT00296400|6363107|P1|Overall Study|Study specific discontinuation criteria|0
1837981|NCT00296400|6363105|P3|Overall Study|Lost to Follow-up|2
1837982|NCT00296400|6363106|P2|Overall Study|Lost to Follow-up|1
1837983|NCT00296400|6363107|P1|Overall Study|Lost to Follow-up|1
1837984|NCT00296400|6363105|P3|Overall Study|Protocol Violation|1
1837985|NCT00296400|6363106|P2|Overall Study|Protocol Violation|1
1837986|NCT00296400|6363107|P1|Overall Study|Protocol Violation|1
1837987|NCT00296400|6363105|P3|Overall Study|Incorrect enrollment|0
1837988|NCT00296400|6363106|P2|Overall Study|Incorrect enrollment|0
1837989|NCT00296400|6363107|P1|Overall Study|Incorrect enrollment|2
1837990|NCT00296400|6363105|P3|Overall Study|Withdrawal by Subject|2
1837991|NCT00296400|6363106|P2|Overall Study|Withdrawal by Subject|6
1837992|NCT00296400|6363107|P1|Overall Study|Withdrawal by Subject|5
1837993|NCT00296400|6363105|P3|Overall Study|Adverse Event|7
1837994|NCT00296400|6363106|P2|Overall Study|Adverse Event|7
1837995|NCT00296400|6363107|P1|Overall Study|Adverse Event|7
1837996|NCT00296374|6363331|P3|Overall Study|Other|1
1837997|NCT00296374|6363332|P2|Overall Study|Other|0
1837998|NCT00296374|6363333|P1|Overall Study|Other|0
1837999|NCT00296374|6363331|P3|Overall Study|Pregnancy|2
1838000|NCT00296374|6363332|P2|Overall Study|Pregnancy|0
1838001|NCT00296374|6363333|P1|Overall Study|Pregnancy|0
1838002|NCT00296374|6363331|P3|Overall Study|Nephrologist introduced ACE|0
1838003|NCT00296374|6363332|P2|Overall Study|Nephrologist introduced ACE|1
1838004|NCT00296374|6363333|P1|Overall Study|Nephrologist introduced ACE|0
1838005|NCT00296374|6363331|P3|Overall Study|Stopped drug before end of study visit|0
1838006|NCT00296374|6363332|P2|Overall Study|Stopped drug before end of study visit|1
1838007|NCT00296374|6363333|P1|Overall Study|Stopped drug before end of study visit|0
1838008|NCT00296374|6363331|P3|Overall Study|Relocated to another state|0
1838009|NCT00296374|6363332|P2|Overall Study|Relocated to another state|0
1838010|NCT00296374|6363333|P1|Overall Study|Relocated to another state|1
1838011|NCT00296374|6363331|P3|Overall Study|Lost to Follow-up|1
1838012|NCT00296374|6363332|P2|Overall Study|Lost to Follow-up|1
1838013|NCT00296374|6363333|P1|Overall Study|Lost to Follow-up|3
1838014|NCT00296374|6363331|P3|Overall Study|Protocol Violation|3
1838015|NCT00296374|6363332|P2|Overall Study|Protocol Violation|2
1838016|NCT00296374|6363333|P1|Overall Study|Protocol Violation|1
1838017|NCT00296374|6363331|P3|Overall Study|Incorrect enrollment|4
1838018|NCT00296374|6363332|P2|Overall Study|Incorrect enrollment|3
1838019|NCT00296374|6363333|P1|Overall Study|Incorrect enrollment|3
1838020|NCT00296374|6363331|P3|Overall Study|Withdrawal by Subject|11
1838021|NCT00296374|6363332|P2|Overall Study|Withdrawal by Subject|5
1838022|NCT00296374|6363333|P1|Overall Study|Withdrawal by Subject|3
1838023|NCT00296374|6363331|P3|Overall Study|Adverse Event|7
1838024|NCT00296374|6363332|P2|Overall Study|Adverse Event|10
1838025|NCT00296374|6363333|P1|Overall Study|Adverse Event|14
1838026|NCT00296335|6363556|P2|Overall Study|Physician Decision|11
1838027|NCT00296335|6363557|P1|Overall Study|Physician Decision|3
1838028|NCT00296335|6363556|P2|Overall Study|Lost to Follow-up|33
1838029|NCT00296335|6363557|P1|Overall Study|Lost to Follow-up|7
1838030|NCT00296335|6363556|P2|Overall Study|Adverse Event|27
1838031|NCT00296335|6363557|P1|Overall Study|Adverse Event|17
1838032|NCT00296335|6363556|P2|Overall Study|Recurrence|51
1838033|NCT00296335|6363557|P1|Overall Study|Recurrence|3
1838034|NCT00296244|6363597|P2|Overall Study|Underwent retransplant|1
1838035|NCT00296244|6363598|P1|Overall Study|Underwent retransplant|0
1838036|NCT00296140|6363662|P2|Overall Study|Discharge to Nursing Home|0
1838037|NCT00296140|6363663|P1|Overall Study|Discharge to Nursing Home|1
1838038|NCT00296140|6363662|P2|Overall Study|Withdrawal by Subject|0
1838039|NCT00296140|6363663|P1|Overall Study|Withdrawal by Subject|1
1838040|NCT00296140|6363662|P2|Overall Study|Lost to Follow-up|0
1838041|NCT00296140|6363663|P1|Overall Study|Lost to Follow-up|1
1838042|NCT00296036|6363675|P6|Overall Study|Protocol Violation|3
1838043|NCT00296036|6363676|P5|Overall Study|Protocol Violation|0
1838044|NCT00296036|6363677|P4|Overall Study|Protocol Violation|0
1838045|NCT00296036|6363678|P3|Overall Study|Protocol Violation|0
1838046|NCT00296036|6363679|P2|Overall Study|Protocol Violation|0
1838047|NCT00296036|6363680|P1|Overall Study|Protocol Violation|0
1838048|NCT00296036|6363675|P6|Overall Study|Withdrawal by Subject|1
1838049|NCT00296036|6363676|P5|Overall Study|Withdrawal by Subject|2
1838050|NCT00296036|6363677|P4|Overall Study|Withdrawal by Subject|1
1838051|NCT00296036|6363678|P3|Overall Study|Withdrawal by Subject|2
1838052|NCT00296036|6363679|P2|Overall Study|Withdrawal by Subject|0
1838053|NCT00296036|6363680|P1|Overall Study|Withdrawal by Subject|1
1838054|NCT00295932|6363717|P11|Overall Study|Not Treated|1
1838055|NCT00295932|6363718|P10|Overall Study|Not Treated|0
1838056|NCT00295932|6363719|P9|Overall Study|Not Treated|0
1838057|NCT00295932|6363720|P8|Overall Study|Not Treated|0
1838058|NCT00295932|6363721|P7|Overall Study|Not Treated|0
1838059|NCT00295932|6363722|P6|Overall Study|Not Treated|0
1838060|NCT00295932|6363723|P5|Overall Study|Not Treated|0
1838061|NCT00295932|6363724|P4|Overall Study|Not Treated|0
1838062|NCT00295932|6363725|P3|Overall Study|Not Treated|0
1838063|NCT00295932|6363726|P2|Overall Study|Not Treated|0
1838064|NCT00295932|6363727|P1|Overall Study|Not Treated|0
1838065|NCT00295880|6363761|P1|Overall Study|Unit randomization did not occur|1
1838066|NCT00295880|6363761|P1|Overall Study|IBMI unit could not be volume reduced|1
1838067|NCT00295854|6363775|P3|Overall Study|Other|1
1838068|NCT00295854|6363776|P2|Overall Study|Other|5
1838069|NCT00295854|6363777|P1|Overall Study|Other|3
1838070|NCT00295854|6363775|P3|Overall Study|required a prohibited medication|0
1838071|NCT00295854|6363776|P2|Overall Study|required a prohibited medication|0
1838072|NCT00295854|6363777|P1|Overall Study|required a prohibited medication|1
1838073|NCT00295854|6363775|P3|Overall Study|did not continue to meet criteria|2
1838074|NCT00295854|6363776|P2|Overall Study|did not continue to meet criteria|1
1838075|NCT00295854|6363777|P1|Overall Study|did not continue to meet criteria|1
1838076|NCT00295854|6363775|P3|Overall Study|Withdrawal by Subject|4
1838077|NCT00295854|6363776|P2|Overall Study|Withdrawal by Subject|7
1838078|NCT00295854|6363777|P1|Overall Study|Withdrawal by Subject|3
1838079|NCT00295854|6363775|P3|Overall Study|Lost to Follow-up|1
1838080|NCT00295854|6363776|P2|Overall Study|Lost to Follow-up|0
1838081|NCT00295854|6363777|P1|Overall Study|Lost to Follow-up|2
1838082|NCT00295854|6363775|P3|Overall Study|Protocol Violation|1
1838083|NCT00295854|6363776|P2|Overall Study|Protocol Violation|1
1838084|NCT00295854|6363777|P1|Overall Study|Protocol Violation|1
1838085|NCT00295854|6363775|P3|Overall Study|Adverse Event|6
1838086|NCT00295854|6363776|P2|Overall Study|Adverse Event|7
1838087|NCT00295854|6363777|P1|Overall Study|Adverse Event|7
1838088|NCT00295750|6363791|P3|Overall Study|Protocol Violation|2
1838089|NCT00295750|6363792|P2|Overall Study|Protocol Violation|4
1838090|NCT00295750|6363793|P1|Overall Study|Protocol Violation|2
1838091|NCT00295750|6363791|P3|Overall Study|Withdrawal by Subject|7
1838092|NCT00295750|6363792|P2|Overall Study|Withdrawal by Subject|4
1838093|NCT00295750|6363793|P1|Overall Study|Withdrawal by Subject|9
1838094|NCT00295750|6363791|P3|Overall Study|Randomized but never received trial drug|3
1838095|NCT00295750|6363792|P2|Overall Study|Randomized but never received trial drug|3
1838096|NCT00295750|6363793|P1|Overall Study|Randomized but never received trial drug|4
1838097|NCT00295750|6363791|P3|Overall Study|Personal reasons|0
1838098|NCT00295750|6363792|P2|Overall Study|Personal reasons|1
1838099|NCT00295750|6363793|P1|Overall Study|Personal reasons|0
1838100|NCT00295750|6363791|P3|Overall Study|Disease progression|0
1838101|NCT00295750|6363792|P2|Overall Study|Disease progression|1
1838102|NCT00295750|6363793|P1|Overall Study|Disease progression|2
1838103|NCT00295750|6363791|P3|Overall Study|Trial drug errors|0
1838104|NCT00295750|6363792|P2|Overall Study|Trial drug errors|1
1838105|NCT00295750|6363793|P1|Overall Study|Trial drug errors|1
1838106|NCT00295750|6363791|P3|Overall Study|Administrative errors|5
1838107|NCT00295750|6363792|P2|Overall Study|Administrative errors|4
1838108|NCT00295750|6363793|P1|Overall Study|Administrative errors|2
1838109|NCT00295750|6363791|P3|Overall Study|Taking prohibited therapy|2
1838110|NCT00295750|6363792|P2|Overall Study|Taking prohibited therapy|3
1838111|NCT00295750|6363793|P1|Overall Study|Taking prohibited therapy|2
1838112|NCT00295750|6363791|P3|Overall Study|Lost to Follow-up|1
1838113|NCT00295750|6363792|P2|Overall Study|Lost to Follow-up|4
1838114|NCT00295750|6363793|P1|Overall Study|Lost to Follow-up|1
1838115|NCT00295750|6363791|P3|Overall Study|Lack of Efficacy|0
1838116|NCT00295750|6363792|P2|Overall Study|Lack of Efficacy|1
1838117|NCT00295750|6363793|P1|Overall Study|Lack of Efficacy|1
1838118|NCT00295750|6363791|P3|Overall Study|Adverse Event|12
1838119|NCT00295750|6363792|P2|Overall Study|Adverse Event|15
1838120|NCT00295750|6363793|P1|Overall Study|Adverse Event|19
1838121|NCT00295633|6363828|P3|Overall Study|Administrative reason by sponsor|1
1838122|NCT00295633|6363829|P2|Overall Study|Administrative reason by sponsor|0
1838123|NCT00295633|6363830|P1|Overall Study|Administrative reason by sponsor|0
1838124|NCT00295633|6363828|P3|Overall Study|Death|0
1838125|NCT00295633|6363829|P2|Overall Study|Death|1
1838126|NCT00295633|6363830|P1|Overall Study|Death|1
1838127|NCT00295633|6363828|P3|Overall Study|Subject No Longer Meets Study Criteria|3
1838128|NCT00295633|6363829|P2|Overall Study|Subject No Longer Meets Study Criteria|3
1838129|NCT00295633|6363830|P1|Overall Study|Subject No Longer Meets Study Criteria|0
1838130|NCT00295633|6363828|P3|Overall Study|Poor/Noncompliance|6
1838131|NCT00295633|6363829|P2|Overall Study|Poor/Noncompliance|2
1838132|NCT00295633|6363830|P1|Overall Study|Poor/Noncompliance|2
1838133|NCT00295633|6363828|P3|Overall Study|Physician Decision|8
1838134|NCT00295633|6363829|P2|Overall Study|Physician Decision|10
1838135|NCT00295633|6363830|P1|Overall Study|Physician Decision|9
1838136|NCT00295633|6363828|P3|Overall Study|Lost to Follow-up|7
1838137|NCT00295633|6363829|P2|Overall Study|Lost to Follow-up|11
1838138|NCT00295633|6363830|P1|Overall Study|Lost to Follow-up|6
1838139|NCT00295633|6363828|P3|Overall Study|Adverse Event|9
1838140|NCT00295633|6363829|P2|Overall Study|Adverse Event|17
1838141|NCT00295633|6363830|P1|Overall Study|Adverse Event|9
1838142|NCT00295633|6363828|P3|Overall Study|Withdrawal of consent by subject|26
1838143|NCT00295633|6363829|P2|Overall Study|Withdrawal of consent by subject|16
1838144|NCT00295633|6363830|P1|Overall Study|Withdrawal of consent by subject|16
1838145|NCT00295633|6363828|P3|Overall Study|Lack of Efficacy|16
1838146|NCT00295633|6363829|P2|Overall Study|Lack of Efficacy|7
1838147|NCT00295633|6363830|P1|Overall Study|Lack of Efficacy|19
1838148|NCT00295620|6363849|P2|Overall Study|Protocol Violation|32
1838149|NCT00295620|6363850|P1|Overall Study|Protocol Violation|30
1838150|NCT00295620|6363849|P2|Overall Study|Discontinuation by sponsor|593
1838151|NCT00295620|6363850|P1|Overall Study|Discontinuation by sponsor|580
1838152|NCT00295620|6363849|P2|Overall Study|Other reasons|9
1838153|NCT00295620|6363850|P1|Overall Study|Other reasons|10
1838154|NCT00295620|6363849|P2|Overall Study|Death|207
1838155|NCT00295620|6363850|P1|Overall Study|Death|206
1838156|NCT00295620|6363849|P2|Overall Study|Withdrawal by Subject|50
1838157|NCT00295620|6363850|P1|Overall Study|Withdrawal by Subject|37
1838158|NCT00295620|6363849|P2|Overall Study|Lost to Follow-up|5
1838159|NCT00295620|6363850|P1|Overall Study|Lost to Follow-up|9
1838160|NCT00295490|6363874|P4|Overall Study|Other|1
1838161|NCT00295490|6363875|P3|Overall Study|Other|0
1838162|NCT00295490|6363876|P2|Overall Study|Other|2
1838163|NCT00295490|6363877|P1|Overall Study|Other|0
1838164|NCT00295490|6363874|P4|Overall Study|Adverse Event|0
1838165|NCT00295490|6363875|P3|Overall Study|Adverse Event|0
1838166|NCT00295490|6363876|P2|Overall Study|Adverse Event|0
1838167|NCT00295490|6363877|P1|Overall Study|Adverse Event|1
1838168|NCT00295490|6363874|P4|Overall Study|Lost to Follow-up|0
1838169|NCT00295490|6363875|P3|Overall Study|Lost to Follow-up|1
1838170|NCT00295490|6363876|P2|Overall Study|Lost to Follow-up|0
1838171|NCT00295490|6363877|P1|Overall Study|Lost to Follow-up|0
1838172|NCT00295490|6363874|P4|Overall Study|Withdrawal by Subject|1
1838173|NCT00295490|6363875|P3|Overall Study|Withdrawal by Subject|0
1838174|NCT00295490|6363876|P2|Overall Study|Withdrawal by Subject|2
1838175|NCT00295490|6363877|P1|Overall Study|Withdrawal by Subject|0
1838176|NCT00295490|6363874|P4|Overall Study|Protocol Violation|3
1838177|NCT00295490|6363875|P3|Overall Study|Protocol Violation|3
1838178|NCT00295490|6363876|P2|Overall Study|Protocol Violation|0
1838179|NCT00295490|6363877|P1|Overall Study|Protocol Violation|0
1838180|NCT00295022|6363927|P3|Overall Study|Withdrawal by Subject|2
1838181|NCT00295022|6363928|P2|Overall Study|Withdrawal by Subject|0
1838182|NCT00295022|6363929|P1|Overall Study|Withdrawal by Subject|0
1838183|NCT00295022|6363927|P3|Overall Study|Lost to Follow-up|1
1838184|NCT00295022|6363928|P2|Overall Study|Lost to Follow-up|0
1838185|NCT00295022|6363929|P1|Overall Study|Lost to Follow-up|0
1838186|NCT00295022|6363927|P3|Overall Study|Adverse Event|2
1838187|NCT00295022|6363928|P2|Overall Study|Adverse Event|1
1838188|NCT00295022|6363929|P1|Overall Study|Adverse Event|1
1838189|NCT00294762|6364045|P2|Overall Study|Did not receive study treatment|3
1838190|NCT00294762|6364046|P1|Overall Study|Did not receive study treatment|3
1838191|NCT00294723|6364065|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
1838192|NCT00294723|6364066|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
1838193|NCT00294723|6364067|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
1838194|NCT00294723|6364065|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1838195|NCT00294723|6364066|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1838196|NCT00294723|6364067|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
1838197|NCT00294723|6364065|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
1838198|NCT00294723|6364066|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
1838199|NCT00294723|6364067|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
1838200|NCT00294723|6364065|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
1838201|NCT00294723|6364066|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1838202|NCT00294723|6364067|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
1838203|NCT00294723|6364065|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
1838204|NCT00294723|6364066|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
1838205|NCT00294723|6364067|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
1838206|NCT00294723|6364065|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
1838207|NCT00294723|6364066|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
1838208|NCT00294723|6364067|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
1838209|NCT00294723|6364065|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
1838210|NCT00294723|6364066|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
1838211|NCT00294723|6364067|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
1838212|NCT00294723|6364065|P3|Open-Label Extension 52 Weeks|Adverse Event|2
1838213|NCT00294723|6364066|P2|Open-Label Extension 52 Weeks|Adverse Event|5
1838214|NCT00294723|6364067|P1|Open-Label Extension 52 Weeks|Adverse Event|5
1838215|NCT00294723|6364065|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
1838216|NCT00294723|6364066|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
1838217|NCT00294723|6364067|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
1838218|NCT00294723|6364065|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
1838219|NCT00294723|6364066|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
1838220|NCT00294723|6364067|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
1838221|NCT00294723|6364065|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
1838222|NCT00294723|6364066|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
1838223|NCT00294723|6364067|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
1838224|NCT00294723|6364065|P3|Double-Blind Period 52 Weeks|Adverse Event|15
1838225|NCT00294723|6364066|P2|Double-Blind Period 52 Weeks|Adverse Event|25
1838226|NCT00294723|6364067|P1|Double-Blind Period 52 Weeks|Adverse Event|18
1838227|NCT00294684|6364128|P2|Overall Study|Lost to Follow-up|8
1838228|NCT00294684|6364129|P1|Overall Study|Lost to Follow-up|5
1838229|NCT00294671|6364169|P2|Overall Study|Death|1
1838230|NCT00294671|6364170|P1|Overall Study|Death|0
1838231|NCT00294671|6364169|P2|Overall Study|Non-compliance|0
1838232|NCT00294671|6364170|P1|Overall Study|Non-compliance|1
1838233|NCT00294671|6364169|P2|Overall Study|Lost to Follow-up|3
1838234|NCT00294671|6364170|P1|Overall Study|Lost to Follow-up|1
1838235|NCT00294671|6364169|P2|Overall Study|Non-drug related AE|2
1838236|NCT00294671|6364170|P1|Overall Study|Non-drug related AE|3
1838237|NCT00294671|6364169|P2|Overall Study|Drug related adverse event (AE)|2
1838238|NCT00294671|6364170|P1|Overall Study|Drug related adverse event (AE)|4
1838239|NCT00294671|6364169|P2|Overall Study|Liver transplant|9
1838240|NCT00294671|6364170|P1|Overall Study|Liver transplant|7
1838241|NCT00294671|6364169|P2|Overall Study|Lack of Efficacy|23
1838242|NCT00294671|6364170|P1|Overall Study|Lack of Efficacy|11
1838243|NCT00294658|6364186|P2|Overall Study|Patient and family were not satisfied|1
1838244|NCT00294658|6364187|P1|Overall Study|Patient and family were not satisfied|0
1838245|NCT00294658|6364186|P2|Overall Study|Found to have invasive thymoma|0
1838246|NCT00294658|6364187|P1|Overall Study|Found to have invasive thymoma|1
1838247|NCT00294658|6364186|P2|Overall Study|Withdrawal by Subject|4
1838248|NCT00294658|6364187|P1|Overall Study|Withdrawal by Subject|0
1838249|NCT00294658|6364186|P2|Overall Study|Pregnancy|1
1838250|NCT00294658|6364187|P1|Overall Study|Pregnancy|0
1838251|NCT00294658|6364186|P2|Overall Study|Physician Decision|2
1838252|NCT00294658|6364187|P1|Overall Study|Physician Decision|1
1838253|NCT00294658|6364186|P2|Overall Study|Lost to Follow-up|0
1838254|NCT00294658|6364187|P1|Overall Study|Lost to Follow-up|4
1838255|NCT00294658|6364186|P2|Overall Study|Death|1
1838256|NCT00294658|6364187|P1|Overall Study|Death|0
1838257|NCT00294645|6364251|P2|Overall Study|Other|10
1838258|NCT00294645|6364252|P1|Overall Study|Other|4
1838259|NCT00294645|6364251|P2|Overall Study|Physician Decision|20
1838260|NCT00294645|6364252|P1|Overall Study|Physician Decision|15
1838261|NCT00294645|6364251|P2|Overall Study|Withdrawal by Subject|34
1838262|NCT00294645|6364252|P1|Overall Study|Withdrawal by Subject|18
1838263|NCT00294645|6364251|P2|Overall Study|Lost to Follow-up|10
1838264|NCT00294645|6364252|P1|Overall Study|Lost to Follow-up|1
1838265|NCT00294645|6364251|P2|Overall Study|Death|18
1838266|NCT00294645|6364252|P1|Overall Study|Death|10
1838267|NCT00294554|6364296|P2|Overall Study|Physician Decision|1
1838268|NCT00294554|6364297|P1|Overall Study|Physician Decision|0
1838269|NCT00294554|6364296|P2|Overall Study|Lack of Efficacy|1
1838270|NCT00294554|6364297|P1|Overall Study|Lack of Efficacy|0
1838271|NCT00294398|6364324|P2|Overall Study|Lost to Follow-up|26
1838272|NCT00294398|6364325|P1|Overall Study|Lost to Follow-up|21
1838273|NCT00294060|6364333|P1|Overall Study|Device explanted/not replaced|23
1838274|NCT00294060|6364333|P1|Overall Study|Medical condition|3
1838275|NCT00294060|6364333|P1|Overall Study|Physician Decision|797
1838276|NCT00294060|6364333|P1|Overall Study|Withdrawal by Subject|11
1838277|NCT00294060|6364333|P1|Overall Study|Lost to Follow-up|55
1838278|NCT00294060|6364333|P1|Overall Study|Other|59
1838279|NCT00294060|6364333|P1|Overall Study|Death|225
1838280|NCT00294047|6364341|P2|Month 84|No consent for Month 84 Follow-up|754
1838281|NCT00294047|6364342|P1|Month 84|No consent for Month 84 Follow-up|731
1838282|NCT00294047|6364341|P2|Month 84|Visit missed|1
1838283|NCT00294047|6364342|P1|Month 84|Visit missed|0
1838284|NCT00294047|6364341|P2|Month 84|Under investigation locally|0
1838285|NCT00294047|6364342|P1|Month 84|Under investigation locally|1
1838286|NCT00294047|6364341|P2|Month 84|Unable to reach study site|0
1838287|NCT00294047|6364342|P1|Month 84|Unable to reach study site|1
1838288|NCT00294047|6364341|P2|Month 84|Transport reimbursement delayed|1
1838289|NCT00294047|6364342|P1|Month 84|Transport reimbursement delayed|0
1838290|NCT00294047|6364341|P2|Month 84|Subject does not want male physician|0
1838291|NCT00294047|6364342|P1|Month 84|Subject does not want male physician|1
1838292|NCT00294047|6364341|P2|Month 84|Personal reason|4
1838293|NCT00294047|6364342|P1|Month 84|Personal reason|2
1838294|NCT00294047|6364341|P2|Month 84|Lack of time|1
1838295|NCT00294047|6364342|P1|Month 84|Lack of time|3
1838296|NCT00294047|6364341|P2|Month 84|Family problems|2
1838297|NCT00294047|6364342|P1|Month 84|Family problems|2
1838298|NCT00294047|6364341|P2|Month 84|Center closed, subject did not transfer|0
1838299|NCT00294047|6364342|P1|Month 84|Center closed, subject did not transfer|1
1838300|NCT00294047|6364341|P2|Month 84|Work related reasons|2
1838301|NCT00294047|6364342|P1|Month 84|Work related reasons|4
1838302|NCT00294047|6364341|P2|Month 84|Absent Cervix|0
1838303|NCT00294047|6364342|P1|Month 84|Absent Cervix|2
1838304|NCT00294047|6364341|P2|Month 84|Lost to Follow-up|190
1838305|NCT00294047|6364342|P1|Month 84|Lost to Follow-up|187
1838306|NCT00294047|6364341|P2|Month 84|Withdrawal by Subject|31
1838307|NCT00294047|6364342|P1|Month 84|Withdrawal by Subject|33
1838308|NCT00294047|6364341|P2|Month 84|Protocol Violation|1
1838309|NCT00294047|6364342|P1|Month 84|Protocol Violation|1
1838310|NCT00294047|6364341|P2|Month 84|Adverse Event|2
1838311|NCT00294047|6364342|P1|Month 84|Adverse Event|4
1838312|NCT00294047|6364341|P2|Month 48|Other|14
1838313|NCT00294047|6364342|P1|Month 48|Other|10
1838314|NCT00294047|6364341|P2|Month 48|Lost to Follow-up|287
1838315|NCT00294047|6364342|P1|Month 48|Lost to Follow-up|272
1838316|NCT00294047|6364341|P2|Month 48|Withdrawal by Subject|115
1838317|NCT00294047|6364342|P1|Month 48|Withdrawal by Subject|111
1838318|NCT00294047|6364341|P2|Month 48|Protocol Violation|4
1838319|NCT00294047|6364342|P1|Month 48|Protocol Violation|4
1838320|NCT00294047|6364341|P2|Month 48|Adverse Event|13
1838321|NCT00294047|6364342|P1|Month 48|Adverse Event|28
1838322|NCT00293813|6364447|P3|Overall Study|Noncompliance|0
1838323|NCT00293813|6364448|P2|Overall Study|Noncompliance|1
1838324|NCT00293813|6364449|P1|Overall Study|Noncompliance|0
1838325|NCT00293813|6364447|P3|Overall Study|Lost to Follow-up|3
1838326|NCT00293813|6364448|P2|Overall Study|Lost to Follow-up|2
1838327|NCT00293813|6364449|P1|Overall Study|Lost to Follow-up|3
1838328|NCT00293813|6364447|P3|Overall Study|Withdrawal by Subject|4
1838329|NCT00293813|6364448|P2|Overall Study|Withdrawal by Subject|4
1838330|NCT00293813|6364449|P1|Overall Study|Withdrawal by Subject|7
1838331|NCT00293813|6364447|P3|Overall Study|Adverse Event|1
1838332|NCT00293813|6364448|P2|Overall Study|Adverse Event|1
1838333|NCT00293813|6364449|P1|Overall Study|Adverse Event|3
1838334|NCT00293813|6364447|P3|Overall Study|Physician Decision|0
1838335|NCT00293813|6364448|P2|Overall Study|Physician Decision|1
1838336|NCT00293813|6364449|P1|Overall Study|Physician Decision|0
1838337|NCT00293722|6364460|P1|Overall Study|Other|427
1838338|NCT00293709|6364474|P1|Overall Study|Other|47
1838339|NCT00293579|6364488|P1|Overall Study|Withdrawal by Subject|1
1838340|NCT00293462|6364507|P3|Overall Study|Physician Decision|0
1838341|NCT00293462|6364508|P2|Overall Study|Physician Decision|1
1838342|NCT00293462|6364509|P1|Overall Study|Physician Decision|0
1838343|NCT00293462|6364507|P3|Overall Study|Low radiation dose in oral cavity|0
1838344|NCT00293462|6364508|P2|Overall Study|Low radiation dose in oral cavity|1
1838345|NCT00293462|6364509|P1|Overall Study|Low radiation dose in oral cavity|0
1838346|NCT00293462|6364507|P3|Overall Study|Possible Tracheostomy leakage|0
1838347|NCT00293462|6364508|P2|Overall Study|Possible Tracheostomy leakage|1
1838348|NCT00293462|6364509|P1|Overall Study|Possible Tracheostomy leakage|0
1838349|NCT00293462|6364507|P3|Overall Study|Ischemic stroke after chemotherapy|1
1838350|NCT00293462|6364508|P2|Overall Study|Ischemic stroke after chemotherapy|0
1838351|NCT00293462|6364509|P1|Overall Study|Ischemic stroke after chemotherapy|0
1838352|NCT00293462|6364507|P3|Overall Study|Blood clot after chemotherapy|1
1838353|NCT00293462|6364508|P2|Overall Study|Blood clot after chemotherapy|0
1838354|NCT00293462|6364509|P1|Overall Study|Blood clot after chemotherapy|0
1838355|NCT00293462|6364507|P3|Overall Study|Went back to his home country|1
1838356|NCT00293462|6364508|P2|Overall Study|Went back to his home country|0
1838357|NCT00293462|6364509|P1|Overall Study|Went back to his home country|0
1838358|NCT00293462|6364507|P3|Overall Study|No Show|1
1838359|NCT00293462|6364508|P2|Overall Study|No Show|0
1838360|NCT00293462|6364509|P1|Overall Study|No Show|0
1838361|NCT00293462|6364507|P3|Overall Study|Refuse Radiation Treatment|0
1838362|NCT00293462|6364508|P2|Overall Study|Refuse Radiation Treatment|0
1838363|NCT00293462|6364509|P1|Overall Study|Refuse Radiation Treatment|1
1838364|NCT00293462|6364507|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1838365|NCT00293462|6364508|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
1838366|NCT00293462|6364509|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
1838367|NCT00293462|6364507|P3|Overall Study|Change Treatment Regimen (ineligible)|0
1838368|NCT00293462|6364508|P2|Overall Study|Change Treatment Regimen (ineligible)|0
1838369|NCT00293462|6364509|P1|Overall Study|Change Treatment Regimen (ineligible)|1
1838370|NCT00293462|6364507|P3|Overall Study|Lost to Follow-up|0
1838371|NCT00293462|6364508|P2|Overall Study|Lost to Follow-up|1
1838372|NCT00293462|6364509|P1|Overall Study|Lost to Follow-up|0
1838373|NCT00293462|6364507|P3|Overall Study|Death|0
1838374|NCT00293462|6364508|P2|Overall Study|Death|0
1838375|NCT00293462|6364509|P1|Overall Study|Death|1
1838376|NCT00293462|6364507|P3|Overall Study|Withdrawal by Subject|6
1838377|NCT00293462|6364508|P2|Overall Study|Withdrawal by Subject|3
1838378|NCT00293462|6364509|P1|Overall Study|Withdrawal by Subject|4
1838379|NCT00293397|6364528|P1|Overall Study|Death|2
1838380|NCT00293384|6364538|P1|Overall Study|Ineligible|2
1838381|NCT00293384|6364538|P1|Overall Study|Missed dosage/study drug|1
1838382|NCT00293384|6364538|P1|Overall Study|Non-compliance|2
1838383|NCT00293293|6364547|P2|Overall Study|Patient discontinued chemotherapy|1
1838384|NCT00293293|6364548|P1|Overall Study|Patient discontinued chemotherapy|0
1838385|NCT00293293|6364547|P2|Overall Study|"Patient too anxious to complete trial"|0
1838386|NCT00293293|6364548|P1|Overall Study|"Patient too anxious to complete trial"|1
1838387|NCT00293293|6364547|P2|Overall Study|Withdrawal by Subject|1
1838388|NCT00293293|6364548|P1|Overall Study|Withdrawal by Subject|1
1838389|NCT00293267|6364576|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
1838390|NCT00293267|6364577|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
1838391|NCT00293267|6364576|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
1838392|NCT00293267|6364577|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
1838393|NCT00293267|6364576|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
1838394|NCT00293267|6364577|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
1838395|NCT00293267|6364576|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1838396|NCT00293267|6364577|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
1838397|NCT00293267|6364576|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
1838398|NCT00293267|6364577|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
1838399|NCT00293267|6364576|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
1838400|NCT00293267|6364577|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
1838401|NCT00293267|6364576|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
1838402|NCT00293267|6364577|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
1838403|NCT00293267|6364576|P2|Extension - Open-Label Week 157-240|Other Reason|1
1838404|NCT00293267|6364577|P1|Extension - Open-Label Week 157-240|Other Reason|3
1838405|NCT00293267|6364576|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
1838406|NCT00293267|6364577|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
1838407|NCT00293267|6364576|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1838408|NCT00293267|6364577|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
1838409|NCT00293267|6364576|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1838410|NCT00293267|6364577|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
1838411|NCT00293267|6364576|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1838412|NCT00293267|6364577|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
1838413|NCT00293267|6364576|P2|Extension - Open-Label Week 157-240|Adverse Event|0
1838414|NCT00293267|6364577|P1|Extension - Open-Label Week 157-240|Adverse Event|5
1838415|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
1838416|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1838417|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Other Reason|0
1838418|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Other Reason|7
1838419|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
1838420|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
1838421|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Death|0
1838422|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Death|3
1838423|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
1838424|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
1838425|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
1838426|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
1838427|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
1838428|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
1838429|NCT00293267|6364576|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
1838430|NCT00293267|6364577|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
1838431|NCT00293267|6364576|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
1838432|NCT00293267|6364577|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
1838433|NCT00293267|6364576|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1838434|NCT00293267|6364577|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1838435|NCT00293267|6364576|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1838436|NCT00293267|6364577|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1838437|NCT00293267|6364576|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1838438|NCT00293267|6364577|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
1838439|NCT00293267|6364576|P2|Primary Study - Double-Blind Week 0-48|Death|3
1838440|NCT00293267|6364577|P1|Primary Study - Double-Blind Week 0-48|Death|3
1838441|NCT00293267|6364576|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1838442|NCT00293267|6364577|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1838443|NCT00293267|6364576|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1838444|NCT00293267|6364577|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1838445|NCT00293254|6364617|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
1838446|NCT00293254|6364618|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
1838447|NCT00293254|6364617|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1838448|NCT00293254|6364618|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
1838449|NCT00293254|6364617|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
1838450|NCT00293254|6364618|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
1838451|NCT00293254|6364617|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
1838452|NCT00293254|6364618|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
1838453|NCT00293254|6364617|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
1838454|NCT00293254|6364618|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
1838455|NCT00293254|6364617|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
1838456|NCT00293254|6364618|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
1838457|NCT00293254|6364617|P2|Extension - Open-Label Week 157-240|Other Reason|0
1838458|NCT00293254|6364618|P1|Extension - Open-Label Week 157-240|Other Reason|4
1838459|NCT00293254|6364617|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
1838460|NCT00293254|6364618|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
1838461|NCT00293254|6364617|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
1838462|NCT00293254|6364618|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
1838463|NCT00293254|6364617|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
1838464|NCT00293254|6364618|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
1838465|NCT00293254|6364617|P2|Extension - Open-Label Week 157-240|Adverse Event|1
1838466|NCT00293254|6364618|P1|Extension - Open-Label Week 157-240|Adverse Event|2
1838467|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
1838468|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
1838469|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Other Reason|2
1838470|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Other Reason|10
1838471|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
1838472|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
1838473|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
1838474|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
1838475|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1838476|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
1838477|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
1838478|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
1838479|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Death|1
1838480|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Death|4
1838481|NCT00293254|6364617|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
1838482|NCT00293254|6364618|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
1838483|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
1838484|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
1838485|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
1838486|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
1838487|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
1838488|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
1838489|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
1838490|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
1838491|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1838492|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
1838493|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Death|2
1838494|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Death|5
1838495|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
1838496|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
1838497|NCT00293254|6364617|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
1838498|NCT00293254|6364618|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
1838499|NCT00293241|6364658|P2|Overall Study|Withdrawal by Subject|8
1838500|NCT00293241|6364659|P1|Overall Study|Withdrawal by Subject|4
1838501|NCT00293241|6364658|P2|Overall Study|Physician Decision|17
1838502|NCT00293241|6364659|P1|Overall Study|Physician Decision|23
1838503|NCT00293241|6364658|P2|Overall Study|Lost to Follow-up|16
1838504|NCT00293241|6364659|P1|Overall Study|Lost to Follow-up|9
1838505|NCT00293059|6364703|P2|Overall Study|missing|5
1838506|NCT00293059|6364704|P1|Overall Study|missing|3
1838507|NCT00293059|6364703|P2|Overall Study|Noncompliant - sanitary pads collection|1
1838508|NCT00293059|6364704|P1|Overall Study|Noncompliant - sanitary pads collection|0
1838509|NCT00293059|6364703|P2|Overall Study|Participant stopped study drug|0
1838510|NCT00293059|6364704|P1|Overall Study|Participant stopped study drug|1
1838511|NCT00293059|6364703|P2|Overall Study|Participant moved out of state|0
1838512|NCT00293059|6364704|P1|Overall Study|Participant moved out of state|1
1838513|NCT00293059|6364703|P2|Overall Study|Withdrawal by Subject|5
1838514|NCT00293059|6364704|P1|Overall Study|Withdrawal by Subject|11
1838515|NCT00293059|6364703|P2|Overall Study|Protocol Violation|0
1838516|NCT00293059|6364704|P1|Overall Study|Protocol Violation|2
1838517|NCT00293059|6364703|P2|Overall Study|Pregnancy|1
1838518|NCT00293059|6364704|P1|Overall Study|Pregnancy|1
1838519|NCT00293059|6364703|P2|Overall Study|Lost to Follow-up|3
1838520|NCT00293059|6364704|P1|Overall Study|Lost to Follow-up|2
1838521|NCT00293059|6364703|P2|Overall Study|Lack of Efficacy|0
1838522|NCT00293059|6364704|P1|Overall Study|Lack of Efficacy|2
1838523|NCT00293059|6364703|P2|Overall Study|Adverse Event|4
1838524|NCT00293059|6364704|P1|Overall Study|Adverse Event|12
1838525|NCT00293033|6364816|P1|Double-blind Treatment Period|Noncompliance|4
1838526|NCT00293033|6364816|P1|Double-blind Treatment Period|Withdrawal by Subject|4
1838527|NCT00293033|6364816|P1|Double-blind Treatment Period|Lack of Efficacy|1
1838528|NCT00293033|6364816|P1|Double-blind Treatment Period|Adverse Event|3
1838529|NCT00293033|6364816|P1|Open-label Titration Period|Noncompliance and other|27
1838530|NCT00293033|6364816|P1|Open-label Titration Period|Withdrawal by Subject|22
1838531|NCT00293033|6364816|P1|Open-label Titration Period|Protocol Violation|2
1838532|NCT00293033|6364816|P1|Open-label Titration Period|Lack of Efficacy|5
1838533|NCT00293033|6364816|P1|Open-label Titration Period|Death|3
1838534|NCT00293033|6364816|P1|Open-label Titration Period|Adverse Event|10
1838535|NCT00293020|6364919|P1|Overall Study|No dose taken|1
1838536|NCT00293020|6364919|P1|Overall Study|Other Reason|22
1838537|NCT00293020|6364919|P1|Overall Study|Physician Decision|21
1838538|NCT00293020|6364919|P1|Overall Study|Protocol Violation|6
1838539|NCT00293020|6364919|P1|Overall Study|Lost to Follow-up|4
1838540|NCT00293020|6364919|P1|Overall Study|Lack of Efficacy|12
1838541|NCT00293020|6364919|P1|Overall Study|Death|32
1838542|NCT00293020|6364919|P1|Overall Study|Adverse Event|30
1838543|NCT00293020|6364919|P1|Overall Study|Withdrawal by Subject|34
1838544|NCT00292981|6364923|P1|Overall Study|Other|3
1838545|NCT00292981|6364923|P1|Overall Study|Withdrawal by Subject|22
1838546|NCT00292981|6364923|P1|Overall Study|Lost to Follow-up|13
1838547|NCT00292981|6364923|P1|Overall Study|Adverse Event|1
1838548|NCT00292942|6364934|P4|Overall Study|Adverse Event|1
1838549|NCT00292942|6364935|P3|Overall Study|Adverse Event|0
1838550|NCT00292942|6364936|P2|Overall Study|Adverse Event|0
1838551|NCT00292942|6364937|P1|Overall Study|Adverse Event|0
1838552|NCT00292942|6364934|P4|Overall Study|Withdrawal by Subject|0
1838553|NCT00292942|6364935|P3|Overall Study|Withdrawal by Subject|1
1838554|NCT00292942|6364936|P2|Overall Study|Withdrawal by Subject|0
1838555|NCT00292942|6364937|P1|Overall Study|Withdrawal by Subject|0
1838556|NCT00292461|6364983|P2|Overall Study|Lost to Follow-up|0
1838557|NCT00292461|6364984|P1|Overall Study|Lost to Follow-up|1
1838558|NCT00292461|6364983|P2|Overall Study|Protocol Violation|3
1838559|NCT00292461|6364984|P1|Overall Study|Protocol Violation|4
1838560|NCT00292461|6364983|P2|Overall Study|Withdrawal by Subject|1
1838561|NCT00292461|6364984|P1|Overall Study|Withdrawal by Subject|0
1838562|NCT00292461|6364983|P2|Overall Study|Lack of Efficacy|0
1838563|NCT00292461|6364984|P1|Overall Study|Lack of Efficacy|1
1838564|NCT00292461|6364983|P2|Overall Study|Adverse Event|2
1838565|NCT00292461|6364984|P1|Overall Study|Adverse Event|4
1838566|NCT00292370|6364999|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
1838567|NCT00292370|6365000|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
1838568|NCT00292370|6365001|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
1838569|NCT00292370|6364999|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
1838570|NCT00292370|6365000|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
1838571|NCT00292370|6365001|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
1838572|NCT00292370|6364999|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1838573|NCT00292370|6365000|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
1838574|NCT00292370|6365001|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
1838575|NCT00292370|6364999|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1838576|NCT00292370|6365000|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
1838577|NCT00292370|6365001|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
1838578|NCT00292370|6364999|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1838579|NCT00292370|6365000|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
1838580|NCT00292370|6365001|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
1838581|NCT00292370|6364999|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1838582|NCT00292370|6365000|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
1838583|NCT00292370|6365001|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
1838584|NCT00292318|6365026|P2|Overall Study|Study terminated by officials|1
1838585|NCT00292318|6365027|P1|Overall Study|Study terminated by officials|2
1838586|NCT00292227|6365037|P3|Patch Period|Withdrawal by Subject|1
1838587|NCT00292227|6365038|P2|Patch Period|Withdrawal by Subject|0
1838588|NCT00292227|6365039|P1|Patch Period|Withdrawal by Subject|0
1838589|NCT00292227|6365037|P3|Patch Period|Adverse Event|2
1838590|NCT00292227|6365038|P2|Patch Period|Adverse Event|0
1838591|NCT00292227|6365039|P1|Patch Period|Adverse Event|1
1838592|NCT00292188|6365121|P3|Double-Blind|Laboratory Abnormality|1
1838593|NCT00292188|6365122|P2|Double-Blind|Laboratory Abnormality|0
1838594|NCT00292188|6365123|P1|Double-Blind|Laboratory Abnormality|0
1838595|NCT00292188|6365121|P3|Double-Blind|Withdrawal by Subject|3
1838596|NCT00292188|6365122|P2|Double-Blind|Withdrawal by Subject|0
1838597|NCT00292188|6365123|P1|Double-Blind|Withdrawal by Subject|0
1838598|NCT00292188|6365121|P3|Double-Blind|Other|4
1838599|NCT00292188|6365122|P2|Double-Blind|Other|3
1838600|NCT00292188|6365123|P1|Double-Blind|Other|0
1838601|NCT00292188|6365121|P3|Double-Blind|Lost to Follow-up|0
1838602|NCT00292188|6365122|P2|Double-Blind|Lost to Follow-up|1
1838603|NCT00292188|6365123|P1|Double-Blind|Lost to Follow-up|0
1838604|NCT00292188|6365121|P3|Double-Blind|Lack of Efficacy|12
1838605|NCT00292188|6365122|P2|Double-Blind|Lack of Efficacy|2
1838606|NCT00292188|6365123|P1|Double-Blind|Lack of Efficacy|0
1838607|NCT00292188|6365121|P3|Double-Blind|Adverse Event|9
1838608|NCT00292188|6365122|P2|Double-Blind|Adverse Event|25
1838609|NCT00292188|6365123|P1|Double-Blind|Adverse Event|0
1838610|NCT00292188|6365121|P3|Single-Blind|Did not receive treatment|0
1838611|NCT00292188|6365122|P2|Single-Blind|Did not receive treatment|0
1838612|NCT00292188|6365123|P1|Single-Blind|Did not receive treatment|1
1838613|NCT00292188|6365121|P3|Single-Blind|Withdrawal by Subject|0
1838614|NCT00292188|6365122|P2|Single-Blind|Withdrawal by Subject|0
1838615|NCT00292188|6365123|P1|Single-Blind|Withdrawal by Subject|12
1838616|NCT00292188|6365121|P3|Single-Blind|Other|0
1838617|NCT00292188|6365122|P2|Single-Blind|Other|0
1838618|NCT00292188|6365123|P1|Single-Blind|Other|77
1838619|NCT00292188|6365121|P3|Single-Blind|Lost to Follow-up|0
1838620|NCT00292188|6365122|P2|Single-Blind|Lost to Follow-up|0
1838621|NCT00292188|6365123|P1|Single-Blind|Lost to Follow-up|3
1838622|NCT00292188|6365121|P3|Single-Blind|Laboratory Abnormality|0
1838623|NCT00292188|6365122|P2|Single-Blind|Laboratory Abnormality|0
1838624|NCT00292188|6365123|P1|Single-Blind|Laboratory Abnormality|5
1838625|NCT00292188|6365121|P3|Single-Blind|Lack of Efficacy|0
1838626|NCT00292188|6365122|P2|Single-Blind|Lack of Efficacy|0
1838627|NCT00292188|6365123|P1|Single-Blind|Lack of Efficacy|2
1838628|NCT00292188|6365121|P3|Single-Blind|Adverse Event|0
1838629|NCT00292188|6365122|P2|Single-Blind|Adverse Event|0
1838630|NCT00292188|6365123|P1|Single-Blind|Adverse Event|14
1838631|NCT00291642|6365240|P5|Overall Study|Intake of prohibited medication|0
1838632|NCT00291642|6365241|P4|Overall Study|Intake of prohibited medication|0
1838633|NCT00291642|6365242|P3|Overall Study|Intake of prohibited medication|0
1838634|NCT00291642|6365243|P2|Overall Study|Intake of prohibited medication|0
1838635|NCT00291642|6365244|P1|Overall Study|Intake of prohibited medication|1
1838636|NCT00291642|6365240|P5|Overall Study|Patient missed visit|0
1838637|NCT00291642|6365241|P4|Overall Study|Patient missed visit|0
1838638|NCT00291642|6365242|P3|Overall Study|Patient missed visit|1
1838639|NCT00291642|6365243|P2|Overall Study|Patient missed visit|0
1838640|NCT00291642|6365244|P1|Overall Study|Patient missed visit|0
1838641|NCT00291642|6365240|P5|Overall Study|Adverse Event|1
1838642|NCT00291642|6365241|P4|Overall Study|Adverse Event|0
1838643|NCT00291642|6365242|P3|Overall Study|Adverse Event|1
1838644|NCT00291642|6365243|P2|Overall Study|Adverse Event|0
1838645|NCT00291642|6365244|P1|Overall Study|Adverse Event|1
1838646|NCT00291577|6365296|P1|Overall Study|Lack of Efficacy|14
1838647|NCT00291577|6365296|P1|Overall Study|Withdrawal by Subject|2
1838648|NCT00291577|6365296|P1|Overall Study|Other|4
1838649|NCT00291577|6365296|P1|Overall Study|Adverse Event|1
1838650|NCT00291551|6365315|P1|Overall Study|Withdrawal by Subject|6
1838651|NCT00291551|6365315|P1|Overall Study|Death|7
1838652|NCT00291330|6365363|P2|Overall Study|Other|1
1838653|NCT00291330|6365364|P1|Overall Study|Other|3
1838654|NCT00291330|6365363|P2|Overall Study|Withdrawal by Subject|25
1838655|NCT00291330|6365364|P1|Overall Study|Withdrawal by Subject|22
1838656|NCT00291330|6365363|P2|Overall Study|Lost to Follow-up|11
1838657|NCT00291330|6365364|P1|Overall Study|Lost to Follow-up|16
1838658|NCT00291330|6365363|P2|Overall Study|Protocol Violation|20
1838659|NCT00291330|6365364|P1|Overall Study|Protocol Violation|13
1838660|NCT00291330|6365363|P2|Overall Study|Adverse Event|40
1838661|NCT00291330|6365364|P1|Overall Study|Adverse Event|47
1838662|NCT00291187|6365406|P4|Overall Study|Protocol Violation- No Drug Administered|0
1838663|NCT00291187|6365407|P3|Overall Study|Protocol Violation- No Drug Administered|1
1838664|NCT00291187|6365408|P2|Overall Study|Protocol Violation- No Drug Administered|0
1838665|NCT00291187|6365409|P1|Overall Study|Protocol Violation- No Drug Administered|0
1838666|NCT00291018|6365453|P3|Overall Study|Lost to Follow-up|18
1838667|NCT00291018|6365454|P2|Overall Study|Lost to Follow-up|4
1838668|NCT00291018|6365455|P1|Overall Study|Lost to Follow-up|3
1838669|NCT00291018|6365453|P3|Overall Study|Failures|5
1838670|NCT00291018|6365454|P2|Overall Study|Failures|12
1838671|NCT00291018|6365455|P1|Overall Study|Failures|5
1838672|NCT00291018|6365453|P3|Overall Study|Withdrawal by Subject|1
1838673|NCT00291018|6365454|P2|Overall Study|Withdrawal by Subject|8
1838674|NCT00291018|6365455|P1|Overall Study|Withdrawal by Subject|2
1838675|NCT00291018|6365453|P3|Overall Study|Death|4
1838676|NCT00291018|6365454|P2|Overall Study|Death|3
1838677|NCT00291018|6365455|P1|Overall Study|Death|3
1838678|NCT00291018|6365453|P3|Overall Study|Not Consented or Declined PAS|15
1838679|NCT00291018|6365454|P2|Overall Study|Not Consented or Declined PAS|15
1838680|NCT00291018|6365455|P1|Overall Study|Not Consented or Declined PAS|12
1838681|NCT00290888|6365495|P2|Overall Study|Physician Decision|1
1838682|NCT00290888|6365496|P1|Overall Study|Physician Decision|3
1838683|NCT00290771|6365513|P2|Overall Study|Lost to Follow-up|1
1838684|NCT00290771|6365514|P1|Overall Study|Lost to Follow-up|0
1838685|NCT00290771|6365513|P2|Overall Study|Protocol Violation|0
1838686|NCT00290771|6365514|P1|Overall Study|Protocol Violation|2
1838687|NCT00290771|6365513|P2|Overall Study|Administrative problems|1
1838688|NCT00290771|6365514|P1|Overall Study|Administrative problems|2
1838689|NCT00290771|6365513|P2|Overall Study|Withdrawal by Subject|6
1838690|NCT00290771|6365514|P1|Overall Study|Withdrawal by Subject|5
1838691|NCT00290771|6365513|P2|Overall Study|Adverse Event|6
1838692|NCT00290771|6365514|P1|Overall Study|Adverse Event|12
1838693|NCT00290771|6365513|P2|Overall Study|Death|10
1838694|NCT00290771|6365514|P1|Overall Study|Death|11
1838695|NCT00290771|6365513|P2|Overall Study|Disease progression|73
1838696|NCT00290771|6365514|P1|Overall Study|Disease progression|95
1838697|NCT00290758|6365538|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
1838698|NCT00290758|6365539|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
1838699|NCT00290758|6365538|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
1838700|NCT00290758|6365539|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
1838701|NCT00290758|6365538|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
1838702|NCT00290758|6365539|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
1838703|NCT00290758|6365538|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
1838704|NCT00290758|6365539|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
1838705|NCT00290758|6365538|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1838706|NCT00290758|6365539|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
1838707|NCT00290758|6365538|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
1838708|NCT00290758|6365539|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
1838709|NCT00290758|6365538|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
1838710|NCT00290758|6365539|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
1838711|NCT00290758|6365538|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
1838712|NCT00290758|6365539|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
1838713|NCT00290732|6365561|P5|Overall Study|Inability to instill drug intraductally.|0
1838714|NCT00290732|6365562|P4|Overall Study|Inability to instill drug intraductally.|0
1838715|NCT00290732|6365563|P3|Overall Study|Inability to instill drug intraductally.|1
1838716|NCT00290732|6365564|P2|Overall Study|Inability to instill drug intraductally.|1
1838717|NCT00290732|6365565|P1|Overall Study|Inability to instill drug intraductally.|0
1838718|NCT00290706|6365587|P4|Overall Study|Physician Decision|1
1838719|NCT00290706|6365588|P3|Overall Study|Physician Decision|0
1838720|NCT00290706|6365589|P2|Overall Study|Physician Decision|0
1838721|NCT00290706|6365590|P1|Overall Study|Physician Decision|0
1838722|NCT00290706|6365587|P4|Overall Study|Receive auto transplant or radiation|1
1838723|NCT00290706|6365588|P3|Overall Study|Receive auto transplant or radiation|0
1838724|NCT00290706|6365589|P2|Overall Study|Receive auto transplant or radiation|0
1838725|NCT00290706|6365590|P1|Overall Study|Receive auto transplant or radiation|0
1838726|NCT00290706|6365587|P4|Overall Study|Adverse Event|0
1838727|NCT00290706|6365588|P3|Overall Study|Adverse Event|2
1838728|NCT00290706|6365589|P2|Overall Study|Adverse Event|1
1838729|NCT00290706|6365590|P1|Overall Study|Adverse Event|0
1838730|NCT00290706|6365587|P4|Overall Study|Progressive Disease|10
1838731|NCT00290706|6365588|P3|Overall Study|Progressive Disease|4
1838732|NCT00290706|6365589|P2|Overall Study|Progressive Disease|5
1838733|NCT00290706|6365590|P1|Overall Study|Progressive Disease|3
1838734|NCT00290706|6365587|P4|Overall Study|Withdrawal by Subject|0
1838735|NCT00290706|6365588|P3|Overall Study|Withdrawal by Subject|0
1838736|NCT00290706|6365589|P2|Overall Study|Withdrawal by Subject|0
1838737|NCT00290706|6365590|P1|Overall Study|Withdrawal by Subject|2
1838738|NCT00290693|6365609|P1|Overall Study|Withdrawal by Subject|2
1838739|NCT00290589|6365637|P2|Overall Study|Lost to Follow-up|2
1838740|NCT00290589|6365638|P1|Overall Study|Lost to Follow-up|2
1838741|NCT00290407|6365671|P1|Overall Study|Physician Decision|2
1838742|NCT00290355|6365678|P2|Overall Study|Other|0
1838743|NCT00290355|6365679|P1|Overall Study|Other|2
1838744|NCT00290355|6365678|P2|Overall Study|Lost to Follow-up|1
1838745|NCT00290355|6365679|P1|Overall Study|Lost to Follow-up|3
1838746|NCT00290355|6365678|P2|Overall Study|Migrated / moved from the study area|0
1838747|NCT00290355|6365679|P1|Overall Study|Migrated / moved from the study area|1
1838748|NCT00290355|6365678|P2|Overall Study|Withdrawal by Subject|0
1838749|NCT00290355|6365679|P1|Overall Study|Withdrawal by Subject|2
1838750|NCT00290355|6365678|P2|Overall Study|Protocol Violation|0
1838751|NCT00290355|6365679|P1|Overall Study|Protocol Violation|1
1838752|NCT00290355|6365678|P2|Overall Study|Study product reactogenicity|0
1838753|NCT00290355|6365679|P1|Overall Study|Study product reactogenicity|1
1838754|NCT00290355|6365678|P2|Overall Study|Serious adverse event|4
1838755|NCT00290355|6365679|P1|Overall Study|Serious adverse event|7
1838756|NCT00290342|6365723|P2|Overall Study|Lost to Follow-up|0
1838757|NCT00290342|6365724|P1|Overall Study|Lost to Follow-up|1
1838758|NCT00290342|6365723|P2|Overall Study|Withdrawal by Subject|4
1838759|NCT00290342|6365724|P1|Overall Study|Withdrawal by Subject|6
1838760|NCT00290342|6365723|P2|Overall Study|Other|1
1838761|NCT00290342|6365724|P1|Overall Study|Other|0
1838762|NCT00290290|6365779|P2|Overall Study|Underwent clean surgical procedure|12
1838763|NCT00290290|6365780|P1|Overall Study|Underwent clean surgical procedure|13
1838764|NCT00290290|6365779|P2|Overall Study|Withdrawal by Subject|2
1838765|NCT00290290|6365780|P1|Overall Study|Withdrawal by Subject|2
1838766|NCT00290290|6365779|P2|Overall Study|Death|4
1838767|NCT00290290|6365780|P1|Overall Study|Death|3
1838768|NCT00290251|6365786|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1838769|NCT00290251|6365787|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
1838770|NCT00290251|6365788|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
1838771|NCT00290251|6365786|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
1838772|NCT00290251|6365787|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
1838773|NCT00290251|6365788|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
1838774|NCT00290251|6365786|P3|Treatment 1 (Months 1 - 3)|headache|0
1838775|NCT00290251|6365787|P2|Treatment 1 (Months 1 - 3)|headache|1
1838776|NCT00290251|6365788|P1|Treatment 1 (Months 1 - 3)|headache|0
1838777|NCT00290251|6365786|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
1838778|NCT00290251|6365787|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1838779|NCT00290251|6365788|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
1838780|NCT00290238|6365800|P2|Overall Study|Withdrawal by Subject|13
1838781|NCT00290238|6365801|P1|Overall Study|Withdrawal by Subject|15
1838782|NCT00290238|6365800|P2|Overall Study|Lost to Follow-up|1
1838783|NCT00290238|6365801|P1|Overall Study|Lost to Follow-up|0
1838784|NCT00290238|6365800|P2|Overall Study|Study terminated|27
1838785|NCT00290238|6365801|P1|Overall Study|Study terminated|27
1838786|NCT00290186|6365826|P2|Overall Study|Withdrawal by Subject|1
1838787|NCT00290186|6365827|P1|Overall Study|Withdrawal by Subject|0
1838788|NCT00290186|6365826|P2|Overall Study|Study was terminated prior to 3-month te|1
1838789|NCT00290186|6365827|P1|Overall Study|Study was terminated prior to 3-month te|1
1838790|NCT00290186|6365826|P2|Overall Study|Lost to Follow-up|2
1838791|NCT00290186|6365827|P1|Overall Study|Lost to Follow-up|3
1838792|NCT00290186|6365826|P2|Overall Study|Adverse Event|1
1838793|NCT00290186|6365827|P1|Overall Study|Adverse Event|1
1838794|NCT00289991|6365878|P2|Overall Study|Other|14
1838795|NCT00289991|6365879|P1|Overall Study|Other|5
1838796|NCT00289991|6365878|P2|Overall Study|Withdrawal by Subject|12
1838797|NCT00289991|6365879|P1|Overall Study|Withdrawal by Subject|2
1838798|NCT00289991|6365878|P2|Overall Study|Lost to Follow-up|1
1838799|NCT00289991|6365879|P1|Overall Study|Lost to Follow-up|0
1838800|NCT00289991|6365878|P2|Overall Study|Fungal breakthrough infection|1
1838801|NCT00289991|6365879|P1|Overall Study|Fungal breakthrough infection|0
1838802|NCT00289991|6365878|P2|Overall Study|Failure of prophylaxis|1
1838803|NCT00289991|6365879|P1|Overall Study|Failure of prophylaxis|1
1838804|NCT00289991|6365878|P2|Overall Study|Adverse Event|13
1838805|NCT00289991|6365879|P1|Overall Study|Adverse Event|15
1838806|NCT00289991|6365878|P2|Overall Study|Death|38
1838807|NCT00289991|6365879|P1|Overall Study|Death|35
1838808|NCT00289978|6365904|P3|Overall Study|Death|2
1838809|NCT00289978|6365905|P2|Overall Study|Death|0
1838810|NCT00289978|6365906|P1|Overall Study|Death|1
1838811|NCT00289978|6365904|P3|Overall Study|Abnormal test procedure result(s)|1
1838812|NCT00289978|6365905|P2|Overall Study|Abnormal test procedure result(s)|1
1838813|NCT00289978|6365906|P1|Overall Study|Abnormal test procedure result(s)|2
1838814|NCT00289978|6365904|P3|Overall Study|Protocol Violation|4
1838815|NCT00289978|6365905|P2|Overall Study|Protocol Violation|5
1838816|NCT00289978|6365906|P1|Overall Study|Protocol Violation|5
1838817|NCT00289978|6365904|P3|Overall Study|Lost to Follow-up|7
1838818|NCT00289978|6365905|P2|Overall Study|Lost to Follow-up|5
1838819|NCT00289978|6365906|P1|Overall Study|Lost to Follow-up|3
1838820|NCT00289978|6365904|P3|Overall Study|Abnormal laboratory value(s)|1
1838821|NCT00289978|6365905|P2|Overall Study|Abnormal laboratory value(s)|9
1838822|NCT00289978|6365906|P1|Overall Study|Abnormal laboratory value(s)|20
1838823|NCT00289978|6365904|P3|Overall Study|Lack of Efficacy|25
1838824|NCT00289978|6365905|P2|Overall Study|Lack of Efficacy|6
1838825|NCT00289978|6365906|P1|Overall Study|Lack of Efficacy|13
1838826|NCT00289978|6365904|P3|Overall Study|Adverse Event|18
1838827|NCT00289978|6365905|P2|Overall Study|Adverse Event|13
1838828|NCT00289978|6365906|P1|Overall Study|Adverse Event|22
1838829|NCT00289978|6365904|P3|Overall Study|Withdrawal by Subject|28
1838830|NCT00289978|6365905|P2|Overall Study|Withdrawal by Subject|17
1838831|NCT00289978|6365906|P1|Overall Study|Withdrawal by Subject|31
1838832|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1838833|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1838834|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1838835|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
1838836|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
1838837|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
1838838|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1838839|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1838840|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1838841|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
1838842|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1838843|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1838844|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1838845|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
1838846|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1838847|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
1838848|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1838849|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
1838850|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
1838851|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
1838852|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
1838853|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1838854|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1838855|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1838856|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
1838857|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1838858|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1838859|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1838860|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1838861|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1838862|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1838863|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
1838864|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
1838865|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
1838866|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
1838867|NCT00289913|6365925|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838868|NCT00289913|6365926|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838869|NCT00289913|6365927|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838870|NCT00289913|6365928|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1838871|NCT00289913|6365929|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838872|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
1838873|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1838874|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1838875|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1838876|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
1838877|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
1838878|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1838879|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1838880|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1838881|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
1838882|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
1838883|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1838884|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1838885|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1838886|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
1838887|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
1838888|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1838889|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1838890|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1838891|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
1838892|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
1838893|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1838894|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1838895|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1838896|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
1838897|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1838898|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1838899|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1838900|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
1838901|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
1838902|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1838903|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1838904|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
1838905|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
1838906|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
1838907|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1838908|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
1838909|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
1838910|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
1838911|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
1838912|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1838913|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1838914|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
1838915|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1838916|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1838917|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1838918|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1838919|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1838920|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
1838921|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
1838922|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1838923|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1838924|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
1838925|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1838926|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
1838927|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1838928|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1838929|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1838930|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
1838931|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
1838932|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
1838933|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1838934|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
1838935|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
1838936|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
1838937|NCT00289913|6365925|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838938|NCT00289913|6365926|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838939|NCT00289913|6365927|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1838940|NCT00289913|6365928|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838941|NCT00289913|6365929|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838942|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1838943|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1838944|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
1838945|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
1838946|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
1838947|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1838948|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
1838949|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
1838950|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
1838951|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
1838952|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
1838953|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1838954|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
1838955|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
1838956|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
1838957|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1838958|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1838959|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
1838960|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
1838961|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
1838962|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1838963|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
1838964|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1838965|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1838966|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
1838967|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
1838968|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1838969|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1838970|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1838971|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
1838972|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1838973|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1838974|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
1838975|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1838976|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
1838977|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
1838978|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1838979|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1838980|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
1838981|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
1838982|NCT00289913|6365925|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838983|NCT00289913|6365926|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838984|NCT00289913|6365927|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838985|NCT00289913|6365928|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
1838986|NCT00289913|6365929|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
1838987|NCT00289900|6365960|P6|Overall Study|Not treated|0
1838988|NCT00289900|6365961|P5|Overall Study|Not treated|0
1838989|NCT00289900|6365962|P4|Overall Study|Not treated|0
1838990|NCT00289900|6365963|P3|Overall Study|Not treated|0
1838991|NCT00289900|6365964|P2|Overall Study|Not treated|1
1838992|NCT00289900|6365965|P1|Overall Study|Not treated|0
1838993|NCT00289900|6365960|P6|Overall Study|site terminated|0
1838994|NCT00289900|6365961|P5|Overall Study|site terminated|0
1838995|NCT00289900|6365962|P4|Overall Study|site terminated|0
1838996|NCT00289900|6365963|P3|Overall Study|site terminated|1
1838997|NCT00289900|6365964|P2|Overall Study|site terminated|0
1838998|NCT00289900|6365965|P1|Overall Study|site terminated|1
1838999|NCT00289900|6365960|P6|Overall Study|Protocol Violation|4
1839000|NCT00289900|6365961|P5|Overall Study|Protocol Violation|7
1839001|NCT00289900|6365962|P4|Overall Study|Protocol Violation|6
1839002|NCT00289900|6365963|P3|Overall Study|Protocol Violation|2
1839003|NCT00289900|6365964|P2|Overall Study|Protocol Violation|9
1839004|NCT00289900|6365965|P1|Overall Study|Protocol Violation|3
1839005|NCT00289900|6365960|P6|Overall Study|Withdrawal by Subject|11
1839006|NCT00289900|6365961|P5|Overall Study|Withdrawal by Subject|12
1839007|NCT00289900|6365962|P4|Overall Study|Withdrawal by Subject|18
1839008|NCT00289900|6365963|P3|Overall Study|Withdrawal by Subject|8
1839009|NCT00289900|6365964|P2|Overall Study|Withdrawal by Subject|21
1839010|NCT00289900|6365965|P1|Overall Study|Withdrawal by Subject|10
1839011|NCT00289900|6365960|P6|Overall Study|Participant moved|1
1839012|NCT00289900|6365961|P5|Overall Study|Participant moved|1
1839013|NCT00289900|6365962|P4|Overall Study|Participant moved|1
1839014|NCT00289900|6365963|P3|Overall Study|Participant moved|0
1839015|NCT00289900|6365964|P2|Overall Study|Participant moved|0
1839016|NCT00289900|6365965|P1|Overall Study|Participant moved|1
1839017|NCT00289900|6365960|P6|Overall Study|Other|0
1839018|NCT00289900|6365961|P5|Overall Study|Other|1
1839019|NCT00289900|6365962|P4|Overall Study|Other|5
1839020|NCT00289900|6365963|P3|Overall Study|Other|0
1839021|NCT00289900|6365964|P2|Overall Study|Other|0
1839022|NCT00289900|6365965|P1|Overall Study|Other|0
1839023|NCT00289900|6365960|P6|Overall Study|Participant had flushing|4
1839024|NCT00289900|6365961|P5|Overall Study|Participant had flushing|0
1839025|NCT00289900|6365962|P4|Overall Study|Participant had flushing|2
1839026|NCT00289900|6365963|P3|Overall Study|Participant had flushing|1
1839027|NCT00289900|6365964|P2|Overall Study|Participant had flushing|42
1839028|NCT00289900|6365965|P1|Overall Study|Participant had flushing|18
1839029|NCT00289900|6365960|P6|Overall Study|Lost to Follow-up|8
1839030|NCT00289900|6365961|P5|Overall Study|Lost to Follow-up|4
1839031|NCT00289900|6365962|P4|Overall Study|Lost to Follow-up|8
1839032|NCT00289900|6365963|P3|Overall Study|Lost to Follow-up|8
1839033|NCT00289900|6365964|P2|Overall Study|Lost to Follow-up|7
1839034|NCT00289900|6365965|P1|Overall Study|Lost to Follow-up|7
1839035|NCT00289900|6365960|P6|Overall Study|Adverse Event|33
1839036|NCT00289900|6365961|P5|Overall Study|Adverse Event|20
1839037|NCT00289900|6365962|P4|Overall Study|Adverse Event|19
1839038|NCT00289900|6365963|P3|Overall Study|Adverse Event|13
1839039|NCT00289900|6365964|P2|Overall Study|Adverse Event|40
1839040|NCT00289900|6365965|P1|Overall Study|Adverse Event|28
1839041|NCT00289887|6366069|P2|Overall Study|Other|3
1839042|NCT00289887|6366070|P1|Overall Study|Other|7
1839043|NCT00289887|6366069|P2|Overall Study|Withdrawal by Subject|8
1839044|NCT00289887|6366070|P1|Overall Study|Withdrawal by Subject|3
1839045|NCT00289887|6366069|P2|Overall Study|Protocol Violation|1
1839046|NCT00289887|6366070|P1|Overall Study|Protocol Violation|3
1839047|NCT00289887|6366069|P2|Overall Study|Lost to Follow-up|3
1839048|NCT00289887|6366070|P1|Overall Study|Lost to Follow-up|3
1839049|NCT00289887|6366069|P2|Overall Study|Lack of Efficacy|11
1839050|NCT00289887|6366070|P1|Overall Study|Lack of Efficacy|3
1839051|NCT00289887|6366069|P2|Overall Study|Adverse Event|3
1839052|NCT00289887|6366070|P1|Overall Study|Adverse Event|3
1839053|NCT00289874|6366088|P2|Overall Study|Did not meet eligibility|0
1839054|NCT00289874|6366089|P1|Overall Study|Did not meet eligibility|1
1839055|NCT00289874|6366088|P2|Overall Study|Protocol Violation|2
1839056|NCT00289874|6366089|P1|Overall Study|Protocol Violation|3
1839057|NCT00289874|6366088|P2|Overall Study|Lost to Follow-up|1
1839058|NCT00289874|6366089|P1|Overall Study|Lost to Follow-up|1
1839059|NCT00289874|6366088|P2|Overall Study|Adverse Event|5
1839060|NCT00289874|6366089|P1|Overall Study|Adverse Event|1
1839061|NCT00289848|6366099|P2|Overall Study|Open-Label AHA Treatment Requested|1
1839062|NCT00289848|6366100|P1|Overall Study|Open-Label AHA Treatment Requested|0
1839063|NCT00289848|6366099|P2|Overall Study|Patient Moved|2
1839064|NCT00289848|6366100|P1|Overall Study|Patient Moved|6
1839065|NCT00289848|6366099|P2|Overall Study|Withdrawal by Subject|11
1839066|NCT00289848|6366100|P1|Overall Study|Withdrawal by Subject|5
1839067|NCT00289848|6366099|P2|Overall Study|Protocol Violation|2
1839068|NCT00289848|6366100|P1|Overall Study|Protocol Violation|5
1839069|NCT00289848|6366099|P2|Overall Study|Lost to Follow-up|1
1839070|NCT00289848|6366100|P1|Overall Study|Lost to Follow-up|3
1839071|NCT00289848|6366099|P2|Overall Study|Lack of Efficacy|24
1839072|NCT00289848|6366100|P1|Overall Study|Lack of Efficacy|20
1839073|NCT00289848|6366099|P2|Overall Study|Death|0
1839074|NCT00289848|6366100|P1|Overall Study|Death|1
1839075|NCT00289848|6366099|P2|Overall Study|Adverse Event|4
1839076|NCT00289848|6366100|P1|Overall Study|Adverse Event|6
1839077|NCT00289783|6366112|P2|Fourth Dose Phase|Other|10
1839078|NCT00289783|6366113|P1|Fourth Dose Phase|Other|22
1839079|NCT00289783|6366112|P2|Fourth Dose Phase|Migration from the study area|1
1839080|NCT00289783|6366113|P1|Fourth Dose Phase|Migration from the study area|1
1839081|NCT00289783|6366112|P2|Fourth Dose Phase|Lost to Follow-up|12
1839082|NCT00289783|6366113|P1|Fourth Dose Phase|Lost to Follow-up|53
1839083|NCT00289783|6366112|P2|Fourth Dose Phase|Withdrawal by Subject|1
1839084|NCT00289783|6366113|P1|Fourth Dose Phase|Withdrawal by Subject|10
1839085|NCT00289783|6366112|P2|Fourth Dose Phase|Adverse Event|0
1839086|NCT00289783|6366113|P1|Fourth Dose Phase|Adverse Event|1
1839087|NCT00289783|6366112|P2|Primary Phase|Other|12
1839088|NCT00289783|6366113|P1|Primary Phase|Other|32
1839089|NCT00289783|6366112|P2|Primary Phase|Migration from the study area|10
1839090|NCT00289783|6366113|P1|Primary Phase|Migration from the study area|26
1839091|NCT00289783|6366112|P2|Primary Phase|Lost to Follow-up|14
1839092|NCT00289783|6366113|P1|Primary Phase|Lost to Follow-up|60
1839093|NCT00289783|6366112|P2|Primary Phase|Withdrawal by Subject|40
1839094|NCT00289783|6366113|P1|Primary Phase|Withdrawal by Subject|93
1839095|NCT00289783|6366112|P2|Primary Phase|Protocol Violation|6
1839096|NCT00289783|6366113|P1|Primary Phase|Protocol Violation|27
1839097|NCT00289783|6366112|P2|Primary Phase|Adverse Event|1
1839098|NCT00289783|6366113|P1|Primary Phase|Adverse Event|10
1839099|NCT00289770|6366291|P1|Year 15|Withdrawal by Subject|1
1839100|NCT00289731|6366337|P3|Overall Study|Other|0
1839101|NCT00289731|6366338|P2|Overall Study|Other|0
1839102|NCT00289731|6366339|P1|Overall Study|Other|1
1839103|NCT00289731|6366337|P3|Overall Study|Adverse Event|2
1839104|NCT00289731|6366338|P2|Overall Study|Adverse Event|2
1839105|NCT00289731|6366339|P1|Overall Study|Adverse Event|1
1839106|NCT00289536|6366451|P3|Period 3|Lost to Follow-up|1
1839107|NCT00289536|6366452|P2|Period 3|Lost to Follow-up|0
1839108|NCT00289536|6366453|P1|Period 3|Lost to Follow-up|0
1839109|NCT00289458|6366499|P3|Overall Study|Withdrawal by Subject|4
1839110|NCT00289458|6366500|P2|Overall Study|Withdrawal by Subject|2
1839111|NCT00289458|6366501|P1|Overall Study|Withdrawal by Subject|2
1839112|NCT00289458|6366499|P3|Overall Study|Physician Decision|2
1839113|NCT00289458|6366500|P2|Overall Study|Physician Decision|4
1839114|NCT00289458|6366501|P1|Overall Study|Physician Decision|3
1839115|NCT00289458|6366499|P3|Overall Study|Death|0
1839116|NCT00289458|6366500|P2|Overall Study|Death|0
1839117|NCT00289458|6366501|P1|Overall Study|Death|1
1839118|NCT00289289|6366562|P3|Overall Study|Other Exit Reason|12
1839119|NCT00289289|6366563|P2|Overall Study|Other Exit Reason|4
1839120|NCT00289289|6366564|P1|Overall Study|Other Exit Reason|6
1839121|NCT00289289|6366562|P3|Overall Study|Did not meet inclusion/exclusion|6
1839122|NCT00289289|6366563|P2|Overall Study|Did not meet inclusion/exclusion|0
1839123|NCT00289289|6366564|P1|Overall Study|Did not meet inclusion/exclusion|0
1839124|NCT00289289|6366562|P3|Overall Study|Non-study device implanted|3
1839125|NCT00289289|6366563|P2|Overall Study|Non-study device implanted|1
1839126|NCT00289289|6366564|P1|Overall Study|Non-study device implanted|2
1839127|NCT00289289|6366562|P3|Overall Study|Physician Decision|6
1839128|NCT00289289|6366563|P2|Overall Study|Physician Decision|0
1839129|NCT00289289|6366564|P1|Overall Study|Physician Decision|1
1839130|NCT00289289|6366562|P3|Overall Study|No implant attempted|1
1839131|NCT00289289|6366563|P2|Overall Study|No implant attempted|0
1839132|NCT00289289|6366564|P1|Overall Study|No implant attempted|0
1839133|NCT00289289|6366562|P3|Overall Study|Death|5
1839134|NCT00289289|6366563|P2|Overall Study|Death|2
1839135|NCT00289289|6366564|P1|Overall Study|Death|4
1839136|NCT00289289|6366562|P3|Overall Study|Lost to Follow-up|1
1839137|NCT00289289|6366563|P2|Overall Study|Lost to Follow-up|0
1839138|NCT00289289|6366564|P1|Overall Study|Lost to Follow-up|1
1839139|NCT00289289|6366562|P3|Overall Study|Withdrawal by Subject|15
1839140|NCT00289289|6366563|P2|Overall Study|Withdrawal by Subject|3
1839141|NCT00289289|6366564|P1|Overall Study|Withdrawal by Subject|5
1839142|NCT00289276|6366579|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
1839143|NCT00289276|6366580|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
1839144|NCT00289276|6366579|P2|Second Part of FAST Study (Expansion)|Death|2
1839145|NCT00289276|6366580|P1|Second Part of FAST Study (Expansion)|Death|0
1839146|NCT00289198|6366615|P2|Overall Study|Other: Impossible to come on visit|1
1839147|NCT00289198|6366616|P1|Overall Study|Other: Impossible to come on visit|0
1839148|NCT00289198|6366615|P2|Overall Study|Other: Miscalculation of the visit date|22
1839149|NCT00289198|6366616|P1|Overall Study|Other: Miscalculation of the visit date|21
1839150|NCT00289198|6366615|P2|Overall Study|Other: Unable to attend on schedule|1
1839151|NCT00289198|6366616|P1|Overall Study|Other: Unable to attend on schedule|2
1839152|NCT00289198|6366615|P2|Overall Study|Other: Physician's decision|1
1839153|NCT00289198|6366616|P1|Overall Study|Other: Physician's decision|0
1839154|NCT00289198|6366615|P2|Overall Study|Other: Low compliance|1
1839155|NCT00289198|6366616|P1|Overall Study|Other: Low compliance|0
1839156|NCT00289198|6366615|P2|Overall Study|Lack of Efficacy|0
1839157|NCT00289198|6366616|P1|Overall Study|Lack of Efficacy|2
1839158|NCT00289198|6366615|P2|Overall Study|Withdrawal by Subject|1
1839159|NCT00289198|6366616|P1|Overall Study|Withdrawal by Subject|4
1839160|NCT00289198|6366615|P2|Overall Study|Protocol Violation|1
1839161|NCT00289198|6366616|P1|Overall Study|Protocol Violation|2
1839162|NCT00289198|6366615|P2|Overall Study|Adverse Event|2
1839163|NCT00289198|6366616|P1|Overall Study|Adverse Event|0
1839164|NCT00289185|6366666|P2|Overall Study|Death|1
1839165|NCT00289185|6366667|P1|Overall Study|Death|1
1839166|NCT00289185|6366666|P2|Overall Study|Lost to Follow-up|17
1839167|NCT00289185|6366667|P1|Overall Study|Lost to Follow-up|23
1839168|NCT00289185|6366666|P2|Overall Study|Withdrawal by Subject|8
1839169|NCT00289185|6366667|P1|Overall Study|Withdrawal by Subject|4
1839170|NCT00289133|6366714|P2|Overall Study|Lost to Follow-up|115
1839171|NCT00289133|6366715|P1|Overall Study|Lost to Follow-up|92
1839172|NCT00289133|6366714|P2|Overall Study|Revision|6
1839173|NCT00289133|6366715|P1|Overall Study|Revision|8
1839174|NCT00289133|6366714|P2|Overall Study|Physician Decision|45
1839175|NCT00289133|6366715|P1|Overall Study|Physician Decision|41
1839176|NCT00289133|6366714|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
1839177|NCT00289133|6366715|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
1839178|NCT00289133|6366714|P2|Overall Study|Death|10
1839179|NCT00289133|6366715|P1|Overall Study|Death|5
1839180|NCT00289133|6366714|P2|Overall Study|Withdrawal by Subject|10
1839181|NCT00289133|6366715|P1|Overall Study|Withdrawal by Subject|9
1839182|NCT00289133|6366714|P2|Overall Study|Protocol Violation|38
1839183|NCT00289133|6366715|P1|Overall Study|Protocol Violation|32
1839184|NCT00289133|6366714|P2|Overall Study|Non-study device implanted|0
1839185|NCT00289133|6366715|P1|Overall Study|Non-study device implanted|12
1839186|NCT00289016|6366771|P1|Overall Study|Other|1
1839187|NCT00289016|6366771|P1|Overall Study|Adverse Event|1
1839188|NCT00289016|6366771|P1|Overall Study|Withdrawal by Subject|2
1839189|NCT00289016|6366771|P1|Overall Study|Unrelated Medical Condition or Accident|2
1839190|NCT00289016|6366771|P1|Overall Study|Death|2
1839191|NCT00289016|6366771|P1|Overall Study|Disease Progression|29
1839192|NCT00288912|6366783|P3|Overall Study|Withdrawal by Subject|12
1839193|NCT00288912|6366784|P2|Overall Study|Withdrawal by Subject|5
1839194|NCT00288912|6366785|P1|Overall Study|Withdrawal by Subject|4
1839195|NCT00288912|6366783|P3|Overall Study|Lost to Follow-up|9
1839196|NCT00288912|6366784|P2|Overall Study|Lost to Follow-up|6
1839197|NCT00288912|6366785|P1|Overall Study|Lost to Follow-up|9
1839198|NCT00288912|6366783|P3|Overall Study|Developed exclusion criterion|7
1839199|NCT00288912|6366784|P2|Overall Study|Developed exclusion criterion|6
1839200|NCT00288912|6366785|P1|Overall Study|Developed exclusion criterion|4
1839201|NCT00288860|6366825|P2|Overall Study|Lost to Follow-up|71
1839202|NCT00288860|6366826|P1|Overall Study|Lost to Follow-up|74
1839203|NCT00288860|6366825|P2|Overall Study|Withdrawal by Subject|15
1839204|NCT00288860|6366826|P1|Overall Study|Withdrawal by Subject|20
1839205|NCT00288860|6366825|P2|Overall Study|Death|3
1839206|NCT00288860|6366826|P1|Overall Study|Death|4
1839207|NCT00288860|6366825|P2|Overall Study|Did not complete intake|8
1839208|NCT00288860|6366826|P1|Overall Study|Did not complete intake|4
1839209|NCT00288704|6366839|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
1839210|NCT00288704|6366840|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1839211|NCT00288704|6366841|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
1839212|NCT00288704|6366839|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
1839213|NCT00288704|6366840|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1839214|NCT00288704|6366841|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
1839215|NCT00288704|6366839|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
1839216|NCT00288704|6366840|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
1839217|NCT00288704|6366841|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
1839218|NCT00288704|6366839|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
1839219|NCT00288704|6366840|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1839220|NCT00288704|6366841|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
1839221|NCT00288704|6366839|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
1839222|NCT00288704|6366840|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1839223|NCT00288704|6366841|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
1839224|NCT00288704|6366839|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1839225|NCT00288704|6366840|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
1839226|NCT00288704|6366841|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
1839227|NCT00288704|6366839|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1839228|NCT00288704|6366840|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
1839229|NCT00288704|6366841|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
1839230|NCT00288639|6366868|P1|Overall Study|Other|1
1839231|NCT00288639|6366868|P1|Overall Study|Withdrawal by Subject|2
1839232|NCT00288639|6366868|P1|Overall Study|Lack of Efficacy|4
1839233|NCT00288639|6366868|P1|Overall Study|Adverse Event|5
1839234|NCT00288626|6366885|P1|Overall Study|Withdrawal by Subject|4
1839235|NCT00288626|6366885|P1|Overall Study|Death|3
1839236|NCT00288587|6366919|P2|Overall Study|Severe Aortic Stenosis|0
1839237|NCT00288587|6366920|P1|Overall Study|Severe Aortic Stenosis|1
1839238|NCT00288587|6366919|P2|Overall Study|Physician Decision|2
1839239|NCT00288587|6366920|P1|Overall Study|Physician Decision|0
1839240|NCT00288587|6366919|P2|Overall Study|Adverse Event|1
1839241|NCT00288587|6366920|P1|Overall Study|Adverse Event|0
1839242|NCT00288587|6366919|P2|Overall Study|Transplant|3
1839243|NCT00288587|6366920|P1|Overall Study|Transplant|0
1839244|NCT00288587|6366919|P2|Overall Study|Death|4
1839245|NCT00288587|6366920|P1|Overall Study|Death|4
1839246|NCT00288509|6366963|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
1839247|NCT00288509|6366963|P1|Treatment Cycle 4|Physician Decision|4
1839248|NCT00288509|6366963|P1|Treatment Cycle 4|Withdrawal by Subject|3
1839249|NCT00288509|6366963|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
1839250|NCT00288509|6366963|P1|Treatment Cycle 3|Lost to Follow-up|2
1839251|NCT00288509|6366963|P1|Treatment Cycle 3|Withdrawal by Subject|1
1839252|NCT00288509|6366963|P1|Treatment Cycle 3|Lack of Efficacy|1
1839253|NCT00288509|6366963|P1|Treatment Cycle 2|Withdrawal by Subject|2
1839254|NCT00288509|6366963|P1|Treatment Cycle 2|Lack of Efficacy|1
1839255|NCT00288509|6366963|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
1839256|NCT00288509|6366963|P1|Treatment Cycle 1|Lost to Follow-up|2
1839257|NCT00288509|6366963|P1|Treatment Cycle 1|Withdrawal by Subject|1
1839258|NCT00288509|6366963|P1|Treatment Cycle 1|Lack of Efficacy|1
1839259|NCT00288509|6366963|P1|Treatment Cycle 1|Adverse Event|1
1839260|NCT00288080|6366981|P2|Overall Study|Protocol Violation|20
1839261|NCT00288080|6366982|P1|Overall Study|Protocol Violation|25
1839262|NCT00288080|6366981|P2|Overall Study|Withdrawal by Subject|3
1839263|NCT00288080|6366982|P1|Overall Study|Withdrawal by Subject|1
1839264|NCT00288054|6367004|P1|Overall Study|Not protocol specified|2
1839265|NCT00288054|6367004|P1|Overall Study|Withdrawal by Subject|1
1839266|NCT00288054|6367004|P1|Overall Study|Adverse Event|3
1839267|NCT00288054|6367004|P1|Overall Study|Lack of Efficacy|16
1839268|NCT00288054|6367004|P1|Overall Study|Protocol Violation|2
1839269|NCT00288015|6367012|P1|Follow up for Survival x 2 Years|Other|9
1839270|NCT00288015|6367012|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
1839271|NCT00288015|6367012|P1|Follow up for Survival x 2 Years|Death|13
1839272|NCT00288015|6367012|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
1839273|NCT00288015|6367012|P1|First Response Assessment|Physician Decision|2
1839274|NCT00288015|6367012|P1|First Response Assessment|Death|1
1839275|NCT00288015|6367012|P1|First Response Assessment|Withdrawal by Subject|1
1839276|NCT00288015|6367012|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
1839277|NCT00288015|6367012|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
1839278|NCT00287690|6367104|P2|Overall Study|Protocol Violation|26
1839279|NCT00287690|6367105|P1|Overall Study|Protocol Violation|20
1839280|NCT00287586|6367117|P2|Overall Study|Recurrent Melanoma|1
1839281|NCT00287586|6367118|P1|Overall Study|Recurrent Melanoma|0
1839282|NCT00287586|6367117|P2|Overall Study|Itchy Swollen Eyes|1
1839283|NCT00287586|6367118|P1|Overall Study|Itchy Swollen Eyes|0
1839284|NCT00287586|6367117|P2|Overall Study|Bradycardia|1
1839285|NCT00287586|6367118|P1|Overall Study|Bradycardia|0
1839286|NCT00287586|6367117|P2|Overall Study|Mood Swings and Irritability|1
1839287|NCT00287586|6367118|P1|Overall Study|Mood Swings and Irritability|0
1839288|NCT00287586|6367117|P2|Overall Study|Mastodynia and Gynecomastia|1
1839289|NCT00287586|6367118|P1|Overall Study|Mastodynia and Gynecomastia|0
1839290|NCT00287586|6367117|P2|Overall Study|Retroperitoneal Cancer|1
1839291|NCT00287586|6367118|P1|Overall Study|Retroperitoneal Cancer|0
1839292|NCT00287586|6367117|P2|Overall Study|Elevated IPSS Score|1
1839293|NCT00287586|6367118|P1|Overall Study|Elevated IPSS Score|0
1839294|NCT00287586|6367117|P2|Overall Study|Lung Cancer|2
1839295|NCT00287586|6367118|P1|Overall Study|Lung Cancer|0
1839296|NCT00287586|6367117|P2|Overall Study|Major Depression|2
1839297|NCT00287586|6367118|P1|Overall Study|Major Depression|0
1839298|NCT00287586|6367117|P2|Overall Study|Enrolled in Another Study|0
1839299|NCT00287586|6367118|P1|Overall Study|Enrolled in Another Study|1
1839300|NCT00287586|6367117|P2|Overall Study|Nonadherence|1
1839301|NCT00287586|6367118|P1|Overall Study|Nonadherence|1
1839302|NCT00287586|6367117|P2|Overall Study|Inappropriate Behaviour with Staff|0
1839303|NCT00287586|6367118|P1|Overall Study|Inappropriate Behaviour with Staff|1
1839304|NCT00287586|6367117|P2|Overall Study|Shoulder Pain|0
1839305|NCT00287586|6367118|P1|Overall Study|Shoulder Pain|1
1839306|NCT00287586|6367117|P2|Overall Study|Sleep Apnea|0
1839307|NCT00287586|6367118|P1|Overall Study|Sleep Apnea|1
1839308|NCT00287586|6367117|P2|Overall Study|Pancreatic Cancer|3
1839309|NCT00287586|6367118|P1|Overall Study|Pancreatic Cancer|1
1839310|NCT00287586|6367117|P2|Overall Study|Cognitive Impairment|0
1839311|NCT00287586|6367118|P1|Overall Study|Cognitive Impairment|1
1839312|NCT00287586|6367117|P2|Overall Study|Lower Urinary Tract Symptoms|0
1839313|NCT00287586|6367118|P1|Overall Study|Lower Urinary Tract Symptoms|1
1839314|NCT00287586|6367117|P2|Overall Study|Myocardial Infarction|0
1839315|NCT00287586|6367118|P1|Overall Study|Myocardial Infarction|1
1839316|NCT00287586|6367117|P2|Overall Study|Stroke|0
1839317|NCT00287586|6367118|P1|Overall Study|Stroke|2
1839318|NCT00287586|6367117|P2|Overall Study|Elevated Prostate Specific Antigen|0
1839319|NCT00287586|6367118|P1|Overall Study|Elevated Prostate Specific Antigen|2
1839320|NCT00287586|6367117|P2|Overall Study|Rash|0
1839321|NCT00287586|6367118|P1|Overall Study|Rash|3
1839322|NCT00287586|6367117|P2|Overall Study|Elevated Hematocrit|0
1839323|NCT00287586|6367118|P1|Overall Study|Elevated Hematocrit|3
1839324|NCT00287586|6367117|P2|Overall Study|Death|3
1839325|NCT00287586|6367118|P1|Overall Study|Death|2
1839326|NCT00287586|6367117|P2|Overall Study|Lost to Follow-up|4
1839327|NCT00287586|6367118|P1|Overall Study|Lost to Follow-up|5
1839328|NCT00287586|6367117|P2|Overall Study|Withdrew Consent|30
1839329|NCT00287586|6367118|P1|Overall Study|Withdrew Consent|19
1839330|NCT00287469|6367156|P2|Overall Study|Lost to Follow-up|69
1839331|NCT00287469|6367157|P1|Overall Study|Lost to Follow-up|74
1839332|NCT00287469|6367156|P2|Overall Study|moved from area|138
1839333|NCT00287469|6367157|P1|Overall Study|moved from area|144
1839334|NCT00287469|6367156|P2|Overall Study|Adverse Event|1
1839335|NCT00287469|6367157|P1|Overall Study|Adverse Event|1
1839336|NCT00287469|6367156|P2|Overall Study|serious adverse event|6
1839337|NCT00287469|6367157|P1|Overall Study|serious adverse event|1
1839338|NCT00287365|6367167|P1|Overall Study|sample not acquired|13
1839339|NCT00287118|6367189|P1|Overall Study|Other|7
1839340|NCT00287118|6367189|P1|Overall Study|Protocol Violation|2
1839341|NCT00287118|6367189|P1|Overall Study|Lost to Follow-up|1
1839342|NCT00287118|6367189|P1|Overall Study|Lack of Efficacy|11
1839343|NCT00287118|6367189|P1|Overall Study|Death|1
1839344|NCT00287118|6367189|P1|Overall Study|Adverse Event|30
1839345|NCT00287079|6367195|P2|Overall Study|Other|0
1839346|NCT00287079|6367196|P1|Overall Study|Other|3
1839347|NCT00287079|6367195|P2|Overall Study|Protocol Violation|0
1839348|NCT00287079|6367196|P1|Overall Study|Protocol Violation|1
1839349|NCT00287079|6367195|P2|Overall Study|Adverse Event|0
1839350|NCT00287079|6367196|P1|Overall Study|Adverse Event|5
1839351|NCT00287079|6367195|P2|Overall Study|Non-qualifying relapse|0
1839352|NCT00287079|6367196|P1|Overall Study|Non-qualifying relapse|1
1839353|NCT00287079|6367195|P2|Overall Study|Qualifying relapse|1
1839354|NCT00287079|6367196|P1|Overall Study|Qualifying relapse|12
1839355|NCT00286754|6367224|P3|Overall Study|Moved out of state|1
1839356|NCT00286754|6367225|P2|Overall Study|Moved out of state|0
1839357|NCT00286754|6367226|P1|Overall Study|Moved out of state|0
1839358|NCT00286754|6367224|P3|Overall Study|Lost to Follow-up|6
1839359|NCT00286754|6367225|P2|Overall Study|Lost to Follow-up|14
1839360|NCT00286754|6367226|P1|Overall Study|Lost to Follow-up|12
1839361|NCT00286754|6367224|P3|Overall Study|Withdrawal by Subject|0
1839362|NCT00286754|6367225|P2|Overall Study|Withdrawal by Subject|2
1839363|NCT00286754|6367226|P1|Overall Study|Withdrawal by Subject|6
1839364|NCT00286754|6367224|P3|Overall Study|Adverse Event|3
1839365|NCT00286754|6367225|P2|Overall Study|Adverse Event|2
1839366|NCT00286754|6367226|P1|Overall Study|Adverse Event|2
1839367|NCT00286494|6367285|P3|Overall Study|Protocol Violation|2
1839368|NCT00286494|6367286|P2|Overall Study|Protocol Violation|1
1839369|NCT00286494|6367287|P1|Overall Study|Protocol Violation|1
1839370|NCT00286494|6367285|P3|Overall Study|Lost to Follow-up|3
1839371|NCT00286494|6367286|P2|Overall Study|Lost to Follow-up|1
1839372|NCT00286494|6367287|P1|Overall Study|Lost to Follow-up|3
1839373|NCT00286494|6367285|P3|Overall Study|Physician Decision|1
1839374|NCT00286494|6367286|P2|Overall Study|Physician Decision|5
1839375|NCT00286494|6367287|P1|Overall Study|Physician Decision|5
1839376|NCT00286494|6367285|P3|Overall Study|Adverse Event|6
1839377|NCT00286494|6367286|P2|Overall Study|Adverse Event|8
1839378|NCT00286494|6367287|P1|Overall Study|Adverse Event|3
1839379|NCT00286494|6367285|P3|Overall Study|Withdrawal by Subject|9
1839380|NCT00286494|6367286|P2|Overall Study|Withdrawal by Subject|10
1839381|NCT00286494|6367287|P1|Overall Study|Withdrawal by Subject|2
1839382|NCT00286494|6367285|P3|Overall Study|Hyperglycemic rescue|18
1839383|NCT00286494|6367286|P2|Overall Study|Hyperglycemic rescue|19
1839384|NCT00286494|6367287|P1|Overall Study|Hyperglycemic rescue|12
1839385|NCT00286468|6367448|P3|Overall Study|Physician Decision|1
1839386|NCT00286468|6367449|P2|Overall Study|Physician Decision|2
1839387|NCT00286468|6367450|P1|Overall Study|Physician Decision|3
1839388|NCT00286468|6367448|P3|Overall Study|Withdrawal by Subject|11
1839389|NCT00286468|6367449|P2|Overall Study|Withdrawal by Subject|8
1839390|NCT00286468|6367450|P1|Overall Study|Withdrawal by Subject|3
1839391|NCT00286468|6367448|P3|Overall Study|Lost to Follow-up|2
1839392|NCT00286468|6367449|P2|Overall Study|Lost to Follow-up|1
1839393|NCT00286468|6367450|P1|Overall Study|Lost to Follow-up|1
1839394|NCT00286468|6367448|P3|Overall Study|Protocol Violation|1
1839395|NCT00286468|6367449|P2|Overall Study|Protocol Violation|3
1839396|NCT00286468|6367450|P1|Overall Study|Protocol Violation|0
1839397|NCT00286468|6367448|P3|Overall Study|Adverse Event|4
1839398|NCT00286468|6367449|P2|Overall Study|Adverse Event|6
1839399|NCT00286468|6367450|P1|Overall Study|Adverse Event|2
1839400|NCT00286468|6367448|P3|Overall Study|Hyperglycemic Rescue|31
1839401|NCT00286468|6367449|P2|Overall Study|Hyperglycemic Rescue|30
1839402|NCT00286468|6367450|P1|Overall Study|Hyperglycemic Rescue|28
1839403|NCT00286455|6367611|P3|Overall Study|Withdrawal by Subject|7
1839404|NCT00286455|6367612|P2|Overall Study|Withdrawal by Subject|8
1839405|NCT00286455|6367613|P1|Overall Study|Withdrawal by Subject|0
1839406|NCT00286455|6367611|P3|Overall Study|Participant Non-compliance|0
1839407|NCT00286455|6367612|P2|Overall Study|Participant Non-compliance|0
1839408|NCT00286455|6367613|P1|Overall Study|Participant Non-compliance|1
1839409|NCT00286455|6367611|P3|Overall Study|Protocol Violation|0
1839410|NCT00286455|6367612|P2|Overall Study|Protocol Violation|1
1839411|NCT00286455|6367613|P1|Overall Study|Protocol Violation|1
1839412|NCT00286455|6367611|P3|Overall Study|Physician Decision|2
1839413|NCT00286455|6367612|P2|Overall Study|Physician Decision|0
1839414|NCT00286455|6367613|P1|Overall Study|Physician Decision|3
1839415|NCT00286455|6367611|P3|Overall Study|Lost to Follow-up|3
1839416|NCT00286455|6367612|P2|Overall Study|Lost to Follow-up|3
1839417|NCT00286455|6367613|P1|Overall Study|Lost to Follow-up|0
1839418|NCT00286455|6367611|P3|Overall Study|Adverse Event|2
1839419|NCT00286455|6367612|P2|Overall Study|Adverse Event|3
1839420|NCT00286455|6367613|P1|Overall Study|Adverse Event|1
1839421|NCT00286455|6367611|P3|Overall Study|Hyperglycemia rescue|10
1839422|NCT00286455|6367612|P2|Overall Study|Hyperglycemia rescue|13
1839423|NCT00286455|6367613|P1|Overall Study|Hyperglycemia rescue|19
1839424|NCT00286442|6367792|P3|Overall Study|Withdrawal by Subject|2
1839425|NCT00286442|6367793|P2|Overall Study|Withdrawal by Subject|14
1839426|NCT00286442|6367794|P1|Overall Study|Withdrawal by Subject|2
1839427|NCT00286442|6367792|P3|Overall Study|Administrative Error|0
1839428|NCT00286442|6367793|P2|Overall Study|Administrative Error|1
1839429|NCT00286442|6367794|P1|Overall Study|Administrative Error|1
1839430|NCT00286442|6367792|P3|Overall Study|Physician Decision|1
1839431|NCT00286442|6367793|P2|Overall Study|Physician Decision|1
1839432|NCT00286442|6367794|P1|Overall Study|Physician Decision|1
1839433|NCT00286442|6367792|P3|Overall Study|Lost to Follow-up|1
1839434|NCT00286442|6367793|P2|Overall Study|Lost to Follow-up|2
1839435|NCT00286442|6367794|P1|Overall Study|Lost to Follow-up|5
1839436|NCT00286442|6367792|P3|Overall Study|Protocol Violation|2
1839437|NCT00286442|6367793|P2|Overall Study|Protocol Violation|4
1839438|NCT00286442|6367794|P1|Overall Study|Protocol Violation|2
1839439|NCT00286442|6367792|P3|Overall Study|Adverse Event|1
1839440|NCT00286442|6367793|P2|Overall Study|Adverse Event|6
1839441|NCT00286442|6367794|P1|Overall Study|Adverse Event|7
1839442|NCT00286442|6367792|P3|Overall Study|Hyperglycemic Rescue|25
1839443|NCT00286442|6367793|P2|Overall Study|Hyperglycemic Rescue|17
1839444|NCT00286442|6367794|P1|Overall Study|Hyperglycemic Rescue|19
1839445|NCT00286429|6367955|P3|Overall Study|Administrative Decision|0
1839446|NCT00286429|6367956|P2|Overall Study|Administrative Decision|1
1839447|NCT00286429|6367957|P1|Overall Study|Administrative Decision|0
1839448|NCT00286429|6367955|P3|Overall Study|Administrative Error|1
1839449|NCT00286429|6367956|P2|Overall Study|Administrative Error|1
1839450|NCT00286429|6367957|P1|Overall Study|Administrative Error|1
1839451|NCT00286429|6367955|P3|Overall Study|Withdrawal by Subject|6
1839452|NCT00286429|6367956|P2|Overall Study|Withdrawal by Subject|2
1839453|NCT00286429|6367957|P1|Overall Study|Withdrawal by Subject|3
1839454|NCT00286429|6367955|P3|Overall Study|Protocol Violation|4
1839455|NCT00286429|6367956|P2|Overall Study|Protocol Violation|5
1839456|NCT00286429|6367957|P1|Overall Study|Protocol Violation|3
1839457|NCT00286429|6367955|P3|Overall Study|Physician Decision|7
1839458|NCT00286429|6367956|P2|Overall Study|Physician Decision|7
1839459|NCT00286429|6367957|P1|Overall Study|Physician Decision|10
1839460|NCT00286429|6367955|P3|Overall Study|Lost to Follow-up|3
1839461|NCT00286429|6367956|P2|Overall Study|Lost to Follow-up|4
1839462|NCT00286429|6367957|P1|Overall Study|Lost to Follow-up|2
1839463|NCT00286429|6367955|P3|Overall Study|Lack of Efficacy|25
1839464|NCT00286429|6367956|P2|Overall Study|Lack of Efficacy|27
1839465|NCT00286429|6367957|P1|Overall Study|Lack of Efficacy|52
1839466|NCT00286429|6367955|P3|Overall Study|Adverse Event|6
1839467|NCT00286429|6367956|P2|Overall Study|Adverse Event|1
1839468|NCT00286429|6367957|P1|Overall Study|Adverse Event|4
1839469|NCT00286221|6368073|P4|Overall Study|Unrecognized exclusion criteria met|0
1839470|NCT00286221|6368074|P3|Overall Study|Unrecognized exclusion criteria met|0
1839471|NCT00286221|6368075|P2|Overall Study|Unrecognized exclusion criteria met|1
1839472|NCT00286221|6368076|P1|Overall Study|Unrecognized exclusion criteria met|0
1839473|NCT00286221|6368073|P4|Overall Study|Inability to trigger PCA|0
1839474|NCT00286221|6368074|P3|Overall Study|Inability to trigger PCA|0
1839475|NCT00286221|6368075|P2|Overall Study|Inability to trigger PCA|0
1839476|NCT00286221|6368076|P1|Overall Study|Inability to trigger PCA|2
1839477|NCT00286221|6368073|P4|Overall Study|Unanticipated Neurosurgical Complication|2
1839478|NCT00286221|6368074|P3|Overall Study|Unanticipated Neurosurgical Complication|3
1839479|NCT00286221|6368075|P2|Overall Study|Unanticipated Neurosurgical Complication|3
1839480|NCT00286221|6368076|P1|Overall Study|Unanticipated Neurosurgical Complication|6
1839481|NCT00286221|6368073|P4|Overall Study|Protocol Violation|4
1839482|NCT00286221|6368074|P3|Overall Study|Protocol Violation|6
1839483|NCT00286221|6368075|P2|Overall Study|Protocol Violation|1
1839484|NCT00286221|6368076|P1|Overall Study|Protocol Violation|2
1839485|NCT00286156|6368102|P3|Overall Study|AE: pneumonia|0
1839486|NCT00286156|6368103|P2|Overall Study|AE: pneumonia|0
1839487|NCT00286156|6368104|P1|Overall Study|AE: pneumonia|1
1839488|NCT00286156|6368102|P3|Overall Study|AE: nephrotic-range proteinuruia|0
1839489|NCT00286156|6368103|P2|Overall Study|AE: nephrotic-range proteinuruia|0
1839490|NCT00286156|6368104|P1|Overall Study|AE: nephrotic-range proteinuruia|1
1839491|NCT00286156|6368102|P3|Overall Study|AE: pulmonary embolus|0
1839492|NCT00286156|6368103|P2|Overall Study|AE: pulmonary embolus|1
1839493|NCT00286156|6368104|P1|Overall Study|AE: pulmonary embolus|0
1839494|NCT00286156|6368102|P3|Overall Study|Missed 12 month visit|1
1839495|NCT00286156|6368103|P2|Overall Study|Missed 12 month visit|0
1839496|NCT00286156|6368104|P1|Overall Study|Missed 12 month visit|0
1839497|NCT00286091|6368117|P2|Open-label Treatment Phase|Missing End of Study Information|1
1839498|NCT00286091|6368118|P1|Open-label Treatment Phase|Missing End of Study Information|0
1839499|NCT00286091|6368117|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
1839500|NCT00286091|6368118|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
1839501|NCT00286091|6368117|P2|Open-label Treatment Phase|Lost to Follow-up|1
1839502|NCT00286091|6368118|P1|Open-label Treatment Phase|Lost to Follow-up|0
1839503|NCT00286091|6368117|P2|Open-label Treatment Phase|Noncompliance|1
1839504|NCT00286091|6368118|P1|Open-label Treatment Phase|Noncompliance|3
1839505|NCT00286091|6368117|P2|Open-label Treatment Phase|Disease Progression|3
1839506|NCT00286091|6368118|P1|Open-label Treatment Phase|Disease Progression|9
1839507|NCT00286091|6368117|P2|Open-label Treatment Phase|Death|7
1839508|NCT00286091|6368118|P1|Open-label Treatment Phase|Death|10
1839509|NCT00286091|6368117|P2|Open-label Treatment Phase|Withdrawal by Subject|10
1839510|NCT00286091|6368118|P1|Open-label Treatment Phase|Withdrawal by Subject|14
1839511|NCT00286091|6368117|P2|Open-label Treatment Phase|Other|11
1839512|NCT00286091|6368118|P1|Open-label Treatment Phase|Other|11
1839513|NCT00286091|6368117|P2|Open-label Treatment Phase|Adverse Event|16
1839514|NCT00286091|6368118|P1|Open-label Treatment Phase|Adverse Event|5
1839515|NCT00286091|6368117|P2|Open-label Treatment Phase|Physician Decision|21
1839516|NCT00286091|6368118|P1|Open-label Treatment Phase|Physician Decision|24
1839604|NCT00284141|6368398|P1|Overall Study|Pneumonia|1
1839517|NCT00286091|6368117|P2|Double-blind Treatment Phase|Ineligibility Determined|2
1839518|NCT00286091|6368118|P1|Double-blind Treatment Phase|Ineligibility Determined|1
1839519|NCT00286091|6368117|P2|Double-blind Treatment Phase|Protocol Deviation|3
1839520|NCT00286091|6368118|P1|Double-blind Treatment Phase|Protocol Deviation|1
1839521|NCT00286091|6368117|P2|Double-blind Treatment Phase|Lost to Follow-up|4
1839522|NCT00286091|6368118|P1|Double-blind Treatment Phase|Lost to Follow-up|11
1839523|NCT00286091|6368117|P2|Double-blind Treatment Phase|Noncompliance|8
1839524|NCT00286091|6368118|P1|Double-blind Treatment Phase|Noncompliance|8
1839525|NCT00286091|6368117|P2|Double-blind Treatment Phase|Administrative Decision|21
1839526|NCT00286091|6368118|P1|Double-blind Treatment Phase|Administrative Decision|20
1839527|NCT00286091|6368117|P2|Double-blind Treatment Phase|Other|33
1839528|NCT00286091|6368118|P1|Double-blind Treatment Phase|Other|25
1839529|NCT00286091|6368117|P2|Double-blind Treatment Phase|Disease Progression|35
1839530|NCT00286091|6368118|P1|Double-blind Treatment Phase|Disease Progression|22
1839531|NCT00286091|6368117|P2|Double-blind Treatment Phase|Adverse Event|40
1839532|NCT00286091|6368118|P1|Double-blind Treatment Phase|Adverse Event|28
1839533|NCT00286091|6368117|P2|Double-blind Treatment Phase|Death|65
1839534|NCT00286091|6368118|P1|Double-blind Treatment Phase|Death|58
1839535|NCT00286091|6368117|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
1839536|NCT00286091|6368118|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
1839537|NCT00286091|6368117|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
1839538|NCT00286091|6368118|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
1839539|NCT00285857|6368141|P1|Overall Study|Adverse Event|1
1839540|NCT00285857|6368141|P1|Overall Study|Inadequate initial breast cytology|1
1839541|NCT00285857|6368141|P1|Overall Study|Withdrawal by Subject|2
1839542|NCT00285818|6368154|P2|Overall Study|Lost to Follow-up|0
1839543|NCT00285818|6368155|P1|Overall Study|Lost to Follow-up|1
1839544|NCT00285818|6368154|P2|Overall Study|Withdrawal by Subject|2
1839545|NCT00285818|6368155|P1|Overall Study|Withdrawal by Subject|3
1839546|NCT00285649|6368200|P3|Overall Study|Withdrawal by Subject|2
1839547|NCT00285649|6368201|P2|Overall Study|Withdrawal by Subject|2
1839548|NCT00285649|6368202|P1|Overall Study|Withdrawal by Subject|3
1839549|NCT00285649|6368200|P3|Overall Study|Lost to Follow-up|4
1839550|NCT00285649|6368201|P2|Overall Study|Lost to Follow-up|4
1839551|NCT00285649|6368202|P1|Overall Study|Lost to Follow-up|6
1839552|NCT00285584|6368212|P2|Month 6|Lost to Follow-up|1
1839553|NCT00285584|6368213|P1|Month 6|Lost to Follow-up|0
1839554|NCT00285584|6368212|P2|Month 3|Withdrawal by Subject|0
1839555|NCT00285584|6368213|P1|Month 3|Withdrawal by Subject|1
1839556|NCT00285584|6368212|P2|Month 3|Lost to Follow-up|3
1839557|NCT00285584|6368213|P1|Month 3|Lost to Follow-up|3
1839558|NCT00285207|6368245|P2|Overall Study|non-compliance|1
1839559|NCT00285207|6368246|P1|Overall Study|non-compliance|0
1839560|NCT00285207|6368245|P2|Overall Study|Pregnancy|1
1839561|NCT00285207|6368246|P1|Overall Study|Pregnancy|1
1839562|NCT00285207|6368245|P2|Overall Study|Withdrawal by Subject|2
1839563|NCT00285207|6368246|P1|Overall Study|Withdrawal by Subject|5
1839564|NCT00285207|6368245|P2|Overall Study|Lost to Follow-up|2
1839565|NCT00285207|6368246|P1|Overall Study|Lost to Follow-up|3
1839566|NCT00285012|6368254|P2|Received Study Tx|Other|5
1839567|NCT00285012|6368255|P1|Received Study Tx|Other|5
1839568|NCT00285012|6368254|P2|Received Study Tx|Withdrawal by Subject|43
1839569|NCT00285012|6368255|P1|Received Study Tx|Withdrawal by Subject|31
1839570|NCT00285012|6368254|P2|Received Study Tx|Lost to Follow-up|31
1839571|NCT00285012|6368255|P1|Received Study Tx|Lost to Follow-up|29
1839572|NCT00285012|6368254|P2|Received Study Tx|Lack of Efficacy|3
1839573|NCT00285012|6368255|P1|Received Study Tx|Lack of Efficacy|0
1839574|NCT00285012|6368254|P2|Received Study Tx|Adverse Event|11
1839575|NCT00285012|6368255|P1|Received Study Tx|Adverse Event|5
1839576|NCT00285012|6368254|P2|Received Study Tx|Death|1
1839577|NCT00285012|6368255|P1|Received Study Tx|Death|2
1839578|NCT00285012|6368254|P2|Assigned to Study Treatment (Tx)|Other|3
1839579|NCT00285012|6368255|P1|Assigned to Study Treatment (Tx)|Other|2
1839580|NCT00284934|6368281|P2|Overall Study|Other reasons|1
1839581|NCT00284934|6368282|P1|Overall Study|Other reasons|3
1839582|NCT00284934|6368281|P2|Overall Study|Adverse Event|2
1839583|NCT00284934|6368282|P1|Overall Study|Adverse Event|1
1839584|NCT00284856|6368297|P3|Overall Study|Other|4
1839585|NCT00284856|6368298|P2|Overall Study|Other|5
1839586|NCT00284856|6368299|P1|Overall Study|Other|4
1839587|NCT00284856|6368297|P3|Overall Study|Withdrawal by Subject|18
1839588|NCT00284856|6368298|P2|Overall Study|Withdrawal by Subject|16
1839589|NCT00284856|6368299|P1|Overall Study|Withdrawal by Subject|12
1839590|NCT00284856|6368297|P3|Overall Study|Protocol Violation|5
1839591|NCT00284856|6368298|P2|Overall Study|Protocol Violation|4
1839592|NCT00284856|6368299|P1|Overall Study|Protocol Violation|5
1839593|NCT00284856|6368297|P3|Overall Study|Lost to Follow-up|22
1839594|NCT00284856|6368298|P2|Overall Study|Lost to Follow-up|21
1839595|NCT00284856|6368299|P1|Overall Study|Lost to Follow-up|25
1839596|NCT00284856|6368297|P3|Overall Study|Lack of Efficacy|8
1839597|NCT00284856|6368298|P2|Overall Study|Lack of Efficacy|1
1839598|NCT00284856|6368299|P1|Overall Study|Lack of Efficacy|2
1839599|NCT00284856|6368297|P3|Overall Study|Adverse Event|3
1839600|NCT00284856|6368298|P2|Overall Study|Adverse Event|3
1839601|NCT00284856|6368299|P1|Overall Study|Adverse Event|3
1839602|NCT00284141|6368398|P1|Overall Study|Ongoing treatment|2
1839603|NCT00284141|6368398|P1|Overall Study|Did not take study medication|2
1839605|NCT00284141|6368398|P1|Overall Study|General decline|1
1839606|NCT00284141|6368398|P1|Overall Study|Clinical deterioration / death|2
1839607|NCT00284141|6368398|P1|Overall Study|Symptomatic / Clinical Progression|11
1839608|NCT00284141|6368398|P1|Overall Study|Participant's request|9
1839609|NCT00284141|6368398|P1|Overall Study|Adverse Event|19
1839610|NCT00284141|6368398|P1|Overall Study|Disease Progression / Lack of efficacy|51
1839611|NCT00284089|6368421|P4|Extension Phase|Withdrawal by Subject|3
1839612|NCT00284089|6368422|P3|Extension Phase|Withdrawal by Subject|1
1839613|NCT00284089|6368423|P2|Extension Phase|Withdrawal by Subject|0
1839614|NCT00284089|6368424|P1|Extension Phase|Withdrawal by Subject|0
1839615|NCT00284089|6368421|P4|Extension Phase|Protocol Violation|0
1839616|NCT00284089|6368422|P3|Extension Phase|Protocol Violation|1
1839617|NCT00284089|6368423|P2|Extension Phase|Protocol Violation|0
1839618|NCT00284089|6368424|P1|Extension Phase|Protocol Violation|0
1839619|NCT00284089|6368421|P4|Extension Phase|condition no longer requires study drug|7
1839620|NCT00284089|6368422|P3|Extension Phase|condition no longer requires study drug|2
1839621|NCT00284089|6368423|P2|Extension Phase|condition no longer requires study drug|0
1839622|NCT00284089|6368424|P1|Extension Phase|condition no longer requires study drug|2
1839623|NCT00284089|6368421|P4|Extension Phase|Adverse Event|2
1839624|NCT00284089|6368422|P3|Extension Phase|Adverse Event|2
1839625|NCT00284089|6368423|P2|Extension Phase|Adverse Event|0
1839626|NCT00284089|6368424|P1|Extension Phase|Adverse Event|0
1839627|NCT00284089|6368421|P4|Multiple Dose Phase|Death|1
1839628|NCT00284089|6368422|P3|Multiple Dose Phase|Death|1
1839629|NCT00284089|6368423|P2|Multiple Dose Phase|Death|0
1839630|NCT00284089|6368424|P1|Multiple Dose Phase|Death|0
1839631|NCT00284089|6368421|P4|Multiple Dose Phase|Withdrawal by Subject|2
1839632|NCT00284089|6368422|P3|Multiple Dose Phase|Withdrawal by Subject|1
1839633|NCT00284089|6368423|P2|Multiple Dose Phase|Withdrawal by Subject|0
1839634|NCT00284089|6368424|P1|Multiple Dose Phase|Withdrawal by Subject|0
1839635|NCT00284089|6368421|P4|Multiple Dose Phase|Protocol Violation|0
1839636|NCT00284089|6368422|P3|Multiple Dose Phase|Protocol Violation|1
1839637|NCT00284089|6368423|P2|Multiple Dose Phase|Protocol Violation|0
1839638|NCT00284089|6368424|P1|Multiple Dose Phase|Protocol Violation|0
1839639|NCT00284089|6368421|P4|Multiple Dose Phase|Adverse Event|1
1839640|NCT00284089|6368422|P3|Multiple Dose Phase|Adverse Event|1
1839641|NCT00284089|6368423|P2|Multiple Dose Phase|Adverse Event|0
1839642|NCT00284089|6368424|P1|Multiple Dose Phase|Adverse Event|1
1839643|NCT00284050|6368453|P3|Overall Study|Death|0
1839644|NCT00284050|6368454|P2|Overall Study|Death|0
1839645|NCT00284050|6368455|P1|Overall Study|Death|1
1839646|NCT00284050|6368453|P3|Overall Study|Lost to Follow-up|1
1839647|NCT00284050|6368454|P2|Overall Study|Lost to Follow-up|0
1839648|NCT00284050|6368455|P1|Overall Study|Lost to Follow-up|1
1839649|NCT00284050|6368453|P3|Overall Study|Withdrawal by Subject|2
1839650|NCT00284050|6368454|P2|Overall Study|Withdrawal by Subject|2
1839651|NCT00284050|6368455|P1|Overall Study|Withdrawal by Subject|2
1839652|NCT00284050|6368453|P3|Overall Study|Protocol Violation|2
1839653|NCT00284050|6368454|P2|Overall Study|Protocol Violation|1
1839654|NCT00284050|6368455|P1|Overall Study|Protocol Violation|0
1839655|NCT00284050|6368453|P3|Overall Study|Lack of Efficacy|3
1839656|NCT00284050|6368454|P2|Overall Study|Lack of Efficacy|1
1839657|NCT00284050|6368455|P1|Overall Study|Lack of Efficacy|0
1839658|NCT00284050|6368453|P3|Overall Study|Adverse Event|1
1839659|NCT00284050|6368454|P2|Overall Study|Adverse Event|1
1839660|NCT00284050|6368455|P1|Overall Study|Adverse Event|1
1839661|NCT00283959|6368469|P1|Extension Period|Low Compliance|1
1839662|NCT00283868|6368481|P2|Overall Study|Lost to Follow-up|8
1839663|NCT00283868|6368482|P1|Overall Study|Lost to Follow-up|7
1839664|NCT00283842|6368499|P5|Overall Study|Lost to Follow-up|1
1839665|NCT00283842|6368500|P4|Overall Study|Lost to Follow-up|1
1839666|NCT00283842|6368501|P3|Overall Study|Lost to Follow-up|4
1839667|NCT00283842|6368502|P2|Overall Study|Lost to Follow-up|2
1839668|NCT00283842|6368503|P1|Overall Study|Lost to Follow-up|0
1839669|NCT00283842|6368499|P5|Overall Study|Lack of Efficacy|3
1839670|NCT00283842|6368500|P4|Overall Study|Lack of Efficacy|0
1839671|NCT00283842|6368501|P3|Overall Study|Lack of Efficacy|1
1839672|NCT00283842|6368502|P2|Overall Study|Lack of Efficacy|3
1839673|NCT00283842|6368503|P1|Overall Study|Lack of Efficacy|1
1839674|NCT00283842|6368499|P5|Overall Study|Withdrawal by Subject|4
1839675|NCT00283842|6368500|P4|Overall Study|Withdrawal by Subject|5
1839676|NCT00283842|6368501|P3|Overall Study|Withdrawal by Subject|1
1839677|NCT00283842|6368502|P2|Overall Study|Withdrawal by Subject|1
1839678|NCT00283842|6368503|P1|Overall Study|Withdrawal by Subject|2
1839679|NCT00283842|6368499|P5|Overall Study|Protocol deviation|2
1839680|NCT00283842|6368500|P4|Overall Study|Protocol deviation|0
1839681|NCT00283842|6368501|P3|Overall Study|Protocol deviation|0
1839682|NCT00283842|6368502|P2|Overall Study|Protocol deviation|0
1839683|NCT00283842|6368503|P1|Overall Study|Protocol deviation|0
1839684|NCT00283842|6368499|P5|Overall Study|Protocol Violation|0
1839685|NCT00283842|6368500|P4|Overall Study|Protocol Violation|0
1839686|NCT00283842|6368501|P3|Overall Study|Protocol Violation|4
1839687|NCT00283842|6368502|P2|Overall Study|Protocol Violation|5
1839688|NCT00283842|6368503|P1|Overall Study|Protocol Violation|1
1839689|NCT00283842|6368499|P5|Overall Study|Adverse Event|5
1839690|NCT00283842|6368500|P4|Overall Study|Adverse Event|21
1839691|NCT00283842|6368501|P3|Overall Study|Adverse Event|21
1839692|NCT00283842|6368502|P2|Overall Study|Adverse Event|7
1839693|NCT00283842|6368503|P1|Overall Study|Adverse Event|8
1839694|NCT00283803|6368535|P1|Overall Study|Withdrawal by Subject|4
1839695|NCT00283803|6368535|P1|Overall Study|Physician Decision|9
1839696|NCT00283712|6368543|P2|Overall Study|Death|1
1839697|NCT00283712|6368544|P1|Overall Study|Death|0
1839698|NCT00283686|6368582|P4|Overall Study|Less than full participation|12
1839699|NCT00283686|6368583|P3|Overall Study|Less than full participation|6
1839700|NCT00283686|6368584|P2|Overall Study|Less than full participation|9
1839701|NCT00283686|6368585|P1|Overall Study|Less than full participation|7
1839702|NCT00283686|6368582|P4|Overall Study|Lost to Follow-up|20
1839703|NCT00283686|6368583|P3|Overall Study|Lost to Follow-up|26
1839704|NCT00283686|6368584|P2|Overall Study|Lost to Follow-up|31
1839705|NCT00283686|6368585|P1|Overall Study|Lost to Follow-up|21
1839706|NCT00283686|6368582|P4|Overall Study|Death|0
1839707|NCT00283686|6368583|P3|Overall Study|Death|1
1839708|NCT00283686|6368584|P2|Overall Study|Death|1
1839709|NCT00283686|6368585|P1|Overall Study|Death|1
1839710|NCT00283595|6368629|P2|Overall Study|Withdrawal by Subject|2
1839711|NCT00283595|6368630|P1|Overall Study|Withdrawal by Subject|1
1839712|NCT00283439|6368655|P4|Overall Study|Other|0
1839713|NCT00283439|6368656|P3|Overall Study|Other|0
1839714|NCT00283439|6368657|P2|Overall Study|Other|0
1839715|NCT00283439|6368658|P1|Overall Study|Other|1
1839716|NCT00283439|6368655|P4|Overall Study|Treatment discontinued|3
1839717|NCT00283439|6368656|P3|Overall Study|Treatment discontinued|1
1839718|NCT00283439|6368657|P2|Overall Study|Treatment discontinued|2
1839719|NCT00283439|6368658|P1|Overall Study|Treatment discontinued|0
1839720|NCT00283439|6368655|P4|Overall Study|Stem cell transplant|3
1839721|NCT00283439|6368656|P3|Overall Study|Stem cell transplant|4
1839722|NCT00283439|6368657|P2|Overall Study|Stem cell transplant|6
1839723|NCT00283439|6368658|P1|Overall Study|Stem cell transplant|6
1839724|NCT00283439|6368655|P4|Overall Study|Requirement for alternative therapy|2
1839725|NCT00283439|6368656|P3|Overall Study|Requirement for alternative therapy|5
1839726|NCT00283439|6368657|P2|Overall Study|Requirement for alternative therapy|2
1839727|NCT00283439|6368658|P1|Overall Study|Requirement for alternative therapy|1
1839728|NCT00283439|6368655|P4|Overall Study|Disease progression|0
1839729|NCT00283439|6368656|P3|Overall Study|Disease progression|0
1839730|NCT00283439|6368657|P2|Overall Study|Disease progression|1
1839731|NCT00283439|6368658|P1|Overall Study|Disease progression|0
1839732|NCT00283439|6368655|P4|Overall Study|Death|0
1839733|NCT00283439|6368656|P3|Overall Study|Death|1
1839734|NCT00283439|6368657|P2|Overall Study|Death|0
1839735|NCT00283439|6368658|P1|Overall Study|Death|0
1839736|NCT00283439|6368655|P4|Overall Study|Adverse Event|1
1839737|NCT00283439|6368656|P3|Overall Study|Adverse Event|0
1839738|NCT00283439|6368657|P2|Overall Study|Adverse Event|0
1839739|NCT00283439|6368658|P1|Overall Study|Adverse Event|0
1839740|NCT00283400|6368684|P4|Overall Study|Death|0
1839741|NCT00283400|6368685|P3|Overall Study|Death|1
1839742|NCT00283400|6368686|P2|Overall Study|Death|0
1839743|NCT00283400|6368687|P1|Overall Study|Death|1
1839744|NCT00283400|6368684|P4|Overall Study|Withdrawal by Subject|0
1839745|NCT00283400|6368685|P3|Overall Study|Withdrawal by Subject|0
1839746|NCT00283400|6368686|P2|Overall Study|Withdrawal by Subject|1
1839747|NCT00283400|6368687|P1|Overall Study|Withdrawal by Subject|1
1839748|NCT00283387|6368705|P2|First Intervention|Withdrawal by Subject|1
1839749|NCT00283387|6368706|P1|First Intervention|Withdrawal by Subject|0
1839750|NCT00283387|6368705|P2|First Intervention|Subject non-compliant|1
1839751|NCT00283387|6368706|P1|First Intervention|Subject non-compliant|1
1839752|NCT00283296|6368712|P1|Overall Study|in-home trial not completed|5
1839753|NCT00283244|6368721|P3|Overall Study|Clinical deterioration|3
1839754|NCT00283244|6368722|P2|Overall Study|Clinical deterioration|3
1839755|NCT00283244|6368723|P1|Overall Study|Clinical deterioration|1
1839756|NCT00283244|6368721|P3|Overall Study|Medical illness (other complicating dz)|6
1839757|NCT00283244|6368722|P2|Overall Study|Medical illness (other complicating dz)|3
1839758|NCT00283244|6368723|P1|Overall Study|Medical illness (other complicating dz)|4
1839759|NCT00283244|6368721|P3|Overall Study|Physician Decision|1
1839760|NCT00283244|6368722|P2|Overall Study|Physician Decision|0
1839761|NCT00283244|6368723|P1|Overall Study|Physician Decision|0
1839762|NCT00283244|6368721|P3|Overall Study|Withdrawal by Subject|2
1839763|NCT00283244|6368722|P2|Overall Study|Withdrawal by Subject|2
1839764|NCT00283244|6368723|P1|Overall Study|Withdrawal by Subject|1
1839765|NCT00283244|6368721|P3|Overall Study|Lack of Efficacy|26
1839766|NCT00283244|6368722|P2|Overall Study|Lack of Efficacy|32
1839767|NCT00283244|6368723|P1|Overall Study|Lack of Efficacy|8
1839768|NCT00283244|6368721|P3|Overall Study|Death|2
1839769|NCT00283244|6368722|P2|Overall Study|Death|3
1839770|NCT00283244|6368723|P1|Overall Study|Death|4
1839771|NCT00283244|6368721|P3|Overall Study|Adverse Event|11
1839772|NCT00283244|6368722|P2|Overall Study|Adverse Event|8
1839773|NCT00283244|6368723|P1|Overall Study|Adverse Event|0
1839774|NCT00283062|6368759|P4|Overall Study|chemotherapy not completed (cycle 6)|0
1839775|NCT00283062|6368760|P3|Overall Study|chemotherapy not completed (cycle 6)|0
1839776|NCT00283062|6368761|P2|Overall Study|chemotherapy not completed (cycle 6)|0
1839777|NCT00283062|6368762|P1|Overall Study|chemotherapy not completed (cycle 6)|1
1839778|NCT00283062|6368759|P4|Overall Study|Undefined|4
1839779|NCT00283062|6368760|P3|Overall Study|Undefined|1
1839780|NCT00283062|6368761|P2|Overall Study|Undefined|1
1839781|NCT00283062|6368762|P1|Overall Study|Undefined|0
1839782|NCT00283062|6368759|P4|Overall Study|Participant did not wish to continue|0
1839783|NCT00283062|6368760|P3|Overall Study|Participant did not wish to continue|1
1839784|NCT00283062|6368761|P2|Overall Study|Participant did not wish to continue|2
1839785|NCT00283062|6368762|P1|Overall Study|Participant did not wish to continue|3
1839786|NCT00283062|6368759|P4|Overall Study|Progressive disease|0
1839787|NCT00283062|6368760|P3|Overall Study|Progressive disease|1
1839788|NCT00283062|6368761|P2|Overall Study|Progressive disease|0
1839789|NCT00283062|6368762|P1|Overall Study|Progressive disease|0
1839790|NCT00283062|6368759|P4|Overall Study|Lost to Follow-up|0
1839791|NCT00283062|6368760|P3|Overall Study|Lost to Follow-up|1
1839792|NCT00283062|6368761|P2|Overall Study|Lost to Follow-up|0
1839793|NCT00283062|6368762|P1|Overall Study|Lost to Follow-up|1
1839794|NCT00283062|6368759|P4|Overall Study|Adverse Event|0
1839795|NCT00283062|6368760|P3|Overall Study|Adverse Event|1
1839796|NCT00283062|6368761|P2|Overall Study|Adverse Event|0
1839797|NCT00283062|6368762|P1|Overall Study|Adverse Event|2
1839798|NCT00283062|6368759|P4|Overall Study|Did not receive any study medication|45
1839799|NCT00283062|6368760|P3|Overall Study|Did not receive any study medication|36
1839800|NCT00283062|6368761|P2|Overall Study|Did not receive any study medication|4
1839801|NCT00283062|6368762|P1|Overall Study|Did not receive any study medication|5
1839802|NCT00283049|6368795|P3|Overall Study|No longer requires study treatment|1
1839803|NCT00283049|6368796|P2|Overall Study|No longer requires study treatment|0
1839804|NCT00283049|6368797|P1|Overall Study|No longer requires study treatment|0
1839805|NCT00283049|6368795|P3|Overall Study|Discontinuation of Study|20
1839806|NCT00283049|6368796|P2|Overall Study|Discontinuation of Study|16
1839807|NCT00283049|6368797|P1|Overall Study|Discontinuation of Study|18
1839808|NCT00283049|6368795|P3|Overall Study|Withdrawal by Subject|19
1839809|NCT00283049|6368796|P2|Overall Study|Withdrawal by Subject|24
1839810|NCT00283049|6368797|P1|Overall Study|Withdrawal by Subject|26
1839811|NCT00283049|6368795|P3|Overall Study|Lost to Follow-up|5
1839812|NCT00283049|6368796|P2|Overall Study|Lost to Follow-up|2
1839813|NCT00283049|6368797|P1|Overall Study|Lost to Follow-up|4
1839814|NCT00283049|6368795|P3|Overall Study|Lack of Efficacy|1
1839815|NCT00283049|6368796|P2|Overall Study|Lack of Efficacy|1
1839816|NCT00283049|6368797|P1|Overall Study|Lack of Efficacy|0
1839817|NCT00283049|6368795|P3|Overall Study|Death|1
1839818|NCT00283049|6368796|P2|Overall Study|Death|1
1839819|NCT00283049|6368797|P1|Overall Study|Death|1
1839820|NCT00283049|6368795|P3|Overall Study|Protocol Violation|3
1839821|NCT00283049|6368796|P2|Overall Study|Protocol Violation|0
1839822|NCT00283049|6368797|P1|Overall Study|Protocol Violation|3
1839823|NCT00283049|6368795|P3|Overall Study|Adverse Event|4
1839824|NCT00283049|6368796|P2|Overall Study|Adverse Event|1
1839825|NCT00283049|6368797|P1|Overall Study|Adverse Event|6
1839826|NCT00282984|6368825|P2|Overall Study|Protocol Violation|0
1839827|NCT00282984|6368826|P1|Overall Study|Protocol Violation|2
1839828|NCT00282984|6368825|P2|Overall Study|in prison|1
1839829|NCT00282984|6368826|P1|Overall Study|in prison|0
1839830|NCT00282984|6368825|P2|Overall Study|lack of motivation|0
1839831|NCT00282984|6368826|P1|Overall Study|lack of motivation|1
1839832|NCT00282984|6368825|P2|Overall Study|Participant used antipsychosis meds|1
1839833|NCT00282984|6368826|P1|Overall Study|Participant used antipsychosis meds|0
1839834|NCT00282984|6368825|P2|Overall Study|Participant only allowed phone follow-up|1
1839835|NCT00282984|6368826|P1|Overall Study|Participant only allowed phone follow-up|0
1839836|NCT00282984|6368825|P2|Overall Study|Participant stopped study medication|2
1839837|NCT00282984|6368826|P1|Overall Study|Participant stopped study medication|2
1839838|NCT00282984|6368825|P2|Overall Study|Withdrawal by Participant|34
1839839|NCT00282984|6368826|P1|Overall Study|Withdrawal by Participant|22
1839840|NCT00282984|6368825|P2|Overall Study|Lost to Follow-up|10
1839841|NCT00282984|6368826|P1|Overall Study|Lost to Follow-up|14
1839842|NCT00282984|6368825|P2|Overall Study|Lack of Efficacy|2
1839843|NCT00282984|6368826|P1|Overall Study|Lack of Efficacy|0
1839844|NCT00282984|6368825|P2|Overall Study|Adverse Event|5
1839845|NCT00282984|6368826|P1|Overall Study|Adverse Event|8
1839846|NCT00282984|6368825|P2|Overall Study|Death|5
1839847|NCT00282984|6368826|P1|Overall Study|Death|2
1839848|NCT00282919|6368863|P1|Overall Study|Asymptomatic Parasitemia|2
1839849|NCT00282919|6368863|P1|Overall Study|Withdrawal by Subject|1
1839850|NCT00282919|6368863|P1|Overall Study|Lack of Efficacy|4
1839851|NCT00282867|6368878|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
1839852|NCT00282867|6368879|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1839853|NCT00282867|6368880|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
1839854|NCT00282568|6368982|P1|Extended Treatment Period|Lost to Follow-up|2
1839855|NCT00282568|6368982|P1|Extended Treatment Period|Physician Decision|1
1839856|NCT00282568|6368982|P1|Extended Treatment Period|Non-compliance|4
1839857|NCT00282568|6368982|P1|Extended Treatment Period|Adverse Event|17
1839858|NCT00282568|6368982|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
1839859|NCT00282568|6368982|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
1839860|NCT00282464|6369008|P2|Overall Study|dropped due to missed visits|1
1839861|NCT00282464|6369009|P1|Overall Study|dropped due to missed visits|0
1839862|NCT00282464|6369008|P2|Overall Study|dispensed wrong kit|1
1839863|NCT00282464|6369009|P1|Overall Study|dispensed wrong kit|0
1839864|NCT00282464|6369008|P2|Overall Study|family crisis|1
1839865|NCT00282464|6369009|P1|Overall Study|family crisis|0
1839866|NCT00282464|6369008|P2|Overall Study|patient incarcerated|1
1839867|NCT00282464|6369009|P1|Overall Study|patient incarcerated|0
1839868|NCT00282464|6369008|P2|Overall Study|patient no show|1
1839869|NCT00282464|6369009|P1|Overall Study|patient no show|0
1839870|NCT00282464|6369008|P2|Overall Study|patient non-compliant|0
1839871|NCT00282464|6369009|P1|Overall Study|patient non-compliant|3
1839872|NCT00282464|6369008|P2|Overall Study|Patient moved|0
1839873|NCT00282464|6369009|P1|Overall Study|Patient moved|1
1839874|NCT00282464|6369008|P2|Overall Study|Protocol Violation|7
1839875|NCT00282464|6369009|P1|Overall Study|Protocol Violation|0
1839876|NCT00282464|6369008|P2|Overall Study|laboratory abnormality|2
1839877|NCT00282464|6369009|P1|Overall Study|laboratory abnormality|1
1839878|NCT00282464|6369008|P2|Overall Study|Withdrawal by Subject|10
1839879|NCT00282464|6369009|P1|Overall Study|Withdrawal by Subject|24
1839880|NCT00282464|6369008|P2|Overall Study|Lost to Follow-up|10
1839881|NCT00282464|6369009|P1|Overall Study|Lost to Follow-up|10
1839882|NCT00282464|6369008|P2|Overall Study|Lack of Efficacy|8
1839883|NCT00282464|6369009|P1|Overall Study|Lack of Efficacy|8
1839884|NCT00282464|6369008|P2|Overall Study|Adverse Event|20
1839885|NCT00282464|6369009|P1|Overall Study|Adverse Event|26
1839886|NCT00282438|6369059|P2|Overall Study|Death|1
1839887|NCT00282438|6369060|P1|Overall Study|Death|0
1839888|NCT00282438|6369059|P2|Overall Study|Lack of Efficacy|0
1839889|NCT00282438|6369060|P1|Overall Study|Lack of Efficacy|1
1839890|NCT00282412|6369070|P1|Overall Study|Death|2
1839891|NCT00282347|6369076|P2|B Cell Follow-up Period|Reason Not Specified|0
1839892|NCT00282347|6369077|P1|B Cell Follow-up Period|Reason Not Specified|2
1839893|NCT00282347|6369076|P2|B Cell Follow-up Period|Physician Decision|0
1839894|NCT00282347|6369077|P1|B Cell Follow-up Period|Physician Decision|1
1839895|NCT00282347|6369076|P2|B Cell Follow-up Period|Withdrawal by Subject|0
1839896|NCT00282347|6369077|P1|B Cell Follow-up Period|Withdrawal by Subject|2
1839897|NCT00282347|6369076|P2|Safety Follow-up Period|Protocol Deviation|2
1839898|NCT00282347|6369077|P1|Safety Follow-up Period|Protocol Deviation|0
1839899|NCT00282347|6369076|P2|Safety Follow-up Period|Physician Decision|1
1839900|NCT00282347|6369077|P1|Safety Follow-up Period|Physician Decision|1
1839901|NCT00282347|6369076|P2|Safety Follow-up Period|Withdrawal by Subject|1
1839902|NCT00282347|6369077|P1|Safety Follow-up Period|Withdrawal by Subject|2
1839903|NCT00282347|6369076|P2|Safety Follow-up Period|Lost to Follow-up|2
1839904|NCT00282347|6369077|P1|Safety Follow-up Period|Lost to Follow-up|0
1839905|NCT00282347|6369076|P2|Treatment Period|Physician Decision|1
1839906|NCT00282347|6369077|P1|Treatment Period|Physician Decision|0
1839907|NCT00282347|6369076|P2|Treatment Period|Withdrawal by Subject|3
1839908|NCT00282347|6369077|P1|Treatment Period|Withdrawal by Subject|1
1839909|NCT00282347|6369076|P2|Treatment Period|Lost to Follow-up|5
1839910|NCT00282347|6369077|P1|Treatment Period|Lost to Follow-up|2
1839911|NCT00282347|6369076|P2|Treatment Period|Death|0
1839912|NCT00282347|6369077|P1|Treatment Period|Death|2
1839913|NCT00282334|6369103|P2|Overall Study|Withdrawal by Subject|5
1839914|NCT00282334|6369104|P1|Overall Study|Withdrawal by Subject|8
1839915|NCT00282308|6369112|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
1839916|NCT00282308|6369113|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1839917|NCT00282308|6369114|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
1839918|NCT00282308|6369112|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
1839919|NCT00282308|6369113|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
1839920|NCT00282308|6369114|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
1839921|NCT00282308|6369112|P3|Safety Follow-up Period|Lost to Follow-up|5
1839922|NCT00282308|6369113|P2|Safety Follow-up Period|Lost to Follow-up|0
1839923|NCT00282308|6369114|P1|Safety Follow-up Period|Lost to Follow-up|0
1839924|NCT00282308|6369112|P3|Safety Follow-up Period|Adverse Event|1
1839925|NCT00282308|6369113|P2|Safety Follow-up Period|Adverse Event|0
1839926|NCT00282308|6369114|P1|Safety Follow-up Period|Adverse Event|0
1839927|NCT00282308|6369112|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
1839928|NCT00282308|6369113|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1839929|NCT00282308|6369114|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
1839930|NCT00282308|6369112|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
1839931|NCT00282308|6369113|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1839932|NCT00282308|6369114|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
1839933|NCT00282308|6369112|P3|Optional Extension Re-treatment Period|Adverse Event|4
1839934|NCT00282308|6369113|P2|Optional Extension Re-treatment Period|Adverse Event|0
1839935|NCT00282308|6369114|P1|Optional Extension Re-treatment Period|Adverse Event|0
1839936|NCT00282308|6369112|P3|Treatment Period|Not Treated with Study Drug|0
1839937|NCT00282308|6369113|P2|Treatment Period|Not Treated with Study Drug|0
1839938|NCT00282308|6369114|P1|Treatment Period|Not Treated with Study Drug|1
1839939|NCT00282308|6369112|P3|Treatment Period|Adverse Event|0
1839940|NCT00282308|6369113|P2|Treatment Period|Adverse Event|2
1839941|NCT00282308|6369114|P1|Treatment Period|Adverse Event|0
1839942|NCT00282308|6369112|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
1839943|NCT00282308|6369113|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
1839944|NCT00282308|6369114|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
1839945|NCT00282308|6369112|P3|Treatment Period|Lost to Follow-up|0
1839946|NCT00282308|6369113|P2|Treatment Period|Lost to Follow-up|0
1839947|NCT00282308|6369114|P1|Treatment Period|Lost to Follow-up|1
1839948|NCT00282295|6369144|P3|Overall Study|Other|0
1839949|NCT00282295|6369145|P2|Overall Study|Other|1
1839950|NCT00282295|6369146|P1|Overall Study|Other|0
1839951|NCT00282295|6369144|P3|Overall Study|Lost to Follow-up|2
1839952|NCT00282295|6369145|P2|Overall Study|Lost to Follow-up|7
1839953|NCT00282295|6369146|P1|Overall Study|Lost to Follow-up|1
1839954|NCT00282295|6369144|P3|Overall Study|Withdrawal by Subject|4
1839955|NCT00282295|6369145|P2|Overall Study|Withdrawal by Subject|6
1839956|NCT00282295|6369146|P1|Overall Study|Withdrawal by Subject|2
1839957|NCT00282295|6369144|P3|Overall Study|Protocol Violation|1
1839958|NCT00282295|6369145|P2|Overall Study|Protocol Violation|2
1839959|NCT00282295|6369146|P1|Overall Study|Protocol Violation|0
1839960|NCT00282295|6369144|P3|Overall Study|Serious Adverse Events|1
1839961|NCT00282295|6369145|P2|Overall Study|Serious Adverse Events|0
1839962|NCT00282295|6369146|P1|Overall Study|Serious Adverse Events|0
1839963|NCT00282295|6369144|P3|Overall Study|Adverse Event|0
1839964|NCT00282295|6369145|P2|Overall Study|Adverse Event|1
1839965|NCT00282295|6369146|P1|Overall Study|Adverse Event|0
1839966|NCT00282256|6369201|P1|Extension Treatment Period|Adverse Event|2
1839967|NCT00282256|6369201|P1|Pharmacokinetic Treatment Period|Poor venous access|1
1839968|NCT00282243|6369222|P1|Extension Treatment Period|Physician Decision|1
1839969|NCT00282243|6369222|P1|Extension Treatment Period|Non-compliance|2
1839970|NCT00282243|6369222|P1|Extension Treatment Period|Withdrawal by Subject|4
1839971|NCT00282243|6369222|P1|Extension Treatment Period|Adverse Event|15
1839972|NCT00282243|6369222|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
1839973|NCT00282243|6369222|P1|Pharmacokinetic Treatment Period|Adverse Event|3
1839974|NCT00282152|6369248|P2|Overall Study|Withdrawal by Subject|0
1839975|NCT00282152|6369249|P1|Overall Study|Withdrawal by Subject|1
1839976|NCT00282113|6369270|P3|Overall Study|Removed at parents request|0
1839977|NCT00282113|6369271|P2|Overall Study|Removed at parents request|0
1839978|NCT00282113|6369272|P1|Overall Study|Removed at parents request|1
1839979|NCT00282087|6369286|P1|Overall Study|Death|1
1839980|NCT00282048|6369299|P1|Overall Study|Ongoing|1
1839981|NCT00282048|6369299|P1|Overall Study|Other|8
1839982|NCT00282048|6369299|P1|Overall Study|Withdrawal by Subject|1
1839983|NCT00282048|6369299|P1|Overall Study|Adverse Event|22
1839984|NCT00282048|6369299|P1|Overall Study|Lack of Efficacy|30
1839985|NCT00281957|6369313|P2|Overall Study|Refusal unrelated to adverse events|1
1839986|NCT00281957|6369314|P1|Overall Study|Refusal unrelated to adverse events|0
1839987|NCT00281957|6369313|P2|Overall Study|Did not start treatment|1
1839988|NCT00281957|6369314|P1|Overall Study|Did not start treatment|3
1839989|NCT00281957|6369313|P2|Overall Study|Not eligible|2
1839990|NCT00281957|6369314|P1|Overall Study|Not eligible|1
1839991|NCT00281957|6369313|P2|Overall Study|Not protocol specified|1
1839992|NCT00281957|6369314|P1|Overall Study|Not protocol specified|8
1839993|NCT00281957|6369313|P2|Overall Study|Progression/relapse|35
1839994|NCT00281957|6369314|P1|Overall Study|Progression/relapse|47
1839995|NCT00281957|6369313|P2|Overall Study|Death|0
1839996|NCT00281957|6369314|P1|Overall Study|Death|1
1839997|NCT00281957|6369313|P2|Overall Study|Adverse Event|2
1839998|NCT00281957|6369314|P1|Overall Study|Adverse Event|7
1839999|NCT00281840|6369388|P1|Overall Study|Complicating Disease|1
1840000|NCT00281840|6369388|P1|Overall Study|exceed maximum delay in treatment|1
1840001|NCT00281840|6369388|P1|Overall Study|Disease Progression|2
1840002|NCT00281840|6369388|P1|Overall Study|Withdrawal by Subject|3
1840003|NCT00281840|6369388|P1|Overall Study|Physician Decision|6
1840004|NCT00281840|6369388|P1|Overall Study|Adverse Event|12
1840005|NCT00281697|6369404|P2|Overall Study|Did not receive study drug|2
1840006|NCT00281697|6369405|P1|Overall Study|Did not receive study drug|3
1840007|NCT00281697|6369404|P2|Overall Study|Subject/guardian's decision to withdraw|6
1840008|NCT00281697|6369405|P1|Overall Study|Subject/guardian's decision to withdraw|33
1840009|NCT00281697|6369404|P2|Overall Study|Physician's decision to withdraw|12
1840010|NCT00281697|6369405|P1|Overall Study|Physician's decision to withdraw|15
1840011|NCT00281697|6369404|P2|Overall Study|Other|6
1840012|NCT00281697|6369405|P1|Overall Study|Other|5
1840013|NCT00281697|6369404|P2|Overall Study|Disease progression|149
1840014|NCT00281697|6369405|P1|Overall Study|Disease progression|279
1840015|NCT00281697|6369404|P2|Overall Study|Death|3
1840016|NCT00281697|6369405|P1|Overall Study|Death|8
1840017|NCT00281697|6369404|P2|Overall Study|Adverse Event|15
1840018|NCT00281697|6369405|P1|Overall Study|Adverse Event|54
1840019|NCT00281697|6369404|P2|Overall Study|> 60 days since last dose of study drug|4
1840020|NCT00281697|6369405|P1|Overall Study|> 60 days since last dose of study drug|4
1840021|NCT00281684|6369425|P4|Overall Study|Withdrawal by Subject|0
1840022|NCT00281684|6369426|P3|Overall Study|Withdrawal by Subject|0
1840023|NCT00281684|6369427|P2|Overall Study|Withdrawal by Subject|0
1840024|NCT00281684|6369428|P1|Overall Study|Withdrawal by Subject|1
1840025|NCT00281684|6369425|P4|Overall Study|Lost to Follow-up|0
1840026|NCT00281684|6369426|P3|Overall Study|Lost to Follow-up|1
1840027|NCT00281684|6369427|P2|Overall Study|Lost to Follow-up|0
1840028|NCT00281684|6369428|P1|Overall Study|Lost to Follow-up|0
1840029|NCT00281658|6369502|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
1840030|NCT00281658|6369503|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1840031|NCT00281658|6369504|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
1840032|NCT00281658|6369502|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
1840033|NCT00281658|6369503|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1840034|NCT00281658|6369504|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
1840035|NCT00281658|6369502|P3|Open-label Monotherapy Extension Phase|Death|97
1840036|NCT00281658|6369503|P2|Open-label Monotherapy Extension Phase|Death|0
1840037|NCT00281658|6369504|P1|Open-label Monotherapy Extension Phase|Death|0
1840038|NCT00281658|6369502|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1840039|NCT00281658|6369503|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
1840040|NCT00281658|6369504|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
1840041|NCT00281658|6369502|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
1840042|NCT00281658|6369503|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1840043|NCT00281658|6369504|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
1840044|NCT00281658|6369502|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
1840045|NCT00281658|6369503|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
1840046|NCT00281658|6369504|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
1840047|NCT00281658|6369502|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
1840048|NCT00281658|6369503|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
1840049|NCT00281658|6369504|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
1840050|NCT00281658|6369502|P3|Double-blind, Randomized Phase|Death|0
1840051|NCT00281658|6369503|P2|Double-blind, Randomized Phase|Death|46
1840052|NCT00281658|6369504|P1|Double-blind, Randomized Phase|Death|120
1840053|NCT00281632|6369521|P1|Overall Study|Ongoing|3
1840054|NCT00281632|6369521|P1|Overall Study|Physician Decision|1
1840055|NCT00281632|6369521|P1|Overall Study|Death|1
1840056|NCT00281632|6369521|P1|Overall Study|Disease Progression|22
1840057|NCT00281632|6369521|P1|Overall Study|Withdrawal by Subject|2
1840058|NCT00281632|6369521|P1|Overall Study|Adverse Event|7
1840059|NCT00281580|6369563|P16|Overall Study|Randomised in error; pregnancy; moving|2
1840060|NCT00281580|6369564|P15|Overall Study|Randomised in error; pregnancy; moving|1
1840061|NCT00281580|6369565|P14|Overall Study|Randomised in error; pregnancy; moving|0
1840062|NCT00281580|6369566|P13|Overall Study|Randomised in error; pregnancy; moving|2
1840063|NCT00281580|6369567|P12|Overall Study|Randomised in error; pregnancy; moving|1
1840064|NCT00281580|6369568|P11|Overall Study|Randomised in error; pregnancy; moving|1
1840065|NCT00281580|6369569|P10|Overall Study|Randomised in error; pregnancy; moving|1
1840066|NCT00281580|6369570|P9|Overall Study|Randomised in error; pregnancy; moving|2
1840067|NCT00281580|6369571|P8|Overall Study|Randomised in error; pregnancy; moving|0
1840068|NCT00281580|6369572|P7|Overall Study|Randomised in error; pregnancy; moving|1
1840069|NCT00281580|6369573|P6|Overall Study|Randomised in error; pregnancy; moving|0
1840070|NCT00281580|6369574|P5|Overall Study|Randomised in error; pregnancy; moving|0
1840071|NCT00281580|6369575|P4|Overall Study|Randomised in error; pregnancy; moving|2
1840072|NCT00281580|6369576|P3|Overall Study|Randomised in error; pregnancy; moving|0
1840073|NCT00281580|6369577|P2|Overall Study|Randomised in error; pregnancy; moving|0
1840074|NCT00281580|6369578|P1|Overall Study|Randomised in error; pregnancy; moving|0
1840075|NCT00281580|6369563|P16|Overall Study|Lost to Follow-up|0
1840076|NCT00281580|6369564|P15|Overall Study|Lost to Follow-up|0
1840077|NCT00281580|6369565|P14|Overall Study|Lost to Follow-up|0
1840078|NCT00281580|6369566|P13|Overall Study|Lost to Follow-up|1
1840079|NCT00281580|6369567|P12|Overall Study|Lost to Follow-up|0
1840080|NCT00281580|6369568|P11|Overall Study|Lost to Follow-up|1
1840081|NCT00281580|6369569|P10|Overall Study|Lost to Follow-up|1
1840082|NCT00281580|6369570|P9|Overall Study|Lost to Follow-up|2
1840083|NCT00281580|6369571|P8|Overall Study|Lost to Follow-up|1
1840084|NCT00281580|6369572|P7|Overall Study|Lost to Follow-up|0
1840085|NCT00281580|6369573|P6|Overall Study|Lost to Follow-up|1
1840086|NCT00281580|6369574|P5|Overall Study|Lost to Follow-up|0
1840087|NCT00281580|6369575|P4|Overall Study|Lost to Follow-up|3
1840088|NCT00281580|6369576|P3|Overall Study|Lost to Follow-up|0
1840089|NCT00281580|6369577|P2|Overall Study|Lost to Follow-up|0
1840090|NCT00281580|6369578|P1|Overall Study|Lost to Follow-up|0
1840091|NCT00281580|6369563|P16|Overall Study|Lack of Efficacy|0
1840092|NCT00281580|6369564|P15|Overall Study|Lack of Efficacy|1
1840093|NCT00281580|6369565|P14|Overall Study|Lack of Efficacy|2
1840094|NCT00281580|6369566|P13|Overall Study|Lack of Efficacy|0
1840095|NCT00281580|6369567|P12|Overall Study|Lack of Efficacy|1
1840096|NCT00281580|6369568|P11|Overall Study|Lack of Efficacy|0
1840097|NCT00281580|6369569|P10|Overall Study|Lack of Efficacy|0
1840098|NCT00281580|6369570|P9|Overall Study|Lack of Efficacy|0
1840099|NCT00281580|6369571|P8|Overall Study|Lack of Efficacy|0
1840100|NCT00281580|6369572|P7|Overall Study|Lack of Efficacy|0
1840101|NCT00281580|6369573|P6|Overall Study|Lack of Efficacy|0
1840102|NCT00281580|6369574|P5|Overall Study|Lack of Efficacy|2
1840103|NCT00281580|6369575|P4|Overall Study|Lack of Efficacy|6
1840104|NCT00281580|6369576|P3|Overall Study|Lack of Efficacy|1
1840105|NCT00281580|6369577|P2|Overall Study|Lack of Efficacy|1
1840106|NCT00281580|6369578|P1|Overall Study|Lack of Efficacy|2
1840107|NCT00281580|6369563|P16|Overall Study|Withdrawal by Subject|5
1840108|NCT00281580|6369564|P15|Overall Study|Withdrawal by Subject|1
1840109|NCT00281580|6369565|P14|Overall Study|Withdrawal by Subject|2
1840110|NCT00281580|6369566|P13|Overall Study|Withdrawal by Subject|2
1840111|NCT00281580|6369567|P12|Overall Study|Withdrawal by Subject|1
1840112|NCT00281580|6369568|P11|Overall Study|Withdrawal by Subject|1
1840113|NCT00281580|6369569|P10|Overall Study|Withdrawal by Subject|4
1840114|NCT00281580|6369570|P9|Overall Study|Withdrawal by Subject|1
1840115|NCT00281580|6369571|P8|Overall Study|Withdrawal by Subject|0
1840116|NCT00281580|6369572|P7|Overall Study|Withdrawal by Subject|2
1840117|NCT00281580|6369573|P6|Overall Study|Withdrawal by Subject|2
1840118|NCT00281580|6369574|P5|Overall Study|Withdrawal by Subject|1
1840119|NCT00281580|6369575|P4|Overall Study|Withdrawal by Subject|1
1840120|NCT00281580|6369576|P3|Overall Study|Withdrawal by Subject|1
1840121|NCT00281580|6369577|P2|Overall Study|Withdrawal by Subject|0
1840122|NCT00281580|6369578|P1|Overall Study|Withdrawal by Subject|3
1840123|NCT00281580|6369563|P16|Overall Study|Protocol Violation|3
1840124|NCT00281580|6369564|P15|Overall Study|Protocol Violation|1
1840125|NCT00281580|6369565|P14|Overall Study|Protocol Violation|1
1840126|NCT00281580|6369566|P13|Overall Study|Protocol Violation|0
1840127|NCT00281580|6369567|P12|Overall Study|Protocol Violation|2
1840128|NCT00281580|6369568|P11|Overall Study|Protocol Violation|1
1840129|NCT00281580|6369569|P10|Overall Study|Protocol Violation|0
1840130|NCT00281580|6369570|P9|Overall Study|Protocol Violation|2
1840131|NCT00281580|6369571|P8|Overall Study|Protocol Violation|0
1840132|NCT00281580|6369572|P7|Overall Study|Protocol Violation|1
1840133|NCT00281580|6369573|P6|Overall Study|Protocol Violation|0
1840134|NCT00281580|6369574|P5|Overall Study|Protocol Violation|0
1840135|NCT00281580|6369575|P4|Overall Study|Protocol Violation|1
1840136|NCT00281580|6369576|P3|Overall Study|Protocol Violation|1
1840137|NCT00281580|6369577|P2|Overall Study|Protocol Violation|0
1840138|NCT00281580|6369578|P1|Overall Study|Protocol Violation|0
1840139|NCT00281580|6369563|P16|Overall Study|Adverse Event|3
1840140|NCT00281580|6369564|P15|Overall Study|Adverse Event|3
1840141|NCT00281580|6369565|P14|Overall Study|Adverse Event|2
1840142|NCT00281580|6369566|P13|Overall Study|Adverse Event|8
1840143|NCT00281580|6369567|P12|Overall Study|Adverse Event|5
1840144|NCT00281580|6369568|P11|Overall Study|Adverse Event|0
1840145|NCT00281580|6369569|P10|Overall Study|Adverse Event|6
1840146|NCT00281580|6369570|P9|Overall Study|Adverse Event|1
1840147|NCT00281580|6369571|P8|Overall Study|Adverse Event|0
1840148|NCT00281580|6369572|P7|Overall Study|Adverse Event|1
1840149|NCT00281580|6369573|P6|Overall Study|Adverse Event|0
1840150|NCT00281580|6369574|P5|Overall Study|Adverse Event|1
1840151|NCT00281580|6369575|P4|Overall Study|Adverse Event|4
1840152|NCT00281580|6369576|P3|Overall Study|Adverse Event|2
1840153|NCT00281580|6369577|P2|Overall Study|Adverse Event|0
1840154|NCT00281580|6369578|P1|Overall Study|Adverse Event|2
1840155|NCT00281528|6369925|P3|Overall Study|Other|5
1840156|NCT00281528|6369926|P2|Overall Study|Other|3
1840157|NCT00281528|6369927|P1|Overall Study|Other|6
1840158|NCT00281528|6369925|P3|Overall Study|Withdrawal by Subject|7
1840159|NCT00281528|6369926|P2|Overall Study|Withdrawal by Subject|5
1840160|NCT00281528|6369927|P1|Overall Study|Withdrawal by Subject|5
1840161|NCT00281528|6369925|P3|Overall Study|Protocol Violation|1
1840162|NCT00281528|6369926|P2|Overall Study|Protocol Violation|0
1840163|NCT00281528|6369927|P1|Overall Study|Protocol Violation|1
1840164|NCT00281528|6369925|P3|Overall Study|Physician Decision|5
1840165|NCT00281528|6369926|P2|Overall Study|Physician Decision|4
1840166|NCT00281528|6369927|P1|Overall Study|Physician Decision|11
1840167|NCT00281528|6369925|P3|Overall Study|Adverse Event-unrelated to treatment|2
1840168|NCT00281528|6369926|P2|Overall Study|Adverse Event-unrelated to treatment|0
1840169|NCT00281528|6369927|P1|Overall Study|Adverse Event-unrelated to treatment|3
1840170|NCT00281528|6369925|P3|Overall Study|Unacceptable Toxicity-related to trt|32
1840171|NCT00281528|6369926|P2|Overall Study|Unacceptable Toxicity-related to trt|24
1840172|NCT00281528|6369927|P1|Overall Study|Unacceptable Toxicity-related to trt|21
1840173|NCT00281528|6369925|P3|Overall Study|Progressive Disease|27
1840174|NCT00281528|6369926|P2|Overall Study|Progressive Disease|18
1840175|NCT00281528|6369927|P1|Overall Study|Progressive Disease|28
1840176|NCT00281320|6369978|P2|Overall Study|Other|1
1840177|NCT00281320|6369979|P1|Overall Study|Other|3
1840178|NCT00281320|6369978|P2|Overall Study|Lost to Follow-up|2
1840179|NCT00281320|6369979|P1|Overall Study|Lost to Follow-up|1
1840180|NCT00281320|6369978|P2|Overall Study|Withdrawal by Subject|6
1840181|NCT00281320|6369979|P1|Overall Study|Withdrawal by Subject|5
1840182|NCT00281320|6369978|P2|Overall Study|Lack of Efficacy|3
1840183|NCT00281320|6369979|P1|Overall Study|Lack of Efficacy|4
1840184|NCT00281320|6369978|P2|Overall Study|Adverse Event|9
1840185|NCT00281320|6369979|P1|Overall Study|Adverse Event|12
1840186|NCT00281099|6370001|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
1840187|NCT00281099|6370002|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
1840188|NCT00281099|6370001|P2|Overall Study|Physician Decision|72
1840189|NCT00281099|6370002|P1|Overall Study|Physician Decision|79
1840190|NCT00281099|6370001|P2|Overall Study|Withdrawal by Subject|70
1840191|NCT00281099|6370002|P1|Overall Study|Withdrawal by Subject|65
1840192|NCT00281099|6370001|P2|Overall Study|Lost to Follow-up|19
1840193|NCT00281099|6370002|P1|Overall Study|Lost to Follow-up|10
1840194|NCT00281099|6370001|P2|Overall Study|Death|57
1840195|NCT00281099|6370002|P1|Overall Study|Death|46
1840196|NCT00280917|6370051|P4|Overall Study|Noncompliance|0
1840197|NCT00280917|6370052|P3|Overall Study|Noncompliance|2
1840198|NCT00280917|6370053|P2|Overall Study|Noncompliance|1
1840199|NCT00280917|6370054|P1|Overall Study|Noncompliance|0
1840200|NCT00280917|6370051|P4|Overall Study|Withdrawal by Subject|1
1840201|NCT00280917|6370052|P3|Overall Study|Withdrawal by Subject|0
1840202|NCT00280917|6370053|P2|Overall Study|Withdrawal by Subject|2
1840203|NCT00280917|6370054|P1|Overall Study|Withdrawal by Subject|0
1840204|NCT00280917|6370051|P4|Overall Study|Change Therapy|0
1840205|NCT00280917|6370052|P3|Overall Study|Change Therapy|0
1840206|NCT00280917|6370053|P2|Overall Study|Change Therapy|2
1840207|NCT00280917|6370054|P1|Overall Study|Change Therapy|1
1840208|NCT00280917|6370051|P4|Overall Study|Adverse Event|1
1840209|NCT00280917|6370052|P3|Overall Study|Adverse Event|4
1840210|NCT00280917|6370053|P2|Overall Study|Adverse Event|1
1840211|NCT00280917|6370054|P1|Overall Study|Adverse Event|1
1840212|NCT00280748|6370077|P1|Overall Study|Extra-cranial disease progression|1
1840213|NCT00280748|6370077|P1|Overall Study|Decline in performance|3
1840214|NCT00280735|6370087|P1|Overall Study|Intercurrent Illness|2
1840215|NCT00280735|6370087|P1|Overall Study|Withdrawal by Subject|8
1840216|NCT00280735|6370087|P1|Overall Study|Lack of Efficacy|3
1840217|NCT00280735|6370087|P1|Overall Study|Adverse Event|5
1840218|NCT00280683|6370099|P2|Overall Study|Adverse Event|1
1840219|NCT00280683|6370100|P1|Overall Study|Adverse Event|1
1840220|NCT00280683|6370099|P2|Overall Study|Withdrawal by Subject|2
1840221|NCT00280683|6370100|P1|Overall Study|Withdrawal by Subject|1
1840222|NCT00280566|6370110|P3|Period 2 Double Blind|miscellaneous|5
1840223|NCT00280566|6370111|P2|Period 2 Double Blind|miscellaneous|10
1840224|NCT00280566|6370112|P1|Period 2 Double Blind|miscellaneous|0
1840225|NCT00280566|6370110|P3|Period 2 Double Blind|Withdrawal by Subject|9
1840226|NCT00280566|6370111|P2|Period 2 Double Blind|Withdrawal by Subject|9
1840227|NCT00280566|6370112|P1|Period 2 Double Blind|Withdrawal by Subject|0
1840228|NCT00280566|6370110|P3|Period 2 Double Blind|Lost to Follow-up|6
1840229|NCT00280566|6370111|P2|Period 2 Double Blind|Lost to Follow-up|3
1840230|NCT00280566|6370112|P1|Period 2 Double Blind|Lost to Follow-up|0
1840231|NCT00280566|6370110|P3|Period 2 Double Blind|Adverse Event|15
1840232|NCT00280566|6370111|P2|Period 2 Double Blind|Adverse Event|11
1840233|NCT00280566|6370112|P1|Period 2 Double Blind|Adverse Event|0
1840234|NCT00280566|6370110|P3|Period 2 Double Blind|Laboratory Abnormality|0
1840235|NCT00280566|6370111|P2|Period 2 Double Blind|Laboratory Abnormality|1
1840236|NCT00280566|6370112|P1|Period 2 Double Blind|Laboratory Abnormality|0
1840237|NCT00280566|6370110|P3|Period 2 Double Blind|Lack of Efficacy|22
1840238|NCT00280566|6370111|P2|Period 2 Double Blind|Lack of Efficacy|9
1840239|NCT00280566|6370112|P1|Period 2 Double Blind|Lack of Efficacy|0
1840240|NCT00280566|6370110|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
1840241|NCT00280566|6370111|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
1840242|NCT00280566|6370112|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
1840243|NCT00280566|6370110|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1840244|NCT00280566|6370111|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
1840245|NCT00280566|6370112|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
1840246|NCT00280566|6370110|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1840247|NCT00280566|6370111|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
1840248|NCT00280566|6370112|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
1840249|NCT00280566|6370110|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
1840250|NCT00280566|6370111|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
1840251|NCT00280566|6370112|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
1840252|NCT00280566|6370110|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1840253|NCT00280566|6370111|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
1840254|NCT00280566|6370112|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
1840255|NCT00280566|6370110|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1840256|NCT00280566|6370111|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
1840257|NCT00280566|6370112|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
1840258|NCT00280397|6370137|P1|Overall Study|Adverse Event|1
1840259|NCT00280293|6370203|P2|Overall Study|Adverse Event|1
1840260|NCT00280293|6370204|P1|Overall Study|Adverse Event|0
1840261|NCT00280293|6370203|P2|Overall Study|Incarceration/Legal Reasons|1
1840262|NCT00280293|6370204|P1|Overall Study|Incarceration/Legal Reasons|1
1840263|NCT00280293|6370203|P2|Overall Study|Withdrawal by Subject|5
1840264|NCT00280293|6370204|P1|Overall Study|Withdrawal by Subject|3
1840265|NCT00280293|6370203|P2|Overall Study|Lost to Follow-up|12
1840266|NCT00280293|6370204|P1|Overall Study|Lost to Follow-up|14
1840267|NCT00280293|6370203|P2|Overall Study|Physician Decision|4
1840268|NCT00280293|6370204|P1|Overall Study|Physician Decision|5
1840269|NCT00280293|6370203|P2|Overall Study|Protocol Violation|0
1840270|NCT00280293|6370204|P1|Overall Study|Protocol Violation|3
1840271|NCT00280150|6370227|P4|Overall Study|Declining Performance Status|1
1840272|NCT00280150|6370228|P3|Overall Study|Declining Performance Status|0
1840273|NCT00280150|6370229|P2|Overall Study|Declining Performance Status|0
1840274|NCT00280150|6370230|P1|Overall Study|Declining Performance Status|0
1840275|NCT00280150|6370227|P4|Overall Study|Did not get consolidation therapy|0
1840276|NCT00280150|6370228|P3|Overall Study|Did not get consolidation therapy|3
1840277|NCT00280150|6370229|P2|Overall Study|Did not get consolidation therapy|0
1840278|NCT00280150|6370230|P1|Overall Study|Did not get consolidation therapy|3
1840279|NCT00280150|6370227|P4|Overall Study|Withdrawal by Subject|1
1840280|NCT00280150|6370228|P3|Overall Study|Withdrawal by Subject|0
1840281|NCT00280150|6370229|P2|Overall Study|Withdrawal by Subject|0
1840282|NCT00280150|6370230|P1|Overall Study|Withdrawal by Subject|0
1840283|NCT00280150|6370227|P4|Overall Study|Protocol Violation|1
1840284|NCT00280150|6370228|P3|Overall Study|Protocol Violation|0
1840285|NCT00280150|6370229|P2|Overall Study|Protocol Violation|0
1840286|NCT00280150|6370230|P1|Overall Study|Protocol Violation|0
1840287|NCT00280150|6370227|P4|Overall Study|Physician Decision|1
1840288|NCT00280150|6370228|P3|Overall Study|Physician Decision|0
1840289|NCT00280150|6370229|P2|Overall Study|Physician Decision|0
1840290|NCT00280150|6370230|P1|Overall Study|Physician Decision|0
1840291|NCT00280150|6370227|P4|Overall Study|Lack of Efficacy|3
1840292|NCT00280150|6370228|P3|Overall Study|Lack of Efficacy|0
1840293|NCT00280150|6370229|P2|Overall Study|Lack of Efficacy|0
1840294|NCT00280150|6370230|P1|Overall Study|Lack of Efficacy|0
1840295|NCT00280150|6370227|P4|Overall Study|Adverse Event|3
1840296|NCT00280150|6370228|P3|Overall Study|Adverse Event|2
1840297|NCT00280150|6370229|P2|Overall Study|Adverse Event|1
1840298|NCT00280150|6370230|P1|Overall Study|Adverse Event|0
1840299|NCT00280059|6370245|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
1840300|NCT00280059|6370246|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
1840301|NCT00280059|6370245|P2|Efficacy Assessment Phase|Other|8
1840302|NCT00280059|6370246|P1|Efficacy Assessment Phase|Other|7
1840303|NCT00280059|6370245|P2|Efficacy Assessment Phase|Lost to Follow-up|13
1840304|NCT00280059|6370246|P1|Efficacy Assessment Phase|Lost to Follow-up|6
1840305|NCT00280059|6370245|P2|Efficacy Assessment Phase|Lack of Efficacy|3
1840306|NCT00280059|6370246|P1|Efficacy Assessment Phase|Lack of Efficacy|19
1840307|NCT00280059|6370245|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
1840308|NCT00280059|6370246|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
1840309|NCT00280059|6370245|P2|Efficacy Assessment Phase|Adverse Event|31
1840310|NCT00280059|6370246|P1|Efficacy Assessment Phase|Adverse Event|33
1840311|NCT00280059|6370245|P2|Efficacy Assessment Phase|Death|0
1840312|NCT00280059|6370246|P1|Efficacy Assessment Phase|Death|2
1840313|NCT00279916|6370310|P2|Overall Study|Lost to Follow-up|2
1840314|NCT00279916|6370311|P1|Overall Study|Lost to Follow-up|3
1840315|NCT00279916|6370310|P2|Overall Study|Withdrawal by Subject|3
1840316|NCT00279916|6370311|P1|Overall Study|Withdrawal by Subject|4
1840317|NCT00279812|6370337|P6|Overall Study|Adverse Event|1
1840318|NCT00279812|6370338|P5|Overall Study|Adverse Event|2
1840319|NCT00279812|6370339|P4|Overall Study|Adverse Event|0
1840320|NCT00279812|6370340|P3|Overall Study|Adverse Event|1
1840321|NCT00279812|6370341|P2|Overall Study|Adverse Event|1
1840322|NCT00279812|6370342|P1|Overall Study|Adverse Event|0
1840323|NCT00279812|6370337|P6|Overall Study|Withdrawal by Subject|0
1840324|NCT00279812|6370338|P5|Overall Study|Withdrawal by Subject|0
1840325|NCT00279812|6370339|P4|Overall Study|Withdrawal by Subject|0
1840326|NCT00279812|6370340|P3|Overall Study|Withdrawal by Subject|2
1840327|NCT00279812|6370341|P2|Overall Study|Withdrawal by Subject|4
1840328|NCT00279812|6370342|P1|Overall Study|Withdrawal by Subject|0
1840329|NCT00279812|6370337|P6|Overall Study|Protocol Violation|0
1840330|NCT00279812|6370338|P5|Overall Study|Protocol Violation|1
1840331|NCT00279812|6370339|P4|Overall Study|Protocol Violation|0
1840332|NCT00279812|6370340|P3|Overall Study|Protocol Violation|0
1840333|NCT00279812|6370341|P2|Overall Study|Protocol Violation|1
1840334|NCT00279812|6370342|P1|Overall Study|Protocol Violation|1
1840335|NCT00279708|6370370|P2|Overall Study|Adverse Event|1
1840336|NCT00279708|6370371|P1|Overall Study|Adverse Event|1
1840337|NCT00279708|6370370|P2|Overall Study|Withdrawal by Subject|3
1840338|NCT00279708|6370371|P1|Overall Study|Withdrawal by Subject|2
1840339|NCT00279305|6370400|P2|Overall Study|FDA Safety Alert|1
1840340|NCT00279305|6370401|P1|Overall Study|FDA Safety Alert|4
1840341|NCT00279305|6370400|P2|Overall Study|Dificulting establishing IV|0
1840342|NCT00279305|6370401|P1|Overall Study|Dificulting establishing IV|1
1840343|NCT00279305|6370400|P2|Overall Study|Withdrawal by Subject|0
1840344|NCT00279305|6370401|P1|Overall Study|Withdrawal by Subject|2
1840345|NCT00279305|6370400|P2|Overall Study|Pregnancy|0
1840346|NCT00279305|6370401|P1|Overall Study|Pregnancy|1
1840347|NCT00279214|6370409|P2|Overall Study|Physician Decision|2
1840348|NCT00279214|6370410|P1|Overall Study|Physician Decision|3
1840349|NCT00279201|6370440|P6|Intensification Addendum|Death|0
1840350|NCT00279201|6370441|P5|Intensification Addendum|Death|1
1840351|NCT00279201|6370442|P4|Intensification Addendum|Death|0
1840352|NCT00279201|6370443|P3|Intensification Addendum|Death|0
1840353|NCT00279201|6370444|P2|Intensification Addendum|Death|0
1840354|NCT00279201|6370445|P1|Intensification Addendum|Death|0
1840355|NCT00279201|6370440|P6|Intensification Addendum|Lack of Efficacy|0
1840356|NCT00279201|6370441|P5|Intensification Addendum|Lack of Efficacy|1
1840357|NCT00279201|6370442|P4|Intensification Addendum|Lack of Efficacy|1
1840358|NCT00279201|6370443|P3|Intensification Addendum|Lack of Efficacy|0
1840359|NCT00279201|6370444|P2|Intensification Addendum|Lack of Efficacy|0
1840360|NCT00279201|6370445|P1|Intensification Addendum|Lack of Efficacy|0
1840361|NCT00279201|6370440|P6|Intensification Addendum|Entry Criteria Exclusion|0
1840362|NCT00279201|6370441|P5|Intensification Addendum|Entry Criteria Exclusion|0
1840363|NCT00279201|6370442|P4|Intensification Addendum|Entry Criteria Exclusion|0
1840364|NCT00279201|6370443|P3|Intensification Addendum|Entry Criteria Exclusion|1
1840365|NCT00279201|6370444|P2|Intensification Addendum|Entry Criteria Exclusion|0
1840366|NCT00279201|6370445|P1|Intensification Addendum|Entry Criteria Exclusion|0
1840367|NCT00279201|6370440|P6|Intensification Addendum|Sponsor Decision|1
1840368|NCT00279201|6370441|P5|Intensification Addendum|Sponsor Decision|1
1840369|NCT00279201|6370442|P4|Intensification Addendum|Sponsor Decision|0
1840370|NCT00279201|6370443|P3|Intensification Addendum|Sponsor Decision|0
1840371|NCT00279201|6370444|P2|Intensification Addendum|Sponsor Decision|0
1840372|NCT00279201|6370445|P1|Intensification Addendum|Sponsor Decision|0
1840373|NCT00279201|6370440|P6|Intensification Addendum|Physician Decision|2
1840374|NCT00279201|6370441|P5|Intensification Addendum|Physician Decision|3
1840375|NCT00279201|6370442|P4|Intensification Addendum|Physician Decision|1
1840376|NCT00279201|6370443|P3|Intensification Addendum|Physician Decision|4
1840377|NCT00279201|6370444|P2|Intensification Addendum|Physician Decision|0
1840378|NCT00279201|6370445|P1|Intensification Addendum|Physician Decision|0
1840379|NCT00279201|6370440|P6|Intensification Addendum|Adverse Event|3
1840380|NCT00279201|6370441|P5|Intensification Addendum|Adverse Event|1
1840381|NCT00279201|6370442|P4|Intensification Addendum|Adverse Event|4
1840382|NCT00279201|6370443|P3|Intensification Addendum|Adverse Event|0
1840383|NCT00279201|6370444|P2|Intensification Addendum|Adverse Event|0
1840384|NCT00279201|6370445|P1|Intensification Addendum|Adverse Event|0
1840385|NCT00279201|6370440|P6|Intensification Addendum|Protocol Violation|6
1840386|NCT00279201|6370441|P5|Intensification Addendum|Protocol Violation|6
1840387|NCT00279201|6370442|P4|Intensification Addendum|Protocol Violation|2
1840388|NCT00279201|6370443|P3|Intensification Addendum|Protocol Violation|2
1840389|NCT00279201|6370444|P2|Intensification Addendum|Protocol Violation|0
1840390|NCT00279201|6370445|P1|Intensification Addendum|Protocol Violation|0
1840391|NCT00279201|6370440|P6|Intensification Addendum|Lost to Follow-up|7
1840392|NCT00279201|6370441|P5|Intensification Addendum|Lost to Follow-up|7
1840393|NCT00279201|6370442|P4|Intensification Addendum|Lost to Follow-up|6
1840394|NCT00279201|6370443|P3|Intensification Addendum|Lost to Follow-up|4
1840395|NCT00279201|6370444|P2|Intensification Addendum|Lost to Follow-up|0
1840396|NCT00279201|6370445|P1|Intensification Addendum|Lost to Follow-up|0
1840397|NCT00279201|6370440|P6|Intensification Addendum|Withdrawal by Subject|18
1840398|NCT00279201|6370441|P5|Intensification Addendum|Withdrawal by Subject|9
1840399|NCT00279201|6370442|P4|Intensification Addendum|Withdrawal by Subject|14
1840400|NCT00279201|6370443|P3|Intensification Addendum|Withdrawal by Subject|12
1840401|NCT00279201|6370444|P2|Intensification Addendum|Withdrawal by Subject|0
1840402|NCT00279201|6370445|P1|Intensification Addendum|Withdrawal by Subject|0
1840403|NCT00279201|6370440|P6|Maintenance|HbA1c>7.5%|0
1840404|NCT00279201|6370441|P5|Maintenance|HbA1c>7.5%|0
1840405|NCT00279201|6370442|P4|Maintenance|HbA1c>7.5%|0
1840406|NCT00279201|6370443|P3|Maintenance|HbA1c>7.5%|0
1840407|NCT00279201|6370444|P2|Maintenance|HbA1c>7.5%|126
1840408|NCT00279201|6370445|P1|Maintenance|HbA1c>7.5%|123
1840409|NCT00279201|6370440|P6|Maintenance|Sponsor Decision|0
1840410|NCT00279201|6370441|P5|Maintenance|Sponsor Decision|0
1840411|NCT00279201|6370442|P4|Maintenance|Sponsor Decision|0
1840412|NCT00279201|6370443|P3|Maintenance|Sponsor Decision|0
1840413|NCT00279201|6370444|P2|Maintenance|Sponsor Decision|0
1840414|NCT00279201|6370445|P1|Maintenance|Sponsor Decision|4
1840415|NCT00279201|6370440|P6|Maintenance|Physician Decision|0
1840416|NCT00279201|6370441|P5|Maintenance|Physician Decision|0
1840417|NCT00279201|6370442|P4|Maintenance|Physician Decision|0
1840418|NCT00279201|6370443|P3|Maintenance|Physician Decision|0
1840419|NCT00279201|6370444|P2|Maintenance|Physician Decision|9
1840420|NCT00279201|6370445|P1|Maintenance|Physician Decision|9
1840421|NCT00279201|6370440|P6|Maintenance|Withdrawal by Subject|0
1840422|NCT00279201|6370441|P5|Maintenance|Withdrawal by Subject|0
1840423|NCT00279201|6370442|P4|Maintenance|Withdrawal by Subject|0
1840424|NCT00279201|6370443|P3|Maintenance|Withdrawal by Subject|0
1840425|NCT00279201|6370444|P2|Maintenance|Withdrawal by Subject|18
1840426|NCT00279201|6370445|P1|Maintenance|Withdrawal by Subject|18
1840427|NCT00279201|6370440|P6|Maintenance|Protocol Violation|0
1840428|NCT00279201|6370441|P5|Maintenance|Protocol Violation|0
1840429|NCT00279201|6370442|P4|Maintenance|Protocol Violation|0
1840430|NCT00279201|6370443|P3|Maintenance|Protocol Violation|0
1840431|NCT00279201|6370444|P2|Maintenance|Protocol Violation|24
1840432|NCT00279201|6370445|P1|Maintenance|Protocol Violation|16
1840433|NCT00279201|6370440|P6|Maintenance|Entry Criteria Exclusion|0
1840434|NCT00279201|6370441|P5|Maintenance|Entry Criteria Exclusion|0
1840435|NCT00279201|6370442|P4|Maintenance|Entry Criteria Exclusion|0
1840436|NCT00279201|6370443|P3|Maintenance|Entry Criteria Exclusion|0
1840437|NCT00279201|6370444|P2|Maintenance|Entry Criteria Exclusion|4
1840438|NCT00279201|6370445|P1|Maintenance|Entry Criteria Exclusion|1
1840439|NCT00279201|6370440|P6|Maintenance|Lost to Follow-up|0
1840440|NCT00279201|6370441|P5|Maintenance|Lost to Follow-up|0
1840441|NCT00279201|6370442|P4|Maintenance|Lost to Follow-up|0
1840442|NCT00279201|6370443|P3|Maintenance|Lost to Follow-up|0
1840443|NCT00279201|6370444|P2|Maintenance|Lost to Follow-up|13
1840444|NCT00279201|6370445|P1|Maintenance|Lost to Follow-up|17
1840445|NCT00279201|6370440|P6|Maintenance|Death|0
1840446|NCT00279201|6370441|P5|Maintenance|Death|0
1840447|NCT00279201|6370442|P4|Maintenance|Death|0
1840448|NCT00279201|6370443|P3|Maintenance|Death|0
1840449|NCT00279201|6370444|P2|Maintenance|Death|4
1840450|NCT00279201|6370445|P1|Maintenance|Death|4
1840451|NCT00279201|6370440|P6|Maintenance|Adverse Event|0
1840452|NCT00279201|6370441|P5|Maintenance|Adverse Event|0
1840453|NCT00279201|6370442|P4|Maintenance|Adverse Event|0
1840454|NCT00279201|6370443|P3|Maintenance|Adverse Event|0
1840455|NCT00279201|6370444|P2|Maintenance|Adverse Event|4
1840456|NCT00279201|6370445|P1|Maintenance|Adverse Event|4
1840457|NCT00279201|6370440|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1840458|NCT00279201|6370441|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1840459|NCT00279201|6370442|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1840460|NCT00279201|6370443|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
1840461|NCT00279201|6370444|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
1840462|NCT00279201|6370445|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
1840463|NCT00279201|6370440|P6|Maintenance|Lack of Efficacy|0
1840464|NCT00279201|6370441|P5|Maintenance|Lack of Efficacy|0
1840465|NCT00279201|6370442|P4|Maintenance|Lack of Efficacy|0
1840466|NCT00279201|6370443|P3|Maintenance|Lack of Efficacy|0
1840467|NCT00279201|6370444|P2|Maintenance|Lack of Efficacy|30
1840468|NCT00279201|6370445|P1|Maintenance|Lack of Efficacy|32
1840469|NCT00279201|6370440|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
1840470|NCT00279201|6370441|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
1840471|NCT00279201|6370442|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
1840472|NCT00279201|6370443|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
1840473|NCT00279201|6370444|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
1840474|NCT00279201|6370445|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
1840475|NCT00279201|6370440|P6|Initiation|Sponsor Decision|0
1840476|NCT00279201|6370441|P5|Initiation|Sponsor Decision|0
1840477|NCT00279201|6370442|P4|Initiation|Sponsor Decision|0
1840478|NCT00279201|6370443|P3|Initiation|Sponsor Decision|0
1840479|NCT00279201|6370444|P2|Initiation|Sponsor Decision|5
1840480|NCT00279201|6370445|P1|Initiation|Sponsor Decision|13
1840481|NCT00279201|6370440|P6|Initiation|Physician Decision|0
1840482|NCT00279201|6370441|P5|Initiation|Physician Decision|0
1840483|NCT00279201|6370442|P4|Initiation|Physician Decision|0
1840484|NCT00279201|6370443|P3|Initiation|Physician Decision|0
1840485|NCT00279201|6370444|P2|Initiation|Physician Decision|18
1840486|NCT00279201|6370445|P1|Initiation|Physician Decision|15
1840487|NCT00279201|6370440|P6|Initiation|Withdrawal by Subject|0
1840488|NCT00279201|6370441|P5|Initiation|Withdrawal by Subject|0
1840489|NCT00279201|6370442|P4|Initiation|Withdrawal by Subject|0
1840490|NCT00279201|6370443|P3|Initiation|Withdrawal by Subject|0
1840491|NCT00279201|6370444|P2|Initiation|Withdrawal by Subject|41
1840492|NCT00279201|6370445|P1|Initiation|Withdrawal by Subject|35
1840493|NCT00279201|6370440|P6|Initiation|Protocol Violation|0
1840494|NCT00279201|6370441|P5|Initiation|Protocol Violation|0
1840495|NCT00279201|6370442|P4|Initiation|Protocol Violation|0
1840496|NCT00279201|6370443|P3|Initiation|Protocol Violation|0
1840497|NCT00279201|6370444|P2|Initiation|Protocol Violation|10
1840498|NCT00279201|6370445|P1|Initiation|Protocol Violation|9
1840499|NCT00279201|6370440|P6|Initiation|Entry Criteria Exclusion|0
1840500|NCT00279201|6370441|P5|Initiation|Entry Criteria Exclusion|0
1840501|NCT00279201|6370442|P4|Initiation|Entry Criteria Exclusion|0
1840502|NCT00279201|6370443|P3|Initiation|Entry Criteria Exclusion|0
1840503|NCT00279201|6370444|P2|Initiation|Entry Criteria Exclusion|9
1840504|NCT00279201|6370445|P1|Initiation|Entry Criteria Exclusion|7
1840505|NCT00279201|6370440|P6|Initiation|Lost to Follow-up|0
1840506|NCT00279201|6370441|P5|Initiation|Lost to Follow-up|0
1840507|NCT00279201|6370442|P4|Initiation|Lost to Follow-up|0
1840508|NCT00279201|6370443|P3|Initiation|Lost to Follow-up|0
1840509|NCT00279201|6370444|P2|Initiation|Lost to Follow-up|41
1840510|NCT00279201|6370445|P1|Initiation|Lost to Follow-up|42
1840511|NCT00279201|6370440|P6|Initiation|Adverse Event|0
1840512|NCT00279201|6370441|P5|Initiation|Adverse Event|0
1840513|NCT00279201|6370442|P4|Initiation|Adverse Event|0
1840514|NCT00279201|6370443|P3|Initiation|Adverse Event|0
1840515|NCT00279201|6370444|P2|Initiation|Adverse Event|15
1840516|NCT00279201|6370445|P1|Initiation|Adverse Event|6
1840517|NCT00279201|6370440|P6|Initiation|Death|0
1840518|NCT00279201|6370441|P5|Initiation|Death|0
1840519|NCT00279201|6370442|P4|Initiation|Death|0
1840520|NCT00279201|6370443|P3|Initiation|Death|0
1840521|NCT00279201|6370444|P2|Initiation|Death|5
1840522|NCT00279201|6370445|P1|Initiation|Death|1
1840523|NCT00278993|6370589|P1|Overall Study|Not Otherwise Specified|4
1840524|NCT00278993|6370589|P1|Overall Study|Physician Decision|9
1840525|NCT00278993|6370589|P1|Overall Study|Progressive Disease|65
1840526|NCT00278993|6370589|P1|Overall Study|Withdrawal by Subject|5
1840527|NCT00278993|6370589|P1|Overall Study|Adverse Event|24
1840528|NCT00278954|6370597|P1|Overall Study|Withdrawal by Subject|1
1840529|NCT00278954|6370597|P1|Overall Study|Lost to Follow-up|1
1840530|NCT00278954|6370597|P1|Overall Study|Adverse Event|3
1840531|NCT00278915|6370605|P1|Overall Study|Lack of Efficacy|1
1840532|NCT00278889|6370641|P3|Overall Study|Death|17
1840533|NCT00278889|6370642|P2|Overall Study|Death|21
1840534|NCT00278889|6370643|P1|Overall Study|Death|24
1840535|NCT00278889|6370641|P3|Overall Study|Lost to Follow-up|0
1840536|NCT00278889|6370642|P2|Overall Study|Lost to Follow-up|1
1840537|NCT00278889|6370643|P1|Overall Study|Lost to Follow-up|1
1840538|NCT00278889|6370641|P3|Overall Study|Withdrawal by Subject|3
1840539|NCT00278889|6370642|P2|Overall Study|Withdrawal by Subject|5
1840540|NCT00278889|6370643|P1|Overall Study|Withdrawal by Subject|0
1840541|NCT00278564|6370691|P1|Overall Study|Lack of Efficacy|4
1840542|NCT00278512|6370708|P2|Overall Study|Death|0
1840543|NCT00278512|6370709|P1|Overall Study|Death|1
1840544|NCT00278473|6370717|P2|Overall Study|drop out|3
1840545|NCT00278473|6370718|P1|Overall Study|drop out|4
1840546|NCT00278395|6370734|P1|Overall Study|Nonevaluable|1
1840547|NCT00278395|6370734|P1|Overall Study|Adverse Event|2
1840548|NCT00278200|6370752|P2|Overall Study|Physician Decision|1
1840549|NCT00278200|6370753|P1|Overall Study|Physician Decision|0
1840550|NCT00278200|6370752|P2|Overall Study|Death|3
1840551|NCT00278200|6370753|P1|Overall Study|Death|1
1840552|NCT00278161|6370762|P1|Overall Study|Death|11
1840555|NCT00277355|6370814|P2|Overall Study|Physician Decision|0
1840556|NCT00277355|6370815|P1|Overall Study|Physician Decision|1
1840557|NCT00277355|6370814|P2|Overall Study|Death|0
1840558|NCT00277355|6370815|P1|Overall Study|Death|3
1840559|NCT00277355|6370814|P2|Overall Study|Adverse Event|0
1840560|NCT00277355|6370815|P1|Overall Study|Adverse Event|5
1840561|NCT00277355|6370814|P2|Overall Study|Lost to Follow-up|2
1840562|NCT00277355|6370815|P1|Overall Study|Lost to Follow-up|2
1840563|NCT00277355|6370814|P2|Overall Study|Withdrawal by Subject|3
1840564|NCT00277355|6370815|P1|Overall Study|Withdrawal by Subject|3
1840565|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
1840566|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
1840567|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
1840568|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
1840569|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
1840570|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
1840571|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
1840572|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
1840573|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
1840574|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
1840575|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
1840576|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
1840577|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
1840578|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
1840579|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
1840580|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1840581|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
1840582|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
1840583|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
1840584|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
1840585|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
1840586|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
1840587|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
1840588|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
1840589|NCT00277212|6370823|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
1840590|NCT00277212|6370824|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
1840591|NCT00277212|6370825|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
1840592|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
1840593|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
1840594|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
1840595|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1840596|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
1840597|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
1840598|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1840599|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
1840600|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
1840601|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
1840602|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
1840603|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
1840604|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1840605|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
1840606|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
1840607|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1840608|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
1840609|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
1840610|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1840611|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
1840612|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
1840613|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
1840614|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
1840615|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
1840616|NCT00277212|6370823|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1840617|NCT00277212|6370824|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
1840618|NCT00277212|6370825|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
1840619|NCT00277095|6370863|P1|Overall Study|Physician Decision|1
1840620|NCT00277095|6370863|P1|Overall Study|Missed Follow-up|9
1840621|NCT00277095|6370863|P1|Overall Study|Lost to Follow-up|2
1840622|NCT00277095|6370863|P1|Overall Study|Explanted|7
1840623|NCT00277095|6370863|P1|Overall Study|Death|2
1840624|NCT00276744|6370872|P1|PART A|Reason unknown|98
1840625|NCT00276614|6370876|P1|Overall Study|Progression of disease under study|3
1840626|NCT00276484|6370887|P2|Overall Study|Could not take time off work|1
1840627|NCT00276484|6370888|P1|Overall Study|Could not take time off work|0
1840628|NCT00276484|6370887|P2|Overall Study|Withdrawal by Subject|3
1840629|NCT00276484|6370888|P1|Overall Study|Withdrawal by Subject|4
1840630|NCT00276484|6370887|P2|Overall Study|Protocol Violation|1
1840631|NCT00276484|6370888|P1|Overall Study|Protocol Violation|0
1840632|NCT00276484|6370887|P2|Overall Study|Lost to Follow-up|1
1840633|NCT00276484|6370888|P1|Overall Study|Lost to Follow-up|1
1840634|NCT00276484|6370887|P2|Overall Study|Adverse Event|7
1840635|NCT00276484|6370888|P1|Overall Study|Adverse Event|4
1840636|NCT00276458|6370920|P2|Overall Study|Protocol Violation|3
1840637|NCT00276458|6370921|P1|Overall Study|Protocol Violation|4
1840638|NCT00276458|6370920|P2|Overall Study|Lost to Follow-up|2
1840639|NCT00276458|6370921|P1|Overall Study|Lost to Follow-up|2
1840640|NCT00276458|6370920|P2|Overall Study|Adverse Event|2
1840641|NCT00276458|6370921|P1|Overall Study|Adverse Event|0
1840642|NCT00276419|6370955|P2|First Intervention|Withdrawal by Subject|2
1840643|NCT00276419|6370956|P1|First Intervention|Withdrawal by Subject|0
1840644|NCT00276419|6370955|P2|First Intervention|Adverse Event|0
1840645|NCT00276419|6370956|P1|First Intervention|Adverse Event|1
1840646|NCT00276380|6370999|P2|Overall Study|Abnormal aPPT Levels|1
1840647|NCT00276380|6371000|P1|Overall Study|Abnormal aPPT Levels|0
1840648|NCT00276380|6370999|P2|Overall Study|Death|3
1840649|NCT00276380|6371000|P1|Overall Study|Death|5
1840650|NCT00276380|6370999|P2|Overall Study|Withdrawal by Subject|6
1840651|NCT00276380|6371000|P1|Overall Study|Withdrawal by Subject|3
1840652|NCT00276380|6370999|P2|Overall Study|Lost to Follow-up|1
1840653|NCT00276380|6371000|P1|Overall Study|Lost to Follow-up|1
1840654|NCT00276380|6370999|P2|Overall Study|Adverse Event|3
1840655|NCT00276380|6371000|P1|Overall Study|Adverse Event|5
1840656|NCT00276159|6371055|P1|Overall Study|Did not receive all 24 doses of 852A|6
1840657|NCT00276094|6371065|P3|Overall Study|Other-Study medication lost|1
1840658|NCT00276094|6371066|P2|Overall Study|Other-Study medication lost|0
1840659|NCT00276094|6371067|P1|Overall Study|Other-Study medication lost|0
1840660|NCT00276094|6371065|P3|Overall Study|Other-Relocation|0
1840661|NCT00276094|6371066|P2|Overall Study|Other-Relocation|1
1840662|NCT00276094|6371067|P1|Overall Study|Other-Relocation|0
1840663|NCT00276094|6371065|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
1840664|NCT00276094|6371066|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
1840665|NCT00276094|6371067|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
1840666|NCT00276094|6371065|P3|Overall Study|Other-Refused follow-up visit|0
1840667|NCT00276094|6371066|P2|Overall Study|Other-Refused follow-up visit|0
1840668|NCT00276094|6371067|P1|Overall Study|Other-Refused follow-up visit|1
1840669|NCT00276094|6371065|P3|Overall Study|Other-Lack of efficacy|0
1840670|NCT00276094|6371066|P2|Overall Study|Other-Lack of efficacy|0
1840671|NCT00276094|6371067|P1|Overall Study|Other-Lack of efficacy|1
1840672|NCT00276094|6371065|P3|Overall Study|Other-Scheduled gastroplasty|0
1840673|NCT00276094|6371066|P2|Overall Study|Other-Scheduled gastroplasty|0
1840674|NCT00276094|6371067|P1|Overall Study|Other-Scheduled gastroplasty|1
1840675|NCT00276094|6371065|P3|Overall Study|Other-Subject moved out of country|0
1840676|NCT00276094|6371066|P2|Overall Study|Other-Subject moved out of country|0
1840677|NCT00276094|6371067|P1|Overall Study|Other-Subject moved out of country|1
1840678|NCT00276094|6371065|P3|Overall Study|Lost to Follow-up|4
1840679|NCT00276094|6371066|P2|Overall Study|Lost to Follow-up|6
1840680|NCT00276094|6371067|P1|Overall Study|Lost to Follow-up|8
1840681|NCT00276094|6371065|P3|Overall Study|Protocol Violation|10
1840682|NCT00276094|6371066|P2|Overall Study|Protocol Violation|7
1840683|NCT00276094|6371067|P1|Overall Study|Protocol Violation|16
1840684|NCT00276094|6371065|P3|Overall Study|Withdrawal by Subject|12
1840685|NCT00276094|6371066|P2|Overall Study|Withdrawal by Subject|14
1840686|NCT00276094|6371067|P1|Overall Study|Withdrawal by Subject|14
1840687|NCT00276094|6371065|P3|Overall Study|Adverse Event|11
1840688|NCT00276094|6371066|P2|Overall Study|Adverse Event|13
1840689|NCT00276094|6371067|P1|Overall Study|Adverse Event|15
1840690|NCT00276016|6371120|P6|Intervention 1|Withdrawal by Subject|0
1840691|NCT00276016|6371121|P5|Intervention 1|Withdrawal by Subject|0
1840692|NCT00276016|6371122|P4|Intervention 1|Withdrawal by Subject|0
1840693|NCT00276016|6371123|P3|Intervention 1|Withdrawal by Subject|0
1840694|NCT00276016|6371124|P2|Intervention 1|Withdrawal by Subject|1
1840695|NCT00276016|6371125|P1|Intervention 1|Withdrawal by Subject|0
1840696|NCT00275821|6371171|P3|Overall Study|Protocol Violation|0
1840697|NCT00275821|6371172|P2|Overall Study|Protocol Violation|1
1840698|NCT00275821|6371173|P1|Overall Study|Protocol Violation|5
1840699|NCT00275821|6371171|P3|Overall Study|Lack of Efficacy|0
1840700|NCT00275821|6371172|P2|Overall Study|Lack of Efficacy|1
1840701|NCT00275821|6371173|P1|Overall Study|Lack of Efficacy|2
1840702|NCT00275821|6371171|P3|Overall Study|Death|1
1840703|NCT00275821|6371172|P2|Overall Study|Death|2
1840704|NCT00275821|6371173|P1|Overall Study|Death|0
1840705|NCT00275821|6371171|P3|Overall Study|Lost to Follow-up|1
1840706|NCT00275821|6371172|P2|Overall Study|Lost to Follow-up|1
1840707|NCT00275821|6371173|P1|Overall Study|Lost to Follow-up|0
1840708|NCT00275821|6371171|P3|Overall Study|Withdrawal by Subject|1
1840709|NCT00275821|6371172|P2|Overall Study|Withdrawal by Subject|2
1840710|NCT00275821|6371173|P1|Overall Study|Withdrawal by Subject|0
1840711|NCT00275821|6371171|P3|Overall Study|Administrative problems|4
1840712|NCT00275821|6371172|P2|Overall Study|Administrative problems|4
1840713|NCT00275821|6371173|P1|Overall Study|Administrative problems|3
1840714|NCT00275821|6371171|P3|Overall Study|Adverse Event|5
1840715|NCT00275821|6371172|P2|Overall Study|Adverse Event|12
1840716|NCT00275821|6371173|P1|Overall Study|Adverse Event|4
1840717|NCT00275561|6371192|P2|Overall Study|Family Issues|2
1840718|NCT00275561|6371193|P1|Overall Study|Family Issues|0
1840719|NCT00275561|6371192|P2|Overall Study|Scheduling|2
1840720|NCT00275561|6371193|P1|Overall Study|Scheduling|1
1840721|NCT00275561|6371192|P2|Overall Study|Travel|1
1840722|NCT00275561|6371193|P1|Overall Study|Travel|1
1840723|NCT00275561|6371192|P2|Overall Study|Withdrawal by Subject|1
1840724|NCT00275561|6371193|P1|Overall Study|Withdrawal by Subject|0
1840725|NCT00275509|6371205|P2|Overall Study|graft thrombosis, post-operative day #8|1
1840726|NCT00275509|6371206|P1|Overall Study|graft thrombosis, post-operative day #8|0
1840727|NCT00275340|6371229|P2|Overall Study|Lost to Follow-up|4
1840728|NCT00275340|6371230|P1|Overall Study|Lost to Follow-up|2
1840729|NCT00275301|6371234|P1|Overall Study|Adverse Event|5
1840730|NCT00275262|6371253|P2|Overall Study|Started Chemotherapy|0
1840731|NCT00275262|6371254|P1|Overall Study|Started Chemotherapy|1
1840732|NCT00275262|6371253|P2|Overall Study|Death|0
1840733|NCT00275262|6371254|P1|Overall Study|Death|1
1840734|NCT00275262|6371253|P2|Overall Study|Protocol Violation|2
1840735|NCT00275262|6371254|P1|Overall Study|Protocol Violation|0
1840736|NCT00275262|6371253|P2|Overall Study|Lost to Follow-up|2
1840737|NCT00275262|6371254|P1|Overall Study|Lost to Follow-up|0
1840738|NCT00275262|6371253|P2|Overall Study|Disease progression|5
1840739|NCT00275262|6371254|P1|Overall Study|Disease progression|2
1840740|NCT00275262|6371253|P2|Overall Study|Adverse Event|0
1840741|NCT00275262|6371254|P1|Overall Study|Adverse Event|2
1840742|NCT00275028|6371268|P1|Overall Study|Physician Decision|2
1840743|NCT00275028|6371268|P1|Overall Study|Progressive Disease|30
1840744|NCT00275028|6371268|P1|Overall Study|Adverse Event|9
1840745|NCT00275028|6371268|P1|Overall Study|Withdrawal by Subject|5
1840746|NCT00275028|6371268|P1|Overall Study|Withdrew consent before treatment began|1
1840747|NCT00275002|6371275|P2|Overall Study|Adverse Event|1
1840748|NCT00275002|6371276|P1|Overall Study|Adverse Event|0
1840749|NCT00275002|6371275|P2|Overall Study|Disease progression|15
1840750|NCT00275002|6371276|P1|Overall Study|Disease progression|21
1840751|NCT00275002|6371275|P2|Overall Study|Death|0
1840752|NCT00275002|6371276|P1|Overall Study|Death|1
1840753|NCT00274937|6371284|P1|Overall Study|Progressive Disease|4
1840754|NCT00274937|6371284|P1|Overall Study|Withdrawal by Subject|6
1840755|NCT00274937|6371284|P1|Overall Study|Physician Decision|10
1840756|NCT00274924|6371296|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1840757|NCT00274924|6371297|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
1840758|NCT00274924|6371298|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
1840759|NCT00274924|6371296|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1840760|NCT00274924|6371297|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
1840761|NCT00274924|6371298|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
1840762|NCT00274924|6371296|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1840763|NCT00274924|6371297|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
1840764|NCT00274924|6371298|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
1840765|NCT00274924|6371296|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1840766|NCT00274924|6371297|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
1840767|NCT00274924|6371298|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
1840768|NCT00274924|6371296|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1840769|NCT00274924|6371297|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
1840770|NCT00274924|6371298|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
1840771|NCT00274924|6371296|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1840772|NCT00274924|6371297|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
1840773|NCT00274924|6371298|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
1840774|NCT00274924|6371296|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
1840775|NCT00274924|6371297|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
1840776|NCT00274924|6371298|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
1840777|NCT00274924|6371296|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
1840778|NCT00274924|6371297|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1840779|NCT00274924|6371298|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
1840780|NCT00274924|6371296|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
1840781|NCT00274924|6371297|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1840782|NCT00274924|6371298|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
1840783|NCT00274924|6371296|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
1840784|NCT00274924|6371297|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1840785|NCT00274924|6371298|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
1840786|NCT00274924|6371296|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
1840787|NCT00274924|6371297|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1840788|NCT00274924|6371298|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
1840789|NCT00274924|6371296|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
1840790|NCT00274924|6371297|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1840791|NCT00274924|6371298|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
1840792|NCT00274924|6371296|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
1840793|NCT00274924|6371297|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
1840794|NCT00274924|6371298|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
1840795|NCT00274846|6371307|P1|Overall Study|Did not receive adequate NK cells|1
1840796|NCT00274742|6371336|P6|Overall Study|Other|0
1840797|NCT00274742|6371337|P5|Overall Study|Other|2
1840798|NCT00274742|6371338|P4|Overall Study|Other|0
1840799|NCT00274742|6371339|P3|Overall Study|Other|0
1840800|NCT00274742|6371340|P2|Overall Study|Other|3
1840801|NCT00274742|6371341|P1|Overall Study|Other|0
1840802|NCT00274742|6371336|P6|Overall Study|Disease Progression|0
1840803|NCT00274742|6371337|P5|Overall Study|Disease Progression|1
1840804|NCT00274742|6371338|P4|Overall Study|Disease Progression|0
1840805|NCT00274742|6371339|P3|Overall Study|Disease Progression|1
1840806|NCT00274742|6371340|P2|Overall Study|Disease Progression|1
1840807|NCT00274742|6371341|P1|Overall Study|Disease Progression|0
1840808|NCT00274742|6371336|P6|Overall Study|End of Study|0
1840809|NCT00274742|6371337|P5|Overall Study|End of Study|0
1840810|NCT00274742|6371338|P4|Overall Study|End of Study|1
1840811|NCT00274742|6371339|P3|Overall Study|End of Study|0
1840812|NCT00274742|6371340|P2|Overall Study|End of Study|0
1840813|NCT00274742|6371341|P1|Overall Study|End of Study|0
1840814|NCT00274742|6371336|P6|Overall Study|Lost to Follow-up|0
1840815|NCT00274742|6371337|P5|Overall Study|Lost to Follow-up|1
1840816|NCT00274742|6371338|P4|Overall Study|Lost to Follow-up|0
1840817|NCT00274742|6371339|P3|Overall Study|Lost to Follow-up|0
1840818|NCT00274742|6371340|P2|Overall Study|Lost to Follow-up|0
1840819|NCT00274742|6371341|P1|Overall Study|Lost to Follow-up|0
1840820|NCT00274742|6371336|P6|Overall Study|Adverse Event|3
1840821|NCT00274742|6371337|P5|Overall Study|Adverse Event|12
1840822|NCT00274742|6371338|P4|Overall Study|Adverse Event|4
1840823|NCT00274742|6371339|P3|Overall Study|Adverse Event|1
1840824|NCT00274742|6371340|P2|Overall Study|Adverse Event|4
1840825|NCT00274742|6371341|P1|Overall Study|Adverse Event|0
1840826|NCT00274716|6371379|P6|Phase B|Lost to Follow-up|0
1840827|NCT00274716|6371380|P5|Phase B|Lost to Follow-up|0
1840828|NCT00274716|6371381|P4|Phase B|Lost to Follow-up|0
1840829|NCT00274716|6371382|P3|Phase B|Lost to Follow-up|0
1840830|NCT00274716|6371383|P2|Phase B|Lost to Follow-up|1
1840831|NCT00274716|6371384|P1|Phase B|Lost to Follow-up|0
1840832|NCT00274716|6371379|P6|Phase B|Other non-reported reason|0
1840833|NCT00274716|6371380|P5|Phase B|Other non-reported reason|0
1840834|NCT00274716|6371381|P4|Phase B|Other non-reported reason|1
1840835|NCT00274716|6371382|P3|Phase B|Other non-reported reason|1
1840836|NCT00274716|6371383|P2|Phase B|Other non-reported reason|0
1840837|NCT00274716|6371384|P1|Phase B|Other non-reported reason|0
1840838|NCT00274716|6371379|P6|Phase B|Participant moved|0
1840839|NCT00274716|6371380|P5|Phase B|Participant moved|0
1840840|NCT00274716|6371381|P4|Phase B|Participant moved|0
1840841|NCT00274716|6371382|P3|Phase B|Participant moved|0
1840842|NCT00274716|6371383|P2|Phase B|Participant moved|0
1840843|NCT00274716|6371384|P1|Phase B|Participant moved|1
1840844|NCT00274716|6371379|P6|Phase B|Withdrawal by Subject|0
1840845|NCT00274716|6371380|P5|Phase B|Withdrawal by Subject|0
1840846|NCT00274716|6371381|P4|Phase B|Withdrawal by Subject|0
1840847|NCT00274716|6371382|P3|Phase B|Withdrawal by Subject|0
1840848|NCT00274716|6371383|P2|Phase B|Withdrawal by Subject|1
1840849|NCT00274716|6371384|P1|Phase B|Withdrawal by Subject|0
1840850|NCT00274716|6371379|P6|Phase B|Protocol Violation|0
1840851|NCT00274716|6371380|P5|Phase B|Protocol Violation|0
1840852|NCT00274716|6371381|P4|Phase B|Protocol Violation|0
1840853|NCT00274716|6371382|P3|Phase B|Protocol Violation|0
1840854|NCT00274716|6371383|P2|Phase B|Protocol Violation|2
1840855|NCT00274716|6371384|P1|Phase B|Protocol Violation|0
1840856|NCT00274716|6371379|P6|Phase B|Adverse Event|1
1840857|NCT00274716|6371380|P5|Phase B|Adverse Event|0
1840858|NCT00274716|6371381|P4|Phase B|Adverse Event|0
1840859|NCT00274716|6371382|P3|Phase B|Adverse Event|2
1840860|NCT00274716|6371383|P2|Phase B|Adverse Event|0
1840861|NCT00274716|6371384|P1|Phase B|Adverse Event|0
1840862|NCT00274716|6371379|P6|Phase A|Completed but did not enter Phase B|1
1840863|NCT00274716|6371380|P5|Phase A|Completed but did not enter Phase B|1
1840864|NCT00274716|6371381|P4|Phase A|Completed but did not enter Phase B|2
1840865|NCT00274716|6371382|P3|Phase A|Completed but did not enter Phase B|2
1840866|NCT00274716|6371383|P2|Phase A|Completed but did not enter Phase B|2
1840867|NCT00274716|6371384|P1|Phase A|Completed but did not enter Phase B|1
1840868|NCT00274716|6371379|P6|Phase A|Adverse Event|0
1840869|NCT00274716|6371380|P5|Phase A|Adverse Event|2
1840870|NCT00274716|6371381|P4|Phase A|Adverse Event|0
1840871|NCT00274716|6371382|P3|Phase A|Adverse Event|3
1840872|NCT00274716|6371383|P2|Phase A|Adverse Event|3
1840873|NCT00274716|6371384|P1|Phase A|Adverse Event|2
1840874|NCT00274716|6371379|P6|Phase A|Withdrawal by Subject|1
1840875|NCT00274716|6371380|P5|Phase A|Withdrawal by Subject|0
1840876|NCT00274716|6371381|P4|Phase A|Withdrawal by Subject|3
1840877|NCT00274716|6371382|P3|Phase A|Withdrawal by Subject|1
1840878|NCT00274716|6371383|P2|Phase A|Withdrawal by Subject|2
1840879|NCT00274716|6371384|P1|Phase A|Withdrawal by Subject|2
1840880|NCT00274716|6371379|P6|Phase A|Met criteria for discontinuation|0
1840881|NCT00274716|6371380|P5|Phase A|Met criteria for discontinuation|0
1840882|NCT00274716|6371381|P4|Phase A|Met criteria for discontinuation|0
1840883|NCT00274716|6371382|P3|Phase A|Met criteria for discontinuation|0
1840884|NCT00274716|6371383|P2|Phase A|Met criteria for discontinuation|1
1840885|NCT00274716|6371384|P1|Phase A|Met criteria for discontinuation|1
1840886|NCT00274716|6371379|P6|Phase A|Protocol Violation|0
1840887|NCT00274716|6371380|P5|Phase A|Protocol Violation|0
1840888|NCT00274716|6371381|P4|Phase A|Protocol Violation|1
1840889|NCT00274716|6371382|P3|Phase A|Protocol Violation|0
1840890|NCT00274716|6371383|P2|Phase A|Protocol Violation|0
1840891|NCT00274716|6371384|P1|Phase A|Protocol Violation|1
1840892|NCT00274716|6371379|P6|Phase A|Site Terminated|0
1840893|NCT00274716|6371380|P5|Phase A|Site Terminated|0
1840894|NCT00274716|6371381|P4|Phase A|Site Terminated|1
1840895|NCT00274716|6371382|P3|Phase A|Site Terminated|0
1840896|NCT00274716|6371383|P2|Phase A|Site Terminated|0
1840897|NCT00274716|6371384|P1|Phase A|Site Terminated|0
1840898|NCT00274716|6371379|P6|Phase A|Participant moved|1
1840899|NCT00274716|6371380|P5|Phase A|Participant moved|0
1840900|NCT00274716|6371381|P4|Phase A|Participant moved|0
1840901|NCT00274716|6371382|P3|Phase A|Participant moved|1
1840902|NCT00274716|6371383|P2|Phase A|Participant moved|0
1840903|NCT00274716|6371384|P1|Phase A|Participant moved|0
1840904|NCT00274716|6371379|P6|Phase A|Other non-reported reason|1
1840905|NCT00274716|6371380|P5|Phase A|Other non-reported reason|0
1840906|NCT00274716|6371381|P4|Phase A|Other non-reported reason|2
1840907|NCT00274716|6371382|P3|Phase A|Other non-reported reason|1
1840908|NCT00274716|6371383|P2|Phase A|Other non-reported reason|2
1840909|NCT00274716|6371384|P1|Phase A|Other non-reported reason|4
1840910|NCT00274651|6371446|P2|Overall Study|Physician Decision|7
1840911|NCT00274651|6371447|P1|Overall Study|Physician Decision|8
1840912|NCT00274651|6371446|P2|Overall Study|Withdrawal by Subject|1
1840913|NCT00274651|6371447|P1|Overall Study|Withdrawal by Subject|0
1840914|NCT00274651|6371446|P2|Overall Study|Death|3
1840915|NCT00274651|6371447|P1|Overall Study|Death|1
1840916|NCT00274651|6371446|P2|Overall Study|Lack of Efficacy|6
1840917|NCT00274651|6371447|P1|Overall Study|Lack of Efficacy|13
1840918|NCT00274651|6371446|P2|Overall Study|Adverse Event|3
1840919|NCT00274651|6371447|P1|Overall Study|Adverse Event|6
1840920|NCT00274625|6371462|P2|Overall Study|Excluded from analysis|8
1840921|NCT00274625|6371463|P1|Overall Study|Excluded from analysis|14
1840922|NCT00274625|6371462|P2|Overall Study|Lost to Follow-up|54
1840923|NCT00274625|6371463|P1|Overall Study|Lost to Follow-up|46
1840924|NCT00274469|6371471|P2|Overall Study|Did not consent to OS follow-up|19
1840925|NCT00274469|6371472|P1|Overall Study|Did not consent to OS follow-up|16
1840926|NCT00274469|6371471|P2|Overall Study|Death|74
1840927|NCT00274469|6371472|P1|Overall Study|Death|63
1840928|NCT00274456|6371492|P4|Overall Study|Withdrawal by Subject|13
1840929|NCT00274456|6371493|P3|Overall Study|Withdrawal by Subject|9
1840930|NCT00274456|6371494|P2|Overall Study|Withdrawal by Subject|13
1840931|NCT00274456|6371495|P1|Overall Study|Withdrawal by Subject|18
1840932|NCT00274456|6371492|P4|Overall Study|Lost to Follow-up|0
1840933|NCT00274456|6371493|P3|Overall Study|Lost to Follow-up|1
1840934|NCT00274456|6371494|P2|Overall Study|Lost to Follow-up|0
1840935|NCT00274456|6371495|P1|Overall Study|Lost to Follow-up|0
1840936|NCT00274456|6371492|P4|Overall Study|Physician Decision|13
1840937|NCT00274456|6371493|P3|Overall Study|Physician Decision|6
1840938|NCT00274456|6371494|P2|Overall Study|Physician Decision|5
1840939|NCT00274456|6371495|P1|Overall Study|Physician Decision|7
1840940|NCT00274456|6371492|P4|Overall Study|Adverse Event|2
1840941|NCT00274456|6371493|P3|Overall Study|Adverse Event|2
1840942|NCT00274456|6371494|P2|Overall Study|Adverse Event|1
1840943|NCT00274456|6371495|P1|Overall Study|Adverse Event|0
1840944|NCT00274456|6371492|P4|Overall Study|Unacceptable toxicity|16
1840945|NCT00274456|6371493|P3|Overall Study|Unacceptable toxicity|12
1840946|NCT00274456|6371494|P2|Overall Study|Unacceptable toxicity|5
1840947|NCT00274456|6371495|P1|Overall Study|Unacceptable toxicity|10
1840948|NCT00274456|6371492|P4|Overall Study|Still on treatment|1
1840949|NCT00274456|6371493|P3|Overall Study|Still on treatment|5
1840950|NCT00274456|6371494|P2|Overall Study|Still on treatment|3
1840951|NCT00274456|6371495|P1|Overall Study|Still on treatment|2
1840952|NCT00274287|6371537|P1|Overall Study|subject non-compliance|1
1840953|NCT00274287|6371537|P1|Overall Study|Withdrawal by Subject|1
1840954|NCT00274261|6371547|P2|Overall Study|Lost to Follow-up|75
1840955|NCT00274261|6371548|P1|Overall Study|Lost to Follow-up|106
1840956|NCT00274261|6371547|P2|Overall Study|Protocol Violation|42
1840957|NCT00274261|6371548|P1|Overall Study|Protocol Violation|71
1840958|NCT00274261|6371547|P2|Overall Study|Withdrawal by Subject|126
1840959|NCT00274261|6371548|P1|Overall Study|Withdrawal by Subject|179
1840960|NCT00274261|6371547|P2|Overall Study|Pregnancy|83
1840961|NCT00274261|6371548|P1|Overall Study|Pregnancy|114
1840962|NCT00274261|6371547|P2|Overall Study|Adverse Event|11
1840963|NCT00274261|6371548|P1|Overall Study|Adverse Event|19
1840964|NCT00273858|6371587|P1|Overall Study|Adverse Event|81
1840965|NCT00273858|6371587|P1|Overall Study|Withdrawal by Subject|21
1840966|NCT00273858|6371587|P1|Overall Study|Lost to Follow-up|101
1840967|NCT00273858|6371587|P1|Overall Study|Not completed 24 month observation time|334
1840968|NCT00273182|6371646|P1|Overall Study|Site exit, system change, 36 m FU missed|36
1840969|NCT00273182|6371646|P1|Overall Study|Device/System Explant|154
1840970|NCT00273182|6371646|P1|Overall Study|Withdrawal by Subject|257
1840971|NCT00273182|6371646|P1|Overall Study|Lost to Follow-up|88
1840972|NCT00273182|6371646|P1|Overall Study|Death|450
1840973|NCT00273052|6371656|P2|Overall Study|Worsening serum lipid levels|2
1840974|NCT00273052|6371657|P1|Overall Study|Worsening serum lipid levels|0
1840975|NCT00273052|6371656|P2|Overall Study|Other|0
1840976|NCT00273052|6371657|P1|Overall Study|Other|2
1840977|NCT00273052|6371656|P2|Overall Study|Non-Compliance|1
1840978|NCT00273052|6371657|P1|Overall Study|Non-Compliance|3
1840979|NCT00273052|6371656|P2|Overall Study|Lack of Efficacy|4
1840980|NCT00273052|6371657|P1|Overall Study|Lack of Efficacy|6
1840981|NCT00273052|6371656|P2|Overall Study|Lost to Follow-up|25
1840982|NCT00273052|6371657|P1|Overall Study|Lost to Follow-up|7
1840983|NCT00273052|6371656|P2|Overall Study|Protocol Violation|18
1840984|NCT00273052|6371657|P1|Overall Study|Protocol Violation|14
1840985|NCT00273052|6371656|P2|Overall Study|Adverse Event|19
1840986|NCT00273052|6371657|P1|Overall Study|Adverse Event|21
1840987|NCT00273052|6371656|P2|Overall Study|Withdrawal by Subject|19
1840988|NCT00273052|6371657|P1|Overall Study|Withdrawal by Subject|16
1840989|NCT00272987|6371692|P3|Overall Study|Ongoing|15
1840990|NCT00272987|6371693|P2|Overall Study|Ongoing|14
1840991|NCT00272987|6371694|P1|Overall Study|Ongoing|20
1840992|NCT00272987|6371692|P3|Overall Study|Missed >3 Visits|1
1840993|NCT00272987|6371693|P2|Overall Study|Missed >3 Visits|0
1840994|NCT00272987|6371694|P1|Overall Study|Missed >3 Visits|0
1840995|NCT00272987|6371692|P3|Overall Study|Withdrawal by Subject|3
1840996|NCT00272987|6371693|P2|Overall Study|Withdrawal by Subject|0
1840997|NCT00272987|6371694|P1|Overall Study|Withdrawal by Subject|0
1840998|NCT00272987|6371692|P3|Overall Study|Adverse Event|0
1840999|NCT00272987|6371693|P2|Overall Study|Adverse Event|0
1841000|NCT00272987|6371694|P1|Overall Study|Adverse Event|1
1841001|NCT00272961|6371758|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
1841002|NCT00272961|6371759|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
1841003|NCT00272961|6371760|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
1841004|NCT00272961|6371761|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
1841005|NCT00272961|6371762|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
1841006|NCT00272961|6371758|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1841007|NCT00272961|6371759|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1841008|NCT00272961|6371760|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1841009|NCT00272961|6371761|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
1841010|NCT00272961|6371762|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
1841011|NCT00272961|6371758|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
1841012|NCT00272961|6371759|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1841013|NCT00272961|6371760|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1841014|NCT00272961|6371761|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
1841015|NCT00272961|6371762|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
1841016|NCT00272961|6371758|P5|Placebo Run-in Phase: Up to Week 2|Other|0
1841017|NCT00272961|6371759|P4|Placebo Run-in Phase: Up to Week 2|Other|0
1841018|NCT00272961|6371760|P3|Placebo Run-in Phase: Up to Week 2|Other|0
1841019|NCT00272961|6371761|P2|Placebo Run-in Phase: Up to Week 2|Other|0
1841020|NCT00272961|6371762|P1|Placebo Run-in Phase: Up to Week 2|Other|2
1841021|NCT00272961|6371758|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1841022|NCT00272961|6371759|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1841023|NCT00272961|6371760|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1841024|NCT00272961|6371761|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
1841025|NCT00272961|6371762|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
1841026|NCT00272961|6371758|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1841027|NCT00272961|6371759|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1841028|NCT00272961|6371760|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1841029|NCT00272961|6371761|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
1841030|NCT00272961|6371762|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
1841031|NCT00272961|6371758|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1841032|NCT00272961|6371759|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1841033|NCT00272961|6371760|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1841034|NCT00272961|6371761|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
1841035|NCT00272961|6371762|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
1841036|NCT00272961|6371758|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1841037|NCT00272961|6371759|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1841038|NCT00272961|6371760|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1841039|NCT00272961|6371761|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
1841040|NCT00272961|6371762|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
1841041|NCT00272844|6371819|P1|Overall Study|Withdrawal by Subject|5
1841042|NCT00272792|6371827|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
1841043|NCT00272792|6371828|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
1841044|NCT00272792|6371827|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
1841045|NCT00272792|6371828|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
1841046|NCT00272792|6371827|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
1841047|NCT00272792|6371828|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
1841048|NCT00272792|6371827|P2|Part 1: Responsiveness|Lost to Follow-up|0
1841049|NCT00272792|6371828|P1|Part 1: Responsiveness|Lost to Follow-up|1
1841050|NCT00272779|6371838|P2|Baseline Through Week 96|Continuing on treatment|38
1841051|NCT00272779|6371839|P1|Baseline Through Week 96|Continuing on treatment|61
1841052|NCT00272779|6371838|P2|Baseline Through Week 96|Never treated|3
1841053|NCT00272779|6371839|P1|Baseline Through Week 96|Never treated|2
1841054|NCT00272779|6371838|P2|Baseline Through Week 96|Pregnancy at Week 96|0
1841055|NCT00272779|6371839|P1|Baseline Through Week 96|Pregnancy at Week 96|1
1841056|NCT00272779|6371838|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
1841057|NCT00272779|6371839|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
1841058|NCT00272779|6371838|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
1841059|NCT00272779|6371839|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
1841133|NCT00271817|6372133|P1|Part 2|Withdrawal by Subject|0
1841060|NCT00272779|6371838|P2|Baseline Through Week 96|Changed address before Week 96|1
1841061|NCT00272779|6371839|P1|Baseline Through Week 96|Changed address before Week 96|0
1841062|NCT00272779|6371838|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
1841063|NCT00272779|6371839|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
1841064|NCT00272779|6371838|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
1841065|NCT00272779|6371839|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
1841066|NCT00272779|6371838|P2|Baseline Through Week 96|Pregnancy before Week 96|7
1841067|NCT00272779|6371839|P1|Baseline Through Week 96|Pregnancy before Week 96|5
1841068|NCT00272779|6371838|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
1841069|NCT00272779|6371839|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
1841070|NCT00272779|6371838|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
1841071|NCT00272779|6371839|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
1841072|NCT00272779|6371838|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
1841073|NCT00272779|6371839|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
1841074|NCT00272779|6371838|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
1841075|NCT00272779|6371839|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
1841076|NCT00272779|6371838|P2|Baseline Through Week 96|Death before Week 96|5
1841077|NCT00272779|6371839|P1|Baseline Through Week 96|Death before Week 96|6
1841078|NCT00272779|6371838|P2|Baseline Through Week 96|Adverse event before Week 96|22
1841079|NCT00272779|6371839|P1|Baseline Through Week 96|Adverse event before Week 96|13
1841080|NCT00272779|6371838|P2|Baseline Through Week 48|Never treated|3
1841081|NCT00272779|6371839|P1|Baseline Through Week 48|Never treated|2
1841082|NCT00272779|6371838|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
1841083|NCT00272779|6371839|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
1841084|NCT00272779|6371838|P2|Baseline Through Week 48|Continuing treatment|368
1841085|NCT00272779|6371839|P1|Baseline Through Week 48|Continuing treatment|385
1841086|NCT00272779|6371838|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
1841087|NCT00272779|6371839|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
1841088|NCT00272779|6371838|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
1841089|NCT00272779|6371839|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
1841090|NCT00272779|6371838|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1841091|NCT00272779|6371839|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
1841092|NCT00272779|6371838|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
1841093|NCT00272779|6371839|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
1841094|NCT00272779|6371838|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
1841095|NCT00272779|6371839|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
1841096|NCT00272779|6371838|P2|Baseline Through Week 48|Death on/after Week 48|1
1841097|NCT00272779|6371839|P1|Baseline Through Week 48|Death on/after Week 48|1
1841098|NCT00272779|6371838|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
1841099|NCT00272779|6371839|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
1841100|NCT00272779|6371838|P2|Baseline Through Week 48|Chose different site before wk 48|1
1841101|NCT00272779|6371839|P1|Baseline Through Week 48|Chose different site before wk 48|0
1841102|NCT00272779|6371838|P2|Baseline Through Week 48|Participant's decision before wk 48|1
1841103|NCT00272779|6371839|P1|Baseline Through Week 48|Participant's decision before wk 48|0
1841104|NCT00272779|6371838|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
1841105|NCT00272779|6371839|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
1841106|NCT00272779|6371838|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
1841107|NCT00272779|6371839|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
1841108|NCT00272779|6371838|P2|Baseline Through Week 48|Pregnancy before Week 48|2
1841109|NCT00272779|6371839|P1|Baseline Through Week 48|Pregnancy before Week 48|2
1841110|NCT00272779|6371838|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
1841111|NCT00272779|6371839|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
1841112|NCT00272779|6371838|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
1841113|NCT00272779|6371839|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
1841114|NCT00272779|6371838|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
1841115|NCT00272779|6371839|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
1841116|NCT00272779|6371838|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
1841117|NCT00272779|6371839|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
1841118|NCT00272779|6371838|P2|Baseline Through Week 48|Death before Week 48|4
1841119|NCT00272779|6371839|P1|Baseline Through Week 48|Death before Week 48|4
1841120|NCT00272779|6371838|P2|Baseline Through Week 48|Adverse event before Week 48|14
1841121|NCT00272779|6371839|P1|Baseline Through Week 48|Adverse event before Week 48|10
1841122|NCT00272038|6372099|P1|Overall Study|withdrew before they received 2 cycles|7
1841123|NCT00271947|6372105|P1|Overall Study|Lost to Follow-up|1
1841124|NCT00271856|6372111|P2|Overall Study|Lost to Follow-up|11
1841125|NCT00271856|6372112|P1|Overall Study|Lost to Follow-up|10
1841126|NCT00271856|6372111|P2|Overall Study|Withdrawal by Subject|7
1841127|NCT00271856|6372112|P1|Overall Study|Withdrawal by Subject|1
1841128|NCT00271817|6372131|P3|Part 2|LDL < 50 mg/dL|4
1841129|NCT00271817|6372132|P2|Part 2|LDL < 50 mg/dL|3
1841130|NCT00271817|6372133|P1|Part 2|LDL < 50 mg/dL|0
1841131|NCT00271817|6372131|P3|Part 2|Withdrawal by Subject|13
1841132|NCT00271817|6372132|P2|Part 2|Withdrawal by Subject|2
1841134|NCT00271817|6372131|P3|Part 2|Patient Moved|5
1841135|NCT00271817|6372132|P2|Part 2|Patient Moved|0
1841136|NCT00271817|6372133|P1|Part 2|Patient Moved|0
1841137|NCT00271817|6372131|P3|Part 2|Protocol Violation|5
1841138|NCT00271817|6372132|P2|Part 2|Protocol Violation|3
1841139|NCT00271817|6372133|P1|Part 2|Protocol Violation|0
1841140|NCT00271817|6372131|P3|Part 2|Lost to Follow-up|18
1841141|NCT00271817|6372132|P2|Part 2|Lost to Follow-up|6
1841142|NCT00271817|6372133|P1|Part 2|Lost to Follow-up|0
1841143|NCT00271817|6372131|P3|Part 2|Lack of Efficacy|6
1841144|NCT00271817|6372132|P2|Part 2|Lack of Efficacy|1
1841145|NCT00271817|6372133|P1|Part 2|Lack of Efficacy|0
1841146|NCT00271817|6372131|P3|Part 2|Adverse Event|33
1841147|NCT00271817|6372132|P2|Part 2|Adverse Event|17
1841148|NCT00271817|6372133|P1|Part 2|Adverse Event|0
1841149|NCT00271817|6372131|P3|Part 1|LDL < 50 mg/dL|48
1841150|NCT00271817|6372132|P2|Part 1|LDL < 50 mg/dL|4
1841151|NCT00271817|6372133|P1|Part 1|LDL < 50 mg/dL|1
1841152|NCT00271817|6372131|P3|Part 1|Withdrawal by Subject|45
1841153|NCT00271817|6372132|P2|Part 1|Withdrawal by Subject|17
1841154|NCT00271817|6372133|P1|Part 1|Withdrawal by Subject|23
1841155|NCT00271817|6372131|P3|Part 1|Patient Moved|5
1841156|NCT00271817|6372132|P2|Part 1|Patient Moved|1
1841157|NCT00271817|6372133|P1|Part 1|Patient Moved|3
1841158|NCT00271817|6372131|P3|Part 1|Protocol Violation|7
1841159|NCT00271817|6372132|P2|Part 1|Protocol Violation|4
1841160|NCT00271817|6372133|P1|Part 1|Protocol Violation|5
1841161|NCT00271817|6372131|P3|Part 1|Lost to Follow-up|24
1841162|NCT00271817|6372132|P2|Part 1|Lost to Follow-up|8
1841163|NCT00271817|6372133|P1|Part 1|Lost to Follow-up|6
1841164|NCT00271817|6372131|P3|Part 1|Adverse Event|156
1841165|NCT00271817|6372132|P2|Part 1|Adverse Event|25
1841166|NCT00271817|6372133|P1|Part 1|Adverse Event|68
1841167|NCT00271609|6372175|P2|Overall Study|Withdrawal by Subject|0
1841168|NCT00271609|6372176|P1|Overall Study|Withdrawal by Subject|2
1841169|NCT00271609|6372175|P2|Overall Study|Adverse Event|3
1841170|NCT00271609|6372176|P1|Overall Study|Adverse Event|11
1841171|NCT00271596|6372186|P2|Overall Study|Withdrawal by Subject|1
1841172|NCT00271596|6372187|P1|Overall Study|Withdrawal by Subject|0
1841173|NCT00271596|6372186|P2|Overall Study|Protocol Violation|0
1841174|NCT00271596|6372187|P1|Overall Study|Protocol Violation|1
1841175|NCT00271544|6372222|P1|Overall Study|Implant not attempted|4
1841176|NCT00271544|6372222|P1|Overall Study|Model 4196 lead not attempted|9
1841177|NCT00271544|6372222|P1|Overall Study|Subjects did not receive a 4196 lead|7
1841178|NCT00271024|6372336|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
1841179|NCT00271024|6372337|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
1841180|NCT00271024|6372338|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
1841181|NCT00271024|6372339|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
1841182|NCT00271024|6372336|P4|Overall Study|Unpleasant Reaction To Tablet|2
1841183|NCT00271024|6372337|P3|Overall Study|Unpleasant Reaction To Tablet|4
1841184|NCT00271024|6372338|P2|Overall Study|Unpleasant Reaction To Tablet|3
1841185|NCT00271024|6372339|P1|Overall Study|Unpleasant Reaction To Tablet|1
1841186|NCT00271024|6372336|P4|Overall Study|Protocol Violation|11
1841187|NCT00271024|6372337|P3|Overall Study|Protocol Violation|5
1841188|NCT00271024|6372338|P2|Overall Study|Protocol Violation|6
1841189|NCT00271024|6372339|P1|Overall Study|Protocol Violation|1
1841190|NCT00271024|6372336|P4|Overall Study|Unknown/Unspecified|4
1841191|NCT00271024|6372337|P3|Overall Study|Unknown/Unspecified|8
1841192|NCT00271024|6372338|P2|Overall Study|Unknown/Unspecified|11
1841193|NCT00271024|6372339|P1|Overall Study|Unknown/Unspecified|11
1841194|NCT00271024|6372336|P4|Overall Study|Lost Interest|3
1841195|NCT00271024|6372337|P3|Overall Study|Lost Interest|2
1841196|NCT00271024|6372338|P2|Overall Study|Lost Interest|4
1841197|NCT00271024|6372339|P1|Overall Study|Lost Interest|3
1841198|NCT00270998|6372389|P3|12 Month Follow-up|Received/desired alternate treatment|1
1841199|NCT00270998|6372390|P2|12 Month Follow-up|Received/desired alternate treatment|4
1841200|NCT00270998|6372391|P1|12 Month Follow-up|Received/desired alternate treatment|1
1841201|NCT00270998|6372389|P3|12 Month Follow-up|Personal/family health|1
1841202|NCT00270998|6372390|P2|12 Month Follow-up|Personal/family health|5
1841203|NCT00270998|6372391|P1|12 Month Follow-up|Personal/family health|0
1841204|NCT00270998|6372389|P3|12 Month Follow-up|Pessary did not fit|0
1841205|NCT00270998|6372390|P2|12 Month Follow-up|Pessary did not fit|0
1841206|NCT00270998|6372391|P1|12 Month Follow-up|Pessary did not fit|1
1841207|NCT00270998|6372389|P3|12 Month Follow-up|Withdrawal by Subject|16
1841208|NCT00270998|6372390|P2|12 Month Follow-up|Withdrawal by Subject|12
1841209|NCT00270998|6372391|P1|12 Month Follow-up|Withdrawal by Subject|7
1841210|NCT00270998|6372389|P3|12 Month Follow-up|Lack of Efficacy|3
1841211|NCT00270998|6372390|P2|12 Month Follow-up|Lack of Efficacy|4
1841212|NCT00270998|6372391|P1|12 Month Follow-up|Lack of Efficacy|5
1841213|NCT00270998|6372389|P3|3 Month Follow-up|Received/desired alternate treatment|2
1841214|NCT00270998|6372390|P2|3 Month Follow-up|Received/desired alternate treatment|5
1841215|NCT00270998|6372391|P1|3 Month Follow-up|Received/desired alternate treatment|13
1841216|NCT00270998|6372389|P3|3 Month Follow-up|Personal/family health|0
1841217|NCT00270998|6372390|P2|3 Month Follow-up|Personal/family health|1
1841218|NCT00270998|6372391|P1|3 Month Follow-up|Personal/family health|1
1841219|NCT00270998|6372389|P3|3 Month Follow-up|Pessary did not fit|0
1841220|NCT00270998|6372390|P2|3 Month Follow-up|Pessary did not fit|0
1841221|NCT00270998|6372391|P1|3 Month Follow-up|Pessary did not fit|12
1841222|NCT00270998|6372389|P3|3 Month Follow-up|Withdrawal by Subject|15
1841223|NCT00270998|6372390|P2|3 Month Follow-up|Withdrawal by Subject|14
1841224|NCT00270998|6372391|P1|3 Month Follow-up|Withdrawal by Subject|11
1841225|NCT00270998|6372389|P3|3 Month Follow-up|Lack of Efficacy|1
1841226|NCT00270998|6372390|P2|3 Month Follow-up|Lack of Efficacy|2
1841227|NCT00270998|6372391|P1|3 Month Follow-up|Lack of Efficacy|1
1841228|NCT00270998|6372389|P3|3 Month Follow-up|Adverse Event|0
1841229|NCT00270998|6372390|P2|3 Month Follow-up|Adverse Event|0
1841230|NCT00270998|6372391|P1|3 Month Follow-up|Adverse Event|1
1841231|NCT00270894|6372420|P1|Overall Study|Withdrawal by Subject|1
1841232|NCT00270894|6372420|P1|Overall Study|Adverse Event|1
1841233|NCT00270855|6372432|P2|Overall Study|Withdrawal by Subject|8
1841234|NCT00270855|6372433|P1|Overall Study|Withdrawal by Subject|8
1841235|NCT00270257|6372569|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
1841236|NCT00270257|6372570|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
1841237|NCT00270231|6372588|P2|Second Intervention|Lost to Follow-up|1
1841238|NCT00270231|6372589|P1|Second Intervention|Lost to Follow-up|0
1841239|NCT00270231|6372588|P2|Washout Period|Lost to Follow-up|0
1841240|NCT00270231|6372589|P1|Washout Period|Lost to Follow-up|1
1841241|NCT00270231|6372588|P2|First Intervention|Lost to Follow-up|1
1841242|NCT00270231|6372589|P1|First Intervention|Lost to Follow-up|1
1841243|NCT00270205|6372599|P4|Overall Study|Lost to Follow-up|1
1841244|NCT00270205|6372600|P3|Overall Study|Lost to Follow-up|0
1841245|NCT00270205|6372601|P2|Overall Study|Lost to Follow-up|0
1841246|NCT00270205|6372602|P1|Overall Study|Lost to Follow-up|1
1841247|NCT00269919|6372720|P1|Overall Study|Started but not treated|1
1841248|NCT00269919|6372720|P1|Overall Study|Other|26
1841249|NCT00269633|6372739|P2|Overall Study|Withdrawal by Subject|0
1841250|NCT00269633|6372740|P1|Overall Study|Withdrawal by Subject|1
1841251|NCT00269477|6372750|P4|Overall Study|Missed post-vaccination blood draw|0
1841252|NCT00269477|6372751|P3|Overall Study|Missed post-vaccination blood draw|0
1841253|NCT00269477|6372752|P2|Overall Study|Missed post-vaccination blood draw|1
1841254|NCT00269477|6372753|P1|Overall Study|Missed post-vaccination blood draw|0
1841255|NCT00269477|6372750|P4|Overall Study|Protocol Violation|0
1841256|NCT00269477|6372751|P3|Overall Study|Protocol Violation|1
1841257|NCT00269477|6372752|P2|Overall Study|Protocol Violation|5
1841258|NCT00269477|6372753|P1|Overall Study|Protocol Violation|5
1841259|NCT00269399|6372769|P2|Overall Study|Development of exclusion criteria|1
1841260|NCT00269399|6372770|P1|Overall Study|Development of exclusion criteria|0
1841261|NCT00269399|6372769|P2|Overall Study|Other|4
1841262|NCT00269399|6372770|P1|Overall Study|Other|0
1841263|NCT00269399|6372769|P2|Overall Study|Negative Lab Result for C. difficile|3
1841264|NCT00269399|6372770|P1|Overall Study|Negative Lab Result for C. difficile|2
1841265|NCT00269399|6372769|P2|Overall Study|Withdrawal by Subject|5
1841266|NCT00269399|6372770|P1|Overall Study|Withdrawal by Subject|2
1841267|NCT00269399|6372769|P2|Overall Study|Adverse Event|4
1841268|NCT00269399|6372770|P1|Overall Study|Adverse Event|10
1841269|NCT00269399|6372769|P2|Overall Study|Lack of Efficacy|10
1841270|NCT00269399|6372770|P1|Overall Study|Lack of Efficacy|27
1841271|NCT00269152|6372780|P2|Overall Study|Protocol Violation|1
1841272|NCT00269152|6372781|P1|Overall Study|Protocol Violation|0
1841273|NCT00269152|6372780|P2|Overall Study|Physician Decision|3
1841274|NCT00269152|6372781|P1|Overall Study|Physician Decision|2
1841275|NCT00269152|6372780|P2|Overall Study|Withdrawal by Subject|3
1841276|NCT00269152|6372781|P1|Overall Study|Withdrawal by Subject|7
1841277|NCT00269152|6372780|P2|Overall Study|Adverse Event|3
1841278|NCT00269152|6372781|P1|Overall Study|Adverse Event|9
1841279|NCT00269113|6372797|P2|Overall Study|Other|2
1841280|NCT00269113|6372798|P1|Overall Study|Other|0
1841281|NCT00269113|6372797|P2|Overall Study|Protocol Violation|5
1841282|NCT00269113|6372798|P1|Overall Study|Protocol Violation|15
1841283|NCT00269113|6372797|P2|Overall Study|Lost to Follow-up|1
1841284|NCT00269113|6372798|P1|Overall Study|Lost to Follow-up|2
1841285|NCT00269113|6372797|P2|Overall Study|Death|2
1841286|NCT00269113|6372798|P1|Overall Study|Death|6
1841287|NCT00269113|6372797|P2|Overall Study|Withdrawal by Subject|2
1841288|NCT00269113|6372798|P1|Overall Study|Withdrawal by Subject|0
1841289|NCT00269113|6372797|P2|Overall Study|Early Improvement|0
1841290|NCT00269113|6372798|P1|Overall Study|Early Improvement|2
1841291|NCT00269113|6372797|P2|Overall Study|Lack of Efficacy|18
1841292|NCT00269113|6372798|P1|Overall Study|Lack of Efficacy|35
1841293|NCT00269113|6372797|P2|Overall Study|Adverse Event|7
1841294|NCT00269113|6372798|P1|Overall Study|Adverse Event|14
1841295|NCT00269087|6372816|P1|Overall Study|Exacerbation of COPD|13
1841296|NCT00269087|6372816|P1|Overall Study|Withdrawal by Subject|1
1841297|NCT00269087|6372816|P1|Overall Study|Adverse Event|20
1841298|NCT00268996|6372846|P2|Overall Study|Other|1
1841299|NCT00268996|6372847|P1|Overall Study|Other|1
1841300|NCT00268996|6372846|P2|Overall Study|Non-compliance|0
1841301|NCT00268996|6372847|P1|Overall Study|Non-compliance|1
1841302|NCT00268996|6372846|P2|Overall Study|Withdrawal by Subject|11
1841303|NCT00268996|6372847|P1|Overall Study|Withdrawal by Subject|5
1841304|NCT00268996|6372846|P2|Overall Study|Lost to Follow-up|1
1841305|NCT00268996|6372847|P1|Overall Study|Lost to Follow-up|3
1841306|NCT00268996|6372846|P2|Overall Study|Adverse Event|7
1841307|NCT00268996|6372847|P1|Overall Study|Adverse Event|11
1841308|NCT00268983|6372891|P2|Overall Study|Death|0
1841309|NCT00268983|6372892|P1|Overall Study|Death|3
1841310|NCT00268905|6372935|P3|Overall Study|Clinical Progression|1
1841311|NCT00268905|6372936|P2|Overall Study|Clinical Progression|4
1841312|NCT00268905|6372937|P1|Overall Study|Clinical Progression|9
1841313|NCT00268905|6372935|P3|Overall Study|Physician Decision|1
1841314|NCT00268905|6372936|P2|Overall Study|Physician Decision|0
1841315|NCT00268905|6372937|P1|Overall Study|Physician Decision|3
1841316|NCT00268905|6372935|P3|Overall Study|Progressive Disease|3
1841317|NCT00268905|6372936|P2|Overall Study|Progressive Disease|4
1841318|NCT00268905|6372937|P1|Overall Study|Progressive Disease|28
1841319|NCT00268905|6372935|P3|Overall Study|Withdrawal by Subject|3
1841320|NCT00268905|6372936|P2|Overall Study|Withdrawal by Subject|0
1841321|NCT00268905|6372937|P1|Overall Study|Withdrawal by Subject|0
1841322|NCT00268905|6372935|P3|Overall Study|Lost to Follow-up|0
1841323|NCT00268905|6372936|P2|Overall Study|Lost to Follow-up|1
1841324|NCT00268905|6372937|P1|Overall Study|Lost to Follow-up|0
1841325|NCT00268905|6372935|P3|Overall Study|Adverse Event|4
1841326|NCT00268905|6372936|P2|Overall Study|Adverse Event|0
1841327|NCT00268905|6372937|P1|Overall Study|Adverse Event|3
1841328|NCT00268892|6372954|P3|Overall Study|Trial Site Closed|2
1841329|NCT00268892|6372955|P2|Overall Study|Trial Site Closed|2
1841330|NCT00268892|6372956|P1|Overall Study|Trial Site Closed|4
1841331|NCT00268892|6372954|P3|Overall Study|Disease Progression|0
1841332|NCT00268892|6372955|P2|Overall Study|Disease Progression|1
1841333|NCT00268892|6372956|P1|Overall Study|Disease Progression|1
1841334|NCT00268892|6372954|P3|Overall Study|Protocol Violation|0
1841335|NCT00268892|6372955|P2|Overall Study|Protocol Violation|1
1841336|NCT00268892|6372956|P1|Overall Study|Protocol Violation|0
1841337|NCT00268892|6372954|P3|Overall Study|Lost to Follow-up|4
1841338|NCT00268892|6372955|P2|Overall Study|Lost to Follow-up|2
1841339|NCT00268892|6372956|P1|Overall Study|Lost to Follow-up|5
1841340|NCT00268892|6372954|P3|Overall Study|Physician Decision|0
1841341|NCT00268892|6372955|P2|Overall Study|Physician Decision|1
1841342|NCT00268892|6372956|P1|Overall Study|Physician Decision|0
1841343|NCT00268892|6372954|P3|Overall Study|Withdrawal by Subject|13
1841344|NCT00268892|6372955|P2|Overall Study|Withdrawal by Subject|15
1841345|NCT00268892|6372956|P1|Overall Study|Withdrawal by Subject|14
1841346|NCT00268892|6372954|P3|Overall Study|Lack of Efficacy|0
1841347|NCT00268892|6372955|P2|Overall Study|Lack of Efficacy|3
1841348|NCT00268892|6372956|P1|Overall Study|Lack of Efficacy|1
1841349|NCT00268892|6372954|P3|Overall Study|Adverse Event|20
1841350|NCT00268892|6372955|P2|Overall Study|Adverse Event|17
1841351|NCT00268892|6372956|P1|Overall Study|Adverse Event|14
1841352|NCT00268463|6372975|P2|Overall Study|study terminated due to low accrual|12
1841353|NCT00268463|6372976|P1|Overall Study|study terminated due to low accrual|10
1841354|NCT00268437|6372992|P1|Overall Study|Ineligible|1
1841355|NCT00268346|6372999|P2|Overall Study|Withdrawal by Subject|1
1841356|NCT00268346|6373000|P1|Overall Study|Withdrawal by Subject|0
1841357|NCT00268346|6372999|P2|Overall Study|Death|1
1841358|NCT00268346|6373000|P1|Overall Study|Death|0
1841359|NCT00268346|6372999|P2|Overall Study|Adverse Event|1
1841360|NCT00268346|6373000|P1|Overall Study|Adverse Event|0
1841361|NCT00268242|6373006|P1|Overall Study|Death|1
1841362|NCT00268203|6373015|P1|Overall Study|Completed 2 Years of Follow-up|62
1841363|NCT00268203|6373015|P1|Overall Study|Reason Not Specified|34
1841364|NCT00268203|6373015|P1|Overall Study|Death|84
1841365|NCT00268203|6373015|P1|Overall Study|Progressive Disease|359
1841366|NCT00268203|6373015|P1|Overall Study|Received Other NHL Therapy|7
1841367|NCT00268203|6373015|P1|Overall Study|Withdrawal by Subject|9
1841368|NCT00268203|6373015|P1|Overall Study|Lost to Follow-up|92
1841369|NCT00267969|6373029|P7|After Controlled Period|Other|25
1841370|NCT00267969|6373030|P6|After Controlled Period|Other|22
1841371|NCT00267969|6373031|P5|After Controlled Period|Other|11
1841372|NCT00267969|6373032|P4|After Controlled Period|Other|13
1841373|NCT00267969|6373033|P3|After Controlled Period|Other|0
1841374|NCT00267969|6373034|P2|After Controlled Period|Other|0
1841375|NCT00267969|6373035|P1|After Controlled Period|Other|0
1841376|NCT00267969|6373029|P7|After Controlled Period|Lost to Follow-up|10
1841377|NCT00267969|6373030|P6|After Controlled Period|Lost to Follow-up|9
1841378|NCT00267969|6373031|P5|After Controlled Period|Lost to Follow-up|8
1841379|NCT00267969|6373032|P4|After Controlled Period|Lost to Follow-up|5
1841380|NCT00267969|6373033|P3|After Controlled Period|Lost to Follow-up|0
1841381|NCT00267969|6373034|P2|After Controlled Period|Lost to Follow-up|0
1841382|NCT00267969|6373035|P1|After Controlled Period|Lost to Follow-up|0
1841383|NCT00267969|6373029|P7|After Controlled Period|Lack of Efficacy|15
1841384|NCT00267969|6373030|P6|After Controlled Period|Lack of Efficacy|28
1841385|NCT00267969|6373031|P5|After Controlled Period|Lack of Efficacy|6
1841386|NCT00267969|6373032|P4|After Controlled Period|Lack of Efficacy|10
1841387|NCT00267969|6373033|P3|After Controlled Period|Lack of Efficacy|0
1841388|NCT00267969|6373034|P2|After Controlled Period|Lack of Efficacy|0
1841389|NCT00267969|6373035|P1|After Controlled Period|Lack of Efficacy|0
1841390|NCT00267969|6373029|P7|After Controlled Period|Death|1
1841391|NCT00267969|6373030|P6|After Controlled Period|Death|0
1841392|NCT00267969|6373031|P5|After Controlled Period|Death|2
1841393|NCT00267969|6373032|P4|After Controlled Period|Death|1
1841394|NCT00267969|6373033|P3|After Controlled Period|Death|0
1841395|NCT00267969|6373034|P2|After Controlled Period|Death|0
1841396|NCT00267969|6373035|P1|After Controlled Period|Death|0
1841397|NCT00267969|6373029|P7|After Controlled Period|Adverse Event|21
1841398|NCT00267969|6373030|P6|After Controlled Period|Adverse Event|23
1841399|NCT00267969|6373031|P5|After Controlled Period|Adverse Event|8
1841400|NCT00267969|6373032|P4|After Controlled Period|Adverse Event|7
1841401|NCT00267969|6373033|P3|After Controlled Period|Adverse Event|0
1841402|NCT00267969|6373034|P2|After Controlled Period|Adverse Event|0
1841403|NCT00267969|6373035|P1|After Controlled Period|Adverse Event|0
1841404|NCT00267969|6373029|P7|Controlled Period|Other|0
1841405|NCT00267969|6373030|P6|Controlled Period|Other|0
1841406|NCT00267969|6373031|P5|Controlled Period|Other|0
1841407|NCT00267969|6373032|P4|Controlled Period|Other|0
1841408|NCT00267969|6373033|P3|Controlled Period|Other|6
1841409|NCT00267969|6373034|P2|Controlled Period|Other|1
1841410|NCT00267969|6373035|P1|Controlled Period|Other|2
1841411|NCT00267969|6373029|P7|Controlled Period|Randomized but not treated|0
1841412|NCT00267969|6373030|P6|Controlled Period|Randomized but not treated|0
1841413|NCT00267969|6373031|P5|Controlled Period|Randomized but not treated|0
1841414|NCT00267969|6373032|P4|Controlled Period|Randomized but not treated|0
1841415|NCT00267969|6373033|P3|Controlled Period|Randomized but not treated|1
1841416|NCT00267969|6373034|P2|Controlled Period|Randomized but not treated|0
1841417|NCT00267969|6373035|P1|Controlled Period|Randomized but not treated|0
1841418|NCT00267969|6373029|P7|Controlled Period|Lost to Follow-up|0
1841419|NCT00267969|6373030|P6|Controlled Period|Lost to Follow-up|0
1841420|NCT00267969|6373031|P5|Controlled Period|Lost to Follow-up|0
1841421|NCT00267969|6373032|P4|Controlled Period|Lost to Follow-up|0
1841422|NCT00267969|6373033|P3|Controlled Period|Lost to Follow-up|1
1841423|NCT00267969|6373034|P2|Controlled Period|Lost to Follow-up|0
1841424|NCT00267969|6373035|P1|Controlled Period|Lost to Follow-up|1
1841425|NCT00267969|6373029|P7|Controlled Period|Lack of Efficacy|0
1841426|NCT00267969|6373030|P6|Controlled Period|Lack of Efficacy|0
1841427|NCT00267969|6373031|P5|Controlled Period|Lack of Efficacy|0
1841428|NCT00267969|6373032|P4|Controlled Period|Lack of Efficacy|0
1841429|NCT00267969|6373033|P3|Controlled Period|Lack of Efficacy|1
1841430|NCT00267969|6373034|P2|Controlled Period|Lack of Efficacy|0
1841431|NCT00267969|6373035|P1|Controlled Period|Lack of Efficacy|3
1841432|NCT00267969|6373029|P7|Controlled Period|Adverse Event|0
1841433|NCT00267969|6373030|P6|Controlled Period|Adverse Event|0
1841434|NCT00267969|6373031|P5|Controlled Period|Adverse Event|0
1841435|NCT00267969|6373032|P4|Controlled Period|Adverse Event|0
1841436|NCT00267969|6373033|P3|Controlled Period|Adverse Event|2
1841437|NCT00267969|6373034|P2|Controlled Period|Adverse Event|0
1841438|NCT00267969|6373035|P1|Controlled Period|Adverse Event|6
1841439|NCT00267956|6373061|P4|After Controlled Period|Withdrew consent|0
1841440|NCT00267956|6373062|P3|After Controlled Period|Withdrew consent|1
1841441|NCT00267956|6373063|P2|After Controlled Period|Withdrew consent|0
1841442|NCT00267956|6373064|P1|After Controlled Period|Withdrew consent|0
1841443|NCT00267956|6373061|P4|After Controlled Period|Lost to Follow-up|0
1841444|NCT00267956|6373062|P3|After Controlled Period|Lost to Follow-up|1
1841445|NCT00267956|6373063|P2|After Controlled Period|Lost to Follow-up|0
1841446|NCT00267956|6373064|P1|After Controlled Period|Lost to Follow-up|0
1841447|NCT00267956|6373061|P4|After Controlled Period|Lack of Efficacy|1
1841448|NCT00267956|6373062|P3|After Controlled Period|Lack of Efficacy|1
1841449|NCT00267956|6373063|P2|After Controlled Period|Lack of Efficacy|0
1841450|NCT00267956|6373064|P1|After Controlled Period|Lack of Efficacy|0
1841451|NCT00267956|6373061|P4|After Controlled Period|Adverse Event|1
1841452|NCT00267956|6373062|P3|After Controlled Period|Adverse Event|2
1841453|NCT00267956|6373063|P2|After Controlled Period|Adverse Event|0
1841454|NCT00267956|6373064|P1|After Controlled Period|Adverse Event|0
1841455|NCT00267956|6373061|P4|Controlled Period|Withdrew consent|0
1841456|NCT00267956|6373062|P3|Controlled Period|Withdrew consent|0
1841457|NCT00267956|6373063|P2|Controlled Period|Withdrew consent|1
1841458|NCT00267956|6373064|P1|Controlled Period|Withdrew consent|3
1841459|NCT00267956|6373061|P4|Controlled Period|Lost to Follow-up|0
1841460|NCT00267956|6373062|P3|Controlled Period|Lost to Follow-up|0
1841461|NCT00267956|6373063|P2|Controlled Period|Lost to Follow-up|0
1841462|NCT00267956|6373064|P1|Controlled Period|Lost to Follow-up|2
1841463|NCT00267956|6373061|P4|Controlled Period|Lack of Efficacy|0
1841464|NCT00267956|6373062|P3|Controlled Period|Lack of Efficacy|0
1841465|NCT00267956|6373063|P2|Controlled Period|Lack of Efficacy|2
1841466|NCT00267956|6373064|P1|Controlled Period|Lack of Efficacy|4
1841467|NCT00267956|6373061|P4|Controlled Period|Adverse Event|0
1841468|NCT00267956|6373062|P3|Controlled Period|Adverse Event|0
1841469|NCT00267956|6373063|P2|Controlled Period|Adverse Event|1
1841470|NCT00267956|6373064|P1|Controlled Period|Adverse Event|4
1841471|NCT00267748|6373096|P3|Randomized Period|randomized but not treated|3
1841472|NCT00267748|6373097|P2|Randomized Period|randomized but not treated|0
1841473|NCT00267748|6373098|P1|Randomized Period|randomized but not treated|0
1841474|NCT00267748|6373096|P3|Randomized Period|Other|6
1841475|NCT00267748|6373097|P2|Randomized Period|Other|9
1841476|NCT00267748|6373098|P1|Randomized Period|Other|0
1841477|NCT00267748|6373096|P3|Randomized Period|Withdrawal by Subject|2
1841478|NCT00267748|6373097|P2|Randomized Period|Withdrawal by Subject|9
1841479|NCT00267748|6373098|P1|Randomized Period|Withdrawal by Subject|0
1841480|NCT00267748|6373096|P3|Randomized Period|Objective progression or relapse|86
1841481|NCT00267748|6373097|P2|Randomized Period|Objective progression or relapse|77
1841482|NCT00267748|6373098|P1|Randomized Period|Objective progression or relapse|0
1841483|NCT00267748|6373096|P3|Randomized Period|Lost to Follow-up|0
1841484|NCT00267748|6373097|P2|Randomized Period|Lost to Follow-up|1
1841485|NCT00267748|6373098|P1|Randomized Period|Lost to Follow-up|0
1841486|NCT00267748|6373096|P3|Randomized Period|Global deterioration of health status|7
1841487|NCT00267748|6373097|P2|Randomized Period|Global deterioration of health status|6
1841488|NCT00267748|6373098|P1|Randomized Period|Global deterioration of health status|0
1841489|NCT00267748|6373096|P3|Randomized Period|Adverse Event|25
1841490|NCT00267748|6373097|P2|Randomized Period|Adverse Event|23
1841491|NCT00267748|6373098|P1|Randomized Period|Adverse Event|0
1841492|NCT00267748|6373096|P3|Randomized Period|Death|3
1841493|NCT00267748|6373097|P2|Randomized Period|Death|2
1841494|NCT00267748|6373098|P1|Randomized Period|Death|0
1841495|NCT00267748|6373096|P3|Non-randomized Period|Other|0
1841496|NCT00267748|6373097|P2|Non-randomized Period|Other|0
1841497|NCT00267748|6373098|P1|Non-randomized Period|Other|3
1841498|NCT00267748|6373096|P3|Non-randomized Period|Participant not willing to participate|0
1841499|NCT00267748|6373097|P2|Non-randomized Period|Participant not willing to participate|0
1841500|NCT00267748|6373098|P1|Non-randomized Period|Participant not willing to participate|1
1841501|NCT00267748|6373096|P3|Non-randomized Period|Death|0
1841502|NCT00267748|6373097|P2|Non-randomized Period|Death|0
1841503|NCT00267748|6373098|P1|Non-randomized Period|Death|1
1841504|NCT00267748|6373096|P3|Non-randomized Period|Adverse Event|0
1841505|NCT00267748|6373097|P2|Non-randomized Period|Adverse Event|0
1841506|NCT00267748|6373098|P1|Non-randomized Period|Adverse Event|8
1841507|NCT00267748|6373096|P3|Non-randomized Period|Progressive disease|0
1841508|NCT00267748|6373097|P2|Non-randomized Period|Progressive disease|0
1841509|NCT00267748|6373098|P1|Non-randomized Period|Progressive disease|10
1841510|NCT00267488|6373155|P1|Overall Study|Other (Disease Progression)|1
1841511|NCT00267488|6373155|P1|Overall Study|Protocol Violation|1
1841512|NCT00267488|6373155|P1|Overall Study|Sponsor Terminated Study|9
1841513|NCT00267202|6373179|P2|Overall Study|Lost to Follow-up|0
1841514|NCT00267202|6373180|P1|Overall Study|Lost to Follow-up|3
1841515|NCT00267202|6373179|P2|Overall Study|Administrative problems|1
1841516|NCT00267202|6373180|P1|Overall Study|Administrative problems|2
1841517|NCT00267202|6373179|P2|Overall Study|Protocol Violation|3
1841518|NCT00267202|6373180|P1|Overall Study|Protocol Violation|2
1841519|NCT00267202|6373179|P2|Overall Study|Adverse Event|7
1841520|NCT00267202|6373180|P1|Overall Study|Adverse Event|13
1841521|NCT00267202|6373179|P2|Overall Study|Withdrawal by Subject|15
1841522|NCT00267202|6373180|P1|Overall Study|Withdrawal by Subject|12
1841523|NCT00267202|6373179|P2|Overall Study|Unsatisfactory therapeutic effect|8
1841524|NCT00267202|6373180|P1|Overall Study|Unsatisfactory therapeutic effect|21
1841525|NCT00267189|6373201|P2|Overall Study|Missing|0
1841526|NCT00267189|6373202|P1|Overall Study|Missing|3
1841527|NCT00267189|6373201|P2|Overall Study|Death|0
1841528|NCT00267189|6373202|P1|Overall Study|Death|1
1841529|NCT00267189|6373201|P2|Overall Study|Patient withdrew consent|1
1841530|NCT00267189|6373202|P1|Overall Study|Patient withdrew consent|1
1841531|NCT00267150|6373212|P1|Overall Study|Adverse Event|1
1841532|NCT00267098|6373236|P8|Overall Study|Sponsor withdrew subject|0
1841533|NCT00267098|6373237|P7|Overall Study|Sponsor withdrew subject|0
1841534|NCT00267098|6373238|P6|Overall Study|Sponsor withdrew subject|0
1841535|NCT00267098|6373239|P5|Overall Study|Sponsor withdrew subject|0
1841536|NCT00267098|6373240|P4|Overall Study|Sponsor withdrew subject|1
1841537|NCT00267098|6373241|P3|Overall Study|Sponsor withdrew subject|0
1841538|NCT00267098|6373242|P2|Overall Study|Sponsor withdrew subject|0
1841539|NCT00267098|6373243|P1|Overall Study|Sponsor withdrew subject|0
1841540|NCT00267098|6373236|P8|Overall Study|Subject listed for heart transplant|0
1841541|NCT00267098|6373237|P7|Overall Study|Subject listed for heart transplant|1
1841542|NCT00267098|6373238|P6|Overall Study|Subject listed for heart transplant|0
1841543|NCT00267098|6373239|P5|Overall Study|Subject listed for heart transplant|0
1841544|NCT00267098|6373240|P4|Overall Study|Subject listed for heart transplant|0
1841545|NCT00267098|6373241|P3|Overall Study|Subject listed for heart transplant|0
1841546|NCT00267098|6373242|P2|Overall Study|Subject listed for heart transplant|0
1841547|NCT00267098|6373243|P1|Overall Study|Subject listed for heart transplant|0
1841548|NCT00267098|6373236|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
1841549|NCT00267098|6373237|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
1841550|NCT00267098|6373238|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
1841551|NCT00267098|6373239|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
1841552|NCT00267098|6373240|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
1841553|NCT00267098|6373241|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
1841554|NCT00267098|6373242|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
1841555|NCT00267098|6373243|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
1841556|NCT00267098|6373236|P8|Overall Study|Explanted Medtronic device|0
1841557|NCT00267098|6373237|P7|Overall Study|Explanted Medtronic device|0
1841558|NCT00267098|6373238|P6|Overall Study|Explanted Medtronic device|0
1841559|NCT00267098|6373239|P5|Overall Study|Explanted Medtronic device|0
1841560|NCT00267098|6373240|P4|Overall Study|Explanted Medtronic device|1
1841561|NCT00267098|6373241|P3|Overall Study|Explanted Medtronic device|0
1841562|NCT00267098|6373242|P2|Overall Study|Explanted Medtronic device|0
1841563|NCT00267098|6373243|P1|Overall Study|Explanted Medtronic device|0
1841564|NCT00267098|6373236|P8|Overall Study|Site closure|0
1841565|NCT00267098|6373237|P7|Overall Study|Site closure|1
1841566|NCT00267098|6373238|P6|Overall Study|Site closure|1
1841567|NCT00267098|6373239|P5|Overall Study|Site closure|0
1841568|NCT00267098|6373240|P4|Overall Study|Site closure|1
1841569|NCT00267098|6373241|P3|Overall Study|Site closure|0
1841570|NCT00267098|6373242|P2|Overall Study|Site closure|0
1841571|NCT00267098|6373243|P1|Overall Study|Site closure|0
1841572|NCT00267098|6373236|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1841573|NCT00267098|6373237|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1841574|NCT00267098|6373238|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1841575|NCT00267098|6373239|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1841576|NCT00267098|6373240|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1841577|NCT00267098|6373241|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1841578|NCT00267098|6373242|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
1841579|NCT00267098|6373243|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
1841580|NCT00267098|6373236|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1841581|NCT00267098|6373237|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1841582|NCT00267098|6373238|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1841583|NCT00267098|6373239|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
1841584|NCT00267098|6373240|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1841585|NCT00267098|6373241|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1841586|NCT00267098|6373242|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
1841587|NCT00267098|6373243|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
1841588|NCT00267098|6373236|P8|Overall Study|Physician Decision|0
1841589|NCT00267098|6373237|P7|Overall Study|Physician Decision|3
1841590|NCT00267098|6373238|P6|Overall Study|Physician Decision|4
1841591|NCT00267098|6373239|P5|Overall Study|Physician Decision|5
1841592|NCT00267098|6373240|P4|Overall Study|Physician Decision|11
1841593|NCT00267098|6373241|P3|Overall Study|Physician Decision|7
1841594|NCT00267098|6373242|P2|Overall Study|Physician Decision|0
1841595|NCT00267098|6373243|P1|Overall Study|Physician Decision|5
1841596|NCT00267098|6373236|P8|Overall Study|Withdrawal by Subject|5
1841597|NCT00267098|6373237|P7|Overall Study|Withdrawal by Subject|12
1841598|NCT00267098|6373238|P6|Overall Study|Withdrawal by Subject|9
1841599|NCT00267098|6373239|P5|Overall Study|Withdrawal by Subject|12
1841600|NCT00267098|6373240|P4|Overall Study|Withdrawal by Subject|21
1841601|NCT00267098|6373241|P3|Overall Study|Withdrawal by Subject|24
1841602|NCT00267098|6373242|P2|Overall Study|Withdrawal by Subject|0
1841603|NCT00267098|6373243|P1|Overall Study|Withdrawal by Subject|8
1841604|NCT00267098|6373236|P8|Overall Study|Lost to Follow-up|1
1841605|NCT00267098|6373237|P7|Overall Study|Lost to Follow-up|1
1841606|NCT00267098|6373238|P6|Overall Study|Lost to Follow-up|3
1841607|NCT00267098|6373239|P5|Overall Study|Lost to Follow-up|2
1841608|NCT00267098|6373240|P4|Overall Study|Lost to Follow-up|5
1841609|NCT00267098|6373241|P3|Overall Study|Lost to Follow-up|6
1841610|NCT00267098|6373242|P2|Overall Study|Lost to Follow-up|0
1841611|NCT00267098|6373243|P1|Overall Study|Lost to Follow-up|0
1841612|NCT00267098|6373236|P8|Overall Study|Death|9
1841613|NCT00267098|6373237|P7|Overall Study|Death|28
1841614|NCT00267098|6373238|P6|Overall Study|Death|23
1841615|NCT00267098|6373239|P5|Overall Study|Death|14
1841616|NCT00267098|6373240|P4|Overall Study|Death|66
1841617|NCT00267098|6373241|P3|Overall Study|Death|57
1841618|NCT00267098|6373242|P2|Overall Study|Death|0
1841619|NCT00267098|6373243|P1|Overall Study|Death|0
1841620|NCT00267046|6373386|P2|Overall Study|Radiation|1
1841621|NCT00267046|6373387|P1|Overall Study|Radiation|0
1841622|NCT00267046|6373386|P2|Overall Study|Withdrawal by Subject|0
1841623|NCT00267046|6373387|P1|Overall Study|Withdrawal by Subject|1
1841624|NCT00267046|6373386|P2|Overall Study|Surgery|1
1841625|NCT00267046|6373387|P1|Overall Study|Surgery|3
1841626|NCT00267046|6373386|P2|Overall Study|Open-label palifermin|7
1841627|NCT00267046|6373387|P1|Overall Study|Open-label palifermin|2
1841628|NCT00267046|6373386|P2|Overall Study|Chemotoxicity|0
1841629|NCT00267046|6373387|P1|Overall Study|Chemotoxicity|2
1841630|NCT00267046|6373386|P2|Overall Study|Disease progression|2
1841631|NCT00267046|6373387|P1|Overall Study|Disease progression|4
1841632|NCT00267007|6373397|P2|Overall Study|Adverse Event|0
1841633|NCT00267007|6373398|P1|Overall Study|Adverse Event|1
1841634|NCT00267007|6373397|P2|Overall Study|Non-compliance|1
1841635|NCT00267007|6373398|P1|Overall Study|Non-compliance|0
1841636|NCT00267007|6373397|P2|Overall Study|Lost to Follow-up|0
1841637|NCT00267007|6373398|P1|Overall Study|Lost to Follow-up|1
1841638|NCT00267007|6373397|P2|Overall Study|Withdrawal by Subject|0
1841639|NCT00267007|6373398|P1|Overall Study|Withdrawal by Subject|6
1841640|NCT00266877|6373409|P3|Overall Study|Concomitant Radiotherapy|0
1841641|NCT00266877|6373410|P2|Overall Study|Concomitant Radiotherapy|1
1841642|NCT00266877|6373411|P1|Overall Study|Concomitant Radiotherapy|0
1841643|NCT00266877|6373409|P3|Overall Study|Hospitalization|0
1841644|NCT00266877|6373410|P2|Overall Study|Hospitalization|0
1841645|NCT00266877|6373411|P1|Overall Study|Hospitalization|1
1841646|NCT00266877|6373409|P3|Overall Study|Symptomatic Deterioration|1
1841647|NCT00266877|6373410|P2|Overall Study|Symptomatic Deterioration|3
1841648|NCT00266877|6373411|P1|Overall Study|Symptomatic Deterioration|6
1841649|NCT00266877|6373409|P3|Overall Study|Disease Progression|23
1841650|NCT00266877|6373410|P2|Overall Study|Disease Progression|37
1841651|NCT00266877|6373411|P1|Overall Study|Disease Progression|72
1841652|NCT00266877|6373409|P3|Overall Study|Withdrawal by Subject|1
1841653|NCT00266877|6373410|P2|Overall Study|Withdrawal by Subject|1
1841654|NCT00266877|6373411|P1|Overall Study|Withdrawal by Subject|3
1841655|NCT00266877|6373409|P3|Overall Study|Physician Decision|1
1841656|NCT00266877|6373410|P2|Overall Study|Physician Decision|1
1841657|NCT00266877|6373411|P1|Overall Study|Physician Decision|2
1841658|NCT00266877|6373409|P3|Overall Study|Adverse Event|1
1841659|NCT00266877|6373410|P2|Overall Study|Adverse Event|4
1841660|NCT00266877|6373411|P1|Overall Study|Adverse Event|6
1841661|NCT00266877|6373409|P3|Overall Study|Death|1
1841662|NCT00266877|6373410|P2|Overall Study|Death|1
1841663|NCT00266877|6373411|P1|Overall Study|Death|1
1841664|NCT00266864|6373430|P2|Overall Study|Withdrawal by Subject|1
1841665|NCT00266864|6373431|P1|Overall Study|Withdrawal by Subject|1
1841666|NCT00266864|6373430|P2|Overall Study|Lost to Follow-up|1
1841667|NCT00266864|6373431|P1|Overall Study|Lost to Follow-up|4
1841668|NCT00266825|6373462|P2|Completed Follow-Up|Withdrawal by Subject|5
1841669|NCT00266825|6373463|P1|Completed Follow-Up|Withdrawal by Subject|11
1841670|NCT00266825|6373462|P2|Completed Follow-Up|Lost to Follow-up|19
1841671|NCT00266825|6373463|P1|Completed Follow-Up|Lost to Follow-up|14
1841672|NCT00266812|6373489|P2|Overall Study|Discontinued before starting study drug|0
1841673|NCT00266812|6373490|P1|Overall Study|Discontinued before starting study drug|4
1841674|NCT00266812|6373489|P2|Overall Study|Withdrawal by Subject|2
1841675|NCT00266812|6373490|P1|Overall Study|Withdrawal by Subject|0
1841676|NCT00266812|6373489|P2|Overall Study|Protocol Violation|1
1841677|NCT00266812|6373490|P1|Overall Study|Protocol Violation|0
1841678|NCT00266812|6373489|P2|Overall Study|Adverse Event|1
1841679|NCT00266812|6373490|P1|Overall Study|Adverse Event|3
1841680|NCT00266812|6373489|P2|Overall Study|Death|4
1841681|NCT00266812|6373490|P1|Overall Study|Death|5
1841682|NCT00266812|6373489|P2|Overall Study|Disease Progression|3
1841683|NCT00266812|6373490|P1|Overall Study|Disease Progression|9
1841684|NCT00266708|6373515|P2|Overall Study|Asthma|2
1841685|NCT00266708|6373516|P1|Overall Study|Asthma|0
1841686|NCT00266708|6373515|P2|Overall Study|Refused biopsy|6
1841687|NCT00266708|6373516|P1|Overall Study|Refused biopsy|3
1841688|NCT00266708|6373515|P2|Overall Study|No renal function|1
1841689|NCT00266708|6373516|P1|Overall Study|No renal function|1
1841690|NCT00266695|6373556|P1|Overall Study|Withdrawal by Subject|15
1841691|NCT00266695|6373556|P1|Overall Study|Lost to Follow-up|3
1841692|NCT00266695|6373556|P1|Overall Study|Physician Decision|1
1841693|NCT00266695|6373556|P1|Overall Study|Death|9
1841694|NCT00266695|6373556|P1|Overall Study|Adverse Event|1
1841695|NCT00266656|6373568|P2|Overall Study|Parent/Caregiver Decision|2
1841696|NCT00266656|6373569|P1|Overall Study|Parent/Caregiver Decision|1
1841697|NCT00266656|6373568|P2|Overall Study|Did Not Reach Final Height|8
1841698|NCT00266656|6373569|P1|Overall Study|Did Not Reach Final Height|4
1841699|NCT00266656|6373568|P2|Overall Study|Withdrawal by Subject|2
1841700|NCT00266656|6373569|P1|Overall Study|Withdrawal by Subject|4
1841701|NCT00266656|6373568|P2|Overall Study|Lost to Follow-up|1
1841702|NCT00266656|6373569|P1|Overall Study|Lost to Follow-up|4
1841703|NCT00266656|6373568|P2|Overall Study|Death|0
1841704|NCT00266656|6373569|P1|Overall Study|Death|1
1841705|NCT00266630|6373593|P2|Overall Study|Other|11
1841706|NCT00266630|6373594|P1|Overall Study|Other|19
1841707|NCT00266630|6373593|P2|Overall Study|Lost to Follow-up|0
1841708|NCT00266630|6373594|P1|Overall Study|Lost to Follow-up|1
1841709|NCT00266630|6373593|P2|Overall Study|Withdrawal by Subject|2
1841710|NCT00266630|6373594|P1|Overall Study|Withdrawal by Subject|10
1841711|NCT00266630|6373593|P2|Overall Study|Physician Decision|2
1841712|NCT00266630|6373594|P1|Overall Study|Physician Decision|1
1841713|NCT00266630|6373593|P2|Overall Study|Protocol Violation|3
1841714|NCT00266630|6373594|P1|Overall Study|Protocol Violation|1
1841715|NCT00266630|6373593|P2|Overall Study|Entry Criteria not met|0
1841716|NCT00266630|6373594|P1|Overall Study|Entry Criteria not met|1
1841717|NCT00266630|6373593|P2|Overall Study|Lack of Efficacy|4
1841718|NCT00266630|6373594|P1|Overall Study|Lack of Efficacy|1
1841719|NCT00266630|6373593|P2|Overall Study|Adverse Event|6
1841720|NCT00266630|6373594|P1|Overall Study|Adverse Event|8
1841721|NCT00266409|6373636|P4|Overall Study|Other|0
1841722|NCT00266409|6373637|P3|Overall Study|Other|2
1841723|NCT00266409|6373638|P2|Overall Study|Other|4
1841724|NCT00266409|6373639|P1|Overall Study|Other|7
1841725|NCT00266409|6373636|P4|Overall Study|Protocol Violation|2
1841726|NCT00266409|6373637|P3|Overall Study|Protocol Violation|4
1841727|NCT00266409|6373638|P2|Overall Study|Protocol Violation|3
1841728|NCT00266409|6373639|P1|Overall Study|Protocol Violation|5
1841729|NCT00266409|6373636|P4|Overall Study|Withdrawal by Subject|9
1841730|NCT00266409|6373637|P3|Overall Study|Withdrawal by Subject|3
1841731|NCT00266409|6373638|P2|Overall Study|Withdrawal by Subject|10
1841732|NCT00266409|6373639|P1|Overall Study|Withdrawal by Subject|6
1841733|NCT00266409|6373636|P4|Overall Study|Lost to Follow-up|8
1841734|NCT00266409|6373637|P3|Overall Study|Lost to Follow-up|6
1841735|NCT00266409|6373638|P2|Overall Study|Lost to Follow-up|21
1841736|NCT00266409|6373639|P1|Overall Study|Lost to Follow-up|18
1841737|NCT00266409|6373636|P4|Overall Study|Adverse Event|1
1841738|NCT00266409|6373637|P3|Overall Study|Adverse Event|1
1841739|NCT00266409|6373638|P2|Overall Study|Adverse Event|2
1841740|NCT00266409|6373639|P1|Overall Study|Adverse Event|7
1841741|NCT00266409|6373636|P4|Overall Study|Lack of Efficacy|2
1841742|NCT00266409|6373637|P3|Overall Study|Lack of Efficacy|1
1841743|NCT00266409|6373638|P2|Overall Study|Lack of Efficacy|6
1841744|NCT00266409|6373639|P1|Overall Study|Lack of Efficacy|2
1841745|NCT00266227|6373927|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
1841825|NCT00266032|6373985|P1|Treatment|Lost to Follow-up|19
1841746|NCT00266227|6373928|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
1841747|NCT00266227|6373929|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
1841748|NCT00266227|6373927|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
1841749|NCT00266227|6373928|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
1841750|NCT00266227|6373929|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
1841751|NCT00266227|6373927|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1841752|NCT00266227|6373928|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
1841753|NCT00266227|6373929|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
1841754|NCT00266227|6373927|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
1841755|NCT00266227|6373928|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
1841756|NCT00266227|6373929|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
1841757|NCT00266227|6373927|P3|Retreatment: Week 48 to Week 72|Death|0
1841758|NCT00266227|6373928|P2|Retreatment: Week 48 to Week 72|Death|1
1841759|NCT00266227|6373929|P1|Retreatment: Week 48 to Week 72|Death|1
1841760|NCT00266227|6373927|P3|Retreatment: Up to Week 48|Pregnancy|0
1841761|NCT00266227|6373928|P2|Retreatment: Up to Week 48|Pregnancy|0
1841762|NCT00266227|6373929|P1|Retreatment: Up to Week 48|Pregnancy|1
1841763|NCT00266227|6373927|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
1841764|NCT00266227|6373928|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
1841765|NCT00266227|6373929|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
1841766|NCT00266227|6373927|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
1841767|NCT00266227|6373928|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
1841768|NCT00266227|6373929|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
1841769|NCT00266227|6373927|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
1841770|NCT00266227|6373928|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
1841771|NCT00266227|6373929|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
1841772|NCT00266227|6373927|P3|Retreatment: Up to Week 48|Adverse Event|0
1841773|NCT00266227|6373928|P2|Retreatment: Up to Week 48|Adverse Event|7
1841774|NCT00266227|6373929|P1|Retreatment: Up to Week 48|Adverse Event|7
1841775|NCT00266227|6373927|P3|Retreatment: Up to Week 48|Death|0
1841776|NCT00266227|6373928|P2|Retreatment: Up to Week 48|Death|0
1841777|NCT00266227|6373929|P1|Retreatment: Up to Week 48|Death|1
1841778|NCT00266227|6373927|P3|Initial Treatment|Pregnancy|1
1841779|NCT00266227|6373928|P2|Initial Treatment|Pregnancy|0
1841780|NCT00266227|6373929|P1|Initial Treatment|Pregnancy|0
1841781|NCT00266227|6373927|P3|Initial Treatment|Physician decision to withdraw|12
1841782|NCT00266227|6373928|P2|Initial Treatment|Physician decision to withdraw|0
1841783|NCT00266227|6373929|P1|Initial Treatment|Physician decision to withdraw|0
1841784|NCT00266227|6373927|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
1841785|NCT00266227|6373928|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
1841786|NCT00266227|6373929|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
1841787|NCT00266227|6373927|P3|Initial Treatment|Lost to Follow-up|6
1841788|NCT00266227|6373928|P2|Initial Treatment|Lost to Follow-up|0
1841789|NCT00266227|6373929|P1|Initial Treatment|Lost to Follow-up|0
1841790|NCT00266227|6373927|P3|Initial Treatment|Adverse Event|13
1841791|NCT00266227|6373928|P2|Initial Treatment|Adverse Event|0
1841792|NCT00266227|6373929|P1|Initial Treatment|Adverse Event|0
1841793|NCT00266032|6373983|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
1841794|NCT00266032|6373984|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
1841795|NCT00266032|6373985|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
1841796|NCT00266032|6373983|P3|Open-label Safety Extension|Withdrawal by Subject|12
1841797|NCT00266032|6373984|P2|Open-label Safety Extension|Withdrawal by Subject|3
1841798|NCT00266032|6373985|P1|Open-label Safety Extension|Withdrawal by Subject|19
1841799|NCT00266032|6373983|P3|Open-label Safety Extension|Protocol Violation|2
1841800|NCT00266032|6373984|P2|Open-label Safety Extension|Protocol Violation|3
1841801|NCT00266032|6373985|P1|Open-label Safety Extension|Protocol Violation|1
1841802|NCT00266032|6373983|P3|Open-label Safety Extension|Pregnancy|2
1841803|NCT00266032|6373984|P2|Open-label Safety Extension|Pregnancy|1
1841804|NCT00266032|6373985|P1|Open-label Safety Extension|Pregnancy|4
1841805|NCT00266032|6373983|P3|Open-label Safety Extension|Lost to Follow-up|4
1841806|NCT00266032|6373984|P2|Open-label Safety Extension|Lost to Follow-up|5
1841807|NCT00266032|6373985|P1|Open-label Safety Extension|Lost to Follow-up|2
1841808|NCT00266032|6373983|P3|Open-label Safety Extension|Adverse Event|4
1841809|NCT00266032|6373984|P2|Open-label Safety Extension|Adverse Event|0
1841810|NCT00266032|6373985|P1|Open-label Safety Extension|Adverse Event|5
1841811|NCT00266032|6373983|P3|Treatment|patient moved/wish for pregnancy/no need|8
1841812|NCT00266032|6373984|P2|Treatment|patient moved/wish for pregnancy/no need|5
1841813|NCT00266032|6373985|P1|Treatment|patient moved/wish for pregnancy/no need|13
1841814|NCT00266032|6373983|P3|Treatment|Withdrawal by Subject|12
1841815|NCT00266032|6373984|P2|Treatment|Withdrawal by Subject|13
1841816|NCT00266032|6373985|P1|Treatment|Withdrawal by Subject|28
1841817|NCT00266032|6373983|P3|Treatment|Protocol Violation|13
1841818|NCT00266032|6373984|P2|Treatment|Protocol Violation|14
1841819|NCT00266032|6373985|P1|Treatment|Protocol Violation|6
1841820|NCT00266032|6373983|P3|Treatment|Pregnancy|2
1841821|NCT00266032|6373984|P2|Treatment|Pregnancy|2
1841822|NCT00266032|6373985|P1|Treatment|Pregnancy|3
1841823|NCT00266032|6373983|P3|Treatment|Lost to Follow-up|2
1841824|NCT00266032|6373984|P2|Treatment|Lost to Follow-up|4
1841826|NCT00266032|6373983|P3|Treatment|Adverse Event|10
1841827|NCT00266032|6373984|P2|Treatment|Adverse Event|26
1841828|NCT00266032|6373985|P1|Treatment|Adverse Event|42
1841829|NCT00265941|6374020|P2|Overall Study|Lost to Follow-up|1
1841830|NCT00265941|6374021|P1|Overall Study|Lost to Follow-up|1
1841831|NCT00265941|6374020|P2|Overall Study|Protocol Violation|25
1841832|NCT00265941|6374021|P1|Overall Study|Protocol Violation|22
1841833|NCT00265889|6374053|P1|Overall Study|Insurance denied the request|3
1841834|NCT00265889|6374053|P1|Overall Study|Protocol Violation|1
1841835|NCT00265889|6374053|P1|Overall Study|Physician Decision|1
1841836|NCT00265785|6374080|P1|Overall Study|Did not receive protocol treatment|2
1841837|NCT00265785|6374080|P1|Overall Study|Ineligible|1
1841838|NCT00265785|6374080|P1|Overall Study|Not protocol specified|2
1841839|NCT00265785|6374080|P1|Overall Study|Progression/Relapse|15
1841840|NCT00265785|6374080|P1|Overall Study|Withdrawal by Subject|3
1841841|NCT00265785|6374080|P1|Overall Study|Adverse Event|4
1841842|NCT00265759|6374093|P4|Overall Study|Discontinued due to intolerability|1
1841843|NCT00265759|6374094|P3|Overall Study|Discontinued due to intolerability|0
1841844|NCT00265759|6374095|P2|Overall Study|Discontinued due to intolerability|0
1841845|NCT00265759|6374096|P1|Overall Study|Discontinued due to intolerability|0
1841846|NCT00265759|6374093|P4|Overall Study|Bilateral disease|2
1841847|NCT00265759|6374094|P3|Overall Study|Bilateral disease|0
1841848|NCT00265759|6374095|P2|Overall Study|Bilateral disease|0
1841849|NCT00265759|6374096|P1|Overall Study|Bilateral disease|0
1841850|NCT00265759|6374093|P4|Overall Study|Ineligible|1
1841851|NCT00265759|6374094|P3|Overall Study|Ineligible|0
1841852|NCT00265759|6374095|P2|Overall Study|Ineligible|0
1841853|NCT00265759|6374096|P1|Overall Study|Ineligible|0
1841854|NCT00265759|6374093|P4|Overall Study|Cancel|3
1841855|NCT00265759|6374094|P3|Overall Study|Cancel|0
1841856|NCT00265759|6374095|P2|Overall Study|Cancel|0
1841857|NCT00265759|6374096|P1|Overall Study|Cancel|0
1841858|NCT00265759|6374093|P4|Overall Study|Withdrawal by Subject|2
1841859|NCT00265759|6374094|P3|Overall Study|Withdrawal by Subject|2
1841860|NCT00265759|6374095|P2|Overall Study|Withdrawal by Subject|1
1841861|NCT00265759|6374096|P1|Overall Study|Withdrawal by Subject|0
1841862|NCT00265395|6374167|P2|Overall Study|Administrative|1
1841863|NCT00265395|6374168|P1|Overall Study|Administrative|0
1841864|NCT00265395|6374167|P2|Overall Study|Lack of Efficacy|1
1841865|NCT00265395|6374168|P1|Overall Study|Lack of Efficacy|0
1841866|NCT00265395|6374167|P2|Overall Study|Protocol Violation|2
1841867|NCT00265395|6374168|P1|Overall Study|Protocol Violation|2
1841868|NCT00265395|6374167|P2|Overall Study|Withdrawal by Subject|6
1841869|NCT00265395|6374168|P1|Overall Study|Withdrawal by Subject|1
1841870|NCT00265395|6374167|P2|Overall Study|Lost to Follow-up|1
1841871|NCT00265395|6374168|P1|Overall Study|Lost to Follow-up|2
1841872|NCT00265395|6374167|P2|Overall Study|Adverse Event|6
1841873|NCT00265395|6374168|P1|Overall Study|Adverse Event|3
1841874|NCT00265382|6374173|P1|Overall Study|Death|1
1841875|NCT00265382|6374173|P1|Overall Study|Study terminated by sponsor|94
1841876|NCT00265382|6374173|P1|Overall Study|Withdrawal by Subject|13
1841877|NCT00265382|6374173|P1|Overall Study|Miscellaneous|6
1841878|NCT00265382|6374173|P1|Overall Study|Lack of Efficacy|6
1841879|NCT00265382|6374173|P1|Overall Study|Lost to Follow-up|3
1841880|NCT00265382|6374173|P1|Overall Study|Laboratory Abnormality|1
1841881|NCT00265382|6374173|P1|Overall Study|Adverse Event|21
1841882|NCT00265343|6374193|P2|Overall Study|Other|3
1841883|NCT00265343|6374194|P1|Overall Study|Other|8
1841884|NCT00265343|6374193|P2|Overall Study|Withdrawal by Subject|9
1841885|NCT00265343|6374194|P1|Overall Study|Withdrawal by Subject|3
1841886|NCT00265343|6374193|P2|Overall Study|Adverse Event|7
1841887|NCT00265343|6374194|P1|Overall Study|Adverse Event|10
1841888|NCT00265330|6374202|P1|Overall Study|Protocol Violation|1
1841889|NCT00265330|6374202|P1|Overall Study|Withdrew Consent|1
1841890|NCT00265330|6374202|P1|Overall Study|Principal Investigators Request|1
1841891|NCT00265330|6374202|P1|Overall Study|Site Closed by Sponsor|1
1841892|NCT00265330|6374202|P1|Overall Study|Discharged from Unit for Long Term Care|1
1841893|NCT00265330|6374202|P1|Overall Study|Began Taking Formulary Geodon|1
1841894|NCT00265330|6374202|P1|Overall Study|Family Scheduling Conflicts|1
1841895|NCT00265330|6374202|P1|Overall Study|Lack of Efficacy|4
1841896|NCT00265330|6374202|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
1841897|NCT00265330|6374202|P1|Overall Study|Withdrawal by Subject|34
1841898|NCT00265330|6374202|P1|Overall Study|Lost to Follow-up|8
1841899|NCT00265330|6374202|P1|Overall Study|Adverse Event|41
1841900|NCT00265317|6374228|P4|Phase 2|Other|1
1841901|NCT00265317|6374229|P3|Phase 2|Other|1
1841902|NCT00265317|6374230|P2|Phase 2|Other|0
1841903|NCT00265317|6374231|P1|Phase 2|Other|0
1841904|NCT00265317|6374228|P4|Phase 2|Study terminated by sponsor|0
1841905|NCT00265317|6374229|P3|Phase 2|Study terminated by sponsor|1
1841906|NCT00265317|6374230|P2|Phase 2|Study terminated by sponsor|0
1841907|NCT00265317|6374231|P1|Phase 2|Study terminated by sponsor|0
1841908|NCT00265317|6374228|P4|Phase 2|Withdrawal/other than adverse event|1
1841909|NCT00265317|6374229|P3|Phase 2|Withdrawal/other than adverse event|2
1841910|NCT00265317|6374230|P2|Phase 2|Withdrawal/other than adverse event|0
1841911|NCT00265317|6374231|P1|Phase 2|Withdrawal/other than adverse event|0
1841912|NCT00265317|6374228|P4|Phase 2|Lost to Follow-up|1
1841913|NCT00265317|6374229|P3|Phase 2|Lost to Follow-up|0
1841914|NCT00265317|6374230|P2|Phase 2|Lost to Follow-up|0
1841915|NCT00265317|6374231|P1|Phase 2|Lost to Follow-up|0
1841916|NCT00265317|6374228|P4|Phase 2|Protocol Violation|4
1841917|NCT00265317|6374229|P3|Phase 2|Protocol Violation|1
1841918|NCT00265317|6374230|P2|Phase 2|Protocol Violation|0
1841919|NCT00265317|6374231|P1|Phase 2|Protocol Violation|0
1841920|NCT00265317|6374228|P4|Phase 2|Death|15
1841921|NCT00265317|6374229|P3|Phase 2|Death|12
1841922|NCT00265317|6374230|P2|Phase 2|Death|0
1841923|NCT00265317|6374231|P1|Phase 2|Death|0
1841924|NCT00265317|6374228|P4|Phase 2|Adverse Event|5
1841925|NCT00265317|6374229|P3|Phase 2|Adverse Event|7
1841926|NCT00265317|6374230|P2|Phase 2|Adverse Event|0
1841927|NCT00265317|6374231|P1|Phase 2|Adverse Event|0
1841928|NCT00265317|6374228|P4|Phase 2|Global deterioration of health status|0
1841929|NCT00265317|6374229|P3|Phase 2|Global deterioration of health status|3
1841930|NCT00265317|6374230|P2|Phase 2|Global deterioration of health status|0
1841931|NCT00265317|6374231|P1|Phase 2|Global deterioration of health status|0
1841932|NCT00265317|6374228|P4|Phase 2|Objective progression or relapse|38
1841933|NCT00265317|6374229|P3|Phase 2|Objective progression or relapse|37
1841934|NCT00265317|6374230|P2|Phase 2|Objective progression or relapse|0
1841935|NCT00265317|6374231|P1|Phase 2|Objective progression or relapse|0
1841936|NCT00265317|6374228|P4|Lead-In|Withdrawal/other than adverse event|0
1841937|NCT00265317|6374229|P3|Lead-In|Withdrawal/other than adverse event|0
1841938|NCT00265317|6374230|P2|Lead-In|Withdrawal/other than adverse event|0
1841939|NCT00265317|6374231|P1|Lead-In|Withdrawal/other than adverse event|1
1841940|NCT00265317|6374228|P4|Lead-In|Death|0
1841941|NCT00265317|6374229|P3|Lead-In|Death|0
1841942|NCT00265317|6374230|P2|Lead-In|Death|5
1841943|NCT00265317|6374231|P1|Lead-In|Death|3
1841944|NCT00265317|6374228|P4|Lead-In|Adverse Event|0
1841945|NCT00265317|6374229|P3|Lead-In|Adverse Event|0
1841946|NCT00265317|6374230|P2|Lead-In|Adverse Event|1
1841947|NCT00265317|6374231|P1|Lead-In|Adverse Event|2
1841948|NCT00265317|6374228|P4|Lead-In|Objective progression or relapse|0
1841949|NCT00265317|6374229|P3|Lead-In|Objective progression or relapse|0
1841950|NCT00265317|6374230|P2|Lead-In|Objective progression or relapse|11
1841951|NCT00265317|6374231|P1|Lead-In|Objective progression or relapse|6
1841952|NCT00265239|6374346|P2|Overall Study|Adverse Event|1
1841953|NCT00265239|6374347|P1|Overall Study|Adverse Event|2
1841954|NCT00265122|6374369|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
1841955|NCT00265122|6374370|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
1841956|NCT00265122|6374371|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
1841957|NCT00265122|6374372|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
1841958|NCT00265122|6374373|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
1841959|NCT00265122|6374374|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
1841960|NCT00265122|6374369|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1841961|NCT00265122|6374370|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1841962|NCT00265122|6374371|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
1841963|NCT00265122|6374372|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1841964|NCT00265122|6374373|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
1841965|NCT00265122|6374374|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
1841966|NCT00265122|6374369|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
1841967|NCT00265122|6374370|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1841968|NCT00265122|6374371|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1841969|NCT00265122|6374372|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
1841970|NCT00265122|6374373|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
1841971|NCT00265122|6374374|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
1841972|NCT00265122|6374369|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
1841973|NCT00265122|6374370|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
1841974|NCT00265122|6374371|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
1841975|NCT00265122|6374372|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
1841976|NCT00265122|6374373|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
1841977|NCT00265122|6374374|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
1841978|NCT00265122|6374369|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1841979|NCT00265122|6374370|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1841980|NCT00265122|6374371|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1841981|NCT00265122|6374372|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1841982|NCT00265122|6374373|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
1841983|NCT00265122|6374374|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
1841984|NCT00265122|6374369|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1841985|NCT00265122|6374370|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1841986|NCT00265122|6374371|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
1841987|NCT00265122|6374372|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
1841988|NCT00265122|6374373|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1841989|NCT00265122|6374374|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
1841990|NCT00265109|6374396|P1|Overall Study|Adverse Event|1
1841991|NCT00265109|6374396|P1|Overall Study|Withdrawal by Subject|5
1841992|NCT00265096|6374415|P3|Overall Study|Other|10
1841993|NCT00265096|6374416|P2|Overall Study|Other|19
1841994|NCT00265096|6374417|P1|Overall Study|Other|11
1841995|NCT00265096|6374415|P3|Overall Study|Unsatisfactory therapeutic effect|6
1841996|NCT00265096|6374416|P2|Overall Study|Unsatisfactory therapeutic effect|8
1841997|NCT00265096|6374417|P1|Overall Study|Unsatisfactory therapeutic effect|9
1841998|NCT00265096|6374415|P3|Overall Study|Death|2
1841999|NCT00265096|6374416|P2|Overall Study|Death|1
1842000|NCT00265096|6374417|P1|Overall Study|Death|0
1842001|NCT00265096|6374415|P3|Overall Study|Lost to Follow-up|3
1842002|NCT00265096|6374416|P2|Overall Study|Lost to Follow-up|5
1842003|NCT00265096|6374417|P1|Overall Study|Lost to Follow-up|2
1842004|NCT00265096|6374415|P3|Overall Study|Adverse Event|18
1842005|NCT00265096|6374416|P2|Overall Study|Adverse Event|18
1842006|NCT00265096|6374417|P1|Overall Study|Adverse Event|14
1842007|NCT00265083|6374449|P3|Overall Study|Other|9
1842008|NCT00265083|6374450|P2|Overall Study|Other|12
1842009|NCT00265083|6374451|P1|Overall Study|Other|1
1842010|NCT00265083|6374449|P3|Overall Study|Unsatisfactory therapeutic effect|14
1842011|NCT00265083|6374450|P2|Overall Study|Unsatisfactory therapeutic effect|13
1842012|NCT00265083|6374451|P1|Overall Study|Unsatisfactory therapeutic effect|8
1842013|NCT00265083|6374449|P3|Overall Study|Lost to Follow-up|4
1842014|NCT00265083|6374450|P2|Overall Study|Lost to Follow-up|4
1842015|NCT00265083|6374451|P1|Overall Study|Lost to Follow-up|3
1842016|NCT00265083|6374449|P3|Overall Study|Adverse Event|15
1842017|NCT00265083|6374450|P2|Overall Study|Adverse Event|13
1842018|NCT00265083|6374451|P1|Overall Study|Adverse Event|5
1842019|NCT00264875|6374472|P1|Overall Study|Withdrawal by Subject|7
1842020|NCT00264875|6374472|P1|Overall Study|Protocol Violation|11
1842021|NCT00264875|6374472|P1|Overall Study|Lost to Follow-up|6
1842022|NCT00264875|6374472|P1|Overall Study|Adverse Event|6
1842023|NCT00264849|6374478|P2|Overall Study|Administrative Problems|0
1842024|NCT00264849|6374479|P1|Overall Study|Administrative Problems|2
1842025|NCT00264849|6374478|P2|Overall Study|Death|1
1842026|NCT00264849|6374479|P1|Overall Study|Death|0
1842027|NCT00264849|6374478|P2|Overall Study|Lost to Follow-up|2
1842028|NCT00264849|6374479|P1|Overall Study|Lost to Follow-up|0
1842029|NCT00264849|6374478|P2|Overall Study|Lack of Efficacy|6
1842030|NCT00264849|6374479|P1|Overall Study|Lack of Efficacy|1
1842031|NCT00264849|6374478|P2|Overall Study|Protocol Violation|3
1842032|NCT00264849|6374479|P1|Overall Study|Protocol Violation|5
1842033|NCT00264849|6374478|P2|Overall Study|Withdrawal by Subject|11
1842034|NCT00264849|6374479|P1|Overall Study|Withdrawal by Subject|7
1842035|NCT00264849|6374478|P2|Overall Study|Adverse Event|2
1842036|NCT00264849|6374479|P1|Overall Study|Adverse Event|7
1842037|NCT00264810|6374513|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
1842038|NCT00264810|6374514|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
1842039|NCT00264810|6374513|P2|Open Label Evaluation Period|Death|2
1842040|NCT00264810|6374514|P1|Open Label Evaluation Period|Death|3
1842041|NCT00264810|6374513|P2|Open Label Evaluation Period|Explant due to infection|1
1842042|NCT00264810|6374514|P1|Open Label Evaluation Period|Explant due to infection|1
1842043|NCT00264810|6374513|P2|Blinded Evaluation Period|Explant due to infection|1
1842044|NCT00264810|6374514|P1|Blinded Evaluation Period|Explant due to infection|1
1842045|NCT00264810|6374513|P2|Stimulation Optimization Period|Death|1
1842046|NCT00264810|6374514|P1|Stimulation Optimization Period|Death|0
1842047|NCT00264810|6374513|P2|Stimulation Optimization Period|Withdrawal by Subject|0
1842048|NCT00264810|6374514|P1|Stimulation Optimization Period|Withdrawal by Subject|1
1842049|NCT00264810|6374513|P2|Baseline|Other|1
1842050|NCT00264810|6374514|P1|Baseline|Other|0
1842051|NCT00264810|6374513|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
1842052|NCT00264810|6374514|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
1842053|NCT00264810|6374513|P2|Baseline|Insufficient Seizure Frequency|2
1842054|NCT00264810|6374514|P1|Baseline|Insufficient Seizure Frequency|2
1842055|NCT00264810|6374513|P2|Baseline|Subject Compliance Failure|3
1842056|NCT00264810|6374514|P1|Baseline|Subject Compliance Failure|3
1842057|NCT00264810|6374513|P2|Baseline|Physician Decision|8
1842058|NCT00264810|6374514|P1|Baseline|Physician Decision|7
1842059|NCT00264810|6374513|P2|Baseline|Withdrawal by Subject|10
1842060|NCT00264810|6374514|P1|Baseline|Withdrawal by Subject|10
1842061|NCT00264797|6374524|P2|Overall Study|Other|4
1842062|NCT00264797|6374525|P1|Overall Study|Other|3
1842063|NCT00264797|6374524|P2|Overall Study|Feels treatment not necessary, not worki|1
1842064|NCT00264797|6374525|P1|Overall Study|Feels treatment not necessary, not worki|0
1842065|NCT00264797|6374524|P2|Overall Study|Pressure/advice from Outsiders|1
1842066|NCT00264797|6374525|P1|Overall Study|Pressure/advice from Outsiders|1
1842067|NCT00264797|6374524|P2|Overall Study|Incarceration|5
1842068|NCT00264797|6374525|P1|Overall Study|Incarceration|4
1842069|NCT00264797|6374524|P2|Overall Study|Practical Problems|3
1842070|NCT00264797|6374525|P1|Overall Study|Practical Problems|2
1842071|NCT00264797|6374524|P2|Overall Study|Moved from area|1
1842072|NCT00264797|6374525|P1|Overall Study|Moved from area|3
1842073|NCT00264797|6374524|P2|Overall Study|Lost to Follow-up|17
1842074|NCT00264797|6374525|P1|Overall Study|Lost to Follow-up|9
1842075|NCT00264797|6374524|P2|Overall Study|Withdrawal by Subject|11
1842076|NCT00264797|6374525|P1|Overall Study|Withdrawal by Subject|11
1842077|NCT00264576|6374547|P2|Overall Study|Lost to Follow-up|1
1842078|NCT00264576|6374548|P1|Overall Study|Lost to Follow-up|1
1842079|NCT00264550|6374572|P4|Overall Study|Other|9
1842080|NCT00264550|6374573|P3|Overall Study|Other|3
1842081|NCT00264550|6374574|P2|Overall Study|Other|7
1842082|NCT00264550|6374575|P1|Overall Study|Other|13
1842083|NCT00264550|6374572|P4|Overall Study|Discontinued oral study agent|0
1842084|NCT00264550|6374573|P3|Overall Study|Discontinued oral study agent|0
1842085|NCT00264550|6374574|P2|Overall Study|Discontinued oral study agent|1
1842086|NCT00264550|6374575|P1|Overall Study|Discontinued oral study agent|0
1842087|NCT00264550|6374572|P4|Overall Study|Unsatisfactory therapeutic effect|6
1842088|NCT00264550|6374573|P3|Overall Study|Unsatisfactory therapeutic effect|4
1842089|NCT00264550|6374574|P2|Overall Study|Unsatisfactory therapeutic effect|11
1842090|NCT00264550|6374575|P1|Overall Study|Unsatisfactory therapeutic effect|4
1842091|NCT00264550|6374572|P4|Overall Study|Adverse Event|14
1842092|NCT00264550|6374573|P3|Overall Study|Adverse Event|9
1842093|NCT00264550|6374574|P2|Overall Study|Adverse Event|18
1842094|NCT00264550|6374575|P1|Overall Study|Adverse Event|23
1842095|NCT00264550|6374572|P4|Overall Study|Lost to Follow-up|1
1842096|NCT00264550|6374573|P3|Overall Study|Lost to Follow-up|1
1842097|NCT00264550|6374574|P2|Overall Study|Lost to Follow-up|1
1842098|NCT00264550|6374575|P1|Overall Study|Lost to Follow-up|3
1842099|NCT00264550|6374572|P4|Overall Study|Death|0
1842100|NCT00264550|6374573|P3|Overall Study|Death|0
1842101|NCT00264550|6374574|P2|Overall Study|Death|3
1842102|NCT00264550|6374575|P1|Overall Study|Death|0
1842103|NCT00264537|6374614|P4|Overall Study|Not treated|0
1842104|NCT00264537|6374615|P3|Overall Study|Not treated|1
1842105|NCT00264537|6374616|P2|Overall Study|Not treated|2
1842106|NCT00264537|6374617|P1|Overall Study|Not treated|0
1842107|NCT00264537|6374614|P4|Overall Study|Other|11
1842108|NCT00264537|6374615|P3|Overall Study|Other|10
1842109|NCT00264537|6374616|P2|Overall Study|Other|11
1842110|NCT00264537|6374617|P1|Overall Study|Other|21
1842111|NCT00264537|6374614|P4|Overall Study|Unsatisfactory therapeutic effect|7
1842112|NCT00264537|6374615|P3|Overall Study|Unsatisfactory therapeutic effect|5
1842113|NCT00264537|6374616|P2|Overall Study|Unsatisfactory therapeutic effect|6
1842114|NCT00264537|6374617|P1|Overall Study|Unsatisfactory therapeutic effect|5
1842115|NCT00264537|6374614|P4|Overall Study|Adverse Event|34
1842116|NCT00264537|6374615|P3|Overall Study|Adverse Event|24
1842117|NCT00264537|6374616|P2|Overall Study|Adverse Event|32
1842118|NCT00264537|6374617|P1|Overall Study|Adverse Event|21
1842119|NCT00264537|6374614|P4|Overall Study|Lost to Follow-up|6
1842120|NCT00264537|6374615|P3|Overall Study|Lost to Follow-up|7
1842121|NCT00264537|6374616|P2|Overall Study|Lost to Follow-up|4
1842122|NCT00264537|6374617|P1|Overall Study|Lost to Follow-up|3
1842123|NCT00264537|6374614|P4|Overall Study|Death|2
1842124|NCT00264537|6374615|P3|Overall Study|Death|3
1842125|NCT00264537|6374616|P2|Overall Study|Death|3
1842126|NCT00264537|6374617|P1|Overall Study|Death|0
1842127|NCT00264498|6374649|P2|Crossover Treatment|Withdrawal by Subject|0
1842128|NCT00264498|6374650|P1|Crossover Treatment|Withdrawal by Subject|1
1842129|NCT00264498|6374649|P2|Crossover Treatment|Study closure|1
1842130|NCT00264498|6374650|P1|Crossover Treatment|Study closure|0
1842131|NCT00264498|6374649|P2|Crossover Treatment|Objective disease progression|5
1842132|NCT00264498|6374650|P1|Crossover Treatment|Objective disease progression|4
1842133|NCT00264498|6374649|P2|Crossover Treatment|Death|3
1842134|NCT00264498|6374650|P1|Crossover Treatment|Death|1
1842135|NCT00264498|6374649|P2|Randomized Treatment|Protocol Violation|0
1842136|NCT00264498|6374650|P1|Randomized Treatment|Protocol Violation|1
1842137|NCT00264498|6374649|P2|Randomized Treatment|Study Closure|0
1842138|NCT00264498|6374650|P1|Randomized Treatment|Study Closure|1
1842139|NCT00264498|6374649|P2|Randomized Treatment|Incorrectly randomized|0
1842140|NCT00264498|6374650|P1|Randomized Treatment|Incorrectly randomized|1
1842141|NCT00264498|6374649|P2|Randomized Treatment|Physician Decision|0
1842142|NCT00264498|6374650|P1|Randomized Treatment|Physician Decision|1
1842143|NCT00264498|6374649|P2|Randomized Treatment|Objective disease Progression|14
1842144|NCT00264498|6374650|P1|Randomized Treatment|Objective disease Progression|13
1842145|NCT00264498|6374649|P2|Randomized Treatment|Withdrawal by Subject|1
1842146|NCT00264498|6374650|P1|Randomized Treatment|Withdrawal by Subject|0
1842147|NCT00264498|6374649|P2|Randomized Treatment|Death|3
1842148|NCT00264498|6374650|P1|Randomized Treatment|Death|0
1842149|NCT00264303|6374673|P2|Overall Study|Various reasons listed in study report|7
1842150|NCT00264303|6374674|P1|Overall Study|Various reasons listed in study report|6
1842151|NCT00264303|6374673|P2|Overall Study|Withdrawal by Subject|3
1842152|NCT00264303|6374674|P1|Overall Study|Withdrawal by Subject|2
1842153|NCT00264303|6374673|P2|Overall Study|Lost to Follow-up|3
1842154|NCT00264303|6374674|P1|Overall Study|Lost to Follow-up|3
1842155|NCT00264303|6374673|P2|Overall Study|Lack of Efficacy|13
1842156|NCT00264303|6374674|P1|Overall Study|Lack of Efficacy|10
1842157|NCT00264303|6374673|P2|Overall Study|Adverse Event|3
1842158|NCT00264303|6374674|P1|Overall Study|Adverse Event|4
1842159|NCT00264290|6374692|P2|Intervention (8 Weeks)|Adverse Event|0
1842160|NCT00264290|6374693|P1|Intervention (8 Weeks)|Adverse Event|1
1842161|NCT00264238|6374699|P1|Overall Study|Protocol Violation|1
1842162|NCT00264147|6374711|P6|Treatment II Period|Pre-scheduled total hip replacement|1
1842163|NCT00264147|6374712|P5|Treatment II Period|Pre-scheduled total hip replacement|0
1842164|NCT00264147|6374713|P4|Treatment II Period|Pre-scheduled total hip replacement|0
1842165|NCT00264147|6374714|P3|Treatment II Period|Pre-scheduled total hip replacement|0
1842166|NCT00264147|6374715|P2|Treatment II Period|Pre-scheduled total hip replacement|0
1842167|NCT00264147|6374716|P1|Treatment II Period|Pre-scheduled total hip replacement|0
1842168|NCT00264147|6374711|P6|Treatment II Period|Withdrawal by Subject|2
1842169|NCT00264147|6374712|P5|Treatment II Period|Withdrawal by Subject|3
1842170|NCT00264147|6374713|P4|Treatment II Period|Withdrawal by Subject|0
1842171|NCT00264147|6374714|P3|Treatment II Period|Withdrawal by Subject|0
1842172|NCT00264147|6374715|P2|Treatment II Period|Withdrawal by Subject|0
1842173|NCT00264147|6374716|P1|Treatment II Period|Withdrawal by Subject|0
1842174|NCT00264147|6374711|P6|Treatment II Period|Lost to Follow-up|1
1842175|NCT00264147|6374712|P5|Treatment II Period|Lost to Follow-up|1
1842176|NCT00264147|6374713|P4|Treatment II Period|Lost to Follow-up|0
1842177|NCT00264147|6374714|P3|Treatment II Period|Lost to Follow-up|0
1842178|NCT00264147|6374715|P2|Treatment II Period|Lost to Follow-up|0
1842179|NCT00264147|6374716|P1|Treatment II Period|Lost to Follow-up|0
1842180|NCT00264147|6374711|P6|Treatment II Period|Lack of Efficacy|19
1842181|NCT00264147|6374712|P5|Treatment II Period|Lack of Efficacy|20
1842182|NCT00264147|6374713|P4|Treatment II Period|Lack of Efficacy|0
1842183|NCT00264147|6374714|P3|Treatment II Period|Lack of Efficacy|0
1842184|NCT00264147|6374715|P2|Treatment II Period|Lack of Efficacy|0
1842185|NCT00264147|6374716|P1|Treatment II Period|Lack of Efficacy|0
1842186|NCT00264147|6374711|P6|Treatment II Period|Laboratory Adverse Event|1
1842187|NCT00264147|6374712|P5|Treatment II Period|Laboratory Adverse Event|0
1842188|NCT00264147|6374713|P4|Treatment II Period|Laboratory Adverse Event|0
1842189|NCT00264147|6374714|P3|Treatment II Period|Laboratory Adverse Event|0
1842190|NCT00264147|6374715|P2|Treatment II Period|Laboratory Adverse Event|0
1842191|NCT00264147|6374716|P1|Treatment II Period|Laboratory Adverse Event|0
1842192|NCT00264147|6374711|P6|Treatment II Period|Adverse Event|9
1842193|NCT00264147|6374712|P5|Treatment II Period|Adverse Event|9
1842194|NCT00264147|6374713|P4|Treatment II Period|Adverse Event|0
1842195|NCT00264147|6374714|P3|Treatment II Period|Adverse Event|0
1842196|NCT00264147|6374715|P2|Treatment II Period|Adverse Event|0
1842197|NCT00264147|6374716|P1|Treatment II Period|Adverse Event|0
1842198|NCT00264147|6374711|P6|Treatment I Period|Reassigned to Treatment II Period|0
1842199|NCT00264147|6374712|P5|Treatment I Period|Reassigned to Treatment II Period|45
1842200|NCT00264147|6374713|P4|Treatment I Period|Reassigned to Treatment II Period|63
1842201|NCT00264147|6374714|P3|Treatment I Period|Reassigned to Treatment II Period|65
1842202|NCT00264147|6374715|P2|Treatment I Period|Reassigned to Treatment II Period|72
1842203|NCT00264147|6374716|P1|Treatment I Period|Reassigned to Treatment II Period|84
1842204|NCT00264147|6374711|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
1842205|NCT00264147|6374712|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
1842206|NCT00264147|6374713|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
1842207|NCT00264147|6374714|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
1842208|NCT00264147|6374715|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
1842209|NCT00264147|6374716|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
1842210|NCT00264147|6374711|P6|Treatment I Period|Patient out of town for an extended time|0
1842211|NCT00264147|6374712|P5|Treatment I Period|Patient out of town for an extended time|0
1842212|NCT00264147|6374713|P4|Treatment I Period|Patient out of town for an extended time|0
1842213|NCT00264147|6374714|P3|Treatment I Period|Patient out of town for an extended time|0
1842214|NCT00264147|6374715|P2|Treatment I Period|Patient out of town for an extended time|1
1842215|NCT00264147|6374716|P1|Treatment I Period|Patient out of town for an extended time|0
1842216|NCT00264147|6374711|P6|Treatment I Period|Withdrawal by Subject|0
1842217|NCT00264147|6374712|P5|Treatment I Period|Withdrawal by Subject|2
1842218|NCT00264147|6374713|P4|Treatment I Period|Withdrawal by Subject|2
1842219|NCT00264147|6374714|P3|Treatment I Period|Withdrawal by Subject|0
1842220|NCT00264147|6374715|P2|Treatment I Period|Withdrawal by Subject|0
1842221|NCT00264147|6374716|P1|Treatment I Period|Withdrawal by Subject|2
1842222|NCT00264147|6374711|P6|Treatment I Period|Protocol Violation|0
1842223|NCT00264147|6374712|P5|Treatment I Period|Protocol Violation|0
1842224|NCT00264147|6374713|P4|Treatment I Period|Protocol Violation|0
1842225|NCT00264147|6374714|P3|Treatment I Period|Protocol Violation|0
1842226|NCT00264147|6374715|P2|Treatment I Period|Protocol Violation|2
1842227|NCT00264147|6374716|P1|Treatment I Period|Protocol Violation|2
1842228|NCT00264147|6374711|P6|Treatment I Period|Lost to Follow-up|0
1842229|NCT00264147|6374712|P5|Treatment I Period|Lost to Follow-up|1
1842230|NCT00264147|6374713|P4|Treatment I Period|Lost to Follow-up|1
1842231|NCT00264147|6374714|P3|Treatment I Period|Lost to Follow-up|0
1842232|NCT00264147|6374715|P2|Treatment I Period|Lost to Follow-up|0
1842233|NCT00264147|6374716|P1|Treatment I Period|Lost to Follow-up|1
1842234|NCT00264147|6374711|P6|Treatment I Period|Lack of Efficacy|0
1842235|NCT00264147|6374712|P5|Treatment I Period|Lack of Efficacy|1
1842236|NCT00264147|6374713|P4|Treatment I Period|Lack of Efficacy|0
1842237|NCT00264147|6374714|P3|Treatment I Period|Lack of Efficacy|8
1842238|NCT00264147|6374715|P2|Treatment I Period|Lack of Efficacy|2
1842239|NCT00264147|6374716|P1|Treatment I Period|Lack of Efficacy|6
1842240|NCT00264147|6374711|P6|Treatment I Period|Laboratory Adverse Event|0
1842241|NCT00264147|6374712|P5|Treatment I Period|Laboratory Adverse Event|0
1842242|NCT00264147|6374713|P4|Treatment I Period|Laboratory Adverse Event|1
1842243|NCT00264147|6374714|P3|Treatment I Period|Laboratory Adverse Event|0
1842244|NCT00264147|6374715|P2|Treatment I Period|Laboratory Adverse Event|0
1842245|NCT00264147|6374716|P1|Treatment I Period|Laboratory Adverse Event|0
1842246|NCT00264147|6374711|P6|Treatment I Period|Adverse Event|0
1842247|NCT00264147|6374712|P5|Treatment I Period|Adverse Event|7
1842248|NCT00264147|6374713|P4|Treatment I Period|Adverse Event|5
1842249|NCT00264147|6374714|P3|Treatment I Period|Adverse Event|3
1842250|NCT00264147|6374715|P2|Treatment I Period|Adverse Event|6
1842251|NCT00264147|6374716|P1|Treatment I Period|Adverse Event|3
1842252|NCT00264004|6374759|P4|Overall Study|Not treated|2
1842253|NCT00264004|6374760|P3|Overall Study|Not treated|2
1842254|NCT00264004|6374761|P2|Overall Study|Not treated|0
1842255|NCT00264004|6374762|P1|Overall Study|Not treated|3
1842256|NCT00264004|6374759|P4|Overall Study|Cond. under inv. worsened|4
1842257|NCT00264004|6374760|P3|Overall Study|Cond. under inv. worsened|3
1842258|NCT00264004|6374761|P2|Overall Study|Cond. under inv. worsened|5
1842259|NCT00264004|6374762|P1|Overall Study|Cond. under inv. worsened|9
1842260|NCT00264004|6374759|P4|Overall Study|Development study specific disc. crit.|0
1842261|NCT00264004|6374760|P3|Overall Study|Development study specific disc. crit.|1
1842262|NCT00264004|6374761|P2|Overall Study|Development study specific disc. crit.|0
1842263|NCT00264004|6374762|P1|Overall Study|Development study specific disc. crit.|1
1842264|NCT00264004|6374759|P4|Overall Study|Other|3
1842265|NCT00264004|6374760|P3|Overall Study|Other|0
1842266|NCT00264004|6374761|P2|Overall Study|Other|2
1842267|NCT00264004|6374762|P1|Overall Study|Other|2
1842268|NCT00264004|6374759|P4|Overall Study|Withdrawal by Subject|2
1842269|NCT00264004|6374760|P3|Overall Study|Withdrawal by Subject|2
1842270|NCT00264004|6374761|P2|Overall Study|Withdrawal by Subject|1
1842271|NCT00264004|6374762|P1|Overall Study|Withdrawal by Subject|0
1842272|NCT00264004|6374759|P4|Overall Study|Adverse Event|4
1842273|NCT00264004|6374760|P3|Overall Study|Adverse Event|6
1842274|NCT00264004|6374761|P2|Overall Study|Adverse Event|3
1842275|NCT00264004|6374762|P1|Overall Study|Adverse Event|2
1842276|NCT00263887|6374790|P2|Overall Study|Lack of Efficacy|1
1842277|NCT00263887|6374791|P1|Overall Study|Lack of Efficacy|0
1842278|NCT00263887|6374790|P2|Overall Study|Disease progression|1
1842279|NCT00263887|6374791|P1|Overall Study|Disease progression|0
1842280|NCT00263887|6374790|P2|Overall Study|Adverse Event|2
1842281|NCT00263887|6374791|P1|Overall Study|Adverse Event|0
1842282|NCT00263887|6374790|P2|Overall Study|Too ill to attend visit|0
1842283|NCT00263887|6374791|P1|Overall Study|Too ill to attend visit|1
1842284|NCT00263887|6374790|P2|Overall Study|Lung transplantation|2
1842285|NCT00263887|6374791|P1|Overall Study|Lung transplantation|1
1842286|NCT00263887|6374790|P2|Overall Study|Withdrawal by Subject|1
1842287|NCT00263887|6374791|P1|Overall Study|Withdrawal by Subject|1
1842288|NCT00263757|6374799|P2|Overall Study|Adverse Event|3
1842289|NCT00263757|6374800|P1|Overall Study|Adverse Event|3
1842290|NCT00263757|6374799|P2|Overall Study|Screen failure|1
1842291|NCT00263757|6374800|P1|Overall Study|Screen failure|0
1842292|NCT00263757|6374799|P2|Overall Study|Withdrawal by Subject|4
1842293|NCT00263757|6374800|P1|Overall Study|Withdrawal by Subject|5
1842294|NCT00263666|6374812|P2|Overall Study|Withdrawal by Subject|1
1842295|NCT00263666|6374813|P1|Overall Study|Withdrawal by Subject|0
1842296|NCT00263666|6374812|P2|Overall Study|Lost to Follow-up|2
1842297|NCT00263666|6374813|P1|Overall Study|Lost to Follow-up|1
1842298|NCT00263666|6374812|P2|Overall Study|Adverse Event|8
1842299|NCT00263666|6374813|P1|Overall Study|Adverse Event|6
1842300|NCT00263588|6374866|P2|Overall Study|Sponsor terminated study|1
1842301|NCT00263588|6374867|P1|Overall Study|Sponsor terminated study|0
1842302|NCT00263588|6374866|P2|Overall Study|Investigator decision|15
1842303|NCT00263588|6374867|P1|Overall Study|Investigator decision|7
1842304|NCT00263588|6374866|P2|Overall Study|Protocol Violation|1
1842305|NCT00263588|6374867|P1|Overall Study|Protocol Violation|0
1842306|NCT00263588|6374866|P2|Overall Study|Withdrawal by Subject|4
1842307|NCT00263588|6374867|P1|Overall Study|Withdrawal by Subject|3
1842308|NCT00263588|6374866|P2|Overall Study|Lost to Follow-up|10
1842309|NCT00263588|6374867|P1|Overall Study|Lost to Follow-up|7
1842310|NCT00263588|6374866|P2|Overall Study|disease progression, coma, 1 unknown|11
1842311|NCT00263588|6374867|P1|Overall Study|disease progression, coma, 1 unknown|10
1842312|NCT00263588|6374866|P2|Overall Study|Death|90
1842313|NCT00263588|6374867|P1|Overall Study|Death|54
1842314|NCT00263328|6374893|P3|Overall Study|Adverse Event|4
1842315|NCT00263328|6374894|P2|Overall Study|Adverse Event|1
1842316|NCT00263328|6374895|P1|Overall Study|Adverse Event|1
1842317|NCT00263328|6374893|P3|Overall Study|Other|1
1842318|NCT00263328|6374894|P2|Overall Study|Other|0
1842319|NCT00263328|6374895|P1|Overall Study|Other|3
1842320|NCT00263328|6374893|P3|Overall Study|Withdrawal by Subject|1
1842321|NCT00263328|6374894|P2|Overall Study|Withdrawal by Subject|0
1842322|NCT00263328|6374895|P1|Overall Study|Withdrawal by Subject|3
1842323|NCT00263328|6374893|P3|Overall Study|Lost to Follow-up|0
1842324|NCT00263328|6374894|P2|Overall Study|Lost to Follow-up|1
1842325|NCT00263328|6374895|P1|Overall Study|Lost to Follow-up|1
1842326|NCT00263328|6374893|P3|Overall Study|Death|1
1842327|NCT00263328|6374894|P2|Overall Study|Death|0
1842328|NCT00263328|6374895|P1|Overall Study|Death|0
1842329|NCT00263211|6375053|P2|Overall Study|Disease Progression|1
1842330|NCT00263211|6375054|P1|Overall Study|Disease Progression|0
1842331|NCT00263211|6375053|P2|Overall Study|Protocol Violation|0
1842332|NCT00263211|6375054|P1|Overall Study|Protocol Violation|1
1842333|NCT00263211|6375053|P2|Overall Study|Withdrawal by Subject|0
1842334|NCT00263211|6375054|P1|Overall Study|Withdrawal by Subject|3
1842335|NCT00263211|6375053|P2|Overall Study|Death|0
1842336|NCT00263211|6375054|P1|Overall Study|Death|1
1842337|NCT00262951|6375105|P1|Overall Study|Off treatment for other disease|1
1842338|NCT00262951|6375105|P1|Overall Study|Alternative treatment|3
1842339|NCT00262951|6375105|P1|Overall Study|Withdrawal by Subject|1
1842340|NCT00262951|6375105|P1|Overall Study|Death|1
1842341|NCT00262951|6375105|P1|Overall Study|Adverse Event|7
1842342|NCT00262951|6375105|P1|Overall Study|Progressive disease/relapse|3
1842343|NCT00262925|6375110|P1|Overall Study|Other|1
1842344|NCT00262925|6375110|P1|Overall Study|alternative therapy|1
1842345|NCT00262925|6375110|P1|Overall Study|Death|2
1842346|NCT00262925|6375110|P1|Overall Study|Adverse Event|4
1842347|NCT00262925|6375110|P1|Overall Study|Lack of Efficacy|3
1842348|NCT00262873|6375116|P1|Overall Study|Withdrawal by Subject|5
1842349|NCT00262873|6375116|P1|Overall Study|Adverse Event|3
1842350|NCT00262860|6375127|P1|Overall Study|Adverse Event|2
1842351|NCT00262847|6375136|P3|Overall Study|Did not receive study treatment|4
1842352|NCT00262847|6375137|P2|Overall Study|Did not receive study treatment|1
1842353|NCT00262847|6375138|P1|Overall Study|Did not receive study treatment|4
1842354|NCT00262847|6375136|P3|Overall Study|Other Reasons|27
1842355|NCT00262847|6375137|P2|Overall Study|Other Reasons|88
1842356|NCT00262847|6375138|P1|Overall Study|Other Reasons|79
1842357|NCT00262847|6375136|P3|Overall Study|Concomitant disease|4
1842358|NCT00262847|6375137|P2|Overall Study|Concomitant disease|2
1842359|NCT00262847|6375138|P1|Overall Study|Concomitant disease|3
1842360|NCT00262847|6375136|P3|Overall Study|Death|11
1842361|NCT00262847|6375137|P2|Overall Study|Death|8
1842362|NCT00262847|6375138|P1|Overall Study|Death|8
1842363|NCT00262847|6375136|P3|Overall Study|Adverse Event|108
1842364|NCT00262847|6375137|P2|Overall Study|Adverse Event|88
1842365|NCT00262847|6375138|P1|Overall Study|Adverse Event|74
1842366|NCT00262847|6375136|P3|Overall Study|Patient Refusal|47
1842367|NCT00262847|6375137|P2|Overall Study|Patient Refusal|52
1842368|NCT00262847|6375138|P1|Overall Study|Patient Refusal|41
1842369|NCT00262847|6375136|P3|Overall Study|Disease Progression|195
1842370|NCT00262847|6375137|P2|Overall Study|Disease Progression|274
1842371|NCT00262847|6375138|P1|Overall Study|Disease Progression|309
1842374|NCT00262821|6375171|P2|Overall Study|Inevaluable - inadequate data|4
1842375|NCT00262821|6375172|P1|Overall Study|Inevaluable - inadequate data|0
1842376|NCT00262821|6375171|P2|Overall Study|Ineligible - required test not done|4
1842377|NCT00262821|6375172|P1|Overall Study|Ineligible - required test not done|1
1842378|NCT00262821|6375171|P2|Overall Study|Ineligible - elevated creatinine|2
1842379|NCT00262821|6375172|P1|Overall Study|Ineligible - elevated creatinine|0
1842380|NCT00262821|6375171|P2|Overall Study|Ineligible - inadequate pathology|3
1842381|NCT00262821|6375172|P1|Overall Study|Ineligible - inadequate pathology|1
1842382|NCT00262821|6375171|P2|Overall Study|Ineligible - wrong primary|1
1842383|NCT00262821|6375172|P1|Overall Study|Ineligible - wrong primary|0
1842384|NCT00262821|6375171|P2|Overall Study|Ineligible - wrong cell type|2
1842385|NCT00262821|6375172|P1|Overall Study|Ineligible - wrong cell type|2
1842386|NCT00262821|6375171|P2|Overall Study|Ineligible - wrong stage|3
1842387|NCT00262821|6375172|P1|Overall Study|Ineligible - wrong stage|0
1842388|NCT00262743|6375184|P2|Overall Study|Disease progression|3
1842389|NCT00262743|6375185|P1|Overall Study|Disease progression|0
1842390|NCT00262743|6375184|P2|Overall Study|Adverse Event|9
1842391|NCT00262743|6375185|P1|Overall Study|Adverse Event|0
1842392|NCT00262600|6375220|P3|Overall Study|Other|62
1842393|NCT00262600|6375221|P2|Overall Study|Other|59
1842394|NCT00262600|6375222|P1|Overall Study|Other|58
1842395|NCT00262600|6375220|P3|Overall Study|Not Treated|24
1842396|NCT00262600|6375221|P2|Overall Study|Not Treated|17
1842397|NCT00262600|6375222|P1|Overall Study|Not Treated|32
1842398|NCT00262600|6375220|P3|Overall Study|Withdrawal by Subject|139
1842399|NCT00262600|6375221|P2|Overall Study|Withdrawal by Subject|145
1842400|NCT00262600|6375222|P1|Overall Study|Withdrawal by Subject|128
1842401|NCT00262600|6375220|P3|Overall Study|Lost to Follow-up|41
1842402|NCT00262600|6375221|P2|Overall Study|Lost to Follow-up|31
1842403|NCT00262600|6375222|P1|Overall Study|Lost to Follow-up|17
1842404|NCT00262522|6375249|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1842405|NCT00262522|6375250|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
1842406|NCT00262522|6375251|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
1842407|NCT00262522|6375252|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
1842408|NCT00262522|6375249|P4|Study Start Through 96 Weeks|Virologic failure|0
1842409|NCT00262522|6375250|P3|Study Start Through 96 Weeks|Virologic failure|8
1842410|NCT00262522|6375251|P2|Study Start Through 96 Weeks|Virologic failure|0
1842411|NCT00262522|6375252|P1|Study Start Through 96 Weeks|Virologic failure|5
1842412|NCT00262522|6375249|P4|Study Start Through 96 Weeks|Death|0
1842413|NCT00262522|6375250|P3|Study Start Through 96 Weeks|Death|2
1842414|NCT00262522|6375251|P2|Study Start Through 96 Weeks|Death|0
1842415|NCT00262522|6375252|P1|Study Start Through 96 Weeks|Death|2
1842416|NCT00262522|6375249|P4|Study Start Through 96 Weeks|Noncompliance|0
1842417|NCT00262522|6375250|P3|Study Start Through 96 Weeks|Noncompliance|11
1842418|NCT00262522|6375251|P2|Study Start Through 96 Weeks|Noncompliance|0
1842419|NCT00262522|6375252|P1|Study Start Through 96 Weeks|Noncompliance|6
1842420|NCT00262522|6375249|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
1842421|NCT00262522|6375250|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
1842422|NCT00262522|6375251|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
1842423|NCT00262522|6375252|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
1842424|NCT00262522|6375249|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
1842425|NCT00262522|6375250|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
1842426|NCT00262522|6375251|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
1842427|NCT00262522|6375252|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
1842428|NCT00262522|6375249|P4|Study Start Through 96 Weeks|Adverse Event|0
1842429|NCT00262522|6375250|P3|Study Start Through 96 Weeks|Adverse Event|16
1842430|NCT00262522|6375251|P2|Study Start Through 96 Weeks|Adverse Event|0
1842431|NCT00262522|6375252|P1|Study Start Through 96 Weeks|Adverse Event|20
1842432|NCT00262522|6375249|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1842433|NCT00262522|6375250|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
1842434|NCT00262522|6375251|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
1842435|NCT00262522|6375252|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
1842436|NCT00262522|6375249|P4|Study Start Through 48 Weeks|Virologic failure|0
1842437|NCT00262522|6375250|P3|Study Start Through 48 Weeks|Virologic failure|4
1842438|NCT00262522|6375251|P2|Study Start Through 48 Weeks|Virologic failure|0
1842439|NCT00262522|6375252|P1|Study Start Through 48 Weeks|Virologic failure|2
1842440|NCT00262522|6375249|P4|Study Start Through 48 Weeks|Death|0
1842441|NCT00262522|6375250|P3|Study Start Through 48 Weeks|Death|1
1842442|NCT00262522|6375251|P2|Study Start Through 48 Weeks|Death|0
1842443|NCT00262522|6375252|P1|Study Start Through 48 Weeks|Death|2
1842444|NCT00262522|6375249|P4|Study Start Through 48 Weeks|Noncompliance|0
1842445|NCT00262522|6375250|P3|Study Start Through 48 Weeks|Noncompliance|8
1842446|NCT00262522|6375251|P2|Study Start Through 48 Weeks|Noncompliance|0
1842447|NCT00262522|6375252|P1|Study Start Through 48 Weeks|Noncompliance|3
1842448|NCT00262522|6375249|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
1842449|NCT00262522|6375250|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
1842450|NCT00262522|6375251|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
1842451|NCT00262522|6375252|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
1842452|NCT00262522|6375249|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
1842453|NCT00262522|6375250|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
1842454|NCT00262522|6375251|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
1842455|NCT00262522|6375252|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
1842456|NCT00262522|6375249|P4|Study Start Through 48 Weeks|Adverse Event|0
1842457|NCT00262522|6375250|P3|Study Start Through 48 Weeks|Adverse Event|10
1842458|NCT00262522|6375251|P2|Study Start Through 48 Weeks|Adverse Event|0
1842459|NCT00262522|6375252|P1|Study Start Through 48 Weeks|Adverse Event|16
1842460|NCT00262522|6375249|P4|Study Start Through 8 Weeks|Death|0
1842461|NCT00262522|6375250|P3|Study Start Through 8 Weeks|Death|0
1842462|NCT00262522|6375251|P2|Study Start Through 8 Weeks|Death|0
1842463|NCT00262522|6375252|P1|Study Start Through 8 Weeks|Death|1
1842464|NCT00262522|6375249|P4|Study Start Through 8 Weeks|Noncompliance|2
1842465|NCT00262522|6375250|P3|Study Start Through 8 Weeks|Noncompliance|2
1842466|NCT00262522|6375251|P2|Study Start Through 8 Weeks|Noncompliance|0
1842467|NCT00262522|6375252|P1|Study Start Through 8 Weeks|Noncompliance|0
1842468|NCT00262522|6375249|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
1842469|NCT00262522|6375250|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
1842470|NCT00262522|6375251|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
1842471|NCT00262522|6375252|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
1842472|NCT00262522|6375249|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
1842473|NCT00262522|6375250|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
1842474|NCT00262522|6375251|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
1842475|NCT00262522|6375252|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
1842476|NCT00262522|6375249|P4|Study Start Through 8 Weeks|Adverse Event|1
1842477|NCT00262522|6375250|P3|Study Start Through 8 Weeks|Adverse Event|3
1842478|NCT00262522|6375251|P2|Study Start Through 8 Weeks|Adverse Event|2
1842479|NCT00262522|6375252|P1|Study Start Through 8 Weeks|Adverse Event|1
1842480|NCT00262314|6375281|P1|Overall Study|Administrative withdrawal|30
1842481|NCT00262314|6375281|P1|Overall Study|Lost to Follow-up|70
1842482|NCT00262314|6375281|P1|Overall Study|Other|95
1842483|NCT00262314|6375281|P1|Overall Study|Patient's decision|92
1842484|NCT00262314|6375281|P1|Overall Study|Death|12
1842485|NCT00262314|6375281|P1|Overall Study|Changing physicians|38
1842486|NCT00262301|6375299|P3|Double-blind Phase|"worsening of HAE symptoms"|0
1842487|NCT00262301|6375300|P2|Double-blind Phase|"worsening of HAE symptoms"|1
1842488|NCT00262301|6375301|P1|Double-blind Phase|"worsening of HAE symptoms"|0
1842489|NCT00262301|6375299|P3|Double-blind Phase|Lost to Follow-up|0
1842490|NCT00262301|6375300|P2|Double-blind Phase|Lost to Follow-up|0
1842491|NCT00262301|6375301|P1|Double-blind Phase|Lost to Follow-up|1
1842492|NCT00262223|6375314|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
1842493|NCT00262223|6375315|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
1842494|NCT00262223|6375314|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
1842495|NCT00262223|6375315|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
1842496|NCT00262223|6375314|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
1842497|NCT00262223|6375315|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
1842498|NCT00262223|6375314|P2|Treatment Phase|Adverse Event|2
1842499|NCT00262223|6375315|P1|Treatment Phase|Adverse Event|1
1842500|NCT00262223|6375314|P2|Treatment Phase|Withdrawal by Subject|6
1842501|NCT00262223|6375315|P1|Treatment Phase|Withdrawal by Subject|3
1842502|NCT00262119|6375326|P3|Overall Study|Death|16
1842503|NCT00262119|6375327|P2|Overall Study|Death|19
1842504|NCT00262119|6375328|P1|Overall Study|Death|20
1842505|NCT00262119|6375326|P3|Overall Study|Lost to Follow-up|42
1842506|NCT00262119|6375327|P2|Overall Study|Lost to Follow-up|51
1842507|NCT00262119|6375328|P1|Overall Study|Lost to Follow-up|38
1842508|NCT00262080|6375348|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1842509|NCT00262080|6375349|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
1842510|NCT00262080|6375350|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
1842511|NCT00262080|6375348|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
1842512|NCT00262080|6375349|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
1842513|NCT00262080|6375350|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
1842514|NCT00262080|6375348|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
1842515|NCT00262080|6375349|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
1842516|NCT00262080|6375350|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
1842517|NCT00262080|6375348|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
1842518|NCT00262080|6375349|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
1842519|NCT00262080|6375350|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
1842520|NCT00262080|6375348|P3|Repeat Dose Treatment Period|Adverse Event|0
1842521|NCT00262080|6375349|P2|Repeat Dose Treatment Period|Adverse Event|0
1842522|NCT00262080|6375350|P1|Repeat Dose Treatment Period|Adverse Event|1
1842523|NCT00262080|6375348|P3|Double Blind Treatment Period|Lost to Follow-up|0
1842524|NCT00262080|6375349|P2|Double Blind Treatment Period|Lost to Follow-up|0
1842525|NCT00262080|6375350|P1|Double Blind Treatment Period|Lost to Follow-up|1
1842526|NCT00262067|6375370|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
1842527|NCT00262067|6375371|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
1842528|NCT00262067|6375372|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
1842529|NCT00262067|6375373|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
1842530|NCT00262067|6375370|P4|Overall Study|Sponsor's Decision to Terminate Study|0
1842531|NCT00262067|6375371|P3|Overall Study|Sponsor's Decision to Terminate Study|0
1842532|NCT00262067|6375372|P2|Overall Study|Sponsor's Decision to Terminate Study|0
1842533|NCT00262067|6375373|P1|Overall Study|Sponsor's Decision to Terminate Study|1
1842534|NCT00262067|6375370|P4|Overall Study|Lost to Follow-up|5
1842535|NCT00262067|6375371|P3|Overall Study|Lost to Follow-up|7
1842536|NCT00262067|6375372|P2|Overall Study|Lost to Follow-up|4
1842537|NCT00262067|6375373|P1|Overall Study|Lost to Follow-up|5
1842538|NCT00262067|6375370|P4|Overall Study|Death|99
1842539|NCT00262067|6375371|P3|Overall Study|Death|186
1842540|NCT00262067|6375372|P2|Overall Study|Death|89
1842541|NCT00262067|6375373|P1|Overall Study|Death|190
1842542|NCT00262041|6375407|P3|Overall Study|Unable to classify|0
1842543|NCT00262041|6375408|P2|Overall Study|Unable to classify|0
1842544|NCT00262041|6375409|P1|Overall Study|Unable to classify|1
1842545|NCT00262041|6375407|P3|Overall Study|Lost to Follow-up|5
1842546|NCT00262041|6375408|P2|Overall Study|Lost to Follow-up|1
1842547|NCT00262041|6375409|P1|Overall Study|Lost to Follow-up|1
1842548|NCT00262041|6375407|P3|Overall Study|Withdrawal by Subject|1
1842549|NCT00262041|6375408|P2|Overall Study|Withdrawal by Subject|3
1842550|NCT00262041|6375409|P1|Overall Study|Withdrawal by Subject|0
1842551|NCT00262028|6375438|P9|Overall Study|Unable to classify|1
1842552|NCT00262028|6375439|P8|Overall Study|Unable to classify|0
1842553|NCT00262028|6375440|P7|Overall Study|Unable to classify|0
1842554|NCT00262028|6375441|P6|Overall Study|Unable to classify|0
1842555|NCT00262028|6375442|P5|Overall Study|Unable to classify|0
1842556|NCT00262028|6375443|P4|Overall Study|Unable to classify|0
1842557|NCT00262028|6375444|P3|Overall Study|Unable to classify|0
1842558|NCT00262028|6375445|P2|Overall Study|Unable to classify|3
1842559|NCT00262028|6375446|P1|Overall Study|Unable to classify|0
1842560|NCT00262028|6375438|P9|Overall Study|Protocol Violation|0
1842561|NCT00262028|6375439|P8|Overall Study|Protocol Violation|0
1842562|NCT00262028|6375440|P7|Overall Study|Protocol Violation|0
1842563|NCT00262028|6375441|P6|Overall Study|Protocol Violation|0
1842564|NCT00262028|6375442|P5|Overall Study|Protocol Violation|0
1842565|NCT00262028|6375443|P4|Overall Study|Protocol Violation|1
1842566|NCT00262028|6375444|P3|Overall Study|Protocol Violation|0
1842567|NCT00262028|6375445|P2|Overall Study|Protocol Violation|0
1842568|NCT00262028|6375446|P1|Overall Study|Protocol Violation|0
1842569|NCT00262028|6375438|P9|Overall Study|Administrative Reason|10
1842570|NCT00262028|6375439|P8|Overall Study|Administrative Reason|6
1842571|NCT00262028|6375440|P7|Overall Study|Administrative Reason|4
1842572|NCT00262028|6375441|P6|Overall Study|Administrative Reason|7
1842573|NCT00262028|6375442|P5|Overall Study|Administrative Reason|6
1842574|NCT00262028|6375443|P4|Overall Study|Administrative Reason|12
1842575|NCT00262028|6375444|P3|Overall Study|Administrative Reason|9
1842576|NCT00262028|6375445|P2|Overall Study|Administrative Reason|14
1842577|NCT00262028|6375446|P1|Overall Study|Administrative Reason|11
1842578|NCT00262028|6375438|P9|Overall Study|Lost to Follow-up|6
1842579|NCT00262028|6375439|P8|Overall Study|Lost to Follow-up|5
1842580|NCT00262028|6375440|P7|Overall Study|Lost to Follow-up|3
1842581|NCT00262028|6375441|P6|Overall Study|Lost to Follow-up|3
1842582|NCT00262028|6375442|P5|Overall Study|Lost to Follow-up|4
1842583|NCT00262028|6375443|P4|Overall Study|Lost to Follow-up|5
1842584|NCT00262028|6375444|P3|Overall Study|Lost to Follow-up|5
1842585|NCT00262028|6375445|P2|Overall Study|Lost to Follow-up|7
1842586|NCT00262028|6375446|P1|Overall Study|Lost to Follow-up|7
1842587|NCT00262028|6375438|P9|Overall Study|Withdrawal by Subject|2
1842588|NCT00262028|6375439|P8|Overall Study|Withdrawal by Subject|7
1842589|NCT00262028|6375440|P7|Overall Study|Withdrawal by Subject|5
1842590|NCT00262028|6375441|P6|Overall Study|Withdrawal by Subject|3
1842591|NCT00262028|6375442|P5|Overall Study|Withdrawal by Subject|2
1842592|NCT00262028|6375443|P4|Overall Study|Withdrawal by Subject|5
1842593|NCT00262028|6375444|P3|Overall Study|Withdrawal by Subject|6
1842594|NCT00262028|6375445|P2|Overall Study|Withdrawal by Subject|3
1842595|NCT00262028|6375446|P1|Overall Study|Withdrawal by Subject|6
1842596|NCT00262002|6375508|P7|Overall Study|Unable to classify|2
1842597|NCT00262002|6375509|P6|Overall Study|Unable to classify|0
1842598|NCT00262002|6375510|P5|Overall Study|Unable to classify|0
1842599|NCT00262002|6375511|P4|Overall Study|Unable to classify|0
1842600|NCT00262002|6375512|P3|Overall Study|Unable to classify|0
1842601|NCT00262002|6375513|P2|Overall Study|Unable to classify|0
1842602|NCT00262002|6375514|P1|Overall Study|Unable to classify|0
1842603|NCT00262002|6375508|P7|Overall Study|Protocol Violation|2
1842604|NCT00262002|6375509|P6|Overall Study|Protocol Violation|3
1842605|NCT00262002|6375510|P5|Overall Study|Protocol Violation|5
1842606|NCT00262002|6375511|P4|Overall Study|Protocol Violation|2
1842607|NCT00262002|6375512|P3|Overall Study|Protocol Violation|0
1842608|NCT00262002|6375513|P2|Overall Study|Protocol Violation|2
1842609|NCT00262002|6375514|P1|Overall Study|Protocol Violation|3
1842610|NCT00262002|6375508|P7|Overall Study|Inapropriate enrollment|0
1842611|NCT00262002|6375509|P6|Overall Study|Inapropriate enrollment|0
1842612|NCT00262002|6375510|P5|Overall Study|Inapropriate enrollment|0
1842613|NCT00262002|6375511|P4|Overall Study|Inapropriate enrollment|0
1842614|NCT00262002|6375512|P3|Overall Study|Inapropriate enrollment|0
1842615|NCT00262002|6375513|P2|Overall Study|Inapropriate enrollment|1
1842616|NCT00262002|6375514|P1|Overall Study|Inapropriate enrollment|0
1842617|NCT00262002|6375508|P7|Overall Study|Lost to Follow-up|0
1842618|NCT00262002|6375509|P6|Overall Study|Lost to Follow-up|1
1842619|NCT00262002|6375510|P5|Overall Study|Lost to Follow-up|0
1842620|NCT00262002|6375511|P4|Overall Study|Lost to Follow-up|2
1842621|NCT00262002|6375512|P3|Overall Study|Lost to Follow-up|0
1842622|NCT00262002|6375513|P2|Overall Study|Lost to Follow-up|0
1842623|NCT00262002|6375514|P1|Overall Study|Lost to Follow-up|2
1842624|NCT00262002|6375508|P7|Overall Study|Withdrawal by Subject|2
1842625|NCT00262002|6375509|P6|Overall Study|Withdrawal by Subject|2
1842626|NCT00262002|6375510|P5|Overall Study|Withdrawal by Subject|2
1842627|NCT00262002|6375511|P4|Overall Study|Withdrawal by Subject|1
1842628|NCT00262002|6375512|P3|Overall Study|Withdrawal by Subject|0
1842629|NCT00262002|6375513|P2|Overall Study|Withdrawal by Subject|2
1842630|NCT00262002|6375514|P1|Overall Study|Withdrawal by Subject|4
1842631|NCT00262002|6375508|P7|Overall Study|Adverse Event|0
1842632|NCT00262002|6375509|P6|Overall Study|Adverse Event|1
1842633|NCT00262002|6375510|P5|Overall Study|Adverse Event|0
1842634|NCT00262002|6375511|P4|Overall Study|Adverse Event|0
1842635|NCT00262002|6375512|P3|Overall Study|Adverse Event|0
1842636|NCT00262002|6375513|P2|Overall Study|Adverse Event|1
1842637|NCT00262002|6375514|P1|Overall Study|Adverse Event|2
1842638|NCT00261950|6375607|P1|Overall Study|Protocol specified Criteria|11
1842639|NCT00261950|6375607|P1|Overall Study|Physician Decision|1
1842640|NCT00261950|6375607|P1|Overall Study|Other|1
1842641|NCT00261950|6375607|P1|Overall Study|Withdrawal by Subject|5
1842642|NCT00261950|6375607|P1|Overall Study|Death|6
1842643|NCT00261950|6375607|P1|Overall Study|Lost to Follow-up|2
1842644|NCT00261846|6375632|P12|Period 2: Part 2 (Efficacy)|Extension study|1
1842645|NCT00261846|6375633|P11|Period 2: Part 2 (Efficacy)|Extension study|1
1842646|NCT00261846|6375634|P10|Period 2: Part 2 (Efficacy)|Extension study|9
1842647|NCT00261846|6375635|P9|Period 2: Part 2 (Efficacy)|Extension study|5
1842648|NCT00261846|6375636|P8|Period 2: Part 2 (Efficacy)|Extension study|9
1842649|NCT00261846|6375637|P7|Period 2: Part 2 (Efficacy)|Extension study|4
1842650|NCT00261846|6375638|P6|Period 2: Part 2 (Efficacy)|Extension study|0
1842651|NCT00261846|6375639|P5|Period 2: Part 2 (Efficacy)|Extension study|27
1842652|NCT00261846|6375640|P4|Period 2: Part 2 (Efficacy)|Extension study|61
1842653|NCT00261846|6375641|P3|Period 2: Part 2 (Efficacy)|Extension study|0
1842654|NCT00261846|6375642|P2|Period 2: Part 2 (Efficacy)|Extension study|0
1842655|NCT00261846|6375643|P1|Period 2: Part 2 (Efficacy)|Extension study|0
1842656|NCT00261846|6375632|P12|Period 2: Part 2 (Efficacy)|Death|22
1842657|NCT00261846|6375633|P11|Period 2: Part 2 (Efficacy)|Death|44
1842658|NCT00261846|6375634|P10|Period 2: Part 2 (Efficacy)|Death|30
1842659|NCT00261846|6375635|P9|Period 2: Part 2 (Efficacy)|Death|3
1842660|NCT00261846|6375636|P8|Period 2: Part 2 (Efficacy)|Death|12
1842661|NCT00261846|6375637|P7|Period 2: Part 2 (Efficacy)|Death|10
1842662|NCT00261846|6375638|P6|Period 2: Part 2 (Efficacy)|Death|1
1842663|NCT00261846|6375639|P5|Period 2: Part 2 (Efficacy)|Death|7
1842664|NCT00261846|6375640|P4|Period 2: Part 2 (Efficacy)|Death|37
1842665|NCT00261846|6375641|P3|Period 2: Part 2 (Efficacy)|Death|0
1842666|NCT00261846|6375642|P2|Period 2: Part 2 (Efficacy)|Death|0
1842667|NCT00261846|6375643|P1|Period 2: Part 2 (Efficacy)|Death|0
1842668|NCT00261846|6375632|P12|Period 2: Part 2 (Efficacy)|Other|0
1842669|NCT00261846|6375633|P11|Period 2: Part 2 (Efficacy)|Other|0
1842670|NCT00261846|6375634|P10|Period 2: Part 2 (Efficacy)|Other|4
1842671|NCT00261846|6375635|P9|Period 2: Part 2 (Efficacy)|Other|4
1842672|NCT00261846|6375636|P8|Period 2: Part 2 (Efficacy)|Other|5
1842673|NCT00261846|6375637|P7|Period 2: Part 2 (Efficacy)|Other|1
1842674|NCT00261846|6375638|P6|Period 2: Part 2 (Efficacy)|Other|0
1842675|NCT00261846|6375639|P5|Period 2: Part 2 (Efficacy)|Other|4
1842676|NCT00261846|6375640|P4|Period 2: Part 2 (Efficacy)|Other|15
1842677|NCT00261846|6375641|P3|Period 2: Part 2 (Efficacy)|Other|0
1842678|NCT00261846|6375642|P2|Period 2: Part 2 (Efficacy)|Other|0
1842679|NCT00261846|6375643|P1|Period 2: Part 2 (Efficacy)|Other|0
1842680|NCT00261846|6375632|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1842681|NCT00261846|6375633|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1842682|NCT00261846|6375634|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1842683|NCT00261846|6375635|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
1842684|NCT00261846|6375636|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1842685|NCT00261846|6375637|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1842686|NCT00261846|6375638|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1842687|NCT00261846|6375639|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
1842688|NCT00261846|6375640|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
1842689|NCT00261846|6375641|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1842690|NCT00261846|6375642|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1842691|NCT00261846|6375643|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
1842692|NCT00261846|6375632|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1842693|NCT00261846|6375633|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1842694|NCT00261846|6375634|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
1842695|NCT00261846|6375635|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1842696|NCT00261846|6375636|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1842697|NCT00261846|6375637|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
1842698|NCT00261846|6375638|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
1842699|NCT00261846|6375639|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
1842700|NCT00261846|6375640|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
1842701|NCT00261846|6375641|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1842702|NCT00261846|6375642|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1842703|NCT00261846|6375643|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
1842704|NCT00261846|6375632|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842705|NCT00261846|6375633|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842706|NCT00261846|6375634|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842707|NCT00261846|6375635|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1842708|NCT00261846|6375636|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842709|NCT00261846|6375637|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842710|NCT00261846|6375638|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842711|NCT00261846|6375639|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842712|NCT00261846|6375640|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
1842713|NCT00261846|6375641|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842714|NCT00261846|6375642|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842715|NCT00261846|6375643|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
1842716|NCT00261846|6375632|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842717|NCT00261846|6375633|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842718|NCT00261846|6375634|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842719|NCT00261846|6375635|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842720|NCT00261846|6375636|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842721|NCT00261846|6375637|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842722|NCT00261846|6375638|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842723|NCT00261846|6375639|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842724|NCT00261846|6375640|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
1842725|NCT00261846|6375641|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
1842726|NCT00261846|6375642|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1842727|NCT00261846|6375643|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
1842728|NCT00261833|6375902|P2|Overall Study|Not interested in being participant|1
1842729|NCT00261833|6375903|P1|Overall Study|Not interested in being participant|0
1842730|NCT00261833|6375902|P2|Overall Study|Missing reason|0
1842731|NCT00261833|6375903|P1|Overall Study|Missing reason|1
1842732|NCT00261833|6375902|P2|Overall Study|Lung transplantation|1
1842733|NCT00261833|6375903|P1|Overall Study|Lung transplantation|1
1842734|NCT00261833|6375902|P2|Overall Study|Suspicion of pulmonary cancer|1
1842735|NCT00261833|6375903|P1|Overall Study|Suspicion of pulmonary cancer|0
1842736|NCT00261833|6375902|P2|Overall Study|Protocol Violation|1
1842737|NCT00261833|6375903|P1|Overall Study|Protocol Violation|0
1842738|NCT00261833|6375902|P2|Overall Study|Withdrawal by Subject|7
1842739|NCT00261833|6375903|P1|Overall Study|Withdrawal by Subject|5
1842740|NCT00261833|6375902|P2|Overall Study|Adverse Event|4
1842741|NCT00261833|6375903|P1|Overall Study|Adverse Event|1
1842742|NCT00261833|6375902|P2|Overall Study|Death|3
1842743|NCT00261833|6375903|P1|Overall Study|Death|1
1842744|NCT00261716|6375937|P2|Overall Study|Lost to Follow-up|2
1842745|NCT00261716|6375938|P1|Overall Study|Lost to Follow-up|0
1842746|NCT00261716|6375937|P2|Overall Study|Withdrawal by Subject|8
1842747|NCT00261716|6375938|P1|Overall Study|Withdrawal by Subject|6
1842748|NCT00261495|6375958|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
1842749|NCT00261495|6375959|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
1842750|NCT00261495|6375958|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
1842751|NCT00261495|6375959|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
1842752|NCT00261495|6375958|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
1842753|NCT00261495|6375959|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
1842754|NCT00261495|6375958|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
1842755|NCT00261495|6375959|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
1842911|NCT00260065|6376485|P1|Overall Study|Progressive Disease|22
1842756|NCT00261495|6375958|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
1842757|NCT00261495|6375959|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
1842758|NCT00261495|6375958|P2|Extension Phase (Weeks 24 to 52)|Other|2
1842759|NCT00261495|6375959|P1|Extension Phase (Weeks 24 to 52)|Other|4
1842760|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
1842761|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
1842762|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
1842763|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
1842764|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1842765|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
1842766|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
1842767|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
1842768|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
1842769|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
1842770|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
1842771|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
1842772|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
1842773|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
1842774|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
1842775|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
1842776|NCT00261495|6375958|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
1842777|NCT00261495|6375959|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
1842778|NCT00261495|6375958|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
1842779|NCT00261495|6375959|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
1842780|NCT00261495|6375958|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
1842781|NCT00261495|6375959|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
1842782|NCT00261495|6375958|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
1842783|NCT00261495|6375959|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
1842784|NCT00261495|6375958|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1842785|NCT00261495|6375959|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
1842786|NCT00261495|6375958|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
1842787|NCT00261495|6375959|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
1842788|NCT00261495|6375958|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
1842789|NCT00261495|6375959|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
1842790|NCT00261443|6376123|P3|4: Extension Phase|Lost to Follow-up|0
1842791|NCT00261443|6376124|P2|4: Extension Phase|Lost to Follow-up|1
1842792|NCT00261443|6376125|P1|4: Extension Phase|Lost to Follow-up|0
1842793|NCT00261443|6376123|P3|4: Extension Phase|Withdrawal by Subject|2
1842794|NCT00261443|6376124|P2|4: Extension Phase|Withdrawal by Subject|1
1842795|NCT00261443|6376125|P1|4: Extension Phase|Withdrawal by Subject|0
1842796|NCT00261443|6376123|P3|4: Extension Phase|Adverse Event|0
1842797|NCT00261443|6376124|P2|4: Extension Phase|Adverse Event|1
1842798|NCT00261443|6376125|P1|4: Extension Phase|Adverse Event|0
1842799|NCT00261443|6376123|P3|3: Assessment of Relapse|Other Reasons|3
1842800|NCT00261443|6376124|P2|3: Assessment of Relapse|Other Reasons|4
1842801|NCT00261443|6376125|P1|3: Assessment of Relapse|Other Reasons|0
1842802|NCT00261443|6376123|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
1842803|NCT00261443|6376124|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1842804|NCT00261443|6376125|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
1842805|NCT00261443|6376123|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
1842806|NCT00261443|6376124|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
1842807|NCT00261443|6376125|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
1842808|NCT00261443|6376123|P3|3: Assessment of Relapse|Pregnancy|1
1842809|NCT00261443|6376124|P2|3: Assessment of Relapse|Pregnancy|2
1842810|NCT00261443|6376125|P1|3: Assessment of Relapse|Pregnancy|0
1842811|NCT00261443|6376123|P3|3: Assessment of Relapse|Poor/Noncompliance|3
1842812|NCT00261443|6376124|P2|3: Assessment of Relapse|Poor/Noncompliance|5
1842813|NCT00261443|6376125|P1|3: Assessment of Relapse|Poor/Noncompliance|0
1842814|NCT00261443|6376123|P3|3: Assessment of Relapse|Lost to Follow-up|6
1842815|NCT00261443|6376124|P2|3: Assessment of Relapse|Lost to Follow-up|7
1842816|NCT00261443|6376125|P1|3: Assessment of Relapse|Lost to Follow-up|0
1842817|NCT00261443|6376123|P3|3: Assessment of Relapse|Death|1
1842818|NCT00261443|6376124|P2|3: Assessment of Relapse|Death|0
1842819|NCT00261443|6376125|P1|3: Assessment of Relapse|Death|0
1842820|NCT00261443|6376123|P3|3: Assessment of Relapse|Withdrawal by Subject|15
1842821|NCT00261443|6376124|P2|3: Assessment of Relapse|Withdrawal by Subject|14
1842822|NCT00261443|6376125|P1|3: Assessment of Relapse|Withdrawal by Subject|0
1842823|NCT00261443|6376123|P3|3: Assessment of Relapse|Adverse Event|19
1842824|NCT00261443|6376124|P2|3: Assessment of Relapse|Adverse Event|15
1842825|NCT00261443|6376125|P1|3: Assessment of Relapse|Adverse Event|0
1842826|NCT00261443|6376123|P3|3: Assessment of Relapse|Lack of Efficacy|14
1842827|NCT00261443|6376124|P2|3: Assessment of Relapse|Lack of Efficacy|31
1842828|NCT00261443|6376125|P1|3: Assessment of Relapse|Lack of Efficacy|0
1842829|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Other Reasons|0
1842830|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Other Reasons|0
1842831|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Other Reasons|13
1842832|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1842833|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
1842834|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
1842835|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1842836|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
1842837|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
1842838|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Pregnancy|0
1842839|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Pregnancy|0
1842840|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Pregnancy|1
1842841|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1842842|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
1842843|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
1842844|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1842845|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
1842846|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
1842847|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1842848|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
1842849|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
1842850|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Adverse Event|0
1842851|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Adverse Event|0
1842852|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Adverse Event|93
1842853|NCT00261443|6376123|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1842854|NCT00261443|6376124|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
1842855|NCT00261443|6376125|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
1842856|NCT00261443|6376123|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
1842857|NCT00261443|6376124|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
1842858|NCT00261443|6376125|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
1842859|NCT00261443|6376123|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1842860|NCT00261443|6376124|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
1842861|NCT00261443|6376125|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
1842862|NCT00261443|6376123|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
1842863|NCT00261443|6376124|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
1842864|NCT00261443|6376125|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
1842865|NCT00261443|6376123|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1842866|NCT00261443|6376124|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
1842867|NCT00261443|6376125|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
1842868|NCT00261443|6376123|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1842869|NCT00261443|6376124|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
1842870|NCT00261443|6376125|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
1842871|NCT00261443|6376123|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1842872|NCT00261443|6376124|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
1842873|NCT00261443|6376125|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
1842874|NCT00261443|6376123|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
1842875|NCT00261443|6376124|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
1842876|NCT00261443|6376125|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
1842877|NCT00260832|6376393|P2|Overall Study|Protocol Violation|1
1842878|NCT00260832|6376394|P1|Overall Study|Protocol Violation|3
1842879|NCT00260832|6376393|P2|Overall Study|Other|7
1842880|NCT00260832|6376394|P1|Overall Study|Other|10
1842881|NCT00260832|6376393|P2|Overall Study|Death|62
1842882|NCT00260832|6376394|P1|Overall Study|Death|43
1842883|NCT00260832|6376393|P2|Overall Study|Physician Decision|9
1842884|NCT00260832|6376394|P1|Overall Study|Physician Decision|15
1842885|NCT00260832|6376393|P2|Overall Study|Withdrawal by Subject|17
1842886|NCT00260832|6376394|P1|Overall Study|Withdrawal by Subject|15
1842887|NCT00260832|6376393|P2|Overall Study|Progression|96
1842888|NCT00260832|6376394|P1|Overall Study|Progression|116
1842889|NCT00260832|6376393|P2|Overall Study|Adverse Event|19
1842890|NCT00260832|6376394|P1|Overall Study|Adverse Event|26
1842891|NCT00260533|6376423|P2|Overall Study|Other|3
1842892|NCT00260533|6376424|P1|Overall Study|Other|3
1842893|NCT00260429|6376432|P2|Overall Study|scheduled hand surgery|0
1842894|NCT00260429|6376433|P1|Overall Study|scheduled hand surgery|1
1842895|NCT00260429|6376432|P2|Overall Study|failure to follow appointments|0
1842896|NCT00260429|6376433|P1|Overall Study|failure to follow appointments|1
1842897|NCT00260208|6376441|P2|Overall Study|Missing|16
1842898|NCT00260208|6376442|P1|Overall Study|Missing|18
1842899|NCT00260208|6376441|P2|Overall Study|Death|10
1842900|NCT00260208|6376442|P1|Overall Study|Death|12
1842901|NCT00260208|6376441|P2|Overall Study|Lost to Follow-up|1
1842902|NCT00260208|6376442|P1|Overall Study|Lost to Follow-up|6
1842903|NCT00260208|6376441|P2|Overall Study|Subject withdrew consent|7
1842904|NCT00260208|6376442|P1|Overall Study|Subject withdrew consent|11
1842905|NCT00260065|6376485|P1|Overall Study|Medication Noncompliance|1
1842906|NCT00260065|6376485|P1|Overall Study|Not otherwise specified|8
1842907|NCT00260065|6376485|P1|Overall Study|Physician Decision|19
1842908|NCT00260065|6376485|P1|Overall Study|Withdrawal by Subject|13
1842909|NCT00260065|6376485|P1|Overall Study|Death|13
1842910|NCT00260065|6376485|P1|Overall Study|Adverse Event|17
1842912|NCT00259857|6376492|P2|24 Months Treatment|Lost to Follow-up|3
1842913|NCT00259857|6376493|P1|24 Months Treatment|Lost to Follow-up|0
1842914|NCT00259857|6376492|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
1842915|NCT00259857|6376493|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
1842916|NCT00259740|6376511|P2|Overall Study|Requirement for alternative therapy|4
1842917|NCT00259740|6376512|P1|Overall Study|Requirement for alternative therapy|0
1842918|NCT00259740|6376511|P2|Overall Study|Other|0
1842919|NCT00259740|6376512|P1|Overall Study|Other|3
1842920|NCT00259740|6376511|P2|Overall Study|Ongoing|3
1842921|NCT00259740|6376512|P1|Overall Study|Ongoing|17
1842922|NCT00259740|6376511|P2|Overall Study|Disease progression|36
1842923|NCT00259740|6376512|P1|Overall Study|Disease progression|19
1842924|NCT00259740|6376511|P2|Overall Study|Death|1
1842925|NCT00259740|6376512|P1|Overall Study|Death|1
1842926|NCT00259740|6376511|P2|Overall Study|Withdrawal by Subject|6
1842927|NCT00259740|6376512|P1|Overall Study|Withdrawal by Subject|2
1842928|NCT00259740|6376511|P2|Overall Study|Adverse Event|2
1842929|NCT00259740|6376512|P1|Overall Study|Adverse Event|0
1842930|NCT00259740|6376511|P2|Overall Study|Physician Decision|1
1842931|NCT00259740|6376512|P1|Overall Study|Physician Decision|1
1842932|NCT00259649|6376522|P1|Overall Study|irregular menses|3
1842933|NCT00259649|6376522|P1|Overall Study|Lost to Follow-up|7
1842934|NCT00259610|6376530|P4|Overall Study|Serious Adverse Event|2
1842935|NCT00259610|6376531|P3|Overall Study|Serious Adverse Event|2
1842936|NCT00259610|6376532|P2|Overall Study|Serious Adverse Event|2
1842937|NCT00259610|6376533|P1|Overall Study|Serious Adverse Event|8
1842938|NCT00259610|6376530|P4|Overall Study|Adverse Event|2
1842939|NCT00259610|6376531|P3|Overall Study|Adverse Event|5
1842940|NCT00259610|6376532|P2|Overall Study|Adverse Event|4
1842941|NCT00259610|6376533|P1|Overall Study|Adverse Event|3
1842942|NCT00259610|6376530|P4|Overall Study|non medical reason|3
1842943|NCT00259610|6376531|P3|Overall Study|non medical reason|10
1842944|NCT00259610|6376532|P2|Overall Study|non medical reason|2
1842945|NCT00259610|6376533|P1|Overall Study|non medical reason|6
1842946|NCT00259610|6376530|P4|Overall Study|Death|0
1842947|NCT00259610|6376531|P3|Overall Study|Death|2
1842948|NCT00259610|6376532|P2|Overall Study|Death|1
1842949|NCT00259610|6376533|P1|Overall Study|Death|1
1842950|NCT00259610|6376530|P4|Overall Study|Physician Decision|2
1842951|NCT00259610|6376531|P3|Overall Study|Physician Decision|7
1842952|NCT00259610|6376532|P2|Overall Study|Physician Decision|4
1842953|NCT00259610|6376533|P1|Overall Study|Physician Decision|6
1842954|NCT00259610|6376530|P4|Overall Study|Lost to Follow-up|15
1842955|NCT00259610|6376531|P3|Overall Study|Lost to Follow-up|18
1842956|NCT00259610|6376532|P2|Overall Study|Lost to Follow-up|8
1842957|NCT00259610|6376533|P1|Overall Study|Lost to Follow-up|19
1842958|NCT00259610|6376530|P4|Overall Study|Withdrawal by Subject|19
1842959|NCT00259610|6376531|P3|Overall Study|Withdrawal by Subject|29
1842960|NCT00259610|6376532|P2|Overall Study|Withdrawal by Subject|25
1842961|NCT00259610|6376533|P1|Overall Study|Withdrawal by Subject|33
1842962|NCT00259298|6376547|P1|Overall Study|Physician Decision|2
1842963|NCT00259298|6376547|P1|Overall Study|Withdrawal by Subject|1
1842964|NCT00259272|6376565|P4|Overall Study|Lost to Follow-up|1
1842965|NCT00259272|6376566|P3|Overall Study|Lost to Follow-up|0
1842966|NCT00259272|6376567|P2|Overall Study|Lost to Follow-up|0
1842967|NCT00259272|6376568|P1|Overall Study|Lost to Follow-up|1
1842968|NCT00259272|6376565|P4|Overall Study|Withdrawal by Subject|7
1842969|NCT00259272|6376566|P3|Overall Study|Withdrawal by Subject|2
1842970|NCT00259272|6376567|P2|Overall Study|Withdrawal by Subject|2
1842971|NCT00259272|6376568|P1|Overall Study|Withdrawal by Subject|4
1842972|NCT00259272|6376565|P4|Overall Study|Sponsor Decision|0
1842973|NCT00259272|6376566|P3|Overall Study|Sponsor Decision|0
1842974|NCT00259272|6376567|P2|Overall Study|Sponsor Decision|1
1842975|NCT00259272|6376568|P1|Overall Study|Sponsor Decision|0
1842976|NCT00259272|6376565|P4|Overall Study|Protocol Violation|1
1842977|NCT00259272|6376566|P3|Overall Study|Protocol Violation|0
1842978|NCT00259272|6376567|P2|Overall Study|Protocol Violation|0
1842979|NCT00259272|6376568|P1|Overall Study|Protocol Violation|2
1842980|NCT00259272|6376565|P4|Overall Study|Physician Decision|3
1842981|NCT00259272|6376566|P3|Overall Study|Physician Decision|1
1842982|NCT00259272|6376567|P2|Overall Study|Physician Decision|2
1842983|NCT00259272|6376568|P1|Overall Study|Physician Decision|1
1842984|NCT00259272|6376565|P4|Overall Study|Lack of Efficacy|6
1842985|NCT00259272|6376566|P3|Overall Study|Lack of Efficacy|2
1842986|NCT00259272|6376567|P2|Overall Study|Lack of Efficacy|1
1842987|NCT00259272|6376568|P1|Overall Study|Lack of Efficacy|5
1842988|NCT00259272|6376565|P4|Overall Study|Adverse Event|3
1842989|NCT00259272|6376566|P3|Overall Study|Adverse Event|0
1842990|NCT00259272|6376567|P2|Overall Study|Adverse Event|1
1842991|NCT00259272|6376568|P1|Overall Study|Adverse Event|2
1842992|NCT00259012|6376664|P2|Overall Study|Protocol Violation|1
1842993|NCT00259012|6376665|P1|Overall Study|Protocol Violation|1
1842994|NCT00259012|6376664|P2|Overall Study|Lost to Follow-up|1
1842995|NCT00259012|6376665|P1|Overall Study|Lost to Follow-up|0
1842996|NCT00259012|6376664|P2|Overall Study|Physician Decision|1
1842997|NCT00259012|6376665|P1|Overall Study|Physician Decision|0
1842998|NCT00259012|6376664|P2|Overall Study|Withdrawal by Subject|0
1842999|NCT00259012|6376665|P1|Overall Study|Withdrawal by Subject|1
1843000|NCT00259012|6376664|P2|Overall Study|Adverse Event|1
1843001|NCT00259012|6376665|P1|Overall Study|Adverse Event|0
1843002|NCT00258960|6376697|P1|Overall Study|Mistake|2
1843003|NCT00258960|6376697|P1|Overall Study|Withdrawal by Subject|1
1843004|NCT00258960|6376697|P1|Overall Study|Physician Decision|1
1843005|NCT00258960|6376697|P1|Overall Study|Adverse Event|4
1843006|NCT00258960|6376697|P1|Overall Study|Disease Progression|7
1843007|NCT00258960|6376697|P1|Overall Study|Death|2
1843008|NCT00258895|6376713|P2|Overall Study|Withdrawal by Subject|0
1843009|NCT00258895|6376714|P1|Overall Study|Withdrawal by Subject|1
1843010|NCT00258895|6376713|P2|Overall Study|Protocol Violation|2
1843011|NCT00258895|6376714|P1|Overall Study|Protocol Violation|6
1843012|NCT00258895|6376713|P2|Overall Study|Lost to Follow-up|1
1843013|NCT00258895|6376714|P1|Overall Study|Lost to Follow-up|3
1843014|NCT00258856|6376750|P4|Overall Study|Non-compliance|1
1843015|NCT00258856|6376751|P3|Overall Study|Non-compliance|0
1843016|NCT00258856|6376752|P2|Overall Study|Non-compliance|0
1843017|NCT00258856|6376753|P1|Overall Study|Non-compliance|2
1843018|NCT00258856|6376750|P4|Overall Study|Lost to Follow-up|0
1843019|NCT00258856|6376751|P3|Overall Study|Lost to Follow-up|2
1843020|NCT00258856|6376752|P2|Overall Study|Lost to Follow-up|0
1843021|NCT00258856|6376753|P1|Overall Study|Lost to Follow-up|1
1843022|NCT00258674|6376794|P3|Overall Study|Death|34
1843023|NCT00258674|6376795|P2|Overall Study|Death|53
1843024|NCT00258674|6376796|P1|Overall Study|Death|32
1843025|NCT00258440|6376855|P3|Overall Study|Withdrawal by Subject|1
1843026|NCT00258440|6376856|P2|Overall Study|Withdrawal by Subject|0
1843027|NCT00258440|6376857|P1|Overall Study|Withdrawal by Subject|0
1843028|NCT00258154|6376895|P2|Overall Study|Patient Moved|1
1843029|NCT00258154|6376896|P1|Overall Study|Patient Moved|3
1843030|NCT00258154|6376895|P2|Overall Study|Withdrawal by Subject|4
1843031|NCT00258154|6376896|P1|Overall Study|Withdrawal by Subject|3
1843032|NCT00258154|6376895|P2|Overall Study|Protocol Violation|1
1843033|NCT00258154|6376896|P1|Overall Study|Protocol Violation|2
1843034|NCT00258154|6376895|P2|Overall Study|Lost to Follow-up|1
1843035|NCT00258154|6376896|P1|Overall Study|Lost to Follow-up|0
1843036|NCT00258154|6376895|P2|Overall Study|Adverse Event|0
1843037|NCT00258154|6376896|P1|Overall Study|Adverse Event|1
1843038|NCT00257920|6376991|P2|Period: Second Intervention|Other|1
1843039|NCT00257920|6376992|P1|Period: Second Intervention|Other|2
1843040|NCT00257920|6376991|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
1843041|NCT00257920|6376992|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
1843042|NCT00257660|6377048|P2|Overall Study|No longer wanted to do blood draws|0
1843043|NCT00257660|6377049|P1|Overall Study|No longer wanted to do blood draws|1
1843044|NCT00257660|6377048|P2|Overall Study|PI & Subject Schedule Conflicts|0
1843045|NCT00257660|6377049|P1|Overall Study|PI & Subject Schedule Conflicts|1
1843046|NCT00257660|6377048|P2|Overall Study|Lost to Follow-up|0
1843047|NCT00257660|6377049|P1|Overall Study|Lost to Follow-up|1
1843048|NCT00257660|6377048|P2|Overall Study|Withdrawal by Subject|0
1843049|NCT00257660|6377049|P1|Overall Study|Withdrawal by Subject|2
1843050|NCT00257660|6377048|P2|Overall Study|Lack of Efficacy|23
1843051|NCT00257660|6377049|P1|Overall Study|Lack of Efficacy|5
1843052|NCT00257608|6377079|P3|Post Chemotherapy Phase|Not treated|7
1843053|NCT00257608|6377080|P2|Post Chemotherapy Phase|Not treated|4
1843054|NCT00257608|6377081|P1|Post Chemotherapy Phase|Not treated|0
1843055|NCT00257608|6377079|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1843056|NCT00257608|6377080|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
1843057|NCT00257608|6377081|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
1843058|NCT00257608|6377079|P3|Post Chemotherapy Phase|Physician Decision|11
1843059|NCT00257608|6377080|P2|Post Chemotherapy Phase|Physician Decision|8
1843060|NCT00257608|6377081|P1|Post Chemotherapy Phase|Physician Decision|0
1843061|NCT00257608|6377079|P3|Post Chemotherapy Phase|Lost to Follow-up|1
1843062|NCT00257608|6377080|P2|Post Chemotherapy Phase|Lost to Follow-up|0
1843063|NCT00257608|6377081|P1|Post Chemotherapy Phase|Lost to Follow-up|0
1843064|NCT00257608|6377079|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
1843065|NCT00257608|6377080|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1843066|NCT00257608|6377081|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
1843067|NCT00257608|6377079|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
1843068|NCT00257608|6377080|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
1843069|NCT00257608|6377081|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
1843070|NCT00257608|6377079|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1843071|NCT00257608|6377080|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
1843072|NCT00257608|6377081|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1843073|NCT00257608|6377079|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
1843074|NCT00257608|6377080|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
1843075|NCT00257608|6377081|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
1843076|NCT00257608|6377079|P3|Post Chemotherapy Phase|Disease progression|168
1843077|NCT00257608|6377080|P2|Post Chemotherapy Phase|Disease progression|204
1843078|NCT00257608|6377081|P1|Post Chemotherapy Phase|Disease progression|0
1843079|NCT00257608|6377079|P3|Post Chemotherapy Phase|Adverse Event|38
1843080|NCT00257608|6377080|P2|Post Chemotherapy Phase|Adverse Event|34
1843081|NCT00257608|6377081|P1|Post Chemotherapy Phase|Adverse Event|0
1843082|NCT00257608|6377079|P3|Chemotherapy Phase|Physician Decision|0
1843083|NCT00257608|6377080|P2|Chemotherapy Phase|Physician Decision|0
1843084|NCT00257608|6377081|P1|Chemotherapy Phase|Physician Decision|28
1843085|NCT00257608|6377079|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
1843086|NCT00257608|6377080|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
1843087|NCT00257608|6377081|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
1843088|NCT00257608|6377079|P3|Chemotherapy Phase|Patient's decision to discontinue|0
1843089|NCT00257608|6377080|P2|Chemotherapy Phase|Patient's decision to discontinue|0
1843090|NCT00257608|6377081|P1|Chemotherapy Phase|Patient's decision to discontinue|35
1843091|NCT00257608|6377079|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1843092|NCT00257608|6377080|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
1843093|NCT00257608|6377081|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
1843094|NCT00257608|6377079|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
1843095|NCT00257608|6377080|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
1843096|NCT00257608|6377081|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
1843097|NCT00257608|6377079|P3|Chemotherapy Phase|Disease progression|0
1843098|NCT00257608|6377080|P2|Chemotherapy Phase|Disease progression|0
1843099|NCT00257608|6377081|P1|Chemotherapy Phase|Disease progression|139
1843100|NCT00257608|6377079|P3|Chemotherapy Phase|Adverse Event|0
1843101|NCT00257608|6377080|P2|Chemotherapy Phase|Adverse Event|0
1843102|NCT00257608|6377081|P1|Chemotherapy Phase|Adverse Event|138
1843103|NCT00257556|6377107|P2|Overall Study|other reason|6
1843104|NCT00257556|6377108|P1|Overall Study|other reason|4
1843105|NCT00257556|6377107|P2|Overall Study|Did not meet hCG criterion|0
1843106|NCT00257556|6377108|P1|Overall Study|Did not meet hCG criterion|3
1843107|NCT00257556|6377107|P2|Overall Study|Physician Decision|0
1843108|NCT00257556|6377108|P1|Overall Study|Physician Decision|6
1843109|NCT00257556|6377107|P2|Overall Study|Adverse Event|4
1843110|NCT00257556|6377108|P1|Overall Study|Adverse Event|1
1843111|NCT00257192|6377152|P2|Overall Study|Miscellaneous|4
1843112|NCT00257192|6377153|P1|Overall Study|Miscellaneous|0
1843113|NCT00257192|6377152|P2|Overall Study|Study terminated by sponsor|0
1843114|NCT00257192|6377153|P1|Overall Study|Study terminated by sponsor|1
1843115|NCT00257192|6377152|P2|Overall Study|Randomized but not treated|1
1843116|NCT00257192|6377153|P1|Overall Study|Randomized but not treated|0
1843117|NCT00257192|6377152|P2|Overall Study|Withdrawal by Subject|2
1843118|NCT00257192|6377153|P1|Overall Study|Withdrawal by Subject|14
1843119|NCT00257192|6377152|P2|Overall Study|Insufficient clinical response|18
1843120|NCT00257192|6377153|P1|Overall Study|Insufficient clinical response|18
1843121|NCT00257192|6377152|P2|Overall Study|Lost to Follow-up|3
1843122|NCT00257192|6377153|P1|Overall Study|Lost to Follow-up|3
1843123|NCT00257192|6377152|P2|Overall Study|Laboratory abnormality|1
1843124|NCT00257192|6377153|P1|Overall Study|Laboratory abnormality|1
1843125|NCT00257192|6377152|P2|Overall Study|Adverse Event|10
1843126|NCT00257192|6377153|P1|Overall Study|Adverse Event|21
1843127|NCT00257166|6377197|P2|Overall Study|Randomized, but not treated|0
1843128|NCT00257166|6377198|P1|Overall Study|Randomized, but not treated|1
1843129|NCT00257166|6377197|P2|Overall Study|Other|21
1843130|NCT00257166|6377198|P1|Overall Study|Other|16
1843131|NCT00257166|6377197|P2|Overall Study|Withdrawal by Subject|2
1843132|NCT00257166|6377198|P1|Overall Study|Withdrawal by Subject|9
1843133|NCT00257166|6377197|P2|Overall Study|Lost to Follow-up|1
1843134|NCT00257166|6377198|P1|Overall Study|Lost to Follow-up|8
1843135|NCT00257166|6377197|P2|Overall Study|Laboratory abnormality|0
1843136|NCT00257166|6377198|P1|Overall Study|Laboratory abnormality|1
1843137|NCT00257166|6377197|P2|Overall Study|Adverse Event|13
1843138|NCT00257166|6377198|P1|Overall Study|Adverse Event|18
1843139|NCT00257010|6377210|P1|Overall Study|no headache reported|9
1843140|NCT00257010|6377210|P1|Overall Study|various|11
1843141|NCT00257010|6377210|P1|Overall Study|Adverse Event|10
1843142|NCT00257010|6377210|P1|Overall Study|Withdrawal by Subject|34
1843143|NCT00257010|6377210|P1|Overall Study|Lost to Follow-up|53
1843144|NCT00257010|6377210|P1|Overall Study|Lack of Efficacy|11
1843145|NCT00256997|6377221|P2|Overall Study|Investigator Withdrew Participant|1
1843146|NCT00256997|6377222|P1|Overall Study|Investigator Withdrew Participant|2
1843147|NCT00256997|6377221|P2|Overall Study|Participant Non-compliant|6
1843148|NCT00256997|6377222|P1|Overall Study|Participant Non-compliant|3
1843149|NCT00256997|6377221|P2|Overall Study|End of Study (As Per Sponsor)|24
1843150|NCT00256997|6377222|P1|Overall Study|End of Study (As Per Sponsor)|12
1843151|NCT00256997|6377221|P2|Overall Study|Other|8
1843152|NCT00256997|6377222|P1|Overall Study|Other|5
1843153|NCT00256997|6377221|P2|Overall Study|Started but not treated|0
1843154|NCT00256997|6377222|P1|Overall Study|Started but not treated|2
1843155|NCT00256997|6377221|P2|Overall Study|Withdrawal by Subject|3
1843156|NCT00256997|6377222|P1|Overall Study|Withdrawal by Subject|13
1843157|NCT00256997|6377221|P2|Overall Study|Lost to Follow-up|5
1843158|NCT00256997|6377222|P1|Overall Study|Lost to Follow-up|3
1843159|NCT00256997|6377221|P2|Overall Study|Adverse Event|0
1843160|NCT00256997|6377222|P1|Overall Study|Adverse Event|4
1843161|NCT00256997|6377221|P2|Overall Study|Death|0
1843162|NCT00256997|6377222|P1|Overall Study|Death|2
1843163|NCT00256997|6377221|P2|Overall Study|Lack of Efficacy|4
1843164|NCT00256997|6377222|P1|Overall Study|Lack of Efficacy|1
1843165|NCT00256997|6377221|P2|Overall Study|Protocol Violation|4
1843166|NCT00256997|6377222|P1|Overall Study|Protocol Violation|1
1843167|NCT00256867|6377264|P8|Overall Study|Withdrawal by participant|0
1843168|NCT00256867|6377265|P7|Overall Study|Withdrawal by participant|0
1843169|NCT00256867|6377266|P6|Overall Study|Withdrawal by participant|1
1843170|NCT00256867|6377267|P5|Overall Study|Withdrawal by participant|0
1843171|NCT00256867|6377268|P4|Overall Study|Withdrawal by participant|0
1843172|NCT00256867|6377269|P3|Overall Study|Withdrawal by participant|0
1843173|NCT00256867|6377270|P2|Overall Study|Withdrawal by participant|0
1843174|NCT00256867|6377271|P1|Overall Study|Withdrawal by participant|0
1843175|NCT00256867|6377264|P8|Overall Study|Participant out of assessment window|0
1843176|NCT00256867|6377265|P7|Overall Study|Participant out of assessment window|0
1843177|NCT00256867|6377266|P6|Overall Study|Participant out of assessment window|0
1843178|NCT00256867|6377267|P5|Overall Study|Participant out of assessment window|0
1843179|NCT00256867|6377268|P4|Overall Study|Participant out of assessment window|0
1843180|NCT00256867|6377269|P3|Overall Study|Participant out of assessment window|1
1843181|NCT00256867|6377270|P2|Overall Study|Participant out of assessment window|0
1843182|NCT00256867|6377271|P1|Overall Study|Participant out of assessment window|0
1843183|NCT00256867|6377264|P8|Overall Study|Participant travelled Overseas|0
1843184|NCT00256867|6377265|P7|Overall Study|Participant travelled Overseas|0
1843185|NCT00256867|6377266|P6|Overall Study|Participant travelled Overseas|0
1843186|NCT00256867|6377267|P5|Overall Study|Participant travelled Overseas|0
1843187|NCT00256867|6377268|P4|Overall Study|Participant travelled Overseas|0
1843188|NCT00256867|6377269|P3|Overall Study|Participant travelled Overseas|0
1843189|NCT00256867|6377270|P2|Overall Study|Participant travelled Overseas|1
1843190|NCT00256867|6377271|P1|Overall Study|Participant travelled Overseas|0
1843191|NCT00256867|6377264|P8|Overall Study|Non-compliance with study medication|1
1843192|NCT00256867|6377265|P7|Overall Study|Non-compliance with study medication|0
1843193|NCT00256867|6377266|P6|Overall Study|Non-compliance with study medication|0
1843194|NCT00256867|6377267|P5|Overall Study|Non-compliance with study medication|0
1843195|NCT00256867|6377268|P4|Overall Study|Non-compliance with study medication|0
1843196|NCT00256867|6377269|P3|Overall Study|Non-compliance with study medication|0
1843197|NCT00256867|6377270|P2|Overall Study|Non-compliance with study medication|0
1843198|NCT00256867|6377271|P1|Overall Study|Non-compliance with study medication|0
1843199|NCT00256867|6377264|P8|Overall Study|Investigator's Decision|0
1843200|NCT00256867|6377265|P7|Overall Study|Investigator's Decision|0
1843201|NCT00256867|6377266|P6|Overall Study|Investigator's Decision|0
1843202|NCT00256867|6377267|P5|Overall Study|Investigator's Decision|1
1843203|NCT00256867|6377268|P4|Overall Study|Investigator's Decision|0
1843204|NCT00256867|6377269|P3|Overall Study|Investigator's Decision|0
1843205|NCT00256867|6377270|P2|Overall Study|Investigator's Decision|0
1843206|NCT00256867|6377271|P1|Overall Study|Investigator's Decision|0
1843207|NCT00256867|6377264|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
1843208|NCT00256867|6377265|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
1843209|NCT00256867|6377266|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
1843210|NCT00256867|6377267|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
1843211|NCT00256867|6377268|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
1843212|NCT00256867|6377269|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
1843213|NCT00256867|6377270|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
1843214|NCT00256867|6377271|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
1843215|NCT00256867|6377264|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
1843216|NCT00256867|6377265|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
1843217|NCT00256867|6377266|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
1843218|NCT00256867|6377267|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
1843219|NCT00256867|6377268|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
1843220|NCT00256867|6377269|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
1843221|NCT00256867|6377270|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
1843222|NCT00256867|6377271|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
1843223|NCT00256867|6377264|P8|Overall Study|Withdrawal by Subject|2
1843224|NCT00256867|6377265|P7|Overall Study|Withdrawal by Subject|3
1843225|NCT00256867|6377266|P6|Overall Study|Withdrawal by Subject|2
1843226|NCT00256867|6377267|P5|Overall Study|Withdrawal by Subject|2
1843227|NCT00256867|6377268|P4|Overall Study|Withdrawal by Subject|1
1843228|NCT00256867|6377269|P3|Overall Study|Withdrawal by Subject|1
1843229|NCT00256867|6377270|P2|Overall Study|Withdrawal by Subject|0
1843230|NCT00256867|6377271|P1|Overall Study|Withdrawal by Subject|0
1843231|NCT00256867|6377264|P8|Overall Study|Protocol Violation|1
1843232|NCT00256867|6377265|P7|Overall Study|Protocol Violation|0
1843233|NCT00256867|6377266|P6|Overall Study|Protocol Violation|1
1843234|NCT00256867|6377267|P5|Overall Study|Protocol Violation|0
1843235|NCT00256867|6377268|P4|Overall Study|Protocol Violation|1
1843236|NCT00256867|6377269|P3|Overall Study|Protocol Violation|0
1843237|NCT00256867|6377270|P2|Overall Study|Protocol Violation|0
1843238|NCT00256867|6377271|P1|Overall Study|Protocol Violation|0
1843239|NCT00256867|6377264|P8|Overall Study|Lost to Follow-up|2
1843240|NCT00256867|6377265|P7|Overall Study|Lost to Follow-up|1
1843241|NCT00256867|6377266|P6|Overall Study|Lost to Follow-up|0
1843242|NCT00256867|6377267|P5|Overall Study|Lost to Follow-up|2
1843243|NCT00256867|6377268|P4|Overall Study|Lost to Follow-up|3
1843244|NCT00256867|6377269|P3|Overall Study|Lost to Follow-up|2
1843245|NCT00256867|6377270|P2|Overall Study|Lost to Follow-up|2
1843246|NCT00256867|6377271|P1|Overall Study|Lost to Follow-up|2
1843247|NCT00256867|6377264|P8|Overall Study|Adverse Event|4
1843248|NCT00256867|6377265|P7|Overall Study|Adverse Event|1
1843249|NCT00256867|6377266|P6|Overall Study|Adverse Event|2
1843250|NCT00256867|6377267|P5|Overall Study|Adverse Event|2
1843251|NCT00256867|6377268|P4|Overall Study|Adverse Event|1
1843252|NCT00256867|6377269|P3|Overall Study|Adverse Event|1
1843253|NCT00256867|6377270|P2|Overall Study|Adverse Event|1
1843254|NCT00256867|6377271|P1|Overall Study|Adverse Event|0
1843255|NCT00256854|6377361|P6|Overall Study|Not compliant with the study drug|0
1843256|NCT00256854|6377362|P5|Overall Study|Not compliant with the study drug|1
1843257|NCT00256854|6377363|P4|Overall Study|Not compliant with the study drug|0
1843258|NCT00256854|6377364|P3|Overall Study|Not compliant with the study drug|0
1843259|NCT00256854|6377365|P2|Overall Study|Not compliant with the study drug|0
1843260|NCT00256854|6377366|P1|Overall Study|Not compliant with the study drug|0
1843261|NCT00256854|6377361|P6|Overall Study|Adverse Event|1
1843262|NCT00256854|6377362|P5|Overall Study|Adverse Event|0
1843263|NCT00256854|6377363|P4|Overall Study|Adverse Event|2
1843264|NCT00256854|6377364|P3|Overall Study|Adverse Event|2
1843265|NCT00256854|6377365|P2|Overall Study|Adverse Event|0
1843266|NCT00256854|6377366|P1|Overall Study|Adverse Event|0
1843267|NCT00256854|6377361|P6|Overall Study|Protocol Violation|0
1843268|NCT00256854|6377362|P5|Overall Study|Protocol Violation|0
1843269|NCT00256854|6377363|P4|Overall Study|Protocol Violation|1
1843270|NCT00256854|6377364|P3|Overall Study|Protocol Violation|1
1843271|NCT00256854|6377365|P2|Overall Study|Protocol Violation|1
1843272|NCT00256854|6377366|P1|Overall Study|Protocol Violation|0
1843273|NCT00256854|6377361|P6|Overall Study|Lack of Efficacy|0
1843274|NCT00256854|6377362|P5|Overall Study|Lack of Efficacy|0
1843275|NCT00256854|6377363|P4|Overall Study|Lack of Efficacy|0
1843276|NCT00256854|6377364|P3|Overall Study|Lack of Efficacy|0
1843277|NCT00256854|6377365|P2|Overall Study|Lack of Efficacy|0
1843278|NCT00256854|6377366|P1|Overall Study|Lack of Efficacy|1
1843279|NCT00256854|6377361|P6|Overall Study|Withdrawal by Subject|0
1843280|NCT00256854|6377362|P5|Overall Study|Withdrawal by Subject|0
1843281|NCT00256854|6377363|P4|Overall Study|Withdrawal by Subject|0
1843282|NCT00256854|6377364|P3|Overall Study|Withdrawal by Subject|0
1843283|NCT00256854|6377365|P2|Overall Study|Withdrawal by Subject|3
1843284|NCT00256854|6377366|P1|Overall Study|Withdrawal by Subject|2
1843285|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Other|5
1843286|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Other|4
1843287|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Other|5
1843288|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
1843289|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1843290|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
1843291|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
1843292|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
1843293|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
1843294|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1843295|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
1843296|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
1843297|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
1843298|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
1843299|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
1843300|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Death|4
1843301|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Death|4
1843302|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Death|9
1843303|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1843304|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
1843305|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
1843306|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
1843307|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
1843308|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
1843309|NCT00256750|6377425|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
1843310|NCT00256750|6377426|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
1843311|NCT00256750|6377427|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
1843312|NCT00256750|6377425|P3|Post-Transplant Treated (36 Months)|Other|1
1843313|NCT00256750|6377426|P2|Post-Transplant Treated (36 Months)|Other|1
1843314|NCT00256750|6377427|P1|Post-Transplant Treated (36 Months)|Other|0
1843315|NCT00256750|6377425|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
1843316|NCT00256750|6377426|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
1843317|NCT00256750|6377427|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
1843318|NCT00256750|6377425|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
1843319|NCT00256750|6377426|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
1843320|NCT00256750|6377427|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
1843321|NCT00256750|6377425|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
1843322|NCT00256750|6377426|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1843323|NCT00256750|6377427|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
1843324|NCT00256750|6377425|P3|Post-Transplant Treated (36 Months)|Death|1
1843325|NCT00256750|6377426|P2|Post-Transplant Treated (36 Months)|Death|2
1843326|NCT00256750|6377427|P1|Post-Transplant Treated (36 Months)|Death|0
1843327|NCT00256750|6377425|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1843328|NCT00256750|6377426|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
1843329|NCT00256750|6377427|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
1843330|NCT00256750|6377425|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
1843331|NCT00256750|6377426|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
1843332|NCT00256750|6377427|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
1843333|NCT00256750|6377425|P3|Post-Transplant Treated (24 Months)|Other|1
1843334|NCT00256750|6377426|P2|Post-Transplant Treated (24 Months)|Other|0
1843335|NCT00256750|6377427|P1|Post-Transplant Treated (24 Months)|Other|2
1843336|NCT00256750|6377425|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
1843337|NCT00256750|6377426|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
1843338|NCT00256750|6377427|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
1843339|NCT00256750|6377425|P3|Post-Transplant Treated (24 Months)|Death|0
1843340|NCT00256750|6377426|P2|Post-Transplant Treated (24 Months)|Death|0
1843341|NCT00256750|6377427|P1|Post-Transplant Treated (24 Months)|Death|3
1843342|NCT00256750|6377425|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
1843343|NCT00256750|6377426|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
1843344|NCT00256750|6377427|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
1843345|NCT00256750|6377425|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
1843346|NCT00256750|6377426|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
1843347|NCT00256750|6377427|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
1843348|NCT00256750|6377425|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
1843349|NCT00256750|6377426|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
1843350|NCT00256750|6377427|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
1843351|NCT00256750|6377425|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
1843352|NCT00256750|6377426|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
1843353|NCT00256750|6377427|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
1843354|NCT00256750|6377425|P3|Post-Transplant Treated (12 Months)|Other|2
1843355|NCT00256750|6377426|P2|Post-Transplant Treated (12 Months)|Other|4
1843356|NCT00256750|6377427|P1|Post-Transplant Treated (12 Months)|Other|5
1843357|NCT00256750|6377425|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1843358|NCT00256750|6377426|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
1843359|NCT00256750|6377427|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
1843360|NCT00256750|6377425|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
1843361|NCT00256750|6377426|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
1843362|NCT00256750|6377427|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
1843363|NCT00256750|6377425|P3|Post-Transplant Treated (12 Months)|Death|4
1843364|NCT00256750|6377426|P2|Post-Transplant Treated (12 Months)|Death|2
1843365|NCT00256750|6377427|P1|Post-Transplant Treated (12 Months)|Death|3
1843366|NCT00256750|6377425|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
1843367|NCT00256750|6377426|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
1843368|NCT00256750|6377427|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
1843369|NCT00256750|6377425|P3|Transplanted Pre-Treatment|Death|0
1843370|NCT00256750|6377426|P2|Transplanted Pre-Treatment|Death|0
1843371|NCT00256750|6377427|P1|Transplanted Pre-Treatment|Death|1
1843372|NCT00256750|6377425|P3|Transplanted Pre-Treatment|Other|0
1843373|NCT00256750|6377426|P2|Transplanted Pre-Treatment|Other|0
1843374|NCT00256750|6377427|P1|Transplanted Pre-Treatment|Other|2
1843375|NCT00256750|6377425|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
1843376|NCT00256750|6377426|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
1843377|NCT00256750|6377427|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
1843378|NCT00256724|6377563|P2|Overall Study|Protocol Violation|3
1843379|NCT00256724|6377564|P1|Overall Study|Protocol Violation|3
1843380|NCT00256724|6377563|P2|Overall Study|Physician Decision|5
1843381|NCT00256724|6377564|P1|Overall Study|Physician Decision|2
1843382|NCT00256698|6377574|P2|Overall Study|Prematurely Discontinued|0
1843383|NCT00256698|6377575|P1|Overall Study|Prematurely Discontinued|1
1843384|NCT00256698|6377574|P2|Overall Study|withdrawn due to osteoporosis|0
1843385|NCT00256698|6377575|P1|Overall Study|withdrawn due to osteoporosis|1
1843386|NCT00256698|6377574|P2|Overall Study|still ongoing at data cut-off|46
1843387|NCT00256698|6377575|P1|Overall Study|still ongoing at data cut-off|41
1843388|NCT00256698|6377574|P2|Overall Study|disease progression|105
1843389|NCT00256698|6377575|P1|Overall Study|disease progression|97
1843390|NCT00256698|6377574|P2|Overall Study|Lost to Follow-up|3
1843391|NCT00256698|6377575|P1|Overall Study|Lost to Follow-up|1
1843392|NCT00256698|6377574|P2|Overall Study|Protocol Violation|5
1843393|NCT00256698|6377575|P1|Overall Study|Protocol Violation|6
1843394|NCT00256698|6377574|P2|Overall Study|Adverse Event|6
1843395|NCT00256698|6377575|P1|Overall Study|Adverse Event|13
1843396|NCT00256698|6377574|P2|Overall Study|Withdrawal by Subject|7
1843397|NCT00256698|6377575|P1|Overall Study|Withdrawal by Subject|7
1843398|NCT00256308|6377622|P1|Overall Study|Death|2
1843399|NCT00256295|6377630|P1|Overall Study|Death|1
1843400|NCT00256295|6377630|P1|Overall Study|Withdrawal by Subject|3
1843401|NCT00256282|6377636|P1|Overall Study|Physician Decision|1
1843402|NCT00256282|6377636|P1|Overall Study|Adverse Event|3
1843403|NCT00256282|6377636|P1|Overall Study|Disease progression, relapse during acti|12
1843404|NCT00256243|6377641|P1|Overall Study|Not treated|1
1843405|NCT00256243|6377641|P1|Overall Study|Death|7
1843406|NCT00256243|6377641|P1|Overall Study|Lost to Follow-up|2
1843407|NCT00256204|6377650|P4|Overall Study|Need for additional prohibited treatment|25
1843408|NCT00256204|6377651|P3|Overall Study|Need for additional prohibited treatment|27
1843409|NCT00256204|6377652|P2|Overall Study|Need for additional prohibited treatment|28
1843410|NCT00256204|6377653|P1|Overall Study|Need for additional prohibited treatment|38
1843411|NCT00256204|6377650|P4|Overall Study|Withdrawal by Subject|5
1843412|NCT00256204|6377651|P3|Overall Study|Withdrawal by Subject|7
1843413|NCT00256204|6377652|P2|Overall Study|Withdrawal by Subject|6
1843414|NCT00256204|6377653|P1|Overall Study|Withdrawal by Subject|17
1843415|NCT00256204|6377650|P4|Overall Study|Physician Decision|2
1843416|NCT00256204|6377651|P3|Overall Study|Physician Decision|1
1843417|NCT00256204|6377652|P2|Overall Study|Physician Decision|0
1843418|NCT00256204|6377653|P1|Overall Study|Physician Decision|0
1843419|NCT00256204|6377650|P4|Overall Study|Protocol Violation|1
1843420|NCT00256204|6377651|P3|Overall Study|Protocol Violation|2
1843421|NCT00256204|6377652|P2|Overall Study|Protocol Violation|0
1843422|NCT00256204|6377653|P1|Overall Study|Protocol Violation|1
1843423|NCT00256204|6377650|P4|Overall Study|Lost to Follow-up|2
1843424|NCT00256204|6377651|P3|Overall Study|Lost to Follow-up|1
1843425|NCT00256204|6377652|P2|Overall Study|Lost to Follow-up|1
1843426|NCT00256204|6377653|P1|Overall Study|Lost to Follow-up|1
1843427|NCT00256204|6377650|P4|Overall Study|Death|0
1843428|NCT00256204|6377651|P3|Overall Study|Death|0
1843429|NCT00256204|6377652|P2|Overall Study|Death|1
1843430|NCT00256204|6377653|P1|Overall Study|Death|0
1843431|NCT00256204|6377650|P4|Overall Study|Adverse Event|14
1843432|NCT00256204|6377651|P3|Overall Study|Adverse Event|16
1843433|NCT00256204|6377652|P2|Overall Study|Adverse Event|14
1843434|NCT00256204|6377653|P1|Overall Study|Adverse Event|10
1843435|NCT00256126|6377668|P2|Overall Study|Other|2
1843436|NCT00256126|6377669|P1|Overall Study|Other|1
1843437|NCT00256126|6377668|P2|Overall Study|Adverse Event|0
1843438|NCT00256126|6377669|P1|Overall Study|Adverse Event|1
1843439|NCT00255840|6377708|P2|Overall Study|Discontinued intervention|56
1843440|NCT00255840|6377709|P1|Overall Study|Discontinued intervention|53
1843441|NCT00255840|6377708|P2|Overall Study|Lost to Follow-up|14
1843442|NCT00255840|6377709|P1|Overall Study|Lost to Follow-up|10
1843443|NCT00255723|6377722|P2|Overall Study|Response Data Not Available|0
1843444|NCT00255723|6377723|P1|Overall Study|Response Data Not Available|1
1843445|NCT00255723|6377722|P2|Overall Study|Death|1
1843446|NCT00255723|6377723|P1|Overall Study|Death|0
1843447|NCT00255723|6377722|P2|Overall Study|Adverse Event|1
1843448|NCT00255723|6377723|P1|Overall Study|Adverse Event|1
1843449|NCT00255346|6377739|P5|Overall Study|Adverse Event|0
1843450|NCT00255346|6377740|P4|Overall Study|Adverse Event|0
1843451|NCT00255346|6377741|P3|Overall Study|Adverse Event|0
1843452|NCT00255346|6377742|P2|Overall Study|Adverse Event|0
1843453|NCT00255346|6377743|P1|Overall Study|Adverse Event|1
1843454|NCT00255190|6377758|P2|Overall Study|Various|23
1843455|NCT00255190|6377759|P1|Overall Study|Various|4
1843456|NCT00255190|6377758|P2|Overall Study|Erosive esophagitis not healed|20
1843457|NCT00255190|6377759|P1|Overall Study|Erosive esophagitis not healed|0
1843458|NCT00255190|6377758|P2|Overall Study|Inclusion/Exclusion criteria not met|1
1843459|NCT00255190|6377759|P1|Overall Study|Inclusion/Exclusion criteria not met|0
1843460|NCT00255190|6377758|P2|Overall Study|Withdrew Consent|48
1843461|NCT00255190|6377759|P1|Overall Study|Withdrew Consent|17
1843462|NCT00255190|6377758|P2|Overall Study|Lost to Follow-up|27
1843463|NCT00255190|6377759|P1|Overall Study|Lost to Follow-up|10
1843464|NCT00255190|6377758|P2|Overall Study|Protocol Violation|2
1843465|NCT00255190|6377759|P1|Overall Study|Protocol Violation|2
1843466|NCT00255190|6377758|P2|Overall Study|Adverse Event|36
1843467|NCT00255190|6377759|P1|Overall Study|Adverse Event|17
1843468|NCT00255164|6377843|P3|Overall Study|Therapeutic Failure|3
1843469|NCT00255164|6377844|P2|Overall Study|Therapeutic Failure|2
1843470|NCT00255164|6377845|P1|Overall Study|Therapeutic Failure|11
1843471|NCT00255164|6377843|P3|Overall Study|Esophageal Stricture|1
1843472|NCT00255164|6377844|P2|Overall Study|Esophageal Stricture|0
1843473|NCT00255164|6377845|P1|Overall Study|Esophageal Stricture|0
1843474|NCT00255164|6377843|P3|Overall Study|Possible Barrett's Esophagus|8
1843475|NCT00255164|6377844|P2|Overall Study|Possible Barrett's Esophagus|3
1843476|NCT00255164|6377845|P1|Overall Study|Possible Barrett's Esophagus|1
1843477|NCT00255164|6377843|P3|Overall Study|Relapse of Erosive Esophagitis|12
1843478|NCT00255164|6377844|P2|Overall Study|Relapse of Erosive Esophagitis|16
1843479|NCT00255164|6377845|P1|Overall Study|Relapse of Erosive Esophagitis|78
1843480|NCT00255164|6377843|P3|Overall Study|Subject Request/Subject Unavailable|2
1843481|NCT00255164|6377844|P2|Overall Study|Subject Request/Subject Unavailable|1
1843482|NCT00255164|6377845|P1|Overall Study|Subject Request/Subject Unavailable|1
1843483|NCT00255164|6377843|P3|Overall Study|Noncompliance|2
1843484|NCT00255164|6377844|P2|Overall Study|Noncompliance|1
1843485|NCT00255164|6377845|P1|Overall Study|Noncompliance|0
1843486|NCT00255164|6377843|P3|Overall Study|Withdrawal by Subject|8
1843487|NCT00255164|6377844|P2|Overall Study|Withdrawal by Subject|17
1843488|NCT00255164|6377845|P1|Overall Study|Withdrawal by Subject|18
1843489|NCT00255164|6377843|P3|Overall Study|Lost to Follow-up|4
1843490|NCT00255164|6377844|P2|Overall Study|Lost to Follow-up|3
1843491|NCT00255164|6377845|P1|Overall Study|Lost to Follow-up|4
1843492|NCT00255164|6377843|P3|Overall Study|Adverse Event|9
1843493|NCT00255164|6377844|P2|Overall Study|Adverse Event|6
1843494|NCT00255164|6377845|P1|Overall Study|Adverse Event|10
1843495|NCT00255151|6377871|P3|Overall Study|Therapeutic Failure|3
1843496|NCT00255151|6377872|P2|Overall Study|Therapeutic Failure|2
1843497|NCT00255151|6377873|P1|Overall Study|Therapeutic Failure|11
1843498|NCT00255151|6377871|P3|Overall Study|Esophageal Stricture|1
1843499|NCT00255151|6377872|P2|Overall Study|Esophageal Stricture|0
1843500|NCT00255151|6377873|P1|Overall Study|Esophageal Stricture|0
1843501|NCT00255151|6377871|P3|Overall Study|Possible Barrett's Esophagus|8
1843502|NCT00255151|6377872|P2|Overall Study|Possible Barrett's Esophagus|3
1843503|NCT00255151|6377873|P1|Overall Study|Possible Barrett's Esophagus|1
1843504|NCT00255151|6377871|P3|Overall Study|Relapse of Erosive Esophagitis|12
1843505|NCT00255151|6377872|P2|Overall Study|Relapse of Erosive Esophagitis|16
1843506|NCT00255151|6377873|P1|Overall Study|Relapse of Erosive Esophagitis|78
1843507|NCT00255151|6377871|P3|Overall Study|Subject Request/Subject Unavailable|2
1843508|NCT00255151|6377872|P2|Overall Study|Subject Request/Subject Unavailable|1
1843509|NCT00255151|6377873|P1|Overall Study|Subject Request/Subject Unavailable|1
1843510|NCT00255151|6377871|P3|Overall Study|Noncompliance|2
1843511|NCT00255151|6377872|P2|Overall Study|Noncompliance|1
1843512|NCT00255151|6377873|P1|Overall Study|Noncompliance|0
1843513|NCT00255151|6377871|P3|Overall Study|Withdrawal by Subject|8
1843514|NCT00255151|6377872|P2|Overall Study|Withdrawal by Subject|17
1843515|NCT00255151|6377873|P1|Overall Study|Withdrawal by Subject|18
1843516|NCT00255151|6377871|P3|Overall Study|Lost to Follow-up|4
1843517|NCT00255151|6377872|P2|Overall Study|Lost to Follow-up|3
1843518|NCT00255151|6377873|P1|Overall Study|Lost to Follow-up|4
1843519|NCT00255151|6377871|P3|Overall Study|Adverse Event|9
1843520|NCT00255151|6377872|P2|Overall Study|Adverse Event|6
1843521|NCT00255151|6377873|P1|Overall Study|Adverse Event|10
1843522|NCT00255086|6377911|P2|Overall Study|Protocol Violation|1
1843523|NCT00255086|6377912|P1|Overall Study|Protocol Violation|1
1843524|NCT00255086|6377911|P2|Overall Study|Adverse Event|1
1843525|NCT00255086|6377912|P1|Overall Study|Adverse Event|1
1843526|NCT00255047|6377924|P4|Overall Study|Withdrawal by Subject|18
1843527|NCT00255047|6377925|P3|Overall Study|Withdrawal by Subject|25
1843528|NCT00255047|6377926|P2|Overall Study|Withdrawal by Subject|23
1843529|NCT00255047|6377927|P1|Overall Study|Withdrawal by Subject|24
1843530|NCT00255047|6377924|P4|Overall Study|Lost to Follow-up|6
1843531|NCT00255047|6377925|P3|Overall Study|Lost to Follow-up|5
1843532|NCT00255047|6377926|P2|Overall Study|Lost to Follow-up|8
1843533|NCT00255047|6377927|P1|Overall Study|Lost to Follow-up|9
1843534|NCT00255047|6377924|P4|Overall Study|Protocol Violation|20
1843535|NCT00255047|6377925|P3|Overall Study|Protocol Violation|16
1843536|NCT00255047|6377926|P2|Overall Study|Protocol Violation|13
1843537|NCT00255047|6377927|P1|Overall Study|Protocol Violation|13
1843538|NCT00255047|6377924|P4|Overall Study|Adverse Event|1
1843539|NCT00255047|6377925|P3|Overall Study|Adverse Event|2
1843540|NCT00255047|6377926|P2|Overall Study|Adverse Event|3
1843541|NCT00255047|6377927|P1|Overall Study|Adverse Event|0
1843542|NCT00255047|6377924|P4|Overall Study|Serious Adverse Events|1
1843543|NCT00255047|6377925|P3|Overall Study|Serious Adverse Events|2
1843544|NCT00255047|6377926|P2|Overall Study|Serious Adverse Events|1
1843545|NCT00255047|6377927|P1|Overall Study|Serious Adverse Events|2
1843546|NCT00255034|6377951|P2|Overall Study|Withdrawal by Subject|38
1843547|NCT00255034|6377952|P1|Overall Study|Withdrawal by Subject|15
1843548|NCT00255008|6377962|P4|Overall Study|Other|2
1843549|NCT00255008|6377963|P3|Overall Study|Other|3
1843550|NCT00255008|6377964|P2|Overall Study|Other|0
1843551|NCT00255008|6377965|P1|Overall Study|Other|7
1843552|NCT00255008|6377962|P4|Overall Study|Adverse lab experience|0
1843553|NCT00255008|6377963|P3|Overall Study|Adverse lab experience|0
1843554|NCT00255008|6377964|P2|Overall Study|Adverse lab experience|0
1843555|NCT00255008|6377965|P1|Overall Study|Adverse lab experience|1
1843556|NCT00255008|6377962|P4|Overall Study|Sponsor request|17
1843557|NCT00255008|6377963|P3|Overall Study|Sponsor request|8
1843558|NCT00255008|6377964|P2|Overall Study|Sponsor request|3
1843559|NCT00255008|6377965|P1|Overall Study|Sponsor request|18
1843560|NCT00255008|6377962|P4|Overall Study|Withdrew consent|0
1843561|NCT00255008|6377963|P3|Overall Study|Withdrew consent|2
1843562|NCT00255008|6377964|P2|Overall Study|Withdrew consent|0
1843563|NCT00255008|6377965|P1|Overall Study|Withdrew consent|0
1843564|NCT00255008|6377962|P4|Overall Study|Did not meet viral reduction criteria|1
1843565|NCT00255008|6377963|P3|Overall Study|Did not meet viral reduction criteria|0
1843566|NCT00255008|6377964|P2|Overall Study|Did not meet viral reduction criteria|5
1843567|NCT00255008|6377965|P1|Overall Study|Did not meet viral reduction criteria|4
1843568|NCT00255008|6377962|P4|Overall Study|Lost to Follow-up|2
1843569|NCT00255008|6377963|P3|Overall Study|Lost to Follow-up|1
1843570|NCT00255008|6377964|P2|Overall Study|Lost to Follow-up|0
1843571|NCT00255008|6377965|P1|Overall Study|Lost to Follow-up|1
1843572|NCT00255008|6377962|P4|Overall Study|Adverse Event|0
1843573|NCT00255008|6377963|P3|Overall Study|Adverse Event|2
1843574|NCT00255008|6377964|P2|Overall Study|Adverse Event|1
1843575|NCT00255008|6377965|P1|Overall Study|Adverse Event|1
1843576|NCT00254982|6378001|P2|Overall Study|Abnormal liver function tests|1
1843577|NCT00254982|6378002|P1|Overall Study|Abnormal liver function tests|2
1843578|NCT00254982|6378001|P2|Overall Study|Opportunistic infection|0
1843579|NCT00254982|6378002|P1|Overall Study|Opportunistic infection|1
1843580|NCT00254982|6378001|P2|Overall Study|Malignancy|2
1843581|NCT00254982|6378002|P1|Overall Study|Malignancy|0
1843582|NCT00254982|6378001|P2|Overall Study|Diagnosis of Tuberculosis|1
1843583|NCT00254982|6378002|P1|Overall Study|Diagnosis of Tuberculosis|1
1843584|NCT00254982|6378001|P2|Overall Study|Protocol deviation|1
1843585|NCT00254982|6378002|P1|Overall Study|Protocol deviation|1
1843586|NCT00254982|6378001|P2|Overall Study|Inclusion/exclusion criteria violation|2
1843587|NCT00254982|6378002|P1|Overall Study|Inclusion/exclusion criteria violation|0
1843588|NCT00254982|6378001|P2|Overall Study|Withdrawal by Subject|1
1843589|NCT00254982|6378002|P1|Overall Study|Withdrawal by Subject|1
1843590|NCT00254982|6378001|P2|Overall Study|Adverse Event|16
1843591|NCT00254982|6378002|P1|Overall Study|Adverse Event|18
1843592|NCT00254982|6378001|P2|Overall Study|Lost to Follow-up|3
1843593|NCT00254982|6378002|P1|Overall Study|Lost to Follow-up|5
1843594|NCT00254982|6378001|P2|Overall Study|Lack of Efficacy|3
1843595|NCT00254982|6378002|P1|Overall Study|Lack of Efficacy|5
1843596|NCT00254982|6378001|P2|Overall Study|Other|1
1843597|NCT00254982|6378002|P1|Overall Study|Other|2
1843598|NCT00254566|6378014|P2|Overall Study|Lost to Follow-up|2
1843599|NCT00254566|6378015|P1|Overall Study|Lost to Follow-up|7
1843600|NCT00254566|6378014|P2|Overall Study|Withdrawal by Subject|6
1843601|NCT00254566|6378015|P1|Overall Study|Withdrawal by Subject|5
1843602|NCT00254566|6378014|P2|Overall Study|Other|5
1843603|NCT00254566|6378015|P1|Overall Study|Other|1
1843604|NCT00254566|6378014|P2|Overall Study|Lack of Efficacy|9
1843605|NCT00254566|6378015|P1|Overall Study|Lack of Efficacy|12
1843606|NCT00254566|6378014|P2|Overall Study|Adverse Event|4
1843607|NCT00254566|6378015|P1|Overall Study|Adverse Event|5
1843608|NCT00254566|6378014|P2|Overall Study|Death|0
1843609|NCT00254566|6378015|P1|Overall Study|Death|1
1843610|NCT00254540|6378039|P2|Overall Study|Laboratory Test Abnormality|1
1843611|NCT00254540|6378040|P1|Overall Study|Laboratory Test Abnormality|0
1843612|NCT00254540|6378039|P2|Overall Study|Death|1
1843613|NCT00254540|6378040|P1|Overall Study|Death|0
1843614|NCT00254540|6378039|P2|Overall Study|Lack of Efficacy|13
1843615|NCT00254540|6378040|P1|Overall Study|Lack of Efficacy|13
1843616|NCT00254540|6378039|P2|Overall Study|Adverse Event|7
1843617|NCT00254540|6378040|P1|Overall Study|Adverse Event|6
1843618|NCT00254501|6378069|P2|Overall Study|Lost to Follow-up|1
1843619|NCT00254501|6378070|P1|Overall Study|Lost to Follow-up|1
1843620|NCT00254397|6378115|P4|Overall Study|Adverse Event|1
1843621|NCT00254397|6378116|P3|Overall Study|Adverse Event|3
1843622|NCT00254397|6378117|P2|Overall Study|Adverse Event|0
1843623|NCT00254397|6378118|P1|Overall Study|Adverse Event|2
1843624|NCT00254397|6378115|P4|Overall Study|Non-Compliant|1
1843625|NCT00254397|6378116|P3|Overall Study|Non-Compliant|0
1843626|NCT00254397|6378117|P2|Overall Study|Non-Compliant|0
1843627|NCT00254397|6378118|P1|Overall Study|Non-Compliant|0
1843628|NCT00254397|6378115|P4|Overall Study|Disease Progression|23
1843629|NCT00254397|6378116|P3|Overall Study|Disease Progression|16
1843630|NCT00254397|6378117|P2|Overall Study|Disease Progression|1
1843631|NCT00254397|6378118|P1|Overall Study|Disease Progression|4
1843632|NCT00254293|6378142|P7|LTE Open Label Fixed Dosing|Other|1
1843633|NCT00254293|6378143|P6|LTE Open Label Fixed Dosing|Other|0
1843634|NCT00254293|6378144|P5|LTE Open Label Fixed Dosing|Other|0
1843635|NCT00254293|6378145|P4|LTE Open Label Fixed Dosing|Other|0
1843636|NCT00254293|6378146|P3|LTE Open Label Fixed Dosing|Other|0
1843637|NCT00254293|6378147|P2|LTE Open Label Fixed Dosing|Other|0
1843638|NCT00254293|6378148|P1|LTE Open Label Fixed Dosing|Other|0
1843639|NCT00254293|6378142|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
1843640|NCT00254293|6378143|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1843641|NCT00254293|6378144|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1843642|NCT00254293|6378145|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1843643|NCT00254293|6378146|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1843644|NCT00254293|6378147|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1843645|NCT00254293|6378148|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
1843646|NCT00254293|6378142|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
1843647|NCT00254293|6378143|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1843648|NCT00254293|6378144|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1843649|NCT00254293|6378145|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1843650|NCT00254293|6378146|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1843651|NCT00254293|6378147|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1843652|NCT00254293|6378148|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
1843653|NCT00254293|6378142|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
1843654|NCT00254293|6378143|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1843655|NCT00254293|6378144|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1843656|NCT00254293|6378145|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1843657|NCT00254293|6378146|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1843658|NCT00254293|6378147|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1843659|NCT00254293|6378148|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
1843660|NCT00254293|6378142|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
1843661|NCT00254293|6378143|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1843662|NCT00254293|6378144|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1843663|NCT00254293|6378145|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1843664|NCT00254293|6378146|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1843665|NCT00254293|6378147|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1843666|NCT00254293|6378148|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
1843667|NCT00254293|6378142|P7|LTE Open Label Fixed Dosing|Adverse Event|1
1843668|NCT00254293|6378143|P6|LTE Open Label Fixed Dosing|Adverse Event|0
1843669|NCT00254293|6378144|P5|LTE Open Label Fixed Dosing|Adverse Event|0
1843670|NCT00254293|6378145|P4|LTE Open Label Fixed Dosing|Adverse Event|0
1843671|NCT00254293|6378146|P3|LTE Open Label Fixed Dosing|Adverse Event|0
1843672|NCT00254293|6378147|P2|LTE Open Label Fixed Dosing|Adverse Event|0
1843673|NCT00254293|6378148|P1|LTE Open Label Fixed Dosing|Adverse Event|0
1843674|NCT00254293|6378142|P7|LTE Open Label Fixed Dosing|Death|3
1843675|NCT00254293|6378143|P6|LTE Open Label Fixed Dosing|Death|0
1843676|NCT00254293|6378144|P5|LTE Open Label Fixed Dosing|Death|0
1843677|NCT00254293|6378145|P4|LTE Open Label Fixed Dosing|Death|0
1843678|NCT00254293|6378146|P3|LTE Open Label Fixed Dosing|Death|0
1843679|NCT00254293|6378147|P2|LTE Open Label Fixed Dosing|Death|0
1843680|NCT00254293|6378148|P1|LTE Open Label Fixed Dosing|Death|0
1843681|NCT00254293|6378142|P7|LTE Open Label Variable SC Dosing|Other|0
1843682|NCT00254293|6378143|P6|LTE Open Label Variable SC Dosing|Other|0
1843683|NCT00254293|6378144|P5|LTE Open Label Variable SC Dosing|Other|0
1843684|NCT00254293|6378145|P4|LTE Open Label Variable SC Dosing|Other|0
1843685|NCT00254293|6378146|P3|LTE Open Label Variable SC Dosing|Other|2
1843686|NCT00254293|6378147|P2|LTE Open Label Variable SC Dosing|Other|0
1843687|NCT00254293|6378148|P1|LTE Open Label Variable SC Dosing|Other|0
1843688|NCT00254293|6378142|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1843689|NCT00254293|6378143|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1843690|NCT00254293|6378144|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1843691|NCT00254293|6378145|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1843692|NCT00254293|6378146|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
1843693|NCT00254293|6378147|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1843694|NCT00254293|6378148|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
1843695|NCT00254293|6378142|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1843696|NCT00254293|6378143|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1843697|NCT00254293|6378144|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1843698|NCT00254293|6378145|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1843699|NCT00254293|6378146|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
1843700|NCT00254293|6378147|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1843701|NCT00254293|6378148|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
1843702|NCT00254293|6378142|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1843703|NCT00254293|6378143|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1843704|NCT00254293|6378144|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1843705|NCT00254293|6378145|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1843706|NCT00254293|6378146|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
1843707|NCT00254293|6378147|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1843708|NCT00254293|6378148|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
1843709|NCT00254293|6378142|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1843710|NCT00254293|6378143|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1843711|NCT00254293|6378144|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
1843712|NCT00254293|6378145|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1843713|NCT00254293|6378146|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1843714|NCT00254293|6378147|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
1843715|NCT00254293|6378148|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
1843716|NCT00254293|6378142|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
1843717|NCT00254293|6378143|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
1843718|NCT00254293|6378144|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
1843719|NCT00254293|6378145|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
1843720|NCT00254293|6378146|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
1843721|NCT00254293|6378147|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
1843722|NCT00254293|6378148|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
1843723|NCT00254293|6378142|P7|LTE Open Label Variable SC Dosing|Death|0
1843724|NCT00254293|6378143|P6|LTE Open Label Variable SC Dosing|Death|0
1843725|NCT00254293|6378144|P5|LTE Open Label Variable SC Dosing|Death|0
1843726|NCT00254293|6378145|P4|LTE Open Label Variable SC Dosing|Death|0
1843727|NCT00254293|6378146|P3|LTE Open Label Variable SC Dosing|Death|1
1843728|NCT00254293|6378147|P2|LTE Open Label Variable SC Dosing|Death|0
1843729|NCT00254293|6378148|P1|LTE Open Label Variable SC Dosing|Death|0
1843730|NCT00254293|6378142|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1843731|NCT00254293|6378143|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1843732|NCT00254293|6378144|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1843733|NCT00254293|6378145|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1843734|NCT00254293|6378146|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
1843735|NCT00254293|6378147|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1843736|NCT00254293|6378148|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
1843737|NCT00254293|6378142|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1843738|NCT00254293|6378143|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1843739|NCT00254293|6378144|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1843740|NCT00254293|6378145|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1843741|NCT00254293|6378146|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
1843742|NCT00254293|6378147|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1843743|NCT00254293|6378148|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
1843744|NCT00254293|6378142|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1843745|NCT00254293|6378143|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1843746|NCT00254293|6378144|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1843747|NCT00254293|6378145|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1843748|NCT00254293|6378146|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1843749|NCT00254293|6378147|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
1843750|NCT00254293|6378148|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
1843751|NCT00254163|6378231|P2|Overall Study|Other|8
1843752|NCT00254163|6378232|P1|Overall Study|Other|8
1843753|NCT00254163|6378231|P2|Overall Study|Death|1
1843754|NCT00254163|6378232|P1|Overall Study|Death|0
1843755|NCT00254163|6378231|P2|Overall Study|Progressive disease|1
1843756|NCT00254163|6378232|P1|Overall Study|Progressive disease|0
1843757|NCT00254163|6378231|P2|Overall Study|Failed entry|3
1843758|NCT00254163|6378232|P1|Overall Study|Failed entry|1
1843759|NCT00254163|6378231|P2|Overall Study|Investigator request|3
1843760|NCT00254163|6378232|P1|Overall Study|Investigator request|1
1843761|NCT00254163|6378231|P2|Overall Study|Patient request/withdrew consent|4
1843762|NCT00254163|6378232|P1|Overall Study|Patient request/withdrew consent|6
1843763|NCT00254163|6378231|P2|Overall Study|Adverse Event|26
1843764|NCT00254163|6378232|P1|Overall Study|Adverse Event|29
1843765|NCT00253747|6378283|P2|Overall Study|Administrative Discharge (1), Other (2)|2
1843766|NCT00253747|6378284|P1|Overall Study|Administrative Discharge (1), Other (2)|1
1843767|NCT00253747|6378283|P2|Overall Study|Withdrawal by Subject|11
1843768|NCT00253747|6378284|P1|Overall Study|Withdrawal by Subject|10
1843769|NCT00253747|6378283|P2|Overall Study|Lost to Follow-up|14
1843770|NCT00253747|6378284|P1|Overall Study|Lost to Follow-up|13
1843771|NCT00253643|6378337|P4|Overall Study|Non-Compliance|2
1843772|NCT00253643|6378338|P3|Overall Study|Non-Compliance|0
1843773|NCT00253643|6378339|P2|Overall Study|Non-Compliance|0
1843774|NCT00253643|6378340|P1|Overall Study|Non-Compliance|0
1843775|NCT00253643|6378337|P4|Overall Study|Withdrawal by Subject|1
1843776|NCT00253643|6378338|P3|Overall Study|Withdrawal by Subject|1
1843777|NCT00253643|6378339|P2|Overall Study|Withdrawal by Subject|0
1843778|NCT00253643|6378340|P1|Overall Study|Withdrawal by Subject|0
1843779|NCT00253630|6378354|P1|Overall Study|ineligible|2
1843780|NCT00253448|6378370|P1|Overall Study|Withdrawal by Subject|1
1843781|NCT00253370|6378389|P1|Overall Study|Abdominal pain due to disease|1
1843782|NCT00253370|6378389|P1|Overall Study|Protocol Violation|1
1843783|NCT00253370|6378389|P1|Overall Study|Physician Decision|1
1843784|NCT00253370|6378389|P1|Overall Study|Non-protocol therapy|1
1843785|NCT00253370|6378389|P1|Overall Study|Withdrawal by Subject|6
1843786|NCT00253370|6378389|P1|Overall Study|Death|2
1843787|NCT00253370|6378389|P1|Overall Study|Disease progression|13
1843788|NCT00253370|6378389|P1|Overall Study|Adverse Event|18
1843789|NCT00252733|6378435|P2|Overall Study|Multiple Reasons|14
1843790|NCT00252733|6378436|P1|Overall Study|Multiple Reasons|14
1843791|NCT00252733|6378435|P2|Overall Study|Lost to Follow-up|6
1843792|NCT00252733|6378436|P1|Overall Study|Lost to Follow-up|12
1843793|NCT00252733|6378435|P2|Overall Study|Death|5
1843794|NCT00252733|6378436|P1|Overall Study|Death|7
1843795|NCT00252733|6378435|P2|Overall Study|Withdrawal by Subject|67
1843796|NCT00252733|6378436|P1|Overall Study|Withdrawal by Subject|73
1843797|NCT00252720|6378446|P2|Overall Study|Mainly patients lost to follow-up|18
1843798|NCT00252720|6378447|P1|Overall Study|Mainly patients lost to follow-up|7
1843799|NCT00252720|6378446|P2|Overall Study|Moving|42
1843800|NCT00252720|6378447|P1|Overall Study|Moving|23
1843801|NCT00252720|6378446|P2|Overall Study|Death|8
1843802|NCT00252720|6378447|P1|Overall Study|Death|7
1843803|NCT00252720|6378446|P2|Overall Study|Withdrawal by Subject|97
1843804|NCT00252720|6378447|P1|Overall Study|Withdrawal by Subject|95
1843805|NCT00252694|6378461|P2|Overall Study|Patient Moving|16
1843806|NCT00252694|6378462|P1|Overall Study|Patient Moving|17
1843807|NCT00252694|6378461|P2|Overall Study|Mostly Lost to Follow Up|13
1843808|NCT00252694|6378462|P1|Overall Study|Mostly Lost to Follow Up|8
1843809|NCT00252694|6378461|P2|Overall Study|Death|34
1843810|NCT00252694|6378462|P1|Overall Study|Death|36
1843811|NCT00252694|6378461|P2|Overall Study|Withdrawal by Subject|91
1843812|NCT00252694|6378462|P1|Overall Study|Withdrawal by Subject|83
1843813|NCT00252577|6378508|P1|Overall Study|Lost to Follow-up|20
1843814|NCT00252564|6378514|P2|Overall Study|Withdrawal by Subject|2
1843815|NCT00252564|6378515|P1|Overall Study|Withdrawal by Subject|0
1843816|NCT00252564|6378514|P2|Overall Study|Patient Request|5
1843817|NCT00252564|6378515|P1|Overall Study|Patient Request|4
1843818|NCT00252564|6378514|P2|Overall Study|Lost to Follow-up|0
1843819|NCT00252564|6378515|P1|Overall Study|Lost to Follow-up|1
1843820|NCT00252564|6378514|P2|Overall Study|Physician Decision|0
1843821|NCT00252564|6378515|P1|Overall Study|Physician Decision|1
1843822|NCT00252564|6378514|P2|Overall Study|Death|3
1843823|NCT00252564|6378515|P1|Overall Study|Death|0
1843824|NCT00252564|6378514|P2|Overall Study|Disease Progression|20
1843825|NCT00252564|6378515|P1|Overall Study|Disease Progression|14
1843826|NCT00252564|6378514|P2|Overall Study|Unrelated Complication|1
1843827|NCT00252564|6378515|P1|Overall Study|Unrelated Complication|2
1843828|NCT00252564|6378514|P2|Overall Study|Adverse Event|13
1843829|NCT00252564|6378515|P1|Overall Study|Adverse Event|17
1843830|NCT00252499|6378555|P3|Overall Study|Lost to Follow-up|0
1843831|NCT00252499|6378556|P2|Overall Study|Lost to Follow-up|0
1843832|NCT00252499|6378557|P1|Overall Study|Lost to Follow-up|1
1843833|NCT00252239|6378589|P4|Overall Study|Lost to Follow-up|0
1843834|NCT00252239|6378590|P3|Overall Study|Lost to Follow-up|2
1843835|NCT00252239|6378591|P2|Overall Study|Lost to Follow-up|0
1843836|NCT00252239|6378592|P1|Overall Study|Lost to Follow-up|0
1843837|NCT00252239|6378589|P4|Overall Study|Withdrawal by Subject|1
1843838|NCT00252239|6378590|P3|Overall Study|Withdrawal by Subject|0
1843839|NCT00252239|6378591|P2|Overall Study|Withdrawal by Subject|0
1843840|NCT00252239|6378592|P1|Overall Study|Withdrawal by Subject|1
1843841|NCT00252187|6378604|P2|Overall Study|Withdrawal by Subject|0
1843842|NCT00252187|6378605|P1|Overall Study|Withdrawal by Subject|1
1843843|NCT00252187|6378604|P2|Overall Study|Adverse Event|1
1843844|NCT00252187|6378605|P1|Overall Study|Adverse Event|3
1843845|NCT00252174|6378628|P3|Overall Study|Withdrawal by Subject|0
1843846|NCT00252174|6378629|P2|Overall Study|Withdrawal by Subject|1
1843847|NCT00252174|6378630|P1|Overall Study|Withdrawal by Subject|0
1843848|NCT00252057|6378670|P2|Overall Study|Participant previously enrolled|1
1843849|NCT00252057|6378671|P1|Overall Study|Participant previously enrolled|0
1843850|NCT00252057|6378670|P2|Overall Study|Death|2
1843851|NCT00252057|6378671|P1|Overall Study|Death|1
1843852|NCT00252057|6378670|P2|Overall Study|Withdrawal by Subject|5
1843853|NCT00252057|6378671|P1|Overall Study|Withdrawal by Subject|2
1843854|NCT00251979|6378679|P2|Overall Study|Death|5
1843855|NCT00251979|6378680|P1|Overall Study|Death|3
1843856|NCT00251979|6378679|P2|Overall Study|Lost to Follow-up|6
1843857|NCT00251979|6378680|P1|Overall Study|Lost to Follow-up|8
1843858|NCT00251979|6378679|P2|Overall Study|Withdrawal by Subject|7
1843859|NCT00251979|6378680|P1|Overall Study|Withdrawal by Subject|13
1843860|NCT00251979|6378679|P2|Overall Study|Adverse Event|17
1843861|NCT00251979|6378680|P1|Overall Study|Adverse Event|11
1843862|NCT00251979|6378679|P2|Overall Study|Protocol Violation|5
1843863|NCT00251979|6378680|P1|Overall Study|Protocol Violation|3
1843864|NCT00251927|6378712|P2|Overall Study|Study procedure non-compliance|6
1843865|NCT00251927|6378713|P1|Overall Study|Study procedure non-compliance|5
1843866|NCT00251927|6378712|P2|Overall Study|Study-specific discont. achieved|2
1843867|NCT00251927|6378713|P1|Overall Study|Study-specific discont. achieved|13
1843868|NCT00251927|6378712|P2|Overall Study|Withdrawal by Subject|25
1843869|NCT00251927|6378713|P1|Overall Study|Withdrawal by Subject|40
1843870|NCT00251927|6378712|P2|Overall Study|Pregnancy|0
1843871|NCT00251927|6378713|P1|Overall Study|Pregnancy|2
1843872|NCT00251927|6378712|P2|Overall Study|Protocol Violation|2
1843873|NCT00251927|6378713|P1|Overall Study|Protocol Violation|1
1843874|NCT00251927|6378712|P2|Overall Study|Lost to Follow-up|8
1843875|NCT00251927|6378713|P1|Overall Study|Lost to Follow-up|22
1843876|NCT00251927|6378712|P2|Overall Study|Lack of Efficacy|16
1843877|NCT00251927|6378713|P1|Overall Study|Lack of Efficacy|22
1843878|NCT00251927|6378712|P2|Overall Study|Adverse Event|15
1843879|NCT00251927|6378713|P1|Overall Study|Adverse Event|3
1843880|NCT00251758|6378765|P3|Overall Study|Per Investigator Request|0
1843881|NCT00251758|6378766|P2|Overall Study|Per Investigator Request|0
1843882|NCT00251758|6378767|P1|Overall Study|Per Investigator Request|1
1843883|NCT00251758|6378765|P3|Overall Study|Per Subject Request|1
1843884|NCT00251758|6378766|P2|Overall Study|Per Subject Request|0
1843885|NCT00251758|6378767|P1|Overall Study|Per Subject Request|0
1843886|NCT00251758|6378765|P3|Overall Study|Pregnancy|0
1843887|NCT00251758|6378766|P2|Overall Study|Pregnancy|1
1843888|NCT00251758|6378767|P1|Overall Study|Pregnancy|0
1843889|NCT00251758|6378765|P3|Overall Study|Noncompliant|2
1843890|NCT00251758|6378766|P2|Overall Study|Noncompliant|2
1843891|NCT00251758|6378767|P1|Overall Study|Noncompliant|0
1843892|NCT00251758|6378765|P3|Overall Study|Lack of Efficacy|0
1843893|NCT00251758|6378766|P2|Overall Study|Lack of Efficacy|0
1843894|NCT00251758|6378767|P1|Overall Study|Lack of Efficacy|3
1843895|NCT00251758|6378765|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1843896|NCT00251758|6378766|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1843897|NCT00251758|6378767|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1843898|NCT00251758|6378765|P3|Overall Study|Withdrawal by Subject|3
1843899|NCT00251758|6378766|P2|Overall Study|Withdrawal by Subject|7
1843900|NCT00251758|6378767|P1|Overall Study|Withdrawal by Subject|13
1843901|NCT00251758|6378765|P3|Overall Study|Lost to Follow-up|5
1843902|NCT00251758|6378766|P2|Overall Study|Lost to Follow-up|2
1843903|NCT00251758|6378767|P1|Overall Study|Lost to Follow-up|4
1843904|NCT00251758|6378765|P3|Overall Study|Adverse Event|11
1843905|NCT00251758|6378766|P2|Overall Study|Adverse Event|9
1843906|NCT00251758|6378767|P1|Overall Study|Adverse Event|7
1843907|NCT00251745|6378787|P3|Overall Study|Per Investigator Request|0
1843908|NCT00251745|6378788|P2|Overall Study|Per Investigator Request|0
1843909|NCT00251745|6378789|P1|Overall Study|Per Investigator Request|1
1843910|NCT00251745|6378787|P3|Overall Study|Per Subject Request|1
1843911|NCT00251745|6378788|P2|Overall Study|Per Subject Request|0
1843912|NCT00251745|6378789|P1|Overall Study|Per Subject Request|0
1843913|NCT00251745|6378787|P3|Overall Study|Pregnancy|0
1843914|NCT00251745|6378788|P2|Overall Study|Pregnancy|1
1843915|NCT00251745|6378789|P1|Overall Study|Pregnancy|0
1843916|NCT00251745|6378787|P3|Overall Study|Noncompliant|2
1843917|NCT00251745|6378788|P2|Overall Study|Noncompliant|2
1843918|NCT00251745|6378789|P1|Overall Study|Noncompliant|0
1843919|NCT00251745|6378787|P3|Overall Study|Lack of Efficacy|0
1843920|NCT00251745|6378788|P2|Overall Study|Lack of Efficacy|0
1843921|NCT00251745|6378789|P1|Overall Study|Lack of Efficacy|3
1843922|NCT00251745|6378787|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
1843923|NCT00251745|6378788|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
1843924|NCT00251745|6378789|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
1843925|NCT00251745|6378787|P3|Overall Study|Withdrawal by Subject|3
1843926|NCT00251745|6378788|P2|Overall Study|Withdrawal by Subject|7
1843927|NCT00251745|6378789|P1|Overall Study|Withdrawal by Subject|13
1843928|NCT00251745|6378787|P3|Overall Study|Lost to Follow-up|5
1843929|NCT00251745|6378788|P2|Overall Study|Lost to Follow-up|2
1843930|NCT00251745|6378789|P1|Overall Study|Lost to Follow-up|4
1843931|NCT00251745|6378787|P3|Overall Study|Adverse Event|11
1843932|NCT00251745|6378788|P2|Overall Study|Adverse Event|9
1843933|NCT00251745|6378789|P1|Overall Study|Adverse Event|7
1843934|NCT00251719|6378809|P3|Overall Study|Barrett's esophagus|0
1843935|NCT00251719|6378810|P2|Overall Study|Barrett's esophagus|2
1843936|NCT00251719|6378811|P1|Overall Study|Barrett's esophagus|2
1843937|NCT00251719|6378809|P3|Overall Study|Noncompliance|1
1843938|NCT00251719|6378810|P2|Overall Study|Noncompliance|3
1843939|NCT00251719|6378811|P1|Overall Study|Noncompliance|2
1843940|NCT00251719|6378809|P3|Overall Study|Investigator decision|0
1843941|NCT00251719|6378810|P2|Overall Study|Investigator decision|1
1843942|NCT00251719|6378811|P1|Overall Study|Investigator decision|1
1843943|NCT00251719|6378809|P3|Overall Study|Inclusion/exclusion criteria not met|2
1843944|NCT00251719|6378810|P2|Overall Study|Inclusion/exclusion criteria not met|6
1843945|NCT00251719|6378811|P1|Overall Study|Inclusion/exclusion criteria not met|12
1843946|NCT00251719|6378809|P3|Overall Study|Lack of Efficacy|0
1843947|NCT00251719|6378810|P2|Overall Study|Lack of Efficacy|1
1843948|NCT00251719|6378811|P1|Overall Study|Lack of Efficacy|2
1843949|NCT00251719|6378809|P3|Overall Study|Withdrawal by Subject|11
1843950|NCT00251719|6378810|P2|Overall Study|Withdrawal by Subject|12
1843951|NCT00251719|6378811|P1|Overall Study|Withdrawal by Subject|14
1843952|NCT00251719|6378809|P3|Overall Study|Lost to Follow-up|8
1843953|NCT00251719|6378810|P2|Overall Study|Lost to Follow-up|11
1843954|NCT00251719|6378811|P1|Overall Study|Lost to Follow-up|5
1843955|NCT00251719|6378809|P3|Overall Study|Protocol Violation|1
1843956|NCT00251719|6378810|P2|Overall Study|Protocol Violation|1
1843957|NCT00251719|6378811|P1|Overall Study|Protocol Violation|1
1843958|NCT00251719|6378809|P3|Overall Study|Adverse Event|7
1843959|NCT00251719|6378810|P2|Overall Study|Adverse Event|8
1843960|NCT00251719|6378811|P1|Overall Study|Adverse Event|14
1843961|NCT00251693|6378837|P3|Overall Study|Abnormal laboratory findings|1
1843962|NCT00251693|6378838|P2|Overall Study|Abnormal laboratory findings|0
1843963|NCT00251693|6378839|P1|Overall Study|Abnormal laboratory findings|0
1843964|NCT00251693|6378837|P3|Overall Study|Subject request/subject unavailable|0
1843965|NCT00251693|6378838|P2|Overall Study|Subject request/subject unavailable|2
1843966|NCT00251693|6378839|P1|Overall Study|Subject request/subject unavailable|1
1843967|NCT00251693|6378837|P3|Overall Study|Possible Barrett's esophagus|2
1843968|NCT00251693|6378838|P2|Overall Study|Possible Barrett's esophagus|5
1843969|NCT00251693|6378839|P1|Overall Study|Possible Barrett's esophagus|3
1843970|NCT00251693|6378837|P3|Overall Study|Noncompliant|2
1843971|NCT00251693|6378838|P2|Overall Study|Noncompliant|0
1843972|NCT00251693|6378839|P1|Overall Study|Noncompliant|0
1843973|NCT00251693|6378837|P3|Overall Study|Inclusion/exclusion criteria not met|8
1843974|NCT00251693|6378838|P2|Overall Study|Inclusion/exclusion criteria not met|3
1843975|NCT00251693|6378839|P1|Overall Study|Inclusion/exclusion criteria not met|5
1843976|NCT00251693|6378837|P3|Overall Study|Lack of Efficacy|0
1843977|NCT00251693|6378838|P2|Overall Study|Lack of Efficacy|1
1843978|NCT00251693|6378839|P1|Overall Study|Lack of Efficacy|0
1843979|NCT00251693|6378837|P3|Overall Study|Withdrawal by Subject|14
1843980|NCT00251693|6378838|P2|Overall Study|Withdrawal by Subject|17
1843981|NCT00251693|6378839|P1|Overall Study|Withdrawal by Subject|11
1843982|NCT00251693|6378837|P3|Overall Study|Lost to Follow-up|8
1843983|NCT00251693|6378838|P2|Overall Study|Lost to Follow-up|7
1843984|NCT00251693|6378839|P1|Overall Study|Lost to Follow-up|12
1843985|NCT00251693|6378837|P3|Overall Study|Protocol Violation|2
1843986|NCT00251693|6378838|P2|Overall Study|Protocol Violation|0
1843987|NCT00251693|6378839|P1|Overall Study|Protocol Violation|2
1843988|NCT00251693|6378837|P3|Overall Study|Adverse Event|9
1843989|NCT00251693|6378838|P2|Overall Study|Adverse Event|9
1843990|NCT00251693|6378839|P1|Overall Study|Adverse Event|17
1843991|NCT00251641|6378864|P2|Overall Study|Switched Treatment|63
1843992|NCT00251641|6378865|P1|Overall Study|Switched Treatment|9
1843993|NCT00251641|6378864|P2|Overall Study|Did not Meet protocol Eligibility|1
1843994|NCT00251641|6378865|P1|Overall Study|Did not Meet protocol Eligibility|2
1843995|NCT00251641|6378864|P2|Overall Study|Protocol Violation|2
1843996|NCT00251641|6378865|P1|Overall Study|Protocol Violation|10
1843997|NCT00251641|6378864|P2|Overall Study|Withdrawal by Subject|8
1843998|NCT00251641|6378865|P1|Overall Study|Withdrawal by Subject|6
1843999|NCT00251641|6378864|P2|Overall Study|Lost to Follow-up|3
1844000|NCT00251641|6378865|P1|Overall Study|Lost to Follow-up|3
1844001|NCT00251641|6378864|P2|Overall Study|Progression of Disease|2
1844002|NCT00251641|6378865|P1|Overall Study|Progression of Disease|0
1844003|NCT00251641|6378864|P2|Overall Study|Lack of Efficacy|1
1844004|NCT00251641|6378865|P1|Overall Study|Lack of Efficacy|2
1844005|NCT00251641|6378864|P2|Overall Study|Adverse Event|8
1844006|NCT00251641|6378865|P1|Overall Study|Adverse Event|80
1844007|NCT00251589|6378883|P4|Overall Study|Discontinued due to progressive disease|1
1844008|NCT00251589|6378884|P3|Overall Study|Discontinued due to progressive disease|0
1844009|NCT00251589|6378885|P2|Overall Study|Discontinued due to progressive disease|1
1844010|NCT00251589|6378886|P1|Overall Study|Discontinued due to progressive disease|9
1844011|NCT00251589|6378883|P4|Overall Study|Withdrawal by Subject|0
1844012|NCT00251589|6378884|P3|Overall Study|Withdrawal by Subject|0
1844013|NCT00251589|6378885|P2|Overall Study|Withdrawal by Subject|1
1844014|NCT00251589|6378886|P1|Overall Study|Withdrawal by Subject|1
1844015|NCT00251589|6378883|P4|Overall Study|Adverse Event|1
1844016|NCT00251589|6378884|P3|Overall Study|Adverse Event|2
1844017|NCT00251589|6378885|P2|Overall Study|Adverse Event|1
1844018|NCT00251589|6378886|P1|Overall Study|Adverse Event|5
1844019|NCT00251316|6378923|P2|Overall Study|Physician Decision|3
1844020|NCT00251316|6378924|P1|Overall Study|Physician Decision|2
1844021|NCT00251004|6378963|P3|Overall Study|Graft Loss|8
1844022|NCT00251004|6378964|P2|Overall Study|Graft Loss|13
1844023|NCT00251004|6378965|P1|Overall Study|Graft Loss|12
1844024|NCT00251004|6378963|P3|Overall Study|Lost to Follow-up|1
1844025|NCT00251004|6378964|P2|Overall Study|Lost to Follow-up|2
1844026|NCT00251004|6378965|P1|Overall Study|Lost to Follow-up|1
1844027|NCT00251004|6378963|P3|Overall Study|Death|8
1844028|NCT00251004|6378964|P2|Overall Study|Death|10
1844029|NCT00251004|6378965|P1|Overall Study|Death|9
1844030|NCT00251004|6378963|P3|Overall Study|Withdrawal by Subject|14
1844031|NCT00251004|6378964|P2|Overall Study|Withdrawal by Subject|16
1844032|NCT00251004|6378965|P1|Overall Study|Withdrawal by Subject|23
1844033|NCT00250835|6378989|P1|Overall Study|Withdrawal by Subject|1
1844034|NCT00250718|6378998|P1|Overall Study|Withdrawal by Subject|1
1844035|NCT00250718|6378998|P1|Overall Study|Adverse Event|1
1844036|NCT00250718|6378998|P1|Overall Study|Death|1
1844037|NCT00250705|6379003|P1|Overall Study|Lack of Efficacy|2
1844038|NCT00250679|6379014|P3|Overall Study|various single events: hip surgery,diary|1
1844039|NCT00250679|6379015|P2|Overall Study|various single events: hip surgery,diary|1
1844040|NCT00250679|6379016|P1|Overall Study|various single events: hip surgery,diary|3
1844041|NCT00250679|6379014|P3|Overall Study|Non-compliance|0
1844042|NCT00250679|6379015|P2|Overall Study|Non-compliance|1
1844043|NCT00250679|6379016|P1|Overall Study|Non-compliance|1
1844044|NCT00250679|6379014|P3|Overall Study|Moved|0
1844045|NCT00250679|6379015|P2|Overall Study|Moved|1
1844046|NCT00250679|6379016|P1|Overall Study|Moved|1
1844047|NCT00250679|6379014|P3|Overall Study|Technical Holter issues|2
1844048|NCT00250679|6379015|P2|Overall Study|Technical Holter issues|0
1844049|NCT00250679|6379016|P1|Overall Study|Technical Holter issues|1
1844050|NCT00250679|6379014|P3|Overall Study|Lack of Efficacy|3
1844051|NCT00250679|6379015|P2|Overall Study|Lack of Efficacy|1
1844052|NCT00250679|6379016|P1|Overall Study|Lack of Efficacy|0
1844053|NCT00250679|6379014|P3|Overall Study|Does Not Meet Entry Criteria|2
1844054|NCT00250679|6379015|P2|Overall Study|Does Not Meet Entry Criteria|4
1844055|NCT00250679|6379016|P1|Overall Study|Does Not Meet Entry Criteria|1
1844056|NCT00250679|6379014|P3|Overall Study|Lost to Follow-up|2
1844057|NCT00250679|6379015|P2|Overall Study|Lost to Follow-up|4
1844058|NCT00250679|6379016|P1|Overall Study|Lost to Follow-up|3
1844059|NCT00250679|6379014|P3|Overall Study|Withdrawal by Subject|15
1844060|NCT00250679|6379015|P2|Overall Study|Withdrawal by Subject|18
1844061|NCT00250679|6379016|P1|Overall Study|Withdrawal by Subject|15
1844062|NCT00250679|6379014|P3|Overall Study|Protocol Violation|3
1844063|NCT00250679|6379015|P2|Overall Study|Protocol Violation|4
1844064|NCT00250679|6379016|P1|Overall Study|Protocol Violation|2
1844065|NCT00250679|6379014|P3|Overall Study|Adverse Event|16
1844066|NCT00250679|6379015|P2|Overall Study|Adverse Event|15
1844067|NCT00250679|6379016|P1|Overall Study|Adverse Event|12
1844068|NCT00250588|6379117|P3|Overall Study|Lost to Follow-up|13
1844069|NCT00250588|6379118|P2|Overall Study|Lost to Follow-up|13
1844070|NCT00250588|6379119|P1|Overall Study|Lost to Follow-up|6
1844071|NCT00250588|6379117|P3|Overall Study|Withdrawal by Subject|0
1844072|NCT00250588|6379118|P2|Overall Study|Withdrawal by Subject|6
1844073|NCT00250588|6379119|P1|Overall Study|Withdrawal by Subject|3
1844074|NCT00250458|6379167|P2|Overall Study|Other|0
1844075|NCT00250458|6379168|P1|Overall Study|Other|1
1844076|NCT00250458|6379167|P2|Overall Study|Qualifying migraine but did not treat|3
1844077|NCT00250458|6379168|P1|Overall Study|Qualifying migraine but did not treat|3
1844078|NCT00250458|6379167|P2|Overall Study|Lack of Migraine Attack|9
1844079|NCT00250458|6379168|P1|Overall Study|Lack of Migraine Attack|20
1844080|NCT00250458|6379167|P2|Overall Study|Withdrawal by Subject|2
1844081|NCT00250458|6379168|P1|Overall Study|Withdrawal by Subject|4
1844082|NCT00250458|6379167|P2|Overall Study|Protocol Violation|1
1844083|NCT00250458|6379168|P1|Overall Study|Protocol Violation|0
1844084|NCT00250458|6379167|P2|Overall Study|Lost to Follow-up|2
1844085|NCT00250458|6379168|P1|Overall Study|Lost to Follow-up|4
1844086|NCT00250432|6379178|P2|Overall Study|Pt was considered untreatable|1
1844087|NCT00250432|6379179|P1|Overall Study|Pt was considered untreatable|0
1844088|NCT00250432|6379178|P2|Overall Study|Pt died out of posttherapy report period|5
1844089|NCT00250432|6379179|P1|Overall Study|Pt died out of posttherapy report period|6
1844090|NCT00250432|6379178|P2|Overall Study|Withdrawal by Subject|2
1844091|NCT00250432|6379179|P1|Overall Study|Withdrawal by Subject|6
1844092|NCT00250432|6379178|P2|Overall Study|Protocol Violation|3
1844093|NCT00250432|6379179|P1|Overall Study|Protocol Violation|0
1844094|NCT00250432|6379178|P2|Overall Study|Patient Moved|1
1844095|NCT00250432|6379179|P1|Overall Study|Patient Moved|0
1844096|NCT00250432|6379178|P2|Overall Study|Lost to Follow-up|5
1844097|NCT00250432|6379179|P1|Overall Study|Lost to Follow-up|6
1844098|NCT00250432|6379178|P2|Overall Study|Lack of Efficacy|1
1844099|NCT00250432|6379179|P1|Overall Study|Lack of Efficacy|2
1844100|NCT00250432|6379178|P2|Overall Study|Adverse Event|29
1844101|NCT00250432|6379179|P1|Overall Study|Adverse Event|25
1844102|NCT00250276|6379191|P4|Overall Study|Lost to Follow-up|8
1844103|NCT00250276|6379192|P3|Overall Study|Lost to Follow-up|13
1844104|NCT00250276|6379193|P2|Overall Study|Lost to Follow-up|18
1844105|NCT00250276|6379194|P1|Overall Study|Lost to Follow-up|11
1844106|NCT00250276|6379191|P4|Overall Study|Migrated/moved from study area|7
1844107|NCT00250276|6379192|P3|Overall Study|Migrated/moved from study area|2
1844108|NCT00250276|6379193|P2|Overall Study|Migrated/moved from study area|0
1844109|NCT00250276|6379194|P1|Overall Study|Migrated/moved from study area|3
1844110|NCT00250276|6379191|P4|Overall Study|Withdrawal by Subject|2
1844111|NCT00250276|6379192|P3|Overall Study|Withdrawal by Subject|3
1844112|NCT00250276|6379193|P2|Overall Study|Withdrawal by Subject|2
1844113|NCT00250276|6379194|P1|Overall Study|Withdrawal by Subject|1
1844114|NCT00250276|6379191|P4|Overall Study|Protocol Violation|0
1844115|NCT00250276|6379192|P3|Overall Study|Protocol Violation|0
1844116|NCT00250276|6379193|P2|Overall Study|Protocol Violation|1
1844117|NCT00250276|6379194|P1|Overall Study|Protocol Violation|0
1844118|NCT00250276|6379191|P4|Overall Study|Non-serious Adverse Event|2
1844119|NCT00250276|6379192|P3|Overall Study|Non-serious Adverse Event|0
1844120|NCT00250276|6379193|P2|Overall Study|Non-serious Adverse Event|0
1844121|NCT00250276|6379194|P1|Overall Study|Non-serious Adverse Event|2
1844122|NCT00250276|6379191|P4|Overall Study|Serious Adverse Event|0
1844123|NCT00250276|6379192|P3|Overall Study|Serious Adverse Event|1
1844124|NCT00250276|6379193|P2|Overall Study|Serious Adverse Event|0
1844125|NCT00250276|6379194|P1|Overall Study|Serious Adverse Event|0
1844126|NCT00249873|6379274|P2|Overall Study|Thromboembolic/outcome event|122
1844127|NCT00249873|6379275|P1|Overall Study|Thromboembolic/outcome event|82
1844128|NCT00249873|6379274|P2|Overall Study|Event related to cardiac condition|21
1844129|NCT00249873|6379275|P1|Overall Study|Event related to cardiac condition|12
1844130|NCT00249873|6379274|P2|Overall Study|Surgery/ procedure|9
1844131|NCT00249873|6379275|P1|Overall Study|Surgery/ procedure|9
1844132|NCT00249873|6379274|P2|Overall Study|Study drug intolerance|0
1844133|NCT00249873|6379275|P1|Overall Study|Study drug intolerance|5
1844134|NCT00249873|6379274|P2|Overall Study|Oral anticoagulant required|157
1844135|NCT00249873|6379275|P1|Overall Study|Oral anticoagulant required|159
1844136|NCT00249873|6379274|P2|Overall Study|Angiotensin II receptor blocker required|0
1844137|NCT00249873|6379275|P1|Overall Study|Angiotensin II receptor blocker required|1
1844138|NCT00249873|6379274|P2|Overall Study|Open label clopidogrel required|42
1844139|NCT00249873|6379275|P1|Overall Study|Open label clopidogrel required|31
1844140|NCT00249873|6379274|P2|Overall Study|Physician withdrew consent|60
1844141|NCT00249873|6379275|P1|Overall Study|Physician withdrew consent|59
1844142|NCT00249873|6379274|P2|Overall Study|Patient not wish to continue after May08|4
1844143|NCT00249873|6379275|P1|Overall Study|Patient not wish to continue after May08|3
1844144|NCT00249873|6379274|P2|Overall Study|Other contraindicated medication|0
1844145|NCT00249873|6379275|P1|Overall Study|Other contraindicated medication|1
1844146|NCT00249873|6379274|P2|Overall Study|Other non serious Adverse Event|108
1844147|NCT00249873|6379275|P1|Overall Study|Other non serious Adverse Event|112
1844148|NCT00249873|6379274|P2|Overall Study|Non-compliance|46
1844149|NCT00249873|6379275|P1|Overall Study|Non-compliance|41
1844150|NCT00249873|6379274|P2|Overall Study|Minor bleeding|37
1844151|NCT00249873|6379275|P1|Overall Study|Minor bleeding|99
1844152|NCT00249873|6379274|P2|Overall Study|Lost to Follow-up|7
1844153|NCT00249873|6379275|P1|Overall Study|Lost to Follow-up|4
1844154|NCT00249873|6379274|P2|Overall Study|Withdrawal by Subject|466
1844155|NCT00249873|6379275|P1|Overall Study|Withdrawal by Subject|504
1844156|NCT00249873|6379274|P2|Overall Study|Contraindication to oral anticoagulant|8
1844157|NCT00249873|6379275|P1|Overall Study|Contraindication to oral anticoagulant|4
1844158|NCT00249873|6379274|P2|Overall Study|Qualifying condition not present|23
1844159|NCT00249873|6379275|P1|Overall Study|Qualifying condition not present|20
1844160|NCT00249873|6379274|P2|Overall Study|Other Serious Adverse Event|97
1844161|NCT00249873|6379275|P1|Overall Study|Other Serious Adverse Event|86
1844162|NCT00249873|6379274|P2|Overall Study|Serious haemorrhagic Adverse Event|30
1844163|NCT00249873|6379275|P1|Overall Study|Serious haemorrhagic Adverse Event|74
1844164|NCT00249873|6379274|P2|Overall Study|Severe allergic reaction|1
1844165|NCT00249873|6379275|P1|Overall Study|Severe allergic reaction|8
1844166|NCT00249873|6379274|P2|Overall Study|Significant thrombocytopenia|8
1844167|NCT00249873|6379275|P1|Overall Study|Significant thrombocytopenia|9
1844168|NCT00249873|6379274|P2|Overall Study|Not treated|8
1844169|NCT00249873|6379275|P1|Overall Study|Not treated|7
1844170|NCT00249834|6379295|P8|Overall Study|Protocol Violation|0
1844171|NCT00249834|6379296|P7|Overall Study|Protocol Violation|0
1844172|NCT00249834|6379297|P6|Overall Study|Protocol Violation|2
1844173|NCT00249834|6379298|P5|Overall Study|Protocol Violation|5
1844174|NCT00249834|6379299|P4|Overall Study|Protocol Violation|8
1844175|NCT00249834|6379300|P3|Overall Study|Protocol Violation|14
1844176|NCT00249834|6379301|P2|Overall Study|Protocol Violation|19
1844177|NCT00249834|6379302|P1|Overall Study|Protocol Violation|0
1844178|NCT00249834|6379295|P8|Overall Study|Failure of down-regulation|0
1844179|NCT00249834|6379296|P7|Overall Study|Failure of down-regulation|1
1844180|NCT00249834|6379297|P6|Overall Study|Failure of down-regulation|0
1844181|NCT00249834|6379298|P5|Overall Study|Failure of down-regulation|0
1844182|NCT00249834|6379299|P4|Overall Study|Failure of down-regulation|0
1844183|NCT00249834|6379300|P3|Overall Study|Failure of down-regulation|0
1844184|NCT00249834|6379301|P2|Overall Study|Failure of down-regulation|0
1844185|NCT00249834|6379302|P1|Overall Study|Failure of down-regulation|0
1844186|NCT00249834|6379295|P8|Overall Study|Ovarian stimulation failed|0
1844187|NCT00249834|6379296|P7|Overall Study|Ovarian stimulation failed|0
1844188|NCT00249834|6379297|P6|Overall Study|Ovarian stimulation failed|0
1844189|NCT00249834|6379298|P5|Overall Study|Ovarian stimulation failed|0
1844190|NCT00249834|6379299|P4|Overall Study|Ovarian stimulation failed|0
1844191|NCT00249834|6379300|P3|Overall Study|Ovarian stimulation failed|0
1844192|NCT00249834|6379301|P2|Overall Study|Ovarian stimulation failed|0
1844193|NCT00249834|6379302|P1|Overall Study|Ovarian stimulation failed|1
1844194|NCT00249821|6379351|P2|Overall Study|Technical problem|1
1844195|NCT00249821|6379352|P1|Overall Study|Technical problem|0
1844196|NCT00249808|6379372|P1|Overall Study|Did Not Provide Post-Baseline Data|11
1844197|NCT00249808|6379372|P1|Overall Study|Lack of Efficacy|52
1844198|NCT00249808|6379372|P1|Overall Study|Adverse Event|81
1844199|NCT00249808|6379372|P1|Overall Study|Lost to Follow-up|8
1844200|NCT00249808|6379372|P1|Overall Study|Protocol Violation|3
1844201|NCT00249808|6379372|P1|Overall Study|Other|27
1844202|NCT00249795|6379380|P2|Overall Study|Missing|1
1844203|NCT00249795|6379381|P1|Overall Study|Missing|0
1844204|NCT00249795|6379380|P2|Overall Study|Lost to Follow-up|2
1844205|NCT00249795|6379381|P1|Overall Study|Lost to Follow-up|0
1844206|NCT00249795|6379380|P2|Overall Study|Site not agree to continue after May08|1
1844207|NCT00249795|6379381|P1|Overall Study|Site not agree to continue after May08|1
1844208|NCT00249795|6379380|P2|Overall Study|Patient not wish to continue after May08|6
1844209|NCT00249795|6379381|P1|Overall Study|Patient not wish to continue after May08|4
1844210|NCT00249795|6379380|P2|Overall Study|Event related to cardiac condition|16
1844211|NCT00249795|6379381|P1|Overall Study|Event related to cardiac condition|17
1844212|NCT00249795|6379380|P2|Overall Study|Other contraindicated medication|1
1844213|NCT00249795|6379381|P1|Overall Study|Other contraindicated medication|1
1844214|NCT00249795|6379380|P2|Overall Study|Hypotension (non-symptomatic)|5
1844215|NCT00249795|6379381|P1|Overall Study|Hypotension (non-symptomatic)|5
1844216|NCT00249795|6379380|P2|Overall Study|Lightheadedness / dizziness|11
1844217|NCT00249795|6379381|P1|Overall Study|Lightheadedness / dizziness|15
1844218|NCT00249795|6379380|P2|Overall Study|Angiotensin II receptor blocker required|58
1844219|NCT00249795|6379381|P1|Overall Study|Angiotensin II receptor blocker required|35
1844220|NCT00249795|6379380|P2|Overall Study|Surgery / procedure|5
1844221|NCT00249795|6379381|P1|Overall Study|Surgery / procedure|4
1844222|NCT00249795|6379380|P2|Overall Study|Physician withdrew consent|63
1844223|NCT00249795|6379381|P1|Overall Study|Physician withdrew consent|71
1844224|NCT00249795|6379380|P2|Overall Study|Other adverse events (non-serious)|159
1844225|NCT00249795|6379381|P1|Overall Study|Other adverse events (non-serious)|188
1844226|NCT00249795|6379380|P2|Overall Study|Study drug intolerance|3
1844227|NCT00249795|6379381|P1|Overall Study|Study drug intolerance|3
1844228|NCT00249795|6379380|P2|Overall Study|Non-compliance|69
1844229|NCT00249795|6379381|P1|Overall Study|Non-compliance|71
1844230|NCT00249795|6379380|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
1844231|NCT00249795|6379381|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
1844232|NCT00249795|6379380|P2|Overall Study|Oral anticoagulant required|0
1844233|NCT00249795|6379381|P1|Overall Study|Oral anticoagulant required|2
1844234|NCT00249795|6379380|P2|Overall Study|Thromboembolic / outcome event|45
1844235|NCT00249795|6379381|P1|Overall Study|Thromboembolic / outcome event|39
1844236|NCT00249795|6379380|P2|Overall Study|Withdrawal by Subject|742
1844237|NCT00249795|6379381|P1|Overall Study|Withdrawal by Subject|678
1844238|NCT00249795|6379380|P2|Overall Study|Qualifying condition not present|29
1844239|NCT00249795|6379381|P1|Overall Study|Qualifying condition not present|26
1844240|NCT00249795|6379380|P2|Overall Study|Other Serious Adverse Event|93
1844241|NCT00249795|6379381|P1|Overall Study|Other Serious Adverse Event|84
1844242|NCT00249795|6379380|P2|Overall Study|Symptomatic hypotension|64
1844243|NCT00249795|6379381|P1|Overall Study|Symptomatic hypotension|127
1844244|NCT00249795|6379380|P2|Overall Study|Not treated|14
1844245|NCT00249795|6379381|P1|Overall Study|Not treated|16
1844246|NCT00249613|6379401|P2|12 Month Follow-up|Lost to Follow-up|8
1844247|NCT00249613|6379402|P1|12 Month Follow-up|Lost to Follow-up|10
1844248|NCT00249613|6379401|P2|12 Month Follow-up|Withdrawal by Subject|6
1844249|NCT00249613|6379402|P1|12 Month Follow-up|Withdrawal by Subject|6
1844250|NCT00249613|6379401|P2|12 Month Follow-up|Death|1
1844251|NCT00249613|6379402|P1|12 Month Follow-up|Death|1
1844252|NCT00249444|6379443|P2|Overall Study|life event|1
1844253|NCT00249444|6379444|P1|Overall Study|life event|0
1844254|NCT00249444|6379443|P2|Overall Study|Adverse Event|1
1844255|NCT00249444|6379444|P1|Overall Study|Adverse Event|1
1844256|NCT00249444|6379443|P2|Overall Study|non-compliant|11
1844257|NCT00249444|6379444|P1|Overall Study|non-compliant|9
1844258|NCT00249444|6379443|P2|Overall Study|Lost to Follow-up|2
1844259|NCT00249444|6379444|P1|Overall Study|Lost to Follow-up|2
1844260|NCT00249288|6379469|P2|Overall Study|Withdrawal by Subject|2
1844261|NCT00249288|6379470|P1|Overall Study|Withdrawal by Subject|2
1844262|NCT00249288|6379469|P2|Overall Study|Lost to Follow-up|3
1844263|NCT00249288|6379470|P1|Overall Study|Lost to Follow-up|3
1844264|NCT00249002|6379562|P1|Overall Study|Other|2
1844265|NCT00249002|6379562|P1|Overall Study|Study cancellation|3
1844266|NCT00249002|6379562|P1|Overall Study|Adverse Event|2
1844267|NCT00248833|6379581|P3|Overall Study|Other|0
1844268|NCT00248833|6379582|P2|Overall Study|Other|1
1844269|NCT00248833|6379583|P1|Overall Study|Other|0
1844270|NCT00248833|6379581|P3|Overall Study|Lost to Follow-up|1
1844271|NCT00248833|6379582|P2|Overall Study|Lost to Follow-up|1
1844272|NCT00248833|6379583|P1|Overall Study|Lost to Follow-up|1
1844273|NCT00248833|6379581|P3|Overall Study|Withdrawal by Subject|1
1844274|NCT00248833|6379582|P2|Overall Study|Withdrawal by Subject|1
1844275|NCT00248833|6379583|P1|Overall Study|Withdrawal by Subject|0
1844276|NCT00248833|6379581|P3|Overall Study|Adverse Event|0
1844277|NCT00248833|6379582|P2|Overall Study|Adverse Event|0
1844278|NCT00248833|6379583|P1|Overall Study|Adverse Event|2
1844279|NCT00248794|6379619|P3|Overall Study|Lost to Follow-up|3
1844280|NCT00248794|6379620|P2|Overall Study|Lost to Follow-up|8
1844281|NCT00248794|6379621|P1|Overall Study|Lost to Follow-up|6
1844282|NCT00248651|6379671|P3|Overall Study|Withdrawal by Subject|32
1844283|NCT00248651|6379672|P2|Overall Study|Withdrawal by Subject|40
1844284|NCT00248651|6379673|P1|Overall Study|Withdrawal by Subject|28
1844285|NCT00248625|6379709|P2|Overall Study|Withdrawal by Subject|2
1844286|NCT00248625|6379710|P1|Overall Study|Withdrawal by Subject|0
1844287|NCT00248495|6379802|P1|Overall Study|Withdrawal by Subject|1
1844300|NCT00248170|6379828|P2|Overall Study|Protocol deviation|19
1844301|NCT00248170|6379829|P1|Overall Study|Protocol deviation|17
1844302|NCT00248170|6379828|P2|Overall Study|Abnormal laboratory values|0
1844303|NCT00248170|6379829|P1|Overall Study|Abnormal laboratory values|4
1844304|NCT00248170|6379828|P2|Overall Study|Abnormal test procedure(s) result|61
1844305|NCT00248170|6379829|P1|Overall Study|Abnormal test procedure(s) result|49
1844306|NCT00248170|6379828|P2|Overall Study|Administrative problems|25
1844307|NCT00248170|6379829|P1|Overall Study|Administrative problems|22
1844308|NCT00248170|6379828|P2|Overall Study|Adverse Event|296
1844309|NCT00248170|6379829|P1|Overall Study|Adverse Event|311
1844310|NCT00248170|6379828|P2|Overall Study|Death|47
1844311|NCT00248170|6379829|P1|Overall Study|Death|28
1844312|NCT00248170|6379828|P2|Overall Study|Disease progression|216
1844313|NCT00248170|6379829|P1|Overall Study|Disease progression|196
1844314|NCT00248170|6379828|P2|Overall Study|Lost to Follow-up|35
1844315|NCT00248170|6379829|P1|Overall Study|Lost to Follow-up|28
1844316|NCT00248170|6379828|P2|Overall Study|Protocol Violation|30
1844317|NCT00248170|6379829|P1|Overall Study|Protocol Violation|35
1844318|NCT00248170|6379828|P2|Overall Study|Withdrawal by Subject|79
1844319|NCT00248170|6379829|P1|Overall Study|Withdrawal by Subject|71
1844320|NCT00247962|6379851|P2|Overall Study|Lack of Efficacy|2
1844321|NCT00247962|6379852|P1|Overall Study|Lack of Efficacy|4
1844322|NCT00247962|6379851|P2|Overall Study|Withdrawal by Subject|2
1844323|NCT00247962|6379852|P1|Overall Study|Withdrawal by Subject|3
1844324|NCT00247962|6379851|P2|Overall Study|Protocol Violation|1
1844325|NCT00247962|6379852|P1|Overall Study|Protocol Violation|1
1844326|NCT00247962|6379851|P2|Overall Study|Physician Decision|1
1844327|NCT00247962|6379852|P1|Overall Study|Physician Decision|0
1844328|NCT00247962|6379851|P2|Overall Study|Lost to Follow-up|1
1844329|NCT00247962|6379852|P1|Overall Study|Lost to Follow-up|3
1844330|NCT00247962|6379851|P2|Overall Study|Adverse Event|12
1844331|NCT00247962|6379852|P1|Overall Study|Adverse Event|15
1844332|NCT00247676|6379860|P1|Overall Study|Withdrawal by Subject|2
1844333|NCT00247676|6379860|P1|Overall Study|Other|3
1844334|NCT00247676|6379860|P1|Overall Study|Lack of Efficacy|15
1844335|NCT00247676|6379860|P1|Overall Study|Adverse Event|11
1844336|NCT00247676|6379860|P1|Overall Study|Death|5
1844337|NCT00247611|6379905|P2|Baselined|Completed baseline only|8
1844338|NCT00247611|6379906|P1|Baselined|Completed baseline only|9
1844339|NCT00247611|6379905|P2|Baselined|Completed baseline, never placed on ARVs|5
1844340|NCT00247611|6379906|P1|Baselined|Completed baseline, never placed on ARVs|8
1844341|NCT00247416|6379924|P2|Overall Study|3 patients were found to be ineligible|2
1844342|NCT00247416|6379925|P1|Overall Study|3 patients were found to be ineligible|1
1844343|NCT00247273|6379966|P2|Overall Study|Did not take any study drug|0
1844344|NCT00247273|6379967|P1|Overall Study|Did not take any study drug|2
1844345|NCT00247273|6379966|P2|Overall Study|Withdrawal by Subject|47
1844346|NCT00247273|6379967|P1|Overall Study|Withdrawal by Subject|46
1844347|NCT00247273|6379966|P2|Overall Study|Lost to Follow-up|7
1844348|NCT00247273|6379967|P1|Overall Study|Lost to Follow-up|7
1844349|NCT00247273|6379966|P2|Overall Study|Physician Decision|3
1844350|NCT00247273|6379967|P1|Overall Study|Physician Decision|6
1844351|NCT00247273|6379966|P2|Overall Study|Adverse Event|80
1844352|NCT00247273|6379967|P1|Overall Study|Adverse Event|85
1844353|NCT00246805|6380013|P2|Phase 1|Lost to Follow-up|0
1844354|NCT00246805|6380014|P1|Phase 1|Lost to Follow-up|1
1844355|NCT00246753|6380020|P1|Overall Study|Unacceptable toxicity|2
1844356|NCT00246753|6380020|P1|Overall Study|Adverse Event|2
1844357|NCT00246753|6380020|P1|Overall Study|Physician Decision|2
1844358|NCT00246753|6380020|P1|Overall Study|Withdrawal by Subject|2
1844359|NCT00246740|6380028|P2|Initial Enrollment|Other|2
1844360|NCT00246740|6380029|P1|Initial Enrollment|Other|1
1844361|NCT00246740|6380028|P2|Initial Enrollment|Surgery schedule change|4
1844362|NCT00246740|6380029|P1|Initial Enrollment|Surgery schedule change|4
1844363|NCT00246740|6380028|P2|Initial Enrollment|Additional surgery scheduled|2
1844364|NCT00246740|6380029|P1|Initial Enrollment|Additional surgery scheduled|0
1844365|NCT00246740|6380028|P2|Initial Enrollment|Death|0
1844366|NCT00246740|6380029|P1|Initial Enrollment|Death|1
1844367|NCT00246571|6380053|P2|Overall Study|Crossover participants|74
1844368|NCT00246571|6380054|P1|Overall Study|Crossover participants|0
1844369|NCT00246571|6380053|P2|Overall Study|Laboratory abnormalities|0
1844370|NCT00246571|6380054|P1|Overall Study|Laboratory abnormalities|1
1844371|NCT00246571|6380053|P2|Overall Study|Did not meet entrance criteria|1
1844372|NCT00246571|6380054|P1|Overall Study|Did not meet entrance criteria|2
1844373|NCT00246571|6380053|P2|Overall Study|Sponsor|1
1844374|NCT00246571|6380054|P1|Overall Study|Sponsor|0
1844375|NCT00246571|6380053|P2|Overall Study|Death|3
1844376|NCT00246571|6380054|P1|Overall Study|Death|17
1844377|NCT00246571|6380053|P2|Overall Study|Lack of Efficacy|21
1844378|NCT00246571|6380054|P1|Overall Study|Lack of Efficacy|84
1844379|NCT00246571|6380053|P2|Overall Study|Withdrawal by Subject|3
1844380|NCT00246571|6380054|P1|Overall Study|Withdrawal by Subject|2
1844381|NCT00246571|6380053|P2|Overall Study|Protocol Violation|1
1844382|NCT00246571|6380054|P1|Overall Study|Protocol Violation|0
1844383|NCT00246571|6380053|P2|Overall Study|Adverse Event|0
1844384|NCT00246571|6380054|P1|Overall Study|Adverse Event|7
1844385|NCT00246376|6380119|P5|Overall Study|Lost to Follow-up|13
1844386|NCT00246376|6380120|P4|Overall Study|Lost to Follow-up|16
1844387|NCT00246376|6380121|P3|Overall Study|Lost to Follow-up|11
1844388|NCT00246376|6380122|P2|Overall Study|Lost to Follow-up|11
1844389|NCT00246376|6380123|P1|Overall Study|Lost to Follow-up|2
1844390|NCT00246376|6380119|P5|Overall Study|Adverse Event|1
1844391|NCT00246376|6380120|P4|Overall Study|Adverse Event|3
1844392|NCT00246376|6380121|P3|Overall Study|Adverse Event|1
1844393|NCT00246376|6380122|P2|Overall Study|Adverse Event|3
1844394|NCT00246376|6380123|P1|Overall Study|Adverse Event|2
1844395|NCT00246376|6380119|P5|Overall Study|Dropped/withdrew during dietary run-in|3
1844396|NCT00246376|6380120|P4|Overall Study|Dropped/withdrew during dietary run-in|7
1844397|NCT00246376|6380121|P3|Overall Study|Dropped/withdrew during dietary run-in|4
1844398|NCT00246376|6380122|P2|Overall Study|Dropped/withdrew during dietary run-in|5
1844399|NCT00246376|6380123|P1|Overall Study|Dropped/withdrew during dietary run-in|11
1844400|NCT00246337|6380174|P9|Overall Study|Reported as completing trial in error|0
1844401|NCT00246337|6380175|P8|Overall Study|Reported as completing trial in error|1
1844402|NCT00246337|6380176|P7|Overall Study|Reported as completing trial in error|0
1844403|NCT00246337|6380177|P6|Overall Study|Reported as completing trial in error|0
1844404|NCT00246337|6380178|P5|Overall Study|Reported as completing trial in error|0
1844405|NCT00246337|6380179|P4|Overall Study|Reported as completing trial in error|0
1844406|NCT00246337|6380180|P3|Overall Study|Reported as completing trial in error|0
1844407|NCT00246337|6380181|P2|Overall Study|Reported as completing trial in error|0
1844408|NCT00246337|6380182|P1|Overall Study|Reported as completing trial in error|0
1844409|NCT00246337|6380174|P9|Overall Study|Protocol Violator|0
1844410|NCT00246337|6380175|P8|Overall Study|Protocol Violator|0
1844411|NCT00246337|6380176|P7|Overall Study|Protocol Violator|0
1844412|NCT00246337|6380177|P6|Overall Study|Protocol Violator|0
1844413|NCT00246337|6380178|P5|Overall Study|Protocol Violator|0
1844414|NCT00246337|6380179|P4|Overall Study|Protocol Violator|0
1844415|NCT00246337|6380180|P3|Overall Study|Protocol Violator|0
1844416|NCT00246337|6380181|P2|Overall Study|Protocol Violator|0
1844417|NCT00246337|6380182|P1|Overall Study|Protocol Violator|1
1844418|NCT00246337|6380174|P9|Overall Study|Overwhelmed|0
1844419|NCT00246337|6380175|P8|Overall Study|Overwhelmed|0
1844420|NCT00246337|6380176|P7|Overall Study|Overwhelmed|0
1844421|NCT00246337|6380177|P6|Overall Study|Overwhelmed|1
1844422|NCT00246337|6380178|P5|Overall Study|Overwhelmed|0
1844423|NCT00246337|6380179|P4|Overall Study|Overwhelmed|0
1844424|NCT00246337|6380180|P3|Overall Study|Overwhelmed|0
1844425|NCT00246337|6380181|P2|Overall Study|Overwhelmed|0
1844426|NCT00246337|6380182|P1|Overall Study|Overwhelmed|0
1844427|NCT00246337|6380174|P9|Overall Study|Abnormal baseline lab values|4
1844428|NCT00246337|6380175|P8|Overall Study|Abnormal baseline lab values|0
1844429|NCT00246337|6380176|P7|Overall Study|Abnormal baseline lab values|2
1844430|NCT00246337|6380177|P6|Overall Study|Abnormal baseline lab values|2
1844431|NCT00246337|6380178|P5|Overall Study|Abnormal baseline lab values|0
1844432|NCT00246337|6380179|P4|Overall Study|Abnormal baseline lab values|0
1844433|NCT00246337|6380180|P3|Overall Study|Abnormal baseline lab values|2
1844434|NCT00246337|6380181|P2|Overall Study|Abnormal baseline lab values|0
1844435|NCT00246337|6380182|P1|Overall Study|Abnormal baseline lab values|7
1844436|NCT00246337|6380174|P9|Overall Study|Site Terminated|2
1844437|NCT00246337|6380175|P8|Overall Study|Site Terminated|6
1844438|NCT00246337|6380176|P7|Overall Study|Site Terminated|1
1844439|NCT00246337|6380177|P6|Overall Study|Site Terminated|7
1844440|NCT00246337|6380178|P5|Overall Study|Site Terminated|0
1844441|NCT00246337|6380179|P4|Overall Study|Site Terminated|0
1844442|NCT00246337|6380180|P3|Overall Study|Site Terminated|0
1844443|NCT00246337|6380181|P2|Overall Study|Site Terminated|0
1844444|NCT00246337|6380182|P1|Overall Study|Site Terminated|10
1844445|NCT00246337|6380174|P9|Overall Study|Lack of Qualifying Event|5
1844446|NCT00246337|6380175|P8|Overall Study|Lack of Qualifying Event|2
1844447|NCT00246337|6380176|P7|Overall Study|Lack of Qualifying Event|3
1844448|NCT00246337|6380177|P6|Overall Study|Lack of Qualifying Event|3
1844449|NCT00246337|6380178|P5|Overall Study|Lack of Qualifying Event|1
1844450|NCT00246337|6380179|P4|Overall Study|Lack of Qualifying Event|1
1844451|NCT00246337|6380180|P3|Overall Study|Lack of Qualifying Event|1
1844452|NCT00246337|6380181|P2|Overall Study|Lack of Qualifying Event|2
1844453|NCT00246337|6380182|P1|Overall Study|Lack of Qualifying Event|8
1844454|NCT00246337|6380174|P9|Overall Study|Withdrawal by Subject|0
1844455|NCT00246337|6380175|P8|Overall Study|Withdrawal by Subject|1
1844456|NCT00246337|6380176|P7|Overall Study|Withdrawal by Subject|1
1844457|NCT00246337|6380177|P6|Overall Study|Withdrawal by Subject|0
1844458|NCT00246337|6380178|P5|Overall Study|Withdrawal by Subject|0
1844459|NCT00246337|6380179|P4|Overall Study|Withdrawal by Subject|0
1844460|NCT00246337|6380180|P3|Overall Study|Withdrawal by Subject|0
1844461|NCT00246337|6380181|P2|Overall Study|Withdrawal by Subject|0
1844462|NCT00246337|6380182|P1|Overall Study|Withdrawal by Subject|2
1844463|NCT00246337|6380174|P9|Overall Study|Protocol Violation|0
1844464|NCT00246337|6380175|P8|Overall Study|Protocol Violation|1
1844465|NCT00246337|6380176|P7|Overall Study|Protocol Violation|1
1844466|NCT00246337|6380177|P6|Overall Study|Protocol Violation|0
1844467|NCT00246337|6380178|P5|Overall Study|Protocol Violation|1
1844468|NCT00246337|6380179|P4|Overall Study|Protocol Violation|0
1844469|NCT00246337|6380180|P3|Overall Study|Protocol Violation|0
1844470|NCT00246337|6380181|P2|Overall Study|Protocol Violation|0
1844471|NCT00246337|6380182|P1|Overall Study|Protocol Violation|1
1844472|NCT00246337|6380174|P9|Overall Study|Lost to Follow-up|0
1844473|NCT00246337|6380175|P8|Overall Study|Lost to Follow-up|2
1844474|NCT00246337|6380176|P7|Overall Study|Lost to Follow-up|1
1844475|NCT00246337|6380177|P6|Overall Study|Lost to Follow-up|2
1844476|NCT00246337|6380178|P5|Overall Study|Lost to Follow-up|2
1844477|NCT00246337|6380179|P4|Overall Study|Lost to Follow-up|0
1844478|NCT00246337|6380180|P3|Overall Study|Lost to Follow-up|0
1844479|NCT00246337|6380181|P2|Overall Study|Lost to Follow-up|0
1844480|NCT00246337|6380182|P1|Overall Study|Lost to Follow-up|3
1844481|NCT00246324|6380229|P1|Overall Study|Withdrawal by Subject|1
1844482|NCT00246259|6380236|P2|Overall Study|randomly assigned, not eligible for ITT|6
1844483|NCT00246259|6380237|P1|Overall Study|randomly assigned, not eligible for ITT|2
1844484|NCT00246259|6380236|P2|Overall Study|Withdrawal by Subject|1
1844485|NCT00246259|6380237|P1|Overall Study|Withdrawal by Subject|5
1844486|NCT00246259|6380236|P2|Overall Study|Lost to Follow-up|4
1844487|NCT00246259|6380237|P1|Overall Study|Lost to Follow-up|3
1844488|NCT00246259|6380236|P2|Overall Study|Adverse Event|0
1844489|NCT00246259|6380237|P1|Overall Study|Adverse Event|5
1844490|NCT00246259|6380236|P2|Overall Study|Investigator withdrew participant|0
1844491|NCT00246259|6380237|P1|Overall Study|Investigator withdrew participant|2
1844492|NCT00246259|6380236|P2|Overall Study|Lack of Efficacy|2
1844493|NCT00246259|6380237|P1|Overall Study|Lack of Efficacy|2
1844494|NCT00246259|6380236|P2|Overall Study|Participant non-compliant|9
1844495|NCT00246259|6380237|P1|Overall Study|Participant non-compliant|4
1844496|NCT00246259|6380236|P2|Overall Study|Not stable by Week 18|1
1844497|NCT00246259|6380237|P1|Overall Study|Not stable by Week 18|2
1844498|NCT00246259|6380236|P2|Overall Study|Other|3
1844499|NCT00246259|6380237|P1|Overall Study|Other|3
1844500|NCT00246090|6380271|P1|Overall Study|Not Otherwise Specified|10
1844501|NCT00246090|6380271|P1|Overall Study|Physician Decision|11
1844502|NCT00246090|6380271|P1|Overall Study|Clinical Progression|30
1844503|NCT00246090|6380271|P1|Overall Study|Progressive Disease|212
1844504|NCT00246090|6380271|P1|Overall Study|Withdrawal by Subject|7
1844505|NCT00246090|6380271|P1|Overall Study|Adverse Event|25
1844506|NCT00246025|6380280|P4|Overall Study|unsuitable medical history was found|1
1844507|NCT00246025|6380281|P3|Overall Study|unsuitable medical history was found|0
1844508|NCT00246025|6380282|P2|Overall Study|unsuitable medical history was found|0
1844509|NCT00246025|6380283|P1|Overall Study|unsuitable medical history was found|0
1844510|NCT00246025|6380280|P4|Overall Study|Withdrawal by Subject|2
1844511|NCT00246025|6380281|P3|Overall Study|Withdrawal by Subject|1
1844512|NCT00246025|6380282|P2|Overall Study|Withdrawal by Subject|0
1844513|NCT00246025|6380283|P1|Overall Study|Withdrawal by Subject|3
1844514|NCT00246025|6380280|P4|Overall Study|Adverse Event|10
1844515|NCT00246025|6380281|P3|Overall Study|Adverse Event|9
1844516|NCT00246025|6380282|P2|Overall Study|Adverse Event|9
1844517|NCT00246025|6380283|P1|Overall Study|Adverse Event|7
1844518|NCT00246012|6380342|P9|Overall Study|Randomly assigned but not treated|0
1844519|NCT00246012|6380343|P8|Overall Study|Randomly assigned but not treated|0
1844520|NCT00246012|6380344|P7|Overall Study|Randomly assigned but not treated|1
1844521|NCT00246012|6380345|P6|Overall Study|Randomly assigned but not treated|1
1844522|NCT00246012|6380346|P5|Overall Study|Randomly assigned but not treated|0
1844523|NCT00246012|6380347|P4|Overall Study|Randomly assigned but not treated|0
1844524|NCT00246012|6380348|P3|Overall Study|Randomly assigned but not treated|0
1844525|NCT00246012|6380349|P2|Overall Study|Randomly assigned but not treated|0
1844526|NCT00246012|6380350|P1|Overall Study|Randomly assigned but not treated|0
1844527|NCT00246012|6380342|P9|Overall Study|Other|0
1844528|NCT00246012|6380343|P8|Overall Study|Other|1
1844529|NCT00246012|6380344|P7|Overall Study|Other|0
1844530|NCT00246012|6380345|P6|Overall Study|Other|0
1844531|NCT00246012|6380346|P5|Overall Study|Other|0
1844532|NCT00246012|6380347|P4|Overall Study|Other|0
1844533|NCT00246012|6380348|P3|Overall Study|Other|0
1844534|NCT00246012|6380349|P2|Overall Study|Other|0
1844535|NCT00246012|6380350|P1|Overall Study|Other|0
1844536|NCT00246012|6380342|P9|Overall Study|Disease progression|26
1844537|NCT00246012|6380343|P8|Overall Study|Disease progression|27
1844538|NCT00246012|6380344|P7|Overall Study|Disease progression|30
1844539|NCT00246012|6380345|P6|Overall Study|Disease progression|25
1844540|NCT00246012|6380346|P5|Overall Study|Disease progression|3
1844541|NCT00246012|6380347|P4|Overall Study|Disease progression|3
1844542|NCT00246012|6380348|P3|Overall Study|Disease progression|2
1844543|NCT00246012|6380349|P2|Overall Study|Disease progression|1
1844544|NCT00246012|6380350|P1|Overall Study|Disease progression|3
1844545|NCT00246012|6380342|P9|Overall Study|Withdrawal by Subject|0
1844546|NCT00246012|6380343|P8|Overall Study|Withdrawal by Subject|0
1844547|NCT00246012|6380344|P7|Overall Study|Withdrawal by Subject|0
1844548|NCT00246012|6380345|P6|Overall Study|Withdrawal by Subject|1
1844549|NCT00246012|6380346|P5|Overall Study|Withdrawal by Subject|0
1844550|NCT00246012|6380347|P4|Overall Study|Withdrawal by Subject|0
1844551|NCT00246012|6380348|P3|Overall Study|Withdrawal by Subject|0
1844552|NCT00246012|6380349|P2|Overall Study|Withdrawal by Subject|0
1844553|NCT00246012|6380350|P1|Overall Study|Withdrawal by Subject|0
1844554|NCT00246012|6380342|P9|Overall Study|Adverse Event|2
1844555|NCT00246012|6380343|P8|Overall Study|Adverse Event|0
1844556|NCT00246012|6380344|P7|Overall Study|Adverse Event|0
1844557|NCT00246012|6380345|P6|Overall Study|Adverse Event|1
1844558|NCT00246012|6380346|P5|Overall Study|Adverse Event|0
1844559|NCT00246012|6380347|P4|Overall Study|Adverse Event|0
1844560|NCT00246012|6380348|P3|Overall Study|Adverse Event|0
1844561|NCT00246012|6380349|P2|Overall Study|Adverse Event|0
1844562|NCT00246012|6380350|P1|Overall Study|Adverse Event|0
1844563|NCT00245960|6380445|P2|Overall Study|Lack of Efficacy|6
1844564|NCT00245960|6380446|P1|Overall Study|Lack of Efficacy|4
1844565|NCT00245960|6380445|P2|Overall Study|Withdrawal by Subject|7
1844566|NCT00245960|6380446|P1|Overall Study|Withdrawal by Subject|5
1844567|NCT00245960|6380445|P2|Overall Study|Protocol Violation|3
1844568|NCT00245960|6380446|P1|Overall Study|Protocol Violation|4
1844569|NCT00245960|6380445|P2|Overall Study|Lost to Follow-up|2
1844570|NCT00245960|6380446|P1|Overall Study|Lost to Follow-up|2
1844571|NCT00245960|6380445|P2|Overall Study|Adverse Event|10
1844572|NCT00245960|6380446|P1|Overall Study|Adverse Event|14
1844573|NCT00245856|6380454|P2|Period Two|Withdrawal by Subject|1
1844574|NCT00245856|6380455|P1|Period Two|Withdrawal by Subject|0
1844575|NCT00245765|6380465|P3|Overall Study|Other|4
1844576|NCT00245765|6380466|P2|Overall Study|Other|4
1844577|NCT00245765|6380467|P1|Overall Study|Other|13
1844578|NCT00245765|6380465|P3|Overall Study|Other reason|1
1844579|NCT00245765|6380466|P2|Overall Study|Other reason|0
1844580|NCT00245765|6380467|P1|Overall Study|Other reason|2
1844581|NCT00245765|6380465|P3|Overall Study|Withdrawal by Subject|3
1844582|NCT00245765|6380466|P2|Overall Study|Withdrawal by Subject|0
1844583|NCT00245765|6380467|P1|Overall Study|Withdrawal by Subject|1
1844584|NCT00245765|6380465|P3|Overall Study|Lost to Follow-up|0
1844585|NCT00245765|6380466|P2|Overall Study|Lost to Follow-up|2
1844586|NCT00245765|6380467|P1|Overall Study|Lost to Follow-up|1
1844587|NCT00245765|6380465|P3|Overall Study|Lack of Efficacy|0
1844588|NCT00245765|6380466|P2|Overall Study|Lack of Efficacy|7
1844589|NCT00245765|6380467|P1|Overall Study|Lack of Efficacy|14
1844590|NCT00245765|6380465|P3|Overall Study|Adverse Event|0
1844591|NCT00245765|6380466|P2|Overall Study|Adverse Event|1
1844592|NCT00245765|6380467|P1|Overall Study|Adverse Event|1
1844593|NCT00245583|6380516|P2|Overall Study|Withdrawal by Subject|3
1844594|NCT00245583|6380517|P1|Overall Study|Withdrawal by Subject|2
1844595|NCT00245583|6380516|P2|Overall Study|Lack of Efficacy|0
1844596|NCT00245583|6380517|P1|Overall Study|Lack of Efficacy|1
1844597|NCT00245583|6380516|P2|Overall Study|Adverse Event|1
1844598|NCT00245583|6380517|P1|Overall Study|Adverse Event|2
1844599|NCT00245583|6380516|P2|Overall Study|Lost to Follow-up|5
1844600|NCT00245583|6380517|P1|Overall Study|Lost to Follow-up|1
1844601|NCT00245570|6380537|P6|Washout Between Periods III and IV|Adverse Event|0
1844602|NCT00245570|6380538|P5|Washout Between Periods III and IV|Adverse Event|0
1844603|NCT00245570|6380539|P4|Washout Between Periods III and IV|Adverse Event|0
1844604|NCT00245570|6380540|P3|Washout Between Periods III and IV|Adverse Event|0
1844605|NCT00245570|6380541|P2|Washout Between Periods III and IV|Adverse Event|1
1844606|NCT00245570|6380542|P1|Washout Between Periods III and IV|Adverse Event|0
1844607|NCT00245466|6380676|P3|Overall Study|Administrative reasons|0
1844608|NCT00245466|6380677|P2|Overall Study|Administrative reasons|1
1844609|NCT00245466|6380678|P1|Overall Study|Administrative reasons|0
1844610|NCT00245466|6380676|P3|Overall Study|Death|0
1844611|NCT00245466|6380677|P2|Overall Study|Death|2
1844612|NCT00245466|6380678|P1|Overall Study|Death|0
1844613|NCT00245466|6380676|P3|Overall Study|Protocol Violation|2
1844614|NCT00245466|6380677|P2|Overall Study|Protocol Violation|2
1844615|NCT00245466|6380678|P1|Overall Study|Protocol Violation|1
1844616|NCT00245466|6380676|P3|Overall Study|Disease progression|1
1844617|NCT00245466|6380677|P2|Overall Study|Disease progression|3
1844618|NCT00245466|6380678|P1|Overall Study|Disease progression|0
1844619|NCT00245466|6380676|P3|Overall Study|Lost to Follow-up|0
1844620|NCT00245466|6380677|P2|Overall Study|Lost to Follow-up|0
1844621|NCT00245466|6380678|P1|Overall Study|Lost to Follow-up|3
1844622|NCT00245466|6380676|P3|Overall Study|Withdrawal by Subject|1
1844623|NCT00245466|6380677|P2|Overall Study|Withdrawal by Subject|2
1844624|NCT00245466|6380678|P1|Overall Study|Withdrawal by Subject|2
1844625|NCT00245466|6380676|P3|Overall Study|Insufficient PSA and testosterone suppr|3
1844626|NCT00245466|6380677|P2|Overall Study|Insufficient PSA and testosterone suppr|0
1844627|NCT00245466|6380678|P1|Overall Study|Insufficient PSA and testosterone suppr|0
1844628|NCT00245466|6380676|P3|Overall Study|Insufficient testosterone suppr|21
1844629|NCT00245466|6380677|P2|Overall Study|Insufficient testosterone suppr|12
1844630|NCT00245466|6380678|P1|Overall Study|Insufficient testosterone suppr|12
1844631|NCT00245466|6380676|P3|Overall Study|Low prostate specific antigen suppr|5
1844632|NCT00245466|6380677|P2|Overall Study|Low prostate specific antigen suppr|14
1844633|NCT00245466|6380678|P1|Overall Study|Low prostate specific antigen suppr|16
1844634|NCT00245466|6380676|P3|Overall Study|Adverse Event|4
1844635|NCT00245466|6380677|P2|Overall Study|Adverse Event|8
1844636|NCT00245466|6380678|P1|Overall Study|Adverse Event|2
1844637|NCT00245102|6380721|P6|Overall Study|Clinical progression|0
1844638|NCT00245102|6380722|P5|Overall Study|Clinical progression|0
1844639|NCT00245102|6380723|P4|Overall Study|Clinical progression|0
1844640|NCT00245102|6380724|P3|Overall Study|Clinical progression|0
1844641|NCT00245102|6380725|P2|Overall Study|Clinical progression|0
1844642|NCT00245102|6380726|P1|Overall Study|Clinical progression|1
1844643|NCT00245102|6380721|P6|Overall Study|Participant needed surgery|0
1844644|NCT00245102|6380722|P5|Overall Study|Participant needed surgery|0
1844645|NCT00245102|6380723|P4|Overall Study|Participant needed surgery|0
1844646|NCT00245102|6380724|P3|Overall Study|Participant needed surgery|1
1844647|NCT00245102|6380725|P2|Overall Study|Participant needed surgery|0
1844648|NCT00245102|6380726|P1|Overall Study|Participant needed surgery|0
1844649|NCT00245102|6380721|P6|Overall Study|Decline in performance|2
1844650|NCT00245102|6380722|P5|Overall Study|Decline in performance|0
1844651|NCT00245102|6380723|P4|Overall Study|Decline in performance|1
1844652|NCT00245102|6380724|P3|Overall Study|Decline in performance|0
1844653|NCT00245102|6380725|P2|Overall Study|Decline in performance|2
1844654|NCT00245102|6380726|P1|Overall Study|Decline in performance|0
1844655|NCT00245102|6380721|P6|Overall Study|Adverse Event|2
1844656|NCT00245102|6380722|P5|Overall Study|Adverse Event|0
1844657|NCT00245102|6380723|P4|Overall Study|Adverse Event|1
1844658|NCT00245102|6380724|P3|Overall Study|Adverse Event|5
1844659|NCT00245102|6380725|P2|Overall Study|Adverse Event|2
1844660|NCT00245102|6380726|P1|Overall Study|Adverse Event|4
1844661|NCT00245102|6380721|P6|Overall Study|Death|0
1844662|NCT00245102|6380722|P5|Overall Study|Death|0
1844663|NCT00245102|6380723|P4|Overall Study|Death|1
1844664|NCT00245102|6380724|P3|Overall Study|Death|0
1844665|NCT00245102|6380725|P2|Overall Study|Death|0
1844666|NCT00245102|6380726|P1|Overall Study|Death|0
1844667|NCT00245102|6380721|P6|Overall Study|Protocol Violation|0
1844668|NCT00245102|6380722|P5|Overall Study|Protocol Violation|0
1844669|NCT00245102|6380723|P4|Overall Study|Protocol Violation|0
1844670|NCT00245102|6380724|P3|Overall Study|Protocol Violation|0
1844671|NCT00245102|6380725|P2|Overall Study|Protocol Violation|0
1844672|NCT00245102|6380726|P1|Overall Study|Protocol Violation|1
1844673|NCT00245102|6380721|P6|Overall Study|Not Treated|0
1844674|NCT00245102|6380722|P5|Overall Study|Not Treated|0
1844675|NCT00245102|6380723|P4|Overall Study|Not Treated|0
1844676|NCT00245102|6380724|P3|Overall Study|Not Treated|1
1844677|NCT00245102|6380725|P2|Overall Study|Not Treated|0
1844678|NCT00245102|6380726|P1|Overall Study|Not Treated|1
1844679|NCT00245063|6380742|P2|Overall Study|Death|0
1844680|NCT00245063|6380743|P1|Overall Study|Death|1
1844681|NCT00245063|6380742|P2|Overall Study|Adverse Event|5
1844682|NCT00245063|6380743|P1|Overall Study|Adverse Event|6
1844683|NCT00245050|6380751|P2|Overall Study|Adverse Event|2
1844684|NCT00245050|6380752|P1|Overall Study|Adverse Event|3
1844685|NCT00245037|6380760|P1|Overall Study|Death|17
1844686|NCT00245011|6380770|P1|Overall Study|Lack of Efficacy|1
1844687|NCT00244933|6380782|P1|Overall Study|Not response evaluable|2
1844688|NCT00244881|6380786|P1|Overall Study|Withdrawal by Subject|3
1844689|NCT00244855|6380794|P2|Overall Study|Withdrawal by Subject|1
1844690|NCT00244855|6380795|P1|Overall Study|Withdrawal by Subject|0
1844691|NCT00244764|6380803|P1|Overall Study|Developed Secondary Malignancy|1
1844692|NCT00244764|6380803|P1|Overall Study|Sponsor Terminated Study|2
1844693|NCT00244764|6380803|P1|Overall Study|Primary Investigator Discretion|2
1844694|NCT00244764|6380803|P1|Overall Study|Participant was Hospitalized until Death|1
1844695|NCT00244764|6380803|P1|Overall Study|Declining Performance Status|1
1844696|NCT00244764|6380803|P1|Overall Study|Off Study Medication for >21 Days|1
1844697|NCT00244764|6380803|P1|Overall Study|Death|1
1844698|NCT00244764|6380803|P1|Overall Study|Protocol Violation|2
1844699|NCT00244764|6380803|P1|Overall Study|Disease Progression|13
1844700|NCT00244764|6380803|P1|Overall Study|Withdrawal by Subject|12
1844701|NCT00244764|6380803|P1|Overall Study|Lost to Follow-up|23
1844702|NCT00244764|6380803|P1|Overall Study|Adverse Event|37
1844703|NCT00244751|6380813|P3|Overall Study|Participant randomized by mistake|1
1844704|NCT00244751|6380814|P2|Overall Study|Participant randomized by mistake|0
1844705|NCT00244751|6380815|P1|Overall Study|Participant randomized by mistake|0
1844706|NCT00244751|6380813|P3|Overall Study|Safety reasons|0
1844707|NCT00244751|6380814|P2|Overall Study|Safety reasons|1
1844708|NCT00244751|6380815|P1|Overall Study|Safety reasons|0
1844709|NCT00244751|6380813|P3|Overall Study|Lack of compliance with protocol|0
1844710|NCT00244751|6380814|P2|Overall Study|Lack of compliance with protocol|1
1844711|NCT00244751|6380815|P1|Overall Study|Lack of compliance with protocol|0
1844712|NCT00244751|6380813|P3|Overall Study|Elevated liver enzymes|0
1844713|NCT00244751|6380814|P2|Overall Study|Elevated liver enzymes|0
1844714|NCT00244751|6380815|P1|Overall Study|Elevated liver enzymes|1
1844715|NCT00244751|6380813|P3|Overall Study|Withdrawal by Subject|3
1844716|NCT00244751|6380814|P2|Overall Study|Withdrawal by Subject|5
1844717|NCT00244751|6380815|P1|Overall Study|Withdrawal by Subject|7
1844718|NCT00244751|6380813|P3|Overall Study|Protocol Violation|1
1844719|NCT00244751|6380814|P2|Overall Study|Protocol Violation|0
1844720|NCT00244751|6380815|P1|Overall Study|Protocol Violation|1
1844721|NCT00244751|6380813|P3|Overall Study|Lost to Follow-up|0
1844722|NCT00244751|6380814|P2|Overall Study|Lost to Follow-up|1
1844723|NCT00244751|6380815|P1|Overall Study|Lost to Follow-up|0
1844724|NCT00244751|6380813|P3|Overall Study|Adverse Event|5
1844725|NCT00244751|6380814|P2|Overall Study|Adverse Event|7
1844726|NCT00244751|6380815|P1|Overall Study|Adverse Event|7
1844727|NCT00244725|6380916|P4|Overall Study|Failed to follow-up|1
1844728|NCT00244725|6380917|P3|Overall Study|Failed to follow-up|1
1844729|NCT00244725|6380918|P2|Overall Study|Failed to follow-up|0
1844730|NCT00244725|6380919|P1|Overall Study|Failed to follow-up|0
1844731|NCT00244725|6380916|P4|Overall Study|Vomit|0
1844732|NCT00244725|6380917|P3|Overall Study|Vomit|1
1844733|NCT00244725|6380918|P2|Overall Study|Vomit|0
1844734|NCT00244725|6380919|P1|Overall Study|Vomit|0
1844735|NCT00244725|6380916|P4|Overall Study|Administrative reason|0
1844736|NCT00244725|6380917|P3|Overall Study|Administrative reason|1
1844737|NCT00244725|6380918|P2|Overall Study|Administrative reason|0
1844738|NCT00244725|6380919|P1|Overall Study|Administrative reason|0
1844739|NCT00244725|6380916|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
1844740|NCT00244725|6380917|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
1844741|NCT00244725|6380918|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
1844742|NCT00244725|6380919|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
1844743|NCT00244725|6380916|P4|Overall Study|Received prohibited medication|1
1844744|NCT00244725|6380917|P3|Overall Study|Received prohibited medication|0
1844745|NCT00244725|6380918|P2|Overall Study|Received prohibited medication|1
1844746|NCT00244725|6380919|P1|Overall Study|Received prohibited medication|0
1844747|NCT00244725|6380916|P4|Overall Study|Headache|0
1844748|NCT00244725|6380917|P3|Overall Study|Headache|0
1844749|NCT00244725|6380918|P2|Overall Study|Headache|1
1844750|NCT00244725|6380919|P1|Overall Study|Headache|0
1844751|NCT00244725|6380916|P4|Overall Study|Rehab Refused to allow participantion|0
1844752|NCT00244725|6380917|P3|Overall Study|Rehab Refused to allow participantion|0
1844753|NCT00244725|6380918|P2|Overall Study|Rehab Refused to allow participantion|1
1844754|NCT00244725|6380919|P1|Overall Study|Rehab Refused to allow participantion|0
1844755|NCT00244725|6380916|P4|Overall Study|Mediciation Error|0
1844756|NCT00244725|6380917|P3|Overall Study|Mediciation Error|0
1844757|NCT00244725|6380918|P2|Overall Study|Mediciation Error|1
1844758|NCT00244725|6380919|P1|Overall Study|Mediciation Error|0
1844759|NCT00244725|6380916|P4|Overall Study|Sponsor withdrew the participant|1
1844760|NCT00244725|6380917|P3|Overall Study|Sponsor withdrew the participant|0
1844761|NCT00244725|6380918|P2|Overall Study|Sponsor withdrew the participant|0
1844762|NCT00244725|6380919|P1|Overall Study|Sponsor withdrew the participant|1
1844763|NCT00244725|6380916|P4|Overall Study|Liver function test abnormality|1
1844764|NCT00244725|6380917|P3|Overall Study|Liver function test abnormality|0
1844765|NCT00244725|6380918|P2|Overall Study|Liver function test abnormality|0
1844766|NCT00244725|6380919|P1|Overall Study|Liver function test abnormality|2
1844767|NCT00244725|6380916|P4|Overall Study|Withdrwal by participant|1
1844768|NCT00244725|6380917|P3|Overall Study|Withdrwal by participant|0
1844769|NCT00244725|6380918|P2|Overall Study|Withdrwal by participant|0
1844770|NCT00244725|6380919|P1|Overall Study|Withdrwal by participant|1
1844771|NCT00244725|6380916|P4|Overall Study|Adverse Events|4
1844772|NCT00244725|6380917|P3|Overall Study|Adverse Events|4
1844773|NCT00244725|6380918|P2|Overall Study|Adverse Events|1
1844774|NCT00244725|6380919|P1|Overall Study|Adverse Events|3
1844775|NCT00244725|6380916|P4|Overall Study|Physician Decision|2
1844776|NCT00244725|6380917|P3|Overall Study|Physician Decision|1
1844777|NCT00244725|6380918|P2|Overall Study|Physician Decision|0
1844778|NCT00244725|6380919|P1|Overall Study|Physician Decision|3
1844779|NCT00244725|6380916|P4|Overall Study|Not meet treatment eligibility criteria|0
1844780|NCT00244725|6380917|P3|Overall Study|Not meet treatment eligibility criteria|0
1844781|NCT00244725|6380918|P2|Overall Study|Not meet treatment eligibility criteria|2
1844782|NCT00244725|6380919|P1|Overall Study|Not meet treatment eligibility criteria|1
1844783|NCT00244725|6380916|P4|Overall Study|Withdrawal by Subject|8
1844784|NCT00244725|6380917|P3|Overall Study|Withdrawal by Subject|7
1844785|NCT00244725|6380918|P2|Overall Study|Withdrawal by Subject|7
1844786|NCT00244725|6380919|P1|Overall Study|Withdrawal by Subject|9
1844787|NCT00244725|6380916|P4|Overall Study|Lost to Follow-up|2
1844788|NCT00244725|6380917|P3|Overall Study|Lost to Follow-up|9
1844789|NCT00244725|6380918|P2|Overall Study|Lost to Follow-up|4
1844790|NCT00244725|6380919|P1|Overall Study|Lost to Follow-up|3
1844791|NCT00244712|6380975|P2|Overall Study|Protocol Violation, disease progression|11
1844792|NCT00244712|6380976|P1|Overall Study|Protocol Violation, disease progression|13
1844793|NCT00244712|6380975|P2|Overall Study|Withdrawal by Subject|23
1844794|NCT00244712|6380976|P1|Overall Study|Withdrawal by Subject|13
1844795|NCT00244712|6380975|P2|Overall Study|Lost to Follow-up|52
1844796|NCT00244712|6380976|P1|Overall Study|Lost to Follow-up|45
1844797|NCT00244712|6380975|P2|Overall Study|Lack of Compliance|11
1844798|NCT00244712|6380976|P1|Overall Study|Lack of Compliance|10
1844799|NCT00244712|6380975|P2|Overall Study|Protocol-Defined Virologic Failure|6
1844800|NCT00244712|6380976|P1|Overall Study|Protocol-Defined Virologic Failure|8
1844801|NCT00244712|6380975|P2|Overall Study|Adverse Event|21
1844802|NCT00244712|6380976|P1|Overall Study|Adverse Event|20
1844803|NCT00244621|6381011|P3|Open-label Treatment Period|Moved abroad|1
1844804|NCT00244621|6381012|P2|Open-label Treatment Period|Moved abroad|0
1844805|NCT00244621|6381013|P1|Open-label Treatment Period|Moved abroad|0
1844806|NCT00244621|6381011|P3|Open-label Treatment Period|Adverse Event|1
1844807|NCT00244621|6381012|P2|Open-label Treatment Period|Adverse Event|0
1844808|NCT00244621|6381013|P1|Open-label Treatment Period|Adverse Event|0
1844809|NCT00244621|6381011|P3|Open-label Treatment Period|Withdrawal by Subject|0
1844810|NCT00244621|6381012|P2|Open-label Treatment Period|Withdrawal by Subject|0
1844811|NCT00244621|6381013|P1|Open-label Treatment Period|Withdrawal by Subject|1
1844812|NCT00244621|6381011|P3|Open-label Treatment Period|Lost to Follow-up|0
1844813|NCT00244621|6381012|P2|Open-label Treatment Period|Lost to Follow-up|1
1844814|NCT00244621|6381013|P1|Open-label Treatment Period|Lost to Follow-up|0
1844815|NCT00244621|6381011|P3|Double-blind Treatment Period|Multiple Reasons|1
1844816|NCT00244621|6381012|P2|Double-blind Treatment Period|Multiple Reasons|1
1844817|NCT00244621|6381013|P1|Double-blind Treatment Period|Multiple Reasons|2
1844818|NCT00244621|6381011|P3|Double-blind Treatment Period|Lack of Efficacy|0
1844819|NCT00244621|6381012|P2|Double-blind Treatment Period|Lack of Efficacy|1
1844820|NCT00244621|6381013|P1|Double-blind Treatment Period|Lack of Efficacy|0
1844821|NCT00244621|6381011|P3|Double-blind Treatment Period|Withdrawal by Subject|0
1844822|NCT00244621|6381012|P2|Double-blind Treatment Period|Withdrawal by Subject|1
1844823|NCT00244621|6381013|P1|Double-blind Treatment Period|Withdrawal by Subject|0
1844824|NCT00244621|6381011|P3|Double-blind Treatment Period|Lost to Follow-up|1
1844825|NCT00244621|6381012|P2|Double-blind Treatment Period|Lost to Follow-up|0
1844826|NCT00244621|6381013|P1|Double-blind Treatment Period|Lost to Follow-up|0
1844827|NCT00244374|6381030|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1844828|NCT00244374|6381031|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1844829|NCT00244374|6381032|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1844830|NCT00244374|6381033|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
1844831|NCT00244374|6381034|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
1844832|NCT00244374|6381030|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1844833|NCT00244374|6381031|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1844834|NCT00244374|6381032|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1844835|NCT00244374|6381033|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
1844836|NCT00244374|6381034|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
1844837|NCT00244374|6381030|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1844838|NCT00244374|6381031|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1844839|NCT00244374|6381032|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1844840|NCT00244374|6381033|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
1844841|NCT00244374|6381034|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
1844842|NCT00244374|6381030|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1844843|NCT00244374|6381031|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1844844|NCT00244374|6381032|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1844845|NCT00244374|6381033|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
1844846|NCT00244374|6381034|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
1844847|NCT00244374|6381030|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1844848|NCT00244374|6381031|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1844849|NCT00244374|6381032|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1844850|NCT00244374|6381033|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
1844851|NCT00244374|6381034|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
1844852|NCT00244374|6381030|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1844853|NCT00244374|6381031|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1844854|NCT00244374|6381032|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1844855|NCT00244374|6381033|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
1844856|NCT00244374|6381034|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
1844857|NCT00244374|6381030|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1844858|NCT00244374|6381031|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1844859|NCT00244374|6381032|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1844860|NCT00244374|6381033|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
1844861|NCT00244374|6381034|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
1844862|NCT00244374|6381030|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1844863|NCT00244374|6381031|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1844864|NCT00244374|6381032|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1844865|NCT00244374|6381033|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
1844866|NCT00244374|6381034|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
1844867|NCT00244374|6381030|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1844868|NCT00244374|6381031|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1844869|NCT00244374|6381032|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1844870|NCT00244374|6381033|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
1844871|NCT00244374|6381034|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
1844872|NCT00243932|6381090|P3|Stage 1: Dose Selection|Lost to Follow-up|0
1844873|NCT00243932|6381091|P2|Stage 1: Dose Selection|Lost to Follow-up|0
1844874|NCT00243932|6381092|P1|Stage 1: Dose Selection|Lost to Follow-up|2
1844875|NCT00243919|6381103|P3|Overall Study|Physician Decision|0
1844876|NCT00243919|6381104|P2|Overall Study|Physician Decision|1
1844877|NCT00243919|6381105|P1|Overall Study|Physician Decision|1
1844878|NCT00243919|6381103|P3|Overall Study|Administrative Error|0
1844879|NCT00243919|6381104|P2|Overall Study|Administrative Error|0
1844880|NCT00243919|6381105|P1|Overall Study|Administrative Error|1
1844881|NCT00243919|6381103|P3|Overall Study|Lost to Follow-up|3
1844882|NCT00243919|6381104|P2|Overall Study|Lost to Follow-up|7
1844883|NCT00243919|6381105|P1|Overall Study|Lost to Follow-up|6
1844884|NCT00243919|6381103|P3|Overall Study|Withdrawal by Subject|2
1844885|NCT00243919|6381104|P2|Overall Study|Withdrawal by Subject|6
1844886|NCT00243919|6381105|P1|Overall Study|Withdrawal by Subject|6
1844887|NCT00243919|6381103|P3|Overall Study|Death|6
1844888|NCT00243919|6381104|P2|Overall Study|Death|4
1844889|NCT00243919|6381105|P1|Overall Study|Death|3
1844890|NCT00243841|6381149|P6|Overall Study|Physician Decision|2
1844891|NCT00243841|6381150|P5|Overall Study|Physician Decision|0
1844892|NCT00243841|6381151|P4|Overall Study|Physician Decision|0
1844893|NCT00243841|6381152|P3|Overall Study|Physician Decision|1
1844894|NCT00243841|6381153|P2|Overall Study|Physician Decision|0
1844895|NCT00243841|6381154|P1|Overall Study|Physician Decision|0
1844896|NCT00243659|6381176|P2|Overall Study|Protocol Violation|2
1844897|NCT00243659|6381177|P1|Overall Study|Protocol Violation|1
1844898|NCT00243659|6381176|P2|Overall Study|Withdrawal by Subject|1
1844899|NCT00243659|6381177|P1|Overall Study|Withdrawal by Subject|1
1844900|NCT00243503|6381185|P1|Overall Study|Other|1
1844901|NCT00243503|6381185|P1|Overall Study|Death|1
1844902|NCT00243503|6381185|P1|Overall Study|Lack of Efficacy|44
1844903|NCT00243503|6381185|P1|Overall Study|Withdrawal by Subject|1
1844904|NCT00243503|6381185|P1|Overall Study|Adverse Event|11
1844905|NCT00243412|6381202|P2|Overall Study|Other|1
1844906|NCT00243412|6381203|P1|Overall Study|Other|1
1844907|NCT00243412|6381202|P2|Overall Study|Withdrawal by Subject|5
1844908|NCT00243412|6381203|P1|Overall Study|Withdrawal by Subject|4
1844909|NCT00243412|6381202|P2|Overall Study|Physician Decision|1
1844910|NCT00243412|6381203|P1|Overall Study|Physician Decision|1
1844911|NCT00243412|6381202|P2|Overall Study|Lost to Follow-up|1
1844912|NCT00243412|6381203|P1|Overall Study|Lost to Follow-up|0
1844913|NCT00243412|6381202|P2|Overall Study|Adverse Event|2
1844914|NCT00243412|6381203|P1|Overall Study|Adverse Event|4
1844915|NCT00243412|6381202|P2|Overall Study|Death|1
1844916|NCT00243412|6381203|P1|Overall Study|Death|0
1844917|NCT00243386|6381229|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1844918|NCT00243386|6381230|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
1844919|NCT00243386|6381231|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
1844920|NCT00243386|6381229|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1844921|NCT00243386|6381230|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
1844922|NCT00243386|6381231|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
1844923|NCT00243386|6381229|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1844924|NCT00243386|6381230|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
1844925|NCT00243386|6381231|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
1844926|NCT00243386|6381229|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1844927|NCT00243386|6381230|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
1844928|NCT00243386|6381231|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
1844929|NCT00243386|6381229|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1844930|NCT00243386|6381230|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
1844931|NCT00243386|6381231|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
1844932|NCT00243386|6381229|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
1844933|NCT00243386|6381230|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
1844934|NCT00243386|6381231|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
1844935|NCT00243386|6381229|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1844936|NCT00243386|6381230|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
1844937|NCT00243386|6381231|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
1844938|NCT00243386|6381229|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1844939|NCT00243386|6381230|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
1844940|NCT00243386|6381231|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
1844941|NCT00243347|6381296|P1|Overall Study|Condition worsened|7
1844942|NCT00243347|6381296|P1|Overall Study|Withdrawal by Subject|5
1844943|NCT00243347|6381296|P1|Overall Study|Death|1
1844944|NCT00243347|6381296|P1|Overall Study|Adverse Event|2
1844945|NCT00243347|6381296|P1|Overall Study|Lack of Efficacy|4
1844946|NCT00243269|6381305|P4|Overall Study|Lost to Follow-up|3
1844947|NCT00243269|6381306|P3|Overall Study|Lost to Follow-up|1
1844948|NCT00243269|6381307|P2|Overall Study|Lost to Follow-up|0
1844949|NCT00243269|6381308|P1|Overall Study|Lost to Follow-up|1
1844950|NCT00243269|6381305|P4|Overall Study|Protocol Violation|1
1844951|NCT00243269|6381306|P3|Overall Study|Protocol Violation|0
1844952|NCT00243269|6381307|P2|Overall Study|Protocol Violation|1
1844953|NCT00243269|6381308|P1|Overall Study|Protocol Violation|2
1844954|NCT00243074|6381343|P1|Overall Study|Did not receive any treatment|1
1844955|NCT00243074|6381343|P1|Overall Study|not protocol specified|1
1844956|NCT00243074|6381343|P1|Overall Study|Death|2
1844957|NCT00243074|6381343|P1|Overall Study|Lack of Efficacy|36
1844958|NCT00243074|6381343|P1|Overall Study|Withdrawal by Subject|2
1844959|NCT00243074|6381343|P1|Overall Study|Adverse Event|6
1844960|NCT00243074|6381343|P1|Overall Study|Ineligible|6
1844961|NCT00243022|6381369|P2|Overall Study|Difficult Travel Distance|1
1844962|NCT00243022|6381370|P1|Overall Study|Difficult Travel Distance|0
1844963|NCT00243022|6381369|P2|Overall Study|Death|0
1844964|NCT00243022|6381370|P1|Overall Study|Death|1
1844965|NCT00243022|6381369|P2|Overall Study|Withdrawal by Subject|0
1844966|NCT00243022|6381370|P1|Overall Study|Withdrawal by Subject|1
1844967|NCT00242710|6381394|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
1844968|NCT00242710|6381395|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
1844969|NCT00242710|6381396|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
1844970|NCT00242710|6381397|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
1844971|NCT00242710|6381394|P4|Study Extension (up to Year 2)|Protocol Violation|1
1844972|NCT00242710|6381395|P3|Study Extension (up to Year 2)|Protocol Violation|0
1844973|NCT00242710|6381396|P2|Study Extension (up to Year 2)|Protocol Violation|2
1844974|NCT00242710|6381397|P1|Study Extension (up to Year 2)|Protocol Violation|0
1844975|NCT00242710|6381394|P4|Study Extension (up to Year 2)|Other|3
1844976|NCT00242710|6381395|P3|Study Extension (up to Year 2)|Other|4
1844977|NCT00242710|6381396|P2|Study Extension (up to Year 2)|Other|5
1844978|NCT00242710|6381397|P1|Study Extension (up to Year 2)|Other|3
1844979|NCT00242710|6381394|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
1844980|NCT00242710|6381395|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
1844981|NCT00242710|6381396|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
1844982|NCT00242710|6381397|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
1844983|NCT00242710|6381394|P4|Study Extension (up to Year 2)|Death|1
1844984|NCT00242710|6381395|P3|Study Extension (up to Year 2)|Death|0
1844985|NCT00242710|6381396|P2|Study Extension (up to Year 2)|Death|0
1844986|NCT00242710|6381397|P1|Study Extension (up to Year 2)|Death|0
1844987|NCT00242710|6381394|P4|Study Extension (up to Year 2)|Adverse Event|4
1844988|NCT00242710|6381395|P3|Study Extension (up to Year 2)|Adverse Event|2
1844989|NCT00242710|6381396|P2|Study Extension (up to Year 2)|Adverse Event|9
1844990|NCT00242710|6381397|P1|Study Extension (up to Year 2)|Adverse Event|7
1844991|NCT00242710|6381394|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
1844992|NCT00242710|6381395|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
1844993|NCT00242710|6381396|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
1844994|NCT00242710|6381397|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
1844995|NCT00242710|6381394|P4|Period Between Core Study and Extension|Protocol Violation|1
1844996|NCT00242710|6381395|P3|Period Between Core Study and Extension|Protocol Violation|2
1844997|NCT00242710|6381396|P2|Period Between Core Study and Extension|Protocol Violation|0
1844998|NCT00242710|6381397|P1|Period Between Core Study and Extension|Protocol Violation|0
1844999|NCT00242710|6381394|P4|Period Between Core Study and Extension|Extension not Available|7
1845000|NCT00242710|6381395|P3|Period Between Core Study and Extension|Extension not Available|8
1845001|NCT00242710|6381396|P2|Period Between Core Study and Extension|Extension not Available|21
1845002|NCT00242710|6381397|P1|Period Between Core Study and Extension|Extension not Available|17
1845003|NCT00242710|6381394|P4|Period Between Core Study and Extension|Other|11
1845004|NCT00242710|6381395|P3|Period Between Core Study and Extension|Other|9
1845005|NCT00242710|6381396|P2|Period Between Core Study and Extension|Other|24
1845006|NCT00242710|6381397|P1|Period Between Core Study and Extension|Other|24
1845007|NCT00242710|6381394|P4|Period Between Core Study and Extension|Physician Decision|0
1845008|NCT00242710|6381395|P3|Period Between Core Study and Extension|Physician Decision|0
1845009|NCT00242710|6381396|P2|Period Between Core Study and Extension|Physician Decision|1
1845010|NCT00242710|6381397|P1|Period Between Core Study and Extension|Physician Decision|1
1845011|NCT00242710|6381394|P4|Period Between Core Study and Extension|Adverse Event|2
1845012|NCT00242710|6381395|P3|Period Between Core Study and Extension|Adverse Event|5
1845013|NCT00242710|6381396|P2|Period Between Core Study and Extension|Adverse Event|3
1845014|NCT00242710|6381397|P1|Period Between Core Study and Extension|Adverse Event|2
1845015|NCT00242710|6381394|P4|Core Study (up to Year 1)|Randomized but not Treated|2
1845016|NCT00242710|6381395|P3|Core Study (up to Year 1)|Randomized but not Treated|4
1845017|NCT00242710|6381396|P2|Core Study (up to Year 1)|Randomized but not Treated|4
1845018|NCT00242710|6381397|P1|Core Study (up to Year 1)|Randomized but not Treated|12
1845019|NCT00242710|6381394|P4|Core Study (up to Year 1)|Lack of Efficacy|0
1845020|NCT00242710|6381395|P3|Core Study (up to Year 1)|Lack of Efficacy|0
1845021|NCT00242710|6381396|P2|Core Study (up to Year 1)|Lack of Efficacy|0
1845022|NCT00242710|6381397|P1|Core Study (up to Year 1)|Lack of Efficacy|1
1845023|NCT00242710|6381394|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
1845024|NCT00242710|6381395|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
1845025|NCT00242710|6381396|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
1845026|NCT00242710|6381397|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
1845027|NCT00242710|6381394|P4|Core Study (up to Year 1)|Protocol Violation|3
1845028|NCT00242710|6381395|P3|Core Study (up to Year 1)|Protocol Violation|1
1845029|NCT00242710|6381396|P2|Core Study (up to Year 1)|Protocol Violation|9
1845030|NCT00242710|6381397|P1|Core Study (up to Year 1)|Protocol Violation|2
1845031|NCT00242710|6381394|P4|Core Study (up to Year 1)|Other|2
1845032|NCT00242710|6381395|P3|Core Study (up to Year 1)|Other|0
1845033|NCT00242710|6381396|P2|Core Study (up to Year 1)|Other|1
1845034|NCT00242710|6381397|P1|Core Study (up to Year 1)|Other|6
1845035|NCT00242710|6381394|P4|Core Study (up to Year 1)|Lost to Follow-up|3
1845036|NCT00242710|6381395|P3|Core Study (up to Year 1)|Lost to Follow-up|7
1845037|NCT00242710|6381396|P2|Core Study (up to Year 1)|Lost to Follow-up|8
1845038|NCT00242710|6381397|P1|Core Study (up to Year 1)|Lost to Follow-up|8
1845039|NCT00242710|6381394|P4|Core Study (up to Year 1)|Physician Decision|1
1845040|NCT00242710|6381395|P3|Core Study (up to Year 1)|Physician Decision|0
1845041|NCT00242710|6381396|P2|Core Study (up to Year 1)|Physician Decision|1
1845042|NCT00242710|6381397|P1|Core Study (up to Year 1)|Physician Decision|0
1845043|NCT00242710|6381394|P4|Core Study (up to Year 1)|Death|0
1845044|NCT00242710|6381395|P3|Core Study (up to Year 1)|Death|1
1845045|NCT00242710|6381396|P2|Core Study (up to Year 1)|Death|0
1845046|NCT00242710|6381397|P1|Core Study (up to Year 1)|Death|0
1845047|NCT00242710|6381394|P4|Core Study (up to Year 1)|Adverse Event|14
1845048|NCT00242710|6381395|P3|Core Study (up to Year 1)|Adverse Event|23
1845049|NCT00242710|6381396|P2|Core Study (up to Year 1)|Adverse Event|25
1845050|NCT00242710|6381397|P1|Core Study (up to Year 1)|Adverse Event|30
1845051|NCT00242658|6381454|P2|Overall Study|Lost to Follow-up|19
1845052|NCT00242658|6381455|P1|Overall Study|Lost to Follow-up|22
1845053|NCT00242580|6381486|P3|Overall Study|Death|1
1845054|NCT00242580|6381487|P2|Overall Study|Death|2
1845055|NCT00242580|6381488|P1|Overall Study|Death|1
1845056|NCT00242580|6381486|P3|Overall Study|Lost to Follow-up|0
1845057|NCT00242580|6381487|P2|Overall Study|Lost to Follow-up|3
1845058|NCT00242580|6381488|P1|Overall Study|Lost to Follow-up|0
1845059|NCT00242580|6381486|P3|Overall Study|Subject withdrew consent|5
1845060|NCT00242580|6381487|P2|Overall Study|Subject withdrew consent|2
1845061|NCT00242580|6381488|P1|Overall Study|Subject withdrew consent|2
1845062|NCT00242580|6381486|P3|Overall Study|Protocol Violation|1
1845063|NCT00242580|6381487|P2|Overall Study|Protocol Violation|0
1845064|NCT00242580|6381488|P1|Overall Study|Protocol Violation|0
1845065|NCT00242580|6381486|P3|Overall Study|Unsatisfactory therapeutic effect|5
1845066|NCT00242580|6381487|P2|Overall Study|Unsatisfactory therapeutic effect|5
1845067|NCT00242580|6381488|P1|Overall Study|Unsatisfactory therapeutic effect|4
1845068|NCT00242580|6381486|P3|Overall Study|Adverse Event|2
1845069|NCT00242580|6381487|P2|Overall Study|Adverse Event|0
1845070|NCT00242580|6381488|P1|Overall Study|Adverse Event|3
1845071|NCT00242567|6381513|P2|Overall Study|Other|9
1845072|NCT00242567|6381514|P1|Overall Study|Other|14
1845073|NCT00242567|6381513|P2|Overall Study|Use of an inhibitor of bone resorption|2
1845074|NCT00242567|6381514|P1|Overall Study|Use of an inhibitor of bone resorption|0
1845075|NCT00242567|6381513|P2|Overall Study|Protocol Violation|12
1845076|NCT00242567|6381514|P1|Overall Study|Protocol Violation|12
1845077|NCT00242567|6381513|P2|Overall Study|Withdrawal by Subject|28
1845078|NCT00242567|6381514|P1|Overall Study|Withdrawal by Subject|33
1845079|NCT00242567|6381513|P2|Overall Study|Lost to Follow-up|19
1845080|NCT00242567|6381514|P1|Overall Study|Lost to Follow-up|9
1845081|NCT00242567|6381513|P2|Overall Study|Lack of Efficacy|2
1845082|NCT00242567|6381514|P1|Overall Study|Lack of Efficacy|2
1845083|NCT00242567|6381513|P2|Overall Study|Symptomatic deterioration|3
1845084|NCT00242567|6381514|P1|Overall Study|Symptomatic deterioration|9
1845085|NCT00242567|6381513|P2|Overall Study|Disease Progression|22
1845086|NCT00242567|6381514|P1|Overall Study|Disease Progression|17
1845087|NCT00242567|6381513|P2|Overall Study|Adverse Event|43
1845088|NCT00242567|6381514|P1|Overall Study|Adverse Event|70
1845089|NCT00242216|6381561|P2|Overall Study|no medicaiton dispensed|1
1845090|NCT00242216|6381562|P1|Overall Study|no medicaiton dispensed|1
1845091|NCT00242216|6381561|P2|Overall Study|Lack of Efficacy|2
1845092|NCT00242216|6381562|P1|Overall Study|Lack of Efficacy|1
1845093|NCT00242216|6381561|P2|Overall Study|Death|2
1845094|NCT00242216|6381562|P1|Overall Study|Death|4
1845095|NCT00242216|6381561|P2|Overall Study|Lost to Follow-up|17
1845096|NCT00242216|6381562|P1|Overall Study|Lost to Follow-up|12
1845097|NCT00241839|6381600|P2|Overall Study|Adverse Event|1
1845098|NCT00241839|6381601|P1|Overall Study|Adverse Event|1
1845099|NCT00241839|6381600|P2|Overall Study|Withdrawal by Subject|17
1845100|NCT00241839|6381601|P1|Overall Study|Withdrawal by Subject|18
1845101|NCT00241644|6381617|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1845102|NCT00241644|6381618|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
1845103|NCT00241644|6381619|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1845104|NCT00241644|6381620|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
1845105|NCT00241644|6381617|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
1845106|NCT00241644|6381618|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
1845107|NCT00241644|6381619|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1845108|NCT00241644|6381620|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
1845109|NCT00241644|6381617|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
1845110|NCT00241644|6381618|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
1845111|NCT00241644|6381619|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
1845112|NCT00241644|6381620|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
1845113|NCT00241644|6381617|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
1845114|NCT00241644|6381618|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
1845115|NCT00241644|6381619|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
1845116|NCT00241644|6381620|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
1845117|NCT00241644|6381617|P4|Second Efficacy Period (Year 2)|Adverse Event|20
1845118|NCT00241644|6381618|P3|Second Efficacy Period (Year 2)|Adverse Event|12
1845119|NCT00241644|6381619|P2|Second Efficacy Period (Year 2)|Adverse Event|9
1845120|NCT00241644|6381620|P1|Second Efficacy Period (Year 2)|Adverse Event|11
1845121|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
1845122|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
1845123|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
1845124|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
1845125|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1845126|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
1845127|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1845128|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
1845129|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
1845130|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
1845131|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
1845132|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
1845133|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Non-compliance|3
1845134|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Non-compliance|2
1845135|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Non-compliance|1
1845136|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Non-compliance|2
1845137|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
1845138|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
1845139|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
1845140|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
1845141|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
1845142|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
1845143|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
1845144|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
1845145|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Protocol Violation|8
1845146|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Protocol Violation|4
1845147|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Protocol Violation|5
1845148|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Protocol Violation|3
1845149|NCT00241644|6381617|P4|First Efficacy Period (Year 1)|Adverse Event|91
1845150|NCT00241644|6381618|P3|First Efficacy Period (Year 1)|Adverse Event|45
1845151|NCT00241644|6381619|P2|First Efficacy Period (Year 1)|Adverse Event|45
1845152|NCT00241644|6381620|P1|First Efficacy Period (Year 1)|Adverse Event|46
1845153|NCT00241631|6381704|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
1845154|NCT00241631|6381705|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
1845155|NCT00241631|6381704|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
1845156|NCT00241631|6381705|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
1845157|NCT00241631|6381704|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
1845158|NCT00241631|6381705|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
1845159|NCT00241631|6381704|P2|Phase 1 (4 Weeks)|sore throat|0
1845160|NCT00241631|6381705|P1|Phase 1 (4 Weeks)|sore throat|1
1845161|NCT00241631|6381704|P2|Run in (2 Weeks)|Physician Decision|3
1845162|NCT00241631|6381705|P1|Run in (2 Weeks)|Physician Decision|3
1845163|NCT00241358|6381718|P3|Overall Study|Determined to be not ineligible|1
1845164|NCT00241358|6381719|P2|Overall Study|Determined to be not ineligible|1
1845165|NCT00241358|6381720|P1|Overall Study|Determined to be not ineligible|0
1845166|NCT00241280|6381753|P2|Overall Study|Excessive Dryness|1
1845167|NCT00241280|6381754|P1|Overall Study|Excessive Dryness|0
1845168|NCT00241280|6381753|P2|Overall Study|Coating on Lens|0
1845169|NCT00241280|6381754|P1|Overall Study|Coating on Lens|1
1845170|NCT00241280|6381753|P2|Overall Study|History of Ocular Surgery|1
1845171|NCT00241280|6381754|P1|Overall Study|History of Ocular Surgery|0
1845172|NCT00241280|6381753|P2|Overall Study|Scheduling Conflict|2
1845173|NCT00241280|6381754|P1|Overall Study|Scheduling Conflict|0
1845174|NCT00241280|6381753|P2|Overall Study|Unacceptable Fit|1
1845175|NCT00241280|6381754|P1|Overall Study|Unacceptable Fit|0
1845176|NCT00241280|6381753|P2|Overall Study|Dispensed incorrect test article|2
1845177|NCT00241280|6381754|P1|Overall Study|Dispensed incorrect test article|1
1845178|NCT00241280|6381753|P2|Overall Study|Subject Ineligible/Dispensed|6
1845179|NCT00241280|6381754|P1|Overall Study|Subject Ineligible/Dispensed|9
1845180|NCT00241280|6381753|P2|Overall Study|Diabetic|0
1845181|NCT00241280|6381754|P1|Overall Study|Diabetic|1
1845182|NCT00241280|6381753|P2|Overall Study|Unsatisfactory Visual Response|1
1845183|NCT00241280|6381754|P1|Overall Study|Unsatisfactory Visual Response|1
1845184|NCT00241280|6381753|P2|Overall Study|Unsatisfactory Physiological Response|1
1845185|NCT00241280|6381754|P1|Overall Study|Unsatisfactory Physiological Response|1
1845186|NCT00241280|6381753|P2|Overall Study|Relocation|4
1845187|NCT00241280|6381754|P1|Overall Study|Relocation|4
1845188|NCT00241280|6381753|P2|Overall Study|Protocol Violation|10
1845189|NCT00241280|6381754|P1|Overall Study|Protocol Violation|4
1845190|NCT00241280|6381753|P2|Overall Study|Withdrawal by Subject|4
1845191|NCT00241280|6381754|P1|Overall Study|Withdrawal by Subject|7
1845192|NCT00241280|6381753|P2|Overall Study|Lost to Follow-up|8
1845193|NCT00241280|6381754|P1|Overall Study|Lost to Follow-up|5
1845194|NCT00241280|6381753|P2|Overall Study|Pregnancy|5
1845195|NCT00241280|6381754|P1|Overall Study|Pregnancy|1
1845196|NCT00241280|6381753|P2|Overall Study|Discomfort|16
1845197|NCT00241280|6381754|P1|Overall Study|Discomfort|11
1845198|NCT00241280|6381753|P2|Overall Study|Adverse Event|6
1845199|NCT00241280|6381754|P1|Overall Study|Adverse Event|2
1845200|NCT00240994|6381769|P1|Overall Study|Graft failure|1
1845201|NCT00240994|6381769|P1|Overall Study|Protocol Violation|1
1845202|NCT00240994|6381769|P1|Overall Study|Lost to Follow-up|1
1845203|NCT00240331|6381904|P2|Overall Study|Option selected by investigator|2
1845204|NCT00240331|6381905|P1|Overall Study|Option selected by investigator|1
1845205|NCT00240331|6381904|P2|Overall Study|Withdrawal by Subject|132
1845206|NCT00240331|6381905|P1|Overall Study|Withdrawal by Subject|125
1845207|NCT00240110|6381948|P2|Overall Study|Lost to Follow-up|7
1845208|NCT00240110|6381949|P1|Overall Study|Lost to Follow-up|6
1845209|NCT00240097|6381957|P1|Part II|did not continue from Part I|23
1845210|NCT00240097|6381957|P1|Part I|unevaluable|1
1845211|NCT00240097|6381957|P1|Part I|histology|1
1845212|NCT00240097|6381957|P1|Part I|Death|1
1845213|NCT00240097|6381957|P1|Part I|Adverse Event|1
1845214|NCT00240071|6381967|P1|Overall Study|Withdrawal by Subject|3
1845215|NCT00239928|6381972|P1|Overall Study|Withdrawal by Subject|2
1845216|NCT00239928|6381972|P1|Overall Study|Not need to continue study|3
1845217|NCT00239928|6381972|P1|Overall Study|Adverse Event|4
1845218|NCT00239928|6381972|P1|Overall Study|Lack of Efficacy|1
1845219|NCT00239837|6381984|P2|Overall Study|Lost to Follow-up|7
1845220|NCT00239837|6381985|P1|Overall Study|Lost to Follow-up|3
1845221|NCT00239720|6382012|P2|Overall Study|Lost to Follow-up|1
1845222|NCT00239720|6382013|P1|Overall Study|Lost to Follow-up|0
1845223|NCT00239720|6382012|P2|Overall Study|Adverse Event|0
1845224|NCT00239720|6382013|P1|Overall Study|Adverse Event|1
1845225|NCT00239681|6382021|P2|Overall Study|No information chacked on CaseReportForm|84
1845226|NCT00239681|6382022|P1|Overall Study|No information chacked on CaseReportForm|90
1845227|NCT00239681|6382021|P2|Overall Study|Physician Decision|17
1845228|NCT00239681|6382022|P1|Overall Study|Physician Decision|13
1845229|NCT00239681|6382021|P2|Overall Study|Protocol Violation|4
1845230|NCT00239681|6382022|P1|Overall Study|Protocol Violation|4
1845231|NCT00239681|6382021|P2|Overall Study|Lost to Follow-up|22
1845232|NCT00239681|6382022|P1|Overall Study|Lost to Follow-up|28
1845233|NCT00239681|6382021|P2|Overall Study|Withdrawal by Subject|489
1845234|NCT00239681|6382022|P1|Overall Study|Withdrawal by Subject|458
1845235|NCT00239681|6382021|P2|Overall Study|Adverse Event|99
1845236|NCT00239681|6382022|P1|Overall Study|Adverse Event|100
1845237|NCT00239590|6382075|P2|Completed Study Protocol|Withdrawal by Subject|1
1845238|NCT00239590|6382076|P1|Completed Study Protocol|Withdrawal by Subject|0
1845239|NCT00239590|6382075|P2|Completed Study Protocol|Adverse Event|1
1845240|NCT00239590|6382076|P1|Completed Study Protocol|Adverse Event|1
1845241|NCT00239590|6382075|P2|Randomized|Withdrawal by Subject|1
1845242|NCT00239590|6382076|P1|Randomized|Withdrawal by Subject|0
1845243|NCT00239590|6382075|P2|Randomized|Lost to Follow-up|1
1845244|NCT00239590|6382076|P1|Randomized|Lost to Follow-up|0
1845245|NCT00239577|6382088|P4|Primary Phase|Other|0
1845246|NCT00239577|6382089|P3|Primary Phase|Other|2
1845247|NCT00239577|6382090|P2|Primary Phase|Other|3
1845248|NCT00239577|6382091|P1|Primary Phase|Other|5
1845249|NCT00239577|6382088|P4|Primary Phase|Adverse Event|0
1845250|NCT00239577|6382089|P3|Primary Phase|Adverse Event|1
1845251|NCT00239577|6382090|P2|Primary Phase|Adverse Event|0
1845252|NCT00239577|6382091|P1|Primary Phase|Adverse Event|0
1845253|NCT00239356|6382195|P2|Overall Study|Drug available on market|2
1845254|NCT00239356|6382196|P1|Overall Study|Drug available on market|11
1845255|NCT00239356|6382195|P2|Overall Study|Administrative reason|1
1845256|NCT00239356|6382196|P1|Overall Study|Administrative reason|0
1845257|NCT00239356|6382195|P2|Overall Study|Pregnancy|0
1845258|NCT00239356|6382196|P1|Overall Study|Pregnancy|1
1845259|NCT00239356|6382195|P2|Overall Study|poor/non-compliance|0
1845260|NCT00239356|6382196|P1|Overall Study|poor/non-compliance|2
1845261|NCT00239356|6382195|P2|Overall Study|Lost to Follow-up|0
1845262|NCT00239356|6382196|P1|Overall Study|Lost to Follow-up|3
1845263|NCT00239356|6382195|P2|Overall Study|Withdrawal by Subject|6
1845264|NCT00239356|6382196|P1|Overall Study|Withdrawal by Subject|15
1845265|NCT00239356|6382195|P2|Overall Study|Adverse Event|0
1845266|NCT00239356|6382196|P1|Overall Study|Adverse Event|6
1845267|NCT00239356|6382195|P2|Overall Study|Lack of Efficacy|0
1845268|NCT00239356|6382196|P1|Overall Study|Lack of Efficacy|1
1845269|NCT00239226|6382218|P4|Overall Study|Lost to Follow-up|0
1845270|NCT00239226|6382219|P3|Overall Study|Lost to Follow-up|1
1845271|NCT00239226|6382220|P2|Overall Study|Lost to Follow-up|0
1845272|NCT00239226|6382221|P1|Overall Study|Lost to Follow-up|1
1845273|NCT00239226|6382218|P4|Overall Study|permAF during stabilization period|3
1845274|NCT00239226|6382219|P3|Overall Study|permAF during stabilization period|0
1845275|NCT00239226|6382220|P2|Overall Study|permAF during stabilization period|0
1845276|NCT00239226|6382221|P1|Overall Study|permAF during stabilization period|0
1845277|NCT00239005|6382233|P2|Overall Study|Lost to Follow-up|1
1845278|NCT00239005|6382234|P1|Overall Study|Lost to Follow-up|0
1845279|NCT00239005|6382233|P2|Overall Study|Subj. cond. no longer needs study drug|1
1845280|NCT00239005|6382234|P1|Overall Study|Subj. cond. no longer needs study drug|0
1845281|NCT00239005|6382233|P2|Overall Study|Protocol Violation|0
1845282|NCT00239005|6382234|P1|Overall Study|Protocol Violation|1
1845283|NCT00239005|6382233|P2|Overall Study|Unsatisfactory Therapeutic effect|0
1845284|NCT00239005|6382234|P1|Overall Study|Unsatisfactory Therapeutic effect|2
1845285|NCT00239005|6382233|P2|Overall Study|Withdrawal by Subject|4
1845286|NCT00239005|6382234|P1|Overall Study|Withdrawal by Subject|3
1845287|NCT00239005|6382233|P2|Overall Study|Adverse Event|6
1845288|NCT00239005|6382234|P1|Overall Study|Adverse Event|6
1845289|NCT00238433|6382250|P1|Overall Study|Death|1
1845290|NCT00238433|6382250|P1|Overall Study|Lost to Follow-up|1
1845291|NCT00238433|6382250|P1|Overall Study|Screen failure|1
1845294|NCT00238303|6382275|P3|Overall Study|Adverse Event|3
1845295|NCT00238303|6382276|P2|Overall Study|Adverse Event|1
1845296|NCT00238303|6382277|P1|Overall Study|Adverse Event|0
1845297|NCT00238303|6382275|P3|Overall Study|Poor tolerance of study treatment|1
1845298|NCT00238303|6382276|P2|Overall Study|Poor tolerance of study treatment|0
1845299|NCT00238303|6382277|P1|Overall Study|Poor tolerance of study treatment|1
1845300|NCT00238303|6382275|P3|Overall Study|Other Medical Problems|2
1845301|NCT00238303|6382276|P2|Overall Study|Other Medical Problems|0
1845302|NCT00238303|6382277|P1|Overall Study|Other Medical Problems|2
1845303|NCT00238303|6382275|P3|Overall Study|Death|1
1845304|NCT00238303|6382276|P2|Overall Study|Death|0
1845305|NCT00238303|6382277|P1|Overall Study|Death|1
1845306|NCT00238303|6382275|P3|Overall Study|Withdrawal by Subject|2
1845307|NCT00238303|6382276|P2|Overall Study|Withdrawal by Subject|1
1845308|NCT00238303|6382277|P1|Overall Study|Withdrawal by Subject|11
1845309|NCT00238264|6382294|P1|Overall Study|Ineligible|7
1845310|NCT00238264|6382294|P1|Overall Study|Withdrawal by Subject|4
1845311|NCT00238264|6382294|P1|Overall Study|Lost to Follow-up|18
1845312|NCT00238264|6382294|P1|Overall Study|Death|7
1845313|NCT00238238|6382307|P3|Overall Study|Withdrawal by Subject|0
1845314|NCT00238238|6382308|P2|Overall Study|Withdrawal by Subject|3
1845315|NCT00238238|6382309|P1|Overall Study|Withdrawal by Subject|0
1845316|NCT00238121|6382322|P2|Overall Study|Adverse Event|1
1845317|NCT00238121|6382323|P1|Overall Study|Adverse Event|2
1845318|NCT00238121|6382322|P2|Overall Study|Withdrawal by Subject|1
1845319|NCT00238121|6382323|P1|Overall Study|Withdrawal by Subject|1
1845320|NCT00237809|6382349|P4|Overall Study|Lost to Follow-up|9
1845321|NCT00237809|6382350|P3|Overall Study|Lost to Follow-up|9
1845322|NCT00237809|6382351|P2|Overall Study|Lost to Follow-up|10
1845323|NCT00237809|6382352|P1|Overall Study|Lost to Follow-up|11
1845324|NCT00237796|6382388|P2|Overall Study|Baseline and one other ILSS required|5
1845325|NCT00237796|6382389|P1|Overall Study|Baseline and one other ILSS required|10
1845326|NCT00237744|6382423|P3|Overall Study|Withdrawal by Subject|0
1845327|NCT00237744|6382424|P2|Overall Study|Withdrawal by Subject|1
1845328|NCT00237744|6382425|P1|Overall Study|Withdrawal by Subject|3
1845329|NCT00237692|6382451|P4|Overall Study|Withdrawal by Subject|4
1845330|NCT00237692|6382452|P3|Overall Study|Withdrawal by Subject|10
1845331|NCT00237692|6382453|P2|Overall Study|Withdrawal by Subject|6
1845332|NCT00237692|6382454|P1|Overall Study|Withdrawal by Subject|4
1845333|NCT00237692|6382451|P4|Overall Study|Excluded - did not meet criteria|9
1845334|NCT00237692|6382452|P3|Overall Study|Excluded - did not meet criteria|5
1845335|NCT00237692|6382453|P2|Overall Study|Excluded - did not meet criteria|3
1845336|NCT00237692|6382454|P1|Overall Study|Excluded - did not meet criteria|4
1845337|NCT00237692|6382451|P4|Overall Study|Death|3
1845338|NCT00237692|6382452|P3|Overall Study|Death|2
1845339|NCT00237692|6382453|P2|Overall Study|Death|2
1845340|NCT00237692|6382454|P1|Overall Study|Death|1
1845341|NCT00237692|6382451|P4|Overall Study|Lost to Follow-up|3
1845342|NCT00237692|6382452|P3|Overall Study|Lost to Follow-up|5
1845343|NCT00237692|6382453|P2|Overall Study|Lost to Follow-up|3
1845344|NCT00237692|6382454|P1|Overall Study|Lost to Follow-up|9
1845345|NCT00237458|6382494|P1|Overall Study|Withdrawal by Subject|1
1845346|NCT00237458|6382494|P1|Overall Study|Adverse Event|1
1845347|NCT00237458|6382494|P1|Overall Study|Lack of Efficacy|1
1845348|NCT00237185|6382512|P2|Extension|Death|1
1845349|NCT00237185|6382513|P1|Extension|Death|1
1845350|NCT00237185|6382512|P2|Extension|Administrative problems|0
1845351|NCT00237185|6382513|P1|Extension|Administrative problems|1
1845352|NCT00237185|6382512|P2|Extension|Lost to Follow-up|0
1845353|NCT00237185|6382513|P1|Extension|Lost to Follow-up|1
1845354|NCT00237185|6382512|P2|Extension|Withdrawal by Subject|2
1845355|NCT00237185|6382513|P1|Extension|Withdrawal by Subject|3
1845356|NCT00237185|6382512|P2|Extension|Condition no longer required study drug|1
1845357|NCT00237185|6382513|P1|Extension|Condition no longer required study drug|0
1845358|NCT00237185|6382512|P2|Extension|Lack of Efficacy|14
1845359|NCT00237185|6382513|P1|Extension|Lack of Efficacy|9
1845360|NCT00237185|6382512|P2|Extension|Abnormal laboratory value|1
1845361|NCT00237185|6382513|P1|Extension|Abnormal laboratory value|0
1845362|NCT00237185|6382512|P2|Extension|Adverse Event|0
1845363|NCT00237185|6382513|P1|Extension|Adverse Event|1
1845364|NCT00237185|6382512|P2|Core|Determined ineligible post randomization|0
1845365|NCT00237185|6382513|P1|Core|Determined ineligible post randomization|1
1845366|NCT00237185|6382512|P2|Core|Death|0
1845367|NCT00237185|6382513|P1|Core|Death|4
1845368|NCT00237185|6382512|P2|Core|Administrative problems|1
1845369|NCT00237185|6382513|P1|Core|Administrative problems|0
1845370|NCT00237185|6382512|P2|Core|Withdrawal by Subject|4
1845371|NCT00237185|6382513|P1|Core|Withdrawal by Subject|4
1845372|NCT00237185|6382512|P2|Core|Protocol Violation|1
1845373|NCT00237185|6382513|P1|Core|Protocol Violation|1
1845374|NCT00237185|6382512|P2|Core|Lack of Efficacy|23
1845375|NCT00237185|6382513|P1|Core|Lack of Efficacy|30
1845376|NCT00237185|6382512|P2|Core|Abnormal test procedure results|0
1845377|NCT00237185|6382513|P1|Core|Abnormal test procedure results|1
1845378|NCT00237185|6382512|P2|Core|Abnormal laboratory value|4
1845379|NCT00237185|6382513|P1|Core|Abnormal laboratory value|0
1845380|NCT00237185|6382512|P2|Core|Adverse Event|4
1845381|NCT00237185|6382513|P1|Core|Adverse Event|3
1845382|NCT00237042|6382544|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
1845383|NCT00237042|6382545|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
1845384|NCT00237042|6382546|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
1845385|NCT00237042|6382544|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
1845386|NCT00237042|6382545|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
1845387|NCT00237042|6382546|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
1845388|NCT00237042|6382544|P3|Treatment|Completed no treatment|21
1845389|NCT00237042|6382545|P2|Treatment|Completed no treatment|5
1845390|NCT00237042|6382546|P1|Treatment|Completed no treatment|5
1845391|NCT00237042|6382544|P3|Treatment|Moved out of state|1
1845392|NCT00237042|6382545|P2|Treatment|Moved out of state|1
1845393|NCT00237042|6382546|P1|Treatment|Moved out of state|1
1845394|NCT00237042|6382544|P3|Treatment|Became ineligible post-randomization|16
1845395|NCT00237042|6382545|P2|Treatment|Became ineligible post-randomization|1
1845396|NCT00237042|6382546|P1|Treatment|Became ineligible post-randomization|0
1845397|NCT00236899|6382620|P4|Overall Study|Lack of Efficacy|23
1845398|NCT00236899|6382621|P3|Overall Study|Lack of Efficacy|25
1845399|NCT00236899|6382622|P2|Overall Study|Lack of Efficacy|18
1845400|NCT00236899|6382623|P1|Overall Study|Lack of Efficacy|18
1845401|NCT00236899|6382620|P4|Overall Study|Satisfactory Response|1
1845402|NCT00236899|6382621|P3|Overall Study|Satisfactory Response|0
1845403|NCT00236899|6382622|P2|Overall Study|Satisfactory Response|0
1845404|NCT00236899|6382623|P1|Overall Study|Satisfactory Response|2
1845405|NCT00236899|6382620|P4|Overall Study|Physician Decision|6
1845406|NCT00236899|6382621|P3|Overall Study|Physician Decision|7
1845407|NCT00236899|6382622|P2|Overall Study|Physician Decision|8
1845408|NCT00236899|6382623|P1|Overall Study|Physician Decision|7
1845409|NCT00236899|6382620|P4|Overall Study|Withdrawal by Subject|2
1845410|NCT00236899|6382621|P3|Overall Study|Withdrawal by Subject|5
1845411|NCT00236899|6382622|P2|Overall Study|Withdrawal by Subject|4
1845412|NCT00236899|6382623|P1|Overall Study|Withdrawal by Subject|6
1845413|NCT00236899|6382620|P4|Overall Study|Protocol Violation|0
1845414|NCT00236899|6382621|P3|Overall Study|Protocol Violation|0
1845415|NCT00236899|6382622|P2|Overall Study|Protocol Violation|0
1845416|NCT00236899|6382623|P1|Overall Study|Protocol Violation|1
1845417|NCT00236899|6382620|P4|Overall Study|Entry Criteria Exclusion|0
1845418|NCT00236899|6382621|P3|Overall Study|Entry Criteria Exclusion|1
1845419|NCT00236899|6382622|P2|Overall Study|Entry Criteria Exclusion|1
1845420|NCT00236899|6382623|P1|Overall Study|Entry Criteria Exclusion|0
1845421|NCT00236899|6382620|P4|Overall Study|Lost to Follow-up|0
1845422|NCT00236899|6382621|P3|Overall Study|Lost to Follow-up|0
1845423|NCT00236899|6382622|P2|Overall Study|Lost to Follow-up|1
1845424|NCT00236899|6382623|P1|Overall Study|Lost to Follow-up|0
1845425|NCT00236899|6382620|P4|Overall Study|Death (Study Drug Toxicity)|0
1845426|NCT00236899|6382621|P3|Overall Study|Death (Study Drug Toxicity)|0
1845427|NCT00236899|6382622|P2|Overall Study|Death (Study Drug Toxicity)|0
1845428|NCT00236899|6382623|P1|Overall Study|Death (Study Drug Toxicity)|1
1845429|NCT00236899|6382620|P4|Overall Study|Death (Not Study Related)|0
1845430|NCT00236899|6382621|P3|Overall Study|Death (Not Study Related)|0
1845431|NCT00236899|6382622|P2|Overall Study|Death (Not Study Related)|0
1845432|NCT00236899|6382623|P1|Overall Study|Death (Not Study Related)|2
1845433|NCT00236899|6382620|P4|Overall Study|Death (Study Disease)|0
1845434|NCT00236899|6382621|P3|Overall Study|Death (Study Disease)|0
1845435|NCT00236899|6382622|P2|Overall Study|Death (Study Disease)|4
1845436|NCT00236899|6382623|P1|Overall Study|Death (Study Disease)|1
1845437|NCT00236899|6382620|P4|Overall Study|Adverse Event (Not Study Related)|7
1845438|NCT00236899|6382621|P3|Overall Study|Adverse Event (Not Study Related)|4
1845439|NCT00236899|6382622|P2|Overall Study|Adverse Event (Not Study Related)|3
1845440|NCT00236899|6382623|P1|Overall Study|Adverse Event (Not Study Related)|3
1845441|NCT00236899|6382620|P4|Overall Study|Adverse Event (Study Related)|1
1845442|NCT00236899|6382621|P3|Overall Study|Adverse Event (Study Related)|2
1845443|NCT00236899|6382622|P2|Overall Study|Adverse Event (Study Related)|1
1845444|NCT00236899|6382623|P1|Overall Study|Adverse Event (Study Related)|1
1845445|NCT00236197|6382655|P2|Overall Study|Other|2
1845446|NCT00236197|6382656|P1|Overall Study|Other|0
1845447|NCT00236197|6382655|P2|Overall Study|Medication non-compliance|2
1845448|NCT00236197|6382656|P1|Overall Study|Medication non-compliance|1
1845449|NCT00236197|6382655|P2|Overall Study|Protocol Violation|3
1845450|NCT00236197|6382656|P1|Overall Study|Protocol Violation|0
1845451|NCT00236197|6382655|P2|Overall Study|Lost to Follow-up|5
1845452|NCT00236197|6382656|P1|Overall Study|Lost to Follow-up|1
1845453|NCT00236197|6382655|P2|Overall Study|Withdrawal by Subject|2
1845454|NCT00236197|6382656|P1|Overall Study|Withdrawal by Subject|3
1845455|NCT00236184|6382664|P2|Overall Study|other|2
1845456|NCT00236184|6382665|P1|Overall Study|other|1
1845457|NCT00236184|6382664|P2|Overall Study|non-compliance with study drug|1
1845458|NCT00236184|6382665|P1|Overall Study|non-compliance with study drug|2
1845459|NCT00236184|6382664|P2|Overall Study|Protocol Violation|0
1845460|NCT00236184|6382665|P1|Overall Study|Protocol Violation|3
1845461|NCT00236184|6382664|P2|Overall Study|Withdrawal by Subject|0
1845462|NCT00236184|6382665|P1|Overall Study|Withdrawal by Subject|3
1845463|NCT00236184|6382664|P2|Overall Study|Physician Decision|1
1845464|NCT00236184|6382665|P1|Overall Study|Physician Decision|1
1845465|NCT00236184|6382664|P2|Overall Study|Lost to Follow-up|4
1845466|NCT00236184|6382665|P1|Overall Study|Lost to Follow-up|3
1845467|NCT00236184|6382664|P2|Overall Study|Lack of Efficacy|1
1845468|NCT00236184|6382665|P1|Overall Study|Lack of Efficacy|0
1845469|NCT00236184|6382664|P2|Overall Study|Adverse Event|2
1845470|NCT00236184|6382665|P1|Overall Study|Adverse Event|5
1845471|NCT00236080|6382676|P5|Overall Study|Miscellaneous|0
1845472|NCT00236080|6382677|P4|Overall Study|Miscellaneous|0
1845473|NCT00236080|6382678|P3|Overall Study|Miscellaneous|1
1845474|NCT00236080|6382679|P2|Overall Study|Miscellaneous|0
1845475|NCT00236080|6382680|P1|Overall Study|Miscellaneous|0
1845476|NCT00236080|6382676|P5|Overall Study|Withdrawal by Subject|0
1845477|NCT00236080|6382677|P4|Overall Study|Withdrawal by Subject|0
1845478|NCT00236080|6382678|P3|Overall Study|Withdrawal by Subject|0
1845479|NCT00236080|6382679|P2|Overall Study|Withdrawal by Subject|0
1845480|NCT00236080|6382680|P1|Overall Study|Withdrawal by Subject|1
1845481|NCT00236080|6382676|P5|Overall Study|Physician Decision|1
1845482|NCT00236080|6382677|P4|Overall Study|Physician Decision|1
1845483|NCT00236080|6382678|P3|Overall Study|Physician Decision|1
1845484|NCT00236080|6382679|P2|Overall Study|Physician Decision|0
1845485|NCT00236080|6382680|P1|Overall Study|Physician Decision|1
1845486|NCT00236080|6382676|P5|Overall Study|Lost to Follow-up|0
1845487|NCT00236080|6382677|P4|Overall Study|Lost to Follow-up|0
1845488|NCT00236080|6382678|P3|Overall Study|Lost to Follow-up|0
1845489|NCT00236080|6382679|P2|Overall Study|Lost to Follow-up|1
1845490|NCT00236080|6382680|P1|Overall Study|Lost to Follow-up|0
1845491|NCT00236080|6382676|P5|Overall Study|Adverse Event|0
1845492|NCT00236080|6382677|P4|Overall Study|Adverse Event|1
1845493|NCT00236080|6382678|P3|Overall Study|Adverse Event|3
1845494|NCT00236080|6382679|P2|Overall Study|Adverse Event|0
1845495|NCT00236080|6382680|P1|Overall Study|Adverse Event|0
1845496|NCT00235989|6382701|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
1845497|NCT00235989|6382702|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
1845498|NCT00235989|6382703|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
1845499|NCT00235989|6382704|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
1845500|NCT00235989|6382705|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
1845501|NCT00235989|6382706|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
1845502|NCT00235989|6382701|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
1845503|NCT00235989|6382702|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
1845504|NCT00235989|6382703|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
1845505|NCT00235989|6382704|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
1845506|NCT00235989|6382705|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
1845507|NCT00235989|6382706|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
1845508|NCT00235989|6382701|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
1845509|NCT00235989|6382702|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
1845510|NCT00235989|6382703|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
1845511|NCT00235989|6382704|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
1845512|NCT00235989|6382705|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
1845513|NCT00235989|6382706|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
1845514|NCT00235989|6382701|P6|Extension Treatment Period (ET)|Adverse Event|0
1845515|NCT00235989|6382702|P5|Extension Treatment Period (ET)|Adverse Event|0
1845516|NCT00235989|6382703|P4|Extension Treatment Period (ET)|Adverse Event|0
1845517|NCT00235989|6382704|P3|Extension Treatment Period (ET)|Adverse Event|2
1845518|NCT00235989|6382705|P2|Extension Treatment Period (ET)|Adverse Event|0
1845519|NCT00235989|6382706|P1|Extension Treatment Period (ET)|Adverse Event|3
1845520|NCT00235989|6382701|P6|Core Treatment Period (CT)|Lost to Follow-up|2
1845521|NCT00235989|6382702|P5|Core Treatment Period (CT)|Lost to Follow-up|0
1845522|NCT00235989|6382703|P4|Core Treatment Period (CT)|Lost to Follow-up|0
1845523|NCT00235989|6382704|P3|Core Treatment Period (CT)|Lost to Follow-up|0
1845524|NCT00235989|6382705|P2|Core Treatment Period (CT)|Lost to Follow-up|0
1845525|NCT00235989|6382706|P1|Core Treatment Period (CT)|Lost to Follow-up|0
1845526|NCT00235872|6382720|P1|Overall Study|Administrative reason|61
1845527|NCT00235872|6382720|P1|Overall Study|Withdrawal by Subject|50
1845528|NCT00235872|6382720|P1|Overall Study|Lost to Follow-up|1
1845529|NCT00235872|6382720|P1|Overall Study|Death|1
1845530|NCT00235872|6382720|P1|Overall Study|Adverse Event|34
1845531|NCT00235755|6382751|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1845532|NCT00235755|6382752|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
1845533|NCT00235755|6382753|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
1845534|NCT00235755|6382751|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
1845535|NCT00235755|6382752|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
1845536|NCT00235755|6382753|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
1845537|NCT00235755|6382751|P3|12-Week Maintenance Phase|Protocol Violation|2
1845538|NCT00235755|6382752|P2|12-Week Maintenance Phase|Protocol Violation|4
1845539|NCT00235755|6382753|P1|12-Week Maintenance Phase|Protocol Violation|0
1845540|NCT00235755|6382751|P3|12-Week Maintenance Phase|Lack of Efficacy|0
1845541|NCT00235755|6382752|P2|12-Week Maintenance Phase|Lack of Efficacy|0
1845542|NCT00235755|6382753|P1|12-Week Maintenance Phase|Lack of Efficacy|5
1845543|NCT00235755|6382751|P3|12-Week Maintenance Phase|Lost to Follow-up|0
1845544|NCT00235755|6382752|P2|12-Week Maintenance Phase|Lost to Follow-up|3
1845545|NCT00235755|6382753|P1|12-Week Maintenance Phase|Lost to Follow-up|2
1845546|NCT00235755|6382751|P3|12-Week Maintenance Phase|Adverse Event|26
1845547|NCT00235755|6382752|P2|12-Week Maintenance Phase|Adverse Event|12
1845548|NCT00235755|6382753|P1|12-Week Maintenance Phase|Adverse Event|8
1845549|NCT00235755|6382751|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1845550|NCT00235755|6382752|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
1845551|NCT00235755|6382753|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
1845552|NCT00235755|6382751|P3|4-Week Titration Phase|Randomization Occurred in Error|0
1845553|NCT00235755|6382752|P2|4-Week Titration Phase|Randomization Occurred in Error|0
1845554|NCT00235755|6382753|P1|4-Week Titration Phase|Randomization Occurred in Error|1
1845555|NCT00235755|6382751|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
1845556|NCT00235755|6382752|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1845557|NCT00235755|6382753|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
1845558|NCT00235755|6382751|P3|4-Week Titration Phase|Withdrawal by Subject|3
1845559|NCT00235755|6382752|P2|4-Week Titration Phase|Withdrawal by Subject|2
1845560|NCT00235755|6382753|P1|4-Week Titration Phase|Withdrawal by Subject|1
1845561|NCT00235755|6382751|P3|4-Week Titration Phase|Protocol Violation|1
1845562|NCT00235755|6382752|P2|4-Week Titration Phase|Protocol Violation|2
1845563|NCT00235755|6382753|P1|4-Week Titration Phase|Protocol Violation|2
1845564|NCT00235755|6382751|P3|4-Week Titration Phase|Lost to Follow-up|1
1845565|NCT00235755|6382752|P2|4-Week Titration Phase|Lost to Follow-up|1
1845566|NCT00235755|6382753|P1|4-Week Titration Phase|Lost to Follow-up|0
1845567|NCT00235755|6382751|P3|4-Week Titration Phase|Adverse Event|20
1845568|NCT00235755|6382752|P2|4-Week Titration Phase|Adverse Event|14
1845569|NCT00235755|6382753|P1|4-Week Titration Phase|Adverse Event|6
1845570|NCT00235716|6382831|P4|Overall Study|Physician Decision|3
1845571|NCT00235716|6382832|P3|Overall Study|Physician Decision|1
1845572|NCT00235716|6382833|P2|Overall Study|Physician Decision|1
1845573|NCT00235716|6382834|P1|Overall Study|Physician Decision|0
1845574|NCT00235716|6382831|P4|Overall Study|Adverse Event|0
1845575|NCT00235716|6382832|P3|Overall Study|Adverse Event|1
1845576|NCT00235716|6382833|P2|Overall Study|Adverse Event|1
1845577|NCT00235716|6382834|P1|Overall Study|Adverse Event|1
1845578|NCT00235716|6382831|P4|Overall Study|Lost to Follow-up|10
1845579|NCT00235716|6382832|P3|Overall Study|Lost to Follow-up|14
1845580|NCT00235716|6382833|P2|Overall Study|Lost to Follow-up|7
1845581|NCT00235716|6382834|P1|Overall Study|Lost to Follow-up|12
1845582|NCT00235716|6382831|P4|Overall Study|Withdrawal by Subject|18
1845583|NCT00235716|6382832|P3|Overall Study|Withdrawal by Subject|17
1845584|NCT00235716|6382833|P2|Overall Study|Withdrawal by Subject|19
1845585|NCT00235716|6382834|P1|Overall Study|Withdrawal by Subject|23
1845586|NCT00235716|6382831|P4|Overall Study|Death|31
1845587|NCT00235716|6382832|P3|Overall Study|Death|32
1845588|NCT00235716|6382833|P2|Overall Study|Death|39
1845589|NCT00235716|6382834|P1|Overall Study|Death|26
1845590|NCT00235495|6382885|P2|Overall Study|Visit/assessmen outside window/missing|10
1845591|NCT00235495|6382886|P1|Overall Study|Visit/assessmen outside window/missing|0
1845592|NCT00235495|6382885|P2|Overall Study|Lost to Follow-up|13
1845593|NCT00235495|6382886|P1|Overall Study|Lost to Follow-up|11
1845594|NCT00235495|6382885|P2|Overall Study|Withdrawal by Subject|3
1845595|NCT00235495|6382886|P1|Overall Study|Withdrawal by Subject|5
1845596|NCT00235495|6382885|P2|Overall Study|Death|42
1845597|NCT00235495|6382886|P1|Overall Study|Death|52
1845598|NCT00235443|6382959|P6|Overall Study|Other reasons for premature termination|6
1845599|NCT00235443|6382960|P5|Overall Study|Other reasons for premature termination|3
1845600|NCT00235443|6382961|P4|Overall Study|Other reasons for premature termination|7
1845601|NCT00235443|6382962|P3|Overall Study|Other reasons for premature termination|6
1845602|NCT00235443|6382963|P2|Overall Study|Other reasons for premature termination|6
1845603|NCT00235443|6382964|P1|Overall Study|Other reasons for premature termination|1
1845604|NCT00235443|6382959|P6|Overall Study|Unsatisfactory compliance|0
1845605|NCT00235443|6382960|P5|Overall Study|Unsatisfactory compliance|1
1845606|NCT00235443|6382961|P4|Overall Study|Unsatisfactory compliance|4
1845607|NCT00235443|6382962|P3|Overall Study|Unsatisfactory compliance|3
1845608|NCT00235443|6382963|P2|Overall Study|Unsatisfactory compliance|2
1845609|NCT00235443|6382964|P1|Overall Study|Unsatisfactory compliance|0
1845610|NCT00235443|6382959|P6|Overall Study|Lost to Follow-up|3
1845611|NCT00235443|6382960|P5|Overall Study|Lost to Follow-up|4
1845612|NCT00235443|6382961|P4|Overall Study|Lost to Follow-up|6
1845613|NCT00235443|6382962|P3|Overall Study|Lost to Follow-up|6
1845614|NCT00235443|6382963|P2|Overall Study|Lost to Follow-up|8
1845615|NCT00235443|6382964|P1|Overall Study|Lost to Follow-up|0
1845616|NCT00235443|6382959|P6|Overall Study|Withdrawal by Subject|12
1845617|NCT00235443|6382960|P5|Overall Study|Withdrawal by Subject|10
1845618|NCT00235443|6382961|P4|Overall Study|Withdrawal by Subject|24
1845619|NCT00235443|6382962|P3|Overall Study|Withdrawal by Subject|25
1845620|NCT00235443|6382963|P2|Overall Study|Withdrawal by Subject|9
1845621|NCT00235443|6382964|P1|Overall Study|Withdrawal by Subject|3
1845622|NCT00235443|6382959|P6|Overall Study|Lack of Efficacy|9
1845623|NCT00235443|6382960|P5|Overall Study|Lack of Efficacy|2
1845624|NCT00235443|6382961|P4|Overall Study|Lack of Efficacy|12
1845625|NCT00235443|6382962|P3|Overall Study|Lack of Efficacy|5
1845626|NCT00235443|6382963|P2|Overall Study|Lack of Efficacy|1
1845627|NCT00235443|6382964|P1|Overall Study|Lack of Efficacy|0
1845628|NCT00235443|6382959|P6|Overall Study|Adverse Event|15
1845629|NCT00235443|6382960|P5|Overall Study|Adverse Event|10
1845630|NCT00235443|6382961|P4|Overall Study|Adverse Event|44
1845631|NCT00235443|6382962|P3|Overall Study|Adverse Event|17
1845632|NCT00235443|6382963|P2|Overall Study|Adverse Event|12
1845633|NCT00235443|6382964|P1|Overall Study|Adverse Event|4
1845634|NCT00235391|6383105|P6|Overall Study|Death|0
1845635|NCT00235391|6383106|P5|Overall Study|Death|0
1845636|NCT00235391|6383107|P4|Overall Study|Death|4
1845637|NCT00235391|6383108|P3|Overall Study|Death|1
1845638|NCT00235391|6383109|P2|Overall Study|Death|0
1845639|NCT00235391|6383110|P1|Overall Study|Death|0
1845640|NCT00235391|6383105|P6|Overall Study|Administrative problems|0
1845641|NCT00235391|6383106|P5|Overall Study|Administrative problems|0
1845642|NCT00235391|6383107|P4|Overall Study|Administrative problems|1
1845643|NCT00235391|6383108|P3|Overall Study|Administrative problems|0
1845644|NCT00235391|6383109|P2|Overall Study|Administrative problems|0
1845645|NCT00235391|6383110|P1|Overall Study|Administrative problems|0
1845646|NCT00235391|6383105|P6|Overall Study|Lost to Follow-up|0
1845647|NCT00235391|6383106|P5|Overall Study|Lost to Follow-up|0
1845648|NCT00235391|6383107|P4|Overall Study|Lost to Follow-up|16
1845649|NCT00235391|6383108|P3|Overall Study|Lost to Follow-up|3
1845650|NCT00235391|6383109|P2|Overall Study|Lost to Follow-up|3
1845651|NCT00235391|6383110|P1|Overall Study|Lost to Follow-up|0
1845652|NCT00235391|6383105|P6|Overall Study|Withdrawal by Subject|0
1845653|NCT00235391|6383106|P5|Overall Study|Withdrawal by Subject|5
1845654|NCT00235391|6383107|P4|Overall Study|Withdrawal by Subject|61
1845655|NCT00235391|6383108|P3|Overall Study|Withdrawal by Subject|3
1845656|NCT00235391|6383109|P2|Overall Study|Withdrawal by Subject|3
1845657|NCT00235391|6383110|P1|Overall Study|Withdrawal by Subject|2
1845658|NCT00235391|6383105|P6|Overall Study|Protocol deviation|0
1845659|NCT00235391|6383106|P5|Overall Study|Protocol deviation|0
1845660|NCT00235391|6383107|P4|Overall Study|Protocol deviation|11
1845661|NCT00235391|6383108|P3|Overall Study|Protocol deviation|1
1845662|NCT00235391|6383109|P2|Overall Study|Protocol deviation|0
1845663|NCT00235391|6383110|P1|Overall Study|Protocol deviation|0
1845664|NCT00235391|6383105|P6|Overall Study|Condition no longer requires treatment|0
1845665|NCT00235391|6383106|P5|Overall Study|Condition no longer requires treatment|1
1845666|NCT00235391|6383107|P4|Overall Study|Condition no longer requires treatment|11
1845667|NCT00235391|6383108|P3|Overall Study|Condition no longer requires treatment|0
1845668|NCT00235391|6383109|P2|Overall Study|Condition no longer requires treatment|0
1845669|NCT00235391|6383110|P1|Overall Study|Condition no longer requires treatment|3
1845670|NCT00235391|6383105|P6|Overall Study|Unsatisfactory therapeutic effect|0
1845671|NCT00235391|6383106|P5|Overall Study|Unsatisfactory therapeutic effect|0
1845672|NCT00235391|6383107|P4|Overall Study|Unsatisfactory therapeutic effect|17
1845673|NCT00235391|6383108|P3|Overall Study|Unsatisfactory therapeutic effect|2
1845674|NCT00235391|6383109|P2|Overall Study|Unsatisfactory therapeutic effect|2
1845675|NCT00235391|6383110|P1|Overall Study|Unsatisfactory therapeutic effect|0
1845676|NCT00235391|6383105|P6|Overall Study|Abnormal laboratory value(s)|2
1845677|NCT00235391|6383106|P5|Overall Study|Abnormal laboratory value(s)|1
1845678|NCT00235391|6383107|P4|Overall Study|Abnormal laboratory value(s)|27
1845679|NCT00235391|6383108|P3|Overall Study|Abnormal laboratory value(s)|4
1845680|NCT00235391|6383109|P2|Overall Study|Abnormal laboratory value(s)|5
1845681|NCT00235391|6383110|P1|Overall Study|Abnormal laboratory value(s)|3
1845682|NCT00235391|6383105|P6|Overall Study|Adverse Event|2
1845683|NCT00235391|6383106|P5|Overall Study|Adverse Event|5
1845684|NCT00235391|6383107|P4|Overall Study|Adverse Event|72
1845685|NCT00235391|6383108|P3|Overall Study|Adverse Event|10
1845686|NCT00235391|6383109|P2|Overall Study|Adverse Event|5
1845687|NCT00235391|6383110|P1|Overall Study|Adverse Event|4
1845688|NCT00235326|6383127|P2|Overall Study|Lost to Follow-up|1400
1845689|NCT00235326|6383128|P1|Overall Study|Lost to Follow-up|746
1845690|NCT00234533|6383168|P1|Overall Study|Enrolled but not treated|3
1845691|NCT00234533|6383168|P1|Overall Study|Adverse Event|2
1845692|NCT00234533|6383168|P1|Overall Study|Withdrawal by Subject|6
1845693|NCT00234494|6383187|P1|Overall Study|Protocol Violation|2
1845694|NCT00234104|6383233|P4|Overall Study|Physician Decision|2
1845695|NCT00234104|6383234|P3|Overall Study|Physician Decision|2
1845696|NCT00234104|6383235|P2|Overall Study|Physician Decision|1
1845697|NCT00234104|6383236|P1|Overall Study|Physician Decision|0
1845698|NCT00234104|6383233|P4|Overall Study|Protocol Violation|1
1845699|NCT00234104|6383234|P3|Overall Study|Protocol Violation|0
1845700|NCT00234104|6383235|P2|Overall Study|Protocol Violation|0
1845701|NCT00234104|6383236|P1|Overall Study|Protocol Violation|0
1845702|NCT00234104|6383233|P4|Overall Study|Adverse Event|5
1845703|NCT00234104|6383234|P3|Overall Study|Adverse Event|3
1845704|NCT00234104|6383235|P2|Overall Study|Adverse Event|0
1845705|NCT00234104|6383236|P1|Overall Study|Adverse Event|4
1845706|NCT00234065|6383277|P2|Overall Study|Not Classified|112
1845707|NCT00234065|6383278|P1|Overall Study|Not Classified|111
1845708|NCT00234065|6383277|P2|Overall Study|Physician Decision|22
1845709|NCT00234065|6383278|P1|Overall Study|Physician Decision|23
1845710|NCT00234065|6383277|P2|Overall Study|Withdrawal by Subject|56
1845711|NCT00234065|6383278|P1|Overall Study|Withdrawal by Subject|73
1845712|NCT00234065|6383277|P2|Overall Study|Adverse Event|166
1845713|NCT00234065|6383278|P1|Overall Study|Adverse Event|268
1845714|NCT00234052|6383294|P1|Follow-up for 5 Years|Other|7
1845715|NCT00234052|6383294|P1|Follow-up for 5 Years|Lost to Follow-up|1
1845716|NCT00234052|6383294|P1|Follow-up for 5 Years|Death|41
1845717|NCT00234052|6383294|P1|Treatment|Progressive Disease|11
1845718|NCT00234052|6383294|P1|Treatment|Death|2
1845719|NCT00234052|6383294|P1|Treatment|Adverse Event|5
1845720|NCT00234052|6383294|P1|Treatment|Withdrawal by Subject|3
1845721|NCT00234039|6383304|P1|Overall Study|No Protocol Treatment Received|2
1845722|NCT00234039|6383304|P1|Overall Study|Ineligible|9
1845723|NCT00234039|6383304|P1|Overall Study|Other - Not Protocol Specified|3
1845724|NCT00234039|6383304|P1|Overall Study|Progression/relapse|34
1845725|NCT00234039|6383304|P1|Overall Study|Adverse Event|2
1845726|NCT00233987|6383311|P1|Overall Study|Ineligible|4
1845727|NCT00233987|6383311|P1|Overall Study|Eligible but No Treatment Received|2
1845728|NCT00233987|6383311|P1|Overall Study|Other - Not Protocol Specified|5
1845729|NCT00233987|6383311|P1|Overall Study|Reason Under Review|1
1845730|NCT00233987|6383311|P1|Overall Study|Lack of Efficacy|2
1845731|NCT00233987|6383311|P1|Overall Study|Withdrawal by Subject|1
1845732|NCT00233948|6383320|P6|Overall Study|Adverse Event|0
1845733|NCT00233948|6383321|P5|Overall Study|Adverse Event|0
1845734|NCT00233948|6383322|P4|Overall Study|Adverse Event|0
1845735|NCT00233948|6383323|P3|Overall Study|Adverse Event|0
1845736|NCT00233948|6383324|P2|Overall Study|Adverse Event|0
1845737|NCT00233948|6383325|P1|Overall Study|Adverse Event|1
1845738|NCT00233454|6383349|P1|Overall Study|Death|6
1845739|NCT00233402|6383357|P2|Overall Study|Lost to follow up etc|21
1845740|NCT00233402|6383358|P1|Overall Study|Lost to follow up etc|3
1845741|NCT00233402|6383357|P2|Overall Study|No Ta/T1|94
1845742|NCT00233402|6383358|P1|Overall Study|No Ta/T1|89
1845743|NCT00233402|6383357|P2|Overall Study|No pathology data|9
1845744|NCT00233402|6383358|P1|Overall Study|No pathology data|12
1845745|NCT00233324|6383373|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1845746|NCT00233324|6383374|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
1845747|NCT00233324|6383375|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
1845748|NCT00233324|6383376|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
1845749|NCT00233324|6383373|P4|Follow up at 18-22 Months Corrected Age|Death|4
1845750|NCT00233324|6383374|P3|Follow up at 18-22 Months Corrected Age|Death|5
1845751|NCT00233324|6383375|P2|Follow up at 18-22 Months Corrected Age|Death|7
1845752|NCT00233324|6383376|P1|Follow up at 18-22 Months Corrected Age|Death|5
1845753|NCT00233324|6383373|P4|Main Study|Death|47
1845754|NCT00233324|6383374|P3|Main Study|Death|62
1845755|NCT00233324|6383375|P2|Main Study|Death|60
1845756|NCT00233324|6383376|P1|Main Study|Death|68
1845757|NCT00233064|6383498|P2|Overall Study|Moved to Dom. Republic|0
1845758|NCT00233064|6383499|P1|Overall Study|Moved to Dom. Republic|1
1845759|NCT00233064|6383498|P2|Overall Study|Protocol Violation|0
1845760|NCT00233064|6383499|P1|Overall Study|Protocol Violation|1
1845761|NCT00233064|6383498|P2|Overall Study|Relocation|1
1845762|NCT00233064|6383499|P1|Overall Study|Relocation|0
1845763|NCT00233064|6383498|P2|Overall Study|Death|1
1845764|NCT00233064|6383499|P1|Overall Study|Death|0
1845765|NCT00233064|6383498|P2|Overall Study|Withdrawal by Subject|3
1845766|NCT00233064|6383499|P1|Overall Study|Withdrawal by Subject|5
1845767|NCT00233064|6383498|P2|Overall Study|Lost to Follow-up|7
1845768|NCT00233064|6383499|P1|Overall Study|Lost to Follow-up|7
1845769|NCT00232596|6383525|P2|12-Week Maintenance Phase|Other|3
1845770|NCT00232596|6383526|P1|12-Week Maintenance Phase|Other|1
1845771|NCT00232596|6383525|P2|12-Week Maintenance Phase|Protocol Violation|1
1845772|NCT00232596|6383526|P1|12-Week Maintenance Phase|Protocol Violation|3
1845773|NCT00232596|6383525|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
1845774|NCT00232596|6383526|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
1845775|NCT00232596|6383525|P2|12-Week Maintenance Phase|Adverse Event|22
1845776|NCT00232596|6383526|P1|12-Week Maintenance Phase|Adverse Event|7
1845777|NCT00232596|6383525|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
1845778|NCT00232596|6383526|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
1845779|NCT00232596|6383525|P2|6-Week Titration Phase|Other|3
1845780|NCT00232596|6383526|P1|6-Week Titration Phase|Other|3
1845781|NCT00232596|6383525|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
1845782|NCT00232596|6383526|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
1845783|NCT00232596|6383525|P2|6-Week Titration Phase|Protocol Violation|3
1845784|NCT00232596|6383526|P1|6-Week Titration Phase|Protocol Violation|1
1845785|NCT00232596|6383525|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
1845786|NCT00232596|6383526|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
1845787|NCT00232596|6383525|P2|6-Week Titration Phase|Failed to Return|1
1845788|NCT00232596|6383526|P1|6-Week Titration Phase|Failed to Return|2
1845789|NCT00232596|6383525|P2|6-Week Titration Phase|Adverse Event|19
1845790|NCT00232596|6383526|P1|6-Week Titration Phase|Adverse Event|6
1845791|NCT00232557|6383617|P2|Overall Study|Lost to Follow-up|5
1845792|NCT00232557|6383618|P1|Overall Study|Lost to Follow-up|3
1845793|NCT00232544|6383628|P2|Overall Study|Lost to Follow-up|15
1845794|NCT00232544|6383629|P1|Overall Study|Lost to Follow-up|20
1845795|NCT00232180|6383660|P3|Open Label Phase|Randomized but not treated|1
1845796|NCT00232180|6383661|P2|Open Label Phase|Randomized but not treated|0
1845797|NCT00232180|6383662|P1|Open Label Phase|Randomized but not treated|0
1845798|NCT00232180|6383660|P3|Open Label Phase|Laboratory abnormality|10
1845799|NCT00232180|6383661|P2|Open Label Phase|Laboratory abnormality|0
1845800|NCT00232180|6383662|P1|Open Label Phase|Laboratory abnormality|0
1845801|NCT00232180|6383660|P3|Open Label Phase|Adverse Event|25
1845802|NCT00232180|6383661|P2|Open Label Phase|Adverse Event|0
1845803|NCT00232180|6383662|P1|Open Label Phase|Adverse Event|0
1845804|NCT00232180|6383660|P3|Open Label Phase|Other|16
1845805|NCT00232180|6383661|P2|Open Label Phase|Other|0
1845806|NCT00232180|6383662|P1|Open Label Phase|Other|0
1845807|NCT00232180|6383660|P3|Open Label Phase|Withdrawal by Subject|37
1845808|NCT00232180|6383661|P2|Open Label Phase|Withdrawal by Subject|0
1845809|NCT00232180|6383662|P1|Open Label Phase|Withdrawal by Subject|0
1845810|NCT00232180|6383660|P3|Open Label Phase|Study terminated by sponsor|3
1845811|NCT00232180|6383661|P2|Open Label Phase|Study terminated by sponsor|0
1845812|NCT00232180|6383662|P1|Open Label Phase|Study terminated by sponsor|0
1845813|NCT00232180|6383660|P3|Open Label Phase|Protocol Violation|3
1845814|NCT00232180|6383661|P2|Open Label Phase|Protocol Violation|0
1845815|NCT00232180|6383662|P1|Open Label Phase|Protocol Violation|0
1845816|NCT00232180|6383660|P3|Open Label Phase|Lost to Follow-up|5
1845817|NCT00232180|6383661|P2|Open Label Phase|Lost to Follow-up|0
1845818|NCT00232180|6383662|P1|Open Label Phase|Lost to Follow-up|0
1845819|NCT00232180|6383660|P3|Open Label Phase|Death|48
1845820|NCT00232180|6383661|P2|Open Label Phase|Death|0
1845821|NCT00232180|6383662|P1|Open Label Phase|Death|0
1845822|NCT00232180|6383660|P3|Double-blind (DB) Phase|Laboratory abnormality|0
1845823|NCT00232180|6383661|P2|Double-blind (DB) Phase|Laboratory abnormality|7
1845824|NCT00232180|6383662|P1|Double-blind (DB) Phase|Laboratory abnormality|6
1845825|NCT00232180|6383660|P3|Double-blind (DB) Phase|Randomized but not treated|0
1845826|NCT00232180|6383661|P2|Double-blind (DB) Phase|Randomized but not treated|4
1845827|NCT00232180|6383662|P1|Double-blind (DB) Phase|Randomized but not treated|3
1845828|NCT00232180|6383660|P3|Double-blind (DB) Phase|Other|0
1845829|NCT00232180|6383661|P2|Double-blind (DB) Phase|Other|75
1845830|NCT00232180|6383662|P1|Double-blind (DB) Phase|Other|70
1845831|NCT00232180|6383660|P3|Double-blind (DB) Phase|Adverse Event|0
1845832|NCT00232180|6383661|P2|Double-blind (DB) Phase|Adverse Event|100
1845833|NCT00232180|6383662|P1|Double-blind (DB) Phase|Adverse Event|83
1845834|NCT00232180|6383660|P3|Double-blind (DB) Phase|Protocol Violation|0
1845835|NCT00232180|6383661|P2|Double-blind (DB) Phase|Protocol Violation|21
1845836|NCT00232180|6383662|P1|Double-blind (DB) Phase|Protocol Violation|28
1845837|NCT00232180|6383660|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
1845838|NCT00232180|6383661|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
1845839|NCT00232180|6383662|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
1845840|NCT00232180|6383660|P3|Double-blind (DB) Phase|Lost to Follow-up|0
1845841|NCT00232180|6383661|P2|Double-blind (DB) Phase|Lost to Follow-up|28
1845842|NCT00232180|6383662|P1|Double-blind (DB) Phase|Lost to Follow-up|34
1845843|NCT00232180|6383660|P3|Double-blind (DB) Phase|Death|0
1845844|NCT00232180|6383661|P2|Double-blind (DB) Phase|Death|222
1845845|NCT00232180|6383662|P1|Double-blind (DB) Phase|Death|186
1845846|NCT00232141|6383707|P2|Overall Study|Withdrawal by Subject|3
1845847|NCT00232141|6383708|P1|Overall Study|Withdrawal by Subject|5
1845848|NCT00232141|6383707|P2|Overall Study|Other|10
1845849|NCT00232141|6383708|P1|Overall Study|Other|8
1845850|NCT00232141|6383707|P2|Overall Study|Lost to Follow-up|6
1845851|NCT00232141|6383708|P1|Overall Study|Lost to Follow-up|9
1845852|NCT00232141|6383707|P2|Overall Study|Lack of Efficacy|3
1845853|NCT00232141|6383708|P1|Overall Study|Lack of Efficacy|0
1845854|NCT00232141|6383707|P2|Overall Study|Adverse Event|4
1845855|NCT00232141|6383708|P1|Overall Study|Adverse Event|9
1845856|NCT00231894|6383778|P2|Overall Study|Withdrawal by Subject|1
1845857|NCT00231894|6383779|P1|Overall Study|Withdrawal by Subject|1
1845858|NCT00231842|6383801|P1|Overall Study|Did not complete the last 3 cycle|8
1845859|NCT00231842|6383801|P1|Overall Study|Withdrawal by Subject|3
1845860|NCT00231816|6383808|P2|Overall Study|Other|1
1845861|NCT00231816|6383809|P1|Overall Study|Other|2
1845862|NCT00231816|6383808|P2|Overall Study|Withdrawal by Subject|3
1845863|NCT00231816|6383809|P1|Overall Study|Withdrawal by Subject|3
1845864|NCT00231816|6383808|P2|Overall Study|Protocol Violation|3
1845865|NCT00231816|6383809|P1|Overall Study|Protocol Violation|2
1845866|NCT00231816|6383808|P2|Overall Study|Lost to Follow-up|5
1845867|NCT00231816|6383809|P1|Overall Study|Lost to Follow-up|8
1845868|NCT00231816|6383808|P2|Overall Study|Adverse Event|0
1845869|NCT00231816|6383809|P1|Overall Study|Adverse Event|1
1845870|NCT00231777|6383824|P2|Overall Study|Other|2
1845871|NCT00231777|6383825|P1|Overall Study|Other|3
1845872|NCT00231777|6383824|P2|Overall Study|Lost to Follow-up|0
1845873|NCT00231777|6383825|P1|Overall Study|Lost to Follow-up|3
1845874|NCT00231478|6383839|P2|Overall Study|Administrative|2
1845875|NCT00231478|6383840|P1|Overall Study|Administrative|3
1845876|NCT00231478|6383839|P2|Overall Study|Adverse Event|1
1845877|NCT00231478|6383840|P1|Overall Study|Adverse Event|0
1845878|NCT00231478|6383839|P2|Overall Study|Withdrawal by Subject|0
1845879|NCT00231478|6383840|P1|Overall Study|Withdrawal by Subject|1
1845880|NCT00231478|6383839|P2|Overall Study|Refused Treatment|1
1845881|NCT00231478|6383840|P1|Overall Study|Refused Treatment|1
1845882|NCT00231478|6383839|P2|Overall Study|Protocol Violation|2
1845883|NCT00231478|6383840|P1|Overall Study|Protocol Violation|3
1845884|NCT00231465|6383852|P1|Overall Study|Did not have follow up CT scans|1
1845885|NCT00231465|6383852|P1|Overall Study|Completed only one cycle|1
1845886|NCT00231413|6383865|P7|Overall Study|Pregnancy|0
1845887|NCT00231413|6383866|P6|Overall Study|Pregnancy|0
1845888|NCT00231413|6383867|P5|Overall Study|Pregnancy|0
1845889|NCT00231413|6383868|P4|Overall Study|Pregnancy|0
1845890|NCT00231413|6383869|P3|Overall Study|Pregnancy|0
1845891|NCT00231413|6383870|P2|Overall Study|Pregnancy|0
1845892|NCT00231413|6383871|P1|Overall Study|Pregnancy|1
1845893|NCT00231413|6383865|P7|Overall Study|Lost to Follow-up|0
1845894|NCT00231413|6383866|P6|Overall Study|Lost to Follow-up|4
1845895|NCT00231413|6383867|P5|Overall Study|Lost to Follow-up|1
1845896|NCT00231413|6383868|P4|Overall Study|Lost to Follow-up|1
1845897|NCT00231413|6383869|P3|Overall Study|Lost to Follow-up|1
1845898|NCT00231413|6383870|P2|Overall Study|Lost to Follow-up|4
1845899|NCT00231413|6383871|P1|Overall Study|Lost to Follow-up|4
1845900|NCT00231413|6383865|P7|Overall Study|Migrated/moved from study area|0
1845901|NCT00231413|6383866|P6|Overall Study|Migrated/moved from study area|1
1845902|NCT00231413|6383867|P5|Overall Study|Migrated/moved from study area|0
1845903|NCT00231413|6383868|P4|Overall Study|Migrated/moved from study area|0
1845904|NCT00231413|6383869|P3|Overall Study|Migrated/moved from study area|1
1845905|NCT00231413|6383870|P2|Overall Study|Migrated/moved from study area|0
1845906|NCT00231413|6383871|P1|Overall Study|Migrated/moved from study area|0
1845907|NCT00231413|6383865|P7|Overall Study|Withdrawal by Subject|3
1845908|NCT00231413|6383866|P6|Overall Study|Withdrawal by Subject|0
1845909|NCT00231413|6383867|P5|Overall Study|Withdrawal by Subject|2
1845910|NCT00231413|6383868|P4|Overall Study|Withdrawal by Subject|2
1845911|NCT00231413|6383869|P3|Overall Study|Withdrawal by Subject|4
1845912|NCT00231413|6383870|P2|Overall Study|Withdrawal by Subject|1
1845913|NCT00231413|6383871|P1|Overall Study|Withdrawal by Subject|3
1845914|NCT00231413|6383865|P7|Overall Study|Non-serious AE|1
1845915|NCT00231413|6383866|P6|Overall Study|Non-serious AE|0
1845916|NCT00231413|6383867|P5|Overall Study|Non-serious AE|0
1845917|NCT00231413|6383868|P4|Overall Study|Non-serious AE|0
1845918|NCT00231413|6383869|P3|Overall Study|Non-serious AE|1
1845919|NCT00231413|6383870|P2|Overall Study|Non-serious AE|0
1845920|NCT00231413|6383871|P1|Overall Study|Non-serious AE|0
1845921|NCT00231179|6384041|P2|Overall Study|Withdrawal by Subject|3
1845922|NCT00231179|6384042|P1|Overall Study|Withdrawal by Subject|3
1845923|NCT00231179|6384041|P2|Overall Study|Lost to Follow-up|21
1845924|NCT00231179|6384042|P1|Overall Study|Lost to Follow-up|21
1845925|NCT00231114|6384069|P2|Post-Treatment Period|Withdrawal by Subject|0
1845926|NCT00231114|6384070|P1|Post-Treatment Period|Withdrawal by Subject|1
1845927|NCT00231114|6384069|P2|Post-Treatment Period|Physician Decision|0
1845928|NCT00231114|6384070|P1|Post-Treatment Period|Physician Decision|1
1845929|NCT00231114|6384069|P2|Post-Treatment Period|Lost to Follow-up|1
1845930|NCT00231114|6384070|P1|Post-Treatment Period|Lost to Follow-up|6
1845931|NCT00231114|6384069|P2|Treatment Period|Death: Motor Vehicle Accident|0
1845932|NCT00231114|6384070|P1|Treatment Period|Death: Motor Vehicle Accident|1
1845933|NCT00231114|6384069|P2|Randomized|Withdrawal by Subject|3
1845934|NCT00231114|6384070|P1|Randomized|Withdrawal by Subject|6
1845935|NCT00231062|6384106|P1|Overall Study|Physician Decision|6
1845936|NCT00230971|6384114|P2|Baseline Participants|Reintervention|0
1845937|NCT00230971|6384115|P1|Baseline Participants|Reintervention|1
1845938|NCT00230971|6384114|P2|Baseline Participants|Failure to return|1
1845939|NCT00230971|6384115|P1|Baseline Participants|Failure to return|1
1845940|NCT00230971|6384114|P2|Baseline Participants|No bacteria observed|0
1845941|NCT00230971|6384115|P1|Baseline Participants|No bacteria observed|1
1845942|NCT00230971|6384114|P2|Baseline Participants|Adverse Event|0
1845943|NCT00230971|6384115|P1|Baseline Participants|Adverse Event|1
1845944|NCT00230971|6384114|P2|Baseline Participants|Withdrawal by Subject|1
1845945|NCT00230971|6384115|P1|Baseline Participants|Withdrawal by Subject|7
1845946|NCT00230971|6384114|P2|Baseline Participants|Death|5
1845947|NCT00230971|6384115|P1|Baseline Participants|Death|6
1845948|NCT00230971|6384114|P2|Baseline Participants|Lost to Follow-up|12
1845949|NCT00230971|6384115|P1|Baseline Participants|Lost to Follow-up|5
1845950|NCT00230971|6384114|P2|Randomization|No study drug administered|3
1845951|NCT00230971|6384115|P1|Randomization|No study drug administered|3
1845952|NCT00230282|6384153|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
1845953|NCT00230282|6384153|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
1845954|NCT00230282|6384153|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
1845955|NCT00230282|6384153|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
1845956|NCT00230178|6384161|P3|Overall Study|Various other reasons|4
1845957|NCT00230178|6384162|P2|Overall Study|Various other reasons|2
1845958|NCT00230178|6384163|P1|Overall Study|Various other reasons|3
1845959|NCT00230178|6384161|P3|Overall Study|Withdrawal by Subject|1
1845960|NCT00230178|6384162|P2|Overall Study|Withdrawal by Subject|0
1845961|NCT00230178|6384163|P1|Overall Study|Withdrawal by Subject|0
1845962|NCT00230178|6384161|P3|Overall Study|Adverse Event|2
1845963|NCT00230178|6384162|P2|Overall Study|Adverse Event|5
1845964|NCT00230178|6384163|P1|Overall Study|Adverse Event|1
1845965|NCT00230048|6384215|P2|Overall Study|Lost to Follow-up|18
1845966|NCT00230048|6384216|P1|Overall Study|Lost to Follow-up|13
1845967|NCT00229931|6384274|P2|Overall Study|Lost to Follow-up|2
1845968|NCT00229931|6384275|P1|Overall Study|Lost to Follow-up|3
1845969|NCT00229931|6384274|P2|Overall Study|Death|0
1845970|NCT00229931|6384275|P1|Overall Study|Death|1
1845971|NCT00229723|6384290|P7|Maintenance Phase|Other|1
1845972|NCT00229723|6384291|P6|Maintenance Phase|Other|3
1845973|NCT00229723|6384292|P5|Maintenance Phase|Other|3
1845974|NCT00229723|6384293|P4|Maintenance Phase|Other|2
1845975|NCT00229723|6384294|P3|Maintenance Phase|Other|1
1845976|NCT00229723|6384295|P2|Maintenance Phase|Other|4
1845977|NCT00229723|6384296|P1|Maintenance Phase|Other|5
1845978|NCT00229723|6384290|P7|Maintenance Phase|Severe non-compliance|0
1845979|NCT00229723|6384291|P6|Maintenance Phase|Severe non-compliance|0
1845980|NCT00229723|6384292|P5|Maintenance Phase|Severe non-compliance|1
1845981|NCT00229723|6384293|P4|Maintenance Phase|Severe non-compliance|0
1845982|NCT00229723|6384294|P3|Maintenance Phase|Severe non-compliance|0
1845983|NCT00229723|6384295|P2|Maintenance Phase|Severe non-compliance|1
1845984|NCT00229723|6384296|P1|Maintenance Phase|Severe non-compliance|3
1845985|NCT00229723|6384290|P7|Maintenance Phase|Informed consent withdrawn|0
1845986|NCT00229723|6384291|P6|Maintenance Phase|Informed consent withdrawn|1
1845987|NCT00229723|6384292|P5|Maintenance Phase|Informed consent withdrawn|1
1845988|NCT00229723|6384293|P4|Maintenance Phase|Informed consent withdrawn|1
1845989|NCT00229723|6384294|P3|Maintenance Phase|Informed consent withdrawn|0
1845990|NCT00229723|6384295|P2|Maintenance Phase|Informed consent withdrawn|0
1845991|NCT00229723|6384296|P1|Maintenance Phase|Informed consent withdrawn|1
1845992|NCT00229723|6384290|P7|Maintenance Phase|Lost to Follow-up|1
1845993|NCT00229723|6384291|P6|Maintenance Phase|Lost to Follow-up|0
1845994|NCT00229723|6384292|P5|Maintenance Phase|Lost to Follow-up|0
1845995|NCT00229723|6384293|P4|Maintenance Phase|Lost to Follow-up|2
1845996|NCT00229723|6384294|P3|Maintenance Phase|Lost to Follow-up|2
1845997|NCT00229723|6384295|P2|Maintenance Phase|Lost to Follow-up|1
1845998|NCT00229723|6384296|P1|Maintenance Phase|Lost to Follow-up|0
1845999|NCT00229723|6384290|P7|Maintenance Phase|Clinical progression|1
1846000|NCT00229723|6384291|P6|Maintenance Phase|Clinical progression|1
1846001|NCT00229723|6384292|P5|Maintenance Phase|Clinical progression|1
1846002|NCT00229723|6384293|P4|Maintenance Phase|Clinical progression|2
1846003|NCT00229723|6384294|P3|Maintenance Phase|Clinical progression|2
1846004|NCT00229723|6384295|P2|Maintenance Phase|Clinical progression|1
1846005|NCT00229723|6384296|P1|Maintenance Phase|Clinical progression|4
1846006|NCT00229723|6384290|P7|Maintenance Phase|Objective disease progression|5
1846007|NCT00229723|6384291|P6|Maintenance Phase|Objective disease progression|9
1846008|NCT00229723|6384292|P5|Maintenance Phase|Objective disease progression|2
1846009|NCT00229723|6384293|P4|Maintenance Phase|Objective disease progression|6
1846010|NCT00229723|6384294|P3|Maintenance Phase|Objective disease progression|3
1846011|NCT00229723|6384295|P2|Maintenance Phase|Objective disease progression|5
1846012|NCT00229723|6384296|P1|Maintenance Phase|Objective disease progression|5
1846013|NCT00229723|6384290|P7|Maintenance Phase|Adverse Event|2
1846014|NCT00229723|6384291|P6|Maintenance Phase|Adverse Event|5
1846015|NCT00229723|6384292|P5|Maintenance Phase|Adverse Event|7
1846016|NCT00229723|6384293|P4|Maintenance Phase|Adverse Event|4
1846017|NCT00229723|6384294|P3|Maintenance Phase|Adverse Event|1
1846018|NCT00229723|6384295|P2|Maintenance Phase|Adverse Event|2
1846019|NCT00229723|6384296|P1|Maintenance Phase|Adverse Event|7
1846020|NCT00229723|6384290|P7|Concomitant Phase|Other|0
1846021|NCT00229723|6384291|P6|Concomitant Phase|Other|2
1846022|NCT00229723|6384292|P5|Concomitant Phase|Other|0
1846023|NCT00229723|6384293|P4|Concomitant Phase|Other|1
1846024|NCT00229723|6384294|P3|Concomitant Phase|Other|1
1846025|NCT00229723|6384295|P2|Concomitant Phase|Other|0
1846026|NCT00229723|6384296|P1|Concomitant Phase|Other|3
1846027|NCT00229723|6384290|P7|Concomitant Phase|Severe non-compliance|0
1846028|NCT00229723|6384291|P6|Concomitant Phase|Severe non-compliance|0
1846029|NCT00229723|6384292|P5|Concomitant Phase|Severe non-compliance|1
1846030|NCT00229723|6384293|P4|Concomitant Phase|Severe non-compliance|0
1846031|NCT00229723|6384294|P3|Concomitant Phase|Severe non-compliance|0
1846032|NCT00229723|6384295|P2|Concomitant Phase|Severe non-compliance|1
1846033|NCT00229723|6384296|P1|Concomitant Phase|Severe non-compliance|0
1846034|NCT00229723|6384290|P7|Concomitant Phase|Informed consent withdrawn|0
1846035|NCT00229723|6384291|P6|Concomitant Phase|Informed consent withdrawn|0
1846036|NCT00229723|6384292|P5|Concomitant Phase|Informed consent withdrawn|0
1846037|NCT00229723|6384293|P4|Concomitant Phase|Informed consent withdrawn|2
1846038|NCT00229723|6384294|P3|Concomitant Phase|Informed consent withdrawn|0
1846039|NCT00229723|6384295|P2|Concomitant Phase|Informed consent withdrawn|2
1846040|NCT00229723|6384296|P1|Concomitant Phase|Informed consent withdrawn|3
1846041|NCT00229723|6384290|P7|Concomitant Phase|Lost to Follow-up|0
1846042|NCT00229723|6384291|P6|Concomitant Phase|Lost to Follow-up|0
1846043|NCT00229723|6384292|P5|Concomitant Phase|Lost to Follow-up|1
1846044|NCT00229723|6384293|P4|Concomitant Phase|Lost to Follow-up|0
1846045|NCT00229723|6384294|P3|Concomitant Phase|Lost to Follow-up|0
1846046|NCT00229723|6384295|P2|Concomitant Phase|Lost to Follow-up|0
1846047|NCT00229723|6384296|P1|Concomitant Phase|Lost to Follow-up|0
1846048|NCT00229723|6384290|P7|Concomitant Phase|Clinical progression|1
1846049|NCT00229723|6384291|P6|Concomitant Phase|Clinical progression|0
1846050|NCT00229723|6384292|P5|Concomitant Phase|Clinical progression|0
1846051|NCT00229723|6384293|P4|Concomitant Phase|Clinical progression|0
1846052|NCT00229723|6384294|P3|Concomitant Phase|Clinical progression|0
1846053|NCT00229723|6384295|P2|Concomitant Phase|Clinical progression|0
1846054|NCT00229723|6384296|P1|Concomitant Phase|Clinical progression|0
1846055|NCT00229723|6384290|P7|Concomitant Phase|Objective disease progression|0
1846056|NCT00229723|6384291|P6|Concomitant Phase|Objective disease progression|0
1846057|NCT00229723|6384292|P5|Concomitant Phase|Objective disease progression|0
1846058|NCT00229723|6384293|P4|Concomitant Phase|Objective disease progression|0
1846059|NCT00229723|6384294|P3|Concomitant Phase|Objective disease progression|0
1846060|NCT00229723|6384295|P2|Concomitant Phase|Objective disease progression|0
1846061|NCT00229723|6384296|P1|Concomitant Phase|Objective disease progression|0
1846062|NCT00229723|6384290|P7|Concomitant Phase|Adverse Event|2
1846063|NCT00229723|6384291|P6|Concomitant Phase|Adverse Event|1
1846064|NCT00229723|6384292|P5|Concomitant Phase|Adverse Event|0
1846065|NCT00229723|6384293|P4|Concomitant Phase|Adverse Event|2
1846066|NCT00229723|6384294|P3|Concomitant Phase|Adverse Event|5
1846067|NCT00229723|6384295|P2|Concomitant Phase|Adverse Event|2
1846068|NCT00229723|6384296|P1|Concomitant Phase|Adverse Event|4
1846069|NCT00229658|6384349|P2|Overall Study|Withdrawal of consent|39
1846070|NCT00229658|6384350|P1|Overall Study|Withdrawal of consent|46
1846071|NCT00229658|6384349|P2|Overall Study|Serious Adverse Event|2
1846072|NCT00229658|6384350|P1|Overall Study|Serious Adverse Event|2
1846073|NCT00229658|6384349|P2|Overall Study|Lost to Follow-up|55
1846074|NCT00229658|6384350|P1|Overall Study|Lost to Follow-up|82
1846075|NCT00229658|6384349|P2|Overall Study|Other|60
1846076|NCT00229658|6384350|P1|Overall Study|Other|80
1846077|NCT00229658|6384349|P2|Overall Study|Investigator decision|10
1846078|NCT00229658|6384350|P1|Overall Study|Investigator decision|13
1846079|NCT00229658|6384349|P2|Overall Study|Administrative|1
1846080|NCT00229658|6384350|P1|Overall Study|Administrative|2
1846081|NCT00229203|6384386|P2|Overall Study|Withdrawal by Subject|4
1846082|NCT00229203|6384387|P1|Overall Study|Withdrawal by Subject|1
1846083|NCT00229203|6384386|P2|Overall Study|Other|3
1846084|NCT00229203|6384387|P1|Overall Study|Other|3
1846085|NCT00229203|6384386|P2|Overall Study|Death|2
1846086|NCT00229203|6384387|P1|Overall Study|Death|4
1846087|NCT00229203|6384386|P2|Overall Study|Toxicity|1
1846088|NCT00229203|6384387|P1|Overall Study|Toxicity|6
1846089|NCT00229203|6384386|P2|Overall Study|Progressive disease|9
1846090|NCT00229203|6384387|P1|Overall Study|Progressive disease|18
1846099|NCT00228813|6384468|P1|Overall Study|Death|4
1846100|NCT00228566|6384474|P1|Overall Study|Miscellaneous|1
1846101|NCT00228566|6384474|P1|Overall Study|Withdrawal by Subject|4
1846102|NCT00228566|6384474|P1|Overall Study|Physician Decision|5
1846103|NCT00228566|6384474|P1|Overall Study|Lost to Follow-up|16
1846104|NCT00228566|6384474|P1|Overall Study|Lack of Efficacy|14
1846105|NCT00228566|6384474|P1|Overall Study|Adverse Event|31
1846106|NCT00228553|6384478|P1|Overall Study|Miscellaneous|46
1846107|NCT00228553|6384478|P1|Overall Study|Pregnancy|2
1846108|NCT00228553|6384478|P1|Overall Study|Withdrawal by Subject|115
1846109|NCT00228553|6384478|P1|Overall Study|Protocol Violation|6
1846110|NCT00228553|6384478|P1|Overall Study|Physician Decision|48
1846111|NCT00228553|6384478|P1|Overall Study|Lost to Follow-up|67
1846112|NCT00228553|6384478|P1|Overall Study|Lack of Efficacy|34
1846113|NCT00228553|6384478|P1|Overall Study|Adverse Event|112
1846114|NCT00228384|6384484|P2|Overall Study|Physician Decision|1
1846115|NCT00228384|6384485|P1|Overall Study|Physician Decision|0
1846116|NCT00228384|6384484|P2|Overall Study|Withdrawal by Subject|10
1846117|NCT00228384|6384485|P1|Overall Study|Withdrawal by Subject|9
1846118|NCT00228384|6384484|P2|Overall Study|Surgical Intervention (bypass)|5
1846119|NCT00228384|6384485|P1|Overall Study|Surgical Intervention (bypass)|5
1846120|NCT00228384|6384484|P2|Overall Study|Lost to Follow-up|10
1846121|NCT00228384|6384485|P1|Overall Study|Lost to Follow-up|6
1846122|NCT00228384|6384484|P2|Overall Study|Death|3
1846123|NCT00228384|6384485|P1|Overall Study|Death|9
1846124|NCT00227903|6384536|P2|Overall Study|Miscarriage|0
1846125|NCT00227903|6384537|P1|Overall Study|Miscarriage|1
1846126|NCT00227903|6384536|P2|Overall Study|Lost to Follow-up|3
1846127|NCT00227903|6384537|P1|Overall Study|Lost to Follow-up|1
1846128|NCT00227903|6384536|P2|Overall Study|Subject moved out of area|2
1846129|NCT00227903|6384537|P1|Overall Study|Subject moved out of area|1
1846130|NCT00227903|6384536|P2|Overall Study|Withdrawal by Subject|5
1846131|NCT00227903|6384537|P1|Overall Study|Withdrawal by Subject|2
1846132|NCT00227877|6384601|P4|12-months Follow-up|Lost to Follow-up|26
1846133|NCT00227877|6384602|P3|12-months Follow-up|Lost to Follow-up|30
1846134|NCT00227877|6384603|P2|12-months Follow-up|Lost to Follow-up|189
1846135|NCT00227877|6384604|P1|12-months Follow-up|Lost to Follow-up|232
1846136|NCT00227877|6384601|P4|12-months Follow-up|Completed late|0
1846137|NCT00227877|6384602|P3|12-months Follow-up|Completed late|1
1846138|NCT00227877|6384603|P2|12-months Follow-up|Completed late|74
1846139|NCT00227877|6384604|P1|12-months Follow-up|Completed late|78
1846140|NCT00227877|6384601|P4|3-months Follow-up|Lost to Follow-up|13
1846141|NCT00227877|6384602|P3|3-months Follow-up|Lost to Follow-up|18
1846142|NCT00227877|6384603|P2|3-months Follow-up|Lost to Follow-up|139
1846143|NCT00227877|6384604|P1|3-months Follow-up|Lost to Follow-up|178
1846144|NCT00227877|6384601|P4|3-months Follow-up|Completed late|8
1846145|NCT00227877|6384602|P3|3-months Follow-up|Completed late|34
1846146|NCT00227877|6384603|P2|3-months Follow-up|Completed late|128
1846147|NCT00227877|6384604|P1|3-months Follow-up|Completed late|135
1846148|NCT00227877|6384601|P4|Post-visit Checklist|Lost to Follow-up|0
1846149|NCT00227877|6384602|P3|Post-visit Checklist|Lost to Follow-up|1
1846150|NCT00227877|6384603|P2|Post-visit Checklist|Lost to Follow-up|13
1846151|NCT00227877|6384604|P1|Post-visit Checklist|Lost to Follow-up|24
1846152|NCT00227877|6384601|P4|Pre-visit Assessment|Technical difficulties|0
1846153|NCT00227877|6384602|P3|Pre-visit Assessment|Technical difficulties|0
1846154|NCT00227877|6384603|P2|Pre-visit Assessment|Technical difficulties|3
1846155|NCT00227877|6384604|P1|Pre-visit Assessment|Technical difficulties|7
1846156|NCT00227721|6384640|P1|Overall Study|On study, but never treated.|1
1846157|NCT00227591|6384662|P1|Overall Study|Withdrawal by Subject|1
1846158|NCT00227539|6384666|P1|Overall Study|Protocol Violation|1
1846159|NCT00227370|6384674|P2|Overall Study|Other reasons|1
1846160|NCT00227370|6384675|P1|Overall Study|Other reasons|2
1846161|NCT00227370|6384674|P2|Overall Study|Physician Decision|6
1846162|NCT00227370|6384675|P1|Overall Study|Physician Decision|9
1846163|NCT00227370|6384674|P2|Overall Study|Adverse Event|11
1846164|NCT00227370|6384675|P1|Overall Study|Adverse Event|6
1846165|NCT00227370|6384674|P2|Overall Study|Death|4
1846166|NCT00227370|6384675|P1|Overall Study|Death|3
1846167|NCT00227370|6384674|P2|Overall Study|Withdrawal by Subject|2
1846168|NCT00227370|6384675|P1|Overall Study|Withdrawal by Subject|1
1846169|NCT00227344|6384695|P2|Overall Study|study terminated early|5
1846170|NCT00227344|6384696|P1|Overall Study|study terminated early|12
1846171|NCT00227305|6384716|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
1846172|NCT00227305|6384716|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
1846173|NCT00227305|6384716|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
1846174|NCT00227305|6384716|P1|Overall Study|Physician Decision|3
1846175|NCT00227305|6384716|P1|Overall Study|Lack of Efficacy|7
1846176|NCT00227305|6384716|P1|Overall Study|MOVED OUT OF AREA|3
1846177|NCT00227305|6384716|P1|Overall Study|Study specific discontinuation|13
1846178|NCT00227305|6384716|P1|Overall Study|Lost to Follow-up|33
1846179|NCT00227305|6384716|P1|Overall Study|Withdrawal by Subject|42
1846180|NCT00227305|6384716|P1|Overall Study|Adverse Event|40
1846181|NCT00227266|6384733|P3|Overall Study|Excessive weight gain|2
1846182|NCT00227266|6384734|P2|Overall Study|Excessive weight gain|0
1846183|NCT00227266|6384735|P1|Overall Study|Excessive weight gain|0
1846184|NCT00227266|6384733|P3|Overall Study|Protocol Violation|1
1846185|NCT00227266|6384734|P2|Overall Study|Protocol Violation|0
1846186|NCT00227266|6384735|P1|Overall Study|Protocol Violation|1
1846187|NCT00227266|6384733|P3|Overall Study|Withdrawal by Subject|1
1846188|NCT00227266|6384734|P2|Overall Study|Withdrawal by Subject|0
1846189|NCT00227266|6384735|P1|Overall Study|Withdrawal by Subject|0
1846190|NCT00226941|6384765|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
1846191|NCT00226941|6384766|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
1846192|NCT00226941|6384767|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
1846193|NCT00226941|6384768|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
1846194|NCT00226941|6384765|P4|Overall Study|Withdrawal by subject - toxicity|1
1846195|NCT00226941|6384766|P3|Overall Study|Withdrawal by subject - toxicity|0
1846196|NCT00226941|6384767|P2|Overall Study|Withdrawal by subject - toxicity|0
1846197|NCT00226941|6384768|P1|Overall Study|Withdrawal by subject - toxicity|0
1846198|NCT00226811|6384802|P1|Overall Study|Withdrawal by Subject|2
1846199|NCT00226811|6384802|P1|Overall Study|Lack of Efficacy|55
1846200|NCT00226811|6384802|P1|Overall Study|Adverse Event|11
1846201|NCT00226811|6384802|P1|Overall Study|Death|8
1846202|NCT00226655|6384812|P1|Overall Study|Clinical deterioration|10
1846203|NCT00226655|6384812|P1|Overall Study|Physician Decision|6
1846204|NCT00226655|6384812|P1|Overall Study|Adverse Event|35
1846205|NCT00226655|6384812|P1|Overall Study|Withdrawal by Subject|15
1846206|NCT00226655|6384812|P1|Overall Study|Death|13
1846207|NCT00226499|6384834|P3|Overall Study|Others|356
1846208|NCT00226499|6384835|P2|Overall Study|Others|1066
1846209|NCT00226499|6384836|P1|Overall Study|Others|1064
1846210|NCT00226499|6384834|P3|Overall Study|Adverse Event|3
1846211|NCT00226499|6384835|P2|Overall Study|Adverse Event|6
1846212|NCT00226499|6384836|P1|Overall Study|Adverse Event|10
1846213|NCT00225758|6384971|P1|Overall Study|Adverse Event|4
1846214|NCT00225277|6385003|P2|Overall Study|Other|9
1846215|NCT00225277|6385004|P1|Overall Study|Other|7
1846216|NCT00225277|6385003|P2|Overall Study|Withdrawal by Subject|34
1846217|NCT00225277|6385004|P1|Overall Study|Withdrawal by Subject|40
1846218|NCT00225277|6385003|P2|Overall Study|Protocol Violation|3
1846219|NCT00225277|6385004|P1|Overall Study|Protocol Violation|6
1846220|NCT00225277|6385003|P2|Overall Study|Physician Decision|8
1846221|NCT00225277|6385004|P1|Overall Study|Physician Decision|6
1846222|NCT00225277|6385003|P2|Overall Study|Lost to Follow-up|6
1846223|NCT00225277|6385004|P1|Overall Study|Lost to Follow-up|4
1846224|NCT00225277|6385003|P2|Overall Study|Lack of Efficacy|1
1846225|NCT00225277|6385004|P1|Overall Study|Lack of Efficacy|4
1846226|NCT00225277|6385003|P2|Overall Study|Adverse Event|34
1846227|NCT00225277|6385004|P1|Overall Study|Adverse Event|30
1846228|NCT00225251|6385022|P2|Overall Study|Withdrawal by Subject|1
1846229|NCT00225251|6385023|P1|Overall Study|Withdrawal by Subject|1
1846230|NCT00225212|6385037|P1|Overall Study|Intercurrent illness|1
1846231|NCT00225212|6385037|P1|Overall Study|Adverse Event|2
1846232|NCT00225212|6385037|P1|Overall Study|Death|1
1846233|NCT00225212|6385037|P1|Overall Study|Disease progression|2
1846234|NCT00225147|6385046|P4|Open-label Phase|Withdrawal by Subject|6
1846235|NCT00225147|6385047|P3|Open-label Phase|Withdrawal by Subject|0
1846236|NCT00225147|6385048|P2|Open-label Phase|Withdrawal by Subject|0
1846237|NCT00225147|6385049|P1|Open-label Phase|Withdrawal by Subject|0
1846238|NCT00225147|6385046|P4|Open-label Phase|Lost to Follow-up|4
1846239|NCT00225147|6385047|P3|Open-label Phase|Lost to Follow-up|0
1846240|NCT00225147|6385048|P2|Open-label Phase|Lost to Follow-up|0
1846241|NCT00225147|6385049|P1|Open-label Phase|Lost to Follow-up|0
1846242|NCT00224874|6385096|P4|Overall Study|Withdrawal by Subject|0
1846243|NCT00224874|6385097|P3|Overall Study|Withdrawal by Subject|1
1846244|NCT00224874|6385098|P2|Overall Study|Withdrawal by Subject|0
1846245|NCT00224874|6385099|P1|Overall Study|Withdrawal by Subject|0
1846246|NCT00224770|6385144|P3|Overall Study|Lost to Follow-up|0
1846247|NCT00224770|6385145|P2|Overall Study|Lost to Follow-up|2
1846248|NCT00224770|6385146|P1|Overall Study|Lost to Follow-up|4
1846249|NCT00224484|6385181|P3|Overall Study|Reason not specified|2
1846250|NCT00224484|6385182|P2|Overall Study|Reason not specified|4
1846251|NCT00224484|6385183|P1|Overall Study|Reason not specified|5
1846252|NCT00224484|6385181|P3|Overall Study|Lost to Follow-up|36
1846253|NCT00224484|6385182|P2|Overall Study|Lost to Follow-up|28
1846254|NCT00224484|6385183|P1|Overall Study|Lost to Follow-up|66
1846255|NCT00224484|6385181|P3|Overall Study|Migrated/moved from study area|5
1846256|NCT00224484|6385182|P2|Overall Study|Migrated/moved from study area|5
1846257|NCT00224484|6385183|P1|Overall Study|Migrated/moved from study area|18
1846258|NCT00224484|6385181|P3|Overall Study|Withdrawal by Subject|16
1846259|NCT00224484|6385182|P2|Overall Study|Withdrawal by Subject|18
1846260|NCT00224484|6385183|P1|Overall Study|Withdrawal by Subject|49
1846261|NCT00224484|6385181|P3|Overall Study|Protocol Violation|0
1846262|NCT00224484|6385182|P2|Overall Study|Protocol Violation|2
1846263|NCT00224484|6385183|P1|Overall Study|Protocol Violation|2
1846264|NCT00224484|6385181|P3|Overall Study|Non-Serious Adverse Event|3
1846265|NCT00224484|6385182|P2|Overall Study|Non-Serious Adverse Event|7
1846266|NCT00224484|6385183|P1|Overall Study|Non-Serious Adverse Event|5
1846267|NCT00224484|6385181|P3|Overall Study|Serious Adverse Event|0
1846268|NCT00224484|6385182|P2|Overall Study|Serious Adverse Event|1
1846269|NCT00224484|6385183|P1|Overall Study|Serious Adverse Event|1
1846270|NCT00224133|6385247|P1|Overall Study|Other|14
1846271|NCT00224133|6385247|P1|Overall Study|Physician Decision|1
1846272|NCT00224133|6385247|P1|Overall Study|Lost to Follow-up|21
1846273|NCT00224133|6385247|P1|Overall Study|Lack of Efficacy|58
1846274|NCT00224133|6385247|P1|Overall Study|Withdrawal by Subject|33
1846275|NCT00224133|6385247|P1|Overall Study|Protocol Violation|6
1846276|NCT00224133|6385247|P1|Overall Study|Adverse Event|93
1846277|NCT00224120|6385253|P2|Overall Study|Other|5
1846278|NCT00224120|6385254|P1|Overall Study|Other|4
1846279|NCT00224120|6385253|P2|Overall Study|Lost to Follow-up|3
1846280|NCT00224120|6385254|P1|Overall Study|Lost to Follow-up|2
1846281|NCT00224120|6385253|P2|Overall Study|Lack of Efficacy|2
1846282|NCT00224120|6385254|P1|Overall Study|Lack of Efficacy|0
1846283|NCT00224120|6385253|P2|Overall Study|Withdrawal by Subject|10
1846284|NCT00224120|6385254|P1|Overall Study|Withdrawal by Subject|5
1846285|NCT00224120|6385253|P2|Overall Study|Protocol Violation|0
1846286|NCT00224120|6385254|P1|Overall Study|Protocol Violation|1
1846287|NCT00224120|6385253|P2|Overall Study|Adverse Event|4
1846288|NCT00224120|6385254|P1|Overall Study|Adverse Event|10
1846289|NCT00224107|6385264|P2|Overall Study|Other|1
1846290|NCT00224107|6385265|P1|Overall Study|Other|1
1846291|NCT00224107|6385264|P2|Overall Study|Physician Decision|0
1846292|NCT00224107|6385265|P1|Overall Study|Physician Decision|1
1846293|NCT00224107|6385264|P2|Overall Study|Lost to Follow-up|0
1846294|NCT00224107|6385265|P1|Overall Study|Lost to Follow-up|4
1846295|NCT00224107|6385264|P2|Overall Study|Lack of Efficacy|0
1846296|NCT00224107|6385265|P1|Overall Study|Lack of Efficacy|2
1846297|NCT00224107|6385264|P2|Overall Study|Withdrawal by Subject|4
1846298|NCT00224107|6385265|P1|Overall Study|Withdrawal by Subject|1
1846299|NCT00224107|6385264|P2|Overall Study|Protocol Violation|3
1846300|NCT00224107|6385265|P1|Overall Study|Protocol Violation|2
1846301|NCT00224107|6385264|P2|Overall Study|Adverse Event|6
1846302|NCT00224107|6385265|P1|Overall Study|Adverse Event|20
1846303|NCT00224055|6385275|P2|Overall Study|Other|0
1846304|NCT00224055|6385276|P1|Overall Study|Other|1
1846305|NCT00224055|6385275|P2|Overall Study|Withdrawal by Subject|2
1846306|NCT00224055|6385276|P1|Overall Study|Withdrawal by Subject|0
1846307|NCT00224055|6385275|P2|Overall Study|Inclusion Violation|6
1846308|NCT00224055|6385276|P1|Overall Study|Inclusion Violation|3
1846309|NCT00224055|6385275|P2|Overall Study|Protocol Violation|1
1846310|NCT00224055|6385276|P1|Overall Study|Protocol Violation|1
1846311|NCT00224055|6385275|P2|Overall Study|Lost to Follow-up|2
1846312|NCT00224055|6385276|P1|Overall Study|Lost to Follow-up|1
1846313|NCT00224055|6385275|P2|Overall Study|Adverse Event|3
1846314|NCT00224055|6385276|P1|Overall Study|Adverse Event|9
1846315|NCT00224042|6385286|P2|Overall Study|Other|0
1846316|NCT00224042|6385287|P1|Overall Study|Other|2
1846317|NCT00224042|6385286|P2|Overall Study|Did not meet lab incusion criteria|3
1846318|NCT00224042|6385287|P1|Overall Study|Did not meet lab incusion criteria|2
1846319|NCT00224042|6385286|P2|Overall Study|Physician Decision|1
1846320|NCT00224042|6385287|P1|Overall Study|Physician Decision|0
1846321|NCT00224042|6385286|P2|Overall Study|Protocol Violation|1
1846322|NCT00224042|6385287|P1|Overall Study|Protocol Violation|0
1846323|NCT00224042|6385286|P2|Overall Study|Adverse Event|1
1846324|NCT00224042|6385287|P1|Overall Study|Adverse Event|2
1846325|NCT00224029|6385299|P1|Overall Study|Other|1
1846326|NCT00224029|6385299|P1|Overall Study|Withdrawal by Subject|4
1846327|NCT00224029|6385299|P1|Overall Study|Lost to Follow-up|1
1846328|NCT00224016|6385305|P2|Maintenance Period|Lost to Follow-up|1
1846329|NCT00224016|6385306|P1|Maintenance Period|Lost to Follow-up|0
1846330|NCT00224016|6385305|P2|Maintenance Period|Withdrawal by Subject|0
1846331|NCT00224016|6385306|P1|Maintenance Period|Withdrawal by Subject|2
1846332|NCT00224016|6385305|P2|Titration Period|Lost to Follow-up|0
1846333|NCT00224016|6385306|P1|Titration Period|Lost to Follow-up|1
1846334|NCT00224016|6385305|P2|Titration Period|Withdrawal by Subject|1
1846335|NCT00224016|6385306|P1|Titration Period|Withdrawal by Subject|0
1846336|NCT00224003|6385314|P1|Overall Study|unk|3
1846337|NCT00224003|6385314|P1|Overall Study|Withdrawal by Subject|1
1846338|NCT00224003|6385314|P1|Overall Study|Protocol Violation|2
1846339|NCT00224003|6385314|P1|Overall Study|Adverse Event|1
1846340|NCT00223977|6385321|P3|Overall Study|Other|0
1846341|NCT00223977|6385322|P2|Overall Study|Other|0
1846342|NCT00223977|6385323|P1|Overall Study|Other|1
1846343|NCT00223977|6385321|P3|Overall Study|Withdrawal by Subject|2
1846344|NCT00223977|6385322|P2|Overall Study|Withdrawal by Subject|1
1846345|NCT00223977|6385323|P1|Overall Study|Withdrawal by Subject|1
1846346|NCT00223977|6385321|P3|Overall Study|Protocol Violation|1
1846347|NCT00223977|6385322|P2|Overall Study|Protocol Violation|0
1846348|NCT00223977|6385323|P1|Overall Study|Protocol Violation|0
1846349|NCT00223977|6385321|P3|Overall Study|Adverse Event|0
1846350|NCT00223977|6385322|P2|Overall Study|Adverse Event|10
1846351|NCT00223977|6385323|P1|Overall Study|Adverse Event|7
1846352|NCT00223808|6385357|P3|Overall Study|<5 hrs therapy before discharge|5
1846353|NCT00223808|6385358|P2|Overall Study|<5 hrs therapy before discharge|5
1846354|NCT00223808|6385359|P1|Overall Study|<5 hrs therapy before discharge|3
1846355|NCT00223795|6385376|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1846356|NCT00223795|6385377|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
1846357|NCT00223795|6385376|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
1846358|NCT00223795|6385377|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
1846359|NCT00223496|6385455|P1|Overall Study|Physician Decision|2
1846360|NCT00223496|6385455|P1|Overall Study|Withdrawal by Subject|1
1846361|NCT00223496|6385455|P1|Overall Study|Lack of Efficacy|6
1846362|NCT00223496|6385455|P1|Overall Study|Lost to Follow-up|4
1846363|NCT00223496|6385455|P1|Overall Study|screen failure|9
1846364|NCT00223080|6385485|P2|Overall Study|Adverse Event|1
1846365|NCT00223080|6385486|P1|Overall Study|Adverse Event|0
1846366|NCT00223080|6385485|P2|Overall Study|Reason not provided|140
1846367|NCT00223080|6385486|P1|Overall Study|Reason not provided|141
1846368|NCT00223080|6385485|P2|Overall Study|Other|11
1846369|NCT00223080|6385486|P1|Overall Study|Other|14
1846370|NCT00223080|6385485|P2|Overall Study|Death|74
1846371|NCT00223080|6385486|P1|Overall Study|Death|85
1846372|NCT00223080|6385485|P2|Overall Study|Lost to Follow-up|284
1846373|NCT00223080|6385486|P1|Overall Study|Lost to Follow-up|259
1846374|NCT00223080|6385485|P2|Overall Study|Moved from study area|47
1846375|NCT00223080|6385486|P1|Overall Study|Moved from study area|37
1846376|NCT00223080|6385485|P2|Overall Study|Non-compliant|7
1846377|NCT00223080|6385486|P1|Overall Study|Non-compliant|7
1846378|NCT00223080|6385485|P2|Overall Study|Required contraindicated med|1
1846379|NCT00223080|6385486|P1|Overall Study|Required contraindicated med|0
1846380|NCT00223080|6385485|P2|Overall Study|Withdrawal by Subject|232
1846381|NCT00223080|6385486|P1|Overall Study|Withdrawal by Subject|253
1846382|NCT00222729|6385504|P1|Overall Study|Adverse Event|3
1846383|NCT00222105|6385522|P1|Overall Study|Death|2
1846384|NCT00222105|6385522|P1|Overall Study|Treatment delays|2
1846385|NCT00222105|6385522|P1|Overall Study|Adverse Event|8
1846386|NCT00222105|6385522|P1|Overall Study|Withdrawal by Subject|1
1846387|NCT00222105|6385522|P1|Overall Study|Removed due to wrong diagnosis|1
1846388|NCT00221195|6385543|P2|Overall Study|Lost to Follow-up|1
1846389|NCT00221195|6385544|P1|Overall Study|Lost to Follow-up|0
1846390|NCT00221195|6385543|P2|Overall Study|Death|1
1846391|NCT00221195|6385544|P1|Overall Study|Death|1
1846392|NCT00221195|6385543|P2|Overall Study|Withdrawal by Subject|1
1846393|NCT00221195|6385544|P1|Overall Study|Withdrawal by Subject|4
1846394|NCT00221104|6385566|P2|Overall Study|Others|47
1846395|NCT00221104|6385567|P1|Overall Study|Others|37
1846396|NCT00221104|6385566|P2|Overall Study|Withdrawal by Subject|29
1846397|NCT00221104|6385567|P1|Overall Study|Withdrawal by Subject|42
1846398|NCT00221104|6385566|P2|Overall Study|Protocol Violation|0
1846399|NCT00221104|6385567|P1|Overall Study|Protocol Violation|2
1846400|NCT00221104|6385566|P2|Overall Study|Physician Decision|0
1846401|NCT00221104|6385567|P1|Overall Study|Physician Decision|1
1846402|NCT00221104|6385566|P2|Overall Study|Adverse Event|0
1846403|NCT00221104|6385567|P1|Overall Study|Adverse Event|1
1846404|NCT00220805|6385600|P2|Overall Study|Develop. of choroidal neovascularization|8
1846405|NCT00220805|6385601|P1|Overall Study|Develop. of choroidal neovascularization|3
1846406|NCT00220805|6385600|P2|Overall Study|Lack of Efficacy|0
1846407|NCT00220805|6385601|P1|Overall Study|Lack of Efficacy|1
1846408|NCT00220805|6385600|P2|Overall Study|Withdrawal by Subject|0
1846409|NCT00220805|6385601|P1|Overall Study|Withdrawal by Subject|3
1846410|NCT00220805|6385600|P2|Overall Study|Adverse Event|3
1846411|NCT00220805|6385601|P1|Overall Study|Adverse Event|1
1846412|NCT00220779|6385622|P3|Overall Study|Lack of Efficacy|1
1846413|NCT00220779|6385623|P2|Overall Study|Lack of Efficacy|0
1846414|NCT00220779|6385624|P1|Overall Study|Lack of Efficacy|3
1846415|NCT00220779|6385622|P3|Overall Study|Pregnancy|2
1846416|NCT00220779|6385623|P2|Overall Study|Pregnancy|0
1846417|NCT00220779|6385624|P1|Overall Study|Pregnancy|0
1846418|NCT00220779|6385622|P3|Overall Study|Too time consuming|0
1846419|NCT00220779|6385623|P2|Overall Study|Too time consuming|0
1846420|NCT00220779|6385624|P1|Overall Study|Too time consuming|1
1846421|NCT00220779|6385622|P3|Overall Study|Non-compliance|0
1846422|NCT00220779|6385623|P2|Overall Study|Non-compliance|0
1846423|NCT00220779|6385624|P1|Overall Study|Non-compliance|1
1846424|NCT00220779|6385622|P3|Overall Study|Withdrawal by Subject|1
1846425|NCT00220779|6385623|P2|Overall Study|Withdrawal by Subject|4
1846426|NCT00220779|6385624|P1|Overall Study|Withdrawal by Subject|1
1846427|NCT00220779|6385622|P3|Overall Study|Adverse Event|0
1846428|NCT00220779|6385623|P2|Overall Study|Adverse Event|0
1846429|NCT00220779|6385624|P1|Overall Study|Adverse Event|1
1846430|NCT00220740|6385634|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
1846431|NCT00220740|6385635|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
1846432|NCT00220740|6385634|P2|Efficacy Period|Protocol Violation|0
1846433|NCT00220740|6385635|P1|Efficacy Period|Protocol Violation|1
1846434|NCT00220740|6385634|P2|Efficacy Period|Withdrawal by Subject|0
1846435|NCT00220740|6385635|P1|Efficacy Period|Withdrawal by Subject|1
1846436|NCT00220740|6385634|P2|Efficacy Period|Adverse Event|1
1846437|NCT00220740|6385635|P1|Efficacy Period|Adverse Event|1
1846438|NCT00220740|6385634|P2|Efficacy Period|Entered rescue treatment with placebo|0
1846439|NCT00220740|6385635|P1|Efficacy Period|Entered rescue treatment with placebo|23
1846440|NCT00220727|6385649|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
1846441|NCT00220727|6385650|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
1846442|NCT00220701|6385666|P2|Overall Study|Lost to Follow-up|4
1846443|NCT00220701|6385667|P1|Overall Study|Lost to Follow-up|5
1846444|NCT00220636|6385683|P1|Overall Study|Withdrawal by Subject|4
1846445|NCT00219557|6385693|P3|Phase 2|Treatment not received|3
1846446|NCT00219557|6385694|P2|Phase 2|Treatment not received|1
1846447|NCT00219557|6385695|P1|Phase 2|Treatment not received|0
1846448|NCT00219557|6385693|P3|Phase 2|Withdrawal by Subject|5
1846449|NCT00219557|6385694|P2|Phase 2|Withdrawal by Subject|9
1846450|NCT00219557|6385695|P1|Phase 2|Withdrawal by Subject|0
1846451|NCT00219557|6385693|P3|Phase 2|Other|6
1846452|NCT00219557|6385694|P2|Phase 2|Other|8
1846453|NCT00219557|6385695|P1|Phase 2|Other|0
1846454|NCT00219557|6385693|P3|Phase 2|Death|2
1846455|NCT00219557|6385694|P2|Phase 2|Death|8
1846456|NCT00219557|6385695|P1|Phase 2|Death|0
1846457|NCT00219557|6385693|P3|Phase 2|Adverse Event|2
1846458|NCT00219557|6385694|P2|Phase 2|Adverse Event|22
1846459|NCT00219557|6385695|P1|Phase 2|Adverse Event|0
1846460|NCT00219557|6385693|P3|Phase 2|Lack of Efficacy|15
1846461|NCT00219557|6385694|P2|Phase 2|Lack of Efficacy|21
1846462|NCT00219557|6385695|P1|Phase 2|Lack of Efficacy|0
1846463|NCT00219557|6385693|P3|Phase 1|Started chemotherapy at other institute|0
1846464|NCT00219557|6385694|P2|Phase 1|Started chemotherapy at other institute|0
1846465|NCT00219557|6385695|P1|Phase 1|Started chemotherapy at other institute|1
1846466|NCT00219557|6385693|P3|Phase 1|Withdrawal by Subject|0
1846467|NCT00219557|6385694|P2|Phase 1|Withdrawal by Subject|0
1846468|NCT00219557|6385695|P1|Phase 1|Withdrawal by Subject|1
1846469|NCT00219557|6385693|P3|Phase 1|Adverse Event|0
1846470|NCT00219557|6385694|P2|Phase 1|Adverse Event|0
1846471|NCT00219557|6385695|P1|Phase 1|Adverse Event|2
1846472|NCT00219557|6385693|P3|Phase 1|Lack of Efficacy|0
1846473|NCT00219557|6385694|P2|Phase 1|Lack of Efficacy|0
1846474|NCT00219557|6385695|P1|Phase 1|Lack of Efficacy|3
1846475|NCT00219544|6385723|P2|Single Blind Treatment Period|Withdrawal by Subject|0
1846476|NCT00219544|6385724|P1|Single Blind Treatment Period|Withdrawal by Subject|1
1846477|NCT00219544|6385723|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
1846478|NCT00219544|6385724|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
1846479|NCT00219544|6385723|P2|Single Blind Treatment Period|Lost to Follow-up|0
1846480|NCT00219544|6385724|P1|Single Blind Treatment Period|Lost to Follow-up|2
1846481|NCT00219544|6385723|P2|Single Blind Treatment Period|Protocol Violation|0
1846482|NCT00219544|6385724|P1|Single Blind Treatment Period|Protocol Violation|4
1846483|NCT00219544|6385723|P2|Single Blind Treatment Period|Adverse Event|0
1846484|NCT00219544|6385724|P1|Single Blind Treatment Period|Adverse Event|9
1846485|NCT00219544|6385723|P2|Single Blind Treatment Period|Lack of Efficacy|0
1846486|NCT00219544|6385724|P1|Single Blind Treatment Period|Lack of Efficacy|5
1846487|NCT00219349|6385762|P1|Escitalopram Phase|Withdrawal by Subject|3
1846488|NCT00219349|6385762|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
1846489|NCT00219349|6385762|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
1846490|NCT00219349|6385762|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
1846491|NCT00219284|6385775|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
1846492|NCT00219284|6385776|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
1846493|NCT00219284|6385775|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
1846494|NCT00219284|6385776|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
1846495|NCT00219284|6385775|P2|Extension Phase - 8 Weeks|Adverse Event|3
1846496|NCT00219284|6385776|P1|Extension Phase - 8 Weeks|Adverse Event|2
1846497|NCT00219284|6385775|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
1846498|NCT00219284|6385776|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
1846499|NCT00219284|6385775|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
1846500|NCT00219284|6385776|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
1846501|NCT00219284|6385775|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
1846502|NCT00219284|6385776|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
1846503|NCT00219284|6385775|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
1846504|NCT00219284|6385776|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
1846505|NCT00219284|6385775|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
1846506|NCT00219284|6385776|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
1846507|NCT00219284|6385775|P2|Treatment Phase - 16 Weeks|Adverse Event|24
1846508|NCT00219284|6385776|P1|Treatment Phase - 16 Weeks|Adverse Event|26
1846509|NCT00219141|6385801|P3|Overall Study|Condition no longer requires study drug|0
1846510|NCT00219141|6385802|P2|Overall Study|Condition no longer requires study drug|0
1846511|NCT00219141|6385803|P1|Overall Study|Condition no longer requires study drug|1
1846512|NCT00219141|6385801|P3|Overall Study|Withdrawal by Subject|5
1846513|NCT00219141|6385802|P2|Overall Study|Withdrawal by Subject|3
1846514|NCT00219141|6385803|P1|Overall Study|Withdrawal by Subject|1
1846515|NCT00219141|6385801|P3|Overall Study|Protocol Violation|1
1846516|NCT00219141|6385802|P2|Overall Study|Protocol Violation|1
1846517|NCT00219141|6385803|P1|Overall Study|Protocol Violation|3
1846518|NCT00219141|6385801|P3|Overall Study|Lost to Follow-up|1
1846519|NCT00219141|6385802|P2|Overall Study|Lost to Follow-up|4
1846520|NCT00219141|6385803|P1|Overall Study|Lost to Follow-up|2
1846521|NCT00219141|6385801|P3|Overall Study|Administrative problems|0
1846522|NCT00219141|6385802|P2|Overall Study|Administrative problems|1
1846523|NCT00219141|6385803|P1|Overall Study|Administrative problems|0
1846524|NCT00219141|6385801|P3|Overall Study|Lack of Efficacy|0
1846525|NCT00219141|6385802|P2|Overall Study|Lack of Efficacy|2
1846526|NCT00219141|6385803|P1|Overall Study|Lack of Efficacy|3
1846527|NCT00219141|6385801|P3|Overall Study|Adverse Event|5
1846528|NCT00219141|6385802|P2|Overall Study|Adverse Event|10
1846529|NCT00219141|6385803|P1|Overall Study|Adverse Event|4
1846530|NCT00218634|6385849|P2|Overall Study|Lost to Follow-up|15
1846531|NCT00218634|6385850|P1|Overall Study|Lost to Follow-up|8
1846532|NCT00218543|6385870|P1|Overall Study|Adverse Event|2
1846533|NCT00218543|6385870|P1|Overall Study|Physician Decision|3
1846534|NCT00218543|6385870|P1|Overall Study|Withdrawal by Subject|1
1846535|NCT00218543|6385870|P1|Overall Study|relocated|1
1846536|NCT00218543|6385870|P1|Overall Study|Lost to Follow-up|8
1846537|NCT00218296|6386048|P2|Overall Study|Randomized but did not enter treatment|67
1846538|NCT00218296|6386049|P1|Overall Study|Randomized but did not enter treatment|66
1846539|NCT00218296|6386048|P2|Overall Study|Withdrawal by Subject|47
1846540|NCT00218296|6386049|P1|Overall Study|Withdrawal by Subject|36
1846541|NCT00218296|6386048|P2|Overall Study|Lost to Follow-up|7
1846542|NCT00218296|6386049|P1|Overall Study|Lost to Follow-up|9
1846543|NCT00217971|6386152|P2|Overall Study|non compliant|0
1846544|NCT00217971|6386153|P1|Overall Study|non compliant|1
1846545|NCT00217971|6386152|P2|Overall Study|Withdrawal by Subject|12
1846546|NCT00217971|6386153|P1|Overall Study|Withdrawal by Subject|7
1846547|NCT00217971|6386152|P2|Overall Study|Physician Decision|1
1846548|NCT00217971|6386153|P1|Overall Study|Physician Decision|0
1846549|NCT00217971|6386152|P2|Overall Study|Lost to Follow-up|19
1846550|NCT00217971|6386153|P1|Overall Study|Lost to Follow-up|15
1846551|NCT00217971|6386152|P2|Overall Study|Adverse Event|1
1846552|NCT00217971|6386153|P1|Overall Study|Adverse Event|1
1846553|NCT00217672|6386168|P2|Follow-up|Lost to Follow-up|0
1846554|NCT00217672|6386169|P1|Follow-up|Lost to Follow-up|1
1846555|NCT00217672|6386168|P2|Follow-up|Withdrawal by Subject|0
1846556|NCT00217672|6386169|P1|Follow-up|Withdrawal by Subject|4
1846557|NCT00217672|6386168|P2|Treatment|secondary malignancy|0
1846558|NCT00217672|6386169|P1|Treatment|secondary malignancy|1
1846559|NCT00217672|6386168|P2|Treatment|Death|0
1846560|NCT00217672|6386169|P1|Treatment|Death|2
1846561|NCT00217672|6386168|P2|Treatment|insurance issues|1
1846562|NCT00217672|6386169|P1|Treatment|insurance issues|1
1846563|NCT00217672|6386168|P2|Treatment|Physician Decision|0
1846564|NCT00217672|6386169|P1|Treatment|Physician Decision|6
1846565|NCT00217672|6386168|P2|Treatment|reqd treatment not permitted by protocol|0
1846566|NCT00217672|6386169|P1|Treatment|reqd treatment not permitted by protocol|6
1846567|NCT00217672|6386168|P2|Treatment|Adverse Event|2
1846568|NCT00217672|6386169|P1|Treatment|Adverse Event|18
1846569|NCT00217672|6386168|P2|Treatment|disease progression|4
1846570|NCT00217672|6386169|P1|Treatment|disease progression|33
1846571|NCT00217672|6386168|P2|Allocation|Ineligible|0
1846572|NCT00217672|6386169|P1|Allocation|Ineligible|2
1846573|NCT00217620|6386175|P1|Overall Study|Never received treatment|1
1846574|NCT00217620|6386175|P1|Overall Study|Ineligible|13
1846575|NCT00217620|6386175|P1|Overall Study|Not Protocol Specified|4
1846576|NCT00217620|6386175|P1|Overall Study|Progression|31
1846577|NCT00217620|6386175|P1|Overall Study|Adverse Event|2
1846578|NCT00217581|6386190|P1|Overall Study|Withdrawal by Subject|1
1846579|NCT00217464|6386219|P1|Overall Study|Other|2
1846580|NCT00217464|6386219|P1|Overall Study|Progression|15
1846581|NCT00217425|6386235|P1|Overall Study|Other|4
1846582|NCT00217425|6386235|P1|Overall Study|Other complicating disease|1
1846583|NCT00217425|6386235|P1|Overall Study|Withdrawal by Subject|4
1846584|NCT00217425|6386235|P1|Overall Study|Adverse Event|8
1846585|NCT00217425|6386235|P1|Overall Study|Lack of Efficacy|13
1846586|NCT00217425|6386235|P1|Overall Study|Patient ineligible|5
1846587|NCT00217425|6386235|P1|Overall Study|Never started treatment|2
1846588|NCT00217087|6386249|P2|Overall Study|completed less than 12 months return|18
1846589|NCT00217087|6386250|P1|Overall Study|completed less than 12 months return|10
1846590|NCT00217087|6386249|P2|Overall Study|decided to have esophagectomy|2
1846591|NCT00217087|6386250|P1|Overall Study|decided to have esophagectomy|1
1846592|NCT00217022|6386264|P2|Overall Study|Withdrawal by Subject|1
1846593|NCT00217022|6386265|P1|Overall Study|Withdrawal by Subject|1
1846594|NCT00216736|6386275|P2|Overall Study|Lost to Follow-up|1
1846595|NCT00216736|6386276|P1|Overall Study|Lost to Follow-up|1
1846596|NCT00216671|6386290|P2|Overall Study|Insufficient Response Adverse Event|1
1846597|NCT00216671|6386291|P1|Overall Study|Insufficient Response Adverse Event|2
1846598|NCT00216671|6386290|P2|Overall Study|Ineligible, no efficacy data|2
1846599|NCT00216671|6386291|P1|Overall Study|Ineligible, no efficacy data|2
1846600|NCT00216671|6386290|P2|Overall Study|Patient Moved|1
1846601|NCT00216671|6386291|P1|Overall Study|Patient Moved|0
1846602|NCT00216671|6386290|P2|Overall Study|Investigator Illness|1
1846603|NCT00216671|6386291|P1|Overall Study|Investigator Illness|0
1846604|NCT00216671|6386290|P2|Overall Study|Relapse|0
1846605|NCT00216671|6386291|P1|Overall Study|Relapse|1
1846606|NCT00216671|6386290|P2|Overall Study|Protocol Violation|5
1846607|NCT00216671|6386291|P1|Overall Study|Protocol Violation|3
1846608|NCT00216671|6386290|P2|Overall Study|Physician Decision|1
1846609|NCT00216671|6386291|P1|Overall Study|Physician Decision|1
1846610|NCT00216671|6386290|P2|Overall Study|Ineligible|2
1846611|NCT00216671|6386291|P1|Overall Study|Ineligible|0
1846612|NCT00216671|6386290|P2|Overall Study|Non compliant|2
1846613|NCT00216671|6386291|P1|Overall Study|Non compliant|2
1846614|NCT00216671|6386290|P2|Overall Study|Lost to Follow-up|5
1846615|NCT00216671|6386291|P1|Overall Study|Lost to Follow-up|3
1846616|NCT00216671|6386290|P2|Overall Study|Insufficient Response|4
1846617|NCT00216671|6386291|P1|Overall Study|Insufficient Response|9
1846618|NCT00216671|6386290|P2|Overall Study|No Need to Continue Medication|1
1846619|NCT00216671|6386291|P1|Overall Study|No Need to Continue Medication|1
1846620|NCT00216671|6386290|P2|Overall Study|Refused Injections|13
1846621|NCT00216671|6386291|P1|Overall Study|Refused Injections|3
1846622|NCT00216671|6386290|P2|Overall Study|Withdrawal by Subject|2
1846623|NCT00216671|6386291|P1|Overall Study|Withdrawal by Subject|4
1846624|NCT00216671|6386290|P2|Overall Study|Pregnancy|1
1846625|NCT00216671|6386291|P1|Overall Study|Pregnancy|0
1846626|NCT00216671|6386290|P2|Overall Study|Adverse Event|9
1846627|NCT00216671|6386291|P1|Overall Study|Adverse Event|4
1846628|NCT00216476|6386309|P3|Overall Study|Patient Moved|0
1846629|NCT00216476|6386310|P2|Overall Study|Patient Moved|2
1846630|NCT00216476|6386311|P1|Overall Study|Patient Moved|2
1846631|NCT00216476|6386309|P3|Overall Study|Protocol Deviation|0
1846632|NCT00216476|6386310|P2|Overall Study|Protocol Deviation|1
1846633|NCT00216476|6386311|P1|Overall Study|Protocol Deviation|5
1846634|NCT00216476|6386309|P3|Overall Study|Administrative Reasons|0
1846635|NCT00216476|6386310|P2|Overall Study|Administrative Reasons|1
1846636|NCT00216476|6386311|P1|Overall Study|Administrative Reasons|1
1846637|NCT00216476|6386309|P3|Overall Study|Higher dose/Extra Medication Required|2
1846638|NCT00216476|6386310|P2|Overall Study|Higher dose/Extra Medication Required|0
1846639|NCT00216476|6386311|P1|Overall Study|Higher dose/Extra Medication Required|2
1846640|NCT00216476|6386309|P3|Overall Study|Non-compliance|1
1846641|NCT00216476|6386310|P2|Overall Study|Non-compliance|4
1846642|NCT00216476|6386311|P1|Overall Study|Non-compliance|0
1846643|NCT00216476|6386309|P3|Overall Study|No Further Need for Treatment|1
1846644|NCT00216476|6386310|P2|Overall Study|No Further Need for Treatment|4
1846645|NCT00216476|6386311|P1|Overall Study|No Further Need for Treatment|3
1846646|NCT00216476|6386309|P3|Overall Study|Refuses Injection|0
1846647|NCT00216476|6386310|P2|Overall Study|Refuses Injection|0
1846648|NCT00216476|6386311|P1|Overall Study|Refuses Injection|11
1846649|NCT00216476|6386309|P3|Overall Study|Other|1
1846650|NCT00216476|6386310|P2|Overall Study|Other|0
1846651|NCT00216476|6386311|P1|Overall Study|Other|0
1846652|NCT00216476|6386309|P3|Overall Study|Pregnancy|1
1846653|NCT00216476|6386310|P2|Overall Study|Pregnancy|1
1846654|NCT00216476|6386311|P1|Overall Study|Pregnancy|0
1846655|NCT00216476|6386309|P3|Overall Study|Death|0
1846656|NCT00216476|6386310|P2|Overall Study|Death|0
1846657|NCT00216476|6386311|P1|Overall Study|Death|2
1846658|NCT00216476|6386309|P3|Overall Study|Lack of Efficacy|0
1846659|NCT00216476|6386310|P2|Overall Study|Lack of Efficacy|3
1846660|NCT00216476|6386311|P1|Overall Study|Lack of Efficacy|4
1846661|NCT00216476|6386309|P3|Overall Study|Adverse Event|1
1846662|NCT00216476|6386310|P2|Overall Study|Adverse Event|10
1846663|NCT00216476|6386311|P1|Overall Study|Adverse Event|6
1846664|NCT00216476|6386309|P3|Overall Study|Lost to Follow-up|1
1846665|NCT00216476|6386310|P2|Overall Study|Lost to Follow-up|9
1846666|NCT00216476|6386311|P1|Overall Study|Lost to Follow-up|10
1846667|NCT00216476|6386309|P3|Overall Study|Withdrawal by Subject|9
1846668|NCT00216476|6386310|P2|Overall Study|Withdrawal by Subject|72
1846669|NCT00216476|6386311|P1|Overall Study|Withdrawal by Subject|59
1846670|NCT00216203|6386348|P1|Overall Study|Withdrawal by Subject|2
1846671|NCT00216086|6386378|P1|Overall Study|Social Reasons|2
1846672|NCT00216086|6386378|P1|Overall Study|Diagnosis of Metastatic Disease|1
1846673|NCT00216086|6386378|P1|Overall Study|Protocol Violation|1
1846674|NCT00215943|6386410|P2|Overall Study|Other complications|1
1846675|NCT00215943|6386411|P1|Overall Study|Other complications|3
1846676|NCT00215943|6386410|P2|Overall Study|Other disease|1
1846677|NCT00215943|6386411|P1|Overall Study|Other disease|0
1846678|NCT00215943|6386410|P2|Overall Study|Adverse Event|6
1846679|NCT00215943|6386411|P1|Overall Study|Adverse Event|3
1846680|NCT00215943|6386410|P2|Overall Study|Alternate therapy|1
1846681|NCT00215943|6386411|P1|Overall Study|Alternate therapy|0
1846682|NCT00215943|6386410|P2|Overall Study|Disease Progression|5
1846683|NCT00215943|6386411|P1|Overall Study|Disease Progression|3
1846684|NCT00215683|6386436|P3|Overall Study|Intermittent therapy required|0
1846685|NCT00215683|6386437|P2|Overall Study|Intermittent therapy required|1
1846686|NCT00215683|6386438|P1|Overall Study|Intermittent therapy required|0
1846687|NCT00215683|6386436|P3|Overall Study|No study drug available|0
1846688|NCT00215683|6386437|P2|Overall Study|No study drug available|1
1846689|NCT00215683|6386438|P1|Overall Study|No study drug available|0
1846690|NCT00215683|6386436|P3|Overall Study|Difficult to attend visits|0
1846691|NCT00215683|6386437|P2|Overall Study|Difficult to attend visits|1
1846692|NCT00215683|6386438|P1|Overall Study|Difficult to attend visits|0
1846693|NCT00215683|6386436|P3|Overall Study|Physician Decision|1
1846694|NCT00215683|6386437|P2|Overall Study|Physician Decision|0
1846695|NCT00215683|6386438|P1|Overall Study|Physician Decision|0
1846696|NCT00215683|6386436|P3|Overall Study|Withdrawal by Subject|13
1846697|NCT00215683|6386437|P2|Overall Study|Withdrawal by Subject|4
1846698|NCT00215683|6386438|P1|Overall Study|Withdrawal by Subject|9
1846699|NCT00215683|6386436|P3|Overall Study|Lost to Follow-up|1
1846700|NCT00215683|6386437|P2|Overall Study|Lost to Follow-up|2
1846701|NCT00215683|6386438|P1|Overall Study|Lost to Follow-up|0
1846702|NCT00215683|6386436|P3|Overall Study|Lack of Efficacy|2
1846703|NCT00215683|6386437|P2|Overall Study|Lack of Efficacy|1
1846704|NCT00215683|6386438|P1|Overall Study|Lack of Efficacy|5
1846705|NCT00215683|6386436|P3|Overall Study|Adverse Event|15
1846706|NCT00215683|6386437|P2|Overall Study|Adverse Event|16
1846707|NCT00215683|6386438|P1|Overall Study|Adverse Event|15
1846708|NCT00215657|6386457|P8|Overall Study|Other|1
1846709|NCT00215657|6386458|P7|Overall Study|Other|6
1846710|NCT00215657|6386459|P6|Overall Study|Other|4
1846711|NCT00215657|6386460|P5|Overall Study|Other|5
1846712|NCT00215657|6386461|P4|Overall Study|Other|3
1846713|NCT00215657|6386462|P3|Overall Study|Other|2
1846714|NCT00215657|6386463|P2|Overall Study|Other|1
1846715|NCT00215657|6386464|P1|Overall Study|Other|3
1846716|NCT00215657|6386457|P8|Overall Study|Insufficient testosterone response|7
1846717|NCT00215657|6386458|P7|Overall Study|Insufficient testosterone response|4
1846718|NCT00215657|6386459|P6|Overall Study|Insufficient testosterone response|12
1846719|NCT00215657|6386460|P5|Overall Study|Insufficient testosterone response|8
1846720|NCT00215657|6386461|P4|Overall Study|Insufficient testosterone response|12
1846721|NCT00215657|6386462|P3|Overall Study|Insufficient testosterone response|1
1846722|NCT00215657|6386463|P2|Overall Study|Insufficient testosterone response|4
1846723|NCT00215657|6386464|P1|Overall Study|Insufficient testosterone response|5
1846724|NCT00215657|6386457|P8|Overall Study|Insuff prostate specific antigen resp|2
1846725|NCT00215657|6386458|P7|Overall Study|Insuff prostate specific antigen resp|3
1846726|NCT00215657|6386459|P6|Overall Study|Insuff prostate specific antigen resp|2
1846727|NCT00215657|6386460|P5|Overall Study|Insuff prostate specific antigen resp|1
1846728|NCT00215657|6386461|P4|Overall Study|Insuff prostate specific antigen resp|2
1846729|NCT00215657|6386462|P3|Overall Study|Insuff prostate specific antigen resp|2
1846730|NCT00215657|6386463|P2|Overall Study|Insuff prostate specific antigen resp|2
1846731|NCT00215657|6386464|P1|Overall Study|Insuff prostate specific antigen resp|3
1846732|NCT00215657|6386457|P8|Overall Study|Withdrawal by Subject|3
1846733|NCT00215657|6386458|P7|Overall Study|Withdrawal by Subject|10
1846734|NCT00215657|6386459|P6|Overall Study|Withdrawal by Subject|1
1846735|NCT00215657|6386460|P5|Overall Study|Withdrawal by Subject|6
1846736|NCT00215657|6386461|P4|Overall Study|Withdrawal by Subject|1
1846737|NCT00215657|6386462|P3|Overall Study|Withdrawal by Subject|3
1846738|NCT00215657|6386463|P2|Overall Study|Withdrawal by Subject|3
1846739|NCT00215657|6386464|P1|Overall Study|Withdrawal by Subject|6
1846740|NCT00215657|6386457|P8|Overall Study|Adverse Event|3
1846741|NCT00215657|6386458|P7|Overall Study|Adverse Event|0
1846742|NCT00215657|6386459|P6|Overall Study|Adverse Event|1
1846743|NCT00215657|6386460|P5|Overall Study|Adverse Event|3
1846744|NCT00215657|6386461|P4|Overall Study|Adverse Event|0
1846745|NCT00215657|6386462|P3|Overall Study|Adverse Event|3
1846746|NCT00215657|6386463|P2|Overall Study|Adverse Event|1
1846747|NCT00215657|6386464|P1|Overall Study|Adverse Event|5
1846748|NCT00215644|6386492|P2|Overall Study|Randomized but Not Treated|0
1846749|NCT00215644|6386493|P1|Overall Study|Randomized but Not Treated|1
1846750|NCT00215644|6386492|P2|Overall Study|Other|15
1846751|NCT00215644|6386493|P1|Overall Study|Other|3
1846752|NCT00215644|6386492|P2|Overall Study|Withdrawal by Subject|0
1846753|NCT00215644|6386493|P1|Overall Study|Withdrawal by Subject|1
1846754|NCT00215644|6386492|P2|Overall Study|Death|2
1846755|NCT00215644|6386493|P1|Overall Study|Death|1
1846756|NCT00215644|6386492|P2|Overall Study|Adverse Event|9
1846757|NCT00215644|6386493|P1|Overall Study|Adverse Event|2
1846758|NCT00215644|6386492|P2|Overall Study|Disease Progression|10
1846759|NCT00215644|6386493|P1|Overall Study|Disease Progression|28
1846760|NCT00215553|6386520|P7|Overall Study|Adverse Event|0
1846761|NCT00215553|6386521|P6|Overall Study|Adverse Event|6
1846762|NCT00215553|6386522|P5|Overall Study|Adverse Event|2
1846763|NCT00215553|6386523|P4|Overall Study|Adverse Event|1
1846764|NCT00215553|6386524|P3|Overall Study|Adverse Event|2
1846765|NCT00215553|6386525|P2|Overall Study|Adverse Event|1
1846766|NCT00215553|6386526|P1|Overall Study|Adverse Event|0
1846767|NCT00215540|6386559|P3|Overall Study|Withdrew from study medication|0
1846768|NCT00215540|6386560|P2|Overall Study|Withdrew from study medication|0
1846769|NCT00215540|6386561|P1|Overall Study|Withdrew from study medication|1
1846770|NCT00215150|6386596|P1|Randomization Phase Placebo|Withdrawal by Subject|1
1846771|NCT00215150|6386596|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
1846772|NCT00215150|6386596|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
1846773|NCT00215150|6386596|P1|Open Label Phase|Did not meet randomization criteria|9
1846774|NCT00215150|6386596|P1|Open Label Phase|Did not complete a post base visit|13
1846775|NCT00215150|6386596|P1|Open Label Phase|Withdrawal by Subject|1
1846776|NCT00215150|6386596|P1|Open Label Phase|Lost to Follow-up|7
1846777|NCT00215137|6386604|P3|Randomization Period|Withdrawal by Subject|0
1846778|NCT00215137|6386605|P2|Randomization Period|Withdrawal by Subject|1
1846779|NCT00215137|6386606|P1|Randomization Period|Withdrawal by Subject|0
1846780|NCT00215137|6386604|P3|Randomization Period|Lost to Follow-up|0
1846781|NCT00215137|6386605|P2|Randomization Period|Lost to Follow-up|1
1846782|NCT00215137|6386606|P1|Randomization Period|Lost to Follow-up|0
1846783|NCT00215137|6386604|P3|Open Label Escitalopram|Lack of Efficacy|0
1846784|NCT00215137|6386605|P2|Open Label Escitalopram|Lack of Efficacy|0
1846785|NCT00215137|6386606|P1|Open Label Escitalopram|Lack of Efficacy|1
1846786|NCT00214500|6386704|P1|Extension Period|Withdrawal by Subject|2
1846787|NCT00214500|6386704|P1|Treatment Period|Adverse Event|1
1846788|NCT00214461|6386725|P4|Overall Study|Withdrawal by Subject|0
1846789|NCT00214461|6386726|P3|Overall Study|Withdrawal by Subject|1
1846790|NCT00214461|6386727|P2|Overall Study|Withdrawal by Subject|0
1846791|NCT00214461|6386728|P1|Overall Study|Withdrawal by Subject|0
1846792|NCT00214461|6386725|P4|Overall Study|Adverse Event|1
1846793|NCT00214461|6386726|P3|Overall Study|Adverse Event|1
1846794|NCT00214461|6386727|P2|Overall Study|Adverse Event|0
1846795|NCT00214461|6386728|P1|Overall Study|Adverse Event|0
1846796|NCT00214422|6386745|P3|Overall Study|Unable to make a radiation treatment|1
1846797|NCT00214422|6386746|P2|Overall Study|Unable to make a radiation treatment|0
1846798|NCT00214422|6386747|P1|Overall Study|Unable to make a radiation treatment|0
1846799|NCT00214422|6386745|P3|Overall Study|Disease progression on study|0
1846800|NCT00214422|6386746|P2|Overall Study|Disease progression on study|0
1846801|NCT00214422|6386747|P1|Overall Study|Disease progression on study|1
1846802|NCT00214422|6386745|P3|Overall Study|Pt taken off study|0
1846803|NCT00214422|6386746|P2|Overall Study|Pt taken off study|1
1846804|NCT00214422|6386747|P1|Overall Study|Pt taken off study|1
1846805|NCT00214422|6386745|P3|Overall Study|Developed esophageal ca|0
1846806|NCT00214422|6386746|P2|Overall Study|Developed esophageal ca|0
1846807|NCT00214422|6386747|P1|Overall Study|Developed esophageal ca|1
1846808|NCT00214422|6386745|P3|Overall Study|Physician Decision|0
1846809|NCT00214422|6386746|P2|Overall Study|Physician Decision|0
1846810|NCT00214422|6386747|P1|Overall Study|Physician Decision|2
1846811|NCT00214383|6386770|P2|Overall Study|Lost to Follow-up|26
1846812|NCT00214383|6386771|P1|Overall Study|Lost to Follow-up|16
1846813|NCT00214201|6386783|P2|Overall Study|Death|2
1846814|NCT00214201|6386784|P1|Overall Study|Death|0
1846815|NCT00214201|6386783|P2|Overall Study|Withdrawal by Subject|0
1846816|NCT00214201|6386784|P1|Overall Study|Withdrawal by Subject|2
1846817|NCT00214136|6386799|P1|Overall Study|Death|5
1846818|NCT00214019|6386844|P1|Overall Study|Screen Failed prior to randomization|17
1846819|NCT00214019|6386844|P1|Overall Study|Withdrawal by Subject|2
1846820|NCT00214019|6386844|P1|Overall Study|Lost to Follow-up|11
1846821|NCT00213980|6386853|P2|Overall Study|Failed to obtain all 3 DXAs|3
1846822|NCT00213980|6386854|P1|Overall Study|Failed to obtain all 3 DXAs|1
1846823|NCT00213980|6386853|P2|Overall Study|Developed ovarian cancer|0
1846824|NCT00213980|6386854|P1|Overall Study|Developed ovarian cancer|1
1846825|NCT00213980|6386853|P2|Overall Study|Disease progression|2
1846826|NCT00213980|6386854|P1|Overall Study|Disease progression|0
1846827|NCT00213980|6386853|P2|Overall Study|Adverse Event|1
1846828|NCT00213980|6386854|P1|Overall Study|Adverse Event|1
1846829|NCT00213980|6386853|P2|Overall Study|Withdrawal by Subject|1
1846830|NCT00213980|6386854|P1|Overall Study|Withdrawal by Subject|3
1846831|NCT00213148|6386881|P5|Cycle 3 (1 Month)|Other|0
1846832|NCT00213148|6386882|P4|Cycle 3 (1 Month)|Other|1
1846833|NCT00213148|6386883|P3|Cycle 3 (1 Month)|Other|1
1846834|NCT00213148|6386884|P2|Cycle 3 (1 Month)|Other|0
1846835|NCT00213148|6386885|P1|Cycle 3 (1 Month)|Other|0
1846836|NCT00213148|6386881|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
1846837|NCT00213148|6386882|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
1846838|NCT00213148|6386883|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
1846839|NCT00213148|6386884|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
1846840|NCT00213148|6386885|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
1846841|NCT00213148|6386881|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
1846842|NCT00213148|6386882|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1846843|NCT00213148|6386883|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
1846844|NCT00213148|6386884|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
1846845|NCT00213148|6386885|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
1846846|NCT00213148|6386881|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1846847|NCT00213148|6386882|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1846848|NCT00213148|6386883|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1846849|NCT00213148|6386884|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
1846850|NCT00213148|6386885|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
1846851|NCT00213148|6386881|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1846852|NCT00213148|6386882|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1846853|NCT00213148|6386883|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1846854|NCT00213148|6386884|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
1846855|NCT00213148|6386885|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
1846856|NCT00213148|6386881|P5|Cycle 2 (1 Month)|Other|7
1846857|NCT00213148|6386882|P4|Cycle 2 (1 Month)|Other|8
1846858|NCT00213148|6386883|P3|Cycle 2 (1 Month)|Other|2
1846859|NCT00213148|6386884|P2|Cycle 2 (1 Month)|Other|1
1846860|NCT00213148|6386885|P1|Cycle 2 (1 Month)|Other|2
1846861|NCT00213148|6386881|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
1846862|NCT00213148|6386882|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
1846863|NCT00213148|6386883|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
1846864|NCT00213148|6386884|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
1846865|NCT00213148|6386885|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
1846866|NCT00213148|6386881|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
1846867|NCT00213148|6386882|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
1846868|NCT00213148|6386883|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
1846869|NCT00213148|6386884|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
1846870|NCT00213148|6386885|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
1846871|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1846872|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
1846873|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
1846874|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
1846875|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
1846876|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
1846877|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1846878|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1846879|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1846880|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
1846881|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1846882|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
1846883|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1846884|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1846885|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
1846886|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Other|7
1846887|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Other|2
1846888|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Other|2
1846889|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Other|0
1846890|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Other|3
1846891|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Protocol Violation|0
1846892|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Protocol Violation|0
1846893|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Protocol Violation|1
1846894|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Protocol Violation|0
1846895|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Protocol Violation|1
1846896|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
1846897|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
1846898|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
1846899|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
1846900|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
1846901|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Adverse Event|0
1846902|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Adverse Event|0
1846903|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Adverse Event|1
1846904|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Adverse Event|0
1846905|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Adverse Event|0
1846906|NCT00213148|6386881|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
1846907|NCT00213148|6386882|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
1846908|NCT00213148|6386883|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
1846909|NCT00213148|6386884|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
1846910|NCT00213148|6386885|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
1846911|NCT00213135|6386912|P3|Overall Study|Other|15
1846912|NCT00213135|6386913|P2|Overall Study|Other|12
1846913|NCT00213135|6386914|P1|Overall Study|Other|21
1846914|NCT00213135|6386912|P3|Overall Study|Disease progression|21
1846915|NCT00213135|6386913|P2|Overall Study|Disease progression|5
1846916|NCT00213135|6386914|P1|Overall Study|Disease progression|4
1846917|NCT00213135|6386912|P3|Overall Study|Death|2
1846918|NCT00213135|6386913|P2|Overall Study|Death|1
1846919|NCT00213135|6386914|P1|Overall Study|Death|1
1846920|NCT00213135|6386912|P3|Overall Study|Protocol Violation|10
1846921|NCT00213135|6386913|P2|Overall Study|Protocol Violation|4
1846922|NCT00213135|6386914|P1|Overall Study|Protocol Violation|4
1846923|NCT00213135|6386912|P3|Overall Study|Lost to Follow-up|4
1846924|NCT00213135|6386913|P2|Overall Study|Lost to Follow-up|8
1846925|NCT00213135|6386914|P1|Overall Study|Lost to Follow-up|11
1846926|NCT00213135|6386912|P3|Overall Study|Adverse Event|5
1846927|NCT00213135|6386913|P2|Overall Study|Adverse Event|5
1846928|NCT00213135|6386914|P1|Overall Study|Adverse Event|9
1846929|NCT00212758|6386957|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1846930|NCT00212758|6386958|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
1846931|NCT00212758|6386957|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
1846932|NCT00212758|6386958|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
1846933|NCT00212355|6386974|P1|Overall Study|A change of address|1
1846934|NCT00212355|6386974|P1|Overall Study|Withdrawal by Subject|1
1846935|NCT00212355|6386974|P1|Overall Study|Adverse Event|1
1846936|NCT00212134|6386995|P2|Phase 3 (Age 10 Years)|On Going|21
1846937|NCT00212134|6386996|P1|Phase 3 (Age 10 Years)|On Going|21
1846938|NCT00211887|6387017|P3|Overall Study|Side effects|5
1846939|NCT00211887|6387018|P2|Overall Study|Side effects|13
1846940|NCT00211887|6387019|P1|Overall Study|Side effects|19
1846941|NCT00211887|6387017|P3|Overall Study|Other medical reason|7
1846942|NCT00211887|6387018|P2|Overall Study|Other medical reason|11
1846943|NCT00211887|6387019|P1|Overall Study|Other medical reason|15
1846944|NCT00211887|6387017|P3|Overall Study|Non-medical reason|8
1846945|NCT00211887|6387018|P2|Overall Study|Non-medical reason|14
1846946|NCT00211887|6387019|P1|Overall Study|Non-medical reason|31
1846947|NCT00211887|6387017|P3|Overall Study|Lost to Follow-up|9
1846948|NCT00211887|6387018|P2|Overall Study|Lost to Follow-up|13
1846949|NCT00211887|6387019|P1|Overall Study|Lost to Follow-up|28
1846950|NCT00211887|6387017|P3|Overall Study|Death|1
1846951|NCT00211887|6387018|P2|Overall Study|Death|1
1846952|NCT00211887|6387019|P1|Overall Study|Death|1
1846953|NCT00211887|6387017|P3|Overall Study|Adverse Event|6
1846954|NCT00211887|6387018|P2|Overall Study|Adverse Event|4
1846955|NCT00211887|6387019|P1|Overall Study|Adverse Event|8
1846956|NCT00211809|6387036|P1|Overall Study|side effects|2
1846957|NCT00211809|6387036|P1|Overall Study|Pregnancy|1
1846958|NCT00211809|6387036|P1|Overall Study|Lost to Follow-up|2
1846959|NCT00211809|6387036|P1|Overall Study|Lack of Efficacy|1
1846960|NCT00211757|6387052|P2|Overall Study|Lack of Efficacy|1
1846961|NCT00211757|6387053|P1|Overall Study|Lack of Efficacy|0
1846962|NCT00211757|6387052|P2|Overall Study|Withdrawal by Subject|1
1846963|NCT00211757|6387053|P1|Overall Study|Withdrawal by Subject|1
1846964|NCT00211536|6387074|P2|Overall Study|Adverse Event|0
1846965|NCT00211536|6387075|P1|Overall Study|Adverse Event|2
1846966|NCT00211536|6387074|P2|Overall Study|Physician Decision|5
1846967|NCT00211536|6387075|P1|Overall Study|Physician Decision|0
1846968|NCT00211536|6387074|P2|Overall Study|Withdrawal by Subject|2
1846969|NCT00211536|6387075|P1|Overall Study|Withdrawal by Subject|2
1846970|NCT00211510|6387091|P2|Overall Study|Withdrawal by Subject|1
1846971|NCT00211510|6387092|P1|Overall Study|Withdrawal by Subject|3
1846972|NCT00211510|6387091|P2|Overall Study|Physician Decision|1
1846973|NCT00211510|6387092|P1|Overall Study|Physician Decision|3
1846974|NCT00211237|6387110|P3|12 Months|unrelated medical problem|1
1846975|NCT00211237|6387111|P2|12 Months|unrelated medical problem|0
1846976|NCT00211237|6387112|P1|12 Months|unrelated medical problem|0
1846977|NCT00211237|6387110|P3|12 Months|Withdrew|1
1846978|NCT00211237|6387111|P2|12 Months|Withdrew|0
1846979|NCT00211237|6387112|P1|12 Months|Withdrew|0
1846980|NCT00211237|6387110|P3|12 Months|Lost to Follow-up|1
1846981|NCT00211237|6387111|P2|12 Months|Lost to Follow-up|0
1846982|NCT00211237|6387112|P1|12 Months|Lost to Follow-up|1
1846983|NCT00211237|6387110|P3|12 Months|Death|3
1846984|NCT00211237|6387111|P2|12 Months|Death|2
1846985|NCT00211237|6387112|P1|12 Months|Death|8
1846986|NCT00211237|6387110|P3|6 Months|Could not comply with protocol|0
1846987|NCT00211237|6387111|P2|6 Months|Could not comply with protocol|2
1846988|NCT00211237|6387112|P1|6 Months|Could not comply with protocol|0
1846989|NCT00211237|6387110|P3|6 Months|Lost to Follow-up|0
1846990|NCT00211237|6387111|P2|6 Months|Lost to Follow-up|0
1846991|NCT00211237|6387112|P1|6 Months|Lost to Follow-up|2
1846992|NCT00211237|6387110|P3|6 Months|Death|3
1846993|NCT00211237|6387111|P2|6 Months|Death|0
1846994|NCT00211237|6387112|P1|6 Months|Death|6
1846995|NCT00211237|6387110|P3|3 Months|Non-medical problem|1
1846996|NCT00211237|6387111|P2|3 Months|Non-medical problem|0
1846997|NCT00211237|6387112|P1|3 Months|Non-medical problem|0
1846998|NCT00211237|6387110|P3|3 Months|Withdrew|0
1846999|NCT00211237|6387111|P2|3 Months|Withdrew|1
1847000|NCT00211237|6387112|P1|3 Months|Withdrew|0
1847001|NCT00211237|6387110|P3|3 Months|Could not comply with protocol|0
1847002|NCT00211237|6387111|P2|3 Months|Could not comply with protocol|0
1847003|NCT00211237|6387112|P1|3 Months|Could not comply with protocol|1
1847004|NCT00211237|6387110|P3|3 Months|Death|0
1847005|NCT00211237|6387111|P2|3 Months|Death|3
1847006|NCT00211237|6387112|P1|3 Months|Death|7
1847007|NCT00211237|6387110|P3|1 Month|Non-medical problem|0
1847008|NCT00211237|6387111|P2|1 Month|Non-medical problem|2
1847009|NCT00211237|6387112|P1|1 Month|Non-medical problem|0
1847010|NCT00211237|6387110|P3|1 Month|Additional surgery needed|0
1847011|NCT00211237|6387111|P2|1 Month|Additional surgery needed|0
1847012|NCT00211237|6387112|P1|1 Month|Additional surgery needed|1
1847013|NCT00211237|6387110|P3|1 Month|Withdrew|0
1847014|NCT00211237|6387111|P2|1 Month|Withdrew|4
1847015|NCT00211237|6387112|P1|1 Month|Withdrew|0
1847016|NCT00211237|6387110|P3|1 Month|Lost to Follow-up|0
1847017|NCT00211237|6387111|P2|1 Month|Lost to Follow-up|2
1847018|NCT00211237|6387112|P1|1 Month|Lost to Follow-up|0
1847019|NCT00211237|6387110|P3|1 Month|Death|0
1847020|NCT00211237|6387111|P2|1 Month|Death|1
1847021|NCT00211237|6387112|P1|1 Month|Death|2
1847022|NCT00211237|6387110|P3|Baseline|Refused random assignment|0
1847023|NCT00211237|6387111|P2|Baseline|Refused random assignment|0
1847024|NCT00211237|6387112|P1|Baseline|Refused random assignment|1
1847025|NCT00211237|6387110|P3|Baseline|Withdrew|0
1847026|NCT00211237|6387111|P2|Baseline|Withdrew|3
1847027|NCT00211237|6387112|P1|Baseline|Withdrew|1
1847028|NCT00211172|6387204|P2|Overall Study|Died or lost health plan eligibility|32
1847029|NCT00211172|6387205|P1|Overall Study|Died or lost health plan eligibility|39
1847030|NCT00211081|6387211|P1|Overall Study|Withdrawal by Subject|2
1847031|NCT00210639|6387223|P2|Overall Study|Other|12
1847032|NCT00210639|6387224|P1|Overall Study|Other|18
1847033|NCT00210639|6387223|P2|Overall Study|Withdrawal by Subject|1
1847034|NCT00210639|6387224|P1|Overall Study|Withdrawal by Subject|8
1847035|NCT00210639|6387223|P2|Overall Study|Lost to Follow-up|29
1847036|NCT00210639|6387224|P1|Overall Study|Lost to Follow-up|37
1847037|NCT00210626|6387232|P2|Overall Study|Other|5
1847038|NCT00210626|6387233|P1|Overall Study|Other|4
1847039|NCT00210626|6387232|P2|Overall Study|Sponser Request|0
1847040|NCT00210626|6387233|P1|Overall Study|Sponser Request|1
1847041|NCT00210626|6387232|P2|Overall Study|Physician Decision|2
1847042|NCT00210626|6387233|P1|Overall Study|Physician Decision|0
1847043|NCT00210626|6387232|P2|Overall Study|Withdrawal by Subject|20
1847044|NCT00210626|6387233|P1|Overall Study|Withdrawal by Subject|29
1847045|NCT00210626|6387232|P2|Overall Study|Death|0
1847046|NCT00210626|6387233|P1|Overall Study|Death|1
1847047|NCT00210626|6387232|P2|Overall Study|Lost to Follow-up|11
1847048|NCT00210626|6387233|P1|Overall Study|Lost to Follow-up|11
1847049|NCT00210626|6387232|P2|Overall Study|Protocol Violation|5
1847050|NCT00210626|6387233|P1|Overall Study|Protocol Violation|1
1847051|NCT00210626|6387232|P2|Overall Study|Adverse Event|2
1847052|NCT00210626|6387233|P1|Overall Study|Adverse Event|1
1847053|NCT00210470|6387241|P1|Overall Study|Subject did not continue to surgery|1
1847054|NCT00209560|6387272|P2|Overall Study|Lack of Efficacy|0
1847055|NCT00209560|6387273|P1|Overall Study|Lack of Efficacy|1
1847056|NCT00209339|6387292|P1|At 5 Years Follow-up|Death|1
1847057|NCT00209339|6387292|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
1847058|NCT00209339|6387292|P1|At 5 Years Follow-up|Withdrawal by Subject|2
1847059|NCT00209339|6387292|P1|At 4 Years Follow-up|Death|1
1847060|NCT00209339|6387292|P1|At 4 Years Follow-up|Withdrawal by Subject|4
1847061|NCT00209339|6387292|P1|At 3 Years Follow-up|Withdrawal by Subject|1
1847062|NCT00209339|6387292|P1|At 24 Months Follow-up|Death|1
1847063|NCT00209339|6387292|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
1847064|NCT00209339|6387292|P1|At 24 Months Follow-up|Withdrawal by Subject|4
1847065|NCT00209339|6387292|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
1847066|NCT00209339|6387292|P1|At 12 Months Follow-up|Death|1
1847067|NCT00209339|6387292|P1|At 12 Months Follow-up|Withdrawal by Subject|8
1847068|NCT00209274|6387376|P2|Overall Study|Randomized not treated (RNT)|15
1847069|NCT00209274|6387377|P1|Overall Study|Randomized not treated (RNT)|6
1847070|NCT00209274|6387376|P2|Overall Study|Withdrawal by Subject|15
1847071|NCT00209274|6387377|P1|Overall Study|Withdrawal by Subject|30
1847072|NCT00209274|6387376|P2|Overall Study|Death|15
1847073|NCT00209274|6387377|P1|Overall Study|Death|32
1847074|NCT00209274|6387376|P2|Overall Study|Missed visit|2
1847075|NCT00209274|6387377|P1|Overall Study|Missed visit|3
1847076|NCT00209170|6387697|P2|Overall Study|Lack of Efficacy|1
1847077|NCT00209170|6387698|P1|Overall Study|Lack of Efficacy|0
1847078|NCT00209170|6387697|P2|Overall Study|Withdrawal by Subject|1
1847079|NCT00209170|6387698|P1|Overall Study|Withdrawal by Subject|2
1847080|NCT00209170|6387697|P2|Overall Study|Adverse Event|1
1847081|NCT00209170|6387698|P1|Overall Study|Adverse Event|0
1847082|NCT00209131|6387706|P2|Overall Study|Lack of personnel due to turnovers.|11
1847083|NCT00209131|6387707|P1|Overall Study|Lack of personnel due to turnovers.|15
1847084|NCT00209092|6387717|P2|Overall Study|Withdrawal by Subject|0
1847085|NCT00209092|6387718|P1|Overall Study|Withdrawal by Subject|1
1847086|NCT00209092|6387717|P2|Overall Study|Adverse Event|1
1847087|NCT00209092|6387718|P1|Overall Study|Adverse Event|0
1847088|NCT00209092|6387717|P2|Overall Study|Progression of disease|1
1847089|NCT00209092|6387718|P1|Overall Study|Progression of disease|7
1847090|NCT00209027|6387728|P2|Overall Study|study terminated|0
1847091|NCT00209027|6387729|P1|Overall Study|study terminated|10
1847092|NCT00208767|6387753|P2|Overall Study|Lost to Follow-up|3
1847093|NCT00208767|6387754|P1|Overall Study|Lost to Follow-up|3
1847094|NCT00208767|6387753|P2|Overall Study|Death|0
1847095|NCT00208767|6387754|P1|Overall Study|Death|1
1847096|NCT00208767|6387753|P2|Overall Study|Withdrawal by Subject|3
1847097|NCT00208767|6387754|P1|Overall Study|Withdrawal by Subject|14
1847098|NCT00208767|6387753|P2|Overall Study|Adverse Event|1
1847099|NCT00208767|6387754|P1|Overall Study|Adverse Event|9
1847100|NCT00208325|6387782|P4|Overall Study|Mis-Randomized|0
1847101|NCT00208325|6387783|P3|Overall Study|Mis-Randomized|0
1847102|NCT00208325|6387784|P2|Overall Study|Mis-Randomized|20
1847103|NCT00208325|6387785|P1|Overall Study|Mis-Randomized|17
1847104|NCT00208325|6387782|P4|Overall Study|Other|0
1847105|NCT00208325|6387783|P3|Overall Study|Other|1
1847106|NCT00208325|6387784|P2|Overall Study|Other|1
1847107|NCT00208325|6387785|P1|Overall Study|Other|2
1847108|NCT00208325|6387782|P4|Overall Study|Does not wish to Continue in Study|2
1847109|NCT00208325|6387783|P3|Overall Study|Does not wish to Continue in Study|3
1847110|NCT00208325|6387784|P2|Overall Study|Does not wish to Continue in Study|8
1847111|NCT00208325|6387785|P1|Overall Study|Does not wish to Continue in Study|5
1847112|NCT00208325|6387782|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
1847113|NCT00208325|6387783|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
1847114|NCT00208325|6387784|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
1847115|NCT00208325|6387785|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
1847116|NCT00208325|6387782|P4|Overall Study|Lost to Follow-up|0
1847117|NCT00208325|6387783|P3|Overall Study|Lost to Follow-up|2
1847118|NCT00208325|6387784|P2|Overall Study|Lost to Follow-up|0
1847119|NCT00208325|6387785|P1|Overall Study|Lost to Follow-up|1
1847120|NCT00208325|6387782|P4|Overall Study|Revision|4
1847121|NCT00208325|6387783|P3|Overall Study|Revision|0
1847122|NCT00208325|6387784|P2|Overall Study|Revision|1
1847123|NCT00208325|6387785|P1|Overall Study|Revision|4
1847124|NCT00208325|6387782|P4|Overall Study|Withdrawal by Subject|0
1847125|NCT00208325|6387783|P3|Overall Study|Withdrawal by Subject|0
1847126|NCT00208325|6387784|P2|Overall Study|Withdrawal by Subject|1
1847127|NCT00208325|6387785|P1|Overall Study|Withdrawal by Subject|0
1847128|NCT00208325|6387782|P4|Overall Study|Death|5
1847129|NCT00208325|6387783|P3|Overall Study|Death|7
1847130|NCT00208325|6387784|P2|Overall Study|Death|19
1847131|NCT00208325|6387785|P1|Overall Study|Death|18
1847132|NCT00207740|6387922|P4|Overall Study|Other|5
1847133|NCT00207740|6387923|P3|Overall Study|Other|7
1847134|NCT00207740|6387924|P2|Overall Study|Other|10
1847135|NCT00207740|6387925|P1|Overall Study|Other|2
1847136|NCT00207740|6387922|P4|Overall Study|Sponsor Directive|21
1847137|NCT00207740|6387923|P3|Overall Study|Sponsor Directive|16
1847138|NCT00207740|6387924|P2|Overall Study|Sponsor Directive|15
1847139|NCT00207740|6387925|P1|Overall Study|Sponsor Directive|22
1847140|NCT00207740|6387922|P4|Overall Study|Death|1
1847141|NCT00207740|6387923|P3|Overall Study|Death|0
1847142|NCT00207740|6387924|P2|Overall Study|Death|0
1847143|NCT00207740|6387925|P1|Overall Study|Death|0
1847144|NCT00207740|6387922|P4|Overall Study|Lost to Follow-up|1
1847145|NCT00207740|6387923|P3|Overall Study|Lost to Follow-up|1
1847146|NCT00207740|6387924|P2|Overall Study|Lost to Follow-up|2
1847147|NCT00207740|6387925|P1|Overall Study|Lost to Follow-up|0
1847148|NCT00207740|6387922|P4|Overall Study|Unsatisfactory therapeutic effect|4
1847149|NCT00207740|6387923|P3|Overall Study|Unsatisfactory therapeutic effect|2
1847150|NCT00207740|6387924|P2|Overall Study|Unsatisfactory therapeutic effect|0
1847151|NCT00207740|6387925|P1|Overall Study|Unsatisfactory therapeutic effect|1
1847152|NCT00207740|6387922|P4|Overall Study|Adverse Event|11
1847153|NCT00207740|6387923|P3|Overall Study|Adverse Event|14
1847154|NCT00207740|6387924|P2|Overall Study|Adverse Event|14
1847155|NCT00207740|6387925|P1|Overall Study|Adverse Event|4
1847156|NCT00207727|6387971|P5|Overall Study|Other|33
1847157|NCT00207727|6387972|P4|Overall Study|Other|37
1847158|NCT00207727|6387973|P3|Overall Study|Other|41
1847159|NCT00207727|6387974|P2|Overall Study|Other|41
1847160|NCT00207727|6387975|P1|Overall Study|Other|38
1847161|NCT00207727|6387971|P5|Overall Study|Lost to Follow-up|0
1847162|NCT00207727|6387972|P4|Overall Study|Lost to Follow-up|0
1847163|NCT00207727|6387973|P3|Overall Study|Lost to Follow-up|0
1847164|NCT00207727|6387974|P2|Overall Study|Lost to Follow-up|1
1847165|NCT00207727|6387975|P1|Overall Study|Lost to Follow-up|0
1847166|NCT00207727|6387971|P5|Overall Study|Withdrawal by Subject|1
1847167|NCT00207727|6387972|P4|Overall Study|Withdrawal by Subject|0
1847168|NCT00207727|6387973|P3|Overall Study|Withdrawal by Subject|0
1847169|NCT00207727|6387974|P2|Overall Study|Withdrawal by Subject|0
1847170|NCT00207727|6387975|P1|Overall Study|Withdrawal by Subject|0
1847171|NCT00207714|6388002|P5|Overall Study|Other|0
1847172|NCT00207714|6388003|P4|Overall Study|Other|1
1847173|NCT00207714|6388004|P3|Overall Study|Other|5
1847174|NCT00207714|6388005|P2|Overall Study|Other|2
1847175|NCT00207714|6388006|P1|Overall Study|Other|3
1847176|NCT00207714|6388002|P5|Overall Study|Unsatisfactory therapeutic effect|4
1847177|NCT00207714|6388003|P4|Overall Study|Unsatisfactory therapeutic effect|4
1847178|NCT00207714|6388004|P3|Overall Study|Unsatisfactory therapeutic effect|1
1847179|NCT00207714|6388005|P2|Overall Study|Unsatisfactory therapeutic effect|3
1847180|NCT00207714|6388006|P1|Overall Study|Unsatisfactory therapeutic effect|5
1847181|NCT00207714|6388002|P5|Overall Study|Adverse Event|1
1847182|NCT00207714|6388003|P4|Overall Study|Adverse Event|3
1847183|NCT00207714|6388004|P3|Overall Study|Adverse Event|4
1847184|NCT00207714|6388005|P2|Overall Study|Adverse Event|2
1847185|NCT00207714|6388006|P1|Overall Study|Adverse Event|6
1847186|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
1847187|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1847188|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1847189|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
1847190|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Death|1
1847191|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Death|0
1847192|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Death|0
1847193|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Death|0
1847194|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
1847195|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1847196|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
1847197|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
1847198|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1847199|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
1847200|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1847201|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
1847202|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
1847203|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
1847204|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
1847205|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
1847206|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1847207|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
1847208|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
1847209|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
1847210|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1847211|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
1847212|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1847213|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
1847214|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
1847215|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1847216|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
1847217|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
1847218|NCT00207142|6388028|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
1847219|NCT00207142|6388029|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
1847220|NCT00207142|6388030|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
1847221|NCT00207142|6388031|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
1847222|NCT00207142|6388028|P4|Induction Phase|Missing lab data|0
1847223|NCT00207142|6388029|P3|Induction Phase|Missing lab data|0
1847224|NCT00207142|6388030|P2|Induction Phase|Missing lab data|0
1847225|NCT00207142|6388031|P1|Induction Phase|Missing lab data|1
1847226|NCT00207142|6388028|P4|Induction Phase|Incarceration|0
1847227|NCT00207142|6388029|P3|Induction Phase|Incarceration|0
1847228|NCT00207142|6388030|P2|Induction Phase|Incarceration|0
1847229|NCT00207142|6388031|P1|Induction Phase|Incarceration|1
1847230|NCT00207142|6388028|P4|Induction Phase|Withdrawal by Subject|0
1847231|NCT00207142|6388029|P3|Induction Phase|Withdrawal by Subject|0
1847232|NCT00207142|6388030|P2|Induction Phase|Withdrawal by Subject|0
1847233|NCT00207142|6388031|P1|Induction Phase|Withdrawal by Subject|4
1847234|NCT00207142|6388028|P4|Induction Phase|Subject no longer meets study criteria|0
1847235|NCT00207142|6388029|P3|Induction Phase|Subject no longer meets study criteria|0
1847236|NCT00207142|6388030|P2|Induction Phase|Subject no longer meets study criteria|0
1847237|NCT00207142|6388031|P1|Induction Phase|Subject no longer meets study criteria|3
1847238|NCT00207142|6388028|P4|Induction Phase|Pregnancy|0
1847239|NCT00207142|6388029|P3|Induction Phase|Pregnancy|0
1847240|NCT00207142|6388030|P2|Induction Phase|Pregnancy|0
1847241|NCT00207142|6388031|P1|Induction Phase|Pregnancy|1
1847242|NCT00207142|6388028|P4|Induction Phase|Poor/noncompliance|0
1847243|NCT00207142|6388029|P3|Induction Phase|Poor/noncompliance|0
1847244|NCT00207142|6388030|P2|Induction Phase|Poor/noncompliance|0
1847245|NCT00207142|6388031|P1|Induction Phase|Poor/noncompliance|2
1847246|NCT00207142|6388028|P4|Induction Phase|Physician Decision|0
1847247|NCT00207142|6388029|P3|Induction Phase|Physician Decision|0
1847248|NCT00207142|6388030|P2|Induction Phase|Physician Decision|0
1847249|NCT00207142|6388031|P1|Induction Phase|Physician Decision|2
1847250|NCT00207142|6388028|P4|Induction Phase|Lost to Follow-up|0
1847251|NCT00207142|6388029|P3|Induction Phase|Lost to Follow-up|0
1847252|NCT00207142|6388030|P2|Induction Phase|Lost to Follow-up|0
1847253|NCT00207142|6388031|P1|Induction Phase|Lost to Follow-up|5
1847254|NCT00207142|6388028|P4|Induction Phase|Lack of Efficacy|0
1847255|NCT00207142|6388029|P3|Induction Phase|Lack of Efficacy|0
1847256|NCT00207142|6388030|P2|Induction Phase|Lack of Efficacy|0
1847257|NCT00207142|6388031|P1|Induction Phase|Lack of Efficacy|1
1847258|NCT00207142|6388028|P4|Induction Phase|Death|0
1847259|NCT00207142|6388029|P3|Induction Phase|Death|0
1847260|NCT00207142|6388030|P2|Induction Phase|Death|0
1847261|NCT00207142|6388031|P1|Induction Phase|Death|1
1847262|NCT00207142|6388028|P4|Induction Phase|Adverse Event|0
1847263|NCT00207142|6388029|P3|Induction Phase|Adverse Event|0
1847264|NCT00207142|6388030|P2|Induction Phase|Adverse Event|0
1847265|NCT00207142|6388031|P1|Induction Phase|Adverse Event|9
1847266|NCT00207090|6388068|P1|Overall Study|Physician Decision|1
1847267|NCT00207090|6388068|P1|Overall Study|Disease progression/relapse|2
1847268|NCT00207090|6388068|P1|Overall Study|Chest wall mass larger|1
1847269|NCT00207090|6388068|P1|Overall Study|Study drug toxicity|3
1847270|NCT00206726|6388097|P1|Overall Study|Withdrawal by Subject|8
1847271|NCT00206726|6388097|P1|Overall Study|Protocol Violation|1
1847272|NCT00206726|6388097|P1|Overall Study|Death|4
1847273|NCT00206726|6388097|P1|Overall Study|Adverse Event|17
1847274|NCT00206726|6388097|P1|Overall Study|Bone marrow transplant|1
1847275|NCT00206726|6388097|P1|Overall Study|Placed on new protocol|1
1847276|NCT00206726|6388097|P1|Overall Study|Progressive disease or relapsed disease|18
1847277|NCT00206726|6388097|P1|Overall Study|Delayed recovery of blood counts|1
1847278|NCT00206518|6388108|P2|Overall Study|Protocol Violation|1
1847279|NCT00206518|6388109|P1|Overall Study|Protocol Violation|1
1847280|NCT00206518|6388108|P2|Overall Study|Physician Decision|0
1847281|NCT00206518|6388109|P1|Overall Study|Physician Decision|1
1847282|NCT00206518|6388108|P2|Overall Study|Adverse Event|1
1847283|NCT00206518|6388109|P1|Overall Study|Adverse Event|2
1847284|NCT00206518|6388108|P2|Overall Study|Lack of Efficacy|4
1847285|NCT00206518|6388109|P1|Overall Study|Lack of Efficacy|6
1847286|NCT00206440|6388121|P2|Overall Study|Adverse Event|2
1847287|NCT00206440|6388122|P1|Overall Study|Adverse Event|4
1847288|NCT00206440|6388121|P2|Overall Study|Protocol Violation|2
1847289|NCT00206440|6388122|P1|Overall Study|Protocol Violation|1
1847290|NCT00206427|6388128|P1|Overall Study|Adverse Event|2
1847291|NCT00206323|6388138|P2|Overall Study|Lost to Follow-up|1
1847292|NCT00206323|6388139|P1|Overall Study|Lost to Follow-up|1
1847293|NCT00206323|6388138|P2|Overall Study|Adverse Event|1
1847294|NCT00206323|6388139|P1|Overall Study|Adverse Event|1
1847295|NCT00206323|6388138|P2|Overall Study|Lack of Efficacy|1
1847296|NCT00206323|6388139|P1|Overall Study|Lack of Efficacy|4
1847297|NCT00206102|6388147|P2|Overall Study|None of those categories|36
1847298|NCT00206102|6388148|P1|Overall Study|None of those categories|42
1847299|NCT00206102|6388147|P2|Overall Study|Study-specific discontinuation criteria|17
1847300|NCT00206102|6388148|P1|Overall Study|Study-specific discontinuation criteria|18
1847301|NCT00206102|6388147|P2|Overall Study|Withdrawal by Subject|101
1847302|NCT00206102|6388148|P1|Overall Study|Withdrawal by Subject|118
1847303|NCT00206102|6388147|P2|Overall Study|Lost to Follow-up|66
1847304|NCT00206102|6388148|P1|Overall Study|Lost to Follow-up|95
1847305|NCT00206102|6388147|P2|Overall Study|Lack of therapeutic response|11
1847306|NCT00206102|6388148|P1|Overall Study|Lack of therapeutic response|16
1847307|NCT00206102|6388147|P2|Overall Study|Protocol Violation|2
1847308|NCT00206102|6388148|P1|Overall Study|Protocol Violation|0
1847309|NCT00206102|6388147|P2|Overall Study|Adverse Event|82
1847310|NCT00206102|6388148|P1|Overall Study|Adverse Event|119
1847311|NCT00206076|6388184|P2|Overall Study|Withdrawal by Subject|1
1847312|NCT00206076|6388185|P1|Overall Study|Withdrawal by Subject|1
1847313|NCT00206076|6388184|P2|Overall Study|Physician Decision|0
1847314|NCT00206076|6388185|P1|Overall Study|Physician Decision|2
1847315|NCT00205881|6388195|P1|Overall Study|Withdrawal by Subject|16
1847316|NCT00205855|6388200|P1|Overall Study|Withdrawal by Subject|5
1847317|NCT00205855|6388200|P1|Overall Study|Only received temporary implants|16
1847318|NCT00205803|6388206|P2|Toddler Dose|Lost to Follow-up|3
1847319|NCT00205803|6388207|P1|Toddler Dose|Lost to Follow-up|2
1847320|NCT00205803|6388206|P2|After Infant Series|Other|4
1847321|NCT00205803|6388207|P1|After Infant Series|Other|10
1847322|NCT00205803|6388206|P2|After Infant Series|Withdrawal by Subject|4
1847323|NCT00205803|6388207|P1|After Infant Series|Withdrawal by Subject|1
1847324|NCT00205803|6388206|P2|After Infant Series|Physician Decision|2
1847325|NCT00205803|6388207|P1|After Infant Series|Physician Decision|3
1847326|NCT00205803|6388206|P2|After Infant Series|Lost to Follow-up|1
1847327|NCT00205803|6388207|P1|After Infant Series|Lost to Follow-up|2
1847328|NCT00205803|6388206|P2|After Infant Series|Protocol Violation|1
1847329|NCT00205803|6388207|P1|After Infant Series|Protocol Violation|1
1847330|NCT00205803|6388206|P2|After Infant Series|Adverse Event|1
1847331|NCT00205803|6388207|P1|After Infant Series|Adverse Event|1
1847332|NCT00205803|6388206|P2|Infant Series|Sponsor request|0
1847333|NCT00205803|6388207|P1|Infant Series|Sponsor request|1
1847334|NCT00205803|6388206|P2|Infant Series|Non-compliant|0
1847335|NCT00205803|6388207|P1|Infant Series|Non-compliant|1
1847336|NCT00205803|6388206|P2|Infant Series|Lost Kaiser coverage|1
1847337|NCT00205803|6388207|P1|Infant Series|Lost Kaiser coverage|0
1847338|NCT00205803|6388206|P2|Infant Series|Protocol Violation|0
1847339|NCT00205803|6388207|P1|Infant Series|Protocol Violation|1
1847340|NCT00205803|6388206|P2|Infant Series|Physician Decision|1
1847341|NCT00205803|6388207|P1|Infant Series|Physician Decision|3
1847342|NCT00205803|6388206|P2|Infant Series|Withdrawal by Subject|5
1847343|NCT00205803|6388207|P1|Infant Series|Withdrawal by Subject|2
1847344|NCT00205803|6388206|P2|Infant Series|Lost to Follow-up|4
1847345|NCT00205803|6388207|P1|Infant Series|Lost to Follow-up|10
1847346|NCT00205777|6388263|P6|Study Extension II|Enrolled but not treated|131
1847347|NCT00205777|6388264|P5|Study Extension II|Enrolled but not treated|0
1847348|NCT00205777|6388265|P4|Study Extension II|Enrolled but not treated|71
1847349|NCT00205777|6388266|P3|Study Extension II|Enrolled but not treated|0
1847350|NCT00205777|6388267|P2|Study Extension II|Enrolled but not treated|0
1847351|NCT00205777|6388268|P1|Study Extension II|Enrolled but not treated|0
1847352|NCT00205777|6388263|P6|Study Extension II|Other Event|20
1847353|NCT00205777|6388264|P5|Study Extension II|Other Event|0
1847354|NCT00205777|6388265|P4|Study Extension II|Other Event|12
1847355|NCT00205777|6388266|P3|Study Extension II|Other Event|0
1847356|NCT00205777|6388267|P2|Study Extension II|Other Event|0
1847357|NCT00205777|6388268|P1|Study Extension II|Other Event|0
1847358|NCT00205777|6388263|P6|Study Extension II|Failed to return|26
1847359|NCT00205777|6388264|P5|Study Extension II|Failed to return|0
1847360|NCT00205777|6388265|P4|Study Extension II|Failed to return|14
1847361|NCT00205777|6388266|P3|Study Extension II|Failed to return|0
1847362|NCT00205777|6388267|P2|Study Extension II|Failed to return|0
1847363|NCT00205777|6388268|P1|Study Extension II|Failed to return|0
1847364|NCT00205777|6388263|P6|Study Extension II|Lack of Efficacy|1
1847365|NCT00205777|6388264|P5|Study Extension II|Lack of Efficacy|0
1847366|NCT00205777|6388265|P4|Study Extension II|Lack of Efficacy|0
1847367|NCT00205777|6388266|P3|Study Extension II|Lack of Efficacy|0
1847368|NCT00205777|6388267|P2|Study Extension II|Lack of Efficacy|0
1847369|NCT00205777|6388268|P1|Study Extension II|Lack of Efficacy|0
1847370|NCT00205777|6388263|P6|Study Extension II|Protocol Violation|10
1847371|NCT00205777|6388264|P5|Study Extension II|Protocol Violation|0
1847372|NCT00205777|6388265|P4|Study Extension II|Protocol Violation|1
1847373|NCT00205777|6388266|P3|Study Extension II|Protocol Violation|0
1847374|NCT00205777|6388267|P2|Study Extension II|Protocol Violation|0
1847375|NCT00205777|6388268|P1|Study Extension II|Protocol Violation|0
1847376|NCT00205777|6388263|P6|Study Extension II|Withdrawal by Subject|59
1847377|NCT00205777|6388264|P5|Study Extension II|Withdrawal by Subject|0
1847378|NCT00205777|6388265|P4|Study Extension II|Withdrawal by Subject|35
1847379|NCT00205777|6388266|P3|Study Extension II|Withdrawal by Subject|0
1847380|NCT00205777|6388267|P2|Study Extension II|Withdrawal by Subject|0
1847381|NCT00205777|6388268|P1|Study Extension II|Withdrawal by Subject|0
1847382|NCT00205777|6388263|P6|Study Extension II|Death|5
1847383|NCT00205777|6388264|P5|Study Extension II|Death|0
1847384|NCT00205777|6388265|P4|Study Extension II|Death|2
1847385|NCT00205777|6388266|P3|Study Extension II|Death|0
1847386|NCT00205777|6388267|P2|Study Extension II|Death|0
1847387|NCT00205777|6388268|P1|Study Extension II|Death|0
1847388|NCT00205777|6388263|P6|Study Extension II|Adverse Event|30
1847389|NCT00205777|6388264|P5|Study Extension II|Adverse Event|0
1847390|NCT00205777|6388265|P4|Study Extension II|Adverse Event|14
1847391|NCT00205777|6388266|P3|Study Extension II|Adverse Event|0
1847392|NCT00205777|6388267|P2|Study Extension II|Adverse Event|0
1847393|NCT00205777|6388268|P1|Study Extension II|Adverse Event|0
1847394|NCT00205777|6388263|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1847395|NCT00205777|6388264|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
1847396|NCT00205777|6388265|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
1847397|NCT00205777|6388266|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1847398|NCT00205777|6388267|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
1847399|NCT00205777|6388268|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
1847400|NCT00205777|6388263|P6|Study Extension I|Withdrawn as per protocol|0
1847401|NCT00205777|6388264|P5|Study Extension I|Withdrawn as per protocol|0
1847402|NCT00205777|6388265|P4|Study Extension I|Withdrawn as per protocol|0
1847403|NCT00205777|6388266|P3|Study Extension I|Withdrawn as per protocol|1070
1847404|NCT00205777|6388267|P2|Study Extension I|Withdrawn as per protocol|0
1847405|NCT00205777|6388268|P1|Study Extension I|Withdrawn as per protocol|0
1847406|NCT00205777|6388263|P6|Study Extension I|Other Event|0
1847407|NCT00205777|6388264|P5|Study Extension I|Other Event|29
1847408|NCT00205777|6388265|P4|Study Extension I|Other Event|34
1847409|NCT00205777|6388266|P3|Study Extension I|Other Event|0
1847410|NCT00205777|6388267|P2|Study Extension I|Other Event|0
1847411|NCT00205777|6388268|P1|Study Extension I|Other Event|34
1847412|NCT00205777|6388263|P6|Study Extension I|Failed to return|0
1847413|NCT00205777|6388264|P5|Study Extension I|Failed to return|13
1847414|NCT00205777|6388265|P4|Study Extension I|Failed to return|17
1847415|NCT00205777|6388266|P3|Study Extension I|Failed to return|0
1847416|NCT00205777|6388267|P2|Study Extension I|Failed to return|0
1847417|NCT00205777|6388268|P1|Study Extension I|Failed to return|15
1847418|NCT00205777|6388263|P6|Study Extension I|Lack of Efficacy|0
1847419|NCT00205777|6388264|P5|Study Extension I|Lack of Efficacy|2
1847420|NCT00205777|6388265|P4|Study Extension I|Lack of Efficacy|1
1847421|NCT00205777|6388266|P3|Study Extension I|Lack of Efficacy|0
1847422|NCT00205777|6388267|P2|Study Extension I|Lack of Efficacy|0
1847423|NCT00205777|6388268|P1|Study Extension I|Lack of Efficacy|0
1847424|NCT00205777|6388263|P6|Study Extension I|Protocol Violation|0
1847425|NCT00205777|6388264|P5|Study Extension I|Protocol Violation|8
1847426|NCT00205777|6388265|P4|Study Extension I|Protocol Violation|8
1847427|NCT00205777|6388266|P3|Study Extension I|Protocol Violation|0
1847428|NCT00205777|6388267|P2|Study Extension I|Protocol Violation|0
1847429|NCT00205777|6388268|P1|Study Extension I|Protocol Violation|4
1847430|NCT00205777|6388263|P6|Study Extension I|Withdrawal by Subject|0
1847431|NCT00205777|6388264|P5|Study Extension I|Withdrawal by Subject|89
1847432|NCT00205777|6388265|P4|Study Extension I|Withdrawal by Subject|106
1847433|NCT00205777|6388266|P3|Study Extension I|Withdrawal by Subject|0
1847434|NCT00205777|6388267|P2|Study Extension I|Withdrawal by Subject|0
1847435|NCT00205777|6388268|P1|Study Extension I|Withdrawal by Subject|99
1847436|NCT00205777|6388263|P6|Study Extension I|Death|0
1847437|NCT00205777|6388264|P5|Study Extension I|Death|2
1847438|NCT00205777|6388265|P4|Study Extension I|Death|1
1847439|NCT00205777|6388266|P3|Study Extension I|Death|0
1847440|NCT00205777|6388267|P2|Study Extension I|Death|0
1847441|NCT00205777|6388268|P1|Study Extension I|Death|5
1847442|NCT00205777|6388263|P6|Study Extension I|Adverse Event|0
1847443|NCT00205777|6388264|P5|Study Extension I|Adverse Event|58
1847444|NCT00205777|6388265|P4|Study Extension I|Adverse Event|61
1847445|NCT00205777|6388266|P3|Study Extension I|Adverse Event|0
1847446|NCT00205777|6388267|P2|Study Extension I|Adverse Event|0
1847447|NCT00205777|6388268|P1|Study Extension I|Adverse Event|57
1847448|NCT00205777|6388263|P6|Completed Core Study, Entered SE I|Other Event|0
1847449|NCT00205777|6388264|P5|Completed Core Study, Entered SE I|Other Event|0
1847450|NCT00205777|6388265|P4|Completed Core Study, Entered SE I|Other Event|50
1847532|NCT00203996|6388669|P6|Overall Study|Scheduling issue|0
1847451|NCT00205777|6388266|P3|Completed Core Study, Entered SE I|Other Event|47
1847452|NCT00205777|6388267|P2|Completed Core Study, Entered SE I|Other Event|46
1847453|NCT00205777|6388268|P1|Completed Core Study, Entered SE I|Other Event|52
1847454|NCT00205777|6388263|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1847455|NCT00205777|6388264|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
1847456|NCT00205777|6388265|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
1847457|NCT00205777|6388266|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
1847458|NCT00205777|6388267|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
1847459|NCT00205777|6388268|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
1847460|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
1847461|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
1847462|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
1847463|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
1847464|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
1847465|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
1847466|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
1847467|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
1847468|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
1847469|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
1847470|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
1847471|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
1847472|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Protocol Violation|0
1847473|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Protocol Violation|0
1847474|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Protocol Violation|42
1847475|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Protocol Violation|50
1847476|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Protocol Violation|55
1847477|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Protocol Violation|53
1847478|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1847479|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
1847480|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
1847481|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
1847482|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
1847483|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
1847484|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Other Event|0
1847485|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Other Event|0
1847486|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Other Event|58
1847487|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Other Event|41
1847488|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Other Event|52
1847489|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Other Event|49
1847490|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Failed to return|0
1847491|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Failed to return|0
1847492|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Failed to return|27
1847493|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Failed to return|27
1847494|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Failed to return|25
1847495|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Failed to return|40
1847496|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Death|0
1847497|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Death|0
1847498|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Death|7
1847499|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Death|14
1847500|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Death|7
1847501|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Death|9
1847502|NCT00205777|6388263|P6|Core Study (Up to 3 Years)|Adverse Event|0
1847503|NCT00205777|6388264|P5|Core Study (Up to 3 Years)|Adverse Event|0
1847504|NCT00205777|6388265|P4|Core Study (Up to 3 Years)|Adverse Event|232
1847505|NCT00205777|6388266|P3|Core Study (Up to 3 Years)|Adverse Event|252
1847506|NCT00205777|6388267|P2|Core Study (Up to 3 Years)|Adverse Event|267
1847507|NCT00205777|6388268|P1|Core Study (Up to 3 Years)|Adverse Event|260
1847508|NCT00205712|6388477|P2|Overall Study|Lost to Follow-up|1
1847509|NCT00205712|6388478|P1|Overall Study|Lost to Follow-up|0
1847510|NCT00205699|6388491|P3|Overall Study|Lack of Efficacy|0
1847511|NCT00205699|6388492|P2|Overall Study|Lack of Efficacy|1
1847512|NCT00205699|6388493|P1|Overall Study|Lack of Efficacy|0
1847513|NCT00205699|6388491|P3|Overall Study|Withdrawal by Subject|1
1847514|NCT00205699|6388492|P2|Overall Study|Withdrawal by Subject|2
1847515|NCT00205699|6388493|P1|Overall Study|Withdrawal by Subject|1
1847516|NCT00205699|6388491|P3|Overall Study|Adverse Event|0
1847517|NCT00205699|6388492|P2|Overall Study|Adverse Event|0
1847518|NCT00205699|6388493|P1|Overall Study|Adverse Event|1
1847519|NCT00205699|6388491|P3|Overall Study|Lost to Follow-up|5
1847520|NCT00205699|6388492|P2|Overall Study|Lost to Follow-up|3
1847521|NCT00205699|6388493|P1|Overall Study|Lost to Follow-up|1
1847522|NCT00205179|6388573|P2|Overall Study|Adverse Event|1
1847523|NCT00205179|6388574|P1|Overall Study|Adverse Event|1
1847524|NCT00205179|6388573|P2|Overall Study|Physician Decision|1
1847525|NCT00205179|6388574|P1|Overall Study|Physician Decision|1
1847526|NCT00205179|6388573|P2|Overall Study|Death|2
1847527|NCT00205179|6388574|P1|Overall Study|Death|0
1847528|NCT00203996|6388665|P10|Overall Study|Scheduling issue|0
1847529|NCT00203996|6388666|P9|Overall Study|Scheduling issue|0
1847530|NCT00203996|6388667|P8|Overall Study|Scheduling issue|2
1847531|NCT00203996|6388668|P7|Overall Study|Scheduling issue|0
1847533|NCT00203996|6388670|P5|Overall Study|Scheduling issue|0
1847534|NCT00203996|6388671|P4|Overall Study|Scheduling issue|0
1847535|NCT00203996|6388672|P3|Overall Study|Scheduling issue|0
1847536|NCT00203996|6388673|P2|Overall Study|Scheduling issue|0
1847537|NCT00203996|6388674|P1|Overall Study|Scheduling issue|0
1847538|NCT00203996|6388665|P10|Overall Study|CPAP machine malfunction|0
1847539|NCT00203996|6388666|P9|Overall Study|CPAP machine malfunction|0
1847540|NCT00203996|6388667|P8|Overall Study|CPAP machine malfunction|0
1847541|NCT00203996|6388668|P7|Overall Study|CPAP machine malfunction|0
1847542|NCT00203996|6388669|P6|Overall Study|CPAP machine malfunction|0
1847543|NCT00203996|6388670|P5|Overall Study|CPAP machine malfunction|0
1847544|NCT00203996|6388671|P4|Overall Study|CPAP machine malfunction|1
1847545|NCT00203996|6388672|P3|Overall Study|CPAP machine malfunction|0
1847546|NCT00203996|6388673|P2|Overall Study|CPAP machine malfunction|0
1847547|NCT00203996|6388674|P1|Overall Study|CPAP machine malfunction|0
1847548|NCT00203996|6388665|P10|Overall Study|Physician Decision|1
1847549|NCT00203996|6388666|P9|Overall Study|Physician Decision|0
1847550|NCT00203996|6388667|P8|Overall Study|Physician Decision|0
1847551|NCT00203996|6388668|P7|Overall Study|Physician Decision|0
1847552|NCT00203996|6388669|P6|Overall Study|Physician Decision|0
1847553|NCT00203996|6388670|P5|Overall Study|Physician Decision|0
1847554|NCT00203996|6388671|P4|Overall Study|Physician Decision|2
1847555|NCT00203996|6388672|P3|Overall Study|Physician Decision|0
1847556|NCT00203996|6388673|P2|Overall Study|Physician Decision|0
1847557|NCT00203996|6388674|P1|Overall Study|Physician Decision|0
1847558|NCT00203996|6388665|P10|Overall Study|Protocol Violation|0
1847559|NCT00203996|6388666|P9|Overall Study|Protocol Violation|0
1847560|NCT00203996|6388667|P8|Overall Study|Protocol Violation|0
1847561|NCT00203996|6388668|P7|Overall Study|Protocol Violation|0
1847562|NCT00203996|6388669|P6|Overall Study|Protocol Violation|0
1847563|NCT00203996|6388670|P5|Overall Study|Protocol Violation|1
1847564|NCT00203996|6388671|P4|Overall Study|Protocol Violation|6
1847565|NCT00203996|6388672|P3|Overall Study|Protocol Violation|0
1847566|NCT00203996|6388673|P2|Overall Study|Protocol Violation|0
1847567|NCT00203996|6388674|P1|Overall Study|Protocol Violation|0
1847568|NCT00203996|6388665|P10|Overall Study|Lost to Follow-up|0
1847569|NCT00203996|6388666|P9|Overall Study|Lost to Follow-up|0
1847570|NCT00203996|6388667|P8|Overall Study|Lost to Follow-up|0
1847571|NCT00203996|6388668|P7|Overall Study|Lost to Follow-up|0
1847572|NCT00203996|6388669|P6|Overall Study|Lost to Follow-up|0
1847573|NCT00203996|6388670|P5|Overall Study|Lost to Follow-up|0
1847574|NCT00203996|6388671|P4|Overall Study|Lost to Follow-up|1
1847575|NCT00203996|6388672|P3|Overall Study|Lost to Follow-up|0
1847576|NCT00203996|6388673|P2|Overall Study|Lost to Follow-up|0
1847577|NCT00203996|6388674|P1|Overall Study|Lost to Follow-up|0
1847578|NCT00203892|6388741|P3|Overall Study|Death|0
1847579|NCT00203892|6388742|P2|Overall Study|Death|0
1847580|NCT00203892|6388743|P1|Overall Study|Death|1
1847581|NCT00203892|6388741|P3|Overall Study|Physician Decision|0
1847582|NCT00203892|6388742|P2|Overall Study|Physician Decision|2
1847583|NCT00203892|6388743|P1|Overall Study|Physician Decision|1
1847584|NCT00203502|6388754|P1|Overall Study|Death|1
1847585|NCT00203476|6388765|P3|Overall Study|Withdrawal by Subject|0
1847586|NCT00203476|6388766|P2|Overall Study|Withdrawal by Subject|1
1847587|NCT00203476|6388767|P1|Overall Study|Withdrawal by Subject|0
1847588|NCT00203476|6388765|P3|Overall Study|Lost to Follow-up|0
1847589|NCT00203476|6388766|P2|Overall Study|Lost to Follow-up|0
1847590|NCT00203476|6388767|P1|Overall Study|Lost to Follow-up|1
1847591|NCT00203424|6388784|P1|Follow-up Period|Lost to Follow-up|1
1847592|NCT00203424|6388784|P1|Follow-up Period|progressive disease|4
1847593|NCT00203424|6388784|P1|Follow-up Period|Withdrawal by Subject|1
1847594|NCT00203424|6388784|P1|Treatment Period|progressive disease|2
1847595|NCT00203424|6388784|P1|Treatment Period|Adverse Event|5
1847596|NCT00203424|6388784|P1|Treatment Period|Withdrawal by Subject|4
1847597|NCT00203411|6388791|P1|Follow-up|Progressive Disease|4
1847598|NCT00203307|6388800|P2|First Intervention|Adverse Event|0
1847599|NCT00203307|6388801|P1|First Intervention|Adverse Event|2
1847600|NCT00203294|6388809|P2|Overall Study|Withdrawal by Subject|13
1847601|NCT00203294|6388810|P1|Overall Study|Withdrawal by Subject|8
1847602|NCT00203268|6388816|P1|Early Treatment|Withdrawal by Subject|1
1847603|NCT00203268|6388816|P1|Early Treatment|Lost to Follow-up|1
1847604|NCT00203268|6388816|P1|Early Treatment|only treated one headache|2
1847605|NCT00203242|6388822|P1|Overall Study|Lost to Follow-up|1
1847606|NCT00203047|6388874|P2|Overall Study|Other|5
1847607|NCT00203047|6388875|P1|Overall Study|Other|5
1847608|NCT00203047|6388874|P2|Overall Study|Pregnancy|0
1847609|NCT00203047|6388875|P1|Overall Study|Pregnancy|3
1847610|NCT00203047|6388874|P2|Overall Study|Death|2
1847611|NCT00203047|6388875|P1|Overall Study|Death|1
1847612|NCT00203047|6388874|P2|Overall Study|Adverse Event|18
1847613|NCT00203047|6388875|P1|Overall Study|Adverse Event|8
1847614|NCT00203047|6388874|P2|Overall Study|Lost to Follow-up|5
1847615|NCT00203047|6388875|P1|Overall Study|Lost to Follow-up|11
1847616|NCT00203047|6388874|P2|Overall Study|Protocol Violation|0
1847617|NCT00203047|6388875|P1|Overall Study|Protocol Violation|1
1847618|NCT00203047|6388874|P2|Overall Study|Non-compliance|8
1847619|NCT00203047|6388875|P1|Overall Study|Non-compliance|4
1847620|NCT00203047|6388874|P2|Overall Study|Physician Decision|7
1847621|NCT00203047|6388875|P1|Overall Study|Physician Decision|8
1847622|NCT00203047|6388874|P2|Overall Study|Teva requested participant withdrawal|1
1847623|NCT00203047|6388875|P1|Overall Study|Teva requested participant withdrawal|1
1847624|NCT00203047|6388874|P2|Overall Study|Withdrawal by Subject|47
1847625|NCT00203047|6388875|P1|Overall Study|Withdrawal by Subject|13
1847626|NCT00203047|6388874|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
1847627|NCT00203047|6388875|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
1847628|NCT00203047|6388874|P2|Overall Study|Ongoing: in database - January 29, 2009|109
1847629|NCT00203047|6388875|P1|Overall Study|Ongoing: in database - January 29, 2009|131
1847640|NCT00202878|6388900|P2|Overall Study|Withdrawal by Subject|808
1847641|NCT00202878|6388901|P1|Overall Study|Withdrawal by Subject|795
1847642|NCT00202878|6388900|P2|Overall Study|Site Closure|36
1847643|NCT00202878|6388901|P1|Overall Study|Site Closure|39
1847644|NCT00202878|6388900|P2|Overall Study|Lost to Follow-up|49
1847645|NCT00202878|6388901|P1|Overall Study|Lost to Follow-up|44
1847646|NCT00202878|6388900|P2|Overall Study|Only Vital Status Known|356
1847647|NCT00202878|6388901|P1|Overall Study|Only Vital Status Known|357
1847648|NCT00202878|6388900|P2|Overall Study|Death|968
1847649|NCT00202878|6388901|P1|Overall Study|Death|964
1847650|NCT00202839|6388915|P2|Overall Study|Lost to Follow-up|2
1847651|NCT00202839|6388916|P1|Overall Study|Lost to Follow-up|3
1847652|NCT00202839|6388915|P2|Overall Study|Protocol Violation|1
1847653|NCT00202839|6388916|P1|Overall Study|Protocol Violation|2
1847654|NCT00202839|6388915|P2|Overall Study|Withdrawal by Subject|2
1847655|NCT00202839|6388916|P1|Overall Study|Withdrawal by Subject|6
1847656|NCT00202839|6388915|P2|Overall Study|Physician Decision|0
1847657|NCT00202839|6388916|P1|Overall Study|Physician Decision|12
1847658|NCT00202839|6388915|P2|Overall Study|Adverse Event|5
1847659|NCT00202839|6388916|P1|Overall Study|Adverse Event|1
1847660|NCT00202644|6388931|P2|Overall Study|Other|1
1847661|NCT00202644|6388932|P1|Overall Study|Other|9
1847662|NCT00202644|6388931|P2|Overall Study|Lost to Follow-up|1
1847663|NCT00202644|6388932|P1|Overall Study|Lost to Follow-up|0
1847664|NCT00202644|6388931|P2|Overall Study|Lack of Efficacy|6
1847665|NCT00202644|6388932|P1|Overall Study|Lack of Efficacy|6
1847666|NCT00202644|6388931|P2|Overall Study|Withdrawal by Subject|6
1847667|NCT00202644|6388932|P1|Overall Study|Withdrawal by Subject|8
1847668|NCT00202644|6388931|P2|Overall Study|Adverse Event|13
1847669|NCT00202644|6388932|P1|Overall Study|Adverse Event|12
1847670|NCT00201851|6388993|P3|Overall Study|Ineligible post enrollment|1
1847671|NCT00201851|6388994|P2|Overall Study|Ineligible post enrollment|1
1847672|NCT00201851|6388995|P1|Overall Study|Ineligible post enrollment|6
1847673|NCT00201851|6388993|P3|Overall Study|Lost to Follow-up|0
1847674|NCT00201851|6388994|P2|Overall Study|Lost to Follow-up|1
1847675|NCT00201851|6388995|P1|Overall Study|Lost to Follow-up|2
1847676|NCT00201643|6389067|P2|Overall Study|Withdrawal by Subject|4
1847677|NCT00201643|6389068|P1|Overall Study|Withdrawal by Subject|5
1847678|NCT00201201|6389132|P2|Overall Study|Withdrawal by Subject|5
1847679|NCT00201201|6389133|P1|Overall Study|Withdrawal by Subject|5
1847680|NCT00201201|6389132|P2|Overall Study|Death|2
1847681|NCT00201201|6389133|P1|Overall Study|Death|0
1847682|NCT00201006|6389171|P3|Overall Study|Adverse Event|1
1847683|NCT00201006|6389172|P2|Overall Study|Adverse Event|0
1847684|NCT00201006|6389173|P1|Overall Study|Adverse Event|1
1847685|NCT00201006|6389171|P3|Overall Study|Withdrawal by Subject|3
1847686|NCT00201006|6389172|P2|Overall Study|Withdrawal by Subject|2
1847687|NCT00201006|6389173|P1|Overall Study|Withdrawal by Subject|7
1847688|NCT00200967|6389183|P2|Run-out Period|Lost to Follow-up|0
1847689|NCT00200967|6389184|P1|Run-out Period|Lost to Follow-up|1
1847690|NCT00200967|6389183|P2|Second Treatment Period|Withdrawal by Subject|2
1847691|NCT00200967|6389184|P1|Second Treatment Period|Withdrawal by Subject|1
1847692|NCT00200967|6389183|P2|Wash-out Period|Lost to Follow-up|1
1847693|NCT00200967|6389184|P1|Wash-out Period|Lost to Follow-up|0
1847694|NCT00200967|6389183|P2|First Treatment Period|Pregnancy|0
1847695|NCT00200967|6389184|P1|First Treatment Period|Pregnancy|1
1847696|NCT00200967|6389183|P2|First Treatment Period|Withdrawal by Subject|1
1847697|NCT00200967|6389184|P1|First Treatment Period|Withdrawal by Subject|5
1847698|NCT00200850|6389234|P3|Overall Study|Adverse Event|2
1847699|NCT00200850|6389235|P2|Overall Study|Adverse Event|1
1847700|NCT00200850|6389236|P1|Overall Study|Adverse Event|1
1847701|NCT00200850|6389234|P3|Overall Study|optic neuritis|1
1847702|NCT00200850|6389235|P2|Overall Study|optic neuritis|0
1847703|NCT00200850|6389236|P1|Overall Study|optic neuritis|0
1847704|NCT00200850|6389234|P3|Overall Study|Poor adherence|1
1847705|NCT00200850|6389235|P2|Overall Study|Poor adherence|0
1847706|NCT00200850|6389236|P1|Overall Study|Poor adherence|0
1847707|NCT00200850|6389234|P3|Overall Study|Pregnancy|1
1847708|NCT00200850|6389235|P2|Overall Study|Pregnancy|0
1847709|NCT00200850|6389236|P1|Overall Study|Pregnancy|0
1847710|NCT00200850|6389234|P3|Overall Study|too busy|0
1847711|NCT00200850|6389235|P2|Overall Study|too busy|0
1847712|NCT00200850|6389236|P1|Overall Study|too busy|1
1847713|NCT00200850|6389234|P3|Overall Study|relocation|1
1847714|NCT00200850|6389235|P2|Overall Study|relocation|0
1847715|NCT00200850|6389236|P1|Overall Study|relocation|1
1847716|NCT00200356|6389257|P2|Overall Study|Nontreatment|0
1847717|NCT00200356|6389258|P1|Overall Study|Nontreatment|1
1847718|NCT00200356|6389257|P2|Overall Study|Protocol Violation|4
1847719|NCT00200356|6389258|P1|Overall Study|Protocol Violation|4
1847720|NCT00200356|6389257|P2|Overall Study|Lack of Efficacy|3
1847721|NCT00200356|6389258|P1|Overall Study|Lack of Efficacy|3
1847722|NCT00200057|6389325|P1|Overall Study|Death|1
1847723|NCT00200057|6389325|P1|Overall Study|Infection|1
1847724|NCT00200057|6389325|P1|Overall Study|Change in medical condition|1
1847725|NCT00200057|6389325|P1|Overall Study|Withdrawal by Subject|1
1847726|NCT00200057|6389325|P1|Overall Study|Exited due to terminal illness of PI|2
1847727|NCT00200057|6389325|P1|Overall Study|Lack of Efficacy|3
1847728|NCT00199875|6389349|P5|Overall Study|Withdrawal by Subject|1
1847729|NCT00199875|6389350|P4|Overall Study|Withdrawal by Subject|0
1847730|NCT00199875|6389351|P3|Overall Study|Withdrawal by Subject|0
1847731|NCT00199875|6389352|P2|Overall Study|Withdrawal by Subject|0
1847732|NCT00199875|6389353|P1|Overall Study|Withdrawal by Subject|0
1847733|NCT00199381|6389375|P1|Overall Study|Study termination by Sponsor|323
1847734|NCT00199381|6389375|P1|Overall Study|Not including due to early termination|37
1847735|NCT00199381|6389375|P1|Overall Study|Lack of Efficacy|27
1847736|NCT00199381|6389375|P1|Overall Study|Protocol Violation|6
1847737|NCT00199381|6389375|P1|Overall Study|Adverse Event|73
1847738|NCT00199381|6389375|P1|Overall Study|Withdrawal by Subject|38
1847739|NCT00198822|6389382|P3|Overall Study|Lost to Follow-up|21
1847740|NCT00198822|6389383|P2|Overall Study|Lost to Follow-up|20
1847741|NCT00198822|6389384|P1|Overall Study|Lost to Follow-up|14
1847742|NCT00198133|6389403|P2|Overall Study|Physician Decision|0
1847743|NCT00198133|6389404|P1|Overall Study|Physician Decision|1
1847744|NCT00198133|6389403|P2|Overall Study|Withdrawal by Subject|0
1847745|NCT00198133|6389404|P1|Overall Study|Withdrawal by Subject|1
1847746|NCT00198133|6389403|P2|Overall Study|Adverse Event|3
1847747|NCT00198133|6389404|P1|Overall Study|Adverse Event|1
1847748|NCT00198133|6389403|P2|Overall Study|Disease progression|5
1847749|NCT00198133|6389404|P1|Overall Study|Disease progression|2
1847750|NCT00198107|6389416|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
1847751|NCT00198107|6389417|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
1847752|NCT00198107|6389418|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
1847753|NCT00198107|6389416|P3|Double-Blind Period|Withdrawal by Subject|0
1847754|NCT00198107|6389417|P2|Double-Blind Period|Withdrawal by Subject|1
1847755|NCT00198107|6389418|P1|Double-Blind Period|Withdrawal by Subject|0
1847756|NCT00198107|6389416|P3|Double-Blind Period|Physician Decision|0
1847757|NCT00198107|6389417|P2|Double-Blind Period|Physician Decision|0
1847758|NCT00198107|6389418|P1|Double-Blind Period|Physician Decision|1
1847759|NCT00198107|6389416|P3|Double-Blind Period|Lost to Follow-up|0
1847760|NCT00198107|6389417|P2|Double-Blind Period|Lost to Follow-up|1
1847761|NCT00198107|6389418|P1|Double-Blind Period|Lost to Follow-up|2
1847762|NCT00198107|6389416|P3|Double-Blind Period|Lack of Efficacy|0
1847763|NCT00198107|6389417|P2|Double-Blind Period|Lack of Efficacy|0
1847764|NCT00198107|6389418|P1|Double-Blind Period|Lack of Efficacy|2
1847765|NCT00198107|6389416|P3|Double-Blind Period|Adverse Event|0
1847766|NCT00198107|6389417|P2|Double-Blind Period|Adverse Event|1
1847767|NCT00198107|6389418|P1|Double-Blind Period|Adverse Event|1
1847768|NCT00198029|6389486|P1|Overall Study|Withdrawal by Subject|4
1847769|NCT00197496|6389493|P2|Follow-up|Lost to Follow-up|1
1847770|NCT00197496|6389494|P1|Follow-up|Lost to Follow-up|2
1847771|NCT00197496|6389493|P2|Baseline to Discharge|Protocol Violation|1
1847772|NCT00197496|6389494|P1|Baseline to Discharge|Protocol Violation|0
1847773|NCT00197496|6389493|P2|Baseline to Discharge|Physician Decision|1
1847774|NCT00197496|6389494|P1|Baseline to Discharge|Physician Decision|0
1847775|NCT00197496|6389493|P2|Baseline to Discharge|MRSA|0
1847776|NCT00197496|6389494|P1|Baseline to Discharge|MRSA|1
1847777|NCT00197496|6389493|P2|Baseline to Discharge|not interested|0
1847778|NCT00197496|6389494|P1|Baseline to Discharge|not interested|1
1847779|NCT00197236|6389542|P3|Overall Study|Returned out of specified time window|1
1847780|NCT00197236|6389543|P2|Overall Study|Returned out of specified time window|0
1847781|NCT00197236|6389544|P1|Overall Study|Returned out of specified time window|0
1847782|NCT00197236|6389542|P3|Overall Study|Study drug/medication expiration|3
1847783|NCT00197236|6389543|P2|Overall Study|Study drug/medication expiration|0
1847784|NCT00197236|6389544|P1|Overall Study|Study drug/medication expiration|1
1847785|NCT00197236|6389542|P3|Overall Study|Withdrawal by Subject|11
1847786|NCT00197236|6389543|P2|Overall Study|Withdrawal by Subject|3
1847787|NCT00197236|6389544|P1|Overall Study|Withdrawal by Subject|7
1847788|NCT00197236|6389542|P3|Overall Study|Protocol Violation|1
1847789|NCT00197236|6389543|P2|Overall Study|Protocol Violation|0
1847790|NCT00197236|6389544|P1|Overall Study|Protocol Violation|0
1847791|NCT00197236|6389542|P3|Overall Study|Lost to Follow-up|6
1847792|NCT00197236|6389543|P2|Overall Study|Lost to Follow-up|14
1847793|NCT00197236|6389544|P1|Overall Study|Lost to Follow-up|5
1847794|NCT00197236|6389542|P3|Overall Study|Adverse Event|1
1847795|NCT00197236|6389543|P2|Overall Study|Adverse Event|0
1847796|NCT00197236|6389544|P1|Overall Study|Adverse Event|1
1847797|NCT00197145|6389618|P2|Period 2 : Open Label Phase|Other|0
1847798|NCT00197145|6389619|P1|Period 2 : Open Label Phase|Other|1
1847799|NCT00197145|6389618|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
1847800|NCT00197145|6389619|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
1847801|NCT00197145|6389618|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
1847802|NCT00197145|6389619|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
1847803|NCT00197145|6389618|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
1847804|NCT00197145|6389619|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
1847805|NCT00197145|6389618|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
1847806|NCT00197145|6389619|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
1847807|NCT00197145|6389618|P2|Period 1: Randomized Treatment Phase|Other|2
1847808|NCT00197145|6389619|P1|Period 1: Randomized Treatment Phase|Other|2
1847809|NCT00197145|6389618|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
1847810|NCT00197145|6389619|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
1847811|NCT00197145|6389618|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
1847812|NCT00197145|6389619|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
1847813|NCT00197106|6389690|P3|Overall Treatment Period|Withdrawal by Subject|2
1847814|NCT00197106|6389691|P2|Overall Treatment Period|Withdrawal by Subject|0
1847815|NCT00197106|6389692|P1|Overall Treatment Period|Withdrawal by Subject|0
1847816|NCT00197106|6389690|P3|Overall Treatment Period|Protocol Violation|2
1847817|NCT00197106|6389691|P2|Overall Treatment Period|Protocol Violation|0
1847818|NCT00197106|6389692|P1|Overall Treatment Period|Protocol Violation|0
1847819|NCT00197106|6389690|P3|Overall Treatment Period|Lost to Follow-up|2
1847820|NCT00197106|6389691|P2|Overall Treatment Period|Lost to Follow-up|0
1847821|NCT00197106|6389692|P1|Overall Treatment Period|Lost to Follow-up|0
1847822|NCT00197106|6389690|P3|Overall Treatment Period|Lack of Efficacy|0
1847823|NCT00197106|6389691|P2|Overall Treatment Period|Lack of Efficacy|1
1847824|NCT00197106|6389692|P1|Overall Treatment Period|Lack of Efficacy|0
1847825|NCT00197106|6389690|P3|4-Week Run-In Period|Did not meet entry criteria|0
1847826|NCT00197106|6389691|P2|4-Week Run-In Period|Did not meet entry criteria|0
1847827|NCT00197106|6389692|P1|4-Week Run-In Period|Did not meet entry criteria|99
1847828|NCT00197028|6389728|P2|Overall Study|Other|6
1847829|NCT00197028|6389729|P1|Overall Study|Other|3
1847830|NCT00197028|6389728|P2|Overall Study|Lost to Follow-up|0
1847831|NCT00197028|6389729|P1|Overall Study|Lost to Follow-up|1
1847832|NCT00197028|6389728|P2|Overall Study|Withdrawal by Subject|12
1847833|NCT00197028|6389729|P1|Overall Study|Withdrawal by Subject|8
1847834|NCT00197028|6389728|P2|Overall Study|Protocol Violation|1
1847835|NCT00197028|6389729|P1|Overall Study|Protocol Violation|2
1847836|NCT00197028|6389728|P2|Overall Study|Adverse Event|2
1847837|NCT00197028|6389729|P1|Overall Study|Adverse Event|2
1847838|NCT00197015|6389772|P3|Overall Study|Other|2
1847839|NCT00197015|6389773|P2|Overall Study|Other|3
1847840|NCT00197015|6389774|P1|Overall Study|Other|2
1847841|NCT00197015|6389772|P3|Overall Study|Lost to Follow-up|37
1847842|NCT00197015|6389773|P2|Overall Study|Lost to Follow-up|46
1847843|NCT00197015|6389774|P1|Overall Study|Lost to Follow-up|28
1847844|NCT00197015|6389772|P3|Overall Study|Withdrawal by Subject|34
1847845|NCT00197015|6389773|P2|Overall Study|Withdrawal by Subject|37
1847846|NCT00197015|6389774|P1|Overall Study|Withdrawal by Subject|17
1847847|NCT00197015|6389772|P3|Overall Study|Protocol Violation|3
1847848|NCT00197015|6389773|P2|Overall Study|Protocol Violation|3
1847849|NCT00197015|6389774|P1|Overall Study|Protocol Violation|0
1847850|NCT00197015|6389772|P3|Overall Study|Adverse Event|1
1847851|NCT00197015|6389773|P2|Overall Study|Adverse Event|0
1847852|NCT00197015|6389774|P1|Overall Study|Adverse Event|3
1847853|NCT00197002|6389833|P3|Overall Study|Others|1
1847854|NCT00197002|6389834|P2|Overall Study|Others|1
1847855|NCT00197002|6389835|P1|Overall Study|Others|3
1847856|NCT00197002|6389833|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
1847857|NCT00197002|6389834|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
1847858|NCT00197002|6389835|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
1847859|NCT00197002|6389833|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
1847860|NCT00197002|6389834|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
1847861|NCT00197002|6389835|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
1847862|NCT00197002|6389833|P3|Overall Study|Migrated/moved from study area|1
1847863|NCT00197002|6389834|P2|Overall Study|Migrated/moved from study area|5
1847864|NCT00197002|6389835|P1|Overall Study|Migrated/moved from study area|3
1847865|NCT00197002|6389833|P3|Overall Study|Withdrawal by Subject|7
1847866|NCT00197002|6389834|P2|Overall Study|Withdrawal by Subject|5
1847867|NCT00197002|6389835|P1|Overall Study|Withdrawal by Subject|9
1847868|NCT00197002|6389833|P3|Overall Study|Protocol Violation|2
1847869|NCT00197002|6389834|P2|Overall Study|Protocol Violation|0
1847870|NCT00197002|6389835|P1|Overall Study|Protocol Violation|1
1847871|NCT00197002|6389833|P3|Overall Study|Adverse Event|0
1847872|NCT00197002|6389834|P2|Overall Study|Adverse Event|1
1847873|NCT00197002|6389835|P1|Overall Study|Adverse Event|0
1847874|NCT00196976|6389886|P14|Booster Study|Lost to Follow-up|0
1847875|NCT00196976|6389887|P13|Booster Study|Lost to Follow-up|0
1847876|NCT00196976|6389888|P12|Booster Study|Lost to Follow-up|2
1847877|NCT00196976|6389889|P11|Booster Study|Lost to Follow-up|1
1847878|NCT00196976|6389890|P10|Booster Study|Lost to Follow-up|0
1847879|NCT00196976|6389891|P9|Booster Study|Lost to Follow-up|0
1847880|NCT00196976|6389892|P8|Booster Study|Lost to Follow-up|0
1847881|NCT00196976|6389893|P7|Booster Study|Lost to Follow-up|0
1847882|NCT00196976|6389894|P6|Booster Study|Lost to Follow-up|0
1847883|NCT00196976|6389895|P5|Booster Study|Lost to Follow-up|0
1847884|NCT00196976|6389896|P4|Booster Study|Lost to Follow-up|0
1847885|NCT00196976|6389897|P3|Booster Study|Lost to Follow-up|0
1847886|NCT00196976|6389898|P2|Booster Study|Lost to Follow-up|0
1847887|NCT00196976|6389899|P1|Booster Study|Lost to Follow-up|0
1847888|NCT00196976|6389886|P14|Booster Study|Withdrawal by Subject|0
1847889|NCT00196976|6389887|P13|Booster Study|Withdrawal by Subject|0
1847890|NCT00196976|6389888|P12|Booster Study|Withdrawal by Subject|0
1847891|NCT00196976|6389889|P11|Booster Study|Withdrawal by Subject|1
1847892|NCT00196976|6389890|P10|Booster Study|Withdrawal by Subject|0
1847893|NCT00196976|6389891|P9|Booster Study|Withdrawal by Subject|0
1847894|NCT00196976|6389892|P8|Booster Study|Withdrawal by Subject|0
1847895|NCT00196976|6389893|P7|Booster Study|Withdrawal by Subject|0
1847896|NCT00196976|6389894|P6|Booster Study|Withdrawal by Subject|0
1847897|NCT00196976|6389895|P5|Booster Study|Withdrawal by Subject|0
1847898|NCT00196976|6389896|P4|Booster Study|Withdrawal by Subject|0
1847899|NCT00196976|6389897|P3|Booster Study|Withdrawal by Subject|0
1847900|NCT00196976|6389898|P2|Booster Study|Withdrawal by Subject|0
1847901|NCT00196976|6389899|P1|Booster Study|Withdrawal by Subject|0
1847902|NCT00196976|6389886|P14|Primary Study|Other|0
1847903|NCT00196976|6389887|P13|Primary Study|Other|0
1847904|NCT00196976|6389888|P12|Primary Study|Other|0
1847905|NCT00196976|6389889|P11|Primary Study|Other|0
1847906|NCT00196976|6389890|P10|Primary Study|Other|0
1847907|NCT00196976|6389891|P9|Primary Study|Other|0
1847908|NCT00196976|6389892|P8|Primary Study|Other|0
1847909|NCT00196976|6389893|P7|Primary Study|Other|0
1847910|NCT00196976|6389894|P6|Primary Study|Other|0
1847911|NCT00196976|6389895|P5|Primary Study|Other|0
1847912|NCT00196976|6389896|P4|Primary Study|Other|0
1847913|NCT00196976|6389897|P3|Primary Study|Other|2
1847914|NCT00196976|6389898|P2|Primary Study|Other|0
1847915|NCT00196976|6389899|P1|Primary Study|Other|0
1847916|NCT00196976|6389886|P14|Primary Study|Lost to Follow-up|0
1847917|NCT00196976|6389887|P13|Primary Study|Lost to Follow-up|0
1847918|NCT00196976|6389888|P12|Primary Study|Lost to Follow-up|0
1847919|NCT00196976|6389889|P11|Primary Study|Lost to Follow-up|0
1847920|NCT00196976|6389890|P10|Primary Study|Lost to Follow-up|0
1847921|NCT00196976|6389891|P9|Primary Study|Lost to Follow-up|0
1847922|NCT00196976|6389892|P8|Primary Study|Lost to Follow-up|2
1847923|NCT00196976|6389893|P7|Primary Study|Lost to Follow-up|0
1847924|NCT00196976|6389894|P6|Primary Study|Lost to Follow-up|1
1847925|NCT00196976|6389895|P5|Primary Study|Lost to Follow-up|1
1847926|NCT00196976|6389896|P4|Primary Study|Lost to Follow-up|0
1847927|NCT00196976|6389897|P3|Primary Study|Lost to Follow-up|0
1847928|NCT00196976|6389898|P2|Primary Study|Lost to Follow-up|0
1847929|NCT00196976|6389899|P1|Primary Study|Lost to Follow-up|0
1847930|NCT00196976|6389886|P14|Primary Study|Withdrawal by Subject|0
1847931|NCT00196976|6389887|P13|Primary Study|Withdrawal by Subject|0
1847932|NCT00196976|6389888|P12|Primary Study|Withdrawal by Subject|0
1847933|NCT00196976|6389889|P11|Primary Study|Withdrawal by Subject|0
1847934|NCT00196976|6389890|P10|Primary Study|Withdrawal by Subject|1
1847935|NCT00196976|6389891|P9|Primary Study|Withdrawal by Subject|0
1847936|NCT00196976|6389892|P8|Primary Study|Withdrawal by Subject|0
1847937|NCT00196976|6389893|P7|Primary Study|Withdrawal by Subject|0
1847938|NCT00196976|6389894|P6|Primary Study|Withdrawal by Subject|1
1847939|NCT00196976|6389895|P5|Primary Study|Withdrawal by Subject|2
1847940|NCT00196976|6389896|P4|Primary Study|Withdrawal by Subject|1
1847941|NCT00196976|6389897|P3|Primary Study|Withdrawal by Subject|1
1847942|NCT00196976|6389898|P2|Primary Study|Withdrawal by Subject|0
1847943|NCT00196976|6389899|P1|Primary Study|Withdrawal by Subject|1
1847944|NCT00196976|6389886|P14|Primary Study|Protocol Violation|0
1847945|NCT00196976|6389887|P13|Primary Study|Protocol Violation|0
1847946|NCT00196976|6389888|P12|Primary Study|Protocol Violation|0
1847947|NCT00196976|6389889|P11|Primary Study|Protocol Violation|0
1847948|NCT00196976|6389890|P10|Primary Study|Protocol Violation|0
1847949|NCT00196976|6389891|P9|Primary Study|Protocol Violation|0
1847950|NCT00196976|6389892|P8|Primary Study|Protocol Violation|0
1847951|NCT00196976|6389893|P7|Primary Study|Protocol Violation|0
1847952|NCT00196976|6389894|P6|Primary Study|Protocol Violation|0
1847953|NCT00196976|6389895|P5|Primary Study|Protocol Violation|0
1847954|NCT00196976|6389896|P4|Primary Study|Protocol Violation|0
1847955|NCT00196976|6389897|P3|Primary Study|Protocol Violation|1
1847956|NCT00196976|6389898|P2|Primary Study|Protocol Violation|1
1847957|NCT00196976|6389899|P1|Primary Study|Protocol Violation|0
1847958|NCT00196976|6389886|P14|Primary Study|Migrated from study area|0
1847959|NCT00196976|6389887|P13|Primary Study|Migrated from study area|0
1847960|NCT00196976|6389888|P12|Primary Study|Migrated from study area|0
1847961|NCT00196976|6389889|P11|Primary Study|Migrated from study area|0
1847962|NCT00196976|6389890|P10|Primary Study|Migrated from study area|0
1847963|NCT00196976|6389891|P9|Primary Study|Migrated from study area|0
1847964|NCT00196976|6389892|P8|Primary Study|Migrated from study area|1
1847965|NCT00196976|6389893|P7|Primary Study|Migrated from study area|0
1847966|NCT00196976|6389894|P6|Primary Study|Migrated from study area|0
1847967|NCT00196976|6389895|P5|Primary Study|Migrated from study area|0
1847968|NCT00196976|6389896|P4|Primary Study|Migrated from study area|0
1847969|NCT00196976|6389897|P3|Primary Study|Migrated from study area|0
1847970|NCT00196976|6389898|P2|Primary Study|Migrated from study area|0
1847971|NCT00196976|6389899|P1|Primary Study|Migrated from study area|0
1847972|NCT00196937|6390095|P3|Overall Study|Other|1
1847973|NCT00196937|6390096|P2|Overall Study|Other|1
1847974|NCT00196937|6390097|P1|Overall Study|Other|3
1847975|NCT00196937|6390095|P3|Overall Study|Lost to Follow-up|3
1847976|NCT00196937|6390096|P2|Overall Study|Lost to Follow-up|3
1847977|NCT00196937|6390097|P1|Overall Study|Lost to Follow-up|4
1847978|NCT00196937|6390095|P3|Overall Study|Withdrawal by Subject|2
1847979|NCT00196937|6390096|P2|Overall Study|Withdrawal by Subject|0
1847980|NCT00196937|6390097|P1|Overall Study|Withdrawal by Subject|0
1847981|NCT00196937|6390095|P3|Overall Study|Non-serious adverse event|1
1847982|NCT00196937|6390096|P2|Overall Study|Non-serious adverse event|1
1847983|NCT00196937|6390097|P1|Overall Study|Non-serious adverse event|1
1847984|NCT00196937|6390095|P3|Overall Study|Serious Adverse Event|0
1847985|NCT00196937|6390096|P2|Overall Study|Serious Adverse Event|0
1847986|NCT00196937|6390097|P1|Overall Study|Serious Adverse Event|1
1847987|NCT00196326|6390151|P1|Overall Study|Other|22
1847988|NCT00196326|6390151|P1|Overall Study|Lost to Follow-up|304
1847989|NCT00196326|6390151|P1|Overall Study|Pregnancy|34
1847990|NCT00196326|6390151|P1|Overall Study|Adverse Event|253
1847991|NCT00196326|6390151|P1|Overall Study|Withdrawal by Subject|225
1847992|NCT00196326|6390151|P1|Overall Study|Physician Decision|3
1847993|NCT00196326|6390151|P1|Overall Study|Non-compliance with the protocol|81
1847994|NCT00196326|6390151|P1|Overall Study|Did not meet protocol requirements|64
1847995|NCT00196313|6390159|P2|Overall Study|Lost to Follow-up|2
1847996|NCT00196313|6390160|P1|Overall Study|Lost to Follow-up|2
1847997|NCT00196313|6390159|P2|Overall Study|Subject Pregnant|1
1847998|NCT00196313|6390160|P1|Overall Study|Subject Pregnant|1
1847999|NCT00196313|6390159|P2|Overall Study|Adverse Event|1
1848000|NCT00196313|6390160|P1|Overall Study|Adverse Event|3
1848001|NCT00196313|6390159|P2|Overall Study|Withdrawal by Subject|1
1848002|NCT00196313|6390160|P1|Overall Study|Withdrawal by Subject|3
1848003|NCT00196313|6390159|P2|Overall Study|Protocol Violation|3
1848004|NCT00196313|6390160|P1|Overall Study|Protocol Violation|2
1848005|NCT00196196|6390174|P1|Overall Study|Did not have required condition (hydroce|5
1848006|NCT00196196|6390174|P1|Overall Study|Withdrawal by Subject|2
1848007|NCT00196105|6390182|P3|Overall Study|Lost to Follow-up|7
1848008|NCT00196105|6390183|P2|Overall Study|Lost to Follow-up|5
1848009|NCT00196105|6390184|P1|Overall Study|Lost to Follow-up|4
1848010|NCT00195819|6390204|P2|Open-label|Withdrawal by Subject|5
1848011|NCT00195819|6390205|P1|Open-label|Withdrawal by Subject|0
1848012|NCT00195819|6390204|P2|Open-label|Moved|1
1848013|NCT00195819|6390205|P1|Open-label|Moved|0
1848014|NCT00195819|6390204|P2|Open-label|Protocol Violation|2
1848015|NCT00195819|6390205|P1|Open-label|Protocol Violation|0
1848016|NCT00195819|6390204|P2|Open-label|Pregnancy|1
1848017|NCT00195819|6390205|P1|Open-label|Pregnancy|0
1848018|NCT00195819|6390204|P2|Open-label|Lack of Efficacy|2
1848019|NCT00195819|6390205|P1|Open-label|Lack of Efficacy|0
1848020|NCT00195819|6390204|P2|Open-label|Adverse Event|9
1848021|NCT00195819|6390205|P1|Open-label|Adverse Event|0
1848022|NCT00195819|6390204|P2|Double-Blind|Moved|0
1848023|NCT00195819|6390205|P1|Double-Blind|Moved|1
1848024|NCT00195819|6390204|P2|Double-Blind|Withdrawal by Subject|0
1848025|NCT00195819|6390205|P1|Double-Blind|Withdrawal by Subject|1
1848026|NCT00195715|6390255|P1|Overall Study|Sponsor discretion - trial ended early|1
1848027|NCT00195715|6390255|P1|Overall Study|Sponsor discontinued trial|1
1848028|NCT00195715|6390255|P1|Overall Study|Colonic stricture|1
1848029|NCT00195715|6390255|P1|Overall Study|Ineligible|1
1848030|NCT00195715|6390255|P1|Overall Study|Increased infection rate|1
1848031|NCT00195715|6390255|P1|Overall Study|Planned surgery|2
1848032|NCT00195715|6390255|P1|Overall Study|Use of prohibited medication|2
1848033|NCT00195715|6390255|P1|Overall Study|Subject wants to get pregnant|4
1848034|NCT00195715|6390255|P1|Overall Study|Investigator's decision|2
1848035|NCT00195715|6390255|P1|Overall Study|Administrative reasons|2
1848036|NCT00195715|6390255|P1|Overall Study|Sponsor stopped study|1
1848037|NCT00195715|6390255|P1|Overall Study|Loss of response/no improvement|3
1848038|NCT00195715|6390255|P1|Overall Study|Subject choice|3
1848039|NCT00195715|6390255|P1|Overall Study|Subject started commercial Humira|5
1848040|NCT00195715|6390255|P1|Overall Study|Subject non-compliance|6
1848041|NCT00195715|6390255|P1|Overall Study|Subject moved/relocated|7
1848042|NCT00195715|6390255|P1|Overall Study|Investigative site closure|8
1848043|NCT00195715|6390255|P1|Overall Study|Pregnancy|14
1848044|NCT00195715|6390255|P1|Overall Study|Lack of Efficacy|93
1848045|NCT00195715|6390255|P1|Overall Study|Protocol Violation|13
1848046|NCT00195715|6390255|P1|Overall Study|Lost to Follow-up|27
1848047|NCT00195715|6390255|P1|Overall Study|Withdrawal by Subject|58
1848048|NCT00195715|6390255|P1|Overall Study|Adverse Event|122
1848049|NCT00195676|6390355|P1|Period R - Retreatment 16 Weeks|Other reasons|6
1848050|NCT00195676|6390355|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
1848051|NCT00195676|6390355|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
1848052|NCT00195676|6390355|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
1848053|NCT00195676|6390355|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
1848054|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
1848055|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
1848056|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
1848057|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
1848058|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
1848059|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
1848060|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Death|2
1848061|NCT00195676|6390355|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
1848062|NCT00195676|6390355|P1|Period O - Open-label Treatment|Other reasons|68
1848063|NCT00195676|6390355|P1|Period O - Open-label Treatment|Administrative reasons|2
1848064|NCT00195676|6390355|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
1848065|NCT00195676|6390355|P1|Period O - Open-label Treatment|Protocol Violation|12
1848066|NCT00195676|6390355|P1|Period O - Open-label Treatment|Lost to Follow-up|91
1848067|NCT00195676|6390355|P1|Period O - Open-label Treatment|Lack of Efficacy|198
1848068|NCT00195676|6390355|P1|Period O - Open-label Treatment|Death|6
1848069|NCT00195676|6390355|P1|Period O - Open-label Treatment|Adverse Event|82
1848070|NCT00195663|6390369|P3|Open-Label Extension Period|Administrative reasons|13
1848071|NCT00195663|6390370|P2|Open-Label Extension Period|Administrative reasons|11
1848072|NCT00195663|6390371|P1|Open-Label Extension Period|Administrative reasons|11
1848073|NCT00195663|6390369|P3|Open-Label Extension Period|Lack of Efficacy|12
1848074|NCT00195663|6390370|P2|Open-Label Extension Period|Lack of Efficacy|6
1848075|NCT00195663|6390371|P1|Open-Label Extension Period|Lack of Efficacy|14
1848076|NCT00195663|6390369|P3|Open-Label Extension Period|Withdrawal by Subject|22
1848077|NCT00195663|6390370|P2|Open-Label Extension Period|Withdrawal by Subject|15
1848078|NCT00195663|6390371|P1|Open-Label Extension Period|Withdrawal by Subject|16
1848079|NCT00195663|6390369|P3|Open-Label Extension Period|Death|2
1848080|NCT00195663|6390370|P2|Open-Label Extension Period|Death|2
1848081|NCT00195663|6390371|P1|Open-Label Extension Period|Death|2
1848082|NCT00195663|6390369|P3|Open-Label Extension Period|Protocol Violation|4
1848083|NCT00195663|6390370|P2|Open-Label Extension Period|Protocol Violation|4
1848084|NCT00195663|6390371|P1|Open-Label Extension Period|Protocol Violation|3
1848085|NCT00195663|6390369|P3|Open-Label Extension Period|Recovery|2
1848086|NCT00195663|6390370|P2|Open-Label Extension Period|Recovery|2
1848087|NCT00195663|6390371|P1|Open-Label Extension Period|Recovery|0
1848088|NCT00195663|6390369|P3|Open-Label Extension Period|Lost to Follow-up|6
1848089|NCT00195663|6390370|P2|Open-Label Extension Period|Lost to Follow-up|2
1848090|NCT00195663|6390371|P1|Open-Label Extension Period|Lost to Follow-up|9
1848091|NCT00195663|6390369|P3|Open-Label Extension Period|Adverse Event|36
1848092|NCT00195663|6390370|P2|Open-Label Extension Period|Adverse Event|32
1848093|NCT00195663|6390371|P1|Open-Label Extension Period|Adverse Event|21
1848094|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Administrative reasons|9
1848095|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Administrative reasons|2
1848096|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Administrative reasons|3
1848097|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Recovery|1
1848098|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Recovery|0
1848099|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Recovery|1
1848100|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
1848101|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
1848102|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
1848103|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Protocol Violation|4
1848104|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Protocol Violation|6
1848105|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Protocol Violation|6
1848106|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
1848107|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
1848108|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
1848109|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
1848110|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
1848111|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
1848112|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
1848113|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
1848114|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
1848115|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Death|0
1848116|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Death|2
1848117|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Death|0
1848118|NCT00195663|6390369|P3|2-year Double-blind Treatment Period|Adverse Event|32
1848119|NCT00195663|6390370|P2|2-year Double-blind Treatment Period|Adverse Event|27
1848120|NCT00195663|6390371|P1|2-year Double-blind Treatment Period|Adverse Event|21
1848121|NCT00195650|6390465|P1|Overall Study|Administrative reasons|83
1848122|NCT00195650|6390465|P1|Overall Study|Protocol Violation|15
1848123|NCT00195650|6390465|P1|Overall Study|Death|23
1848124|NCT00195650|6390465|P1|Overall Study|Lost to Follow-up|44
1848125|NCT00195650|6390465|P1|Overall Study|Withdrawal by Subject|67
1848126|NCT00195650|6390465|P1|Overall Study|Lack of Efficacy|99
1848127|NCT00195650|6390465|P1|Overall Study|Adverse Event|194
1848128|NCT00195507|6390490|P2|Overall Study|Protocol Deviation|3
1848129|NCT00195507|6390491|P1|Overall Study|Protocol Deviation|6
1848130|NCT00195507|6390490|P2|Overall Study|Withdrawal by Subject|23
1848131|NCT00195507|6390491|P1|Overall Study|Withdrawal by Subject|16
1848132|NCT00195507|6390490|P2|Overall Study|Lack of Efficacy|67
1848133|NCT00195507|6390491|P1|Overall Study|Lack of Efficacy|40
1848134|NCT00195507|6390490|P2|Overall Study|Protocol Violation|4
1848135|NCT00195507|6390491|P1|Overall Study|Protocol Violation|5
1848136|NCT00195507|6390490|P2|Overall Study|Lost to Follow-up|2
1848137|NCT00195507|6390491|P1|Overall Study|Lost to Follow-up|3
1848138|NCT00195507|6390490|P2|Overall Study|Physician Decision|2
1848139|NCT00195507|6390491|P1|Overall Study|Physician Decision|1
1848140|NCT00195507|6390490|P2|Overall Study|Failed to Return|3
1848141|NCT00195507|6390491|P1|Overall Study|Failed to Return|4
1848142|NCT00195507|6390490|P2|Overall Study|Death|1
1848143|NCT00195507|6390491|P1|Overall Study|Death|0
1848144|NCT00195507|6390490|P2|Overall Study|Adverse Event|13
1848145|NCT00195507|6390491|P1|Overall Study|Adverse Event|24
1848146|NCT00195494|6390505|P6|Year 2|System toxicity|0
1848147|NCT00195494|6390506|P5|Year 2|System toxicity|0
1848148|NCT00195494|6390507|P4|Year 2|System toxicity|1
1848149|NCT00195494|6390508|P3|Year 2|System toxicity|0
1848150|NCT00195494|6390509|P2|Year 2|System toxicity|0
1848151|NCT00195494|6390510|P1|Year 2|System toxicity|0
1848152|NCT00195494|6390505|P6|Year 2|Withdrawal by Subject|0
1848153|NCT00195494|6390506|P5|Year 2|Withdrawal by Subject|0
1848154|NCT00195494|6390507|P4|Year 2|Withdrawal by Subject|3
1848155|NCT00195494|6390508|P3|Year 2|Withdrawal by Subject|4
1848156|NCT00195494|6390509|P2|Year 2|Withdrawal by Subject|5
1848157|NCT00195494|6390510|P1|Year 2|Withdrawal by Subject|1
1848158|NCT00195494|6390505|P6|Year 2|Physician Decision|0
1848159|NCT00195494|6390506|P5|Year 2|Physician Decision|0
1848160|NCT00195494|6390507|P4|Year 2|Physician Decision|0
1848161|NCT00195494|6390508|P3|Year 2|Physician Decision|0
1848162|NCT00195494|6390509|P2|Year 2|Physician Decision|1
1848163|NCT00195494|6390510|P1|Year 2|Physician Decision|1
1848164|NCT00195494|6390505|P6|Year 2|Protocol deviation|0
1848165|NCT00195494|6390506|P5|Year 2|Protocol deviation|0
1848166|NCT00195494|6390507|P4|Year 2|Protocol deviation|0
1848167|NCT00195494|6390508|P3|Year 2|Protocol deviation|0
1848168|NCT00195494|6390509|P2|Year 2|Protocol deviation|1
1848169|NCT00195494|6390510|P1|Year 2|Protocol deviation|0
1848170|NCT00195494|6390505|P6|Year 2|Missed >4 consecutive doses|0
1848171|NCT00195494|6390506|P5|Year 2|Missed >4 consecutive doses|0
1848172|NCT00195494|6390507|P4|Year 2|Missed >4 consecutive doses|0
1848173|NCT00195494|6390508|P3|Year 2|Missed >4 consecutive doses|1
1848174|NCT00195494|6390509|P2|Year 2|Missed >4 consecutive doses|1
1848175|NCT00195494|6390510|P1|Year 2|Missed >4 consecutive doses|1
1848176|NCT00195494|6390505|P6|Year 2|Lost to Follow-up|0
1848177|NCT00195494|6390506|P5|Year 2|Lost to Follow-up|0
1848178|NCT00195494|6390507|P4|Year 2|Lost to Follow-up|1
1848179|NCT00195494|6390508|P3|Year 2|Lost to Follow-up|1
1848180|NCT00195494|6390509|P2|Year 2|Lost to Follow-up|0
1848181|NCT00195494|6390510|P1|Year 2|Lost to Follow-up|0
1848182|NCT00195494|6390505|P6|Year 2|Compliance|0
1848183|NCT00195494|6390506|P5|Year 2|Compliance|0
1848184|NCT00195494|6390507|P4|Year 2|Compliance|2
1848185|NCT00195494|6390508|P3|Year 2|Compliance|0
1848186|NCT00195494|6390509|P2|Year 2|Compliance|0
1848187|NCT00195494|6390510|P1|Year 2|Compliance|1
1848188|NCT00195494|6390505|P6|Year 2|Lack of Efficacy|0
1848189|NCT00195494|6390506|P5|Year 2|Lack of Efficacy|0
1848190|NCT00195494|6390507|P4|Year 2|Lack of Efficacy|7
1848191|NCT00195494|6390508|P3|Year 2|Lack of Efficacy|7
1848192|NCT00195494|6390509|P2|Year 2|Lack of Efficacy|1
1848193|NCT00195494|6390510|P1|Year 2|Lack of Efficacy|0
1848194|NCT00195494|6390505|P6|Year 2|Adverse Event|0
1848195|NCT00195494|6390506|P5|Year 2|Adverse Event|0
1848196|NCT00195494|6390507|P4|Year 2|Adverse Event|9
1848197|NCT00195494|6390508|P3|Year 2|Adverse Event|5
1848198|NCT00195494|6390509|P2|Year 2|Adverse Event|7
1848199|NCT00195494|6390510|P1|Year 2|Adverse Event|3
1848200|NCT00195494|6390505|P6|Year 1|Protocol Violation|1
1848201|NCT00195494|6390506|P5|Year 1|Protocol Violation|1
1848202|NCT00195494|6390507|P4|Year 1|Protocol Violation|0
1848203|NCT00195494|6390508|P3|Year 1|Protocol Violation|0
1848204|NCT00195494|6390509|P2|Year 1|Protocol Violation|0
1848205|NCT00195494|6390510|P1|Year 1|Protocol Violation|0
1848206|NCT00195494|6390505|P6|Year 1|Withdrawal by Subject|9
1848207|NCT00195494|6390506|P5|Year 1|Withdrawal by Subject|8
1848208|NCT00195494|6390507|P4|Year 1|Withdrawal by Subject|0
1848209|NCT00195494|6390508|P3|Year 1|Withdrawal by Subject|0
1848210|NCT00195494|6390509|P2|Year 1|Withdrawal by Subject|0
1848211|NCT00195494|6390510|P1|Year 1|Withdrawal by Subject|0
1848212|NCT00195494|6390505|P6|Year 1|Physician Decision|0
1848213|NCT00195494|6390506|P5|Year 1|Physician Decision|1
1848214|NCT00195494|6390507|P4|Year 1|Physician Decision|0
1848215|NCT00195494|6390508|P3|Year 1|Physician Decision|0
1848216|NCT00195494|6390509|P2|Year 1|Physician Decision|0
1848217|NCT00195494|6390510|P1|Year 1|Physician Decision|0
1848218|NCT00195494|6390505|P6|Year 1|Protocol deviation|3
1848219|NCT00195494|6390506|P5|Year 1|Protocol deviation|2
1848220|NCT00195494|6390507|P4|Year 1|Protocol deviation|0
1848221|NCT00195494|6390508|P3|Year 1|Protocol deviation|0
1848222|NCT00195494|6390509|P2|Year 1|Protocol deviation|0
1848223|NCT00195494|6390510|P1|Year 1|Protocol deviation|0
1848224|NCT00195494|6390505|P6|Year 1|Missed >4 consecutive doses|2
1848225|NCT00195494|6390506|P5|Year 1|Missed >4 consecutive doses|3
1848226|NCT00195494|6390507|P4|Year 1|Missed >4 consecutive doses|0
1848227|NCT00195494|6390508|P3|Year 1|Missed >4 consecutive doses|0
1848228|NCT00195494|6390509|P2|Year 1|Missed >4 consecutive doses|0
1848229|NCT00195494|6390510|P1|Year 1|Missed >4 consecutive doses|0
1848230|NCT00195494|6390505|P6|Year 1|Lost to Follow-up|0
1848231|NCT00195494|6390506|P5|Year 1|Lost to Follow-up|1
1848232|NCT00195494|6390507|P4|Year 1|Lost to Follow-up|0
1848233|NCT00195494|6390508|P3|Year 1|Lost to Follow-up|0
1848234|NCT00195494|6390509|P2|Year 1|Lost to Follow-up|0
1848235|NCT00195494|6390510|P1|Year 1|Lost to Follow-up|0
1848236|NCT00195494|6390505|P6|Year 1|Compliance|1
1848237|NCT00195494|6390506|P5|Year 1|Compliance|5
1848238|NCT00195494|6390507|P4|Year 1|Compliance|0
1848239|NCT00195494|6390508|P3|Year 1|Compliance|0
1848240|NCT00195494|6390509|P2|Year 1|Compliance|0
1848241|NCT00195494|6390510|P1|Year 1|Compliance|0
1848242|NCT00195494|6390505|P6|Year 1|Lack of Efficacy|9
1848243|NCT00195494|6390506|P5|Year 1|Lack of Efficacy|24
1848244|NCT00195494|6390507|P4|Year 1|Lack of Efficacy|0
1848245|NCT00195494|6390508|P3|Year 1|Lack of Efficacy|0
1848246|NCT00195494|6390509|P2|Year 1|Lack of Efficacy|0
1848247|NCT00195494|6390510|P1|Year 1|Lack of Efficacy|0
1848248|NCT00195494|6390505|P6|Year 1|System Toxicity|1
1848249|NCT00195494|6390506|P5|Year 1|System Toxicity|0
1848250|NCT00195494|6390507|P4|Year 1|System Toxicity|0
1848251|NCT00195494|6390508|P3|Year 1|System Toxicity|0
1848252|NCT00195494|6390509|P2|Year 1|System Toxicity|0
1848253|NCT00195494|6390510|P1|Year 1|System Toxicity|0
1848254|NCT00195494|6390505|P6|Year 1|Adverse Event|27
1848255|NCT00195494|6390506|P5|Year 1|Adverse Event|34
1848256|NCT00195494|6390507|P4|Year 1|Adverse Event|0
1848257|NCT00195494|6390508|P3|Year 1|Adverse Event|0
1848258|NCT00195494|6390509|P2|Year 1|Adverse Event|0
1848259|NCT00195494|6390510|P1|Year 1|Adverse Event|0
1848260|NCT00195442|6390528|P1|Overall Study|Other|14
1848261|NCT00195442|6390528|P1|Overall Study|Poor cooperation|2
1848262|NCT00195442|6390528|P1|Overall Study|No reason specified|4
1848263|NCT00195442|6390528|P1|Overall Study|Death|7
1848264|NCT00195442|6390528|P1|Overall Study|Intermittent product shortage|21
1848265|NCT00195442|6390528|P1|Overall Study|Switch to other Factor VIII preparation|23
1848266|NCT00195442|6390528|P1|Overall Study|Lost to Follow-up|27
1848267|NCT00195442|6390528|P1|Overall Study|Less than expected therapeutic effect|38
1848268|NCT00195429|6390547|P2|Overall Study|Lost to Follow-up|0
1848269|NCT00195429|6390548|P1|Overall Study|Lost to Follow-up|1
1848270|NCT00195429|6390547|P2|Overall Study|Lack of Efficacy|1
1848271|NCT00195429|6390548|P1|Overall Study|Lack of Efficacy|2
1848272|NCT00195429|6390547|P2|Overall Study|Adverse Event|4
1848273|NCT00195429|6390548|P1|Overall Study|Adverse Event|2
1848274|NCT00195351|6390564|P2|Overall Study|Lack of Efficacy|1
1848275|NCT00195351|6390565|P1|Overall Study|Lack of Efficacy|0
1848276|NCT00195351|6390564|P2|Overall Study|Death|1
1848277|NCT00195351|6390565|P1|Overall Study|Death|3
1848278|NCT00195351|6390564|P2|Overall Study|Protocol Deviation|2
1848279|NCT00195351|6390565|P1|Overall Study|Protocol Deviation|3
1848280|NCT00195351|6390564|P2|Overall Study|Withdrawal by Subject|3
1848281|NCT00195351|6390565|P1|Overall Study|Withdrawal by Subject|6
1848282|NCT00195351|6390564|P2|Overall Study|Lost to Follow-up|9
1848283|NCT00195351|6390565|P1|Overall Study|Lost to Follow-up|9
1848284|NCT00195338|6390575|P1|Overall Study|Early closure of the site|4
1848285|NCT00195338|6390575|P1|Overall Study|Lack of Efficacy|1
1848286|NCT00195338|6390575|P1|Overall Study|Adverse Event|5
1848287|NCT00195338|6390575|P1|Overall Study|Lost to Follow-up|2
1848288|NCT00195273|6390585|P2|Overall Study|Procedural complications|3
1848289|NCT00195273|6390586|P1|Overall Study|Procedural complications|9
1848290|NCT00195273|6390585|P2|Overall Study|Lack of Efficacy|1
1848291|NCT00195273|6390586|P1|Overall Study|Lack of Efficacy|3
1848292|NCT00195273|6390585|P2|Overall Study|Protocol deviation|1
1848293|NCT00195273|6390586|P1|Overall Study|Protocol deviation|0
1848294|NCT00195273|6390585|P2|Overall Study|Adverse Event|9
1848295|NCT00195273|6390586|P1|Overall Study|Adverse Event|9
1848296|NCT00195260|6390600|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
1848297|NCT00195260|6390601|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
1848298|NCT00195260|6390602|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
1848299|NCT00195260|6390603|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848300|NCT00195260|6390604|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848301|NCT00195260|6390605|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848302|NCT00195260|6390606|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848303|NCT00195260|6390607|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848304|NCT00195260|6390608|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848305|NCT00195260|6390609|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848306|NCT00195260|6390610|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
1848307|NCT00195260|6390600|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
1848308|NCT00195260|6390601|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
1848309|NCT00195260|6390602|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
1848310|NCT00195260|6390603|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848311|NCT00195260|6390604|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848312|NCT00195260|6390605|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848313|NCT00195260|6390606|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848314|NCT00195260|6390607|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848315|NCT00195260|6390608|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848316|NCT00195260|6390609|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848317|NCT00195260|6390610|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
1848318|NCT00195260|6390600|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
1848319|NCT00195260|6390601|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
1848320|NCT00195260|6390602|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
1848321|NCT00195260|6390603|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848322|NCT00195260|6390604|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848323|NCT00195260|6390605|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848324|NCT00195260|6390606|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848325|NCT00195260|6390607|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848326|NCT00195260|6390608|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848327|NCT00195260|6390609|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848328|NCT00195260|6390610|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
1848329|NCT00195260|6390600|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
1848330|NCT00195260|6390601|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
1848331|NCT00195260|6390602|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
1848332|NCT00195260|6390603|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848333|NCT00195260|6390604|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848334|NCT00195260|6390605|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848335|NCT00195260|6390606|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848336|NCT00195260|6390607|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848337|NCT00195260|6390608|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848338|NCT00195260|6390609|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848339|NCT00195260|6390610|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
1848340|NCT00195260|6390600|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
1848341|NCT00195260|6390601|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
1848342|NCT00195260|6390602|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
1848343|NCT00195260|6390603|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
1848344|NCT00195260|6390604|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
1848345|NCT00195260|6390605|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
1848346|NCT00195260|6390606|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
1848347|NCT00195260|6390607|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
1848348|NCT00195260|6390608|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
1848349|NCT00195260|6390609|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
1848350|NCT00195260|6390610|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
1848351|NCT00195260|6390600|P11|Part 1: Dose Escalation|Disease Progression|0
1848352|NCT00195260|6390601|P10|Part 1: Dose Escalation|Disease Progression|0
1848353|NCT00195260|6390602|P9|Part 1: Dose Escalation|Disease Progression|0
1848354|NCT00195260|6390603|P8|Part 1: Dose Escalation|Disease Progression|4
1848355|NCT00195260|6390604|P7|Part 1: Dose Escalation|Disease Progression|7
1848356|NCT00195260|6390605|P6|Part 1: Dose Escalation|Disease Progression|6
1848357|NCT00195260|6390606|P5|Part 1: Dose Escalation|Disease Progression|4
1848358|NCT00195260|6390607|P4|Part 1: Dose Escalation|Disease Progression|6
1848359|NCT00195260|6390608|P3|Part 1: Dose Escalation|Disease Progression|5
1848360|NCT00195260|6390609|P2|Part 1: Dose Escalation|Disease Progression|2
1848361|NCT00195260|6390610|P1|Part 1: Dose Escalation|Disease Progression|3
1848362|NCT00195260|6390600|P11|Part 1: Dose Escalation|Death|0
1848363|NCT00195260|6390601|P10|Part 1: Dose Escalation|Death|0
1848364|NCT00195260|6390602|P9|Part 1: Dose Escalation|Death|0
1848365|NCT00195260|6390603|P8|Part 1: Dose Escalation|Death|1
1848366|NCT00195260|6390604|P7|Part 1: Dose Escalation|Death|0
1848367|NCT00195260|6390605|P6|Part 1: Dose Escalation|Death|0
1848368|NCT00195260|6390606|P5|Part 1: Dose Escalation|Death|0
1848369|NCT00195260|6390607|P4|Part 1: Dose Escalation|Death|0
1848370|NCT00195260|6390608|P3|Part 1: Dose Escalation|Death|0
1848371|NCT00195260|6390609|P2|Part 1: Dose Escalation|Death|0
1848372|NCT00195260|6390610|P1|Part 1: Dose Escalation|Death|0
1848373|NCT00195260|6390600|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
1848374|NCT00195260|6390601|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
1848375|NCT00195260|6390602|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
1848376|NCT00195260|6390603|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
1848377|NCT00195260|6390604|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
1848378|NCT00195260|6390605|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
1848379|NCT00195260|6390606|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
1848380|NCT00195260|6390607|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
1848381|NCT00195260|6390608|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
1848382|NCT00195260|6390609|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
1848383|NCT00195260|6390610|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
1848384|NCT00195260|6390600|P11|Part 1: Dose Escalation|Adverse Event|0
1848385|NCT00195260|6390601|P10|Part 1: Dose Escalation|Adverse Event|0
1848386|NCT00195260|6390602|P9|Part 1: Dose Escalation|Adverse Event|0
1848387|NCT00195260|6390603|P8|Part 1: Dose Escalation|Adverse Event|0
1848388|NCT00195260|6390604|P7|Part 1: Dose Escalation|Adverse Event|3
1848389|NCT00195260|6390605|P6|Part 1: Dose Escalation|Adverse Event|0
1848390|NCT00195260|6390606|P5|Part 1: Dose Escalation|Adverse Event|1
1848391|NCT00195260|6390607|P4|Part 1: Dose Escalation|Adverse Event|1
1848392|NCT00195260|6390608|P3|Part 1: Dose Escalation|Adverse Event|0
1848393|NCT00195260|6390609|P2|Part 1: Dose Escalation|Adverse Event|1
1848394|NCT00195260|6390610|P1|Part 1: Dose Escalation|Adverse Event|0
1848395|NCT00194987|6390778|P2|Overall Study|Withdrawal by Subject|3
1848396|NCT00194987|6390779|P1|Overall Study|Withdrawal by Subject|0
1848397|NCT00194792|6390812|P1|Overall Study|Withdrawal by Subject|1
1848398|NCT00194675|6390836|P2|Overall Study|Death|0
1848399|NCT00194675|6390837|P1|Overall Study|Death|1
1848400|NCT00194675|6390836|P2|Overall Study|Protocol Violation|0
1848401|NCT00194675|6390837|P1|Overall Study|Protocol Violation|1
1848402|NCT00194675|6390836|P2|Overall Study|"withdrew due to edgy feeling"|0
1848403|NCT00194675|6390837|P1|Overall Study|"withdrew due to edgy feeling"|1
1848404|NCT00194675|6390836|P2|Overall Study|lack of interest|1
1848405|NCT00194675|6390837|P1|Overall Study|lack of interest|1
1848406|NCT00194675|6390836|P2|Overall Study|Lost to Follow-up|1
1848407|NCT00194675|6390837|P1|Overall Study|Lost to Follow-up|1
1848408|NCT00194077|6390912|P2|Overall Study|Withdrawal by Subject|1
1848409|NCT00194077|6390913|P1|Overall Study|Withdrawal by Subject|1
1848410|NCT00194077|6390912|P2|Overall Study|Study nonadherence|0
1848411|NCT00194077|6390913|P1|Overall Study|Study nonadherence|1
1848412|NCT00194077|6390912|P2|Overall Study|Lack of Efficacy|29
1848413|NCT00194077|6390913|P1|Overall Study|Lack of Efficacy|22
1848414|NCT00194025|6390919|P1|Overall Study|non-adherence with study medication|4
1848415|NCT00194025|6390919|P1|Overall Study|Adverse Event|1
1848416|NCT00194012|6390934|P2|Open Label Extension (OLE)|Lack of Efficacy|0
1848417|NCT00194012|6390935|P1|Open Label Extension (OLE)|Lack of Efficacy|1
1848418|NCT00194012|6390934|P2|Open Label Extension (OLE)|Lost to Follow-up|5
1848419|NCT00194012|6390935|P1|Open Label Extension (OLE)|Lost to Follow-up|3
1848420|NCT00194012|6390934|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
1848421|NCT00194012|6390935|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
1848422|NCT00194012|6390934|P2|Open Label Extension (OLE)|Weight Gain|0
1848423|NCT00194012|6390935|P1|Open Label Extension (OLE)|Weight Gain|1
1848424|NCT00194012|6390934|P2|Randomized Phase|Oral/nasal twitching|1
1848425|NCT00194012|6390935|P1|Randomized Phase|Oral/nasal twitching|0
1848426|NCT00194012|6390934|P2|Randomized Phase|Emesis and enuresis|1
1848427|NCT00194012|6390935|P1|Randomized Phase|Emesis and enuresis|0
1848428|NCT00194012|6390934|P2|Randomized Phase|Participant reported having a rash|0
1848429|NCT00194012|6390935|P1|Randomized Phase|Participant reported having a rash|1
1848430|NCT00194012|6390934|P2|Randomized Phase|Adverse Event|1
1848431|NCT00194012|6390935|P1|Randomized Phase|Adverse Event|2
1848432|NCT00194012|6390934|P2|Randomized Phase|Withdrawal by Subject|3
1848433|NCT00194012|6390935|P1|Randomized Phase|Withdrawal by Subject|3
1848434|NCT00194012|6390934|P2|Randomized Phase|Study nonadherence|1
1848435|NCT00194012|6390935|P1|Randomized Phase|Study nonadherence|2
1848436|NCT00194012|6390934|P2|Randomized Phase|Lack of Efficacy|18
1848437|NCT00194012|6390935|P1|Randomized Phase|Lack of Efficacy|8
1848438|NCT00193609|6390971|P1|Overall Study|Adverse Event|2
1848439|NCT00193609|6390971|P1|Overall Study|Lack of Efficacy|2
1848440|NCT00193479|6390998|P1|Induction Chemotherapy|Disease Progression|1
1848441|NCT00193479|6390998|P1|Induction Chemotherapy|Adverse Event|2
1848442|NCT00193206|6391039|P1|Postoperative Therapy|Protocol Violation|1
1848443|NCT00193206|6391039|P1|Postoperative Therapy|Lack of Efficacy|1
1848444|NCT00193206|6391039|P1|Postoperative Therapy|Intercurrent Illness|2
1848445|NCT00193206|6391039|P1|Postoperative Therapy|Physician Decision|3
1848446|NCT00193206|6391039|P1|Postoperative Therapy|Withdrawal by Subject|7
1848447|NCT00193206|6391039|P1|Preoperative Therapy|False Positive Pregnancy Test|1
1848448|NCT00193206|6391039|P1|Preoperative Therapy|Withdrawal by Subject|2
1848449|NCT00193206|6391039|P1|Preoperative Therapy|Adverse Event|2
1848450|NCT00193206|6391039|P1|Preoperative Therapy|Lack of Efficacy|2
1848451|NCT00193180|6391043|P1|Overall Study|Protocol Violation|1
1848452|NCT00193180|6391043|P1|Overall Study|Adverse Event|8
1848453|NCT00193180|6391043|P1|Overall Study|Lack of Efficacy|1
1848454|NCT00193063|6391058|P1|Overall Study|Adverse Event|1
1848455|NCT00193063|6391058|P1|Overall Study|Lack of Efficacy|3
1848456|NCT00193050|6391064|P1|Adjuvant|Lack of Efficacy|2
1848457|NCT00193050|6391064|P1|Adjuvant|Intercurrent Hospitalization|3
1848458|NCT00193050|6391064|P1|Adjuvant|Physician Decision|5
1848459|NCT00193050|6391064|P1|Neoadjuvant Treatment|Adverse Event|2
1848460|NCT00193050|6391064|P1|Neoadjuvant Treatment|Physician Decision|2
1848461|NCT00193050|6391064|P1|Neoadjuvant Treatment|Intercurrent Illness|3
1848462|NCT00193050|6391064|P1|Neoadjuvant Treatment|Lack of Efficacy|2
1848463|NCT00192647|6391081|P2|Overall Study|Other/Administrative|3
1848464|NCT00192647|6391082|P1|Overall Study|Other/Administrative|5
1848465|NCT00192647|6391081|P2|Overall Study|Failure to Return|13
1848466|NCT00192647|6391082|P1|Overall Study|Failure to Return|11
1848467|NCT00192647|6391081|P2|Overall Study|Refused Treatment/Did not Cooperate|8
1848468|NCT00192647|6391082|P1|Overall Study|Refused Treatment/Did not Cooperate|10
1848469|NCT00192647|6391081|P2|Overall Study|Protocol Violation|1
1848470|NCT00192647|6391082|P1|Overall Study|Protocol Violation|3
1848471|NCT00192647|6391081|P2|Overall Study|Entry Criteria Violation|6
1848472|NCT00192647|6391082|P1|Overall Study|Entry Criteria Violation|6
1848473|NCT00192647|6391081|P2|Overall Study|Insufficient Therapeutic Response|83
1848474|NCT00192647|6391082|P1|Overall Study|Insufficient Therapeutic Response|53
1848475|NCT00192647|6391081|P2|Overall Study|Laboratory Test Abnormality|2
1848476|NCT00192647|6391082|P1|Overall Study|Laboratory Test Abnormality|4
1848477|NCT00192647|6391081|P2|Overall Study|Adverse Event|29
1848478|NCT00192647|6391082|P1|Overall Study|Adverse Event|35
1848479|NCT00192647|6391081|P2|Overall Study|Death|1
1848480|NCT00192647|6391082|P1|Overall Study|Death|1
1848481|NCT00192296|6391102|P4|Overall Study|Withdrawal by Subject|0
1848482|NCT00192296|6391103|P3|Overall Study|Withdrawal by Subject|0
1848483|NCT00192296|6391104|P2|Overall Study|Withdrawal by Subject|1
1848484|NCT00192296|6391105|P1|Overall Study|Withdrawal by Subject|0
1848485|NCT00192075|6391161|P2|Overall Study|Other|2
1848486|NCT00192075|6391162|P1|Overall Study|Other|5
1848487|NCT00192075|6391161|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
1848488|NCT00192075|6391162|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
1848489|NCT00192075|6391161|P2|Overall Study|Patient Non-Compliance|1
1848490|NCT00192075|6391162|P1|Overall Study|Patient Non-Compliance|0
1848491|NCT00192075|6391161|P2|Overall Study|Withdrawal by Subject|5
1848492|NCT00192075|6391162|P1|Overall Study|Withdrawal by Subject|5
1848493|NCT00192075|6391161|P2|Overall Study|Physician Decision|0
1848494|NCT00192075|6391162|P1|Overall Study|Physician Decision|3
1848495|NCT00192075|6391161|P2|Overall Study|Lack of Efficacy|0
1848496|NCT00192075|6391162|P1|Overall Study|Lack of Efficacy|0
1848497|NCT00192075|6391161|P2|Overall Study|Death|1
1848498|NCT00192075|6391162|P1|Overall Study|Death|0
1848499|NCT00192075|6391161|P2|Overall Study|Adverse Event|3
1848500|NCT00192075|6391162|P1|Overall Study|Adverse Event|1
1848501|NCT00192075|6391161|P2|Overall Study|Disease Progression|6
1848502|NCT00192075|6391162|P1|Overall Study|Disease Progression|23
1848503|NCT00192036|6391187|P1|Overall Study|Unknown or Not Specified|5
1848504|NCT00192036|6391187|P1|Overall Study|Death|1
1848505|NCT00192036|6391187|P1|Overall Study|Clinical Disease Progression|1
1848506|NCT00192036|6391187|P1|Overall Study|Objective Tumor Progression|4
1848507|NCT00192036|6391187|P1|Overall Study|Patient/Physician Perception|1
1848508|NCT00192036|6391187|P1|Overall Study|Adverse Event|6
1848509|NCT00192036|6391187|P1|Overall Study|Protocol Violation|3
1848510|NCT00192023|6391197|P2|Period IV - Optional Open-Label|Physician Decision|0
1848511|NCT00192023|6391198|P1|Period IV - Optional Open-Label|Physician Decision|9
1848512|NCT00192023|6391197|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
1848513|NCT00192023|6391198|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
1848514|NCT00192023|6391197|P2|Period IV - Optional Open-Label|Protocol Violation|0
1848515|NCT00192023|6391198|P1|Period IV - Optional Open-Label|Protocol Violation|1
1848516|NCT00192023|6391197|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
1848517|NCT00192023|6391198|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
1848518|NCT00192023|6391197|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
1848519|NCT00192023|6391198|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
1848520|NCT00192023|6391197|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
1848521|NCT00192023|6391198|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
1848522|NCT00192023|6391197|P2|Period IV - Optional Open-Label|Adverse Event|0
1848523|NCT00192023|6391198|P1|Period IV - Optional Open-Label|Adverse Event|6
1848524|NCT00192023|6391197|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
1848525|NCT00192023|6391198|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
1848526|NCT00192023|6391197|P2|Period III - Double-Blind|Physician Decision|0
1848527|NCT00192023|6391198|P1|Period III - Double-Blind|Physician Decision|2
1848528|NCT00192023|6391197|P2|Period III - Double-Blind|Adverse Event|0
1848529|NCT00192023|6391198|P1|Period III - Double-Blind|Adverse Event|3
1848530|NCT00191984|6391220|P1|Overall Study|Physician Decision|4
1848531|NCT00191984|6391220|P1|Overall Study|Withdrawal by Subject|7
1848532|NCT00191984|6391220|P1|Overall Study|Entry Criteria Exclusion|1
1848533|NCT00191984|6391220|P1|Overall Study|Death|2
1848534|NCT00191984|6391220|P1|Overall Study|Adverse Event|4
1848535|NCT00191984|6391220|P1|Overall Study|Disease Progression|21
1848536|NCT00191945|6391230|P2|Double-Blind Acute Treatment|Physician Decision|2
1848537|NCT00191945|6391231|P1|Double-Blind Acute Treatment|Physician Decision|0
1848538|NCT00191945|6391230|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
1848539|NCT00191945|6391231|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
1848540|NCT00191945|6391230|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
1848541|NCT00191945|6391231|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
1848542|NCT00191945|6391230|P2|Double-Blind Acute Treatment|Parent's Decision|0
1848543|NCT00191945|6391231|P1|Double-Blind Acute Treatment|Parent's Decision|3
1848544|NCT00191906|6391267|P4|Study Period III|Lack of Efficacy|0
1848545|NCT00191906|6391268|P3|Study Period III|Lack of Efficacy|0
1848546|NCT00191906|6391269|P2|Study Period III|Lack of Efficacy|3
1848547|NCT00191906|6391270|P1|Study Period III|Lack of Efficacy|3
1848548|NCT00191906|6391267|P4|Study Period III|Parent/Caregiver Decision|0
1848549|NCT00191906|6391268|P3|Study Period III|Parent/Caregiver Decision|0
1848550|NCT00191906|6391269|P2|Study Period III|Parent/Caregiver Decision|0
1848551|NCT00191906|6391270|P1|Study Period III|Parent/Caregiver Decision|1
1848552|NCT00191906|6391267|P4|Study Period III|Lost to Follow-up|0
1848553|NCT00191906|6391268|P3|Study Period III|Lost to Follow-up|0
1848554|NCT00191906|6391269|P2|Study Period III|Lost to Follow-up|1
1848555|NCT00191906|6391270|P1|Study Period III|Lost to Follow-up|0
1848556|NCT00191906|6391267|P4|Study Period III|Adverse Event|0
1848557|NCT00191906|6391268|P3|Study Period III|Adverse Event|0
1848558|NCT00191906|6391269|P2|Study Period III|Adverse Event|0
1848559|NCT00191906|6391270|P1|Study Period III|Adverse Event|1
1848560|NCT00191906|6391267|P4|Study Period II|Entry Criteria Exclusion|0
1848561|NCT00191906|6391268|P3|Study Period II|Entry Criteria Exclusion|1
1848562|NCT00191906|6391269|P2|Study Period II|Entry Criteria Exclusion|0
1848563|NCT00191906|6391270|P1|Study Period II|Entry Criteria Exclusion|0
1848564|NCT00191906|6391267|P4|Study Period II|Parent/Caregiver Decision|0
1848565|NCT00191906|6391268|P3|Study Period II|Parent/Caregiver Decision|0
1848566|NCT00191906|6391269|P2|Study Period II|Parent/Caregiver Decision|1
1848567|NCT00191906|6391270|P1|Study Period II|Parent/Caregiver Decision|0
1848568|NCT00191906|6391267|P4|Study Period II|Withdrawal by Subject|0
1848569|NCT00191906|6391268|P3|Study Period II|Withdrawal by Subject|0
1848570|NCT00191906|6391269|P2|Study Period II|Withdrawal by Subject|3
1848571|NCT00191906|6391270|P1|Study Period II|Withdrawal by Subject|0
1848572|NCT00191906|6391267|P4|Study Period II|Adverse Event|0
1848573|NCT00191906|6391268|P3|Study Period II|Adverse Event|0
1848574|NCT00191906|6391269|P2|Study Period II|Adverse Event|1
1848575|NCT00191906|6391270|P1|Study Period II|Adverse Event|0
1848576|NCT00191854|6391313|P3|Overall Study|Screen Failure|1
1848577|NCT00191854|6391314|P2|Overall Study|Screen Failure|0
1848578|NCT00191854|6391315|P1|Overall Study|Screen Failure|0
1848579|NCT00191854|6391313|P3|Overall Study|Sponsor Decision|1
1848580|NCT00191854|6391314|P2|Overall Study|Sponsor Decision|0
1848581|NCT00191854|6391315|P1|Overall Study|Sponsor Decision|0
1848582|NCT00191854|6391313|P3|Overall Study|Withdrawal by Subject|3
1848583|NCT00191854|6391314|P2|Overall Study|Withdrawal by Subject|2
1848584|NCT00191854|6391315|P1|Overall Study|Withdrawal by Subject|4
1848585|NCT00191854|6391313|P3|Overall Study|Lost to Follow-up|5
1848586|NCT00191854|6391314|P2|Overall Study|Lost to Follow-up|5
1848587|NCT00191854|6391315|P1|Overall Study|Lost to Follow-up|7
1848588|NCT00191854|6391313|P3|Overall Study|Death|29
1848589|NCT00191854|6391314|P2|Overall Study|Death|23
1848590|NCT00191854|6391315|P1|Overall Study|Death|26
1848591|NCT00191815|6391335|P1|Overall Study|Withdrawal by Subject|7
1848592|NCT00191815|6391335|P1|Overall Study|Physician Decision|2
1848593|NCT00191815|6391335|P1|Overall Study|Protocol Violation|3
1848594|NCT00191815|6391335|P1|Overall Study|Death|2
1848595|NCT00191815|6391335|P1|Overall Study|Disease progression or relapse|24
1848596|NCT00191815|6391335|P1|Overall Study|Adverse Event|2
1848597|NCT00191789|6391347|P1|Overall Study|Death - Not Study-Drug Related|1
1848598|NCT00191789|6391347|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
1848599|NCT00191789|6391347|P1|Overall Study|Death - Possibly Study Drug Related|4
1848600|NCT00191789|6391347|P1|Overall Study|Withdrawal by Subject|4
1848601|NCT00191789|6391347|P1|Overall Study|Patient/Physician: Satisfactory Response|4
1848602|NCT00191789|6391347|P1|Overall Study|Patient: Satisfactory Response|5
1848603|NCT00191789|6391347|P1|Overall Study|Adverse Event|5
1848604|NCT00191724|6391364|P5|Overall Study|Withdrawal by Subject|0
1848605|NCT00191724|6391365|P4|Overall Study|Withdrawal by Subject|1
1848606|NCT00191724|6391366|P3|Overall Study|Withdrawal by Subject|0
1848607|NCT00191724|6391367|P2|Overall Study|Withdrawal by Subject|0
1848608|NCT00191724|6391368|P1|Overall Study|Withdrawal by Subject|0
1848609|NCT00191724|6391364|P5|Overall Study|Lost to Follow-up|3
1848610|NCT00191724|6391365|P4|Overall Study|Lost to Follow-up|2
1848611|NCT00191724|6391366|P3|Overall Study|Lost to Follow-up|0
1848612|NCT00191724|6391367|P2|Overall Study|Lost to Follow-up|1
1848613|NCT00191724|6391368|P1|Overall Study|Lost to Follow-up|1
1848614|NCT00191724|6391364|P5|Overall Study|Adverse Event|0
1848615|NCT00191724|6391365|P4|Overall Study|Adverse Event|0
1848616|NCT00191724|6391366|P3|Overall Study|Adverse Event|1
1848617|NCT00191724|6391367|P2|Overall Study|Adverse Event|0
1848618|NCT00191724|6391368|P1|Overall Study|Adverse Event|0
1848619|NCT00191646|6391397|P2|Overall Study|Missing Data|11
1848620|NCT00191646|6391398|P1|Overall Study|Missing Data|18
1848621|NCT00191646|6391397|P2|Overall Study|Other|34
1848622|NCT00191646|6391398|P1|Overall Study|Other|33
1848623|NCT00191646|6391397|P2|Overall Study|Death|8
1848624|NCT00191646|6391398|P1|Overall Study|Death|6
1848625|NCT00191646|6391397|P2|Overall Study|Protocol Violation|7
1848626|NCT00191646|6391398|P1|Overall Study|Protocol Violation|5
1848627|NCT00191646|6391397|P2|Overall Study|Withdrawal by Subject|39
1848628|NCT00191646|6391398|P1|Overall Study|Withdrawal by Subject|58
1848629|NCT00191646|6391397|P2|Overall Study|Physician Decision|11
1848630|NCT00191646|6391398|P1|Overall Study|Physician Decision|20
1848631|NCT00191646|6391397|P2|Overall Study|Disease Progression|6
1848632|NCT00191646|6391398|P1|Overall Study|Disease Progression|5
1848633|NCT00191646|6391397|P2|Overall Study|Toxicity|37
1848634|NCT00191646|6391398|P1|Overall Study|Toxicity|26
1848635|NCT00191477|6391418|P2|Overall Study|Discontinued Prior to Instillation|14
1848636|NCT00191477|6391419|P1|Overall Study|Discontinued Prior to Instillation|13
1848637|NCT00191477|6391418|P2|Overall Study|Pathological Specimen Lost|0
1848638|NCT00191477|6391419|P1|Overall Study|Pathological Specimen Lost|1
1848639|NCT00191477|6391418|P2|Overall Study|Not Eligible|38
1848640|NCT00191477|6391419|P1|Overall Study|Not Eligible|41
1848641|NCT00191477|6391418|P2|Overall Study|Other|0
1848642|NCT00191477|6391419|P1|Overall Study|Other|2
1848643|NCT00191477|6391418|P2|Overall Study|Withdrawal by Subject|0
1848644|NCT00191477|6391419|P1|Overall Study|Withdrawal by Subject|2
1848645|NCT00191477|6391418|P2|Overall Study|Treatment Change|0
1848646|NCT00191477|6391419|P1|Overall Study|Treatment Change|2
1848647|NCT00191477|6391418|P2|Overall Study|Protocol Violation|1
1848648|NCT00191477|6391419|P1|Overall Study|Protocol Violation|1
1848649|NCT00191477|6391418|P2|Overall Study|Lost to Follow-up|21
1848650|NCT00191477|6391419|P1|Overall Study|Lost to Follow-up|23
1848651|NCT00191477|6391418|P2|Overall Study|Death, Other Cause|6
1848652|NCT00191477|6391419|P1|Overall Study|Death, Other Cause|3
1848653|NCT00191477|6391418|P2|Overall Study|Death, Study Disease|1
1848654|NCT00191477|6391419|P1|Overall Study|Death, Study Disease|1
1848655|NCT00191477|6391418|P2|Overall Study|Tumor Recurrence|48
1848656|NCT00191477|6391419|P1|Overall Study|Tumor Recurrence|49
1848657|NCT00191451|6391438|P3|Overall Study|Reason Not Specified|3
1848658|NCT00191451|6391439|P2|Overall Study|Reason Not Specified|1
1848659|NCT00191451|6391440|P1|Overall Study|Reason Not Specified|2
1848660|NCT00191451|6391438|P3|Overall Study|Ineligible|0
1848661|NCT00191451|6391439|P2|Overall Study|Ineligible|1
1848662|NCT00191451|6391440|P1|Overall Study|Ineligible|0
1848663|NCT00191451|6391438|P3|Overall Study|Sponsor Decision|0
1848664|NCT00191451|6391439|P2|Overall Study|Sponsor Decision|0
1848665|NCT00191451|6391440|P1|Overall Study|Sponsor Decision|1
1848666|NCT00191451|6391438|P3|Overall Study|Physician Decision|6
1848667|NCT00191451|6391439|P2|Overall Study|Physician Decision|9
1848668|NCT00191451|6391440|P1|Overall Study|Physician Decision|2
1848669|NCT00191451|6391438|P3|Overall Study|Withdrawal by Subject|5
1848670|NCT00191451|6391439|P2|Overall Study|Withdrawal by Subject|3
1848671|NCT00191451|6391440|P1|Overall Study|Withdrawal by Subject|2
1848672|NCT00191386|6391460|P1|Overall Study|Lack of Efficacy|15
1848673|NCT00191386|6391460|P1|Overall Study|Physician Decision|11
1848674|NCT00191386|6391460|P1|Overall Study|Withdrawal by Subject|96
1848675|NCT00191386|6391460|P1|Overall Study|Protocol Violation|18
1848676|NCT00191386|6391460|P1|Overall Study|Entry Criteria Exclusion|3
1848677|NCT00191386|6391460|P1|Overall Study|Lost to Follow-up|1
1848678|NCT00191386|6391460|P1|Overall Study|Adverse Event|16
1848679|NCT00191334|6391467|P1|Overall Study|Withdrawal by Subject|4
1848680|NCT00191334|6391467|P1|Overall Study|Physician Decision|1
1848681|NCT00191334|6391467|P1|Overall Study|Disease Progression or Relapse|8
1848682|NCT00191334|6391467|P1|Overall Study|Adverse Event|4
1848683|NCT00191308|6391475|P1|Overall Study|Adverse Event|1
1848684|NCT00191282|6391485|P2|Overall Study|Lost to Follow-up|31
1848685|NCT00191282|6391486|P1|Overall Study|Lost to Follow-up|24
1848686|NCT00191282|6391485|P2|Overall Study|Sponsor's decision|2
1848687|NCT00191282|6391486|P1|Overall Study|Sponsor's decision|2
1848688|NCT00191282|6391485|P2|Overall Study|Severity of outcome|5
1848689|NCT00191282|6391486|P1|Overall Study|Severity of outcome|2
1848690|NCT00191282|6391485|P2|Overall Study|Protocol Violation|12
1848691|NCT00191282|6391486|P1|Overall Study|Protocol Violation|9
1848692|NCT00191282|6391485|P2|Overall Study|Protocol entry criteria not met|9
1848693|NCT00191282|6391486|P1|Overall Study|Protocol entry criteria not met|14
1848694|NCT00191282|6391485|P2|Overall Study|Physician Decision|15
1848695|NCT00191282|6391486|P1|Overall Study|Physician Decision|18
1848696|NCT00191282|6391485|P2|Overall Study|Withdrawal by Subject|44
1848697|NCT00191282|6391486|P1|Overall Study|Withdrawal by Subject|59
1848698|NCT00191282|6391485|P2|Overall Study|Patient moved|14
1848699|NCT00191282|6391486|P1|Overall Study|Patient moved|11
1848700|NCT00191282|6391485|P2|Overall Study|Noncompliance|17
1848701|NCT00191282|6391486|P1|Overall Study|Noncompliance|14
1848702|NCT00191282|6391485|P2|Overall Study|Lack of Efficacy|6
1848703|NCT00191282|6391486|P1|Overall Study|Lack of Efficacy|11
1848704|NCT00191282|6391485|P2|Overall Study|Death|51
1848705|NCT00191282|6391486|P1|Overall Study|Death|51
1848706|NCT00191282|6391485|P2|Overall Study|Adverse Event|6
1848707|NCT00191282|6391486|P1|Overall Study|Adverse Event|5
1848708|NCT00191269|6391546|P2|Overall Study|Physician Decision|3
1848709|NCT00191269|6391547|P1|Overall Study|Physician Decision|0
1848710|NCT00191269|6391546|P2|Overall Study|Pathologic Aggrevation|1
1848711|NCT00191269|6391547|P1|Overall Study|Pathologic Aggrevation|0
1848712|NCT00191269|6391546|P2|Overall Study|Withdrawal by Subject|1
1848713|NCT00191269|6391547|P1|Overall Study|Withdrawal by Subject|0
1848714|NCT00191269|6391546|P2|Overall Study|Lack of Efficacy|5
1848715|NCT00191269|6391547|P1|Overall Study|Lack of Efficacy|1
1848716|NCT00191269|6391546|P2|Overall Study|Progression of Disease|42
1848717|NCT00191269|6391547|P1|Overall Study|Progression of Disease|4
1848718|NCT00191269|6391546|P2|Overall Study|Adverse Event|4
1848719|NCT00191269|6391547|P1|Overall Study|Adverse Event|1
1848720|NCT00191269|6391546|P2|Overall Study|Protocol Violation|2
1848721|NCT00191269|6391547|P1|Overall Study|Protocol Violation|0
1848722|NCT00191191|6391563|P2|Overall Study|Good Clinical Practice Violation|1
1848723|NCT00191191|6391564|P1|Overall Study|Good Clinical Practice Violation|0
1848724|NCT00191191|6391563|P2|Overall Study|Physician Decision|2
1848725|NCT00191191|6391564|P1|Overall Study|Physician Decision|3
1848726|NCT00191191|6391563|P2|Overall Study|Lost to Follow-up|0
1848727|NCT00191191|6391564|P1|Overall Study|Lost to Follow-up|1
1848728|NCT00191191|6391563|P2|Overall Study|Family/Caregiver Decision|7
1848729|NCT00191191|6391564|P1|Overall Study|Family/Caregiver Decision|5
1848730|NCT00191191|6391563|P2|Overall Study|Toxicity After Dose Reduction|8
1848731|NCT00191191|6391564|P1|Overall Study|Toxicity After Dose Reduction|7
1848732|NCT00191191|6391563|P2|Overall Study|Progressive Disease|72
1848733|NCT00191191|6391564|P1|Overall Study|Progressive Disease|84
1848734|NCT00191191|6391563|P2|Overall Study|Adverse Event|21
1848735|NCT00191191|6391564|P1|Overall Study|Adverse Event|11
1848736|NCT00191191|6391563|P2|Overall Study|Treated with Another Systemic Agent|1
1848737|NCT00191191|6391564|P1|Overall Study|Treated with Another Systemic Agent|1
1848738|NCT00191191|6391563|P2|Overall Study|Entry Criteria Exclusion|0
1848739|NCT00191191|6391564|P1|Overall Study|Entry Criteria Exclusion|2
1848740|NCT00191165|6391580|P2|Overall Study|Participant Moved Away|1
1848741|NCT00191165|6391581|P1|Overall Study|Participant Moved Away|0
1848742|NCT00191165|6391580|P2|Overall Study|Protocol Violation|1
1848743|NCT00191165|6391581|P1|Overall Study|Protocol Violation|0
1848744|NCT00191165|6391580|P2|Overall Study|Adverse Event|0
1848745|NCT00191165|6391581|P1|Overall Study|Adverse Event|2
1848746|NCT00191152|6391593|P2|Crossover Treatment|Other|3
1848747|NCT00191152|6391594|P1|Crossover Treatment|Other|4
1848748|NCT00191152|6391593|P2|Crossover Treatment|Lost to Follow-up|1
1848749|NCT00191152|6391594|P1|Crossover Treatment|Lost to Follow-up|2
1848750|NCT00191152|6391593|P2|Crossover Treatment|Withdrawal by Subject|9
1848751|NCT00191152|6391594|P1|Crossover Treatment|Withdrawal by Subject|6
1848752|NCT00191152|6391593|P2|Crossover Treatment|Physician Decision|7
1848753|NCT00191152|6391594|P1|Crossover Treatment|Physician Decision|7
1848754|NCT00191152|6391593|P2|Crossover Treatment|Adverse Event|8
1848755|NCT00191152|6391594|P1|Crossover Treatment|Adverse Event|8
1848756|NCT00191152|6391593|P2|Initial Treatment|Other|21
1848757|NCT00191152|6391594|P1|Initial Treatment|Other|18
1848758|NCT00191152|6391593|P2|Initial Treatment|Lost to Follow-up|6
1848759|NCT00191152|6391594|P1|Initial Treatment|Lost to Follow-up|0
1848760|NCT00191152|6391593|P2|Initial Treatment|Withdrawal by Subject|28
1848761|NCT00191152|6391594|P1|Initial Treatment|Withdrawal by Subject|40
1848762|NCT00191152|6391593|P2|Initial Treatment|Physician Decision|31
1848763|NCT00191152|6391594|P1|Initial Treatment|Physician Decision|40
1848764|NCT00191152|6391593|P2|Initial Treatment|Adverse Event|67
1848765|NCT00191152|6391594|P1|Initial Treatment|Adverse Event|43
1848766|NCT00191139|6391626|P2|Overall Study|Other|2
1848767|NCT00191139|6391627|P1|Overall Study|Other|1
1848768|NCT00191139|6391626|P2|Overall Study|Disease Progression|1
1848769|NCT00191139|6391627|P1|Overall Study|Disease Progression|0
1848770|NCT00191139|6391626|P2|Overall Study|Withdrawal by Subject|3
1848771|NCT00191139|6391627|P1|Overall Study|Withdrawal by Subject|0
1848772|NCT00191139|6391626|P2|Overall Study|Death|0
1848773|NCT00191139|6391627|P1|Overall Study|Death|2
1848774|NCT00191139|6391626|P2|Overall Study|Adverse Event|6
1848775|NCT00191139|6391627|P1|Overall Study|Adverse Event|2
1848776|NCT00191113|6391643|P2|Core Study|Death|0
1848777|NCT00191113|6391644|P1|Core Study|Death|1
1848778|NCT00191113|6391643|P2|Core Study|Lack of Efficacy|2
1848779|NCT00191113|6391644|P1|Core Study|Lack of Efficacy|0
1848780|NCT00191113|6391643|P2|Core Study|Adverse Event|2
1848781|NCT00191113|6391644|P1|Core Study|Adverse Event|0
1848782|NCT00191113|6391643|P2|Core Study|Lost to Follow-up|0
1848783|NCT00191113|6391644|P1|Core Study|Lost to Follow-up|3
1848784|NCT00191113|6391643|P2|Core Study|Protocol Violation|2
1848785|NCT00191113|6391644|P1|Core Study|Protocol Violation|6
1848786|NCT00191113|6391643|P2|Core Study|Withdrawal by Subject|9
1848787|NCT00191113|6391644|P1|Core Study|Withdrawal by Subject|25
1848788|NCT00191100|6391686|P2|Overall Study|Reason Not Specified|1
1848789|NCT00191100|6391687|P1|Overall Study|Reason Not Specified|0
1848790|NCT00191100|6391686|P2|Overall Study|Death from Other Cause|0
1848791|NCT00191100|6391687|P1|Overall Study|Death from Other Cause|1
1848792|NCT00191100|6391686|P2|Overall Study|Protocol Violation|1
1848793|NCT00191100|6391687|P1|Overall Study|Protocol Violation|1
1848794|NCT00191100|6391686|P2|Overall Study|Death from Study Drug Toxicity|0
1848795|NCT00191100|6391687|P1|Overall Study|Death from Study Drug Toxicity|2
1848796|NCT00191100|6391686|P2|Overall Study|Physician Decision|1
1848797|NCT00191100|6391687|P1|Overall Study|Physician Decision|3
1848798|NCT00191100|6391686|P2|Overall Study|Lack of Efficacy, Stable Disease|0
1848799|NCT00191100|6391687|P1|Overall Study|Lack of Efficacy, Stable Disease|1
1848800|NCT00191100|6391686|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
1848801|NCT00191100|6391687|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
1848802|NCT00191100|6391686|P2|Overall Study|Clinical Relapse|1
1848803|NCT00191100|6391687|P1|Overall Study|Clinical Relapse|2
1848804|NCT00191100|6391686|P2|Overall Study|Protocol Entry Criteria Not Met|1
1848805|NCT00191100|6391687|P1|Overall Study|Protocol Entry Criteria Not Met|2
1848806|NCT00191100|6391686|P2|Overall Study|Withdrawal by Subject|3
1848807|NCT00191100|6391687|P1|Overall Study|Withdrawal by Subject|9
1848808|NCT00191100|6391686|P2|Overall Study|Patient Moved|1
1848809|NCT00191100|6391687|P1|Overall Study|Patient Moved|0
1848810|NCT00191100|6391686|P2|Overall Study|Lost to Follow-up|0
1848811|NCT00191100|6391687|P1|Overall Study|Lost to Follow-up|2
1848812|NCT00191100|6391686|P2|Overall Study|Adverse Event|1
1848813|NCT00191100|6391687|P1|Overall Study|Adverse Event|18
1848814|NCT00190983|6391703|P1|Overall Study|Inevaluable (never treated)|2
1848815|NCT00190775|6391712|P2|Overall Study|Exclusion Criteria Met|3
1848816|NCT00190775|6391713|P1|Overall Study|Exclusion Criteria Met|1
1848817|NCT00190775|6391712|P2|Overall Study|Protocol Violation|1
1848818|NCT00190775|6391713|P1|Overall Study|Protocol Violation|0
1848819|NCT00190775|6391712|P2|Overall Study|Noncompliance|5
1848820|NCT00190775|6391713|P1|Overall Study|Noncompliance|3
1848821|NCT00190775|6391712|P2|Overall Study|Physician Decision|0
1848822|NCT00190775|6391713|P1|Overall Study|Physician Decision|3
1848823|NCT00190775|6391712|P2|Overall Study|Sponsor Decision|0
1848824|NCT00190775|6391713|P1|Overall Study|Sponsor Decision|1
1848825|NCT00190775|6391712|P2|Overall Study|Withdrawal by Subject|13
1848826|NCT00190775|6391713|P1|Overall Study|Withdrawal by Subject|24
1848827|NCT00190775|6391712|P2|Overall Study|Participant Moved|1
1848828|NCT00190775|6391713|P1|Overall Study|Participant Moved|0
1848829|NCT00190775|6391712|P2|Overall Study|Lost to Follow-up|23
1848830|NCT00190775|6391713|P1|Overall Study|Lost to Follow-up|31
1848831|NCT00190775|6391712|P2|Overall Study|Lack of Efficacy|32
1848832|NCT00190775|6391713|P1|Overall Study|Lack of Efficacy|28
1848833|NCT00190775|6391712|P2|Overall Study|Satisfactory Response|0
1848834|NCT00190775|6391713|P1|Overall Study|Satisfactory Response|1
1848835|NCT00190775|6391712|P2|Overall Study|Adverse Event|22
1848836|NCT00190775|6391713|P1|Overall Study|Adverse Event|57
1848837|NCT00190749|6391784|P2|Overall Study|Sponsor Decision|0
1848838|NCT00190749|6391785|P1|Overall Study|Sponsor Decision|1
1848839|NCT00190749|6391784|P2|Overall Study|Reason Not Specified|2
1848840|NCT00190749|6391785|P1|Overall Study|Reason Not Specified|0
1848841|NCT00190749|6391784|P2|Overall Study|Lack of Efficacy|3
1848842|NCT00190749|6391785|P1|Overall Study|Lack of Efficacy|2
1848843|NCT00190749|6391784|P2|Overall Study|Adverse Event|5
1848844|NCT00190749|6391785|P1|Overall Study|Adverse Event|0
1848845|NCT00190749|6391784|P2|Overall Study|Protocol Violation|4
1848846|NCT00190749|6391785|P1|Overall Study|Protocol Violation|5
1848847|NCT00190749|6391784|P2|Overall Study|Withdrawal by Subject|6
1848848|NCT00190749|6391785|P1|Overall Study|Withdrawal by Subject|10
1848849|NCT00190749|6391784|P2|Overall Study|Lost to Follow-up|11
1848850|NCT00190749|6391785|P1|Overall Study|Lost to Follow-up|8
1848851|NCT00190684|6391849|P1|Overall Study|Study Period V Completed|1
1848852|NCT00190684|6391849|P1|Overall Study|Study Period III Completed|103
1848853|NCT00190684|6391849|P1|Overall Study|Protocol Violation|123
1848854|NCT00190684|6391849|P1|Overall Study|Physician Decision|84
1848855|NCT00190684|6391849|P1|Overall Study|Sponsor's decision|17
1848856|NCT00190684|6391849|P1|Overall Study|Clinical relapse|67
1848857|NCT00190684|6391849|P1|Overall Study|Patient Decision|432
1848858|NCT00190684|6391849|P1|Overall Study|Patient moved|60
1848859|NCT00190684|6391849|P1|Overall Study|Lost to Follow-up|232
1848860|NCT00190684|6391849|P1|Overall Study|Lack of efficacy|204
1848861|NCT00190684|6391849|P1|Overall Study|Satisfactory response|80
1848862|NCT00190684|6391849|P1|Overall Study|Adverse Event|86
1848863|NCT00190671|6391870|P2|Overall Study|Withdrawal by Subject|2
1848864|NCT00190671|6391871|P1|Overall Study|Withdrawal by Subject|0
1848865|NCT00190671|6391870|P2|Overall Study|Protocol Violation|1
1848866|NCT00190671|6391871|P1|Overall Study|Protocol Violation|0
1848867|NCT00190671|6391870|P2|Overall Study|Death from Other Causes|2
1848868|NCT00190671|6391871|P1|Overall Study|Death from Other Causes|0
1848869|NCT00190671|6391870|P2|Overall Study|Death from Study-Drug Toxicity|2
1848870|NCT00190671|6391871|P1|Overall Study|Death from Study-Drug Toxicity|0
1848871|NCT00190671|6391870|P2|Overall Study|Clinical Relapse|1
1848872|NCT00190671|6391871|P1|Overall Study|Clinical Relapse|0
1848873|NCT00190671|6391870|P2|Overall Study|Adverse Event|2
1848874|NCT00190671|6391871|P1|Overall Study|Adverse Event|3
1848875|NCT00190671|6391870|P2|Overall Study|Death from Study Disease|1
1848876|NCT00190671|6391871|P1|Overall Study|Death from Study Disease|1
1848877|NCT00190671|6391870|P2|Overall Study|Lack of Efficacy|24
1848878|NCT00190671|6391871|P1|Overall Study|Lack of Efficacy|19
1848879|NCT00190671|6391870|P2|Overall Study|Satisfactory Response|7
1848880|NCT00190671|6391871|P1|Overall Study|Satisfactory Response|4
1848881|NCT00189540|6391891|P2|Overall Study|Death|1
1848882|NCT00189540|6391892|P1|Overall Study|Death|4
1848883|NCT00189540|6391891|P2|Overall Study|Withdrawal by Subject|0
1848884|NCT00189540|6391892|P1|Overall Study|Withdrawal by Subject|3
1848885|NCT00189488|6391910|P2|Overall Study|Other|0
1848886|NCT00189488|6391911|P1|Overall Study|Other|1
1848887|NCT00189488|6391910|P2|Overall Study|Death|8
1848888|NCT00189488|6391911|P1|Overall Study|Death|5
1848889|NCT00189488|6391910|P2|Overall Study|Administrative Decision|2
1848890|NCT00189488|6391911|P1|Overall Study|Administrative Decision|0
1848891|NCT00189488|6391910|P2|Overall Study|Disease progression|4
1848892|NCT00189488|6391911|P1|Overall Study|Disease progression|2
1848893|NCT00189488|6391910|P2|Overall Study|Withdrawal by Subject|6
1848894|NCT00189488|6391911|P1|Overall Study|Withdrawal by Subject|2
1848895|NCT00189488|6391910|P2|Overall Study|Adverse Event|1
1848896|NCT00189488|6391911|P1|Overall Study|Adverse Event|2
1848897|NCT00189488|6391910|P2|Overall Study|Protocol deviation|1
1848898|NCT00189488|6391911|P1|Overall Study|Protocol deviation|2
1848899|NCT00189488|6391910|P2|Overall Study|Ineligibility determined|0
1848900|NCT00189488|6391911|P1|Overall Study|Ineligibility determined|1
1848901|NCT00189462|6391942|P2|Overall Study|Lost to Follow-up|20
1848902|NCT00189462|6391943|P1|Overall Study|Lost to Follow-up|18
1848903|NCT00189462|6391942|P2|Overall Study|Lack of Efficacy|1
1848904|NCT00189462|6391943|P1|Overall Study|Lack of Efficacy|5
1848905|NCT00189423|6391960|P2|Overall Study|Lost to Follow-up|10
1848906|NCT00189423|6391961|P1|Overall Study|Lost to Follow-up|10
1848907|NCT00189423|6391960|P2|Overall Study|Withdrawal by Subject|9
1848908|NCT00189423|6391961|P1|Overall Study|Withdrawal by Subject|9
1848909|NCT00189423|6391960|P2|Overall Study|Death|747
1848910|NCT00189423|6391961|P1|Overall Study|Death|746
1848911|NCT00189306|6391983|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
1848912|NCT00189306|6391983|P1|Long-Term Follow-up|Lost to Follow-up|9
1848913|NCT00189306|6391983|P1|Long-Term Follow-up|Intercurrent disease|2
1848914|NCT00189306|6391983|P1|Long-Term Follow-up|Withdrawal by Subject|1
1848915|NCT00189306|6391983|P1|Long-Term Follow-up|Death|4
1848916|NCT00189306|6391983|P1|Long-Term Follow-up|Adverse Event|2
1848917|NCT00189306|6391983|P1|Posttreatment Period|Local skin reaction/sign|1
1848918|NCT00189306|6391983|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
1848919|NCT00189306|6391983|P1|Posttreatment Period|Protocol Violation|1
1848920|NCT00189306|6391983|P1|Posttreatment Period|Target lesion excised|1
1848921|NCT00189306|6391983|P1|Posttreatment Period|Noncompliance|1
1848922|NCT00189306|6391983|P1|Posttreatment Period|Withdrawal by Subject|2
1848923|NCT00189306|6391983|P1|Posttreatment Period|Death|1
1848924|NCT00189306|6391983|P1|Treatment Period|Protocol Violation|1
1848925|NCT00189306|6391983|P1|Treatment Period|Adverse Event|2
1848926|NCT00189306|6391983|P1|Treatment Period|Withdrawal by Subject|2
1848927|NCT00189202|6391992|P1|Overall Study|Physician Decision|5
1848928|NCT00187889|6392033|P2|Overall Study|Withdrawal by Subject|4
1848929|NCT00187889|6392034|P1|Overall Study|Withdrawal by Subject|6
1848930|NCT00187486|6392076|P1|Overall Study|Protocol Violation|1
1848931|NCT00187135|6392127|P6|Visit Three|Study Discontinued|6
1848932|NCT00187135|6392128|P5|Visit Three|Study Discontinued|7
1848933|NCT00187135|6392129|P4|Visit Three|Study Discontinued|7
1848934|NCT00187135|6392130|P3|Visit Three|Study Discontinued|7
1848935|NCT00187135|6392131|P2|Visit Three|Study Discontinued|6
1848936|NCT00187135|6392132|P1|Visit Three|Study Discontinued|7
1848937|NCT00187135|6392127|P6|Visit Three|Withdrawal by Subject|0
1848938|NCT00187135|6392128|P5|Visit Three|Withdrawal by Subject|0
1848939|NCT00187135|6392129|P4|Visit Three|Withdrawal by Subject|2
1848940|NCT00187135|6392130|P3|Visit Three|Withdrawal by Subject|1
1848941|NCT00187135|6392131|P2|Visit Three|Withdrawal by Subject|1
1848942|NCT00187135|6392132|P1|Visit Three|Withdrawal by Subject|0
1848943|NCT00187135|6392127|P6|Visit Three|Death|0
1848944|NCT00187135|6392128|P5|Visit Three|Death|1
1848945|NCT00187135|6392129|P4|Visit Three|Death|0
1848946|NCT00187135|6392130|P3|Visit Three|Death|1
1848947|NCT00187135|6392131|P2|Visit Three|Death|0
1848948|NCT00187135|6392132|P1|Visit Three|Death|0
1848949|NCT00187135|6392127|P6|Visit Two|Study Discontinued|6
1848950|NCT00187135|6392128|P5|Visit Two|Study Discontinued|5
1848951|NCT00187135|6392129|P4|Visit Two|Study Discontinued|7
1848952|NCT00187135|6392130|P3|Visit Two|Study Discontinued|1
1848953|NCT00187135|6392131|P2|Visit Two|Study Discontinued|2
1848954|NCT00187135|6392132|P1|Visit Two|Study Discontinued|3
1848955|NCT00187135|6392127|P6|Visit Two|Withdrawal by Subject|1
1848956|NCT00187135|6392128|P5|Visit Two|Withdrawal by Subject|1
1848957|NCT00187135|6392129|P4|Visit Two|Withdrawal by Subject|0
1848958|NCT00187135|6392130|P3|Visit Two|Withdrawal by Subject|1
1848959|NCT00187135|6392131|P2|Visit Two|Withdrawal by Subject|1
1848960|NCT00187135|6392132|P1|Visit Two|Withdrawal by Subject|1
1848961|NCT00187135|6392127|P6|Visit Two|Physician Decision|0
1848962|NCT00187135|6392128|P5|Visit Two|Physician Decision|0
1848963|NCT00187135|6392129|P4|Visit Two|Physician Decision|0
1848964|NCT00187135|6392130|P3|Visit Two|Physician Decision|0
1848965|NCT00187135|6392131|P2|Visit Two|Physician Decision|0
1848966|NCT00187135|6392132|P1|Visit Two|Physician Decision|1
1848967|NCT00187135|6392127|P6|Visit Two|Death|1
1848968|NCT00187135|6392128|P5|Visit Two|Death|0
1848969|NCT00187135|6392129|P4|Visit Two|Death|1
1848970|NCT00187135|6392130|P3|Visit Two|Death|0
1848971|NCT00187135|6392131|P2|Visit Two|Death|0
1848972|NCT00187135|6392132|P1|Visit Two|Death|0
1848973|NCT00187135|6392127|P6|Visit One|Physician Decision|1
1848974|NCT00187135|6392128|P5|Visit One|Physician Decision|0
1848975|NCT00187135|6392129|P4|Visit One|Physician Decision|0
1848976|NCT00187135|6392130|P3|Visit One|Physician Decision|0
1848977|NCT00187135|6392131|P2|Visit One|Physician Decision|1
1848978|NCT00187135|6392132|P1|Visit One|Physician Decision|3
1848979|NCT00187135|6392127|P6|Visit One|Withdrawal by Subject|1
1848980|NCT00187135|6392128|P5|Visit One|Withdrawal by Subject|0
1848981|NCT00187135|6392129|P4|Visit One|Withdrawal by Subject|0
1848982|NCT00187135|6392130|P3|Visit One|Withdrawal by Subject|0
1848983|NCT00187135|6392131|P2|Visit One|Withdrawal by Subject|0
1848984|NCT00187135|6392132|P1|Visit One|Withdrawal by Subject|1
1848985|NCT00187096|6392155|P3|Overall Study|unacceptable toxicity|1
1848986|NCT00187096|6392156|P2|Overall Study|unacceptable toxicity|0
1848987|NCT00187096|6392157|P1|Overall Study|unacceptable toxicity|0
1848988|NCT00186901|6392195|P3|Overall Study|Bone Mineral Density > 0|149
1848989|NCT00186901|6392196|P2|Overall Study|Bone Mineral Density > 0|0
1848990|NCT00186901|6392197|P1|Overall Study|Bone Mineral Density > 0|0
1848991|NCT00186901|6392195|P3|Overall Study|Limited adherence to study requirements|0
1848992|NCT00186901|6392196|P2|Overall Study|Limited adherence to study requirements|23
1848993|NCT00186901|6392197|P1|Overall Study|Limited adherence to study requirements|20
1848994|NCT00186901|6392195|P3|Overall Study|Open label|0
1848995|NCT00186901|6392196|P2|Overall Study|Open label|2
1848996|NCT00186901|6392197|P1|Overall Study|Open label|3
1848997|NCT00186901|6392195|P3|Overall Study|Withdrawal by Subject|0
1848998|NCT00186901|6392196|P2|Overall Study|Withdrawal by Subject|5
1848999|NCT00186901|6392197|P1|Overall Study|Withdrawal by Subject|4
1849000|NCT00186901|6392195|P3|Overall Study|ALL relapse or second malignancy|0
1849001|NCT00186901|6392196|P2|Overall Study|ALL relapse or second malignancy|2
1849002|NCT00186901|6392197|P1|Overall Study|ALL relapse or second malignancy|1
1849003|NCT00186901|6392195|P3|Overall Study|Bone Mineral Density dropped > 5%|0
1849004|NCT00186901|6392196|P2|Overall Study|Bone Mineral Density dropped > 5%|7
1849005|NCT00186901|6392197|P1|Overall Study|Bone Mineral Density dropped > 5%|9
1849006|NCT00186901|6392195|P3|Overall Study|Lost to Follow-up|0
1849007|NCT00186901|6392196|P2|Overall Study|Lost to Follow-up|3
1849008|NCT00186901|6392197|P1|Overall Study|Lost to Follow-up|6
1849009|NCT00186901|6392195|P3|Overall Study|Pregnancy|0
1849010|NCT00186901|6392196|P2|Overall Study|Pregnancy|3
1849011|NCT00186901|6392197|P1|Overall Study|Pregnancy|6
1849012|NCT00186888|6392237|P3|Overall Study|Relapse or progression of disease|0
1849013|NCT00186888|6392238|P2|Overall Study|Relapse or progression of disease|2
1849014|NCT00186888|6392239|P1|Overall Study|Relapse or progression of disease|4
1849015|NCT00186888|6392237|P3|Overall Study|Toxicity|0
1849016|NCT00186888|6392238|P2|Overall Study|Toxicity|1
1849017|NCT00186888|6392239|P1|Overall Study|Toxicity|0
1849018|NCT00186628|6392331|P1|Overall Study|Withdrawal by subject (before treatment)|1
1849019|NCT00186628|6392331|P1|Overall Study|Death|2
1849020|NCT00186537|6392342|P3|Overall Study|ALT > 1.5 x ULN|0
1849021|NCT00186537|6392343|P2|Overall Study|ALT > 1.5 x ULN|0
1849022|NCT00186537|6392344|P1|Overall Study|ALT > 1.5 x ULN|3
1849023|NCT00186537|6392342|P3|Overall Study|Withdrawal by Subject|3
1849024|NCT00186537|6392343|P2|Overall Study|Withdrawal by Subject|0
1849025|NCT00186537|6392344|P1|Overall Study|Withdrawal by Subject|4
1849026|NCT00186485|6392367|P1|Overall Study|Lost to Follow-up|3
1849027|NCT00186186|6392379|P1|Overall Study|Not reported as to reason|2
1849028|NCT00186186|6392379|P1|Overall Study|Withdrawal by Subject|3
1849029|NCT00186186|6392379|P1|Overall Study|Lack of Efficacy|3
1849030|NCT00186121|6392384|P1|Overall Study|Not eligible (no treatment)|1
1849031|NCT00186121|6392384|P1|Overall Study|Underwent oophorectomy (no treatment)|1
1849032|NCT00186121|6392384|P1|Overall Study|Subject withdrawal (no treatment)|1
1849033|NCT00186043|6392418|P2|Overall Study|Protocol Violation|1
1849034|NCT00186043|6392419|P1|Overall Study|Protocol Violation|2
1849035|NCT00186043|6392418|P2|Overall Study|Adverse Event|3
1849036|NCT00186043|6392419|P1|Overall Study|Adverse Event|7
1849037|NCT00186043|6392418|P2|Overall Study|Withdrawal by Subject|0
1849038|NCT00186043|6392419|P1|Overall Study|Withdrawal by Subject|1
1849039|NCT00186043|6392418|P2|Overall Study|Lost to Follow-up|6
1849040|NCT00186043|6392419|P1|Overall Study|Lost to Follow-up|4
1849041|NCT00186043|6392418|P2|Overall Study|Lack of Efficacy|3
1849042|NCT00186043|6392419|P1|Overall Study|Lack of Efficacy|1
1849043|NCT00185965|6392446|P2|Overall Study|Adverse Event|1
1849044|NCT00185965|6392447|P1|Overall Study|Adverse Event|0
1849045|NCT00185731|6392472|P1|Overall Study|Not Eligible|1
1849046|NCT00185731|6392472|P1|Overall Study|Withdrawal by Subject|1
1849047|NCT00185640|6392489|P1|Overall Study|Death|138
1849048|NCT00185640|6392489|P1|Overall Study|Withdrawal by Subject|3
1849049|NCT00185640|6392489|P1|Overall Study|Not Eligible|4
1849050|NCT00185614|6392498|P1|Inter-treatment Period|Lack of allogenic donor|1
1849051|NCT00185614|6392498|P1|Inter-treatment Period|Relapse|2
1849052|NCT00185614|6392498|P1|Inter-treatment Period|Physician Decision|1
1849053|NCT00185588|6392510|P4|Overall Study|Physician Decision|0
1849054|NCT00185588|6392511|P3|Overall Study|Physician Decision|1
1849055|NCT00185588|6392512|P2|Overall Study|Physician Decision|0
1849056|NCT00185588|6392513|P1|Overall Study|Physician Decision|0
1849057|NCT00185588|6392510|P4|Overall Study|Withdrawal by Subject|0
1849058|NCT00185588|6392511|P3|Overall Study|Withdrawal by Subject|0
1849059|NCT00185588|6392512|P2|Overall Study|Withdrawal by Subject|1
1849060|NCT00185588|6392513|P1|Overall Study|Withdrawal by Subject|0
1849061|NCT00185588|6392510|P4|Overall Study|Lost to Follow-up|2
1849062|NCT00185588|6392511|P3|Overall Study|Lost to Follow-up|1
1849063|NCT00185588|6392512|P2|Overall Study|Lost to Follow-up|0
1849064|NCT00185588|6392513|P1|Overall Study|Lost to Follow-up|0
1849065|NCT00185588|6392510|P4|Overall Study|Adverse Event|2
1849066|NCT00185588|6392511|P3|Overall Study|Adverse Event|4
1849067|NCT00185588|6392512|P2|Overall Study|Adverse Event|1
1849068|NCT00185588|6392513|P1|Overall Study|Adverse Event|3
1849069|NCT00185458|6392527|P1|HRT Phase|Withdrawal by Subject|3
1849070|NCT00185458|6392527|P1|HRT Phase|Protocol Violation|2
1849071|NCT00185458|6392527|P1|HRT Phase|Lost to Follow-up|4
1849072|NCT00185458|6392527|P1|HRT Phase|Adverse Event|18
1849073|NCT00185458|6392527|P1|Contraception Phase|Withdrawal by Subject|7
1849074|NCT00185458|6392527|P1|Contraception Phase|Physician Decision|2
1849075|NCT00185458|6392527|P1|Contraception Phase|Protocol Violation|2
1849076|NCT00185458|6392527|P1|Contraception Phase|Lost to Follow-up|10
1849077|NCT00185458|6392527|P1|Contraception Phase|Adverse Event|37
1849078|NCT00185380|6392590|P3|Overall Study|personal reason|1
1849079|NCT00185380|6392591|P2|Overall Study|personal reason|1
1849080|NCT00185380|6392592|P1|Overall Study|personal reason|6
1849081|NCT00185380|6392590|P3|Overall Study|Could not attend visits|4
1849082|NCT00185380|6392591|P2|Overall Study|Could not attend visits|0
1849083|NCT00185380|6392592|P1|Overall Study|Could not attend visits|2
1849084|NCT00185380|6392590|P3|Overall Study|No need for contraception|3
1849085|NCT00185380|6392591|P2|Overall Study|No need for contraception|3
1849086|NCT00185380|6392592|P1|Overall Study|No need for contraception|3
1849087|NCT00185380|6392590|P3|Overall Study|Planned pregnancy|12
1849088|NCT00185380|6392591|P2|Overall Study|Planned pregnancy|12
1849089|NCT00185380|6392592|P1|Overall Study|Planned pregnancy|9
1849090|NCT00185380|6392590|P3|Overall Study|Failed insertion|2
1849091|NCT00185380|6392591|P2|Overall Study|Failed insertion|1
1849092|NCT00185380|6392592|P1|Overall Study|Failed insertion|1
1849093|NCT00185380|6392590|P3|Overall Study|Withdrawal by Subject|0
1849094|NCT00185380|6392591|P2|Overall Study|Withdrawal by Subject|2
1849095|NCT00185380|6392592|P1|Overall Study|Withdrawal by Subject|1
1849096|NCT00185380|6392590|P3|Overall Study|Protocol Violation|1
1849097|NCT00185380|6392591|P2|Overall Study|Protocol Violation|2
1849098|NCT00185380|6392592|P1|Overall Study|Protocol Violation|2
1849099|NCT00185380|6392590|P3|Overall Study|Pregnancy|0
1849100|NCT00185380|6392591|P2|Overall Study|Pregnancy|4
1849101|NCT00185380|6392592|P1|Overall Study|Pregnancy|1
1849102|NCT00185380|6392590|P3|Overall Study|Lost to Follow-up|3
1849103|NCT00185380|6392591|P2|Overall Study|Lost to Follow-up|4
1849104|NCT00185380|6392592|P1|Overall Study|Lost to Follow-up|0
1849105|NCT00185380|6392590|P3|Overall Study|Adverse Event|48
1849106|NCT00185380|6392591|P2|Overall Study|Adverse Event|43
1849107|NCT00185380|6392592|P1|Overall Study|Adverse Event|41
1849108|NCT00185211|6392620|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
1849109|NCT00185211|6392621|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
1849110|NCT00185211|6392620|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
1849111|NCT00185211|6392621|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
1849112|NCT00185211|6392620|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
1849113|NCT00185211|6392621|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
1849114|NCT00185211|6392620|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
1849115|NCT00185211|6392621|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
1849116|NCT00185211|6392620|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
1849117|NCT00185211|6392621|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
1849118|NCT00185211|6392620|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
1849119|NCT00185211|6392621|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
1849120|NCT00185211|6392620|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
1849121|NCT00185211|6392621|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
1849122|NCT00185211|6392620|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
1849123|NCT00185211|6392621|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
1849124|NCT00185211|6392620|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
1849125|NCT00185211|6392621|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
1849126|NCT00185211|6392620|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
1849127|NCT00185211|6392621|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
1849128|NCT00185211|6392620|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
1849129|NCT00185211|6392621|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
1849130|NCT00185211|6392620|P2|Placebo-controlled Study (92012)|Adverse Event|0
1849131|NCT00185211|6392621|P1|Placebo-controlled Study (92012)|Adverse Event|8
1849132|NCT00184600|6392694|P3|Overall Study|Unclassified|3
1849133|NCT00184600|6392695|P2|Overall Study|Unclassified|5
1849134|NCT00184600|6392696|P1|Overall Study|Unclassified|4
1849135|NCT00184600|6392694|P3|Overall Study|Withdrawal by Subject|12
1849136|NCT00184600|6392695|P2|Overall Study|Withdrawal by Subject|28
1849137|NCT00184600|6392696|P1|Overall Study|Withdrawal by Subject|20
1849138|NCT00184600|6392694|P3|Overall Study|Protocol Violation|3
1849139|NCT00184600|6392695|P2|Overall Study|Protocol Violation|2
1849140|NCT00184600|6392696|P1|Overall Study|Protocol Violation|2
1849141|NCT00184600|6392694|P3|Overall Study|Lost to Follow-up|1
1849142|NCT00184600|6392695|P2|Overall Study|Lost to Follow-up|6
1849143|NCT00184600|6392696|P1|Overall Study|Lost to Follow-up|4
1849144|NCT00184600|6392694|P3|Overall Study|Lack of Efficacy|3
1849145|NCT00184600|6392695|P2|Overall Study|Lack of Efficacy|1
1849146|NCT00184600|6392696|P1|Overall Study|Lack of Efficacy|3
1849147|NCT00184600|6392694|P3|Overall Study|Death|7
1849148|NCT00184600|6392695|P2|Overall Study|Death|9
1849149|NCT00184600|6392696|P1|Overall Study|Death|3
1849150|NCT00184600|6392694|P3|Overall Study|Adverse Event|5
1849151|NCT00184600|6392695|P2|Overall Study|Adverse Event|0
1849152|NCT00184600|6392696|P1|Overall Study|Adverse Event|9
1849153|NCT00184093|6392787|P1|Overall Study|Withdrawal by Subject|2
1849154|NCT00184093|6392787|P1|Overall Study|Physician Decision|1
1849155|NCT00184093|6392787|P1|Overall Study|Lost to Follow-up|3
1849156|NCT00184093|6392787|P1|Overall Study|Adverse Event|3
1849157|NCT00184054|6392792|P1|Overall Study|Adverse Event|1
1849158|NCT00184028|6392797|P1|Overall Study|Non-compliance|2
1849159|NCT00184028|6392797|P1|Overall Study|Withdrawal by Subject|1
1849160|NCT00184028|6392797|P1|Overall Study|Adverse Event|2
1849161|NCT00184028|6392797|P1|Overall Study|Lack of Efficacy|4
1849162|NCT00184028|6392797|P1|Overall Study|Death|1
1849163|NCT00184002|6392802|P1|Overall Study|Withdrawal by Subject|4
1849164|NCT00184002|6392802|P1|Overall Study|Physician Decision|1
1849165|NCT00184002|6392802|P1|Overall Study|Death|3
1849166|NCT00184002|6392802|P1|Overall Study|Adverse Event|9
1849167|NCT00183872|6392828|P1|Overall Study|Drug delayed more than 28 days|2
1849168|NCT00183872|6392828|P1|Overall Study|Withdrawal by Subject|2
1849169|NCT00183872|6392828|P1|Overall Study|Adverse Event|9
1849170|NCT00183872|6392828|P1|Overall Study|Death|3
1849171|NCT00183625|6392857|P4|Overall Study|Withdrawal by Subject|14
1849172|NCT00183625|6392858|P3|Overall Study|Withdrawal by Subject|19
1849173|NCT00183625|6392859|P2|Overall Study|Withdrawal by Subject|18
1849174|NCT00183625|6392860|P1|Overall Study|Withdrawal by Subject|18
1849175|NCT00183430|6392957|P2|Overall Study|Withdrawal by Subject|0
1849176|NCT00183430|6392958|P1|Overall Study|Withdrawal by Subject|1
1849177|NCT00183430|6392957|P2|Overall Study|did not meet inclusion criteria|0
1849178|NCT00183430|6392958|P1|Overall Study|did not meet inclusion criteria|1
1849179|NCT00183430|6392957|P2|Overall Study|Lost to Follow-up|0
1849180|NCT00183430|6392958|P1|Overall Study|Lost to Follow-up|3
1849181|NCT00183430|6392957|P2|Overall Study|Adverse Event|0
1849182|NCT00183430|6392958|P1|Overall Study|Adverse Event|1
1849183|NCT00183391|6392970|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
1849184|NCT00183391|6392971|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
1849185|NCT00183391|6392970|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
1849186|NCT00183391|6392971|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
1849187|NCT00183274|6393044|P6|Phase 3: Double-Blind|Relapsed|2
1849188|NCT00183274|6393045|P5|Phase 3: Double-Blind|Relapsed|11
1849189|NCT00183274|6393046|P4|Phase 3: Double-Blind|Relapsed|1
1849190|NCT00183274|6393047|P3|Phase 3: Double-Blind|Relapsed|0
1849191|NCT00183274|6393048|P2|Phase 3: Double-Blind|Relapsed|0
1849192|NCT00183274|6393049|P1|Phase 3: Double-Blind|Relapsed|0
1849193|NCT00183274|6393044|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
1849194|NCT00183274|6393045|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
1849195|NCT00183274|6393046|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
1849196|NCT00183274|6393047|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
1849197|NCT00183274|6393048|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
1849198|NCT00183274|6393049|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
1849199|NCT00183274|6393044|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
1849200|NCT00183274|6393045|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
1849201|NCT00183274|6393046|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
1849202|NCT00183274|6393047|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
1849203|NCT00183274|6393048|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
1849204|NCT00183274|6393049|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
1849205|NCT00183274|6393044|P6|Phase 2: Double-Blind|Relapsed|0
1849206|NCT00183274|6393045|P5|Phase 2: Double-Blind|Relapsed|0
1849207|NCT00183274|6393046|P4|Phase 2: Double-Blind|Relapsed|0
1849208|NCT00183274|6393047|P3|Phase 2: Double-Blind|Relapsed|29
1849209|NCT00183274|6393048|P2|Phase 2: Double-Blind|Relapsed|8
1849210|NCT00183274|6393049|P1|Phase 2: Double-Blind|Relapsed|0
1849211|NCT00183274|6393044|P6|Phase 1: Open-Label|Other|0
1849212|NCT00183274|6393045|P5|Phase 1: Open-Label|Other|0
1849213|NCT00183274|6393046|P4|Phase 1: Open-Label|Other|0
1849214|NCT00183274|6393047|P3|Phase 1: Open-Label|Other|0
1849215|NCT00183274|6393048|P2|Phase 1: Open-Label|Other|0
1849216|NCT00183274|6393049|P1|Phase 1: Open-Label|Other|9
1849217|NCT00183274|6393044|P6|Phase 1: Open-Label|Lost to Follow-up|0
1849218|NCT00183274|6393045|P5|Phase 1: Open-Label|Lost to Follow-up|0
1849219|NCT00183274|6393046|P4|Phase 1: Open-Label|Lost to Follow-up|0
1849220|NCT00183274|6393047|P3|Phase 1: Open-Label|Lost to Follow-up|0
1849221|NCT00183274|6393048|P2|Phase 1: Open-Label|Lost to Follow-up|0
1849222|NCT00183274|6393049|P1|Phase 1: Open-Label|Lost to Follow-up|33
1849223|NCT00183274|6393044|P6|Phase 1: Open-Label|Withdrawal by Subject|0
1849224|NCT00183274|6393045|P5|Phase 1: Open-Label|Withdrawal by Subject|0
1849225|NCT00183274|6393046|P4|Phase 1: Open-Label|Withdrawal by Subject|0
1849226|NCT00183274|6393047|P3|Phase 1: Open-Label|Withdrawal by Subject|0
1849227|NCT00183274|6393048|P2|Phase 1: Open-Label|Withdrawal by Subject|0
1849228|NCT00183274|6393049|P1|Phase 1: Open-Label|Withdrawal by Subject|13
1849229|NCT00183274|6393044|P6|Phase 1: Open-Label|Protocol Violation|0
1849230|NCT00183274|6393045|P5|Phase 1: Open-Label|Protocol Violation|0
1849231|NCT00183274|6393046|P4|Phase 1: Open-Label|Protocol Violation|0
1849232|NCT00183274|6393047|P3|Phase 1: Open-Label|Protocol Violation|0
1849233|NCT00183274|6393048|P2|Phase 1: Open-Label|Protocol Violation|0
1849234|NCT00183274|6393049|P1|Phase 1: Open-Label|Protocol Violation|11
1849235|NCT00183274|6393044|P6|Phase 1: Open-Label|Lack of Efficacy|0
1849236|NCT00183274|6393045|P5|Phase 1: Open-Label|Lack of Efficacy|0
1849237|NCT00183274|6393046|P4|Phase 1: Open-Label|Lack of Efficacy|0
1849238|NCT00183274|6393047|P3|Phase 1: Open-Label|Lack of Efficacy|0
1849239|NCT00183274|6393048|P2|Phase 1: Open-Label|Lack of Efficacy|0
1849240|NCT00183274|6393049|P1|Phase 1: Open-Label|Lack of Efficacy|13
1849241|NCT00183274|6393044|P6|Phase 1: Open-Label|Adverse Event|0
1849242|NCT00183274|6393045|P5|Phase 1: Open-Label|Adverse Event|0
1849243|NCT00183274|6393046|P4|Phase 1: Open-Label|Adverse Event|0
1849244|NCT00183274|6393047|P3|Phase 1: Open-Label|Adverse Event|0
1849245|NCT00183274|6393048|P2|Phase 1: Open-Label|Adverse Event|0
1849246|NCT00183274|6393049|P1|Phase 1: Open-Label|Adverse Event|31
1849247|NCT00183248|6393066|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
1849248|NCT00183248|6393067|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
1849249|NCT00183248|6393066|P2|Overall Study|Lost to Follow-up|1
1849250|NCT00183248|6393067|P1|Overall Study|Lost to Follow-up|0
1849251|NCT00183196|6393088|P3|Overall Study|Required more intensive care|2
1849252|NCT00183196|6393089|P2|Overall Study|Required more intensive care|1
1849253|NCT00183196|6393090|P1|Overall Study|Required more intensive care|0
1849254|NCT00183196|6393088|P3|Overall Study|Legal event|1
1849255|NCT00183196|6393089|P2|Overall Study|Legal event|1
1849256|NCT00183196|6393090|P1|Overall Study|Legal event|1
1849257|NCT00183196|6393088|P3|Overall Study|Adverse Event|2
1849258|NCT00183196|6393089|P2|Overall Study|Adverse Event|2
1849259|NCT00183196|6393090|P1|Overall Study|Adverse Event|1
1849260|NCT00183196|6393088|P3|Overall Study|Withdrawal by Subject|13
1849261|NCT00183196|6393089|P2|Overall Study|Withdrawal by Subject|11
1849262|NCT00183196|6393090|P1|Overall Study|Withdrawal by Subject|18
1849263|NCT00182689|6393173|P2|Overall Study|Never received treatment|0
1849264|NCT00182689|6393174|P1|Overall Study|Never received treatment|1
1849265|NCT00182689|6393173|P2|Overall Study|Ineligible|4
1849266|NCT00182689|6393174|P1|Overall Study|Ineligible|1
1849267|NCT00182689|6393173|P2|Overall Study|not protocol specified|3
1849268|NCT00182689|6393174|P1|Overall Study|not protocol specified|0
1849269|NCT00182689|6393173|P2|Overall Study|Death|0
1849270|NCT00182689|6393174|P1|Overall Study|Death|1
1849271|NCT00182689|6393173|P2|Overall Study|Progression|29
1849272|NCT00182689|6393174|P1|Overall Study|Progression|27
1849273|NCT00182689|6393173|P2|Overall Study|Withdrawal by Subject|2
1849274|NCT00182689|6393174|P1|Overall Study|Withdrawal by Subject|2
1849275|NCT00182689|6393173|P2|Overall Study|Adverse Event|11
1849276|NCT00182689|6393174|P1|Overall Study|Adverse Event|8
1849277|NCT00182637|6393184|P1|Overall Study|Disease Progression|1
1849278|NCT00182637|6393184|P1|Overall Study|Adverse Event|2
1849279|NCT00182325|6393192|P2|Overall Study|Did not complete survey|43
1849280|NCT00182325|6393193|P1|Overall Study|Did not complete survey|22
1849281|NCT00182325|6393192|P2|Overall Study|Miscarriage|3
1849282|NCT00182325|6393193|P1|Overall Study|Miscarriage|5
1849283|NCT00182325|6393192|P2|Overall Study|Lost to Follow-up|7
1849284|NCT00182325|6393193|P1|Overall Study|Lost to Follow-up|7
1849285|NCT00182091|6393221|P4|Overall Study|Withdrawal by Subject|0
1849286|NCT00182091|6393222|P3|Overall Study|Withdrawal by Subject|0
1849287|NCT00182091|6393223|P2|Overall Study|Withdrawal by Subject|0
1849288|NCT00182091|6393224|P1|Overall Study|Withdrawal by Subject|1
1849289|NCT00182078|6393240|P2|Overall Study|Withdrawal by Subject|0
1849290|NCT00182078|6393241|P1|Overall Study|Withdrawal by Subject|1
1849291|NCT00181883|6393269|P1|Overall Study|Lost to Follow-up|1
1849292|NCT00181883|6393269|P1|Overall Study|Withdrawal by Subject|4
1849293|NCT00181883|6393269|P1|Overall Study|Treatment Limiting AEs|3
1849294|NCT00181883|6393269|P1|Overall Study|Lack of Efficacy|2
1849295|NCT00181844|6393273|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
1849296|NCT00181844|6393273|P1|Exposed to Study Medication|Withdrawal by Subject|1
1849297|NCT00181844|6393273|P1|Exposed to Study Medication|Non-compliance|2
1849298|NCT00181844|6393273|P1|Exposed to Study Medication|Lack of Efficacy|2
1849299|NCT00181844|6393273|P1|Exposed to Study Medication|Adverse Event|10
1849300|NCT00181844|6393273|P1|Signed Consent|Did not meet entrance criteria|7
1849301|NCT00181844|6393273|P1|Signed Consent|Withdrawal by Subject|5
1849302|NCT00181766|6393277|P1|Overall Study|non-compliance|2
1849303|NCT00181766|6393277|P1|Overall Study|Adverse Event|4
1849304|NCT00181766|6393277|P1|Overall Study|Lost to Follow-up|6
1849305|NCT00181155|6393351|P2|Overall Study|Withdrawal by Subject|0
1849306|NCT00181155|6393352|P1|Overall Study|Withdrawal by Subject|1
1849307|NCT00181155|6393351|P2|Overall Study|Physician Decision|0
1849308|NCT00181155|6393352|P1|Overall Study|Physician Decision|1
1849309|NCT00180713|6393362|P2|Overall Study|Adverse Event|3
1849310|NCT00180713|6393363|P1|Overall Study|Adverse Event|3
1849311|NCT00180713|6393362|P2|Overall Study|Withdrawal by Subject|0
1849312|NCT00180713|6393363|P1|Overall Study|Withdrawal by Subject|2
1849313|NCT00180479|6393427|P2|Overall Study|Informed consent not signed|1
1849314|NCT00180479|6393428|P1|Overall Study|Informed consent not signed|0
1849315|NCT00180479|6393427|P2|Overall Study|Withdrawal by Subject|3
1849316|NCT00180479|6393428|P1|Overall Study|Withdrawal by Subject|3
1849317|NCT00180479|6393427|P2|Overall Study|Lost to Follow-up|7
1849318|NCT00180479|6393428|P1|Overall Study|Lost to Follow-up|9
1849319|NCT00180479|6393427|P2|Overall Study|Death|2
1849320|NCT00180479|6393428|P1|Overall Study|Death|4
1849321|NCT00179959|6393553|P2|Overall Study|Withdrawal by Subject|2
1849322|NCT00179959|6393554|P1|Overall Study|Withdrawal by Subject|3
1849323|NCT00179959|6393553|P2|Overall Study|Lost to Follow-up|1
1849324|NCT00179959|6393554|P1|Overall Study|Lost to Follow-up|3
1849325|NCT00179673|6393560|P1|Overall Study|Other Observations and options|14
1849326|NCT00179673|6393560|P1|Overall Study|Death|4
1849327|NCT00179673|6393560|P1|Overall Study|Withdrawal by Subject|3
1849328|NCT00179673|6393560|P1|Overall Study|Lack of Efficacy|15
1849329|NCT00179673|6393560|P1|Overall Study|Adverse Event|7
1849330|NCT00179660|6393568|P1|Overall Study|Other - Unspecified|9
1849331|NCT00179660|6393568|P1|Overall Study|Death|3
1849332|NCT00179660|6393568|P1|Overall Study|Lost to Follow-up|1
1849333|NCT00179660|6393568|P1|Overall Study|Withdrawal by Subject|2
1849334|NCT00179660|6393568|P1|Overall Study|Lack of therapeutic effect|28
1849335|NCT00179660|6393568|P1|Overall Study|Adverse Event|7
1849336|NCT00179647|6393577|P1|Overall Study|Other|960
1849337|NCT00179647|6393577|P1|Overall Study|Death|94
1849338|NCT00179647|6393577|P1|Overall Study|Lost to Follow-up|4
1849339|NCT00179647|6393577|P1|Overall Study|Withdrawal by Subject|83
1849340|NCT00179647|6393577|P1|Overall Study|Lack of Efficacy|478
1849341|NCT00179647|6393577|P1|Overall Study|Adverse Event|294
1849342|NCT00179621|6393584|P4|Open-Label Period|Other|2
1849343|NCT00179621|6393585|P3|Open-Label Period|Other|1
1849344|NCT00179621|6393586|P2|Open-Label Period|Other|1
1849345|NCT00179621|6393587|P1|Open-Label Period|Other|0
1849346|NCT00179621|6393584|P4|Open-Label Period|Death|2
1849347|NCT00179621|6393585|P3|Open-Label Period|Death|1
1849348|NCT00179621|6393586|P2|Open-Label Period|Death|0
1849349|NCT00179621|6393587|P1|Open-Label Period|Death|0
1849350|NCT00179621|6393584|P4|Open-Label Period|Withdrawal by Subject|2
1849351|NCT00179621|6393585|P3|Open-Label Period|Withdrawal by Subject|2
1849352|NCT00179621|6393586|P2|Open-Label Period|Withdrawal by Subject|2
1849353|NCT00179621|6393587|P1|Open-Label Period|Withdrawal by Subject|0
1849354|NCT00179621|6393584|P4|Open-Label Period|Adverse Event|6
1849355|NCT00179621|6393585|P3|Open-Label Period|Adverse Event|5
1849356|NCT00179621|6393586|P2|Open-Label Period|Adverse Event|6
1849357|NCT00179621|6393587|P1|Open-Label Period|Adverse Event|0
1849358|NCT00179621|6393584|P4|Open-Label Period|Lack of Therapeutic Effect|31
1849359|NCT00179621|6393585|P3|Open-Label Period|Lack of Therapeutic Effect|19
1849360|NCT00179621|6393586|P2|Open-Label Period|Lack of Therapeutic Effect|19
1849361|NCT00179621|6393587|P1|Open-Label Period|Lack of Therapeutic Effect|0
1849362|NCT00179621|6393584|P4|Double-Blind Period|Other|0
1849363|NCT00179621|6393585|P3|Double-Blind Period|Other|2
1849364|NCT00179621|6393586|P2|Double-Blind Period|Other|2
1849365|NCT00179621|6393587|P1|Double-Blind Period|Other|0
1849366|NCT00179621|6393584|P4|Double-Blind Period|Protocol Violation|0
1849367|NCT00179621|6393585|P3|Double-Blind Period|Protocol Violation|0
1849368|NCT00179621|6393586|P2|Double-Blind Period|Protocol Violation|0
1849369|NCT00179621|6393587|P1|Double-Blind Period|Protocol Violation|1
1849370|NCT00179621|6393584|P4|Double-Blind Period|Death|0
1849371|NCT00179621|6393585|P3|Double-Blind Period|Death|2
1849372|NCT00179621|6393586|P2|Double-Blind Period|Death|1
1849373|NCT00179621|6393587|P1|Double-Blind Period|Death|0
1849374|NCT00179621|6393584|P4|Double-Blind Period|Withdrawal by Subject|0
1849375|NCT00179621|6393585|P3|Double-Blind Period|Withdrawal by Subject|3
1849376|NCT00179621|6393586|P2|Double-Blind Period|Withdrawal by Subject|1
1849377|NCT00179621|6393587|P1|Double-Blind Period|Withdrawal by Subject|2
1849378|NCT00179621|6393584|P4|Double-Blind Period|Adverse Event|0
1849379|NCT00179621|6393585|P3|Double-Blind Period|Adverse Event|4
1849380|NCT00179621|6393586|P2|Double-Blind Period|Adverse Event|7
1849381|NCT00179621|6393587|P1|Double-Blind Period|Adverse Event|2
1849382|NCT00179621|6393584|P4|Double-Blind Period|Lack of Therapeutic Effect|0
1849383|NCT00179621|6393585|P3|Double-Blind Period|Lack of Therapeutic Effect|19
1849384|NCT00179621|6393586|P2|Double-Blind Period|Lack of Therapeutic Effect|35
1849385|NCT00179621|6393587|P1|Double-Blind Period|Lack of Therapeutic Effect|59
1849386|NCT00179517|6393640|P2|Overall Study|Withdrawal by Subject|1
1849387|NCT00179517|6393641|P1|Overall Study|Withdrawal by Subject|2
1849388|NCT00179413|6393679|P2|Overall Study|Withdrawal by Subject|95
1849389|NCT00179413|6393680|P1|Overall Study|Withdrawal by Subject|87
1849390|NCT00179413|6393679|P2|Overall Study|Adverse Event|20
1849391|NCT00179413|6393680|P1|Overall Study|Adverse Event|38
1849392|NCT00179309|6393692|P2|Treatment|Allergy|0
1849393|NCT00179309|6393693|P1|Treatment|Allergy|1
1849394|NCT00179309|6393692|P2|Treatment|Withdrawal by Subject|2
1849395|NCT00179309|6393693|P1|Treatment|Withdrawal by Subject|1
1849396|NCT00179309|6393692|P2|Treatment|Toxicity|3
1849397|NCT00179309|6393693|P1|Treatment|Toxicity|2
1849398|NCT00179010|6393716|P2|Overall Study|Failure to place arterial line|1
1849399|NCT00179010|6393717|P1|Overall Study|Failure to place arterial line|0
1849400|NCT00179010|6393716|P2|Overall Study|Muscle probe defective|1
1849401|NCT00179010|6393717|P1|Overall Study|Muscle probe defective|1
1849402|NCT00178685|6393756|P3|Overall Study|Withdrawal by Subject|7
1849403|NCT00178685|6393757|P2|Overall Study|Withdrawal by Subject|14
1849404|NCT00178685|6393758|P1|Overall Study|Withdrawal by Subject|8
1849405|NCT00178685|6393756|P3|Overall Study|Lost to Follow-up|183
1849406|NCT00178685|6393757|P2|Overall Study|Lost to Follow-up|187
1849407|NCT00178685|6393758|P1|Overall Study|Lost to Follow-up|100
1849408|NCT00178685|6393756|P3|Overall Study|Death|6
1849409|NCT00178685|6393757|P2|Overall Study|Death|3
1849410|NCT00178685|6393758|P1|Overall Study|Death|3
1849411|NCT00178633|6393769|P1|Overall Study|Lost to Follow-up|6
1849412|NCT00178464|6393799|P1|Overall Study|Physician Decision|1
1849413|NCT00178464|6393799|P1|Overall Study|Withdrawal by Subject|1
1849414|NCT00178399|6393804|P1|Overall Study|Lost to Follow-up|1
1849415|NCT00178399|6393804|P1|Overall Study|Withdrawal by Subject|8
1849416|NCT00178399|6393804|P1|Overall Study|Physician Decision|4
1849417|NCT00178256|6393811|P4|Overall Study|Cancer progression|1
1849418|NCT00178256|6393812|P3|Overall Study|Cancer progression|0
1849419|NCT00178256|6393813|P2|Overall Study|Cancer progression|0
1849420|NCT00178256|6393814|P1|Overall Study|Cancer progression|2
1849421|NCT00178256|6393811|P4|Overall Study|Death|1
1849422|NCT00178256|6393812|P3|Overall Study|Death|0
1849423|NCT00178256|6393813|P2|Overall Study|Death|1
1849424|NCT00178256|6393814|P1|Overall Study|Death|0
1849425|NCT00178256|6393811|P4|Overall Study|Adverse Event|0
1849426|NCT00178256|6393812|P3|Overall Study|Adverse Event|0
1849427|NCT00178256|6393813|P2|Overall Study|Adverse Event|0
1849428|NCT00178256|6393814|P1|Overall Study|Adverse Event|2
1849429|NCT00178126|6393853|P2|Overall Study|did not receive intervention|6
1849430|NCT00178126|6393854|P1|Overall Study|did not receive intervention|4
1849431|NCT00178126|6393853|P2|Overall Study|Lost to Follow-up|21
1849432|NCT00178126|6393854|P1|Overall Study|Lost to Follow-up|21
1849433|NCT00177671|6393896|P2|Overall Study|Physician Decision|8
1849434|NCT00177671|6393897|P1|Overall Study|Physician Decision|12
1849435|NCT00177671|6393896|P2|Overall Study|Adverse Event|0
1849436|NCT00177671|6393897|P1|Overall Study|Adverse Event|6
1849437|NCT00177671|6393896|P2|Overall Study|medical complications|0
1849438|NCT00177671|6393897|P1|Overall Study|medical complications|2
1849439|NCT00177671|6393896|P2|Overall Study|Withdrawal by Subject|6
1849440|NCT00177671|6393897|P1|Overall Study|Withdrawal by Subject|5
1849441|NCT00177307|6393909|P1|Overall Study|Withdrawal by Subject|1
1849442|NCT00177294|6393918|P2|Overall Study|Withdrawal by Subject|5
1849443|NCT00177294|6393919|P1|Overall Study|Withdrawal by Subject|7
1849444|NCT00177216|6393933|P3|Overall Study|Withdrawal by Subject|1
1849445|NCT00177216|6393934|P2|Overall Study|Withdrawal by Subject|3
1849446|NCT00177216|6393935|P1|Overall Study|Withdrawal by Subject|6
1849447|NCT00177164|6393951|P2|Overall Study|Pregnancy|1
1849448|NCT00177164|6393952|P1|Overall Study|Pregnancy|0
1849449|NCT00177164|6393951|P2|Overall Study|Lack of Efficacy|1
1849450|NCT00177164|6393952|P1|Overall Study|Lack of Efficacy|2
1849451|NCT00177164|6393951|P2|Overall Study|discharge from hospital|0
1849452|NCT00177164|6393952|P1|Overall Study|discharge from hospital|1
1849453|NCT00177164|6393951|P2|Overall Study|Adverse Event|0
1849454|NCT00177164|6393952|P1|Overall Study|Adverse Event|1
1849455|NCT00177164|6393951|P2|Overall Study|increase in alcohol and drug use|2
1849456|NCT00177164|6393952|P1|Overall Study|increase in alcohol and drug use|1
1849457|NCT00177164|6393951|P2|Overall Study|Lost to Follow-up|5
1849458|NCT00177164|6393952|P1|Overall Study|Lost to Follow-up|4
1849459|NCT00177164|6393951|P2|Overall Study|Protocol Violation|7
1849460|NCT00177164|6393952|P1|Overall Study|Protocol Violation|0
1849461|NCT00176644|6394128|P1|Overall Study|Withdrawal by Subject|1
1849462|NCT00176605|6394141|P1|Overall Study|Withdrawal by Subject|2
1849463|NCT00176488|6394152|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
1849464|NCT00176462|6394160|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
1849465|NCT00176462|6394161|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
1849466|NCT00176462|6394160|P2|Intensive Continuation (8X8-week Cycles)|Death|0
1849467|NCT00176462|6394161|P1|Intensive Continuation (8X8-week Cycles)|Death|1
1849468|NCT00176462|6394160|P2|Consolidation (12 Weeks)|Not documented|1
1849469|NCT00176462|6394161|P1|Consolidation (12 Weeks)|Not documented|0
1849470|NCT00176462|6394160|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
1849471|NCT00176462|6394161|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
1849472|NCT00176462|6394160|P2|Consolidation (12 Weeks)|Adverse Event|1
1849473|NCT00176462|6394161|P1|Consolidation (12 Weeks)|Adverse Event|0
1849474|NCT00176462|6394160|P2|Consolidation (12 Weeks)|Patient moved to another state|1
1849475|NCT00176462|6394161|P1|Consolidation (12 Weeks)|Patient moved to another state|0
1849476|NCT00176462|6394160|P2|Induction (4 Weeks)|Lack of Efficacy|1
1849477|NCT00176462|6394161|P1|Induction (4 Weeks)|Lack of Efficacy|0
1849478|NCT00176462|6394160|P2|Induction (4 Weeks)|Death|2
1849479|NCT00176462|6394161|P1|Induction (4 Weeks)|Death|1
1849480|NCT00176462|6394160|P2|Induction (4 Weeks)|Withdrawal by Subject|2
1849481|NCT00176462|6394161|P1|Induction (4 Weeks)|Withdrawal by Subject|0
1849482|NCT00176254|6394181|P1|Overall Study|Lost to Follow-up|1
1849483|NCT00175877|6394209|P1|Overall Study|Withdrawal by subject & Other|1
1849484|NCT00175877|6394209|P1|Overall Study|AE & Other|1
1849485|NCT00175877|6394209|P1|Overall Study|Other Reason|20
1849486|NCT00175877|6394209|P1|Overall Study|Protocol Violation|15
1849487|NCT00175877|6394209|P1|Overall Study|Lack of Efficacy|26
1849488|NCT00175877|6394209|P1|Overall Study|Lost to Follow-up|9
1849489|NCT00175877|6394209|P1|Overall Study|Withdrawal by Subject|141
1849490|NCT00175877|6394209|P1|Overall Study|Adverse Event|136
1849491|NCT00175825|6394244|P4|Overall Study|Withdrawal by Subject|0
1849492|NCT00175825|6394245|P3|Overall Study|Withdrawal by Subject|0
1849493|NCT00175825|6394246|P2|Overall Study|Withdrawal by Subject|0
1849494|NCT00175825|6394247|P1|Overall Study|Withdrawal by Subject|1
1849495|NCT00175825|6394244|P4|Overall Study|Lost to Follow-up|0
1849496|NCT00175825|6394245|P3|Overall Study|Lost to Follow-up|0
1849497|NCT00175825|6394246|P2|Overall Study|Lost to Follow-up|2
1849498|NCT00175825|6394247|P1|Overall Study|Lost to Follow-up|1
1849499|NCT00175825|6394244|P4|Overall Study|Adverse Event|1
1849500|NCT00175825|6394245|P3|Overall Study|Adverse Event|1
1849501|NCT00175825|6394246|P2|Overall Study|Adverse Event|2
1849502|NCT00175825|6394247|P1|Overall Study|Adverse Event|3
1849503|NCT00175019|6394300|P3|Overall Study|Reason Not Specified|11
1849504|NCT00175019|6394301|P2|Overall Study|Reason Not Specified|34
1849505|NCT00175019|6394302|P1|Overall Study|Reason Not Specified|40
1849506|NCT00175019|6394300|P3|Overall Study|Gout Flare|0
1849507|NCT00175019|6394301|P2|Overall Study|Gout Flare|3
1849508|NCT00175019|6394302|P1|Overall Study|Gout Flare|2
1849509|NCT00175019|6394300|P3|Overall Study|Therapeutic Failure|22
1849510|NCT00175019|6394301|P2|Overall Study|Therapeutic Failure|38
1849511|NCT00175019|6394302|P1|Overall Study|Therapeutic Failure|10
1849512|NCT00175019|6394300|P3|Overall Study|Personal Reason(s)|8
1849513|NCT00175019|6394301|P2|Overall Study|Personal Reason(s)|31
1849514|NCT00175019|6394302|P1|Overall Study|Personal Reason(s)|39
1849515|NCT00175019|6394300|P3|Overall Study|Did not continue under Amendment 4|2
1849516|NCT00175019|6394301|P2|Overall Study|Did not continue under Amendment 4|1
1849517|NCT00175019|6394302|P1|Overall Study|Did not continue under Amendment 4|1
1849518|NCT00175019|6394300|P3|Overall Study|Lost to Follow-up|9
1849519|NCT00175019|6394301|P2|Overall Study|Lost to Follow-up|39
1849520|NCT00175019|6394302|P1|Overall Study|Lost to Follow-up|42
1849521|NCT00175019|6394300|P3|Overall Study|Protocol Violation|3
1849522|NCT00175019|6394301|P2|Overall Study|Protocol Violation|3
1849523|NCT00175019|6394302|P1|Overall Study|Protocol Violation|6
1849524|NCT00175019|6394300|P3|Overall Study|Adverse Event|2
1849525|NCT00175019|6394301|P2|Overall Study|Adverse Event|22
1849526|NCT00175019|6394302|P1|Overall Study|Adverse Event|54
1849527|NCT00174967|6394355|P4|Overall Study|Other|0
1849528|NCT00174967|6394356|P3|Overall Study|Other|0
1849529|NCT00174967|6394357|P2|Overall Study|Other|1
1849530|NCT00174967|6394358|P1|Overall Study|Other|0
1849531|NCT00174967|6394355|P4|Overall Study|Gout Flare|1
1849532|NCT00174967|6394356|P3|Overall Study|Gout Flare|0
1849533|NCT00174967|6394357|P2|Overall Study|Gout Flare|0
1849534|NCT00174967|6394358|P1|Overall Study|Gout Flare|0
1849535|NCT00174967|6394355|P4|Overall Study|Adverse Event|1
1849536|NCT00174967|6394356|P3|Overall Study|Adverse Event|2
1849537|NCT00174967|6394357|P2|Overall Study|Adverse Event|2
1849538|NCT00174967|6394358|P1|Overall Study|Adverse Event|1
1849539|NCT00174954|6394404|P1|Overall Study|Physician Decision|1
1849540|NCT00174954|6394404|P1|Overall Study|No tophi found in MRI|1
1849541|NCT00174954|6394404|P1|Overall Study|Adverse Event|2
1849542|NCT00174941|6394412|P4|Overall Study|Reason Not Specified|9
1849543|NCT00174941|6394413|P3|Overall Study|Reason Not Specified|2
1849544|NCT00174941|6394414|P2|Overall Study|Reason Not Specified|6
1849545|NCT00174941|6394415|P1|Overall Study|Reason Not Specified|1
1849546|NCT00174941|6394412|P4|Overall Study|Gout Flare|8
1849547|NCT00174941|6394413|P3|Overall Study|Gout Flare|4
1849548|NCT00174941|6394414|P2|Overall Study|Gout Flare|4
1849549|NCT00174941|6394415|P1|Overall Study|Gout Flare|0
1849550|NCT00174941|6394412|P4|Overall Study|Personal Reason(s)|22
1849551|NCT00174941|6394413|P3|Overall Study|Personal Reason(s)|8
1849552|NCT00174941|6394414|P2|Overall Study|Personal Reason(s)|14
1849553|NCT00174941|6394415|P1|Overall Study|Personal Reason(s)|0
1849554|NCT00174941|6394412|P4|Overall Study|Lost to Follow-up|5
1849555|NCT00174941|6394413|P3|Overall Study|Lost to Follow-up|2
1849556|NCT00174941|6394414|P2|Overall Study|Lost to Follow-up|3
1849557|NCT00174941|6394415|P1|Overall Study|Lost to Follow-up|0
1849558|NCT00174941|6394412|P4|Overall Study|Protocol Violation|1
1849559|NCT00174941|6394413|P3|Overall Study|Protocol Violation|0
1849560|NCT00174941|6394414|P2|Overall Study|Protocol Violation|1
1849561|NCT00174941|6394415|P1|Overall Study|Protocol Violation|0
1849562|NCT00174941|6394412|P4|Overall Study|Adverse Event|13
1849563|NCT00174941|6394413|P3|Overall Study|Adverse Event|2
1849564|NCT00174941|6394414|P2|Overall Study|Adverse Event|10
1849565|NCT00174941|6394415|P1|Overall Study|Adverse Event|1
1849566|NCT00174915|6394490|P5|Overall Study|Therapeutic Failure|3
1849567|NCT00174915|6394491|P4|Overall Study|Therapeutic Failure|1
1849568|NCT00174915|6394492|P3|Overall Study|Therapeutic Failure|2
1849569|NCT00174915|6394493|P2|Overall Study|Therapeutic Failure|3
1849570|NCT00174915|6394494|P1|Overall Study|Therapeutic Failure|6
1849571|NCT00174915|6394490|P5|Overall Study|Protocol Violation|3
1849572|NCT00174915|6394491|P4|Overall Study|Protocol Violation|6
1849573|NCT00174915|6394492|P3|Overall Study|Protocol Violation|3
1849574|NCT00174915|6394493|P2|Overall Study|Protocol Violation|3
1849575|NCT00174915|6394494|P1|Overall Study|Protocol Violation|6
1849576|NCT00174915|6394490|P5|Overall Study|Gout Flare|0
1849577|NCT00174915|6394491|P4|Overall Study|Gout Flare|1
1849578|NCT00174915|6394492|P3|Overall Study|Gout Flare|8
1849579|NCT00174915|6394493|P2|Overall Study|Gout Flare|6
1849580|NCT00174915|6394494|P1|Overall Study|Gout Flare|13
1849581|NCT00174915|6394490|P5|Overall Study|Other|3
1849582|NCT00174915|6394491|P4|Overall Study|Other|5
1849583|NCT00174915|6394492|P3|Overall Study|Other|6
1849584|NCT00174915|6394493|P2|Overall Study|Other|8
1849585|NCT00174915|6394494|P1|Overall Study|Other|15
1849586|NCT00174915|6394490|P5|Overall Study|Personal Reason(s)|9
1849587|NCT00174915|6394491|P4|Overall Study|Personal Reason(s)|9
1849588|NCT00174915|6394492|P3|Overall Study|Personal Reason(s)|9
1849589|NCT00174915|6394493|P2|Overall Study|Personal Reason(s)|16
1849590|NCT00174915|6394494|P1|Overall Study|Personal Reason(s)|16
1849591|NCT00174915|6394490|P5|Overall Study|Adverse Event|5
1849592|NCT00174915|6394491|P4|Overall Study|Adverse Event|18
1849593|NCT00174915|6394492|P3|Overall Study|Adverse Event|11
1849594|NCT00174915|6394493|P2|Overall Study|Adverse Event|16
1849595|NCT00174915|6394494|P1|Overall Study|Adverse Event|18
1849596|NCT00174915|6394490|P5|Overall Study|Lost to Follow-up|10
1849597|NCT00174915|6394491|P4|Overall Study|Lost to Follow-up|17
1849598|NCT00174915|6394492|P3|Overall Study|Lost to Follow-up|9
1849599|NCT00174915|6394493|P2|Overall Study|Lost to Follow-up|17
1849600|NCT00174915|6394494|P1|Overall Study|Lost to Follow-up|19
1849601|NCT00174785|6394553|P2|Overall Study|Not pre-specified/Not coded|70
1849602|NCT00174785|6394554|P1|Overall Study|Not pre-specified/Not coded|56
1849603|NCT00174785|6394553|P2|Overall Study|Family request|8
1849604|NCT00174785|6394554|P1|Overall Study|Family request|6
1849605|NCT00174785|6394553|P2|Overall Study|Other prohibited medication|3
1849606|NCT00174785|6394554|P1|Overall Study|Other prohibited medication|5
1849607|NCT00174785|6394553|P2|Overall Study|Prohibited antiarrhythmic medication|88
1849608|NCT00174785|6394554|P1|Overall Study|Prohibited antiarrhythmic medication|39
1849609|NCT00174785|6394553|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
1849610|NCT00174785|6394554|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
1849611|NCT00174785|6394553|P2|Overall Study|Withdrawal by Subject|175
1849612|NCT00174785|6394554|P1|Overall Study|Withdrawal by Subject|173
1849613|NCT00174785|6394553|P2|Overall Study|Protocol Violation|14
1849614|NCT00174785|6394554|P1|Overall Study|Protocol Violation|14
1849615|NCT00174785|6394553|P2|Overall Study|Adverse Event|191
1849616|NCT00174785|6394554|P1|Overall Study|Adverse Event|293
1849617|NCT00174460|6394570|P2|Overall Study|Withdrawal by Subject|1
1849618|NCT00174460|6394571|P1|Overall Study|Withdrawal by Subject|0
1849619|NCT00174447|6394617|P1|Overall Study|Administrative reason/Other|2
1849620|NCT00174447|6394617|P1|Overall Study|Lack of Efficacy|1
1849621|NCT00174447|6394617|P1|Overall Study|Protocol Violation|1
1849622|NCT00174447|6394617|P1|Overall Study|Withdrawal by Subject|15
1849623|NCT00174447|6394617|P1|Overall Study|Adverse Event|19
1849624|NCT00174382|6394626|P1|Overall Study|Lost to Follow-up|1
1849625|NCT00174382|6394626|P1|Overall Study|Subject felt pill not effective enough|1
1849626|NCT00174382|6394626|P1|Overall Study|Arrived early for last visit in error|1
1849627|NCT00174382|6394626|P1|Overall Study|Protocol Violation|3
1849628|NCT00174382|6394626|P1|Overall Study|Withdrawal by Subject|6
1849629|NCT00174382|6394626|P1|Overall Study|Adverse Event|19
1849630|NCT00174382|6394626|P1|Overall Study|Death|2
1849631|NCT00174291|6394645|P2|Overall Study|Withdrawal by Subject|3
1849632|NCT00174291|6394646|P1|Overall Study|Withdrawal by Subject|3
1849633|NCT00174291|6394645|P2|Overall Study|Study terminated by sponsor|0
1849634|NCT00174291|6394646|P1|Overall Study|Study terminated by sponsor|1
1849635|NCT00174291|6394645|P2|Overall Study|Protocol Violation|2
1849636|NCT00174291|6394646|P1|Overall Study|Protocol Violation|0
1849637|NCT00174291|6394645|P2|Overall Study|Lost to Follow-up|1
1849638|NCT00174291|6394646|P1|Overall Study|Lost to Follow-up|1
1849639|NCT00174265|6394676|P2|Overall Study|Other (Not specified)|10
1849640|NCT00174265|6394677|P1|Overall Study|Other (Not specified)|16
1849641|NCT00174265|6394676|P2|Overall Study|Lost to Follow-up|0
1849642|NCT00174265|6394677|P1|Overall Study|Lost to Follow-up|1
1849643|NCT00174265|6394676|P2|Overall Study|Withdrawal by Subject|5
1849644|NCT00174265|6394677|P1|Overall Study|Withdrawal by Subject|3
1849645|NCT00174265|6394676|P2|Overall Study|Lack of Efficacy|2
1849646|NCT00174265|6394677|P1|Overall Study|Lack of Efficacy|2
1849647|NCT00174265|6394676|P2|Overall Study|Adverse Event|4
1849648|NCT00174265|6394677|P1|Overall Study|Adverse Event|7
1849649|NCT00174252|6394685|P1|Overall Study|Protocol Violation|2
1849650|NCT00174187|6394720|P3|Period 2 (After 3 Years)|Other|5
1849651|NCT00174187|6394721|P2|Period 2 (After 3 Years)|Other|0
1849652|NCT00174187|6394722|P1|Period 2 (After 3 Years)|Other|0
1849653|NCT00174187|6394720|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
1849654|NCT00174187|6394721|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
1849655|NCT00174187|6394722|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
1849656|NCT00174187|6394720|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
1849657|NCT00174187|6394721|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
1849658|NCT00174187|6394722|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
1849659|NCT00174187|6394720|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
1849660|NCT00174187|6394721|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1849661|NCT00174187|6394722|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
1849662|NCT00174187|6394720|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
1849663|NCT00174187|6394721|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
1849664|NCT00174187|6394722|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
1849665|NCT00174187|6394720|P3|Period 1 (up to 3 Years)|Other|0
1849666|NCT00174187|6394721|P2|Period 1 (up to 3 Years)|Other|1
1849667|NCT00174187|6394722|P1|Period 1 (up to 3 Years)|Other|0
1849668|NCT00174187|6394720|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1849669|NCT00174187|6394721|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
1849670|NCT00174187|6394722|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
1849671|NCT00174187|6394720|P3|Period 1 (up to 3 Years)|Non compliance|0
1849672|NCT00174187|6394721|P2|Period 1 (up to 3 Years)|Non compliance|1
1849673|NCT00174187|6394722|P1|Period 1 (up to 3 Years)|Non compliance|0
1849674|NCT00174187|6394720|P3|Period 1 (up to 3 Years)|Serious adverse event|0
1849675|NCT00174187|6394721|P2|Period 1 (up to 3 Years)|Serious adverse event|1
1849676|NCT00174187|6394722|P1|Period 1 (up to 3 Years)|Serious adverse event|0
1849677|NCT00172185|6394787|P4|Overall Study|Withdrawal by Subject|0
1849678|NCT00172185|6394788|P3|Overall Study|Withdrawal by Subject|1
1849679|NCT00172185|6394789|P2|Overall Study|Withdrawal by Subject|0
1849680|NCT00172185|6394790|P1|Overall Study|Withdrawal by Subject|0
1849681|NCT00172185|6394787|P4|Overall Study|SPONSOR Decision|0
1849682|NCT00172185|6394788|P3|Overall Study|SPONSOR Decision|0
1849683|NCT00172185|6394789|P2|Overall Study|SPONSOR Decision|1
1849684|NCT00172185|6394790|P1|Overall Study|SPONSOR Decision|0
1849685|NCT00172185|6394787|P4|Overall Study|Physician Decision|0
1849686|NCT00172185|6394788|P3|Overall Study|Physician Decision|1
1849687|NCT00172185|6394789|P2|Overall Study|Physician Decision|0
1849688|NCT00172185|6394790|P1|Overall Study|Physician Decision|0
1849689|NCT00172185|6394787|P4|Overall Study|Adverse Event|4
1849690|NCT00172185|6394788|P3|Overall Study|Adverse Event|3
1849691|NCT00172185|6394789|P2|Overall Study|Adverse Event|1
1849692|NCT00172185|6394790|P1|Overall Study|Adverse Event|0
1849693|NCT00172042|6394806|P2|Overall Study|Death|42
1849694|NCT00172042|6394807|P1|Overall Study|Death|42
1849695|NCT00172042|6394806|P2|Overall Study|Administrative problems|10
1849696|NCT00172042|6394807|P1|Overall Study|Administrative problems|13
1849697|NCT00172042|6394806|P2|Overall Study|Lost to Follow-up|5
1849698|NCT00172042|6394807|P1|Overall Study|Lost to Follow-up|3
1849699|NCT00172042|6394806|P2|Overall Study|Withdrawal by Subject|25
1849700|NCT00172042|6394807|P1|Overall Study|Withdrawal by Subject|37
1849701|NCT00172042|6394806|P2|Overall Study|Protocol Violation|7
1849702|NCT00172042|6394807|P1|Overall Study|Protocol Violation|8
1849703|NCT00172042|6394806|P2|Overall Study|Patient no longer requires study drug|8
1849704|NCT00172042|6394807|P1|Overall Study|Patient no longer requires study drug|10
1849705|NCT00172042|6394806|P2|Overall Study|Unsatisfactory therapeutic effect|11
1849706|NCT00172042|6394807|P1|Overall Study|Unsatisfactory therapeutic effect|13
1849707|NCT00172042|6394806|P2|Overall Study|Abnormal test procedure(s)|3
1849708|NCT00172042|6394807|P1|Overall Study|Abnormal test procedure(s)|0
1849709|NCT00172042|6394806|P2|Overall Study|Abnormal laboratory value(s)|1
1849710|NCT00172042|6394807|P1|Overall Study|Abnormal laboratory value(s)|5
1849711|NCT00172042|6394806|P2|Overall Study|Adverse Event|13
1849712|NCT00172042|6394807|P1|Overall Study|Adverse Event|27
1849713|NCT00171925|6394829|P2|Overall Study|Death|2
1849714|NCT00171925|6394830|P1|Overall Study|Death|1
1849715|NCT00171925|6394829|P2|Overall Study|Administrative problems|11
1849716|NCT00171925|6394830|P1|Overall Study|Administrative problems|10
1849717|NCT00171925|6394829|P2|Overall Study|Lost to Follow-up|2
1849718|NCT00171925|6394830|P1|Overall Study|Lost to Follow-up|2
1849719|NCT00171925|6394829|P2|Overall Study|Withdrawal by Subject|9
1849720|NCT00171925|6394830|P1|Overall Study|Withdrawal by Subject|6
1849721|NCT00171925|6394829|P2|Overall Study|Protocol Violation|1
1849722|NCT00171925|6394830|P1|Overall Study|Protocol Violation|1
1849723|NCT00171925|6394829|P2|Overall Study|Adverse Event|6
1849724|NCT00171925|6394830|P1|Overall Study|Adverse Event|10
1849725|NCT00171873|6394842|P2|Overall Study|Switched to Octreotide|1
1849726|NCT00171873|6394843|P1|Overall Study|Switched to Octreotide|0
1849727|NCT00171873|6394842|P2|Overall Study|Adverse Event|0
1849728|NCT00171873|6394843|P1|Overall Study|Adverse Event|5
1849729|NCT00171873|6394842|P2|Overall Study|Withdrawal by Subject|2
1849730|NCT00171873|6394843|P1|Overall Study|Withdrawal by Subject|4
1849731|NCT00171834|6394856|P7|Overall Study|Treatment Duration Completed|0
1849732|NCT00171834|6394857|P6|Overall Study|Treatment Duration Completed|1
1849733|NCT00171834|6394858|P5|Overall Study|Treatment Duration Completed|2
1849734|NCT00171834|6394859|P4|Overall Study|Treatment Duration Completed|0
1849735|NCT00171834|6394860|P3|Overall Study|Treatment Duration Completed|1
1849736|NCT00171834|6394861|P2|Overall Study|Treatment Duration Completed|0
1849737|NCT00171834|6394862|P1|Overall Study|Treatment Duration Completed|0
1849738|NCT00171834|6394856|P7|Overall Study|Disease Progression|3
1849739|NCT00171834|6394857|P6|Overall Study|Disease Progression|18
1849740|NCT00171834|6394858|P5|Overall Study|Disease Progression|2
1849741|NCT00171834|6394859|P4|Overall Study|Disease Progression|9
1849742|NCT00171834|6394860|P3|Overall Study|Disease Progression|8
1849743|NCT00171834|6394861|P2|Overall Study|Disease Progression|8
1849744|NCT00171834|6394862|P1|Overall Study|Disease Progression|4
1849745|NCT00171834|6394856|P7|Overall Study|Death from study indication|0
1849746|NCT00171834|6394857|P6|Overall Study|Death from study indication|0
1849747|NCT00171834|6394858|P5|Overall Study|Death from study indication|1
1849748|NCT00171834|6394859|P4|Overall Study|Death from study indication|0
1849749|NCT00171834|6394860|P3|Overall Study|Death from study indication|0
1849750|NCT00171834|6394861|P2|Overall Study|Death from study indication|1
1849751|NCT00171834|6394862|P1|Overall Study|Death from study indication|0
1849752|NCT00171834|6394856|P7|Overall Study|Withdrawal by Subject|0
1849753|NCT00171834|6394857|P6|Overall Study|Withdrawal by Subject|1
1849754|NCT00171834|6394858|P5|Overall Study|Withdrawal by Subject|1
1849755|NCT00171834|6394859|P4|Overall Study|Withdrawal by Subject|1
1849756|NCT00171834|6394860|P3|Overall Study|Withdrawal by Subject|0
1849757|NCT00171834|6394861|P2|Overall Study|Withdrawal by Subject|2
1849758|NCT00171834|6394862|P1|Overall Study|Withdrawal by Subject|0
1849759|NCT00171834|6394856|P7|Overall Study|Adverse Event|1
1849760|NCT00171834|6394857|P6|Overall Study|Adverse Event|15
1849761|NCT00171834|6394858|P5|Overall Study|Adverse Event|2
1849762|NCT00171834|6394859|P4|Overall Study|Adverse Event|2
1849763|NCT00171834|6394860|P3|Overall Study|Adverse Event|3
1849764|NCT00171834|6394861|P2|Overall Study|Adverse Event|1
1849765|NCT00171834|6394862|P1|Overall Study|Adverse Event|2
1849766|NCT00171704|6394902|P2|Overall Study|Protocol Violation|1
1849767|NCT00171704|6394903|P1|Overall Study|Protocol Violation|0
1849768|NCT00171704|6394902|P2|Overall Study|Withdrawal by Subject|3
1849769|NCT00171704|6394903|P1|Overall Study|Withdrawal by Subject|1
1849770|NCT00171704|6394902|P2|Overall Study|Death|2
1849771|NCT00171704|6394903|P1|Overall Study|Death|2
1849772|NCT00171704|6394902|P2|Overall Study|Administrative Problems|1
1849773|NCT00171704|6394903|P1|Overall Study|Administrative Problems|2
1849774|NCT00171704|6394902|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
1849775|NCT00171704|6394903|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
1849776|NCT00171704|6394902|P2|Overall Study|Disease Progression|9
1849777|NCT00171704|6394903|P1|Overall Study|Disease Progression|14
1849778|NCT00171704|6394902|P2|Overall Study|Adverse Event|33
1849779|NCT00171704|6394903|P1|Overall Study|Adverse Event|24
1849780|NCT00171340|6394925|P2|Overall Study|Death|6
1849781|NCT00171340|6394926|P1|Overall Study|Death|6
1849782|NCT00171340|6394925|P2|Overall Study|Administrative Problems|2
1849783|NCT00171340|6394926|P1|Overall Study|Administrative Problems|5
1849784|NCT00171340|6394925|P2|Overall Study|No Longer Required Study Drug|1
1849785|NCT00171340|6394926|P1|Overall Study|No Longer Required Study Drug|1
1849786|NCT00171340|6394925|P2|Overall Study|Abnormal Test Procedure Results|11
1849787|NCT00171340|6394926|P1|Overall Study|Abnormal Test Procedure Results|6
1849788|NCT00171340|6394925|P2|Overall Study|Abnormal Laboratory Results|0
1849789|NCT00171340|6394926|P1|Overall Study|Abnormal Laboratory Results|2
1849790|NCT00171340|6394925|P2|Overall Study|Lost to Follow-up|5
1849791|NCT00171340|6394926|P1|Overall Study|Lost to Follow-up|0
1849792|NCT00171340|6394925|P2|Overall Study|Withdrawal by Subject|19
1849793|NCT00171340|6394926|P1|Overall Study|Withdrawal by Subject|22
1849794|NCT00171340|6394925|P2|Overall Study|Protocol Violation|8
1849795|NCT00171340|6394926|P1|Overall Study|Protocol Violation|7
1849796|NCT00171340|6394925|P2|Overall Study|Lack of Efficacy|41
1849797|NCT00171340|6394926|P1|Overall Study|Lack of Efficacy|29
1849798|NCT00171340|6394925|P2|Overall Study|Adverse Event|42
1849799|NCT00171340|6394926|P1|Overall Study|Adverse Event|46
1849800|NCT00171314|6394942|P2|Overall Study|Death|1
1849801|NCT00171314|6394943|P1|Overall Study|Death|2
1849802|NCT00171314|6394942|P2|Overall Study|Lost to Follow-up|3
1849803|NCT00171314|6394943|P1|Overall Study|Lost to Follow-up|1
1849804|NCT00171314|6394942|P2|Overall Study|Administrative Problems|3
1849805|NCT00171314|6394943|P1|Overall Study|Administrative Problems|4
1849806|NCT00171314|6394942|P2|Overall Study|Protocol Violation|7
1849807|NCT00171314|6394943|P1|Overall Study|Protocol Violation|3
1849808|NCT00171314|6394942|P2|Overall Study|Abnormal Test Procedure Results|3
1849809|NCT00171314|6394943|P1|Overall Study|Abnormal Test Procedure Results|9
1849810|NCT00171314|6394942|P2|Overall Study|Withdrawal by Subject|6
1849811|NCT00171314|6394943|P1|Overall Study|Withdrawal by Subject|9
1849812|NCT00171314|6394942|P2|Overall Study|Lack of Efficacy|14
1849813|NCT00171314|6394943|P1|Overall Study|Lack of Efficacy|19
1849814|NCT00171314|6394942|P2|Overall Study|Adverse Event|41
1849815|NCT00171314|6394943|P1|Overall Study|Adverse Event|44
1849816|NCT00171301|6394959|P2|Overall Study|Withdrawal by Subject|1
1849817|NCT00171301|6394960|P1|Overall Study|Withdrawal by Subject|0
1849818|NCT00171301|6394959|P2|Overall Study|Protocol Violation|2
1849819|NCT00171301|6394960|P1|Overall Study|Protocol Violation|0
1849820|NCT00171301|6394959|P2|Overall Study|Lost to Follow-up|2
1849821|NCT00171301|6394960|P1|Overall Study|Lost to Follow-up|6
1849822|NCT00171301|6394959|P2|Overall Study|Adverse Event|2
1849823|NCT00171301|6394960|P1|Overall Study|Adverse Event|1
1849824|NCT00171301|6394959|P2|Overall Study|Death|2
1849825|NCT00171301|6394960|P1|Overall Study|Death|1
1849826|NCT00171210|6394973|P2|Overall Study|Stopped at end of extension 1|1
1849827|NCT00171210|6394974|P1|Overall Study|Stopped at end of extension 1|0
1849828|NCT00171210|6394973|P2|Overall Study|Stopped at end of core|32
1849829|NCT00171210|6394974|P1|Overall Study|Stopped at end of core|0
1849830|NCT00171210|6394973|P2|Overall Study|Death|3
1849831|NCT00171210|6394974|P1|Overall Study|Death|2
1849832|NCT00171210|6394973|P2|Overall Study|Administrative problems|1
1849833|NCT00171210|6394974|P1|Overall Study|Administrative problems|1
1849834|NCT00171210|6394973|P2|Overall Study|Lost to Follow-up|0
1849835|NCT00171210|6394974|P1|Overall Study|Lost to Follow-up|1
1849836|NCT00171210|6394973|P2|Overall Study|Withdrawal by Subject|30
1849837|NCT00171210|6394974|P1|Overall Study|Withdrawal by Subject|32
1849838|NCT00171210|6394973|P2|Overall Study|Protocol Violation|2
1849839|NCT00171210|6394974|P1|Overall Study|Protocol Violation|0
1849840|NCT00171210|6394973|P2|Overall Study|Unsatisfactory therapeutic effect|15
1849841|NCT00171210|6394974|P1|Overall Study|Unsatisfactory therapeutic effect|11
1849842|NCT00171210|6394973|P2|Overall Study|Abnormal test procedure result(s)|1
1849843|NCT00171210|6394974|P1|Overall Study|Abnormal test procedure result(s)|0
1849844|NCT00171210|6394973|P2|Overall Study|Abnormal laboratory value(s)|3
1849845|NCT00171210|6394974|P1|Overall Study|Abnormal laboratory value(s)|6
1849846|NCT00171210|6394973|P2|Overall Study|Adverse Event|27
1849847|NCT00171210|6394974|P1|Overall Study|Adverse Event|16
1849848|NCT00171054|6395004|P2|Overall Study|Condition no longer required study drug|1
1849849|NCT00171054|6395005|P1|Overall Study|Condition no longer required study drug|0
1849850|NCT00171054|6395004|P2|Overall Study|Adverse Event|8
1849851|NCT00171054|6395005|P1|Overall Study|Adverse Event|8
1849852|NCT00171054|6395004|P2|Overall Study|Lost to Follow-up|1
1849853|NCT00171054|6395005|P1|Overall Study|Lost to Follow-up|0
1849854|NCT00171054|6395004|P2|Overall Study|Patient withdrew consent|0
1849855|NCT00171054|6395005|P1|Overall Study|Patient withdrew consent|1
1849856|NCT00171054|6395004|P2|Overall Study|Protocol Violation|2
1849857|NCT00171054|6395005|P1|Overall Study|Protocol Violation|1
1849858|NCT00170950|6395037|P2|Overall Study|Termination Data Not Recorded|22
1849859|NCT00170950|6395038|P1|Overall Study|Termination Data Not Recorded|17
1849860|NCT00170950|6395037|P2|Overall Study|Missing|1
1849861|NCT00170950|6395038|P1|Overall Study|Missing|2
1849862|NCT00170950|6395037|P2|Overall Study|Lost to Follow-up|115
1849863|NCT00170950|6395038|P1|Overall Study|Lost to Follow-up|134
1849864|NCT00170950|6395037|P2|Overall Study|Withdrawal by Subject|498
1849865|NCT00170950|6395038|P1|Overall Study|Withdrawal by Subject|496
1849866|NCT00170950|6395037|P2|Overall Study|Death|274
1849867|NCT00170950|6395038|P1|Overall Study|Death|236
1849868|NCT00170846|6395051|P3|Overall Study|Reason Missing|0
1849869|NCT00170846|6395052|P2|Overall Study|Reason Missing|1
1849870|NCT00170846|6395053|P1|Overall Study|Reason Missing|0
1849871|NCT00170846|6395051|P3|Overall Study|Death|3
1849872|NCT00170846|6395052|P2|Overall Study|Death|3
1849873|NCT00170846|6395053|P1|Overall Study|Death|0
1849874|NCT00170846|6395051|P3|Overall Study|Lost to Follow-up|2
1849875|NCT00170846|6395052|P2|Overall Study|Lost to Follow-up|3
1849876|NCT00170846|6395053|P1|Overall Study|Lost to Follow-up|6
1849877|NCT00170846|6395051|P3|Overall Study|Subject withdrew Informed Consent|8
1849878|NCT00170846|6395052|P2|Overall Study|Subject withdrew Informed Consent|12
1849879|NCT00170846|6395053|P1|Overall Study|Subject withdrew Informed Consent|5
1849880|NCT00169442|6395085|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
1849881|NCT00169442|6395086|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
1849882|NCT00169442|6395087|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
1849883|NCT00169442|6395088|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
1849884|NCT00169442|6395089|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
1849885|NCT00169442|6395090|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
1849886|NCT00169442|6395085|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
1849887|NCT00169442|6395086|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
1849888|NCT00169442|6395087|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
1849889|NCT00169442|6395088|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
1849890|NCT00169442|6395089|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
1849891|NCT00169442|6395090|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
1849892|NCT00169442|6395085|P6|Overall Study|Migrated/moved from study area|2
1849893|NCT00169442|6395086|P5|Overall Study|Migrated/moved from study area|0
1849894|NCT00169442|6395087|P4|Overall Study|Migrated/moved from study area|0
1849895|NCT00169442|6395088|P3|Overall Study|Migrated/moved from study area|0
1849896|NCT00169442|6395089|P2|Overall Study|Migrated/moved from study area|0
1849897|NCT00169442|6395090|P1|Overall Study|Migrated/moved from study area|0
1849898|NCT00169442|6395085|P6|Overall Study|Withdrawal by Subject|0
1849899|NCT00169442|6395086|P5|Overall Study|Withdrawal by Subject|0
1849900|NCT00169442|6395087|P4|Overall Study|Withdrawal by Subject|0
1849901|NCT00169442|6395088|P3|Overall Study|Withdrawal by Subject|1
1849902|NCT00169442|6395089|P2|Overall Study|Withdrawal by Subject|0
1849903|NCT00169442|6395090|P1|Overall Study|Withdrawal by Subject|0
1849904|NCT00169104|6395199|P2|Overall Study|Physician Decision|1
1849905|NCT00169104|6395200|P1|Overall Study|Physician Decision|0
1849906|NCT00169104|6395199|P2|Overall Study|Protocol Violation|1
1849907|NCT00169104|6395200|P1|Overall Study|Protocol Violation|0
1849908|NCT00169104|6395199|P2|Overall Study|Withdrawal by Subject|0
1849909|NCT00169104|6395200|P1|Overall Study|Withdrawal by Subject|2
1849910|NCT00168844|6395214|P3|Overall Study|Other|9
1849911|NCT00168844|6395215|P2|Overall Study|Other|7
1849912|NCT00168844|6395216|P1|Overall Study|Other|6
1849913|NCT00168844|6395214|P3|Overall Study|Protocol Violation|4
1849914|NCT00168844|6395215|P2|Overall Study|Protocol Violation|2
1849915|NCT00168844|6395216|P1|Overall Study|Protocol Violation|2
1849916|NCT00168844|6395214|P3|Overall Study|Withdrawal by Subject|19
1849917|NCT00168844|6395215|P2|Overall Study|Withdrawal by Subject|9
1849918|NCT00168844|6395216|P1|Overall Study|Withdrawal by Subject|12
1849919|NCT00168844|6395214|P3|Overall Study|Lost to Follow-up|11
1849920|NCT00168844|6395215|P2|Overall Study|Lost to Follow-up|5
1849921|NCT00168844|6395216|P1|Overall Study|Lost to Follow-up|4
1849922|NCT00168844|6395214|P3|Overall Study|Adverse Event|48
1849923|NCT00168844|6395215|P2|Overall Study|Adverse Event|32
1849924|NCT00168844|6395216|P1|Overall Study|Adverse Event|31
1849925|NCT00168831|6395398|P3|Overall Study|Other|6
1849926|NCT00168831|6395399|P2|Overall Study|Other|3
1849927|NCT00168831|6395400|P1|Overall Study|Other|6
1849928|NCT00168831|6395398|P3|Overall Study|Protocol Violation|11
1849929|NCT00168831|6395399|P2|Overall Study|Protocol Violation|11
1849930|NCT00168831|6395400|P1|Overall Study|Protocol Violation|6
1849931|NCT00168831|6395398|P3|Overall Study|Withdrawal by Subject|19
1849932|NCT00168831|6395399|P2|Overall Study|Withdrawal by Subject|14
1849933|NCT00168831|6395400|P1|Overall Study|Withdrawal by Subject|7
1849934|NCT00168831|6395398|P3|Overall Study|Lost to Follow-up|4
1849935|NCT00168831|6395399|P2|Overall Study|Lost to Follow-up|6
1849936|NCT00168831|6395400|P1|Overall Study|Lost to Follow-up|5
1849937|NCT00168831|6395398|P3|Overall Study|Adverse Event|74
1849938|NCT00168831|6395399|P2|Overall Study|Adverse Event|47
1849939|NCT00168831|6395400|P1|Overall Study|Adverse Event|36
1849940|NCT00168818|6395582|P3|Treatment|Other|31
1849941|NCT00168818|6395583|P2|Treatment|Other|29
1849942|NCT00168818|6395584|P1|Treatment|Other|23
1849943|NCT00168818|6395582|P3|Treatment|Withdrawal by Subject|22
1849944|NCT00168818|6395583|P2|Treatment|Withdrawal by Subject|20
1849945|NCT00168818|6395584|P1|Treatment|Withdrawal by Subject|25
1849946|NCT00168818|6395582|P3|Treatment|Lost to Follow-up|1
1849947|NCT00168818|6395583|P2|Treatment|Lost to Follow-up|2
1849948|NCT00168818|6395584|P1|Treatment|Lost to Follow-up|0
1849949|NCT00168818|6395582|P3|Treatment|Protocol Violation|11
1849950|NCT00168818|6395583|P2|Treatment|Protocol Violation|11
1849951|NCT00168818|6395584|P1|Treatment|Protocol Violation|8
1849952|NCT00168818|6395582|P3|Treatment|Adverse Event|68
1849953|NCT00168818|6395583|P2|Treatment|Adverse Event|89
1849954|NCT00168818|6395584|P1|Treatment|Adverse Event|77
1849955|NCT00168818|6395582|P3|Overall Study|Other|30
1849956|NCT00168818|6395583|P2|Overall Study|Other|24
1849957|NCT00168818|6395584|P1|Overall Study|Other|22
1849958|NCT00168818|6395582|P3|Overall Study|Withdrawal by Subject|37
1849959|NCT00168818|6395583|P2|Overall Study|Withdrawal by Subject|41
1849960|NCT00168818|6395584|P1|Overall Study|Withdrawal by Subject|43
1849961|NCT00168818|6395582|P3|Overall Study|Lost to Follow-up|15
1849962|NCT00168818|6395583|P2|Overall Study|Lost to Follow-up|4
1849963|NCT00168818|6395584|P1|Overall Study|Lost to Follow-up|13
1849964|NCT00168818|6395582|P3|Overall Study|Protocol Violation|11
1849965|NCT00168818|6395583|P2|Overall Study|Protocol Violation|11
1849966|NCT00168818|6395584|P1|Overall Study|Protocol Violation|16
1849967|NCT00168818|6395582|P3|Overall Study|Adverse Event|31
1849968|NCT00168818|6395583|P2|Overall Study|Adverse Event|29
1849969|NCT00168818|6395584|P1|Overall Study|Adverse Event|23
1849970|NCT00168805|6395628|P3|Treatment|Other|17
1849971|NCT00168805|6395629|P2|Treatment|Other|18
1849972|NCT00168805|6395630|P1|Treatment|Other|18
1849973|NCT00168805|6395628|P3|Treatment|Withdrawal by Subject|8
1849974|NCT00168805|6395629|P2|Treatment|Withdrawal by Subject|7
1849975|NCT00168805|6395630|P1|Treatment|Withdrawal by Subject|3
1849976|NCT00168805|6395628|P3|Treatment|Protocol Violation|5
1849977|NCT00168805|6395629|P2|Treatment|Protocol Violation|5
1849978|NCT00168805|6395630|P1|Treatment|Protocol Violation|3
1849979|NCT00168805|6395628|P3|Treatment|Adverse Event|32
1849980|NCT00168805|6395629|P2|Treatment|Adverse Event|26
1849981|NCT00168805|6395630|P1|Treatment|Adverse Event|25
1849982|NCT00168805|6395628|P3|Overall Study|Other|22
1849983|NCT00168805|6395629|P2|Overall Study|Other|21
1849984|NCT00168805|6395630|P1|Overall Study|Other|24
1849985|NCT00168805|6395628|P3|Overall Study|Withdrawal by Subject|21
1849986|NCT00168805|6395629|P2|Overall Study|Withdrawal by Subject|18
1849987|NCT00168805|6395630|P1|Overall Study|Withdrawal by Subject|16
1849988|NCT00168805|6395628|P3|Overall Study|Lost to Follow-up|11
1849989|NCT00168805|6395629|P2|Overall Study|Lost to Follow-up|17
1849990|NCT00168805|6395630|P1|Overall Study|Lost to Follow-up|12
1849991|NCT00168805|6395628|P3|Overall Study|Protocol Violation|8
1849992|NCT00168805|6395629|P2|Overall Study|Protocol Violation|11
1849993|NCT00168805|6395630|P1|Overall Study|Protocol Violation|12
1849994|NCT00168805|6395628|P3|Overall Study|Adverse Event|16
1849995|NCT00168805|6395629|P2|Overall Study|Adverse Event|11
1849996|NCT00168805|6395630|P1|Overall Study|Adverse Event|7
1849997|NCT00168103|6395866|P4|Overall Study|Lost to Follow-up|0
1849998|NCT00168103|6395867|P3|Overall Study|Lost to Follow-up|0
1849999|NCT00168103|6395868|P2|Overall Study|Lost to Follow-up|3
1850000|NCT00168103|6395869|P1|Overall Study|Lost to Follow-up|1
1850001|NCT00168103|6395866|P4|Overall Study|Withdrawal by Subject|0
1850002|NCT00168103|6395867|P3|Overall Study|Withdrawal by Subject|1
1850003|NCT00168103|6395868|P2|Overall Study|Withdrawal by Subject|2
1850004|NCT00168103|6395869|P1|Overall Study|Withdrawal by Subject|1
1850005|NCT00168064|6395891|P2|Overall Study|Various|3
1850006|NCT00168064|6395892|P1|Overall Study|Various|4
1850007|NCT00168064|6395891|P2|Overall Study|Subject's Best interest|2
1850008|NCT00168064|6395892|P1|Overall Study|Subject's Best interest|2
1850009|NCT00168064|6395891|P2|Overall Study|Concurrent Illness|3
1850010|NCT00168064|6395892|P1|Overall Study|Concurrent Illness|4
1850011|NCT00168064|6395891|P2|Overall Study|Non-compliance|3
1850012|NCT00168064|6395892|P1|Overall Study|Non-compliance|2
1850013|NCT00168064|6395891|P2|Overall Study|Lost to Follow-up|3
1850014|NCT00168064|6395892|P1|Overall Study|Lost to Follow-up|4
1850015|NCT00168064|6395891|P2|Overall Study|Lack of Efficacy|4
1850016|NCT00168064|6395892|P1|Overall Study|Lack of Efficacy|4
1850017|NCT00168064|6395891|P2|Overall Study|Withdrawal by Subject|4
1850018|NCT00168064|6395892|P1|Overall Study|Withdrawal by Subject|3
1850019|NCT00168064|6395891|P2|Overall Study|Adverse Event|22
1850020|NCT00168064|6395892|P1|Overall Study|Adverse Event|26
1850021|NCT00168038|6395900|P1|Overall Study|Therapy failure|1
1850022|NCT00168038|6395900|P1|Overall Study|Adverse Event|1
1850023|NCT00167778|6395923|P1|Overall Study|Withdrawal by Subject|1
1850024|NCT00167414|6395989|P1|Overall Study|Death|10
1850025|NCT00167310|6396014|P2|Overall Study|Withdrawal by Subject|7
1850026|NCT00167310|6396015|P1|Overall Study|Withdrawal by Subject|3
1850027|NCT00167310|6396014|P2|Overall Study|Protocol Violation|3
1850028|NCT00167310|6396015|P1|Overall Study|Protocol Violation|5
1850029|NCT00167245|6396025|P2|Overall Study|Drowsy|0
1850030|NCT00167245|6396026|P1|Overall Study|Drowsy|1
1850031|NCT00167245|6396025|P2|Overall Study|Incarcerated|2
1850032|NCT00167245|6396026|P1|Overall Study|Incarcerated|3
1850033|NCT00167245|6396025|P2|Overall Study|Withdrawal by Subject|8
1850034|NCT00167245|6396026|P1|Overall Study|Withdrawal by Subject|5
1850035|NCT00167245|6396025|P2|Overall Study|Lost to Follow-up|31
1850036|NCT00167245|6396026|P1|Overall Study|Lost to Follow-up|20
1850037|NCT00166712|6396076|P2|Overall Study|Physician Decision|2
1850038|NCT00166712|6396077|P1|Overall Study|Physician Decision|0
1850039|NCT00166712|6396076|P2|Overall Study|Withdrawal by Subject|2
1850040|NCT00166712|6396077|P1|Overall Study|Withdrawal by Subject|1
1850041|NCT00166712|6396076|P2|Overall Study|Adverse Event|0
1850042|NCT00166712|6396077|P1|Overall Study|Adverse Event|1
1850043|NCT00166712|6396076|P2|Overall Study|Death|1
1850044|NCT00166712|6396077|P1|Overall Study|Death|0
1850045|NCT00166517|6396094|P2|Overall Study|Withdrawal by Subject|1
1850046|NCT00166517|6396095|P1|Overall Study|Withdrawal by Subject|0
1850047|NCT00166517|6396094|P2|Overall Study|Protocol Violation|1
1850048|NCT00166517|6396095|P1|Overall Study|Protocol Violation|4
1850049|NCT00166517|6396094|P2|Overall Study|Lost to Follow-up|0
1850050|NCT00166517|6396095|P1|Overall Study|Lost to Follow-up|1
1850051|NCT00166504|6396105|P2|Overall Study|Withdrawal by Subject|0
1850052|NCT00166504|6396106|P1|Overall Study|Withdrawal by Subject|1
1850053|NCT00166504|6396105|P2|Overall Study|Lost to Follow-up|1
1850054|NCT00166504|6396106|P1|Overall Study|Lost to Follow-up|1
1850055|NCT00166504|6396105|P2|Overall Study|Adverse Event|3
1850056|NCT00166504|6396106|P1|Overall Study|Adverse Event|3
1850057|NCT00166439|6396112|P1|Overall Study|Ineligible|5
1850058|NCT00166296|6396129|P2|Overall Study|Lost to Follow-up|2
1850059|NCT00166296|6396130|P1|Overall Study|Lost to Follow-up|4
1850060|NCT00166296|6396129|P2|Overall Study|Adverse Event|4
1850061|NCT00166296|6396130|P1|Overall Study|Adverse Event|2
1850062|NCT00166296|6396129|P2|Overall Study|Withdrawal by Subject|3
1850063|NCT00166296|6396130|P1|Overall Study|Withdrawal by Subject|1
1850064|NCT00166114|6396182|P2|Overall Study|Adverse Event|1
1850065|NCT00166114|6396183|P1|Overall Study|Adverse Event|2
1850066|NCT00166114|6396182|P2|Overall Study|Withdrawal by Subject|4
1850067|NCT00166114|6396183|P1|Overall Study|Withdrawal by Subject|10
1850068|NCT00166114|6396182|P2|Overall Study|Protocol Violation|1
1850069|NCT00166114|6396183|P1|Overall Study|Protocol Violation|2
1850070|NCT00165984|6396200|P1|Overall Study|Death|15
1850071|NCT00165841|6396218|P2|Overall Study|Medication Noncompliance|1
1850072|NCT00165841|6396219|P1|Overall Study|Medication Noncompliance|1
1850073|NCT00165841|6396218|P2|Overall Study|Other|5
1850074|NCT00165841|6396219|P1|Overall Study|Other|3
1850075|NCT00165841|6396218|P2|Overall Study|Protocol Violation|8
1850076|NCT00165841|6396219|P1|Overall Study|Protocol Violation|6
1850077|NCT00165841|6396218|P2|Overall Study|Physician Decision|0
1850078|NCT00165841|6396219|P1|Overall Study|Physician Decision|1
1850079|NCT00165841|6396218|P2|Overall Study|Withdrawal by Subject|8
1850080|NCT00165841|6396219|P1|Overall Study|Withdrawal by Subject|7
1850081|NCT00165841|6396218|P2|Overall Study|Lost to Follow-up|4
1850082|NCT00165841|6396219|P1|Overall Study|Lost to Follow-up|4
1850083|NCT00165841|6396218|P2|Overall Study|Lack of Efficacy|33
1850084|NCT00165841|6396219|P1|Overall Study|Lack of Efficacy|6
1850085|NCT00165841|6396218|P2|Overall Study|Adverse Event|3
1850086|NCT00165841|6396219|P1|Overall Study|Adverse Event|2
1850087|NCT00165789|6396229|P4|Overall Study|Withdrawal by Subject|2
1850088|NCT00165789|6396230|P3|Overall Study|Withdrawal by Subject|1
1850089|NCT00165789|6396231|P2|Overall Study|Withdrawal by Subject|1
1850090|NCT00165789|6396232|P1|Overall Study|Withdrawal by Subject|0
1850091|NCT00165789|6396229|P4|Overall Study|Adverse Event|12
1850092|NCT00165789|6396230|P3|Overall Study|Adverse Event|0
1850093|NCT00165789|6396231|P2|Overall Study|Adverse Event|3
1850094|NCT00165789|6396232|P1|Overall Study|Adverse Event|0
1850095|NCT00165776|6396286|P4|Overall Study|Worsening of Cervical Dystonia|1
1850096|NCT00165776|6396287|P3|Overall Study|Worsening of Cervical Dystonia|0
1850097|NCT00165776|6396288|P2|Overall Study|Worsening of Cervical Dystonia|0
1850098|NCT00165776|6396289|P1|Overall Study|Worsening of Cervical Dystonia|0
1850099|NCT00165776|6396286|P4|Overall Study|Withdrawal by Subject|0
1850100|NCT00165776|6396287|P3|Overall Study|Withdrawal by Subject|2
1850101|NCT00165776|6396288|P2|Overall Study|Withdrawal by Subject|1
1850102|NCT00165776|6396289|P1|Overall Study|Withdrawal by Subject|4
1850103|NCT00165776|6396286|P4|Overall Study|Lack of Efficacy|1
1850104|NCT00165776|6396287|P3|Overall Study|Lack of Efficacy|0
1850105|NCT00165776|6396288|P2|Overall Study|Lack of Efficacy|0
1850106|NCT00165776|6396289|P1|Overall Study|Lack of Efficacy|0
1850107|NCT00165698|6396325|P2|Overall Study|Not Taken/Lost the medicine|2
1850108|NCT00165698|6396326|P1|Overall Study|Not Taken/Lost the medicine|1
1850109|NCT00165698|6396325|P2|Overall Study|Protocol Violation|0
1850110|NCT00165698|6396326|P1|Overall Study|Protocol Violation|1
1850111|NCT00165698|6396325|P2|Overall Study|Withdrawal by Subject|1
1850112|NCT00165698|6396326|P1|Overall Study|Withdrawal by Subject|2
1850113|NCT00165698|6396325|P2|Overall Study|Lost to Follow-up|2
1850114|NCT00165698|6396326|P1|Overall Study|Lost to Follow-up|2
1850115|NCT00165698|6396325|P2|Overall Study|Adverse Event|10
1850116|NCT00165698|6396326|P1|Overall Study|Adverse Event|2
1850117|NCT00165672|6396352|P2|Overall Study|Adverse Event|1
1850118|NCT00165672|6396353|P1|Overall Study|Adverse Event|0
1850119|NCT00165646|6396362|P3|Overall Study|Protocol Violation|0
1850120|NCT00165646|6396363|P2|Overall Study|Protocol Violation|0
1850121|NCT00165646|6396364|P1|Overall Study|Protocol Violation|1
1850122|NCT00165646|6396362|P3|Overall Study|Physician Decision|2
1850123|NCT00165646|6396363|P2|Overall Study|Physician Decision|0
1850124|NCT00165646|6396364|P1|Overall Study|Physician Decision|2
1850125|NCT00165646|6396362|P3|Overall Study|Withdrawal by Subject|1
1850126|NCT00165646|6396363|P2|Overall Study|Withdrawal by Subject|2
1850127|NCT00165646|6396364|P1|Overall Study|Withdrawal by Subject|0
1850128|NCT00165646|6396362|P3|Overall Study|Lack of Efficacy|0
1850129|NCT00165646|6396363|P2|Overall Study|Lack of Efficacy|2
1850130|NCT00165646|6396364|P1|Overall Study|Lack of Efficacy|1
1850131|NCT00165646|6396362|P3|Overall Study|Adverse Event|1
1850132|NCT00165646|6396363|P2|Overall Study|Adverse Event|1
1850133|NCT00165646|6396364|P1|Overall Study|Adverse Event|1
1850134|NCT00165503|6396372|P1|Overall Study|Unresectable|3
1850135|NCT00165503|6396372|P1|Overall Study|Lost to Follow-up|12
1850136|NCT00165503|6396372|P1|Overall Study|Death|1
1850137|NCT00163657|6396379|P3|Overall Study|Other reason|3
1850138|NCT00163657|6396380|P2|Overall Study|Other reason|1
1850139|NCT00163657|6396381|P1|Overall Study|Other reason|0
1850140|NCT00163657|6396379|P3|Overall Study|Lost to Follow-up|10
1850141|NCT00163657|6396380|P2|Overall Study|Lost to Follow-up|3
1850142|NCT00163657|6396381|P1|Overall Study|Lost to Follow-up|1
1850143|NCT00163657|6396379|P3|Overall Study|Non Compliance|0
1850144|NCT00163657|6396380|P2|Overall Study|Non Compliance|0
1850145|NCT00163657|6396381|P1|Overall Study|Non Compliance|1
1850146|NCT00163657|6396379|P3|Overall Study|Physician Decision|1
1850147|NCT00163657|6396380|P2|Overall Study|Physician Decision|1
1850148|NCT00163657|6396381|P1|Overall Study|Physician Decision|0
1850149|NCT00163657|6396379|P3|Overall Study|Withdrawal by Subject|2
1850150|NCT00163657|6396380|P2|Overall Study|Withdrawal by Subject|3
1850151|NCT00163657|6396381|P1|Overall Study|Withdrawal by Subject|2
1850152|NCT00163657|6396379|P3|Overall Study|graft loss|2
1850153|NCT00163657|6396380|P2|Overall Study|graft loss|1
1850154|NCT00163657|6396381|P1|Overall Study|graft loss|4
1850155|NCT00163657|6396379|P3|Overall Study|Death|19
1850156|NCT00163657|6396380|P2|Overall Study|Death|14
1850157|NCT00163657|6396381|P1|Overall Study|Death|12
1850158|NCT00163215|6396471|P1|Overall Study|Other|7
1850159|NCT00163215|6396471|P1|Overall Study|Withdrawal by Subject|5
1850160|NCT00163215|6396471|P1|Overall Study|Lack of Efficacy|3
1850161|NCT00163189|6396491|P1|Overall Study|Did not meet continuation criterion|16
1850162|NCT00163189|6396491|P1|Overall Study|Withdrawal by Subject|11
1850163|NCT00163189|6396491|P1|Overall Study|Study terminated by sponsor|11
1850164|NCT00163189|6396491|P1|Overall Study|Lack of Efficacy|7
1850165|NCT00163189|6396491|P1|Overall Study|Adverse Event|6
1850166|NCT00163189|6396491|P1|Overall Study|Death|3
1850167|NCT00163189|6396491|P1|Overall Study|Protocol Violation|2
1850168|NCT00163189|6396491|P1|Overall Study|Lost to Follow-up|1
1850169|NCT00163189|6396491|P1|Overall Study|Other|6
1850170|NCT00163020|6396515|P2|Overall Study|Lost to Follow-up|2
1850171|NCT00163020|6396516|P1|Overall Study|Lost to Follow-up|0
1850172|NCT00162981|6396556|P2|Overall Study|Physician Decision|0
1850173|NCT00162981|6396557|P1|Overall Study|Physician Decision|1
1850174|NCT00162981|6396556|P2|Overall Study|Withdrawal by Subject|1
1850175|NCT00162981|6396557|P1|Overall Study|Withdrawal by Subject|1
1850176|NCT00162981|6396556|P2|Overall Study|Adverse Event|5
1850177|NCT00162981|6396557|P1|Overall Study|Adverse Event|2
1850178|NCT00162942|6396573|P2|Overall Study|2 or more consecutive treatments missed|0
1850179|NCT00162942|6396574|P1|Overall Study|2 or more consecutive treatments missed|1
1850180|NCT00162942|6396573|P2|Overall Study|Flare During Active Treatment|3
1850181|NCT00162942|6396574|P1|Overall Study|Flare During Active Treatment|7
1850182|NCT00162942|6396573|P2|Overall Study|Lack of Efficacy|0
1850183|NCT00162942|6396574|P1|Overall Study|Lack of Efficacy|1
1850184|NCT00162942|6396573|P2|Overall Study|Alternate Therapy|2
1850185|NCT00162942|6396574|P1|Overall Study|Alternate Therapy|6
1850186|NCT00162942|6396573|P2|Overall Study|Enter Open-Label Study|35
1850187|NCT00162942|6396574|P1|Overall Study|Enter Open-Label Study|76
1850188|NCT00162942|6396573|P2|Overall Study|Physician Decision|0
1850189|NCT00162942|6396574|P1|Overall Study|Physician Decision|1
1850190|NCT00162942|6396573|P2|Overall Study|Withdrawal by Subject|6
1850191|NCT00162942|6396574|P1|Overall Study|Withdrawal by Subject|3
1850192|NCT00162942|6396573|P2|Overall Study|Death|0
1850193|NCT00162942|6396574|P1|Overall Study|Death|1
1850194|NCT00162942|6396573|P2|Overall Study|Adverse Event|6
1850195|NCT00162942|6396574|P1|Overall Study|Adverse Event|10
1850196|NCT00162773|6396622|P1|Overall Study|P.I, Left institution. Study terminated|22
1850197|NCT00162370|6396626|P1|Efficacy Population|Lost to Follow-up|51
1850198|NCT00162266|6396634|P4|Open-Label Period|Other Reasons|15
1850199|NCT00162266|6396635|P3|Open-Label Period|Other Reasons|0
1850200|NCT00162266|6396636|P2|Open-Label Period|Other Reasons|0
1850201|NCT00162266|6396637|P1|Open-Label Period|Other Reasons|0
1850202|NCT00162266|6396634|P4|Open-Label Period|Administrative Reason By Sponsor|9
1850203|NCT00162266|6396635|P3|Open-Label Period|Administrative Reason By Sponsor|0
1850204|NCT00162266|6396636|P2|Open-Label Period|Administrative Reason By Sponsor|0
1850205|NCT00162266|6396637|P1|Open-Label Period|Administrative Reason By Sponsor|0
1850206|NCT00162266|6396634|P4|Open-Label Period|Withdrawal by Subject|31
1850207|NCT00162266|6396635|P3|Open-Label Period|Withdrawal by Subject|0
1850208|NCT00162266|6396636|P2|Open-Label Period|Withdrawal by Subject|0
1850209|NCT00162266|6396637|P1|Open-Label Period|Withdrawal by Subject|0
1850210|NCT00162266|6396634|P4|Open-Label Period|Lost to Follow-up|3
1850211|NCT00162266|6396635|P3|Open-Label Period|Lost to Follow-up|0
1850212|NCT00162266|6396636|P2|Open-Label Period|Lost to Follow-up|0
1850213|NCT00162266|6396637|P1|Open-Label Period|Lost to Follow-up|0
1850214|NCT00162266|6396634|P4|Open-Label Period|Lack of Efficacy|26
1850215|NCT00162266|6396635|P3|Open-Label Period|Lack of Efficacy|0
1850216|NCT00162266|6396636|P2|Open-Label Period|Lack of Efficacy|0
1850217|NCT00162266|6396637|P1|Open-Label Period|Lack of Efficacy|0
1850218|NCT00162266|6396634|P4|Open-Label Period|Adverse Event|46
1850219|NCT00162266|6396635|P3|Open-Label Period|Adverse Event|0
1850220|NCT00162266|6396636|P2|Open-Label Period|Adverse Event|0
1850221|NCT00162266|6396637|P1|Open-Label Period|Adverse Event|0
1850222|NCT00162266|6396634|P4|Open-Label Period|Death|7
1850223|NCT00162266|6396635|P3|Open-Label Period|Death|0
1850224|NCT00162266|6396636|P2|Open-Label Period|Death|0
1850225|NCT00162266|6396637|P1|Open-Label Period|Death|0
1850226|NCT00162266|6396634|P4|Double-Blind Period|Withdrawal by Subject|0
1850227|NCT00162266|6396635|P3|Double-Blind Period|Withdrawal by Subject|6
1850228|NCT00162266|6396636|P2|Double-Blind Period|Withdrawal by Subject|2
1850229|NCT00162266|6396637|P1|Double-Blind Period|Withdrawal by Subject|5
1850230|NCT00162266|6396634|P4|Double-Blind Period|Lack of Efficacy|0
1850231|NCT00162266|6396635|P3|Double-Blind Period|Lack of Efficacy|30
1850232|NCT00162266|6396636|P2|Double-Blind Period|Lack of Efficacy|17
1850233|NCT00162266|6396637|P1|Double-Blind Period|Lack of Efficacy|13
1850234|NCT00162266|6396634|P4|Double-Blind Period|Other Reason|0
1850235|NCT00162266|6396635|P3|Double-Blind Period|Other Reason|1
1850236|NCT00162266|6396636|P2|Double-Blind Period|Other Reason|0
1850237|NCT00162266|6396637|P1|Double-Blind Period|Other Reason|1
1850238|NCT00162266|6396634|P4|Double-Blind Period|Lost to Follow-up|0
1850239|NCT00162266|6396635|P3|Double-Blind Period|Lost to Follow-up|0
1850240|NCT00162266|6396636|P2|Double-Blind Period|Lost to Follow-up|2
1850241|NCT00162266|6396637|P1|Double-Blind Period|Lost to Follow-up|1
1850242|NCT00162266|6396634|P4|Double-Blind Period|Death|0
1850243|NCT00162266|6396635|P3|Double-Blind Period|Death|0
1850244|NCT00162266|6396636|P2|Double-Blind Period|Death|1
1850245|NCT00162266|6396637|P1|Double-Blind Period|Death|0
1850246|NCT00162266|6396634|P4|Double-Blind Period|Adverse Event|0
1850247|NCT00162266|6396635|P3|Double-Blind Period|Adverse Event|11
1850248|NCT00162266|6396636|P2|Double-Blind Period|Adverse Event|9
1850249|NCT00162266|6396637|P1|Double-Blind Period|Adverse Event|5
1850250|NCT00162136|6396838|P1|Overall Study|Withdrawal by Subject|1
1850251|NCT00162136|6396838|P1|Overall Study|Study Drug Toxicity|4
1850252|NCT00162136|6396838|P1|Overall Study|Investigator Request|5
1850253|NCT00162136|6396838|P1|Overall Study|Disease Progression/Relapse|23
1850254|NCT00162136|6396838|P1|Overall Study|Death|1
1850255|NCT00162136|6396838|P1|Overall Study|Adverse Event|1
1850256|NCT00162123|6396870|P8|Overall Study|Follow-up only (not treated or assessed)|57
1850257|NCT00162123|6396871|P7|Overall Study|Follow-up only (not treated or assessed)|0
1850258|NCT00162123|6396872|P6|Overall Study|Follow-up only (not treated or assessed)|0
1850259|NCT00162123|6396873|P5|Overall Study|Follow-up only (not treated or assessed)|0
1850260|NCT00162123|6396874|P4|Overall Study|Follow-up only (not treated or assessed)|0
1850261|NCT00162123|6396875|P3|Overall Study|Follow-up only (not treated or assessed)|0
1850262|NCT00162123|6396876|P2|Overall Study|Follow-up only (not treated or assessed)|0
1850263|NCT00162123|6396877|P1|Overall Study|Follow-up only (not treated or assessed)|0
1850264|NCT00162123|6396870|P8|Overall Study|Tumor assessment only (not treated)|1
1850265|NCT00162123|6396871|P7|Overall Study|Tumor assessment only (not treated)|0
1850266|NCT00162123|6396872|P6|Overall Study|Tumor assessment only (not treated)|0
1850267|NCT00162123|6396873|P5|Overall Study|Tumor assessment only (not treated)|0
1850268|NCT00162123|6396874|P4|Overall Study|Tumor assessment only (not treated)|0
1850269|NCT00162123|6396875|P3|Overall Study|Tumor assessment only (not treated)|0
1850270|NCT00162123|6396876|P2|Overall Study|Tumor assessment only (not treated)|0
1850271|NCT00162123|6396877|P1|Overall Study|Tumor assessment only (not treated)|0
1850272|NCT00162123|6396870|P8|Overall Study|Physician Decision|0
1850273|NCT00162123|6396871|P7|Overall Study|Physician Decision|1
1850274|NCT00162123|6396872|P6|Overall Study|Physician Decision|1
1850275|NCT00162123|6396873|P5|Overall Study|Physician Decision|0
1850276|NCT00162123|6396874|P4|Overall Study|Physician Decision|0
1850277|NCT00162123|6396875|P3|Overall Study|Physician Decision|0
1850278|NCT00162123|6396876|P2|Overall Study|Physician Decision|2
1850279|NCT00162123|6396877|P1|Overall Study|Physician Decision|1
1850280|NCT00162123|6396870|P8|Overall Study|Not specified (after start of treatment)|0
1850281|NCT00162123|6396871|P7|Overall Study|Not specified (after start of treatment)|0
1850282|NCT00162123|6396872|P6|Overall Study|Not specified (after start of treatment)|0
1850283|NCT00162123|6396873|P5|Overall Study|Not specified (after start of treatment)|3
1850284|NCT00162123|6396874|P4|Overall Study|Not specified (after start of treatment)|0
1850285|NCT00162123|6396875|P3|Overall Study|Not specified (after start of treatment)|0
1850286|NCT00162123|6396876|P2|Overall Study|Not specified (after start of treatment)|0
1850287|NCT00162123|6396877|P1|Overall Study|Not specified (after start of treatment)|0
1850288|NCT00162123|6396870|P8|Overall Study|Not specified (before treatment)|0
1850289|NCT00162123|6396871|P7|Overall Study|Not specified (before treatment)|0
1850290|NCT00162123|6396872|P6|Overall Study|Not specified (before treatment)|1
1850291|NCT00162123|6396873|P5|Overall Study|Not specified (before treatment)|12
1850292|NCT00162123|6396874|P4|Overall Study|Not specified (before treatment)|0
1850293|NCT00162123|6396875|P3|Overall Study|Not specified (before treatment)|0
1850294|NCT00162123|6396876|P2|Overall Study|Not specified (before treatment)|0
1850295|NCT00162123|6396877|P1|Overall Study|Not specified (before treatment)|2
1850296|NCT00162123|6396870|P8|Overall Study|Adverse Event|0
1850297|NCT00162123|6396871|P7|Overall Study|Adverse Event|0
1850298|NCT00162123|6396872|P6|Overall Study|Adverse Event|0
1850299|NCT00162123|6396873|P5|Overall Study|Adverse Event|1
1850300|NCT00162123|6396874|P4|Overall Study|Adverse Event|2
1850301|NCT00162123|6396875|P3|Overall Study|Adverse Event|0
1850302|NCT00162123|6396876|P2|Overall Study|Adverse Event|2
1850303|NCT00162123|6396877|P1|Overall Study|Adverse Event|1
1850304|NCT00162123|6396870|P8|Overall Study|Deterioration without progression|0
1850305|NCT00162123|6396871|P7|Overall Study|Deterioration without progression|0
1850306|NCT00162123|6396872|P6|Overall Study|Deterioration without progression|0
1850307|NCT00162123|6396873|P5|Overall Study|Deterioration without progression|1
1850308|NCT00162123|6396874|P4|Overall Study|Deterioration without progression|0
1850309|NCT00162123|6396875|P3|Overall Study|Deterioration without progression|3
1850310|NCT00162123|6396876|P2|Overall Study|Deterioration without progression|2
1850311|NCT00162123|6396877|P1|Overall Study|Deterioration without progression|2
1850312|NCT00162123|6396870|P8|Overall Study|Withdrawal by Subject|0
1850313|NCT00162123|6396871|P7|Overall Study|Withdrawal by Subject|1
1850314|NCT00162123|6396872|P6|Overall Study|Withdrawal by Subject|2
1850315|NCT00162123|6396873|P5|Overall Study|Withdrawal by Subject|1
1850316|NCT00162123|6396874|P4|Overall Study|Withdrawal by Subject|1
1850317|NCT00162123|6396875|P3|Overall Study|Withdrawal by Subject|2
1850318|NCT00162123|6396876|P2|Overall Study|Withdrawal by Subject|0
1850319|NCT00162123|6396877|P1|Overall Study|Withdrawal by Subject|2
1850320|NCT00162123|6396870|P8|Overall Study|Death|0
1850321|NCT00162123|6396871|P7|Overall Study|Death|0
1850322|NCT00162123|6396872|P6|Overall Study|Death|1
1850323|NCT00162123|6396873|P5|Overall Study|Death|1
1850324|NCT00162123|6396874|P4|Overall Study|Death|1
1850325|NCT00162123|6396875|P3|Overall Study|Death|1
1850326|NCT00162123|6396876|P2|Overall Study|Death|3
1850327|NCT00162123|6396877|P1|Overall Study|Death|3
1850328|NCT00162123|6396870|P8|Overall Study|Study drug toxicity|0
1850329|NCT00162123|6396871|P7|Overall Study|Study drug toxicity|1
1850330|NCT00162123|6396872|P6|Overall Study|Study drug toxicity|1
1850331|NCT00162123|6396873|P5|Overall Study|Study drug toxicity|4
1850332|NCT00162123|6396874|P4|Overall Study|Study drug toxicity|0
1850333|NCT00162123|6396875|P3|Overall Study|Study drug toxicity|5
1850334|NCT00162123|6396876|P2|Overall Study|Study drug toxicity|1
1850335|NCT00162123|6396877|P1|Overall Study|Study drug toxicity|6
1850336|NCT00162123|6396870|P8|Overall Study|Disease progression|0
1850337|NCT00162123|6396871|P7|Overall Study|Disease progression|1
1850338|NCT00162123|6396872|P6|Overall Study|Disease progression|3
1850339|NCT00162123|6396873|P5|Overall Study|Disease progression|8
1850340|NCT00162123|6396874|P4|Overall Study|Disease progression|4
1850341|NCT00162123|6396875|P3|Overall Study|Disease progression|10
1850342|NCT00162123|6396876|P2|Overall Study|Disease progression|19
1850343|NCT00162123|6396877|P1|Overall Study|Disease progression|27
1850344|NCT00162097|6396910|P4|Overall Study|Participant no longer met study criteria|1
1850345|NCT00162097|6396911|P3|Overall Study|Participant no longer met study criteria|0
1850346|NCT00162097|6396912|P2|Overall Study|Participant no longer met study criteria|0
1850347|NCT00162097|6396913|P1|Overall Study|Participant no longer met study criteria|0
1850348|NCT00162032|6396975|P2|Overall Study|Reason not specified|0
1850349|NCT00162032|6396976|P1|Overall Study|Reason not specified|1
1850350|NCT00162032|6396975|P2|Overall Study|Lost to Follow-up|2
1850351|NCT00162032|6396976|P1|Overall Study|Lost to Follow-up|4
1850352|NCT00161616|6396997|P2|Overall Study|Protocol deviation|0
1850353|NCT00161616|6396998|P1|Overall Study|Protocol deviation|1
1850354|NCT00161616|6396997|P2|Overall Study|Lost to Follow-up|13
1850355|NCT00161616|6396998|P1|Overall Study|Lost to Follow-up|17
1850356|NCT00161616|6396997|P2|Overall Study|Death|1
1850357|NCT00161616|6396998|P1|Overall Study|Death|1
1850358|NCT00161616|6396997|P2|Overall Study|Physician Decision|0
1850359|NCT00161616|6396998|P1|Overall Study|Physician Decision|1
1850360|NCT00161616|6396997|P2|Overall Study|Withdrawal by Subject|5
1850361|NCT00161616|6396998|P1|Overall Study|Withdrawal by Subject|6
1850362|NCT00161213|6397030|P1|Overall Study|Evaluable for toxicity but not response|1
1850363|NCT00161213|6397030|P1|Overall Study|Withdrawal by Subject|1
1850364|NCT00160706|6397037|P1|Overall Study|Other Reason|11
1850365|NCT00160706|6397037|P1|Overall Study|Lack of Efficacy and Other|1
1850366|NCT00160706|6397037|P1|Overall Study|Lack of Efficacy|42
1850367|NCT00160706|6397037|P1|Overall Study|Lost to Follow-up and Other|1
1850368|NCT00160706|6397037|P1|Overall Study|Lost to Follow-up|4
1850369|NCT00160706|6397037|P1|Overall Study|Physician Decision and Other|3
1850370|NCT00160706|6397037|P1|Overall Study|Physician Decision|10
1850371|NCT00160706|6397037|P1|Overall Study|Withdrawal by Subject and Other|12
1850372|NCT00160706|6397037|P1|Overall Study|Withdrawal by Subject|41
1850373|NCT00160706|6397037|P1|Overall Study|Protocol Violation|3
1850374|NCT00160706|6397037|P1|Overall Study|Adverse Event and Other Reason|105
1850375|NCT00160706|6397037|P1|Overall Study|Adverse Event|53
1850376|NCT00160693|6397049|P1|Overall Study|Study terminated by sponsor|15
1850377|NCT00160693|6397049|P1|Overall Study|Withdrawal by Subject|54
1850378|NCT00160693|6397049|P1|Overall Study|Lost to Follow-up|15
1850379|NCT00160693|6397049|P1|Overall Study|Protocol Violation|24
1850380|NCT00160693|6397049|P1|Overall Study|Lack of Efficacy|30
1850381|NCT00160693|6397049|P1|Overall Study|Adverse Event|97
1850382|NCT00160680|6397068|P2|Overall Study|Withdrawal by Subject|9
1850383|NCT00160680|6397069|P1|Overall Study|Withdrawal by Subject|4
1850384|NCT00160680|6397068|P2|Overall Study|Lost to Follow-up|2
1850385|NCT00160680|6397069|P1|Overall Study|Lost to Follow-up|3
1850386|NCT00160680|6397068|P2|Overall Study|Lack of Efficacy|1
1850387|NCT00160680|6397069|P1|Overall Study|Lack of Efficacy|2
1850388|NCT00160680|6397068|P2|Overall Study|Adverse Event|1
1850389|NCT00160680|6397069|P1|Overall Study|Adverse Event|0
1850390|NCT00160667|6397104|P3|Overall Study|Patient decision|1
1850391|NCT00160667|6397105|P2|Overall Study|Patient decision|0
1850392|NCT00160667|6397106|P1|Overall Study|Patient decision|0
1850393|NCT00160667|6397104|P3|Overall Study|Protocol Violation|0
1850394|NCT00160667|6397105|P2|Overall Study|Protocol Violation|1
1850395|NCT00160667|6397106|P1|Overall Study|Protocol Violation|0
1850396|NCT00160667|6397104|P3|Overall Study|Lack of Efficacy|0
1850397|NCT00160667|6397105|P2|Overall Study|Lack of Efficacy|1
1850398|NCT00160667|6397106|P1|Overall Study|Lack of Efficacy|0
1850399|NCT00160667|6397104|P3|Overall Study|Withdrawal by Subject|1
1850400|NCT00160667|6397105|P2|Overall Study|Withdrawal by Subject|0
1850401|NCT00160667|6397106|P1|Overall Study|Withdrawal by Subject|2
1850402|NCT00160667|6397104|P3|Overall Study|Adverse Event|4
1850403|NCT00160667|6397105|P2|Overall Study|Adverse Event|1
1850404|NCT00160667|6397106|P1|Overall Study|Adverse Event|3
1850405|NCT00160641|6397153|P1|Overall Study|Other|9
1850406|NCT00160641|6397153|P1|Overall Study|Protocol Violation|3
1850407|NCT00160641|6397153|P1|Overall Study|Lack of Efficacy|12
1850408|NCT00160641|6397153|P1|Overall Study|Lost to Follow-up|8
1850409|NCT00160641|6397153|P1|Overall Study|Withdrawal by Subject|87
1850410|NCT00160641|6397153|P1|Overall Study|Adverse Event|102
1850411|NCT00160615|6397186|P2|Overall Study|Poor compliance|1
1850412|NCT00160615|6397187|P1|Overall Study|Poor compliance|0
1850413|NCT00160615|6397186|P2|Overall Study|Non-compliance was suspected|1
1850414|NCT00160615|6397187|P1|Overall Study|Non-compliance was suspected|0
1850415|NCT00160615|6397186|P2|Overall Study|Switch to surgical treatment|2
1850416|NCT00160615|6397187|P1|Overall Study|Switch to surgical treatment|0
1850417|NCT00160615|6397186|P2|Overall Study|AE agents had to be discontinued (exam.)|1
1850418|NCT00160615|6397187|P1|Overall Study|AE agents had to be discontinued (exam.)|0
1850419|NCT00160615|6397186|P2|Overall Study|Investigator decision|1
1850420|NCT00160615|6397187|P1|Overall Study|Investigator decision|1
1850421|NCT00160615|6397186|P2|Overall Study|Patient decision|2
1850422|NCT00160615|6397187|P1|Overall Study|Patient decision|1
1850423|NCT00160615|6397186|P2|Overall Study|Lack of Efficacy|23
1850424|NCT00160615|6397187|P1|Overall Study|Lack of Efficacy|11
1850425|NCT00160615|6397186|P2|Overall Study|Withdrawal by Subject|2
1850426|NCT00160615|6397187|P1|Overall Study|Withdrawal by Subject|0
1850427|NCT00160615|6397186|P2|Overall Study|Adverse Event|12
1850428|NCT00160615|6397187|P1|Overall Study|Adverse Event|5
1850429|NCT00160563|6397210|P3|Overall Study|Missing reason|0
1850430|NCT00160563|6397211|P2|Overall Study|Missing reason|1
1850431|NCT00160563|6397212|P1|Overall Study|Missing reason|0
1850432|NCT00160563|6397210|P3|Overall Study|Other (listed in the study report)|81
1850433|NCT00160563|6397211|P2|Overall Study|Other (listed in the study report)|40
1850434|NCT00160563|6397212|P1|Overall Study|Other (listed in the study report)|48
1850435|NCT00160563|6397210|P3|Overall Study|Withdrawal by Subject|3
1850436|NCT00160563|6397211|P2|Overall Study|Withdrawal by Subject|2
1850437|NCT00160563|6397212|P1|Overall Study|Withdrawal by Subject|1
1850438|NCT00160563|6397210|P3|Overall Study|Protocol Violation|3
1850439|NCT00160563|6397211|P2|Overall Study|Protocol Violation|0
1850440|NCT00160563|6397212|P1|Overall Study|Protocol Violation|0
1850441|NCT00160563|6397210|P3|Overall Study|Lost to Follow-up|2
1850442|NCT00160563|6397211|P2|Overall Study|Lost to Follow-up|1
1850443|NCT00160563|6397212|P1|Overall Study|Lost to Follow-up|1
1850444|NCT00160563|6397210|P3|Overall Study|Adverse Event|1
1850445|NCT00160563|6397211|P2|Overall Study|Adverse Event|1
1850446|NCT00160563|6397212|P1|Overall Study|Adverse Event|1
1850447|NCT00160524|6397224|P1|Overall Study|Other|20
1850448|NCT00160524|6397224|P1|Overall Study|Lack of Efficacy and Other|1
1850449|NCT00160524|6397224|P1|Overall Study|Lack of Efficacy|21
1850450|NCT00160524|6397224|P1|Overall Study|Lost to Follow-up and Other|1
1850451|NCT00160524|6397224|P1|Overall Study|Lost to Follow-up|13
1850452|NCT00160524|6397224|P1|Overall Study|Physician Decision and Other|6
1850453|NCT00160524|6397224|P1|Overall Study|Physician Decision|27
1850454|NCT00160524|6397224|P1|Overall Study|Withdrawal by Subject and Other|17
1850455|NCT00160524|6397224|P1|Overall Study|Withdrawal by Subject|141
1850456|NCT00160524|6397224|P1|Overall Study|Protocol Violation and Other|2
1850457|NCT00160524|6397224|P1|Overall Study|Protocol Violation|16
1850458|NCT00160524|6397224|P1|Overall Study|Adverse Event and Other|94
1850459|NCT00160524|6397224|P1|Overall Study|Adverse Event|119
1850460|NCT00160251|6397241|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
1850461|NCT00160251|6397242|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1850462|NCT00160251|6397243|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1850463|NCT00160251|6397244|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1850464|NCT00160251|6397245|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1850465|NCT00160251|6397246|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1850466|NCT00160251|6397247|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1850467|NCT00160251|6397248|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
1850468|NCT00160251|6397241|P8|Post-amendment 2|Lack of Efficacy|24
1850469|NCT00160251|6397242|P7|Post-amendment 2|Lack of Efficacy|0
1850470|NCT00160251|6397243|P6|Post-amendment 2|Lack of Efficacy|0
1850471|NCT00160251|6397244|P5|Post-amendment 2|Lack of Efficacy|0
1850472|NCT00160251|6397245|P4|Post-amendment 2|Lack of Efficacy|0
1850473|NCT00160251|6397246|P3|Post-amendment 2|Lack of Efficacy|0
1850474|NCT00160251|6397247|P2|Post-amendment 2|Lack of Efficacy|0
1850475|NCT00160251|6397248|P1|Post-amendment 2|Lack of Efficacy|0
1850476|NCT00160251|6397241|P8|Post-amendment 2|Adverse Event|20
1850477|NCT00160251|6397242|P7|Post-amendment 2|Adverse Event|0
1850478|NCT00160251|6397243|P6|Post-amendment 2|Adverse Event|0
1850479|NCT00160251|6397244|P5|Post-amendment 2|Adverse Event|0
1850480|NCT00160251|6397245|P4|Post-amendment 2|Adverse Event|0
1850481|NCT00160251|6397246|P3|Post-amendment 2|Adverse Event|0
1850482|NCT00160251|6397247|P2|Post-amendment 2|Adverse Event|0
1850483|NCT00160251|6397248|P1|Post-amendment 2|Adverse Event|0
1850484|NCT00160251|6397241|P8|Prior to Amendment 2|Completed Treatment Phase|0
1850485|NCT00160251|6397242|P7|Prior to Amendment 2|Completed Treatment Phase|0
1850486|NCT00160251|6397243|P6|Prior to Amendment 2|Completed Treatment Phase|23
1850487|NCT00160251|6397244|P5|Prior to Amendment 2|Completed Treatment Phase|0
1850488|NCT00160251|6397245|P4|Prior to Amendment 2|Completed Treatment Phase|0
1850489|NCT00160251|6397246|P3|Prior to Amendment 2|Completed Treatment Phase|0
1850490|NCT00160251|6397247|P2|Prior to Amendment 2|Completed Treatment Phase|0
1850491|NCT00160251|6397248|P1|Prior to Amendment 2|Completed Treatment Phase|3
1850492|NCT00160251|6397241|P8|Prior to Amendment 2|Noncompliance with protocol|0
1850493|NCT00160251|6397242|P7|Prior to Amendment 2|Noncompliance with protocol|0
1850494|NCT00160251|6397243|P6|Prior to Amendment 2|Noncompliance with protocol|0
1850495|NCT00160251|6397244|P5|Prior to Amendment 2|Noncompliance with protocol|0
1850496|NCT00160251|6397245|P4|Prior to Amendment 2|Noncompliance with protocol|0
1850497|NCT00160251|6397246|P3|Prior to Amendment 2|Noncompliance with protocol|0
1850498|NCT00160251|6397247|P2|Prior to Amendment 2|Noncompliance with protocol|0
1850499|NCT00160251|6397248|P1|Prior to Amendment 2|Noncompliance with protocol|1
1850500|NCT00160251|6397241|P8|Prior to Amendment 2|Withdrawal by Subject|0
1850501|NCT00160251|6397242|P7|Prior to Amendment 2|Withdrawal by Subject|3
1850502|NCT00160251|6397243|P6|Prior to Amendment 2|Withdrawal by Subject|3
1850503|NCT00160251|6397244|P5|Prior to Amendment 2|Withdrawal by Subject|2
1850504|NCT00160251|6397245|P4|Prior to Amendment 2|Withdrawal by Subject|4
1850505|NCT00160251|6397246|P3|Prior to Amendment 2|Withdrawal by Subject|3
1850506|NCT00160251|6397247|P2|Prior to Amendment 2|Withdrawal by Subject|1
1850507|NCT00160251|6397248|P1|Prior to Amendment 2|Withdrawal by Subject|3
1850508|NCT00160251|6397241|P8|Prior to Amendment 2|Lost to Follow-up|0
1850509|NCT00160251|6397242|P7|Prior to Amendment 2|Lost to Follow-up|0
1850510|NCT00160251|6397243|P6|Prior to Amendment 2|Lost to Follow-up|1
1850511|NCT00160251|6397244|P5|Prior to Amendment 2|Lost to Follow-up|1
1850512|NCT00160251|6397245|P4|Prior to Amendment 2|Lost to Follow-up|0
1850513|NCT00160251|6397246|P3|Prior to Amendment 2|Lost to Follow-up|1
1850514|NCT00160251|6397247|P2|Prior to Amendment 2|Lost to Follow-up|0
1850515|NCT00160251|6397248|P1|Prior to Amendment 2|Lost to Follow-up|0
1850516|NCT00160251|6397241|P8|Prior to Amendment 2|Lack of Efficacy|0
1850517|NCT00160251|6397242|P7|Prior to Amendment 2|Lack of Efficacy|0
1850518|NCT00160251|6397243|P6|Prior to Amendment 2|Lack of Efficacy|55
1850519|NCT00160251|6397244|P5|Prior to Amendment 2|Lack of Efficacy|24
1850520|NCT00160251|6397245|P4|Prior to Amendment 2|Lack of Efficacy|35
1850521|NCT00160251|6397246|P3|Prior to Amendment 2|Lack of Efficacy|37
1850522|NCT00160251|6397247|P2|Prior to Amendment 2|Lack of Efficacy|4
1850523|NCT00160251|6397248|P1|Prior to Amendment 2|Lack of Efficacy|0
1850524|NCT00160251|6397241|P8|Prior to Amendment 2|Adverse Event|0
1850525|NCT00160251|6397242|P7|Prior to Amendment 2|Adverse Event|1
1850526|NCT00160251|6397243|P6|Prior to Amendment 2|Adverse Event|1
1850527|NCT00160251|6397244|P5|Prior to Amendment 2|Adverse Event|1
1850528|NCT00160251|6397245|P4|Prior to Amendment 2|Adverse Event|1
1850529|NCT00160251|6397246|P3|Prior to Amendment 2|Adverse Event|3
1850530|NCT00160251|6397247|P2|Prior to Amendment 2|Adverse Event|1
1850531|NCT00160251|6397248|P1|Prior to Amendment 2|Adverse Event|2
1850532|NCT00160199|6397324|P2|Overall Study|Protocol Violation|8
1850533|NCT00160199|6397325|P1|Overall Study|Protocol Violation|8
1850534|NCT00160199|6397324|P2|Overall Study|Administrative|1
1850535|NCT00160199|6397325|P1|Overall Study|Administrative|0
1850536|NCT00160199|6397324|P2|Overall Study|Withdrawal by Subject|6
1850537|NCT00160199|6397325|P1|Overall Study|Withdrawal by Subject|4
1850538|NCT00160199|6397324|P2|Overall Study|Lost to Follow-up|7
1850539|NCT00160199|6397325|P1|Overall Study|Lost to Follow-up|7
1850540|NCT00160199|6397324|P2|Overall Study|Lack of Efficacy|1
1850541|NCT00160199|6397325|P1|Overall Study|Lack of Efficacy|0
1850542|NCT00160199|6397324|P2|Overall Study|Adverse Event|14
1850543|NCT00160199|6397325|P1|Overall Study|Adverse Event|5
1850544|NCT00159913|6397382|P4|Overall Study|Protocol Violation|0
1850545|NCT00159913|6397383|P3|Overall Study|Protocol Violation|1
1850546|NCT00159913|6397384|P2|Overall Study|Protocol Violation|0
1850547|NCT00159913|6397385|P1|Overall Study|Protocol Violation|1
1850548|NCT00159913|6397382|P4|Overall Study|Lost to Follow-up|1
1850549|NCT00159913|6397383|P3|Overall Study|Lost to Follow-up|0
1850550|NCT00159913|6397384|P2|Overall Study|Lost to Follow-up|0
1850551|NCT00159913|6397385|P1|Overall Study|Lost to Follow-up|0
1850552|NCT00159913|6397382|P4|Overall Study|Withdrawal by Subject|1
1850553|NCT00159913|6397383|P3|Overall Study|Withdrawal by Subject|0
1850554|NCT00159913|6397384|P2|Overall Study|Withdrawal by Subject|0
1850555|NCT00159913|6397385|P1|Overall Study|Withdrawal by Subject|0
1850556|NCT00159913|6397382|P4|Overall Study|Adverse Event|0
1850557|NCT00159913|6397383|P3|Overall Study|Adverse Event|1
1850558|NCT00159913|6397384|P2|Overall Study|Adverse Event|0
1850559|NCT00159913|6397385|P1|Overall Study|Adverse Event|1
1850560|NCT00159874|6397459|P7|Overall Study|Pregnancy|0
1850561|NCT00159874|6397460|P6|Overall Study|Pregnancy|0
1850562|NCT00159874|6397461|P5|Overall Study|Pregnancy|0
1850563|NCT00159874|6397462|P4|Overall Study|Pregnancy|0
1850564|NCT00159874|6397463|P3|Overall Study|Pregnancy|0
1850565|NCT00159874|6397464|P2|Overall Study|Pregnancy|1
1850566|NCT00159874|6397465|P1|Overall Study|Pregnancy|1
1850567|NCT00159874|6397459|P7|Overall Study|Withdrawal by Subject|1
1850568|NCT00159874|6397460|P6|Overall Study|Withdrawal by Subject|2
1850569|NCT00159874|6397461|P5|Overall Study|Withdrawal by Subject|3
1850570|NCT00159874|6397462|P4|Overall Study|Withdrawal by Subject|4
1850571|NCT00159874|6397463|P3|Overall Study|Withdrawal by Subject|8
1850572|NCT00159874|6397464|P2|Overall Study|Withdrawal by Subject|6
1850573|NCT00159874|6397465|P1|Overall Study|Withdrawal by Subject|2
1850574|NCT00159874|6397459|P7|Overall Study|Death|0
1850575|NCT00159874|6397460|P6|Overall Study|Death|2
1850576|NCT00159874|6397461|P5|Overall Study|Death|1
1850577|NCT00159874|6397462|P4|Overall Study|Death|0
1850578|NCT00159874|6397463|P3|Overall Study|Death|15
1850579|NCT00159874|6397464|P2|Overall Study|Death|8
1850580|NCT00159874|6397465|P1|Overall Study|Death|3
1850581|NCT00159874|6397459|P7|Overall Study|Protocol Violation|0
1850582|NCT00159874|6397460|P6|Overall Study|Protocol Violation|0
1850583|NCT00159874|6397461|P5|Overall Study|Protocol Violation|0
1850584|NCT00159874|6397462|P4|Overall Study|Protocol Violation|0
1850585|NCT00159874|6397463|P3|Overall Study|Protocol Violation|2
1850586|NCT00159874|6397464|P2|Overall Study|Protocol Violation|5
1850587|NCT00159874|6397465|P1|Overall Study|Protocol Violation|0
1850588|NCT00159874|6397459|P7|Overall Study|Other|3
1850589|NCT00159874|6397460|P6|Overall Study|Other|1
1850590|NCT00159874|6397461|P5|Overall Study|Other|2
1850591|NCT00159874|6397462|P4|Overall Study|Other|0
1850592|NCT00159874|6397463|P3|Overall Study|Other|8
1850593|NCT00159874|6397464|P2|Overall Study|Other|8
1850594|NCT00159874|6397465|P1|Overall Study|Other|8
1850595|NCT00159874|6397459|P7|Overall Study|Lost to Follow-up|1
1850596|NCT00159874|6397460|P6|Overall Study|Lost to Follow-up|2
1850597|NCT00159874|6397461|P5|Overall Study|Lost to Follow-up|1
1850598|NCT00159874|6397462|P4|Overall Study|Lost to Follow-up|0
1850599|NCT00159874|6397463|P3|Overall Study|Lost to Follow-up|3
1850600|NCT00159874|6397464|P2|Overall Study|Lost to Follow-up|0
1850601|NCT00159874|6397465|P1|Overall Study|Lost to Follow-up|1
1850602|NCT00159874|6397459|P7|Overall Study|Lack of Efficacy|0
1850603|NCT00159874|6397460|P6|Overall Study|Lack of Efficacy|3
1850604|NCT00159874|6397461|P5|Overall Study|Lack of Efficacy|0
1850605|NCT00159874|6397462|P4|Overall Study|Lack of Efficacy|1
1850606|NCT00159874|6397463|P3|Overall Study|Lack of Efficacy|1
1850607|NCT00159874|6397464|P2|Overall Study|Lack of Efficacy|0
1850608|NCT00159874|6397465|P1|Overall Study|Lack of Efficacy|2
1850609|NCT00159874|6397459|P7|Overall Study|Does Not Meet Entrance Criteria|0
1850610|NCT00159874|6397460|P6|Overall Study|Does Not Meet Entrance Criteria|0
1850611|NCT00159874|6397461|P5|Overall Study|Does Not Meet Entrance Criteria|0
1850612|NCT00159874|6397462|P4|Overall Study|Does Not Meet Entrance Criteria|0
1850613|NCT00159874|6397463|P3|Overall Study|Does Not Meet Entrance Criteria|1
1850614|NCT00159874|6397464|P2|Overall Study|Does Not Meet Entrance Criteria|0
1850615|NCT00159874|6397465|P1|Overall Study|Does Not Meet Entrance Criteria|1
1850616|NCT00159874|6397459|P7|Overall Study|Adverse Event|0
1850617|NCT00159874|6397460|P6|Overall Study|Adverse Event|2
1850618|NCT00159874|6397461|P5|Overall Study|Adverse Event|1
1850619|NCT00159874|6397462|P4|Overall Study|Adverse Event|1
1850620|NCT00159874|6397463|P3|Overall Study|Adverse Event|5
1850621|NCT00159874|6397464|P2|Overall Study|Adverse Event|2
1850622|NCT00159874|6397465|P1|Overall Study|Adverse Event|2
1850623|NCT00159861|6397635|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
1850624|NCT00159861|6397636|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
1850625|NCT00159861|6397635|P2|Extension Study - up to 3 Years|Reason Unspecified|19
1850626|NCT00159861|6397636|P1|Extension Study - up to 3 Years|Reason Unspecified|12
1850627|NCT00159861|6397635|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
1850628|NCT00159861|6397636|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
1850629|NCT00159861|6397635|P2|Extension Study - up to 3 Years|Adverse Event|14
1850630|NCT00159861|6397636|P1|Extension Study - up to 3 Years|Adverse Event|14
1850631|NCT00159861|6397635|P2|Extension Study - up to 3 Years|Death|28
1850632|NCT00159861|6397636|P1|Extension Study - up to 3 Years|Death|24
1850633|NCT00159861|6397635|P2|Core Study - 16 Weeks|Randomized but not Treated|0
1850634|NCT00159861|6397636|P1|Core Study - 16 Weeks|Randomized but not Treated|2
1850635|NCT00159861|6397635|P2|Core Study - 16 Weeks|Subject Defaulted|0
1850636|NCT00159861|6397636|P1|Core Study - 16 Weeks|Subject Defaulted|1
1850637|NCT00159861|6397635|P2|Core Study - 16 Weeks|Reason Unspecified|3
1850638|NCT00159861|6397636|P1|Core Study - 16 Weeks|Reason Unspecified|5
1850639|NCT00159861|6397635|P2|Core Study - 16 Weeks|Lack of Efficacy|3
1850640|NCT00159861|6397636|P1|Core Study - 16 Weeks|Lack of Efficacy|2
1850641|NCT00159861|6397635|P2|Core Study - 16 Weeks|Adverse Event|6
1850642|NCT00159861|6397636|P1|Core Study - 16 Weeks|Adverse Event|12
1850643|NCT00159861|6397635|P2|Core Study - 16 Weeks|Death|0
1850644|NCT00159861|6397636|P1|Core Study - 16 Weeks|Death|3
1850645|NCT00159822|6397657|P1|Post-treatment Follow-up Period|Reason unspecified|1
1850646|NCT00159822|6397657|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
1850647|NCT00159822|6397657|P1|Post-treatment Follow-up Period|Death|1
1850648|NCT00159822|6397657|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
1850649|NCT00159822|6397657|P1|Voriconazole Treatment Period|Lost to Follow-up|2
1850650|NCT00159822|6397657|P1|Voriconazole Treatment Period|Protocol Violation|2
1850651|NCT00159822|6397657|P1|Voriconazole Treatment Period|Death|4
1850652|NCT00159822|6397657|P1|Voriconazole Treatment Period|Adverse Event|9
1850653|NCT00159822|6397657|P1|Voriconazole Treatment Period|Lack of Efficacy|3
1850654|NCT00159783|6397675|P3|Overall Study|Other|4
1850655|NCT00159783|6397676|P2|Overall Study|Other|2
1850656|NCT00159783|6397677|P1|Overall Study|Other|0
1850657|NCT00159783|6397675|P3|Overall Study|Lost to Follow-up|11
1850658|NCT00159783|6397676|P2|Overall Study|Lost to Follow-up|5
1850659|NCT00159783|6397677|P1|Overall Study|Lost to Follow-up|6
1850660|NCT00159783|6397675|P3|Overall Study|Withdrawal by Subject|12
1850661|NCT00159783|6397676|P2|Overall Study|Withdrawal by Subject|11
1850662|NCT00159783|6397677|P1|Overall Study|Withdrawal by Subject|7
1850663|NCT00159783|6397675|P3|Overall Study|Lack of Efficacy|3
1850664|NCT00159783|6397676|P2|Overall Study|Lack of Efficacy|2
1850665|NCT00159783|6397677|P1|Overall Study|Lack of Efficacy|1
1850666|NCT00159783|6397675|P3|Overall Study|Adverse Event|9
1850667|NCT00159783|6397676|P2|Overall Study|Adverse Event|7
1850668|NCT00159783|6397677|P1|Overall Study|Adverse Event|5
1850669|NCT00159432|6397707|P1|Overall Study|Lack of Efficacy|8
1850670|NCT00159432|6397707|P1|Overall Study|Death|1
1850671|NCT00159432|6397707|P1|Overall Study|Adverse Event|1
1850672|NCT00158860|6397781|P2|Overall Study|Closed per sponsor|1
1850673|NCT00158860|6397782|P1|Overall Study|Closed per sponsor|0
1850674|NCT00158860|6397781|P2|Overall Study|Lost to Follow up but returned per GSK|1
1850675|NCT00158860|6397782|P1|Overall Study|Lost to Follow up but returned per GSK|0
1850676|NCT00158860|6397781|P2|Overall Study|SPONSOR REQUEST|1
1850677|NCT00158860|6397782|P1|Overall Study|SPONSOR REQUEST|0
1850678|NCT00158860|6397781|P2|Overall Study|SPONSOR STOPPED STUDY|2
1850679|NCT00158860|6397782|P1|Overall Study|SPONSOR STOPPED STUDY|2
1850680|NCT00158860|6397781|P2|Overall Study|Pregnancy|3
1850681|NCT00158860|6397782|P1|Overall Study|Pregnancy|3
1850682|NCT00158860|6397781|P2|Overall Study|MOVING OUT OF STATE|0
1850683|NCT00158860|6397782|P1|Overall Study|MOVING OUT OF STATE|1
1850684|NCT00158860|6397781|P2|Overall Study|Withdrawal by Subject|17
1850685|NCT00158860|6397782|P1|Overall Study|Withdrawal by Subject|7
1850686|NCT00158860|6397781|P2|Overall Study|Protocol Violation|23
1850687|NCT00158860|6397782|P1|Overall Study|Protocol Violation|8
1850688|NCT00158860|6397781|P2|Overall Study|Lost to Follow-up|17
1850689|NCT00158860|6397782|P1|Overall Study|Lost to Follow-up|11
1850690|NCT00158860|6397781|P2|Overall Study|Adverse Event|6
1850691|NCT00158860|6397782|P1|Overall Study|Adverse Event|3
1850692|NCT00158756|6397801|P5|Overall Study|Serious adverse event|0
1850693|NCT00158756|6397802|P4|Overall Study|Serious adverse event|0
1850694|NCT00158756|6397803|P3|Overall Study|Serious adverse event|1
1850695|NCT00158756|6397804|P2|Overall Study|Serious adverse event|0
1850696|NCT00158756|6397805|P1|Overall Study|Serious adverse event|0
1850697|NCT00158756|6397801|P5|Overall Study|Adverse Event|0
1850698|NCT00158756|6397802|P4|Overall Study|Adverse Event|0
1850699|NCT00158756|6397803|P3|Overall Study|Adverse Event|1
1850700|NCT00158756|6397804|P2|Overall Study|Adverse Event|0
1850701|NCT00158756|6397805|P1|Overall Study|Adverse Event|0
1850702|NCT00158756|6397801|P5|Overall Study|Withdrawal by Subject|3
1850703|NCT00158756|6397802|P4|Overall Study|Withdrawal by Subject|1
1850704|NCT00158756|6397803|P3|Overall Study|Withdrawal by Subject|6
1850705|NCT00158756|6397804|P2|Overall Study|Withdrawal by Subject|0
1850706|NCT00158756|6397805|P1|Overall Study|Withdrawal by Subject|5
1850707|NCT00158600|6397911|P2|Overall Study|Withdrawal by Subject|2
1850708|NCT00158600|6397912|P1|Overall Study|Withdrawal by Subject|2
1850709|NCT00158600|6397911|P2|Overall Study|Death|0
1850710|NCT00158600|6397912|P1|Overall Study|Death|1
1850711|NCT00158600|6397911|P2|Overall Study|Adverse Event|1
1850712|NCT00158600|6397912|P1|Overall Study|Adverse Event|2
1850713|NCT00158600|6397911|P2|Overall Study|unable to commit time to study|1
1850714|NCT00158600|6397912|P1|Overall Study|unable to commit time to study|0
1850715|NCT00158262|6397937|P2|Overall Study|Lost to Follow-up|1
1850716|NCT00158262|6397938|P1|Overall Study|Lost to Follow-up|1
1850717|NCT00158184|6397999|P2|Overall Study|Adverse Event|1
1850718|NCT00158184|6398000|P1|Overall Study|Adverse Event|1
1850719|NCT00158184|6397999|P2|Overall Study|failed for follow unit/study rules|0
1850720|NCT00158184|6398000|P1|Overall Study|failed for follow unit/study rules|2
1850721|NCT00158184|6397999|P2|Overall Study|personal issues|1
1850722|NCT00158184|6398000|P1|Overall Study|personal issues|3
1850723|NCT00158054|6398010|P2|Overall Study|Unavailable for follow up|3
1850724|NCT00158054|6398011|P1|Overall Study|Unavailable for follow up|7
1850725|NCT00158054|6398010|P2|Overall Study|Refused to continue|0
1850726|NCT00158054|6398011|P1|Overall Study|Refused to continue|3
1850727|NCT00157950|6398025|P2|Overall Study|Death|0
1850728|NCT00157950|6398026|P1|Overall Study|Death|1
1850729|NCT00157820|6398043|P3|2nd 8 Months|Premature cross-over|9
1850730|NCT00157820|6398044|P2|2nd 8 Months|Premature cross-over|7
1850731|NCT00157820|6398045|P1|2nd 8 Months|Premature cross-over|1
1850732|NCT00157820|6398043|P3|2nd 8 Months|Lost to Follow-up|2
1850733|NCT00157820|6398044|P2|2nd 8 Months|Lost to Follow-up|5
1850734|NCT00157820|6398045|P1|2nd 8 Months|Lost to Follow-up|1
1850735|NCT00157820|6398043|P3|2nd 8 Months|Death|3
1850736|NCT00157820|6398044|P2|2nd 8 Months|Death|1
1850737|NCT00157820|6398045|P1|2nd 8 Months|Death|3
1850738|NCT00157820|6398043|P3|1st 8 Month|Premature cross-over|2
1850739|NCT00157820|6398044|P2|1st 8 Month|Premature cross-over|2
1850740|NCT00157820|6398045|P1|1st 8 Month|Premature cross-over|0
1850741|NCT00157820|6398043|P3|1st 8 Month|Lost to Follow-up|1
1850742|NCT00157820|6398044|P2|1st 8 Month|Lost to Follow-up|2
1850743|NCT00157820|6398045|P1|1st 8 Month|Lost to Follow-up|1
1850744|NCT00157820|6398043|P3|1st 8 Month|Death|3
1850745|NCT00157820|6398044|P2|1st 8 Month|Death|8
1850746|NCT00157820|6398045|P1|1st 8 Month|Death|7
1850747|NCT00157820|6398043|P3|Randomized|Protocol Violation|2
1850748|NCT00157820|6398044|P2|Randomized|Protocol Violation|1
1850749|NCT00157820|6398045|P1|Randomized|Protocol Violation|2
1850750|NCT00157820|6398043|P3|Randomized|Withdrawal by Subject|3
1850751|NCT00157820|6398044|P2|Randomized|Withdrawal by Subject|2
1850752|NCT00157820|6398045|P1|Randomized|Withdrawal by Subject|1
1850753|NCT00157820|6398043|P3|Randomized|Physician Decision|3
1850754|NCT00157820|6398044|P2|Randomized|Physician Decision|2
1850755|NCT00157820|6398045|P1|Randomized|Physician Decision|4
1850756|NCT00157755|6398058|P6|Overall Study|Study completion|2
1850757|NCT00157755|6398059|P5|Overall Study|Study completion|1
1850758|NCT00157755|6398060|P4|Overall Study|Study completion|0
1850759|NCT00157755|6398061|P3|Overall Study|Study completion|0
1850760|NCT00157755|6398062|P2|Overall Study|Study completion|0
1850761|NCT00157755|6398063|P1|Overall Study|Study completion|0
1850762|NCT00157755|6398058|P6|Overall Study|Subject non-compliance|1
1850763|NCT00157755|6398059|P5|Overall Study|Subject non-compliance|0
1850764|NCT00157755|6398060|P4|Overall Study|Subject non-compliance|0
1850765|NCT00157755|6398061|P3|Overall Study|Subject non-compliance|0
1850766|NCT00157755|6398062|P2|Overall Study|Subject non-compliance|0
1850767|NCT00157755|6398063|P1|Overall Study|Subject non-compliance|0
1850768|NCT00157755|6398058|P6|Overall Study|Study site closure|0
1850769|NCT00157755|6398059|P5|Overall Study|Study site closure|0
1850770|NCT00157755|6398060|P4|Overall Study|Study site closure|0
1850771|NCT00157755|6398061|P3|Overall Study|Study site closure|0
1850772|NCT00157755|6398062|P2|Overall Study|Study site closure|1
1850773|NCT00157755|6398063|P1|Overall Study|Study site closure|0
1850774|NCT00157755|6398058|P6|Overall Study|Medical reason|0
1850775|NCT00157755|6398059|P5|Overall Study|Medical reason|0
1850776|NCT00157755|6398060|P4|Overall Study|Medical reason|1
1850777|NCT00157755|6398061|P3|Overall Study|Medical reason|1
1850778|NCT00157755|6398062|P2|Overall Study|Medical reason|0
1850779|NCT00157755|6398063|P1|Overall Study|Medical reason|0
1850780|NCT00157755|6398058|P6|Overall Study|Explant due to infection|0
1850781|NCT00157755|6398059|P5|Overall Study|Explant due to infection|0
1850782|NCT00157755|6398060|P4|Overall Study|Explant due to infection|0
1850783|NCT00157755|6398061|P3|Overall Study|Explant due to infection|1
1850784|NCT00157755|6398062|P2|Overall Study|Explant due to infection|0
1850785|NCT00157755|6398063|P1|Overall Study|Explant due to infection|0
1850786|NCT00157755|6398058|P6|Overall Study|Withdrawal by Subject|2
1850787|NCT00157755|6398059|P5|Overall Study|Withdrawal by Subject|1
1850788|NCT00157755|6398060|P4|Overall Study|Withdrawal by Subject|1
1850789|NCT00157755|6398061|P3|Overall Study|Withdrawal by Subject|1
1850790|NCT00157755|6398062|P2|Overall Study|Withdrawal by Subject|0
1850791|NCT00157755|6398063|P1|Overall Study|Withdrawal by Subject|0
1850792|NCT00157755|6398058|P6|Overall Study|Lost to Follow-up|0
1850793|NCT00157755|6398059|P5|Overall Study|Lost to Follow-up|0
1850794|NCT00157755|6398060|P4|Overall Study|Lost to Follow-up|0
1850795|NCT00157755|6398061|P3|Overall Study|Lost to Follow-up|1
1850796|NCT00157755|6398062|P2|Overall Study|Lost to Follow-up|0
1850797|NCT00157755|6398063|P1|Overall Study|Lost to Follow-up|0
1850798|NCT00157755|6398058|P6|Overall Study|Death|0
1850799|NCT00157755|6398059|P5|Overall Study|Death|0
1850800|NCT00157755|6398060|P4|Overall Study|Death|2
1850801|NCT00157755|6398061|P3|Overall Study|Death|3
1850802|NCT00157755|6398062|P2|Overall Study|Death|3
1850803|NCT00157755|6398063|P1|Overall Study|Death|2
1850804|NCT00157248|6398099|P4|Overall Study|site closures, subject moving|9
1850805|NCT00157248|6398100|P3|Overall Study|site closures, subject moving|3
1850806|NCT00157248|6398101|P2|Overall Study|site closures, subject moving|7
1850807|NCT00157248|6398102|P1|Overall Study|site closures, subject moving|7
1850808|NCT00157248|6398099|P4|Overall Study|Withdrawal by Subject|3
1850809|NCT00157248|6398100|P3|Overall Study|Withdrawal by Subject|3
1850810|NCT00157248|6398101|P2|Overall Study|Withdrawal by Subject|4
1850811|NCT00157248|6398102|P1|Overall Study|Withdrawal by Subject|1
1850812|NCT00157248|6398099|P4|Overall Study|Lost to Follow-up|0
1850813|NCT00157248|6398100|P3|Overall Study|Lost to Follow-up|0
1850814|NCT00157248|6398101|P2|Overall Study|Lost to Follow-up|1
1850815|NCT00157248|6398102|P1|Overall Study|Lost to Follow-up|0
1850816|NCT00157248|6398099|P4|Overall Study|Protocol Violation|2
1850817|NCT00157248|6398100|P3|Overall Study|Protocol Violation|2
1850818|NCT00157248|6398101|P2|Overall Study|Protocol Violation|0
1850819|NCT00157248|6398102|P1|Overall Study|Protocol Violation|4
1850820|NCT00157248|6398099|P4|Overall Study|Adverse Event|33
1850821|NCT00157248|6398100|P3|Overall Study|Adverse Event|13
1850822|NCT00157248|6398101|P2|Overall Study|Adverse Event|25
1850823|NCT00157248|6398102|P1|Overall Study|Adverse Event|36
1850824|NCT00157209|6398208|P2|Overall Study|Ongoing at data cut-off|0
1850825|NCT00157209|6398209|P1|Overall Study|Ongoing at data cut-off|10
1850826|NCT00157196|6398223|P1|Overall Study|Ongoing at data cut-off|9
1850827|NCT00157157|6398229|P1|Overall Study|Inclusion not met- baseline FVIII value|1
1850828|NCT00157157|6398229|P1|Overall Study|Met exclusion criteria|1
1850829|NCT00157157|6398229|P1|Overall Study|Enrolled in another study|1
1850830|NCT00157157|6398229|P1|Overall Study|Lost to Follow-up|1
1850831|NCT00157157|6398229|P1|Overall Study|Physician Decision|1
1850832|NCT00157157|6398229|P1|Overall Study|Withdrawal by Subject|6
1850833|NCT00157014|6398256|P4|Overall Study|Withdrawal by Subject|0
1850834|NCT00157014|6398257|P3|Overall Study|Withdrawal by Subject|0
1850835|NCT00157014|6398258|P2|Overall Study|Withdrawal by Subject|0
1850836|NCT00157014|6398259|P1|Overall Study|Withdrawal by Subject|1
1850837|NCT00157014|6398256|P4|Overall Study|Patient would not receive transplant|0
1850838|NCT00157014|6398257|P3|Overall Study|Patient would not receive transplant|0
1850839|NCT00157014|6398258|P2|Overall Study|Patient would not receive transplant|1
1850840|NCT00157014|6398259|P1|Overall Study|Patient would not receive transplant|0
1850841|NCT00157014|6398256|P4|Overall Study|Patient unable to return in nursing home|0
1850842|NCT00157014|6398257|P3|Overall Study|Patient unable to return in nursing home|0
1850843|NCT00157014|6398258|P2|Overall Study|Patient unable to return in nursing home|0
1850844|NCT00157014|6398259|P1|Overall Study|Patient unable to return in nursing home|1
1850845|NCT00157014|6398256|P4|Overall Study|Patient withdrawn by investigator|0
1850846|NCT00157014|6398257|P3|Overall Study|Patient withdrawn by investigator|0
1850847|NCT00157014|6398258|P2|Overall Study|Patient withdrawn by investigator|0
1850848|NCT00157014|6398259|P1|Overall Study|Patient withdrawn by investigator|1
1850849|NCT00157014|6398256|P4|Overall Study|Medications withdrawn on family request|0
1850850|NCT00157014|6398257|P3|Overall Study|Medications withdrawn on family request|0
1850851|NCT00157014|6398258|P2|Overall Study|Medications withdrawn on family request|1
1850852|NCT00157014|6398259|P1|Overall Study|Medications withdrawn on family request|0
1850853|NCT00157014|6398256|P4|Overall Study|Physician Decision|0
1850854|NCT00157014|6398257|P3|Overall Study|Physician Decision|0
1850855|NCT00157014|6398258|P2|Overall Study|Physician Decision|1
1850856|NCT00157014|6398259|P1|Overall Study|Physician Decision|0
1850857|NCT00157014|6398256|P4|Overall Study|Death|1
1850858|NCT00157014|6398257|P3|Overall Study|Death|1
1850859|NCT00157014|6398258|P2|Overall Study|Death|2
1850860|NCT00157014|6398259|P1|Overall Study|Death|4
1850861|NCT00156819|6398375|P3|Overall Study|Lost to Follow-up|3
1850862|NCT00156819|6398376|P2|Overall Study|Lost to Follow-up|1
1850863|NCT00156819|6398377|P1|Overall Study|Lost to Follow-up|1
1850864|NCT00156533|6398394|P4|Overall Study|Failed Screening|1
1850865|NCT00156533|6398395|P3|Overall Study|Failed Screening|1
1850866|NCT00156533|6398396|P2|Overall Study|Failed Screening|0
1850867|NCT00156533|6398397|P1|Overall Study|Failed Screening|1
1850868|NCT00156533|6398394|P4|Overall Study|Withdrawal by Subject|1
1850869|NCT00156533|6398395|P3|Overall Study|Withdrawal by Subject|0
1850870|NCT00156533|6398396|P2|Overall Study|Withdrawal by Subject|0
1850871|NCT00156533|6398397|P1|Overall Study|Withdrawal by Subject|1
1850872|NCT00156533|6398394|P4|Overall Study|Withdrawn - Medication Expiration|0
1850873|NCT00156533|6398395|P3|Overall Study|Withdrawn - Medication Expiration|1
1850874|NCT00156533|6398396|P2|Overall Study|Withdrawn - Medication Expiration|2
1850875|NCT00156533|6398397|P1|Overall Study|Withdrawn - Medication Expiration|0
1850876|NCT00156065|6398431|P3|Overall Study|Other|3
1850877|NCT00156065|6398432|P2|Overall Study|Other|9
1850878|NCT00156065|6398433|P1|Overall Study|Other|2
1850879|NCT00156065|6398431|P3|Overall Study|Lost to Follow-up|1
1850880|NCT00156065|6398432|P2|Overall Study|Lost to Follow-up|7
1850881|NCT00156065|6398433|P1|Overall Study|Lost to Follow-up|5
1850882|NCT00156065|6398431|P3|Overall Study|Withdrawal by Subject|16
1850883|NCT00156065|6398432|P2|Overall Study|Withdrawal by Subject|26
1850884|NCT00156065|6398433|P1|Overall Study|Withdrawal by Subject|13
1850885|NCT00156065|6398431|P3|Overall Study|Lack of Efficacy|3
1850886|NCT00156065|6398432|P2|Overall Study|Lack of Efficacy|9
1850887|NCT00156065|6398433|P1|Overall Study|Lack of Efficacy|2
1850888|NCT00156065|6398431|P3|Overall Study|Adverse Event|4
1850889|NCT00156065|6398432|P2|Overall Study|Adverse Event|11
1850890|NCT00156065|6398433|P1|Overall Study|Adverse Event|8
1850891|NCT00156065|6398431|P3|Overall Study|Enrolled But Never Received Treatment|0
1850892|NCT00156065|6398432|P2|Overall Study|Enrolled But Never Received Treatment|1
1850893|NCT00156065|6398433|P1|Overall Study|Enrolled But Never Received Treatment|1
1850894|NCT00154375|6398467|P2|Overall Study|Suspected progression of disease|30
1850895|NCT00154375|6398468|P1|Overall Study|Suspected progression of disease|44
1850896|NCT00154375|6398467|P2|Overall Study|Protocol Violation|1
1850897|NCT00154375|6398468|P1|Overall Study|Protocol Violation|0
1850898|NCT00154375|6398467|P2|Overall Study|Abnormal laboratory value(s)|2
1850899|NCT00154375|6398468|P1|Overall Study|Abnormal laboratory value(s)|0
1850900|NCT00154375|6398467|P2|Overall Study|Lost to Follow-up|1
1850901|NCT00154375|6398468|P1|Overall Study|Lost to Follow-up|2
1850902|NCT00154375|6398467|P2|Overall Study|Study drug no longer required|3
1850903|NCT00154375|6398468|P1|Overall Study|Study drug no longer required|5
1850904|NCT00154375|6398467|P2|Overall Study|Death|13
1850905|NCT00154375|6398468|P1|Overall Study|Death|5
1850906|NCT00154375|6398467|P2|Overall Study|Withdrawal by Subject|10
1850907|NCT00154375|6398468|P1|Overall Study|Withdrawal by Subject|14
1850908|NCT00154375|6398467|P2|Overall Study|Adverse Event|20
1850909|NCT00154375|6398468|P1|Overall Study|Adverse Event|18
1850910|NCT00154375|6398467|P2|Overall Study|Unsatisfactory therapeutic effect|26
1850911|NCT00154375|6398468|P1|Overall Study|Unsatisfactory therapeutic effect|25
1850912|NCT00154310|6398479|P2|Overall Study|Death|1
1850913|NCT00154310|6398480|P1|Overall Study|Death|0
1850914|NCT00154310|6398479|P2|Overall Study|Administrative problems|1
1850915|NCT00154310|6398480|P1|Overall Study|Administrative problems|0
1850916|NCT00154310|6398479|P2|Overall Study|Lost to Follow-up|8
1850917|NCT00154310|6398480|P1|Overall Study|Lost to Follow-up|0
1850918|NCT00154310|6398479|P2|Overall Study|Withdrawal by Subject|3
1850919|NCT00154310|6398480|P1|Overall Study|Withdrawal by Subject|9
1850920|NCT00154310|6398479|P2|Overall Study|Protocol Violation|2
1850921|NCT00154310|6398480|P1|Overall Study|Protocol Violation|4
1850922|NCT00154310|6398479|P2|Overall Study|Lack of Efficacy|4
1850923|NCT00154310|6398480|P1|Overall Study|Lack of Efficacy|5
1850924|NCT00154310|6398479|P2|Overall Study|Adverse Event|9
1850925|NCT00154310|6398480|P1|Overall Study|Adverse Event|19
1850926|NCT00154297|6398496|P2|Overall Study|Lost to Follow-up|0
1850927|NCT00154297|6398497|P1|Overall Study|Lost to Follow-up|3
1850928|NCT00154297|6398496|P2|Overall Study|Withdrawal by Subject|5
1850929|NCT00154297|6398497|P1|Overall Study|Withdrawal by Subject|0
1850930|NCT00154297|6398496|P2|Overall Study|Death|2
1850931|NCT00154297|6398497|P1|Overall Study|Death|5
1850932|NCT00154284|6398515|P2|Overall Study|Protocol Violation|1
1850933|NCT00154284|6398516|P1|Overall Study|Protocol Violation|0
1850934|NCT00154284|6398515|P2|Overall Study|Lack of Efficacy|2
1850935|NCT00154284|6398516|P1|Overall Study|Lack of Efficacy|1
1850936|NCT00154284|6398515|P2|Overall Study|Abnormal laboratory value(s)|1
1850937|NCT00154284|6398516|P1|Overall Study|Abnormal laboratory value(s)|0
1850938|NCT00154284|6398515|P2|Overall Study|Adverse Event|9
1850939|NCT00154284|6398516|P1|Overall Study|Adverse Event|6
1850940|NCT00154102|6398530|P2|Overall Study|investigational study phase ongoing|2
1850941|NCT00154102|6398531|P1|Overall Study|investigational study phase ongoing|7
1850942|NCT00154063|6398567|P2|Overall Study|Other|3
1850943|NCT00154063|6398568|P1|Overall Study|Other|3
1850944|NCT00154063|6398567|P2|Overall Study|Withdrawal by Subject|9
1850945|NCT00154063|6398568|P1|Overall Study|Withdrawal by Subject|4
1850946|NCT00154063|6398567|P2|Overall Study|Investigator or Sponsor Request|1
1850947|NCT00154063|6398568|P1|Overall Study|Investigator or Sponsor Request|0
1850948|NCT00154063|6398567|P2|Overall Study|Protocol Violation|1
1850949|NCT00154063|6398568|P1|Overall Study|Protocol Violation|1
1850950|NCT00154063|6398567|P2|Overall Study|Adverse Event|8
1850951|NCT00154063|6398568|P1|Overall Study|Adverse Event|4
1850952|NCT00153920|6398630|P1|Overall Study|Progressive Disease before Trt|1
1850953|NCT00153920|6398630|P1|Overall Study|Withdrawal of Consent before Trt|1
1850954|NCT00153920|6398630|P1|Overall Study|Non-Protocol Therapy|1
1850955|NCT00153920|6398630|P1|Overall Study|Withdrawal by Subject|1
1850956|NCT00153920|6398630|P1|Overall Study|Death|2
1850957|NCT00153920|6398630|P1|Overall Study|Lack of Response|3
1850958|NCT00153920|6398630|P1|Overall Study|Physician Decision|3
1850959|NCT00153920|6398630|P1|Overall Study|Progressive Disease|9
1850960|NCT00153920|6398630|P1|Overall Study|Adverse Event|9
1850961|NCT00153816|6398656|P6|Overall Study|Follow-up exam done, histology missing|2
1850962|NCT00153816|6398657|P5|Overall Study|Follow-up exam done, histology missing|1
1850963|NCT00153816|6398658|P4|Overall Study|Follow-up exam done, histology missing|3
1850964|NCT00153816|6398659|P3|Overall Study|Follow-up exam done, histology missing|3
1850965|NCT00153816|6398660|P2|Overall Study|Follow-up exam done, histology missing|3
1850966|NCT00153816|6398661|P1|Overall Study|Follow-up exam done, histology missing|2
1850967|NCT00153816|6398656|P6|Overall Study|Follow-up exam not done|9
1850968|NCT00153816|6398657|P5|Overall Study|Follow-up exam not done|8
1850969|NCT00153816|6398658|P4|Overall Study|Follow-up exam not done|10
1850970|NCT00153816|6398659|P3|Overall Study|Follow-up exam not done|11
1850971|NCT00153816|6398660|P2|Overall Study|Follow-up exam not done|7
1850972|NCT00153816|6398661|P1|Overall Study|Follow-up exam not done|8
1850973|NCT00153816|6398656|P6|Overall Study|Withdrawal by Subject|5
1850974|NCT00153816|6398657|P5|Overall Study|Withdrawal by Subject|1
1850975|NCT00153816|6398658|P4|Overall Study|Withdrawal by Subject|4
1850976|NCT00153816|6398659|P3|Overall Study|Withdrawal by Subject|9
1850977|NCT00153816|6398660|P2|Overall Study|Withdrawal by Subject|9
1850978|NCT00153816|6398661|P1|Overall Study|Withdrawal by Subject|9
1850979|NCT00153816|6398656|P6|Overall Study|Lost to Follow-up|9
1850980|NCT00153816|6398657|P5|Overall Study|Lost to Follow-up|7
1850981|NCT00153816|6398658|P4|Overall Study|Lost to Follow-up|8
1850982|NCT00153816|6398659|P3|Overall Study|Lost to Follow-up|5
1850983|NCT00153816|6398660|P2|Overall Study|Lost to Follow-up|8
1850984|NCT00153816|6398661|P1|Overall Study|Lost to Follow-up|7
1850985|NCT00153816|6398656|P6|Overall Study|Death|2
1850986|NCT00153816|6398657|P5|Overall Study|Death|0
1850987|NCT00153816|6398658|P4|Overall Study|Death|6
1850988|NCT00153816|6398659|P3|Overall Study|Death|4
1850989|NCT00153816|6398660|P2|Overall Study|Death|5
1850990|NCT00153816|6398661|P1|Overall Study|Death|6
1850991|NCT00153179|6398702|P4|Study Visit Day 2|Withdrawal by Subject|2
1850992|NCT00153179|6398703|P3|Study Visit Day 2|Withdrawal by Subject|2
1850993|NCT00153179|6398704|P2|Study Visit Day 2|Withdrawal by Subject|0
1850994|NCT00153179|6398705|P1|Study Visit Day 2|Withdrawal by Subject|1
1850995|NCT00153101|6398737|P5|Overall Study|Withdrawal by Subject|5
1850996|NCT00153101|6398738|P4|Overall Study|Withdrawal by Subject|3
1850997|NCT00153101|6398739|P3|Overall Study|Withdrawal by Subject|3
1850998|NCT00153101|6398740|P2|Overall Study|Withdrawal by Subject|4
1850999|NCT00153101|6398741|P1|Overall Study|Withdrawal by Subject|3
1851000|NCT00153101|6398737|P5|Overall Study|Lost to Follow-up|5
1851001|NCT00153101|6398738|P4|Overall Study|Lost to Follow-up|5
1851002|NCT00153101|6398739|P3|Overall Study|Lost to Follow-up|12
1851003|NCT00153101|6398740|P2|Overall Study|Lost to Follow-up|14
1851004|NCT00153101|6398741|P1|Overall Study|Lost to Follow-up|14
1851005|NCT00153062|6398849|P4|Overall Study|Other|0
1851006|NCT00153062|6398850|P3|Overall Study|Other|1
1851007|NCT00153062|6398851|P2|Overall Study|Other|0
1851008|NCT00153062|6398852|P1|Overall Study|Other|0
1851009|NCT00153062|6398849|P4|Overall Study|No disposition data available|1
1851010|NCT00153062|6398850|P3|Overall Study|No disposition data available|1
1851011|NCT00153062|6398851|P2|Overall Study|No disposition data available|1
1851012|NCT00153062|6398852|P1|Overall Study|No disposition data available|1
1851013|NCT00153062|6398849|P4|Overall Study|Protocol Violation|1
1851014|NCT00153062|6398850|P3|Overall Study|Protocol Violation|1
1851015|NCT00153062|6398851|P2|Overall Study|Protocol Violation|2
1851016|NCT00153062|6398852|P1|Overall Study|Protocol Violation|0
1851017|NCT00153062|6398849|P4|Overall Study|Adverse Event|0
1851018|NCT00153062|6398850|P3|Overall Study|Adverse Event|1
1851019|NCT00153062|6398851|P2|Overall Study|Adverse Event|1
1851020|NCT00153062|6398852|P1|Overall Study|Adverse Event|0
1851021|NCT00153062|6398849|P4|Overall Study|Lost to Follow-up|16
1851022|NCT00153062|6398850|P3|Overall Study|Lost to Follow-up|15
1851023|NCT00153062|6398851|P2|Overall Study|Lost to Follow-up|20
1851024|NCT00153062|6398852|P1|Overall Study|Lost to Follow-up|12
1851025|NCT00153062|6398849|P4|Overall Study|Withdrawal by Subject|28
1851026|NCT00153062|6398850|P3|Overall Study|Withdrawal by Subject|27
1851027|NCT00153062|6398851|P2|Overall Study|Withdrawal by Subject|30
1851028|NCT00153062|6398852|P1|Overall Study|Withdrawal by Subject|14
1851029|NCT00153062|6398849|P4|Overall Study|Death|365
1851030|NCT00153062|6398850|P3|Overall Study|Death|369
1851031|NCT00153062|6398851|P2|Overall Study|Death|352
1851032|NCT00153062|6398852|P1|Overall Study|Death|360
1851033|NCT00152971|6398871|P3|Treatment|Other|10
1851034|NCT00152971|6398872|P2|Treatment|Other|11
1851035|NCT00152971|6398873|P1|Treatment|Other|9
1851036|NCT00152971|6398871|P3|Treatment|Withdrawal by Subject|5
1851037|NCT00152971|6398872|P2|Treatment|Withdrawal by Subject|4
1851038|NCT00152971|6398873|P1|Treatment|Withdrawal by Subject|4
1851039|NCT00152971|6398871|P3|Treatment|Lost to Follow-up|1
1851040|NCT00152971|6398872|P2|Treatment|Lost to Follow-up|2
1851041|NCT00152971|6398873|P1|Treatment|Lost to Follow-up|1
1851042|NCT00152971|6398871|P3|Treatment|Protocol Violation|10
1851043|NCT00152971|6398872|P2|Treatment|Protocol Violation|6
1851044|NCT00152971|6398873|P1|Treatment|Protocol Violation|8
1851045|NCT00152971|6398871|P3|Treatment|Adverse Event|54
1851046|NCT00152971|6398872|P2|Treatment|Adverse Event|40
1851047|NCT00152971|6398873|P1|Treatment|Adverse Event|49
1851048|NCT00152971|6398871|P3|Overall Study|Other|5
1851049|NCT00152971|6398872|P2|Overall Study|Other|5
1851050|NCT00152971|6398873|P1|Overall Study|Other|3
1851051|NCT00152971|6398871|P3|Overall Study|Withdrawal by Subject|14
1851052|NCT00152971|6398872|P2|Overall Study|Withdrawal by Subject|8
1851053|NCT00152971|6398873|P1|Overall Study|Withdrawal by Subject|9
1851054|NCT00152971|6398871|P3|Overall Study|Lost to Follow-up|13
1851055|NCT00152971|6398872|P2|Overall Study|Lost to Follow-up|14
1851056|NCT00152971|6398873|P1|Overall Study|Lost to Follow-up|17
1851057|NCT00152971|6398871|P3|Overall Study|Protocol Violation|8
1851058|NCT00152971|6398872|P2|Overall Study|Protocol Violation|11
1851059|NCT00152971|6398873|P1|Overall Study|Protocol Violation|10
1851060|NCT00152971|6398871|P3|Overall Study|Adverse Event|9
1851061|NCT00152971|6398872|P2|Overall Study|Adverse Event|10
1851062|NCT00152971|6398873|P1|Overall Study|Adverse Event|12
1851063|NCT00152763|6398909|P4|Overall Study|Lost to Follow-up|13
1851064|NCT00152763|6398910|P3|Overall Study|Lost to Follow-up|2
1851065|NCT00152763|6398911|P2|Overall Study|Lost to Follow-up|4
1851066|NCT00152763|6398912|P1|Overall Study|Lost to Follow-up|6
1851067|NCT00152763|6398909|P4|Overall Study|Death|1
1851068|NCT00152763|6398910|P3|Overall Study|Death|2
1851069|NCT00152763|6398911|P2|Overall Study|Death|1
1851070|NCT00152763|6398912|P1|Overall Study|Death|4
1851071|NCT00152516|6399028|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
1851072|NCT00152516|6399028|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
1851073|NCT00152516|6399028|P1|Overall Study|Other: Moved Out Of State|1
1851074|NCT00152516|6399028|P1|Overall Study|Other: Primary Care Physician's Decision|1
1851075|NCT00152516|6399028|P1|Overall Study|Other: Non-Compliance|2
1851076|NCT00152516|6399028|P1|Overall Study|Other: Parents Withdrew Consent|2
1851077|NCT00152516|6399028|P1|Overall Study|Other: Given Commercial Drug in Error|2
1851078|NCT00152516|6399028|P1|Overall Study|Other: Mother Refused To Cooperate|1
1851079|NCT00152516|6399028|P1|Overall Study|Protocol Violation|3
1851080|NCT00152516|6399028|P1|Overall Study|Withdrawal by Subject|8
1851081|NCT00152516|6399028|P1|Overall Study|Lost to Follow-up|5
1851082|NCT00152516|6399028|P1|Overall Study|Lack and Loss of Efficacy|30
1851083|NCT00152516|6399028|P1|Overall Study|Adverse Event|18
1851084|NCT00152464|6399054|P2|Overall Study|Patient relocated|0
1851085|NCT00152464|6399055|P1|Overall Study|Patient relocated|1
1851086|NCT00152464|6399054|P2|Overall Study|Eczema poorly controlled|0
1851087|NCT00152464|6399055|P1|Overall Study|Eczema poorly controlled|1
1851088|NCT00152464|6399054|P2|Overall Study|Lack of Efficacy|0
1851089|NCT00152464|6399055|P1|Overall Study|Lack of Efficacy|1
1851090|NCT00152464|6399054|P2|Overall Study|Investigator decision|0
1851091|NCT00152464|6399055|P1|Overall Study|Investigator decision|1
1851092|NCT00152464|6399054|P2|Overall Study|Parent decision|1
1851093|NCT00152464|6399055|P1|Overall Study|Parent decision|1
1851094|NCT00152464|6399054|P2|Overall Study|Eczema deterioration|1
1851095|NCT00152464|6399055|P1|Overall Study|Eczema deterioration|0
1851096|NCT00152464|6399054|P2|Overall Study|Atopic dermatitis poorly controlled|1
1851097|NCT00152464|6399055|P1|Overall Study|Atopic dermatitis poorly controlled|0
1851098|NCT00152464|6399054|P2|Overall Study|Withdrawal by Subject|22
1851099|NCT00152464|6399055|P1|Overall Study|Withdrawal by Subject|21
1851100|NCT00152464|6399054|P2|Overall Study|Protocol Violation|1
1851101|NCT00152464|6399055|P1|Overall Study|Protocol Violation|3
1851102|NCT00152464|6399054|P2|Overall Study|Lost to Follow-up|4
1851103|NCT00152464|6399055|P1|Overall Study|Lost to Follow-up|8
1851104|NCT00152464|6399054|P2|Overall Study|Adverse Event|6
1851105|NCT00152464|6399055|P1|Overall Study|Adverse Event|3
1851106|NCT00152009|6399083|P4|Overall Study|Sponsor's decision|3
1851107|NCT00152009|6399084|P3|Overall Study|Sponsor's decision|1
1851108|NCT00152009|6399085|P2|Overall Study|Sponsor's decision|3
1851109|NCT00152009|6399086|P1|Overall Study|Sponsor's decision|3
1851110|NCT00152009|6399083|P4|Overall Study|ECG abnormalities|1
1851111|NCT00152009|6399084|P3|Overall Study|ECG abnormalities|2
1851112|NCT00152009|6399085|P2|Overall Study|ECG abnormalities|2
1851113|NCT00152009|6399086|P1|Overall Study|ECG abnormalities|2
1851114|NCT00152009|6399083|P4|Overall Study|Lack of Efficacy|15
1851115|NCT00152009|6399084|P3|Overall Study|Lack of Efficacy|7
1851116|NCT00152009|6399085|P2|Overall Study|Lack of Efficacy|6
1851117|NCT00152009|6399086|P1|Overall Study|Lack of Efficacy|8
1851118|NCT00152009|6399083|P4|Overall Study|Lost to Follow-up|3
1851119|NCT00152009|6399084|P3|Overall Study|Lost to Follow-up|3
1851120|NCT00152009|6399085|P2|Overall Study|Lost to Follow-up|4
1851121|NCT00152009|6399086|P1|Overall Study|Lost to Follow-up|2
1851122|NCT00152009|6399083|P4|Overall Study|Withdrawal by Subject|9
1851123|NCT00152009|6399084|P3|Overall Study|Withdrawal by Subject|4
1851124|NCT00152009|6399085|P2|Overall Study|Withdrawal by Subject|3
1851125|NCT00152009|6399086|P1|Overall Study|Withdrawal by Subject|2
1851126|NCT00152009|6399083|P4|Overall Study|Protocol Violation|1
1851127|NCT00152009|6399084|P3|Overall Study|Protocol Violation|0
1851128|NCT00152009|6399085|P2|Overall Study|Protocol Violation|0
1851129|NCT00152009|6399086|P1|Overall Study|Protocol Violation|3
1851130|NCT00152009|6399083|P4|Overall Study|Adverse Event|1
1851131|NCT00152009|6399084|P3|Overall Study|Adverse Event|20
1851132|NCT00152009|6399085|P2|Overall Study|Adverse Event|13
1851133|NCT00152009|6399086|P1|Overall Study|Adverse Event|9
1851134|NCT00151996|6399118|P2|Overall Study|Sponsor's decision|2
1851135|NCT00151996|6399119|P1|Overall Study|Sponsor's decision|0
1851136|NCT00151996|6399118|P2|Overall Study|Protocol Violation|2
1851137|NCT00151996|6399119|P1|Overall Study|Protocol Violation|1
1851138|NCT00151996|6399118|P2|Overall Study|Withdrawal by Subject|1
1851139|NCT00151996|6399119|P1|Overall Study|Withdrawal by Subject|1
1851140|NCT00151996|6399118|P2|Overall Study|Adverse Event|2
1851141|NCT00151996|6399119|P1|Overall Study|Adverse Event|3
1851142|NCT00151892|6399135|P2|Overall Study|Lack of study medication at center|1
1851143|NCT00151892|6399136|P1|Overall Study|Lack of study medication at center|0
1851144|NCT00151892|6399135|P2|Overall Study|Used prohibited corticosteroids|0
1851145|NCT00151892|6399136|P1|Overall Study|Used prohibited corticosteroids|1
1851146|NCT00151892|6399135|P2|Overall Study|Did not return for a visit|0
1851147|NCT00151892|6399136|P1|Overall Study|Did not return for a visit|1
1851148|NCT00151892|6399135|P2|Overall Study|Pregnancy|1
1851149|NCT00151892|6399136|P1|Overall Study|Pregnancy|0
1851150|NCT00151892|6399135|P2|Overall Study|Non-compliance|1
1851151|NCT00151892|6399136|P1|Overall Study|Non-compliance|0
1851152|NCT00151892|6399135|P2|Overall Study|Protocol Violation|3
1851153|NCT00151892|6399136|P1|Overall Study|Protocol Violation|3
1851154|NCT00151892|6399135|P2|Overall Study|Adverse Event|3
1851155|NCT00151892|6399136|P1|Overall Study|Adverse Event|6
1851156|NCT00151892|6399135|P2|Overall Study|Lost to Follow-up|10
1851157|NCT00151892|6399136|P1|Overall Study|Lost to Follow-up|5
1851158|NCT00151892|6399135|P2|Overall Study|Patient request|7
1851159|NCT00151892|6399136|P1|Overall Study|Patient request|10
1851160|NCT00151892|6399135|P2|Overall Study|Lack of Efficacy|57
1851161|NCT00151892|6399136|P1|Overall Study|Lack of Efficacy|50
1851162|NCT00151775|6399181|P12|Period 4: Open Label|Protocol Violation|0
1851163|NCT00151775|6399182|P11|Period 4: Open Label|Protocol Violation|0
1851164|NCT00151775|6399183|P10|Period 4: Open Label|Protocol Violation|0
1851165|NCT00151775|6399184|P9|Period 4: Open Label|Protocol Violation|0
1851166|NCT00151775|6399185|P8|Period 4: Open Label|Protocol Violation|0
1851167|NCT00151775|6399186|P7|Period 4: Open Label|Protocol Violation|0
1851168|NCT00151775|6399187|P6|Period 4: Open Label|Protocol Violation|0
1851169|NCT00151775|6399188|P5|Period 4: Open Label|Protocol Violation|1
1851170|NCT00151775|6399189|P4|Period 4: Open Label|Protocol Violation|0
1851171|NCT00151775|6399190|P3|Period 4: Open Label|Protocol Violation|0
1851172|NCT00151775|6399191|P2|Period 4: Open Label|Protocol Violation|0
1851173|NCT00151775|6399192|P1|Period 4: Open Label|Protocol Violation|0
1851174|NCT00151775|6399181|P12|Period 4: Open Label|Physician Decision|0
1851175|NCT00151775|6399182|P11|Period 4: Open Label|Physician Decision|0
1851176|NCT00151775|6399183|P10|Period 4: Open Label|Physician Decision|2
1851177|NCT00151775|6399184|P9|Period 4: Open Label|Physician Decision|0
1851178|NCT00151775|6399185|P8|Period 4: Open Label|Physician Decision|0
1851179|NCT00151775|6399186|P7|Period 4: Open Label|Physician Decision|0
1851180|NCT00151775|6399187|P6|Period 4: Open Label|Physician Decision|0
1851181|NCT00151775|6399188|P5|Period 4: Open Label|Physician Decision|0
1851182|NCT00151775|6399189|P4|Period 4: Open Label|Physician Decision|0
1851183|NCT00151775|6399190|P3|Period 4: Open Label|Physician Decision|0
1851184|NCT00151775|6399191|P2|Period 4: Open Label|Physician Decision|0
1851185|NCT00151775|6399192|P1|Period 4: Open Label|Physician Decision|0
1851186|NCT00151775|6399181|P12|Period 4: Open Label|Other|0
1851187|NCT00151775|6399182|P11|Period 4: Open Label|Other|0
1851188|NCT00151775|6399183|P10|Period 4: Open Label|Other|3
1851189|NCT00151775|6399184|P9|Period 4: Open Label|Other|0
1851190|NCT00151775|6399185|P8|Period 4: Open Label|Other|0
1851191|NCT00151775|6399186|P7|Period 4: Open Label|Other|0
1851192|NCT00151775|6399187|P6|Period 4: Open Label|Other|0
1851193|NCT00151775|6399188|P5|Period 4: Open Label|Other|1
1851194|NCT00151775|6399189|P4|Period 4: Open Label|Other|0
1851195|NCT00151775|6399190|P3|Period 4: Open Label|Other|0
1851196|NCT00151775|6399191|P2|Period 4: Open Label|Other|0
1851197|NCT00151775|6399192|P1|Period 4: Open Label|Other|0
1851198|NCT00151775|6399181|P12|Period 4: Open Label|Non-compliance with protocol|0
1851199|NCT00151775|6399182|P11|Period 4: Open Label|Non-compliance with protocol|0
1851200|NCT00151775|6399183|P10|Period 4: Open Label|Non-compliance with protocol|4
1851201|NCT00151775|6399184|P9|Period 4: Open Label|Non-compliance with protocol|0
1851202|NCT00151775|6399185|P8|Period 4: Open Label|Non-compliance with protocol|0
1851203|NCT00151775|6399186|P7|Period 4: Open Label|Non-compliance with protocol|0
1851204|NCT00151775|6399187|P6|Period 4: Open Label|Non-compliance with protocol|0
1851205|NCT00151775|6399188|P5|Period 4: Open Label|Non-compliance with protocol|4
1851206|NCT00151775|6399189|P4|Period 4: Open Label|Non-compliance with protocol|0
1851207|NCT00151775|6399190|P3|Period 4: Open Label|Non-compliance with protocol|0
1851208|NCT00151775|6399191|P2|Period 4: Open Label|Non-compliance with protocol|0
1851209|NCT00151775|6399192|P1|Period 4: Open Label|Non-compliance with protocol|0
1851210|NCT00151775|6399181|P12|Period 4: Open Label|Lost to Follow-up|0
1851211|NCT00151775|6399182|P11|Period 4: Open Label|Lost to Follow-up|0
1851212|NCT00151775|6399183|P10|Period 4: Open Label|Lost to Follow-up|7
1851213|NCT00151775|6399184|P9|Period 4: Open Label|Lost to Follow-up|0
1851214|NCT00151775|6399185|P8|Period 4: Open Label|Lost to Follow-up|0
1851215|NCT00151775|6399186|P7|Period 4: Open Label|Lost to Follow-up|0
1851216|NCT00151775|6399187|P6|Period 4: Open Label|Lost to Follow-up|0
1851217|NCT00151775|6399188|P5|Period 4: Open Label|Lost to Follow-up|17
1851218|NCT00151775|6399189|P4|Period 4: Open Label|Lost to Follow-up|0
1851219|NCT00151775|6399190|P3|Period 4: Open Label|Lost to Follow-up|0
1851220|NCT00151775|6399191|P2|Period 4: Open Label|Lost to Follow-up|0
1851221|NCT00151775|6399192|P1|Period 4: Open Label|Lost to Follow-up|0
1851222|NCT00151775|6399181|P12|Period 4: Open Label|Adverse Event|0
1851223|NCT00151775|6399182|P11|Period 4: Open Label|Adverse Event|0
1851224|NCT00151775|6399183|P10|Period 4: Open Label|Adverse Event|2
1851225|NCT00151775|6399184|P9|Period 4: Open Label|Adverse Event|0
1851226|NCT00151775|6399185|P8|Period 4: Open Label|Adverse Event|0
1851227|NCT00151775|6399186|P7|Period 4: Open Label|Adverse Event|0
1851228|NCT00151775|6399187|P6|Period 4: Open Label|Adverse Event|0
1851229|NCT00151775|6399188|P5|Period 4: Open Label|Adverse Event|1
1851230|NCT00151775|6399189|P4|Period 4: Open Label|Adverse Event|0
1851231|NCT00151775|6399190|P3|Period 4: Open Label|Adverse Event|0
1851232|NCT00151775|6399191|P2|Period 4: Open Label|Adverse Event|0
1851233|NCT00151775|6399192|P1|Period 4: Open Label|Adverse Event|0
1851234|NCT00151775|6399181|P12|Period 4: Open Label|Withdrawal by Subject|0
1851235|NCT00151775|6399182|P11|Period 4: Open Label|Withdrawal by Subject|0
1851236|NCT00151775|6399183|P10|Period 4: Open Label|Withdrawal by Subject|2
1851237|NCT00151775|6399184|P9|Period 4: Open Label|Withdrawal by Subject|0
1851238|NCT00151775|6399185|P8|Period 4: Open Label|Withdrawal by Subject|0
1851239|NCT00151775|6399186|P7|Period 4: Open Label|Withdrawal by Subject|0
1851240|NCT00151775|6399187|P6|Period 4: Open Label|Withdrawal by Subject|0
1851241|NCT00151775|6399188|P5|Period 4: Open Label|Withdrawal by Subject|5
1851242|NCT00151775|6399189|P4|Period 4: Open Label|Withdrawal by Subject|0
1851243|NCT00151775|6399190|P3|Period 4: Open Label|Withdrawal by Subject|0
1851244|NCT00151775|6399191|P2|Period 4: Open Label|Withdrawal by Subject|0
1851245|NCT00151775|6399192|P1|Period 4: Open Label|Withdrawal by Subject|0
1851246|NCT00151775|6399181|P12|Period 4: Open Label|Increased blood pressure|0
1851247|NCT00151775|6399182|P11|Period 4: Open Label|Increased blood pressure|0
1851248|NCT00151775|6399183|P10|Period 4: Open Label|Increased blood pressure|1
1851249|NCT00151775|6399184|P9|Period 4: Open Label|Increased blood pressure|0
1851250|NCT00151775|6399185|P8|Period 4: Open Label|Increased blood pressure|0
1851251|NCT00151775|6399186|P7|Period 4: Open Label|Increased blood pressure|0
1851252|NCT00151775|6399187|P6|Period 4: Open Label|Increased blood pressure|0
1851253|NCT00151775|6399188|P5|Period 4: Open Label|Increased blood pressure|1
1851254|NCT00151775|6399189|P4|Period 4: Open Label|Increased blood pressure|0
1851255|NCT00151775|6399190|P3|Period 4: Open Label|Increased blood pressure|0
1851256|NCT00151775|6399191|P2|Period 4: Open Label|Increased blood pressure|0
1851257|NCT00151775|6399192|P1|Period 4: Open Label|Increased blood pressure|0
1851258|NCT00151775|6399181|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
1851259|NCT00151775|6399182|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851260|NCT00151775|6399183|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851261|NCT00151775|6399184|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851262|NCT00151775|6399185|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851263|NCT00151775|6399186|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851264|NCT00151775|6399187|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851265|NCT00151775|6399188|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851266|NCT00151775|6399189|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851267|NCT00151775|6399190|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851268|NCT00151775|6399191|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851269|NCT00151775|6399192|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
1851270|NCT00151775|6399181|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851271|NCT00151775|6399182|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851272|NCT00151775|6399183|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851273|NCT00151775|6399184|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851274|NCT00151775|6399185|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851275|NCT00151775|6399186|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851276|NCT00151775|6399187|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851277|NCT00151775|6399188|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851278|NCT00151775|6399189|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851279|NCT00151775|6399190|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
1851280|NCT00151775|6399191|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851281|NCT00151775|6399192|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
1851282|NCT00151775|6399181|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851283|NCT00151775|6399182|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851284|NCT00151775|6399183|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851285|NCT00151775|6399184|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851286|NCT00151775|6399185|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851287|NCT00151775|6399186|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851288|NCT00151775|6399187|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851289|NCT00151775|6399188|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851290|NCT00151775|6399189|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851291|NCT00151775|6399190|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
1851292|NCT00151775|6399191|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851293|NCT00151775|6399192|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
1851294|NCT00151775|6399181|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851295|NCT00151775|6399182|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851296|NCT00151775|6399183|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851297|NCT00151775|6399184|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851298|NCT00151775|6399185|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851299|NCT00151775|6399186|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
1851300|NCT00151775|6399187|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851301|NCT00151775|6399188|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851302|NCT00151775|6399189|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851303|NCT00151775|6399190|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851304|NCT00151775|6399191|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851305|NCT00151775|6399192|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
1851306|NCT00151775|6399181|P12|Period 3: Double-blind, Withdrawal|Other|0
1851307|NCT00151775|6399182|P11|Period 3: Double-blind, Withdrawal|Other|0
1851308|NCT00151775|6399183|P10|Period 3: Double-blind, Withdrawal|Other|0
1851309|NCT00151775|6399184|P9|Period 3: Double-blind, Withdrawal|Other|0
1851310|NCT00151775|6399185|P8|Period 3: Double-blind, Withdrawal|Other|1
1851311|NCT00151775|6399186|P7|Period 3: Double-blind, Withdrawal|Other|0
1851312|NCT00151775|6399187|P6|Period 3: Double-blind, Withdrawal|Other|0
1851313|NCT00151775|6399188|P5|Period 3: Double-blind, Withdrawal|Other|0
1851314|NCT00151775|6399189|P4|Period 3: Double-blind, Withdrawal|Other|0
1851315|NCT00151775|6399190|P3|Period 3: Double-blind, Withdrawal|Other|1
1851316|NCT00151775|6399191|P2|Period 3: Double-blind, Withdrawal|Other|0
1851317|NCT00151775|6399192|P1|Period 3: Double-blind, Withdrawal|Other|0
1851318|NCT00151775|6399181|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851319|NCT00151775|6399182|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851320|NCT00151775|6399183|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851321|NCT00151775|6399184|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851322|NCT00151775|6399185|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851323|NCT00151775|6399186|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851324|NCT00151775|6399187|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
1851325|NCT00151775|6399188|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851326|NCT00151775|6399189|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851327|NCT00151775|6399190|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851328|NCT00151775|6399191|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851329|NCT00151775|6399192|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
1851330|NCT00151775|6399181|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851331|NCT00151775|6399182|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851332|NCT00151775|6399183|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851333|NCT00151775|6399184|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851334|NCT00151775|6399185|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851335|NCT00151775|6399186|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
1851336|NCT00151775|6399187|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851337|NCT00151775|6399188|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851338|NCT00151775|6399189|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851339|NCT00151775|6399190|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851340|NCT00151775|6399191|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851341|NCT00151775|6399192|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
1851342|NCT00151775|6399181|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851343|NCT00151775|6399182|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851344|NCT00151775|6399183|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851345|NCT00151775|6399184|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851346|NCT00151775|6399185|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851347|NCT00151775|6399186|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851348|NCT00151775|6399187|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
1851349|NCT00151775|6399188|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851350|NCT00151775|6399189|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851351|NCT00151775|6399190|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851352|NCT00151775|6399191|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851353|NCT00151775|6399192|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
1851354|NCT00151775|6399181|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
1851355|NCT00151775|6399182|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
1851356|NCT00151775|6399183|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
1851357|NCT00151775|6399184|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
1851358|NCT00151775|6399185|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
1851359|NCT00151775|6399186|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
1851360|NCT00151775|6399187|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
1851361|NCT00151775|6399188|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
1851362|NCT00151775|6399189|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
1851363|NCT00151775|6399190|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
1851364|NCT00151775|6399191|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
1851365|NCT00151775|6399192|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
1851366|NCT00151775|6399181|P12|Period 2 - Double-Blind Dose Response|Other|0
1851367|NCT00151775|6399182|P11|Period 2 - Double-Blind Dose Response|Other|0
1851368|NCT00151775|6399183|P10|Period 2 - Double-Blind Dose Response|Other|0
1851369|NCT00151775|6399184|P9|Period 2 - Double-Blind Dose Response|Other|0
1851370|NCT00151775|6399185|P8|Period 2 - Double-Blind Dose Response|Other|0
1851371|NCT00151775|6399186|P7|Period 2 - Double-Blind Dose Response|Other|1
1851372|NCT00151775|6399187|P6|Period 2 - Double-Blind Dose Response|Other|0
1851373|NCT00151775|6399188|P5|Period 2 - Double-Blind Dose Response|Other|0
1851374|NCT00151775|6399189|P4|Period 2 - Double-Blind Dose Response|Other|0
1851375|NCT00151775|6399190|P3|Period 2 - Double-Blind Dose Response|Other|0
1851376|NCT00151775|6399191|P2|Period 2 - Double-Blind Dose Response|Other|0
1851377|NCT00151775|6399192|P1|Period 2 - Double-Blind Dose Response|Other|0
1851378|NCT00151775|6399181|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851379|NCT00151775|6399182|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851380|NCT00151775|6399183|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851381|NCT00151775|6399184|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851382|NCT00151775|6399185|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851383|NCT00151775|6399186|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851384|NCT00151775|6399187|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851385|NCT00151775|6399188|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851386|NCT00151775|6399189|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851387|NCT00151775|6399190|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851388|NCT00151775|6399191|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
1851389|NCT00151775|6399192|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
1851390|NCT00151775|6399181|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851391|NCT00151775|6399182|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1851392|NCT00151775|6399183|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851393|NCT00151775|6399184|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851394|NCT00151775|6399185|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851395|NCT00151775|6399186|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1851396|NCT00151775|6399187|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851397|NCT00151775|6399188|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851398|NCT00151775|6399189|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851399|NCT00151775|6399190|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851400|NCT00151775|6399191|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
1851401|NCT00151775|6399192|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
1851402|NCT00151775|6399181|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851403|NCT00151775|6399182|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851404|NCT00151775|6399183|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851405|NCT00151775|6399184|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851406|NCT00151775|6399185|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851407|NCT00151775|6399186|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851408|NCT00151775|6399187|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851409|NCT00151775|6399188|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851410|NCT00151775|6399189|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851411|NCT00151775|6399190|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
1851412|NCT00151775|6399191|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
1851413|NCT00151775|6399192|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
1851414|NCT00151476|6399236|P2|FAP Analyzed Subjects|Other study participation|1
1851415|NCT00151476|6399237|P1|FAP Analyzed Subjects|Other study participation|0
1851416|NCT00151476|6399236|P2|FAP Analyzed Subjects|Lost to Follow-up|2
1851417|NCT00151476|6399237|P1|FAP Analyzed Subjects|Lost to Follow-up|0
1851418|NCT00151476|6399236|P2|FAP Identified Subjects|Protocol Violation|1
1851419|NCT00151476|6399237|P1|FAP Identified Subjects|Protocol Violation|0
1851420|NCT00151411|6399294|P2|Overall Study|Pregnancy|4
1851421|NCT00151411|6399295|P1|Overall Study|Pregnancy|0
1851422|NCT00151411|6399294|P2|Overall Study|Adverse Event|0
1851423|NCT00151411|6399295|P1|Overall Study|Adverse Event|6
1851424|NCT00151411|6399294|P2|Overall Study|Withdrawal by Subject|20
1851425|NCT00151411|6399295|P1|Overall Study|Withdrawal by Subject|12
1851426|NCT00151411|6399294|P2|Overall Study|Lost to Follow-up|19
1851427|NCT00151411|6399295|P1|Overall Study|Lost to Follow-up|15
1851428|NCT00151372|6399307|P2|Overall Study|Withdrawal by Subject|7
1851429|NCT00151372|6399308|P1|Overall Study|Withdrawal by Subject|7
1851430|NCT00151372|6399307|P2|Overall Study|Too sick medically to continue|6
1851431|NCT00151372|6399308|P1|Overall Study|Too sick medically to continue|5
1851432|NCT00151372|6399307|P2|Overall Study|Lost to Follow-up|5
1851433|NCT00151372|6399308|P1|Overall Study|Lost to Follow-up|5
1851434|NCT00151372|6399307|P2|Overall Study|Death|11
1851435|NCT00151372|6399308|P1|Overall Study|Death|12
1851436|NCT00151281|6399323|P1|Overall Study|Not evaluable|3
1851437|NCT00150969|6399332|P2|24-48 Month Extension|Other Reason|91
1851438|NCT00150969|6399333|P1|24-48 Month Extension|Other Reason|81
1851439|NCT00150969|6399332|P2|24-48 Month Extension|Adverse Event|3
1851440|NCT00150969|6399333|P1|24-48 Month Extension|Adverse Event|1
1851441|NCT00150969|6399332|P2|24-48 Month Extension|Lack of Efficacy|1
1851442|NCT00150969|6399333|P1|24-48 Month Extension|Lack of Efficacy|0
1851443|NCT00150969|6399332|P2|24-48 Month Extension|Withdrawal by Subject|5
1851444|NCT00150969|6399333|P1|24-48 Month Extension|Withdrawal by Subject|6
1851445|NCT00150969|6399332|P2|24 Month Main Study|Withdrawal by Subject|4
1851446|NCT00150969|6399333|P1|24 Month Main Study|Withdrawal by Subject|7
1851447|NCT00150969|6399332|P2|24 Month Main Study|Protocol Violation|2
1851448|NCT00150969|6399333|P1|24 Month Main Study|Protocol Violation|4
1851449|NCT00150969|6399332|P2|24 Month Main Study|Lost to Follow-up|2
1851450|NCT00150969|6399333|P1|24 Month Main Study|Lost to Follow-up|3
1851451|NCT00150969|6399332|P2|24 Month Main Study|Lack of Efficacy|8
1851452|NCT00150969|6399333|P1|24 Month Main Study|Lack of Efficacy|1
1851453|NCT00150969|6399332|P2|24 Month Main Study|Death|1
1851454|NCT00150969|6399333|P1|24 Month Main Study|Death|1
1851455|NCT00150969|6399332|P2|24 Month Main Study|Adverse Event|4
1851456|NCT00150969|6399333|P1|24 Month Main Study|Adverse Event|3
1851457|NCT00150813|6399365|P1|Overall Study|Switch to commercially available LEV|2
1851458|NCT00150813|6399365|P1|Overall Study|Planned pregancy|1
1851459|NCT00150813|6399365|P1|Overall Study|Remission|3
1851460|NCT00150813|6399365|P1|Overall Study|Withdrawal by Subject|5
1851461|NCT00150813|6399365|P1|Overall Study|Lost to Follow-up|5
1851462|NCT00150813|6399365|P1|Overall Study|Lack of Efficacy|1
1851463|NCT00150813|6399365|P1|Overall Study|Adverse Event|1
1851464|NCT00150800|6399369|P1|Overall Study|PI discontinuation request|1
1851465|NCT00150800|6399369|P1|Overall Study|Pregnancy planned|1
1851466|NCT00150800|6399369|P1|Overall Study|Surgical intervention|4
1851467|NCT00150800|6399369|P1|Overall Study|Patient insurance|1
1851468|NCT00150800|6399369|P1|Overall Study|PI leaving site|2
1851469|NCT00150800|6399369|P1|Overall Study|PI retiring|2
1851470|NCT00150800|6399369|P1|Overall Study|Moved from area/country|8
1851471|NCT00150800|6399369|P1|Overall Study|Generalized Epilepsy|1
1851472|NCT00150800|6399369|P1|Overall Study|Sponsor's request|2
1851473|NCT00150800|6399369|P1|Overall Study|Visit refusal|3
1851474|NCT00150800|6399369|P1|Overall Study|BRV monotherapy|1
1851475|NCT00150800|6399369|P1|Overall Study|Neurosurgery|2
1851476|NCT00150800|6399369|P1|Overall Study|Distance too long for patient|1
1851477|NCT00150800|6399369|P1|Overall Study|Nobody to accompany patient|1
1851478|NCT00150800|6399369|P1|Overall Study|Protocol non-adherence|2
1851479|NCT00150800|6399369|P1|Overall Study|Site closure|24
1851480|NCT00150800|6399369|P1|Overall Study|IP misshandling|1
1851481|NCT00150800|6399369|P1|Overall Study|No compliance|18
1851482|NCT00150800|6399369|P1|Overall Study|Subject's choice|90
1851483|NCT00150800|6399369|P1|Overall Study|Lost to Follow-up|58
1851484|NCT00150800|6399369|P1|Overall Study|Lack of Efficacy|166
1851485|NCT00150800|6399369|P1|Overall Study|Death|18
1851486|NCT00150800|6399369|P1|Overall Study|Adverse Event|89
1851487|NCT00150618|6399383|P5|Overall Study|Sponsor's decision|0
1851488|NCT00150618|6399384|P4|Overall Study|Sponsor's decision|1
1851489|NCT00150618|6399385|P3|Overall Study|Sponsor's decision|0
1851490|NCT00150618|6399386|P2|Overall Study|Sponsor's decision|0
1851491|NCT00150618|6399387|P1|Overall Study|Sponsor's decision|0
1851492|NCT00150618|6399383|P5|Overall Study|Abnormal ECG|0
1851493|NCT00150618|6399384|P4|Overall Study|Abnormal ECG|0
1851494|NCT00150618|6399385|P3|Overall Study|Abnormal ECG|0
1851495|NCT00150618|6399386|P2|Overall Study|Abnormal ECG|0
1851496|NCT00150618|6399387|P1|Overall Study|Abnormal ECG|1
1851497|NCT00150618|6399383|P5|Overall Study|Lack of compliance|1
1851498|NCT00150618|6399384|P4|Overall Study|Lack of compliance|0
1851499|NCT00150618|6399385|P3|Overall Study|Lack of compliance|1
1851500|NCT00150618|6399386|P2|Overall Study|Lack of compliance|1
1851501|NCT00150618|6399387|P1|Overall Study|Lack of compliance|2
1851502|NCT00150618|6399383|P5|Overall Study|Physician Decision|1
1851503|NCT00150618|6399384|P4|Overall Study|Physician Decision|0
1851504|NCT00150618|6399385|P3|Overall Study|Physician Decision|0
1851505|NCT00150618|6399386|P2|Overall Study|Physician Decision|2
1851506|NCT00150618|6399387|P1|Overall Study|Physician Decision|0
1851507|NCT00150618|6399383|P5|Overall Study|No study meds|2
1851508|NCT00150618|6399384|P4|Overall Study|No study meds|0
1851509|NCT00150618|6399385|P3|Overall Study|No study meds|0
1851510|NCT00150618|6399386|P2|Overall Study|No study meds|0
1851511|NCT00150618|6399387|P1|Overall Study|No study meds|0
1851512|NCT00150618|6399383|P5|Overall Study|Lack of Efficacy|6
1851513|NCT00150618|6399384|P4|Overall Study|Lack of Efficacy|4
1851514|NCT00150618|6399385|P3|Overall Study|Lack of Efficacy|7
1851515|NCT00150618|6399386|P2|Overall Study|Lack of Efficacy|4
1851516|NCT00150618|6399387|P1|Overall Study|Lack of Efficacy|1
1851517|NCT00150618|6399383|P5|Overall Study|Protocol Violation|1
1851518|NCT00150618|6399384|P4|Overall Study|Protocol Violation|0
1851519|NCT00150618|6399385|P3|Overall Study|Protocol Violation|0
1851520|NCT00150618|6399386|P2|Overall Study|Protocol Violation|0
1851521|NCT00150618|6399387|P1|Overall Study|Protocol Violation|1
1851522|NCT00150618|6399383|P5|Overall Study|Lost to Follow-up|4
1851523|NCT00150618|6399384|P4|Overall Study|Lost to Follow-up|8
1851524|NCT00150618|6399385|P3|Overall Study|Lost to Follow-up|5
1851525|NCT00150618|6399386|P2|Overall Study|Lost to Follow-up|1
1851526|NCT00150618|6399387|P1|Overall Study|Lost to Follow-up|4
1851527|NCT00150618|6399383|P5|Overall Study|Withdrawal by Subject|5
1851528|NCT00150618|6399384|P4|Overall Study|Withdrawal by Subject|4
1851529|NCT00150618|6399385|P3|Overall Study|Withdrawal by Subject|8
1851530|NCT00150618|6399386|P2|Overall Study|Withdrawal by Subject|8
1851531|NCT00150618|6399387|P1|Overall Study|Withdrawal by Subject|6
1851532|NCT00150618|6399383|P5|Overall Study|Adverse Event|5
1851533|NCT00150618|6399384|P4|Overall Study|Adverse Event|9
1851534|NCT00150618|6399385|P3|Overall Study|Adverse Event|6
1851535|NCT00150618|6399386|P2|Overall Study|Adverse Event|2
1851536|NCT00150618|6399387|P1|Overall Study|Adverse Event|2
1851537|NCT00150592|6399421|P2|Overall Study|Non-compliance|0
1851538|NCT00150592|6399422|P1|Overall Study|Non-compliance|1
1851539|NCT00150592|6399421|P2|Overall Study|Withdrawal by Subject|2
1851540|NCT00150592|6399422|P1|Overall Study|Withdrawal by Subject|1
1851541|NCT00150592|6399421|P2|Overall Study|Protocol Violation|0
1851542|NCT00150592|6399422|P1|Overall Study|Protocol Violation|1
1851543|NCT00150592|6399421|P2|Overall Study|Adverse Event|1
1851544|NCT00150592|6399422|P1|Overall Study|Adverse Event|4
1851545|NCT00150462|6399453|P11|Overall Study|Other|1
1851546|NCT00150462|6399454|P10|Overall Study|Other|1
1851547|NCT00150462|6399455|P9|Overall Study|Other|0
1851548|NCT00150462|6399456|P8|Overall Study|Other|0
1851549|NCT00150462|6399457|P7|Overall Study|Other|0
1851550|NCT00150462|6399458|P6|Overall Study|Other|0
1851551|NCT00150462|6399459|P5|Overall Study|Other|0
1851552|NCT00150462|6399460|P4|Overall Study|Other|0
1851553|NCT00150462|6399461|P3|Overall Study|Other|0
1851554|NCT00150462|6399462|P2|Overall Study|Other|0
1851555|NCT00150462|6399463|P1|Overall Study|Other|0
1851556|NCT00150462|6399453|P11|Overall Study|Physician Decision|0
1851557|NCT00150462|6399454|P10|Overall Study|Physician Decision|0
1851558|NCT00150462|6399455|P9|Overall Study|Physician Decision|0
1851559|NCT00150462|6399456|P8|Overall Study|Physician Decision|0
1851560|NCT00150462|6399457|P7|Overall Study|Physician Decision|0
1851561|NCT00150462|6399458|P6|Overall Study|Physician Decision|0
1851562|NCT00150462|6399459|P5|Overall Study|Physician Decision|0
1851563|NCT00150462|6399460|P4|Overall Study|Physician Decision|1
1851564|NCT00150462|6399461|P3|Overall Study|Physician Decision|1
1851565|NCT00150462|6399462|P2|Overall Study|Physician Decision|0
1851566|NCT00150462|6399463|P1|Overall Study|Physician Decision|0
1851567|NCT00150462|6399453|P11|Overall Study|Adverse Event|0
1851568|NCT00150462|6399454|P10|Overall Study|Adverse Event|1
1851569|NCT00150462|6399455|P9|Overall Study|Adverse Event|0
1851570|NCT00150462|6399456|P8|Overall Study|Adverse Event|2
1851571|NCT00150462|6399457|P7|Overall Study|Adverse Event|0
1851572|NCT00150462|6399458|P6|Overall Study|Adverse Event|0
1851573|NCT00150462|6399459|P5|Overall Study|Adverse Event|0
1851574|NCT00150462|6399460|P4|Overall Study|Adverse Event|1
1851575|NCT00150462|6399461|P3|Overall Study|Adverse Event|0
1851576|NCT00150462|6399462|P2|Overall Study|Adverse Event|0
1851577|NCT00150462|6399463|P1|Overall Study|Adverse Event|0
1851578|NCT00150462|6399453|P11|Overall Study|Death|0
1851579|NCT00150462|6399454|P10|Overall Study|Death|0
1851580|NCT00150462|6399455|P9|Overall Study|Death|1
1851581|NCT00150462|6399456|P8|Overall Study|Death|0
1851582|NCT00150462|6399457|P7|Overall Study|Death|0
1851583|NCT00150462|6399458|P6|Overall Study|Death|0
1851584|NCT00150462|6399459|P5|Overall Study|Death|0
1851585|NCT00150462|6399460|P4|Overall Study|Death|0
1851586|NCT00150462|6399461|P3|Overall Study|Death|0
1851587|NCT00150462|6399462|P2|Overall Study|Death|1
1851588|NCT00150462|6399463|P1|Overall Study|Death|0
1851589|NCT00150462|6399453|P11|Overall Study|Withdrawal by Subject|0
1851590|NCT00150462|6399454|P10|Overall Study|Withdrawal by Subject|1
1851591|NCT00150462|6399455|P9|Overall Study|Withdrawal by Subject|0
1851592|NCT00150462|6399456|P8|Overall Study|Withdrawal by Subject|1
1851593|NCT00150462|6399457|P7|Overall Study|Withdrawal by Subject|0
1851594|NCT00150462|6399458|P6|Overall Study|Withdrawal by Subject|2
1851595|NCT00150462|6399459|P5|Overall Study|Withdrawal by Subject|1
1851596|NCT00150462|6399460|P4|Overall Study|Withdrawal by Subject|0
1851597|NCT00150462|6399461|P3|Overall Study|Withdrawal by Subject|1
1851598|NCT00150462|6399462|P2|Overall Study|Withdrawal by Subject|1
1851599|NCT00150462|6399463|P1|Overall Study|Withdrawal by Subject|0
1851600|NCT00150462|6399453|P11|Overall Study|Disease Progression or Relapse|2
1851601|NCT00150462|6399454|P10|Overall Study|Disease Progression or Relapse|3
1851602|NCT00150462|6399455|P9|Overall Study|Disease Progression or Relapse|5
1851603|NCT00150462|6399456|P8|Overall Study|Disease Progression or Relapse|5
1851604|NCT00150462|6399457|P7|Overall Study|Disease Progression or Relapse|3
1851605|NCT00150462|6399458|P6|Overall Study|Disease Progression or Relapse|2
1851606|NCT00150462|6399459|P5|Overall Study|Disease Progression or Relapse|2
1851607|NCT00150462|6399460|P4|Overall Study|Disease Progression or Relapse|1
1851608|NCT00150462|6399461|P3|Overall Study|Disease Progression or Relapse|2
1851609|NCT00150462|6399462|P2|Overall Study|Disease Progression or Relapse|1
1851610|NCT00150462|6399463|P1|Overall Study|Disease Progression or Relapse|3
1851611|NCT00150345|6399573|P2|Overall Study|Other|14
1851612|NCT00150345|6399574|P1|Overall Study|Other|12
1851613|NCT00150345|6399573|P2|Overall Study|Laboratory abnormality|2
1851614|NCT00150345|6399574|P1|Overall Study|Laboratory abnormality|1
1851615|NCT00150345|6399573|P2|Overall Study|Withdrawal by Subject|4
1851616|NCT00150345|6399574|P1|Overall Study|Withdrawal by Subject|3
1851617|NCT00150345|6399573|P2|Overall Study|Lack of Efficacy|4
1851618|NCT00150345|6399574|P1|Overall Study|Lack of Efficacy|5
1851619|NCT00150345|6399573|P2|Overall Study|Adverse Event|6
1851620|NCT00150345|6399574|P1|Overall Study|Adverse Event|8
1851621|NCT00150345|6399573|P2|Overall Study|Death|2
1851622|NCT00150345|6399574|P1|Overall Study|Death|5
1851623|NCT00150176|6399638|P2|Overall Study|OTHER|13
1851624|NCT00150176|6399639|P1|Overall Study|OTHER|11
1851625|NCT00150176|6399638|P2|Overall Study|Lost to Follow-up|3
1851626|NCT00150176|6399639|P1|Overall Study|Lost to Follow-up|3
1851627|NCT00150176|6399638|P2|Overall Study|Withdrawal by Subject|12
1851628|NCT00150176|6399639|P1|Overall Study|Withdrawal by Subject|19
1851629|NCT00150176|6399638|P2|Overall Study|Relapse/Impending relapse, non-AE|39
1851630|NCT00150176|6399639|P1|Overall Study|Relapse/Impending relapse, non-AE|10
1851631|NCT00150176|6399638|P2|Overall Study|Adverse Event|53
1851632|NCT00150176|6399639|P1|Overall Study|Adverse Event|16
1851633|NCT00149994|6399650|P2|Overall Study|Protocol Violation|1
1851634|NCT00149994|6399651|P1|Overall Study|Protocol Violation|0
1851635|NCT00149994|6399650|P2|Overall Study|Administrative problems:|0
1851636|NCT00149994|6399651|P1|Overall Study|Administrative problems:|1
1851637|NCT00149890|6399659|P2|Overall Study|Graft Loss|1
1851638|NCT00149890|6399660|P1|Overall Study|Graft Loss|2
1851639|NCT00149890|6399659|P2|Overall Study|Lost to Follow-up|0
1851640|NCT00149890|6399660|P1|Overall Study|Lost to Follow-up|1
1851641|NCT00149890|6399659|P2|Overall Study|Protocol Violation|0
1851642|NCT00149890|6399660|P1|Overall Study|Protocol Violation|1
1851643|NCT00149890|6399659|P2|Overall Study|Lack of Efficacy|9
1851644|NCT00149890|6399660|P1|Overall Study|Lack of Efficacy|8
1851645|NCT00149890|6399659|P2|Overall Study|Adverse Event|8
1851646|NCT00149890|6399660|P1|Overall Study|Adverse Event|1
1851647|NCT00149825|6399695|P2|Overall Study|Other|0
1851648|NCT00149825|6399696|P1|Overall Study|Other|1
1851649|NCT00149825|6399695|P2|Overall Study|Not liking insomnia therapy|0
1851650|NCT00149825|6399696|P1|Overall Study|Not liking insomnia therapy|1
1851651|NCT00149825|6399695|P2|Overall Study|Time commitments|1
1851652|NCT00149825|6399696|P1|Overall Study|Time commitments|2
1851653|NCT00149825|6399695|P2|Overall Study|Intolerance to medication side effects|2
1851654|NCT00149825|6399696|P1|Overall Study|Intolerance to medication side effects|1
1851655|NCT00149747|6399724|P2|Overall Study|Withdrawal by Subject|3
1851656|NCT00149747|6399725|P1|Overall Study|Withdrawal by Subject|3
1851657|NCT00149747|6399724|P2|Overall Study|Death|0
1851658|NCT00149747|6399725|P1|Overall Study|Death|1
1851659|NCT00149630|6399771|P2|Overall Study|Adverse Event|0
1851660|NCT00149630|6399772|P1|Overall Study|Adverse Event|2
1851661|NCT00149630|6399771|P2|Overall Study|Treatment Programs|5
1851662|NCT00149630|6399772|P1|Overall Study|Treatment Programs|4
1851663|NCT00149630|6399771|P2|Overall Study|Incarceration|0
1851664|NCT00149630|6399772|P1|Overall Study|Incarceration|2
1851665|NCT00149396|6399782|P1|Overall Study|other treatment|5
1851666|NCT00149396|6399782|P1|Overall Study|Subject noncompliance|2
1851667|NCT00149396|6399782|P1|Overall Study|Withdrawal by Subject|1
1851668|NCT00149396|6399782|P1|Overall Study|Death|15
1851669|NCT00149214|6399852|P2|Overall Study|Progressive Disease|3
1851670|NCT00149214|6399853|P1|Overall Study|Progressive Disease|7
1851671|NCT00149214|6399852|P2|Overall Study|Sponsor Decision|1
1851672|NCT00149214|6399853|P1|Overall Study|Sponsor Decision|0
1851673|NCT00149214|6399852|P2|Overall Study|Physician Decision|3
1851674|NCT00149214|6399853|P1|Overall Study|Physician Decision|3
1851675|NCT00149214|6399852|P2|Overall Study|Withdrawal by Subject|1
1851676|NCT00149214|6399853|P1|Overall Study|Withdrawal by Subject|4
1851677|NCT00149214|6399852|P2|Overall Study|Adverse Event|9
1851678|NCT00149214|6399853|P1|Overall Study|Adverse Event|12
1851679|NCT00148941|6399880|P4|Overall Study|Other|2
1851680|NCT00148941|6399881|P3|Overall Study|Other|1
1851681|NCT00148941|6399882|P2|Overall Study|Other|0
1851682|NCT00148941|6399883|P1|Overall Study|Other|0
1851683|NCT00148941|6399880|P4|Overall Study|Withdrawal by Subject|0
1851684|NCT00148941|6399881|P3|Overall Study|Withdrawal by Subject|1
1851685|NCT00148941|6399882|P2|Overall Study|Withdrawal by Subject|0
1851686|NCT00148941|6399883|P1|Overall Study|Withdrawal by Subject|1
1851687|NCT00148941|6399880|P4|Overall Study|Lost to Follow-up|22
1851688|NCT00148941|6399881|P3|Overall Study|Lost to Follow-up|18
1851689|NCT00148941|6399882|P2|Overall Study|Lost to Follow-up|24
1851690|NCT00148941|6399883|P1|Overall Study|Lost to Follow-up|17
1851691|NCT00148759|6399998|P2|Overall Study|Lost to Follow-up|0
1851692|NCT00148759|6399999|P1|Overall Study|Lost to Follow-up|1
1851693|NCT00148759|6399998|P2|Overall Study|Withdrawal by Subject|1
1851694|NCT00148759|6399999|P1|Overall Study|Withdrawal by Subject|1
1851695|NCT00148343|6400027|P2|Overall Study|Physician Decision|4
1851696|NCT00148343|6400028|P1|Overall Study|Physician Decision|3
1851697|NCT00148343|6400027|P2|Overall Study|Withdrawal by Subject|7
1851698|NCT00148343|6400028|P1|Overall Study|Withdrawal by Subject|12
1851699|NCT00148317|6400042|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
1851700|NCT00148317|6400042|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
1851701|NCT00148317|6400042|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
1851702|NCT00148122|6400049|P1|Overall Study|Withdrawal by Subject|2
1851703|NCT00148109|6400057|P2|Overall Study|Withdrawal by Subject|0
1851704|NCT00148109|6400058|P1|Overall Study|Withdrawal by Subject|2
1851705|NCT00148109|6400057|P2|Overall Study|Adverse Event|2
1851706|NCT00148109|6400058|P1|Overall Study|Adverse Event|0
1851707|NCT00148109|6400057|P2|Overall Study|Lack of Efficacy|18
1851708|NCT00148109|6400058|P1|Overall Study|Lack of Efficacy|10
1851709|NCT00147823|6400074|P2|Overall Study|Did not receive vitoss due to infection|2
1851710|NCT00147823|6400075|P1|Overall Study|Did not receive vitoss due to infection|6
1851711|NCT00147823|6400074|P2|Overall Study|Withdrawal by Subject|1
1851712|NCT00147823|6400075|P1|Overall Study|Withdrawal by Subject|0
1851713|NCT00147823|6400074|P2|Overall Study|Physician Decision|0
1851714|NCT00147823|6400075|P1|Overall Study|Physician Decision|1
1851715|NCT00147823|6400074|P2|Overall Study|Lost to Follow-up|12
1851716|NCT00147823|6400075|P1|Overall Study|Lost to Follow-up|6
1851717|NCT00147745|6400106|P3|Overall Study|Withdrawal by Subject|0
1851718|NCT00147745|6400107|P2|Overall Study|Withdrawal by Subject|0
1851719|NCT00147745|6400108|P1|Overall Study|Withdrawal by Subject|1
1851720|NCT00147537|6400130|P11|Phase 2|Randomized but not treated|1
1851721|NCT00147537|6400131|P10|Phase 2|Randomized but not treated|1
1851722|NCT00147537|6400132|P9|Phase 2|Randomized but not treated|0
1851723|NCT00147537|6400133|P8|Phase 2|Randomized but not treated|0
1851724|NCT00147537|6400134|P7|Phase 2|Randomized but not treated|0
1851725|NCT00147537|6400135|P6|Phase 2|Randomized but not treated|0
1851726|NCT00147537|6400136|P5|Phase 2|Randomized but not treated|0
1851727|NCT00147537|6400137|P4|Phase 2|Randomized but not treated|0
1851728|NCT00147537|6400138|P3|Phase 2|Randomized but not treated|0
1851729|NCT00147537|6400139|P2|Phase 2|Randomized but not treated|0
1851730|NCT00147537|6400140|P1|Phase 2|Randomized but not treated|0
1851731|NCT00147537|6400130|P11|Phase 2|Withdrawal by Subject|4
1851732|NCT00147537|6400131|P10|Phase 2|Withdrawal by Subject|16
1851733|NCT00147537|6400132|P9|Phase 2|Withdrawal by Subject|0
1851734|NCT00147537|6400133|P8|Phase 2|Withdrawal by Subject|0
1851735|NCT00147537|6400134|P7|Phase 2|Withdrawal by Subject|0
1851736|NCT00147537|6400135|P6|Phase 2|Withdrawal by Subject|0
1851737|NCT00147537|6400136|P5|Phase 2|Withdrawal by Subject|0
1851738|NCT00147537|6400137|P4|Phase 2|Withdrawal by Subject|0
1851739|NCT00147537|6400138|P3|Phase 2|Withdrawal by Subject|0
1851740|NCT00147537|6400139|P2|Phase 2|Withdrawal by Subject|0
1851741|NCT00147537|6400140|P1|Phase 2|Withdrawal by Subject|0
1851742|NCT00147537|6400130|P11|Phase 2|Other|12
1851743|NCT00147537|6400131|P10|Phase 2|Other|47
1851744|NCT00147537|6400132|P9|Phase 2|Other|0
1851745|NCT00147537|6400133|P8|Phase 2|Other|0
1851746|NCT00147537|6400134|P7|Phase 2|Other|0
1851747|NCT00147537|6400135|P6|Phase 2|Other|0
1851748|NCT00147537|6400136|P5|Phase 2|Other|0
1851749|NCT00147537|6400137|P4|Phase 2|Other|0
1851750|NCT00147537|6400138|P3|Phase 2|Other|0
1851751|NCT00147537|6400139|P2|Phase 2|Other|0
1851752|NCT00147537|6400140|P1|Phase 2|Other|0
1851753|NCT00147537|6400130|P11|Phase 2|Lost to Follow-up|4
1851754|NCT00147537|6400131|P10|Phase 2|Lost to Follow-up|12
1851755|NCT00147537|6400132|P9|Phase 2|Lost to Follow-up|0
1851756|NCT00147537|6400133|P8|Phase 2|Lost to Follow-up|0
1851757|NCT00147537|6400134|P7|Phase 2|Lost to Follow-up|0
1851758|NCT00147537|6400135|P6|Phase 2|Lost to Follow-up|0
1851759|NCT00147537|6400136|P5|Phase 2|Lost to Follow-up|0
1851760|NCT00147537|6400137|P4|Phase 2|Lost to Follow-up|0
1851761|NCT00147537|6400138|P3|Phase 2|Lost to Follow-up|0
1851762|NCT00147537|6400139|P2|Phase 2|Lost to Follow-up|0
1851763|NCT00147537|6400140|P1|Phase 2|Lost to Follow-up|0
1851764|NCT00147537|6400130|P11|Phase 2|Death|31
1851765|NCT00147537|6400131|P10|Phase 2|Death|85
1851766|NCT00147537|6400132|P9|Phase 2|Death|0
1851767|NCT00147537|6400133|P8|Phase 2|Death|0
1851768|NCT00147537|6400134|P7|Phase 2|Death|0
1851769|NCT00147537|6400135|P6|Phase 2|Death|0
1851770|NCT00147537|6400136|P5|Phase 2|Death|0
1851771|NCT00147537|6400137|P4|Phase 2|Death|0
1851772|NCT00147537|6400138|P3|Phase 2|Death|0
1851773|NCT00147537|6400139|P2|Phase 2|Death|0
1851774|NCT00147537|6400140|P1|Phase 2|Death|0
1851775|NCT00147537|6400130|P11|Phase 1b|Randomized but not treated|0
1851776|NCT00147537|6400131|P10|Phase 1b|Randomized but not treated|0
1851777|NCT00147537|6400132|P9|Phase 1b|Randomized but not treated|1
1851778|NCT00147537|6400133|P8|Phase 1b|Randomized but not treated|0
1851779|NCT00147537|6400134|P7|Phase 1b|Randomized but not treated|1
1851780|NCT00147537|6400135|P6|Phase 1b|Randomized but not treated|0
1851781|NCT00147537|6400136|P5|Phase 1b|Randomized but not treated|0
1851782|NCT00147537|6400137|P4|Phase 1b|Randomized but not treated|0
1851783|NCT00147537|6400138|P3|Phase 1b|Randomized but not treated|0
1851784|NCT00147537|6400139|P2|Phase 1b|Randomized but not treated|0
1851785|NCT00147537|6400140|P1|Phase 1b|Randomized but not treated|0
1851786|NCT00147537|6400130|P11|Phase 1b|Withdrawal by Subject|0
1851787|NCT00147537|6400131|P10|Phase 1b|Withdrawal by Subject|0
1851788|NCT00147537|6400132|P9|Phase 1b|Withdrawal by Subject|2
1851789|NCT00147537|6400133|P8|Phase 1b|Withdrawal by Subject|0
1851790|NCT00147537|6400134|P7|Phase 1b|Withdrawal by Subject|0
1851791|NCT00147537|6400135|P6|Phase 1b|Withdrawal by Subject|0
1851792|NCT00147537|6400136|P5|Phase 1b|Withdrawal by Subject|0
1851793|NCT00147537|6400137|P4|Phase 1b|Withdrawal by Subject|0
1851794|NCT00147537|6400138|P3|Phase 1b|Withdrawal by Subject|0
1851795|NCT00147537|6400139|P2|Phase 1b|Withdrawal by Subject|0
1851796|NCT00147537|6400140|P1|Phase 1b|Withdrawal by Subject|0
1851797|NCT00147537|6400130|P11|Phase 1b|Other|0
1851798|NCT00147537|6400131|P10|Phase 1b|Other|0
1851799|NCT00147537|6400132|P9|Phase 1b|Other|4
1851800|NCT00147537|6400133|P8|Phase 1b|Other|4
1851801|NCT00147537|6400134|P7|Phase 1b|Other|14
1851802|NCT00147537|6400135|P6|Phase 1b|Other|1
1851803|NCT00147537|6400136|P5|Phase 1b|Other|1
1851804|NCT00147537|6400137|P4|Phase 1b|Other|1
1851805|NCT00147537|6400138|P3|Phase 1b|Other|2
1851806|NCT00147537|6400139|P2|Phase 1b|Other|0
1851807|NCT00147537|6400140|P1|Phase 1b|Other|0
1851808|NCT00147537|6400130|P11|Phase 1b|Lost to Follow-up|0
1851809|NCT00147537|6400131|P10|Phase 1b|Lost to Follow-up|0
1851810|NCT00147537|6400132|P9|Phase 1b|Lost to Follow-up|1
1851811|NCT00147537|6400133|P8|Phase 1b|Lost to Follow-up|0
1851812|NCT00147537|6400134|P7|Phase 1b|Lost to Follow-up|2
1851813|NCT00147537|6400135|P6|Phase 1b|Lost to Follow-up|0
1851814|NCT00147537|6400136|P5|Phase 1b|Lost to Follow-up|0
1851815|NCT00147537|6400137|P4|Phase 1b|Lost to Follow-up|0
1851816|NCT00147537|6400138|P3|Phase 1b|Lost to Follow-up|0
1851817|NCT00147537|6400139|P2|Phase 1b|Lost to Follow-up|1
1851818|NCT00147537|6400140|P1|Phase 1b|Lost to Follow-up|2
1851819|NCT00147537|6400130|P11|Phase 1b|Death|0
1851820|NCT00147537|6400131|P10|Phase 1b|Death|0
1851821|NCT00147537|6400132|P9|Phase 1b|Death|9
1851822|NCT00147537|6400133|P8|Phase 1b|Death|3
1851823|NCT00147537|6400134|P7|Phase 1b|Death|1
1851824|NCT00147537|6400135|P6|Phase 1b|Death|2
1851825|NCT00147537|6400136|P5|Phase 1b|Death|2
1851826|NCT00147537|6400137|P4|Phase 1b|Death|1
1851827|NCT00147537|6400138|P3|Phase 1b|Death|2
1851828|NCT00147537|6400139|P2|Phase 1b|Death|1
1851829|NCT00147537|6400140|P1|Phase 1b|Death|0
1851830|NCT00147498|6400323|P4|Overall Study|Other|3
1851831|NCT00147498|6400324|P3|Overall Study|Other|3
1851832|NCT00147498|6400325|P2|Overall Study|Other|1
1851833|NCT00147498|6400326|P1|Overall Study|Other|1
1851834|NCT00147498|6400323|P4|Overall Study|Participant defaulted|3
1851835|NCT00147498|6400324|P3|Overall Study|Participant defaulted|4
1851836|NCT00147498|6400325|P2|Overall Study|Participant defaulted|1
1851837|NCT00147498|6400326|P1|Overall Study|Participant defaulted|0
1851838|NCT00147498|6400323|P4|Overall Study|Laboratory abnormality|0
1851839|NCT00147498|6400324|P3|Overall Study|Laboratory abnormality|2
1851840|NCT00147498|6400325|P2|Overall Study|Laboratory abnormality|0
1851841|NCT00147498|6400326|P1|Overall Study|Laboratory abnormality|0
1851842|NCT00147498|6400323|P4|Overall Study|Lack of Efficacy|8
1851843|NCT00147498|6400324|P3|Overall Study|Lack of Efficacy|1
1851844|NCT00147498|6400325|P2|Overall Study|Lack of Efficacy|1
1851845|NCT00147498|6400326|P1|Overall Study|Lack of Efficacy|1
1851846|NCT00147498|6400323|P4|Overall Study|Adverse Event|3
1851847|NCT00147498|6400324|P3|Overall Study|Adverse Event|7
1851848|NCT00147498|6400325|P2|Overall Study|Adverse Event|6
1851849|NCT00147498|6400326|P1|Overall Study|Adverse Event|1
1851850|NCT00147238|6400450|P1|Overall Study|Inevaluable|8
1851851|NCT00147225|6400460|P6|Overall Study|Chemotherapy Changed|1
1851852|NCT00147225|6400461|P5|Overall Study|Chemotherapy Changed|0
1851853|NCT00147225|6400462|P4|Overall Study|Chemotherapy Changed|0
1851854|NCT00147225|6400463|P3|Overall Study|Chemotherapy Changed|0
1851855|NCT00147225|6400464|P2|Overall Study|Chemotherapy Changed|0
1851856|NCT00147225|6400465|P1|Overall Study|Chemotherapy Changed|0
1851857|NCT00147225|6400460|P6|Overall Study|Screen Failure|0
1851858|NCT00147225|6400461|P5|Overall Study|Screen Failure|1
1851859|NCT00147225|6400462|P4|Overall Study|Screen Failure|0
1851860|NCT00147225|6400463|P3|Overall Study|Screen Failure|0
1851861|NCT00147225|6400464|P2|Overall Study|Screen Failure|0
1851862|NCT00147225|6400465|P1|Overall Study|Screen Failure|0
1851863|NCT00147225|6400460|P6|Overall Study|Adverse Event|0
1851864|NCT00147225|6400461|P5|Overall Study|Adverse Event|0
1851865|NCT00147225|6400462|P4|Overall Study|Adverse Event|1
1851866|NCT00147225|6400463|P3|Overall Study|Adverse Event|1
1851867|NCT00147225|6400464|P2|Overall Study|Adverse Event|0
1851868|NCT00147225|6400465|P1|Overall Study|Adverse Event|0
1851869|NCT00147225|6400460|P6|Overall Study|Withdrawal by Subject|1
1851870|NCT00147225|6400461|P5|Overall Study|Withdrawal by Subject|0
1851871|NCT00147225|6400462|P4|Overall Study|Withdrawal by Subject|0
1851872|NCT00147225|6400463|P3|Overall Study|Withdrawal by Subject|1
1851873|NCT00147225|6400464|P2|Overall Study|Withdrawal by Subject|0
1851874|NCT00147225|6400465|P1|Overall Study|Withdrawal by Subject|1
1851875|NCT00146848|6400640|P3|Post-randomization|Withdrawn|27
1851876|NCT00146848|6400641|P2|Post-randomization|Withdrawn|32
1851877|NCT00146848|6400642|P1|Post-randomization|Withdrawn|26
1851878|NCT00146848|6400640|P3|Post-randomization|Lost to Follow-up|12
1851879|NCT00146848|6400641|P2|Post-randomization|Lost to Follow-up|15
1851880|NCT00146848|6400642|P1|Post-randomization|Lost to Follow-up|12
1851881|NCT00146848|6400640|P3|Pre-randomization|Withdrawal by Subject|0
1851882|NCT00146848|6400641|P2|Pre-randomization|Withdrawal by Subject|0
1851883|NCT00146848|6400642|P1|Pre-randomization|Withdrawal by Subject|40
1851884|NCT00146848|6400640|P3|Pre-randomization|Protocol Violation|0
1851885|NCT00146848|6400641|P2|Pre-randomization|Protocol Violation|0
1851886|NCT00146848|6400642|P1|Pre-randomization|Protocol Violation|172
1851887|NCT00146848|6400640|P3|Pre-randomization|Physician Decision|0
1851888|NCT00146848|6400641|P2|Pre-randomization|Physician Decision|0
1851889|NCT00146848|6400642|P1|Pre-randomization|Physician Decision|8
1851890|NCT00146848|6400640|P3|Pre-randomization|Lost to Follow-up|0
1851891|NCT00146848|6400641|P2|Pre-randomization|Lost to Follow-up|0
1851892|NCT00146848|6400642|P1|Pre-randomization|Lost to Follow-up|70
1851893|NCT00146848|6400640|P3|Pre-randomization|Death|0
1851894|NCT00146848|6400641|P2|Pre-randomization|Death|0
1851895|NCT00146848|6400642|P1|Pre-randomization|Death|19
1851896|NCT00146770|6400658|P2|Overall Study|Withdrawal by Subject|0
1851897|NCT00146770|6400659|P1|Overall Study|Withdrawal by Subject|2
1851898|NCT00146770|6400658|P2|Overall Study|Pregnancy|0
1851899|NCT00146770|6400659|P1|Overall Study|Pregnancy|1
1851900|NCT00146770|6400658|P2|Overall Study|Adverse Event|0
1851901|NCT00146770|6400659|P1|Overall Study|Adverse Event|2
1851902|NCT00146757|6400677|P2|Overall Study|Adverse Event|0
1851903|NCT00146757|6400678|P1|Overall Study|Adverse Event|1
1851904|NCT00146757|6400677|P2|Overall Study|Death|0
1851905|NCT00146757|6400678|P1|Overall Study|Death|1
1851906|NCT00146640|6400697|P2|Overall Study|Non-Medical Reasons|4
1851907|NCT00146640|6400698|P1|Overall Study|Non-Medical Reasons|8
1851908|NCT00146640|6400697|P2|Overall Study|Medical Reasons|0
1851909|NCT00146640|6400698|P1|Overall Study|Medical Reasons|3
1851910|NCT00146640|6400697|P2|Overall Study|Adverse Event|10
1851911|NCT00146640|6400698|P1|Overall Study|Adverse Event|12
1851912|NCT00146328|6400721|P3|Overall Study|Interaction with other medication|1
1851913|NCT00146328|6400722|P2|Overall Study|Interaction with other medication|0
1851914|NCT00146328|6400723|P1|Overall Study|Interaction with other medication|2
1851915|NCT00146328|6400721|P3|Overall Study|Moved|0
1851916|NCT00146328|6400722|P2|Overall Study|Moved|0
1851917|NCT00146328|6400723|P1|Overall Study|Moved|2
1851918|NCT00146328|6400721|P3|Overall Study|Death|1
1851919|NCT00146328|6400722|P2|Overall Study|Death|1
1851920|NCT00146328|6400723|P1|Overall Study|Death|0
1851921|NCT00146328|6400721|P3|Overall Study|Enroll into other trial|2
1851922|NCT00146328|6400722|P2|Overall Study|Enroll into other trial|4
1851923|NCT00146328|6400723|P1|Overall Study|Enroll into other trial|2
1851924|NCT00146328|6400721|P3|Overall Study|Patient decision to end|6
1851925|NCT00146328|6400722|P2|Overall Study|Patient decision to end|1
1851926|NCT00146328|6400723|P1|Overall Study|Patient decision to end|0
1851927|NCT00146328|6400721|P3|Overall Study|Trial ended/site closed|19
1851928|NCT00146328|6400722|P2|Overall Study|Trial ended/site closed|2
1851929|NCT00146328|6400723|P1|Overall Study|Trial ended/site closed|8
1851930|NCT00146328|6400721|P3|Overall Study|Virologic Failure/lack of efficacy|142
1851931|NCT00146328|6400722|P2|Overall Study|Virologic Failure/lack of efficacy|72
1851932|NCT00146328|6400723|P1|Overall Study|Virologic Failure/lack of efficacy|54
1851933|NCT00146328|6400721|P3|Overall Study|Withdrawal by Subject|22
1851934|NCT00146328|6400722|P2|Overall Study|Withdrawal by Subject|16
1851935|NCT00146328|6400723|P1|Overall Study|Withdrawal by Subject|16
1851936|NCT00146328|6400721|P3|Overall Study|Lost to Follow-up|7
1851937|NCT00146328|6400722|P2|Overall Study|Lost to Follow-up|4
1851938|NCT00146328|6400723|P1|Overall Study|Lost to Follow-up|7
1851939|NCT00146328|6400721|P3|Overall Study|Protocol Violation|12
1851940|NCT00146328|6400722|P2|Overall Study|Protocol Violation|6
1851941|NCT00146328|6400723|P1|Overall Study|Protocol Violation|11
1851942|NCT00146328|6400721|P3|Overall Study|Adverse Event|79
1851943|NCT00146328|6400722|P2|Overall Study|Adverse Event|48
1851944|NCT00146328|6400723|P1|Overall Study|Adverse Event|39
1851945|NCT00146172|6400814|P8|Overall Study|Symptomatic Deterioration|2
1851946|NCT00146172|6400815|P7|Overall Study|Symptomatic Deterioration|0
1851947|NCT00146172|6400816|P6|Overall Study|Symptomatic Deterioration|2
1851948|NCT00146172|6400817|P5|Overall Study|Symptomatic Deterioration|1
1851949|NCT00146172|6400818|P4|Overall Study|Symptomatic Deterioration|0
1851950|NCT00146172|6400819|P3|Overall Study|Symptomatic Deterioration|1
1851951|NCT00146172|6400820|P2|Overall Study|Symptomatic Deterioration|0
1851952|NCT00146172|6400821|P1|Overall Study|Symptomatic Deterioration|1
1851953|NCT00146172|6400814|P8|Overall Study|Withdrawal by Subject|4
1851954|NCT00146172|6400815|P7|Overall Study|Withdrawal by Subject|1
1851955|NCT00146172|6400816|P6|Overall Study|Withdrawal by Subject|1
1851956|NCT00146172|6400817|P5|Overall Study|Withdrawal by Subject|0
1851957|NCT00146172|6400818|P4|Overall Study|Withdrawal by Subject|0
1851958|NCT00146172|6400819|P3|Overall Study|Withdrawal by Subject|0
1851959|NCT00146172|6400820|P2|Overall Study|Withdrawal by Subject|0
1851960|NCT00146172|6400821|P1|Overall Study|Withdrawal by Subject|0
1851961|NCT00146172|6400814|P8|Overall Study|Physician Decision|1
1851962|NCT00146172|6400815|P7|Overall Study|Physician Decision|0
1851963|NCT00146172|6400816|P6|Overall Study|Physician Decision|0
1851964|NCT00146172|6400817|P5|Overall Study|Physician Decision|0
1851965|NCT00146172|6400818|P4|Overall Study|Physician Decision|0
1851966|NCT00146172|6400819|P3|Overall Study|Physician Decision|0
1851967|NCT00146172|6400820|P2|Overall Study|Physician Decision|0
1851968|NCT00146172|6400821|P1|Overall Study|Physician Decision|0
1851969|NCT00146172|6400814|P8|Overall Study|Death|0
1851970|NCT00146172|6400815|P7|Overall Study|Death|1
1851971|NCT00146172|6400816|P6|Overall Study|Death|0
1851972|NCT00146172|6400817|P5|Overall Study|Death|0
1851973|NCT00146172|6400818|P4|Overall Study|Death|0
1851974|NCT00146172|6400819|P3|Overall Study|Death|0
1851975|NCT00146172|6400820|P2|Overall Study|Death|0
1851976|NCT00146172|6400821|P1|Overall Study|Death|0
1851977|NCT00146172|6400814|P8|Overall Study|Disease Progression|22
1851978|NCT00146172|6400815|P7|Overall Study|Disease Progression|1
1851979|NCT00146172|6400816|P6|Overall Study|Disease Progression|2
1851980|NCT00146172|6400817|P5|Overall Study|Disease Progression|2
1851981|NCT00146172|6400818|P4|Overall Study|Disease Progression|5
1851982|NCT00146172|6400819|P3|Overall Study|Disease Progression|2
1851983|NCT00146172|6400820|P2|Overall Study|Disease Progression|4
1851984|NCT00146172|6400821|P1|Overall Study|Disease Progression|2
1851985|NCT00146172|6400814|P8|Overall Study|Lost to Follow-up|1
1851986|NCT00146172|6400815|P7|Overall Study|Lost to Follow-up|0
1851987|NCT00146172|6400816|P6|Overall Study|Lost to Follow-up|0
1851988|NCT00146172|6400817|P5|Overall Study|Lost to Follow-up|0
1851989|NCT00146172|6400818|P4|Overall Study|Lost to Follow-up|0
1851990|NCT00146172|6400819|P3|Overall Study|Lost to Follow-up|0
1851991|NCT00146172|6400820|P2|Overall Study|Lost to Follow-up|0
1851992|NCT00146172|6400821|P1|Overall Study|Lost to Follow-up|0
1851993|NCT00146172|6400814|P8|Overall Study|Adverse Event|10
1851994|NCT00146172|6400815|P7|Overall Study|Adverse Event|3
1851995|NCT00146172|6400816|P6|Overall Study|Adverse Event|2
1851996|NCT00146172|6400817|P5|Overall Study|Adverse Event|0
1851997|NCT00146172|6400818|P4|Overall Study|Adverse Event|1
1851998|NCT00146172|6400819|P3|Overall Study|Adverse Event|1
1851999|NCT00146172|6400820|P2|Overall Study|Adverse Event|0
1852000|NCT00146172|6400821|P1|Overall Study|Adverse Event|0
1852001|NCT00145977|6400856|P2|Overall Study|Withdrawal by Subject|0
1852002|NCT00145977|6400857|P1|Overall Study|Withdrawal by Subject|1
1852003|NCT00145977|6400856|P2|Overall Study|Lost to Follow-up|0
1852004|NCT00145977|6400857|P1|Overall Study|Lost to Follow-up|1
1852005|NCT00145977|6400856|P2|Overall Study|Lack of Efficacy|4
1852006|NCT00145977|6400857|P1|Overall Study|Lack of Efficacy|0
1852007|NCT00145795|6400883|P2|Overall Study|Adverse Event|0
1852008|NCT00145795|6400884|P1|Overall Study|Adverse Event|1
1852009|NCT00145626|6400919|P1|Overall Study|Withdrawal by Subject|1
1852010|NCT00145626|6400919|P1|Overall Study|Death|1
1852011|NCT00145626|6400919|P1|Overall Study|Turned 2 years old before treatment|1
1852012|NCT00145626|6400919|P1|Overall Study|Did not have NK infusions|2
1852013|NCT00145600|6400965|P4|Overall Study|Withdrawal by Subject|1
1852014|NCT00145600|6400966|P3|Overall Study|Withdrawal by Subject|0
1852015|NCT00145600|6400967|P2|Overall Study|Withdrawal by Subject|2
1852016|NCT00145600|6400968|P1|Overall Study|Withdrawal by Subject|1
1852017|NCT00145600|6400965|P4|Overall Study|Noncompliance|0
1852018|NCT00145600|6400966|P3|Overall Study|Noncompliance|0
1852019|NCT00145600|6400967|P2|Overall Study|Noncompliance|0
1852020|NCT00145600|6400968|P1|Overall Study|Noncompliance|1
1852021|NCT00145600|6400965|P4|Overall Study|Lost to Follow-up|4
1852022|NCT00145600|6400966|P3|Overall Study|Lost to Follow-up|2
1852023|NCT00145600|6400967|P2|Overall Study|Lost to Follow-up|6
1852024|NCT00145600|6400968|P1|Overall Study|Lost to Follow-up|2
1852025|NCT00145600|6400965|P4|Overall Study|Ineligible|5
1852026|NCT00145600|6400966|P3|Overall Study|Ineligible|1
1852027|NCT00145600|6400967|P2|Overall Study|Ineligible|0
1852028|NCT00145600|6400968|P1|Overall Study|Ineligible|3
1852029|NCT00145600|6400965|P4|Overall Study|Death|6
1852030|NCT00145600|6400966|P3|Overall Study|Death|2
1852031|NCT00145600|6400967|P2|Overall Study|Death|2
1852032|NCT00145600|6400968|P1|Overall Study|Death|1
1852033|NCT00145574|6401092|P3|Open Label Long-term Extension|required restricted medicine|1
1852034|NCT00145574|6401093|P2|Open Label Long-term Extension|required restricted medicine|0
1852035|NCT00145574|6401094|P1|Open Label Long-term Extension|required restricted medicine|0
1852036|NCT00145574|6401092|P3|Open Label Long-term Extension|Withdrawal by Subject|4
1852037|NCT00145574|6401093|P2|Open Label Long-term Extension|Withdrawal by Subject|0
1852038|NCT00145574|6401094|P1|Open Label Long-term Extension|Withdrawal by Subject|0
1852039|NCT00145574|6401092|P3|Open Label Long-term Extension|Lost to Follow-up|1
1852040|NCT00145574|6401093|P2|Open Label Long-term Extension|Lost to Follow-up|0
1852041|NCT00145574|6401094|P1|Open Label Long-term Extension|Lost to Follow-up|0
1852042|NCT00145574|6401092|P3|Open Label Long-term Extension|Adverse Event|5
1852043|NCT00145574|6401093|P2|Open Label Long-term Extension|Adverse Event|0
1852044|NCT00145574|6401094|P1|Open Label Long-term Extension|Adverse Event|0
1852045|NCT00145574|6401092|P3|Double Blind|required restricted medicine|0
1852046|NCT00145574|6401093|P2|Double Blind|required restricted medicine|1
1852047|NCT00145574|6401094|P1|Double Blind|required restricted medicine|0
1852048|NCT00145574|6401092|P3|Double Blind|Withdrawal by Subject|1
1852049|NCT00145574|6401093|P2|Double Blind|Withdrawal by Subject|1
1852050|NCT00145574|6401094|P1|Double Blind|Withdrawal by Subject|1
1852051|NCT00145574|6401092|P3|Double Blind|Adverse Event|1
1852052|NCT00145574|6401093|P2|Double Blind|Adverse Event|3
1852053|NCT00145574|6401094|P1|Double Blind|Adverse Event|0
1852054|NCT00145509|6401151|P2|Overall Study|Reason not provided|1
1852055|NCT00145509|6401152|P1|Overall Study|Reason not provided|2
1852056|NCT00145509|6401151|P2|Overall Study|Withdrew Consent|7
1852057|NCT00145509|6401152|P1|Overall Study|Withdrew Consent|2
1852058|NCT00145509|6401151|P2|Overall Study|Lost to Follow-up|9
1852059|NCT00145509|6401152|P1|Overall Study|Lost to Follow-up|5
1852060|NCT00145509|6401151|P2|Overall Study|Lack of Efficacy|1
1852061|NCT00145509|6401152|P1|Overall Study|Lack of Efficacy|3
1852062|NCT00145509|6401151|P2|Overall Study|Adverse Event|3
1852063|NCT00145509|6401152|P1|Overall Study|Adverse Event|10
1852064|NCT00145496|6401166|P2|Overall Study|Other|13
1852065|NCT00145496|6401167|P1|Overall Study|Other|25
1852066|NCT00145496|6401166|P2|Overall Study|Lost to Follow-up|5
1852067|NCT00145496|6401167|P1|Overall Study|Lost to Follow-up|12
1852068|NCT00145496|6401166|P2|Overall Study|Withdrawal by Subject|26
1852069|NCT00145496|6401167|P1|Overall Study|Withdrawal by Subject|32
1852070|NCT00145496|6401166|P2|Overall Study|Lack of Efficacy|7
1852071|NCT00145496|6401167|P1|Overall Study|Lack of Efficacy|12
1852072|NCT00145496|6401166|P2|Overall Study|Adverse Event|30
1852073|NCT00145496|6401167|P1|Overall Study|Adverse Event|42
1852074|NCT00145470|6401179|P2|Overall Study|Reason Not Reported|9
1852075|NCT00145470|6401180|P1|Overall Study|Reason Not Reported|9
1852076|NCT00145470|6401179|P2|Overall Study|Lost to Follow-up|17
1852077|NCT00145470|6401180|P1|Overall Study|Lost to Follow-up|21
1852078|NCT00145470|6401179|P2|Overall Study|Withdrawal by Subject|34
1852079|NCT00145470|6401180|P1|Overall Study|Withdrawal by Subject|36
1852080|NCT00145470|6401179|P2|Overall Study|Lack of Efficacy|13
1852081|NCT00145470|6401180|P1|Overall Study|Lack of Efficacy|27
1852082|NCT00145470|6401179|P2|Overall Study|Adverse Event|25
1852083|NCT00145470|6401180|P1|Overall Study|Adverse Event|19
1852084|NCT00145327|6401250|P3|Overall Study|Missing – not stated|1
1852085|NCT00145327|6401251|P2|Overall Study|Missing – not stated|0
1852086|NCT00145327|6401252|P1|Overall Study|Missing – not stated|1
1852087|NCT00145327|6401250|P3|Overall Study|Abnormal laboratory value(s)|2
1852088|NCT00145327|6401251|P2|Overall Study|Abnormal laboratory value(s)|0
1852089|NCT00145327|6401252|P1|Overall Study|Abnormal laboratory value(s)|1
1852090|NCT00145327|6401250|P3|Overall Study|Protocol Violation|2
1852091|NCT00145327|6401251|P2|Overall Study|Protocol Violation|0
1852092|NCT00145327|6401252|P1|Overall Study|Protocol Violation|2
1852093|NCT00145327|6401250|P3|Overall Study|Administrative problems|13
1852094|NCT00145327|6401251|P2|Overall Study|Administrative problems|9
1852095|NCT00145327|6401252|P1|Overall Study|Administrative problems|12
1852096|NCT00145327|6401250|P3|Overall Study|Lost to Follow-up|14
1852097|NCT00145327|6401251|P2|Overall Study|Lost to Follow-up|14
1852098|NCT00145327|6401252|P1|Overall Study|Lost to Follow-up|9
1852099|NCT00145327|6401250|P3|Overall Study|Adverse Event|22
1852100|NCT00145327|6401251|P2|Overall Study|Adverse Event|11
1852101|NCT00145327|6401252|P1|Overall Study|Adverse Event|14
1852102|NCT00145327|6401250|P3|Overall Study|Death|30
1852103|NCT00145327|6401251|P2|Overall Study|Death|18
1852104|NCT00145327|6401252|P1|Overall Study|Death|26
1852105|NCT00145327|6401250|P3|Overall Study|Withdrawal by Subject|164
1852106|NCT00145327|6401251|P2|Overall Study|Withdrawal by Subject|72
1852107|NCT00145327|6401252|P1|Overall Study|Withdrawal by Subject|77
1852108|NCT00145119|6401351|P1|Overall Study|Death|45
1852109|NCT00144781|6401369|P4|Overall Study|Non-compliant|0
1852110|NCT00144781|6401370|P3|Overall Study|Non-compliant|0
1852111|NCT00144781|6401371|P2|Overall Study|Non-compliant|1
1852112|NCT00144781|6401372|P1|Overall Study|Non-compliant|0
1852113|NCT00144781|6401369|P4|Overall Study|Adverse Event|0
1852114|NCT00144781|6401370|P3|Overall Study|Adverse Event|0
1852115|NCT00144781|6401371|P2|Overall Study|Adverse Event|1
1852116|NCT00144781|6401372|P1|Overall Study|Adverse Event|0
1852117|NCT00144339|6401401|P2|Overall Study|Other|60
1852118|NCT00144339|6401402|P1|Overall Study|Other|58
1852119|NCT00144339|6401401|P2|Overall Study|Lost to Follow-up|64
1852120|NCT00144339|6401402|P1|Overall Study|Lost to Follow-up|76
1852121|NCT00144339|6401401|P2|Overall Study|Withdrawal by Subject|300
1852122|NCT00144339|6401402|P1|Overall Study|Withdrawal by Subject|403
1852123|NCT00144339|6401401|P2|Overall Study|Protocol Violation|48
1852124|NCT00144339|6401402|P1|Overall Study|Protocol Violation|75
1852125|NCT00144339|6401401|P2|Overall Study|Adverse Event|627
1852126|NCT00144339|6401402|P1|Overall Study|Adverse Event|746
1852127|NCT00144300|6401610|P2|Overall Study|Other reason (not specified)|3
1852128|NCT00144300|6401611|P1|Overall Study|Other reason (not specified)|1
1852129|NCT00144300|6401610|P2|Overall Study|Withdrawal by Subject|6
1852130|NCT00144300|6401611|P1|Overall Study|Withdrawal by Subject|6
1852131|NCT00144300|6401610|P2|Overall Study|Lost to Follow-up|0
1852132|NCT00144300|6401611|P1|Overall Study|Lost to Follow-up|3
1852133|NCT00144300|6401610|P2|Overall Study|Protocol Violation|3
1852134|NCT00144300|6401611|P1|Overall Study|Protocol Violation|1
1852135|NCT00144300|6401610|P2|Overall Study|Adverse Event|16
1852136|NCT00144300|6401611|P1|Overall Study|Adverse Event|18
1852137|NCT00144170|6401659|P2|Overall Study|Other reason not defined above|316
1852138|NCT00144170|6401660|P1|Overall Study|Other reason not defined above|211
1852139|NCT00144170|6401659|P2|Overall Study|Withdrawal by Subject|13
1852140|NCT00144170|6401660|P1|Overall Study|Withdrawal by Subject|29
1852141|NCT00144170|6401659|P2|Overall Study|Lost to Follow-up|10
1852142|NCT00144170|6401660|P1|Overall Study|Lost to Follow-up|5
1852143|NCT00144170|6401659|P2|Overall Study|Protocol Violation|16
1852144|NCT00144170|6401660|P1|Overall Study|Protocol Violation|23
1852145|NCT00144170|6401659|P2|Overall Study|Adverse Event|41
1852146|NCT00144170|6401660|P1|Overall Study|Adverse Event|84
1852147|NCT00144027|6401850|P2|Overall Study|did not complete baseline assessment|6
1852148|NCT00144027|6401851|P1|Overall Study|did not complete baseline assessment|0
1852149|NCT00144027|6401850|P2|Overall Study|Withdrawal by Subject|2
1852150|NCT00144027|6401851|P1|Overall Study|Withdrawal by Subject|2
1852151|NCT00144027|6401850|P2|Overall Study|Lost to Follow-up|3
1852152|NCT00144027|6401851|P1|Overall Study|Lost to Follow-up|1
1852153|NCT00143598|6401881|P2|Overall Study|Death|36
1852154|NCT00143598|6401882|P1|Overall Study|Death|36
1852155|NCT00143598|6401881|P2|Overall Study|Withdrawal by Subject|37
1852156|NCT00143598|6401882|P1|Overall Study|Withdrawal by Subject|33
1852157|NCT00143598|6401881|P2|Overall Study|Lost to Follow-up|21
1852158|NCT00143598|6401882|P1|Overall Study|Lost to Follow-up|23
1852159|NCT00143507|6401896|P2|Overall Study|Withdrawn by sponsor's decision|3
1852160|NCT00143507|6401897|P1|Overall Study|Withdrawn by sponsor's decision|0
1852161|NCT00143507|6401896|P2|Overall Study|Lost to Follow-up|0
1852162|NCT00143507|6401897|P1|Overall Study|Lost to Follow-up|1
1852163|NCT00143507|6401896|P2|Overall Study|Withdrawal by Subject|102
1852164|NCT00143507|6401897|P1|Overall Study|Withdrawal by Subject|114
1852165|NCT00143507|6401896|P2|Overall Study|Death|547
1852166|NCT00143507|6401897|P1|Overall Study|Death|572
1852167|NCT00143455|6401931|P4|Cohort 2|Randomized But Not Treated|1
1852168|NCT00143455|6401932|P3|Cohort 2|Randomized But Not Treated|1
1852169|NCT00143455|6401933|P2|Cohort 2|Randomized But Not Treated|0
1852170|NCT00143455|6401934|P1|Cohort 2|Randomized But Not Treated|0
1852171|NCT00143455|6401931|P4|Cohort 2|Other|6
1852172|NCT00143455|6401932|P3|Cohort 2|Other|7
1852173|NCT00143455|6401933|P2|Cohort 2|Other|0
1852174|NCT00143455|6401934|P1|Cohort 2|Other|0
1852175|NCT00143455|6401931|P4|Cohort 2|Withdrawal by Subject|12
1852176|NCT00143455|6401932|P3|Cohort 2|Withdrawal by Subject|13
1852177|NCT00143455|6401933|P2|Cohort 2|Withdrawal by Subject|0
1852178|NCT00143455|6401934|P1|Cohort 2|Withdrawal by Subject|0
1852179|NCT00143455|6401931|P4|Cohort 2|Progressive Disease|27
1852180|NCT00143455|6401932|P3|Cohort 2|Progressive Disease|20
1852181|NCT00143455|6401933|P2|Cohort 2|Progressive Disease|0
1852182|NCT00143455|6401934|P1|Cohort 2|Progressive Disease|0
1852183|NCT00143455|6401931|P4|Cohort 2|Death|12
1852184|NCT00143455|6401932|P3|Cohort 2|Death|20
1852185|NCT00143455|6401933|P2|Cohort 2|Death|0
1852186|NCT00143455|6401934|P1|Cohort 2|Death|0
1852187|NCT00143455|6401931|P4|Cohort 2|Lost to Follow-up|4
1852188|NCT00143455|6401932|P3|Cohort 2|Lost to Follow-up|1
1852189|NCT00143455|6401933|P2|Cohort 2|Lost to Follow-up|0
1852190|NCT00143455|6401934|P1|Cohort 2|Lost to Follow-up|0
1852191|NCT00143455|6401931|P4|Cohort 2|Protocol Violation|1
1852192|NCT00143455|6401932|P3|Cohort 2|Protocol Violation|1
1852193|NCT00143455|6401933|P2|Cohort 2|Protocol Violation|0
1852194|NCT00143455|6401934|P1|Cohort 2|Protocol Violation|0
1852195|NCT00143455|6401931|P4|Cohort 2|No Longer Required Study Treatment|0
1852196|NCT00143455|6401932|P3|Cohort 2|No Longer Required Study Treatment|1
1852197|NCT00143455|6401933|P2|Cohort 2|No Longer Required Study Treatment|0
1852198|NCT00143455|6401934|P1|Cohort 2|No Longer Required Study Treatment|0
1852199|NCT00143455|6401931|P4|Cohort 2|Adverse Event|30
1852200|NCT00143455|6401932|P3|Cohort 2|Adverse Event|42
1852201|NCT00143455|6401933|P2|Cohort 2|Adverse Event|0
1852202|NCT00143455|6401934|P1|Cohort 2|Adverse Event|0
1852203|NCT00143455|6401931|P4|Cohort 1|Randomized But Not Treated|0
1852204|NCT00143455|6401932|P3|Cohort 1|Randomized But Not Treated|0
1852205|NCT00143455|6401933|P2|Cohort 1|Randomized But Not Treated|1
1852206|NCT00143455|6401934|P1|Cohort 1|Randomized But Not Treated|0
1852207|NCT00143455|6401931|P4|Cohort 1|Withdrawal by Subject|0
1852208|NCT00143455|6401932|P3|Cohort 1|Withdrawal by Subject|0
1852209|NCT00143455|6401933|P2|Cohort 1|Withdrawal by Subject|4
1852210|NCT00143455|6401934|P1|Cohort 1|Withdrawal by Subject|1
1852211|NCT00143455|6401931|P4|Cohort 1|Progressive Disease|0
1852212|NCT00143455|6401932|P3|Cohort 1|Progressive Disease|0
1852213|NCT00143455|6401933|P2|Cohort 1|Progressive Disease|6
1852214|NCT00143455|6401934|P1|Cohort 1|Progressive Disease|0
1852215|NCT00143455|6401931|P4|Cohort 1|Death|0
1852216|NCT00143455|6401932|P3|Cohort 1|Death|0
1852217|NCT00143455|6401933|P2|Cohort 1|Death|2
1852218|NCT00143455|6401934|P1|Cohort 1|Death|5
1852219|NCT00143455|6401931|P4|Cohort 1|Adverse Event|0
1852220|NCT00143455|6401932|P3|Cohort 1|Adverse Event|0
1852221|NCT00143455|6401933|P2|Cohort 1|Adverse Event|4
1852222|NCT00143455|6401934|P1|Cohort 1|Adverse Event|8
1852223|NCT00143403|6401968|P2|Overall Study|Randomized Not Treated|8
1852224|NCT00143403|6401969|P1|Overall Study|Randomized Not Treated|7
1852225|NCT00143403|6401968|P2|Overall Study|specified by site|9
1852226|NCT00143403|6401969|P1|Overall Study|specified by site|4
1852227|NCT00143403|6401968|P2|Overall Study|Protocol Violation|2
1852228|NCT00143403|6401969|P1|Overall Study|Protocol Violation|2
1852229|NCT00143403|6401968|P2|Overall Study|Relapse|7
1852230|NCT00143403|6401969|P1|Overall Study|Relapse|15
1852231|NCT00143403|6401968|P2|Overall Study|Withdrawal by Subject|12
1852232|NCT00143403|6401969|P1|Overall Study|Withdrawal by Subject|3
1852233|NCT00143403|6401968|P2|Overall Study|Death|0
1852234|NCT00143403|6401969|P1|Overall Study|Death|1
1852235|NCT00143403|6401968|P2|Overall Study|Adverse Event|8
1852236|NCT00143403|6401969|P1|Overall Study|Adverse Event|3
1852237|NCT00143390|6401979|P2|Overall Study|Other|2
1852238|NCT00143390|6401980|P1|Overall Study|Other|1
1852239|NCT00143390|6401979|P2|Overall Study|Adverse Event|8
1852240|NCT00143390|6401980|P1|Overall Study|Adverse Event|9
1852241|NCT00143390|6401979|P2|Overall Study|Study termination|15
1852242|NCT00143390|6401980|P1|Overall Study|Study termination|10
1852243|NCT00143390|6401979|P2|Overall Study|Protocol Violation|0
1852244|NCT00143390|6401980|P1|Overall Study|Protocol Violation|2
1852245|NCT00143390|6401979|P2|Overall Study|Progressive disease|115
1852246|NCT00143390|6401980|P1|Overall Study|Progressive disease|119
1852247|NCT00143390|6401979|P2|Overall Study|Withdrawal by Subject|4
1852248|NCT00143390|6401980|P1|Overall Study|Withdrawal by Subject|4
1852249|NCT00143390|6401979|P2|Overall Study|Not meeting entry criteria|5
1852250|NCT00143390|6401980|P1|Overall Study|Not meeting entry criteria|2
1852251|NCT00143390|6401979|P2|Overall Study|Death|0
1852252|NCT00143390|6401980|P1|Overall Study|Death|2
1852253|NCT00143312|6401996|P1|Overall Study|Withdrawal by Subject|1
1852254|NCT00143312|6401996|P1|Overall Study|Other|1
1852255|NCT00143312|6401996|P1|Overall Study|Lost to Follow-up|1
1852256|NCT00143312|6401996|P1|Overall Study|Adverse Event|2
1852257|NCT00143312|6401996|P1|Overall Study|Death|11
1852258|NCT00143247|6402006|P1|Overall Study|Other|12
1852259|NCT00143247|6402006|P1|Overall Study|following inaccurate lab adverse event|1
1852260|NCT00143247|6402006|P1|Overall Study|Lost to Follow-up|12
1852261|NCT00143247|6402006|P1|Overall Study|Protocol Violation|15
1852262|NCT00143247|6402006|P1|Overall Study|Study terminated by sponsor|31
1852263|NCT00143247|6402006|P1|Overall Study|Withdrawal by Subject|55
1852264|NCT00143247|6402006|P1|Overall Study|Lack of Efficacy|3
1852265|NCT00143247|6402006|P1|Overall Study|Adverse Event|19
1852266|NCT00143247|6402006|P1|Overall Study|Death|8
1852267|NCT00142935|6402023|P3|Overall Study|Death|1
1852268|NCT00142935|6402024|P2|Overall Study|Death|2
1852269|NCT00142935|6402025|P1|Overall Study|Death|0
1852270|NCT00142935|6402023|P3|Overall Study|Lost to Follow-up|5
1852271|NCT00142935|6402024|P2|Overall Study|Lost to Follow-up|5
1852272|NCT00142935|6402025|P1|Overall Study|Lost to Follow-up|2
1852273|NCT00142935|6402023|P3|Overall Study|Other reason|1
1852274|NCT00142935|6402024|P2|Overall Study|Other reason|1
1852275|NCT00142935|6402025|P1|Overall Study|Other reason|1
1852276|NCT00142909|6402050|P2|Medications Begin|Withdrawal by Subject|0
1852277|NCT00142909|6402051|P1|Medications Begin|Withdrawal by Subject|2
1852278|NCT00142909|6402050|P2|Medications Begin|Withdrawal by Subject|3
1852279|NCT00142909|6402051|P1|Medications Begin|Withdrawal by Subject|5
1852280|NCT00142909|6402050|P2|Medications Begin|Protocol Violation|0
1852281|NCT00142909|6402051|P1|Medications Begin|Protocol Violation|2
1852282|NCT00142909|6402050|P2|Randomization|Various Reasons|10
1852283|NCT00142909|6402051|P1|Randomization|Various Reasons|7
1852284|NCT00142792|6402087|P3|Overall Study|No category|1
1852285|NCT00142792|6402088|P2|Overall Study|No category|2
1852286|NCT00142792|6402089|P1|Overall Study|No category|1
1852287|NCT00142792|6402087|P3|Overall Study|Lost to Follow-up|7
1852288|NCT00142792|6402088|P2|Overall Study|Lost to Follow-up|11
1852289|NCT00142792|6402089|P1|Overall Study|Lost to Follow-up|8
1852290|NCT00142792|6402087|P3|Overall Study|Withdrawal by Subject|3
1852291|NCT00142792|6402088|P2|Overall Study|Withdrawal by Subject|2
1852292|NCT00142792|6402089|P1|Overall Study|Withdrawal by Subject|3
1852293|NCT00142792|6402087|P3|Overall Study|Death|1
1852294|NCT00142792|6402088|P2|Overall Study|Death|0
1852295|NCT00142792|6402089|P1|Overall Study|Death|0
1852296|NCT00142519|6402111|P2|Overall Study|Withdrawal by Subject|7
1852297|NCT00142519|6402112|P1|Overall Study|Withdrawal by Subject|10
1852298|NCT00142519|6402111|P2|Overall Study|Protocol Violation|0
1852299|NCT00142519|6402112|P1|Overall Study|Protocol Violation|1
1852300|NCT00142519|6402111|P2|Overall Study|Not Treated|9
1852301|NCT00142519|6402112|P1|Overall Study|Not Treated|7
1852302|NCT00142415|6402135|P6|Overall Study|Physician Decision|2
1852303|NCT00142415|6402136|P5|Overall Study|Physician Decision|1
1852304|NCT00142415|6402137|P4|Overall Study|Physician Decision|0
1852305|NCT00142415|6402138|P3|Overall Study|Physician Decision|0
1852306|NCT00142415|6402139|P2|Overall Study|Physician Decision|0
1852307|NCT00142415|6402140|P1|Overall Study|Physician Decision|0
1852308|NCT00142298|6402178|P10|Overall Study|Treatment Failure|0
1852309|NCT00142298|6402179|P9|Overall Study|Treatment Failure|0
1852310|NCT00142298|6402180|P8|Overall Study|Treatment Failure|0
1852311|NCT00142298|6402181|P7|Overall Study|Treatment Failure|2
1852312|NCT00142298|6402182|P6|Overall Study|Treatment Failure|2
1852313|NCT00142298|6402183|P5|Overall Study|Treatment Failure|0
1852314|NCT00142298|6402184|P4|Overall Study|Treatment Failure|0
1852315|NCT00142298|6402185|P3|Overall Study|Treatment Failure|0
1852316|NCT00142298|6402186|P2|Overall Study|Treatment Failure|0
1852317|NCT00142298|6402187|P1|Overall Study|Treatment Failure|0
1852318|NCT00142298|6402178|P10|Overall Study|Lost to Follow-up|0
1852319|NCT00142298|6402179|P9|Overall Study|Lost to Follow-up|0
1852320|NCT00142298|6402180|P8|Overall Study|Lost to Follow-up|0
1852321|NCT00142298|6402181|P7|Overall Study|Lost to Follow-up|2
1852322|NCT00142298|6402182|P6|Overall Study|Lost to Follow-up|0
1852323|NCT00142298|6402183|P5|Overall Study|Lost to Follow-up|0
1852324|NCT00142298|6402184|P4|Overall Study|Lost to Follow-up|0
1852325|NCT00142298|6402185|P3|Overall Study|Lost to Follow-up|0
1852326|NCT00142298|6402186|P2|Overall Study|Lost to Follow-up|0
1852327|NCT00142298|6402187|P1|Overall Study|Lost to Follow-up|0
1852328|NCT00142298|6402178|P10|Overall Study|Other- not specified|0
1852329|NCT00142298|6402179|P9|Overall Study|Other- not specified|0
1852330|NCT00142298|6402180|P8|Overall Study|Other- not specified|0
1852331|NCT00142298|6402181|P7|Overall Study|Other- not specified|0
1852332|NCT00142298|6402182|P6|Overall Study|Other- not specified|0
1852333|NCT00142298|6402183|P5|Overall Study|Other- not specified|0
1852334|NCT00142298|6402184|P4|Overall Study|Other- not specified|1
1852335|NCT00142298|6402185|P3|Overall Study|Other- not specified|0
1852336|NCT00142298|6402186|P2|Overall Study|Other- not specified|3
1852337|NCT00142298|6402187|P1|Overall Study|Other- not specified|0
1852338|NCT00142298|6402178|P10|Overall Study|Virologic breakthrough|0
1852339|NCT00142298|6402179|P9|Overall Study|Virologic breakthrough|0
1852340|NCT00142298|6402180|P8|Overall Study|Virologic breakthrough|0
1852341|NCT00142298|6402181|P7|Overall Study|Virologic breakthrough|3
1852342|NCT00142298|6402182|P6|Overall Study|Virologic breakthrough|3
1852343|NCT00142298|6402183|P5|Overall Study|Virologic breakthrough|2
1852344|NCT00142298|6402184|P4|Overall Study|Virologic breakthrough|7
1852345|NCT00142298|6402185|P3|Overall Study|Virologic breakthrough|9
1852346|NCT00142298|6402186|P2|Overall Study|Virologic breakthrough|23
1852347|NCT00142298|6402187|P1|Overall Study|Virologic breakthrough|19
1852348|NCT00142298|6402178|P10|Overall Study|Pregnancy|0
1852349|NCT00142298|6402179|P9|Overall Study|Pregnancy|1
1852350|NCT00142298|6402180|P8|Overall Study|Pregnancy|0
1852351|NCT00142298|6402181|P7|Overall Study|Pregnancy|0
1852352|NCT00142298|6402182|P6|Overall Study|Pregnancy|0
1852353|NCT00142298|6402183|P5|Overall Study|Pregnancy|0
1852354|NCT00142298|6402184|P4|Overall Study|Pregnancy|3
1852355|NCT00142298|6402185|P3|Overall Study|Pregnancy|2
1852356|NCT00142298|6402186|P2|Overall Study|Pregnancy|4
1852357|NCT00142298|6402187|P1|Overall Study|Pregnancy|4
1852358|NCT00142298|6402178|P10|Overall Study|Patient, Investigator,or Sponsor request|0
1852359|NCT00142298|6402179|P9|Overall Study|Patient, Investigator,or Sponsor request|1
1852360|NCT00142298|6402180|P8|Overall Study|Patient, Investigator,or Sponsor request|4
1852361|NCT00142298|6402181|P7|Overall Study|Patient, Investigator,or Sponsor request|1
1852362|NCT00142298|6402182|P6|Overall Study|Patient, Investigator,or Sponsor request|3
1852363|NCT00142298|6402183|P5|Overall Study|Patient, Investigator,or Sponsor request|4
1852364|NCT00142298|6402184|P4|Overall Study|Patient, Investigator,or Sponsor request|51
1852365|NCT00142298|6402185|P3|Overall Study|Patient, Investigator,or Sponsor request|11
1852366|NCT00142298|6402186|P2|Overall Study|Patient, Investigator,or Sponsor request|60
1852367|NCT00142298|6402187|P1|Overall Study|Patient, Investigator,or Sponsor request|66
1852368|NCT00142298|6402178|P10|Overall Study|Non-compliance|0
1852369|NCT00142298|6402179|P9|Overall Study|Non-compliance|3
1852370|NCT00142298|6402180|P8|Overall Study|Non-compliance|3
1852371|NCT00142298|6402181|P7|Overall Study|Non-compliance|0
1852372|NCT00142298|6402182|P6|Overall Study|Non-compliance|0
1852373|NCT00142298|6402183|P5|Overall Study|Non-compliance|1
1852374|NCT00142298|6402184|P4|Overall Study|Non-compliance|6
1852375|NCT00142298|6402185|P3|Overall Study|Non-compliance|0
1852376|NCT00142298|6402186|P2|Overall Study|Non-compliance|13
1852377|NCT00142298|6402187|P1|Overall Study|Non-compliance|15
1852378|NCT00142298|6402178|P10|Overall Study|Lack of Efficacy|0
1852379|NCT00142298|6402179|P9|Overall Study|Lack of Efficacy|0
1852380|NCT00142298|6402180|P8|Overall Study|Lack of Efficacy|1
1852381|NCT00142298|6402181|P7|Overall Study|Lack of Efficacy|0
1852382|NCT00142298|6402182|P6|Overall Study|Lack of Efficacy|0
1852383|NCT00142298|6402183|P5|Overall Study|Lack of Efficacy|1
1852384|NCT00142298|6402184|P4|Overall Study|Lack of Efficacy|12
1852385|NCT00142298|6402185|P3|Overall Study|Lack of Efficacy|9
1852386|NCT00142298|6402186|P2|Overall Study|Lack of Efficacy|62
1852387|NCT00142298|6402187|P1|Overall Study|Lack of Efficacy|44
1852388|NCT00142298|6402178|P10|Overall Study|Death|0
1852389|NCT00142298|6402179|P9|Overall Study|Death|0
1852390|NCT00142298|6402180|P8|Overall Study|Death|0
1852391|NCT00142298|6402181|P7|Overall Study|Death|0
1852392|NCT00142298|6402182|P6|Overall Study|Death|6
1852393|NCT00142298|6402183|P5|Overall Study|Death|0
1852394|NCT00142298|6402184|P4|Overall Study|Death|0
1852395|NCT00142298|6402185|P3|Overall Study|Death|1
1852396|NCT00142298|6402186|P2|Overall Study|Death|1
1852397|NCT00142298|6402187|P1|Overall Study|Death|1
1852398|NCT00142298|6402178|P10|Overall Study|Clinical disease progression|0
1852399|NCT00142298|6402179|P9|Overall Study|Clinical disease progression|0
1852400|NCT00142298|6402180|P8|Overall Study|Clinical disease progression|0
1852401|NCT00142298|6402181|P7|Overall Study|Clinical disease progression|0
1852402|NCT00142298|6402182|P6|Overall Study|Clinical disease progression|0
1852403|NCT00142298|6402183|P5|Overall Study|Clinical disease progression|0
1852404|NCT00142298|6402184|P4|Overall Study|Clinical disease progression|0
1852405|NCT00142298|6402185|P3|Overall Study|Clinical disease progression|0
1852406|NCT00142298|6402186|P2|Overall Study|Clinical disease progression|0
1852407|NCT00142298|6402187|P1|Overall Study|Clinical disease progression|1
1852408|NCT00142298|6402178|P10|Overall Study|Adverse Event|0
1852409|NCT00142298|6402179|P9|Overall Study|Adverse Event|0
1852410|NCT00142298|6402180|P8|Overall Study|Adverse Event|0
1852411|NCT00142298|6402181|P7|Overall Study|Adverse Event|0
1852412|NCT00142298|6402182|P6|Overall Study|Adverse Event|2
1852413|NCT00142298|6402183|P5|Overall Study|Adverse Event|2
1852414|NCT00142298|6402184|P4|Overall Study|Adverse Event|5
1852415|NCT00142298|6402185|P3|Overall Study|Adverse Event|1
1852416|NCT00142298|6402186|P2|Overall Study|Adverse Event|10
1852417|NCT00142298|6402187|P1|Overall Study|Adverse Event|10
1852418|NCT00141921|6402221|P1|Overall Study|Other|8
1852419|NCT00141921|6402221|P1|Overall Study|Ineligibility Determined|2
1852420|NCT00141921|6402221|P1|Overall Study|Pregnancy|4
1852421|NCT00141921|6402221|P1|Overall Study|Administrative Decision|2
1852422|NCT00141921|6402221|P1|Overall Study|Adverse Event|5
1852423|NCT00141921|6402221|P1|Overall Study|Protocol Deviation|7
1852424|NCT00141921|6402221|P1|Overall Study|Disease Progression|7
1852425|NCT00141921|6402221|P1|Overall Study|Noncompliance|17
1852426|NCT00141921|6402221|P1|Overall Study|Lost to Follow-up|19
1852427|NCT00141921|6402221|P1|Overall Study|Withdrawal by Subject|42
1852428|NCT00141921|6402221|P1|Overall Study|Remain on Study|28
1852429|NCT00141817|6402247|P4|Overall Study|Parent request|0
1852430|NCT00141817|6402248|P3|Overall Study|Parent request|0
1852431|NCT00141817|6402249|P2|Overall Study|Parent request|0
1852432|NCT00141817|6402250|P1|Overall Study|Parent request|1
1852433|NCT00141817|6402247|P4|Overall Study|Protocol Violation|0
1852434|NCT00141817|6402248|P3|Overall Study|Protocol Violation|1
1852435|NCT00141817|6402249|P2|Overall Study|Protocol Violation|0
1852436|NCT00141817|6402250|P1|Overall Study|Protocol Violation|0
1852437|NCT00141778|6402291|P3|Started Study Medication|Chest Discomfort|1
1852438|NCT00141778|6402292|P2|Started Study Medication|Chest Discomfort|0
1852439|NCT00141778|6402293|P1|Started Study Medication|Chest Discomfort|0
1852440|NCT00141778|6402291|P3|Started Study Medication|Difficulty Swallowing|0
1852441|NCT00141778|6402292|P2|Started Study Medication|Difficulty Swallowing|1
1852442|NCT00141778|6402293|P1|Started Study Medication|Difficulty Swallowing|0
1852443|NCT00141778|6402291|P3|Started Study Medication|Withdrawal by Subject|0
1852444|NCT00141778|6402292|P2|Started Study Medication|Withdrawal by Subject|2
1852445|NCT00141778|6402293|P1|Started Study Medication|Withdrawal by Subject|0
1852446|NCT00141778|6402291|P3|Started Study Medication|Met safety criteria for discontinuation|3
1852447|NCT00141778|6402292|P2|Started Study Medication|Met safety criteria for discontinuation|4
1852448|NCT00141778|6402293|P1|Started Study Medication|Met safety criteria for discontinuation|2
1852449|NCT00141778|6402291|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
1852450|NCT00141778|6402292|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
1852451|NCT00141778|6402293|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
1852452|NCT00141726|6402346|P1|Overall Study|Completed <50% Scheduled Dosing|3
1852453|NCT00141518|6402354|P3|Overall Study|Lack of Efficacy|0
1852454|NCT00141518|6402355|P2|Overall Study|Lack of Efficacy|0
1852455|NCT00141518|6402356|P1|Overall Study|Lack of Efficacy|5
1852456|NCT00141518|6402354|P3|Overall Study|Protocol Violation|2
1852457|NCT00141518|6402355|P2|Overall Study|Protocol Violation|1
1852458|NCT00141518|6402356|P1|Overall Study|Protocol Violation|1
1852459|NCT00141518|6402354|P3|Overall Study|Withdrawal by Subject|2
1852460|NCT00141518|6402355|P2|Overall Study|Withdrawal by Subject|0
1852461|NCT00141518|6402356|P1|Overall Study|Withdrawal by Subject|2
1852462|NCT00141518|6402354|P3|Overall Study|Adverse Event|2
1852463|NCT00141518|6402355|P2|Overall Study|Adverse Event|5
1852464|NCT00141518|6402356|P1|Overall Study|Adverse Event|7
1852465|NCT00141518|6402354|P3|Overall Study|Withdrew Consent Prior to Treatment|0
1852466|NCT00141518|6402355|P2|Overall Study|Withdrew Consent Prior to Treatment|0
1852467|NCT00141518|6402356|P1|Overall Study|Withdrew Consent Prior to Treatment|1
1852468|NCT00141453|6402545|P2|Overall Study|Protocol Violation|5
1852469|NCT00141453|6402546|P1|Overall Study|Protocol Violation|6
1852470|NCT00141297|6402560|P10|Overall Study|Transitioned|0
1852471|NCT00141297|6402561|P9|Overall Study|Transitioned|0
1852472|NCT00141297|6402562|P8|Overall Study|Transitioned|0
1852473|NCT00141297|6402563|P7|Overall Study|Transitioned|0
1852474|NCT00141297|6402564|P6|Overall Study|Transitioned|0
1852475|NCT00141297|6402565|P5|Overall Study|Transitioned|1
1852476|NCT00141297|6402566|P4|Overall Study|Transitioned|0
1852477|NCT00141297|6402567|P3|Overall Study|Transitioned|0
1852478|NCT00141297|6402568|P2|Overall Study|Transitioned|0
1852479|NCT00141297|6402569|P1|Overall Study|Transitioned|0
1852480|NCT00141297|6402560|P10|Overall Study|Progressive Disease|6
1852481|NCT00141297|6402561|P9|Overall Study|Progressive Disease|15
1852482|NCT00141297|6402562|P8|Overall Study|Progressive Disease|3
1852483|NCT00141297|6402563|P7|Overall Study|Progressive Disease|3
1852484|NCT00141297|6402564|P6|Overall Study|Progressive Disease|2
1852485|NCT00141297|6402565|P5|Overall Study|Progressive Disease|15
1852486|NCT00141297|6402566|P4|Overall Study|Progressive Disease|2
1852487|NCT00141297|6402567|P3|Overall Study|Progressive Disease|6
1852488|NCT00141297|6402568|P2|Overall Study|Progressive Disease|3
1852489|NCT00141297|6402569|P1|Overall Study|Progressive Disease|2
1852490|NCT00141297|6402560|P10|Overall Study|Other|0
1852491|NCT00141297|6402561|P9|Overall Study|Other|2
1852492|NCT00141297|6402562|P8|Overall Study|Other|0
1852493|NCT00141297|6402563|P7|Overall Study|Other|0
1852494|NCT00141297|6402564|P6|Overall Study|Other|0
1852495|NCT00141297|6402565|P5|Overall Study|Other|5
1852496|NCT00141297|6402566|P4|Overall Study|Other|1
1852497|NCT00141297|6402567|P3|Overall Study|Other|0
1852498|NCT00141297|6402568|P2|Overall Study|Other|0
1852499|NCT00141297|6402569|P1|Overall Study|Other|0
1852500|NCT00141297|6402560|P10|Overall Study|Withdrawal by Subject|0
1852501|NCT00141297|6402561|P9|Overall Study|Withdrawal by Subject|1
1852502|NCT00141297|6402562|P8|Overall Study|Withdrawal by Subject|0
1852503|NCT00141297|6402563|P7|Overall Study|Withdrawal by Subject|0
1852504|NCT00141297|6402564|P6|Overall Study|Withdrawal by Subject|0
1852505|NCT00141297|6402565|P5|Overall Study|Withdrawal by Subject|0
1852506|NCT00141297|6402566|P4|Overall Study|Withdrawal by Subject|0
1852507|NCT00141297|6402567|P3|Overall Study|Withdrawal by Subject|0
1852508|NCT00141297|6402568|P2|Overall Study|Withdrawal by Subject|0
1852509|NCT00141297|6402569|P1|Overall Study|Withdrawal by Subject|0
1852510|NCT00141297|6402560|P10|Overall Study|Death|0
1852511|NCT00141297|6402561|P9|Overall Study|Death|1
1852512|NCT00141297|6402562|P8|Overall Study|Death|0
1852513|NCT00141297|6402563|P7|Overall Study|Death|0
1852514|NCT00141297|6402564|P6|Overall Study|Death|0
1852515|NCT00141297|6402565|P5|Overall Study|Death|0
1852516|NCT00141297|6402566|P4|Overall Study|Death|0
1852517|NCT00141297|6402567|P3|Overall Study|Death|0
1852518|NCT00141297|6402568|P2|Overall Study|Death|0
1852519|NCT00141297|6402569|P1|Overall Study|Death|1
1852520|NCT00141297|6402560|P10|Overall Study|Adverse Event|0
1852521|NCT00141297|6402561|P9|Overall Study|Adverse Event|1
1852522|NCT00141297|6402562|P8|Overall Study|Adverse Event|1
1852523|NCT00141297|6402563|P7|Overall Study|Adverse Event|0
1852524|NCT00141297|6402564|P6|Overall Study|Adverse Event|1
1852525|NCT00141297|6402565|P5|Overall Study|Adverse Event|1
1852526|NCT00141297|6402566|P4|Overall Study|Adverse Event|0
1852527|NCT00141297|6402567|P3|Overall Study|Adverse Event|1
1852528|NCT00141297|6402568|P2|Overall Study|Adverse Event|0
1852529|NCT00141297|6402569|P1|Overall Study|Adverse Event|0
1852530|NCT00141271|6402847|P3|Overall Study|Other|5
1852531|NCT00141271|6402848|P2|Overall Study|Other|12
1852532|NCT00141271|6402849|P1|Overall Study|Other|11
1852533|NCT00141271|6402847|P3|Overall Study|Withdrawal by Subject|10
1852534|NCT00141271|6402848|P2|Overall Study|Withdrawal by Subject|9
1852535|NCT00141271|6402849|P1|Overall Study|Withdrawal by Subject|14
1852536|NCT00141271|6402847|P3|Overall Study|Lost to Follow-up|21
1852537|NCT00141271|6402848|P2|Overall Study|Lost to Follow-up|15
1852538|NCT00141271|6402849|P1|Overall Study|Lost to Follow-up|15
1852539|NCT00141271|6402847|P3|Overall Study|Lack of Efficacy|3
1852540|NCT00141271|6402848|P2|Overall Study|Lack of Efficacy|7
1852541|NCT00141271|6402849|P1|Overall Study|Lack of Efficacy|7
1852542|NCT00141271|6402847|P3|Overall Study|Laboratory Abnormality|1
1852543|NCT00141271|6402848|P2|Overall Study|Laboratory Abnormality|1
1852544|NCT00141271|6402849|P1|Overall Study|Laboratory Abnormality|2
1852545|NCT00141271|6402847|P3|Overall Study|Adverse Event|17
1852546|NCT00141271|6402848|P2|Overall Study|Adverse Event|19
1852547|NCT00141271|6402849|P1|Overall Study|Adverse Event|31
1852548|NCT00141219|6402970|P2|Overall Study|Withdrawal by Subject|2
1852549|NCT00141219|6402971|P1|Overall Study|Withdrawal by Subject|6
1852550|NCT00141219|6402970|P2|Overall Study|Lack of Efficacy|4
1852551|NCT00141219|6402971|P1|Overall Study|Lack of Efficacy|5
1852552|NCT00141219|6402970|P2|Overall Study|Adverse Event|6
1852553|NCT00141219|6402971|P1|Overall Study|Adverse Event|8
1852554|NCT00141219|6402970|P2|Overall Study|Protocol violations|4
1852555|NCT00141219|6402971|P1|Overall Study|Protocol violations|5
1852556|NCT00141102|6403028|P2|Overall Study|Death|2
1852557|NCT00141102|6403029|P1|Overall Study|Death|2
1852558|NCT00141102|6403028|P2|Overall Study|Randomized But Did Not Receive Treatment|9
1852559|NCT00141102|6403029|P1|Overall Study|Randomized But Did Not Receive Treatment|15
1852560|NCT00141102|6403028|P2|Overall Study|Withdrawal by Subject|142
1852561|NCT00141102|6403029|P1|Overall Study|Withdrawal by Subject|112
1852562|NCT00141102|6403028|P2|Overall Study|Other|76
1852563|NCT00141102|6403029|P1|Overall Study|Other|87
1852564|NCT00141102|6403028|P2|Overall Study|Lost to Follow-up|32
1852565|NCT00141102|6403029|P1|Overall Study|Lost to Follow-up|29
1852566|NCT00141102|6403028|P2|Overall Study|Lack of Efficacy|26
1852567|NCT00141102|6403029|P1|Overall Study|Lack of Efficacy|21
1852568|NCT00141102|6403028|P2|Overall Study|Laboratory Abnormality|33
1852569|NCT00141102|6403029|P1|Overall Study|Laboratory Abnormality|9
1852570|NCT00141102|6403028|P2|Overall Study|Adverse Event|305
1852571|NCT00141102|6403029|P1|Overall Study|Adverse Event|233
1852572|NCT00141037|6403069|P2|Overall Study|Graft Failure|4
1852573|NCT00141037|6403070|P1|Overall Study|Graft Failure|3
1852574|NCT00141037|6403069|P2|Overall Study|Moved from area|7
1852575|NCT00141037|6403070|P1|Overall Study|Moved from area|1
1852576|NCT00141037|6403069|P2|Overall Study|Other|1
1852577|NCT00141037|6403070|P1|Overall Study|Other|0
1852578|NCT00141037|6403069|P2|Overall Study|Withdrawal by Subject|1
1852579|NCT00141037|6403070|P1|Overall Study|Withdrawal by Subject|2
1852580|NCT00141037|6403069|P2|Overall Study|Protocol Violation|2
1852581|NCT00141037|6403070|P1|Overall Study|Protocol Violation|0
1852582|NCT00141037|6403069|P2|Overall Study|Lost to Follow-up|1
1852583|NCT00141037|6403070|P1|Overall Study|Lost to Follow-up|3
1852584|NCT00141037|6403069|P2|Overall Study|Physician Decision|2
1852585|NCT00141037|6403070|P1|Overall Study|Physician Decision|1
1852586|NCT00140426|6403105|P2|Overall Study|Withdrawal by Subject|3
1852587|NCT00140426|6403106|P1|Overall Study|Withdrawal by Subject|0
1852588|NCT00140413|6403139|P2|Overall Study|Withdrawal by Subject|0
1852589|NCT00140413|6403140|P1|Overall Study|Withdrawal by Subject|2
1852590|NCT00140413|6403139|P2|Overall Study|Lost to Follow-up|0
1852591|NCT00140413|6403140|P1|Overall Study|Lost to Follow-up|1
1852592|NCT00140140|6403271|P3|Overall Study|Physician Decision|0
1852593|NCT00140140|6403272|P2|Overall Study|Physician Decision|1
1852594|NCT00140140|6403273|P1|Overall Study|Physician Decision|1
1852595|NCT00140140|6403271|P3|Overall Study|Unacceptable toxicity|2
1852596|NCT00140140|6403272|P2|Overall Study|Unacceptable toxicity|1
1852597|NCT00140140|6403273|P1|Overall Study|Unacceptable toxicity|1
1852598|NCT00139776|6403323|P4|Period III|Withdrawal by Subject|21
1852599|NCT00139776|6403324|P3|Period III|Withdrawal by Subject|16
1852600|NCT00139776|6403325|P2|Period III|Withdrawal by Subject|0
1852601|NCT00139776|6403326|P1|Period III|Withdrawal by Subject|0
1852602|NCT00139776|6403323|P4|Period III|Lost to Follow-up|4
1852603|NCT00139776|6403324|P3|Period III|Lost to Follow-up|5
1852604|NCT00139776|6403325|P2|Period III|Lost to Follow-up|0
1852605|NCT00139776|6403326|P1|Period III|Lost to Follow-up|0
1852606|NCT00139776|6403323|P4|Period III|Lack of Efficacy|24
1852607|NCT00139776|6403324|P3|Period III|Lack of Efficacy|10
1852608|NCT00139776|6403325|P2|Period III|Lack of Efficacy|0
1852609|NCT00139776|6403326|P1|Period III|Lack of Efficacy|0
1852610|NCT00139776|6403323|P4|Period III|Other|34
1852611|NCT00139776|6403324|P3|Period III|Other|23
1852612|NCT00139776|6403325|P2|Period III|Other|0
1852613|NCT00139776|6403326|P1|Period III|Other|0
1852614|NCT00139776|6403323|P4|Period III|Adverse Event|23
1852615|NCT00139776|6403324|P3|Period III|Adverse Event|22
1852616|NCT00139776|6403325|P2|Period III|Adverse Event|0
1852617|NCT00139776|6403326|P1|Period III|Adverse Event|0
1852618|NCT00139776|6403323|P4|Period II|Not Randomized into Period III|0
1852619|NCT00139776|6403324|P3|Period II|Not Randomized into Period III|0
1852620|NCT00139776|6403325|P2|Period II|Not Randomized into Period III|322
1852621|NCT00139776|6403326|P1|Period II|Not Randomized into Period III|0
1852622|NCT00139776|6403323|P4|Period I|Did not enter Period II|0
1852623|NCT00139776|6403324|P3|Period I|Did not enter Period II|0
1852624|NCT00139776|6403325|P2|Period I|Did not enter Period II|0
1852625|NCT00139776|6403326|P1|Period I|Did not enter Period II|575
1852626|NCT00139737|6403361|P1|Overall Study|Screened, Not Treated|13
1852627|NCT00139737|6403361|P1|Overall Study|Did Not Meet Entrance Criteria|1
1852628|NCT00139737|6403361|P1|Overall Study|Withdrew During Screening Phase|8
1852629|NCT00139737|6403361|P1|Overall Study|Protocol Violation|18
1852630|NCT00139737|6403361|P1|Overall Study|Laboratory Abnormality|2
1852631|NCT00139737|6403361|P1|Overall Study|Death|3
1852632|NCT00139737|6403361|P1|Overall Study|Lost to Follow-up|8
1852633|NCT00139737|6403361|P1|Overall Study|Lack of Efficacy|40
1852634|NCT00139737|6403361|P1|Overall Study|Adverse Event|58
1852635|NCT00139737|6403361|P1|Overall Study|Withdrawal by Subject|190
1852636|NCT00139659|6403367|P2|Overall Study|Withdrawal by Subject|10
1852637|NCT00139659|6403368|P1|Overall Study|Withdrawal by Subject|14
1852638|NCT00139659|6403367|P2|Overall Study|Reason not Specified|3
1852639|NCT00139659|6403368|P1|Overall Study|Reason not Specified|6
1852640|NCT00139659|6403367|P2|Overall Study|Lost to Follow-up|3
1852641|NCT00139659|6403368|P1|Overall Study|Lost to Follow-up|7
1852642|NCT00139659|6403367|P2|Overall Study|Lack of Efficacy|1
1852643|NCT00139659|6403368|P1|Overall Study|Lack of Efficacy|1
1852644|NCT00139659|6403367|P2|Overall Study|Adverse Event|1
1852645|NCT00139659|6403368|P1|Overall Study|Adverse Event|12
1852646|NCT00139477|6403446|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
1852647|NCT00139477|6403447|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
1852648|NCT00139477|6403446|P2|Second Intervention -6Months to 12Months|Relocation|0
1852649|NCT00139477|6403447|P1|Second Intervention -6Months to 12Months|Relocation|1
1852650|NCT00139477|6403446|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
1852651|NCT00139477|6403447|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
1852652|NCT00139477|6403446|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
1852653|NCT00139477|6403447|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
1852654|NCT00139477|6403446|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1852655|NCT00139477|6403447|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
1852656|NCT00139477|6403446|P2|First Intervention -Baseline to 6Months|Relocation|2
1852657|NCT00139477|6403447|P1|First Intervention -Baseline to 6Months|Relocation|1
1852658|NCT00139477|6403446|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
1852659|NCT00139477|6403447|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
1852660|NCT00138671|6403482|P2|Overall Study|Other|3
1852661|NCT00138671|6403483|P1|Overall Study|Other|3
1852662|NCT00138671|6403482|P2|Overall Study|Withdrawal by Subject|5
1852663|NCT00138671|6403483|P1|Overall Study|Withdrawal by Subject|3
1852664|NCT00138671|6403482|P2|Overall Study|Lost to Follow-up|2
1852665|NCT00138671|6403483|P1|Overall Study|Lost to Follow-up|1
1852666|NCT00138671|6403482|P2|Overall Study|Adverse Event|3
1852667|NCT00138671|6403483|P1|Overall Study|Adverse Event|6
1852668|NCT00138671|6403482|P2|Overall Study|Death|3
1852669|NCT00138671|6403483|P1|Overall Study|Death|0
1852670|NCT00138658|6403533|P1|Overall Study|Withdrawal by Subject|5
1852671|NCT00138658|6403533|P1|Overall Study|Physician Decision|11
1852672|NCT00138658|6403533|P1|Overall Study|Disease Progression|21
1852673|NCT00138658|6403533|P1|Overall Study|Death|1
1852674|NCT00138658|6403533|P1|Overall Study|Adverse Event|23
1852675|NCT00138424|6403556|P4|Overall Study|Physician Decision|0
1852676|NCT00138424|6403557|P3|Overall Study|Physician Decision|0
1852677|NCT00138424|6403558|P2|Overall Study|Physician Decision|1
1852678|NCT00138424|6403559|P1|Overall Study|Physician Decision|0
1852679|NCT00138151|6403642|P1|Overall Study|Physician Decision|1
1852680|NCT00138151|6403642|P1|Overall Study|Withdrawal by Subject|3
1852681|NCT00138073|6403652|P1|Overall Study|lack of resources|55
1852682|NCT00137839|6403691|P1|Overall Study|Prolonged Treatment Delay|1
1852683|NCT00137839|6403691|P1|Overall Study|Not Start Treatment|1
1852684|NCT00137839|6403691|P1|Overall Study|Disease Progression|60
1852685|NCT00137839|6403691|P1|Overall Study|Death|8
1852686|NCT00137839|6403691|P1|Overall Study|Physician Decision|7
1852687|NCT00137839|6403691|P1|Overall Study|Adverse Event|7
1852688|NCT00137631|6403704|P2|Overall Study|Lost to Follow-up|41
1852689|NCT00137631|6403705|P1|Overall Study|Lost to Follow-up|37
1852690|NCT00137449|6403721|P2|Overall Study|Withdrawal by Subject|1
1852691|NCT00137449|6403722|P1|Overall Study|Withdrawal by Subject|1
1852692|NCT00137449|6403721|P2|Overall Study|Adverse Event|1
1852693|NCT00137449|6403722|P1|Overall Study|Adverse Event|3
1852694|NCT00137449|6403721|P2|Overall Study|Death|3
1852695|NCT00137449|6403722|P1|Overall Study|Death|4
1852696|NCT00137449|6403721|P2|Overall Study|Disease Progression|13
1852697|NCT00137449|6403722|P1|Overall Study|Disease Progression|8
1852698|NCT00137436|6403759|P1|Overall Study|Other|5
1852699|NCT00137436|6403759|P1|Overall Study|Withdrawal by Subject|6
1852700|NCT00137436|6403759|P1|Overall Study|Lack of Efficacy|17
1852701|NCT00137436|6403759|P1|Overall Study|Death|2
1852702|NCT00137436|6403759|P1|Overall Study|Adverse Event|13
1852703|NCT00137423|6403778|P2|Overall Study|Death|1
1852704|NCT00137423|6403779|P1|Overall Study|Death|0
1852705|NCT00137423|6403778|P2|Overall Study|Lack of Efficacy|33
1852706|NCT00137423|6403779|P1|Overall Study|Lack of Efficacy|31
1852707|NCT00137423|6403778|P2|Overall Study|consent withdrawn|1
1852708|NCT00137423|6403779|P1|Overall Study|consent withdrawn|1
1852709|NCT00137423|6403778|P2|Overall Study|Adverse Event|9
1852710|NCT00137423|6403779|P1|Overall Study|Adverse Event|7
1852711|NCT00137267|6403816|P2|Overall Study|Lost to Follow-up|21
1852712|NCT00137267|6403817|P1|Overall Study|Lost to Follow-up|15
1852713|NCT00137111|6403829|P4|Total Therapy|Non Compliance|0
1852714|NCT00137111|6403830|P3|Total Therapy|Non Compliance|0
1852715|NCT00137111|6403831|P2|Total Therapy|Non Compliance|0
1852716|NCT00137111|6403832|P1|Total Therapy|Non Compliance|5
1852717|NCT00137111|6403829|P4|Total Therapy|Death|0
1852718|NCT00137111|6403830|P3|Total Therapy|Death|0
1852719|NCT00137111|6403831|P2|Total Therapy|Death|0
1852720|NCT00137111|6403832|P1|Total Therapy|Death|35
1852721|NCT00137046|6403846|P2|Overall Study|Withdrew prior to study treatment|1
1852722|NCT00137046|6403847|P1|Overall Study|Withdrew prior to study treatment|1
1852723|NCT00137046|6403846|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
1852724|NCT00137046|6403847|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
1852725|NCT00137046|6403846|P2|Overall Study|Withdrawal by Subject|42
1852726|NCT00137046|6403847|P1|Overall Study|Withdrawal by Subject|33
1852727|NCT00137046|6403846|P2|Overall Study|Other|19
1852728|NCT00137046|6403847|P1|Overall Study|Other|23
1852729|NCT00137046|6403846|P2|Overall Study|Lost to Follow-up|24
1852730|NCT00137046|6403847|P1|Overall Study|Lost to Follow-up|8
1852731|NCT00137046|6403846|P2|Overall Study|Lack of Efficacy|1
1852732|NCT00137046|6403847|P1|Overall Study|Lack of Efficacy|13
1852733|NCT00137046|6403846|P2|Overall Study|Laboratory Abnormality|0
1852734|NCT00137046|6403847|P1|Overall Study|Laboratory Abnormality|2
1852735|NCT00137046|6403846|P2|Overall Study|Adverse Event|5
1852736|NCT00137046|6403847|P1|Overall Study|Adverse Event|16
1852737|NCT00137046|6403846|P2|Overall Study|Death|1
1852738|NCT00137046|6403847|P1|Overall Study|Death|2
1852739|NCT00136955|6403895|P1|Overall Study|Incl. prog. disease, protocol violation|12
1852740|NCT00136955|6403895|P1|Overall Study|Withdrawal by Subject|2
1852741|NCT00136955|6403895|P1|Overall Study|Lost to Follow-up|1
1852742|NCT00136955|6403895|P1|Overall Study|Adverse Event|8
1852743|NCT00136916|6403904|P2|Overall Study|Discontinued in follow up period|0
1852744|NCT00136916|6403905|P1|Overall Study|Discontinued in follow up period|3
1852745|NCT00136916|6403904|P2|Overall Study|Other|24
1852746|NCT00136916|6403905|P1|Overall Study|Other|22
1852747|NCT00136916|6403904|P2|Overall Study|Withdrawal by Subject|46
1852748|NCT00136916|6403905|P1|Overall Study|Withdrawal by Subject|44
1852749|NCT00136916|6403904|P2|Overall Study|Lost to Follow-up|14
1852750|NCT00136916|6403905|P1|Overall Study|Lost to Follow-up|12
1852751|NCT00136916|6403904|P2|Overall Study|Lack of Efficacy|3
1852752|NCT00136916|6403905|P1|Overall Study|Lack of Efficacy|13
1852753|NCT00136916|6403904|P2|Overall Study|Laboratory abnormality|1
1852754|NCT00136916|6403905|P1|Overall Study|Laboratory abnormality|0
1852755|NCT00136916|6403904|P2|Overall Study|Adverse Event|8
1852756|NCT00136916|6403905|P1|Overall Study|Adverse Event|27
1852757|NCT00136916|6403904|P2|Overall Study|Death|3
1852758|NCT00136916|6403905|P1|Overall Study|Death|1
1852759|NCT00136916|6403904|P2|Overall Study|Never received study treatment|5
1852760|NCT00136916|6403905|P1|Overall Study|Never received study treatment|3
1852771|NCT00136357|6404124|P2|Overall Study|Withdrawal by Subject|2
1852772|NCT00136357|6404125|P1|Overall Study|Withdrawal by Subject|3
1852773|NCT00136318|6404133|P2|Overall Study|Withdrawal by Subject|2
1852774|NCT00136318|6404134|P1|Overall Study|Withdrawal by Subject|2
1852775|NCT00136318|6404133|P2|Overall Study|Adverse Event|5
1852776|NCT00136318|6404134|P1|Overall Study|Adverse Event|5
1852777|NCT00136084|6404161|P2|Overall Study|Withdrawal by Subject|1
1852778|NCT00136084|6404162|P1|Overall Study|Withdrawal by Subject|5
1852779|NCT00136084|6404161|P2|Overall Study|No Response|2
1852780|NCT00136084|6404162|P1|Overall Study|No Response|1
1852781|NCT00136084|6404161|P2|Overall Study|Lost to Follow-up|0
1852782|NCT00136084|6404162|P1|Overall Study|Lost to Follow-up|2
1852783|NCT00136084|6404161|P2|Overall Study|Relapse|23
1852784|NCT00136084|6404162|P1|Overall Study|Relapse|20
1852785|NCT00136084|6404161|P2|Overall Study|Unacceptable toxicity|11
1852786|NCT00136084|6404162|P1|Overall Study|Unacceptable toxicity|8
1852787|NCT00136084|6404161|P2|Overall Study|Death|5
1852788|NCT00136084|6404162|P1|Overall Study|Death|12
1852789|NCT00135707|6404198|P2|Overall Study|Institutional review board request|0
1852790|NCT00135707|6404199|P1|Overall Study|Institutional review board request|1
1852791|NCT00135707|6404198|P2|Overall Study|Withdrawal by Subject|1
1852792|NCT00135707|6404199|P1|Overall Study|Withdrawal by Subject|0
1852793|NCT00135707|6404198|P2|Overall Study|Lost to Follow-up|89
1852794|NCT00135707|6404199|P1|Overall Study|Lost to Follow-up|94
1852795|NCT00135694|6404282|P3|Overall Study|Ineligible for Random assignment|0
1852796|NCT00135694|6404283|P2|Overall Study|Ineligible for Random assignment|0
1852797|NCT00135694|6404284|P1|Overall Study|Ineligible for Random assignment|42
1852798|NCT00135694|6404282|P3|Overall Study|Hepatitis C related reasons|0
1852799|NCT00135694|6404283|P2|Overall Study|Hepatitis C related reasons|1
1852800|NCT00135694|6404284|P1|Overall Study|Hepatitis C related reasons|39
1852801|NCT00135694|6404282|P3|Overall Study|Protocol Violation|0
1852802|NCT00135694|6404283|P2|Overall Study|Protocol Violation|1
1852803|NCT00135694|6404284|P1|Overall Study|Protocol Violation|19
1852804|NCT00135694|6404282|P3|Overall Study|Withdrawal by Subject|4
1852805|NCT00135694|6404283|P2|Overall Study|Withdrawal by Subject|7
1852806|NCT00135694|6404284|P1|Overall Study|Withdrawal by Subject|41
1852807|NCT00135694|6404282|P3|Overall Study|Lost to Follow-up|1
1852808|NCT00135694|6404283|P2|Overall Study|Lost to Follow-up|7
1852809|NCT00135694|6404284|P1|Overall Study|Lost to Follow-up|8
1852810|NCT00135694|6404282|P3|Overall Study|Death|2
1852811|NCT00135694|6404283|P2|Overall Study|Death|1
1852812|NCT00135694|6404284|P1|Overall Study|Death|14
1852813|NCT00135694|6404282|P3|Overall Study|Adverse Event|0
1852814|NCT00135694|6404283|P2|Overall Study|Adverse Event|4
1852815|NCT00135694|6404284|P1|Overall Study|Adverse Event|17
1852816|NCT00135512|6404302|P1|Overall Study|Other|42
1852817|NCT00135512|6404302|P1|Overall Study|Lack of Efficacy|25
1852818|NCT00135512|6404302|P1|Overall Study|Adverse Event|56
1852819|NCT00135356|6404314|P2|Overall Study|Withdrawal by Subject|4
1852820|NCT00135356|6404315|P1|Overall Study|Withdrawal by Subject|2
1852821|NCT00135356|6404314|P2|Overall Study|No longer meets study criteria|0
1852822|NCT00135356|6404315|P1|Overall Study|No longer meets study criteria|2
1852823|NCT00135356|6404314|P2|Overall Study|Poor/noncompliance|1
1852824|NCT00135356|6404315|P1|Overall Study|Poor/noncompliance|1
1852825|NCT00135356|6404314|P2|Overall Study|Change in antiviral regimen|1
1852826|NCT00135356|6404315|P1|Overall Study|Change in antiviral regimen|0
1852827|NCT00135356|6404314|P2|Overall Study|Surgery for abdominal fat|0
1852828|NCT00135356|6404315|P1|Overall Study|Surgery for abdominal fat|1
1852829|NCT00135356|6404314|P2|Overall Study|Lost to Follow-up|1
1852830|NCT00135356|6404315|P1|Overall Study|Lost to Follow-up|3
1852831|NCT00135356|6404314|P2|Overall Study|Lack of Efficacy|0
1852832|NCT00135356|6404315|P1|Overall Study|Lack of Efficacy|2
1852833|NCT00135356|6404314|P2|Overall Study|Adverse Event|2
1852834|NCT00135356|6404315|P1|Overall Study|Adverse Event|6
1852835|NCT00135330|6404358|P3|Overall Study|Sponsor Decision|0
1852836|NCT00135330|6404359|P2|Overall Study|Sponsor Decision|1
1852837|NCT00135330|6404360|P1|Overall Study|Sponsor Decision|0
1852838|NCT00135330|6404358|P3|Overall Study|Patient Decision|4
1852839|NCT00135330|6404359|P2|Overall Study|Patient Decision|1
1852840|NCT00135330|6404360|P1|Overall Study|Patient Decision|5
1852841|NCT00135330|6404358|P3|Overall Study|Protocol Violation|3
1852842|NCT00135330|6404359|P2|Overall Study|Protocol Violation|3
1852843|NCT00135330|6404360|P1|Overall Study|Protocol Violation|4
1852844|NCT00135330|6404358|P3|Overall Study|Physician Decision|0
1852845|NCT00135330|6404359|P2|Overall Study|Physician Decision|1
1852846|NCT00135330|6404360|P1|Overall Study|Physician Decision|1
1852847|NCT00135330|6404358|P3|Overall Study|Lost to Follow-up|3
1852848|NCT00135330|6404359|P2|Overall Study|Lost to Follow-up|2
1852849|NCT00135330|6404360|P1|Overall Study|Lost to Follow-up|0
1852850|NCT00135330|6404358|P3|Overall Study|Adverse Event|1
1852851|NCT00135330|6404359|P2|Overall Study|Adverse Event|5
1852852|NCT00135330|6404360|P1|Overall Study|Adverse Event|2
1852853|NCT00134901|6404558|P2|Overall Study|discontinued intervention|10
1852854|NCT00134901|6404559|P1|Overall Study|discontinued intervention|12
1852855|NCT00134901|6404558|P2|Overall Study|Lost to Follow-up|5
1852856|NCT00134901|6404559|P1|Overall Study|Lost to Follow-up|5
1852857|NCT00134784|6404571|P4|Overall Study|Withdrawal by Subject|1
1852858|NCT00134784|6404572|P3|Overall Study|Withdrawal by Subject|2
1852859|NCT00134784|6404573|P2|Overall Study|Withdrawal by Subject|2
1852860|NCT00134784|6404574|P1|Overall Study|Withdrawal by Subject|2
1852861|NCT00134719|6404584|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1852862|NCT00134719|6404585|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
1852863|NCT00134719|6404586|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
1852864|NCT00134719|6404584|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1852865|NCT00134719|6404585|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
1852866|NCT00134719|6404586|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
1852867|NCT00134719|6404584|P3|Primary Vaccination Phase|Lost to Follow-up|3
1852868|NCT00134719|6404585|P2|Primary Vaccination Phase|Lost to Follow-up|3
1852869|NCT00134719|6404586|P1|Primary Vaccination Phase|Lost to Follow-up|7
1852870|NCT00134719|6404584|P3|Primary Vaccination Phase|Withdrawal by Subject|2
1852871|NCT00134719|6404585|P2|Primary Vaccination Phase|Withdrawal by Subject|3
1852872|NCT00134719|6404586|P1|Primary Vaccination Phase|Withdrawal by Subject|2
1852873|NCT00134719|6404584|P3|Primary Vaccination Phase|Protocol Violation|0
1852874|NCT00134719|6404585|P2|Primary Vaccination Phase|Protocol Violation|0
1852875|NCT00134719|6404586|P1|Primary Vaccination Phase|Protocol Violation|1
1852876|NCT00134719|6404584|P3|Primary Vaccination Phase|Adverse Event|0
1852877|NCT00134719|6404585|P2|Primary Vaccination Phase|Adverse Event|0
1852878|NCT00134719|6404586|P1|Primary Vaccination Phase|Adverse Event|4
1852879|NCT00134563|6404717|P3|Overall Study|Reason other than above|5
1852880|NCT00134563|6404718|P2|Overall Study|Reason other than above|2
1852881|NCT00134563|6404719|P1|Overall Study|Reason other than above|0
1852882|NCT00134563|6404717|P3|Overall Study|did not wish to continue|26
1852883|NCT00134563|6404718|P2|Overall Study|did not wish to continue|32
1852884|NCT00134563|6404719|P1|Overall Study|did not wish to continue|33
1852885|NCT00134563|6404717|P3|Overall Study|progressive disease|2
1852886|NCT00134563|6404718|P2|Overall Study|progressive disease|4
1852887|NCT00134563|6404719|P1|Overall Study|progressive disease|11
1852888|NCT00134563|6404717|P3|Overall Study|Lost to Follow-up|2
1852889|NCT00134563|6404718|P2|Overall Study|Lost to Follow-up|0
1852890|NCT00134563|6404719|P1|Overall Study|Lost to Follow-up|4
1852891|NCT00134563|6404717|P3|Overall Study|Protocol Violation|5
1852892|NCT00134563|6404718|P2|Overall Study|Protocol Violation|2
1852893|NCT00134563|6404719|P1|Overall Study|Protocol Violation|3
1852894|NCT00134563|6404717|P3|Overall Study|Lack of Efficacy|17
1852895|NCT00134563|6404718|P2|Overall Study|Lack of Efficacy|14
1852896|NCT00134563|6404719|P1|Overall Study|Lack of Efficacy|24
1852897|NCT00134563|6404717|P3|Overall Study|Adverse Event|38
1852898|NCT00134563|6404718|P2|Overall Study|Adverse Event|37
1852899|NCT00134563|6404719|P1|Overall Study|Adverse Event|29
1852900|NCT00134563|6404717|P3|Overall Study|Not treated due to protocol violation|1
1852901|NCT00134563|6404718|P2|Overall Study|Not treated due to protocol violation|1
1852902|NCT00134563|6404719|P1|Overall Study|Not treated due to protocol violation|0
1852903|NCT00134082|6404780|P1|Overall Study|Death|1
1852904|NCT00134082|6404780|P1|Overall Study|Adverse Event|2
1852905|NCT00134056|6404789|P2|Eligible for Protocol Assigned Treatment|Other|56
1852906|NCT00134056|6404790|P1|Eligible for Protocol Assigned Treatment|Other|55
1852907|NCT00134056|6404789|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
1852908|NCT00134056|6404790|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
1852909|NCT00134056|6404789|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
1852910|NCT00134056|6404790|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
1852911|NCT00134056|6404789|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1852912|NCT00134056|6404790|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
1852913|NCT00134056|6404789|P2|Randomization|Not eligible for assigned treatment|20
1852914|NCT00134056|6404790|P1|Randomization|Not eligible for assigned treatment|22
1852915|NCT00133991|6404834|P1|Overall Study|Death|4
1852916|NCT00133952|6404873|P2|Overall Study|Sponsor Decision|1
1852917|NCT00133952|6404874|P1|Overall Study|Sponsor Decision|0
1852918|NCT00133952|6404873|P2|Overall Study|Physician Decision|3
1852919|NCT00133952|6404874|P1|Overall Study|Physician Decision|4
1852920|NCT00133952|6404873|P2|Overall Study|Withdrawal by Subject|4
1852921|NCT00133952|6404874|P1|Overall Study|Withdrawal by Subject|20
1852922|NCT00133952|6404873|P2|Overall Study|Protocol Violation|1
1852923|NCT00133952|6404874|P1|Overall Study|Protocol Violation|1
1852924|NCT00133952|6404873|P2|Overall Study|Protocol Entry Criteria Exclusion|1
1852925|NCT00133952|6404874|P1|Overall Study|Protocol Entry Criteria Exclusion|4
1852926|NCT00133952|6404873|P2|Overall Study|Lost to Follow-up|14
1852927|NCT00133952|6404874|P1|Overall Study|Lost to Follow-up|9
1852928|NCT00133952|6404873|P2|Overall Study|Death|2
1852929|NCT00133952|6404874|P1|Overall Study|Death|3
1852930|NCT00133952|6404873|P2|Overall Study|Adverse Event|2
1852931|NCT00133952|6404874|P1|Overall Study|Adverse Event|1
1852932|NCT00133705|6404905|P2|Overall Study|Withdrawal by Subject|3
1852933|NCT00133705|6404906|P1|Overall Study|Withdrawal by Subject|2
1852934|NCT00132873|6405041|P1|Overall Study|Planned Pregnancy|1
1852935|NCT00132873|6405041|P1|Overall Study|Withdrawal by Subject|3
1852936|NCT00132873|6405041|P1|Overall Study|Lack of Efficacy|1
1852937|NCT00132873|6405041|P1|Overall Study|Lost to Follow-up|1
1852938|NCT00132873|6405041|P1|Overall Study|Adverse Event|3
1852939|NCT00132808|6405049|P3|Stratum II|Withdrawal by Subject|6
1852940|NCT00132808|6405050|P2|Stratum II|Withdrawal by Subject|9
1852941|NCT00132808|6405051|P1|Stratum II|Withdrawal by Subject|4
1852942|NCT00132808|6405049|P3|Stratum II|Protocol Violation|1
1852943|NCT00132808|6405050|P2|Stratum II|Protocol Violation|2
1852944|NCT00132808|6405051|P1|Stratum II|Protocol Violation|0
1852945|NCT00132808|6405049|P3|Stratum II|Lost to Follow-up|1
1852946|NCT00132808|6405050|P2|Stratum II|Lost to Follow-up|2
1852947|NCT00132808|6405051|P1|Stratum II|Lost to Follow-up|2
1852948|NCT00132808|6405049|P3|Stratum II|Death|0
1852949|NCT00132808|6405050|P2|Stratum II|Death|0
1852950|NCT00132808|6405051|P1|Stratum II|Death|1
1852951|NCT00132808|6405049|P3|Stratum II|Adverse Event|1
1852952|NCT00132808|6405050|P2|Stratum II|Adverse Event|2
1852953|NCT00132808|6405051|P1|Stratum II|Adverse Event|1
1852954|NCT00132808|6405049|P3|Stratum I|Abnormal test procedure result (s)|1
1852955|NCT00132808|6405050|P2|Stratum I|Abnormal test procedure result (s)|0
1852956|NCT00132808|6405051|P1|Stratum I|Abnormal test procedure result (s)|0
1852957|NCT00132808|6405049|P3|Stratum I|Withdrawal by Subject|3
1852958|NCT00132808|6405050|P2|Stratum I|Withdrawal by Subject|7
1852959|NCT00132808|6405051|P1|Stratum I|Withdrawal by Subject|4
1852960|NCT00132808|6405049|P3|Stratum I|Lost to Follow-up|1
1852961|NCT00132808|6405050|P2|Stratum I|Lost to Follow-up|4
1852962|NCT00132808|6405051|P1|Stratum I|Lost to Follow-up|3
1852963|NCT00132808|6405049|P3|Stratum I|Adverse Event|0
1852964|NCT00132808|6405050|P2|Stratum I|Adverse Event|1
1852965|NCT00132808|6405051|P1|Stratum I|Adverse Event|2
1852966|NCT00132769|6405076|P2|Overall Study|Protocol Violation|1
1852967|NCT00132769|6405077|P1|Overall Study|Protocol Violation|1
1852968|NCT00132769|6405076|P2|Overall Study|Adverse Event|1
1852969|NCT00132769|6405077|P1|Overall Study|Adverse Event|2
1852970|NCT00132769|6405076|P2|Overall Study|Lack of Efficacy|6
1852971|NCT00132769|6405077|P1|Overall Study|Lack of Efficacy|7
1852972|NCT00132769|6405076|P2|Overall Study|Withdrawal by Subject|3
1852973|NCT00132769|6405077|P1|Overall Study|Withdrawal by Subject|1
1852974|NCT00132730|6405103|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
1852975|NCT00132730|6405104|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
1852976|NCT00132730|6405105|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
1852977|NCT00132730|6405106|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
1852978|NCT00132730|6405107|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
1852979|NCT00132730|6405108|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
1852980|NCT00132730|6405103|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
1852981|NCT00132730|6405104|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
1852982|NCT00132730|6405105|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
1852983|NCT00132730|6405106|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
1852984|NCT00132730|6405107|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
1852985|NCT00132730|6405108|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
1852986|NCT00132730|6405103|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1852987|NCT00132730|6405104|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
1852988|NCT00132730|6405105|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1852989|NCT00132730|6405106|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1852990|NCT00132730|6405107|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1852991|NCT00132730|6405108|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
1852992|NCT00132730|6405103|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1852993|NCT00132730|6405104|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
1852994|NCT00132730|6405105|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1852995|NCT00132730|6405106|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1852996|NCT00132730|6405107|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1852997|NCT00132730|6405108|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
1852998|NCT00132730|6405103|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
1852999|NCT00132730|6405104|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
1853000|NCT00132730|6405105|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
1853001|NCT00132730|6405106|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
1853002|NCT00132730|6405107|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
1853003|NCT00132730|6405108|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
1853004|NCT00132730|6405103|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
1853005|NCT00132730|6405104|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
1853006|NCT00132730|6405105|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
1853007|NCT00132730|6405106|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
1853008|NCT00132730|6405107|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
1853009|NCT00132730|6405108|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
1853010|NCT00132730|6405103|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1853011|NCT00132730|6405104|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1853012|NCT00132730|6405105|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
1853013|NCT00132730|6405106|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1853014|NCT00132730|6405107|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1853015|NCT00132730|6405108|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
1853016|NCT00132730|6405103|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1853017|NCT00132730|6405104|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1853018|NCT00132730|6405105|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
1853019|NCT00132730|6405106|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
1853020|NCT00132730|6405107|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1853021|NCT00132730|6405108|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
1853022|NCT00132730|6405103|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
1853023|NCT00132730|6405104|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
1853024|NCT00132730|6405105|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
1853025|NCT00132730|6405106|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
1853026|NCT00132730|6405107|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
1853027|NCT00132730|6405108|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
1853028|NCT00132730|6405103|P6|Period II - 12-week Treatment (Base)|Other reasons|0
1853029|NCT00132730|6405104|P5|Period II - 12-week Treatment (Base)|Other reasons|0
1853030|NCT00132730|6405105|P4|Period II - 12-week Treatment (Base)|Other reasons|13
1853031|NCT00132730|6405106|P3|Period II - 12-week Treatment (Base)|Other reasons|9
1853032|NCT00132730|6405107|P2|Period II - 12-week Treatment (Base)|Other reasons|10
1853033|NCT00132730|6405108|P1|Period II - 12-week Treatment (Base)|Other reasons|11
1853034|NCT00132730|6405103|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1853035|NCT00132730|6405104|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1853036|NCT00132730|6405105|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1853037|NCT00132730|6405106|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
1853038|NCT00132730|6405107|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1853039|NCT00132730|6405108|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
1853040|NCT00132730|6405103|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1853041|NCT00132730|6405104|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
1853042|NCT00132730|6405105|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1853043|NCT00132730|6405106|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
1853044|NCT00132730|6405107|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
1853045|NCT00132730|6405108|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
1853046|NCT00132691|6405152|P2|Overall Study|Death|0
1853047|NCT00132691|6405153|P1|Overall Study|Death|2
1853048|NCT00132691|6405152|P2|Overall Study|Missed 2-year visit|4
1853049|NCT00132691|6405153|P1|Overall Study|Missed 2-year visit|4
1853050|NCT00132691|6405152|P2|Overall Study|Lost to Follow-up|8
1853051|NCT00132691|6405153|P1|Overall Study|Lost to Follow-up|5
1853052|NCT00132678|6405193|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
1853053|NCT00132678|6405194|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
1853054|NCT00132678|6405195|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
1853055|NCT00132678|6405193|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
1853056|NCT00132678|6405194|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
1853057|NCT00132678|6405195|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
1853058|NCT00132678|6405193|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
1853059|NCT00132678|6405194|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
1853060|NCT00132678|6405195|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
1853061|NCT00132678|6405193|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
1853062|NCT00132678|6405194|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
1853063|NCT00132678|6405195|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
1853064|NCT00132678|6405193|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
1853065|NCT00132678|6405194|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
1853066|NCT00132678|6405195|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
1853067|NCT00132678|6405193|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
1853068|NCT00132678|6405194|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1853069|NCT00132678|6405195|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
1853070|NCT00132678|6405193|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
1853071|NCT00132678|6405194|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
1853072|NCT00132678|6405195|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
1853073|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Pregnancy|0
1853074|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Pregnancy|0
1853075|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Pregnancy|2
1853076|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Physician Decision|0
1853077|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Physician Decision|0
1853078|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Physician Decision|1
1853079|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
1853080|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
1853081|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
1853082|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1853083|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
1853084|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
1853085|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1853086|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
1853087|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
1853088|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1853089|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
1853090|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
1853091|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Non responder|0
1853092|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Non responder|0
1853093|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Non responder|107
1853094|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Adverse Event|0
1853095|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Adverse Event|0
1853096|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Adverse Event|12
1853097|NCT00132678|6405193|P3|Period III (Open-Label Stabilization)|Death|0
1853098|NCT00132678|6405194|P2|Period III (Open-Label Stabilization)|Death|0
1853099|NCT00132678|6405195|P1|Period III (Open-Label Stabilization)|Death|2
1853100|NCT00132678|6405193|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
1853101|NCT00132678|6405194|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1853102|NCT00132678|6405195|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
1853103|NCT00132678|6405193|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
1853104|NCT00132678|6405194|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1853105|NCT00132678|6405195|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
1853106|NCT00132678|6405193|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
1853107|NCT00132678|6405194|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1853108|NCT00132678|6405195|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
1853109|NCT00132678|6405193|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
1853110|NCT00132678|6405194|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1853111|NCT00132678|6405195|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
1853112|NCT00132678|6405193|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
1853113|NCT00132678|6405194|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
1853114|NCT00132678|6405195|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
1853115|NCT00132678|6405193|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
1853116|NCT00132678|6405194|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1853117|NCT00132678|6405195|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
1853118|NCT00132678|6405193|P3|Period II (Open-Label Oral Risperidone)|Death|1
1853119|NCT00132678|6405194|P2|Period II (Open-Label Oral Risperidone)|Death|0
1853120|NCT00132678|6405195|P1|Period II (Open-Label Oral Risperidone)|Death|0
1853121|NCT00132496|6405209|P2|Overall Study|Physician Decision|0
1853122|NCT00132496|6405210|P1|Overall Study|Physician Decision|1
1853123|NCT00132496|6405209|P2|Overall Study|Withdrawal by Subject|2
1853124|NCT00132496|6405210|P1|Overall Study|Withdrawal by Subject|1
1853125|NCT00132314|6405218|P2|Overall Study|Refused intervention at baseline|7
1853126|NCT00132314|6405219|P1|Overall Study|Refused intervention at baseline|2
1853127|NCT00132314|6405218|P2|Overall Study|Lacked SSN|3
1853128|NCT00132314|6405219|P1|Overall Study|Lacked SSN|1
1853129|NCT00132314|6405218|P2|Overall Study|Lost to Follow-up|62
1853130|NCT00132314|6405219|P1|Overall Study|Lost to Follow-up|70
1853131|NCT00132301|6405229|P2|Overall Study|Excluded by Data Monitoring Committee|0
1853132|NCT00132301|6405230|P1|Overall Study|Excluded by Data Monitoring Committee|1
1853133|NCT00132301|6405229|P2|Overall Study|Other|1
1853134|NCT00132301|6405230|P1|Overall Study|Other|1
1853135|NCT00132301|6405229|P2|Overall Study|Lost to Follow-up|3
1853136|NCT00132301|6405230|P1|Overall Study|Lost to Follow-up|5
1853137|NCT00132301|6405229|P2|Overall Study|Physician Decision|1
1853138|NCT00132301|6405230|P1|Overall Study|Physician Decision|1
1853139|NCT00132301|6405229|P2|Overall Study|Withdrawal by Subject|2
1853140|NCT00132301|6405230|P1|Overall Study|Withdrawal by Subject|5
1853141|NCT00132301|6405229|P2|Overall Study|Death|6
1853142|NCT00132301|6405230|P1|Overall Study|Death|7
1853143|NCT00132132|6405238|P2|Overall Study|Lost to Follow-up|2
1853144|NCT00132132|6405239|P1|Overall Study|Lost to Follow-up|7
1853145|NCT00132028|6405247|P1|Overall Study|Physician Decision|3
1853146|NCT00132028|6405247|P1|Overall Study|not eligible|2
1853147|NCT00132028|6405247|P1|Overall Study|Withdrawal by Subject|2
1853148|NCT00132028|6405247|P1|Overall Study|Lack of Efficacy|11
1853149|NCT00132028|6405247|P1|Overall Study|Death|2
1853150|NCT00132028|6405247|P1|Overall Study|Adverse Event|7
1853151|NCT00131937|6405259|P1|Overall Study|Alternative therapy|1
1853152|NCT00131937|6405259|P1|Overall Study|Disease Progression|7
1853153|NCT00131937|6405259|P1|Overall Study|Physician Decision|1
1853154|NCT00131937|6405259|P1|Overall Study|Withdrawal by Subject|2
1853155|NCT00131937|6405259|P1|Overall Study|Adverse Event|3
1853156|NCT00131911|6405267|P2|Overall Study|Withdrawal by Subject|0
1853157|NCT00131911|6405268|P1|Overall Study|Withdrawal by Subject|1
1853158|NCT00131664|6405338|P6|Second Period (Additional Drug Added)|Administrative reasons|0
1853159|NCT00131664|6405339|P5|Second Period (Additional Drug Added)|Administrative reasons|1
1853160|NCT00131664|6405340|P4|Second Period (Additional Drug Added)|Administrative reasons|0
1853161|NCT00131664|6405341|P3|Second Period (Additional Drug Added)|Administrative reasons|0
1853162|NCT00131664|6405342|P2|Second Period (Additional Drug Added)|Administrative reasons|2
1853163|NCT00131664|6405343|P1|Second Period (Additional Drug Added)|Administrative reasons|4
1853164|NCT00131664|6405338|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1853165|NCT00131664|6405339|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1853166|NCT00131664|6405340|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
1853167|NCT00131664|6405341|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1853168|NCT00131664|6405342|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1853169|NCT00131664|6405343|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
1853170|NCT00131664|6405338|P6|Second Period (Additional Drug Added)|Adverse Event|1
1853171|NCT00131664|6405339|P5|Second Period (Additional Drug Added)|Adverse Event|0
1853172|NCT00131664|6405340|P4|Second Period (Additional Drug Added)|Adverse Event|0
1853173|NCT00131664|6405341|P3|Second Period (Additional Drug Added)|Adverse Event|0
1853174|NCT00131664|6405342|P2|Second Period (Additional Drug Added)|Adverse Event|1
1853175|NCT00131664|6405343|P1|Second Period (Additional Drug Added)|Adverse Event|0
1853176|NCT00131664|6405338|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1853177|NCT00131664|6405339|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1853178|NCT00131664|6405340|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1853179|NCT00131664|6405341|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1853180|NCT00131664|6405342|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
1853181|NCT00131664|6405343|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
1853182|NCT00131664|6405338|P6|Second Period (Additional Drug Added)|Protocol Violation|0
1853183|NCT00131664|6405339|P5|Second Period (Additional Drug Added)|Protocol Violation|0
1853184|NCT00131664|6405340|P4|Second Period (Additional Drug Added)|Protocol Violation|0
1853185|NCT00131664|6405341|P3|Second Period (Additional Drug Added)|Protocol Violation|1
1853186|NCT00131664|6405342|P2|Second Period (Additional Drug Added)|Protocol Violation|1
1853187|NCT00131664|6405343|P1|Second Period (Additional Drug Added)|Protocol Violation|0
1853188|NCT00131664|6405338|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
1853189|NCT00131664|6405339|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
1853190|NCT00131664|6405340|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
1853191|NCT00131664|6405341|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
1853192|NCT00131664|6405342|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
1853193|NCT00131664|6405343|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
1853194|NCT00131664|6405338|P6|First Period (First 6 Months)|Administrative reasons|0
1853195|NCT00131664|6405339|P5|First Period (First 6 Months)|Administrative reasons|0
1853196|NCT00131664|6405340|P4|First Period (First 6 Months)|Administrative reasons|0
1853197|NCT00131664|6405341|P3|First Period (First 6 Months)|Administrative reasons|5
1853198|NCT00131664|6405342|P2|First Period (First 6 Months)|Administrative reasons|0
1853199|NCT00131664|6405343|P1|First Period (First 6 Months)|Administrative reasons|2
1853200|NCT00131664|6405338|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1853201|NCT00131664|6405339|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1853202|NCT00131664|6405340|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1853203|NCT00131664|6405341|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
1853204|NCT00131664|6405342|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
1853205|NCT00131664|6405343|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
1853206|NCT00131664|6405338|P6|First Period (First 6 Months)|Adverse Event|0
1853207|NCT00131664|6405339|P5|First Period (First 6 Months)|Adverse Event|0
1853208|NCT00131664|6405340|P4|First Period (First 6 Months)|Adverse Event|0
1853209|NCT00131664|6405341|P3|First Period (First 6 Months)|Adverse Event|5
1853210|NCT00131664|6405342|P2|First Period (First 6 Months)|Adverse Event|4
1853211|NCT00131664|6405343|P1|First Period (First 6 Months)|Adverse Event|9
1853212|NCT00131664|6405338|P6|First Period (First 6 Months)|Withdrawal by Subject|0
1853213|NCT00131664|6405339|P5|First Period (First 6 Months)|Withdrawal by Subject|0
1853214|NCT00131664|6405340|P4|First Period (First 6 Months)|Withdrawal by Subject|0
1853215|NCT00131664|6405341|P3|First Period (First 6 Months)|Withdrawal by Subject|2
1853216|NCT00131664|6405342|P2|First Period (First 6 Months)|Withdrawal by Subject|6
1853217|NCT00131664|6405343|P1|First Period (First 6 Months)|Withdrawal by Subject|4
1853218|NCT00131664|6405338|P6|First Period (First 6 Months)|Protocol Violation|0
1853219|NCT00131664|6405339|P5|First Period (First 6 Months)|Protocol Violation|0
1853220|NCT00131664|6405340|P4|First Period (First 6 Months)|Protocol Violation|0
1853221|NCT00131664|6405341|P3|First Period (First 6 Months)|Protocol Violation|1
1853222|NCT00131664|6405342|P2|First Period (First 6 Months)|Protocol Violation|2
1853223|NCT00131664|6405343|P1|First Period (First 6 Months)|Protocol Violation|2
1853224|NCT00131664|6405338|P6|First Period (First 6 Months)|Death|0
1853225|NCT00131664|6405339|P5|First Period (First 6 Months)|Death|0
1853226|NCT00131664|6405340|P4|First Period (First 6 Months)|Death|0
1853227|NCT00131664|6405341|P3|First Period (First 6 Months)|Death|0
1853228|NCT00131664|6405342|P2|First Period (First 6 Months)|Death|1
1853229|NCT00131664|6405343|P1|First Period (First 6 Months)|Death|0
1853230|NCT00131664|6405338|P6|First Period (First 6 Months)|Lost to Follow-up|0
1853231|NCT00131664|6405339|P5|First Period (First 6 Months)|Lost to Follow-up|0
1853232|NCT00131664|6405340|P4|First Period (First 6 Months)|Lost to Follow-up|0
1853233|NCT00131664|6405341|P3|First Period (First 6 Months)|Lost to Follow-up|3
1853234|NCT00131664|6405342|P2|First Period (First 6 Months)|Lost to Follow-up|3
1853235|NCT00131664|6405343|P1|First Period (First 6 Months)|Lost to Follow-up|7
1853236|NCT00131508|6405415|P2|Overall Study|Withdrawal by Subject|2
1853237|NCT00131508|6405416|P1|Overall Study|Withdrawal by Subject|1
1853238|NCT00131508|6405415|P2|Overall Study|Non-Compliance|4
1853239|NCT00131508|6405416|P1|Overall Study|Non-Compliance|2
1853240|NCT00131508|6405415|P2|Overall Study|Disease progression|2
1853241|NCT00131508|6405416|P1|Overall Study|Disease progression|0
1853242|NCT00131469|6405440|P2|Overall Study|scan not analyzable|6
1853243|NCT00131469|6405441|P1|Overall Study|scan not analyzable|3
1853244|NCT00131469|6405440|P2|Overall Study|Lost to Follow-up|1
1853245|NCT00131469|6405441|P1|Overall Study|Lost to Follow-up|0
1853246|NCT00131469|6405440|P2|Overall Study|Death|1
1853247|NCT00131469|6405441|P1|Overall Study|Death|0
1853248|NCT00131469|6405440|P2|Overall Study|Protocol Violation|1
1853249|NCT00131469|6405441|P1|Overall Study|Protocol Violation|3
1853250|NCT00131469|6405440|P2|Overall Study|Withdrawal by Subject|4
1853251|NCT00131469|6405441|P1|Overall Study|Withdrawal by Subject|3
1853252|NCT00131365|6405487|P1|Overall Study|Alternative treatment|3
1853253|NCT00131365|6405487|P1|Overall Study|Withdrawal by Subject|1
1853254|NCT00131352|6405494|P2|Repeat Treatment Period|Other|0
1853255|NCT00131352|6405495|P1|Repeat Treatment Period|Other|1
1853256|NCT00131352|6405494|P2|Repeat Treatment Period|Adverse Event|0
1853257|NCT00131352|6405495|P1|Repeat Treatment Period|Adverse Event|1
1853258|NCT00131352|6405494|P2|Initial Treatment Period|Other|2
1853259|NCT00131352|6405495|P1|Initial Treatment Period|Other|0
1853260|NCT00131352|6405494|P2|Initial Treatment Period|Lack of Efficacy|4
1853261|NCT00131352|6405495|P1|Initial Treatment Period|Lack of Efficacy|6
1853262|NCT00131352|6405494|P2|Initial Treatment Period|Withdrawal by Subject|1
1853263|NCT00131352|6405495|P1|Initial Treatment Period|Withdrawal by Subject|1
1853264|NCT00131352|6405494|P2|Initial Treatment Period|Non-compliant|2
1853265|NCT00131352|6405495|P1|Initial Treatment Period|Non-compliant|1
1853266|NCT00131352|6405494|P2|Initial Treatment Period|Adverse Event|3
1853267|NCT00131352|6405495|P1|Initial Treatment Period|Adverse Event|1
1853268|NCT00131248|6405517|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
1853269|NCT00131248|6405518|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
1853270|NCT00130832|6405545|P2|Overall Study|Other|3
1853271|NCT00130832|6405546|P1|Overall Study|Other|0
1853272|NCT00130832|6405545|P2|Overall Study|Moved|2
1853273|NCT00130832|6405546|P1|Overall Study|Moved|2
1853274|NCT00130832|6405545|P2|Overall Study|Withdrawal by Subject|1
1853275|NCT00130832|6405546|P1|Overall Study|Withdrawal by Subject|6
1853276|NCT00130832|6405545|P2|Overall Study|Protocol Violation|8
1853277|NCT00130832|6405546|P1|Overall Study|Protocol Violation|6
1853278|NCT00130832|6405545|P2|Overall Study|Lost to Follow-up|2
1853279|NCT00130832|6405546|P1|Overall Study|Lost to Follow-up|1
1853280|NCT00130832|6405545|P2|Overall Study|Adverse Event|1
1853281|NCT00130832|6405546|P1|Overall Study|Adverse Event|1
1853282|NCT00130793|6405558|P2|Overall Study|Withdrew consent|0
1853283|NCT00130793|6405559|P1|Overall Study|Withdrew consent|2
1853284|NCT00130793|6405558|P2|Overall Study|Lost to Follow-up|4
1853285|NCT00130793|6405559|P1|Overall Study|Lost to Follow-up|1
1853286|NCT00130728|6405580|P2|Overall Study|Withdrawal by Subject|2
1853287|NCT00130728|6405581|P1|Overall Study|Withdrawal by Subject|0
1853288|NCT00130728|6405580|P2|Overall Study|Lost to Follow-up|0
1853289|NCT00130728|6405581|P1|Overall Study|Lost to Follow-up|4
1853290|NCT00130728|6405580|P2|Overall Study|Death|211
1853291|NCT00130728|6405581|P1|Overall Study|Death|207
1853292|NCT00130689|6405593|P1|Overall Study|Ineligible|6
1853293|NCT00130689|6405593|P1|Overall Study|Withdrawal by Subject|3
1853294|NCT00130689|6405593|P1|Overall Study|Clinical Deterioration|4
1853295|NCT00130689|6405593|P1|Overall Study|Death|1
1853296|NCT00130689|6405593|P1|Overall Study|Progressive Disease|29
1853297|NCT00130637|6405597|P1|Overall Study|Withdrawal by Subject|1
1853298|NCT00130637|6405597|P1|Overall Study|Adverse Event|2
1853299|NCT00130533|6405604|P2|Overall Study|Other|5
1853300|NCT00130533|6405605|P1|Overall Study|Other|12
1853301|NCT00130533|6405604|P2|Overall Study|Second Primary Malignancy|1
1853302|NCT00130533|6405605|P1|Overall Study|Second Primary Malignancy|0
1853303|NCT00130533|6405604|P2|Overall Study|Sponsor´s decision|0
1853304|NCT00130533|6405605|P1|Overall Study|Sponsor´s decision|2
1853305|NCT00130533|6405604|P2|Overall Study|Lost to Follow-up|1
1853306|NCT00130533|6405605|P1|Overall Study|Lost to Follow-up|1
1853307|NCT00130533|6405604|P2|Overall Study|Protocol Violation|1
1853308|NCT00130533|6405605|P1|Overall Study|Protocol Violation|5
1853309|NCT00130533|6405604|P2|Overall Study|Death|2
1853310|NCT00130533|6405605|P1|Overall Study|Death|4
1853311|NCT00130533|6405604|P2|Overall Study|Interruption of treatment > 3 weeks|0
1853312|NCT00130533|6405605|P1|Overall Study|Interruption of treatment > 3 weeks|11
1853313|NCT00130533|6405604|P2|Overall Study|Disease relapse|13
1853314|NCT00130533|6405605|P1|Overall Study|Disease relapse|9
1853315|NCT00130533|6405604|P2|Overall Study|Adverse Event|1
1853316|NCT00130533|6405605|P1|Overall Study|Adverse Event|34
1853317|NCT00130533|6405604|P2|Overall Study|Withdrawal by Subject|6
1853318|NCT00130533|6405605|P1|Overall Study|Withdrawal by Subject|33
1853319|NCT00130520|6405617|P1|Overall Study|Did not meet re-treatment criteria|1
1853320|NCT00130520|6405617|P1|Overall Study|Protocol non-compliance|1
1853321|NCT00130520|6405617|P1|Overall Study|Disease Progression|23
1853322|NCT00130520|6405617|P1|Overall Study|Withdrawal by Subject|1
1853323|NCT00130520|6405617|P1|Overall Study|Physician Decision|1
1853324|NCT00130520|6405617|P1|Overall Study|Death|1
1853325|NCT00130520|6405617|P1|Overall Study|Adverse Event|11
1853326|NCT00130286|6405627|P4|Overall Study|Missing lab specimens|0
1853327|NCT00130286|6405628|P3|Overall Study|Missing lab specimens|0
1853328|NCT00130286|6405629|P2|Overall Study|Missing lab specimens|2
1853329|NCT00130286|6405630|P1|Overall Study|Missing lab specimens|0
1853330|NCT00130286|6405627|P4|Overall Study|Adverse Event|0
1853331|NCT00130286|6405628|P3|Overall Study|Adverse Event|2
1853332|NCT00130286|6405629|P2|Overall Study|Adverse Event|0
1853333|NCT00130286|6405630|P1|Overall Study|Adverse Event|0
1853334|NCT00130286|6405627|P4|Overall Study|Withdrawal by Subject|2
1853335|NCT00130286|6405628|P3|Overall Study|Withdrawal by Subject|2
1853336|NCT00130286|6405629|P2|Overall Study|Withdrawal by Subject|1
1853337|NCT00130286|6405630|P1|Overall Study|Withdrawal by Subject|0
1853338|NCT00130247|6405650|P2|Overall Study|Not compliant with DOT|2
1853339|NCT00130247|6405651|P1|Overall Study|Not compliant with DOT|0
1853340|NCT00130247|6405650|P2|Overall Study|Post-randomization exclusion|2
1853341|NCT00130247|6405651|P1|Overall Study|Post-randomization exclusion|1
1853342|NCT00130247|6405650|P2|Overall Study|Pregnancy|0
1853343|NCT00130247|6405651|P1|Overall Study|Pregnancy|1
1853344|NCT00130208|6405669|P2|Washout Period (8 Weeks)|Other|1
1853345|NCT00130208|6405670|P1|Washout Period (8 Weeks)|Other|1
1853346|NCT00130208|6405669|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
1853347|NCT00130208|6405670|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
1853348|NCT00130208|6405669|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
1853349|NCT00130208|6405670|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
1853350|NCT00130208|6405669|P2|Washout Period (8 Weeks)|Adverse Event|6
1853351|NCT00130208|6405670|P1|Washout Period (8 Weeks)|Adverse Event|3
1853352|NCT00130208|6405669|P2|Maintenance Period (26 Weeks)|Other|1
1853353|NCT00130208|6405670|P1|Maintenance Period (26 Weeks)|Other|1
1853354|NCT00130208|6405669|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
1853355|NCT00130208|6405670|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
1853356|NCT00130208|6405669|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
1853357|NCT00130208|6405670|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
1853358|NCT00130208|6405669|P2|Maintenance Period (26 Weeks)|Physician Decision|2
1853359|NCT00130208|6405670|P1|Maintenance Period (26 Weeks)|Physician Decision|0
1853360|NCT00130208|6405669|P2|Maintenance Period (26 Weeks)|Adverse Event|12
1853361|NCT00130208|6405670|P1|Maintenance Period (26 Weeks)|Adverse Event|10
1853362|NCT00130039|6405706|P2|Overall Study|clinical events without follow up MRI|4
1853363|NCT00130039|6405707|P1|Overall Study|clinical events without follow up MRI|5
1853364|NCT00130039|6405706|P2|Overall Study|Physician Decision|0
1853365|NCT00130039|6405707|P1|Overall Study|Physician Decision|3
1853366|NCT00130039|6405706|P2|Overall Study|Adverse Event|2
1853367|NCT00130039|6405707|P1|Overall Study|Adverse Event|4
1853368|NCT00130039|6405706|P2|Overall Study|Lost to Follow-up|1
1853369|NCT00130039|6405707|P1|Overall Study|Lost to Follow-up|3
1853370|NCT00130039|6405706|P2|Overall Study|Withdrawal by Subject|11
1853371|NCT00130039|6405707|P1|Overall Study|Withdrawal by Subject|15
1853372|NCT00129987|6405725|P2|1 Year|Withdrawal by Subject|21
1853373|NCT00129987|6405726|P1|1 Year|Withdrawal by Subject|32
1853374|NCT00129987|6405725|P2|1st Educational Session|Withdrawal by Subject|109
1853375|NCT00129987|6405726|P1|1st Educational Session|Withdrawal by Subject|141
1853376|NCT00129974|6405738|P1|Overall Study|Other|1
1853377|NCT00129961|6405745|P2|Overall Study|Missing Record|1
1853378|NCT00129961|6405746|P1|Overall Study|Missing Record|0
1853379|NCT00129961|6405745|P2|Overall Study|Withdrawal by Subject|1
1853380|NCT00129961|6405746|P1|Overall Study|Withdrawal by Subject|2
1853381|NCT00129961|6405745|P2|Overall Study|Physician Decision|0
1853382|NCT00129961|6405746|P1|Overall Study|Physician Decision|1
1853383|NCT00129961|6405745|P2|Overall Study|Withdrawal by Sponsor|20
1853384|NCT00129961|6405746|P1|Overall Study|Withdrawal by Sponsor|14
1853385|NCT00129961|6405745|P2|Overall Study|Death|1
1853386|NCT00129961|6405746|P1|Overall Study|Death|1
1853387|NCT00129961|6405745|P2|Overall Study|Adverse Event|0
1853388|NCT00129961|6405746|P1|Overall Study|Adverse Event|1
1853389|NCT00129935|6405782|P2|Overall Study|Incorrect study treatment|0
1853390|NCT00129935|6405783|P1|Overall Study|Incorrect study treatment|1
1853391|NCT00129935|6405782|P2|Overall Study|Crossed to the other arm|1
1853392|NCT00129935|6405783|P1|Overall Study|Crossed to the other arm|2
1853393|NCT00129935|6405782|P2|Overall Study|Other|2
1853394|NCT00129935|6405783|P1|Overall Study|Other|3
1853395|NCT00129935|6405782|P2|Overall Study|Second primary|1
1853396|NCT00129935|6405783|P1|Overall Study|Second primary|0
1853397|NCT00129935|6405782|P2|Overall Study|Recurrence|3
1853398|NCT00129935|6405783|P1|Overall Study|Recurrence|1
1853399|NCT00129935|6405782|P2|Overall Study|Physician Decision|4
1853400|NCT00129935|6405783|P1|Overall Study|Physician Decision|3
1853401|NCT00129935|6405782|P2|Overall Study|Protocol Violation|4
1853402|NCT00129935|6405783|P1|Overall Study|Protocol Violation|0
1853403|NCT00129935|6405782|P2|Overall Study|Withdrawal by Subject|20
1853404|NCT00129935|6405783|P1|Overall Study|Withdrawal by Subject|7
1853405|NCT00129935|6405782|P2|Overall Study|Death|1
1853406|NCT00129935|6405783|P1|Overall Study|Death|1
1853407|NCT00129935|6405782|P2|Overall Study|Adverse Event|56
1853408|NCT00129935|6405783|P1|Overall Study|Adverse Event|18
1853409|NCT00129766|6405801|P2|Overall Study|Lost to Follow-up|21
1853410|NCT00129766|6405802|P1|Overall Study|Lost to Follow-up|26
1853411|NCT00129766|6405801|P2|Overall Study|Withdrawal of consent|30
1853412|NCT00129766|6405802|P1|Overall Study|Withdrawal of consent|31
1853413|NCT00129766|6405801|P2|Overall Study|Death|8
1853414|NCT00129766|6405802|P1|Overall Study|Death|3
1853415|NCT00129701|6405851|P1|Overall Study|Withdrawal by Subject|33
1853416|NCT00129649|6405860|P2|Overall Study|Withdrawal by Subject|65
1853417|NCT00129649|6405861|P1|Overall Study|Withdrawal by Subject|76
1853418|NCT00129623|6405869|P2|Overall Study|Uncertainty to return|1
1853419|NCT00129623|6405870|P1|Overall Study|Uncertainty to return|0
1853420|NCT00129623|6405869|P2|Overall Study|Relocated job out of state|0
1853421|NCT00129623|6405870|P1|Overall Study|Relocated job out of state|1
1853422|NCT00129623|6405869|P2|Overall Study|Failure to Return|1
1853423|NCT00129623|6405870|P1|Overall Study|Failure to Return|1
1853424|NCT00129623|6405869|P2|Overall Study|Refused Treatment|3
1853425|NCT00129623|6405870|P1|Overall Study|Refused Treatment|5
1853426|NCT00129623|6405869|P2|Overall Study|Adverse Event|7
1853427|NCT00129623|6405870|P1|Overall Study|Adverse Event|3
1853428|NCT00129545|6405895|P3|Overall Study|Device not implanted|0
1853429|NCT00129545|6405896|P2|Overall Study|Device not implanted|61
1853430|NCT00129545|6405897|P1|Overall Study|Device not implanted|16
1853431|NCT00129545|6405895|P3|Overall Study|Physician Decision|10
1853432|NCT00129545|6405896|P2|Overall Study|Physician Decision|3
1853433|NCT00129545|6405897|P1|Overall Study|Physician Decision|0
1853434|NCT00129545|6405895|P3|Overall Study|Lost to Follow-up|13
1853435|NCT00129545|6405896|P2|Overall Study|Lost to Follow-up|22
1853436|NCT00129545|6405897|P1|Overall Study|Lost to Follow-up|2
1853437|NCT00129545|6405895|P3|Overall Study|Withdrawal by Subject|44
1853438|NCT00129545|6405896|P2|Overall Study|Withdrawal by Subject|18
1853439|NCT00129545|6405897|P1|Overall Study|Withdrawal by Subject|3
1853440|NCT00129545|6405895|P3|Overall Study|Death|44
1853441|NCT00129545|6405896|P2|Overall Study|Death|60
1853442|NCT00129545|6405897|P1|Overall Study|Death|5
1853443|NCT00129467|6405926|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
1853444|NCT00129467|6405927|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
1853445|NCT00129467|6405926|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
1853446|NCT00129467|6405927|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
1853447|NCT00129467|6405926|P2|Received Intervention|Dizzyness, fatigue|1
1853448|NCT00129467|6405927|P1|Received Intervention|Dizzyness, fatigue|0
1853449|NCT00129467|6405926|P2|Received Intervention|Intolerance to citalopram|1
1853450|NCT00129467|6405927|P1|Received Intervention|Intolerance to citalopram|0
1853451|NCT00129467|6405926|P2|Received Intervention|Nausea|0
1853452|NCT00129467|6405927|P1|Received Intervention|Nausea|1
1853453|NCT00129467|6405926|P2|Received Intervention|Withdrawal by Subject|0
1853454|NCT00129467|6405927|P1|Received Intervention|Withdrawal by Subject|1
1853455|NCT00129467|6405926|P2|Received Intervention|Delirium|0
1853456|NCT00129467|6405927|P1|Received Intervention|Delirium|2
1853457|NCT00129467|6405926|P2|Received Intervention|Cardiac SAE (hypertension)|1
1853458|NCT00129467|6405927|P1|Received Intervention|Cardiac SAE (hypertension)|1
1853459|NCT00129467|6405926|P2|Received Intervention|Death|1
1853460|NCT00129467|6405927|P1|Received Intervention|Death|1
1853461|NCT00129402|6405958|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
1853462|NCT00129402|6405959|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1853463|NCT00129402|6405960|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1853464|NCT00129402|6405961|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1853465|NCT00129402|6405962|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1853466|NCT00129402|6405963|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1853467|NCT00129402|6405964|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
1853468|NCT00129402|6405958|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
1853469|NCT00129402|6405959|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1853470|NCT00129402|6405960|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1853471|NCT00129402|6405961|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1853472|NCT00129402|6405962|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1853473|NCT00129402|6405963|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1853474|NCT00129402|6405964|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
1853475|NCT00129402|6405958|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
1853476|NCT00129402|6405959|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1853477|NCT00129402|6405960|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1853478|NCT00129402|6405961|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1853479|NCT00129402|6405962|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1853480|NCT00129402|6405963|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1853481|NCT00129402|6405964|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
1853482|NCT00129402|6405958|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
1853483|NCT00129402|6405959|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1853484|NCT00129402|6405960|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1853485|NCT00129402|6405961|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1853486|NCT00129402|6405962|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1853487|NCT00129402|6405963|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1853488|NCT00129402|6405964|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
1853489|NCT00129402|6405958|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1853490|NCT00129402|6405959|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1853491|NCT00129402|6405960|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1853492|NCT00129402|6405961|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1853493|NCT00129402|6405962|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
1853494|NCT00129402|6405963|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1853495|NCT00129402|6405964|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
1853496|NCT00129402|6405958|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1853497|NCT00129402|6405959|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
1853498|NCT00129402|6405960|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1853499|NCT00129402|6405961|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1853500|NCT00129402|6405962|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
1853501|NCT00129402|6405963|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1853502|NCT00129402|6405964|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
1853503|NCT00129402|6405958|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1853504|NCT00129402|6405959|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1853505|NCT00129402|6405960|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1853506|NCT00129402|6405961|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1853507|NCT00129402|6405962|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
1853508|NCT00129402|6405963|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1853509|NCT00129402|6405964|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
1853510|NCT00129402|6405958|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1853511|NCT00129402|6405959|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
1853512|NCT00129402|6405960|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1853513|NCT00129402|6405961|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1853514|NCT00129402|6405962|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
1853515|NCT00129402|6405963|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1853516|NCT00129402|6405964|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
1853517|NCT00129402|6405958|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1853518|NCT00129402|6405959|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1853519|NCT00129402|6405960|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1853520|NCT00129402|6405961|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1853521|NCT00129402|6405962|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
1853522|NCT00129402|6405963|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1853523|NCT00129402|6405964|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
1853524|NCT00129402|6405958|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1853525|NCT00129402|6405959|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1853526|NCT00129402|6405960|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1853527|NCT00129402|6405961|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1853528|NCT00129402|6405962|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
1853529|NCT00129402|6405963|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1853530|NCT00129402|6405964|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
1853531|NCT00129402|6405958|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1853532|NCT00129402|6405959|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1853533|NCT00129402|6405960|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1853534|NCT00129402|6405961|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
1853535|NCT00129402|6405962|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1853536|NCT00129402|6405963|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1853537|NCT00129402|6405964|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
1853538|NCT00129402|6405958|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1853539|NCT00129402|6405959|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
1853540|NCT00129402|6405960|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1853541|NCT00129402|6405961|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1853542|NCT00129402|6405962|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1853543|NCT00129402|6405963|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1853544|NCT00129402|6405964|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
1853545|NCT00129402|6405958|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1853546|NCT00129402|6405959|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1853547|NCT00129402|6405960|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1853548|NCT00129402|6405961|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1853549|NCT00129402|6405962|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1853550|NCT00129402|6405963|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
1853551|NCT00129402|6405964|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
1853552|NCT00129389|6405983|P2|Overall Study|Crossed to the other arm|16
1853553|NCT00129389|6405984|P1|Overall Study|Crossed to the other arm|1
1853554|NCT00129389|6405983|P2|Overall Study|Not eligible|2
1853555|NCT00129389|6405984|P1|Overall Study|Not eligible|1
1853556|NCT00129389|6405983|P2|Overall Study|Relapse|0
1853557|NCT00129389|6405984|P1|Overall Study|Relapse|1
1853558|NCT00129389|6405983|P2|Overall Study|Withdrawal by Subject|23
1853559|NCT00129389|6405984|P1|Overall Study|Withdrawal by Subject|9
1853560|NCT00129389|6405983|P2|Overall Study|Protocol Violation|6
1853561|NCT00129389|6405984|P1|Overall Study|Protocol Violation|0
1853562|NCT00129389|6405983|P2|Overall Study|Physician Decision|4
1853563|NCT00129389|6405984|P1|Overall Study|Physician Decision|0
1853564|NCT00129389|6405983|P2|Overall Study|Lost to Follow-up|1
1853565|NCT00129389|6405984|P1|Overall Study|Lost to Follow-up|2
1853566|NCT00129389|6405983|P2|Overall Study|Death|1
1853567|NCT00129389|6405984|P1|Overall Study|Death|0
1853568|NCT00129389|6405983|P2|Overall Study|Adverse Event|87
1853569|NCT00129389|6405984|P1|Overall Study|Adverse Event|19
1853570|NCT00129376|6405992|P1|Overall Study|Lack of Efficacy|1
1853571|NCT00129376|6405992|P1|Overall Study|Adverse Event|1
1853572|NCT00129311|6406002|P2|Overall Study|Withdrawal by Subject|19
1853573|NCT00129311|6406003|P1|Overall Study|Withdrawal by Subject|12
1853574|NCT00129272|6406032|P2|Overall Study|Withdrawal by Subject|11
1853575|NCT00129272|6406033|P1|Overall Study|Withdrawal by Subject|5
1853576|NCT00129272|6406032|P2|Overall Study|Lost to Follow-up|11
1853577|NCT00129272|6406033|P1|Overall Study|Lost to Follow-up|12
1853578|NCT00129259|6406043|P2|Overall Study|Only available minimal phone assessments|1
1853579|NCT00129259|6406044|P1|Overall Study|Only available minimal phone assessments|0
1853580|NCT00129259|6406043|P2|Overall Study|Withdrawal by Subject|1
1853581|NCT00129259|6406044|P1|Overall Study|Withdrawal by Subject|2
1853582|NCT00129259|6406043|P2|Overall Study|Lost to Follow-up|1
1853583|NCT00129259|6406044|P1|Overall Study|Lost to Follow-up|1
1853584|NCT00129220|6406072|P3|Study Period III|Reason Not Specified|2
1853585|NCT00129220|6406073|P2|Study Period III|Reason Not Specified|0
1853586|NCT00129220|6406074|P1|Study Period III|Reason Not Specified|9
1853587|NCT00129220|6406072|P3|Study Period III|Sponsor Decision|0
1853588|NCT00129220|6406073|P2|Study Period III|Sponsor Decision|0
1853589|NCT00129220|6406074|P1|Study Period III|Sponsor Decision|1
1853590|NCT00129220|6406072|P3|Study Period III|Withdrawal by Subject|3
1853591|NCT00129220|6406073|P2|Study Period III|Withdrawal by Subject|0
1853592|NCT00129220|6406074|P1|Study Period III|Withdrawal by Subject|1
1853593|NCT00129220|6406072|P3|Study Period III|Protocol Violation|2
1853594|NCT00129220|6406073|P2|Study Period III|Protocol Violation|1
1853595|NCT00129220|6406074|P1|Study Period III|Protocol Violation|1
1853596|NCT00129220|6406072|P3|Study Period III|Adverse Event|3
1853597|NCT00129220|6406073|P2|Study Period III|Adverse Event|0
1853598|NCT00129220|6406074|P1|Study Period III|Adverse Event|1
1853599|NCT00129220|6406072|P3|Study Period II|Reason Not Specified|5
1853600|NCT00129220|6406073|P2|Study Period II|Reason Not Specified|0
1853601|NCT00129220|6406074|P1|Study Period II|Reason Not Specified|2
1853602|NCT00129220|6406072|P3|Study Period II|Withdrawal by Subject|4
1853603|NCT00129220|6406073|P2|Study Period II|Withdrawal by Subject|3
1853604|NCT00129220|6406074|P1|Study Period II|Withdrawal by Subject|1
1853605|NCT00129220|6406072|P3|Study Period II|Physician Decision|0
1853606|NCT00129220|6406073|P2|Study Period II|Physician Decision|1
1853607|NCT00129220|6406074|P1|Study Period II|Physician Decision|0
1853608|NCT00129220|6406072|P3|Study Period II|Protocol Violation|1
1853609|NCT00129220|6406073|P2|Study Period II|Protocol Violation|2
1853610|NCT00129220|6406074|P1|Study Period II|Protocol Violation|4
1853611|NCT00129220|6406072|P3|Study Period II|Entry Criteria Not Met|2
1853612|NCT00129220|6406073|P2|Study Period II|Entry Criteria Not Met|0
1853613|NCT00129220|6406074|P1|Study Period II|Entry Criteria Not Met|2
1853614|NCT00129220|6406072|P3|Study Period II|Lack of Efficacy|28
1853615|NCT00129220|6406073|P2|Study Period II|Lack of Efficacy|1
1853616|NCT00129220|6406074|P1|Study Period II|Lack of Efficacy|15
1853617|NCT00129220|6406072|P3|Study Period II|Adverse Event|7
1853618|NCT00129220|6406073|P2|Study Period II|Adverse Event|5
1853619|NCT00129220|6406074|P1|Study Period II|Adverse Event|9
1853620|NCT00129129|6406114|P5|Fourth Dose Phase|Protocol Violation|0
1853621|NCT00129129|6406115|P4|Fourth Dose Phase|Protocol Violation|1
1853622|NCT00129129|6406116|P3|Fourth Dose Phase|Protocol Violation|0
1853623|NCT00129129|6406117|P2|Fourth Dose Phase|Protocol Violation|0
1853624|NCT00129129|6406118|P1|Fourth Dose Phase|Protocol Violation|0
1853625|NCT00129129|6406114|P5|Fourth Dose Phase|Other|1
1853626|NCT00129129|6406115|P4|Fourth Dose Phase|Other|1
1853627|NCT00129129|6406116|P3|Fourth Dose Phase|Other|0
1853628|NCT00129129|6406117|P2|Fourth Dose Phase|Other|0
1853629|NCT00129129|6406118|P1|Fourth Dose Phase|Other|0
1853630|NCT00129129|6406114|P5|Fourth Dose Phase|Migration from study area|2
1853631|NCT00129129|6406115|P4|Fourth Dose Phase|Migration from study area|0
1853632|NCT00129129|6406116|P3|Fourth Dose Phase|Migration from study area|0
1853633|NCT00129129|6406117|P2|Fourth Dose Phase|Migration from study area|0
1853634|NCT00129129|6406118|P1|Fourth Dose Phase|Migration from study area|0
1853635|NCT00129129|6406114|P5|Fourth Dose Phase|Withdrawal by Subject|1
1853636|NCT00129129|6406115|P4|Fourth Dose Phase|Withdrawal by Subject|0
1853637|NCT00129129|6406116|P3|Fourth Dose Phase|Withdrawal by Subject|0
1853638|NCT00129129|6406117|P2|Fourth Dose Phase|Withdrawal by Subject|0
1853639|NCT00129129|6406118|P1|Fourth Dose Phase|Withdrawal by Subject|0
1853640|NCT00129129|6406114|P5|Fourth Dose Phase|Lost to Follow-up|2
1853641|NCT00129129|6406115|P4|Fourth Dose Phase|Lost to Follow-up|2
1853642|NCT00129129|6406116|P3|Fourth Dose Phase|Lost to Follow-up|0
1853643|NCT00129129|6406117|P2|Fourth Dose Phase|Lost to Follow-up|0
1853644|NCT00129129|6406118|P1|Fourth Dose Phase|Lost to Follow-up|4
1853645|NCT00129129|6406114|P5|Primary Phase|Other|0
1853646|NCT00129129|6406115|P4|Primary Phase|Other|0
1853647|NCT00129129|6406116|P3|Primary Phase|Other|0
1853648|NCT00129129|6406117|P2|Primary Phase|Other|5
1853649|NCT00129129|6406118|P1|Primary Phase|Other|2
1853650|NCT00129129|6406114|P5|Primary Phase|Lost to Follow-up|0
1853651|NCT00129129|6406115|P4|Primary Phase|Lost to Follow-up|0
1853652|NCT00129129|6406116|P3|Primary Phase|Lost to Follow-up|0
1853653|NCT00129129|6406117|P2|Primary Phase|Lost to Follow-up|6
1853654|NCT00129129|6406118|P1|Primary Phase|Lost to Follow-up|8
1853655|NCT00129129|6406114|P5|Primary Phase|Migration from study area|0
1853656|NCT00129129|6406115|P4|Primary Phase|Migration from study area|0
1853657|NCT00129129|6406116|P3|Primary Phase|Migration from study area|0
1853658|NCT00129129|6406117|P2|Primary Phase|Migration from study area|3
1853659|NCT00129129|6406118|P1|Primary Phase|Migration from study area|1
1853660|NCT00129129|6406114|P5|Primary Phase|Withdrawal by Subject|0
1853661|NCT00129129|6406115|P4|Primary Phase|Withdrawal by Subject|0
1853662|NCT00129129|6406116|P3|Primary Phase|Withdrawal by Subject|0
1853663|NCT00129129|6406117|P2|Primary Phase|Withdrawal by Subject|10
1853664|NCT00129129|6406118|P1|Primary Phase|Withdrawal by Subject|12
1853665|NCT00129129|6406114|P5|Primary Phase|Adverse Event|0
1853666|NCT00129129|6406115|P4|Primary Phase|Adverse Event|0
1853667|NCT00129129|6406116|P3|Primary Phase|Adverse Event|0
1853668|NCT00129129|6406117|P2|Primary Phase|Adverse Event|1
1853669|NCT00129129|6406118|P1|Primary Phase|Adverse Event|2
1853670|NCT00129116|6406325|P5|Booster Phase|Lost to Follow-up|1
1853671|NCT00129116|6406326|P4|Booster Phase|Lost to Follow-up|0
1853672|NCT00129116|6406327|P3|Booster Phase|Lost to Follow-up|0
1853673|NCT00129116|6406328|P2|Booster Phase|Lost to Follow-up|0
1853674|NCT00129116|6406329|P1|Booster Phase|Lost to Follow-up|2
1853675|NCT00129116|6406325|P5|Primary Phase|Other|0
1853676|NCT00129116|6406326|P4|Primary Phase|Other|0
1853677|NCT00129116|6406327|P3|Primary Phase|Other|1
1853678|NCT00129116|6406328|P2|Primary Phase|Other|0
1853679|NCT00129116|6406329|P1|Primary Phase|Other|0
1853680|NCT00129116|6406325|P5|Primary Phase|Withdrawal by Subject|0
1853681|NCT00129116|6406326|P4|Primary Phase|Withdrawal by Subject|0
1853682|NCT00129116|6406327|P3|Primary Phase|Withdrawal by Subject|0
1853683|NCT00129116|6406328|P2|Primary Phase|Withdrawal by Subject|1
1853684|NCT00129116|6406329|P1|Primary Phase|Withdrawal by Subject|0
1853685|NCT00129116|6406325|P5|Primary Phase|Adverse Event|0
1853686|NCT00129116|6406326|P4|Primary Phase|Adverse Event|0
1853687|NCT00129116|6406327|P3|Primary Phase|Adverse Event|0
1853688|NCT00129116|6406328|P2|Primary Phase|Adverse Event|1
1853689|NCT00129116|6406329|P1|Primary Phase|Adverse Event|1
1853690|NCT00129116|6406325|P5|Primary Phase|Protocol Violation|0
1853691|NCT00129116|6406326|P4|Primary Phase|Protocol Violation|0
1853692|NCT00129116|6406327|P3|Primary Phase|Protocol Violation|0
1853693|NCT00129116|6406328|P2|Primary Phase|Protocol Violation|1
1853694|NCT00129116|6406329|P1|Primary Phase|Protocol Violation|0
1853695|NCT00129116|6406325|P5|Primary Phase|Lost to Follow-up|1
1853696|NCT00129116|6406326|P4|Primary Phase|Lost to Follow-up|1
1853697|NCT00129116|6406327|P3|Primary Phase|Lost to Follow-up|0
1853698|NCT00129116|6406328|P2|Primary Phase|Lost to Follow-up|1
1853699|NCT00129116|6406329|P1|Primary Phase|Lost to Follow-up|1
1853700|NCT00128830|6406613|P1|Overall Study|Other|9
1853701|NCT00128830|6406613|P1|Overall Study|Discontinued or ineligible for study|2
1853702|NCT00128830|6406613|P1|Overall Study|Non-compliant|4
1853703|NCT00128830|6406613|P1|Overall Study|Reached a virologic endpoint|29
1853704|NCT00128830|6406613|P1|Overall Study|Lost to Follow-up|4
1853705|NCT00128830|6406613|P1|Overall Study|Withdrawal by Subject|14
1853706|NCT00128830|6406613|P1|Overall Study|Adverse Event|10
1853707|NCT00128661|6406655|P2|Overall Study|Other|8
1853708|NCT00128661|6406656|P1|Overall Study|Other|7
1853709|NCT00128661|6406655|P2|Overall Study|Withdrawal by Subject|232
1853710|NCT00128661|6406656|P1|Overall Study|Withdrawal by Subject|243
1853711|NCT00128661|6406655|P2|Overall Study|Lost to Follow-up|7
1853712|NCT00128661|6406656|P1|Overall Study|Lost to Follow-up|10
1853713|NCT00128661|6406655|P2|Overall Study|Adverse Event|11
1853714|NCT00128661|6406656|P1|Overall Study|Adverse Event|14
1853715|NCT00128492|6406702|P2|Overall Study|Pregnancy|1
1853716|NCT00128492|6406703|P1|Overall Study|Pregnancy|0
1853717|NCT00128492|6406702|P2|Overall Study|Withdrawal by Subject|5
1853718|NCT00128492|6406703|P1|Overall Study|Withdrawal by Subject|3
1853719|NCT00128492|6406702|P2|Overall Study|Personal or administrative|22
1853720|NCT00128492|6406703|P1|Overall Study|Personal or administrative|10
1853721|NCT00128492|6406702|P2|Overall Study|Noncompliance|5
1853722|NCT00128492|6406703|P1|Overall Study|Noncompliance|0
1853723|NCT00128492|6406702|P2|Overall Study|Lost to Follow-up|5
1853724|NCT00128492|6406703|P1|Overall Study|Lost to Follow-up|1
1853725|NCT00128492|6406702|P2|Overall Study|Death|0
1853726|NCT00128492|6406703|P1|Overall Study|Death|1
1853727|NCT00128492|6406702|P2|Overall Study|AE related to study|4
1853728|NCT00128492|6406703|P1|Overall Study|AE related to study|1
1853729|NCT00128492|6406702|P2|Overall Study|Study drug intolerance (AE)|8
1853730|NCT00128492|6406703|P1|Overall Study|Study drug intolerance (AE)|2
1853731|NCT00128492|6406702|P2|Overall Study|AE unrelated to study|9
1853732|NCT00128492|6406703|P1|Overall Study|AE unrelated to study|2
1853733|NCT00128206|6406860|P2|Overall Study|Adverse Event|2
1853734|NCT00128206|6406861|P1|Overall Study|Adverse Event|0
1853735|NCT00128206|6406860|P2|Overall Study|Lost to Follow-up|118
1853736|NCT00128206|6406861|P1|Overall Study|Lost to Follow-up|137
1853737|NCT00127933|6407153|P2|Overall Study|Randomized but not dosed|0
1853738|NCT00127933|6407154|P1|Overall Study|Randomized but not dosed|1
1853739|NCT00127855|6407175|P5|Primary Vaccination Course|Other|1
1853740|NCT00127855|6407176|P4|Primary Vaccination Course|Other|0
1853741|NCT00127855|6407177|P3|Primary Vaccination Course|Other|0
1853742|NCT00127855|6407178|P2|Primary Vaccination Course|Other|0
1853743|NCT00127855|6407179|P1|Primary Vaccination Course|Other|0
1853744|NCT00127855|6407175|P5|Primary Vaccination Course|Lost to Follow-up|2
1853745|NCT00127855|6407176|P4|Primary Vaccination Course|Lost to Follow-up|0
1853746|NCT00127855|6407177|P3|Primary Vaccination Course|Lost to Follow-up|1
1853747|NCT00127855|6407178|P2|Primary Vaccination Course|Lost to Follow-up|1
1853748|NCT00127855|6407179|P1|Primary Vaccination Course|Lost to Follow-up|1
1853749|NCT00127855|6407175|P5|Primary Vaccination Course|Withdrawal by Subject|1
1853750|NCT00127855|6407176|P4|Primary Vaccination Course|Withdrawal by Subject|0
1853751|NCT00127855|6407177|P3|Primary Vaccination Course|Withdrawal by Subject|0
1853752|NCT00127855|6407178|P2|Primary Vaccination Course|Withdrawal by Subject|0
1853753|NCT00127855|6407179|P1|Primary Vaccination Course|Withdrawal by Subject|1
1853754|NCT00127855|6407175|P5|Primary Vaccination Course|Adverse Event|0
1853755|NCT00127855|6407176|P4|Primary Vaccination Course|Adverse Event|0
1853756|NCT00127855|6407177|P3|Primary Vaccination Course|Adverse Event|1
1853757|NCT00127855|6407178|P2|Primary Vaccination Course|Adverse Event|0
1853758|NCT00127855|6407179|P1|Primary Vaccination Course|Adverse Event|0
1853759|NCT00127842|6407361|P1|Overall Study|Other|5
1853760|NCT00127842|6407361|P1|Overall Study|Protocol Violation|1
1853761|NCT00127842|6407361|P1|Overall Study|Noncompliance|2
1853762|NCT00127842|6407361|P1|Overall Study|Lack of Efficacy|12
1853763|NCT00127842|6407361|P1|Overall Study|Lost to Follow-up|1
1853764|NCT00127842|6407361|P1|Overall Study|Withdrawal by Subject|3
1853765|NCT00127842|6407361|P1|Overall Study|Adverse Event|15
1853766|NCT00127803|6407379|P4|Overall Study|Lost to Follow-up|1
1853767|NCT00127803|6407380|P3|Overall Study|Lost to Follow-up|0
1853768|NCT00127803|6407381|P2|Overall Study|Lost to Follow-up|0
1853769|NCT00127803|6407382|P1|Overall Study|Lost to Follow-up|0
1853770|NCT00127803|6407379|P4|Overall Study|Withdrawal by Subject|0
1853771|NCT00127803|6407380|P3|Overall Study|Withdrawal by Subject|0
1853772|NCT00127803|6407381|P2|Overall Study|Withdrawal by Subject|0
1853773|NCT00127803|6407382|P1|Overall Study|Withdrawal by Subject|1
1853774|NCT00127803|6407379|P4|Overall Study|Adverse Event|0
1853775|NCT00127803|6407380|P3|Overall Study|Adverse Event|0
1853776|NCT00127803|6407381|P2|Overall Study|Adverse Event|0
1853777|NCT00127803|6407382|P1|Overall Study|Adverse Event|2
1853778|NCT00127712|6407431|P2|Overall Study|Lack of GI access to continue|0
1853779|NCT00127712|6407432|P1|Overall Study|Lack of GI access to continue|2
1853780|NCT00127712|6407431|P2|Overall Study|Adverse Event|0
1853781|NCT00127712|6407432|P1|Overall Study|Adverse Event|3
1853782|NCT00127660|6407448|P4|Overall Study|Protocol Violation|0
1853783|NCT00127660|6407449|P3|Overall Study|Protocol Violation|5
1853784|NCT00127660|6407450|P2|Overall Study|Protocol Violation|3
1853785|NCT00127660|6407451|P1|Overall Study|Protocol Violation|3
1853786|NCT00127608|6407461|P1|Overall Study|VZV DNA negative|1
1853787|NCT00127413|6407505|P4|Overall Study|Lost to Follow-up|2
1853788|NCT00127413|6407506|P3|Overall Study|Lost to Follow-up|8
1853789|NCT00127413|6407507|P2|Overall Study|Lost to Follow-up|4
1853790|NCT00127413|6407508|P1|Overall Study|Lost to Follow-up|6
1853791|NCT00127205|6407549|P3|Overall Study|Progression|84
1853792|NCT00127205|6407550|P2|Overall Study|Progression|130
1853793|NCT00127205|6407551|P1|Overall Study|Progression|127
1853794|NCT00127205|6407549|P3|Overall Study|Under Review|6
1853795|NCT00127205|6407550|P2|Overall Study|Under Review|21
1853796|NCT00127205|6407551|P1|Overall Study|Under Review|13
1853797|NCT00127205|6407549|P3|Overall Study|Other-non protocol specified|77
1853798|NCT00127205|6407550|P2|Overall Study|Other-non protocol specified|129
1853799|NCT00127205|6407551|P1|Overall Study|Other-non protocol specified|141
1853800|NCT00127205|6407549|P3|Overall Study|Withdrawal by Subject|172
1853801|NCT00127205|6407550|P2|Overall Study|Withdrawal by Subject|308
1853802|NCT00127205|6407551|P1|Overall Study|Withdrawal by Subject|318
1853803|NCT00127205|6407549|P3|Overall Study|Death|6
1853804|NCT00127205|6407550|P2|Overall Study|Death|6
1853805|NCT00127205|6407551|P1|Overall Study|Death|8
1853806|NCT00127205|6407549|P3|Overall Study|Adverse Event|272
1853807|NCT00127205|6407550|P2|Overall Study|Adverse Event|386
1853808|NCT00127205|6407551|P1|Overall Study|Adverse Event|228
1853809|NCT00127192|6407573|P5|Overall Study|Adverse event in pre-treatment period|0
1853810|NCT00127192|6407574|P4|Overall Study|Adverse event in pre-treatment period|0
1853811|NCT00127192|6407575|P3|Overall Study|Adverse event in pre-treatment period|0
1853812|NCT00127192|6407576|P2|Overall Study|Adverse event in pre-treatment period|0
1853813|NCT00127192|6407577|P1|Overall Study|Adverse event in pre-treatment period|1
1853814|NCT00127192|6407573|P5|Overall Study|Withdrawal by Subject|3
1853815|NCT00127192|6407574|P4|Overall Study|Withdrawal by Subject|0
1853816|NCT00127192|6407575|P3|Overall Study|Withdrawal by Subject|1
1853817|NCT00127192|6407576|P2|Overall Study|Withdrawal by Subject|0
1853818|NCT00127192|6407577|P1|Overall Study|Withdrawal by Subject|0
1853819|NCT00127192|6407573|P5|Overall Study|Lack of Efficacy|2
1853820|NCT00127192|6407574|P4|Overall Study|Lack of Efficacy|0
1853821|NCT00127192|6407575|P3|Overall Study|Lack of Efficacy|0
1853822|NCT00127192|6407576|P2|Overall Study|Lack of Efficacy|0
1853823|NCT00127192|6407577|P1|Overall Study|Lack of Efficacy|2
1853824|NCT00127192|6407573|P5|Overall Study|Adverse Event|0
1853825|NCT00127192|6407574|P4|Overall Study|Adverse Event|1
1853826|NCT00127192|6407575|P3|Overall Study|Adverse Event|1
1853827|NCT00127192|6407576|P2|Overall Study|Adverse Event|1
1853828|NCT00127192|6407577|P1|Overall Study|Adverse Event|0
1853829|NCT00127166|6407601|P2|Period II|Patient did not perform Visit 6 exercise|0
1853830|NCT00127166|6407602|P1|Period II|Patient did not perform Visit 6 exercise|1
1853831|NCT00127166|6407601|P2|Period II|Withdrawal by Subject|0
1853832|NCT00127166|6407602|P1|Period II|Withdrawal by Subject|2
1853833|NCT00127166|6407601|P2|Washout Period|Patient did not meet inclusion criteria|1
1853834|NCT00127166|6407602|P1|Washout Period|Patient did not meet inclusion criteria|0
1853835|NCT00127166|6407601|P2|Period I|Patient did not meet inclusion criteria|0
1853836|NCT00127166|6407602|P1|Period I|Patient did not meet inclusion criteria|1
1853837|NCT00127166|6407601|P2|Period I|Withdrawal by Subject|0
1853838|NCT00127166|6407602|P1|Period I|Withdrawal by Subject|2
1853839|NCT00127166|6407601|P2|Period I|Protocol Violation|2
1853840|NCT00127166|6407602|P1|Period I|Protocol Violation|0
1853841|NCT00127101|6407622|P6|Continuation Phase|Withdrawal by Subject|1
1853842|NCT00127101|6407623|P5|Continuation Phase|Withdrawal by Subject|2
1853843|NCT00127101|6407624|P4|Continuation Phase|Withdrawal by Subject|0
1853844|NCT00127101|6407625|P3|Continuation Phase|Withdrawal by Subject|1
1853845|NCT00127101|6407626|P2|Continuation Phase|Withdrawal by Subject|0
1853846|NCT00127101|6407627|P1|Continuation Phase|Withdrawal by Subject|0
1853847|NCT00127101|6407622|P6|Continuation Phase|Lack of Efficacy|1
1853848|NCT00127101|6407623|P5|Continuation Phase|Lack of Efficacy|0
1853849|NCT00127101|6407624|P4|Continuation Phase|Lack of Efficacy|0
1853850|NCT00127101|6407625|P3|Continuation Phase|Lack of Efficacy|0
1853851|NCT00127101|6407626|P2|Continuation Phase|Lack of Efficacy|0
1853852|NCT00127101|6407627|P1|Continuation Phase|Lack of Efficacy|0
1853853|NCT00127101|6407622|P6|Continuation Phase|Adverse Event|1
1853854|NCT00127101|6407623|P5|Continuation Phase|Adverse Event|1
1853855|NCT00127101|6407624|P4|Continuation Phase|Adverse Event|0
1853856|NCT00127101|6407625|P3|Continuation Phase|Adverse Event|0
1853857|NCT00127101|6407626|P2|Continuation Phase|Adverse Event|0
1853858|NCT00127101|6407627|P1|Continuation Phase|Adverse Event|0
1853859|NCT00127101|6407622|P6|Base Protocol|Withdrawal by Subject|1
1853860|NCT00127101|6407623|P5|Base Protocol|Withdrawal by Subject|0
1853861|NCT00127101|6407624|P4|Base Protocol|Withdrawal by Subject|0
1853862|NCT00127101|6407625|P3|Base Protocol|Withdrawal by Subject|1
1853863|NCT00127101|6407626|P2|Base Protocol|Withdrawal by Subject|2
1853864|NCT00127101|6407627|P1|Base Protocol|Withdrawal by Subject|1
1853865|NCT00127101|6407622|P6|Base Protocol|Lack of Efficacy|0
1853866|NCT00127101|6407623|P5|Base Protocol|Lack of Efficacy|2
1853867|NCT00127101|6407624|P4|Base Protocol|Lack of Efficacy|0
1853868|NCT00127101|6407625|P3|Base Protocol|Lack of Efficacy|0
1853869|NCT00127101|6407626|P2|Base Protocol|Lack of Efficacy|0
1853870|NCT00127101|6407627|P1|Base Protocol|Lack of Efficacy|1
1853871|NCT00127101|6407622|P6|Base Protocol|Adverse Event|0
1853872|NCT00127101|6407623|P5|Base Protocol|Adverse Event|0
1853873|NCT00127101|6407624|P4|Base Protocol|Adverse Event|0
1853874|NCT00127101|6407625|P3|Base Protocol|Adverse Event|1
1853875|NCT00127101|6407626|P2|Base Protocol|Adverse Event|2
1853876|NCT00127101|6407627|P1|Base Protocol|Adverse Event|0
1853877|NCT00127036|6407662|P2|Overall Study|Screen Failure|0
1853878|NCT00127036|6407663|P1|Overall Study|Screen Failure|2
1853879|NCT00127036|6407662|P2|Overall Study|Insufficient Data for Analysis|11
1853880|NCT00127036|6407663|P1|Overall Study|Insufficient Data for Analysis|6
1853881|NCT00126776|6407675|P2|Overall Study|follow up complete on all patients|0
1853882|NCT00126776|6407676|P1|Overall Study|follow up complete on all patients|0
1853883|NCT00126659|6407725|P3|Overall Study|Adverse Event|2
1853884|NCT00126659|6407726|P2|Overall Study|Adverse Event|0
1853885|NCT00126659|6407727|P1|Overall Study|Adverse Event|0
1853886|NCT00126594|6407735|P2|Overall Study|Disease Progression|24
1853887|NCT00126594|6407736|P1|Overall Study|Disease Progression|29
1853888|NCT00126594|6407735|P2|Overall Study|Non-compliance|1
1853889|NCT00126594|6407736|P1|Overall Study|Non-compliance|0
1853890|NCT00126594|6407735|P2|Overall Study|Adverse Event|5
1853891|NCT00126594|6407736|P1|Overall Study|Adverse Event|7
1853892|NCT00126594|6407735|P2|Overall Study|Physician Decision|3
1853893|NCT00126594|6407736|P1|Overall Study|Physician Decision|1
1853894|NCT00126594|6407735|P2|Overall Study|Withdrawal by Subject|4
1853895|NCT00126594|6407736|P1|Overall Study|Withdrawal by Subject|0
1853896|NCT00126594|6407735|P2|Overall Study|Ineligible|0
1853897|NCT00126594|6407736|P1|Overall Study|Ineligible|2
1853898|NCT00126581|6407753|P2|Overall Study|Other illness/MD discretion|4
1853899|NCT00126581|6407754|P1|Overall Study|Other illness/MD discretion|3
1853900|NCT00126581|6407753|P2|Overall Study|Alternative therapy|3
1853901|NCT00126581|6407754|P1|Overall Study|Alternative therapy|3
1853902|NCT00126581|6407753|P2|Overall Study|Withdrawal by Subject|4
1853903|NCT00126581|6407754|P1|Overall Study|Withdrawal by Subject|1
1853904|NCT00126581|6407753|P2|Overall Study|Death|2
1853905|NCT00126581|6407754|P1|Overall Study|Death|3
1853906|NCT00126581|6407753|P2|Overall Study|Adverse Event|7
1853907|NCT00126581|6407754|P1|Overall Study|Adverse Event|3
1853908|NCT00126568|6407774|P1|Overall Study|Death|2
1853909|NCT00126555|6407781|P1|Overall Study|Progressive Disease|3
1853910|NCT00126555|6407781|P1|Overall Study|Adverse Event|2
1853911|NCT00126555|6407781|P1|Overall Study|Withdrawal by Subject|1
1853912|NCT00126503|6407803|P2|Overall Study|Physician Decision|1
1853913|NCT00126503|6407804|P1|Overall Study|Physician Decision|2
1853914|NCT00126503|6407803|P2|Overall Study|non-compliant|0
1853915|NCT00126503|6407804|P1|Overall Study|non-compliant|1
1853916|NCT00126503|6407803|P2|Overall Study|Adverse Event|3
1853917|NCT00126503|6407804|P1|Overall Study|Adverse Event|13
1853918|NCT00126503|6407803|P2|Overall Study|Death|0
1853919|NCT00126503|6407804|P1|Overall Study|Death|3
1853920|NCT00126503|6407803|P2|Overall Study|other complicating disease|1
1853921|NCT00126503|6407804|P1|Overall Study|other complicating disease|4
1853922|NCT00126503|6407803|P2|Overall Study|alternative therapy|1
1853923|NCT00126503|6407804|P1|Overall Study|alternative therapy|1
1853924|NCT00126503|6407803|P2|Overall Study|Withdrawal by Subject|1
1853925|NCT00126503|6407804|P1|Overall Study|Withdrawal by Subject|0
1853926|NCT00126503|6407803|P2|Overall Study|disease progression|14
1853927|NCT00126503|6407804|P1|Overall Study|disease progression|23
1853928|NCT00126490|6407816|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
1853929|NCT00126438|6407826|P2|Overall Study|Withdrawal by Subject|2
1853930|NCT00126438|6407827|P1|Overall Study|Withdrawal by Subject|3
1853931|NCT00126438|6407826|P2|Overall Study|Protocol Violation|8
1853932|NCT00126438|6407827|P1|Overall Study|Protocol Violation|8
1853933|NCT00126438|6407826|P2|Overall Study|Lost to Follow-up|0
1853934|NCT00126438|6407827|P1|Overall Study|Lost to Follow-up|22
1853935|NCT00126438|6407826|P2|Overall Study|Withdrawal due to adverse event|0
1853936|NCT00126438|6407827|P1|Overall Study|Withdrawal due to adverse event|1
1853937|NCT00126425|6407835|P2|Overall Study|Other|0
1853938|NCT00126425|6407836|P1|Overall Study|Other|5
1853939|NCT00126425|6407835|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
1853940|NCT00126425|6407836|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
1853941|NCT00126425|6407835|P2|Overall Study|Adverse Event|0
1853942|NCT00126425|6407836|P1|Overall Study|Adverse Event|1
1853943|NCT00126425|6407835|P2|Overall Study|Protocol Violation|6
1853944|NCT00126425|6407836|P1|Overall Study|Protocol Violation|9
1853945|NCT00126425|6407835|P2|Overall Study|Lost to Follow-up|4
1853946|NCT00126425|6407836|P1|Overall Study|Lost to Follow-up|8
1853947|NCT00126425|6407835|P2|Overall Study|Withdrawal by Subject|1
1853948|NCT00126425|6407836|P1|Overall Study|Withdrawal by Subject|17
1853949|NCT00126191|6407844|P2|Overall Study|Death|1
1853950|NCT00126191|6407845|P1|Overall Study|Death|0
1853951|NCT00126191|6407844|P2|Overall Study|Physician Decision|1
1853952|NCT00126191|6407845|P1|Overall Study|Physician Decision|0
1853953|NCT00126126|6407855|P2|Overall Study|Lost to Follow-up|2
1853954|NCT00126126|6407856|P1|Overall Study|Lost to Follow-up|0
1853955|NCT00125853|6407895|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
1853956|NCT00125853|6407896|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
1853957|NCT00125359|6408010|P1|Overall Study|Physician Decision|14
1853958|NCT00125359|6408010|P1|Overall Study|Adverse Event|5
1853959|NCT00125359|6408010|P1|Overall Study|Death|4
1853960|NCT00125268|6408019|P2|Overall Study|Withdrawal by Subject|1
1853961|NCT00125268|6408020|P1|Overall Study|Withdrawal by Subject|1
1853962|NCT00125242|6408032|P2|Overall Study|did not qualify|2
1853963|NCT00125242|6408033|P1|Overall Study|did not qualify|7
1853964|NCT00125190|6408038|P1|Overall Study|Non-compliance|2
1853965|NCT00125190|6408038|P1|Overall Study|other|1
1853966|NCT00125190|6408038|P1|Overall Study|Patient/Parent Decision|7
1853967|NCT00125190|6408038|P1|Overall Study|Lost to Follow-up|4
1853968|NCT00125190|6408038|P1|Overall Study|Adverse Event|1
1853969|NCT00125164|6408056|P4|Overall Study|Withdrawal by Subject|1
1853970|NCT00125164|6408057|P3|Overall Study|Withdrawal by Subject|1
1853971|NCT00125164|6408058|P2|Overall Study|Withdrawal by Subject|0
1853972|NCT00125164|6408059|P1|Overall Study|Withdrawal by Subject|2
1853973|NCT00125164|6408056|P4|Overall Study|Lost to Follow-up|1
1853974|NCT00125164|6408057|P3|Overall Study|Lost to Follow-up|1
1853975|NCT00125164|6408058|P2|Overall Study|Lost to Follow-up|0
1853976|NCT00125164|6408059|P1|Overall Study|Lost to Follow-up|0
1853977|NCT00125164|6408056|P4|Overall Study|Adverse Event|4
1853978|NCT00125164|6408057|P3|Overall Study|Adverse Event|2
1853979|NCT00125164|6408058|P2|Overall Study|Adverse Event|0
1853980|NCT00125164|6408059|P1|Overall Study|Adverse Event|0
1853981|NCT00125138|6408113|P4|Overall Study|Sponsor decision-pt moved to assist care|1
1853982|NCT00125138|6408114|P3|Overall Study|Sponsor decision-pt moved to assist care|0
1853983|NCT00125138|6408115|P2|Overall Study|Sponsor decision-pt moved to assist care|0
1853984|NCT00125138|6408116|P1|Overall Study|Sponsor decision-pt moved to assist care|0
1853985|NCT00125138|6408113|P4|Overall Study|Lack of Efficacy|1
1853986|NCT00125138|6408114|P3|Overall Study|Lack of Efficacy|0
1853987|NCT00125138|6408115|P2|Overall Study|Lack of Efficacy|0
1853988|NCT00125138|6408116|P1|Overall Study|Lack of Efficacy|0
1853989|NCT00125138|6408113|P4|Overall Study|Withdrawal by Subject|1
1853990|NCT00125138|6408114|P3|Overall Study|Withdrawal by Subject|1
1853991|NCT00125138|6408115|P2|Overall Study|Withdrawal by Subject|3
1853992|NCT00125138|6408116|P1|Overall Study|Withdrawal by Subject|2
1853993|NCT00125138|6408113|P4|Overall Study|Adverse Event|2
1853994|NCT00125138|6408114|P3|Overall Study|Adverse Event|3
1853995|NCT00125138|6408115|P2|Overall Study|Adverse Event|0
1853996|NCT00125138|6408116|P1|Overall Study|Adverse Event|1
1853997|NCT00124982|6408165|P3|Long-term Period|Neurologist Recommendation|1
1853998|NCT00124982|6408166|P2|Long-term Period|Neurologist Recommendation|0
1853999|NCT00124982|6408167|P1|Long-term Period|Neurologist Recommendation|0
1854000|NCT00124982|6408165|P3|Long-term Period|Administrative Reason by Sponsor|1
1854001|NCT00124982|6408166|P2|Long-term Period|Administrative Reason by Sponsor|0
1854002|NCT00124982|6408167|P1|Long-term Period|Administrative Reason by Sponsor|0
1854003|NCT00124982|6408165|P3|Long-term Period|Poor/Non-compliance|2
1854004|NCT00124982|6408166|P2|Long-term Period|Poor/Non-compliance|0
1854005|NCT00124982|6408167|P1|Long-term Period|Poor/Non-compliance|0
1854006|NCT00124982|6408165|P3|Long-term Period|Pregnancy|1
1854007|NCT00124982|6408166|P2|Long-term Period|Pregnancy|0
1854008|NCT00124982|6408167|P1|Long-term Period|Pregnancy|0
1854009|NCT00124982|6408165|P3|Long-term Period|Withdrawal by Subject|16
1854010|NCT00124982|6408166|P2|Long-term Period|Withdrawal by Subject|0
1854011|NCT00124982|6408167|P1|Long-term Period|Withdrawal by Subject|0
1854012|NCT00124982|6408165|P3|Long-term Period|Lost to Follow-up|4
1854013|NCT00124982|6408166|P2|Long-term Period|Lost to Follow-up|0
1854014|NCT00124982|6408167|P1|Long-term Period|Lost to Follow-up|0
1854015|NCT00124982|6408165|P3|Long-term Period|Lack of Efficacy|46
1854016|NCT00124982|6408166|P2|Long-term Period|Lack of Efficacy|0
1854017|NCT00124982|6408167|P1|Long-term Period|Lack of Efficacy|0
1854018|NCT00124982|6408165|P3|Long-term Period|Adverse Event|17
1854019|NCT00124982|6408166|P2|Long-term Period|Adverse Event|0
1854020|NCT00124982|6408167|P1|Long-term Period|Adverse Event|0
1854021|NCT00124982|6408165|P3|Long-term Period|Death|1
1854022|NCT00124982|6408166|P2|Long-term Period|Death|0
1854023|NCT00124982|6408167|P1|Long-term Period|Death|0
1854024|NCT00124982|6408165|P3|Short-term Period|Participant Had Lymphopenia|0
1854025|NCT00124982|6408166|P2|Short-term Period|Participant Had Lymphopenia|0
1854026|NCT00124982|6408167|P1|Short-term Period|Participant Had Lymphopenia|1
1854027|NCT00124982|6408165|P3|Short-term Period|Investigator Decision-No Specific AE|0
1854028|NCT00124982|6408166|P2|Short-term Period|Investigator Decision-No Specific AE|0
1854029|NCT00124982|6408167|P1|Short-term Period|Investigator Decision-No Specific AE|1
1854030|NCT00124982|6408165|P3|Short-term Period|Participant Chose Own Doctor|0
1854031|NCT00124982|6408166|P2|Short-term Period|Participant Chose Own Doctor|1
1854032|NCT00124982|6408167|P1|Short-term Period|Participant Chose Own Doctor|0
1854033|NCT00124982|6408165|P3|Short-term Period|Participant Decision|0
1854034|NCT00124982|6408166|P2|Short-term Period|Participant Decision|0
1854035|NCT00124982|6408167|P1|Short-term Period|Participant Decision|1
1854036|NCT00124982|6408165|P3|Short-term Period|No Longer Meets Study Criteria|0
1854037|NCT00124982|6408166|P2|Short-term Period|No Longer Meets Study Criteria|2
1854038|NCT00124982|6408167|P1|Short-term Period|No Longer Meets Study Criteria|1
1854039|NCT00124982|6408165|P3|Short-term Period|Poor/Non-compliance|0
1854040|NCT00124982|6408166|P2|Short-term Period|Poor/Non-compliance|1
1854041|NCT00124982|6408167|P1|Short-term Period|Poor/Non-compliance|3
1854042|NCT00124982|6408165|P3|Short-term Period|Withdrawal of Consent|0
1854043|NCT00124982|6408166|P2|Short-term Period|Withdrawal of Consent|9
1854044|NCT00124982|6408167|P1|Short-term Period|Withdrawal of Consent|7
1854045|NCT00124982|6408165|P3|Short-term Period|Lost to Follow-up|0
1854046|NCT00124982|6408166|P2|Short-term Period|Lost to Follow-up|5
1854047|NCT00124982|6408167|P1|Short-term Period|Lost to Follow-up|8
1854048|NCT00124982|6408165|P3|Short-term Period|Lack of Efficacy|0
1854049|NCT00124982|6408166|P2|Short-term Period|Lack of Efficacy|73
1854050|NCT00124982|6408167|P1|Short-term Period|Lack of Efficacy|32
1854051|NCT00124982|6408165|P3|Short-term Period|Adverse Event|0
1854052|NCT00124982|6408166|P2|Short-term Period|Adverse Event|22
1854053|NCT00124982|6408167|P1|Short-term Period|Adverse Event|17
1854054|NCT00124982|6408165|P3|Short-term Period|Death|0
1854055|NCT00124982|6408166|P2|Short-term Period|Death|1
1854056|NCT00124982|6408167|P1|Short-term Period|Death|1
1854057|NCT00124943|6408249|P4|Phase II|Withdrawal by Subject|2
1854058|NCT00124943|6408250|P3|Phase II|Withdrawal by Subject|0
1854059|NCT00124943|6408251|P2|Phase II|Withdrawal by Subject|0
1854060|NCT00124943|6408252|P1|Phase II|Withdrawal by Subject|0
1854061|NCT00124943|6408249|P4|Phase II|Lost to Follow-up|1
1854062|NCT00124943|6408250|P3|Phase II|Lost to Follow-up|0
1854063|NCT00124943|6408251|P2|Phase II|Lost to Follow-up|0
1854064|NCT00124943|6408252|P1|Phase II|Lost to Follow-up|0
1854065|NCT00124943|6408249|P4|Phase II|Protocol Violation|1
1854066|NCT00124943|6408250|P3|Phase II|Protocol Violation|0
1854067|NCT00124943|6408251|P2|Phase II|Protocol Violation|0
1854068|NCT00124943|6408252|P1|Phase II|Protocol Violation|0
1854069|NCT00124943|6408249|P4|Phase II|Adverse Event|1
1854070|NCT00124943|6408250|P3|Phase II|Adverse Event|0
1854071|NCT00124943|6408251|P2|Phase II|Adverse Event|2
1854072|NCT00124943|6408252|P1|Phase II|Adverse Event|0
1854073|NCT00124917|6408290|P1|Overall Study|Physician Decision|3
1854074|NCT00124748|6408300|P2|Overall Study|Death|3
1854075|NCT00124748|6408301|P1|Overall Study|Death|1
1854076|NCT00124748|6408300|P2|Overall Study|Administrative Problem(Study Terminated)|174
1854077|NCT00124748|6408301|P1|Overall Study|Administrative Problem(Study Terminated)|101
1854078|NCT00124748|6408300|P2|Overall Study|Lost to Follow-up|7
1854079|NCT00124748|6408301|P1|Overall Study|Lost to Follow-up|2
1854080|NCT00124748|6408300|P2|Overall Study|Withdrawal by Subject|15
1854081|NCT00124748|6408301|P1|Overall Study|Withdrawal by Subject|5
1854082|NCT00124748|6408300|P2|Overall Study|Protocol Violation|1
1854083|NCT00124748|6408301|P1|Overall Study|Protocol Violation|3
1854084|NCT00124748|6408300|P2|Overall Study|No longer requires study drug|1
1854085|NCT00124748|6408301|P1|Overall Study|No longer requires study drug|1
1854086|NCT00124748|6408300|P2|Overall Study|Lack of Efficacy|41
1854087|NCT00124748|6408301|P1|Overall Study|Lack of Efficacy|20
1854088|NCT00124748|6408300|P2|Overall Study|Abnormal Procedure|1
1854089|NCT00124748|6408301|P1|Overall Study|Abnormal Procedure|0
1854090|NCT00124748|6408300|P2|Overall Study|Abnormal laboratory Value|2
1854091|NCT00124748|6408301|P1|Overall Study|Abnormal laboratory Value|2
1854092|NCT00124748|6408300|P2|Overall Study|Adverse Event|39
1854093|NCT00124748|6408301|P1|Overall Study|Adverse Event|8
1854094|NCT00124709|6408408|P2|Overall Study|Lost to Follow-up|120
1854095|NCT00124709|6408409|P1|Overall Study|Lost to Follow-up|114
1854096|NCT00124709|6408408|P2|Overall Study|Withdrawal by Subject|136
1854097|NCT00124709|6408409|P1|Overall Study|Withdrawal by Subject|127
1854098|NCT00124709|6408408|P2|Overall Study|Protocol Violation|5
1854099|NCT00124709|6408409|P1|Overall Study|Protocol Violation|3
1854100|NCT00124709|6408408|P2|Overall Study|Lack of Efficacy|10
1854101|NCT00124709|6408409|P1|Overall Study|Lack of Efficacy|5
1854102|NCT00124709|6408408|P2|Overall Study|Adverse Event|0
1854103|NCT00124709|6408409|P1|Overall Study|Adverse Event|3
1854104|NCT00124709|6408408|P2|Overall Study|Randomized but did not take medication|1
1854105|NCT00124709|6408409|P1|Overall Study|Randomized but did not take medication|3
1854106|NCT00124657|6408426|P3|Overall Study|Intercurrent illness|0
1854107|NCT00124657|6408427|P2|Overall Study|Intercurrent illness|0
1854108|NCT00124657|6408428|P1|Overall Study|Intercurrent illness|1
1854109|NCT00124657|6408426|P3|Overall Study|Progressive disease|27
1854110|NCT00124657|6408427|P2|Overall Study|Progressive disease|5
1854111|NCT00124657|6408428|P1|Overall Study|Progressive disease|14
1854112|NCT00124657|6408426|P3|Overall Study|Non-compliance|4
1854113|NCT00124657|6408427|P2|Overall Study|Non-compliance|0
1854114|NCT00124657|6408428|P1|Overall Study|Non-compliance|1
1854115|NCT00124657|6408426|P3|Overall Study|Toxicity|1
1854116|NCT00124657|6408427|P2|Overall Study|Toxicity|0
1854117|NCT00124657|6408428|P1|Overall Study|Toxicity|0
1854118|NCT00124618|6408463|P1|Overall Study|Ineligible|1
1854119|NCT00124462|6408478|P2|Overall Study|Device fitting, n=2, other hlth issues|1
1854120|NCT00124462|6408479|P1|Overall Study|Device fitting, n=2, other hlth issues|1
1854121|NCT00124462|6408478|P2|Overall Study|Withdrawal by Subject|5
1854122|NCT00124462|6408479|P1|Overall Study|Withdrawal by Subject|4
1854123|NCT00124462|6408478|P2|Overall Study|Physician Decision|4
1854124|NCT00124462|6408479|P1|Overall Study|Physician Decision|3
1854125|NCT00124462|6408478|P2|Overall Study|Lost to Follow-up|3
1854126|NCT00124462|6408479|P1|Overall Study|Lost to Follow-up|3
1854127|NCT00124449|6408489|P2|18-Month Untreated Observation Period|Relocated|0
1854128|NCT00124449|6408490|P1|18-Month Untreated Observation Period|Relocated|1
1854129|NCT00124449|6408489|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
1854130|NCT00124449|6408490|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
1854131|NCT00124449|6408489|P2|18-Month Untreated Observation Period|Pregnancy|0
1854132|NCT00124449|6408490|P1|18-Month Untreated Observation Period|Pregnancy|1
1854133|NCT00124449|6408489|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
1854134|NCT00124449|6408490|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
1854135|NCT00124449|6408489|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
1854136|NCT00124449|6408490|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
1854137|NCT00124449|6408489|P2|18-Month Untreated Observation Period|Adverse Event|1
1854138|NCT00124449|6408490|P1|18-Month Untreated Observation Period|Adverse Event|0
1854139|NCT00124449|6408489|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
1854140|NCT00124449|6408490|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
1854141|NCT00124449|6408489|P2|6-month Double-Blind Treatment Period|Sponsor request|1
1854142|NCT00124449|6408490|P1|6-month Double-Blind Treatment Period|Sponsor request|0
1854143|NCT00124449|6408489|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
1854144|NCT00124449|6408490|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
1854145|NCT00124449|6408489|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1854146|NCT00124449|6408490|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
1854147|NCT00124449|6408489|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
1854148|NCT00124449|6408490|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
1854149|NCT00124449|6408489|P2|6-month Double-Blind Treatment Period|Adverse Event|0
1854150|NCT00124449|6408490|P1|6-month Double-Blind Treatment Period|Adverse Event|1
1854151|NCT00124072|6408544|P4|Overall Study|Death|480
1854152|NCT00124072|6408545|P3|Overall Study|Death|471
1854153|NCT00124072|6408546|P2|Overall Study|Death|484
1854154|NCT00124072|6408547|P1|Overall Study|Death|499
1854155|NCT00124072|6408544|P4|Overall Study|Lost to Follow-up for Morbidity|18
1854156|NCT00124072|6408545|P3|Overall Study|Lost to Follow-up for Morbidity|19
1854157|NCT00124072|6408546|P2|Overall Study|Lost to Follow-up for Morbidity|25
1854158|NCT00124072|6408547|P1|Overall Study|Lost to Follow-up for Morbidity|15
1854159|NCT00124072|6408544|P4|Overall Study|Lost to Follow-up for Mortality|2
1854160|NCT00124072|6408545|P3|Overall Study|Lost to Follow-up for Mortality|2
1854161|NCT00124072|6408546|P2|Overall Study|Lost to Follow-up for Mortality|3
1854162|NCT00124072|6408547|P1|Overall Study|Lost to Follow-up for Mortality|0
1854163|NCT00124020|6408559|P2|Overall Study|Transfer to another hospital|0
1854164|NCT00124020|6408560|P1|Overall Study|Transfer to another hospital|2
1854165|NCT00124020|6408559|P2|Overall Study|Other|1
1854166|NCT00124020|6408560|P1|Overall Study|Other|1
1854167|NCT00124020|6408559|P2|Overall Study|Lost to Follow-up|8
1854168|NCT00124020|6408560|P1|Overall Study|Lost to Follow-up|5
1854169|NCT00124020|6408559|P2|Overall Study|Withdrawal by Subject|11
1854170|NCT00124020|6408560|P1|Overall Study|Withdrawal by Subject|13
1854171|NCT00124020|6408559|P2|Overall Study|Death|71
1854172|NCT00124020|6408560|P1|Overall Study|Death|67
1854173|NCT00123955|6408568|P2|Overall Study|Death|1
1854174|NCT00123955|6408569|P1|Overall Study|Death|0
1854175|NCT00123955|6408568|P2|Overall Study|Withdrawal by Subject|3
1854176|NCT00123955|6408569|P1|Overall Study|Withdrawal by Subject|4
1854177|NCT00123955|6408568|P2|Overall Study|Adverse Event|0
1854178|NCT00123955|6408569|P1|Overall Study|Adverse Event|1
1854179|NCT00123734|6408581|P1|Overall Study|Withdrawal by Subject|1
1854180|NCT00123734|6408581|P1|Overall Study|Dropout|1
1854181|NCT00123734|6408581|P1|Overall Study|Lost to Follow-up|3
1854182|NCT00123734|6408581|P1|Overall Study|Death|3
1854183|NCT00123487|6408666|P2|Treated With Study Drug|Unknown (case report form lost)|1
1854184|NCT00123487|6408667|P1|Treated With Study Drug|Unknown (case report form lost)|0
1854185|NCT00123487|6408666|P2|Treated With Study Drug|Withdrawal by Subject|13
1854186|NCT00123487|6408667|P1|Treated With Study Drug|Withdrawal by Subject|11
1854187|NCT00123487|6408666|P2|Treated With Study Drug|Study Drug Toxicity|80
1854188|NCT00123487|6408667|P1|Treated With Study Drug|Study Drug Toxicity|62
1854189|NCT00123487|6408666|P2|Treated With Study Drug|Other|58
1854190|NCT00123487|6408667|P1|Treated With Study Drug|Other|59
1854191|NCT00123487|6408666|P2|Treated With Study Drug|Physician Decision|9
1854192|NCT00123487|6408667|P1|Treated With Study Drug|Physician Decision|8
1854193|NCT00123487|6408666|P2|Treated With Study Drug|Disease Progression|122
1854194|NCT00123487|6408667|P1|Treated With Study Drug|Disease Progression|141
1854195|NCT00123487|6408666|P2|Treated With Study Drug|Adverse Event|22
1854196|NCT00123487|6408667|P1|Treated With Study Drug|Adverse Event|23
1854197|NCT00123487|6408666|P2|Randomized|SAE prior to starting treatment|0
1854198|NCT00123487|6408667|P1|Randomized|SAE prior to starting treatment|1
1854199|NCT00123487|6408666|P2|Randomized|Death prior to starting treatment|1
1854200|NCT00123487|6408667|P1|Randomized|Death prior to starting treatment|0
1854201|NCT00123474|6408711|P4|As Treated at Study Closure|Withdrawal by Subject|16
1854202|NCT00123474|6408712|P3|As Treated at Study Closure|Withdrawal by Subject|18
1854203|NCT00123474|6408713|P2|As Treated at Study Closure|Withdrawal by Subject|19
1854204|NCT00123474|6408714|P1|As Treated at Study Closure|Withdrawal by Subject|14
1854205|NCT00123474|6408711|P4|As Treated at Study Closure|Study Drug Toxicity|51
1854206|NCT00123474|6408712|P3|As Treated at Study Closure|Study Drug Toxicity|45
1854207|NCT00123474|6408713|P2|As Treated at Study Closure|Study Drug Toxicity|45
1854208|NCT00123474|6408714|P1|As Treated at Study Closure|Study Drug Toxicity|39
1854209|NCT00123474|6408711|P4|As Treated at Study Closure|non-specified|60
1854210|NCT00123474|6408712|P3|As Treated at Study Closure|non-specified|57
1854211|NCT00123474|6408713|P2|As Treated at Study Closure|non-specified|47
1854212|NCT00123474|6408714|P1|As Treated at Study Closure|non-specified|54
1854213|NCT00123474|6408711|P4|As Treated at Study Closure|Investigator Request|5
1854214|NCT00123474|6408712|P3|As Treated at Study Closure|Investigator Request|7
1854215|NCT00123474|6408713|P2|As Treated at Study Closure|Investigator Request|6
1854216|NCT00123474|6408714|P1|As Treated at Study Closure|Investigator Request|12
1854217|NCT00123474|6408711|P4|As Treated at Study Closure|Disease Progression|27
1854218|NCT00123474|6408712|P3|As Treated at Study Closure|Disease Progression|29
1854219|NCT00123474|6408713|P2|As Treated at Study Closure|Disease Progression|42
1854220|NCT00123474|6408714|P1|As Treated at Study Closure|Disease Progression|35
1854221|NCT00123474|6408711|P4|As Treated at Study Closure|Adverse Event|8
1854222|NCT00123474|6408712|P3|As Treated at Study Closure|Adverse Event|10
1854223|NCT00123474|6408713|P2|As Treated at Study Closure|Adverse Event|4
1854224|NCT00123474|6408714|P1|As Treated at Study Closure|Adverse Event|10
1854225|NCT00123474|6408711|P4|As Treated at Study Closure|not reported when site closed|0
1854226|NCT00123474|6408712|P3|As Treated at Study Closure|not reported when site closed|1
1854227|NCT00123474|6408713|P2|As Treated at Study Closure|not reported when site closed|0
1854228|NCT00123474|6408714|P1|As Treated at Study Closure|not reported when site closed|1
1854229|NCT00123474|6408711|P4|Randomized to Treatment|Randomized, never treated|1
1854230|NCT00123474|6408712|P3|Randomized to Treatment|Randomized, never treated|2
1854231|NCT00123474|6408713|P2|Randomized to Treatment|Randomized, never treated|4
1854232|NCT00123474|6408714|P1|Randomized to Treatment|Randomized, never treated|1
1854233|NCT00123422|6408808|P3|Overall Study|Lost to Follow-up|2
1854234|NCT00123422|6408809|P2|Overall Study|Lost to Follow-up|2
1854235|NCT00123422|6408810|P1|Overall Study|Lost to Follow-up|1
1854236|NCT00123422|6408808|P3|Overall Study|Withdrawal by Subject|2
1854237|NCT00123422|6408809|P2|Overall Study|Withdrawal by Subject|2
1854238|NCT00123422|6408810|P1|Overall Study|Withdrawal by Subject|1
1854239|NCT00123422|6408808|P3|Overall Study|Physician Decision|6
1854240|NCT00123422|6408809|P2|Overall Study|Physician Decision|2
1854241|NCT00123422|6408810|P1|Overall Study|Physician Decision|2
1854242|NCT00122980|6408898|P2|Overall Study|Study termination|35
1854243|NCT00122980|6408899|P1|Overall Study|Study termination|27
1854244|NCT00122980|6408898|P2|Overall Study|Adjudicated stroke (study endpoint)|0
1854245|NCT00122980|6408899|P1|Overall Study|Adjudicated stroke (study endpoint)|7
1854246|NCT00122980|6408898|P2|Overall Study|Withdrawal by Subject|3
1854247|NCT00122980|6408899|P1|Overall Study|Withdrawal by Subject|2
1854248|NCT00122980|6408898|P2|Overall Study|Protocol Violation|1
1854249|NCT00122980|6408899|P1|Overall Study|Protocol Violation|5
1854250|NCT00122980|6408898|P2|Overall Study|Physician Decision|0
1854251|NCT00122980|6408899|P1|Overall Study|Physician Decision|2
1854252|NCT00122980|6408898|P2|Overall Study|Death|1
1854253|NCT00122980|6408899|P1|Overall Study|Death|0
1854254|NCT00122954|6408923|P2|Overall Study|Protocol Violation|1
1854255|NCT00122954|6408924|P1|Overall Study|Protocol Violation|0
1854256|NCT00122954|6408923|P2|Overall Study|Withdrawal by Subject|2
1854257|NCT00122954|6408924|P1|Overall Study|Withdrawal by Subject|2
1854258|NCT00122681|6408934|P2|Overall Study|Personal reasons|147
1854259|NCT00122681|6408935|P1|Overall Study|Personal reasons|150
1854260|NCT00122681|6408934|P2|Overall Study|Withdrawal by Subject|251
1854261|NCT00122681|6408935|P1|Overall Study|Withdrawal by Subject|257
1854262|NCT00122681|6408934|P2|Overall Study|Protocol Violation|10
1854263|NCT00122681|6408935|P1|Overall Study|Protocol Violation|7
1854264|NCT00122681|6408934|P2|Overall Study|Lost to Follow-up|1097
1854265|NCT00122681|6408935|P1|Overall Study|Lost to Follow-up|1080
1854266|NCT00122681|6408934|P2|Overall Study|Adverse Event|16
1854267|NCT00122681|6408935|P1|Overall Study|Adverse Event|20
1854268|NCT00122460|6409009|P2|Overall Study|investigational study phase ongoing|1
1854269|NCT00122460|6409010|P1|Overall Study|investigational study phase ongoing|7
1854270|NCT00122382|6409059|P3|Open-Label Study|Withdrawal of Consent|4
1854271|NCT00122382|6409060|P2|Open-Label Study|Withdrawal of Consent|0
1854272|NCT00122382|6409061|P1|Open-Label Study|Withdrawal of Consent|0
1854273|NCT00122382|6409059|P3|Open-Label Study|Poor/Non-Compliance|1
1854274|NCT00122382|6409060|P2|Open-Label Study|Poor/Non-Compliance|0
1854275|NCT00122382|6409061|P1|Open-Label Study|Poor/Non-Compliance|0
1854276|NCT00122382|6409059|P3|Open-Label Study|Pregnancy|2
1854277|NCT00122382|6409060|P2|Open-Label Study|Pregnancy|0
1854278|NCT00122382|6409061|P1|Open-Label Study|Pregnancy|0
1854279|NCT00122382|6409059|P3|Open-Label Study|Lost to Follow-up|3
1854280|NCT00122382|6409060|P2|Open-Label Study|Lost to Follow-up|0
1854281|NCT00122382|6409061|P1|Open-Label Study|Lost to Follow-up|0
1854282|NCT00122382|6409059|P3|Open-Label Study|Lack of Efficacy|3
1854283|NCT00122382|6409060|P2|Open-Label Study|Lack of Efficacy|0
1854284|NCT00122382|6409061|P1|Open-Label Study|Lack of Efficacy|0
1854285|NCT00122382|6409059|P3|Open-Label Study|Death|2
1854286|NCT00122382|6409060|P2|Open-Label Study|Death|0
1854287|NCT00122382|6409061|P1|Open-Label Study|Death|0
1854288|NCT00122382|6409059|P3|Open-Label Study|Adverse Event|11
1854289|NCT00122382|6409060|P2|Open-Label Study|Adverse Event|0
1854290|NCT00122382|6409061|P1|Open-Label Study|Adverse Event|0
1854291|NCT00122382|6409059|P3|Double-Blind Study|Randomized but not treated|0
1854292|NCT00122382|6409060|P2|Double-Blind Study|Randomized but not treated|2
1854293|NCT00122382|6409061|P1|Double-Blind Study|Randomized but not treated|0
1854294|NCT00122382|6409059|P3|Double-Blind Study|Methotrexate Discontinued|0
1854295|NCT00122382|6409060|P2|Double-Blind Study|Methotrexate Discontinued|1
1854296|NCT00122382|6409061|P1|Double-Blind Study|Methotrexate Discontinued|0
1854297|NCT00122382|6409059|P3|Double-Blind Study|Protocol Violation|0
1854298|NCT00122382|6409060|P2|Double-Blind Study|Protocol Violation|0
1854299|NCT00122382|6409061|P1|Double-Blind Study|Protocol Violation|1
1854300|NCT00122382|6409059|P3|Double-Blind Study|Withdrawal of Consent|0
1854301|NCT00122382|6409060|P2|Double-Blind Study|Withdrawal of Consent|3
1854302|NCT00122382|6409061|P1|Double-Blind Study|Withdrawal of Consent|7
1854303|NCT00122382|6409059|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1854304|NCT00122382|6409060|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
1854305|NCT00122382|6409061|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
1854306|NCT00122382|6409059|P3|Double-Blind Study|Pregnancy|0
1854307|NCT00122382|6409060|P2|Double-Blind Study|Pregnancy|0
1854308|NCT00122382|6409061|P1|Double-Blind Study|Pregnancy|2
1854309|NCT00122382|6409059|P3|Double-Blind Study|Lost to Follow-up|0
1854310|NCT00122382|6409060|P2|Double-Blind Study|Lost to Follow-up|1
1854311|NCT00122382|6409061|P1|Double-Blind Study|Lost to Follow-up|2
1854312|NCT00122382|6409059|P3|Double-Blind Study|Lack of Efficacy|0
1854313|NCT00122382|6409060|P2|Double-Blind Study|Lack of Efficacy|8
1854314|NCT00122382|6409061|P1|Double-Blind Study|Lack of Efficacy|0
1854315|NCT00122382|6409059|P3|Double-Blind Study|Death|0
1854316|NCT00122382|6409060|P2|Double-Blind Study|Death|2
1854317|NCT00122382|6409061|P1|Double-Blind Study|Death|2
1854318|NCT00122382|6409059|P3|Double-Blind Study|Adverse Event|0
1854319|NCT00122382|6409060|P2|Double-Blind Study|Adverse Event|11
1854320|NCT00122382|6409061|P1|Double-Blind Study|Adverse Event|9
1854321|NCT00122317|6409205|P1|Overall Study|Withdrawal by Subject|1
1854322|NCT00122317|6409205|P1|Overall Study|patient non-compliance|1
1854323|NCT00122317|6409205|P1|Overall Study|Physician Decision|2
1854324|NCT00122317|6409205|P1|Overall Study|Adverse Event|4
1854325|NCT00122317|6409205|P1|Overall Study|Death|3
1854326|NCT00122278|6409214|P2|Overall Study|Lost to Follow-up|0
1854327|NCT00122278|6409215|P1|Overall Study|Lost to Follow-up|2
1854328|NCT00122187|6409225|P2|Overall Study|Withdrew because of resource limitations|2
1854329|NCT00122187|6409226|P1|Overall Study|Withdrew because of resource limitations|2
1854330|NCT00122135|6409240|P2|Overall Study|Withdrawal by Subject|0
1854331|NCT00122135|6409241|P1|Overall Study|Withdrawal by Subject|3
1854332|NCT00122109|6409249|P2|Overall Study|Did not meet criteria|7
1854333|NCT00122109|6409250|P1|Overall Study|Did not meet criteria|6
1854334|NCT00121719|6409312|P14|Food-Effect Pilot Study (4 Weeks)|Other|0
1854335|NCT00121719|6409313|P13|Food-Effect Pilot Study (4 Weeks)|Other|0
1854336|NCT00121719|6409314|P12|Food-Effect Pilot Study (4 Weeks)|Other|1
1854337|NCT00121719|6409315|P11|Food-Effect Pilot Study (4 Weeks)|Other|1
1854338|NCT00121719|6409316|P10|Food-Effect Pilot Study (4 Weeks)|Other|0
1854339|NCT00121719|6409317|P9|Food-Effect Pilot Study (4 Weeks)|Other|0
1854340|NCT00121719|6409318|P8|Food-Effect Pilot Study (4 Weeks)|Other|0
1854341|NCT00121719|6409319|P7|Food-Effect Pilot Study (4 Weeks)|Other|0
1854342|NCT00121719|6409320|P6|Food-Effect Pilot Study (4 Weeks)|Other|0
1854343|NCT00121719|6409321|P5|Food-Effect Pilot Study (4 Weeks)|Other|0
1854344|NCT00121719|6409322|P4|Food-Effect Pilot Study (4 Weeks)|Other|0
1854345|NCT00121719|6409323|P3|Food-Effect Pilot Study (4 Weeks)|Other|0
1854346|NCT00121719|6409324|P2|Food-Effect Pilot Study (4 Weeks)|Other|0
1854347|NCT00121719|6409325|P1|Food-Effect Pilot Study (4 Weeks)|Other|0
1854348|NCT00121719|6409312|P14|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854349|NCT00121719|6409313|P13|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854350|NCT00121719|6409314|P12|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|1
1854351|NCT00121719|6409315|P11|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854352|NCT00121719|6409316|P10|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854353|NCT00121719|6409317|P9|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854354|NCT00121719|6409318|P8|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854355|NCT00121719|6409319|P7|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854356|NCT00121719|6409320|P6|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854357|NCT00121719|6409321|P5|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854358|NCT00121719|6409322|P4|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854359|NCT00121719|6409323|P3|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854360|NCT00121719|6409324|P2|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854361|NCT00121719|6409325|P1|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
1854362|NCT00121719|6409312|P14|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854363|NCT00121719|6409313|P13|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854364|NCT00121719|6409314|P12|Food-Effect Pilot Study (4 Weeks)|Progressive disease|3
1854365|NCT00121719|6409315|P11|Food-Effect Pilot Study (4 Weeks)|Progressive disease|4
1854366|NCT00121719|6409316|P10|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854367|NCT00121719|6409317|P9|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854368|NCT00121719|6409318|P8|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854369|NCT00121719|6409319|P7|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854370|NCT00121719|6409320|P6|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854371|NCT00121719|6409321|P5|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854372|NCT00121719|6409322|P4|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854373|NCT00121719|6409323|P3|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854374|NCT00121719|6409324|P2|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854375|NCT00121719|6409325|P1|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
1854376|NCT00121719|6409312|P14|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854377|NCT00121719|6409313|P13|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854378|NCT00121719|6409314|P12|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854379|NCT00121719|6409315|P11|Food-Effect Pilot Study (4 Weeks)|Adverse Event|1
1854380|NCT00121719|6409316|P10|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854381|NCT00121719|6409317|P9|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854382|NCT00121719|6409318|P8|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854383|NCT00121719|6409319|P7|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854384|NCT00121719|6409320|P6|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854385|NCT00121719|6409321|P5|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854386|NCT00121719|6409322|P4|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854387|NCT00121719|6409323|P3|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854388|NCT00121719|6409324|P2|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854389|NCT00121719|6409325|P1|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
1854390|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854391|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Continuing/ongoing patients|3
1854392|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854393|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854394|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854395|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854396|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Continuing/ongoing patients|1
1854397|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854398|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854399|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854400|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854401|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854402|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854403|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
1854404|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Other|1
1854405|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Other|1
1854406|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Other|0
1854407|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Other|0
1854408|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Other|0
1854409|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Other|1
1854410|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Other|0
1854411|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Other|1
1854412|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Other|0
1854413|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Other|0
1854414|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Other|1
1854415|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Other|1
1854416|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Other|0
1854417|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Other|0
1854418|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Physician Decision|0
1854419|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Physician Decision|1
1854420|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Physician Decision|0
1854421|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Physician Decision|0
1854422|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Physician Decision|0
1854423|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Physician Decision|0
1854424|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Physician Decision|0
1854425|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Physician Decision|0
1854426|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Physician Decision|0
1854427|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Physician Decision|0
1854428|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Physician Decision|0
1854429|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Physician Decision|0
1854430|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Physician Decision|1
1854431|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Physician Decision|0
1854432|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Clinical deterioration|2
1854433|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Clinical deterioration|2
1854434|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Clinical deterioration|0
1854435|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Clinical deterioration|0
1854436|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Clinical deterioration|2
1854437|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Clinical deterioration|2
1854438|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Clinical deterioration|1
1854439|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Clinical deterioration|2
1854440|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Clinical deterioration|0
1854441|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Clinical deterioration|1
1854442|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Clinical deterioration|0
1854443|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Clinical deterioration|1
1854444|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Clinical deterioration|1
1854445|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Clinical deterioration|0
1854446|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Progressive disease|4
1854447|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Progressive disease|13
1854448|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Progressive disease|0
1854449|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Progressive disease|0
1854450|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Progressive disease|1
1854451|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Progressive disease|3
1854452|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Progressive disease|5
1854453|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Progressive disease|7
1854454|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Progressive disease|1
1854455|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Progressive disease|2
1854456|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Progressive disease|2
1854457|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Progressive disease|0
1854458|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Progressive disease|1
1854459|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Progressive disease|2
1854460|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854461|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854462|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854463|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854464|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854465|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854466|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854467|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854468|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854469|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854470|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854471|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854472|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
1854473|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Withdrawal by Subject|1
1854474|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Protocol deviation|0
1854475|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Protocol deviation|0
1854476|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Protocol deviation|0
1854477|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Protocol deviation|0
1854478|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Protocol deviation|0
1854479|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Protocol deviation|0
1854480|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Protocol deviation|0
1854481|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Protocol deviation|0
1854482|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Protocol deviation|0
1854483|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Protocol deviation|0
1854484|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Protocol deviation|0
1854485|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Protocol deviation|1
1854486|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Protocol deviation|0
1854487|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Protocol deviation|0
1854488|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854489|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
1854490|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854491|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854492|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854493|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854494|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
1854495|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854496|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854497|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854498|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854499|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
1854500|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
1854501|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
1854502|NCT00121719|6409312|P14|Dose Escalation (4 Weeks)|Adverse Event|0
1854503|NCT00121719|6409313|P13|Dose Escalation (4 Weeks)|Adverse Event|3
1854504|NCT00121719|6409314|P12|Dose Escalation (4 Weeks)|Adverse Event|0
1854505|NCT00121719|6409315|P11|Dose Escalation (4 Weeks)|Adverse Event|0
1854506|NCT00121719|6409316|P10|Dose Escalation (4 Weeks)|Adverse Event|0
1854507|NCT00121719|6409317|P9|Dose Escalation (4 Weeks)|Adverse Event|0
1854508|NCT00121719|6409318|P8|Dose Escalation (4 Weeks)|Adverse Event|1
1854509|NCT00121719|6409319|P7|Dose Escalation (4 Weeks)|Adverse Event|2
1854510|NCT00121719|6409320|P6|Dose Escalation (4 Weeks)|Adverse Event|2
1854511|NCT00121719|6409321|P5|Dose Escalation (4 Weeks)|Adverse Event|0
1854512|NCT00121719|6409322|P4|Dose Escalation (4 Weeks)|Adverse Event|0
1854513|NCT00121719|6409323|P3|Dose Escalation (4 Weeks)|Adverse Event|1
1854514|NCT00121719|6409324|P2|Dose Escalation (4 Weeks)|Adverse Event|0
1854515|NCT00121719|6409325|P1|Dose Escalation (4 Weeks)|Adverse Event|0
1854516|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Death|2
1854517|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Death|0
1854518|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Death|0
1854519|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Death|1
1854520|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1854521|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
1854522|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1854523|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
1854524|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
1854525|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
1854526|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
1854527|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
1854528|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
1854529|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
1854530|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
1854531|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
1854532|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
1854533|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
1854534|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
1854535|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
1854536|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
1854537|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
1854538|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1854539|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
1854540|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
1854541|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
1854542|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
1854543|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
1854544|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
1854545|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
1854546|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
1854547|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
1854548|NCT00121667|6409502|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
1854549|NCT00121667|6409503|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
1854550|NCT00121667|6409504|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
1854551|NCT00121667|6409505|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
1854552|NCT00121667|6409502|P4|Short Term (ST) Period|Pregnancy|1
1854553|NCT00121667|6409503|P3|Short Term (ST) Period|Pregnancy|0
1854554|NCT00121667|6409504|P2|Short Term (ST) Period|Pregnancy|0
1854555|NCT00121667|6409505|P1|Short Term (ST) Period|Pregnancy|0
1854556|NCT00121667|6409502|P4|Short Term (ST) Period|Death|1
1854557|NCT00121667|6409503|P3|Short Term (ST) Period|Death|0
1854558|NCT00121667|6409504|P2|Short Term (ST) Period|Death|0
1854559|NCT00121667|6409505|P1|Short Term (ST) Period|Death|0
1854560|NCT00121667|6409502|P4|Short Term (ST) Period|Other Reason|0
1854561|NCT00121667|6409503|P3|Short Term (ST) Period|Other Reason|0
1854562|NCT00121667|6409504|P2|Short Term (ST) Period|Other Reason|0
1854563|NCT00121667|6409505|P1|Short Term (ST) Period|Other Reason|3
1854564|NCT00121667|6409502|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1854565|NCT00121667|6409503|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1854566|NCT00121667|6409504|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
1854567|NCT00121667|6409505|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
1854568|NCT00121667|6409502|P4|Short Term (ST) Period|Poor / Non-compliance|2
1854569|NCT00121667|6409503|P3|Short Term (ST) Period|Poor / Non-compliance|1
1854570|NCT00121667|6409504|P2|Short Term (ST) Period|Poor / Non-compliance|1
1854571|NCT00121667|6409505|P1|Short Term (ST) Period|Poor / Non-compliance|0
1854572|NCT00121667|6409502|P4|Short Term (ST) Period|Lost to Follow-up|3
1854573|NCT00121667|6409503|P3|Short Term (ST) Period|Lost to Follow-up|4
1854574|NCT00121667|6409504|P2|Short Term (ST) Period|Lost to Follow-up|4
1854575|NCT00121667|6409505|P1|Short Term (ST) Period|Lost to Follow-up|3
1854576|NCT00121667|6409502|P4|Short Term (ST) Period|Adverse Event|3
1854577|NCT00121667|6409503|P3|Short Term (ST) Period|Adverse Event|5
1854578|NCT00121667|6409504|P2|Short Term (ST) Period|Adverse Event|6
1854579|NCT00121667|6409505|P1|Short Term (ST) Period|Adverse Event|5
1854580|NCT00121667|6409502|P4|Short Term (ST) Period|Subject Withdrew Consent|11
1854581|NCT00121667|6409503|P3|Short Term (ST) Period|Subject Withdrew Consent|4
1854582|NCT00121667|6409504|P2|Short Term (ST) Period|Subject Withdrew Consent|13
1854583|NCT00121667|6409505|P1|Short Term (ST) Period|Subject Withdrew Consent|8
1854584|NCT00121667|6409502|P4|Short Term (ST) Period|Lack of Efficacy|44
1854585|NCT00121667|6409503|P3|Short Term (ST) Period|Lack of Efficacy|27
1854586|NCT00121667|6409504|P2|Short Term (ST) Period|Lack of Efficacy|22
1854587|NCT00121667|6409505|P1|Short Term (ST) Period|Lack of Efficacy|25
1854588|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Other Reason|1
1854589|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Other Reason|0
1854590|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Other Reason|2
1854591|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Other Reason|3
1854592|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Other Reason|5
1854593|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Missing|0
1854594|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Missing|0
1854595|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Missing|1
1854596|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Missing|0
1854597|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Missing|0
1854598|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Death|0
1854599|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Death|1
1854600|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Death|0
1854601|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Death|0
1854602|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Death|0
1854603|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1854604|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1854605|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
1854606|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
1854607|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
1854608|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Pregnancy|0
1854609|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Pregnancy|1
1854610|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Pregnancy|0
1854611|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Pregnancy|1
1854612|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Pregnancy|0
1854613|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1854614|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1854615|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
1854616|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
1854617|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
1854618|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1854619|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
1854620|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1854621|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
1854622|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
1854623|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
1854624|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
1854625|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
1854626|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
1854627|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
1854628|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Adverse Event|5
1854629|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Adverse Event|5
1854630|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Adverse Event|10
1854631|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Adverse Event|10
1854632|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Adverse Event|9
1854633|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
1854634|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
1854635|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
1854636|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
1854637|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
1854638|NCT00121641|6409603|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
1854639|NCT00121641|6409604|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
1854640|NCT00121641|6409605|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
1854641|NCT00121641|6409606|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
1854642|NCT00121641|6409607|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
1854643|NCT00121641|6409603|P5|24-week Short-term Treatment Period|Other Reason|0
1854644|NCT00121641|6409604|P4|24-week Short-term Treatment Period|Other Reason|0
1854645|NCT00121641|6409605|P3|24-week Short-term Treatment Period|Other Reason|0
1854646|NCT00121641|6409606|P2|24-week Short-term Treatment Period|Other Reason|0
1854647|NCT00121641|6409607|P1|24-week Short-term Treatment Period|Other Reason|1
1854648|NCT00121641|6409603|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1854649|NCT00121641|6409604|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1854650|NCT00121641|6409605|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
1854651|NCT00121641|6409606|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1854652|NCT00121641|6409607|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
1854653|NCT00121641|6409603|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
1854654|NCT00121641|6409604|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
1854655|NCT00121641|6409605|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
1854656|NCT00121641|6409606|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
1854657|NCT00121641|6409607|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
1854658|NCT00121641|6409603|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
1854659|NCT00121641|6409604|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
1854660|NCT00121641|6409605|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
1854661|NCT00121641|6409606|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
1854662|NCT00121641|6409607|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
1854663|NCT00121641|6409603|P5|24-week Short-term Treatment Period|Adverse Event|2
1854664|NCT00121641|6409604|P4|24-week Short-term Treatment Period|Adverse Event|0
1854665|NCT00121641|6409605|P3|24-week Short-term Treatment Period|Adverse Event|4
1854666|NCT00121641|6409606|P2|24-week Short-term Treatment Period|Adverse Event|3
1854667|NCT00121641|6409607|P1|24-week Short-term Treatment Period|Adverse Event|3
1854668|NCT00121641|6409603|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
1854669|NCT00121641|6409604|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
1854670|NCT00121641|6409605|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
1854671|NCT00121641|6409606|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
1854672|NCT00121641|6409607|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
1854673|NCT00121641|6409603|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
1854674|NCT00121641|6409604|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
1854675|NCT00121641|6409605|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
1854676|NCT00121641|6409606|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
1854677|NCT00121641|6409607|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
1854678|NCT00121485|6409720|P2|Overall Study|Crossover|2
1854679|NCT00121485|6409721|P1|Overall Study|Crossover|0
1854680|NCT00121485|6409720|P2|Overall Study|Not implanted|5
1854681|NCT00121485|6409721|P1|Overall Study|Not implanted|1
1854682|NCT00121238|6409766|P1|Overall Study|Protocol Violation|2
1854683|NCT00121238|6409766|P1|Overall Study|disease progression before intervention|1
1854684|NCT00121199|6409782|P1|Overall Study|Ineligible|9
1854685|NCT00121199|6409782|P1|Overall Study|Other - Not Protocol Specified|3
1854686|NCT00121199|6409782|P1|Overall Study|Death|3
1854687|NCT00121199|6409782|P1|Overall Study|Progression/Relapse|1
1854688|NCT00121199|6409782|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1854689|NCT00121199|6409782|P1|Overall Study|Adverse Event|11
1854690|NCT00121134|6409826|P4|Overall Study|Patient Personal Reasons|0
1854691|NCT00121134|6409827|P3|Overall Study|Patient Personal Reasons|0
1854692|NCT00121134|6409828|P2|Overall Study|Patient Personal Reasons|1
1854693|NCT00121134|6409829|P1|Overall Study|Patient Personal Reasons|0
1854694|NCT00121134|6409826|P4|Overall Study|Intercurrent Illness|1
1854695|NCT00121134|6409827|P3|Overall Study|Intercurrent Illness|0
1854696|NCT00121134|6409828|P2|Overall Study|Intercurrent Illness|0
1854697|NCT00121134|6409829|P1|Overall Study|Intercurrent Illness|0
1854698|NCT00121134|6409826|P4|Overall Study|Treatment Delay|0
1854699|NCT00121134|6409827|P3|Overall Study|Treatment Delay|0
1854700|NCT00121134|6409828|P2|Overall Study|Treatment Delay|0
1854701|NCT00121134|6409829|P1|Overall Study|Treatment Delay|1
1854702|NCT00121134|6409826|P4|Overall Study|Physician Decision|1
1854703|NCT00121134|6409827|P3|Overall Study|Physician Decision|4
1854704|NCT00121134|6409828|P2|Overall Study|Physician Decision|4
1854705|NCT00121134|6409829|P1|Overall Study|Physician Decision|6
1854706|NCT00121134|6409826|P4|Overall Study|Toxicity|5
1854707|NCT00121134|6409827|P3|Overall Study|Toxicity|13
1854708|NCT00121134|6409828|P2|Overall Study|Toxicity|7
1854709|NCT00121134|6409829|P1|Overall Study|Toxicity|4
1854710|NCT00121134|6409826|P4|Overall Study|Progression of Disease|2
1854711|NCT00121134|6409827|P3|Overall Study|Progression of Disease|4
1854712|NCT00121134|6409828|P2|Overall Study|Progression of Disease|3
1854713|NCT00121134|6409829|P1|Overall Study|Progression of Disease|5
1854714|NCT00120874|6409841|P2|Overall Study|Death|1
1854715|NCT00120874|6409842|P1|Overall Study|Death|0
1854716|NCT00120627|6409880|P2|Overall Study|Withdrawal by Subject|5
1854717|NCT00120627|6409881|P1|Overall Study|Withdrawal by Subject|5
1854718|NCT00120406|6409932|P2|Overall Study|patient moved but has not withdrawn|1
1854719|NCT00120406|6409933|P1|Overall Study|patient moved but has not withdrawn|0
1854720|NCT00120406|6409932|P2|Overall Study|received non-study stent|2
1854721|NCT00120406|6409933|P1|Overall Study|received non-study stent|0
1854722|NCT00120406|6409932|P2|Overall Study|Lost to Follow-up|2
1854723|NCT00120406|6409933|P1|Overall Study|Lost to Follow-up|5
1854724|NCT00120406|6409932|P2|Overall Study|Withdrawal by Subject|7
1854725|NCT00120406|6409933|P1|Overall Study|Withdrawal by Subject|5
1854726|NCT00120406|6409932|P2|Overall Study|Death|4
1854727|NCT00120406|6409933|P1|Overall Study|Death|9
1854728|NCT00120289|6409943|P2|Overall Study|Withdrawal by Subject|13
1854729|NCT00120289|6409944|P1|Overall Study|Withdrawal by Subject|14
1854730|NCT00120289|6409943|P2|Overall Study|Lost to Follow-up|14
1854731|NCT00120289|6409944|P1|Overall Study|Lost to Follow-up|11
1854732|NCT00120289|6409943|P2|Overall Study|Death|82
1854733|NCT00120289|6409944|P1|Overall Study|Death|96
1854734|NCT00120250|6409956|P2|Overall Study|Protocol Violation|1
1854735|NCT00120250|6409957|P1|Overall Study|Protocol Violation|0
1854736|NCT00120250|6409956|P2|Overall Study|Lost to Follow-up|1
1854737|NCT00120250|6409957|P1|Overall Study|Lost to Follow-up|1
1854738|NCT00120042|6409973|P3|Overall Study|all completed protocl|0
1854739|NCT00120042|6409974|P2|Overall Study|all completed protocl|0
1854740|NCT00120042|6409975|P1|Overall Study|all completed protocl|0
1854741|NCT00119678|6409998|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
1854742|NCT00119678|6409999|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
1854743|NCT00119678|6409998|P2|Open-label Treatment Period|Pregnancy|0
1854744|NCT00119678|6409999|P1|Open-label Treatment Period|Pregnancy|1
1854745|NCT00119678|6409998|P2|Open-label Treatment Period|Participants not meeting study criteria|0
1854746|NCT00119678|6409999|P1|Open-label Treatment Period|Participants not meeting study criteria|2
1854747|NCT00119678|6409998|P2|Open-label Treatment Period|Participant withdrew consent|0
1854748|NCT00119678|6409999|P1|Open-label Treatment Period|Participant withdrew consent|4
1854749|NCT00119678|6409998|P2|Open-label Treatment Period|Lost to Follow-up|0
1854750|NCT00119678|6409999|P1|Open-label Treatment Period|Lost to Follow-up|3
1854751|NCT00119678|6409998|P2|Open-label Treatment Period|Lack of Efficacy|0
1854752|NCT00119678|6409999|P1|Open-label Treatment Period|Lack of Efficacy|9
1854753|NCT00119678|6409998|P2|Open-label Treatment Period|Adverse Event|0
1854754|NCT00119678|6409999|P1|Open-label Treatment Period|Adverse Event|3
1854755|NCT00119678|6409998|P2|Open-label Treatment Period|Death|0
1854756|NCT00119678|6409999|P1|Open-label Treatment Period|Death|1
1854757|NCT00119678|6409998|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
1854758|NCT00119678|6409999|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
1854759|NCT00119678|6409998|P2|Double-blind Treatment Period|Not treated|2
1854760|NCT00119678|6409999|P1|Double-blind Treatment Period|Not treated|1
1854761|NCT00119678|6409998|P2|Double-blind Treatment Period|Pregnancy|2
1854762|NCT00119678|6409999|P1|Double-blind Treatment Period|Pregnancy|0
1854763|NCT00119678|6409998|P2|Double-blind Treatment Period|Poor/Non-compliance|0
1854764|NCT00119678|6409999|P1|Double-blind Treatment Period|Poor/Non-compliance|3
1854765|NCT00119678|6409998|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
1854766|NCT00119678|6409999|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
1854767|NCT00119678|6409998|P2|Double-blind Treatment Period|Participant withdrew consent|4
1854768|NCT00119678|6409999|P1|Double-blind Treatment Period|Participant withdrew consent|4
1854769|NCT00119678|6409998|P2|Double-blind Treatment Period|Lost to Follow-up|2
1854770|NCT00119678|6409999|P1|Double-blind Treatment Period|Lost to Follow-up|1
1854771|NCT00119678|6409998|P2|Double-blind Treatment Period|Lack of Efficacy|12
1854772|NCT00119678|6409999|P1|Double-blind Treatment Period|Lack of Efficacy|21
1854773|NCT00119678|6409998|P2|Double-blind Treatment Period|Adverse Event|1
1854774|NCT00119678|6409999|P1|Double-blind Treatment Period|Adverse Event|7
1854775|NCT00119678|6409998|P2|Double-blind Treatment Period|Death|0
1854776|NCT00119678|6409999|P1|Double-blind Treatment Period|Death|1
1854777|NCT00119405|6410045|P1|Overall Study|Withdrawal by Subject|1
1854778|NCT00119379|6410059|P2|Overall Study|Adverse Event|1
1854779|NCT00119379|6410060|P1|Overall Study|Adverse Event|4
1854780|NCT00119262|6410078|P2|Overall Study|others|5
1854781|NCT00119262|6410079|P1|Overall Study|others|0
1854782|NCT00119262|6410078|P2|Overall Study|ineligble|2
1854783|NCT00119262|6410079|P1|Overall Study|ineligble|1
1854784|NCT00119262|6410078|P2|Overall Study|other disease|2
1854785|NCT00119262|6410079|P1|Overall Study|other disease|0
1854786|NCT00119262|6410078|P2|Overall Study|Adverse Event|35
1854787|NCT00119262|6410079|P1|Overall Study|Adverse Event|33
1854788|NCT00119262|6410078|P2|Overall Study|Withdrawal by Subject|11
1854789|NCT00119262|6410079|P1|Overall Study|Withdrawal by Subject|12
1854790|NCT00119262|6410078|P2|Overall Study|Lack of Efficacy|3
1854791|NCT00119262|6410079|P1|Overall Study|Lack of Efficacy|0
1854792|NCT00119015|6410116|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1854793|NCT00119015|6410117|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
1854794|NCT00119015|6410118|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
1854795|NCT00118911|6410134|P2|Overall Study|Withdrawal by Subject|5
1854796|NCT00118911|6410135|P1|Overall Study|Withdrawal by Subject|2
1854797|NCT00118898|6410147|P4|Overall Study|Not able to get to clinic|40
1854798|NCT00118898|6410148|P3|Overall Study|Not able to get to clinic|31
1854799|NCT00118898|6410149|P2|Overall Study|Not able to get to clinic|43
1854800|NCT00118898|6410150|P1|Overall Study|Not able to get to clinic|34
1854801|NCT00118898|6410147|P4|Overall Study|Not compliant with requirements|11
1854802|NCT00118898|6410148|P3|Overall Study|Not compliant with requirements|11
1854803|NCT00118898|6410149|P2|Overall Study|Not compliant with requirements|13
1854804|NCT00118898|6410150|P1|Overall Study|Not compliant with requirements|11
1854805|NCT00118898|6410147|P4|Overall Study|Severe debilitation|4
1854806|NCT00118898|6410148|P3|Overall Study|Severe debilitation|6
1854807|NCT00118898|6410149|P2|Overall Study|Severe debilitation|4
1854808|NCT00118898|6410150|P1|Overall Study|Severe debilitation|1
1854809|NCT00118898|6410147|P4|Overall Study|Site Closure|37
1854810|NCT00118898|6410148|P3|Overall Study|Site Closure|28
1854811|NCT00118898|6410149|P2|Overall Study|Site Closure|31
1854812|NCT00118898|6410150|P1|Overall Study|Site Closure|33
1854813|NCT00118898|6410147|P4|Overall Study|Withdrawal by Subject|8
1854814|NCT00118898|6410148|P3|Overall Study|Withdrawal by Subject|8
1854815|NCT00118898|6410149|P2|Overall Study|Withdrawal by Subject|5
1854816|NCT00118898|6410150|P1|Overall Study|Withdrawal by Subject|10
1854817|NCT00118898|6410147|P4|Overall Study|Lost to Follow-up|33
1854818|NCT00118898|6410148|P3|Overall Study|Lost to Follow-up|33
1854819|NCT00118898|6410149|P2|Overall Study|Lost to Follow-up|34
1854820|NCT00118898|6410150|P1|Overall Study|Lost to Follow-up|26
1854821|NCT00118898|6410147|P4|Overall Study|Death|8
1854822|NCT00118898|6410148|P3|Overall Study|Death|6
1854823|NCT00118898|6410149|P2|Overall Study|Death|11
1854824|NCT00118898|6410150|P1|Overall Study|Death|6
1854825|NCT00118716|6410276|P2|Overall Study|Investigator discretion|1
1854826|NCT00118716|6410277|P1|Overall Study|Investigator discretion|0
1854827|NCT00118716|6410276|P2|Overall Study|Expired drug use|2
1854828|NCT00118716|6410277|P1|Overall Study|Expired drug use|1
1854829|NCT00118716|6410276|P2|Overall Study|misrandomized|1
1854830|NCT00118716|6410277|P1|Overall Study|misrandomized|1
1854831|NCT00118716|6410276|P2|Overall Study|Non-compliance|3
1854832|NCT00118716|6410277|P1|Overall Study|Non-compliance|1
1854833|NCT00118716|6410276|P2|Overall Study|Discontinued by sponsor|1
1854834|NCT00118716|6410277|P1|Overall Study|Discontinued by sponsor|1
1854835|NCT00118716|6410276|P2|Overall Study|Exacerbation|2
1854836|NCT00118716|6410277|P1|Overall Study|Exacerbation|2
1854837|NCT00118716|6410276|P2|Overall Study|Withdrawal by Subject|1
1854838|NCT00118716|6410277|P1|Overall Study|Withdrawal by Subject|0
1854839|NCT00118716|6410276|P2|Overall Study|Protocol Violation|4
1854840|NCT00118716|6410277|P1|Overall Study|Protocol Violation|5
1854841|NCT00118716|6410276|P2|Overall Study|Adverse Event|7
1854842|NCT00118716|6410277|P1|Overall Study|Adverse Event|2
1854843|NCT00118703|6410297|P2|Overall Study|Lost to Follow-up|2
1854844|NCT00118703|6410298|P1|Overall Study|Lost to Follow-up|1
1854845|NCT00118703|6410297|P2|Overall Study|Withdrawal by Subject|5
1854846|NCT00118703|6410298|P1|Overall Study|Withdrawal by Subject|2
1854847|NCT00118703|6410297|P2|Overall Study|Participant took two different treatment|1
1854848|NCT00118703|6410298|P1|Overall Study|Participant took two different treatment|0
1854849|NCT00118703|6410297|P2|Overall Study|Adverse Event|1
1854850|NCT00118703|6410298|P1|Overall Study|Adverse Event|1
1854851|NCT00118703|6410297|P2|Overall Study|Protocol Violation|0
1854852|NCT00118703|6410298|P1|Overall Study|Protocol Violation|1
1854853|NCT00118482|6410395|P2|Overall Study|Withdrawal by Subject|22
1854854|NCT00118482|6410396|P1|Overall Study|Withdrawal by Subject|23
1854855|NCT00118482|6410395|P2|Overall Study|Lost to Follow-up|7
1854856|NCT00118482|6410396|P1|Overall Study|Lost to Follow-up|7
1854857|NCT00118430|6410411|P3|Overall Study|Lost to Follow-up|28
1854858|NCT00118430|6410412|P2|Overall Study|Lost to Follow-up|22
1854859|NCT00118430|6410413|P1|Overall Study|Lost to Follow-up|15
1854860|NCT00118430|6410411|P3|Overall Study|Withdrawal by Subject|0
1854861|NCT00118430|6410412|P2|Overall Study|Withdrawal by Subject|2
1854862|NCT00118430|6410413|P1|Overall Study|Withdrawal by Subject|6
1854863|NCT00118417|6410428|P2|Phase II (Weeks 6 to 12)|Remission|2
1854864|NCT00118417|6410429|P1|Phase II (Weeks 6 to 12)|Remission|1
1854865|NCT00118417|6410428|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1854866|NCT00118417|6410429|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
1854867|NCT00118417|6410428|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
1854868|NCT00118417|6410429|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
1854869|NCT00118417|6410428|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
1854870|NCT00118417|6410429|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
1854871|NCT00118417|6410428|P2|Phase I (Weeks 0 to 6)|Remission|0
1854872|NCT00118417|6410429|P1|Phase I (Weeks 0 to 6)|Remission|8
1854873|NCT00118287|6410573|P1|Overall Study|Muscle pain|1
1854874|NCT00118287|6410573|P1|Overall Study|Intracranial haemorrhage|1
1854875|NCT00118157|6410593|P1|Overall Study|Withdrawal by Subject|2
1854876|NCT00118157|6410593|P1|Overall Study|Death|8
1854877|NCT00118157|6410593|P1|Overall Study|Adverse Event|2
1854878|NCT00118092|6410611|P1|Overall Study|Protocol Violation|1
1854879|NCT00118092|6410611|P1|Overall Study|Withdrawal by Subject|1
1854880|NCT00118040|6410629|P3|Overall Study|Other|1
1854881|NCT00118040|6410630|P2|Overall Study|Other|0
1854882|NCT00118040|6410631|P1|Overall Study|Other|0
1854883|NCT00118040|6410629|P3|Overall Study|Non-Compliant Participant|2
1854884|NCT00118040|6410630|P2|Overall Study|Non-Compliant Participant|1
1854885|NCT00118040|6410631|P1|Overall Study|Non-Compliant Participant|1
1854886|NCT00118040|6410629|P3|Overall Study|Medical Contraindication|1
1854887|NCT00118040|6410630|P2|Overall Study|Medical Contraindication|0
1854888|NCT00118040|6410631|P1|Overall Study|Medical Contraindication|0
1854889|NCT00118040|6410629|P3|Overall Study|Withdrawal by Subject|2
1854890|NCT00118040|6410630|P2|Overall Study|Withdrawal by Subject|0
1854891|NCT00118040|6410631|P1|Overall Study|Withdrawal by Subject|0
1854892|NCT00118040|6410629|P3|Overall Study|Adverse Event|0
1854893|NCT00118040|6410630|P2|Overall Study|Adverse Event|1
1854894|NCT00118040|6410631|P1|Overall Study|Adverse Event|0
1854895|NCT00117988|6410692|P1|Overall Study|Adverse Event|1
1854896|NCT00117988|6410692|P1|Overall Study|Death|3
1854897|NCT00117949|6410715|P4|Overall Study|Hepatic abnormalities|1
1854898|NCT00117949|6410716|P3|Overall Study|Hepatic abnormalities|0
1854899|NCT00117949|6410717|P2|Overall Study|Hepatic abnormalities|1
1854900|NCT00117949|6410718|P1|Overall Study|Hepatic abnormalities|0
1854901|NCT00117949|6410715|P4|Overall Study|PSA reduction <=50%|4
1854902|NCT00117949|6410716|P3|Overall Study|PSA reduction <=50%|2
1854903|NCT00117949|6410717|P2|Overall Study|PSA reduction <=50%|2
1854904|NCT00117949|6410718|P1|Overall Study|PSA reduction <=50%|0
1854905|NCT00117949|6410715|P4|Overall Study|PSA increase >=10ng/mL|0
1854906|NCT00117949|6410716|P3|Overall Study|PSA increase >=10ng/mL|1
1854907|NCT00117949|6410717|P2|Overall Study|PSA increase >=10ng/mL|1
1854908|NCT00117949|6410718|P1|Overall Study|PSA increase >=10ng/mL|0
1854909|NCT00117949|6410715|P4|Overall Study|Prostate-specific antigen increase >=25%|2
1854910|NCT00117949|6410716|P3|Overall Study|Prostate-specific antigen increase >=25%|1
1855059|NCT00117572|6410998|P1|Overall Study|Protocol Violation|1
1854911|NCT00117949|6410717|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1854912|NCT00117949|6410718|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1854913|NCT00117949|6410715|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1854914|NCT00117949|6410716|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1854915|NCT00117949|6410717|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1854916|NCT00117949|6410718|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1854917|NCT00117949|6410715|P4|Overall Study|Testosterone >1.0 ng/mL|15
1854918|NCT00117949|6410716|P3|Overall Study|Testosterone >1.0 ng/mL|17
1854919|NCT00117949|6410717|P2|Overall Study|Testosterone >1.0 ng/mL|18
1854920|NCT00117949|6410718|P1|Overall Study|Testosterone >1.0 ng/mL|10
1854921|NCT00117845|6410752|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
1854922|NCT00117793|6410770|P1|Overall Study|Withdrawal by Subject|12
1854923|NCT00117676|6410793|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
1854924|NCT00117676|6410794|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
1854925|NCT00117676|6410793|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1854926|NCT00117676|6410794|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
1854927|NCT00117676|6410793|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
1854928|NCT00117676|6410794|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
1854929|NCT00117676|6410793|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
1854930|NCT00117676|6410794|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
1854931|NCT00117676|6410793|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
1854932|NCT00117676|6410794|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
1854933|NCT00117676|6410793|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
1854934|NCT00117676|6410794|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
1854935|NCT00117676|6410793|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
1854936|NCT00117676|6410794|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
1854937|NCT00117676|6410793|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
1854938|NCT00117676|6410794|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
1854939|NCT00117676|6410793|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1854940|NCT00117676|6410794|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
1854941|NCT00117676|6410793|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
1854942|NCT00117676|6410794|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
1854943|NCT00117676|6410793|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1854944|NCT00117676|6410794|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
1854945|NCT00117676|6410793|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
1854946|NCT00117676|6410794|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
1854947|NCT00117676|6410793|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
1854948|NCT00117676|6410794|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
1854949|NCT00117676|6410793|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1854950|NCT00117676|6410794|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
1854951|NCT00117676|6410793|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
1854952|NCT00117676|6410794|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
1854953|NCT00117676|6410793|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
1854954|NCT00117676|6410794|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
1854955|NCT00117676|6410793|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
1854956|NCT00117676|6410794|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
1854957|NCT00117676|6410793|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
1854958|NCT00117676|6410794|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
1854959|NCT00117676|6410793|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
1854960|NCT00117676|6410794|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1854961|NCT00117676|6410793|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
1854962|NCT00117676|6410794|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
1854963|NCT00117676|6410793|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1854964|NCT00117676|6410794|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
1854965|NCT00117676|6410793|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
1854966|NCT00117676|6410794|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
1854967|NCT00117676|6410793|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
1854968|NCT00117676|6410794|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
1854969|NCT00117676|6410793|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
1854970|NCT00117676|6410794|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
1854971|NCT00117676|6410793|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
1854972|NCT00117676|6410794|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
1854973|NCT00117676|6410793|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
1854974|NCT00117676|6410794|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
1854975|NCT00117676|6410793|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
1854976|NCT00117676|6410794|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
1854977|NCT00117676|6410793|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
1854978|NCT00117676|6410794|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
1854979|NCT00117676|6410793|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1854980|NCT00117676|6410794|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
1854981|NCT00117676|6410793|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
1854982|NCT00117676|6410794|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
1854983|NCT00117676|6410793|P2|Double-blind Period Through Week 48|Withdrew Consent|1
1854984|NCT00117676|6410794|P1|Double-blind Period Through Week 48|Withdrew Consent|0
1854985|NCT00117676|6410793|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
1854986|NCT00117676|6410794|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
1854987|NCT00117676|6410793|P2|Double-blind Period Through Week 48|Protocol Violation|1
1854988|NCT00117676|6410794|P1|Double-blind Period Through Week 48|Protocol Violation|0
1854989|NCT00117676|6410793|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
1854990|NCT00117676|6410794|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
1854991|NCT00117676|6410793|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
1854992|NCT00117676|6410794|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
1854993|NCT00117637|6410883|P2|Second Intervention (Period 2)|reason not reported|0
1854994|NCT00117637|6410884|P1|Second Intervention (Period 2)|reason not reported|1
1854995|NCT00117637|6410883|P2|Second Intervention (Period 2)|non compliant with study medication|1
1854996|NCT00117637|6410884|P1|Second Intervention (Period 2)|non compliant with study medication|1
1854997|NCT00117637|6410883|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
1854998|NCT00117637|6410884|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
1854999|NCT00117637|6410883|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
1855000|NCT00117637|6410884|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
1855001|NCT00117637|6410883|P2|Second Intervention (Period 2)|Protocol Violation|0
1855002|NCT00117637|6410884|P1|Second Intervention (Period 2)|Protocol Violation|1
1855003|NCT00117637|6410883|P2|Second Intervention (Period 2)|Lost to Follow-up|0
1855004|NCT00117637|6410884|P1|Second Intervention (Period 2)|Lost to Follow-up|1
1855005|NCT00117637|6410883|P2|Second Intervention (Period 2)|Adverse Event|9
1855006|NCT00117637|6410884|P1|Second Intervention (Period 2)|Adverse Event|0
1855007|NCT00117637|6410883|P2|First Intervention (Period 1)|reason not reported|1
1855008|NCT00117637|6410884|P1|First Intervention (Period 1)|reason not reported|0
1855009|NCT00117637|6410883|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
1855010|NCT00117637|6410884|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
1855011|NCT00117637|6410883|P2|First Intervention (Period 1)|protocol driven decision point|0
1855012|NCT00117637|6410884|P1|First Intervention (Period 1)|protocol driven decision point|1
1855013|NCT00117637|6410883|P2|First Intervention (Period 1)|study terminated by the sponsor|1
1855014|NCT00117637|6410884|P1|First Intervention (Period 1)|study terminated by the sponsor|3
1855015|NCT00117637|6410883|P2|First Intervention (Period 1)|Withdrawal by Subject|4
1855016|NCT00117637|6410884|P1|First Intervention (Period 1)|Withdrawal by Subject|2
1855017|NCT00117637|6410883|P2|First Intervention (Period 1)|Protocol Violation|0
1855018|NCT00117637|6410884|P1|First Intervention (Period 1)|Protocol Violation|1
1855019|NCT00117637|6410883|P2|First Intervention (Period 1)|Lost to Follow-up|2
1855020|NCT00117637|6410884|P1|First Intervention (Period 1)|Lost to Follow-up|0
1855021|NCT00117637|6410883|P2|First Intervention (Period 1)|Adverse Event|16
1855022|NCT00117637|6410884|P1|First Intervention (Period 1)|Adverse Event|11
1855023|NCT00117598|6410959|P5|After Treament Cross Over|Other|2
1855024|NCT00117598|6410960|P4|After Treament Cross Over|Other|1
1855025|NCT00117598|6410961|P3|After Treament Cross Over|Other|0
1855026|NCT00117598|6410962|P2|After Treament Cross Over|Other|0
1855027|NCT00117598|6410963|P1|After Treament Cross Over|Other|0
1855028|NCT00117598|6410959|P5|After Treament Cross Over|Withdrawal by Subject|0
1855029|NCT00117598|6410960|P4|After Treament Cross Over|Withdrawal by Subject|1
1855030|NCT00117598|6410961|P3|After Treament Cross Over|Withdrawal by Subject|0
1855031|NCT00117598|6410962|P2|After Treament Cross Over|Withdrawal by Subject|0
1855032|NCT00117598|6410963|P1|After Treament Cross Over|Withdrawal by Subject|0
1855033|NCT00117598|6410959|P5|After Treament Cross Over|Death|2
1855034|NCT00117598|6410960|P4|After Treament Cross Over|Death|1
1855035|NCT00117598|6410961|P3|After Treament Cross Over|Death|0
1855036|NCT00117598|6410962|P2|After Treament Cross Over|Death|0
1855037|NCT00117598|6410963|P1|After Treament Cross Over|Death|0
1855038|NCT00117598|6410959|P5|Prior to Treatment Cross Over|Other|0
1855039|NCT00117598|6410960|P4|Prior to Treatment Cross Over|Other|0
1855040|NCT00117598|6410961|P3|Prior to Treatment Cross Over|Other|9
1855041|NCT00117598|6410962|P2|Prior to Treatment Cross Over|Other|9
1855042|NCT00117598|6410963|P1|Prior to Treatment Cross Over|Other|15
1855043|NCT00117598|6410959|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
1855044|NCT00117598|6410960|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
1855045|NCT00117598|6410961|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
1855046|NCT00117598|6410962|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
1855047|NCT00117598|6410963|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
1855048|NCT00117598|6410959|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
1855049|NCT00117598|6410960|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
1855050|NCT00117598|6410961|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
1855051|NCT00117598|6410962|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
1855052|NCT00117598|6410963|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
1855053|NCT00117598|6410959|P5|Prior to Treatment Cross Over|Death|0
1855054|NCT00117598|6410960|P4|Prior to Treatment Cross Over|Death|0
1855055|NCT00117598|6410961|P3|Prior to Treatment Cross Over|Death|37
1855056|NCT00117598|6410962|P2|Prior to Treatment Cross Over|Death|41
1855057|NCT00117598|6410963|P1|Prior to Treatment Cross Over|Death|40
1855058|NCT00117572|6410997|P2|Overall Study|Protocol Violation|0
1855060|NCT00117572|6410997|P2|Overall Study|Withdrawal by Subject|3
1855061|NCT00117572|6410998|P1|Overall Study|Withdrawal by Subject|3
1855062|NCT00117572|6410997|P2|Overall Study|Site withdrew before starting treatment|3
1855063|NCT00117572|6410998|P1|Overall Study|Site withdrew before starting treatment|2
1855064|NCT00117338|6411039|P2|Overall Study|Lack of Efficacy|1
1855065|NCT00117338|6411040|P1|Overall Study|Lack of Efficacy|0
1855066|NCT00117338|6411039|P2|Overall Study|Did not meet Inclusion Criteria|0
1855067|NCT00117338|6411040|P1|Overall Study|Did not meet Inclusion Criteria|1
1855068|NCT00117338|6411039|P2|Overall Study|Withdrawal by Subject|0
1855069|NCT00117338|6411040|P1|Overall Study|Withdrawal by Subject|1
1855070|NCT00117338|6411039|P2|Overall Study|Protocol Violation|2
1855071|NCT00117338|6411040|P1|Overall Study|Protocol Violation|3
1855072|NCT00117338|6411039|P2|Overall Study|Adverse Event|1
1855073|NCT00117338|6411040|P1|Overall Study|Adverse Event|0
1855074|NCT00117325|6411060|P2|Overall Study|Admisnitrative|0
1855075|NCT00117325|6411061|P1|Overall Study|Admisnitrative|1
1855076|NCT00117325|6411060|P2|Overall Study|Early termination|1
1855077|NCT00117325|6411061|P1|Overall Study|Early termination|1
1855078|NCT00117325|6411060|P2|Overall Study|Use of prohibited medicine|2
1855079|NCT00117325|6411061|P1|Overall Study|Use of prohibited medicine|1
1855080|NCT00117325|6411060|P2|Overall Study|Lack of Efficacy|0
1855081|NCT00117325|6411061|P1|Overall Study|Lack of Efficacy|1
1855082|NCT00117325|6411060|P2|Overall Study|Withdrawal by Subject|2
1855083|NCT00117325|6411061|P1|Overall Study|Withdrawal by Subject|3
1855084|NCT00117325|6411060|P2|Overall Study|Protocol Violation|3
1855085|NCT00117325|6411061|P1|Overall Study|Protocol Violation|2
1855086|NCT00117325|6411060|P2|Overall Study|Lost to Follow-up|1
1855087|NCT00117325|6411061|P1|Overall Study|Lost to Follow-up|1
1855088|NCT00117325|6411060|P2|Overall Study|Adverse Event|3
1855089|NCT00117325|6411061|P1|Overall Study|Adverse Event|3
1855090|NCT00117312|6411093|P4|Overall Study|Withdrawal by Subject|0
1855091|NCT00117312|6411094|P3|Overall Study|Withdrawal by Subject|0
1855092|NCT00117312|6411095|P2|Overall Study|Withdrawal by Subject|2
1855093|NCT00117312|6411096|P1|Overall Study|Withdrawal by Subject|0
1855094|NCT00117312|6411093|P4|Overall Study|Hepatic abnormality|1
1855095|NCT00117312|6411094|P3|Overall Study|Hepatic abnormality|0
1855096|NCT00117312|6411095|P2|Overall Study|Hepatic abnormality|1
1855097|NCT00117312|6411096|P1|Overall Study|Hepatic abnormality|0
1855098|NCT00117312|6411093|P4|Overall Study|PSA increase >= 10ng/mL|0
1855099|NCT00117312|6411094|P3|Overall Study|PSA increase >= 10ng/mL|1
1855100|NCT00117312|6411095|P2|Overall Study|PSA increase >= 10ng/mL|1
1855101|NCT00117312|6411096|P1|Overall Study|PSA increase >= 10ng/mL|0
1855102|NCT00117312|6411093|P4|Overall Study|PSA decrease <=50%|4
1855103|NCT00117312|6411094|P3|Overall Study|PSA decrease <=50%|2
1855104|NCT00117312|6411095|P2|Overall Study|PSA decrease <=50%|2
1855105|NCT00117312|6411096|P1|Overall Study|PSA decrease <=50%|0
1855106|NCT00117312|6411093|P4|Overall Study|Protocol Violation|0
1855107|NCT00117312|6411094|P3|Overall Study|Protocol Violation|3
1855108|NCT00117312|6411095|P2|Overall Study|Protocol Violation|1
1855109|NCT00117312|6411096|P1|Overall Study|Protocol Violation|0
1855110|NCT00117312|6411093|P4|Overall Study|Adverse Event|0
1855111|NCT00117312|6411094|P3|Overall Study|Adverse Event|0
1855112|NCT00117312|6411095|P2|Overall Study|Adverse Event|2
1855113|NCT00117312|6411096|P1|Overall Study|Adverse Event|0
1855114|NCT00117312|6411093|P4|Overall Study|Patient choice|1
1855115|NCT00117312|6411094|P3|Overall Study|Patient choice|2
1855116|NCT00117312|6411095|P2|Overall Study|Patient choice|0
1855117|NCT00117312|6411096|P1|Overall Study|Patient choice|0
1855118|NCT00117312|6411093|P4|Overall Study|Other|1
1855119|NCT00117312|6411094|P3|Overall Study|Other|3
1855120|NCT00117312|6411095|P2|Overall Study|Other|1
1855121|NCT00117312|6411096|P1|Overall Study|Other|0
1855122|NCT00117312|6411093|P4|Overall Study|Prostate-specific antigen increase >=25%|3
1855123|NCT00117312|6411094|P3|Overall Study|Prostate-specific antigen increase >=25%|5
1855124|NCT00117312|6411095|P2|Overall Study|Prostate-specific antigen increase >=25%|1
1855125|NCT00117312|6411096|P1|Overall Study|Prostate-specific antigen increase >=25%|0
1855126|NCT00117312|6411093|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
1855127|NCT00117312|6411094|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
1855128|NCT00117312|6411095|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
1855129|NCT00117312|6411096|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
1855130|NCT00117312|6411093|P4|Overall Study|Testosterone >1.0 ng/mL|9
1855131|NCT00117312|6411094|P3|Overall Study|Testosterone >1.0 ng/mL|5
1855132|NCT00117312|6411095|P2|Overall Study|Testosterone >1.0 ng/mL|9
1855133|NCT00117312|6411096|P1|Overall Study|Testosterone >1.0 ng/mL|9
1855134|NCT00117286|6411112|P2|Overall Study|Research site closing|2
1855135|NCT00117286|6411113|P1|Overall Study|Research site closing|0
1855136|NCT00117286|6411112|P2|Overall Study|Lack of Efficacy|1
1855137|NCT00117286|6411113|P1|Overall Study|Lack of Efficacy|2
1855138|NCT00117286|6411112|P2|Overall Study|Physician Decision|7
1855139|NCT00117286|6411113|P1|Overall Study|Physician Decision|3
1855140|NCT00117286|6411112|P2|Overall Study|Withdrawal by Subject|2
1855141|NCT00117286|6411113|P1|Overall Study|Withdrawal by Subject|6
1855142|NCT00117286|6411112|P2|Overall Study|Protocol Violation|3
1855143|NCT00117286|6411113|P1|Overall Study|Protocol Violation|3
1855144|NCT00117286|6411112|P2|Overall Study|Lost to Follow-up|0
1855145|NCT00117286|6411113|P1|Overall Study|Lost to Follow-up|2
1855146|NCT00117286|6411112|P2|Overall Study|Adverse Event|6
1855147|NCT00117286|6411113|P1|Overall Study|Adverse Event|12
1855148|NCT00117156|6411121|P1|Overall Study|Trt for Pre-Exist Second Primary|1
1855149|NCT00117156|6411121|P1|Overall Study|Physician Decision|1
1855150|NCT00117156|6411121|P1|Overall Study|Adverse Event|9
1855151|NCT00116844|6411189|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1855152|NCT00116844|6411190|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
1855153|NCT00116844|6411189|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
1855154|NCT00116844|6411190|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
1855155|NCT00116844|6411189|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
1855156|NCT00116844|6411190|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
1855157|NCT00116844|6411189|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
1855158|NCT00116844|6411190|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
1855159|NCT00116844|6411189|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
1855160|NCT00116844|6411190|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
1855161|NCT00116844|6411189|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
1855162|NCT00116844|6411190|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
1855163|NCT00116844|6411189|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
1855164|NCT00116844|6411190|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
1855165|NCT00116844|6411189|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
1855166|NCT00116844|6411190|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
1855167|NCT00116844|6411189|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1855168|NCT00116844|6411190|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
1855169|NCT00116831|6411208|P2|Overall Study|Missing data for participant|0
1855170|NCT00116831|6411209|P1|Overall Study|Missing data for participant|1
1855171|NCT00116831|6411208|P2|Overall Study|Insufficient therapeutic effect|1
1855172|NCT00116831|6411209|P1|Overall Study|Insufficient therapeutic effect|0
1855173|NCT00116831|6411208|P2|Overall Study|Withdrawal by Subject|32
1855174|NCT00116831|6411209|P1|Overall Study|Withdrawal by Subject|32
1855175|NCT00116831|6411208|P2|Overall Study|Withdrawn investigational product|0
1855176|NCT00116831|6411209|P1|Overall Study|Withdrawn investigational product|1
1855177|NCT00116831|6411208|P2|Overall Study|Low haemoglobin on screening|0
1855178|NCT00116831|6411209|P1|Overall Study|Low haemoglobin on screening|1
1855179|NCT00116831|6411208|P2|Overall Study|Hypoglycaemic events|0
1855180|NCT00116831|6411209|P1|Overall Study|Hypoglycaemic events|1
1855181|NCT00116831|6411208|P2|Overall Study|Protocol Violation|6
1855182|NCT00116831|6411209|P1|Overall Study|Protocol Violation|3
1855183|NCT00116831|6411208|P2|Overall Study|Lost to Follow-up|6
1855184|NCT00116831|6411209|P1|Overall Study|Lost to Follow-up|8
1855185|NCT00116831|6411208|P2|Overall Study|Baseline IVUS determined unevaluable|11
1855186|NCT00116831|6411209|P1|Overall Study|Baseline IVUS determined unevaluable|12
1855187|NCT00116831|6411208|P2|Overall Study|Adverse Event|16
1855188|NCT00116831|6411209|P1|Overall Study|Adverse Event|14
1855189|NCT00116805|6411287|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
1855190|NCT00116805|6411288|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
1855191|NCT00116805|6411287|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
1855192|NCT00116805|6411288|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
1855193|NCT00116805|6411287|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
1855194|NCT00116805|6411288|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
1855195|NCT00116805|6411287|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
1855196|NCT00116805|6411288|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
1855197|NCT00116805|6411287|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
1855198|NCT00116805|6411288|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
1855199|NCT00116805|6411287|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
1855200|NCT00116805|6411288|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
1855201|NCT00116805|6411287|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
1855202|NCT00116805|6411288|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
1855203|NCT00116805|6411287|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
1855204|NCT00116805|6411288|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
1855205|NCT00116805|6411287|P2|Open-label Period Weeks 337 - 384|Completed Study|0
1855206|NCT00116805|6411288|P1|Open-label Period Weeks 337 - 384|Completed Study|1
1855207|NCT00116805|6411287|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
1855208|NCT00116805|6411288|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
1855209|NCT00116805|6411287|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
1855210|NCT00116805|6411288|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
1855211|NCT00116805|6411287|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
1855212|NCT00116805|6411288|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
1855213|NCT00116805|6411287|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
1855214|NCT00116805|6411288|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
1855215|NCT00116805|6411287|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1855216|NCT00116805|6411288|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
1855217|NCT00116805|6411287|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
1855218|NCT00116805|6411288|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
1855219|NCT00116805|6411287|P2|Open-label Period Weeks 289 - 336|Completed Study|1
1855220|NCT00116805|6411288|P1|Open-label Period Weeks 289 - 336|Completed Study|0
1855221|NCT00116805|6411287|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
1855222|NCT00116805|6411288|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
1855223|NCT00116805|6411287|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
1855224|NCT00116805|6411288|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
1855225|NCT00116805|6411287|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
1855226|NCT00116805|6411288|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
1855227|NCT00116805|6411287|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1855228|NCT00116805|6411288|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
1855229|NCT00116805|6411287|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
1855230|NCT00116805|6411288|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
1855231|NCT00116805|6411287|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
1855232|NCT00116805|6411288|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
1855233|NCT00116805|6411287|P2|Open-label Period Weeks 193 - 240|Completed Study|1
1855234|NCT00116805|6411288|P1|Open-label Period Weeks 193 - 240|Completed Study|0
1855235|NCT00116805|6411287|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
1855236|NCT00116805|6411288|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
1855237|NCT00116805|6411287|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
1855238|NCT00116805|6411288|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
1855239|NCT00116805|6411287|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
1855240|NCT00116805|6411288|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
1855241|NCT00116805|6411287|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
1855242|NCT00116805|6411288|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
1855243|NCT00116805|6411287|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
1855244|NCT00116805|6411288|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
1855245|NCT00116805|6411287|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
1855246|NCT00116805|6411288|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
1855247|NCT00116805|6411287|P2|Open-label Period Weeks 145 - 192|Completed Study|1
1855248|NCT00116805|6411288|P1|Open-label Period Weeks 145 - 192|Completed Study|1
1855249|NCT00116805|6411287|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
1855250|NCT00116805|6411288|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
1855251|NCT00116805|6411287|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
1855252|NCT00116805|6411288|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
1855253|NCT00116805|6411287|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
1855254|NCT00116805|6411288|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
1855255|NCT00116805|6411287|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
1855256|NCT00116805|6411288|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
1855257|NCT00116805|6411287|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
1855258|NCT00116805|6411288|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
1855259|NCT00116805|6411287|P2|Open-label Period Weeks 97 - 144|Completed Study|0
1855260|NCT00116805|6411288|P1|Open-label Period Weeks 97 - 144|Completed Study|1
1855261|NCT00116805|6411287|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
1855262|NCT00116805|6411288|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
1855263|NCT00116805|6411287|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
1855264|NCT00116805|6411288|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
1855265|NCT00116805|6411287|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
1855266|NCT00116805|6411288|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
1855267|NCT00116805|6411287|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
1855268|NCT00116805|6411288|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
1855269|NCT00116805|6411287|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
1855270|NCT00116805|6411288|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
1855271|NCT00116805|6411287|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
1855272|NCT00116805|6411288|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
1855273|NCT00116805|6411287|P2|Double-blind Period Through Week 48|Withdrew Consent|2
1855274|NCT00116805|6411288|P1|Double-blind Period Through Week 48|Withdrew Consent|4
1855275|NCT00116805|6411287|P2|Double-blind Period Through Week 48|Protocol Violation|1
1855276|NCT00116805|6411288|P1|Double-blind Period Through Week 48|Protocol Violation|1
1855277|NCT00116805|6411287|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
1855278|NCT00116805|6411288|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
1855279|NCT00116779|6411381|P2|Overall Study|Elevated PSA levels|2
1855280|NCT00116779|6411382|P1|Overall Study|Elevated PSA levels|2
1855281|NCT00116779|6411381|P2|Overall Study|Physician Decision|1
1855282|NCT00116779|6411382|P1|Overall Study|Physician Decision|3
1855283|NCT00116779|6411381|P2|Overall Study|Inadequate testosterone suppression|9
1855284|NCT00116779|6411382|P1|Overall Study|Inadequate testosterone suppression|7
1855285|NCT00116779|6411381|P2|Overall Study|Withdrawal by Subject|1
1855286|NCT00116779|6411382|P1|Overall Study|Withdrawal by Subject|4
1855287|NCT00116779|6411381|P2|Overall Study|Protocol Violation|4
1855288|NCT00116779|6411382|P1|Overall Study|Protocol Violation|1
1855289|NCT00116779|6411381|P2|Overall Study|Adverse Event|2
1855290|NCT00116779|6411382|P1|Overall Study|Adverse Event|4
1855291|NCT00116753|6411415|P3|Overall Study|Dosing Error|0
1855292|NCT00116753|6411416|P2|Overall Study|Dosing Error|1
1855293|NCT00116753|6411417|P1|Overall Study|Dosing Error|0
1855294|NCT00116753|6411415|P3|Overall Study|Progressive Parkinson's Disease|0
1855295|NCT00116753|6411416|P2|Overall Study|Progressive Parkinson's Disease|0
1855296|NCT00116753|6411417|P1|Overall Study|Progressive Parkinson's Disease|1
1855297|NCT00116753|6411415|P3|Overall Study|Abnormal Echocardiogram|1
1855298|NCT00116753|6411416|P2|Overall Study|Abnormal Echocardiogram|0
1855299|NCT00116753|6411417|P1|Overall Study|Abnormal Echocardiogram|0
1855300|NCT00116753|6411415|P3|Overall Study|Disease Progression|3
1855301|NCT00116753|6411416|P2|Overall Study|Disease Progression|4
1855302|NCT00116753|6411417|P1|Overall Study|Disease Progression|3
1855303|NCT00116753|6411415|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
1855304|NCT00116753|6411416|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
1855305|NCT00116753|6411417|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
1855306|NCT00116753|6411415|P3|Overall Study|Protocol Violation|1
1855307|NCT00116753|6411416|P2|Overall Study|Protocol Violation|0
1855308|NCT00116753|6411417|P1|Overall Study|Protocol Violation|0
1855309|NCT00116753|6411415|P3|Overall Study|Lost to Follow-up|1
1855310|NCT00116753|6411416|P2|Overall Study|Lost to Follow-up|2
1855311|NCT00116753|6411417|P1|Overall Study|Lost to Follow-up|0
1855312|NCT00116753|6411415|P3|Overall Study|Withdrawal by Subject|8
1855313|NCT00116753|6411416|P2|Overall Study|Withdrawal by Subject|12
1855314|NCT00116753|6411417|P1|Overall Study|Withdrawal by Subject|11
1855315|NCT00116753|6411415|P3|Overall Study|Adverse Event|7
1855316|NCT00116753|6411416|P2|Overall Study|Adverse Event|10
1855317|NCT00116753|6411417|P1|Overall Study|Adverse Event|16
1855318|NCT00116688|6411439|P2|Overall Study|Other|0
1855319|NCT00116688|6411440|P1|Overall Study|Other|11
1855320|NCT00116688|6411439|P2|Overall Study|Pregnancy|0
1855321|NCT00116688|6411440|P1|Overall Study|Pregnancy|1
1855322|NCT00116688|6411439|P2|Overall Study|Protocol-specified criteria|0
1855323|NCT00116688|6411440|P1|Overall Study|Protocol-specified criteria|3
1855324|NCT00116688|6411439|P2|Overall Study|Death|0
1855325|NCT00116688|6411440|P1|Overall Study|Death|15
1855326|NCT00116688|6411439|P2|Overall Study|Lost to Follow-up|0
1855327|NCT00116688|6411440|P1|Overall Study|Lost to Follow-up|3
1855328|NCT00116688|6411439|P2|Overall Study|Physician Decision|0
1855329|NCT00116688|6411440|P1|Overall Study|Physician Decision|7
1855330|NCT00116688|6411439|P2|Overall Study|Requirement for alternative therapy|1
1855331|NCT00116688|6411440|P1|Overall Study|Requirement for alternative therapy|11
1855332|NCT00116688|6411439|P2|Overall Study|Withdrawal by Subject|2
1855333|NCT00116688|6411440|P1|Overall Study|Withdrawal by Subject|26
1855334|NCT00116688|6411439|P2|Overall Study|Adverse Event|0
1855335|NCT00116688|6411440|P1|Overall Study|Adverse Event|11
1855336|NCT00116688|6411439|P2|Overall Study|Noncompliance|1
1855337|NCT00116688|6411440|P1|Overall Study|Noncompliance|3
1855338|NCT00116688|6411439|P2|Overall Study|Protocol deviation|0
1855339|NCT00116688|6411440|P1|Overall Study|Protocol deviation|1
1855340|NCT00116649|6411455|P1|Overall Study|Protocol Specified|7
1855341|NCT00116649|6411455|P1|Overall Study|Various Reasons|18
1855342|NCT00116649|6411455|P1|Overall Study|Local Skin Reaction|9
1855343|NCT00116649|6411455|P1|Overall Study|Withdrawal by Subject|68
1855344|NCT00116649|6411455|P1|Overall Study|Lost to Follow-up|32
1855345|NCT00116649|6411455|P1|Overall Study|Lack of Efficacy|1
1855346|NCT00116649|6411455|P1|Overall Study|Adverse Event|20
1855347|NCT00116558|6411463|P3|Overall Study|disease progression|18
1855348|NCT00116558|6411464|P2|Overall Study|disease progression|7
1855349|NCT00116558|6411465|P1|Overall Study|disease progression|3
1855350|NCT00116558|6411463|P3|Overall Study|Withdrawal by Subject|12
1855351|NCT00116558|6411464|P2|Overall Study|Withdrawal by Subject|3
1855352|NCT00116558|6411465|P1|Overall Study|Withdrawal by Subject|17
1855353|NCT00116558|6411463|P3|Overall Study|Death|3
1855354|NCT00116558|6411464|P2|Overall Study|Death|5
1855355|NCT00116558|6411465|P1|Overall Study|Death|11
1855356|NCT00116428|6411476|P2|Overall Study|Did not meet inclusion criteria|0
1855357|NCT00116428|6411477|P1|Overall Study|Did not meet inclusion criteria|1
1855358|NCT00116428|6411476|P2|Overall Study|Withdrawal by Subject|5
1855359|NCT00116428|6411477|P1|Overall Study|Withdrawal by Subject|2
1855360|NCT00116272|6411495|P2|Overall Study|Lost to Follow-up|6
1855361|NCT00116272|6411496|P1|Overall Study|Lost to Follow-up|11
1855362|NCT00116168|6411565|P4|Overall Study|Lost to Follow-up|0
1855363|NCT00116168|6411566|P3|Overall Study|Lost to Follow-up|0
1855364|NCT00116168|6411567|P2|Overall Study|Lost to Follow-up|5
1855365|NCT00116168|6411568|P1|Overall Study|Lost to Follow-up|6
1855366|NCT00115934|6411632|P2|Overall Study|Did not receive intervention|2
1855367|NCT00115934|6411633|P1|Overall Study|Did not receive intervention|3
1855368|NCT00115934|6411632|P2|Overall Study|Lost to Follow-up|0
1855369|NCT00115934|6411633|P1|Overall Study|Lost to Follow-up|1
1855370|NCT00115804|6411682|P1|Overall Study|Adverse Event|2
1855371|NCT00115778|6411693|P2|Overall Study|Withdrawal by Subject|1
1855372|NCT00115778|6411694|P1|Overall Study|Withdrawal by Subject|0
1855373|NCT00115765|6411714|P4|Overall Study|Other|2
1855374|NCT00115765|6411715|P3|Overall Study|Other|9
1855375|NCT00115765|6411716|P2|Overall Study|Other|12
1855376|NCT00115765|6411717|P1|Overall Study|Other|6
1855377|NCT00115765|6411714|P4|Overall Study|Lost to Follow-up|1
1855378|NCT00115765|6411715|P3|Overall Study|Lost to Follow-up|18
1855379|NCT00115765|6411716|P2|Overall Study|Lost to Follow-up|20
1855380|NCT00115765|6411717|P1|Overall Study|Lost to Follow-up|3
1855381|NCT00115765|6411714|P4|Overall Study|Physician Decision|13
1855382|NCT00115765|6411715|P3|Overall Study|Physician Decision|18
1855383|NCT00115765|6411716|P2|Overall Study|Physician Decision|15
1855384|NCT00115765|6411717|P1|Overall Study|Physician Decision|4
1855385|NCT00115765|6411714|P4|Overall Study|Withdrawal by Subject|15
1855386|NCT00115765|6411715|P3|Overall Study|Withdrawal by Subject|76
1855387|NCT00115765|6411716|P2|Overall Study|Withdrawal by Subject|53
1855388|NCT00115765|6411717|P1|Overall Study|Withdrawal by Subject|22
1855389|NCT00115739|6411755|P1|Overall Study|Lost to Follow-up|3
1855390|NCT00115349|6411764|P2|Overall Study|Study closed due to low enrollment.|9
1855391|NCT00115349|6411765|P1|Overall Study|Study closed due to low enrollment.|11
1855392|NCT00115063|6411786|P2|Overall Study|Death|0
1855393|NCT00115063|6411787|P1|Overall Study|Death|1
1855394|NCT00115063|6411786|P2|Overall Study|Lost to Follow-up|104
1855395|NCT00115063|6411787|P1|Overall Study|Lost to Follow-up|98
1855396|NCT00115037|6411805|P6|Phase2|Lost to Follow-up|10
1855397|NCT00115037|6411806|P5|Phase2|Lost to Follow-up|4
1855398|NCT00115037|6411807|P4|Phase2|Lost to Follow-up|14
1855399|NCT00115037|6411808|P3|Phase2|Lost to Follow-up|12
1855400|NCT00115037|6411809|P2|Phase2|Lost to Follow-up|0
1855401|NCT00115037|6411810|P1|Phase2|Lost to Follow-up|0
1855402|NCT00115037|6411805|P6|Phase2|Withdrawal by Subject|1
1855403|NCT00115037|6411806|P5|Phase2|Withdrawal by Subject|2
1855404|NCT00115037|6411807|P4|Phase2|Withdrawal by Subject|1
1855405|NCT00115037|6411808|P3|Phase2|Withdrawal by Subject|2
1855406|NCT00115037|6411809|P2|Phase2|Withdrawal by Subject|0
1855407|NCT00115037|6411810|P1|Phase2|Withdrawal by Subject|0
1855408|NCT00115037|6411805|P6|Phase2|Death|1
1855409|NCT00115037|6411806|P5|Phase2|Death|0
1855410|NCT00115037|6411807|P4|Phase2|Death|0
1855411|NCT00115037|6411808|P3|Phase2|Death|1
1855412|NCT00115037|6411809|P2|Phase2|Death|0
1855413|NCT00115037|6411810|P1|Phase2|Death|0
1855414|NCT00115037|6411805|P6|Phase1|Withdrawal by Subject|0
1855415|NCT00115037|6411806|P5|Phase1|Withdrawal by Subject|0
1855416|NCT00115037|6411807|P4|Phase1|Withdrawal by Subject|0
1855417|NCT00115037|6411808|P3|Phase1|Withdrawal by Subject|0
1855418|NCT00115037|6411809|P2|Phase1|Withdrawal by Subject|4
1855419|NCT00115037|6411810|P1|Phase1|Withdrawal by Subject|9
1855420|NCT00115037|6411805|P6|Phase1|Lost to Follow-up|0
1855421|NCT00115037|6411806|P5|Phase1|Lost to Follow-up|0
1855422|NCT00115037|6411807|P4|Phase1|Lost to Follow-up|0
1855423|NCT00115037|6411808|P3|Phase1|Lost to Follow-up|0
1855424|NCT00115037|6411809|P2|Phase1|Lost to Follow-up|23
1855425|NCT00115037|6411810|P1|Phase1|Lost to Follow-up|16
1855426|NCT00114972|6411826|P2|Overall Study|Lost to Follow-up|5
1855427|NCT00114972|6411827|P1|Overall Study|Lost to Follow-up|8
1855428|NCT00114972|6411826|P2|Overall Study|Withdrawal by Subject|7
1855429|NCT00114972|6411827|P1|Overall Study|Withdrawal by Subject|40
1855430|NCT00114959|6411847|P1|Overall Study|Death|1
1855431|NCT00114959|6411847|P1|Overall Study|Physician Decision|1
1855432|NCT00114959|6411847|P1|Overall Study|Lack of Efficacy|6
1855433|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Other|2
1855434|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Other|0
1855435|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Other|2
1855436|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
1855437|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1855438|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
1855439|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
1855440|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
1855441|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
1855442|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
1855443|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
1855444|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
1855445|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Adverse Event|7
1855446|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Adverse Event|14
1855447|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Adverse Event|15
1855448|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
1855449|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1855450|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
1855451|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
1855452|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
1855453|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
1855454|NCT00114777|6411857|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1855455|NCT00114777|6411858|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
1855456|NCT00114777|6411859|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
1855457|NCT00114777|6411857|P3|Long-Term Extension to Month 84|Death|7
1855458|NCT00114777|6411858|P2|Long-Term Extension to Month 84|Death|13
1855459|NCT00114777|6411859|P1|Long-Term Extension to Month 84|Death|8
1855460|NCT00114777|6411857|P3|Randomization to Month 36|Other|12
1855461|NCT00114777|6411858|P2|Randomization to Month 36|Other|3
1855462|NCT00114777|6411859|P1|Randomization to Month 36|Other|9
1855463|NCT00114777|6411857|P3|Randomization to Month 36|Withdrawal by Subject|5
1855464|NCT00114777|6411858|P2|Randomization to Month 36|Withdrawal by Subject|4
1855465|NCT00114777|6411859|P1|Randomization to Month 36|Withdrawal by Subject|3
1855466|NCT00114777|6411857|P3|Randomization to Month 36|Adverse Event|44
1855467|NCT00114777|6411858|P2|Randomization to Month 36|Adverse Event|35
1855468|NCT00114777|6411859|P1|Randomization to Month 36|Adverse Event|34
1855469|NCT00114777|6411857|P3|Randomization to Month 36|Poor or Non-Compliance|1
1855470|NCT00114777|6411858|P2|Randomization to Month 36|Poor or Non-Compliance|0
1855471|NCT00114777|6411859|P1|Randomization to Month 36|Poor or Non-Compliance|0
1855472|NCT00114777|6411857|P3|Randomization to Month 36|Lack of Efficacy|17
1855473|NCT00114777|6411858|P2|Randomization to Month 36|Lack of Efficacy|15
1855474|NCT00114777|6411859|P1|Randomization to Month 36|Lack of Efficacy|19
1855475|NCT00114777|6411857|P3|Randomization to Month 36|No Longer Met Study Criteria|2
1855476|NCT00114777|6411858|P2|Randomization to Month 36|No Longer Met Study Criteria|0
1855477|NCT00114777|6411859|P1|Randomization to Month 36|No Longer Met Study Criteria|0
1855478|NCT00114777|6411857|P3|Randomization to Month 36|Death|3
1855479|NCT00114777|6411858|P2|Randomization to Month 36|Death|4
1855480|NCT00114777|6411859|P1|Randomization to Month 36|Death|10
1855481|NCT00114738|6411933|P3|Screening for Randomization|Other|0
1855482|NCT00114738|6411934|P2|Screening for Randomization|Other|0
1855483|NCT00114738|6411935|P1|Screening for Randomization|Other|1
1855484|NCT00114738|6411933|P3|Screening for Randomization|CNS Hemorrhage|0
1855485|NCT00114738|6411934|P2|Screening for Randomization|CNS Hemorrhage|0
1855486|NCT00114738|6411935|P1|Screening for Randomization|CNS Hemorrhage|1
1855487|NCT00114738|6411933|P3|Screening for Randomization|Progressive disease|0
1855488|NCT00114738|6411934|P2|Screening for Randomization|Progressive disease|0
1855489|NCT00114738|6411935|P1|Screening for Randomization|Progressive disease|2
1855490|NCT00114738|6411933|P3|Screening for Randomization|Neuropathy|0
1855491|NCT00114738|6411934|P2|Screening for Randomization|Neuropathy|0
1855492|NCT00114738|6411935|P1|Screening for Randomization|Neuropathy|17
1855493|NCT00114738|6411933|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1855494|NCT00114738|6411934|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
1855495|NCT00114738|6411935|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
1855496|NCT00114738|6411933|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1855497|NCT00114738|6411934|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
1855498|NCT00114738|6411935|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
1855499|NCT00114634|6411948|P1|Overall Study|failure to return forms|3
1855500|NCT00114530|6411964|P2|Overall Study|Ineligible|0
1855501|NCT00114530|6411965|P1|Overall Study|Ineligible|1
1855502|NCT00114530|6411964|P2|Overall Study|Subject decision after endpoint failure|1
1855503|NCT00114530|6411965|P1|Overall Study|Subject decision after endpoint failure|0
1855504|NCT00114530|6411964|P2|Overall Study|Breast Cancer|0
1855505|NCT00114530|6411965|P1|Overall Study|Breast Cancer|1
1855506|NCT00114530|6411964|P2|Overall Study|Withdrawal by Subject|6
1855507|NCT00114530|6411965|P1|Overall Study|Withdrawal by Subject|2
1855508|NCT00114530|6411964|P2|Overall Study|Physician Decision|1
1855509|NCT00114530|6411965|P1|Overall Study|Physician Decision|1
1855510|NCT00114530|6411964|P2|Overall Study|Lost to Follow-up|1
1855511|NCT00114530|6411965|P1|Overall Study|Lost to Follow-up|1
1855512|NCT00114530|6411964|P2|Overall Study|Death|11
1855513|NCT00114530|6411965|P1|Overall Study|Death|3
1855514|NCT00114244|6412102|P2|Overall Study|Withdrawal by Subject|2
1855515|NCT00114244|6412103|P1|Overall Study|Withdrawal by Subject|0
1855516|NCT00114244|6412102|P2|Overall Study|Adverse Event|5
1855517|NCT00114244|6412103|P1|Overall Study|Adverse Event|2
1855518|NCT00114231|6412115|P2|Overall Study|Biopsy done after registration|0
1855519|NCT00114231|6412116|P1|Overall Study|Biopsy done after registration|1
1855520|NCT00114231|6412115|P2|Overall Study|No Absolute Neutrophil Count|0
1855521|NCT00114231|6412116|P1|Overall Study|No Absolute Neutrophil Count|2
1855522|NCT00114231|6412115|P2|Overall Study|Tumor fixed on digital exam|1
1855523|NCT00114231|6412116|P1|Overall Study|Tumor fixed on digital exam|0
1855524|NCT00114231|6412115|P2|Overall Study|Tumor size > 4cm|0
1855525|NCT00114231|6412116|P1|Overall Study|Tumor size > 4cm|1
1855526|NCT00114231|6412115|P2|Overall Study|Low creatinine clearance|1
1855527|NCT00114231|6412116|P1|Overall Study|Low creatinine clearance|0
1855528|NCT00114231|6412115|P2|Overall Study|No adenocarcinoma|0
1855529|NCT00114231|6412116|P1|Overall Study|No adenocarcinoma|1
1855530|NCT00114231|6412115|P2|Overall Study|Suspected metastatic disease|0
1855531|NCT00114231|6412116|P1|Overall Study|Suspected metastatic disease|1
1855532|NCT00114231|6412115|P2|Overall Study|QARC requirement not met|0
1855533|NCT00114231|6412116|P1|Overall Study|QARC requirement not met|1
1855534|NCT00114231|6412115|P2|Overall Study|No consent|0
1855535|NCT00114231|6412116|P1|Overall Study|No consent|2
1855536|NCT00114218|6412125|P1|Overall Study|Never Treated|1
1855537|NCT00114218|6412125|P1|Overall Study|Wrong Primary|1
1855538|NCT00114218|6412125|P1|Overall Study|Wrong Cell Type|2
1855539|NCT00114166|6412132|P2|Overall Study|Wrong primary|1
1855540|NCT00114166|6412133|P1|Overall Study|Wrong primary|0
1855541|NCT00114140|6412143|P1|Overall Study|Protocol Violation|7
1855542|NCT00114127|6412157|P2|Overall Study|Withdrawal by Subject|3
1855543|NCT00114127|6412158|P1|Overall Study|Withdrawal by Subject|1
1855544|NCT00114127|6412157|P2|Overall Study|Lost to Follow-up|0
1855545|NCT00114127|6412158|P1|Overall Study|Lost to Follow-up|1
1855546|NCT00114127|6412157|P2|Overall Study|Adverse Event|1
1855547|NCT00114127|6412158|P1|Overall Study|Adverse Event|2
1855548|NCT00113919|6412230|P1|Overall Study|Death|6
1855549|NCT00113919|6412230|P1|Overall Study|Physician Decision|8
1855550|NCT00113841|6412298|P2|Overall Study|Non-compliant|0
1855551|NCT00113841|6412299|P1|Overall Study|Non-compliant|1
1855552|NCT00113841|6412298|P2|Overall Study|Disease progression|2
1855553|NCT00113841|6412299|P1|Overall Study|Disease progression|0
1855554|NCT00113763|6412307|P2|Overall Study|Ongoing|0
1855555|NCT00113763|6412308|P1|Overall Study|Ongoing|1
1855556|NCT00113763|6412307|P2|Overall Study|Non-compliance|0
1855557|NCT00113763|6412308|P1|Overall Study|Non-compliance|1
1855558|NCT00113763|6412307|P2|Overall Study|Other|6
1855559|NCT00113763|6412308|P1|Overall Study|Other|27
1855560|NCT00113763|6412307|P2|Overall Study|Withdrawal by Subject|4
1855561|NCT00113763|6412308|P1|Overall Study|Withdrawal by Subject|1
1855562|NCT00113763|6412307|P2|Overall Study|Lost to Follow-up|0
1855563|NCT00113763|6412308|P1|Overall Study|Lost to Follow-up|10
1855564|NCT00113763|6412307|P2|Overall Study|Disease Progression|14
1855565|NCT00113763|6412308|P1|Overall Study|Disease Progression|28
1855566|NCT00113763|6412307|P2|Overall Study|Adverse Event|2
1855567|NCT00113763|6412308|P1|Overall Study|Adverse Event|5
1855568|NCT00113607|6412334|P2|Overall Study|Other|32
1855569|NCT00113607|6412335|P1|Overall Study|Other|43
1855570|NCT00113607|6412334|P2|Overall Study|Complete Response (Confirmed)|24
1855571|NCT00113607|6412335|P1|Overall Study|Complete Response (Confirmed)|14
1855572|NCT00113607|6412334|P2|Overall Study|Disease Progression|142
1855573|NCT00113607|6412335|P1|Overall Study|Disease Progression|180
1855574|NCT00113607|6412334|P2|Overall Study|Lost to Follow-up|2
1855575|NCT00113607|6412335|P1|Overall Study|Lost to Follow-up|0
1855576|NCT00113607|6412334|P2|Overall Study|Withdrawal by Subject|58
1855577|NCT00113607|6412335|P1|Overall Study|Withdrawal by Subject|50
1855578|NCT00113607|6412334|P2|Overall Study|Death|8
1855579|NCT00113607|6412335|P1|Overall Study|Death|8
1855580|NCT00113607|6412334|P2|Overall Study|Adverse Event|71
1855581|NCT00113607|6412335|P1|Overall Study|Adverse Event|40
1855582|NCT00113568|6412349|P1|Overall Study|Other|112
1855583|NCT00113568|6412349|P1|Overall Study|Withdrawal by Subject|117
1855584|NCT00113568|6412349|P1|Overall Study|Protocol Violation|32
1855585|NCT00113568|6412349|P1|Overall Study|Lost to Follow-up|156
1855586|NCT00113568|6412349|P1|Overall Study|Lack of Efficacy|30
1855587|NCT00113568|6412349|P1|Overall Study|Death|1
1855588|NCT00113568|6412349|P1|Overall Study|Adverse Event|97
1855589|NCT00113555|6412361|P1|Overall Study|Lost to Follow-up|8
1855590|NCT00113555|6412361|P1|Overall Study|Missed Followup|4
1855591|NCT00113555|6412361|P1|Overall Study|Death|1
1855592|NCT00113555|6412361|P1|Overall Study|Permanently Explanted|7
1855593|NCT00113555|6412361|P1|Overall Study|Baseline Failure|59
1855594|NCT00113529|6412371|P1|Overall Study|Withdrawal by Subject|4
1855595|NCT00113529|6412371|P1|Overall Study|Decision of sponsor|6
1855596|NCT00113529|6412371|P1|Overall Study|Lack of Efficacy|20
1855597|NCT00113529|6412371|P1|Overall Study|Adverse Event|4
1855598|NCT00113516|6412404|P2|Part 2|Ongoing|1
1855599|NCT00113516|6412405|P1|Part 2|Ongoing|0
1855600|NCT00113516|6412404|P2|Part 2|Laboratory Abnormality|1
1855601|NCT00113516|6412405|P1|Part 2|Laboratory Abnormality|0
1855602|NCT00113516|6412404|P2|Part 2|Other|3
1855603|NCT00113516|6412405|P1|Part 2|Other|0
1855604|NCT00113516|6412404|P2|Part 2|Withdrawal by Subject|3
1855605|NCT00113516|6412405|P1|Part 2|Withdrawal by Subject|0
1855606|NCT00113516|6412404|P2|Part 2|Lack of Efficacy|37
1855607|NCT00113516|6412405|P1|Part 2|Lack of Efficacy|0
1855608|NCT00113516|6412404|P2|Part 2|Death|5
1855609|NCT00113516|6412405|P1|Part 2|Death|0
1855610|NCT00113516|6412404|P2|Part 2|Adverse Event|16
1855611|NCT00113516|6412405|P1|Part 2|Adverse Event|0
1855612|NCT00113516|6412404|P2|Part 1|Missing|0
1855613|NCT00113516|6412405|P1|Part 1|Missing|65
1855614|NCT00113516|6412404|P2|Part 1|Ongoing|0
1855615|NCT00113516|6412405|P1|Part 1|Ongoing|1
1855616|NCT00113516|6412404|P2|Part 1|Laboratory Abnormality|0
1855617|NCT00113516|6412405|P1|Part 1|Laboratory Abnormality|1
1855618|NCT00113516|6412404|P2|Part 1|Did Not Meet Entrance Criteria|0
1855619|NCT00113516|6412405|P1|Part 1|Did Not Meet Entrance Criteria|1
1855620|NCT00113516|6412404|P2|Part 1|Lack of Efficacy|0
1855621|NCT00113516|6412405|P1|Part 1|Lack of Efficacy|2
1855622|NCT00113516|6412404|P2|Part 1|Withdrawal by Subject|0
1855623|NCT00113516|6412405|P1|Part 1|Withdrawal by Subject|2
1855624|NCT00113516|6412404|P2|Part 1|Other|0
1855625|NCT00113516|6412405|P1|Part 1|Other|3
1855626|NCT00113516|6412404|P2|Part 1|Death|0
1855627|NCT00113516|6412405|P1|Part 1|Death|3
1855628|NCT00113516|6412404|P2|Part 1|Adverse Event|0
1855629|NCT00113516|6412405|P1|Part 1|Adverse Event|6
1855630|NCT00113490|6412448|P2|Overall Study|Lost to Follow-up|0
1855631|NCT00113490|6412449|P1|Overall Study|Lost to Follow-up|1
1855632|NCT00113490|6412448|P2|Overall Study|Withdrawal by Subject|3
1855633|NCT00113490|6412449|P1|Overall Study|Withdrawal by Subject|1
1855634|NCT00113399|6412482|P2|Overall Study|Other|1
1855635|NCT00113399|6412483|P1|Overall Study|Other|0
1855636|NCT00113399|6412482|P2|Overall Study|Complete Response|1
1855637|NCT00113399|6412483|P1|Overall Study|Complete Response|0
1855638|NCT00113399|6412482|P2|Overall Study|Withdrawal by Subject|2
1855639|NCT00113399|6412483|P1|Overall Study|Withdrawal by Subject|1
1855640|NCT00113399|6412482|P2|Overall Study|Death|1
1855641|NCT00113399|6412483|P1|Overall Study|Death|1
1855642|NCT00113386|6412491|P2|Overall Study|Unknown - Lost to Follow-Up|1
1855643|NCT00113386|6412492|P1|Overall Study|Unknown - Lost to Follow-Up|2
1855644|NCT00113386|6412491|P2|Overall Study|Ineligible|2
1855645|NCT00113386|6412492|P1|Overall Study|Ineligible|1
1855646|NCT00113386|6412491|P2|Overall Study|Toxicity|0
1855647|NCT00113386|6412492|P1|Overall Study|Toxicity|3
1855648|NCT00113386|6412491|P2|Overall Study|Physician Decision|1
1855649|NCT00113386|6412492|P1|Overall Study|Physician Decision|0
1855650|NCT00113386|6412491|P2|Overall Study|Withdrawal by Subject|0
1855651|NCT00113386|6412492|P1|Overall Study|Withdrawal by Subject|1
1855652|NCT00113373|6412498|P1|Overall Study|Never Treated|1
1855653|NCT00113373|6412498|P1|Overall Study|Ineligible: second primary|1
1855654|NCT00113373|6412498|P1|Overall Study|Ineligible: wrong primary|1
1855655|NCT00113360|6412513|P1|Overall Study|Did not meet eligibility criteria|3
1855656|NCT00113360|6412513|P1|Overall Study|Subject required surgery|1
1855657|NCT00113360|6412513|P1|Overall Study|Adverse Event|3
1855658|NCT00113295|6412527|P2|Overall Study|Unrelated Medical Illness|0
1855659|NCT00113295|6412528|P1|Overall Study|Unrelated Medical Illness|1
1855660|NCT00113295|6412527|P2|Overall Study|Adverse Event|1
1855661|NCT00113295|6412528|P1|Overall Study|Adverse Event|4
1855662|NCT00113269|6412547|P4|Overall Study|Unable to return for follow up|0
1855663|NCT00113269|6412548|P3|Overall Study|Unable to return for follow up|0
1855664|NCT00113269|6412549|P2|Overall Study|Unable to return for follow up|1
1855665|NCT00113269|6412550|P1|Overall Study|Unable to return for follow up|2
1855666|NCT00113269|6412547|P4|Overall Study|Did not meet eligibility criteria|1
1855667|NCT00113269|6412548|P3|Overall Study|Did not meet eligibility criteria|0
1855668|NCT00113269|6412549|P2|Overall Study|Did not meet eligibility criteria|0
1855669|NCT00113269|6412550|P1|Overall Study|Did not meet eligibility criteria|1
1855670|NCT00113269|6412547|P4|Overall Study|Withdrew consent, Prednisone initiated|1
1855671|NCT00113269|6412548|P3|Overall Study|Withdrew consent, Prednisone initiated|0
1855672|NCT00113269|6412549|P2|Overall Study|Withdrew consent, Prednisone initiated|0
1855673|NCT00113269|6412550|P1|Overall Study|Withdrew consent, Prednisone initiated|0
1855674|NCT00113269|6412547|P4|Overall Study|Received pancreas transplant|2
1855675|NCT00113269|6412548|P3|Overall Study|Received pancreas transplant|0
1855676|NCT00113269|6412549|P2|Overall Study|Received pancreas transplant|0
1855677|NCT00113269|6412550|P1|Overall Study|Received pancreas transplant|0
1855678|NCT00113269|6412547|P4|Overall Study|Moved|3
1855679|NCT00113269|6412548|P3|Overall Study|Moved|0
1855680|NCT00113269|6412549|P2|Overall Study|Moved|1
1855681|NCT00113269|6412550|P1|Overall Study|Moved|0
1855682|NCT00113269|6412547|P4|Overall Study|Discontinued due to rejection|0
1855683|NCT00113269|6412548|P3|Overall Study|Discontinued due to rejection|1
1855684|NCT00113269|6412549|P2|Overall Study|Discontinued due to rejection|0
1855685|NCT00113269|6412550|P1|Overall Study|Discontinued due to rejection|0
1855686|NCT00113269|6412547|P4|Overall Study|Sponsor elected to discontinue patient|1
1855687|NCT00113269|6412548|P3|Overall Study|Sponsor elected to discontinue patient|0
1855688|NCT00113269|6412549|P2|Overall Study|Sponsor elected to discontinue patient|0
1855689|NCT00113269|6412550|P1|Overall Study|Sponsor elected to discontinue patient|1
1855690|NCT00113269|6412547|P4|Overall Study|Lost to Follow-up|3
1855691|NCT00113269|6412548|P3|Overall Study|Lost to Follow-up|6
1855692|NCT00113269|6412549|P2|Overall Study|Lost to Follow-up|3
1855693|NCT00113269|6412550|P1|Overall Study|Lost to Follow-up|2
1855694|NCT00113269|6412547|P4|Overall Study|Protocol Violation|2
1855695|NCT00113269|6412548|P3|Overall Study|Protocol Violation|4
1855696|NCT00113269|6412549|P2|Overall Study|Protocol Violation|0
1855697|NCT00113269|6412550|P1|Overall Study|Protocol Violation|1
1855698|NCT00113269|6412547|P4|Overall Study|Graft loss|9
1855699|NCT00113269|6412548|P3|Overall Study|Graft loss|4
1855700|NCT00113269|6412549|P2|Overall Study|Graft loss|6
1855701|NCT00113269|6412550|P1|Overall Study|Graft loss|6
1855702|NCT00113269|6412547|P4|Overall Study|Withdrawal by Subject|2
1855703|NCT00113269|6412548|P3|Overall Study|Withdrawal by Subject|4
1855704|NCT00113269|6412549|P2|Overall Study|Withdrawal by Subject|3
1855705|NCT00113269|6412550|P1|Overall Study|Withdrawal by Subject|4
1855706|NCT00113269|6412547|P4|Overall Study|Adverse Event|7
1855707|NCT00113269|6412548|P3|Overall Study|Adverse Event|11
1855708|NCT00113269|6412549|P2|Overall Study|Adverse Event|7
1855709|NCT00113269|6412550|P1|Overall Study|Adverse Event|2
1855710|NCT00113269|6412547|P4|Overall Study|Did not meet eligibility – pre-treatment|2
1855711|NCT00113269|6412548|P3|Overall Study|Did not meet eligibility – pre-treatment|0
1855712|NCT00113269|6412549|P2|Overall Study|Did not meet eligibility – pre-treatment|0
1855713|NCT00113269|6412550|P1|Overall Study|Did not meet eligibility – pre-treatment|0
1855714|NCT00113269|6412547|P4|Overall Study|Death in operating room|1
1855715|NCT00113269|6412548|P3|Overall Study|Death in operating room|0
1855716|NCT00113269|6412549|P2|Overall Study|Death in operating room|0
1855717|NCT00113269|6412550|P1|Overall Study|Death in operating room|0
1855718|NCT00113269|6412547|P4|Overall Study|Early graft loss, technical|0
1855719|NCT00113269|6412548|P3|Overall Study|Early graft loss, technical|2
1855720|NCT00113269|6412549|P2|Overall Study|Early graft loss, technical|0
1855721|NCT00113269|6412550|P1|Overall Study|Early graft loss, technical|0
1855722|NCT00113269|6412547|P4|Overall Study|Not transplanted, recipient issues|4
1855723|NCT00113269|6412548|P3|Overall Study|Not transplanted, recipient issues|7
1855724|NCT00113269|6412549|P2|Overall Study|Not transplanted, recipient issues|1
1855725|NCT00113269|6412550|P1|Overall Study|Not transplanted, recipient issues|2
1855726|NCT00113269|6412547|P4|Overall Study|Not transplanted, donor issues|2
1855727|NCT00113269|6412548|P3|Overall Study|Not transplanted, donor issues|2
1855728|NCT00113269|6412549|P2|Overall Study|Not transplanted, donor issues|0
1855729|NCT00113269|6412550|P1|Overall Study|Not transplanted, donor issues|4
1855730|NCT00113087|6412610|P2|Overall Study|Family or MD withdrew subject|5
1855731|NCT00113087|6412611|P1|Overall Study|Family or MD withdrew subject|10
1855732|NCT00113087|6412610|P2|Overall Study|Death or Transplant|16
1855733|NCT00113087|6412611|P1|Overall Study|Death or Transplant|14
1855734|NCT00112957|6412682|P1|Overall Study|Physician Decision|1
1855735|NCT00112957|6412682|P1|Overall Study|Progressive disease|18
1855736|NCT00112905|6412722|P1|Overall Study|performance status was deteiorating|1
1855737|NCT00112905|6412722|P1|Overall Study|Alternative treatment|1
1855738|NCT00112905|6412722|P1|Overall Study|Ineligibility|5
1855739|NCT00112905|6412722|P1|Overall Study|Death|1
1855740|NCT00112905|6412722|P1|Overall Study|Adverse Event|4
1855741|NCT00112866|6412731|P2|Overall Study|did not start treatment post-op|2
1855742|NCT00112866|6412732|P1|Overall Study|did not start treatment post-op|1
1855743|NCT00112866|6412731|P2|Overall Study|Protocol Violation|0
1855744|NCT00112866|6412732|P1|Overall Study|Protocol Violation|1
1855745|NCT00112840|6412754|P3|Overall Study|Protocol Violation|5
1855746|NCT00112840|6412755|P2|Overall Study|Protocol Violation|0
1855747|NCT00112840|6412756|P1|Overall Study|Protocol Violation|0
1855748|NCT00112840|6412754|P3|Overall Study|Withdrawal by Subject|1
1855749|NCT00112840|6412755|P2|Overall Study|Withdrawal by Subject|0
1855750|NCT00112840|6412756|P1|Overall Study|Withdrawal by Subject|1
1855751|NCT00112840|6412754|P3|Overall Study|Physician Decision|0
1855752|NCT00112840|6412755|P2|Overall Study|Physician Decision|0
1855753|NCT00112840|6412756|P1|Overall Study|Physician Decision|1
1855754|NCT00112736|6412775|P2|Overall Study|1 pt never had had RX due rapid decline|0
1855755|NCT00112736|6412776|P1|Overall Study|1 pt never had had RX due rapid decline|1
1855756|NCT00112489|6412833|P1|Overall Study|Ineligible|7
1855757|NCT00112489|6412833|P1|Overall Study|Patient never treated|2
1855758|NCT00112489|6412833|P1|Overall Study|Other, Not Specified|9
1855759|NCT00112489|6412833|P1|Overall Study|Death|2
1855760|NCT00112489|6412833|P1|Overall Study|Adverse Event|12
1855761|NCT00112489|6412833|P1|Overall Study|Refused further treatment|8
1855762|NCT00112463|6412843|P1|Overall Study|Never started treatment|2
1855763|NCT00112463|6412843|P1|Overall Study|Withdrawal by Subject|2
1855764|NCT00112463|6412843|P1|Overall Study|Toxicity|3
1855765|NCT00112463|6412843|P1|Overall Study|Second Primary|1
1855766|NCT00112463|6412843|P1|Overall Study|Progression|30
1855767|NCT00112463|6412843|P1|Overall Study|Physician Decision|1
1855768|NCT00112437|6412855|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
1855769|NCT00112437|6412856|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855770|NCT00112437|6412857|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
1855771|NCT00112437|6412858|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
1855772|NCT00112437|6412859|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855773|NCT00112437|6412860|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855774|NCT00112437|6412861|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855775|NCT00112437|6412862|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855776|NCT00112437|6412863|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855777|NCT00112437|6412864|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855778|NCT00112437|6412865|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855779|NCT00112437|6412866|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855780|NCT00112437|6412867|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855781|NCT00112437|6412868|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855782|NCT00112437|6412869|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855783|NCT00112437|6412870|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855784|NCT00112437|6412871|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855785|NCT00112437|6412872|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855786|NCT00112437|6412873|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855787|NCT00112437|6412874|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855788|NCT00112437|6412875|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855789|NCT00112437|6412876|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855790|NCT00112437|6412877|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855791|NCT00112437|6412878|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855792|NCT00112437|6412879|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855793|NCT00112437|6412880|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
1855794|NCT00112437|6412855|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
1855795|NCT00112437|6412856|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
1855796|NCT00112437|6412857|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
1855797|NCT00112437|6412858|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
1855798|NCT00112437|6412859|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
1855799|NCT00112437|6412860|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
1855800|NCT00112437|6412861|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
1855801|NCT00112437|6412862|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
1855802|NCT00112437|6412863|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
1855803|NCT00112437|6412864|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
1855804|NCT00112437|6412865|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
1855805|NCT00112437|6412866|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
1855806|NCT00112437|6412867|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
1855807|NCT00112437|6412868|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
1855808|NCT00112437|6412869|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
1855809|NCT00112437|6412870|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
1855810|NCT00112437|6412871|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
1855811|NCT00112437|6412872|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
1855812|NCT00112437|6412873|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
1855813|NCT00112437|6412874|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
1855814|NCT00112437|6412875|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
1855815|NCT00112437|6412876|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
1855816|NCT00112437|6412877|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
1855817|NCT00112437|6412878|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
1855818|NCT00112437|6412879|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
1855819|NCT00112437|6412880|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
1855820|NCT00112437|6412855|P26|Years 6-10 (60-Month Extension)|Other|0
1855821|NCT00112437|6412856|P25|Years 6-10 (60-Month Extension)|Other|1
1855822|NCT00112437|6412857|P24|Years 6-10 (60-Month Extension)|Other|0
1855823|NCT00112437|6412858|P23|Years 6-10 (60-Month Extension)|Other|0
1855824|NCT00112437|6412859|P22|Years 6-10 (60-Month Extension)|Other|0
1855825|NCT00112437|6412860|P21|Years 6-10 (60-Month Extension)|Other|0
1855826|NCT00112437|6412861|P20|Years 6-10 (60-Month Extension)|Other|0
1855827|NCT00112437|6412862|P19|Years 6-10 (60-Month Extension)|Other|0
1855828|NCT00112437|6412863|P18|Years 6-10 (60-Month Extension)|Other|0
1855829|NCT00112437|6412864|P17|Years 6-10 (60-Month Extension)|Other|0
1855830|NCT00112437|6412865|P16|Years 6-10 (60-Month Extension)|Other|0
1855831|NCT00112437|6412866|P15|Years 6-10 (60-Month Extension)|Other|0
1855832|NCT00112437|6412867|P14|Years 6-10 (60-Month Extension)|Other|0
1855833|NCT00112437|6412868|P13|Years 6-10 (60-Month Extension)|Other|0
1855834|NCT00112437|6412869|P12|Years 6-10 (60-Month Extension)|Other|0
1855835|NCT00112437|6412870|P11|Years 6-10 (60-Month Extension)|Other|0
1855836|NCT00112437|6412871|P10|Years 6-10 (60-Month Extension)|Other|0
1855837|NCT00112437|6412872|P9|Years 6-10 (60-Month Extension)|Other|0
1855838|NCT00112437|6412873|P8|Years 6-10 (60-Month Extension)|Other|0
1855839|NCT00112437|6412874|P7|Years 6-10 (60-Month Extension)|Other|0
1855840|NCT00112437|6412875|P6|Years 6-10 (60-Month Extension)|Other|0
1855841|NCT00112437|6412876|P5|Years 6-10 (60-Month Extension)|Other|0
1855842|NCT00112437|6412877|P4|Years 6-10 (60-Month Extension)|Other|0
1855843|NCT00112437|6412878|P3|Years 6-10 (60-Month Extension)|Other|0
1855844|NCT00112437|6412879|P2|Years 6-10 (60-Month Extension)|Other|0
1855845|NCT00112437|6412880|P1|Years 6-10 (60-Month Extension)|Other|0
1855846|NCT00112437|6412855|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
1855847|NCT00112437|6412856|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855848|NCT00112437|6412857|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855849|NCT00112437|6412858|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855850|NCT00112437|6412859|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855851|NCT00112437|6412860|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855852|NCT00112437|6412861|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855853|NCT00112437|6412862|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855854|NCT00112437|6412863|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855855|NCT00112437|6412864|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855856|NCT00112437|6412865|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855857|NCT00112437|6412866|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855858|NCT00112437|6412867|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855859|NCT00112437|6412868|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855860|NCT00112437|6412869|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855861|NCT00112437|6412870|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855862|NCT00112437|6412871|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855863|NCT00112437|6412872|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855864|NCT00112437|6412873|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855865|NCT00112437|6412874|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855866|NCT00112437|6412875|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855867|NCT00112437|6412876|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855868|NCT00112437|6412877|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855869|NCT00112437|6412878|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855870|NCT00112437|6412879|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855871|NCT00112437|6412880|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
1855872|NCT00112437|6412855|P26|Years 6-10 (60-Month Extension)|Death|0
1855873|NCT00112437|6412856|P25|Years 6-10 (60-Month Extension)|Death|0
1855874|NCT00112437|6412857|P24|Years 6-10 (60-Month Extension)|Death|2
1855875|NCT00112437|6412858|P23|Years 6-10 (60-Month Extension)|Death|0
1855876|NCT00112437|6412859|P22|Years 6-10 (60-Month Extension)|Death|0
1855877|NCT00112437|6412860|P21|Years 6-10 (60-Month Extension)|Death|0
1855878|NCT00112437|6412861|P20|Years 6-10 (60-Month Extension)|Death|0
1855879|NCT00112437|6412862|P19|Years 6-10 (60-Month Extension)|Death|0
1855880|NCT00112437|6412863|P18|Years 6-10 (60-Month Extension)|Death|0
1855881|NCT00112437|6412864|P17|Years 6-10 (60-Month Extension)|Death|0
1855882|NCT00112437|6412865|P16|Years 6-10 (60-Month Extension)|Death|0
1855883|NCT00112437|6412866|P15|Years 6-10 (60-Month Extension)|Death|0
1855884|NCT00112437|6412867|P14|Years 6-10 (60-Month Extension)|Death|0
1855885|NCT00112437|6412868|P13|Years 6-10 (60-Month Extension)|Death|0
1855886|NCT00112437|6412869|P12|Years 6-10 (60-Month Extension)|Death|0
1855887|NCT00112437|6412870|P11|Years 6-10 (60-Month Extension)|Death|0
1855888|NCT00112437|6412871|P10|Years 6-10 (60-Month Extension)|Death|0
1855889|NCT00112437|6412872|P9|Years 6-10 (60-Month Extension)|Death|0
1855890|NCT00112437|6412873|P8|Years 6-10 (60-Month Extension)|Death|0
1855891|NCT00112437|6412874|P7|Years 6-10 (60-Month Extension)|Death|0
1855892|NCT00112437|6412875|P6|Years 6-10 (60-Month Extension)|Death|0
1855893|NCT00112437|6412876|P5|Years 6-10 (60-Month Extension)|Death|0
1855894|NCT00112437|6412877|P4|Years 6-10 (60-Month Extension)|Death|0
1855895|NCT00112437|6412878|P3|Years 6-10 (60-Month Extension)|Death|0
1855896|NCT00112437|6412879|P2|Years 6-10 (60-Month Extension)|Death|0
1855897|NCT00112437|6412880|P1|Years 6-10 (60-Month Extension)|Death|0
1855898|NCT00112437|6412855|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
1855899|NCT00112437|6412856|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
1855900|NCT00112437|6412857|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
1855901|NCT00112437|6412858|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
1855902|NCT00112437|6412859|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
1855903|NCT00112437|6412860|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
1855904|NCT00112437|6412861|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
1855905|NCT00112437|6412862|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
1855906|NCT00112437|6412863|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
1855907|NCT00112437|6412864|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
1855908|NCT00112437|6412865|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
1855909|NCT00112437|6412866|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
1855910|NCT00112437|6412867|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
1855911|NCT00112437|6412868|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
1855912|NCT00112437|6412869|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
1855913|NCT00112437|6412870|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
1855914|NCT00112437|6412871|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
1855915|NCT00112437|6412872|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
1855916|NCT00112437|6412873|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
1855917|NCT00112437|6412874|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
1855918|NCT00112437|6412875|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
1855919|NCT00112437|6412876|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
1855920|NCT00112437|6412877|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
1855921|NCT00112437|6412878|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
1855922|NCT00112437|6412879|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
1855923|NCT00112437|6412880|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
1855924|NCT00112437|6412855|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855925|NCT00112437|6412856|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855926|NCT00112437|6412857|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855927|NCT00112437|6412858|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855928|NCT00112437|6412859|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
1855929|NCT00112437|6412860|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
1855930|NCT00112437|6412861|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855931|NCT00112437|6412862|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855932|NCT00112437|6412863|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855933|NCT00112437|6412864|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855934|NCT00112437|6412865|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855935|NCT00112437|6412866|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855936|NCT00112437|6412867|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855937|NCT00112437|6412868|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855938|NCT00112437|6412869|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855939|NCT00112437|6412870|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855940|NCT00112437|6412871|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855941|NCT00112437|6412872|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855942|NCT00112437|6412873|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855943|NCT00112437|6412874|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855944|NCT00112437|6412875|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855945|NCT00112437|6412876|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855946|NCT00112437|6412877|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855947|NCT00112437|6412878|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855948|NCT00112437|6412879|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855949|NCT00112437|6412880|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
1855950|NCT00112437|6412855|P26|Years 4-5 (24-Month Extension)|Participant moved|0
1855951|NCT00112437|6412856|P25|Years 4-5 (24-Month Extension)|Participant moved|0
1855952|NCT00112437|6412857|P24|Years 4-5 (24-Month Extension)|Participant moved|0
1855953|NCT00112437|6412858|P23|Years 4-5 (24-Month Extension)|Participant moved|0
1855954|NCT00112437|6412859|P22|Years 4-5 (24-Month Extension)|Participant moved|1
1855955|NCT00112437|6412860|P21|Years 4-5 (24-Month Extension)|Participant moved|0
1855956|NCT00112437|6412861|P20|Years 4-5 (24-Month Extension)|Participant moved|0
1855957|NCT00112437|6412862|P19|Years 4-5 (24-Month Extension)|Participant moved|0
1855958|NCT00112437|6412863|P18|Years 4-5 (24-Month Extension)|Participant moved|0
1855959|NCT00112437|6412864|P17|Years 4-5 (24-Month Extension)|Participant moved|0
1855960|NCT00112437|6412865|P16|Years 4-5 (24-Month Extension)|Participant moved|0
1855961|NCT00112437|6412866|P15|Years 4-5 (24-Month Extension)|Participant moved|0
1855962|NCT00112437|6412867|P14|Years 4-5 (24-Month Extension)|Participant moved|0
1855963|NCT00112437|6412868|P13|Years 4-5 (24-Month Extension)|Participant moved|0
1855964|NCT00112437|6412869|P12|Years 4-5 (24-Month Extension)|Participant moved|0
1855965|NCT00112437|6412870|P11|Years 4-5 (24-Month Extension)|Participant moved|0
1855966|NCT00112437|6412871|P10|Years 4-5 (24-Month Extension)|Participant moved|0
1855967|NCT00112437|6412872|P9|Years 4-5 (24-Month Extension)|Participant moved|0
1855968|NCT00112437|6412873|P8|Years 4-5 (24-Month Extension)|Participant moved|0
1855969|NCT00112437|6412874|P7|Years 4-5 (24-Month Extension)|Participant moved|0
1855970|NCT00112437|6412875|P6|Years 4-5 (24-Month Extension)|Participant moved|0
1855971|NCT00112437|6412876|P5|Years 4-5 (24-Month Extension)|Participant moved|0
1855972|NCT00112437|6412877|P4|Years 4-5 (24-Month Extension)|Participant moved|0
1855973|NCT00112437|6412878|P3|Years 4-5 (24-Month Extension)|Participant moved|0
1855974|NCT00112437|6412879|P2|Years 4-5 (24-Month Extension)|Participant moved|0
1855975|NCT00112437|6412880|P1|Years 4-5 (24-Month Extension)|Participant moved|0
1855976|NCT00112437|6412855|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
1855977|NCT00112437|6412856|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
1855978|NCT00112437|6412857|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
1855979|NCT00112437|6412858|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
1855980|NCT00112437|6412859|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
1855981|NCT00112437|6412860|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
1855982|NCT00112437|6412861|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
1855983|NCT00112437|6412862|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
1855984|NCT00112437|6412863|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
1855985|NCT00112437|6412864|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
1855986|NCT00112437|6412865|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
1855987|NCT00112437|6412866|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
1855988|NCT00112437|6412867|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
1855989|NCT00112437|6412868|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
1855990|NCT00112437|6412869|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
1855991|NCT00112437|6412870|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
1855992|NCT00112437|6412871|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
1855993|NCT00112437|6412872|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
1855994|NCT00112437|6412873|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
1855995|NCT00112437|6412874|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
1855996|NCT00112437|6412875|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
1855997|NCT00112437|6412876|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
1855998|NCT00112437|6412877|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
1855999|NCT00112437|6412878|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
1856000|NCT00112437|6412879|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
1856001|NCT00112437|6412880|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
1856002|NCT00112437|6412855|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856003|NCT00112437|6412856|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856004|NCT00112437|6412857|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856005|NCT00112437|6412858|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856006|NCT00112437|6412859|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856007|NCT00112437|6412860|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
1856008|NCT00112437|6412861|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856009|NCT00112437|6412862|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856010|NCT00112437|6412863|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856011|NCT00112437|6412864|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856012|NCT00112437|6412865|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856013|NCT00112437|6412866|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856014|NCT00112437|6412867|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856015|NCT00112437|6412868|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856016|NCT00112437|6412869|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856017|NCT00112437|6412870|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856018|NCT00112437|6412871|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856019|NCT00112437|6412872|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856020|NCT00112437|6412873|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856021|NCT00112437|6412874|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856022|NCT00112437|6412875|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856023|NCT00112437|6412876|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856024|NCT00112437|6412877|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856025|NCT00112437|6412878|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856026|NCT00112437|6412879|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856027|NCT00112437|6412880|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
1856028|NCT00112437|6412855|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856029|NCT00112437|6412856|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856030|NCT00112437|6412857|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856031|NCT00112437|6412858|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856032|NCT00112437|6412859|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
1856033|NCT00112437|6412860|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
1856034|NCT00112437|6412861|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856035|NCT00112437|6412862|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856036|NCT00112437|6412863|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856037|NCT00112437|6412864|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856038|NCT00112437|6412865|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856039|NCT00112437|6412866|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856040|NCT00112437|6412867|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856041|NCT00112437|6412868|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856042|NCT00112437|6412869|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856043|NCT00112437|6412870|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856044|NCT00112437|6412871|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856045|NCT00112437|6412872|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856046|NCT00112437|6412873|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856047|NCT00112437|6412874|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856048|NCT00112437|6412875|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856049|NCT00112437|6412876|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856050|NCT00112437|6412877|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856051|NCT00112437|6412878|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856052|NCT00112437|6412879|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856053|NCT00112437|6412880|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
1856054|NCT00112437|6412855|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856055|NCT00112437|6412856|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856056|NCT00112437|6412857|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856057|NCT00112437|6412858|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856058|NCT00112437|6412859|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856059|NCT00112437|6412860|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856060|NCT00112437|6412861|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856061|NCT00112437|6412862|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856062|NCT00112437|6412863|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856063|NCT00112437|6412864|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856064|NCT00112437|6412865|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856065|NCT00112437|6412866|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856066|NCT00112437|6412867|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856067|NCT00112437|6412868|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856068|NCT00112437|6412869|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1856069|NCT00112437|6412870|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
1856070|NCT00112437|6412871|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856071|NCT00112437|6412872|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856072|NCT00112437|6412873|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856073|NCT00112437|6412874|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856074|NCT00112437|6412875|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856075|NCT00112437|6412876|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856076|NCT00112437|6412877|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856077|NCT00112437|6412878|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856078|NCT00112437|6412879|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856079|NCT00112437|6412880|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
1856080|NCT00112437|6412855|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856081|NCT00112437|6412856|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856082|NCT00112437|6412857|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856083|NCT00112437|6412858|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856084|NCT00112437|6412859|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856085|NCT00112437|6412860|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856086|NCT00112437|6412861|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856087|NCT00112437|6412862|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856088|NCT00112437|6412863|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856089|NCT00112437|6412864|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856090|NCT00112437|6412865|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856091|NCT00112437|6412866|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
1856092|NCT00112437|6412867|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856093|NCT00112437|6412868|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856094|NCT00112437|6412869|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
1856095|NCT00112437|6412870|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856096|NCT00112437|6412871|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856097|NCT00112437|6412872|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856098|NCT00112437|6412873|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856099|NCT00112437|6412874|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856100|NCT00112437|6412875|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856101|NCT00112437|6412876|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856102|NCT00112437|6412877|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856103|NCT00112437|6412878|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856104|NCT00112437|6412879|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856105|NCT00112437|6412880|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
1856106|NCT00112437|6412855|P26|Year 3 (12-Month Extension)|Protocol Violation|0
1856107|NCT00112437|6412856|P25|Year 3 (12-Month Extension)|Protocol Violation|0
1856108|NCT00112437|6412857|P24|Year 3 (12-Month Extension)|Protocol Violation|0
1856109|NCT00112437|6412858|P23|Year 3 (12-Month Extension)|Protocol Violation|0
1856110|NCT00112437|6412859|P22|Year 3 (12-Month Extension)|Protocol Violation|0
1856111|NCT00112437|6412860|P21|Year 3 (12-Month Extension)|Protocol Violation|0
1856112|NCT00112437|6412861|P20|Year 3 (12-Month Extension)|Protocol Violation|0
1856113|NCT00112437|6412862|P19|Year 3 (12-Month Extension)|Protocol Violation|0
1856114|NCT00112437|6412863|P18|Year 3 (12-Month Extension)|Protocol Violation|0
1856115|NCT00112437|6412864|P17|Year 3 (12-Month Extension)|Protocol Violation|0
1856116|NCT00112437|6412865|P16|Year 3 (12-Month Extension)|Protocol Violation|1
1856117|NCT00112437|6412866|P15|Year 3 (12-Month Extension)|Protocol Violation|0
1856118|NCT00112437|6412867|P14|Year 3 (12-Month Extension)|Protocol Violation|0
1856119|NCT00112437|6412868|P13|Year 3 (12-Month Extension)|Protocol Violation|0
1856120|NCT00112437|6412869|P12|Year 3 (12-Month Extension)|Protocol Violation|0
1856121|NCT00112437|6412870|P11|Year 3 (12-Month Extension)|Protocol Violation|0
1856122|NCT00112437|6412871|P10|Year 3 (12-Month Extension)|Protocol Violation|0
1856123|NCT00112437|6412872|P9|Year 3 (12-Month Extension)|Protocol Violation|0
1856124|NCT00112437|6412873|P8|Year 3 (12-Month Extension)|Protocol Violation|0
1856125|NCT00112437|6412874|P7|Year 3 (12-Month Extension)|Protocol Violation|0
1856126|NCT00112437|6412875|P6|Year 3 (12-Month Extension)|Protocol Violation|0
1856127|NCT00112437|6412876|P5|Year 3 (12-Month Extension)|Protocol Violation|0
1856128|NCT00112437|6412877|P4|Year 3 (12-Month Extension)|Protocol Violation|0
1856129|NCT00112437|6412878|P3|Year 3 (12-Month Extension)|Protocol Violation|0
1856130|NCT00112437|6412879|P2|Year 3 (12-Month Extension)|Protocol Violation|0
1856131|NCT00112437|6412880|P1|Year 3 (12-Month Extension)|Protocol Violation|0
1856132|NCT00112437|6412855|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856133|NCT00112437|6412856|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856134|NCT00112437|6412857|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856135|NCT00112437|6412858|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856136|NCT00112437|6412859|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856137|NCT00112437|6412860|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856138|NCT00112437|6412861|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856139|NCT00112437|6412862|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856140|NCT00112437|6412863|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856141|NCT00112437|6412864|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856142|NCT00112437|6412865|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
1856143|NCT00112437|6412866|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856144|NCT00112437|6412867|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856145|NCT00112437|6412868|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856146|NCT00112437|6412869|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856147|NCT00112437|6412870|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856148|NCT00112437|6412871|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856149|NCT00112437|6412872|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856150|NCT00112437|6412873|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856151|NCT00112437|6412874|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856152|NCT00112437|6412875|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856153|NCT00112437|6412876|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856154|NCT00112437|6412877|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856155|NCT00112437|6412878|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856156|NCT00112437|6412879|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856157|NCT00112437|6412880|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
1856158|NCT00112437|6412855|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856159|NCT00112437|6412856|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856160|NCT00112437|6412857|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856161|NCT00112437|6412858|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856162|NCT00112437|6412859|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856163|NCT00112437|6412860|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856164|NCT00112437|6412861|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856165|NCT00112437|6412862|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
1856166|NCT00112437|6412863|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856167|NCT00112437|6412864|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856168|NCT00112437|6412865|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
1856169|NCT00112437|6412866|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856170|NCT00112437|6412867|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
1856171|NCT00112437|6412868|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856172|NCT00112437|6412869|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
1856173|NCT00112437|6412870|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856174|NCT00112437|6412871|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856175|NCT00112437|6412872|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856176|NCT00112437|6412873|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856177|NCT00112437|6412874|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856178|NCT00112437|6412875|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856179|NCT00112437|6412876|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856180|NCT00112437|6412877|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856181|NCT00112437|6412878|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856182|NCT00112437|6412879|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856183|NCT00112437|6412880|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
1856184|NCT00112437|6412855|P26|Year 3 (12-Month Extension)|Adverse Event|0
1856185|NCT00112437|6412856|P25|Year 3 (12-Month Extension)|Adverse Event|0
1856186|NCT00112437|6412857|P24|Year 3 (12-Month Extension)|Adverse Event|0
1856187|NCT00112437|6412858|P23|Year 3 (12-Month Extension)|Adverse Event|0
1856188|NCT00112437|6412859|P22|Year 3 (12-Month Extension)|Adverse Event|0
1856189|NCT00112437|6412860|P21|Year 3 (12-Month Extension)|Adverse Event|0
1856190|NCT00112437|6412861|P20|Year 3 (12-Month Extension)|Adverse Event|1
1856191|NCT00112437|6412862|P19|Year 3 (12-Month Extension)|Adverse Event|0
1856192|NCT00112437|6412863|P18|Year 3 (12-Month Extension)|Adverse Event|1
1856193|NCT00112437|6412864|P17|Year 3 (12-Month Extension)|Adverse Event|3
1856194|NCT00112437|6412865|P16|Year 3 (12-Month Extension)|Adverse Event|1
1856195|NCT00112437|6412866|P15|Year 3 (12-Month Extension)|Adverse Event|0
1856196|NCT00112437|6412867|P14|Year 3 (12-Month Extension)|Adverse Event|0
1856197|NCT00112437|6412868|P13|Year 3 (12-Month Extension)|Adverse Event|0
1856198|NCT00112437|6412869|P12|Year 3 (12-Month Extension)|Adverse Event|0
1856199|NCT00112437|6412870|P11|Year 3 (12-Month Extension)|Adverse Event|1
1856200|NCT00112437|6412871|P10|Year 3 (12-Month Extension)|Adverse Event|0
1856201|NCT00112437|6412872|P9|Year 3 (12-Month Extension)|Adverse Event|0
1856202|NCT00112437|6412873|P8|Year 3 (12-Month Extension)|Adverse Event|0
1856203|NCT00112437|6412874|P7|Year 3 (12-Month Extension)|Adverse Event|0
1856204|NCT00112437|6412875|P6|Year 3 (12-Month Extension)|Adverse Event|0
1856205|NCT00112437|6412876|P5|Year 3 (12-Month Extension)|Adverse Event|0
1856206|NCT00112437|6412877|P4|Year 3 (12-Month Extension)|Adverse Event|0
1856207|NCT00112437|6412878|P3|Year 3 (12-Month Extension)|Adverse Event|0
1856208|NCT00112437|6412879|P2|Year 3 (12-Month Extension)|Adverse Event|0
1856209|NCT00112437|6412880|P1|Year 3 (12-Month Extension)|Adverse Event|0
1856210|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|Moved|0
1856211|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|Moved|0
1856212|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|Moved|0
1856213|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|Moved|0
1856214|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|Moved|0
1856215|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|Moved|0
1856216|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|Moved|0
1856217|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|Moved|0
1856218|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|Moved|0
1856219|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|Moved|0
1856220|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|Moved|0
1856221|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|Moved|0
1856222|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|Moved|0
1856223|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|Moved|0
1856224|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|Moved|0
1856225|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|Moved|0
1856226|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|Moved|1
1856227|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|Moved|0
1856228|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|Moved|0
1856229|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|Moved|0
1856230|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|Moved|0
1856231|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|Moved|0
1856232|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|Moved|0
1856233|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|Moved|0
1856234|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|Moved|0
1856235|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|Moved|0
1856236|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|patient was out of windows|0
1856237|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|patient was out of windows|0
1856238|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|patient was out of windows|0
1856239|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|patient was out of windows|0
1856240|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|patient was out of windows|0
1856241|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|patient was out of windows|0
1856242|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|patient was out of windows|0
1856243|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|patient was out of windows|0
1856244|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|patient was out of windows|0
1856245|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|patient was out of windows|0
1856246|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|patient was out of windows|0
1856247|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|patient was out of windows|0
1856248|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|patient was out of windows|0
1856249|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|patient was out of windows|0
1856250|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|patient was out of windows|0
1856251|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|patient was out of windows|0
1856252|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|patient was out of windows|1
1856253|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|patient was out of windows|0
1856254|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|patient was out of windows|0
1856255|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|patient was out of windows|0
1856256|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|patient was out of windows|0
1856257|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|patient was out of windows|0
1856258|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|patient was out of windows|0
1856259|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|patient was out of windows|0
1856260|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|patient was out of windows|0
1856261|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|patient was out of windows|0
1856262|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856263|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856413|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|Adverse Event|0
1856264|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856265|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856266|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856267|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856268|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856269|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856270|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856271|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856272|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856273|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856274|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856275|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856276|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856277|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856278|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
1856279|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856280|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856281|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856282|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856283|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856284|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856285|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856286|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856287|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
1856288|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856289|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856290|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856291|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856292|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856293|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856294|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856295|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856296|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856297|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856298|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856299|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856300|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856301|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856302|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856303|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856304|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1856305|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
1856306|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
1856307|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1856308|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
1856309|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856310|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856311|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856312|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856313|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
1856314|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|Protocol Violation|0
1856315|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|Protocol Violation|0
1856316|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|Protocol Violation|0
1856317|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|Protocol Violation|0
1856318|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|Protocol Violation|0
1856319|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|Protocol Violation|0
1856320|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|Protocol Violation|0
1856321|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|Protocol Violation|0
1856322|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|Protocol Violation|0
1856323|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|Protocol Violation|0
1856324|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|Protocol Violation|0
1856325|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|Protocol Violation|0
1856326|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|Protocol Violation|0
1856327|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|Protocol Violation|0
1856328|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|Protocol Violation|0
1856329|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|Protocol Violation|0
1856330|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|Protocol Violation|0
1856331|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|Protocol Violation|1
1856332|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|Protocol Violation|0
1856333|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|Protocol Violation|0
1856334|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|Protocol Violation|0
1856335|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|Protocol Violation|0
1856336|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|Protocol Violation|0
1856337|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|Protocol Violation|0
1856338|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|Protocol Violation|0
1856339|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|Protocol Violation|0
1856340|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856341|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856342|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856343|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856344|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856345|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856346|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856347|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856348|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856349|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856350|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856351|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856352|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856353|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856354|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856355|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856356|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856357|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
1856358|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856359|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856360|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856361|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856362|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856363|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856364|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856365|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
1856366|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856367|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856368|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856369|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856370|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856371|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856372|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856373|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856374|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856375|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856376|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856377|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856378|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856379|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856380|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856381|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856382|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
1856383|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856384|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856385|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
1856386|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
1856387|NCT00112437|6412876|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856388|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856389|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856390|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856391|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
1856392|NCT00112437|6412855|P26|Year 2 (12-Month Extension)|Adverse Event|0
1856393|NCT00112437|6412856|P25|Year 2 (12-Month Extension)|Adverse Event|0
1856394|NCT00112437|6412857|P24|Year 2 (12-Month Extension)|Adverse Event|0
1856395|NCT00112437|6412858|P23|Year 2 (12-Month Extension)|Adverse Event|0
1856396|NCT00112437|6412859|P22|Year 2 (12-Month Extension)|Adverse Event|0
1856397|NCT00112437|6412860|P21|Year 2 (12-Month Extension)|Adverse Event|0
1856398|NCT00112437|6412861|P20|Year 2 (12-Month Extension)|Adverse Event|0
1856399|NCT00112437|6412862|P19|Year 2 (12-Month Extension)|Adverse Event|0
1856400|NCT00112437|6412863|P18|Year 2 (12-Month Extension)|Adverse Event|0
1856401|NCT00112437|6412864|P17|Year 2 (12-Month Extension)|Adverse Event|0
1856402|NCT00112437|6412865|P16|Year 2 (12-Month Extension)|Adverse Event|0
1856403|NCT00112437|6412866|P15|Year 2 (12-Month Extension)|Adverse Event|0
1856404|NCT00112437|6412867|P14|Year 2 (12-Month Extension)|Adverse Event|0
1856405|NCT00112437|6412868|P13|Year 2 (12-Month Extension)|Adverse Event|0
1856406|NCT00112437|6412869|P12|Year 2 (12-Month Extension)|Adverse Event|0
1856407|NCT00112437|6412870|P11|Year 2 (12-Month Extension)|Adverse Event|0
1856408|NCT00112437|6412871|P10|Year 2 (12-Month Extension)|Adverse Event|7
1856409|NCT00112437|6412872|P9|Year 2 (12-Month Extension)|Adverse Event|1
1856410|NCT00112437|6412873|P8|Year 2 (12-Month Extension)|Adverse Event|6
1856411|NCT00112437|6412874|P7|Year 2 (12-Month Extension)|Adverse Event|2
1856412|NCT00112437|6412875|P6|Year 2 (12-Month Extension)|Adverse Event|1
1856414|NCT00112437|6412877|P4|Year 2 (12-Month Extension)|Adverse Event|0
1856415|NCT00112437|6412878|P3|Year 2 (12-Month Extension)|Adverse Event|0
1856416|NCT00112437|6412879|P2|Year 2 (12-Month Extension)|Adverse Event|0
1856417|NCT00112437|6412880|P1|Year 2 (12-Month Extension)|Adverse Event|0
1856418|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856419|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856420|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856421|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856422|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856423|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856424|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856425|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856426|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856427|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856428|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856429|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856430|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856431|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856432|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856433|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856434|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856435|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856436|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856437|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856438|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856439|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
1856440|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856441|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856442|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856443|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
1856444|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856445|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856446|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856447|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856448|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856449|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856450|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856451|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856452|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856453|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856454|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856455|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856456|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856457|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856458|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856459|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856460|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856461|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856462|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856463|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856464|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856465|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856466|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
1856467|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856468|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856469|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
1856470|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|moved|0
1856471|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|moved|0
1856472|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|moved|0
1856473|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|moved|0
1856474|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|moved|0
1856475|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|moved|0
1856476|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|moved|0
1856477|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|moved|0
1856478|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|moved|0
1856479|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|moved|0
1856480|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|moved|0
1856481|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|moved|0
1856482|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|moved|0
1856483|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|moved|0
1856484|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|moved|0
1856485|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|moved|0
1856486|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|moved|0
1856487|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|moved|0
1856488|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|moved|0
1856489|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|moved|0
1856490|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|moved|0
1856491|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|moved|0
1856492|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|moved|0
1856493|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|moved|1
1856494|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|moved|1
1856495|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|moved|0
1856496|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856497|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856498|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856499|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856500|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856501|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856502|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856503|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856504|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856505|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856506|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856507|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856508|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856509|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856510|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856511|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856512|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856513|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856514|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856515|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856516|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
1856517|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
1856518|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
1856519|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
1856520|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1856521|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
1856522|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
1856523|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
1856524|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
1856525|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
1856526|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
1856527|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
1856528|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
1856529|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
1856530|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
1856531|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
1856532|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
1856533|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
1856534|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
1856535|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
1856536|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
1856537|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
1856538|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
1856539|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
1856540|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
1856541|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
1856542|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
1856543|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
1856544|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
1856545|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
1856546|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
1856547|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
1856548|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856549|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856550|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856551|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856552|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856553|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856554|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856555|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856556|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856557|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856558|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856559|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856560|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856561|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856562|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856563|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856564|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856565|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856566|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856567|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856568|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856569|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856570|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856571|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856572|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
1856573|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
1856574|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856575|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856576|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856577|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856578|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856579|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856580|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856581|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856582|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856583|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856584|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856585|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856586|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856587|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856588|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856589|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856590|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856591|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856592|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856593|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856594|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856595|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856596|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856597|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856598|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
1856599|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
1856600|NCT00112437|6412855|P26|Year 1 (12-Month Base Study)|Adverse Event|0
1856601|NCT00112437|6412856|P25|Year 1 (12-Month Base Study)|Adverse Event|0
1856602|NCT00112437|6412857|P24|Year 1 (12-Month Base Study)|Adverse Event|0
1856603|NCT00112437|6412858|P23|Year 1 (12-Month Base Study)|Adverse Event|0
1856604|NCT00112437|6412859|P22|Year 1 (12-Month Base Study)|Adverse Event|0
1856605|NCT00112437|6412860|P21|Year 1 (12-Month Base Study)|Adverse Event|0
1856606|NCT00112437|6412861|P20|Year 1 (12-Month Base Study)|Adverse Event|0
1856607|NCT00112437|6412862|P19|Year 1 (12-Month Base Study)|Adverse Event|0
1856608|NCT00112437|6412863|P18|Year 1 (12-Month Base Study)|Adverse Event|0
1856609|NCT00112437|6412864|P17|Year 1 (12-Month Base Study)|Adverse Event|0
1856610|NCT00112437|6412865|P16|Year 1 (12-Month Base Study)|Adverse Event|0
1856611|NCT00112437|6412866|P15|Year 1 (12-Month Base Study)|Adverse Event|0
1856612|NCT00112437|6412867|P14|Year 1 (12-Month Base Study)|Adverse Event|0
1856613|NCT00112437|6412868|P13|Year 1 (12-Month Base Study)|Adverse Event|0
1856614|NCT00112437|6412869|P12|Year 1 (12-Month Base Study)|Adverse Event|0
1856615|NCT00112437|6412870|P11|Year 1 (12-Month Base Study)|Adverse Event|0
1856616|NCT00112437|6412871|P10|Year 1 (12-Month Base Study)|Adverse Event|0
1856617|NCT00112437|6412872|P9|Year 1 (12-Month Base Study)|Adverse Event|0
1856618|NCT00112437|6412873|P8|Year 1 (12-Month Base Study)|Adverse Event|0
1856619|NCT00112437|6412874|P7|Year 1 (12-Month Base Study)|Adverse Event|0
1856620|NCT00112437|6412875|P6|Year 1 (12-Month Base Study)|Adverse Event|0
1856621|NCT00112437|6412876|P5|Year 1 (12-Month Base Study)|Adverse Event|3
1856622|NCT00112437|6412877|P4|Year 1 (12-Month Base Study)|Adverse Event|4
1856623|NCT00112437|6412878|P3|Year 1 (12-Month Base Study)|Adverse Event|6
1856624|NCT00112437|6412879|P2|Year 1 (12-Month Base Study)|Adverse Event|10
1856625|NCT00112437|6412880|P1|Year 1 (12-Month Base Study)|Adverse Event|9
1856626|NCT00112385|6413160|P2|Overall Study|Withdrawal by Subject|1
1856627|NCT00112385|6413161|P1|Overall Study|Withdrawal by Subject|0
1856628|NCT00112385|6413160|P2|Overall Study|Lost to Follow-up|0
1856629|NCT00112385|6413161|P1|Overall Study|Lost to Follow-up|1
1856630|NCT00112359|6413251|P2|Overall Study|Other|0
1856631|NCT00112359|6413252|P1|Overall Study|Other|3
1856632|NCT00112359|6413251|P2|Overall Study|Personal/administrative|1
1856633|NCT00112359|6413252|P1|Overall Study|Personal/administrative|1
1856634|NCT00112359|6413251|P2|Overall Study|Lost to Follow-up|1
1856635|NCT00112359|6413252|P1|Overall Study|Lost to Follow-up|0
1856636|NCT00112359|6413251|P2|Overall Study|Related adverse event|3
1856637|NCT00112359|6413252|P1|Overall Study|Related adverse event|5
1856638|NCT00112359|6413251|P2|Overall Study|Trial drug intolerance (adverse event)|0
1856639|NCT00112359|6413252|P1|Overall Study|Trial drug intolerance (adverse event)|2
1856640|NCT00112359|6413251|P2|Overall Study|Unrelated adverse event|8
1856641|NCT00112359|6413252|P1|Overall Study|Unrelated adverse event|16
1856642|NCT00112294|6413278|P2|Overall Study|Still on study|0
1856643|NCT00112294|6413279|P1|Overall Study|Still on study|5
1856644|NCT00112047|6413502|P2|Atripla Phase|Other|1
1856645|NCT00112047|6413503|P1|Atripla Phase|Other|3
1856646|NCT00112047|6413502|P2|Atripla Phase|Non-compliance|0
1856647|NCT00112047|6413503|P1|Atripla Phase|Non-compliance|1
1856648|NCT00112047|6413502|P2|Atripla Phase|Sub-optimal virological response|1
1856649|NCT00112047|6413503|P1|Atripla Phase|Sub-optimal virological response|0
1856650|NCT00112047|6413502|P2|Atripla Phase|Withdrew consent|7
1856651|NCT00112047|6413503|P1|Atripla Phase|Withdrew consent|7
1856652|NCT00112047|6413502|P2|Atripla Phase|Death|2
1856653|NCT00112047|6413503|P1|Atripla Phase|Death|0
1856654|NCT00112047|6413502|P2|Atripla Phase|Pregnancy|1
1856655|NCT00112047|6413503|P1|Atripla Phase|Pregnancy|0
1856656|NCT00112047|6413502|P2|Atripla Phase|Lost to Follow-up|7
1856657|NCT00112047|6413503|P1|Atripla Phase|Lost to Follow-up|5
1856658|NCT00112047|6413502|P2|Atripla Phase|Adverse Event|1
1856659|NCT00112047|6413503|P1|Atripla Phase|Adverse Event|2
1856660|NCT00112047|6413502|P2|Randomized Phase|High Hepatitis B DNA|1
1856661|NCT00112047|6413503|P1|Randomized Phase|High Hepatitis B DNA|0
1856662|NCT00112047|6413502|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
1856663|NCT00112047|6413503|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
1856664|NCT00112047|6413502|P2|Randomized Phase|Moved out of State|1
1856665|NCT00112047|6413503|P1|Randomized Phase|Moved out of State|0
1856666|NCT00112047|6413502|P2|Randomized Phase|Incarceration|2
1856667|NCT00112047|6413503|P1|Randomized Phase|Incarceration|3
1856668|NCT00112047|6413502|P2|Randomized Phase|Inability to swallow pills|1
1856669|NCT00112047|6413503|P1|Randomized Phase|Inability to swallow pills|0
1856670|NCT00112047|6413502|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
1856671|NCT00112047|6413503|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
1856672|NCT00112047|6413502|P2|Randomized Phase|Death|3
1856673|NCT00112047|6413503|P1|Randomized Phase|Death|1
1856674|NCT00112047|6413502|P2|Randomized Phase|Pregnancy|1
1856675|NCT00112047|6413503|P1|Randomized Phase|Pregnancy|3
1856676|NCT00112047|6413502|P2|Randomized Phase|Protocol Violation|0
1856677|NCT00112047|6413503|P1|Randomized Phase|Protocol Violation|2
1856678|NCT00112047|6413502|P2|Randomized Phase|Noncompliance|4
1856679|NCT00112047|6413503|P1|Randomized Phase|Noncompliance|8
1856680|NCT00112047|6413502|P2|Randomized Phase|Sub-optimal virological response|13
1856681|NCT00112047|6413503|P1|Randomized Phase|Sub-optimal virological response|3
1856682|NCT00112047|6413502|P2|Randomized Phase|Withrawal of consent|18
1856683|NCT00112047|6413503|P1|Randomized Phase|Withrawal of consent|10
1856684|NCT00112047|6413502|P2|Randomized Phase|Adverse Event|10
1856685|NCT00112047|6413503|P1|Randomized Phase|Adverse Event|10
1856686|NCT00112047|6413502|P2|Randomized Phase|Lost to Follow-up|33
1856687|NCT00112047|6413503|P1|Randomized Phase|Lost to Follow-up|26
1856688|NCT00111917|6413603|P2|Overall Study|Withdrawal by Subject|1
1856689|NCT00111917|6413604|P1|Overall Study|Withdrawal by Subject|1
1856690|NCT00111839|6413619|P3|Overall Study|Randomized but Not Treated|2
1856691|NCT00111839|6413620|P2|Overall Study|Randomized but Not Treated|0
1856692|NCT00111839|6413621|P1|Overall Study|Randomized but Not Treated|0
1856693|NCT00111839|6413619|P3|Overall Study|Other|3
1856694|NCT00111839|6413620|P2|Overall Study|Other|3
1856695|NCT00111839|6413621|P1|Overall Study|Other|6
1856696|NCT00111839|6413619|P3|Overall Study|Logistical Constraint|0
1856697|NCT00111839|6413620|P2|Overall Study|Logistical Constraint|0
1856698|NCT00111839|6413621|P1|Overall Study|Logistical Constraint|1
1856699|NCT00111839|6413619|P3|Overall Study|Lost to Follow-up|0
1856700|NCT00111839|6413620|P2|Overall Study|Lost to Follow-up|0
1856701|NCT00111839|6413621|P1|Overall Study|Lost to Follow-up|1
1856702|NCT00111839|6413619|P3|Overall Study|Withdrawal by Subject|2
1856703|NCT00111839|6413620|P2|Overall Study|Withdrawal by Subject|2
1856704|NCT00111839|6413621|P1|Overall Study|Withdrawal by Subject|2
1856705|NCT00111839|6413619|P3|Overall Study|Death|6
1856706|NCT00111839|6413620|P2|Overall Study|Death|1
1856707|NCT00111839|6413621|P1|Overall Study|Death|1
1856708|NCT00111839|6413619|P3|Overall Study|Protocol Violation|2
1856709|NCT00111839|6413620|P2|Overall Study|Protocol Violation|4
1856710|NCT00111839|6413621|P1|Overall Study|Protocol Violation|2
1856711|NCT00111839|6413619|P3|Overall Study|Adverse Event|1
1856712|NCT00111839|6413620|P2|Overall Study|Adverse Event|3
1856713|NCT00111839|6413621|P1|Overall Study|Adverse Event|5
1856714|NCT00111839|6413619|P3|Overall Study|Disease Progression|33
1856715|NCT00111839|6413620|P2|Overall Study|Disease Progression|33
1856716|NCT00111839|6413621|P1|Overall Study|Disease Progression|30
1856717|NCT00111813|6413641|P6|Overall Study|Other|0
1856718|NCT00111813|6413642|P5|Overall Study|Other|0
1856719|NCT00111813|6413643|P4|Overall Study|Other|0
1856720|NCT00111813|6413644|P3|Overall Study|Other|1
1856721|NCT00111813|6413645|P2|Overall Study|Other|0
1856722|NCT00111813|6413646|P1|Overall Study|Other|0
1856723|NCT00111813|6413641|P6|Overall Study|Lack of Efficacy|1
1856724|NCT00111813|6413642|P5|Overall Study|Lack of Efficacy|0
1856725|NCT00111813|6413643|P4|Overall Study|Lack of Efficacy|0
1856726|NCT00111813|6413644|P3|Overall Study|Lack of Efficacy|0
1856727|NCT00111813|6413645|P2|Overall Study|Lack of Efficacy|0
1856728|NCT00111813|6413646|P1|Overall Study|Lack of Efficacy|0
1856729|NCT00111813|6413641|P6|Overall Study|Progressive disease|3
1856730|NCT00111813|6413642|P5|Overall Study|Progressive disease|4
1856731|NCT00111813|6413643|P4|Overall Study|Progressive disease|3
1856732|NCT00111813|6413644|P3|Overall Study|Progressive disease|5
1856733|NCT00111813|6413645|P2|Overall Study|Progressive disease|1
1856734|NCT00111813|6413646|P1|Overall Study|Progressive disease|2
1856735|NCT00111813|6413641|P6|Overall Study|Adverse Event|2
1856736|NCT00111813|6413642|P5|Overall Study|Adverse Event|2
1856737|NCT00111813|6413643|P4|Overall Study|Adverse Event|2
1856738|NCT00111813|6413644|P3|Overall Study|Adverse Event|4
1856739|NCT00111813|6413645|P2|Overall Study|Adverse Event|2
1856740|NCT00111813|6413646|P1|Overall Study|Adverse Event|1
1856741|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1856742|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1856743|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1856744|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
1856745|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1856746|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
1856747|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1856748|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1856749|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1856750|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
1856751|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1856752|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
1856753|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1856754|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1856755|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1856756|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1856757|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
1856758|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
1856759|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1856760|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1856761|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1856762|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
1856763|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1856764|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
1856765|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1856766|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1856767|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1856768|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1856769|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
1856770|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
1856771|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1856772|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
1856773|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1856774|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1856775|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
1856776|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
1856777|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1856778|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1856779|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1856780|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1856781|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
1856782|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
1856783|NCT00111800|6413685|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1856784|NCT00111800|6413686|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1856785|NCT00111800|6413687|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
1856786|NCT00111800|6413688|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
1856787|NCT00111800|6413689|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
1856788|NCT00111800|6413690|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
1856789|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
1856790|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1856791|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1856792|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1856793|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1856794|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
1856795|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1856796|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
1856797|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1856798|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1856799|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1856800|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
1856801|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1856802|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
1856803|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1856804|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1856805|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1856806|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
1856807|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1856808|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1856809|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
1856810|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1856811|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1856812|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
1856813|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1856814|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1856815|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
1856816|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1856817|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1856818|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
1856819|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1856820|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1856821|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1856822|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1856823|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
1856824|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
1856825|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1856826|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1856827|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1856828|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1856829|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
1856830|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
1856831|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1856832|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1856833|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1856834|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1856835|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
1856836|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
1856837|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1856838|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1856839|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1856840|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1856841|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
1856842|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
1856843|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1856844|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1856845|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1856846|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1856847|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
1856848|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
1856849|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1856850|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1856851|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1856852|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
1856853|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1856854|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
1856855|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1856856|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1856857|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1856858|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
1856859|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1856860|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
1856861|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1856862|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1856863|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1856864|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1856865|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
1856866|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
1856867|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1856868|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1856869|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
1856870|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1856871|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
1856872|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
1856873|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
1856874|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1856875|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
1856876|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
1856877|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1856878|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
1856879|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1856880|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
1856881|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1856882|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
1856883|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
1856884|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
1856885|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1856886|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1856887|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1856888|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
1856889|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
1856890|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
1856891|NCT00111800|6413685|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1856892|NCT00111800|6413686|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
1856893|NCT00111800|6413687|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1856894|NCT00111800|6413688|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
1856895|NCT00111800|6413689|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
1856896|NCT00111800|6413690|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
1856897|NCT00111761|6413860|P2|Part 2|Other|0
1856898|NCT00111761|6413861|P1|Part 2|Other|1
1856899|NCT00111761|6413860|P2|Part 2|Protocol-specified criteria|0
1856900|NCT00111761|6413861|P1|Part 2|Protocol-specified criteria|1
1856901|NCT00111761|6413860|P2|Part 2|Disease progression|0
1856902|NCT00111761|6413861|P1|Part 2|Disease progression|3
1856903|NCT00111761|6413860|P2|Part 2|Death|0
1856904|NCT00111761|6413861|P1|Part 2|Death|1
1856905|NCT00111761|6413860|P2|Part 2|Physician Decision|0
1856906|NCT00111761|6413861|P1|Part 2|Physician Decision|1
1856907|NCT00111761|6413860|P2|Part 2|Adverse Event|0
1856908|NCT00111761|6413861|P1|Part 2|Adverse Event|1
1856909|NCT00111761|6413860|P2|Part 1|Withdrawal by Subject|1
1856910|NCT00111761|6413861|P1|Part 1|Withdrawal by Subject|0
1856911|NCT00111761|6413860|P2|Part 1|Other|1
1856912|NCT00111761|6413861|P1|Part 1|Other|0
1856913|NCT00111761|6413860|P2|Part 1|Death|2
1856914|NCT00111761|6413861|P1|Part 1|Death|0
1856915|NCT00111761|6413860|P2|Part 1|Physician Decision|1
1856916|NCT00111761|6413861|P1|Part 1|Physician Decision|0
1856917|NCT00111475|6413898|P10|Overall Study|Lost to Follow-up|0
1856918|NCT00111475|6413899|P9|Overall Study|Lost to Follow-up|0
1856919|NCT00111475|6413900|P8|Overall Study|Lost to Follow-up|0
1856920|NCT00111475|6413901|P7|Overall Study|Lost to Follow-up|0
1856921|NCT00111475|6413902|P6|Overall Study|Lost to Follow-up|1
1856922|NCT00111475|6413903|P5|Overall Study|Lost to Follow-up|0
1856923|NCT00111475|6413904|P4|Overall Study|Lost to Follow-up|0
1856924|NCT00111475|6413905|P3|Overall Study|Lost to Follow-up|0
1856925|NCT00111475|6413906|P2|Overall Study|Lost to Follow-up|0
1856926|NCT00111475|6413907|P1|Overall Study|Lost to Follow-up|0
1856927|NCT00111241|6414025|P2|Overall Study|Adverse Event|0
1856928|NCT00111241|6414026|P1|Overall Study|Adverse Event|1
1856929|NCT00111241|6414025|P2|Overall Study|Protocol Violation|8
1856930|NCT00111241|6414026|P1|Overall Study|Protocol Violation|9
1856931|NCT00111241|6414025|P2|Overall Study|Withdrawal by Subject|0
1856932|NCT00111241|6414026|P1|Overall Study|Withdrawal by Subject|4
1856933|NCT00111241|6414025|P2|Overall Study|Lost to Follow-up|0
1856934|NCT00111241|6414026|P1|Overall Study|Lost to Follow-up|1
1856935|NCT00111228|6414037|P3|Overall Study|Withdrawal by Subject|0
1856936|NCT00111228|6414038|P2|Overall Study|Withdrawal by Subject|1
1856937|NCT00111228|6414039|P1|Overall Study|Withdrawal by Subject|5
1856938|NCT00111007|6414052|P2|Long Term Follow-up|Missing|3
1856939|NCT00111007|6414053|P1|Long Term Follow-up|Missing|10
1856940|NCT00111007|6414052|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
1856941|NCT00111007|6414053|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
1856942|NCT00111007|6414052|P2|Long Term Follow-up|Withdrawal by Subject|1
1856943|NCT00111007|6414053|P1|Long Term Follow-up|Withdrawal by Subject|0
1856944|NCT00111007|6414052|P2|Long Term Follow-up|Lost to Follow-up|1
1856945|NCT00111007|6414053|P1|Long Term Follow-up|Lost to Follow-up|1
1856946|NCT00111007|6414052|P2|Long Term Follow-up|Death|39
1856947|NCT00111007|6414053|P1|Long Term Follow-up|Death|34
1856948|NCT00111007|6414052|P2|Active Follow-up|Disease progression/recurrence/relapse|2
1856949|NCT00111007|6414053|P1|Active Follow-up|Disease progression/recurrence/relapse|3
1856950|NCT00111007|6414052|P2|Active Follow-up|Death|0
1856951|NCT00111007|6414053|P1|Active Follow-up|Death|2
1856952|NCT00111007|6414052|P2|Active Follow-up|Adverse Event|0
1856953|NCT00111007|6414053|P1|Active Follow-up|Adverse Event|1
1856954|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Primary reason with other category|1
1856955|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Primary reason with other category|0
1856956|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
1856957|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
1856958|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
1856959|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
1856960|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Relapse|0
1856961|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Relapse|1
1856962|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
1856963|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
1856964|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
1856965|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
1856966|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Protocol Violation|1
1856967|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Protocol Violation|0
1856968|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Death|2
1856969|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Death|5
1856970|NCT00111007|6414052|P2|Double-blind (DB) Treatment|Adverse Event|4
1856971|NCT00111007|6414053|P1|Double-blind (DB) Treatment|Adverse Event|12
1856972|NCT00110994|6414069|P2|Long Term Follow-up|Death|17
1856973|NCT00110994|6414070|P1|Long Term Follow-up|Death|19
1856974|NCT00110994|6414069|P2|Active Follow-up|Other reasons|2
1856975|NCT00110994|6414070|P1|Active Follow-up|Other reasons|0
1856976|NCT00110994|6414069|P2|Active Follow-up|Disease progression/recurrence/replace|0
1856977|NCT00110994|6414070|P1|Active Follow-up|Disease progression/recurrence/replace|1
1856978|NCT00110994|6414069|P2|Double-blind (DB) Treatment|other reasons|3
1856979|NCT00110994|6414070|P1|Double-blind (DB) Treatment|other reasons|2
1856980|NCT00110994|6414069|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
1856981|NCT00110994|6414070|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
1856982|NCT00110994|6414069|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
1856983|NCT00110994|6414070|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
1856984|NCT00110994|6414069|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
1856985|NCT00110994|6414070|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
1856986|NCT00110994|6414069|P2|Double-blind (DB) Treatment|Death|0
1856987|NCT00110994|6414070|P1|Double-blind (DB) Treatment|Death|1
1856988|NCT00110994|6414069|P2|Double-blind (DB) Treatment|Adverse Event|0
1856989|NCT00110994|6414070|P1|Double-blind (DB) Treatment|Adverse Event|3
1856990|NCT00110890|6414096|P2|Overall Study|Did not enter follow-up phase|4
1856991|NCT00110890|6414097|P1|Overall Study|Did not enter follow-up phase|10
1856992|NCT00110890|6414096|P2|Overall Study|Parathyroidectomy|1
1856993|NCT00110890|6414097|P1|Overall Study|Parathyroidectomy|0
1856994|NCT00110890|6414096|P2|Overall Study|Disease progression|1
1856995|NCT00110890|6414097|P1|Overall Study|Disease progression|0
1856996|NCT00110890|6414096|P2|Overall Study|Requirement for alternative therapy|1
1856997|NCT00110890|6414097|P1|Overall Study|Requirement for alternative therapy|0
1856998|NCT00110890|6414096|P2|Overall Study|Ineligibility determined|0
1856999|NCT00110890|6414097|P1|Overall Study|Ineligibility determined|3
1857000|NCT00110890|6414096|P2|Overall Study|Other|23
1857001|NCT00110890|6414097|P1|Overall Study|Other|34
1857002|NCT00110890|6414096|P2|Overall Study|Invest. Product Commercially Available|110
1857003|NCT00110890|6414097|P1|Overall Study|Invest. Product Commercially Available|217
1857004|NCT00110890|6414096|P2|Overall Study|Kidney Transplant|12
1857005|NCT00110890|6414097|P1|Overall Study|Kidney Transplant|16
1857006|NCT00110890|6414096|P2|Overall Study|Noncompliance|0
1857007|NCT00110890|6414097|P1|Overall Study|Noncompliance|10
1857008|NCT00110890|6414096|P2|Overall Study|Protocol Deviation|0
1857009|NCT00110890|6414097|P1|Overall Study|Protocol Deviation|1
1857010|NCT00110890|6414096|P2|Overall Study|Withdrawal by Subject|5
1857011|NCT00110890|6414097|P1|Overall Study|Withdrawal by Subject|17
1857012|NCT00110890|6414096|P2|Overall Study|Physician Decision|5
1857013|NCT00110890|6414097|P1|Overall Study|Physician Decision|4
1857014|NCT00110890|6414096|P2|Overall Study|Lost to Follow-up|1
1857015|NCT00110890|6414097|P1|Overall Study|Lost to Follow-up|3
1857016|NCT00110890|6414096|P2|Overall Study|Death|9
1857017|NCT00110890|6414097|P1|Overall Study|Death|16
1857018|NCT00110890|6414096|P2|Overall Study|Adverse Event|7
1857019|NCT00110890|6414097|P1|Overall Study|Adverse Event|30
1857020|NCT00110812|6414114|P3|Extended Follow-up|Lost to Follow-up|1
1857021|NCT00110812|6414115|P2|Extended Follow-up|Lost to Follow-up|3
1857022|NCT00110812|6414116|P1|Extended Follow-up|Lost to Follow-up|1
1857023|NCT00110812|6414114|P3|Extended Follow-up|Withdrawal by Subject|0
1857024|NCT00110812|6414115|P2|Extended Follow-up|Withdrawal by Subject|1
1857025|NCT00110812|6414116|P1|Extended Follow-up|Withdrawal by Subject|0
1857026|NCT00110812|6414114|P3|Extended Follow-up|Death|3
1857027|NCT00110812|6414115|P2|Extended Follow-up|Death|0
1857028|NCT00110812|6414116|P1|Extended Follow-up|Death|1
1857029|NCT00110812|6414114|P3|Main Study|Lost to Follow-up|10
1857030|NCT00110812|6414115|P2|Main Study|Lost to Follow-up|11
1857031|NCT00110812|6414116|P1|Main Study|Lost to Follow-up|8
1857032|NCT00110812|6414114|P3|Main Study|Withdrawal by Subject|1
1857033|NCT00110812|6414115|P2|Main Study|Withdrawal by Subject|0
1857034|NCT00110812|6414116|P1|Main Study|Withdrawal by Subject|0
1857035|NCT00110812|6414114|P3|Main Study|Death|2
1857036|NCT00110812|6414115|P2|Main Study|Death|0
1857037|NCT00110812|6414116|P1|Main Study|Death|0
1857038|NCT00110617|6414161|P2|Overall Study|Did not receive study drug|12
1857039|NCT00110617|6414162|P1|Overall Study|Did not receive study drug|0
1857040|NCT00110617|6414161|P2|Overall Study|Death|1
1857041|NCT00110617|6414162|P1|Overall Study|Death|1
1857042|NCT00110617|6414161|P2|Overall Study|Administrative problems|5
1857043|NCT00110617|6414162|P1|Overall Study|Administrative problems|6
1857044|NCT00110617|6414161|P2|Overall Study|Lost to Follow-up|1
1857045|NCT00110617|6414162|P1|Overall Study|Lost to Follow-up|9
1857046|NCT00110617|6414161|P2|Overall Study|Withdrawal by Subject|4
1857047|NCT00110617|6414162|P1|Overall Study|Withdrawal by Subject|10
1857048|NCT00110617|6414161|P2|Overall Study|Protocol Violation|0
1857049|NCT00110617|6414162|P1|Overall Study|Protocol Violation|5
1857050|NCT00110617|6414161|P2|Overall Study|Patient no longer requires study drug|0
1857051|NCT00110617|6414162|P1|Overall Study|Patient no longer requires study drug|1
1857052|NCT00110617|6414161|P2|Overall Study|Lack of Efficacy|0
1857053|NCT00110617|6414162|P1|Overall Study|Lack of Efficacy|1
1857054|NCT00110617|6414161|P2|Overall Study|Abnormal Laboratory Value|2
1857055|NCT00110617|6414162|P1|Overall Study|Abnormal Laboratory Value|4
1857056|NCT00110617|6414161|P2|Overall Study|Adverse Event|4
1857057|NCT00110617|6414162|P1|Overall Study|Adverse Event|2
1857058|NCT00110396|6414279|P1|Overall Study|Patient is to be administered copaxone|1
1857059|NCT00110396|6414279|P1|Overall Study|The patient has refused to visit site|1
1857060|NCT00110396|6414279|P1|Overall Study|The patient has refused|2
1857061|NCT00110396|6414279|P1|Overall Study|Patient refused to come back|1
1857062|NCT00110396|6414279|P1|Overall Study|Protocol Violation|2
1857063|NCT00110396|6414279|P1|Overall Study|Pregnancy (Protocol violation)|2
1857064|NCT00110396|6414279|P1|Overall Study|Pregnancy|1
1857065|NCT00110396|6414279|P1|Overall Study|Participation in MS vaccine study|1
1857066|NCT00110396|6414279|P1|Overall Study|Patient's decision|1
1857067|NCT00110396|6414279|P1|Overall Study|Patient will|1
1857068|NCT00110396|6414279|P1|Overall Study|Patient refused to participate|1
1857069|NCT00110396|6414279|P1|Overall Study|Patient refused to continue|1
1857070|NCT00110396|6414279|P1|Overall Study|Patient non-compliance|1
1857071|NCT00110396|6414279|P1|Overall Study|Decided not to continue treatment|1
1857072|NCT00110396|6414279|P1|Overall Study|Lack of Efficacy|1
1857073|NCT00110396|6414279|P1|Overall Study|Initiated mitoxantrone therapy|1
1857074|NCT00110396|6414279|P1|Overall Study|Administration of plasmapheresis|1
1857075|NCT00110396|6414279|P1|Overall Study|Lost to Follow-up|1
1857076|NCT00110396|6414279|P1|Overall Study|Adverse Event|15
1857077|NCT00110357|6414287|P2|Overall Study|Withdrawal by Subject|1
1857078|NCT00110357|6414288|P1|Overall Study|Withdrawal by Subject|3
1857079|NCT00110357|6414287|P2|Overall Study|Study Drug Toxicity|3
1857080|NCT00110357|6414288|P1|Overall Study|Study Drug Toxicity|1
1857081|NCT00110357|6414287|P2|Overall Study|Study Closure|0
1857082|NCT00110357|6414288|P1|Overall Study|Study Closure|1
1857083|NCT00110357|6414287|P2|Overall Study|Disease progression/relapse|15
1857084|NCT00110357|6414288|P1|Overall Study|Disease progression/relapse|20
1857085|NCT00110357|6414287|P2|Overall Study|Deterioration without progression|0
1857086|NCT00110357|6414288|P1|Overall Study|Deterioration without progression|2
1857087|NCT00110305|6414376|P2|Overall Study|Other|2
1857088|NCT00110305|6414377|P1|Overall Study|Other|8
1857089|NCT00110305|6414376|P2|Overall Study|Lost to Follow-up|3
1857090|NCT00110305|6414377|P1|Overall Study|Lost to Follow-up|20
1857091|NCT00110305|6414376|P2|Overall Study|Withdrawal by Subject|7
1857092|NCT00110305|6414377|P1|Overall Study|Withdrawal by Subject|7
1857093|NCT00110305|6414376|P2|Overall Study|Protocol Violation|1
1857094|NCT00110305|6414377|P1|Overall Study|Protocol Violation|0
1857095|NCT00110305|6414376|P2|Overall Study|Subject Reached A Virologic Endpoint|3
1857096|NCT00110305|6414377|P1|Overall Study|Subject Reached A Virologic Endpoint|21
1857097|NCT00110305|6414376|P2|Overall Study|Subject Ineligible To Continue The Trial|1
1857098|NCT00110305|6414377|P1|Overall Study|Subject Ineligible To Continue The Trial|2
1857099|NCT00110305|6414376|P2|Overall Study|Subject Non-Compliant|2
1857100|NCT00110305|6414377|P1|Overall Study|Subject Non-Compliant|9
1857101|NCT00110305|6414376|P2|Overall Study|Sponsors Decision|0
1857102|NCT00110305|6414377|P1|Overall Study|Sponsors Decision|1
1857103|NCT00110305|6414376|P2|Overall Study|Adverse Event|13
1857104|NCT00110305|6414377|P1|Overall Study|Adverse Event|46
1857105|NCT00110214|6414430|P2|Overall Study|Other (not specified)|75
1857106|NCT00110214|6414431|P1|Overall Study|Other (not specified)|61
1857107|NCT00110214|6414430|P2|Overall Study|Refused further treatment|65
1857108|NCT00110214|6414431|P1|Overall Study|Refused further treatment|52
1857109|NCT00110214|6414430|P2|Overall Study|Adverse Event|192
1857110|NCT00110214|6414431|P1|Overall Study|Adverse Event|115
1857111|NCT00110214|6414430|P2|Overall Study|Disease progression or death|151
1857112|NCT00110214|6414431|P1|Overall Study|Disease progression or death|260
1857113|NCT00110214|6414430|P2|Overall Study|Never started treatment|20
1857114|NCT00110214|6414431|P1|Overall Study|Never started treatment|21
1857115|NCT00110149|6414443|P1|Overall Study|Physician Decision|3
1857116|NCT00110084|6414457|P1|Overall Study|Other|2
1857117|NCT00110084|6414457|P1|Overall Study|Intercurrent Illness|1
1857118|NCT00110084|6414457|P1|Overall Study|Alternate Therapy|5
1857119|NCT00110084|6414457|P1|Overall Study|Patient Refusal|10
1857120|NCT00110084|6414457|P1|Overall Study|Death|1
1857121|NCT00110084|6414457|P1|Overall Study|Adverse Event|9
1857122|NCT00110019|6414466|P2|Overall Study|other reasons|30
1857123|NCT00110019|6414467|P1|Overall Study|other reasons|22
1857124|NCT00110019|6414466|P2|Overall Study|Not start protocol therapy|16
1857125|NCT00110019|6414467|P1|Overall Study|Not start protocol therapy|17
1857126|NCT00110019|6414466|P2|Overall Study|symptom deterioration|16
1857127|NCT00110019|6414467|P1|Overall Study|symptom deterioration|13
1857128|NCT00110019|6414466|P2|Overall Study|complicating disease|1
1857129|NCT00110019|6414467|P1|Overall Study|complicating disease|1
1857130|NCT00110019|6414466|P2|Overall Study|alternative therapy|1
1857131|NCT00110019|6414467|P1|Overall Study|alternative therapy|5
1857132|NCT00110019|6414466|P2|Overall Study|Withdrawal by Subject|9
1857133|NCT00110019|6414467|P1|Overall Study|Withdrawal by Subject|21
1857134|NCT00110019|6414466|P2|Overall Study|Death|15
1857135|NCT00110019|6414467|P1|Overall Study|Death|13
1857136|NCT00110019|6414466|P2|Overall Study|Adverse Event|40
1857137|NCT00110019|6414467|P1|Overall Study|Adverse Event|61
1857138|NCT00110019|6414466|P2|Overall Study|Lack of Efficacy|285
1857139|NCT00110019|6414467|P1|Overall Study|Lack of Efficacy|253
1857140|NCT00109967|6414479|P2|Overall Study|Death|2
1857141|NCT00109967|6414480|P1|Overall Study|Death|0
1857142|NCT00109967|6414479|P2|Overall Study|Physician Decision|3
1857143|NCT00109967|6414480|P1|Overall Study|Physician Decision|1
1857144|NCT00109967|6414479|P2|Overall Study|Withdrawal by Subject|0
1857145|NCT00109967|6414480|P1|Overall Study|Withdrawal by Subject|5
1857146|NCT00109967|6414479|P2|Overall Study|Adverse Event|1
1857147|NCT00109967|6414480|P1|Overall Study|Adverse Event|12
1857148|NCT00109967|6414479|P2|Overall Study|Cancel Prior to Treatment|0
1857149|NCT00109967|6414480|P1|Overall Study|Cancel Prior to Treatment|2
1857150|NCT00109928|6414494|P1|Overall Study|not eligible|1
1857151|NCT00109928|6414494|P1|Overall Study|not protocol specified|2
1857152|NCT00109928|6414494|P1|Overall Study|Death|2
1857153|NCT00109928|6414494|P1|Overall Study|Progression|6
1857154|NCT00109928|6414494|P1|Overall Study|Adverse Event|2
1857155|NCT00109850|6414511|P1|Overall Study|Ineligible|1
1857156|NCT00109850|6414511|P1|Overall Study|Death|2
1857157|NCT00109850|6414511|P1|Overall Study|Adverse Event|1
1857158|NCT00109837|6414518|P1|Overall Study|Ineligible|1
1857159|NCT00109837|6414518|P1|Overall Study|Not treated|1
1857160|NCT00109837|6414518|P1|Overall Study|BCR/ABL+ or Ph+|17
1857161|NCT00109837|6414518|P1|Overall Study|Death|1
1857162|NCT00109837|6414518|P1|Overall Study|Refusal unrelated to adverse effects|1
1857163|NCT00109837|6414518|P1|Overall Study|Adverse Event|2
1857164|NCT00109772|6414528|P2|Open-label Extension|Other|10
1857165|NCT00109772|6414529|P1|Open-label Extension|Other|4
1857166|NCT00109772|6414528|P2|Open-label Extension|Protocol Violation|2
1857167|NCT00109772|6414529|P1|Open-label Extension|Protocol Violation|2
1857168|NCT00109772|6414528|P2|Open-label Extension|Death|1
1857169|NCT00109772|6414529|P1|Open-label Extension|Death|0
1857170|NCT00109772|6414528|P2|Open-label Extension|Lost to Follow-up|0
1857171|NCT00109772|6414529|P1|Open-label Extension|Lost to Follow-up|1
1857172|NCT00109772|6414528|P2|Open-label Extension|Withdrawal by Subject|6
1857173|NCT00109772|6414529|P1|Open-label Extension|Withdrawal by Subject|9
1857174|NCT00109772|6414528|P2|Open-label Extension|Lack of Efficacy|11
1857175|NCT00109772|6414529|P1|Open-label Extension|Lack of Efficacy|19
1857176|NCT00109772|6414528|P2|Open-label Extension|Adverse Event|19
1857177|NCT00109772|6414529|P1|Open-label Extension|Adverse Event|10
1857178|NCT00109772|6414528|P2|Double-blind Treatment|Withdrew prior to treatment|1
1857179|NCT00109772|6414529|P1|Double-blind Treatment|Withdrew prior to treatment|3
1857180|NCT00109772|6414528|P2|Double-blind Treatment|Other|4
1857181|NCT00109772|6414529|P1|Double-blind Treatment|Other|0
1857182|NCT00109772|6414528|P2|Double-blind Treatment|Protocol Violation|1
1857183|NCT00109772|6414529|P1|Double-blind Treatment|Protocol Violation|0
1857184|NCT00109772|6414528|P2|Double-blind Treatment|Lost to Follow-up|3
1857185|NCT00109772|6414529|P1|Double-blind Treatment|Lost to Follow-up|2
1857186|NCT00109772|6414528|P2|Double-blind Treatment|Withdrawal by Subject|1
1857187|NCT00109772|6414529|P1|Double-blind Treatment|Withdrawal by Subject|2
1857188|NCT00109772|6414528|P2|Double-blind Treatment|Lack of Efficacy|0
1857189|NCT00109772|6414529|P1|Double-blind Treatment|Lack of Efficacy|1
1857190|NCT00109772|6414528|P2|Double-blind Treatment|Adverse Event|5
1857191|NCT00109772|6414529|P1|Double-blind Treatment|Adverse Event|14
1857192|NCT00109733|6414569|P2|Overall Study|Could not commit time for study|1
1857193|NCT00109733|6414570|P1|Overall Study|Could not commit time for study|1
1857194|NCT00109733|6414569|P2|Overall Study|Non-compliant|1
1857195|NCT00109733|6414570|P1|Overall Study|Non-compliant|0
1857196|NCT00109733|6414569|P2|Overall Study|Stopped taking study drug|1
1857197|NCT00109733|6414570|P1|Overall Study|Stopped taking study drug|1
1857198|NCT00109733|6414569|P2|Overall Study|Protocol Violation|1
1857199|NCT00109733|6414570|P1|Overall Study|Protocol Violation|0
1857200|NCT00109590|6414587|P3|Overall Study|Never Started Treatment|3
1857201|NCT00109590|6414588|P2|Overall Study|Never Started Treatment|2
1857202|NCT00109590|6414589|P1|Overall Study|Never Started Treatment|1
1857203|NCT00109590|6414587|P3|Overall Study|Lost to Follow-up|1
1857204|NCT00109590|6414588|P2|Overall Study|Lost to Follow-up|0
1857205|NCT00109590|6414589|P1|Overall Study|Lost to Follow-up|1
1857206|NCT00109577|6414631|P2|Overall Study|Withdrawal by Subject|3
1857207|NCT00109577|6414632|P1|Overall Study|Withdrawal by Subject|3
1857208|NCT00109343|6414663|P3|Overall Study|Other|1
1857209|NCT00109343|6414664|P2|Overall Study|Other|2
1857210|NCT00109343|6414665|P1|Overall Study|Other|5
1857211|NCT00109343|6414663|P3|Overall Study|Subject Moved|1
1857212|NCT00109343|6414664|P2|Overall Study|Subject Moved|2
1857213|NCT00109343|6414665|P1|Overall Study|Subject Moved|6
1857214|NCT00109343|6414663|P3|Overall Study|Withdrawal by Subject|10
1857215|NCT00109343|6414664|P2|Overall Study|Withdrawal by Subject|11
1857216|NCT00109343|6414665|P1|Overall Study|Withdrawal by Subject|15
1857217|NCT00109343|6414663|P3|Overall Study|Protocol Violation|2
1857218|NCT00109343|6414664|P2|Overall Study|Protocol Violation|2
1857219|NCT00109343|6414665|P1|Overall Study|Protocol Violation|1
1857220|NCT00109343|6414663|P3|Overall Study|Lost to Follow-up|14
1857221|NCT00109343|6414664|P2|Overall Study|Lost to Follow-up|20
1857222|NCT00109343|6414665|P1|Overall Study|Lost to Follow-up|35
1857223|NCT00109343|6414663|P3|Overall Study|Lack of Efficacy|0
1857224|NCT00109343|6414664|P2|Overall Study|Lack of Efficacy|0
1857225|NCT00109343|6414665|P1|Overall Study|Lack of Efficacy|1
1857226|NCT00109343|6414663|P3|Overall Study|Adverse Event|2
1857227|NCT00109343|6414664|P2|Overall Study|Adverse Event|0
1857228|NCT00109343|6414665|P1|Overall Study|Adverse Event|1
1857229|NCT00109031|6414710|P4|Overall Study|Protocol Violation|0
1857230|NCT00109031|6414711|P3|Overall Study|Protocol Violation|1
1857231|NCT00109031|6414712|P2|Overall Study|Protocol Violation|0
1857232|NCT00109031|6414713|P1|Overall Study|Protocol Violation|0
1857233|NCT00109031|6414710|P4|Overall Study|Physician Decision|0
1857234|NCT00109031|6414711|P3|Overall Study|Physician Decision|0
1857235|NCT00109031|6414712|P2|Overall Study|Physician Decision|1
1857236|NCT00109031|6414713|P1|Overall Study|Physician Decision|0
1857237|NCT00109031|6414710|P4|Overall Study|Withdrawal by Subject|0
1857238|NCT00109031|6414711|P3|Overall Study|Withdrawal by Subject|0
1857239|NCT00109031|6414712|P2|Overall Study|Withdrawal by Subject|1
1857240|NCT00109031|6414713|P1|Overall Study|Withdrawal by Subject|0
1857241|NCT00109031|6414710|P4|Overall Study|Adverse Event|0
1857242|NCT00109031|6414711|P3|Overall Study|Adverse Event|1
1857243|NCT00109031|6414712|P2|Overall Study|Adverse Event|0
1857244|NCT00109031|6414713|P1|Overall Study|Adverse Event|0
1857245|NCT00108953|6414764|P2|Follow-up|Study terminated by sponsor|6
1857246|NCT00108953|6414765|P1|Follow-up|Study terminated by sponsor|10
1857247|NCT00108953|6414764|P2|Follow-up|Lost to Follow-up|1
1857248|NCT00108953|6414765|P1|Follow-up|Lost to Follow-up|1
1857249|NCT00108953|6414764|P2|Follow-up|Death|26
1857250|NCT00108953|6414765|P1|Follow-up|Death|18
1857251|NCT00108862|6414787|P2|Overall Study|Lost to Follow-up|19
1857252|NCT00108862|6414788|P1|Overall Study|Lost to Follow-up|27
1857253|NCT00108862|6414787|P2|Overall Study|Withdrawal by Subject|6
1857254|NCT00108862|6414788|P1|Overall Study|Withdrawal by Subject|10
1857255|NCT00108862|6414787|P2|Overall Study|Death|37
1857256|NCT00108862|6414788|P1|Overall Study|Death|31
1857257|NCT00108732|6414816|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
1857258|NCT00108732|6414816|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
1857259|NCT00108732|6414816|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
1857260|NCT00108732|6414816|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
1857261|NCT00108732|6414816|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
1857262|NCT00108732|6414816|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
1857263|NCT00108732|6414816|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
1857264|NCT00108628|6414825|P2|Overall Study|Death|0
1857265|NCT00108628|6414826|P1|Overall Study|Death|1
1857266|NCT00108628|6414825|P2|Overall Study|Lack of Efficacy|1
1857267|NCT00108628|6414826|P1|Overall Study|Lack of Efficacy|2
1857268|NCT00108628|6414825|P2|Overall Study|Withdrawal by Subject|9
1857269|NCT00108628|6414826|P1|Overall Study|Withdrawal by Subject|17
1857270|NCT00108485|6414876|P2|Overall Study|Lost to Follow-up|2
1857271|NCT00108485|6414877|P1|Overall Study|Lost to Follow-up|0
1857272|NCT00108485|6414876|P2|Overall Study|Withdrawal by Subject|0
1857273|NCT00108485|6414877|P1|Overall Study|Withdrawal by Subject|3
1857274|NCT00108433|6414885|P2|Overall Study|Other|14
1857275|NCT00108433|6414886|P1|Overall Study|Other|14
1857276|NCT00108433|6414885|P2|Overall Study|Adverse Event|1
1857277|NCT00108433|6414886|P1|Overall Study|Adverse Event|3
1857278|NCT00108433|6414885|P2|Overall Study|Death|0
1857279|NCT00108433|6414886|P1|Overall Study|Death|3
1857280|NCT00108433|6414885|P2|Overall Study|Lack of Efficacy|2
1857281|NCT00108433|6414886|P1|Overall Study|Lack of Efficacy|1
1857282|NCT00108355|6414902|P2|Overall Study|Loculated ascites, limiting paracentesis|1
1857283|NCT00108355|6414903|P1|Overall Study|Loculated ascites, limiting paracentesis|1
1857284|NCT00108355|6414902|P2|Overall Study|Peritonitis at index paracentesis|1
1857285|NCT00108355|6414903|P1|Overall Study|Peritonitis at index paracentesis|1
1857286|NCT00108160|6414952|P2|Overall Study|Protocol Violation|5
1857287|NCT00108160|6414953|P1|Overall Study|Protocol Violation|9
1857288|NCT00108160|6414952|P2|Overall Study|Withdrawal by Subject|2
1857289|NCT00108160|6414953|P1|Overall Study|Withdrawal by Subject|4
1857290|NCT00108160|6414952|P2|Overall Study|Death|2
1857291|NCT00108160|6414953|P1|Overall Study|Death|1
1857292|NCT00108160|6414952|P2|Overall Study|Lost to Follow-up|12
1857293|NCT00108160|6414953|P1|Overall Study|Lost to Follow-up|25
1857294|NCT00108082|6414966|P3|Overall Study|Blood Pressure Not Controlled|0
1857295|NCT00108082|6414967|P2|Overall Study|Blood Pressure Not Controlled|0
1857296|NCT00108082|6414968|P1|Overall Study|Blood Pressure Not Controlled|1
1857297|NCT00108082|6414966|P3|Overall Study|Investigator Not at Site|0
1857298|NCT00108082|6414967|P2|Overall Study|Investigator Not at Site|0
1857299|NCT00108082|6414968|P1|Overall Study|Investigator Not at Site|1
1857300|NCT00108082|6414966|P3|Overall Study|Subject Left Site Location|0
1857301|NCT00108082|6414967|P2|Overall Study|Subject Left Site Location|0
1857302|NCT00108082|6414968|P1|Overall Study|Subject Left Site Location|1
1857303|NCT00108082|6414966|P3|Overall Study|Study Medication Not Tapered|0
1857304|NCT00108082|6414967|P2|Overall Study|Study Medication Not Tapered|1
1857305|NCT00108082|6414968|P1|Overall Study|Study Medication Not Tapered|0
1857306|NCT00108082|6414966|P3|Overall Study|Protocol Amendment|0
1857307|NCT00108082|6414967|P2|Overall Study|Protocol Amendment|1
1857308|NCT00108082|6414968|P1|Overall Study|Protocol Amendment|0
1857309|NCT00108082|6414966|P3|Overall Study|Site Closed Study|0
1857310|NCT00108082|6414967|P2|Overall Study|Site Closed Study|2
1857311|NCT00108082|6414968|P1|Overall Study|Site Closed Study|0
1857312|NCT00108082|6414966|P3|Overall Study|Stopped Study Medication|1
1857313|NCT00108082|6414967|P2|Overall Study|Stopped Study Medication|0
1857314|NCT00108082|6414968|P1|Overall Study|Stopped Study Medication|0
1857315|NCT00108082|6414966|P3|Overall Study|Non-compliance|2
1857316|NCT00108082|6414967|P2|Overall Study|Non-compliance|0
1857317|NCT00108082|6414968|P1|Overall Study|Non-compliance|1
1857318|NCT00108082|6414966|P3|Overall Study|Incorrectly Randomized|2
1857319|NCT00108082|6414967|P2|Overall Study|Incorrectly Randomized|0
1857320|NCT00108082|6414968|P1|Overall Study|Incorrectly Randomized|0
1857321|NCT00108082|6414966|P3|Overall Study|Woman of Child-bearing Potential|2
1857322|NCT00108082|6414967|P2|Overall Study|Woman of Child-bearing Potential|0
1857323|NCT00108082|6414968|P1|Overall Study|Woman of Child-bearing Potential|2
1857324|NCT00108082|6414966|P3|Overall Study|Amendment 4: > Month 12|5
1857325|NCT00108082|6414967|P2|Overall Study|Amendment 4: > Month 12|7
1857326|NCT00108082|6414968|P1|Overall Study|Amendment 4: > Month 12|5
1857327|NCT00108082|6414966|P3|Overall Study|Lack of Efficacy|2
1857328|NCT00108082|6414967|P2|Overall Study|Lack of Efficacy|1
1857329|NCT00108082|6414968|P1|Overall Study|Lack of Efficacy|3
1857330|NCT00108082|6414966|P3|Overall Study|Protocol Violation|0
1857331|NCT00108082|6414967|P2|Overall Study|Protocol Violation|2
1857332|NCT00108082|6414968|P1|Overall Study|Protocol Violation|1
1857333|NCT00108082|6414966|P3|Overall Study|Consent Withdrawn|5
1857334|NCT00108082|6414967|P2|Overall Study|Consent Withdrawn|3
1857335|NCT00108082|6414968|P1|Overall Study|Consent Withdrawn|3
1857336|NCT00108082|6414966|P3|Overall Study|Lost to Follow-up|7
1857337|NCT00108082|6414967|P2|Overall Study|Lost to Follow-up|3
1857338|NCT00108082|6414968|P1|Overall Study|Lost to Follow-up|6
1857339|NCT00108082|6414966|P3|Overall Study|Adverse Event|17
1857340|NCT00108082|6414967|P2|Overall Study|Adverse Event|12
1857341|NCT00108082|6414968|P1|Overall Study|Adverse Event|14
1857342|NCT00108069|6415017|P2|Overall Study|Progessive disease|11
1857343|NCT00108069|6415018|P1|Overall Study|Progessive disease|27
1857344|NCT00108069|6415017|P2|Overall Study|Death|0
1857345|NCT00108069|6415018|P1|Overall Study|Death|1
1857346|NCT00108069|6415017|P2|Overall Study|Withdrawal by Subject|0
1857347|NCT00108069|6415018|P1|Overall Study|Withdrawal by Subject|1
1857348|NCT00108069|6415017|P2|Overall Study|Adverse Event|1
1857349|NCT00108069|6415018|P1|Overall Study|Adverse Event|1
1857350|NCT00108069|6415017|P2|Overall Study|Never rec'd study drug|1
1857351|NCT00108069|6415018|P1|Overall Study|Never rec'd study drug|0
1857352|NCT00107991|6415032|P1|18-Week Post Treatment Assessment|Adverse Event|2
1857353|NCT00107991|6415032|P1|12 Week Treatment Period|Incarcerated|1
1857354|NCT00107991|6415032|P1|12 Week Treatment Period|Protocol Violation|1
1857355|NCT00107991|6415032|P1|12 Week Treatment Period|Adverse Event|1
1857356|NCT00107991|6415032|P1|12 Week Treatment Period|Lack of Efficacy|2
1857357|NCT00107991|6415032|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
1857358|NCT00107991|6415032|P1|Eligibility Assessment|chronic uncontrolled asthma|1
1857359|NCT00107991|6415032|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
1857360|NCT00107991|6415032|P1|Eligibility Assessment|Abnormal labs|2
1857361|NCT00107991|6415032|P1|Eligibility Assessment|Positive purified protein derivative|4
1857362|NCT00107991|6415032|P1|Eligibility Assessment|Unwilling to participate|7
1857363|NCT00107991|6415032|P1|Eligibility Assessment|Disease not severe enough|7
1857364|NCT00107978|6415042|P2|Overall Study|Other|4
1857365|NCT00107978|6415043|P1|Overall Study|Other|5
1857366|NCT00107978|6415042|P2|Overall Study|Protocol Violation|1
1857367|NCT00107978|6415043|P1|Overall Study|Protocol Violation|0
1857368|NCT00107978|6415042|P2|Overall Study|Withdrawal by Subject|9
1857369|NCT00107978|6415043|P1|Overall Study|Withdrawal by Subject|4
1857370|NCT00107978|6415042|P2|Overall Study|Lost to Follow-up|28
1857371|NCT00107978|6415043|P1|Overall Study|Lost to Follow-up|20
1857372|NCT00107978|6415042|P2|Overall Study|Death|3
1857373|NCT00107978|6415043|P1|Overall Study|Death|3
1857374|NCT00107978|6415042|P2|Overall Study|Adverse Event|5
1857375|NCT00107978|6415043|P1|Overall Study|Adverse Event|1
1857376|NCT00107952|6415051|P2|Overall Study|Never received study treatment|6
1857377|NCT00107952|6415052|P1|Overall Study|Never received study treatment|9
1857378|NCT00107952|6415051|P2|Overall Study|Other|5
1857379|NCT00107952|6415052|P1|Overall Study|Other|2
1857380|NCT00107952|6415051|P2|Overall Study|Withdrawal by Subject|6
1857381|NCT00107952|6415052|P1|Overall Study|Withdrawal by Subject|9
1857382|NCT00107952|6415051|P2|Overall Study|Lost to Follow-up|3
1857383|NCT00107952|6415052|P1|Overall Study|Lost to Follow-up|0
1857384|NCT00107952|6415051|P2|Overall Study|Death|61
1857385|NCT00107952|6415052|P1|Overall Study|Death|75
1857386|NCT00107900|6415064|P6|Overall Study|Administrative Reasons|0
1857387|NCT00107900|6415065|P5|Overall Study|Administrative Reasons|2
1857388|NCT00107900|6415066|P4|Overall Study|Administrative Reasons|2
1857389|NCT00107900|6415067|P3|Overall Study|Administrative Reasons|2
1857390|NCT00107900|6415068|P2|Overall Study|Administrative Reasons|0
1857391|NCT00107900|6415069|P1|Overall Study|Administrative Reasons|1
1857392|NCT00107900|6415064|P6|Overall Study|Withdrawal by Subject|1
1857393|NCT00107900|6415065|P5|Overall Study|Withdrawal by Subject|1
1857394|NCT00107900|6415066|P4|Overall Study|Withdrawal by Subject|0
1857395|NCT00107900|6415067|P3|Overall Study|Withdrawal by Subject|5
1857396|NCT00107900|6415068|P2|Overall Study|Withdrawal by Subject|0
1857397|NCT00107900|6415069|P1|Overall Study|Withdrawal by Subject|1
1857398|NCT00107900|6415064|P6|Overall Study|Protocol Violation|0
1857399|NCT00107900|6415065|P5|Overall Study|Protocol Violation|7
1857400|NCT00107900|6415066|P4|Overall Study|Protocol Violation|5
1857401|NCT00107900|6415067|P3|Overall Study|Protocol Violation|5
1857402|NCT00107900|6415068|P2|Overall Study|Protocol Violation|0
1857403|NCT00107900|6415069|P1|Overall Study|Protocol Violation|1
1857404|NCT00107900|6415064|P6|Overall Study|Lost to Follow-up|5
1857405|NCT00107900|6415065|P5|Overall Study|Lost to Follow-up|5
1857406|NCT00107900|6415066|P4|Overall Study|Lost to Follow-up|2
1857407|NCT00107900|6415067|P3|Overall Study|Lost to Follow-up|3
1857408|NCT00107900|6415068|P2|Overall Study|Lost to Follow-up|1
1857409|NCT00107900|6415069|P1|Overall Study|Lost to Follow-up|4
1857410|NCT00107900|6415064|P6|Overall Study|Death|0
1857411|NCT00107900|6415065|P5|Overall Study|Death|1
1857412|NCT00107900|6415066|P4|Overall Study|Death|0
1857413|NCT00107900|6415067|P3|Overall Study|Death|0
1857414|NCT00107900|6415068|P2|Overall Study|Death|0
1857415|NCT00107900|6415069|P1|Overall Study|Death|0
1857416|NCT00107900|6415064|P6|Overall Study|Adverse Event|3
1857417|NCT00107900|6415065|P5|Overall Study|Adverse Event|5
1857418|NCT00107900|6415066|P4|Overall Study|Adverse Event|3
1857419|NCT00107900|6415067|P3|Overall Study|Adverse Event|10
1857420|NCT00107900|6415068|P2|Overall Study|Adverse Event|2
1857421|NCT00107900|6415069|P1|Overall Study|Adverse Event|3
1857422|NCT00107783|6415103|P2|Overall Study|Second hip replacement|1
1857423|NCT00107783|6415104|P1|Overall Study|Second hip replacement|1
1857424|NCT00107783|6415103|P2|Overall Study|Withdrawal by Subject|0
1857425|NCT00107783|6415104|P1|Overall Study|Withdrawal by Subject|2
1857426|NCT00107783|6415103|P2|Overall Study|Death|1
1857427|NCT00107783|6415104|P1|Overall Study|Death|0
1857428|NCT00107783|6415103|P2|Overall Study|Adverse Event|2
1857429|NCT00107783|6415104|P1|Overall Study|Adverse Event|0
1857430|NCT00107653|6415139|P2|Overall Study|Administrative Reasons|3
1857431|NCT00107653|6415140|P1|Overall Study|Administrative Reasons|3
1857432|NCT00107653|6415139|P2|Overall Study|Lost to Follow-up|5
1857433|NCT00107653|6415140|P1|Overall Study|Lost to Follow-up|13
1857434|NCT00107653|6415139|P2|Overall Study|Withdrawal by Subject|13
1857435|NCT00107653|6415140|P1|Overall Study|Withdrawal by Subject|12
1857436|NCT00107653|6415139|P2|Overall Study|Protocol Violation|0
1857437|NCT00107653|6415140|P1|Overall Study|Protocol Violation|1
1857438|NCT00107653|6415139|P2|Overall Study|Violation of Selection Criteria at Entry|1
1857439|NCT00107653|6415140|P1|Overall Study|Violation of Selection Criteria at Entry|1
1857440|NCT00107653|6415139|P2|Overall Study|Insufficient Therapeutic Response|11
1857441|NCT00107653|6415140|P1|Overall Study|Insufficient Therapeutic Response|25
1857442|NCT00107653|6415139|P2|Overall Study|Adverse Event|43
1857443|NCT00107653|6415140|P1|Overall Study|Adverse Event|24
1857444|NCT00107614|6415186|P1|Overall Study|Death|2
1857445|NCT00107614|6415186|P1|Overall Study|Physician Decision|10
1857446|NCT00107380|6415217|P1|Overall Study|Ineligible|2
1857447|NCT00107380|6415217|P1|Overall Study|Other - not protocol specified|7
1857448|NCT00107380|6415217|P1|Overall Study|Death|3
1857449|NCT00107380|6415217|P1|Overall Study|Progression/relapse|4
1857450|NCT00107380|6415217|P1|Overall Study|Refusal Unrelated to Adverse Event|7
1857451|NCT00107380|6415217|P1|Overall Study|Adverse Event|7
1857452|NCT00107315|6415223|P1|Overall Study|Withdrawal by Subject|2
1857453|NCT00107315|6415223|P1|Overall Study|Adverse Event|4
1857454|NCT00107315|6415223|P1|Overall Study|Disease Progression|9
1857455|NCT00107276|6415230|P1|Overall Study|Ineligible|16
1857456|NCT00107276|6415230|P1|Overall Study|Death|1
1857457|NCT00107276|6415230|P1|Overall Study|Patient refusal|1
1857458|NCT00107276|6415230|P1|Overall Study|M.D. decision|2
1857459|NCT00107276|6415230|P1|Overall Study|Adverse Event|6
1857460|NCT00107276|6415230|P1|Overall Study|Progression|46
1857461|NCT00107198|6415236|P1|Overall Study|Ineligible|5
1857462|NCT00107198|6415236|P1|Overall Study|Withdrawal by Subject|6
1857463|NCT00107198|6415236|P1|Overall Study|Protocol Violation|1
1857464|NCT00107198|6415236|P1|Overall Study|Lost to Follow-up|12
1857465|NCT00107198|6415236|P1|Overall Study|Lack of Efficacy|28
1857466|NCT00107172|6415246|P2|Overall Study|Other Reason|3
1857467|NCT00107172|6415247|P1|Overall Study|Other Reason|4
1857468|NCT00107172|6415246|P2|Overall Study|Death|2
1857469|NCT00107172|6415247|P1|Overall Study|Death|0
1857470|NCT00107172|6415246|P2|Overall Study|Withdrawal by Subject|0
1857471|NCT00107172|6415247|P1|Overall Study|Withdrawal by Subject|1
1857472|NCT00107120|6415277|P2|Overall Study|death of parent|1
1857473|NCT00107120|6415278|P1|Overall Study|death of parent|0
1857474|NCT00107120|6415277|P2|Overall Study|moving away from site|1
1857475|NCT00107120|6415278|P1|Overall Study|moving away from site|1
1857476|NCT00107120|6415277|P2|Overall Study|Pregnancy|1
1857477|NCT00107120|6415278|P1|Overall Study|Pregnancy|0
1857478|NCT00107120|6415277|P2|Overall Study|Lost to Follow-up|6
1857479|NCT00107120|6415278|P1|Overall Study|Lost to Follow-up|8
1857480|NCT00107120|6415277|P2|Overall Study|Withdrawal by Subject|9
1857481|NCT00107120|6415278|P1|Overall Study|Withdrawal by Subject|8
1857482|NCT00107120|6415277|P2|Overall Study|Protocol Violation|0
1857483|NCT00107120|6415278|P1|Overall Study|Protocol Violation|3
1857484|NCT00107120|6415277|P2|Overall Study|Lack of Efficacy|5
1857485|NCT00107120|6415278|P1|Overall Study|Lack of Efficacy|5
1857486|NCT00107120|6415277|P2|Overall Study|Adverse Event|1
1857487|NCT00107120|6415278|P1|Overall Study|Adverse Event|4
1857488|NCT00107042|6415290|P2|Overall Study|Disallowed medications|2
1857489|NCT00107042|6415291|P1|Overall Study|Disallowed medications|0
1857490|NCT00107042|6415290|P2|Overall Study|vaccinated outside window|1
1857491|NCT00107042|6415291|P1|Overall Study|vaccinated outside window|1
1857492|NCT00107042|6415290|P2|Overall Study|Inadvertent enrollment|1
1857493|NCT00107042|6415291|P1|Overall Study|Inadvertent enrollment|0
1857494|NCT00107042|6415290|P2|Overall Study|Pregnancy|1
1857495|NCT00107042|6415291|P1|Overall Study|Pregnancy|1
1857496|NCT00107042|6415290|P2|Overall Study|Moved out of area|3
1857497|NCT00107042|6415291|P1|Overall Study|Moved out of area|5
1857498|NCT00107042|6415290|P2|Overall Study|Withdrawal by Subject|1
1857499|NCT00107042|6415291|P1|Overall Study|Withdrawal by Subject|6
1857500|NCT00107042|6415290|P2|Overall Study|Lost to Follow-up|7
1857501|NCT00107042|6415291|P1|Overall Study|Lost to Follow-up|9
1857502|NCT00106964|6415357|P3|Overall Study|Required disallowed medication|0
1857503|NCT00106964|6415358|P2|Overall Study|Required disallowed medication|1
1857504|NCT00106964|6415359|P1|Overall Study|Required disallowed medication|0
1857505|NCT00106964|6415357|P3|Overall Study|Did not meet eligibility criteria|2
1857506|NCT00106964|6415358|P2|Overall Study|Did not meet eligibility criteria|2
1857507|NCT00106964|6415359|P1|Overall Study|Did not meet eligibility criteria|0
1857508|NCT00106964|6415357|P3|Overall Study|Failure to adhere|0
1857509|NCT00106964|6415358|P2|Overall Study|Failure to adhere|0
1857510|NCT00106964|6415359|P1|Overall Study|Failure to adhere|2
1857511|NCT00106964|6415357|P3|Overall Study|Site Funding Terminated|1
1857512|NCT00106964|6415358|P2|Overall Study|Site Funding Terminated|1
1857513|NCT00106964|6415359|P1|Overall Study|Site Funding Terminated|0
1857514|NCT00106964|6415357|P3|Overall Study|Incarceration|0
1857515|NCT00106964|6415358|P2|Overall Study|Incarceration|1
1857516|NCT00106964|6415359|P1|Overall Study|Incarceration|0
1857517|NCT00106964|6415357|P3|Overall Study|Death|0
1857518|NCT00106964|6415358|P2|Overall Study|Death|1
1857519|NCT00106964|6415359|P1|Overall Study|Death|1
1857520|NCT00106964|6415357|P3|Overall Study|Pregnancy|2
1857521|NCT00106964|6415358|P2|Overall Study|Pregnancy|3
1857522|NCT00106964|6415359|P1|Overall Study|Pregnancy|2
1857523|NCT00106964|6415357|P3|Overall Study|Lost to Follow-up|2
1857524|NCT00106964|6415358|P2|Overall Study|Lost to Follow-up|6
1857525|NCT00106964|6415359|P1|Overall Study|Lost to Follow-up|8
1857526|NCT00106704|6415454|P2|Overall Study|Laboratory test|1
1857527|NCT00106704|6415455|P1|Overall Study|Laboratory test|1
1857528|NCT00106704|6415454|P2|Overall Study|Unable to re-enter US|0
1857529|NCT00106704|6415455|P1|Overall Study|Unable to re-enter US|1
1857530|NCT00106704|6415454|P2|Overall Study|Patient Received Glycemic Medication|41
1857531|NCT00106704|6415455|P1|Overall Study|Patient Received Glycemic Medication|22
1857532|NCT00106704|6415454|P2|Overall Study|Planned major surgery|0
1857533|NCT00106704|6415455|P1|Overall Study|Planned major surgery|1
1857534|NCT00106704|6415454|P2|Overall Study|Site terminated|1
1857535|NCT00106704|6415455|P1|Overall Study|Site terminated|0
1857536|NCT00106704|6415454|P2|Overall Study|Patient moved|0
1857537|NCT00106704|6415455|P1|Overall Study|Patient moved|1
1857538|NCT00106704|6415454|P2|Overall Study|Withdrawal by Subject|21
1857539|NCT00106704|6415455|P1|Overall Study|Withdrawal by Subject|14
1857540|NCT00106704|6415454|P2|Overall Study|Protocol Violation|7
1857541|NCT00106704|6415455|P1|Overall Study|Protocol Violation|4
1857542|NCT00106704|6415454|P2|Overall Study|Pregnancy|0
1857543|NCT00106704|6415455|P1|Overall Study|Pregnancy|1
1857544|NCT00106704|6415454|P2|Overall Study|Lost to Follow-up|3
1857545|NCT00106704|6415455|P1|Overall Study|Lost to Follow-up|7
1857546|NCT00106704|6415454|P2|Overall Study|Lack of Efficacy|69
1857547|NCT00106704|6415455|P1|Overall Study|Lack of Efficacy|67
1857548|NCT00106704|6415454|P2|Overall Study|Death|1
1857549|NCT00106704|6415455|P1|Overall Study|Death|2
1857550|NCT00106704|6415454|P2|Overall Study|Adverse Event|7
1857551|NCT00106704|6415455|P1|Overall Study|Adverse Event|10
1857552|NCT00106639|6415466|P3|Overall Study|Participant defaulted|1
1857553|NCT00106639|6415467|P2|Overall Study|Participant defaulted|1
1857554|NCT00106639|6415468|P1|Overall Study|Participant defaulted|0
1857555|NCT00106639|6415466|P3|Overall Study|Withdrawal by Subject|0
1857556|NCT00106639|6415467|P2|Overall Study|Withdrawal by Subject|1
1857557|NCT00106639|6415468|P1|Overall Study|Withdrawal by Subject|0
1857558|NCT00106639|6415466|P3|Overall Study|Protocol Violation|0
1857559|NCT00106639|6415467|P2|Overall Study|Protocol Violation|1
1857560|NCT00106639|6415468|P1|Overall Study|Protocol Violation|0
1857561|NCT00106639|6415466|P3|Overall Study|Adverse Event|1
1857562|NCT00106639|6415467|P2|Overall Study|Adverse Event|4
1857563|NCT00106639|6415468|P1|Overall Study|Adverse Event|3
1857564|NCT00106626|6415595|P4|Overall Study|> 14 day delay in therapy start|0
1857565|NCT00106626|6415596|P3|Overall Study|> 14 day delay in therapy start|0
1857566|NCT00106626|6415597|P2|Overall Study|> 14 day delay in therapy start|1
1857567|NCT00106626|6415598|P1|Overall Study|> 14 day delay in therapy start|0
1857568|NCT00106626|6415595|P4|Overall Study|Received radiation on new therapy|0
1857569|NCT00106626|6415596|P3|Overall Study|Received radiation on new therapy|0
1857570|NCT00106626|6415597|P2|Overall Study|Received radiation on new therapy|0
1857571|NCT00106626|6415598|P1|Overall Study|Received radiation on new therapy|1
1857572|NCT00106626|6415595|P4|Overall Study|Progressive Disease|10
1857573|NCT00106626|6415596|P3|Overall Study|Progressive Disease|9
1857574|NCT00106626|6415597|P2|Overall Study|Progressive Disease|1
1857575|NCT00106626|6415598|P1|Overall Study|Progressive Disease|4
1857576|NCT00106626|6415595|P4|Overall Study|Adverse Event|3
1857577|NCT00106626|6415596|P3|Overall Study|Adverse Event|3
1857578|NCT00106626|6415597|P2|Overall Study|Adverse Event|4
1857579|NCT00106626|6415598|P1|Overall Study|Adverse Event|5
1857580|NCT00106353|6415943|P7|Part 2|Physician Decision|0
1857581|NCT00106353|6415944|P6|Part 2|Physician Decision|1
1857582|NCT00106353|6415945|P5|Part 2|Physician Decision|0
1857583|NCT00106353|6415946|P4|Part 2|Physician Decision|0
1857584|NCT00106353|6415947|P3|Part 2|Physician Decision|0
1857585|NCT00106353|6415948|P2|Part 2|Physician Decision|0
1857586|NCT00106353|6415949|P1|Part 2|Physician Decision|0
1857587|NCT00106353|6415943|P7|Part 2|Withdrawal by Subject|0
1857588|NCT00106353|6415944|P6|Part 2|Withdrawal by Subject|0
1857589|NCT00106353|6415945|P5|Part 2|Withdrawal by Subject|1
1857590|NCT00106353|6415946|P4|Part 2|Withdrawal by Subject|0
1857591|NCT00106353|6415947|P3|Part 2|Withdrawal by Subject|0
1857592|NCT00106353|6415948|P2|Part 2|Withdrawal by Subject|0
1857593|NCT00106353|6415949|P1|Part 2|Withdrawal by Subject|0
1857594|NCT00106353|6415943|P7|Part 2|Other|1
1857595|NCT00106353|6415944|P6|Part 2|Other|1
1857596|NCT00106353|6415945|P5|Part 2|Other|1
1857597|NCT00106353|6415946|P4|Part 2|Other|0
1857598|NCT00106353|6415947|P3|Part 2|Other|0
1857599|NCT00106353|6415948|P2|Part 2|Other|0
1857600|NCT00106353|6415949|P1|Part 2|Other|0
1857601|NCT00106353|6415943|P7|Part 2|Adverse Event|1
1857602|NCT00106353|6415944|P6|Part 2|Adverse Event|2
1857603|NCT00106353|6415945|P5|Part 2|Adverse Event|0
1857604|NCT00106353|6415946|P4|Part 2|Adverse Event|0
1857605|NCT00106353|6415947|P3|Part 2|Adverse Event|0
1857606|NCT00106353|6415948|P2|Part 2|Adverse Event|0
1857607|NCT00106353|6415949|P1|Part 2|Adverse Event|0
1857608|NCT00106353|6415943|P7|Part 2|Symptomatic deterioration|0
1857609|NCT00106353|6415944|P6|Part 2|Symptomatic deterioration|0
1857610|NCT00106353|6415945|P5|Part 2|Symptomatic deterioration|3
1857611|NCT00106353|6415946|P4|Part 2|Symptomatic deterioration|0
1857612|NCT00106353|6415947|P3|Part 2|Symptomatic deterioration|0
1857613|NCT00106353|6415948|P2|Part 2|Symptomatic deterioration|0
1857614|NCT00106353|6415949|P1|Part 2|Symptomatic deterioration|0
1857615|NCT00106353|6415943|P7|Part 2|Death|1
1857616|NCT00106353|6415944|P6|Part 2|Death|0
1857617|NCT00106353|6415945|P5|Part 2|Death|3
1857618|NCT00106353|6415946|P4|Part 2|Death|0
1857619|NCT00106353|6415947|P3|Part 2|Death|0
1857620|NCT00106353|6415948|P2|Part 2|Death|0
1857621|NCT00106353|6415949|P1|Part 2|Death|0
1857622|NCT00106353|6415943|P7|Part 2|Disease progression|13
1857623|NCT00106353|6415944|P6|Part 2|Disease progression|14
1857624|NCT00106353|6415945|P5|Part 2|Disease progression|8
1857625|NCT00106353|6415946|P4|Part 2|Disease progression|0
1857626|NCT00106353|6415947|P3|Part 2|Disease progression|0
1857627|NCT00106353|6415948|P2|Part 2|Disease progression|0
1857628|NCT00106353|6415949|P1|Part 2|Disease progression|0
1857629|NCT00106353|6415943|P7|Part 1|Adverse Event|0
1857630|NCT00106353|6415944|P6|Part 1|Adverse Event|0
1857631|NCT00106353|6415945|P5|Part 1|Adverse Event|0
1857632|NCT00106353|6415946|P4|Part 1|Adverse Event|1
1857633|NCT00106353|6415947|P3|Part 1|Adverse Event|0
1857634|NCT00106353|6415948|P2|Part 1|Adverse Event|0
1857635|NCT00106353|6415949|P1|Part 1|Adverse Event|0
1857636|NCT00106353|6415943|P7|Part 1|Entered follow-up phase|0
1857637|NCT00106353|6415944|P6|Part 1|Entered follow-up phase|0
1857638|NCT00106353|6415945|P5|Part 1|Entered follow-up phase|0
1857639|NCT00106353|6415946|P4|Part 1|Entered follow-up phase|1
1857640|NCT00106353|6415947|P3|Part 1|Entered follow-up phase|0
1857641|NCT00106353|6415948|P2|Part 1|Entered follow-up phase|1
1857642|NCT00106353|6415949|P1|Part 1|Entered follow-up phase|1
1857643|NCT00106353|6415943|P7|Part 1|Symptomatic deterioration|0
1857644|NCT00106353|6415944|P6|Part 1|Symptomatic deterioration|0
1857645|NCT00106353|6415945|P5|Part 1|Symptomatic deterioration|0
1857646|NCT00106353|6415946|P4|Part 1|Symptomatic deterioration|0
1857647|NCT00106353|6415947|P3|Part 1|Symptomatic deterioration|1
1857648|NCT00106353|6415948|P2|Part 1|Symptomatic deterioration|0
1857649|NCT00106353|6415949|P1|Part 1|Symptomatic deterioration|0
1857650|NCT00106353|6415943|P7|Part 1|Withdrawal by Subject|0
1857651|NCT00106353|6415944|P6|Part 1|Withdrawal by Subject|0
1857652|NCT00106353|6415945|P5|Part 1|Withdrawal by Subject|0
1857653|NCT00106353|6415946|P4|Part 1|Withdrawal by Subject|2
1857654|NCT00106353|6415947|P3|Part 1|Withdrawal by Subject|1
1857655|NCT00106353|6415948|P2|Part 1|Withdrawal by Subject|0
1857656|NCT00106353|6415949|P1|Part 1|Withdrawal by Subject|0
1857657|NCT00106353|6415943|P7|Part 1|Disease progression|0
1857658|NCT00106353|6415944|P6|Part 1|Disease progression|0
1857659|NCT00106353|6415945|P5|Part 1|Disease progression|0
1857660|NCT00106353|6415946|P4|Part 1|Disease progression|3
1857661|NCT00106353|6415947|P3|Part 1|Disease progression|1
1857662|NCT00106353|6415948|P2|Part 1|Disease progression|4
1857663|NCT00106353|6415949|P1|Part 1|Disease progression|3
1857664|NCT00106249|6416076|P2|Overall Study|Lost to Follow-up|2
1857665|NCT00106249|6416077|P1|Overall Study|Lost to Follow-up|3
1857666|NCT00106184|6416089|P2|Overall Study|Withdrawal by Subject|2
1857667|NCT00106184|6416090|P1|Overall Study|Withdrawal by Subject|3
1857668|NCT00106080|6416132|P2|Overall Study|Withdrew/Loss to follow-up|27
1857669|NCT00106080|6416133|P1|Overall Study|Withdrew/Loss to follow-up|43
1857670|NCT00106028|6416143|P2|Overall Study|Lost to Follow-up|1
1857671|NCT00106028|6416144|P1|Overall Study|Lost to Follow-up|0
1857672|NCT00106028|6416143|P2|Overall Study|Withdrawal by Subject|8
1857673|NCT00106028|6416144|P1|Overall Study|Withdrawal by Subject|2
1857674|NCT00106028|6416143|P2|Overall Study|Protocol Violation|1
1857675|NCT00106028|6416144|P1|Overall Study|Protocol Violation|1
1857676|NCT00106028|6416143|P2|Overall Study|Adverse Event|2
1857677|NCT00106028|6416144|P1|Overall Study|Adverse Event|3
1857678|NCT00106002|6416238|P1|Overall Study|Ineligible after Registration|1
1857679|NCT00106002|6416238|P1|Overall Study|Did not take any study drug|1
1857680|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1857681|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
1857682|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
1857683|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
1857684|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Death|0
1857685|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Death|0
1857686|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
1857687|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
1857688|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
1857689|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
1857690|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
1857691|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
1857692|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1857693|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
1857694|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1857695|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
1857696|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
1857697|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
1857698|NCT00105989|6416246|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
1857699|NCT00105989|6416247|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
1857700|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1857701|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
1857702|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
1857703|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
1857704|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Death|0
1857705|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Death|0
1857706|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
1857707|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
1857708|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
1857709|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
1857710|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
1857711|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
1857712|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
1857713|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
1857714|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
1857715|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
1857716|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
1857717|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
1857718|NCT00105989|6416246|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
1857719|NCT00105989|6416247|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
1857720|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1857721|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
1857722|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1857723|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
1857724|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Death|0
1857725|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Death|1
1857726|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Physician Decision|0
1857727|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Physician Decision|0
1857728|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
1857729|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
1857730|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
1857731|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
1857732|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
1857733|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
1857734|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
1857735|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
1857736|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
1857737|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
1857738|NCT00105989|6416246|P2|Acute - Open Label: Week 0-10|Adverse Event|0
1857739|NCT00105989|6416247|P1|Acute - Open Label: Week 0-10|Adverse Event|33
1857740|NCT00105586|6416363|P2|Overall Study|Physician Decision|13
1857741|NCT00105586|6416364|P1|Overall Study|Physician Decision|13
1857742|NCT00105586|6416363|P2|Overall Study|Adverse Event|3
1857743|NCT00105586|6416364|P1|Overall Study|Adverse Event|4
1857744|NCT00105560|6416372|P1|Overall Study|Lost to Follow-up|1
1857745|NCT00105534|6416394|P2|Overall Study|Other Reason|2
1857746|NCT00105534|6416395|P1|Overall Study|Other Reason|0
1857747|NCT00105534|6416394|P2|Overall Study|Treatment unmasked|0
1857748|NCT00105534|6416395|P1|Overall Study|Treatment unmasked|1
1857749|NCT00105534|6416394|P2|Overall Study|Lack of Efficacy|15
1857750|NCT00105534|6416395|P1|Overall Study|Lack of Efficacy|7
1857751|NCT00105534|6416394|P2|Overall Study|Lost to Follow-up|1
1857752|NCT00105534|6416395|P1|Overall Study|Lost to Follow-up|5
1857753|NCT00105534|6416394|P2|Overall Study|Withdrawal by Subject|6
1857754|NCT00105534|6416395|P1|Overall Study|Withdrawal by Subject|6
1857755|NCT00105534|6416394|P2|Overall Study|Protocol Violation|4
1857756|NCT00105534|6416395|P1|Overall Study|Protocol Violation|1
1857757|NCT00105534|6416394|P2|Overall Study|Adverse Event|5
1857758|NCT00105534|6416395|P1|Overall Study|Adverse Event|2
1857759|NCT00105521|6416407|P4|Overall Study|Lost to Follow-up|0
1857760|NCT00105521|6416408|P3|Overall Study|Lost to Follow-up|0
1857761|NCT00105521|6416409|P2|Overall Study|Lost to Follow-up|1
1857762|NCT00105521|6416410|P1|Overall Study|Lost to Follow-up|0
1857763|NCT00105521|6416407|P4|Overall Study|Protocol Violation|4
1857764|NCT00105521|6416408|P3|Overall Study|Protocol Violation|4
1857765|NCT00105521|6416409|P2|Overall Study|Protocol Violation|5
1857766|NCT00105521|6416410|P1|Overall Study|Protocol Violation|3
1857767|NCT00105521|6416407|P4|Overall Study|Lack of Efficacy|1
1857768|NCT00105521|6416408|P3|Overall Study|Lack of Efficacy|0
1857769|NCT00105521|6416409|P2|Overall Study|Lack of Efficacy|0
1857770|NCT00105521|6416410|P1|Overall Study|Lack of Efficacy|0
1857771|NCT00105521|6416407|P4|Overall Study|Withdrawal by Subject|4
1857772|NCT00105521|6416408|P3|Overall Study|Withdrawal by Subject|1
1857773|NCT00105521|6416409|P2|Overall Study|Withdrawal by Subject|0
1857774|NCT00105521|6416410|P1|Overall Study|Withdrawal by Subject|1
1857775|NCT00105521|6416407|P4|Overall Study|Adverse Event|8
1857776|NCT00105521|6416408|P3|Overall Study|Adverse Event|10
1857777|NCT00105521|6416409|P2|Overall Study|Adverse Event|4
1857778|NCT00105521|6416410|P1|Overall Study|Adverse Event|10
1857779|NCT00105521|6416407|P4|Overall Study|Other|0
1857780|NCT00105521|6416408|P3|Overall Study|Other|2
1857781|NCT00105521|6416409|P2|Overall Study|Other|1
1857782|NCT00105521|6416410|P1|Overall Study|Other|1
1857783|NCT00105508|6416434|P2|Overall Study|Other|9
1857784|NCT00105508|6416435|P1|Overall Study|Other|8
1857785|NCT00105508|6416434|P2|Overall Study|Protocol Violation|2
1857786|NCT00105508|6416435|P1|Overall Study|Protocol Violation|1
1857787|NCT00105508|6416434|P2|Overall Study|Lost to Follow-up|0
1857788|NCT00105508|6416435|P1|Overall Study|Lost to Follow-up|3
1857789|NCT00105508|6416434|P2|Overall Study|Withdrawal by Subject|6
1857790|NCT00105508|6416435|P1|Overall Study|Withdrawal by Subject|10
1857791|NCT00105508|6416434|P2|Overall Study|Insufficient Efficacy|0
1857792|NCT00105508|6416435|P1|Overall Study|Insufficient Efficacy|1
1857793|NCT00105508|6416434|P2|Overall Study|Adverse Event|19
1857794|NCT00105508|6416435|P1|Overall Study|Adverse Event|16
1857795|NCT00105508|6416434|P2|Overall Study|Prephase Dropout|0
1857796|NCT00105508|6416435|P1|Overall Study|Prephase Dropout|1
1857797|NCT00105482|6416449|P2|Overall Study|Withdrawn by PI|1
1857798|NCT00105482|6416450|P1|Overall Study|Withdrawn by PI|1
1857799|NCT00105482|6416449|P2|Overall Study|Scheduling Conflict|3
1857800|NCT00105482|6416450|P1|Overall Study|Scheduling Conflict|2
1857801|NCT00105482|6416449|P2|Overall Study|Lost Interest|32
1857802|NCT00105482|6416450|P1|Overall Study|Lost Interest|29
1857803|NCT00105482|6416449|P2|Overall Study|Withdrawal by Subject|1
1857804|NCT00105482|6416450|P1|Overall Study|Withdrawal by Subject|0
1857805|NCT00105482|6416449|P2|Overall Study|Lost to Follow-up|17
1857806|NCT00105482|6416450|P1|Overall Study|Lost to Follow-up|26
1857807|NCT00105482|6416449|P2|Overall Study|Adverse Event|1
1857808|NCT00105482|6416450|P1|Overall Study|Adverse Event|1
1857809|NCT00105469|6416466|P2|Overall Study|Other Reason|0
1857810|NCT00105469|6416467|P1|Overall Study|Other Reason|4
1857811|NCT00105469|6416466|P2|Overall Study|Lack of Efficacy|0
1857812|NCT00105469|6416467|P1|Overall Study|Lack of Efficacy|2
1857813|NCT00105469|6416466|P2|Overall Study|Lost to Follow-up|0
1857814|NCT00105469|6416467|P1|Overall Study|Lost to Follow-up|1
1857815|NCT00105469|6416466|P2|Overall Study|Withdrawal by Subject|3
1857816|NCT00105469|6416467|P1|Overall Study|Withdrawal by Subject|2
1857817|NCT00105469|6416466|P2|Overall Study|Protocol Violation|0
1857818|NCT00105469|6416467|P1|Overall Study|Protocol Violation|4
1857819|NCT00105469|6416466|P2|Overall Study|Adverse Event|8
1857820|NCT00105469|6416467|P1|Overall Study|Adverse Event|9
1857821|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
1857822|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1857823|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
1857824|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
1857825|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1857826|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1857827|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
1857828|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
1857829|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
1857830|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1857831|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1857832|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
1857833|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1857834|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1857835|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
1857836|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
1857837|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1857838|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
1857839|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1857840|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
1857841|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1857842|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
1857843|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
1857844|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
1857845|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1857846|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1857847|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
1857848|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
1857849|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
1857850|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1857851|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
1857852|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
1857853|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1857854|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1857855|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
1857856|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
1857857|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
1857858|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
1857859|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
1857860|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
1857861|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
1857862|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
1857863|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
1857864|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
1857865|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
1857866|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
1857867|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
1857868|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
1857869|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1857870|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
1857871|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
1857872|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
1857873|NCT00105443|6416477|P4|Follow-up and/or Open Label Nexavar|Death|4
1857874|NCT00105443|6416478|P3|Follow-up and/or Open Label Nexavar|Death|219
1857875|NCT00105443|6416479|P2|Follow-up and/or Open Label Nexavar|Death|7
1857876|NCT00105443|6416480|P1|Follow-up and/or Open Label Nexavar|Death|180
1857877|NCT00105443|6416477|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
1857878|NCT00105443|6416478|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
1857879|NCT00105443|6416479|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
1857880|NCT00105443|6416480|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
1857881|NCT00105443|6416477|P4|Double-Blind Treatment|Physician Decision|0
1857882|NCT00105443|6416478|P3|Double-Blind Treatment|Physician Decision|2
1857883|NCT00105443|6416479|P2|Double-Blind Treatment|Physician Decision|0
1857884|NCT00105443|6416480|P1|Double-Blind Treatment|Physician Decision|1
1857885|NCT00105443|6416477|P4|Double-Blind Treatment|Withdrawal by Subject|0
1857886|NCT00105443|6416478|P3|Double-Blind Treatment|Withdrawal by Subject|7
1857887|NCT00105443|6416479|P2|Double-Blind Treatment|Withdrawal by Subject|0
1857888|NCT00105443|6416480|P1|Double-Blind Treatment|Withdrawal by Subject|8
1857889|NCT00105443|6416477|P4|Double-Blind Treatment|Lost to Follow-up|0
1857890|NCT00105443|6416478|P3|Double-Blind Treatment|Lost to Follow-up|1
1857891|NCT00105443|6416479|P2|Double-Blind Treatment|Lost to Follow-up|0
1857892|NCT00105443|6416480|P1|Double-Blind Treatment|Lost to Follow-up|0
1857893|NCT00105443|6416477|P4|Double-Blind Treatment|Adverse Event|0
1857894|NCT00105443|6416478|P3|Double-Blind Treatment|Adverse Event|0
1857895|NCT00105443|6416479|P2|Double-Blind Treatment|Adverse Event|0
1857896|NCT00105443|6416480|P1|Double-Blind Treatment|Adverse Event|1
1857897|NCT00105235|6416507|P1|Overall Study|Withdrawal by Subject|2
1857898|NCT00105235|6416507|P1|Overall Study|Physician Decision|1
1857899|NCT00105235|6416507|P1|Overall Study|Death|4
1857900|NCT00105196|6416520|P2|Overall Study|Subject became unblinded|1
1857901|NCT00105196|6416521|P1|Overall Study|Subject became unblinded|0
1857902|NCT00105196|6416520|P2|Overall Study|marijuana use|1
1857903|NCT00105196|6416521|P1|Overall Study|marijuana use|0
1857904|NCT00105196|6416520|P2|Overall Study|pending surgery|1
1857905|NCT00105196|6416521|P1|Overall Study|pending surgery|0
1857906|NCT00105196|6416520|P2|Overall Study|Protocol Violation|2
1857907|NCT00105196|6416521|P1|Overall Study|Protocol Violation|5
1857908|NCT00105196|6416520|P2|Overall Study|Poor/noncompliance|4
1857909|NCT00105196|6416521|P1|Overall Study|Poor/noncompliance|3
1857910|NCT00105196|6416520|P2|Overall Study|Lost to Follow-up|2
1857911|NCT00105196|6416521|P1|Overall Study|Lost to Follow-up|3
1857912|NCT00105196|6416520|P2|Overall Study|Withdrawal by Subject|6
1857913|NCT00105196|6416521|P1|Overall Study|Withdrawal by Subject|6
1857914|NCT00105196|6416520|P2|Overall Study|Adverse Event|3
1857915|NCT00105196|6416521|P1|Overall Study|Adverse Event|11
1857916|NCT00105196|6416520|P2|Overall Study|Lack of Efficacy|3
1857917|NCT00105196|6416521|P1|Overall Study|Lack of Efficacy|2
1857918|NCT00105183|6416544|P3|Overall Study|Other reason|0
1857919|NCT00105183|6416545|P2|Overall Study|Other reason|2
1857920|NCT00105183|6416546|P1|Overall Study|Other reason|1
1857921|NCT00105183|6416544|P3|Overall Study|Lost to Follow-up|1
1857922|NCT00105183|6416545|P2|Overall Study|Lost to Follow-up|1
1857923|NCT00105183|6416546|P1|Overall Study|Lost to Follow-up|0
1857924|NCT00105183|6416544|P3|Overall Study|Physician Decision|3
1857925|NCT00105183|6416545|P2|Overall Study|Physician Decision|2
1857926|NCT00105183|6416546|P1|Overall Study|Physician Decision|1
1857927|NCT00105183|6416544|P3|Overall Study|Withdrawal by Subject|4
1857928|NCT00105183|6416545|P2|Overall Study|Withdrawal by Subject|1
1857929|NCT00105183|6416546|P1|Overall Study|Withdrawal by Subject|1
1857930|NCT00105183|6416544|P3|Overall Study|Death|15
1857931|NCT00105183|6416545|P2|Overall Study|Death|13
1857932|NCT00105183|6416546|P1|Overall Study|Death|19
1857933|NCT00105157|6416582|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1857934|NCT00105157|6416583|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1857935|NCT00105157|6416584|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
1857936|NCT00105157|6416585|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
1857937|NCT00105157|6416582|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
1857938|NCT00105157|6416583|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1857939|NCT00105157|6416584|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1857940|NCT00105157|6416585|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
1857941|NCT00105157|6416582|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1857942|NCT00105157|6416583|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1857943|NCT00105157|6416584|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
1857944|NCT00105157|6416585|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
1857945|NCT00105157|6416582|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
1857946|NCT00105157|6416583|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
1857947|NCT00105157|6416584|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
1857948|NCT00105157|6416585|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
1857949|NCT00105157|6416582|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
1857950|NCT00105157|6416583|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1857951|NCT00105157|6416584|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1857952|NCT00105157|6416585|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
1857953|NCT00105157|6416582|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
1857954|NCT00105157|6416583|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
1857955|NCT00105157|6416584|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
1857956|NCT00105157|6416585|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
1857957|NCT00105157|6416582|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
1857958|NCT00105157|6416583|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
1857959|NCT00105157|6416584|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
1857960|NCT00105157|6416585|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
1857961|NCT00105157|6416582|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
1857962|NCT00105157|6416583|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
1857963|NCT00105157|6416584|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
1857964|NCT00105157|6416585|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
1857965|NCT00105157|6416582|P4|Open-Label Continuation of DB|Lost to Follow-up|0
1857966|NCT00105157|6416583|P3|Open-Label Continuation of DB|Lost to Follow-up|1
1857967|NCT00105157|6416584|P2|Open-Label Continuation of DB|Lost to Follow-up|1
1857968|NCT00105157|6416585|P1|Open-Label Continuation of DB|Lost to Follow-up|1
1857969|NCT00105157|6416582|P4|Open-Label Continuation of DB|Lack of Efficacy|1
1857970|NCT00105157|6416583|P3|Open-Label Continuation of DB|Lack of Efficacy|3
1857971|NCT00105157|6416584|P2|Open-Label Continuation of DB|Lack of Efficacy|4
1857972|NCT00105157|6416585|P1|Open-Label Continuation of DB|Lack of Efficacy|1
1857973|NCT00105157|6416582|P4|Open-Label Continuation of DB|Adverse Event|0
1857974|NCT00105157|6416583|P3|Open-Label Continuation of DB|Adverse Event|0
1857975|NCT00105157|6416584|P2|Open-Label Continuation of DB|Adverse Event|1
1857976|NCT00105157|6416585|P1|Open-Label Continuation of DB|Adverse Event|3
1857977|NCT00105157|6416582|P4|Double-Blind (DB)|Lack of Efficacy|38
1857978|NCT00105157|6416583|P3|Double-Blind (DB)|Lack of Efficacy|11
1857979|NCT00105157|6416584|P2|Double-Blind (DB)|Lack of Efficacy|14
1857980|NCT00105157|6416585|P1|Double-Blind (DB)|Lack of Efficacy|11
1857981|NCT00105157|6416582|P4|Double-Blind (DB)|Adverse Event|1
1857982|NCT00105157|6416583|P3|Double-Blind (DB)|Adverse Event|1
1857983|NCT00105157|6416584|P2|Double-Blind (DB)|Adverse Event|0
1857984|NCT00105157|6416585|P1|Double-Blind (DB)|Adverse Event|2
1857985|NCT00105157|6416582|P4|Double-Blind (DB)|Never Treated|0
1857986|NCT00105157|6416583|P3|Double-Blind (DB)|Never Treated|0
1857987|NCT00105157|6416584|P2|Double-Blind (DB)|Never Treated|0
1857988|NCT00105157|6416585|P1|Double-Blind (DB)|Never Treated|1
1857989|NCT00105079|6416779|P2|Overall Study|Other|1
1857990|NCT00105079|6416780|P1|Overall Study|Other|3
1857991|NCT00105079|6416779|P2|Overall Study|Protocol Violation|0
1857992|NCT00105079|6416780|P1|Overall Study|Protocol Violation|1
1857993|NCT00105079|6416779|P2|Overall Study|Violation of selection criteria at entry|2
1857994|NCT00105079|6416780|P1|Overall Study|Violation of selection criteria at entry|0
1857995|NCT00105079|6416779|P2|Overall Study|Refused treatment|4
1857996|NCT00105079|6416780|P1|Overall Study|Refused treatment|6
1857997|NCT00105079|6416779|P2|Overall Study|Lack of Efficacy|3
1857998|NCT00105079|6416780|P1|Overall Study|Lack of Efficacy|9
1857999|NCT00105079|6416779|P2|Overall Study|Lost to Follow-up|12
1858000|NCT00105079|6416780|P1|Overall Study|Lost to Follow-up|12
1858001|NCT00105079|6416779|P2|Overall Study|Death|1
1858002|NCT00105079|6416780|P1|Overall Study|Death|3
1858003|NCT00105079|6416779|P2|Overall Study|Adverse Event|12
1858004|NCT00105079|6416780|P1|Overall Study|Adverse Event|5
1858005|NCT00105066|6416798|P2|Overall Study|Adverse Event|5
1858006|NCT00105066|6416799|P1|Overall Study|Adverse Event|2
1858007|NCT00104884|6416877|P1|Overall Study|Disease progression|4
1858008|NCT00104871|6416881|P1|Overall Study|Not evaluable|1
1858009|NCT00104728|6416902|P1|Overall Study|screen failures|19
1858010|NCT00104650|6416910|P3|Follow-up Period|Other|0
1858011|NCT00104650|6416911|P2|Follow-up Period|Other|1
1858012|NCT00104650|6416912|P1|Follow-up Period|Other|0
1858013|NCT00104650|6416910|P3|Follow-up Period|Lost to Follow-up|2
1858014|NCT00104650|6416911|P2|Follow-up Period|Lost to Follow-up|1
1858015|NCT00104650|6416912|P1|Follow-up Period|Lost to Follow-up|0
1858016|NCT00104650|6416910|P3|Follow-up Period|Disease progression|0
1858017|NCT00104650|6416911|P2|Follow-up Period|Disease progression|1
1858018|NCT00104650|6416912|P1|Follow-up Period|Disease progression|3
1858019|NCT00104650|6416910|P3|Follow-up Period|Death|4
1858020|NCT00104650|6416911|P2|Follow-up Period|Death|6
1858021|NCT00104650|6416912|P1|Follow-up Period|Death|6
1858022|NCT00104650|6416910|P3|Follow-up Period|Withdrawal by Subject|3
1858023|NCT00104650|6416911|P2|Follow-up Period|Withdrawal by Subject|3
1858024|NCT00104650|6416912|P1|Follow-up Period|Withdrawal by Subject|0
1858025|NCT00104650|6416910|P3|Follow-up Period|Adverse Event|1
1858026|NCT00104650|6416911|P2|Follow-up Period|Adverse Event|0
1858027|NCT00104650|6416912|P1|Follow-up Period|Adverse Event|1
1858028|NCT00104650|6416910|P3|Follow-up Period|Physician Decision|0
1858029|NCT00104650|6416911|P2|Follow-up Period|Physician Decision|1
1858030|NCT00104650|6416912|P1|Follow-up Period|Physician Decision|1
1858031|NCT00104650|6416910|P3|Treatment Period (25 Weeks)|Protocol deviation|0
1858032|NCT00104650|6416911|P2|Treatment Period (25 Weeks)|Protocol deviation|1
1858033|NCT00104650|6416912|P1|Treatment Period (25 Weeks)|Protocol deviation|0
1858034|NCT00104650|6416910|P3|Treatment Period (25 Weeks)|Other|0
1858035|NCT00104650|6416911|P2|Treatment Period (25 Weeks)|Other|0
1858036|NCT00104650|6416912|P1|Treatment Period (25 Weeks)|Other|1
1858037|NCT00104650|6416910|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
1858038|NCT00104650|6416911|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
1858039|NCT00104650|6416912|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
1858040|NCT00104650|6416910|P3|Treatment Period (25 Weeks)|Disease progression|2
1858041|NCT00104650|6416911|P2|Treatment Period (25 Weeks)|Disease progression|3
1858042|NCT00104650|6416912|P1|Treatment Period (25 Weeks)|Disease progression|2
1858043|NCT00104650|6416910|P3|Treatment Period (25 Weeks)|Death|6
1858044|NCT00104650|6416911|P2|Treatment Period (25 Weeks)|Death|5
1858045|NCT00104650|6416912|P1|Treatment Period (25 Weeks)|Death|7
1858046|NCT00104650|6416910|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1858047|NCT00104650|6416911|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
1858048|NCT00104650|6416912|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
1858049|NCT00104650|6416910|P3|Treatment Period (25 Weeks)|Physician Decision|1
1858050|NCT00104650|6416911|P2|Treatment Period (25 Weeks)|Physician Decision|0
1858051|NCT00104650|6416912|P1|Treatment Period (25 Weeks)|Physician Decision|0
1858052|NCT00104637|6416944|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
1858053|NCT00104637|6416945|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
1858054|NCT00104572|6416974|P3|Overall Study|Withdrawal by Subject|0
1858055|NCT00104572|6416975|P2|Overall Study|Withdrawal by Subject|3
1858056|NCT00104572|6416976|P1|Overall Study|Withdrawal by Subject|3
1858057|NCT00104520|6416995|P2|Overall Study|Other|5
1858058|NCT00104520|6416996|P1|Overall Study|Other|1
1858059|NCT00104520|6416995|P2|Overall Study|Personal/administrative|1
1858060|NCT00104520|6416996|P1|Overall Study|Personal/administrative|1
1858061|NCT00104520|6416995|P2|Overall Study|Noncompliance|2
1858062|NCT00104520|6416996|P1|Overall Study|Noncompliance|0
1858063|NCT00104520|6416995|P2|Overall Study|Lost to Follow-up|0
1858064|NCT00104520|6416996|P1|Overall Study|Lost to Follow-up|1
1858065|NCT00104520|6416995|P2|Overall Study|Related adverse event|15
1858066|NCT00104520|6416996|P1|Overall Study|Related adverse event|13
1858067|NCT00104520|6416995|P2|Overall Study|Study drug intolerance|1
1858068|NCT00104520|6416996|P1|Overall Study|Study drug intolerance|0
1858069|NCT00104520|6416995|P2|Overall Study|Unrelated adverse event|47
1858070|NCT00104520|6416996|P1|Overall Study|Unrelated adverse event|34
1858071|NCT00104416|6417016|P5|Continuation Phase|Non-compliance|1
1858072|NCT00104416|6417017|P4|Continuation Phase|Non-compliance|0
1858073|NCT00104416|6417018|P3|Continuation Phase|Non-compliance|0
1858074|NCT00104416|6417019|P2|Continuation Phase|Non-compliance|0
1858075|NCT00104416|6417020|P1|Continuation Phase|Non-compliance|0
1858076|NCT00104416|6417016|P5|Continuation Phase|Pregnancy|0
1858077|NCT00104416|6417017|P4|Continuation Phase|Pregnancy|1
1858078|NCT00104416|6417018|P3|Continuation Phase|Pregnancy|1
1858079|NCT00104416|6417019|P2|Continuation Phase|Pregnancy|0
1858080|NCT00104416|6417020|P1|Continuation Phase|Pregnancy|0
1858081|NCT00104416|6417016|P5|Continuation Phase|Withdrawal by Subject|1
1858082|NCT00104416|6417017|P4|Continuation Phase|Withdrawal by Subject|1
1858083|NCT00104416|6417018|P3|Continuation Phase|Withdrawal by Subject|2
1858084|NCT00104416|6417019|P2|Continuation Phase|Withdrawal by Subject|0
1858085|NCT00104416|6417020|P1|Continuation Phase|Withdrawal by Subject|0
1858086|NCT00104416|6417016|P5|Continuation Phase|Lost to Follow-up|1
1858087|NCT00104416|6417017|P4|Continuation Phase|Lost to Follow-up|0
1858088|NCT00104416|6417018|P3|Continuation Phase|Lost to Follow-up|1
1858089|NCT00104416|6417019|P2|Continuation Phase|Lost to Follow-up|0
1858090|NCT00104416|6417020|P1|Continuation Phase|Lost to Follow-up|0
1858091|NCT00104416|6417016|P5|Continuation Phase|Adverse Event|2
1858092|NCT00104416|6417017|P4|Continuation Phase|Adverse Event|0
1858093|NCT00104416|6417018|P3|Continuation Phase|Adverse Event|2
1858094|NCT00104416|6417019|P2|Continuation Phase|Adverse Event|0
1858095|NCT00104416|6417020|P1|Continuation Phase|Adverse Event|0
1858096|NCT00104416|6417016|P5|Double-Blind Phase|Participant Did Not Take Drug|0
1858097|NCT00104416|6417017|P4|Double-Blind Phase|Participant Did Not Take Drug|0
1858098|NCT00104416|6417018|P3|Double-Blind Phase|Participant Did Not Take Drug|0
1858099|NCT00104416|6417019|P2|Double-Blind Phase|Participant Did Not Take Drug|4
1858100|NCT00104416|6417020|P1|Double-Blind Phase|Participant Did Not Take Drug|3
1858101|NCT00104416|6417016|P5|Double-Blind Phase|Pregnancy|0
1858102|NCT00104416|6417017|P4|Double-Blind Phase|Pregnancy|0
1858103|NCT00104416|6417018|P3|Double-Blind Phase|Pregnancy|0
1858104|NCT00104416|6417019|P2|Double-Blind Phase|Pregnancy|0
1858105|NCT00104416|6417020|P1|Double-Blind Phase|Pregnancy|1
1858106|NCT00104416|6417016|P5|Double-Blind Phase|Withdrawal by Subject|0
1858107|NCT00104416|6417017|P4|Double-Blind Phase|Withdrawal by Subject|0
1858108|NCT00104416|6417018|P3|Double-Blind Phase|Withdrawal by Subject|0
1858109|NCT00104416|6417019|P2|Double-Blind Phase|Withdrawal by Subject|3
1858110|NCT00104416|6417020|P1|Double-Blind Phase|Withdrawal by Subject|2
1858111|NCT00104416|6417016|P5|Double-Blind Phase|Protocol Violation|0
1858112|NCT00104416|6417017|P4|Double-Blind Phase|Protocol Violation|0
1858113|NCT00104416|6417018|P3|Double-Blind Phase|Protocol Violation|0
1858114|NCT00104416|6417019|P2|Double-Blind Phase|Protocol Violation|1
1858115|NCT00104416|6417020|P1|Double-Blind Phase|Protocol Violation|0
1858116|NCT00104416|6417016|P5|Double-Blind Phase|Lost to Follow-up|0
1858117|NCT00104416|6417017|P4|Double-Blind Phase|Lost to Follow-up|0
1858118|NCT00104416|6417018|P3|Double-Blind Phase|Lost to Follow-up|0
1858119|NCT00104416|6417019|P2|Double-Blind Phase|Lost to Follow-up|1
1858120|NCT00104416|6417020|P1|Double-Blind Phase|Lost to Follow-up|0
1858121|NCT00104416|6417016|P5|Double-Blind Phase|Adverse Event|0
1858122|NCT00104416|6417017|P4|Double-Blind Phase|Adverse Event|0
1858123|NCT00104416|6417018|P3|Double-Blind Phase|Adverse Event|0
1858124|NCT00104416|6417019|P2|Double-Blind Phase|Adverse Event|1
1858125|NCT00104416|6417020|P1|Double-Blind Phase|Adverse Event|2
1858126|NCT00104299|6417065|P2|Overall Study|To have renal transplant|0
1858127|NCT00104299|6417066|P1|Overall Study|To have renal transplant|1
1858128|NCT00104299|6417065|P2|Overall Study|Physician Decision|1
1858129|NCT00104299|6417066|P1|Overall Study|Physician Decision|1
1858130|NCT00104299|6417065|P2|Overall Study|Withdrawal by Subject|6
1858131|NCT00104299|6417066|P1|Overall Study|Withdrawal by Subject|2
1858132|NCT00104299|6417065|P2|Overall Study|Death|2
1858133|NCT00104299|6417066|P1|Overall Study|Death|2
1858134|NCT00104299|6417065|P2|Overall Study|Adverse Event|1
1858135|NCT00104299|6417066|P1|Overall Study|Adverse Event|3
1858136|NCT00104247|6417088|P2|Overall Study|Noncompliant with dosing|1
1858137|NCT00104247|6417089|P1|Overall Study|Noncompliant with dosing|0
1858138|NCT00104247|6417088|P2|Overall Study|Withdrawal by Subject|0
1858139|NCT00104247|6417089|P1|Overall Study|Withdrawal by Subject|1
1858140|NCT00104104|6417108|P2|Overall Study|Death|6
1858141|NCT00104104|6417109|P1|Overall Study|Death|9
1858142|NCT00104104|6417108|P2|Overall Study|Administrative problems|13
1858143|NCT00104104|6417109|P1|Overall Study|Administrative problems|12
1858144|NCT00104104|6417108|P2|Overall Study|Lost to Follow-up|7
1858145|NCT00104104|6417109|P1|Overall Study|Lost to Follow-up|3
1858146|NCT00104104|6417108|P2|Overall Study|Withdrawal by Subject|15
1858147|NCT00104104|6417109|P1|Overall Study|Withdrawal by Subject|11
1858148|NCT00104104|6417108|P2|Overall Study|Protocol Violation|2
1858149|NCT00104104|6417109|P1|Overall Study|Protocol Violation|5
1858150|NCT00104104|6417108|P2|Overall Study|Condition no longer requires study drug|4
1858151|NCT00104104|6417109|P1|Overall Study|Condition no longer requires study drug|7
1858152|NCT00104104|6417108|P2|Overall Study|Lack of Efficacy|3
1858153|NCT00104104|6417109|P1|Overall Study|Lack of Efficacy|0
1858154|NCT00104104|6417108|P2|Overall Study|Abnormal laboratory value(s)|14
1858155|NCT00104104|6417109|P1|Overall Study|Abnormal laboratory value(s)|20
1858156|NCT00104104|6417108|P2|Overall Study|Adverse Event|8
1858157|NCT00104104|6417109|P1|Overall Study|Adverse Event|8
1858158|NCT00104052|6417123|P1|Overall Study|Discontinuation unrelated to treatment|2
1858159|NCT00104052|6417123|P1|Overall Study|Lack of Efficacy|26
1858160|NCT00104052|6417123|P1|Overall Study|Adverse Event|1
1858161|NCT00103857|6417134|P7|50-Week Extension Study|reason unspecified|0
1858162|NCT00103857|6417135|P6|50-Week Extension Study|reason unspecified|0
1858163|NCT00103857|6417136|P5|50-Week Extension Study|reason unspecified|1
1858164|NCT00103857|6417137|P4|50-Week Extension Study|reason unspecified|0
1858165|NCT00103857|6417138|P3|50-Week Extension Study|reason unspecified|0
1858166|NCT00103857|6417139|P2|50-Week Extension Study|reason unspecified|0
1858167|NCT00103857|6417140|P1|50-Week Extension Study|reason unspecified|0
1858168|NCT00103857|6417134|P7|50-Week Extension Study|patient scheduled for elective surgery|0
1858169|NCT00103857|6417135|P6|50-Week Extension Study|patient scheduled for elective surgery|0
1858170|NCT00103857|6417136|P5|50-Week Extension Study|patient scheduled for elective surgery|0
1858171|NCT00103857|6417137|P4|50-Week Extension Study|patient scheduled for elective surgery|0
1858172|NCT00103857|6417138|P3|50-Week Extension Study|patient scheduled for elective surgery|1
1858173|NCT00103857|6417139|P2|50-Week Extension Study|patient scheduled for elective surgery|0
1858174|NCT00103857|6417140|P1|50-Week Extension Study|patient scheduled for elective surgery|0
1858175|NCT00103857|6417134|P7|50-Week Extension Study|patient moved|0
1858176|NCT00103857|6417135|P6|50-Week Extension Study|patient moved|0
1858177|NCT00103857|6417136|P5|50-Week Extension Study|patient moved|0
1858178|NCT00103857|6417137|P4|50-Week Extension Study|patient moved|2
1858179|NCT00103857|6417138|P3|50-Week Extension Study|patient moved|1
1858180|NCT00103857|6417139|P2|50-Week Extension Study|patient moved|0
1858181|NCT00103857|6417140|P1|50-Week Extension Study|patient moved|0
1858182|NCT00103857|6417134|P7|50-Week Extension Study|non-compliance with study procedures|0
1858183|NCT00103857|6417135|P6|50-Week Extension Study|non-compliance with study procedures|0
1858184|NCT00103857|6417136|P5|50-Week Extension Study|non-compliance with study procedures|1
1858185|NCT00103857|6417137|P4|50-Week Extension Study|non-compliance with study procedures|1
1858186|NCT00103857|6417138|P3|50-Week Extension Study|non-compliance with study procedures|0
1858187|NCT00103857|6417139|P2|50-Week Extension Study|non-compliance with study procedures|0
1858188|NCT00103857|6417140|P1|50-Week Extension Study|non-compliance with study procedures|1
1858189|NCT00103857|6417134|P7|50-Week Extension Study|protocol discontinuation criteria|0
1858190|NCT00103857|6417135|P6|50-Week Extension Study|protocol discontinuation criteria|3
1858191|NCT00103857|6417136|P5|50-Week Extension Study|protocol discontinuation criteria|3
1858192|NCT00103857|6417137|P4|50-Week Extension Study|protocol discontinuation criteria|2
1858193|NCT00103857|6417138|P3|50-Week Extension Study|protocol discontinuation criteria|3
1858194|NCT00103857|6417139|P2|50-Week Extension Study|protocol discontinuation criteria|2
1858195|NCT00103857|6417140|P1|50-Week Extension Study|protocol discontinuation criteria|2
1858196|NCT00103857|6417134|P7|50-Week Extension Study|Withdrawal by Subject|0
1858197|NCT00103857|6417135|P6|50-Week Extension Study|Withdrawal by Subject|3
1858198|NCT00103857|6417136|P5|50-Week Extension Study|Withdrawal by Subject|3
1858199|NCT00103857|6417137|P4|50-Week Extension Study|Withdrawal by Subject|8
1858200|NCT00103857|6417138|P3|50-Week Extension Study|Withdrawal by Subject|2
1858201|NCT00103857|6417139|P2|50-Week Extension Study|Withdrawal by Subject|5
1858202|NCT00103857|6417140|P1|50-Week Extension Study|Withdrawal by Subject|2
1858203|NCT00103857|6417134|P7|50-Week Extension Study|Protocol Violation|0
1858204|NCT00103857|6417135|P6|50-Week Extension Study|Protocol Violation|1
1858205|NCT00103857|6417136|P5|50-Week Extension Study|Protocol Violation|0
1858206|NCT00103857|6417137|P4|50-Week Extension Study|Protocol Violation|2
1858207|NCT00103857|6417138|P3|50-Week Extension Study|Protocol Violation|1
1858208|NCT00103857|6417139|P2|50-Week Extension Study|Protocol Violation|1
1858209|NCT00103857|6417140|P1|50-Week Extension Study|Protocol Violation|1
1858210|NCT00103857|6417134|P7|50-Week Extension Study|Pregnancy|0
1858211|NCT00103857|6417135|P6|50-Week Extension Study|Pregnancy|0
1858212|NCT00103857|6417136|P5|50-Week Extension Study|Pregnancy|1
1858213|NCT00103857|6417137|P4|50-Week Extension Study|Pregnancy|0
1858214|NCT00103857|6417138|P3|50-Week Extension Study|Pregnancy|1
1858215|NCT00103857|6417139|P2|50-Week Extension Study|Pregnancy|0
1858216|NCT00103857|6417140|P1|50-Week Extension Study|Pregnancy|0
1858217|NCT00103857|6417134|P7|50-Week Extension Study|Physician Decision|0
1858218|NCT00103857|6417135|P6|50-Week Extension Study|Physician Decision|0
1858219|NCT00103857|6417136|P5|50-Week Extension Study|Physician Decision|0
1858220|NCT00103857|6417137|P4|50-Week Extension Study|Physician Decision|0
1858221|NCT00103857|6417138|P3|50-Week Extension Study|Physician Decision|1
1858222|NCT00103857|6417139|P2|50-Week Extension Study|Physician Decision|1
1858223|NCT00103857|6417140|P1|50-Week Extension Study|Physician Decision|0
1858224|NCT00103857|6417134|P7|50-Week Extension Study|Lost to Follow-up|0
1858225|NCT00103857|6417135|P6|50-Week Extension Study|Lost to Follow-up|3
1858226|NCT00103857|6417136|P5|50-Week Extension Study|Lost to Follow-up|3
1858227|NCT00103857|6417137|P4|50-Week Extension Study|Lost to Follow-up|4
1858228|NCT00103857|6417138|P3|50-Week Extension Study|Lost to Follow-up|1
1858229|NCT00103857|6417139|P2|50-Week Extension Study|Lost to Follow-up|0
1858230|NCT00103857|6417140|P1|50-Week Extension Study|Lost to Follow-up|4
1858231|NCT00103857|6417134|P7|50-Week Extension Study|Lack of Efficacy|0
1858232|NCT00103857|6417135|P6|50-Week Extension Study|Lack of Efficacy|8
1858233|NCT00103857|6417136|P5|50-Week Extension Study|Lack of Efficacy|8
1858234|NCT00103857|6417137|P4|50-Week Extension Study|Lack of Efficacy|16
1858235|NCT00103857|6417138|P3|50-Week Extension Study|Lack of Efficacy|13
1858236|NCT00103857|6417139|P2|50-Week Extension Study|Lack of Efficacy|15
1858237|NCT00103857|6417140|P1|50-Week Extension Study|Lack of Efficacy|26
1858238|NCT00103857|6417134|P7|50-Week Extension Study|Death|0
1858239|NCT00103857|6417135|P6|50-Week Extension Study|Death|1
1858240|NCT00103857|6417136|P5|50-Week Extension Study|Death|0
1858241|NCT00103857|6417137|P4|50-Week Extension Study|Death|1
1858242|NCT00103857|6417138|P3|50-Week Extension Study|Death|0
1858243|NCT00103857|6417139|P2|50-Week Extension Study|Death|0
1858244|NCT00103857|6417140|P1|50-Week Extension Study|Death|0
1858245|NCT00103857|6417134|P7|50-Week Extension Study|Adverse Event|0
1858246|NCT00103857|6417135|P6|50-Week Extension Study|Adverse Event|1
1858247|NCT00103857|6417136|P5|50-Week Extension Study|Adverse Event|1
1858248|NCT00103857|6417137|P4|50-Week Extension Study|Adverse Event|0
1858249|NCT00103857|6417138|P3|50-Week Extension Study|Adverse Event|2
1858250|NCT00103857|6417139|P2|50-Week Extension Study|Adverse Event|3
1858251|NCT00103857|6417140|P1|50-Week Extension Study|Adverse Event|2
1858252|NCT00103857|6417134|P7|54-Week Base Study|patient intolerance to rescue therapy|0
1858253|NCT00103857|6417135|P6|54-Week Base Study|patient intolerance to rescue therapy|0
1858254|NCT00103857|6417136|P5|54-Week Base Study|patient intolerance to rescue therapy|0
1858255|NCT00103857|6417137|P4|54-Week Base Study|patient intolerance to rescue therapy|0
1858256|NCT00103857|6417138|P3|54-Week Base Study|patient intolerance to rescue therapy|0
1858257|NCT00103857|6417139|P2|54-Week Base Study|patient intolerance to rescue therapy|0
1858258|NCT00103857|6417140|P1|54-Week Base Study|patient intolerance to rescue therapy|1
1858259|NCT00103857|6417134|P7|54-Week Base Study|site error|0
1858260|NCT00103857|6417135|P6|54-Week Base Study|site error|1
1858261|NCT00103857|6417136|P5|54-Week Base Study|site error|0
1858262|NCT00103857|6417137|P4|54-Week Base Study|site error|0
1858263|NCT00103857|6417138|P3|54-Week Base Study|site error|0
1858264|NCT00103857|6417139|P2|54-Week Base Study|site error|0
1858265|NCT00103857|6417140|P1|54-Week Base Study|site error|0
1858266|NCT00103857|6417134|P7|54-Week Base Study|laboratory reporting error|0
1858267|NCT00103857|6417135|P6|54-Week Base Study|laboratory reporting error|0
1858268|NCT00103857|6417136|P5|54-Week Base Study|laboratory reporting error|1
1858269|NCT00103857|6417137|P4|54-Week Base Study|laboratory reporting error|0
1858270|NCT00103857|6417138|P3|54-Week Base Study|laboratory reporting error|0
1858271|NCT00103857|6417139|P2|54-Week Base Study|laboratory reporting error|0
1858272|NCT00103857|6417140|P1|54-Week Base Study|laboratory reporting error|0
1858273|NCT00103857|6417134|P7|54-Week Base Study|patient incarcerated|0
1858274|NCT00103857|6417135|P6|54-Week Base Study|patient incarcerated|1
1858275|NCT00103857|6417136|P5|54-Week Base Study|patient incarcerated|1
1858276|NCT00103857|6417137|P4|54-Week Base Study|patient incarcerated|0
1858277|NCT00103857|6417138|P3|54-Week Base Study|patient incarcerated|0
1858278|NCT00103857|6417139|P2|54-Week Base Study|patient incarcerated|0
1858279|NCT00103857|6417140|P1|54-Week Base Study|patient incarcerated|0
1858280|NCT00103857|6417134|P7|54-Week Base Study|non-compliance with study procedures|0
1858281|NCT00103857|6417135|P6|54-Week Base Study|non-compliance with study procedures|2
1858282|NCT00103857|6417136|P5|54-Week Base Study|non-compliance with study procedures|0
1858283|NCT00103857|6417137|P4|54-Week Base Study|non-compliance with study procedures|0
1858284|NCT00103857|6417138|P3|54-Week Base Study|non-compliance with study procedures|0
1858285|NCT00103857|6417139|P2|54-Week Base Study|non-compliance with study procedures|2
1858286|NCT00103857|6417140|P1|54-Week Base Study|non-compliance with study procedures|1
1858287|NCT00103857|6417134|P7|54-Week Base Study|patient moved|0
1858288|NCT00103857|6417135|P6|54-Week Base Study|patient moved|1
1858289|NCT00103857|6417136|P5|54-Week Base Study|patient moved|3
1858290|NCT00103857|6417137|P4|54-Week Base Study|patient moved|2
1858291|NCT00103857|6417138|P3|54-Week Base Study|patient moved|1
1858292|NCT00103857|6417139|P2|54-Week Base Study|patient moved|1
1858293|NCT00103857|6417140|P1|54-Week Base Study|patient moved|0
1858294|NCT00103857|6417134|P7|54-Week Base Study|protocol discontinuation criteria|5
1858295|NCT00103857|6417135|P6|54-Week Base Study|protocol discontinuation criteria|3
1858296|NCT00103857|6417136|P5|54-Week Base Study|protocol discontinuation criteria|5
1858297|NCT00103857|6417137|P4|54-Week Base Study|protocol discontinuation criteria|6
1858298|NCT00103857|6417138|P3|54-Week Base Study|protocol discontinuation criteria|2
1858299|NCT00103857|6417139|P2|54-Week Base Study|protocol discontinuation criteria|5
1858300|NCT00103857|6417140|P1|54-Week Base Study|protocol discontinuation criteria|2
1858301|NCT00103857|6417134|P7|54-Week Base Study|Withdrawal by Subject|4
1858302|NCT00103857|6417135|P6|54-Week Base Study|Withdrawal by Subject|15
1858303|NCT00103857|6417136|P5|54-Week Base Study|Withdrawal by Subject|10
1858304|NCT00103857|6417137|P4|54-Week Base Study|Withdrawal by Subject|15
1858305|NCT00103857|6417138|P3|54-Week Base Study|Withdrawal by Subject|16
1858306|NCT00103857|6417139|P2|54-Week Base Study|Withdrawal by Subject|16
1858307|NCT00103857|6417140|P1|54-Week Base Study|Withdrawal by Subject|17
1858308|NCT00103857|6417134|P7|54-Week Base Study|Protocol Violation|3
1858309|NCT00103857|6417135|P6|54-Week Base Study|Protocol Violation|3
1858310|NCT00103857|6417136|P5|54-Week Base Study|Protocol Violation|0
1858311|NCT00103857|6417137|P4|54-Week Base Study|Protocol Violation|4
1858312|NCT00103857|6417138|P3|54-Week Base Study|Protocol Violation|2
1858313|NCT00103857|6417139|P2|54-Week Base Study|Protocol Violation|4
1858314|NCT00103857|6417140|P1|54-Week Base Study|Protocol Violation|6
1858315|NCT00103857|6417134|P7|54-Week Base Study|Pregnancy|1
1858316|NCT00103857|6417135|P6|54-Week Base Study|Pregnancy|0
1858317|NCT00103857|6417136|P5|54-Week Base Study|Pregnancy|1
1858318|NCT00103857|6417137|P4|54-Week Base Study|Pregnancy|0
1858319|NCT00103857|6417138|P3|54-Week Base Study|Pregnancy|0
1858320|NCT00103857|6417139|P2|54-Week Base Study|Pregnancy|0
1858321|NCT00103857|6417140|P1|54-Week Base Study|Pregnancy|1
1858322|NCT00103857|6417134|P7|54-Week Base Study|Physician Decision|0
1858323|NCT00103857|6417135|P6|54-Week Base Study|Physician Decision|0
1858324|NCT00103857|6417136|P5|54-Week Base Study|Physician Decision|1
1858325|NCT00103857|6417137|P4|54-Week Base Study|Physician Decision|0
1858326|NCT00103857|6417138|P3|54-Week Base Study|Physician Decision|0
1858327|NCT00103857|6417139|P2|54-Week Base Study|Physician Decision|1
1858328|NCT00103857|6417140|P1|54-Week Base Study|Physician Decision|1
1858329|NCT00103857|6417134|P7|54-Week Base Study|Lost to Follow-up|3
1858330|NCT00103857|6417135|P6|54-Week Base Study|Lost to Follow-up|9
1858331|NCT00103857|6417136|P5|54-Week Base Study|Lost to Follow-up|10
1858332|NCT00103857|6417137|P4|54-Week Base Study|Lost to Follow-up|5
1858333|NCT00103857|6417138|P3|54-Week Base Study|Lost to Follow-up|7
1858334|NCT00103857|6417139|P2|54-Week Base Study|Lost to Follow-up|4
1858335|NCT00103857|6417140|P1|54-Week Base Study|Lost to Follow-up|5
1858336|NCT00103857|6417134|P7|54-Week Base Study|Lack of Efficacy|19
1858337|NCT00103857|6417135|P6|54-Week Base Study|Lack of Efficacy|14
1858338|NCT00103857|6417136|P5|54-Week Base Study|Lack of Efficacy|3
1858339|NCT00103857|6417137|P4|54-Week Base Study|Lack of Efficacy|4
1858340|NCT00103857|6417138|P3|54-Week Base Study|Lack of Efficacy|8
1858341|NCT00103857|6417139|P2|54-Week Base Study|Lack of Efficacy|14
1858342|NCT00103857|6417140|P1|54-Week Base Study|Lack of Efficacy|11
1858343|NCT00103857|6417134|P7|54-Week Base Study|Death|0
1858344|NCT00103857|6417135|P6|54-Week Base Study|Death|1
1858345|NCT00103857|6417136|P5|54-Week Base Study|Death|1
1858346|NCT00103857|6417137|P4|54-Week Base Study|Death|0
1858347|NCT00103857|6417138|P3|54-Week Base Study|Death|0
1858348|NCT00103857|6417139|P2|54-Week Base Study|Death|0
1858349|NCT00103857|6417140|P1|54-Week Base Study|Death|0
1858350|NCT00103857|6417134|P7|54-Week Base Study|Adverse Event|3
1858351|NCT00103857|6417135|P6|54-Week Base Study|Adverse Event|11
1858352|NCT00103857|6417136|P5|54-Week Base Study|Adverse Event|5
1858353|NCT00103857|6417137|P4|54-Week Base Study|Adverse Event|6
1858354|NCT00103857|6417138|P3|54-Week Base Study|Adverse Event|11
1858355|NCT00103857|6417139|P2|54-Week Base Study|Adverse Event|9
1858356|NCT00103857|6417140|P1|54-Week Base Study|Adverse Event|12
1858357|NCT00103740|6417239|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
1858358|NCT00103740|6417240|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
1858359|NCT00103740|6417239|P2|Period 2 - Extended Observation Period|Death|2
1858360|NCT00103740|6417240|P1|Period 2 - Extended Observation Period|Death|6
1858361|NCT00103740|6417239|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
1858362|NCT00103740|6417240|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
1858363|NCT00103740|6417239|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
1858364|NCT00103740|6417240|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
1858365|NCT00103740|6417239|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
1858366|NCT00103740|6417240|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
1858367|NCT00103740|6417239|P2|Period 1 - Core|Patient withdrew consent|2
1858368|NCT00103740|6417240|P1|Period 1 - Core|Patient withdrew consent|3
1858369|NCT00103740|6417239|P2|Period 1 - Core|Protocol Violation|2
1858370|NCT00103740|6417240|P1|Period 1 - Core|Protocol Violation|3
1858371|NCT00103740|6417239|P2|Period 1 - Core|Adverse Event|0
1858372|NCT00103740|6417240|P1|Period 1 - Core|Adverse Event|1
1858373|NCT00103662|6417268|P2|Overall Study|Intercurrent illness|0
1858374|NCT00103662|6417269|P1|Overall Study|Intercurrent illness|1
1858375|NCT00103662|6417268|P2|Overall Study|Failed mobilization|4
1858376|NCT00103662|6417269|P1|Overall Study|Failed mobilization|0
1858377|NCT00103662|6417268|P2|Overall Study|Other|9
1858378|NCT00103662|6417269|P1|Overall Study|Other|6
1858379|NCT00103662|6417268|P2|Overall Study|Lost to Follow-up|1
1858380|NCT00103662|6417269|P1|Overall Study|Lost to Follow-up|0
1858381|NCT00103662|6417268|P2|Overall Study|Elective Withdrawal|5
1858382|NCT00103662|6417269|P1|Overall Study|Elective Withdrawal|5
1858383|NCT00103662|6417268|P2|Overall Study|Death|7
1858384|NCT00103662|6417269|P1|Overall Study|Death|7
1858385|NCT00103662|6417268|P2|Overall Study|Entered Rescue Procedure|7
1858386|NCT00103662|6417269|P1|Overall Study|Entered Rescue Procedure|0
1858387|NCT00103610|6417295|P2|Overall Study|Noncompliance|1
1858388|NCT00103610|6417296|P1|Overall Study|Noncompliance|0
1858389|NCT00103610|6417295|P2|Overall Study|Failed mobilization|5
1858390|NCT00103610|6417296|P1|Overall Study|Failed mobilization|1
1858391|NCT00103610|6417295|P2|Overall Study|Other|7
1858392|NCT00103610|6417296|P1|Overall Study|Other|2
1858393|NCT00103610|6417295|P2|Overall Study|Adverse Event|2
1858394|NCT00103610|6417296|P1|Overall Study|Adverse Event|2
1858395|NCT00103610|6417295|P2|Overall Study|Lost to Follow-up|1
1858396|NCT00103610|6417296|P1|Overall Study|Lost to Follow-up|3
1858397|NCT00103610|6417295|P2|Overall Study|Elective Withdrawal|0
1858398|NCT00103610|6417296|P1|Overall Study|Elective Withdrawal|4
1858399|NCT00103610|6417295|P2|Overall Study|Death|12
1858400|NCT00103610|6417296|P1|Overall Study|Death|16
1858401|NCT00103610|6417295|P2|Overall Study|Entered Rescue Procedure|52
1858402|NCT00103610|6417296|P1|Overall Study|Entered Rescue Procedure|10
1858403|NCT00103506|6417320|P2|Overall Study|Withdrawal by Subject|21
1858404|NCT00103506|6417321|P1|Overall Study|Withdrawal by Subject|18
1858405|NCT00103506|6417320|P2|Overall Study|Lost to Follow-up|13
1858406|NCT00103506|6417321|P1|Overall Study|Lost to Follow-up|13
1858407|NCT00103506|6417320|P2|Overall Study|Death|253
1858408|NCT00103506|6417321|P1|Overall Study|Death|257
1858409|NCT00103506|6417320|P2|Overall Study|Study closed by sponsor|37
1858410|NCT00103506|6417321|P1|Overall Study|Study closed by sponsor|34
1858411|NCT00103311|6417352|P2|Overall Study|Adverse Event|0
1858412|NCT00103311|6417353|P1|Overall Study|Adverse Event|1
1858413|NCT00103311|6417352|P2|Overall Study|Withdrawal by Subject|1
1858414|NCT00103311|6417353|P1|Overall Study|Withdrawal by Subject|2
1858415|NCT00103311|6417352|P2|Overall Study|Lost to Follow-up|0
1858416|NCT00103311|6417353|P1|Overall Study|Lost to Follow-up|1
1858417|NCT00103285|6417363|P8|Response Assignment|Other|53
1858418|NCT00103285|6417364|P7|Response Assignment|Other|11
1858419|NCT00103285|6417365|P6|Response Assignment|Other|17
1858420|NCT00103285|6417366|P5|Response Assignment|Other|37
1858421|NCT00103285|6417367|P4|Response Assignment|Other|38
1858422|NCT00103285|6417368|P3|Response Assignment|Other|48
1858423|NCT00103285|6417369|P2|Response Assignment|Other|30
1858424|NCT00103285|6417370|P1|Response Assignment|Other|0
1858425|NCT00103285|6417363|P8|Response Assignment|Refusal|10
1858426|NCT00103285|6417364|P7|Response Assignment|Refusal|30
1858427|NCT00103285|6417365|P6|Response Assignment|Refusal|15
1858428|NCT00103285|6417366|P5|Response Assignment|Refusal|25
1858429|NCT00103285|6417367|P4|Response Assignment|Refusal|3
1858430|NCT00103285|6417368|P3|Response Assignment|Refusal|5
1858431|NCT00103285|6417369|P2|Response Assignment|Refusal|53
1858432|NCT00103285|6417370|P1|Response Assignment|Refusal|0
1858433|NCT00103285|6417363|P8|Response Assignment|Ineligible|5
1858434|NCT00103285|6417364|P7|Response Assignment|Ineligible|1
1858435|NCT00103285|6417365|P6|Response Assignment|Ineligible|3
1858436|NCT00103285|6417366|P5|Response Assignment|Ineligible|0
1858437|NCT00103285|6417367|P4|Response Assignment|Ineligible|2
1858438|NCT00103285|6417368|P3|Response Assignment|Ineligible|6
1858439|NCT00103285|6417369|P2|Response Assignment|Ineligible|8
1858440|NCT00103285|6417370|P1|Response Assignment|Ineligible|0
1858441|NCT00103285|6417363|P8|Response Assignment|Withdrawal by Subject|2
1858442|NCT00103285|6417364|P7|Response Assignment|Withdrawal by Subject|0
1858443|NCT00103285|6417365|P6|Response Assignment|Withdrawal by Subject|2
1858444|NCT00103285|6417366|P5|Response Assignment|Withdrawal by Subject|2
1858445|NCT00103285|6417367|P4|Response Assignment|Withdrawal by Subject|1
1858446|NCT00103285|6417368|P3|Response Assignment|Withdrawal by Subject|1
1858447|NCT00103285|6417369|P2|Response Assignment|Withdrawal by Subject|4
1858448|NCT00103285|6417370|P1|Response Assignment|Withdrawal by Subject|0
1858449|NCT00103285|6417363|P8|Response Assignment|Protocol Violation|0
1858450|NCT00103285|6417364|P7|Response Assignment|Protocol Violation|0
1858451|NCT00103285|6417365|P6|Response Assignment|Protocol Violation|0
1858452|NCT00103285|6417366|P5|Response Assignment|Protocol Violation|0
1858453|NCT00103285|6417367|P4|Response Assignment|Protocol Violation|0
1858454|NCT00103285|6417368|P3|Response Assignment|Protocol Violation|0
1858455|NCT00103285|6417369|P2|Response Assignment|Protocol Violation|2
1858456|NCT00103285|6417370|P1|Response Assignment|Protocol Violation|0
1858457|NCT00103285|6417363|P8|Response Assignment|Physician Decision|35
1858458|NCT00103285|6417364|P7|Response Assignment|Physician Decision|4
1858459|NCT00103285|6417365|P6|Response Assignment|Physician Decision|7
1858460|NCT00103285|6417366|P5|Response Assignment|Physician Decision|13
1858461|NCT00103285|6417367|P4|Response Assignment|Physician Decision|9
1858462|NCT00103285|6417368|P3|Response Assignment|Physician Decision|14
1858463|NCT00103285|6417369|P2|Response Assignment|Physician Decision|13
1858464|NCT00103285|6417370|P1|Response Assignment|Physician Decision|0
1858465|NCT00103285|6417363|P8|Response Assignment|Lost to Follow-up|5
1858466|NCT00103285|6417364|P7|Response Assignment|Lost to Follow-up|2
1858467|NCT00103285|6417365|P6|Response Assignment|Lost to Follow-up|2
1858468|NCT00103285|6417366|P5|Response Assignment|Lost to Follow-up|1
1858469|NCT00103285|6417367|P4|Response Assignment|Lost to Follow-up|5
1858470|NCT00103285|6417368|P3|Response Assignment|Lost to Follow-up|5
1858471|NCT00103285|6417369|P2|Response Assignment|Lost to Follow-up|9
1858472|NCT00103285|6417370|P1|Response Assignment|Lost to Follow-up|0
1858473|NCT00103285|6417363|P8|Response Assignment|Death|8
1858474|NCT00103285|6417364|P7|Response Assignment|Death|0
1858475|NCT00103285|6417365|P6|Response Assignment|Death|1
1858476|NCT00103285|6417366|P5|Response Assignment|Death|3
1858477|NCT00103285|6417367|P4|Response Assignment|Death|2
1858478|NCT00103285|6417368|P3|Response Assignment|Death|2
1858479|NCT00103285|6417369|P2|Response Assignment|Death|5
1858480|NCT00103285|6417370|P1|Response Assignment|Death|0
1858481|NCT00103285|6417363|P8|Response Assignment|Adverse Event|2
1858482|NCT00103285|6417364|P7|Response Assignment|Adverse Event|1
1858483|NCT00103285|6417365|P6|Response Assignment|Adverse Event|1
1858484|NCT00103285|6417366|P5|Response Assignment|Adverse Event|3
1858485|NCT00103285|6417367|P4|Response Assignment|Adverse Event|2
1858486|NCT00103285|6417368|P3|Response Assignment|Adverse Event|3
1858487|NCT00103285|6417369|P2|Response Assignment|Adverse Event|8
1858488|NCT00103285|6417370|P1|Response Assignment|Adverse Event|0
1858489|NCT00103285|6417363|P8|Induction|Other|0
1858490|NCT00103285|6417364|P7|Induction|Other|0
1858491|NCT00103285|6417365|P6|Induction|Other|0
1858492|NCT00103285|6417366|P5|Induction|Other|0
1858493|NCT00103285|6417367|P4|Induction|Other|0
1858494|NCT00103285|6417368|P3|Induction|Other|0
1858495|NCT00103285|6417369|P2|Induction|Other|0
1858496|NCT00103285|6417370|P1|Induction|Other|258
1858497|NCT00103285|6417363|P8|Induction|Refusal|0
1858498|NCT00103285|6417364|P7|Induction|Refusal|0
1858499|NCT00103285|6417365|P6|Induction|Refusal|0
1858500|NCT00103285|6417366|P5|Induction|Refusal|0
1858501|NCT00103285|6417367|P4|Induction|Refusal|0
1858502|NCT00103285|6417368|P3|Induction|Refusal|0
1858503|NCT00103285|6417369|P2|Induction|Refusal|0
1858504|NCT00103285|6417370|P1|Induction|Refusal|906
1858505|NCT00103285|6417363|P8|Induction|Ineligible|0
1858506|NCT00103285|6417364|P7|Induction|Ineligible|0
1858507|NCT00103285|6417365|P6|Induction|Ineligible|0
1858508|NCT00103285|6417366|P5|Induction|Ineligible|0
1858509|NCT00103285|6417367|P4|Induction|Ineligible|0
1858510|NCT00103285|6417368|P3|Induction|Ineligible|0
1858511|NCT00103285|6417369|P2|Induction|Ineligible|0
1858512|NCT00103285|6417370|P1|Induction|Ineligible|43
1858513|NCT00103285|6417363|P8|Induction|Withdrawal by Subject|0
1858514|NCT00103285|6417364|P7|Induction|Withdrawal by Subject|0
1858515|NCT00103285|6417365|P6|Induction|Withdrawal by Subject|0
1858516|NCT00103285|6417366|P5|Induction|Withdrawal by Subject|0
1858517|NCT00103285|6417367|P4|Induction|Withdrawal by Subject|0
1858518|NCT00103285|6417368|P3|Induction|Withdrawal by Subject|0
1858519|NCT00103285|6417369|P2|Induction|Withdrawal by Subject|0
1858520|NCT00103285|6417370|P1|Induction|Withdrawal by Subject|1
1858521|NCT00103285|6417363|P8|Induction|Physician Decision|0
1858522|NCT00103285|6417364|P7|Induction|Physician Decision|0
1858523|NCT00103285|6417365|P6|Induction|Physician Decision|0
1858524|NCT00103285|6417366|P5|Induction|Physician Decision|0
1858525|NCT00103285|6417367|P4|Induction|Physician Decision|0
1858526|NCT00103285|6417368|P3|Induction|Physician Decision|0
1858527|NCT00103285|6417369|P2|Induction|Physician Decision|0
1858528|NCT00103285|6417370|P1|Induction|Physician Decision|103
1858529|NCT00103285|6417363|P8|Induction|Death|0
1858530|NCT00103285|6417364|P7|Induction|Death|0
1858531|NCT00103285|6417365|P6|Induction|Death|0
1858532|NCT00103285|6417366|P5|Induction|Death|0
1858533|NCT00103285|6417367|P4|Induction|Death|0
1858534|NCT00103285|6417368|P3|Induction|Death|0
1858535|NCT00103285|6417369|P2|Induction|Death|0
1858536|NCT00103285|6417370|P1|Induction|Death|24
1858537|NCT00103285|6417363|P8|Induction|Adverse Event|0
1858538|NCT00103285|6417364|P7|Induction|Adverse Event|0
1858539|NCT00103285|6417365|P6|Induction|Adverse Event|0
1858540|NCT00103285|6417366|P5|Induction|Adverse Event|0
1858541|NCT00103285|6417367|P4|Induction|Adverse Event|0
1858542|NCT00103285|6417368|P3|Induction|Adverse Event|0
1858543|NCT00103285|6417369|P2|Induction|Adverse Event|0
1858544|NCT00103285|6417370|P1|Induction|Adverse Event|14
1858545|NCT00103259|6417399|P2|Overall Study|ineligible/no protocol therapy|6
1858546|NCT00103259|6417400|P1|Overall Study|ineligible/no protocol therapy|4
1858547|NCT00103259|6417399|P2|Overall Study|other (reasons were not specified)|1
1858548|NCT00103259|6417400|P1|Overall Study|other (reasons were not specified)|2
1858549|NCT00103259|6417399|P2|Overall Study|alternative therapy|0
1858550|NCT00103259|6417400|P1|Overall Study|alternative therapy|1
1858551|NCT00103259|6417399|P2|Overall Study|Withdrawal by Subject|3
1858552|NCT00103259|6417400|P1|Overall Study|Withdrawal by Subject|2
1858553|NCT00103259|6417399|P2|Overall Study|Death|2
1858554|NCT00103259|6417400|P1|Overall Study|Death|3
1858555|NCT00103207|6417412|P1|Overall Study|Diagnosis of BAC not confirmed|27
1858556|NCT00103207|6417412|P1|Overall Study|Ineligible|4
1858557|NCT00103207|6417412|P1|Overall Study|Other complicating disease|1
1858558|NCT00103207|6417412|P1|Overall Study|Withdrawal by Subject|2
1858559|NCT00103207|6417412|P1|Overall Study|Death|1
1858560|NCT00103207|6417412|P1|Overall Study|Adverse Event|3
1858561|NCT00103142|6417431|P2|Overall Study|Progression of disease|1
1858562|NCT00103142|6417432|P1|Overall Study|Progression of disease|2
1858563|NCT00103142|6417431|P2|Overall Study|Adverse Event|0
1858564|NCT00103142|6417432|P1|Overall Study|Adverse Event|1
1858565|NCT00103012|6417448|P3|Overall Study|Subject non-compliant with medications|1
1858566|NCT00103012|6417449|P2|Overall Study|Subject non-compliant with medications|0
1858567|NCT00103012|6417450|P1|Overall Study|Subject non-compliant with medications|0
1858568|NCT00103012|6417448|P3|Overall Study|Adverse Event|1
1858569|NCT00103012|6417449|P2|Overall Study|Adverse Event|0
1858570|NCT00103012|6417450|P1|Overall Study|Adverse Event|0
1858571|NCT00103012|6417448|P3|Overall Study|Pregnancy|0
1858572|NCT00103012|6417449|P2|Overall Study|Pregnancy|0
1858573|NCT00103012|6417450|P1|Overall Study|Pregnancy|1
1858574|NCT00103012|6417448|P3|Overall Study|Withdrawal by Subject|2
1858575|NCT00103012|6417449|P2|Overall Study|Withdrawal by Subject|1
1858576|NCT00103012|6417450|P1|Overall Study|Withdrawal by Subject|2
1858577|NCT00102960|6417461|P3|Overall Study|Withdrawal by Subject|1
1858578|NCT00102960|6417462|P2|Overall Study|Withdrawal by Subject|0
1858579|NCT00102960|6417463|P1|Overall Study|Withdrawal by Subject|1
1858580|NCT00102960|6417461|P3|Overall Study|Lost to Follow-up|16
1858581|NCT00102960|6417462|P2|Overall Study|Lost to Follow-up|12
1858582|NCT00102960|6417463|P1|Overall Study|Lost to Follow-up|6
1858583|NCT00102960|6417461|P3|Overall Study|Death|11
1858584|NCT00102960|6417462|P2|Overall Study|Death|11
1858585|NCT00102960|6417463|P1|Overall Study|Death|23
1858586|NCT00102804|6417512|P2|Overall Study|Alive, Receiving Treatment|2
1858587|NCT00102804|6417513|P1|Overall Study|Alive, Receiving Treatment|7
1858588|NCT00102804|6417512|P2|Overall Study|Sponsor Decision|0
1858589|NCT00102804|6417513|P1|Overall Study|Sponsor Decision|1
1858590|NCT00102804|6417512|P2|Overall Study|Satisfactory Response|0
1858591|NCT00102804|6417513|P1|Overall Study|Satisfactory Response|2
1858592|NCT00102804|6417512|P2|Overall Study|Protocol Violation|1
1858593|NCT00102804|6417513|P1|Overall Study|Protocol Violation|2
1858594|NCT00102804|6417512|P2|Overall Study|Lost to Follow-up|1
1858595|NCT00102804|6417513|P1|Overall Study|Lost to Follow-up|4
1858596|NCT00102804|6417512|P2|Overall Study|Enrollment Criteria Not Met|0
1858597|NCT00102804|6417513|P1|Overall Study|Enrollment Criteria Not Met|6
1858598|NCT00102804|6417512|P2|Overall Study|Death|6
1858599|NCT00102804|6417513|P1|Overall Study|Death|5
1858600|NCT00102804|6417512|P2|Overall Study|Physician Decision|6
1858601|NCT00102804|6417513|P1|Overall Study|Physician Decision|24
1858602|NCT00102804|6417512|P2|Overall Study|Adverse Event|3
1858603|NCT00102804|6417513|P1|Overall Study|Adverse Event|37
1858604|NCT00102804|6417512|P2|Overall Study|Withdrawal by Subject|7
1858605|NCT00102804|6417513|P1|Overall Study|Withdrawal by Subject|46
1858606|NCT00102804|6417512|P2|Overall Study|Progressive Disease (PD)|196
1858607|NCT00102804|6417513|P1|Overall Study|Progressive Disease (PD)|307
1858608|NCT00102687|6417534|P5|Maintenance Period|Physician Decision|4
1858609|NCT00102687|6417535|P4|Maintenance Period|Physician Decision|0
1858610|NCT00102687|6417536|P3|Maintenance Period|Physician Decision|3
1858611|NCT00102687|6417537|P2|Maintenance Period|Physician Decision|2
1858612|NCT00102687|6417538|P1|Maintenance Period|Physician Decision|1
1858613|NCT00102687|6417534|P5|Maintenance Period|Death|1
1858614|NCT00102687|6417535|P4|Maintenance Period|Death|1
1858615|NCT00102687|6417536|P3|Maintenance Period|Death|0
1858616|NCT00102687|6417537|P2|Maintenance Period|Death|0
1858617|NCT00102687|6417538|P1|Maintenance Period|Death|0
1858618|NCT00102687|6417534|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
1858619|NCT00102687|6417535|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
1858620|NCT00102687|6417536|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1858621|NCT00102687|6417537|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1858622|NCT00102687|6417538|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
1858623|NCT00102687|6417534|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
1858624|NCT00102687|6417535|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
1858625|NCT00102687|6417536|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
1858626|NCT00102687|6417537|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
1858627|NCT00102687|6417538|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
1858628|NCT00102687|6417534|P5|Maintenance Period|Adverse Event|3
1858629|NCT00102687|6417535|P4|Maintenance Period|Adverse Event|1
1858630|NCT00102687|6417536|P3|Maintenance Period|Adverse Event|0
1858631|NCT00102687|6417537|P2|Maintenance Period|Adverse Event|0
1858632|NCT00102687|6417538|P1|Maintenance Period|Adverse Event|1
1858633|NCT00102687|6417534|P5|Maintenance Period|Withdrawal by Subject|1
1858634|NCT00102687|6417535|P4|Maintenance Period|Withdrawal by Subject|3
1858635|NCT00102687|6417536|P3|Maintenance Period|Withdrawal by Subject|2
1858636|NCT00102687|6417537|P2|Maintenance Period|Withdrawal by Subject|0
1858637|NCT00102687|6417538|P1|Maintenance Period|Withdrawal by Subject|4
1858638|NCT00102687|6417534|P5|Initial Period|Death|0
1858639|NCT00102687|6417535|P4|Initial Period|Death|0
1858640|NCT00102687|6417536|P3|Initial Period|Death|1
1858641|NCT00102687|6417537|P2|Initial Period|Death|1
1858642|NCT00102687|6417538|P1|Initial Period|Death|1
1858643|NCT00102687|6417534|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
1858644|NCT00102687|6417535|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
1858645|NCT00102687|6417536|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
1858646|NCT00102687|6417537|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
1858647|NCT00102687|6417538|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
1858648|NCT00102687|6417534|P5|Initial Period|Sponsor's decision|0
1858649|NCT00102687|6417535|P4|Initial Period|Sponsor's decision|0
1858650|NCT00102687|6417536|P3|Initial Period|Sponsor's decision|1
1858651|NCT00102687|6417537|P2|Initial Period|Sponsor's decision|1
1858652|NCT00102687|6417538|P1|Initial Period|Sponsor's decision|0
1858653|NCT00102687|6417534|P5|Initial Period|Physician Decision|0
1858654|NCT00102687|6417535|P4|Initial Period|Physician Decision|0
1858655|NCT00102687|6417536|P3|Initial Period|Physician Decision|6
1858656|NCT00102687|6417537|P2|Initial Period|Physician Decision|9
1858657|NCT00102687|6417538|P1|Initial Period|Physician Decision|2
1858658|NCT00102687|6417534|P5|Initial Period|Protocol Violation|0
1858659|NCT00102687|6417535|P4|Initial Period|Protocol Violation|0
1858660|NCT00102687|6417536|P3|Initial Period|Protocol Violation|2
1858661|NCT00102687|6417537|P2|Initial Period|Protocol Violation|0
1858662|NCT00102687|6417538|P1|Initial Period|Protocol Violation|0
1858663|NCT00102687|6417534|P5|Initial Period|Transformation to AML (blast > 30%)|0
1858664|NCT00102687|6417535|P4|Initial Period|Transformation to AML (blast > 30%)|0
1858665|NCT00102687|6417536|P3|Initial Period|Transformation to AML (blast > 30%)|0
1858666|NCT00102687|6417537|P2|Initial Period|Transformation to AML (blast > 30%)|3
1858667|NCT00102687|6417538|P1|Initial Period|Transformation to AML (blast > 30%)|1
1858668|NCT00102687|6417534|P5|Initial Period|Adverse Event|0
1858669|NCT00102687|6417535|P4|Initial Period|Adverse Event|0
1858670|NCT00102687|6417536|P3|Initial Period|Adverse Event|9
1858671|NCT00102687|6417537|P2|Initial Period|Adverse Event|7
1858672|NCT00102687|6417538|P1|Initial Period|Adverse Event|4
1858673|NCT00102687|6417534|P5|Initial Period|Withdrawal by Subject|0
1858674|NCT00102687|6417535|P4|Initial Period|Withdrawal by Subject|0
1858675|NCT00102687|6417536|P3|Initial Period|Withdrawal by Subject|5
1858676|NCT00102687|6417537|P2|Initial Period|Withdrawal by Subject|3
1858677|NCT00102687|6417538|P1|Initial Period|Withdrawal by Subject|6
1858678|NCT00102596|6417602|P2|Part A|Adverse Event|0
1858679|NCT00102596|6417603|P1|Part A|Adverse Event|1
1858680|NCT00102596|6417602|P2|Part A|Screen failures|0
1858681|NCT00102596|6417603|P1|Part A|Screen failures|6
1858682|NCT00102531|6417614|P2|Overall Study|Physician Decision|1
1858683|NCT00102531|6417615|P1|Overall Study|Physician Decision|0
1858684|NCT00102531|6417614|P2|Overall Study|Disease Progression|9
1858685|NCT00102531|6417615|P1|Overall Study|Disease Progression|5
1858686|NCT00102531|6417614|P2|Overall Study|Adverse Event|1
1858687|NCT00102531|6417615|P1|Overall Study|Adverse Event|0
1858688|NCT00102440|6417630|P3|Overall Study|Protocol Violation|1
1858689|NCT00102440|6417631|P2|Overall Study|Protocol Violation|2
1858690|NCT00102440|6417632|P1|Overall Study|Protocol Violation|7
1858691|NCT00102440|6417630|P3|Overall Study|Other|14
1858692|NCT00102440|6417631|P2|Overall Study|Other|14
1858693|NCT00102440|6417632|P1|Overall Study|Other|11
1858694|NCT00102440|6417630|P3|Overall Study|Personal Reason(s)|13
1858695|NCT00102440|6417631|P2|Overall Study|Personal Reason(s)|13
1858696|NCT00102440|6417632|P1|Overall Study|Personal Reason(s)|19
1858697|NCT00102440|6417630|P3|Overall Study|Gout Flare|9
1858698|NCT00102440|6417631|P2|Overall Study|Gout Flare|28
1858699|NCT00102440|6417632|P1|Overall Study|Gout Flare|10
1858700|NCT00102440|6417630|P3|Overall Study|Adverse Event|8
1858701|NCT00102440|6417631|P2|Overall Study|Adverse Event|23
1858702|NCT00102440|6417632|P1|Overall Study|Adverse Event|16
1858703|NCT00102440|6417630|P3|Overall Study|Lost to Follow-up|21
1858704|NCT00102440|6417631|P2|Overall Study|Lost to Follow-up|18
1858705|NCT00102440|6417632|P1|Overall Study|Lost to Follow-up|25
1858706|NCT00102063|6417682|P3|Overall Study|Protocol Violation|1
1858707|NCT00102063|6417683|P2|Overall Study|Protocol Violation|1
1858708|NCT00102063|6417684|P1|Overall Study|Protocol Violation|0
1858709|NCT00102063|6417682|P3|Overall Study|Lost to Follow-up|1
1858710|NCT00102063|6417683|P2|Overall Study|Lost to Follow-up|0
1858711|NCT00102063|6417684|P1|Overall Study|Lost to Follow-up|0
1858712|NCT00102063|6417682|P3|Overall Study|Withdrawal by Subject|5
1858713|NCT00102063|6417683|P2|Overall Study|Withdrawal by Subject|12
1858714|NCT00102063|6417684|P1|Overall Study|Withdrawal by Subject|4
1858715|NCT00102063|6417682|P3|Overall Study|Adverse Event|2
1858716|NCT00102063|6417683|P2|Overall Study|Adverse Event|4
1858717|NCT00102063|6417684|P1|Overall Study|Adverse Event|7
1858718|NCT00102063|6417682|P3|Overall Study|Lack of Efficacy|1
1858719|NCT00102063|6417683|P2|Overall Study|Lack of Efficacy|1
1858720|NCT00102063|6417684|P1|Overall Study|Lack of Efficacy|5
1858721|NCT00101907|6417742|P6|Overall Study|Withdrawal by Subject|0
1858722|NCT00101907|6417743|P5|Overall Study|Withdrawal by Subject|1
1858723|NCT00101907|6417744|P4|Overall Study|Withdrawal by Subject|0
1858724|NCT00101907|6417745|P3|Overall Study|Withdrawal by Subject|1
1858725|NCT00101907|6417746|P2|Overall Study|Withdrawal by Subject|0
1858726|NCT00101907|6417747|P1|Overall Study|Withdrawal by Subject|1
1858727|NCT00101907|6417742|P6|Overall Study|Physician Decision|0
1858728|NCT00101907|6417743|P5|Overall Study|Physician Decision|1
1858729|NCT00101907|6417744|P4|Overall Study|Physician Decision|1
1858730|NCT00101907|6417745|P3|Overall Study|Physician Decision|0
1858731|NCT00101907|6417746|P2|Overall Study|Physician Decision|0
1858732|NCT00101907|6417747|P1|Overall Study|Physician Decision|0
1858733|NCT00101907|6417742|P6|Overall Study|Death|0
1858734|NCT00101907|6417743|P5|Overall Study|Death|3
1858735|NCT00101907|6417744|P4|Overall Study|Death|0
1858736|NCT00101907|6417745|P3|Overall Study|Death|0
1858737|NCT00101907|6417746|P2|Overall Study|Death|1
1858738|NCT00101907|6417747|P1|Overall Study|Death|0
1858739|NCT00101907|6417742|P6|Overall Study|Adverse Event|0
1858740|NCT00101907|6417743|P5|Overall Study|Adverse Event|0
1858741|NCT00101907|6417744|P4|Overall Study|Adverse Event|0
1858742|NCT00101907|6417745|P3|Overall Study|Adverse Event|0
1858743|NCT00101907|6417746|P2|Overall Study|Adverse Event|0
1858744|NCT00101907|6417747|P1|Overall Study|Adverse Event|1
1858745|NCT00101868|6417789|P2|Overall Study|Lost to Follow-up|13
1858746|NCT00101868|6417790|P1|Overall Study|Lost to Follow-up|8
1858747|NCT00101868|6417789|P2|Overall Study|Protocol Violation|0
1858748|NCT00101868|6417790|P1|Overall Study|Protocol Violation|3
1858749|NCT00101868|6417789|P2|Overall Study|Withdrawal by Subject|9
1858750|NCT00101868|6417790|P1|Overall Study|Withdrawal by Subject|8
1858751|NCT00101868|6417789|P2|Overall Study|Death|10
1858752|NCT00101868|6417790|P1|Overall Study|Death|10
1858753|NCT00101686|6417860|P10|Overall Study|Withdrawal by Subject|9
1858754|NCT00101686|6417861|P9|Overall Study|Withdrawal by Subject|8
1858755|NCT00101686|6417862|P8|Overall Study|Withdrawal by Subject|7
1858756|NCT00101686|6417863|P7|Overall Study|Withdrawal by Subject|7
1858757|NCT00101686|6417864|P6|Overall Study|Withdrawal by Subject|7
1858758|NCT00101686|6417865|P5|Overall Study|Withdrawal by Subject|8
1858759|NCT00101686|6417866|P4|Overall Study|Withdrawal by Subject|8
1858760|NCT00101686|6417867|P3|Overall Study|Withdrawal by Subject|6
1858761|NCT00101686|6417868|P2|Overall Study|Withdrawal by Subject|8
1858762|NCT00101686|6417869|P1|Overall Study|Withdrawal by Subject|9
1858763|NCT00101686|6417860|P10|Overall Study|Other|3
1858764|NCT00101686|6417861|P9|Overall Study|Other|3
1858765|NCT00101686|6417862|P8|Overall Study|Other|5
1858766|NCT00101686|6417863|P7|Overall Study|Other|1
1858767|NCT00101686|6417864|P6|Overall Study|Other|12
1858768|NCT00101686|6417865|P5|Overall Study|Other|2
1858769|NCT00101686|6417866|P4|Overall Study|Other|6
1858770|NCT00101686|6417867|P3|Overall Study|Other|1
1858771|NCT00101686|6417868|P2|Overall Study|Other|4
1858772|NCT00101686|6417869|P1|Overall Study|Other|1
1858773|NCT00101686|6417860|P10|Overall Study|Physician Decision|1
1858774|NCT00101686|6417861|P9|Overall Study|Physician Decision|1
1858775|NCT00101686|6417862|P8|Overall Study|Physician Decision|5
1858776|NCT00101686|6417863|P7|Overall Study|Physician Decision|5
1858777|NCT00101686|6417864|P6|Overall Study|Physician Decision|9
1858778|NCT00101686|6417865|P5|Overall Study|Physician Decision|8
1858779|NCT00101686|6417866|P4|Overall Study|Physician Decision|7
1858780|NCT00101686|6417867|P3|Overall Study|Physician Decision|6
1858781|NCT00101686|6417868|P2|Overall Study|Physician Decision|13
1858782|NCT00101686|6417869|P1|Overall Study|Physician Decision|10
1858783|NCT00101686|6417860|P10|Overall Study|intercurrent non-cancer related illness|1
1858784|NCT00101686|6417861|P9|Overall Study|intercurrent non-cancer related illness|1
1858785|NCT00101686|6417862|P8|Overall Study|intercurrent non-cancer related illness|0
1858786|NCT00101686|6417863|P7|Overall Study|intercurrent non-cancer related illness|1
1858787|NCT00101686|6417864|P6|Overall Study|intercurrent non-cancer related illness|3
1858788|NCT00101686|6417865|P5|Overall Study|intercurrent non-cancer related illness|1
1858789|NCT00101686|6417866|P4|Overall Study|intercurrent non-cancer related illness|0
1858790|NCT00101686|6417867|P3|Overall Study|intercurrent non-cancer related illness|2
1858791|NCT00101686|6417868|P2|Overall Study|intercurrent non-cancer related illness|0
1858792|NCT00101686|6417869|P1|Overall Study|intercurrent non-cancer related illness|0
1858793|NCT00101686|6417860|P10|Overall Study|Randomized but did not receive treament|1
1858794|NCT00101686|6417861|P9|Overall Study|Randomized but did not receive treament|0
1858795|NCT00101686|6417862|P8|Overall Study|Randomized but did not receive treament|1
1858796|NCT00101686|6417863|P7|Overall Study|Randomized but did not receive treament|0
1858797|NCT00101686|6417864|P6|Overall Study|Randomized but did not receive treament|2
1858798|NCT00101686|6417865|P5|Overall Study|Randomized but did not receive treament|2
1858799|NCT00101686|6417866|P4|Overall Study|Randomized but did not receive treament|2
1858800|NCT00101686|6417867|P3|Overall Study|Randomized but did not receive treament|2
1858801|NCT00101686|6417868|P2|Overall Study|Randomized but did not receive treament|6
1858802|NCT00101686|6417869|P1|Overall Study|Randomized but did not receive treament|1
1858803|NCT00101686|6417860|P10|Overall Study|unacceptable toxicity|4
1858804|NCT00101686|6417861|P9|Overall Study|unacceptable toxicity|1
1858805|NCT00101686|6417862|P8|Overall Study|unacceptable toxicity|2
1858806|NCT00101686|6417863|P7|Overall Study|unacceptable toxicity|4
1858807|NCT00101686|6417864|P6|Overall Study|unacceptable toxicity|10
1858808|NCT00101686|6417865|P5|Overall Study|unacceptable toxicity|16
1858809|NCT00101686|6417866|P4|Overall Study|unacceptable toxicity|6
1858810|NCT00101686|6417867|P3|Overall Study|unacceptable toxicity|10
1858811|NCT00101686|6417868|P2|Overall Study|unacceptable toxicity|9
1858812|NCT00101686|6417869|P1|Overall Study|unacceptable toxicity|3
1858813|NCT00101686|6417860|P10|Overall Study|>3 week delay treatment due toxicity|0
1858814|NCT00101686|6417861|P9|Overall Study|>3 week delay treatment due toxicity|3
1858815|NCT00101686|6417862|P8|Overall Study|>3 week delay treatment due toxicity|1
1858816|NCT00101686|6417863|P7|Overall Study|>3 week delay treatment due toxicity|2
1858817|NCT00101686|6417864|P6|Overall Study|>3 week delay treatment due toxicity|3
1858818|NCT00101686|6417865|P5|Overall Study|>3 week delay treatment due toxicity|7
1858819|NCT00101686|6417866|P4|Overall Study|>3 week delay treatment due toxicity|2
1858820|NCT00101686|6417867|P3|Overall Study|>3 week delay treatment due toxicity|1
1858821|NCT00101686|6417868|P2|Overall Study|>3 week delay treatment due toxicity|2
1858822|NCT00101686|6417869|P1|Overall Study|>3 week delay treatment due toxicity|6
1858823|NCT00101686|6417860|P10|Overall Study|initiation other anti-cancer treatment|3
1858824|NCT00101686|6417861|P9|Overall Study|initiation other anti-cancer treatment|3
1858825|NCT00101686|6417862|P8|Overall Study|initiation other anti-cancer treatment|2
1858826|NCT00101686|6417863|P7|Overall Study|initiation other anti-cancer treatment|2
1858827|NCT00101686|6417864|P6|Overall Study|initiation other anti-cancer treatment|1
1858828|NCT00101686|6417865|P5|Overall Study|initiation other anti-cancer treatment|1
1858829|NCT00101686|6417866|P4|Overall Study|initiation other anti-cancer treatment|3
1858830|NCT00101686|6417867|P3|Overall Study|initiation other anti-cancer treatment|4
1858831|NCT00101686|6417868|P2|Overall Study|initiation other anti-cancer treatment|3
1858832|NCT00101686|6417869|P1|Overall Study|initiation other anti-cancer treatment|4
1858833|NCT00101686|6417860|P10|Overall Study|Progressive Disease|8
1858834|NCT00101686|6417861|P9|Overall Study|Progressive Disease|10
1858835|NCT00101686|6417862|P8|Overall Study|Progressive Disease|7
1858836|NCT00101686|6417863|P7|Overall Study|Progressive Disease|5
1858837|NCT00101686|6417864|P6|Overall Study|Progressive Disease|25
1858838|NCT00101686|6417865|P5|Overall Study|Progressive Disease|28
1858839|NCT00101686|6417866|P4|Overall Study|Progressive Disease|38
1858840|NCT00101686|6417867|P3|Overall Study|Progressive Disease|37
1858841|NCT00101686|6417868|P2|Overall Study|Progressive Disease|28
1858842|NCT00101686|6417869|P1|Overall Study|Progressive Disease|37
1858843|NCT00101582|6417986|P2|Overall Study|Other|1
1858844|NCT00101582|6417987|P1|Overall Study|Other|0
1858845|NCT00101582|6417986|P2|Overall Study|Death|5
1858846|NCT00101582|6417987|P1|Overall Study|Death|3
1858847|NCT00101582|6417986|P2|Overall Study|Physician Decision|0
1858848|NCT00101582|6417987|P1|Overall Study|Physician Decision|1
1858849|NCT00101582|6417986|P2|Overall Study|Withdrawal by Subject|4
1858850|NCT00101582|6417987|P1|Overall Study|Withdrawal by Subject|6
1858851|NCT00101582|6417986|P2|Overall Study|Adverse Event|4
1858852|NCT00101582|6417987|P1|Overall Study|Adverse Event|1
1858853|NCT00101582|6417986|P2|Overall Study|Ineligibility determined|1
1858854|NCT00101582|6417987|P1|Overall Study|Ineligibility determined|0
1858855|NCT00101452|6418010|P3|Overall Study|Other|12
1858856|NCT00101452|6418011|P2|Overall Study|Other|16
1858857|NCT00101452|6418012|P1|Overall Study|Other|15
1858858|NCT00101452|6418010|P3|Overall Study|Protocol Violation|3
1858859|NCT00101452|6418011|P2|Overall Study|Protocol Violation|1
1858860|NCT00101452|6418012|P1|Overall Study|Protocol Violation|2
1858861|NCT00101452|6418010|P3|Overall Study|Physician Decision|2
1858862|NCT00101452|6418011|P2|Overall Study|Physician Decision|3
1858863|NCT00101452|6418012|P1|Overall Study|Physician Decision|0
1858864|NCT00101452|6418010|P3|Overall Study|Baseline Fail|2
1858865|NCT00101452|6418011|P2|Overall Study|Baseline Fail|1
1858866|NCT00101452|6418012|P1|Overall Study|Baseline Fail|2
1858867|NCT00101452|6418010|P3|Overall Study|Withdrawal by Subject|9
1858868|NCT00101452|6418011|P2|Overall Study|Withdrawal by Subject|14
1858869|NCT00101452|6418012|P1|Overall Study|Withdrawal by Subject|10
1858870|NCT00101452|6418010|P3|Overall Study|Lost to Follow-up|14
1858871|NCT00101452|6418011|P2|Overall Study|Lost to Follow-up|8
1858872|NCT00101452|6418012|P1|Overall Study|Lost to Follow-up|13
1858873|NCT00101452|6418010|P3|Overall Study|Adverse Event|1
1858874|NCT00101452|6418011|P2|Overall Study|Adverse Event|0
1858875|NCT00101452|6418012|P1|Overall Study|Adverse Event|2
1858876|NCT00101439|6418026|P2|Period 2|Withdrawal by Subject|2
1858877|NCT00101439|6418027|P1|Period 2|Withdrawal by Subject|0
1858878|NCT00101400|6418043|P1|Survival Follow-Up|Alive|7
1858879|NCT00101283|6418063|P2|Overall Study|Prostate Cancer Recurrence|1
1858880|NCT00101283|6418064|P1|Overall Study|Prostate Cancer Recurrence|0
1858881|NCT00101283|6418063|P2|Overall Study|Insurance Refusal|1
1858882|NCT00101283|6418064|P1|Overall Study|Insurance Refusal|0
1858883|NCT00101283|6418063|P2|Overall Study|Withdrawal by Subject|1
1858884|NCT00101283|6418064|P1|Overall Study|Withdrawal by Subject|0
1858885|NCT00101192|6418074|P1|Overall Study|Inevaluable|1
1858886|NCT00101192|6418074|P1|Overall Study|Ineligible|6
1858887|NCT00101166|6418078|P1|Overall Study|progressive disease|10
1858888|NCT00101101|6418086|P1|Overall Study|never received vaccine|20
1858889|NCT00100932|6418109|P2|Overall Study|Other|2
1858890|NCT00100932|6418110|P1|Overall Study|Other|5
1858891|NCT00100932|6418109|P2|Overall Study|Physician Decision|5
1858892|NCT00100932|6418110|P1|Overall Study|Physician Decision|7
1858893|NCT00100932|6418109|P2|Overall Study|Progressive Disease|18
1858894|NCT00100932|6418110|P1|Overall Study|Progressive Disease|44
1858895|NCT00100932|6418109|P2|Overall Study|Withdrawal by Subject|0
1858896|NCT00100932|6418110|P1|Overall Study|Withdrawal by Subject|6
1858897|NCT00100932|6418109|P2|Overall Study|Adverse Event|2
1858898|NCT00100932|6418110|P1|Overall Study|Adverse Event|11
1858899|NCT00100828|6418125|P1|Overall Study|Physician Decision|6
1858900|NCT00100815|6418129|P1|Overall Study|Other|3
1858901|NCT00100815|6418129|P1|Overall Study|Death|4
1858902|NCT00100815|6418129|P1|Overall Study|Adverse Event|18
1858903|NCT00100815|6418129|P1|Overall Study|Progression|24
1858904|NCT00100802|6418137|P1|Overall Study|Ineligible|12
1858905|NCT00100802|6418137|P1|Overall Study|Withdrawal by Subject|5
1858906|NCT00100802|6418137|P1|Overall Study|Protocol Violation|1
1858907|NCT00100802|6418137|P1|Overall Study|Physician Decision|5
1858908|NCT00100802|6418137|P1|Overall Study|Lack of Efficacy|47
1858909|NCT00100802|6418137|P1|Overall Study|Death|1
1858910|NCT00100802|6418137|P1|Overall Study|Adverse Event|9
1858911|NCT00100789|6418142|P1|Overall Study|Never received treatment|1
1858912|NCT00100789|6418142|P1|Overall Study|Ineligible|3
1858913|NCT00100789|6418142|P1|Overall Study|Not protocol specified|5
1858914|NCT00100789|6418142|P1|Overall Study|Death|2
1858915|NCT00100789|6418142|P1|Overall Study|Progression/relapse|42
1858916|NCT00100789|6418142|P1|Overall Study|Withdrawal by Subject|1
1858917|NCT00100789|6418142|P1|Overall Study|Adverse Event|10
1858918|NCT00100178|6418219|P3|Overall Study|Physician Decision|3
1858919|NCT00100178|6418220|P2|Overall Study|Physician Decision|1
1858920|NCT00100178|6418221|P1|Overall Study|Physician Decision|6
1858921|NCT00100178|6418219|P3|Overall Study|Withdrawal by Subject|1
1858922|NCT00100178|6418220|P2|Overall Study|Withdrawal by Subject|1
1858923|NCT00100178|6418221|P1|Overall Study|Withdrawal by Subject|1
1858924|NCT00100178|6418219|P3|Overall Study|Adverse Event|1
1858925|NCT00100178|6418220|P2|Overall Study|Adverse Event|2
1858926|NCT00100178|6418221|P1|Overall Study|Adverse Event|2
1858927|NCT00100178|6418219|P3|Overall Study|Lost to Follow-up|5
1858928|NCT00100178|6418220|P2|Overall Study|Lost to Follow-up|6
1858929|NCT00100178|6418221|P1|Overall Study|Lost to Follow-up|0
1858930|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1858931|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1858932|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
1858933|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1858934|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1858935|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
1858936|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1858937|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1858938|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
1858939|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
1858940|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1858941|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
1858942|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
1858943|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
1858944|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
1858945|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
1858946|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
1858947|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
1858948|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
1858949|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
1858950|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
1858951|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1858952|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
1858953|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
1858954|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1858955|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
1858956|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1858957|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
1858958|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
1858959|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
1858960|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
1858961|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1858962|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1858963|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
1858964|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
1858965|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
1858966|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1858967|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1858968|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1858969|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
1858970|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
1858971|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
1858972|NCT00100048|6418250|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
1858973|NCT00100048|6418251|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
1858974|NCT00100048|6418252|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
1858975|NCT00100048|6418253|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
1858976|NCT00100048|6418254|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
1858977|NCT00100048|6418255|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
1858978|NCT00099983|6418364|P2|Overall Study|Other issue|0
1858979|NCT00099983|6418365|P1|Overall Study|Other issue|1
1858980|NCT00099983|6418364|P2|Overall Study|Intolerant of burden of visits|1
1858981|NCT00099983|6418365|P1|Overall Study|Intolerant of burden of visits|0
1858982|NCT00099983|6418364|P2|Overall Study|Incarcerated|1
1858983|NCT00099983|6418365|P1|Overall Study|Incarcerated|0
1858984|NCT00099983|6418364|P2|Overall Study|Other psychiatric problem|0
1858985|NCT00099983|6418365|P1|Overall Study|Other psychiatric problem|1
1858986|NCT00099983|6418364|P2|Overall Study|Moved|0
1858987|NCT00099983|6418365|P1|Overall Study|Moved|1
1858988|NCT00099983|6418364|P2|Overall Study|Unable to return for appointments|1
1858989|NCT00099983|6418365|P1|Overall Study|Unable to return for appointments|1
1858990|NCT00099983|6418364|P2|Overall Study|Lack of Efficacy|1
1858991|NCT00099983|6418365|P1|Overall Study|Lack of Efficacy|0
1858992|NCT00099983|6418364|P2|Overall Study|Adverse Event|1
1858993|NCT00099983|6418365|P1|Overall Study|Adverse Event|1
1858994|NCT00099983|6418364|P2|Overall Study|Withdrawal by Subject|2
1858995|NCT00099983|6418365|P1|Overall Study|Withdrawal by Subject|3
1858996|NCT00099983|6418364|P2|Overall Study|Missing Source Documents|15
1858997|NCT00099983|6418365|P1|Overall Study|Missing Source Documents|14
1858998|NCT00099983|6418364|P2|Overall Study|Lost to Follow-up|3
1858999|NCT00099983|6418365|P1|Overall Study|Lost to Follow-up|2
1859000|NCT00099632|6418377|P6|Overall Study|Protocol Violation|1
1859001|NCT00099632|6418378|P5|Overall Study|Protocol Violation|0
1859002|NCT00099632|6418379|P4|Overall Study|Protocol Violation|0
1859003|NCT00099632|6418380|P3|Overall Study|Protocol Violation|0
1859004|NCT00099632|6418381|P2|Overall Study|Protocol Violation|0
1859005|NCT00099632|6418382|P1|Overall Study|Protocol Violation|0
1859006|NCT00099632|6418377|P6|Overall Study|Withdrawal by Subject|1
1859007|NCT00099632|6418378|P5|Overall Study|Withdrawal by Subject|0
1859008|NCT00099632|6418379|P4|Overall Study|Withdrawal by Subject|0
1859009|NCT00099632|6418380|P3|Overall Study|Withdrawal by Subject|0
1859010|NCT00099632|6418381|P2|Overall Study|Withdrawal by Subject|1
1859011|NCT00099632|6418382|P1|Overall Study|Withdrawal by Subject|0
1859012|NCT00099632|6418377|P6|Overall Study|Lost to Follow-up|0
1859013|NCT00099632|6418378|P5|Overall Study|Lost to Follow-up|1
1859014|NCT00099632|6418379|P4|Overall Study|Lost to Follow-up|1
1859015|NCT00099632|6418380|P3|Overall Study|Lost to Follow-up|3
1859016|NCT00099632|6418381|P2|Overall Study|Lost to Follow-up|0
1859017|NCT00099632|6418382|P1|Overall Study|Lost to Follow-up|1
1859018|NCT00099437|6418422|P2|Overall Study|Ongoing in FU but not on treatment|45
1859019|NCT00099437|6418423|P1|Overall Study|Ongoing in FU but not on treatment|37
1859020|NCT00099437|6418422|P2|Overall Study|Withdrawal by Subject|10
1859021|NCT00099437|6418423|P1|Overall Study|Withdrawal by Subject|6
1859022|NCT00099437|6418422|P2|Overall Study|Death|261
1859023|NCT00099437|6418423|P1|Overall Study|Death|293
1859024|NCT00099437|6418422|P2|Overall Study|Lost to Follow-up|33
1859025|NCT00099437|6418423|P1|Overall Study|Lost to Follow-up|30
1859026|NCT00099359|6418446|P3|Overall Study|moved out of area|4
1859027|NCT00099359|6418447|P2|Overall Study|moved out of area|7
1859028|NCT00099359|6418448|P1|Overall Study|moved out of area|9
1859029|NCT00099359|6418446|P3|Overall Study|Lost to Follow-up|24
1859030|NCT00099359|6418447|P2|Overall Study|Lost to Follow-up|24
1859031|NCT00099359|6418448|P1|Overall Study|Lost to Follow-up|15
1859032|NCT00099359|6418446|P3|Overall Study|Withdrawal by Subject|23
1859033|NCT00099359|6418447|P2|Overall Study|Withdrawal by Subject|19
1859034|NCT00099359|6418448|P1|Overall Study|Withdrawal by Subject|19
1859035|NCT00099359|6418446|P3|Overall Study|Death|17
1859036|NCT00099359|6418447|P2|Overall Study|Death|15
1859037|NCT00099359|6418448|P1|Overall Study|Death|11
1859038|NCT00099268|6418471|P2|Overall Study|Death|1
1859039|NCT00099268|6418472|P1|Overall Study|Death|3
1859040|NCT00099268|6418471|P2|Overall Study|Administrative problems|4
1859041|NCT00099268|6418472|P1|Overall Study|Administrative problems|4
1859042|NCT00099268|6418471|P2|Overall Study|Lack of Efficacy|18
1859043|NCT00099268|6418472|P1|Overall Study|Lack of Efficacy|5
1859044|NCT00099268|6418471|P2|Overall Study|Lost to Follow-up|4
1859045|NCT00099268|6418472|P1|Overall Study|Lost to Follow-up|6
1859046|NCT00099268|6418471|P2|Overall Study|Protocol Violation|8
1859047|NCT00099268|6418472|P1|Overall Study|Protocol Violation|9
1859048|NCT00099268|6418471|P2|Overall Study|Adverse Event|19
1859049|NCT00099268|6418472|P1|Overall Study|Adverse Event|19
1859050|NCT00099268|6418471|P2|Overall Study|Withdrawal by Subject|28
1859051|NCT00099268|6418472|P1|Overall Study|Withdrawal by Subject|46
1859052|NCT00098865|6418512|P1|Overall Study|Alternative Therapy|1
1859053|NCT00098865|6418512|P1|Overall Study|Adverse Event|2
1859054|NCT00098865|6418512|P1|Overall Study|Progressive Disease|6
1859055|NCT00098839|6418520|P2|Overall Study|Ineligible|0
1859056|NCT00098839|6418521|P1|Overall Study|Ineligible|2
1859057|NCT00098839|6418520|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
1859058|NCT00098839|6418521|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
1859059|NCT00098839|6418520|P2|Overall Study|Relapse|3
1859060|NCT00098839|6418521|P1|Overall Study|Relapse|6
1859061|NCT00098839|6418520|P2|Overall Study|Refusal of further protocol therapy|1
1859062|NCT00098839|6418521|P1|Overall Study|Refusal of further protocol therapy|3
1859063|NCT00098839|6418520|P2|Overall Study|Withdrawal by Subject|0
1859064|NCT00098839|6418521|P1|Overall Study|Withdrawal by Subject|1
1859065|NCT00098839|6418520|P2|Overall Study|Physician Decision|14
1859066|NCT00098839|6418521|P1|Overall Study|Physician Decision|4
1859067|NCT00098839|6418520|P2|Overall Study|Death|2
1859068|NCT00098839|6418521|P1|Overall Study|Death|1
1859069|NCT00098839|6418520|P2|Overall Study|Adverse Event|2
1859070|NCT00098839|6418521|P1|Overall Study|Adverse Event|5
1859071|NCT00098813|6418532|P1|Overall Study|Reversal of RAI resistance|1
1859072|NCT00098813|6418532|P1|Overall Study|Other complicating disease|1
1859073|NCT00098813|6418532|P1|Overall Study|Progression of Disease|1
1859074|NCT00098813|6418532|P1|Overall Study|Withdrawal by Subject|7
1859075|NCT00098813|6418532|P1|Overall Study|Protocol Violation|1
1859076|NCT00098813|6418532|P1|Overall Study|Death|8
1859077|NCT00098787|6418539|P3|Overall Study|Other|9
1859078|NCT00098787|6418540|P2|Overall Study|Other|6
1859079|NCT00098787|6418541|P1|Overall Study|Other|7
1859080|NCT00098787|6418539|P3|Overall Study|Alternative therapy|13
1859081|NCT00098787|6418540|P2|Overall Study|Alternative therapy|13
1859082|NCT00098787|6418541|P1|Overall Study|Alternative therapy|8
1859083|NCT00098787|6418539|P3|Overall Study|Withdrawal by Subject|6
1859084|NCT00098787|6418540|P2|Overall Study|Withdrawal by Subject|12
1859085|NCT00098787|6418541|P1|Overall Study|Withdrawal by Subject|4
1859086|NCT00098787|6418539|P3|Overall Study|Death|0
1859087|NCT00098787|6418540|P2|Overall Study|Death|1
1859088|NCT00098787|6418541|P1|Overall Study|Death|6
1859089|NCT00098787|6418539|P3|Overall Study|Adverse Event|8
1859090|NCT00098787|6418540|P2|Overall Study|Adverse Event|17
1859091|NCT00098787|6418541|P1|Overall Study|Adverse Event|8
1859092|NCT00098787|6418539|P3|Overall Study|Disease progression|23
1859093|NCT00098787|6418540|P2|Overall Study|Disease progression|17
1859094|NCT00098787|6418541|P1|Overall Study|Disease progression|28
1859095|NCT00098787|6418539|P3|Overall Study|Ineligible|3
1859096|NCT00098787|6418540|P2|Overall Study|Ineligible|7
1859097|NCT00098787|6418541|P1|Overall Study|Ineligible|9
1859098|NCT00098787|6418539|P3|Overall Study|Never started treatment|1
1859099|NCT00098787|6418540|P2|Overall Study|Never started treatment|2
1859100|NCT00098787|6418541|P1|Overall Study|Never started treatment|3
1859101|NCT00098774|6418555|P1|Overall Study|Physician Decision|2
1859102|NCT00098774|6418555|P1|Overall Study|Failed (to respond) during induction|4
1859103|NCT00098774|6418555|P1|Overall Study|Withdrawal by Subject|1
1859104|NCT00098774|6418555|P1|Overall Study|Disease Progression|9
1859105|NCT00098774|6418555|P1|Overall Study|Adverse Event|2
1859106|NCT00098748|6418565|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
1859107|NCT00098748|6418566|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
1859108|NCT00098748|6418567|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
1859109|NCT00098748|6418565|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
1859110|NCT00098748|6418566|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
1859111|NCT00098748|6418567|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
1859112|NCT00098748|6418565|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
1859113|NCT00098748|6418566|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
1859114|NCT00098748|6418567|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
1859115|NCT00098748|6418565|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
1859116|NCT00098748|6418566|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
1859117|NCT00098748|6418567|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
1859118|NCT00098748|6418565|P3|Continued on Open-Label Treatment|Adverse Event|0
1859119|NCT00098748|6418566|P2|Continued on Open-Label Treatment|Adverse Event|1
1859120|NCT00098748|6418567|P1|Continued on Open-Label Treatment|Adverse Event|0
1859121|NCT00098748|6418565|P3|Received Study Treatment|Subject defaulted|4
1859122|NCT00098748|6418566|P2|Received Study Treatment|Subject defaulted|4
1859123|NCT00098748|6418567|P1|Received Study Treatment|Subject defaulted|3
1859124|NCT00098748|6418565|P3|Received Study Treatment|Other|6
1859125|NCT00098748|6418566|P2|Received Study Treatment|Other|2
1859126|NCT00098748|6418567|P1|Received Study Treatment|Other|2
1859127|NCT00098748|6418565|P3|Received Study Treatment|Lack of Efficacy|27
1859128|NCT00098748|6418566|P2|Received Study Treatment|Lack of Efficacy|27
1859129|NCT00098748|6418567|P1|Received Study Treatment|Lack of Efficacy|40
1859130|NCT00098748|6418565|P3|Received Study Treatment|Adverse Event|5
1859131|NCT00098748|6418566|P2|Received Study Treatment|Adverse Event|2
1859132|NCT00098748|6418567|P1|Received Study Treatment|Adverse Event|1
1859133|NCT00098748|6418565|P3|Received Study Treatment|Death|2
1859134|NCT00098748|6418566|P2|Received Study Treatment|Death|1
1859135|NCT00098748|6418567|P1|Received Study Treatment|Death|2
1859136|NCT00098748|6418565|P3|Assigned to Study Treatment|Randomized, but not treated|2
1859137|NCT00098748|6418566|P2|Assigned to Study Treatment|Randomized, but not treated|2
1859138|NCT00098748|6418567|P1|Assigned to Study Treatment|Randomized, but not treated|0
1859139|NCT00098722|6418623|P7|Observation Phase|Other|10
1859140|NCT00098722|6418624|P6|Observation Phase|Other|21
1859141|NCT00098722|6418625|P5|Observation Phase|Other|0
1859142|NCT00098722|6418626|P4|Observation Phase|Other|0
1859143|NCT00098722|6418627|P3|Observation Phase|Other|0
1859144|NCT00098722|6418628|P2|Observation Phase|Other|0
1859145|NCT00098722|6418629|P1|Observation Phase|Other|0
1859146|NCT00098722|6418623|P7|Observation Phase|Participant defaulted|4
1859147|NCT00098722|6418624|P6|Observation Phase|Participant defaulted|17
1859148|NCT00098722|6418625|P5|Observation Phase|Participant defaulted|0
1859149|NCT00098722|6418626|P4|Observation Phase|Participant defaulted|0
1859150|NCT00098722|6418627|P3|Observation Phase|Participant defaulted|0
1859151|NCT00098722|6418628|P2|Observation Phase|Participant defaulted|0
1859152|NCT00098722|6418629|P1|Observation Phase|Participant defaulted|0
1859153|NCT00098722|6418623|P7|Observation Phase|Lack of Efficacy|0
1859154|NCT00098722|6418624|P6|Observation Phase|Lack of Efficacy|2
1859155|NCT00098722|6418625|P5|Observation Phase|Lack of Efficacy|0
1859156|NCT00098722|6418626|P4|Observation Phase|Lack of Efficacy|0
1859157|NCT00098722|6418627|P3|Observation Phase|Lack of Efficacy|0
1859158|NCT00098722|6418628|P2|Observation Phase|Lack of Efficacy|0
1859159|NCT00098722|6418629|P1|Observation Phase|Lack of Efficacy|0
1859160|NCT00098722|6418623|P7|Observation Phase|Death|3
1859161|NCT00098722|6418624|P6|Observation Phase|Death|5
1859162|NCT00098722|6418625|P5|Observation Phase|Death|0
1859163|NCT00098722|6418626|P4|Observation Phase|Death|0
1859164|NCT00098722|6418627|P3|Observation Phase|Death|0
1859165|NCT00098722|6418628|P2|Observation Phase|Death|0
1859166|NCT00098722|6418629|P1|Observation Phase|Death|0
1859167|NCT00098722|6418623|P7|Open Label Phase|Other|0
1859168|NCT00098722|6418624|P6|Open Label Phase|Other|0
1859169|NCT00098722|6418625|P5|Open Label Phase|Other|0
1859170|NCT00098722|6418626|P4|Open Label Phase|Other|18
1859171|NCT00098722|6418627|P3|Open Label Phase|Other|0
1859172|NCT00098722|6418628|P2|Open Label Phase|Other|0
1859173|NCT00098722|6418629|P1|Open Label Phase|Other|0
1859174|NCT00098722|6418623|P7|Open Label Phase|Ongoing at cut-off date|0
1859175|NCT00098722|6418624|P6|Open Label Phase|Ongoing at cut-off date|0
1859176|NCT00098722|6418625|P5|Open Label Phase|Ongoing at cut-off date|50
1859177|NCT00098722|6418626|P4|Open Label Phase|Ongoing at cut-off date|220
1859178|NCT00098722|6418627|P3|Open Label Phase|Ongoing at cut-off date|0
1859179|NCT00098722|6418628|P2|Open Label Phase|Ongoing at cut-off date|0
1859180|NCT00098722|6418629|P1|Open Label Phase|Ongoing at cut-off date|0
1859181|NCT00098722|6418623|P7|Open Label Phase|Participant defaulted|0
1859182|NCT00098722|6418624|P6|Open Label Phase|Participant defaulted|0
1859183|NCT00098722|6418625|P5|Open Label Phase|Participant defaulted|0
1859184|NCT00098722|6418626|P4|Open Label Phase|Participant defaulted|18
1859185|NCT00098722|6418627|P3|Open Label Phase|Participant defaulted|0
1859186|NCT00098722|6418628|P2|Open Label Phase|Participant defaulted|0
1859187|NCT00098722|6418629|P1|Open Label Phase|Participant defaulted|0
1859188|NCT00098722|6418623|P7|Open Label Phase|Pregnancy|0
1859189|NCT00098722|6418624|P6|Open Label Phase|Pregnancy|0
1859190|NCT00098722|6418625|P5|Open Label Phase|Pregnancy|0
1859191|NCT00098722|6418626|P4|Open Label Phase|Pregnancy|1
1859192|NCT00098722|6418627|P3|Open Label Phase|Pregnancy|0
1859193|NCT00098722|6418628|P2|Open Label Phase|Pregnancy|0
1859194|NCT00098722|6418629|P1|Open Label Phase|Pregnancy|0
1859195|NCT00098722|6418623|P7|Open Label Phase|Lack of Efficacy|0
1859196|NCT00098722|6418624|P6|Open Label Phase|Lack of Efficacy|0
1859197|NCT00098722|6418625|P5|Open Label Phase|Lack of Efficacy|0
1859198|NCT00098722|6418626|P4|Open Label Phase|Lack of Efficacy|8
1859199|NCT00098722|6418627|P3|Open Label Phase|Lack of Efficacy|0
1859200|NCT00098722|6418628|P2|Open Label Phase|Lack of Efficacy|0
1859201|NCT00098722|6418629|P1|Open Label Phase|Lack of Efficacy|0
1859202|NCT00098722|6418623|P7|Open Label Phase|Death|0
1859203|NCT00098722|6418624|P6|Open Label Phase|Death|0
1859204|NCT00098722|6418625|P5|Open Label Phase|Death|0
1859205|NCT00098722|6418626|P4|Open Label Phase|Death|2
1859206|NCT00098722|6418627|P3|Open Label Phase|Death|0
1859207|NCT00098722|6418628|P2|Open Label Phase|Death|0
1859208|NCT00098722|6418629|P1|Open Label Phase|Death|0
1859209|NCT00098722|6418623|P7|Open Label Phase|Adverse Event|0
1859210|NCT00098722|6418624|P6|Open Label Phase|Adverse Event|0
1859211|NCT00098722|6418625|P5|Open Label Phase|Adverse Event|0
1859212|NCT00098722|6418626|P4|Open Label Phase|Adverse Event|5
1859213|NCT00098722|6418627|P3|Open Label Phase|Adverse Event|0
1859214|NCT00098722|6418628|P2|Open Label Phase|Adverse Event|0
1859215|NCT00098722|6418629|P1|Open Label Phase|Adverse Event|0
1859216|NCT00098722|6418623|P7|Double Blind Phase|Other|0
1859217|NCT00098722|6418624|P6|Double Blind Phase|Other|0
1859218|NCT00098722|6418625|P5|Double Blind Phase|Other|0
1859219|NCT00098722|6418626|P4|Double Blind Phase|Other|0
1859220|NCT00098722|6418627|P3|Double Blind Phase|Other|7
1859221|NCT00098722|6418628|P2|Double Blind Phase|Other|8
1859222|NCT00098722|6418629|P1|Double Blind Phase|Other|7
1859223|NCT00098722|6418623|P7|Double Blind Phase|Ongoing at cut-off date|0
1859224|NCT00098722|6418624|P6|Double Blind Phase|Ongoing at cut-off date|0
1859225|NCT00098722|6418625|P5|Double Blind Phase|Ongoing at cut-off date|0
1859226|NCT00098722|6418626|P4|Double Blind Phase|Ongoing at cut-off date|0
1859227|NCT00098722|6418627|P3|Double Blind Phase|Ongoing at cut-off date|57
1859228|NCT00098722|6418628|P2|Double Blind Phase|Ongoing at cut-off date|137
1859229|NCT00098722|6418629|P1|Double Blind Phase|Ongoing at cut-off date|128
1859230|NCT00098722|6418623|P7|Double Blind Phase|Randomized, not treated|0
1859231|NCT00098722|6418624|P6|Double Blind Phase|Randomized, not treated|0
1859232|NCT00098722|6418625|P5|Double Blind Phase|Randomized, not treated|0
1859233|NCT00098722|6418626|P4|Double Blind Phase|Randomized, not treated|0
1859234|NCT00098722|6418627|P3|Double Blind Phase|Randomized, not treated|3
1859235|NCT00098722|6418628|P2|Double Blind Phase|Randomized, not treated|3
1859236|NCT00098722|6418629|P1|Double Blind Phase|Randomized, not treated|4
1859237|NCT00098722|6418623|P7|Double Blind Phase|Pregnancy|0
1859238|NCT00098722|6418624|P6|Double Blind Phase|Pregnancy|0
1859239|NCT00098722|6418625|P5|Double Blind Phase|Pregnancy|0
1859240|NCT00098722|6418626|P4|Double Blind Phase|Pregnancy|0
1859241|NCT00098722|6418627|P3|Double Blind Phase|Pregnancy|0
1859242|NCT00098722|6418628|P2|Double Blind Phase|Pregnancy|0
1859243|NCT00098722|6418629|P1|Double Blind Phase|Pregnancy|1
1859244|NCT00098722|6418623|P7|Double Blind Phase|Participant defaulted|0
1859245|NCT00098722|6418624|P6|Double Blind Phase|Participant defaulted|0
1859246|NCT00098722|6418625|P5|Double Blind Phase|Participant defaulted|0
1859247|NCT00098722|6418626|P4|Double Blind Phase|Participant defaulted|0
1859248|NCT00098722|6418627|P3|Double Blind Phase|Participant defaulted|9
1859249|NCT00098722|6418628|P2|Double Blind Phase|Participant defaulted|11
1859250|NCT00098722|6418629|P1|Double Blind Phase|Participant defaulted|16
1859251|NCT00098722|6418623|P7|Double Blind Phase|Lack of Efficacy|0
1859252|NCT00098722|6418624|P6|Double Blind Phase|Lack of Efficacy|0
1859253|NCT00098722|6418625|P5|Double Blind Phase|Lack of Efficacy|0
1859254|NCT00098722|6418626|P4|Double Blind Phase|Lack of Efficacy|0
1859255|NCT00098722|6418627|P3|Double Blind Phase|Lack of Efficacy|15
1859256|NCT00098722|6418628|P2|Double Blind Phase|Lack of Efficacy|23
1859257|NCT00098722|6418629|P1|Double Blind Phase|Lack of Efficacy|21
1859258|NCT00098722|6418623|P7|Double Blind Phase|Death|0
1859259|NCT00098722|6418624|P6|Double Blind Phase|Death|0
1859260|NCT00098722|6418625|P5|Double Blind Phase|Death|0
1859261|NCT00098722|6418626|P4|Double Blind Phase|Death|0
1859262|NCT00098722|6418627|P3|Double Blind Phase|Death|0
1859263|NCT00098722|6418628|P2|Double Blind Phase|Death|5
1859264|NCT00098722|6418629|P1|Double Blind Phase|Death|2
1859265|NCT00098722|6418623|P7|Double Blind Phase|Adverse Event|0
1859266|NCT00098722|6418624|P6|Double Blind Phase|Adverse Event|0
1859267|NCT00098722|6418625|P5|Double Blind Phase|Adverse Event|0
1859268|NCT00098722|6418626|P4|Double Blind Phase|Adverse Event|0
1859269|NCT00098722|6418627|P3|Double Blind Phase|Adverse Event|3
1859270|NCT00098722|6418628|P2|Double Blind Phase|Adverse Event|7
1859271|NCT00098722|6418629|P1|Double Blind Phase|Adverse Event|7
1859272|NCT00098475|6418703|P4|Step 2|Never started treatment|0
1859273|NCT00098475|6418704|P3|Step 2|Never started treatment|0
1859274|NCT00098475|6418705|P2|Step 2|Never started treatment|1
1859275|NCT00098475|6418706|P1|Step 2|Never started treatment|1
1859276|NCT00098475|6418703|P4|Step 2|Alternative therapy|0
1859277|NCT00098475|6418704|P3|Step 2|Alternative therapy|0
1859278|NCT00098475|6418705|P2|Step 2|Alternative therapy|2
1859279|NCT00098475|6418706|P1|Step 2|Alternative therapy|1
1859280|NCT00098475|6418703|P4|Step 2|Physician Decision|0
1859281|NCT00098475|6418704|P3|Step 2|Physician Decision|0
1859282|NCT00098475|6418705|P2|Step 2|Physician Decision|1
1859283|NCT00098475|6418706|P1|Step 2|Physician Decision|0
1859284|NCT00098475|6418703|P4|Step 2|Withdrawal by Subject|0
1859285|NCT00098475|6418704|P3|Step 2|Withdrawal by Subject|0
1859286|NCT00098475|6418705|P2|Step 2|Withdrawal by Subject|2
1859287|NCT00098475|6418706|P1|Step 2|Withdrawal by Subject|0
1859288|NCT00098475|6418703|P4|Step 2|Adverse Event|0
1859289|NCT00098475|6418704|P3|Step 2|Adverse Event|0
1859290|NCT00098475|6418705|P2|Step 2|Adverse Event|0
1859291|NCT00098475|6418706|P1|Step 2|Adverse Event|2
1859292|NCT00098475|6418703|P4|Step 2|Disease progression|0
1859293|NCT00098475|6418704|P3|Step 2|Disease progression|0
1859294|NCT00098475|6418705|P2|Step 2|Disease progression|4
1859295|NCT00098475|6418706|P1|Step 2|Disease progression|1
1859296|NCT00098475|6418703|P4|Step 1|Not documented|0
1859297|NCT00098475|6418704|P3|Step 1|Not documented|0
1859298|NCT00098475|6418705|P2|Step 1|Not documented|1
1859299|NCT00098475|6418706|P1|Step 1|Not documented|0
1859300|NCT00098475|6418703|P4|Step 1|Patient fell with fracture|0
1859301|NCT00098475|6418704|P3|Step 1|Patient fell with fracture|0
1859302|NCT00098475|6418705|P2|Step 1|Patient fell with fracture|0
1859303|NCT00098475|6418706|P1|Step 1|Patient fell with fracture|1
1859304|NCT00098475|6418703|P4|Step 1|Misinterpretation of lab data|0
1859305|NCT00098475|6418704|P3|Step 1|Misinterpretation of lab data|0
1859306|NCT00098475|6418705|P2|Step 1|Misinterpretation of lab data|1
1859307|NCT00098475|6418706|P1|Step 1|Misinterpretation of lab data|0
1859308|NCT00098475|6418703|P4|Step 1|Criteria to continue treatment not met|0
1859309|NCT00098475|6418704|P3|Step 1|Criteria to continue treatment not met|0
1859310|NCT00098475|6418705|P2|Step 1|Criteria to continue treatment not met|1
1859311|NCT00098475|6418706|P1|Step 1|Criteria to continue treatment not met|0
1859312|NCT00098475|6418703|P4|Step 1|Referred to other physicians|0
1859313|NCT00098475|6418704|P3|Step 1|Referred to other physicians|0
1859314|NCT00098475|6418705|P2|Step 1|Referred to other physicians|1
1859315|NCT00098475|6418706|P1|Step 1|Referred to other physicians|0
1859316|NCT00098475|6418703|P4|Step 1|Rising paraprotein|0
1859317|NCT00098475|6418704|P3|Step 1|Rising paraprotein|0
1859318|NCT00098475|6418705|P2|Step 1|Rising paraprotein|1
1859319|NCT00098475|6418706|P1|Step 1|Rising paraprotein|0
1859320|NCT00098475|6418703|P4|Step 1|Insurance issue|0
1859321|NCT00098475|6418704|P3|Step 1|Insurance issue|0
1859322|NCT00098475|6418705|P2|Step 1|Insurance issue|1
1859323|NCT00098475|6418706|P1|Step 1|Insurance issue|0
1859324|NCT00098475|6418703|P4|Step 1|Declining performance status|0
1859325|NCT00098475|6418704|P3|Step 1|Declining performance status|0
1859326|NCT00098475|6418705|P2|Step 1|Declining performance status|1
1859327|NCT00098475|6418706|P1|Step 1|Declining performance status|0
1859328|NCT00098475|6418703|P4|Step 1|Off treatment for > specified timeframe|0
1859329|NCT00098475|6418704|P3|Step 1|Off treatment for > specified timeframe|0
1859330|NCT00098475|6418705|P2|Step 1|Off treatment for > specified timeframe|1
1859331|NCT00098475|6418706|P1|Step 1|Off treatment for > specified timeframe|1
1859332|NCT00098475|6418703|P4|Step 1|Incorrect disease assessment|0
1859333|NCT00098475|6418704|P3|Step 1|Incorrect disease assessment|0
1859334|NCT00098475|6418705|P2|Step 1|Incorrect disease assessment|0
1859335|NCT00098475|6418706|P1|Step 1|Incorrect disease assessment|2
1859336|NCT00098475|6418703|P4|Step 1|Both patient and physician's decision|0
1859337|NCT00098475|6418704|P3|Step 1|Both patient and physician's decision|0
1859338|NCT00098475|6418705|P2|Step 1|Both patient and physician's decision|1
1859339|NCT00098475|6418706|P1|Step 1|Both patient and physician's decision|2
1859340|NCT00098475|6418703|P4|Step 1|Cannot comply due to other tx|0
1859341|NCT00098475|6418704|P3|Step 1|Cannot comply due to other tx|0
1859342|NCT00098475|6418705|P2|Step 1|Cannot comply due to other tx|1
1859343|NCT00098475|6418706|P1|Step 1|Cannot comply due to other tx|0
1859344|NCT00098475|6418703|P4|Step 1|Complications|0
1859345|NCT00098475|6418704|P3|Step 1|Complications|0
1859346|NCT00098475|6418705|P2|Step 1|Complications|0
1859347|NCT00098475|6418706|P1|Step 1|Complications|1
1859348|NCT00098475|6418703|P4|Step 1|Knee surgery|0
1859349|NCT00098475|6418704|P3|Step 1|Knee surgery|0
1859350|NCT00098475|6418705|P2|Step 1|Knee surgery|0
1859351|NCT00098475|6418706|P1|Step 1|Knee surgery|1
1859352|NCT00098475|6418703|P4|Step 1|Still on treatment as of this analysis|0
1859353|NCT00098475|6418704|P3|Step 1|Still on treatment as of this analysis|0
1859354|NCT00098475|6418705|P2|Step 1|Still on treatment as of this analysis|27
1859355|NCT00098475|6418706|P1|Step 1|Still on treatment as of this analysis|14
1859356|NCT00098475|6418703|P4|Step 1|Never started treatment|0
1859357|NCT00098475|6418704|P3|Step 1|Never started treatment|0
1859358|NCT00098475|6418705|P2|Step 1|Never started treatment|2
1859359|NCT00098475|6418706|P1|Step 1|Never started treatment|0
1859360|NCT00098475|6418703|P4|Step 1|Other disease|0
1859361|NCT00098475|6418704|P3|Step 1|Other disease|1
1859362|NCT00098475|6418705|P2|Step 1|Other disease|1
1859363|NCT00098475|6418706|P1|Step 1|Other disease|2
1859364|NCT00098475|6418703|P4|Step 1|Alternative therapy|0
1859365|NCT00098475|6418704|P3|Step 1|Alternative therapy|1
1859366|NCT00098475|6418705|P2|Step 1|Alternative therapy|43
1859367|NCT00098475|6418706|P1|Step 1|Alternative therapy|31
1859368|NCT00098475|6418703|P4|Step 1|Physician Decision|0
1859369|NCT00098475|6418704|P3|Step 1|Physician Decision|0
1859370|NCT00098475|6418705|P2|Step 1|Physician Decision|2
1859371|NCT00098475|6418706|P1|Step 1|Physician Decision|5
1859372|NCT00098475|6418703|P4|Step 1|Withdrawal by Subject|0
1859373|NCT00098475|6418704|P3|Step 1|Withdrawal by Subject|0
1859374|NCT00098475|6418705|P2|Step 1|Withdrawal by Subject|11
1859375|NCT00098475|6418706|P1|Step 1|Withdrawal by Subject|14
1859376|NCT00098475|6418703|P4|Step 1|Death|1
1859377|NCT00098475|6418704|P3|Step 1|Death|0
1859378|NCT00098475|6418705|P2|Step 1|Death|5
1859379|NCT00098475|6418706|P1|Step 1|Death|8
1859380|NCT00098475|6418703|P4|Step 1|Adverse Event|1
1859381|NCT00098475|6418704|P3|Step 1|Adverse Event|0
1859382|NCT00098475|6418705|P2|Step 1|Adverse Event|37
1859383|NCT00098475|6418706|P1|Step 1|Adverse Event|56
1859384|NCT00098475|6418703|P4|Step 1|Progressive disease|1
1859385|NCT00098475|6418704|P3|Step 1|Progressive disease|2
1859386|NCT00098475|6418705|P2|Step 1|Progressive disease|35
1859387|NCT00098475|6418706|P1|Step 1|Progressive disease|33
1859388|NCT00098345|6418743|P1|Overall Study|progression|4
1859389|NCT00098345|6418743|P1|Overall Study|Withdrawal by Subject|2
1859390|NCT00098345|6418743|P1|Overall Study|Adverse Event|7
1859391|NCT00098306|6418756|P7|Observational Phase|Un-specified|4
1859392|NCT00098306|6418757|P6|Observational Phase|Un-specified|7
1859393|NCT00098306|6418758|P5|Observational Phase|Un-specified|0
1859394|NCT00098306|6418759|P4|Observational Phase|Un-specified|0
1859395|NCT00098306|6418760|P3|Observational Phase|Un-specified|0
1859396|NCT00098306|6418761|P2|Observational Phase|Un-specified|0
1859397|NCT00098306|6418762|P1|Observational Phase|Un-specified|0
1859398|NCT00098306|6418756|P7|Observational Phase|Participant defaulted|18
1859399|NCT00098306|6418757|P6|Observational Phase|Participant defaulted|34
1859400|NCT00098306|6418758|P5|Observational Phase|Participant defaulted|0
1859401|NCT00098306|6418759|P4|Observational Phase|Participant defaulted|0
1859402|NCT00098306|6418760|P3|Observational Phase|Participant defaulted|0
1859403|NCT00098306|6418761|P2|Observational Phase|Participant defaulted|0
1859404|NCT00098306|6418762|P1|Observational Phase|Participant defaulted|0
1859405|NCT00098306|6418756|P7|Observational Phase|Death|4
1859406|NCT00098306|6418757|P6|Observational Phase|Death|5
1859407|NCT00098306|6418758|P5|Observational Phase|Death|0
1859408|NCT00098306|6418759|P4|Observational Phase|Death|0
1859409|NCT00098306|6418760|P3|Observational Phase|Death|0
1859410|NCT00098306|6418761|P2|Observational Phase|Death|0
1859411|NCT00098306|6418762|P1|Observational Phase|Death|0
1859412|NCT00098306|6418756|P7|Open Label|Ongoing at cut-off date|0
1859413|NCT00098306|6418757|P6|Open Label|Ongoing at cut-off date|0
1859414|NCT00098306|6418758|P5|Open Label|Ongoing at cut-off date|62
1859415|NCT00098306|6418759|P4|Open Label|Ongoing at cut-off date|269
1859416|NCT00098306|6418760|P3|Open Label|Ongoing at cut-off date|0
1859417|NCT00098306|6418761|P2|Open Label|Ongoing at cut-off date|0
1859418|NCT00098306|6418762|P1|Open Label|Ongoing at cut-off date|0
1859419|NCT00098306|6418756|P7|Open Label|Un-specified|0
1859420|NCT00098306|6418757|P6|Open Label|Un-specified|0
1859421|NCT00098306|6418758|P5|Open Label|Un-specified|0
1859422|NCT00098306|6418759|P4|Open Label|Un-specified|15
1859423|NCT00098306|6418760|P3|Open Label|Un-specified|0
1859424|NCT00098306|6418761|P2|Open Label|Un-specified|0
1859425|NCT00098306|6418762|P1|Open Label|Un-specified|0
1859426|NCT00098306|6418756|P7|Open Label|Participant defaulted|0
1859427|NCT00098306|6418757|P6|Open Label|Participant defaulted|0
1859428|NCT00098306|6418758|P5|Open Label|Participant defaulted|0
1859429|NCT00098306|6418759|P4|Open Label|Participant defaulted|24
1859430|NCT00098306|6418760|P3|Open Label|Participant defaulted|0
1859431|NCT00098306|6418761|P2|Open Label|Participant defaulted|0
1859432|NCT00098306|6418762|P1|Open Label|Participant defaulted|0
1859433|NCT00098306|6418756|P7|Open Label|Death|0
1859434|NCT00098306|6418757|P6|Open Label|Death|0
1859435|NCT00098306|6418758|P5|Open Label|Death|0
1859436|NCT00098306|6418759|P4|Open Label|Death|4
1859437|NCT00098306|6418760|P3|Open Label|Death|0
1859438|NCT00098306|6418761|P2|Open Label|Death|0
1859439|NCT00098306|6418762|P1|Open Label|Death|0
1859440|NCT00098306|6418756|P7|Open Label|Adverse Event|0
1859441|NCT00098306|6418757|P6|Open Label|Adverse Event|0
1859442|NCT00098306|6418758|P5|Open Label|Adverse Event|0
1859443|NCT00098306|6418759|P4|Open Label|Adverse Event|2
1859444|NCT00098306|6418760|P3|Open Label|Adverse Event|0
1859445|NCT00098306|6418761|P2|Open Label|Adverse Event|0
1859446|NCT00098306|6418762|P1|Open Label|Adverse Event|0
1859447|NCT00098306|6418756|P7|Open Label|Lack of Efficacy|0
1859448|NCT00098306|6418757|P6|Open Label|Lack of Efficacy|0
1859449|NCT00098306|6418758|P5|Open Label|Lack of Efficacy|0
1859450|NCT00098306|6418759|P4|Open Label|Lack of Efficacy|13
1859451|NCT00098306|6418760|P3|Open Label|Lack of Efficacy|0
1859452|NCT00098306|6418761|P2|Open Label|Lack of Efficacy|0
1859453|NCT00098306|6418762|P1|Open Label|Lack of Efficacy|0
1859454|NCT00098306|6418756|P7|Double Blind|Un-specified|0
1859455|NCT00098306|6418757|P6|Double Blind|Un-specified|0
1859456|NCT00098306|6418758|P5|Double Blind|Un-specified|0
1859457|NCT00098306|6418759|P4|Double Blind|Un-specified|0
1859458|NCT00098306|6418760|P3|Double Blind|Un-specified|11
1859459|NCT00098306|6418761|P2|Double Blind|Un-specified|3
1859460|NCT00098306|6418762|P1|Double Blind|Un-specified|7
1859461|NCT00098306|6418756|P7|Double Blind|Participant defaulted|0
1859462|NCT00098306|6418757|P6|Double Blind|Participant defaulted|0
1859463|NCT00098306|6418758|P5|Double Blind|Participant defaulted|0
1859464|NCT00098306|6418759|P4|Double Blind|Participant defaulted|0
1859465|NCT00098306|6418760|P3|Double Blind|Participant defaulted|11
1859466|NCT00098306|6418761|P2|Double Blind|Participant defaulted|18
1859467|NCT00098306|6418762|P1|Double Blind|Participant defaulted|19
1859468|NCT00098306|6418756|P7|Double Blind|Death|0
1859469|NCT00098306|6418757|P6|Double Blind|Death|0
1859470|NCT00098306|6418758|P5|Double Blind|Death|0
1859471|NCT00098306|6418759|P4|Double Blind|Death|0
1859472|NCT00098306|6418760|P3|Double Blind|Death|1
1859473|NCT00098306|6418761|P2|Double Blind|Death|4
1859474|NCT00098306|6418762|P1|Double Blind|Death|1
1859475|NCT00098306|6418756|P7|Double Blind|Lack of Efficacy|0
1859476|NCT00098306|6418757|P6|Double Blind|Lack of Efficacy|0
1859477|NCT00098306|6418758|P5|Double Blind|Lack of Efficacy|0
1859478|NCT00098306|6418759|P4|Double Blind|Lack of Efficacy|0
1859479|NCT00098306|6418760|P3|Double Blind|Lack of Efficacy|17
1859480|NCT00098306|6418761|P2|Double Blind|Lack of Efficacy|34
1859481|NCT00098306|6418762|P1|Double Blind|Lack of Efficacy|43
1859482|NCT00098306|6418756|P7|Double Blind|Adverse Event|0
1859483|NCT00098306|6418757|P6|Double Blind|Adverse Event|0
1859484|NCT00098306|6418758|P5|Double Blind|Adverse Event|0
1859485|NCT00098306|6418759|P4|Double Blind|Adverse Event|0
1859486|NCT00098306|6418760|P3|Double Blind|Adverse Event|6
1859487|NCT00098306|6418761|P2|Double Blind|Adverse Event|10
1859488|NCT00098306|6418762|P1|Double Blind|Adverse Event|11
1859489|NCT00098306|6418756|P7|Double Blind|Ongoing at cut-off date|0
1859490|NCT00098306|6418757|P6|Double Blind|Ongoing at cut-off date|0
1859491|NCT00098306|6418758|P5|Double Blind|Ongoing at cut-off date|0
1859492|NCT00098306|6418759|P4|Double Blind|Ongoing at cut-off date|0
1859493|NCT00098306|6418760|P3|Double Blind|Ongoing at cut-off date|72
1859494|NCT00098306|6418761|P2|Double Blind|Ongoing at cut-off date|166
1859495|NCT00098306|6418762|P1|Double Blind|Ongoing at cut-off date|151
1859496|NCT00098306|6418756|P7|Double Blind|Randomized, not treated|0
1859497|NCT00098306|6418757|P6|Double Blind|Randomized, not treated|0
1859498|NCT00098306|6418758|P5|Double Blind|Randomized, not treated|0
1859499|NCT00098306|6418759|P4|Double Blind|Randomized, not treated|0
1859500|NCT00098306|6418760|P3|Double Blind|Randomized, not treated|2
1859501|NCT00098306|6418761|P2|Double Blind|Randomized, not treated|5
1859502|NCT00098306|6418762|P1|Double Blind|Randomized, not treated|9
1859503|NCT00098293|6418828|P5|Supplemental Phase (SP)|Other|22
1859504|NCT00098293|6418829|P4|Supplemental Phase (SP)|Other|0
1859505|NCT00098293|6418830|P3|Supplemental Phase (SP)|Other|0
1859506|NCT00098293|6418831|P2|Supplemental Phase (SP)|Other|0
1859507|NCT00098293|6418832|P1|Supplemental Phase (SP)|Other|0
1859508|NCT00098293|6418828|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
1859509|NCT00098293|6418829|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
1859510|NCT00098293|6418830|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
1859511|NCT00098293|6418831|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
1859512|NCT00098293|6418832|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
1859513|NCT00098293|6418828|P5|Supplemental Phase (SP)|Lost to Follow-up|2
1859514|NCT00098293|6418829|P4|Supplemental Phase (SP)|Lost to Follow-up|0
1859515|NCT00098293|6418830|P3|Supplemental Phase (SP)|Lost to Follow-up|0
1859516|NCT00098293|6418831|P2|Supplemental Phase (SP)|Lost to Follow-up|0
1859517|NCT00098293|6418832|P1|Supplemental Phase (SP)|Lost to Follow-up|0
1859518|NCT00098293|6418828|P5|Supplemental Phase (SP)|Death|1
1859519|NCT00098293|6418829|P4|Supplemental Phase (SP)|Death|0
1859520|NCT00098293|6418830|P3|Supplemental Phase (SP)|Death|0
1859521|NCT00098293|6418831|P2|Supplemental Phase (SP)|Death|0
1859522|NCT00098293|6418832|P1|Supplemental Phase (SP)|Death|0
1859523|NCT00098293|6418828|P5|Open-label (OL) Phase|Death|0
1859524|NCT00098293|6418829|P4|Open-label (OL) Phase|Death|0
1859525|NCT00098293|6418830|P3|Open-label (OL) Phase|Death|3
1859526|NCT00098293|6418831|P2|Open-label (OL) Phase|Death|2
1859527|NCT00098293|6418832|P1|Open-label (OL) Phase|Death|0
1859528|NCT00098293|6418828|P5|Open-label (OL) Phase|Participant Defaulted|0
1859529|NCT00098293|6418829|P4|Open-label (OL) Phase|Participant Defaulted|20
1859530|NCT00098293|6418830|P3|Open-label (OL) Phase|Participant Defaulted|16
1859531|NCT00098293|6418831|P2|Open-label (OL) Phase|Participant Defaulted|6
1859532|NCT00098293|6418832|P1|Open-label (OL) Phase|Participant Defaulted|0
1859533|NCT00098293|6418828|P5|Open-label (OL) Phase|Protocol Violation|0
1859534|NCT00098293|6418829|P4|Open-label (OL) Phase|Protocol Violation|16
1859535|NCT00098293|6418830|P3|Open-label (OL) Phase|Protocol Violation|13
1859536|NCT00098293|6418831|P2|Open-label (OL) Phase|Protocol Violation|6
1859537|NCT00098293|6418832|P1|Open-label (OL) Phase|Protocol Violation|0
1859538|NCT00098293|6418828|P5|Open-label (OL) Phase|Pregnancy|0
1859539|NCT00098293|6418829|P4|Open-label (OL) Phase|Pregnancy|3
1859540|NCT00098293|6418830|P3|Open-label (OL) Phase|Pregnancy|0
1859541|NCT00098293|6418831|P2|Open-label (OL) Phase|Pregnancy|1
1859542|NCT00098293|6418832|P1|Open-label (OL) Phase|Pregnancy|0
1859543|NCT00098293|6418828|P5|Open-label (OL) Phase|Lack of Efficacy|0
1859544|NCT00098293|6418829|P4|Open-label (OL) Phase|Lack of Efficacy|20
1859545|NCT00098293|6418830|P3|Open-label (OL) Phase|Lack of Efficacy|2
1859546|NCT00098293|6418831|P2|Open-label (OL) Phase|Lack of Efficacy|7
1859547|NCT00098293|6418832|P1|Open-label (OL) Phase|Lack of Efficacy|0
1859548|NCT00098293|6418828|P5|Open-label (OL) Phase|Adverse Event|0
1859549|NCT00098293|6418829|P4|Open-label (OL) Phase|Adverse Event|6
1859550|NCT00098293|6418830|P3|Open-label (OL) Phase|Adverse Event|7
1859551|NCT00098293|6418831|P2|Open-label (OL) Phase|Adverse Event|3
1859552|NCT00098293|6418832|P1|Open-label (OL) Phase|Adverse Event|0
1859553|NCT00098293|6418828|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1859554|NCT00098293|6418829|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1859555|NCT00098293|6418830|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
1859556|NCT00098293|6418831|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1859557|NCT00098293|6418832|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
1859558|NCT00098293|6418828|P5|Double-blind (DB) Phase|Terminated by sponsor|0
1859559|NCT00098293|6418829|P4|Double-blind (DB) Phase|Terminated by sponsor|0
1859560|NCT00098293|6418830|P3|Double-blind (DB) Phase|Terminated by sponsor|0
1859561|NCT00098293|6418831|P2|Double-blind (DB) Phase|Terminated by sponsor|0
1859562|NCT00098293|6418832|P1|Double-blind (DB) Phase|Terminated by sponsor|135
1859563|NCT00098293|6418828|P5|Double-blind (DB) Phase|Protocol Violation|0
1859564|NCT00098293|6418829|P4|Double-blind (DB) Phase|Protocol Violation|0
1859565|NCT00098293|6418830|P3|Double-blind (DB) Phase|Protocol Violation|22
1859566|NCT00098293|6418831|P2|Double-blind (DB) Phase|Protocol Violation|18
1859567|NCT00098293|6418832|P1|Double-blind (DB) Phase|Protocol Violation|2
1859568|NCT00098293|6418828|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
1859569|NCT00098293|6418829|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
1859570|NCT00098293|6418830|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
1859571|NCT00098293|6418831|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
1859572|NCT00098293|6418832|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
1859573|NCT00098293|6418828|P5|Double-blind (DB) Phase|Death|0
1859574|NCT00098293|6418829|P4|Double-blind (DB) Phase|Death|0
1859575|NCT00098293|6418830|P3|Double-blind (DB) Phase|Death|2
1859576|NCT00098293|6418831|P2|Double-blind (DB) Phase|Death|2
1859577|NCT00098293|6418832|P1|Double-blind (DB) Phase|Death|1
1859578|NCT00098293|6418828|P5|Double-blind (DB) Phase|Lack of Efficacy|0
1859579|NCT00098293|6418829|P4|Double-blind (DB) Phase|Lack of Efficacy|0
1859580|NCT00098293|6418830|P3|Double-blind (DB) Phase|Lack of Efficacy|30
1859581|NCT00098293|6418831|P2|Double-blind (DB) Phase|Lack of Efficacy|64
1859582|NCT00098293|6418832|P1|Double-blind (DB) Phase|Lack of Efficacy|11
1859583|NCT00098293|6418828|P5|Double-blind (DB) Phase|Participant Defaulted|0
1859584|NCT00098293|6418829|P4|Double-blind (DB) Phase|Participant Defaulted|0
1859585|NCT00098293|6418830|P3|Double-blind (DB) Phase|Participant Defaulted|36
1859586|NCT00098293|6418831|P2|Double-blind (DB) Phase|Participant Defaulted|40
1859587|NCT00098293|6418832|P1|Double-blind (DB) Phase|Participant Defaulted|11
1859588|NCT00098293|6418828|P5|Double-blind (DB) Phase|Pregnancy|0
1859589|NCT00098293|6418829|P4|Double-blind (DB) Phase|Pregnancy|0
1859590|NCT00098293|6418830|P3|Double-blind (DB) Phase|Pregnancy|9
1859591|NCT00098293|6418831|P2|Double-blind (DB) Phase|Pregnancy|7
1859592|NCT00098293|6418832|P1|Double-blind (DB) Phase|Pregnancy|0
1859593|NCT00098293|6418828|P5|Double-blind (DB) Phase|Adverse Event|0
1859594|NCT00098293|6418829|P4|Double-blind (DB) Phase|Adverse Event|0
1859595|NCT00098293|6418830|P3|Double-blind (DB) Phase|Adverse Event|60
1859596|NCT00098293|6418831|P2|Double-blind (DB) Phase|Adverse Event|27
1859597|NCT00098293|6418832|P1|Double-blind (DB) Phase|Adverse Event|14
1859598|NCT00098254|6418885|P1|Overall Study|Death|1
1859599|NCT00098254|6418885|P1|Overall Study|Adverse Event|2
1859600|NCT00098020|6418951|P1|Overall Study|Low epidermal growth factor receptor|1
1859601|NCT00098020|6418951|P1|Overall Study|Low urine PCR|1
1859602|NCT00098020|6418951|P1|Overall Study|elevated liver enzymes|1
1859603|NCT00098020|6418951|P1|Overall Study|Lost to Follow-up|1
1859604|NCT00098020|6418951|P1|Overall Study|Adverse Event|2
1859605|NCT00097981|6418958|P2|Overall Study|Other|13
1859606|NCT00097981|6418959|P1|Overall Study|Other|19
1859607|NCT00097981|6418958|P2|Overall Study|Transplant planned|27
1859608|NCT00097981|6418959|P1|Overall Study|Transplant planned|28
1859609|NCT00097981|6418958|P2|Overall Study|Disease Progression|2
1859610|NCT00097981|6418959|P1|Overall Study|Disease Progression|8
1859611|NCT00097981|6418958|P2|Overall Study|Physician Decision|1
1859612|NCT00097981|6418959|P1|Overall Study|Physician Decision|7
1859613|NCT00097981|6418958|P2|Overall Study|Death|4
1859614|NCT00097981|6418959|P1|Overall Study|Death|2
1859615|NCT00097981|6418958|P2|Overall Study|Protocol Violation|1
1859616|NCT00097981|6418959|P1|Overall Study|Protocol Violation|1
1859617|NCT00097981|6418958|P2|Overall Study|Withdrawal by Subject|8
1859618|NCT00097981|6418959|P1|Overall Study|Withdrawal by Subject|10
1859619|NCT00097981|6418958|P2|Overall Study|Adverse Event|44
1859620|NCT00097981|6418959|P1|Overall Study|Adverse Event|31
1859621|NCT00097786|6418981|P4|Overall Study|lost to follow-up for all-cause death|310
1859622|NCT00097786|6418982|P3|Overall Study|lost to follow-up for all-cause death|313
1859623|NCT00097786|6418983|P2|Overall Study|lost to follow-up for all-cause death|292
1859624|NCT00097786|6418984|P1|Overall Study|lost to follow-up for all-cause death|296
1859625|NCT00097773|6419006|P4|Overall Study|Other|0
1859626|NCT00097773|6419007|P3|Overall Study|Other|2
1859627|NCT00097773|6419008|P2|Overall Study|Other|0
1859628|NCT00097773|6419009|P1|Overall Study|Other|1
1859629|NCT00097773|6419006|P4|Overall Study|Adverse Event|0
1859630|NCT00097773|6419007|P3|Overall Study|Adverse Event|0
1859631|NCT00097773|6419008|P2|Overall Study|Adverse Event|1
1859632|NCT00097773|6419009|P1|Overall Study|Adverse Event|0
1859633|NCT00097773|6419006|P4|Overall Study|Withdrawal by Subject|1
1859634|NCT00097773|6419007|P3|Overall Study|Withdrawal by Subject|3
1859635|NCT00097773|6419008|P2|Overall Study|Withdrawal by Subject|3
1859636|NCT00097773|6419009|P1|Overall Study|Withdrawal by Subject|3
1859637|NCT00097773|6419006|P4|Overall Study|Physician Decision|1
1859638|NCT00097773|6419007|P3|Overall Study|Physician Decision|3
1859639|NCT00097773|6419008|P2|Overall Study|Physician Decision|2
1859640|NCT00097773|6419009|P1|Overall Study|Physician Decision|2
1859641|NCT00097773|6419006|P4|Overall Study|Lost to Follow-up|1
1859642|NCT00097773|6419007|P3|Overall Study|Lost to Follow-up|0
1859643|NCT00097773|6419008|P2|Overall Study|Lost to Follow-up|2
1859644|NCT00097773|6419009|P1|Overall Study|Lost to Follow-up|2
1859645|NCT00097721|6419029|P2|Overall Study|Reason not given|1
1859646|NCT00097721|6419030|P1|Overall Study|Reason not given|1
1859647|NCT00097721|6419029|P2|Overall Study|Physician Decision|3
1859648|NCT00097721|6419030|P1|Overall Study|Physician Decision|1
1859649|NCT00097721|6419029|P2|Overall Study|Progressive Disease|27
1859650|NCT00097721|6419030|P1|Overall Study|Progressive Disease|55
1859651|NCT00097721|6419029|P2|Overall Study|Withdrawal by Subject|1
1859652|NCT00097721|6419030|P1|Overall Study|Withdrawal by Subject|6
1859653|NCT00097721|6419029|P2|Overall Study|Adverse Event|1
1859654|NCT00097721|6419030|P1|Overall Study|Adverse Event|8
1859655|NCT00097591|6419080|P2|Overall Study|Other|3
1859656|NCT00097591|6419081|P1|Overall Study|Other|0
1859657|NCT00097591|6419080|P2|Overall Study|Lost to follow up|10
1859658|NCT00097591|6419081|P1|Overall Study|Lost to follow up|6
1859659|NCT00097591|6419080|P2|Overall Study|Unable to attend termination visit|51
1859660|NCT00097591|6419081|P1|Overall Study|Unable to attend termination visit|53
1859661|NCT00097591|6419080|P2|Overall Study|Less than 6 months on study drug|7
1859662|NCT00097591|6419081|P1|Overall Study|Less than 6 months on study drug|9
1859663|NCT00097591|6419080|P2|Overall Study|Withdrawal of consent|323
1859664|NCT00097591|6419081|P1|Overall Study|Withdrawal of consent|342
1859665|NCT00097539|6419104|P7|Overall Study|Reason not Specified|2
1859666|NCT00097539|6419105|P6|Overall Study|Reason not Specified|40
1859667|NCT00097539|6419106|P5|Overall Study|Reason not Specified|11
1859668|NCT00097539|6419107|P4|Overall Study|Reason not Specified|21
1859669|NCT00097539|6419108|P3|Overall Study|Reason not Specified|53
1859670|NCT00097539|6419109|P2|Overall Study|Reason not Specified|49
1859671|NCT00097539|6419110|P1|Overall Study|Reason not Specified|111
1859672|NCT00097539|6419104|P7|Overall Study|Reasons Other Than Above|34
1859673|NCT00097539|6419105|P6|Overall Study|Reasons Other Than Above|1244
1859674|NCT00097539|6419106|P5|Overall Study|Reasons Other Than Above|361
1859675|NCT00097539|6419107|P4|Overall Study|Reasons Other Than Above|692
1859676|NCT00097539|6419108|P3|Overall Study|Reasons Other Than Above|1757
1859677|NCT00097539|6419109|P2|Overall Study|Reasons Other Than Above|1382
1859678|NCT00097539|6419110|P1|Overall Study|Reasons Other Than Above|3602
1859679|NCT00097539|6419104|P7|Overall Study|Death|0
1859680|NCT00097539|6419105|P6|Overall Study|Death|3
1859681|NCT00097539|6419106|P5|Overall Study|Death|1
1859682|NCT00097539|6419107|P4|Overall Study|Death|0
1859683|NCT00097539|6419108|P3|Overall Study|Death|0
1859684|NCT00097539|6419109|P2|Overall Study|Death|7
1859685|NCT00097539|6419110|P1|Overall Study|Death|2
1859686|NCT00097539|6419104|P7|Overall Study|Adverse Event|1
1859687|NCT00097539|6419105|P6|Overall Study|Adverse Event|59
1859688|NCT00097539|6419106|P5|Overall Study|Adverse Event|30
1859689|NCT00097539|6419107|P4|Overall Study|Adverse Event|27
1859690|NCT00097539|6419108|P3|Overall Study|Adverse Event|37
1859691|NCT00097539|6419109|P2|Overall Study|Adverse Event|133
1859692|NCT00097539|6419110|P1|Overall Study|Adverse Event|78
1859693|NCT00097539|6419104|P7|Overall Study|Lack of Efficacy|5
1859694|NCT00097539|6419105|P6|Overall Study|Lack of Efficacy|228
1859695|NCT00097539|6419106|P5|Overall Study|Lack of Efficacy|45
1859696|NCT00097539|6419107|P4|Overall Study|Lack of Efficacy|105
1859697|NCT00097539|6419108|P3|Overall Study|Lack of Efficacy|202
1859698|NCT00097539|6419109|P2|Overall Study|Lack of Efficacy|122
1859699|NCT00097539|6419110|P1|Overall Study|Lack of Efficacy|249
1859700|NCT00097539|6419104|P7|Overall Study|Participant Non-compliant|18
1859701|NCT00097539|6419105|P6|Overall Study|Participant Non-compliant|543
1859702|NCT00097539|6419106|P5|Overall Study|Participant Non-compliant|136
1859703|NCT00097539|6419107|P4|Overall Study|Participant Non-compliant|353
1859704|NCT00097539|6419108|P3|Overall Study|Participant Non-compliant|1067
1859705|NCT00097539|6419109|P2|Overall Study|Participant Non-compliant|567
1859706|NCT00097539|6419110|P1|Overall Study|Participant Non-compliant|2140
1859707|NCT00097539|6419104|P7|Overall Study|Withdrawal by Subject|3
1859708|NCT00097539|6419105|P6|Overall Study|Withdrawal by Subject|229
1859709|NCT00097539|6419106|P5|Overall Study|Withdrawal by Subject|68
1859710|NCT00097539|6419107|P4|Overall Study|Withdrawal by Subject|217
1859711|NCT00097539|6419108|P3|Overall Study|Withdrawal by Subject|346
1859712|NCT00097539|6419109|P2|Overall Study|Withdrawal by Subject|323
1859713|NCT00097539|6419110|P1|Overall Study|Withdrawal by Subject|925
1859714|NCT00097539|6419104|P7|Overall Study|Status Unknown (Or no final evaluation)|108
1859715|NCT00097539|6419105|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
1859716|NCT00097539|6419106|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
1859717|NCT00097539|6419107|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
1859718|NCT00097539|6419108|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
1859719|NCT00097539|6419109|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
1859720|NCT00097539|6419110|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
1859721|NCT00097500|6419156|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
1859722|NCT00097500|6419157|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
1859723|NCT00097500|6419156|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
1859724|NCT00097500|6419157|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
1859725|NCT00097500|6419156|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
1859726|NCT00097500|6419157|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
1859727|NCT00097500|6419156|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
1859728|NCT00097500|6419157|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
1859729|NCT00097500|6419156|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
1859730|NCT00097500|6419157|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
1859731|NCT00097500|6419156|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
1859732|NCT00097500|6419157|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
1859733|NCT00097500|6419156|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1859734|NCT00097500|6419157|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
1859735|NCT00097370|6419188|P1|Stage 3|Lost to Follow-up|1
1859736|NCT00097370|6419188|P1|Stage 3|Sponsor Terminated Study|52
1859737|NCT00097370|6419188|P1|Stage 3|Lack of Efficacy|1
1859738|NCT00097370|6419188|P1|Stage 3|Withdrawal by Subject|3
1859739|NCT00097370|6419188|P1|Stage 3|Adverse Event|2
1859740|NCT00097370|6419188|P1|Stage 2|Lost to Follow-up|1
1859741|NCT00097370|6419188|P1|Stage 2|Sponsor Terminated Study|2
1859742|NCT00097370|6419188|P1|Stage 2|Pregnancy|1
1859743|NCT00097370|6419188|P1|Stage 2|Lack of Efficacy|3
1859744|NCT00097370|6419188|P1|Stage 2|Withdrawal by Subject|1
1859745|NCT00097370|6419188|P1|Stage 2|Adverse Event|5
1859746|NCT00097370|6419188|P1|Stage 1|Lack of Efficacy|2
1859747|NCT00097370|6419188|P1|Stage 1|Withdrawal by Subject|1
1859748|NCT00097370|6419188|P1|Stage 1|Adverse Event|3
1859749|NCT00096993|6419222|P2|Overall Study|Other unspecified|1
1859750|NCT00096993|6419223|P1|Overall Study|Other unspecified|1
1859751|NCT00096993|6419222|P2|Overall Study|Non-compliance|1
1859752|NCT00096993|6419223|P1|Overall Study|Non-compliance|0
1859753|NCT00096993|6419222|P2|Overall Study|Physician Decision|1
1859754|NCT00096993|6419223|P1|Overall Study|Physician Decision|2
1859755|NCT00096993|6419222|P2|Overall Study|Subject's decision|1
1859756|NCT00096993|6419223|P1|Overall Study|Subject's decision|3
1859757|NCT00096993|6419222|P2|Overall Study|Adverse Event|8
1859758|NCT00096993|6419223|P1|Overall Study|Adverse Event|2
1859759|NCT00096993|6419222|P2|Overall Study|Disease progression|53
1859760|NCT00096993|6419223|P1|Overall Study|Disease progression|56
1859761|NCT00096993|6419222|P2|Overall Study|Death|0
1859762|NCT00096993|6419223|P1|Overall Study|Death|1
1859763|NCT00096954|6419239|P2|Overall Study|Lost to Follow-up|5
1859764|NCT00096954|6419240|P1|Overall Study|Lost to Follow-up|8
1859765|NCT00096954|6419239|P2|Overall Study|Non-compliance|3
1859766|NCT00096954|6419240|P1|Overall Study|Non-compliance|0
1859767|NCT00096954|6419239|P2|Overall Study|Initiation of immunotherapy|0
1859768|NCT00096954|6419240|P1|Overall Study|Initiation of immunotherapy|1
1859769|NCT00096954|6419239|P2|Overall Study|Pregnancy|1
1859770|NCT00096954|6419240|P1|Overall Study|Pregnancy|1
1859771|NCT00096954|6419239|P2|Overall Study|Sponsors Decision|1
1859772|NCT00096954|6419240|P1|Overall Study|Sponsors Decision|1
1859773|NCT00096954|6419239|P2|Overall Study|Physician Decision|1
1859774|NCT00096954|6419240|P1|Overall Study|Physician Decision|1
1859775|NCT00096954|6419239|P2|Overall Study|Withdrawal by Subject|8
1859776|NCT00096954|6419240|P1|Overall Study|Withdrawal by Subject|9
1859777|NCT00096954|6419239|P2|Overall Study|Adverse Event|1
1859778|NCT00096954|6419240|P1|Overall Study|Adverse Event|3
1859779|NCT00096941|6419252|P1|Overall Study|disease progression|3
1859780|NCT00096785|6419259|P2|Overall Study|Relocated|0
1859781|NCT00096785|6419260|P1|Overall Study|Relocated|1
1859782|NCT00096785|6419259|P2|Overall Study|Withdrawal by Subject|1
1859783|NCT00096785|6419260|P1|Overall Study|Withdrawal by Subject|0
1859784|NCT00096785|6419259|P2|Overall Study|Lost to Follow-up|0
1859785|NCT00096785|6419260|P1|Overall Study|Lost to Follow-up|1
1859786|NCT00096538|6419289|P1|Overall Study|Withdrawal by Subject|1
1859787|NCT00096486|6419297|P4|Overall Study|Not Treated|1
1859788|NCT00096486|6419298|P3|Overall Study|Not Treated|1
1859789|NCT00096486|6419299|P2|Overall Study|Not Treated|0
1859790|NCT00096486|6419300|P1|Overall Study|Not Treated|0
1859791|NCT00096486|6419297|P4|Overall Study|Withdrawal by Subject|1
1859792|NCT00096486|6419298|P3|Overall Study|Withdrawal by Subject|1
1859793|NCT00096486|6419299|P2|Overall Study|Withdrawal by Subject|0
1859794|NCT00096486|6419300|P1|Overall Study|Withdrawal by Subject|0
1859795|NCT00096447|6419319|P1|Overall Study|Never treated|1
1859796|NCT00096382|6419335|P2|Overall Study|Death during treatment|0
1859797|NCT00096382|6419336|P1|Overall Study|Death during treatment|1
1859798|NCT00096382|6419335|P2|Overall Study|Not treated|0
1859799|NCT00096382|6419336|P1|Overall Study|Not treated|1
1859800|NCT00096356|6419346|P2|Overall Study|multiple reasons|18
1859801|NCT00096356|6419347|P1|Overall Study|multiple reasons|10
1859802|NCT00096356|6419346|P2|Overall Study|Lack of Efficacy|0
1859803|NCT00096356|6419347|P1|Overall Study|Lack of Efficacy|1
1859804|NCT00096356|6419346|P2|Overall Study|Withdrawal by Subject|23
1859805|NCT00096356|6419347|P1|Overall Study|Withdrawal by Subject|17
1859806|NCT00096356|6419346|P2|Overall Study|Physician Decision|3
1859807|NCT00096356|6419347|P1|Overall Study|Physician Decision|5
1859808|NCT00096356|6419346|P2|Overall Study|Adverse Event|9
1859809|NCT00096356|6419347|P1|Overall Study|Adverse Event|11
1859810|NCT00096278|6419359|P2|Overall Study|Patient not at risk for primary endpoint|2
1859811|NCT00096278|6419360|P1|Overall Study|Patient not at risk for primary endpoint|3
1859812|NCT00096278|6419359|P2|Overall Study|No follow-up data|18
1859813|NCT00096278|6419360|P1|Overall Study|No follow-up data|15
1859814|NCT00096265|6419379|P3|Overall Study|Ineligible|0
1859815|NCT00096265|6419380|P2|Overall Study|Ineligible|0
1859816|NCT00096265|6419381|P1|Overall Study|Ineligible|1
1859817|NCT00096226|6419407|P1|Overall Study|Protocol treatment not started|1
1859818|NCT00096226|6419407|P1|Overall Study|Ineligible|2
1859819|NCT00096200|6419421|P3|Overall Study|Ineligible pathology|0
1859820|NCT00096200|6419422|P2|Overall Study|Ineligible pathology|1
1859821|NCT00096200|6419423|P1|Overall Study|Ineligible pathology|0
1859822|NCT00096200|6419421|P3|Overall Study|Withdrawal by Subject|0
1859823|NCT00096200|6419422|P2|Overall Study|Withdrawal by Subject|2
1859824|NCT00096200|6419423|P1|Overall Study|Withdrawal by Subject|1
1859825|NCT00096200|6419421|P3|Overall Study|Adverse Event|0
1859826|NCT00096200|6419422|P2|Overall Study|Adverse Event|4
1859827|NCT00096200|6419423|P1|Overall Study|Adverse Event|0
1859828|NCT00096174|6419437|P1|Overall Study|other reason|8
1859829|NCT00096174|6419437|P1|Overall Study|Ineligible|6
1859830|NCT00096174|6419437|P1|Overall Study|Not started protocol therapy|3
1859831|NCT00096174|6419437|P1|Overall Study|Withdrawal by Subject|15
1859832|NCT00096174|6419437|P1|Overall Study|Death|6
1859833|NCT00096174|6419437|P1|Overall Study|Adverse Event|15
1859834|NCT00096174|6419437|P1|Overall Study|Lack of Efficacy|9
1859835|NCT00096135|6419482|P2|Overall Study|Ineligible|0
1859836|NCT00096135|6419483|P1|Overall Study|Ineligible|2
1859837|NCT00096135|6419482|P2|Overall Study|Other, specify|3
1859838|NCT00096135|6419483|P1|Overall Study|Other, specify|15
1859839|NCT00096135|6419482|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
1859840|NCT00096135|6419483|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
1859841|NCT00096135|6419482|P2|Overall Study|Refusal of further protocol therapy|1
1859842|NCT00096135|6419483|P1|Overall Study|Refusal of further protocol therapy|4
1859843|NCT00096135|6419482|P2|Overall Study|Physician Decision|4
1859844|NCT00096135|6419483|P1|Overall Study|Physician Decision|20
1859845|NCT00096044|6419499|P1|Overall Study|Disease Progression|4
1859846|NCT00096044|6419499|P1|Overall Study|Adverse Event|21
1859847|NCT00096044|6419499|P1|Overall Study|Withdrawal by Subject|9
1859848|NCT00096031|6419508|P1|Overall Study|Not protocol specified|5
1859849|NCT00096031|6419508|P1|Overall Study|Ineligible|8
1859850|NCT00096031|6419508|P1|Overall Study|Withdrawal by Subject|1
1859851|NCT00096031|6419508|P1|Overall Study|Death|4
1859852|NCT00096031|6419508|P1|Overall Study|Lack of Efficacy|42
1859853|NCT00096031|6419508|P1|Overall Study|Adverse Event|3
1859854|NCT00096018|6419516|P2|Overall Study|Miscellaneous|1
1859855|NCT00096018|6419517|P1|Overall Study|Miscellaneous|2
1859856|NCT00096018|6419516|P2|Overall Study|Withdrawal by Subject|2
1859857|NCT00096018|6419517|P1|Overall Study|Withdrawal by Subject|0
1859858|NCT00096018|6419516|P2|Overall Study|Death|1
1859859|NCT00096018|6419517|P1|Overall Study|Death|0
1859860|NCT00096018|6419516|P2|Overall Study|Adverse Event|5
1859861|NCT00096018|6419517|P1|Overall Study|Adverse Event|0
1859862|NCT00096018|6419516|P2|Overall Study|Miscellaneous (not treated)|2
1859863|NCT00096018|6419517|P1|Overall Study|Miscellaneous (not treated)|0
1859864|NCT00096018|6419516|P2|Overall Study|Became Ineligible (not treated)|3
1859865|NCT00096018|6419517|P1|Overall Study|Became Ineligible (not treated)|0
1859866|NCT00095979|6419525|P1|Overall Study|Ineligible: Second primary cancer site|2
1859867|NCT00095940|6419543|P9|Lapatinib Continuation/Phase II|Adverse Event|0
1859868|NCT00095940|6419544|P8|Lapatinib Continuation/Phase II|Adverse Event|1
1859869|NCT00095940|6419545|P7|Lapatinib Continuation/Phase II|Adverse Event|0
1859870|NCT00095940|6419546|P6|Lapatinib Continuation/Phase II|Adverse Event|0
1859871|NCT00095940|6419547|P5|Lapatinib Continuation/Phase II|Adverse Event|0
1859872|NCT00095940|6419548|P4|Lapatinib Continuation/Phase II|Adverse Event|0
1859873|NCT00095940|6419549|P3|Lapatinib Continuation/Phase II|Adverse Event|0
1859874|NCT00095940|6419550|P2|Lapatinib Continuation/Phase II|Adverse Event|0
1859875|NCT00095940|6419551|P1|Lapatinib Continuation/Phase II|Adverse Event|0
1859876|NCT00095940|6419543|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1859877|NCT00095940|6419544|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1859878|NCT00095940|6419545|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1859879|NCT00095940|6419546|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1859880|NCT00095940|6419547|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1859881|NCT00095940|6419548|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
1859882|NCT00095940|6419549|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1859883|NCT00095940|6419550|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1859884|NCT00095940|6419551|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
1859885|NCT00095940|6419543|P9|Lapatinib Continuation/Phase II|Disease Progression|12
1859886|NCT00095940|6419544|P8|Lapatinib Continuation/Phase II|Disease Progression|1
1859887|NCT00095940|6419545|P7|Lapatinib Continuation/Phase II|Disease Progression|2
1859888|NCT00095940|6419546|P6|Lapatinib Continuation/Phase II|Disease Progression|13
1859889|NCT00095940|6419547|P5|Lapatinib Continuation/Phase II|Disease Progression|0
1859890|NCT00095940|6419548|P4|Lapatinib Continuation/Phase II|Disease Progression|0
1859891|NCT00095940|6419549|P3|Lapatinib Continuation/Phase II|Disease Progression|15
1859892|NCT00095940|6419550|P2|Lapatinib Continuation/Phase II|Disease Progression|1
1859893|NCT00095940|6419551|P1|Lapatinib Continuation/Phase II|Disease Progression|1
1859894|NCT00095836|6419584|P1|Overall Study|Death|2
1859895|NCT00095836|6419584|P1|Overall Study|Adverse Event|1
1859896|NCT00095836|6419584|P1|Overall Study|Lost to Follow-up|1
1859897|NCT00095628|6419614|P1|Overall Study|Disease progression prior to treatment|1
1859898|NCT00095576|6419625|P2|Overall Study|Subject moved|36
1859899|NCT00095576|6419626|P1|Overall Study|Subject moved|30
1859900|NCT00095576|6419625|P2|Overall Study|Site terminated|67
1859901|NCT00095576|6419626|P1|Overall Study|Site terminated|75
1859902|NCT00095576|6419625|P2|Overall Study|Option to switch to a rollover study|1099
1859903|NCT00095576|6419626|P1|Overall Study|Option to switch to a rollover study|1097
1859904|NCT00095576|6419625|P2|Overall Study|Withdrawal by Subject|47
1859905|NCT00095576|6419626|P1|Overall Study|Withdrawal by Subject|34
1859906|NCT00095576|6419625|P2|Overall Study|Protocol Violation|0
1859907|NCT00095576|6419626|P1|Overall Study|Protocol Violation|1
1859908|NCT00095576|6419625|P2|Overall Study|Lost to Follow-up|229
1859909|NCT00095576|6419626|P1|Overall Study|Lost to Follow-up|233
1859910|NCT00095576|6419625|P2|Overall Study|Adverse Event|3
1859911|NCT00095576|6419626|P1|Overall Study|Adverse Event|5
1859912|NCT00095498|6419650|P3|Overall Study|Requirement for alternative therapy|2
1859913|NCT00095498|6419651|P2|Overall Study|Requirement for alternative therapy|0
1859914|NCT00095498|6419652|P1|Overall Study|Requirement for alternative therapy|1
1859915|NCT00095498|6419650|P3|Overall Study|Protocol Violation|1
1859916|NCT00095498|6419651|P2|Overall Study|Protocol Violation|0
1859917|NCT00095498|6419652|P1|Overall Study|Protocol Violation|0
1859918|NCT00095498|6419650|P3|Overall Study|Other|6
1859919|NCT00095498|6419651|P2|Overall Study|Other|7
1859920|NCT00095498|6419652|P1|Overall Study|Other|6
1859921|NCT00095498|6419650|P3|Overall Study|Noncompliance|1
1859922|NCT00095498|6419651|P2|Overall Study|Noncompliance|0
1859923|NCT00095498|6419652|P1|Overall Study|Noncompliance|1
1859924|NCT00095498|6419650|P3|Overall Study|Lost to Follow-up|2
1859925|NCT00095498|6419651|P2|Overall Study|Lost to Follow-up|1
1859926|NCT00095498|6419652|P1|Overall Study|Lost to Follow-up|1
1859927|NCT00095498|6419650|P3|Overall Study|Ineligibility determined|2
1859928|NCT00095498|6419651|P2|Overall Study|Ineligibility determined|0
1859929|NCT00095498|6419652|P1|Overall Study|Ineligibility determined|3
1859930|NCT00095498|6419650|P3|Overall Study|Disease progression|1
1859931|NCT00095498|6419651|P2|Overall Study|Disease progression|1
1859932|NCT00095498|6419652|P1|Overall Study|Disease progression|0
1859933|NCT00095498|6419650|P3|Overall Study|Withdrawal by Subject|15
1859934|NCT00095498|6419651|P2|Overall Study|Withdrawal by Subject|16
1859935|NCT00095498|6419652|P1|Overall Study|Withdrawal by Subject|15
1859936|NCT00095498|6419650|P3|Overall Study|Adverse Event|1
1859937|NCT00095498|6419651|P2|Overall Study|Adverse Event|0
1859938|NCT00095498|6419652|P1|Overall Study|Adverse Event|1
1859939|NCT00095498|6419650|P3|Overall Study|Physician Decision|8
1859940|NCT00095498|6419651|P2|Overall Study|Physician Decision|10
1859941|NCT00095498|6419652|P1|Overall Study|Physician Decision|9
1859942|NCT00095303|6420079|P2|Follow Up Study|Lost to Follow-up|58
1859943|NCT00095303|6420080|P1|Follow Up Study|Lost to Follow-up|59
1859944|NCT00095303|6420079|P2|Main Study|Lost to Follow-up|87
1859945|NCT00095303|6420080|P1|Main Study|Lost to Follow-up|91
1859946|NCT00095238|6420148|P2|Overall Study|Other Reasons|88
1859947|NCT00095238|6420149|P1|Overall Study|Other Reasons|87
1859948|NCT00095238|6420148|P2|Overall Study|Missing|0
1859949|NCT00095238|6420149|P1|Overall Study|Missing|1
1859950|NCT00095238|6420148|P2|Overall Study|Study terminated by sponsor|1
1859951|NCT00095238|6420149|P1|Overall Study|Study terminated by sponsor|0
1859952|NCT00095238|6420148|P2|Overall Study|No longer met study criteria|5
1859953|NCT00095238|6420149|P1|Overall Study|No longer met study criteria|4
1859954|NCT00095238|6420148|P2|Overall Study|Noncompliance|45
1859955|NCT00095238|6420149|P1|Overall Study|Noncompliance|44
1859956|NCT00095238|6420148|P2|Overall Study|Lost to Follow-up|24
1859957|NCT00095238|6420149|P1|Overall Study|Lost to Follow-up|19
1859958|NCT00095238|6420148|P2|Overall Study|Death|170
1859959|NCT00095238|6420149|P1|Overall Study|Death|154
1859960|NCT00095238|6420148|P2|Overall Study|Subject Withdrew Consent|223
1859961|NCT00095238|6420149|P1|Overall Study|Subject Withdrew Consent|208
1859962|NCT00095238|6420148|P2|Overall Study|Adverse Event|287
1859963|NCT00095238|6420149|P1|Overall Study|Adverse Event|331
1859964|NCT00095238|6420148|P2|Overall Study|Lack of Efficacy|9
1859965|NCT00095238|6420149|P1|Overall Study|Lack of Efficacy|9
1859966|NCT00095212|6420211|P2|Overall Study|Withdrawal by Subject|3
1859967|NCT00095212|6420212|P1|Overall Study|Withdrawal by Subject|1
1859968|NCT00095199|6420242|P4|Overall Study|Data inadvertently lost by site|0
1859969|NCT00095199|6420243|P3|Overall Study|Data inadvertently lost by site|0
1859970|NCT00095199|6420244|P2|Overall Study|Data inadvertently lost by site|0
1859971|NCT00095199|6420245|P1|Overall Study|Data inadvertently lost by site|1
1859972|NCT00095199|6420242|P4|Overall Study|Primary tumor removed in other surgery|0
1859973|NCT00095199|6420243|P3|Overall Study|Primary tumor removed in other surgery|0
1859974|NCT00095199|6420244|P2|Overall Study|Primary tumor removed in other surgery|1
1859975|NCT00095199|6420245|P1|Overall Study|Primary tumor removed in other surgery|0
1859976|NCT00095199|6420242|P4|Overall Study|Started radiotherapy regimen|0
1859977|NCT00095199|6420243|P3|Overall Study|Started radiotherapy regimen|0
1859978|NCT00095199|6420244|P2|Overall Study|Started radiotherapy regimen|1
1859979|NCT00095199|6420245|P1|Overall Study|Started radiotherapy regimen|0
1859980|NCT00095199|6420242|P4|Overall Study|Started Palliative Radiotherapy|0
1859981|NCT00095199|6420243|P3|Overall Study|Started Palliative Radiotherapy|0
1859982|NCT00095199|6420244|P2|Overall Study|Started Palliative Radiotherapy|0
1859983|NCT00095199|6420245|P1|Overall Study|Started Palliative Radiotherapy|1
1859984|NCT00095199|6420242|P4|Overall Study|Not eligible|1
1859985|NCT00095199|6420243|P3|Overall Study|Not eligible|0
1859986|NCT00095199|6420244|P2|Overall Study|Not eligible|7
1859987|NCT00095199|6420245|P1|Overall Study|Not eligible|1
1859988|NCT00095199|6420242|P4|Overall Study|Physician Decision|1
1859989|NCT00095199|6420243|P3|Overall Study|Physician Decision|1
1859990|NCT00095199|6420244|P2|Overall Study|Physician Decision|6
1859991|NCT00095199|6420245|P1|Overall Study|Physician Decision|5
1859992|NCT00095199|6420242|P4|Overall Study|Surgery needed could not start in 7 days|0
1859993|NCT00095199|6420243|P3|Overall Study|Surgery needed could not start in 7 days|1
1859994|NCT00095199|6420244|P2|Overall Study|Surgery needed could not start in 7 days|0
1859995|NCT00095199|6420245|P1|Overall Study|Surgery needed could not start in 7 days|0
1859996|NCT00095199|6420242|P4|Overall Study|Liver function test results elevated|1
1859997|NCT00095199|6420243|P3|Overall Study|Liver function test results elevated|1
1859998|NCT00095199|6420244|P2|Overall Study|Liver function test results elevated|0
1859999|NCT00095199|6420245|P1|Overall Study|Liver function test results elevated|0
1860000|NCT00095199|6420242|P4|Overall Study|Protocol Violation|0
1860001|NCT00095199|6420243|P3|Overall Study|Protocol Violation|2
1860002|NCT00095199|6420244|P2|Overall Study|Protocol Violation|4
1860003|NCT00095199|6420245|P1|Overall Study|Protocol Violation|4
1860004|NCT00095199|6420242|P4|Overall Study|Withdrawal by Subject|22
1860005|NCT00095199|6420243|P3|Overall Study|Withdrawal by Subject|13
1860006|NCT00095199|6420244|P2|Overall Study|Withdrawal by Subject|16
1860007|NCT00095199|6420245|P1|Overall Study|Withdrawal by Subject|21
1860008|NCT00095199|6420242|P4|Overall Study|Death|9
1860009|NCT00095199|6420243|P3|Overall Study|Death|11
1860010|NCT00095199|6420244|P2|Overall Study|Death|6
1860011|NCT00095199|6420245|P1|Overall Study|Death|10
1860012|NCT00095199|6420242|P4|Overall Study|Progressive disease|98
1860013|NCT00095199|6420243|P3|Overall Study|Progressive disease|105
1860014|NCT00095199|6420244|P2|Overall Study|Progressive disease|179
1860015|NCT00095199|6420245|P1|Overall Study|Progressive disease|213
1860016|NCT00095199|6420242|P4|Overall Study|Adverse Event|11
1860017|NCT00095199|6420243|P3|Overall Study|Adverse Event|26
1860018|NCT00095199|6420244|P2|Overall Study|Adverse Event|22
1860019|NCT00095199|6420245|P1|Overall Study|Adverse Event|40
1860020|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Other|8
1860021|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Other|6
1860022|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Other|4
1860023|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Other|0
1860024|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Other|0
1860025|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Other|0
1860026|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
1860027|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
1860028|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
1860029|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
1860030|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
1860031|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
1860032|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1860033|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
1860034|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1860035|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1860036|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1860037|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
1860038|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1860039|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
1860040|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1860041|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1860042|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1860043|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
1860044|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1860045|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
1860046|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
1860047|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1860048|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1860049|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
1860050|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
1860051|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
1860052|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
1860053|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1860054|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1860055|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
1860056|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
1860057|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
1860058|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
1860059|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1860060|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1860061|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
1860062|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
1860063|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
1860064|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
1860065|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
1860066|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
1860067|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
1860068|NCT00095173|6420283|P6|Open-Label Extension Phase (Period C)|Death|1
1860069|NCT00095173|6420284|P5|Open-Label Extension Phase (Period C)|Death|0
1860070|NCT00095173|6420285|P4|Open-Label Extension Phase (Period C)|Death|0
1860071|NCT00095173|6420286|P3|Open-Label Extension Phase (Period C)|Death|0
1860072|NCT00095173|6420287|P2|Open-Label Extension Phase (Period C)|Death|0
1860073|NCT00095173|6420288|P1|Open-Label Extension Phase (Period C)|Death|0
1860074|NCT00095173|6420283|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1860075|NCT00095173|6420284|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1860076|NCT00095173|6420285|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1860077|NCT00095173|6420286|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1860078|NCT00095173|6420287|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
1860079|NCT00095173|6420288|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
1860080|NCT00095173|6420283|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
1860081|NCT00095173|6420284|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
1860082|NCT00095173|6420285|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
1860083|NCT00095173|6420286|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
1860084|NCT00095173|6420287|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
1860085|NCT00095173|6420288|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
1860086|NCT00095173|6420283|P6|Open-Label Lead-In Phase (Period A)|Other|0
1860087|NCT00095173|6420284|P5|Open-Label Lead-In Phase (Period A)|Other|0
1860088|NCT00095173|6420285|P4|Open-Label Lead-In Phase (Period A)|Other|0
1860089|NCT00095173|6420286|P3|Open-Label Lead-In Phase (Period A)|Other|0
1860090|NCT00095173|6420287|P2|Open-Label Lead-In Phase (Period A)|Other|0
1860091|NCT00095173|6420288|P1|Open-Label Lead-In Phase (Period A)|Other|1
1860092|NCT00095173|6420283|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1860093|NCT00095173|6420284|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1860094|NCT00095173|6420285|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1860095|NCT00095173|6420286|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1860096|NCT00095173|6420287|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
1860097|NCT00095173|6420288|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
1860098|NCT00095173|6420283|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1860099|NCT00095173|6420284|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1860100|NCT00095173|6420285|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1860101|NCT00095173|6420286|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1860102|NCT00095173|6420287|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
1860103|NCT00095173|6420288|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
1860104|NCT00095173|6420283|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1860105|NCT00095173|6420284|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1860106|NCT00095173|6420285|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1860107|NCT00095173|6420286|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1860108|NCT00095173|6420287|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
1860109|NCT00095173|6420288|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
1860110|NCT00095147|6420326|P5|Long-term Extension Period|Leaving country|1
1860111|NCT00095147|6420327|P4|Long-term Extension Period|Leaving country|0
1860112|NCT00095147|6420328|P3|Long-term Extension Period|Leaving country|0
1860113|NCT00095147|6420329|P2|Long-term Extension Period|Leaving country|0
1860114|NCT00095147|6420330|P1|Long-term Extension Period|Leaving country|0
1860115|NCT00095147|6420326|P5|Long-term Extension Period|Participant chose to use Revellex|1
1860116|NCT00095147|6420327|P4|Long-term Extension Period|Participant chose to use Revellex|0
1860117|NCT00095147|6420328|P3|Long-term Extension Period|Participant chose to use Revellex|0
1860118|NCT00095147|6420329|P2|Long-term Extension Period|Participant chose to use Revellex|0
1860119|NCT00095147|6420330|P1|Long-term Extension Period|Participant chose to use Revellex|0
1860120|NCT00095147|6420326|P5|Long-term Extension Period|No longer meets study criteria|1
1860121|NCT00095147|6420327|P4|Long-term Extension Period|No longer meets study criteria|0
1860122|NCT00095147|6420328|P3|Long-term Extension Period|No longer meets study criteria|0
1860123|NCT00095147|6420329|P2|Long-term Extension Period|No longer meets study criteria|0
1860124|NCT00095147|6420330|P1|Long-term Extension Period|No longer meets study criteria|0
1860125|NCT00095147|6420326|P5|Long-term Extension Period|Pregnancy|1
1860126|NCT00095147|6420327|P4|Long-term Extension Period|Pregnancy|0
1860127|NCT00095147|6420328|P3|Long-term Extension Period|Pregnancy|0
1860128|NCT00095147|6420329|P2|Long-term Extension Period|Pregnancy|0
1860129|NCT00095147|6420330|P1|Long-term Extension Period|Pregnancy|0
1860130|NCT00095147|6420326|P5|Long-term Extension Period|Withdrawal of consent|12
1860131|NCT00095147|6420327|P4|Long-term Extension Period|Withdrawal of consent|0
1860132|NCT00095147|6420328|P3|Long-term Extension Period|Withdrawal of consent|0
1860133|NCT00095147|6420329|P2|Long-term Extension Period|Withdrawal of consent|0
1860134|NCT00095147|6420330|P1|Long-term Extension Period|Withdrawal of consent|0
1860135|NCT00095147|6420326|P5|Long-term Extension Period|Lost to Follow-up|6
1860136|NCT00095147|6420327|P4|Long-term Extension Period|Lost to Follow-up|0
1860137|NCT00095147|6420328|P3|Long-term Extension Period|Lost to Follow-up|0
1860138|NCT00095147|6420329|P2|Long-term Extension Period|Lost to Follow-up|0
1860139|NCT00095147|6420330|P1|Long-term Extension Period|Lost to Follow-up|0
1860140|NCT00095147|6420326|P5|Long-term Extension Period|Lack of Efficacy|9
1860141|NCT00095147|6420327|P4|Long-term Extension Period|Lack of Efficacy|0
1860142|NCT00095147|6420328|P3|Long-term Extension Period|Lack of Efficacy|0
1860143|NCT00095147|6420329|P2|Long-term Extension Period|Lack of Efficacy|0
1860144|NCT00095147|6420330|P1|Long-term Extension Period|Lack of Efficacy|0
1860145|NCT00095147|6420326|P5|Long-term Extension Period|Adverse Event|11
1860146|NCT00095147|6420327|P4|Long-term Extension Period|Adverse Event|0
1860147|NCT00095147|6420328|P3|Long-term Extension Period|Adverse Event|0
1860148|NCT00095147|6420329|P2|Long-term Extension Period|Adverse Event|0
1860149|NCT00095147|6420330|P1|Long-term Extension Period|Adverse Event|0
1860150|NCT00095147|6420326|P5|Long-term Extension Period|Death|3
1860151|NCT00095147|6420327|P4|Long-term Extension Period|Death|0
1860152|NCT00095147|6420328|P3|Long-term Extension Period|Death|0
1860153|NCT00095147|6420329|P2|Long-term Extension Period|Death|0
1860154|NCT00095147|6420330|P1|Long-term Extension Period|Death|0
1860155|NCT00095147|6420326|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1860156|NCT00095147|6420327|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1860157|NCT00095147|6420328|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1860158|NCT00095147|6420329|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
1860159|NCT00095147|6420330|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
1860160|NCT00095147|6420326|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1860161|NCT00095147|6420327|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1860162|NCT00095147|6420328|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
1860163|NCT00095147|6420329|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
1860164|NCT00095147|6420330|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
1860165|NCT00095147|6420326|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1860166|NCT00095147|6420327|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
1860167|NCT00095147|6420328|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
1860168|NCT00095147|6420329|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
1860169|NCT00095147|6420330|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
1860170|NCT00095147|6420326|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1860171|NCT00095147|6420327|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1860172|NCT00095147|6420328|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
1860173|NCT00095147|6420329|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
1860174|NCT00095147|6420330|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
1860175|NCT00095147|6420326|P5|Double-blind Period 2 (Days 198-365)|Death|0
1860176|NCT00095147|6420327|P4|Double-blind Period 2 (Days 198-365)|Death|1
1860177|NCT00095147|6420328|P3|Double-blind Period 2 (Days 198-365)|Death|0
1860178|NCT00095147|6420329|P2|Double-blind Period 2 (Days 198-365)|Death|1
1860179|NCT00095147|6420330|P1|Double-blind Period 2 (Days 198-365)|Death|0
1860180|NCT00095147|6420326|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1860181|NCT00095147|6420327|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1860182|NCT00095147|6420328|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
1860183|NCT00095147|6420329|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1860184|NCT00095147|6420330|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
1860185|NCT00095147|6420326|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1860186|NCT00095147|6420327|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1860187|NCT00095147|6420328|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1860188|NCT00095147|6420329|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
1860189|NCT00095147|6420330|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
1860190|NCT00095147|6420326|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1860191|NCT00095147|6420327|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1860192|NCT00095147|6420328|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
1860193|NCT00095147|6420329|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1860194|NCT00095147|6420330|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
1860195|NCT00095147|6420326|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1860196|NCT00095147|6420327|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
1860197|NCT00095147|6420328|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
1860198|NCT00095147|6420329|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1860199|NCT00095147|6420330|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
1860200|NCT00095147|6420326|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1860201|NCT00095147|6420327|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
1860202|NCT00095147|6420328|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
1860203|NCT00095147|6420329|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
1860204|NCT00095147|6420330|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
1860205|NCT00095147|6420326|P5|Double-blind Period 1 (Days 1-197)|Death|0
1860206|NCT00095147|6420327|P4|Double-blind Period 1 (Days 1-197)|Death|0
1860207|NCT00095147|6420328|P3|Double-blind Period 1 (Days 1-197)|Death|0
1860208|NCT00095147|6420329|P2|Double-blind Period 1 (Days 1-197)|Death|0
1860209|NCT00095147|6420330|P1|Double-blind Period 1 (Days 1-197)|Death|1
1860210|NCT00095121|6420525|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
1860211|NCT00095121|6420526|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
1860212|NCT00095121|6420525|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
1860213|NCT00095121|6420526|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
1860214|NCT00095056|6420572|P2|Phase B (Weeks 12-54)|Protocol Violation|1
1860215|NCT00095056|6420573|P1|Phase B (Weeks 12-54)|Protocol Violation|0
1860216|NCT00095056|6420572|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
1860217|NCT00095056|6420573|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
1860218|NCT00095056|6420572|P2|Phase B (Weeks 12-54)|Death|1
1860219|NCT00095056|6420573|P1|Phase B (Weeks 12-54)|Death|3
1860220|NCT00095056|6420572|P2|Phase B (Weeks 12-54)|Patient Moved|0
1860221|NCT00095056|6420573|P1|Phase B (Weeks 12-54)|Patient Moved|1
1860222|NCT00095056|6420572|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
1860223|NCT00095056|6420573|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
1860224|NCT00095056|6420572|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
1860225|NCT00095056|6420573|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
1860226|NCT00095056|6420572|P2|Phase B (Weeks 12-54)|Adverse Event|2
1860227|NCT00095056|6420573|P1|Phase B (Weeks 12-54)|Adverse Event|2
1860228|NCT00095056|6420572|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
1860229|NCT00095056|6420573|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
1860230|NCT00095056|6420572|P2|Phase A (Weeks 0-12)|Death|0
1860231|NCT00095056|6420573|P1|Phase A (Weeks 0-12)|Death|1
1860232|NCT00095056|6420572|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
1860233|NCT00095056|6420573|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
1860234|NCT00095056|6420572|P2|Phase A (Weeks 0-12)|Adverse Event|1
1860235|NCT00095056|6420573|P1|Phase A (Weeks 0-12)|Adverse Event|1
1860236|NCT00094861|6420702|P2|Overall Study|Other|0
1860237|NCT00094861|6420703|P1|Overall Study|Other|3
1860238|NCT00094861|6420702|P2|Overall Study|Death|2
1860239|NCT00094861|6420703|P1|Overall Study|Death|4
1860240|NCT00094861|6420702|P2|Overall Study|Lost to Follow-up|1
1860241|NCT00094861|6420703|P1|Overall Study|Lost to Follow-up|0
1860242|NCT00094861|6420702|P2|Overall Study|Physician Decision|1
1860243|NCT00094861|6420703|P1|Overall Study|Physician Decision|1
1860244|NCT00094861|6420702|P2|Overall Study|Withdrawal by Subject|3
1860245|NCT00094861|6420703|P1|Overall Study|Withdrawal by Subject|5
1860246|NCT00094861|6420702|P2|Overall Study|Adverse Event|2
1860247|NCT00094861|6420703|P1|Overall Study|Adverse Event|5
1860248|NCT00094835|6420730|P7|Overall Study|Other|0
1860249|NCT00094835|6420731|P6|Overall Study|Other|0
1860250|NCT00094835|6420732|P5|Overall Study|Other|0
1860251|NCT00094835|6420733|P4|Overall Study|Other|1
1860252|NCT00094835|6420734|P3|Overall Study|Other|1
1860253|NCT00094835|6420735|P2|Overall Study|Other|1
1860254|NCT00094835|6420736|P1|Overall Study|Other|1
1860255|NCT00094835|6420730|P7|Overall Study|Non-compliance|1
1860256|NCT00094835|6420731|P6|Overall Study|Non-compliance|2
1860257|NCT00094835|6420732|P5|Overall Study|Non-compliance|2
1860258|NCT00094835|6420733|P4|Overall Study|Non-compliance|0
1860259|NCT00094835|6420734|P3|Overall Study|Non-compliance|2
1860260|NCT00094835|6420735|P2|Overall Study|Non-compliance|2
1860261|NCT00094835|6420736|P1|Overall Study|Non-compliance|1
1860262|NCT00094835|6420730|P7|Overall Study|Death|0
1860263|NCT00094835|6420731|P6|Overall Study|Death|0
1860264|NCT00094835|6420732|P5|Overall Study|Death|1
1860265|NCT00094835|6420733|P4|Overall Study|Death|0
1860266|NCT00094835|6420734|P3|Overall Study|Death|0
1860267|NCT00094835|6420735|P2|Overall Study|Death|0
1860268|NCT00094835|6420736|P1|Overall Study|Death|1
1860269|NCT00094835|6420730|P7|Overall Study|Lost to Follow-up|0
1860270|NCT00094835|6420731|P6|Overall Study|Lost to Follow-up|0
1860271|NCT00094835|6420732|P5|Overall Study|Lost to Follow-up|1
1860272|NCT00094835|6420733|P4|Overall Study|Lost to Follow-up|0
1860273|NCT00094835|6420734|P3|Overall Study|Lost to Follow-up|0
1860274|NCT00094835|6420735|P2|Overall Study|Lost to Follow-up|0
1860275|NCT00094835|6420736|P1|Overall Study|Lost to Follow-up|0
1860276|NCT00094835|6420730|P7|Overall Study|Withdrawal by Subject|1
1860277|NCT00094835|6420731|P6|Overall Study|Withdrawal by Subject|0
1860278|NCT00094835|6420732|P5|Overall Study|Withdrawal by Subject|0
1860279|NCT00094835|6420733|P4|Overall Study|Withdrawal by Subject|0
1860280|NCT00094835|6420734|P3|Overall Study|Withdrawal by Subject|0
1860281|NCT00094835|6420735|P2|Overall Study|Withdrawal by Subject|0
1860282|NCT00094835|6420736|P1|Overall Study|Withdrawal by Subject|0
1860283|NCT00094835|6420730|P7|Overall Study|Physician Decision|0
1860284|NCT00094835|6420731|P6|Overall Study|Physician Decision|1
1860285|NCT00094835|6420732|P5|Overall Study|Physician Decision|0
1860286|NCT00094835|6420733|P4|Overall Study|Physician Decision|0
1860287|NCT00094835|6420734|P3|Overall Study|Physician Decision|0
1860288|NCT00094835|6420735|P2|Overall Study|Physician Decision|0
1860289|NCT00094835|6420736|P1|Overall Study|Physician Decision|1
1860290|NCT00094809|6420814|P2|Overall Study|Other|1
1860291|NCT00094809|6420815|P1|Overall Study|Other|1
1860292|NCT00094809|6420814|P2|Overall Study|Study drug not received|8
1860293|NCT00094809|6420815|P1|Overall Study|Study drug not received|2
1860294|NCT00094809|6420814|P2|Overall Study|Informed consent signed after treatment|0
1860295|NCT00094809|6420815|P1|Overall Study|Informed consent signed after treatment|1
1860296|NCT00094809|6420814|P2|Overall Study|Other|4
1860297|NCT00094809|6420815|P1|Overall Study|Other|2
1860298|NCT00094809|6420814|P2|Overall Study|Protocol-specified criteria|1
1860299|NCT00094809|6420815|P1|Overall Study|Protocol-specified criteria|1
1860300|NCT00094809|6420814|P2|Overall Study|Death|25
1860301|NCT00094809|6420815|P1|Overall Study|Death|19
1860302|NCT00094809|6420814|P2|Overall Study|Lost to Follow-up|6
1860303|NCT00094809|6420815|P1|Overall Study|Lost to Follow-up|6
1860304|NCT00094809|6420814|P2|Overall Study|Physician Decision|5
1860305|NCT00094809|6420815|P1|Overall Study|Physician Decision|3
1860306|NCT00094809|6420814|P2|Overall Study|Disease progression|3
1860307|NCT00094809|6420815|P1|Overall Study|Disease progression|3
1860308|NCT00094809|6420814|P2|Overall Study|Withdrawal by Subject|9
1860309|NCT00094809|6420815|P1|Overall Study|Withdrawal by Subject|8
1860310|NCT00094809|6420814|P2|Overall Study|Adverse Event|1
1860311|NCT00094809|6420815|P1|Overall Study|Adverse Event|3
1860312|NCT00094809|6420814|P2|Overall Study|Noncompliance|0
1860313|NCT00094809|6420815|P1|Overall Study|Noncompliance|1
1860314|NCT00094809|6420814|P2|Overall Study|Protocol deviation|2
1860315|NCT00094809|6420815|P1|Overall Study|Protocol deviation|2
1860316|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Other|23
1860317|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Other|15
1860318|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
1860319|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
1860320|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
1860321|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
1860322|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
1860323|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
1860324|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
1860325|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
1860326|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
1860327|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
1860328|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
1860329|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
1860330|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
1860331|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
1860332|NCT00094770|6420841|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
1860333|NCT00094770|6420842|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
1860334|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Other|11
1860335|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Other|10
1860336|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1860337|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
1860338|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
1860339|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
1860340|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
1860341|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
1860342|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
1860343|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
1860344|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1860345|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
1860346|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
1860347|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
1860348|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
1860349|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
1860350|NCT00094770|6420841|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
1860351|NCT00094770|6420842|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
1860352|NCT00094757|6420873|P3|Overall Study|Protocol specified discontinuation|0
1860353|NCT00094757|6420874|P2|Overall Study|Protocol specified discontinuation|3
1860354|NCT00094757|6420875|P1|Overall Study|Protocol specified discontinuation|1
1860355|NCT00094757|6420873|P3|Overall Study|Other|1
1860356|NCT00094757|6420874|P2|Overall Study|Other|3
1860357|NCT00094757|6420875|P1|Overall Study|Other|3
1860358|NCT00094757|6420873|P3|Overall Study|Withdrawal by Subject|5
1860359|NCT00094757|6420874|P2|Overall Study|Withdrawal by Subject|21
1860360|NCT00094757|6420875|P1|Overall Study|Withdrawal by Subject|14
1860361|NCT00094757|6420873|P3|Overall Study|Protocol Violation|3
1860362|NCT00094757|6420874|P2|Overall Study|Protocol Violation|5
1860363|NCT00094757|6420875|P1|Overall Study|Protocol Violation|8
1860364|NCT00094757|6420873|P3|Overall Study|Patient Moved|1
1860365|NCT00094757|6420874|P2|Overall Study|Patient Moved|1
1860366|NCT00094757|6420875|P1|Overall Study|Patient Moved|2
1860367|NCT00094757|6420873|P3|Overall Study|Lost to Follow-up|6
1860368|NCT00094757|6420874|P2|Overall Study|Lost to Follow-up|5
1860369|NCT00094757|6420875|P1|Overall Study|Lost to Follow-up|3
1860370|NCT00094757|6420873|P3|Overall Study|Lack of Efficacy|8
1860371|NCT00094757|6420874|P2|Overall Study|Lack of Efficacy|15
1860372|NCT00094757|6420875|P1|Overall Study|Lack of Efficacy|11
1860373|NCT00094757|6420873|P3|Overall Study|Adverse Event|6
1860374|NCT00094757|6420874|P2|Overall Study|Adverse Event|9
1860375|NCT00094757|6420875|P1|Overall Study|Adverse Event|11
1860376|NCT00094653|6420895|P3|Overall Study|Protocol Violation|1
1860377|NCT00094653|6420896|P2|Overall Study|Protocol Violation|0
1860378|NCT00094653|6420897|P1|Overall Study|Protocol Violation|0
1860379|NCT00094653|6420895|P3|Overall Study|Lost to Follow-up|1
1860380|NCT00094653|6420896|P2|Overall Study|Lost to Follow-up|2
1860381|NCT00094653|6420897|P1|Overall Study|Lost to Follow-up|3
1860382|NCT00094653|6420895|P3|Overall Study|Other|2
1860383|NCT00094653|6420896|P2|Overall Study|Other|2
1860384|NCT00094653|6420897|P1|Overall Study|Other|2
1860385|NCT00094653|6420895|P3|Overall Study|Subject Withdrew Consent|3
1860386|NCT00094653|6420896|P2|Overall Study|Subject Withdrew Consent|2
1860387|NCT00094653|6420897|P1|Overall Study|Subject Withdrew Consent|10
1860388|NCT00094653|6420895|P3|Overall Study|Death|119
1860389|NCT00094653|6420896|P2|Overall Study|Death|100
1860390|NCT00094653|6420897|P1|Overall Study|Death|306
1860391|NCT00094575|6420960|P2|Overall Study|Death|146
1860392|NCT00094575|6420961|P1|Overall Study|Death|146
1860393|NCT00094536|6420981|P1|Treatment and Follow-up|Unable to attend visits|1
1860394|NCT00094536|6420981|P1|Treatment and Follow-up|Subject non-compliance|9
1860395|NCT00094536|6420981|P1|Treatment and Follow-up|Withdrawal by Subject|1
1860396|NCT00094536|6420981|P1|Treatment and Follow-up|Lost to Follow-up|7
1860397|NCT00094536|6420981|P1|Treatment and Follow-up|Lack of Efficacy|9
1860398|NCT00094536|6420981|P1|Treatment and Follow-up|Adverse Event|4
1860399|NCT00094536|6420981|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
1860400|NCT00094458|6421005|P6|OLE: Open-Label Extension|Patient decision|0
1860401|NCT00094458|6421006|P5|OLE: Open-Label Extension|Patient decision|1
1860402|NCT00094458|6421007|P4|OLE: Open-Label Extension|Patient decision|0
1860403|NCT00094458|6421008|P3|OLE: Open-Label Extension|Patient decision|0
1860404|NCT00094458|6421009|P2|OLE: Open-Label Extension|Patient decision|0
1860405|NCT00094458|6421010|P1|OLE: Open-Label Extension|Patient decision|0
1860406|NCT00094458|6421005|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1860407|NCT00094458|6421006|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1860408|NCT00094458|6421007|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
1860409|NCT00094458|6421008|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1860410|NCT00094458|6421009|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1860411|NCT00094458|6421010|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
1860412|NCT00094458|6421005|P6|OLE: Open-Label Extension|Adverse Event|4
1860413|NCT00094458|6421006|P5|OLE: Open-Label Extension|Adverse Event|3
1860414|NCT00094458|6421007|P4|OLE: Open-Label Extension|Adverse Event|0
1860415|NCT00094458|6421008|P3|OLE: Open-Label Extension|Adverse Event|0
1860416|NCT00094458|6421009|P2|OLE: Open-Label Extension|Adverse Event|0
1860417|NCT00094458|6421010|P1|OLE: Open-Label Extension|Adverse Event|0
1860418|NCT00094458|6421005|P6|Study Extension: Week 30 Through Week 50|Other|0
1860419|NCT00094458|6421006|P5|Study Extension: Week 30 Through Week 50|Other|0
1860420|NCT00094458|6421007|P4|Study Extension: Week 30 Through Week 50|Other|0
1860421|NCT00094458|6421008|P3|Study Extension: Week 30 Through Week 50|Other|3
1860422|NCT00094458|6421009|P2|Study Extension: Week 30 Through Week 50|Other|2
1860423|NCT00094458|6421010|P1|Study Extension: Week 30 Through Week 50|Other|1
1860424|NCT00094458|6421005|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
1860425|NCT00094458|6421006|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
1860426|NCT00094458|6421007|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
1860427|NCT00094458|6421008|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
1860428|NCT00094458|6421009|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
1860429|NCT00094458|6421010|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
1860430|NCT00094458|6421005|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1860431|NCT00094458|6421006|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1860432|NCT00094458|6421007|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1860433|NCT00094458|6421008|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
1860434|NCT00094458|6421009|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
1860435|NCT00094458|6421010|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
1860436|NCT00094458|6421005|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1860437|NCT00094458|6421006|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1860438|NCT00094458|6421007|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
1860439|NCT00094458|6421008|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
1860440|NCT00094458|6421009|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
1860441|NCT00094458|6421010|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
1860442|NCT00094458|6421005|P6|Main Study: Through Week 30|Other|0
1860443|NCT00094458|6421006|P5|Main Study: Through Week 30|Other|0
1860444|NCT00094458|6421007|P4|Main Study: Through Week 30|Other|0
1860445|NCT00094458|6421008|P3|Main Study: Through Week 30|Other|9
1860446|NCT00094458|6421009|P2|Main Study: Through Week 30|Other|16
1860447|NCT00094458|6421010|P1|Main Study: Through Week 30|Other|19
1860448|NCT00094458|6421005|P6|Main Study: Through Week 30|Death|0
1860449|NCT00094458|6421006|P5|Main Study: Through Week 30|Death|0
1860450|NCT00094458|6421007|P4|Main Study: Through Week 30|Death|0
1860451|NCT00094458|6421008|P3|Main Study: Through Week 30|Death|0
1860452|NCT00094458|6421009|P2|Main Study: Through Week 30|Death|0
1860453|NCT00094458|6421010|P1|Main Study: Through Week 30|Death|1
1860454|NCT00094458|6421005|P6|Main Study: Through Week 30|Adverse Event|0
1860455|NCT00094458|6421006|P5|Main Study: Through Week 30|Adverse Event|0
1860456|NCT00094458|6421007|P4|Main Study: Through Week 30|Adverse Event|0
1860457|NCT00094458|6421008|P3|Main Study: Through Week 30|Adverse Event|28
1860458|NCT00094458|6421009|P2|Main Study: Through Week 30|Adverse Event|20
1860459|NCT00094458|6421010|P1|Main Study: Through Week 30|Adverse Event|38
1860460|NCT00094458|6421005|P6|Main Study: Through Week 30|Withdrawal by Subject|0
1860461|NCT00094458|6421006|P5|Main Study: Through Week 30|Withdrawal by Subject|0
1860462|NCT00094458|6421007|P4|Main Study: Through Week 30|Withdrawal by Subject|0
1860463|NCT00094458|6421008|P3|Main Study: Through Week 30|Withdrawal by Subject|7
1860464|NCT00094458|6421009|P2|Main Study: Through Week 30|Withdrawal by Subject|9
1860465|NCT00094458|6421010|P1|Main Study: Through Week 30|Withdrawal by Subject|18
1860466|NCT00094458|6421005|P6|Main Study: Through Week 30|Lost to Follow-up|0
1860467|NCT00094458|6421006|P5|Main Study: Through Week 30|Lost to Follow-up|0
1860468|NCT00094458|6421007|P4|Main Study: Through Week 30|Lost to Follow-up|0
1860469|NCT00094458|6421008|P3|Main Study: Through Week 30|Lost to Follow-up|2
1860470|NCT00094458|6421009|P2|Main Study: Through Week 30|Lost to Follow-up|5
1860471|NCT00094458|6421010|P1|Main Study: Through Week 30|Lost to Follow-up|5
1860472|NCT00094458|6421005|P6|Main Study: Through Week 30|Eligibility criteria not met|0
1860473|NCT00094458|6421006|P5|Main Study: Through Week 30|Eligibility criteria not met|0
1860474|NCT00094458|6421007|P4|Main Study: Through Week 30|Eligibility criteria not met|0
1860475|NCT00094458|6421008|P3|Main Study: Through Week 30|Eligibility criteria not met|2
1860476|NCT00094458|6421009|P2|Main Study: Through Week 30|Eligibility criteria not met|8
1860477|NCT00094458|6421010|P1|Main Study: Through Week 30|Eligibility criteria not met|3
1860478|NCT00094328|6421048|P1|Overall Study|Lost to Follow-up|1
1860479|NCT00094302|6421062|P2|Overall Study|Death|246
1860480|NCT00094302|6421063|P1|Overall Study|Death|266
1860481|NCT00094302|6421062|P2|Overall Study|Withdrawal by Subject|111
1860482|NCT00094302|6421063|P1|Overall Study|Withdrawal by Subject|103
1860483|NCT00094302|6421062|P2|Overall Study|Physician Decision|8
1860484|NCT00094302|6421063|P1|Overall Study|Physician Decision|5
1860485|NCT00094302|6421062|P2|Overall Study|Lost to Follow-up|41
1860486|NCT00094302|6421063|P1|Overall Study|Lost to Follow-up|43
1860487|NCT00094172|6421152|P2|Overall Study|Started other MS therapy due to disease|0
1860488|NCT00094172|6421153|P1|Overall Study|Started other MS therapy due to disease|1
1860489|NCT00094172|6421152|P2|Overall Study|Primary endpoint met.|0
1860490|NCT00094172|6421153|P1|Overall Study|Primary endpoint met.|1
1860491|NCT00094172|6421152|P2|Overall Study|Withdrawal by Subject|5
1860492|NCT00094172|6421153|P1|Overall Study|Withdrawal by Subject|10
1860493|NCT00094172|6421152|P2|Overall Study|Protocol Violation|1
1860494|NCT00094172|6421153|P1|Overall Study|Protocol Violation|0
1860495|NCT00094172|6421152|P2|Overall Study|Lost to Follow-up|0
1860496|NCT00094172|6421153|P1|Overall Study|Lost to Follow-up|2
1860497|NCT00094172|6421152|P2|Overall Study|Adverse Event|1
1860498|NCT00094172|6421153|P1|Overall Study|Adverse Event|0
1860499|NCT00094107|6421163|P1|Overall Study|Withdrawal due to Disease Progression|1
1860500|NCT00094107|6421163|P1|Overall Study|Adverse Event|3
1860501|NCT00094107|6421163|P1|Overall Study|Death|5
1860502|NCT00094107|6421163|P1|Overall Study|Lack of Efficacy|23
1860503|NCT00094094|6421172|P1|Overall Study|Adverse Event|7
1860504|NCT00094094|6421172|P1|Overall Study|Lack of Efficacy|23
1860505|NCT00094094|6421172|P1|Overall Study|Death|2
1860506|NCT00094055|6421181|P1|Overall Study|Withdrawal by Subject|9
1860507|NCT00094055|6421181|P1|Overall Study|roll-over to another study|14
1860508|NCT00094055|6421181|P1|Overall Study|clinical progression|1
1860509|NCT00094055|6421181|P1|Overall Study|progressive disease|2
1860510|NCT00094055|6421181|P1|Overall Study|Lost to Follow-up|2
1860511|NCT00094055|6421181|P1|Overall Study|Lack of Efficacy|17
1860512|NCT00094055|6421181|P1|Overall Study|Death|4
1860513|NCT00094055|6421181|P1|Overall Study|Adverse Event|11
1860514|NCT00093808|6421238|P1|Overall Study|Protocol Violation|1
1860515|NCT00093808|6421238|P1|Overall Study|Cancel participation before receiving tx|1
1860516|NCT00093795|6421248|P3|Overall Study|No follow up data|17
1860517|NCT00093795|6421249|P2|Overall Study|No follow up data|16
1860518|NCT00093795|6421250|P1|Overall Study|No follow up data|20
1860519|NCT00093496|6421295|P2|Overall Study|Protocol Violation|3
1860520|NCT00093496|6421296|P1|Overall Study|Protocol Violation|1
1860521|NCT00093470|6421309|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
1860522|NCT00093470|6421310|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
1860523|NCT00093470|6421309|P2|Overall Study|Never started treatment|0
1860524|NCT00093470|6421310|P1|Overall Study|Never started treatment|1
1860525|NCT00093470|6421309|P2|Overall Study|Physician Decision|0
1860526|NCT00093470|6421310|P1|Overall Study|Physician Decision|2
1860527|NCT00093470|6421309|P2|Overall Study|Other complicating disease|0
1860528|NCT00093470|6421310|P1|Overall Study|Other complicating disease|3
1860529|NCT00093470|6421309|P2|Overall Study|Alternative therapy|0
1860530|NCT00093470|6421310|P1|Overall Study|Alternative therapy|2
1860531|NCT00093470|6421309|P2|Overall Study|Withdrawal by Subject|0
1860532|NCT00093470|6421310|P1|Overall Study|Withdrawal by Subject|8
1860533|NCT00093470|6421309|P2|Overall Study|Death|0
1860534|NCT00093470|6421310|P1|Overall Study|Death|2
1860535|NCT00093470|6421309|P2|Overall Study|Adverse Event|0
1860536|NCT00093470|6421310|P1|Overall Study|Adverse Event|15
1860537|NCT00093470|6421309|P2|Overall Study|Disease progression|0
1860538|NCT00093470|6421310|P1|Overall Study|Disease progression|39
1860539|NCT00093145|6421324|P1|Overall Study|Other|1
1860540|NCT00093145|6421324|P1|Overall Study|Withdrawal by Subject|9
1860541|NCT00093145|6421324|P1|Overall Study|Physician Decision|5
1860542|NCT00093145|6421324|P1|Overall Study|Unacceptable Toxicity Only|2
1860543|NCT00093015|6421366|P2|Overall Study|Death|385
1860544|NCT00093015|6421367|P1|Overall Study|Death|375
1860545|NCT00093015|6421366|P2|Overall Study|Lost to Follow-up|108
1860546|NCT00093015|6421367|P1|Overall Study|Lost to Follow-up|96
1860547|NCT00093015|6421366|P2|Overall Study|Withdrawal by Subject|171
1860548|NCT00093015|6421367|P1|Overall Study|Withdrawal by Subject|194
1860549|NCT00092677|6421395|P2|Overall Study|Adminstrative|9
1860550|NCT00092677|6421396|P1|Overall Study|Adminstrative|5
1860551|NCT00092677|6421395|P2|Overall Study|Lost to Follow-up|2
1860552|NCT00092677|6421396|P1|Overall Study|Lost to Follow-up|0
1860553|NCT00092547|6421440|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1860554|NCT00092547|6421441|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
1860555|NCT00092547|6421442|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
1860556|NCT00092547|6421440|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
1860557|NCT00092547|6421441|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
1860558|NCT00092547|6421442|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
1860559|NCT00092547|6421440|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
1860560|NCT00092547|6421441|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
1860561|NCT00092547|6421442|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
1860562|NCT00092547|6421440|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1860563|NCT00092547|6421441|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
1860564|NCT00092547|6421442|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
1860565|NCT00092547|6421440|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1860566|NCT00092547|6421441|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
1860567|NCT00092547|6421442|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
1860568|NCT00092547|6421440|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1860569|NCT00092547|6421441|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
1860570|NCT00092547|6421442|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
1860571|NCT00092547|6421440|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
1860572|NCT00092547|6421441|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
1860573|NCT00092547|6421442|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
1860574|NCT00092547|6421440|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
1860575|NCT00092547|6421441|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
1860576|NCT00092547|6421442|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
1860577|NCT00092547|6421440|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1860578|NCT00092547|6421441|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
1860579|NCT00092547|6421442|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
1860580|NCT00092547|6421440|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1860581|NCT00092547|6421441|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
1860582|NCT00092547|6421442|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
1860583|NCT00092547|6421440|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
1860584|NCT00092547|6421441|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
1860585|NCT00092547|6421442|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
1860586|NCT00092547|6421440|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
1860587|NCT00092547|6421441|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
1860588|NCT00092547|6421442|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
1860589|NCT00092547|6421440|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
1860590|NCT00092547|6421441|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
1860591|NCT00092547|6421442|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
1860592|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
1860593|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
1860594|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
1860595|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1860596|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
1860597|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
1860598|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1860599|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
1860600|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
1860601|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
1860602|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
1860603|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
1860604|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
1860605|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
1860606|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
1860771|NCT00092534|6421486|P5|Base Study Vaccination Period|Adverse Event|0
1860607|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
1860608|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
1860609|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
1860610|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
1860611|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
1860612|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
1860613|NCT00092547|6421440|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
1860614|NCT00092547|6421441|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
1860615|NCT00092547|6421442|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
1860616|NCT00092534|6421486|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1860617|NCT00092534|6421487|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
1860618|NCT00092534|6421488|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1860619|NCT00092534|6421489|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1860620|NCT00092534|6421490|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
1860621|NCT00092534|6421486|P5|Base Study EXT|Protocol Violation|0
1860622|NCT00092534|6421487|P4|Base Study EXT|Protocol Violation|0
1860623|NCT00092534|6421488|P3|Base Study EXT|Protocol Violation|15
1860624|NCT00092534|6421489|P2|Base Study EXT|Protocol Violation|0
1860625|NCT00092534|6421490|P1|Base Study EXT|Protocol Violation|0
1860626|NCT00092534|6421486|P5|Base Study EXT|Study ended|0
1860627|NCT00092534|6421487|P4|Base Study EXT|Study ended|0
1860628|NCT00092534|6421488|P3|Base Study EXT|Study ended|29
1860629|NCT00092534|6421489|P2|Base Study EXT|Study ended|0
1860630|NCT00092534|6421490|P1|Base Study EXT|Study ended|0
1860631|NCT00092534|6421486|P5|Base Study EXT|Site closed|0
1860632|NCT00092534|6421487|P4|Base Study EXT|Site closed|0
1860633|NCT00092534|6421488|P3|Base Study EXT|Site closed|21
1860634|NCT00092534|6421489|P2|Base Study EXT|Site closed|0
1860635|NCT00092534|6421490|P1|Base Study EXT|Site closed|0
1860636|NCT00092534|6421486|P5|Base Study EXT|Travel|0
1860637|NCT00092534|6421487|P4|Base Study EXT|Travel|0
1860638|NCT00092534|6421488|P3|Base Study EXT|Travel|2
1860639|NCT00092534|6421489|P2|Base Study EXT|Travel|0
1860640|NCT00092534|6421490|P1|Base Study EXT|Travel|0
1860641|NCT00092534|6421486|P5|Base Study EXT|Participant moved|0
1860642|NCT00092534|6421487|P4|Base Study EXT|Participant moved|0
1860643|NCT00092534|6421488|P3|Base Study EXT|Participant moved|6
1860644|NCT00092534|6421489|P2|Base Study EXT|Participant moved|0
1860645|NCT00092534|6421490|P1|Base Study EXT|Participant moved|0
1860646|NCT00092534|6421486|P5|Base Study EXT|Withdrawal by Subject|0
1860647|NCT00092534|6421487|P4|Base Study EXT|Withdrawal by Subject|0
1860648|NCT00092534|6421488|P3|Base Study EXT|Withdrawal by Subject|18
1860649|NCT00092534|6421489|P2|Base Study EXT|Withdrawal by Subject|0
1860650|NCT00092534|6421490|P1|Base Study EXT|Withdrawal by Subject|0
1860651|NCT00092534|6421486|P5|Base Study EXT|Pregnancy|0
1860652|NCT00092534|6421487|P4|Base Study EXT|Pregnancy|0
1860653|NCT00092534|6421488|P3|Base Study EXT|Pregnancy|12
1860654|NCT00092534|6421489|P2|Base Study EXT|Pregnancy|0
1860655|NCT00092534|6421490|P1|Base Study EXT|Pregnancy|0
1860656|NCT00092534|6421486|P5|Base Study EXT|Physician Decision|0
1860657|NCT00092534|6421487|P4|Base Study EXT|Physician Decision|0
1860658|NCT00092534|6421488|P3|Base Study EXT|Physician Decision|1
1860659|NCT00092534|6421489|P2|Base Study EXT|Physician Decision|0
1860660|NCT00092534|6421490|P1|Base Study EXT|Physician Decision|0
1860661|NCT00092534|6421486|P5|Base Study EXT|Lost to Follow-up|0
1860662|NCT00092534|6421487|P4|Base Study EXT|Lost to Follow-up|0
1860663|NCT00092534|6421488|P3|Base Study EXT|Lost to Follow-up|41
1860664|NCT00092534|6421489|P2|Base Study EXT|Lost to Follow-up|0
1860665|NCT00092534|6421490|P1|Base Study EXT|Lost to Follow-up|0
1860666|NCT00092534|6421486|P5|Base Study Follow-Up Period|Subjects in extension|0
1860667|NCT00092534|6421487|P4|Base Study Follow-Up Period|Subjects in extension|0
1860668|NCT00092534|6421488|P3|Base Study Follow-Up Period|Subjects in extension|0
1860669|NCT00092534|6421489|P2|Base Study Follow-Up Period|Subjects in extension|371
1860670|NCT00092534|6421490|P1|Base Study Follow-Up Period|Subjects in extension|15
1860671|NCT00092534|6421486|P5|Base Study Follow-Up Period|Subjects continuing|0
1860672|NCT00092534|6421487|P4|Base Study Follow-Up Period|Subjects continuing|0
1860673|NCT00092534|6421488|P3|Base Study Follow-Up Period|Subjects continuing|0
1860674|NCT00092534|6421489|P2|Base Study Follow-Up Period|Subjects continuing|31
1860675|NCT00092534|6421490|P1|Base Study Follow-Up Period|Subjects continuing|27
1860676|NCT00092534|6421486|P5|Base Study Follow-Up Period|Site Closed|0
1860677|NCT00092534|6421487|P4|Base Study Follow-Up Period|Site Closed|0
1860678|NCT00092534|6421488|P3|Base Study Follow-Up Period|Site Closed|0
1860679|NCT00092534|6421489|P2|Base Study Follow-Up Period|Site Closed|2
1860680|NCT00092534|6421490|P1|Base Study Follow-Up Period|Site Closed|0
1860681|NCT00092534|6421486|P5|Base Study Follow-Up Period|Travel|0
1860682|NCT00092534|6421487|P4|Base Study Follow-Up Period|Travel|0
1860683|NCT00092534|6421488|P3|Base Study Follow-Up Period|Travel|0
1860684|NCT00092534|6421489|P2|Base Study Follow-Up Period|Travel|7
1860685|NCT00092534|6421490|P1|Base Study Follow-Up Period|Travel|10
1860686|NCT00092534|6421486|P5|Base Study Follow-Up Period|Moved|0
1860687|NCT00092534|6421487|P4|Base Study Follow-Up Period|Moved|0
1860688|NCT00092534|6421488|P3|Base Study Follow-Up Period|Moved|0
1860689|NCT00092534|6421489|P2|Base Study Follow-Up Period|Moved|58
1860690|NCT00092534|6421490|P1|Base Study Follow-Up Period|Moved|62
1860691|NCT00092534|6421486|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
1860692|NCT00092534|6421487|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
1860693|NCT00092534|6421488|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
1860694|NCT00092534|6421489|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
1860695|NCT00092534|6421490|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
1860696|NCT00092534|6421486|P5|Base Study Follow-Up Period|Protocol Violation|0
1860697|NCT00092534|6421487|P4|Base Study Follow-Up Period|Protocol Violation|0
1860698|NCT00092534|6421488|P3|Base Study Follow-Up Period|Protocol Violation|0
1860699|NCT00092534|6421489|P2|Base Study Follow-Up Period|Protocol Violation|2
1860700|NCT00092534|6421490|P1|Base Study Follow-Up Period|Protocol Violation|1
1860701|NCT00092534|6421486|P5|Base Study Follow-Up Period|Pregnancy|0
1860702|NCT00092534|6421487|P4|Base Study Follow-Up Period|Pregnancy|0
1860703|NCT00092534|6421488|P3|Base Study Follow-Up Period|Pregnancy|0
1860704|NCT00092534|6421489|P2|Base Study Follow-Up Period|Pregnancy|10
1860705|NCT00092534|6421490|P1|Base Study Follow-Up Period|Pregnancy|6
1860706|NCT00092534|6421486|P5|Base Study Follow-Up Period|Lost to Follow-up|0
1860707|NCT00092534|6421487|P4|Base Study Follow-Up Period|Lost to Follow-up|0
1860708|NCT00092534|6421488|P3|Base Study Follow-Up Period|Lost to Follow-up|0
1860709|NCT00092534|6421489|P2|Base Study Follow-Up Period|Lost to Follow-up|146
1860710|NCT00092534|6421490|P1|Base Study Follow-Up Period|Lost to Follow-up|120
1860711|NCT00092534|6421486|P5|Base Study Follow-Up Period|Death|0
1860712|NCT00092534|6421487|P4|Base Study Follow-Up Period|Death|0
1860713|NCT00092534|6421488|P3|Base Study Follow-Up Period|Death|0
1860714|NCT00092534|6421489|P2|Base Study Follow-Up Period|Death|1
1860715|NCT00092534|6421490|P1|Base Study Follow-Up Period|Death|2
1860716|NCT00092534|6421486|P5|Base Study Follow-Up Period|Adverse Event|0
1860717|NCT00092534|6421487|P4|Base Study Follow-Up Period|Adverse Event|0
1860718|NCT00092534|6421488|P3|Base Study Follow-Up Period|Adverse Event|0
1860719|NCT00092534|6421489|P2|Base Study Follow-Up Period|Adverse Event|4
1860720|NCT00092534|6421490|P1|Base Study Follow-Up Period|Adverse Event|2
1860721|NCT00092534|6421486|P5|Base Study Vaccination Period|Site Closed|0
1860722|NCT00092534|6421487|P4|Base Study Vaccination Period|Site Closed|0
1860723|NCT00092534|6421488|P3|Base Study Vaccination Period|Site Closed|0
1860724|NCT00092534|6421489|P2|Base Study Vaccination Period|Site Closed|1
1860725|NCT00092534|6421490|P1|Base Study Vaccination Period|Site Closed|0
1860726|NCT00092534|6421486|P5|Base Study Vaccination Period|Travel|0
1860727|NCT00092534|6421487|P4|Base Study Vaccination Period|Travel|0
1860728|NCT00092534|6421488|P3|Base Study Vaccination Period|Travel|0
1860729|NCT00092534|6421489|P2|Base Study Vaccination Period|Travel|0
1860730|NCT00092534|6421490|P1|Base Study Vaccination Period|Travel|1
1860731|NCT00092534|6421486|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
1860732|NCT00092534|6421487|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
1860733|NCT00092534|6421488|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
1860734|NCT00092534|6421489|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
1860735|NCT00092534|6421490|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
1860736|NCT00092534|6421486|P5|Base Study Vaccination Period|Moved|0
1860737|NCT00092534|6421487|P4|Base Study Vaccination Period|Moved|0
1860738|NCT00092534|6421488|P3|Base Study Vaccination Period|Moved|0
1860739|NCT00092534|6421489|P2|Base Study Vaccination Period|Moved|12
1860740|NCT00092534|6421490|P1|Base Study Vaccination Period|Moved|14
1860741|NCT00092534|6421486|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1860742|NCT00092534|6421487|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1860743|NCT00092534|6421488|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1860744|NCT00092534|6421489|P2|Base Study Vaccination Period|Withdrawal by Subject|58
1860745|NCT00092534|6421490|P1|Base Study Vaccination Period|Withdrawal by Subject|85
1860746|NCT00092534|6421486|P5|Base Study Vaccination Period|Protocol Violation|0
1860747|NCT00092534|6421487|P4|Base Study Vaccination Period|Protocol Violation|0
1860748|NCT00092534|6421488|P3|Base Study Vaccination Period|Protocol Violation|0
1860749|NCT00092534|6421489|P2|Base Study Vaccination Period|Protocol Violation|1
1860750|NCT00092534|6421490|P1|Base Study Vaccination Period|Protocol Violation|2
1860751|NCT00092534|6421486|P5|Base Study Vaccination Period|Pregnancy|0
1860752|NCT00092534|6421487|P4|Base Study Vaccination Period|Pregnancy|0
1860753|NCT00092534|6421488|P3|Base Study Vaccination Period|Pregnancy|0
1860754|NCT00092534|6421489|P2|Base Study Vaccination Period|Pregnancy|7
1860755|NCT00092534|6421490|P1|Base Study Vaccination Period|Pregnancy|9
1860756|NCT00092534|6421486|P5|Base Study Vaccination Period|Physician Decision|0
1860757|NCT00092534|6421487|P4|Base Study Vaccination Period|Physician Decision|0
1860758|NCT00092534|6421488|P3|Base Study Vaccination Period|Physician Decision|0
1860759|NCT00092534|6421489|P2|Base Study Vaccination Period|Physician Decision|0
1860760|NCT00092534|6421490|P1|Base Study Vaccination Period|Physician Decision|1
1860761|NCT00092534|6421486|P5|Base Study Vaccination Period|Lost to Follow-up|0
1860762|NCT00092534|6421487|P4|Base Study Vaccination Period|Lost to Follow-up|0
1860763|NCT00092534|6421488|P3|Base Study Vaccination Period|Lost to Follow-up|0
1860764|NCT00092534|6421489|P2|Base Study Vaccination Period|Lost to Follow-up|37
1860765|NCT00092534|6421490|P1|Base Study Vaccination Period|Lost to Follow-up|41
1860766|NCT00092534|6421486|P5|Base Study Vaccination Period|Death|0
1860767|NCT00092534|6421487|P4|Base Study Vaccination Period|Death|0
1860768|NCT00092534|6421488|P3|Base Study Vaccination Period|Death|0
1860769|NCT00092534|6421489|P2|Base Study Vaccination Period|Death|4
1860770|NCT00092534|6421490|P1|Base Study Vaccination Period|Death|5
1860772|NCT00092534|6421487|P4|Base Study Vaccination Period|Adverse Event|0
1860773|NCT00092534|6421488|P3|Base Study Vaccination Period|Adverse Event|0
1860774|NCT00092534|6421489|P2|Base Study Vaccination Period|Adverse Event|1
1860775|NCT00092534|6421490|P1|Base Study Vaccination Period|Adverse Event|3
1860776|NCT00092534|6421486|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
1860777|NCT00092534|6421487|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
1860778|NCT00092534|6421488|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1860779|NCT00092534|6421489|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
1860780|NCT00092534|6421490|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
1860781|NCT00092521|6421521|P4|Extension Study (Group 4)|Unable/unwilling to return|25
1860782|NCT00092521|6421522|P3|Extension Study (Group 4)|Unable/unwilling to return|0
1860783|NCT00092521|6421523|P2|Extension Study (Group 4)|Unable/unwilling to return|0
1860784|NCT00092521|6421524|P1|Extension Study (Group 4)|Unable/unwilling to return|0
1860785|NCT00092521|6421521|P4|Extension Study (Group 4)|Site Terminated|4
1860786|NCT00092521|6421522|P3|Extension Study (Group 4)|Site Terminated|0
1860787|NCT00092521|6421523|P2|Extension Study (Group 4)|Site Terminated|0
1860788|NCT00092521|6421524|P1|Extension Study (Group 4)|Site Terminated|0
1860789|NCT00092521|6421521|P4|Extension Study (Group 4)|Moved|16
1860790|NCT00092521|6421522|P3|Extension Study (Group 4)|Moved|0
1860791|NCT00092521|6421523|P2|Extension Study (Group 4)|Moved|0
1860792|NCT00092521|6421524|P1|Extension Study (Group 4)|Moved|0
1860793|NCT00092521|6421521|P4|Extension Study (Group 4)|Withdrawal by Subject|46
1860794|NCT00092521|6421522|P3|Extension Study (Group 4)|Withdrawal by Subject|0
1860795|NCT00092521|6421523|P2|Extension Study (Group 4)|Withdrawal by Subject|0
1860796|NCT00092521|6421524|P1|Extension Study (Group 4)|Withdrawal by Subject|0
1860797|NCT00092521|6421521|P4|Extension Study (Group 4)|Protocol Violation|2
1860798|NCT00092521|6421522|P3|Extension Study (Group 4)|Protocol Violation|0
1860799|NCT00092521|6421523|P2|Extension Study (Group 4)|Protocol Violation|0
1860800|NCT00092521|6421524|P1|Extension Study (Group 4)|Protocol Violation|0
1860801|NCT00092521|6421521|P4|Extension Study (Group 4)|Pregnancy|4
1860802|NCT00092521|6421522|P3|Extension Study (Group 4)|Pregnancy|0
1860803|NCT00092521|6421523|P2|Extension Study (Group 4)|Pregnancy|0
1860804|NCT00092521|6421524|P1|Extension Study (Group 4)|Pregnancy|0
1860805|NCT00092521|6421521|P4|Extension Study (Group 4)|Lost to Follow-up|87
1860806|NCT00092521|6421522|P3|Extension Study (Group 4)|Lost to Follow-up|0
1860807|NCT00092521|6421523|P2|Extension Study (Group 4)|Lost to Follow-up|0
1860808|NCT00092521|6421524|P1|Extension Study (Group 4)|Lost to Follow-up|0
1860809|NCT00092521|6421521|P4|Extension Study (Group 4)|Adverse Event|2
1860810|NCT00092521|6421522|P3|Extension Study (Group 4)|Adverse Event|0
1860811|NCT00092521|6421523|P2|Extension Study (Group 4)|Adverse Event|0
1860812|NCT00092521|6421524|P1|Extension Study (Group 4)|Adverse Event|0
1860813|NCT00092521|6421521|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
1860814|NCT00092521|6421522|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
1860815|NCT00092521|6421523|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
1860816|NCT00092521|6421524|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
1860817|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Visits Compressed|0
1860818|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Visits Compressed|5
1860819|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Visits Compressed|0
1860820|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Visits Compressed|5
1860821|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Travel|0
1860822|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Travel|0
1860823|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Travel|0
1860824|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Travel|2
1860825|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Site Terminated|0
1860826|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Site Terminated|3
1860827|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Site Terminated|0
1860828|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Site Terminated|3
1860829|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Moved|0
1860830|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Moved|28
1860831|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Moved|2
1860832|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Moved|32
1860833|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
1860834|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
1860835|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
1860836|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
1860837|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Protocol Violation|0
1860838|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Protocol Violation|5
1860839|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Protocol Violation|1
1860840|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Protocol Violation|1
1860841|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
1860842|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
1860843|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
1860844|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
1860845|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Death|0
1860846|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Death|1
1860847|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Death|0
1860848|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Death|2
1860849|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Adverse Event|0
1860850|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Adverse Event|0
1860851|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Adverse Event|0
1860852|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Adverse Event|1
1860853|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Subjects in Extension|0
1860854|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Subjects in Extension|412
1860855|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Subjects in Extension|109
1860856|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Subjects in Extension|13
1860857|NCT00092521|6421521|P4|Follow-Up (After Month 7)|Subjects Continuing|0
1860858|NCT00092521|6421522|P3|Follow-Up (After Month 7)|Subjects Continuing|35
1860859|NCT00092521|6421523|P2|Follow-Up (After Month 7)|Subjects Continuing|4
1860860|NCT00092521|6421524|P1|Follow-Up (After Month 7)|Subjects Continuing|34
1860861|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1860862|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1860863|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
1860864|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
1860865|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
1860866|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
1860867|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
1860868|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
1860869|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Moved|0
1860870|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Moved|18
1860871|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Moved|1
1860872|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Moved|14
1860873|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
1860874|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
1860875|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
1860876|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
1860877|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1860878|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
1860879|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
1860880|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
1860881|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
1860882|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
1860883|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
1860884|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
1860885|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Death|0
1860886|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Death|1
1860887|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Death|0
1860888|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Death|0
1860889|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1860890|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
1860891|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
1860892|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
1860893|NCT00092521|6421521|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1860894|NCT00092521|6421522|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
1860895|NCT00092521|6421523|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
1860896|NCT00092521|6421524|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
1860897|NCT00092495|6421538|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1860898|NCT00092495|6421539|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1860899|NCT00092495|6421540|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1860900|NCT00092495|6421541|P2|Base Study Follow-up Period|Withdrawal by Subject|0
1860901|NCT00092495|6421542|P1|Base Study Follow-up Period|Withdrawal by Subject|2
1860902|NCT00092495|6421538|P5|Base Study Follow-up Period|Lost to Follow-up|0
1860903|NCT00092495|6421539|P4|Base Study Follow-up Period|Lost to Follow-up|12
1860904|NCT00092495|6421540|P3|Base Study Follow-up Period|Lost to Follow-up|3
1860905|NCT00092495|6421541|P2|Base Study Follow-up Period|Lost to Follow-up|3
1860906|NCT00092495|6421542|P1|Base Study Follow-up Period|Lost to Follow-up|1
1860907|NCT00092495|6421538|P5|Base Study Follow-up Period|Extended|0
1860908|NCT00092495|6421539|P4|Base Study Follow-up Period|Extended|2
1860909|NCT00092495|6421540|P3|Base Study Follow-up Period|Extended|1
1860910|NCT00092495|6421541|P2|Base Study Follow-up Period|Extended|0
1860911|NCT00092495|6421542|P1|Base Study Follow-up Period|Extended|0
1860912|NCT00092495|6421538|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1860913|NCT00092495|6421539|P4|Base Study Vaccination Period|Withdrawal by Subject|25
1860914|NCT00092495|6421540|P3|Base Study Vaccination Period|Withdrawal by Subject|14
1860915|NCT00092495|6421541|P2|Base Study Vaccination Period|Withdrawal by Subject|10
1860916|NCT00092495|6421542|P1|Base Study Vaccination Period|Withdrawal by Subject|9
1860917|NCT00092495|6421538|P5|Base Study Vaccination Period|Protocol Violation|0
1860918|NCT00092495|6421539|P4|Base Study Vaccination Period|Protocol Violation|0
1860919|NCT00092495|6421540|P3|Base Study Vaccination Period|Protocol Violation|0
1860920|NCT00092495|6421541|P2|Base Study Vaccination Period|Protocol Violation|0
1860921|NCT00092495|6421542|P1|Base Study Vaccination Period|Protocol Violation|1
1860922|NCT00092495|6421538|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
1860923|NCT00092495|6421539|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
1860924|NCT00092495|6421540|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
1860925|NCT00092495|6421541|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
1861012|NCT00092443|6421660|P1|Overall Study|Adverse Event|9
1860926|NCT00092495|6421542|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
1860927|NCT00092495|6421538|P5|Base Study Vaccination Period|Pregnancy|0
1860928|NCT00092495|6421539|P4|Base Study Vaccination Period|Pregnancy|0
1860929|NCT00092495|6421540|P3|Base Study Vaccination Period|Pregnancy|0
1860930|NCT00092495|6421541|P2|Base Study Vaccination Period|Pregnancy|0
1860931|NCT00092495|6421542|P1|Base Study Vaccination Period|Pregnancy|2
1860932|NCT00092495|6421538|P5|Base Study Vaccination Period|Other|0
1860933|NCT00092495|6421539|P4|Base Study Vaccination Period|Other|2
1860934|NCT00092495|6421540|P3|Base Study Vaccination Period|Other|0
1860935|NCT00092495|6421541|P2|Base Study Vaccination Period|Other|1
1860936|NCT00092495|6421542|P1|Base Study Vaccination Period|Other|1
1860937|NCT00092495|6421538|P5|Base Study Vaccination Period|Moved|0
1860938|NCT00092495|6421539|P4|Base Study Vaccination Period|Moved|2
1860939|NCT00092495|6421540|P3|Base Study Vaccination Period|Moved|2
1860940|NCT00092495|6421541|P2|Base Study Vaccination Period|Moved|1
1860941|NCT00092495|6421542|P1|Base Study Vaccination Period|Moved|3
1860942|NCT00092495|6421538|P5|Base Study Vaccination Period|Lost to Follow-up|0
1860943|NCT00092495|6421539|P4|Base Study Vaccination Period|Lost to Follow-up|36
1860944|NCT00092495|6421540|P3|Base Study Vaccination Period|Lost to Follow-up|11
1860945|NCT00092495|6421541|P2|Base Study Vaccination Period|Lost to Follow-up|6
1860946|NCT00092495|6421542|P1|Base Study Vaccination Period|Lost to Follow-up|16
1860947|NCT00092495|6421538|P5|Base Study Vaccination Period|Adverse Event|0
1860948|NCT00092495|6421539|P4|Base Study Vaccination Period|Adverse Event|3
1860949|NCT00092495|6421540|P3|Base Study Vaccination Period|Adverse Event|0
1860950|NCT00092495|6421541|P2|Base Study Vaccination Period|Adverse Event|0
1860951|NCT00092495|6421542|P1|Base Study Vaccination Period|Adverse Event|1
1860952|NCT00092495|6421538|P5|Base Study Vaccination Period|*Pregnancy|0
1860953|NCT00092495|6421539|P4|Base Study Vaccination Period|*Pregnancy|7
1860954|NCT00092495|6421540|P3|Base Study Vaccination Period|*Pregnancy|5
1860955|NCT00092495|6421541|P2|Base Study Vaccination Period|*Pregnancy|2
1860956|NCT00092495|6421542|P1|Base Study Vaccination Period|*Pregnancy|0
1860957|NCT00092495|6421538|P5|Base Study Vaccination Period|*Other reasons|0
1860958|NCT00092495|6421539|P4|Base Study Vaccination Period|*Other reasons|1
1860959|NCT00092495|6421540|P3|Base Study Vaccination Period|*Other reasons|0
1860960|NCT00092495|6421541|P2|Base Study Vaccination Period|*Other reasons|0
1860961|NCT00092495|6421542|P1|Base Study Vaccination Period|*Other reasons|1
1860962|NCT00092495|6421538|P5|Base Study Vaccination Period|*Clinical AE|0
1860963|NCT00092495|6421539|P4|Base Study Vaccination Period|*Clinical AE|2
1860964|NCT00092495|6421540|P3|Base Study Vaccination Period|*Clinical AE|1
1860965|NCT00092495|6421541|P2|Base Study Vaccination Period|*Clinical AE|0
1860966|NCT00092495|6421542|P1|Base Study Vaccination Period|*Clinical AE|1
1860967|NCT00092495|6421538|P5|Base Study Vaccination Period|Extended|0
1860968|NCT00092495|6421539|P4|Base Study Vaccination Period|Extended|1
1860969|NCT00092495|6421540|P3|Base Study Vaccination Period|Extended|0
1860970|NCT00092495|6421541|P2|Base Study Vaccination Period|Extended|0
1860971|NCT00092495|6421542|P1|Base Study Vaccination Period|Extended|0
1860972|NCT00092495|6421538|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1860973|NCT00092495|6421539|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
1860974|NCT00092495|6421540|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1860975|NCT00092495|6421541|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
1860976|NCT00092495|6421542|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
1860977|NCT00092456|6421608|P4|Overall Study|Other|0
1860978|NCT00092456|6421609|P3|Overall Study|Other|3
1860979|NCT00092456|6421610|P2|Overall Study|Other|2
1860980|NCT00092456|6421611|P1|Overall Study|Other|4
1860981|NCT00092456|6421608|P4|Overall Study|Moved|1
1860982|NCT00092456|6421609|P3|Overall Study|Moved|0
1860983|NCT00092456|6421610|P2|Overall Study|Moved|1
1860984|NCT00092456|6421611|P1|Overall Study|Moved|1
1860985|NCT00092456|6421608|P4|Overall Study|Withdrawal by Subject|6
1860986|NCT00092456|6421609|P3|Overall Study|Withdrawal by Subject|16
1860987|NCT00092456|6421610|P2|Overall Study|Withdrawal by Subject|5
1860988|NCT00092456|6421611|P1|Overall Study|Withdrawal by Subject|13
1860989|NCT00092456|6421608|P4|Overall Study|Protocol Violation|6
1860990|NCT00092456|6421609|P3|Overall Study|Protocol Violation|8
1860991|NCT00092456|6421610|P2|Overall Study|Protocol Violation|7
1860992|NCT00092456|6421611|P1|Overall Study|Protocol Violation|5
1860993|NCT00092456|6421608|P4|Overall Study|Lost to Follow-up|2
1860994|NCT00092456|6421609|P3|Overall Study|Lost to Follow-up|1
1860995|NCT00092456|6421610|P2|Overall Study|Lost to Follow-up|2
1860996|NCT00092456|6421611|P1|Overall Study|Lost to Follow-up|2
1860997|NCT00092456|6421608|P4|Overall Study|Adverse Event|1
1860998|NCT00092456|6421609|P3|Overall Study|Adverse Event|1
1860999|NCT00092456|6421610|P2|Overall Study|Adverse Event|0
1861000|NCT00092456|6421611|P1|Overall Study|Adverse Event|0
1861001|NCT00092443|6421659|P2|Overall Study|Other|13
1861002|NCT00092443|6421660|P1|Overall Study|Other|17
1861003|NCT00092443|6421659|P2|Overall Study|Moved|5
1861004|NCT00092443|6421660|P1|Overall Study|Moved|5
1861005|NCT00092443|6421659|P2|Overall Study|Withdrawal by Subject|11
1861006|NCT00092443|6421660|P1|Overall Study|Withdrawal by Subject|9
1861007|NCT00092443|6421659|P2|Overall Study|Protocol Violation|9
1861008|NCT00092443|6421660|P1|Overall Study|Protocol Violation|11
1861009|NCT00092443|6421659|P2|Overall Study|Lost to Follow-up|3
1861010|NCT00092443|6421660|P1|Overall Study|Lost to Follow-up|7
1861011|NCT00092443|6421659|P2|Overall Study|Adverse Event|13
1861013|NCT00092417|6421678|P2|Overall Study|Other|0
1861014|NCT00092417|6421679|P1|Overall Study|Other|1
1861015|NCT00092417|6421678|P2|Overall Study|Withdrawal by Subject|1
1861016|NCT00092417|6421679|P1|Overall Study|Withdrawal by Subject|2
1861017|NCT00092417|6421678|P2|Overall Study|Lost to Follow-up|0
1861018|NCT00092417|6421679|P1|Overall Study|Lost to Follow-up|2
1861019|NCT00092131|6421693|P2|Treatment Period II|Adverse Event|1
1861020|NCT00092131|6421694|P1|Treatment Period II|Adverse Event|0
1861021|NCT00092131|6421693|P2|Treatment Period I|Adverse Event|0
1861022|NCT00092131|6421694|P1|Treatment Period I|Adverse Event|1
1861023|NCT00092118|6421724|P2|Overall Study|Other|5
1861024|NCT00092118|6421725|P1|Overall Study|Other|6
1861025|NCT00092118|6421724|P2|Overall Study|Withdrawal by Subject|10
1861026|NCT00092118|6421725|P1|Overall Study|Withdrawal by Subject|4
1861027|NCT00092118|6421724|P2|Overall Study|Protocol Violation|25
1861028|NCT00092118|6421725|P1|Overall Study|Protocol Violation|23
1861029|NCT00092118|6421724|P2|Overall Study|Lost to Follow-up|3
1861030|NCT00092118|6421725|P1|Overall Study|Lost to Follow-up|4
1861031|NCT00092118|6421724|P2|Overall Study|Lack of Efficacy|14
1861032|NCT00092118|6421725|P1|Overall Study|Lack of Efficacy|12
1861033|NCT00092118|6421724|P2|Overall Study|Adverse Event|32
1861034|NCT00092118|6421725|P1|Overall Study|Adverse Event|35
1861035|NCT00091949|6421759|P2|Overall Study|Lost to Follow-up|41
1861036|NCT00091949|6421760|P1|Overall Study|Lost to Follow-up|58
1861037|NCT00091949|6421759|P2|Overall Study|Withdrawal by Subject|110
1861038|NCT00091949|6421760|P1|Overall Study|Withdrawal by Subject|117
1861039|NCT00091832|6421784|P6|Overall Study|Protocol Violation|1
1861040|NCT00091832|6421785|P5|Overall Study|Protocol Violation|0
1861041|NCT00091832|6421786|P4|Overall Study|Protocol Violation|0
1861042|NCT00091832|6421787|P3|Overall Study|Protocol Violation|1
1861043|NCT00091832|6421788|P2|Overall Study|Protocol Violation|0
1861044|NCT00091832|6421789|P1|Overall Study|Protocol Violation|0
1861045|NCT00091832|6421784|P6|Overall Study|Other|0
1861046|NCT00091832|6421785|P5|Overall Study|Other|0
1861047|NCT00091832|6421786|P4|Overall Study|Other|0
1861048|NCT00091832|6421787|P3|Overall Study|Other|2
1861049|NCT00091832|6421788|P2|Overall Study|Other|1
1861050|NCT00091832|6421789|P1|Overall Study|Other|0
1861051|NCT00091832|6421784|P6|Overall Study|Noncompliance|0
1861052|NCT00091832|6421785|P5|Overall Study|Noncompliance|0
1861053|NCT00091832|6421786|P4|Overall Study|Noncompliance|0
1861054|NCT00091832|6421787|P3|Overall Study|Noncompliance|0
1861055|NCT00091832|6421788|P2|Overall Study|Noncompliance|1
1861056|NCT00091832|6421789|P1|Overall Study|Noncompliance|0
1861057|NCT00091832|6421784|P6|Overall Study|Lost to Follow-up|1
1861058|NCT00091832|6421785|P5|Overall Study|Lost to Follow-up|2
1861059|NCT00091832|6421786|P4|Overall Study|Lost to Follow-up|3
1861060|NCT00091832|6421787|P3|Overall Study|Lost to Follow-up|3
1861061|NCT00091832|6421788|P2|Overall Study|Lost to Follow-up|0
1861062|NCT00091832|6421789|P1|Overall Study|Lost to Follow-up|1
1861063|NCT00091832|6421784|P6|Overall Study|Ineligibility Determined|0
1861064|NCT00091832|6421785|P5|Overall Study|Ineligibility Determined|1
1861065|NCT00091832|6421786|P4|Overall Study|Ineligibility Determined|0
1861066|NCT00091832|6421787|P3|Overall Study|Ineligibility Determined|1
1861067|NCT00091832|6421788|P2|Overall Study|Ineligibility Determined|0
1861068|NCT00091832|6421789|P1|Overall Study|Ineligibility Determined|0
1861069|NCT00091832|6421784|P6|Overall Study|Disease Progression|2
1861070|NCT00091832|6421785|P5|Overall Study|Disease Progression|1
1861071|NCT00091832|6421786|P4|Overall Study|Disease Progression|1
1861072|NCT00091832|6421787|P3|Overall Study|Disease Progression|0
1861073|NCT00091832|6421788|P2|Overall Study|Disease Progression|0
1861074|NCT00091832|6421789|P1|Overall Study|Disease Progression|2
1861075|NCT00091832|6421784|P6|Overall Study|Death|6
1861076|NCT00091832|6421785|P5|Overall Study|Death|5
1861077|NCT00091832|6421786|P4|Overall Study|Death|8
1861078|NCT00091832|6421787|P3|Overall Study|Death|5
1861079|NCT00091832|6421788|P2|Overall Study|Death|4
1861080|NCT00091832|6421789|P1|Overall Study|Death|6
1861081|NCT00091832|6421784|P6|Overall Study|Withdrawal by Subject|1
1861082|NCT00091832|6421785|P5|Overall Study|Withdrawal by Subject|3
1861083|NCT00091832|6421786|P4|Overall Study|Withdrawal by Subject|1
1861084|NCT00091832|6421787|P3|Overall Study|Withdrawal by Subject|0
1861085|NCT00091832|6421788|P2|Overall Study|Withdrawal by Subject|5
1861086|NCT00091832|6421789|P1|Overall Study|Withdrawal by Subject|4
1861087|NCT00091832|6421784|P6|Overall Study|Adverse Event|0
1861088|NCT00091832|6421785|P5|Overall Study|Adverse Event|3
1861089|NCT00091832|6421786|P4|Overall Study|Adverse Event|1
1861090|NCT00091832|6421787|P3|Overall Study|Adverse Event|0
1861091|NCT00091832|6421788|P2|Overall Study|Adverse Event|0
1861092|NCT00091832|6421789|P1|Overall Study|Adverse Event|0
1861093|NCT00091832|6421784|P6|Overall Study|Physician Decision|0
1861094|NCT00091832|6421785|P5|Overall Study|Physician Decision|0
1861095|NCT00091832|6421786|P4|Overall Study|Physician Decision|0
1861096|NCT00091832|6421787|P3|Overall Study|Physician Decision|0
1861097|NCT00091832|6421788|P2|Overall Study|Physician Decision|0
1861098|NCT00091832|6421789|P1|Overall Study|Physician Decision|1
1861099|NCT00091819|6421907|P2|Overall Study|Never received study treatment|4
1861100|NCT00091819|6421908|P1|Overall Study|Never received study treatment|3
1861101|NCT00091819|6421907|P2|Overall Study|Other|3
1861102|NCT00091819|6421908|P1|Overall Study|Other|2
1861103|NCT00091819|6421907|P2|Overall Study|Protocol Violation|2
1861104|NCT00091819|6421908|P1|Overall Study|Protocol Violation|1
1861105|NCT00091819|6421907|P2|Overall Study|Withdrawal by Subject|8
1861106|NCT00091819|6421908|P1|Overall Study|Withdrawal by Subject|5
1861107|NCT00091819|6421907|P2|Overall Study|Lost to Follow-up|23
1861108|NCT00091819|6421908|P1|Overall Study|Lost to Follow-up|26
1861109|NCT00091819|6421907|P2|Overall Study|Death|5
1861110|NCT00091819|6421908|P1|Overall Study|Death|4
1861111|NCT00091819|6421907|P2|Overall Study|Adverse Event|1
1861112|NCT00091819|6421908|P1|Overall Study|Adverse Event|1
1861113|NCT00091793|6421916|P2|Overall Study|Other|0
1861114|NCT00091793|6421917|P1|Overall Study|Other|2
1861115|NCT00091793|6421916|P2|Overall Study|Noncompliance|0
1861116|NCT00091793|6421917|P1|Overall Study|Noncompliance|2
1861117|NCT00091793|6421916|P2|Overall Study|Lost to Follow-up|5
1861118|NCT00091793|6421917|P1|Overall Study|Lost to Follow-up|7
1861119|NCT00091793|6421916|P2|Overall Study|Ineligibility determined|0
1861120|NCT00091793|6421917|P1|Overall Study|Ineligibility determined|2
1861121|NCT00091793|6421916|P2|Overall Study|Withdrawal by Subject|15
1861122|NCT00091793|6421917|P1|Overall Study|Withdrawal by Subject|10
1861123|NCT00091793|6421916|P2|Overall Study|Adverse Event|2
1861124|NCT00091793|6421917|P1|Overall Study|Adverse Event|1
1861125|NCT00091572|6421941|P2|Overall Study|Toxicity (Related AE)|9
1861126|NCT00091572|6421942|P1|Overall Study|Toxicity (Related AE)|53
1861127|NCT00091572|6421941|P2|Overall Study|Major Protocol Violation|0
1861128|NCT00091572|6421942|P1|Overall Study|Major Protocol Violation|2
1861129|NCT00091572|6421941|P2|Overall Study|Ongoing (still on treatment)|12
1861130|NCT00091572|6421942|P1|Overall Study|Ongoing (still on treatment)|8
1861131|NCT00091572|6421941|P2|Overall Study|Other Reason|13
1861132|NCT00091572|6421942|P1|Overall Study|Other Reason|6
1861133|NCT00091572|6421941|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
1861134|NCT00091572|6421942|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
1861135|NCT00091572|6421941|P2|Overall Study|Death not due to malignancy/toxicity|3
1861136|NCT00091572|6421942|P1|Overall Study|Death not due to malignancy/toxicity|1
1861137|NCT00091572|6421941|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
1861138|NCT00091572|6421942|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
1861139|NCT00091572|6421941|P2|Overall Study|Lost to Follow-up|1
1861140|NCT00091572|6421942|P1|Overall Study|Lost to Follow-up|1
1861141|NCT00091442|6421973|P2|Overall Study|Other|6
1861142|NCT00091442|6421974|P1|Overall Study|Other|2
1861143|NCT00091442|6421973|P2|Overall Study|Lost to Follow-up|3
1861144|NCT00091442|6421974|P1|Overall Study|Lost to Follow-up|1
1861145|NCT00091442|6421973|P2|Overall Study|Death|7
1861146|NCT00091442|6421974|P1|Overall Study|Death|9
1861147|NCT00091442|6421973|P2|Overall Study|2cycles therapy beyond Complete response|16
1861148|NCT00091442|6421974|P1|Overall Study|2cycles therapy beyond Complete response|9
1861149|NCT00091442|6421973|P2|Overall Study|Adverse Event|48
1861150|NCT00091442|6421974|P1|Overall Study|Adverse Event|29
1861151|NCT00091442|6421973|P2|Overall Study|Withdrawal by Subject|46
1861152|NCT00091442|6421974|P1|Overall Study|Withdrawal by Subject|38
1861153|NCT00091442|6421973|P2|Overall Study|Physician Decision|58
1861154|NCT00091442|6421974|P1|Overall Study|Physician Decision|61
1861155|NCT00091442|6421973|P2|Overall Study|Progressive Disease|189
1861156|NCT00091442|6421974|P1|Overall Study|Progressive Disease|220
1861157|NCT00091390|6421984|P1|Overall Study|Protocol Violation|2
1861158|NCT00091390|6421984|P1|Overall Study|Withdrawal by Subject|2
1861159|NCT00091169|6422002|P2|Overall Study|Not start protocol therapy|17
1861160|NCT00091169|6422003|P1|Overall Study|Not start protocol therapy|26
1861161|NCT00091169|6422002|P2|Overall Study|Other|4
1861162|NCT00091169|6422003|P1|Overall Study|Other|3
1861163|NCT00091169|6422002|P2|Overall Study|Withdrawal by Subject|13
1861164|NCT00091169|6422003|P1|Overall Study|Withdrawal by Subject|10
1861165|NCT00091169|6422002|P2|Overall Study|Death|1
1861166|NCT00091169|6422003|P1|Overall Study|Death|4
1861167|NCT00091169|6422002|P2|Overall Study|Adverse Event|17
1861168|NCT00091169|6422003|P1|Overall Study|Adverse Event|11
1861169|NCT00091169|6422002|P2|Overall Study|Disease progression|1
1861170|NCT00091169|6422003|P1|Overall Study|Disease progression|3
1861171|NCT00091026|6422021|P2|Overall Study|Unknown-never received treatment|1
1861172|NCT00091026|6422022|P1|Overall Study|Unknown-never received treatment|0
1861173|NCT00091026|6422021|P2|Overall Study|Patient withdrew and never received trea|2
1861174|NCT00091026|6422022|P1|Overall Study|Patient withdrew and never received trea|0
1861175|NCT00091026|6422021|P2|Overall Study|Patient deemed non eligible-never receiv|0
1861176|NCT00091026|6422022|P1|Overall Study|Patient deemed non eligible-never receiv|1
1861177|NCT00090987|6422032|P1|Overall Study|Incarcerated|1
1861178|NCT00090987|6422032|P1|Overall Study|Non-compliance|4
1861179|NCT00090987|6422032|P1|Overall Study|alternative therapy|1
1861180|NCT00090987|6422032|P1|Overall Study|Withdrawal by Subject|3
1861181|NCT00090987|6422032|P1|Overall Study|Lack of Efficacy|7
1861182|NCT00090987|6422032|P1|Overall Study|Adverse Event|5
1861183|NCT00090857|6422045|P2|Overall Study|Adverse Event|2
1861184|NCT00090857|6422046|P1|Overall Study|Adverse Event|2
1861185|NCT00090857|6422045|P2|Overall Study|Withdrawal by Subject|0
1861186|NCT00090857|6422046|P1|Overall Study|Withdrawal by Subject|2
1861187|NCT00090857|6422045|P2|Overall Study|Lost to Follow-up|1
1861188|NCT00090857|6422046|P1|Overall Study|Lost to Follow-up|0
1861189|NCT00090779|6422085|P2|Step 3|Off extended study due to study closure|3
1861190|NCT00090779|6422086|P1|Step 3|Off extended study due to study closure|4
1861191|NCT00090779|6422085|P2|Step 3|Initiation of ART and off extended study|2
1861192|NCT00090779|6422086|P1|Step 3|Initiation of ART and off extended study|3
1861193|NCT00090779|6422085|P2|Step 2|Non-compliance to study requirements|1
1861194|NCT00090779|6422086|P1|Step 2|Non-compliance to study requirements|0
1861195|NCT00090779|6422085|P2|Step 2|Subject relocated|1
1861196|NCT00090779|6422086|P1|Step 2|Subject relocated|0
1861197|NCT00090779|6422085|P2|Step 2|Off study per study closure|16
1861198|NCT00090779|6422086|P1|Step 2|Off study per study closure|6
1861199|NCT00090779|6422085|P2|Step 1|Subject relocated|8
1861200|NCT00090779|6422086|P1|Step 1|Subject relocated|2
1861201|NCT00090779|6422085|P2|Step 1|Non-compliance to study requirements|1
1861202|NCT00090779|6422086|P1|Step 1|Non-compliance to study requirements|0
1861203|NCT00090779|6422085|P2|Step 1|Pregnancy|0
1861204|NCT00090779|6422086|P1|Step 1|Pregnancy|1
1861205|NCT00090779|6422085|P2|Step 1|Physician Decision|0
1861206|NCT00090779|6422086|P1|Step 1|Physician Decision|1
1861207|NCT00090779|6422085|P2|Step 1|Death|2
1861208|NCT00090779|6422086|P1|Step 1|Death|0
1861209|NCT00090779|6422085|P2|Step 1|Lost to Follow-up|2
1861210|NCT00090779|6422086|P1|Step 1|Lost to Follow-up|3
1861211|NCT00090779|6422085|P2|Step 1|Withdrawal by Subject|2
1861212|NCT00090779|6422086|P1|Step 1|Withdrawal by Subject|4
1861213|NCT00090766|6422110|P3|Overall Study|Lost to Follow-up|2
1861214|NCT00090766|6422111|P2|Overall Study|Lost to Follow-up|0
1861215|NCT00090766|6422112|P1|Overall Study|Lost to Follow-up|2
1861216|NCT00090766|6422110|P3|Overall Study|Admin|0
1861217|NCT00090766|6422111|P2|Overall Study|Admin|2
1861218|NCT00090766|6422112|P1|Overall Study|Admin|0
1861219|NCT00090766|6422110|P3|Overall Study|Death|0
1861220|NCT00090766|6422111|P2|Overall Study|Death|0
1861221|NCT00090766|6422112|P1|Overall Study|Death|1
1861222|NCT00090766|6422110|P3|Overall Study|Nephrectomy Planned|1
1861223|NCT00090766|6422111|P2|Overall Study|Nephrectomy Planned|0
1861224|NCT00090766|6422112|P1|Overall Study|Nephrectomy Planned|0
1861225|NCT00090753|6422154|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
1861226|NCT00090753|6422155|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
1861227|NCT00090753|6422154|P2|Extended Treatment Period|Mircera Commercialization|93
1861228|NCT00090753|6422155|P1|Extended Treatment Period|Mircera Commercialization|188
1861229|NCT00090753|6422154|P2|Extended Treatment Period|Renal Transplant|12
1861230|NCT00090753|6422155|P1|Extended Treatment Period|Renal Transplant|15
1861231|NCT00090753|6422154|P2|Extended Treatment Period|Lost to Follow-up|1
1861232|NCT00090753|6422155|P1|Extended Treatment Period|Lost to Follow-up|3
1861233|NCT00090753|6422154|P2|Extended Treatment Period|Refused Treatment|12
1861234|NCT00090753|6422155|P1|Extended Treatment Period|Refused Treatment|18
1861235|NCT00090753|6422154|P2|Extended Treatment Period|Lack of Efficacy|0
1861236|NCT00090753|6422155|P1|Extended Treatment Period|Lack of Efficacy|1
1861237|NCT00090753|6422154|P2|Extended Treatment Period|Death|30
1861238|NCT00090753|6422155|P1|Extended Treatment Period|Death|58
1861239|NCT00090753|6422154|P2|Extended Treatment Period|Adverse Event|0
1861240|NCT00090753|6422155|P1|Extended Treatment Period|Adverse Event|11
1861241|NCT00090753|6422154|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
1861242|NCT00090753|6422155|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
1861243|NCT00090753|6422154|P2|First Treatment Period|Mircera Commercialization|0
1861244|NCT00090753|6422155|P1|First Treatment Period|Mircera Commercialization|1
1861245|NCT00090753|6422154|P2|First Treatment Period|Renal Transplant|50
1861246|NCT00090753|6422155|P1|First Treatment Period|Renal Transplant|70
1861247|NCT00090753|6422154|P2|First Treatment Period|Lost to Follow-up|4
1861248|NCT00090753|6422155|P1|First Treatment Period|Lost to Follow-up|4
1861249|NCT00090753|6422154|P2|First Treatment Period|Refused Treatment|25
1861250|NCT00090753|6422155|P1|First Treatment Period|Refused Treatment|32
1861251|NCT00090753|6422154|P2|First Treatment Period|Lack of Efficacy|1
1861252|NCT00090753|6422155|P1|First Treatment Period|Lack of Efficacy|2
1861253|NCT00090753|6422154|P2|First Treatment Period|Death|62
1861254|NCT00090753|6422155|P1|First Treatment Period|Death|88
1861255|NCT00090753|6422154|P2|First Treatment Period|Adverse Event|8
1861256|NCT00090753|6422155|P1|First Treatment Period|Adverse Event|20
1861257|NCT00090610|6422165|P2|Overall Study|Withdrawal by Subject|1
1861258|NCT00090610|6422166|P1|Overall Study|Withdrawal by Subject|1
1861259|NCT00090584|6422182|P2|Baseline to 8 Months|Lost to Follow-up|41
1861260|NCT00090584|6422183|P1|Baseline to 8 Months|Lost to Follow-up|44
1861261|NCT00090584|6422182|P2|Baseline to 10 Weeks|Lost to Follow-up|12
1861262|NCT00090584|6422183|P1|Baseline to 10 Weeks|Lost to Follow-up|15
1861263|NCT00090519|6422215|P2|Overall Study|Sponsor Decision|1
1861264|NCT00090519|6422216|P1|Overall Study|Sponsor Decision|3
1861265|NCT00090519|6422215|P2|Overall Study|Physician Decision|3
1861266|NCT00090519|6422216|P1|Overall Study|Physician Decision|2
1861267|NCT00090519|6422215|P2|Overall Study|Withdrawal by Subject|29
1861268|NCT00090519|6422216|P1|Overall Study|Withdrawal by Subject|28
1861269|NCT00090519|6422215|P2|Overall Study|Lost to Follow-up|29
1861270|NCT00090519|6422216|P1|Overall Study|Lost to Follow-up|26
1861271|NCT00090519|6422215|P2|Overall Study|Death|9
1861272|NCT00090519|6422216|P1|Overall Study|Death|9
1861273|NCT00090519|6422215|P2|Overall Study|Adverse Event|4
1861274|NCT00090519|6422216|P1|Overall Study|Adverse Event|5
1861275|NCT00090493|6422240|P1|Overall Study|Physician Decision|2
1861276|NCT00090363|6422247|P3|Overall Study|Continuing on study off treatment|16
1861277|NCT00090363|6422248|P2|Overall Study|Continuing on study off treatment|13
1861278|NCT00090363|6422249|P1|Overall Study|Continuing on study off treatment|14
1861279|NCT00090363|6422247|P3|Overall Study|Reasons not specified|1
1861280|NCT00090363|6422248|P2|Overall Study|Reasons not specified|1
1861281|NCT00090363|6422249|P1|Overall Study|Reasons not specified|2
1861282|NCT00090363|6422247|P3|Overall Study|Consent expired|9
1861283|NCT00090363|6422248|P2|Overall Study|Consent expired|10
1861284|NCT00090363|6422249|P1|Overall Study|Consent expired|7
1861285|NCT00090363|6422247|P3|Overall Study|Eligibility criteria not fulfilled|1
1861286|NCT00090363|6422248|P2|Overall Study|Eligibility criteria not fulfilled|0
1861287|NCT00090363|6422249|P1|Overall Study|Eligibility criteria not fulfilled|0
1861288|NCT00090363|6422247|P3|Overall Study|Study-specific discontinuation criteria|62
1861289|NCT00090363|6422248|P2|Overall Study|Study-specific discontinuation criteria|74
1861290|NCT00090363|6422249|P1|Overall Study|Study-specific discontinuation criteria|75
1861291|NCT00090363|6422247|P3|Overall Study|Withdrawal by Subject|6
1861292|NCT00090363|6422248|P2|Overall Study|Withdrawal by Subject|7
1861293|NCT00090363|6422249|P1|Overall Study|Withdrawal by Subject|7
1861294|NCT00090363|6422247|P3|Overall Study|Lost to Follow-up|1
1861295|NCT00090363|6422248|P2|Overall Study|Lost to Follow-up|2
1861296|NCT00090363|6422249|P1|Overall Study|Lost to Follow-up|1
1861297|NCT00090545|6422271|P2|Overall Study|Adverse Event|2
1861298|NCT00090545|6422272|P1|Overall Study|Adverse Event|0
1861299|NCT00090545|6422271|P2|Overall Study|Death|1
1861300|NCT00090545|6422272|P1|Overall Study|Death|0
1861301|NCT00090545|6422271|P2|Overall Study|Refused further treatment|4
1861302|NCT00090545|6422272|P1|Overall Study|Refused further treatment|1
1861303|NCT00090545|6422271|P2|Overall Study|Disease progression on study|17
1861304|NCT00090545|6422272|P1|Overall Study|Disease progression on study|21
1861305|NCT00090285|6422292|P6|Long-term Follow-up (EXT2)|Physician Decision|5
1861306|NCT00090285|6422293|P5|Long-term Follow-up (EXT2)|Physician Decision|6
1861307|NCT00090285|6422294|P4|Long-term Follow-up (EXT2)|Physician Decision|0
1861308|NCT00090285|6422295|P3|Long-term Follow-up (EXT2)|Physician Decision|0
1861309|NCT00090285|6422296|P2|Long-term Follow-up (EXT2)|Physician Decision|0
1861310|NCT00090285|6422297|P1|Long-term Follow-up (EXT2)|Physician Decision|0
1861311|NCT00090285|6422292|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
1861312|NCT00090285|6422293|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
1861313|NCT00090285|6422294|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861314|NCT00090285|6422295|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861315|NCT00090285|6422296|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861316|NCT00090285|6422297|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861317|NCT00090285|6422292|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
1861318|NCT00090285|6422293|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
1861319|NCT00090285|6422294|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861320|NCT00090285|6422295|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861321|NCT00090285|6422296|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861322|NCT00090285|6422297|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861323|NCT00090285|6422292|P6|Long-term Follow-up (EXT2)|Adverse Event|2
1861324|NCT00090285|6422293|P5|Long-term Follow-up (EXT2)|Adverse Event|5
1861325|NCT00090285|6422294|P4|Long-term Follow-up (EXT2)|Adverse Event|0
1861326|NCT00090285|6422295|P3|Long-term Follow-up (EXT2)|Adverse Event|0
1861327|NCT00090285|6422296|P2|Long-term Follow-up (EXT2)|Adverse Event|0
1861328|NCT00090285|6422297|P1|Long-term Follow-up (EXT2)|Adverse Event|0
1861329|NCT00090285|6422292|P6|Extension 1|Moved|0
1861330|NCT00090285|6422293|P5|Extension 1|Moved|0
1861331|NCT00090285|6422294|P4|Extension 1|Moved|0
1861332|NCT00090285|6422295|P3|Extension 1|Moved|3
1861333|NCT00090285|6422296|P2|Extension 1|Moved|0
1861334|NCT00090285|6422297|P1|Extension 1|Moved|0
1861335|NCT00090285|6422292|P6|Extension 1|Other|0
1861336|NCT00090285|6422293|P5|Extension 1|Other|0
1861337|NCT00090285|6422294|P4|Extension 1|Other|0
1861338|NCT00090285|6422295|P3|Extension 1|Other|4
1861339|NCT00090285|6422296|P2|Extension 1|Other|0
1861340|NCT00090285|6422297|P1|Extension 1|Other|0
1861341|NCT00090285|6422292|P6|Extension 1|Withdrawal by Subject|0
1861342|NCT00090285|6422293|P5|Extension 1|Withdrawal by Subject|0
1861343|NCT00090285|6422294|P4|Extension 1|Withdrawal by Subject|1
1861344|NCT00090285|6422295|P3|Extension 1|Withdrawal by Subject|13
1861345|NCT00090285|6422296|P2|Extension 1|Withdrawal by Subject|0
1861346|NCT00090285|6422297|P1|Extension 1|Withdrawal by Subject|0
1861347|NCT00090285|6422292|P6|Extension 1|Lost to Follow-up|0
1861348|NCT00090285|6422293|P5|Extension 1|Lost to Follow-up|0
1861349|NCT00090285|6422294|P4|Extension 1|Lost to Follow-up|0
1861350|NCT00090285|6422295|P3|Extension 1|Lost to Follow-up|35
1861351|NCT00090285|6422296|P2|Extension 1|Lost to Follow-up|0
1861352|NCT00090285|6422297|P1|Extension 1|Lost to Follow-up|0
1861353|NCT00090285|6422292|P6|Extension 1|Adverse Event|0
1861354|NCT00090285|6422293|P5|Extension 1|Adverse Event|0
1861355|NCT00090285|6422294|P4|Extension 1|Adverse Event|0
1861356|NCT00090285|6422295|P3|Extension 1|Adverse Event|2
1861357|NCT00090285|6422296|P2|Extension 1|Adverse Event|0
1861358|NCT00090285|6422297|P1|Extension 1|Adverse Event|0
1861359|NCT00090285|6422292|P6|Base Study Follow-up Period|Subject Incarcerated|0
1861360|NCT00090285|6422293|P5|Base Study Follow-up Period|Subject Incarcerated|0
1861361|NCT00090285|6422294|P4|Base Study Follow-up Period|Subject Incarcerated|0
1861362|NCT00090285|6422295|P3|Base Study Follow-up Period|Subject Incarcerated|0
1861363|NCT00090285|6422296|P2|Base Study Follow-up Period|Subject Incarcerated|2
1861364|NCT00090285|6422297|P1|Base Study Follow-up Period|Subject Incarcerated|0
1861365|NCT00090285|6422292|P6|Base Study Follow-up Period|Uncooperative|0
1861366|NCT00090285|6422293|P5|Base Study Follow-up Period|Uncooperative|0
1861367|NCT00090285|6422294|P4|Base Study Follow-up Period|Uncooperative|0
1861368|NCT00090285|6422295|P3|Base Study Follow-up Period|Uncooperative|0
1861369|NCT00090285|6422296|P2|Base Study Follow-up Period|Uncooperative|4
1861370|NCT00090285|6422297|P1|Base Study Follow-up Period|Uncooperative|3
1861371|NCT00090285|6422292|P6|Base Study Follow-up Period|Protocol Violation|0
1861372|NCT00090285|6422293|P5|Base Study Follow-up Period|Protocol Violation|0
1861373|NCT00090285|6422294|P4|Base Study Follow-up Period|Protocol Violation|0
1861374|NCT00090285|6422295|P3|Base Study Follow-up Period|Protocol Violation|0
1861375|NCT00090285|6422296|P2|Base Study Follow-up Period|Protocol Violation|0
1861376|NCT00090285|6422297|P1|Base Study Follow-up Period|Protocol Violation|1
1861377|NCT00090285|6422292|P6|Base Study Follow-up Period|Other|0
1861378|NCT00090285|6422293|P5|Base Study Follow-up Period|Other|0
1861379|NCT00090285|6422294|P4|Base Study Follow-up Period|Other|0
1861380|NCT00090285|6422295|P3|Base Study Follow-up Period|Other|0
1861381|NCT00090285|6422296|P2|Base Study Follow-up Period|Other|0
1861382|NCT00090285|6422297|P1|Base Study Follow-up Period|Other|2
1861383|NCT00090285|6422292|P6|Base Study Follow-up Period|Moved|0
1861384|NCT00090285|6422293|P5|Base Study Follow-up Period|Moved|0
1861385|NCT00090285|6422294|P4|Base Study Follow-up Period|Moved|0
1861386|NCT00090285|6422295|P3|Base Study Follow-up Period|Moved|0
1861387|NCT00090285|6422296|P2|Base Study Follow-up Period|Moved|36
1861388|NCT00090285|6422297|P1|Base Study Follow-up Period|Moved|41
1861389|NCT00090285|6422292|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1861390|NCT00090285|6422293|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1861391|NCT00090285|6422294|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1861392|NCT00090285|6422295|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1861393|NCT00090285|6422296|P2|Base Study Follow-up Period|Withdrawal by Subject|64
1861394|NCT00090285|6422297|P1|Base Study Follow-up Period|Withdrawal by Subject|53
1861395|NCT00090285|6422292|P6|Base Study Follow-up Period|Lost to Follow-up|0
1861396|NCT00090285|6422293|P5|Base Study Follow-up Period|Lost to Follow-up|0
1861397|NCT00090285|6422294|P4|Base Study Follow-up Period|Lost to Follow-up|0
1861398|NCT00090285|6422295|P3|Base Study Follow-up Period|Lost to Follow-up|0
1861399|NCT00090285|6422296|P2|Base Study Follow-up Period|Lost to Follow-up|226
1861400|NCT00090285|6422297|P1|Base Study Follow-up Period|Lost to Follow-up|232
1861401|NCT00090285|6422292|P6|Base Study Follow-up Period|Adverse Event|0
1861402|NCT00090285|6422293|P5|Base Study Follow-up Period|Adverse Event|0
1861403|NCT00090285|6422294|P4|Base Study Follow-up Period|Adverse Event|0
1861404|NCT00090285|6422295|P3|Base Study Follow-up Period|Adverse Event|0
1861405|NCT00090285|6422296|P2|Base Study Follow-up Period|Adverse Event|10
1861406|NCT00090285|6422297|P1|Base Study Follow-up Period|Adverse Event|3
1861407|NCT00090285|6422292|P6|Base Study Vaccination Period|HIV positive|0
1861408|NCT00090285|6422293|P5|Base Study Vaccination Period|HIV positive|0
1861409|NCT00090285|6422294|P4|Base Study Vaccination Period|HIV positive|0
1861410|NCT00090285|6422295|P3|Base Study Vaccination Period|HIV positive|0
1861411|NCT00090285|6422296|P2|Base Study Vaccination Period|HIV positive|1
1861412|NCT00090285|6422297|P1|Base Study Vaccination Period|HIV positive|1
1861413|NCT00090285|6422292|P6|Base Study Vaccination Period|Subject Incarcerated|0
1861414|NCT00090285|6422293|P5|Base Study Vaccination Period|Subject Incarcerated|0
1861415|NCT00090285|6422294|P4|Base Study Vaccination Period|Subject Incarcerated|0
1861416|NCT00090285|6422295|P3|Base Study Vaccination Period|Subject Incarcerated|0
1861417|NCT00090285|6422296|P2|Base Study Vaccination Period|Subject Incarcerated|2
1861418|NCT00090285|6422297|P1|Base Study Vaccination Period|Subject Incarcerated|2
1861419|NCT00090285|6422292|P6|Base Study Vaccination Period|Other|0
1861420|NCT00090285|6422293|P5|Base Study Vaccination Period|Other|0
1861421|NCT00090285|6422294|P4|Base Study Vaccination Period|Other|0
1861422|NCT00090285|6422295|P3|Base Study Vaccination Period|Other|0
1861423|NCT00090285|6422296|P2|Base Study Vaccination Period|Other|2
1861424|NCT00090285|6422297|P1|Base Study Vaccination Period|Other|2
1861425|NCT00090285|6422292|P6|Base Study Vaccination Period|Site Terminated|0
1861426|NCT00090285|6422293|P5|Base Study Vaccination Period|Site Terminated|0
1861427|NCT00090285|6422294|P4|Base Study Vaccination Period|Site Terminated|0
1861428|NCT00090285|6422295|P3|Base Study Vaccination Period|Site Terminated|0
1861429|NCT00090285|6422296|P2|Base Study Vaccination Period|Site Terminated|0
1861430|NCT00090285|6422297|P1|Base Study Vaccination Period|Site Terminated|1
1861431|NCT00090285|6422292|P6|Base Study Vaccination Period|Moved|0
1861432|NCT00090285|6422293|P5|Base Study Vaccination Period|Moved|0
1861433|NCT00090285|6422294|P4|Base Study Vaccination Period|Moved|0
1861434|NCT00090285|6422295|P3|Base Study Vaccination Period|Moved|0
1861435|NCT00090285|6422296|P2|Base Study Vaccination Period|Moved|21
1861436|NCT00090285|6422297|P1|Base Study Vaccination Period|Moved|20
1861437|NCT00090285|6422292|P6|Base Study Vaccination Period|Uncooperative|0
1861438|NCT00090285|6422293|P5|Base Study Vaccination Period|Uncooperative|0
1861439|NCT00090285|6422294|P4|Base Study Vaccination Period|Uncooperative|0
1861440|NCT00090285|6422295|P3|Base Study Vaccination Period|Uncooperative|0
1861441|NCT00090285|6422296|P2|Base Study Vaccination Period|Uncooperative|2
1861442|NCT00090285|6422297|P1|Base Study Vaccination Period|Uncooperative|2
1861443|NCT00090285|6422292|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1861444|NCT00090285|6422293|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1861527|NCT00090220|6422378|P4|Extension 1 (EXT1)|Protocol Violation|1
1861445|NCT00090285|6422294|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1861446|NCT00090285|6422295|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1861447|NCT00090285|6422296|P2|Base Study Vaccination Period|Withdrawal by Subject|69
1861448|NCT00090285|6422297|P1|Base Study Vaccination Period|Withdrawal by Subject|64
1861449|NCT00090285|6422292|P6|Base Study Vaccination Period|Protocol Violation|0
1861450|NCT00090285|6422293|P5|Base Study Vaccination Period|Protocol Violation|0
1861451|NCT00090285|6422294|P4|Base Study Vaccination Period|Protocol Violation|0
1861452|NCT00090285|6422295|P3|Base Study Vaccination Period|Protocol Violation|0
1861453|NCT00090285|6422296|P2|Base Study Vaccination Period|Protocol Violation|3
1861454|NCT00090285|6422297|P1|Base Study Vaccination Period|Protocol Violation|2
1861455|NCT00090285|6422292|P6|Base Study Vaccination Period|Lost to Follow-up|0
1861456|NCT00090285|6422293|P5|Base Study Vaccination Period|Lost to Follow-up|0
1861457|NCT00090285|6422294|P4|Base Study Vaccination Period|Lost to Follow-up|0
1861458|NCT00090285|6422295|P3|Base Study Vaccination Period|Lost to Follow-up|0
1861459|NCT00090285|6422296|P2|Base Study Vaccination Period|Lost to Follow-up|112
1861460|NCT00090285|6422297|P1|Base Study Vaccination Period|Lost to Follow-up|111
1861461|NCT00090285|6422292|P6|Base Study Vaccination Period|Adverse Event|0
1861462|NCT00090285|6422293|P5|Base Study Vaccination Period|Adverse Event|0
1861463|NCT00090285|6422294|P4|Base Study Vaccination Period|Adverse Event|0
1861464|NCT00090285|6422295|P3|Base Study Vaccination Period|Adverse Event|0
1861465|NCT00090285|6422296|P2|Base Study Vaccination Period|Adverse Event|4
1861466|NCT00090285|6422297|P1|Base Study Vaccination Period|Adverse Event|2
1861467|NCT00090285|6422292|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
1861468|NCT00090285|6422293|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
1861469|NCT00090285|6422294|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
1861470|NCT00090285|6422295|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
1861471|NCT00090285|6422296|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
1861472|NCT00090285|6422297|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
1861473|NCT00090259|6422334|P2|Overall Study|Investigator site closed|7
1861474|NCT00090259|6422335|P1|Overall Study|Investigator site closed|11
1861475|NCT00090259|6422334|P2|Overall Study|Withdrawal by Subject|15
1861476|NCT00090259|6422335|P1|Overall Study|Withdrawal by Subject|21
1861477|NCT00090259|6422334|P2|Overall Study|Lost to Follow-up|26
1861478|NCT00090259|6422335|P1|Overall Study|Lost to Follow-up|30
1861479|NCT00090233|6422351|P2|Overall Study|Data not available at data cut-off point|1563
1861480|NCT00090233|6422352|P1|Overall Study|Data not available at data cut-off point|1552
1861481|NCT00090233|6422351|P2|Overall Study|Other|1160
1861482|NCT00090233|6422352|P1|Overall Study|Other|1211
1861483|NCT00090233|6422351|P2|Overall Study|Moved|189
1861484|NCT00090233|6422352|P1|Overall Study|Moved|203
1861485|NCT00090233|6422351|P2|Overall Study|Withdrawal by Subject|211
1861486|NCT00090233|6422352|P1|Overall Study|Withdrawal by Subject|182
1861487|NCT00090233|6422351|P2|Overall Study|Protocol Violation|1022
1861488|NCT00090233|6422352|P1|Overall Study|Protocol Violation|960
1861489|NCT00090233|6422351|P2|Overall Study|Lost to Follow-up|95
1861490|NCT00090233|6422352|P1|Overall Study|Lost to Follow-up|68
1861491|NCT00090233|6422351|P2|Overall Study|Adverse Event|198
1861492|NCT00090233|6422352|P1|Overall Study|Adverse Event|214
1861493|NCT00090233|6422351|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
1861494|NCT00090233|6422352|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
1861495|NCT00090220|6422376|P6|Long-term Follow-up (EXT2)|Other|0
1861496|NCT00090220|6422377|P5|Long-term Follow-up (EXT2)|Other|1
1861497|NCT00090220|6422378|P4|Long-term Follow-up (EXT2)|Other|0
1861498|NCT00090220|6422379|P3|Long-term Follow-up (EXT2)|Other|0
1861499|NCT00090220|6422380|P2|Long-term Follow-up (EXT2)|Other|0
1861500|NCT00090220|6422381|P1|Long-term Follow-up (EXT2)|Other|0
1861501|NCT00090220|6422376|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1861502|NCT00090220|6422377|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
1861503|NCT00090220|6422378|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861504|NCT00090220|6422379|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861505|NCT00090220|6422380|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861506|NCT00090220|6422381|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
1861507|NCT00090220|6422376|P6|Long-term Follow-up (EXT2)|Death|1
1861508|NCT00090220|6422377|P5|Long-term Follow-up (EXT2)|Death|1
1861509|NCT00090220|6422378|P4|Long-term Follow-up (EXT2)|Death|0
1861510|NCT00090220|6422379|P3|Long-term Follow-up (EXT2)|Death|0
1861511|NCT00090220|6422380|P2|Long-term Follow-up (EXT2)|Death|0
1861512|NCT00090220|6422381|P1|Long-term Follow-up (EXT2)|Death|0
1861513|NCT00090220|6422376|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
1861514|NCT00090220|6422377|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
1861515|NCT00090220|6422378|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861516|NCT00090220|6422379|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861517|NCT00090220|6422380|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861518|NCT00090220|6422381|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
1861519|NCT00090220|6422376|P6|Extension 1 (EXT1)|Other reason|0
1861520|NCT00090220|6422377|P5|Extension 1 (EXT1)|Other reason|0
1861521|NCT00090220|6422378|P4|Extension 1 (EXT1)|Other reason|0
1861522|NCT00090220|6422379|P3|Extension 1 (EXT1)|Other reason|2
1861523|NCT00090220|6422380|P2|Extension 1 (EXT1)|Other reason|0
1861524|NCT00090220|6422381|P1|Extension 1 (EXT1)|Other reason|0
1861525|NCT00090220|6422376|P6|Extension 1 (EXT1)|Protocol Violation|0
1861526|NCT00090220|6422377|P5|Extension 1 (EXT1)|Protocol Violation|0
1861528|NCT00090220|6422379|P3|Extension 1 (EXT1)|Protocol Violation|0
1861529|NCT00090220|6422380|P2|Extension 1 (EXT1)|Protocol Violation|0
1861530|NCT00090220|6422381|P1|Extension 1 (EXT1)|Protocol Violation|0
1861531|NCT00090220|6422376|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
1861532|NCT00090220|6422377|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
1861533|NCT00090220|6422378|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
1861534|NCT00090220|6422379|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
1861535|NCT00090220|6422380|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
1861536|NCT00090220|6422381|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
1861537|NCT00090220|6422376|P6|Extension 1 (EXT1)|Moved|0
1861538|NCT00090220|6422377|P5|Extension 1 (EXT1)|Moved|0
1861539|NCT00090220|6422378|P4|Extension 1 (EXT1)|Moved|1
1861540|NCT00090220|6422379|P3|Extension 1 (EXT1)|Moved|2
1861541|NCT00090220|6422380|P2|Extension 1 (EXT1)|Moved|0
1861542|NCT00090220|6422381|P1|Extension 1 (EXT1)|Moved|0
1861543|NCT00090220|6422376|P6|Extension 1 (EXT1)|Lost to Follow-up|0
1861544|NCT00090220|6422377|P5|Extension 1 (EXT1)|Lost to Follow-up|0
1861545|NCT00090220|6422378|P4|Extension 1 (EXT1)|Lost to Follow-up|0
1861546|NCT00090220|6422379|P3|Extension 1 (EXT1)|Lost to Follow-up|22
1861547|NCT00090220|6422380|P2|Extension 1 (EXT1)|Lost to Follow-up|0
1861548|NCT00090220|6422381|P1|Extension 1 (EXT1)|Lost to Follow-up|0
1861549|NCT00090220|6422376|P6|Extension 1 (EXT1)|Adverse Event|0
1861550|NCT00090220|6422377|P5|Extension 1 (EXT1)|Adverse Event|0
1861551|NCT00090220|6422378|P4|Extension 1 (EXT1)|Adverse Event|0
1861552|NCT00090220|6422379|P3|Extension 1 (EXT1)|Adverse Event|4
1861553|NCT00090220|6422380|P2|Extension 1 (EXT1)|Adverse Event|0
1861554|NCT00090220|6422381|P1|Extension 1 (EXT1)|Adverse Event|0
1861555|NCT00090220|6422376|P6|Base Study Follow-up Period|Other|0
1861556|NCT00090220|6422377|P5|Base Study Follow-up Period|Other|0
1861557|NCT00090220|6422378|P4|Base Study Follow-up Period|Other|0
1861558|NCT00090220|6422379|P3|Base Study Follow-up Period|Other|0
1861559|NCT00090220|6422380|P2|Base Study Follow-up Period|Other|21
1861560|NCT00090220|6422381|P1|Base Study Follow-up Period|Other|19
1861561|NCT00090220|6422376|P6|Base Study Follow-up Period|Patient Moved|0
1861562|NCT00090220|6422377|P5|Base Study Follow-up Period|Patient Moved|0
1861563|NCT00090220|6422378|P4|Base Study Follow-up Period|Patient Moved|0
1861564|NCT00090220|6422379|P3|Base Study Follow-up Period|Patient Moved|0
1861565|NCT00090220|6422380|P2|Base Study Follow-up Period|Patient Moved|28
1861566|NCT00090220|6422381|P1|Base Study Follow-up Period|Patient Moved|20
1861567|NCT00090220|6422376|P6|Base Study Follow-up Period|Withdrawal by Subject|0
1861568|NCT00090220|6422377|P5|Base Study Follow-up Period|Withdrawal by Subject|0
1861569|NCT00090220|6422378|P4|Base Study Follow-up Period|Withdrawal by Subject|0
1861570|NCT00090220|6422379|P3|Base Study Follow-up Period|Withdrawal by Subject|0
1861571|NCT00090220|6422380|P2|Base Study Follow-up Period|Withdrawal by Subject|36
1861572|NCT00090220|6422381|P1|Base Study Follow-up Period|Withdrawal by Subject|27
1861573|NCT00090220|6422376|P6|Base Study Follow-up Period|Lost to Follow-up|0
1861574|NCT00090220|6422377|P5|Base Study Follow-up Period|Lost to Follow-up|0
1861575|NCT00090220|6422378|P4|Base Study Follow-up Period|Lost to Follow-up|0
1861576|NCT00090220|6422379|P3|Base Study Follow-up Period|Lost to Follow-up|0
1861577|NCT00090220|6422380|P2|Base Study Follow-up Period|Lost to Follow-up|78
1861578|NCT00090220|6422381|P1|Base Study Follow-up Period|Lost to Follow-up|88
1861579|NCT00090220|6422376|P6|Base Study Follow-up Period|Adverse Event|0
1861580|NCT00090220|6422377|P5|Base Study Follow-up Period|Adverse Event|0
1861581|NCT00090220|6422378|P4|Base Study Follow-up Period|Adverse Event|0
1861582|NCT00090220|6422379|P3|Base Study Follow-up Period|Adverse Event|0
1861583|NCT00090220|6422380|P2|Base Study Follow-up Period|Adverse Event|1
1861584|NCT00090220|6422381|P1|Base Study Follow-up Period|Adverse Event|6
1861585|NCT00090220|6422376|P6|Base Study Vaccination Period|Other|0
1861586|NCT00090220|6422377|P5|Base Study Vaccination Period|Other|0
1861587|NCT00090220|6422378|P4|Base Study Vaccination Period|Other|0
1861588|NCT00090220|6422379|P3|Base Study Vaccination Period|Other|0
1861589|NCT00090220|6422380|P2|Base Study Vaccination Period|Other|4
1861590|NCT00090220|6422381|P1|Base Study Vaccination Period|Other|4
1861591|NCT00090220|6422376|P6|Base Study Vaccination Period|Patient Moved|0
1861592|NCT00090220|6422377|P5|Base Study Vaccination Period|Patient Moved|0
1861593|NCT00090220|6422378|P4|Base Study Vaccination Period|Patient Moved|0
1861594|NCT00090220|6422379|P3|Base Study Vaccination Period|Patient Moved|0
1861595|NCT00090220|6422380|P2|Base Study Vaccination Period|Patient Moved|2
1861596|NCT00090220|6422381|P1|Base Study Vaccination Period|Patient Moved|6
1861597|NCT00090220|6422376|P6|Base Study Vaccination Period|Withdrawal by Subject|0
1861598|NCT00090220|6422377|P5|Base Study Vaccination Period|Withdrawal by Subject|0
1861599|NCT00090220|6422378|P4|Base Study Vaccination Period|Withdrawal by Subject|0
1861600|NCT00090220|6422379|P3|Base Study Vaccination Period|Withdrawal by Subject|0
1861601|NCT00090220|6422380|P2|Base Study Vaccination Period|Withdrawal by Subject|27
1861602|NCT00090220|6422381|P1|Base Study Vaccination Period|Withdrawal by Subject|23
1861603|NCT00090220|6422376|P6|Base Study Vaccination Period|Lost to Follow-up|0
1861604|NCT00090220|6422377|P5|Base Study Vaccination Period|Lost to Follow-up|0
1861605|NCT00090220|6422378|P4|Base Study Vaccination Period|Lost to Follow-up|0
1861606|NCT00090220|6422379|P3|Base Study Vaccination Period|Lost to Follow-up|0
1861607|NCT00090220|6422380|P2|Base Study Vaccination Period|Lost to Follow-up|28
1861608|NCT00090220|6422381|P1|Base Study Vaccination Period|Lost to Follow-up|24
1861609|NCT00090220|6422376|P6|Base Study Vaccination Period|Adverse Event|0
1861610|NCT00090220|6422377|P5|Base Study Vaccination Period|Adverse Event|0
1861611|NCT00090220|6422378|P4|Base Study Vaccination Period|Adverse Event|0
1861612|NCT00090220|6422379|P3|Base Study Vaccination Period|Adverse Event|0
1861613|NCT00090220|6422380|P2|Base Study Vaccination Period|Adverse Event|1
1861614|NCT00090220|6422381|P1|Base Study Vaccination Period|Adverse Event|6
1861615|NCT00090220|6422376|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
1861616|NCT00090220|6422377|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
1861617|NCT00090220|6422378|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
1861618|NCT00090220|6422379|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
1861619|NCT00090220|6422380|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
1861620|NCT00090220|6422381|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
1861621|NCT00090402|6422476|P3|Overall Study|stopped taking study medication|1
1861622|NCT00090402|6422477|P2|Overall Study|stopped taking study medication|0
1861623|NCT00090402|6422478|P1|Overall Study|stopped taking study medication|1
1861624|NCT00090402|6422476|P3|Overall Study|subject moved|0
1861625|NCT00090402|6422477|P2|Overall Study|subject moved|1
1861626|NCT00090402|6422478|P1|Overall Study|subject moved|0
1861627|NCT00090402|6422476|P3|Overall Study|Death|0
1861628|NCT00090402|6422477|P2|Overall Study|Death|1
1861629|NCT00090402|6422478|P1|Overall Study|Death|1
1861630|NCT00090142|6422492|P2|Treatment Period II|Other|0
1861631|NCT00090142|6422493|P1|Treatment Period II|Other|1
1861632|NCT00090142|6422492|P2|Treatment Period I|Other|1
1861633|NCT00090142|6422493|P1|Treatment Period I|Other|0
1861634|NCT00090142|6422492|P2|Treatment Period I|Withdrawal by Subject|0
1861635|NCT00090142|6422493|P1|Treatment Period I|Withdrawal by Subject|2
1861636|NCT00090142|6422492|P2|Treatment Period I|Protocol Violation|0
1861637|NCT00090142|6422493|P1|Treatment Period I|Protocol Violation|2
1861638|NCT00090142|6422492|P2|Treatment Period I|Lost to Follow-up|2
1861639|NCT00090142|6422493|P1|Treatment Period I|Lost to Follow-up|1
1861640|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Other|0
1861641|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Other|1
1861642|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Other|0
1861643|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Jailed|0
1861644|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Jailed|1
1861645|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Jailed|0
1861646|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1861647|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
1861648|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
1861649|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Depression|0
1861650|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Depression|1
1861651|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Depression|0
1861652|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
1861653|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
1861654|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
1861655|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
1861656|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
1861657|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
1861658|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Back Pain|0
1861659|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Back Pain|1
1861660|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Back Pain|0
1861661|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
1861662|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
1861663|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
1861664|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
1861665|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
1861666|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
1861667|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
1861668|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
1861669|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
1861670|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Gyneomastia|0
1861671|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Gyneomastia|0
1861672|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Gyneomastia|1
1861673|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Death|1
1861674|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Death|0
1861675|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Death|1
1861676|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
1861677|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
1861678|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
1861679|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Enrollment Error|2
1861680|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Enrollment Error|0
1861681|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Enrollment Error|1
1861682|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Loss of Libido|0
1861683|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Loss of Libido|0
1861684|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Loss of Libido|1
1861685|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
1861686|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
1861687|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
1861688|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
1861689|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
1861690|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
1861691|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
1861692|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
1861693|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
1861694|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1861695|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
1861696|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
1861697|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Participant relocated|1
1861698|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Participant relocated|3
1861699|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Participant relocated|2
1861700|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1861701|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
1861702|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
1861703|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Loss of Contact|2
1861704|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Loss of Contact|0
1861705|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Loss of Contact|4
1861706|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
1861707|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
1861708|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
1861709|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
1861710|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
1861711|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
1861712|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Protocol Violation|17
1861713|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Protocol Violation|18
1861714|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Protocol Violation|18
1861715|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
1861716|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
1861717|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
1861718|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
1861719|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
1861720|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
1861721|NCT00090103|6422524|P3|16-Week Safety Follow-up Period|Adverse Event|44
1861722|NCT00090103|6422525|P2|16-Week Safety Follow-up Period|Adverse Event|39
1861723|NCT00090103|6422526|P1|16-Week Safety Follow-up Period|Adverse Event|34
1861724|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1861725|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
1861726|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
1861727|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
1861728|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1861729|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
1861730|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
1861731|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1861732|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
1861733|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
1861734|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
1861735|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
1861736|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1861737|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
1861738|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
1861739|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1861740|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
1861741|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
1861742|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
1861743|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
1861744|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
1861745|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1861746|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
1861747|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
1861748|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1861749|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
1861750|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
1861751|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1861752|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
1861753|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
1861754|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1861755|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
1861756|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
1861757|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1861758|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
1861759|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
1861760|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1861761|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
1861762|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
1861763|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
1861764|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
1861765|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
1861766|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
1861767|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
1861768|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
1861769|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
1861770|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
1861771|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
1861772|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
1861773|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
1861774|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
1861775|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1861776|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
1861777|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
1861778|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1861779|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
1861780|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
1861781|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
1861782|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1861783|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
1861784|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
1861785|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
1861786|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
1861787|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
1861788|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
1861789|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
1861790|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
1861791|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
1861792|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
1861793|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
1861794|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
1861795|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
1861796|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
1861797|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1861798|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
1861799|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
1861800|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
1861801|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
1861802|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
1861803|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
1861804|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
1861805|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
1861806|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1861807|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
1861808|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
1861809|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
1861810|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
1861811|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
1861812|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
1861813|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
1861814|NCT00090103|6422524|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
1861815|NCT00090103|6422525|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
1861816|NCT00090103|6422526|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
1861817|NCT00089999|6422692|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
1861818|NCT00089999|6422693|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
1861819|NCT00089999|6422692|P2|Overall Study|Patient Underwent Surgery|0
1861820|NCT00089999|6422693|P1|Overall Study|Patient Underwent Surgery|2
1861821|NCT00089999|6422692|P2|Overall Study|Physician Decision|2
1861822|NCT00089999|6422693|P1|Overall Study|Physician Decision|2
1861823|NCT00089999|6422692|P2|Overall Study|Clinical Progression|2
1861824|NCT00089999|6422693|P1|Overall Study|Clinical Progression|1
1861825|NCT00089999|6422692|P2|Overall Study|Poor General Condition|0
1861826|NCT00089999|6422693|P1|Overall Study|Poor General Condition|1
1861827|NCT00089999|6422692|P2|Overall Study|Death|3
1861828|NCT00089999|6422693|P1|Overall Study|Death|3
1861829|NCT00089999|6422692|P2|Overall Study|Symptomatic Progression of Cancer|5
1861830|NCT00089999|6422693|P1|Overall Study|Symptomatic Progression of Cancer|2
1861831|NCT00089999|6422692|P2|Overall Study|Radiological Progression of Cancer|44
1861832|NCT00089999|6422693|P1|Overall Study|Radiological Progression of Cancer|52
1861833|NCT00089999|6422692|P2|Overall Study|Lost to Follow-up|1
1861834|NCT00089999|6422693|P1|Overall Study|Lost to Follow-up|2
1861835|NCT00089999|6422692|P2|Overall Study|Withdrawal by Subject|4
1861836|NCT00089999|6422693|P1|Overall Study|Withdrawal by Subject|0
1861837|NCT00089999|6422692|P2|Overall Study|Adverse Event|7
1861838|NCT00089999|6422693|P1|Overall Study|Adverse Event|4
1861839|NCT00089986|6422716|P3|Overall Study|Withdrawal by Subject|2
1861840|NCT00089986|6422717|P2|Overall Study|Withdrawal by Subject|6
1861841|NCT00089986|6422718|P1|Overall Study|Withdrawal by Subject|3
1861842|NCT00089986|6422716|P3|Overall Study|Do not resuscitate (DNR)|1
1861843|NCT00089986|6422717|P2|Overall Study|Do not resuscitate (DNR)|0
1861844|NCT00089986|6422718|P1|Overall Study|Do not resuscitate (DNR)|0
1861845|NCT00089986|6422716|P3|Overall Study|Family decision|0
1861846|NCT00089986|6422717|P2|Overall Study|Family decision|1
1861847|NCT00089986|6422718|P1|Overall Study|Family decision|0
1861848|NCT00089986|6422716|P3|Overall Study|Enrollment in another study|0
1861849|NCT00089986|6422717|P2|Overall Study|Enrollment in another study|1
1861850|NCT00089986|6422718|P1|Overall Study|Enrollment in another study|0
1861851|NCT00089986|6422716|P3|Overall Study|Investigator decision to withdrew|0
1861852|NCT00089986|6422717|P2|Overall Study|Investigator decision to withdrew|1
1861853|NCT00089986|6422718|P1|Overall Study|Investigator decision to withdrew|0
1861854|NCT00089986|6422716|P3|Overall Study|Hemohlobin stopping rule|0
1861855|NCT00089986|6422717|P2|Overall Study|Hemohlobin stopping rule|1
1861856|NCT00089986|6422718|P1|Overall Study|Hemohlobin stopping rule|0
1861857|NCT00089986|6422716|P3|Overall Study|Subject withdrew but agreed follow up|0
1861858|NCT00089986|6422717|P2|Overall Study|Subject withdrew but agreed follow up|2
1861859|NCT00089986|6422718|P1|Overall Study|Subject withdrew but agreed follow up|1
1861860|NCT00089986|6422716|P3|Overall Study|Patient transferred to another hospital|0
1861861|NCT00089986|6422717|P2|Overall Study|Patient transferred to another hospital|1
1861862|NCT00089986|6422718|P1|Overall Study|Patient transferred to another hospital|2
1861863|NCT00089986|6422716|P3|Overall Study|Protocol Violation|0
1861864|NCT00089986|6422717|P2|Overall Study|Protocol Violation|1
1861865|NCT00089986|6422718|P1|Overall Study|Protocol Violation|0
1861866|NCT00089986|6422716|P3|Overall Study|Lost to Follow-up|1
1861867|NCT00089986|6422717|P2|Overall Study|Lost to Follow-up|1
1861868|NCT00089986|6422718|P1|Overall Study|Lost to Follow-up|3
1861869|NCT00089986|6422716|P3|Overall Study|Adverse Event|6
1861870|NCT00089986|6422717|P2|Overall Study|Adverse Event|9
1861871|NCT00089986|6422718|P1|Overall Study|Adverse Event|6
1861872|NCT00089973|6422735|P1|Overall Study|Death|1
1861873|NCT00089973|6422735|P1|Overall Study|Disease progression|45
1861874|NCT00089973|6422735|P1|Overall Study|Withdrawal by Subject|1
1861875|NCT00089973|6422735|P1|Overall Study|Adverse Event|3
1861876|NCT00089895|6422750|P2|Overall Study|Missing|2
1861877|NCT00089895|6422751|P1|Overall Study|Missing|4
1861878|NCT00089895|6422750|P2|Overall Study|Not otherwise specified|8
1861879|NCT00089895|6422751|P1|Overall Study|Not otherwise specified|4
1861880|NCT00089895|6422750|P2|Overall Study|Exclusion criteria met|6
1861881|NCT00089895|6422751|P1|Overall Study|Exclusion criteria met|6
1861882|NCT00089895|6422750|P2|Overall Study|Physician Decision|7
1861883|NCT00089895|6422751|P1|Overall Study|Physician Decision|3
1861884|NCT00089895|6422750|P2|Overall Study|Bleeding|2
1861885|NCT00089895|6422751|P1|Overall Study|Bleeding|0
1861886|NCT00089895|6422750|P2|Overall Study|Surgery|1
1861887|NCT00089895|6422751|P1|Overall Study|Surgery|0
1861888|NCT00089895|6422750|P2|Overall Study|Technical reason|2
1861889|NCT00089895|6422751|P1|Overall Study|Technical reason|7
1861890|NCT00089895|6422750|P2|Overall Study|Consent Withdrawn|14
1861891|NCT00089895|6422751|P1|Overall Study|Consent Withdrawn|11
1861892|NCT00089843|6422763|P4|Overall Study|Physician Decision|1
1861893|NCT00089843|6422764|P3|Overall Study|Physician Decision|0
1861894|NCT00089843|6422765|P2|Overall Study|Physician Decision|0
1861895|NCT00089843|6422766|P1|Overall Study|Physician Decision|1
1861896|NCT00089843|6422763|P4|Overall Study|Withdrawal by Subject|6
1861897|NCT00089843|6422764|P3|Overall Study|Withdrawal by Subject|5
1861898|NCT00089843|6422765|P2|Overall Study|Withdrawal by Subject|4
1861899|NCT00089843|6422766|P1|Overall Study|Withdrawal by Subject|1
1861900|NCT00089791|6422778|P2|Overall Study|Requirement for alternative therapy|4
1861901|NCT00089791|6422779|P1|Overall Study|Requirement for alternative therapy|7
1861902|NCT00089791|6422778|P2|Overall Study|Protocol deviation|10
1861903|NCT00089791|6422779|P1|Overall Study|Protocol deviation|12
1861904|NCT00089791|6422778|P2|Overall Study|Other|32
1861905|NCT00089791|6422779|P1|Overall Study|Other|20
1861906|NCT00089791|6422778|P2|Overall Study|Noncompliance|13
1861907|NCT00089791|6422779|P1|Overall Study|Noncompliance|17
1861908|NCT00089791|6422778|P2|Overall Study|Lost to Follow-up|57
1861909|NCT00089791|6422779|P1|Overall Study|Lost to Follow-up|57
1861910|NCT00089791|6422778|P2|Overall Study|Ineligibility determined|9
1861911|NCT00089791|6422779|P1|Overall Study|Ineligibility determined|12
1861912|NCT00089791|6422778|P2|Overall Study|Disease progression|3
1861913|NCT00089791|6422779|P1|Overall Study|Disease progression|7
1861914|NCT00089791|6422778|P2|Overall Study|Death|62
1861915|NCT00089791|6422779|P1|Overall Study|Death|78
1861916|NCT00089791|6422778|P2|Overall Study|Withdrawal by Subject|344
1861917|NCT00089791|6422779|P1|Overall Study|Withdrawal by Subject|403
1861918|NCT00089791|6422778|P2|Overall Study|Adverse Event|93
1861919|NCT00089791|6422779|P1|Overall Study|Adverse Event|81
1861920|NCT00089791|6422778|P2|Overall Study|Physician Decision|3
1861921|NCT00089791|6422779|P1|Overall Study|Physician Decision|6
1861922|NCT00089778|6422813|P3|Overall Study|Protocol Violation|1
1861923|NCT00089778|6422814|P2|Overall Study|Protocol Violation|0
1861924|NCT00089778|6422815|P1|Overall Study|Protocol Violation|0
1861925|NCT00089674|6422828|P2|Overall Study|Requirement for alternative therapy|4
1861926|NCT00089674|6422829|P1|Overall Study|Requirement for alternative therapy|14
1861927|NCT00089674|6422828|P2|Overall Study|Other|9
1861928|NCT00089674|6422829|P1|Overall Study|Other|5
1861929|NCT00089674|6422828|P2|Overall Study|Noncompliance|3
1861930|NCT00089674|6422829|P1|Overall Study|Noncompliance|7
1861931|NCT00089674|6422828|P2|Overall Study|Lost to Follow-up|17
1861932|NCT00089674|6422829|P1|Overall Study|Lost to Follow-up|21
1861933|NCT00089674|6422828|P2|Overall Study|Ineligibility determined|10
1861934|NCT00089674|6422829|P1|Overall Study|Ineligibility determined|8
1861935|NCT00089674|6422828|P2|Overall Study|Disease progression|23
1861936|NCT00089674|6422829|P1|Overall Study|Disease progression|21
1861937|NCT00089674|6422828|P2|Overall Study|Death|43
1861938|NCT00089674|6422829|P1|Overall Study|Death|43
1861939|NCT00089674|6422828|P2|Overall Study|Withdrawal by Subject|127
1861940|NCT00089674|6422829|P1|Overall Study|Withdrawal by Subject|143
1861941|NCT00089674|6422828|P2|Overall Study|Adverse Event|29
1861942|NCT00089674|6422829|P1|Overall Study|Adverse Event|23
1861943|NCT00089674|6422828|P2|Overall Study|Physician Decision|2
1861944|NCT00089674|6422829|P1|Overall Study|Physician Decision|4
1861945|NCT00089661|6422855|P2|Overall Study|Other|1
1861946|NCT00089661|6422856|P1|Overall Study|Other|2
1861947|NCT00089661|6422855|P2|Overall Study|Noncompliance|4
1861948|NCT00089661|6422856|P1|Overall Study|Noncompliance|2
1861949|NCT00089661|6422855|P2|Overall Study|Ineligibility determined|4
1861950|NCT00089661|6422856|P1|Overall Study|Ineligibility determined|4
1861951|NCT00089661|6422855|P2|Overall Study|Disease progression|3
1861952|NCT00089661|6422856|P1|Overall Study|Disease progression|1
1861953|NCT00089661|6422855|P2|Overall Study|Withdrawal by Subject|9
1861954|NCT00089661|6422856|P1|Overall Study|Withdrawal by Subject|11
1861955|NCT00089661|6422855|P2|Overall Study|Lost to Follow-up|3
1861956|NCT00089661|6422856|P1|Overall Study|Lost to Follow-up|0
1861957|NCT00089661|6422855|P2|Overall Study|Death|0
1861958|NCT00089661|6422856|P1|Overall Study|Death|1
1861959|NCT00089661|6422855|P2|Overall Study|Adverse Event|2
1861960|NCT00089661|6422856|P1|Overall Study|Adverse Event|0
1861961|NCT00089648|6422872|P1|Overall Study|Lack of Efficacy|33
1861962|NCT00089648|6422872|P1|Overall Study|Withdrawal by Subject|1
1861963|NCT00089648|6422872|P1|Overall Study|Adverse Event|7
1861964|NCT00089635|6422888|P1|Overall Study|Other|2
1861965|NCT00089635|6422888|P1|Overall Study|Ineligibility determined|1
1861966|NCT00089635|6422888|P1|Overall Study|Withdrawal by Subject|6
1861967|NCT00089635|6422888|P1|Overall Study|Lost to Follow-up|3
1861968|NCT00089635|6422888|P1|Overall Study|Disease Progression|12
1861969|NCT00089635|6422888|P1|Overall Study|Death|17
1861970|NCT00089635|6422888|P1|Overall Study|Adverse Event|2
1861971|NCT00089583|6422902|P2|Overall Study|Participant Incarcerated|1
1861972|NCT00089583|6422903|P1|Overall Study|Participant Incarcerated|0
1861973|NCT00089583|6422902|P2|Overall Study|Necessity to Use Prohibited Drug|0
1861974|NCT00089583|6422903|P1|Overall Study|Necessity to Use Prohibited Drug|1
1861975|NCT00089583|6422902|P2|Overall Study|Start of Disallowed Medication|1
1861976|NCT00089583|6422903|P1|Overall Study|Start of Disallowed Medication|0
1861977|NCT00089583|6422902|P2|Overall Study|Principal Investigator Decision|10
1861978|NCT00089583|6422903|P1|Overall Study|Principal Investigator Decision|0
1861979|NCT00089583|6422902|P2|Overall Study|Protocol Violation|3
1861980|NCT00089583|6422903|P1|Overall Study|Protocol Violation|0
1861981|NCT00089583|6422902|P2|Overall Study|Reason Not Provided|1
1861982|NCT00089583|6422903|P1|Overall Study|Reason Not Provided|0
1861983|NCT00089583|6422902|P2|Overall Study|Participant Management Criteria Met|1
1861984|NCT00089583|6422903|P1|Overall Study|Participant Management Criteria Met|0
1861985|NCT00089583|6422902|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
1861986|NCT00089583|6422903|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
1861987|NCT00089583|6422902|P2|Overall Study|Non-Compliance|4
1861988|NCT00089583|6422903|P1|Overall Study|Non-Compliance|0
1861989|NCT00089583|6422902|P2|Overall Study|Participant Refused Study Medication|2
1861990|NCT00089583|6422903|P1|Overall Study|Participant Refused Study Medication|0
1861991|NCT00089583|6422902|P2|Overall Study|Participant (Par) Didn't Take Medication|0
1861992|NCT00089583|6422903|P1|Overall Study|Participant (Par) Didn't Take Medication|1
1861993|NCT00089583|6422902|P2|Overall Study|Withdrawal by Subject|4
1861994|NCT00089583|6422903|P1|Overall Study|Withdrawal by Subject|0
1861995|NCT00089583|6422902|P2|Overall Study|Insufficient Viral Load Response|5
1861996|NCT00089583|6422903|P1|Overall Study|Insufficient Viral Load Response|5
1861997|NCT00089583|6422902|P2|Overall Study|Adverse Event|3
1861998|NCT00089583|6422903|P1|Overall Study|Adverse Event|0
1861999|NCT00089609|6422997|P2|Overall Study|Withdrawal by Subject|1
1862000|NCT00089609|6422998|P1|Overall Study|Withdrawal by Subject|3
1862001|NCT00089544|6423017|P2|Overall Study|Ineligible|0
1862002|NCT00089544|6423018|P1|Overall Study|Ineligible|1
1862003|NCT00089505|6423032|P4|Overall Study|Protocol Violation|0
1862004|NCT00089505|6423033|P3|Overall Study|Protocol Violation|1
1862005|NCT00089505|6423034|P2|Overall Study|Protocol Violation|0
1862006|NCT00089505|6423035|P1|Overall Study|Protocol Violation|0
1862007|NCT00089505|6423032|P4|Overall Study|Physician Decision|0
1862008|NCT00089505|6423033|P3|Overall Study|Physician Decision|0
1862009|NCT00089505|6423034|P2|Overall Study|Physician Decision|0
1862010|NCT00089505|6423035|P1|Overall Study|Physician Decision|1
1862011|NCT00089505|6423032|P4|Overall Study|Lost to Follow-up|7
1862012|NCT00089505|6423033|P3|Overall Study|Lost to Follow-up|9
1862013|NCT00089505|6423034|P2|Overall Study|Lost to Follow-up|1
1862014|NCT00089505|6423035|P1|Overall Study|Lost to Follow-up|1
1862015|NCT00089505|6423032|P4|Overall Study|Withdrawal by Subject|6
1862016|NCT00089505|6423033|P3|Overall Study|Withdrawal by Subject|6
1862017|NCT00089505|6423034|P2|Overall Study|Withdrawal by Subject|0
1862018|NCT00089505|6423035|P1|Overall Study|Withdrawal by Subject|3
1862019|NCT00089505|6423032|P4|Overall Study|Death|8
1862020|NCT00089505|6423033|P3|Overall Study|Death|5
1862021|NCT00089505|6423034|P2|Overall Study|Death|1
1862022|NCT00089505|6423035|P1|Overall Study|Death|4
1862023|NCT00089479|6423079|P2|Overall Study|Lost to Follow-up|107
1862024|NCT00089479|6423080|P1|Overall Study|Lost to Follow-up|137
1862025|NCT00089479|6423079|P2|Overall Study|Withdrawal by Subject|107
1862026|NCT00089479|6423080|P1|Overall Study|Withdrawal by Subject|86
1862027|NCT00089479|6423079|P2|Overall Study|Death|75
1862028|NCT00089479|6423080|P1|Overall Study|Death|108
1862029|NCT00089297|6423123|P1|Overall Study|Non-compliance|1
1862030|NCT00089297|6423123|P1|Overall Study|IRB approval not ready|1
1862031|NCT00089297|6423123|P1|Overall Study|Secondary malignancy|1
1862032|NCT00089297|6423123|P1|Overall Study|Ineligible|11
1862033|NCT00089297|6423123|P1|Overall Study|Disease progression|2
1862034|NCT00089297|6423123|P1|Overall Study|Withdrawal by Subject|12
1862035|NCT00089297|6423123|P1|Overall Study|Death|1
1862036|NCT00089297|6423123|P1|Overall Study|Adverse Event|9
1862037|NCT00089284|6423135|P7|Overall Study|Adverse event before starting treatment|1
1862038|NCT00089284|6423136|P6|Overall Study|Adverse event before starting treatment|0
1862039|NCT00089284|6423137|P5|Overall Study|Adverse event before starting treatment|0
1862040|NCT00089284|6423138|P4|Overall Study|Adverse event before starting treatment|0
1862041|NCT00089284|6423139|P3|Overall Study|Adverse event before starting treatment|0
1862042|NCT00089284|6423140|P2|Overall Study|Adverse event before starting treatment|0
1862043|NCT00089284|6423141|P1|Overall Study|Adverse event before starting treatment|0
1862044|NCT00089141|6423178|P2|Overall Study|Termination of trial|24
1862045|NCT00089141|6423179|P1|Overall Study|Termination of trial|18
1862046|NCT00089076|6423215|P1|Overall Study|Progression|7
1862047|NCT00089076|6423215|P1|Overall Study|Withdrawal by Subject|2
1862048|NCT00089076|6423215|P1|Overall Study|Alternate Therapy|1
1862049|NCT00088907|6423272|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
1862050|NCT00088907|6423273|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
1862051|NCT00088907|6423272|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
1862052|NCT00088907|6423273|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
1862053|NCT00088907|6423272|P2|Single Gefitinib Treatment (Step 2)|Death|0
1862054|NCT00088907|6423273|P1|Single Gefitinib Treatment (Step 2)|Death|1
1862055|NCT00088907|6423272|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
1862056|NCT00088907|6423273|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
1862057|NCT00088907|6423272|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
1862058|NCT00088907|6423273|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
1862059|NCT00088907|6423272|P2|Randomized Study (Step 1)|unknown/not specify|13
1862060|NCT00088907|6423273|P1|Randomized Study (Step 1)|unknown/not specify|24
1862061|NCT00088907|6423272|P2|Randomized Study (Step 1)|complicating disease|1
1862062|NCT00088907|6423273|P1|Randomized Study (Step 1)|complicating disease|3
1862063|NCT00088907|6423272|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
1862064|NCT00088907|6423273|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
1862065|NCT00088907|6423272|P2|Randomized Study (Step 1)|Death|12
1862066|NCT00088907|6423273|P1|Randomized Study (Step 1)|Death|11
1862067|NCT00088907|6423272|P2|Randomized Study (Step 1)|Adverse Event|19
1862068|NCT00088907|6423273|P1|Randomized Study (Step 1)|Adverse Event|14
1862069|NCT00088907|6423272|P2|Randomized Study (Step 1)|Lack of Efficacy|62
1862070|NCT00088907|6423273|P1|Randomized Study (Step 1)|Lack of Efficacy|55
1862071|NCT00088881|6423284|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
1862072|NCT00088881|6423284|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
1862073|NCT00088881|6423284|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
1862074|NCT00088881|6423284|P1|Step 1 - R-CHOP|Physician Decision|1
1862075|NCT00088881|6423284|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
1862076|NCT00088881|6423284|P1|Step 1 - R-CHOP|Adverse Event|1
1862077|NCT00088881|6423284|P1|Step 1 - R-CHOP|Patient ineligible|9
1862078|NCT00088829|6423293|P1|Overall Study|PI left institution and study was close|22
1862079|NCT00088595|6423335|P1|Overall Study|New Cancer Therapy|2
1862080|NCT00088595|6423335|P1|Overall Study|Ongoing (After Core)|7
1862081|NCT00088595|6423335|P1|Overall Study|Withdrawal by Subject|8
1862082|NCT00088595|6423335|P1|Overall Study|Adverse Event|11
1862083|NCT00088530|6423353|P2|Overall Study|Patient never treated|0
1862084|NCT00088530|6423354|P1|Overall Study|Patient never treated|1
1862085|NCT00088530|6423353|P2|Overall Study|Sponsor decision|1
1862086|NCT00088530|6423354|P1|Overall Study|Sponsor decision|0
1862087|NCT00088530|6423353|P2|Overall Study|Physician Decision|0
1862088|NCT00088530|6423354|P1|Overall Study|Physician Decision|2
1862089|NCT00088530|6423353|P2|Overall Study|Lost to Follow-up|0
1862090|NCT00088530|6423354|P1|Overall Study|Lost to Follow-up|2
1862091|NCT00088530|6423353|P2|Overall Study|Withdrawal by Subject|5
1862092|NCT00088530|6423354|P1|Overall Study|Withdrawal by Subject|2
1862093|NCT00088530|6423353|P2|Overall Study|Adverse Event|9
1862094|NCT00088530|6423354|P1|Overall Study|Adverse Event|15
1862095|NCT00088530|6423353|P2|Overall Study|Progressive/Relapsed Disease|39
1862096|NCT00088530|6423354|P1|Overall Study|Progressive/Relapsed Disease|28
1862097|NCT00088465|6423366|P1|Overall Study|Death|11
1862098|NCT00088465|6423366|P1|Overall Study|Protocol Violation|17
1862099|NCT00088465|6423366|P1|Overall Study|Lack of Efficacy|27
1862100|NCT00088465|6423366|P1|Overall Study|Sponsor Decision|37
1862101|NCT00088465|6423366|P1|Overall Study|Physician Decision|45
1862102|NCT00088465|6423366|P1|Overall Study|Lost to Follow-up|57
1862103|NCT00088465|6423366|P1|Overall Study|Adverse Event|77
1862104|NCT00088465|6423366|P1|Overall Study|Withdrawal by Subject|290
1862105|NCT00088413|6423393|P4|Overall Study|Patient unevaluable due to adverse event|0
1862106|NCT00088413|6423394|P3|Overall Study|Patient unevaluable due to adverse event|1
1862107|NCT00088413|6423395|P2|Overall Study|Patient unevaluable due to adverse event|0
1862108|NCT00088413|6423396|P1|Overall Study|Patient unevaluable due to adverse event|0
1862109|NCT00088413|6423393|P4|Overall Study|Other|0
1862110|NCT00088413|6423394|P3|Overall Study|Other|0
1862111|NCT00088413|6423395|P2|Overall Study|Other|1
1862112|NCT00088413|6423396|P1|Overall Study|Other|0
1862113|NCT00088413|6423393|P4|Overall Study|Progressive disease|14
1862114|NCT00088413|6423394|P3|Overall Study|Progressive disease|8
1862115|NCT00088413|6423395|P2|Overall Study|Progressive disease|11
1862116|NCT00088413|6423396|P1|Overall Study|Progressive disease|9
1862117|NCT00088413|6423393|P4|Overall Study|Death|0
1862118|NCT00088413|6423394|P3|Overall Study|Death|0
1862119|NCT00088413|6423395|P2|Overall Study|Death|1
1862120|NCT00088413|6423396|P1|Overall Study|Death|0
1862121|NCT00088413|6423393|P4|Overall Study|Off study due to missing a vaccine dose|0
1862122|NCT00088413|6423394|P3|Overall Study|Off study due to missing a vaccine dose|0
1862123|NCT00088413|6423395|P2|Overall Study|Off study due to missing a vaccine dose|0
1862124|NCT00088413|6423396|P1|Overall Study|Off study due to missing a vaccine dose|1
1862125|NCT00088413|6423393|P4|Overall Study|Refused trmt Off-study per pt wishes|0
1862126|NCT00088413|6423394|P3|Overall Study|Refused trmt Off-study per pt wishes|1
1862127|NCT00088413|6423395|P2|Overall Study|Refused trmt Off-study per pt wishes|1
1862128|NCT00088413|6423396|P1|Overall Study|Refused trmt Off-study per pt wishes|0
1862129|NCT00088413|6423393|P4|Overall Study|Adverse Events/Side Effects|0
1862130|NCT00088413|6423394|P3|Overall Study|Adverse Events/Side Effects|1
1862131|NCT00088413|6423395|P2|Overall Study|Adverse Events/Side Effects|1
1862132|NCT00088413|6423396|P1|Overall Study|Adverse Events/Side Effects|0
1862133|NCT00088413|6423393|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
1862134|NCT00088413|6423394|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
1862135|NCT00088413|6423395|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
1862136|NCT00088413|6423396|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
1862137|NCT00088374|6423410|P1|Overall Study|patient received <1 cycle only of 17AAG|1
1862138|NCT00088374|6423410|P1|Overall Study|patient did not receive any 17AAG|1
1862139|NCT00088166|6423430|P2|Overall Study|Withdrawal by Subject|5
1862140|NCT00088166|6423431|P1|Overall Study|Withdrawal by Subject|5
1862141|NCT00088166|6423430|P2|Overall Study|Patient deterioration|39
1862142|NCT00088166|6423431|P1|Overall Study|Patient deterioration|29
1862143|NCT00088166|6423430|P2|Overall Study|Protocol Violation|5
1862144|NCT00088166|6423431|P1|Overall Study|Protocol Violation|1
1862145|NCT00088166|6423430|P2|Overall Study|Physician Decision|1
1862146|NCT00088166|6423431|P1|Overall Study|Physician Decision|4
1862147|NCT00088166|6423430|P2|Overall Study|Lost to Follow-up|1
1862148|NCT00088166|6423431|P1|Overall Study|Lost to Follow-up|0
1862149|NCT00088166|6423430|P2|Overall Study|Death|1
1862150|NCT00088166|6423431|P1|Overall Study|Death|3
1862151|NCT00088166|6423430|P2|Overall Study|Adverse Event|9
1862152|NCT00088166|6423431|P1|Overall Study|Adverse Event|11
1862153|NCT00088153|6423455|P2|Overall Study|Lost to Follow-up|12
1862154|NCT00088153|6423456|P1|Overall Study|Lost to Follow-up|11
1862155|NCT00088153|6423455|P2|Overall Study|Withdrawal by Subject|10
1862156|NCT00088153|6423456|P1|Overall Study|Withdrawal by Subject|10
1862157|NCT00088153|6423455|P2|Overall Study|Physician Decision|3
1862158|NCT00088153|6423456|P1|Overall Study|Physician Decision|3
1862159|NCT00087698|6423466|P1|Overall Study|Protocol Violation|1
1862160|NCT00087698|6423466|P1|Overall Study|Death from Study Drug Toxicity|2
1862161|NCT00087698|6423466|P1|Overall Study|Death from Study Disease|2
1862162|NCT00087698|6423466|P1|Overall Study|Clinical Relapse|1
1862163|NCT00087698|6423466|P1|Overall Study|Protocol Entry Criteria Not Met|2
1862164|NCT00087698|6423466|P1|Overall Study|Lack of Efficacy, Physician Perception|3
1862165|NCT00087698|6423466|P1|Overall Study|Withdrawal by Subject|4
1862166|NCT00087698|6423466|P1|Overall Study|Adverse Event|4
1862167|NCT00087698|6423466|P1|Overall Study|Death from Other Causes|3
1862168|NCT00087698|6423466|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
1862169|NCT00087685|6423475|P1|Overall Study|Withdrawal by Subject|3
1862170|NCT00087685|6423475|P1|Overall Study|Progressive Disease|5
1862171|NCT00087685|6423475|P1|Overall Study|Non-Compliance|1
1862172|NCT00087685|6423475|P1|Overall Study|Adverse Event|5
1862173|NCT00087646|6423488|P4|Overall Study|Violation of Selection Criteria at Entry|1
1862174|NCT00087646|6423489|P3|Overall Study|Violation of Selection Criteria at Entry|0
1862175|NCT00087646|6423490|P2|Overall Study|Violation of Selection Criteria at Entry|0
1862176|NCT00087646|6423491|P1|Overall Study|Violation of Selection Criteria at Entry|1
1862177|NCT00087646|6423488|P4|Overall Study|Other Protocol Violation|0
1862178|NCT00087646|6423489|P3|Overall Study|Other Protocol Violation|0
1862179|NCT00087646|6423490|P2|Overall Study|Other Protocol Violation|1
1862180|NCT00087646|6423491|P1|Overall Study|Other Protocol Violation|3
1862181|NCT00087646|6423488|P4|Overall Study|Administrative/Other|2
1862182|NCT00087646|6423489|P3|Overall Study|Administrative/Other|1
1862183|NCT00087646|6423490|P2|Overall Study|Administrative/Other|1
1862184|NCT00087646|6423491|P1|Overall Study|Administrative/Other|6
1862185|NCT00087646|6423488|P4|Overall Study|Failure to Return|3
1862186|NCT00087646|6423489|P3|Overall Study|Failure to Return|2
1862187|NCT00087646|6423490|P2|Overall Study|Failure to Return|2
1862188|NCT00087646|6423491|P1|Overall Study|Failure to Return|5
1862189|NCT00087646|6423488|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
1862190|NCT00087646|6423489|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
1862191|NCT00087646|6423490|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
1862192|NCT00087646|6423491|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
1862193|NCT00087646|6423488|P4|Overall Study|Insufficient therapeutic response|51
1862194|NCT00087646|6423489|P3|Overall Study|Insufficient therapeutic response|38
1862195|NCT00087646|6423490|P2|Overall Study|Insufficient therapeutic response|24
1862196|NCT00087646|6423491|P1|Overall Study|Insufficient therapeutic response|64
1862197|NCT00087646|6423488|P4|Overall Study|Withdrawal by Subject|2
1862198|NCT00087646|6423489|P3|Overall Study|Withdrawal by Subject|2
1862199|NCT00087646|6423490|P2|Overall Study|Withdrawal by Subject|1
1862200|NCT00087646|6423491|P1|Overall Study|Withdrawal by Subject|6
1862201|NCT00087646|6423488|P4|Overall Study|Death|0
1862202|NCT00087646|6423489|P3|Overall Study|Death|0
1862203|NCT00087646|6423490|P2|Overall Study|Death|1
1862204|NCT00087646|6423491|P1|Overall Study|Death|0
1862205|NCT00087646|6423488|P4|Overall Study|Adverse Event|20
1862206|NCT00087646|6423489|P3|Overall Study|Adverse Event|18
1862207|NCT00087646|6423490|P2|Overall Study|Adverse Event|6
1862208|NCT00087646|6423491|P1|Overall Study|Adverse Event|37
1862209|NCT00087607|6423530|P2|Overall Study|Violation of Selection Criteria at Entry|1
1862210|NCT00087607|6423531|P1|Overall Study|Violation of Selection Criteria at Entry|0
1862211|NCT00087607|6423530|P2|Overall Study|Other Protocol Violation|2
1862212|NCT00087607|6423531|P1|Overall Study|Other Protocol Violation|5
1862213|NCT00087607|6423530|P2|Overall Study|Refused Treatment|7
1862214|NCT00087607|6423531|P1|Overall Study|Refused Treatment|5
1862215|NCT00087607|6423530|P2|Overall Study|Administrative|12
1862216|NCT00087607|6423531|P1|Overall Study|Administrative|12
1862217|NCT00087607|6423530|P2|Overall Study|Withdrew Consent|16
1862218|NCT00087607|6423531|P1|Overall Study|Withdrew Consent|12
1862219|NCT00087607|6423530|P2|Overall Study|Failure to return|17
1862220|NCT00087607|6423531|P1|Overall Study|Failure to return|21
1862221|NCT00087607|6423530|P2|Overall Study|Insufficient Therapeutic Response|42
1862222|NCT00087607|6423531|P1|Overall Study|Insufficient Therapeutic Response|53
1862223|NCT00087607|6423530|P2|Overall Study|Death|1
1862224|NCT00087607|6423531|P1|Overall Study|Death|0
1862225|NCT00087607|6423530|P2|Overall Study|Adverse Event|24
1862226|NCT00087607|6423531|P1|Overall Study|Adverse Event|14
1862227|NCT00087594|6423571|P2|Overall Study|Lack of Efficacy|5
1862228|NCT00087594|6423572|P1|Overall Study|Lack of Efficacy|2
1862229|NCT00087594|6423571|P2|Overall Study|Withdrawal by Subject|2
1862230|NCT00087594|6423572|P1|Overall Study|Withdrawal by Subject|4
1862231|NCT00087594|6423571|P2|Overall Study|Lost to Follow-up|2
1862232|NCT00087594|6423572|P1|Overall Study|Lost to Follow-up|0
1862233|NCT00087594|6423571|P2|Overall Study|Adverse Event|3
1862234|NCT00087594|6423572|P1|Overall Study|Adverse Event|2
1862235|NCT00087568|6423606|P2|Overall Study|Lack of Efficacy|1
1862236|NCT00087568|6423607|P1|Overall Study|Lack of Efficacy|24
1862237|NCT00087568|6423606|P2|Overall Study|Lost to Follow-up|0
1862238|NCT00087568|6423607|P1|Overall Study|Lost to Follow-up|1
1862239|NCT00087568|6423606|P2|Overall Study|Withdrawal by Subject|1
1862240|NCT00087568|6423607|P1|Overall Study|Withdrawal by Subject|1
1862241|NCT00087568|6423606|P2|Overall Study|Adverse Event|0
1862242|NCT00087568|6423607|P1|Overall Study|Adverse Event|4
1862243|NCT00087555|6423634|P3|Overall Study|Patient wanted to go back on Med|0
1862244|NCT00087555|6423635|P2|Overall Study|Patient wanted to go back on Med|0
1862245|NCT00087555|6423636|P1|Overall Study|Patient wanted to go back on Med|1
1862246|NCT00087555|6423634|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
1862247|NCT00087555|6423635|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
1862248|NCT00087555|6423636|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
1862249|NCT00087555|6423634|P3|Overall Study|Non Compliance|1
1862250|NCT00087555|6423635|P2|Overall Study|Non Compliance|0
1862251|NCT00087555|6423636|P1|Overall Study|Non Compliance|0
1862252|NCT00087555|6423634|P3|Overall Study|Lack of Efficacy|1
1862253|NCT00087555|6423635|P2|Overall Study|Lack of Efficacy|0
1862254|NCT00087555|6423636|P1|Overall Study|Lack of Efficacy|2
1862255|NCT00087555|6423634|P3|Overall Study|Withdrawal by Subject|1
1862256|NCT00087555|6423635|P2|Overall Study|Withdrawal by Subject|2
1862257|NCT00087555|6423636|P1|Overall Study|Withdrawal by Subject|3
1862258|NCT00087555|6423634|P3|Overall Study|Pregnancy|1
1862259|NCT00087555|6423635|P2|Overall Study|Pregnancy|1
1862260|NCT00087555|6423636|P1|Overall Study|Pregnancy|0
1862261|NCT00087555|6423634|P3|Overall Study|Screen Failure|0
1862262|NCT00087555|6423635|P2|Overall Study|Screen Failure|1
1862263|NCT00087555|6423636|P1|Overall Study|Screen Failure|1
1862264|NCT00087555|6423634|P3|Overall Study|Protocol Violation|2
1862265|NCT00087555|6423635|P2|Overall Study|Protocol Violation|0
1862266|NCT00087555|6423636|P1|Overall Study|Protocol Violation|0
1862267|NCT00087555|6423634|P3|Overall Study|Non - Compliance|0
1862268|NCT00087555|6423635|P2|Overall Study|Non - Compliance|0
1862269|NCT00087555|6423636|P1|Overall Study|Non - Compliance|1
1862270|NCT00087555|6423634|P3|Overall Study|Lost to Follow-up|1
1862271|NCT00087555|6423635|P2|Overall Study|Lost to Follow-up|1
1862272|NCT00087555|6423636|P1|Overall Study|Lost to Follow-up|0
1862273|NCT00087555|6423634|P3|Overall Study|Adverse Event|14
1862274|NCT00087555|6423635|P2|Overall Study|Adverse Event|6
1862275|NCT00087555|6423636|P1|Overall Study|Adverse Event|3
1862276|NCT00087529|6423646|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
1862277|NCT00087529|6423647|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
1862278|NCT00087529|6423646|P2|Overall Study|Disease Progression|4
1862279|NCT00087529|6423647|P1|Overall Study|Disease Progression|5
1862280|NCT00087529|6423646|P2|Overall Study|Participant Noncompliance|1
1862281|NCT00087529|6423647|P1|Overall Study|Participant Noncompliance|0
1862282|NCT00087529|6423646|P2|Overall Study|Initiation of Excluded Therapy|1
1862283|NCT00087529|6423647|P1|Overall Study|Initiation of Excluded Therapy|0
1862284|NCT00087529|6423646|P2|Overall Study|Physician Decision|8
1862285|NCT00087529|6423647|P1|Overall Study|Physician Decision|4
1862286|NCT00087529|6423646|P2|Overall Study|Participant Decision|37
1862287|NCT00087529|6423647|P1|Overall Study|Participant Decision|14
1862288|NCT00087529|6423646|P2|Overall Study|Lost to Follow-up|3
1862289|NCT00087529|6423647|P1|Overall Study|Lost to Follow-up|2
1862290|NCT00087529|6423646|P2|Overall Study|Pregnancy|1
1862291|NCT00087529|6423647|P1|Overall Study|Pregnancy|0
1862292|NCT00087529|6423646|P2|Overall Study|Adverse Event|8
1862293|NCT00087529|6423647|P1|Overall Study|Adverse Event|0
1862294|NCT00087529|6423646|P2|Overall Study|Death|0
1862295|NCT00087529|6423647|P1|Overall Study|Death|1
1862296|NCT00087516|6423662|P4|Overall Study|Other|0
1862297|NCT00087516|6423663|P3|Overall Study|Other|1
1862298|NCT00087516|6423664|P2|Overall Study|Other|0
1862299|NCT00087516|6423665|P1|Overall Study|Other|0
1862300|NCT00087516|6423662|P4|Overall Study|Recommendation of Primary Care Physician|1
1862301|NCT00087516|6423663|P3|Overall Study|Recommendation of Primary Care Physician|0
1862302|NCT00087516|6423664|P2|Overall Study|Recommendation of Primary Care Physician|0
1862303|NCT00087516|6423665|P1|Overall Study|Recommendation of Primary Care Physician|0
1862304|NCT00087516|6423662|P4|Overall Study|Patient was non-compliant|0
1862305|NCT00087516|6423663|P3|Overall Study|Patient was non-compliant|0
1862306|NCT00087516|6423664|P2|Overall Study|Patient was non-compliant|1
1862307|NCT00087516|6423665|P1|Overall Study|Patient was non-compliant|3
1862308|NCT00087516|6423662|P4|Overall Study|Patient moved|0
1862309|NCT00087516|6423663|P3|Overall Study|Patient moved|1
1862310|NCT00087516|6423664|P2|Overall Study|Patient moved|2
1862311|NCT00087516|6423665|P1|Overall Study|Patient moved|3
1862312|NCT00087516|6423662|P4|Overall Study|Protocol specified discontinuation|26
1862313|NCT00087516|6423663|P3|Overall Study|Protocol specified discontinuation|33
1862314|NCT00087516|6423664|P2|Overall Study|Protocol specified discontinuation|33
1862315|NCT00087516|6423665|P1|Overall Study|Protocol specified discontinuation|35
1862316|NCT00087516|6423662|P4|Overall Study|Site terminated|0
1862317|NCT00087516|6423663|P3|Overall Study|Site terminated|1
1862318|NCT00087516|6423664|P2|Overall Study|Site terminated|2
1862319|NCT00087516|6423665|P1|Overall Study|Site terminated|0
1862320|NCT00087516|6423662|P4|Overall Study|Withdrawal by Subject|12
1862321|NCT00087516|6423663|P3|Overall Study|Withdrawal by Subject|11
1862322|NCT00087516|6423664|P2|Overall Study|Withdrawal by Subject|27
1862323|NCT00087516|6423665|P1|Overall Study|Withdrawal by Subject|16
1862324|NCT00087516|6423662|P4|Overall Study|Protocol Violation|6
1862325|NCT00087516|6423663|P3|Overall Study|Protocol Violation|3
1862326|NCT00087516|6423664|P2|Overall Study|Protocol Violation|8
1862327|NCT00087516|6423665|P1|Overall Study|Protocol Violation|4
1862328|NCT00087516|6423662|P4|Overall Study|Lost to Follow-up|5
1862329|NCT00087516|6423663|P3|Overall Study|Lost to Follow-up|5
1862330|NCT00087516|6423664|P2|Overall Study|Lost to Follow-up|6
1862331|NCT00087516|6423665|P1|Overall Study|Lost to Follow-up|8
1862332|NCT00087516|6423662|P4|Overall Study|Lack of Efficacy|29
1862333|NCT00087516|6423663|P3|Overall Study|Lack of Efficacy|39
1862334|NCT00087516|6423664|P2|Overall Study|Lack of Efficacy|80
1862335|NCT00087516|6423665|P1|Overall Study|Lack of Efficacy|82
1862336|NCT00087516|6423662|P4|Overall Study|Adverse Event|6
1862337|NCT00087516|6423663|P3|Overall Study|Adverse Event|3
1862338|NCT00087516|6423664|P2|Overall Study|Adverse Event|10
1862339|NCT00087516|6423665|P1|Overall Study|Adverse Event|10
1862340|NCT00087490|6423694|P2|Overall Study|Randomized but not treated|18
1862341|NCT00087490|6423695|P1|Overall Study|Randomized but not treated|7
1862342|NCT00087490|6423694|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
1862343|NCT00087490|6423695|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
1862344|NCT00087490|6423694|P2|Overall Study|Protocol Violation or (/) Unspecified|201
1862345|NCT00087490|6423695|P1|Overall Study|Protocol Violation or (/) Unspecified|214
1862346|NCT00087490|6423694|P2|Overall Study|Lack of Efficacy|2
1862347|NCT00087490|6423695|P1|Overall Study|Lack of Efficacy|0
1862348|NCT00087490|6423694|P2|Overall Study|Adverse Event|8
1862349|NCT00087490|6423695|P1|Overall Study|Adverse Event|3
1862350|NCT00087490|6423694|P2|Overall Study|Death|4
1862351|NCT00087490|6423695|P1|Overall Study|Death|6
1862352|NCT00087438|6423729|P1|Overall Study|Ineligible / No protocol treatment|4
1862353|NCT00087152|6423739|P1|Overall Study|Ineligible|6
1862354|NCT00087139|6423748|P3|Overall Study|Extradural disease|1
1862355|NCT00087139|6423749|P2|Overall Study|Extradural disease|0
1862356|NCT00087139|6423750|P1|Overall Study|Extradural disease|0
1862357|NCT00087139|6423748|P3|Overall Study|Response achieved|0
1862358|NCT00087139|6423749|P2|Overall Study|Response achieved|1
1862359|NCT00087139|6423750|P1|Overall Study|Response achieved|0
1862360|NCT00087139|6423748|P3|Overall Study|Use of coumadin|0
1862361|NCT00087139|6423749|P2|Overall Study|Use of coumadin|0
1862362|NCT00087139|6423750|P1|Overall Study|Use of coumadin|1
1862363|NCT00087139|6423748|P3|Overall Study|Symptomatic deterioration|3
1862364|NCT00087139|6423749|P2|Overall Study|Symptomatic deterioration|1
1862365|NCT00087139|6423750|P1|Overall Study|Symptomatic deterioration|1
1862366|NCT00087139|6423748|P3|Overall Study|Ineligible|4
1862367|NCT00087139|6423749|P2|Overall Study|Ineligible|7
1862368|NCT00087139|6423750|P1|Overall Study|Ineligible|4
1862369|NCT00087139|6423748|P3|Overall Study|Disease progression|12
1862370|NCT00087139|6423749|P2|Overall Study|Disease progression|19
1862371|NCT00087139|6423750|P1|Overall Study|Disease progression|9
1862372|NCT00087139|6423748|P3|Overall Study|Physician Decision|1
1862373|NCT00087139|6423749|P2|Overall Study|Physician Decision|1
1862374|NCT00087139|6423750|P1|Overall Study|Physician Decision|1
1862375|NCT00087139|6423748|P3|Overall Study|Withdrawal by Subject|2
1862376|NCT00087139|6423749|P2|Overall Study|Withdrawal by Subject|2
1862377|NCT00087139|6423750|P1|Overall Study|Withdrawal by Subject|3
1862378|NCT00087139|6423748|P3|Overall Study|Death|0
1862379|NCT00087139|6423749|P2|Overall Study|Death|1
1862380|NCT00087139|6423750|P1|Overall Study|Death|2
1862381|NCT00087139|6423748|P3|Overall Study|Adverse Event|13
1862382|NCT00087139|6423749|P2|Overall Study|Adverse Event|17
1862383|NCT00087139|6423750|P1|Overall Study|Adverse Event|18
1862384|NCT00087126|6423765|P1|Overall Study|Never treated|1
1862385|NCT00087126|6423765|P1|Overall Study|Ineligible - second primary|1
1862386|NCT00086996|6423790|P1|Overall Study|not eligible|5
1862387|NCT00086996|6423790|P1|Overall Study|Other|6
1862388|NCT00086996|6423790|P1|Overall Study|Withdrawal by Subject|13
1862389|NCT00086996|6423790|P1|Overall Study|progression/relapse|7
1862390|NCT00086996|6423790|P1|Overall Study|Death|4
1862391|NCT00086996|6423790|P1|Overall Study|Adverse Event|29
1862392|NCT00086684|6423812|P3|Overall Study|Other|3
1862393|NCT00086684|6423813|P2|Overall Study|Other|2
1862394|NCT00086684|6423814|P1|Overall Study|Other|4
1862395|NCT00086684|6423812|P3|Overall Study|WITHDRAWAL OF CONSENT|5
1862396|NCT00086684|6423813|P2|Overall Study|WITHDRAWAL OF CONSENT|7
1862397|NCT00086684|6423814|P1|Overall Study|WITHDRAWAL OF CONSENT|5
1862398|NCT00086684|6423812|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
1862399|NCT00086684|6423813|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
1862400|NCT00086684|6423814|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
1862401|NCT00086684|6423812|P3|Overall Study|NONCOMPLIANCE|6
1862402|NCT00086684|6423813|P2|Overall Study|NONCOMPLIANCE|7
1862403|NCT00086684|6423814|P1|Overall Study|NONCOMPLIANCE|5
1862404|NCT00086684|6423812|P3|Overall Study|Withdrawal by Subject|10
1862405|NCT00086684|6423813|P2|Overall Study|Withdrawal by Subject|4
1862406|NCT00086684|6423814|P1|Overall Study|Withdrawal by Subject|0
1862407|NCT00086684|6423812|P3|Overall Study|Protocol Violation|0
1862408|NCT00086684|6423813|P2|Overall Study|Protocol Violation|3
1862409|NCT00086684|6423814|P1|Overall Study|Protocol Violation|8
1862410|NCT00086684|6423812|P3|Overall Study|Lost to Follow-up|10
1862411|NCT00086684|6423813|P2|Overall Study|Lost to Follow-up|8
1862412|NCT00086684|6423814|P1|Overall Study|Lost to Follow-up|15
1862413|NCT00086684|6423812|P3|Overall Study|Lack of Efficacy|5
1862414|NCT00086684|6423813|P2|Overall Study|Lack of Efficacy|6
1862415|NCT00086684|6423814|P1|Overall Study|Lack of Efficacy|6
1862416|NCT00086684|6423812|P3|Overall Study|Adverse Event|14
1862417|NCT00086684|6423813|P2|Overall Study|Adverse Event|17
1862418|NCT00086684|6423814|P1|Overall Study|Adverse Event|12
1862419|NCT00086619|6423827|P2|Overall Study|Protocol Violation|1
1862420|NCT00086619|6423828|P1|Overall Study|Protocol Violation|1
1862421|NCT00086619|6423827|P2|Overall Study|Adverse Event|10
1862422|NCT00086619|6423828|P1|Overall Study|Adverse Event|8
1862423|NCT00086619|6423827|P2|Overall Study|Withdrawal by Subject|6
1862424|NCT00086619|6423828|P1|Overall Study|Withdrawal by Subject|6
1862425|NCT00086580|6423838|P2|Observation Period|Other|7
1862426|NCT00086580|6423839|P1|Observation Period|Other|8
1862427|NCT00086580|6423838|P2|Observation Period|Death|55
1862428|NCT00086580|6423839|P1|Observation Period|Death|33
1862429|NCT00086580|6423838|P2|Observation Period|Withdrawal by Subject|2
1862430|NCT00086580|6423839|P1|Observation Period|Withdrawal by Subject|4
1862431|NCT00086580|6423838|P2|Observation Period|Unable to comply with protocol|1
1862432|NCT00086580|6423839|P1|Observation Period|Unable to comply with protocol|1
1862433|NCT00086580|6423838|P2|Follow-up Period|Other|6
1862434|NCT00086580|6423839|P1|Follow-up Period|Other|7
1862435|NCT00086580|6423838|P2|Follow-up Period|Death|7
1862436|NCT00086580|6423839|P1|Follow-up Period|Death|13
1862437|NCT00086580|6423838|P2|Follow-up Period|AE - not related|0
1862438|NCT00086580|6423839|P1|Follow-up Period|AE - not related|1
1862439|NCT00086580|6423838|P2|Follow-up Period|Physician Decision|1
1862440|NCT00086580|6423839|P1|Follow-up Period|Physician Decision|0
1862441|NCT00086580|6423838|P2|Follow-up Period|Withdrawal by Subject|6
1862442|NCT00086580|6423839|P1|Follow-up Period|Withdrawal by Subject|6
1862443|NCT00086580|6423838|P2|Follow-up Period|Unable to comply with protocol|0
1862444|NCT00086580|6423839|P1|Follow-up Period|Unable to comply with protocol|5
1862445|NCT00086580|6423838|P2|Follow-up Period|Disease progression|99
1862446|NCT00086580|6423839|P1|Follow-up Period|Disease progression|72
1862447|NCT00086580|6423838|P2|Treatment Period|Other|3
1862448|NCT00086580|6423839|P1|Treatment Period|Other|5
1862449|NCT00086580|6423838|P2|Treatment Period|Death|7
1862450|NCT00086580|6423839|P1|Treatment Period|Death|5
1862451|NCT00086580|6423838|P2|Treatment Period|Anemia or thrombocytopenia|4
1862452|NCT00086580|6423839|P1|Treatment Period|Anemia or thrombocytopenia|1
1862453|NCT00086580|6423838|P2|Treatment Period|Toxicity - treatment related|15
1862454|NCT00086580|6423839|P1|Treatment Period|Toxicity - treatment related|15
1862455|NCT00086580|6423838|P2|Treatment Period|AE - not treatment related|7
1862456|NCT00086580|6423839|P1|Treatment Period|AE - not treatment related|7
1862457|NCT00086580|6423838|P2|Treatment Period|Physician Decision|7
1862458|NCT00086580|6423839|P1|Treatment Period|Physician Decision|13
1862459|NCT00086580|6423838|P2|Treatment Period|Withdrawal by Subject|8
1862460|NCT00086580|6423839|P1|Treatment Period|Withdrawal by Subject|7
1862461|NCT00086580|6423838|P2|Treatment Period|Unable to comply with protocol|1
1862462|NCT00086580|6423839|P1|Treatment Period|Unable to comply with protocol|3
1862463|NCT00086580|6423838|P2|Treatment Period|Disease progression|8
1862464|NCT00086580|6423839|P1|Treatment Period|Disease progression|9
1862465|NCT00086411|6423887|P4|Overall Study|Lost to Follow-up|12
1862466|NCT00086411|6423888|P3|Overall Study|Lost to Follow-up|13
1862467|NCT00086411|6423889|P2|Overall Study|Lost to Follow-up|11
1862468|NCT00086411|6423890|P1|Overall Study|Lost to Follow-up|11
1862469|NCT00086385|6423908|P4|Overall Study|Death|1
1862470|NCT00086385|6423909|P3|Overall Study|Death|1
1862471|NCT00086385|6423910|P2|Overall Study|Death|2
1862472|NCT00086385|6423911|P1|Overall Study|Death|2
1862473|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Discontinued in error|0
1862474|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Discontinued in error|1
1862475|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
1862476|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
1862477|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
1862478|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
1862479|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Patient Died|1
1862480|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Patient Died|3
1862481|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
1862482|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
1862483|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
1862484|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
1862485|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Patient Moved|2
1862486|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Patient Moved|2
1862487|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
1862488|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
1862489|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Protocol Violation|0
1862490|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Protocol Violation|1
1862491|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Physician Decision|0
1862492|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Physician Decision|3
1862493|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
1862494|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
1862495|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
1862496|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
1862497|NCT00086515|6423923|P2|Phase B (Weeks 24-104)|Adverse Event|10
1862498|NCT00086515|6423924|P1|Phase B (Weeks 24-104)|Adverse Event|16
1862499|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
1862500|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
1862501|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Poor compliance|0
1862502|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Poor compliance|1
1862503|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1862504|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
1862505|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
1862506|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
1862507|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Protocol Violation|1
1862508|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Protocol Violation|0
1862509|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
1862510|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
1862511|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
1862512|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
1862513|NCT00086515|6423923|P2|Phase A to Phase B Transition Period|Adverse Event|1
1862514|NCT00086515|6423924|P1|Phase A to Phase B Transition Period|Adverse Event|2
1862515|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
1862516|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
1862517|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
1862518|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
1862519|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Poor compliance|0
1862520|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Poor compliance|1
1862521|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
1862522|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
1862523|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Patient Moved|3
1862524|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Patient Moved|2
1862525|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1862526|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
1862527|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Protocol Violation|1
1862528|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Protocol Violation|3
1862529|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
1862530|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
1862531|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
1862532|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
1862533|NCT00086515|6423923|P2|Phase A (Weeks 0-24)|Adverse Event|9
1862534|NCT00086515|6423924|P1|Phase A (Weeks 0-24)|Adverse Event|17
1862535|NCT00086502|6423936|P2|Overall Study|Patient Accidentally Unblinded|0
1862536|NCT00086502|6423937|P1|Overall Study|Patient Accidentally Unblinded|1
1862537|NCT00086502|6423936|P2|Overall Study|Protocol Discontinuation Criteria|3
1862538|NCT00086502|6423937|P1|Overall Study|Protocol Discontinuation Criteria|1
1862539|NCT00086502|6423936|P2|Overall Study|Patient Moved|1
1862540|NCT00086502|6423937|P1|Overall Study|Patient Moved|1
1862541|NCT00086502|6423936|P2|Overall Study|Withdrawal by Subject|6
1862542|NCT00086502|6423937|P1|Overall Study|Withdrawal by Subject|5
1862543|NCT00086502|6423936|P2|Overall Study|Protocol Violation|3
1862544|NCT00086502|6423937|P1|Overall Study|Protocol Violation|3
1862545|NCT00086502|6423936|P2|Overall Study|Pregnancy|1
1862546|NCT00086502|6423937|P1|Overall Study|Pregnancy|0
1862547|NCT00086502|6423936|P2|Overall Study|Physician Decision|1
1862548|NCT00086502|6423937|P1|Overall Study|Physician Decision|1
1862549|NCT00086502|6423936|P2|Overall Study|Lost to Follow-up|1
1862550|NCT00086502|6423937|P1|Overall Study|Lost to Follow-up|3
1862551|NCT00086502|6423936|P2|Overall Study|Lack of Efficacy|2
1862552|NCT00086502|6423937|P1|Overall Study|Lack of Efficacy|0
1862553|NCT00086502|6423936|P2|Overall Study|Adverse Event|2
1862554|NCT00086502|6423937|P1|Overall Study|Adverse Event|11
1862555|NCT00086346|6423962|P2|Patients Dosed With Test Article|Lack of Efficacy|0
1862556|NCT00086346|6423963|P1|Patients Dosed With Test Article|Lack of Efficacy|11
1862557|NCT00086346|6423962|P2|Patients Dosed With Test Article|Protocol Violation|3
1862558|NCT00086346|6423963|P1|Patients Dosed With Test Article|Protocol Violation|11
1862559|NCT00086346|6423962|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
1862560|NCT00086346|6423963|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
1862561|NCT00086346|6423962|P2|Patients Dosed With Test Article|Nonmedical event|3
1862562|NCT00086346|6423963|P1|Patients Dosed With Test Article|Nonmedical event|7
1862563|NCT00086346|6423962|P2|Patients Dosed With Test Article|Lost to Follow-up|3
1862564|NCT00086346|6423963|P1|Patients Dosed With Test Article|Lost to Follow-up|1
1862565|NCT00086346|6423962|P2|Patients Dosed With Test Article|Adverse Event|11
1862566|NCT00086346|6423963|P1|Patients Dosed With Test Article|Adverse Event|94
1862567|NCT00086346|6423962|P2|Randomization|Did not receive test article|4
1862568|NCT00086346|6423963|P1|Randomization|Did not receive test article|4
1862569|NCT00086281|6423990|P15|Phase 2|Adverse Event|0
1862570|NCT00086281|6423991|P14|Phase 2|Adverse Event|1
1862571|NCT00086281|6423992|P13|Phase 2|Adverse Event|1
1862572|NCT00086281|6423993|P12|Phase 2|Adverse Event|0
1862573|NCT00086281|6423994|P11|Phase 2|Adverse Event|0
1862574|NCT00086281|6423995|P10|Phase 2|Adverse Event|0
1862575|NCT00086281|6423996|P9|Phase 2|Adverse Event|0
1862576|NCT00086281|6423997|P8|Phase 2|Adverse Event|0
1862577|NCT00086281|6423998|P7|Phase 2|Adverse Event|0
1862578|NCT00086281|6423999|P6|Phase 2|Adverse Event|0
1862579|NCT00086281|6424000|P5|Phase 2|Adverse Event|0
1862580|NCT00086281|6424001|P4|Phase 2|Adverse Event|0
1862581|NCT00086281|6424002|P3|Phase 2|Adverse Event|0
1862582|NCT00086281|6424003|P2|Phase 2|Adverse Event|0
1862583|NCT00086281|6424004|P1|Phase 2|Adverse Event|0
1862584|NCT00086281|6423990|P15|Phase 1|Serious Adverse Event|1
1862585|NCT00086281|6423991|P14|Phase 1|Serious Adverse Event|0
1862586|NCT00086281|6423992|P13|Phase 1|Serious Adverse Event|0
1862587|NCT00086281|6423993|P12|Phase 1|Serious Adverse Event|0
1862588|NCT00086281|6423994|P11|Phase 1|Serious Adverse Event|0
1862589|NCT00086281|6423995|P10|Phase 1|Serious Adverse Event|0
1862590|NCT00086281|6423996|P9|Phase 1|Serious Adverse Event|0
1862591|NCT00086281|6423997|P8|Phase 1|Serious Adverse Event|0
1862592|NCT00086281|6423998|P7|Phase 1|Serious Adverse Event|0
1862593|NCT00086281|6423999|P6|Phase 1|Serious Adverse Event|0
1862594|NCT00086281|6424000|P5|Phase 1|Serious Adverse Event|0
1862595|NCT00086281|6424001|P4|Phase 1|Serious Adverse Event|0
1862596|NCT00086281|6424002|P3|Phase 1|Serious Adverse Event|0
1862597|NCT00086281|6424003|P2|Phase 1|Serious Adverse Event|0
1862598|NCT00086281|6424004|P1|Phase 1|Serious Adverse Event|0
1862599|NCT00086281|6423990|P15|Phase 1|Protocol Violation|0
1862600|NCT00086281|6423991|P14|Phase 1|Protocol Violation|0
1862601|NCT00086281|6423992|P13|Phase 1|Protocol Violation|0
1862602|NCT00086281|6423993|P12|Phase 1|Protocol Violation|0
1862603|NCT00086281|6423994|P11|Phase 1|Protocol Violation|1
1862604|NCT00086281|6423995|P10|Phase 1|Protocol Violation|0
1862605|NCT00086281|6423996|P9|Phase 1|Protocol Violation|0
1862606|NCT00086281|6423997|P8|Phase 1|Protocol Violation|0
1862607|NCT00086281|6423998|P7|Phase 1|Protocol Violation|0
1862608|NCT00086281|6423999|P6|Phase 1|Protocol Violation|0
1862609|NCT00086281|6424000|P5|Phase 1|Protocol Violation|0
1862610|NCT00086281|6424001|P4|Phase 1|Protocol Violation|0
1862611|NCT00086281|6424002|P3|Phase 1|Protocol Violation|0
1862612|NCT00086281|6424003|P2|Phase 1|Protocol Violation|0
1862613|NCT00086281|6424004|P1|Phase 1|Protocol Violation|0
1862614|NCT00086281|6423990|P15|Phase 1|Adverse Event|2
1862615|NCT00086281|6423991|P14|Phase 1|Adverse Event|1
1862616|NCT00086281|6423992|P13|Phase 1|Adverse Event|1
1862617|NCT00086281|6423993|P12|Phase 1|Adverse Event|1
1862618|NCT00086281|6423994|P11|Phase 1|Adverse Event|2
1862619|NCT00086281|6423995|P10|Phase 1|Adverse Event|1
1862620|NCT00086281|6423996|P9|Phase 1|Adverse Event|0
1862621|NCT00086281|6423997|P8|Phase 1|Adverse Event|0
1862622|NCT00086281|6423998|P7|Phase 1|Adverse Event|0
1862623|NCT00086281|6423999|P6|Phase 1|Adverse Event|0
1862624|NCT00086281|6424000|P5|Phase 1|Adverse Event|0
1862625|NCT00086281|6424001|P4|Phase 1|Adverse Event|0
1862626|NCT00086281|6424002|P3|Phase 1|Adverse Event|0
1862627|NCT00086281|6424003|P2|Phase 1|Adverse Event|0
1862628|NCT00086281|6424004|P1|Phase 1|Adverse Event|0
1862629|NCT00086307|6424017|P3|Overall Study|Withdrawal by Subject|2
1862630|NCT00086307|6424018|P2|Overall Study|Withdrawal by Subject|0
1862631|NCT00086307|6424019|P1|Overall Study|Withdrawal by Subject|0
1862632|NCT00086307|6424017|P3|Overall Study|Fatigue and difficulty falling asleep|1
1862633|NCT00086307|6424018|P2|Overall Study|Fatigue and difficulty falling asleep|0
1862634|NCT00086307|6424019|P1|Overall Study|Fatigue and difficulty falling asleep|0
1862635|NCT00086307|6424017|P3|Overall Study|Suicidal ideation|1
1862636|NCT00086307|6424018|P2|Overall Study|Suicidal ideation|0
1862637|NCT00086307|6424019|P1|Overall Study|Suicidal ideation|0
1862638|NCT00086307|6424017|P3|Overall Study|Constipation and sleepiness|1
1862639|NCT00086307|6424018|P2|Overall Study|Constipation and sleepiness|0
1862640|NCT00086307|6424019|P1|Overall Study|Constipation and sleepiness|0
1862641|NCT00086307|6424017|P3|Overall Study|Nausea and headaches|1
1862642|NCT00086307|6424018|P2|Overall Study|Nausea and headaches|0
1862643|NCT00086307|6424019|P1|Overall Study|Nausea and headaches|0
1862644|NCT00086307|6424017|P3|Overall Study|Shortness of breath and muscle spasms|0
1862645|NCT00086307|6424018|P2|Overall Study|Shortness of breath and muscle spasms|0
1862646|NCT00086307|6424019|P1|Overall Study|Shortness of breath and muscle spasms|1
1862647|NCT00086307|6424017|P3|Overall Study|Lack of Efficacy|2
1862648|NCT00086307|6424018|P2|Overall Study|Lack of Efficacy|1
1862649|NCT00086307|6424019|P1|Overall Study|Lack of Efficacy|1
1862650|NCT00086190|6424030|P3|Overall Study|Worsening depression|2
1862651|NCT00086190|6424031|P2|Overall Study|Worsening depression|0
1862652|NCT00086190|6424032|P1|Overall Study|Worsening depression|0
1862653|NCT00086190|6424030|P3|Overall Study|Moved|0
1862654|NCT00086190|6424031|P2|Overall Study|Moved|0
1862655|NCT00086190|6424032|P1|Overall Study|Moved|1
1862656|NCT00086190|6424030|P3|Overall Study|Protocol Violation|0
1862657|NCT00086190|6424031|P2|Overall Study|Protocol Violation|0
1862658|NCT00086190|6424032|P1|Overall Study|Protocol Violation|1
1862659|NCT00086190|6424030|P3|Overall Study|Withdrawal by Subject|2
1862660|NCT00086190|6424031|P2|Overall Study|Withdrawal by Subject|2
1862661|NCT00086190|6424032|P1|Overall Study|Withdrawal by Subject|0
1862662|NCT00086190|6424030|P3|Overall Study|Adverse Event|2
1862663|NCT00086190|6424031|P2|Overall Study|Adverse Event|2
1862664|NCT00086190|6424032|P1|Overall Study|Adverse Event|6
1862665|NCT00086047|6424101|P2|Overall Study|Physician Decision|1
1862666|NCT00086047|6424102|P1|Overall Study|Physician Decision|0
1862667|NCT00086047|6424101|P2|Overall Study|Lost to Follow-up|6
1862668|NCT00086047|6424102|P1|Overall Study|Lost to Follow-up|7
1862669|NCT00085917|6424110|P2|Overall Study|Adverse Event|3
1862670|NCT00085917|6424111|P1|Overall Study|Adverse Event|4
1862671|NCT00085735|6424140|P6|Overall Study|Pt transferred to inst w/out study open|0
1862672|NCT00085735|6424141|P5|Overall Study|Pt transferred to inst w/out study open|0
1862673|NCT00085735|6424142|P4|Overall Study|Pt transferred to inst w/out study open|0
1862674|NCT00085735|6424143|P3|Overall Study|Pt transferred to inst w/out study open|0
1862675|NCT00085735|6424144|P2|Overall Study|Pt transferred to inst w/out study open|0
1862676|NCT00085735|6424145|P1|Overall Study|Pt transferred to inst w/out study open|1
1862677|NCT00085735|6424140|P6|Overall Study|Reason not documented|0
1862678|NCT00085735|6424141|P5|Overall Study|Reason not documented|1
1862679|NCT00085735|6424142|P4|Overall Study|Reason not documented|0
1862680|NCT00085735|6424143|P3|Overall Study|Reason not documented|1
1862681|NCT00085735|6424144|P2|Overall Study|Reason not documented|0
1862682|NCT00085735|6424145|P1|Overall Study|Reason not documented|1
1862683|NCT00085735|6424140|P6|Overall Study|Excess residual disease|4
1862684|NCT00085735|6424141|P5|Overall Study|Excess residual disease|1
1862685|NCT00085735|6424142|P4|Overall Study|Excess residual disease|1
1862686|NCT00085735|6424143|P3|Overall Study|Excess residual disease|1
1862687|NCT00085735|6424144|P2|Overall Study|Excess residual disease|2
1862688|NCT00085735|6424145|P1|Overall Study|Excess residual disease|2
1862689|NCT00085735|6424140|P6|Overall Study|Patient ineligible|8
1862690|NCT00085735|6424141|P5|Overall Study|Patient ineligible|17
1862691|NCT00085735|6424142|P4|Overall Study|Patient ineligible|7
1862692|NCT00085735|6424143|P3|Overall Study|Patient ineligible|3
1862693|NCT00085735|6424144|P2|Overall Study|Patient ineligible|0
1862694|NCT00085735|6424145|P1|Overall Study|Patient ineligible|1
1862695|NCT00085735|6424140|P6|Overall Study|Withdrawal by Subject|8
1862696|NCT00085735|6424141|P5|Overall Study|Withdrawal by Subject|7
1862697|NCT00085735|6424142|P4|Overall Study|Withdrawal by Subject|5
1862698|NCT00085735|6424143|P3|Overall Study|Withdrawal by Subject|4
1862699|NCT00085735|6424144|P2|Overall Study|Withdrawal by Subject|0
1862700|NCT00085735|6424145|P1|Overall Study|Withdrawal by Subject|1
1862701|NCT00085735|6424140|P6|Overall Study|Protocol Violation|0
1862702|NCT00085735|6424141|P5|Overall Study|Protocol Violation|0
1862703|NCT00085735|6424142|P4|Overall Study|Protocol Violation|0
1862704|NCT00085735|6424143|P3|Overall Study|Protocol Violation|0
1862705|NCT00085735|6424144|P2|Overall Study|Protocol Violation|0
1862706|NCT00085735|6424145|P1|Overall Study|Protocol Violation|1
1862707|NCT00085735|6424140|P6|Overall Study|Physician Decision|8
1862708|NCT00085735|6424141|P5|Overall Study|Physician Decision|11
1862709|NCT00085735|6424142|P4|Overall Study|Physician Decision|3
1862710|NCT00085735|6424143|P3|Overall Study|Physician Decision|2
1862711|NCT00085735|6424144|P2|Overall Study|Physician Decision|3
1862712|NCT00085735|6424145|P1|Overall Study|Physician Decision|2
1862713|NCT00085735|6424140|P6|Overall Study|Lost to Follow-up|0
1862714|NCT00085735|6424141|P5|Overall Study|Lost to Follow-up|1
1862715|NCT00085735|6424142|P4|Overall Study|Lost to Follow-up|0
1862716|NCT00085735|6424143|P3|Overall Study|Lost to Follow-up|0
1862717|NCT00085735|6424144|P2|Overall Study|Lost to Follow-up|1
1862718|NCT00085735|6424145|P1|Overall Study|Lost to Follow-up|0
1862719|NCT00085735|6424140|P6|Overall Study|Lack of Efficacy|3
1862720|NCT00085735|6424141|P5|Overall Study|Lack of Efficacy|4
1862721|NCT00085735|6424142|P4|Overall Study|Lack of Efficacy|3
1862722|NCT00085735|6424143|P3|Overall Study|Lack of Efficacy|6
1862723|NCT00085735|6424144|P2|Overall Study|Lack of Efficacy|4
1862724|NCT00085735|6424145|P1|Overall Study|Lack of Efficacy|2
1862725|NCT00085735|6424140|P6|Overall Study|Adverse Event|0
1862726|NCT00085735|6424141|P5|Overall Study|Adverse Event|0
1862727|NCT00085735|6424142|P4|Overall Study|Adverse Event|0
1862728|NCT00085735|6424143|P3|Overall Study|Adverse Event|0
1862729|NCT00085735|6424144|P2|Overall Study|Adverse Event|0
1862730|NCT00085735|6424145|P1|Overall Study|Adverse Event|1
1862731|NCT00085709|6424200|P2|Overall Study|Withdrawal by Subject|1
1862732|NCT00085709|6424201|P1|Overall Study|Withdrawal by Subject|2
1862733|NCT00085709|6424200|P2|Overall Study|Not eligible|19
1862734|NCT00085709|6424201|P1|Overall Study|Not eligible|19
1862735|NCT00085709|6424200|P2|Overall Study|Not protocol specified|22
1862736|NCT00085709|6424201|P1|Overall Study|Not protocol specified|12
1862737|NCT00085709|6424200|P2|Overall Study|Progression|4
1862738|NCT00085709|6424201|P1|Overall Study|Progression|3
1862739|NCT00085709|6424200|P2|Overall Study|Refusal unrelated to adverse events|2
1862740|NCT00085709|6424201|P1|Overall Study|Refusal unrelated to adverse events|1
1862741|NCT00085709|6424200|P2|Overall Study|Death|2
1862742|NCT00085709|6424201|P1|Overall Study|Death|8
1862743|NCT00085709|6424200|P2|Overall Study|Adverse Event|0
1862744|NCT00085709|6424201|P1|Overall Study|Adverse Event|8
1862745|NCT00085644|6424217|P3|Open-Label Period|Personal reason|4
1862746|NCT00085644|6424218|P2|Open-Label Period|Personal reason|0
1862747|NCT00085644|6424219|P1|Open-Label Period|Personal reason|0
1862748|NCT00085644|6424217|P3|Open-Label Period|Protocol Violation|4
1862749|NCT00085644|6424218|P2|Open-Label Period|Protocol Violation|0
1862750|NCT00085644|6424219|P1|Open-Label Period|Protocol Violation|0
1862751|NCT00085644|6424217|P3|Open-Label Period|Contemplating pregnancy|3
1862752|NCT00085644|6424218|P2|Open-Label Period|Contemplating pregnancy|0
1862753|NCT00085644|6424219|P1|Open-Label Period|Contemplating pregnancy|0
1862754|NCT00085644|6424217|P3|Open-Label Period|Pregnancy|3
1862755|NCT00085644|6424218|P2|Open-Label Period|Pregnancy|0
1862756|NCT00085644|6424219|P1|Open-Label Period|Pregnancy|0
1862757|NCT00085644|6424217|P3|Open-Label Period|Lack of Efficacy|15
1862758|NCT00085644|6424218|P2|Open-Label Period|Lack of Efficacy|0
1862759|NCT00085644|6424219|P1|Open-Label Period|Lack of Efficacy|0
1862760|NCT00085644|6424217|P3|Open-Label Period|Lost to Follow-up|13
1862761|NCT00085644|6424218|P2|Open-Label Period|Lost to Follow-up|0
1862762|NCT00085644|6424219|P1|Open-Label Period|Lost to Follow-up|0
1862763|NCT00085644|6424217|P3|Open-Label Period|Withdrawal by Subject|29
1862764|NCT00085644|6424218|P2|Open-Label Period|Withdrawal by Subject|0
1862765|NCT00085644|6424219|P1|Open-Label Period|Withdrawal by Subject|0
1862766|NCT00085644|6424217|P3|Open-Label Period|Adverse Event|38
1862767|NCT00085644|6424218|P2|Open-Label Period|Adverse Event|0
1862768|NCT00085644|6424219|P1|Open-Label Period|Adverse Event|0
1862769|NCT00085644|6424217|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
1862770|NCT00085644|6424218|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
1862771|NCT00085644|6424219|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
1862772|NCT00085644|6424217|P3|Double-Blind Period|Contemplating pregnancy|0
1862773|NCT00085644|6424218|P2|Double-Blind Period|Contemplating pregnancy|0
1862774|NCT00085644|6424219|P1|Double-Blind Period|Contemplating pregnancy|1
1862775|NCT00085644|6424217|P3|Double-Blind Period|Lack/loss of efficacy|0
1862776|NCT00085644|6424218|P2|Double-Blind Period|Lack/loss of efficacy|2
1862777|NCT00085644|6424219|P1|Double-Blind Period|Lack/loss of efficacy|2
1862778|NCT00085644|6424217|P3|Double-Blind Period|Lost to Follow-up|0
1862779|NCT00085644|6424218|P2|Double-Blind Period|Lost to Follow-up|1
1862780|NCT00085644|6424219|P1|Double-Blind Period|Lost to Follow-up|2
1862781|NCT00085644|6424217|P3|Double-Blind Period|Withdrawal by Subject|0
1862782|NCT00085644|6424218|P2|Double-Blind Period|Withdrawal by Subject|0
1862783|NCT00085644|6424219|P1|Double-Blind Period|Withdrawal by Subject|3
1862784|NCT00085644|6424217|P3|Double-Blind Period|Adverse Event|0
1862785|NCT00085644|6424218|P2|Double-Blind Period|Adverse Event|2
1862786|NCT00085644|6424219|P1|Double-Blind Period|Adverse Event|5
1862787|NCT00085631|6424260|P3|Overall Study|Missing Data|7
1862788|NCT00085631|6424261|P2|Overall Study|Missing Data|11
1862789|NCT00085631|6424262|P1|Overall Study|Missing Data|4
1862790|NCT00085566|6424272|P3|Overall Study|Clinical progression|1
1862791|NCT00085566|6424273|P2|Overall Study|Clinical progression|0
1862792|NCT00085566|6424274|P1|Overall Study|Clinical progression|0
1862793|NCT00085566|6424272|P3|Overall Study|Patient Not treated|3
1862794|NCT00085566|6424273|P2|Overall Study|Patient Not treated|0
1862795|NCT00085566|6424274|P1|Overall Study|Patient Not treated|0
1862796|NCT00085566|6424272|P3|Overall Study|Adverse Event|10
1862797|NCT00085566|6424273|P2|Overall Study|Adverse Event|0
1862798|NCT00085566|6424274|P1|Overall Study|Adverse Event|0
1862799|NCT00085540|6424284|P2|Overall Study|Protocol Violation|1
1862800|NCT00085540|6424285|P1|Overall Study|Protocol Violation|0
1862801|NCT00085540|6424284|P2|Overall Study|Withdrawal by Subject|1
1862802|NCT00085540|6424285|P1|Overall Study|Withdrawal by Subject|0
1862803|NCT00085423|6424297|P1|Overall Study|screen failure|1
1862804|NCT00085423|6424297|P1|Overall Study|Withdrawal by Subject|1
1862805|NCT00085202|6424348|P2|Overall Study|Progressive disease|11
1862806|NCT00085202|6424349|P1|Overall Study|Progressive disease|1
1862807|NCT00085202|6424348|P2|Overall Study|Physician Decision|1
1862808|NCT00085202|6424349|P1|Overall Study|Physician Decision|4
1862809|NCT00085202|6424348|P2|Overall Study|Withdrawal by Subject|1
1862810|NCT00085202|6424349|P1|Overall Study|Withdrawal by Subject|2
1862811|NCT00085202|6424348|P2|Overall Study|Non-specified|5
1862812|NCT00085202|6424349|P1|Overall Study|Non-specified|3
1862813|NCT00085202|6424348|P2|Overall Study|Excessive toxicity|5
1862814|NCT00085202|6424349|P1|Overall Study|Excessive toxicity|6
1862815|NCT00085202|6424348|P2|Overall Study|Bone involvement confirmed by bone scan|1
1862816|NCT00085202|6424349|P1|Overall Study|Bone involvement confirmed by bone scan|0
1862817|NCT00085202|6424348|P2|Overall Study|Still on therapy|0
1862818|NCT00085202|6424349|P1|Overall Study|Still on therapy|2
1862819|NCT00085098|6424370|P2|Overall Study|Ineligible|1
1862820|NCT00085098|6424371|P1|Overall Study|Ineligible|1
1862821|NCT00085098|6424370|P2|Overall Study|Withdrawal by Subject|1
1862822|NCT00085098|6424371|P1|Overall Study|Withdrawal by Subject|0
1862823|NCT00084864|6424385|P4|Overall Study|Adverse Event|0
1862824|NCT00084864|6424386|P3|Overall Study|Adverse Event|0
1862825|NCT00084864|6424387|P2|Overall Study|Adverse Event|0
1862826|NCT00084864|6424388|P1|Overall Study|Adverse Event|1
1862827|NCT00084838|6424414|P1|Overall Study|Ineligible|4
1862828|NCT00084838|6424414|P1|Overall Study|Pt Non-Compliance|1
1862829|NCT00084838|6424414|P1|Overall Study|Progressive Disease|4
1862830|NCT00084838|6424414|P1|Overall Study|Withdrawal by Subject|1
1862831|NCT00084838|6424414|P1|Overall Study|Adverse Event|2
1862832|NCT00084838|6424414|P1|Overall Study|Death|1
1862833|NCT00084747|6424436|P1|Overall Study|Withdrawal by Subject|2
1862834|NCT00084747|6424436|P1|Overall Study|Death|3
1862835|NCT00084747|6424436|P1|Overall Study|Relapsed|8
1862836|NCT00084682|6424441|P1|Overall Study|Withdrawal by Subject|1
1862837|NCT00084617|6424445|P1|Overall Study|Protocol Violation|1
1862838|NCT00084617|6424445|P1|Overall Study|Lack of Efficacy|1
1862839|NCT00084617|6424445|P1|Overall Study|Withdrawal by Subject|7
1862840|NCT00084487|6424451|P1|Overall Study|Death|1
1862841|NCT00084318|6424495|P2|Overall Study|No protocol treatment|0
1862842|NCT00084318|6424496|P1|Overall Study|No protocol treatment|2
1862843|NCT00084318|6424495|P2|Overall Study|Protocol Violation|11
1862844|NCT00084318|6424496|P1|Overall Study|Protocol Violation|15
1862845|NCT00084318|6424495|P2|Overall Study|Withdrawal by Subject|2
1862846|NCT00084318|6424496|P1|Overall Study|Withdrawal by Subject|5
1862847|NCT00084266|6424516|P2|Overall Study|Randomized not treated|20
1862848|NCT00084266|6424517|P1|Overall Study|Randomized not treated|21
1862849|NCT00084266|6424516|P2|Overall Study|Other|344
1862850|NCT00084266|6424517|P1|Overall Study|Other|360
1862851|NCT00084266|6424516|P2|Overall Study|Participant not willing to participate|8
1862852|NCT00084266|6424517|P1|Overall Study|Participant not willing to participate|3
1862853|NCT00084266|6424516|P2|Overall Study|Lost to Follow-up|3
1862854|NCT00084266|6424517|P1|Overall Study|Lost to Follow-up|5
1862855|NCT00084266|6424516|P2|Overall Study|Lack of Efficacy|4
1862856|NCT00084266|6424517|P1|Overall Study|Lack of Efficacy|2
1862857|NCT00084266|6424516|P2|Overall Study|Adverse Event|5
1862858|NCT00084266|6424517|P1|Overall Study|Adverse Event|8
1862859|NCT00084266|6424516|P2|Overall Study|Death|39
1862860|NCT00084266|6424517|P1|Overall Study|Death|42
1862861|NCT00084136|6424575|P3|NRTI Comparison|Not reason above|0
1862862|NCT00084136|6424576|P2|NRTI Comparison|Not reason above|0
1862863|NCT00084136|6424577|P1|NRTI Comparison|Not reason above|1
1862864|NCT00084136|6424575|P3|NRTI Comparison|Clinic site closed|14
1862865|NCT00084136|6424576|P2|NRTI Comparison|Clinic site closed|0
1862866|NCT00084136|6424577|P1|NRTI Comparison|Clinic site closed|12
1862867|NCT00084136|6424575|P3|NRTI Comparison|Withdrawal by Subject|38
1862868|NCT00084136|6424576|P2|NRTI Comparison|Withdrawal by Subject|0
1862869|NCT00084136|6424577|P1|NRTI Comparison|Withdrawal by Subject|54
1862870|NCT00084136|6424575|P3|NRTI Comparison|Lost to Follow-up|12
1862871|NCT00084136|6424576|P2|NRTI Comparison|Lost to Follow-up|0
1862872|NCT00084136|6424577|P1|NRTI Comparison|Lost to Follow-up|14
1862873|NCT00084136|6424575|P3|NRTI Comparison|Death|18
1862874|NCT00084136|6424576|P2|NRTI Comparison|Death|0
1862875|NCT00084136|6424577|P1|NRTI Comparison|Death|20
1862876|NCT00084136|6424575|P3|PI Comparison|Clinic site closed|0
1862877|NCT00084136|6424576|P2|PI Comparison|Clinic site closed|0
1862878|NCT00084136|6424577|P1|PI Comparison|Clinic site closed|1
1862879|NCT00084136|6424575|P3|PI Comparison|Withdrawal by Subject|0
1862880|NCT00084136|6424576|P2|PI Comparison|Withdrawal by Subject|30
1862881|NCT00084136|6424577|P1|PI Comparison|Withdrawal by Subject|33
1862882|NCT00084136|6424575|P3|PI Comparison|Lost to Follow-up|0
1862883|NCT00084136|6424576|P2|PI Comparison|Lost to Follow-up|8
1862884|NCT00084136|6424577|P1|PI Comparison|Lost to Follow-up|11
1862885|NCT00084136|6424575|P3|PI Comparison|Death|0
1862886|NCT00084136|6424576|P2|PI Comparison|Death|9
1862887|NCT00084136|6424577|P1|PI Comparison|Death|10
1862888|NCT00084084|6424636|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
1862889|NCT00084084|6424636|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
1862890|NCT00083915|6424646|P2|Overall Study|Insurance issues|1
1862891|NCT00083915|6424647|P1|Overall Study|Insurance issues|1
1862892|NCT00083915|6424646|P2|Overall Study|No response|1
1862893|NCT00083915|6424647|P1|Overall Study|No response|3
1862894|NCT00083915|6424646|P2|Overall Study|Failure to collect|0
1862895|NCT00083915|6424647|P1|Overall Study|Failure to collect|3
1862896|NCT00083915|6424646|P2|Overall Study|disease progression|23
1862897|NCT00083915|6424647|P1|Overall Study|disease progression|18
1862898|NCT00083915|6424646|P2|Overall Study|Withdrawal by Subject|3
1862899|NCT00083915|6424647|P1|Overall Study|Withdrawal by Subject|8
1862900|NCT00083915|6424646|P2|Overall Study|Physician Decision|6
1862901|NCT00083915|6424647|P1|Overall Study|Physician Decision|11
1862902|NCT00083915|6424646|P2|Overall Study|Death|3
1862903|NCT00083915|6424647|P1|Overall Study|Death|6
1862904|NCT00083889|6424655|P2|Overall Study|Crossover to SU011248|25
1862905|NCT00083889|6424656|P1|Overall Study|Crossover to SU011248|0
1862906|NCT00083889|6424655|P2|Overall Study|Completed on marketed sunitinub|0
1862907|NCT00083889|6424656|P1|Overall Study|Completed on marketed sunitinub|3
1862908|NCT00083889|6424655|P2|Overall Study|Randomized: did not take study drug|15
1862909|NCT00083889|6424656|P1|Overall Study|Randomized: did not take study drug|0
1862910|NCT00083889|6424655|P2|Overall Study|Decision of sponsor|4
1862911|NCT00083889|6424656|P1|Overall Study|Decision of sponsor|32
1862912|NCT00083889|6424655|P2|Overall Study|Lack of Efficacy|219
1862913|NCT00083889|6424656|P1|Overall Study|Lack of Efficacy|240
1862914|NCT00083889|6424655|P2|Overall Study|Withdrawal by Subject|24
1862915|NCT00083889|6424656|P1|Overall Study|Withdrawal by Subject|22
1862916|NCT00083889|6424655|P2|Overall Study|Protocol Violation|2
1862917|NCT00083889|6424656|P1|Overall Study|Protocol Violation|2
1862918|NCT00083889|6424655|P2|Overall Study|Adverse Event|86
1862919|NCT00083889|6424656|P1|Overall Study|Adverse Event|76
1862920|NCT00083759|6424714|P2|Overall Study|Other|13
1862921|NCT00083759|6424715|P1|Overall Study|Other|14
1862922|NCT00083759|6424714|P2|Overall Study|Sponsor's Discretion|29
1862923|NCT00083759|6424715|P1|Overall Study|Sponsor's Discretion|28
1862924|NCT00083759|6424714|P2|Overall Study|Non-Compliance|0
1862925|NCT00083759|6424715|P1|Overall Study|Non-Compliance|1
1862926|NCT00083759|6424714|P2|Overall Study|Subject Withdrew Consent|2
1862927|NCT00083759|6424715|P1|Overall Study|Subject Withdrew Consent|2
1862928|NCT00083759|6424714|P2|Overall Study|Inadequate Therapeutic Response|35
1862929|NCT00083759|6424715|P1|Overall Study|Inadequate Therapeutic Response|32
1862930|NCT00083759|6424714|P2|Overall Study|Death|1
1862931|NCT00083759|6424715|P1|Overall Study|Death|1
1862932|NCT00083759|6424714|P2|Overall Study|Lost to Follow-up|0
1862933|NCT00083759|6424715|P1|Overall Study|Lost to Follow-up|1
1862934|NCT00083759|6424714|P2|Overall Study|Adverse Event|3
1862935|NCT00083759|6424715|P1|Overall Study|Adverse Event|5
1862936|NCT00083616|6424733|P1|Overall Study|Other|6
1862937|NCT00083616|6424733|P1|Overall Study|Non-compliance|1
1862938|NCT00083616|6424733|P1|Overall Study|Ineligibility determined|2
1862939|NCT00083616|6424733|P1|Overall Study|Withdrawal by Subject|3
1862940|NCT00083616|6424733|P1|Overall Study|Physician Decision|2
1862941|NCT00083616|6424733|P1|Overall Study|Lost to Follow-up|1
1862942|NCT00083616|6424733|P1|Overall Study|Disease Progression|16
1862943|NCT00082888|6424758|P1|Overall Study|Still receiving treatment|4
1862944|NCT00082888|6424758|P1|Overall Study|Other Medical Problems|2
1862945|NCT00082888|6424758|P1|Overall Study|Alternate Treatment|1
1862946|NCT00082888|6424758|P1|Overall Study|Withdrawal by Subject|9
1862947|NCT00082888|6424758|P1|Overall Study|Adverse Event|4
1862948|NCT00082888|6424758|P1|Overall Study|Death|2
1862949|NCT00082810|6424762|P1|Overall Study|Withdrawal by Subject|4
1862950|NCT00082810|6424762|P1|Overall Study|Progressive disease|24
1862951|NCT00082810|6424762|P1|Overall Study|Adverse Event|3
1862952|NCT00082758|6424773|P3|Overall Study|Protocol Violation|0
1862953|NCT00082758|6424774|P2|Overall Study|Protocol Violation|1
1862954|NCT00082758|6424775|P1|Overall Study|Protocol Violation|0
1862955|NCT00082758|6424773|P3|Overall Study|Withdrawal by Subject|0
1862956|NCT00082758|6424774|P2|Overall Study|Withdrawal by Subject|0
1862957|NCT00082758|6424775|P1|Overall Study|Withdrawal by Subject|3
1862958|NCT00082758|6424773|P3|Overall Study|Physician Decision|0
1862959|NCT00082758|6424774|P2|Overall Study|Physician Decision|1
1862960|NCT00082758|6424775|P1|Overall Study|Physician Decision|0
1862961|NCT00082758|6424773|P3|Overall Study|Lack of Efficacy|0
1862962|NCT00082758|6424774|P2|Overall Study|Lack of Efficacy|13
1862963|NCT00082758|6424775|P1|Overall Study|Lack of Efficacy|12
1862964|NCT00082758|6424773|P3|Overall Study|Adverse Event|0
1862965|NCT00082758|6424774|P2|Overall Study|Adverse Event|2
1862966|NCT00082758|6424775|P1|Overall Study|Adverse Event|0
1862967|NCT00083226|6424795|P1|Overall Study|ineligible or not receiving treatment|4
1862968|NCT00083226|6424795|P1|Overall Study|Other|2
1862969|NCT00083226|6424795|P1|Overall Study|Withdrawal by Subject|4
1862970|NCT00083226|6424795|P1|Overall Study|Death|4
1862971|NCT00083226|6424795|P1|Overall Study|Adverse Event|9
1862972|NCT00083226|6424795|P1|Overall Study|Lack of Efficacy|19
1862973|NCT00082628|6424839|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
1862974|NCT00082628|6424840|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1862975|NCT00082628|6424841|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
1862976|NCT00082628|6424842|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1862977|NCT00082628|6424843|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
1862978|NCT00082628|6424839|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1862979|NCT00082628|6424840|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
1862980|NCT00082628|6424841|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1862981|NCT00082628|6424842|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1862982|NCT00082628|6424843|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
1862983|NCT00082628|6424839|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
1862984|NCT00082628|6424840|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1862985|NCT00082628|6424841|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1862986|NCT00082628|6424842|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1862987|NCT00082628|6424843|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
1862988|NCT00082628|6424839|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1862989|NCT00082628|6424840|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1862990|NCT00082628|6424841|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
1862991|NCT00082628|6424842|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
1862992|NCT00082628|6424843|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
1862993|NCT00082628|6424839|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1862994|NCT00082628|6424840|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1862995|NCT00082628|6424841|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
1862996|NCT00082628|6424842|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
1862997|NCT00082628|6424843|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
1862998|NCT00082628|6424839|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1862999|NCT00082628|6424840|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1863000|NCT00082628|6424841|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
1863001|NCT00082628|6424842|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
1863002|NCT00082628|6424843|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
1863003|NCT00082628|6424839|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1863004|NCT00082628|6424840|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1863005|NCT00082628|6424841|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1863006|NCT00082628|6424842|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
1863007|NCT00082628|6424843|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
1863008|NCT00082433|6424863|P2|Overall Study|Impending surgery|1
1863009|NCT00082433|6424864|P1|Overall Study|Impending surgery|0
1863010|NCT00082433|6424863|P2|Overall Study|New primary cancer|0
1863011|NCT00082433|6424864|P1|Overall Study|New primary cancer|1
1863012|NCT00082433|6424863|P2|Overall Study|Noncompliance|1
1863013|NCT00082433|6424864|P1|Overall Study|Noncompliance|2
1863014|NCT00082433|6424863|P2|Overall Study|Ineligible|1
1863015|NCT00082433|6424864|P1|Overall Study|Ineligible|2
1863016|NCT00082433|6424863|P2|Overall Study|Not Treated|11
1863017|NCT00082433|6424864|P1|Overall Study|Not Treated|12
1863018|NCT00082433|6424863|P2|Overall Study|Still On Treatment|1
1863019|NCT00082433|6424864|P1|Overall Study|Still On Treatment|2
1863020|NCT00082433|6424863|P2|Overall Study|Withdrawal by Subject|30
1863021|NCT00082433|6424864|P1|Overall Study|Withdrawal by Subject|55
1863022|NCT00082433|6424863|P2|Overall Study|Study Drug Toxicity|66
1863023|NCT00082433|6424864|P1|Overall Study|Study Drug Toxicity|179
1863024|NCT00082433|6424863|P2|Overall Study|Lost to Follow-up|2
1863025|NCT00082433|6424864|P1|Overall Study|Lost to Follow-up|1
1863026|NCT00082433|6424863|P2|Overall Study|Physician Decision|61
1863027|NCT00082433|6424864|P1|Overall Study|Physician Decision|50
1863028|NCT00082433|6424863|P2|Overall Study|Disease Progression/Relapse|388
1863029|NCT00082433|6424864|P1|Overall Study|Disease Progression/Relapse|270
1863030|NCT00082433|6424863|P2|Overall Study|Death|18
1863031|NCT00082433|6424864|P1|Overall Study|Death|8
1863032|NCT00082433|6424863|P2|Overall Study|Adverse Event|17
1863033|NCT00082433|6424864|P1|Overall Study|Adverse Event|12
1863034|NCT00082381|6424884|P2|Overall Study|Loss of Glucose Control|0
1863035|NCT00082381|6424885|P1|Overall Study|Loss of Glucose Control|4
1863036|NCT00082381|6424884|P2|Overall Study|Protocol Violation|11
1863037|NCT00082381|6424885|P1|Overall Study|Protocol Violation|10
1863038|NCT00082381|6424884|P2|Overall Study|Physician Decision|2
1863039|NCT00082381|6424885|P1|Overall Study|Physician Decision|1
1863040|NCT00082381|6424884|P2|Overall Study|Patient Decision|4
1863041|NCT00082381|6424885|P1|Overall Study|Patient Decision|8
1863042|NCT00082381|6424884|P2|Overall Study|Lost to Follow-up|7
1863043|NCT00082381|6424885|P1|Overall Study|Lost to Follow-up|5
1863044|NCT00082381|6424884|P2|Overall Study|Adverse Event|2
1863045|NCT00082381|6424885|P1|Overall Study|Adverse Event|27
1863046|NCT00082407|6424905|P2|Overall Study|Lost to Follow-up|3
1863047|NCT00082407|6424906|P1|Overall Study|Lost to Follow-up|0
1863048|NCT00082407|6424905|P2|Overall Study|Death|1
1863049|NCT00082407|6424906|P1|Overall Study|Death|2
1863050|NCT00082407|6424905|P2|Overall Study|Loss of Glucose Control|2
1863051|NCT00082407|6424906|P1|Overall Study|Loss of Glucose Control|2
1863052|NCT00082407|6424905|P2|Overall Study|Physician Decision|3
1863053|NCT00082407|6424906|P1|Overall Study|Physician Decision|5
1863054|NCT00082407|6424905|P2|Overall Study|Patient Decision|6
1863055|NCT00082407|6424906|P1|Overall Study|Patient Decision|13
1863056|NCT00082407|6424905|P2|Overall Study|Protocol Violation|12
1863057|NCT00082407|6424906|P1|Overall Study|Protocol Violation|14
1863058|NCT00082407|6424905|P2|Overall Study|Adverse Event|0
1863059|NCT00082407|6424906|P1|Overall Study|Adverse Event|20
1863060|NCT00082368|6424924|P1|Overall Study|Not treated-pt had poor IV access|1
1863061|NCT00082355|6424929|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
1863062|NCT00082355|6424929|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
1863063|NCT00082355|6424929|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
1863064|NCT00082173|6424963|P2|Overall Study|Culture negative or resistant at baselin|6
1863065|NCT00082173|6424964|P1|Overall Study|Culture negative or resistant at baselin|5
1863066|NCT00082173|6424963|P2|Overall Study|Adverse Event|0
1863067|NCT00082173|6424964|P1|Overall Study|Adverse Event|1
1863068|NCT00082173|6424963|P2|Overall Study|Lost to Follow-up|0
1863069|NCT00082173|6424964|P1|Overall Study|Lost to Follow-up|1
1863070|NCT00082173|6424963|P2|Overall Study|Withdrawal by Subject|5
1863071|NCT00082173|6424964|P1|Overall Study|Withdrawal by Subject|3
1863072|NCT00081770|6425009|P3|Overall Study|Other|8
1863073|NCT00081770|6425010|P2|Overall Study|Other|7
1863074|NCT00081770|6425011|P1|Overall Study|Other|2
1863075|NCT00081770|6425009|P3|Overall Study|Administrative|1
1863076|NCT00081770|6425010|P2|Overall Study|Administrative|0
1863077|NCT00081770|6425011|P1|Overall Study|Administrative|1
1863078|NCT00081770|6425009|P3|Overall Study|Did not meet protocol eligibility|3
1863079|NCT00081770|6425010|P2|Overall Study|Did not meet protocol eligibility|0
1863080|NCT00081770|6425011|P1|Overall Study|Did not meet protocol eligibility|2
1863081|NCT00081770|6425009|P3|Overall Study|Withdrawal by Subject|42
1863082|NCT00081770|6425010|P2|Overall Study|Withdrawal by Subject|40
1863083|NCT00081770|6425011|P1|Overall Study|Withdrawal by Subject|45
1863084|NCT00081770|6425009|P3|Overall Study|Protocol Violation|10
1863085|NCT00081770|6425010|P2|Overall Study|Protocol Violation|10
1863086|NCT00081770|6425011|P1|Overall Study|Protocol Violation|15
1863087|NCT00081770|6425009|P3|Overall Study|Lost to Follow-up|45
1863088|NCT00081770|6425010|P2|Overall Study|Lost to Follow-up|34
1863089|NCT00081770|6425011|P1|Overall Study|Lost to Follow-up|45
1863090|NCT00081770|6425009|P3|Overall Study|Lack of Efficacy|211
1863091|NCT00081770|6425010|P2|Overall Study|Lack of Efficacy|357
1863092|NCT00081770|6425011|P1|Overall Study|Lack of Efficacy|262
1863093|NCT00081770|6425009|P3|Overall Study|Adverse Event|136
1863094|NCT00081770|6425010|P2|Overall Study|Adverse Event|98
1863095|NCT00081770|6425011|P1|Overall Study|Adverse Event|130
1863096|NCT00081731|6425030|P2|Overall Study|scientific integrity issue|8
1863097|NCT00081731|6425031|P1|Overall Study|scientific integrity issue|8
1863098|NCT00081653|6425051|P2|Overall Study|Loss of bone mass|2
1863099|NCT00081653|6425052|P1|Overall Study|Loss of bone mass|0
1863100|NCT00081653|6425051|P2|Overall Study|Participant leaving country|0
1863101|NCT00081653|6425052|P1|Overall Study|Participant leaving country|1
1863102|NCT00081653|6425051|P2|Overall Study|Bone loss|0
1863103|NCT00081653|6425052|P1|Overall Study|Bone loss|2
1863104|NCT00081653|6425051|P2|Overall Study|Low bone mineral density|0
1863105|NCT00081653|6425052|P1|Overall Study|Low bone mineral density|1
1863106|NCT00081653|6425051|P2|Overall Study|Refused Treatment|14
1863107|NCT00081653|6425052|P1|Overall Study|Refused Treatment|18
1863108|NCT00081653|6425051|P2|Overall Study|Lost to Follow-up|4
1863109|NCT00081653|6425052|P1|Overall Study|Lost to Follow-up|2
1863110|NCT00081653|6425051|P2|Overall Study|Adverse Event|17
1863111|NCT00081653|6425052|P1|Overall Study|Adverse Event|23
1863112|NCT00081497|6425070|P2|Overall Study|Non-compliance|1
1863113|NCT00081497|6425071|P1|Overall Study|Non-compliance|0
1863114|NCT00081497|6425070|P2|Overall Study|Withdrawal by Subject|0
1863115|NCT00081497|6425071|P1|Overall Study|Withdrawal by Subject|1
1863116|NCT00081497|6425070|P2|Overall Study|Death|1
1863117|NCT00081497|6425071|P1|Overall Study|Death|0
1863118|NCT00081497|6425070|P2|Overall Study|Adverse Event|0
1863119|NCT00081497|6425071|P1|Overall Study|Adverse Event|2
1863120|NCT00081458|6425089|P3|Overall Study|Randomized but not dosed|1
1863121|NCT00081458|6425090|P2|Overall Study|Randomized but not dosed|0
1863122|NCT00081458|6425091|P1|Overall Study|Randomized but not dosed|0
1863123|NCT00081458|6425089|P3|Overall Study|Withdrawal by Subject|1
1863124|NCT00081458|6425090|P2|Overall Study|Withdrawal by Subject|3
1863125|NCT00081458|6425091|P1|Overall Study|Withdrawal by Subject|0
1863126|NCT00081458|6425089|P3|Overall Study|Adverse Event|2
1863127|NCT00081458|6425090|P2|Overall Study|Adverse Event|5
1863128|NCT00081458|6425091|P1|Overall Study|Adverse Event|1
1863133|NCT00081263|6425156|P2|Overall Study|Inadequate data|10
1863134|NCT00081263|6425157|P1|Overall Study|Inadequate data|5
1863135|NCT00081263|6425156|P2|Overall Study|Never treated|5
1863136|NCT00081263|6425157|P1|Overall Study|Never treated|4
1863137|NCT00081263|6425156|P2|Overall Study|Inadequate pathology|1
1863138|NCT00081263|6425157|P1|Overall Study|Inadequate pathology|0
1863139|NCT00081263|6425156|P2|Overall Study|improper pre-protocol therapy|1
1863140|NCT00081263|6425157|P1|Overall Study|improper pre-protocol therapy|0
1863141|NCT00081263|6425156|P2|Overall Study|wrong cell type|5
1863142|NCT00081263|6425157|P1|Overall Study|wrong cell type|7
1863143|NCT00081263|6425156|P2|Overall Study|clerical error|0
1863144|NCT00081263|6425157|P1|Overall Study|clerical error|1
1863145|NCT00081159|6425167|P2|Overall Study|Lost to Follow-up|1
1863146|NCT00081159|6425168|P1|Overall Study|Lost to Follow-up|2
1863147|NCT00081159|6425167|P2|Overall Study|Myelosuppression prior to treatment|1
1863148|NCT00081159|6425168|P1|Overall Study|Myelosuppression prior to treatment|0
1863149|NCT00081159|6425167|P2|Overall Study|Withdrawal by Subject|3
1863150|NCT00081159|6425168|P1|Overall Study|Withdrawal by Subject|0
1863151|NCT00080938|6425178|P1|Overall Study|Ineligible|4
1863152|NCT00080938|6425178|P1|Overall Study|Not started protocol therapy|1
1863153|NCT00080938|6425178|P1|Overall Study|other disease|1
1863154|NCT00080938|6425178|P1|Overall Study|Lack of Efficacy|7
1863155|NCT00080938|6425178|P1|Overall Study|Death|2
1863156|NCT00080938|6425178|P1|Overall Study|Withdrawal by Subject|6
1863157|NCT00080938|6425178|P1|Overall Study|Adverse Event|3
1863158|NCT00080899|6425194|P1|Overall Study|Adverse Event|1
1863159|NCT00080483|6425206|P2|Overall Study|Physician Decision|1
1863160|NCT00080483|6425207|P1|Overall Study|Physician Decision|1
1863161|NCT00080483|6425206|P2|Overall Study|Lost to Follow-up|1
1863162|NCT00080483|6425207|P1|Overall Study|Lost to Follow-up|1
1863163|NCT00002525|6425215|P2|Overall Study|Never start protocol therapy|0
1863164|NCT00002525|6425216|P1|Overall Study|Never start protocol therapy|8
1863165|NCT00002525|6425215|P2|Overall Study|Other|0
1863166|NCT00002525|6425216|P1|Overall Study|Other|26
1863167|NCT00002525|6425215|P2|Overall Study|Error|0
1863168|NCT00002525|6425216|P1|Overall Study|Error|6
1863169|NCT00002525|6425215|P2|Overall Study|Duke's A, B1, D disease|0
1863170|NCT00002525|6425216|P1|Overall Study|Duke's A, B1, D disease|92
1863171|NCT00002525|6425215|P2|Overall Study|Other complicating disease|0
1863172|NCT00002525|6425216|P1|Overall Study|Other complicating disease|1
1863173|NCT00002525|6425215|P2|Overall Study|Start non-protocol therapy|0
1863174|NCT00002525|6425216|P1|Overall Study|Start non-protocol therapy|1
1863175|NCT00002525|6425215|P2|Overall Study|Withdrawal by Subject|0
1863176|NCT00002525|6425216|P1|Overall Study|Withdrawal by Subject|11
1863177|NCT00002525|6425215|P2|Overall Study|Death|0
1863178|NCT00002525|6425216|P1|Overall Study|Death|5
1863179|NCT00002525|6425215|P2|Overall Study|Adverse Event|0
1863180|NCT00002525|6425216|P1|Overall Study|Adverse Event|36
1863181|NCT00080301|6425243|P2|Overall Study|Still on Treatment as of CSR date|1
1863182|NCT00080301|6425244|P1|Overall Study|Still on Treatment as of CSR date|0
1863183|NCT00080301|6425243|P2|Overall Study|Randomized but Never Treated|10
1863184|NCT00080301|6425244|P1|Overall Study|Randomized but Never Treated|5
1863185|NCT00080288|6425264|P2|Overall Study|Miscellaneous|11
1863186|NCT00080288|6425265|P1|Overall Study|Miscellaneous|11
1863187|NCT00080288|6425264|P2|Overall Study|Withdrawal by Subject|16
1863188|NCT00080288|6425265|P1|Overall Study|Withdrawal by Subject|3
1863189|NCT00080288|6425264|P2|Overall Study|Physician Decision|2
1863190|NCT00080288|6425265|P1|Overall Study|Physician Decision|6
1863191|NCT00080288|6425264|P2|Overall Study|Lost to Follow-up|5
1863192|NCT00080288|6425265|P1|Overall Study|Lost to Follow-up|3
1863193|NCT00080288|6425264|P2|Overall Study|Adverse Event|4
1863194|NCT00080288|6425265|P1|Overall Study|Adverse Event|7
1863195|NCT00080223|6425273|P1|Overall Study|Physician Decision|1
1863196|NCT00080223|6425273|P1|Overall Study|Participant unwilling to continue|2
1863197|NCT00080223|6425273|P1|Overall Study|Non-compliance With Study Treatment|7
1863198|NCT00080223|6425273|P1|Overall Study|Lung Transplantation|9
1863199|NCT00080223|6425273|P1|Overall Study|Withdrawal by Subject|13
1863200|NCT00080223|6425273|P1|Overall Study|Death|21
1863201|NCT00080223|6425273|P1|Overall Study|Adverse Event|23
1863202|NCT00002540|6425283|P2|Overall Study|Refused Screen (Prostate Screening)|2433
1863203|NCT00002540|6425284|P1|Overall Study|Refused Screen (Prostate Screening)|0
1863204|NCT00002540|6425283|P2|Overall Study|Refused ASU (Control)|0
1863205|NCT00002540|6425284|P1|Overall Study|Refused ASU (Control)|597
1863206|NCT00002540|6425283|P2|Overall Study|Died Before ASU (Control)|0
1863207|NCT00002540|6425284|P1|Overall Study|Died Before ASU (Control)|202
1863208|NCT00002540|6425283|P2|Overall Study|Died Before Randomization|6
1863209|NCT00002540|6425284|P1|Overall Study|Died Before Randomization|2
1863210|NCT00002540|6425283|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
1863211|NCT00002540|6425284|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
1863212|NCT00080119|6425314|P4|Overall Study|Lost to Follow-up|14
1863213|NCT00080119|6425315|P3|Overall Study|Lost to Follow-up|19
1863214|NCT00080119|6425316|P2|Overall Study|Lost to Follow-up|19
1863215|NCT00080119|6425317|P1|Overall Study|Lost to Follow-up|16
1863216|NCT00080119|6425314|P4|Overall Study|Unwilling to adhere to study requirement|1
1863217|NCT00080119|6425315|P3|Overall Study|Unwilling to adhere to study requirement|5
1863218|NCT00080119|6425316|P2|Overall Study|Unwilling to adhere to study requirement|2
1863219|NCT00080119|6425317|P1|Overall Study|Unwilling to adhere to study requirement|3
1863220|NCT00080119|6425314|P4|Overall Study|Consent withdrawn|6
1863221|NCT00080119|6425315|P3|Overall Study|Consent withdrawn|4
1863222|NCT00080119|6425316|P2|Overall Study|Consent withdrawn|17
1863223|NCT00080119|6425317|P1|Overall Study|Consent withdrawn|13
1863224|NCT00080119|6425314|P4|Overall Study|Unable to get to clinic|1
1863225|NCT00080119|6425315|P3|Overall Study|Unable to get to clinic|7
1863226|NCT00080119|6425316|P2|Overall Study|Unable to get to clinic|24
1863227|NCT00080119|6425317|P1|Overall Study|Unable to get to clinic|24
1863228|NCT00080119|6425314|P4|Overall Study|Discontinued because of study closure|141
1863229|NCT00080119|6425315|P3|Overall Study|Discontinued because of study closure|130
1863230|NCT00080119|6425316|P2|Overall Study|Discontinued because of study closure|0
1863231|NCT00080119|6425317|P1|Overall Study|Discontinued because of study closure|0
1863232|NCT00079937|6425351|P2|Overall Study|Administrative problems|11
1863233|NCT00079937|6425352|P1|Overall Study|Administrative problems|22
1863234|NCT00079937|6425351|P2|Overall Study|Lost to Follow-up|5
1863235|NCT00079937|6425352|P1|Overall Study|Lost to Follow-up|12
1863236|NCT00079937|6425351|P2|Overall Study|Withdrawal by Subject|7
1863237|NCT00079937|6425352|P1|Overall Study|Withdrawal by Subject|21
1863238|NCT00079937|6425351|P2|Overall Study|Protocol Violation|6
1863239|NCT00079937|6425352|P1|Overall Study|Protocol Violation|8
1863240|NCT00079937|6425351|P2|Overall Study|Subject no longer requires study drug|0
1863241|NCT00079937|6425352|P1|Overall Study|Subject no longer requires study drug|3
1863242|NCT00079937|6425351|P2|Overall Study|Unsatisfactory therapeutic effect|2
1863243|NCT00079937|6425352|P1|Overall Study|Unsatisfactory therapeutic effect|1
1863244|NCT00079937|6425351|P2|Overall Study|Adverse Event|1
1863245|NCT00079937|6425352|P1|Overall Study|Adverse Event|2
1863246|NCT00009737|6425370|P2|Overall Study|Administrative/Other Reasons|1
1863247|NCT00009737|6425371|P1|Overall Study|Administrative/Other Reasons|7
1863248|NCT00009737|6425370|P2|Overall Study|Lost to Follow-up|1
1863249|NCT00009737|6425371|P1|Overall Study|Lost to Follow-up|1
1863250|NCT00009737|6425370|P2|Overall Study|Refused Treatment|16
1863251|NCT00009737|6425371|P1|Overall Study|Refused Treatment|15
1863252|NCT00009737|6425370|P2|Overall Study|Other Protocol Violation|0
1863253|NCT00009737|6425371|P1|Overall Study|Other Protocol Violation|1
1863254|NCT00009737|6425370|P2|Overall Study|Violation of Selection Criteria at Entry|9
1863255|NCT00009737|6425371|P1|Overall Study|Violation of Selection Criteria at Entry|13
1863256|NCT00009737|6425370|P2|Overall Study|Lack of Efficacy|15
1863257|NCT00009737|6425371|P1|Overall Study|Lack of Efficacy|17
1863258|NCT00009737|6425370|P2|Overall Study|Death|6
1863259|NCT00009737|6425371|P1|Overall Study|Death|4
1863260|NCT00009737|6425370|P2|Overall Study|Adverse Event|75
1863261|NCT00009737|6425371|P1|Overall Study|Adverse Event|112
1863262|NCT00079781|6425390|P3|Follow-up Period|Death|1
1863263|NCT00079781|6425391|P2|Follow-up Period|Death|0
1863264|NCT00079781|6425392|P1|Follow-up Period|Death|0
1863265|NCT00079781|6425390|P3|Follow-up Period|Lost to Follow-up|0
1863266|NCT00079781|6425391|P2|Follow-up Period|Lost to Follow-up|0
1863267|NCT00079781|6425392|P1|Follow-up Period|Lost to Follow-up|1
1863268|NCT00079781|6425390|P3|Follow-up Period|Withdrawal by Subject|1
1863269|NCT00079781|6425391|P2|Follow-up Period|Withdrawal by Subject|0
1863270|NCT00079781|6425392|P1|Follow-up Period|Withdrawal by Subject|3
1863271|NCT00079781|6425390|P3|Pre-implant Period|Did not meet I/E criteria|1
1863272|NCT00079781|6425391|P2|Pre-implant Period|Did not meet I/E criteria|1
1863273|NCT00079781|6425392|P1|Pre-implant Period|Did not meet I/E criteria|1
1863274|NCT00079781|6425390|P3|Pre-implant Period|Withdrawal by Subject|0
1863275|NCT00079781|6425391|P2|Pre-implant Period|Withdrawal by Subject|0
1863276|NCT00079781|6425392|P1|Pre-implant Period|Withdrawal by Subject|2
1863277|NCT00079677|6425401|P2|Overall Study|Miscellaneous|0
1863278|NCT00079677|6425402|P1|Overall Study|Miscellaneous|2
1863279|NCT00079677|6425401|P2|Overall Study|Withdrawal by Subject|3
1863280|NCT00079677|6425402|P1|Overall Study|Withdrawal by Subject|5
1863281|NCT00079677|6425401|P2|Overall Study|Protocol Violation|3
1863282|NCT00079677|6425402|P1|Overall Study|Protocol Violation|2
1863283|NCT00079677|6425401|P2|Overall Study|Physician Decision|0
1863284|NCT00079677|6425402|P1|Overall Study|Physician Decision|3
1863285|NCT00079677|6425401|P2|Overall Study|Lost to Follow-up|2
1863286|NCT00079677|6425402|P1|Overall Study|Lost to Follow-up|2
1863287|NCT00079677|6425401|P2|Overall Study|Lack of Efficacy|0
1863288|NCT00079677|6425402|P1|Overall Study|Lack of Efficacy|1
1863289|NCT00079677|6425401|P2|Overall Study|Adverse Event|6
1863290|NCT00079677|6425402|P1|Overall Study|Adverse Event|5
1863291|NCT00079417|6425418|P1|Overall Study|Ineligible|7
1863292|NCT00079417|6425418|P1|Overall Study|Physician Decision|2
1863293|NCT00079391|6425426|P1|Overall Study|Withdrawal by Subject|1
1863294|NCT00079339|6425438|P3|Overall Study|Disease progression|2
1863295|NCT00079339|6425439|P2|Overall Study|Disease progression|28
1863296|NCT00079339|6425440|P1|Overall Study|Disease progression|3
1863297|NCT00079339|6425438|P3|Overall Study|Withdrawal by Subject|1
1863298|NCT00079339|6425439|P2|Overall Study|Withdrawal by Subject|4
1863299|NCT00079339|6425440|P1|Overall Study|Withdrawal by Subject|0
1863300|NCT00079339|6425438|P3|Overall Study|Non-compliance|1
1863301|NCT00079339|6425439|P2|Overall Study|Non-compliance|0
1863302|NCT00079339|6425440|P1|Overall Study|Non-compliance|0
1863303|NCT00079339|6425438|P3|Overall Study|Death|0
1863304|NCT00079339|6425439|P2|Overall Study|Death|0
1863305|NCT00079339|6425440|P1|Overall Study|Death|1
1863306|NCT00079339|6425438|P3|Overall Study|Adverse Event|2
1863307|NCT00079339|6425439|P2|Overall Study|Adverse Event|7
1863308|NCT00079339|6425440|P1|Overall Study|Adverse Event|1
1863309|NCT00079274|6425471|P7|Overall Study|Other|0
1863310|NCT00079274|6425472|P6|Overall Study|Other|2
1863311|NCT00079274|6425473|P5|Overall Study|Other|1
1863312|NCT00079274|6425474|P4|Overall Study|Other|55
1863313|NCT00079274|6425475|P3|Overall Study|Other|5
1863314|NCT00079274|6425476|P2|Overall Study|Other|7
1863315|NCT00079274|6425477|P1|Overall Study|Other|43
1863316|NCT00079274|6425471|P7|Overall Study|Cytogenetic resistance|0
1863317|NCT00079274|6425472|P6|Overall Study|Cytogenetic resistance|0
1863318|NCT00079274|6425473|P5|Overall Study|Cytogenetic resistance|0
1863319|NCT00079274|6425474|P4|Overall Study|Cytogenetic resistance|2
1863320|NCT00079274|6425475|P3|Overall Study|Cytogenetic resistance|0
1863321|NCT00079274|6425476|P2|Overall Study|Cytogenetic resistance|0
1863322|NCT00079274|6425477|P1|Overall Study|Cytogenetic resistance|0
1863323|NCT00079274|6425471|P7|Overall Study|Death|0
1863324|NCT00079274|6425472|P6|Overall Study|Death|0
1863325|NCT00079274|6425473|P5|Overall Study|Death|0
1863326|NCT00079274|6425474|P4|Overall Study|Death|15
1863327|NCT00079274|6425475|P3|Overall Study|Death|1
1863328|NCT00079274|6425476|P2|Overall Study|Death|0
1863329|NCT00079274|6425477|P1|Overall Study|Death|4
1863330|NCT00079274|6425471|P7|Overall Study|Other Medical Problems|0
1863331|NCT00079274|6425472|P6|Overall Study|Other Medical Problems|0
1863332|NCT00079274|6425473|P5|Overall Study|Other Medical Problems|0
1863333|NCT00079274|6425474|P4|Overall Study|Other Medical Problems|7
1863334|NCT00079274|6425475|P3|Overall Study|Other Medical Problems|0
1863335|NCT00079274|6425476|P2|Overall Study|Other Medical Problems|1
1863336|NCT00079274|6425477|P1|Overall Study|Other Medical Problems|6
1863337|NCT00079274|6425471|P7|Overall Study|Alternate Treatment|0
1863338|NCT00079274|6425472|P6|Overall Study|Alternate Treatment|0
1863339|NCT00079274|6425473|P5|Overall Study|Alternate Treatment|0
1863340|NCT00079274|6425474|P4|Overall Study|Alternate Treatment|3
1863341|NCT00079274|6425475|P3|Overall Study|Alternate Treatment|0
1863342|NCT00079274|6425476|P2|Overall Study|Alternate Treatment|1
1863343|NCT00079274|6425477|P1|Overall Study|Alternate Treatment|6
1863344|NCT00079274|6425471|P7|Overall Study|Recurrence|0
1863345|NCT00079274|6425472|P6|Overall Study|Recurrence|2
1863346|NCT00079274|6425473|P5|Overall Study|Recurrence|0
1863347|NCT00079274|6425474|P4|Overall Study|Recurrence|15
1863348|NCT00079274|6425475|P3|Overall Study|Recurrence|1
1863349|NCT00079274|6425476|P2|Overall Study|Recurrence|0
1863350|NCT00079274|6425477|P1|Overall Study|Recurrence|21
1863351|NCT00079274|6425471|P7|Overall Study|Adverse Event|0
1863352|NCT00079274|6425472|P6|Overall Study|Adverse Event|8
1863353|NCT00079274|6425473|P5|Overall Study|Adverse Event|7
1863354|NCT00079274|6425474|P4|Overall Study|Adverse Event|184
1863355|NCT00079274|6425475|P3|Overall Study|Adverse Event|8
1863356|NCT00079274|6425476|P2|Overall Study|Adverse Event|8
1863357|NCT00079274|6425477|P1|Overall Study|Adverse Event|130
1863358|NCT00079274|6425471|P7|Overall Study|Withdrawal by Subject|0
1863359|NCT00079274|6425472|P6|Overall Study|Withdrawal by Subject|8
1863360|NCT00079274|6425473|P5|Overall Study|Withdrawal by Subject|7
1863361|NCT00079274|6425474|P4|Overall Study|Withdrawal by Subject|163
1863362|NCT00079274|6425475|P3|Overall Study|Withdrawal by Subject|12
1863363|NCT00079274|6425476|P2|Overall Study|Withdrawal by Subject|10
1863364|NCT00079274|6425477|P1|Overall Study|Withdrawal by Subject|111
1863365|NCT00079183|6425498|P1|Overall Study|Specimen collection non-compliance|1
1863366|NCT00079183|6425498|P1|Overall Study|Study medication non-compliance|2
1863367|NCT00079183|6425498|P1|Overall Study|Withdrawal by Subject|4
1863368|NCT00079040|6425513|P1|Overall Study|Ineligible|1
1863369|NCT00079040|6425513|P1|Overall Study|Withdrew before treatment|1
1863374|NCT00078819|6425568|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
1863375|NCT00078819|6425569|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
1863376|NCT00078819|6425570|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
1863377|NCT00078819|6425571|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
1863378|NCT00078819|6425568|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
1863379|NCT00078819|6425569|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
1863380|NCT00078819|6425570|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
1863381|NCT00078819|6425571|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
1863382|NCT00078819|6425568|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
1863383|NCT00078819|6425569|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
1863384|NCT00078819|6425570|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
1863385|NCT00078819|6425571|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
1863386|NCT00078819|6425568|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
1863387|NCT00078819|6425569|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
1863388|NCT00078819|6425570|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
1863389|NCT00078819|6425571|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
1863390|NCT00078819|6425568|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
1863391|NCT00078819|6425569|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
1863392|NCT00078819|6425570|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
1863393|NCT00078819|6425571|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
1863394|NCT00078819|6425568|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
1863395|NCT00078819|6425569|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
1863396|NCT00078819|6425570|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
1863397|NCT00078819|6425571|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
1863398|NCT00078819|6425568|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
1863399|NCT00078819|6425569|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
1863400|NCT00078819|6425570|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
1863401|NCT00078819|6425571|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
1863402|NCT00078819|6425568|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
1863403|NCT00078819|6425569|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
1863404|NCT00078819|6425570|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
1863405|NCT00078819|6425571|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
1863406|NCT00078806|6425596|P4|Part 2|Adverse Event|0
1863407|NCT00078806|6425597|P3|Part 2|Adverse Event|0
1863408|NCT00078806|6425598|P2|Part 2|Adverse Event|1
1863409|NCT00078806|6425599|P1|Part 2|Adverse Event|0
1863410|NCT00078806|6425596|P4|Part 1B|Lack of Efficacy|0
1863411|NCT00078806|6425597|P3|Part 1B|Lack of Efficacy|0
1863412|NCT00078806|6425598|P2|Part 1B|Lack of Efficacy|0
1863413|NCT00078806|6425599|P1|Part 1B|Lack of Efficacy|7
1863414|NCT00078806|6425596|P4|Part 1B|Adverse Event|0
1863415|NCT00078806|6425597|P3|Part 1B|Adverse Event|0
1863416|NCT00078806|6425598|P2|Part 1B|Adverse Event|0
1863417|NCT00078806|6425599|P1|Part 1B|Adverse Event|1
1863418|NCT00078806|6425596|P4|Part 1A|Other|0
1863419|NCT00078806|6425597|P3|Part 1A|Other|0
1863420|NCT00078806|6425598|P2|Part 1A|Other|0
1863421|NCT00078806|6425599|P1|Part 1A|Other|1
1863422|NCT00078806|6425596|P4|Part 1A|Lack of Efficacy|0
1863423|NCT00078806|6425597|P3|Part 1A|Lack of Efficacy|0
1863424|NCT00078806|6425598|P2|Part 1A|Lack of Efficacy|0
1863425|NCT00078806|6425599|P1|Part 1A|Lack of Efficacy|7
1863426|NCT00078806|6425596|P4|Part 1A|Adverse Event|0
1863427|NCT00078806|6425597|P3|Part 1A|Adverse Event|0
1863428|NCT00078806|6425598|P2|Part 1A|Adverse Event|0
1863429|NCT00078806|6425599|P1|Part 1A|Adverse Event|2
1863430|NCT00078767|6425635|P2|Overall Study|Withdrawal by Subject|1
1863431|NCT00078767|6425636|P1|Overall Study|Withdrawal by Subject|1
1863432|NCT00005947|6425683|P2|Overall Study|Site Closure|0
1863433|NCT00005947|6425684|P1|Overall Study|Site Closure|1
1863434|NCT00005947|6425683|P2|Overall Study|Patient Refused to Continue|1
1863435|NCT00005947|6425684|P1|Overall Study|Patient Refused to Continue|2
1863436|NCT00005947|6425683|P2|Overall Study|Death|40
1863437|NCT00005947|6425684|P1|Overall Study|Death|54
1863438|NCT00002597|6425720|P2|Overall Study|Withdrawal by Subject|6
1863439|NCT00002597|6425721|P1|Overall Study|Withdrawal by Subject|7
1863440|NCT00002597|6425720|P2|Overall Study|Protocol Violation|17
1863441|NCT00002597|6425721|P1|Overall Study|Protocol Violation|19
1863442|NCT00078377|6425746|P3|Overall Study|Miscellaneous|1
1863443|NCT00078377|6425747|P2|Overall Study|Miscellaneous|6
1863444|NCT00078377|6425748|P1|Overall Study|Miscellaneous|2
1863445|NCT00078377|6425746|P3|Overall Study|Withdrawal by Subject|4
1863446|NCT00078377|6425747|P2|Overall Study|Withdrawal by Subject|4
1863447|NCT00078377|6425748|P1|Overall Study|Withdrawal by Subject|3
1863448|NCT00078377|6425746|P3|Overall Study|Physician Decision|0
1863449|NCT00078377|6425747|P2|Overall Study|Physician Decision|0
1863450|NCT00078377|6425748|P1|Overall Study|Physician Decision|2
1863451|NCT00078377|6425746|P3|Overall Study|Lost to Follow-up|1
1863452|NCT00078377|6425747|P2|Overall Study|Lost to Follow-up|1
1863453|NCT00078377|6425748|P1|Overall Study|Lost to Follow-up|0
1863454|NCT00078377|6425746|P3|Overall Study|Lack of Efficacy|2
1863455|NCT00078377|6425747|P2|Overall Study|Lack of Efficacy|0
1863456|NCT00078377|6425748|P1|Overall Study|Lack of Efficacy|2
1863457|NCT00078377|6425746|P3|Overall Study|Adverse Event|1
1863458|NCT00078377|6425747|P2|Overall Study|Adverse Event|5
1863459|NCT00078377|6425748|P1|Overall Study|Adverse Event|2
1863460|NCT00078338|6425763|P2|Overall Study|Subjects randomized, but not treated|3
1863461|NCT00078338|6425764|P1|Overall Study|Subjects randomized, but not treated|3
1863462|NCT00078338|6425763|P2|Overall Study|Other|16
1863463|NCT00078338|6425764|P1|Overall Study|Other|28
1863464|NCT00078338|6425763|P2|Overall Study|Disease Progression|7
1863465|NCT00078338|6425764|P1|Overall Study|Disease Progression|4
1863466|NCT00078338|6425763|P2|Overall Study|Protocol Violation|2
1863467|NCT00078338|6425764|P1|Overall Study|Protocol Violation|2
1863468|NCT00078338|6425763|P2|Overall Study|Lost to Follow-up|2
1863469|NCT00078338|6425764|P1|Overall Study|Lost to Follow-up|17
1863470|NCT00078338|6425763|P2|Overall Study|Adverse Event|24
1863471|NCT00078338|6425764|P1|Overall Study|Adverse Event|31
1863472|NCT00078325|6425857|P3|Overall Study|Miscellaneous|1
1863473|NCT00078325|6425858|P2|Overall Study|Miscellaneous|1
1863474|NCT00078325|6425859|P1|Overall Study|Miscellaneous|1
1863475|NCT00078325|6425857|P3|Overall Study|Physician Decision|1
1863476|NCT00078325|6425858|P2|Overall Study|Physician Decision|0
1863477|NCT00078325|6425859|P1|Overall Study|Physician Decision|2
1863478|NCT00078325|6425857|P3|Overall Study|Lost to Follow-up|1
1863479|NCT00078325|6425858|P2|Overall Study|Lost to Follow-up|1
1863480|NCT00078325|6425859|P1|Overall Study|Lost to Follow-up|0
1863481|NCT00078325|6425857|P3|Overall Study|Withdrawal by Subject|3
1863482|NCT00078325|6425858|P2|Overall Study|Withdrawal by Subject|5
1863483|NCT00078325|6425859|P1|Overall Study|Withdrawal by Subject|1
1863484|NCT00078325|6425857|P3|Overall Study|Protocol Violation|0
1863485|NCT00078325|6425858|P2|Overall Study|Protocol Violation|2
1863486|NCT00078325|6425859|P1|Overall Study|Protocol Violation|2
1863487|NCT00078325|6425857|P3|Overall Study|Adverse Event|5
1863488|NCT00078325|6425858|P2|Overall Study|Adverse Event|10
1863489|NCT00078325|6425859|P1|Overall Study|Adverse Event|15
1863490|NCT00078312|6425870|P1|Overall Study|Miscellaneous|33
1863491|NCT00078312|6425870|P1|Overall Study|Withdrawal by Subject|33
1863492|NCT00078312|6425870|P1|Overall Study|Protocol Violation|3
1863493|NCT00078312|6425870|P1|Overall Study|Physician Decision|9
1863494|NCT00078312|6425870|P1|Overall Study|Lost to Follow-up|41
1863495|NCT00078312|6425870|P1|Overall Study|Lack of Efficacy|15
1863496|NCT00078312|6425870|P1|Overall Study|Adverse Event|43
1863497|NCT00077974|6425885|P1|Overall Study|Decision of Sponsor|2
1863498|NCT00077974|6425885|P1|Overall Study|Lack of Efficacy|76
1863499|NCT00077974|6425885|P1|Overall Study|Withdrawal by Subject|3
1863500|NCT00077974|6425885|P1|Overall Study|Protocol Violation|1
1863501|NCT00077974|6425885|P1|Overall Study|Adverse Event|22
1863502|NCT00077857|6425902|P2|Overall Study|Other|13
1863503|NCT00077857|6425903|P1|Overall Study|Other|15
1863504|NCT00077857|6425902|P2|Overall Study|Failure to return|5
1863505|NCT00077857|6425903|P1|Overall Study|Failure to return|5
1863506|NCT00077857|6425902|P2|Overall Study|Refused treatment|21
1863507|NCT00077857|6425903|P1|Overall Study|Refused treatment|29
1863508|NCT00077857|6425902|P2|Overall Study|Other protocol violation|1
1863509|NCT00077857|6425903|P1|Overall Study|Other protocol violation|0
1863510|NCT00077857|6425902|P2|Overall Study|Violation of selection criteria at entry|1
1863511|NCT00077857|6425903|P1|Overall Study|Violation of selection criteria at entry|3
1863512|NCT00077857|6425902|P2|Overall Study|Insufficient therapeutic response|128
1863513|NCT00077857|6425903|P1|Overall Study|Insufficient therapeutic response|112
1863514|NCT00077857|6425902|P2|Overall Study|Death|3
1863515|NCT00077857|6425903|P1|Overall Study|Death|7
1863516|NCT00077857|6425902|P2|Overall Study|Adverse Event|32
1863517|NCT00077857|6425903|P1|Overall Study|Adverse Event|30
1863518|NCT00077766|6425923|P2|Overall Study|Participants Vacation|1
1863519|NCT00077766|6425924|P1|Overall Study|Participants Vacation|2
1863520|NCT00077766|6425923|P2|Overall Study|Stop Dialysis|1
1863521|NCT00077766|6425924|P1|Overall Study|Stop Dialysis|0
1863522|NCT00077766|6425923|P2|Overall Study|Started Nocturnal Dialysis|1
1863523|NCT00077766|6425924|P1|Overall Study|Started Nocturnal Dialysis|0
1863524|NCT00077766|6425923|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
1863525|NCT00077766|6425924|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
1863526|NCT00077766|6425923|P2|Overall Study|Dialysis|1
1863527|NCT00077766|6425924|P1|Overall Study|Dialysis|0
1863528|NCT00077766|6425923|P2|Overall Study|Dialysis Discontinued|0
1863529|NCT00077766|6425924|P1|Overall Study|Dialysis Discontinued|1
1863530|NCT00077766|6425923|P2|Overall Study|Participant's decision|0
1863531|NCT00077766|6425924|P1|Overall Study|Participant's decision|1
1863532|NCT00077766|6425923|P2|Overall Study|Investigators Discretion|0
1863533|NCT00077766|6425924|P1|Overall Study|Investigators Discretion|1
1863534|NCT00077766|6425923|P2|Overall Study|Transplantation|1
1863535|NCT00077766|6425924|P1|Overall Study|Transplantation|5
1863536|NCT00077766|6425923|P2|Overall Study|Kidney Transplantation|5
1863537|NCT00077766|6425924|P1|Overall Study|Kidney Transplantation|9
1863538|NCT00077766|6425923|P2|Overall Study|Protocol Violation|0
1863539|NCT00077766|6425924|P1|Overall Study|Protocol Violation|1
1863540|NCT00077766|6425923|P2|Overall Study|Lost to Follow-up|0
1863541|NCT00077766|6425924|P1|Overall Study|Lost to Follow-up|2
1863542|NCT00077766|6425923|P2|Overall Study|Death|10
1863543|NCT00077766|6425924|P1|Overall Study|Death|12
1863544|NCT00077766|6425923|P2|Overall Study|Withdrawal by Subject|3
1863545|NCT00077766|6425924|P1|Overall Study|Withdrawal by Subject|4
1863546|NCT00077766|6425923|P2|Overall Study|Adverse Event|1
1863547|NCT00077766|6425924|P1|Overall Study|Adverse Event|1
1863548|NCT00077675|6425949|P2|Overall Study|Never received study treatment|3
1863549|NCT00077675|6425950|P1|Overall Study|Never received study treatment|3
1863550|NCT00077675|6425949|P2|Overall Study|Other|1
1863551|NCT00077675|6425950|P1|Overall Study|Other|0
1863552|NCT00077675|6425949|P2|Overall Study|Withdrawal by Subject|0
1863553|NCT00077675|6425950|P1|Overall Study|Withdrawal by Subject|1
1863554|NCT00077675|6425949|P2|Overall Study|Lost to Follow-up|3
1863555|NCT00077675|6425950|P1|Overall Study|Lost to Follow-up|6
1863556|NCT00077675|6425949|P2|Overall Study|Adverse Event|2
1863557|NCT00077675|6425950|P1|Overall Study|Adverse Event|1
1863558|NCT00077649|6425960|P4|Overall Study|Randomized but never dosed|0
1863559|NCT00077649|6425961|P3|Overall Study|Randomized but never dosed|0
1863560|NCT00077649|6425962|P2|Overall Study|Randomized but never dosed|0
1863561|NCT00077649|6425963|P1|Overall Study|Randomized but never dosed|1
1863562|NCT00077649|6425960|P4|Overall Study|Abnormality of Laboratory Test|2
1863563|NCT00077649|6425961|P3|Overall Study|Abnormality of Laboratory Test|1
1863564|NCT00077649|6425962|P2|Overall Study|Abnormality of Laboratory Test|2
1863565|NCT00077649|6425963|P1|Overall Study|Abnormality of Laboratory Test|1
1863566|NCT00077649|6425960|P4|Overall Study|Lost to Follow-up|2
1863567|NCT00077649|6425961|P3|Overall Study|Lost to Follow-up|3
1863568|NCT00077649|6425962|P2|Overall Study|Lost to Follow-up|2
1863569|NCT00077649|6425963|P1|Overall Study|Lost to Follow-up|2
1863570|NCT00077649|6425960|P4|Overall Study|Withdrawal by Subject|2
1863571|NCT00077649|6425961|P3|Overall Study|Withdrawal by Subject|1
1863572|NCT00077649|6425962|P2|Overall Study|Withdrawal by Subject|1
1863573|NCT00077649|6425963|P1|Overall Study|Withdrawal by Subject|0
1863574|NCT00077649|6425960|P4|Overall Study|Lack of Efficacy|2
1863575|NCT00077649|6425961|P3|Overall Study|Lack of Efficacy|3
1863576|NCT00077649|6425962|P2|Overall Study|Lack of Efficacy|3
1863577|NCT00077649|6425963|P1|Overall Study|Lack of Efficacy|5
1863578|NCT00077649|6425960|P4|Overall Study|Adverse Event|9
1863579|NCT00077649|6425961|P3|Overall Study|Adverse Event|7
1863580|NCT00077649|6425962|P2|Overall Study|Adverse Event|1
1863581|NCT00077649|6425963|P1|Overall Study|Adverse Event|5
1863582|NCT00077636|6426011|P2|Overall Study|Abnormality Of Laboratory Test|2
1863583|NCT00077636|6426012|P1|Overall Study|Abnormality Of Laboratory Test|3
1863584|NCT00077636|6426011|P2|Overall Study|Lost to Follow-up|18
1863585|NCT00077636|6426012|P1|Overall Study|Lost to Follow-up|10
1863586|NCT00077636|6426011|P2|Overall Study|Protocol Violation|2
1863587|NCT00077636|6426012|P1|Overall Study|Protocol Violation|0
1863588|NCT00077636|6426011|P2|Overall Study|Adverse Event|34
1863589|NCT00077636|6426012|P1|Overall Study|Adverse Event|17
1863590|NCT00077636|6426011|P2|Overall Study|Withdrawal by Subject|2
1863591|NCT00077636|6426012|P1|Overall Study|Withdrawal by Subject|2
1863592|NCT00077636|6426011|P2|Overall Study|Admin|3
1863593|NCT00077636|6426012|P1|Overall Study|Admin|3
1863594|NCT00077636|6426011|P2|Overall Study|Refused Treatment|31
1863595|NCT00077636|6426012|P1|Overall Study|Refused Treatment|9
1863596|NCT00077623|6426033|P3|Overall Study|Failure to return|0
1863597|NCT00077623|6426034|P2|Overall Study|Failure to return|0
1863598|NCT00077623|6426035|P1|Overall Study|Failure to return|1
1863599|NCT00077623|6426033|P3|Overall Study|Death|11
1863600|NCT00077623|6426034|P2|Overall Study|Death|18
1863601|NCT00077623|6426035|P1|Overall Study|Death|12
1863602|NCT00077623|6426033|P3|Overall Study|Insufficient therapeutic response|0
1863603|NCT00077623|6426034|P2|Overall Study|Insufficient therapeutic response|0
1863604|NCT00077623|6426035|P1|Overall Study|Insufficient therapeutic response|2
1863605|NCT00077623|6426033|P3|Overall Study|Other-Non safety reason|19
1863606|NCT00077623|6426034|P2|Overall Study|Other-Non safety reason|15
1863607|NCT00077623|6426035|P1|Overall Study|Other-Non safety reason|18
1863608|NCT00077623|6426033|P3|Overall Study|Withdrawal by Subject|1
1863609|NCT00077623|6426034|P2|Overall Study|Withdrawal by Subject|10
1863610|NCT00077623|6426035|P1|Overall Study|Withdrawal by Subject|2
1863611|NCT00077623|6426033|P3|Overall Study|Adverse Event|1
1863612|NCT00077623|6426034|P2|Overall Study|Adverse Event|0
1863613|NCT00077623|6426035|P1|Overall Study|Adverse Event|1
1863614|NCT00077610|6426070|P3|Overall Study|Sponsors decision to withdraw|1
1863615|NCT00077610|6426071|P2|Overall Study|Sponsors decision to withdraw|0
1863616|NCT00077610|6426072|P1|Overall Study|Sponsors decision to withdraw|0
1863617|NCT00077610|6426070|P3|Overall Study|Financial issues|0
1863618|NCT00077610|6426071|P2|Overall Study|Financial issues|1
1863619|NCT00077610|6426072|P1|Overall Study|Financial issues|0
1863620|NCT00077610|6426070|P3|Overall Study|Relocation|5
1863621|NCT00077610|6426071|P2|Overall Study|Relocation|8
1863622|NCT00077610|6426072|P1|Overall Study|Relocation|0
1863623|NCT00077610|6426070|P3|Overall Study|Change in dialysis modality|0
1863624|NCT00077610|6426071|P2|Overall Study|Change in dialysis modality|0
1863625|NCT00077610|6426072|P1|Overall Study|Change in dialysis modality|1
1863626|NCT00077610|6426070|P3|Overall Study|Transfer to other center for surgery|0
1863627|NCT00077610|6426071|P2|Overall Study|Transfer to other center for surgery|0
1863628|NCT00077610|6426072|P1|Overall Study|Transfer to other center for surgery|1
1863629|NCT00077610|6426070|P3|Overall Study|Transfer to satellite unit|0
1863630|NCT00077610|6426071|P2|Overall Study|Transfer to satellite unit|0
1863631|NCT00077610|6426072|P1|Overall Study|Transfer to satellite unit|1
1863632|NCT00077610|6426070|P3|Overall Study|Transferred to nursing home|1
1863633|NCT00077610|6426071|P2|Overall Study|Transferred to nursing home|0
1863634|NCT00077610|6426072|P1|Overall Study|Transferred to nursing home|0
1863635|NCT00077610|6426070|P3|Overall Study|Transferred to other unit|1
1863636|NCT00077610|6426071|P2|Overall Study|Transferred to other unit|0
1863637|NCT00077610|6426072|P1|Overall Study|Transferred to other unit|0
1863638|NCT00077610|6426070|P3|Overall Study|Given Epogen in hospital|0
1863639|NCT00077610|6426071|P2|Overall Study|Given Epogen in hospital|0
1863640|NCT00077610|6426072|P1|Overall Study|Given Epogen in hospital|1
1863641|NCT00077610|6426070|P3|Overall Study|Worsening of health condition|0
1863642|NCT00077610|6426071|P2|Overall Study|Worsening of health condition|1
1863643|NCT00077610|6426072|P1|Overall Study|Worsening of health condition|1
1863644|NCT00077610|6426070|P3|Overall Study|Principal Investigator's decision|1
1863645|NCT00077610|6426071|P2|Overall Study|Principal Investigator's decision|0
1863646|NCT00077610|6426072|P1|Overall Study|Principal Investigator's decision|1
1863647|NCT00077610|6426070|P3|Overall Study|Multiple blood transfusions|1
1863648|NCT00077610|6426071|P2|Overall Study|Multiple blood transfusions|0
1863649|NCT00077610|6426072|P1|Overall Study|Multiple blood transfusions|0
1863650|NCT00077610|6426070|P3|Overall Study|Insufficient Therapeutic Response|0
1863651|NCT00077610|6426071|P2|Overall Study|Insufficient Therapeutic Response|0
1863652|NCT00077610|6426072|P1|Overall Study|Insufficient Therapeutic Response|1
1863653|NCT00077610|6426070|P3|Overall Study|Withdrew from dialysis care|3
1863654|NCT00077610|6426071|P2|Overall Study|Withdrew from dialysis care|0
1863655|NCT00077610|6426072|P1|Overall Study|Withdrew from dialysis care|5
1863656|NCT00077610|6426070|P3|Overall Study|Renal transplant|11
1863657|NCT00077610|6426071|P2|Overall Study|Renal transplant|15
1863658|NCT00077610|6426072|P1|Overall Study|Renal transplant|12
1863659|NCT00077610|6426070|P3|Overall Study|Death|13
1863660|NCT00077610|6426071|P2|Overall Study|Death|13
1863661|NCT00077610|6426072|P1|Overall Study|Death|17
1863662|NCT00077610|6426070|P3|Overall Study|Withdrawal by Subject|6
1863663|NCT00077610|6426071|P2|Overall Study|Withdrawal by Subject|10
1863664|NCT00077610|6426072|P1|Overall Study|Withdrawal by Subject|4
1863665|NCT00077610|6426070|P3|Overall Study|Lost to Follow-up|2
1863666|NCT00077610|6426071|P2|Overall Study|Lost to Follow-up|1
1863667|NCT00077610|6426072|P1|Overall Study|Lost to Follow-up|0
1863668|NCT00077610|6426070|P3|Overall Study|Adverse Event|1
1863669|NCT00077610|6426071|P2|Overall Study|Adverse Event|7
1863670|NCT00077610|6426072|P1|Overall Study|Adverse Event|9
1863671|NCT00077376|6426101|P1|Overall Study|Insurance ran out|1
1863672|NCT00077376|6426101|P1|Overall Study|Surgery|1
1863673|NCT00077376|6426101|P1|Overall Study|Symptomatic deterioration|1
1863674|NCT00077376|6426101|P1|Overall Study|Still on treatment|1
1863675|NCT00077376|6426101|P1|Overall Study|Complicating disease|1
1863676|NCT00077376|6426101|P1|Overall Study|Alternative therapy|5
1863677|NCT00077376|6426101|P1|Overall Study|Physician Decision|1
1863678|NCT00077376|6426101|P1|Overall Study|Death|1
1863679|NCT00077376|6426101|P1|Overall Study|Withdrawal by Subject|2
1863680|NCT00077376|6426101|P1|Overall Study|Adverse Event|8
1863681|NCT00077207|6426112|P1|Overall Study|Ineligible|1
1863682|NCT00077207|6426112|P1|Overall Study|Withdrawal by Subject|6
1863683|NCT00077207|6426112|P1|Overall Study|Physician Decision|6
1863684|NCT00077207|6426112|P1|Overall Study|Lack of Efficacy|12
1863685|NCT00077207|6426112|P1|Overall Study|Adverse Event|5
1863686|NCT00077064|6426124|P2|Overall Study|Patient refusal|2
1863687|NCT00077064|6426125|P1|Overall Study|Patient refusal|0
1863688|NCT00077064|6426124|P2|Overall Study|Adverse Event|4
1863689|NCT00077064|6426125|P1|Overall Study|Adverse Event|0
1863690|NCT00076999|6426141|P5|Overall Study|Other reason (not specified)|13
1863691|NCT00076999|6426142|P4|Overall Study|Other reason (not specified)|1
1863692|NCT00076999|6426143|P3|Overall Study|Other reason (not specified)|4
1863693|NCT00076999|6426144|P2|Overall Study|Other reason (not specified)|8
1863694|NCT00076999|6426145|P1|Overall Study|Other reason (not specified)|8
1863695|NCT00076999|6426141|P5|Overall Study|Withdrawal by Subject|1
1863696|NCT00076999|6426142|P4|Overall Study|Withdrawal by Subject|0
1863697|NCT00076999|6426143|P3|Overall Study|Withdrawal by Subject|3
1863698|NCT00076999|6426144|P2|Overall Study|Withdrawal by Subject|4
1863699|NCT00076999|6426145|P1|Overall Study|Withdrawal by Subject|0
1863700|NCT00076999|6426141|P5|Overall Study|Lost to Follow-up|0
1863701|NCT00076999|6426142|P4|Overall Study|Lost to Follow-up|0
1863702|NCT00076999|6426143|P3|Overall Study|Lost to Follow-up|0
1863703|NCT00076999|6426144|P2|Overall Study|Lost to Follow-up|1
1863704|NCT00076999|6426145|P1|Overall Study|Lost to Follow-up|2
1863705|NCT00076999|6426141|P5|Overall Study|Protocol Violation|9
1863706|NCT00076999|6426142|P4|Overall Study|Protocol Violation|0
1863707|NCT00076999|6426143|P3|Overall Study|Protocol Violation|4
1863708|NCT00076999|6426144|P2|Overall Study|Protocol Violation|3
1863709|NCT00076999|6426145|P1|Overall Study|Protocol Violation|0
1863710|NCT00076999|6426141|P5|Overall Study|Adverse Event|2
1863711|NCT00076999|6426142|P4|Overall Study|Adverse Event|0
1863712|NCT00076999|6426143|P3|Overall Study|Adverse Event|6
1863713|NCT00076999|6426144|P2|Overall Study|Adverse Event|8
1863714|NCT00076999|6426145|P1|Overall Study|Adverse Event|2
1863715|NCT00003222|6426264|P2|Overall Study|Physician Decision|1
1863716|NCT00003222|6426265|P1|Overall Study|Physician Decision|0
1863717|NCT00076804|6426277|P2|Overall Study|Early study Closure|32
1863718|NCT00076804|6426278|P1|Overall Study|Early study Closure|32
1863719|NCT00076804|6426277|P2|Overall Study|Withdrawal by Subject|8
1863720|NCT00076804|6426278|P1|Overall Study|Withdrawal by Subject|10
1863721|NCT00076804|6426277|P2|Overall Study|Lost to Follow-up|9
1863722|NCT00076804|6426278|P1|Overall Study|Lost to Follow-up|9
1863723|NCT00076804|6426277|P2|Overall Study|Death|20
1863724|NCT00076804|6426278|P1|Overall Study|Death|9
1863725|NCT00076752|6426290|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
1863726|NCT00076752|6426290|P1|Overall Study|Death|2
1863727|NCT00076570|6426336|P2|Overall Study|Drug intolerance|8
1863728|NCT00076570|6426337|P1|Overall Study|Drug intolerance|8
1863729|NCT00003298|6426345|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
1863730|NCT00003298|6426345|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
1863731|NCT00003298|6426345|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
1863732|NCT00003298|6426345|P1|Step 2 (Adjuvant Therapy)|Death|1
1863733|NCT00003298|6426345|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
1863734|NCT00003298|6426345|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
1863735|NCT00003298|6426345|P1|Re-register to Step 2 After Surgery|Reason unknown|1
1863736|NCT00003298|6426345|P1|Re-register to Step 2 After Surgery|Other complications|2
1863737|NCT00003298|6426345|P1|Re-register to Step 2 After Surgery|Positive margins|5
1863738|NCT00003298|6426345|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
1863739|NCT00003298|6426345|P1|Surgery|Unevaluable and off study|2
1863740|NCT00003298|6426345|P1|Surgery|Progression before surgery|2
1863741|NCT00003298|6426345|P1|Surgery|Unresectable at surgery|3
1863742|NCT00003298|6426345|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
1863743|NCT00003298|6426345|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
1863744|NCT00076336|6426355|P2|Overall Study|Treatment failure|5
1863745|NCT00076336|6426356|P1|Overall Study|Treatment failure|4
1863746|NCT00076336|6426355|P2|Overall Study|Virologic Breakthrough|16
1863747|NCT00076336|6426356|P1|Overall Study|Virologic Breakthrough|14
1863748|NCT00076336|6426355|P2|Overall Study|Liver Transplantation|3
1863749|NCT00076336|6426356|P1|Overall Study|Liver Transplantation|3
1863750|NCT00076336|6426355|P2|Overall Study|Patient, Investigator, Sponsor request|6
1863751|NCT00076336|6426356|P1|Overall Study|Patient, Investigator, Sponsor request|8
1863752|NCT00076336|6426355|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
1863753|NCT00076336|6426356|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
1863754|NCT00076336|6426355|P2|Overall Study|Non-Compliance|0
1863755|NCT00076336|6426356|P1|Overall Study|Non-Compliance|2
1863756|NCT00076336|6426355|P2|Overall Study|Lost to Follow-up|4
1863757|NCT00076336|6426356|P1|Overall Study|Lost to Follow-up|4
1863758|NCT00076336|6426355|P2|Overall Study|Adverse Event|4
1863759|NCT00076336|6426356|P1|Overall Study|Adverse Event|4
1863760|NCT00076336|6426355|P2|Overall Study|Death|17
1863761|NCT00076336|6426356|P1|Overall Study|Death|13
1863762|NCT00076102|6426409|P1|Overall Study|refusal of further therapy|2
1863763|NCT00076102|6426409|P1|Overall Study|plexiform neurofibroma surgery|1
1863764|NCT00076102|6426409|P1|Overall Study|Progression in pre-existing brain tumor|1
1863765|NCT00076102|6426409|P1|Overall Study|Clinical progression|1
1863766|NCT00076024|6426437|P4|Phase 2, Open-label|Other|2
1863767|NCT00076024|6426438|P3|Phase 2, Open-label|Other|0
1863768|NCT00076024|6426439|P2|Phase 2, Open-label|Other|0
1863769|NCT00076024|6426440|P1|Phase 2, Open-label|Other|0
1863770|NCT00076024|6426437|P4|Phase 2, Open-label|Withdrawal by Subject|1
1863771|NCT00076024|6426438|P3|Phase 2, Open-label|Withdrawal by Subject|0
1863772|NCT00076024|6426439|P2|Phase 2, Open-label|Withdrawal by Subject|0
1863773|NCT00076024|6426440|P1|Phase 2, Open-label|Withdrawal by Subject|0
1863774|NCT00076024|6426437|P4|Phase 2, Open-label|Lack of Efficacy|11
1863775|NCT00076024|6426438|P3|Phase 2, Open-label|Lack of Efficacy|0
1863776|NCT00076024|6426439|P2|Phase 2, Open-label|Lack of Efficacy|0
1863777|NCT00076024|6426440|P1|Phase 2, Open-label|Lack of Efficacy|0
1863778|NCT00076024|6426437|P4|Phase 2, Open-label|Adverse Event|2
1863779|NCT00076024|6426438|P3|Phase 2, Open-label|Adverse Event|0
1863780|NCT00076024|6426439|P2|Phase 2, Open-label|Adverse Event|0
1863781|NCT00076024|6426440|P1|Phase 2, Open-label|Adverse Event|0
1863782|NCT00076024|6426437|P4|Phase 2, Double-blind|Randomized but not treated|0
1863783|NCT00076024|6426438|P3|Phase 2, Double-blind|Randomized but not treated|0
1863784|NCT00076024|6426439|P2|Phase 2, Double-blind|Randomized but not treated|1
1863785|NCT00076024|6426440|P1|Phase 2, Double-blind|Randomized but not treated|0
1863786|NCT00076024|6426437|P4|Phase 2, Double-blind|Un-specified|0
1863787|NCT00076024|6426438|P3|Phase 2, Double-blind|Un-specified|6
1863788|NCT00076024|6426439|P2|Phase 2, Double-blind|Un-specified|14
1863789|NCT00076024|6426440|P1|Phase 2, Double-blind|Un-specified|0
1863790|NCT00076024|6426437|P4|Phase 2, Double-blind|Adverse Event|0
1863791|NCT00076024|6426438|P3|Phase 2, Double-blind|Adverse Event|6
1863792|NCT00076024|6426439|P2|Phase 2, Double-blind|Adverse Event|25
1863793|NCT00076024|6426440|P1|Phase 2, Double-blind|Adverse Event|0
1863794|NCT00076024|6426437|P4|Phase 2, Double-blind|Withdrawal by Subject|0
1863795|NCT00076024|6426438|P3|Phase 2, Double-blind|Withdrawal by Subject|4
1863796|NCT00076024|6426439|P2|Phase 2, Double-blind|Withdrawal by Subject|13
1863797|NCT00076024|6426440|P1|Phase 2, Double-blind|Withdrawal by Subject|0
1863798|NCT00076024|6426437|P4|Phase 2, Double-blind|Lack of Efficacy|0
1863799|NCT00076024|6426438|P3|Phase 2, Double-blind|Lack of Efficacy|40
1863800|NCT00076024|6426439|P2|Phase 2, Double-blind|Lack of Efficacy|59
1863801|NCT00076024|6426440|P1|Phase 2, Double-blind|Lack of Efficacy|0
1863802|NCT00076024|6426437|P4|Phase 1, Lead-in|Clinical progression|0
1863803|NCT00076024|6426438|P3|Phase 1, Lead-in|Clinical progression|0
1863804|NCT00076024|6426439|P2|Phase 1, Lead-in|Clinical progression|0
1863805|NCT00076024|6426440|P1|Phase 1, Lead-in|Clinical progression|1
1863806|NCT00076024|6426437|P4|Phase 1, Lead-in|Adverse Event|0
1863807|NCT00076024|6426438|P3|Phase 1, Lead-in|Adverse Event|0
1863808|NCT00076024|6426439|P2|Phase 1, Lead-in|Adverse Event|0
1863809|NCT00076024|6426440|P1|Phase 1, Lead-in|Adverse Event|1
1863810|NCT00076024|6426437|P4|Phase 1, Lead-in|Lack of Efficacy|0
1863811|NCT00076024|6426438|P3|Phase 1, Lead-in|Lack of Efficacy|0
1863812|NCT00076024|6426439|P2|Phase 1, Lead-in|Lack of Efficacy|0
1863813|NCT00076024|6426440|P1|Phase 1, Lead-in|Lack of Efficacy|4
1863814|NCT00076011|6426454|P1|Overall Study|Ongoing|1
1863815|NCT00076011|6426454|P1|Overall Study|Other|11
1863816|NCT00076011|6426454|P1|Overall Study|Study terminated by sponsor|3
1863817|NCT00076011|6426454|P1|Overall Study|Withdrawal by Subject|1
1863818|NCT00076011|6426454|P1|Overall Study|Lack of Efficacy|25
1863819|NCT00076011|6426454|P1|Overall Study|Adverse Event|10
1863820|NCT00076011|6426454|P1|Overall Study|Death|1
1863821|NCT00075946|6426466|P5|Overall Study|Other|0
1863822|NCT00075946|6426467|P4|Overall Study|Other|2
1863823|NCT00075946|6426468|P3|Overall Study|Other|0
1863824|NCT00075946|6426469|P2|Overall Study|Other|13
1863825|NCT00075946|6426470|P1|Overall Study|Other|5
1863826|NCT00075946|6426466|P5|Overall Study|Time to progression less than 6 months|0
1863827|NCT00075946|6426467|P4|Overall Study|Time to progression less than 6 months|3
1863828|NCT00075946|6426468|P3|Overall Study|Time to progression less than 6 months|8
1863829|NCT00075946|6426469|P2|Overall Study|Time to progression less than 6 months|30
1863830|NCT00075946|6426470|P1|Overall Study|Time to progression less than 6 months|15
1863831|NCT00075946|6426466|P5|Overall Study|No response to retreatment|0
1863832|NCT00075946|6426467|P4|Overall Study|No response to retreatment|0
1863833|NCT00075946|6426468|P3|Overall Study|No response to retreatment|2
1863834|NCT00075946|6426469|P2|Overall Study|No response to retreatment|0
1863835|NCT00075946|6426470|P1|Overall Study|No response to retreatment|23
1863836|NCT00075946|6426466|P5|Overall Study|Other complicating disease|0
1863837|NCT00075946|6426467|P4|Overall Study|Other complicating disease|4
1863838|NCT00075946|6426468|P3|Overall Study|Other complicating disease|1
1863839|NCT00075946|6426469|P2|Overall Study|Other complicating disease|13
1863840|NCT00075946|6426470|P1|Overall Study|Other complicating disease|7
1863841|NCT00075946|6426466|P5|Overall Study|Alternative therapy|0
1863842|NCT00075946|6426467|P4|Overall Study|Alternative therapy|0
1863843|NCT00075946|6426468|P3|Overall Study|Alternative therapy|5
1863844|NCT00075946|6426469|P2|Overall Study|Alternative therapy|2
1863845|NCT00075946|6426470|P1|Overall Study|Alternative therapy|16
1863846|NCT00075946|6426466|P5|Overall Study|Withdrawal by Subject|0
1863847|NCT00075946|6426467|P4|Overall Study|Withdrawal by Subject|9
1863848|NCT00075946|6426468|P3|Overall Study|Withdrawal by Subject|4
1863849|NCT00075946|6426469|P2|Overall Study|Withdrawal by Subject|58
1863850|NCT00075946|6426470|P1|Overall Study|Withdrawal by Subject|23
1863851|NCT00075946|6426466|P5|Overall Study|Death|0
1863852|NCT00075946|6426467|P4|Overall Study|Death|0
1863853|NCT00075946|6426468|P3|Overall Study|Death|0
1863854|NCT00075946|6426469|P2|Overall Study|Death|1
1863855|NCT00075946|6426470|P1|Overall Study|Death|0
1863856|NCT00075946|6426466|P5|Overall Study|Adverse Event|0
1863857|NCT00075946|6426467|P4|Overall Study|Adverse Event|2
1863858|NCT00075946|6426468|P3|Overall Study|Adverse Event|0
1863859|NCT00075946|6426469|P2|Overall Study|Adverse Event|10
1863860|NCT00075946|6426470|P1|Overall Study|Adverse Event|2
1863861|NCT00075946|6426466|P5|Overall Study|Still on treatment at time of analysis|0
1863862|NCT00075946|6426467|P4|Overall Study|Still on treatment at time of analysis|9
1863863|NCT00075946|6426468|P3|Overall Study|Still on treatment at time of analysis|3
1863864|NCT00075946|6426469|P2|Overall Study|Still on treatment at time of analysis|19
1863865|NCT00075946|6426470|P1|Overall Study|Still on treatment at time of analysis|52
1863866|NCT00075946|6426466|P5|Overall Study|Incorrectly randomized (no response)|0
1863867|NCT00075946|6426467|P4|Overall Study|Incorrectly randomized (no response)|1
1863868|NCT00075946|6426468|P3|Overall Study|Incorrectly randomized (no response)|5
1863869|NCT00075946|6426469|P2|Overall Study|Incorrectly randomized (no response)|5
1863870|NCT00075946|6426470|P1|Overall Study|Incorrectly randomized (no response)|5
1863871|NCT00075946|6426466|P5|Overall Study|Did not achieve response after induction|182
1863872|NCT00075946|6426467|P4|Overall Study|Did not achieve response after induction|0
1863873|NCT00075946|6426468|P3|Overall Study|Did not achieve response after induction|0
1863874|NCT00075946|6426469|P2|Overall Study|Did not achieve response after induction|0
1863875|NCT00075946|6426470|P1|Overall Study|Did not achieve response after induction|0
1863876|NCT00075946|6426466|P5|Overall Study|Path ineligible: undetermined histology|6
1863877|NCT00075946|6426467|P4|Overall Study|Path ineligible: undetermined histology|0
1863878|NCT00075946|6426468|P3|Overall Study|Path ineligible: undetermined histology|0
1863879|NCT00075946|6426469|P2|Overall Study|Path ineligible: undetermined histology|0
1863880|NCT00075946|6426470|P1|Overall Study|Path ineligible: undetermined histology|0
1863881|NCT00075881|6426485|P1|Overall Study|never start protocol therapy|1
1863882|NCT00075881|6426485|P1|Overall Study|Ineligible|1
1863883|NCT00075881|6426485|P1|Overall Study|missing data|2
1863884|NCT00075881|6426485|P1|Overall Study|other|4
1863885|NCT00075881|6426485|P1|Overall Study|other complicating disease|3
1863886|NCT00075881|6426485|P1|Overall Study|Protocol Violation|4
1863887|NCT00075881|6426485|P1|Overall Study|Withdrawal by Subject|2
1863888|NCT00075881|6426485|P1|Overall Study|Death|1
1863889|NCT00075881|6426485|P1|Overall Study|Adverse Event|7
1863890|NCT00075881|6426485|P1|Overall Study|Lack of Efficacy|18
1863891|NCT00075816|6426529|P2|Overall Study|Did not undergo transplantation|11
1863892|NCT00075816|6426530|P1|Overall Study|Did not undergo transplantation|14
1863893|NCT00075764|6426599|P2|Overall Study|Under review|1
1863894|NCT00075764|6426600|P1|Overall Study|Under review|0
1863895|NCT00075764|6426599|P2|Overall Study|Not protocol specified|19
1863896|NCT00075764|6426600|P1|Overall Study|Not protocol specified|27
1863897|NCT00075764|6426599|P2|Overall Study|Delinquent|2
1863898|NCT00075764|6426600|P1|Overall Study|Delinquent|4
1863899|NCT00075764|6426599|P2|Overall Study|Still on treatment|15
1863900|NCT00075764|6426600|P1|Overall Study|Still on treatment|8
1863901|NCT00075764|6426599|P2|Overall Study|Progression|274
1863902|NCT00075764|6426600|P1|Overall Study|Progression|269
1863903|NCT00075764|6426599|P2|Overall Study|Withdrawal by Subject|18
1863904|NCT00075764|6426600|P1|Overall Study|Withdrawal by Subject|28
1863905|NCT00075764|6426599|P2|Overall Study|Death|8
1863906|NCT00075764|6426600|P1|Overall Study|Death|4
1863907|NCT00075764|6426599|P2|Overall Study|Adverse Event|12
1863908|NCT00075764|6426600|P1|Overall Study|Adverse Event|5
1863909|NCT00075725|6426624|P12|Overall Study|Pt incarcerated|0
1863910|NCT00075725|6426625|P11|Overall Study|Pt incarcerated|0
1863911|NCT00075725|6426626|P10|Overall Study|Pt incarcerated|0
1863912|NCT00075725|6426627|P9|Overall Study|Pt incarcerated|0
1863913|NCT00075725|6426628|P8|Overall Study|Pt incarcerated|1
1863914|NCT00075725|6426629|P7|Overall Study|Pt incarcerated|0
1863915|NCT00075725|6426630|P6|Overall Study|Pt incarcerated|0
1863916|NCT00075725|6426631|P5|Overall Study|Pt incarcerated|0
1863917|NCT00075725|6426632|P4|Overall Study|Pt incarcerated|0
1863918|NCT00075725|6426633|P3|Overall Study|Pt incarcerated|0
1863919|NCT00075725|6426634|P2|Overall Study|Pt incarcerated|0
1863920|NCT00075725|6426635|P1|Overall Study|Pt incarcerated|0
1863921|NCT00075725|6426624|P12|Overall Study|Pt care terminated due to pt behavior|0
1863922|NCT00075725|6426625|P11|Overall Study|Pt care terminated due to pt behavior|0
1863923|NCT00075725|6426626|P10|Overall Study|Pt care terminated due to pt behavior|0
1863924|NCT00075725|6426627|P9|Overall Study|Pt care terminated due to pt behavior|0
1863925|NCT00075725|6426628|P8|Overall Study|Pt care terminated due to pt behavior|1
1863926|NCT00075725|6426629|P7|Overall Study|Pt care terminated due to pt behavior|0
1863927|NCT00075725|6426630|P6|Overall Study|Pt care terminated due to pt behavior|0
1863928|NCT00075725|6426631|P5|Overall Study|Pt care terminated due to pt behavior|0
1863929|NCT00075725|6426632|P4|Overall Study|Pt care terminated due to pt behavior|0
1863930|NCT00075725|6426633|P3|Overall Study|Pt care terminated due to pt behavior|0
1863931|NCT00075725|6426634|P2|Overall Study|Pt care terminated due to pt behavior|0
1863932|NCT00075725|6426635|P1|Overall Study|Pt care terminated due to pt behavior|0
1863933|NCT00075725|6426624|P12|Overall Study|Other complications|0
1863934|NCT00075725|6426625|P11|Overall Study|Other complications|0
1863935|NCT00075725|6426626|P10|Overall Study|Other complications|0
1863936|NCT00075725|6426627|P9|Overall Study|Other complications|0
1863937|NCT00075725|6426628|P8|Overall Study|Other complications|0
1863938|NCT00075725|6426629|P7|Overall Study|Other complications|0
1863939|NCT00075725|6426630|P6|Overall Study|Other complications|1
1863940|NCT00075725|6426631|P5|Overall Study|Other complications|0
1863941|NCT00075725|6426632|P4|Overall Study|Other complications|0
1863942|NCT00075725|6426633|P3|Overall Study|Other complications|0
1863943|NCT00075725|6426634|P2|Overall Study|Other complications|0
1863944|NCT00075725|6426635|P1|Overall Study|Other complications|0
1863945|NCT00075725|6426624|P12|Overall Study|Study Closure|0
1863946|NCT00075725|6426625|P11|Overall Study|Study Closure|0
1863947|NCT00075725|6426626|P10|Overall Study|Study Closure|0
1863948|NCT00075725|6426627|P9|Overall Study|Study Closure|0
1863949|NCT00075725|6426628|P8|Overall Study|Study Closure|1
1863950|NCT00075725|6426629|P7|Overall Study|Study Closure|0
1863951|NCT00075725|6426630|P6|Overall Study|Study Closure|3
1863952|NCT00075725|6426631|P5|Overall Study|Study Closure|1
1863953|NCT00075725|6426632|P4|Overall Study|Study Closure|0
1863954|NCT00075725|6426633|P3|Overall Study|Study Closure|0
1863955|NCT00075725|6426634|P2|Overall Study|Study Closure|0
1863956|NCT00075725|6426635|P1|Overall Study|Study Closure|1
1863957|NCT00075725|6426624|P12|Overall Study|Institution Terminated|0
1863958|NCT00075725|6426625|P11|Overall Study|Institution Terminated|0
1863959|NCT00075725|6426626|P10|Overall Study|Institution Terminated|0
1863960|NCT00075725|6426627|P9|Overall Study|Institution Terminated|0
1863961|NCT00075725|6426628|P8|Overall Study|Institution Terminated|3
1863962|NCT00075725|6426629|P7|Overall Study|Institution Terminated|0
1863963|NCT00075725|6426630|P6|Overall Study|Institution Terminated|0
1863964|NCT00075725|6426631|P5|Overall Study|Institution Terminated|1
1863965|NCT00075725|6426632|P4|Overall Study|Institution Terminated|0
1863966|NCT00075725|6426633|P3|Overall Study|Institution Terminated|0
1863967|NCT00075725|6426634|P2|Overall Study|Institution Terminated|0
1863968|NCT00075725|6426635|P1|Overall Study|Institution Terminated|0
1863969|NCT00075725|6426624|P12|Overall Study|Pt relocated|0
1863970|NCT00075725|6426625|P11|Overall Study|Pt relocated|0
1863971|NCT00075725|6426626|P10|Overall Study|Pt relocated|0
1863972|NCT00075725|6426627|P9|Overall Study|Pt relocated|1
1863973|NCT00075725|6426628|P8|Overall Study|Pt relocated|2
1863974|NCT00075725|6426629|P7|Overall Study|Pt relocated|1
1863975|NCT00075725|6426630|P6|Overall Study|Pt relocated|1
1863976|NCT00075725|6426631|P5|Overall Study|Pt relocated|0
1863977|NCT00075725|6426632|P4|Overall Study|Pt relocated|2
1863978|NCT00075725|6426633|P3|Overall Study|Pt relocated|0
1863979|NCT00075725|6426634|P2|Overall Study|Pt relocated|0
1863980|NCT00075725|6426635|P1|Overall Study|Pt relocated|0
1863981|NCT00075725|6426624|P12|Overall Study|Pt received additional steroids|0
1863982|NCT00075725|6426625|P11|Overall Study|Pt received additional steroids|0
1863983|NCT00075725|6426626|P10|Overall Study|Pt received additional steroids|0
1863984|NCT00075725|6426627|P9|Overall Study|Pt received additional steroids|0
1863985|NCT00075725|6426628|P8|Overall Study|Pt received additional steroids|0
1863986|NCT00075725|6426629|P7|Overall Study|Pt received additional steroids|0
1863987|NCT00075725|6426630|P6|Overall Study|Pt received additional steroids|0
1863988|NCT00075725|6426631|P5|Overall Study|Pt received additional steroids|0
1863989|NCT00075725|6426632|P4|Overall Study|Pt received additional steroids|1
1863990|NCT00075725|6426633|P3|Overall Study|Pt received additional steroids|0
1863991|NCT00075725|6426634|P2|Overall Study|Pt received additional steroids|0
1863992|NCT00075725|6426635|P1|Overall Study|Pt received additional steroids|0
1863993|NCT00075725|6426624|P12|Overall Study|Pt went to transplant|0
1863994|NCT00075725|6426625|P11|Overall Study|Pt went to transplant|0
1863995|NCT00075725|6426626|P10|Overall Study|Pt went to transplant|0
1863996|NCT00075725|6426627|P9|Overall Study|Pt went to transplant|0
1863997|NCT00075725|6426628|P8|Overall Study|Pt went to transplant|0
1863998|NCT00075725|6426629|P7|Overall Study|Pt went to transplant|0
1863999|NCT00075725|6426630|P6|Overall Study|Pt went to transplant|1
1864000|NCT00075725|6426631|P5|Overall Study|Pt went to transplant|0
1864001|NCT00075725|6426632|P4|Overall Study|Pt went to transplant|1
1864002|NCT00075725|6426633|P3|Overall Study|Pt went to transplant|0
1864003|NCT00075725|6426634|P2|Overall Study|Pt went to transplant|0
1864004|NCT00075725|6426635|P1|Overall Study|Pt went to transplant|0
1864005|NCT00075725|6426624|P12|Overall Study|specimen(s) not submitted|0
1864006|NCT00075725|6426625|P11|Overall Study|specimen(s) not submitted|0
1864007|NCT00075725|6426626|P10|Overall Study|specimen(s) not submitted|0
1864008|NCT00075725|6426627|P9|Overall Study|specimen(s) not submitted|0
1864009|NCT00075725|6426628|P8|Overall Study|specimen(s) not submitted|0
1864010|NCT00075725|6426629|P7|Overall Study|specimen(s) not submitted|0
1864011|NCT00075725|6426630|P6|Overall Study|specimen(s) not submitted|0
1864012|NCT00075725|6426631|P5|Overall Study|specimen(s) not submitted|0
1864013|NCT00075725|6426632|P4|Overall Study|specimen(s) not submitted|0
1864014|NCT00075725|6426633|P3|Overall Study|specimen(s) not submitted|2
1864015|NCT00075725|6426634|P2|Overall Study|specimen(s) not submitted|0
1864016|NCT00075725|6426635|P1|Overall Study|specimen(s) not submitted|0
1864017|NCT00075725|6426624|P12|Overall Study|Unsuccessful institutional transfer|0
1864018|NCT00075725|6426625|P11|Overall Study|Unsuccessful institutional transfer|0
1864019|NCT00075725|6426626|P10|Overall Study|Unsuccessful institutional transfer|1
1864020|NCT00075725|6426627|P9|Overall Study|Unsuccessful institutional transfer|0
1864021|NCT00075725|6426628|P8|Overall Study|Unsuccessful institutional transfer|0
1864022|NCT00075725|6426629|P7|Overall Study|Unsuccessful institutional transfer|0
1864023|NCT00075725|6426630|P6|Overall Study|Unsuccessful institutional transfer|0
1864024|NCT00075725|6426631|P5|Overall Study|Unsuccessful institutional transfer|0
1864025|NCT00075725|6426632|P4|Overall Study|Unsuccessful institutional transfer|0
1864026|NCT00075725|6426633|P3|Overall Study|Unsuccessful institutional transfer|2
1864027|NCT00075725|6426634|P2|Overall Study|Unsuccessful institutional transfer|0
1864028|NCT00075725|6426635|P1|Overall Study|Unsuccessful institutional transfer|0
1864029|NCT00075725|6426624|P12|Overall Study|Clinic chart lost unable to recreate|0
1864030|NCT00075725|6426625|P11|Overall Study|Clinic chart lost unable to recreate|0
1864031|NCT00075725|6426626|P10|Overall Study|Clinic chart lost unable to recreate|0
1864032|NCT00075725|6426627|P9|Overall Study|Clinic chart lost unable to recreate|0
1864033|NCT00075725|6426628|P8|Overall Study|Clinic chart lost unable to recreate|0
1864034|NCT00075725|6426629|P7|Overall Study|Clinic chart lost unable to recreate|0
1864035|NCT00075725|6426630|P6|Overall Study|Clinic chart lost unable to recreate|0
1864036|NCT00075725|6426631|P5|Overall Study|Clinic chart lost unable to recreate|0
1864037|NCT00075725|6426632|P4|Overall Study|Clinic chart lost unable to recreate|0
1864038|NCT00075725|6426633|P3|Overall Study|Clinic chart lost unable to recreate|1
1864039|NCT00075725|6426634|P2|Overall Study|Clinic chart lost unable to recreate|0
1864040|NCT00075725|6426635|P1|Overall Study|Clinic chart lost unable to recreate|0
1864041|NCT00075725|6426624|P12|Overall Study|Pt trying to find a BM donor|0
1864042|NCT00075725|6426625|P11|Overall Study|Pt trying to find a BM donor|0
1864043|NCT00075725|6426626|P10|Overall Study|Pt trying to find a BM donor|0
1864044|NCT00075725|6426627|P9|Overall Study|Pt trying to find a BM donor|0
1864045|NCT00075725|6426628|P8|Overall Study|Pt trying to find a BM donor|0
1864046|NCT00075725|6426629|P7|Overall Study|Pt trying to find a BM donor|0
1864047|NCT00075725|6426630|P6|Overall Study|Pt trying to find a BM donor|0
1864048|NCT00075725|6426631|P5|Overall Study|Pt trying to find a BM donor|0
1864049|NCT00075725|6426632|P4|Overall Study|Pt trying to find a BM donor|0
1864050|NCT00075725|6426633|P3|Overall Study|Pt trying to find a BM donor|0
1864051|NCT00075725|6426634|P2|Overall Study|Pt trying to find a BM donor|1
1864052|NCT00075725|6426635|P1|Overall Study|Pt trying to find a BM donor|0
1864053|NCT00075725|6426624|P12|Overall Study|Other|3
1864054|NCT00075725|6426625|P11|Overall Study|Other|0
1864055|NCT00075725|6426626|P10|Overall Study|Other|1
1864056|NCT00075725|6426627|P9|Overall Study|Other|2
1864057|NCT00075725|6426628|P8|Overall Study|Other|9
1864058|NCT00075725|6426629|P7|Overall Study|Other|2
1864059|NCT00075725|6426630|P6|Overall Study|Other|4
1864060|NCT00075725|6426631|P5|Overall Study|Other|1
1864061|NCT00075725|6426632|P4|Overall Study|Other|1
1864062|NCT00075725|6426633|P3|Overall Study|Other|1
1864063|NCT00075725|6426634|P2|Overall Study|Other|2
1864064|NCT00075725|6426635|P1|Overall Study|Other|4
1864065|NCT00075725|6426624|P12|Overall Study|Inevaluable|0
1864066|NCT00075725|6426625|P11|Overall Study|Inevaluable|1
1864067|NCT00075725|6426626|P10|Overall Study|Inevaluable|0
1864068|NCT00075725|6426627|P9|Overall Study|Inevaluable|2
1864069|NCT00075725|6426628|P8|Overall Study|Inevaluable|11
1864070|NCT00075725|6426629|P7|Overall Study|Inevaluable|1
1864071|NCT00075725|6426630|P6|Overall Study|Inevaluable|9
1864072|NCT00075725|6426631|P5|Overall Study|Inevaluable|2
1864073|NCT00075725|6426632|P4|Overall Study|Inevaluable|2
1864074|NCT00075725|6426633|P3|Overall Study|Inevaluable|4
1864075|NCT00075725|6426634|P2|Overall Study|Inevaluable|1
1864076|NCT00075725|6426635|P1|Overall Study|Inevaluable|1
1864077|NCT00075725|6426624|P12|Overall Study|Pt has very high risk ALL characteristic|3
1864078|NCT00075725|6426625|P11|Overall Study|Pt has very high risk ALL characteristic|0
1864079|NCT00075725|6426626|P10|Overall Study|Pt has very high risk ALL characteristic|1
1864080|NCT00075725|6426627|P9|Overall Study|Pt has very high risk ALL characteristic|29
1864081|NCT00075725|6426628|P8|Overall Study|Pt has very high risk ALL characteristic|74
1864082|NCT00075725|6426629|P7|Overall Study|Pt has very high risk ALL characteristic|23
1864083|NCT00075725|6426630|P6|Overall Study|Pt has very high risk ALL characteristic|75
1864084|NCT00075725|6426631|P5|Overall Study|Pt has very high risk ALL characteristic|11
1864085|NCT00075725|6426632|P4|Overall Study|Pt has very high risk ALL characteristic|18
1864086|NCT00075725|6426633|P3|Overall Study|Pt has very high risk ALL characteristic|26
1864087|NCT00075725|6426634|P2|Overall Study|Pt has very high risk ALL characteristic|11
1864088|NCT00075725|6426635|P1|Overall Study|Pt has very high risk ALL characteristic|15
1864089|NCT00075725|6426624|P12|Overall Study|MRD positive after extended ind|0
1864090|NCT00075725|6426625|P11|Overall Study|MRD positive after extended ind|0
1864091|NCT00075725|6426626|P10|Overall Study|MRD positive after extended ind|0
1864092|NCT00075725|6426627|P9|Overall Study|MRD positive after extended ind|0
1864093|NCT00075725|6426628|P8|Overall Study|MRD positive after extended ind|1
1864094|NCT00075725|6426629|P7|Overall Study|MRD positive after extended ind|0
1864095|NCT00075725|6426630|P6|Overall Study|MRD positive after extended ind|2
1864096|NCT00075725|6426631|P5|Overall Study|MRD positive after extended ind|1
1864097|NCT00075725|6426632|P4|Overall Study|MRD positive after extended ind|0
1864098|NCT00075725|6426633|P3|Overall Study|MRD positive after extended ind|1
1864099|NCT00075725|6426634|P2|Overall Study|MRD positive after extended ind|1
1864100|NCT00075725|6426635|P1|Overall Study|MRD positive after extended ind|0
1864101|NCT00075725|6426624|P12|Overall Study|Insurance issues|0
1864102|NCT00075725|6426625|P11|Overall Study|Insurance issues|0
1864103|NCT00075725|6426626|P10|Overall Study|Insurance issues|0
1864104|NCT00075725|6426627|P9|Overall Study|Insurance issues|0
1864105|NCT00075725|6426628|P8|Overall Study|Insurance issues|1
1864106|NCT00075725|6426629|P7|Overall Study|Insurance issues|0
1864107|NCT00075725|6426630|P6|Overall Study|Insurance issues|1
1864108|NCT00075725|6426631|P5|Overall Study|Insurance issues|1
1864109|NCT00075725|6426632|P4|Overall Study|Insurance issues|1
1864110|NCT00075725|6426633|P3|Overall Study|Insurance issues|0
1864111|NCT00075725|6426634|P2|Overall Study|Insurance issues|1
1864112|NCT00075725|6426635|P1|Overall Study|Insurance issues|0
1864113|NCT00075725|6426624|P12|Overall Study|Pt age out of range for treatment|0
1864114|NCT00075725|6426625|P11|Overall Study|Pt age out of range for treatment|0
1864115|NCT00075725|6426626|P10|Overall Study|Pt age out of range for treatment|0
1864116|NCT00075725|6426627|P9|Overall Study|Pt age out of range for treatment|0
1864117|NCT00075725|6426628|P8|Overall Study|Pt age out of range for treatment|1
1864118|NCT00075725|6426629|P7|Overall Study|Pt age out of range for treatment|0
1864119|NCT00075725|6426630|P6|Overall Study|Pt age out of range for treatment|1
1864120|NCT00075725|6426631|P5|Overall Study|Pt age out of range for treatment|0
1864121|NCT00075725|6426632|P4|Overall Study|Pt age out of range for treatment|0
1864122|NCT00075725|6426633|P3|Overall Study|Pt age out of range for treatment|0
1864123|NCT00075725|6426634|P2|Overall Study|Pt age out of range for treatment|1
1864124|NCT00075725|6426635|P1|Overall Study|Pt age out of range for treatment|0
1864125|NCT00075725|6426624|P12|Overall Study|Pt non compliant with therapy|0
1864126|NCT00075725|6426625|P11|Overall Study|Pt non compliant with therapy|0
1864127|NCT00075725|6426626|P10|Overall Study|Pt non compliant with therapy|0
1864128|NCT00075725|6426627|P9|Overall Study|Pt non compliant with therapy|3
1864129|NCT00075725|6426628|P8|Overall Study|Pt non compliant with therapy|5
1864130|NCT00075725|6426629|P7|Overall Study|Pt non compliant with therapy|2
1864131|NCT00075725|6426630|P6|Overall Study|Pt non compliant with therapy|14
1864132|NCT00075725|6426631|P5|Overall Study|Pt non compliant with therapy|2
1864133|NCT00075725|6426632|P4|Overall Study|Pt non compliant with therapy|0
1864134|NCT00075725|6426633|P3|Overall Study|Pt non compliant with therapy|1
1864135|NCT00075725|6426634|P2|Overall Study|Pt non compliant with therapy|1
1864136|NCT00075725|6426635|P1|Overall Study|Pt non compliant with therapy|2
1864137|NCT00075725|6426624|P12|Overall Study|Pt/Guardian refused RT therapy|0
1864138|NCT00075725|6426625|P11|Overall Study|Pt/Guardian refused RT therapy|0
1864139|NCT00075725|6426626|P10|Overall Study|Pt/Guardian refused RT therapy|0
1864140|NCT00075725|6426627|P9|Overall Study|Pt/Guardian refused RT therapy|0
1864141|NCT00075725|6426628|P8|Overall Study|Pt/Guardian refused RT therapy|0
1864142|NCT00075725|6426629|P7|Overall Study|Pt/Guardian refused RT therapy|0
1864143|NCT00075725|6426630|P6|Overall Study|Pt/Guardian refused RT therapy|0
1864144|NCT00075725|6426631|P5|Overall Study|Pt/Guardian refused RT therapy|1
1864145|NCT00075725|6426632|P4|Overall Study|Pt/Guardian refused RT therapy|2
1864146|NCT00075725|6426633|P3|Overall Study|Pt/Guardian refused RT therapy|1
1864147|NCT00075725|6426634|P2|Overall Study|Pt/Guardian refused RT therapy|0
1864148|NCT00075725|6426635|P1|Overall Study|Pt/Guardian refused RT therapy|1
1864149|NCT00075725|6426624|P12|Overall Study|Ineligible or wrong diagnosis|4
1864150|NCT00075725|6426625|P11|Overall Study|Ineligible or wrong diagnosis|2
1864151|NCT00075725|6426626|P10|Overall Study|Ineligible or wrong diagnosis|1
1864152|NCT00075725|6426627|P9|Overall Study|Ineligible or wrong diagnosis|10
1864153|NCT00075725|6426628|P8|Overall Study|Ineligible or wrong diagnosis|9
1864154|NCT00075725|6426629|P7|Overall Study|Ineligible or wrong diagnosis|6
1864155|NCT00075725|6426630|P6|Overall Study|Ineligible or wrong diagnosis|17
1864156|NCT00075725|6426631|P5|Overall Study|Ineligible or wrong diagnosis|3
1864157|NCT00075725|6426632|P4|Overall Study|Ineligible or wrong diagnosis|10
1864158|NCT00075725|6426633|P3|Overall Study|Ineligible or wrong diagnosis|3
1864159|NCT00075725|6426634|P2|Overall Study|Ineligible or wrong diagnosis|3
1864160|NCT00075725|6426635|P1|Overall Study|Ineligible or wrong diagnosis|8
1864161|NCT00075725|6426624|P12|Overall Study|Patient off treatment|0
1864162|NCT00075725|6426625|P11|Overall Study|Patient off treatment|0
1864163|NCT00075725|6426626|P10|Overall Study|Patient off treatment|0
1864164|NCT00075725|6426627|P9|Overall Study|Patient off treatment|1
1864165|NCT00075725|6426628|P8|Overall Study|Patient off treatment|2
1864166|NCT00075725|6426629|P7|Overall Study|Patient off treatment|0
1864167|NCT00075725|6426630|P6|Overall Study|Patient off treatment|0
1864168|NCT00075725|6426631|P5|Overall Study|Patient off treatment|1
1864169|NCT00075725|6426632|P4|Overall Study|Patient off treatment|2
1864170|NCT00075725|6426633|P3|Overall Study|Patient off treatment|1
1864171|NCT00075725|6426634|P2|Overall Study|Patient off treatment|0
1864172|NCT00075725|6426635|P1|Overall Study|Patient off treatment|0
1864173|NCT00075725|6426624|P12|Overall Study|Disease Progression, all other reasons|5
1864174|NCT00075725|6426625|P11|Overall Study|Disease Progression, all other reasons|0
1864175|NCT00075725|6426626|P10|Overall Study|Disease Progression, all other reasons|4
1864176|NCT00075725|6426627|P9|Overall Study|Disease Progression, all other reasons|21
1864177|NCT00075725|6426628|P8|Overall Study|Disease Progression, all other reasons|46
1864178|NCT00075725|6426629|P7|Overall Study|Disease Progression, all other reasons|20
1864179|NCT00075725|6426630|P6|Overall Study|Disease Progression, all other reasons|59
1864180|NCT00075725|6426631|P5|Overall Study|Disease Progression, all other reasons|21
1864181|NCT00075725|6426632|P4|Overall Study|Disease Progression, all other reasons|6
1864182|NCT00075725|6426633|P3|Overall Study|Disease Progression, all other reasons|33
1864183|NCT00075725|6426634|P2|Overall Study|Disease Progression, all other reasons|5
1864184|NCT00075725|6426635|P1|Overall Study|Disease Progression, all other reasons|17
1864185|NCT00075725|6426624|P12|Overall Study|Withdrawal by Subject|0
1864186|NCT00075725|6426625|P11|Overall Study|Withdrawal by Subject|0
1864187|NCT00075725|6426626|P10|Overall Study|Withdrawal by Subject|2
1864188|NCT00075725|6426627|P9|Overall Study|Withdrawal by Subject|10
1864189|NCT00075725|6426628|P8|Overall Study|Withdrawal by Subject|31
1864190|NCT00075725|6426629|P7|Overall Study|Withdrawal by Subject|7
1864191|NCT00075725|6426630|P6|Overall Study|Withdrawal by Subject|27
1864192|NCT00075725|6426631|P5|Overall Study|Withdrawal by Subject|6
1864193|NCT00075725|6426632|P4|Overall Study|Withdrawal by Subject|10
1864194|NCT00075725|6426633|P3|Overall Study|Withdrawal by Subject|6
1864195|NCT00075725|6426634|P2|Overall Study|Withdrawal by Subject|3
1864196|NCT00075725|6426635|P1|Overall Study|Withdrawal by Subject|12
1864197|NCT00075725|6426624|P12|Overall Study|Protocol Violation|1
1864198|NCT00075725|6426625|P11|Overall Study|Protocol Violation|0
1864199|NCT00075725|6426626|P10|Overall Study|Protocol Violation|0
1864200|NCT00075725|6426627|P9|Overall Study|Protocol Violation|3
1864201|NCT00075725|6426628|P8|Overall Study|Protocol Violation|2
1864202|NCT00075725|6426629|P7|Overall Study|Protocol Violation|1
1864203|NCT00075725|6426630|P6|Overall Study|Protocol Violation|2
1864204|NCT00075725|6426631|P5|Overall Study|Protocol Violation|3
1864205|NCT00075725|6426632|P4|Overall Study|Protocol Violation|3
1864206|NCT00075725|6426633|P3|Overall Study|Protocol Violation|0
1864207|NCT00075725|6426634|P2|Overall Study|Protocol Violation|1
1864208|NCT00075725|6426635|P1|Overall Study|Protocol Violation|1
1864209|NCT00075725|6426624|P12|Overall Study|Pregnancy|0
1864210|NCT00075725|6426625|P11|Overall Study|Pregnancy|0
1864211|NCT00075725|6426626|P10|Overall Study|Pregnancy|0
1864212|NCT00075725|6426627|P9|Overall Study|Pregnancy|0
1864213|NCT00075725|6426628|P8|Overall Study|Pregnancy|1
1864214|NCT00075725|6426629|P7|Overall Study|Pregnancy|0
1864215|NCT00075725|6426630|P6|Overall Study|Pregnancy|1
1864216|NCT00075725|6426631|P5|Overall Study|Pregnancy|0
1864217|NCT00075725|6426632|P4|Overall Study|Pregnancy|0
1864218|NCT00075725|6426633|P3|Overall Study|Pregnancy|0
1864219|NCT00075725|6426634|P2|Overall Study|Pregnancy|0
1864220|NCT00075725|6426635|P1|Overall Study|Pregnancy|0
1864221|NCT00075725|6426624|P12|Overall Study|Physician Decision|0
1864222|NCT00075725|6426625|P11|Overall Study|Physician Decision|1
1864223|NCT00075725|6426626|P10|Overall Study|Physician Decision|0
1864224|NCT00075725|6426627|P9|Overall Study|Physician Decision|5
1864225|NCT00075725|6426628|P8|Overall Study|Physician Decision|17
1864226|NCT00075725|6426629|P7|Overall Study|Physician Decision|3
1864227|NCT00075725|6426630|P6|Overall Study|Physician Decision|19
1864228|NCT00075725|6426631|P5|Overall Study|Physician Decision|4
1864229|NCT00075725|6426632|P4|Overall Study|Physician Decision|8
1864230|NCT00075725|6426633|P3|Overall Study|Physician Decision|5
1864231|NCT00075725|6426634|P2|Overall Study|Physician Decision|6
1864232|NCT00075725|6426635|P1|Overall Study|Physician Decision|2
1864233|NCT00075725|6426624|P12|Overall Study|Lost to Follow-up|0
1864234|NCT00075725|6426625|P11|Overall Study|Lost to Follow-up|0
1864235|NCT00075725|6426626|P10|Overall Study|Lost to Follow-up|0
1864236|NCT00075725|6426627|P9|Overall Study|Lost to Follow-up|1
1864237|NCT00075725|6426628|P8|Overall Study|Lost to Follow-up|4
1864238|NCT00075725|6426629|P7|Overall Study|Lost to Follow-up|2
1864239|NCT00075725|6426630|P6|Overall Study|Lost to Follow-up|13
1864240|NCT00075725|6426631|P5|Overall Study|Lost to Follow-up|0
1864241|NCT00075725|6426632|P4|Overall Study|Lost to Follow-up|1
1864242|NCT00075725|6426633|P3|Overall Study|Lost to Follow-up|4
1864243|NCT00075725|6426634|P2|Overall Study|Lost to Follow-up|1
1864244|NCT00075725|6426635|P1|Overall Study|Lost to Follow-up|1
1864245|NCT00075725|6426624|P12|Overall Study|Death|0
1864246|NCT00075725|6426625|P11|Overall Study|Death|3
1864247|NCT00075725|6426626|P10|Overall Study|Death|4
1864248|NCT00075725|6426627|P9|Overall Study|Death|14
1864249|NCT00075725|6426628|P8|Overall Study|Death|22
1864250|NCT00075725|6426629|P7|Overall Study|Death|4
1864251|NCT00075725|6426630|P6|Overall Study|Death|25
1864252|NCT00075725|6426631|P5|Overall Study|Death|3
1864253|NCT00075725|6426632|P4|Overall Study|Death|2
1864254|NCT00075725|6426633|P3|Overall Study|Death|10
1864255|NCT00075725|6426634|P2|Overall Study|Death|5
1864256|NCT00075725|6426635|P1|Overall Study|Death|3
1864257|NCT00075725|6426624|P12|Overall Study|Adverse Event|2
1864258|NCT00075725|6426625|P11|Overall Study|Adverse Event|2
1864259|NCT00075725|6426626|P10|Overall Study|Adverse Event|4
1864260|NCT00075725|6426627|P9|Overall Study|Adverse Event|15
1864261|NCT00075725|6426628|P8|Overall Study|Adverse Event|51
1864262|NCT00075725|6426629|P7|Overall Study|Adverse Event|3
1864263|NCT00075725|6426630|P6|Overall Study|Adverse Event|38
1864264|NCT00075725|6426631|P5|Overall Study|Adverse Event|4
1864265|NCT00075725|6426632|P4|Overall Study|Adverse Event|8
1864266|NCT00075725|6426633|P3|Overall Study|Adverse Event|20
1864267|NCT00075725|6426634|P2|Overall Study|Adverse Event|6
1864268|NCT00075725|6426635|P1|Overall Study|Adverse Event|6
1864269|NCT00075582|6426732|P2|Overall Study|Ineligible for study|16
1864270|NCT00075582|6426733|P1|Overall Study|Ineligible for study|36
1864271|NCT00075582|6426732|P2|Overall Study|Withdrawal by Subject|2
1864272|NCT00075582|6426733|P1|Overall Study|Withdrawal by Subject|2
1864273|NCT00075582|6426732|P2|Overall Study|Physician Decision|8
1864274|NCT00075582|6426733|P1|Overall Study|Physician Decision|5
1864275|NCT00075582|6426732|P2|Overall Study|Lack of Efficacy|8
1864276|NCT00075582|6426733|P1|Overall Study|Lack of Efficacy|4
1864277|NCT00075582|6426732|P2|Overall Study|Adverse Event|1
1864278|NCT00075582|6426733|P1|Overall Study|Adverse Event|3
1864279|NCT00075504|6426747|P2|Overall Study|Withdrawal by Subject|7
1864280|NCT00075504|6426748|P1|Overall Study|Withdrawal by Subject|9
1864281|NCT00075478|6426760|P2|Overall Study|Physician Decision|1
1864282|NCT00075478|6426761|P1|Overall Study|Physician Decision|0
1864283|NCT00075478|6426760|P2|Overall Study|not eligible|0
1864284|NCT00075478|6426761|P1|Overall Study|not eligible|1
1864285|NCT00075400|6426781|P1|Overall Study|Never treated|2
1864286|NCT00075400|6426781|P1|Overall Study|Ineligible: wrong primary|1
1864287|NCT00075270|6426802|P2|Overall Study|Missing|13
1864288|NCT00075270|6426803|P1|Overall Study|Missing|26
1864289|NCT00075270|6426802|P2|Overall Study|Other/Unknown|5
1864290|NCT00075270|6426803|P1|Overall Study|Other/Unknown|9
1864291|NCT00075270|6426802|P2|Overall Study|Death|215
1864292|NCT00075270|6426803|P1|Overall Study|Death|198
1864293|NCT00075270|6426802|P2|Overall Study|Protocol Violation|2
1864294|NCT00075270|6426803|P1|Overall Study|Protocol Violation|0
1864295|NCT00075270|6426802|P2|Overall Study|Lost to Follow-up|28
1864296|NCT00075270|6426803|P1|Overall Study|Lost to Follow-up|25
1864297|NCT00075270|6426802|P2|Overall Study|Withdrawal by Subject|21
1864298|NCT00075270|6426803|P1|Overall Study|Withdrawal by Subject|28
1864299|NCT00075218|6426849|P3|Open-Label Treatment|enrolled in a separate continuation|9
1864300|NCT00075218|6426850|P2|Open-Label Treatment|enrolled in a separate continuation|0
1864301|NCT00075218|6426851|P1|Open-Label Treatment|enrolled in a separate continuation|0
1864302|NCT00075218|6426849|P3|Open-Label Treatment|Protocol Violation|1
1864303|NCT00075218|6426850|P2|Open-Label Treatment|Protocol Violation|0
1864304|NCT00075218|6426851|P1|Open-Label Treatment|Protocol Violation|0
1864305|NCT00075218|6426849|P3|Open-Label Treatment|Decision of Sponsor|8
1864306|NCT00075218|6426850|P2|Open-Label Treatment|Decision of Sponsor|0
1864307|NCT00075218|6426851|P1|Open-Label Treatment|Decision of Sponsor|0
1864308|NCT00075218|6426849|P3|Open-Label Treatment|Withdrawal by Subject|12
1864309|NCT00075218|6426850|P2|Open-Label Treatment|Withdrawal by Subject|0
1864310|NCT00075218|6426851|P1|Open-Label Treatment|Withdrawal by Subject|0
1864311|NCT00075218|6426849|P3|Open-Label Treatment|Adverse Event|51
1864312|NCT00075218|6426850|P2|Open-Label Treatment|Adverse Event|0
1864313|NCT00075218|6426851|P1|Open-Label Treatment|Adverse Event|0
1864314|NCT00075218|6426849|P3|Open-Label Treatment|Lack of Efficacy|174
1864315|NCT00075218|6426850|P2|Open-Label Treatment|Lack of Efficacy|0
1864316|NCT00075218|6426851|P1|Open-Label Treatment|Lack of Efficacy|0
1864317|NCT00075218|6426849|P3|Double-Blind Treatment|No study medication taken|0
1864318|NCT00075218|6426850|P2|Double-Blind Treatment|No study medication taken|0
1864319|NCT00075218|6426851|P1|Double-Blind Treatment|No study medication taken|2
1864320|NCT00075218|6426849|P3|Double-Blind Treatment|Decision of Sponsor|0
1864321|NCT00075218|6426850|P2|Double-Blind Treatment|Decision of Sponsor|1
1864322|NCT00075218|6426851|P1|Double-Blind Treatment|Decision of Sponsor|0
1864323|NCT00075218|6426849|P3|Double-Blind Treatment|Lack of Efficacy|0
1864324|NCT00075218|6426850|P2|Double-Blind Treatment|Lack of Efficacy|6
1864325|NCT00075218|6426851|P1|Double-Blind Treatment|Lack of Efficacy|58
1864326|NCT00075218|6426849|P3|Double-Blind Treatment|Lost to Follow-up|0
1864327|NCT00075218|6426850|P2|Double-Blind Treatment|Lost to Follow-up|0
1864328|NCT00075218|6426851|P1|Double-Blind Treatment|Lost to Follow-up|1
1864329|NCT00075218|6426849|P3|Double-Blind Treatment|Withdrawal by Subject|0
1864330|NCT00075218|6426850|P2|Double-Blind Treatment|Withdrawal by Subject|4
1864331|NCT00075218|6426851|P1|Double-Blind Treatment|Withdrawal by Subject|7
1864332|NCT00075218|6426849|P3|Double-Blind Treatment|Adverse Event|0
1864333|NCT00075218|6426850|P2|Double-Blind Treatment|Adverse Event|4
1864334|NCT00075218|6426851|P1|Double-Blind Treatment|Adverse Event|23
1864335|NCT00075023|6426900|P2|Pilot Study|Withdrawal by Subject|0
1864336|NCT00075023|6426901|P1|Pilot Study|Withdrawal by Subject|1
1864337|NCT00075023|6426900|P2|Pilot Study|Physician Decision|2
1864338|NCT00075023|6426901|P1|Pilot Study|Physician Decision|1
1864339|NCT00074984|6426910|P2|Overall Study|Patient Withdrawn Per Protocol|3
1864340|NCT00074984|6426911|P1|Overall Study|Patient Withdrawn Per Protocol|0
1864341|NCT00074984|6426910|P2|Overall Study|Withdrawal by Subject|3
1864342|NCT00074984|6426911|P1|Overall Study|Withdrawal by Subject|2
1864343|NCT00074984|6426910|P2|Overall Study|Death|2
1864344|NCT00074984|6426911|P1|Overall Study|Death|1
1864345|NCT00074958|6426926|P1|Overall Study|Adverse Event|1
1864346|NCT00074711|6426967|P2|Overall Study|Participant stopped study drug|6
1864347|NCT00074711|6426968|P1|Overall Study|Participant stopped study drug|4
1864348|NCT00074711|6426967|P2|Overall Study|Lost to Follow-up|8
1864349|NCT00074711|6426968|P1|Overall Study|Lost to Follow-up|10
1864350|NCT00074711|6426967|P2|Overall Study|Withdrawal by Subject|1
1864351|NCT00074711|6426968|P1|Overall Study|Withdrawal by Subject|1
1864352|NCT00074581|6426986|P2|Overall Study|Other|19
1864353|NCT00074581|6426987|P1|Overall Study|Other|14
1864354|NCT00074581|6426986|P2|Overall Study|Ended relationship w. index participant|106
1864355|NCT00074581|6426987|P1|Overall Study|Ended relationship w. index participant|117
1864356|NCT00074581|6426986|P2|Overall Study|Lost to Follow-up|11
1864357|NCT00074581|6426987|P1|Overall Study|Lost to Follow-up|16
1864358|NCT00074581|6426986|P2|Overall Study|Were withdrawn by investigator|2
1864359|NCT00074581|6426987|P1|Overall Study|Were withdrawn by investigator|5
1864360|NCT00074581|6426986|P2|Overall Study|Relocated|9
1864361|NCT00074581|6426987|P1|Overall Study|Relocated|14
1864362|NCT00074581|6426986|P2|Overall Study|Unable to adhere to visit schedule|14
1864363|NCT00074581|6426987|P1|Overall Study|Unable to adhere to visit schedule|13
1864364|NCT00074581|6426986|P2|Overall Study|Withdrawal by Subject|49
1864365|NCT00074581|6426987|P1|Overall Study|Withdrawal by Subject|50
1864366|NCT00074581|6426986|P2|Overall Study|Death|16
1864367|NCT00074581|6426987|P1|Overall Study|Death|15
1864368|NCT00074490|6427000|P6|Overall Study|Progressive malignancy|0
1864369|NCT00074490|6427001|P5|Overall Study|Progressive malignancy|3
1864370|NCT00074490|6427002|P4|Overall Study|Progressive malignancy|0
1864371|NCT00074490|6427003|P3|Overall Study|Progressive malignancy|0
1864372|NCT00074490|6427004|P2|Overall Study|Progressive malignancy|7
1864373|NCT00074490|6427005|P1|Overall Study|Progressive malignancy|0
1864374|NCT00074412|6427039|P2|Overall Study|Lost to Follow-up|58
1864375|NCT00074412|6427040|P1|Overall Study|Lost to Follow-up|52
1864376|NCT00074412|6427039|P2|Overall Study|Death|26
1864377|NCT00074412|6427040|P1|Overall Study|Death|30
1864378|NCT00074282|6427071|P3|Step 2|Ineligible|1
1864379|NCT00074282|6427072|P2|Step 2|Ineligible|0
1864380|NCT00074282|6427073|P1|Step 2|Ineligible|0
1864381|NCT00074282|6427071|P3|Step 2|Physician Decision|1
1864382|NCT00074282|6427072|P2|Step 2|Physician Decision|0
1864383|NCT00074282|6427073|P1|Step 2|Physician Decision|0
1864384|NCT00074282|6427071|P3|Step 2|Withdrawal by Subject|2
1864385|NCT00074282|6427072|P2|Step 2|Withdrawal by Subject|0
1864386|NCT00074282|6427073|P1|Step 2|Withdrawal by Subject|0
1864387|NCT00074282|6427071|P3|Step 2|Death|3
1864388|NCT00074282|6427072|P2|Step 2|Death|0
1864389|NCT00074282|6427073|P1|Step 2|Death|0
1864390|NCT00074282|6427071|P3|Step 2|Disease progression|5
1864391|NCT00074282|6427072|P2|Step 2|Disease progression|0
1864392|NCT00074282|6427073|P1|Step 2|Disease progression|0
1864393|NCT00074282|6427071|P3|Step 2|Adverse Event|12
1864394|NCT00074282|6427072|P2|Step 2|Adverse Event|2
1864395|NCT00074282|6427073|P1|Step 2|Adverse Event|0
1864396|NCT00074282|6427071|P3|Step 1|Never started treatment|0
1864397|NCT00074282|6427072|P2|Step 1|Never started treatment|0
1864398|NCT00074282|6427073|P1|Step 1|Never started treatment|2
1864399|NCT00074282|6427071|P3|Step 1|Ineligible|0
1864400|NCT00074282|6427072|P2|Step 1|Ineligible|0
1864401|NCT00074282|6427073|P1|Step 1|Ineligible|4
1864402|NCT00074282|6427071|P3|Step 1|Physician Decision|0
1864403|NCT00074282|6427072|P2|Step 1|Physician Decision|0
1864404|NCT00074282|6427073|P1|Step 1|Physician Decision|1
1864405|NCT00074282|6427071|P3|Step 1|Other complicating disease|0
1864406|NCT00074282|6427072|P2|Step 1|Other complicating disease|0
1864407|NCT00074282|6427073|P1|Step 1|Other complicating disease|2
1864408|NCT00074282|6427071|P3|Step 1|Alternative therapy|0
1864409|NCT00074282|6427072|P2|Step 1|Alternative therapy|0
1864410|NCT00074282|6427073|P1|Step 1|Alternative therapy|2
1864411|NCT00074282|6427071|P3|Step 1|Disease progression|0
1864412|NCT00074282|6427072|P2|Step 1|Disease progression|0
1864413|NCT00074282|6427073|P1|Step 1|Disease progression|2
1864414|NCT00074282|6427071|P3|Step 1|Withdrawal by Subject|0
1864415|NCT00074282|6427072|P2|Step 1|Withdrawal by Subject|0
1864416|NCT00074282|6427073|P1|Step 1|Withdrawal by Subject|7
1864417|NCT00074282|6427071|P3|Step 1|Death|0
1864418|NCT00074282|6427072|P2|Step 1|Death|0
1864419|NCT00074282|6427073|P1|Step 1|Death|6
1864420|NCT00074282|6427071|P3|Step 1|Adverse Event|0
1864421|NCT00074282|6427072|P2|Step 1|Adverse Event|0
1864422|NCT00074282|6427073|P1|Step 1|Adverse Event|32
1864423|NCT00074152|6427099|P2|Overall Study|Lack of Efficacy|24
1864424|NCT00074152|6427100|P1|Overall Study|Lack of Efficacy|34
1864425|NCT00074152|6427099|P2|Overall Study|Death|9
1864426|NCT00074152|6427100|P1|Overall Study|Death|21
1864427|NCT00073983|6427117|P1|Overall Study|not evaluable|1
1864428|NCT00073918|6427138|P1|Overall Study|Eligibility requirement not met-low CD20|1
1864429|NCT00073918|6427138|P1|Overall Study|Rapid disease progression|2
1864430|NCT00073918|6427138|P1|Overall Study|Eligibility requirement not met - HAMA+|1
1864431|NCT00073749|6427152|P7|Overall Study|Other|0
1864432|NCT00073749|6427153|P6|Overall Study|Other|2
1864433|NCT00073749|6427154|P5|Overall Study|Other|0
1864434|NCT00073749|6427155|P4|Overall Study|Other|0
1864435|NCT00073749|6427156|P3|Overall Study|Other|0
1864436|NCT00073749|6427157|P2|Overall Study|Other|0
1864437|NCT00073749|6427158|P1|Overall Study|Other|0
1864438|NCT00073749|6427152|P7|Overall Study|Lost to Follow-up|2
1864439|NCT00073749|6427153|P6|Overall Study|Lost to Follow-up|0
1864440|NCT00073749|6427154|P5|Overall Study|Lost to Follow-up|0
1864441|NCT00073749|6427155|P4|Overall Study|Lost to Follow-up|0
1864442|NCT00073749|6427156|P3|Overall Study|Lost to Follow-up|0
1864443|NCT00073749|6427157|P2|Overall Study|Lost to Follow-up|0
1864444|NCT00073749|6427158|P1|Overall Study|Lost to Follow-up|0
1864445|NCT00073749|6427152|P7|Overall Study|Discontinuation of Study by Sponsor|4
1864446|NCT00073749|6427153|P6|Overall Study|Discontinuation of Study by Sponsor|0
1864447|NCT00073749|6427154|P5|Overall Study|Discontinuation of Study by Sponsor|0
1864448|NCT00073749|6427155|P4|Overall Study|Discontinuation of Study by Sponsor|0
1864449|NCT00073749|6427156|P3|Overall Study|Discontinuation of Study by Sponsor|0
1864450|NCT00073749|6427157|P2|Overall Study|Discontinuation of Study by Sponsor|0
1864451|NCT00073749|6427158|P1|Overall Study|Discontinuation of Study by Sponsor|0
1864452|NCT00073749|6427152|P7|Overall Study|Withdrawal by Subject|2
1864453|NCT00073749|6427153|P6|Overall Study|Withdrawal by Subject|0
1864454|NCT00073749|6427154|P5|Overall Study|Withdrawal by Subject|1
1864455|NCT00073749|6427155|P4|Overall Study|Withdrawal by Subject|0
1864456|NCT00073749|6427156|P3|Overall Study|Withdrawal by Subject|0
1864457|NCT00073749|6427157|P2|Overall Study|Withdrawal by Subject|1
1864458|NCT00073749|6427158|P1|Overall Study|Withdrawal by Subject|0
1864459|NCT00073749|6427152|P7|Overall Study|Physician Decision|0
1864460|NCT00073749|6427153|P6|Overall Study|Physician Decision|2
1864461|NCT00073749|6427154|P5|Overall Study|Physician Decision|0
1864462|NCT00073749|6427155|P4|Overall Study|Physician Decision|0
1864463|NCT00073749|6427156|P3|Overall Study|Physician Decision|1
1864464|NCT00073749|6427157|P2|Overall Study|Physician Decision|0
1864465|NCT00073749|6427158|P1|Overall Study|Physician Decision|0
1864466|NCT00073749|6427152|P7|Overall Study|Adverse Event|0
1864467|NCT00073749|6427153|P6|Overall Study|Adverse Event|1
1864468|NCT00073749|6427154|P5|Overall Study|Adverse Event|2
1864469|NCT00073749|6427155|P4|Overall Study|Adverse Event|4
1864470|NCT00073749|6427156|P3|Overall Study|Adverse Event|6
1864471|NCT00073749|6427157|P2|Overall Study|Adverse Event|3
1864472|NCT00073749|6427158|P1|Overall Study|Adverse Event|0
1864473|NCT00073749|6427152|P7|Overall Study|Death|29
1864474|NCT00073749|6427153|P6|Overall Study|Death|0
1864475|NCT00073749|6427154|P5|Overall Study|Death|0
1864476|NCT00073749|6427155|P4|Overall Study|Death|0
1864477|NCT00073749|6427156|P3|Overall Study|Death|1
1864478|NCT00073749|6427157|P2|Overall Study|Death|1
1864479|NCT00073749|6427158|P1|Overall Study|Death|0
1864480|NCT00073749|6427152|P7|Overall Study|Disease Progression|3
1864481|NCT00073749|6427153|P6|Overall Study|Disease Progression|1
1864482|NCT00073749|6427154|P5|Overall Study|Disease Progression|3
1864483|NCT00073749|6427155|P4|Overall Study|Disease Progression|2
1864484|NCT00073749|6427156|P3|Overall Study|Disease Progression|3
1864485|NCT00073749|6427157|P2|Overall Study|Disease Progression|0
1864486|NCT00073749|6427158|P1|Overall Study|Disease Progression|2
1864487|NCT00073528|6427189|P2|Overall Study|Ongoing|344
1864488|NCT00073528|6427190|P1|Overall Study|Ongoing|349
1864489|NCT00073528|6427189|P2|Overall Study|Non-compliance|1
1864490|NCT00073528|6427190|P1|Overall Study|Non-compliance|0
1864491|NCT00073528|6427189|P2|Overall Study|Enrolled in Error|1
1864492|NCT00073528|6427190|P1|Overall Study|Enrolled in Error|0
1864493|NCT00073528|6427189|P2|Overall Study|Participant Was Unblinded|1
1864494|NCT00073528|6427190|P1|Overall Study|Participant Was Unblinded|0
1864495|NCT00073528|6427189|P2|Overall Study|Progressive Disease|1
1864496|NCT00073528|6427190|P1|Overall Study|Progressive Disease|0
1864497|NCT00073528|6427189|P2|Overall Study|Randomized in Error; Not Treated|0
1864498|NCT00073528|6427190|P1|Overall Study|Randomized in Error; Not Treated|2
1864499|NCT00073528|6427189|P2|Overall Study|Mastectomy Intervention|0
1864500|NCT00073528|6427190|P1|Overall Study|Mastectomy Intervention|1
1864501|NCT00073528|6427189|P2|Overall Study|Death|238
1864502|NCT00073528|6427190|P1|Overall Study|Death|229
1864503|NCT00073528|6427189|P2|Overall Study|Protocol Violation|5
1864504|NCT00073528|6427190|P1|Overall Study|Protocol Violation|3
1864505|NCT00073528|6427189|P2|Overall Study|Lost to Follow-up|22
1864506|NCT00073528|6427190|P1|Overall Study|Lost to Follow-up|26
1864507|NCT00073528|6427189|P2|Overall Study|Withdrawal by Subject|29
1864508|NCT00073528|6427190|P1|Overall Study|Withdrawal by Subject|34
1864509|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
1864510|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
1864511|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
1864512|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
1864513|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
1864514|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
1864515|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
1864516|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
1864517|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
1864518|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
1864519|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1864520|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
1864521|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1864522|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
1864523|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
1864524|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1864525|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
1864526|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
1864527|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
1864528|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
1864529|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
1864530|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
1864531|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
1864532|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
1864533|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1864534|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
1864535|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
1864536|NCT00073307|6427279|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
1864537|NCT00073307|6427280|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
1864538|NCT00073307|6427281|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
1864539|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1864540|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
1864541|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
1864542|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
1864543|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
1864544|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
1864545|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1864546|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
1864547|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
1864548|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1864549|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
1864550|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
1864551|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
1864552|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
1864553|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
1864554|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
1864555|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1864556|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
1864557|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
1864558|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
1864559|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
1864560|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
1864561|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
1864562|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
1864563|NCT00073307|6427279|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
1864564|NCT00073307|6427280|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
1864565|NCT00073307|6427281|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
1864566|NCT00073021|6427312|P2|Overall Study|Lack of Efficacy|5
1864567|NCT00073021|6427313|P1|Overall Study|Lack of Efficacy|11
1864568|NCT00073021|6427312|P2|Overall Study|Physician Decision|1
1864569|NCT00073021|6427313|P1|Overall Study|Physician Decision|3
1864570|NCT00073021|6427312|P2|Overall Study|Withdrawal by Subject|5
1864571|NCT00073021|6427313|P1|Overall Study|Withdrawal by Subject|6
1864572|NCT00073021|6427312|P2|Overall Study|Adverse Event|4
1864573|NCT00073021|6427313|P1|Overall Study|Adverse Event|4
1864574|NCT00073021|6427312|P2|Overall Study|Protocol Violation|1
1864575|NCT00073021|6427313|P1|Overall Study|Protocol Violation|2
1864576|NCT00073008|6427343|P2|Overall Study|"Other selected on Case Report Form"|5
1864577|NCT00073008|6427344|P1|Overall Study|"Other selected on Case Report Form"|7
1864578|NCT00073008|6427343|P2|Overall Study|Death|47
1864579|NCT00073008|6427344|P1|Overall Study|Death|46
1864580|NCT00073008|6427343|P2|Overall Study|Lost to Follow-up|3
1864581|NCT00073008|6427344|P1|Overall Study|Lost to Follow-up|1
1864582|NCT00073008|6427343|P2|Overall Study|Withdrawal by Subject|2
1864583|NCT00073008|6427344|P1|Overall Study|Withdrawal by Subject|2
1864584|NCT00073008|6427343|P2|Overall Study|Missing|6
1864585|NCT00073008|6427344|P1|Overall Study|Missing|6
1864586|NCT00072475|6427383|P1|Overall Study|Patient/Investigator Decision|4
1864587|NCT00072475|6427383|P1|Overall Study|Withdrawal by Subject|46
1864588|NCT00072475|6427383|P1|Overall Study|Death|3
1864589|NCT00072475|6427383|P1|Overall Study|Adverse Event|44
1864590|NCT00072384|6427398|P1|Overall Study|Ineligible|8
1864591|NCT00072384|6427398|P1|Overall Study|Physician Decision|1
1864592|NCT00072293|6427411|P2|Overall Study|Withdrawal by Subject|1
1864593|NCT00072293|6427412|P1|Overall Study|Withdrawal by Subject|0
1864594|NCT00072293|6427411|P2|Overall Study|Lost to Follow-up|1
1864595|NCT00072293|6427412|P1|Overall Study|Lost to Follow-up|1
1864596|NCT00072280|6427424|P2|Follow-up|Early termination of study|2
1864597|NCT00072280|6427425|P1|Follow-up|Early termination of study|2
1864598|NCT00072280|6427424|P2|Treatment|Found ineligible|2
1864599|NCT00072280|6427425|P1|Treatment|Found ineligible|1
1864600|NCT00072189|6427430|P1|Overall Study|Withdrawal by Subject|1
1864601|NCT00072176|6427438|P2|Overall Study|Protocol Violation|1
1864602|NCT00072176|6427439|P1|Overall Study|Protocol Violation|0
1864603|NCT00072176|6427438|P2|Overall Study|Withdrawal by Subject|0
1864604|NCT00072176|6427439|P1|Overall Study|Withdrawal by Subject|1
1864605|NCT00071981|6427451|P4|Overall Study|others (not specified in the study)|0
1864606|NCT00071981|6427452|P3|Overall Study|others (not specified in the study)|2
1864607|NCT00071981|6427453|P2|Overall Study|others (not specified in the study)|2
1864608|NCT00071981|6427454|P1|Overall Study|others (not specified in the study)|0
1864609|NCT00071981|6427451|P4|Overall Study|No protocol therapy|0
1864610|NCT00071981|6427452|P3|Overall Study|No protocol therapy|1
1864611|NCT00071981|6427453|P2|Overall Study|No protocol therapy|5
1864612|NCT00071981|6427454|P1|Overall Study|No protocol therapy|2
1864613|NCT00071981|6427451|P4|Overall Study|Withdrawal by Subject|0
1864614|NCT00071981|6427452|P3|Overall Study|Withdrawal by Subject|0
1864615|NCT00071981|6427453|P2|Overall Study|Withdrawal by Subject|1
1864616|NCT00071981|6427454|P1|Overall Study|Withdrawal by Subject|3
1864617|NCT00071981|6427451|P4|Overall Study|Death|1
1864618|NCT00071981|6427452|P3|Overall Study|Death|1
1864619|NCT00071981|6427453|P2|Overall Study|Death|0
1864620|NCT00071981|6427454|P1|Overall Study|Death|0
1864621|NCT00071981|6427451|P4|Overall Study|Adverse Event|1
1864622|NCT00071981|6427452|P3|Overall Study|Adverse Event|3
1864623|NCT00071981|6427453|P2|Overall Study|Adverse Event|4
1864624|NCT00071981|6427454|P1|Overall Study|Adverse Event|4
1864625|NCT00071981|6427451|P4|Overall Study|Lack of Efficacy|43
1864626|NCT00071981|6427452|P3|Overall Study|Lack of Efficacy|30
1864627|NCT00071981|6427453|P2|Overall Study|Lack of Efficacy|29
1864628|NCT00071981|6427454|P1|Overall Study|Lack of Efficacy|37
1864629|NCT00071812|6427497|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1864630|NCT00071812|6427498|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
1864631|NCT00071812|6427499|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1864632|NCT00071812|6427500|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1864633|NCT00071812|6427497|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
1864634|NCT00071812|6427498|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1864635|NCT00071812|6427499|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1864636|NCT00071812|6427500|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1864637|NCT00071812|6427497|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1864638|NCT00071812|6427498|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1864639|NCT00071812|6427499|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1864640|NCT00071812|6427500|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1864641|NCT00071812|6427497|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
1864642|NCT00071812|6427498|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1864643|NCT00071812|6427499|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1864644|NCT00071812|6427500|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1864645|NCT00071812|6427497|P4|24-Week Open-Label Extension Period|Adverse Event|7
1864646|NCT00071812|6427498|P3|24-Week Open-Label Extension Period|Adverse Event|0
1864647|NCT00071812|6427499|P2|24-Week Open-Label Extension Period|Adverse Event|0
1864648|NCT00071812|6427500|P1|24-Week Open-Label Extension Period|Adverse Event|0
1864649|NCT00071812|6427497|P4|24-Week Double-Blind Period|Protocol Violation|1
1864650|NCT00071812|6427498|P3|24-Week Double-Blind Period|Protocol Violation|0
1864651|NCT00071812|6427499|P2|24-Week Double-Blind Period|Protocol Violation|0
1864652|NCT00071812|6427500|P1|24-Week Double-Blind Period|Protocol Violation|0
1864653|NCT00071812|6427497|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
1864654|NCT00071812|6427498|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
1864655|NCT00071812|6427499|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
1864656|NCT00071812|6427500|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
1864657|NCT00071812|6427497|P4|24-Week Double-Blind Period|Lost to Follow-up|0
1864658|NCT00071812|6427498|P3|24-Week Double-Blind Period|Lost to Follow-up|1
1864659|NCT00071812|6427499|P2|24-Week Double-Blind Period|Lost to Follow-up|1
1864660|NCT00071812|6427500|P1|24-Week Double-Blind Period|Lost to Follow-up|0
1864661|NCT00071812|6427497|P4|24-Week Double-Blind Period|Lack of Efficacy|1
1864662|NCT00071812|6427498|P3|24-Week Double-Blind Period|Lack of Efficacy|2
1864663|NCT00071812|6427499|P2|24-Week Double-Blind Period|Lack of Efficacy|1
1864664|NCT00071812|6427500|P1|24-Week Double-Blind Period|Lack of Efficacy|3
1864665|NCT00071812|6427497|P4|24-Week Double-Blind Period|Adverse Event|4
1864666|NCT00071812|6427498|P3|24-Week Double-Blind Period|Adverse Event|4
1864667|NCT00071812|6427499|P2|24-Week Double-Blind Period|Adverse Event|3
1864668|NCT00071812|6427500|P1|24-Week Double-Blind Period|Adverse Event|2
1864669|NCT00071799|6427542|P2|Overall Study|Not Documented|2
1864670|NCT00071799|6427543|P1|Overall Study|Not Documented|0
1864671|NCT00071799|6427542|P2|Overall Study|Different Central+Local Pathology Review|1
1864672|NCT00071799|6427543|P1|Overall Study|Different Central+Local Pathology Review|0
1864673|NCT00071799|6427542|P2|Overall Study|Disease Progression|20
1864674|NCT00071799|6427543|P1|Overall Study|Disease Progression|23
1864675|NCT00071799|6427542|P2|Overall Study|Lack of Efficacy|18
1864676|NCT00071799|6427543|P1|Overall Study|Lack of Efficacy|11
1864677|NCT00071799|6427542|P2|Overall Study|Physician Decision|2
1864678|NCT00071799|6427543|P1|Overall Study|Physician Decision|0
1864679|NCT00071799|6427542|P2|Overall Study|Withdrawal by Subject|37
1864680|NCT00071799|6427543|P1|Overall Study|Withdrawal by Subject|15
1864681|NCT00071799|6427542|P2|Overall Study|Lost to Follow-up|1
1864682|NCT00071799|6427543|P1|Overall Study|Lost to Follow-up|1
1864683|NCT00071799|6427542|P2|Overall Study|Protocol Violation|7
1864684|NCT00071799|6427543|P1|Overall Study|Protocol Violation|1
1864685|NCT00071799|6427542|P2|Overall Study|Adverse Event|10
1864686|NCT00071799|6427543|P1|Overall Study|Adverse Event|19
1864687|NCT00071760|6427596|P1|Overall Study|Ongoing|25
1864688|NCT00071760|6427596|P1|Overall Study|Study Team Rec./Resistance|1
1864689|NCT00071760|6427596|P1|Overall Study|Investigator's Recommendation (Rec.)|4
1864690|NCT00071760|6427596|P1|Overall Study|Relocation|1
1864691|NCT00071760|6427596|P1|Overall Study|Unavailability of RTV|8
1864692|NCT00071760|6427596|P1|Overall Study|Pulmonary Tuberculosis|1
1864693|NCT00071760|6427596|P1|Overall Study|Insufficient Viral Load Response|3
1864694|NCT00071760|6427596|P1|Overall Study|Withdrawal by Subject|3
1864695|NCT00071760|6427596|P1|Overall Study|Protocol Violation|1
1864696|NCT00071760|6427596|P1|Overall Study|Lost to Follow-up|4
1864697|NCT00071760|6427596|P1|Overall Study|Adverse Event|3
1864698|NCT00071513|6427676|P2|Follow-up Assessment|Withdrawal by Subject|6
1864699|NCT00071513|6427677|P1|Follow-up Assessment|Withdrawal by Subject|6
1864700|NCT00071513|6427676|P2|Intervention Component|Withdrawal by Subject|3
1864701|NCT00071513|6427677|P1|Intervention Component|Withdrawal by Subject|2
1864702|NCT00071487|6427689|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
1864703|NCT00071487|6427690|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
1864704|NCT00071487|6427691|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
1864705|NCT00071487|6427692|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
1864706|NCT00071487|6427689|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
1864707|NCT00071487|6427690|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
1864708|NCT00071487|6427691|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
1864709|NCT00071487|6427692|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
1864710|NCT00071487|6427689|P4|24-Week Open-Label Extension Period|Pregnancy|1
1864711|NCT00071487|6427690|P3|24-Week Open-Label Extension Period|Pregnancy|0
1864712|NCT00071487|6427691|P2|24-Week Open-Label Extension Period|Pregnancy|0
1864713|NCT00071487|6427692|P1|24-Week Open-Label Extension Period|Pregnancy|0
1864714|NCT00071487|6427689|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
1864715|NCT00071487|6427690|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1864716|NCT00071487|6427691|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1864717|NCT00071487|6427692|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
1864718|NCT00071487|6427689|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
1864719|NCT00071487|6427690|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
1864720|NCT00071487|6427691|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
1864721|NCT00071487|6427692|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
1864722|NCT00071487|6427689|P4|24-Week Open-Label Extension Period|Adverse Event|6
1864723|NCT00071487|6427690|P3|24-Week Open-Label Extension Period|Adverse Event|1
1864724|NCT00071487|6427691|P2|24-Week Open-Label Extension Period|Adverse Event|0
1864725|NCT00071487|6427692|P1|24-Week Open-Label Extension Period|Adverse Event|0
1864726|NCT00071487|6427689|P4|52-Week Double-Blind Period|Lack of Compliance|3
1864727|NCT00071487|6427690|P3|52-Week Double-Blind Period|Lack of Compliance|3
1864728|NCT00071487|6427691|P2|52-Week Double-Blind Period|Lack of Compliance|3
1864729|NCT00071487|6427692|P1|52-Week Double-Blind Period|Lack of Compliance|6
1864730|NCT00071487|6427689|P4|52-Week Double-Blind Period|Death|0
1864731|NCT00071487|6427690|P3|52-Week Double-Blind Period|Death|0
1864732|NCT00071487|6427691|P2|52-Week Double-Blind Period|Death|1
1864733|NCT00071487|6427692|P1|52-Week Double-Blind Period|Death|0
1864734|NCT00071487|6427689|P4|52-Week Double-Blind Period|Protocol Violation|0
1864735|NCT00071487|6427690|P3|52-Week Double-Blind Period|Protocol Violation|1
1864736|NCT00071487|6427691|P2|52-Week Double-Blind Period|Protocol Violation|1
1864737|NCT00071487|6427692|P1|52-Week Double-Blind Period|Protocol Violation|0
1864738|NCT00071487|6427689|P4|52-Week Double-Blind Period|Pregnancy|0
1864739|NCT00071487|6427690|P3|52-Week Double-Blind Period|Pregnancy|0
1864740|NCT00071487|6427691|P2|52-Week Double-Blind Period|Pregnancy|1
1864741|NCT00071487|6427692|P1|52-Week Double-Blind Period|Pregnancy|0
1864742|NCT00071487|6427689|P4|52-Week Double-Blind Period|Lost to Follow-up|2
1864743|NCT00071487|6427690|P3|52-Week Double-Blind Period|Lost to Follow-up|2
1864744|NCT00071487|6427691|P2|52-Week Double-Blind Period|Lost to Follow-up|0
1864745|NCT00071487|6427692|P1|52-Week Double-Blind Period|Lost to Follow-up|0
1864746|NCT00071487|6427689|P4|52-Week Double-Blind Period|Physician Decision|0
1864747|NCT00071487|6427690|P3|52-Week Double-Blind Period|Physician Decision|0
1864748|NCT00071487|6427691|P2|52-Week Double-Blind Period|Physician Decision|0
1864749|NCT00071487|6427692|P1|52-Week Double-Blind Period|Physician Decision|1
1864750|NCT00071487|6427689|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
1864751|NCT00071487|6427690|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
1864752|NCT00071487|6427691|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
1864753|NCT00071487|6427692|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
1864754|NCT00071487|6427689|P4|52-Week Double-Blind Period|Lack of Efficacy|1
1864755|NCT00071487|6427690|P3|52-Week Double-Blind Period|Lack of Efficacy|0
1864756|NCT00071487|6427691|P2|52-Week Double-Blind Period|Lack of Efficacy|2
1864757|NCT00071487|6427692|P1|52-Week Double-Blind Period|Lack of Efficacy|1
1864758|NCT00071487|6427689|P4|52-Week Double-Blind Period|Adverse Event|8
1864759|NCT00071487|6427690|P3|52-Week Double-Blind Period|Adverse Event|4
1864760|NCT00071487|6427691|P2|52-Week Double-Blind Period|Adverse Event|8
1864761|NCT00071487|6427692|P1|52-Week Double-Blind Period|Adverse Event|5
1864762|NCT00071396|6427736|P1|Overall Study|Physician Decision|2
1864763|NCT00071396|6427736|P1|Overall Study|Withdrawal by Subject|1
1864764|NCT00071110|6427742|P2|Overall Study|Protocol Violation|4
1864765|NCT00071110|6427743|P1|Overall Study|Protocol Violation|0
1864766|NCT00071032|6427757|P2|Overall Study|Missing Primary Outcome|1
1864767|NCT00071032|6427758|P1|Overall Study|Missing Primary Outcome|0
1864768|NCT00071032|6427757|P2|Overall Study|Withdrawal by Subject|6
1864769|NCT00071032|6427758|P1|Overall Study|Withdrawal by Subject|8
1864770|NCT00071032|6427757|P2|Overall Study|Lost to Follow-up|1
1864771|NCT00071032|6427758|P1|Overall Study|Lost to Follow-up|1
1864772|NCT00071006|6427766|P1|Overall Study|Other|3
1864773|NCT00071006|6427766|P1|Overall Study|Withdrawal by Subject|1
1864774|NCT00071006|6427766|P1|Overall Study|Adverse Event|1
1864775|NCT00071006|6427766|P1|Overall Study|Lack of Efficacy|7
1864776|NCT00070941|6427779|P3|Overall Study|Adverse Event|4
1864777|NCT00070941|6427780|P2|Overall Study|Adverse Event|8
1864778|NCT00070941|6427781|P1|Overall Study|Adverse Event|10
1864779|NCT00071058|6427789|P1|Overall Study|brain tumor-removed from study|1
1864780|NCT00070707|6427796|P2|Overall Study|Unrelated to Study Medication|0
1864781|NCT00070707|6427797|P1|Overall Study|Unrelated to Study Medication|1
1864782|NCT00070707|6427796|P2|Overall Study|Protocol Violation|4
1864783|NCT00070707|6427797|P1|Overall Study|Protocol Violation|8
1864784|NCT00070707|6427796|P2|Overall Study|Lack of Efficacy|1
1864785|NCT00070707|6427797|P1|Overall Study|Lack of Efficacy|4
1864786|NCT00070707|6427796|P2|Overall Study|Adverse Event|2
1864787|NCT00070707|6427797|P1|Overall Study|Adverse Event|1
1864788|NCT00003907|6427845|P2|Overall Study|ineligible or not treated|2
1864789|NCT00003907|6427846|P1|Overall Study|ineligible or not treated|2
1864790|NCT00003907|6427845|P2|Overall Study|Other|3
1864791|NCT00003907|6427846|P1|Overall Study|Other|1
1864792|NCT00003907|6427845|P2|Overall Study|Complicating disease|0
1864793|NCT00003907|6427846|P1|Overall Study|Complicating disease|1
1864794|NCT00003907|6427845|P2|Overall Study|Progressive disease|4
1864795|NCT00003907|6427846|P1|Overall Study|Progressive disease|4
1864796|NCT00003907|6427845|P2|Overall Study|Withdrawal by Subject|3
1864797|NCT00003907|6427846|P1|Overall Study|Withdrawal by Subject|1
1864798|NCT00003907|6427845|P2|Overall Study|Death|0
1864799|NCT00003907|6427846|P1|Overall Study|Death|2
1864800|NCT00003907|6427845|P2|Overall Study|Adverse Event|11
1864801|NCT00003907|6427846|P1|Overall Study|Adverse Event|2
1864802|NCT00070564|6427862|P6|Overall Study|Not reported|0
1864803|NCT00070564|6427863|P5|Overall Study|Not reported|1
1864804|NCT00070564|6427864|P4|Overall Study|Not reported|0
1864805|NCT00070564|6427865|P3|Overall Study|Not reported|0
1864806|NCT00070564|6427866|P2|Overall Study|Not reported|0
1864807|NCT00070564|6427867|P1|Overall Study|Not reported|0
1864808|NCT00070564|6427862|P6|Overall Study|Withdrawal by Subject|8
1864809|NCT00070564|6427863|P5|Overall Study|Withdrawal by Subject|8
1864810|NCT00070564|6427864|P4|Overall Study|Withdrawal by Subject|30
1864811|NCT00070564|6427865|P3|Overall Study|Withdrawal by Subject|23
1864812|NCT00070564|6427866|P2|Overall Study|Withdrawal by Subject|37
1864813|NCT00070564|6427867|P1|Overall Study|Withdrawal by Subject|26
1864814|NCT00070564|6427862|P6|Overall Study|Other, not protocol specified|7
1864815|NCT00070564|6427863|P5|Overall Study|Other, not protocol specified|6
1864816|NCT00070564|6427864|P4|Overall Study|Other, not protocol specified|19
1864817|NCT00070564|6427865|P3|Overall Study|Other, not protocol specified|14
1864818|NCT00070564|6427866|P2|Overall Study|Other, not protocol specified|15
1864819|NCT00070564|6427867|P1|Overall Study|Other, not protocol specified|17
1864820|NCT00070564|6427862|P6|Overall Study|Death|1
1864821|NCT00070564|6427863|P5|Overall Study|Death|0
1864822|NCT00070564|6427864|P4|Overall Study|Death|3
1864823|NCT00070564|6427865|P3|Overall Study|Death|5
1864824|NCT00070564|6427866|P2|Overall Study|Death|1
1864825|NCT00070564|6427867|P1|Overall Study|Death|4
1864826|NCT00070564|6427862|P6|Overall Study|Adverse Event|36
1864827|NCT00070564|6427863|P5|Overall Study|Adverse Event|63
1864828|NCT00070564|6427864|P4|Overall Study|Adverse Event|108
1864829|NCT00070564|6427865|P3|Overall Study|Adverse Event|120
1864830|NCT00070564|6427866|P2|Overall Study|Adverse Event|142
1864831|NCT00070564|6427867|P1|Overall Study|Adverse Event|150
1864832|NCT00070564|6427862|P6|Overall Study|Delinquent|0
1864833|NCT00070564|6427863|P5|Overall Study|Delinquent|0
1864834|NCT00070564|6427864|P4|Overall Study|Delinquent|0
1864835|NCT00070564|6427865|P3|Overall Study|Delinquent|2
1864836|NCT00070564|6427866|P2|Overall Study|Delinquent|4
1864837|NCT00070564|6427867|P1|Overall Study|Delinquent|1
1864838|NCT00070564|6427862|P6|Overall Study|Progression|0
1864839|NCT00070564|6427863|P5|Overall Study|Progression|1
1864840|NCT00070564|6427864|P4|Overall Study|Progression|7
1864841|NCT00070564|6427865|P3|Overall Study|Progression|7
1864842|NCT00070564|6427866|P2|Overall Study|Progression|4
1864843|NCT00070564|6427867|P1|Overall Study|Progression|2
1864844|NCT00070499|6427921|P4|Overall Study|Not eligible|2
1864845|NCT00070499|6427922|P3|Overall Study|Not eligible|3
1864846|NCT00070499|6427923|P2|Overall Study|Not eligible|5
1864847|NCT00070499|6427924|P1|Overall Study|Not eligible|2
1864848|NCT00070499|6427921|P4|Overall Study|Did not start treatment|2
1864849|NCT00070499|6427922|P3|Overall Study|Did not start treatment|0
1864850|NCT00070499|6427923|P2|Overall Study|Did not start treatment|0
1864851|NCT00070499|6427924|P1|Overall Study|Did not start treatment|1
1864852|NCT00070499|6427921|P4|Overall Study|Still on protocol treatment|57
1864853|NCT00070499|6427922|P3|Overall Study|Still on protocol treatment|79
1864854|NCT00070499|6427923|P2|Overall Study|Still on protocol treatment|4
1864855|NCT00070499|6427924|P1|Overall Study|Still on protocol treatment|10
1864856|NCT00070499|6427921|P4|Overall Study|Other - not protocol specified|20
1864857|NCT00070499|6427922|P3|Overall Study|Other - not protocol specified|12
1864858|NCT00070499|6427923|P2|Overall Study|Other - not protocol specified|3
1864859|NCT00070499|6427924|P1|Overall Study|Other - not protocol specified|7
1864860|NCT00070499|6427921|P4|Overall Study|Death|2
1864861|NCT00070499|6427922|P3|Overall Study|Death|1
1864862|NCT00070499|6427923|P2|Overall Study|Death|1
1864863|NCT00070499|6427924|P1|Overall Study|Death|1
1864864|NCT00070499|6427921|P4|Overall Study|Progression/relapse|4
1864865|NCT00070499|6427922|P3|Overall Study|Progression/relapse|1
1864866|NCT00070499|6427923|P2|Overall Study|Progression/relapse|2
1864867|NCT00070499|6427924|P1|Overall Study|Progression/relapse|4
1864868|NCT00070499|6427921|P4|Overall Study|Refusal unrelated to adverse effects|8
1864869|NCT00070499|6427922|P3|Overall Study|Refusal unrelated to adverse effects|5
1864870|NCT00070499|6427923|P2|Overall Study|Refusal unrelated to adverse effects|5
1864871|NCT00070499|6427924|P1|Overall Study|Refusal unrelated to adverse effects|7
1864872|NCT00070499|6427921|P4|Overall Study|Adverse Event|15
1864873|NCT00070499|6427922|P3|Overall Study|Adverse Event|19
1864874|NCT00070499|6427923|P2|Overall Study|Adverse Event|6
1864875|NCT00070499|6427924|P1|Overall Study|Adverse Event|6
1864876|NCT00070317|6427950|P1|Overall Study|Ineligible-Inadequate pathology|6
1864877|NCT00070317|6427950|P1|Overall Study|Ineligible-Improper prior treatment|2
1864878|NCT00070317|6427950|P1|Overall Study|Ineligible required test not done|1
1864879|NCT00070317|6427950|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
1864880|NCT00070317|6427950|P1|Overall Study|Inevaluable (Never Treated)|1
1864881|NCT00070291|6427955|P1|Step 2|Adverse Event|1
1864882|NCT00070291|6427955|P1|Step 1|Adverse Event|1
1864883|NCT00070291|6427955|P1|Step 1|Withdrawal by Subject|1
1864884|NCT00070109|6427971|P5|Overall Study|removed from prot thpy prior to chemo|0
1864885|NCT00070109|6427972|P4|Overall Study|removed from prot thpy prior to chemo|1
1864886|NCT00070109|6427973|P3|Overall Study|removed from prot thpy prior to chemo|0
1864887|NCT00070109|6427974|P2|Overall Study|removed from prot thpy prior to chemo|0
1864888|NCT00070109|6427975|P1|Overall Study|removed from prot thpy prior to chemo|0
1864889|NCT00070109|6427971|P5|Overall Study|Adverse Event|2
1864890|NCT00070109|6427972|P4|Overall Study|Adverse Event|4
1864891|NCT00070109|6427973|P3|Overall Study|Adverse Event|2
1864892|NCT00070109|6427974|P2|Overall Study|Adverse Event|0
1864893|NCT00070109|6427975|P1|Overall Study|Adverse Event|0
1864894|NCT00070109|6427971|P5|Overall Study|Withdrawal by Subject|0
1864895|NCT00070109|6427972|P4|Overall Study|Withdrawal by Subject|0
1864896|NCT00070109|6427973|P3|Overall Study|Withdrawal by Subject|1
1864897|NCT00070109|6427974|P2|Overall Study|Withdrawal by Subject|1
1864898|NCT00070109|6427975|P1|Overall Study|Withdrawal by Subject|0
1864899|NCT00070109|6427971|P5|Overall Study|Physician Decision|0
1864900|NCT00070109|6427972|P4|Overall Study|Physician Decision|0
1864901|NCT00070109|6427973|P3|Overall Study|Physician Decision|0
1864902|NCT00070109|6427974|P2|Overall Study|Physician Decision|0
1864903|NCT00070109|6427975|P1|Overall Study|Physician Decision|1
1864904|NCT00070109|6427971|P5|Overall Study|Lack of Efficacy|5
1864905|NCT00070109|6427972|P4|Overall Study|Lack of Efficacy|15
1864906|NCT00070109|6427973|P3|Overall Study|Lack of Efficacy|5
1864907|NCT00070109|6427974|P2|Overall Study|Lack of Efficacy|4
1864908|NCT00070109|6427975|P1|Overall Study|Lack of Efficacy|6
1864909|NCT00070109|6427971|P5|Overall Study|Death|1
1864910|NCT00070109|6427972|P4|Overall Study|Death|0
1864911|NCT00070109|6427973|P3|Overall Study|Death|0
1864912|NCT00070109|6427974|P2|Overall Study|Death|1
1864913|NCT00070109|6427975|P1|Overall Study|Death|1
1864914|NCT00070018|6428003|P1|Overall Study|Withdrawal by Subject|1
1864915|NCT00070018|6428003|P1|Overall Study|Lack of Efficacy|1
1864916|NCT00070018|6428003|P1|Overall Study|Adverse Event|2
1864917|NCT00069953|6428007|P1|Overall Study|Protocol Violation|2
1864918|NCT00069784|6428013|P2|Overall Study|Other|0
1864919|NCT00069784|6428014|P1|Overall Study|Other|17
1864920|NCT00069784|6428013|P2|Overall Study|Withdrawal by Subject|0
1864921|NCT00069784|6428014|P1|Overall Study|Withdrawal by Subject|1090
1864922|NCT00069784|6428013|P2|Overall Study|Adverse Event|0
1864923|NCT00069784|6428014|P1|Overall Study|Adverse Event|105
1864924|NCT00069823|6428034|P2|Overall Study|Did not have follow-up diary cards|3
1864925|NCT00069823|6428035|P1|Overall Study|Did not have follow-up diary cards|6
1864926|NCT00069641|6428078|P3|Overall Study|Death|1
1864927|NCT00069641|6428079|P2|Overall Study|Death|0
1864928|NCT00069641|6428080|P1|Overall Study|Death|1
1864929|NCT00069576|6428107|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
1864930|NCT00069576|6428108|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
1864931|NCT00069576|6428107|P2|Original Trial|Lost to Follow-up|33
1864932|NCT00069576|6428108|P1|Original Trial|Lost to Follow-up|25
1864933|NCT00069277|6428158|P1|Overall Study|Physician Decision|2
1864934|NCT00069277|6428158|P1|Overall Study|Progressive Disease|15
1864935|NCT00069277|6428158|P1|Overall Study|Withdrawal by Subject|1
1864936|NCT00069277|6428158|P1|Overall Study|Adverse Event|3
1864937|NCT00069264|6428162|P1|Overall Study|Discon Therapy|3
1864938|NCT00069264|6428162|P1|Overall Study|Withdrawal by Subject|3
1864939|NCT00069264|6428162|P1|Overall Study|Progressive Disease|23
1864940|NCT00069264|6428162|P1|Overall Study|Adverse Event|3
1864941|NCT00069238|6428190|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
1864942|NCT00069238|6428191|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1864943|NCT00069238|6428192|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
1864944|NCT00069238|6428190|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1864945|NCT00069238|6428191|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
1864946|NCT00069238|6428192|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
1864947|NCT00069238|6428190|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1864948|NCT00069238|6428191|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
1864949|NCT00069238|6428192|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
1864950|NCT00069121|6428200|P2|Overall Study|Lost to Follow-up|57
1864951|NCT00069121|6428201|P1|Overall Study|Lost to Follow-up|57
1864952|NCT00069121|6428200|P2|Overall Study|Withdrawal by Subject|22
1864953|NCT00069121|6428201|P1|Overall Study|Withdrawal by Subject|20
1864954|NCT00069121|6428200|P2|Overall Study|Death|197
1864955|NCT00069121|6428201|P1|Overall Study|Death|225
1864956|NCT00069108|6428223|P2|Overall Study|Refused treatment|10
1864957|NCT00069108|6428224|P1|Overall Study|Refused treatment|5
1864958|NCT00069108|6428223|P2|Overall Study|Violation criteria|4
1864959|NCT00069108|6428224|P1|Overall Study|Violation criteria|1
1864960|NCT00069108|6428223|P2|Overall Study|Insufficient therapy|144
1864961|NCT00069108|6428224|P1|Overall Study|Insufficient therapy|117
1864962|NCT00069108|6428223|P2|Overall Study|Administration|4
1864963|NCT00069108|6428224|P1|Overall Study|Administration|15
1864964|NCT00069108|6428223|P2|Overall Study|Death|6
1864965|NCT00069108|6428224|P1|Overall Study|Death|6
1864966|NCT00069108|6428223|P2|Overall Study|Adverse Event|42
1864967|NCT00069108|6428224|P1|Overall Study|Adverse Event|64
1864968|NCT00069108|6428223|P2|Overall Study|Withdrawal by Subject|9
1864969|NCT00069108|6428224|P1|Overall Study|Withdrawal by Subject|5
1864970|NCT00069095|6428256|P6|Follow-up Phase|Death|101
1864971|NCT00069095|6428257|P5|Follow-up Phase|Death|92
1864972|NCT00069095|6428258|P4|Follow-up Phase|Death|112
1864973|NCT00069095|6428259|P3|Follow-up Phase|Death|120
1864974|NCT00069095|6428260|P2|Follow-up Phase|Death|206
1864975|NCT00069095|6428261|P1|Follow-up Phase|Death|174
1864976|NCT00069095|6428256|P6|Post-study Treatment Phase|Investigator decision|1
1864977|NCT00069095|6428257|P5|Post-study Treatment Phase|Investigator decision|0
1864978|NCT00069095|6428258|P4|Post-study Treatment Phase|Investigator decision|0
1864979|NCT00069095|6428259|P3|Post-study Treatment Phase|Investigator decision|0
1864980|NCT00069095|6428260|P2|Post-study Treatment Phase|Investigator decision|0
1864981|NCT00069095|6428261|P1|Post-study Treatment Phase|Investigator decision|0
1864982|NCT00069095|6428256|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1864983|NCT00069095|6428257|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
1864984|NCT00069095|6428258|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1864985|NCT00069095|6428259|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1864986|NCT00069095|6428260|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1864987|NCT00069095|6428261|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
1864988|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
1864989|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
1864990|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
1864991|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
1864992|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
1864993|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
1864994|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant had progressive disease|0
1864995|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant had progressive disease|1
1864996|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant had progressive disease|0
1864997|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant had progressive disease|0
1864998|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant had progressive disease|0
1864999|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant had progressive disease|0
1865000|NCT00069095|6428256|P6|Post-study Treatment Phase|Death|0
1865001|NCT00069095|6428257|P5|Post-study Treatment Phase|Death|1
1865002|NCT00069095|6428258|P4|Post-study Treatment Phase|Death|0
1865003|NCT00069095|6428259|P3|Post-study Treatment Phase|Death|0
1865004|NCT00069095|6428260|P2|Post-study Treatment Phase|Death|0
1865005|NCT00069095|6428261|P1|Post-study Treatment Phase|Death|0
1865006|NCT00069095|6428256|P6|Post-study Treatment Phase|Surgery|0
1865007|NCT00069095|6428257|P5|Post-study Treatment Phase|Surgery|1
1865008|NCT00069095|6428258|P4|Post-study Treatment Phase|Surgery|1
1865009|NCT00069095|6428259|P3|Post-study Treatment Phase|Surgery|0
1865010|NCT00069095|6428260|P2|Post-study Treatment Phase|Surgery|0
1865011|NCT00069095|6428261|P1|Post-study Treatment Phase|Surgery|0
1865012|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant completed treatment|0
1865013|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant completed treatment|0
1865014|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant completed treatment|1
1865015|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant completed treatment|0
1865016|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant completed treatment|0
1865017|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant completed treatment|0
1865018|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
1865019|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
1865020|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
1865021|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
1865022|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
1865023|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
1865024|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant will start new treatment|0
1865025|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant will start new treatment|0
1865026|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant will start new treatment|0
1865027|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant will start new treatment|1
1865028|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant will start new treatment|0
1865029|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant will start new treatment|0
1865030|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant withdrew consent|0
1865031|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant withdrew consent|0
1865032|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant withdrew consent|0
1865033|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant withdrew consent|1
1865034|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant withdrew consent|0
1865035|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant withdrew consent|0
1865036|NCT00069095|6428256|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1865037|NCT00069095|6428257|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1865038|NCT00069095|6428258|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1865039|NCT00069095|6428259|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1865040|NCT00069095|6428260|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
1865041|NCT00069095|6428261|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
1865042|NCT00069095|6428256|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
1865043|NCT00069095|6428257|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
1865044|NCT00069095|6428258|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
1865045|NCT00069095|6428259|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
1865046|NCT00069095|6428260|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
1865047|NCT00069095|6428261|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
1865048|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant had complete response|0
1865049|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant had complete response|0
1865050|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant had complete response|0
1865051|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant had complete response|0
1865052|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant had complete response|1
1865053|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant had complete response|1
1865054|NCT00069095|6428256|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1865055|NCT00069095|6428257|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1865056|NCT00069095|6428258|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1865057|NCT00069095|6428259|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1865058|NCT00069095|6428260|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
1865059|NCT00069095|6428261|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
1865060|NCT00069095|6428256|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
1865061|NCT00069095|6428257|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
1865062|NCT00069095|6428258|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
1865063|NCT00069095|6428259|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
1865064|NCT00069095|6428260|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
1865065|NCT00069095|6428261|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
1865066|NCT00069095|6428256|P6|Post-study Treatment Phase|Eligible for surgery|0
1865067|NCT00069095|6428257|P5|Post-study Treatment Phase|Eligible for surgery|0
1865068|NCT00069095|6428258|P4|Post-study Treatment Phase|Eligible for surgery|0
1865069|NCT00069095|6428259|P3|Post-study Treatment Phase|Eligible for surgery|0
1865070|NCT00069095|6428260|P2|Post-study Treatment Phase|Eligible for surgery|0
1865071|NCT00069095|6428261|P1|Post-study Treatment Phase|Eligible for surgery|2
1865072|NCT00069095|6428256|P6|Post-study Treatment Phase|Adverse Event|1
1865073|NCT00069095|6428257|P5|Post-study Treatment Phase|Adverse Event|5
1865074|NCT00069095|6428258|P4|Post-study Treatment Phase|Adverse Event|0
1865075|NCT00069095|6428259|P3|Post-study Treatment Phase|Adverse Event|1
1865076|NCT00069095|6428260|P2|Post-study Treatment Phase|Adverse Event|3
1865077|NCT00069095|6428261|P1|Post-study Treatment Phase|Adverse Event|2
1865078|NCT00069095|6428256|P6|Post-study Treatment Phase|Missing reason|17
1865079|NCT00069095|6428257|P5|Post-study Treatment Phase|Missing reason|18
1865080|NCT00069095|6428258|P4|Post-study Treatment Phase|Missing reason|8
1865081|NCT00069095|6428259|P3|Post-study Treatment Phase|Missing reason|12
1865082|NCT00069095|6428260|P2|Post-study Treatment Phase|Missing reason|3
1865083|NCT00069095|6428261|P1|Post-study Treatment Phase|Missing reason|1
1865084|NCT00069095|6428256|P6|Primary Treatment Phase|Violation criteria|5
1865085|NCT00069095|6428257|P5|Primary Treatment Phase|Violation criteria|1
1865086|NCT00069095|6428258|P4|Primary Treatment Phase|Violation criteria|3
1865087|NCT00069095|6428259|P3|Primary Treatment Phase|Violation criteria|4
1865088|NCT00069095|6428260|P2|Primary Treatment Phase|Violation criteria|2
1865089|NCT00069095|6428261|P1|Primary Treatment Phase|Violation criteria|0
1865090|NCT00069095|6428256|P6|Primary Treatment Phase|Other Violation|1
1865091|NCT00069095|6428257|P5|Primary Treatment Phase|Other Violation|0
1865092|NCT00069095|6428258|P4|Primary Treatment Phase|Other Violation|1
1865093|NCT00069095|6428259|P3|Primary Treatment Phase|Other Violation|1
1865094|NCT00069095|6428260|P2|Primary Treatment Phase|Other Violation|1
1865095|NCT00069095|6428261|P1|Primary Treatment Phase|Other Violation|0
1865096|NCT00069095|6428256|P6|Primary Treatment Phase|Withdrew|9
1865097|NCT00069095|6428257|P5|Primary Treatment Phase|Withdrew|4
1865098|NCT00069095|6428258|P4|Primary Treatment Phase|Withdrew|2
1865099|NCT00069095|6428259|P3|Primary Treatment Phase|Withdrew|8
1865100|NCT00069095|6428260|P2|Primary Treatment Phase|Withdrew|3
1865101|NCT00069095|6428261|P1|Primary Treatment Phase|Withdrew|2
1865102|NCT00069095|6428256|P6|Primary Treatment Phase|Refused treatment|27
1865103|NCT00069095|6428257|P5|Primary Treatment Phase|Refused treatment|24
1865104|NCT00069095|6428258|P4|Primary Treatment Phase|Refused treatment|31
1865105|NCT00069095|6428259|P3|Primary Treatment Phase|Refused treatment|17
1865106|NCT00069095|6428260|P2|Primary Treatment Phase|Refused treatment|26
1865107|NCT00069095|6428261|P1|Primary Treatment Phase|Refused treatment|15
1865108|NCT00069095|6428256|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
1865109|NCT00069095|6428257|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
1865110|NCT00069095|6428258|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
1865111|NCT00069095|6428259|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
1865112|NCT00069095|6428260|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
1865113|NCT00069095|6428261|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
1865114|NCT00069095|6428256|P6|Primary Treatment Phase|Failure to return|2
1865115|NCT00069095|6428257|P5|Primary Treatment Phase|Failure to return|0
1865116|NCT00069095|6428258|P4|Primary Treatment Phase|Failure to return|0
1865117|NCT00069095|6428259|P3|Primary Treatment Phase|Failure to return|0
1865118|NCT00069095|6428260|P2|Primary Treatment Phase|Failure to return|5
1865119|NCT00069095|6428261|P1|Primary Treatment Phase|Failure to return|5
1865120|NCT00069095|6428256|P6|Primary Treatment Phase|Death|8
1865121|NCT00069095|6428257|P5|Primary Treatment Phase|Death|8
1865122|NCT00069095|6428258|P4|Primary Treatment Phase|Death|5
1865123|NCT00069095|6428259|P3|Primary Treatment Phase|Death|2
1865124|NCT00069095|6428260|P2|Primary Treatment Phase|Death|8
1865125|NCT00069095|6428261|P1|Primary Treatment Phase|Death|14
1865126|NCT00069095|6428256|P6|Primary Treatment Phase|Adverse Event|101
1865127|NCT00069095|6428257|P5|Primary Treatment Phase|Adverse Event|109
1865128|NCT00069095|6428258|P4|Primary Treatment Phase|Adverse Event|72
1865129|NCT00069095|6428259|P3|Primary Treatment Phase|Adverse Event|71
1865130|NCT00069095|6428260|P2|Primary Treatment Phase|Adverse Event|92
1865131|NCT00069095|6428261|P1|Primary Treatment Phase|Adverse Event|99
1865132|NCT00069095|6428256|P6|Primary Treatment Phase|Admin/Other|42
1865133|NCT00069095|6428257|P5|Primary Treatment Phase|Admin/Other|48
1865134|NCT00069095|6428258|P4|Primary Treatment Phase|Admin/Other|45
1865135|NCT00069095|6428259|P3|Primary Treatment Phase|Admin/Other|31
1865136|NCT00069095|6428260|P2|Primary Treatment Phase|Admin/Other|38
1865137|NCT00069095|6428261|P1|Primary Treatment Phase|Admin/Other|29
1865138|NCT00069095|6428256|P6|Primary Treatment Phase|Ongoing|4
1865139|NCT00069095|6428257|P5|Primary Treatment Phase|Ongoing|7
1865140|NCT00069095|6428258|P4|Primary Treatment Phase|Ongoing|7
1865141|NCT00069095|6428259|P3|Primary Treatment Phase|Ongoing|5
1865142|NCT00069095|6428260|P2|Primary Treatment Phase|Ongoing|0
1865143|NCT00069095|6428261|P1|Primary Treatment Phase|Ongoing|0
1865144|NCT00068822|6428331|P2|First Randomized Intervention|Lost to Follow-up|2
1865145|NCT00068822|6428332|P1|First Randomized Intervention|Lost to Follow-up|1
1865146|NCT00068692|6428366|P8|Step 2: Randomization|never start protocol therapy|0
1865147|NCT00068692|6428367|P7|Step 2: Randomization|never start protocol therapy|0
1865148|NCT00068692|6428368|P6|Step 2: Randomization|never start protocol therapy|0
1865149|NCT00068692|6428369|P5|Step 2: Randomization|never start protocol therapy|1
1865150|NCT00068692|6428370|P4|Step 2: Randomization|never start protocol therapy|0
1865151|NCT00068692|6428371|P3|Step 2: Randomization|never start protocol therapy|1
1865152|NCT00068692|6428372|P2|Step 2: Randomization|never start protocol therapy|0
1865153|NCT00068692|6428373|P1|Step 2: Randomization|never start protocol therapy|0
1865154|NCT00068692|6428366|P8|Step 2: Randomization|Other|0
1865155|NCT00068692|6428367|P7|Step 2: Randomization|Other|0
1865156|NCT00068692|6428368|P6|Step 2: Randomization|Other|1
1865157|NCT00068692|6428369|P5|Step 2: Randomization|Other|0
1865158|NCT00068692|6428370|P4|Step 2: Randomization|Other|1
1865159|NCT00068692|6428371|P3|Step 2: Randomization|Other|0
1865160|NCT00068692|6428372|P2|Step 2: Randomization|Other|0
1865161|NCT00068692|6428373|P1|Step 2: Randomization|Other|0
1865162|NCT00068692|6428366|P8|Step 2: Randomization|Physician Decision|0
1865163|NCT00068692|6428367|P7|Step 2: Randomization|Physician Decision|0
1865164|NCT00068692|6428368|P6|Step 2: Randomization|Physician Decision|0
1865165|NCT00068692|6428369|P5|Step 2: Randomization|Physician Decision|1
1865166|NCT00068692|6428370|P4|Step 2: Randomization|Physician Decision|1
1865167|NCT00068692|6428371|P3|Step 2: Randomization|Physician Decision|0
1865168|NCT00068692|6428372|P2|Step 2: Randomization|Physician Decision|0
1865169|NCT00068692|6428373|P1|Step 2: Randomization|Physician Decision|0
1865170|NCT00068692|6428366|P8|Step 2: Randomization|alternative therapy|0
1865171|NCT00068692|6428367|P7|Step 2: Randomization|alternative therapy|0
1865172|NCT00068692|6428368|P6|Step 2: Randomization|alternative therapy|0
1865173|NCT00068692|6428369|P5|Step 2: Randomization|alternative therapy|1
1865174|NCT00068692|6428370|P4|Step 2: Randomization|alternative therapy|1
1865175|NCT00068692|6428371|P3|Step 2: Randomization|alternative therapy|0
1865176|NCT00068692|6428372|P2|Step 2: Randomization|alternative therapy|0
1865177|NCT00068692|6428373|P1|Step 2: Randomization|alternative therapy|0
1865178|NCT00068692|6428366|P8|Step 2: Randomization|Withdrawal by Subject|3
1865179|NCT00068692|6428367|P7|Step 2: Randomization|Withdrawal by Subject|0
1865180|NCT00068692|6428368|P6|Step 2: Randomization|Withdrawal by Subject|2
1865181|NCT00068692|6428369|P5|Step 2: Randomization|Withdrawal by Subject|3
1865182|NCT00068692|6428370|P4|Step 2: Randomization|Withdrawal by Subject|6
1865183|NCT00068692|6428371|P3|Step 2: Randomization|Withdrawal by Subject|4
1865184|NCT00068692|6428372|P2|Step 2: Randomization|Withdrawal by Subject|0
1865185|NCT00068692|6428373|P1|Step 2: Randomization|Withdrawal by Subject|0
1865186|NCT00068692|6428366|P8|Step 2: Randomization|Death|1
1865187|NCT00068692|6428367|P7|Step 2: Randomization|Death|0
1865188|NCT00068692|6428368|P6|Step 2: Randomization|Death|0
1865189|NCT00068692|6428369|P5|Step 2: Randomization|Death|1
1865190|NCT00068692|6428370|P4|Step 2: Randomization|Death|0
1865191|NCT00068692|6428371|P3|Step 2: Randomization|Death|0
1865192|NCT00068692|6428372|P2|Step 2: Randomization|Death|0
1865193|NCT00068692|6428373|P1|Step 2: Randomization|Death|0
1865194|NCT00068692|6428366|P8|Step 2: Randomization|Adverse Event|4
1865195|NCT00068692|6428367|P7|Step 2: Randomization|Adverse Event|4
1865196|NCT00068692|6428368|P6|Step 2: Randomization|Adverse Event|3
1865197|NCT00068692|6428369|P5|Step 2: Randomization|Adverse Event|2
1865198|NCT00068692|6428370|P4|Step 2: Randomization|Adverse Event|2
1865199|NCT00068692|6428371|P3|Step 2: Randomization|Adverse Event|4
1865200|NCT00068692|6428372|P2|Step 2: Randomization|Adverse Event|0
1865201|NCT00068692|6428373|P1|Step 2: Randomization|Adverse Event|0
1865202|NCT00068692|6428366|P8|Step 2: Randomization|Disesae progression/replase|0
1865203|NCT00068692|6428367|P7|Step 2: Randomization|Disesae progression/replase|0
1865204|NCT00068692|6428368|P6|Step 2: Randomization|Disesae progression/replase|0
1865205|NCT00068692|6428369|P5|Step 2: Randomization|Disesae progression/replase|0
1865206|NCT00068692|6428370|P4|Step 2: Randomization|Disesae progression/replase|1
1865207|NCT00068692|6428371|P3|Step 2: Randomization|Disesae progression/replase|1
1865208|NCT00068692|6428372|P2|Step 2: Randomization|Disesae progression/replase|0
1865209|NCT00068692|6428373|P1|Step 2: Randomization|Disesae progression/replase|0
1865210|NCT00068692|6428366|P8|Step 1: Registration|Registered but not randomized|0
1865211|NCT00068692|6428367|P7|Step 1: Registration|Registered but not randomized|0
1865212|NCT00068692|6428368|P6|Step 1: Registration|Registered but not randomized|0
1865213|NCT00068692|6428369|P5|Step 1: Registration|Registered but not randomized|0
1865214|NCT00068692|6428370|P4|Step 1: Registration|Registered but not randomized|0
1865215|NCT00068692|6428371|P3|Step 1: Registration|Registered but not randomized|0
1865216|NCT00068692|6428372|P2|Step 1: Registration|Registered but not randomized|1
1865217|NCT00068692|6428373|P1|Step 1: Registration|Registered but not randomized|0
1865218|NCT00068692|6428366|P8|Step 1: Registration|Not start protocol therapy|0
1865219|NCT00068692|6428367|P7|Step 1: Registration|Not start protocol therapy|0
1865220|NCT00068692|6428368|P6|Step 1: Registration|Not start protocol therapy|0
1865221|NCT00068692|6428369|P5|Step 1: Registration|Not start protocol therapy|0
1865222|NCT00068692|6428370|P4|Step 1: Registration|Not start protocol therapy|0
1865223|NCT00068692|6428371|P3|Step 1: Registration|Not start protocol therapy|0
1865224|NCT00068692|6428372|P2|Step 1: Registration|Not start protocol therapy|0
1865225|NCT00068692|6428373|P1|Step 1: Registration|Not start protocol therapy|3
1865226|NCT00068692|6428366|P8|Step 1: Registration|Other|0
1865227|NCT00068692|6428367|P7|Step 1: Registration|Other|0
1865228|NCT00068692|6428368|P6|Step 1: Registration|Other|0
1865229|NCT00068692|6428369|P5|Step 1: Registration|Other|0
1865230|NCT00068692|6428370|P4|Step 1: Registration|Other|0
1865231|NCT00068692|6428371|P3|Step 1: Registration|Other|0
1865232|NCT00068692|6428372|P2|Step 1: Registration|Other|0
1865233|NCT00068692|6428373|P1|Step 1: Registration|Other|2
1865234|NCT00068692|6428366|P8|Step 1: Registration|Not eligible|0
1865235|NCT00068692|6428367|P7|Step 1: Registration|Not eligible|0
1865236|NCT00068692|6428368|P6|Step 1: Registration|Not eligible|0
1865237|NCT00068692|6428369|P5|Step 1: Registration|Not eligible|0
1865238|NCT00068692|6428370|P4|Step 1: Registration|Not eligible|0
1865239|NCT00068692|6428371|P3|Step 1: Registration|Not eligible|0
1865240|NCT00068692|6428372|P2|Step 1: Registration|Not eligible|0
1865241|NCT00068692|6428373|P1|Step 1: Registration|Not eligible|6
1865242|NCT00068692|6428366|P8|Step 1: Registration|Protocol Violation|0
1865243|NCT00068692|6428367|P7|Step 1: Registration|Protocol Violation|0
1865244|NCT00068692|6428368|P6|Step 1: Registration|Protocol Violation|0
1865245|NCT00068692|6428369|P5|Step 1: Registration|Protocol Violation|0
1865246|NCT00068692|6428370|P4|Step 1: Registration|Protocol Violation|0
1865247|NCT00068692|6428371|P3|Step 1: Registration|Protocol Violation|0
1865248|NCT00068692|6428372|P2|Step 1: Registration|Protocol Violation|0
1865249|NCT00068692|6428373|P1|Step 1: Registration|Protocol Violation|1
1865250|NCT00068692|6428366|P8|Step 1: Registration|Complicating disease|0
1865251|NCT00068692|6428367|P7|Step 1: Registration|Complicating disease|0
1865252|NCT00068692|6428368|P6|Step 1: Registration|Complicating disease|0
1865253|NCT00068692|6428369|P5|Step 1: Registration|Complicating disease|0
1865254|NCT00068692|6428370|P4|Step 1: Registration|Complicating disease|0
1865255|NCT00068692|6428371|P3|Step 1: Registration|Complicating disease|0
1865256|NCT00068692|6428372|P2|Step 1: Registration|Complicating disease|0
1865257|NCT00068692|6428373|P1|Step 1: Registration|Complicating disease|2
1865258|NCT00068692|6428366|P8|Step 1: Registration|Alternative therapy|0
1865259|NCT00068692|6428367|P7|Step 1: Registration|Alternative therapy|0
1865260|NCT00068692|6428368|P6|Step 1: Registration|Alternative therapy|0
1865261|NCT00068692|6428369|P5|Step 1: Registration|Alternative therapy|0
1865262|NCT00068692|6428370|P4|Step 1: Registration|Alternative therapy|0
1865263|NCT00068692|6428371|P3|Step 1: Registration|Alternative therapy|0
1865264|NCT00068692|6428372|P2|Step 1: Registration|Alternative therapy|0
1865265|NCT00068692|6428373|P1|Step 1: Registration|Alternative therapy|2
1865266|NCT00068692|6428366|P8|Step 1: Registration|Withdrawal by Subject|0
1865267|NCT00068692|6428367|P7|Step 1: Registration|Withdrawal by Subject|0
1865268|NCT00068692|6428368|P6|Step 1: Registration|Withdrawal by Subject|0
1865269|NCT00068692|6428369|P5|Step 1: Registration|Withdrawal by Subject|0
1865270|NCT00068692|6428370|P4|Step 1: Registration|Withdrawal by Subject|0
1865271|NCT00068692|6428371|P3|Step 1: Registration|Withdrawal by Subject|0
1865272|NCT00068692|6428372|P2|Step 1: Registration|Withdrawal by Subject|0
1865273|NCT00068692|6428373|P1|Step 1: Registration|Withdrawal by Subject|11
1865274|NCT00068692|6428366|P8|Step 1: Registration|Death|0
1865275|NCT00068692|6428367|P7|Step 1: Registration|Death|0
1865276|NCT00068692|6428368|P6|Step 1: Registration|Death|0
1865277|NCT00068692|6428369|P5|Step 1: Registration|Death|0
1865278|NCT00068692|6428370|P4|Step 1: Registration|Death|0
1865279|NCT00068692|6428371|P3|Step 1: Registration|Death|0
1865280|NCT00068692|6428372|P2|Step 1: Registration|Death|0
1865281|NCT00068692|6428373|P1|Step 1: Registration|Death|1
1865282|NCT00068692|6428366|P8|Step 1: Registration|Adverse Event|0
1865283|NCT00068692|6428367|P7|Step 1: Registration|Adverse Event|0
1865284|NCT00068692|6428368|P6|Step 1: Registration|Adverse Event|0
1865285|NCT00068692|6428369|P5|Step 1: Registration|Adverse Event|0
1865286|NCT00068692|6428370|P4|Step 1: Registration|Adverse Event|0
1865287|NCT00068692|6428371|P3|Step 1: Registration|Adverse Event|0
1865288|NCT00068692|6428372|P2|Step 1: Registration|Adverse Event|0
1865289|NCT00068692|6428373|P1|Step 1: Registration|Adverse Event|7
1865290|NCT00068692|6428366|P8|Step 1: Registration|Disese progression/relapse|0
1865291|NCT00068692|6428367|P7|Step 1: Registration|Disese progression/relapse|0
1865292|NCT00068692|6428368|P6|Step 1: Registration|Disese progression/relapse|0
1865293|NCT00068692|6428369|P5|Step 1: Registration|Disese progression/relapse|0
1865294|NCT00068692|6428370|P4|Step 1: Registration|Disese progression/relapse|0
1865295|NCT00068692|6428371|P3|Step 1: Registration|Disese progression/relapse|0
1865296|NCT00068692|6428372|P2|Step 1: Registration|Disese progression/relapse|0
1865297|NCT00068692|6428373|P1|Step 1: Registration|Disese progression/relapse|5
1865298|NCT00068601|6428396|P2|Overall Study|Missing primary outcome data|34
1865299|NCT00068601|6428397|P1|Overall Study|Missing primary outcome data|30
1865300|NCT00068601|6428396|P2|Overall Study|Lost to Follow-up|2
1865301|NCT00068601|6428397|P1|Overall Study|Lost to Follow-up|3
1865302|NCT00068601|6428396|P2|Overall Study|Death|3
1865303|NCT00068601|6428397|P1|Overall Study|Death|11
1865304|NCT00068601|6428396|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
1865305|NCT00068601|6428397|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
1865306|NCT00068601|6428396|P2|Overall Study|Not evaluable: withdrew consent|4
1865307|NCT00068601|6428397|P1|Overall Study|Not evaluable: withdrew consent|5
1865308|NCT00068601|6428396|P2|Overall Study|Ineligible|13
1865309|NCT00068601|6428397|P1|Overall Study|Ineligible|11
1865310|NCT00068588|6428410|P3|Overall Study|Poor KPS|1
1865311|NCT00068588|6428411|P2|Overall Study|Poor KPS|0
1865312|NCT00068588|6428412|P1|Overall Study|Poor KPS|0
1865313|NCT00068588|6428410|P3|Overall Study|Withdrawal by Subject|1
1865314|NCT00068588|6428411|P2|Overall Study|Withdrawal by Subject|0
1865315|NCT00068588|6428412|P1|Overall Study|Withdrawal by Subject|0
1865316|NCT00068588|6428410|P3|Overall Study|Adverse Event|2
1865317|NCT00068588|6428411|P2|Overall Study|Adverse Event|0
1865318|NCT00068588|6428412|P1|Overall Study|Adverse Event|0
1865319|NCT00068445|6428428|P2|Treatment|Other (Specifics not available)|5
1865320|NCT00068445|6428429|P1|Treatment|Other (Specifics not available)|9
1865321|NCT00068445|6428428|P2|Treatment|Adverse Event|1
1865322|NCT00068445|6428429|P1|Treatment|Adverse Event|7
1865323|NCT00068445|6428428|P2|Treatment|Refused Further Treatment|10
1865324|NCT00068445|6428429|P1|Treatment|Refused Further Treatment|13
1865325|NCT00068445|6428428|P2|Randomization|Ineligible|1
1865326|NCT00068445|6428429|P1|Randomization|Ineligible|1
1865327|NCT00068445|6428428|P2|Randomization|Cancel|3
1865328|NCT00068445|6428429|P1|Randomization|Cancel|1
1865335|NCT00068406|6428462|P1|Overall Study|Ineligible-Inadequate Pathology|2
1865336|NCT00068406|6428462|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
1865337|NCT00068393|6428467|P1|Overall Study|Quality of life worsening|1
1865338|NCT00068393|6428467|P1|Overall Study|Alternative treatment|1
1865339|NCT00068393|6428467|P1|Overall Study|Withdrawal by Subject|3
1865340|NCT00068393|6428467|P1|Overall Study|Death|3
1865341|NCT00068393|6428467|P1|Overall Study|Adverse Event|2
1865342|NCT00068380|6428473|P1|Overall Study|Adverse Event|2
1865343|NCT00068380|6428473|P1|Overall Study|Withdrawal by Subject|3
1865344|NCT00068250|6428517|P4|Phase I: Dose Level 2|Protocol Violation|0
1865345|NCT00068250|6428518|P3|Phase I: Dose Level 2|Protocol Violation|0
1865346|NCT00068250|6428519|P2|Phase I: Dose Level 2|Protocol Violation|1
1865347|NCT00068250|6428520|P1|Phase I: Dose Level 2|Protocol Violation|0
1865348|NCT00068237|6428530|P1|Overall Study|No protocol treatment received|2
1865349|NCT00068237|6428530|P1|Overall Study|Ineligible|3
1865350|NCT00068107|6428542|P1|Overall Study|Withdrawal by Subject|1
1865351|NCT00068107|6428542|P1|Overall Study|Death|2
1865352|NCT00068107|6428542|P1|Overall Study|end-stage renal disease|6
1865353|NCT00067990|6428555|P2|Overall Study|Withdrawal by Subject|12
1865354|NCT00067990|6428556|P1|Overall Study|Withdrawal by Subject|4
1865355|NCT00067990|6428555|P2|Overall Study|ESRD, Non IF/TA|3
1865356|NCT00067990|6428556|P1|Overall Study|ESRD, Non IF/TA|1
1865357|NCT00067990|6428555|P2|Overall Study|Death|7
1865358|NCT00067990|6428556|P1|Overall Study|Death|5
1865359|NCT00067470|6428579|P2|Overall Study|Withdrawal by Subject|1
1865360|NCT00067470|6428580|P1|Overall Study|Withdrawal by Subject|0
1865361|NCT00067002|6428601|P2|Overall Study|Graft Failure|6
1865362|NCT00067002|6428602|P1|Overall Study|Graft Failure|5
1865363|NCT00067002|6428601|P2|Overall Study|Delayed|1
1865364|NCT00067002|6428602|P1|Overall Study|Delayed|1
1865365|NCT00067002|6428601|P2|Overall Study|Early Death|2
1865366|NCT00067002|6428602|P1|Overall Study|Early Death|1
1865367|NCT00066807|6428660|P2|Overall Study|Study was terminated early|15
1865368|NCT00066807|6428661|P1|Overall Study|Study was terminated early|14
1865369|NCT00066742|6428686|P1|Consolidation Chemotherapy|Ineligible|2
1865370|NCT00066742|6428686|P1|Consolidation Chemotherapy|not protocol specified|1
1865371|NCT00066742|6428686|P1|Induction Chemoradiotherapy|Ineligible|3
1865372|NCT00066742|6428686|P1|Induction Chemoradiotherapy|not protocol specified|2
1865373|NCT00066742|6428686|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
1865374|NCT00066742|6428686|P1|Induction Chemoradiotherapy|Adverse Event|21
1865375|NCT00066742|6428686|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
1865376|NCT00066703|6428695|P2|Overall Study|Treatment ongoing|311
1865377|NCT00066703|6428696|P1|Overall Study|Treatment ongoing|346
1865378|NCT00066703|6428695|P2|Overall Study|Withdrawal by Subject|63
1865379|NCT00066703|6428696|P1|Overall Study|Withdrawal by Subject|38
1865380|NCT00066703|6428695|P2|Overall Study|Lost to Follow-up|28
1865381|NCT00066703|6428696|P1|Overall Study|Lost to Follow-up|31
1865382|NCT00066703|6428695|P2|Overall Study|Lack of Efficacy|69
1865383|NCT00066703|6428696|P1|Overall Study|Lack of Efficacy|114
1865384|NCT00066703|6428695|P2|Overall Study|Death|0
1865385|NCT00066703|6428696|P1|Overall Study|Death|3
1865386|NCT00066703|6428695|P2|Overall Study|Adverse Event|111
1865387|NCT00066703|6428696|P1|Overall Study|Adverse Event|80
1865388|NCT00066690|6428711|P3|Overall Study|Treatment Ongoing|282
1865389|NCT00066690|6428712|P2|Overall Study|Treatment Ongoing|278
1865390|NCT00066690|6428713|P1|Overall Study|Treatment Ongoing|246
1865391|NCT00066690|6428711|P3|Overall Study|Withdrawal by Subject|49
1865392|NCT00066690|6428712|P2|Overall Study|Withdrawal by Subject|55
1865393|NCT00066690|6428713|P1|Overall Study|Withdrawal by Subject|50
1865394|NCT00066690|6428711|P3|Overall Study|Lost to Follow-up|29
1865395|NCT00066690|6428712|P2|Overall Study|Lost to Follow-up|21
1865396|NCT00066690|6428713|P1|Overall Study|Lost to Follow-up|40
1865397|NCT00066690|6428711|P3|Overall Study|Lack of Efficacy|76
1865398|NCT00066690|6428712|P2|Overall Study|Lack of Efficacy|110
1865399|NCT00066690|6428713|P1|Overall Study|Lack of Efficacy|114
1865400|NCT00066690|6428711|P3|Overall Study|Death|2
1865401|NCT00066690|6428712|P2|Overall Study|Death|0
1865402|NCT00066690|6428713|P1|Overall Study|Death|3
1865403|NCT00066690|6428711|P3|Overall Study|Adverse Event|126
1865404|NCT00066690|6428712|P2|Overall Study|Adverse Event|58
1865405|NCT00066690|6428713|P1|Overall Study|Adverse Event|145
1865406|NCT00066573|6428732|P2|Overall Study|Did not received protocol treatment|28
1865407|NCT00066573|6428733|P1|Overall Study|Did not received protocol treatment|28
1865408|NCT00066469|6428745|P1|Overall Study|ineligible|1
1865409|NCT00066469|6428745|P1|Overall Study|Withdrawal by Subject|1
1865410|NCT00066469|6428745|P1|Overall Study|Physician Decision|1
1865411|NCT00066469|6428745|P1|Overall Study|Lost to Follow-up|1
1865412|NCT00066469|6428745|P1|Overall Study|Lack of Efficacy|9
1865413|NCT00066469|6428745|P1|Overall Study|Death|3
1865414|NCT00066365|6428751|P2|Overall Study|Ineligible|2
1865415|NCT00066365|6428752|P1|Overall Study|Ineligible|4
1865416|NCT00066365|6428751|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
1865417|NCT00066365|6428752|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
1865418|NCT00066365|6428751|P2|Overall Study|Physician Decision|0
1865419|NCT00066365|6428752|P1|Overall Study|Physician Decision|1
1865420|NCT00066365|6428751|P2|Overall Study|Lack of Efficacy|12
1865421|NCT00066365|6428752|P1|Overall Study|Lack of Efficacy|15
1865422|NCT00066365|6428751|P2|Overall Study|Adverse Event|0
1865423|NCT00066365|6428752|P1|Overall Study|Adverse Event|1
1865424|NCT00066222|6428780|P1|Overall Study|No protocol treatment received|1
1865425|NCT00066170|6428793|P4|Overall Study|Other|0
1865426|NCT00066170|6428794|P3|Overall Study|Other|2
1865427|NCT00066170|6428795|P2|Overall Study|Other|5
1865428|NCT00066170|6428796|P1|Overall Study|Other|1
1865429|NCT00066170|6428793|P4|Overall Study|Protocol Violation|0
1865430|NCT00066170|6428794|P3|Overall Study|Protocol Violation|0
1865431|NCT00066170|6428795|P2|Overall Study|Protocol Violation|0
1865432|NCT00066170|6428796|P1|Overall Study|Protocol Violation|3
1865433|NCT00066170|6428793|P4|Overall Study|Non-Compliance with Trial Medicine|1
1865434|NCT00066170|6428794|P3|Overall Study|Non-Compliance with Trial Medicine|0
1865435|NCT00066170|6428795|P2|Overall Study|Non-Compliance with Trial Medicine|0
1865436|NCT00066170|6428796|P1|Overall Study|Non-Compliance with Trial Medicine|1
1865437|NCT00066170|6428793|P4|Overall Study|Lost to Follow-up|0
1865438|NCT00066170|6428794|P3|Overall Study|Lost to Follow-up|0
1865439|NCT00066170|6428795|P2|Overall Study|Lost to Follow-up|1
1865440|NCT00066170|6428796|P1|Overall Study|Lost to Follow-up|0
1865441|NCT00066170|6428793|P4|Overall Study|Serious Adverse Event|1
1865442|NCT00066170|6428794|P3|Overall Study|Serious Adverse Event|1
1865443|NCT00066170|6428795|P2|Overall Study|Serious Adverse Event|0
1865444|NCT00066170|6428796|P1|Overall Study|Serious Adverse Event|0
1865445|NCT00066170|6428793|P4|Overall Study|Adverse Event|7
1865446|NCT00066170|6428794|P3|Overall Study|Adverse Event|1
1865447|NCT00066170|6428795|P2|Overall Study|Adverse Event|4
1865448|NCT00066170|6428796|P1|Overall Study|Adverse Event|2
1865449|NCT00066066|6428809|P6|Overall Study|Lost to Follow-up|5
1865450|NCT00066066|6428810|P5|Overall Study|Lost to Follow-up|3
1865451|NCT00066066|6428811|P4|Overall Study|Lost to Follow-up|4
1865452|NCT00066066|6428812|P3|Overall Study|Lost to Follow-up|7
1865453|NCT00066066|6428813|P2|Overall Study|Lost to Follow-up|4
1865454|NCT00066066|6428814|P1|Overall Study|Lost to Follow-up|6
1865455|NCT00065507|6428892|P2|Overall Study|Subject No Longer Meets Study Criteria|0
1865456|NCT00065507|6428893|P1|Overall Study|Subject No Longer Meets Study Criteria|1
1865457|NCT00065507|6428892|P2|Overall Study|Subject Withdrew Consent|1
1865458|NCT00065507|6428893|P1|Overall Study|Subject Withdrew Consent|2
1865459|NCT00065507|6428892|P2|Overall Study|Lost to Follow-up|0
1865460|NCT00065507|6428893|P1|Overall Study|Lost to Follow-up|3
1865461|NCT00065507|6428892|P2|Overall Study|Poor/Non-compliance|2
1865462|NCT00065507|6428893|P1|Overall Study|Poor/Non-compliance|3
1865463|NCT00065507|6428892|P2|Overall Study|Lack of Efficacy|6
1865464|NCT00065507|6428893|P1|Overall Study|Lack of Efficacy|0
1865465|NCT00065507|6428892|P2|Overall Study|Adverse Event|3
1865466|NCT00065507|6428893|P1|Overall Study|Adverse Event|4
1865467|NCT00065507|6428892|P2|Overall Study|Death|17
1865468|NCT00065507|6428893|P1|Overall Study|Death|16
1865469|NCT00065468|6428958|P3|Overall Study|Other|18
1865470|NCT00065468|6428959|P2|Overall Study|Other|24
1865471|NCT00065468|6428960|P1|Overall Study|Other|14
1865472|NCT00065468|6428958|P3|Overall Study|Disease progression|1
1865473|NCT00065468|6428959|P2|Overall Study|Disease progression|0
1865474|NCT00065468|6428960|P1|Overall Study|Disease progression|0
1865475|NCT00065468|6428958|P3|Overall Study|Discontinuation of study by Sponsor|13
1865476|NCT00065468|6428959|P2|Overall Study|Discontinuation of study by Sponsor|9
1865477|NCT00065468|6428960|P1|Overall Study|Discontinuation of study by Sponsor|13
1865478|NCT00065468|6428958|P3|Overall Study|Lost to Follow-up|2
1865479|NCT00065468|6428959|P2|Overall Study|Lost to Follow-up|3
1865480|NCT00065468|6428960|P1|Overall Study|Lost to Follow-up|5
1865481|NCT00065468|6428958|P3|Overall Study|Withdrawal by Subject|5
1865482|NCT00065468|6428959|P2|Overall Study|Withdrawal by Subject|4
1865483|NCT00065468|6428960|P1|Overall Study|Withdrawal by Subject|3
1865484|NCT00065468|6428958|P3|Overall Study|Death|171
1865485|NCT00065468|6428959|P2|Overall Study|Death|169
1865486|NCT00065468|6428960|P1|Overall Study|Death|172
1865487|NCT00065442|6428991|P2|Overall Study|Withdrawal by Subject|9
1865488|NCT00065442|6428992|P1|Overall Study|Withdrawal by Subject|3
1865489|NCT00065442|6428991|P2|Overall Study|Death|210
1865490|NCT00065442|6428992|P1|Overall Study|Death|121
1865491|NCT00065442|6428991|P2|Overall Study|Lost to Follow-up|1
1865492|NCT00065442|6428992|P1|Overall Study|Lost to Follow-up|1
1865493|NCT00065429|6429007|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1865494|NCT00065429|6429008|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1865495|NCT00065429|6429009|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
1865496|NCT00065429|6429010|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1865497|NCT00065429|6429011|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1865498|NCT00065429|6429012|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1865499|NCT00065429|6429013|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
1865500|NCT00065429|6429007|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1865501|NCT00065429|6429008|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1865502|NCT00065429|6429009|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
1865503|NCT00065429|6429010|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1865504|NCT00065429|6429011|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1865505|NCT00065429|6429012|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1865506|NCT00065429|6429013|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
1865507|NCT00065429|6429007|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
1865508|NCT00065429|6429008|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
1865509|NCT00065429|6429009|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
1865510|NCT00065429|6429010|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
1865511|NCT00065429|6429011|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
1865512|NCT00065429|6429012|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
1865513|NCT00065429|6429013|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
1865514|NCT00065429|6429007|P7|Phase I - May 2001 - Oct 2002|Death|0
1865515|NCT00065429|6429008|P6|Phase I - May 2001 - Oct 2002|Death|0
1865516|NCT00065429|6429009|P5|Phase I - May 2001 - Oct 2002|Death|1
1865517|NCT00065429|6429010|P4|Phase I - May 2001 - Oct 2002|Death|0
1865518|NCT00065429|6429011|P3|Phase I - May 2001 - Oct 2002|Death|0
1865519|NCT00065429|6429012|P2|Phase I - May 2001 - Oct 2002|Death|0
1865520|NCT00065429|6429013|P1|Phase I - May 2001 - Oct 2002|Death|0
1865521|NCT00065429|6429007|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
1865522|NCT00065429|6429008|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
1865523|NCT00065429|6429009|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
1865524|NCT00065429|6429010|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
1865525|NCT00065429|6429011|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
1865526|NCT00065429|6429012|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
1865527|NCT00065429|6429013|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
1865528|NCT00065429|6429007|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1865529|NCT00065429|6429008|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1865530|NCT00065429|6429009|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1865531|NCT00065429|6429010|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1865532|NCT00065429|6429011|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
1865533|NCT00065429|6429012|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1865534|NCT00065429|6429013|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
1865535|NCT00065429|6429007|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1865536|NCT00065429|6429008|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
1865537|NCT00065429|6429009|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1865538|NCT00065429|6429010|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1865539|NCT00065429|6429011|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1865540|NCT00065429|6429012|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1865541|NCT00065429|6429013|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
1865542|NCT00065260|6429027|P2|Overall Study|Death|1
1865543|NCT00065260|6429028|P1|Overall Study|Death|0
1865544|NCT00065182|6429036|P2|Overall Study|Decline in Status|1
1865545|NCT00065182|6429037|P1|Overall Study|Decline in Status|0
1865546|NCT00065182|6429036|P2|Overall Study|Death|1
1865547|NCT00065182|6429037|P1|Overall Study|Death|0
1865548|NCT00065182|6429036|P2|Overall Study|No clinical benefit|0
1865549|NCT00065182|6429037|P1|Overall Study|No clinical benefit|1
1865550|NCT00065182|6429036|P2|Overall Study|Withdrawal by Subject|3
1865551|NCT00065182|6429037|P1|Overall Study|Withdrawal by Subject|8
1865552|NCT00065182|6429036|P2|Overall Study|Sponsor Decision|7
1865553|NCT00065182|6429037|P1|Overall Study|Sponsor Decision|11
1865554|NCT00065182|6429036|P2|Overall Study|Serious adverse events (SAE)|0
1865555|NCT00065182|6429037|P1|Overall Study|Serious adverse events (SAE)|1
1865556|NCT00065182|6429036|P2|Overall Study|Protocol Violation|4
1865557|NCT00065182|6429037|P1|Overall Study|Protocol Violation|3
1865558|NCT00065182|6429036|P2|Overall Study|Lost to Follow-up|4
1865559|NCT00065182|6429037|P1|Overall Study|Lost to Follow-up|0
1865560|NCT00065182|6429036|P2|Overall Study|Adverse Event|17
1865561|NCT00065182|6429037|P1|Overall Study|Adverse Event|24
1865562|NCT00065156|6429063|P1|Overall Study|Secondary Malign Disease|1
1865563|NCT00065156|6429063|P1|Overall Study|Loss of Response|1
1865564|NCT00065156|6429063|P1|Overall Study|Non-Compliance|2
1865565|NCT00065156|6429063|P1|Overall Study|Investigator Decision|2
1865566|NCT00065156|6429063|P1|Overall Study|Disease Progression|7
1865567|NCT00065156|6429063|P1|Overall Study|Study Closed by Sponsor|2
1865568|NCT00065156|6429063|P1|Overall Study|Death|11
1865569|NCT00065156|6429063|P1|Overall Study|Lost to Follow-up|1
1865570|NCT00065156|6429063|P1|Overall Study|Withdrawal by Subject|8
1865571|NCT00065156|6429063|P1|Overall Study|Lack of Efficacy|52
1865572|NCT00065156|6429063|P1|Overall Study|Adverse Event|37
1865573|NCT00065065|6429080|P2|Overall Study|Other|2
1865574|NCT00065065|6429081|P1|Overall Study|Other|2
1865575|NCT00065065|6429080|P2|Overall Study|Lack of Efficacy|11
1865576|NCT00065065|6429081|P1|Overall Study|Lack of Efficacy|4
1865577|NCT00065065|6429080|P2|Overall Study|Withdrawal by Subject|5
1865578|NCT00065065|6429081|P1|Overall Study|Withdrawal by Subject|1
1865579|NCT00065065|6429080|P2|Overall Study|Adverse Event|2
1865580|NCT00065065|6429081|P1|Overall Study|Adverse Event|3
1865581|NCT00003895|6429093|P2|Overall Study|Withdrawal by Subject|3
1865582|NCT00003895|6429094|P1|Overall Study|Withdrawal by Subject|0
1865583|NCT00003895|6429093|P2|Overall Study|Patient Vacation|0
1865584|NCT00003895|6429094|P1|Overall Study|Patient Vacation|2
1865585|NCT00003895|6429093|P2|Overall Study|Lack of Efficacy|1
1865586|NCT00003895|6429094|P1|Overall Study|Lack of Efficacy|1
1865587|NCT00003895|6429093|P2|Overall Study|Adverse Event|0
1865588|NCT00003895|6429094|P1|Overall Study|Adverse Event|4
1865589|NCT00064987|6429102|P2|Overall Study|Physician Decision|0
1865590|NCT00064987|6429103|P1|Overall Study|Physician Decision|3
1865591|NCT00064753|6429134|P2|Overall Study|Lost to Follow-up|235
1865592|NCT00064753|6429135|P1|Overall Study|Lost to Follow-up|225
1865593|NCT00064753|6429134|P2|Overall Study|Withdrawal by Subject|171
1865594|NCT00064753|6429135|P1|Overall Study|Withdrawal by Subject|198
1865595|NCT00064753|6429134|P2|Overall Study|Death|242
1865596|NCT00064753|6429135|P1|Overall Study|Death|251
1865597|NCT00064792|6429165|P2|Overall Study|Adverse Event|0
1865598|NCT00064792|6429166|P1|Overall Study|Adverse Event|3
1865599|NCT00064792|6429165|P2|Overall Study|Withdrawal by Subject|0
1865600|NCT00064792|6429166|P1|Overall Study|Withdrawal by Subject|2
1865601|NCT00064701|6429177|P3|Clinical Continuation Phase|Patient opted out|1
1865602|NCT00064701|6429178|P2|Clinical Continuation Phase|Patient opted out|0
1865603|NCT00064701|6429179|P1|Clinical Continuation Phase|Patient opted out|0
1865604|NCT00064701|6429177|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
1865605|NCT00064701|6429178|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
1865606|NCT00064701|6429179|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
1865607|NCT00064701|6429177|P3|Clinical Continuation Phase|Discharged to nursing home|0
1865608|NCT00064701|6429178|P2|Clinical Continuation Phase|Discharged to nursing home|1
1865609|NCT00064701|6429179|P1|Clinical Continuation Phase|Discharged to nursing home|0
1865610|NCT00064701|6429177|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1865611|NCT00064701|6429178|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
1865612|NCT00064701|6429179|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
1865613|NCT00064701|6429177|P3|Clinical Continuation Phase|Pancreas transplant|0
1865614|NCT00064701|6429178|P2|Clinical Continuation Phase|Pancreas transplant|0
1865615|NCT00064701|6429179|P1|Clinical Continuation Phase|Pancreas transplant|1
1865616|NCT00064701|6429177|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
1865617|NCT00064701|6429178|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
1865618|NCT00064701|6429179|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
1865619|NCT00064701|6429177|P3|Clinical Continuation Phase|Physician Decision|0
1865620|NCT00064701|6429178|P2|Clinical Continuation Phase|Physician Decision|3
1865621|NCT00064701|6429179|P1|Clinical Continuation Phase|Physician Decision|1
1865622|NCT00064701|6429177|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
1865623|NCT00064701|6429178|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
1865624|NCT00064701|6429179|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
1865625|NCT00064701|6429177|P3|Clinical Continuation Phase|Sponsor discontinued study|79
1865626|NCT00064701|6429178|P2|Clinical Continuation Phase|Sponsor discontinued study|129
1865627|NCT00064701|6429179|P1|Clinical Continuation Phase|Sponsor discontinued study|113
1865628|NCT00064701|6429177|P3|Clinical Continuation Phase|Rejection|2
1865629|NCT00064701|6429178|P2|Clinical Continuation Phase|Rejection|2
1865630|NCT00064701|6429179|P1|Clinical Continuation Phase|Rejection|1
1865631|NCT00064701|6429177|P3|Clinical Continuation Phase|Graft Failure|2
1865632|NCT00064701|6429178|P2|Clinical Continuation Phase|Graft Failure|5
1865633|NCT00064701|6429179|P1|Clinical Continuation Phase|Graft Failure|5
1865634|NCT00064701|6429177|P3|Clinical Continuation Phase|Lost to Follow-up|6
1865635|NCT00064701|6429178|P2|Clinical Continuation Phase|Lost to Follow-up|3
1865636|NCT00064701|6429179|P1|Clinical Continuation Phase|Lost to Follow-up|6
1865637|NCT00064701|6429177|P3|Clinical Continuation Phase|Withdrawal by Subject|22
1865638|NCT00064701|6429178|P2|Clinical Continuation Phase|Withdrawal by Subject|3
1865639|NCT00064701|6429179|P1|Clinical Continuation Phase|Withdrawal by Subject|22
1865640|NCT00064701|6429177|P3|Clinical Continuation Phase|Non-compliance|7
1865641|NCT00064701|6429178|P2|Clinical Continuation Phase|Non-compliance|6
1865642|NCT00064701|6429179|P1|Clinical Continuation Phase|Non-compliance|8
1865643|NCT00064701|6429177|P3|Clinical Continuation Phase|Adverse Event|14
1865644|NCT00064701|6429178|P2|Clinical Continuation Phase|Adverse Event|21
1865645|NCT00064701|6429179|P1|Clinical Continuation Phase|Adverse Event|12
1865646|NCT00064701|6429177|P3|One Year Post-transplant|Pancreas transplant|1
1865647|NCT00064701|6429178|P2|One Year Post-transplant|Pancreas transplant|0
1865648|NCT00064701|6429179|P1|One Year Post-transplant|Pancreas transplant|0
1865649|NCT00064701|6429177|P3|One Year Post-transplant|Poor absorption|0
1865650|NCT00064701|6429178|P2|One Year Post-transplant|Poor absorption|1
1865651|NCT00064701|6429179|P1|One Year Post-transplant|Poor absorption|0
1865652|NCT00064701|6429177|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
1865653|NCT00064701|6429178|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
1865654|NCT00064701|6429179|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
1865655|NCT00064701|6429177|P3|One Year Post-transplant|Incorrect study drug dispensed|0
1865656|NCT00064701|6429178|P2|One Year Post-transplant|Incorrect study drug dispensed|1
1865657|NCT00064701|6429179|P1|One Year Post-transplant|Incorrect study drug dispensed|0
1865658|NCT00064701|6429177|P3|One Year Post-transplant|Acute tubular necrosis|0
1865659|NCT00064701|6429178|P2|One Year Post-transplant|Acute tubular necrosis|0
1865660|NCT00064701|6429179|P1|One Year Post-transplant|Acute tubular necrosis|1
1865661|NCT00064701|6429177|P3|One Year Post-transplant|Converted to rapamycin|0
1865662|NCT00064701|6429178|P2|One Year Post-transplant|Converted to rapamycin|0
1865663|NCT00064701|6429179|P1|One Year Post-transplant|Converted to rapamycin|1
1865664|NCT00064701|6429177|P3|One Year Post-transplant|Lost to Follow-up|0
1865665|NCT00064701|6429178|P2|One Year Post-transplant|Lost to Follow-up|0
1865666|NCT00064701|6429179|P1|One Year Post-transplant|Lost to Follow-up|1
1865667|NCT00064701|6429177|P3|One Year Post-transplant|Withdrawal by Subject|1
1865668|NCT00064701|6429178|P2|One Year Post-transplant|Withdrawal by Subject|4
1865669|NCT00064701|6429179|P1|One Year Post-transplant|Withdrawal by Subject|0
1865670|NCT00064701|6429177|P3|One Year Post-transplant|Graft Failure|1
1865671|NCT00064701|6429178|P2|One Year Post-transplant|Graft Failure|2
1865672|NCT00064701|6429179|P1|One Year Post-transplant|Graft Failure|3
1865673|NCT00064701|6429177|P3|One Year Post-transplant|Non-compliance|5
1865674|NCT00064701|6429178|P2|One Year Post-transplant|Non-compliance|2
1865675|NCT00064701|6429179|P1|One Year Post-transplant|Non-compliance|4
1865676|NCT00064701|6429177|P3|One Year Post-transplant|Rejection|16
1865677|NCT00064701|6429178|P2|One Year Post-transplant|Rejection|1
1865678|NCT00064701|6429179|P1|One Year Post-transplant|Rejection|0
1865679|NCT00064701|6429177|P3|One Year Post-transplant|Adverse Event|37
1865680|NCT00064701|6429178|P2|One Year Post-transplant|Adverse Event|19
1865681|NCT00064701|6429179|P1|One Year Post-transplant|Adverse Event|23
1865682|NCT00064701|6429177|P3|One Year Post-transplant|Did not receive study drug|11
1865683|NCT00064701|6429178|P2|One Year Post-transplant|Did not receive study drug|12
1865684|NCT00064701|6429179|P1|One Year Post-transplant|Did not receive study drug|7
1865685|NCT00064662|6429231|P2|Overall Study|Administratively withdrawn|2
1865686|NCT00064662|6429232|P1|Overall Study|Administratively withdrawn|2
1865687|NCT00064662|6429231|P2|Overall Study|Withdrawal by Subject|14
1865688|NCT00064662|6429232|P1|Overall Study|Withdrawal by Subject|14
1865689|NCT00064662|6429231|P2|Overall Study|Lost to Follow-up|44
1865690|NCT00064662|6429232|P1|Overall Study|Lost to Follow-up|57
1865691|NCT00064662|6429231|P2|Overall Study|Death|1
1865692|NCT00064662|6429232|P1|Overall Study|Death|1
1865693|NCT00064350|6429243|P3|Cross-Over|Other|0
1865694|NCT00064350|6429244|P2|Cross-Over|Other|2
1865695|NCT00064350|6429245|P1|Cross-Over|Other|0
1865696|NCT00064350|6429243|P3|Cross-Over|Ineligible or never started treatment|0
1865697|NCT00064350|6429244|P2|Cross-Over|Ineligible or never started treatment|6
1865698|NCT00064350|6429245|P1|Cross-Over|Ineligible or never started treatment|3
1865699|NCT00064350|6429243|P3|Cross-Over|Withdrawal by Subject|0
1865700|NCT00064350|6429244|P2|Cross-Over|Withdrawal by Subject|2
1865701|NCT00064350|6429245|P1|Cross-Over|Withdrawal by Subject|2
1865702|NCT00064350|6429243|P3|Cross-Over|Death|0
1865703|NCT00064350|6429244|P2|Cross-Over|Death|3
1865704|NCT00064350|6429245|P1|Cross-Over|Death|1
1865705|NCT00064350|6429243|P3|Cross-Over|Adverse Event|0
1865706|NCT00064350|6429244|P2|Cross-Over|Adverse Event|1
1865707|NCT00064350|6429245|P1|Cross-Over|Adverse Event|0
1865708|NCT00064350|6429243|P3|Randomization|Other|0
1865709|NCT00064350|6429244|P2|Randomization|Other|0
1865710|NCT00064350|6429245|P1|Randomization|Other|5
1865711|NCT00064350|6429243|P3|Randomization|Ineligible or never started treatment|0
1865712|NCT00064350|6429244|P2|Randomization|Ineligible or never started treatment|15
1865713|NCT00064350|6429245|P1|Randomization|Ineligible or never started treatment|9
1865714|NCT00064350|6429243|P3|Randomization|Withdrawal by Subject|0
1865715|NCT00064350|6429244|P2|Randomization|Withdrawal by Subject|0
1865716|NCT00064350|6429245|P1|Randomization|Withdrawal by Subject|1
1865717|NCT00064350|6429243|P3|Randomization|Death|0
1865718|NCT00064350|6429244|P2|Randomization|Death|0
1865719|NCT00064350|6429245|P1|Randomization|Death|3
1865720|NCT00064350|6429243|P3|Randomization|Adverse Event|0
1865721|NCT00064350|6429244|P2|Randomization|Adverse Event|3
1865722|NCT00064350|6429245|P1|Randomization|Adverse Event|8
1865723|NCT00064350|6429243|P3|Induction Treatment|Other|13
1865724|NCT00064350|6429244|P2|Induction Treatment|Other|0
1865725|NCT00064350|6429245|P1|Induction Treatment|Other|0
1865726|NCT00064350|6429243|P3|Induction Treatment|Ineligible or never started treatment|34
1865727|NCT00064350|6429244|P2|Induction Treatment|Ineligible or never started treatment|6
1865728|NCT00064350|6429245|P1|Induction Treatment|Ineligible or never started treatment|3
1865729|NCT00064350|6429243|P3|Induction Treatment|Withdrawal by Subject|21
1865730|NCT00064350|6429244|P2|Induction Treatment|Withdrawal by Subject|0
1865731|NCT00064350|6429245|P1|Induction Treatment|Withdrawal by Subject|0
1865732|NCT00064350|6429243|P3|Induction Treatment|Death|9
1865733|NCT00064350|6429244|P2|Induction Treatment|Death|0
1865734|NCT00064350|6429245|P1|Induction Treatment|Death|0
1865735|NCT00064350|6429243|P3|Induction Treatment|Adverse Event|49
1865736|NCT00064350|6429244|P2|Induction Treatment|Adverse Event|2
1865737|NCT00064350|6429245|P1|Induction Treatment|Adverse Event|0
1865738|NCT00064350|6429243|P3|Induction Treatment|Disease Progression|110
1865739|NCT00064350|6429244|P2|Induction Treatment|Disease Progression|1
1865740|NCT00064350|6429245|P1|Induction Treatment|Disease Progression|5
1865741|NCT00064337|6429260|P1|Maintenance|Death|1
1865742|NCT00064337|6429260|P1|Maintenance|Not protocol-specified|2
1865743|NCT00064337|6429260|P1|Maintenance|On treatment at time of analysis|2
1865744|NCT00064337|6429260|P1|Maintenance|Progression|2
1865745|NCT00064337|6429260|P1|Maintenance|Adverse Event|3
1865746|NCT00064337|6429260|P1|Transplant|Progression|2
1865747|NCT00064337|6429260|P1|Transplant|Patient Refusal|2
1865748|NCT00064337|6429260|P1|Transplant|Death|3
1865749|NCT00064337|6429260|P1|Transplant|Not protocol-specified|5
1865750|NCT00064337|6429260|P1|Transplant|Adverse Event|9
1865751|NCT00064337|6429260|P1|PBSCC or Induction/PBSCC|Death|2
1865752|NCT00064337|6429260|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
1865753|NCT00064337|6429260|P1|PBSCC or Induction/PBSCC|Progression|3
1865754|NCT00064337|6429260|P1|PBSCC or Induction/PBSCC|Adverse Event|6
1865755|NCT00064337|6429260|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
1865756|NCT00064298|6429269|P2|Overall Study|Disease Progression|1
1865757|NCT00064298|6429270|P1|Overall Study|Disease Progression|2
1865758|NCT00064298|6429269|P2|Overall Study|Death|1
1865759|NCT00064298|6429270|P1|Overall Study|Death|0
1865760|NCT00064298|6429269|P2|Overall Study|Lost to Follow-up|2
1865761|NCT00064298|6429270|P1|Overall Study|Lost to Follow-up|2
1865762|NCT00064298|6429269|P2|Overall Study|Withdrawal by Subject|1
1865763|NCT00064298|6429270|P1|Overall Study|Withdrawal by Subject|2
1865764|NCT00064259|6429278|P4|Overall Study|Adverse Event|1
1865765|NCT00064259|6429279|P3|Overall Study|Adverse Event|0
1865766|NCT00064259|6429280|P2|Overall Study|Adverse Event|0
1865767|NCT00064259|6429281|P1|Overall Study|Adverse Event|1
1865768|NCT00064077|6429289|P4|Overall Study|Other reasons|2
1865769|NCT00064077|6429290|P3|Overall Study|Other reasons|1
1865770|NCT00064077|6429291|P2|Overall Study|Other reasons|2
1865771|NCT00064077|6429292|P1|Overall Study|Other reasons|2
1865772|NCT00064077|6429289|P4|Overall Study|No tumor|0
1865773|NCT00064077|6429290|P3|Overall Study|No tumor|1
1865774|NCT00064077|6429291|P2|Overall Study|No tumor|0
1865775|NCT00064077|6429292|P1|Overall Study|No tumor|0
1865776|NCT00064077|6429289|P4|Overall Study|No surgery|0
1865777|NCT00064077|6429290|P3|Overall Study|No surgery|1
1865778|NCT00064077|6429291|P2|Overall Study|No surgery|0
1865779|NCT00064077|6429292|P1|Overall Study|No surgery|0
1865780|NCT00064077|6429289|P4|Overall Study|Pathology|4
1865781|NCT00064077|6429290|P3|Overall Study|Pathology|3
1865782|NCT00064077|6429291|P2|Overall Study|Pathology|7
1865783|NCT00064077|6429292|P1|Overall Study|Pathology|10
1865784|NCT00064077|6429289|P4|Overall Study|Poor risk|1
1865785|NCT00064077|6429290|P3|Overall Study|Poor risk|1
1865786|NCT00064077|6429291|P2|Overall Study|Poor risk|0
1865787|NCT00064077|6429292|P1|Overall Study|Poor risk|2
1865788|NCT00064077|6429289|P4|Overall Study|Improper prior treatment|0
1865789|NCT00064077|6429290|P3|Overall Study|Improper prior treatment|0
1865790|NCT00064077|6429291|P2|Overall Study|Improper prior treatment|0
1865791|NCT00064077|6429292|P1|Overall Study|Improper prior treatment|1
1865792|NCT00064025|6429336|P1|Overall Study|Inevaluable|3
1865793|NCT00064025|6429336|P1|Overall Study|Ineligible|4
1865794|NCT00063999|6429345|P2|Overall Study|Ineligible|24
1865795|NCT00063999|6429346|P1|Overall Study|Ineligible|44
1865796|NCT00063999|6429345|P2|Overall Study|Withdrawal by Subject|0
1865797|NCT00063999|6429346|P1|Overall Study|Withdrawal by Subject|1
1865798|NCT00063986|6429362|P1|Overall Study|Intra-operatively ineligible|4
1865799|NCT00063986|6429362|P1|Overall Study|Ineligible|1
1865800|NCT00063986|6429362|P1|Overall Study|Withdrawal by Subject|1
1865801|NCT00063934|6429374|P1|Overall Study|Ineligible|1
1865802|NCT00063882|6429383|P2|Overall Study|Withdrawal by Subject|1
1865803|NCT00063882|6429384|P1|Overall Study|Withdrawal by Subject|2
1865804|NCT00063882|6429383|P2|Overall Study|Protocol Violation|3
1865805|NCT00063882|6429384|P1|Overall Study|Protocol Violation|3
1865806|NCT00063258|6429511|P2|Overall Study|Lack of Efficacy|0
1865807|NCT00063258|6429512|P1|Overall Study|Lack of Efficacy|2
1865808|NCT00063258|6429511|P2|Overall Study|Physician Decision|0
1865809|NCT00063258|6429512|P1|Overall Study|Physician Decision|2
1865810|NCT00063154|6429518|P1|Overall Study|Did not receive treatment|8
1865811|NCT00063154|6429518|P1|Overall Study|Reason unspecified|1
1865812|NCT00063154|6429518|P1|Overall Study|Death|3
1865813|NCT00063154|6429518|P1|Overall Study|Physician Decision|10
1865814|NCT00063154|6429518|P1|Overall Study|Adverse Event|2
1865815|NCT00063154|6429518|P1|Overall Study|Disease progression|27
1865816|NCT00062868|6429552|P21|Dose Level 3|Withdrew|0
1865817|NCT00062868|6429553|P20|Dose Level 3|Withdrew|0
1865818|NCT00062868|6429554|P19|Dose Level 3|Withdrew|0
1865819|NCT00062868|6429555|P18|Dose Level 3|Withdrew|0
1865820|NCT00062868|6429556|P17|Dose Level 3|Withdrew|0
1865821|NCT00062868|6429557|P16|Dose Level 3|Withdrew|0
1865822|NCT00062868|6429558|P15|Dose Level 3|Withdrew|0
1865823|NCT00062868|6429559|P14|Dose Level 3|Withdrew|0
1865824|NCT00062868|6429560|P13|Dose Level 3|Withdrew|0
1865825|NCT00062868|6429561|P12|Dose Level 3|Withdrew|0
1865826|NCT00062868|6429562|P11|Dose Level 3|Withdrew|0
1865827|NCT00062868|6429563|P10|Dose Level 3|Withdrew|0
1865828|NCT00062868|6429564|P9|Dose Level 3|Withdrew|0
1865829|NCT00062868|6429565|P8|Dose Level 3|Withdrew|0
1865830|NCT00062868|6429566|P7|Dose Level 3|Withdrew|0
1865831|NCT00062868|6429567|P6|Dose Level 3|Withdrew|0
1865832|NCT00062868|6429568|P5|Dose Level 3|Withdrew|0
1865833|NCT00062868|6429569|P4|Dose Level 3|Withdrew|0
1865834|NCT00062868|6429570|P3|Dose Level 3|Withdrew|2
1865835|NCT00062868|6429571|P2|Dose Level 3|Withdrew|0
1865836|NCT00062868|6429572|P1|Dose Level 3|Withdrew|0
1865837|NCT00062868|6429552|P21|Dose Level 3|Lost to Follow-up|0
1865838|NCT00062868|6429553|P20|Dose Level 3|Lost to Follow-up|0
1865839|NCT00062868|6429554|P19|Dose Level 3|Lost to Follow-up|0
1865840|NCT00062868|6429555|P18|Dose Level 3|Lost to Follow-up|0
1865841|NCT00062868|6429556|P17|Dose Level 3|Lost to Follow-up|0
1865842|NCT00062868|6429557|P16|Dose Level 3|Lost to Follow-up|0
1865843|NCT00062868|6429558|P15|Dose Level 3|Lost to Follow-up|1
1865844|NCT00062868|6429559|P14|Dose Level 3|Lost to Follow-up|0
1865845|NCT00062868|6429560|P13|Dose Level 3|Lost to Follow-up|0
1865846|NCT00062868|6429561|P12|Dose Level 3|Lost to Follow-up|0
1865847|NCT00062868|6429562|P11|Dose Level 3|Lost to Follow-up|0
1865848|NCT00062868|6429563|P10|Dose Level 3|Lost to Follow-up|0
1865849|NCT00062868|6429564|P9|Dose Level 3|Lost to Follow-up|0
1865850|NCT00062868|6429565|P8|Dose Level 3|Lost to Follow-up|0
1865851|NCT00062868|6429566|P7|Dose Level 3|Lost to Follow-up|0
1865852|NCT00062868|6429567|P6|Dose Level 3|Lost to Follow-up|0
1865853|NCT00062868|6429568|P5|Dose Level 3|Lost to Follow-up|0
1865854|NCT00062868|6429569|P4|Dose Level 3|Lost to Follow-up|0
1865855|NCT00062868|6429570|P3|Dose Level 3|Lost to Follow-up|0
1865856|NCT00062868|6429571|P2|Dose Level 3|Lost to Follow-up|0
1865857|NCT00062868|6429572|P1|Dose Level 3|Lost to Follow-up|0
1865858|NCT00062868|6429552|P21|Dose Level 3|Death|0
1865859|NCT00062868|6429553|P20|Dose Level 3|Death|0
1865860|NCT00062868|6429554|P19|Dose Level 3|Death|0
1865861|NCT00062868|6429555|P18|Dose Level 3|Death|1
1865862|NCT00062868|6429556|P17|Dose Level 3|Death|0
1865863|NCT00062868|6429557|P16|Dose Level 3|Death|0
1865864|NCT00062868|6429558|P15|Dose Level 3|Death|0
1865865|NCT00062868|6429559|P14|Dose Level 3|Death|0
1865866|NCT00062868|6429560|P13|Dose Level 3|Death|0
1865867|NCT00062868|6429561|P12|Dose Level 3|Death|1
1865868|NCT00062868|6429562|P11|Dose Level 3|Death|0
1865869|NCT00062868|6429563|P10|Dose Level 3|Death|0
1865870|NCT00062868|6429564|P9|Dose Level 3|Death|0
1865871|NCT00062868|6429565|P8|Dose Level 3|Death|0
1865872|NCT00062868|6429566|P7|Dose Level 3|Death|0
1865873|NCT00062868|6429567|P6|Dose Level 3|Death|0
1865874|NCT00062868|6429568|P5|Dose Level 3|Death|0
1865875|NCT00062868|6429569|P4|Dose Level 3|Death|0
1865876|NCT00062868|6429570|P3|Dose Level 3|Death|0
1865877|NCT00062868|6429571|P2|Dose Level 3|Death|0
1865878|NCT00062868|6429572|P1|Dose Level 3|Death|0
1865879|NCT00062868|6429552|P21|Dose Level 2|Lost to Follow-up|0
1865880|NCT00062868|6429553|P20|Dose Level 2|Lost to Follow-up|0
1865881|NCT00062868|6429554|P19|Dose Level 2|Lost to Follow-up|0
1865882|NCT00062868|6429555|P18|Dose Level 2|Lost to Follow-up|0
1865883|NCT00062868|6429556|P17|Dose Level 2|Lost to Follow-up|1
1865884|NCT00062868|6429557|P16|Dose Level 2|Lost to Follow-up|0
1865885|NCT00062868|6429558|P15|Dose Level 2|Lost to Follow-up|0
1865886|NCT00062868|6429559|P14|Dose Level 2|Lost to Follow-up|1
1865887|NCT00062868|6429560|P13|Dose Level 2|Lost to Follow-up|0
1865888|NCT00062868|6429561|P12|Dose Level 2|Lost to Follow-up|0
1865889|NCT00062868|6429562|P11|Dose Level 2|Lost to Follow-up|0
1865890|NCT00062868|6429563|P10|Dose Level 2|Lost to Follow-up|0
1865891|NCT00062868|6429564|P9|Dose Level 2|Lost to Follow-up|0
1865892|NCT00062868|6429565|P8|Dose Level 2|Lost to Follow-up|0
1865893|NCT00062868|6429566|P7|Dose Level 2|Lost to Follow-up|0
1865894|NCT00062868|6429567|P6|Dose Level 2|Lost to Follow-up|0
1865895|NCT00062868|6429568|P5|Dose Level 2|Lost to Follow-up|0
1865896|NCT00062868|6429569|P4|Dose Level 2|Lost to Follow-up|0
1865897|NCT00062868|6429570|P3|Dose Level 2|Lost to Follow-up|0
1865898|NCT00062868|6429571|P2|Dose Level 2|Lost to Follow-up|0
1865899|NCT00062868|6429572|P1|Dose Level 2|Lost to Follow-up|0
1865900|NCT00062868|6429552|P21|Dose Level 2|Death|0
1865901|NCT00062868|6429553|P20|Dose Level 2|Death|0
1865902|NCT00062868|6429554|P19|Dose Level 2|Death|0
1865903|NCT00062868|6429555|P18|Dose Level 2|Death|0
1865904|NCT00062868|6429556|P17|Dose Level 2|Death|2
1865905|NCT00062868|6429557|P16|Dose Level 2|Death|0
1865906|NCT00062868|6429558|P15|Dose Level 2|Death|0
1865907|NCT00062868|6429559|P14|Dose Level 2|Death|0
1865908|NCT00062868|6429560|P13|Dose Level 2|Death|0
1865909|NCT00062868|6429561|P12|Dose Level 2|Death|0
1865910|NCT00062868|6429562|P11|Dose Level 2|Death|1
1865911|NCT00062868|6429563|P10|Dose Level 2|Death|0
1865912|NCT00062868|6429564|P9|Dose Level 2|Death|0
1865913|NCT00062868|6429565|P8|Dose Level 2|Death|0
1865914|NCT00062868|6429566|P7|Dose Level 2|Death|0
1865915|NCT00062868|6429567|P6|Dose Level 2|Death|0
1865916|NCT00062868|6429568|P5|Dose Level 2|Death|2
1865917|NCT00062868|6429569|P4|Dose Level 2|Death|0
1865918|NCT00062868|6429570|P3|Dose Level 2|Death|0
1865919|NCT00062868|6429571|P2|Dose Level 2|Death|3
1865920|NCT00062868|6429572|P1|Dose Level 2|Death|0
1865921|NCT00062868|6429552|P21|Dose Level 1|Lost to Follow-up|1
1865922|NCT00062868|6429553|P20|Dose Level 1|Lost to Follow-up|0
1865923|NCT00062868|6429554|P19|Dose Level 1|Lost to Follow-up|2
1865924|NCT00062868|6429555|P18|Dose Level 1|Lost to Follow-up|0
1865925|NCT00062868|6429556|P17|Dose Level 1|Lost to Follow-up|0
1865926|NCT00062868|6429557|P16|Dose Level 1|Lost to Follow-up|0
1865927|NCT00062868|6429558|P15|Dose Level 1|Lost to Follow-up|0
1865928|NCT00062868|6429559|P14|Dose Level 1|Lost to Follow-up|0
1865929|NCT00062868|6429560|P13|Dose Level 1|Lost to Follow-up|1
1865930|NCT00062868|6429561|P12|Dose Level 1|Lost to Follow-up|0
1865931|NCT00062868|6429562|P11|Dose Level 1|Lost to Follow-up|0
1865932|NCT00062868|6429563|P10|Dose Level 1|Lost to Follow-up|0
1865933|NCT00062868|6429564|P9|Dose Level 1|Lost to Follow-up|0
1865934|NCT00062868|6429565|P8|Dose Level 1|Lost to Follow-up|0
1865935|NCT00062868|6429566|P7|Dose Level 1|Lost to Follow-up|0
1865936|NCT00062868|6429567|P6|Dose Level 1|Lost to Follow-up|0
1865937|NCT00062868|6429568|P5|Dose Level 1|Lost to Follow-up|0
1865938|NCT00062868|6429569|P4|Dose Level 1|Lost to Follow-up|0
1865939|NCT00062868|6429570|P3|Dose Level 1|Lost to Follow-up|0
1865940|NCT00062868|6429571|P2|Dose Level 1|Lost to Follow-up|0
1865941|NCT00062868|6429572|P1|Dose Level 1|Lost to Follow-up|0
1865942|NCT00062868|6429552|P21|Dose Level 1|Death|1
1865943|NCT00062868|6429553|P20|Dose Level 1|Death|0
1865944|NCT00062868|6429554|P19|Dose Level 1|Death|7
1865945|NCT00062868|6429555|P18|Dose Level 1|Death|0
1865946|NCT00062868|6429556|P17|Dose Level 1|Death|0
1865947|NCT00062868|6429557|P16|Dose Level 1|Death|0
1865948|NCT00062868|6429558|P15|Dose Level 1|Death|0
1865949|NCT00062868|6429559|P14|Dose Level 1|Death|0
1865950|NCT00062868|6429560|P13|Dose Level 1|Death|0
1865951|NCT00062868|6429561|P12|Dose Level 1|Death|0
1865952|NCT00062868|6429562|P11|Dose Level 1|Death|0
1865953|NCT00062868|6429563|P10|Dose Level 1|Death|0
1865954|NCT00062868|6429564|P9|Dose Level 1|Death|0
1865955|NCT00062868|6429565|P8|Dose Level 1|Death|0
1865956|NCT00062868|6429566|P7|Dose Level 1|Death|3
1865957|NCT00062868|6429567|P6|Dose Level 1|Death|0
1865958|NCT00062868|6429568|P5|Dose Level 1|Death|0
1865959|NCT00062868|6429569|P4|Dose Level 1|Death|2
1865960|NCT00062868|6429570|P3|Dose Level 1|Death|0
1865961|NCT00062868|6429571|P2|Dose Level 1|Death|0
1865962|NCT00062868|6429572|P1|Dose Level 1|Death|2
1865963|NCT00062751|6429671|P5|Overall Study|Death|0
1865964|NCT00062751|6429672|P4|Overall Study|Death|0
1865965|NCT00062751|6429673|P3|Overall Study|Death|1
1865966|NCT00062751|6429674|P2|Overall Study|Death|0
1865967|NCT00062751|6429675|P1|Overall Study|Death|1
1865968|NCT00062751|6429671|P5|Overall Study|Symptomatic deterioration|1
1865969|NCT00062751|6429672|P4|Overall Study|Symptomatic deterioration|0
1865970|NCT00062751|6429673|P3|Overall Study|Symptomatic deterioration|0
1865971|NCT00062751|6429674|P2|Overall Study|Symptomatic deterioration|1
1865972|NCT00062751|6429675|P1|Overall Study|Symptomatic deterioration|1
1865973|NCT00062751|6429671|P5|Overall Study|Withdrawal by Subject|0
1865974|NCT00062751|6429672|P4|Overall Study|Withdrawal by Subject|1
1865975|NCT00062751|6429673|P3|Overall Study|Withdrawal by Subject|2
1865976|NCT00062751|6429674|P2|Overall Study|Withdrawal by Subject|2
1865977|NCT00062751|6429675|P1|Overall Study|Withdrawal by Subject|1
1865978|NCT00062751|6429671|P5|Overall Study|Other|1
1865979|NCT00062751|6429672|P4|Overall Study|Other|0
1865980|NCT00062751|6429673|P3|Overall Study|Other|1
1865981|NCT00062751|6429674|P2|Overall Study|Other|3
1865982|NCT00062751|6429675|P1|Overall Study|Other|2
1865983|NCT00062751|6429671|P5|Overall Study|Adverse Event|2
1865984|NCT00062751|6429672|P4|Overall Study|Adverse Event|2
1865985|NCT00062751|6429673|P3|Overall Study|Adverse Event|2
1865986|NCT00062751|6429674|P2|Overall Study|Adverse Event|7
1865987|NCT00062751|6429675|P1|Overall Study|Adverse Event|4
1865988|NCT00062751|6429671|P5|Overall Study|Disease progression|2
1865989|NCT00062751|6429672|P4|Overall Study|Disease progression|2
1865990|NCT00062751|6429673|P3|Overall Study|Disease progression|24
1865991|NCT00062751|6429674|P2|Overall Study|Disease progression|17
1865992|NCT00062751|6429675|P1|Overall Study|Disease progression|24
1865993|NCT00062647|6429761|P2|Overall Study|Never received study treatment|1
1865994|NCT00062647|6429762|P1|Overall Study|Never received study treatment|1
1865995|NCT00062647|6429761|P2|Overall Study|Other|4
1865996|NCT00062647|6429762|P1|Overall Study|Other|4
1865997|NCT00062647|6429761|P2|Overall Study|Failed continuation criteria|2
1865998|NCT00062647|6429762|P1|Overall Study|Failed continuation criteria|4
1865999|NCT00062647|6429761|P2|Overall Study|Lost to Follow-up|2
1866000|NCT00062647|6429762|P1|Overall Study|Lost to Follow-up|1
1866001|NCT00062647|6429761|P2|Overall Study|Protocol Violation|0
1866002|NCT00062647|6429762|P1|Overall Study|Protocol Violation|1
1866003|NCT00062647|6429761|P2|Overall Study|Withdrawal by Subject|1
1866004|NCT00062647|6429762|P1|Overall Study|Withdrawal by Subject|2
1866005|NCT00062647|6429761|P2|Overall Study|Adverse Event|1
1866006|NCT00062647|6429762|P1|Overall Study|Adverse Event|1
1866007|NCT00062647|6429761|P2|Overall Study|Death|2
1866008|NCT00062647|6429762|P1|Overall Study|Death|2
1866009|NCT00062439|6429768|P1|Consolidation Chemotherapy|Adverse Event|2
1866010|NCT00062439|6429768|P1|Surgery|Adverse Event|2
1866011|NCT00062439|6429768|P1|Surgery|Death|1
1866012|NCT00062439|6429768|P1|Surgery|Physician Decision|4
1866013|NCT00062439|6429768|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
1866014|NCT00062439|6429768|P1|Post Chemoradiation Assessment|Physician Decision|1
1866015|NCT00062439|6429768|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
1866016|NCT00062439|6429768|P1|Post Chemoradiation Assessment|Disease progression|2
1866017|NCT00062439|6429768|P1|Post Chemoradiation Assessment|Death|1
1866018|NCT00062439|6429768|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
1866019|NCT00062439|6429768|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
1866020|NCT00062439|6429768|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
1866021|NCT00062439|6429768|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
1866022|NCT00062374|6429780|P1|Overall Study|Not treated|12
1866023|NCT00062166|6429785|P1|Overall Study|Withdrawal by Subject|6
1866024|NCT00062010|6429793|P1|Overall Study|Ineligible|3
1866025|NCT00061945|6429801|P2|Course IV: Alemtuzumab|Early exits|15
1866026|NCT00061945|6429802|P1|Course IV: Alemtuzumab|Early exits|6
1866027|NCT00061945|6429801|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1866028|NCT00061945|6429802|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
1866029|NCT00061945|6429801|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
1866030|NCT00061945|6429802|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
1866031|NCT00061945|6429801|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
1866032|NCT00061945|6429802|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
1866033|NCT00061932|6429812|P2|Overall Study|Withdrawal by Subject|4
1866034|NCT00061932|6429813|P1|Overall Study|Withdrawal by Subject|13
1866035|NCT00061633|6429826|P2|Overall Study|Never received study treatment|2
1866036|NCT00061633|6429827|P1|Overall Study|Never received study treatment|0
1866037|NCT00061633|6429826|P2|Overall Study|Other|1
1866038|NCT00061633|6429827|P1|Overall Study|Other|1
1866039|NCT00061633|6429826|P2|Overall Study|Lost to Follow-up|4
1866040|NCT00061633|6429827|P1|Overall Study|Lost to Follow-up|1
1866041|NCT00061633|6429826|P2|Overall Study|Withdrawal by Subject|2
1866042|NCT00061633|6429827|P1|Overall Study|Withdrawal by Subject|2
1866043|NCT00061633|6429826|P2|Overall Study|Adverse Event|2
1866044|NCT00061633|6429827|P1|Overall Study|Adverse Event|1
1866045|NCT00061048|6429852|P1|Overall Study|disease progression|20
1866046|NCT00061048|6429852|P1|Overall Study|Adverse Event|2
1866047|NCT00060944|6429862|P2|Overall Study|randomized but not treated|4
1866048|NCT00060944|6429863|P1|Overall Study|randomized but not treated|6
1866049|NCT00060944|6429862|P2|Overall Study|Other|4
1866050|NCT00060944|6429863|P1|Overall Study|Other|2
1866051|NCT00060944|6429862|P2|Overall Study|Treatment Switch|13
1866052|NCT00060944|6429863|P1|Overall Study|Treatment Switch|0
1866053|NCT00060944|6429862|P2|Overall Study|Subject Ineligible To Continue|1
1866054|NCT00060944|6429863|P1|Overall Study|Subject Ineligible To Continue|2
1866055|NCT00060944|6429862|P2|Overall Study|Lost to Follow-up|0
1866056|NCT00060944|6429863|P1|Overall Study|Lost to Follow-up|1
1866057|NCT00060944|6429862|P2|Overall Study|Disease Progression|94
1866058|NCT00060944|6429863|P1|Overall Study|Disease Progression|93
1866059|NCT00060944|6429862|P2|Overall Study|Withdrawal by Subject|5
1866060|NCT00060944|6429863|P1|Overall Study|Withdrawal by Subject|18
1866061|NCT00060944|6429862|P2|Overall Study|Death|3
1866062|NCT00060944|6429863|P1|Overall Study|Death|2
1866063|NCT00060944|6429862|P2|Overall Study|Adverse Event|10
1866064|NCT00060944|6429863|P1|Overall Study|Adverse Event|12
1866065|NCT00060840|6429879|P2|Overall Study|Other|0
1866066|NCT00060840|6429880|P1|Overall Study|Other|1
1866067|NCT00060840|6429879|P2|Overall Study|Physician Decision|0
1866068|NCT00060840|6429880|P1|Overall Study|Physician Decision|1
1866069|NCT00060840|6429879|P2|Overall Study|Subinvestigator unavailable|1
1866070|NCT00060840|6429880|P1|Overall Study|Subinvestigator unavailable|0
1866071|NCT00060840|6429879|P2|Overall Study|Withdrawal by Subject|1
1866072|NCT00060840|6429880|P1|Overall Study|Withdrawal by Subject|0
1866073|NCT00060840|6429879|P2|Overall Study|Death|1
1866074|NCT00060840|6429880|P1|Overall Study|Death|0
1866075|NCT00060840|6429879|P2|Overall Study|Change in surgical plan|6
1866076|NCT00060840|6429880|P1|Overall Study|Change in surgical plan|2
1866077|NCT00059839|6429933|P2|Overall Study|Ineligible|3
1866078|NCT00059839|6429934|P1|Overall Study|Ineligible|1
1866079|NCT00059839|6429933|P2|Overall Study|Withdrawal by Subject|6
1866080|NCT00059839|6429934|P1|Overall Study|Withdrawal by Subject|1
1866081|NCT00059839|6429933|P2|Overall Study|Physician Decision|2
1866082|NCT00059839|6429934|P1|Overall Study|Physician Decision|1
1866083|NCT00059839|6429933|P2|Overall Study|Lost to Follow-up|0
1866084|NCT00059839|6429934|P1|Overall Study|Lost to Follow-up|2
1866085|NCT00059839|6429933|P2|Overall Study|Lack of Efficacy|5
1866086|NCT00059839|6429934|P1|Overall Study|Lack of Efficacy|6
1866087|NCT00059839|6429933|P2|Overall Study|Death|1
1866088|NCT00059839|6429934|P1|Overall Study|Death|1
1866089|NCT00059787|6429940|P1|Overall Study|Other|4
1866090|NCT00059787|6429940|P1|Overall Study|ineligible|1
1866091|NCT00059787|6429940|P1|Overall Study|disease progression|2
1866092|NCT00059787|6429940|P1|Overall Study|Adverse Event|13
1866093|NCT00059332|6429991|P2|Overall Study|Lost to Follow-up|1
1866094|NCT00059332|6429992|P1|Overall Study|Lost to Follow-up|1
1866095|NCT00059332|6429991|P2|Overall Study|Withdrawal by Subject|1
1866096|NCT00059332|6429992|P1|Overall Study|Withdrawal by Subject|2
1866097|NCT00059215|6430018|P4|Overall Study|Physician Decision|1
1866098|NCT00059215|6430019|P3|Overall Study|Physician Decision|1
1866099|NCT00059215|6430020|P2|Overall Study|Physician Decision|2
1866100|NCT00059215|6430021|P1|Overall Study|Physician Decision|1
1866101|NCT00059215|6430018|P4|Overall Study|Protocol entry criteria not met|2
1866102|NCT00059215|6430019|P3|Overall Study|Protocol entry criteria not met|0
1866103|NCT00059215|6430020|P2|Overall Study|Protocol entry criteria not met|1
1866104|NCT00059215|6430021|P1|Overall Study|Protocol entry criteria not met|1
1866105|NCT00059215|6430018|P4|Overall Study|Protocol Violation|0
1866106|NCT00059215|6430019|P3|Overall Study|Protocol Violation|1
1866107|NCT00059215|6430020|P2|Overall Study|Protocol Violation|0
1866108|NCT00059215|6430021|P1|Overall Study|Protocol Violation|1
1866109|NCT00059215|6430018|P4|Overall Study|Withdrawal by Subject|3
1866110|NCT00059215|6430019|P3|Overall Study|Withdrawal by Subject|1
1866111|NCT00059215|6430020|P2|Overall Study|Withdrawal by Subject|4
1866112|NCT00059215|6430021|P1|Overall Study|Withdrawal by Subject|4
1866113|NCT00059215|6430018|P4|Overall Study|Lost to Follow-up|0
1866114|NCT00059215|6430019|P3|Overall Study|Lost to Follow-up|0
1866115|NCT00059215|6430020|P2|Overall Study|Lost to Follow-up|2
1866116|NCT00059215|6430021|P1|Overall Study|Lost to Follow-up|1
1866117|NCT00059215|6430018|P4|Overall Study|Death|0
1866118|NCT00059215|6430019|P3|Overall Study|Death|3
1866119|NCT00059215|6430020|P2|Overall Study|Death|0
1866120|NCT00059215|6430021|P1|Overall Study|Death|0
1866121|NCT00059215|6430018|P4|Overall Study|Adverse Event|9
1866122|NCT00059215|6430019|P3|Overall Study|Adverse Event|9
1866123|NCT00059215|6430020|P2|Overall Study|Adverse Event|5
1866124|NCT00059215|6430021|P1|Overall Study|Adverse Event|5
1866125|NCT00058825|6430058|P1|Overall Study|Death|3
1866126|NCT00058825|6430058|P1|Overall Study|Graft Failure|5
1866127|NCT00058825|6430058|P1|Overall Study|Progressive Disease|5
1866128|NCT00058825|6430058|P1|Overall Study|Relapse|9
1866129|NCT00058552|6430074|P2|Overall Study|Clinical disease progression|4
1866130|NCT00058552|6430075|P1|Overall Study|Clinical disease progression|0
1866131|NCT00058552|6430074|P2|Overall Study|Physician Decision|5
1866132|NCT00058552|6430075|P1|Overall Study|Physician Decision|2
1866133|NCT00058552|6430074|P2|Overall Study|Withdrawal by Subject|5
1866134|NCT00058552|6430075|P1|Overall Study|Withdrawal by Subject|3
1866135|NCT00058552|6430074|P2|Overall Study|Adverse Event|2
1866136|NCT00058552|6430075|P1|Overall Study|Adverse Event|4
1866137|NCT00058552|6430074|P2|Overall Study|Disease progression|44
1866138|NCT00058552|6430075|P1|Overall Study|Disease progression|52
1866139|NCT00058552|6430074|P2|Overall Study|Died prior to receiving treatment|2
1866140|NCT00058552|6430075|P1|Overall Study|Died prior to receiving treatment|4
1866141|NCT00058539|6430093|P1|Overall Study|Death|1
1866142|NCT00058539|6430093|P1|Overall Study|Physician Decision|9
1866143|NCT00058539|6430093|P1|Overall Study|Withdrawal by Subject|5
1866144|NCT00058539|6430093|P1|Overall Study|Adverse Event|3
1866145|NCT00058539|6430093|P1|Overall Study|Disease progression|24
1866146|NCT00058214|6430120|P1|Overall Study|Adverse Event|1
1866147|NCT00058123|6430125|P1|Overall Study|Received >3 prior treatments|1
1866148|NCT00058123|6430125|P1|Overall Study|Wrong histology|9
1866149|NCT00058058|6430132|P1|Overall Study|Poor positioning, illness,pain|3
1866150|NCT00058058|6430132|P1|Overall Study|technical issues|6
1866151|NCT00058058|6430132|P1|Overall Study|Claustrophobic|5
1866152|NCT00058058|6430132|P1|Overall Study|Ineligible|20
1866153|NCT00058058|6430132|P1|Overall Study|Withdrawal by Subject|4
1866154|NCT00057954|6430157|P1|Overall Study|Disease progression|1
1866155|NCT00057954|6430157|P1|Overall Study|Death|1
1866156|NCT00057941|6430165|P2|Overall Study|Ineligible|5
1866157|NCT00057941|6430166|P1|Overall Study|Ineligible|2
1866158|NCT00057941|6430165|P2|Overall Study|insurance, symptomatic deterioration|3
1866159|NCT00057941|6430166|P1|Overall Study|insurance, symptomatic deterioration|1
1866160|NCT00057941|6430165|P2|Overall Study|still on treatment|1
1866161|NCT00057941|6430166|P1|Overall Study|still on treatment|3
1866162|NCT00057941|6430165|P2|Overall Study|Withdrawal by Subject|1
1866163|NCT00057941|6430166|P1|Overall Study|Withdrawal by Subject|6
1866164|NCT00057941|6430165|P2|Overall Study|Lack of Efficacy|53
1866165|NCT00057941|6430166|P1|Overall Study|Lack of Efficacy|54
1866166|NCT00057941|6430165|P2|Overall Study|Adverse Event|9
1866167|NCT00057941|6430166|P1|Overall Study|Adverse Event|7
1866168|NCT00057941|6430165|P2|Overall Study|Death|2
1866169|NCT00057941|6430166|P1|Overall Study|Death|1
1866170|NCT00057876|6430174|P2|Overall Study|other complicating disease|0
1866171|NCT00057876|6430175|P1|Overall Study|other complicating disease|1
1866172|NCT00057876|6430174|P2|Overall Study|other reason|2
1866173|NCT00057876|6430175|P1|Overall Study|other reason|2
1866174|NCT00057876|6430174|P2|Overall Study|Ineligible|2
1866175|NCT00057876|6430175|P1|Overall Study|Ineligible|1
1866176|NCT00057876|6430174|P2|Overall Study|Lack of Efficacy|8
1866177|NCT00057876|6430175|P1|Overall Study|Lack of Efficacy|10
1866178|NCT00057876|6430174|P2|Overall Study|Withdrawal by Subject|6
1866179|NCT00057876|6430175|P1|Overall Study|Withdrawal by Subject|5
1866180|NCT00057876|6430174|P2|Overall Study|Death|1
1866181|NCT00057876|6430175|P1|Overall Study|Death|2
1866182|NCT00057876|6430174|P2|Overall Study|Adverse Event|8
1866183|NCT00057876|6430175|P1|Overall Study|Adverse Event|8
1866184|NCT00057863|6430185|P1|Overall Study|Withdrawal by Subject|2
1866185|NCT00057863|6430185|P1|Overall Study|Death|1
1866186|NCT00057837|6430194|P2|Overall Study|Never started treatment|1
1866187|NCT00057837|6430195|P1|Overall Study|Never started treatment|1
1866188|NCT00057837|6430194|P2|Overall Study|Ineligible|3
1866189|NCT00057837|6430195|P1|Overall Study|Ineligible|3
1866190|NCT00057837|6430194|P2|Overall Study|Physician Decision|0
1866191|NCT00057837|6430195|P1|Overall Study|Physician Decision|1
1866192|NCT00057837|6430194|P2|Overall Study|Other complicating disease|1
1866193|NCT00057837|6430195|P1|Overall Study|Other complicating disease|2
1866194|NCT00057837|6430194|P2|Overall Study|Alternative therapy|1
1866195|NCT00057837|6430195|P1|Overall Study|Alternative therapy|0
1866196|NCT00057837|6430194|P2|Overall Study|Withdrawal by Subject|3
1866197|NCT00057837|6430195|P1|Overall Study|Withdrawal by Subject|5
1866198|NCT00057837|6430194|P2|Overall Study|Death|4
1866199|NCT00057837|6430195|P1|Overall Study|Death|5
1866200|NCT00057837|6430194|P2|Overall Study|Adverse Event|12
1866201|NCT00057837|6430195|P1|Overall Study|Adverse Event|2
1866202|NCT00057837|6430194|P2|Overall Study|Progression/relapse|14
1866203|NCT00057837|6430195|P1|Overall Study|Progression/relapse|12
1866204|NCT00057811|6430207|P2|Overall Study|Inevaluable|2
1866205|NCT00057811|6430208|P1|Overall Study|Inevaluable|1
1866206|NCT00057811|6430207|P2|Overall Study|Ineligible|2
1866207|NCT00057811|6430208|P1|Overall Study|Ineligible|4
1866208|NCT00057811|6430207|P2|Overall Study|Withdrawal by Subject|4
1866209|NCT00057811|6430208|P1|Overall Study|Withdrawal by Subject|3
1866210|NCT00057811|6430207|P2|Overall Study|Physician Decision|0
1866211|NCT00057811|6430208|P1|Overall Study|Physician Decision|1
1866212|NCT00057811|6430207|P2|Overall Study|Lack of Efficacy|4
1866213|NCT00057811|6430208|P1|Overall Study|Lack of Efficacy|1
1866214|NCT00057746|6430227|P3|Overall Study|Withdrawal by Subject|1
1866215|NCT00057746|6430228|P2|Overall Study|Withdrawal by Subject|0
1866216|NCT00057746|6430229|P1|Overall Study|Withdrawal by Subject|0
1866217|NCT00023673|6430240|P4|Overall Study|Patient withdrew consent|1
1866218|NCT00023673|6430241|P3|Overall Study|Patient withdrew consent|0
1866219|NCT00023673|6430242|P2|Overall Study|Patient withdrew consent|0
1866220|NCT00023673|6430243|P1|Overall Study|Patient withdrew consent|0
1866221|NCT00023673|6430240|P4|Overall Study|Ineligible / no protocol treatment|1
1866222|NCT00023673|6430241|P3|Overall Study|Ineligible / no protocol treatment|0
1866223|NCT00023673|6430242|P2|Overall Study|Ineligible / no protocol treatment|0
1866224|NCT00023673|6430243|P1|Overall Study|Ineligible / no protocol treatment|0
1866225|NCT00057330|6430307|P2|Overall Study|Other|206
1866226|NCT00057330|6430308|P1|Overall Study|Other|260
1866227|NCT00057330|6430307|P2|Overall Study|Physician Decision|0
1866228|NCT00057330|6430308|P1|Overall Study|Physician Decision|1
1866229|NCT00057330|6430307|P2|Overall Study|Lost to Follow-up|617
1866230|NCT00057330|6430308|P1|Overall Study|Lost to Follow-up|745
1866231|NCT00057330|6430307|P2|Overall Study|Withdrawal by Subject|84
1866232|NCT00057330|6430308|P1|Overall Study|Withdrawal by Subject|115
1866233|NCT00057330|6430307|P2|Overall Study|Protocol Violation|1
1866234|NCT00057330|6430308|P1|Overall Study|Protocol Violation|1
1866235|NCT00057330|6430307|P2|Overall Study|Death|0
1866236|NCT00057330|6430308|P1|Overall Study|Death|1
1866237|NCT00057330|6430307|P2|Overall Study|Adverse Event|12
1866238|NCT00057330|6430308|P1|Overall Study|Adverse Event|9
1866239|NCT00056862|6430338|P2|Overall Study|Protocol Violation|0
1866240|NCT00056862|6430339|P1|Overall Study|Protocol Violation|1
1866241|NCT00056407|6430397|P2|Overall Study|Missing|34
1866242|NCT00056407|6430398|P1|Overall Study|Missing|25
1866243|NCT00056407|6430397|P2|Overall Study|"Listed as Other on Case Report Form"|60
1866244|NCT00056407|6430398|P1|Overall Study|"Listed as Other on Case Report Form"|98
1866245|NCT00056407|6430397|P2|Overall Study|Diagnosed with Prostate Cancer|166
1866246|NCT00056407|6430398|P1|Overall Study|Diagnosed with Prostate Cancer|202
1866247|NCT00056407|6430397|P2|Overall Study|Protocol Violation|95
1866248|NCT00056407|6430398|P1|Overall Study|Protocol Violation|104
1866249|NCT00056407|6430397|P2|Overall Study|Lost to Follow-up|113
1866250|NCT00056407|6430398|P1|Overall Study|Lost to Follow-up|123
1866251|NCT00056407|6430397|P2|Overall Study|Withdrawal by Subject|361
1866252|NCT00056407|6430398|P1|Overall Study|Withdrawal by Subject|377
1866253|NCT00056407|6430397|P2|Overall Study|Adverse Event|364
1866254|NCT00056407|6430398|P1|Overall Study|Adverse Event|282
1866255|NCT00056316|6430456|P2|Overall Study|Death/NH placement of pt|1
1866256|NCT00056316|6430457|P1|Overall Study|Death/NH placement of pt|1
1866257|NCT00056316|6430456|P2|Overall Study|Withdrawal by Subject|2
1866258|NCT00056316|6430457|P1|Overall Study|Withdrawal by Subject|2
1866259|NCT00056160|6430471|P2|Final Follow-up|Adverse Event|0
1866260|NCT00056160|6430472|P1|Final Follow-up|Adverse Event|1
1866261|NCT00056160|6430471|P2|Final Follow-up|Transferred into RevAssist Program|0
1866262|NCT00056160|6430472|P1|Final Follow-up|Transferred into RevAssist Program|2
1866263|NCT00056160|6430471|P2|Final Follow-up|Transferred into expanded access study.|0
1866264|NCT00056160|6430472|P1|Final Follow-up|Transferred into expanded access study.|3
1866265|NCT00056160|6430471|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
1866266|NCT00056160|6430472|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
1866267|NCT00056160|6430471|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
1866268|NCT00056160|6430472|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
1866269|NCT00056160|6430471|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
1866270|NCT00056160|6430472|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
1866271|NCT00056160|6430471|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
1866272|NCT00056160|6430472|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
1866273|NCT00056160|6430471|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
1866274|NCT00056160|6430472|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
1866275|NCT00056160|6430471|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
1866276|NCT00056160|6430472|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
1866277|NCT00056160|6430471|P2|Up to Unblinding (07 Jun 2005)|Other|7
1866278|NCT00056160|6430472|P1|Up to Unblinding (07 Jun 2005)|Other|8
1866279|NCT00056160|6430471|P2|Up to Unblinding (07 Jun 2005)|Death|1
1866280|NCT00056160|6430472|P1|Up to Unblinding (07 Jun 2005)|Death|2
1866281|NCT00056160|6430471|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1866282|NCT00056160|6430472|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
1866283|NCT00056160|6430471|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
1866284|NCT00056160|6430472|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
1866285|NCT00056160|6430471|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
1866286|NCT00056160|6430472|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
1866287|NCT00056160|6430471|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
1866288|NCT00056160|6430472|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
1866289|NCT00055601|6430495|P2|Overall Study|No protocol treatment received|1
1866290|NCT00055601|6430496|P1|Overall Study|No protocol treatment received|1
1866291|NCT00055601|6430495|P2|Overall Study|Protocol Violation|1
1866292|NCT00055601|6430496|P1|Overall Study|Protocol Violation|1
1866293|NCT00055497|6430510|P4|Overall Study|Other|11
1866294|NCT00055497|6430511|P3|Overall Study|Other|0
1866295|NCT00055497|6430512|P2|Overall Study|Other|0
1866296|NCT00055497|6430513|P1|Overall Study|Other|0
1866297|NCT00055497|6430510|P4|Overall Study|Administrative Reasons|1
1866298|NCT00055497|6430511|P3|Overall Study|Administrative Reasons|0
1866299|NCT00055497|6430512|P2|Overall Study|Administrative Reasons|0
1866300|NCT00055497|6430513|P1|Overall Study|Administrative Reasons|0
1866301|NCT00055497|6430510|P4|Overall Study|Lack of Efficacy|27
1866302|NCT00055497|6430511|P3|Overall Study|Lack of Efficacy|0
1866303|NCT00055497|6430512|P2|Overall Study|Lack of Efficacy|0
1866304|NCT00055497|6430513|P1|Overall Study|Lack of Efficacy|1
1866305|NCT00055497|6430510|P4|Overall Study|Protocol Violation|3
1866306|NCT00055497|6430511|P3|Overall Study|Protocol Violation|0
1866307|NCT00055497|6430512|P2|Overall Study|Protocol Violation|0
1866308|NCT00055497|6430513|P1|Overall Study|Protocol Violation|0
1866309|NCT00055497|6430510|P4|Overall Study|Lost to Follow-up|5
1866310|NCT00055497|6430511|P3|Overall Study|Lost to Follow-up|0
1866311|NCT00055497|6430512|P2|Overall Study|Lost to Follow-up|1
1866312|NCT00055497|6430513|P1|Overall Study|Lost to Follow-up|0
1866313|NCT00055497|6430510|P4|Overall Study|Withdrawal by Subject|15
1866314|NCT00055497|6430511|P3|Overall Study|Withdrawal by Subject|1
1866315|NCT00055497|6430512|P2|Overall Study|Withdrawal by Subject|1
1866316|NCT00055497|6430513|P1|Overall Study|Withdrawal by Subject|3
1866317|NCT00055497|6430510|P4|Overall Study|Adverse Event|28
1866318|NCT00055497|6430511|P3|Overall Study|Adverse Event|1
1866319|NCT00055497|6430512|P2|Overall Study|Adverse Event|1
1866320|NCT00055497|6430513|P1|Overall Study|Adverse Event|1
1866321|NCT00055471|6430558|P3|Period 1: Dose Escalation Period|Disease progression|0
1866322|NCT00055471|6430559|P2|Period 1: Dose Escalation Period|Disease progression|1
1866323|NCT00055471|6430560|P1|Period 1: Dose Escalation Period|Disease progression|0
1866324|NCT00055471|6430558|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
1866325|NCT00055471|6430559|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1866326|NCT00055471|6430560|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
1866327|NCT00055471|6430558|P3|Period 1: Dose Escalation Period|Adverse Event|2
1866328|NCT00055471|6430559|P2|Period 1: Dose Escalation Period|Adverse Event|1
1866329|NCT00055471|6430560|P1|Period 1: Dose Escalation Period|Adverse Event|0
1866330|NCT00054717|6430615|P2|Overall Study|Other reason not defined above|217
1866331|NCT00054717|6430616|P1|Overall Study|Other reason not defined above|117
1866332|NCT00054717|6430615|P2|Overall Study|Withdrawal by Subject|20
1866333|NCT00054717|6430616|P1|Overall Study|Withdrawal by Subject|32
1866334|NCT00054717|6430615|P2|Overall Study|Lost to Follow-up|13
1866335|NCT00054717|6430616|P1|Overall Study|Lost to Follow-up|23
1866336|NCT00054717|6430615|P2|Overall Study|Protocol Violation|19
1866337|NCT00054717|6430616|P1|Overall Study|Protocol Violation|18
1866338|NCT00054717|6430615|P2|Overall Study|Adverse Event|22
1866339|NCT00054717|6430616|P1|Overall Study|Adverse Event|70
1866340|NCT00054717|6430615|P2|Overall Study|Randomized but not treated|8
1866341|NCT00054717|6430616|P1|Overall Study|Randomized but not treated|2
1866342|NCT00054704|6430804|P2|Overall Study|Lost to Follow-up|1
1866343|NCT00054704|6430805|P1|Overall Study|Lost to Follow-up|0
1866344|NCT00054704|6430804|P2|Overall Study|Adverse Event|1
1866345|NCT00054704|6430805|P1|Overall Study|Adverse Event|3
1866346|NCT00054704|6430804|P2|Overall Study|Lack of Efficacy|3
1866347|NCT00054704|6430805|P1|Overall Study|Lack of Efficacy|2
1866348|NCT00054691|6430811|P1|Overall Study|Noncompliant|1
1866349|NCT00054691|6430811|P1|Overall Study|Unmeasurable Disease|2
1866350|NCT00054639|6430825|P1|Overall Study|Physician Decision|1
1866351|NCT00054639|6430825|P1|Overall Study|Lack of Efficacy|1
1866352|NCT00054327|6430858|P6|Overall Study|Engraftment failure|0
1866353|NCT00054327|6430859|P5|Overall Study|Engraftment failure|0
1866354|NCT00054327|6430860|P4|Overall Study|Engraftment failure|0
1866355|NCT00054327|6430861|P3|Overall Study|Engraftment failure|0
1866356|NCT00054327|6430862|P2|Overall Study|Engraftment failure|0
1866357|NCT00054327|6430863|P1|Overall Study|Engraftment failure|1
1866358|NCT00054275|6430901|P1|Overall Study|Physician Decision|1
1866359|NCT00054275|6430901|P1|Overall Study|Progressive disease in cycle 1|1
1866360|NCT00054275|6430901|P1|Overall Study|Adverse Event|5
1866361|NCT00054275|6430901|P1|Overall Study|Withdrawal by Subject|4
1866362|NCT00054132|6430907|P1|Overall Study|Not Treated|1
1866363|NCT00053898|6430934|P2|Overall Study|Follow-up from telephone contact only|1
1866364|NCT00053898|6430935|P1|Overall Study|Follow-up from telephone contact only|5
1866365|NCT00053898|6430934|P2|Overall Study|No follow-up data from any source|12
1866366|NCT00053898|6430935|P1|Overall Study|No follow-up data from any source|9
1866367|NCT00053846|6430961|P2|Overall Study|Pills too large|1
1866368|NCT00053846|6430962|P1|Overall Study|Pills too large|0
1866369|NCT00053846|6430961|P2|Overall Study|Quit due to side effects|3
1866370|NCT00053846|6430962|P1|Overall Study|Quit due to side effects|1
1866371|NCT00053846|6430961|P2|Overall Study|Did not return data|2
1866372|NCT00053846|6430962|P1|Overall Study|Did not return data|1
1866373|NCT00053846|6430961|P2|Overall Study|Became ineligible|1
1866374|NCT00053846|6430962|P1|Overall Study|Became ineligible|3
1866375|NCT00053846|6430961|P2|Overall Study|Expired|0
1866376|NCT00053846|6430962|P1|Overall Study|Expired|5
1866377|NCT00053846|6430961|P2|Overall Study|Became too ill|7
1866378|NCT00053846|6430962|P1|Overall Study|Became too ill|8
1866379|NCT00053846|6430961|P2|Overall Study|Changed mind|13
1866380|NCT00053846|6430962|P1|Overall Study|Changed mind|8
1866381|NCT00053417|6431121|P4|Overall Study|Lost to Follow-up|0
1866382|NCT00053417|6431122|P3|Overall Study|Lost to Follow-up|0
1866383|NCT00053417|6431123|P2|Overall Study|Lost to Follow-up|1
1866384|NCT00053417|6431124|P1|Overall Study|Lost to Follow-up|1
1866385|NCT00053417|6431121|P4|Overall Study|Withdrawal by Subject|0
1866386|NCT00053417|6431122|P3|Overall Study|Withdrawal by Subject|0
1866387|NCT00053417|6431123|P2|Overall Study|Withdrawal by Subject|1
1866388|NCT00053417|6431124|P1|Overall Study|Withdrawal by Subject|0
1866389|NCT00053417|6431121|P4|Overall Study|Non-Compliance|1
1866390|NCT00053417|6431122|P3|Overall Study|Non-Compliance|0
1866391|NCT00053417|6431123|P2|Overall Study|Non-Compliance|0
1866392|NCT00053417|6431124|P1|Overall Study|Non-Compliance|0
1866393|NCT00053417|6431121|P4|Overall Study|Adverse Event|5
1866394|NCT00053417|6431122|P3|Overall Study|Adverse Event|1
1866395|NCT00053417|6431123|P2|Overall Study|Adverse Event|0
1866396|NCT00053417|6431124|P1|Overall Study|Adverse Event|1
1866397|NCT00053365|6431134|P1|Overall Study|Never treated|4
1866398|NCT00053365|6431134|P1|Overall Study|Platinum-sensitive interval >12 months|1
1866399|NCT00053365|6431134|P1|Overall Study|Incorrect cell type|1
1866400|NCT00053352|6431143|P2|Overall Study|Disease at new site|0
1866401|NCT00053352|6431144|P1|Overall Study|Disease at new site|1
1866402|NCT00053352|6431143|P2|Overall Study|Ineligible|8
1866403|NCT00053352|6431144|P1|Overall Study|Ineligible|8
1866404|NCT00053352|6431143|P2|Overall Study|Withdrawal by Subject|0
1866405|NCT00053352|6431144|P1|Overall Study|Withdrawal by Subject|1
1866406|NCT00053352|6431143|P2|Overall Study|Physician Decision|1
1866407|NCT00053352|6431144|P1|Overall Study|Physician Decision|11
1866408|NCT00053352|6431143|P2|Overall Study|Lost to Follow-up|1
1866409|NCT00053352|6431144|P1|Overall Study|Lost to Follow-up|0
1866410|NCT00003830|6431160|P2|Overall Study|Sentinel node positive patients|793
1866411|NCT00003830|6431161|P1|Overall Study|Sentinel node positive patients|829
1866412|NCT00003830|6431160|P2|Overall Study|No follow up data|0
1866413|NCT00003830|6431161|P1|Overall Study|No follow up data|3
1866414|NCT00052962|6431187|P2|Overall Study|Not randomized/not evaluable|0
1866415|NCT00052962|6431188|P1|Overall Study|Not randomized/not evaluable|1
1866416|NCT00052962|6431187|P2|Overall Study|Not evaluable|2
1866417|NCT00052962|6431188|P1|Overall Study|Not evaluable|0
1866418|NCT00052715|6431207|P1|Overall Study|wrong histology|1
1866419|NCT00049543|6431223|P2|Overall Study|still on treatment|9
1866420|NCT00049543|6431224|P1|Overall Study|still on treatment|2
1866421|NCT00049530|6431234|P1|Overall Study|ineligible|3
1866422|NCT00049530|6431234|P1|Overall Study|symptomatic deterioration|1
1866423|NCT00049530|6431234|P1|Overall Study|Death|1
1866424|NCT00049530|6431234|P1|Overall Study|Adverse Event|2
1866425|NCT00049530|6431234|P1|Overall Study|Lack of Efficacy|25
1866426|NCT00049517|6431243|P6|Conditioning/Transplant|Reasons not reported|5
1866427|NCT00049517|6431244|P5|Conditioning/Transplant|Reasons not reported|5
1866428|NCT00049517|6431245|P4|Conditioning/Transplant|Reasons not reported|15
1866429|NCT00049517|6431246|P3|Conditioning/Transplant|Reasons not reported|18
1866430|NCT00049517|6431247|P2|Conditioning/Transplant|Reasons not reported|31
1866431|NCT00049517|6431248|P1|Conditioning/Transplant|Reasons not reported|25
1866432|NCT00049517|6431243|P6|Conditioning/Transplant|Other complicating disease|1
1866433|NCT00049517|6431244|P5|Conditioning/Transplant|Other complicating disease|0
1866434|NCT00049517|6431245|P4|Conditioning/Transplant|Other complicating disease|4
1866435|NCT00049517|6431246|P3|Conditioning/Transplant|Other complicating disease|0
1866436|NCT00049517|6431247|P2|Conditioning/Transplant|Other complicating disease|0
1866437|NCT00049517|6431248|P1|Conditioning/Transplant|Other complicating disease|2
1866438|NCT00049517|6431243|P6|Conditioning/Transplant|Alternative therapy|0
1866439|NCT00049517|6431244|P5|Conditioning/Transplant|Alternative therapy|1
1866440|NCT00049517|6431245|P4|Conditioning/Transplant|Alternative therapy|1
1866441|NCT00049517|6431246|P3|Conditioning/Transplant|Alternative therapy|2
1866442|NCT00049517|6431247|P2|Conditioning/Transplant|Alternative therapy|4
1866443|NCT00049517|6431248|P1|Conditioning/Transplant|Alternative therapy|4
1866444|NCT00049517|6431243|P6|Conditioning/Transplant|Withdrawal by Subject|0
1866445|NCT00049517|6431244|P5|Conditioning/Transplant|Withdrawal by Subject|0
1866446|NCT00049517|6431245|P4|Conditioning/Transplant|Withdrawal by Subject|7
1866447|NCT00049517|6431246|P3|Conditioning/Transplant|Withdrawal by Subject|4
1866448|NCT00049517|6431247|P2|Conditioning/Transplant|Withdrawal by Subject|8
1866449|NCT00049517|6431248|P1|Conditioning/Transplant|Withdrawal by Subject|4
1866450|NCT00049517|6431243|P6|Conditioning/Transplant|Death|0
1866451|NCT00049517|6431244|P5|Conditioning/Transplant|Death|0
1866452|NCT00049517|6431245|P4|Conditioning/Transplant|Death|2
1866453|NCT00049517|6431246|P3|Conditioning/Transplant|Death|0
1866454|NCT00049517|6431247|P2|Conditioning/Transplant|Death|0
1866455|NCT00049517|6431248|P1|Conditioning/Transplant|Death|1
1866456|NCT00049517|6431243|P6|Conditioning/Transplant|Adverse Event|0
1866457|NCT00049517|6431244|P5|Conditioning/Transplant|Adverse Event|0
1866458|NCT00049517|6431245|P4|Conditioning/Transplant|Adverse Event|8
1866459|NCT00049517|6431246|P3|Conditioning/Transplant|Adverse Event|4
1866460|NCT00049517|6431247|P2|Conditioning/Transplant|Adverse Event|1
1866461|NCT00049517|6431248|P1|Conditioning/Transplant|Adverse Event|2
1866462|NCT00049517|6431243|P6|Conditioning/Transplant|Disease progression|0
1866463|NCT00049517|6431244|P5|Conditioning/Transplant|Disease progression|0
1866464|NCT00049517|6431245|P4|Conditioning/Transplant|Disease progression|6
1866465|NCT00049517|6431246|P3|Conditioning/Transplant|Disease progression|10
1866466|NCT00049517|6431247|P2|Conditioning/Transplant|Disease progression|6
1866467|NCT00049517|6431248|P1|Conditioning/Transplant|Disease progression|14
1866468|NCT00049517|6431243|P6|Induction|Reasons not reported|25
1866469|NCT00049517|6431244|P5|Induction|Reasons not reported|22
1866470|NCT00049517|6431245|P4|Induction|Reasons not reported|0
1866471|NCT00049517|6431246|P3|Induction|Reasons not reported|0
1866472|NCT00049517|6431247|P2|Induction|Reasons not reported|0
1866473|NCT00049517|6431248|P1|Induction|Reasons not reported|0
1866474|NCT00049517|6431243|P6|Induction|Other complicating disease|0
1866475|NCT00049517|6431244|P5|Induction|Other complicating disease|3
1866476|NCT00049517|6431245|P4|Induction|Other complicating disease|0
1866477|NCT00049517|6431246|P3|Induction|Other complicating disease|0
1866478|NCT00049517|6431247|P2|Induction|Other complicating disease|0
1866479|NCT00049517|6431248|P1|Induction|Other complicating disease|0
1866480|NCT00049517|6431243|P6|Induction|Alternative therapy|2
1866481|NCT00049517|6431244|P5|Induction|Alternative therapy|2
1866482|NCT00049517|6431245|P4|Induction|Alternative therapy|0
1866483|NCT00049517|6431246|P3|Induction|Alternative therapy|0
1866484|NCT00049517|6431247|P2|Induction|Alternative therapy|0
1866485|NCT00049517|6431248|P1|Induction|Alternative therapy|0
1866486|NCT00049517|6431243|P6|Induction|Withdrawal by Subject|3
1866487|NCT00049517|6431244|P5|Induction|Withdrawal by Subject|1
1866488|NCT00049517|6431245|P4|Induction|Withdrawal by Subject|0
1866489|NCT00049517|6431246|P3|Induction|Withdrawal by Subject|0
1866490|NCT00049517|6431247|P2|Induction|Withdrawal by Subject|0
1866491|NCT00049517|6431248|P1|Induction|Withdrawal by Subject|0
1866492|NCT00049517|6431243|P6|Induction|Death|6
1866493|NCT00049517|6431244|P5|Induction|Death|9
1866494|NCT00049517|6431245|P4|Induction|Death|0
1866495|NCT00049517|6431246|P3|Induction|Death|0
1866496|NCT00049517|6431247|P2|Induction|Death|0
1866497|NCT00049517|6431248|P1|Induction|Death|0
1866498|NCT00049517|6431243|P6|Induction|Adverse Event|7
1866499|NCT00049517|6431244|P5|Induction|Adverse Event|5
1866500|NCT00049517|6431245|P4|Induction|Adverse Event|0
1866501|NCT00049517|6431246|P3|Induction|Adverse Event|0
1866502|NCT00049517|6431247|P2|Induction|Adverse Event|0
1866503|NCT00049517|6431248|P1|Induction|Adverse Event|0
1866504|NCT00049517|6431243|P6|Induction|Disease progression|11
1866505|NCT00049517|6431244|P5|Induction|Disease progression|18
1866506|NCT00049517|6431245|P4|Induction|Disease progression|0
1866507|NCT00049517|6431246|P3|Induction|Disease progression|0
1866508|NCT00049517|6431247|P2|Induction|Disease progression|0
1866509|NCT00049517|6431248|P1|Induction|Disease progression|0
1866510|NCT00049322|6431266|P2|Overall Study|refused angio|3
1866511|NCT00049322|6431267|P1|Overall Study|refused angio|0
1866512|NCT00049322|6431266|P2|Overall Study|Adverse Event|0
1866513|NCT00049322|6431267|P1|Overall Study|Adverse Event|1
1866514|NCT00049322|6431266|P2|Overall Study|disease burden|3
1866515|NCT00049322|6431267|P1|Overall Study|disease burden|0
1866516|NCT00049257|6431279|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
1866517|NCT00049257|6431279|P1|Carboplatin, Paclitaxel|Death|2
1866518|NCT00049257|6431279|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
1866519|NCT00049257|6431279|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
1866520|NCT00049127|6431291|P5|Overall Study|Withdrawal by Subject|0
1866521|NCT00049127|6431292|P4|Overall Study|Withdrawal by Subject|0
1866522|NCT00049127|6431293|P3|Overall Study|Withdrawal by Subject|1
1866523|NCT00049127|6431294|P2|Overall Study|Withdrawal by Subject|0
1866524|NCT00049127|6431295|P1|Overall Study|Withdrawal by Subject|0
1866525|NCT00048997|6431333|P2|Overall Study|Withdrawal by Subject|1
1866526|NCT00048997|6431334|P1|Overall Study|Withdrawal by Subject|6
1866527|NCT00048997|6431333|P2|Overall Study|Protocol Violation|2
1866528|NCT00048997|6431334|P1|Overall Study|Protocol Violation|7
1866529|NCT00047385|6431357|P2|Overall Study|Eligible for screening but had no screen|492
1866530|NCT00047385|6431358|P1|Overall Study|Eligible for screening but had no screen|260
1866531|NCT00047385|6431357|P2|Overall Study|Lung Cancer diagnosed before screening|3
1866532|NCT00047385|6431358|P1|Overall Study|Lung Cancer diagnosed before screening|5
1866533|NCT00047385|6431357|P2|Overall Study|Death before any screening|5
1866534|NCT00047385|6431358|P1|Overall Study|Death before any screening|2
1866535|NCT00047320|6431376|P1|Overall Study|Ineligible|2
1866536|NCT00047320|6431376|P1|Overall Study|Withdrawal by Subject|9
1866537|NCT00047320|6431376|P1|Overall Study|Physician Decision|8
1866538|NCT00047320|6431376|P1|Overall Study|Lost to Follow-up|1
1866539|NCT00047320|6431376|P1|Overall Study|Lack of Efficacy|8
1866540|NCT00047008|6431391|P2|Overall Study|Ineligible|8
1866541|NCT00047008|6431392|P1|Overall Study|Ineligible|9
1866542|NCT00047008|6431391|P2|Overall Study|Withdrawn consent|3
1866543|NCT00047008|6431392|P1|Overall Study|Withdrawn consent|2
1866544|NCT00046930|6431400|P2|Overall Study|Ineligible|4
1866545|NCT00046930|6431401|P1|Overall Study|Ineligible|12
1866546|NCT00046891|6431416|P2|Overall Study|Adverse Event|5
1866547|NCT00046891|6431417|P1|Overall Study|Adverse Event|5
1866548|NCT00046891|6431416|P2|Overall Study|Withdrawal by Subject|15
1866549|NCT00046891|6431417|P1|Overall Study|Withdrawal by Subject|18
1866550|NCT00046891|6431416|P2|Overall Study|Ineligible|1
1866551|NCT00046891|6431417|P1|Overall Study|Ineligible|1
1866552|NCT00046891|6431416|P2|Overall Study|Cancels|9
1866553|NCT00046891|6431417|P1|Overall Study|Cancels|5
1866554|NCT00046839|6431437|P2|Overall Study|Withdrawal of consent|0
1866555|NCT00046839|6431438|P1|Overall Study|Withdrawal of consent|1
1866556|NCT00046839|6431437|P2|Overall Study|Ineligible / No protocol treatment|2
1866557|NCT00046839|6431438|P1|Overall Study|Ineligible / No protocol treatment|0
1866558|NCT00045734|6431445|P1|Overall Study|Protocol Violation|1
1866559|NCT00045708|6431460|P3|Phase 1|early progressive disease|0
1866560|NCT00045708|6431461|P2|Phase 1|early progressive disease|1
1866561|NCT00045708|6431462|P1|Phase 1|early progressive disease|0
1866562|NCT00045630|6431487|P1|Overall Study|Ineligible|2
1866563|NCT00045630|6431487|P1|Overall Study|Death|1
1866564|NCT00045630|6431487|P1|Overall Study|Progression/relapse|1
1866565|NCT00045630|6431487|P1|Overall Study|Refusal unrelated to adverse event|1
1866566|NCT00045630|6431487|P1|Overall Study|Adverse Event|1
1866567|NCT00045305|6431506|P1|Overall Study|site error|2
1866568|NCT00045305|6431506|P1|Overall Study|Death|3
1866569|NCT00045305|6431506|P1|Overall Study|Adverse Event|3
1866570|NCT00045305|6431506|P1|Overall Study|Lack of Efficacy|6
1866571|NCT00045162|6431517|P2|Overall Study|Other|16
1866572|NCT00045162|6431518|P1|Overall Study|Other|21
1866573|NCT00045162|6431517|P2|Overall Study|Withdrawal by Subject|3
1866574|NCT00045162|6431518|P1|Overall Study|Withdrawal by Subject|5
1866575|NCT00045162|6431517|P2|Overall Study|Death|10
1866576|NCT00045162|6431518|P1|Overall Study|Death|10
1866577|NCT00045162|6431517|P2|Overall Study|Lack of Efficacy|29
1866578|NCT00045162|6431518|P1|Overall Study|Lack of Efficacy|32
1866579|NCT00045162|6431517|P2|Overall Study|Adverse Event|50
1866580|NCT00045162|6431518|P1|Overall Study|Adverse Event|55
1866581|NCT00045162|6431517|P2|Overall Study|Not treated|2
1866582|NCT00045162|6431518|P1|Overall Study|Not treated|7
1866583|NCT00045162|6431517|P2|Overall Study|Ineligible|8
1866584|NCT00045162|6431518|P1|Overall Study|Ineligible|12
1866585|NCT00045110|6431533|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
1866586|NCT00045110|6431534|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
1866587|NCT00045110|6431535|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
1866588|NCT00045110|6431533|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
1866589|NCT00045110|6431534|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
1866590|NCT00045110|6431535|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
1866591|NCT00045110|6431533|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
1866592|NCT00045110|6431534|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
1866593|NCT00045110|6431535|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
1866594|NCT00045032|6431584|P3|Overall Study|Other|105
1866595|NCT00045032|6431585|P2|Overall Study|Other|84
1866596|NCT00045032|6431586|P1|Overall Study|Other|93
1866597|NCT00045032|6431584|P3|Overall Study|Failure to Return|61
1866598|NCT00045032|6431585|P2|Overall Study|Failure to Return|62
1866599|NCT00045032|6431586|P1|Overall Study|Failure to Return|57
1866600|NCT00045032|6431584|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
1866601|NCT00045032|6431585|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
1866602|NCT00045032|6431586|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
1866603|NCT00045032|6431584|P3|Overall Study|Other Protocol Violation|1
1866604|NCT00045032|6431585|P2|Overall Study|Other Protocol Violation|0
1866605|NCT00045032|6431586|P1|Overall Study|Other Protocol Violation|2
1866606|NCT00045032|6431584|P3|Overall Study|Violation of Selection Criteria at Entry|6
1866607|NCT00045032|6431585|P2|Overall Study|Violation of Selection Criteria at Entry|6
1866608|NCT00045032|6431586|P1|Overall Study|Violation of Selection Criteria at Entry|3
1866609|NCT00045032|6431584|P3|Overall Study|Insufficient Therapeutic Response|445
1866610|NCT00045032|6431585|P2|Overall Study|Insufficient Therapeutic Response|437
1866611|NCT00045032|6431586|P1|Overall Study|Insufficient Therapeutic Response|542
1866612|NCT00045032|6431584|P3|Overall Study|Death|17
1866613|NCT00045032|6431585|P2|Overall Study|Death|24
1866614|NCT00045032|6431586|P1|Overall Study|Death|22
1866615|NCT00045032|6431584|P3|Overall Study|Adverse Event/Intercurrent Illness|7
1866616|NCT00045032|6431585|P2|Overall Study|Adverse Event/Intercurrent Illness|2
1866617|NCT00045032|6431586|P1|Overall Study|Adverse Event/Intercurrent Illness|2
1866618|NCT00042991|6431720|P7|Overall Study|Alternative Therapy|0
1866619|NCT00042991|6431721|P6|Overall Study|Alternative Therapy|0
1866620|NCT00042991|6431722|P5|Overall Study|Alternative Therapy|1
1866621|NCT00042991|6431723|P4|Overall Study|Alternative Therapy|0
1866622|NCT00042991|6431724|P3|Overall Study|Alternative Therapy|0
1866623|NCT00042991|6431725|P2|Overall Study|Alternative Therapy|0
1866624|NCT00042991|6431726|P1|Overall Study|Alternative Therapy|0
1866625|NCT00042991|6431720|P7|Overall Study|Disease Progression|2
1866626|NCT00042991|6431721|P6|Overall Study|Disease Progression|4
1866627|NCT00042991|6431722|P5|Overall Study|Disease Progression|1
1866628|NCT00042991|6431723|P4|Overall Study|Disease Progression|2
1866629|NCT00042991|6431724|P3|Overall Study|Disease Progression|2
1866630|NCT00042991|6431725|P2|Overall Study|Disease Progression|29
1866631|NCT00042991|6431726|P1|Overall Study|Disease Progression|5
1866632|NCT00042991|6431720|P7|Overall Study|Withdrawal by Subject|0
1866633|NCT00042991|6431721|P6|Overall Study|Withdrawal by Subject|0
1866634|NCT00042991|6431722|P5|Overall Study|Withdrawal by Subject|1
1866635|NCT00042991|6431723|P4|Overall Study|Withdrawal by Subject|0
1866636|NCT00042991|6431724|P3|Overall Study|Withdrawal by Subject|2
1866637|NCT00042991|6431725|P2|Overall Study|Withdrawal by Subject|7
1866638|NCT00042991|6431726|P1|Overall Study|Withdrawal by Subject|0
1866639|NCT00042991|6431720|P7|Overall Study|Adverse Event|0
1866640|NCT00042991|6431721|P6|Overall Study|Adverse Event|1
1866641|NCT00042991|6431722|P5|Overall Study|Adverse Event|0
1866642|NCT00042991|6431723|P4|Overall Study|Adverse Event|0
1866643|NCT00042991|6431724|P3|Overall Study|Adverse Event|2
1866644|NCT00042991|6431725|P2|Overall Study|Adverse Event|4
1866645|NCT00042991|6431726|P1|Overall Study|Adverse Event|1
1866646|NCT00042939|6431769|P2|Overall Study|Did not start treatment|1
1866647|NCT00042939|6431770|P1|Overall Study|Did not start treatment|2
1866648|NCT00042939|6431769|P2|Overall Study|Treatment break > 4 weeks|1
1866649|NCT00042939|6431770|P1|Overall Study|Treatment break > 4 weeks|0
1866650|NCT00042939|6431769|P2|Overall Study|Still on treatment|0
1866651|NCT00042939|6431770|P1|Overall Study|Still on treatment|1
1866652|NCT00042939|6431769|P2|Overall Study|Patient non-compliance|0
1866653|NCT00042939|6431770|P1|Overall Study|Patient non-compliance|1
1866654|NCT00042939|6431769|P2|Overall Study|Rising ca 19-9|0
1866655|NCT00042939|6431770|P1|Overall Study|Rising ca 19-9|1
1866656|NCT00042939|6431769|P2|Overall Study|QOL diminished|0
1866657|NCT00042939|6431770|P1|Overall Study|QOL diminished|1
1866658|NCT00042939|6431769|P2|Overall Study|Deterioration of health|4
1866659|NCT00042939|6431770|P1|Overall Study|Deterioration of health|3
1866660|NCT00042939|6431769|P2|Overall Study|Ineligible|2
1866661|NCT00042939|6431770|P1|Overall Study|Ineligible|2
1866662|NCT00042939|6431769|P2|Overall Study|Other disease|0
1866663|NCT00042939|6431770|P1|Overall Study|Other disease|1
1866664|NCT00042939|6431769|P2|Overall Study|Withdrawal by Subject|4
1866665|NCT00042939|6431770|P1|Overall Study|Withdrawal by Subject|3
1866666|NCT00042939|6431769|P2|Overall Study|Death|2
1866667|NCT00042939|6431770|P1|Overall Study|Death|3
1866668|NCT00042939|6431769|P2|Overall Study|Adverse Event|7
1866669|NCT00042939|6431770|P1|Overall Study|Adverse Event|6
1866670|NCT00041132|6431784|P1|Overall Study|Physician Decision|2
1866671|NCT00041132|6431784|P1|Overall Study|Withdrawal by Subject|1
1866672|NCT00041132|6431784|P1|Overall Study|Not Eligible|7
1866673|NCT00041132|6431784|P1|Overall Study|Death|1
1866674|NCT00041132|6431784|P1|Overall Study|Adverse Event|19
1866675|NCT00041080|6431819|P2|Overall Study|Ineligible|0
1866676|NCT00041080|6431820|P1|Overall Study|Ineligible|1
1866677|NCT00041080|6431819|P2|Overall Study|Did not start therapy|1
1866678|NCT00041080|6431820|P1|Overall Study|Did not start therapy|1
1866679|NCT00041080|6431819|P2|Overall Study|Concommitant Illness/Other|2
1866680|NCT00041080|6431820|P1|Overall Study|Concommitant Illness/Other|1
1866681|NCT00041080|6431819|P2|Overall Study|Withdrawal by Subject|6
1866682|NCT00041080|6431820|P1|Overall Study|Withdrawal by Subject|6
1866683|NCT00041080|6431819|P2|Overall Study|Adverse Event|1
1866684|NCT00041080|6431820|P1|Overall Study|Adverse Event|21
1866685|NCT00041067|6431826|P1|Overall Study|Ineligible|2
1866686|NCT00041067|6431826|P1|Overall Study|Other reasons|23
1866687|NCT00041067|6431826|P1|Overall Study|Patient refusal|12
1866688|NCT00041067|6431826|P1|Overall Study|Progression|19
1866689|NCT00041067|6431826|P1|Overall Study|Adverse Event|20
1866690|NCT00040742|6431893|P4|Overall Study|Other medical|5
1866691|NCT00040742|6431894|P3|Overall Study|Other medical|5
1866692|NCT00040742|6431895|P2|Overall Study|Other medical|5
1866693|NCT00040742|6431896|P1|Overall Study|Other medical|7
1866694|NCT00040742|6431893|P4|Overall Study|Incomplete Forms|5
1866695|NCT00040742|6431894|P3|Overall Study|Incomplete Forms|4
1866696|NCT00040742|6431895|P2|Overall Study|Incomplete Forms|10
1866697|NCT00040742|6431896|P1|Overall Study|Incomplete Forms|6
1866698|NCT00040742|6431893|P4|Overall Study|Chemotoxicity|2
1866699|NCT00040742|6431894|P3|Overall Study|Chemotoxicity|5
1866700|NCT00040742|6431895|P2|Overall Study|Chemotoxicity|3
1866701|NCT00040742|6431896|P1|Overall Study|Chemotoxicity|4
1866702|NCT00040742|6431893|P4|Overall Study|Withdrawal by Subject|13
1866703|NCT00040742|6431894|P3|Overall Study|Withdrawal by Subject|10
1866704|NCT00040742|6431895|P2|Overall Study|Withdrawal by Subject|15
1866705|NCT00040742|6431896|P1|Overall Study|Withdrawal by Subject|7
1866706|NCT00040742|6431893|P4|Overall Study|Adverse Event|9
1866707|NCT00040742|6431894|P3|Overall Study|Adverse Event|21
1866708|NCT00040742|6431895|P2|Overall Study|Adverse Event|16
1866709|NCT00040742|6431896|P1|Overall Study|Adverse Event|15
1866710|NCT00040742|6431893|P4|Overall Study|Death|0
1866711|NCT00040742|6431894|P3|Overall Study|Death|1
1866712|NCT00040742|6431895|P2|Overall Study|Death|0
1866713|NCT00040742|6431896|P1|Overall Study|Death|0
1866714|NCT00039377|6431910|P4|Initial Registration|Withdrawal by Subject|0
1866715|NCT00039377|6431911|P3|Initial Registration|Withdrawal by Subject|0
1866716|NCT00039377|6431912|P2|Initial Registration|Withdrawal by Subject|0
1866717|NCT00039377|6431913|P1|Initial Registration|Withdrawal by Subject|3
1866718|NCT00039377|6431910|P4|Initial Registration|Received non-protocol therapy|0
1866719|NCT00039377|6431911|P3|Initial Registration|Received non-protocol therapy|0
1866720|NCT00039377|6431912|P2|Initial Registration|Received non-protocol therapy|0
1866721|NCT00039377|6431913|P1|Initial Registration|Received non-protocol therapy|11
1866722|NCT00039377|6431910|P4|Initial Registration|Relapsed|0
1866723|NCT00039377|6431911|P3|Initial Registration|Relapsed|0
1866724|NCT00039377|6431912|P2|Initial Registration|Relapsed|0
1866725|NCT00039377|6431913|P1|Initial Registration|Relapsed|6
1866726|NCT00039377|6431910|P4|Initial Registration|Adverse Event|0
1866727|NCT00039377|6431911|P3|Initial Registration|Adverse Event|0
1866728|NCT00039377|6431912|P2|Initial Registration|Adverse Event|0
1866729|NCT00039377|6431913|P1|Initial Registration|Adverse Event|2
1866730|NCT00039130|6431929|P1|Overall Study|Physician Decision|3
1866731|NCT00039130|6431929|P1|Overall Study|Subsequent treatment|2
1866732|NCT00039130|6431929|P1|Overall Study|Progression|2
1866733|NCT00039130|6431929|P1|Overall Study|Withdrawal by Subject|3
1866734|NCT00039130|6431929|P1|Overall Study|Death|9
1866735|NCT00039130|6431929|P1|Overall Study|Adverse Event|11
1866736|NCT00033657|6431945|P2|Adjuvant Chemotherapy|Other|2
1866737|NCT00033657|6431946|P1|Adjuvant Chemotherapy|Other|0
1866738|NCT00033657|6431945|P2|Adjuvant Chemotherapy|alternative therapy|0
1866739|NCT00033657|6431946|P1|Adjuvant Chemotherapy|alternative therapy|1
1866740|NCT00033657|6431945|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
1866741|NCT00033657|6431946|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
1866742|NCT00033657|6431945|P2|Adjuvant Chemotherapy|Death|1
1866743|NCT00033657|6431946|P1|Adjuvant Chemotherapy|Death|2
1866744|NCT00033657|6431945|P2|Adjuvant Chemotherapy|Adverse Event|10
1866745|NCT00033657|6431946|P1|Adjuvant Chemotherapy|Adverse Event|7
1866746|NCT00033657|6431945|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
1866747|NCT00033657|6431946|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
1866748|NCT00033657|6431945|P2|Surgical Resection|not complete resection|3
1866749|NCT00033657|6431946|P1|Surgical Resection|not complete resection|0
1866750|NCT00033657|6431945|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
1866751|NCT00033657|6431946|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
1866752|NCT00033657|6431945|P2|Neoadjuvant Chemotherapy|Ineligible|4
1866753|NCT00033657|6431946|P1|Neoadjuvant Chemotherapy|Ineligible|8
1866754|NCT00033657|6431945|P2|Neoadjuvant Chemotherapy|other complicating disease|1
1866755|NCT00033657|6431946|P1|Neoadjuvant Chemotherapy|other complicating disease|0
1866756|NCT00033657|6431945|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
1866757|NCT00033657|6431946|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
1866758|NCT00033657|6431945|P2|Neoadjuvant Chemotherapy|Death|1
1866759|NCT00033657|6431946|P1|Neoadjuvant Chemotherapy|Death|1
1866760|NCT00033657|6431945|P2|Neoadjuvant Chemotherapy|Adverse Event|2
1866761|NCT00033657|6431946|P1|Neoadjuvant Chemotherapy|Adverse Event|0
1866762|NCT00033657|6431945|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
1866763|NCT00033657|6431946|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
1866764|NCT00033631|6431960|P2|Overall Study|Withdrawal by Subject|4
1866765|NCT00033631|6431961|P1|Overall Study|Withdrawal by Subject|4
1866766|NCT00033631|6431960|P2|Overall Study|Protocol Violation|11
1866767|NCT00033631|6431961|P1|Overall Study|Protocol Violation|14
1866768|NCT00033540|6431979|P1|Overall Study|Never received treatment|2
1866769|NCT00033540|6431979|P1|Overall Study|Ineligible|3
1866770|NCT00033540|6431979|P1|Overall Study|Other|5
1866771|NCT00033540|6431979|P1|Overall Study|Withdrawal by Subject|6
1866772|NCT00033540|6431979|P1|Overall Study|Progression|26
1866773|NCT00033540|6431979|P1|Overall Study|Death|1
1866774|NCT00033540|6431979|P1|Overall Study|Adverse Event|14
1866775|NCT00033514|6431989|P2|Overall Study|Withdrawal by Subject|3
1866776|NCT00033514|6431990|P1|Overall Study|Withdrawal by Subject|0
1866777|NCT00033514|6431989|P2|Overall Study|Lost to Follow-up|1
1866778|NCT00033514|6431990|P1|Overall Study|Lost to Follow-up|1
1866779|NCT00033371|6432000|P2|Overall Study|Disease Progression|1
1866780|NCT00033371|6432001|P1|Overall Study|Disease Progression|0
1866781|NCT00033371|6432000|P2|Overall Study|Withdrawal by Subject|3
1866782|NCT00033371|6432001|P1|Overall Study|Withdrawal by Subject|3
1866783|NCT00033371|6432000|P2|Overall Study|Lost to Follow-up|1
1866784|NCT00033371|6432001|P1|Overall Study|Lost to Follow-up|2
1866785|NCT00033371|6432000|P2|Overall Study|Adverse Event|5
1866786|NCT00033371|6432001|P1|Overall Study|Adverse Event|1
1866787|NCT00033293|6432009|P2|Overall Study|Treatment refused|6
1866788|NCT00033293|6432010|P1|Overall Study|Treatment refused|0
1866789|NCT00033293|6432009|P2|Overall Study|Could not be weaned from steroid therapy|1
1866790|NCT00033293|6432010|P1|Overall Study|Could not be weaned from steroid therapy|1
1866791|NCT00033293|6432009|P2|Overall Study|Withdrawal by Subject|0
1866792|NCT00033293|6432010|P1|Overall Study|Withdrawal by Subject|1
1866793|NCT00033293|6432009|P2|Overall Study|Physician Decision|1
1866794|NCT00033293|6432010|P1|Overall Study|Physician Decision|3
1866795|NCT00033293|6432009|P2|Overall Study|Lost to Follow-up|1
1866796|NCT00033293|6432010|P1|Overall Study|Lost to Follow-up|0
1866797|NCT00033293|6432009|P2|Overall Study|Lack of Efficacy|8
1866798|NCT00033293|6432010|P1|Overall Study|Lack of Efficacy|5
1866799|NCT00033293|6432009|P2|Overall Study|Death|1
1866800|NCT00033293|6432010|P1|Overall Study|Death|0
1866801|NCT00031694|6432028|P1|Overall Study|Withdrawal by Subject|5
1866802|NCT00031694|6432028|P1|Overall Study|Death|2
1866803|NCT00031694|6432028|P1|Overall Study|Adverse Event|12
1866804|NCT00031590|6432032|P1|Overall Study|Withdrawal by parents|2
1866805|NCT00031590|6432032|P1|Overall Study|Adverse Event|1
1866806|NCT00030901|6432039|P3|Randomization|Ineligible|14
1866807|NCT00030901|6432040|P2|Randomization|Ineligible|15
1866808|NCT00030901|6432041|P1|Randomization|Ineligible|0
1866809|NCT00030901|6432039|P3|Randomization|Other|33
1866810|NCT00030901|6432040|P2|Randomization|Other|36
1866811|NCT00030901|6432041|P1|Randomization|Other|0
1866812|NCT00030901|6432039|P3|Randomization|Death|3
1866813|NCT00030901|6432040|P2|Randomization|Death|1
1866814|NCT00030901|6432041|P1|Randomization|Death|0
1866815|NCT00030901|6432039|P3|Randomization|Progression/Relapse|21
1866816|NCT00030901|6432040|P2|Randomization|Progression/Relapse|22
1866817|NCT00030901|6432041|P1|Randomization|Progression/Relapse|0
1866818|NCT00030901|6432039|P3|Randomization|Refusal Unrelated to Adverse Event|10
1866819|NCT00030901|6432040|P2|Randomization|Refusal Unrelated to Adverse Event|16
1866820|NCT00030901|6432041|P1|Randomization|Refusal Unrelated to Adverse Event|0
1866821|NCT00030901|6432039|P3|Randomization|Adverse Event|7
1866822|NCT00030901|6432040|P2|Randomization|Adverse Event|11
1866823|NCT00030901|6432041|P1|Randomization|Adverse Event|0
1866824|NCT00030901|6432039|P3|Initial Registration|Ineligible|0
1866825|NCT00030901|6432040|P2|Initial Registration|Ineligible|0
1866826|NCT00030901|6432041|P1|Initial Registration|Ineligible|167
1866827|NCT00030823|6432049|P1|Overall Study|Withdrawal by Subject|1
1866828|NCT00028769|6432057|P1|Overall Study|Not Analyzable|1
1866829|NCT00028769|6432057|P1|Overall Study|Ineligible|5
1866830|NCT00028769|6432057|P1|Overall Study|Other - Not Protocol Specified|1
1866831|NCT00028769|6432057|P1|Overall Study|Progression or Death|31
1866832|NCT00028769|6432057|P1|Overall Study|Refusal Unrelated to Adverse Events|1
1866833|NCT00028769|6432057|P1|Overall Study|Adverse Event|2
1866834|NCT00028002|6432063|P1|Overall Study|Ineligible|8
1866835|NCT00028002|6432063|P1|Overall Study|Withdrawal by Subject|3
1866836|NCT00027846|6432073|P3|Overall Study|Neuraxis dissemination during/after ther|5
1866837|NCT00027846|6432074|P2|Overall Study|Neuraxis dissemination during/after ther|2
1866838|NCT00027846|6432075|P1|Overall Study|Neuraxis dissemination during/after ther|0
1866839|NCT00027846|6432073|P3|Overall Study|Entry into another COG therapeutic study|2
1866840|NCT00027846|6432074|P2|Overall Study|Entry into another COG therapeutic study|5
1866841|NCT00027846|6432075|P1|Overall Study|Entry into another COG therapeutic study|0
1866842|NCT00027846|6432073|P3|Overall Study|Ineligible for study|14
1866843|NCT00027846|6432074|P2|Overall Study|Ineligible for study|6
1866844|NCT00027846|6432075|P1|Overall Study|Ineligible for study|2
1866845|NCT00027846|6432073|P3|Overall Study|Withdrawal by Subject|7
1866846|NCT00027846|6432074|P2|Overall Study|Withdrawal by Subject|14
1866847|NCT00027846|6432075|P1|Overall Study|Withdrawal by Subject|0
1866848|NCT00027846|6432073|P3|Overall Study|Lost to Follow-up|9
1866849|NCT00027846|6432074|P2|Overall Study|Lost to Follow-up|41
1866850|NCT00027846|6432075|P1|Overall Study|Lost to Follow-up|0
1866851|NCT00027560|6432093|P1|Overall Study|Withdrawal by Subject|1
1866852|NCT00026494|6432106|P4|Overall Study|Clinical progression|0
1866853|NCT00026494|6432107|P3|Overall Study|Clinical progression|3
1866854|NCT00026494|6432108|P2|Overall Study|Clinical progression|0
1866855|NCT00026494|6432109|P1|Overall Study|Clinical progression|0
1866856|NCT00026494|6432106|P4|Overall Study|Patient not treated|0
1866857|NCT00026494|6432107|P3|Overall Study|Patient not treated|2
1866858|NCT00026494|6432108|P2|Overall Study|Patient not treated|0
1866859|NCT00026494|6432109|P1|Overall Study|Patient not treated|0
1866860|NCT00026494|6432106|P4|Overall Study|Patient non-compliance|0
1866861|NCT00026494|6432107|P3|Overall Study|Patient non-compliance|0
1866862|NCT00026494|6432108|P2|Overall Study|Patient non-compliance|0
1866863|NCT00026494|6432109|P1|Overall Study|Patient non-compliance|1
1866864|NCT00026494|6432106|P4|Overall Study|Withdrawal by Subject|0
1866865|NCT00026494|6432107|P3|Overall Study|Withdrawal by Subject|1
1866866|NCT00026494|6432108|P2|Overall Study|Withdrawal by Subject|0
1866867|NCT00026494|6432109|P1|Overall Study|Withdrawal by Subject|1
1866868|NCT00026312|6432121|P2|Overall Study|Refusal by patient/parent/guardian|59
1866869|NCT00026312|6432122|P1|Overall Study|Refusal by patient/parent/guardian|8
1866870|NCT00026312|6432121|P2|Overall Study|Entry onto another COG study|1
1866871|NCT00026312|6432122|P1|Overall Study|Entry onto another COG study|0
1866872|NCT00026312|6432121|P2|Overall Study|Ineligible|5
1866873|NCT00026312|6432122|P1|Overall Study|Ineligible|4
1866874|NCT00026312|6432121|P2|Overall Study|Withdrawal by Subject|6
1866875|NCT00026312|6432122|P1|Overall Study|Withdrawal by Subject|1
1866876|NCT00026312|6432121|P2|Overall Study|Protocol Violation|3
1866877|NCT00026312|6432122|P1|Overall Study|Protocol Violation|0
1866878|NCT00026312|6432121|P2|Overall Study|Physician Decision|37
1866879|NCT00026312|6432122|P1|Overall Study|Physician Decision|1
1866880|NCT00026312|6432121|P2|Overall Study|Lost to Follow-up|5
1866881|NCT00026312|6432122|P1|Overall Study|Lost to Follow-up|0
1866882|NCT00026312|6432121|P2|Overall Study|Lack of Efficacy|114
1866883|NCT00026312|6432122|P1|Overall Study|Lack of Efficacy|19
1866884|NCT00026312|6432121|P2|Overall Study|Death|7
1866885|NCT00026312|6432122|P1|Overall Study|Death|1
1866886|NCT00026312|6432121|P2|Overall Study|Adverse Event|32
1866887|NCT00026312|6432122|P1|Overall Study|Adverse Event|0
1866888|NCT00026208|6432161|P2|Overall Study|Complications of auto accident|0
1866889|NCT00026208|6432162|P1|Overall Study|Complications of auto accident|1
1866890|NCT00025662|6432180|P1|Overall Study|Technical failure of manipulation|1
1866891|NCT00025662|6432180|P1|Overall Study|Withdrawal by Subject|2
1866892|NCT00025506|6432188|P1|Overall Study|Never Treated|2
1866893|NCT00025506|6432188|P1|Overall Study|Ineligible: inadequate pathology|2
1866894|NCT00025506|6432188|P1|Overall Study|Ineligible: wrong cell type|5
1866895|NCT00025506|6432188|P1|Overall Study|Ineligible: clerical error|1
1866896|NCT00025259|6432209|P7|Overall Study|Adverse Event|0
1866897|NCT00025259|6432210|P6|Overall Study|Adverse Event|0
1866898|NCT00025259|6432211|P5|Overall Study|Adverse Event|0
1866899|NCT00025259|6432212|P4|Overall Study|Adverse Event|0
1866900|NCT00025259|6432213|P3|Overall Study|Adverse Event|0
1866901|NCT00025259|6432214|P2|Overall Study|Adverse Event|0
1866902|NCT00025259|6432215|P1|Overall Study|Adverse Event|1
1866903|NCT00025259|6432209|P7|Overall Study|Randomization error|2
1866904|NCT00025259|6432210|P6|Overall Study|Randomization error|7
1866905|NCT00025259|6432211|P5|Overall Study|Randomization error|1
1866906|NCT00025259|6432212|P4|Overall Study|Randomization error|0
1866907|NCT00025259|6432213|P3|Overall Study|Randomization error|0
1866908|NCT00025259|6432214|P2|Overall Study|Randomization error|0
1866909|NCT00025259|6432215|P1|Overall Study|Randomization error|1
1866910|NCT00025259|6432209|P7|Overall Study|Ineligible|1
1866911|NCT00025259|6432210|P6|Overall Study|Ineligible|0
1866912|NCT00025259|6432211|P5|Overall Study|Ineligible|6
1866913|NCT00025259|6432212|P4|Overall Study|Ineligible|0
1866914|NCT00025259|6432213|P3|Overall Study|Ineligible|0
1866915|NCT00025259|6432214|P2|Overall Study|Ineligible|1
1866916|NCT00025259|6432215|P1|Overall Study|Ineligible|14
1866917|NCT00025259|6432209|P7|Overall Study|Withdrawal by Subject|3
1866918|NCT00025259|6432210|P6|Overall Study|Withdrawal by Subject|8
1866919|NCT00025259|6432211|P5|Overall Study|Withdrawal by Subject|11
1866920|NCT00025259|6432212|P4|Overall Study|Withdrawal by Subject|14
1866921|NCT00025259|6432213|P3|Overall Study|Withdrawal by Subject|6
1866922|NCT00025259|6432214|P2|Overall Study|Withdrawal by Subject|27
1866923|NCT00025259|6432215|P1|Overall Study|Withdrawal by Subject|9
1866924|NCT00025259|6432209|P7|Overall Study|Protocol Violation|3
1866925|NCT00025259|6432210|P6|Overall Study|Protocol Violation|1
1866926|NCT00025259|6432211|P5|Overall Study|Protocol Violation|2
1866927|NCT00025259|6432212|P4|Overall Study|Protocol Violation|1
1866928|NCT00025259|6432213|P3|Overall Study|Protocol Violation|2
1866929|NCT00025259|6432214|P2|Overall Study|Protocol Violation|2
1866930|NCT00025259|6432215|P1|Overall Study|Protocol Violation|3
1866931|NCT00025259|6432209|P7|Overall Study|Physician Decision|1
1866932|NCT00025259|6432210|P6|Overall Study|Physician Decision|2
1866933|NCT00025259|6432211|P5|Overall Study|Physician Decision|4
1866934|NCT00025259|6432212|P4|Overall Study|Physician Decision|5
1866935|NCT00025259|6432213|P3|Overall Study|Physician Decision|0
1866936|NCT00025259|6432214|P2|Overall Study|Physician Decision|1
1866937|NCT00025259|6432215|P1|Overall Study|Physician Decision|12
1866938|NCT00025259|6432209|P7|Overall Study|Lost to Follow-up|1
1866939|NCT00025259|6432210|P6|Overall Study|Lost to Follow-up|3
1866940|NCT00025259|6432211|P5|Overall Study|Lost to Follow-up|1
1866941|NCT00025259|6432212|P4|Overall Study|Lost to Follow-up|13
1866942|NCT00025259|6432213|P3|Overall Study|Lost to Follow-up|13
1866943|NCT00025259|6432214|P2|Overall Study|Lost to Follow-up|9
1866944|NCT00025259|6432215|P1|Overall Study|Lost to Follow-up|2
1866945|NCT00025259|6432209|P7|Overall Study|Lack of Efficacy|38
1866946|NCT00025259|6432210|P6|Overall Study|Lack of Efficacy|30
1866947|NCT00025259|6432211|P5|Overall Study|Lack of Efficacy|11
1866948|NCT00025259|6432212|P4|Overall Study|Lack of Efficacy|78
1866949|NCT00025259|6432213|P3|Overall Study|Lack of Efficacy|60
1866950|NCT00025259|6432214|P2|Overall Study|Lack of Efficacy|46
1866951|NCT00025259|6432215|P1|Overall Study|Lack of Efficacy|2
1866952|NCT00025259|6432209|P7|Overall Study|Death|2
1866953|NCT00025259|6432210|P6|Overall Study|Death|1
1866954|NCT00025259|6432211|P5|Overall Study|Death|0
1866955|NCT00025259|6432212|P4|Overall Study|Death|3
1866956|NCT00025259|6432213|P3|Overall Study|Death|0
1866957|NCT00025259|6432214|P2|Overall Study|Death|3
1866958|NCT00025259|6432215|P1|Overall Study|Death|1
1866959|NCT00025233|6432251|P1|Overall Study|Never treated|1
1866960|NCT00025233|6432251|P1|Overall Study|Ineligible: improper prior treatment|1
1866961|NCT00025233|6432251|P1|Overall Study|Ineligible: wrong primary|1
1866962|NCT00025233|6432251|P1|Overall Study|Ineligible: wrong cell type|1
1866963|NCT00025155|6432266|P1|Overall Study|Ineligible: Second primary cancer site|1
1866964|NCT00025155|6432266|P1|Overall Study|Ineligible: Wrong primary cancer site|1
1866965|NCT00024258|6432277|P1|Overall Study|Disease Progression|8
1866966|NCT00024258|6432277|P1|Overall Study|Withdrawal by Subject|1
1866967|NCT00024167|6432284|P2|Overall Study|Death|47
1866968|NCT00024167|6432285|P1|Overall Study|Death|53
1866969|NCT00023764|6432309|P1|Overall Study|delay in obtaining staging images|1
1866970|NCT00023764|6432309|P1|Overall Study|patient received other treatment|1
1866971|NCT00023764|6432309|P1|Overall Study|Progression of disease|6
1866972|NCT00023764|6432309|P1|Overall Study|Withdrawal by Subject|1
1866973|NCT00023764|6432309|P1|Overall Study|Adverse Event|4
1866974|NCT00023764|6432309|P1|Overall Study|Other|1
1866975|NCT00023712|6432316|P2|Overall Study|Never treated|1
1866976|NCT00023712|6432317|P1|Overall Study|Never treated|1
1866977|NCT00023712|6432316|P2|Overall Study|Not platinum sensitive|0
1866978|NCT00023712|6432317|P1|Overall Study|Not platinum sensitive|1
1866979|NCT00022698|6432341|P2|Overall Study|Administrative /other|7
1866980|NCT00022698|6432342|P1|Overall Study|Administrative /other|1
1866981|NCT00022698|6432341|P2|Overall Study|Insufficient therapeutic response|14
1866982|NCT00022698|6432342|P1|Overall Study|Insufficient therapeutic response|2
1866983|NCT00022698|6432341|P2|Overall Study|Refused treatment|2
1866984|NCT00022698|6432342|P1|Overall Study|Refused treatment|0
1866985|NCT00022698|6432341|P2|Overall Study|Failure to return|1
1866986|NCT00022698|6432342|P1|Overall Study|Failure to return|0
1866987|NCT00022698|6432341|P2|Overall Study|Death|2
1866988|NCT00022698|6432342|P1|Overall Study|Death|0
1866989|NCT00022698|6432341|P2|Overall Study|Adverse Event|9
1866990|NCT00022698|6432342|P1|Overall Study|Adverse Event|5
1866991|NCT00022672|6432367|P2|Extension Phase|Other|1
1866992|NCT00022672|6432368|P1|Extension Phase|Other|1
1866993|NCT00022672|6432367|P2|Extension Phase|Refused Treatment|2
1866994|NCT00022672|6432368|P1|Extension Phase|Refused Treatment|0
1866995|NCT00022672|6432367|P2|Extension Phase|Insufficient Therapeutic Response|44
1866996|NCT00022672|6432368|P1|Extension Phase|Insufficient Therapeutic Response|1
1866997|NCT00022672|6432367|P2|Extension Phase|Death|1
1866998|NCT00022672|6432368|P1|Extension Phase|Death|0
1866999|NCT00022672|6432367|P2|Extension Phase|Adverse Event|3
1867000|NCT00022672|6432368|P1|Extension Phase|Adverse Event|1
1867001|NCT00022672|6432367|P2|Main Phase: 24 Months|Other|0
1867002|NCT00022672|6432368|P1|Main Phase: 24 Months|Other|1
1867003|NCT00022672|6432367|P2|Main Phase: 24 Months|Failure to Return|1
1867004|NCT00022672|6432368|P1|Main Phase: 24 Months|Failure to Return|1
1867005|NCT00022672|6432367|P2|Main Phase: 24 Months|Refused Treatment|4
1867006|NCT00022672|6432368|P1|Main Phase: 24 Months|Refused Treatment|3
1867007|NCT00022672|6432367|P2|Main Phase: 24 Months|Other Protocol Violation|0
1867008|NCT00022672|6432368|P1|Main Phase: 24 Months|Other Protocol Violation|1
1867009|NCT00022672|6432367|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
1867010|NCT00022672|6432368|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
1867011|NCT00022672|6432367|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
1867012|NCT00022672|6432368|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
1867013|NCT00022672|6432367|P2|Main Phase: 24 Months|Death|3
1867014|NCT00022672|6432368|P1|Main Phase: 24 Months|Death|0
1867015|NCT00022672|6432367|P2|Main Phase: 24 Months|Adverse Event|0
1867016|NCT00022672|6432368|P1|Main Phase: 24 Months|Adverse Event|6
1867017|NCT00022659|6432401|P1|Overall Study|Never treated|1
1867018|NCT00022659|6432401|P1|Overall Study|Ineligible: wrong primary|1
1867019|NCT00022633|6432414|P2|Overall Study|Ineligible|0
1867020|NCT00022633|6432415|P1|Overall Study|Ineligible|4
1867021|NCT00022633|6432414|P2|Overall Study|Other - not protocol specified|2
1867022|NCT00022633|6432415|P1|Overall Study|Other - not protocol specified|3
1867023|NCT00022633|6432414|P2|Overall Study|Death|0
1867024|NCT00022633|6432415|P1|Overall Study|Death|4
1867025|NCT00022633|6432414|P2|Overall Study|Progression/relapse|2
1867026|NCT00022633|6432415|P1|Overall Study|Progression/relapse|9
1867027|NCT00022633|6432414|P2|Overall Study|Refusal unrelated to adverse event|0
1867028|NCT00022633|6432415|P1|Overall Study|Refusal unrelated to adverse event|1
1867029|NCT00022633|6432414|P2|Overall Study|Adverse Event|1
1867030|NCT00022633|6432415|P1|Overall Study|Adverse Event|11
1867031|NCT00022516|6432428|P2|Overall Study|Incomplete documentation|27
1867032|NCT00022516|6432429|P1|Overall Study|Incomplete documentation|0
1867033|NCT00022516|6432428|P2|Overall Study|Withdrawal by Subject|113
1867034|NCT00022516|6432429|P1|Overall Study|Withdrawal by Subject|2
1867035|NCT00022516|6432428|P2|Overall Study|Protocol Violation|3
1867036|NCT00022516|6432429|P1|Overall Study|Protocol Violation|1
1867037|NCT00022516|6432428|P2|Overall Study|Physician Decision|1
1867038|NCT00022516|6432429|P1|Overall Study|Physician Decision|0
1867039|NCT00022516|6432428|P2|Overall Study|Lack of Efficacy|27
1867040|NCT00022516|6432429|P1|Overall Study|Lack of Efficacy|0
1867041|NCT00022516|6432428|P2|Overall Study|Adverse Event|59
1867042|NCT00022516|6432429|P1|Overall Study|Adverse Event|0
1867043|NCT00021255|6432448|P3|Overall Study|Randomized but not treated|18
1867044|NCT00021255|6432449|P2|Overall Study|Randomized but not treated|2
1867045|NCT00021255|6432450|P1|Overall Study|Randomized but not treated|28
1867046|NCT00021255|6432448|P3|Overall Study|Missing|13
1867047|NCT00021255|6432449|P2|Overall Study|Missing|27
1867048|NCT00021255|6432450|P1|Overall Study|Missing|0
1867049|NCT00021255|6432448|P3|Overall Study|Other than specified above|19
1867050|NCT00021255|6432449|P2|Overall Study|Other than specified above|38
1867051|NCT00021255|6432450|P1|Overall Study|Other than specified above|0
1867052|NCT00021255|6432448|P3|Overall Study|Protocol Violation|0
1867053|NCT00021255|6432449|P2|Overall Study|Protocol Violation|2
1867054|NCT00021255|6432450|P1|Overall Study|Protocol Violation|0
1867055|NCT00021255|6432448|P3|Overall Study|Adverse Event|18
1867056|NCT00021255|6432449|P2|Overall Study|Adverse Event|30
1867057|NCT00021255|6432450|P1|Overall Study|Adverse Event|46
1867058|NCT00021255|6432448|P3|Overall Study|Herceptin toxicity|6
1867059|NCT00021255|6432449|P2|Overall Study|Herceptin toxicity|22
1867060|NCT00021255|6432450|P1|Overall Study|Herceptin toxicity|0
1867061|NCT00021255|6432448|P3|Overall Study|Cardiac toxicity|32
1867062|NCT00021255|6432449|P2|Overall Study|Cardiac toxicity|61
1867063|NCT00021255|6432450|P1|Overall Study|Cardiac toxicity|0
1867064|NCT00021255|6432448|P3|Overall Study|Lost to Follow-up|3
1867065|NCT00021255|6432449|P2|Overall Study|Lost to Follow-up|2
1867066|NCT00021255|6432450|P1|Overall Study|Lost to Follow-up|0
1867067|NCT00021255|6432448|P3|Overall Study|Withdrawal by Subject|26
1867068|NCT00021255|6432449|P2|Overall Study|Withdrawal by Subject|64
1867069|NCT00021255|6432450|P1|Overall Study|Withdrawal by Subject|41
1867070|NCT00021255|6432448|P3|Overall Study|Second primary malignancy|1
1867071|NCT00021255|6432449|P2|Overall Study|Second primary malignancy|4
1867072|NCT00021255|6432450|P1|Overall Study|Second primary malignancy|0
1867073|NCT00021255|6432448|P3|Overall Study|Breast cancer relapse|11
1867074|NCT00021255|6432449|P2|Overall Study|Breast cancer relapse|18
1867075|NCT00021255|6432450|P1|Overall Study|Breast cancer relapse|5
1867076|NCT00021255|6432448|P3|Overall Study|Death|2
1867077|NCT00021255|6432449|P2|Overall Study|Death|0
1867078|NCT00021255|6432450|P1|Overall Study|Death|1
1867079|NCT00021229|6432467|P3|Overall Study|Punctate hemmorrhage post RT|0
1867080|NCT00021229|6432468|P2|Overall Study|Punctate hemmorrhage post RT|0
1867081|NCT00021229|6432469|P1|Overall Study|Punctate hemmorrhage post RT|2
1867082|NCT00021229|6432467|P3|Overall Study|Physician Decision|1
1867083|NCT00021229|6432468|P2|Overall Study|Physician Decision|0
1867084|NCT00021229|6432469|P1|Overall Study|Physician Decision|0
1867085|NCT00021229|6432467|P3|Overall Study|Protocol Violation|0
1867086|NCT00021229|6432468|P2|Overall Study|Protocol Violation|1
1867087|NCT00021229|6432469|P1|Overall Study|Protocol Violation|1
1867088|NCT00021229|6432467|P3|Overall Study|Progressive Disease|12
1867089|NCT00021229|6432468|P2|Overall Study|Progressive Disease|19
1867090|NCT00021229|6432469|P1|Overall Study|Progressive Disease|15
1867091|NCT00021229|6432467|P3|Overall Study|Withdrawal by Subject|1
1867092|NCT00021229|6432468|P2|Overall Study|Withdrawal by Subject|7
1867093|NCT00021229|6432469|P1|Overall Study|Withdrawal by Subject|7
1867094|NCT00021229|6432467|P3|Overall Study|Death|0
1867095|NCT00021229|6432468|P2|Overall Study|Death|1
1867096|NCT00021229|6432469|P1|Overall Study|Death|0
1867097|NCT00021229|6432467|P3|Overall Study|Adverse Event|2
1867098|NCT00021229|6432468|P2|Overall Study|Adverse Event|5
1867099|NCT00021229|6432469|P1|Overall Study|Adverse Event|10
1867100|NCT00019604|6432524|P1|Overall Study|Details for other not available|4
1867101|NCT00019604|6432524|P1|Overall Study|Unable to evaluate|1
1867102|NCT00019604|6432524|P1|Overall Study|Too much disease|1
1867103|NCT00019604|6432524|P1|Overall Study|Pt going to immunotherapy study|1
1867104|NCT00019604|6432524|P1|Overall Study|Started new chemo regimen|1
1867105|NCT00019604|6432524|P1|Overall Study|Resectable disease|1
1867106|NCT00019604|6432524|P1|Overall Study|Non compliant|1
1867107|NCT00019604|6432524|P1|Overall Study|Non compliant on systemic CH|1
1867108|NCT00019604|6432524|P1|Overall Study|Move to a different study|1
1867109|NCT00019604|6432524|P1|Overall Study|Going to have liver transplant|1
1867110|NCT00019604|6432524|P1|Overall Study|Carcinoid tumor, not treatable|1
1867111|NCT00019604|6432524|P1|Overall Study|Refused treatment|1
1867112|NCT00019604|6432524|P1|Overall Study|Progressive disease|23
1867113|NCT00019604|6432524|P1|Overall Study|Death|1
1867114|NCT00016354|6432547|P8|Overall Study|Lack of Efficacy|1
1867115|NCT00016354|6432548|P7|Overall Study|Lack of Efficacy|0
1867116|NCT00016354|6432549|P6|Overall Study|Lack of Efficacy|0
1867117|NCT00016354|6432550|P5|Overall Study|Lack of Efficacy|0
1867118|NCT00016354|6432551|P4|Overall Study|Lack of Efficacy|0
1867119|NCT00016354|6432552|P3|Overall Study|Lack of Efficacy|0
1867120|NCT00016354|6432553|P2|Overall Study|Lack of Efficacy|0
1867121|NCT00016354|6432554|P1|Overall Study|Lack of Efficacy|0
1867122|NCT00014495|6432568|P4|Overall Study|Clinical deterioration|1
1867123|NCT00014495|6432569|P3|Overall Study|Clinical deterioration|0
1867124|NCT00014495|6432570|P2|Overall Study|Clinical deterioration|0
1867125|NCT00014495|6432571|P1|Overall Study|Clinical deterioration|0
1867126|NCT00014495|6432568|P4|Overall Study|Death|0
1867127|NCT00014495|6432569|P3|Overall Study|Death|1
1867128|NCT00014495|6432570|P2|Overall Study|Death|0
1867129|NCT00014495|6432571|P1|Overall Study|Death|0
1867130|NCT00012012|6432621|P2|Overall Study|Withdrawal by Subject|2
1867131|NCT00012012|6432622|P1|Overall Study|Withdrawal by Subject|0
1867132|NCT00012012|6432621|P2|Overall Study|Protocol Violation|1
1867133|NCT00012012|6432622|P1|Overall Study|Protocol Violation|1
1867134|NCT00010257|6432661|P2|Overall Study|Withdrawal by Subject|0
1867135|NCT00010257|6432662|P1|Overall Study|Withdrawal by Subject|1
1867136|NCT00009945|6432672|P2|Overall Study|no follow up data|5
1867137|NCT00009945|6432673|P1|Overall Study|no follow up data|7
1867138|NCT00008385|6432689|P2|Overall Study|Not start protocol therapy|175
1867139|NCT00008385|6432690|P1|Overall Study|Not start protocol therapy|44
1867140|NCT00008385|6432689|P2|Overall Study|Other|212
1867141|NCT00008385|6432690|P1|Overall Study|Other|105
1867142|NCT00008385|6432689|P2|Overall Study|Maximum dose reached|2
1867143|NCT00008385|6432690|P1|Overall Study|Maximum dose reached|0
1867144|NCT00008385|6432689|P2|Overall Study|Other complicating disease|30
1867145|NCT00008385|6432690|P1|Overall Study|Other complicating disease|17
1867146|NCT00008385|6432689|P2|Overall Study|Start non-protocol therapy|1
1867147|NCT00008385|6432690|P1|Overall Study|Start non-protocol therapy|3
1867148|NCT00008385|6432689|P2|Overall Study|Withdrawal by Subject|157
1867149|NCT00008385|6432690|P1|Overall Study|Withdrawal by Subject|67
1867150|NCT00008385|6432689|P2|Overall Study|Death|18
1867151|NCT00008385|6432690|P1|Overall Study|Death|12
1867152|NCT00008385|6432689|P2|Overall Study|Adverse Event|20
1867153|NCT00008385|6432690|P1|Overall Study|Adverse Event|8
1867154|NCT00008385|6432689|P2|Overall Study|Progressive disease|117
1867155|NCT00008385|6432690|P1|Overall Study|Progressive disease|52
1867156|NCT00008385|6432689|P2|Overall Study|Off treatment reasons not reported|70
1867157|NCT00008385|6432690|P1|Overall Study|Off treatment reasons not reported|79
1867158|NCT00008138|6432700|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
1867159|NCT00008138|6432700|P1|Post-Cytoreduction Chemotherapy|Progression|1
1867160|NCT00008138|6432700|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
1867161|NCT00008138|6432700|P1|Interval Debulking|Withdrawal by Subject|2
1867162|NCT00008138|6432700|P1|Neoadjuvant Chemotherapy|not protocol specified|8
1867163|NCT00008138|6432700|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
1867164|NCT00008138|6432700|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
1867165|NCT00008138|6432700|P1|Neoadjuvant Chemotherapy|Adverse Event|3
1867166|NCT00006916|6432706|P1|Overall Study|Complication of device insertion|1
1867167|NCT00006916|6432706|P1|Overall Study|Device not inserted|4
1867168|NCT00006903|6432712|P3|Overall Study|Ineligible|2
1867169|NCT00006903|6432713|P2|Overall Study|Ineligible|1
1867170|NCT00006903|6432714|P1|Overall Study|Ineligible|10
1867171|NCT00006903|6432712|P3|Overall Study|Patient never treated|1
1867172|NCT00006903|6432713|P2|Overall Study|Patient never treated|0
1867173|NCT00006903|6432714|P1|Overall Study|Patient never treated|0
1867174|NCT00006903|6432712|P3|Overall Study|Death|0
1867175|NCT00006903|6432713|P2|Overall Study|Death|1
1867176|NCT00006903|6432714|P1|Overall Study|Death|0
1867177|NCT00006903|6432712|P3|Overall Study|Adverse Event|1
1867178|NCT00006903|6432713|P2|Overall Study|Adverse Event|0
1867179|NCT00006903|6432714|P1|Overall Study|Adverse Event|0
1867180|NCT00006903|6432712|P3|Overall Study|Refused further treatment|1
1867181|NCT00006903|6432713|P2|Overall Study|Refused further treatment|2
1867182|NCT00006903|6432714|P1|Overall Study|Refused further treatment|0
1867183|NCT00006903|6432712|P3|Overall Study|Still receiving treatment|1
1867184|NCT00006903|6432713|P2|Overall Study|Still receiving treatment|0
1867185|NCT00006903|6432714|P1|Overall Study|Still receiving treatment|0
1867186|NCT00006721|6432727|P3|Overall Study|Eligible but no Treatment Received|0
1867187|NCT00006721|6432728|P2|Overall Study|Eligible but no Treatment Received|0
1867188|NCT00006721|6432729|P1|Overall Study|Eligible but no Treatment Received|1
1867189|NCT00006721|6432727|P3|Overall Study|Ineligible|10
1867190|NCT00006721|6432728|P2|Overall Study|Ineligible|12
1867191|NCT00006721|6432729|P1|Overall Study|Ineligible|2
1867192|NCT00006721|6432727|P3|Overall Study|Other - Not Protocol Specified|7
1867193|NCT00006721|6432728|P2|Overall Study|Other - Not Protocol Specified|7
1867194|NCT00006721|6432729|P1|Overall Study|Other - Not Protocol Specified|0
1867195|NCT00006721|6432727|P3|Overall Study|Death|2
1867196|NCT00006721|6432728|P2|Overall Study|Death|1
1867197|NCT00006721|6432729|P1|Overall Study|Death|0
1867198|NCT00006721|6432727|P3|Overall Study|Progression/Relapse|2
1867199|NCT00006721|6432728|P2|Overall Study|Progression/Relapse|1
1867200|NCT00006721|6432729|P1|Overall Study|Progression/Relapse|0
1867201|NCT00006721|6432727|P3|Overall Study|Refusal Unrelated to Adverse Event|8
1867202|NCT00006721|6432728|P2|Overall Study|Refusal Unrelated to Adverse Event|0
1867203|NCT00006721|6432729|P1|Overall Study|Refusal Unrelated to Adverse Event|1
1867204|NCT00006721|6432727|P3|Overall Study|Adverse Event|4
1867205|NCT00006721|6432728|P2|Overall Study|Adverse Event|4
1867206|NCT00006721|6432729|P1|Overall Study|Adverse Event|0
1867207|NCT00006478|6432747|P1|Overall Study|Physician Decision|6
1867208|NCT00006478|6432747|P1|Overall Study|Vaccine could not be produced|1
1867209|NCT00006392|6432758|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1867210|NCT00006392|6432759|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1867211|NCT00006392|6432760|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
1867212|NCT00006392|6432761|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
1867213|NCT00006392|6432758|P4|Overall Study|Ineligible|5
1867214|NCT00006392|6432759|P3|Overall Study|Ineligible|5
1867215|NCT00006392|6432760|P2|Overall Study|Ineligible|3
1867216|NCT00006392|6432761|P1|Overall Study|Ineligible|11
1867217|NCT00006389|6432791|P1|Overall Study|Adverse Event|1
1867218|NCT00006237|6432808|P2|Overall Study|Not protocol specified|5
1867219|NCT00006237|6432809|P1|Overall Study|Not protocol specified|14
1867220|NCT00006237|6432808|P2|Overall Study|Withdrawal by Subject|1
1867221|NCT00006237|6432809|P1|Overall Study|Withdrawal by Subject|0
1867222|NCT00006237|6432808|P2|Overall Study|Not eligible|20
1867223|NCT00006237|6432809|P1|Overall Study|Not eligible|9
1867224|NCT00006237|6432808|P2|Overall Study|Progression/relapse|2
1867225|NCT00006237|6432809|P1|Overall Study|Progression/relapse|54
1867226|NCT00006237|6432808|P2|Overall Study|Refusal unrelated to adverse effects|4
1867227|NCT00006237|6432809|P1|Overall Study|Refusal unrelated to adverse effects|8
1867228|NCT00006237|6432808|P2|Overall Study|Death|0
1867229|NCT00006237|6432809|P1|Overall Study|Death|1
1867230|NCT00006237|6432808|P2|Overall Study|Adverse Event|29
1867231|NCT00006237|6432809|P1|Overall Study|Adverse Event|39
1867232|NCT00006011|6432846|P3|Overall Study|Ineligible|9
1867233|NCT00006011|6432847|P2|Overall Study|Ineligible|16
1867234|NCT00006011|6432848|P1|Overall Study|Ineligible|18
1867235|NCT00006011|6432846|P3|Overall Study|Other|5
1867236|NCT00006011|6432847|P2|Overall Study|Other|2
1867237|NCT00006011|6432848|P1|Overall Study|Other|4
1867238|NCT00006011|6432846|P3|Overall Study|Death|2
1867239|NCT00006011|6432847|P2|Overall Study|Death|1
1867240|NCT00006011|6432848|P1|Overall Study|Death|0
1867241|NCT00006011|6432846|P3|Overall Study|Adverse Event|5
1867242|NCT00006011|6432847|P2|Overall Study|Adverse Event|39
1867243|NCT00006011|6432848|P1|Overall Study|Adverse Event|15
1867244|NCT00006011|6432846|P3|Overall Study|Refused further treatment|26
1867245|NCT00006011|6432847|P2|Overall Study|Refused further treatment|13
1867246|NCT00006011|6432848|P1|Overall Study|Refused further treatment|15
1867247|NCT00006011|6432846|P3|Overall Study|Disease progression|26
1867248|NCT00006011|6432847|P2|Overall Study|Disease progression|6
1867249|NCT00006011|6432848|P1|Overall Study|Disease progression|13
1867250|NCT00005957|6432856|P2|Overall Study|Crossover to the other arm|19
1867251|NCT00005957|6432857|P1|Overall Study|Crossover to the other arm|5
1867252|NCT00005957|6432856|P2|Overall Study|No treated|9
1867253|NCT00005957|6432857|P1|Overall Study|No treated|3
1867254|NCT00005879|6432867|P2|Overall Study|Withdrawal by Subject|10
1867255|NCT00005879|6432868|P1|Overall Study|Withdrawal by Subject|8
1867256|NCT00005047|6432891|P4|Overall Study|Lack of Efficacy|0
1867257|NCT00005047|6432892|P3|Overall Study|Lack of Efficacy|0
1867258|NCT00005047|6432893|P2|Overall Study|Lack of Efficacy|0
1867259|NCT00005047|6432894|P1|Overall Study|Lack of Efficacy|1
1867260|NCT00005047|6432891|P4|Overall Study|Lost to Follow-up|0
1867261|NCT00005047|6432892|P3|Overall Study|Lost to Follow-up|0
1867262|NCT00005047|6432893|P2|Overall Study|Lost to Follow-up|0
1867263|NCT00005047|6432894|P1|Overall Study|Lost to Follow-up|1
1867264|NCT00005047|6432891|P4|Overall Study|Adverse Event|0
1867265|NCT00005047|6432892|P3|Overall Study|Adverse Event|0
1867266|NCT00005047|6432893|P2|Overall Study|Adverse Event|0
1867267|NCT00005047|6432894|P1|Overall Study|Adverse Event|5
1867268|NCT00005047|6432891|P4|Overall Study|Withdrawal by Subject|0
1867269|NCT00005047|6432892|P3|Overall Study|Withdrawal by Subject|0
1867270|NCT00005047|6432893|P2|Overall Study|Withdrawal by Subject|0
1867271|NCT00005047|6432894|P1|Overall Study|Withdrawal by Subject|12
1867272|NCT00005044|6432910|P2|Overall Study|No protocol treatment|1
1867273|NCT00005044|6432911|P1|Overall Study|No protocol treatment|0
1867274|NCT00005044|6432910|P2|Overall Study|Withdrawal by Subject|5
1867275|NCT00005044|6432911|P1|Overall Study|Withdrawal by Subject|1
1867276|NCT00005044|6432910|P2|Overall Study|Protocol Violation|46
1867277|NCT00005044|6432911|P1|Overall Study|Protocol Violation|37
1867278|NCT00004888|6432931|P2|Overall Study|Toxic death|0
1867279|NCT00004888|6432932|P1|Overall Study|Toxic death|1
1867280|NCT00004888|6432931|P2|Overall Study|Death without progressive disease|1
1867281|NCT00004888|6432932|P1|Overall Study|Death without progressive disease|0
1867282|NCT00004888|6432931|P2|Overall Study|Progressive Disease|9
1867283|NCT00004888|6432932|P1|Overall Study|Progressive Disease|4
1867284|NCT00004888|6432931|P2|Overall Study|Physician Decision|1
1867285|NCT00004888|6432932|P1|Overall Study|Physician Decision|1
1867286|NCT00004888|6432931|P2|Overall Study|Withdrawal by Subject|3
1867287|NCT00004888|6432932|P1|Overall Study|Withdrawal by Subject|0
1867288|NCT00004888|6432931|P2|Overall Study|Adverse Event|10
1867289|NCT00004888|6432932|P1|Overall Study|Adverse Event|5
1867290|NCT00004859|6432950|P2|Overall Study|Other|21
1867291|NCT00004859|6432951|P1|Overall Study|Other|13
1867292|NCT00004859|6432950|P2|Overall Study|missing data|11
1867293|NCT00004859|6432951|P1|Overall Study|missing data|14
1867294|NCT00004859|6432950|P2|Overall Study|error|1
1867295|NCT00004859|6432951|P1|Overall Study|error|3
1867296|NCT00004859|6432950|P2|Overall Study|other disease|3
1867297|NCT00004859|6432951|P1|Overall Study|other disease|0
1867298|NCT00004859|6432950|P2|Overall Study|Protocol Violation|2
1867299|NCT00004859|6432951|P1|Overall Study|Protocol Violation|2
1867300|NCT00004859|6432950|P2|Overall Study|Withdrawal by Subject|33
1867301|NCT00004859|6432951|P1|Overall Study|Withdrawal by Subject|7
1867302|NCT00004859|6432950|P2|Overall Study|Death|5
1867303|NCT00004859|6432951|P1|Overall Study|Death|5
1867304|NCT00004859|6432950|P2|Overall Study|Adverse Event|93
1867305|NCT00004859|6432951|P1|Overall Study|Adverse Event|31
1867306|NCT00004859|6432950|P2|Overall Study|Lack of Efficacy|113
1867307|NCT00004859|6432951|P1|Overall Study|Lack of Efficacy|43
1867308|NCT00004259|6432965|P4|Overall Study|Withdrawal by Subject|0
1867309|NCT00004259|6432966|P3|Overall Study|Withdrawal by Subject|0
1867310|NCT00004259|6432967|P2|Overall Study|Withdrawal by Subject|2
1867311|NCT00004259|6432968|P1|Overall Study|Withdrawal by Subject|0
1867312|NCT00004259|6432965|P4|Overall Study|Protocol Violation|0
1867313|NCT00004259|6432966|P3|Overall Study|Protocol Violation|0
1867314|NCT00004259|6432967|P2|Overall Study|Protocol Violation|2
1867315|NCT00004259|6432968|P1|Overall Study|Protocol Violation|1
1867316|NCT00004228|6432993|P7|Overall Study|ineligible|5
1867317|NCT00004228|6432994|P6|Overall Study|ineligible|2
1867318|NCT00004228|6432995|P5|Overall Study|ineligible|1
1867319|NCT00004228|6432996|P4|Overall Study|ineligible|1
1867320|NCT00004228|6432997|P3|Overall Study|ineligible|4
1867321|NCT00004228|6432998|P2|Overall Study|ineligible|2
1867322|NCT00004228|6432999|P1|Overall Study|ineligible|4
1867323|NCT00004228|6432993|P7|Overall Study|Other|0
1867324|NCT00004228|6432994|P6|Overall Study|Other|0
1867325|NCT00004228|6432995|P5|Overall Study|Other|0
1867326|NCT00004228|6432996|P4|Overall Study|Other|0
1867327|NCT00004228|6432997|P3|Overall Study|Other|1
1867328|NCT00004228|6432998|P2|Overall Study|Other|0
1867329|NCT00004228|6432999|P1|Overall Study|Other|0
1867330|NCT00004228|6432993|P7|Overall Study|Withdrawal by Subject|2
1867331|NCT00004228|6432994|P6|Overall Study|Withdrawal by Subject|1
1867332|NCT00004228|6432995|P5|Overall Study|Withdrawal by Subject|2
1867333|NCT00004228|6432996|P4|Overall Study|Withdrawal by Subject|0
1867334|NCT00004228|6432997|P3|Overall Study|Withdrawal by Subject|1
1867335|NCT00004228|6432998|P2|Overall Study|Withdrawal by Subject|0
1867336|NCT00004228|6432999|P1|Overall Study|Withdrawal by Subject|3
1867337|NCT00004228|6432993|P7|Overall Study|Protocol Violation|0
1867338|NCT00004228|6432994|P6|Overall Study|Protocol Violation|2
1867339|NCT00004228|6432995|P5|Overall Study|Protocol Violation|1
1867340|NCT00004228|6432996|P4|Overall Study|Protocol Violation|1
1867341|NCT00004228|6432997|P3|Overall Study|Protocol Violation|2
1867342|NCT00004228|6432998|P2|Overall Study|Protocol Violation|5
1867343|NCT00004228|6432999|P1|Overall Study|Protocol Violation|0
1867344|NCT00004228|6432993|P7|Overall Study|Physician Decision|1
1867345|NCT00004228|6432994|P6|Overall Study|Physician Decision|1
1867346|NCT00004228|6432995|P5|Overall Study|Physician Decision|1
1867347|NCT00004228|6432996|P4|Overall Study|Physician Decision|2
1867348|NCT00004228|6432997|P3|Overall Study|Physician Decision|3
1867349|NCT00004228|6432998|P2|Overall Study|Physician Decision|0
1867350|NCT00004228|6432999|P1|Overall Study|Physician Decision|1
1867351|NCT00004228|6432993|P7|Overall Study|Lost to Follow-up|0
1867352|NCT00004228|6432994|P6|Overall Study|Lost to Follow-up|0
1867353|NCT00004228|6432995|P5|Overall Study|Lost to Follow-up|0
1867354|NCT00004228|6432996|P4|Overall Study|Lost to Follow-up|0
1867355|NCT00004228|6432997|P3|Overall Study|Lost to Follow-up|1
1867356|NCT00004228|6432998|P2|Overall Study|Lost to Follow-up|0
1867357|NCT00004228|6432999|P1|Overall Study|Lost to Follow-up|0
1867358|NCT00004228|6432993|P7|Overall Study|Lack of Efficacy|4
1867359|NCT00004228|6432994|P6|Overall Study|Lack of Efficacy|8
1867360|NCT00004228|6432995|P5|Overall Study|Lack of Efficacy|9
1867361|NCT00004228|6432996|P4|Overall Study|Lack of Efficacy|3
1867362|NCT00004228|6432997|P3|Overall Study|Lack of Efficacy|5
1867363|NCT00004228|6432998|P2|Overall Study|Lack of Efficacy|6
1867364|NCT00004228|6432999|P1|Overall Study|Lack of Efficacy|1
1867365|NCT00004228|6432993|P7|Overall Study|Death|0
1867366|NCT00004228|6432994|P6|Overall Study|Death|0
1867367|NCT00004228|6432995|P5|Overall Study|Death|1
1867368|NCT00004228|6432996|P4|Overall Study|Death|0
1867369|NCT00004228|6432997|P3|Overall Study|Death|2
1867370|NCT00004228|6432998|P2|Overall Study|Death|1
1867371|NCT00004228|6432999|P1|Overall Study|Death|0
1867372|NCT00004228|6432993|P7|Overall Study|Adverse Event|0
1867373|NCT00004228|6432994|P6|Overall Study|Adverse Event|0
1867374|NCT00004228|6432995|P5|Overall Study|Adverse Event|1
1867375|NCT00004228|6432996|P4|Overall Study|Adverse Event|0
1867376|NCT00004228|6432997|P3|Overall Study|Adverse Event|0
1867377|NCT00004228|6432998|P2|Overall Study|Adverse Event|1
1867378|NCT00004228|6432999|P1|Overall Study|Adverse Event|0
1867379|NCT00004124|6433033|P2|Overall Study|Received no protocol therapy|20
1867380|NCT00004124|6433034|P1|Overall Study|Received no protocol therapy|12
1867381|NCT00004088|6433059|P1|Overall Study|Physician Decision|1
1867382|NCT00004088|6433059|P1|Overall Study|Protocol Violation|3
1867383|NCT00004088|6433059|P1|Overall Study|Withdrawal by Subject|1
1867384|NCT00004088|6433059|P1|Overall Study|No C2 given due to study on hold by IRB|4
1867385|NCT00003901|6433092|P1|Overall Study|Medical problems|6
1867386|NCT00003901|6433092|P1|Overall Study|Chest X-Ray not done prior registration|1
1867387|NCT00003901|6433092|P1|Overall Study|CT Scan not within protocol requirement|2
1867388|NCT00003901|6433092|P1|Overall Study|Ineligible|6
1867389|NCT00003901|6433092|P1|Overall Study|Withdrawal by Subject|1
1867390|NCT00003901|6433092|P1|Overall Study|Adverse Event|1
1867391|NCT00003896|6433103|P1|Overall Study|ineligible|5
1867392|NCT00003896|6433103|P1|Overall Study|not protocol specified|3
1867393|NCT00003896|6433103|P1|Overall Study|Death|3
1867394|NCT00003896|6433103|P1|Overall Study|Lack of Efficacy|1
1867395|NCT00003896|6433103|P1|Overall Study|Withdrawal by Subject|1
1867396|NCT00003896|6433103|P1|Overall Study|Adverse Event|16
1867397|NCT00003875|6433109|P1|Overall Study|Screen Failed|1
1867398|NCT00003869|6433118|P2|Overall Study|Alternative treatmnt, medical problems|4
1867399|NCT00003869|6433119|P1|Overall Study|Alternative treatmnt, medical problems|5
1867400|NCT00003869|6433118|P2|Overall Study|Death|2
1867401|NCT00003869|6433119|P1|Overall Study|Death|1
1867402|NCT00003869|6433118|P2|Overall Study|Withdrawal by Subject|3
1867403|NCT00003869|6433119|P1|Overall Study|Withdrawal by Subject|21
1867404|NCT00003869|6433118|P2|Overall Study|Adverse Event|3
1867405|NCT00003869|6433119|P1|Overall Study|Adverse Event|14
1867406|NCT00003782|6433145|P3|Overall Study|No follow up data|26
1867407|NCT00003782|6433146|P2|Overall Study|No follow up data|31
1867408|NCT00003782|6433147|P1|Overall Study|No follow up data|30
1867409|NCT00003702|6433157|P2|Overall Study|Inadequate documentation of disease|3
1867410|NCT00003702|6433158|P1|Overall Study|Inadequate documentation of disease|1
1867411|NCT00003702|6433157|P2|Overall Study|WHO score > 6|1
1867412|NCT00003702|6433158|P1|Overall Study|WHO score > 6|2
1867413|NCT00003702|6433157|P2|Overall Study|Did not meet criteria for persistence|5
1867414|NCT00003702|6433158|P1|Overall Study|Did not meet criteria for persistence|8
1867415|NCT00003702|6433157|P2|Overall Study|Ineligible cell types|2
1867416|NCT00003702|6433158|P1|Overall Study|Ineligible cell types|2
1867417|NCT00003659|6433167|P1|Overall Study|Withdrawal by Subject|3
1867418|NCT00003641|6433188|P2|Overall Study|Never started interferon|12
1867419|NCT00003641|6433189|P1|Overall Study|Never started interferon|567
1867420|NCT00003641|6433188|P2|Overall Study|Should not receive interferon therapy|0
1867421|NCT00003641|6433189|P1|Overall Study|Should not receive interferon therapy|2
1867422|NCT00003641|6433188|P2|Overall Study|Unknown/missing|22
1867423|NCT00003641|6433189|P1|Overall Study|Unknown/missing|0
1867424|NCT00003641|6433188|P2|Overall Study|Disease progression|2
1867425|NCT00003641|6433189|P1|Overall Study|Disease progression|0
1867426|NCT00003641|6433188|P2|Overall Study|Adverse Event|38
1867427|NCT00003641|6433189|P1|Overall Study|Adverse Event|0
1867428|NCT00003641|6433188|P2|Overall Study|Withdrawal by Subject|100
1867429|NCT00003641|6433189|P1|Overall Study|Withdrawal by Subject|0
1867430|NCT00003631|6433200|P3|Overall Study|Evaluable for toxicity only|2
1867431|NCT00003631|6433201|P2|Overall Study|Evaluable for toxicity only|0
1867432|NCT00003631|6433202|P1|Overall Study|Evaluable for toxicity only|0
1867433|NCT00003631|6433200|P3|Overall Study|Death|1
1867434|NCT00003631|6433201|P2|Overall Study|Death|0
1867435|NCT00003631|6433202|P1|Overall Study|Death|0
1867436|NCT00003631|6433200|P3|Overall Study|Adverse Event|5
1867437|NCT00003631|6433201|P2|Overall Study|Adverse Event|1
1867438|NCT00003631|6433202|P1|Overall Study|Adverse Event|1
1867439|NCT00003631|6433200|P3|Overall Study|Protocol Violation|0
1867440|NCT00003631|6433201|P2|Overall Study|Protocol Violation|0
1867441|NCT00003631|6433202|P1|Overall Study|Protocol Violation|1
1867442|NCT00003631|6433200|P3|Overall Study|Patient not treated|1
1867443|NCT00003631|6433201|P2|Overall Study|Patient not treated|0
1867444|NCT00003631|6433202|P1|Overall Study|Patient not treated|1
1867445|NCT00003590|6433210|P1|Overall Study|Physician Decision|1
1867446|NCT00003590|6433210|P1|Overall Study|Death|1
1867447|NCT00003590|6433210|P1|Overall Study|Lack of Efficacy|11
1867448|NCT00003590|6433210|P1|Overall Study|Withdrawal by Subject|1
1867449|NCT00003590|6433210|P1|Overall Study|Adverse Event|7
1867450|NCT00003590|6433210|P1|Overall Study|Ineligible Patient|1
1867451|NCT00003537|6433215|P1|Overall Study|Not evalauable|1
1867452|NCT00003535|6433220|P1|Overall Study|Not evaluable|5
1867453|NCT00003499|6433225|P1|Overall Study|Not evaluable|8
1867454|NCT00003483|6433230|P1|Overall Study|Not evaluable|1
1867455|NCT00003479|6433235|P1|Overall Study|Not evaluable|3
1867456|NCT00003477|6433240|P1|Overall Study|Not evalauable|4
1867457|NCT00003476|6433245|P1|Overall Study|Not evaluable|1
1867458|NCT00003475|6433250|P1|Overall Study|Not evaluable|13
1867459|NCT00003474|6433255|P1|Overall Study|Not Evaluable|14
1867460|NCT00003473|6433260|P1|Overall Study|Three patients were not evaluable.|3
1867461|NCT00003472|6433265|P1|Overall Study|Not evaluable|3
1867462|NCT00003471|6433270|P1|Overall Study|Not evaluable|4
1867463|NCT00003470|6433275|P1|Overall Study|Not evaluable|6
1867464|NCT00003458|6433300|P1|Overall Study|Not evaluable|4
1867465|NCT00003457|6433305|P1|Overall Study|Not evaluable|9
1867466|NCT00003456|6433310|P1|Overall Study|Not evaluable|8
1867467|NCT00003389|6433327|P2|Overall Study|Ineligible|27
1867468|NCT00003389|6433328|P1|Overall Study|Ineligible|33
1867469|NCT00003389|6433327|P2|Overall Study|Off-treatment reason missing|21
1867470|NCT00003389|6433328|P1|Overall Study|Off-treatment reason missing|31
1867471|NCT00003389|6433327|P2|Overall Study|Complicating disease|0
1867472|NCT00003389|6433328|P1|Overall Study|Complicating disease|1
1867473|NCT00003389|6433327|P2|Overall Study|Alternative therapy|1
1867474|NCT00003389|6433328|P1|Overall Study|Alternative therapy|2
1867475|NCT00003389|6433327|P2|Overall Study|Withdrawal by Subject|5
1867476|NCT00003389|6433328|P1|Overall Study|Withdrawal by Subject|12
1867477|NCT00003389|6433327|P2|Overall Study|Death|3
1867478|NCT00003389|6433328|P1|Overall Study|Death|0
1867479|NCT00003389|6433327|P2|Overall Study|Adverse Event|2
1867480|NCT00003389|6433328|P1|Overall Study|Adverse Event|13
1867481|NCT00003389|6433327|P2|Overall Study|Disease progression|1
1867482|NCT00003389|6433328|P1|Overall Study|Disease progression|6
1867483|NCT00003377|6433343|P5|Period II|Ureteral stent complications|1
1867484|NCT00003377|6433344|P4|Period II|Ureteral stent complications|0
1867485|NCT00003377|6433345|P3|Period II|Ureteral stent complications|0
1867486|NCT00003377|6433346|P2|Period II|Ureteral stent complications|0
1867487|NCT00003377|6433347|P1|Period II|Ureteral stent complications|0
1867488|NCT00003377|6433343|P5|Period I|Dose Limiting Toxicity(DLT)|0
1867489|NCT00003377|6433344|P4|Period I|Dose Limiting Toxicity(DLT)|1
1867490|NCT00003377|6433345|P3|Period I|Dose Limiting Toxicity(DLT)|1
1867491|NCT00003377|6433346|P2|Period I|Dose Limiting Toxicity(DLT)|0
1867492|NCT00003377|6433347|P1|Period I|Dose Limiting Toxicity(DLT)|0
1867493|NCT00003199|6433361|P1|Overall Study|Screen fail|15
1867494|NCT00003199|6433361|P1|Overall Study|Lack of insurance clearance|2
1867495|NCT00003199|6433361|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
1867496|NCT00003138|6433369|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
1867497|NCT00003138|6433370|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
1867498|NCT00003138|6433369|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
1867499|NCT00003138|6433370|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
1867500|NCT00003138|6433369|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
1867501|NCT00003138|6433370|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
1867502|NCT00003138|6433369|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
1867503|NCT00003138|6433370|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
1867504|NCT00003138|6433369|P2|Step 1|Never started treatment|0
1867505|NCT00003138|6433370|P1|Step 1|Never started treatment|1
1867506|NCT00003138|6433369|P2|Step 1|Reasons off treatment not documented|57
1867507|NCT00003138|6433370|P1|Step 1|Reasons off treatment not documented|60
1867508|NCT00002931|6433387|P1|Overall Study|rapidly progressing disease during|2
1867509|NCT00002874|6433395|P2|Overall Study|Protocol Violation|34
1867510|NCT00002874|6433396|P1|Overall Study|Protocol Violation|44
1867511|NCT00002874|6433395|P2|Overall Study|Withdrawal by Subject|1
1867512|NCT00002874|6433396|P1|Overall Study|Withdrawal by Subject|1
1867513|NCT00002850|6433421|P3|Overall Study|Withdrawal by Subject|0
1867514|NCT00002850|6433422|P2|Overall Study|Withdrawal by Subject|1
1867515|NCT00002850|6433423|P1|Overall Study|Withdrawal by Subject|0
1867516|NCT00002850|6433421|P3|Overall Study|Protocol Violation|1
1867517|NCT00002850|6433422|P2|Overall Study|Protocol Violation|0
1867518|NCT00002850|6433423|P1|Overall Study|Protocol Violation|1
1867519|NCT00002850|6433421|P3|Overall Study|Death|3
1867520|NCT00002850|6433422|P2|Overall Study|Death|1
1867521|NCT00002850|6433423|P1|Overall Study|Death|4
1867522|NCT00002842|6433431|P1|Overall Study|ineligible for surgical resection|27
1867523|NCT00002766|6433437|P2|Overall Study|Protocol Violation|0
1867524|NCT00002766|6433438|P1|Overall Study|Protocol Violation|1
1867525|NCT00002766|6433437|P2|Overall Study|Adverse Event|1
1867526|NCT00002766|6433438|P1|Overall Study|Adverse Event|1
1867527|NCT00002766|6433437|P2|Overall Study|Patient Not Treated|2
1867528|NCT00002766|6433438|P1|Overall Study|Patient Not Treated|1
1867529|NCT00002766|6433437|P2|Overall Study|Withdrawal by Subject|1
1867530|NCT00002766|6433438|P1|Overall Study|Withdrawal by Subject|0
1867531|NCT00002651|6433446|P3|Consolidation and Randomization|not eligible|112
1867532|NCT00002651|6433447|P2|Consolidation and Randomization|not eligible|102
1867533|NCT00002651|6433448|P1|Consolidation and Randomization|not eligible|0
1867534|NCT00002651|6433446|P3|Consolidation and Randomization|Other|313
1867535|NCT00002651|6433447|P2|Consolidation and Randomization|Other|314
1867536|NCT00002651|6433448|P1|Consolidation and Randomization|Other|0
1867537|NCT00002651|6433446|P3|Consolidation and Randomization|Death|48
1867538|NCT00002651|6433447|P2|Consolidation and Randomization|Death|38
1867539|NCT00002651|6433448|P1|Consolidation and Randomization|Death|0
1867540|NCT00002651|6433446|P3|Consolidation and Randomization|Progression/relapse|298
1867541|NCT00002651|6433447|P2|Consolidation and Randomization|Progression/relapse|295
1867542|NCT00002651|6433448|P1|Consolidation and Randomization|Progression/relapse|0
1867543|NCT00002651|6433446|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
1867544|NCT00002651|6433447|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
1867545|NCT00002651|6433448|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
1867546|NCT00002651|6433446|P3|Consolidation and Randomization|Adverse Event|14
1867547|NCT00002651|6433447|P2|Consolidation and Randomization|Adverse Event|36
1867548|NCT00002651|6433448|P1|Consolidation and Randomization|Adverse Event|0
1867549|NCT00002651|6433446|P3|Induction|not eligible|0
1867550|NCT00002651|6433447|P2|Induction|not eligible|0
1867551|NCT00002651|6433448|P1|Induction|not eligible|90
1867552|NCT00002651|6433446|P3|Induction|Other|0
1867553|NCT00002651|6433447|P2|Induction|Other|0
1867554|NCT00002651|6433448|P1|Induction|Other|823
1867555|NCT00002651|6433446|P3|Induction|Death|0
1867556|NCT00002651|6433447|P2|Induction|Death|0
1867557|NCT00002651|6433448|P1|Induction|Death|62
1867558|NCT00002651|6433446|P3|Induction|Progression/relapse|0
1867559|NCT00002651|6433447|P2|Induction|Progression/relapse|0
1867560|NCT00002651|6433448|P1|Induction|Progression/relapse|274
1867561|NCT00002651|6433446|P3|Induction|Refusal unrelated to adverse event|0
1867562|NCT00002651|6433447|P2|Induction|Refusal unrelated to adverse event|0
1867563|NCT00002651|6433448|P1|Induction|Refusal unrelated to adverse event|50
1867564|NCT00002651|6433446|P3|Induction|Adverse Event|0
1867565|NCT00002651|6433447|P2|Induction|Adverse Event|0
1867566|NCT00002651|6433448|P1|Induction|Adverse Event|44
1867567|NCT00002558|6433466|P2|Overall Study|Withdrawal by Subject|1
1867568|NCT00002558|6433467|P1|Overall Study|Withdrawal by Subject|0
1867569|NCT00051636|6433492|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
1867570|NCT00051636|6433493|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
1867571|NCT00051636|6433492|P2|Period 2- Extended Observation Period|Death|5
1867572|NCT00051636|6433493|P1|Period 2- Extended Observation Period|Death|4
1867573|NCT00051636|6433492|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
1867574|NCT00051636|6433493|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
1867575|NCT00051636|6433492|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
1867576|NCT00051636|6433493|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
1867577|NCT00051636|6433492|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
1867578|NCT00051636|6433493|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
1867579|NCT00051636|6433492|P2|Period 1 - Core|Lost to Follow-up|2
1867580|NCT00051636|6433493|P1|Period 1 - Core|Lost to Follow-up|0
1867581|NCT00051636|6433492|P2|Period 1 - Core|Withdrawal by Subject|2
1867582|NCT00051636|6433493|P1|Period 1 - Core|Withdrawal by Subject|1
1867583|NCT00051636|6433492|P2|Period 1 - Core|Protocol Violation|0
1867584|NCT00051636|6433493|P1|Period 1 - Core|Protocol Violation|1
1867585|NCT00051636|6433492|P2|Period 1 - Core|Adverse Event|2
1867586|NCT00051636|6433493|P1|Period 1 - Core|Adverse Event|2
1867587|NCT00051558|6433521|P2|Overall Study|Physician Decision|0
1867588|NCT00051558|6433522|P1|Overall Study|Physician Decision|5
1867589|NCT00051558|6433521|P2|Overall Study|Significant Lab Value|0
1867590|NCT00051558|6433522|P1|Overall Study|Significant Lab Value|2
1867591|NCT00051558|6433521|P2|Overall Study|Other|1
1867592|NCT00051558|6433522|P1|Overall Study|Other|2
1867593|NCT00051558|6433521|P2|Overall Study|Sponsor Decision|1
1867594|NCT00051558|6433522|P1|Overall Study|Sponsor Decision|6
1867595|NCT00051558|6433521|P2|Overall Study|Protocol Entry Criteria Unmet|2
1867596|NCT00051558|6433522|P1|Overall Study|Protocol Entry Criteria Unmet|1
1867597|NCT00051558|6433521|P2|Overall Study|Protocol Violation|4
1867598|NCT00051558|6433522|P1|Overall Study|Protocol Violation|3
1867599|NCT00051558|6433521|P2|Overall Study|Lost to Follow-up|13
1867600|NCT00051558|6433522|P1|Overall Study|Lost to Follow-up|4
1867601|NCT00051558|6433521|P2|Overall Study|Death|15
1867602|NCT00051558|6433522|P1|Overall Study|Death|9
1867603|NCT00051558|6433521|P2|Overall Study|Withdrawal by Subject|42
1867604|NCT00051558|6433522|P1|Overall Study|Withdrawal by Subject|29
1867605|NCT00051558|6433521|P2|Overall Study|Adverse Event|18
1867606|NCT00051558|6433522|P1|Overall Study|Adverse Event|30
1867607|NCT00051363|6433558|P2|Overall Study|Excluded Pre-Randomization|5
1867608|NCT00051363|6433559|P1|Overall Study|Excluded Pre-Randomization|2
1867609|NCT00051363|6433558|P2|Overall Study|Death|2
1867610|NCT00051363|6433559|P1|Overall Study|Death|2
1867611|NCT00051363|6433558|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
1867612|NCT00051363|6433559|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
1867613|NCT00051363|6433558|P2|Overall Study|Dropped Post-Rand for Any Reason|126
1867614|NCT00051363|6433559|P1|Overall Study|Dropped Post-Rand for Any Reason|102
1867615|NCT00051025|6433599|P2|Overall Study|Death|1
1867616|NCT00051025|6433600|P1|Overall Study|Death|0
1867617|NCT00051025|6433599|P2|Overall Study|Withdrawal by Subject|1
1867618|NCT00051025|6433600|P1|Overall Study|Withdrawal by Subject|0
1867619|NCT00051025|6433599|P2|Overall Study|Adverse Event|1
1867620|NCT00051025|6433600|P1|Overall Study|Adverse Event|1
1867621|NCT00051025|6433599|P2|Overall Study|Progressive Disease|1
1867622|NCT00051025|6433600|P1|Overall Study|Progressive Disease|1
1867623|NCT00050960|6433614|P2|Overall Study|Death|15
1867624|NCT00050960|6433615|P1|Overall Study|Death|13
1867625|NCT00050960|6433614|P2|Overall Study|Non-compliance|1
1867626|NCT00050960|6433615|P1|Overall Study|Non-compliance|3
1867627|NCT00050960|6433614|P2|Overall Study|Administrative|46
1867628|NCT00050960|6433615|P1|Overall Study|Administrative|31
1867629|NCT00050960|6433614|P2|Overall Study|Withdrawal by Subject|18
1867630|NCT00050960|6433615|P1|Overall Study|Withdrawal by Subject|23
1867631|NCT00050960|6433614|P2|Overall Study|Lost to Follow-up|1
1867632|NCT00050960|6433615|P1|Overall Study|Lost to Follow-up|0
1867633|NCT00050960|6433614|P2|Overall Study|Adverse Event|61
1867634|NCT00050960|6433615|P1|Overall Study|Adverse Event|62
1867635|NCT00050960|6433614|P2|Overall Study|Complete Response|2
1867636|NCT00050960|6433615|P1|Overall Study|Complete Response|0
1867637|NCT00050960|6433614|P2|Overall Study|Partial Response|19
1867638|NCT00050960|6433615|P1|Overall Study|Partial Response|14
1867639|NCT00050960|6433614|P2|Overall Study|Stable Disease|48
1867640|NCT00050960|6433615|P1|Overall Study|Stable Disease|19
1867641|NCT00050960|6433614|P2|Overall Study|Progressive Disease|93
1867642|NCT00050960|6433615|P1|Overall Study|Progressive Disease|137
1867643|NCT00050778|6433624|P3|Overall Study|Familial and personal reasons|0
1867644|NCT00050778|6433625|P2|Overall Study|Familial and personal reasons|0
1867645|NCT00050778|6433626|P1|Overall Study|Familial and personal reasons|1
1867646|NCT00050778|6433624|P3|Overall Study|Randomized but not treated|2
1867647|NCT00050778|6433625|P2|Overall Study|Randomized but not treated|5
1867648|NCT00050778|6433626|P1|Overall Study|Randomized but not treated|4
1867649|NCT00050778|6433624|P3|Overall Study|Withdrawal by Subject|4
1867650|NCT00050778|6433625|P2|Overall Study|Withdrawal by Subject|8
1867651|NCT00050778|6433626|P1|Overall Study|Withdrawal by Subject|6
1867652|NCT00050778|6433624|P3|Overall Study|Protocol Violation|1
1867653|NCT00050778|6433625|P2|Overall Study|Protocol Violation|0
1867654|NCT00050778|6433626|P1|Overall Study|Protocol Violation|2
1867655|NCT00050778|6433624|P3|Overall Study|Physician Decision|2
1867656|NCT00050778|6433625|P2|Overall Study|Physician Decision|0
1867657|NCT00050778|6433626|P1|Overall Study|Physician Decision|3
1867658|NCT00050778|6433624|P3|Overall Study|Lost to Follow-up|4
1867659|NCT00050778|6433625|P2|Overall Study|Lost to Follow-up|2
1867660|NCT00050778|6433626|P1|Overall Study|Lost to Follow-up|0
1867661|NCT00050778|6433624|P3|Overall Study|Lack of Efficacy|2
1867662|NCT00050778|6433625|P2|Overall Study|Lack of Efficacy|2
1867663|NCT00050778|6433626|P1|Overall Study|Lack of Efficacy|16
1867664|NCT00050778|6433624|P3|Overall Study|Death|1
1867665|NCT00050778|6433625|P2|Overall Study|Death|1
1867666|NCT00050778|6433626|P1|Overall Study|Death|0
1867667|NCT00050778|6433624|P3|Overall Study|Adverse Event|2
1867668|NCT00050778|6433625|P2|Overall Study|Adverse Event|3
1867669|NCT00050778|6433626|P1|Overall Study|Adverse Event|13
1867670|NCT00050622|6433652|P1|Overall Study|Adverse Event|1
1867671|NCT00050167|6433690|P2|Overall Study|not eligible not invasive|1
1867672|NCT00050167|6433691|P1|Overall Study|not eligible not invasive|1
1867673|NCT00050011|6433724|P2|Overall Study|Unknown - Reason is missing|2
1867674|NCT00050011|6433725|P1|Overall Study|Unknown - Reason is missing|0
1867675|NCT00050011|6433724|P2|Overall Study|Death|4
1867676|NCT00050011|6433725|P1|Overall Study|Death|7
1867677|NCT00050011|6433724|P2|Overall Study|Administrative problems|6
1867678|NCT00050011|6433725|P1|Overall Study|Administrative problems|10
1867679|NCT00050011|6433724|P2|Overall Study|Lost to Follow-up|9
1867680|NCT00050011|6433725|P1|Overall Study|Lost to Follow-up|7
1867681|NCT00050011|6433724|P2|Overall Study|Withdrawal by Subject|26
1867682|NCT00050011|6433725|P1|Overall Study|Withdrawal by Subject|34
1867683|NCT00050011|6433724|P2|Overall Study|Protocol Violation|10
1867684|NCT00050011|6433725|P1|Overall Study|Protocol Violation|4
1867685|NCT00050011|6433724|P2|Overall Study|Participant condition no longer required|0
1867686|NCT00050011|6433725|P1|Overall Study|Participant condition no longer required|1
1867687|NCT00050011|6433724|P2|Overall Study|Lack of Efficacy|21
1867688|NCT00050011|6433725|P1|Overall Study|Lack of Efficacy|16
1867689|NCT00050011|6433724|P2|Overall Study|Abnormal test procedure results|1
1867690|NCT00050011|6433725|P1|Overall Study|Abnormal test procedure results|0
1867691|NCT00050011|6433724|P2|Overall Study|Abnormal laboratory value(s)|1
1867692|NCT00050011|6433725|P1|Overall Study|Abnormal laboratory value(s)|1
1867693|NCT00050011|6433724|P2|Overall Study|Adverse Event|46
1867694|NCT00050011|6433725|P1|Overall Study|Adverse Event|41
1867695|NCT00049842|6433747|P2|Follow-up Phase|Other|4
1867696|NCT00049842|6433748|P1|Follow-up Phase|Other|1
1867697|NCT00049842|6433747|P2|Follow-up Phase|Adverse Event|1
1867698|NCT00049842|6433748|P1|Follow-up Phase|Adverse Event|6
1867777|NCT00048932|6433766|P3|Open Label Period (OL)|Lack of Efficacy|81
1867699|NCT00049842|6433747|P2|Treatment Phase|Did not meet protocol eligibility|1
1867700|NCT00049842|6433748|P1|Treatment Phase|Did not meet protocol eligibility|0
1867701|NCT00049842|6433747|P2|Treatment Phase|Administrative|3
1867702|NCT00049842|6433748|P1|Treatment Phase|Administrative|0
1867703|NCT00049842|6433747|P2|Treatment Phase|Lost to Follow-up|8
1867704|NCT00049842|6433748|P1|Treatment Phase|Lost to Follow-up|4
1867705|NCT00049842|6433747|P2|Treatment Phase|Non-compliance with protocol|8
1867706|NCT00049842|6433748|P1|Treatment Phase|Non-compliance with protocol|7
1867707|NCT00049842|6433747|P2|Treatment Phase|Withdrawal by Subject|46
1867708|NCT00049842|6433748|P1|Treatment Phase|Withdrawal by Subject|35
1867709|NCT00049842|6433747|P2|Treatment Phase|Adverse Event|12
1867710|NCT00049842|6433748|P1|Treatment Phase|Adverse Event|47
1867711|NCT00048932|6433766|P3|Open Label Period (OL)|Participant Surgery|1
1867712|NCT00048932|6433767|P2|Open Label Period (OL)|Participant Surgery|0
1867713|NCT00048932|6433768|P1|Open Label Period (OL)|Participant Surgery|0
1867714|NCT00048932|6433766|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
1867715|NCT00048932|6433767|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
1867716|NCT00048932|6433768|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
1867717|NCT00048932|6433766|P3|Open Label Period (OL)|Site Staff Issues|2
1867718|NCT00048932|6433767|P2|Open Label Period (OL)|Site Staff Issues|0
1867719|NCT00048932|6433768|P1|Open Label Period (OL)|Site Staff Issues|0
1867720|NCT00048932|6433766|P3|Open Label Period (OL)|Investigator Decision|4
1867721|NCT00048932|6433767|P2|Open Label Period (OL)|Investigator Decision|0
1867722|NCT00048932|6433768|P1|Open Label Period (OL)|Investigator Decision|0
1867723|NCT00048932|6433766|P3|Open Label Period (OL)|Medication Lost Efficacy|1
1867724|NCT00048932|6433767|P2|Open Label Period (OL)|Medication Lost Efficacy|0
1867725|NCT00048932|6433768|P1|Open Label Period (OL)|Medication Lost Efficacy|0
1867726|NCT00048932|6433766|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
1867727|NCT00048932|6433767|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1867728|NCT00048932|6433768|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
1867729|NCT00048932|6433766|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
1867730|NCT00048932|6433767|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
1867731|NCT00048932|6433768|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
1867732|NCT00048932|6433766|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
1867733|NCT00048932|6433767|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
1867734|NCT00048932|6433768|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
1867735|NCT00048932|6433766|P3|Open Label Period (OL)|Patient Decision|4
1867736|NCT00048932|6433767|P2|Open Label Period (OL)|Patient Decision|0
1867737|NCT00048932|6433768|P1|Open Label Period (OL)|Patient Decision|0
1867738|NCT00048932|6433766|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
1867739|NCT00048932|6433767|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
1867740|NCT00048932|6433768|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
1867741|NCT00048932|6433766|P3|Open Label Period (OL)|Trial Terminated|1
1867742|NCT00048932|6433767|P2|Open Label Period (OL)|Trial Terminated|0
1867743|NCT00048932|6433768|P1|Open Label Period (OL)|Trial Terminated|0
1867744|NCT00048932|6433766|P3|Open Label Period (OL)|Site Closure|3
1867745|NCT00048932|6433767|P2|Open Label Period (OL)|Site Closure|0
1867746|NCT00048932|6433768|P1|Open Label Period (OL)|Site Closure|0
1867747|NCT00048932|6433766|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
1867748|NCT00048932|6433767|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
1867749|NCT00048932|6433768|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
1867750|NCT00048932|6433766|P3|Open Label Period (OL)|Participant Relocated|6
1867751|NCT00048932|6433767|P2|Open Label Period (OL)|Participant Relocated|0
1867752|NCT00048932|6433768|P1|Open Label Period (OL)|Participant Relocated|0
1867753|NCT00048932|6433766|P3|Open Label Period (OL)|Participant Transportation Issues|1
1867754|NCT00048932|6433767|P2|Open Label Period (OL)|Participant Transportation Issues|0
1867755|NCT00048932|6433768|P1|Open Label Period (OL)|Participant Transportation Issues|0
1867756|NCT00048932|6433766|P3|Open Label Period (OL)|Investigator Retiring|2
1867757|NCT00048932|6433767|P2|Open Label Period (OL)|Investigator Retiring|0
1867758|NCT00048932|6433768|P1|Open Label Period (OL)|Investigator Retiring|0
1867759|NCT00048932|6433766|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
1867760|NCT00048932|6433767|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
1867761|NCT00048932|6433768|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
1867762|NCT00048932|6433766|P3|Open Label Period (OL)|Pregnancy|6
1867763|NCT00048932|6433767|P2|Open Label Period (OL)|Pregnancy|0
1867764|NCT00048932|6433768|P1|Open Label Period (OL)|Pregnancy|0
1867765|NCT00048932|6433766|P3|Open Label Period (OL)|Poor/Non-Compliance|13
1867766|NCT00048932|6433767|P2|Open Label Period (OL)|Poor/Non-Compliance|0
1867767|NCT00048932|6433768|P1|Open Label Period (OL)|Poor/Non-Compliance|0
1867768|NCT00048932|6433766|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
1867769|NCT00048932|6433767|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
1867770|NCT00048932|6433768|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
1867771|NCT00048932|6433766|P3|Open Label Period (OL)|Withdrawal by Subject|117
1867772|NCT00048932|6433767|P2|Open Label Period (OL)|Withdrawal by Subject|0
1867773|NCT00048932|6433768|P1|Open Label Period (OL)|Withdrawal by Subject|0
1867774|NCT00048932|6433766|P3|Open Label Period (OL)|Lost to Follow-up|27
1867775|NCT00048932|6433767|P2|Open Label Period (OL)|Lost to Follow-up|0
1867776|NCT00048932|6433768|P1|Open Label Period (OL)|Lost to Follow-up|0
1867778|NCT00048932|6433767|P2|Open Label Period (OL)|Lack of Efficacy|0
1867779|NCT00048932|6433768|P1|Open Label Period (OL)|Lack of Efficacy|0
1867780|NCT00048932|6433766|P3|Open Label Period (OL)|Adverse Event|103
1867781|NCT00048932|6433767|P2|Open Label Period (OL)|Adverse Event|0
1867782|NCT00048932|6433768|P1|Open Label Period (OL)|Adverse Event|0
1867783|NCT00048932|6433766|P3|Open Label Period (OL)|Death|25
1867784|NCT00048932|6433767|P2|Open Label Period (OL)|Death|0
1867785|NCT00048932|6433768|P1|Open Label Period (OL)|Death|0
1867786|NCT00048932|6433766|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
1867787|NCT00048932|6433767|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
1867788|NCT00048932|6433768|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
1867789|NCT00048932|6433766|P3|Double Blind Period (DB)|Withdrawal by Subject|0
1867790|NCT00048932|6433767|P2|Double Blind Period (DB)|Withdrawal by Subject|10
1867791|NCT00048932|6433768|P1|Double Blind Period (DB)|Withdrawal by Subject|24
1867792|NCT00048932|6433766|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
1867793|NCT00048932|6433767|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
1867794|NCT00048932|6433768|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
1867795|NCT00048932|6433766|P3|Double Blind Period (DB)|Pregnancy|0
1867796|NCT00048932|6433767|P2|Double Blind Period (DB)|Pregnancy|0
1867797|NCT00048932|6433768|P1|Double Blind Period (DB)|Pregnancy|1
1867798|NCT00048932|6433766|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1867799|NCT00048932|6433767|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
1867800|NCT00048932|6433768|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
1867801|NCT00048932|6433766|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
1867802|NCT00048932|6433767|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
1867803|NCT00048932|6433768|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
1867804|NCT00048932|6433766|P3|Double Blind Period (DB)|Relocation|0
1867805|NCT00048932|6433767|P2|Double Blind Period (DB)|Relocation|0
1867806|NCT00048932|6433768|P1|Double Blind Period (DB)|Relocation|1
1867807|NCT00048932|6433766|P3|Double Blind Period (DB)|Lost to Follow-up|0
1867808|NCT00048932|6433767|P2|Double Blind Period (DB)|Lost to Follow-up|4
1867809|NCT00048932|6433768|P1|Double Blind Period (DB)|Lost to Follow-up|3
1867810|NCT00048932|6433766|P3|Double Blind Period (DB)|Lack of Efficacy|0
1867811|NCT00048932|6433767|P2|Double Blind Period (DB)|Lack of Efficacy|44
1867812|NCT00048932|6433768|P1|Double Blind Period (DB)|Lack of Efficacy|26
1867813|NCT00048932|6433766|P3|Double Blind Period (DB)|Death|0
1867814|NCT00048932|6433767|P2|Double Blind Period (DB)|Death|3
1867815|NCT00048932|6433768|P1|Double Blind Period (DB)|Death|5
1867816|NCT00048932|6433766|P3|Double Blind Period (DB)|Adverse Event|0
1867817|NCT00048932|6433767|P2|Double Blind Period (DB)|Adverse Event|19
1867818|NCT00048932|6433768|P1|Double Blind Period (DB)|Adverse Event|51
1867819|NCT00048932|6433766|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1867820|NCT00048932|6433767|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
1867821|NCT00048932|6433768|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
1867822|NCT00048581|6433810|P3|Open-Label Period|Study Ended By Sponsor|1
1867823|NCT00048581|6433811|P2|Open-Label Period|Study Ended By Sponsor|0
1867824|NCT00048581|6433812|P1|Open-Label Period|Study Ended By Sponsor|0
1867825|NCT00048581|6433810|P3|Open-Label Period|Primary Investigator Retired|2
1867826|NCT00048581|6433811|P2|Open-Label Period|Primary Investigator Retired|0
1867827|NCT00048581|6433812|P1|Open-Label Period|Primary Investigator Retired|0
1867828|NCT00048581|6433810|P3|Open-Label Period|Problem With Transportation To Site|1
1867829|NCT00048581|6433811|P2|Open-Label Period|Problem With Transportation To Site|0
1867830|NCT00048581|6433812|P1|Open-Label Period|Problem With Transportation To Site|0
1867831|NCT00048581|6433810|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
1867832|NCT00048581|6433811|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1867833|NCT00048581|6433812|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
1867834|NCT00048581|6433810|P3|Open-Label Period|Study Site Closure|2
1867835|NCT00048581|6433811|P2|Open-Label Period|Study Site Closure|0
1867836|NCT00048581|6433812|P1|Open-Label Period|Study Site Closure|0
1867837|NCT00048581|6433810|P3|Open-Label Period|Pregnancy|7
1867838|NCT00048581|6433811|P2|Open-Label Period|Pregnancy|0
1867839|NCT00048581|6433812|P1|Open-Label Period|Pregnancy|0
1867840|NCT00048581|6433810|P3|Open-Label Period|Poor/Non-compliance|5
1867841|NCT00048581|6433811|P2|Open-Label Period|Poor/Non-compliance|0
1867842|NCT00048581|6433812|P1|Open-Label Period|Poor/Non-compliance|0
1867843|NCT00048581|6433810|P3|Open-Label Period|No Longer Meets Study Criteria|2
1867844|NCT00048581|6433811|P2|Open-Label Period|No Longer Meets Study Criteria|0
1867845|NCT00048581|6433812|P1|Open-Label Period|No Longer Meets Study Criteria|0
1867846|NCT00048581|6433810|P3|Open-Label Period|Withdrawal by Subject|20
1867847|NCT00048581|6433811|P2|Open-Label Period|Withdrawal by Subject|0
1867848|NCT00048581|6433812|P1|Open-Label Period|Withdrawal by Subject|0
1867849|NCT00048581|6433810|P3|Open-Label Period|Lost to Follow-up|14
1867850|NCT00048581|6433811|P2|Open-Label Period|Lost to Follow-up|0
1867851|NCT00048581|6433812|P1|Open-Label Period|Lost to Follow-up|0
1867852|NCT00048581|6433810|P3|Open-Label Period|Lack of Efficacy|69
1867853|NCT00048581|6433811|P2|Open-Label Period|Lack of Efficacy|0
1867854|NCT00048581|6433812|P1|Open-Label Period|Lack of Efficacy|0
1867855|NCT00048581|6433810|P3|Open-Label Period|Adverse Event|37
1867856|NCT00048581|6433811|P2|Open-Label Period|Adverse Event|0
1867857|NCT00048581|6433812|P1|Open-Label Period|Adverse Event|0
1867858|NCT00048581|6433810|P3|Open-Label Period|Death|4
1867859|NCT00048581|6433811|P2|Open-Label Period|Death|0
1867860|NCT00048581|6433812|P1|Open-Label Period|Death|0
1867861|NCT00048581|6433810|P3|Double-Blind Period|Investigator Decision|0
1867862|NCT00048581|6433811|P2|Double-Blind Period|Investigator Decision|0
1867863|NCT00048581|6433812|P1|Double-Blind Period|Investigator Decision|1
1867864|NCT00048581|6433810|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
1867865|NCT00048581|6433811|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
1867866|NCT00048581|6433812|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
1867867|NCT00048581|6433810|P3|Double-Blind Period|Withdrawal by Subject|0
1867868|NCT00048581|6433811|P2|Double-Blind Period|Withdrawal by Subject|2
1867869|NCT00048581|6433812|P1|Double-Blind Period|Withdrawal by Subject|5
1867870|NCT00048581|6433810|P3|Double-Blind Period|Lost to Follow-up|0
1867871|NCT00048581|6433811|P2|Double-Blind Period|Lost to Follow-up|0
1867872|NCT00048581|6433812|P1|Double-Blind Period|Lost to Follow-up|5
1867873|NCT00048581|6433810|P3|Double-Blind Period|Lack of Efficacy|0
1867874|NCT00048581|6433811|P2|Double-Blind Period|Lack of Efficacy|27
1867875|NCT00048581|6433812|P1|Double-Blind Period|Lack of Efficacy|14
1867876|NCT00048581|6433810|P3|Double-Blind Period|Adverse Event|0
1867877|NCT00048581|6433811|P2|Double-Blind Period|Adverse Event|5
1867878|NCT00048581|6433812|P1|Double-Blind Period|Adverse Event|9
1867879|NCT00048568|6433979|P3|Open-Label Period|Lost to Follow-up|7
1867880|NCT00048568|6433980|P2|Open-Label Period|Lost to Follow-up|0
1867881|NCT00048568|6433981|P1|Open-Label Period|Lost to Follow-up|0
1867882|NCT00048568|6433979|P3|Open-Label Period|Unknown Reasons|25
1867883|NCT00048568|6433980|P2|Open-Label Period|Unknown Reasons|0
1867884|NCT00048568|6433981|P1|Open-Label Period|Unknown Reasons|0
1867885|NCT00048568|6433979|P3|Open-Label Period|Administrative Decision By Sponsor|1
1867886|NCT00048568|6433980|P2|Open-Label Period|Administrative Decision By Sponsor|0
1867887|NCT00048568|6433981|P1|Open-Label Period|Administrative Decision By Sponsor|0
1867888|NCT00048568|6433979|P3|Open-Label Period|No Longer Met Study Criteria|2
1867889|NCT00048568|6433980|P2|Open-Label Period|No Longer Met Study Criteria|0
1867890|NCT00048568|6433981|P1|Open-Label Period|No Longer Met Study Criteria|0
1867891|NCT00048568|6433979|P3|Open-Label Period|Pregnancy|5
1867892|NCT00048568|6433980|P2|Open-Label Period|Pregnancy|0
1867893|NCT00048568|6433981|P1|Open-Label Period|Pregnancy|0
1867894|NCT00048568|6433979|P3|Open-Label Period|Withdrawal by Subject|26
1867895|NCT00048568|6433980|P2|Open-Label Period|Withdrawal by Subject|0
1867896|NCT00048568|6433981|P1|Open-Label Period|Withdrawal by Subject|0
1867897|NCT00048568|6433979|P3|Open-Label Period|Lack of Efficacy|32
1867898|NCT00048568|6433980|P2|Open-Label Period|Lack of Efficacy|0
1867899|NCT00048568|6433981|P1|Open-Label Period|Lack of Efficacy|0
1867900|NCT00048568|6433979|P3|Open-Label Period|Adverse Event|49
1867901|NCT00048568|6433980|P2|Open-Label Period|Adverse Event|0
1867902|NCT00048568|6433981|P1|Open-Label Period|Adverse Event|0
1867903|NCT00048568|6433979|P3|Open-Label Period|Death|13
1867904|NCT00048568|6433980|P2|Open-Label Period|Death|0
1867905|NCT00048568|6433981|P1|Open-Label Period|Death|0
1867906|NCT00048568|6433979|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
1867907|NCT00048568|6433980|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1867908|NCT00048568|6433981|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
1867909|NCT00048568|6433979|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
1867910|NCT00048568|6433980|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
1867911|NCT00048568|6433981|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
1867912|NCT00048568|6433979|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1867913|NCT00048568|6433980|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
1867914|NCT00048568|6433981|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
1867915|NCT00048568|6433979|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
1867916|NCT00048568|6433980|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
1867917|NCT00048568|6433981|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
1867918|NCT00048568|6433979|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
1867919|NCT00048568|6433980|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
1867920|NCT00048568|6433981|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
1867921|NCT00048568|6433979|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
1867922|NCT00048568|6433980|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
1867923|NCT00048568|6433981|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
1867924|NCT00048568|6433979|P3|Double-Blind Period Days 170 to 365|Death|0
1867925|NCT00048568|6433980|P2|Double-Blind Period Days 170 to 365|Death|1
1867926|NCT00048568|6433981|P1|Double-Blind Period Days 170 to 365|Death|1
1867927|NCT00048568|6433979|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
1867928|NCT00048568|6433980|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
1867929|NCT00048568|6433981|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
1867930|NCT00048568|6433979|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
1867931|NCT00048568|6433980|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
1867932|NCT00048568|6433981|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
1867933|NCT00048568|6433979|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
1867934|NCT00048568|6433980|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1867935|NCT00048568|6433981|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
1867936|NCT00048568|6433979|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
1867937|NCT00048568|6433980|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
1867938|NCT00048568|6433981|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
1867939|NCT00048568|6433979|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
1867940|NCT00048568|6433980|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
1867941|NCT00048568|6433981|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
1867942|NCT00048724|6434286|P2|Overall Study|Administrative|1
1867943|NCT00048724|6434287|P1|Overall Study|Administrative|1
1867944|NCT00048724|6434286|P2|Overall Study|Did Not Meet Protocol Eligibility|2
1867945|NCT00048724|6434287|P1|Overall Study|Did Not Meet Protocol Eligibility|2
1867946|NCT00048724|6434286|P2|Overall Study|Noncompliance With Protocol|12
1867947|NCT00048724|6434287|P1|Overall Study|Noncompliance With Protocol|4
1867948|NCT00048724|6434286|P2|Overall Study|Protocol-defined Clinical Event|32
1867949|NCT00048724|6434287|P1|Overall Study|Protocol-defined Clinical Event|17
1867950|NCT00048724|6434286|P2|Overall Study|Lost to Follow-up|5
1867951|NCT00048724|6434287|P1|Overall Study|Lost to Follow-up|5
1867952|NCT00048724|6434286|P2|Overall Study|Withdrawal by Subject|54
1867953|NCT00048724|6434287|P1|Overall Study|Withdrawal by Subject|34
1867954|NCT00048724|6434286|P2|Overall Study|Adverse Event|12
1867955|NCT00048724|6434287|P1|Overall Study|Adverse Event|53
1867956|NCT00048542|6434299|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
1867957|NCT00048542|6434300|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
1867958|NCT00048542|6434301|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1867959|NCT00048542|6434302|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1867960|NCT00048542|6434303|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1867961|NCT00048542|6434304|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1867962|NCT00048542|6434305|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1867963|NCT00048542|6434306|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
1867964|NCT00048542|6434299|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
1867965|NCT00048542|6434300|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
1867966|NCT00048542|6434301|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1867967|NCT00048542|6434302|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1867968|NCT00048542|6434303|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1867969|NCT00048542|6434304|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1867970|NCT00048542|6434305|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1867971|NCT00048542|6434306|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
1867972|NCT00048542|6434299|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1867973|NCT00048542|6434300|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
1867974|NCT00048542|6434301|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1867975|NCT00048542|6434302|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1867976|NCT00048542|6434303|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1867977|NCT00048542|6434304|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1867978|NCT00048542|6434305|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1867979|NCT00048542|6434306|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
1867980|NCT00048542|6434299|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
1867981|NCT00048542|6434300|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
1867982|NCT00048542|6434301|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1867983|NCT00048542|6434302|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1867984|NCT00048542|6434303|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1867985|NCT00048542|6434304|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1867986|NCT00048542|6434305|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1867987|NCT00048542|6434306|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
1867988|NCT00048542|6434299|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1867989|NCT00048542|6434300|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
1867990|NCT00048542|6434301|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1867991|NCT00048542|6434302|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1867992|NCT00048542|6434303|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1867993|NCT00048542|6434304|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1867994|NCT00048542|6434305|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1867995|NCT00048542|6434306|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
1867996|NCT00048542|6434299|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
1867997|NCT00048542|6434300|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
1867998|NCT00048542|6434301|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1867999|NCT00048542|6434302|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1868000|NCT00048542|6434303|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1868001|NCT00048542|6434304|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1868002|NCT00048542|6434305|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1868003|NCT00048542|6434306|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
1868004|NCT00048542|6434299|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
1868005|NCT00048542|6434300|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
1868006|NCT00048542|6434301|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
1868007|NCT00048542|6434302|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
1868008|NCT00048542|6434303|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
1868009|NCT00048542|6434304|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
1868010|NCT00048542|6434305|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
1868011|NCT00048542|6434306|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
1868012|NCT00048542|6434299|P8|Open-Label Extension BSA Phase|Adverse Event|0
1868013|NCT00048542|6434300|P7|Open-Label Extension BSA Phase|Adverse Event|0
1868014|NCT00048542|6434301|P6|Open-Label Extension BSA Phase|Adverse Event|1
1868015|NCT00048542|6434302|P5|Open-Label Extension BSA Phase|Adverse Event|1
1868016|NCT00048542|6434303|P4|Open-Label Extension BSA Phase|Adverse Event|0
1868017|NCT00048542|6434304|P3|Open-Label Extension BSA Phase|Adverse Event|0
1868018|NCT00048542|6434305|P2|Open-Label Extension BSA Phase|Adverse Event|0
1868019|NCT00048542|6434306|P1|Open-Label Extension BSA Phase|Adverse Event|0
1868020|NCT00048542|6434299|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
1868021|NCT00048542|6434300|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
1868022|NCT00048542|6434301|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
1868023|NCT00048542|6434302|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
1868024|NCT00048542|6434303|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
1868025|NCT00048542|6434304|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
1868026|NCT00048542|6434305|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
1868027|NCT00048542|6434306|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
1868028|NCT00048542|6434299|P8|Open-Label Extension BSA Phase|Protocol Violation|0
1868029|NCT00048542|6434300|P7|Open-Label Extension BSA Phase|Protocol Violation|0
1868030|NCT00048542|6434301|P6|Open-Label Extension BSA Phase|Protocol Violation|1
1868031|NCT00048542|6434302|P5|Open-Label Extension BSA Phase|Protocol Violation|0
1868032|NCT00048542|6434303|P4|Open-Label Extension BSA Phase|Protocol Violation|0
1868033|NCT00048542|6434304|P3|Open-Label Extension BSA Phase|Protocol Violation|0
1868034|NCT00048542|6434305|P2|Open-Label Extension BSA Phase|Protocol Violation|0
1868035|NCT00048542|6434306|P1|Open-Label Extension BSA Phase|Protocol Violation|0
1868036|NCT00048542|6434299|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1868037|NCT00048542|6434300|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1868038|NCT00048542|6434301|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
1868039|NCT00048542|6434302|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
1868040|NCT00048542|6434303|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1868041|NCT00048542|6434304|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1868042|NCT00048542|6434305|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1868043|NCT00048542|6434306|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
1868044|NCT00048542|6434299|P8|Double-Blind Phase|Randomized in error|0
1868045|NCT00048542|6434300|P7|Double-Blind Phase|Randomized in error|0
1868046|NCT00048542|6434301|P6|Double-Blind Phase|Randomized in error|0
1868047|NCT00048542|6434302|P5|Double-Blind Phase|Randomized in error|0
1868048|NCT00048542|6434303|P4|Double-Blind Phase|Randomized in error|0
1868049|NCT00048542|6434304|P3|Double-Blind Phase|Randomized in error|0
1868050|NCT00048542|6434305|P2|Double-Blind Phase|Randomized in error|0
1868051|NCT00048542|6434306|P1|Double-Blind Phase|Randomized in error|1
1868052|NCT00048542|6434299|P8|Double-Blind Phase|Sponsor request or decision|0
1868053|NCT00048542|6434300|P7|Double-Blind Phase|Sponsor request or decision|0
1868054|NCT00048542|6434301|P6|Double-Blind Phase|Sponsor request or decision|0
1868055|NCT00048542|6434302|P5|Double-Blind Phase|Sponsor request or decision|0
1868056|NCT00048542|6434303|P4|Double-Blind Phase|Sponsor request or decision|0
1868057|NCT00048542|6434304|P3|Double-Blind Phase|Sponsor request or decision|0
1868058|NCT00048542|6434305|P2|Double-Blind Phase|Sponsor request or decision|0
1868059|NCT00048542|6434306|P1|Double-Blind Phase|Sponsor request or decision|2
1868060|NCT00048542|6434299|P8|Double-Blind Phase|Protocol Violation|0
1868061|NCT00048542|6434300|P7|Double-Blind Phase|Protocol Violation|0
1868062|NCT00048542|6434301|P6|Double-Blind Phase|Protocol Violation|0
1868063|NCT00048542|6434302|P5|Double-Blind Phase|Protocol Violation|0
1868064|NCT00048542|6434303|P4|Double-Blind Phase|Protocol Violation|0
1868065|NCT00048542|6434304|P3|Double-Blind Phase|Protocol Violation|1
1868066|NCT00048542|6434305|P2|Double-Blind Phase|Protocol Violation|0
1868067|NCT00048542|6434306|P1|Double-Blind Phase|Protocol Violation|0
1868068|NCT00048542|6434299|P8|Double-Blind Phase|Withdrawal by Subject|0
1868069|NCT00048542|6434300|P7|Double-Blind Phase|Withdrawal by Subject|0
1868070|NCT00048542|6434301|P6|Double-Blind Phase|Withdrawal by Subject|0
1868071|NCT00048542|6434302|P5|Double-Blind Phase|Withdrawal by Subject|0
1868072|NCT00048542|6434303|P4|Double-Blind Phase|Withdrawal by Subject|0
1868073|NCT00048542|6434304|P3|Double-Blind Phase|Withdrawal by Subject|0
1868074|NCT00048542|6434305|P2|Double-Blind Phase|Withdrawal by Subject|1
1868075|NCT00048542|6434306|P1|Double-Blind Phase|Withdrawal by Subject|0
1868076|NCT00048347|6434372|P1|Overall Study|Screen failure|2
1868077|NCT00048165|6434378|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
1868078|NCT00048165|6434379|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
1868079|NCT00048165|6434378|P2|Completed 12 Months Study|Death|1
1868080|NCT00048165|6434379|P1|Completed 12 Months Study|Death|2
1868081|NCT00048165|6434378|P2|Completed 12 Months Study|Administration/Other|2
1868082|NCT00048165|6434379|P1|Completed 12 Months Study|Administration/Other|0
1868083|NCT00048165|6434378|P2|Completed 6 Months Study|Did not receive study drug|6
1868084|NCT00048165|6434379|P1|Completed 6 Months Study|Did not receive study drug|6
1868085|NCT00048165|6434378|P2|Completed 6 Months Study|Violation criteria|2
1868086|NCT00048165|6434379|P1|Completed 6 Months Study|Violation criteria|0
1868087|NCT00048165|6434378|P2|Completed 6 Months Study|Refused treatment|5
1868088|NCT00048165|6434379|P1|Completed 6 Months Study|Refused treatment|5
1868089|NCT00048165|6434378|P2|Completed 6 Months Study|Other violation|6
1868090|NCT00048165|6434379|P1|Completed 6 Months Study|Other violation|4
1868091|NCT00048165|6434378|P2|Completed 6 Months Study|Insufficient therapy|4
1868092|NCT00048165|6434379|P1|Completed 6 Months Study|Insufficient therapy|1
1868093|NCT00048165|6434378|P2|Completed 6 Months Study|Death|6
1868094|NCT00048165|6434379|P1|Completed 6 Months Study|Death|12
1868095|NCT00048165|6434378|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
1868096|NCT00048165|6434379|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
1868097|NCT00048165|6434378|P2|Completed 6 Months Study|Abnormality of laboratory test|0
1868098|NCT00048165|6434379|P1|Completed 6 Months Study|Abnormality of laboratory test|1
1868099|NCT00048165|6434378|P2|Completed 6 Months Study|Administration/Other|8
1868100|NCT00048165|6434379|P1|Completed 6 Months Study|Administration/Other|8
1868101|NCT00048074|6434414|P3|Overall Study|Social reasons|0
1868102|NCT00048074|6434415|P2|Overall Study|Social reasons|0
1868103|NCT00048074|6434416|P1|Overall Study|Social reasons|1
1868104|NCT00048074|6434414|P3|Overall Study|Out of station|1
1868105|NCT00048074|6434415|P2|Overall Study|Out of station|1
1868106|NCT00048074|6434416|P1|Overall Study|Out of station|0
1868107|NCT00048074|6434414|P3|Overall Study|Poor compliance|0
1868108|NCT00048074|6434415|P2|Overall Study|Poor compliance|1
1868109|NCT00048074|6434416|P1|Overall Study|Poor compliance|0
1868110|NCT00048074|6434414|P3|Overall Study|Husband ill|0
1868111|NCT00048074|6434415|P2|Overall Study|Husband ill|1
1868112|NCT00048074|6434416|P1|Overall Study|Husband ill|0
1868113|NCT00048074|6434414|P3|Overall Study|Study participation was terminated|0
1868114|NCT00048074|6434415|P2|Overall Study|Study participation was terminated|1
1868115|NCT00048074|6434416|P1|Overall Study|Study participation was terminated|0
1868116|NCT00048074|6434414|P3|Overall Study|Protocol Violation|0
1868117|NCT00048074|6434415|P2|Overall Study|Protocol Violation|3
1868118|NCT00048074|6434416|P1|Overall Study|Protocol Violation|1
1868119|NCT00048074|6434414|P3|Overall Study|Withdrawal by Subject|35
1868120|NCT00048074|6434415|P2|Overall Study|Withdrawal by Subject|30
1868121|NCT00048074|6434416|P1|Overall Study|Withdrawal by Subject|28
1868122|NCT00048074|6434414|P3|Overall Study|Lost to Follow-up|6
1868123|NCT00048074|6434415|P2|Overall Study|Lost to Follow-up|6
1868124|NCT00048074|6434416|P1|Overall Study|Lost to Follow-up|2
1868125|NCT00048074|6434414|P3|Overall Study|Death|2
1868126|NCT00048074|6434415|P2|Overall Study|Death|3
1868127|NCT00048074|6434416|P1|Overall Study|Death|3
1868128|NCT00048074|6434414|P3|Overall Study|Adverse Event|53
1868129|NCT00048074|6434415|P2|Overall Study|Adverse Event|41
1868130|NCT00048074|6434416|P1|Overall Study|Adverse Event|46
1868131|NCT00048061|6434473|P4|Overall Study|Early improvement|0
1868132|NCT00048061|6434474|P3|Overall Study|Early improvement|3
1868133|NCT00048061|6434475|P2|Overall Study|Early improvement|5
1868134|NCT00048061|6434476|P1|Overall Study|Early improvement|6
1868135|NCT00048061|6434473|P4|Overall Study|Did not follow-up|5
1868136|NCT00048061|6434474|P3|Overall Study|Did not follow-up|4
1868137|NCT00048061|6434475|P2|Overall Study|Did not follow-up|5
1868138|NCT00048061|6434476|P1|Overall Study|Did not follow-up|5
1868139|NCT00048061|6434473|P4|Overall Study|Withdrawal by Subject|32
1868140|NCT00048061|6434474|P3|Overall Study|Withdrawal by Subject|29
1868141|NCT00048061|6434475|P2|Overall Study|Withdrawal by Subject|29
1868142|NCT00048061|6434476|P1|Overall Study|Withdrawal by Subject|20
1868143|NCT00048061|6434473|P4|Overall Study|Lost to Follow-up|5
1868144|NCT00048061|6434474|P3|Overall Study|Lost to Follow-up|4
1868145|NCT00048061|6434475|P2|Overall Study|Lost to Follow-up|2
1868146|NCT00048061|6434476|P1|Overall Study|Lost to Follow-up|3
1868147|NCT00048061|6434473|P4|Overall Study|Adverse Event|37
1868148|NCT00048061|6434474|P3|Overall Study|Adverse Event|44
1868149|NCT00048061|6434475|P2|Overall Study|Adverse Event|32
1868150|NCT00048061|6434476|P1|Overall Study|Adverse Event|41
1868151|NCT00048048|6434555|P12|Extension Year 2|Early withdrawals|2
1868152|NCT00048048|6434556|P11|Extension Year 2|Early withdrawals|4
1868153|NCT00048048|6434557|P10|Extension Year 2|Early withdrawals|0
1868154|NCT00048048|6434558|P9|Extension Year 2|Early withdrawals|0
1868155|NCT00048048|6434559|P8|Extension Year 2|Early withdrawals|0
1868156|NCT00048048|6434560|P7|Extension Year 2|Early withdrawals|0
1868157|NCT00048048|6434561|P6|Extension Year 2|Early withdrawals|0
1868158|NCT00048048|6434562|P5|Extension Year 2|Early withdrawals|0
1868159|NCT00048048|6434563|P4|Extension Year 2|Early withdrawals|0
1868160|NCT00048048|6434564|P3|Extension Year 2|Early withdrawals|0
1868161|NCT00048048|6434565|P2|Extension Year 2|Early withdrawals|0
1868162|NCT00048048|6434566|P1|Extension Year 2|Early withdrawals|0
1868163|NCT00048048|6434555|P12|Extension Year 1|Early withdrawals|4
1868164|NCT00048048|6434556|P11|Extension Year 1|Early withdrawals|2
1868165|NCT00048048|6434557|P10|Extension Year 1|Early withdrawals|2
1868166|NCT00048048|6434558|P9|Extension Year 1|Early withdrawals|0
1868167|NCT00048048|6434559|P8|Extension Year 1|Early withdrawals|0
1868168|NCT00048048|6434560|P7|Extension Year 1|Early withdrawals|0
1868169|NCT00048048|6434561|P6|Extension Year 1|Early withdrawals|0
1868170|NCT00048048|6434562|P5|Extension Year 1|Early withdrawals|0
1868171|NCT00048048|6434563|P4|Extension Year 1|Early withdrawals|0
1868172|NCT00048048|6434564|P3|Extension Year 1|Early withdrawals|0
1868173|NCT00048048|6434565|P2|Extension Year 1|Early withdrawals|0
1868174|NCT00048048|6434566|P1|Extension Year 1|Early withdrawals|0
1868175|NCT00048048|6434555|P12|Core Treatment|Adverse Event|0
1868176|NCT00048048|6434556|P11|Core Treatment|Adverse Event|0
1868177|NCT00048048|6434557|P10|Core Treatment|Adverse Event|0
1868178|NCT00048048|6434558|P9|Core Treatment|Adverse Event|0
1868179|NCT00048048|6434559|P8|Core Treatment|Adverse Event|1
1868180|NCT00048048|6434560|P7|Core Treatment|Adverse Event|0
1868181|NCT00048048|6434561|P6|Core Treatment|Adverse Event|0
1868182|NCT00048048|6434562|P5|Core Treatment|Adverse Event|0
1868183|NCT00048048|6434563|P4|Core Treatment|Adverse Event|0
1868184|NCT00048048|6434564|P3|Core Treatment|Adverse Event|0
1868185|NCT00048048|6434565|P2|Core Treatment|Adverse Event|0
1868186|NCT00048048|6434566|P1|Core Treatment|Adverse Event|0
1868187|NCT00048048|6434555|P12|Core Treatment|Withdrawal by Subject|0
1868188|NCT00048048|6434556|P11|Core Treatment|Withdrawal by Subject|0
1868189|NCT00048048|6434557|P10|Core Treatment|Withdrawal by Subject|0
1868190|NCT00048048|6434558|P9|Core Treatment|Withdrawal by Subject|0
1868191|NCT00048048|6434559|P8|Core Treatment|Withdrawal by Subject|0
1868192|NCT00048048|6434560|P7|Core Treatment|Withdrawal by Subject|0
1868193|NCT00048048|6434561|P6|Core Treatment|Withdrawal by Subject|0
1868194|NCT00048048|6434562|P5|Core Treatment|Withdrawal by Subject|0
1868195|NCT00048048|6434563|P4|Core Treatment|Withdrawal by Subject|0
1868196|NCT00048048|6434564|P3|Core Treatment|Withdrawal by Subject|1
1868197|NCT00048048|6434565|P2|Core Treatment|Withdrawal by Subject|0
1868198|NCT00048048|6434566|P1|Core Treatment|Withdrawal by Subject|0
1868199|NCT00048035|6434622|P8|Extension Year 2|Early Withdrawals|3
1868200|NCT00048035|6434623|P7|Extension Year 2|Early Withdrawals|3
1868201|NCT00048035|6434624|P6|Extension Year 2|Early Withdrawals|0
1868202|NCT00048035|6434625|P5|Extension Year 2|Early Withdrawals|0
1868203|NCT00048035|6434626|P4|Extension Year 2|Early Withdrawals|0
1868204|NCT00048035|6434627|P3|Extension Year 2|Early Withdrawals|0
1868205|NCT00048035|6434628|P2|Extension Year 2|Early Withdrawals|0
1868206|NCT00048035|6434629|P1|Extension Year 2|Early Withdrawals|0
1868207|NCT00048035|6434622|P8|Extension Year 1|Early Withdrawals|11
1868208|NCT00048035|6434623|P7|Extension Year 1|Early Withdrawals|11
1868209|NCT00048035|6434624|P6|Extension Year 1|Early Withdrawals|0
1868210|NCT00048035|6434625|P5|Extension Year 1|Early Withdrawals|0
1868211|NCT00048035|6434626|P4|Extension Year 1|Early Withdrawals|0
1868212|NCT00048035|6434627|P3|Extension Year 1|Early Withdrawals|0
1868213|NCT00048035|6434628|P2|Extension Year 1|Early Withdrawals|0
1868214|NCT00048035|6434629|P1|Extension Year 1|Early Withdrawals|0
1868215|NCT00048035|6434622|P8|Core Period|Early Withdrawals|0
1868216|NCT00048035|6434623|P7|Core Period|Early Withdrawals|0
1868217|NCT00048035|6434624|P6|Core Period|Early Withdrawals|1
1868218|NCT00048035|6434625|P5|Core Period|Early Withdrawals|1
1868219|NCT00048035|6434626|P4|Core Period|Early Withdrawals|1
1868220|NCT00048035|6434627|P3|Core Period|Early Withdrawals|1
1868221|NCT00048035|6434628|P2|Core Period|Early Withdrawals|2
1868222|NCT00048035|6434629|P1|Core Period|Early Withdrawals|4
1868223|NCT00047879|6434667|P2|Overall Study|Progressive disease|3
1868224|NCT00047879|6434668|P1|Overall Study|Progressive disease|4
1868225|NCT00047463|6434704|P2|Overall Study|Withdrawal by Subject|3
1868226|NCT00047463|6434705|P1|Overall Study|Withdrawal by Subject|0
1868227|NCT00045942|6434822|P9|PKC412A2104E2|Death|0
1868228|NCT00045942|6434823|P8|PKC412A2104E2|Death|0
1868229|NCT00045942|6434824|P7|PKC412A2104E2|Death|2
1868230|NCT00045942|6434825|P6|PKC412A2104E2|Death|1
1868231|NCT00045942|6434826|P5|PKC412A2104E2|Death|0
1868232|NCT00045942|6434827|P4|PKC412A2104E2|Death|0
1868233|NCT00045942|6434828|P3|PKC412A2104E2|Death|0
1868234|NCT00045942|6434829|P2|PKC412A2104E2|Death|0
1868235|NCT00045942|6434830|P1|PKC412A2104E2|Death|0
1868236|NCT00045942|6434822|P9|PKC412A2104E2|Adverse Event|0
1868237|NCT00045942|6434823|P8|PKC412A2104E2|Adverse Event|1
1868238|NCT00045942|6434824|P7|PKC412A2104E2|Adverse Event|3
1868239|NCT00045942|6434825|P6|PKC412A2104E2|Adverse Event|4
1868240|NCT00045942|6434826|P5|PKC412A2104E2|Adverse Event|0
1868241|NCT00045942|6434827|P4|PKC412A2104E2|Adverse Event|0
1868242|NCT00045942|6434828|P3|PKC412A2104E2|Adverse Event|0
1868243|NCT00045942|6434829|P2|PKC412A2104E2|Adverse Event|0
1868244|NCT00045942|6434830|P1|PKC412A2104E2|Adverse Event|0
1868245|NCT00045942|6434822|P9|PKC412A2104E2|Lack of Efficacy|6
1868246|NCT00045942|6434823|P8|PKC412A2104E2|Lack of Efficacy|2
1868247|NCT00045942|6434824|P7|PKC412A2104E2|Lack of Efficacy|2
1868248|NCT00045942|6434825|P6|PKC412A2104E2|Lack of Efficacy|3
1868249|NCT00045942|6434826|P5|PKC412A2104E2|Lack of Efficacy|0
1868250|NCT00045942|6434827|P4|PKC412A2104E2|Lack of Efficacy|0
1868251|NCT00045942|6434828|P3|PKC412A2104E2|Lack of Efficacy|0
1868252|NCT00045942|6434829|P2|PKC412A2104E2|Lack of Efficacy|0
1868253|NCT00045942|6434830|P1|PKC412A2104E2|Lack of Efficacy|0
1868254|NCT00045942|6434822|P9|PKC412A2104E2|Withdrawal by Subject|0
1868255|NCT00045942|6434823|P8|PKC412A2104E2|Withdrawal by Subject|1
1868256|NCT00045942|6434824|P7|PKC412A2104E2|Withdrawal by Subject|0
1868257|NCT00045942|6434825|P6|PKC412A2104E2|Withdrawal by Subject|1
1868258|NCT00045942|6434826|P5|PKC412A2104E2|Withdrawal by Subject|0
1868259|NCT00045942|6434827|P4|PKC412A2104E2|Withdrawal by Subject|0
1868260|NCT00045942|6434828|P3|PKC412A2104E2|Withdrawal by Subject|0
1868261|NCT00045942|6434829|P2|PKC412A2104E2|Withdrawal by Subject|0
1868262|NCT00045942|6434830|P1|PKC412A2104E2|Withdrawal by Subject|0
1868263|NCT00045942|6434822|P9|PKC412A2104E2|Lost to Follow-up|0
1868264|NCT00045942|6434823|P8|PKC412A2104E2|Lost to Follow-up|3
1868265|NCT00045942|6434824|P7|PKC412A2104E2|Lost to Follow-up|0
1868266|NCT00045942|6434825|P6|PKC412A2104E2|Lost to Follow-up|0
1868267|NCT00045942|6434826|P5|PKC412A2104E2|Lost to Follow-up|0
1868268|NCT00045942|6434827|P4|PKC412A2104E2|Lost to Follow-up|0
1868269|NCT00045942|6434828|P3|PKC412A2104E2|Lost to Follow-up|0
1868270|NCT00045942|6434829|P2|PKC412A2104E2|Lost to Follow-up|0
1868271|NCT00045942|6434830|P1|PKC412A2104E2|Lost to Follow-up|0
1868272|NCT00045942|6434822|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1868273|NCT00045942|6434823|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1868274|NCT00045942|6434824|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1868275|NCT00045942|6434825|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1868276|NCT00045942|6434826|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1868277|NCT00045942|6434827|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1868278|NCT00045942|6434828|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
1868279|NCT00045942|6434829|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1868280|NCT00045942|6434830|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
1868281|NCT00045942|6434822|P9|PKC412A2104E1|Death|0
1868282|NCT00045942|6434823|P8|PKC412A2104E1|Death|0
1868283|NCT00045942|6434824|P7|PKC412A2104E1|Death|0
1868284|NCT00045942|6434825|P6|PKC412A2104E1|Death|0
1868285|NCT00045942|6434826|P5|PKC412A2104E1|Death|1
1868286|NCT00045942|6434827|P4|PKC412A2104E1|Death|1
1868287|NCT00045942|6434828|P3|PKC412A2104E1|Death|1
1868288|NCT00045942|6434829|P2|PKC412A2104E1|Death|4
1868289|NCT00045942|6434830|P1|PKC412A2104E1|Death|0
1868290|NCT00045942|6434822|P9|PKC412A2104E1|Adverse Event|0
1868291|NCT00045942|6434823|P8|PKC412A2104E1|Adverse Event|0
1868292|NCT00045942|6434824|P7|PKC412A2104E1|Adverse Event|0
1868293|NCT00045942|6434825|P6|PKC412A2104E1|Adverse Event|0
1868294|NCT00045942|6434826|P5|PKC412A2104E1|Adverse Event|6
1868295|NCT00045942|6434827|P4|PKC412A2104E1|Adverse Event|3
1868296|NCT00045942|6434828|P3|PKC412A2104E1|Adverse Event|1
1868297|NCT00045942|6434829|P2|PKC412A2104E1|Adverse Event|1
1868298|NCT00045942|6434830|P1|PKC412A2104E1|Adverse Event|0
1868299|NCT00045942|6434822|P9|PKC412A2104E1|Abnormal laboratory value|0
1868300|NCT00045942|6434823|P8|PKC412A2104E1|Abnormal laboratory value|0
1868301|NCT00045942|6434824|P7|PKC412A2104E1|Abnormal laboratory value|0
1868302|NCT00045942|6434825|P6|PKC412A2104E1|Abnormal laboratory value|0
1868303|NCT00045942|6434826|P5|PKC412A2104E1|Abnormal laboratory value|0
1868304|NCT00045942|6434827|P4|PKC412A2104E1|Abnormal laboratory value|0
1868305|NCT00045942|6434828|P3|PKC412A2104E1|Abnormal laboratory value|0
1868306|NCT00045942|6434829|P2|PKC412A2104E1|Abnormal laboratory value|1
1868307|NCT00045942|6434830|P1|PKC412A2104E1|Abnormal laboratory value|0
1868308|NCT00045942|6434822|P9|PKC412A2104E1|Lack of Efficacy|0
1868309|NCT00045942|6434823|P8|PKC412A2104E1|Lack of Efficacy|0
1868310|NCT00045942|6434824|P7|PKC412A2104E1|Lack of Efficacy|0
1868311|NCT00045942|6434825|P6|PKC412A2104E1|Lack of Efficacy|0
1868312|NCT00045942|6434826|P5|PKC412A2104E1|Lack of Efficacy|17
1868313|NCT00045942|6434827|P4|PKC412A2104E1|Lack of Efficacy|23
1868314|NCT00045942|6434828|P3|PKC412A2104E1|Lack of Efficacy|11
1868315|NCT00045942|6434829|P2|PKC412A2104E1|Lack of Efficacy|11
1868316|NCT00045942|6434830|P1|PKC412A2104E1|Lack of Efficacy|0
1868317|NCT00045942|6434822|P9|PKC412A2104E1|Condition no longer requires study drug|0
1868318|NCT00045942|6434823|P8|PKC412A2104E1|Condition no longer requires study drug|0
1868319|NCT00045942|6434824|P7|PKC412A2104E1|Condition no longer requires study drug|0
1868320|NCT00045942|6434825|P6|PKC412A2104E1|Condition no longer requires study drug|0
1868321|NCT00045942|6434826|P5|PKC412A2104E1|Condition no longer requires study drug|1
1868322|NCT00045942|6434827|P4|PKC412A2104E1|Condition no longer requires study drug|0
1868323|NCT00045942|6434828|P3|PKC412A2104E1|Condition no longer requires study drug|1
1868324|NCT00045942|6434829|P2|PKC412A2104E1|Condition no longer requires study drug|1
1868325|NCT00045942|6434830|P1|PKC412A2104E1|Condition no longer requires study drug|0
1868326|NCT00045942|6434822|P9|PKC412A2104E1|Withdrawal by Subject|0
1868327|NCT00045942|6434823|P8|PKC412A2104E1|Withdrawal by Subject|0
1868328|NCT00045942|6434824|P7|PKC412A2104E1|Withdrawal by Subject|0
1868329|NCT00045942|6434825|P6|PKC412A2104E1|Withdrawal by Subject|0
1868330|NCT00045942|6434826|P5|PKC412A2104E1|Withdrawal by Subject|2
1868331|NCT00045942|6434827|P4|PKC412A2104E1|Withdrawal by Subject|5
1868332|NCT00045942|6434828|P3|PKC412A2104E1|Withdrawal by Subject|2
1868333|NCT00045942|6434829|P2|PKC412A2104E1|Withdrawal by Subject|0
1868334|NCT00045942|6434830|P1|PKC412A2104E1|Withdrawal by Subject|0
1868335|NCT00045942|6434822|P9|PKC412A2104 (Core)|Death|0
1868336|NCT00045942|6434823|P8|PKC412A2104 (Core)|Death|0
1868337|NCT00045942|6434824|P7|PKC412A2104 (Core)|Death|0
1868338|NCT00045942|6434825|P6|PKC412A2104 (Core)|Death|0
1868339|NCT00045942|6434826|P5|PKC412A2104 (Core)|Death|0
1868340|NCT00045942|6434827|P4|PKC412A2104 (Core)|Death|0
1868341|NCT00045942|6434828|P3|PKC412A2104 (Core)|Death|0
1868342|NCT00045942|6434829|P2|PKC412A2104 (Core)|Death|0
1868343|NCT00045942|6434830|P1|PKC412A2104 (Core)|Death|1
1868344|NCT00045942|6434822|P9|PKC412A2104 (Core)|Lack of Efficacy|0
1868345|NCT00045942|6434823|P8|PKC412A2104 (Core)|Lack of Efficacy|0
1868346|NCT00045942|6434824|P7|PKC412A2104 (Core)|Lack of Efficacy|0
1868347|NCT00045942|6434825|P6|PKC412A2104 (Core)|Lack of Efficacy|0
1868348|NCT00045942|6434826|P5|PKC412A2104 (Core)|Lack of Efficacy|0
1868349|NCT00045942|6434827|P4|PKC412A2104 (Core)|Lack of Efficacy|0
1868350|NCT00045942|6434828|P3|PKC412A2104 (Core)|Lack of Efficacy|0
1868351|NCT00045942|6434829|P2|PKC412A2104 (Core)|Lack of Efficacy|0
1868352|NCT00045942|6434830|P1|PKC412A2104 (Core)|Lack of Efficacy|13
1868353|NCT00045942|6434822|P9|PKC412A2104 (Core)|Adverse Event|0
1868354|NCT00045942|6434823|P8|PKC412A2104 (Core)|Adverse Event|0
1868355|NCT00045942|6434824|P7|PKC412A2104 (Core)|Adverse Event|0
1868356|NCT00045942|6434825|P6|PKC412A2104 (Core)|Adverse Event|0
1868357|NCT00045942|6434826|P5|PKC412A2104 (Core)|Adverse Event|0
1868358|NCT00045942|6434827|P4|PKC412A2104 (Core)|Adverse Event|0
1868359|NCT00045942|6434828|P3|PKC412A2104 (Core)|Adverse Event|0
1868360|NCT00045942|6434829|P2|PKC412A2104 (Core)|Adverse Event|0
1868361|NCT00045942|6434830|P1|PKC412A2104 (Core)|Adverse Event|5
1868362|NCT00045942|6434822|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
1868363|NCT00045942|6434823|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
1868364|NCT00045942|6434824|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
1868365|NCT00045942|6434825|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
1868366|NCT00045942|6434826|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
1868367|NCT00045942|6434827|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
1868368|NCT00045942|6434828|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
1868369|NCT00045942|6434829|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
1868370|NCT00045942|6434830|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
1868371|NCT00044512|6434919|P1|Follow Up|Lost to Follow-up|2
1868372|NCT00044213|6434934|P4|Overall Study|Lost to Follow-up|4
1868373|NCT00044213|6434935|P3|Overall Study|Lost to Follow-up|5
1868374|NCT00044213|6434936|P2|Overall Study|Lost to Follow-up|5
1868375|NCT00044213|6434937|P1|Overall Study|Lost to Follow-up|8
1868376|NCT00044213|6434934|P4|Overall Study|Death|49
1868377|NCT00044213|6434935|P3|Overall Study|Death|42
1868378|NCT00044213|6434936|P2|Overall Study|Death|42
1868379|NCT00044213|6434937|P1|Overall Study|Death|42
1868380|NCT00044213|6434934|P4|Overall Study|Withdrawal by Subject|83
1868381|NCT00044213|6434935|P3|Overall Study|Withdrawal by Subject|91
1868382|NCT00044213|6434936|P2|Overall Study|Withdrawal by Subject|65
1868383|NCT00044213|6434937|P1|Overall Study|Withdrawal by Subject|50
1868384|NCT00044083|6435002|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
1868385|NCT00044083|6435003|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
1868386|NCT00044083|6435002|P2|First Intervention (One Week) Patients|Used illegal drug|0
1868387|NCT00044083|6435003|P1|First Intervention (One Week) Patients|Used illegal drug|1
1868388|NCT00044083|6435002|P2|First Intervention (One Week) Patients|Not follow directions|2
1868389|NCT00044083|6435003|P1|First Intervention (One Week) Patients|Not follow directions|0
1868390|NCT00044083|6435002|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
1868391|NCT00044083|6435003|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
1868392|NCT00044083|6435002|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
1868393|NCT00044083|6435003|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
1868394|NCT00044083|6435002|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
1868395|NCT00044083|6435003|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
1868396|NCT00044083|6435002|P2|First Intervention (One Week)- HV's|Pregnancy|0
1868397|NCT00044083|6435003|P1|First Intervention (One Week)- HV's|Pregnancy|1
1868398|NCT00044083|6435002|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
1868399|NCT00044083|6435003|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
1868400|NCT00044083|6435002|P2|First Intervention (One Week)- HV's|Not follow directions|2
1868401|NCT00044083|6435003|P1|First Intervention (One Week)- HV's|Not follow directions|2
1868402|NCT00044083|6435002|P2|First Intervention (One Week)- HV's|Adverse Event|0
1868403|NCT00044083|6435003|P1|First Intervention (One Week)- HV's|Adverse Event|1
1868404|NCT00043979|6435041|P3|Period 1|recipient with progressive disease|3
1868405|NCT00043979|6435042|P2|Period 1|recipient with progressive disease|4
1868406|NCT00043979|6435043|P1|Period 1|recipient with progressive disease|7
1868407|NCT00043550|6435064|P3|Overall Study|Withdrawal by Subject|20
1868408|NCT00043550|6435065|P2|Overall Study|Withdrawal by Subject|12
1868409|NCT00043550|6435066|P1|Overall Study|Withdrawal by Subject|22
1868410|NCT00043186|6435083|P9|Overall Study|Other|0
1868411|NCT00043186|6435084|P8|Overall Study|Other|0
1868412|NCT00043186|6435085|P7|Overall Study|Other|0
1868413|NCT00043186|6435086|P6|Overall Study|Other|0
1868414|NCT00043186|6435087|P5|Overall Study|Other|0
1868415|NCT00043186|6435088|P4|Overall Study|Other|1
1868416|NCT00043186|6435089|P3|Overall Study|Other|1
1868417|NCT00043186|6435090|P2|Overall Study|Other|0
1868418|NCT00043186|6435091|P1|Overall Study|Other|0
1868419|NCT00043186|6435083|P9|Overall Study|Noncompliance|0
1868420|NCT00043186|6435084|P8|Overall Study|Noncompliance|0
1868421|NCT00043186|6435085|P7|Overall Study|Noncompliance|0
1868422|NCT00043186|6435086|P6|Overall Study|Noncompliance|0
1868423|NCT00043186|6435087|P5|Overall Study|Noncompliance|0
1868424|NCT00043186|6435088|P4|Overall Study|Noncompliance|1
1868425|NCT00043186|6435089|P3|Overall Study|Noncompliance|1
1868426|NCT00043186|6435090|P2|Overall Study|Noncompliance|0
1868427|NCT00043186|6435091|P1|Overall Study|Noncompliance|0
1868428|NCT00043186|6435083|P9|Overall Study|Lost to Follow-up|2
1868429|NCT00043186|6435084|P8|Overall Study|Lost to Follow-up|1
1868430|NCT00043186|6435085|P7|Overall Study|Lost to Follow-up|1
1868431|NCT00043186|6435086|P6|Overall Study|Lost to Follow-up|1
1868432|NCT00043186|6435087|P5|Overall Study|Lost to Follow-up|1
1868433|NCT00043186|6435088|P4|Overall Study|Lost to Follow-up|1
1868434|NCT00043186|6435089|P3|Overall Study|Lost to Follow-up|1
1868435|NCT00043186|6435090|P2|Overall Study|Lost to Follow-up|5
1868436|NCT00043186|6435091|P1|Overall Study|Lost to Follow-up|3
1868437|NCT00043186|6435083|P9|Overall Study|Ineligibility determined|1
1868438|NCT00043186|6435084|P8|Overall Study|Ineligibility determined|0
1868439|NCT00043186|6435085|P7|Overall Study|Ineligibility determined|0
1868440|NCT00043186|6435086|P6|Overall Study|Ineligibility determined|0
1868441|NCT00043186|6435087|P5|Overall Study|Ineligibility determined|0
1868442|NCT00043186|6435088|P4|Overall Study|Ineligibility determined|0
1868443|NCT00043186|6435089|P3|Overall Study|Ineligibility determined|0
1868444|NCT00043186|6435090|P2|Overall Study|Ineligibility determined|0
1868445|NCT00043186|6435091|P1|Overall Study|Ineligibility determined|0
1868446|NCT00043186|6435083|P9|Overall Study|Disease progression|0
1868447|NCT00043186|6435084|P8|Overall Study|Disease progression|4
1868448|NCT00043186|6435085|P7|Overall Study|Disease progression|0
1868449|NCT00043186|6435086|P6|Overall Study|Disease progression|0
1868450|NCT00043186|6435087|P5|Overall Study|Disease progression|0
1868451|NCT00043186|6435088|P4|Overall Study|Disease progression|3
1868452|NCT00043186|6435089|P3|Overall Study|Disease progression|0
1868453|NCT00043186|6435090|P2|Overall Study|Disease progression|0
1868454|NCT00043186|6435091|P1|Overall Study|Disease progression|1
1868455|NCT00043186|6435083|P9|Overall Study|Death|0
1868456|NCT00043186|6435084|P8|Overall Study|Death|0
1868457|NCT00043186|6435085|P7|Overall Study|Death|2
1868458|NCT00043186|6435086|P6|Overall Study|Death|0
1868459|NCT00043186|6435087|P5|Overall Study|Death|0
1868460|NCT00043186|6435088|P4|Overall Study|Death|0
1868461|NCT00043186|6435089|P3|Overall Study|Death|1
1868462|NCT00043186|6435090|P2|Overall Study|Death|0
1868463|NCT00043186|6435091|P1|Overall Study|Death|0
1868464|NCT00043186|6435083|P9|Overall Study|Withdrawal by Subject|10
1868465|NCT00043186|6435084|P8|Overall Study|Withdrawal by Subject|9
1868466|NCT00043186|6435085|P7|Overall Study|Withdrawal by Subject|12
1868467|NCT00043186|6435086|P6|Overall Study|Withdrawal by Subject|6
1868468|NCT00043186|6435087|P5|Overall Study|Withdrawal by Subject|14
1868469|NCT00043186|6435088|P4|Overall Study|Withdrawal by Subject|13
1868470|NCT00043186|6435089|P3|Overall Study|Withdrawal by Subject|11
1868471|NCT00043186|6435090|P2|Overall Study|Withdrawal by Subject|8
1868472|NCT00043186|6435091|P1|Overall Study|Withdrawal by Subject|11
1868473|NCT00043186|6435083|P9|Overall Study|Adverse Event|3
1868474|NCT00043186|6435084|P8|Overall Study|Adverse Event|1
1868475|NCT00043186|6435085|P7|Overall Study|Adverse Event|2
1868476|NCT00043186|6435086|P6|Overall Study|Adverse Event|1
1868477|NCT00043186|6435087|P5|Overall Study|Adverse Event|2
1868478|NCT00043186|6435088|P4|Overall Study|Adverse Event|3
1868479|NCT00043186|6435089|P3|Overall Study|Adverse Event|2
1868480|NCT00043186|6435090|P2|Overall Study|Adverse Event|2
1868481|NCT00043186|6435091|P1|Overall Study|Adverse Event|2
1868482|NCT00043186|6435083|P9|Overall Study|Physician Decision|1
1868483|NCT00043186|6435084|P8|Overall Study|Physician Decision|1
1868484|NCT00043186|6435085|P7|Overall Study|Physician Decision|0
1868485|NCT00043186|6435086|P6|Overall Study|Physician Decision|0
1868486|NCT00043186|6435087|P5|Overall Study|Physician Decision|1
1868487|NCT00043186|6435088|P4|Overall Study|Physician Decision|0
1868488|NCT00043186|6435089|P3|Overall Study|Physician Decision|3
1868489|NCT00043186|6435090|P2|Overall Study|Physician Decision|0
1868490|NCT00043186|6435091|P1|Overall Study|Physician Decision|0
1868491|NCT00042432|6435419|P2|Overall Study|Other|0
1868492|NCT00042432|6435420|P1|Overall Study|Other|2
1868493|NCT00042432|6435419|P2|Overall Study|Initiation of maintenance dialysis|1
1868494|NCT00042432|6435420|P1|Overall Study|Initiation of maintenance dialysis|1
1868495|NCT00042432|6435419|P2|Overall Study|Ineligibility determined|0
1868496|NCT00042432|6435420|P1|Overall Study|Ineligibility determined|1
1868497|NCT00042432|6435419|P2|Overall Study|Death|2
1868498|NCT00042432|6435420|P1|Overall Study|Death|0
1868499|NCT00042432|6435419|P2|Overall Study|Withdrawal by Subject|3
1868500|NCT00042432|6435420|P1|Overall Study|Withdrawal by Subject|1
1868501|NCT00042432|6435419|P2|Overall Study|Adverse Event|1
1868502|NCT00042432|6435420|P1|Overall Study|Adverse Event|4
1868503|NCT00041756|6435473|P5|Overall Study|Data Monitoring Committee Recommendation|21
1868504|NCT00041756|6435474|P4|Overall Study|Data Monitoring Committee Recommendation|0
1868505|NCT00041756|6435475|P3|Overall Study|Data Monitoring Committee Recommendation|0
1868506|NCT00041756|6435476|P2|Overall Study|Data Monitoring Committee Recommendation|0
1868507|NCT00041756|6435477|P1|Overall Study|Data Monitoring Committee Recommendation|0
1868508|NCT00041756|6435473|P5|Overall Study|Unable to meet protocol criteria|1
1868509|NCT00041756|6435474|P4|Overall Study|Unable to meet protocol criteria|0
1868510|NCT00041756|6435475|P3|Overall Study|Unable to meet protocol criteria|1
1868511|NCT00041756|6435476|P2|Overall Study|Unable to meet protocol criteria|0
1868512|NCT00041756|6435477|P1|Overall Study|Unable to meet protocol criteria|0
1868513|NCT00041756|6435473|P5|Overall Study|Lost to Follow-up|0
1868514|NCT00041756|6435474|P4|Overall Study|Lost to Follow-up|1
1868515|NCT00041756|6435475|P3|Overall Study|Lost to Follow-up|0
1868516|NCT00041756|6435476|P2|Overall Study|Lost to Follow-up|1
1868517|NCT00041756|6435477|P1|Overall Study|Lost to Follow-up|0
1868518|NCT00041756|6435473|P5|Overall Study|Withdrawal by Subject|3
1868519|NCT00041756|6435474|P4|Overall Study|Withdrawal by Subject|2
1868520|NCT00041756|6435475|P3|Overall Study|Withdrawal by Subject|4
1868521|NCT00041756|6435476|P2|Overall Study|Withdrawal by Subject|3
1868522|NCT00041756|6435477|P1|Overall Study|Withdrawal by Subject|3
1868523|NCT00041756|6435473|P5|Overall Study|Protocol Violation|1
1868524|NCT00041756|6435474|P4|Overall Study|Protocol Violation|2
1868525|NCT00041756|6435475|P3|Overall Study|Protocol Violation|2
1868526|NCT00041756|6435476|P2|Overall Study|Protocol Violation|1
1868527|NCT00041756|6435477|P1|Overall Study|Protocol Violation|1
1868528|NCT00041756|6435473|P5|Overall Study|Adverse Event|34
1868529|NCT00041756|6435474|P4|Overall Study|Adverse Event|11
1868530|NCT00041756|6435475|P3|Overall Study|Adverse Event|6
1868531|NCT00041756|6435476|P2|Overall Study|Adverse Event|10
1868532|NCT00041756|6435477|P1|Overall Study|Adverse Event|4
1868533|NCT00041470|6435505|P1|Overall Study|Loss of Funding|38
1868534|NCT00040664|6435510|P4|Overall Study|Non-viability of oral suspension|0
1868535|NCT00040664|6435511|P3|Overall Study|Non-viability of oral suspension|1
1868536|NCT00040664|6435512|P2|Overall Study|Non-viability of oral suspension|0
1868537|NCT00040664|6435513|P1|Overall Study|Non-viability of oral suspension|1
1868538|NCT00040664|6435510|P4|Overall Study|Change of formulation|0
1868539|NCT00040664|6435511|P3|Overall Study|Change of formulation|0
1868540|NCT00040664|6435512|P2|Overall Study|Change of formulation|2
1868541|NCT00040664|6435513|P1|Overall Study|Change of formulation|2
1868542|NCT00040664|6435510|P4|Overall Study|Pharmacokinetic target not achieved|1
1868543|NCT00040664|6435511|P3|Overall Study|Pharmacokinetic target not achieved|0
1868544|NCT00040664|6435512|P2|Overall Study|Pharmacokinetic target not achieved|1
1868545|NCT00040664|6435513|P1|Overall Study|Pharmacokinetic target not achieved|2
1868546|NCT00040664|6435510|P4|Overall Study|Poor taste|0
1868547|NCT00040664|6435511|P3|Overall Study|Poor taste|2
1868548|NCT00040664|6435512|P2|Overall Study|Poor taste|0
1868549|NCT00040664|6435513|P1|Overall Study|Poor taste|2
1868550|NCT00040664|6435510|P4|Overall Study|Medication adherence/compliance problems|5
1868551|NCT00040664|6435511|P3|Overall Study|Medication adherence/compliance problems|1
1868552|NCT00040664|6435512|P2|Overall Study|Medication adherence/compliance problems|2
1868553|NCT00040664|6435513|P1|Overall Study|Medication adherence/compliance problems|8
1868554|NCT00040664|6435510|P4|Overall Study|Pregnancy|3
1868555|NCT00040664|6435511|P3|Overall Study|Pregnancy|0
1868556|NCT00040664|6435512|P2|Overall Study|Pregnancy|0
1868557|NCT00040664|6435513|P1|Overall Study|Pregnancy|3
1868558|NCT00040664|6435510|P4|Overall Study|Withdrawal by Subject|4
1868559|NCT00040664|6435511|P3|Overall Study|Withdrawal by Subject|3
1868560|NCT00040664|6435512|P2|Overall Study|Withdrawal by Subject|0
1868561|NCT00040664|6435513|P1|Overall Study|Withdrawal by Subject|7
1868562|NCT00040664|6435510|P4|Overall Study|Protocol Violation|1
1868563|NCT00040664|6435511|P3|Overall Study|Protocol Violation|0
1868564|NCT00040664|6435512|P2|Overall Study|Protocol Violation|1
1868565|NCT00040664|6435513|P1|Overall Study|Protocol Violation|2
1868566|NCT00040664|6435510|P4|Overall Study|Lost to Follow-up|2
1868567|NCT00040664|6435511|P3|Overall Study|Lost to Follow-up|0
1868568|NCT00040664|6435512|P2|Overall Study|Lost to Follow-up|2
1868569|NCT00040664|6435513|P1|Overall Study|Lost to Follow-up|4
1868570|NCT00040664|6435510|P4|Overall Study|Insufficient CD4 response|0
1868571|NCT00040664|6435511|P3|Overall Study|Insufficient CD4 response|1
1868572|NCT00040664|6435512|P2|Overall Study|Insufficient CD4 response|0
1868573|NCT00040664|6435513|P1|Overall Study|Insufficient CD4 response|1
1868574|NCT00040664|6435510|P4|Overall Study|Lack of Efficacy|4
1868575|NCT00040664|6435511|P3|Overall Study|Lack of Efficacy|3
1868576|NCT00040664|6435512|P2|Overall Study|Lack of Efficacy|2
1868577|NCT00040664|6435513|P1|Overall Study|Lack of Efficacy|9
1868578|NCT00040664|6435510|P4|Overall Study|Adverse Event|7
1868579|NCT00040664|6435511|P3|Overall Study|Adverse Event|2
1868580|NCT00040664|6435512|P2|Overall Study|Adverse Event|3
1868581|NCT00040664|6435513|P1|Overall Study|Adverse Event|12
1868582|NCT00040365|6435579|P1|Overall Study|Lost to Follow-up|3
1868583|NCT00040365|6435579|P1|Overall Study|Progressive disease|7
1868584|NCT00040365|6435579|P1|Overall Study|Death|1
1868585|NCT00039871|6435588|P1|Overall Study|Never entered follow-up|7
1868586|NCT00039871|6435588|P1|Overall Study|Discontinued at Week 12 per protocol|1061
1868587|NCT00039871|6435588|P1|Overall Study|Administrative|1
1868588|NCT00039871|6435588|P1|Overall Study|Did not meet eligibility criteria|11
1868589|NCT00039871|6435588|P1|Overall Study|Withdrawal by Subject|97
1868590|NCT00039871|6435588|P1|Overall Study|Protocol Violation|24
1868591|NCT00039871|6435588|P1|Overall Study|Lost to Follow-up|18
1868592|NCT00039871|6435588|P1|Overall Study|Adverse Event|165
1868593|NCT00039741|6435598|P4|Overall Study|Missed final visit|2
1868594|NCT00039741|6435599|P3|Overall Study|Missed final visit|2
1868595|NCT00039741|6435600|P2|Overall Study|Missed final visit|1
1868596|NCT00039741|6435601|P1|Overall Study|Missed final visit|2
1868597|NCT00039741|6435598|P4|Overall Study|Withdrew consent|1
1868598|NCT00039741|6435599|P3|Overall Study|Withdrew consent|0
1868599|NCT00039741|6435600|P2|Overall Study|Withdrew consent|5
1868600|NCT00039741|6435601|P1|Overall Study|Withdrew consent|0
1868601|NCT00039741|6435598|P4|Overall Study|Non-compliance with protocol|0
1868602|NCT00039741|6435599|P3|Overall Study|Non-compliance with protocol|1
1868603|NCT00039741|6435600|P2|Overall Study|Non-compliance with protocol|0
1868604|NCT00039741|6435601|P1|Overall Study|Non-compliance with protocol|1
1868605|NCT00039741|6435598|P4|Overall Study|Moved|6
1868606|NCT00039741|6435599|P3|Overall Study|Moved|3
1868607|NCT00039741|6435600|P2|Overall Study|Moved|2
1868608|NCT00039741|6435601|P1|Overall Study|Moved|3
1868609|NCT00039741|6435598|P4|Overall Study|Not able to get to clinic|3
1868610|NCT00039741|6435599|P3|Overall Study|Not able to get to clinic|0
1868611|NCT00039741|6435600|P2|Overall Study|Not able to get to clinic|2
1868612|NCT00039741|6435601|P1|Overall Study|Not able to get to clinic|5
1868613|NCT00039741|6435598|P4|Overall Study|Confounding medical condition|0
1868614|NCT00039741|6435599|P3|Overall Study|Confounding medical condition|0
1868615|NCT00039741|6435600|P2|Overall Study|Confounding medical condition|0
1868616|NCT00039741|6435601|P1|Overall Study|Confounding medical condition|1
1868617|NCT00039741|6435598|P4|Overall Study|Lost to Follow-up|2
1868618|NCT00039741|6435599|P3|Overall Study|Lost to Follow-up|5
1868619|NCT00039741|6435600|P2|Overall Study|Lost to Follow-up|1
1868620|NCT00039741|6435601|P1|Overall Study|Lost to Follow-up|3
1868621|NCT00039741|6435598|P4|Overall Study|Death|0
1868622|NCT00039741|6435599|P3|Overall Study|Death|0
1868623|NCT00039741|6435600|P2|Overall Study|Death|1
1868624|NCT00039741|6435601|P1|Overall Study|Death|0
1868625|NCT00038948|6435645|P2|Overall Study|Lack of Efficacy|6
1868626|NCT00038948|6435646|P1|Overall Study|Lack of Efficacy|3
1868627|NCT00038948|6435645|P2|Overall Study|Protocol Violation|7
1868628|NCT00038948|6435646|P1|Overall Study|Protocol Violation|3
1868629|NCT00038948|6435645|P2|Overall Study|Withdrawal by Subject|10
1868630|NCT00038948|6435646|P1|Overall Study|Withdrawal by Subject|23
1868631|NCT00038948|6435645|P2|Overall Study|Nonmedical event|7
1868632|NCT00038948|6435646|P1|Overall Study|Nonmedical event|5
1868633|NCT00038948|6435645|P2|Overall Study|Lost to Follow-up|4
1868634|NCT00038948|6435646|P1|Overall Study|Lost to Follow-up|4
1868635|NCT00038948|6435645|P2|Overall Study|Adverse Event|43
1868636|NCT00038948|6435646|P1|Overall Study|Adverse Event|131
1868637|NCT00038649|6435681|P1|Overall Study|Adverse Event|9
1868638|NCT00038467|6435694|P2|Overall Study|Other|28
1868639|NCT00038467|6435695|P1|Overall Study|Other|26
1868640|NCT00038467|6435694|P2|Overall Study|Randomized, but not treated|35
1868641|NCT00038467|6435695|P1|Overall Study|Randomized, but not treated|31
1868642|NCT00038467|6435694|P2|Overall Study|Recurrence|179
1868643|NCT00038467|6435695|P1|Overall Study|Recurrence|109
1868644|NCT00038467|6435694|P2|Overall Study|Lost to Follow-up|10
1868645|NCT00038467|6435695|P1|Overall Study|Lost to Follow-up|15
1868646|NCT00038467|6435694|P2|Overall Study|Death|16
1868647|NCT00038467|6435695|P1|Overall Study|Death|22
1868648|NCT00038467|6435694|P2|Overall Study|Protocol Violation|22
1868649|NCT00038467|6435695|P1|Overall Study|Protocol Violation|19
1868650|NCT00038467|6435694|P2|Overall Study|Withdrawal by Subject|107
1868651|NCT00038467|6435695|P1|Overall Study|Withdrawal by Subject|150
1868652|NCT00038467|6435694|P2|Overall Study|Adverse Event|145
1868653|NCT00038467|6435695|P1|Overall Study|Adverse Event|170
1868654|NCT00038142|6435757|P2|Overall Study|Unknown Reason|0
1868655|NCT00038142|6435758|P1|Overall Study|Unknown Reason|8
1868656|NCT00038142|6435757|P2|Overall Study|Adverse Event|0
1868657|NCT00038142|6435758|P1|Overall Study|Adverse Event|1
1868658|NCT00038142|6435757|P2|Overall Study|Death|0
1868659|NCT00038142|6435758|P1|Overall Study|Death|1
1868660|NCT00038142|6435757|P2|Overall Study|Progressive Disease|7
1868661|NCT00038142|6435758|P1|Overall Study|Progressive Disease|11
1868662|NCT00038142|6435757|P2|Overall Study|Ineligible|0
1868663|NCT00038142|6435758|P1|Overall Study|Ineligible|1
1868664|NCT00038103|6435766|P2|Overall Study|Randomized/never treated|0
1868665|NCT00038103|6435767|P1|Overall Study|Randomized/never treated|2
1868666|NCT00038103|6435766|P2|Overall Study|Sponsor Decision|1
1868667|NCT00038103|6435767|P1|Overall Study|Sponsor Decision|0
1868668|NCT00038103|6435766|P2|Overall Study|Protocol Violation|2
1868669|NCT00038103|6435767|P1|Overall Study|Protocol Violation|0
1868670|NCT00038103|6435766|P2|Overall Study|Lost to Follow-up|3
1868671|NCT00038103|6435767|P1|Overall Study|Lost to Follow-up|0
1868672|NCT00038103|6435766|P2|Overall Study|Withdrawal by Subject|3
1868673|NCT00038103|6435767|P1|Overall Study|Withdrawal by Subject|0
1868674|NCT00038103|6435766|P2|Overall Study|Lack of Efficacy|41
1868675|NCT00038103|6435767|P1|Overall Study|Lack of Efficacy|48
1868676|NCT00038103|6435766|P2|Overall Study|Adverse Event|6
1868677|NCT00038103|6435767|P1|Overall Study|Adverse Event|5
1868678|NCT00037830|6435790|P3|Overall Study|Unrelated Medical Problem|0
1868679|NCT00037830|6435791|P2|Overall Study|Unrelated Medical Problem|0
1868680|NCT00037830|6435792|P1|Overall Study|Unrelated Medical Problem|2
1868681|NCT00037830|6435790|P3|Overall Study|Protocol Violation|0
1868682|NCT00037830|6435791|P2|Overall Study|Protocol Violation|2
1868683|NCT00037830|6435792|P1|Overall Study|Protocol Violation|2
1868684|NCT00037830|6435790|P3|Overall Study|Withdrawal by Subject|1
1868685|NCT00037830|6435791|P2|Overall Study|Withdrawal by Subject|5
1868686|NCT00037830|6435792|P1|Overall Study|Withdrawal by Subject|4
1868687|NCT00037830|6435790|P3|Overall Study|Adverse Event|0
1868688|NCT00037830|6435791|P2|Overall Study|Adverse Event|0
1868689|NCT00037830|6435792|P1|Overall Study|Adverse Event|2
1868690|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
1868691|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
1868692|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Too early switch|103
1868693|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Too early switch|0
1868694|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
1868695|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
1868696|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Protocol Violation|91
1868697|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Protocol Violation|23
1868698|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
1868699|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
1868700|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Treatment refusal|208
1868701|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Treatment refusal|113
1868702|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Other|288
1868703|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Other|277
1868704|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Adverse Event|782
1868705|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Adverse Event|501
1868706|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
1868707|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
1868708|NCT00036270|6435824|P2|Study Treatment to 5 Year Report|Ongoing|736
1868709|NCT00036270|6435825|P1|Study Treatment to 5 Year Report|Ongoing|1081
1868710|NCT00036270|6435824|P2|Randomized to Study Treatment|Withdrawal by Subject|7
1868711|NCT00036270|6435825|P1|Randomized to Study Treatment|Withdrawal by Subject|6
1868712|NCT00035932|6435844|P3|Overall Study|Lack of Efficacy|28
1868713|NCT00035932|6435845|P2|Overall Study|Lack of Efficacy|33
1868714|NCT00035932|6435846|P1|Overall Study|Lack of Efficacy|33
1868715|NCT00035932|6435844|P3|Overall Study|Study Termination by Sponsor|0
1868716|NCT00035932|6435845|P2|Overall Study|Study Termination by Sponsor|0
1868717|NCT00035932|6435846|P1|Overall Study|Study Termination by Sponsor|1
1868718|NCT00035932|6435844|P3|Overall Study|Withdrawal by Subject|0
1868719|NCT00035932|6435845|P2|Overall Study|Withdrawal by Subject|5
1868720|NCT00035932|6435846|P1|Overall Study|Withdrawal by Subject|1
1868721|NCT00035932|6435844|P3|Overall Study|Protocol Violation While on Study|2
1868722|NCT00035932|6435845|P2|Overall Study|Protocol Violation While on Study|1
1868723|NCT00035932|6435846|P1|Overall Study|Protocol Violation While on Study|0
1868724|NCT00035932|6435844|P3|Overall Study|Noncompliance|6
1868725|NCT00035932|6435845|P2|Overall Study|Noncompliance|7
1868726|NCT00035932|6435846|P1|Overall Study|Noncompliance|6
1868727|NCT00035932|6435844|P3|Overall Study|Lost to Follow-up|3
1868728|NCT00035932|6435845|P2|Overall Study|Lost to Follow-up|4
1868729|NCT00035932|6435846|P1|Overall Study|Lost to Follow-up|4
1868730|NCT00035932|6435844|P3|Overall Study|Disease Progression / Relapse|0
1868731|NCT00035932|6435845|P2|Overall Study|Disease Progression / Relapse|1
1868732|NCT00035932|6435846|P1|Overall Study|Disease Progression / Relapse|1
1868733|NCT00035932|6435844|P3|Overall Study|Death|1
1868734|NCT00035932|6435845|P2|Overall Study|Death|0
1868735|NCT00035932|6435846|P1|Overall Study|Death|0
1868736|NCT00035932|6435844|P3|Overall Study|Adverse Event|9
1868737|NCT00035932|6435845|P2|Overall Study|Adverse Event|9
1868738|NCT00035932|6435846|P1|Overall Study|Adverse Event|10
1868739|NCT00035815|6435972|P2|Overall Study|Withdrawal by Subject|11
1868740|NCT00035815|6435973|P1|Overall Study|Withdrawal by Subject|17
1868741|NCT00035555|6435986|P3|Overall Study|Received cyclosporin in error|1
1868742|NCT00035555|6435987|P2|Overall Study|Received cyclosporin in error|0
1868743|NCT00035555|6435988|P1|Overall Study|Received cyclosporin in error|0
1868744|NCT00035555|6435986|P3|Overall Study|Investigator deemed not a good candidate|1
1868745|NCT00035555|6435987|P2|Overall Study|Investigator deemed not a good candidate|0
1868746|NCT00035555|6435988|P1|Overall Study|Investigator deemed not a good candidate|0
1868747|NCT00035555|6435986|P3|Overall Study|Withdrawal by Subject|2
1868748|NCT00035555|6435987|P2|Overall Study|Withdrawal by Subject|0
1868749|NCT00035555|6435988|P1|Overall Study|Withdrawal by Subject|2
1868750|NCT00035555|6435986|P3|Overall Study|Treatment failure/lack of efficacy|3
1868751|NCT00035555|6435987|P2|Overall Study|Treatment failure/lack of efficacy|5
1868752|NCT00035555|6435988|P1|Overall Study|Treatment failure/lack of efficacy|7
1868753|NCT00035555|6435986|P3|Overall Study|Prohibited medication|0
1868754|NCT00035555|6435987|P2|Overall Study|Prohibited medication|1
1868755|NCT00035555|6435988|P1|Overall Study|Prohibited medication|1
1868756|NCT00035555|6435986|P3|Overall Study|Noncompliance|1
1868757|NCT00035555|6435987|P2|Overall Study|Noncompliance|1
1868758|NCT00035555|6435988|P1|Overall Study|Noncompliance|0
1868759|NCT00035555|6435986|P3|Overall Study|Lost to Follow-up|1
1868760|NCT00035555|6435987|P2|Overall Study|Lost to Follow-up|0
1868761|NCT00035555|6435988|P1|Overall Study|Lost to Follow-up|0
1868762|NCT00035555|6435986|P3|Overall Study|Death|2
1868763|NCT00035555|6435987|P2|Overall Study|Death|0
1868764|NCT00035555|6435988|P1|Overall Study|Death|0
1868765|NCT00035555|6435986|P3|Overall Study|Allograft loss|2
1868766|NCT00035555|6435987|P2|Overall Study|Allograft loss|1
1868767|NCT00035555|6435988|P1|Overall Study|Allograft loss|1
1868768|NCT00035555|6435986|P3|Overall Study|Adverse Event|9
1868769|NCT00035555|6435987|P2|Overall Study|Adverse Event|8
1868770|NCT00035555|6435988|P1|Overall Study|Adverse Event|5
1868771|NCT00032487|6436072|P2|Overall Study|Had other reason|12
1868772|NCT00032487|6436073|P1|Overall Study|Had other reason|12
1868773|NCT00032487|6436072|P2|Overall Study|Lost to Follow-up|58
1868774|NCT00032487|6436073|P1|Overall Study|Lost to Follow-up|57
1868775|NCT00032487|6436072|P2|Overall Study|Adverse Event|7
1868776|NCT00032487|6436073|P1|Overall Study|Adverse Event|3
1868777|NCT00032487|6436072|P2|Overall Study|Withdrawal by Subject|43
1868778|NCT00032487|6436073|P1|Overall Study|Withdrawal by Subject|67
1868779|NCT00031551|6436083|P2|Overall Study|Withdrew due to chemotherapy effects|0
1868780|NCT00031551|6436084|P1|Overall Study|Withdrew due to chemotherapy effects|2
1868781|NCT00031486|6436096|P2|Overall Study|Other|1
1868782|NCT00031486|6436097|P1|Overall Study|Other|1
1868783|NCT00031486|6436096|P2|Overall Study|Did not meet eligibility requirement|1
1868784|NCT00031486|6436097|P1|Overall Study|Did not meet eligibility requirement|2
1868785|NCT00031486|6436096|P2|Overall Study|Non-compliant|4
1868786|NCT00031486|6436097|P1|Overall Study|Non-compliant|0
1868787|NCT00031486|6436096|P2|Overall Study|Death|3
1868788|NCT00031486|6436097|P1|Overall Study|Death|0
1868789|NCT00031486|6436096|P2|Overall Study|Withdrawal by Subject|2
1868790|NCT00031486|6436097|P1|Overall Study|Withdrawal by Subject|3
1868791|NCT00031486|6436096|P2|Overall Study|Lost to Follow-up|1
1868792|NCT00031486|6436097|P1|Overall Study|Lost to Follow-up|0
1868793|NCT00031486|6436096|P2|Overall Study|Adverse Event|0
1868794|NCT00031486|6436097|P1|Overall Study|Adverse Event|1
1868795|NCT00031460|6436123|P2|Overall Study|Confirmed unevaluable|1
1868796|NCT00031460|6436124|P1|Overall Study|Confirmed unevaluable|0
1868797|NCT00031460|6436123|P2|Overall Study|Disruption of blinded drug supply|0
1868798|NCT00031460|6436124|P1|Overall Study|Disruption of blinded drug supply|2
1868799|NCT00031460|6436123|P2|Overall Study|Reactivation of Disease|9
1868800|NCT00031460|6436124|P1|Overall Study|Reactivation of Disease|5
1868801|NCT00031460|6436123|P2|Overall Study|Death|1
1868802|NCT00031460|6436124|P1|Overall Study|Death|0
1868803|NCT00031460|6436123|P2|Overall Study|Non-Compliant|1
1868804|NCT00031460|6436124|P1|Overall Study|Non-Compliant|1
1868805|NCT00031460|6436123|P2|Overall Study|Withdrawal by Subject|1
1868806|NCT00031460|6436124|P1|Overall Study|Withdrawal by Subject|1
1868807|NCT00031460|6436123|P2|Overall Study|Lost to Follow-up|1
1868808|NCT00031460|6436124|P1|Overall Study|Lost to Follow-up|0
1868809|NCT00031447|6436138|P2|Overall Study|Disruption of blinded study drug supply|4
1868810|NCT00031447|6436139|P1|Overall Study|Disruption of blinded study drug supply|7
1868811|NCT00031447|6436138|P2|Overall Study|Re-activation of Disease|1
1868812|NCT00031447|6436139|P1|Overall Study|Re-activation of Disease|2
1868813|NCT00031447|6436138|P2|Overall Study|Non-compliant|1
1868814|NCT00031447|6436139|P1|Overall Study|Non-compliant|1
1868815|NCT00031447|6436138|P2|Overall Study|Lost to Follow-up|1
1868816|NCT00031447|6436139|P1|Overall Study|Lost to Follow-up|0
1868817|NCT00029146|6436214|P2|Overall Study|Lost to Follow-up|1
1868818|NCT00029146|6436215|P1|Overall Study|Lost to Follow-up|2
1868819|NCT00027378|6436266|P2|Overall Study|Physician Decision|3
1868820|NCT00027378|6436267|P1|Overall Study|Physician Decision|0
1868821|NCT00027027|6436280|P5|Overall Study|Withdrawal by Subject|1
1868822|NCT00027027|6436281|P4|Overall Study|Withdrawal by Subject|0
1868823|NCT00027027|6436282|P3|Overall Study|Withdrawal by Subject|0
1868824|NCT00027027|6436283|P2|Overall Study|Withdrawal by Subject|0
1868825|NCT00027027|6436284|P1|Overall Study|Withdrawal by Subject|0
1868826|NCT00027027|6436280|P5|Overall Study|Physician Decision Due To PD|5
1868827|NCT00027027|6436281|P4|Overall Study|Physician Decision Due To PD|3
1868828|NCT00027027|6436282|P3|Overall Study|Physician Decision Due To PD|2
1868829|NCT00027027|6436283|P2|Overall Study|Physician Decision Due To PD|3
1868830|NCT00027027|6436284|P1|Overall Study|Physician Decision Due To PD|2
1868831|NCT00027027|6436280|P5|Overall Study|PD Requiring Surgery|0
1868832|NCT00027027|6436281|P4|Overall Study|PD Requiring Surgery|0
1868833|NCT00027027|6436282|P3|Overall Study|PD Requiring Surgery|1
1868834|NCT00027027|6436283|P2|Overall Study|PD Requiring Surgery|0
1868835|NCT00027027|6436284|P1|Overall Study|PD Requiring Surgery|0
1868836|NCT00027027|6436280|P5|Overall Study|Clinical Symptoms Progression not PD|0
1868837|NCT00027027|6436281|P4|Overall Study|Clinical Symptoms Progression not PD|0
1868838|NCT00027027|6436282|P3|Overall Study|Clinical Symptoms Progression not PD|0
1868839|NCT00027027|6436283|P2|Overall Study|Clinical Symptoms Progression not PD|0
1868840|NCT00027027|6436284|P1|Overall Study|Clinical Symptoms Progression not PD|1
1868841|NCT00027027|6436280|P5|Overall Study|Admitted for Signs of PD|1
1868842|NCT00027027|6436281|P4|Overall Study|Admitted for Signs of PD|0
1868843|NCT00027027|6436282|P3|Overall Study|Admitted for Signs of PD|0
1868844|NCT00027027|6436283|P2|Overall Study|Admitted for Signs of PD|0
1868845|NCT00027027|6436284|P1|Overall Study|Admitted for Signs of PD|0
1868846|NCT00027027|6436280|P5|Overall Study|Adverse Event|1
1868847|NCT00027027|6436281|P4|Overall Study|Adverse Event|0
1868848|NCT00027027|6436282|P3|Overall Study|Adverse Event|1
1868849|NCT00027027|6436283|P2|Overall Study|Adverse Event|0
1868850|NCT00027027|6436284|P1|Overall Study|Adverse Event|0
1868851|NCT00025883|6436331|P1|Overall Study|didn't reach 6 months of Metreleptin|10
1868852|NCT00025883|6436331|P1|Overall Study|Adverse Event|1
1868853|NCT00025883|6436331|P1|Overall Study|Death|1
1868854|NCT00025883|6436331|P1|Overall Study|no baseline data|1
1868855|NCT00025883|6436331|P1|Overall Study|had atypical progeriod lipodystrophy|4
1868856|NCT00023595|6436343|P5|10 Year Follow up|Lost to Follow-up|0
1868857|NCT00023595|6436344|P4|10 Year Follow up|Lost to Follow-up|0
1868858|NCT00023595|6436345|P3|10 Year Follow up|Lost to Follow-up|3
1868859|NCT00023595|6436346|P2|10 Year Follow up|Lost to Follow-up|10
1868860|NCT00023595|6436347|P1|10 Year Follow up|Lost to Follow-up|12
1868861|NCT00023595|6436343|P5|5 Year Follow up|Lost to Follow-up|3
1868862|NCT00023595|6436344|P4|5 Year Follow up|Lost to Follow-up|7
1868863|NCT00023595|6436345|P3|5 Year Follow up|Lost to Follow-up|1
1868864|NCT00023595|6436346|P2|5 Year Follow up|Lost to Follow-up|2
1868865|NCT00023595|6436347|P1|5 Year Follow up|Lost to Follow-up|2
1868866|NCT00023452|6436558|P2|Overall Study|Other|69
1868867|NCT00023452|6436559|P1|Overall Study|Other|204
1868868|NCT00023452|6436558|P2|Overall Study|Pregnant|20
1868869|NCT00023452|6436559|P1|Overall Study|Pregnant|53
1868870|NCT00023452|6436558|P2|Overall Study|Refused Treatment (continued follow-up)|224
1868871|NCT00023452|6436559|P1|Overall Study|Refused Treatment (continued follow-up)|225
1868872|NCT00023452|6436558|P2|Overall Study|Physician Decision|21
1868873|NCT00023452|6436559|P1|Overall Study|Physician Decision|49
1868874|NCT00023452|6436558|P2|Overall Study|Lost to Follow-up|60
1868875|NCT00023452|6436559|P1|Overall Study|Lost to Follow-up|293
1868876|NCT00023452|6436558|P2|Overall Study|Adverse Event|196
1868877|NCT00023452|6436559|P1|Overall Study|Adverse Event|139
1868878|NCT00023452|6436558|P2|Overall Study|Withdrawal by Subject|54
1868879|NCT00023452|6436559|P1|Overall Study|Withdrawal by Subject|66
1868880|NCT00023452|6436558|P2|Overall Study|Death|0
1868881|NCT00023452|6436559|P1|Overall Study|Death|2
1868882|NCT00023452|6436558|P2|Overall Study|Out of Window|69
1868883|NCT00023452|6436559|P1|Overall Study|Out of Window|129
1868884|NCT00023452|6436558|P2|Overall Study|Ineligible for Study|159
1868885|NCT00023452|6436559|P1|Overall Study|Ineligible for Study|163
1868886|NCT00023322|6436583|P1|Overall Study|Lost to Follow-up|1
1868887|NCT00022763|6436607|P2|Overall Study|Admin|2
1868888|NCT00022763|6436608|P1|Overall Study|Admin|3
1868889|NCT00022763|6436607|P2|Overall Study|Insufficient Therapy|0
1868890|NCT00022763|6436608|P1|Overall Study|Insufficient Therapy|1
1868891|NCT00022763|6436607|P2|Overall Study|Withdrawal by Subject|7
1868892|NCT00022763|6436608|P1|Overall Study|Withdrawal by Subject|4
1868893|NCT00022763|6436607|P2|Overall Study|Lost to Follow-up|3
1868894|NCT00022763|6436608|P1|Overall Study|Lost to Follow-up|0
1868895|NCT00022763|6436607|P2|Overall Study|Death|1
1868896|NCT00022763|6436608|P1|Overall Study|Death|0
1868897|NCT00022763|6436607|P2|Overall Study|Injection Site Reactions|2
1868898|NCT00022763|6436608|P1|Overall Study|Injection Site Reactions|0
1868899|NCT00022763|6436607|P2|Overall Study|Adverse Event|2
1868900|NCT00022763|6436608|P1|Overall Study|Adverse Event|1
1868901|NCT00014911|6436650|P1|Overall Study|Immunosuppression-related Side Effects|1
1868902|NCT00014911|6436650|P1|Overall Study|Unknown Reasons|2
1868903|NCT00014911|6436650|P1|Overall Study|Withdrawal by Subject|6
1868904|NCT00014911|6436650|P1|Overall Study|Lost to Follow-up|1
1868905|NCT00014911|6436650|P1|Overall Study|Adverse Event|1
1868906|NCT00006604|6436666|P17|Overall Study|Other Reason|0
1868907|NCT00006604|6436667|P16|Overall Study|Other Reason|0
1868908|NCT00006604|6436668|P15|Overall Study|Other Reason|0
1868909|NCT00006604|6436669|P14|Overall Study|Other Reason|0
1868910|NCT00006604|6436670|P13|Overall Study|Other Reason|0
1868911|NCT00006604|6436671|P12|Overall Study|Other Reason|0
1868912|NCT00006604|6436672|P11|Overall Study|Other Reason|0
1868913|NCT00006604|6436673|P10|Overall Study|Other Reason|1
1868914|NCT00006604|6436674|P9|Overall Study|Other Reason|0
1868915|NCT00006604|6436675|P8|Overall Study|Other Reason|0
1868916|NCT00006604|6436676|P7|Overall Study|Other Reason|0
1868917|NCT00006604|6436677|P6|Overall Study|Other Reason|1
1868918|NCT00006604|6436678|P5|Overall Study|Other Reason|0
1868919|NCT00006604|6436679|P4|Overall Study|Other Reason|0
1868920|NCT00006604|6436680|P3|Overall Study|Other Reason|0
1868921|NCT00006604|6436681|P2|Overall Study|Other Reason|0
1868922|NCT00006604|6436682|P1|Overall Study|Other Reason|0
1868923|NCT00006604|6436666|P17|Overall Study|Lost to Follow-up|3
1868924|NCT00006604|6436667|P16|Overall Study|Lost to Follow-up|1
1868925|NCT00006604|6436668|P15|Overall Study|Lost to Follow-up|0
1868926|NCT00006604|6436669|P14|Overall Study|Lost to Follow-up|0
1868927|NCT00006604|6436670|P13|Overall Study|Lost to Follow-up|0
1868928|NCT00006604|6436671|P12|Overall Study|Lost to Follow-up|0
1868929|NCT00006604|6436672|P11|Overall Study|Lost to Follow-up|0
1868930|NCT00006604|6436673|P10|Overall Study|Lost to Follow-up|2
1868931|NCT00006604|6436674|P9|Overall Study|Lost to Follow-up|0
1868932|NCT00006604|6436675|P8|Overall Study|Lost to Follow-up|1
1868933|NCT00006604|6436676|P7|Overall Study|Lost to Follow-up|0
1868934|NCT00006604|6436677|P6|Overall Study|Lost to Follow-up|0
1868935|NCT00006604|6436678|P5|Overall Study|Lost to Follow-up|0
1868936|NCT00006604|6436679|P4|Overall Study|Lost to Follow-up|0
1868937|NCT00006604|6436680|P3|Overall Study|Lost to Follow-up|0
1868938|NCT00006604|6436681|P2|Overall Study|Lost to Follow-up|0
1868939|NCT00006604|6436682|P1|Overall Study|Lost to Follow-up|0
1868940|NCT00006604|6436666|P17|Overall Study|Subj/parent not willing to adhere to req|4
1868941|NCT00006604|6436667|P16|Overall Study|Subj/parent not willing to adhere to req|3
1868942|NCT00006604|6436668|P15|Overall Study|Subj/parent not willing to adhere to req|3
1868943|NCT00006604|6436669|P14|Overall Study|Subj/parent not willing to adhere to req|2
1868944|NCT00006604|6436670|P13|Overall Study|Subj/parent not willing to adhere to req|0
1868945|NCT00006604|6436671|P12|Overall Study|Subj/parent not willing to adhere to req|0
1868946|NCT00006604|6436672|P11|Overall Study|Subj/parent not willing to adhere to req|3
1868947|NCT00006604|6436673|P10|Overall Study|Subj/parent not willing to adhere to req|6
1868948|NCT00006604|6436674|P9|Overall Study|Subj/parent not willing to adhere to req|0
1868949|NCT00006604|6436675|P8|Overall Study|Subj/parent not willing to adhere to req|1
1868950|NCT00006604|6436676|P7|Overall Study|Subj/parent not willing to adhere to req|3
1868951|NCT00006604|6436677|P6|Overall Study|Subj/parent not willing to adhere to req|0
1868952|NCT00006604|6436678|P5|Overall Study|Subj/parent not willing to adhere to req|0
1868953|NCT00006604|6436679|P4|Overall Study|Subj/parent not willing to adhere to req|3
1868954|NCT00006604|6436680|P3|Overall Study|Subj/parent not willing to adhere to req|1
1868955|NCT00006604|6436681|P2|Overall Study|Subj/parent not willing to adhere to req|0
1868956|NCT00006604|6436682|P1|Overall Study|Subj/parent not willing to adhere to req|0
1868957|NCT00006604|6436666|P17|Overall Study|Withdrawal by Subject|1
1868958|NCT00006604|6436667|P16|Overall Study|Withdrawal by Subject|0
1868959|NCT00006604|6436668|P15|Overall Study|Withdrawal by Subject|1
1868960|NCT00006604|6436669|P14|Overall Study|Withdrawal by Subject|2
1868961|NCT00006604|6436670|P13|Overall Study|Withdrawal by Subject|1
1868962|NCT00006604|6436671|P12|Overall Study|Withdrawal by Subject|0
1868963|NCT00006604|6436672|P11|Overall Study|Withdrawal by Subject|2
1868964|NCT00006604|6436673|P10|Overall Study|Withdrawal by Subject|3
1868965|NCT00006604|6436674|P9|Overall Study|Withdrawal by Subject|1
1868966|NCT00006604|6436675|P8|Overall Study|Withdrawal by Subject|0
1868967|NCT00006604|6436676|P7|Overall Study|Withdrawal by Subject|2
1868968|NCT00006604|6436677|P6|Overall Study|Withdrawal by Subject|2
1868969|NCT00006604|6436678|P5|Overall Study|Withdrawal by Subject|1
1868970|NCT00006604|6436679|P4|Overall Study|Withdrawal by Subject|0
1868971|NCT00006604|6436680|P3|Overall Study|Withdrawal by Subject|2
1868972|NCT00006604|6436681|P2|Overall Study|Withdrawal by Subject|0
1868973|NCT00006604|6436682|P1|Overall Study|Withdrawal by Subject|1
1868974|NCT00006604|6436666|P17|Overall Study|Site closing|1
1868975|NCT00006604|6436667|P16|Overall Study|Site closing|0
1868976|NCT00006604|6436668|P15|Overall Study|Site closing|0
1868977|NCT00006604|6436669|P14|Overall Study|Site closing|1
1868978|NCT00006604|6436670|P13|Overall Study|Site closing|1
1868979|NCT00006604|6436671|P12|Overall Study|Site closing|1
1868980|NCT00006604|6436672|P11|Overall Study|Site closing|0
1868981|NCT00006604|6436673|P10|Overall Study|Site closing|0
1868982|NCT00006604|6436674|P9|Overall Study|Site closing|0
1868983|NCT00006604|6436675|P8|Overall Study|Site closing|1
1868984|NCT00006604|6436676|P7|Overall Study|Site closing|0
1868985|NCT00006604|6436677|P6|Overall Study|Site closing|0
1868986|NCT00006604|6436678|P5|Overall Study|Site closing|0
1868987|NCT00006604|6436679|P4|Overall Study|Site closing|1
1868988|NCT00006604|6436680|P3|Overall Study|Site closing|1
1868989|NCT00006604|6436681|P2|Overall Study|Site closing|0
1868990|NCT00006604|6436682|P1|Overall Study|Site closing|0
1868991|NCT00006604|6436666|P17|Overall Study|Subj/Parent not able to get to clinic|0
1868992|NCT00006604|6436667|P16|Overall Study|Subj/Parent not able to get to clinic|0
1868993|NCT00006604|6436668|P15|Overall Study|Subj/Parent not able to get to clinic|3
1868994|NCT00006604|6436669|P14|Overall Study|Subj/Parent not able to get to clinic|1
1868995|NCT00006604|6436670|P13|Overall Study|Subj/Parent not able to get to clinic|1
1868996|NCT00006604|6436671|P12|Overall Study|Subj/Parent not able to get to clinic|1
1868997|NCT00006604|6436672|P11|Overall Study|Subj/Parent not able to get to clinic|2
1868998|NCT00006604|6436673|P10|Overall Study|Subj/Parent not able to get to clinic|1
1868999|NCT00006604|6436674|P9|Overall Study|Subj/Parent not able to get to clinic|0
1869000|NCT00006604|6436675|P8|Overall Study|Subj/Parent not able to get to clinic|0
1869001|NCT00006604|6436676|P7|Overall Study|Subj/Parent not able to get to clinic|1
1869002|NCT00006604|6436677|P6|Overall Study|Subj/Parent not able to get to clinic|0
1869003|NCT00006604|6436678|P5|Overall Study|Subj/Parent not able to get to clinic|1
1869004|NCT00006604|6436679|P4|Overall Study|Subj/Parent not able to get to clinic|1
1869005|NCT00006604|6436680|P3|Overall Study|Subj/Parent not able to get to clinic|0
1869006|NCT00006604|6436681|P2|Overall Study|Subj/Parent not able to get to clinic|0
1869007|NCT00006604|6436682|P1|Overall Study|Subj/Parent not able to get to clinic|0
1869008|NCT00006604|6436666|P17|Overall Study|Severe debilitation, unable to continue|0
1869009|NCT00006604|6436667|P16|Overall Study|Severe debilitation, unable to continue|0
1869010|NCT00006604|6436668|P15|Overall Study|Severe debilitation, unable to continue|2
1869011|NCT00006604|6436669|P14|Overall Study|Severe debilitation, unable to continue|0
1869012|NCT00006604|6436670|P13|Overall Study|Severe debilitation, unable to continue|1
1869013|NCT00006604|6436671|P12|Overall Study|Severe debilitation, unable to continue|2
1869014|NCT00006604|6436672|P11|Overall Study|Severe debilitation, unable to continue|0
1869015|NCT00006604|6436673|P10|Overall Study|Severe debilitation, unable to continue|5
1869016|NCT00006604|6436674|P9|Overall Study|Severe debilitation, unable to continue|0
1869017|NCT00006604|6436675|P8|Overall Study|Severe debilitation, unable to continue|0
1869018|NCT00006604|6436676|P7|Overall Study|Severe debilitation, unable to continue|3
1869019|NCT00006604|6436677|P6|Overall Study|Severe debilitation, unable to continue|0
1869020|NCT00006604|6436678|P5|Overall Study|Severe debilitation, unable to continue|0
1869021|NCT00006604|6436679|P4|Overall Study|Severe debilitation, unable to continue|0
1869022|NCT00006604|6436680|P3|Overall Study|Severe debilitation, unable to continue|0
1869023|NCT00006604|6436681|P2|Overall Study|Severe debilitation, unable to continue|0
1869024|NCT00006604|6436682|P1|Overall Study|Severe debilitation, unable to continue|0
1869025|NCT00006604|6436666|P17|Overall Study|Death|0
1869026|NCT00006604|6436667|P16|Overall Study|Death|0
1869027|NCT00006604|6436668|P15|Overall Study|Death|0
1869028|NCT00006604|6436669|P14|Overall Study|Death|0
1869029|NCT00006604|6436670|P13|Overall Study|Death|0
1869030|NCT00006604|6436671|P12|Overall Study|Death|1
1869031|NCT00006604|6436672|P11|Overall Study|Death|1
1869032|NCT00006604|6436673|P10|Overall Study|Death|1
1869033|NCT00006604|6436674|P9|Overall Study|Death|0
1869034|NCT00006604|6436675|P8|Overall Study|Death|0
1869035|NCT00006604|6436676|P7|Overall Study|Death|0
1869036|NCT00006604|6436677|P6|Overall Study|Death|0
1869037|NCT00006604|6436678|P5|Overall Study|Death|0
1869038|NCT00006604|6436679|P4|Overall Study|Death|0
1869039|NCT00006604|6436680|P3|Overall Study|Death|0
1869040|NCT00006604|6436681|P2|Overall Study|Death|0
1869041|NCT00006604|6436682|P1|Overall Study|Death|0
1869042|NCT00006604|6436666|P17|Overall Study|Randomization entry error-no RX, no FU|0
1869043|NCT00006604|6436667|P16|Overall Study|Randomization entry error-no RX, no FU|0
1869044|NCT00006604|6436668|P15|Overall Study|Randomization entry error-no RX, no FU|0
1869045|NCT00006604|6436669|P14|Overall Study|Randomization entry error-no RX, no FU|0
1869046|NCT00006604|6436670|P13|Overall Study|Randomization entry error-no RX, no FU|0
1869047|NCT00006604|6436671|P12|Overall Study|Randomization entry error-no RX, no FU|1
1869048|NCT00006604|6436672|P11|Overall Study|Randomization entry error-no RX, no FU|0
1869049|NCT00006604|6436673|P10|Overall Study|Randomization entry error-no RX, no FU|0
1869050|NCT00006604|6436674|P9|Overall Study|Randomization entry error-no RX, no FU|0
1869051|NCT00006604|6436675|P8|Overall Study|Randomization entry error-no RX, no FU|0
1869052|NCT00006604|6436676|P7|Overall Study|Randomization entry error-no RX, no FU|0
1869053|NCT00006604|6436677|P6|Overall Study|Randomization entry error-no RX, no FU|0
1869054|NCT00006604|6436678|P5|Overall Study|Randomization entry error-no RX, no FU|0
1869055|NCT00006604|6436679|P4|Overall Study|Randomization entry error-no RX, no FU|0
1869056|NCT00006604|6436680|P3|Overall Study|Randomization entry error-no RX, no FU|0
1869057|NCT00006604|6436681|P2|Overall Study|Randomization entry error-no RX, no FU|0
1869058|NCT00006604|6436682|P1|Overall Study|Randomization entry error-no RX, no FU|0
1869059|NCT00006604|6436666|P17|Overall Study|Met study objective - no further FU|0
1869060|NCT00006604|6436667|P16|Overall Study|Met study objective - no further FU|1
1869061|NCT00006604|6436668|P15|Overall Study|Met study objective - no further FU|1
1869062|NCT00006604|6436669|P14|Overall Study|Met study objective - no further FU|0
1869063|NCT00006604|6436670|P13|Overall Study|Met study objective - no further FU|0
1869064|NCT00006604|6436671|P12|Overall Study|Met study objective - no further FU|0
1869065|NCT00006604|6436672|P11|Overall Study|Met study objective - no further FU|0
1869066|NCT00006604|6436673|P10|Overall Study|Met study objective - no further FU|0
1869067|NCT00006604|6436674|P9|Overall Study|Met study objective - no further FU|0
1869068|NCT00006604|6436675|P8|Overall Study|Met study objective - no further FU|0
1869069|NCT00006604|6436676|P7|Overall Study|Met study objective - no further FU|0
1869070|NCT00006604|6436677|P6|Overall Study|Met study objective - no further FU|0
1869071|NCT00006604|6436678|P5|Overall Study|Met study objective - no further FU|0
1869072|NCT00006604|6436679|P4|Overall Study|Met study objective - no further FU|0
1869073|NCT00006604|6436680|P3|Overall Study|Met study objective - no further FU|0
1869074|NCT00006604|6436681|P2|Overall Study|Met study objective - no further FU|0
1869075|NCT00006604|6436682|P1|Overall Study|Met study objective - no further FU|1
1869076|NCT00004978|6436798|P2|Overall Study|site closure - not in analysis cohort|20
1869077|NCT00004978|6436799|P1|Overall Study|site closure - not in analysis cohort|19
1869078|NCT00004978|6436798|P2|Overall Study|Withdrawal by Subject|26
1869079|NCT00004978|6436799|P1|Overall Study|Withdrawal by Subject|17
1869080|NCT00004978|6436798|P2|Overall Study|Lost to Follow-up|108
1869081|NCT00004978|6436799|P1|Overall Study|Lost to Follow-up|101
1869082|NCT00004978|6436798|P2|Overall Study|Death|116
1869083|NCT00004978|6436799|P1|Overall Study|Death|107
1869084|NCT00021541|6436825|P2|Period 2-crossover|Pts that did not progress|3
1869085|NCT00021541|6436826|P1|Period 2-crossover|Pts that did not progress|2
1869086|NCT00021541|6436825|P2|Period 2-crossover|non-adherence|0
1869087|NCT00021541|6436826|P1|Period 2-crossover|non-adherence|1
1869088|NCT00021541|6436825|P2|Period 2-crossover|Adverse Event|2
1869089|NCT00021541|6436826|P1|Period 2-crossover|Adverse Event|2
1869090|NCT00021541|6436825|P2|Period 2-crossover|Withdrawal by Subject|4
1869091|NCT00021541|6436826|P1|Period 2-crossover|Withdrawal by Subject|3
1869092|NCT00021541|6436825|P2|Period 2-crossover|refused phase B|2
1869093|NCT00021541|6436826|P1|Period 2-crossover|refused phase B|2
1869094|NCT00021541|6436825|P2|Period 1-First Treatment|Ineligible|2
1869095|NCT00021541|6436826|P1|Period 1-First Treatment|Ineligible|0
1869096|NCT00021541|6436825|P2|Period 1-First Treatment|Pts that did not progress|2
1869097|NCT00021541|6436826|P1|Period 1-First Treatment|Pts that did not progress|2
1869098|NCT00021541|6436825|P2|Period 1-First Treatment|Death|0
1869099|NCT00021541|6436826|P1|Period 1-First Treatment|Death|1
1869100|NCT00021541|6436825|P2|Period 1-First Treatment|non-adherence|0
1869101|NCT00021541|6436826|P1|Period 1-First Treatment|non-adherence|3
1869102|NCT00021541|6436825|P2|Period 1-First Treatment|Adverse Event|1
1869103|NCT00021541|6436826|P1|Period 1-First Treatment|Adverse Event|2
1869104|NCT00021541|6436825|P2|Period 1-First Treatment|Withdrawal by Subject|3
1869105|NCT00021541|6436826|P1|Period 1-First Treatment|Withdrawal by Subject|3
1869106|NCT00015457|6436840|P2|Second Intervention|Withdrawal by Subject|0
1869107|NCT00015457|6436841|P1|Second Intervention|Withdrawal by Subject|1
1869108|NCT00015457|6436840|P2|First Intervention|Lack of Efficacy|1
1869109|NCT00015457|6436841|P1|First Intervention|Lack of Efficacy|0
1869110|NCT00015457|6436840|P2|First Intervention|Adverse Event|2
1869111|NCT00015457|6436841|P1|First Intervention|Adverse Event|0
1869112|NCT00013611|6436851|P2|Overall Study|Lost to Follow-up|100
1869113|NCT00013611|6436852|P1|Overall Study|Lost to Follow-up|91
1869114|NCT00010803|6436870|P2|Overall Study|Withdrawal by Subject|98
1869115|NCT00010803|6436871|P1|Overall Study|Withdrawal by Subject|97
1869116|NCT00007475|6436898|P4|Overall Study|Adverse Event|0
1869117|NCT00007475|6436899|P3|Overall Study|Adverse Event|0
1869118|NCT00007475|6436900|P2|Overall Study|Adverse Event|0
1869119|NCT00007475|6436901|P1|Overall Study|Adverse Event|3
1869120|NCT00007475|6436898|P4|Overall Study|Withdrawal by Subject|0
1869121|NCT00007475|6436899|P3|Overall Study|Withdrawal by Subject|0
1869122|NCT00007475|6436900|P2|Overall Study|Withdrawal by Subject|0
1869123|NCT00007475|6436901|P1|Overall Study|Withdrawal by Subject|1
1869124|NCT00007345|6436923|P2|Overall Study|Death on study|1
1869125|NCT00007345|6436924|P1|Overall Study|Death on study|1
1869126|NCT00007345|6436923|P2|Overall Study|Intercurrent illness|0
1869127|NCT00007345|6436924|P1|Overall Study|Intercurrent illness|1
1869128|NCT00007345|6436923|P2|Overall Study|Switched to alternative treatment|3
1869129|NCT00007345|6436924|P1|Overall Study|Switched to alternative treatment|0
1869130|NCT00007345|6436923|P2|Overall Study|Refused further treatment|7
1869131|NCT00007345|6436924|P1|Overall Study|Refused further treatment|0
1869132|NCT00006489|6436946|P4|Overall Study|Death|1
1869133|NCT00006489|6436947|P3|Overall Study|Death|0
1869134|NCT00006489|6436948|P2|Overall Study|Death|0
1869135|NCT00006489|6436949|P1|Overall Study|Death|0
1869136|NCT00006489|6436946|P4|Overall Study|Scheduling Conflict|1
1869137|NCT00006489|6436947|P3|Overall Study|Scheduling Conflict|2
1869138|NCT00006489|6436948|P2|Overall Study|Scheduling Conflict|3
1869139|NCT00006489|6436949|P1|Overall Study|Scheduling Conflict|0
1869140|NCT00006489|6436946|P4|Overall Study|Withdrawal by Subject|6
1869141|NCT00006489|6436947|P3|Overall Study|Withdrawal by Subject|9
1869142|NCT00006489|6436948|P2|Overall Study|Withdrawal by Subject|9
1869143|NCT00006489|6436949|P1|Overall Study|Withdrawal by Subject|10
1869144|NCT00006489|6436946|P4|Overall Study|Adverse Event|3
1869145|NCT00006489|6436947|P3|Overall Study|Adverse Event|4
1869146|NCT00006489|6436948|P2|Overall Study|Adverse Event|2
1869147|NCT00006489|6436949|P1|Overall Study|Adverse Event|3
1869148|NCT00006409|6436984|P6|Post-3 Year Intervention|Protocol Violation|62
1869149|NCT00006409|6436985|P5|Post-3 Year Intervention|Protocol Violation|62
1869150|NCT00006409|6436986|P4|Post-3 Year Intervention|Protocol Violation|0
1869151|NCT00006409|6436987|P3|Post-3 Year Intervention|Protocol Violation|0
1869152|NCT00006409|6436988|P2|Post-3 Year Intervention|Protocol Violation|0
1869153|NCT00006409|6436989|P1|Post-3 Year Intervention|Protocol Violation|0
1869154|NCT00006409|6436984|P6|Post-2 Year Intervention|Protocol Violation|0
1869155|NCT00006409|6436985|P5|Post-2 Year Intervention|Protocol Violation|0
1869156|NCT00006409|6436986|P4|Post-2 Year Intervention|Protocol Violation|168
1869157|NCT00006409|6436987|P3|Post-2 Year Intervention|Protocol Violation|251
1869158|NCT00006409|6436988|P2|Post-2 Year Intervention|Protocol Violation|0
1869159|NCT00006409|6436989|P1|Post-2 Year Intervention|Protocol Violation|0
1869160|NCT00006409|6436984|P6|Baseline|Protocol Violation|0
1869161|NCT00006409|6436985|P5|Baseline|Protocol Violation|0
1869162|NCT00006409|6436986|P4|Baseline|Protocol Violation|0
1869163|NCT00006409|6436987|P3|Baseline|Protocol Violation|0
1869164|NCT00006409|6436988|P2|Baseline|Protocol Violation|70
1869165|NCT00006409|6436989|P1|Baseline|Protocol Violation|48
1869166|NCT00006305|6437013|P4|Overall Study|Withdrawal by Subject|14
1869167|NCT00006305|6437014|P3|Overall Study|Withdrawal by Subject|15
1869168|NCT00006305|6437015|P2|Overall Study|Withdrawal by Subject|10
1869169|NCT00006305|6437016|P1|Overall Study|Withdrawal by Subject|17
1869170|NCT00006289|6437032|P2|Second Intervention (5 Weeks)|Protocol Violation|1
1869171|NCT00006289|6437033|P1|Second Intervention (5 Weeks)|Protocol Violation|1
1869172|NCT00006289|6437032|P2|First Intervention (5 Weeks)|Adverse Event|0
1869173|NCT00006289|6437033|P1|First Intervention (5 Weeks)|Adverse Event|1
1869174|NCT00006184|6437051|P2|Overall Study|Death|0
1869175|NCT00006184|6437052|P1|Overall Study|Death|1
1869176|NCT00006164|6437103|P2|Overall Study|Withdrew or lost to follow-up|81
1869177|NCT00006164|6437104|P1|Overall Study|Withdrew or lost to follow-up|70
1869178|NCT00005937|6437147|P1|Overall Study|Lack of Efficacy|5
1869179|NCT00005908|6437151|P2|Overall Study|Withdrawal by Subject|0
1869180|NCT00005908|6437152|P1|Overall Study|Withdrawal by Subject|1
1869181|NCT00005906|6437161|P1|Overall Study|Lack of Efficacy|3
1869182|NCT00004980|6437205|P2|Overall Study|Physician Decision|1
1869183|NCT00004980|6437206|P1|Overall Study|Physician Decision|0
1869184|NCT00004980|6437205|P2|Overall Study|memory difficulties|1
1869185|NCT00004980|6437206|P1|Overall Study|memory difficulties|1
1869186|NCT00004980|6437205|P2|Overall Study|Withdrawal by Subject|0
1869187|NCT00004980|6437206|P1|Overall Study|Withdrawal by Subject|1
1869188|NCT00004732|6437220|P2|Overall Study|Lost to Follow-up|47
1869189|NCT00004732|6437221|P1|Overall Study|Lost to Follow-up|33
1869190|NCT00004732|6437220|P2|Overall Study|Withdrawal by Subject|64
1869191|NCT00004732|6437221|P1|Overall Study|Withdrawal by Subject|36
1869192|NCT00004635|6437231|P2|Period Two|discrepancy in data entry|1
1869193|NCT00004635|6437232|P1|Period Two|discrepancy in data entry|0
1869194|NCT00004635|6437231|P2|Period Two|Lost to Follow-up|0
1869195|NCT00004635|6437232|P1|Period Two|Lost to Follow-up|1
1869196|NCT00004635|6437231|P2|Period Two|secondary malignancy|1
1869197|NCT00004635|6437232|P1|Period Two|secondary malignancy|1
1869198|NCT00004635|6437231|P2|Period Two|travel issues|1
1869199|NCT00004635|6437232|P1|Period Two|travel issues|0
1869200|NCT00004635|6437231|P2|Period Two|health problem|1
1869201|NCT00004635|6437232|P1|Period Two|health problem|1
1869202|NCT00004635|6437231|P2|Period Two|refused|2
1869203|NCT00004635|6437232|P1|Period Two|refused|0
1869204|NCT00004635|6437231|P2|Period Two|Adverse Event|0
1869205|NCT00004635|6437232|P1|Period Two|Adverse Event|1
1869206|NCT00004635|6437231|P2|Period Two|progression|3
1869207|NCT00004635|6437232|P1|Period Two|progression|2
1869208|NCT00004635|6437231|P2|Period One|discrepancy in data entry|1
1869209|NCT00004635|6437232|P1|Period One|discrepancy in data entry|0
1869210|NCT00004635|6437231|P2|Period One|health problem|1
1869211|NCT00004635|6437232|P1|Period One|health problem|0
1869212|NCT00004635|6437231|P2|Period One|progressed|2
1869213|NCT00004635|6437232|P1|Period One|progressed|0
1869214|NCT00004635|6437231|P2|Period One|second malignancy|0
1869215|NCT00004635|6437232|P1|Period One|second malignancy|1
1869216|NCT00004635|6437231|P2|Period One|PSA did not go <5 ng/mL|0
1869217|NCT00004635|6437232|P1|Period One|PSA did not go <5 ng/mL|1
1869218|NCT00004635|6437231|P2|Period One|Protocol Violation|0
1869219|NCT00004635|6437232|P1|Period One|Protocol Violation|1
1869220|NCT00004635|6437231|P2|Period One|Withdrawal by Subject|1
1869221|NCT00004635|6437232|P1|Period One|Withdrawal by Subject|1
1869222|NCT00004635|6437231|P2|Period One|refused|1
1869223|NCT00004635|6437232|P1|Period One|refused|2
1869224|NCT00004563|6437244|P2|Overall Study|Death|3
1869225|NCT00004563|6437245|P1|Overall Study|Death|2
1869226|NCT00004563|6437244|P2|Overall Study|Lack of Efficacy|5
1869227|NCT00004563|6437245|P1|Overall Study|Lack of Efficacy|3
1869228|NCT00004563|6437244|P2|Overall Study|Withdrawal by Subject|16
1869229|NCT00004563|6437245|P1|Overall Study|Withdrawal by Subject|20
1869230|NCT00004562|6437257|P2|Overall Study|Lost to Follow-up|91
1869231|NCT00004562|6437258|P1|Overall Study|Lost to Follow-up|102
1869232|NCT00001962|6437299|P1|Overall Study|Adverse Event|1
1869233|NCT00001962|6437299|P1|Overall Study|Lost to Follow-up|2
1869234|NCT00001962|6437299|P1|Overall Study|Death|1
1869235|NCT00001962|6437299|P1|Overall Study|Lack of Accrual|6
1869236|NCT00001962|6437299|P1|Overall Study|Lack of Efficacy|18
1869237|NCT00001959|6437303|P1|Overall Study|non-compliance|1
1869238|NCT00001959|6437303|P1|Overall Study|disabling sedation|1
1869239|NCT00001959|6437303|P1|Overall Study|newly diagnosed colon cancer|1
1869240|NCT00001941|6437309|P5|Overall Study|not treated- rapidly progressing disease|1
1869241|NCT00001941|6437310|P4|Overall Study|not treated- rapidly progressing disease|0
1869242|NCT00001941|6437311|P3|Overall Study|not treated- rapidly progressing disease|0
1869243|NCT00001941|6437312|P2|Overall Study|not treated- rapidly progressing disease|0
1869244|NCT00001941|6437313|P1|Overall Study|not treated- rapidly progressing disease|0
1869245|NCT00001832|6437345|P15|Treatment Period|Not treated|0
1869246|NCT00001832|6437346|P14|Treatment Period|Not treated|0
1869247|NCT00001832|6437347|P13|Treatment Period|Not treated|0
1869248|NCT00001832|6437348|P12|Treatment Period|Not treated|0
1869249|NCT00001832|6437349|P11|Treatment Period|Not treated|0
1869250|NCT00001832|6437350|P10|Treatment Period|Not treated|0
1869251|NCT00001832|6437351|P9|Treatment Period|Not treated|0
1869252|NCT00001832|6437352|P8|Treatment Period|Not treated|1
1869253|NCT00001832|6437353|P7|Treatment Period|Not treated|0
1869254|NCT00001832|6437354|P6|Treatment Period|Not treated|0
1869255|NCT00001832|6437355|P5|Treatment Period|Not treated|0
1869256|NCT00001832|6437356|P4|Treatment Period|Not treated|0
1869257|NCT00001832|6437357|P3|Treatment Period|Not treated|0
1869258|NCT00001832|6437358|P2|Treatment Period|Not treated|0
1869259|NCT00001832|6437359|P1|Treatment Period|Not treated|0
1869260|NCT00001832|6437345|P15|Treatment Period|Death during treatment|0
1869261|NCT00001832|6437346|P14|Treatment Period|Death during treatment|0
1869262|NCT00001832|6437347|P13|Treatment Period|Death during treatment|0
1869263|NCT00001832|6437348|P12|Treatment Period|Death during treatment|0
1869264|NCT00001832|6437349|P11|Treatment Period|Death during treatment|0
1869265|NCT00001832|6437350|P10|Treatment Period|Death during treatment|0
1869266|NCT00001832|6437351|P9|Treatment Period|Death during treatment|0
1869267|NCT00001832|6437352|P8|Treatment Period|Death during treatment|0
1869268|NCT00001832|6437353|P7|Treatment Period|Death during treatment|0
1869269|NCT00001832|6437354|P6|Treatment Period|Death during treatment|1
1869270|NCT00001832|6437355|P5|Treatment Period|Death during treatment|0
1869271|NCT00001832|6437356|P4|Treatment Period|Death during treatment|0
1869272|NCT00001832|6437357|P3|Treatment Period|Death during treatment|0
1869273|NCT00001832|6437358|P2|Treatment Period|Death during treatment|0
1869274|NCT00001832|6437359|P1|Treatment Period|Death during treatment|0
1869275|NCT00001832|6437345|P15|Apheresis Period|not able to manufacture treatment cells|0
1869276|NCT00001832|6437346|P14|Apheresis Period|not able to manufacture treatment cells|0
1869277|NCT00001832|6437347|P13|Apheresis Period|not able to manufacture treatment cells|0
1869278|NCT00001832|6437348|P12|Apheresis Period|not able to manufacture treatment cells|0
1869279|NCT00001832|6437349|P11|Apheresis Period|not able to manufacture treatment cells|0
1869280|NCT00001832|6437350|P10|Apheresis Period|not able to manufacture treatment cells|0
1869281|NCT00001832|6437351|P9|Apheresis Period|not able to manufacture treatment cells|0
1869282|NCT00001832|6437352|P8|Apheresis Period|not able to manufacture treatment cells|0
1869283|NCT00001832|6437353|P7|Apheresis Period|not able to manufacture treatment cells|0
1869284|NCT00001832|6437354|P6|Apheresis Period|not able to manufacture treatment cells|0
1869285|NCT00001832|6437355|P5|Apheresis Period|not able to manufacture treatment cells|0
1869286|NCT00001832|6437356|P4|Apheresis Period|not able to manufacture treatment cells|0
1869287|NCT00001832|6437357|P3|Apheresis Period|not able to manufacture treatment cells|0
1869288|NCT00001832|6437358|P2|Apheresis Period|not able to manufacture treatment cells|0
1869289|NCT00001832|6437359|P1|Apheresis Period|not able to manufacture treatment cells|60
1869290|NCT00001723|6437405|P2|Overall Study|medication intolerance|2
1869291|NCT00001723|6437406|P1|Overall Study|medication intolerance|1
1869292|NCT00001723|6437405|P2|Overall Study|Lost to Follow-up|2
1869293|NCT00001723|6437406|P1|Overall Study|Lost to Follow-up|2
1869294|NCT00001723|6437405|P2|Overall Study|Lack of family interest|5
1869295|NCT00001723|6437406|P1|Overall Study|Lack of family interest|4
1869296|NCT00001723|6437405|P2|Overall Study|Lack of Efficacy|7
1869297|NCT00001723|6437406|P1|Overall Study|Lack of Efficacy|6
1869298|NCT00001703|6437422|P1|Overall Study|recurrent disease|2
1869299|NCT00001703|6437422|P1|Overall Study|No evidence of disease|1
1869300|NCT00001703|6437422|P1|Overall Study|progressed disease|2
1869301|NCT00001596|6437460|P2|Overall Study|Adverse Event|0
1869302|NCT00001596|6437461|P1|Overall Study|Adverse Event|1
1869303|NCT00001596|6437460|P2|Overall Study|Study Termination|9
1869304|NCT00001596|6437461|P1|Overall Study|Study Termination|12
1869305|NCT00001596|6437460|P2|Overall Study|Withdrawal by Subject|1
1869306|NCT00001596|6437461|P1|Overall Study|Withdrawal by Subject|3
1869307|NCT00001596|6437460|P2|Overall Study|Death|0
1869308|NCT00001596|6437461|P1|Overall Study|Death|1
1869309|NCT00001575|6437492|P1|Overall Study|Withdrawn/deaths|23
1869310|NCT00001575|6437492|P1|Overall Study|Screening failures-Ph I portion|22
1869311|NCT00001566|6437498|P1|Overall Study|unable to complete initial apheresis|1
1869312|NCT00001566|6437498|P1|Overall Study|Lost to Follow-up|1
1869313|NCT00001566|6437498|P1|Overall Study|Death|13
1869314|NCT00001566|6437498|P1|Overall Study|stopped after C3 due to symptomatic PD|1
1869315|NCT00001566|6437498|P1|Overall Study|patients' choice to discontinue protocol|3
1869316|NCT00001262|6437538|P3|Overall Study|Withdrawal by Subject|0
1869317|NCT00001262|6437539|P2|Overall Study|Withdrawal by Subject|3
1869318|NCT00001262|6437540|P1|Overall Study|Withdrawal by Subject|0
1869319|NCT00001262|6437538|P3|Overall Study|Death|0
1869320|NCT00001262|6437539|P2|Overall Study|Death|11
1869321|NCT00001262|6437540|P1|Overall Study|Death|10
1869322|NCT00001213|6437566|P1|Overall Study|Death|18
1869323|NCT00000378|6437577|P2|Overall Study|Lack of Efficacy|14
1869324|NCT00000378|6437578|P1|Overall Study|Lack of Efficacy|16
1869325|NCT00000620|6437595|P8|Overall Study|missed closeout visit|16
1869326|NCT00000620|6437596|P7|Overall Study|missed closeout visit|13
1869327|NCT00000620|6437597|P6|Overall Study|missed closeout visit|28
1869328|NCT00000620|6437598|P5|Overall Study|missed closeout visit|26
1869329|NCT00000620|6437599|P4|Overall Study|missed closeout visit|11
1869330|NCT00000620|6437600|P3|Overall Study|missed closeout visit|16
1869331|NCT00000620|6437601|P2|Overall Study|missed closeout visit|28
1869332|NCT00000620|6437602|P1|Overall Study|missed closeout visit|22
1869333|NCT00000620|6437595|P8|Overall Study|Withdrawal by Subject|21
1869334|NCT00000620|6437596|P7|Overall Study|Withdrawal by Subject|32
1869335|NCT00000620|6437597|P6|Overall Study|Withdrawal by Subject|32
1869336|NCT00000620|6437598|P5|Overall Study|Withdrawal by Subject|30
1869337|NCT00000620|6437599|P4|Overall Study|Withdrawal by Subject|27
1869338|NCT00000620|6437600|P3|Overall Study|Withdrawal by Subject|28
1869339|NCT00000620|6437601|P2|Overall Study|Withdrawal by Subject|27
1869340|NCT00000620|6437602|P1|Overall Study|Withdrawal by Subject|40
1869341|NCT00000620|6437595|P8|Overall Study|Lost to Follow-up|14
1869342|NCT00000620|6437596|P7|Overall Study|Lost to Follow-up|13
1869343|NCT00000620|6437597|P6|Overall Study|Lost to Follow-up|15
1869344|NCT00000620|6437598|P5|Overall Study|Lost to Follow-up|15
1869345|NCT00000620|6437599|P4|Overall Study|Lost to Follow-up|14
1869346|NCT00000620|6437600|P3|Overall Study|Lost to Follow-up|14
1869347|NCT00000620|6437601|P2|Overall Study|Lost to Follow-up|14
1869348|NCT00000620|6437602|P1|Overall Study|Lost to Follow-up|14
1869349|NCT00000620|6437595|P8|Overall Study|Death|95
1869350|NCT00000620|6437596|P7|Overall Study|Death|91
1869351|NCT00000620|6437597|P6|Overall Study|Death|77
1869352|NCT00000620|6437598|P5|Overall Study|Death|64
1869353|NCT00000620|6437599|P4|Overall Study|Death|126
1869354|NCT00000620|6437600|P3|Overall Study|Death|112
1869355|NCT00000620|6437601|P2|Overall Study|Death|67
1869356|NCT00000620|6437602|P1|Overall Study|Death|86
1869357|NCT00004445|6437683|P1|Overall Study|Withdrawal by Subject|1
1869358|NCT00004445|6437683|P1|Overall Study|Physician Decision|2
1869359|NCT00004412|6437691|P3|Randomized Period|Moved to Crossover Period|0
1869360|NCT00004412|6437692|P2|Randomized Period|Moved to Crossover Period|0
1869361|NCT00004412|6437693|P1|Randomized Period|Moved to Crossover Period|3
1869362|NCT00000135|6437734|P2|Overall Study|Death|14
1869363|NCT00000135|6437735|P1|Overall Study|Death|27
1869375|NCT03700671|6438034|P2|Overall Study|Lack of Efficacy|2
1869376|NCT03700671|6438035|P1|Overall Study|Lack of Efficacy|1
1871688|NCT03678870|6446916|P2|Overall Study|Lost to Follow-up|2
1871689|NCT03678870|6446917|P1|Overall Study|Lost to Follow-up|3
1871690|NCT03678870|6446916|P2|Overall Study|prescribed non- protocol medications|6
1871691|NCT03678870|6446917|P1|Overall Study|prescribed non- protocol medications|10
1871700|NCT03585296|6447029|P1|Overall Study|Withdrawal by Subject|2
1871701|NCT03585296|6447029|P1|Overall Study|Lost to Follow-up|2
1871702|NCT03585296|6447029|P1|Overall Study|Adverse Event|1
1871712|NCT03473236|6447153|P10|Overall Study|Withdrawal by Subject|0
1871713|NCT03473236|6447154|P9|Overall Study|Withdrawal by Subject|1
1871714|NCT03473236|6447155|P8|Overall Study|Withdrawal by Subject|0
1871715|NCT03473236|6447156|P7|Overall Study|Withdrawal by Subject|0
1871716|NCT03473236|6447157|P6|Overall Study|Withdrawal by Subject|1
1871717|NCT03473236|6447158|P5|Overall Study|Withdrawal by Subject|0
1871718|NCT03473236|6447159|P4|Overall Study|Withdrawal by Subject|0
1871719|NCT03473236|6447160|P3|Overall Study|Withdrawal by Subject|0
1871720|NCT03473236|6447161|P2|Overall Study|Withdrawal by Subject|0
1871721|NCT03473236|6447162|P1|Overall Study|Withdrawal by Subject|0
1871722|NCT03471871|6447284|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1871723|NCT03471871|6447285|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
1871724|NCT03471871|6447286|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1871725|NCT03471871|6447287|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1871726|NCT03471871|6447288|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
1871727|NCT03471871|6447284|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
1871728|NCT03471871|6447285|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1871729|NCT03471871|6447286|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1871730|NCT03471871|6447287|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1871731|NCT03471871|6447288|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
1871732|NCT03471871|6447284|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
1871733|NCT03471871|6447285|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1871734|NCT03471871|6447286|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1871735|NCT03471871|6447287|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1871736|NCT03471871|6447288|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
1871737|NCT03471871|6447284|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
1871738|NCT03471871|6447285|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
1871739|NCT03471871|6447286|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
1871740|NCT03471871|6447287|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
1871741|NCT03471871|6447288|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
1871742|NCT03471871|6447284|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1871743|NCT03471871|6447285|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1871744|NCT03471871|6447286|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
1871745|NCT03471871|6447287|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1871746|NCT03471871|6447288|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
1871753|NCT03439072|6447349|P2|Overall Study|Physician Decision|1
1871754|NCT03439072|6447350|P1|Overall Study|Physician Decision|0
1871755|NCT03439072|6447349|P2|Overall Study|Withdrawal by Subject|3
1871756|NCT03439072|6447350|P1|Overall Study|Withdrawal by Subject|2
1871795|NCT03248492|6447682|P5|Overall Study|Other|0
1871796|NCT03248492|6447683|P4|Overall Study|Other|4
1871797|NCT03248492|6447684|P3|Overall Study|Other|0
1871798|NCT03248492|6447685|P2|Overall Study|Other|1
1871799|NCT03248492|6447686|P1|Overall Study|Other|0
1871800|NCT03248492|6447682|P5|Overall Study|Death|0
1871801|NCT03248492|6447683|P4|Overall Study|Death|6
1871802|NCT03248492|6447684|P3|Overall Study|Death|0
1871803|NCT03248492|6447685|P2|Overall Study|Death|0
1871804|NCT03248492|6447686|P1|Overall Study|Death|1
1871805|NCT03248492|6447682|P5|Overall Study|Physician Decision|0
1871806|NCT03248492|6447683|P4|Overall Study|Physician Decision|2
1871807|NCT03248492|6447684|P3|Overall Study|Physician Decision|1
1871808|NCT03248492|6447685|P2|Overall Study|Physician Decision|0
1871809|NCT03248492|6447686|P1|Overall Study|Physician Decision|1
1871810|NCT03248492|6447682|P5|Overall Study|Withdrawal by Subject|1
1871811|NCT03248492|6447683|P4|Overall Study|Withdrawal by Subject|3
1871812|NCT03248492|6447684|P3|Overall Study|Withdrawal by Subject|0
1871813|NCT03248492|6447685|P2|Overall Study|Withdrawal by Subject|3
1871814|NCT03248492|6447686|P1|Overall Study|Withdrawal by Subject|3
1871815|NCT03248492|6447682|P5|Overall Study|Adverse Event|1
1871816|NCT03248492|6447683|P4|Overall Study|Adverse Event|8
1871817|NCT03248492|6447684|P3|Overall Study|Adverse Event|8
1871818|NCT03248492|6447685|P2|Overall Study|Adverse Event|6
1871819|NCT03248492|6447686|P1|Overall Study|Adverse Event|6
1871820|NCT03248492|6447682|P5|Overall Study|Progressive disease per RECIST v1.1|0
1871821|NCT03248492|6447683|P4|Overall Study|Progressive disease per RECIST v1.1|22
1871822|NCT03248492|6447684|P3|Overall Study|Progressive disease per RECIST v1.1|9
1871823|NCT03248492|6447685|P2|Overall Study|Progressive disease per RECIST v1.1|12
1871824|NCT03248492|6447686|P1|Overall Study|Progressive disease per RECIST v1.1|16
1871825|NCT03248492|6447682|P5|Overall Study|Ongoing|2
1871826|NCT03248492|6447683|P4|Overall Study|Ongoing|85
1871827|NCT03248492|6447684|P3|Overall Study|Ongoing|3
1871828|NCT03248492|6447685|P2|Overall Study|Ongoing|26
1871829|NCT03248492|6447686|P1|Overall Study|Ongoing|23
1871984|NCT03099187|6448053|P2|Overall Study|Non-compliance with Protocol procedure|2
1871985|NCT03099187|6448054|P1|Overall Study|Non-compliance with Protocol procedure|1
1871986|NCT03099187|6448053|P2|Overall Study|Randomization error|2
1871987|NCT03099187|6448054|P1|Overall Study|Randomization error|0
1871988|NCT03099187|6448053|P2|Overall Study|Symptomatic deterioration|1
1871989|NCT03099187|6448054|P1|Overall Study|Symptomatic deterioration|0
1871990|NCT03099187|6448053|P2|Overall Study|Disease progression|1
1871991|NCT03099187|6448054|P1|Overall Study|Disease progression|0
1871992|NCT03099187|6448053|P2|Overall Study|Non-compliance with study drug|1
1871993|NCT03099187|6448054|P1|Overall Study|Non-compliance with study drug|0
1871994|NCT03099187|6448053|P2|Overall Study|Lung transplantation|3
1871995|NCT03099187|6448054|P1|Overall Study|Lung transplantation|1
1871996|NCT03099187|6448053|P2|Overall Study|Withdrawal by Subject|6
1871997|NCT03099187|6448054|P1|Overall Study|Withdrawal by Subject|11
1871998|NCT03099187|6448053|P2|Overall Study|Physician Decision|2
1871999|NCT03099187|6448054|P1|Overall Study|Physician Decision|2
1872000|NCT03099187|6448053|P2|Overall Study|Lack of Efficacy|0
1872001|NCT03099187|6448054|P1|Overall Study|Lack of Efficacy|1
1872002|NCT03099187|6448053|P2|Overall Study|Death|7
1872003|NCT03099187|6448054|P1|Overall Study|Death|4
1872004|NCT03099187|6448053|P2|Overall Study|Adverse Event|9
1872005|NCT03099187|6448054|P1|Overall Study|Adverse Event|23
1872023|NCT03058991|6448222|P3|Overall Study|Withdrawal by Subject|0
1872024|NCT03058991|6448223|P2|Overall Study|Withdrawal by Subject|0
1872025|NCT03058991|6448224|P1|Overall Study|Withdrawal by Subject|1
1872026|NCT03058991|6448222|P3|Overall Study|Lost to Follow-up|12
1872027|NCT03058991|6448223|P2|Overall Study|Lost to Follow-up|12
1872028|NCT03058991|6448224|P1|Overall Study|Lost to Follow-up|17
1872063|NCT03001557|6448588|P5|Overall Study|Randomized but not treated|0
1872064|NCT03001557|6448589|P4|Overall Study|Randomized but not treated|0
1872065|NCT03001557|6448590|P3|Overall Study|Randomized but not treated|1
1872066|NCT03001557|6448591|P2|Overall Study|Randomized but not treated|0
1872067|NCT03001557|6448592|P1|Overall Study|Randomized but not treated|0
1872072|NCT02984995|6449013|P2|Overall Study|Adverse Event|0
1872073|NCT02984995|6449014|P1|Overall Study|Adverse Event|1
1872074|NCT02984995|6449013|P2|Overall Study|Progressive disease|1
1872075|NCT02984995|6449014|P1|Overall Study|Progressive disease|11
1872076|NCT02984995|6449013|P2|Overall Study|Required stem cell transplant|2
1872077|NCT02984995|6449014|P1|Overall Study|Required stem cell transplant|13
1872177|NCT02906930|6449415|P4|Overall Study|Other|2
1872178|NCT02906930|6449416|P3|Overall Study|Other|1
1872179|NCT02906930|6449417|P2|Overall Study|Other|2
1872180|NCT02906930|6449418|P1|Overall Study|Other|1
1872181|NCT02906930|6449415|P4|Overall Study|Death|0
1872182|NCT02906930|6449416|P3|Overall Study|Death|1
1872183|NCT02906930|6449417|P2|Overall Study|Death|0
1872184|NCT02906930|6449418|P1|Overall Study|Death|0
1872185|NCT02906930|6449415|P4|Overall Study|Lost to Follow-up|2
1872186|NCT02906930|6449416|P3|Overall Study|Lost to Follow-up|5
1872187|NCT02906930|6449417|P2|Overall Study|Lost to Follow-up|7
1872188|NCT02906930|6449418|P1|Overall Study|Lost to Follow-up|5
1872189|NCT02906930|6449415|P4|Overall Study|Withdrawal by Subject|4
1872190|NCT02906930|6449416|P3|Overall Study|Withdrawal by Subject|5
1872191|NCT02906930|6449417|P2|Overall Study|Withdrawal by Subject|5
1872192|NCT02906930|6449418|P1|Overall Study|Withdrawal by Subject|0
1872211|NCT02849080|6450054|P2|Overall Study|Death|2
1872212|NCT02849080|6450055|P1|Overall Study|Death|0
1872213|NCT02849080|6450054|P2|Overall Study|Withdrawal by Subject|1
1872214|NCT02849080|6450055|P1|Overall Study|Withdrawal by Subject|5
1872215|NCT02849080|6450054|P2|Overall Study|Lost to Follow-up|4
1872216|NCT02849080|6450055|P1|Overall Study|Lost to Follow-up|7
1872234|NCT02836249|6450180|P2|Overall Study|Still on Study|55
1872235|NCT02836249|6450181|P1|Overall Study|Still on Study|121
1872236|NCT02836249|6450180|P2|Overall Study|Lost to Follow-up|1
1872237|NCT02836249|6450181|P1|Overall Study|Lost to Follow-up|0
1872238|NCT02836249|6450180|P2|Overall Study|Withdrew Consent|1
1872239|NCT02836249|6450181|P1|Overall Study|Withdrew Consent|0
1872240|NCT02836249|6450180|P2|Overall Study|Pregnancy|0
1872241|NCT02836249|6450181|P1|Overall Study|Pregnancy|2
1872242|NCT02836249|6450180|P2|Overall Study|Randomized but Never Treated|1
1872243|NCT02836249|6450181|P1|Overall Study|Randomized but Never Treated|0
1872244|NCT02827708|6450207|P2|Overall Study|Death|2
1872245|NCT02827708|6450208|P1|Overall Study|Death|1
1872246|NCT02827708|6450207|P2|Overall Study|Withdrawal by Subject|2
1872247|NCT02827708|6450208|P1|Overall Study|Withdrawal by Subject|1
1872248|NCT02827708|6450207|P2|Overall Study|Lost to Follow-up|1
1872249|NCT02827708|6450208|P1|Overall Study|Lost to Follow-up|3
1872274|NCT02819726|6450417|P4|Part B (All Participants)|Protocol non-compliance|0
1872275|NCT02819726|6450418|P3|Part B (All Participants)|Protocol non-compliance|1
1872276|NCT02819726|6450419|P2|Part B (All Participants)|Protocol non-compliance|0
1872277|NCT02819726|6450420|P1|Part B (All Participants)|Protocol non-compliance|0
1872278|NCT02819726|6450417|P4|Part B (All Participants)|Withdrawal by Subject|0
1872279|NCT02819726|6450418|P3|Part B (All Participants)|Withdrawal by Subject|1
1872280|NCT02819726|6450419|P2|Part B (All Participants)|Withdrawal by Subject|1
1872281|NCT02819726|6450420|P1|Part B (All Participants)|Withdrawal by Subject|2
1872282|NCT02819726|6450417|P4|Part B (All Participants)|Lost to Follow-up|2
1872283|NCT02819726|6450418|P3|Part B (All Participants)|Lost to Follow-up|2
1872284|NCT02819726|6450419|P2|Part B (All Participants)|Lost to Follow-up|1
1872285|NCT02819726|6450420|P1|Part B (All Participants)|Lost to Follow-up|1
1872286|NCT02819726|6450417|P4|Part A (All Participants)|Protocol non-compliance|0
1872287|NCT02819726|6450418|P3|Part A (All Participants)|Protocol non-compliance|5
1872288|NCT02819726|6450419|P2|Part A (All Participants)|Protocol non-compliance|4
1872289|NCT02819726|6450420|P1|Part A (All Participants)|Protocol non-compliance|3
1872290|NCT02819726|6450417|P4|Part A (All Participants)|Withdrawal by Subject|0
1872291|NCT02819726|6450418|P3|Part A (All Participants)|Withdrawal by Subject|6
1872292|NCT02819726|6450419|P2|Part A (All Participants)|Withdrawal by Subject|5
1872293|NCT02819726|6450420|P1|Part A (All Participants)|Withdrawal by Subject|3
1872294|NCT02819726|6450417|P4|Part A (All Participants)|Lost to Follow-up|0
1872295|NCT02819726|6450418|P3|Part A (All Participants)|Lost to Follow-up|0
1872296|NCT02819726|6450419|P2|Part A (All Participants)|Lost to Follow-up|1
1872297|NCT02819726|6450420|P1|Part A (All Participants)|Lost to Follow-up|0
1872304|NCT02788656|6450558|P2|Overall Study|Withdrawal by Subject|0
1872305|NCT02788656|6450559|P1|Overall Study|Withdrawal by Subject|1
1872331|NCT02775435|6450685|P2|Overall Study|Not Treated|1
1872332|NCT02775435|6450686|P1|Overall Study|Not Treated|0
1872333|NCT02775435|6450685|P2|Overall Study|Ongoing in Study|72
1872334|NCT02775435|6450686|P1|Overall Study|Ongoing in Study|121
1872335|NCT02775435|6450685|P2|Overall Study|Clinical Progression|26
1872336|NCT02775435|6450686|P1|Overall Study|Clinical Progression|13
1872337|NCT02775435|6450685|P2|Overall Study|Progressive Disease|140
1872338|NCT02775435|6450686|P1|Overall Study|Progressive Disease|86
1872339|NCT02775435|6450685|P2|Overall Study|Withdrawal by Subject|9
1872340|NCT02775435|6450686|P1|Overall Study|Withdrawal by Subject|5
1872341|NCT02775435|6450685|P2|Overall Study|Physician Decision|6
1872342|NCT02775435|6450686|P1|Overall Study|Physician Decision|5
1872343|NCT02775435|6450685|P2|Overall Study|Lost to Follow-up|2
1872344|NCT02775435|6450686|P1|Overall Study|Lost to Follow-up|0
1872345|NCT02775435|6450685|P2|Overall Study|Adverse Event|25
1872346|NCT02775435|6450686|P1|Overall Study|Adverse Event|48
1872478|NCT02702401|6451086|P2|Overall Study|Ongoing in study|34
1872479|NCT02702401|6451087|P1|Overall Study|Ongoing in study|94
1872480|NCT02702401|6451086|P2|Overall Study|Withdrawal by Subject|0
1872481|NCT02702401|6451087|P1|Overall Study|Withdrawal by Subject|4
1872482|NCT02702401|6451086|P2|Overall Study|Death|101
1872483|NCT02702401|6451087|P1|Overall Study|Death|180
1872567|NCT02613208|6451548|P1|Overall Study|Death|37
1872568|NCT02613208|6451548|P1|Overall Study|Lost to Follow-up|5
1872569|NCT02613208|6451548|P1|Overall Study|Physician Decision|2
1872570|NCT02613208|6451548|P1|Overall Study|Change of address|2
1872571|NCT02613208|6451548|P1|Overall Study|Withdrawal by Subject|1
1872658|NCT02562482|6452031|P2|Overall Study|Illness/Injury unrelated to product|1
1872659|NCT02562482|6452032|P1|Overall Study|Illness/Injury unrelated to product|0
1872660|NCT02562482|6452031|P2|Overall Study|Physician Decision|3
1872661|NCT02562482|6452032|P1|Overall Study|Physician Decision|1
1872662|NCT02562482|6452031|P2|Overall Study|Withdrawal by Subject|3
1872663|NCT02562482|6452032|P1|Overall Study|Withdrawal by Subject|5
1872664|NCT02562482|6452031|P2|Overall Study|Moved from area|3
1872665|NCT02562482|6452032|P1|Overall Study|Moved from area|2
1872666|NCT02562482|6452031|P2|Overall Study|Lost to Follow-up|6
1872667|NCT02562482|6452032|P1|Overall Study|Lost to Follow-up|9
1872668|NCT02562482|6452031|P2|Overall Study|Enrolled, but did not receive product|0
1872669|NCT02562482|6452032|P1|Overall Study|Enrolled, but did not receive product|4
1872687|NCT02547766|6452139|P1|Overall Study|Withdrawal by Subject|1
1872748|NCT02540291|6452278|P4|Overall Study|Other|0
1872749|NCT02540291|6452279|P3|Overall Study|Other|1
1872750|NCT02540291|6452280|P2|Overall Study|Other|0
1872751|NCT02540291|6452281|P1|Overall Study|Other|0
1872752|NCT02540291|6452278|P4|Overall Study|Study Terminated By Sponsor|0
1872753|NCT02540291|6452279|P3|Overall Study|Study Terminated By Sponsor|0
1872754|NCT02540291|6452280|P2|Overall Study|Study Terminated By Sponsor|0
1872755|NCT02540291|6452281|P1|Overall Study|Study Terminated By Sponsor|1
1872756|NCT02540291|6452278|P4|Overall Study|Withdrawal Of Consent|0
1872757|NCT02540291|6452279|P3|Overall Study|Withdrawal Of Consent|0
1872758|NCT02540291|6452280|P2|Overall Study|Withdrawal Of Consent|1
1872759|NCT02540291|6452281|P1|Overall Study|Withdrawal Of Consent|0
1872760|NCT02540291|6452278|P4|Overall Study|Lost to Follow-up|0
1872761|NCT02540291|6452279|P3|Overall Study|Lost to Follow-up|1
1872762|NCT02540291|6452280|P2|Overall Study|Lost to Follow-up|0
1872763|NCT02540291|6452281|P1|Overall Study|Lost to Follow-up|0
1872764|NCT02540291|6452278|P4|Overall Study|Death|7
1872765|NCT02540291|6452279|P3|Overall Study|Death|5
1872766|NCT02540291|6452280|P2|Overall Study|Death|7
1872767|NCT02540291|6452281|P1|Overall Study|Death|7
1872856|NCT02515669|6452788|P4|48 Week Open-Label Phase|Other|0
1872857|NCT02515669|6452789|P3|48 Week Open-Label Phase|Other|1
1872858|NCT02515669|6452790|P2|48 Week Open-Label Phase|Other|0
1872859|NCT02515669|6452791|P1|48 Week Open-Label Phase|Other|0
1872892|NCT02422797|6453109|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
1872893|NCT02422797|6453110|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
1872894|NCT02422797|6453109|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
1872895|NCT02422797|6453110|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
1872896|NCT02422797|6453109|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
1872897|NCT02422797|6453110|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
1872898|NCT02422797|6453109|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
1872899|NCT02422797|6453110|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
1872900|NCT02422797|6453109|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
1872901|NCT02422797|6453110|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
1872902|NCT02422797|6453109|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
1872903|NCT02422797|6453110|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
1872904|NCT02422797|6453109|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
1872905|NCT02422797|6453110|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
1872906|NCT02422797|6453109|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
1872907|NCT02422797|6453110|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
1872908|NCT02422797|6453109|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
1872909|NCT02422797|6453110|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
1872910|NCT02422797|6453109|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
1872911|NCT02422797|6453110|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
1872912|NCT02422797|6453109|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1872913|NCT02422797|6453110|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
1872914|NCT02422797|6453109|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
1872915|NCT02422797|6453110|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
1872916|NCT02422797|6453109|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
1872917|NCT02422797|6453110|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
1872918|NCT02422797|6453109|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
1872919|NCT02422797|6453110|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
1873032|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
1873033|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
1873034|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
1873035|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
1873036|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
1873037|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
1873038|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
1873039|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
1873040|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
1873041|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
1873042|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
1873043|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
1873044|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
1873045|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
1873046|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
1873047|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
1873048|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
1873049|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
1873050|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
1873051|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
1873052|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
1873053|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
1873054|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
1873055|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
1873056|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
1873057|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
1873058|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
1873059|NCT02362503|6453628|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
1873060|NCT02362503|6453629|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
1873061|NCT02362503|6453630|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
1873062|NCT02362503|6453628|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
1873063|NCT02362503|6453629|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
1873064|NCT02362503|6453630|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
1873065|NCT02362503|6453628|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
1873066|NCT02362503|6453629|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
1873067|NCT02362503|6453630|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
1873068|NCT02362503|6453628|P3|Double-blind Period-Up to 8 Days|Death|0
1873069|NCT02362503|6453629|P2|Double-blind Period-Up to 8 Days|Death|1
1873070|NCT02362503|6453630|P1|Double-blind Period-Up to 8 Days|Death|1
1873071|NCT02362503|6453628|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
1873072|NCT02362503|6453629|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
1873073|NCT02362503|6453630|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
1873074|NCT02358031|6453658|P3|Overall Study|Ongoing in Study|33
1873075|NCT02358031|6453659|P2|Overall Study|Ongoing in Study|64
1873076|NCT02358031|6453660|P1|Overall Study|Ongoing in Study|61
1873077|NCT02358031|6453658|P3|Overall Study|Withdrawal by Subject|17
1873078|NCT02358031|6453659|P2|Overall Study|Withdrawal by Subject|12
1873079|NCT02358031|6453660|P1|Overall Study|Withdrawal by Subject|14
1873080|NCT02358031|6453658|P3|Overall Study|Lost to Follow-up|1
1873081|NCT02358031|6453659|P2|Overall Study|Lost to Follow-up|1
1873082|NCT02358031|6453660|P1|Overall Study|Lost to Follow-up|0
1873083|NCT02358031|6453658|P3|Overall Study|Death|249
1873084|NCT02358031|6453659|P2|Overall Study|Death|204
1873085|NCT02358031|6453660|P1|Overall Study|Death|226
1873226|NCT02319044|6454262|P3|Overall Study|Not treated|2
1873227|NCT02319044|6454263|P2|Overall Study|Not treated|2
1873228|NCT02319044|6454264|P1|Overall Study|Not treated|0
1873229|NCT02319044|6454262|P3|Overall Study|Study specific discontinuation criteria|1
1873230|NCT02319044|6454263|P2|Overall Study|Study specific discontinuation criteria|2
1873231|NCT02319044|6454264|P1|Overall Study|Study specific discontinuation criteria|2
1873232|NCT02319044|6454262|P3|Overall Study|Adverse Event|8
1873233|NCT02319044|6454263|P2|Overall Study|Adverse Event|2
1873234|NCT02319044|6454264|P1|Overall Study|Adverse Event|17
1873235|NCT02319044|6454262|P3|Overall Study|Condition under investigation worsened|46
1873236|NCT02319044|6454263|P2|Overall Study|Condition under investigation worsened|50
1873237|NCT02319044|6454264|P1|Overall Study|Condition under investigation worsened|100
1873238|NCT02319044|6454262|P3|Overall Study|Withdrawal by Subject|6
1873239|NCT02319044|6454263|P2|Overall Study|Withdrawal by Subject|3
1873240|NCT02319044|6454264|P1|Overall Study|Withdrawal by Subject|3
1873241|NCT02319044|6454262|P3|Overall Study|Death, PI/sponsor decision, med history|4
1873242|NCT02319044|6454263|P2|Overall Study|Death, PI/sponsor decision, med history|1
1873243|NCT02319044|6454264|P1|Overall Study|Death, PI/sponsor decision, med history|0
1873308|NCT02291913|6454557|P1|Overall Study|Protocol Violation|1
1873309|NCT02291913|6454557|P1|Overall Study|Withdrawal by Subject|1
1873310|NCT02291913|6454557|P1|Overall Study|Physician Decision|1
1873311|NCT02291913|6454557|P1|Overall Study|Death|2
1873312|NCT02291913|6454557|P1|Overall Study|Adverse Event|11
1873313|NCT02291913|6454557|P1|Overall Study|Progressive Disease|32
1873363|NCT02208063|6454735|P2|Overall Study|Lost to Follow-up|0
1873364|NCT02208063|6454736|P1|Overall Study|Lost to Follow-up|1
1873365|NCT02208063|6454735|P2|Overall Study|Withdrawal by Subject|2
1873366|NCT02208063|6454736|P1|Overall Study|Withdrawal by Subject|5
1873367|NCT02208063|6454735|P2|Overall Study|Not Specified in report|4
1873368|NCT02208063|6454736|P1|Overall Study|Not Specified in report|3
1873369|NCT02208063|6454735|P2|Overall Study|Death|5
1873370|NCT02208063|6454736|P1|Overall Study|Death|3
1873371|NCT02207530|6454748|P1|Overall Study|Adverse Event|8
1873372|NCT02207530|6454748|P1|Overall Study|Patient decision to stop study treatment|5
1873373|NCT02207530|6454748|P1|Overall Study|Worsening condition under investigation|78
1873410|NCT02189473|6454851|P2|Overall Study|Lost to Follow-up|2
1873411|NCT02189473|6454852|P1|Overall Study|Lost to Follow-up|1
1873412|NCT02189473|6454851|P2|Overall Study|Death|23
1873413|NCT02189473|6454852|P1|Overall Study|Death|22
1873414|NCT02178709|6454898|P1|Overall Study|Disease Progression|5
1873415|NCT02178709|6454898|P1|Overall Study|Physician Decision|2
1873416|NCT02178709|6454898|P1|Overall Study|Withdrawal by Subject|2
1873417|NCT02178709|6454898|P1|Overall Study|Death|2
1873418|NCT02178709|6454898|P1|Overall Study|Adverse Event|5
1873419|NCT02163902|6454911|P2|Overall Study|Administrative Decision|2
1873420|NCT02163902|6454912|P1|Overall Study|Administrative Decision|2
1873421|NCT02163902|6454911|P2|Overall Study|Lost to Follow-up|7
1873422|NCT02163902|6454912|P1|Overall Study|Lost to Follow-up|6
1873423|NCT02163902|6454911|P2|Overall Study|Subject's Request|4
1873424|NCT02163902|6454912|P1|Overall Study|Subject's Request|3
1873425|NCT02161406|6454930|P2|Overall Study|relocation|1
1873426|NCT02161406|6454931|P1|Overall Study|relocation|0
1873427|NCT02161406|6454930|P2|Overall Study|Lack of Efficacy|1
1873428|NCT02161406|6454931|P1|Overall Study|Lack of Efficacy|1
1873429|NCT02161406|6454930|P2|Overall Study|investigator withdrew subject|1
1873430|NCT02161406|6454931|P1|Overall Study|investigator withdrew subject|3
1873431|NCT02161406|6454930|P2|Overall Study|Withdrawal by Subject|4
1873432|NCT02161406|6454931|P1|Overall Study|Withdrawal by Subject|2
1873433|NCT02161406|6454930|P2|Overall Study|Lost to Follow-up|1
1873434|NCT02161406|6454931|P1|Overall Study|Lost to Follow-up|2
1873435|NCT02161406|6454930|P2|Overall Study|Death|1
1873436|NCT02161406|6454931|P1|Overall Study|Death|2
1873437|NCT02159729|6455007|P2|Overall Study|Other Unspecified|1
1873438|NCT02159729|6455008|P1|Overall Study|Other Unspecified|3
1873439|NCT02159729|6455007|P2|Overall Study|Non compliance|0
1873440|NCT02159729|6455008|P1|Overall Study|Non compliance|2
1873441|NCT02159729|6455007|P2|Overall Study|Lost to Follow-up|9
1873442|NCT02159729|6455008|P1|Overall Study|Lost to Follow-up|24
1873443|NCT02159729|6455007|P2|Overall Study|Subject's Request|10
1873444|NCT02159729|6455008|P1|Overall Study|Subject's Request|13
1873445|NCT02159729|6455007|P2|Overall Study|Adverse Event|1
1873446|NCT02159729|6455008|P1|Overall Study|Adverse Event|0
1873467|NCT02146365|6455102|P8|Overall Study|Other|0
1873468|NCT02146365|6455103|P7|Overall Study|Other|0
1873469|NCT02146365|6455104|P6|Overall Study|Other|0
1873470|NCT02146365|6455105|P5|Overall Study|Other|0
1873471|NCT02146365|6455106|P4|Overall Study|Other|1
1873472|NCT02146365|6455107|P3|Overall Study|Other|2
1873473|NCT02146365|6455108|P2|Overall Study|Other|0
1873474|NCT02146365|6455109|P1|Overall Study|Other|1
1873475|NCT02146365|6455102|P8|Overall Study|Unable to Comply with Protocol|0
1873476|NCT02146365|6455103|P7|Overall Study|Unable to Comply with Protocol|0
1873477|NCT02146365|6455104|P6|Overall Study|Unable to Comply with Protocol|0
1873478|NCT02146365|6455105|P5|Overall Study|Unable to Comply with Protocol|0
1873479|NCT02146365|6455106|P4|Overall Study|Unable to Comply with Protocol|0
1873480|NCT02146365|6455107|P3|Overall Study|Unable to Comply with Protocol|1
1873481|NCT02146365|6455108|P2|Overall Study|Unable to Comply with Protocol|1
1873482|NCT02146365|6455109|P1|Overall Study|Unable to Comply with Protocol|0
1873483|NCT02146365|6455102|P8|Overall Study|Withdrawal by Subject|0
1873484|NCT02146365|6455103|P7|Overall Study|Withdrawal by Subject|0
1873485|NCT02146365|6455104|P6|Overall Study|Withdrawal by Subject|0
1873486|NCT02146365|6455105|P5|Overall Study|Withdrawal by Subject|1
1873487|NCT02146365|6455106|P4|Overall Study|Withdrawal by Subject|5
1873488|NCT02146365|6455107|P3|Overall Study|Withdrawal by Subject|1
1873489|NCT02146365|6455108|P2|Overall Study|Withdrawal by Subject|2
1873490|NCT02146365|6455109|P1|Overall Study|Withdrawal by Subject|1
1873491|NCT02146365|6455102|P8|Overall Study|Lost to Follow-up|1
1873492|NCT02146365|6455103|P7|Overall Study|Lost to Follow-up|0
1873493|NCT02146365|6455104|P6|Overall Study|Lost to Follow-up|1
1873494|NCT02146365|6455105|P5|Overall Study|Lost to Follow-up|1
1873495|NCT02146365|6455106|P4|Overall Study|Lost to Follow-up|3
1873496|NCT02146365|6455107|P3|Overall Study|Lost to Follow-up|3
1873497|NCT02146365|6455108|P2|Overall Study|Lost to Follow-up|1
1873498|NCT02146365|6455109|P1|Overall Study|Lost to Follow-up|2
1873543|NCT02123134|6455404|P2|Overall Study|Administrative decision|1
1873544|NCT02123134|6455405|P1|Overall Study|Administrative decision|0
1873545|NCT02123134|6455404|P2|Overall Study|Withdrawal of consent|2
1873546|NCT02123134|6455405|P1|Overall Study|Withdrawal of consent|3
1873601|NCT02035267|6455748|P4|Overall Study|Other unspecified|0
1873602|NCT02035267|6455749|P3|Overall Study|Other unspecified|0
1873603|NCT02035267|6455750|P2|Overall Study|Other unspecified|1
1873604|NCT02035267|6455751|P1|Overall Study|Other unspecified|0
1873605|NCT02035267|6455748|P4|Overall Study|Lost to Follow-up|1
1873606|NCT02035267|6455749|P3|Overall Study|Lost to Follow-up|0
1873607|NCT02035267|6455750|P2|Overall Study|Lost to Follow-up|0
1873608|NCT02035267|6455751|P1|Overall Study|Lost to Follow-up|0
1873609|NCT02035267|6455748|P4|Overall Study|Adverse Event|0
1873610|NCT02035267|6455749|P3|Overall Study|Adverse Event|1
1873611|NCT02035267|6455750|P2|Overall Study|Adverse Event|0
1873612|NCT02035267|6455751|P1|Overall Study|Adverse Event|0
1873613|NCT02035267|6455748|P4|Overall Study|Withdrawal consent-subject convenience|0
1873614|NCT02035267|6455749|P3|Overall Study|Withdrawal consent-subject convenience|1
1873615|NCT02035267|6455750|P2|Overall Study|Withdrawal consent-subject convenience|0
1873616|NCT02035267|6455751|P1|Overall Study|Withdrawal consent-subject convenience|0
1873623|NCT02011945|6455852|P3|Overall Study|Sub-Optimal Response to dasatinib|0
1873624|NCT02011945|6455853|P2|Overall Study|Sub-Optimal Response to dasatinib|0
1873625|NCT02011945|6455854|P1|Overall Study|Sub-Optimal Response to dasatinib|1
1873626|NCT02011945|6455852|P3|Overall Study|Proceeded to stem cell transplant|1
1873627|NCT02011945|6455853|P2|Overall Study|Proceeded to stem cell transplant|0
1873628|NCT02011945|6455854|P1|Overall Study|Proceeded to stem cell transplant|0
1873629|NCT02011945|6455852|P3|Overall Study|No Longer Meets Study Criteria|0
1873630|NCT02011945|6455853|P2|Overall Study|No Longer Meets Study Criteria|0
1873631|NCT02011945|6455854|P1|Overall Study|No Longer Meets Study Criteria|1
1873632|NCT02011945|6455852|P3|Overall Study|Treatment Failure|6
1873633|NCT02011945|6455853|P2|Overall Study|Treatment Failure|7
1873634|NCT02011945|6455854|P1|Overall Study|Treatment Failure|0
1873635|NCT02011945|6455852|P3|Overall Study|Study Drug Toxicity|1
1873636|NCT02011945|6455853|P2|Overall Study|Study Drug Toxicity|0
1873637|NCT02011945|6455854|P1|Overall Study|Study Drug Toxicity|0
1873638|NCT02011945|6455852|P3|Overall Study|Adverse Event unrelated to Drug|1
1873639|NCT02011945|6455853|P2|Overall Study|Adverse Event unrelated to Drug|2
1873640|NCT02011945|6455854|P1|Overall Study|Adverse Event unrelated to Drug|0
1873641|NCT02011945|6455852|P3|Overall Study|Participant requested to Discontinue|1
1873642|NCT02011945|6455853|P2|Overall Study|Participant requested to Discontinue|1
1873643|NCT02011945|6455854|P1|Overall Study|Participant requested to Discontinue|0
1873726|NCT01921179|6456334|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
1873727|NCT01921179|6456335|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
1873728|NCT01921179|6456334|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
1873729|NCT01921179|6456335|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
1873788|NCT01883492|6456486|P2|Overall Study|bone anatomy did not meet study criteria|1
1873789|NCT01883492|6456487|P1|Overall Study|bone anatomy did not meet study criteria|1
1873790|NCT01883492|6456486|P2|Overall Study|inappropriate implant used|1
1873791|NCT01883492|6456487|P1|Overall Study|inappropriate implant used|1
1873792|NCT01883492|6456486|P2|Overall Study|Withdrawal by Subject|0
1873793|NCT01883492|6456487|P1|Overall Study|Withdrawal by Subject|1
1873794|NCT01883492|6456486|P2|Overall Study|Poor X-ray quality|4
1873795|NCT01883492|6456487|P1|Overall Study|Poor X-ray quality|7
1873796|NCT01883492|6456486|P2|Overall Study|Surgery on contra-lateral hip|1
1873797|NCT01883492|6456487|P1|Overall Study|Surgery on contra-lateral hip|0
1873798|NCT01883492|6456486|P2|Overall Study|Lost to Follow-up|4
1873799|NCT01883492|6456487|P1|Overall Study|Lost to Follow-up|3
1873809|NCT01817959|6456587|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
1873810|NCT01817959|6456588|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
1873811|NCT01817959|6456587|P2|Overall Study|Adverse Event|0
1873812|NCT01817959|6456588|P1|Overall Study|Adverse Event|1
1873813|NCT01817959|6456587|P2|Overall Study|forbidden medication|1
1873814|NCT01817959|6456588|P1|Overall Study|forbidden medication|1
1873815|NCT01817959|6456587|P2|Overall Study|Graft loss|1
1873816|NCT01817959|6456588|P1|Overall Study|Graft loss|1
1873955|NCT01671488|6457083|P1|Overall Study|Withdrawal by Subject|1
1874029|NCT01475162|6457360|P1|Overall Study|Study closed for safety|3
1874030|NCT01475162|6457360|P1|Overall Study|Death|10
1874031|NCT01475162|6457360|P1|Overall Study|Physician Decision|1
1874083|NCT01445171|6457512|P1|Overall Study|Consented but did not receive device|8
1874084|NCT01445171|6457512|P1|Overall Study|Subjects declined to return for followup|9
1874085|NCT01445171|6457512|P1|Overall Study|Death|51
1874086|NCT01445171|6457512|P1|Overall Study|Withdrawal by Subject|16
1874087|NCT01445171|6457512|P1|Overall Study|Lost to Follow-up|11
1874105|NCT01402063|6457602|P2|Overall Study|Withdrawal by Subject|3
1874106|NCT01402063|6457603|P1|Overall Study|Withdrawal by Subject|3
1874154|NCT01264419|6457777|P1|Overall Study|Lost to Follow-up|3
1874384|NCT00942331|6458309|P2|Overall Study|Did not start treatment|22
1874385|NCT00942331|6458310|P1|Overall Study|Did not start treatment|15
1874454|NCT00720941|6458559|P2|Overall Study|Ongoing|23
1874455|NCT00720941|6458560|P1|Overall Study|Ongoing|34
1874456|NCT00720941|6458559|P2|Overall Study|Withdrawal by Subject|35
1874457|NCT00720941|6458560|P1|Overall Study|Withdrawal by Subject|27
1874458|NCT00720941|6458559|P2|Overall Study|Physician Decision|5
1874459|NCT00720941|6458560|P1|Overall Study|Physician Decision|1
1874460|NCT00720941|6458559|P2|Overall Study|Lost to Follow-up|15
1874461|NCT00720941|6458560|P1|Overall Study|Lost to Follow-up|17
1874462|NCT00720941|6458559|P2|Overall Study|Protocol Violation|2
1874463|NCT00720941|6458560|P1|Overall Study|Protocol Violation|0
1874464|NCT00720941|6458559|P2|Overall Study|Death|335
1874465|NCT00720941|6458560|P1|Overall Study|Death|334
1874466|NCT00717756|6458600|P1|Overall Study|Withdrawal by Subject|1
1874470|NCT00698997|6458610|P2|Overall Study|Withdrawal by Subject|27
1874471|NCT00698997|6458611|P1|Overall Study|Withdrawal by Subject|7
1874472|NCT00698997|6458610|P2|Overall Study|Lost to Follow-up|0
1874473|NCT00698997|6458611|P1|Overall Study|Lost to Follow-up|3
1874583|NCT00579527|6458823|P1|Overall Study|Death|4
1874584|NCT00576836|6458835|P2|Overall Study|Physician Decision|1
1874585|NCT00576836|6458836|P1|Overall Study|Physician Decision|0
1874586|NCT00576836|6458835|P2|Overall Study|Death|1
1874587|NCT00576836|6458836|P1|Overall Study|Death|0
1874588|NCT00576407|6458848|P1|Overall Study|Physician Decision|1
1874589|NCT00576407|6458848|P1|Overall Study|Death|7
1874590|NCT00504829|6458906|P3|Overall Study|Protocol Violation|10
1874591|NCT00504829|6458907|P2|Overall Study|Protocol Violation|4
1874592|NCT00504829|6458908|P1|Overall Study|Protocol Violation|6
1874593|NCT00478426|6458917|P1|Overall Study|Withdrawal by Subject|1
1874612|NCT00439179|6458985|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1874613|NCT00439179|6458986|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1874614|NCT00439179|6458987|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
1874615|NCT00439179|6458988|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
1874718|NCT00203021|6459255|P2|Overall Study|Other than specified|16
1874719|NCT00203021|6459256|P1|Overall Study|Other than specified|11
1874720|NCT00203021|6459255|P2|Overall Study|Lost to Follow-up|7
1874721|NCT00203021|6459256|P1|Overall Study|Lost to Follow-up|9
1874722|NCT00203021|6459255|P2|Overall Study|Withdrawal by Subject|48
1874723|NCT00203021|6459256|P1|Overall Study|Withdrawal by Subject|45
1874724|NCT00203021|6459255|P2|Overall Study|Adverse Event|5
1874725|NCT00203021|6459256|P1|Overall Study|Adverse Event|10
1874726|NCT00203021|6459255|P2|Overall Study|Death|1
1874727|NCT00203021|6459256|P1|Overall Study|Death|4
1876927|NCT03694821|6468074|P3|Overall Study|Study terminated|4
1876928|NCT03694821|6468075|P2|Overall Study|Study terminated|8
1876929|NCT03694821|6468076|P1|Overall Study|Study terminated|4
1876935|NCT03639675|6468147|P1|Overall Study|Withdrawal by Subject|1
1876940|NCT03504189|6468348|P1|Overall Study|Device Failure|2
1876941|NCT03504189|6468348|P1|Overall Study|Screening Failure|1
1876942|NCT03504189|6468348|P1|Overall Study|Withdrawal by Subject|1
1876947|NCT03447821|6468398|P3|Overall Study|Lost to Follow-up|1
1876948|NCT03447821|6468399|P2|Overall Study|Lost to Follow-up|0
1876949|NCT03447821|6468400|P1|Overall Study|Lost to Follow-up|0
1876950|NCT03447821|6468398|P3|Overall Study|Withdrawal by Subject|0
1876951|NCT03447821|6468399|P2|Overall Study|Withdrawal by Subject|1
1876952|NCT03447821|6468400|P1|Overall Study|Withdrawal by Subject|1
1877079|NCT03152526|6469033|P2|Overall Study|Withdrawal by Subject|1
1877080|NCT03152526|6469034|P1|Overall Study|Withdrawal by Subject|0
1877160|NCT03101371|6469164|P2|Overall Study|Did not meet eligibility criteria|1
1877161|NCT03101371|6469165|P1|Overall Study|Did not meet eligibility criteria|2
1877162|NCT03101371|6469164|P2|Overall Study|Lost to Follow-up|4
1877163|NCT03101371|6469165|P1|Overall Study|Lost to Follow-up|1
1877164|NCT03101371|6469164|P2|Overall Study|Physician Decision|1
1877165|NCT03101371|6469165|P1|Overall Study|Physician Decision|0
1877460|NCT02844946|6471099|P2|Overall Study|Lost to Follow-up|0
1877461|NCT02844946|6471100|P1|Overall Study|Lost to Follow-up|7
1877462|NCT02842866|6471120|P2|Overall Study|Withdrawal by Subject|0
1877463|NCT02842866|6471121|P1|Overall Study|Withdrawal by Subject|1
1877464|NCT02842866|6471120|P2|Overall Study|Lost to Follow-up|0
1877465|NCT02842866|6471121|P1|Overall Study|Lost to Follow-up|2
1877466|NCT02842866|6471120|P2|Overall Study|Protocol Violation|2
1877467|NCT02842866|6471121|P1|Overall Study|Protocol Violation|4
1877468|NCT02842866|6471120|P2|Overall Study|Serious Adverse Event|1
1877469|NCT02842866|6471121|P1|Overall Study|Serious Adverse Event|0
1877498|NCT02818920|6471305|P1|Overall Study|Refused Further Treatment|1
1877499|NCT02818920|6471305|P1|Overall Study|Developed Other Disease|1
1877500|NCT02818920|6471305|P1|Overall Study|Adverse Event|3
1877501|NCT02818920|6471305|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
1877502|NCT02818920|6471305|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
1877503|NCT02818920|6471305|P1|Overall Study|Unresectable|4
1877524|NCT02785913|6471415|P1|Overall Study|Ineligible|4
1877525|NCT02785913|6471415|P1|Overall Study|Never Received Treatment|1
1877526|NCT02785913|6471415|P1|Overall Study|Not protocol specified|1
1877527|NCT02785913|6471415|P1|Overall Study|Progression|18
1877528|NCT02785913|6471415|P1|Overall Study|Death|2
1877529|NCT02785913|6471415|P1|Overall Study|Adverse Event|5
1877541|NCT02743949|6471528|P3|Overall Study|Voluntary Withdrawal|0
1877542|NCT02743949|6471529|P2|Overall Study|Voluntary Withdrawal|1
1877543|NCT02743949|6471530|P1|Overall Study|Voluntary Withdrawal|2
1877544|NCT02743949|6471528|P3|Overall Study|Significant Protocol Deviation|1
1877545|NCT02743949|6471529|P2|Overall Study|Significant Protocol Deviation|0
1877546|NCT02743949|6471530|P1|Overall Study|Significant Protocol Deviation|2
1877547|NCT02743949|6471528|P3|Overall Study|Adverse Event|2
1877548|NCT02743949|6471529|P2|Overall Study|Adverse Event|0
1877549|NCT02743949|6471530|P1|Overall Study|Adverse Event|0
1877944|NCT02559687|6473159|P1|Overall Study|Ongoing Follow-Up|14
1877945|NCT02559687|6473159|P1|Overall Study|Withdrawal by Subject|4
1877946|NCT02559687|6473159|P1|Overall Study|Death|103
1878094|NCT02527434|6473747|P3|Overall Study|Site closure|0
1878095|NCT02527434|6473748|P2|Overall Study|Site closure|0
1878096|NCT02527434|6473749|P1|Overall Study|Site closure|1
1878097|NCT02527434|6473747|P3|Overall Study|Reason Not Specified|0
1878098|NCT02527434|6473748|P2|Overall Study|Reason Not Specified|0
1878099|NCT02527434|6473749|P1|Overall Study|Reason Not Specified|1
1878100|NCT02527434|6473747|P3|Overall Study|Withdrawal by Subject|3
1878101|NCT02527434|6473748|P2|Overall Study|Withdrawal by Subject|3
1878102|NCT02527434|6473749|P1|Overall Study|Withdrawal by Subject|5
1878103|NCT02527434|6473747|P3|Overall Study|Death|17
1878104|NCT02527434|6473748|P2|Overall Study|Death|6
1878105|NCT02527434|6473749|P1|Overall Study|Death|19
1878106|NCT02527434|6473747|P3|Overall Study|Lost to Follow-up|0
1878107|NCT02527434|6473748|P2|Overall Study|Lost to Follow-up|2
1878108|NCT02527434|6473749|P1|Overall Study|Lost to Follow-up|2
1878141|NCT02418182|6474100|P2|Overall Study|Lost to Follow-up|2
1878142|NCT02418182|6474101|P1|Overall Study|Lost to Follow-up|0
1878143|NCT02418182|6474100|P2|Overall Study|Unable to re-consent|15
1878144|NCT02418182|6474101|P1|Overall Study|Unable to re-consent|18
1878291|NCT02387970|6474574|P2|Overall Study|Did not complete 1-year follow up|2
1878292|NCT02387970|6474575|P1|Overall Study|Did not complete 1-year follow up|1
1878491|NCT02296125|6475308|P4|Overall Study|Any reason not specifically recorded|0
1878492|NCT02296125|6475309|P3|Overall Study|Any reason not specifically recorded|0
1878493|NCT02296125|6475310|P2|Overall Study|Any reason not specifically recorded|3
1878494|NCT02296125|6475311|P1|Overall Study|Any reason not specifically recorded|3
1878495|NCT02296125|6475308|P4|Overall Study|Condition under investigation worsened|39
1878496|NCT02296125|6475309|P3|Overall Study|Condition under investigation worsened|24
1878497|NCT02296125|6475310|P2|Overall Study|Condition under investigation worsened|151
1878498|NCT02296125|6475311|P1|Overall Study|Condition under investigation worsened|87
1878499|NCT02296125|6475308|P4|Overall Study|Severe non-compliance to protocol|0
1878500|NCT02296125|6475309|P3|Overall Study|Severe non-compliance to protocol|0
1878501|NCT02296125|6475310|P2|Overall Study|Severe non-compliance to protocol|1
1878502|NCT02296125|6475311|P1|Overall Study|Severe non-compliance to protocol|0
1878503|NCT02296125|6475308|P4|Overall Study|Adverse Event|4
1878504|NCT02296125|6475309|P3|Overall Study|Adverse Event|9
1878505|NCT02296125|6475310|P2|Overall Study|Adverse Event|50
1878506|NCT02296125|6475311|P1|Overall Study|Adverse Event|36
1878507|NCT02296125|6475308|P4|Overall Study|Withdrawal by Subject|1
1878508|NCT02296125|6475309|P3|Overall Study|Withdrawal by Subject|5
1878509|NCT02296125|6475310|P2|Overall Study|Withdrawal by Subject|8
1878510|NCT02296125|6475311|P1|Overall Study|Withdrawal by Subject|12
1878511|NCT02269917|6475401|P2|Overall Study|Randomized but not treated|5
1878512|NCT02269917|6475402|P1|Overall Study|Randomized but not treated|3
1878513|NCT02269917|6475401|P2|Overall Study|Non-compliance with study drug|0
1878514|NCT02269917|6475402|P1|Overall Study|Non-compliance with study drug|2
1878515|NCT02269917|6475401|P2|Overall Study|Adverse Event|4
1878516|NCT02269917|6475402|P1|Overall Study|Adverse Event|11
1878517|NCT02269917|6475401|P2|Overall Study|Withdrawal by Subject|8
1878518|NCT02269917|6475402|P1|Overall Study|Withdrawal by Subject|9
1878519|NCT02269917|6475401|P2|Overall Study|Other|3
1878520|NCT02269917|6475402|P1|Overall Study|Other|6
1878521|NCT02269917|6475401|P2|Overall Study|Ongoing|360
1878522|NCT02269917|6475402|P1|Overall Study|Ongoing|731
1878523|NCT02269917|6475401|P2|Overall Study|Lost to Follow-up|3
1878524|NCT02269917|6475402|P1|Overall Study|Lost to Follow-up|4
1878525|NCT02241512|6475455|P2|Overall Study|Pump malfunction, drug not delivered|0
1878526|NCT02241512|6475456|P1|Overall Study|Pump malfunction, drug not delivered|1
1878599|NCT02159521|6475711|P1|Overall Study|Other than specified|1
1878600|NCT02159521|6475711|P1|Overall Study|Death|1
1878601|NCT02159521|6475711|P1|Overall Study|Lost to Follow-up|6
1878602|NCT02159521|6475711|P1|Overall Study|Withdrawal by Subject|7
1878603|NCT02159521|6475711|P1|Overall Study|Enrolled but not treated|3
1878605|NCT02151981|6475742|P2|Overall Study|Eligibility criteria not fulfilled|1
1878606|NCT02151981|6475743|P1|Overall Study|Eligibility criteria not fulfilled|0
1878607|NCT02151981|6475742|P2|Overall Study|Ongoing Study at Data Cut-off|95
1878608|NCT02151981|6475743|P1|Overall Study|Ongoing Study at Data Cut-off|224
1878609|NCT02151981|6475742|P2|Overall Study|Withdrawal by Subject|18
1878610|NCT02151981|6475743|P1|Overall Study|Withdrawal by Subject|19
1878611|NCT02151981|6475742|P2|Overall Study|Lost to Follow-up|0
1878612|NCT02151981|6475743|P1|Overall Study|Lost to Follow-up|1
1878613|NCT02151981|6475742|P2|Overall Study|Death|26
1878614|NCT02151981|6475743|P1|Overall Study|Death|35
1878713|NCT02082340|6476248|P2|Overall Study|Lost to Follow-up|1
1878714|NCT02082340|6476249|P1|Overall Study|Lost to Follow-up|1
1878898|NCT01878084|6476953|P1|Overall Study|Physician Decision|2
1878913|NCT01828073|6477023|P2|Overall Study|Lost to Follow-up|2
1878914|NCT01828073|6477024|P1|Overall Study|Lost to Follow-up|1
1879025|NCT01705509|6477325|P1|CPET w/ Ranexa|Screen Failure|2
1879026|NCT01705509|6477325|P1|Inclusion CPET|Withdrawal by Subject|2
1879027|NCT01705509|6477325|P1|Inclusion CPET|Screen Failure|5
1879221|NCT01524679|6477974|P2|Overall Study|e.g.wish for children, relocation|1
1879222|NCT01524679|6477975|P1|Overall Study|e.g.wish for children, relocation|6
1879223|NCT01524679|6477974|P2|Overall Study|Lack of Efficacy|0
1879224|NCT01524679|6477975|P1|Overall Study|Lack of Efficacy|2
1879225|NCT01524679|6477974|P2|Overall Study|Protocol Violation|0
1879226|NCT01524679|6477975|P1|Overall Study|Protocol Violation|1
1879227|NCT01524679|6477974|P2|Overall Study|Adverse Event|0
1879228|NCT01524679|6477975|P1|Overall Study|Adverse Event|9
1879229|NCT01524679|6477974|P2|Overall Study|Withdrawal by Subject|4
1879230|NCT01524679|6477975|P1|Overall Study|Withdrawal by Subject|4
1879231|NCT01524679|6477974|P2|Overall Study|Lost to Follow-up|4
1879232|NCT01524679|6477975|P1|Overall Study|Lost to Follow-up|1
1879264|NCT01460160|6478114|P2|Follow-up|Lost to Follow-up|0
1879265|NCT01460160|6478115|P1|Follow-up|Lost to Follow-up|1
1879266|NCT01460160|6478114|P2|Follow-up|Death|2
1879267|NCT01460160|6478115|P1|Follow-up|Death|7
1879268|NCT01460160|6478114|P2|Follow-up|Withdrawal by Subject|0
1879269|NCT01460160|6478115|P1|Follow-up|Withdrawal by Subject|3
1879270|NCT01460160|6478114|P2|Treatment|Subject refused to continue Chemo|0
1879271|NCT01460160|6478115|P1|Treatment|Subject refused to continue Chemo|1
1879272|NCT01460160|6478114|P2|Treatment|Family did not wish to restart after SCT|0
1879273|NCT01460160|6478115|P1|Treatment|Family did not wish to restart after SCT|1
1879274|NCT01460160|6478114|P2|Treatment|PI decision to pursue other options|1
1879275|NCT01460160|6478115|P1|Treatment|PI decision to pursue other options|1
1879276|NCT01460160|6478114|P2|Treatment|PI not to follow protocol therapy|0
1879277|NCT01460160|6478115|P1|Treatment|PI not to follow protocol therapy|1
1879278|NCT01460160|6478114|P2|Treatment|PI decision to not re-initiate after SCT|2
1879279|NCT01460160|6478115|P1|Treatment|PI decision to not re-initiate after SCT|2
1879280|NCT01460160|6478114|P2|Treatment|Death|2
1879281|NCT01460160|6478115|P1|Treatment|Death|0
1879282|NCT01460160|6478114|P2|Treatment|Withdrawal by Subject|0
1879283|NCT01460160|6478115|P1|Treatment|Withdrawal by Subject|4
1879284|NCT01460160|6478114|P2|Treatment|Adverse Event|0
1879285|NCT01460160|6478115|P1|Treatment|Adverse Event|8
1879286|NCT01460160|6478114|P2|Treatment|Study Drug Toxicity|0
1879287|NCT01460160|6478115|P1|Treatment|Study Drug Toxicity|2
1879288|NCT01460160|6478114|P2|Treatment|Lack of Efficacy|0
1879289|NCT01460160|6478115|P1|Treatment|Lack of Efficacy|3
1879311|NCT01383018|6478234|P1|Overall Study|Subject Incarcerated|1
1879312|NCT01383018|6478234|P1|Overall Study|Patient moved away from site|1
1879313|NCT01383018|6478234|P1|Overall Study|Site closed early-not compliance related|7
1879314|NCT01383018|6478234|P1|Overall Study|Missed Visit|247
1879315|NCT01383018|6478234|P1|Overall Study|Subject not implanted|76
1879316|NCT01383018|6478234|P1|Overall Study|Withdrawal by Subject|9
1879317|NCT01383018|6478234|P1|Overall Study|Physician Decision|5
1879318|NCT01383018|6478234|P1|Overall Study|Lost to Follow-up|5
1879319|NCT01383018|6478234|P1|Overall Study|Death|10
1879320|NCT01383018|6478234|P1|Overall Study|Adverse Event|14
1879356|NCT01338415|6478426|P2|Overall Study|Other (administrative reason)|0
1879357|NCT01338415|6478427|P1|Overall Study|Other (administrative reason)|1
1879358|NCT01338415|6478426|P2|Overall Study|Other (PAH not the main etiology of PH)|2
1879359|NCT01338415|6478427|P1|Overall Study|Other (PAH not the main etiology of PH)|0
1879360|NCT01338415|6478426|P2|Overall Study|Withdrawal by Subject|1
1879361|NCT01338415|6478427|P1|Overall Study|Withdrawal by Subject|1
1879362|NCT01338415|6478426|P2|Overall Study|Adverse Event|6
1879363|NCT01338415|6478427|P1|Overall Study|Adverse Event|8
1879578|NCT01005745|6478991|P1|Overall Study|Inappropriate antidiuretic hormone|1
1879579|NCT01005745|6478991|P1|Overall Study|Death prior to treatment|1
1879580|NCT01005745|6478991|P1|Overall Study|Disease progressed during TIL growth|3
1879581|NCT01005745|6478991|P1|Overall Study|No TIL growth|1
1879585|NCT00972478|6479006|P2|Overall Study|Not start protocol treatment|2
1879586|NCT00972478|6479007|P1|Overall Study|Not start protocol treatment|1
1879587|NCT00972478|6479006|P2|Overall Study|Ineligible|7
1879588|NCT00972478|6479007|P1|Overall Study|Ineligible|1
1879589|NCT00972478|6479006|P2|Overall Study|Not protocol specified|1
1879590|NCT00972478|6479007|P1|Overall Study|Not protocol specified|1
1879591|NCT00972478|6479006|P2|Overall Study|Death|2
1879592|NCT00972478|6479007|P1|Overall Study|Death|0
1879593|NCT00972478|6479006|P2|Overall Study|Progression/Relapse|2
1879594|NCT00972478|6479007|P1|Overall Study|Progression/Relapse|0
1879595|NCT00972478|6479006|P2|Overall Study|Withdrawal by Subject|8
1879596|NCT00972478|6479007|P1|Overall Study|Withdrawal by Subject|1
1879597|NCT00972478|6479006|P2|Overall Study|Adverse Event|16
1879598|NCT00972478|6479007|P1|Overall Study|Adverse Event|3
1879676|NCT00736944|6479256|P1|Definitive Treatment|Physician Decision|1
1879677|NCT00736944|6479256|P1|Induction|Death|1
1879732|NCT00667368|6479376|P2|Overall Study|Discontinued early|17
1879733|NCT00667368|6479377|P1|Overall Study|Discontinued early|24
1879734|NCT00667368|6479376|P2|Overall Study|Lost to Follow-up|155
1879735|NCT00667368|6479377|P1|Overall Study|Lost to Follow-up|176
1879807|NCT00443599|6479598|P2|Overall Study|Cardiopulmonary bypass canceled|1
1879808|NCT00443599|6479599|P1|Overall Study|Cardiopulmonary bypass canceled|3
1879809|NCT00443599|6479598|P2|Overall Study|Death|1
1879810|NCT00443599|6479599|P1|Overall Study|Death|1
1879811|NCT00443599|6479598|P2|Overall Study|Physician Decision|1
1879812|NCT00443599|6479599|P1|Overall Study|Physician Decision|2
1879891|NCT00419562|6479668|P2|Overall Study|Participant Institutionalized|0
1879892|NCT00419562|6479669|P1|Overall Study|Participant Institutionalized|1
1879893|NCT00419562|6479668|P2|Overall Study|Withdrawal by Subject|18
1879894|NCT00419562|6479669|P1|Overall Study|Withdrawal by Subject|20
1879895|NCT00419562|6479668|P2|Overall Study|Lost to Follow-up|13
1879896|NCT00419562|6479669|P1|Overall Study|Lost to Follow-up|12
1879919|NCT04002648|6479909|P2|Overall Study|Lost to Follow-up|0
1879920|NCT04002648|6479910|P1|Overall Study|Lost to Follow-up|2
1879921|NCT03965403|6479918|P1|Overall Study|Subject not meeting eligibility criteria|1
1879955|NCT03426631|6480427|P2|Overall Study|Lost to Follow-up|1
1879956|NCT03426631|6480428|P1|Overall Study|Lost to Follow-up|0
1879959|NCT03387462|6480551|P1|Overall Study|Lost to Follow-up|1
1879962|NCT03374995|6480569|P2|Overall Study|Withdrawal by Subject|1
1879963|NCT03374995|6480570|P1|Overall Study|Withdrawal by Subject|0
1879964|NCT03305731|6480617|P1|Overall Study|Protocol Violation|1
1880037|NCT03200860|6480873|P2|Overall Study|Withdrawal by Subject|0
1880038|NCT03200860|6480874|P1|Overall Study|Withdrawal by Subject|1
1880069|NCT03181503|6480912|P2|Overall Study|Lost to Follow-up|1
1880070|NCT03181503|6480913|P1|Overall Study|Lost to Follow-up|1
1880071|NCT03181503|6480912|P2|Overall Study|Withdrawal by Subject|0
1880072|NCT03181503|6480913|P1|Overall Study|Withdrawal by Subject|3
1880073|NCT03181503|6480912|P2|Overall Study|Protocol Violation|0
1880074|NCT03181503|6480913|P1|Overall Study|Protocol Violation|1
1880075|NCT03181503|6480912|P2|Overall Study|Adverse Event|2
1880076|NCT03181503|6480913|P1|Overall Study|Adverse Event|2
1880085|NCT03136861|6481024|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1880086|NCT03136861|6481025|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1880087|NCT03136861|6481026|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1880088|NCT03136861|6481027|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1880089|NCT03136861|6481028|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
1880090|NCT03136861|6481029|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1880091|NCT03136861|6481030|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
1880092|NCT03136861|6481024|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1880093|NCT03136861|6481025|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1880094|NCT03136861|6481026|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1880095|NCT03136861|6481027|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1880096|NCT03136861|6481028|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
1880097|NCT03136861|6481029|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1880098|NCT03136861|6481030|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
1880099|NCT03136861|6481024|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
1880100|NCT03136861|6481025|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1880101|NCT03136861|6481026|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
1880102|NCT03136861|6481027|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
1880103|NCT03136861|6481028|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1880104|NCT03136861|6481029|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1880105|NCT03136861|6481030|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
1880106|NCT03136861|6481024|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1880107|NCT03136861|6481025|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1880108|NCT03136861|6481026|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1880109|NCT03136861|6481027|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1880110|NCT03136861|6481028|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
1880111|NCT03136861|6481029|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
1880112|NCT03136861|6481030|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
1880113|NCT03136861|6481024|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1880114|NCT03136861|6481025|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1880115|NCT03136861|6481026|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1880116|NCT03136861|6481027|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1880117|NCT03136861|6481028|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1880118|NCT03136861|6481029|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
1880119|NCT03136861|6481030|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
1880120|NCT03136861|6481024|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1880121|NCT03136861|6481025|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1880122|NCT03136861|6481026|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1880123|NCT03136861|6481027|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1880124|NCT03136861|6481028|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
1880125|NCT03136861|6481029|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
1880126|NCT03136861|6481030|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
1880127|NCT03136861|6481024|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1880128|NCT03136861|6481025|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1880129|NCT03136861|6481026|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1880130|NCT03136861|6481027|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1880131|NCT03136861|6481028|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
1880132|NCT03136861|6481029|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
1880133|NCT03136861|6481030|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
1880134|NCT03136861|6481024|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1880135|NCT03136861|6481025|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1880136|NCT03136861|6481026|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1880137|NCT03136861|6481027|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1880138|NCT03136861|6481028|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
1880139|NCT03136861|6481029|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
1880140|NCT03136861|6481030|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
1880434|NCT02859246|6482567|P1|Overall Study|Withdrawal by Subject|1
1880435|NCT02859246|6482567|P1|Overall Study|Adverse Event|1
1880436|NCT02859246|6482567|P1|Overall Study|Screen fails|3
1880451|NCT02845375|6482996|P3|Overall Study|upper airway obstruction|1
1880452|NCT02845375|6482997|P2|Overall Study|upper airway obstruction|2
1880453|NCT02845375|6482998|P1|Overall Study|upper airway obstruction|1
1880513|NCT02736825|6483374|P2|Overall Study|Early Termination|1
1880514|NCT02736825|6483375|P1|Overall Study|Early Termination|0
1880515|NCT02736825|6483374|P2|Overall Study|Lost to Follow-up|11
1880516|NCT02736825|6483375|P1|Overall Study|Lost to Follow-up|10
1880548|NCT02706951|6483435|P3|Overall Study|Other|0
1880549|NCT02706951|6483436|P2|Overall Study|Other|1
1880550|NCT02706951|6483437|P1|Overall Study|Other|2
1880551|NCT02706951|6483435|P3|Overall Study|Lost to Follow-up|1
1880552|NCT02706951|6483436|P2|Overall Study|Lost to Follow-up|4
1880553|NCT02706951|6483437|P1|Overall Study|Lost to Follow-up|0
1880554|NCT02706951|6483435|P3|Overall Study|Withdrawal by Subject|6
1880555|NCT02706951|6483436|P2|Overall Study|Withdrawal by Subject|6
1880556|NCT02706951|6483437|P1|Overall Study|Withdrawal by Subject|11
1880557|NCT02706951|6483435|P3|Overall Study|Adverse Event|3
1880558|NCT02706951|6483436|P2|Overall Study|Adverse Event|5
1880559|NCT02706951|6483437|P1|Overall Study|Adverse Event|1
1880659|NCT02680834|6483925|P2|Overall Study|Lost to Follow-up|1
1880660|NCT02680834|6483926|P1|Overall Study|Lost to Follow-up|0
1880661|NCT02680834|6483925|P2|Overall Study|Withdrawal by Subject|0
1880662|NCT02680834|6483926|P1|Overall Study|Withdrawal by Subject|6
1880663|NCT02680834|6483925|P2|Overall Study|Physician Decision|2
1880664|NCT02680834|6483926|P1|Overall Study|Physician Decision|5
1880699|NCT02677896|6483992|P2|Overall Study|Did not receive study drug|2
1880700|NCT02677896|6483993|P1|Overall Study|Did not receive study drug|2
1880701|NCT02677896|6483992|P2|Overall Study|Miscellaneous|11
1880702|NCT02677896|6483993|P1|Overall Study|Miscellaneous|6
1880703|NCT02677896|6483992|P2|Overall Study|Withdrawal by patient:|30
1880704|NCT02677896|6483993|P1|Overall Study|Withdrawal by patient:|25
1880705|NCT02677896|6483992|P2|Overall Study|Protocol deviation|1
1880706|NCT02677896|6483993|P1|Overall Study|Protocol deviation|2
1880707|NCT02677896|6483992|P2|Overall Study|Progressive disease:|171
1880708|NCT02677896|6483993|P1|Overall Study|Progressive disease:|65
1880709|NCT02677896|6483992|P2|Overall Study|Lost to Follow-up|1
1880710|NCT02677896|6483993|P1|Overall Study|Lost to Follow-up|0
1880711|NCT02677896|6483992|P2|Overall Study|Death|7
1880712|NCT02677896|6483993|P1|Overall Study|Death|9
1880713|NCT02677896|6483992|P2|Overall Study|Adverse Event|21
1880714|NCT02677896|6483993|P1|Overall Study|Adverse Event|28
1880715|NCT02675426|6484022|P3|Overall Study|Other|2
1880716|NCT02675426|6484023|P2|Overall Study|Other|1
1880717|NCT02675426|6484024|P1|Overall Study|Other|3
1880718|NCT02675426|6484022|P3|Overall Study|Lost to Follow-up|2
1880719|NCT02675426|6484023|P2|Overall Study|Lost to Follow-up|0
1880720|NCT02675426|6484024|P1|Overall Study|Lost to Follow-up|1
1880721|NCT02675426|6484022|P3|Overall Study|Withdrawal by Subject|5
1880722|NCT02675426|6484023|P2|Overall Study|Withdrawal by Subject|5
1880723|NCT02675426|6484024|P1|Overall Study|Withdrawal by Subject|3
1880724|NCT02675426|6484022|P3|Overall Study|Adverse Event|9
1880725|NCT02675426|6484023|P2|Overall Study|Adverse Event|2
1880726|NCT02675426|6484024|P1|Overall Study|Adverse Event|6
1880864|NCT02585830|6484866|P1|Overall Study|Withdrawal by Subject|3
1881063|NCT02478359|6485610|P2|Overall Study|Disenrolled from health plan|65
1881064|NCT02478359|6485611|P1|Overall Study|Disenrolled from health plan|106
1881252|NCT02344004|6486335|P2|Overall Study|Protocol Violation|0
1881253|NCT02344004|6486336|P1|Overall Study|Protocol Violation|1
1881254|NCT02344004|6486335|P2|Overall Study|Other Not Specified|0
1881255|NCT02344004|6486336|P1|Overall Study|Other Not Specified|12
1881256|NCT02344004|6486335|P2|Overall Study|Rescue Medication|0
1881257|NCT02344004|6486336|P1|Overall Study|Rescue Medication|2
1881258|NCT02344004|6486335|P2|Overall Study|Withdrawal by Subject|5
1881259|NCT02344004|6486336|P1|Overall Study|Withdrawal by Subject|22
1881260|NCT02344004|6486335|P2|Overall Study|Physician Decision|1
1881261|NCT02344004|6486336|P1|Overall Study|Physician Decision|4
1881262|NCT02344004|6486335|P2|Overall Study|Death|7
1881263|NCT02344004|6486336|P1|Overall Study|Death|9
1881264|NCT02344004|6486335|P2|Overall Study|Adverse Event|1
1881265|NCT02344004|6486336|P1|Overall Study|Adverse Event|11
1881910|NCT01693523|6488723|P3|Overall Study|Chemotherapy was held|0
1881911|NCT01693523|6488724|P2|Overall Study|Chemotherapy was held|2
1881912|NCT01693523|6488725|P1|Overall Study|Chemotherapy was held|1
1881913|NCT01693523|6488723|P3|Overall Study|Lack of compliance study medication|0
1881914|NCT01693523|6488724|P2|Overall Study|Lack of compliance study medication|2
1881915|NCT01693523|6488725|P1|Overall Study|Lack of compliance study medication|1
1881916|NCT01693523|6488723|P3|Overall Study|Withdrawal by Subject|2
1881917|NCT01693523|6488724|P2|Overall Study|Withdrawal by Subject|2
1881918|NCT01693523|6488725|P1|Overall Study|Withdrawal by Subject|1
1881919|NCT01693523|6488723|P3|Overall Study|Physician Decision|1
1881920|NCT01693523|6488724|P2|Overall Study|Physician Decision|0
1881921|NCT01693523|6488725|P1|Overall Study|Physician Decision|0
1881922|NCT01693523|6488723|P3|Overall Study|Lost to Follow-up|4
1881923|NCT01693523|6488724|P2|Overall Study|Lost to Follow-up|0
1881924|NCT01693523|6488725|P1|Overall Study|Lost to Follow-up|0
1881925|NCT01693523|6488723|P3|Overall Study|Death|1
1881926|NCT01693523|6488724|P2|Overall Study|Death|1
1881927|NCT01693523|6488725|P1|Overall Study|Death|0
1881928|NCT01693523|6488723|P3|Overall Study|Adverse Event|0
1881929|NCT01693523|6488724|P2|Overall Study|Adverse Event|1
1881930|NCT01693523|6488725|P1|Overall Study|Adverse Event|2
1881971|NCT01665768|6488932|P1|Overall Study|Withdrawal by Subject|1
1881972|NCT01665768|6488932|P1|Overall Study|Lack of Efficacy|19
1881973|NCT01665768|6488932|P1|Overall Study|Adverse Event|3
1882131|NCT01461005|6489472|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
1882134|NCT01420926|6489490|P2|Overall Study|Continues on active treatment|3
1882135|NCT01420926|6489491|P1|Overall Study|Continues on active treatment|1
1882136|NCT01420926|6489490|P2|Overall Study|Physician Decision|5
1882137|NCT01420926|6489491|P1|Overall Study|Physician Decision|7
1882138|NCT01420926|6489490|P2|Overall Study|Non-protocol treatment|20
1882139|NCT01420926|6489491|P1|Overall Study|Non-protocol treatment|17
1882140|NCT01420926|6489490|P2|Overall Study|Withdrawal by Subject|16
1882141|NCT01420926|6489491|P1|Overall Study|Withdrawal by Subject|11
1882142|NCT01420926|6489490|P2|Overall Study|Death|17
1882143|NCT01420926|6489491|P1|Overall Study|Death|18
1882144|NCT01420926|6489490|P2|Overall Study|Adverse Event|4
1882145|NCT01420926|6489491|P1|Overall Study|Adverse Event|6
1882146|NCT01413191|6489505|P1|Overall Study|Death|1
1882147|NCT01413191|6489505|P1|Overall Study|Disease Progression|5
1882148|NCT01413191|6489505|P1|Overall Study|Lost to Follow-up|5
1882153|NCT01380535|6489565|P2|Overall Study|Lack of Efficacy|3
1882154|NCT01380535|6489566|P1|Overall Study|Lack of Efficacy|0
1882155|NCT01380535|6489565|P2|Overall Study|Protocol Violation|2
1882156|NCT01380535|6489566|P1|Overall Study|Protocol Violation|0
1882157|NCT01380535|6489565|P2|Overall Study|Withdrawal by Subject|2
1882158|NCT01380535|6489566|P1|Overall Study|Withdrawal by Subject|1
1882159|NCT01380535|6489565|P2|Overall Study|Study site closed|5
1882160|NCT01380535|6489566|P1|Overall Study|Study site closed|0
1882161|NCT01380535|6489565|P2|Overall Study|Death|0
1882162|NCT01380535|6489566|P1|Overall Study|Death|3
1882163|NCT01380535|6489565|P2|Overall Study|Adverse Event|3
1882164|NCT01380535|6489566|P1|Overall Study|Adverse Event|3
1882187|NCT01346410|6489708|P1|Overall Study|Death|1
1882194|NCT01266603|6489783|P1|Overall Study|Failed screening; MAGE-A3 negative|26
1882195|NCT01266603|6489783|P1|Overall Study|Withdrawal by Subject|1
1882196|NCT01266603|6489783|P1|Overall Study|Lack of Efficacy|14
1882197|NCT01266603|6489783|P1|Overall Study|Adverse Event|1
1882328|NCT01064648|6490136|P4|Phase II|Under Review|0
1882329|NCT01064648|6490137|P3|Phase II|Under Review|2
1882330|NCT01064648|6490138|P2|Phase II|Under Review|0
1882331|NCT01064648|6490139|P1|Phase II|Under Review|0
1882332|NCT01064648|6490136|P4|Phase II|Non-protocol specified|3
1882333|NCT01064648|6490137|P3|Phase II|Non-protocol specified|5
1882334|NCT01064648|6490138|P2|Phase II|Non-protocol specified|0
1882335|NCT01064648|6490139|P1|Phase II|Non-protocol specified|0
1882336|NCT01064648|6490136|P4|Phase II|Progression|27
1882337|NCT01064648|6490137|P3|Phase II|Progression|21
1882338|NCT01064648|6490138|P2|Phase II|Progression|0
1882339|NCT01064648|6490139|P1|Phase II|Progression|0
1882340|NCT01064648|6490136|P4|Phase II|Withdrawal by Subject|5
1882341|NCT01064648|6490137|P3|Phase II|Withdrawal by Subject|2
1882342|NCT01064648|6490138|P2|Phase II|Withdrawal by Subject|0
1882343|NCT01064648|6490139|P1|Phase II|Withdrawal by Subject|0
1882344|NCT01064648|6490136|P4|Phase II|Death|5
1882345|NCT01064648|6490137|P3|Phase II|Death|4
1882346|NCT01064648|6490138|P2|Phase II|Death|0
1882347|NCT01064648|6490139|P1|Phase II|Death|0
1882348|NCT01064648|6490136|P4|Phase II|Adverse Event|8
1882349|NCT01064648|6490137|P3|Phase II|Adverse Event|15
1882350|NCT01064648|6490138|P2|Phase II|Adverse Event|0
1882351|NCT01064648|6490139|P1|Phase II|Adverse Event|0
1882352|NCT01064648|6490136|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1882353|NCT01064648|6490137|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1882354|NCT01064648|6490138|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
1882355|NCT01064648|6490139|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
1882356|NCT01064648|6490136|P4|Phase I Cohort 2: Dose Level 2|Progression|0
1882357|NCT01064648|6490137|P3|Phase I Cohort 2: Dose Level 2|Progression|0
1882358|NCT01064648|6490138|P2|Phase I Cohort 2: Dose Level 2|Progression|5
1882359|NCT01064648|6490139|P1|Phase I Cohort 2: Dose Level 2|Progression|0
1882360|NCT01064648|6490136|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1882361|NCT01064648|6490137|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1882362|NCT01064648|6490138|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
1882363|NCT01064648|6490139|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
1882364|NCT01064648|6490136|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1882365|NCT01064648|6490137|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1882366|NCT01064648|6490138|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
1882367|NCT01064648|6490139|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
1882368|NCT01064648|6490136|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1882369|NCT01064648|6490137|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1882370|NCT01064648|6490138|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
1882371|NCT01064648|6490139|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
1882372|NCT01064648|6490136|P4|Phase I Cohort1: Dose Level 1|Progression|0
1882373|NCT01064648|6490137|P3|Phase I Cohort1: Dose Level 1|Progression|0
1882374|NCT01064648|6490138|P2|Phase I Cohort1: Dose Level 1|Progression|0
1882375|NCT01064648|6490139|P1|Phase I Cohort1: Dose Level 1|Progression|5
1882402|NCT00979992|6490251|P1|Overall Study|Refused – Never Treated|2
1882403|NCT00979992|6490251|P1|Overall Study|Ineligible - wrong cell type|2
1882404|NCT00979992|6490251|P1|Overall Study|Ineligible - inadequate pathology|1
1882607|NCT00440726|6490783|P3|Phase 2|Adverse Event|1
1882608|NCT00440726|6490784|P2|Phase 2|Adverse Event|0
1882609|NCT00440726|6490785|P1|Phase 2|Adverse Event|0
1882610|NCT00440726|6490783|P3|Phase 2|Death|1
1882611|NCT00440726|6490784|P2|Phase 2|Death|0
1882612|NCT00440726|6490785|P1|Phase 2|Death|0
1882613|NCT00440726|6490783|P3|Phase 1|Physician Decision|0
1882614|NCT00440726|6490784|P2|Phase 1|Physician Decision|0
1882615|NCT00440726|6490785|P1|Phase 1|Physician Decision|1
1882616|NCT00440726|6490783|P3|Phase 1|Dose-Limiting Toxicity|0
1882617|NCT00440726|6490784|P2|Phase 1|Dose-Limiting Toxicity|1
1882618|NCT00440726|6490785|P1|Phase 1|Dose-Limiting Toxicity|0
1882689|NCT00278109|6490914|P1|Overall Study|social circumstances|1
1882690|NCT00278109|6490914|P1|Overall Study|Adverse Event|3
1882691|NCT00262834|6490920|P2|Overall Study|Surgery delayed/tissue not collected|4
1882692|NCT00262834|6490921|P1|Overall Study|Surgery delayed/tissue not collected|1
1882693|NCT00248287|6490934|P2|Overall Study|Other|2
1882694|NCT00248287|6490935|P1|Overall Study|Other|3
1882695|NCT00248287|6490934|P2|Overall Study|Patient Request|3
1882696|NCT00248287|6490935|P1|Overall Study|Patient Request|5
1882697|NCT00248287|6490934|P2|Overall Study|Investigator Request|3
1882698|NCT00248287|6490935|P1|Overall Study|Investigator Request|4
1882699|NCT00248287|6490934|P2|Overall Study|Lost to Follow-up|1
1882700|NCT00248287|6490935|P1|Overall Study|Lost to Follow-up|0
1882701|NCT00248287|6490934|P2|Overall Study|Death|0
1882702|NCT00248287|6490935|P1|Overall Study|Death|1
1882703|NCT00248287|6490934|P2|Overall Study|Adverse Event|10
1882704|NCT00248287|6490935|P1|Overall Study|Adverse Event|11
1882733|NCT00068419|6491265|P1|Overall Study|Ineligible|11
1882734|NCT00068419|6491265|P1|Overall Study|Withdrawal by Subject|14
1882735|NCT00068419|6491265|P1|Overall Study|Physician Decision|7
1882736|NCT00068419|6491265|P1|Overall Study|Lost to Follow-up|1
1882737|NCT00068419|6491265|P1|Overall Study|Lack of Efficacy|24
1882738|NCT00068419|6491265|P1|Overall Study|Adverse Event|3
1882739|NCT04272775|6491300|P2|Overall Study|Progressive Disease|1
1882740|NCT04272775|6491301|P1|Overall Study|Progressive Disease|3
1882741|NCT04272775|6491300|P2|Overall Study|Adverse Event|2
1882742|NCT04272775|6491301|P1|Overall Study|Adverse Event|1
1882743|NCT04272775|6491300|P2|Overall Study|Withdrawal by Subject|2
1882744|NCT04272775|6491301|P1|Overall Study|Withdrawal by Subject|1
1882745|NCT04272775|6491300|P2|Overall Study|Symptomatic Deterioration|1
1882746|NCT04272775|6491301|P1|Overall Study|Symptomatic Deterioration|1
1882747|NCT04272775|6491300|P2|Overall Study|Protocol Violation|1
1882748|NCT04272775|6491301|P1|Overall Study|Protocol Violation|0
1882749|NCT04272775|6491300|P2|Overall Study|Study Terminated by Sponsor|0
1882750|NCT04272775|6491301|P1|Overall Study|Study Terminated by Sponsor|1
1882751|NCT04080297|6491444|P2|Overall Study|concurrent illness|0
1882752|NCT04080297|6491445|P1|Overall Study|concurrent illness|1
1882753|NCT04080297|6491444|P2|Overall Study|Adverse Event|3
1882754|NCT04080297|6491445|P1|Overall Study|Adverse Event|1
1882755|NCT04053465|6491465|P2|Overall Study|Withdrawal by Subject|4
1882756|NCT04053465|6491466|P1|Overall Study|Withdrawal by Subject|4
1882757|NCT03933449|6491484|P2|Overall Study|Ongoing in Study|6
1882758|NCT03933449|6491485|P1|Overall Study|Ongoing in Study|20
1882759|NCT03933449|6491484|P2|Overall Study|Death|51
1882760|NCT03933449|6491485|P1|Overall Study|Death|36
1882761|NCT03933449|6491484|P2|Overall Study|Adverse Event|4
1882762|NCT03933449|6491485|P1|Overall Study|Adverse Event|6
1882763|NCT03868631|6491522|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
1882764|NCT03868631|6491523|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
1882765|NCT03868631|6491522|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
1882766|NCT03868631|6491523|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
1882767|NCT03868631|6491522|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
1882768|NCT03868631|6491523|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
1882769|NCT03868631|6491522|P2|Baseline to Week 6|Withdrawal by Subject|0
1882770|NCT03868631|6491523|P1|Baseline to Week 6|Withdrawal by Subject|3
1882771|NCT03868631|6491522|P2|Baseline to Week 6|Protocol Violation|1
1882772|NCT03868631|6491523|P1|Baseline to Week 6|Protocol Violation|1
1882773|NCT03868631|6491522|P2|Baseline to Week 6|Adverse Event|3
1882774|NCT03868631|6491523|P1|Baseline to Week 6|Adverse Event|0
1882775|NCT03831282|6491535|P1|Overall Study|Could not place sensor|1
1882776|NCT03722264|6491715|P1|Overall Study|Physician Decision|3
1882777|NCT03640052|6491725|P5|Overall Study|Lost to Follow-up|0
1882778|NCT03640052|6491726|P4|Overall Study|Lost to Follow-up|0
1882779|NCT03640052|6491727|P3|Overall Study|Lost to Follow-up|0
1882780|NCT03640052|6491728|P2|Overall Study|Lost to Follow-up|1
1882781|NCT03640052|6491729|P1|Overall Study|Lost to Follow-up|0
1882782|NCT03629054|6491748|P2|Period 2 (4 Days)|Not treated|1
1882783|NCT03629054|6491749|P1|Period 2 (4 Days)|Not treated|0
1882784|NCT03546842|6491879|P1|Overall Study|Withdrawal by Subject|2
1882785|NCT03546842|6491879|P1|Overall Study|Protocol Violation|1
1882786|NCT03497039|6491923|P2|Overall Study|Protocol Violation|1
1882787|NCT03497039|6491924|P1|Overall Study|Protocol Violation|0
1882788|NCT03497039|6491923|P2|Overall Study|Withdrawal by Subject|0
1882789|NCT03497039|6491924|P1|Overall Study|Withdrawal by Subject|1
1882790|NCT03404843|6492014|P2|Overall Study|Study difficulties unrelated to Tx|1
1882791|NCT03404843|6492015|P1|Overall Study|Study difficulties unrelated to Tx|4
1882792|NCT03383887|6492041|P2|Overall Study|Lost to Follow-up|1
1882793|NCT03383887|6492042|P1|Overall Study|Lost to Follow-up|0
1882794|NCT03303521|6492052|P2|Overall Study|Adverse Event|0
1882795|NCT03303521|6492053|P1|Overall Study|Adverse Event|1
1882796|NCT03303521|6492052|P2|Overall Study|Non-comliance to study protocol|1
1882797|NCT03303521|6492053|P1|Overall Study|Non-comliance to study protocol|0
1882798|NCT03303521|6492052|P2|Overall Study|Transferred to non-study dialysis center|0
1882799|NCT03303521|6492053|P1|Overall Study|Transferred to non-study dialysis center|1
1882800|NCT03303521|6492052|P2|Overall Study|Investigational product discontinuation|1
1882801|NCT03303521|6492053|P1|Overall Study|Investigational product discontinuation|0
1882802|NCT03303521|6492052|P2|Overall Study|Kidney transplantation|1
1882803|NCT03303521|6492053|P1|Overall Study|Kidney transplantation|0
1882804|NCT03303521|6492052|P2|Overall Study|Death|0
1882805|NCT03303521|6492053|P1|Overall Study|Death|1
1882806|NCT03303521|6492052|P2|Overall Study|Withdrawal by Subject|0
1882807|NCT03303521|6492053|P1|Overall Study|Withdrawal by Subject|2
1882808|NCT03289208|6492097|P3|Overall Study|Adverse Event|0
1882809|NCT03289208|6492098|P2|Overall Study|Adverse Event|0
1882810|NCT03289208|6492099|P1|Overall Study|Adverse Event|1
1882811|NCT03271021|6492135|P2|Overall Study|Miscellaneous|8
1882812|NCT03271021|6492136|P1|Overall Study|Miscellaneous|9
1882813|NCT03271021|6492135|P2|Overall Study|Abnormal Lab Results|0
1882814|NCT03271021|6492136|P1|Overall Study|Abnormal Lab Results|1
1882815|NCT03271021|6492135|P2|Overall Study|Protocol Violation|4
1882816|NCT03271021|6492136|P1|Overall Study|Protocol Violation|6
1882817|NCT03271021|6492135|P2|Overall Study|Lost to Follow-up|39
1882818|NCT03271021|6492136|P1|Overall Study|Lost to Follow-up|34
1882819|NCT03271021|6492135|P2|Overall Study|Withdrawal by Subject|53
1882820|NCT03271021|6492136|P1|Overall Study|Withdrawal by Subject|36
1882821|NCT03271021|6492135|P2|Overall Study|Adverse Event|2
1882822|NCT03271021|6492136|P1|Overall Study|Adverse Event|3
1882823|NCT03259490|6492165|P2|Period 2|Protocol Violation|0
1882824|NCT03259490|6492166|P1|Period 2|Protocol Violation|1
1882825|NCT03259490|6492165|P2|Period 1|Withdrawal by Subject|1
1882826|NCT03259490|6492166|P1|Period 1|Withdrawal by Subject|0
1882827|NCT03238911|6492190|P2|Overall Study|Lost to Follow-up|1
1882828|NCT03238911|6492191|P1|Overall Study|Lost to Follow-up|2
1882829|NCT03238911|6492190|P2|Overall Study|Withdrawal by Subject|2
1882830|NCT03238911|6492191|P1|Overall Study|Withdrawal by Subject|1
1882831|NCT03237065|6492233|P2|Overall Study|Unable to obtain venous access|1
1882832|NCT03237065|6492234|P1|Overall Study|Unable to obtain venous access|0
1882833|NCT03237065|6492233|P2|Overall Study|Lost to Follow-up|0
1882834|NCT03237065|6492234|P1|Overall Study|Lost to Follow-up|1
1882835|NCT03237065|6492233|P2|Overall Study|Withdrawal by Subject|0
1882836|NCT03237065|6492234|P1|Overall Study|Withdrawal by Subject|3
1882837|NCT03237065|6492233|P2|Overall Study|Protocol Violation|1
1882838|NCT03237065|6492234|P1|Overall Study|Protocol Violation|0
1882839|NCT03237065|6492233|P2|Overall Study|Adverse Event|2
1882840|NCT03237065|6492234|P1|Overall Study|Adverse Event|0
1882841|NCT03226392|6492276|P2|Overall Study|Subject/Guardian Decision|6
1882842|NCT03226392|6492277|P1|Overall Study|Subject/Guardian Decision|7
1882843|NCT03226392|6492276|P2|Overall Study|Technical Problems|2
1882844|NCT03226392|6492277|P1|Overall Study|Technical Problems|0
1882845|NCT03226392|6492276|P2|Overall Study|Adverse Event|0
1882846|NCT03226392|6492277|P1|Overall Study|Adverse Event|1
1882847|NCT03226392|6492276|P2|Overall Study|Lost to Follow-up|0
1882848|NCT03226392|6492277|P1|Overall Study|Lost to Follow-up|1
1882849|NCT03226392|6492276|P2|Overall Study|Physician Decision|0
1882850|NCT03226392|6492277|P1|Overall Study|Physician Decision|1
1882851|NCT03226392|6492276|P2|Overall Study|Protocol Deviation|0
1882852|NCT03226392|6492277|P1|Overall Study|Protocol Deviation|1
1882853|NCT03201900|6492289|P1|Extension Phase (Up to 124 Weeks)|Ongoing|41
1882854|NCT03201900|6492289|P1|Extension Phase (Up to 124 Weeks)|Withdrawal of consent|1
1882855|NCT03201900|6492289|P1|Extension Phase (Up to 124 Weeks)|Lost to Follow-up|1
1882856|NCT03201900|6492289|P1|Extension Phase (Up to 124 Weeks)|Inadequate therapeutic effect|1
1882857|NCT03201900|6492289|P1|Extension Phase (Up to 124 Weeks)|Pregnancy|1
1882858|NCT03201900|6492289|P1|Extension Phase (Up to 124 Weeks)|Subject choice|1
1882859|NCT03201900|6492289|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
1882860|NCT03201900|6492289|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
1882861|NCT03201900|6492289|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
1882862|NCT03201900|6492289|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
1882863|NCT03201900|6492289|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
1882864|NCT03201900|6492289|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
1882865|NCT03201900|6492289|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
1882866|NCT03187197|6492298|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
1882867|NCT03187197|6492299|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
1882868|NCT03187197|6492300|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
1882869|NCT03187197|6492298|P3|Overall Study|Status missing|3
1882870|NCT03187197|6492299|P2|Overall Study|Status missing|33
1882871|NCT03187197|6492300|P1|Overall Study|Status missing|2
1882872|NCT03187197|6492298|P3|Overall Study|Missing|3
1882873|NCT03187197|6492299|P2|Overall Study|Missing|32
1882874|NCT03187197|6492300|P1|Overall Study|Missing|1
1882875|NCT03187197|6492298|P3|Overall Study|Reason not listed|1
1882876|NCT03187197|6492299|P2|Overall Study|Reason not listed|54
1882877|NCT03187197|6492300|P1|Overall Study|Reason not listed|2
1882878|NCT03187197|6492298|P3|Overall Study|Administrative problem|0
1882879|NCT03187197|6492299|P2|Overall Study|Administrative problem|1
1882880|NCT03187197|6492300|P1|Overall Study|Administrative problem|1
1882881|NCT03187197|6492298|P3|Overall Study|Death|0
1882882|NCT03187197|6492299|P2|Overall Study|Death|11
1882883|NCT03187197|6492300|P1|Overall Study|Death|0
1882884|NCT03187197|6492298|P3|Overall Study|Adverse Event|0
1882885|NCT03187197|6492299|P2|Overall Study|Adverse Event|29
1882886|NCT03187197|6492300|P1|Overall Study|Adverse Event|6
1882887|NCT03187197|6492298|P3|Overall Study|Lost to Follow-up|7
1882888|NCT03187197|6492299|P2|Overall Study|Lost to Follow-up|60
1882889|NCT03187197|6492300|P1|Overall Study|Lost to Follow-up|1
1882890|NCT03187197|6492298|P3|Overall Study|Withdrawal by Subject|4
1882891|NCT03187197|6492299|P2|Overall Study|Withdrawal by Subject|63
1882892|NCT03187197|6492300|P1|Overall Study|Withdrawal by Subject|8
1882893|NCT03187197|6492298|P3|Overall Study|Stopped Pradaxa®/VKA|4
1882894|NCT03187197|6492299|P2|Overall Study|Stopped Pradaxa®/VKA|65
1882895|NCT03187197|6492300|P1|Overall Study|Stopped Pradaxa®/VKA|11
1882896|NCT03155178|6492315|P4|Overall Study|Did not meet treatment day baseline|7
1882897|NCT03155178|6492316|P3|Overall Study|Did not meet treatment day baseline|7
1882898|NCT03155178|6492317|P2|Overall Study|Did not meet treatment day baseline|7
1882899|NCT03155178|6492318|P1|Overall Study|Did not meet treatment day baseline|7
1882900|NCT03146741|6492336|P1|Overall Study|Awaiting txp|2
1882901|NCT03146741|6492336|P1|Overall Study|Physician Decision|2
1882902|NCT03146741|6492336|P1|Overall Study|Listeted for MOT|2
1882903|NCT03146741|6492336|P1|Overall Study|Txp with non-HCV+ heart|4
1882904|NCT03126539|6492381|P5|Overall Study|Lost to Follow-up|0
1882905|NCT03126539|6492382|P4|Overall Study|Lost to Follow-up|0
1882906|NCT03126539|6492383|P3|Overall Study|Lost to Follow-up|1
1882907|NCT03126539|6492384|P2|Overall Study|Lost to Follow-up|1
1882908|NCT03126539|6492385|P1|Overall Study|Lost to Follow-up|1
1882909|NCT03125915|6492402|P4|6 Month Follow-up|Lost to Follow-up|3
1882910|NCT03125915|6492403|P3|6 Month Follow-up|Lost to Follow-up|6
1882911|NCT03125915|6492404|P2|6 Month Follow-up|Lost to Follow-up|3
1882912|NCT03125915|6492405|P1|6 Month Follow-up|Lost to Follow-up|7
1882913|NCT03125915|6492402|P4|3 Month Follow-up|Lost to Follow-up|2
1882914|NCT03125915|6492403|P3|3 Month Follow-up|Lost to Follow-up|4
1882915|NCT03125915|6492404|P2|3 Month Follow-up|Lost to Follow-up|4
1882916|NCT03125915|6492405|P1|3 Month Follow-up|Lost to Follow-up|6
1882917|NCT03125915|6492402|P4|1 Month Follow up|Lost to Follow-up|3
1882918|NCT03125915|6492403|P3|1 Month Follow up|Lost to Follow-up|2
1882919|NCT03125915|6492404|P2|1 Month Follow up|Lost to Follow-up|3
1882920|NCT03125915|6492405|P1|1 Month Follow up|Lost to Follow-up|3
1882921|NCT03105362|6492423|P1|Overall Study|Lost to Follow-up|1
1882922|NCT03105362|6492423|P1|Overall Study|Withdrawal by Subject|1
1882923|NCT03093181|6492433|P3|Overall Study|Other (Protocol violation)|1
1882924|NCT03093181|6492434|P2|Overall Study|Other (Protocol violation)|0
1882925|NCT03093181|6492435|P1|Overall Study|Other (Protocol violation)|0
1882926|NCT03093181|6492433|P3|Overall Study|Adverse Event|0
1882927|NCT03093181|6492434|P2|Overall Study|Adverse Event|1
1882928|NCT03093181|6492435|P1|Overall Study|Adverse Event|0
1882929|NCT03093181|6492433|P3|Overall Study|Other (Not specified)|0
1882930|NCT03093181|6492434|P2|Overall Study|Other (Not specified)|0
1882931|NCT03093181|6492435|P1|Overall Study|Other (Not specified)|1
1882932|NCT03093181|6492433|P3|Overall Study|Withdrawal by Subject|2
1882933|NCT03093181|6492434|P2|Overall Study|Withdrawal by Subject|1
1882934|NCT03093181|6492435|P1|Overall Study|Withdrawal by Subject|2
1882935|NCT03092375|6492465|P4|Overall Study|Lack of Efficacy|0
1882936|NCT03092375|6492466|P3|Overall Study|Lack of Efficacy|1
1882937|NCT03092375|6492467|P2|Overall Study|Lack of Efficacy|1
1882938|NCT03092375|6492468|P1|Overall Study|Lack of Efficacy|0
1882939|NCT03069352|6492549|P2|Overall Study|Ongoing|40
1882940|NCT03069352|6492550|P1|Overall Study|Ongoing|12
1882941|NCT03066193|6492601|P1|Overall Study|Withdrawal by Subject|1
1882942|NCT03055260|6492607|P2|Overall Study|Withdrawal by Subject|0
1882943|NCT03055260|6492608|P1|Overall Study|Withdrawal by Subject|1
1882944|NCT03055195|6492618|P2|Overall Study|Physician Decision|0
1882945|NCT03055195|6492619|P1|Overall Study|Physician Decision|1
1882946|NCT03055195|6492618|P2|Overall Study|Protocol Violation|1
1882947|NCT03055195|6492619|P1|Overall Study|Protocol Violation|2
1882948|NCT03055195|6492618|P2|Overall Study|Study Terminated by Sponsor|6
1882949|NCT03055195|6492619|P1|Overall Study|Study Terminated by Sponsor|2
1882950|NCT03055195|6492618|P2|Overall Study|Withdrawal by Subject|7
1882951|NCT03055195|6492619|P1|Overall Study|Withdrawal by Subject|6
1882952|NCT03055195|6492618|P2|Overall Study|Lack of Efficacy|0
1882953|NCT03055195|6492619|P1|Overall Study|Lack of Efficacy|1
1882954|NCT03049852|6492674|P3|Overall Study|Lost to Follow-up|0
1882955|NCT03049852|6492675|P2|Overall Study|Lost to Follow-up|1
1882956|NCT03049852|6492676|P1|Overall Study|Lost to Follow-up|0
1882957|NCT03015181|6492853|P7|Overall Study|Physician Decision|1
1882958|NCT03015181|6492854|P6|Overall Study|Physician Decision|0
1882959|NCT03015181|6492855|P5|Overall Study|Physician Decision|0
1882960|NCT03015181|6492856|P4|Overall Study|Physician Decision|0
1882961|NCT03015181|6492857|P3|Overall Study|Physician Decision|0
1882962|NCT03015181|6492858|P2|Overall Study|Physician Decision|0
1882963|NCT03015181|6492859|P1|Overall Study|Physician Decision|0
1882964|NCT03015181|6492853|P7|Overall Study|Withdrawal by Subject|0
1882965|NCT03015181|6492854|P6|Overall Study|Withdrawal by Subject|1
1882966|NCT03015181|6492855|P5|Overall Study|Withdrawal by Subject|0
1882967|NCT03015181|6492856|P4|Overall Study|Withdrawal by Subject|0
1882968|NCT03015181|6492857|P3|Overall Study|Withdrawal by Subject|0
1882969|NCT03015181|6492858|P2|Overall Study|Withdrawal by Subject|0
1882970|NCT03015181|6492859|P1|Overall Study|Withdrawal by Subject|0
1882971|NCT03015181|6492853|P7|Overall Study|Enrolled, but product never administered|0
1882972|NCT03015181|6492854|P6|Overall Study|Enrolled, but product never administered|0
1882973|NCT03015181|6492855|P5|Overall Study|Enrolled, but product never administered|0
1882974|NCT03015181|6492856|P4|Overall Study|Enrolled, but product never administered|0
1882975|NCT03015181|6492857|P3|Overall Study|Enrolled, but product never administered|0
1882976|NCT03015181|6492858|P2|Overall Study|Enrolled, but product never administered|0
1882977|NCT03015181|6492859|P1|Overall Study|Enrolled, but product never administered|1
1882978|NCT03006562|6492972|P2|Overall Study|Lost to Follow-up|1
1882979|NCT03006562|6492973|P1|Overall Study|Lost to Follow-up|0
1882980|NCT02997163|6492995|P4|Overall Study|Adverse Event|1
1882981|NCT02997163|6492996|P3|Overall Study|Adverse Event|0
1882982|NCT02997163|6492997|P2|Overall Study|Adverse Event|0
1882983|NCT02997163|6492998|P1|Overall Study|Adverse Event|1
1882984|NCT02996500|6493134|P6|Overall Study|Withdrawal by Subject|0
1882985|NCT02996500|6493135|P5|Overall Study|Withdrawal by Subject|2
1882986|NCT02996500|6493136|P4|Overall Study|Withdrawal by Subject|0
1882987|NCT02996500|6493137|P3|Overall Study|Withdrawal by Subject|3
1882988|NCT02996500|6493138|P2|Overall Study|Withdrawal by Subject|0
1882989|NCT02996500|6493139|P1|Overall Study|Withdrawal by Subject|3
1882990|NCT02996500|6493134|P6|Overall Study|Protocol Violation|0
1882991|NCT02996500|6493135|P5|Overall Study|Protocol Violation|0
1882992|NCT02996500|6493136|P4|Overall Study|Protocol Violation|1
1882993|NCT02996500|6493137|P3|Overall Study|Protocol Violation|0
1882994|NCT02996500|6493138|P2|Overall Study|Protocol Violation|0
1882995|NCT02996500|6493139|P1|Overall Study|Protocol Violation|0
1882996|NCT02996500|6493134|P6|Overall Study|Other|0
1882997|NCT02996500|6493135|P5|Overall Study|Other|0
1882998|NCT02996500|6493136|P4|Overall Study|Other|0
1882999|NCT02996500|6493137|P3|Overall Study|Other|2
1883000|NCT02996500|6493138|P2|Overall Study|Other|0
1883001|NCT02996500|6493139|P1|Overall Study|Other|2
1883002|NCT02996500|6493134|P6|Overall Study|Progressive Disease|0
1883003|NCT02996500|6493135|P5|Overall Study|Progressive Disease|0
1883004|NCT02996500|6493136|P4|Overall Study|Progressive Disease|0
1883005|NCT02996500|6493137|P3|Overall Study|Progressive Disease|0
1883006|NCT02996500|6493138|P2|Overall Study|Progressive Disease|0
1883007|NCT02996500|6493139|P1|Overall Study|Progressive Disease|1
1883008|NCT02996500|6493134|P6|Overall Study|Non-Compliance With Study Drug|1
1883009|NCT02996500|6493135|P5|Overall Study|Non-Compliance With Study Drug|0
1883010|NCT02996500|6493136|P4|Overall Study|Non-Compliance With Study Drug|0
1883011|NCT02996500|6493137|P3|Overall Study|Non-Compliance With Study Drug|0
1883012|NCT02996500|6493138|P2|Overall Study|Non-Compliance With Study Drug|0
1883013|NCT02996500|6493139|P1|Overall Study|Non-Compliance With Study Drug|0
1883014|NCT02996500|6493134|P6|Overall Study|No Longer Meets Eligibility Criteria|0
1883015|NCT02996500|6493135|P5|Overall Study|No Longer Meets Eligibility Criteria|0
1883016|NCT02996500|6493136|P4|Overall Study|No Longer Meets Eligibility Criteria|0
1883017|NCT02996500|6493137|P3|Overall Study|No Longer Meets Eligibility Criteria|1
1883018|NCT02996500|6493138|P2|Overall Study|No Longer Meets Eligibility Criteria|0
1883019|NCT02996500|6493139|P1|Overall Study|No Longer Meets Eligibility Criteria|0
1883020|NCT02996500|6493134|P6|Overall Study|Lost to Follow-up|1
1883021|NCT02996500|6493135|P5|Overall Study|Lost to Follow-up|0
1883022|NCT02996500|6493136|P4|Overall Study|Lost to Follow-up|0
1883023|NCT02996500|6493137|P3|Overall Study|Lost to Follow-up|0
1883024|NCT02996500|6493138|P2|Overall Study|Lost to Follow-up|0
1883025|NCT02996500|6493139|P1|Overall Study|Lost to Follow-up|1
1883026|NCT02996500|6493134|P6|Overall Study|Lack of Efficacy|0
1883027|NCT02996500|6493135|P5|Overall Study|Lack of Efficacy|2
1883028|NCT02996500|6493136|P4|Overall Study|Lack of Efficacy|0
1883029|NCT02996500|6493137|P3|Overall Study|Lack of Efficacy|0
1883030|NCT02996500|6493138|P2|Overall Study|Lack of Efficacy|0
1883031|NCT02996500|6493139|P1|Overall Study|Lack of Efficacy|0
1883032|NCT02996500|6493134|P6|Overall Study|Adverse Event|2
1883033|NCT02996500|6493135|P5|Overall Study|Adverse Event|1
1883034|NCT02996500|6493136|P4|Overall Study|Adverse Event|3
1883035|NCT02996500|6493137|P3|Overall Study|Adverse Event|4
1883036|NCT02996500|6493138|P2|Overall Study|Adverse Event|1
1883037|NCT02996500|6493139|P1|Overall Study|Adverse Event|1
1883038|NCT02983617|6493339|P2|Overall Study|Still on Study|28
1883039|NCT02983617|6493340|P1|Overall Study|Still on Study|6
1883040|NCT02983617|6493339|P2|Overall Study|Death|1
1883041|NCT02983617|6493340|P1|Overall Study|Death|0
1883042|NCT02983617|6493339|P2|Overall Study|Adverse Event|1
1883043|NCT02983617|6493340|P1|Overall Study|Adverse Event|0
1883044|NCT02975206|6493357|P3|Overall Study|Other (e.g., lost to follow up)|6
1883045|NCT02975206|6493358|P2|Overall Study|Other (e.g., lost to follow up)|6
1883046|NCT02975206|6493359|P1|Overall Study|Other (e.g., lost to follow up)|13
1883047|NCT02975206|6493357|P3|Overall Study|Withdrawal by Subject|11
1883048|NCT02975206|6493358|P2|Overall Study|Withdrawal by Subject|11
1883049|NCT02975206|6493359|P1|Overall Study|Withdrawal by Subject|14
1883050|NCT02959177|6493376|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
1883051|NCT02959177|6493377|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
1883052|NCT02959177|6493378|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
1883053|NCT02959177|6493376|P3|Follow-up Post Treatment Phase|Adverse Event|0
1883054|NCT02959177|6493377|P2|Follow-up Post Treatment Phase|Adverse Event|1
1883055|NCT02959177|6493378|P1|Follow-up Post Treatment Phase|Adverse Event|0
1883056|NCT02959177|6493376|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
1883057|NCT02959177|6493377|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
1883058|NCT02959177|6493378|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
1883059|NCT02959177|6493376|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
1883060|NCT02959177|6493377|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
1883061|NCT02959177|6493378|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
1883062|NCT02959177|6493376|P3|Double-Blind Treatment Phase|Protocol Violation|0
1883063|NCT02959177|6493377|P2|Double-Blind Treatment Phase|Protocol Violation|1
1883064|NCT02959177|6493378|P1|Double-Blind Treatment Phase|Protocol Violation|0
1883065|NCT02959177|6493376|P3|Double-Blind Treatment Phase|Physician Decision|0
1883066|NCT02959177|6493377|P2|Double-Blind Treatment Phase|Physician Decision|0
1883067|NCT02959177|6493378|P1|Double-Blind Treatment Phase|Physician Decision|1
1883068|NCT02959177|6493376|P3|Double-Blind Treatment Phase|Adverse Event|0
1883069|NCT02959177|6493377|P2|Double-Blind Treatment Phase|Adverse Event|2
1883070|NCT02959177|6493378|P1|Double-Blind Treatment Phase|Adverse Event|5
1883071|NCT02953938|6493432|P2|Overall Study|Withdrawal by Subject|1
1883072|NCT02953938|6493433|P1|Overall Study|Withdrawal by Subject|1
1883073|NCT02953938|6493432|P2|Overall Study|Adverse Event|1
1883074|NCT02953938|6493433|P1|Overall Study|Adverse Event|0
1883075|NCT02951819|6493450|P2|Overall Study|Ongoing|11
1883076|NCT02951819|6493451|P1|Overall Study|Ongoing|83
1883077|NCT02951819|6493450|P2|Overall Study|Other|0
1883078|NCT02951819|6493451|P1|Overall Study|Other|1
1883079|NCT02951819|6493450|P2|Overall Study|Progressive Disease|0
1883080|NCT02951819|6493451|P1|Overall Study|Progressive Disease|1
1883081|NCT02951819|6493450|P2|Overall Study|Withdrawal by Subject|0
1883082|NCT02951819|6493451|P1|Overall Study|Withdrawal by Subject|1
1883083|NCT02951819|6493450|P2|Overall Study|Death|3
1883084|NCT02951819|6493451|P1|Overall Study|Death|1
1883085|NCT02951533|6493475|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
1883086|NCT02951533|6493476|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
1883087|NCT02951533|6493477|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
1883088|NCT02951533|6493475|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
1883089|NCT02951533|6493476|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
1883090|NCT02951533|6493477|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
1883091|NCT02951533|6493475|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
1883092|NCT02951533|6493476|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
1883093|NCT02951533|6493477|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
1883094|NCT02951533|6493475|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
1883095|NCT02951533|6493476|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
1883096|NCT02951533|6493477|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
1883097|NCT02951533|6493475|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
1883098|NCT02951533|6493476|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
1883099|NCT02951533|6493477|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
1883100|NCT02951533|6493475|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
1883101|NCT02951533|6493476|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
1883102|NCT02951533|6493477|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
1883103|NCT02951533|6493475|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
1883104|NCT02951533|6493476|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
1883105|NCT02951533|6493477|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
1883106|NCT02951533|6493475|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
1883107|NCT02951533|6493476|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
1883108|NCT02951533|6493477|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
1883109|NCT02951533|6493475|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
1883110|NCT02951533|6493476|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
1883111|NCT02951533|6493477|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
1883112|NCT02951533|6493475|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
1883113|NCT02951533|6493476|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
1883114|NCT02951533|6493477|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
1883115|NCT02951533|6493475|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
1883116|NCT02951533|6493476|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
1883117|NCT02951533|6493477|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
1883118|NCT02939599|6493581|P2|Overall Study|Study Terminated By Sponsor|2
1883119|NCT02939599|6493582|P1|Overall Study|Study Terminated By Sponsor|2
1883120|NCT02939599|6493581|P2|Overall Study|Adverse Event|0
1883121|NCT02939599|6493582|P1|Overall Study|Adverse Event|1
1883122|NCT02939014|6493598|P2|Overall Study|In Overall Survival Follow-up|4
1883123|NCT02939014|6493599|P1|Overall Study|In Overall Survival Follow-up|22
1883124|NCT02939014|6493598|P2|Overall Study|In Progression-Free Survival Follow-up|2
1883125|NCT02939014|6493599|P1|Overall Study|In Progression-Free Survival Follow-up|5
1883126|NCT02939014|6493598|P2|Overall Study|Death|3
1883127|NCT02939014|6493599|P1|Overall Study|Death|3
1883128|NCT02928029|6493628|P2|Overall Study|AE not related to clinical progression|1
1883129|NCT02928029|6493629|P1|Overall Study|AE not related to clinical progression|1
1883130|NCT02928029|6493628|P2|Overall Study|Clinical progression|2
1883131|NCT02928029|6493629|P1|Overall Study|Clinical progression|1
1883132|NCT02928029|6493628|P2|Overall Study|Radiological progression|0
1883133|NCT02928029|6493629|P1|Overall Study|Radiological progression|1
1883134|NCT02928029|6493628|P2|Overall Study|Withdrawal by Subject|1
1883135|NCT02928029|6493629|P1|Overall Study|Withdrawal by Subject|0
1883136|NCT02927366|6493641|P2|Overall Study|Patient schedule|0
1883137|NCT02927366|6493642|P1|Overall Study|Patient schedule|1
1883138|NCT02927366|6493641|P2|Overall Study|Adverse Event|0
1883139|NCT02927366|6493642|P1|Overall Study|Adverse Event|1
1883140|NCT02924688|6493680|P6|Overall Study|Withdrawal by Subject|14
1883141|NCT02924688|6493681|P5|Overall Study|Withdrawal by Subject|13
1883142|NCT02924688|6493682|P4|Overall Study|Withdrawal by Subject|12
1883143|NCT02924688|6493683|P3|Overall Study|Withdrawal by Subject|9
1883144|NCT02924688|6493684|P2|Overall Study|Withdrawal by Subject|13
1883145|NCT02924688|6493685|P1|Overall Study|Withdrawal by Subject|14
1883146|NCT02924688|6493680|P6|Overall Study|Physician Decision|1
1883147|NCT02924688|6493681|P5|Overall Study|Physician Decision|1
1883148|NCT02924688|6493682|P4|Overall Study|Physician Decision|1
1883149|NCT02924688|6493683|P3|Overall Study|Physician Decision|0
1883150|NCT02924688|6493684|P2|Overall Study|Physician Decision|1
1883151|NCT02924688|6493685|P1|Overall Study|Physician Decision|2
1883152|NCT02924688|6493680|P6|Overall Study|Lost to Follow-up|4
1883153|NCT02924688|6493681|P5|Overall Study|Lost to Follow-up|2
1883154|NCT02924688|6493682|P4|Overall Study|Lost to Follow-up|4
1883155|NCT02924688|6493683|P3|Overall Study|Lost to Follow-up|2
1883156|NCT02924688|6493684|P2|Overall Study|Lost to Follow-up|4
1883157|NCT02924688|6493685|P1|Overall Study|Lost to Follow-up|2
1883158|NCT02924688|6493680|P6|Overall Study|Protocol defined withdrawal criteria met|0
1883159|NCT02924688|6493681|P5|Overall Study|Protocol defined withdrawal criteria met|1
1883160|NCT02924688|6493682|P4|Overall Study|Protocol defined withdrawal criteria met|1
1883161|NCT02924688|6493683|P3|Overall Study|Protocol defined withdrawal criteria met|1
1883162|NCT02924688|6493684|P2|Overall Study|Protocol defined withdrawal criteria met|0
1883163|NCT02924688|6493685|P1|Overall Study|Protocol defined withdrawal criteria met|1
1883164|NCT02924688|6493680|P6|Overall Study|Protocol Violation|2
1883165|NCT02924688|6493681|P5|Overall Study|Protocol Violation|2
1883166|NCT02924688|6493682|P4|Overall Study|Protocol Violation|6
1883167|NCT02924688|6493683|P3|Overall Study|Protocol Violation|5
1883168|NCT02924688|6493684|P2|Overall Study|Protocol Violation|7
1883169|NCT02924688|6493685|P1|Overall Study|Protocol Violation|3
1883170|NCT02924688|6493680|P6|Overall Study|Lack of Efficacy|1
1883171|NCT02924688|6493681|P5|Overall Study|Lack of Efficacy|1
1883172|NCT02924688|6493682|P4|Overall Study|Lack of Efficacy|2
1883173|NCT02924688|6493683|P3|Overall Study|Lack of Efficacy|4
1883174|NCT02924688|6493684|P2|Overall Study|Lack of Efficacy|3
1883175|NCT02924688|6493685|P1|Overall Study|Lack of Efficacy|2
1883176|NCT02924688|6493680|P6|Overall Study|Adverse Event|2
1883177|NCT02924688|6493681|P5|Overall Study|Adverse Event|3
1883178|NCT02924688|6493682|P4|Overall Study|Adverse Event|2
1883179|NCT02924688|6493683|P3|Overall Study|Adverse Event|2
1883180|NCT02924688|6493684|P2|Overall Study|Adverse Event|3
1883181|NCT02924688|6493685|P1|Overall Study|Adverse Event|9
1883182|NCT02911948|6493762|P2|Overall Study|Unclassified|3
1883183|NCT02911948|6493763|P1|Overall Study|Unclassified|0
1883184|NCT02911948|6493762|P2|Overall Study|Lack of Efficacy|1
1883185|NCT02911948|6493763|P1|Overall Study|Lack of Efficacy|0
1883186|NCT02911948|6493762|P2|Overall Study|Withdrawal by Subject|2
1883187|NCT02911948|6493763|P1|Overall Study|Withdrawal by Subject|0
1883188|NCT02911948|6493762|P2|Overall Study|Protocol Violation|1
1883189|NCT02911948|6493763|P1|Overall Study|Protocol Violation|0
1883190|NCT02891200|6493835|P2|Overall Study|Withdrawal by Subject|4
1883191|NCT02891200|6493836|P1|Overall Study|Withdrawal by Subject|1
1883192|NCT02891200|6493835|P2|Overall Study|Death|9
1883193|NCT02891200|6493836|P1|Overall Study|Death|10
1883194|NCT02891200|6493835|P2|Overall Study|Lost to Follow-up|36
1883195|NCT02891200|6493836|P1|Overall Study|Lost to Follow-up|31
1883196|NCT02859454|6493868|P1|Overall Study|PI discretion/off study prior to trtmt|1
1883197|NCT02858401|6493886|P7|Overall Study|Lost to Follow-up|0
1883198|NCT02858401|6493887|P6|Overall Study|Lost to Follow-up|0
1883199|NCT02858401|6493888|P5|Overall Study|Lost to Follow-up|0
1883200|NCT02858401|6493889|P4|Overall Study|Lost to Follow-up|0
1883201|NCT02858401|6493890|P3|Overall Study|Lost to Follow-up|0
1883202|NCT02858401|6493891|P2|Overall Study|Lost to Follow-up|1
1883203|NCT02858401|6493892|P1|Overall Study|Lost to Follow-up|0
1883204|NCT02858401|6493886|P7|Overall Study|Withdrew Consent|0
1883205|NCT02858401|6493887|P6|Overall Study|Withdrew Consent|1
1883206|NCT02858401|6493888|P5|Overall Study|Withdrew Consent|0
1883207|NCT02858401|6493889|P4|Overall Study|Withdrew Consent|0
1883208|NCT02858401|6493890|P3|Overall Study|Withdrew Consent|0
1883209|NCT02858401|6493891|P2|Overall Study|Withdrew Consent|0
1883210|NCT02858401|6493892|P1|Overall Study|Withdrew Consent|0
1883211|NCT02836496|6494302|P2|Overall Study|Withdrawal by Subject|1
1883212|NCT02836496|6494303|P1|Overall Study|Withdrawal by Subject|0
1883213|NCT02836496|6494302|P2|Overall Study|Adverse Event|1
1883214|NCT02836496|6494303|P1|Overall Study|Adverse Event|2
1883215|NCT02822235|6494319|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
1883216|NCT02822235|6494320|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
1883217|NCT02822235|6494319|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
1883218|NCT02822235|6494320|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
1883219|NCT02822235|6494319|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
1883220|NCT02822235|6494320|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
1883221|NCT02822235|6494319|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
1883222|NCT02822235|6494320|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
1883223|NCT02822235|6494319|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
1883224|NCT02822235|6494320|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
1883225|NCT02822235|6494319|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
1883226|NCT02822235|6494320|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
1883227|NCT02821910|6494379|P6|Overall Study|Other than specified|0
1883228|NCT02821910|6494380|P5|Overall Study|Other than specified|0
1883229|NCT02821910|6494381|P4|Overall Study|Other than specified|0
1883230|NCT02821910|6494382|P3|Overall Study|Other than specified|1
1883231|NCT02821910|6494383|P2|Overall Study|Other than specified|0
1883232|NCT02821910|6494384|P1|Overall Study|Other than specified|1
1883233|NCT02821910|6494379|P6|Overall Study|Withdrawal by Subject|1
1883234|NCT02821910|6494380|P5|Overall Study|Withdrawal by Subject|0
1883235|NCT02821910|6494381|P4|Overall Study|Withdrawal by Subject|0
1883236|NCT02821910|6494382|P3|Overall Study|Withdrawal by Subject|1
1883237|NCT02821910|6494383|P2|Overall Study|Withdrawal by Subject|0
1883238|NCT02821910|6494384|P1|Overall Study|Withdrawal by Subject|0
1883239|NCT02801578|6494476|P1|Overall Study|Adverse Event|2
1883240|NCT02788175|6494489|P1|Overall Study|Ineligible prior to study agent|6
1883241|NCT02788175|6494489|P1|Overall Study|Withdrawal by Subject|4
1883242|NCT02788175|6494489|P1|Overall Study|Protocol Violation|3
1883243|NCT02787863|6494502|P8|Overall Study|Withdrawal by Subject|0
1883244|NCT02787863|6494503|P7|Overall Study|Withdrawal by Subject|0
1883245|NCT02787863|6494504|P6|Overall Study|Withdrawal by Subject|0
1883246|NCT02787863|6494505|P5|Overall Study|Withdrawal by Subject|0
1883247|NCT02787863|6494506|P4|Overall Study|Withdrawal by Subject|0
1883248|NCT02787863|6494507|P3|Overall Study|Withdrawal by Subject|1
1883249|NCT02787863|6494508|P2|Overall Study|Withdrawal by Subject|1
1883250|NCT02787863|6494509|P1|Overall Study|Withdrawal by Subject|0
1883251|NCT02787863|6494502|P8|Overall Study|Death|0
1883252|NCT02787863|6494503|P7|Overall Study|Death|0
1883253|NCT02787863|6494504|P6|Overall Study|Death|0
1883254|NCT02787863|6494505|P5|Overall Study|Death|0
1883255|NCT02787863|6494506|P4|Overall Study|Death|0
1883256|NCT02787863|6494507|P3|Overall Study|Death|1
1883257|NCT02787863|6494508|P2|Overall Study|Death|0
1883258|NCT02787863|6494509|P1|Overall Study|Death|1
1883259|NCT02774681|6494586|P1|Follow-Up for 3 Years|Stopped collecting data-study closed|7
1883260|NCT02774681|6494586|P1|Follow-Up for 3 Years|Death|5
1883261|NCT02774681|6494586|P1|Treatment on Study|Progressive Disease|7
1883262|NCT02755818|6494613|P4|Overall Study|withdrawal by PI|1
1883263|NCT02755818|6494614|P3|Overall Study|withdrawal by PI|1
1883264|NCT02755818|6494615|P2|Overall Study|withdrawal by PI|0
1883265|NCT02755818|6494616|P1|Overall Study|withdrawal by PI|0
1883266|NCT02755818|6494613|P4|Overall Study|Withdrawal by Subject|2
1883267|NCT02755818|6494614|P3|Overall Study|Withdrawal by Subject|0
1883268|NCT02755818|6494615|P2|Overall Study|Withdrawal by Subject|0
1883269|NCT02755818|6494616|P1|Overall Study|Withdrawal by Subject|0
1883270|NCT02725671|6494650|P1|Overall Study|Lost to Follow-up|1
1883271|NCT02709538|6494657|P3|Overall Study|Other|5
1883272|NCT02709538|6494658|P2|Overall Study|Other|7
1883273|NCT02709538|6494659|P1|Overall Study|Other|16
1883274|NCT02709538|6494657|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
1883275|NCT02709538|6494658|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
1883276|NCT02709538|6494659|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
1883277|NCT02709538|6494657|P3|Overall Study|Protocol deviation|4
1883278|NCT02709538|6494658|P2|Overall Study|Protocol deviation|4
1883279|NCT02709538|6494659|P1|Overall Study|Protocol deviation|10
1883280|NCT02709538|6494657|P3|Overall Study|Non-compliance with study drug|0
1883281|NCT02709538|6494658|P2|Overall Study|Non-compliance with study drug|0
1883282|NCT02709538|6494659|P1|Overall Study|Non-compliance with study drug|2
1883283|NCT02709538|6494657|P3|Overall Study|Non-compliance with study procedures|0
1883284|NCT02709538|6494658|P2|Overall Study|Non-compliance with study procedures|0
1883285|NCT02709538|6494659|P1|Overall Study|Non-compliance with study procedures|5
1883286|NCT02709538|6494657|P3|Overall Study|Withdrawal by Subject|4
1883287|NCT02709538|6494658|P2|Overall Study|Withdrawal by Subject|7
1883288|NCT02709538|6494659|P1|Overall Study|Withdrawal by Subject|40
1883289|NCT02709538|6494657|P3|Overall Study|Physician Decision|0
1883290|NCT02709538|6494658|P2|Overall Study|Physician Decision|0
1883291|NCT02709538|6494659|P1|Overall Study|Physician Decision|1
1883292|NCT02709538|6494657|P3|Overall Study|Lost to Follow-up|4
1883293|NCT02709538|6494658|P2|Overall Study|Lost to Follow-up|8
1883294|NCT02709538|6494659|P1|Overall Study|Lost to Follow-up|24
1883295|NCT02709538|6494657|P3|Overall Study|Lack of Efficacy|0
1883296|NCT02709538|6494658|P2|Overall Study|Lack of Efficacy|0
1883297|NCT02709538|6494659|P1|Overall Study|Lack of Efficacy|1
1883298|NCT02709538|6494657|P3|Overall Study|Adverse Event|3
1883299|NCT02709538|6494658|P2|Overall Study|Adverse Event|2
1883300|NCT02709538|6494659|P1|Overall Study|Adverse Event|13
1883301|NCT02706873|6494671|P4|Overall Study|Ongoing|1
1883302|NCT02706873|6494672|P3|Overall Study|Ongoing|0
1883303|NCT02706873|6494673|P2|Overall Study|Ongoing|0
1883304|NCT02706873|6494674|P1|Overall Study|Ongoing|0
1883305|NCT02706873|6494671|P4|Overall Study|Not Dosed|1
1883306|NCT02706873|6494672|P3|Overall Study|Not Dosed|0
1883307|NCT02706873|6494673|P2|Overall Study|Not Dosed|0
1883308|NCT02706873|6494674|P1|Overall Study|Not Dosed|1
1883309|NCT02706873|6494671|P4|Overall Study|Other|3
1883310|NCT02706873|6494672|P3|Overall Study|Other|2
1883311|NCT02706873|6494673|P2|Overall Study|Other|1
1883312|NCT02706873|6494674|P1|Overall Study|Other|5
1883313|NCT02706873|6494671|P4|Overall Study|Lack of Efficacy|3
1883314|NCT02706873|6494672|P3|Overall Study|Lack of Efficacy|0
1883315|NCT02706873|6494673|P2|Overall Study|Lack of Efficacy|0
1883316|NCT02706873|6494674|P1|Overall Study|Lack of Efficacy|10
1883317|NCT02706873|6494671|P4|Overall Study|Lost to Follow-up|2
1883318|NCT02706873|6494672|P3|Overall Study|Lost to Follow-up|4
1883319|NCT02706873|6494673|P2|Overall Study|Lost to Follow-up|0
1883320|NCT02706873|6494674|P1|Overall Study|Lost to Follow-up|3
1883321|NCT02706873|6494671|P4|Overall Study|Withdrawal by Subject|11
1883322|NCT02706873|6494672|P3|Overall Study|Withdrawal by Subject|8
1883323|NCT02706873|6494673|P2|Overall Study|Withdrawal by Subject|0
1883324|NCT02706873|6494674|P1|Overall Study|Withdrawal by Subject|15
1883325|NCT02706873|6494671|P4|Overall Study|Adverse Event|12
1883326|NCT02706873|6494672|P3|Overall Study|Adverse Event|13
1883327|NCT02706873|6494673|P2|Overall Study|Adverse Event|3
1883328|NCT02706873|6494674|P1|Overall Study|Adverse Event|13
1883329|NCT02706847|6494774|P4|Week 12 to Week 24|Other|4
1883330|NCT02706847|6494775|P3|Week 12 to Week 24|Other|1
1883331|NCT02706847|6494776|P2|Week 12 to Week 24|Other|0
1883332|NCT02706847|6494777|P1|Week 12 to Week 24|Other|1
1883333|NCT02706847|6494774|P4|Week 12 to Week 24|Lost to Follow-up|1
1883334|NCT02706847|6494775|P3|Week 12 to Week 24|Lost to Follow-up|0
1883335|NCT02706847|6494776|P2|Week 12 to Week 24|Lost to Follow-up|0
1883336|NCT02706847|6494777|P1|Week 12 to Week 24|Lost to Follow-up|0
1883337|NCT02706847|6494774|P4|Week 12 to Week 24|Withdrawal by Subject|4
1883338|NCT02706847|6494775|P3|Week 12 to Week 24|Withdrawal by Subject|1
1883339|NCT02706847|6494776|P2|Week 12 to Week 24|Withdrawal by Subject|0
1883340|NCT02706847|6494777|P1|Week 12 to Week 24|Withdrawal by Subject|1
1883341|NCT02706847|6494774|P4|Week 12 to Week 24|Adverse Event|5
1883342|NCT02706847|6494775|P3|Week 12 to Week 24|Adverse Event|2
1883343|NCT02706847|6494776|P2|Week 12 to Week 24|Adverse Event|2
1883344|NCT02706847|6494777|P1|Week 12 to Week 24|Adverse Event|1
1883345|NCT02706847|6494774|P4|Day 1 to Week 12|Randomized in Error|0
1883346|NCT02706847|6494775|P3|Day 1 to Week 12|Randomized in Error|1
1883347|NCT02706847|6494776|P2|Day 1 to Week 12|Randomized in Error|0
1883348|NCT02706847|6494777|P1|Day 1 to Week 12|Randomized in Error|0
1883349|NCT02706847|6494774|P4|Day 1 to Week 12|Other|2
1883350|NCT02706847|6494775|P3|Day 1 to Week 12|Other|2
1883351|NCT02706847|6494776|P2|Day 1 to Week 12|Other|4
1883352|NCT02706847|6494777|P1|Day 1 to Week 12|Other|4
1883353|NCT02706847|6494774|P4|Day 1 to Week 12|Lost to Follow-up|0
1883354|NCT02706847|6494775|P3|Day 1 to Week 12|Lost to Follow-up|0
1883355|NCT02706847|6494776|P2|Day 1 to Week 12|Lost to Follow-up|1
1883356|NCT02706847|6494777|P1|Day 1 to Week 12|Lost to Follow-up|2
1883357|NCT02706847|6494774|P4|Day 1 to Week 12|Withdrawal by Subject|2
1883358|NCT02706847|6494775|P3|Day 1 to Week 12|Withdrawal by Subject|4
1883359|NCT02706847|6494776|P2|Day 1 to Week 12|Withdrawal by Subject|1
1883360|NCT02706847|6494777|P1|Day 1 to Week 12|Withdrawal by Subject|2
1883361|NCT02706847|6494774|P4|Day 1 to Week 12|Adverse Event|12
1883362|NCT02706847|6494775|P3|Day 1 to Week 12|Adverse Event|1
1883363|NCT02706847|6494776|P2|Day 1 to Week 12|Adverse Event|2
1883364|NCT02706847|6494777|P1|Day 1 to Week 12|Adverse Event|2
1883365|NCT02693834|6494823|P2|Week 2 Practice|Adverse Event|1
1883366|NCT02693834|6494824|P1|Week 2 Practice|Adverse Event|0
1883367|NCT02693834|6494823|P2|Baseline Measurement|Adverse Event|0
1883368|NCT02693834|6494824|P1|Baseline Measurement|Adverse Event|1
1883369|NCT02693834|6494823|P2|Baseline Measurement|Withdrawal by Subject|0
1883370|NCT02693834|6494824|P1|Baseline Measurement|Withdrawal by Subject|1
1883371|NCT02692716|6494834|P2|Overall Study|Withdrawal by Subject|1
1883372|NCT02692716|6494835|P1|Overall Study|Withdrawal by Subject|3
1883373|NCT02692716|6494834|P2|Overall Study|Lost to Follow-up|5
1883374|NCT02692716|6494835|P1|Overall Study|Lost to Follow-up|2
1883375|NCT02689206|6494880|P5|Overall Study|Withdrawal by Subject|0
1883376|NCT02689206|6494881|P4|Overall Study|Withdrawal by Subject|0
1883377|NCT02689206|6494882|P3|Overall Study|Withdrawal by Subject|1
1883378|NCT02689206|6494883|P2|Overall Study|Withdrawal by Subject|0
1883379|NCT02689206|6494884|P1|Overall Study|Withdrawal by Subject|1
1883380|NCT02689206|6494880|P5|Overall Study|Physician Decision|0
1883381|NCT02689206|6494881|P4|Overall Study|Physician Decision|0
1883382|NCT02689206|6494882|P3|Overall Study|Physician Decision|0
1883383|NCT02689206|6494883|P2|Overall Study|Physician Decision|0
1883384|NCT02689206|6494884|P1|Overall Study|Physician Decision|1
1883385|NCT02689206|6494880|P5|Overall Study|Other: Reached stopping criteria|4
1883386|NCT02689206|6494881|P4|Overall Study|Other: Reached stopping criteria|3
1883387|NCT02689206|6494882|P3|Overall Study|Other: Reached stopping criteria|2
1883388|NCT02689206|6494883|P2|Overall Study|Other: Reached stopping criteria|1
1883389|NCT02689206|6494884|P1|Overall Study|Other: Reached stopping criteria|0
1883390|NCT02689206|6494880|P5|Overall Study|Protocol Violation|2
1883391|NCT02689206|6494881|P4|Overall Study|Protocol Violation|1
1883392|NCT02689206|6494882|P3|Overall Study|Protocol Violation|0
1883393|NCT02689206|6494883|P2|Overall Study|Protocol Violation|0
1883394|NCT02689206|6494884|P1|Overall Study|Protocol Violation|1
1883395|NCT02689206|6494880|P5|Overall Study|Adverse Event|2
1883396|NCT02689206|6494881|P4|Overall Study|Adverse Event|0
1883397|NCT02689206|6494882|P3|Overall Study|Adverse Event|1
1883398|NCT02689206|6494883|P2|Overall Study|Adverse Event|0
1883399|NCT02689206|6494884|P1|Overall Study|Adverse Event|0
1883400|NCT02680756|6495123|P2|Overall Study|other|2
1883401|NCT02680756|6495124|P1|Overall Study|other|3
1883402|NCT02680756|6495123|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
1883403|NCT02680756|6495124|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
1883404|NCT02680756|6495123|P2|Overall Study|Protocol Violation|0
1883405|NCT02680756|6495124|P1|Overall Study|Protocol Violation|1
1883406|NCT02680756|6495123|P2|Overall Study|Death|0
1883407|NCT02680756|6495124|P1|Overall Study|Death|1
1883408|NCT02680756|6495123|P2|Overall Study|Blood transfusion for any reason|1
1883409|NCT02680756|6495124|P1|Overall Study|Blood transfusion for any reason|0
1883410|NCT02680756|6495123|P2|Overall Study|Hb ≤7.5 g/dL|2
1883411|NCT02680756|6495124|P1|Overall Study|Hb ≤7.5 g/dL|0
1883412|NCT02680756|6495123|P2|Overall Study|Physician Decision|1
1883413|NCT02680756|6495124|P1|Overall Study|Physician Decision|4
1883414|NCT02680756|6495123|P2|Overall Study|Withdrawal by Subject|5
1883415|NCT02680756|6495124|P1|Overall Study|Withdrawal by Subject|5
1883416|NCT02680756|6495123|P2|Overall Study|Lost to Follow-up|6
1883417|NCT02680756|6495124|P1|Overall Study|Lost to Follow-up|7
1883418|NCT02680756|6495123|P2|Overall Study|Adverse Event|2
1883419|NCT02680756|6495124|P1|Overall Study|Adverse Event|10
1883420|NCT02679573|6495158|P2|Overall Study|Lost to Follow-up|3
1883421|NCT02679573|6495159|P1|Overall Study|Lost to Follow-up|0
1883422|NCT02679573|6495158|P2|Overall Study|Physician Decision|4
1883423|NCT02679573|6495159|P1|Overall Study|Physician Decision|2
1883424|NCT02679573|6495158|P2|Overall Study|Death|0
1883425|NCT02679573|6495159|P1|Overall Study|Death|2
1883426|NCT02679573|6495158|P2|Overall Study|Withdrawal by Subject|9
1883427|NCT02679573|6495159|P1|Overall Study|Withdrawal by Subject|2
1883428|NCT02679573|6495158|P2|Overall Study|Could not complete required study visits|2
1883429|NCT02679573|6495159|P1|Overall Study|Could not complete required study visits|6
1883430|NCT02679573|6495158|P2|Overall Study|Lack of Efficacy|15
1883431|NCT02679573|6495159|P1|Overall Study|Lack of Efficacy|12
1883432|NCT02679573|6495158|P2|Overall Study|Adverse Event|6
1883433|NCT02679573|6495159|P1|Overall Study|Adverse Event|13
1883434|NCT02645409|6495207|P2|Overall Study|Physician Decision|0
1883435|NCT02645409|6495208|P1|Overall Study|Physician Decision|1
1883436|NCT02645409|6495207|P2|Overall Study|Withdrawal by Subject|0
1883437|NCT02645409|6495208|P1|Overall Study|Withdrawal by Subject|3
1883438|NCT02638103|6495217|P4|Overall Study|Other than specified|4
1883439|NCT02638103|6495218|P3|Overall Study|Other than specified|2
1883440|NCT02638103|6495219|P2|Overall Study|Other than specified|4
1883441|NCT02638103|6495220|P1|Overall Study|Other than specified|5
1883442|NCT02638103|6495217|P4|Overall Study|Lack of Efficacy|22
1883443|NCT02638103|6495218|P3|Overall Study|Lack of Efficacy|12
1883444|NCT02638103|6495219|P2|Overall Study|Lack of Efficacy|10
1883445|NCT02638103|6495220|P1|Overall Study|Lack of Efficacy|14
1883446|NCT02638103|6495217|P4|Overall Study|Lost to Follow-up|37
1883447|NCT02638103|6495218|P3|Overall Study|Lost to Follow-up|20
1883448|NCT02638103|6495219|P2|Overall Study|Lost to Follow-up|33
1883449|NCT02638103|6495220|P1|Overall Study|Lost to Follow-up|26
1883450|NCT02638103|6495217|P4|Overall Study|Non-compliance to Study Procedures|1
1883451|NCT02638103|6495218|P3|Overall Study|Non-compliance to Study Procedures|1
1883452|NCT02638103|6495219|P2|Overall Study|Non-compliance to Study Procedures|1
1883453|NCT02638103|6495220|P1|Overall Study|Non-compliance to Study Procedures|2
1883454|NCT02638103|6495217|P4|Overall Study|Pregnancy|1
1883455|NCT02638103|6495218|P3|Overall Study|Pregnancy|0
1883456|NCT02638103|6495219|P2|Overall Study|Pregnancy|3
1883457|NCT02638103|6495220|P1|Overall Study|Pregnancy|2
1883458|NCT02638103|6495217|P4|Overall Study|Protocol Violation|4
1883459|NCT02638103|6495218|P3|Overall Study|Protocol Violation|1
1883460|NCT02638103|6495219|P2|Overall Study|Protocol Violation|2
1883461|NCT02638103|6495220|P1|Overall Study|Protocol Violation|1
1883462|NCT02638103|6495217|P4|Overall Study|Withdrawal by Subject|61
1883463|NCT02638103|6495218|P3|Overall Study|Withdrawal by Subject|30
1883464|NCT02638103|6495219|P2|Overall Study|Withdrawal by Subject|53
1883465|NCT02638103|6495220|P1|Overall Study|Withdrawal by Subject|43
1883466|NCT02638103|6495217|P4|Overall Study|Adverse Event|12
1883467|NCT02638103|6495218|P3|Overall Study|Adverse Event|19
1883468|NCT02638103|6495219|P2|Overall Study|Adverse Event|12
1883469|NCT02638103|6495220|P1|Overall Study|Adverse Event|13
1883470|NCT02607865|6495332|P4|Overall Study|Unclassified|0
1883471|NCT02607865|6495333|P3|Overall Study|Unclassified|2
1883472|NCT02607865|6495334|P2|Overall Study|Unclassified|1
1883473|NCT02607865|6495335|P1|Overall Study|Unclassified|1
1883474|NCT02607865|6495332|P4|Overall Study|Death|3
1883475|NCT02607865|6495333|P3|Overall Study|Death|1
1883476|NCT02607865|6495334|P2|Overall Study|Death|4
1883477|NCT02607865|6495335|P1|Overall Study|Death|5
1883478|NCT02607865|6495332|P4|Overall Study|Withdrawal by Subject|8
1883479|NCT02607865|6495333|P3|Overall Study|Withdrawal by Subject|17
1883480|NCT02607865|6495334|P2|Overall Study|Withdrawal by Subject|18
1883481|NCT02607865|6495335|P1|Overall Study|Withdrawal by Subject|18
1883482|NCT02607865|6495332|P4|Overall Study|Lost to Follow-up|5
1883483|NCT02607865|6495333|P3|Overall Study|Lost to Follow-up|7
1883484|NCT02607865|6495334|P2|Overall Study|Lost to Follow-up|7
1883485|NCT02607865|6495335|P1|Overall Study|Lost to Follow-up|9
1883486|NCT02607306|6495510|P3|Overall Study|Protocol Violation|1
1883487|NCT02607306|6495511|P2|Overall Study|Protocol Violation|2
1883488|NCT02607306|6495512|P1|Overall Study|Protocol Violation|4
1883489|NCT02607306|6495510|P3|Overall Study|Lack of Efficacy|1
1883490|NCT02607306|6495511|P2|Overall Study|Lack of Efficacy|1
1883491|NCT02607306|6495512|P1|Overall Study|Lack of Efficacy|0
1883492|NCT02607306|6495510|P3|Overall Study|Withdrawal by Subject|2
1883493|NCT02607306|6495511|P2|Overall Study|Withdrawal by Subject|10
1883494|NCT02607306|6495512|P1|Overall Study|Withdrawal by Subject|8
1883495|NCT02607306|6495510|P3|Overall Study|Unclassified|0
1883496|NCT02607306|6495511|P2|Overall Study|Unclassified|4
1883497|NCT02607306|6495512|P1|Overall Study|Unclassified|1
1883498|NCT02607306|6495510|P3|Overall Study|Adverse Event|6
1883499|NCT02607306|6495511|P2|Overall Study|Adverse Event|6
1883500|NCT02607306|6495512|P1|Overall Study|Adverse Event|8
1883501|NCT02592434|6495632|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
1883502|NCT02592434|6495633|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
1883503|NCT02592434|6495634|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
1883504|NCT02592434|6495632|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
1883505|NCT02592434|6495633|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
1883506|NCT02592434|6495634|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
1883507|NCT02592434|6495632|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
1883508|NCT02592434|6495633|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
1883509|NCT02592434|6495634|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
1883510|NCT02592434|6495632|P3|Double Blind Phase (26 Weeks)|Other|0
1883511|NCT02592434|6495633|P2|Double Blind Phase (26 Weeks)|Other|1
1883512|NCT02592434|6495634|P1|Double Blind Phase (26 Weeks)|Other|0
1883513|NCT02592434|6495632|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
1883514|NCT02592434|6495633|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
1883515|NCT02592434|6495634|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
1883516|NCT02592434|6495632|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
1883517|NCT02592434|6495633|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
1883518|NCT02592434|6495634|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
1883519|NCT02592434|6495632|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
1883520|NCT02592434|6495633|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
1883521|NCT02592434|6495634|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
1883522|NCT02592434|6495632|P3|Open-Label Phase (18 Weeks)|Other|0
1883523|NCT02592434|6495633|P2|Open-Label Phase (18 Weeks)|Other|0
1883524|NCT02592434|6495634|P1|Open-Label Phase (18 Weeks)|Other|3
1883525|NCT02592434|6495632|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
1883526|NCT02592434|6495633|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
1883527|NCT02592434|6495634|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
1883528|NCT02592434|6495632|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
1883529|NCT02592434|6495633|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
1883530|NCT02592434|6495634|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
1883531|NCT02588092|6495760|P10|Overall Study|Sponsor Decision|1
1883532|NCT02588092|6495761|P9|Overall Study|Sponsor Decision|1
1883533|NCT02588092|6495762|P8|Overall Study|Sponsor Decision|0
1883534|NCT02588092|6495763|P7|Overall Study|Sponsor Decision|0
1883535|NCT02588092|6495764|P6|Overall Study|Sponsor Decision|0
1883536|NCT02588092|6495765|P5|Overall Study|Sponsor Decision|0
1883537|NCT02588092|6495766|P4|Overall Study|Sponsor Decision|0
1883538|NCT02588092|6495767|P3|Overall Study|Sponsor Decision|0
1883539|NCT02588092|6495768|P2|Overall Study|Sponsor Decision|0
1883540|NCT02588092|6495769|P1|Overall Study|Sponsor Decision|0
1883541|NCT02588092|6495760|P10|Overall Study|Started Another Treatment|0
1883542|NCT02588092|6495761|P9|Overall Study|Started Another Treatment|0
1883543|NCT02588092|6495762|P8|Overall Study|Started Another Treatment|1
1883544|NCT02588092|6495763|P7|Overall Study|Started Another Treatment|0
1883545|NCT02588092|6495764|P6|Overall Study|Started Another Treatment|0
1883546|NCT02588092|6495765|P5|Overall Study|Started Another Treatment|1
1883547|NCT02588092|6495766|P4|Overall Study|Started Another Treatment|0
1883548|NCT02588092|6495767|P3|Overall Study|Started Another Treatment|0
1883549|NCT02588092|6495768|P2|Overall Study|Started Another Treatment|0
1883550|NCT02588092|6495769|P1|Overall Study|Started Another Treatment|0
1883551|NCT02588092|6495760|P10|Overall Study|Withdrawal by Subject|0
1883552|NCT02588092|6495761|P9|Overall Study|Withdrawal by Subject|0
1883553|NCT02588092|6495762|P8|Overall Study|Withdrawal by Subject|2
1883554|NCT02588092|6495763|P7|Overall Study|Withdrawal by Subject|1
1883555|NCT02588092|6495764|P6|Overall Study|Withdrawal by Subject|1
1883556|NCT02588092|6495765|P5|Overall Study|Withdrawal by Subject|0
1883557|NCT02588092|6495766|P4|Overall Study|Withdrawal by Subject|0
1883558|NCT02588092|6495767|P3|Overall Study|Withdrawal by Subject|0
1883559|NCT02588092|6495768|P2|Overall Study|Withdrawal by Subject|0
1883560|NCT02588092|6495769|P1|Overall Study|Withdrawal by Subject|0
1883561|NCT02588092|6495760|P10|Overall Study|Death|2
1883562|NCT02588092|6495761|P9|Overall Study|Death|5
1883563|NCT02588092|6495762|P8|Overall Study|Death|1
1883564|NCT02588092|6495763|P7|Overall Study|Death|2
1883565|NCT02588092|6495764|P6|Overall Study|Death|2
1883566|NCT02588092|6495765|P5|Overall Study|Death|2
1883567|NCT02588092|6495766|P4|Overall Study|Death|3
1883568|NCT02588092|6495767|P3|Overall Study|Death|3
1883569|NCT02588092|6495768|P2|Overall Study|Death|3
1883570|NCT02588092|6495769|P1|Overall Study|Death|4
1883571|NCT02579759|6495966|P3|Overall Study|Lost to Follow-up|2
1883572|NCT02579759|6495967|P2|Overall Study|Lost to Follow-up|2
1883573|NCT02579759|6495968|P1|Overall Study|Lost to Follow-up|2
1883574|NCT02579759|6495966|P3|Overall Study|Withdrawal by Subject|5
1883575|NCT02579759|6495967|P2|Overall Study|Withdrawal by Subject|3
1883576|NCT02579759|6495968|P1|Overall Study|Withdrawal by Subject|3
1883577|NCT02579759|6495966|P3|Overall Study|Adverse Event|1
1883578|NCT02579759|6495967|P2|Overall Study|Adverse Event|3
1883579|NCT02579759|6495968|P1|Overall Study|Adverse Event|4
1883580|NCT02579759|6495966|P3|Overall Study|Inclusion/exclusion criteria|1
1883581|NCT02579759|6495967|P2|Overall Study|Inclusion/exclusion criteria|0
1883582|NCT02579759|6495968|P1|Overall Study|Inclusion/exclusion criteria|0
1883583|NCT02579759|6495966|P3|Overall Study|Pregnancy|0
1883584|NCT02579759|6495967|P2|Overall Study|Pregnancy|1
1883585|NCT02579759|6495968|P1|Overall Study|Pregnancy|0
1883586|NCT02579759|6495966|P3|Overall Study|Non compliance|0
1883587|NCT02579759|6495967|P2|Overall Study|Non compliance|1
1883588|NCT02579759|6495968|P1|Overall Study|Non compliance|0
1883589|NCT02579759|6495966|P3|Overall Study|Sponsor stopped Dose 2|0
1883590|NCT02579759|6495967|P2|Overall Study|Sponsor stopped Dose 2|41
1883591|NCT02579759|6495968|P1|Overall Study|Sponsor stopped Dose 2|0
1883592|NCT02579759|6495966|P3|Overall Study|BfArM hold|12
1883593|NCT02579759|6495967|P2|Overall Study|BfArM hold|12
1883594|NCT02579759|6495968|P1|Overall Study|BfArM hold|13
1883595|NCT02579759|6495966|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
1883596|NCT02579759|6495967|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
1883597|NCT02579759|6495968|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
1883598|NCT02579759|6495966|P3|Overall Study|Protocol Violation|0
1883599|NCT02579759|6495967|P2|Overall Study|Protocol Violation|0
1883600|NCT02579759|6495968|P1|Overall Study|Protocol Violation|2
1883601|NCT02576678|6496015|P3|Overall Study|Miscellaneous|0
1883602|NCT02576678|6496016|P2|Overall Study|Miscellaneous|0
1883603|NCT02576678|6496017|P1|Overall Study|Miscellaneous|2
1883604|NCT02576678|6496015|P3|Overall Study|Lost to Follow-up|1
1883605|NCT02576678|6496016|P2|Overall Study|Lost to Follow-up|0
1883606|NCT02576678|6496017|P1|Overall Study|Lost to Follow-up|0
1883607|NCT02576678|6496015|P3|Overall Study|Withdrawal by Subject|2
1883608|NCT02576678|6496016|P2|Overall Study|Withdrawal by Subject|1
1883609|NCT02576678|6496017|P1|Overall Study|Withdrawal by Subject|3
1883610|NCT02576678|6496015|P3|Overall Study|Adverse Event|2
1883611|NCT02576678|6496016|P2|Overall Study|Adverse Event|0
1883612|NCT02576678|6496017|P1|Overall Study|Adverse Event|0
1883613|NCT02552966|6496049|P1|Overall Study|Withdrawal by Subject|3
1883614|NCT02552966|6496049|P1|Overall Study|Lost to Follow-up|2
1883615|NCT02550652|6496058|P2|Overall Study|Ongoing in study|56
1883616|NCT02550652|6496059|P1|Overall Study|Ongoing in study|59
1883617|NCT02550652|6496058|P2|Overall Study|Withdrawal by Subject|4
1883618|NCT02550652|6496059|P1|Overall Study|Withdrawal by Subject|3
1883619|NCT02550652|6496058|P2|Overall Study|Lack of Efficacy|0
1883620|NCT02550652|6496059|P1|Overall Study|Lack of Efficacy|1
1883621|NCT02550652|6496058|P2|Overall Study|Death|2
1883622|NCT02550652|6496059|P1|Overall Study|Death|0
1883623|NCT02550106|6496101|P1|Overall Study|Withdrawal by Subject|2
1883624|NCT02550106|6496101|P1|Overall Study|Protocol Violation|6
1883625|NCT02550106|6496101|P1|Overall Study|Lack of Efficacy|3
1883626|NCT02550106|6496101|P1|Overall Study|Adverse Event|1
1883627|NCT02541604|6496137|P12|Overall Study|Medical condition may jeopardize safety|0
1883628|NCT02541604|6496138|P11|Overall Study|Medical condition may jeopardize safety|0
1883629|NCT02541604|6496139|P10|Overall Study|Medical condition may jeopardize safety|0
1883630|NCT02541604|6496140|P9|Overall Study|Medical condition may jeopardize safety|0
1883631|NCT02541604|6496141|P8|Overall Study|Medical condition may jeopardize safety|1
1883632|NCT02541604|6496142|P7|Overall Study|Medical condition may jeopardize safety|0
1883633|NCT02541604|6496143|P6|Overall Study|Medical condition may jeopardize safety|0
1883634|NCT02541604|6496144|P5|Overall Study|Medical condition may jeopardize safety|0
1883635|NCT02541604|6496145|P4|Overall Study|Medical condition may jeopardize safety|0
1883636|NCT02541604|6496146|P3|Overall Study|Medical condition may jeopardize safety|0
1883637|NCT02541604|6496147|P2|Overall Study|Medical condition may jeopardize safety|0
1883638|NCT02541604|6496148|P1|Overall Study|Medical condition may jeopardize safety|0
1883639|NCT02541604|6496137|P12|Overall Study|Study Terminated by Sponsor|0
1883640|NCT02541604|6496138|P11|Overall Study|Study Terminated by Sponsor|0
1883641|NCT02541604|6496139|P10|Overall Study|Study Terminated by Sponsor|0
1883642|NCT02541604|6496140|P9|Overall Study|Study Terminated by Sponsor|0
1883643|NCT02541604|6496141|P8|Overall Study|Study Terminated by Sponsor|0
1883644|NCT02541604|6496142|P7|Overall Study|Study Terminated by Sponsor|0
1883645|NCT02541604|6496143|P6|Overall Study|Study Terminated by Sponsor|0
1883646|NCT02541604|6496144|P5|Overall Study|Study Terminated by Sponsor|0
1883647|NCT02541604|6496145|P4|Overall Study|Study Terminated by Sponsor|1
1883648|NCT02541604|6496146|P3|Overall Study|Study Terminated by Sponsor|2
1883649|NCT02541604|6496147|P2|Overall Study|Study Terminated by Sponsor|4
1883650|NCT02541604|6496148|P1|Overall Study|Study Terminated by Sponsor|1
1883651|NCT02541604|6496137|P12|Overall Study|Withdrawal by Subject|0
1883652|NCT02541604|6496138|P11|Overall Study|Withdrawal by Subject|0
1883653|NCT02541604|6496139|P10|Overall Study|Withdrawal by Subject|0
1883654|NCT02541604|6496140|P9|Overall Study|Withdrawal by Subject|1
1883655|NCT02541604|6496141|P8|Overall Study|Withdrawal by Subject|0
1883656|NCT02541604|6496142|P7|Overall Study|Withdrawal by Subject|0
1883657|NCT02541604|6496143|P6|Overall Study|Withdrawal by Subject|1
1883658|NCT02541604|6496144|P5|Overall Study|Withdrawal by Subject|1
1883659|NCT02541604|6496145|P4|Overall Study|Withdrawal by Subject|0
1883660|NCT02541604|6496146|P3|Overall Study|Withdrawal by Subject|1
1883661|NCT02541604|6496147|P2|Overall Study|Withdrawal by Subject|0
1883662|NCT02541604|6496148|P1|Overall Study|Withdrawal by Subject|2
1883663|NCT02541604|6496137|P12|Overall Study|Lost to Follow-up|0
1883664|NCT02541604|6496138|P11|Overall Study|Lost to Follow-up|0
1883665|NCT02541604|6496139|P10|Overall Study|Lost to Follow-up|0
1883666|NCT02541604|6496140|P9|Overall Study|Lost to Follow-up|0
1883667|NCT02541604|6496141|P8|Overall Study|Lost to Follow-up|0
1883668|NCT02541604|6496142|P7|Overall Study|Lost to Follow-up|1
1883669|NCT02541604|6496143|P6|Overall Study|Lost to Follow-up|1
1883670|NCT02541604|6496144|P5|Overall Study|Lost to Follow-up|0
1883671|NCT02541604|6496145|P4|Overall Study|Lost to Follow-up|0
1883672|NCT02541604|6496146|P3|Overall Study|Lost to Follow-up|1
1883673|NCT02541604|6496147|P2|Overall Study|Lost to Follow-up|0
1883674|NCT02541604|6496148|P1|Overall Study|Lost to Follow-up|2
1883675|NCT02541604|6496137|P12|Overall Study|Death|3
1883676|NCT02541604|6496138|P11|Overall Study|Death|2
1883677|NCT02541604|6496139|P10|Overall Study|Death|4
1883678|NCT02541604|6496140|P9|Overall Study|Death|3
1883679|NCT02541604|6496141|P8|Overall Study|Death|9
1883680|NCT02541604|6496142|P7|Overall Study|Death|9
1883681|NCT02541604|6496143|P6|Overall Study|Death|8
1883682|NCT02541604|6496144|P5|Overall Study|Death|9
1883683|NCT02541604|6496145|P4|Overall Study|Death|2
1883684|NCT02541604|6496146|P3|Overall Study|Death|7
1883685|NCT02541604|6496147|P2|Overall Study|Death|5
1883686|NCT02541604|6496148|P1|Overall Study|Death|6
1883687|NCT02539225|6496255|P2|Part B|Physician Decision|9
1883688|NCT02539225|6496256|P1|Part B|Physician Decision|0
1883689|NCT02539225|6496255|P2|Part B|Withdrawal by Subject|3
1883690|NCT02539225|6496256|P1|Part B|Withdrawal by Subject|0
1883691|NCT02539225|6496255|P2|Part B|Adverse Event|4
1883692|NCT02539225|6496256|P1|Part B|Adverse Event|4
1883693|NCT02539225|6496255|P2|Pre Treatment for Part B|Physician Decision|0
1883694|NCT02539225|6496256|P1|Pre Treatment for Part B|Physician Decision|2
1883695|NCT02539225|6496255|P2|Pre Treatment for Part B|Withdrawal by Subject|0
1883696|NCT02539225|6496256|P1|Pre Treatment for Part B|Withdrawal by Subject|1
1883697|NCT02539225|6496255|P2|Pre Treatment for Part B|Adverse Event|1
1883698|NCT02539225|6496256|P1|Pre Treatment for Part B|Adverse Event|1
1883699|NCT02539225|6496255|P2|Pre Treatment for Part B|Progressive disease|1
1883700|NCT02539225|6496256|P1|Pre Treatment for Part B|Progressive disease|1
1883701|NCT02539225|6496255|P2|Part A|Did Not Receive study Drug|1
1883702|NCT02539225|6496256|P1|Part A|Did Not Receive study Drug|1
1883703|NCT02539225|6496255|P2|Part A|Physician Decision|7
1883704|NCT02539225|6496256|P1|Part A|Physician Decision|4
1883705|NCT02539225|6496255|P2|Part A|Withdrawal by Subject|4
1883706|NCT02539225|6496256|P1|Part A|Withdrawal by Subject|2
1883707|NCT02539225|6496255|P2|Part A|Adverse Event|4
1883708|NCT02539225|6496256|P1|Part A|Adverse Event|13
1883709|NCT02538666|6496280|P3|Overall Study|Withdrew Consent|1
1883710|NCT02538666|6496281|P2|Overall Study|Withdrew Consent|1
1883711|NCT02538666|6496282|P1|Overall Study|Withdrew Consent|0
1883712|NCT02538666|6496280|P3|Overall Study|no longer meets study criteria|0
1883713|NCT02538666|6496281|P2|Overall Study|no longer meets study criteria|0
1883714|NCT02538666|6496282|P1|Overall Study|no longer meets study criteria|1
1883715|NCT02538666|6496280|P3|Overall Study|Disease progression|0
1883716|NCT02538666|6496281|P2|Overall Study|Disease progression|0
1883717|NCT02538666|6496282|P1|Overall Study|Disease progression|1
1883718|NCT02532374|6496301|P1|Overall Study|Physician Decision|1
1883719|NCT02532374|6496301|P1|Overall Study|Withdrawal by Subject|1
1883720|NCT02528253|6496330|P5|Overall Study|Withdrawn Due to Pregnancy|1
1883721|NCT02528253|6496331|P4|Overall Study|Withdrawn Due to Pregnancy|0
1883722|NCT02528253|6496332|P3|Overall Study|Withdrawn Due to Pregnancy|0
1883723|NCT02528253|6496333|P2|Overall Study|Withdrawn Due to Pregnancy|1
1883724|NCT02528253|6496334|P1|Overall Study|Withdrawn Due to Pregnancy|0
1883725|NCT02528253|6496330|P5|Overall Study|Protocol Violation|4
1883726|NCT02528253|6496331|P4|Overall Study|Protocol Violation|0
1883727|NCT02528253|6496332|P3|Overall Study|Protocol Violation|4
1883728|NCT02528253|6496333|P2|Overall Study|Protocol Violation|2
1883729|NCT02528253|6496334|P1|Overall Study|Protocol Violation|1
1883730|NCT02528253|6496330|P5|Overall Study|Withdrawal by Subject|73
1883731|NCT02528253|6496331|P4|Overall Study|Withdrawal by Subject|48
1883732|NCT02528253|6496332|P3|Overall Study|Withdrawal by Subject|29
1883733|NCT02528253|6496333|P2|Overall Study|Withdrawal by Subject|20
1883734|NCT02528253|6496334|P1|Overall Study|Withdrawal by Subject|25
1883735|NCT02528253|6496330|P5|Overall Study|Other|76
1883736|NCT02528253|6496331|P4|Overall Study|Other|52
1883737|NCT02528253|6496332|P3|Overall Study|Other|58
1883738|NCT02528253|6496333|P2|Overall Study|Other|22
1883739|NCT02528253|6496334|P1|Overall Study|Other|21
1883740|NCT02528253|6496330|P5|Overall Study|Lost to Follow-up|34
1883741|NCT02528253|6496331|P4|Overall Study|Lost to Follow-up|16
1883742|NCT02528253|6496332|P3|Overall Study|Lost to Follow-up|31
1883743|NCT02528253|6496333|P2|Overall Study|Lost to Follow-up|9
1883744|NCT02528253|6496334|P1|Overall Study|Lost to Follow-up|16
1883745|NCT02528253|6496330|P5|Overall Study|Insufficient clinical response|16
1883746|NCT02528253|6496331|P4|Overall Study|Insufficient clinical response|12
1883747|NCT02528253|6496332|P3|Overall Study|Insufficient clinical response|13
1883748|NCT02528253|6496333|P2|Overall Study|Insufficient clinical response|10
1883749|NCT02528253|6496334|P1|Overall Study|Insufficient clinical response|7
1883750|NCT02528253|6496330|P5|Overall Study|Death|1
1883751|NCT02528253|6496331|P4|Overall Study|Death|0
1883752|NCT02528253|6496332|P3|Overall Study|Death|1
1883753|NCT02528253|6496333|P2|Overall Study|Death|2
1883754|NCT02528253|6496334|P1|Overall Study|Death|2
1883755|NCT02528253|6496330|P5|Overall Study|Adverse Event|18
1883756|NCT02528253|6496331|P4|Overall Study|Adverse Event|8
1883757|NCT02528253|6496332|P3|Overall Study|Adverse Event|4
1883758|NCT02528253|6496333|P2|Overall Study|Adverse Event|4
1883759|NCT02528253|6496334|P1|Overall Study|Adverse Event|3
1883760|NCT02510664|6496639|P3|Overall Study|Time Constraints|0
1883761|NCT02510664|6496640|P2|Overall Study|Time Constraints|1
1883762|NCT02510664|6496641|P1|Overall Study|Time Constraints|1
1883763|NCT02510664|6496639|P3|Overall Study|Provider Retired/No Time to Reschedule|0
1883764|NCT02510664|6496640|P2|Overall Study|Provider Retired/No Time to Reschedule|10
1883765|NCT02510664|6496641|P1|Overall Study|Provider Retired/No Time to Reschedule|10
1883766|NCT02510664|6496639|P3|Overall Study|Transferred Care|0
1883767|NCT02510664|6496640|P2|Overall Study|Transferred Care|9
1883768|NCT02510664|6496641|P1|Overall Study|Transferred Care|9
1883769|NCT02473965|6496696|P2|Overall Study|Physician Decision|2
1883770|NCT02473965|6496697|P1|Overall Study|Physician Decision|0
1883771|NCT02473965|6496696|P2|Overall Study|Withdrawal by Subject|3
1883772|NCT02473965|6496697|P1|Overall Study|Withdrawal by Subject|2
1883773|NCT02473965|6496696|P2|Overall Study|MG worsening|1
1883774|NCT02473965|6496697|P1|Overall Study|MG worsening|4
1883775|NCT02473965|6496696|P2|Overall Study|Adverse Event|4
1883776|NCT02473965|6496697|P1|Overall Study|Adverse Event|6
1883777|NCT02472795|6496712|P5|Overall Study|Withdrawal by Subject|1
1883778|NCT02472795|6496713|P4|Overall Study|Withdrawal by Subject|0
1883779|NCT02472795|6496714|P3|Overall Study|Withdrawal by Subject|0
1883780|NCT02472795|6496715|P2|Overall Study|Withdrawal by Subject|0
1883781|NCT02472795|6496716|P1|Overall Study|Withdrawal by Subject|0
1883782|NCT02472795|6496712|P5|Overall Study|Adverse Event|2
1883783|NCT02472795|6496713|P4|Overall Study|Adverse Event|0
1883784|NCT02472795|6496714|P3|Overall Study|Adverse Event|0
1883785|NCT02472795|6496715|P2|Overall Study|Adverse Event|1
1883786|NCT02472795|6496716|P1|Overall Study|Adverse Event|0
1883787|NCT02438384|6496751|P3|Overall Study|Lost to Follow-up|4
1883788|NCT02438384|6496752|P2|Overall Study|Lost to Follow-up|6
1883789|NCT02438384|6496753|P1|Overall Study|Lost to Follow-up|8
1883790|NCT02412722|6496807|P6|Overall Study|Reason not Specified|6
1883791|NCT02412722|6496808|P5|Overall Study|Reason not Specified|2
1883792|NCT02412722|6496809|P4|Overall Study|Reason not Specified|1
1883793|NCT02412722|6496810|P3|Overall Study|Reason not Specified|2
1883794|NCT02412722|6496811|P2|Overall Study|Reason not Specified|0
1883795|NCT02412722|6496812|P1|Overall Study|Reason not Specified|3
1883796|NCT02412722|6496807|P6|Overall Study|Received drug in run-in and discontinued|0
1883797|NCT02412722|6496808|P5|Overall Study|Received drug in run-in and discontinued|0
1883798|NCT02412722|6496809|P4|Overall Study|Received drug in run-in and discontinued|0
1883799|NCT02412722|6496810|P3|Overall Study|Received drug in run-in and discontinued|0
1883800|NCT02412722|6496811|P2|Overall Study|Received drug in run-in and discontinued|2
1883801|NCT02412722|6496812|P1|Overall Study|Received drug in run-in and discontinued|0
1883802|NCT02412722|6496807|P6|Overall Study|Lost to Follow-up|0
1883803|NCT02412722|6496808|P5|Overall Study|Lost to Follow-up|1
1883804|NCT02412722|6496809|P4|Overall Study|Lost to Follow-up|0
1883805|NCT02412722|6496810|P3|Overall Study|Lost to Follow-up|0
1883806|NCT02412722|6496811|P2|Overall Study|Lost to Follow-up|0
1883807|NCT02412722|6496812|P1|Overall Study|Lost to Follow-up|0
1883808|NCT02412722|6496807|P6|Overall Study|Withdrawal by Subject|1
1883809|NCT02412722|6496808|P5|Overall Study|Withdrawal by Subject|1
1883810|NCT02412722|6496809|P4|Overall Study|Withdrawal by Subject|2
1883811|NCT02412722|6496810|P3|Overall Study|Withdrawal by Subject|1
1883812|NCT02412722|6496811|P2|Overall Study|Withdrawal by Subject|0
1883813|NCT02412722|6496812|P1|Overall Study|Withdrawal by Subject|2
1883814|NCT02412722|6496807|P6|Overall Study|Progressive Disease|3
1883815|NCT02412722|6496808|P5|Overall Study|Progressive Disease|3
1883816|NCT02412722|6496809|P4|Overall Study|Progressive Disease|9
1883817|NCT02412722|6496810|P3|Overall Study|Progressive Disease|4
1883818|NCT02412722|6496811|P2|Overall Study|Progressive Disease|4
1883819|NCT02412722|6496812|P1|Overall Study|Progressive Disease|6
1883820|NCT02412722|6496807|P6|Overall Study|Adverse Event|3
1883821|NCT02412722|6496808|P5|Overall Study|Adverse Event|0
1883822|NCT02412722|6496809|P4|Overall Study|Adverse Event|3
1883823|NCT02412722|6496810|P3|Overall Study|Adverse Event|0
1883824|NCT02412722|6496811|P2|Overall Study|Adverse Event|2
1883825|NCT02412722|6496812|P1|Overall Study|Adverse Event|0
1883826|NCT02407236|6496888|P8|Maintenance Study (44 Weeks)|Other|1
1883827|NCT02407236|6496889|P7|Maintenance Study (44 Weeks)|Other|2
1883828|NCT02407236|6496890|P6|Maintenance Study (44 Weeks)|Other|1
1883829|NCT02407236|6496891|P5|Maintenance Study (44 Weeks)|Other|1
1883830|NCT02407236|6496892|P4|Maintenance Study (44 Weeks)|Other|0
1883831|NCT02407236|6496893|P3|Maintenance Study (44 Weeks)|Other|0
1883832|NCT02407236|6496894|P2|Maintenance Study (44 Weeks)|Other|0
1883833|NCT02407236|6496895|P1|Maintenance Study (44 Weeks)|Other|0
1883834|NCT02407236|6496888|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
1883835|NCT02407236|6496889|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
1883836|NCT02407236|6496890|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
1883837|NCT02407236|6496891|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
1883838|NCT02407236|6496892|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
1883839|NCT02407236|6496893|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
1883840|NCT02407236|6496894|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
1883841|NCT02407236|6496895|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
1883842|NCT02407236|6496888|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
1883843|NCT02407236|6496889|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
1883844|NCT02407236|6496890|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
1883928|NCT02388737|6497218|P2|Overall Study|Lost to Follow-up|1
1883845|NCT02407236|6496891|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
1883846|NCT02407236|6496892|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
1883847|NCT02407236|6496893|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
1883848|NCT02407236|6496894|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
1883849|NCT02407236|6496895|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
1883850|NCT02407236|6496888|P8|Maintenance Study (44 Weeks)|Death|1
1883851|NCT02407236|6496889|P7|Maintenance Study (44 Weeks)|Death|0
1883852|NCT02407236|6496890|P6|Maintenance Study (44 Weeks)|Death|0
1883853|NCT02407236|6496891|P5|Maintenance Study (44 Weeks)|Death|0
1883854|NCT02407236|6496892|P4|Maintenance Study (44 Weeks)|Death|0
1883855|NCT02407236|6496893|P3|Maintenance Study (44 Weeks)|Death|0
1883856|NCT02407236|6496894|P2|Maintenance Study (44 Weeks)|Death|0
1883857|NCT02407236|6496895|P1|Maintenance Study (44 Weeks)|Death|0
1883858|NCT02407236|6496888|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1883859|NCT02407236|6496889|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1883860|NCT02407236|6496890|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1883861|NCT02407236|6496891|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1883862|NCT02407236|6496892|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
1883863|NCT02407236|6496893|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1883864|NCT02407236|6496894|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1883865|NCT02407236|6496895|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
1883866|NCT02407236|6496888|P8|Induction Study (8 Weeks)|Other|0
1883867|NCT02407236|6496889|P7|Induction Study (8 Weeks)|Other|0
1883868|NCT02407236|6496890|P6|Induction Study (8 Weeks)|Other|0
1883869|NCT02407236|6496891|P5|Induction Study (8 Weeks)|Other|0
1883870|NCT02407236|6496892|P4|Induction Study (8 Weeks)|Other|0
1883871|NCT02407236|6496893|P3|Induction Study (8 Weeks)|Other|5
1883872|NCT02407236|6496894|P2|Induction Study (8 Weeks)|Other|1
1883873|NCT02407236|6496895|P1|Induction Study (8 Weeks)|Other|2
1883874|NCT02407236|6496888|P8|Induction Study (8 Weeks)|Physician Decision|0
1883875|NCT02407236|6496889|P7|Induction Study (8 Weeks)|Physician Decision|0
1883876|NCT02407236|6496890|P6|Induction Study (8 Weeks)|Physician Decision|0
1883877|NCT02407236|6496891|P5|Induction Study (8 Weeks)|Physician Decision|0
1883878|NCT02407236|6496892|P4|Induction Study (8 Weeks)|Physician Decision|0
1883879|NCT02407236|6496893|P3|Induction Study (8 Weeks)|Physician Decision|0
1883880|NCT02407236|6496894|P2|Induction Study (8 Weeks)|Physician Decision|1
1883881|NCT02407236|6496895|P1|Induction Study (8 Weeks)|Physician Decision|1
1883882|NCT02407236|6496888|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
1883883|NCT02407236|6496889|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
1883884|NCT02407236|6496890|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
1883885|NCT02407236|6496891|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
1883886|NCT02407236|6496892|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
1883887|NCT02407236|6496893|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
1883888|NCT02407236|6496894|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
1883889|NCT02407236|6496895|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
1883890|NCT02407236|6496888|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
1883891|NCT02407236|6496889|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
1883892|NCT02407236|6496890|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
1883893|NCT02407236|6496891|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
1883894|NCT02407236|6496892|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
1883895|NCT02407236|6496893|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
1883896|NCT02407236|6496894|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
1883897|NCT02407236|6496895|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
1883898|NCT02407236|6496888|P8|Induction Study (8 Weeks)|Death|0
1883899|NCT02407236|6496889|P7|Induction Study (8 Weeks)|Death|0
1883900|NCT02407236|6496890|P6|Induction Study (8 Weeks)|Death|0
1883901|NCT02407236|6496891|P5|Induction Study (8 Weeks)|Death|0
1883902|NCT02407236|6496892|P4|Induction Study (8 Weeks)|Death|0
1883903|NCT02407236|6496893|P3|Induction Study (8 Weeks)|Death|1
1883904|NCT02407236|6496894|P2|Induction Study (8 Weeks)|Death|0
1883905|NCT02407236|6496895|P1|Induction Study (8 Weeks)|Death|0
1883906|NCT02407236|6496888|P8|Induction Study (8 Weeks)|Adverse Event|0
1883907|NCT02407236|6496889|P7|Induction Study (8 Weeks)|Adverse Event|0
1883908|NCT02407236|6496890|P6|Induction Study (8 Weeks)|Adverse Event|0
1883909|NCT02407236|6496891|P5|Induction Study (8 Weeks)|Adverse Event|0
1883910|NCT02407236|6496892|P4|Induction Study (8 Weeks)|Adverse Event|0
1883911|NCT02407236|6496893|P3|Induction Study (8 Weeks)|Adverse Event|1
1883912|NCT02407236|6496894|P2|Induction Study (8 Weeks)|Adverse Event|0
1883913|NCT02407236|6496895|P1|Induction Study (8 Weeks)|Adverse Event|3
1883914|NCT02397837|6497134|P2|Overall Study|Physician Decision|1
1883915|NCT02397837|6497135|P1|Overall Study|Physician Decision|1
1883916|NCT02397837|6497134|P2|Overall Study|Withdrawal by Subject|5
1883917|NCT02397837|6497135|P1|Overall Study|Withdrawal by Subject|6
1883918|NCT02388737|6497217|P3|Overall Study|Reason Not Specified|4
1883919|NCT02388737|6497218|P2|Overall Study|Reason Not Specified|5
1883920|NCT02388737|6497219|P1|Overall Study|Reason Not Specified|5
1883921|NCT02388737|6497217|P3|Overall Study|Lack of Efficacy|3
1883922|NCT02388737|6497218|P2|Overall Study|Lack of Efficacy|0
1883923|NCT02388737|6497219|P1|Overall Study|Lack of Efficacy|3
1883924|NCT02388737|6497217|P3|Overall Study|Voluntary Withdrawal|17
1883925|NCT02388737|6497218|P2|Overall Study|Voluntary Withdrawal|18
1883926|NCT02388737|6497219|P1|Overall Study|Voluntary Withdrawal|10
1883927|NCT02388737|6497217|P3|Overall Study|Lost to Follow-up|4
1883929|NCT02388737|6497219|P1|Overall Study|Lost to Follow-up|5
1883930|NCT02388737|6497217|P3|Overall Study|Major Protocol Deviation|22
1883931|NCT02388737|6497218|P2|Overall Study|Major Protocol Deviation|25
1883932|NCT02388737|6497219|P1|Overall Study|Major Protocol Deviation|18
1883933|NCT02388737|6497217|P3|Overall Study|Pretreatment Event/Adverse Event|12
1883934|NCT02388737|6497218|P2|Overall Study|Pretreatment Event/Adverse Event|11
1883935|NCT02388737|6497219|P1|Overall Study|Pretreatment Event/Adverse Event|13
1883936|NCT02379052|6497253|P2|Overall Study|Subject was Incarcerated|1
1883937|NCT02379052|6497254|P1|Overall Study|Subject was Incarcerated|0
1883938|NCT02379052|6497253|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
1883939|NCT02379052|6497254|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
1883940|NCT02379052|6497253|P2|Overall Study|Lost to Follow-up|1
1883941|NCT02379052|6497254|P1|Overall Study|Lost to Follow-up|2
1883942|NCT02379052|6497253|P2|Overall Study|Withdrawal by Subject|0
1883943|NCT02379052|6497254|P1|Overall Study|Withdrawal by Subject|2
1883944|NCT02379052|6497253|P2|Overall Study|Physician Decision|1
1883945|NCT02379052|6497254|P1|Overall Study|Physician Decision|1
1883946|NCT02379052|6497253|P2|Overall Study|Adverse Event|1
1883947|NCT02379052|6497254|P1|Overall Study|Adverse Event|0
1883948|NCT02379052|6497253|P2|Overall Study|Protocol Violation|1
1883949|NCT02379052|6497254|P1|Overall Study|Protocol Violation|0
1883950|NCT02346136|6497311|P2|Overall Study|Study termination|18
1883951|NCT02346136|6497312|P1|Overall Study|Study termination|14
1883952|NCT02346136|6497311|P2|Overall Study|Death|0
1883953|NCT02346136|6497312|P1|Overall Study|Death|1
1883954|NCT02346136|6497311|P2|Overall Study|Withdrawal by Subject|5
1883955|NCT02346136|6497312|P1|Overall Study|Withdrawal by Subject|7
1883956|NCT02336451|6497356|P5|Overall Study|Patient/guardian decision|1
1883957|NCT02336451|6497357|P4|Overall Study|Patient/guardian decision|2
1883958|NCT02336451|6497358|P3|Overall Study|Patient/guardian decision|0
1883959|NCT02336451|6497359|P2|Overall Study|Patient/guardian decision|4
1883960|NCT02336451|6497360|P1|Overall Study|Patient/guardian decision|2
1883961|NCT02336451|6497356|P5|Overall Study|Protocol Violation|0
1883962|NCT02336451|6497357|P4|Overall Study|Protocol Violation|0
1883963|NCT02336451|6497358|P3|Overall Study|Protocol Violation|0
1883964|NCT02336451|6497359|P2|Overall Study|Protocol Violation|0
1883965|NCT02336451|6497360|P1|Overall Study|Protocol Violation|1
1883966|NCT02336451|6497356|P5|Overall Study|Progressive disease|4
1883967|NCT02336451|6497357|P4|Overall Study|Progressive disease|14
1883968|NCT02336451|6497358|P3|Overall Study|Progressive disease|2
1883969|NCT02336451|6497359|P2|Overall Study|Progressive disease|26
1883970|NCT02336451|6497360|P1|Overall Study|Progressive disease|23
1883971|NCT02336451|6497356|P5|Overall Study|Physician Decision|3
1883972|NCT02336451|6497357|P4|Overall Study|Physician Decision|16
1883973|NCT02336451|6497358|P3|Overall Study|Physician Decision|7
1883974|NCT02336451|6497359|P2|Overall Study|Physician Decision|6
1883975|NCT02336451|6497360|P1|Overall Study|Physician Decision|9
1883976|NCT02336451|6497356|P5|Overall Study|Death|6
1883977|NCT02336451|6497357|P4|Overall Study|Death|6
1883978|NCT02336451|6497358|P3|Overall Study|Death|3
1883979|NCT02336451|6497359|P2|Overall Study|Death|2
1883980|NCT02336451|6497360|P1|Overall Study|Death|6
1883981|NCT02336451|6497356|P5|Overall Study|Adverse Event|4
1883982|NCT02336451|6497357|P4|Overall Study|Adverse Event|6
1883983|NCT02336451|6497358|P3|Overall Study|Adverse Event|0
1883984|NCT02336451|6497359|P2|Overall Study|Adverse Event|2
1883985|NCT02336451|6497360|P1|Overall Study|Adverse Event|1
1883986|NCT02327169|6497519|P15|Overall Study|Lost to Follow-up|0
1883987|NCT02327169|6497520|P14|Overall Study|Lost to Follow-up|0
1883988|NCT02327169|6497521|P13|Overall Study|Lost to Follow-up|0
1883989|NCT02327169|6497522|P12|Overall Study|Lost to Follow-up|0
1883990|NCT02327169|6497523|P11|Overall Study|Lost to Follow-up|0
1883991|NCT02327169|6497524|P10|Overall Study|Lost to Follow-up|0
1883992|NCT02327169|6497525|P9|Overall Study|Lost to Follow-up|0
1883993|NCT02327169|6497526|P8|Overall Study|Lost to Follow-up|0
1883994|NCT02327169|6497527|P7|Overall Study|Lost to Follow-up|0
1883995|NCT02327169|6497528|P6|Overall Study|Lost to Follow-up|0
1883996|NCT02327169|6497529|P5|Overall Study|Lost to Follow-up|1
1883997|NCT02327169|6497530|P4|Overall Study|Lost to Follow-up|0
1883998|NCT02327169|6497531|P3|Overall Study|Lost to Follow-up|0
1883999|NCT02327169|6497532|P2|Overall Study|Lost to Follow-up|0
1884000|NCT02327169|6497533|P1|Overall Study|Lost to Follow-up|0
1884001|NCT02327169|6497519|P15|Overall Study|Withdrawal by Subject|3
1884002|NCT02327169|6497520|P14|Overall Study|Withdrawal by Subject|0
1884003|NCT02327169|6497521|P13|Overall Study|Withdrawal by Subject|0
1884004|NCT02327169|6497522|P12|Overall Study|Withdrawal by Subject|0
1884005|NCT02327169|6497523|P11|Overall Study|Withdrawal by Subject|0
1884006|NCT02327169|6497524|P10|Overall Study|Withdrawal by Subject|0
1884007|NCT02327169|6497525|P9|Overall Study|Withdrawal by Subject|0
1884008|NCT02327169|6497526|P8|Overall Study|Withdrawal by Subject|1
1884009|NCT02327169|6497527|P7|Overall Study|Withdrawal by Subject|0
1884010|NCT02327169|6497528|P6|Overall Study|Withdrawal by Subject|0
1884011|NCT02327169|6497529|P5|Overall Study|Withdrawal by Subject|1
1884012|NCT02327169|6497530|P4|Overall Study|Withdrawal by Subject|0
1884013|NCT02327169|6497531|P3|Overall Study|Withdrawal by Subject|0
1884014|NCT02327169|6497532|P2|Overall Study|Withdrawal by Subject|0
1884015|NCT02327169|6497533|P1|Overall Study|Withdrawal by Subject|1
1884016|NCT02327169|6497519|P15|Overall Study|Reason Not Specified|2
1884017|NCT02327169|6497520|P14|Overall Study|Reason Not Specified|0
1884018|NCT02327169|6497521|P13|Overall Study|Reason Not Specified|0
1884019|NCT02327169|6497522|P12|Overall Study|Reason Not Specified|1
1884020|NCT02327169|6497523|P11|Overall Study|Reason Not Specified|2
1884021|NCT02327169|6497524|P10|Overall Study|Reason Not Specified|1
1884022|NCT02327169|6497525|P9|Overall Study|Reason Not Specified|0
1884023|NCT02327169|6497526|P8|Overall Study|Reason Not Specified|0
1884024|NCT02327169|6497527|P7|Overall Study|Reason Not Specified|0
1884025|NCT02327169|6497528|P6|Overall Study|Reason Not Specified|0
1884026|NCT02327169|6497529|P5|Overall Study|Reason Not Specified|0
1884027|NCT02327169|6497530|P4|Overall Study|Reason Not Specified|0
1884028|NCT02327169|6497531|P3|Overall Study|Reason Not Specified|1
1884029|NCT02327169|6497532|P2|Overall Study|Reason Not Specified|0
1884030|NCT02327169|6497533|P1|Overall Study|Reason Not Specified|0
1884031|NCT02327169|6497519|P15|Overall Study|Symptomatic Deterioration|1
1884032|NCT02327169|6497520|P14|Overall Study|Symptomatic Deterioration|2
1884033|NCT02327169|6497521|P13|Overall Study|Symptomatic Deterioration|0
1884034|NCT02327169|6497522|P12|Overall Study|Symptomatic Deterioration|0
1884035|NCT02327169|6497523|P11|Overall Study|Symptomatic Deterioration|0
1884036|NCT02327169|6497524|P10|Overall Study|Symptomatic Deterioration|1
1884037|NCT02327169|6497525|P9|Overall Study|Symptomatic Deterioration|2
1884038|NCT02327169|6497526|P8|Overall Study|Symptomatic Deterioration|0
1884039|NCT02327169|6497527|P7|Overall Study|Symptomatic Deterioration|0
1884040|NCT02327169|6497528|P6|Overall Study|Symptomatic Deterioration|1
1884041|NCT02327169|6497529|P5|Overall Study|Symptomatic Deterioration|1
1884042|NCT02327169|6497530|P4|Overall Study|Symptomatic Deterioration|0
1884043|NCT02327169|6497531|P3|Overall Study|Symptomatic Deterioration|1
1884044|NCT02327169|6497532|P2|Overall Study|Symptomatic Deterioration|0
1884045|NCT02327169|6497533|P1|Overall Study|Symptomatic Deterioration|0
1884046|NCT02327169|6497519|P15|Overall Study|Adverse Event|1
1884047|NCT02327169|6497520|P14|Overall Study|Adverse Event|2
1884048|NCT02327169|6497521|P13|Overall Study|Adverse Event|0
1884049|NCT02327169|6497522|P12|Overall Study|Adverse Event|3
1884050|NCT02327169|6497523|P11|Overall Study|Adverse Event|0
1884051|NCT02327169|6497524|P10|Overall Study|Adverse Event|2
1884052|NCT02327169|6497525|P9|Overall Study|Adverse Event|0
1884053|NCT02327169|6497526|P8|Overall Study|Adverse Event|0
1884054|NCT02327169|6497527|P7|Overall Study|Adverse Event|0
1884055|NCT02327169|6497528|P6|Overall Study|Adverse Event|0
1884056|NCT02327169|6497529|P5|Overall Study|Adverse Event|1
1884057|NCT02327169|6497530|P4|Overall Study|Adverse Event|0
1884058|NCT02327169|6497531|P3|Overall Study|Adverse Event|1
1884059|NCT02327169|6497532|P2|Overall Study|Adverse Event|0
1884060|NCT02327169|6497533|P1|Overall Study|Adverse Event|2
1884061|NCT02327169|6497519|P15|Overall Study|Progressive Disease|3
1884062|NCT02327169|6497520|P14|Overall Study|Progressive Disease|3
1884063|NCT02327169|6497521|P13|Overall Study|Progressive Disease|1
1884064|NCT02327169|6497522|P12|Overall Study|Progressive Disease|3
1884065|NCT02327169|6497523|P11|Overall Study|Progressive Disease|4
1884066|NCT02327169|6497524|P10|Overall Study|Progressive Disease|4
1884067|NCT02327169|6497525|P9|Overall Study|Progressive Disease|4
1884068|NCT02327169|6497526|P8|Overall Study|Progressive Disease|3
1884069|NCT02327169|6497527|P7|Overall Study|Progressive Disease|3
1884070|NCT02327169|6497528|P6|Overall Study|Progressive Disease|3
1884071|NCT02327169|6497529|P5|Overall Study|Progressive Disease|4
1884072|NCT02327169|6497530|P4|Overall Study|Progressive Disease|3
1884073|NCT02327169|6497531|P3|Overall Study|Progressive Disease|4
1884074|NCT02327169|6497532|P2|Overall Study|Progressive Disease|3
1884075|NCT02327169|6497533|P1|Overall Study|Progressive Disease|1
1884076|NCT02316717|6497757|P3|Overall Study|TBC|0
1884077|NCT02316717|6497758|P2|Overall Study|TBC|0
1884078|NCT02316717|6497759|P1|Overall Study|TBC|1
1884079|NCT02316717|6497757|P3|Overall Study|Physician Decision|0
1884080|NCT02316717|6497758|P2|Overall Study|Physician Decision|1
1884081|NCT02316717|6497759|P1|Overall Study|Physician Decision|0
1884082|NCT02316717|6497757|P3|Overall Study|Death|1
1884083|NCT02316717|6497758|P2|Overall Study|Death|0
1884084|NCT02316717|6497759|P1|Overall Study|Death|0
1884085|NCT02316717|6497757|P3|Overall Study|Withdrawal by Subject|1
1884086|NCT02316717|6497758|P2|Overall Study|Withdrawal by Subject|1
1884087|NCT02316717|6497759|P1|Overall Study|Withdrawal by Subject|2
1884088|NCT02316717|6497757|P3|Overall Study|Protocol Violation|0
1884089|NCT02316717|6497758|P2|Overall Study|Protocol Violation|0
1884090|NCT02316717|6497759|P1|Overall Study|Protocol Violation|2
1884091|NCT02316717|6497757|P3|Overall Study|Non compliance|0
1884092|NCT02316717|6497758|P2|Overall Study|Non compliance|1
1884093|NCT02316717|6497759|P1|Overall Study|Non compliance|3
1884094|NCT02316717|6497757|P3|Overall Study|Lost to Follow-up|1
1884095|NCT02316717|6497758|P2|Overall Study|Lost to Follow-up|2
1884096|NCT02316717|6497759|P1|Overall Study|Lost to Follow-up|1
1884097|NCT02316717|6497757|P3|Overall Study|Adverse Event|0
1884098|NCT02316717|6497758|P2|Overall Study|Adverse Event|2
1884099|NCT02316717|6497759|P1|Overall Study|Adverse Event|2
1884100|NCT02302066|6497891|P4|Overall Study|Reason Not Specified|1
1884101|NCT02302066|6497892|P3|Overall Study|Reason Not Specified|9
1884102|NCT02302066|6497893|P2|Overall Study|Reason Not Specified|1
1884103|NCT02302066|6497894|P1|Overall Study|Reason Not Specified|1
1884104|NCT02302066|6497891|P4|Overall Study|Pregnancy|0
1884105|NCT02302066|6497892|P3|Overall Study|Pregnancy|12
1884106|NCT02302066|6497893|P2|Overall Study|Pregnancy|10
1884107|NCT02302066|6497894|P1|Overall Study|Pregnancy|2
1884108|NCT02302066|6497891|P4|Overall Study|Withdrawal by Subject|33
1884109|NCT02302066|6497892|P3|Overall Study|Withdrawal by Subject|124
1884110|NCT02302066|6497893|P2|Overall Study|Withdrawal by Subject|58
1884111|NCT02302066|6497894|P1|Overall Study|Withdrawal by Subject|25
1884112|NCT02302066|6497891|P4|Overall Study|Lost to Follow-up|7
1884113|NCT02302066|6497892|P3|Overall Study|Lost to Follow-up|24
1884114|NCT02302066|6497893|P2|Overall Study|Lost to Follow-up|5
1884115|NCT02302066|6497894|P1|Overall Study|Lost to Follow-up|4
1884116|NCT02302066|6497891|P4|Overall Study|Adverse Event|0
1884117|NCT02302066|6497892|P3|Overall Study|Adverse Event|3
1884118|NCT02302066|6497893|P2|Overall Study|Adverse Event|1
1884119|NCT02302066|6497894|P1|Overall Study|Adverse Event|1
1884120|NCT02231892|6497975|P3|Overall Study|Could not find reliable motor hotspot|1
1884121|NCT02231892|6497976|P2|Overall Study|Could not find reliable motor hotspot|0
1884122|NCT02231892|6497977|P1|Overall Study|Could not find reliable motor hotspot|0
1884123|NCT02231892|6497975|P3|Overall Study|Could not find motor threshold|1
1884124|NCT02231892|6497976|P2|Overall Study|Could not find motor threshold|0
1884125|NCT02231892|6497977|P1|Overall Study|Could not find motor threshold|2
1884126|NCT02231892|6497975|P3|Overall Study|Participant motor threshold was >83%|9
1884127|NCT02231892|6497976|P2|Overall Study|Participant motor threshold was >83%|0
1884128|NCT02231892|6497977|P1|Overall Study|Participant motor threshold was >83%|0
1884129|NCT02231892|6497975|P3|Overall Study|Motor activity when stimulating ante ACC|12
1884130|NCT02231892|6497976|P2|Overall Study|Motor activity when stimulating ante ACC|7
1884131|NCT02231892|6497977|P1|Overall Study|Motor activity when stimulating ante ACC|4
1884132|NCT02231892|6497975|P3|Overall Study|Physician Decision|4
1884133|NCT02231892|6497976|P2|Overall Study|Physician Decision|2
1884134|NCT02231892|6497977|P1|Overall Study|Physician Decision|0
1884135|NCT02231892|6497975|P3|Overall Study|Withdrawal by Subject|15
1884136|NCT02231892|6497976|P2|Overall Study|Withdrawal by Subject|3
1884137|NCT02231892|6497977|P1|Overall Study|Withdrawal by Subject|4
1884138|NCT02231892|6497975|P3|Overall Study|Lost to Follow-up|3
1884139|NCT02231892|6497976|P2|Overall Study|Lost to Follow-up|0
1884140|NCT02231892|6497977|P1|Overall Study|Lost to Follow-up|1
1884141|NCT02220894|6498007|P2|Overall Study|Ongoing in Study|183
1884142|NCT02220894|6498008|P1|Overall Study|Ongoing in Study|265
1884143|NCT02220894|6498007|P2|Overall Study|Withdrawal by Subject|13
1884144|NCT02220894|6498008|P1|Overall Study|Withdrawal by Subject|2
1884145|NCT02220894|6498007|P2|Overall Study|Withdrawal by Parent/Guardian|1
1884146|NCT02220894|6498008|P1|Overall Study|Withdrawal by Parent/Guardian|0
1884147|NCT02220894|6498007|P2|Overall Study|Lost to Follow-up|2
1884148|NCT02220894|6498008|P1|Overall Study|Lost to Follow-up|0
1884149|NCT02220894|6498007|P2|Overall Study|Death|368
1884150|NCT02220894|6498008|P1|Overall Study|Death|252
1884151|NCT02220894|6498007|P2|Overall Study|Adverse Event|70
1884152|NCT02220894|6498008|P1|Overall Study|Adverse Event|118
1884153|NCT02200614|6498036|P2|Follow-up Period|personal reason|72
1884154|NCT02200614|6498037|P1|Follow-up Period|personal reason|81
1884155|NCT02200614|6498036|P2|Follow-up Period|Other|28
1884156|NCT02200614|6498037|P1|Follow-up Period|Other|23
1884157|NCT02200614|6498036|P2|Follow-up Period|Lost to Follow-up|12
1884158|NCT02200614|6498037|P1|Follow-up Period|Lost to Follow-up|6
1884159|NCT02200614|6498036|P2|Follow-up Period|Death|51
1884160|NCT02200614|6498037|P1|Follow-up Period|Death|64
1884161|NCT02200614|6498036|P2|Treatment Period to Primary Completion|Study drug never administered|0
1884162|NCT02200614|6498037|P1|Treatment Period to Primary Completion|Study drug never administered|1
1884163|NCT02200614|6498036|P2|Treatment Period to Primary Completion|Personal reason|78
1884164|NCT02200614|6498037|P1|Treatment Period to Primary Completion|Personal reason|68
1884165|NCT02200614|6498036|P2|Treatment Period to Primary Completion|Protocol deviation|7
1884166|NCT02200614|6498037|P1|Treatment Period to Primary Completion|Protocol deviation|13
1884167|NCT02200614|6498036|P2|Treatment Period to Primary Completion|Judgment of the investigator|91
1884168|NCT02200614|6498037|P1|Treatment Period to Primary Completion|Judgment of the investigator|54
1884169|NCT02200614|6498036|P2|Treatment Period to Primary Completion|Confirmed metastasis|129
1884170|NCT02200614|6498037|P1|Treatment Period to Primary Completion|Confirmed metastasis|112
1884171|NCT02200614|6498036|P2|Treatment Period to Primary Completion|Other reason|2
1884172|NCT02200614|6498037|P1|Treatment Period to Primary Completion|Other reason|6
1884173|NCT02200614|6498036|P2|Treatment Period to Primary Completion|Adverse Event|47
1884174|NCT02200614|6498037|P1|Treatment Period to Primary Completion|Adverse Event|86
1884175|NCT02191397|6498064|P2|Overall Study|Withdrawal by Subject|27
1884176|NCT02191397|6498065|P1|Overall Study|Withdrawal by Subject|22
1884177|NCT02191397|6498064|P2|Overall Study|Physician Decision|3
1884178|NCT02191397|6498065|P1|Overall Study|Physician Decision|8
1884179|NCT02191397|6498064|P2|Overall Study|Lost to Follow-up|11
1884180|NCT02191397|6498065|P1|Overall Study|Lost to Follow-up|10
1884181|NCT02191397|6498064|P2|Overall Study|Met protocol-defined stopping criteria|4
1884182|NCT02191397|6498065|P1|Overall Study|Met protocol-defined stopping criteria|5
1884183|NCT02191397|6498064|P2|Overall Study|Protocol Violation|3
1884184|NCT02191397|6498065|P1|Overall Study|Protocol Violation|0
1884185|NCT02191397|6498064|P2|Overall Study|Lack of Efficacy|5
1884186|NCT02191397|6498065|P1|Overall Study|Lack of Efficacy|10
1884187|NCT02191397|6498064|P2|Overall Study|Adverse Event|17
1884188|NCT02191397|6498065|P1|Overall Study|Adverse Event|28
1884189|NCT02168101|6498185|P3|Overall Study|Death|1
1884190|NCT02168101|6498186|P2|Overall Study|Death|2
1884191|NCT02168101|6498187|P1|Overall Study|Death|2
1884192|NCT02156804|6498215|P1|Overall Study|Withdrawal by Subject|1
1884193|NCT02151591|6498225|P2|Overall Study|Lost to Follow-up|3
1884194|NCT02151591|6498226|P1|Overall Study|Lost to Follow-up|6
1884195|NCT02148250|6498236|P2|Screening|Withdrawal by Subject|0
1884196|NCT02148250|6498237|P1|Screening|Withdrawal by Subject|5
1884197|NCT02138747|6498255|P4|Treatment Period 2|Other - Miscellaneous|0
1884198|NCT02138747|6498256|P3|Treatment Period 2|Other - Miscellaneous|0
1884199|NCT02138747|6498257|P2|Treatment Period 2|Other - Miscellaneous|0
1884200|NCT02138747|6498258|P1|Treatment Period 2|Other - Miscellaneous|3
1884201|NCT02138747|6498255|P4|Treatment Period 2|Withdrawal by Subject|2
1884202|NCT02138747|6498256|P3|Treatment Period 2|Withdrawal by Subject|1
1884203|NCT02138747|6498257|P2|Treatment Period 2|Withdrawal by Subject|4
1884204|NCT02138747|6498258|P1|Treatment Period 2|Withdrawal by Subject|5
1884205|NCT02138747|6498255|P4|Treatment Period 2|Protocol Violation|0
1884206|NCT02138747|6498256|P3|Treatment Period 2|Protocol Violation|0
1884207|NCT02138747|6498257|P2|Treatment Period 2|Protocol Violation|0
1884208|NCT02138747|6498258|P1|Treatment Period 2|Protocol Violation|1
1884209|NCT02138747|6498255|P4|Treatment Period 2|Lost to Follow-up|0
1884210|NCT02138747|6498256|P3|Treatment Period 2|Lost to Follow-up|0
1884211|NCT02138747|6498257|P2|Treatment Period 2|Lost to Follow-up|0
1884212|NCT02138747|6498258|P1|Treatment Period 2|Lost to Follow-up|2
1884213|NCT02138747|6498255|P4|Treatment Period 2|Adverse Event|1
1884214|NCT02138747|6498256|P3|Treatment Period 2|Adverse Event|1
1884215|NCT02138747|6498257|P2|Treatment Period 2|Adverse Event|3
1884216|NCT02138747|6498258|P1|Treatment Period 2|Adverse Event|6
1884217|NCT02138747|6498255|P4|Treatment Period 1|Other - Miscellaneous|0
1884218|NCT02138747|6498256|P3|Treatment Period 1|Other - Miscellaneous|0
1884219|NCT02138747|6498257|P2|Treatment Period 1|Other - Miscellaneous|4
1884220|NCT02138747|6498258|P1|Treatment Period 1|Other - Miscellaneous|2
1884221|NCT02138747|6498255|P4|Treatment Period 1|Withdrawal by Subject|3
1884222|NCT02138747|6498256|P3|Treatment Period 1|Withdrawal by Subject|1
1884223|NCT02138747|6498257|P2|Treatment Period 1|Withdrawal by Subject|4
1884224|NCT02138747|6498258|P1|Treatment Period 1|Withdrawal by Subject|8
1884225|NCT02138747|6498255|P4|Treatment Period 1|Protocol Violation|0
1884226|NCT02138747|6498256|P3|Treatment Period 1|Protocol Violation|0
1884227|NCT02138747|6498257|P2|Treatment Period 1|Protocol Violation|2
1884228|NCT02138747|6498258|P1|Treatment Period 1|Protocol Violation|0
1884229|NCT02138747|6498255|P4|Treatment Period 1|Lost to Follow-up|0
1884230|NCT02138747|6498256|P3|Treatment Period 1|Lost to Follow-up|1
1884231|NCT02138747|6498257|P2|Treatment Period 1|Lost to Follow-up|1
1884232|NCT02138747|6498258|P1|Treatment Period 1|Lost to Follow-up|0
1884233|NCT02138747|6498255|P4|Treatment Period 1|Adverse Event|1
1884234|NCT02138747|6498256|P3|Treatment Period 1|Adverse Event|2
1884235|NCT02138747|6498257|P2|Treatment Period 1|Adverse Event|14
1884236|NCT02138747|6498258|P1|Treatment Period 1|Adverse Event|10
1884237|NCT02133742|6498309|P1|Period 2:Dose Expansion Phase (903 Days)|Ongoing at date of cutoff|41
1884238|NCT02133742|6498309|P1|Period 2:Dose Expansion Phase (903 Days)|Death|5
1884239|NCT02133742|6498309|P1|Period 2:Dose Expansion Phase (903 Days)|Other|2
1884240|NCT02133742|6498309|P1|Period 2:Dose Expansion Phase (903 Days)|Lost to Follow-up|4
1884241|NCT02082977|6498417|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884242|NCT02082977|6498418|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884243|NCT02082977|6498419|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
1884244|NCT02082977|6498420|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884245|NCT02082977|6498421|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884246|NCT02082977|6498422|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884247|NCT02082977|6498423|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884248|NCT02082977|6498424|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884249|NCT02082977|6498425|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884250|NCT02082977|6498426|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
1884251|NCT02082977|6498417|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
1884252|NCT02082977|6498418|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
1884253|NCT02082977|6498419|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
1884254|NCT02082977|6498420|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
1884255|NCT02082977|6498421|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
1884256|NCT02082977|6498422|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
1884257|NCT02082977|6498423|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
1884258|NCT02082977|6498424|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
1884259|NCT02082977|6498425|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
1884260|NCT02082977|6498426|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
1884261|NCT02082977|6498417|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884262|NCT02082977|6498418|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884263|NCT02082977|6498419|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884264|NCT02082977|6498420|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884265|NCT02082977|6498421|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
1884266|NCT02082977|6498422|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884267|NCT02082977|6498423|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884268|NCT02082977|6498424|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884269|NCT02082977|6498425|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884270|NCT02082977|6498426|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
1884271|NCT02082977|6498417|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884272|NCT02082977|6498418|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884273|NCT02082977|6498419|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
1884274|NCT02082977|6498420|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884275|NCT02082977|6498421|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884276|NCT02082977|6498422|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884277|NCT02082977|6498423|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884278|NCT02082977|6498424|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884279|NCT02082977|6498425|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884280|NCT02082977|6498426|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
1884281|NCT02082977|6498417|P10|Part 1 (Up to 3.2 Years)|Death|0
1884282|NCT02082977|6498418|P9|Part 1 (Up to 3.2 Years)|Death|1
1884283|NCT02082977|6498419|P8|Part 1 (Up to 3.2 Years)|Death|0
1884284|NCT02082977|6498420|P7|Part 1 (Up to 3.2 Years)|Death|2
1884285|NCT02082977|6498421|P6|Part 1 (Up to 3.2 Years)|Death|1
1884286|NCT02082977|6498422|P5|Part 1 (Up to 3.2 Years)|Death|0
1884287|NCT02082977|6498423|P4|Part 1 (Up to 3.2 Years)|Death|0
1884288|NCT02082977|6498424|P3|Part 1 (Up to 3.2 Years)|Death|0
1884289|NCT02082977|6498425|P2|Part 1 (Up to 3.2 Years)|Death|0
1884290|NCT02082977|6498426|P1|Part 1 (Up to 3.2 Years)|Death|1
1884291|NCT02066311|6498678|P1|Overall Study|Withdrawal by Subject|1
1884292|NCT02066311|6498678|P1|Overall Study|Adverse Event|4
1884293|NCT02060370|6498682|P1|Overall Study|Physician Decision|1
1884294|NCT02019667|6498702|P2|2nd Intervention (6 Months)|Physician Decision|1
1884295|NCT02019667|6498703|P1|2nd Intervention (6 Months)|Physician Decision|0
1884296|NCT02019667|6498702|P2|2nd Intervention (6 Months)|Adverse Event|1
1884297|NCT02019667|6498703|P1|2nd Intervention (6 Months)|Adverse Event|0
1884298|NCT02019667|6498702|P2|First Intervention (6 Months)|Adverse Event|1
1884299|NCT02019667|6498703|P1|First Intervention (6 Months)|Adverse Event|0
1884300|NCT02005471|6498763|P2|Overall Study|Withdrawal by Subject|7
1884301|NCT02005471|6498764|P1|Overall Study|Withdrawal by Subject|18
1884302|NCT02005471|6498763|P2|Overall Study|Progressive Disease|0
1884303|NCT02005471|6498764|P1|Overall Study|Progressive Disease|3
1884304|NCT02005471|6498763|P2|Overall Study|Physician Decision|1
1884305|NCT02005471|6498764|P1|Overall Study|Physician Decision|2
1884306|NCT02005471|6498763|P2|Overall Study|Lost to Follow-up|0
1884307|NCT02005471|6498764|P1|Overall Study|Lost to Follow-up|1
1884308|NCT02005471|6498763|P2|Overall Study|Death|15
1884309|NCT02005471|6498764|P1|Overall Study|Death|26
1884310|NCT02005471|6498763|P2|Overall Study|Adverse Event|0
1884311|NCT02005471|6498764|P1|Overall Study|Adverse Event|1
1884312|NCT02005471|6498763|P2|Overall Study|Ongoing in Study|171
1884313|NCT02005471|6498764|P1|Overall Study|Ongoing in Study|144
1884314|NCT02000622|6498819|P2|Overall Study|Withdrawal by Subject|7
1884315|NCT02000622|6498820|P1|Overall Study|Withdrawal by Subject|5
1884316|NCT02000622|6498819|P2|Overall Study|Death|46
1884317|NCT02000622|6498820|P1|Overall Study|Death|94
1884318|NCT02000622|6498819|P2|Overall Study|Lost to Follow-up|0
1884319|NCT02000622|6498820|P1|Overall Study|Lost to Follow-up|1
1884320|NCT02000622|6498819|P2|Overall Study|Withdrawn due to site closure|0
1884321|NCT02000622|6498820|P1|Overall Study|Withdrawn due to site closure|1
1884322|NCT01979523|6498842|P2|Overall Study|Withdrawal by Subject|0
1884323|NCT01979523|6498843|P1|Overall Study|Withdrawal by Subject|1
1884324|NCT01968213|6498914|P2|Overall Study|Ongoing|9
1884325|NCT01968213|6498915|P1|Overall Study|Ongoing|90
1884326|NCT01964378|6498926|P2|Overall Study|Other|2
1884327|NCT01964378|6498927|P1|Overall Study|Other|1
1884328|NCT01964378|6498926|P2|Overall Study|Inclusion/exclusion criteria not met|3
1884329|NCT01964378|6498927|P1|Overall Study|Inclusion/exclusion criteria not met|1
1884330|NCT01964378|6498926|P2|Overall Study|Withdrawal by Subject|5
1884331|NCT01964378|6498927|P1|Overall Study|Withdrawal by Subject|7
1884332|NCT01964378|6498926|P2|Overall Study|Lost to Follow-up|1
1884333|NCT01964378|6498927|P1|Overall Study|Lost to Follow-up|0
1884334|NCT01964378|6498926|P2|Overall Study|Protocol Violation|1
1884335|NCT01964378|6498927|P1|Overall Study|Protocol Violation|0
1884336|NCT01964378|6498926|P2|Overall Study|Lack of Efficacy|1
1884337|NCT01964378|6498927|P1|Overall Study|Lack of Efficacy|0
1884338|NCT01964378|6498926|P2|Overall Study|Adverse Event|5
1884339|NCT01964378|6498927|P1|Overall Study|Adverse Event|12
1884340|NCT01964378|6498926|P2|Overall Study|Death|2
1884341|NCT01964378|6498927|P1|Overall Study|Death|3
1884342|NCT01964378|6498926|P2|Overall Study|Disc. due to AE before first dosing|0
1884343|NCT01964378|6498927|P1|Overall Study|Disc. due to AE before first dosing|1
1884344|NCT01964378|6498926|P2|Overall Study|Disc. due to death before first dosing|1
1884345|NCT01964378|6498927|P1|Overall Study|Disc. due to death before first dosing|0
1884346|NCT01964300|6498961|P2|Overall Study|Weight criteria not met|1
1884347|NCT01964300|6498962|P1|Overall Study|Weight criteria not met|0
1884348|NCT01964300|6498961|P2|Overall Study|Enlargement of cyst requiring drainage|0
1884349|NCT01964300|6498962|P1|Overall Study|Enlargement of cyst requiring drainage|1
1884350|NCT01964300|6498961|P2|Overall Study|To receive alternative therapy|2
1884351|NCT01964300|6498962|P1|Overall Study|To receive alternative therapy|1
1884352|NCT01964300|6498961|P2|Overall Study|Withdrawal by Subject|1
1884353|NCT01964300|6498962|P1|Overall Study|Withdrawal by Subject|0
1884354|NCT01964300|6498961|P2|Overall Study|Lack of Efficacy|5
1884355|NCT01964300|6498962|P1|Overall Study|Lack of Efficacy|3
1884356|NCT01964300|6498961|P2|Overall Study|Adverse Event|1
1884357|NCT01964300|6498962|P1|Overall Study|Adverse Event|1
1884358|NCT01964300|6498961|P2|Overall Study|Ineligible after enrollment|1
1884359|NCT01964300|6498962|P1|Overall Study|Ineligible after enrollment|0
1884360|NCT01924806|6499086|P2|Overall Study|Physician Decision|1
1884361|NCT01924806|6499087|P1|Overall Study|Physician Decision|2
1884362|NCT01923181|6499108|P9|Overall Study|Lost to Follow-up|1
1884363|NCT01923181|6499109|P8|Overall Study|Lost to Follow-up|3
1884364|NCT01923181|6499110|P7|Overall Study|Lost to Follow-up|3
1884365|NCT01923181|6499111|P6|Overall Study|Lost to Follow-up|1
1884366|NCT01923181|6499112|P5|Overall Study|Lost to Follow-up|2
1884367|NCT01923181|6499113|P4|Overall Study|Lost to Follow-up|1
1884368|NCT01923181|6499114|P3|Overall Study|Lost to Follow-up|2
1884369|NCT01923181|6499115|P2|Overall Study|Lost to Follow-up|3
1884370|NCT01923181|6499116|P1|Overall Study|Lost to Follow-up|0
1884371|NCT01923181|6499108|P9|Overall Study|Other|0
1884372|NCT01923181|6499109|P8|Overall Study|Other|0
1884373|NCT01923181|6499110|P7|Overall Study|Other|0
1884374|NCT01923181|6499111|P6|Overall Study|Other|0
1884375|NCT01923181|6499112|P5|Overall Study|Other|0
1884376|NCT01923181|6499113|P4|Overall Study|Other|1
1884377|NCT01923181|6499114|P3|Overall Study|Other|0
1884378|NCT01923181|6499115|P2|Overall Study|Other|0
1884379|NCT01923181|6499116|P1|Overall Study|Other|1
1884380|NCT01923181|6499108|P9|Overall Study|Withdrawal by Subject|1
1884381|NCT01923181|6499109|P8|Overall Study|Withdrawal by Subject|3
1884382|NCT01923181|6499110|P7|Overall Study|Withdrawal by Subject|4
1884383|NCT01923181|6499111|P6|Overall Study|Withdrawal by Subject|2
1884384|NCT01923181|6499112|P5|Overall Study|Withdrawal by Subject|4
1884385|NCT01923181|6499113|P4|Overall Study|Withdrawal by Subject|1
1884386|NCT01923181|6499114|P3|Overall Study|Withdrawal by Subject|0
1884387|NCT01923181|6499115|P2|Overall Study|Withdrawal by Subject|1
1884388|NCT01923181|6499116|P1|Overall Study|Withdrawal by Subject|0
1884389|NCT01923181|6499108|P9|Overall Study|Protocol Violation|1
1884390|NCT01923181|6499109|P8|Overall Study|Protocol Violation|2
1884391|NCT01923181|6499110|P7|Overall Study|Protocol Violation|1
1884392|NCT01923181|6499111|P6|Overall Study|Protocol Violation|1
1884393|NCT01923181|6499112|P5|Overall Study|Protocol Violation|2
1884394|NCT01923181|6499113|P4|Overall Study|Protocol Violation|2
1884395|NCT01923181|6499114|P3|Overall Study|Protocol Violation|0
1884396|NCT01923181|6499115|P2|Overall Study|Protocol Violation|2
1884397|NCT01923181|6499116|P1|Overall Study|Protocol Violation|2
1884398|NCT01919411|6499193|P2|Overall Study|Protocol Violation|1
1884399|NCT01919411|6499194|P1|Overall Study|Protocol Violation|2
1884400|NCT01919411|6499193|P2|Overall Study|Physician Decision|0
1884401|NCT01919411|6499194|P1|Overall Study|Physician Decision|1
1884402|NCT01919411|6499193|P2|Overall Study|Lost to Follow-up|4
1884403|NCT01919411|6499194|P1|Overall Study|Lost to Follow-up|2
1884404|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
1884405|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
1884406|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
1884407|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
1884408|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1884409|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
1884410|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
1884411|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1884412|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
1884413|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
1884414|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1884415|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
1884416|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
1884417|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1884418|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
1884419|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1884420|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
1884421|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
1884422|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1884423|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
1884424|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
1884425|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
1884426|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
1884427|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
1884428|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1884429|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
1884430|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
1884431|NCT01912339|6499212|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1884432|NCT01912339|6499213|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
1884433|NCT01912339|6499214|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
1884434|NCT01912339|6499212|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1884435|NCT01912339|6499213|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
1884436|NCT01912339|6499214|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
1884437|NCT01912339|6499212|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
1884438|NCT01912339|6499213|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
1884439|NCT01912339|6499214|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
1884440|NCT01912339|6499212|P3|Blinded (0 to 3 Months)|Declined to participate|0
1884441|NCT01912339|6499213|P2|Blinded (0 to 3 Months)|Declined to participate|0
1884442|NCT01912339|6499214|P1|Blinded (0 to 3 Months)|Declined to participate|1
1884443|NCT01908699|6499230|P2|Overall Study|Progressive Disease|29
1884444|NCT01908699|6499231|P1|Overall Study|Progressive Disease|30
1884445|NCT01908699|6499230|P2|Overall Study|Death|12
1884446|NCT01908699|6499231|P1|Overall Study|Death|9
1884447|NCT01908699|6499230|P2|Overall Study|Randomized in Error|0
1884448|NCT01908699|6499231|P1|Overall Study|Randomized in Error|1
1884449|NCT01908699|6499230|P2|Overall Study|Pregnancy|1
1884450|NCT01908699|6499231|P1|Overall Study|Pregnancy|0
1884451|NCT01908699|6499230|P2|Overall Study|Withdrawal by Subject|10
1884452|NCT01908699|6499231|P1|Overall Study|Withdrawal by Subject|15
1884453|NCT01908699|6499230|P2|Overall Study|Physician Decision|8
1884454|NCT01908699|6499231|P1|Overall Study|Physician Decision|8
1884455|NCT01908699|6499230|P2|Overall Study|Lost to Follow-up|4
1884456|NCT01908699|6499231|P1|Overall Study|Lost to Follow-up|2
1884457|NCT01908699|6499230|P2|Overall Study|Lack of Efficacy|2
1884458|NCT01908699|6499231|P1|Overall Study|Lack of Efficacy|2
1884459|NCT01908699|6499230|P2|Overall Study|Adverse Event|12
1884460|NCT01908699|6499231|P1|Overall Study|Adverse Event|8
1884461|NCT01900730|6499249|P2|Overall Study|Screen Failure|0
1884462|NCT01900730|6499250|P1|Overall Study|Screen Failure|1
1884463|NCT01900730|6499249|P2|Overall Study|Withdrawal by Subject|0
1884464|NCT01900730|6499250|P1|Overall Study|Withdrawal by Subject|1
1884465|NCT01892540|6499259|P3|Overall Study|Did not fit in scanner|1
1884466|NCT01892540|6499260|P2|Overall Study|Did not fit in scanner|0
1884467|NCT01892540|6499261|P1|Overall Study|Did not fit in scanner|0
1884468|NCT01892540|6499259|P3|Overall Study|Did not complete PET/MRI|2
1884469|NCT01892540|6499260|P2|Overall Study|Did not complete PET/MRI|0
1884470|NCT01892540|6499261|P1|Overall Study|Did not complete PET/MRI|0
1884471|NCT01886872|6499281|P3|Overall Study|Ineligible|12
1884472|NCT01886872|6499282|P2|Overall Study|Ineligible|4
1884473|NCT01886872|6499283|P1|Overall Study|Ineligible|7
1884474|NCT01866826|6499326|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
1884475|NCT01866826|6499327|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
1884476|NCT01866826|6499326|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
1884477|NCT01866826|6499327|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
1884478|NCT01866826|6499326|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
1884479|NCT01866826|6499327|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
1884480|NCT01853644|6499341|P1|Follow up for 3 Years or Until Death|Still in the follow up period|3
1884481|NCT01853644|6499341|P1|Continued Treatment After First Response|Progressive Diseaes|10
1884482|NCT01853644|6499341|P1|Continued Treatment After First Response|Adverse Event|2
1884483|NCT01853644|6499341|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
1884484|NCT01853644|6499341|P1|Reached First Response/Complete 2 Cycles|Other|1
1884485|NCT01853644|6499341|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
1884486|NCT01853644|6499341|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
1884487|NCT01853644|6499341|P1|Registration and Treatment Start|Did not start treatment|1
1884488|NCT01807299|6499394|P4|Overall Study|Protocol Violation|2
1884489|NCT01807299|6499395|P3|Overall Study|Protocol Violation|0
1884490|NCT01807299|6499396|P2|Overall Study|Protocol Violation|1
1884491|NCT01807299|6499397|P1|Overall Study|Protocol Violation|3
1884492|NCT01797263|6499409|P2|Overall Study|Lost to Follow-up|15
1884493|NCT01797263|6499410|P1|Overall Study|Lost to Follow-up|15
1884494|NCT01797263|6499409|P2|Overall Study|Death|0
1884495|NCT01797263|6499410|P1|Overall Study|Death|1
1884496|NCT01797263|6499409|P2|Overall Study|Withdrawal by Subject|25
1884497|NCT01797263|6499410|P1|Overall Study|Withdrawal by Subject|21
1884498|NCT01787292|6499442|P2|Home Based Exercise Program|Withdrawal by Subject|1
1884499|NCT01787292|6499443|P1|Home Based Exercise Program|Withdrawal by Subject|3
1884500|NCT01787292|6499442|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
1884501|NCT01787292|6499443|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
1884502|NCT01753401|6499462|P4|Open Label Period (44 Weeks)|Reason not provided|2
1884503|NCT01753401|6499463|P3|Open Label Period (44 Weeks)|Reason not provided|0
1884504|NCT01753401|6499464|P2|Open Label Period (44 Weeks)|Reason not provided|0
1884505|NCT01753401|6499465|P1|Open Label Period (44 Weeks)|Reason not provided|0
1884506|NCT01753401|6499462|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
1884507|NCT01753401|6499463|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
1884508|NCT01753401|6499464|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
1884509|NCT01753401|6499465|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
1884510|NCT01753401|6499462|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
1884511|NCT01753401|6499463|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
1884512|NCT01753401|6499464|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
1884513|NCT01753401|6499465|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
1884514|NCT01753401|6499462|P4|Open Label Period (44 Weeks)|Adverse Event|4
1884515|NCT01753401|6499463|P3|Open Label Period (44 Weeks)|Adverse Event|3
1884516|NCT01753401|6499464|P2|Open Label Period (44 Weeks)|Adverse Event|0
1884517|NCT01753401|6499465|P1|Open Label Period (44 Weeks)|Adverse Event|0
1884518|NCT01753401|6499462|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
1884519|NCT01753401|6499463|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
1884520|NCT01753401|6499464|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
1884521|NCT01753401|6499465|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
1884522|NCT01753401|6499462|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
1884523|NCT01753401|6499463|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
1884524|NCT01753401|6499464|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
1884525|NCT01753401|6499465|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
1884526|NCT01753401|6499462|P4|Double-blind Period (8 Weeks)|Adverse Event|0
1884527|NCT01753401|6499463|P3|Double-blind Period (8 Weeks)|Adverse Event|0
1884528|NCT01753401|6499464|P2|Double-blind Period (8 Weeks)|Adverse Event|2
1884529|NCT01753401|6499465|P1|Double-blind Period (8 Weeks)|Adverse Event|0
1884530|NCT01740427|6499526|P2|Overall Study|Study terminated by Sponsor|0
1884531|NCT01740427|6499527|P1|Overall Study|Study terminated by Sponsor|1
1884532|NCT01740427|6499526|P2|Overall Study|Lost to Follow-up|0
1884533|NCT01740427|6499527|P1|Overall Study|Lost to Follow-up|1
1884534|NCT01740427|6499526|P2|Overall Study|Protocol Violation|3
1884535|NCT01740427|6499527|P1|Overall Study|Protocol Violation|5
1884536|NCT01740427|6499526|P2|Overall Study|Death|2
1884537|NCT01740427|6499527|P1|Overall Study|Death|6
1884538|NCT01740427|6499526|P2|Overall Study|Unspecified reasons|4
1884539|NCT01740427|6499527|P1|Overall Study|Unspecified reasons|6
1884540|NCT01740427|6499526|P2|Overall Study|Subject refused continued treatment|9
1884541|NCT01740427|6499527|P1|Overall Study|Subject refused continued treatment|12
1884542|NCT01740427|6499526|P2|Overall Study|Global deterioration of health status|9
1884543|NCT01740427|6499527|P1|Overall Study|Global deterioration of health status|16
1884544|NCT01740427|6499526|P2|Overall Study|Adverse Event|9
1884545|NCT01740427|6499527|P1|Overall Study|Adverse Event|20
1884546|NCT01740427|6499526|P2|Overall Study|Objective progression or relapse|125
1884547|NCT01740427|6499527|P1|Overall Study|Objective progression or relapse|172
1884548|NCT01740427|6499526|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
1884549|NCT01740427|6499527|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
1884550|NCT01729208|6499556|P2|36 Months Follow-up|Withdrawal by Subject|4
1884551|NCT01729208|6499557|P1|36 Months Follow-up|Withdrawal by Subject|2
1884552|NCT01729208|6499556|P2|36 Months Follow-up|Physician Decision|0
1884553|NCT01729208|6499557|P1|36 Months Follow-up|Physician Decision|1
1884554|NCT01729208|6499556|P2|24 Months Follow-up|Lost to Follow-up|0
1884555|NCT01729208|6499557|P1|24 Months Follow-up|Lost to Follow-up|3
1884556|NCT01729208|6499556|P2|12 Months Follow-up|Lost to Follow-up|3
1884557|NCT01729208|6499557|P1|12 Months Follow-up|Lost to Follow-up|3
1884558|NCT01729208|6499556|P2|12 Months Follow-up|Withdrawal by Subject|7
1884559|NCT01729208|6499557|P1|12 Months Follow-up|Withdrawal by Subject|4
1884560|NCT01729208|6499556|P2|Baseline|Physician Decision|4
1884561|NCT01729208|6499557|P1|Baseline|Physician Decision|5
1884562|NCT01723826|6499591|P4|Overall Study|Withdrawal by Subject|48
1884563|NCT01723826|6499592|P3|Overall Study|Withdrawal by Subject|27
1884564|NCT01723826|6499593|P2|Overall Study|Withdrawal by Subject|17
1884565|NCT01723826|6499594|P1|Overall Study|Withdrawal by Subject|10
1884566|NCT01723826|6499591|P4|Overall Study|Protocol Violation|1
1884567|NCT01723826|6499592|P3|Overall Study|Protocol Violation|3
1884568|NCT01723826|6499593|P2|Overall Study|Protocol Violation|1
1884569|NCT01723826|6499594|P1|Overall Study|Protocol Violation|1
1884570|NCT01723826|6499591|P4|Overall Study|Physician Decision|11
1884571|NCT01723826|6499592|P3|Overall Study|Physician Decision|4
1884572|NCT01723826|6499593|P2|Overall Study|Physician Decision|3
1884573|NCT01723826|6499594|P1|Overall Study|Physician Decision|1
1884574|NCT01723826|6499591|P4|Overall Study|Other Reason|14
1884575|NCT01723826|6499592|P3|Overall Study|Other Reason|12
1884576|NCT01723826|6499593|P2|Overall Study|Other Reason|6
1884577|NCT01723826|6499594|P1|Overall Study|Other Reason|8
1884578|NCT01723826|6499591|P4|Overall Study|Non-compliance With Study Drug|0
1884579|NCT01723826|6499592|P3|Overall Study|Non-compliance With Study Drug|0
1884580|NCT01723826|6499593|P2|Overall Study|Non-compliance With Study Drug|1
1884581|NCT01723826|6499594|P1|Overall Study|Non-compliance With Study Drug|0
1884582|NCT01723826|6499591|P4|Overall Study|Non-compliance|3
1884583|NCT01723826|6499592|P3|Overall Study|Non-compliance|3
1884584|NCT01723826|6499593|P2|Overall Study|Non-compliance|1
1884585|NCT01723826|6499594|P1|Overall Study|Non-compliance|0
1884586|NCT01723826|6499591|P4|Overall Study|Lost to Follow-up|1
1884587|NCT01723826|6499592|P3|Overall Study|Lost to Follow-up|1
1884588|NCT01723826|6499593|P2|Overall Study|Lost to Follow-up|3
1884589|NCT01723826|6499594|P1|Overall Study|Lost to Follow-up|1
1884590|NCT01723826|6499591|P4|Overall Study|Death according to AE eCRF|7
1884591|NCT01723826|6499592|P3|Overall Study|Death according to AE eCRF|3
1884592|NCT01723826|6499593|P2|Overall Study|Death according to AE eCRF|3
1884593|NCT01723826|6499594|P1|Overall Study|Death according to AE eCRF|2
1884594|NCT01723826|6499591|P4|Overall Study|Adverse Event|5
1884595|NCT01723826|6499592|P3|Overall Study|Adverse Event|4
1884596|NCT01723826|6499593|P2|Overall Study|Adverse Event|1
1884597|NCT01723826|6499594|P1|Overall Study|Adverse Event|4
1884598|NCT01697800|6499626|P2|Overall Study|Death|1
1884599|NCT01697800|6499627|P1|Overall Study|Death|0
1884600|NCT01691898|6499648|P6|Overall Study|Non-Compliance|0
1884601|NCT01691898|6499649|P5|Overall Study|Non-Compliance|1
1884602|NCT01691898|6499650|P4|Overall Study|Non-Compliance|0
1884603|NCT01691898|6499651|P3|Overall Study|Non-Compliance|0
1884604|NCT01691898|6499652|P2|Overall Study|Non-Compliance|0
1884605|NCT01691898|6499653|P1|Overall Study|Non-Compliance|0
1884606|NCT01691898|6499648|P6|Overall Study|Withdrawal by Subject|3
1884607|NCT01691898|6499649|P5|Overall Study|Withdrawal by Subject|3
1884608|NCT01691898|6499650|P4|Overall Study|Withdrawal by Subject|1
1884609|NCT01691898|6499651|P3|Overall Study|Withdrawal by Subject|2
1884610|NCT01691898|6499652|P2|Overall Study|Withdrawal by Subject|8
1884611|NCT01691898|6499653|P1|Overall Study|Withdrawal by Subject|9
1884612|NCT01691898|6499648|P6|Overall Study|Lost to Follow-up|0
1884613|NCT01691898|6499649|P5|Overall Study|Lost to Follow-up|1
1884614|NCT01691898|6499650|P4|Overall Study|Lost to Follow-up|0
1884615|NCT01691898|6499651|P3|Overall Study|Lost to Follow-up|0
1884616|NCT01691898|6499652|P2|Overall Study|Lost to Follow-up|1
1884617|NCT01691898|6499653|P1|Overall Study|Lost to Follow-up|3
1884618|NCT01691898|6499648|P6|Overall Study|Progression of Disease|1
1884619|NCT01691898|6499649|P5|Overall Study|Progression of Disease|0
1884620|NCT01691898|6499650|P4|Overall Study|Progression of Disease|0
1884621|NCT01691898|6499651|P3|Overall Study|Progression of Disease|1
1884622|NCT01691898|6499652|P2|Overall Study|Progression of Disease|2
1884623|NCT01691898|6499653|P1|Overall Study|Progression of Disease|1
1884624|NCT01691898|6499648|P6|Overall Study|Adverse Event|0
1884625|NCT01691898|6499649|P5|Overall Study|Adverse Event|1
1884626|NCT01691898|6499650|P4|Overall Study|Adverse Event|1
1884627|NCT01691898|6499651|P3|Overall Study|Adverse Event|0
1884628|NCT01691898|6499652|P2|Overall Study|Adverse Event|1
1884629|NCT01691898|6499653|P1|Overall Study|Adverse Event|0
1884630|NCT01691898|6499648|P6|Overall Study|Death|31
1884631|NCT01691898|6499649|P5|Overall Study|Death|8
1884632|NCT01691898|6499650|P4|Overall Study|Death|3
1884633|NCT01691898|6499651|P3|Overall Study|Death|6
1884634|NCT01691898|6499652|P2|Overall Study|Death|32
1884635|NCT01691898|6499653|P1|Overall Study|Death|34
1884636|NCT01668355|6499809|P2|Overall Study|Withdrawal by Subject|1
1884637|NCT01668355|6499810|P1|Overall Study|Withdrawal by Subject|6
1884638|NCT01668355|6499809|P2|Overall Study|Death|1
1884639|NCT01668355|6499810|P1|Overall Study|Death|3
1884640|NCT01665144|6499832|P2|Overall Study|Withdrawal by Subject|77
1884641|NCT01665144|6499833|P1|Overall Study|Withdrawal by Subject|96
1884642|NCT01665144|6499832|P2|Overall Study|Adverse Event|18
1884643|NCT01665144|6499833|P1|Overall Study|Adverse Event|45
1884644|NCT01665144|6499832|P2|Overall Study|Lack of Efficacy|11
1884645|NCT01665144|6499833|P1|Overall Study|Lack of Efficacy|16
1884646|NCT01665144|6499832|P2|Overall Study|Physician Decision|1
1884647|NCT01665144|6499833|P1|Overall Study|Physician Decision|13
1884648|NCT01665144|6499832|P2|Overall Study|Lost to Follow-up|8
1884649|NCT01665144|6499833|P1|Overall Study|Lost to Follow-up|9
1884650|NCT01665144|6499832|P2|Overall Study|Progressive disease|4
1884651|NCT01665144|6499833|P1|Overall Study|Progressive disease|8
1884652|NCT01665144|6499832|P2|Overall Study|Non-compliance w/study treatment|0
1884653|NCT01665144|6499833|P1|Overall Study|Non-compliance w/study treatment|5
1884654|NCT01665144|6499832|P2|Overall Study|Protocol deviation|1
1884655|NCT01665144|6499833|P1|Overall Study|Protocol deviation|3
1884656|NCT01665144|6499832|P2|Overall Study|Death|1
1884657|NCT01665144|6499833|P1|Overall Study|Death|3
1884658|NCT01665144|6499832|P2|Overall Study|Technical problems|0
1884659|NCT01665144|6499833|P1|Overall Study|Technical problems|2
1884660|NCT01665144|6499832|P2|Overall Study|New therapy for study indication|1
1884661|NCT01665144|6499833|P1|Overall Study|New therapy for study indication|2
1884662|NCT01649765|6499841|P2|Overall Study|Withdrawal by Subject|1
1884663|NCT01649765|6499842|P1|Overall Study|Withdrawal by Subject|2
1884664|NCT01649765|6499841|P2|Overall Study|Protocol Violation|0
1884665|NCT01649765|6499842|P1|Overall Study|Protocol Violation|1
1884666|NCT01649765|6499841|P2|Overall Study|Physician Decision|3
1884667|NCT01649765|6499842|P1|Overall Study|Physician Decision|0
1884668|NCT01649765|6499841|P2|Overall Study|Lack of Efficacy|1
1884669|NCT01649765|6499842|P1|Overall Study|Lack of Efficacy|1
1884670|NCT01649765|6499841|P2|Overall Study|Adverse Event|3
1884671|NCT01649765|6499842|P1|Overall Study|Adverse Event|5
1884672|NCT01643850|6499888|P9|Overall Study|Administrative Problems|0
1884673|NCT01643850|6499889|P8|Overall Study|Administrative Problems|0
1884674|NCT01643850|6499890|P7|Overall Study|Administrative Problems|0
1884675|NCT01643850|6499891|P6|Overall Study|Administrative Problems|0
1884676|NCT01643850|6499892|P5|Overall Study|Administrative Problems|1
1884677|NCT01643850|6499893|P4|Overall Study|Administrative Problems|0
1884678|NCT01643850|6499894|P3|Overall Study|Administrative Problems|1
1884679|NCT01643850|6499895|P2|Overall Study|Administrative Problems|0
1884680|NCT01643850|6499896|P1|Overall Study|Administrative Problems|0
1884681|NCT01643850|6499888|P9|Overall Study|Adverse Event|0
1884682|NCT01643850|6499889|P8|Overall Study|Adverse Event|0
1884683|NCT01643850|6499890|P7|Overall Study|Adverse Event|0
1884684|NCT01643850|6499891|P6|Overall Study|Adverse Event|0
1884685|NCT01643850|6499892|P5|Overall Study|Adverse Event|1
1884686|NCT01643850|6499893|P4|Overall Study|Adverse Event|0
1884687|NCT01643850|6499894|P3|Overall Study|Adverse Event|0
1884688|NCT01643850|6499895|P2|Overall Study|Adverse Event|0
1884689|NCT01643850|6499896|P1|Overall Study|Adverse Event|0
1884690|NCT01643850|6499888|P9|Overall Study|Lost to Follow-up|1
1884691|NCT01643850|6499889|P8|Overall Study|Lost to Follow-up|0
1884692|NCT01643850|6499890|P7|Overall Study|Lost to Follow-up|1
1884693|NCT01643850|6499891|P6|Overall Study|Lost to Follow-up|0
1884694|NCT01643850|6499892|P5|Overall Study|Lost to Follow-up|0
1884695|NCT01643850|6499893|P4|Overall Study|Lost to Follow-up|0
1884696|NCT01643850|6499894|P3|Overall Study|Lost to Follow-up|0
1884697|NCT01643850|6499895|P2|Overall Study|Lost to Follow-up|0
1884698|NCT01643850|6499896|P1|Overall Study|Lost to Follow-up|0
1884699|NCT01643850|6499888|P9|Overall Study|Withdrawal by Subject|0
1884700|NCT01643850|6499889|P8|Overall Study|Withdrawal by Subject|0
1884701|NCT01643850|6499890|P7|Overall Study|Withdrawal by Subject|0
1884702|NCT01643850|6499891|P6|Overall Study|Withdrawal by Subject|0
1884703|NCT01643850|6499892|P5|Overall Study|Withdrawal by Subject|1
1884704|NCT01643850|6499893|P4|Overall Study|Withdrawal by Subject|0
1884705|NCT01643850|6499894|P3|Overall Study|Withdrawal by Subject|0
1884706|NCT01643850|6499895|P2|Overall Study|Withdrawal by Subject|0
1884707|NCT01643850|6499896|P1|Overall Study|Withdrawal by Subject|0
1884708|NCT01640366|6500035|P1|Overall Study|Lost to Follow-up|5
1884709|NCT01640366|6500035|P1|Overall Study|Protocol Violation|16
1884710|NCT01640366|6500035|P1|Overall Study|Withdrawal by Subject|1
1884711|NCT01619085|6500085|P1|Overall Study|Ongoing on trial|27
1884712|NCT01619085|6500085|P1|Overall Study|Not treated|1
1884713|NCT01619085|6500085|P1|Overall Study|Other than specified|94
1884714|NCT01619085|6500085|P1|Overall Study|Withdrawal by Subject|15
1884715|NCT01619085|6500085|P1|Overall Study|Lost to Follow-up|10
1884716|NCT01619085|6500085|P1|Overall Study|Protocol Violation|10
1884717|NCT01619085|6500085|P1|Overall Study|Adverse Event|212
1884718|NCT01615029|6500094|P5|Overall Study|Ongoing|23
1884719|NCT01615029|6500095|P4|Overall Study|Ongoing|2
1884720|NCT01615029|6500096|P3|Overall Study|Ongoing|3
1884721|NCT01615029|6500097|P2|Overall Study|Ongoing|2
1884722|NCT01615029|6500098|P1|Overall Study|Ongoing|1
1884723|NCT01615029|6500094|P5|Overall Study|Physician Decision|1
1884724|NCT01615029|6500095|P4|Overall Study|Physician Decision|0
1884725|NCT01615029|6500096|P3|Overall Study|Physician Decision|0
1884726|NCT01615029|6500097|P2|Overall Study|Physician Decision|0
1884727|NCT01615029|6500098|P1|Overall Study|Physician Decision|0
1884728|NCT01615029|6500094|P5|Overall Study|Progressive disease|5
1884729|NCT01615029|6500095|P4|Overall Study|Progressive disease|1
1884730|NCT01615029|6500096|P3|Overall Study|Progressive disease|1
1884731|NCT01615029|6500097|P2|Overall Study|Progressive disease|1
1884732|NCT01615029|6500098|P1|Overall Study|Progressive disease|2
1884733|NCT01615029|6500094|P5|Overall Study|Lost to Follow-up|1
1884734|NCT01615029|6500095|P4|Overall Study|Lost to Follow-up|0
1884735|NCT01615029|6500096|P3|Overall Study|Lost to Follow-up|0
1884736|NCT01615029|6500097|P2|Overall Study|Lost to Follow-up|0
1884737|NCT01615029|6500098|P1|Overall Study|Lost to Follow-up|0
1884738|NCT01615029|6500094|P5|Overall Study|Death|1
1884739|NCT01615029|6500095|P4|Overall Study|Death|0
1884740|NCT01615029|6500096|P3|Overall Study|Death|0
1884741|NCT01615029|6500097|P2|Overall Study|Death|0
1884742|NCT01615029|6500098|P1|Overall Study|Death|0
1884743|NCT01615029|6500094|P5|Overall Study|Adverse Event|1
1884744|NCT01615029|6500095|P4|Overall Study|Adverse Event|0
1884745|NCT01615029|6500096|P3|Overall Study|Adverse Event|0
1884746|NCT01615029|6500097|P2|Overall Study|Adverse Event|0
1884747|NCT01615029|6500098|P1|Overall Study|Adverse Event|0
1884748|NCT01569594|6500132|P1|Overall Study|No ECM used|9
1884749|NCT01569594|6500132|P1|Overall Study|Other|4
1884750|NCT01569594|6500132|P1|Overall Study|Withdrawal by Subject|13
1884751|NCT01569594|6500132|P1|Overall Study|Adverse Event|2
1884752|NCT01569594|6500132|P1|Overall Study|Lost to Follow-up|22
1884753|NCT01569594|6500132|P1|Overall Study|Death|13
1884754|NCT01569594|6500132|P1|Overall Study|Physician Decision|4
1884755|NCT01566695|6500138|P2|Overall Study|Miscellaneous|6
1884756|NCT01566695|6500139|P1|Overall Study|Miscellaneous|4
1884757|NCT01566695|6500138|P2|Overall Study|Progressive Disease|6
1884758|NCT01566695|6500139|P1|Overall Study|Progressive Disease|11
1884759|NCT01566695|6500138|P2|Overall Study|Withdrawal by Subject|7
1884760|NCT01566695|6500139|P1|Overall Study|Withdrawal by Subject|14
1884761|NCT01566695|6500138|P2|Overall Study|Death|8
1884762|NCT01566695|6500139|P1|Overall Study|Death|20
1884763|NCT01566695|6500138|P2|Overall Study|Adverse Event|27
1884764|NCT01566695|6500139|P1|Overall Study|Adverse Event|28
1884765|NCT01566695|6500138|P2|Overall Study|Lack of Efficacy|45
1884766|NCT01566695|6500139|P1|Overall Study|Lack of Efficacy|18
1884767|NCT01467427|6500273|P2|Overall Study|Not continuing in extension phase|2
1884768|NCT01467427|6500274|P1|Overall Study|Not continuing in extension phase|0
1884769|NCT01467427|6500273|P2|Overall Study|Entered extension phase|11
1884770|NCT01467427|6500274|P1|Overall Study|Entered extension phase|11
1884771|NCT01467427|6500273|P2|Overall Study|Withdrawal by Subject|0
1884772|NCT01467427|6500274|P1|Overall Study|Withdrawal by Subject|1
1884773|NCT01463306|6500295|P3|Overall Study|Approval expiry at site|0
1884774|NCT01463306|6500296|P2|Overall Study|Approval expiry at site|0
1884775|NCT01463306|6500297|P1|Overall Study|Approval expiry at site|1
1884776|NCT01463306|6500295|P3|Overall Study|Other|0
1884777|NCT01463306|6500296|P2|Overall Study|Other|13
1884778|NCT01463306|6500297|P1|Overall Study|Other|26
1884779|NCT01463306|6500295|P3|Overall Study|Withdrawal by Subject|1
1884780|NCT01463306|6500296|P2|Overall Study|Withdrawal by Subject|9
1884781|NCT01463306|6500297|P1|Overall Study|Withdrawal by Subject|19
1884782|NCT01463306|6500295|P3|Overall Study|Protocol Violation|0
1884783|NCT01463306|6500296|P2|Overall Study|Protocol Violation|0
1884784|NCT01463306|6500297|P1|Overall Study|Protocol Violation|4
1884785|NCT01463306|6500295|P3|Overall Study|Lost to Follow-up|0
1884786|NCT01463306|6500296|P2|Overall Study|Lost to Follow-up|2
1884787|NCT01463306|6500297|P1|Overall Study|Lost to Follow-up|5
1884788|NCT01463306|6500295|P3|Overall Study|Lack of Efficacy|1
1884789|NCT01463306|6500296|P2|Overall Study|Lack of Efficacy|16
1884790|NCT01463306|6500297|P1|Overall Study|Lack of Efficacy|22
1884791|NCT01463306|6500295|P3|Overall Study|Death|0
1884792|NCT01463306|6500296|P2|Overall Study|Death|3
1884793|NCT01463306|6500297|P1|Overall Study|Death|3
1884794|NCT01463306|6500295|P3|Overall Study|Adverse Event|3
1884795|NCT01463306|6500296|P2|Overall Study|Adverse Event|9
1884796|NCT01463306|6500297|P1|Overall Study|Adverse Event|6
1884797|NCT01438177|6500365|P1|Overall Study|Initiation of new therapy|1
1884798|NCT01438177|6500365|P1|Overall Study|Withdrawal by Subject|1
1884799|NCT01393821|6500407|P2|Overall Study|not evaluable for primary endpoint|2
1884800|NCT01393821|6500408|P1|Overall Study|not evaluable for primary endpoint|4
1884801|NCT01393821|6500407|P2|Overall Study|Cancel|1
1884802|NCT01393821|6500408|P1|Overall Study|Cancel|1
1884803|NCT01371305|6500426|P6|Overall Study|Subject request|1
1884804|NCT01371305|6500427|P5|Overall Study|Subject request|0
1884805|NCT01371305|6500428|P4|Overall Study|Subject request|0
1884806|NCT01371305|6500429|P3|Overall Study|Subject request|0
1884807|NCT01371305|6500430|P2|Overall Study|Subject request|0
1884808|NCT01371305|6500431|P1|Overall Study|Subject request|0
1884809|NCT01371305|6500426|P6|Overall Study|Study terminated by sponsor|1
1884810|NCT01371305|6500427|P5|Overall Study|Study terminated by sponsor|3
1884811|NCT01371305|6500428|P4|Overall Study|Study terminated by sponsor|0
1884812|NCT01371305|6500429|P3|Overall Study|Study terminated by sponsor|0
1884813|NCT01371305|6500430|P2|Overall Study|Study terminated by sponsor|0
1884814|NCT01371305|6500431|P1|Overall Study|Study terminated by sponsor|0
1884815|NCT01371305|6500426|P6|Overall Study|Adverse Event|0
1884816|NCT01371305|6500427|P5|Overall Study|Adverse Event|1
1884817|NCT01371305|6500428|P4|Overall Study|Adverse Event|2
1884818|NCT01371305|6500429|P3|Overall Study|Adverse Event|0
1884819|NCT01371305|6500430|P2|Overall Study|Adverse Event|0
1884820|NCT01371305|6500431|P1|Overall Study|Adverse Event|0
1884821|NCT01369199|6500502|P1|Overall Study|Lost to Follow-up|2
1884822|NCT01369199|6500502|P1|Overall Study|Withdrawal by Subject|1
1884823|NCT01348542|6500539|P2|Overall Study|Withdrawal by Subject|0
1884824|NCT01348542|6500540|P1|Overall Study|Withdrawal by Subject|3
1884825|NCT01317160|6500590|P2|Overall Study|Withdrawal by Subject|2
1884826|NCT01317160|6500591|P1|Overall Study|Withdrawal by Subject|0
1884827|NCT01317160|6500590|P2|Overall Study|Lost to Follow-up|3
1884828|NCT01317160|6500591|P1|Overall Study|Lost to Follow-up|3
1884829|NCT01317160|6500590|P2|Overall Study|Incorrect inclusion|1
1884830|NCT01317160|6500591|P1|Overall Study|Incorrect inclusion|1
1884831|NCT01202409|6500635|P1|Overall Study|Ineligible - KRAS mutants|7
1884832|NCT01202409|6500635|P1|Overall Study|Adverse Event|1
1884833|NCT01149096|6500642|P2|Overall Study|Lost to Follow-up|1
1884834|NCT01149096|6500643|P1|Overall Study|Lost to Follow-up|0
1884835|NCT01096550|6500778|P2|Overall Study|Lost to Follow-up|9
1884836|NCT01096550|6500779|P1|Overall Study|Lost to Follow-up|12
1884837|NCT01096550|6500778|P2|Overall Study|non-African American participant|6
1884838|NCT01096550|6500779|P1|Overall Study|non-African American participant|13
1884839|NCT01096550|6500778|P2|Overall Study|Withdrawal by Subject|1
1884840|NCT01096550|6500779|P1|Overall Study|Withdrawal by Subject|0
1884841|NCT01096550|6500778|P2|Overall Study|clinic readmission|1
1884842|NCT01096550|6500779|P1|Overall Study|clinic readmission|1
1884843|NCT01096550|6500778|P2|Overall Study|non-regular treatment track at clinic|1
1884844|NCT01096550|6500779|P1|Overall Study|non-regular treatment track at clinic|1
1884845|NCT01096550|6500778|P2|Overall Study|discontinued site|11
1884846|NCT01096550|6500779|P1|Overall Study|discontinued site|10
1884847|NCT01094782|6500791|P6|Overall Study|Noncompliance With Study Schedule|0
1884848|NCT01094782|6500792|P5|Overall Study|Noncompliance With Study Schedule|0
1884849|NCT01094782|6500793|P4|Overall Study|Noncompliance With Study Schedule|1
1884850|NCT01094782|6500794|P3|Overall Study|Noncompliance With Study Schedule|0
1884851|NCT01094782|6500795|P2|Overall Study|Noncompliance With Study Schedule|0
1884852|NCT01094782|6500796|P1|Overall Study|Noncompliance With Study Schedule|0
1884853|NCT01094782|6500791|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
1884854|NCT01094782|6500792|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
1884855|NCT01094782|6500793|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
1884856|NCT01094782|6500794|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
1884857|NCT01094782|6500795|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
1884858|NCT01094782|6500796|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
1884859|NCT01094782|6500791|P6|Overall Study|Recent Interventional Injection|1
1884860|NCT01094782|6500792|P5|Overall Study|Recent Interventional Injection|0
1884861|NCT01094782|6500793|P4|Overall Study|Recent Interventional Injection|0
1884862|NCT01094782|6500794|P3|Overall Study|Recent Interventional Injection|0
1884863|NCT01094782|6500795|P2|Overall Study|Recent Interventional Injection|0
1884864|NCT01094782|6500796|P1|Overall Study|Recent Interventional Injection|0
1884865|NCT01094782|6500791|P6|Overall Study|Wrong Pain Condition|1
1884866|NCT01094782|6500792|P5|Overall Study|Wrong Pain Condition|1
1884867|NCT01094782|6500793|P4|Overall Study|Wrong Pain Condition|2
1884868|NCT01094782|6500794|P3|Overall Study|Wrong Pain Condition|0
1884869|NCT01094782|6500795|P2|Overall Study|Wrong Pain Condition|0
1884870|NCT01094782|6500796|P1|Overall Study|Wrong Pain Condition|0
1884871|NCT01094782|6500791|P6|Overall Study|Hypertension|0
1884872|NCT01094782|6500792|P5|Overall Study|Hypertension|0
1884873|NCT01094782|6500793|P4|Overall Study|Hypertension|0
1884874|NCT01094782|6500794|P3|Overall Study|Hypertension|1
1884875|NCT01094782|6500795|P2|Overall Study|Hypertension|0
1884876|NCT01094782|6500796|P1|Overall Study|Hypertension|0
1884877|NCT01094782|6500791|P6|Overall Study|Healthy Subject Had Pain|0
1884878|NCT01094782|6500792|P5|Overall Study|Healthy Subject Had Pain|0
1884879|NCT01094782|6500793|P4|Overall Study|Healthy Subject Had Pain|0
1884880|NCT01094782|6500794|P3|Overall Study|Healthy Subject Had Pain|0
1884881|NCT01094782|6500795|P2|Overall Study|Healthy Subject Had Pain|1
1884882|NCT01094782|6500796|P1|Overall Study|Healthy Subject Had Pain|0
1884883|NCT01094782|6500791|P6|Overall Study|Unable to Complete Questionnaires|0
1884884|NCT01094782|6500792|P5|Overall Study|Unable to Complete Questionnaires|0
1884885|NCT01094782|6500793|P4|Overall Study|Unable to Complete Questionnaires|0
1884886|NCT01094782|6500794|P3|Overall Study|Unable to Complete Questionnaires|0
1884887|NCT01094782|6500795|P2|Overall Study|Unable to Complete Questionnaires|1
1884888|NCT01094782|6500796|P1|Overall Study|Unable to Complete Questionnaires|0
1884889|NCT01094782|6500791|P6|Overall Study|Sensory Deficit at Site of QST|0
1884890|NCT01094782|6500792|P5|Overall Study|Sensory Deficit at Site of QST|0
1884891|NCT01094782|6500793|P4|Overall Study|Sensory Deficit at Site of QST|0
1884892|NCT01094782|6500794|P3|Overall Study|Sensory Deficit at Site of QST|0
1884893|NCT01094782|6500795|P2|Overall Study|Sensory Deficit at Site of QST|1
1884894|NCT01094782|6500796|P1|Overall Study|Sensory Deficit at Site of QST|0
1884895|NCT01094782|6500791|P6|Overall Study|Positive Drug Screen|2
1884896|NCT01094782|6500792|P5|Overall Study|Positive Drug Screen|3
1884897|NCT01094782|6500793|P4|Overall Study|Positive Drug Screen|1
1884898|NCT01094782|6500794|P3|Overall Study|Positive Drug Screen|1
1884899|NCT01094782|6500795|P2|Overall Study|Positive Drug Screen|2
1884900|NCT01094782|6500796|P1|Overall Study|Positive Drug Screen|2
1884901|NCT01094782|6500791|P6|Overall Study|Lost to Follow-up|4
1884902|NCT01094782|6500792|P5|Overall Study|Lost to Follow-up|1
1884903|NCT01094782|6500793|P4|Overall Study|Lost to Follow-up|2
1884904|NCT01094782|6500794|P3|Overall Study|Lost to Follow-up|0
1884905|NCT01094782|6500795|P2|Overall Study|Lost to Follow-up|0
1884906|NCT01094782|6500796|P1|Overall Study|Lost to Follow-up|1
1884907|NCT01094782|6500791|P6|Overall Study|Withdrawal by Subject|0
1884908|NCT01094782|6500792|P5|Overall Study|Withdrawal by Subject|5
1884909|NCT01094782|6500793|P4|Overall Study|Withdrawal by Subject|5
1884910|NCT01094782|6500794|P3|Overall Study|Withdrawal by Subject|1
1884911|NCT01094782|6500795|P2|Overall Study|Withdrawal by Subject|5
1884912|NCT01094782|6500796|P1|Overall Study|Withdrawal by Subject|5
1884913|NCT01065454|6500844|P4|Follow up|study ongoing|41
1884914|NCT01065454|6500845|P3|Follow up|study ongoing|15
1884915|NCT01065454|6500846|P2|Follow up|study ongoing|22
1884916|NCT01065454|6500847|P1|Follow up|study ongoing|37
1884917|NCT01065454|6500844|P4|Follow up|Withdrawal by Subject|0
1884918|NCT01065454|6500845|P3|Follow up|Withdrawal by Subject|1
1884919|NCT01065454|6500846|P2|Follow up|Withdrawal by Subject|1
1884920|NCT01065454|6500847|P1|Follow up|Withdrawal by Subject|1
1884921|NCT01065454|6500844|P4|Follow up|Progressive disease|1
1884922|NCT01065454|6500845|P3|Follow up|Progressive disease|0
1884923|NCT01065454|6500846|P2|Follow up|Progressive disease|0
1884924|NCT01065454|6500847|P1|Follow up|Progressive disease|0
1884925|NCT01065454|6500844|P4|Follow up|Lost to Follow-up|1
1884926|NCT01065454|6500845|P3|Follow up|Lost to Follow-up|0
1884927|NCT01065454|6500846|P2|Follow up|Lost to Follow-up|0
1884928|NCT01065454|6500847|P1|Follow up|Lost to Follow-up|0
1884929|NCT01065454|6500844|P4|Follow up|Death|0
1884930|NCT01065454|6500845|P3|Follow up|Death|1
1884931|NCT01065454|6500846|P2|Follow up|Death|1
1884932|NCT01065454|6500847|P1|Follow up|Death|0
1884933|NCT01065454|6500844|P4|Follow up|Adverse Event|1
1884934|NCT01065454|6500845|P3|Follow up|Adverse Event|0
1884935|NCT01065454|6500846|P2|Follow up|Adverse Event|0
1884936|NCT01065454|6500847|P1|Follow up|Adverse Event|1
1884937|NCT01065454|6500844|P4|Treatment|Withdrawal by Subject|3
1884938|NCT01065454|6500845|P3|Treatment|Withdrawal by Subject|2
1884939|NCT01065454|6500846|P2|Treatment|Withdrawal by Subject|1
1884940|NCT01065454|6500847|P1|Treatment|Withdrawal by Subject|3
1884941|NCT01065454|6500844|P4|Treatment|Protocol Violation|0
1884942|NCT01065454|6500845|P3|Treatment|Protocol Violation|1
1884943|NCT01065454|6500846|P2|Treatment|Protocol Violation|0
1884944|NCT01065454|6500847|P1|Treatment|Protocol Violation|1
1884945|NCT01065454|6500844|P4|Treatment|Protocol Decision|2
1884946|NCT01065454|6500845|P3|Treatment|Protocol Decision|3
1884947|NCT01065454|6500846|P2|Treatment|Protocol Decision|0
1884948|NCT01065454|6500847|P1|Treatment|Protocol Decision|0
1884949|NCT01065454|6500844|P4|Treatment|Non-compliance|1
1884950|NCT01065454|6500845|P3|Treatment|Non-compliance|0
1884951|NCT01065454|6500846|P2|Treatment|Non-compliance|0
1884952|NCT01065454|6500847|P1|Treatment|Non-compliance|1
1884953|NCT01065454|6500844|P4|Treatment|Death|0
1884954|NCT01065454|6500845|P3|Treatment|Death|0
1884955|NCT01065454|6500846|P2|Treatment|Death|0
1884956|NCT01065454|6500847|P1|Treatment|Death|1
1884957|NCT01065454|6500844|P4|Treatment|Adverse Event|6
1884958|NCT01065454|6500845|P3|Treatment|Adverse Event|3
1884959|NCT01065454|6500846|P2|Treatment|Adverse Event|4
1884960|NCT01065454|6500847|P1|Treatment|Adverse Event|7
1884961|NCT01063517|6500959|P2|Overall Study|Death|48
1884962|NCT01063517|6500960|P1|Overall Study|Death|33
1884963|NCT01063517|6500959|P2|Overall Study|Withdrawal by Subject|2
1884964|NCT01063517|6500960|P1|Overall Study|Withdrawal by Subject|1
1884965|NCT01063517|6500959|P2|Overall Study|Lost to Follow-up|3
1884966|NCT01063517|6500960|P1|Overall Study|Lost to Follow-up|4
1884967|NCT01063517|6500959|P2|Overall Study|Study reached data cut-off|7
1884968|NCT01063517|6500960|P1|Overall Study|Study reached data cut-off|19
1884969|NCT01063517|6500959|P2|Overall Study|Consent withdrawal|0
1884970|NCT01063517|6500960|P1|Overall Study|Consent withdrawal|1
1884971|NCT01015833|6501000|P2|Overall Study|Did not start treatment|0
1884972|NCT01015833|6501001|P1|Overall Study|Did not start treatment|1
1884973|NCT01015833|6501000|P2|Overall Study|Motor Vehicle Accidents|0
1884974|NCT01015833|6501001|P1|Overall Study|Motor Vehicle Accidents|1
1884975|NCT01015833|6501000|P2|Overall Study|Other|1
1884976|NCT01015833|6501001|P1|Overall Study|Other|5
1884977|NCT01015833|6501000|P2|Overall Study|Symptomatic deterioration|1
1884978|NCT01015833|6501001|P1|Overall Study|Symptomatic deterioration|0
1884979|NCT01015833|6501000|P2|Overall Study|Physician Decision|0
1884980|NCT01015833|6501001|P1|Overall Study|Physician Decision|2
1884981|NCT01015833|6501000|P2|Overall Study|Adverse Event|1
1884982|NCT01015833|6501001|P1|Overall Study|Adverse Event|0
1884983|NCT01015833|6501000|P2|Overall Study|Withdrawal by Subject|2
1884984|NCT01015833|6501001|P1|Overall Study|Withdrawal by Subject|3
1884985|NCT01015833|6501000|P2|Overall Study|Death|0
1884986|NCT01015833|6501001|P1|Overall Study|Death|1
1884987|NCT00969332|6501042|P1|Overall Study|Withdrawal by Subject|3
1884988|NCT00969332|6501042|P1|Overall Study|Physician Decision|8
1884989|NCT00952588|6501071|P2|Overall Study|Lack of Efficacy|2
1884990|NCT00952588|6501072|P1|Overall Study|Lack of Efficacy|2
1884991|NCT00952588|6501071|P2|Overall Study|Physician Decision|1
1884992|NCT00952588|6501072|P1|Overall Study|Physician Decision|0
1884993|NCT00952588|6501071|P2|Overall Study|Lost to Follow-up|0
1884994|NCT00952588|6501072|P1|Overall Study|Lost to Follow-up|2
1884995|NCT00952588|6501071|P2|Overall Study|Adverse Event|3
1884996|NCT00952588|6501072|P1|Overall Study|Adverse Event|2
1884997|NCT00952588|6501071|P2|Overall Study|Withdrawal by Subject|5
1884998|NCT00952588|6501072|P1|Overall Study|Withdrawal by Subject|2
1884999|NCT00952588|6501071|P2|Overall Study|Death|13
1885000|NCT00952588|6501072|P1|Overall Study|Death|28
1885001|NCT00951496|6501093|P3|Overall Study|Did not initiate study treatment|13
1885002|NCT00951496|6501094|P2|Overall Study|Did not initiate study treatment|8
1885003|NCT00951496|6501095|P1|Overall Study|Did not initiate study treatment|10
1885004|NCT00948064|6501124|P3|Phase II|Withdrawal by Subject|0
1885005|NCT00948064|6501125|P2|Phase II|Withdrawal by Subject|1
1885006|NCT00948064|6501126|P1|Phase II|Withdrawal by Subject|0
1885007|NCT00948064|6501124|P3|Phase II|Physician Decision|1
1885008|NCT00948064|6501125|P2|Phase II|Physician Decision|0
1885009|NCT00948064|6501126|P1|Phase II|Physician Decision|0
1885010|NCT00948064|6501124|P3|Phase I|No treatment received|0
1885011|NCT00948064|6501125|P2|Phase I|No treatment received|0
1885012|NCT00948064|6501126|P1|Phase I|No treatment received|1
1885013|NCT00918333|6501148|P2|Overall Study|Withdrawal by Subject|1
1885014|NCT00918333|6501149|P1|Overall Study|Withdrawal by Subject|0
1885015|NCT00918333|6501148|P2|Overall Study|Ineligible|0
1885016|NCT00918333|6501149|P1|Overall Study|Ineligible|1
1885017|NCT00918333|6501148|P2|Overall Study|Inadequate amount of drugs provided|4
1885018|NCT00918333|6501149|P1|Overall Study|Inadequate amount of drugs provided|1
1885019|NCT00918333|6501148|P2|Overall Study|Drug not taken per protocol|0
1885020|NCT00918333|6501149|P1|Overall Study|Drug not taken per protocol|1
1885021|NCT00868166|6501179|P2|Overall Study|Non-compliance with IMP|1
1885022|NCT00868166|6501180|P1|Overall Study|Non-compliance with IMP|1
1885023|NCT00868166|6501179|P2|Overall Study|Lack of efficacy, logistics, unwell|10
1885024|NCT00868166|6501180|P1|Overall Study|Lack of efficacy, logistics, unwell|9
1885025|NCT00868166|6501179|P2|Overall Study|Adverse Event|10
1885026|NCT00868166|6501180|P1|Overall Study|Adverse Event|9
1885027|NCT00868166|6501179|P2|Overall Study|Lost to Follow-up|3
1885028|NCT00868166|6501180|P1|Overall Study|Lost to Follow-up|1
1885029|NCT00868166|6501179|P2|Overall Study|Protocol Violation|0
1885030|NCT00868166|6501180|P1|Overall Study|Protocol Violation|1
1885031|NCT00868166|6501179|P2|Overall Study|Withdrawal by Subject|25
1885032|NCT00868166|6501180|P1|Overall Study|Withdrawal by Subject|33
1885033|NCT00868166|6501179|P2|Overall Study|Death|65
1885034|NCT00868166|6501180|P1|Overall Study|Death|58
1885035|NCT00846742|6501200|P1|Overall Study|Withdrawal by Subject|1
1885036|NCT00792948|6501217|P1|Overall Study|Protocol Violation|1
1885037|NCT00792948|6501217|P1|Overall Study|Physician Decision|11
1885038|NCT00792948|6501217|P1|Overall Study|Insurance denial - not treated|1
1885039|NCT00792948|6501217|P1|Overall Study|Ineligible|2
1885040|NCT00792948|6501217|P1|Overall Study|Withdrawal by Subject|3
1885041|NCT00792948|6501217|P1|Overall Study|Death|4
1885042|NCT00792948|6501217|P1|Overall Study|Adverse Event|6
1885043|NCT00785291|6501238|P3|Overall Study|Other Medical Reasons|15
1885044|NCT00785291|6501239|P2|Overall Study|Other Medical Reasons|25
1885045|NCT00785291|6501240|P1|Overall Study|Other Medical Reasons|29
1885046|NCT00785291|6501238|P3|Overall Study|Complicating illness|4
1885047|NCT00785291|6501239|P2|Overall Study|Complicating illness|4
1885048|NCT00785291|6501240|P1|Overall Study|Complicating illness|6
1885049|NCT00785291|6501238|P3|Overall Study|Alternative Therapy|7
1885050|NCT00785291|6501239|P2|Overall Study|Alternative Therapy|6
1885051|NCT00785291|6501240|P1|Overall Study|Alternative Therapy|12
1885052|NCT00785291|6501238|P3|Overall Study|Withdrawal by Subject|17
1885053|NCT00785291|6501239|P2|Overall Study|Withdrawal by Subject|36
1885054|NCT00785291|6501240|P1|Overall Study|Withdrawal by Subject|35
1885055|NCT00785291|6501238|P3|Overall Study|Death|3
1885056|NCT00785291|6501239|P2|Overall Study|Death|4
1885057|NCT00785291|6501240|P1|Overall Study|Death|7
1885058|NCT00785291|6501238|P3|Overall Study|Adverse Event|56
1885059|NCT00785291|6501239|P2|Overall Study|Adverse Event|70
1885060|NCT00785291|6501240|P1|Overall Study|Adverse Event|39
1885061|NCT00785291|6501238|P3|Overall Study|Never began treatment|4
1885062|NCT00785291|6501239|P2|Overall Study|Never began treatment|4
1885063|NCT00785291|6501240|P1|Overall Study|Never began treatment|8
1885064|NCT00727441|6501279|P3|Overall Study|Withdrawal by Subject|0
1885065|NCT00727441|6501280|P2|Overall Study|Withdrawal by Subject|1
1885066|NCT00727441|6501281|P1|Overall Study|Withdrawal by Subject|0
1885067|NCT00727441|6501279|P3|Overall Study|Physician Decision|0
1885068|NCT00727441|6501280|P2|Overall Study|Physician Decision|1
1885069|NCT00727441|6501281|P1|Overall Study|Physician Decision|0
1885070|NCT00727441|6501279|P3|Overall Study|Death|1
1885071|NCT00727441|6501280|P2|Overall Study|Death|1
1885072|NCT00727441|6501281|P1|Overall Study|Death|0
1885073|NCT00727441|6501279|P3|Overall Study|Eligibility|7
1885074|NCT00727441|6501280|P2|Overall Study|Eligibility|5
1885075|NCT00727441|6501281|P1|Overall Study|Eligibility|7
1885076|NCT00727441|6501279|P3|Overall Study|Disease Progression|17
1885077|NCT00727441|6501280|P2|Overall Study|Disease Progression|14
1885078|NCT00727441|6501281|P1|Overall Study|Disease Progression|11
1885079|NCT00700882|6501301|P1|Overall Study|No KIT mutation|51
1885080|NCT00700882|6501301|P1|Overall Study|Ineligible|2
1885081|NCT00700882|6501301|P1|Overall Study|Never received treatment|6
1885082|NCT00676689|6501305|P1|Overall Study|Continuing FU|49
1885083|NCT00676689|6501305|P1|Overall Study|Withdrawal by Subject|3
1885084|NCT00676689|6501305|P1|Overall Study|Physician Decision|1
1885085|NCT00676689|6501305|P1|Overall Study|Lost to Follow-up|4
1885086|NCT00676689|6501305|P1|Overall Study|Death|2
1885087|NCT00676689|6501305|P1|Overall Study|Screen Failure|2
1885088|NCT00673790|6501314|P3|Overall Study|Randomization criteria not met|0
1885089|NCT00673790|6501315|P2|Overall Study|Randomization criteria not met|1
1885090|NCT00673790|6501316|P1|Overall Study|Randomization criteria not met|0
1885091|NCT00673790|6501314|P3|Overall Study|Unconfirmed pregnancy|0
1885092|NCT00673790|6501315|P2|Overall Study|Unconfirmed pregnancy|1
1885093|NCT00673790|6501316|P1|Overall Study|Unconfirmed pregnancy|0
1885094|NCT00673790|6501314|P3|Overall Study|Participated in two Nebivolol studies|1
1885095|NCT00673790|6501315|P2|Overall Study|Participated in two Nebivolol studies|0
1885096|NCT00673790|6501316|P1|Overall Study|Participated in two Nebivolol studies|0
1885097|NCT00673790|6501314|P3|Overall Study|Poor compliance|0
1885098|NCT00673790|6501315|P2|Overall Study|Poor compliance|0
1885099|NCT00673790|6501316|P1|Overall Study|Poor compliance|1
1885100|NCT00673790|6501314|P3|Overall Study|Sponsor Terminated due to PI oversight|0
1885101|NCT00673790|6501315|P2|Overall Study|Sponsor Terminated due to PI oversight|1
1885102|NCT00673790|6501316|P1|Overall Study|Sponsor Terminated due to PI oversight|0
1885103|NCT00673790|6501314|P3|Overall Study|Lost to Follow-up|5
1885104|NCT00673790|6501315|P2|Overall Study|Lost to Follow-up|6
1885105|NCT00673790|6501316|P1|Overall Study|Lost to Follow-up|6
1885106|NCT00673790|6501314|P3|Overall Study|Withdrawal by Subject|1
1885107|NCT00673790|6501315|P2|Overall Study|Withdrawal by Subject|4
1885108|NCT00673790|6501316|P1|Overall Study|Withdrawal by Subject|7
1885109|NCT00673790|6501314|P3|Overall Study|Protocol Violation|1
1885110|NCT00673790|6501315|P2|Overall Study|Protocol Violation|9
1885111|NCT00673790|6501316|P1|Overall Study|Protocol Violation|6
1885112|NCT00673790|6501314|P3|Overall Study|Lack of Efficacy|2
1885113|NCT00673790|6501315|P2|Overall Study|Lack of Efficacy|2
1885114|NCT00673790|6501316|P1|Overall Study|Lack of Efficacy|2
1885115|NCT00673790|6501314|P3|Overall Study|Adverse Event|2
1885116|NCT00673790|6501315|P2|Overall Study|Adverse Event|14
1885117|NCT00673790|6501316|P1|Overall Study|Adverse Event|23
1885118|NCT00667251|6501328|P2|Overall Study|Symptomatic progression|2
1885119|NCT00667251|6501329|P1|Overall Study|Symptomatic progression|1
1885120|NCT00667251|6501328|P2|Overall Study|Intercurrent Illness|3
1885121|NCT00667251|6501329|P1|Overall Study|Intercurrent Illness|4
1885122|NCT00667251|6501328|P2|Overall Study|Other/missing|84
1885123|NCT00667251|6501329|P1|Overall Study|Other/missing|46
1885124|NCT00667251|6501328|P2|Overall Study|Withdrawal by Subject|2
1885125|NCT00667251|6501329|P1|Overall Study|Withdrawal by Subject|6
1885126|NCT00667251|6501328|P2|Overall Study|Adverse Event|4
1885127|NCT00667251|6501329|P1|Overall Study|Adverse Event|13
1885128|NCT00661193|6501355|P2|Overall Study|Not protocol specified|0
1885129|NCT00661193|6501356|P1|Overall Study|Not protocol specified|1
1885130|NCT00661193|6501355|P2|Overall Study|Progression|24
1885131|NCT00661193|6501356|P1|Overall Study|Progression|27
1885132|NCT00661193|6501355|P2|Overall Study|Withdrawal by Subject|1
1885133|NCT00661193|6501356|P1|Overall Study|Withdrawal by Subject|3
1885134|NCT00661193|6501355|P2|Overall Study|Adverse Event|1
1885135|NCT00661193|6501356|P1|Overall Study|Adverse Event|2
1885136|NCT00658814|6501366|P2|Maintenance Therapy|Not eligible|0
1885137|NCT00658814|6501367|P1|Maintenance Therapy|Not eligible|1
1885138|NCT00658814|6501366|P2|Maintenance Therapy|Not protocol specified|0
1885139|NCT00658814|6501367|P1|Maintenance Therapy|Not protocol specified|1
1885140|NCT00658814|6501366|P2|Maintenance Therapy|Adverse Event|1
1885141|NCT00658814|6501367|P1|Maintenance Therapy|Adverse Event|1
1885142|NCT00658814|6501366|P2|Consolidation Therapy|Not eligible|2
1885143|NCT00658814|6501367|P1|Consolidation Therapy|Not eligible|2
1885144|NCT00658814|6501366|P2|Consolidation Therapy|Not protocol specified|1
1885145|NCT00658814|6501367|P1|Consolidation Therapy|Not protocol specified|0
1885146|NCT00658814|6501366|P2|Remission Induction Chemotherapy|Not eligible|2
1885147|NCT00658814|6501367|P1|Remission Induction Chemotherapy|Not eligible|1
1885148|NCT00658814|6501366|P2|Remission Induction Chemotherapy|Not protocol specified|4
1885149|NCT00658814|6501367|P1|Remission Induction Chemotherapy|Not protocol specified|2
1885150|NCT00658814|6501366|P2|Remission Induction Chemotherapy|Death|4
1885151|NCT00658814|6501367|P1|Remission Induction Chemotherapy|Death|1
1885152|NCT00658814|6501366|P2|Remission Induction Chemotherapy|Progression/Relapse|1
1885153|NCT00658814|6501367|P1|Remission Induction Chemotherapy|Progression/Relapse|0
1885154|NCT00658814|6501366|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
1885155|NCT00658814|6501367|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
1885156|NCT00658814|6501366|P2|Remission Induction Chemotherapy|Adverse Event|3
1885157|NCT00658814|6501367|P1|Remission Induction Chemotherapy|Adverse Event|1
1885158|NCT00654732|6501383|P2|Overall Study|Adverse Event|6
1885159|NCT00654732|6501384|P1|Overall Study|Adverse Event|4
1885160|NCT00625846|6501394|P4|Overall Study|Withdrawal by Subject|2
1885161|NCT00625846|6501395|P3|Overall Study|Withdrawal by Subject|1
1885162|NCT00625846|6501396|P2|Overall Study|Withdrawal by Subject|0
1885163|NCT00625846|6501397|P1|Overall Study|Withdrawal by Subject|2
1885164|NCT00616967|6501425|P3|Overall Study|Withdrawal by Subject|1
1885165|NCT00616967|6501426|P2|Overall Study|Withdrawal by Subject|0
1885166|NCT00616967|6501427|P1|Overall Study|Withdrawal by Subject|0
1885167|NCT00601900|6501451|P2|Overall Study|Withdrawal by Subject|3
1885168|NCT00601900|6501452|P1|Overall Study|Withdrawal by Subject|0
1885169|NCT00588770|6501468|P2|Overall Study|Patient non-compliance|2
1885170|NCT00588770|6501469|P1|Overall Study|Patient non-compliance|2
1885171|NCT00588770|6501468|P2|Overall Study|Physician discretion|0
1885172|NCT00588770|6501469|P1|Overall Study|Physician discretion|2
1885173|NCT00588770|6501468|P2|Overall Study|Lack of Efficacy|10
1885174|NCT00588770|6501469|P1|Overall Study|Lack of Efficacy|8
1885175|NCT00588770|6501468|P2|Overall Study|Not start protocol therapy|9
1885176|NCT00588770|6501469|P1|Overall Study|Not start protocol therapy|0
1885177|NCT00588770|6501468|P2|Overall Study|Other complicating disease|2
1885178|NCT00588770|6501469|P1|Overall Study|Other complicating disease|3
1885179|NCT00588770|6501468|P2|Overall Study|Alternative therapy|4
1885180|NCT00588770|6501469|P1|Overall Study|Alternative therapy|2
1885181|NCT00588770|6501468|P2|Overall Study|Withdrawal by Subject|25
1885182|NCT00588770|6501469|P1|Overall Study|Withdrawal by Subject|15
1885183|NCT00588770|6501468|P2|Overall Study|Death|22
1885184|NCT00588770|6501469|P1|Overall Study|Death|13
1885185|NCT00588770|6501468|P2|Overall Study|Adverse Event|58
1885186|NCT00588770|6501469|P1|Overall Study|Adverse Event|29
1885187|NCT00588770|6501468|P2|Overall Study|Disease progression|68
1885188|NCT00588770|6501469|P1|Overall Study|Disease progression|85
1885189|NCT00433511|6501516|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
1885190|NCT00433511|6501517|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
1885191|NCT00433511|6501518|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
1885192|NCT00433511|6501516|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
1885193|NCT00433511|6501517|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
1885194|NCT00433511|6501518|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
1885195|NCT00433511|6501516|P3|Step 2 (Arm D)|Suspected recurrence|1
1885196|NCT00433511|6501517|P2|Step 2 (Arm D)|Suspected recurrence|0
1885197|NCT00433511|6501518|P1|Step 2 (Arm D)|Suspected recurrence|0
1885198|NCT00433511|6501516|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
1885199|NCT00433511|6501517|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
1885200|NCT00433511|6501518|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
1885201|NCT00433511|6501516|P3|Step 2 (Arm D)|Other complicating disease|3
1885202|NCT00433511|6501517|P2|Step 2 (Arm D)|Other complicating disease|0
1885203|NCT00433511|6501518|P1|Step 2 (Arm D)|Other complicating disease|0
1885204|NCT00433511|6501516|P3|Step 2 (Arm D)|Disease progression, relapse|7
1885205|NCT00433511|6501517|P2|Step 2 (Arm D)|Disease progression, relapse|0
1885206|NCT00433511|6501518|P1|Step 2 (Arm D)|Disease progression, relapse|0
1885207|NCT00433511|6501516|P3|Step 2 (Arm D)|Physician Decision|9
1885208|NCT00433511|6501517|P2|Step 2 (Arm D)|Physician Decision|0
1885209|NCT00433511|6501518|P1|Step 2 (Arm D)|Physician Decision|0
1885210|NCT00433511|6501516|P3|Step 2 (Arm D)|Never started protocol therapy|148
1885211|NCT00433511|6501517|P2|Step 2 (Arm D)|Never started protocol therapy|0
1885212|NCT00433511|6501518|P1|Step 2 (Arm D)|Never started protocol therapy|0
1885213|NCT00433511|6501516|P3|Step 2 (Arm D)|Withdrawal by Subject|181
1885214|NCT00433511|6501517|P2|Step 2 (Arm D)|Withdrawal by Subject|0
1885215|NCT00433511|6501518|P1|Step 2 (Arm D)|Withdrawal by Subject|0
1885216|NCT00433511|6501516|P3|Step 2 (Arm D)|Adverse Event|135
1885217|NCT00433511|6501517|P2|Step 2 (Arm D)|Adverse Event|0
1885218|NCT00433511|6501518|P1|Step 2 (Arm D)|Adverse Event|0
1885219|NCT00433511|6501516|P3|Step 1|Patient moved|1
1885220|NCT00433511|6501517|P2|Step 1|Patient moved|0
1885221|NCT00433511|6501518|P1|Step 1|Patient moved|0
1885222|NCT00433511|6501516|P3|Step 1|Insurance/drug distribution issues|2
1885223|NCT00433511|6501517|P2|Step 1|Insurance/drug distribution issues|1
1885224|NCT00433511|6501518|P1|Step 1|Insurance/drug distribution issues|0
1885225|NCT00433511|6501516|P3|Step 1|Suspected recurrence|0
1885226|NCT00433511|6501517|P2|Step 1|Suspected recurrence|1
1885227|NCT00433511|6501518|P1|Step 1|Suspected recurrence|0
1885228|NCT00433511|6501516|P3|Step 1|Non-breast cancer surgery/wound issues|1
1885229|NCT00433511|6501517|P2|Step 1|Non-breast cancer surgery/wound issues|4
1885230|NCT00433511|6501518|P1|Step 1|Non-breast cancer surgery/wound issues|0
1885231|NCT00433511|6501516|P3|Step 1|Other complicating disease|3
1885232|NCT00433511|6501517|P2|Step 1|Other complicating disease|6
1885233|NCT00433511|6501518|P1|Step 1|Other complicating disease|2
1885234|NCT00433511|6501516|P3|Step 1|Disease progression, relapse|3
1885235|NCT00433511|6501517|P2|Step 1|Disease progression, relapse|3
1885236|NCT00433511|6501518|P1|Step 1|Disease progression, relapse|5
1885237|NCT00433511|6501516|P3|Step 1|Alternative therapy|3
1885238|NCT00433511|6501517|P2|Step 1|Alternative therapy|1
1885239|NCT00433511|6501518|P1|Step 1|Alternative therapy|2
1885240|NCT00433511|6501516|P3|Step 1|Never started protocol therapy|66
1885241|NCT00433511|6501517|P2|Step 1|Never started protocol therapy|64
1885242|NCT00433511|6501518|P1|Step 1|Never started protocol therapy|28
1885243|NCT00433511|6501516|P3|Step 1|Physician Decision|3
1885244|NCT00433511|6501517|P2|Step 1|Physician Decision|4
1885245|NCT00433511|6501518|P1|Step 1|Physician Decision|1
1885246|NCT00433511|6501516|P3|Step 1|Death|1
1885247|NCT00433511|6501517|P2|Step 1|Death|1
1885248|NCT00433511|6501518|P1|Step 1|Death|3
1885249|NCT00433511|6501516|P3|Step 1|Withdrawal by Subject|154
1885250|NCT00433511|6501517|P2|Step 1|Withdrawal by Subject|143
1885251|NCT00433511|6501518|P1|Step 1|Withdrawal by Subject|45
1885252|NCT00433511|6501516|P3|Step 1|Adverse Event|153
1885253|NCT00433511|6501517|P2|Step 1|Adverse Event|157
1885254|NCT00433511|6501518|P1|Step 1|Adverse Event|50
1885255|NCT00376688|6501532|P1|Overall Study|Death|1
1885256|NCT00376688|6501532|P1|Overall Study|Adverse Event|3
1885257|NCT00367458|6501538|P2|First Intervention - 8 Weeks|Adverse Event|0
1885258|NCT00367458|6501539|P1|First Intervention - 8 Weeks|Adverse Event|2
1885259|NCT00238420|6501569|P2|Overall Study|Protocol Violation|1
1885260|NCT00238420|6501570|P1|Overall Study|Protocol Violation|1
1885261|NCT00228917|6501588|P8|Overall Study|Migrated/moved from study area|0
1885262|NCT00228917|6501589|P7|Overall Study|Migrated/moved from study area|0
1885263|NCT00228917|6501590|P6|Overall Study|Migrated/moved from study area|2
1885264|NCT00228917|6501591|P5|Overall Study|Migrated/moved from study area|0
1885265|NCT00228917|6501592|P4|Overall Study|Migrated/moved from study area|0
1885266|NCT00228917|6501593|P3|Overall Study|Migrated/moved from study area|0
1885267|NCT00228917|6501594|P2|Overall Study|Migrated/moved from study area|0
1885268|NCT00228917|6501595|P1|Overall Study|Migrated/moved from study area|0
1885269|NCT00136604|6501707|P5|Overall Study|Migrated/moved from study area|0
1885270|NCT00136604|6501708|P4|Overall Study|Migrated/moved from study area|0
1885271|NCT00136604|6501709|P3|Overall Study|Migrated/moved from study area|0
1885272|NCT00136604|6501710|P2|Overall Study|Migrated/moved from study area|1
1885273|NCT00136604|6501711|P1|Overall Study|Migrated/moved from study area|0
1885274|NCT00136604|6501707|P5|Overall Study|Lost to Follow-up|1
1885275|NCT00136604|6501708|P4|Overall Study|Lost to Follow-up|0
1885276|NCT00136604|6501709|P3|Overall Study|Lost to Follow-up|0
1885277|NCT00136604|6501710|P2|Overall Study|Lost to Follow-up|0
1885278|NCT00136604|6501711|P1|Overall Study|Lost to Follow-up|1
1885279|NCT00081289|6501819|P2|Overall Study|Ineligible / no protocol treatment|4
1885280|NCT00081289|6501820|P1|Overall Study|Ineligible / no protocol treatment|3
1885281|NCT00081289|6501819|P2|Overall Study|Accrued prior to chemotherapy amendment|17
1885282|NCT00081289|6501820|P1|Overall Study|Accrued prior to chemotherapy amendment|18
1885283|NCT00078949|6501866|P4|Overall Study|No treated|3
1885284|NCT00078949|6501867|P3|Overall Study|No treated|3
1885285|NCT00078949|6501868|P2|Overall Study|No treated|5
1885286|NCT00078949|6501869|P1|Overall Study|No treated|4
